PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Goodson, JM; Weldy, CS; MacDonald, JW; Liu, YG; Bammler, TK; Chien, WM; Chin, MT				Goodson, Jamie M.; Weldy, Chad S.; MacDonald, James W.; Liu, Yonggang; Bammler, Theo K.; Chien, Wei-Ming; Chin, Michael T.			In utero exposure to diesel exhaust particulates is associated with an altered cardiac transcriptional response to transverse aortic constriction and altered DNA methylation	FASEB JOURNAL			English	Article						PM2.5; heart failure; miR133a-2; Ptprf; Pamr1	PROTEIN-TYROSINE-PHOSPHATASE; SHORT-TERM EXPOSURE; AIR-POLLUTION; CARDIOVASCULAR-DISEASE; SIGNAL-TRANSDUCTION; VASCULAR-RESPONSES; INSULIN-RECEPTOR; BLOOD-PRESSURE; HEART-FAILURE; HYPERTROPHY	In utero exposure to diesel exhaust air pollution has been associated with increased adult susceptibility to heart failure in mice, but the mechanisms by which this exposure promotes susceptibility to heart failure are poorly understood. To identify the potential transcriptional effects that mediate this susceptibility, we have performed RNA sequencing analysis on adult hearts from mice that were exposed to diesel exhaust in utero and that have subsequently undergone transverse aortic constriction. We identified 3 target genes, Mir133a-2, Ptprf, and Pamr1, which demonstrate dysregulation after exposure and aortic constriction. Examination of expression patterns in human heart tissues indicates a correlation between expression and heart failure. We subsequently assessed DNA methylation modifications at these candidate loci in neonatal cultured cardiac myocytes after in utero exposure to diesel exhaust and found that the promoter for Mir133a-2 is differentially methylated. These target genes in the heart are the first genes to be identified that likely play an important role inmediating adult sensitivity to heart failure. We have also shown a change in DNA methylation within cardiomyocytes as a result of in utero exposure to diesel exhaust.-Goodson, J. M., Weldy, C. S., MacDonald, J. W., Liu, Y., Bammler, T. K., Chien, W.-M., Chin, M. T. In utero exposure to diesel exhaust particulates is associated with an altered cardiac transcriptional response to transverse aortic constriction and altered DNA methylation.	[Goodson, Jamie M.; Weldy, Chad S.; Chin, Michael T.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Weldy, Chad S.; Liu, Yonggang; Chien, Wei-Ming; Chin, Michael T.] Univ Washington, Sch Med, Dept Med, Div Cardiol, Seattle, WA 98195 USA; [MacDonald, James W.; Bammler, Theo K.] Univ Washington, Sch Publ Hlth, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Chin, MT (corresponding author), Univ Washington, Sch Med, Ctr Cardiovasc Biol, Brotman 353,Box 358050,850 Republican St, Seattle, WA 98109 USA.	mtchin@u.washington.edu		Weldy, Chad/0000-0003-4652-6422; Goodson, Jamie/0000-0002-9091-8362	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences (NIEHS) Training Grant [T32 ES007032]; NIH National Heart, Lung, and Blood Institute Training Grant [T32 HL007312]; NIH NIEHS Grant [P30ES07033, ES023015]; American Heart Association [15GRNT25390012]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033, T32ES007032] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences (NIEHS) Training Grant; NIH National Heart, Lung, and Blood Institute Training Grant; NIH NIEHS Grant; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank James Stewart (University of Washington) for expert technical assistance with diesel exhaust exposures. J.M.G. was supported by U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences (NIEHS) Training Grant T32 ES007032. C.S.W. was supported by NIH National Heart, Lung, and Blood Institute Training Grant T32 HL007312. J.W.M. and T.K.B. were supported by NIH NIEHS Grant P30ES07033 to the University of Washington Center for Exposures, Diseases, Genomics and Environment (EDGE). M.T.C. was supported by NIH NIEHS Grant ES023015 and American Heart Association Grant 15GRNT25390012.	Ahmad F, 1997, J BIOL CHEM, V272, P448; Baccarelli A, 2009, AM J RESP CRIT CARE, V179, P572, DOI 10.1164/rccm.200807-1097OC; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brauer M, 2016, ENVIRON SCI TECHNOL, V50, P79, DOI 10.1021/acs.est.5b03709; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chagnon MJ, 2004, BIOCHEM CELL BIOL, V82, P664, DOI 10.1139/O04-120; Chen WS, 2012, ONCOL REP, V28, P1069, DOI 10.3892/or.2012.1899; Dakhlallah D, 2015, J CARDIOVASC PHARM, V65, P241, DOI 10.1097/FJC.0000000000000183; Drawnel FM, 2012, J CELL BIOL, V199, P783, DOI 10.1083/jcb.201111095; Feng H, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku154; Garcia R, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000211; Gilsbach R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6288; Gould T, 2008, INHAL TOXICOL, V20, P49, DOI [10.1080/08958370701758478, 10.1080/08958370701758478 ]; Greco S, 2012, DIABETES, V61, P1633, DOI 10.2337/db11-0952; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Hansen KD, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r83, 10.1186/gb-2012-13-10-R83]; He B, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-22; Huang LX, 2016, SCI REP-UK, V6, DOI 10.1038/srep20105; Janssen BG, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-22; Krishnan RM, 2012, J AM COLL CARDIOL, V60, P2158, DOI 10.1016/j.jacc.2012.08.973; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; KULAS DT, 1995, J BIOL CHEM, V270, P2435, DOI 10.1074/jbc.270.6.2435; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lewne M, 2007, ANN OCCUP HYG, V51, P693, DOI 10.1093/annhyg/mem046; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Liu N, 2011, J CLIN INVEST, V121, P3258, DOI 10.1172/JCI46267; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; LIU YG, 2013, PART FIBRE TOXICOL, V10; Liu YG, 2010, AM J PHYSIOL-HEART C, V298, pH2082, DOI 10.1152/ajpheart.00747.2009; Lo PHY, 2015, ONCOL REP, V33, P267, DOI 10.3892/or.2014.3581; Matkovich SJ, 2010, CIRC RES, V106, P166, DOI 10.1161/CIRCRESAHA.109.202176; Menzaghi C, 2008, J INTERN MED, V263, P653, DOI 10.1111/j.1365-2796.2008.01924.x; Nakayama Y, 2004, AM J PATHOL, V164, P1773, DOI 10.1016/S0002-9440(10)63735-2; Ni L, 2015, FRONT PHYSIOL, V6, DOI [10.3339/fphys.2015.00294, 10.3389/fphys.2015.00294]; Pope CA, 2006, CIRCULATION, V114, P2443, DOI 10.1161/CIRCULATIONAHA.106.636977; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Saenen ND, 2016, AM J EPIDEMIOL, V184, P442, DOI 10.1093/aje/kww007; Sharma PR, 2015, ENDOCRINOLOGY, V156, P3147, DOI 10.1210/en.2015-1203; Tarantini L, 2009, ENVIRON HEALTH PERSP, V117, P217, DOI 10.1289/ehp.11898; Tonks NK, 2013, FEBS J, V280, P346, DOI 10.1111/febs.12077; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; van den Hooven EH, 2012, ENVIRON HEALTH PERSP, V120, P150, DOI 10.1289/ehp.1003316; van Rossem L, 2015, ENVIRON HEALTH PERSP, V123, P353, DOI 10.1289/ehp.1307419; Wang Y, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000983; Wauters A, 2013, HYPERTENSION, V62, P352, DOI 10.1161/HYPERTENSIONAHA.111.00991; Weldy CS, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-59; Weldy CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088582; Weldy CS, 2013, INHAL TOXICOL, V25, P444, DOI 10.3109/08958378.2013.801004; Westerholm R, 2001, ENVIRON SCI TECHNOL, V35, P1748, DOI 10.1021/es000113i; Xiang F, 2006, AM J PHYSIOL-HEART C, V290, pH1997, DOI 10.1152/ajpheart.01106.2005; Yin F, 2013, ARTERIOSCL THROM VAS, V33, P1153, DOI 10.1161/ATVBAHA.112.300552; Zabolotny JM, 2001, P NATL ACAD SCI USA, V98, P5187, DOI 10.1073/pnas.071050398; Zhang WR, 1996, MOL ENDOCRINOL, V10, P575, DOI 10.1210/me.10.5.575; Zuo L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023116	58	15	17	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4935	4945		10.1096/fj.201700032R	http://dx.doi.org/10.1096/fj.201700032R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28751527	Green Published			2022-12-26	WOS:000413398500024
J	Ebert, M; Schweyen, P; Broring, M; Laass, S; Hartig, E; Jahn, D				Ebert, Matthias; Schweyen, Peter; Broering, Martin; Laass, Sebastian; Haertig, Elisabeth; Jahn, Dieter			Heme and nitric oxide binding by the transcriptional regulator DnrF from the marine bacterium Dinoroseobacter shibae increases napD promoter affinity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRATE RESPIRATION REGULATOR; GENE-EXPRESSION; PARACOCCUS-DENITRIFICANS; METABOLIC ADAPTATION; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; FNR; ACTIVATION; PROTEINS; OXYGEN	Under oxygen-limiting conditions, the marine bacterium Dinoroseobacter shibae DFL12(T) generates energy via denitrification, a respiratory process in which nitric oxide (NO) is an intermediate. Accumulation of NO may cause cytotoxic effects. The response to this nitrosative (NO-triggered) stress is controlled by the Crp/Fnr-type transcriptional regulator DnrF. We analyzed the response to NO and the mechanism of NO sensing by the DnrF regulator. Using reporter gene fusions and transcriptomics, here we report that DnrF selectively repressed nitrate reductase (nap) genes, preventing further NO formation. In addition, DnrF induced the expression of the NO reductase genes (norCB), which promote NO consumption. We used UV-visible and EPR spectroscopy to characterize heme binding to DnrF and subsequent NO coordination. DnrF detects NO via its bound heme cofactor. We found that the dimeric DnrF bound one molecule of heme per subunit. Purified recombinant apo-DnrF bound its target promoter sequences (napD, nosR2, norC, hemA, and dnrE) in electromobility shift assays, and we identified a specific palindromic DNA-binding site 5'-TTGATN4ATCAA-3' in these target sequences via mutagenesis studies. Most importantly, successive addition of heme as well as heme and NO to purified recombinant apo-DnrF protein increased affinity of the holo-DnrF for its specific binding motif in the napD promoter. On the basis of these results, we propose a model for the DnrF-mediated NO stress response of this marine bacterium.	[Ebert, Matthias; Haertig, Elisabeth] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, Spielmannstr 7, D-38106 Braunschweig, Germany; [Schweyen, Peter; Broering, Martin] Tech Univ Carolo Wilhelmina Braunschweig, Inst Inorgan & Analyt Chem, Hagenring 30, D-38106 Braunschweig, Germany; [Laass, Sebastian] Goethe Univ Frankfurt, Inst Mol Biosci, Max von Laue Str 9, D-60438 Frankfurt, Germany; [Jahn, Dieter] Tech Univ Carolo Wilhelmina Braunschweig, Braunschweig Integrated Ctr Syst Biol BRICS, Rebenring 56, D-38106 Braunschweig, Germany	Braunschweig University of Technology; Braunschweig University of Technology; Goethe University Frankfurt; Braunschweig University of Technology	Hartig, E (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, Spielmannstr 7, D-38106 Braunschweig, Germany.	e.haertig@tu-bs.de	Schweyen, Peter/AAP-5374-2020	Jahn, Dieter/0000-0002-4064-9205; Schweyen, Peter/0000-0003-3222-0502	Deutsche Forschungsgemeinschaft [TRR 51]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (TRR 51). The authors declare that they have no conflicts of interest with the contents of this article.	Aono S, 2012, ANTIOXID REDOX SIGN, V16, P678, DOI 10.1089/ars.2011.4248; ARAI H, 1995, FEBS LETT, V371, P73, DOI 10.1016/0014-5793(95)00885-D; Arai H, 2003, MICROBIOL-SGM, V149, P29, DOI 10.1099/mic.0.25936-0; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Biebl H, 2005, INT J SYST EVOL MICR, V55, P1089, DOI 10.1099/ijs.0.63511-0; Castiglione N, 2009, MICROBIOL-SGM, V155, P2838, DOI 10.1099/mic.0.028027-0; Cruz-Ramos H, 2002, EMBO J, V21, P3235, DOI 10.1093/emboj/cdf339; Cutruzzola F, 2014, BIOMETALS, V27, P763, DOI 10.1007/s10534-014-9770-3; Ebert M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00642; Ebert M, 2013, J BACTERIOL, V195, P4769, DOI 10.1128/JB.00860-13; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fleischhacker AS, 2011, CURR OPIN CHEM BIOL, V15, P335, DOI 10.1016/j.cbpa.2011.01.006; Giardina G, 2008, J MOL BIOL, V378, P1002, DOI 10.1016/j.jmb.2008.03.013; Giardina G, 2011, BIOCHEM SOC T, V39, P294, DOI 10.1042/BST0390294; Giardina G, 2009, PROTEINS, V77, P174, DOI 10.1002/prot.22428; Girvan HM, 2013, J BIOL CHEM, V288, P13194, DOI 10.1074/jbc.R112.422642; GREEN J, 1993, FEMS MICROBIOL LETT, V113, P219, DOI 10.1111/j.1574-6968.1993.tb06517.x; Green J, 2001, ADV MICROB PHYSIOL, V44, P1, DOI 10.1016/S0065-2911(01)44010-0; Green J, 1996, BIOCHEM J, V316, P887, DOI 10.1042/bj3160887; Hartig E, 2012, ADV MICROB PHYSIOL, V61, P195, DOI 10.1016/B978-0-12-394423-8.00005-6; Karnaukhova E, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00465; Kiley PJ, 1998, FEMS MICROBIOL REV, V22, P341, DOI 10.1111/j.1574-6976.1998.tb00375.x; KILEY PJ, 1991, J BACTERIOL, V173, P16, DOI 10.1128/jb.173.1.16-22.1991; Korner H, 2003, FEMS MICROBIOL REV, V27, P559, DOI 10.1016/S0168-6445(03)00066-4; Laass S, 2014, J BIOL CHEM, V289, P13219, DOI 10.1074/jbc.M113.545004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee YY, 2006, MICROBIOL-SGM, V152, P1461, DOI 10.1099/mic.0.28796-0; Leung V, 2012, J BACTERIOL, V194, P2265, DOI 10.1128/JB.06707-11; Lobato L, 2014, J BIOL CHEM, V289, P26514, DOI 10.1074/jbc.M114.571398; Moore CM, 2004, J BACTERIOL, V186, P4655, DOI 10.1128/JB.186.14.4655-4664.2004; Nakano MM, 2006, J BACTERIOL, V188, P5878, DOI 10.1128/JB.00486-06; Nakano MM, 2002, J BACTERIOL, V184, P1783, DOI 10.1128/JB.184.6.1783-1787.2002; Righetti P. G., 1990, IMMOBILIZED PH GRADI; Rinaldo S, 2012, ANTIOXID REDOX SIGN, V17, P1178, DOI 10.1089/ars.2011.4226; Rompf A, 1998, MOL MICROBIOL, V29, P985, DOI 10.1046/j.1365-2958.1998.00980.x; Sawai H, 2012, J BIOL CHEM, V287, P30755, DOI 10.1074/jbc.M112.370916; Schreiber K, 2007, J BACTERIOL, V189, P4310, DOI 10.1128/JB.00240-07; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; Stevanin TM, 2005, INFECT IMMUN, V73, P3322, DOI 10.1128/IAI.73.6.3322-3329.2005; Thoma S, 2009, FEMS MICROBIOL LETT, V294, P127, DOI 10.1111/j.1574-6968.2009.01556.x; Tomasch J, 2011, ISME J, V5, P1957, DOI 10.1038/ismej.2011.68; Tosques IE, 1996, J BACTERIOL, V178, P4958, DOI 10.1128/jb.178.16.4958-4964.1996; TRAGESER M, 1989, MOL MICROBIOL, V3, P593, DOI 10.1111/j.1365-2958.1989.tb00206.x; Trunk K, 2010, ENVIRON MICROBIOL, V12, P1719, DOI 10.1111/j.1462-2920.2010.02252.x; Van Spanning RJM, 1999, J BACTERIOL, V181, P4129, DOI 10.1128/JB.181.13.4129-4132.1999; VANSPANNING RJM, 1995, FEBS LETT, V360, P151, DOI 10.1016/0014-5793(95)00091-M; Vollack KU, 2001, J BACTERIOL, V183, P2516, DOI 10.1128/JB.183.8.2516-2526.2001; Wagner-Dobler I, 2010, ISME J, V4, P61, DOI 10.1038/ismej.2009.94; Weichsel A, 2005, P NATL ACAD SCI USA, V102, P594, DOI 10.1073/pnas.0406549102; WING HJ, 1995, J BACTERIOL, V177, P6704, DOI 10.1128/jb.177.23.6704-6710.1995; Yuki ET, 2008, BIOCHEMISTRY-US, V47, P13084, DOI 10.1021/bi801342x; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	52	8	9	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15468	15480		10.1074/jbc.M117.798728	http://dx.doi.org/10.1074/jbc.M117.798728			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28765283	Green Published, hybrid			2022-12-26	WOS:000410809800026
J	Brana, MT; Cimmarusti, MT; Haidukowski, M; Logrieco, AF; Altomare, C				Brana, Maria Teresa; Cimmarusti, Maria Teresa; Haidukowski, Miriam; Logrieco, Antonio Francesco; Altomare, Claudio			Bioremediation of aflatoxin B1-contaminated maize by king oyster mushroom (Pleurotus eryngii)	PLOS ONE			English	Article							CATALYTIC-PROPERTIES; PURIFICATION; ISOENZYMES; LACCASE; PRODUCT; FUNGI; B-1	Aflatoxin B1 (AFB(1)) is the most harmful mycotoxin that occurs as natural contaminant of agricultural commodities, particularly maize. Practical solutions for detoxification of contaminated staples and reduction of agricultural wastes are scarce. We investigated the capability of the white-rot and edible fungus Plerotus eryngii (king oyster mushroom) to degrade AFB(1) both in vitro and in a laboratory-scale mushroom cultivation, using a substrate similar to that routinely used in mushroom farms. In malt extract broth, degradation of AFB(1) (500 ng/mL) by nine isolates of P. eryngii ranged from 81 to 99% after 10 days growth, and reached 100% for all isolates after 30 days. The growth of P. eryngii on solid medium (malt extract-agar, MEA) was significantly reduced at concentrations of AFB(1) 500 ng/mL or higher. However, the addition of 5% wheat straw to the culture medium increased the tolerance of P. eryngii to AFB(1) and no inhibition was observed at a AFB(1) content of 500 ng/mL; degradation of AFB(1) in MEA supplemented with 5% wheat straw and 2.5% (w/v) maize flour was 71 - 94% after 30 days of growth. Further, AFB(1) degradation by P. eryngii strain ITEM 13681 was tested in a laboratory-scale mushroom cultivation. The mushroom growth medium contained 25% (w/w) of maize spiked with AFB(1) to the final content of 128 mu g/kg. Pleurotus eryngii degraded up to 86% of the AFB(1) in 28 days, with no significant reduction of either biological efficiency or mushroom yield. Neither the biomass produced on the mushroom substrate nor the mature basidiocarps contained detectable levels of AFB(1) or its metabolite aflatoxicol, thus ruling out the translocation of these toxins through the fungal thallus. These findings make a contribution towards the development of a novel technology for remediation of AFB(1)-contaminated corn through the exploitation of the degradative capability of P. eryngii and its bioconversion into high nutritional value material intended for feed production.	[Brana, Maria Teresa; Cimmarusti, Maria Teresa; Haidukowski, Miriam; Logrieco, Antonio Francesco; Altomare, Claudio] Natl Res Council Italy, Inst Sci Food Prod, Bari, Italy; [Cimmarusti, Maria Teresa] Univ Foggia, Dept Econ, Foggia, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Scienze delle Produzioni Alimentari (ISPA-CNR); University of Foggia	Logrieco, AF (corresponding author), Natl Res Council Italy, Inst Sci Food Prod, Bari, Italy.	antonio.logrieco@ispa.cnr.it	Altomare, Claudio/B-6495-2015; Haidukowski, Miriam/AAU-2538-2021; Branà, Maria Teresa/P-6874-2018	Altomare, Claudio/0000-0002-6975-6012; Branà, Maria Teresa/0000-0002-0878-9363; Logrieco, Antonio Francesco/0000-0002-8606-451X; CIMMARUSTI, MARIA TERESA/0000-0001-7399-3902	European Union's Horizon Research and innovation programme (MycoKey) [678781]	European Union's Horizon Research and innovation programme (MycoKey)	The present work has received funding by the European Union's Horizon2020 Research and innovation programme under Grant Agreement No.678781 (MycoKey). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The present work has received funding by the European Union's Horizon2020 Research and innovation programme under Grant Agreement No.678781 (MycoKey).	Alberts JF, 2009, INT J FOOD MICROBIOL; AOAC, 2000, 97122 AOAC; Basappa SC, 1996, J FOOD SCI TECH MYS, V33, P95; Bennett JW, 2003, CLIN MICROBIOL REV, V16, P497, DOI 10.1128/CMR.16.3.497-516.2003; Cullen J. M., 1993, The toxicology of aflatoxins: human health, veterinary and agricultural significance., P3; DETROY RW, 1970, CAN J BIOCHEM CELL B, V48, P830, DOI 10.1139/o70-130; Elisashvili V, 2009, J BIOTECHNOL; Estrada AER, 2009, BIORESOURCE TECHNOL; Fua ZH, 2008, J CHROMATOGR A, V1209, P271, DOI 10.1016/j.chroma.2008.09.054; Gao X, 2011, EUR FOOD RES TECHNOL, V232, P957, DOI 10.1007/s00217-011-1463-3; Hatakka A., 1994, FEMS MICROBIOL REV; Herzallah S, 2008, J APPL POULTRY RES; Hormisch D, 2004, SYST APPL MICROBIOL, V27, P653, DOI 10.1078/0723202042369866; INT AGCY RES CANC, 1993, IARC MONOG EVAL CARC, V56, P245; Kabak B, 2006, CRIT REV FOOD SCI, V46, P593, DOI 10.1080/10408390500436185; Loi M, 2016, TOXINS, V8, DOI 10.3390/toxins8090245; Martinez MJ, 1996, EUR J BIOCHEM, V237, P424, DOI 10.1111/j.1432-1033.1996.0424k.x; Mau J. L., 1998, J AGR FOOD CHEM; Mendez-Albores A, 2005, FOOD CHEM TOXICOL; MILLER JD, 1995, J STORED PROD RES, V31, P1, DOI 10.1016/0022-474X(94)00039-V; Mishra HN, 2003, CRIT REV FOOD SCI; Motomura M, 2003, MICROBIOL RES, V158, P237, DOI 10.1078/0944-5013-00199; Munoz C, 1997, APPL ENVIRON MICROB, V63, P2166; Munoz C, 1997, CURR MICROBIOL, V34, P1, DOI 10.1007/s002849900134; NAKAZATO M, 1990, APPL ENVIRON MICROB, V56, P1465, DOI 10.1128/AEM.56.5.1465-1470.1990; Petchkongkaew A, 2008, J APPL MICROBIOL, V104, P1495, DOI 10.1111/j.1365-2672.2007.03700.x; Pickard MA, 1999, APPL ENVIRON MICROB, V65, P3805; Piscitelli A, 2011, CURR GENOMICS; Rustom IY, 1997, FOOD CHEM; Sanchez C, 2010, APPL MICROBIOL BIOT; Tejada-Castaneda ZI, 2008, POULTRY SCI, V87, P1569, DOI 10.3382/ps.2007-00304; Topcu A, 2010, INT J FOOD MICROBIOL; Vanhoutte I, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00561; Villani A, 2015, SYDOWIA; Williams JH, 2004, AM J CLIN NUTR, V80, P1106, DOI 10.1093/ajcn/80.5.1106; Yehia RS, 2014, BRAZ J MICROBIOL, V45, P127, DOI 10.1590/S1517-83822014005000026	36	21	23	4	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182574	10.1371/journal.pone.0182574	http://dx.doi.org/10.1371/journal.pone.0182574			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771640	gold, Green Submitted, Green Published			2022-12-26	WOS:000406853600143
J	De Riva, A; Wallberg, M; Ronchi, F; Coulson, R; Sage, A; Thorne, L; Goodfellow, I; McCoy, KD; Azuma, M; Cooke, A; Busch, R				De Riva, Alessandra; Wallberg, Maja; Ronchi, Francesca; Coulson, Richard; Sage, Andrew; Thorne, Lucy; Goodfellow, Ian; McCoy, Kathy D.; Azuma, Miyuki; Cooke, Anne; Busch, Robert			Regulation of type 1 diabetes development and B-cell activation in nonobese diabetic mice by early life exposure to a diabetogenic environment	PLOS ONE			English	Article							T-CELL; GUT MICROBIOTA; NOD MOUSE; INTESTINAL MICROBIOTA; LYMPHOCYTE DEPLETION; AUTOIMMUNE-DISEASE; RABBIT COLONIES; BOWEL-DISEASE; PD-1 PATHWAY; IN-VIVO	Microbes, including viruses, influence type 1 diabetes (T1D) development, but many such influences remain undefined. Previous work on underlying immune mechanisms has focussed on cytokines and T cells. Here, we compared two nonobese diabetic (NOD) mouse colonies, NODlow and NODhigh, differing markedly in their cumulative T1D incidence (22% vs. 90% by 30 weeks in females). NODhigh mice harbored more complex intestinal microbiota, including several pathobionts; both colonies harbored segmented filamentous bacteria (SFB), thought to suppress T1D. Young NODhigh females had increased B-cell activation in their mesenteric lymph nodes. These phenotypes were transmissible. Co-housing of NODlow with NODhigh mice after weaning did not change T1D development, but T1D incidence was increased in female offspring of co-housed NODlow mice, which were exposed to the NODhigh environment both before and after weaning. These offspring also acquired microbiota and B-cell activation approaching those of NODhigh mice. In NODlow females, the low rate of T1D was unaffected by cyclophosphamide but increased by PD-L1 blockade. Thus, environmental exposures that are innocuous later in life may promote T1D progression if acquired early during immune development, possibly by altering B-cell activation and/or PD-L1 function. Moreover, T1D suppression in NOD mice by SFB may depend on the presence of other microbial influences. The complexity of microbial immune regulation revealed in this murine model may also be relevant to the environmental regulation of human T1D.	[De Riva, Alessandra; Coulson, Richard; Sage, Andrew; Busch, Robert] Univ Cambridge, Dept Med, Cambridge, England; [Wallberg, Maja; Thorne, Lucy; Goodfellow, Ian; Cooke, Anne] Univ Cambridge, Dept Pathol, Cambridge, England; [Ronchi, Francesca; McCoy, Kathy D.] Univ Bern, Univ Klin Viszerale Chirurg & Med Inselspital, Maurice Muller Labs DKF, Bern, Switzerland; [Azuma, Miyuki] Tokyo Med & Dent Univ, Grad Sch, Dept Mol Immunol, Tokyo, Japan; [Busch, Robert] Univ Roehampton, Dept Life Sci, London, England	University of Cambridge; University of Cambridge; University of Bern; University Hospital of Bern; Tokyo Medical & Dental University (TMDU); Roehampton University	De Riva, A; Busch, R (corresponding author), Univ Cambridge, Dept Med, Cambridge, England.; Busch, R (corresponding author), Univ Roehampton, Dept Life Sci, London, England.	alessandra.de.riva@cantab.net; robert.busch@roehampton.ac.uk	McCoy, Kathy/ABD-5814-2021; Cooke, Anne/S-4763-2019; Azuma, Miyuki/AAT-8928-2021	Cooke, Anne/0000-0003-3327-6081; Azuma, Miyuki/0000-0002-3529-4585; Sage, Andrew/0000-0001-7255-3497; Ronchi, Francesca/0000-0002-2035-6528; Goodfellow, Ian/0000-0002-9483-510X; Busch, Robert/0000-0002-4132-0751	Arthritis Research UK [18543, 20648]; National Centre [NC/M001083/1]; Cambridge NIHR BRC Cell Phenotyping Hub; Diabetes UK; British Heart Foundation [FS/15/57/31557] Funding Source: researchfish; Versus Arthritis [20648] Funding Source: researchfish; National Centre for the Replacement [NC/M001083/1] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); National Centre; Cambridge NIHR BRC Cell Phenotyping Hub; Diabetes UK(Diabetes UK); British Heart Foundation(British Heart Foundation); Versus Arthritis(Versus Arthritis); National Centre for the Replacement	This work was funded by Arthritis Research UK (http://www.arthritisresearchuk.org/, ref. 18543 and 20648, to R.B.) with contributions from Diabetes UK (https://www.diabetes.org.uk/,, ref. 12/0004572, to R.B. and A.D.R.). M.W. was funded by the National Centre for the 3Rs (https://www.nc3rs.org.uk/, ref. NC/M001083/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank Lisa Wright and Lucy Tredgett for animal husbandry and maintenance; Mike Bacon for DNA extractions; Dr Sarah Howlett and Professor Linda Wicker for NOD<SUP>low</SUP> founders, and the excellent support staff at the two animal facilities used. We are grateful for excellent flow cytometry support from the Cambridge NIHR BRC Cell Phenotyping Hub. We appreciate the helpful suggestions of the reviewers and editors in regard to the literature on B-cell autoimmunity.	Alam C, 2011, DIABETOLOGIA, V54, P1398, DOI 10.1007/s00125-011-2097-5; Alkanani AK, 2015, DIABETES, V64, P3510, DOI 10.2337/db14-1847; Ansari MJI, 2003, J EXP MED, V198, P63, DOI 10.1084/jem.20022125; Atkinson MA, 1999, NAT MED, V5, P601, DOI 10.1038/9442; Banday VS, 2016, IMMUNOLOGY, V149, P297, DOI 10.1111/imm.12651; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Ben Nasr M, 2015, PHARMACOL RES, V98, P31, DOI 10.1016/j.phrs.2014.07.004; Brode S, 2006, J IMMUNOL, V177, P6603, DOI 10.4049/jimmunol.177.10.6603; Brodie GM, 2008, DIABETES, V57, P909, DOI 10.2337/db07-1256; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cooke A, 2009, IMMUNOLOGY, V126, P12, DOI 10.1111/j.1365-2567.2008.03009.x; de Goffau MC, 2014, DIABETOLOGIA, V57, P1569, DOI 10.1007/s00125-014-3274-0; De Riva A, 2013, J IMMUNOL, V190, P5961, DOI 10.4049/jimmunol.1300551; Denman SE, 2006, FEMS MICROBIOL ECOL, V58, P572, DOI 10.1111/j.1574-6941.2006.00190.x; EBINO KY, 1988, LAB ANIM, V22, P1, DOI 10.1258/002367788780746548; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; El-Sheikh A, 1999, J AUTOIMMUN, V12, P109, DOI 10.1006/jaut.1998.0264; Endesfelder D, 2014, DIABETES, V63, P2006, DOI 10.2337/db13-1676; Mejia-Leon ME, 2014, SCI REP-UK, V4, DOI 10.1038/srep03814; Feng SL, 2005, CLIN DIAGN LAB IMMUN, V12, P531, DOI 10.1128/CDLI.12.4.531-536.2005; Fife BT, 2006, J EXP MED, V203, P2737, DOI 10.1084/jem.20061577; Fiorina P, 2008, DIABETES, V57, P3013, DOI 10.2337/db08-0420; Fiorina Paolo, 2009, F1000 Biol Rep, V1, P39, DOI 10.3410/B1-39; Foltz CJ, 1998, HELICOBACTER, V3, P69, DOI 10.1046/j.1523-5378.1998.08006.x; Fox JG, 1997, LAB ANIM SCI, V47, P222; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Gower JC, 2005, PRINCIPAL COORDINATE; GREENWOO.BM, 1968, LANCET, V2, P573; GREENWOOD BM, 1970, NATURE, V226, P266, DOI 10.1038/226266a0; Guleria I, 2007, CLIN IMMUNOL, V125, P16, DOI 10.1016/j.clim.2007.05.013; Gupta S, 2016, THER ADV GASTROENTER, V9, P229, DOI 10.1177/1756283X15607414; Hansen CHF, 2012, DIABETOLOGIA, V55, P2285, DOI 10.1007/s00125-012-2564-7; HARADA M, 1987, EXP CLIN ENDOCRINOL, V89, P251, DOI 10.1055/s-0029-1210647; Hinman RM, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0543-8; Hinman RM, 2014, IMMUNOL LETT, V160, P128, DOI 10.1016/j.imlet.2014.01.010; Holodniy M, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014764, 10.1371/journal.pone.0025792]; HUTCHINGS PR, 1990, J AUTOIMMUN, V3, P175, DOI 10.1016/0896-8411(90)90139-J; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; King C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017049; Kleffel S, 2015, DIABETES, V64, P158, DOI 10.2337/db13-1639; Kostic AD, 2015, CELL HOST MICROBE, V17, P260, DOI 10.1016/j.chom.2015.01.001; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; Kullberg MC, 1998, INFECT IMMUN, V66, P5157, DOI 10.1128/IAI.66.11.5157-5166.1998; Larsson PG, 2015, DIABETOLOGIA, V58, P346, DOI 10.1007/s00125-014-3436-0; Lehuen A, 2010, NAT REV IMMUNOL, V10, P501, DOI 10.1038/nri2787; LEITER EH, 1987, AM J PATHOL, V128, P380; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Mahler M, 2014, LAB ANIM-UK, V48, P178, DOI 10.1177/0023677213516312; Makino S, 1980, Jikken Dobutsu, V29, P1; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Mauri C, 2010, NAT REV RHEUMATOL, V6, P636, DOI 10.1038/nrrheum.2010.140; McCall KD, 2015, ENDOCRINOLOGY, V156, P453, DOI 10.1210/en.2013-2006; MILLER BJ, 1988, J IMMUNOL, V140, P52; Miller PG, 2015, J IMMUNOL, V195, P4668, DOI 10.4049/jimmunol.1501664; Newland SA, 2011, EUR J IMMUNOL, V41, P2966, DOI 10.1002/eji.201141544; Ng LG, 2004, J IMMUNOL, V173, P807, DOI 10.4049/jimmunol.173.2.807; Nicklas W, 2002, LAB ANIM-UK, V36, P20, DOI 10.1258/0023677021911740; Pane JA, 2014, VIRUS RES, V179, P73, DOI 10.1016/j.virusres.2013.11.009; Patterson CC, 2012, DIABETOLOGIA, V55, P2142, DOI 10.1007/s00125-012-2571-8; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Peng J, 2014, J AUTOIMMUN, V53, P85, DOI 10.1016/j.jaut.2014.03.005; Pescovitz MD, 2014, DIABETES CARE, V37, P453, DOI 10.2337/dc13-0626; POZZILLI P, 1993, IMMUNOL TODAY, V14, P193, DOI 10.1016/0167-5699(93)90160-M; Quinn WJ, 2006, J IMMUNOL, V176, P7159, DOI 10.4049/jimmunol.176.12.7159; Redondo MJ, 2001, DIABETOLOGIA, V44, P354, DOI 10.1007/s001250051626; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Serreze DV, 1996, J EXP MED, V184, P2049, DOI 10.1084/jem.184.5.2049; SOAVE O, 1991, CORNELL VET, V81, P357; Sofi MH, 2014, DIABETES, V63, P632, DOI 10.2337/db13-0981; Song-Zhao GX, 2014, METHODS MOL BIOL, V1193, P199, DOI 10.1007/978-1-4939-1212-4_18; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Thompson CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010335; Tormo-Badia N, 2014, SCAND J IMMUNOL, V80, P250, DOI 10.1111/sji.12205; Tyler AD, 2014, AM J GASTROENTEROL, V109, P983, DOI 10.1038/ajg.2014.73; Ward JM, 1996, LAB ANIM SCI, V46, P15; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; WICKER LS, 1987, J EXP MED, V165, P1639, DOI 10.1084/jem.165.6.1639; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Xiu Y, 2008, J IMMUNOL, V180, P2863, DOI 10.4049/jimmunol.180.5.2863; Zaccone P, 2004, EUR J IMMUNOL, V34, P3246, DOI 10.1002/eji.200425285; Zekavat G, 2008, J IMMUNOL, V181, P8133, DOI 10.4049/jimmunol.181.11.8133	81	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0181964	10.1371/journal.pone.0181964	http://dx.doi.org/10.1371/journal.pone.0181964			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771521	gold, Green Published, Green Submitted			2022-12-26	WOS:000406853600049
J	Kor-anantakul, O; Suntharasaj, T; Suwanrath, C; Hanprasertpong, T; Pranpanus, S; Pruksanusak, N; Janwadee, S; Geater, A				Kor-anantakul, Ounjai; Suntharasaj, Thitima; Suwanrath, Chitkasaem; Hanprasertpong, Tharangrut; Pranpanus, Savitree; Pruksanusak, Ninlapa; Janwadee, Suthiraporn; Geater, Alan			Normative weight-adjusted models for the median levels of first trimester serum biomarkers for trisomy 21 screening in a specific ethnicity	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; FREE BETA-HCG; DOWN-SYNDROME; PLASMA-PROTEIN; PAPP-A; 1ST-TRIMESTER; PREGNANCY; MULTICENTER; IMPACT	Objective To establish normative weight-adjusted models for the median levels of first trimester serum biomarkers for trisomy 21 screening in southern Thai women, and to compare these reference levels with Caucasian-specific and northern Thai models. Methods A cross-sectional study was conducted in 1,150 normal singleton pregnancy women to determine serum pregnancy-associated plasma protein-A (PAPP-A) and free beta-human chorionic gonadotropin (beta-hCG) concentrations in women from southern Thailand. The predicted median values were compared with published equations for Caucasians and northern Thai women. Results The best-fitting regression equations for the expected median serum levels of PAPP-A (mIU/L) and free beta-hCG (ng/mL) according to maternal weight (Wt in kg) and gestational age (GA in days) were: median PAPP - A = e([8.4454 - 0.01950 (Wt-55)+ 0.05747 (GA-87)]), and median free beta - hCG = e([3.6409 - 0.01703 (Wt-55)- 0.03345 (GA-87)]). Both equations were selected with a statistically significant contribution (p< 0.05). Compared with the Caucasian model, the median values of PAPP-A were higher and the median values of free beta-hCG were lower in the southern Thai women. And compared with the northern Thai models, the median values of both biomarkers were lower in southern Thai women. Conclusion The study has successfully developed maternal-weight-and gestational-age-adjusted median normative models to convert the PAPP-A and free beta-hCG levels into their Multiple of Median equivalents in southern Thai women. These models confirmed ethnic differences.	[Kor-anantakul, Ounjai; Suntharasaj, Thitima; Suwanrath, Chitkasaem; Hanprasertpong, Tharangrut; Pranpanus, Savitree; Pruksanusak, Ninlapa; Janwadee, Suthiraporn] Prince Songkla Univ, Dept Obstet & Gynaecol, Fac Med, Hat Yai, Songkhla, Thailand; [Geater, Alan] Prince Songkla Univ, Epidemiol Unit2, Fac Med, Hat Yai, Songkhla, Thailand	Prince of Songkla University; Prince of Songkla University	Kor-anantakul, O (corresponding author), Prince Songkla Univ, Dept Obstet & Gynaecol, Fac Med, Hat Yai, Songkhla, Thailand.	ounjai.k@gmail.com	Suwanrath, Chitkasaem/ABC-5631-2020		Faculty of Medicine, Prince of Songkla University [EC 53-096-12-1-2]	Faculty of Medicine, Prince of Songkla University	This research project was supported by a grant from the Faculty of Medicine, Prince of Songkla University through contract no EC 53-096-12-1-2. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Huang TH, 2013, PRENATAL DIAG, V33, P471, DOI 10.1002/pd.4090; Kagan KO, 2008, ULTRASOUND OBST GYN, V31, P493, DOI 10.1002/uog.5332; Kor-anantakul O, 2011, GYNECOL OBSTET INVES, V71, P124, DOI 10.1159/000320754; Krantz DA, 1996, AM J OBSTET GYNECOL, V174, P612, DOI 10.1016/S0002-9378(96)70436-2; Leung TY, 2007, ULTRASOUND OBST GYN, V29, P14, DOI 10.1002/uog.3893; Leung TY, 2006, FETAL DIAGN THER, V21, P140, DOI 10.1159/000089064; Luewan S, 2012, INT J GYNECOL OBSTET, V117, P140, DOI 10.1016/j.ijgo.2011.11.026; Malone FD, 2005, NEW ENGL J MED, V353, P2001, DOI 10.1056/NEJMoa043693; Manotaya S, 2015, PRENATAL DIAG, V35, P735, DOI 10.1002/pd.4602; Nicolaides KH, 2011, PRENATAL DIAG, V31, P7, DOI 10.1002/pd.2637; Spencer K, 2003, PRENATAL DIAG, V23, P851, DOI 10.1002/pd.708; Spencer K, 2000, PRENATAL DIAG, V20, P491, DOI 10.1002/1097-0223(200006)20:6<491::AID-PD844>3.0.CO;2-3; Wright D, 2010, ULTRASOUND OBST GYN, V36, P404, DOI 10.1002/uog.7755	13	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182538	10.1371/journal.pone.0182538	http://dx.doi.org/10.1371/journal.pone.0182538			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771606	gold, Green Published, Green Submitted			2022-12-26	WOS:000406853600137
J	Nagase, H; Yao, SH; Ikeda, S				Nagase, Hiroki; Yao, Shuhei; Ikeda, Shota			Acute and chronic effects of exercise on mRNA expression in the skeletal muscle of two mouse models of peripheral artery disease	PLOS ONE			English	Article							GENE-EXPRESSION; INTERLEUKIN-6; METABOLISM; REGULATORS	Endurance exercise improves walking performance in patients with peripheral artery disease (PAD), which is characterized by skeletal muscle dysfunction caused by lower extremity ischemia. Although transcriptional analyses of exercise-induced changes in normal animals and healthy volunteers have been reported, no detailed study has explored exercise-induced alterations in gene expression in PAD animal models. Here, we determined the acute and chronic effects of exercise on mRNA expression in the skeletal muscles of two mouse models of PAD. Three particular gene categories were investigated: known exercise-responsive genes (Pgc1a, Il6, Nr4a1, Nr4a2, and Nr4a3); myogenic and muscle regeneration-related genes (Myf5, Myogenin, Myomaker, and Myh3); and Gpr56 and its ligand Col3a1. PAD was induced by bilateral femoral artery ligation in normal C57BL/6 and diabetic KK-A(y) mice. From 1 week after surgery, repetitive twice-weekly 30-min treadmill endurance exercise sessions were applied. Altered mRNA expression in the soleus muscles was measured in both the acute and chronic phases. In the acute phase, transcript levels of exercise-inducible genes showed significant increases in both C57BL/6 and diabetic KK-A(y) PAD mice; levels of regeneration-related genes showed little alteration, and those of Gpr56 increased immediately and significantly after exercise in both models. In the chronic phase, transcript levels of Pgc1a, Myf5, Myogenin, Myomaker, Myh3, Gpr56, and Col3a1 were upregulated significantly in sedentary C57BL/6 PAD mice compared with that in sham-operated mice. Exercise training inhibited the upregulation of Col3a1, Myf5, and Myogenin significantly. In KK-A(y) PAD mice, only Gpr56 mRNA levels increased significantly compared with those in sham-operated mice. RNA sequence analysis revealed 33 and 166 differentially upregulated, and 363 and 99 downregulated, genes after exercise training in C57BL/6 PAD and KK-A(y) PAD mice, respectively. In summary, we detected significant alterations of skeletal muscle genes after exercise in PAD mouse models and characterized their expression patterns.	[Nagase, Hiroki; Ikeda, Shota] Takeda Pharmaceut Co Ltd, Pharmaceut Res Div, Cardiovasc & Metab Drug Discovery Unit, Fujisawa, Kanagawa, Japan; [Yao, Shuhei] Takeda Pharmaceut Co Ltd, Pharmaceut Res Div, Integrated Technol Res Labs, Fujisawa, Kanagawa, Japan	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd	Ikeda, S (corresponding author), Takeda Pharmaceut Co Ltd, Pharmaceut Res Div, Cardiovasc & Metab Drug Discovery Unit, Fujisawa, Kanagawa, Japan.	shota.ikeda.0001@gmail.com		Ikeda, Shota/0000-0003-1358-524X	Takeda Pharmaceutical Company Ltd.	Takeda Pharmaceutical Company Ltd.(Takeda Pharmaceutical Company Ltd)	The authors have performed this work as paid employees of Takeda Pharmaceutical Company Ltd. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragno M, 2004, DIABETES, V53, P1082, DOI 10.2337/diabetes.53.4.1082; Belch J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1840; Bianchi L, 2016, ACTA DIABETOL, V53, P879, DOI 10.1007/s00592-016-0880-y; Catoire M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051066; Criqui MH, 2015, CIRC RES, V116, P1509, DOI 10.1161/CIRCRESAHA.116.303849; D'Souza DM, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00379; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Fokkenrood HJP, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005263.pub3; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Gopinath SD, 2008, AGING CELL, V7, P590, DOI 10.1111/j.1474-9726.2008.00399.x; He S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167305; Hiatt WR, 2015, CIRC RES, V116, P1527, DOI 10.1161/CIRCRESAHA.116.303566; HIATT WR, 1994, CIRCULATION, V90, P1866, DOI 10.1161/01.CIR.90.4.1866; Hiatt WR, 1985, J APPL PHYSL 1985, V1996, P780; Lotfi S, 2013, ATHEROSCLEROSIS, V227, P1, DOI 10.1016/j.atherosclerosis.2012.10.060; Mahoney DJ, 2005, FASEB J, V19, P1498, DOI 10.1096/fj.04-3149fje; McKay BR, 2013, AM J PHYSIOL-CELL PH, V304, pC717, DOI 10.1152/ajpcell.00305.2012; Morimoto Y, 2011, J ATHEROSCLER THROMB, V18, P200, DOI 10.5551/jat.6437; Munoz-Canoves P, 2013, FEBS J, V280, P4131, DOI 10.1111/febs.12338; Murphy TP, 2012, CIRCULATION, V125, P130, DOI 10.1161/CIRCULATIONAHA.111.075770; Norheim F, 2014, FEBS J, V281, P739, DOI 10.1111/febs.12619; Pal M, 2014, IMMUNOL CELL BIOL, V92, P331, DOI 10.1038/icb.2014.16; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Sala D, 2015, CELL MOL LIFE SCI, V72, P3803, DOI 10.1007/s00018-015-1954-7; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Stewart KJ, 2002, NEW ENGL J MED, V347, P1941, DOI 10.1056/NEJMra021135; Sugo T, 2016, J CONTROL RELEASE, V237, P1, DOI 10.1016/j.jconrel.2016.06.036; Toth KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017392; White JP, 2014, P NATL ACAD SCI USA, V111, P15756, DOI 10.1073/pnas.1417898111; Yang YF, 2005, J APPL PHYSIOL, V98, P1745, DOI 10.1152/japplphysiol.01185.2004; Zhao Y, 2010, ARTERIOSCL THROM VAS, V30, P1535, DOI 10.1161/ATVBAHA.109.191163	32	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182456	10.1371/journal.pone.0182456	http://dx.doi.org/10.1371/journal.pone.0182456			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771574	Green Published, gold, Green Submitted			2022-12-26	WOS:000406853600118
J	Tuersunjiang, N; Odhiambo, JF; Shasa, DR; Smith, AM; Nathanielsz, PW; Ford, SP				Tuersunjiang, Nuermaimaiti; Odhiambo, John F.; Shasa, Desiree R.; Smith, Ashley M.; Nathanielsz, Peter W.; Ford, Stephen P.			Maternal obesity programs reduced leptin signaling in the pituitary and altered GH/IGF1 axis function leading to increased adiposity in adult sheep offspring	PLOS ONE			English	Article							GROWTH-FACTOR-I; REGULATING GH OUTPUT; INSULIN-RESISTANCE; POSTNATAL LEPTIN; GENE-EXPRESSION; IGF-I; HORMONE; RECEPTOR; HYPERTENSION; METABOLISM	Studies in rodents highlight a role for leptin in stimulation of pituitary growth hormone (GH) secretion, with an impact on body composition regulation. We have reported that maternal obesity (MO) during ovine pregnancy results in hyperphagia, glucose-insulin dysregulation, increased adiposity, hypercortisolemia and hyperleptinemia in mature offspring subjected to a bout of ad libitum feeding. We hypothesized that MO reduces leptin signaling in the pituitary and down regulates the GH/IGF1 axis and increases circulating cortisol leading to increased adiposity in their adult offspring. Male lambs born to MO (n = 6) or control (CON, n = 6) ewes were fed only to requirements until placed on a 12 week ad libitum feeding trial at maturity. The pituitary, hypothalamic arcuate nucleus, and liver were collected at necropsy and mRNA and protein expression determined. Plasma cortisol concentrations were increased (P<0.05) in MO vs. CON offspring at the end of the feeding trial. Further, serum concentrations of IGF1 decreased (P<0.01) and GH tended to decrease (P<0.08) in MO vs. CON offspring. Pituitary mRNA and leptin receptor protein expression were decreased in MO vs. CON offspring in association with decreased GH mRNA expression, and decreased IGF1 mRNA and protein expression in liver. Liver 11 beta-hydroxysteroid dehydrogenase 1 (11 beta HSD1) expression was increased (P<0.01) and its cofactor hexose-6-phosphate dehydrogenase tended to increase (P<0.06) in MO vs. CON offspring. 11 beta HSD2 expression remained unchanged. These data indicate that MO induced an increase in liver conversion of cortisone to cortisol in adult offspring and support a role for leptin signaling in the pituitary in mediating offspring adiposity.	[Tuersunjiang, Nuermaimaiti; Odhiambo, John F.; Shasa, Desiree R.; Smith, Ashley M.; Nathanielsz, Peter W.; Ford, Stephen P.] Univ Wyoming, Dept Anim Sci, Ctr Study Fetal Programming, Laramie, WY 82071 USA; [Tuersunjiang, Nuermaimaiti] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA	University of Wyoming; University of California System; University of California Irvine	Ford, SP (corresponding author), Univ Wyoming, Dept Anim Sci, Ctr Study Fetal Programming, Laramie, WY 82071 USA.	spford@uwyo.edu	odhiambo, john/AAC-2444-2020; Smith, Ashley/GZB-0298-2022	odhiambo, john/0000-0002-1005-3486; Nathanielsz, Peter/0000-0001-8410-6280	University of Wyoming National Institutes of Health (NIH) INBRE [P20 RR016474]; NIH [1 R01 HD070096-01A1]	University of Wyoming National Institutes of Health (NIH) INBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the University of Wyoming National Institutes of Health (NIH) Grant INBRE #P20 RR016474 and NIH Grant 1 R01 HD070096-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abs R, 2013, EUR J ENDOCRINOL, V168, P297, DOI 10.1530/EJE-12-0807; Agha A, 2007, CLIN ENDOCRINOL, V66, P459, DOI 10.1111/j.1365-2265.2007.02763.x; Ahima RS, 1998, J CLIN INVEST, V101, P1020, DOI 10.1172/JCI1176; Allensworth-James ML, 2015, ENDOCRINOLOGY, V156, P3253, DOI 10.1210/EN.2015-1198; Alvarez P, 2002, CLIN ENDOCRINOL, V56, P487, DOI 10.1046/j.1365-2265.2002.01487.x; Asada N, 2000, MOL CELL ENDOCRINOL, V162, P121, DOI 10.1016/S0303-7207(00)00202-1; Attig L, 2011, ORGANOGENESIS, V7, P88, DOI 10.4161/org.7.2.14871; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; BLUM WF, 1990, ACTA PAEDIATR SCAND, P55; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Bredella MA, 2012, EUR J ENDOCRINOL, V166, P601, DOI 10.1530/EJE-11-1068; Breier BH, 1999, DOMEST ANIM ENDOCRIN, V17, P209, DOI 10.1016/S0739-7240(99)00038-7; Cai AH, 1999, ENDOCRINOLOGY, V140, P3609, DOI 10.1210/en.140.8.3609; Catalano PM, 2009, DIABETES CARE, V32, P1076, DOI 10.2337/dc08-2077; CEDA GP, 1987, ENDOCRINOLOGY, V120, P1658, DOI 10.1210/endo-120-4-1658; Childs GV, 2011, ENDOCRINOLOGY, V152, P69, DOI 10.1210/en.2010-0498; Djurhuus CB, 2004, AM J PHYSIOL-ENDOC M, V286, pE488, DOI 10.1152/ajpendo.00199.2003; Dunger DB, 1997, DIABETIC MED, V14, P723, DOI 10.1002/(SICI)1096-9136(199709)14:9<723::AID-DIA480>3.0.CO;2-S; Fernandez-Twinn DS, 2006, PHYSIOL BEHAV, V88, P234, DOI 10.1016/j.physbeh.2006.05.039; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Ford SP, 2009, AM J PHYSIOL-REG I, V297, pR835, DOI 10.1152/ajpregu.00072.2009; Guo CM, 2013, DIABETES, V62, P1175, DOI 10.2337/db12-0561; HOEFLER WC, 1987, THERIOGENOLOGY, V27, P887, DOI 10.1016/0093-691X(87)90210-X; Iqbal J, 2000, ENDOCRINOLOGY, V141, P1515, DOI 10.1210/en.141.4.1515; Isozaki Osamu, 1999, Endocrine Journal, V46, pS17, DOI 10.1507/endocrj.46.Suppl_S17; Jin L, 2000, ENDOCRINOLOGY, V141, P333, DOI 10.1210/en.141.1.333; Kershaw EE, 2005, DIABETES, V54, P1023, DOI 10.2337/diabetes.54.4.1023; Lloyd R V, 2001, Pituitary, V4, P33, DOI 10.1023/A:1012982626401; Long NM, 2010, J ANIM SCI, V88, P3546, DOI 10.2527/jas.2010-3083; Long NM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122152; Long NM, 2011, J PHYSIOL-LONDON, V589, P1455, DOI 10.1113/jphysiol.2010.201681; Luque RM, 2008, MOL CELL ENDOCRINOL, V286, P155, DOI 10.1016/j.mce.2007.12.005; Luque RM, 2011, ANN NY ACAD SCI, V1220, P82, DOI 10.1111/j.1749-6632.2010.05913.x; Ma Y, 2010, AM J PHYSIOL-REG I, V299, pR249, DOI 10.1152/ajpregu.00498.2009; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Mauras N, 2000, J CLIN ENDOCR METAB, V85, P1686, DOI 10.1210/jc.85.4.1686; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; McGarry JD, 1995, CURR BIOL, V5, P1342, DOI 10.1016/S0960-9822(95)00264-8; McMillen IC, 2006, REPRODUCTION, V131, P415, DOI 10.1530/rep.1.00303; Mercer JG, 1998, REGUL PEPTIDES, V75-6, P271, DOI 10.1016/S0167-0115(98)00078-0; Misra M, 2008, AM J PHYSIOL-ENDOC M, V295, pE385, DOI 10.1152/ajpendo.00052.2008; Monson JP, 2003, EUR J ENDOCRINOL, V148, pS9, DOI 10.1530/eje.0.148S009; Moore JS, 1999, J CLIN ENDOCR METAB, V84, P4172, DOI 10.1210/jc.84.11.4172; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Narayan KMV, 2006, DIABETES CARE, V29, P2114, DOI 10.2337/dc06-1136; Nelson SM, 2010, HUM REPROD UPDATE, V16, P255, DOI 10.1093/humupd/dmp050; Odle AK, 2016, ENDOCRINOLOGY, V157, P3958, DOI 10.1210/en.2016-1472; Pombo M, 2001, Eat Weight Disord, V6, P22; Popovic V, 2001, Pituitary, V4, P7, DOI 10.1023/A:1012938308654; POWELLBRAXTON L, 1993, GENE DEV, V7, P2609, DOI 10.1101/gad.7.12b.2609; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Scacchi M, 1999, INT J OBESITY, V23, P260, DOI 10.1038/sj.ijo.0800807; Shasa DR, 2015, INT J OBESITY, V39, P695, DOI 10.1038/ijo.2014.190; Sone M, 2001, CELL TISSUE RES, V305, P351, DOI 10.1007/s004410100407; Urbanski HF, 2001, TRENDS ENDOCRIN MET, V12, P428, DOI 10.1016/S1043-2760(01)00505-7; Vickers MH, 2005, ENDOCRINOLOGY, V146, P4211, DOI 10.1210/en.2005-0581; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Vickers MH, 2002, J ENDOCRINOL, V175, P615, DOI 10.1677/joe.0.1750615; Vickers MH, 2001, ENDOCRINOLOGY, V142, P3964, DOI 10.1210/en.142.9.3964; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301	60	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0181795	10.1371/journal.pone.0181795	http://dx.doi.org/10.1371/journal.pone.0181795			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771488	gold, Green Published, Green Submitted			2022-12-26	WOS:000406853600035
J	Han, MKL; van der Krogt, GNM; de Rooij, J				Han, Mitchell K. L.; van der Krogt, Gerard N. M.; de Rooij, Johan			Zygotic vinculin is not essential for embryonic development in zebrafish	PLOS ONE			English	Article							ALPHA-E-CATENIN; FOCAL-ADHESION; BINDING-PROTEIN; CELL-CELL; TALIN; CYTOSKELETAL; GENE; PHOSPHORYLATION; ACTIVATION; MECHANOTRANSDUCTION	The formation of multicellular tissues during development is governed by mechanical forces that drive cell shape and tissue architecture. Protein complexes at sites of adhesion to the extracellular matrix (ECM) and cell neighbors, not only transmit these mechanical forces, but also allow cells to respond to changes in force by inducing biochemical feedback pathways. Such force-induced signaling processes are termed mechanotransduction. Vinculin is a central protein in mechanotransduction that in both integrin-mediated cell-ECM and cadherin-mediated cell-cell adhesions mediates force-induced cytoskeletal remodeling and adhesion strengthening. Vinculin was found to be important for the integrity and remodeling of epithelial tissues in cell culture models and could therefore be expected to be of broad importance in epithelial morphogenesis in vivo. Besides a function in mouse heart development, however, the importance of vinculin in morphogenesis of other vertebrate tissues has remained unclear. To investigate this further, we knocked out vinculin functioning in zebrafish, which contain two fully functional isoforms designated as vinculin A and vinculin B that both show high sequence conservation with higher vertebrates. Using TALEN and CRISPR-Cas gene editing technology we generated vinculin-deficient zebrafish. While single vinculin A mutants are viable and able to reproduce, additional loss of zygotic vinculin B was lethal after embryonic stages. Remarkably, vinculin-deficient embryos do not show major developmental defects, apart from mild pericardial edemas. These results lead to the conclusion that vinculin is not of broad importance for the development and morphogenesis of zebrafish tissues.	[Han, Mitchell K. L.; van der Krogt, Gerard N. M.; de Rooij, Johan] Univ Med Ctr Utrecht, Ctr Mol Med, Mol Canc Res, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	de Rooij, J (corresponding author), Univ Med Ctr Utrecht, Ctr Mol Med, Mol Canc Res, Utrecht, Netherlands.	j.derooij-3@umcutrecht.nl	de rooij, johan/C-1325-2019	de rooij, johan/0000-0001-6101-7875; Han, Mitchell/0000-0002-9243-1136				Alatortsev VE, 1997, FEBS LETT, V413, P197, DOI 10.1016/S0014-5793(97)00901-0; Armenti Stephen T, 2012, Subcell Biochem, V60, P279, DOI 10.1007/978-94-007-4186-7_12; Atherton P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10038; Auernheimer V, 2015, J CELL SCI, V128, P3435, DOI 10.1242/jcs.172031; Auernheimer V, 2014, BIOCHEM BIOPH RES CO, V450, P1095, DOI 10.1016/j.bbrc.2014.06.122; Baena-Lopez LA, 2013, DEVELOPMENT, V140, P4818, DOI 10.1242/dev.100933; Bakkers J, 2011, CARDIOVASC RES, V91, P279, DOI 10.1093/cvr/cvr098; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; BARSTEAD RJ, 1991, J CELL BIOL, V114, P715, DOI 10.1083/jcb.114.4.715; Bays JL, 2014, J CELL BIOL, V205, P251, DOI 10.1083/jcb.201309092; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Bharadwaj R, 2013, DEVELOPMENT, V140, P627, DOI 10.1242/dev.085100; Brindle NPJ, 1996, BIOCHEM J, V318, P753, DOI 10.1042/bj3180753; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Bruce AEE, 2016, DEV DYNAM, V245, P244, DOI 10.1002/dvdy.24353; Buckley CD, 2014, SCIENCE, V346, P600, DOI 10.1126/science.1254211; Camara-Pereira ES, 2009, HISTOL HISTOPATHOL, V24, P187, DOI 10.14670/HH-24.187; Carisey A, 2013, CURR BIOL, V23, P271, DOI 10.1016/j.cub.2013.01.009; Case LB, 2015, NAT CELL BIOL, V17, P880, DOI 10.1038/ncb3180; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Charvet B, 2013, DEVELOPMENT, V140, P4602, DOI 10.1242/dev.096024; Cheng F, 2016, DEVELOPMENT, V143, P3522, DOI 10.1242/dev.132936; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Engler A. J., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P335; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Glasauer SMK, 2014, MOL GENET GENOMICS, V289, P1045, DOI 10.1007/s00438-014-0889-2; Golji J, 2011, BIOPHYS J, V100, P332, DOI 10.1016/j.bpj.2010.11.024; Gupta V, 2012, FASEB J, V26, P1892, DOI 10.1096/fj.11-194548; Hagel M, 2002, MOL CELL BIOL, V22, P901, DOI 10.1128/MCB.22.3.901-915.2002; Han MKL, 2016, BIOL OPEN, V5, P1461, DOI 10.1242/bio.021378; Han MK, 2016, TRENDS CELL BIOL; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Huveneers S, 2013, J CELL SCI, V126, P403, DOI 10.1242/jcs.109447; Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jacob AE, 2017, DEV BIOL, V425, P70, DOI 10.1016/j.ydbio.2017.03.012; Janssen MEW, 2006, MOL CELL, V21, P271, DOI 10.1016/j.molcel.2005.11.020; Kardash E, 2010, NAT CELL BIOL, V12, P47, DOI 10.1038/ncb2003; Kaushik G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5843; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; Kioka N, 1999, J CELL BIOL, V144, P59, DOI 10.1083/jcb.144.1.59; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; KROEMKER M, 1994, FEBS LETT, V355, P259, DOI 10.1016/0014-5793(94)01216-4; Lagendijk AK, 2014, CELL ADHES MIGR, V8, P136, DOI 10.4161/cam.28229; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Leerberg JM, 2014, CURR BIOL, V24, P1689, DOI 10.1016/j.cub.2014.06.028; Maartens AP, 2016, J CELL SCI, V129, P4354, DOI 10.1242/jcs.189878; Miller PW, 2013, J BIOL CHEM, V288, P22324, DOI 10.1074/jbc.M113.458406; Neu-Yilik G, 2011, RNA, V17, P843, DOI 10.1261/rna.2401811; ODELL G, 1980, J MATH BIOL, V9, P291, DOI 10.1007/BF00276030; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Peng X, 2010, J CELL SCI, V123, P567, DOI 10.1242/jcs.056432; Postel R, 2008, DEV BIOL, V318, P92, DOI 10.1016/j.ydbio.2008.03.024; Rangarajan ES, 2012, J BIOL CHEM, V287, P18492, DOI 10.1074/jbc.M112.351023; Rauskolb C, 2014, CELL, V158, P143, DOI 10.1016/j.cell.2014.05.035; Rauzi M, 2010, NATURE, V468, P1110, DOI 10.1038/nature09566; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Shen K, 2011, J BIOL CHEM, V286, P45103, DOI 10.1074/jbc.M111.244293; Slanchev K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000563; Thompson PM, 2014, STRUCTURE, V22, P697, DOI 10.1016/j.str.2014.03.002; Thompson PM, 2013, FEBS LETT, V587, P1220, DOI 10.1016/j.febslet.2013.02.042; Tolbert CE, 2014, BIOCHEMISTRY-US, V53, P5526, DOI 10.1021/bi500678x; Twiss F, 2013, CELL MOL LIFE SCI, V70, P4101, DOI 10.1007/s00018-013-1329-x; Twiss F, 2012, BIOL OPEN, V1, P1128, DOI 10.1242/bio.20122428; van Impel A, 2014, DEVELOPMENT, V141, P1228, DOI 10.1242/dev.105031; Vogel B, 2009, BIOCHEM BIOPH RES CO, V390, P516, DOI 10.1016/j.bbrc.2009.09.129; Wen WS, 2016, INT J CANCER, V138, P1328, DOI 10.1002/ijc.29626; Xu WM, 1998, DEVELOPMENT, V125, P327; Yan J, 2015, CELL MOL BIOENG, V8, P151, DOI 10.1007/s12195-014-0364-5; Yao MX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5525; Yao MX, 2014, SCI REP-UK, V4, DOI 10.1038/srep04610; Zemljic-Harpf AE, 2004, AM J PATHOL, V165, P1033, DOI 10.1016/S0002-9440(10)63364-0; Zemljic-Harpf A, 2009, J INVEST MED, V57, P849, DOI 10.2310/JIM.0b013e3181c5e074; Zemljic-Harpf AE, 2007, MOL CELL BIOL, V27, P7522, DOI 10.1128/MCB.00728-07	78	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182278	10.1371/journal.pone.0182278	http://dx.doi.org/10.1371/journal.pone.0182278			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767718	Green Published, gold			2022-12-26	WOS:000406768200063
J	Rockendorf, N; Meckelein, B; Scherf, KA; Schalk, K; Koehler, P; Frey, A				Roeckendorf, Niels; Meckelein, Barbara; Scherf, Katharina A.; Schalk, Kathrin; Koehler, Peter; Frey, Andreas			Identification of novel antibody-reactive detection sites for comprehensive gluten monitoring	PLOS ONE			English	Article							CELIAC-DISEASE; MONOCLONAL-ANTIBODIES; GLIADIN; PEPTIDES	Certain cereals like wheat, rye or barley contain gluten, a protein mixture that can trigger celiac disease (CD). To make gluten-free diets available for affected individuals the gluten content of foodstuff must be monitored. For this purpose, antibody-based assays exist which rely on the recognition of certain linear gluten sequence motifs. Yet, not all CD-active gluten constituents and fragments formed during food processing/fermentation may be covered by those tests. In this study, we therefore assayed the coverage of reportedly CD-active gluten components by currently available detection antibodies and determined the antibody-inducing capacity of wheat gluten constituents in order to provide novel diagnostic targets for comprehensive gluten quantitation. Immunizations of outbred mice with purified gliadins and glutenins were conducted and the linear target recognition profile of the sera was recorded using synthetic peptide arrays that covered the sequence space of gluten constituents present in those preparations. The resulting murine immunorecognition profile of gluten demonstrated that further linear binding sites beyond those recognized by the monoclonal antibodies alpha 20, R5 and G12 exist and may be exploitable as diagnostic targets. We conclude that the safety of foodstuffs for CD patients can be further improved by complementing current tests with antibodies directed against additional CD-active gluten components. Currently unrepresented linear gluten detection sites in glutenins and alpha-gliadins suggest sequences QQQYPS, PQQSFP, QPGQGQQG and QQPPFS as novel targets for antibody generation.	[Roeckendorf, Niels; Meckelein, Barbara; Frey, Andreas] Res Ctr Borstel, Div Mucosal Immunol & Diagnost, Prior Area Asthma & Allergy, Borstel, Germany; [Scherf, Katharina A.; Schalk, Kathrin; Koehler, Peter] Leibniz Inst, Deutsch Forsch Anstalt Lebensmittelchem, Freising Weihenstephan, Germany; [Koehler, Peter] Biotask AG, Esslingen, Germany	Forschungszentrum Borstel; Leibniz-Institute for Food Systems Biology at the Technical University of Munich	Frey, A (corresponding author), Res Ctr Borstel, Div Mucosal Immunol & Diagnost, Prior Area Asthma & Allergy, Borstel, Germany.	afrey@fz-borstel.de	SCHERF, Katharina/B-8141-2019; Scherf, Katharina/AAM-7029-2020	SCHERF, Katharina/0000-0001-8315-5400; 	German Ministry for Education and Research [13GW0042A, 13GW0042B]; Open Access Fund of the Leibniz Association	German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Open Access Fund of the Leibniz Association	This work was supported by the German Ministry for Education and Research, 13GW0042A, to Dr. Andreas Frey and the German Ministry for Education and Research, 13GW0042B, to Prof. Peter Koehler. The publication of this article was funded by the Open Access Fund of the Leibniz Association.	[Anonymous], DET CRUD PROT GRAIN; [Anonymous], DET MOIST CONT CER C; [Anonymous], DET ASH CER CER PROD; [Anonymous], 2013, FED REG; Blandino A, 2003, FOOD RES INT, V36, P527, DOI 10.1016/S0963-9969(03)00009-7; Briant DJ, 2009, METHODS MOL BIOL, V570, P175, DOI 10.1007/978-1-60327-394-7_6; Bugyi Z, 2013, QUAL ASSUR SAF CROP, V5, P79, DOI 10.3920/QAS2012.0174; Catassi C, 2015, DIGEST DIS, V33, P141, DOI 10.1159/000369518; CICLITIRA PJ, 1984, CLIN SCI, V66, P357, DOI 10.1042/cs0660357; Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7; Frey A, 2000, J IMMUNOL METHODS, V233, P47, DOI 10.1016/S0022-1759(99)00166-0; Frey A, 1999, VACCINE, V17, P3007, DOI 10.1016/S0264-410X(99)00163-2; Goodman RE, 2016, MOL NUTR FOOD RES; Hovhannisyan Z, 2008, NATURE, V456, P534, DOI 10.1038/nature07524; Howdle PD, 2006, EUR J GASTROEN HEPAT, V18, P703, DOI 10.1097/01.meg.0000221847.09792.34; Kahlenberg F, 2006, EUR FOOD RES TECHNOL, V222, P78, DOI 10.1007/s00217-005-0100-4; KENDALL MJ, 1972, LANCET, V2, P1065; Koenig A, 2015, FOOD CHEM, V168, P176, DOI 10.1016/j.foodchem.2014.07.040; Kok MS, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-10; Lagrain B, 2012, J CEREAL SCI, V56, P726, DOI 10.1016/j.jcs.2012.08.003; Martinez-Esteso MJ, 2016, J PROTEOMICS, V147, P156, DOI 10.1016/j.jprot.2016.03.015; Mitea C, 2008, AM J CLIN NUTR, V88, P1057, DOI 10.1093/ajcn/88.4.1057; Moron B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002294; Osman AA, 2001, EUR J GASTROEN HEPAT, V13, P1189, DOI 10.1097/00042737-200110000-00011; Pahlavan A, 2016, FOOD CHEM, V208, P264, DOI 10.1016/j.foodchem.2016.03.092; Pflaum T, 2013, J AGR FOOD CHEM, V61, P6485, DOI 10.1021/jf4012906; Rzychon M, 2017, FOOD CHEM, V234, P144, DOI 10.1016/j.foodchem.2017.04.092; Schalk K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172819; Scherf KA, 2016, J AGR FOOD CHEM, V64, P7622, DOI 10.1021/acs.jafc.6b02512; Scherf KA, 2016, EUR FOOD RES TECHNOL, V242, P1837, DOI 10.1007/s00217-016-2683-3; Scherf KA, 2016, J CEREAL SCI, V67, P2, DOI 10.1016/j.jcs.2015.07.008; Scherf KA, 2016, J CEREAL SCI, V67, P112, DOI 10.1016/j.jcs.2015.08.006; Sollid LM, 2012, IMMUNOGENETICS, V64, P455, DOI 10.1007/s00251-012-0599-z; Stepniak D, 2005, IMMUNOGENETICS, V57, P8, DOI 10.1007/s00251-005-0780-8; Stern M, 2001, EUR J GASTROEN HEPAT, V13, P741, DOI 10.1097/00042737-200106000-00023; STURGESS R, 1994, LANCET, V343, P758, DOI 10.1016/S0140-6736(94)91837-6; Tye-Din JA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001012; Vader W, 2002, GASTROENTEROLOGY, V122, P1729, DOI 10.1053/gast.2002.33606; Winkler DFH, 2009, METHODS MOL BIOL, V570, P157, DOI 10.1007/978-1-60327-394-7_5	39	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0181566	10.1371/journal.pone.0181566	http://dx.doi.org/10.1371/journal.pone.0181566			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759621	Green Published, Green Submitted, gold			2022-12-26	WOS:000406761600020
J	Adeyemo, OS; Chavarriaga, P; Tohme, J; Fregene, M; Davis, SJ; Setter, TL				Adeyemo, O. Sarah; Chavarriaga, Paul; Tohme, Joe; Fregene, Martin; Davis, Seth J.; Setter, Tim L.			Overexpression of Arabidopsis FLOWERING LOCUS T (FT) gene improves floral development in cassava (Manihot esculenta, Crantz)	PLOS ONE			English	Article							EXPRESSION SYSTEM; TOBACCO PLANTS; GROWTH; TRANSFORMATION; INDUCTION; SELECTION; FLORIGEN; PROTEIN; SWITCH	Cassava is a tropical storage-root crop that serves as a worldwide source of staple food for over 800 million people. Flowering is one of the most important breeding challenges in cassava because in most lines flowering is late and non-synchronized, and flower production is sparse. The FLOWERING LOCUS T (FT) gene is pivotal for floral induction in all examined angiosperms. The objective of the current work was to determine the potential roles of the FT signaling system in cassava. The Arabidopsis thaliana FT gene (atFT) was transformed into the cassava cultivar 60444 through Agrobacterium-mediated transformation and was found to be overexpressed constitutively. FT overexpression hastened flower initiation and associated fork-type branching, indicating that cassava has the necessary signaling factors to interact with and respond to the atFT gene product. In addition, overexpression stimulated lateral branching, increased the prolificacy of flower production and extended the longevity of flower development. While FT homologs in some plant species stimulate development of vegetative storage organs, atFT inhibited storage-root development and decreased root harvest index in cassava. These findings collectively contribute to our understanding of flower development in cassava and have the potential for applications in breeding.	[Adeyemo, O. Sarah; Setter, Tim L.] Cornell Univ, Sch Integrat Plant Sci, Soil & Crop Sci Sect, Ithaca, NY 14850 USA; [Adeyemo, O. Sarah; Davis, Seth J.] Max Planck Inst Plant Breeding Res, Dept Plant Dev Biol, Cologne, Germany; [Adeyemo, O. Sarah; Chavarriaga, Paul; Tohme, Joe; Fregene, Martin] Int Ctr Trop Agr CIAT, Cali, Colombia; [Fregene, Martin] African Dev Bank Grp, Abidjan, Cote Ivoire; [Davis, Seth J.] Univ York, York, N Yorkshire, England	Cornell University; Max Planck Society; Alliance; International Center for Tropical Agriculture - CIAT; African Development Bank Group (AfDB); University of York - UK	Setter, TL (corresponding author), Cornell Univ, Sch Integrat Plant Sci, Soil & Crop Sci Sect, Ithaca, NY 14850 USA.; Davis, SJ (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Dev Biol, Cologne, Germany.	seth.davis@york.ac.uk; TLS1@cornell.edu	Setter, Tim/GNH-3718-2022	Setter, Tim/0000-0002-0736-1453	Rockefeller Foundation; Max Planck Society; Next Generation (NEXTGEN) Cassava project at Cornell University; Bill & Melinda Gates Foundation; Department for International Development of the United Kingdom	Rockefeller Foundation; Max Planck Society(Max Planck SocietyFoundation CELLEX); Next Generation (NEXTGEN) Cassava project at Cornell University; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Department for International Development of the United Kingdom	The production of the cassava transgenic lines was supported by grants from the Rockefeller Foundation and internal funds of the Max Planck Society. Work on characterizing the lines was supported by the Next Generation (NEXTGEN) Cassava project at Cornell University, which is supported by a grant from the Bill & Melinda Gates Foundation and the Department for International Development of the United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2015, PLANT J, V83, P1059, DOI 10.1111/tpj.12951; Abelenda JA, 2014, TRENDS PLANT SCI, V19, P115, DOI 10.1016/j.tplants.2013.09.010; Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; Bredeson JV, 2016, NAT BIOTECHNOL, V34, P562, DOI 10.1038/nbt.3535; Ceballos H, 2004, PLANT MOL BIOL, V56, P503, DOI 10.1007/s11103-004-5010-5; Ceballos H, 2017, J PLANT BREEDING CRO, V9; Ceballos H, 2016, FRONT PLANT SCI, V7, DOI [10.3359/fpls.2016.01227, 10.3389/fpls.2016.01227]; Ceballos H, 2015, THEOR APPL GENET, V128, P1647, DOI 10.1007/s00122-015-2555-4; Davis AM, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-3; Dumet D, 2002, CASSAVA IN VITRO PRO; Filichkin SA, 2006, PLANT CELL REP, V25, P660, DOI 10.1007/s00299-005-0112-3; Fregene M, 2000, THEOR APPL GENET, V100, P678, DOI 10.1007/s001220051339; Gonzalez AE, 1998, PLANT CELL REP, V17, P827, DOI 10.1007/s002990050492; Hao XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126030; Harig L, 2012, PLANT J, V72, P908, DOI 10.1111/j.1365-313X.2012.05125.x; Hsu CY, 2011, P NATL ACAD SCI USA, V108, P10756, DOI 10.1073/pnas.1104713108; Jung C, 2009, TRENDS PLANT SCI, V14, P563, DOI 10.1016/j.tplants.2009.07.005; Junker BH, 2003, FEBS LETT, V535, P136, DOI 10.1016/S0014-5793(02)03889-9; Klocko AL, 2016, PLANT BIOTECHNOL J, V14, P808, DOI 10.1111/pbi.12431; Kobayashi M, 1979, INT S TROP ROOT TUB, P49; LARDIZABAL RD, 1990, HORTSCIENCE, V25, P79, DOI 10.21273/HORTSCI.25.1.79; Lee R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3884; Li C, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00454; Li CQ, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-125; LIAN TS, 1979, FIELD CROP RES, V2, P281, DOI 10.1016/0378-4290(79)90029-7; McGarry RC, 2013, TRENDS PLANT SCI, V18, P198, DOI 10.1016/j.tplants.2013.01.004; McGarry RC, 2012, PLANT SCI, V188, P71, DOI 10.1016/j.plantsci.2012.03.002; Monger WA, 2001, PLANT PATHOL, V50, P768, DOI 10.1046/j.1365-3059.2001.00647.x; Navarro C, 2011, NATURE, V478, P119, DOI 10.1038/nature10431; Notaguchi M, 2009, PLANT SIGNAL BEHAV, V4, P123, DOI 10.4161/psb.4.2.7558; Perera PIP, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/pls046; Pin PA, 2012, PLANT CELL ENVIRON, V35, P1742, DOI 10.1111/j.1365-3040.2012.02558.x; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; Roberts GR, 2005, PLANT PHYSIOL, V138, P1259, DOI 10.1104/pp.105.059659; Roslan HA, 2001, PLANT J, V28, P225, DOI 10.1046/j.1365-313X.2001.01146.x; Sarria R, 2000, PLANT CELL REP, V19, P339, DOI 10.1007/s002990050737; Schaarschmidt S, 2004, PLANT CELL PHYSIOL, V45, P1566, DOI 10.1093/pcp/pch177; Shalit A, 2009, P NATL ACAD SCI USA, V106, P8392, DOI 10.1073/pnas.0810810106; Song GQ, 2013, PLANT CELL REP, V32, P1759, DOI 10.1007/s00299-013-1489-z; Sweetman JP, 2002, PLANT PHYSIOL, V129, P943, DOI 10.1104/pp.010937; Tanaka N, 2014, PLANT BIOTECHNOL-NAR, V31, P11, DOI 10.5511/plantbiotechnology.13.0912a; Trankner C, 2010, PLANTA, V232, P1309, DOI 10.1007/s00425-010-1254-2; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; van Dongen JT, 2003, PLANT PHYSIOL, V131, P1529, DOI 10.1104/pp.102.017202; Wenzel S, 2013, PLANT CELL TISS ORG, V115, P127, DOI 10.1007/s11240-013-0346-7; Wickland DP, 2015, MOL PLANT, V8, P983, DOI 10.1016/j.molp.2015.01.007; Zhang HL, 2010, J EXP BOT, V61, P2549, DOI 10.1093/jxb/erq092	48	28	29	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0181460	10.1371/journal.pone.0181460	http://dx.doi.org/10.1371/journal.pone.0181460			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753668	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000406579300019
J	Chung, S; Kim, S; Kim, M; Koh, ES; Shin, SJ; Park, CW; Chang, YS; Kim, HS				Chung, Sungjin; Kim, Soojeong; Kim, Minyoung; Koh, Eun Sil; Shin, Seok Joon; Park, Cheol Whee; Chang, Yoon Sik; Kim, Ho-Shik			Treatment combining aliskiren with paricalcitol is effective against progressive renal tubulointerstitial fibrosis via dual blockade of intrarenal renin	PLOS ONE			English	Article							UNILATERAL URETERAL OBSTRUCTION; ANGIOTENSIN-ALDOSTERONE SYSTEM; CHRONIC KIDNEY-DISEASE; NF-KAPPA-B; DIABETIC-NEPHROPATHY; INTERSTITIAL FIBROSIS; INDUCED NEPHROTOXICITY; COMBINATION THERAPY; (PRO)RENIN RECEPTOR; OXIDATIVE STRESS	The aim of this study was to assess any potential additive effects of a treatment combining aliskiren with paricalcitol on reducing renal fibrosis. C57BL/6J mice were treated individually with aliskiren and/or paricalcitol until 7 days after initiation of unilateral ureteral obstruction (UUO). In obstructed kidneys of UUO mice, monotherapy with aliskiren or paricalcitol significantly attenuated interstitial fibrosis, collagen IV accumulation, and a-smooth muscle actin-and terminal deoxynucleotidyl transferase-mediated biotin nick end-labeling-positive cells. The combination treatment showed additive efficacy in inhibition of these parameters. Renal NADPH oxidase (Nox) 1 and Nox2 were significantly decreased by aliskiren or paricalcitol alone or in combination, while renal Nox4 expression was significantly reduced by paricalcitol mono-or combination treatment. Increased levels of p-Erk and p-p38 MAPK, and NF-kappa B in UUO kidneys were also significantly reduced by either aliskiren or paricalcitol treatment alone or in combination. Aliskiren or paricalcitol monotherapy significantly reduced the expression of (pro) renin receptor in UUO kidneys. In addition, aliskiren tended to augment renin expression in UUO kidneys, but paricalcitol reduced its expression level. The combination treatment effectively blocked both (pro) renin receptor and renin expression induced by aliskiren, and resulted in a further reduction of the renal expression of angiotensin II AT1 receptor. Aliskiren failed to increase the expression of vitamin D receptor in UUO kidneys, but the combination treatment restored its expression level. Taken together, a treatment combining aliskiren with paricalcitol better inhibits UUO-induced renal injury. The mechanism of this synergy may involve more profound inhibition of the intrarenal renin-angiotensin system.	[Chung, Sungjin; Kim, Minyoung; Koh, Eun Sil; Shin, Seok Joon; Park, Cheol Whee; Chang, Yoon Sik] Catholic Univ Korea, Dept Internal Med, Coll Med, Seoul, South Korea; [Chung, Sungjin] Vanderbilt Univ, Sch Med, Dept Med, Div Nephrol & Hypertens, Nashville, TN 37212 USA; [Kim, Soojeong; Kim, Ho-Shik] Catholic Univ Korea, Dept Biochem, Coll Med, Seoul, South Korea	Catholic University of Korea; Vanderbilt University; Catholic University of Korea	Kim, HS (corresponding author), Catholic Univ Korea, Dept Biochem, Coll Med, Seoul, South Korea.	hoshik@catholic.ac.kr	Chung, Sungjin/AAJ-8836-2020; kim, soojeong/GRX-1470-2022	kim, soojeong/0000-0001-5829-7298; Chung, Sungjin/0000-0002-9886-8339	National Research Foundation (NRF) of Korea - Ministry of Science, ICT & Future Planning, Republic of Korea [NRF-2015R1C1A1A02037258]	National Research Foundation (NRF) of Korea - Ministry of Science, ICT & Future Planning, Republic of Korea	This research was supported by the Basic Science Research Program through the National Research Foundation (NRF) of Korea funded by the Ministry of Science, ICT & Future Planning, Republic of Korea (NRF-2015R1C1A1A02037258). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ari E, 2012, BRIT J RADIOL, V85, P1038, DOI 10.1259/bjr/16327485; Bhandari SK, 2016, KIDNEY RES CLIN PRAC, V35, P219, DOI 10.1016/j.krcp.2016.07.004; Brewster UC, 2004, AM J MED, V116, P263, DOI 10.1016/j.amjmed.2003.09.034; Bulut G, 2016, RENAL FAILURE, V38, P751, DOI 10.3109/0886022X.2016.1158071; Choi DE, 2011, J UROLOGY, V186, P694, DOI 10.1016/j.juro.2011.03.122; Chung S, 2016, KOREAN J INTERN MED, V31, P323, DOI 10.3904/kjim.2015.004; Chung S, 2016, AM J TRANSL RES, V8, P4574; Chung S, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-2; Das K, 2017, FOOD CHEM TOXICOL, V100, P225, DOI 10.1016/j.fct.2016.12.033; de Borst MH, 2011, J AM SOC NEPHROL, V22, P1603, DOI 10.1681/ASN.2010121251; Dong YF, 2010, J HYPERTENS, V28, P1554, DOI 10.1097/HJH.0b013e328338bb11; Eddy AA, 2012, PEDIATR NEPHROL, V27, P1233, DOI 10.1007/s00467-011-1938-2; Eren Z, 2014, KIDNEY BLOOD PRESS R, V39, P581, DOI 10.1159/000368471; Hammad Fayez T, 2016, Int J Physiol Pathophysiol Pharmacol, V8, P70; Hong YA, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-50; Huang Y, 2007, KIDNEY INT, V72, P45, DOI 10.1038/sj.ki.5002243; Kaneshiro Y, 2007, J AM SOC NEPHROL, V18, P1789, DOI 10.1681/ASN.2006091062; Kavvadas P, 2013, HYPERTENSION, V61, P901, DOI 10.1161/HYPERTENSIONAHA.111.00639; Kelly DJ, 2007, DIABETOLOGIA, V50, P2398, DOI 10.1007/s00125-007-0795-9; Kim S, 2015, INT J MED SCI, V12, P891, DOI 10.7150/ijms.13187; Kurtz A, 2016, KIDNEY INT, V90, P1153, DOI 10.1016/j.kint.2016.08.018; Lopez MLSS, 2004, DEV CELL, V6, P719; Lv LL, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00117; Mahfoz AM, 2016, N-S ARCH PHARMACOL, V389, P1315, DOI 10.1007/s00210-016-1299-2; Garcia IM, 2012, AM J PHYSIOL-RENAL, V302, pF1595, DOI 10.1152/ajprenal.00617.2011; Ning XH, 2013, INT IMMUNOPHARMACOL, V15, P406, DOI 10.1016/j.intimp.2012.12.019; Piao SG, 2012, TRANSPL P, V44, P642, DOI 10.1016/j.transproceed.2011.12.004; Rashikh A, 2013, J RENIN-ANGIO-ALDO S, V14, P14, DOI 10.1177/1470320312459980; Renke M, 2014, ADV MED SCI-POLAND, V59, P256, DOI 10.1016/j.advms.2014.03.003; Riera M, 2016, AM J PHYSIOL-RENAL, V310, pF534, DOI 10.1152/ajprenal.00082.2015; Romero C, 2015, NAT REV ENDOCRINOL, V11, P242, DOI 10.1038/nrendo.2015.6; Saito S, 2014, ENDOCRINOLOGY, V155, P1899, DOI 10.1210/en.2013-1937; Sakuraya K, 2014, J UROLOGY, V191, P1139, DOI 10.1016/j.juro.2013.10.053; Sanchez-Nino MD, 2012, AM J PHYSIOL-RENAL, V302, pF647, DOI 10.1152/ajprenal.00090.2011; Tan XY, 2008, J AM SOC NEPHROL, V19, P1741, DOI 10.1681/ASN.2007060666; Tan XY, 2006, J AM SOC NEPHROL, V17, P3382, DOI 10.1681/ASN.2006050520; Tan XY, 2009, KIDNEY INT, V76, P1248, DOI 10.1038/ki.2009.346; Wu WP, 2010, AM J PHYSIOL-RENAL, V299, pF929, DOI 10.1152/ajprenal.00192.2010; Yuan WH, 2007, J BIOL CHEM, V282, P29821, DOI 10.1074/jbc.M705495200; Zeisberg M, 2015, CLIN J AM SOC NEPHRO, V10, P1831, DOI 10.2215/CJN.00640114; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zhou D, 2016, NAT REV NEPHROL, V12, P68, DOI 10.1038/nrneph.2015.215	42	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0181757	10.1371/journal.pone.0181757	http://dx.doi.org/10.1371/journal.pone.0181757			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753620	Green Submitted, gold, Green Published			2022-12-26	WOS:000406579300025
J	Schwenkgrub, J; Zaremba, M; Joniec-Maciejak, I; Cudna, A; Mirowska-Guzel, D; Kurkowska-Jastrzebska, I				Schwenkgrub, Joanna; Zaremba, Malgorzata; Joniec-Maciejak, Ilona; Cudna, Agnieszka; Mirowska-Guzel, Dagmara; Kurkowska-Jastrzebska, Iwona			The phosphodiesterase inhibitor, ibudilast, attenuates neuroinflammation in the MPTP model of Parkinson's disease	PLOS ONE			English	Article							MURINE MODEL; MESSENGER-RNA; ANIMAL-MODELS; EXPRESSION; NEURODEGENERATION; PROTECTS; BRAIN; DEATH; RAT; NEUROTOXICITY	Background/Aims Since the degeneration of the nigrostriatal dopaminergic pathway in Parkinson's disease (PD) is associated with the inflammation process and decreased levels of cyclic nucleotides, inhibition of up-regulated cyclic nucleotide phosphodiesterases (PDEs) appears to be a promising therapeutic strategy. We used ibudilast (IBD), a non-selective PDE3,4,10,11 inhibitor, due to the abundant PDE 4 and 10 expression in the striatum. The present study for the first time examined the efficacy of IBD in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of PD. Methods IBD [ 0, 20, 30, 40, or 50 mg/kg] was injected b.i.d. subcutaneously for nine days to threemonth-old male C57Bl/10Tar mice, beginning two days prior to MPTP (60 mg/kg) intoxication. High-pressure liquid chromatography, Western blot analysis, and real time RT-PCR methods were applied. Results Our study demonstrated that chronic administration of IBD attenuated astroglial reactivity and increased glial cell-derived neurotrophic factor (GDNF) production in the striatum. Moreover, IBD reduced TNF-alpha, IL-6, and IL-1 beta expression. Conclusion IBD had a well-defined effect on astroglial activation in the mouse model of PD; however, there was no protective effect in the acute phase of injury. Diminished inflammation and an increased level of GDNF may provide a better outcome in the later stages of neurodegeneration.	[Schwenkgrub, Joanna; Zaremba, Malgorzata; Joniec-Maciejak, Ilona; Cudna, Agnieszka; Mirowska-Guzel, Dagmara] Med Univ Warsaw, Dept Expt & Clin Pharmacol, Ctr Preclin Res & Technol CePT, Warsaw, Poland; [Zaremba, Malgorzata] PAS, Mossakowski Med Res Ctr, Lab Magnet Resonance Imaging Small Anim, Warsaw, Poland; [Cudna, Agnieszka; Kurkowska-Jastrzebska, Iwona] Inst Psychiat & Neurol, Dept Neurol 2, Warsaw, Poland; [Schwenkgrub, Joanna] CNRS, UNIC, Gif Sur Yvette, France; [Zaremba, Malgorzata] Penn State Univ, Dept Anesthesiol & Perioperat Med, Coll Med, Hershey, PA 17033 USA	Medical University of Warsaw; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Institute of Psychiatry & Neurology; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Zaremba, M (corresponding author), Med Univ Warsaw, Dept Expt & Clin Pharmacol, Ctr Preclin Res & Technol CePT, Warsaw, Poland.; Zaremba, M (corresponding author), PAS, Mossakowski Med Res Ctr, Lab Magnet Resonance Imaging Small Anim, Warsaw, Poland.; Zaremba, M (corresponding author), Penn State Univ, Dept Anesthesiol & Perioperat Med, Coll Med, Hershey, PA 17033 USA.	mzaremba@wum.edu.pl	Joniec-Maciejak, Ilona/AGI-1938-2022; Joniec-Maciejak, Ilona/N-9735-2018	Joniec-Maciejak, Ilona/0000-0002-6869-4016; Joniec-Maciejak, Ilona/0000-0002-6869-4016; Mirowska-Guzel, Dagmara/0000-0001-6294-3256; Cudna, Agnieszka/0000-0002-8912-2973; Kurkowska-Jastrzebska, Iwona/0000-0001-6553-9080	CePT infrastructure - European Union -the European Regional Development Fund within the Operational Programme "Innovative economy"	CePT infrastructure - European Union -the European Regional Development Fund within the Operational Programme "Innovative economy"	This research subject was supported by the CePT infrastructure, financed by the European Union -the European Regional Development Fund within the Operational Programme "Innovative economy" for 2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad F, 2015, ORAL DIS, V21, pE25, DOI 10.1111/odi.12275; Athauda D, 2015, NAT REV NEUROL, V11, P25, DOI 10.1038/nrneurol.2014.226; Banner KH, 2009, BRIT J PHARMACOL, V157, P892, DOI 10.1111/j.1476-5381.2009.00170.x; Beal MF, 2014, JAMA NEUROL, V71, P543, DOI 10.1001/jamaneurol.2014.131; Bezard E, 2013, MOVEMENT DISORD, V28, P61, DOI 10.1002/mds.25108; Cho Y, 2010, P NATL ACAD SCI USA, V107, P11313, DOI 10.1073/pnas.1002716107; Ciesielska A, 2003, ACTA NEUROBIOL EXP, V63, P117; Ciesielska A, 2009, INFLAMM RES, V58, P747, DOI 10.1007/s00011-009-0026-6; Clarkson ED, 1995, NEUROREPORT, V7, P145, DOI 10.1097/00001756-199512290-00035; Coskran TM, 2006, J HISTOCHEM CYTOCHEM, V54, P1205, DOI 10.1369/JHC.6A6930.2006; Czlonkowska Anna, 2002, Med Sci Monit, V8, pRA165; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; El-Hage N, 2014, AIDS, V28, P1409, DOI 10.1097/QAD.0000000000000291; Fujimoto T, 1999, J NEUROIMMUNOL, V95, P35, DOI 10.1016/S0165-5728(98)00251-3; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; Gerlach M, 1996, J NEURAL TRANSM, V103, P987, DOI 10.1007/BF01291788; Giampa C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013417; Giorgi M, 2011, NEUROBIOL DIS, V43, P293, DOI 10.1016/j.nbd.2011.04.006; Goetz CG, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6258; Jenner P, 2009, PARKINSONISM RELAT D, V15, P406, DOI [10.1016/j.parkreldis.2008.12.006, 10.1016/S1353-8020(09)70829-6]; Jenner P, 2008, ANN NEUROL, V64, pS16, DOI 10.1002/ana.21489; Joniec-Maciejak I, 2014, PHARMACOL REP, V66, P660, DOI 10.1016/j.pharep.2014.03.008; Keravis T, 2012, BRIT J PHARMACOL, V165, P1288, DOI 10.1111/j.1476-5381.2011.01729.x; Kohutnicka M, 1998, IMMUNOPHARMACOLOGY, V39, P167, DOI 10.1016/S0162-3109(98)00022-8; Kurkowska-Jastrzebska I, 2002, INT IMMUNOPHARMACOL, V2, P1213, DOI 10.1016/S1567-5769(02)00078-4; Kurkowska-Jastrzebska I, 2009, INT IMMUNOPHARMACOL, V9, P781, DOI 10.1016/j.intimp.2009.03.003; Lakics V, 2010, NEUROPHARMACOLOGY, V59, P367, DOI 10.1016/j.neuropharm.2010.05.004; Langston JW, 2017, J PARKINSON DIS, V7, pS11, DOI 10.3233/JPD-179006; Ledeboer A, 2006, NEURON GLIA BIOL, V2, P279, DOI 10.1017/S1740925X0700035X; Ledeboer A, 2007, EXPERT OPIN INV DRUG, V16, P935, DOI 10.1517/13543784.16.7.935; Li CY, 2014, EXP THER MED, V7, P375, DOI 10.3892/etm.2013.1413; Mizuno T, 2004, NEUROPHARMACOLOGY, V46, P404, DOI 10.1016/j.neuropharm.2003.09.009; Nishino N, 1993, Rev Neurosci, V4, P213; Nuytemans K, 2010, HUM MUTAT, V31, P763, DOI 10.1002/humu.21277; Park A, 2015, DRUGS, V75, P2065, DOI 10.1007/s40265-015-0497-4; Patel NK, 2005, ANN NEUROL, V57, P298, DOI 10.1002/ana.20374; Pilleri M, 2015, EXPERT OPIN DRUG SAF, V14, P281, DOI 10.1517/14740338.2015.988137; POLLI JW, 1994, J NEUROSCI, V14, P1251, DOI 10.1523/JNEUROSCI.14-03-01251.1994; Ramirez Andres D., 2014, Central Nervous System Agents in Medicinal Chemistry, V14, P72; Ren ZH, 2013, SCI REP-UK, V3, DOI 10.1038/srep02786; Rolan P, 2009, EXPERT OPIN PHARMACO, V10, P2897, DOI 10.1517/14656560903426189; Schmidt CJ, 2008, J PHARMACOL EXP THER, V325, P681, DOI 10.1124/jpet.107.132910; Schwenkgrub J, 2013, PHARMACOL REP, V65, P44, DOI 10.1016/S1734-1140(13)70962-9; Sharma S, 2015, NEUROSCIENCE, V286, P393, DOI 10.1016/j.neuroscience.2014.12.008; Sharma S, 2013, EUR J PHARMACOL, V714, P486, DOI 10.1016/j.ejphar.2013.06.038; Slevin JT, 2005, J NEUROSURG, V102, P216, DOI 10.3171/jns.2005.102.2.0216; Stephenson DT, 2012, NEUROSCIENCE, V226, P145, DOI 10.1016/j.neuroscience.2012.09.011; Stojkovska I, 2015, EXP BIOL MED, V240, P1387, DOI 10.1177/1535370215576313; Sugama S, 2003, BRAIN RES, V964, P288, DOI 10.1016/S0006-8993(02)04085-4; Swiatkiewicz M, 2013, PHARMACOL REP, V65, P1227; Takuma K, 2001, BRIT J PHARMACOL, V133, P841, DOI 10.1038/sj.bjp.0704146; Tansey MG, 2007, EXP NEUROL, V208, P1, DOI 10.1016/j.expneurol.2007.07.004; Tominaga Y, 1996, CLIN EXP PHARM PHYSL, V23, P6; Van Wagoner NJ, 1999, J NEUROIMMUNOL, V100, P124, DOI 10.1016/S0165-5728(99)00187-3; Vargas JLC, 2016, NEUROBIOL DIS, V93, P156, DOI 10.1016/j.nbd.2016.05.002; Vesterinen HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117705; Wakita H, 2003, BRAIN RES, V992, P53, DOI 10.1016/j.brainres.2003.08.028; Wang H, 2014, PHARMACOL BIOCHEM BE, V124, P373, DOI 10.1016/j.pbb.2014.07.006; Yang L, 2008, EXP NEUROL, V211, P311, DOI 10.1016/j.expneurol.2007.02.010; Yoshioka A, 2000, J NEUROCHEM, V74, P633, DOI 10.1046/j.1471-4159.2000.740633.x; Yoshioka M, 2002, PHARMACOL RES, V45, P305, DOI 10.1006/phrs.2002.0949; Zhang Feng, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS213, DOI 10.1016/S1353-8020(11)70066-9	62	31	33	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0182019	10.1371/journal.pone.0182019	http://dx.doi.org/10.1371/journal.pone.0182019			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753652	Green Published, Green Submitted, gold			2022-12-26	WOS:000406579300042
J	Bombara, CB; Durr, S; Machovsky-Capuska, GE; Jones, PW; Ward, MP				Bombara, Courtenay B.; Duerr, Salome; Machovsky-Capuska, Gabriel E.; Jones, Peter W.; Ward, Michael P.			A preliminary study to estimate contact rates between free-roaming domestic dogs using novel miniature cameras	PLOS ONE			English	Article							REMOTE ABORIGINAL COMMUNITIES; DISEASE TRANSMISSION; NORTHERN AUSTRALIA; CANINE RABIES; VIDEO-CAMERA; BEHAVIOR; PREVALENCE; DEPLOYMENT; TERRITORY; SCIENCE	Information on contacts between individuals within a population is crucial to inform disease control strategies, via parameterisation of disease spread models. In this study we investigated the use of dog-borne video cameras-in conjunction with global positioning systems (GPS) loggers-to both characterise dog-to-dog contacts and to estimate contact rates. We customized miniaturised video cameras, enclosed within 3D-printed plastic cases, and attached these to nylon dog collars. Using two 3400 mAh NCR lithium Li-ion batteries, cameras could record a maximum of 22 hr of continuous video footage. Together with a GPS logger, collars were attached to six free roaming domestic dogs (FRDDs) in two remote Indigenous communities in northern Australia. We recorded a total of 97 hr of video footage, ranging from 4.5 to 22 hr (mean 19.1) per dog, and observed a wide range of social behaviours. The majority (69%) of all observed interactions between community dogs involved direct physical contact. Direct contact behaviours included sniffing, licking, mouthing and play fighting. No contacts appeared to be aggressive, however multiple teeth baring incidents were observed during play fights. We identified a total of 153 contacts-equating to 8 to 147 contacts per dog per 24 hr-from the videos of the five dogs with camera data that could be analysed. These contacts were attributed to 42 unique dogs (range 1 to 19 per video) which could be identified (based on colour patterns and markings). Most dog activity was observed in urban (houses and roads) environments, but contacts were more common in bushland and beach environments. A variety of foraging behaviours were observed, included scavenging through rubbish and rolling on dead animal carcasses. Identified food consumed included chicken, raw bones, animal carcasses, rubbish, grass and cheese. For characterising contacts between FRDD, several benefits of analysing videos compared to GPS fixes alone were identified in this study, including visualisation of the nature of the contact between two dogs; and inclusion of a greater number of dogs in the study (which do not need to be wearing video or GPS collars). Some limitations identified included visualisation of contacts only during daylight hours; the camera lens being obscured on occasion by the dog's mandible or the dog resting on the camera; an insufficiently wide viewing angle (36 E); battery life and robustness of the deployments; high costs of the deployment; and analysis of large volumes of often unsteady video footage. This study demonstrates that dog-borne video cameras, are a feasible technology for estimating and characterising contacts between FRDDs. Modifying camera specifications and developing new analytical methods will improve applicability of this technology for monitoring FRDD populations, providing insights into dog-to-dog contacts and therefore how disease might spread within these populations.	[Bombara, Courtenay B.; Machovsky-Capuska, Gabriel E.; Ward, Michael P.] Univ Sydney, Sydney Sch Vet Sci, Camden, NSW, Australia; [Duerr, Salome] Univ Bern, Vet Publ Hlth Inst, Liebefeld, Switzerland; [Machovsky-Capuska, Gabriel E.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia; [Machovsky-Capuska, Gabriel E.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia; [Jones, Peter W.] Univ Sydney, Sch Elect & Informat Engn, Sydney, NSW, Australia	University of Sydney; University of Bern; University of Sydney; University of Sydney; University of Sydney	Ward, MP (corresponding author), Univ Sydney, Sydney Sch Vet Sci, Camden, NSW, Australia.	michael.ward@sydney.edu.au	Ward, Michael/C-5758-2009; Ward, Michael Patrick/W-1897-2019; Dürr, Salome/AAS-9109-2020; Ward, Michael Patrick/GRX-1851-2022; Durr, Salome/C-1343-2014	Ward, Michael/0000-0002-9921-4986; Ward, Michael Patrick/0000-0002-9921-4986; Durr, Salome/0000-0002-7321-5980; Machovsky-Capuska, Gabriel/0000-0001-8698-8424; Jones, Peter/0000-0002-0229-3527	Australian Department of Agriculture's Wildlife Exotic Disease Preparedness Program; Swiss National Science Foundation [PASMP3 142737]; Loxton Research Fellowship from the Faculty of Veterinary Science, The University of Sydney; Faculty of Veterinary Science DVC Compact Research fund (The University of Sydney)	Australian Department of Agriculture's Wildlife Exotic Disease Preparedness Program; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Loxton Research Fellowship from the Faculty of Veterinary Science, The University of Sydney; Faculty of Veterinary Science DVC Compact Research fund (The University of Sydney)	This study was funded by the Australian Department of Agriculture's Wildlife Exotic Disease Preparedness Program. SD's salary was funded by the Swiss National Science Foundation (grant number PASMP3 142737). GEM-C was supported by the Loxton Research Fellowship from the Faculty of Veterinary Science, The University of Sydney. Cameras used in this research were funded by Faculty of Veterinary Science DVC Compact Research fund (The University of Sydney). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bombara C, 2017, AUST VET J, V95, P182, DOI 10.1111/avj.12592; Boyd Ian L., 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P1; Bradbury L, 2006, AUST VET J, V84, P317, DOI 10.1111/j.1751-0813.2006.00028.x; Brookes VJ, 2017, ZOONOSES PUBLIC HLTH, V64, P156, DOI 10.1111/zph.12284; Brown GK, 2006, AUST VET J, V84, P321, DOI 10.1111/j.1751-0813.2006.00029.x; Brown GK, 2006, THESIS; Carr-Smith S, 1997, CANINE PARVOVIRUS 1, V19, P125; Creech TG, 2011, THESIS; Durr S, 2017, EPIDEMIOL INFECT, V145, P1339, DOI 10.1017/S095026881700022X; Durr S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003876; Durr S, 2014, PREV VET MED, V117, P340, DOI 10.1016/j.prevetmed.2014.07.008; Hii SF, 2012, AUST VET J, V90, P130, DOI 10.1111/j.1751-0813.2012.00898.x; Holway J, 2013, STEADICAM OPERATORS; Hudson EG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004649; Jenkins DJ, 2014, AUST VET J, V92, P292, DOI 10.1111/avj.12218; Jenkins DJ, 2005, INT J PARASITOL, V35, P733, DOI 10.1016/j.ijpara.2005.03.001; Kesteren FV, 2013, PARASITOLOGY, V140, P1674; Lavelle MJ, 2014, BIOSCIENCE, V64, P524, DOI 10.1093/biosci/biu055; Lavelle MJ, 2012, WILDLIFE SOC B, V36, P828, DOI 10.1002/wsb.216; Loyd KAT, 2013, BIOL CONSERV, V160, P183, DOI 10.1016/j.biocon.2013.01.008; Machovsky-Capuska GE, 2016, NEW ZEAL J MAR FRESH, V50, P418, DOI 10.1080/00288330.2016.1152981; Machovsky-Capuska GE, 2016, ETHOLOGY, V122, P703, DOI 10.1111/eth.12523; Majumder SS, 2014, ACTA ETHOL, V17, P1, DOI 10.1007/s10211-013-0158-0; MELONI BP, 1993, MED J AUSTRALIA, V158, P157, DOI 10.5694/j.1326-5377.1993.tb121692.x; Moil RJ, 2007, TRENDS ECOL EVOL, V22, P660, DOI 10.1016/j.tree.2007.09.007; Moll RJ, 2009, COMPUT ELECTRON AGR, V66, P133, DOI 10.1016/j.compag.2009.01.001; Molloy S, 2017, AUST VET J, V95, P55, DOI 10.1111/avj.12562; Pearson HC, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3079-z; Ropert-Coudert Y, 2005, FRONT ECOL ENVIRON, V3, P437, DOI 10.2307/3868660; Rutz C, 2013, METHODS ECOL EVOL, V4, P114, DOI 10.1111/2041-210x.12003; Rutz C, 2009, BIOL LETTERS, V5, P289, DOI 10.1098/rsbl.2009.0089; SHEN DT, 1981, VET MED SM ANIM CLIN, V76, P1175; Sparkes J, 2015, ZOONOSES PUBLIC HLTH, V62, P237, DOI 10.1111/zph.12142; Warrell MJ, 2004, LANCET, V363, P959, DOI 10.1016/S0140-6736(04)15792-9; Yoda K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019602	35	14	16	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181859	10.1371/journal.pone.0181859	http://dx.doi.org/10.1371/journal.pone.0181859			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750073	Green Published, Green Submitted, gold			2022-12-26	WOS:000406575700092
J	Zapata-Perez, R; Martinez-Monino, AB; Garcia-Saura, AG; Cabanes, J; Takami, H; Sanchez-Ferrer, A				Zapata-Perez, Ruben; Martinez-Monino, Ana-Belen; Garcia-Saura, Antonio-Gines; Cabanes, Juana; Takami, Hideto; Sanchez-Ferrer, Alvaro			Biochemical characterization of a new nicotinamidase from an unclassified bacterium thriving in a geothermal water stream microbial mat community	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE NICOTINAMIDASE; BORRELIA-BURGDORFERI; CATALYTIC MECHANISM; CRYSTAL-STRUCTURE; PURIFICATION; INHIBITION; METABOLISM; DEAMIDASE; ENZYME; GENE	Nicotinamidases are amidohydrolases that convert nicotinamide into nicotinic acid, contributing to NAD(+) homeostasis in most organisms. In order to increase the number of nicotinamidases described to date, this manuscript characterizes a nicotinamidase obtained from a metagenomic library fosmid clone (JFF054_F02) obtained from a geothermal water stream microbial mat community in a Japanese epithermal mine. The enzyme showed an optimum temperature of 90 degrees C, making it the first hyperthermophilic bacterial nicotinamidase to be characterized, since the phylogenetic analysis of this fosmid clone placed it in a clade of uncultured geothermal bacteria. The enzyme, named as UbNic, not only showed an alkaline optimum pH, but also a biphasic pH dependence of its k(cat), with a maximum at pH 9.5-10.0. The two pK(a) values obtained were 4.2 and 8.6 for pK(es1) and pK(es2), respectively. These results suggest a possible flexible catalytic mechanism for nicotinamidases, which reconciles the two previously proposed mechanisms. In addition, the enzyme showed a high catalytic efficiency, not only toward nicotinamide, but also toward other nicotinamide analogs. Its mutational analysis showed that a tryptophan (W83) is needed in one of the faces of the active site to maintain low Km values toward all the substrates tested. Furthermore, UbNic proved to contain a Fe2+ ion in its metal binding site, and was revealed to belong to a new nicotinamidase subgroup. All these characteristics, together with its high pH-and thermal stability, distinguish UbNic from previously described nicotinamidases, and suggest that a wide diversity of enzymes remains to be discovered in extreme environments.	[Zapata-Perez, Ruben; Martinez-Monino, Ana-Belen; Garcia-Saura, Antonio-Gines; Cabanes, Juana; Sanchez-Ferrer, Alvaro] Univ Murcia, Dept Biochem & Mol Biol A, Fac Biol, Reg Campus Int Excellence Campus Mare Nostrum, Murcia, Spain; [Cabanes, Juana; Sanchez-Ferrer, Alvaro] Murcia Biomed Res Inst IMIB, Murcia, Spain; [Takami, Hideto] JAMSTEC, Microbial Genome Res Grp, Yokohama Inst, Kanazawa Ku, Yokohama, Kanagawa, Japan	University of Murcia; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Sanchez-Ferrer, A (corresponding author), Univ Murcia, Dept Biochem & Mol Biol A, Fac Biol, Reg Campus Int Excellence Campus Mare Nostrum, Murcia, Spain.; Sanchez-Ferrer, A (corresponding author), Murcia Biomed Res Inst IMIB, Murcia, Spain.	alvaro@um.es	Takami, Hideto/D-4200-2012; Zapata-Perez, Ruben/AAA-9782-2020; Sánchez-Ferrer, Alvaro/M-1631-2014	Takami, Hideto/0000-0003-3433-7018; Zapata-Perez, Ruben/0000-0003-4432-9652; Sánchez-Ferrer, Alvaro/0000-0001-7266-4402	Spanish grants from MINECO/AEI/FEDER [BI02013-45336-R]; Ayudas a los Grupos y Unidades de Excelencia Cientifica de la Region de Murcia, Fundacion Seneca - Agencia de Ciencia y Tecnologia de la Region de Murcia [19893/GERM/15]; Ministry of Education, Culture, Sports, Science and Technology of Japan [20310124]; University of Murcia; MINECO/AEI/FEDER [BIO02013-45336-R]; Grants-in-Aid for Scientific Research [15KT0039] Funding Source: KAKEN	Spanish grants from MINECO/AEI/FEDER; Ayudas a los Grupos y Unidades de Excelencia Cientifica de la Region de Murcia, Fundacion Seneca - Agencia de Ciencia y Tecnologia de la Region de Murcia; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); University of Murcia; MINECO/AEI/FEDER; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partially supported by Spanish grants from MINECO/AEI/FEDER (BI02013-45336-R) and from the Ayudas a los Grupos y Unidades de Excelencia Cientifica de la Region de Murcia, Fundacion Seneca - Agencia de Ciencia y Tecnologia de la Region de Murcia (19893/GERM/15, Programa de Apoyo a la Investigacion 2014). This study was also supported in part by Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan to HT (no. 20310124). A-GG-S is supported by the corresponding predoctoral fellowships (FPU-UMU) from the University of Murcia. A-BM-M and RZ-P have a predoctoral research fellowship associated with the above MINECO/AEI/FEDER (BIO02013-45336-R) project.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Boshoff HIM, 1998, J BACTERIOL, V180, P5809, DOI 10.1128/JB.180.22.5809-5814.1998; CALBREATH DF, 1971, J BIOL CHEM, V246, P4334; Chen D, 2011, J BIOL CHEM, V286, P13261, DOI 10.1074/jbc.M110.206771; Du XL, 2001, BIOCHEMISTRY-US, V40, P14166, DOI 10.1021/bi0115479; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Ely F, 2010, BIOCHEM J, V432, P565, DOI 10.1042/BJ20101054; French JB, 2010, BIOCHEMISTRY-US, V49, P10421, DOI 10.1021/bi1012518; French JB, 2010, BIOCHEMISTRY-US, V49, P8803, DOI 10.1021/bi1012436; Fyfe PK, 2009, ANGEW CHEM INT EDIT, V48, P9176, DOI 10.1002/anie.200903407; GADD REA, 1974, INT J BIOCHEM, V5, P397, DOI 10.1016/0020-711X(74)90136-0; Gazanion E, 2011, MOL MICROBIOL, V82, P21, DOI 10.1111/j.1365-2958.2011.07799.x; Ghislain M, 2002, YEAST, V19, P215, DOI 10.1002/yea.810; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GROSSOWICZ N, 1956, BIOCHIM BIOPHYS ACTA, V20, P576, DOI 10.1016/0006-3002(56)90365-1; Hirayama H, 2005, EXTREMOPHILES, V9, P169, DOI 10.1007/s00792-005-0433-8; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Hu G, 2007, ARCH BIOCHEM BIOPHYS, V461, P66, DOI 10.1016/j.abb.2007.01.037; Hubbard BP, 2013, METHODS MOL BIOL, V1077, P167, DOI 10.1007/978-1-62703-637-5_11; HUGHES DE, 1953, BIOCHEM J, V55, P851, DOI 10.1042/bj0550851; HUGHES DE, 1952, BIOCHEM J, V51, P330, DOI 10.1042/bj0510330; Ion BF, 2014, MOLECULES, V19, P15735, DOI 10.3390/molecules191015735; Jackson VE, 2015, J PHYS CHEM A, V119, P2926, DOI 10.1021/jp5118272; Jewett MW, 2011, MICROBIOL-SGM, V157, P2831, DOI 10.1099/mic.0.051706-0; JOSHI JG, 1962, J BIOL CHEM, V237, P929; KAGAYAMA T, 1990, AGR BIOL CHEM TOKYO, V54, P2565, DOI 10.1080/00021369.1990.10870351; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Liu X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024227; Murphy DJ, 2004, ANAL BIOCHEM, V327, P61, DOI 10.1016/j.ab.2003.12.018; Noguchi H, 2008, DNA RES, V15, P387, DOI 10.1093/dnares/dsn027; Nunoura T, 2005, ENVIRON MICROBIOL, V7, P1967, DOI 10.1111/j.1462-2920.2005.00881.x; PARDEE AB, 1971, J BIOL CHEM, V246, P6792; Pei JM, 2014, METHODS MOL BIOL, V1079, P263, DOI 10.1007/978-1-62703-646-7_17; Petrella S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015785; Purser JE, 2003, MOL MICROBIOL, V48, P753, DOI 10.1046/j.1365-2958.2003.03452.x; Rack JGM, 2016, ANNU REV BIOCHEM, V85, P431, DOI 10.1146/annurev-biochem-060815-014935; Sakiyama T, 2000, BIOSCI BIOTECH BIOCH, V64, P670, DOI 10.1271/bbb.64.670; Sanchez-Carron G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056727; Sanchez-Carron G, 2011, APPL ENVIRON MICROB, V77, P2471, DOI 10.1128/AEM.02927-10; Sauve AA, 2008, J PHARMACOL EXP THER, V324, P883, DOI 10.1124/jpet.107.120758; Segel IH., 1993, ENZYME KINETICS BEHA; Seiner DR, 2010, BIOCHEMISTRY-US, V49, P9613, DOI 10.1021/bi1011157; Sheng X, 2014, ORG BIOMOL CHEM, V12, P1265, DOI 10.1039/c3ob42182a; Smith BC, 2012, BIOCHEMISTRY-US, V51, P243, DOI 10.1021/bi2015508; Sorci L, 2010, J BIOL CHEM, V285, P39490, DOI 10.1074/jbc.M110.185629; Stekhanova TN, 2014, BIOCHEMISTRY-MOSCOW+, V79, P54, DOI 10.1134/S0006297914010088; Takami H, 2000, NUCLEIC ACIDS RES, V28, P4317, DOI 10.1093/nar/28.21.4317; Takami H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030559; TANIGAWA Y, 1972, J BIOL CHEM, V247, P8036; van der Horst A, 2007, MECH AGEING DEV, V128, P346, DOI 10.1016/j.mad.2007.01.004; Wang GD, 2007, PLANT J, V49, P1020, DOI 10.1111/j.1365-313X.2006.03013.x; Wang XL, 2016, APPL ENVIRON MICROB, V82, P5815, DOI 10.1128/AEM.01829-16; Wilkins MR, 1999, METH MOL B, V112, P531; YAN C, 1987, J BIOL CHEM, V262, P9082; Yang Y, 2016, BBA-PROTEINS PROTEOM, V1864, P1787, DOI 10.1016/j.bbapap.2016.06.014; Zapata-Perez R, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01915; Zhang H, 2008, FEBS J, V275, P753, DOI 10.1111/j.1742-4658.2007.06241.x; Zhang RM, 2010, CURR OPIN DRUG DISC, V13, P389	61	2	2	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181561	10.1371/journal.pone.0181561	http://dx.doi.org/10.1371/journal.pone.0181561			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750065	Green Submitted, Green Published, gold			2022-12-26	WOS:000406575700057
J	Lee, JH; Han, YS; Yoon, YM; Yun, CW; Yun, SP; Kim, SM; Kwon, HY; Jeong, D; Baek, MJ; Lee, HJ; Lee, SJ; Han, HJ; Lee, SH				Lee, J. H.; Han, Y-S; Yoon, Y. M.; Yun, C. W.; Yun, S. P.; Kim, S. M.; Kwon, H. Y.; Jeong, D.; Baek, M. J.; Lee, H. J.; Lee, S-J; Han, H. J.; Lee, S. H.			Role of HSPA1L as a cellular prion protein stabilizer in tumor progression via HIF-1 alpha/GP78 axis	ONCOGENE			English	Article							PROMOTES SARCOMA METASTASIS; COLORECTAL-CANCER CELLS; HEAT-SHOCK PROTEINS; STEM-CELLS; NEUROBLASTOMA-CELLS; DEGRADATION; HYPOXIA; ACTIVATION; EXPRESSION; UBIQUITIN	The cellular prion protein (PrPC) is associated with metastasis, tumor progression and recurrence; however, the precise mechanisms underlying its action is not well understood. Our study found that PrPC degradation decreased tumor progression in colorectal cancer (CRC). In a CRC cell line and human CRC tissue exposed to hypoxia, induced heat-shock 70-kDa protein-1-like (HSPA1L) expression stabilized hypoxia-inducible factor-1 alpha (HIF-1 alpha) protein and promoted PrPC accumulation and tumorigenicity in vivo. PrPC was degraded via the proteasome pathway mediated by the ubiquitin-protein E3 ligase glycoprotein 78 (GP78), which interacts directly with PrPC. However, hypoxia-induced HSPA1L interacted with GP78 and inhibited its functions. HSPA1L knockdown facilitated the interaction of GP78 and PrPC, thereby increasing PrPC ubiquitination. Thus, GP78 was identified as the ubiquitinase for PrPC, thereby revealing an essential mechanism that controls PrPC levels in CRC. Our results suggest that the HSPA1L/HIF-1 alpha/GP78 axis has a crucial role in PrPC accumulation during tumor progression.	[Lee, J. H.] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham Sch Med, Birmingham, AL USA; [Han, Y-S; Yoon, Y. M.; Yun, C. W.; Lee, S. H.] Soonchunhyang Univ, Seoul Hosp, Med Sci Res Inst, Seoul, South Korea; [Han, Y-S; Yoon, Y. M.; Yun, C. W.; Lee, S. H.] Soonchunhyang Univ, Coll Med, Dept Biochem, Cheonan, South Korea; [Yun, S. P.; Kim, S. M.] Johns Hopkins Univ, Sch Med, Neuroregenerat & Stem Cell Programs, Inst Cell Engn,Dept Neurol, Baltimore, MD USA; [Kwon, H. Y.] Soonchunhyang Univ, Soonchunhyang Inst Medibio Sci, Cheonan, South Korea; [Jeong, D.] Soonchunhyang Univ, Coll Med, Dept Pathol, Cheonan, South Korea; [Baek, M. J.] Soonchunhyang Univ, Coll Med, Dept Surg, Cheonan, South Korea; [Lee, H. J.; Lee, S-J; Han, H. J.] Seoul Natl Univ, Coll Vet Med, Dept Vet Physiol, Seoul 151741, South Korea; [Lee, H. J.; Lee, S-J; Han, H. J.] Seoul Natl Univ, Res Inst Vet Sci, Seoul 151741, South Korea; [Lee, H. J.; Lee, S-J; Han, H. J.] Seoul Natl Univ, PLUS Creat Vet Res Ctr BK21, Seoul, South Korea	University of Alabama System; University of Alabama Birmingham; Soonchunhyang University; Soonchunhyang University; Johns Hopkins University; Soonchunhyang University; Soonchunhyang University; Soonchunhyang University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Han, HJ (corresponding author), Seoul Natl Univ, Coll Vet Med, Dept Vet Physiol, Seoul 151741, South Korea.; Han, HJ (corresponding author), Seoul Natl Univ, Res Inst Vet Sci, Seoul 151741, South Korea.; Lee, SH (corresponding author), Soonchunhyang Univ, Seoul Hosp, Soonchunhyang Med Sci Res Inst, Dept Biochem, 59 Daesagwan Ro,657 Hannam Dong, Seoul 140887, South Korea.	hjhan@snu.ac.kr; ykckss1114@nate.com	lee, sang hun/Q-4650-2019; Baek, Moo-Jun/W-1736-2019; Lee, Sei-Jung/V-8772-2019; Han, Ho Jae/M-1476-2016	lee, sang hun/0000-0002-9005-5966; Baek, Moo-Jun/0000-0003-3567-6687; Han, Ho Jae/0000-0002-0657-1766	Soonchunhyang University Research Fund; National Research Foundation - Korean government [NRF-2011-0009610]; NRF - Ministry of Education [2016R1D1A3B01007727, 2017M3A9B4032528]; Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI14C2253]; Next-Generation Bio-Green 21 Program, Rural Development Administration, Republic of Korea [PJ011141]	Soonchunhyang University Research Fund; National Research Foundation - Korean government(Korean Government); NRF - Ministry of Education; Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea; Next-Generation Bio-Green 21 Program, Rural Development Administration, Republic of Korea	This work was supported by the Soonchunhyang University Research Fund; a National Research Foundation grant funded by the Korean government (NRF-2011-0009610); NRF funded by the Ministry of Education (2016R1D1A3B01007727, 2017M3A9B4032528); a grant from the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI14C2253); and a grant from the Next-Generation Bio-Green 21 Program (No. PJ011141), Rural Development Administration, Republic of Korea. The funders had no role in the study design, data collection or analysis, decision to publish or preparation of the manuscript.	Amelio I, 2015, P NATL ACAD SCI USA, V112, P226, DOI 10.1073/pnas.1410609111; Atarod S, 2015, TRANSPL IMMUNOL, V32, P188, DOI 10.1016/j.trim.2015.02.002; Azad AA, 2015, NAT REV UROL, V12, P26, DOI 10.1038/nrurol.2014.320; Bartolini A, 2016, CLIN CANCER RES, V22, P4923, DOI 10.1158/1078-0432.CCR-15-2664; Boyle P, 2005, ANN ONCOL, V16, P481, DOI 10.1093/annonc/mdi098; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Chang E, 2015, CLIN CANCER RES, V21, P335, DOI 10.1158/1078-0432.CCR-14-0217; Chang YW, 2016, ONCOGENE, V35, P1517, DOI 10.1038/onc.2015.214; Cheng YY, 2014, MOL CARCINOGEN, V53, P686, DOI 10.1002/mc.22021; Chiche L, 2016, NEW ENGL J MED, V374, P2183, DOI 10.1056/NEJMc1602584; Chieng CKL, 2015, TUMOR BIOL, V36, P8107, DOI 10.1007/s13277-015-3530-z; Corsaro A, 2016, ONCOTARGET, V7, P38638, DOI 10.18632/oncotarget.9575; de Wit M, 2012, GUT, V61, P855, DOI 10.1136/gutjnl-2011-300511; Du L, 2013, CANCER RES, V73, P2682, DOI 10.1158/0008-5472.CAN-12-3759; El-Naggar AM, 2015, CANCER CELL, V27, P682, DOI 10.1016/j.ccell.2015.04.003; Gabai VL, 2012, MOL CELL BIOL, V32, P929, DOI 10.1128/MCB.05921-11; Grillari J, 2010, ADV EXP MED BIOL, V694, P172; Hu Y, 2015, CELL BIOCHEM BIOPHYS, V72, P131, DOI 10.1007/s12013-014-0420-8; Jain AK, 2010, CANCER BIOL THER, V10, P665, DOI 10.4161/cbt.10.7.13445; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jones MF, 2015, P NATL ACAD SCI USA, V112, pE1550, DOI 10.1073/pnas.1503370112; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Ledford H, 2011, NATURE, V472, P273, DOI 10.1038/472273a; Lee SH, 2012, J CELL PHYSIOL, V227, P1731, DOI 10.1002/jcp.22897; Li N, 2015, GENE DEV, V29, P157, DOI 10.1101/gad.251785.114; Li NN, 2015, ONCOTARGET, V6, P9240, DOI 10.18632/oncotarget.3284; Li QQ, 2011, CANCER SCI, V102, P400, DOI 10.1111/j.1349-7006.2010.01811.x; Lianos GD, 2015, CANCER LETT, V360, P114, DOI 10.1016/j.canlet.2015.02.026; Liu X, 2016, INT J MOL MED, V37, P825, DOI 10.3892/ijmm.2016.2482; Lopes MH, 2015, ONCOGENE, V34, P3305, DOI 10.1038/onc.2014.261; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; Minet E, 1999, FEBS LETT, V460, P251, DOI 10.1016/S0014-5793(99)01359-9; Mirzaei MR, 2016, CELL J, V17, P608; Mo JH, 2012, CANCER SCI, V103, P464, DOI 10.1111/j.1349-7006.2011.02181.x; Mohammadi A, 2016, INFLAMMATION, V39, P1116, DOI 10.1007/s10753-016-0343-1; Nagaraju GP, 2015, MOL CARCINOGEN, V54, P1147, DOI 10.1002/mc.22185; Natalwala A, 2008, WORLD J GASTROENTERO, V14, P3792, DOI 10.3748/wjg.14.3792; Park JY, 2015, ONCOTARGET, V6, P5342, DOI 10.18632/oncotarget.3028; Peer CJ, 2011, CANCER BIOL THER, V11, P549, DOI 10.4161/cbt.11.6.14834; Powles T, 2016, J CLIN ONCOL, V34, P1660, DOI 10.1200/JCO.2015.64.8808; Pratt WB, 2010, EXP BIOL MED, V235, P278, DOI 10.1258/ebm.2009.009250; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; Shao J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092290; Sherman MY, 2015, ONCOGENE, V34, P4153, DOI 10.1038/onc.2014.349; Srivastava S, 2016, GENE, V585, P154, DOI 10.1016/j.gene.2016.03.031; Tsai YC, 2007, NAT MED, V13, P1504, DOI 10.1038/nm1686; Vilches S, 2016, MOL NEUROBIOL, V53, P4438, DOI 10.1007/s12035-015-9360-6; Wang QW, 2012, ONCOL REP, V28, P2029, DOI 10.3892/or.2012.2025; Ward HA, 2016, BRIT J NUTR, V116, P316, DOI 10.1017/S0007114516001859; Watanabe T, 2012, NEUROSCI LETT, V531, P114, DOI 10.1016/j.neulet.2012.10.032; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Welch HG, 2016, NEW ENGL J MED, V374, P1605, DOI 10.1056/NEJMp1600448; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wigerup C, 2016, PHARMACOL THERAPEUT, V164, P152, DOI 10.1016/j.pharmthera.2016.04.009; Young GP, 2005, MOL NUTR FOOD RES, V49, P571, DOI 10.1002/mnfr.200500026; Zhang DY, 2010, CANCER RES, V70, P813, DOI 10.1158/0008-5472.CAN-09-0448; Zhang TP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118448; Zomosa-Signoret V, 2008, VET RES, V39, DOI 10.1051/vetres:2007048	59	29	29	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 23	2017	36	47					6555	6567		10.1038/onc.2017.263	http://dx.doi.org/10.1038/onc.2017.263			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FN5LN	28759037				2022-12-26	WOS:000416049200005
J	Gong, X; Liu, J; Zhang, D; Yang, DW; Min, ZH; Wen, XX; Wang, GF; Li, HY; Song, YL; Bai, CX; Li, J; Zhou, J				Gong, Xin; Liu, Jing; Zhang, Dan; Yang, Dawei; Min, Zhihui; Wen, Xiaoxing; Wang, Guifang; Li, Huayin; Song, Yuanlin; Bai, Chunxue; Li, Jing; Zhou, Jian			GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin	PLOS ONE			English	Article							P53 TARGET GENE; TUMOR-SUPPRESSOR; RTVP-1; IDENTIFICATION; METHYLATION; EXPRESSION; SURVIVAL	Background and objective Chemotherapy drugs, such as cisplatin (DDP), improve the survival of patients with lung cancer by inducing apoptosis in cancer cells, which quickly develop resistance to DDP through uncharacterized mechanisms. Glioma Pathogenesis-Related Protein 1 (GLIPR1) plays an important role in cell proliferation, migration and apoptosis. However, the expression and function of GLIPR1 in mediating DDP resistance in human lung adenocarcinoma A549/DDP and human large cell lung cancer H460/DDP cells has not yet been reported. Methods In this study, real-time PCR (RT-PCR) and western blot were used to examine the mRNA and protein expression of GLIPR1, respectively. Bright-field microscopy, the cell counting kit-8 (CCK-8) assay, flow cytometry analysis and JC-1 dye were used to measure the cellular morphology, proliferation, apoptosis and mitochondrial membrane potential, respectively. Results Compared to human lung adenocarcinoma A549 cells, the mRNA and protein expression of GLIPR1 were significantly increased in DDP-resistant A549/DDP cells (p < 0.05). Similarly, the mRNA level of GLIPR1 in DDP-resistant H460/DDP cells was also significantly higher than that in DDP-sensitive H460 cells (p < 0.05). Silencing of GLIPR1 in A549/DDP and H460/DDP cells led to increased apoptosis via a mitochondrial signaling pathway following incubation with various concentrations of DDP. Furthermore, GLIPR1 downregulation markedly reduced the protein expression of Bcl-2, and increased the cleaved Poly (ADPRibose) Polymerase (PARP) and cleaved caspase-3 in DDP-resistant A549/DDP cells. Conclusion In this study, we demonstrated for the first time that GLIPR1 could modulate the response of DDP-resistant A549/DDP and H460/DDP cells to cisplatin. Therefore, GLIPR1 deserves further investigation in the context of none-small lung cancer (NSCLC).	[Gong, Xin; Zhang, Dan; Yang, Dawei; Wen, Xiaoxing; Li, Huayin; Song, Yuanlin; Bai, Chunxue; Li, Jing; Zhou, Jian] Fudan Univ, Zhongshan Hosp, Shanghai Resp Res Inst, Dept Pulm Med, Shanghai, Peoples R China; [Liu, Jing] Qingdao Univ, Affiliated Yantai Yuhuangding Hosp, Dept Pathol, Yantai, Peoples R China; [Min, Zhihui] Fudan Univ, Zhongshan Hosp, Biomed Res Ctr, Shanghai, Peoples R China; [Wang, Guifang] Fudan Univ, Huashan Hosp, Dept Pulm Med, Shanghai, Peoples R China; [Bai, Chunxue] Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China	Fudan University; Qingdao University; Fudan University; Fudan University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Li, J; Zhou, J (corresponding author), Fudan Univ, Zhongshan Hosp, Shanghai Resp Res Inst, Dept Pulm Med, Shanghai, Peoples R China.	liumiao.lijing@163.com; zhou.jian@fudan.edu.cn		Bai, Chunxue/0000-0001-5798-3130; Yang, Dawei/0000-0002-8928-143X	973 Program of the Ministry of Science and Technology of China [2012CB933304]; Doctoral Program of Higher Education of China [20130071120063]; National Key Scientific & Technology Support Program [201313AI091309]; Youth Foundation of Zhongshan Hospital Fudan University [2015ZSQN26]; Shanghai Committee of Science and Technology [12411950100]; Natural Science Foundation of China [81570028, 81400018]	973 Program of the Ministry of Science and Technology of China(National Basic Research Program of China); Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Key Scientific & Technology Support Program; Youth Foundation of Zhongshan Hospital Fudan University; Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The grants and their roles in this study are listed below: 1. The 973 Program of the Ministry of Science and Technology of China (2012CB933304), playing a role in the design of the study; 2. The Natural Science Foundation of China (81570028 and 81400018), in data collection; 3. The Doctoral Program of Higher Education of China (20130071120063), in data analysis; 4. The National Key Scientific & Technology Support Program (201313AI091309), in data interpretation; 5. Youth Foundation of Zhongshan Hospital Fudan University (2015ZSQN26), in writing and editing the manuscript. 6. The Shanghai Committee of Science and Technology (12411950100), in the design of the study and data analysis.	Arriagada R, 2010, J CLIN ONCOL, V28, P35, DOI 10.1200/JCO.2009.23.2272; Awasthi A, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00225; Barr MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054193; Bier A, 2013, ONCOTARGET, V4, P665, DOI 10.18632/oncotarget.928; Chilukamarri L, 2007, NEOPLASIA, V9, P970, DOI 10.1593/neo.07661; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Helbig L, 2011, J BIOL CHEM, V286, P12991, DOI 10.1074/jbc.M110.190645; Huang ZX, 2007, ACTA BIOCH BIOPH SIN, V39, P835, DOI 10.1111/j.1745-7270.2007.00356.x; Jacoby E, 2014, ONCOL LETT, V7, P1209, DOI 10.3892/ol.2014.1829; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Li L, 2008, CANCER RES, V68, P434, DOI 10.1158/0008-5472.CAN-07-2931; Li LK, 2013, MOL ONCOL, V7, P484, DOI 10.1016/j.molonc.2012.12.005; Li LK, 2011, CANCER RES, V71, P7694, DOI 10.1158/0008-5472.CAN-11-1714; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Ly JD, MITOCHONDRIAL MEMBRA; MURPHY EV, 1995, GENE, V159, P131, DOI 10.1016/0378-1119(95)00061-A; Nishio Kazuto, 1999, Current Opinion in Oncology, V11, P109, DOI 10.1097/00001622-199903000-00006; Ren CH, 2002, MOL CELL BIOL, V22, P3345, DOI 10.1128/MCB.22.10.3345-3357.2002; Ren CZ, 2006, GENOMICS, V88, P163, DOI 10.1016/j.ygeno.2006.03.021; Ren CZ, 2004, CANCER RES, V64, P969, DOI 10.1158/0008-5472.CAN-03-2592; Rich T, 1996, GENE, V180, P125, DOI 10.1016/S0378-1119(96)00431-3; Rosenzweig T, 2006, CANCER RES, V66, P4139, DOI 10.1158/0008-5472.CAN-05-2851; Sheng XM, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0508-4; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Tan XL, 2011, CLIN CANCER RES, V17, P5801, DOI 10.1158/1078-0432.CCR-11-1133; Xiang CL, 2007, BIOCHEM BIOPH RES CO, V362, P612, DOI 10.1016/j.bbrc.2007.08.138; Xiao YH, 2011, J CANCER RES CLIN, V137, P1831, DOI 10.1007/s00432-011-1065-2	27	4	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182410	10.1371/journal.pone.0182410	http://dx.doi.org/10.1371/journal.pone.0182410			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771580	Green Submitted, Green Published, gold			2022-12-26	WOS:000406853600105
J	Taylor, PK; Van Kessel, ATM; Colavita, A; Hancock, REW; Mah, TF				Taylor, Patrick K.; Van Kessel, Antonius T. M.; Colavita, Antonio; Hancock, Robert E. W.; Mah, Thien-Fah			A novel small RNA is important for biofilm formation and pathogenicity in Pseudomonas aeruginosa	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; BACTERIAL; IDENTIFICATION; MOTILITY; SYSTEM; GENOME; DNA; TRANSFORMATION; INFECTION; MODELS	The regulation of biofilm development requires multiple mechanisms and pathways, but it is not fully understood how these are integrated. Small RNA post-transcriptional regulators are a strong candidate as a regulatory mechanism of biofilm formation. More than 200 small RNAs in the P. aeruginosa genome have been characterized in the literature to date; however, little is known about their biological roles in the cell. Here we describe the identification of the novel regulatory small RNA, SrbA. This locus was up-regulated 45-fold in P. aeruginosa strain PA14 biofilm cultures. Loss of SrbA expression in a deletion strain resulted in a 66% reduction in biofilm mass. Furthermore, the mortality rate over 72 hours in C. elegans infections was reduced to 39% when infected with the srbA deletion strain compared to 78% mortality when infected with the parental wild-type P. aeruginosa strain. There was no significant effect on culture growth or adherence to surfaces with loss of SrbA expression. Also loss of SrbA expression had no effect on antibiotic resistance to ciprofloxacin, gentamicin, and tobramycin. We conclude that SrbA is important for biofilm formation and full pathogenicity of P. aeruginosa.	[Taylor, Patrick K.; Van Kessel, Antonius T. M.; Mah, Thien-Fah] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Colavita, Antonio] Ottawa Hosp, Res Inst, Neurosci Program, Ottawa, ON, Canada; [Hancock, Robert E. W.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of British Columbia	Mah, TF (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	tmah@uottawa.ca	Hancock, Robert E. W./E-1145-2013	Hancock, Robert E. W./0000-0001-5989-8503; Van Kessel, Antonius T.M./0000-0002-5646-6358; Colavita, Antonio/0000-0001-9391-5282	Natural Sciences and Engineering Research Council (NSERC) [RGPIN-2016-05650]; Cystic Fibrosis Canada (CFC) [2613]; Canadian Institutes of Health Research (CIHR); Queen Elizabeth II Graduate Scholarship in Science and Technology (QEII-GSST); Natural Sciences and Engineering Research Council (NSERC); Cystic Fibrosis Canada (CFC)	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Cystic Fibrosis Canada (CFC); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Queen Elizabeth II Graduate Scholarship in Science and Technology (QEII-GSST); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Cystic Fibrosis Canada (CFC)	This work was supported by grants from the Natural Sciences and Engineering Research Council (NSERC, Grant: RGPIN-2016-05650) and Cystic Fibrosis Canada (CFC, Grant: 2613) held by TFM. REWH holds a Canada Research Chair in Health and Genomics, a UBC Killam Professorship, and a grant from the Canadian Institutes of Health Research (CIHR). PKT was supported by a Queen Elizabeth II Graduate Scholarship in Science and Technology (QEII-GSST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the Natural Sciences and Engineering Research Council (NSERC) and Cystic Fibrosis Canada (CFC) held by TFM. REWH holds a Canada Research Chair in Health and Genomics, a UBC Killam Professorship, and a grant from the Canadian Institutes of Health Research (CIHR). PKT was supported by a Queen Elizabeth II Graduate Scholarship in Science and Technology (QEII-GSST). We are appreciative for training and preparation for working with C. elegans provided by Tony Roenspies. We would like to thank Clayton W. Hall for reading and providing input on this manuscript.	Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Artimo Panu, 2012, Nucleic Acids Res, V40, pW597, DOI 10.1093/nar/gks400; Barken KB, 2008, ENVIRON MICROBIOL, V10, P2331, DOI 10.1111/j.1462-2920.2008.01658.x; Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011; Brackman G, 2011, ANTIMICROB AGENTS CH, V55, P2655, DOI 10.1128/AAC.00045-11; Camins BC, 2013, SEMIN DIALYSIS, V26, P476, DOI 10.1111/sdi.12117; Chenoweth C, 2013, CRIT CARE CLIN, V29, P19, DOI 10.1016/j.ccc.2012.10.005; Colvin KM, 2012, ENVIRON MICROBIOL, V14, P1913, DOI 10.1111/j.1462-2920.2011.02657.x; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Edwards S, 2012, FEMS IMMUNOL MED MIC, V65, P205, DOI 10.1111/j.1574-695X.2012.00975.x; Fernandez L, 2016, SCI REP-UK, V6, DOI 10.1038/srep26811; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Gilbert Peter, 2002, Adv Microb Physiol, V46, P202; Gill EE, 2016, BIORXIVORG; Giltner CL, 2006, MOL MICROBIOL, V59, P1083, DOI 10.1111/j.1365-2958.2005.05002.x; Gomez-Lozano M, 2012, ENVIRON MICROBIOL, V14, P2006, DOI 10.1111/j.1462-2920.2012.02759.x; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Gottesman S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003798; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hmelo LR, 2015, NAT PROTOC, V10, P1820, DOI 10.1038/nprot.2015.115; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Jensen PO, 2010, FEMS IMMUNOL MED MIC, V59, P292, DOI 10.1111/j.1574-695X.2010.00706.x; Kerr KG, 2009, J HOSP INFECT, V73, P338, DOI 10.1016/j.jhin.2009.04.020; Kery MB, 2014, NUCLEIC ACIDS RES, V42, pW124, DOI 10.1093/nar/gku317; Kirienko NV, 2014, METHODS MOL BIOL, V1149, P653, DOI 10.1007/978-1-4939-0473-0_50; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Mah TF, 2012, FUTURE MICROBIOL, V7, P1061, DOI [10.2217/FMB.12.76, 10.2217/fmb.12.76]; Michaux C, 2014, MICROBIOL-SGM, V160, P1007, DOI 10.1099/mic.0.076208-0; Mikkelsen H, 2009, MICROBIOL-SGM, V155, P687, DOI 10.1099/mic.0.025551-0; Mulcahy LR, 2014, MICROB ECOL, V68, P1, DOI 10.1007/s00248-013-0297-x; Munch R, 2003, NUCLEIC ACIDS RES, V31, P266, DOI 10.1093/nar/gkg037; OTOOLE GA, 1998, MOL MICROBIOL, V30, P295, DOI [10.1046/j.1365-2958.1998.01062.x, DOI 10.1046/J.1365-2958.1998.01062.X]; Overhage J, 2007, J BACTERIOL, V189, P2164, DOI 10.1128/JB.01623-06; Petrova OE, 2016, CURR OPIN MICROBIOL, V30, P67, DOI 10.1016/j.mib.2016.01.004; Petrova OE, 2010, J BACTERIOL, V192, P5275, DOI 10.1128/JB.00387-10; Powell Jennifer R., 2008, V415, P403, DOI 10.1007/978-1-59745-570-1_24; Pusic P, 2016, SCI REP-UK, V6, DOI 10.1038/srep39621; Richards GR, 2011, BBA-GENE REGUL MECH, V1809, P525, DOI 10.1016/j.bbagrm.2011.07.013; Ryder C, 2007, CURR OPIN MICROBIOL, V10, P644, DOI 10.1016/j.mib.2007.09.010; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; SCHWEIZER HP, 1991, GENE, V97, P109, DOI 10.1016/0378-1119(91)90016-5; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SMITH AW, 1989, NUCLEIC ACIDS RES, V17, P10509, DOI 10.1093/nar/17.24.10509; Sonnleitner E, 2011, APPL MICROBIOL BIOT, V91, P63, DOI 10.1007/s00253-011-3332-1; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Toyofuku M, 2012, J PROTEOME RES, V11, P4906, DOI 10.1021/pr300395j; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Winsor GL, 2016, NUCLEIC ACIDS RES, V44, pD646, DOI 10.1093/nar/gkv1227; Wurtzel O, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002945	55	12	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182582	10.1371/journal.pone.0182582	http://dx.doi.org/10.1371/journal.pone.0182582			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771593	Green Published, Green Submitted, gold			2022-12-26	WOS:000406853600145
J	Torroba-Balmori, P; Budde, KB; Heer, K; Gonzalez-Martinez, SC; Olsson, S; Scotti-Saintagne, C; Casalis, M; Sonke, B; Dick, CW; Heuertz, M				Torroba-Balmori, Paloma; Budde, Katharina B.; Heer, Katrin; Gonzalez-Martinez, Santiago C.; Olsson, Sanna; Scotti-Saintagne, Caroline; Casalis, Maxime; Sonke, Bonaventure; Dick, Christopher W.; Heuertz, Myriam			Altitudinal gradients, biogeographic history and microhabitat adaptation affect fine-scale spatial genetic structure in African and Neotropical populations of an ancient tropical tree species	PLOS ONE			English	Article							RAIN-FOREST TREE; TAMARINS LEONTOPITHECUS-ROSALIA; SEED-DISPERSAL; POLLEN DISPERSAL; SYMPHONIA-GLOBULIFERA; COMPUTER-PROGRAM; CERATOGYMNA HORNBILLS; POLLINATION BIOLOGY; DJA RESERVE; LANDSCAPE	The analysis of fine-scale spatial genetic structure (FSGS) within populations can provide insights into eco-evolutionary processes. Restricted dispersal and locally occurring genetic drift are the primary causes for FSGS at equilibrium, as described in the isolation by distance (IBD) model. Beyond IBD expectations, spatial, environmental or historical factors can affect FSGS. We examined FSGS in seven African and Neotropical populations of the late-successional rain forest tree Symphonia globulifera L.f. (Clusiaceae) to discriminate the influence of drift-dispersal vs. landscape/ecological features and historical processes on FSGS. We used spatial principal component analysis and Bayesian clustering to assess spatial genetic heterogeneity at SSRs and examined its association with plastid DNA and habitat features. African populations (from Cameroon and Sao Tome A) displayed a stronger FSGS than Neotropical populations at both marker types (mean Sp = 0.025 vs. Sp = 0.008 at SSRs) and had a stronger spatial genetic heterogeneity. All three African populations occurred in pronounced altitudinal gradients, possibly restricting animal-mediated seed dispersal. Cyto-nuclear disequilibria in Cameroonian populations also suggested a legacy of biogeographic history to explain these genetic patterns. Conversely, Neotropical populations exhibited a weaker FSGS, which may reflect more efficient wide-ranging seed dispersal by Neotropical bats and other dispersers. The population from French Guiana displayed an association of plastid haplotypes with two morphotypes characterized by differential habitat preferences. Our results highlight the importance of the microenvironment for eco-evolutionary processes within persistent tropical tree populations.	[Torroba-Balmori, Paloma; Gonzalez-Martinez, Santiago C.; Olsson, Sanna; Heuertz, Myriam] INIA Forest Res Ctr, Dept Forest Ecol & Genet, Madrid, Spain; [Torroba-Balmori, Paloma; Gonzalez-Martinez, Santiago C.] Univ Valladolid, INIA, Sustainable Forest Management Res Inst, Palencia, Spain; [Budde, Katharina B.; Gonzalez-Martinez, Santiago C.; Heuertz, Myriam] Univ Bordeaux, UMR BIOGECO, INRA, Cestas, France; [Heer, Katrin] Univ Ulm, Inst Expt Ecol, Ulm, Germany; [Heer, Katrin] Univ Marburg, Conservat Biol & Ecol, Marburg, Germany; [Scotti-Saintagne, Caroline] INRA, UR Ecol Forets Mediterraneennes, Avignon, France; [Casalis, Maxime] INRA, UMR EcoFoG, Kourou, French Guiana; [Sonke, Bonaventure] Univ Yaounde I, Ecole Normale Super, Yaounde, Cameroon; [Sonke, Bonaventure; Heuertz, Myriam] Univ Libre Bruxelles, Fac Sci, Evolutionary Biol & Ecol, Brussels, Belgium; [Dick, Christopher W.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Dick, Christopher W.] Smithsonian Trop Res Inst, Panama City, Panama	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Universidad de Valladolid; INRAE; UDICE-French Research Universities; Universite de Bordeaux; Ulm University; Philipps University Marburg; INRAE; INRAE; University of Yaounde I; Universite Libre de Bruxelles; University of Michigan System; University of Michigan; Smithsonian Institution; Smithsonian Tropical Research Institute	Heuertz, M (corresponding author), INIA Forest Res Ctr, Dept Forest Ecol & Genet, Madrid, Spain.; Heuertz, M (corresponding author), Univ Bordeaux, UMR BIOGECO, INRA, Cestas, France.; Heuertz, M (corresponding author), Univ Libre Bruxelles, Fac Sci, Evolutionary Biol & Ecol, Brussels, Belgium.	myriam.heuertz@inra.fr	Olsson, Sanna/W-4515-2017; Torroba-Balmori, Paloma/E-7908-2016; Budde, Katharina Birgit/ABE-2022-2021; Gonzalez-Martinez, Santiago C/H-2014-2012; Heer, Katrin/C-6725-2018; Scotti-Saintagne, Caroline/AAC-1938-2020; Budde, Katharina Birgit B./B-6915-2015; Heuertz, Myriam/A-7831-2011	Olsson, Sanna/0000-0002-1199-4499; Torroba-Balmori, Paloma/0000-0001-9218-430X; Gonzalez-Martinez, Santiago C/0000-0002-4534-3766; Heer, Katrin/0000-0002-1036-599X; Budde, Katharina Birgit B./0000-0002-5361-2815; Heuertz, Myriam/0000-0002-6322-3645; Scotti-Saintagne, Caroline/0000-0001-6891-7315	Ministerio de Ciencia e Innovacion (ES) [CGL2012-40129-C02-02, FPI BES-2009-015443]; 'Ramon y Cajal' fellowship [RYC2009-04537]; Ministerio de Educacion, Cultura y Deporte [FPU 12/00125]; European Commission FP7 People: Marie Curie Actions; Marie-Curie Intra-European fellowship [PIEF-GA-2012-329088, 203822/E40]; German National Academic Foundation; Agence Nationale de la Recherche (FR); "Investissement d'Avenir" grant CEBA [ANR-10-LABX-0025]; European Social Fund	Ministerio de Ciencia e Innovacion (ES); 'Ramon y Cajal' fellowship(Spanish Government); Ministerio de Educacion, Cultura y Deporte; European Commission FP7 People: Marie Curie Actions; Marie-Curie Intra-European fellowship(European Commission); German National Academic Foundation; Agence Nationale de la Recherche (FR)(French National Research Agency (ANR)); "Investissement d'Avenir" grant CEBA(French National Research Agency (ANR)); European Social Fund(European Social Fund (ESF))	This work was supported by the Ministerio de Ciencia e Innovacion (ES), http://www.idi.mineco.gob.es/portal/site/MICINN/, grant CGL2012-40129-C02-02, to MH; Ministerio de Ciencia e Innovacion (ES), PhD scholarship FPI BES-2009-015443 to KBB; Ministerio de Ciencia e Innovacion (ES), Ramon y Cajal fellowship RYC2009-04537 to MH; Ministerio de Educacion, Cultura y Deporte, http://www.mecd.gob.es/portada-mecd/, PhD scholarship FPU 12/00125 to PTB; European Commission FP7 People: Marie Curie Actions, http://ec.europa.eu/programmes/horizon2020/, Marie-Curie Intra-European fellowship PIEF-GA-2012-329088 to MH; Research Council of Norway, http://www.forskningsradet.no/, grant 203822/E40 to MH; German National Academic Foundation, http://www.studienstiftung.de/, PhD scholarship to KH; Agence Nationale de la Recherche (FR), http://www.agence-nationale-recherche.fr/, "Investissement dAvenir" grant CEBA, ref. ANR-10-LABX-0025, to CSS and MH and the European Social Fund, http://ec.europa.eu/esf/home.jsp, PhD grant to MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Salim K., 2002, THESIS; Aldrich PR, 1998, SCIENCE, V281, P103, DOI 10.1126/science.281.5373.103; Aldrich PR, 1998, MOL ECOL, V7, P933, DOI 10.1046/j.1365-294x.1998.00396.x; Allie E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141488; Andrew RL, 2012, MOL ECOL, V21, P2078, DOI 10.1111/j.1365-294X.2012.05454.x; [Anonymous], 2014, R LANG ENV STAT COMP; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; ASMUSSEN MA, 1989, GENETICS, V122, P923; Audigeos D, 2013, J EVOLUTION BIOL, V26, P529, DOI 10.1111/jeb.12069; AUGSPURGER CK, 1980, EVOLUTION, V34, P475, DOI [10.2307/2408217, 10.1111/j.1558-5646.1980.tb04837.x]; Baraloto C, 2007, ECOLOGY, V88, P478, DOI 10.1890/0012-9658(2007)88[478:SWSTAH]2.0.CO;2; Barthe S, 2016, MOL ECOL; BAWA KS, 1985, AM J BOT, V72, P346, DOI 10.2307/2443527; Bittrich V, 1996, PLANT SYST EVOL, V200, P101, DOI 10.1007/BF00984751; Born C, 2008, MOL ECOL, V17, P2041, DOI 10.1111/j.1365-294X.2007.03685.x; Brewer SW, 1999, J VEG SCI, V10, P165, DOI 10.2307/3237138; Brookfield JFY, 1996, MOL ECOL, V5, P453, DOI 10.1046/j.1365-294X.1996.00098.x; Brooks D.M., 1997, TAPIRS STATUS SURVEY; Brousseau L, 2015, PLOS ONE, P10; Budde KB, 2013, HEREDITY, V111, P66, DOI 10.1038/hdy.2013.21; Budde KB, 2017, ANN BOT-LONDON, V119, P1061, DOI 10.1093/aob/mcw286; CANOVA L, 1993, B ZOOL, V60, P193, DOI 10.1080/11250009309355809; Carneiro FD, 2009, FOREST ECOL MANAG, V258, P1260, DOI 10.1016/j.foreco.2009.06.019; Carneirol FDS, 2007, BIOTROPICA, V39, P628, DOI 10.1111/j.1744-7429.2007.00314.x; Charles-Dominique P, 1986, FRUGIVORES SEED DISP, P119, DOI DOI 10.1007/978-94-009-4812-9_12; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Clark CJ, 2001, BIOTROPICA, V33, P606, DOI 10.1111/j.1744-7429.2001.tb00219.x; Cordeiro NJ, 2009, ECOLOGY, V90, P1030, DOI 10.1890/07-1208.1; Cortes MC, 2013, BIOL REV, V88, P255, DOI 10.1111/j.1469-185X.2012.00250.x; De-Lucas AI, 2009, MOL ECOL, V18, P4564, DOI 10.1111/j.1365-294X.2009.04372.x; Debout GDG, 2011, HEREDITY, V106, P88, DOI 10.1038/hdy.2010.35; Degen B, 2006, BIOL CONSERV, V131, P386, DOI 10.1016/j.biocon.2006.02.014; Degen B, 2004, HEREDITY, V93, P585, DOI 10.1038/sj.hdy.6800560; Dick C. W., 2008, Tropical Plant Biology, V1, P20, DOI 10.1007/s12042-007-9006-6; Dick CW, 2008, EVOLUTION, V62, P2760, DOI 10.1111/j.1558-5646.2008.00506.x; Dick CW, 2013, ECOL EVOL, V3, P162, DOI 10.1002/ece3.441; Dick CW, 2003, AM NAT, V162, P691, DOI 10.1086/379795; Dick CW, 2003, MOL ECOL, V12, P753, DOI 10.1046/j.1365-294X.2003.01760.x; DUBOST G, 1984, J MAMMAL, V65, P298, DOI 10.2307/1381169; Dyer RJ, 2012, LANDSCAPE ECOL, V27, P239, DOI 10.1007/s10980-011-9696-x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Feder JL, 2012, TRENDS GENET, V28, P342, DOI 10.1016/j.tig.2012.03.009; Fields PD, 2014, HEREDITY, V112, P99, DOI 10.1038/hdy.2013.79; Forget P. M., 2007, Seed dispersal: theory and its application in a changing world, P5, DOI 10.1079/9781845931650.0005; FORGET PM, 1990, J TROP ECOL, V6, P459, DOI 10.1017/S0266467400004867; Fragoso JMV, 1997, J ECOL, V85, P519, DOI 10.2307/2960574; Francois O, 2010, MOL ECOL RESOUR, V10, P773, DOI 10.1111/j.1755-0998.2010.02868.x; Frantz AC, 2009, J APPL ECOL, V46, P493, DOI 10.1111/j.1365-2664.2008.01606.x; GAUTIERHION A, 1985, OECOLOGIA, V65, P324, DOI 10.1007/BF00378906; GAUTIERHION A, 1980, OECOLOGIA, V45, P182, DOI 10.1007/BF00346458; Gill GE, 1998, BIOTROPICA, V30, P139, DOI 10.1111/j.1744-7429.1998.tb00378.x; Giometto M.G., 2016, BOUND-LAY METEOROL, P1; Giordano AR, 2007, MOL ECOL, V16, P1625, DOI 10.1111/j.1365-294X.2006.03223.x; Girard P, 2008, GENETICA, V134, P187, DOI 10.1007/s10709-007-9224-8; Gonmadje C. F., 2013, Scripta Botanica Belgica, V50, P244; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Guichoux E, 2013, MOL ECOL, V22, P450, DOI 10.1111/mec.12125; Hardy O., 2013, SPAGEDI 1 4 PROGRAM; Hardy OJ, 2006, MOL ECOL, V15, P559, DOI 10.1111/j.1365-294X.2005.02785.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hendry AP, 2005, MOL ECOL, V14, P901, DOI 10.1111/j.1365-294X.2005.02480.x; Henry O, 2000, BIOTROPICA, V32, P364, DOI 10.1646/0006-3606(2000)032[0364:DOTLTT]2.0.CO;2; Heuertz M, 2003, MOL ECOL, V12, P2483, DOI 10.1046/j.1365-294X.2003.01923.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holbrook KM, 2000, OECOLOGIA, V125, P249, DOI 10.1007/s004420000445; Jan du Chene R, 1978, REV ESP MICROPALEONT, V10, P285; Jha S, 2010, P NATL ACAD SCI USA, V107, P13760, DOI 10.1073/pnas.1002490107; Jombart T, 2008, HEREDITY, V101, P92, DOI 10.1038/hdy.2008.34; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jones FA, 2013, J BIOGEOGR, V40, P720, DOI 10.1111/jbi.12037; Jordano P, 2007, P NATL ACAD SCI USA, V104, P3278, DOI 10.1073/pnas.0606793104; Kaplin Beth A., 2002, P351, DOI 10.1079/9780851995250.0351; Kremer A, 2002, FOREST ECOL MANAG, V156, P75, DOI 10.1016/S0378-1127(01)00635-1; Lapenta MJ, 2008, TROP CONSERV SCI, V1, P122, DOI 10.1177/194008290800100205; Lapenta MJ, 2003, MAMMALIA, V67, P41, DOI 10.1515/mamm.2003.67.1.41; LINHART YB, 1977, BIOTROPICA, V9, P143, DOI 10.2307/2387672; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; MAGUIRE B, 1976, TAXON, V25, P241, DOI 10.2307/1219446; Malecot G., 1951, ANN U LYON, V13, P339; Maley J, 1996, P ROYAL SOC EDINBURG, V104B, P31, DOI 10.1017/S0269727000006114; Mann CF, 2001, GUIDE SUNBIRDS FLOWE; McCain CM, 2005, ECOLOGY, V86, P366, DOI 10.1890/03-3147; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; Melo FPL, 2009, BIOTROPICA, V41, P737, DOI 10.1111/j.1744-7429.2009.00528.x; Miller KE, 2005, INT J PRIMATOL, V26, P1291, DOI 10.1007/s10764-005-8854-7; Misiewicz TM, 2014, MOL ECOL, V23, P2543, DOI 10.1111/mec.12746; Mitton JB, 2000, MOL ECOL, V9, P91, DOI 10.1046/j.1365-294x.2000.00840.x; MORRISON DW, 1980, J MAMMAL, V61, P20, DOI 10.2307/1379953; MORRISON DW, 1978, ECOLOGY, V59, P716, DOI 10.2307/1938775; Ndiade-Bourobou D, 2010, MOL ECOL, V19, P4949, DOI 10.1111/j.1365-294X.2010.04864.x; Nosil P, 2008, EVOLUTION, V62, P316, DOI 10.1111/j.1558-5646.2007.00299.x; Olsson S, 2016, MOL ECOL RESOUR; Orozco-terWengel P, 2011, MOL ECOL, V20, P1108, DOI 10.1111/j.1365-294X.2010.04990.x; ORTEGA J, 2001, AM SOC MAMMALOGISTS, V662, P1, DOI DOI 10.1644/1545-1410(2001)662%3C0001:AJ%3E2.0.C0;2; Oyen L., PROTA PLANT RESOURCE; Paquette SR, 2012, PACKAGE POPGENKIT US; Pascarella John B., 1992, Brenesia, V0, P83; Perez-Espona S, 2008, MOL ECOL, V17, P981, DOI 10.1111/j.1365-294X.2007.03629.x; Petkova D, 2016, NAT GENET, V48, P94, DOI 10.1038/ng.3464; Piotti A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073391; Poulsen JR, 2001, J TROP ECOL, V17, P787, DOI 10.1017/S0266467401001602; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2010, DOCUMENTATION STRUCT; QGIS Development Team, 2009, QGIS GEOGR INF SYST; Rhodes MK, 2014, J HERED, V105, P806, DOI 10.1093/jhered/esu051; RICHARDS AJ, 1990, BOT J LINN SOC, V103, P233, DOI 10.1111/j.1095-8339.1990.tb00186.x; Robledo-Arnuncio JJ, 2005, J BIOGEOGR, V32, P595, DOI 10.1111/j.1365-2699.2004.01196.x; Rousset F, 2000, J EVOLUTION BIOL, V13, P58; Sagnard F, 2011, TREE GENET GENOMES, V7, P37, DOI 10.1007/s11295-010-0313-y; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; SCHUPP EW, 1993, VEGETATIO, V108, P15; Schwartz MK, 2009, CONSERV GENET, V10, P441, DOI 10.1007/s10592-008-9622-1; Scotti I, 2016, ANN FOREST SCI, V73, P69, DOI 10.1007/s13595-015-0471-z; Shafer ABA, 2013, ECOL LETT, V16, P940, DOI 10.1111/ele.12120; Storfer A, 2010, MOL ECOL, V19, P3496, DOI 10.1111/j.1365-294X.2010.04691.x; Sweeney PW, 2008, INT J PLANT SCI, V169, P1288, DOI 10.1086/591990; Tchouto MGP, 2009, SYST BIODIVERS, V7, P21, DOI 10.1017/S1477200008002892; The Plant List, 2013, VERS 1 1; Ukizintambara T, 2009, THESIS; Van der Niet T, 2015, BOT J LINN SOC, V177, P141, DOI 10.1111/boj.12229; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Vinson CC, 2005, MOL ECOL NOTES, V5, P202, DOI 10.1111/j.1471-8286.2005.00876.x; Wang IJ, 2011, MOL ECOL, V20, P2480, DOI 10.1111/j.1365-294X.2011.05123.x; WEBB CJ, 1983, EVOLUTION, V37, P1258, DOI 10.1111/j.1558-5646.1983.tb00242.x; Whitney KD, 1998, J TROP ECOL, V14, P351, DOI 10.1017/S0266467498000273; Wright S, 1943, GENETICS, V28, P114; Yuan N, 2014, AM J BOT, V101, P521, DOI 10.3732/ajb.1400043	129	20	20	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182515	10.1371/journal.pone.0182515	http://dx.doi.org/10.1371/journal.pone.0182515			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771629	Green Published, gold, Green Submitted			2022-12-26	WOS:000406853600132
J	Shete, PB; Ravindran, R; Chang, E; Worodria, W; Chaisson, LH; Andama, A; Davis, JL; Luciw, PA; Huang, L; Khan, IH; Cattamanchi, A				Shete, Priya B.; Ravindran, Resmi; Chang, Emily; Worodria, William; Chaisson, Lelia H.; Andama, Alfred; Davis, J. Lucian; Luciw, Paul A.; Huang, Laurence; Khan, Imran H.; Cattamanchi, Adithya			Evaluation of antibody responses to panels of M. tuberculosis antigens as a screening tool for active tuberculosis in Uganda	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; SERODIAGNOSIS; DIAGNOSTICS; PROFILES; NEEDS	Background Improved systematic screening of high-risk groups is a key component of the tuberculosis (TB) elimination strategy endorsed by the World Health Organization (WHO). We used a multiplex microbead immunoassay to measure antibody responses to 28 M. tuberculosis (M.tb) antigens, and assessed whether combinations of antibody responses achieve accuracy thresholds required for a TB screening test. Methods A random selection of plasma samples obtained from consecutive HIV-negative adults who were admitted to Mulago Hospital in Kampala, Uganda with cough >= 2 weeks' but <6 months' duration were analyzed for serological response to 28 M.tb antigens using an in-house multiplex microbead immunoassay. We compared the median difference of the antibody response to each antigen between patients with and without culture-confirmed TB, ranked each antigen according to variable importance (VIM), and assessed the sensitivity and specificity of combinations of antibody responses using an advanced classification algorithm, SuperLearner. Results Among the 237 patients included in the analysis, 119 (50%) were female, median age was 32 years (IQR 25, 46), and 113 (48%) had TB. Median antibody levels to eight antigens were significantly different between patients with and without TB. A panel including eight of the top ranked antigens had a sensitivity of 90.6% (95% CI 89.4, 93.8) and a specificity of 88.6% (95% CI 78.2, 97.6) (Ag85B, Ag85A, Ag85C, Rv0934-P38, Rv3881, BfrB, Rv3873, and Rv2878c). With sensitivity constrained to be >90%, specificity remained close to 70% with as few as 3 antigens included in the panels. Conclusions Measuring antibody responses to combinations of antigens could facilitate TB screening and should be further evaluated in populations being targeted for systematic screening.	[Shete, Priya B.; Chang, Emily; Huang, Laurence; Cattamanchi, Adithya] Univ Calif San Francisco, Div Pulm & Crit Care, San Francisco, CA 94143 USA; [Shete, Priya B.; Chang, Emily; Huang, Laurence; Cattamanchi, Adithya] Zuckerberg San Francisco Gen Hosp, San Francisco, CA USA; [Shete, Priya B.; Huang, Laurence; Cattamanchi, Adithya] Univ Calif San Francisco, Curry Int TB Ctr, San Francisco, CA 94143 USA; [Ravindran, Resmi; Luciw, Paul A.; Khan, Imran H.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Worodria, William; Andama, Alfred] Makerere Univ, Dept Med, Coll Hlth Sci, Kampala, Uganda; [Chaisson, Lelia H.] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Davis, J. Lucian] Yale Univ, Epidemiol Microbial Dis, Sch Publ Hlth, New Haven, CT USA; [Davis, J. Lucian] Yale Univ, Sch Med, Pulm Crit Care & Sleep Med Sect, New Haven, CT USA; [Huang, Laurence] Univ Calif San Francisco, HIV Infect Dis & Global Med Div, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis; Makerere University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Yale University; Yale University; University of California System; University of California San Francisco	Khan, IH (corresponding author), Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA.	ihkhan@ucdavis.edu	Huang, Laurence/AAE-1590-2019; Huang, Laurence/AAZ-7120-2021; Khan, imran/GQQ-2176-2022; Davis, J. Lucian/AAC-8376-2019; Khan, Imran Ali/GVT-0232-2022	Huang, Laurence/0000-0003-3888-2195; Davis, J. Lucian/0000-0002-8629-9992; Khan, Imran Ali/0000-0002-8774-2896	National Institutes of Health [K24 HL087713, R01 HL090335, U01 HL098964]; UCSF Center for AIDS Research National Institutes of Health/National Institute for Allergy and Infectious Disease [P30-AI027763]; National Heart, Lung, Blood Institute [T32 5T32HL007185-35]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090335, U01HL098964, K24HL087713, R01HL128156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Center for AIDS Research National Institutes of Health/National Institute for Allergy and Infectious Disease; National Heart, Lung, Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the following sources of funding: National Institutes of Health grants K24 HL087713 (AC), R01 HL090335 (LH), and U01 HL098964 (LH); a pilot award from the UCSF Center for AIDS Research National Institutes of Health/National Institute for Allergy and Infectious Disease grant number P30-AI027763 (AC), and an institutional training grant from the National Heart, Lung, Blood Institute T32 5T32HL007185-35 (PS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Burbelo PD, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0545-y; Cattamanchi A, 2011, AM J RESP CRIT CARE, V183, P547, DOI 10.1164/rccm.201008-1207OC; Denkinger CM, 2015, J INFECT DIS, V211, pS29, DOI 10.1093/infdis/jiu821; Gelman A, 2008, ANN APPL STAT, V2, P1360, DOI 10.1214/08-AOAS191; Golub JE, 2005, INT J TUBERC LUNG D, V9, P1183; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hoff ST, 2007, CLIN INFECT DIS, V45, P575, DOI 10.1086/520662; Hubbard A, 2013, J TRAUMA ACUTE CARE, V75, pS53, DOI 10.1097/TA.0b013e3182914553; Ireton GC, 2010, CLIN VACCINE IMMUNOL, V17, P1539, DOI 10.1128/CVI.00198-10; Ivanyi J, 2012, TUBERCULOSIS, V92, P31, DOI 10.1016/j.tube.2011.09.001; Khan IH, 2008, CLIN VACCINE IMMUNOL, V15, P433, DOI 10.1128/CVI.00354-07; Khan IH, 2011, CLIN VACCINE IMMUNOL, V18, P2148, DOI 10.1128/CVI.05304-11; Kik SV, 2014, EUR RESPIR J, V44, P537, DOI 10.1183/09031936.00027714; Koss CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126591; Lonnroth K, 2013, INT J TUBERC LUNG D, V17, P289, DOI 10.5588/ijtld.12.0797; Lyashchenko K, 1998, INFECT IMMUN, V66, P3936, DOI 10.1128/IAI.66.8.3936-3940.1998; NASSAU E, 1976, TUBERCLE, V57, P67, DOI 10.1016/0041-3879(76)90019-2; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; Pai M, 2015, J INFECT DIS, V211, pS21, DOI 10.1093/infdis/jiu803; Polley E. C., 2010, SUPER LEARNER PREDIC; Singh S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040213; Steingart KR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001062; WHO, 2011, COMM SER TESTS DIAGN; World Health Organization, 2015, SYSTEMATIC SCREENING; World Health Organization, 2014, HIGH PRIOR TARG PROD; Yoo SDJ, 2010, JAIDS-J ACQ IMM DEF, V54, P269, DOI 10.1097/QAI.0b013e3181ce6b19	27	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0180122	10.1371/journal.pone.0180122	http://dx.doi.org/10.1371/journal.pone.0180122			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767658	Green Published, Green Submitted, gold			2022-12-26	WOS:000406768200004
J	Le Gouellec, N; Duhamel, A; Perez, T; Hachulla, AL; Sobanski, V; Faivre, JB; Morell-Dubois, S; Lambert, M; Hatron, PY; Hachulla, E; Behal, H; Matran, R; Launay, D; Remy-Jardin, M				Le Gouellec, Noemie; Duhamel, Alain; Perez, Thierry; Hachulla, Anne-Lise; Sobanski, Vincent; Faivre, Jean-Baptiste; Morell-Dubois, Sandrine; Lambert, Marc; Hatron, Pierre-Yves; Hachulla, Eric; Behal, Helene; Matran, Regis; Launay, David; Remy-Jardin, Martine			Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease	PLOS ONE			English	Article							RESOLUTION COMPUTED-TOMOGRAPHY; FIBROSING ALVEOLITIS; SCLERODERMA LUNG; RISK-FACTORS; PLACEBO; CYCLOPHOSPHAMIDE; STANDARDIZATION; CAPACITY; ULCERS; DEATH	Systemic sclerosis-related interstitial lung disease (SSc-ILD) is the leading cause of death in SSc. In this study, we aimed to describe the baseline severity and evolution of forced vital capacity (FVC) and diffusing capacity for carbon monoxide (DLCO) in patients with SSc-ILD and to assess the baseline clinical, biological and high-resolution CT scan (HRCT) predictors of this evolution. Baseline and serial FVC and DLCO were collected in 75 SSc-ILD patients followed during 6.4 +/- 4.2 years (n = 557 individual data). FVC and DLCO evolution was modelled using a linear mixed model with random effect. During follow-up, FVC was stable while DLCO significantly decreased (-1.5 +/- 0.3%/year (p<0.0001). Baseline NYHA functional class III/IV, extensive SSc-ILD on HRCT and DLCO<80% were associated with a lower baseline FVC. Absence of digital ulcers extensive SSc-ILD, and FVC<80%and were associated with a lower baseline DLCO. Presence or history of digital ulcers and presence of pulmonary hypertension at baseline or during follow-up were associated with a faster decline of DLCO overtime. Neither age, gender, subtype of SSc nor specificity of autoantibodies were associated with baseline severity or outcome of lung function tests. In this SScILD population, FVC was therefore stable while DLCO significantly declined over time. ILD extension was associated with baseline FVC and DLCO but not with their evolution. Presence or history of digital ulcers and pulmonary hypertension were predictors of a faster decline of DLCO over time.	[Le Gouellec, Noemie; Sobanski, Vincent; Morell-Dubois, Sandrine; Lambert, Marc; Hatron, Pierre-Yves; Hachulla, Eric; Launay, David] Univ Lille, U995, LIRIC, Lille, France; [Le Gouellec, Noemie; Sobanski, Vincent; Morell-Dubois, Sandrine; Lambert, Marc; Hatron, Pierre-Yves; Hachulla, Eric; Launay, David] INSERM, U995, Lille, France; [Le Gouellec, Noemie; Sobanski, Vincent; Morell-Dubois, Sandrine; Lambert, Marc; Hatron, Pierre-Yves; Hachulla, Eric; Launay, David] CHU Lille, Dept Med Interne & Immunol Clin, Lille, France; [Le Gouellec, Noemie; Sobanski, Vincent; Morell-Dubois, Sandrine; Lambert, Marc; Hatron, Pierre-Yves; Hachulla, Eric; Launay, David] Ctr Natl Ref Malad Syst & Autoimmunes Rares Scler, Lille, France; [Duhamel, Alain; Behal, Helene] UFR Med, EA 2694, UDSL, Lille, France; [Perez, Thierry; Matran, Regis] CHRU Lille, Serv Explorat Fonctionnelles Resp, Lille, France; [Hachulla, Anne-Lise; Faivre, Jean-Baptiste; Remy-Jardin, Martine] CHRU Lille, Dept Imagerie Thorac, Lille, France	Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille	Launay, D (corresponding author), Univ Lille, U995, LIRIC, Lille, France.; Launay, D (corresponding author), INSERM, U995, Lille, France.; Launay, D (corresponding author), CHU Lille, Dept Med Interne & Immunol Clin, Lille, France.; Launay, D (corresponding author), Ctr Natl Ref Malad Syst & Autoimmunes Rares Scler, Lille, France.	david.launay@univ-lille2.fr	Launay, David/H-1674-2016; Thierry, PEREZ/AAB-4853-2020; Sobanski, Vincent/U-5676-2019; HACHULLA, ERIC/R-8488-2018; Sobanski, Vincent/Q-6411-2016; lambert, marc/V-7380-2017; Launay, David/A-5270-2018	Launay, David/0000-0003-1840-1817; HACHULLA, ERIC/0000-0001-7432-847X; Sobanski, Vincent/0000-0003-3083-2441; lambert, marc/0000-0002-3485-8238; Launay, David/0000-0003-1840-1817				Alivernini S, 2009, J AM ACAD DERMATOL, V60, P426, DOI 10.1016/j.jaad.2008.11.025; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Bouros D, 2002, AM J RESP CRIT CARE, V165, P1581, DOI 10.1164/rccm.2106012; Brown H., 1999, APPL MIXED MODELS ME; Castellvi I, 2014, J RHEUMATOL; Clements PJ, 2007, ANN RHEUM DIS, V66, P1641, DOI 10.1136/ard.2007.069518; Goh NSL, 2008, AM J RESP CRIT CARE, V177, P1248, DOI 10.1164/rccm.200706-877OC; Goh NS, LID, P2326; Hachulla E, 2011, CLIN REV ALLERG IMMU, V40, P78, DOI 10.1007/s12016-010-8198-y; Hoyles RK, 2006, ARTHRITIS RHEUM-US, V54, P3962, DOI 10.1002/art.22204; Khanna D, 2011, ARTHRITIS RHEUM-US, V63, P3078, DOI 10.1002/art.30467; Launay D, 2016, J SCLERODER IN PRESS; Launay D, 2006, J RHEUMATOL, V33, P1789; LeRoy EC, 2001, J RHEUMATOL, V28, P1573; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Man A, 2015, RHEUMATOLOGY, V54, P1464, DOI 10.1093/rheumatology/kev016; McCulloch CE, 2002, STAT MED, V21, P417, DOI 10.1002/sim.1027; Mihai C, 2015, ANN RHEUM D IN PRESS; Moore OA, 2015, CLIN EXP RHEUMATOL, V33, pS111; Moore OA, 2013, RHEUMATOLOGY, V52, P155, DOI 10.1093/rheumatology/kes289; Silva I, 2015, AUTOIMMUN REV, V14, P140, DOI 10.1016/j.autrev.2014.10.009; STEEN VD, 1992, ARTHRITIS RHEUM, V35, P765, DOI 10.1002/art.1780350709; Steen VD, 2007, ANN RHEUM DIS, V66, P940, DOI 10.1136/ard.2006.066068; STUPI AM, 1986, ARTHRITIS RHEUM, V29, P515, DOI 10.1002/art.1780290409; Tashkin DP, 2006, NEW ENGL J MED, V354, P2655, DOI 10.1056/NEJMoa055120; Tyndall AJ, 2010, ANN RHEUM DIS, V69, P1809, DOI 10.1136/ard.2009.114264; Verbeke G., 2000, LINEAR MIXED MODELS, P55; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Wells AU, 2009, RHEUMATOLOGY, V48, P40, DOI 10.1093/rheumatology/kep109; Wells AU, 2014, PRESSE MED, V43, pE329, DOI 10.1016/j.lpm.2014.08.002; WELLS AU, 1994, AM J RESP CRIT CARE, V149, P1583, DOI 10.1164/ajrccm.149.6.8004317	31	54	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0181692	10.1371/journal.pone.0181692	http://dx.doi.org/10.1371/journal.pone.0181692			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763468	gold, Green Published, Green Submitted			2022-12-26	WOS:000406766500016
J	Wang, ZL; Yang, LY; Chen, HH; Lin, HH; Tsai, YT; Huang, WJ				Wang, Zhong-Lin; Yang, Ling-Yu; Chen, Hong-Huan; Lin, Hsiao-Hsin; Tsai, Yi-Ting; Huang, William J.			Effects of TNF-alpha on penile structure alteration in rats with hyperprolactinemia	PLOS ONE			English	Article							ERECTILE DYSFUNCTION; CORPUS CAVERNOSUM; SILDENAFIL CITRATE; SEXUAL DYSFUNCTION; STEM-CELLS; TESTOSTERONE; PROLACTIN; MECHANISMS; SECRETION; INCREASE	This study aimed to investigate the effects of anti-tumor necrosis factor (TNF)-alpha antibody (Ab) on alteration of penile structure in the hyperprolactinemia (hyperPRL) rat model. HyperPRL was induced in 8-week-old male Sprague-Dawley rats by allografting anterior pituitary (AP) glands under the renal capsule (+AP rats). Rats implanted with cerebral cortex (CX) were used as sham control (+CX rats). At 6 weeks post implantation, rats received either a single intra-testicular dose of TNF-alpha Ab (12.5 mu g/kg) or testosterone replacement (2 doses of testosterone enanthate [TE], 3 mg/kg), and they were sacrificed 1 week later. Blood and penile tissue was collected for analysis. Compared to +CX rats, the +AP group had lower serum testosterone concentration and neuronal nitric oxide synthase (nNOS) expression, but exhibited a higher ratio of collagen III/I in the corpus cavernosum. Smooth muscle content exhibited no significant changes. At 1 week post TNF-alpha Ab injection, the collagen III/I ratio in the +AP group was decreased, and the smooth muscle content and nNOS expression increased significantly. These findings were comparable to those observed in +AP rats receiving TE. Testicular TNF-alpha suppresses testosterone release, which in turn results in the erectile dysfunction (ED) seen in hyperPRL. Intra-testicular TNF-alpha Ab treatment is as effective as testosterone supplementation on penile structure normalization in the hyperPRL model.	[Wang, Zhong-Lin; Chen, Hong-Huan; Lin, Hsiao-Hsin; Tsai, Yi-Ting; Huang, William J.] Natl Yang Ming Univ, Sch Med, Dept Physiol, Taipei, Taiwan; [Yang, Ling-Yu] Natl Yang Ming Univ, Sch Med, Dept Pediat, Taipei, Taiwan; [Yang, Ling-Yu] Taipei Vet Gen Hosp, Dept Med Educ & Pediat, Taipei, Taiwan; [Huang, William J.] Natl Yang Ming Univ, Shu Tien Urol Res Ctr, Sch Med, Dept Urol, Taipei, Taiwan; [Huang, William J.] Taipei Vet Gen Hosp, Dept Urol, Div Male Reprod Med, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Huang, WJ (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Physiol, Taipei, Taiwan.; Huang, WJ (corresponding author), Natl Yang Ming Univ, Shu Tien Urol Res Ctr, Sch Med, Dept Urol, Taipei, Taiwan.; Huang, WJ (corresponding author), Taipei Vet Gen Hosp, Dept Urol, Div Male Reprod Med, Taipei, Taiwan.	jshuang@vghtpe.gov.tw	Wang, Zhong Lin/E-2176-2011; wang, jie/GRS-0942-2022	Wang, Zhong Lin/0000-0002-5530-0380; Huang, William/0000-0001-9048-4990; Wang, Zhong-Lin/0000-0002-0568-657X	Taipei Veterans General Hospital [V103C-139]; Ministry of Science and Technology, R.O.C. [NSC101-2314-6-010-003-MY3]	Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Science and Technology, R.O.C.	This work was supported by V103C-139, Taipei Veterans General Hospital, Grant to Huang WJ, http://wd.vghtpe.gov.tw/mre/Fpage.action? muid=5; and NSC101-2314-6-010-003-MY3, Ministry of Science and Technology, R.O.C., Grant to Huang WJ, https://www.most.gov.tw/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidu-Figueiredo M, 2011, BJU INT, V108, P400, DOI 10.1111/j.1464-410X.2010.09944.x; Ajmal A, 2014, PSYCHOSOMATICS, V55, P29, DOI 10.1016/j.psym.2013.08.008; Alwaal A, 2015, ADV DRUG DELIVER REV, V82-83, P137, DOI 10.1016/j.addr.2014.11.012; AOKI H, 1995, J UROLOGY, V154, P595, DOI 10.1016/S0022-5347(01)67118-0; Baba K, 2000, BJU INT, V85, P953, DOI 10.1046/j.1464-410x.2000.00598.x; BARTKE A, 1971, J ENDOCRINOL, V49, P311, DOI 10.1677/joe.0.0490311; Carneiro FS, 2010, J SEX MED, V7, P3823, DOI 10.1111/j.1743-6109.2010.01762.x; Carneiro FS, 2009, J SEX MED, V6, P311, DOI 10.1111/j.1743-6109.2008.01189.x; Carneiro FS, 2009, J SEX MED, V6, P115, DOI 10.1111/j.1743-6109.2008.01029.x; Chen KK, 2010, J SEX MED, V7, P89; Coker F, 2010, CNS DRUGS, V24, P563, DOI 10.2165/11533140-000000000-00000; Gopalakrishnan R, 2006, AM J PSYCHIAT, V163, P494, DOI 10.1176/appi.ajp.163.3.494; Hashimoto H, 2013, J MOL CELL CARDIOL, V62, P69, DOI 10.1016/j.yjmcc.2013.05.008; HOSTETTER MW, 1977, BIOL REPROD, V17, P574, DOI 10.1095/biolreprod17.4.574; Huang WJ, 2003, J CELL BIOCHEM, V88, P766, DOI 10.1002/jcb.10412; Huang WJ, 1999, J CELL BIOCHEM, V74, P111, DOI 10.1002/(SICI)1097-4644(19990701)74:1<111::AID-JCB12>3.3.CO;2-9; Liao CH, 2013, ANDROLOGY-US, V1, P563, DOI 10.1111/j.2047-2927.2013.00086.x; Montejo AL, 2010, J SEX MED, V7, P3404, DOI 10.1111/j.1743-6109.2010.01709.x; Nurnberg HG, 2002, UROLOGY, V60, P58, DOI 10.1016/S0090-4295(02)01691-6; Oh JS, 2009, INT J IMPOT RES, V21, P372, DOI 10.1038/ijir.2009.44; Rehman J, 2000, INT J IMPOT RES, V12, P23, DOI 10.1038/sj.ijir.3900473; Seidman SN, 2001, AM J PSYCHIAT, V158, P1623, DOI 10.1176/appi.ajp.158.10.1623; WANG PS, 1994, J BONE MINER RES, V9, P1583; Xu LJ, 2015, GENET MOL RES, V14, P9951, DOI 10.4238/2015.August.21.1; Zeitlin S I, 2000, Rev Urol, V2, P39; Zhang H, 2016, AM J TRANSL RES, V8, P3049	26	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0181952	10.1371/journal.pone.0181952	http://dx.doi.org/10.1371/journal.pone.0181952			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763467	Green Submitted, Green Published, gold			2022-12-26	WOS:000406766500029
J	He, DT; Zou, TD; Gai, XR; Ma, JD; Li, MZ; Huang, ZQ; Chen, DW				He, Dongting; Zou, Tiande; Gai, Xiangrong; Ma, Jideng; Li, Mingzhou; Huang, Zhiqing; Chen, Daiwen			MicroRNA expression profiles differ between primary myofiber of lean and obese pig breeds	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; SKELETAL-MUSCLE; MESSENGER-RNA; PROLIFERATION; GENOTYPE; DIFFERENTIATION; SPECIFICATION; PATHWAY; TARGETS; QUALITY	MicroRNAs (miRNAs) are non-coding small miRNAs similar to 22 nucleotides in length and play a vital role in muscle development by binding to messenger RNAs (mRNAs). Large White (LW, a lean type pig) and Meishan pigs (MS, a Chinese indigenous obese breed) have significant postnatal phenotype differences in growth rate, muscle mass and meat quality, and these differences are programmed during prenatal muscle development. Little research shed light directly on the miRNA transcriptome difference in prenatal muscles between these two distinct pig breeds. Myofiber phenotypes of LW and MS were measured at developmental stages of 35, 55 and 90 days post-conception (dpc), which revealed that the myogenesis process is more intense in MS than in LW at 35 dpc. To investigate the role of miRNAs involved in regulating muscle development at earlier stages of myogenesis and decipher the miRNAs transcriptome difference between LW and MS, here, the miRNAomes of longissimus dorsi muscle collected at 35 dpc from female LW and MS were analyzed by deep sequencing. Overall, 1147 unique miRNAs comprising 434 known miRNAs, 239 conserved miRNAs and 474 candidate miRNAs were identified. Expression analysis of the 10 most abundant miRNAs in every library indicated that functional miRNAome may be a small amount and tend to be greater expressed. These sets of miRNA may play house keeping roles that were involved in myogenesis. A total of 87 miRNAs were significantly differentially expressed between LW and MS (reads > 1000, P < 0.05). Gene ontology (GO) and KEGG pathway enrichment analysis revealed that the differentially expressed miRNAs (DE miRNAs) were associated mainly with muscle contraction, WNT, mTOR, and MAPK signaling pathways. Some myogenesis related miRNAs (miR-133, miR-1, miR-206 and miR-148a) are highly abundant in MS, while other miRNAs (let-7 family, miR-214, miR-181) highly expressed in LW. In addition, the expression patterns of miRNAs (miR-1, - 133, - 206) at three prenatal stages (35, 55 and 90 dpc) were determined using qRT-PCR. Notably, sscmiR- 133 was significantly more highly expressed in LW pigs skeletal muscle at all prenatal stages compared with its expression in LW pigs skeletal muscle. Taken together, the main functional miRNAs during muscle development are different between lean and obese pig breeds. The present study adds new information to existing data on porcine miRNAs and will be helpful to investigate the dominant (main functional) muscle-related miRNAs sets in different pig breeds.	[He, Dongting; Zou, Tiande; Huang, Zhiqing; Chen, Daiwen] Sichuan Agr Univ, Inst Anim Nutr, Chengdu, Sichuan, Peoples R China; [Gai, Xiangrong] China Agr Univ, Minist Agr Feed Ind Ctr, State Key Lab Anim Nutr, Beijing, Peoples R China; [Ma, Jideng; Li, Mingzhou] Sichuan Agr Univ, Inst Anim Genet & Breeding, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; China Agricultural University; Sichuan Agricultural University	Huang, ZQ; Chen, DW (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Chengdu, Sichuan, Peoples R China.	zqhuang@sicau.edu.cn; dwchen@sicau.edu.cn	zou, tiande/AAE-6768-2019	Li, Mingzhou/0000-0001-8681-7684	National Program on Key Basic Research Project of China [2012CB12470]	National Program on Key Basic Research Project of China(National Basic Research Program of China)	The present study was supported by the National Program on Key Basic Research Project of China (2012CB12470; http://program.most.gov.cn/). DC and ZH received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The present study was supported by the National Program on Key Basic Research Project of China (2012CB12470).	Acharjee S, 2014, J CELL SCI, V127, P599, DOI 10.1242/jcs.136648; Al-Shanti N, 2009, BIOL REV, V84, P637, DOI 10.1111/j.1469-185X.2009.00090.x; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JF, 2009, J CELL SCI, V122, P13, DOI 10.1242/jcs.041723; Chen JH, 2008, ASIAN AUSTRAL J ANIM, V21, P954, DOI 10.5713/ajas.2008.70521; Choe JH, 2008, MEAT SCI, V80, P355, DOI 10.1016/j.meatsci.2007.12.019; da Costa Martins PA, 2010, NAT CELL BIOL, V12, P1220, DOI [10.1038/ncb2126., DOI 10.1038/NCB2126]; DEVRIES AG, 1994, LIVEST PROD SCI, V40, P277, DOI 10.1016/0301-6226(94)90095-7; Feng Y, 2011, CELL BIOCHEM FUNCT, V29, P378, DOI 10.1002/cbf.1760; Gagan J, 2012, J BIOL CHEM, V287, P40360, DOI 10.1074/jbc.M112.378414; Ge YJ, 2011, J CELL BIOL, V192, P69, DOI 10.1083/jcb.201007165; Gee HE, 2008, NATURE, V455, DOI 10.1038/nature07362; Guo LH, 2013, INT J MOL SCI, V14, P14171, DOI 10.3390/ijms140714171; Hou XH, 2016, MOL GENET GENOMICS, V291, P559, DOI 10.1007/s00438-015-1126-3; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Kang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048536; Keren A, 2006, MOL CELL ENDOCRINOL, V252, P224, DOI 10.1016/j.mce.2006.03.017; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kollias HD, 2008, J APPL PHYSIOL, V104, P579, DOI 10.1152/japplphysiol.01091.2007; Lefaucheur L., 2005, Archiv fur Tierzucht, V48, P117; LEFAUCHEUR L, 1986, MEAT SCI, V16, P199, DOI 10.1016/0309-1740(86)90026-4; Lefaucheur L, 2002, J HISTOCHEM CYTOCHEM, V50, P719, DOI 10.1177/002215540205000513; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li L, 2012, J CELL BIOCHEM, V113, P1235, DOI 10.1002/jcb.23457; Li MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012183; Louis M, 2004, FEBS LETT, V557, P243, DOI 10.1016/S0014-5793(03)01504-7; Mai MM, 2016, PEERJ, V4, DOI 10.7717/peerj.1504; Maltin CA, 1998, ANIM SCI, V66, P341, DOI 10.1017/S1357729800009462; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Qin LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072418; Rehfeldt C, 2000, LIVEST PROD SCI, V66, P177, DOI 10.1016/S0301-6226(00)00225-6; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Ryu HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017343; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; SEIDEMAN SC, 1986, MEAT SCI, V17, P55, DOI 10.1016/0309-1740(86)90083-5; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; SUZUKI A, 1980, J ANIM SCI, V51, P1449, DOI 10.2527/jas1981.5161449x; Tang ZL, 2015, SCI REP-UK, V5, DOI 10.1038/srep15544; von Maltzahn J, 2012, TRENDS CELL BIOL, V22, P602, DOI 10.1016/j.tcb.2012.07.008; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Wei F, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-81; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Xu YJ, 2009, J ANIM SCI, V87, P2519, DOI 10.2527/jas.2008-1708; Zhang J, 2012, J BIOL CHEM, V287, P21093, DOI 10.1074/jbc.M111.330381; Zhou B, 2010, ANIM GENET, V41, P499, DOI 10.1111/j.1365-2052.2010.02026.x; Zou T, 2015, EUR J NUTR	51	18	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0181897	10.1371/journal.pone.0181897	http://dx.doi.org/10.1371/journal.pone.0181897			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759650	gold, Green Published, Green Submitted			2022-12-26	WOS:000406761600036
J	Yemshanov, D; Haight, RG; Koch, FH; Venette, R; Studens, K; Fournier, RE; Swystun, T; Turgeon, JJ				Yemshanov, Denys; Haight, Robert G.; Koch, Frank H.; Venette, Robert; Studens, Kala; Fournier, Ronald E.; Swystun, Tom; Turgeon, Jean J.			A safety rule approach to surveillance and eradication of biological invasions	PLOS ONE			English	Article							ANOPLOPHORA-GLABRIPENNIS COLEOPTERA; ASIAN LONGHORNED BEETLE; CERAMBYCIDAE; RISK; COST; INFESTATION; DISPERSAL; MODEL; OPTIMIZATION; UNCERTAINTY	Uncertainty about future spread of invasive organisms hinders planning of effective response measures. We present a two-stage scenario optimization model that accounts for uncertainty about the spread of an invader, and determines survey and eradication strategies that minimize the expected program cost subject to a safety rule for eradication success. The safety rule includes a risk standard for the desired probability of eradication in each invasion scenario. Because the risk standard may not be attainable in every scenario, the safety rule defines a minimum proportion of scenarios with successful eradication. We apply the model to the problem of allocating resources to survey and eradicate the Asian longhorned beetle (ALB, Anoplophora glabripennis) after its discovery in the Greater Toronto Area, Ontario, Canada. We use historical data on ALB spread to generate a set of plausible invasion scenarios that characterizes the uncertainty of the beetle's extent. We use these scenarios in the model to find survey and tree removal strategies that minimize the expected program cost while satisfying the safety rule. We also identify strategies that reduce the risk of very high program costs. Our results reveal two alternative strategies: (i) delimiting surveys and subsequent tree removal based on the surveys' outcomes, or (ii) preventive host tree removal without referring to delimiting surveys. The second strategy is more likely to meet the stated objectives when the capacity to detect an invader is low or the aspirations to eradicate it are high. Our results provide practical guidelines to identify the best management strategy given aspirational targets for eradication and spending.	[Yemshanov, Denys; Studens, Kala; Fournier, Ronald E.; Swystun, Tom; Turgeon, Jean J.] Nat Resources Canada, Canadian Forest Serv, Great Lakes Forestry Ctr, Sault Ste Marie, ON, Canada; [Haight, Robert G.; Venette, Robert] US Forest Serv, USDA, Northern Res Stn, St Paul, MN USA; [Koch, Frank H.] US Forest Serv, USDA, Southern Res Stn, Eastern Forest Environm Threat Assessment Ctr, Res Triangle Pk, NC USA	Natural Resources Canada; Canadian Forest Service; Great Lakes Forestry Centre; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service	Yemshanov, D (corresponding author), Nat Resources Canada, Canadian Forest Serv, Great Lakes Forestry Ctr, Sault Ste Marie, ON, Canada.	Denys.Yemshanov@canada.ca	Fournier, Ronald E/HCG-9133-2022	Fournier, Ronald E/0000-0001-5833-4677; Turgeon, Jean/0000-0002-1487-1718; Yemshanov, Denys/0000-0002-6992-9614	Natural Resources Canada interdepartmental Forest Alien Invasive Species Initiative	Natural Resources Canada interdepartmental Forest Alien Invasive Species Initiative(Natural Resources Canada)	This work was funded by Natural Resources Canada interdepartmental Forest Alien Invasive Species Initiative.	Acerbi C., 2002, EC NOTES BANCA MONTE, V31, P379, DOI DOI 10.1111/1468-0300.00091; Animal Plant Health Inspection Service (APHIS), 2016, AS LONGH BEETL ER PR; Animal Plant Health Inspection Service (APHIS), 2013, AS LONGH BEETL COOP; Artzner P, 1999, MATH FINANC, V9, P203, DOI 10.1111/1467-9965.00068; Bogich TL, 2008, J APPL ECOL, V45, P1134, DOI 10.1111/j.1365-2664.2008.01494.x; Buck James H., 2008, Great Lakes Entomologist, V41, P197; Canadian Food Inspection Agency (CFIA), 2014, AN GLABR MOTSCH AS L; Carrasco LR, 2010, J R SOC INTERFACE, V7, P529, DOI 10.1098/rsif.2009.0266; Carter ME, 2009, CAN ENTOMOL, V141, P582, DOI 10.4039/n09-026; City of Toronto Parks Forestry and Recreation Urban Forestry, 2013, PARKS FOR RECR URB F; Cook G., 2013, TRAFFIC PATTERN PROJ; Davidovitch L, 2009, J ENVIRON MANAGE, V90, P2785, DOI 10.1016/j.jenvman.2009.03.011; Duffie D., 1997, J DERIV, V4, P7, DOI [DOI 10.3905/JOD.1997.407971, 10.3905/jod.1997.407971]; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Environmental Systems Research Institute (ESRI), 2014, STREET MAP PREM ARCG; Epanchin-Niell RS, 2014, ECOL APPL, V24, P1258, DOI 10.1890/13-1331.1; Epanchin-Niell RS, 2012, ECOL LETT, V15, P803, DOI 10.1111/j.1461-0248.2012.01800.x; EPPO, 2008, EPPO REPORTING SERVI; EPPO (European and Mediterranean Plant Protection Organization), 2014, B OEPP EPPO B, V44, P107; Favaro R, 2015, ENTOMOL EXP APPL, V155, P95, DOI 10.1111/eea.12292; GAMS (GAMS Development Corporation), 2015, GEN ALG MOD SYST GAM, V24, P6; Gao YL, 2017, ANNU REV ENTOMOL, V62, P165, DOI 10.1146/annurev-ento-031616-035425; GISD (Global Invasive Species Database), 2016, 100 WORLDS WORST INV; GUROBI. Optimization Inc, 2016, GUROBI OPTIMIZER REF; Haack RA, 2010, ANNU REV ENTOMOL, V55, P521, DOI 10.1146/annurev-ento-112408-085427; HAIGHT RG, 1995, ECOL APPL, V5, P767, DOI 10.2307/1941984; Hardy M., 2003, INVESTMENT GUARANTEE; Hauser CE, 2009, ECOL LETT, V12, P683, DOI 10.1111/j.1461-0248.2009.01323.x; Hester SM, 2010, WEED RES, V50, P269, DOI 10.1111/j.1365-3180.2010.00778.x; Hester S, 2012, HUM ECOL RISK ASSESS, V18, P181, DOI 10.1080/10807039.2012.632307; Hopkin A., 2004, FOREST HLTH BIODIVER, V8, P1; Horie T, 2013, ECOL ECON, V86, P78, DOI 10.1016/j.ecolecon.2012.09.017; Hudgins EJ, 2017, ECOL LETT, V20, P426, DOI 10.1111/ele.12741; Inui K, 2005, J BANK FINANC, V29, P853, DOI 10.1016/j.jbankfin.2004.08.005; Jorion P, 2006, VALUE RISK NEW BENCH; Kim C. S., 2006, Agricultural and Resource Economics Review, V35, P29; Koch FH, 2009, RISK ANAL, V29, P1227, DOI 10.1111/j.1539-6924.2009.01251.x; Kriticos DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054861; Krokhmal P, 2003, COOPERAT SYST, V1, P165; Lee Y, 2013, CAN J FOREST RES, V43, P56, DOI 10.1139/cjfr-2011-0433; LICHTENBERG E, 1988, Q J ECON, V103, P167, DOI 10.2307/1882647; LICHTENBERG E, 1989, J ENVIRON ECON MANAG, V17, P22, DOI 10.1016/0095-0696(89)90034-X; Lingafelter S.W., 2002, REVISION ANOPLOPHORA; Mak WK, 1999, OPER RES LETT, V24, P47, DOI 10.1016/S0167-6377(98)00054-6; Mason Andrew J., 2013, INFORMS Transactions on Education, V14, P45, DOI 10.1287/ited.2013.0112; Maspero M., 2007, Bollettino di Zoologia Agraria e di Bachicoltura, V39, P161; Moore AL, 2016, METHODS ECOL EVOL, V7, P891, DOI 10.1111/2041-210X.12564; Nehme ME, 2014, ENVIRON ENTOMOL, V43, P1034, DOI 10.1603/EN14049; NISC (National Invasive Species Council), 2007, FACT SHEET NAT INV S; Nowak DJ, 2001, J ECON ENTOMOL, V94, P116, DOI 10.1603/0022-0493-94.1.116; Peterson AT, 2004, AM MIDL NAT, V151, P170, DOI 10.1674/0003-0031(2004)151[0170:PGDOAG]2.0.CO;2; Pflug G.C., 2000, PROBABILISTIC CONSTR, V49, P272, DOI DOI 10.1007/978-1-4757-3150-7; Pysek P, 2010, ANNU REV ENV RESOUR, V35, P25, DOI 10.1146/annurev-environ-033009-095548; Rachev S. T., 2007, ADV STOCHASTIC MODEL; Rafoss T, 2003, RISK ANAL, V23, P651, DOI 10.1111/1539-6924.00344; Reaser JK, 2008, BIOL INVASIONS, V10, P1085, DOI 10.1007/s10530-007-9186-x; Rockafellar R. T., 2000, J RISK, V2, P21, DOI 10.21314/JOR.2000.038; Rockafellar RT, 2002, J BANK FINANC, V26, P1443, DOI 10.1016/S0378-4266(02)00271-6; Sarykalin S., 2008, TUTORIALS OPER RES, P270, DOI [10.1287/educ.1080.0052, DOI 10.1287/EDUC.1080.0052]; Shatz AJ, 2013, APPL GEOGR, V45, P259, DOI 10.1016/j.apgeog.2013.10.002; Smith M.T., 2008, INT PEST CONTROL, V50, P311; Smith MT, 2004, ENVIRON ENTOMOL, V33, P435, DOI 10.1603/0046-225X-33.2.435; Smith MT, 2001, ENVIRON ENTOMOL, V30, P1036, DOI 10.1603/0046-225X-30.6.1036; Snyder S, 2004, BIOL CONSERV, V119, P565, DOI 10.1016/j.biocon.2004.01.018; Southern Ontario Land Resource Information System (SOLRIS), 2008, LAND US DAT; Standing Advisory Committee on Trunk Road Appraisal (SACTRA), 1999, TRANSP EC FULL REP S; Straw NA, 2015, FORESTRY, V88, P84, DOI 10.1093/forestry/cpu037; Studer G., 1997, THESIS; Tasche D, 2002, J BANK FINANC, V26, P1519, DOI 10.1016/S0378-4266(02)00272-8; Tetrad Inc, 2014, TRAFFICMETRIX CAN; Tobin P. C., 2008, NRS37 USDA FOR SERV; Trotter III E.T., 2015, BIOL INVASIONS; Turgeon JJ, 2015, COLEOPTS BULL, V69, P674, DOI 10.1649/0010-065X-69.4.674; Turgeon JJ, 2010, CAN ENTOMOL, V142, P80, DOI 10.4039/n09-049; UN- FAO. International Standards for Phytosanitary Measures, 1998, 9 UNFAO ISPM; USDA Animal Plant Health Inspection Service (APHIS), 2005, AS LONGH BEETL AN GL; Wang B., 2005, GEN TECHNICAL REPORT, P89; Williams DW, 2004, ENVIRON ENTOMOL, V33, P540, DOI 10.1603/0046-225X-33.3.540; Yemshanov D, 2017, ECOL ECON, V133, P86, DOI 10.1016/j.ecolecon.2016.11.018; Yemshanov D, 2009, RISK ANAL, V29, P868, DOI 10.1111/j.1539-6924.2009.01203.x; ZADEH LA, 1963, IEEE T AUTOMAT CONTR, VAC 8, P59, DOI 10.1109/TAC.1963.1105511; [No title captured]	82	11	11	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0181482	10.1371/journal.pone.0181482	http://dx.doi.org/10.1371/journal.pone.0181482			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC3TH	28759584	Green Published, Green Submitted, gold			2022-12-26	WOS:000406761600017
J	Belhaj, A; Dewachter, L; Rorive, S; Remmelink, M; Weynand, B; Melot, C; Hupkens, E; Dewachter, C; Creteur, J; Mc Entee, K; Naeije, R; Rondelet, B				Belhaj, Asmae; Dewachter, Laurence; Rorive, Sandrine; Remmelink, Myriam; Weynand, Birgit; Melot, Christian; Hupkens, Emeline; Dewachter, Celine; Creteur, Jacques; Mc Entee, Kathleen; Naeije, Robert; Rondelet, Benoit			Mechanical versus humoral determinants of brain death-induced lung injury	PLOS ONE			English	Article							NEUROGENIC PULMONARY-EDEMA; RESPIRATORY-DISTRESS-SYNDROME; SUBARACHNOID HEMORRHAGE; INFLAMMATORY CYTOKINES; INTRACRANIAL-PRESSURE; VASCULAR-PERMEABILITY; MOLECULAR-MECHANISMS; CAPILLARY-PRESSURE; OXIDATIVE STRESS; TRANSPLANT DONOR	Background The mechanisms of brain death (BD)-induced lung injury remain incompletely understood, as uncertainties persist about time-course and relative importance of mechanical and humoral perturbations. Methods Brain death was induced by slow intracranial blood infusion in anesthetized pigs after randomization to placebo (n = 11) or to methylprednisolone (n = 8) to inhibit the expression of pro-inflammatory mediators. Pulmonary artery pressure (PAP), wedged PAP (PAWP), pulmonary vascular resistance (PVR) and effective pulmonary capillary pressure (PCP) were measured 1 and 5 hours after Cushing reflex. Lung tissue was sampled to determine gene expressions of cytokines and oxidative stress molecules, and pathologically score lung injury. Results Intracranial hypertension caused a transient increase in blood pressure followed, after brain death was diagnosed, by persistent increases in PAP, PCP and the venous component of PVR, while PAWP did not change. Arterial PO2/fraction of inspired O-2 (PaO2/FiO(2)) decreased. Brain death was associated with an accumulation of neutrophils and an increased apoptotic rate in lung tissue together with increased pro-inflammatory interleukin (IL)-6/IL-10 ratio and increased heme oxygenase(HO)-1 and hypoxia inducible factor(HIF)-1 alpha expression. Blood expressions of IL-6 and IL-1 beta were also increased. Methylprednisolone pre-treatment was associated with a blunting of increased PCP and PVR venous component, which returned to baseline 5 hours after BD, and partially corrected lung tissue biological perturbations. PaO2/FiO(2) was inversely correlated to PCP and lung injury score. Conclusions Brain death-induced lung injury may be best explained by an initial excessive increase in pulmonary capillary pressure with increased pulmonary venous resistance, and was associated with lung activation of inflammatory apoptotic processes which were partially prevented by methylprednisolone.	[Belhaj, Asmae; Rondelet, Benoit] Catholic Univ Louvain, Dept Cardiovasc Thorac Surg & Lung Transplantat, CHU UcL Namur, Yvoir, Belgium; [Belhaj, Asmae; Dewachter, Laurence; Melot, Christian; Hupkens, Emeline; Dewachter, Celine; Mc Entee, Kathleen; Naeije, Robert; Rondelet, Benoit] Univ Libre Bruxelles, Lab Physiol & Pharmacol, Fac Med, Brussels, Belgium; [Rorive, Sandrine; Remmelink, Myriam] Erasmus Acad Hosp, Dept Anatomopathol, Brussels, Belgium; [Rorive, Sandrine] DIAPATH, Ctr Microscopy & Mol Imaging, Gosselies, Belgium; [Weynand, Birgit] Katholiek Univ Leuven, Dept Anatomopathol, UZ Leuven, Brussels, Belgium; [Melot, Christian] Erasmus Acad Hosp, Dept Emergency, Brussels, Belgium; [Creteur, Jacques] Erasmus Acad Hosp, Dept Intens Care, Brussels, Belgium	Universite Catholique Louvain; Universite Libre de Bruxelles	Belhaj, A (corresponding author), Catholic Univ Louvain, Dept Cardiovasc Thorac Surg & Lung Transplantat, CHU UcL Namur, Yvoir, Belgium.; Belhaj, A (corresponding author), Univ Libre Bruxelles, Lab Physiol & Pharmacol, Fac Med, Brussels, Belgium.	asmae.belhaj@uclouvain.be	Weynand, Birgit/H-9587-2019	MELOT, Christian/0000-0002-6172-0330	Fonds de la Recherche Scientifique Medicale [3.4515.05]; Belgian Foundation; Fondation Mont-Godinne (Belgium); European Regional Development Fund; Walloon Region	Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Belgian Foundation; Fondation Mont-Godinne (Belgium); European Regional Development Fund(European Commission); Walloon Region	This work was supported by grants from Fonds de la Recherche Scientifique Medicale (grant no. 3.4515.05), the Belgian Foundation for the cardiac surgery and the Fondation Mont-Godinne (Belgium). AB is a fellow of the Fondation Mont-Godinne (Belgium). LD was a FNRS post-doctoral fellow. CMMI is supported by the European Regional Development Fund and the Walloon Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avlonitis VS, 2007, AM J TRANSPLANT, V7, P83, DOI 10.1111/j.1600-6143.2006.01593.x; Avlonitis VS, 2005, AM J TRANSPLANT, V5, P684, DOI 10.1111/j.1600-6143.2005.00755.x; BACONNIER PF, 1992, J APPL PHYSIOL, V73, P1351, DOI 10.1152/jappl.1992.73.4.1351; Barnes PJ, 1998, CLIN SCI, V94, P557, DOI 10.1042/cs0940557; Belhaj A, 2016, J HEART LUNG TRANSPL, pS1053; Biswal S, 2007, ANTIOXID REDOX SIGN, V9, P1959, DOI 10.1089/ars.2007.1808; BRIGHAM KL, 1981, J CLIN INVEST, V67, P1103, DOI 10.1172/JCI110123; Butt Y, 2016, ARCH PATHOL LAB MED, V140, P345, DOI 10.5858/arpa.2015-0519-RA; CAREY PD, 1992, SURGERY, V112, P45; Ciccone AM, 2002, J THORAC CARDIOV SUR, V123, P429, DOI 10.1067/mtc.2002.120732; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; CONNOR RCR, 1969, AM HEART J, V78, P145, DOI 10.1016/0002-8703(69)90001-5; Cypel M, 2011, J HEART LUNG TRANSPL, V30, P452, DOI 10.1016/j.healun.2010.11.012; Davison DL, 2012, CRIT CARE, V16, DOI 10.1186/cc11226; DEMLING R, 1990, CRIT CARE MED, V18, P768, DOI 10.1097/00003246-199007000-00019; Dewachter C, 2010, CRIT CARE MED, V38, P1405, DOI 10.1097/CCM.0b013e3181de8bd3; DONNELLY SC, 1993, LANCET, V341, P643, DOI 10.1016/0140-6736(93)90416-E; ELLIOTT AR, 1992, J APPL PHYSIOL, V73, P1150, DOI 10.1152/jappl.1992.73.3.1150; Fassbender K, 2001, J NEUROL NEUROSUR PS, V70, P534, DOI 10.1136/jnnp.70.4.534; FEIN IA, 1982, CHEST, V81, P318, DOI 10.1378/chest.81.3.318; Fesler P, 2003, EUR RESPIR J, V21, P31, DOI 10.1183/09031936.03.00054202; Fodstad H, 2006, NEUROSURGERY, V59, P1132, DOI 10.1227/01.NEU.0000245582.08532.7C; Follette DM, 1998, J HEART LUNG TRANSPL, V17, P423; GUYTON AC, 1959, CIRC RES, V7, P649, DOI 10.1161/01.RES.7.4.649; HASLETT C, 1987, AM REV RESPIR DIS, V136, P9, DOI 10.1164/ajrccm/136.1.9; HOFMAN WF, 1983, J APPL PHYSIOL, V54, P926, DOI 10.1152/jappl.1983.54.4.926; Hong SB, 2005, CRIT CARE MED, V33, P2049, DOI 10.1097/01.CCM.0000178186.37167.53; Hvas CL, 2012, ACTA ANAESTH SCAND, V56, P995, DOI 10.1111/j.1399-6576.2012.02682.x; Kurdowska A, 1996, J IMMUNOL, V157, P2699; Le W, 1999, J NEUROSCI RES, V56, P652; Liu H, 2015, INT IMMUNOPHARMACOL, V29, P937, DOI 10.1016/j.intimp.2015.10.010; Araujo LFL, 2014, CLINICS, V69, P128, DOI 10.6061/clinics/2014(02)09; Lund LH, 2015, J HEART LUNG TRANSPL, V34, P1244, DOI 10.1016/j.healun.2015.08.003; Maggiorini M, 2001, CIRCULATION, V103, P2078; Maggiorini M, 2006, ANN INTERN MED, V145, P497, DOI 10.7326/0003-4819-145-7-200610030-00007; MARON MB, 1989, J APPL PHYSIOL, V67, P305, DOI 10.1152/jappl.1989.67.1.305; MARON MB, 1994, J APPL PHYSIOL, V77, P1155, DOI 10.1152/jappl.1994.77.3.1155; MCCLELLAN MD, 1989, J APPL PHYSIOL, V67, P1185, DOI 10.1152/jappl.1989.67.3.1185; MEDURI GU, 1995, CHEST, V107, P1062, DOI 10.1378/chest.107.4.1062; Modelska K, 1999, AM J RESP CRIT CARE, V160, P1450, DOI 10.1164/ajrccm.160.5.9901096; Morenski John D, 2003, J Intensive Care Med, V18, P211, DOI 10.1177/0885066603254359; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Osuka K, 1998, ACTA NEUROCHIR, V140, P943, DOI 10.1007/s007010050197; Parsons PE, 2005, CRIT CARE MED, V33, P1, DOI 10.1097/01.CCM.0000149854.61192.DC; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pilla ES, 2013, J BRAS PNEUMOL, V39, P173, DOI 10.1590/S1806-37132013000200008; Preira P, 2016, CRIT CARE, V20, DOI 10.1186/s13054-015-1157-5; Qi XF, 2011, J CELL PHYSIOL, V226, P58, DOI 10.1002/jcp.22303; Rassler B, 2003, MOL CELL BIOCHEM, V250, P55, DOI 10.1023/A:1024942132705; Rostron AJ, 2008, TRANSPLANTATION, V85, P597, DOI 10.1097/TP.0b013e31816398dd; Rothoerl RD, 2006, CEREBROVASC DIS, V22, P143, DOI 10.1159/000093243; SARNOFF SJ, 1952, CIRCULATION, V6, P51, DOI 10.1161/01.CIR.6.1.51; Scillia P, 1999, RADIOLOGY, V211, P161, DOI 10.1148/radiology.211.1.r99ap07161; Scott JB, 2013, RESP CARE, V58, P532, DOI 10.4187/respcare.01962; SHIVALKAR B, 1993, CIRCULATION, V87, P230, DOI 10.1161/01.CIR.87.1.230; Skrabal CA, 2005, J SURG RES, V123, P118, DOI 10.1016/j.jss.2004.07.245; SMITH LJ, 1983, J LAB CLIN MED, V101, P629; Swenson ER, 2002, JAMA-J AM MED ASSOC, V287, P2228, DOI 10.1001/jama.287.17.2228; THEODORE J, 1976, AM REV RESPIR DIS, V113, P405; Valenza F, 2014, INTENS CARE MED EXP, V2, DOI 10.1186/2197-425X-2-12; Van Raemdonck Dirk, 2009, Proc Am Thorac Soc, V6, P28, DOI 10.1513/pats.200808-098GO; Xie X, 2013, BRAIN RES, V1512, P89, DOI 10.1016/j.brainres.2013.03.041; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Zhang H, 2000, INTENS CARE MED, V26, P474, DOI 10.1007/s001340051185; Zhou HC, 2010, EXP BIOL MED, V235, P1236, DOI 10.1258/ebm.2010.010147; Zweers N, 2004, TRANSPLANTATION, V78, P1251, DOI 10.1097/01.TP.0000142679.45418.96	66	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0181899	10.1371/journal.pone.0181899	http://dx.doi.org/10.1371/journal.pone.0181899			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753621	Green Submitted, gold, Green Published			2022-12-26	WOS:000406579300032
J	Matsuo, J; Do, SH; Yamamoto, C; Nagashima, S; Chuon, C; Katayama, K; Takahashi, K; Tanaka, J				Matsuo, Junko; Do, Son Huy; Yamamoto, Chikako; Nagashima, Shintaro; Chuon, Channarena; Katayama, Keiko; Takahashi, Kazuaki; Tanaka, Junko			Clustering infection of hepatitis B virus genotype B4 among residents in Vietnam, and its genomic characters both intra- and extra-family	PLOS ONE			English	Article							MATERNO-FETAL TRANSMISSION; HEPATOCELLULAR-CARCINOMA; PERINATAL TRANSMISSION; CORE PROMOTER; RURAL VIETNAM; HBV; MUTATIONS; RISK; DNA; CLASSIFICATION	Vietnam has a high rate of hepatitis B virus (HBV) infection and a high mortality rate from hepatocellular carcinoma. We performed a detailed genetic analysis of 48 residents and four families from Binh Thuan Province, a southern coastal area of Vietnam. The route of infection and genomic characteristics related to hepatocellular carcinoma (HCC) were studied in HBV spread among carriers that we detected in our previous hepatitis survey. The HBV genotype was B4 in 91.7% and C1 in 8.3% of the cases. The intra-family's HBV sequence homology was high at 96.8-99.4%. However, it was also high at 99.4-99.8% among residents of the same age and sex as family members. In addition, full genome analysis was performed in 21 cases. The core region of all 20 isolates with genotype B4 was a recombinant of genotype C, and pre-S deletion was found in 20% of cases. The promoter mutation G1613A was found in 13.6% of cases, and a 24 bp insertion from nt1673 in the X region was found in 6.3% of cases. The phylogenetic tree and homology analysis of the HBV full genome suggested the probability and its possibility of horizontal transmission not only within families nor vertical transmission but within cohorts of the same generation in the population. Moreover, the HBV genotype B4 isolates were found not only to be recombinants of genotype C, which results in a high cancer risk, but also to have other risk of HCC, pre-S deletions, the G1613A mutation, and X region insertions corresponding to the promoter. These genomic characters were suggested to be one of the factors to explain the high HCC mortality rate in Vietnam.	[Matsuo, Junko; Yamamoto, Chikako; Nagashima, Shintaro; Chuon, Channarena; Katayama, Keiko; Tanaka, Junko] Hiroshima Univ, Dept Epidemiol Infect Dis Control & Prevent, Inst Biomed & Hlth Sci, Hiroshima, Japan; [Do, Son Huy] Binh Thuan Med Coll, Phan Thiet City, Binh Thuan Prov, Vietnam; [Takahashi, Kazuaki] Toshiba Gen Hosp, Dept Med Sci, Tokyo, Japan	Hiroshima University; Toshiba Corporation	Tanaka, J (corresponding author), Hiroshima Univ, Dept Epidemiol Infect Dis Control & Prevent, Inst Biomed & Hlth Sci, Hiroshima, Japan.	jun-tanaka@hiroshima-u.ac.jp	Tanaka, Junko/G-6166-2019	Tanaka, Junko/0000-0002-5669-4051	Research on Hepatitis of the Ministry of Health, Labor and Welfare, Japan [H28-KanSei-Ippan-001]; Grants-in-Aid for Scientific Research [17H03589, 17H04168] Funding Source: KAKEN	Research on Hepatitis of the Ministry of Health, Labor and Welfare, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants for the Research on Hepatitis of the Ministry of Health, Labor and Welfare, Japan.The number is H28-KanSei-Ippan-001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASALAMAH AH, 1984, J INFECTION, V8, P200, DOI 10.1016/S0163-4453(84)93835-0; Chan HLY, 2008, J CLIN ONCOL, V26, P177, DOI 10.1200/JCO.2007.13.2043; Chen BF, 2016, WORLD J GASTROENTERO, V22, P8041, DOI 10.3748/wjg.v22.i35.8041; Croagh CMN, 2015, WORLD J HEPATOL, V7, P289, DOI 10.4254/wjh.v7.i3.289; Cuong HN, 2011, J MED VIROL, V83, P399, DOI 10.1002/jmv.21978; de Martel C, 2015, HEPATOLOGY, V62, P1190, DOI 10.1002/hep.27969; Dunford L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039027; FRANKS AL, 1989, NEW ENGL J MED, V321, P1301, DOI 10.1056/NEJM198911093211905; Ganova-Raeva L, 2015, J INFECT DIS, V212, P1962, DOI 10.1093/infdis/jiv315; GHENDON Y, 1987, J VIROL METHODS, V17, P69, DOI 10.1016/0166-0934(87)90070-X; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; Hadziyannis SJ, 2011, J HEPATOL, V55, P183, DOI 10.1016/j.jhep.2010.12.030; Kramvis A, 2007, HEPATOL RES, V37, pS9, DOI 10.1111/j.1872-034X.2007.00098.x; Viet L, 2012, INDIAN J MED RES, V136, P74; Li MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021856; Li ZX, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.30; Liu F, 2014, J CLIN MICROBIOL, V52, P1556, DOI 10.1128/JCM.03338-13; MARINIER E, 1985, J PEDIATR-US, V106, P843, DOI 10.1016/S0022-3476(85)80371-1; Nguyen VTT, 2007, J GASTROEN HEPATOL, V22, P2093, DOI 10.1111/j.1440-1746.2007.05010.x; OKAMOTO H, 1988, J GEN VIROL, V69, P2575, DOI 10.1099/0022-1317-69-10-2575; OKAMOTO H, 1987, JPN J EXP MED, V57, P231; ORITO E, 1989, P NATL ACAD SCI USA, V86, P7059, DOI 10.1073/pnas.86.18.7059; Phung TBT, 2010, J MED VIROL, V82, P1327, DOI 10.1002/jmv.21775; Qu LS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098257; Sakamoto T, 2007, J INFECT DIS, V196, P1487, DOI 10.1086/523111; Shi WF, 2012, VIROLOGY, V427, P51, DOI 10.1016/j.virol.2012.01.030; Do SH, 2015, HEPATOL RES, V45, P259, DOI 10.1111/hepr.12350; Sugauchi F, 2002, J VIROL, V76, P5985, DOI 10.1128/JVI.76.12.5985-5992.2002; Takahashi K, 1998, ARCH VIROL, V143, P2313, DOI 10.1007/s007050050463; Tatsukawa M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-458; Tran HTT, 2003, HEPATOL RES, V26, P275, DOI 10.1016/S1386-6346(03)00166-9; Truong BX, 2007, INT J MOL MED, V19, P293; Wang C, 2015, MED SCI MONITOR, V21, P1072, DOI [10.12659/MSM.894058, 10.12659/MSM.892875]; WHO, 2016, HEP B MED CTR WHO201; World Health Organization, 2012, GLOBOCAN 2012 CANC F; Yang Y, 2015, CHINESE J CANCER RES, V27, P497, DOI 10.3978/j.issn.1000-9604.2015.10.05; Yin JH, 2015, CANCER PREV RES, V8, P978, DOI 10.1158/1940-6207.CAPR-15-0160; Yuen MF, 2008, GUT, V57, P98, DOI 10.1136/gut.2007.119859; Zhang QR, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-92; Zhang ZH, 2016, WORLD J GASTROENTERO, V22, P126, DOI 10.3748/wjg.v22.i1.126	40	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0177248	10.1371/journal.pone.0177248	http://dx.doi.org/10.1371/journal.pone.0177248			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753615	Green Published, Green Submitted, gold			2022-12-26	WOS:000406579300001
J	You, JHS; Tam, LP; Lee, NLS				You, Joyce H. S.; Tam, Lok-pui; Lee, Nelson L. S.			Cost-effectiveness of molecular point-of-care testing for influenza viruses in elderly patients at ambulatory care setting	PLOS ONE			English	Article							HONG-KONG; ADULTS; OSELTAMIVIR; INFECTION; MORTALITY; ILLNESS; VACCINE	Background Early initiation of antiviral therapy in elderly patients with influenza is associated with reduced risk of extra clinic visit, hospitalization and death. This study examined the costeffectiveness of molecular POCT for detection of influenza viruses in Hong Kong elderly patients with influenza-like illness (ILI) in the outpatient clinics. Methods A decision analytic model was used to simulate outcomes of a hypothetical cohort of elderly patients presented with ILI at outpatient clinics during peak season of influenza with two diagnostic approaches: Rapid molecular assay (POCT-PCR group) and clinical judgement with no POCT. Outcome measures included influenza-associated direct medical cost, hospitalization and mortality rates, quality-adjusted life year loss (QALY loss), and incremental cost per QALY saved (ICER). Results In base-case analysis, POCT-PCR group was expected to reduce hospitalization (1.38% versus 2.85%) and mortality rate (0.08% versus 0.16%) and save 0.00112 QALYs at higher cost (by USD33.2 per ILI patient), comparing with clinical judgement group. The ICER of POCTPCR was 29,582 USD/QALY saved. One-way sensitivity analyses found ICER sensitive to: Hospitalization rate without prompt antiviral therapy; odds ratio of hospitalization with prompt therapy; influenza prevalence; patient age and mortality rate of hospitalized patients. POCTPCR was cost-effective in 60.6% and 99.4% of 10,000 Monte Carlo simulations at willingnessto- pay threshold of 1x and 3x gross domestic product per capita of Hong Kong, respectively. Conclusions Molecular POCT for influenza detection in elderly patients with ILI at outpatient clinics during peak influenza season appeared to be cost-effective in Hong Kong.	[You, Joyce H. S.; Tam, Lok-pui] Chinese Univ Hong Kong, Fac Med, Sch Pharm, Shatin, Hong Kong, Peoples R China; [Lee, Nelson L. S.] Chinese Univ Hong Kong, Dept Med & Therapeut, Div Infect Dis, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	You, JHS (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Pharm, Shatin, Hong Kong, Peoples R China.	joyceyou@cuhk.edu.hk	Lee, Nelson/B-6418-2008; You, Joyce H. S./C-2984-2008	Lee, Nelson/0000-0002-0783-6607; You, Joyce H. S./0000-0002-5763-7403				[Anonymous], HONG KONG LIF TABL 2; [Anonymous], GUID CLIN US RT PCR; Brendish NJ, 2017, LANCET RESP MED, V5, P401, DOI [10.1016/S2213-2600(17)30120-0, 10.1016/s2213-2600(17)30120-0]; Census and Statistics Department The Government of Hong Kong SAR, PROJ MID YEAR POP AG; Centers for Disease Control and Prevention, INFL ANT MED SUMM CL; Centre for Health Protection Department of Health, DET INFL VIR RESP SP; Chan D, 2013, COMMUNICABLE DIS WAT, V10, P74; Chan YK, 2017, ANTIVIR THER, V22, P173, DOI 10.3851/IMP3102; Chowell G, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-97; Gold MR, 1998, MED CARE, V36, P778, DOI 10.1097/00005650-199806000-00002; Jefferson T, 2014, COCHRANE DB SYST REV, DOI [10.1590/1516-3180.20141324T2, 10.1002/14651858.CD008965.pub4]; Jefferson T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2545; Lee BY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011284; Lee N, 2010, THORAX, V65, P510, DOI 10.1136/thx.2009.130799; Lee N, 2007, ANTIVIR THER, V12, P501; Lee N, 2011, J INFECT DIS, V203, P1739, DOI 10.1093/infdis/jir187; Ng S, 2010, CLIN INFECT DIS, V50, P707, DOI 10.1086/650458; Nie SP, 2014, J CLIN MICROBIOL, V52, P3339, DOI 10.1128/JCM.01132-14; Petrie JG, 2011, J INFECT DIS, V203, P1309, DOI 10.1093/infdis/jir015; Soto M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146620; Stein J, 2005, ANN EMERG MED, V46, P412, DOI 10.1016/j.annemergmed.2005.05.020; Wang CB, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001070; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Wu P, 2012, J INFECT DIS, V206, P1862, DOI 10.1093/infdis/jis628; You JHS, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0618-9	25	22	22	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							0182091	10.1371/journal.pone.0182091	http://dx.doi.org/10.1371/journal.pone.0182091			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750092	Green Submitted, Green Published, gold			2022-12-26	WOS:000406575700133
J	Yu, PY; Gardner, HL; Roberts, R; Cam, H; Hariharan, S; Ren, L; LeBlanc, AK; Xiao, H; Lin, JY; Guttridge, DC; Mo, XK; Bennett, CE; Coss, CC; Ling, YH; Phelps, MA; Houghton, P; London, CA				Yu, Peter Y.; Gardner, Heather L.; Roberts, Ryan; Cam, Hakan; Hariharan, Seethalakshmi; Ren, Ling; LeBlanc, Amy K.; Xiao, Hui; Lin, Jiayuh; Guttridge, Denis C.; Mo, Xiaokui; Bennett, Chad E.; Coss, Christopher C.; Ling, Yonghua; Phelps, Mitch A.; Houghton, Peter; London, Cheryl A.			Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma	PLOS ONE			English	Article							ANTITUMOR-ACTIVITY; SIGNAL TRANSDUCER; CELL VIABILITY; MEK INHIBITOR; CANCER; ACTIVATION; PATHWAY; MIGRATION; THERAPY; BIOLOGY	Background STAT3 is a transcription factor involved in cytokine and receptor kinase signal transduction that is aberrantly activated in a variety of sarcomas, promoting metastasis and chemotherapy resistance. The purpose of this work was to develop and test a novel putative STAT3 inhibitor, LY5. Methods and findings An in silico fragment-based drug design strategy was used to create LY5, a small molecule inhibitor that blocks the STAT3 SH2 domain phosphotyrosine binding site, inhibiting homodimerization. LY5 was evaluated in vitro demonstrating good biologic activity against rhabdomyosarcoma, osteosarcoma and Ewing's sarcoma cell lines at high nanomolar/low micromolar concentrations, as well as specific inhibition of STAT3 phosphorylation without effects on other STAT3 family members. LY5 exhibited excellent oral bioavailability in both mice and healthy dogs, and drug absorption was enhanced in the fasted state with tolerable dosing in mice at 40 mg/kg BID. However, RNAi-mediated knockdown of STAT3 did not phenocopy the biologic effects of LY5 in sarcoma cell lines. Moreover, concentrations needed to inhibit ex vivo metastasis growth using the PuMA assay were significantly higher than those needed to inhibit STAT3 phosphorylation in vitro. Lastly, LY5 treatment did not inhibit the growth of sarcoma xenografts or prevent pulmonary metastasis in mice. Conclusions LY5 is a novel small molecule inhibitor that effectively inhibits STAT3 phosphorylation and cell proliferation at nanomolar concentrations. LY5 demonstrates good oral bioavailability in mice and dogs. However LY5 did not decrease tumor growth in xenograft mouse models and STAT3 knockdown did not induce concordant biologic effects. These data suggest that the anti-cancer effects of LY5 identified in vitro were not mediated through STAT3 inhibition.	[Yu, Peter Y.] Ohio State Univ, Coll Med, Wexner Med Ctr, Med Student Res Program, Columbus, OH 43210 USA; [Gardner, Heather L.; London, Cheryl A.] Ohio State Univ, Dept Vet Biosci & Clin Sci, Columbus, OH 43210 USA; [Roberts, Ryan; Cam, Hakan; Xiao, Hui; Lin, Jiayuh; London, Cheryl A.] Nationwide Childrens Hosp, Ctr Childhood Canc, Columbus, OH USA; [Hariharan, Seethalakshmi; Houghton, Peter] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Ren, Ling; LeBlanc, Amy K.] NCI, Comparat Oncol Program, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Guttridge, Denis C.] Ohio State Univ, Wexner Med Ctr, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA; [Guttridge, Denis C.] Ohio State Univ, Wexner Med Ctr, Dept Canc Biol & Genet, Columbus, OH 43210 USA; [Mo, Xiaokui] Ohio State Univ, Wexner Med Ctr, Ctr Biostat, Columbus, OH 43210 USA; [Bennett, Chad E.] Ohio State Univ, Wexner Med Ctr, Med Chem Shared Resource, Columbus, OH 43210 USA; [Coss, Christopher C.; Ling, Yonghua; Phelps, Mitch A.] Ohio State Univ, Wexner Med Ctr, Pharmacoanalyt Shared Resource, Columbus, OH 43210 USA; [London, Cheryl A.] Tufts Univ, Cummings Sch Vet Med, Grafton, MA 01536 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of Texas System; University of Texas Health San Antonio; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Tufts University	London, CA (corresponding author), Ohio State Univ, Dept Vet Biosci & Clin Sci, Columbus, OH 43210 USA.; London, CA (corresponding author), Tufts Univ, Cummings Sch Vet Med, Grafton, MA 01536 USA.	Cheryl.London@tufts.edu	Roberts, Ryan D/D-2573-2013; Phelps, Mitch/H-3941-2013	Roberts, Ryan D/0000-0001-5028-744X; Phelps, Mitch/0000-0002-1615-5280; Yu, Peter/0000-0001-6084-2603; Coss, Christopher/0000-0002-8184-9190; Guttridge, Denis/0000-0002-7276-6609	National Cancer Institute [P01 CM 65995, P30 CA016058]; National Center for Advancing Translational Sciences [UL1 TR001070]; NATIONAL CANCER INSTITUTE [P01CA165995, K12CA133250, P30CA016058, P01CA023099] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by National Cancer Institute grants, P01 CM 65995 (CL, PH, DG, JL), P30 CA016058 (CL), and National Center for Advancing Translational Sciences grant UL1 TR001070 (CL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt CAS, 2012, MAYO CLIN PROC, V87, P475, DOI 10.1016/j.mayocp.2012.01.015; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bid HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035513; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chai EZP, 2016, PHARMACOL THERAPEUT, V162, P86, DOI 10.1016/j.pharmthera.2015.10.004; Chen CL, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-111; Chen Z, 2012, ACTA PHARMACOL SIN, V33, P101, DOI 10.1038/aps.2011.164; Cook D, 2014, NAT REV DRUG DISCOV, V13, P419, DOI 10.1038/nrd4309; Couto JI, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-244; Faruqi TR, 2001, P NATL ACAD SCI USA, V98, P9014, DOI 10.1073/pnas.161281298; Fossey SL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-125; Fossey SL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-81; Hinson ARP, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00183; Horvath Curt M, 2004, Sci STKE, V2004, ptr10, DOI 10.1126/stke.2602004tr10; Hosoi H, 2016, PEDIATR INT, V58, P81, DOI 10.1111/ped.12867; Houghton PJ, 2007, PEDIATR BLOOD CANCER, V49, P928, DOI 10.1002/pbc.21078; Kaptein A, 1996, J BIOL CHEM, V271, P5961, DOI 10.1074/jbc.271.11.5961; Kerns EH, 2003, DRUG DISCOV TODAY, V8, P316, DOI 10.1016/S1359-6446(03)02649-7; Kurmasheva RT, 2009, CANCER RES, V69, P7662, DOI 10.1158/0008-5472.CAN-09-1693; Lai R, 2006, J PATHOL, V208, P624, DOI 10.1002/path.1941; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Liu YW, 2013, TOXICOLOGY, V304, P120, DOI 10.1016/j.tox.2012.12.018; Mendoza A, 2010, J CLIN INVEST, V120, P2979, DOI 10.1172/JCI40252; Onimoe GI, 2012, INVEST NEW DRUG, V30, P916, DOI 10.1007/s10637-011-9645-1; Pammolli F, 2011, NAT REV DRUG DISCOV, V10, P428, DOI 10.1038/nrd3405; Peck RW, 2015, NAT REV DRUG DISCOV, V14, P663, DOI 10.1038/nrd4725; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Ren L, 2015, ONCOTARGET, V6, P29469, DOI 10.18632/oncotarget.5177; Ryu K, 2010, J ORTHOP RES, V28, P971, DOI 10.1002/jor.21088; Siddiquee KAZ, 2008, CELL RES, V18, P254, DOI 10.1038/cr.2008.18; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wake MS, 2015, FEBS J, V282, P2600, DOI 10.1111/febs.13285; Wu XJ, 2016, CURR CANCER DRUG TAR, V16, P631, DOI 10.2174/1568009615666150916093110; Wurster AL, 2000, ONCOGENE, V19, P2577, DOI 10.1038/sj.onc.1203485; Xiao H, 2015, J BIOL CHEM, V290, P3418, DOI 10.1074/jbc.M114.616748; Yu HJ, 2017, ONCOTARGET, V8, P5523, DOI 10.18632/oncotarget.12566; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Yu WY, 2013, J MED CHEM, V56, P4402, DOI 10.1021/jm400080c; Yue P, 2009, EXPERT OPIN INV DRUG, V18, P45, DOI 10.1517/13543780802565791 ; Zhao CG, 2015, ONCOTARGET, V6, P14472, DOI 10.18632/oncotarget.3991; Zhao C, 2016, ONCOTARGET, V7, P12917, DOI 10.18632/oncotarget.7338	41	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181885	10.1371/journal.pone.0181885	http://dx.doi.org/10.1371/journal.pone.0181885			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750090	Green Submitted, gold, Green Published			2022-12-26	WOS:000406575700097
J	Bakouh, N; Bellanca, S; Nyboer, B; Cubel, SM; Karim, Z; Sanchez, CP; Stein, WD; Planelles, G; Lanzer, M				Bakouh, Naziha; Bellanca, Sebastiano; Nyboer, Britta; Cubel, Sonia Moliner; Karim, Zoubida; Sanchez, Cecilia P.; Stein, Wilfred D.; Planelles, Gabrielle; Lanzer, Michael			Iron is a substrate of the Plasmodium falciparum chloroquine resistance transporter PfCRT in Xenopus oocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALARIA PARASITES; DIGESTIVE VACUOLE; DRUG-RESISTANCE; H+ LEAK; CHANNEL; PROTEIN; ACTIVATION; INHIBITION; MUTATIONS; MEMBRANE	The chloroquine resistance transporter of the human malaria parasite Plasmodium falciparum, PfCRT, is an important determinant of resistance to several quinoline and quinoline-like antimalarial drugs. PfCRT also plays an essential role in the physiology of the parasite during development inside erythrocytes. However, the function of this transporter besides its role in drug resistance is still unclear. Using electrophysiological and flux experiments conducted on PfCRT-expressing Xenopus laevis oocytes, we show here that both wild-type PfCRT and a PfCRT variant associated with chloroquine resistance transport both ferrous and ferric iron, albeit with different kinetics. In particular, we found that the ability to transport ferrous iron is reduced by the specific polymorphisms acquired by the PfCRT variant as a result of chloroquine selection. We further show that iron and chloroquine transport via PfCRT is electrogenic. If these findings in the Xenopus model extend to P. falciparum in vivo, our data suggest that PfCRT might play a role in iron homeostasis, which is essential for the parasite's development in erythrocytes.	[Bakouh, Naziha; Planelles, Gabrielle] Univ Paris 06, INSERM, Ctr Rech Cordeliers, CNRS ERL8228,Unite 1138, F-75006 Paris, France; [Bakouh, Naziha; Planelles, Gabrielle] Univ Paris 05, F-75006 Paris, France; [Bellanca, Sebastiano; Nyboer, Britta; Cubel, Sonia Moliner; Sanchez, Cecilia P.; Lanzer, Michael] Heidelberg Univ Hosp, Ctr Infect Dis, Parasitol, Neuenheimer Feld 324, D-69120 Heidelberg, Germany; [Karim, Zoubida] Univ Paris Diderot, INSERM, CNRS ERL 8252, UMR1149, F-75890 Paris, France; [Stein, Wilfred D.] Hebrew Univ Jerusalem, Silberman Inst Life Sci, Biol Chem, IL-91904 Jerusalem, Israel; [Planelles, Gabrielle] CNRS, INSERM, Paris, France; [Lanzer, Michael] Res Cluster Excellence CellNetworks, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Ruprecht Karls University Heidelberg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Hebrew University of Jerusalem; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Planelles, G (corresponding author), Univ Paris 06, INSERM, Ctr Rech Cordeliers, CNRS ERL8228,Unite 1138, F-75006 Paris, France.; Planelles, G (corresponding author), Univ Paris 05, F-75006 Paris, France.; Lanzer, M (corresponding author), Heidelberg Univ Hosp, Ctr Infect Dis, Parasitol, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.	gabrielle.planelles@inserm.fr; michael.lanzer@med.uni-heidelberg.de	Lanzer, Michael/E-9752-2013; Planelles, Gabrielle/F-9603-2013	Lanzer, Michael/0000-0002-0220-6526; Planelles, Gabrielle/0000-0002-7314-8837; KARIM, Zoubida/0000-0002-3724-5592	French-German Research Initiative - Agence Nationale de la Recherche (ANR); Deutsche Forschungsgemeinschaft (DFG) [EVOTRANSPORT/ANR-14-CE35-0012-01, LA 941/11-1]; PHC PROCOPE Grants [30995WE, 57051467]; INSERM; CNRS; Universite Paris-Descartes	French-German Research Initiative - Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); PHC PROCOPE Grants; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paris-Descartes	This work was supported by the joint French-German Research Initiative sponsored by the Agence Nationale de la Recherche (ANR) and the Deutsche Forschungsgemeinschaft (DFG) Grants EVOTRANSPORT/ANR-14-CE35-0012-01 and LA 941/11-1 and PHC PROCOPE Grants 30995WE and ID 57051467. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by INSERM, CNRS, and the Universite Paris-Descartes. To whom correspondence may be addressed. Tel.: 33-1-44-27-50-55; E-mail: gabrielle.planelles@inserm.fr.	Abriel H, 1999, J PHYSIOL-LONDON, V516, P31, DOI 10.1111/j.1469-7793.1999.031aa.x; Bakouh N, 2004, J BIOL CHEM, V279, P15975, DOI 10.1074/jbc.M308528200; BATAILLE N, 1990, J CELL BIOL, V111, P1571, DOI 10.1083/jcb.111.4.1571; BD Biosciences, 2006, BD BION TECHN MAN; Bellanca S, 2014, J BIOL CHEM, V289, P36336, DOI 10.1074/jbc.M114.614206; Chaudhry FA, 2001, EMBO J, V20, P7041, DOI 10.1093/emboj/20.24.7041; Choi I, 2000, NATURE, V405, P571, DOI 10.1038/35014615; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Cougnon M, 2002, AM J PHYSIOL-CELL PH, V282, pC1445, DOI 10.1152/ajpcell.00410.2001; Cougnon M, 1998, P NATL ACAD SCI USA, V95, P6516, DOI 10.1073/pnas.95.11.6516; Diakov A, 2004, J BIOL CHEM, V279, P38134, DOI 10.1074/jbc.M403260200; Ecker A, 2012, TRENDS PARASITOL, V28, P504, DOI 10.1016/j.pt.2012.08.002; Egan TJ, 2002, BIOCHEM J, V365, P343, DOI 10.1042/BJ20020793; Fei YJ, 2000, J BIOL CHEM, V275, P23707, DOI 10.1074/jbc.M002282200; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; GOGELEIN H, 1989, PFLUG ARCH EUR J PHY, V413, P287, DOI 10.1007/BF00583543; Jones ML, 2012, CELL HOST MICROBE, V12, P246, DOI 10.1016/j.chom.2012.06.005; Juge N, 2015, P NATL ACAD SCI USA, V112, P3356, DOI 10.1073/pnas.1417102112; Kuhn Y, 2007, CELL MICROBIOL, V9, P1004, DOI 10.1111/j.1462-5822.2006.00847.x; Kuhn Y, 2010, TRAFFIC, V11, P236, DOI 10.1111/j.1600-0854.2009.01018.x; Labarbuta P, 2017, SCI REP-UK, V7, DOI 10.1038/srep42850; Lakshmanan V, 2005, EMBO J, V24, P2294, DOI 10.1038/sj.emboj.7600681; Lehane AM, 2008, ANTIMICROB AGENTS CH, V52, P4374, DOI 10.1128/AAC.00666-08; Lehane AM, 2008, J CELL SCI, V121, P1624, DOI 10.1242/jcs.016758; Lehane AM, 2010, MOL MICROBIOL, V77, P1039, DOI 10.1111/j.1365-2958.2010.07272.x; Mackenzie B, 2006, PFLUG ARCH EUR J PHY, V451, P544, DOI 10.1007/s00424-005-1494-3; Mackenzie B, 2007, BIOCHEM J, V403, P59, DOI 10.1042/BJ20061290; Martin RE, 2004, MOL BIOL EVOL, V21, P1938, DOI 10.1093/molbev/msh205; Martin RE, 2009, SCIENCE, V325, P1680, DOI 10.1126/science.1175667; MARTIN SK, 1987, SCIENCE, V235, P899, DOI 10.1126/science.3544220; Maughan SC, 2010, P NATL ACAD SCI USA, V107, P2331, DOI 10.1073/pnas.0913689107; Meierjohann S, 2002, BIOCHEM J, V368, P761, DOI 10.1042/BJ20020962; Mita T, 2004, MOL BIOCHEM PARASIT, V135, P159, DOI 10.1016/j.molbiopara.2004.01.011; Mylonas C, 1999, IN VIVO, V13, P295; Nessler S, 2004, J BIOL CHEM, V279, P39438, DOI 10.1074/jbc.M404671200; NEWMEYER DD, 1986, EMBO J, V5, P501, DOI 10.1002/j.1460-2075.1986.tb04239.x; Papakrivos J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039569; Patzewitz EM, 2013, ANTIOXID REDOX SIGN, V19, P683, DOI 10.1089/ars.2012.4625; Petersen I, 2015, MOL MICROBIOL, V97, P381, DOI 10.1111/mmi.13035; Pujol-Gimenez J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06446-y; Richards SN, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005725; Roth M, 2012, BRIT J PHARMACOL, V165, P1260, DOI 10.1111/j.1476-5381.2011.01724.x; Rotmann A, 2010, MOL MICROBIOL, V76, P1591, DOI 10.1111/j.1365-2958.2010.07187.x; Sa JM, 2009, P NATL ACAD SCI USA, V106, P18883, DOI 10.1073/pnas.0911317106; Sanchez CP, 2007, TRENDS PARASITOL, V23, P332, DOI 10.1016/j.pt.2007.04.013; Sanchez CP, 2007, MOL MICROBIOL, V64, P407, DOI 10.1111/j.1365-2958.2007.05664.x; Savalas LRT, 2011, BIOCHEM J, V439, P113, DOI 10.1042/BJ20110166; Slavic K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10403; Smith DE, 2013, MOL ASPECTS MED, V34, P323, DOI 10.1016/j.mam.2012.11.003; Solis-Garrido LM, 2004, J BIOL CHEM, V279, P52414, DOI 10.1074/jbc.M408872200; Summers RL, 2014, P NATL ACAD SCI USA, V111, pE1759, DOI 10.1073/pnas.1322965111; Summers RL, 2012, CELL MOL LIFE SCI, V69, P1967, DOI 10.1007/s00018-011-0906-0; Tran CV, 2004, MICROBIOL-SGM, V150, P1, DOI 10.1099/mic.0.26818-0; van Schalkwyk DA, 2016, J INFECT DIS, V213, P800, DOI 10.1093/infdis/jiv509; Warhurst DC, 2002, LANCET, V360, P1527, DOI 10.1016/S0140-6736(02)11577-7	55	15	15	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16109	16121		10.1074/jbc.M117.805200	http://dx.doi.org/10.1074/jbc.M117.805200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28768767	hybrid, Green Published			2022-12-26	WOS:000412109400011
J	Park, SK; Jin, YD; Park, YK; Yeon, SH; Xu, J; Han, RN; Rha, KS; Kim, YM				Park, Soo-Kyoung; Jin, Yong-De; Park, Yeong-Kyu; Yeon, Sun-Hee; Xu, Jun; Han, Rui-Ning; Rha, Ki-Sang; Kim, Yong-Min			IL-25-induced activation of nasal fibroblast and its association with the remodeling of chronic rhinosinusitis with nasal polyposis	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; SUBEPITHELIAL FIBROSIS; UPPER AIRWAYS; IL-25; INTERLEUKIN-25; INFLAMMATION; EXPRESSION; PATHWAY; DEPOSITION; PROMOTES	Background and objective Interleukin (IL)-25 has been shown to play an important role in the pathogenesis of chronic rhinosinusitis with nasal polyps. Nasal polyps are associated with chronic inflammation of the mucous membranes in the paranasal sinuses and are involved in extracellular matrix (ECM) accumulation. The aim of this study is to evaluate the effects of IL-25 on myofibro-blast differentiation, ECM production and the expression of matrix metalloproteinases in nasal polyp derived fibroblasts (NPDFs) and to determine the molecular mechanism underlying these processes. Materials and methods A total of 40 patients were enrolled in this study for Immunofluorescence studies. Expression of IL17 receptor B was evaluated by real time reverse transcription polymerase chain reaction (PCR) in NPDFs. NPDFs were stimulated with IL-25 for 48 h in the presence or absence of mitogen-activated protein kinase (MAPK) and NF-kappa B inhibitors or small interfering RNAs (siRNA). The protein levels of fibrosis active mediators were examined using western blotting. Fibroblast migration was evaluated with a scratch assay. The total collagen amount was analyzed with the Sircol collagen assay. Results IL-25 induced alpha-SMA, fibronectin, and MMP-1 and -13, which were dependent on IL-17RB. IL-25 also induced activation of NF-kappa B and mitogen-activated protein kinase (MAPKs). By using the specific inhibitor of ERK, p38, JNK and NF-kappa B (U, SB, SP and Bay), we found that IL-25-induced expressions of alpha-SMA, fibronectin, and MMPs was regulated by the signaling pathways of MAPKs and NF-kappa B. IL-25 also induces alpha-SMA, fibronectin, and MMPs expression through IL-17RB-dependent pathways in NPDFs. The increased migration ability induced by IL-25 was suppressed by the specific inhibitors of MAPKs and NF-kappa B. Conclusion Our data indicate that IL-25 induced myofibroblast differentiation, fibronectin production, and MMP-1 and -13 expressions through the signaling pathways of MAPKs and NF-kappa B. in NPDFs and increased expression of IL-25 were also involved in the pathogenesis of nasal polyposis by affecting nasal fibroblasts in chronic rhinosinusitis with nasal polyps.	[Park, Soo-Kyoung; Park, Yeong-Kyu; Yeon, Sun-Hee; Xu, Jun; Han, Rui-Ning; Rha, Ki-Sang; Kim, Yong-Min] Chungnam Natl Univ, Sch Med, Res Inst Med Sci, Dept Otorhinolaryngol Head & Neck Surg, Daejeon, South Korea; [Jin, Yong-De; Xu, Jun; Han, Rui-Ning] Yanbian Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Yanji, Peoples R China	Chungnam National University; Yanbian University	Kim, YM (corresponding author), Chungnam Natl Univ, Sch Med, Res Inst Med Sci, Dept Otorhinolaryngol Head & Neck Surg, Daejeon, South Korea.	entkym@cnu.ac.kr		Rha, Ki-Sang/0000-0001-9981-057X; Kim, Yong Min/0000-0001-5414-8332	Chungnam National University; national research fund [NRF-2016R1D1A3B03934918]	Chungnam National University; national research fund(Luxembourg National Research Fund)	This work was supported by research fund of Chungnam National University 2016 and the national research fund, fund number: NRF-2016R1D1A3B03934918.	Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Berger G, 2002, LARYNGOSCOPE, V112, P738, DOI 10.1097/00005537-200204000-00026; Bugdayci G, 2010, ACTA HISTOCHEM, V112, P92, DOI 10.1016/j.acthis.2008.07.002; Cho JS, 2015, ALLERGY ASTHMA IMMUN, V7, P276, DOI 10.4168/aair.2015.7.3.276; Claudio E, 2009, J IMMUNOL, V182, P1617, DOI 10.4049/jimmunol.182.3.1617; Callejas FD, 2015, LARYNGOSCOPE, V125, pE158, DOI 10.1002/lary.25147; Callejas FD, 2013, AM J RHINOL ALLERGY, V27, pE69, DOI 10.2500/ajra.2013.27.3908; De Coster L, 2012, RHINOLOGY, V50, P393, DOI [10.4193/Rhin11.164, 10.4193/Rhino11.164]; Dolgachev V, 2009, J IMMUNOL, V183, P5705, DOI 10.4049/jimmunol.0901666; Fisher GJ, 1997, NEW ENGL J MED, V337, P1419, DOI 10.1056/NEJM199711133372003; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Gabasa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065445; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Gregory LG, 2013, THORAX, V68, P82, DOI 10.1136/thoraxjnl-2012-202003; Hoshino M, 1998, J ALLERGY CLIN IMMUN, V102, P783, DOI 10.1016/S0091-6749(98)70018-1; HOWARTH PH, 1995, ALLERGY, V50, P6, DOI 10.1111/j.1398-9995.1995.tb02734.x; Huang J, 1999, AM J RESP CRIT CARE, V160, P725, DOI 10.1164/ajrccm.160.2.9809040; KAKOI H, 1987, ACTA OTO-LARYNGOL, V103, P137, DOI 10.3109/00016488709134709; Kirsche H, 2010, ALLERGY, V65, P24, DOI 10.1111/j.1398-9995.2009.02174.x; Kubiczkova L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-183; Lam M, 2015, AM J RHINOL ALLERGY, V29, P175, DOI 10.2500/ajra.2015.29.4176; Li XY, 2010, J ALLERGY CLIN IMMUN, V125, P1061, DOI 10.1016/j.jaci.2010.02.023; Li ZP, 2014, IRAN J ALLERGY ASTHM, V13, P412; Maezawa Y, 2006, J IMMUNOL, V176, P1013, DOI 10.4049/jimmunol.176.2.1013; Malinsky RR, 2013, EUR ARCH OTO-RHINO-L, V270, P1345, DOI 10.1007/s00405-012-2219-9; Molet SM, 2003, LARYNGOSCOPE, V113, P1803, DOI 10.1097/00005537-200310000-00027; Mori S, 2012, ALLERGY ASTHMA IMMUN, V4, P231, DOI 10.4168/aair.2012.4.4.231; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Muro S, 2000, CLIN CHEST MED, V21, P225, DOI 10.1016/S0272-5231(05)70263-X; MURPHY G, 1992, AM J RESP CELL MOL, V7, P120, DOI 10.1165/ajrcmb/7.2.120; Nagase H, 1997, BIOL CHEM, V378, P151; Norlander T, 1996, LARYNGOSCOPE, V106, P196, DOI 10.1097/00005537-199602000-00017; Pawankar R, 2007, CURR ALLERGY ASTHM R, V7, P202, DOI 10.1007/s11882-007-0073-4; Redington AE, 2000, CLIN EXP ALLERGY, V30, P42; Rickel EA, 2008, J IMMUNOL, V181, P4299, DOI 10.4049/jimmunol.181.6.4299; Rittie L, 2002, AGEING RES REV, V1, P705, DOI 10.1016/S1568-1637(02)00024-7; ROCHE WR, 1989, LANCET, V1, P520; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Salib RJ, 2003, CLIN EXP ALLERGY, V33, P1629, DOI 10.1111/j.1365-2222.2003.01828.x; Samarakoon R, 2013, CELL SIGNAL, V25, P264, DOI 10.1016/j.cellsig.2012.10.003; Shapiro SD, 1999, AM J RESP CELL MOL, V20, P1100, DOI 10.1165/ajrcmb.20.6.f151; Shin HW, 2015, J ALLERGY CLIN IMMUN, V135, P1476, DOI 10.1016/j.jaci.2015.01.003; Soler ZM, 2012, AM J RHINOL ALLERGY, V26, P110, DOI 10.2500/ajra.2012.26.3741; Swaidani S, 2011, J IMMUNOL, V187, P3155, DOI 10.4049/jimmunol.1002790; Swaidani S, 2009, J IMMUNOL, V182, P1631, DOI 10.4049/jimmunol.182.3.1631; Tamachi T, 2006, J ALLERGY CLIN IMMUN, V118, P606, DOI 10.1016/j.jaci.2006.04.051; Valizadeh A, 2015, J CLIN DIAGN RES, V9; Van Bruaene N, 2008, J ALLERGY CLIN IMMUN, V121, P1435, DOI 10.1016/j.jaci.2008.02.018; Watelet JB, 2006, ALLERGY, V61, P1249, DOI 10.1111/j.1398-9995.2006.01226.x; Wong CK, 2005, AM J RESP CELL MOL, V33, P186, DOI 10.1165/rcmb.2005-0034OC; Wu L, 2015, J IMMUNOL, V194, P4528, DOI 10.4049/jimmunol.1402760; Xu J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161013	53	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0181806	10.1371/journal.pone.0181806	http://dx.doi.org/10.1371/journal.pone.0181806			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771607	gold, Green Published, Green Submitted			2022-12-26	WOS:000406853600036
J	Mahapatra, S; Mace, EM; Minard, CG; Forbes, LR; Vargas-Hernandez, A; Duryea, TK; Makedonas, G; Banerjee, PP; Shearer, WT; Orange, JS				Mahapatra, Sanjana; Mace, Emily M.; Minard, Charles G.; Forbes, Lisa R.; Vargas-Hernandez, Alexander; Duryea, Teresa K.; Makedonas, George; Banerjee, Pinaki P.; Shearer, William T.; Orange, Jordan S.			High-resolution phenotyping identifies NK cell subsets that distinguish healthy children from adults	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; HEPATITIS-C VIRUS; HUMAN CYTOMEGALOVIRUS-INFECTION; IMMUNOLOGICAL SYNAPSE; FOOD ALLERGY; INCREASED PROPORTION; CYTOLYTIC ACTIVITY; CYTOMETRY DATA; UNITED-STATES; IMMUNE-SYSTEM	Natural killer (NK) cells are critical in immune defense against infected, stressed or transformed cells. Their function is regulated by the heterogeneous expression of a wide array of surface receptors that shape its phenotypic diversity. Although NK cells develop in the bone marrow and secondary lymphoid tissues, substantive differentiation is apparent in the peripheral blood including known age-related variation. In order to gain greater insight into phenotypic and functional variation within peripheral blood NK cells across age groups, we used multi-parametric, polyfunctional flow cytometry to interrogate the NK cell variability in 20 healthy adults and 15 5-10, 11-15 and 16-20 year-old children. We found that the normative ranges in both adults and children displayed great inter-individual variation for most markers. While the expression of several receptors did not differ, among those that did, the majority of the differences existed between adults and the three pediatric groups, rather than among children of different ages. Interestingly, we also identified variation in the individual expression of some markers by sex and ethnicity. Combinatorial analysis of NK cell receptors revealed intermediate subsets between the CD56(bright) and CD56(dim) NK cells. Furthermore, on examining the NK cell diversity by age, adults were discovered to have the lowest developmental diversity. Thus, our findings identify previously unappreciated NK cell subsets potentially distinguishing children from adults and suggest functional correlates that may have relevance in age-specific host defense.	[Mahapatra, Sanjana; Mace, Emily M.; Makedonas, George; Orange, Jordan S.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Mahapatra, Sanjana; Mace, Emily M.; Forbes, Lisa R.; Vargas-Hernandez, Alexander; Makedonas, George; Banerjee, Pinaki P.; Shearer, William T.; Orange, Jordan S.] Texas Childrens Hosp, Ctr Human mmunobiol, Houston, TX 77030 USA; [Mace, Emily M.; Forbes, Lisa R.; Duryea, Teresa K.; Makedonas, George; Shearer, William T.; Orange, Jordan S.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Minard, Charles G.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Duryea, Teresa K.] Texas Childrens Hosp, Residents Primary Care Grp, Houston, TX 77030 USA; [Orange, Jordan S.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Banerjee, Pinaki P.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Mace, EM; Orange, JS (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.; Mace, EM; Orange, JS (corresponding author), Texas Childrens Hosp, Ctr Human mmunobiol, Houston, TX 77030 USA.; Mace, EM; Orange, JS (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.; Orange, JS (corresponding author), Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA.	mace@bcm.edu; orange@bcm.edu		Mace, Emily/0000-0003-0226-7393; Shearer, William/0000-0002-2483-2130; orange, jordan/0000-0001-7117-7725	National Institute of Allergy and Infectious Diseases [R01A1067956, R01A1120989]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by R01A1067956 and R01A1120989 from National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov/) to JSO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison EG, 2005, IMMUNOLOGY, V116, P354, DOI 10.1111/j.1365-2567.2005.02235.x; Ahlenstiel G, 2008, J CLIN INVEST, V118, P1017, DOI 10.1172/JCI32400; Al-Attar A, 2016, MECH AGEING DEV, V156, P25, DOI 10.1016/j.mad.2016.04.001; Almeida-Oliveira A, 2011, HUM IMMUNOL, V72, P319, DOI 10.1016/j.humimm.2011.01.009; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Angelo LS, 2015, IMMUNOL RES, V62, P341, DOI 10.1007/s12026-015-8664-y; Barcelos W, 2008, SCAND J IMMUNOL, V68, P92, DOI 10.1111/j.1365-3083.2008.02116.x; Beziat V, 2012, EUR J IMMUNOL, V42, P447, DOI 10.1002/eji.201141826; Beziat V, 2011, J IMMUNOL, V186, P6753, DOI 10.4049/jimmunol.1100330; Bielekova B, 2006, P NATL ACAD SCI USA, V103, P5941, DOI 10.1073/pnas.0601335103; Bjorkstrom NK, 2011, J EXP MED, V208, P13, DOI 10.1084/jem.20100762; Borrego F, 1999, IMMUNOLOGY, V97, P159, DOI 10.1046/j.1365-2567.1999.00738.x; Boulet S, 2008, AIDS, V22, P595, DOI 10.1097/QAD.0b013e3282f56b23; Brady J, 2010, J IMMUNOL, V185, P6679, DOI 10.4049/jimmunol.0903354; Branum AM, 2009, PEDIATRICS, V124, P1549, DOI 10.1542/peds.2009-1210; Brooks AG, 1999, J IMMUNOL, V162, P305; Brunetta E, 2010, AIDS, V24, P27, DOI 10.1097/QAD.0b013e3283328d1f; Cac NN, 2006, J ALLERGY CLIN IMMUN, V118, P526, DOI 10.1016/j.jaci.2006.04.023; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Clausen J, FUNCTIONAL SIGNIFICA; Cole DK, 2004, CELL MOL IMMUNOL, V1, P81; ComansBitter WM, 1997, J PEDIATR-US, V130, P388, DOI 10.1016/S0022-3476(97)70200-2; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; de Andrade LF, 2014, IMMUNOL CELL BIOL, V92, P237, DOI 10.1038/icb.2013.95; Deniz G, 2013, J ALLERGY CLIN IMMUN, V132, P527, DOI 10.1016/j.jaci.2013.07.030; Galea-Lauri J, EXPRESSION VARIANT C; Gao XJ, 2010, CLIN IMMUNOL, V137, P139, DOI 10.1016/j.clim.2010.05.011; Gardiner CM, 2008, INT J IMMUNOGENET, V35, P1, DOI 10.1111/j.1744-313X.2007.00739.x; Golden-Mason L, 2008, GUT, V57, P1121, DOI 10.1136/gut.2007.130963; Goodier MR, 2007, J VIROL, V81, P430, DOI 10.1128/JVI.01567-06; Goodier MR, 2014, BLOOD, V124, P2213, DOI 10.1182/blood-2014-05-576124; Gupta RS, 2011, PEDIATRICS, V128, pE9, DOI 10.1542/peds.2011-0204; Hak Lukasz, 2007, Immun Ageing, V4, P3, DOI 10.1186/1742-4933-4-3; Hermodsson S., 1982, CLIN IMMUNOL IMMUNOP, V25, P325; Hoffmann SC, 2011, J IMMUNOL, V186, P2757, DOI 10.4049/jimmunol.1002867; Horowitz A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006702; Hudspeth K, NATURAL CYTOTOXICITY; Jamil KM, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/298348; Jonges LE, 2001, SCAND J IMMUNOL, V53, P103, DOI 10.1046/j.1365-3083.2001.00838.x; Juelke K, 2010, BLOOD, V116, P1299, DOI 10.1182/blood-2009-11-253286; Knapp S, 2010, HEPATOLOGY, V51, P1168, DOI 10.1002/hep.23477; Kuhne T, 2000, PEDIATR RES, V48, P374; Lalani SR, 2016, AM J HUM GENET, V98, P347, DOI 10.1016/j.ajhg.2015.12.008; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Le Garff-Tavernier M, 2010, AGING CELL, V9, P527, DOI 10.1111/j.1474-9726.2010.00584.x; Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005; Lopez-Verges S, 2011, P NATL ACAD SCI USA, V108, P14725, DOI 10.1073/pnas.1110900108; Loza MJ, 2001, NAT IMMUNOL, V2, P917, DOI 10.1038/ni1001-917; Loza MJ, EXPRESSION TYPE 1 IN; Luci C, 2008, INT J BIOCHEM CELL B, V40, P2335, DOI 10.1016/j.biocel.2008.05.001; Luetke-Eversloh M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00499; Lutz CT, 2005, MECH AGEING DEV, V126, P722, DOI 10.1016/j.mad.2005.01.004; Mace EM, 2014, IMMUNOL CELL BIOL, V92, P245, DOI 10.1038/icb.2013.96; Makedonas G, 2009, J IMMUNOL, V182, P5560, DOI 10.4049/jimmunol.0803945; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Mazzone A, LEUKOCYTE CD11 CD18; Middleton D, 2010, IMMUNOLOGY, V129, P8, DOI 10.1111/j.1365-2567.2009.03208.x; Orange JS, 2008, NAT REV IMMUNOL, V8, P713, DOI 10.1038/nri2381; Orange JS, 2013, J ALLERGY CLIN IMMUN, V132, P515, DOI 10.1016/j.jaci.2013.07.020; Orange JS, 2003, P NATL ACAD SCI USA, V100, P14151, DOI 10.1073/pnas.1835830100; Pegram HJ, 2011, IMMUNOL CELL BIOL, V89, P216, DOI 10.1038/icb.2010.78; Peritt D, 1998, J IMMUNOL, V161, P5821; Petitdemange C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002268; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; ROBERTSON MJ, 1990, BLOOD, V76, P2421; Robertson MJ, HUMAN NATURAL KILLER; Romero V, 2008, MOL IMMUNOL, V45, P2429, DOI 10.1016/j.molimm.2008.01.002; Sampson HA, 2004, J ALLERGY CLIN IMMUN, V113, P805, DOI 10.1016/j.jaci.2004.03.014; Schepis D, 2009, IMMUNOLOGY, V126, P140, DOI 10.1111/j.1365-2567.2008.02887.x; Scordamaglia F, 2008, J ALLERGY CLIN IMMUN, V121, P479, DOI 10.1016/j.jaci.2007.09.047; Shaoul R, 2009, DIGEST DIS SCI, V54, P142, DOI 10.1007/s10620-008-0326-7; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Shephard RJ, 1999, SPORTS MED, V28, P177, DOI 10.2165/00007256-199928030-00003; Sivori S, 1997, J EXP MED, V186, P1129, DOI 10.1084/jem.186.7.1129; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; Sohlberg E, 2013, J IMMUNOL, V191, P5669, DOI 10.4049/jimmunol.1301343; Solly F, 2013, CYTOM PART A, V83, P1066, DOI 10.1002/cyto.a.22404; Strauss-Albee DM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5722; Strauss-Albee DM, 2014, J IMMUNOL, V193, P4871, DOI 10.4049/jimmunol.1401821; Sullivan LC, 2007, IMMUNITY, V27, P900, DOI 10.1016/j.immuni.2007.10.013; Sundstrom Y, 2007, SCAND J IMMUNOL, V66, P335, DOI 10.1111/j.1365-3083.2007.01980.x; Villanueva J, 2005, ARTHRITIS RES THER, V7, pR30, DOI 10.1186/ar1453; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Wenzel BE, 1998, THYROID, V8, P1019, DOI 10.1089/thy.1998.8.1019; Wu J, ACTIVATING IMMUNOREC; Ygberg S, 2012, ACTA PAEDIATR, V101, P120, DOI 10.1111/j.1651-2227.2011.02494.x; Yu JH, 2013, TRENDS IMMUNOL, V34, P573, DOI 10.1016/j.it.2013.07.005; Yu JH, 2010, BLOOD, V115, P274, DOI 10.1182/blood-2009-04-215491; Zuniga J, 2009, MOL IMMUNOL, V46, P2723, DOI 10.1016/j.molimm.2009.05.014	91	28	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0181134	10.1371/journal.pone.0181134	http://dx.doi.org/10.1371/journal.pone.0181134			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767726	Green Published, Green Submitted, gold			2022-12-26	WOS:000406768200017
J	Slotta, C; Schluter, T; Ruiz-Perera, LM; Kadhim, HM; Tertel, T; Henkel, E; Hubner, W; Greiner, JFW; Huser, T; Kaltschmidt, B; Kaltschmidt, C				Slotta, Carsten; Schlueter, Thomas; Ruiz-Perera, Lucia M.; Kadhim, Hussamadin M.; Tertel, Tobias; Henkel, Elena; Huebner, Wolfgang; Greiner, Johannes F. W.; Huser, Thomas; Kaltschmidt, Barbara; Kaltschmidt, Christian			CRISPR/Cas9-mediated knockout of c-REL in HeLa cells results in profound defects of the cell cycle	PLOS ONE			English	Article							NF-KAPPA-B; CERVICAL-CANCER; HUMAN-PAPILLOMAVIRUS; TRANSCRIPTION FACTOR; HUMAN GENOME; LUNG-CANCER; APOPTOSIS; ACTIVATION; EXPRESSION; GENE	Cervical cancer is the fourth common cancer in women resulting worldwide in 266,000 deaths per year. Belonging to the carcinomas, new insights into cervical cancer biology may also have great implications for finding new treatment strategies for other kinds of epithelial cancers. Although the transcription factor NF-kappa B is known as a key player in tumor formation, the relevance of its particular subunits is still underestimated. Here, we applied CRISPR/Cas9n-mediated genome editing to successfully knockout the NF-kappa B subunit c-REL in HeLa Kyoto cells as a model system for cervical cancers. We successfully generated a homozygous deletion in the c-REL gene, which we validated using sequencing, qPCR, immunocytochemistry, western blot analysis, EMSA and analysis of off-target effects. On the functional level, we observed the deletion of c-REL to result in a significantly decreased cell proliferation in comparison to wildtype (wt) without affecting apoptosis. The impaired proliferative behavior of c-REL-/- cells was accompanied by a strongly decreased amount of the H2B protein as well as a significant delay in the prometaphase of mitosis compared to c-REL+/+ HeLa Kyoto cells. c-REL-/- cells further showed significantly decreased expression levels of c-REL target genes in comparison to wt. In accordance to our proliferation data, we observed the c-REL knockout to result in a significantly increased resistance against the chemotherapeutic agents 5-Fluoro-2'-deoxyuridine (5-FUDR) and cisplatin. In summary, our findings emphasize the importance of c-REL signaling in a cellular model of cervical cancer with direct clinical implications for the development of new treatment strategies.	[Slotta, Carsten; Schlueter, Thomas; Kadhim, Hussamadin M.; Tertel, Tobias; Henkel, Elena; Greiner, Johannes F. W.; Kaltschmidt, Barbara; Kaltschmidt, Christian] Univ Bielefeld, Dept Cell Biol, Bielefeld, Germany; [Ruiz-Perera, Lucia M.; Kaltschmidt, Barbara] Univ Bielefeld, AG Mol Neurobiol, Bielefeld, Germany; [Huebner, Wolfgang; Huser, Thomas] Univ Bielefeld, Biomol Photon, Bielefeld, Germany	University of Bielefeld; University of Bielefeld; University of Bielefeld	Kaltschmidt, C (corresponding author), Univ Bielefeld, Dept Cell Biol, Bielefeld, Germany.	c.kaltschmidt@uni-bielefeld.de	Huser, Thomas/K-7291-2019; Greiner, Johannes/Y-6372-2019; Hubner, Wolfgang/O-7907-2016	Huser, Thomas/0000-0003-2348-7416; Greiner, Johannes/0000-0002-0524-662X; Hubner, Wolfgang/0000-0002-1128-6468				Adli M, 2006, J BIOL CHEM, P281; [Anonymous], 2005, CELL INT, V5, P10; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; De Siervi A, 2009, CELL CYCLE, V8, P2093, DOI 10.4161/cc.8.13.8926; Eddy SF, 2005, CANCER RES, V65, P11375, DOI 10.1158/0008-5472.CAN-05-1602; Forbes SA, 2014, CANC; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garland SM, 2002, PATHOLOGY, V34, P213, DOI 10.1080/00313020212469; Gilmore TD, 1999, ONCOGENE, V18, P6925, DOI 10.1038/sj.onc.1203222; Gilmore TD, 2004, ONCOGENE, V23, P2275, DOI 10.1038/sj.onc.1207410; Gilmore TD, 2001, ONCOGENE, V20, P7098, DOI 10.1038/sj.onc.1204898; Gilmore TD, NF KB TARGET GENES; Grey ST, 1999, J EXP MED, V190, P1135, DOI 10.1084/jem.190.8.1135; Grossmann M, 2000, EMBO J, V19, P6351, DOI 10.1093/emboj/19.23.6351; Grumont R, 2004, IMMUNITY, V21, P19, DOI 10.1016/j.immuni.2004.06.004; Grumont RJ, 1998, J EXP MED, V187, P663, DOI 10.1084/jem.187.5.663; Hamada K, 1996, CANCER RES, V56, P3047; Harris J, 2006, J IMMUNOL, V177, P2527, DOI 10.4049/jimmunol.177.4.2527; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Houldsworth J, 2004, BLOOD, V103, P1862, DOI 10.1182/blood-2003-04-1359; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Kaltschmidt B, 1999, ONCOGENE, V18, P3213, DOI 10.1038/sj.onc.1202657; Kaltschmidt B, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001271; Kang YJ, 2015, CANCER EPIDEMIOL, V39, P600, DOI 10.1016/j.canep.2015.04.009; Krappmann D, 1999, ONCOGENE, V18, P943, DOI 10.1038/sj.onc.1202351; Li QT, 2005, TRENDS IMMUNOL, V26, P318, DOI 10.1016/j.it.2005.04.003; Lorenz VN, 2014, J INVEST DERMATOL, V134, P415, DOI 10.1038/jid.2013.315; Lorusso D, 2014, GYNECOL ONCOL, V133, P117, DOI 10.1016/j.ygyno.2014.01.042; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802; Nair A, 2003, ONCOGENE, V22, P50, DOI 10.1038/sj.onc.1206043; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Nishiyama M, 1999, CLIN CANCER RES, V5, P2620; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Peters GJ, 2002, BBA-MOL BASIS DIS, V1587, P194, DOI 10.1016/S0925-4439(02)00082-0; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Rosette C, 2005, CARCINOGENESIS, V26, P943, DOI 10.1093/carcin/bgi070; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Shehata M, 2005, CELL BIOL INT, V29, P429, DOI 10.1016/j.cellbi.2004.12.014; Shehata M, 2004, CELL BIOL INT, V28, P895, DOI 10.1016/j.cellbi.2004.09.002; Soucek L, 2013, GENE DEV, V27, P504, DOI 10.1101/gad.205542.112; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Stewart B. W., 2003, World Cancer Report; Strutz F, 2001, KIDNEY INT, V59, P579, DOI 10.1046/j.1523-1755.2001.059002579.x; Tian WZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005028; Tokunaga S, 2014, ANAL BIOCHEM, V465, P70, DOI 10.1016/j.ab.2014.06.020; Vidya Priyadarsini R, 2010, Eur J Pharmacol, V649, P84, DOI 10.1016/j.ejphar.2010.09.020; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; WILHELMSEN KC, 1984, J VIROL, V52, P172, DOI 10.1128/JVI.52.1.172-182.1984; Xia YF, 2014, CANCER IMMUNOL RES, V2, P823, DOI 10.1158/2326-6066.CIR-14-0112; Yang LN, 2015, CANCER LETT, V357, P520, DOI 10.1016/j.canlet.2014.12.003; Zhao Y, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/3/035001	64	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182373	10.1371/journal.pone.0182373	http://dx.doi.org/10.1371/journal.pone.0182373			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767691	Green Published, Green Submitted, gold			2022-12-26	WOS:000406768200073
J	Wong, MW; Chen, MJ; Chen, HL; Kuo, YC; Lin, IT; Wu, CH; Lee, YK; Cheng, CH; Bair, MJ				Wong, Ming-Wun; Chen, Ming-Jen; Chen, Huan-Lin; Kuo, Yu-Chi; Lin, I-Tsung; Wu, Chia-Hsien; Lee, Yuan-Kai; Cheng, Chun-Han; Bair, Ming-Jong			Application of chronic liver failure-sequential organ failure assessment score for the predication of mortality after esophageal variceal hemorrhage post endoscopic ligation	PLOS ONE			English	Article							INJECTION SCLEROTHERAPY; GLASGOW-BLATCHFORD; IMPROVED SURVIVAL; RISK-ASSESSMENT; PROGNOSIS; SYSTEMS; CARE	Background Esophageal variceal hemorrhage (EVH) is one of the high mortality complications in cirrhotic patients. Endoscopic variceal ligation (EVL) is currently the standard therapy for EVH. However, some patients have expired during hospitalization or survived shortly after management. Aim To evaluate hospital and 6-week mortality by receiver operating characteristic (ROC) curve of chronic liver failure-sequential organ failure assessment (CLIF-SOFA) score compared to a model for end-stage liver disease (MELD) score and Child-Turcotte-Pugh (CTP) class. Methods We retrospectively collected 714 cirrhotic patients with EVH post EVL between July 2010 and June 2016 at Taitung MacKay Memorial Hospital, Taiwan. CLIF-SOFA score, MELD score, and CTP class were calculated for all patients admitted. Results Among the 714 patients, the overall hospital and 6-week mortality rates were 6.9% (49/715) and 13.1% (94/715) respectively. For predicting hospital death, area under receiver operating characteristic curve (AUROC) values of CLIF-SOFA score, MELD score, and CTP class were 0.964, 0.876, and 0.846. For predicting 6-week death, AUROC values of CLIF-SOFA score, MELD score, and CTP class were 0.943, 0.817, and 0.834. CLIF-SOFA score had higher AUROC value with statistical significance under pairwise comparison than did MELD score and CTP class in prediction of not only hospital but also 6-week mortality. The history of hepatocellular carcinoma was the risk factor for 6-week mortality. For patients with hepatocellular carcinoma the cut-point of CLIF-SOFA score was 5.5 for 6-week mortality and 6.5 for hospital mortality on admission. For patients without hepatocellular carcinoma, the cut-point of CLIF-SOFA score was 6.5 for both 6-week and hospital mortality. Conclusion CLIF-SOFA score predicted post-EVL prognosis well. For patients without hepatocellular carcinoma, CLIF-SOFA score >= 6 suggests higher 6-week mortality and CLIF-SOFA score >= 7 suggests higher hospital mortality. For patients with hepatocellular carcinoma, CLIF-SOFA score >= 7 suggests higher 6-week and hospital mortality.	[Wong, Ming-Wun] Buddhist Tzu Chi Gen Hosp, Dept Med, Hualien, Taiwan; [Wong, Ming-Wun] Tzu Chi Univ, Hualien, Taiwan; [Wong, Ming-Wun; Chen, Huan-Lin; Kuo, Yu-Chi; Lin, I-Tsung; Wu, Chia-Hsien; Lee, Yuan-Kai; Cheng, Chun-Han; Bair, Ming-Jong] Taitung MacKay Mem Hosp, Dept Internal Med, Div Gastroenterol, Taitung, Taiwan; [Chen, Ming-Jen] MacKay Mem Hosp, Dept Internal Med, Div Gastroenterol, Taitung, Taiwan; [Chen, Ming-Jen] MacKay Med Nursing & Management Coll, Taipei, Taiwan; [Chen, Ming-Jen; Bair, Ming-Jong] MacKay Med Coll, New Taipei, Taiwan; [Kuo, Yu-Chi; Bair, Ming-Jong] Meiho Univ, Dept Nursing, Pingtung, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; Mackay Medical College	Bair, MJ (corresponding author), Taitung MacKay Mem Hosp, Dept Internal Med, Div Gastroenterol, Taitung, Taiwan.; Bair, MJ (corresponding author), MacKay Med Coll, New Taipei, Taiwan.; Bair, MJ (corresponding author), Meiho Univ, Dept Nursing, Pingtung, Taiwan.	hypertr42@gmail.com		Bair, Ming-jong/0000-0001-7069-5459; Cheng, Chun-han/0000-0002-7262-861X				Al-Freah MAB, 2014, ALIMENT PHARM THER, V39, P1286, DOI 10.1111/apt.12744; Almela P, 2004, GASTROINTEST ENDOSC, V59, P772, DOI 10.1016/S0016-5107(04)00362-1; Amitrano L, 2005, J HEPATOL, V42, P820, DOI 10.1016/j.jhep.2005.01.021; Bambha K, 2008, GUT, V57, P814, DOI 10.1136/gut.2007.137489; Blatchford O, 2000, LANCET, V356, P1318, DOI 10.1016/S0140-6736(00)02816-6; Budimir I, 2016, SCAND J GASTROENTERO, V51, P1375, DOI 10.1080/00365521.2016.1200138; Carbonell N, 2004, HEPATOLOGY, V40, P652, DOI 10.1002/hep.20339; Cho H, 2016, HEPATOL RES, V46, P1338, DOI 10.1111/hepr.12692; Dai C, 2015, WORLD J GASTROENTERO, V21, P2534, DOI 10.3748/wjg.v21.i8.2534; de Franchis R, 2015, J HEPATOL, V63, P743, DOI 10.1016/j.jhep.2015.05.022; El-Serag HB, 2000, AM J GASTROENTEROL, V95, P3566; Hyett BH, 2013, GASTROINTEST ENDOSC, V77, P551, DOI 10.1016/j.gie.2012.11.022; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kuipers EJ, 2010, NAT REV GASTRO HEPAT, V7, P480, DOI 10.1038/nrgastro.2010.119; Letier MH, 2000, HEPATO-GASTROENTEROL, V47, P1680; McCormick PA, 2001, GUT, V49, P682, DOI 10.1136/gut.49.5.682; Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; de Souza AR, 2015, HEPATOLOGY, V62, P1840, DOI 10.1002/hep.28151; Rockall TA, 1996, GUT, V38, P316, DOI 10.1136/gut.38.3.316; Stokkeland K, 2006, HEPATOLOGY, V43, P500, DOI 10.1002/hep.21089; Thanapirom K, 2016, J GASTROEN HEPATOL, V31, P761, DOI 10.1111/jgh.13222; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zou KH, 2007, CIRCULATION, V115, P654, DOI 10.1161/CIRCULATIONAHA.105.594929	25	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182529	10.1371/journal.pone.0182529	http://dx.doi.org/10.1371/journal.pone.0182529			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767684	Green Published, gold, Green Submitted			2022-12-26	WOS:000406768200083
J	Arends, M; Biegstraaten, M; Hughes, DA; Mehta, A; Elliott, PM; Oder, D; Watkinson, OT; Vaz, FM; van Kuilenburg, AABP; Wanner, C; Hollak, CEM				Arends, Maarten; Biegstraaten, Marieke; Hughes, Derralynn A.; Mehta, Atul; Elliott, Perry M.; Oder, Daniel; Watkinson, Oliver T.; Vaz, Frederic M.; van Kuilenburg, Andre A. B. P.; Wanner, Christoph; Hollak, Carla E. M.			Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: Analysis of prognostic factors	PLOS ONE			English	Article							AGALSIDASE-BETA THERAPY; MAGNETIC-RESONANCE; CLINICAL MANIFESTATIONS; UNCERTAIN DIAGNOSIS; ALPHA-GALACTOSIDASE; QUANTIFICATION; PROGRESSION; CONSENSUS; IMPACT; KIDNEY	Despite enzyme replacement therapy, disease progression is observed in patients with Fabry disease. Identification of factors that predict disease progression is needed to refine guidelines on initiation and cessation of enzyme replacement therapy. To study the association of potential biochemical and clinical prognostic factors with the disease course (clinical events, progression of cardiac and renal disease) we retrospectively evaluated 293 treated patients from three international centers of excellence. As expected, age, sex and phenotype were important predictors of event rate. Clinical events before enzyme replacement therapy, cardiac mass and eGFR at baseline predicted an increased event rate. eGFR was the most important predictor: hazard ratios increased from 2 at eGFR <90 ml/min/1.73m(2) to 4 at eGFR <30, compared to patients with an eGFR >90. In addition, men with classical disease and a baseline eGFR <60 ml/min/1.73m(2) had a faster yearly decline (-2.0 ml/min/1.73m(2)) than those with a baseline eGFR of >60. Proteinuria was a further independent risk factor for decline in eGFR. Increased cardiac mass at baseline was associated with the most robust decrease in cardiac mass during treatment, while presence of cardiac fibrosis predicted a stronger increase in cardiac mass (3.36 gram/m(2)/year). Of other cardiovascular risk factors, hypertension significantly predicted the risk for clinical events. In conclusion, besides increasing age, male sex and classical phenotype, faster disease progression while on enzyme replacement therapy is predicted by renal function, proteinuria and to a lesser extent cardiac fibrosis and hypertension.	[Arends, Maarten; Biegstraaten, Marieke; Hollak, Carla E. M.] Acad Med Ctr, Dept Endocrinol & Metab, Amsterdam, Netherlands; [Hughes, Derralynn A.; Mehta, Atul] Royal Free London NHS Fdn Trust, Dept Haematol, London, England; [Hughes, Derralynn A.; Mehta, Atul; Elliott, Perry M.; Watkinson, Oliver T.] UCL, London, England; [Elliott, Perry M.; Watkinson, Oliver T.] St Bartholomews Hosp, Dept Cardiol, London, England; [Oder, Daniel; Wanner, Christoph] Univ Hosp Wuerzburg, CHFC, Div Cardiol & Nephrol, Dept Internal Med 1, Wurzburg, Germany; [Oder, Daniel; Wanner, Christoph] Univ Hosp Wuerzburg, Fabry Ctr Interdisciplinary Therapy FAZIT, Div Cardiol & Nephrol, Dept Internal Med 1, Wurzburg, Germany; [Vaz, Frederic M.; van Kuilenburg, Andre A. B. P.] Acad Med Ctr, Lab Genet Metab Dis, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of London; University College London; Royal Free London NHS Foundation Trust; University of London; University College London; University of London; Queen Mary University London; University of Wurzburg; University of Wurzburg; University of Amsterdam; Academic Medical Center Amsterdam	Arends, M (corresponding author), Acad Med Ctr, Dept Endocrinol & Metab, Amsterdam, Netherlands.	m.arends@amc.uva.nl	Mehta, Atul/GPC-7364-2022; Mehta, Atul/AAF-3559-2022; Elliott, Perry/AAR-3430-2020; Mehta, Atul/AFI-0044-2022; hughes, derralynn/J-8012-2013	Elliott, Perry/0000-0003-3383-3984; hughes, derralynn/0000-0003-4531-9173; Vaz, Frederic/0000-0002-9048-1041; Hollak, Carla/0000-0003-0464-1078; van Kuilenburg, Andre/0000-0002-7989-4910	Ministry of Health (ZonMw) of the Netherlands [836011009]; Bundesministerium fur Bildung und Forschung of the Federal Republic of Germany (BMBF) [01EO1504 MO2]	Ministry of Health (ZonMw) of the Netherlands; Bundesministerium fur Bildung und Forschung of the Federal Republic of Germany (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was supported by a grant (project number: 836011009) from the Ministry of Health (ZonMw) of the Netherlands. Researchers worked independently from the funders. The funding source had no involvement in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit an article for publication. The collection of data at University Hospital Wuerzburg has been supported by the Bundesministerium fur Bildung und Forschung of the Federal Republic of Germany (BMBF 01EO1504 MO2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JM, 2008, P NATL ACAD SCI USA, V105, P2812, DOI 10.1073/pnas.0712309105; Arends M, 2017, J AM SOC NEPHROL, V28, P1631, DOI 10.1681/ASN.2016090964; Arends M, 2016, MOL GENET METAB, V117, P194, DOI 10.1016/j.ymgme.2015.11.014; Banikazemi M, 2007, ANN INTERN MED, V146, P77, DOI 10.7326/0003-4819-146-2-200701160-00148; Biegstraaten M, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0253-6; BRADY RO, 1967, NEW ENGL J MED, V276, P1163, DOI 10.1056/NEJM196705252762101; Buechner S, 2008, J NEUROL NEUROSUR PS, V79, P1249, DOI 10.1136/jnnp.2008.143693; Cartwright DJ, 2004, J INHERIT METAB DIS, V27, P791, DOI 10.1023/B:BOLI.0000045841.27968.06; Desnick RJ, 2013, OMMBID ONL MET MOL B; Elliott PM, 2006, HEART, V92, P357, DOI 10.1136/hrt.2004.054015; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Fellgiebel A, 2014, CEREBROVASC DIS, V38, P448, DOI 10.1159/000369293; Germain DP, 2007, J AM SOC NEPHROL, V18, P1547, DOI 10.1681/ASN.2006080816; Germain DP, 2015, J MED GENET, V52, P353, DOI 10.1136/jmedgenet-2014-102797; Gold H, 2013, CLIN CHEM, V59, P547, DOI 10.1373/clinchem.2012.192138; Gommans DHF, 2016, NETH HEART J, V24, P326, DOI 10.1007/s12471-016-0805-y; Hollak CEM, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-16; Hughes DA, 2016, CURR OPIN CARDIOL, V31, P434, DOI 10.1097/HCO.0000000000000308; Jardim LB, 2006, ARQ NEURO-PSIQUIAT, V64, P711, DOI 10.1590/S0004-282X2006000500002; Kampmann C, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0338-2; Kawel-Boehm N, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0111-7; KINT J A, 1970, Science (Washington D C), V167, P1268, DOI 10.1126/science.167.3922.1268; Kramer J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140627; Kramer J, 2014, AM J CARDIOL, V114, P895, DOI 10.1016/j.amjcard.2014.06.019; Kruger R, 2012, J CHROMATOGR B, V883, P128, DOI 10.1016/j.jchromb.2011.11.020; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lenders M, 2016, NEPHROLOGY DIALYSIS; Levin A, 2013, KIDNEY INT S, V3, P1, DOI [DOI 10.1038/KISUP.2012.73, 10.1038/kisup.2012.73]; MacDermot KD, 2001, J MED GENET, V38, P750, DOI 10.1136/jmg.38.11.750; MacDermot KD, 2001, J MED GENET, V38, P769, DOI 10.1136/jmg.38.11.769; Rombach SM, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-47; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743; Schiffmann R, 2017, KIDNEY INT, V91, P284, DOI 10.1016/j.kint.2016.10.004; Sirrs SM, 2014, MOL GENET METAB, V111, P499, DOI 10.1016/j.ymgme.2014.01.014; Smid BE, 2014, INT J CARDIOL, V177, P400, DOI 10.1016/j.ijcard.2014.09.001; van Breemen MJ, 2011, BBA-MOL BASIS DIS, V1812, P70, DOI 10.1016/j.bbadis.2010.09.007; van der Tol L, 2014, JIMD REP, V17, P83, DOI 10.1007/8904_2014_342; Vogel-Claussen J, 2006, J COMPUT ASSIST TOMO, V30, P426, DOI 10.1097/00004728-200605000-00013; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Wanner C, 2010, CLIN J AM SOC NEPHRO, V5, P2220, DOI 10.2215/CJN.04340510; Warnock DG, 2015, J MED GENET, V52, P860, DOI 10.1136/jmedgenet-2015-103471; Warnock DG, 2012, NEPHROL DIAL TRANSPL, V27, P1042, DOI 10.1093/ndt/gfr420; Weidemann F, 2005, EUR HEART J, V26, P1221, DOI 10.1093/eurheartj/ehi143; Weidemann F, 2013, J INTERN MED, V274, P331, DOI 10.1111/joim.12077; Weidemann F, 2009, CIRCULATION, V119, P524, DOI 10.1161/CIRCULATIONAHA.108.794529; Wijburg FA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124987; Zon MW, 2013, TREATM PAT FABR DIS	47	59	61	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0182379	10.1371/journal.pone.0182379	http://dx.doi.org/10.1371/journal.pone.0182379			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763515	Green Published, Green Submitted, gold			2022-12-26	WOS:000406766500063
J	Filardi, M; Pizza, F; Tonetti, L; Antelmi, E; Natale, V; Plazzi, G				Filardi, Marco; Pizza, Fabio; Tonetti, Lorenzo; Antelmi, Elena; Natale, Vincenzo; Plazzi, Giuseppe			Attention impairments and ADHD symptoms in adult narcoleptic patients with and without hypocretin deficiency	PLOS ONE			English	Article							REPORT SCALE ASRS; SLEEP DISORDERS; ITALIAN VERSION; PERFORMANCE; CATAPLEXY; NETWORKS; CONSOLIDATION; DYSFUNCTION; ACTIVATION; DEPRESSION	Background Attentional complaints are common in narcolepsy patients and can overlap with daytime sleepiness features. Few studies attempted to characterize attentional domains in narcolepsy leading to controversial results. We aimed to assess the impact of hypocretin deficiency on attentional functioning by comparing performances on the attention network test (ANT) of narcoleptic patients with hypocretin deficiency (narcolepsy type 1-NT1) versus patients without hypocretin deficiency (narcolepsy type 2-NT2) and healthy controls. We also addressed frequency and severity of psychopathological symptoms and their influence on performances on ANT. Methods Twenty-one NT1 patients, fifteen NT2 patients and twenty-two healthy controls underwent the ANT, which allows assessing three separate attentional processes (alerting, orienting and executive control), and a psychometric assessment including questionnaires on attention-deficit hyperactivity disorder (ADHD), obsessive-compulsive disorder, anxiety and depression symptoms. Results NT1 and NT2 patients presented with slower reaction times compared to controls. NT1 patients exhibited an impairment of alerting network relative to NT2 and healthy controls, while orienting and executive control networks efficiency were comparable between groups. NT1 and NT2 displayed higher severity of ADHD inattentive domain than controls, NT1 patients also displayed higher severity of ADHD hyperactive domain and depressive symptoms. In NT1, ADHD and depressive symptoms were positively correlated. Conclusions Despite a shared slowing of reaction times in both NT1 and NT2, a selective impairment of alerting network was present only in hypocretin deficient patients. Clinicians should carefully consider attentional deficits and psychopathological symptoms, including ADHD symptoms, in the clinical assessment and management of patients with narcolepsy.	[Filardi, Marco; Pizza, Fabio; Antelmi, Elena; Plazzi, Giuseppe] Univ Bologna, Dept Biomed & Neuromotor Sci, DIBINEM, Bologna, Italy; [Pizza, Fabio; Antelmi, Elena; Plazzi, Giuseppe] AUSL Bologna, IRCCS, Ist Sci Neurol, Bologna, Italy; [Tonetti, Lorenzo; Natale, Vincenzo] Univ Bologna, Dept Psychol, Bologna, Italy	University of Bologna; AUSL di Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna	Plazzi, G (corresponding author), Univ Bologna, Dept Biomed & Neuromotor Sci, DIBINEM, Bologna, Italy.; Plazzi, G (corresponding author), AUSL Bologna, IRCCS, Ist Sci Neurol, Bologna, Italy.	giuseppe.plazzi@unibo.it	Filardi, Marco/AAJ-6790-2021; Plazzi, Giuseppe/AAB-9627-2020; Antelmi, Elena/K-3252-2018; Tonetti, Lorenzo/B-8594-2017; Natale, Vincenzo/I-7068-2019; Pizza, Fabio/AAC-1794-2020	Filardi, Marco/0000-0001-9702-8314; Tonetti, Lorenzo/0000-0001-6797-9266; Natale, Vincenzo/0000-0001-8438-7828; Plazzi, Giuseppe/0000-0002-1051-0472; Antelmi, Elena/0000-0003-1739-6139				[Anonymous], 2014, INT CLASSIFICATION S; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Bayard S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033525; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Booth JE, 2007, ARCH CLIN NEUROPSYCH, V22, P423, DOI 10.1016/j.acn.2007.01.017; Bourgin P, 2008, LANCET NEUROL, V7, P649, DOI 10.1016/S1474-4422(08)70140-6; Cipolli C, 2013, SLEEP MED REV, V17, P91, DOI 10.1016/j.smrv.2012.01.004; Cipolli C, 2009, J SLEEP RES, V18, P209, DOI 10.1111/j.1365-2869.2008.00712.x; Dauvilliers Y, 2007, LANCET, V369, P499, DOI 10.1016/S0140-6736(07)60237-2; Delazer M, 2011, NEUROPSYCHOLOGY, V25, P477, DOI 10.1037/a0022357; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Findley LJ, 1999, SLEEP, V22, P804, DOI 10.1093/sleep/22.6.804; Fortuyn HAD, 2010, GEN HOSP PSYCHIAT, V32, P49, DOI 10.1016/j.genhosppsych.2009.08.007; Fronczek R, 2006, SLEEP, V29, P187; Fulda S, 2001, SLEEP MED REV, V5, P423, DOI 10.1053/smrv.2001.0157; Gooding DC, 2006, SCHIZOPHR RES, V88, P169, DOI 10.1016/j.schres.2006.07.009; Ha KS, 2007, ACTA NEUROL SCAND, V116, P312, DOI 10.1111/j.1600-0404.2007.00891.x; Hood B, 1997, J SLEEP RES, V6, P205, DOI 10.1046/j.1365-2869.1997.00044.x; Huang YS, 2016, SLEEP MED, V23, P137, DOI 10.1016/j.sleep.2015.11.023; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Kessler RC, 2007, INT J METH PSYCH RES, V16, P52, DOI 10.1002/mpr.208; Lecendreux M, 2015, SLEEP, V38, P1285, DOI 10.5665/sleep.4910; Luca G, 2013, J SLEEP RES, V22, P482, DOI 10.1111/jsr.12044; Mahler SV, 2014, NAT NEUROSCI, V17, P1298, DOI 10.1038/nn.3810; Matchock RL, 2009, EXP BRAIN RES, V192, P189, DOI 10.1007/s00221-008-1567-6; Modestino EJ, 2013, J ATTEN DISORD, V17, P574, DOI 10.1177/1087054713480033; Natale V., 2006, SLEEP BIOL RHYTHMS, V4, P72, DOI [10.1111/j.1479-8425.2006.00192.x, DOI 10.1111/J.1479-8425.2006.00192.X]; Naumann A, 2006, J SLEEP RES, V15, P329, DOI 10.1111/j.1365-2869.2006.00533.x; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Pizza F, 2013, J SLEEP RES, V22, P32, DOI 10.1111/j.1365-2869.2012.01032.x; Posner MI, 2008, ANN NY ACAD SCI, V1129, P193, DOI 10.1196/annals.1417.011; Richardson JTE, 2011, EDUC RES REV-NETH, V6, P135, DOI 10.1016/j.edurev.2010.12.001; Rieger M, 2003, SLEEP, V26, P36; Rinne P, 2013, NEUROLOGY, V81, P812, DOI 10.1212/WNL.0b013e3182a2ca34; ROGERS AE, 1990, SLEEP, V13, P42; Ruoff CM, 2016, J CLIN PSYCHIAT; Sica C, 2009, J ANXIETY DISORD, V23, P204, DOI 10.1016/j.janxdis.2008.07.001; SPIELBERGER CD, 1983, MANUAL STATE TRAIT A, P1; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Urbanek C, 2010, MULT SCLER J, V16, P93, DOI 10.1177/1352458509350308; Vignatelli L, 2003, NEUROL SCI, V23, P295, DOI 10.1007/s100720300004; Zamarian L, 2015, SLEEP MED, V16, P45, DOI 10.1016/j.sleep.2014.07.025	43	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0182085	10.1371/journal.pone.0182085	http://dx.doi.org/10.1371/journal.pone.0182085			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC3VC	28763482	Green Published, gold, Green Submitted			2022-12-26	WOS:000406766500040
J	Klarner, B; Winkelmann, H; Krashevska, V; Maraun, M; Widyastuti, R; Scheu, S				Klarner, Bernhard; Winkelmann, Helge; Krashevska, Valentyna; Maraun, Mark; Widyastuti, Rahayu; Scheu, Stefan			Trophic niches, diversity and community composition of invertebrate top predators (Chilopoda) as affected by conversion of tropical lowland rainforest in Sumatra (Indonesia)	PLOS ONE			English	Article							STABLE-ISOTOPE ANALYSIS; FOOD-WEB; LAND-USE; MICROBIAL BIOMASS; NITROGEN ISOTOPES; SOIL MACROFAUNA; BIODIVERSITY; CARBON; DELTA-N-15; DIET	Conversion of tropical rainforests into plantations fundamentally alters ecological niches of animal species. Generalist predators such as centipedes (Chilopoda) may be able to persist in converted ecosystems due to their ability to adapt and switch to alternative prey populations. We investigated variations in community composition and trophic niches of soil and litter living centipedes in a range of ecosystems including rainforests, jungle rubber agroforests, and rubber and oil palm monocultures in two landscapes in Sumatra, Indonesia. Including information on environmental factors in the soil and litter habitat, we explored drivers shaping ecological niches of soil living invertebrate predators in one of the world's hotspots of rainforest conversion. Conversion of rainforests into agroforests and plantations was associated with a marked change in the composition of centipede communities. However, irrespective of major differences in habitat characteristics, changes in total abundances were small and the overall diversity and biomass of centipedes was similar in each of the systems investigated, suggesting that the number of ecological niches for this group of predators remains unchanged. By using stable isotope analysis (N-15 and C-13), we investigated trophic niche shifts of the centipede community; lower delta C-13 values of centipedes in oil palm plantations as compared to other ecosystems suggests that centipedes switch from decomposer prey to other prey, presumably understory associated herbivores, due to reduced availability of litter associated prey species. The results suggest that the ability to utilize alternative prey is a key feature enabling invertebrate predators to persist in ecosystems undergoing major structural changes due to anthropogenic land use change.	[Klarner, Bernhard; Winkelmann, Helge; Krashevska, Valentyna; Maraun, Mark; Scheu, Stefan] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol Anim Ecol, Gottingen, Germany; [Widyastuti, Rahayu] IPB, Dept Soil Sci & Land Resources, Bogor, Indonesia; [Scheu, Stefan] Ctr Biodivers & Sustainable Land Use, Gottingen, Germany	University of Gottingen; Bogor Agricultural University	Klarner, B (corresponding author), Univ Gottingen, JF Blumenbach Inst Zool & Anthropol Anim Ecol, Gottingen, Germany.	bklarne@gwdg.de	Scheu, Stefan/H-7049-2015; Krashevska, Valentyna/C-2517-2017; Widyastuti, Rahayu/GPK-6479-2022	Krashevska, Valentyna/0000-0002-9765-5833; Klarner, Bernhard/0000-0003-1867-4911	Deutsche Forschungsgemeinschaft (DFG); German Research Foundation (DFG) [CRC990]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG))	The study was financed by the Deutsche Forschungsgemeinschaft (DFG) (www.dfg.de) as part of the project B08 in the framework of the German-Indonesian Collaborative Research Center 990 entitled "Ecological and Socioeconomic Function of Tropical Lowland Rainforest Transformation Systems" (EFForTs) (https//www.uni-goettingen.de/en/310995.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the village heads, local site owners, PT REKI and Bukit Duabelas National Park for granting access to their properties and the counterparts and local assistants for support. We are grateful to Dr. Lucio Bonato from the University of Padova for inspecting sample specimens and giving feedback on the taxonomy of Geophilomorpha in the study region. We further like to thank two unknown referees for their help in improving the manuscript. Financial support was provided by the German Research Foundation (DFG) in the framework of the collaborative German -Indonesian research project CRC990 (EFForTS).	Adis Joachim, 1996, Ecotropica, V2, P165; Allen K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133325; ANDERSON JPE, 1978, SOIL BIOL BIOCHEM, V10, P215, DOI 10.1016/0038-0717(78)90099-8; Barnes AD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6351; Bates D., 2005, R R NEWS, V5, P27, DOI DOI 10.18637/JSS.V067.I01; Bivand R., 2020, SPDEP SPATIAL DEPEND; Bluthgen N, 2003, OECOLOGIA, V137, P426, DOI 10.1007/s00442-003-1347-8; Caruso T, 2007, BIODIVERS CONSERV, V16, P3277, DOI 10.1007/s10531-006-9137-3; Clough Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13137; COLLINS NM, 1980, OECOLOGIA, V44, P263, DOI 10.1007/BF00572689; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Didden W, 2001, ECOTOX ENVIRON SAFE, V50, P25, DOI 10.1006/eesa.2001.2075; Donoso DA, 2013, SOIL BIOL BIOCHEM, V61, P45, DOI 10.1016/j.soilbio.2013.02.004; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Drescher J, PHILOS T B; FAOSTAT, 2015, STAT DIV; Fitzherbert EB, 2008, TRENDS ECOL EVOL, V23, P538, DOI 10.1016/j.tree.2008.06.012; Gatto M, 2015, LAND USE POLICY, V46, P292, DOI 10.1016/j.landusepol.2015.03.001; Gilbert N, 2012, NATURE, V487, P286; Gunther B, 2014, OIKOS, V123, P1192, DOI 10.1111/j.1600-0706.2013.00868.x; Guillaume T, 2015, GLOBAL CHANGE BIOL, V21, P3548, DOI 10.1111/gcb.12907; Hattenschwiler S, 2011, NEW PHYTOL, V189, P950, DOI 10.1111/j.1469-8137.2010.03483.x; HAGVAR S, 1980, OIKOS, V34, P245, DOI 10.2307/3544284; Halaj J, 2005, PEDOBIOLOGIA, V49, P109, DOI 10.1016/j.pedobi.2004.09.002; Hassler E, 2015, BIOGEOSCIENCES, V12, P5831, DOI 10.5194/bg-12-5831-2015; Hyodo F, 2015, ENTOMOL SCI, V18, P295, DOI 10.1111/ens.12128; Hyodo F, 2015, FUNCT ECOL, V29, P423, DOI 10.1111/1365-2435.12357; Hyodo F, 2010, J TROP ECOL, V26, P205, DOI 10.1017/S0266467409990502; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Kempson D., 1963, Pedobiologia, V3, P1; Klarner B, 2014, OIKOS, V123, P1173, DOI 10.1111/j.1600-0706.2013.00939.x; Kotowska MM, 2015, GLOBAL CHANGE BIOL, V21, P3620, DOI 10.1111/gcb.12979; Krashevska V, 2015, BIOL FERT SOILS, V51, P697, DOI 10.1007/s00374-015-1021-4; Kudrin AA, 2015, SOIL BIOL BIOCHEM, V86, P193, DOI 10.1016/j.soilbio.2015.03.017; Laumonier Y, 2010, BIODIVERS CONSERV, V19, P1153, DOI 10.1007/s10531-010-9784-2; Lavelle P, 2006, EUR J SOIL BIOL, V42, pS3, DOI 10.1016/j.ejsobi.2006.10.002; Lavelle P, 1997, EUR J SOIL BIOL, V33, P159; Lensing JR, 2006, P NATL ACAD SCI USA, V103, P15502, DOI 10.1073/pnas.0607064103; Lewis J.G.E., 2006, BIOL CENTIPEDES; Marimin, 2014, J CLEAN PROD, V85, P201, DOI 10.1016/j.jclepro.2014.01.098; Martius C, 2004, NUTR CYCL AGROECOSYS, V68, P137, DOI 10.1023/B:FRES.0000017468.76807.50; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Molinari J, 2005, CARIBB J SCI, V41, P340; Moya-Larano J, 2007, ECOLOGY, V88, P1454, DOI 10.1890/05-1474; Mumme S, 2015, BIOL CONSERV, V191, P750, DOI 10.1016/j.biocon.2015.08.033; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Oelbermann K, 2010, B ENTOMOL RES, V100, P511, DOI 10.1017/S0007485309990587; Oksanen J, 2013, PACKAGE VEGAN COMMUN, P2; Ott D, 2014, OIKOS, V123, P1212, DOI 10.1111/oik.01670; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Pollierer MM, 2009, SOIL BIOL BIOCHEM, V41, P1221, DOI 10.1016/j.soilbio.2009.03.002; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; REINEKING A, 1993, ISOTOPENPRAXIS, V29, P169, DOI 10.1080/10256019308046151; Sahner J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138077; Sanders D, 2011, J ANIM ECOL, V80, P569, DOI 10.1111/j.1365-2656.2010.01796.x; SCHAEFER M, 1990, OECOLOGIA, V82, P128, DOI 10.1007/BF00318544; SCHEU S, 1992, SOIL BIOL BIOCHEM, V24, P1113, DOI 10.1016/0038-0717(92)90061-2; Scheu S, 1996, APPL SOIL ECOL, V3, P115, DOI 10.1016/0929-1393(95)00079-8; Scheu S, 2000, OECOLOGIA, V123, P285, DOI 10.1007/s004420051015; Schneider D, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01339; Steffan-Dewenter I, 2007, P NATL ACAD SCI USA, V104, P4973, DOI 10.1073/pnas.0608409104; Team RC, 2015, R LANG ENV STAT COMP; Tiunov AV, 2007, BIOL BULL+, V34, P395, DOI 10.1134/S1062359007040127; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; von Berg K, 2008, B ENTOMOL RES, V98, P257, DOI 10.1017/S0007485308006007; von Berg K, 2010, OECOLOGIA, V163, P1033, DOI 10.1007/s00442-010-1604-6; Vucic-Pestic O, 2011, GLOBAL CHANGE BIOL, V17, P1301, DOI 10.1111/j.1365-2486.2010.02329.x; Whalen J.K., 2010, SOIL ECOLOGY MANAGEM; Wilcove DS, 2013, TRENDS ECOL EVOL, V28, P531, DOI 10.1016/j.tree.2013.04.005; Wolters Volkmar, 1997, P265; Zalewski M, 2014, ANN ZOOL FENN, V51, P301, DOI 10.5735/086.051.0302	73	26	27	7	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0180915	10.1371/journal.pone.0180915	http://dx.doi.org/10.1371/journal.pone.0180915			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763453	Green Published, Green Submitted, gold			2022-12-26	WOS:000406766500008
J	Tahara, T; Takahama, K; Tahara, S; Yoshida, D; Horiguchi, N; Kawamura, T; Okubo, M; Nagasaka, M; Nakagawa, Y; Urano, M; Shibata, T; Tuskamoto, T; Ieda, HO; Kuroda, M; Ohmiya, N				Tahara, Tomomitsu; Takahama, Kazuya; Tahara, Sayumi; Yoshida, Dai; Horiguchi, Noriyuki; Kawamura, Tomohiko; Okubo, Masaaki; Nagasaka, Mitsuo; Nakagawa, Yoshihito; Urano, Makoto; Shibata, Tomoyuki; Tuskamoto, Tetsuya; Ieda, Hiro-o; Kuroda, Makoto; Ohmiya, Naoki			Endoscopic features of lymphoid follicles using blue laser imaging (BLI) endoscopy in the colorectum and its association with chronic bowel symptoms	PLOS ONE			English	Article							UNITED-STATES; DIAGNOSIS; SYSTEM; ACTIVATION; POLYPS; CANCER; BURDEN	Background/Aim In the colorectum, lymphoid follicles hyperplasia (LH) is sometimes observed as small, round, yellowish-white nodules. The novel image-enhanced endoscopy system named blue laser imaging (BLI) provides enhanced the contrast of surface vessels using lasers for light illumination. We investigated the endoscopic features of LH observed by using BLI endoscopy and its association with chronic bowel symptoms. Patients/Methods 300 participants undergoing colonoscopy for various indications were enrolled. Entire colorectum was observed by using BLI-bright mode with non-magnification view. LH was defined as well demarcated white nodules. Elevated LH with erythema was distinguished as LH severe. Results LHs were observed more clearly by using BLI-bright mode compared to conventional white light colonoscopy and were also histologically confirmed as intense infiltration of lymphocytes or plasmacytes. LH was observed in 134 subjects (44.6%) and 67 (22.3%) were LH severe. LH was associated younger age (Odds ratio (OR) = 1.05, 95% Confidence Interval (95%CI) = 1.03-1.07, P<0.0001) and chronic bowel symptoms including constipation, hard stools, diarrhea and loose stools (all LH: OR = 4.03, 95%CI = 2.36-6.89, P<0.0001, LH severe: OR = 5.31, 95%CI = 2.64-10.71, P<0.0001). LH severe was closely associated with both constipation associated symptoms (OR = 3.94, 95%CI = 1.79-8.66, P = 0.0007) and diarrhea associated symptoms (OR = 5.22, 95%CI = 2.09-13.05, P = 0.0004). In particular, LH severe in the ascending colon was strongly associated with bowel symptoms (P<0.0001). Conclusion LH, visualized by using BLI endoscopy was associated with bowel symptom, raising the possibility of pathogenic role of this endoscopic finding in the functional lower gastrointestinal disorders.	[Tahara, Tomomitsu; Takahama, Kazuya; Yoshida, Dai; Horiguchi, Noriyuki; Kawamura, Tomohiko; Okubo, Masaaki; Nagasaka, Mitsuo; Nakagawa, Yoshihito; Shibata, Tomoyuki; Ohmiya, Naoki] Fujita Hlth Univ, Sch Med, Dept Gastroenterol, Toyoake, Aichi, Japan; [Takahama, Kazuya; Ieda, Hiro-o] Ieda Hosp, Endoscop Ctr, Toyota, Japan; [Tahara, Sayumi; Urano, Makoto; Tuskamoto, Tetsuya; Kuroda, Makoto] Fujita Hlth Univ, Sch Med, Dept Diagnost Pathol 1, Toyoake, Aichi, Japan	Fujita Health University; Fujita Health University	Tahara, T (corresponding author), Fujita Hlth Univ, Sch Med, Dept Gastroenterol, Toyoake, Aichi, Japan.	tomomiccyu@yahoo.co.jp						Bhuiyan M R, 2010, Mymensingh Med J, V19, P275; Chadwick VS, 2002, GASTROENTEROLOGY, V122, P1778, DOI 10.1053/gast.2002.33579; Cremon C, 2009, AM J GASTROENTEROL, V104, P392, DOI 10.1038/ajg.2008.94; DiBonaventura M, 2011, CURR MED RES OPIN, V27, P2213, DOI 10.1185/03007995.2011.623157; Drossman DA, 2002, GASTROENTEROLOGY, V123, P2108, DOI 10.1053/gast.2002.37095; Ezoe Y, 2011, GASTROENTEROLOGY, V141, P2017, DOI 10.1053/j.gastro.2011.08.007; Goda K, 2007, GASTROINTEST ENDOSC, V65, P36, DOI 10.1016/j.gie.2006.03.938; HARVEY RF, 1983, LANCET, V1, P632; Hayashi S, 2015, DIGEST ENDOSC, V27, P53, DOI 10.1111/den.12335; Machida H, 2004, ENDOSCOPY, V36, P1094, DOI 10.1055/s-2004-826040; Mansueto P, 2012, ALIMENT PHARM THER, V35, P1000, DOI 10.1111/j.1365-2036.2012.05062.x; Miyaki R, 2015, J CLIN GASTROENTEROL, V49, P108, DOI 10.1097/MCG.0000000000000104; Ohman L, 2010, NAT REV GASTRO HEPAT, V7, P163, DOI 10.1038/nrgastro.2010.4; Osawa H, 2014, DIGEST ENDOSC, V26, P105, DOI 10.1111/den.12205; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Sandler RS, 2002, GASTROENTEROLOGY, V122, P1500, DOI 10.1053/gast.2002.32978; Tahara T, 2009, GASTROINTEST ENDOSC, V70, P246, DOI 10.1016/j.gie.2008.11.046; TALLEY NJ, 1995, GASTROENTEROLOGY, V109, P1736, DOI 10.1016/0016-5085(95)90738-6; Yoshida N, 2015, GASTROINTEST ENDOSC, V82, P542, DOI 10.1016/j.gie.2015.01.030; Yoshida N, 2014, DIGEST ENDOSC, V26, P250, DOI 10.1111/den.12127	20	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0182224	10.1371/journal.pone.0182224	http://dx.doi.org/10.1371/journal.pone.0182224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763491	gold, Green Published, Green Submitted			2022-12-26	WOS:000406766500054
J	Wolf, S; Gelis, L; Dorrich, S; Hatt, H; Kraft, P				Wolf, Steffen; Gelis, Lian; Doerrich, Steffen; Hatt, Hanns; Kraft, Philip			Evidence for a shape-based recognition of odorants in vivo in the human nose from an analysis of the molecular mechanism of lily-of-the-valley odorants detection in the Lilial and Bourgeonal family using the C/Si/Ge/Sn switch strategy	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; SITE-DIRECTED MUTAGENESIS; MAMMALIAN OLFACTORY-BULB; PROSTATE-CANCER; LIGAND COMPLEXES; ANTENNAL LOBE; ACTIVATION; MODEL; GPCR; CELLS	We performed an analysis of possible mechanisms of ligand recognition in the human nose. The analysis is based on in vivo odor threshold determination and in vitro Ca2+ imaging assays with a C/Si/Ge/Sn switch strategy applied to the compounds Lilial and Bourgeonal, to differentiate between different molecular mechanisms of odorant detection. Our results suggest that odorant detection under threshold conditions is mainly based on the molecular shape, i.e. the van der Waals surface, and electrostatics of the odorants. Furthermore, we show that a single olfactory receptor type is responsible for odor detection of Bourgeonal at the threshold level in humans in vivo. Carrying out a QM analysis of vibrational energies contained in the odorants, there is no evidence for a vibration-based recognition.	[Wolf, Steffen] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Computat Biol, Dept Biophys,CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China; [Wolf, Steffen] Ruhr Univ Bochum, Dept Biophys, Bochum, Germany; [Gelis, Lian; Hatt, Hanns] Ruhr Univ Bochum, Dept Cellphysiol, Bochum, Germany; [Doerrich, Steffen] Univ Wurzburg, Inst Inorgan Chem, Wurzburg, Germany; [Kraft, Philip] Givaudan Schweiz AG, Fragrance Res, Dubendorf, Switzerland	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Ruhr University Bochum; Ruhr University Bochum; University of Wurzburg; Givaudan SA	Wolf, S (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Computat Biol, Dept Biophys,CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China.; Wolf, S (corresponding author), Ruhr Univ Bochum, Dept Biophys, Bochum, Germany.	swolf@picb.ac.cn	Kraft, Philip/AAA-5390-2019; Wolf, Steffen/A-1721-2010	Kraft, Philip/0000-0002-4801-5389; Wolf, Steffen/0000-0003-1752-6175	National Natural Science Foundation of China [31250110070]; MERCATOR Research Center Ruhr; Deutsche Forschungsgemeinschaft [SFB642]; Givaudan Schweiz AG (Fragrance Research)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MERCATOR Research Center Ruhr; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Givaudan Schweiz AG (Fragrance Research)	This work was supported by National Natural Science Foundation of China (grant no. 31250110070), http://www.nsfc.gov.cn/publish/portal1/; MERCATOR Research Center Ruhr, http://www.mercur-research.de/en/; and Deutsche Forschungsgemeinschaft (SFB642), http://www.dfg.de/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Givaudan Schweiz AG (Fragrance Research) provided support in the form of salaries for P.K. and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; S.W. would like to thank Jurgen Schlitter for helpful discussions. S.W. further acknowledges a grant from the National Natural Science Foundation of China Young Scientist Fund (grant no. 31250110070) and a travel grant from the MERCATOR Research Center Ruhr. This work was supported by a grant to H.H. from the Deutsche Forschungsgemeinschaft (SFB642). QM calculations were performed on the HPC PURE cluster at the Biophysics Department of the Ruhr-Universitat Bochum. Docking calculations were performed on the HPC cluster of the PICB Shanghai.	Ache BW, 2010, CHEM SENSES, V35, P533, DOI 10.1093/chemse/bjq045; Auffarth B, 2013, NEUROSCI BIOBEHAV R, V37, P1667, DOI 10.1016/j.neubiorev.2013.06.009; Bajgrowicz JA, 2001, TETRAHEDRON-ASYMMETR, V12, P2049, DOI 10.1016/S0957-4166(01)00360-3; Berg J.M, 2001, BIOCHEMISTRY; Blanchet MA, 1996, NAT STRUCT BIOL, V3, P934, DOI 10.1038/nsb1196-934; Block E, 2015, P NATL ACAD SCI USA, V112, pE2766, DOI 10.1073/pnas.1503054112; Block E, 2013, ACS SYM SER, V1152, P1; Braun T, 2007, GASTROENTEROLOGY, V132, P1890, DOI 10.1053/j.gastro.2007.02.036; Brookes JC, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.038101; Brookes JC, 2012, SENSORS-BASEL, V12, P15709, DOI 10.3390/s121115709; Bush A, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20166910; Busse D, 2014, J INVEST DERMATOL, V134, P2823, DOI 10.1038/jid.2014.273; Checinska A, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4905377; Cheng L, 2010, MONATSH CHEM, V141, P953, DOI 10.1007/s00706-010-0347-8; Cui T, 2013, PANCREAS, V42, P373; Deupi X, 2014, BBA-BIOENERGETICS, V1837, P674, DOI 10.1016/j.bbabio.2013.09.002; Diem M., 2015, MODERN VIBRATIONAL S; Dorrich S, 2014, CHEMPLUSCHEM, V79, P1747, DOI 10.1002/cplu.201402160; Doszczak L, 2007, ANGEW CHEM INT EDIT, V46, P3367, DOI 10.1002/anie.200605002; Duan XF, 2012, P NATL ACAD SCI USA, V109, P3492, DOI 10.1073/pnas.1111297109; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Flegel C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055368; Franco MI, 2011, P NATL ACAD SCI USA, V108, P3797, DOI 10.1073/pnas.1012293108; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Frisch M. J., 2009, GAUSSIAN 16 REVISION; Fuessel S, 2006, CANCER LETT, V236, P95, DOI 10.1016/j.canlet.2005.05.005; Gane S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055780; Gautam SH, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00081; Gelis L, 2016, J BIOL CHEM, V291, P17772, DOI 10.1074/jbc.M116.734517; Gelis L, 2012, ANGEW CHEM INT EDIT, V51, P1274, DOI 10.1002/anie.201103980; GETCHELL TV, 1984, PROG NEUROBIOL, V23, P317, DOI 10.1016/0301-0082(84)90008-X; Giandomenico V, 2013, J MOL ENDOCRINOL, V51, P277, DOI 10.1530/JME-13-0144; Ho JH, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005912; Horie S, 2016, ANAT REC; Jang S, 2017, J PHYS CHEM B, V121, P1304, DOI 10.1021/acs.jpcb.7b00486; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; Kalbe B, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00339; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kenakin T, 2002, NAT REV DRUG DISCOV, V1, P103, DOI 10.1038/nrd722; KOLLMAN P, 1993, CHEM REV, V93, P2395, DOI 10.1021/cr00023a004; Koulakov A, 2007, J NEUROPHYSIOL, V98, P3134, DOI 10.1152/jn.00560.2007; Kraft P, 2000, ANGEW CHEM INT EDIT, V39, P2981; Krishnamoorthy BS, 2006, J MOL STRUC-THEOCHEM, V761, P89, DOI 10.1016/j.theochem.2005.12.011; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Lebon G, 2012, CURR OPIN STRUC BIOL, V22, P482, DOI 10.1016/j.sbi.2012.03.007; Li SJ, 2016, J AM CHEM SOC, V138, P13281, DOI 10.1021/jacs.6b06983; Liu JH, 2016, EUR J ORG CHEM, V2016, P976, DOI 10.1002/ejoc.201501338; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Manteniotis S, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2015.70; Massberg D, 2015, ARCH BIOCHEM BIOPHYS, V566, P100, DOI 10.1016/j.abb.2014.12.004; MILLIS KK, 1993, J ORG CHEM, V58, P4144, DOI 10.1021/jo00067a060; Neuhaus EM, 2009, J BIOL CHEM, V284, P16218, DOI 10.1074/jbc.M109.012096; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Ochterski J.W., 2000, THERMOCHEMISTRY GAUS; Palczewski K, 2012, J BIOL CHEM, V287, P1612, DOI 10.1074/jbc.R111.301150; Racine J, 2006, J APPL ECONOMET, V21, P133, DOI 10.1002/jae.885; Rawson NE, 2000, J NEUROCHEM, V75, P185, DOI 10.1046/j.1471-4159.2000.0750185.x; Reed MA, 2008, MATER TODAY, V11, P46, DOI 10.1016/S1369-7021(08)70238-4; Rinaldi A, 2007, EMBO REP, V8, P629, DOI 10.1038/sj.embor.7401029; Saberi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep25103; Sachse S, 2003, EUR J NEUROSCI, V18, P2119, DOI 10.1046/j.1460-9568.2003.02931.x; Sanz G, 2008, CHEM SENSES, V33, P639, DOI 10.1093/chemse/bjn032; Schneider M, 2011, FEBS LETT, V585, P3587, DOI 10.1016/j.febslet.2011.10.027; Schnell M, 2006, PHYS CHEM CHEM PHYS, V8, P2225, DOI 10.1039/b600682e; Schrodinger L., 2020, PYMOL; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sekharan S, 2014, BIOPHYS J, V107, pL05, DOI [10.1016/j.bpj.2014.07.031, 10.1016/j.bpj.2014.07.03]; SINGH UC, 1984, J COMPUT CHEM, V5, P129, DOI 10.1002/jcc.540050204; Smit RHM, 2002, NATURE, V419, P906, DOI 10.1038/nature01103; Solov'yov IA, 2012, PHYS CHEM CHEM PHYS, V14, P13861, DOI 10.1039/c2cp41436h; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; Spors H, 2012, J NEUROSCI, V32, P14102, DOI 10.1523/JNEUROSCI.3328-12.2012; Stipe BC, 1998, SCIENCE; Tacke R, 1999, BIOORGANOGERMANIUM C, V150, P69; Tacke R, 2008, CHEM BIODIVERS, V5, P920, DOI 10.1002/cbdv.200890105; TEMBE BL, 1984, COMPUT CHEM, V8, P281, DOI 10.1016/0097-8485(84)85020-2; Topin J, 2014, CHEM-EUR J, V20, P10227, DOI 10.1002/chem.201402486; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Turin L, 2002, J THEOR BIOL, V216, P367, DOI 10.1006/jtbi.2001.2504; Turin L, 1996, CHEM SENSES, V21, P773, DOI 10.1093/chemse/21.6.773; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Voet D., 2013, FUNDAMENTALS BIOCH; Wang JH, 2006, PROSTATE, V66, P847, DOI 10.1002/pros.20389; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang RX, 2004, J MED CHEM, V47, P2977, DOI 10.1021/jm030580l; Warne T, 2013, BIOCHEM SOC T, V41, P159, DOI 10.1042/BST20120228; Weng JS, 2006, INT J CANCER, V118, P1471, DOI 10.1002/ijc.21527; Wolf S, 2008, FEBS LETT, V582, P3335, DOI 10.1016/j.febslet.2008.08.022; Wolf S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123533; Wolf S, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab0600; Zacharias N, 2002, TRENDS PHARMACOL SCI, V23, P281, DOI 10.1016/S0165-6147(02)02027-8; Zhao W, 2013, J ALZHEIMERS DIS, V34, P417, DOI 10.3233/JAD-121894; Zhou ZS, 2012, CELL REP, V2, P1143, DOI 10.1016/j.celrep.2012.09.035; Zou Y, 2012, CHEM-EUR J, V18, P7010, DOI 10.1002/chem.201200882; Zozulya S, 2001, GENOME BIOL, V2	97	9	9	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0182147	10.1371/journal.pone.0182147	http://dx.doi.org/10.1371/journal.pone.0182147			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763484	Green Published, gold, Green Submitted			2022-12-26	WOS:000406766500046
J	Xu, JY; Wang, LQ; Tang, JY; Jia, G; Liu, GM; Chen, XL; Cai, JY; Shang, HY; Zhao, H				Xu, Jingyang; Wang, Longqiong; Tang, Jiayong; Jia, Gang; Liu, Guangmang; Chen, Xiaoling; Cai, Jingyi; Shang, Haiying; Zhao, Hua			Pancreatic atrophy caused by dietary selenium deficiency induces hypoinsulinemic hyperglycemia via global down-regulation of selenoprotein encoding genes in broilers	PLOS ONE			English	Article							CELLULAR GLUTATHIONE-PEROXIDASE; INSULIN-RESISTANCE; VITAMIN-E; IN-VIVO; LIPID-METABOLISM; SKELETAL-MUSCLE; HUMAN HEALTH; BETA-CELLS; TRANSCRIPTION FACTORS; EXUDATIVE DIATHESIS	This study was envisaged to comprehensively profile genes in selected tissues along with a few biochemical indicators and integrate resulting information with dietary selenium (Se) deficiency symptoms in broilers. A total of 120 one-day-old Cobb male broilers were equally divided into two groups and fed a Se deficient corn-soybean-based basal diet supplemented with 0.3 mg/kg sodium selenite (Control, Se adequate) or without selenite (Se deficiency) for five weeks. Effects of Se deficiency on mRNA abundance of twenty-three selenoprotein encoding genes and seventeen insulin signaling related genes were studied at day 35 in pancreas, liver and muscle along with plasma biochemical constituents and enzyme activities. Compared to healthy birds in control diet, Se deficient diet induced deficiency symptoms in 90% birds and classic nutritional pancreatic atrophy, depressed growth performance of broilers, and decreased (P < 0.01 to P < 0.05) total antioxidant capacity and activities of superoxide dismutase and glutathione peroxidase in plasma and three other tissues. Se deficiency resulted in 58% higher mortality than control birds. Dietary Se deficiency down-regulated (P < 0.01-0.05) eighteen selenoprotein encoding genes in pancreas, fourteen genes in muscle and nine genes in liver, and up-regulated (P < 0.05) Txnrd1 and Selx in liver. Meanwhile, six, thirteen and five insulin signaling related genes were down-regulated (P < 0.01-0.05) in pancreas, muscle and liver, respectively, and three genes were up-regulated (P < 0.01) in liver. The decrease (P < 0.05) in levels of plasma insulin, total triglyceride and total cholesterol, and concurrent elevated (P < 0.05) levels of plasma glucose and inflammatory cytokines accompanied the global down-regulation of selenoprotein encoding-and insulin signaling related-genes in Se deficient birds. It was concluded that dietary Se deficiency induces nutritional pancreatic atrophy and metabolic disorder of glucose and lipid in broilers via down-regulation of selenoprotein encoding-and insulin signaling related-genes, indicating potential roles of these genes in metabolic regulation.	[Xu, Jingyang; Wang, Longqiong; Tang, Jiayong; Jia, Gang; Liu, Guangmang; Chen, Xiaoling; Cai, Jingyi; Shang, Haiying; Zhao, Hua] Sichuan Agr Univ, Anim Nutr Inst, Chengdu, Sichuan, Peoples R China; [Tang, Jiayong; Jia, Gang; Zhao, Hua] Sichuan Agr Univ, Trace Element Res Ctr, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Zhao, H (corresponding author), Sichuan Agr Univ, Anim Nutr Inst, Chengdu, Sichuan, Peoples R China.; Zhao, H (corresponding author), Sichuan Agr Univ, Trace Element Res Ctr, Chengdu, Sichuan, Peoples R China.	zhua666@126.com		Zhao, Hua/0000-0002-0334-4189	National Natural Science Foundation of China [31272468, 31072043]; Sichuan Longda animal husbandry science and technology co., Ltd [2015SCLD001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Longda animal husbandry science and technology co., Ltd	National Natural Science Foundation of China (No 31272468 and 31072043) and Sichuan Longda animal husbandry science and technology co., Ltd (No: 2015SCLD001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; ASAYAMA K, 1986, J LAB CLIN MED, V107, P459; Barnes KM, 2009, J NUTR, V139, P199, DOI 10.3945/jn.108.098624; Brenneisen Peter, 2005, Molecular Aspects of Medicine, V26, P256, DOI 10.1016/j.mam.2005.07.004; BUNK MJ, 1981, J NUTR, V111, P1611, DOI 10.1093/jn/111.9.1611; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; Castets P, 2012, J MOL MED, V90, P1095, DOI 10.1007/s00109-012-0896-x; Chariot P, 2003, MUSCLE NERVE, V27, P662, DOI 10.1002/mus.10304; Cheng WH, 1998, J NUTR, V128, P1070, DOI 10.1093/jn/128.7.1070; COMBS GE, 1974, J NUTR, V104, P1297, DOI 10.1093/jn/104.10.1297; Curran JE, 2005, NAT GENET, V37, P1234, DOI 10.1038/ng1655; Erbayraktar Z, 2007, BIOL TRACE ELEM RES, V118, P217, DOI 10.1007/s12011-007-0037-5; EZAKI O, 1990, J BIOL CHEM, V265, P1124; Furnsinn C, 1996, LIFE SCI, V59, P1989, DOI 10.1016/S0024-3205(96)00550-4; GLIENKE LR, 1977, J ANIM SCI, V45, P1334, DOI 10.2527/jas1977.4561334x; Goldstein BJ, 2000, J BIOL CHEM, V275, P4283, DOI 10.1074/jbc.275.6.4283; GRIES CL, 1972, J NUTR, V102, P1287, DOI 10.1093/jn/102.10.1287; Gu CY, 2010, CELL METAB, V11, P298, DOI 10.1016/j.cmet.2010.03.006; Hansen SK, 2002, J CLIN INVEST, V110, P827, DOI 10.1172/JCI200215085; Horibata Y, 2007, J LIPID RES, V48, P503, DOI 10.1194/jlr.C600019-JLR200; Huang JQ, 2011, J NUTR, V141, P1605, DOI 10.3945/jn.111.145722; Huang XF, 2016, RSC ADV, V6, P84990, DOI 10.1039/c6ra14932d; Im SS, 2006, CURR DIABETES REV, V2, P11, DOI 10.2174/157339906775473581; Jeong DW, 2002, FEBS LETT, V517, P225, DOI 10.1016/S0014-5793(02)02628-5; Katic M, 2007, AGING CELL, V6, P827, DOI 10.1111/j.1474-9726.2007.00346.x; Labunskyy VM, 2011, ANTIOXID REDOX SIGN, V14, P2327, DOI 10.1089/ars.2010.3526; Lantz KA, 2004, J CLIN INVEST, V114, P512, DOI 10.1172/JCI200421149; Lee CS, 2002, DIABETES, V51, P2546, DOI 10.2337/diabetes.51.8.2546; Lei XG, 2011, ANTIOXID REDOX SIGN, V14, P489, DOI 10.1089/ars.2010.3416; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Li JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152392; Liu Y, 2012, J NUTR, V142, P1410, DOI 10.3945/jn.112.159020; Lobanov AV, 2009, BBA-GEN SUBJECTS, V1790, P1424, DOI 10.1016/j.bbagen.2009.05.014; Lu CL, 2006, FEBS LETT, V580, P5189, DOI 10.1016/j.febslet.2006.08.065; McClung JP, 2004, P NATL ACAD SCI USA, V101, P8852, DOI 10.1073/pnas.0308096101; Mueller AS, 2006, J NUTR BIOCHEM, V17, P548, DOI 10.1016/j.jnutbio.2005.10.006; NOGUCHI T, 1973, J NUTR, V103, P444, DOI 10.1093/jn/103.3.444; NOGUCHI T, 1973, J NUTR, V103, P1502, DOI 10.1093/jn/103.10.1502; Pappas AC, 2008, COMP BIOCHEM PHYS B, V151, P361, DOI 10.1016/j.cbpb.2008.08.009; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; PILLAY TS, 1992, FEBS LETT, V308, P38, DOI 10.1016/0014-5793(92)81045-N; Pinto A, 2011, J INORG BIOCHEM, V105, P812, DOI 10.1016/j.jinorgbio.2011.03.010; Previs SF, 2000, J BIOL CHEM, V275, P38990, DOI 10.1074/jbc.M006490200; Rajpathak S, 2005, J AM COLL NUTR, V24, P250, DOI 10.1080/07315724.2005.10719472; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Reeves MA, 2010, ANTIOXID REDOX SIGN, V12, P809, DOI 10.1089/ars.2009.2883; Roman M, 2014, METALLOMICS, V6, P25, DOI 10.1039/c3mt00185g; Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schinner S, 2005, DIABETIC MED, V22, P674, DOI 10.1111/j.1464-5491.2005.01566.x; Shih DQ, 2001, DIABETES, V50, P2472, DOI 10.2337/diabetes.50.11.2472; Speckmann B, 2011, J BIOL CHEM, V286, P10764, DOI 10.1074/jbc.M110.216028; Speckmann B, 2008, HEPATOLOGY, V48, P1998, DOI 10.1002/hep.22526; Stadtman TC, 2000, ANN NY ACAD SCI, V899, P399, DOI 10.1111/j.1749-6632.2000.tb06203.x; Stapleton SR, 1997, BBA-MOL CELL RES, V1355, P259, DOI 10.1016/S0167-4889(96)00140-1; Steinbrenner H, 2013, FREE RADICAL BIO MED, V65, P1538, DOI 10.1016/j.freeradbiomed.2013.07.016; Steinbrenner H, 2009, BBA-GEN SUBJECTS, V1790, P1478, DOI 10.1016/j.bbagen.2009.02.014; Stranges S, 2010, J NUTR, V140, P81, DOI 10.3945/jn.109.111252; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Sun QA, 1999, J BIOL CHEM, V274, P24522, DOI 10.1074/jbc.274.35.24522; Szypowska AA, 2011, ANTIOXID REDOX SIGN, V15, P219, DOI 10.1089/ars.2010.3794; THOMPSON JN, 1969, J NUTR, V97, P335, DOI 10.1093/jn/97.3.335; THOMPSON JN, 1970, J NUTR, V100, P797, DOI 10.1093/jn/100.7.797; Tomas E, 2002, ANN NY ACAD SCI, V967, P43; Wang RH, 2011, J INORG BIOCHEM, V105, P1156, DOI 10.1016/j.jinorgbio.2011.05.022; Yang SJ, 2011, J CLIN ENDOCR METAB, V96, pE1325, DOI 10.1210/jc.2011-0620; Yao HD, 2014, BIOL TRACE ELEM RES, V161, P318, DOI 10.1007/s12011-014-0125-2; Zeng MS, 2012, FREE RADICAL BIO MED, V52, P1335, DOI 10.1016/j.freeradbiomed.2012.01.017; Zhao H, 2015, J NUTR, V145, P1394, DOI 10.3945/jn.115.211318; Zhao L, 2005, J BIOL CHEM, V280, P11887, DOI 10.1074/jbc.M409475200; Zhao X, 2014, BIOL TRACE ELEM RES, V161, P341, DOI 10.1007/s12011-014-0139-9; Zhou JC, 2009, J NUTR, V139, P1061, DOI 10.3945/jn.109.104901; Zhou J, 2013, FREE RADICAL BIO MED, V65, P1548, DOI 10.1016/j.freeradbiomed.2013.07.012	74	33	34	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0182079	10.1371/journal.pone.0182079	http://dx.doi.org/10.1371/journal.pone.0182079			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763492	Green Published, Green Submitted, gold			2022-12-26	WOS:000406766500038
J	Sagnelli, C; Uberti-Foppa, C; Hasson, H; Bellini, G; Minichini, C; Salpietro, S; Messina, E; Barbanotti, D; Merli, M; Punzo, F; Coppola, N; Lazzarin, A; Sagnelli, E; Rossi, F				Sagnelli, Caterina; Uberti-Foppa, Caterina; Hasson, Hamid; Bellini, Giulia; Minichini, Carmine; Salpietro, Stefania; Messina, Emanuela; Barbanotti, Diletta; Merli, Marco; Punzo, Francesca; Coppola, Nicola; Lazzarin, Adriano; Sagnelli, Evangelista; Rossi, Francesca			Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; LIVER FIBROSIS PROGRESSION; ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; ENDOCANNABINOID SYSTEM; MONOINFECTED PATIENTS; CLINICAL PROGRESSION; GENETIC-VARIATION; NATURAL-HISTORY	Objective This is the first study to analyze the impact of the rs35761398 variant of the CNR2 gene leading to the substitution of GLN (Q) of codon 63 of the cannabinoid receptor 2 (CB2) with ARG (R) on the clinical presentation of chronic hepatitis in HIV/HCV coinfected patients. Methods Enrolled in this study were 166 consecutive HIV/HCV coinfected patients, naive for HCV treatment. A pathologist unaware of the patients' condition graded liver fibrosis, necroinflammation (Ishak) and steatosis. All patients were screened for the CB2 rs35761398 polymorphism. Results Of the 166 HIV/HCV coinfected patients, 72.9% were males, 42.5% were infected with HCV-genotype-3 and 60.2% had been intravenous drug users. The median age was 40.6 years and the immunological condition good (median CD4(+) cells/mm(3) = 507, IQR: 398.0 - 669.5). Thirty-five (21.1%) patients were naive for ART and 131(78.9%) were on ART. The CB2-RR variant was detected in 45.8% of patients, QR in 38.6% and QQ in 15.7%. Patients with CB2-RR showed a necroinflammation score (HAI) >= 9 more frequently than those with CB2-QQ or CB2-QR (32.9% vs. 11.5% and 14.1%, respectively, p <= 0.001). In the multivariate analysis, the CB2-RR variant (p = 0.03) and liver fibrosis were both identified as independent predictors of the entity of liver necroinflammation (p = 0.0001). Conclusion This study shows interesting interplay between the CB2-RR variant and liver necroinflammation in chronic hepatitis patients with HIV/HCV coinfection, an observation of clinical value that coincides with the interest in the use of the CB2 agonists and antagonists in clinical practice emerging from the literature.	[Sagnelli, Caterina; Minichini, Carmine; Coppola, Nicola; Sagnelli, Evangelista] Univ Campania Luigi Vanvitelli, Sect Infect Dis, Dept Mental Hlth & Publ Med, Naples, Italy; [Uberti-Foppa, Caterina; Hasson, Hamid; Salpietro, Stefania; Messina, Emanuela; Barbanotti, Diletta; Merli, Marco; Lazzarin, Adriano] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Dept Infect Dis, Milan, Italy; [Bellini, Giulia; Punzo, Francesca; Rossi, Francesca] Univ Campania Luigi Vanvitelli, Dept Pediat, Naples, Italy	Universita della Campania Vanvitelli; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Universita della Campania Vanvitelli	Sagnelli, E (corresponding author), Univ Campania Luigi Vanvitelli, Sect Infect Dis, Dept Mental Hlth & Publ Med, Naples, Italy.	evangelistasagnelli@libero.it	Sagnelli, Caterina/AAD-4950-2022; Foppa, Caterina Uberti/ABH-3089-2020; LAZZARIN, Adriano/K-3607-2018	Sagnelli, Caterina/0000-0002-6413-7810; Foppa, Caterina Uberti/0000-0001-5271-9138; Sagnelli, Evangelista/0000-0003-2817-8436; Merli, Marco/0000-0001-5081-8669; Rossi, Francesca/0000-0003-2879-6277; LAZZARIN, Adriano/0000-0003-2551-7754				Adinolfi LE, 2001, HEPATOLOGY, V33, P1358, DOI 10.1053/jhep.2001.24432; ALTER MJ, 1992, NEW ENGL J MED, V327, P1899, DOI 10.1056/NEJM199212313272702; Angeli E, 2009, CURR HIV RES, V7, P447, DOI 10.2174/157016209788680507; Basu PP, 2014, ALIMENT PHARM THER, V39, P790, DOI 10.1111/apt.12673; Benhamou Y, 2001, HEPATOLOGY, V34, P283, DOI 10.1053/jhep.2001.26517; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Brau N, 2006, J HEPATOL, V44, P47, DOI 10.1016/j.jhep.2005.07.006; Cabral G. A., 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P159, DOI 10.2174/187153008785700118; Cabral GA, 2005, HANDB EXP PHARMACOL, V168, P385; Carrasquer A, 2010, PHARMACOGENET GENOM, V20, P157, DOI 10.1097/FPC.0b013e3283367c6b; Cencioni MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008688; Chu C, 2011, J URBAN HEALTH, V88, P507, DOI 10.1007/s11524-010-9540-7; Coppola N, 2016, DIGEST LIVER DIS, V48, P1364, DOI 10.1016/j.dld.2016.07.005; Coppola N, 2015, WORLD J CLIN CASES, V3, P807, DOI 10.12998/wjcc.v3.i9.807; Coppola N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099450; Coppola N, 2014, CLIN GASTROENTEROL H, V12, P334, DOI 10.1016/j.cgh.2013.05.008; Costantino CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033961; Frederick T, 2009, AIDS PATIENT CARE ST, V23, P915, DOI 10.1089/apc.2009.0111; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghosh S, 2006, MOL IMMUNOL, V43, P2169, DOI 10.1016/j.molimm.2006.01.005; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Gui H, 2015, INT IMMUNOPHARMACOL, V26, P86, DOI 10.1016/j.intimp.2015.03.006; Herman KE, 2002, CLIN INFECT DIS, V34, P831; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Ishida JH, 2008, CLIN GASTROENTEROL H, V6, P69, DOI 10.1016/j.cgh.2007.10.021; Kim AY, 2006, PLOS MED, V3, P2324, DOI 10.1371/journal.pmed.0030492; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Koziel MJ, 2006, J HEPATOL, V44, pS14, DOI 10.1016/j.jhep.2005.11.006; Lo Re V, 2014, ANN INTERN MED, V160, P369, DOI 10.7326/M13-1829; Louvet A, 2011, HEPATOLOGY, V54, P1217, DOI 10.1002/hep.24524; Miller AM, 2008, BRIT J PHARMACOL, V153, P299, DOI 10.1038/sj.bjp.0707523; Montecucco F, 2008, AM J PHYSIOL-HEART C, V294, pH1145, DOI 10.1152/ajpheart.01328.2007; Pineda JA, 2007, HEPATOLOGY, V46, P622, DOI 10.1002/hep.21757; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Qurishi N, 2003, LANCET, V362, P1708, DOI 10.1016/S0140-6736(03)14844-1; Raborn ES, 2014, LIFE SCI, V104, P15, DOI 10.1016/j.lfs.2014.04.008; Raymond HF, 2011, SEX TRANSM DIS, V38, P219, DOI 10.1097/OLQ.0b013e3181f68ed4; Rock RB, 2007, J NEUROIMMUNE PHARM, V2, P178, DOI 10.1007/s11481-006-9040-4; Rom S, 2013, J NEUROIMMUNE PHARM, V8, P608, DOI 10.1007/s11481-013-9445-9; Rossi F, 2012, PHARMACOL RES, V66, P88, DOI 10.1016/j.phrs.2012.03.011; Rossi F, 2011, HAEMATOL-HEMATOL J, V96, P1883, DOI 10.3324/haematol.2011.045732; Rossi F, 2011, HEPATOLOGY, V54, P1102, DOI 10.1002/hep.24440; Sagnelli C, 2016, CLIN MICROBIOL INFEC, V22, P372, DOI 10.1016/j.cmi.2015.11.025; Sagnelli C, 2013, INFECTION, V41, P959, DOI 10.1007/s15010-013-0502-3; Sagnelli C, 2016, WORLD J GASTROENTERO, V22, P8509, DOI 10.3748/wjg.v22.i38.8509; Sagnelli C, 2015, WORLD J HEPATOL, V7, P2510, DOI 10.4254/wjh.v7.i24.2510; Sagnelli C, 2014, BRAZ J INFECT DIS, V18, P164, DOI 10.1016/j.bjid.2013.06.005; Sagnelli C, 2010, JAIDS-J ACQ IMM DEF, V54, P107, DOI 10.1097/QAI.0b013e3181cf4d8b; Sagnelli E, 2009, HEPATOLOGY, V49, P1090, DOI 10.1002/hep.22794; Schiavini M, 2011, HEPAT MON, V11, P525; Sipe JC, 2005, J LEUKOCYTE BIOL, V78, P231, DOI 10.1189/jlb.0205111; Thein HH, 2008, AIDS, V22, P1979, DOI 10.1097/QAD.0b013e32830e6d51; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Ubeti-Foppa C, 2006, JAIDS-J ACQ IMM DEF, V41, P63, DOI 10.1097/01.qai.0000192001.15777.15; Wiley TE, 1998, HEPATOLOGY, V28, P805, DOI 10.1002/hep.510280330; Yu DY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000633	56	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0181890	10.1371/journal.pone.0181890	http://dx.doi.org/10.1371/journal.pone.0181890			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759568	Green Submitted, gold, Green Published			2022-12-26	WOS:000406761600035
J	Schahab, N; Sudan, S; Schaefer, C; Tiyerili, V; Steinmetz, M; Nickenig, G; Skowasch, D; Pizarro, C				Schahab, Nadjib; Sudan, Sarah; Schaefer, Christian; Tiyerili, Vedat; Steinmetz, Martin; Nickenig, Georg; Skowasch, Dirk; Pizarro, Carmen			Sleep apnoea is common in severe peripheral arterial disease	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; CARDIOVASCULAR OUTCOMES; ADULTS; RISK; MANAGEMENT; DIAGNOSIS	Background Atherosclerotic conditions have been demonstrated to be associated with sleep-disordered breathing (SDB). Peripheral arterial disease (PAD) represents severe atherosclerosis with a high mortality. In early stages of PAD a substantial prevalence of sleep apnoea has already been shown. Here, we sought to determine the frequency of undiagnosed sleep apnoea in a homogeneous group of advanced PAD patients undergoing percutaneous revascularization. Methods 59 consecutive patients (mean age: 71.1 +/- 9.8 years, 67.8% males) with PAD in Fontaine stages IIb-IV that underwent percutaneous transluminal angioplasty at our department were enrolled for pre-procedural polygraphy. Results Patients appertained to Fontaine clinical stage IIb, III and IV in 54.2%, 23.8% and 22.% of cases, respectively, and were principally intervened for femoropopliteal occlusive disease (71.2% of total study population). Polygraphy revealed sleep apnoea in 48 out of 59 patients (81.4%), of whom 60.4% offered a primarily obstructive-driven genesis. Among those patients with polygraphically confirmed sleep apnoea, mean apnoea hypopnoea index (AHI) and mean oxygen desaturation index (ODI) averaged 28.2 +/- 19.5/h and 26.7 +/- 18.8/h, respectively. 18 patients even offered an AHI >= 30/h that is indicative of severe sleep apnoea. For obstructive-driven apnoeic events, AHI correlated significantly with PAD severity stages (p = 0.042). Conclusions In our PAD collective, sleep apnoea was frequent and obstructive sleep apnoea's severity correlated with PAD severity stages. Long-term results regarding the vasoprotective impact of CPAP treatment on PAD course remains to be determined.	[Schahab, Nadjib; Sudan, Sarah; Schaefer, Christian; Tiyerili, Vedat; Steinmetz, Martin; Nickenig, Georg; Skowasch, Dirk; Pizarro, Carmen] Univ Hosp Bonn, Dept Internal Med Cardiol Pneumol & Angiol 2, Bonn, Germany	University of Bonn	Schahab, N; Sudan, S (corresponding author), Univ Hosp Bonn, Dept Internal Med Cardiol Pneumol & Angiol 2, Bonn, Germany.	Nadjib.Schahab@ukb.uni-bonn.de; Sarah.Sudan@ukb.uni-bonn.de	Tiyerili, Vedat/CAF-1914-2022	Steinmetz, Martin/0000-0002-5452-6687				Allahdadi KJ, 2005, HYPERTENSION, V45, P705, DOI 10.1161/01.HYP.0000153794.52852.04; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Cassar A, 2007, J AM COLL CARDIOL, V50, P1310, DOI 10.1016/j.jacc.2007.06.028; Dingli K, 2003, EUR RESPIR J, V21, P253, DOI 10.1183/09031936.03.00298103; Doherty LS, 2005, CHEST, V127, P2076, DOI 10.1378/chest.127.6.2076; Drager LF, 2013, J AM COLL CARDIOL, V62, P569, DOI 10.1016/j.jacc.2013.05.045; Dyugovskaya L, 2002, AM J RESP CRIT CARE, V165, P934, DOI 10.1164/ajrccm.165.7.2104126; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Ip MSM, 2004, AM J RESP CRIT CARE, V169, P348, DOI 10.1164/rccm.200306-767OC; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Lavie L, 2003, SLEEP MED REV, V7, P35, DOI 10.1053/smrv.2002.0261; Loke YK, 2012, CIRC-CARDIOVASC QUAL, V5, P720, DOI 10.1161/CIRCOUTCOMES.111.964783; Luthje L, 2008, SLEEP MED REV, V12, P19, DOI 10.1016/j.smrv.2007.08.002; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; McEvoy RD, 2016, NEW ENGL J MED, V375, P919, DOI 10.1056/NEJMoa1606599; Milleron O, 2004, EUR HEART J, V25, P728, DOI 10.1016/j.ehj.2004.02.008; Olin JW, 2010, MAYO CLIN PROC, V85, P678, DOI 10.4065/mcp.2010.0133; Peker Y, 2016, AM J RESP CRIT CARE, V194, P613, DOI 10.1164/rccm.201601-0088OC; Pizarro C, 2015, RESPIRATION, V89, P214, DOI 10.1159/000371355; Preppard PE, 2013, AM J EPIDEMIOL, V177, P1006; Prinz C, 2011, POSTGRAD MED J, V87, P458, DOI 10.1136/pgmj.2010.112052; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Solin P, 1999, CIRCULATION, V99, P1574, DOI 10.1161/01.CIR.99.12.1574; Svatikova A, 2003, CIRCULATION, V108, P1451, DOI 10.1161/01.CIR.0000089091.09527.B8; Tendera M, 2012, TURK KARDIYOL DERN A, V40, P5, DOI 10.1093/eurheartj/ehr211; Tie YX, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15027808; Utriainen KT, 2013, EUR RESPIR J, V41, P616, DOI 10.1183/09031936.00227611; Young T, 2004, JAMA-J AM MED ASSOC, V291, P2013, DOI 10.1001/jama.291.16.2013	30	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0181733	10.1371/journal.pone.0181733	http://dx.doi.org/10.1371/journal.pone.0181733			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759652	gold, Green Published, Green Submitted			2022-12-26	WOS:000406761600024
J	Tschernegg, M; Neuper, C; Schmidt, R; Wood, G; Kronbichler, M; Fazekas, F; Enzinger, C; Koini, M				Tschernegg, Melanie; Neuper, Christa; Schmidt, Reinhold; Wood, Guilherme; Kronbichler, Martin; Fazekas, Franz; Enzinger, Christian; Koini, Marisa			FMRI to probe sex-related differences in brain function with multitasking	PLOS ONE			English	Article							DUAL-TASK INTERFERENCE; WORKING-MEMORY; GENDER-DIFFERENCES; DIVIDED ATTENTION; ACTIVATION; PERFORMANCE; INTELLIGENCE; MECHANISMS; PATTERNS; CORTEX	Background Although established as a general notion in society, there is no solid scientific foundation for the existence of sex-differences in multitasking. Reaction time and accuracy in dual task conditions have an inverse relationship relative to single task, independently from sex. While a more disseminated network, parallel to decreasing accuracy and reaction time has been demonstrated in dual task fMRI studies, little is known so far whether there exist respective sex-related differences in activation. Methods We subjected 20 women (mean age = 25.45; SD = 5.23) and 20 men (mean age = 27.55; SD = 4.00) to a combined verbal and spatial fMRI paradigm at 3.0T to assess sex-related skills, based on the assumption that generally women better perform in verbal tasks while men do better in spatial tasks. We also obtained behavioral tests for verbal and spatial intelligence, attention, executive functions, and working memory. Results No differences between women and men were observed in behavioral measures of dual-tasking or cognitive performance. Generally, brain activation increased with higher task load, mainly in the bilateral inferior and prefrontal gyri, the anterior cingulum, thalamus, putamen and occipital areas. Comparing sexes, women showed increased activation in the inferior frontal gyrus in the verbal dual-task while men demonstrated increased activation in the precuneus and adjacent visual areas in the spatial task. Conclusion Against the background of equal cognitive and behavioral dual-task performance in both sexes, we provide first evidence for sex-related activation differences in functional networks for verbal and spatial dual-tasking.	[Tschernegg, Melanie; Neuper, Christa; Wood, Guilherme] Karl Franzens Univ Graz, Inst Psychol, Graz, Austria; [Tschernegg, Melanie; Kronbichler, Martin] Univ Salzburg, Ctr Cognit Neurosci, Salzburg, Austria; [Tschernegg, Melanie; Kronbichler, Martin] Univ Salzburg, Dept Psychol, Salzburg, Austria; [Schmidt, Reinhold; Koini, Marisa] Med Univ Graz, Dept Neurogeriatr, Graz, Austria; [Kronbichler, Martin] Paracelsus Med Univ Salzburg, Neurosci Inst, Salzburg, Austria; [Kronbichler, Martin] Paracelsus Med Univ Salzburg, Ctr Neurocognit Res, Christian Doppler Klin, Salzburg, Austria; [Fazekas, Franz; Enzinger, Christian] Med Univ Graz, Dept Neurol, Graz, Austria; [Enzinger, Christian] Med Univ Graz, Dept Neurol, Div Neuroradiol, Graz, Austria; [Enzinger, Christian] BioTechMed Graz, Graz, Austria	University of Graz; Salzburg University; Salzburg University; Medical University of Graz; Paracelsus Private Medical University; Paracelsus Private Medical University; Medical University of Graz; Medical University of Graz	Koini, M (corresponding author), Med Univ Graz, Dept Neurogeriatr, Graz, Austria.	marisa.koini@medunigraz.at	Kronbichler, Martin/A-5599-2008; cohorts, Doctoral College Imaging the Mind - all/I-4689-2018; Schmidt, Reinhold/E-1137-2014; Kronbichler, Martin/AAY-1519-2021	Kronbichler, Martin/0000-0003-2240-2812; Kronbichler, Martin/0000-0003-2240-2812; Maia de Oliveira Wood, Guilherme/0000-0001-5055-5336; Koini (nee Loitfelder), Marisa/0000-0002-1756-1379	city of Graz, Austria	city of Graz, Austria	This study was funded by the city of Graz, Austria to Marisa Koini. The sponsor was not involved in study design, data collection, analyses, decision to publish, or preparation of the manuscript.	Amthauer R, 2001, INTELLIGENZSTRUKTURT; Collette F, 2005, COGNITIVE BRAIN RES, V24, P237, DOI 10.1016/j.cogbrainres.2005.01.023; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; Dietrich T, 2001, NEUROIMAGE, V13, P425, DOI 10.1006/nimg.2001.0703; Duff SJ, 2001, BRAIN COGNITION, V47, P470, DOI 10.1006/brcg.2001.1326; Eliot L, 2011, NEURON, V72, P895, DOI 10.1016/j.neuron.2011.12.001; Erickson KI, 2007, CEREB CORTEX, V17, P192, DOI 10.1093/cercor/bhj137; GUR RC, 1995, SCIENCE, V267, P528, DOI 10.1126/science.7824953; Gur RC, 2000, BRAIN LANG, V74, P157, DOI 10.1006/brln.2000.2325; Herath P, 2001, CEREB CORTEX, V11, P796, DOI 10.1093/cercor/11.9.796; Jiang YH, 2004, NEUROIMAGE, V22, P748, DOI 10.1016/j.neuroimage.2004.01.043; Just MA, 2001, NEUROIMAGE, V14, P417, DOI 10.1006/nimg.2001.0826; Klingberg T, 1998, CEREB CORTEX, V8, P593, DOI 10.1093/cercor/8.7.593; Klingberg T, 2008, OVERFLOWING BRAIN IN; Konig CJ, 2005, HUM PERFORM, V18, P243, DOI 10.1207/s15327043hup1803_3; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; Mantyla T, 2013, PSYCHOL SCI, V24, P514, DOI 10.1177/0956797612459660; MASTERS MS, 1993, BEHAV GENET, V23, P337, DOI 10.1007/BF01067434; Nebel K, 2005, COGNITIVE BRAIN RES, V25, P760, DOI 10.1016/j.cogbrainres.2005.09.011; Neubauer AC, 2005, COGNITIVE BRAIN RES, V25, P217, DOI 10.1016/j.cogbrainres.2005.05.011; Nixon P, 2004, J COGNITIVE NEUROSCI, V16, P289, DOI 10.1162/089892904322984571; Offer S, 2011, AM SOCIOL REV, V76, P809, DOI 10.1177/0003122411425170; Paridon HM, 2010, EUR J PSYCHOL, V6, P110; PASHLER H, 1984, J EXP PSYCHOL HUMAN, V10, P358, DOI 10.1037/0096-1523.10.3.358; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; PASHLER H, 1993, AM SCI, V81, P48; Phillips MD, 2001, RADIOLOGY, V220, P202, DOI 10.1148/radiology.220.1.r01jl34202; Schubert T, 2003, COGNITIVE BRAIN RES, V17, P733, DOI 10.1016/S0926-6410(03)00198-8; Semrud-Clikeman M, 2012, INT J NEUROSCI, V122, P590, DOI 10.3109/00207454.2012.693999; Speck O, 2000, NEUROREPORT, V11, P2581, DOI 10.1097/00001756-200008030-00046; Stelzel C, 2009, NEUROIMAGE, V48, P237, DOI 10.1016/j.neuroimage.2009.06.064; Szameitat AJ, 2006, PSYCHOL RES-PSYCH FO, V70, P541, DOI 10.1007/s00426-005-0015-5; Zaidi Z. F., 2010, OPEN ANATOMY J, V2, DOI 10.2174/1877609401002010037; Zakzanis KK, 2005, NEUROPSYCHOLOGIA, V43, P1878, DOI 10.1016/j.neuropsychologia.2005.03.013; Zysset S, 2001, NEUROIMAGE, V13, P29, DOI 10.1006/nimg.2000.0665	35	8	9	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0181554	10.1371/journal.pone.0181554	http://dx.doi.org/10.1371/journal.pone.0181554			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759619	gold, Green Published, Green Submitted			2022-12-26	WOS:000406761600019
J	Lavoue, S; Bertrand, JAM; Wang, HY; Chen, WJ; Ho, HC; Motomura, H; Hata, H; Sado, T; Miya, M				Lavoue, Sebastien; Bertrand, Joris A. M.; Wang, Hui-Yu; Chen, Wei-Jen; Ho, Hsuan-Ching; Motomura, Hiroyuki; Hata, Harutaka; Sado, Tetsuya; Miya, Masaki			Molecular systematics of the anchovy genus Encrasicholina in the Northwest Pacific	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; SP-NOV TELEOSTEI; CLUPEIFORMES ENGRAULIDAE; FAMILY ENGRAULIDAE; COASTAL WATERS; LARVAL ANCHOVY; FISH; MITOGENOME; SEQUENCE; ORGANIZATION	The anchovy genus Encrasicholina is an important coastal marine resource of the tropical Indo-West Pacific (IWP) region for which insufficient comparative data are available to evaluate the effects of current exploitation levels on the sustainability of its species and populations. Encrasicholina currently comprises nine valid species that are morphologically very similar. Only three, Encrasicholina punctifer, E. heteroloba, and E. pseudoheteroloba, occur in the Northwest Pacific subregion of the northeastern part of the IWP region. These species are otherwise broadly distributed and abundant in the IWP region, making them the most important anchovy species for local fisheries. In this study, we reconstructed the phylogeny of these three species of Encrasicholina within the Engraulidae. We sequenced 10 complete mitochondrial genomes (using high-throughput and Sanger DNA sequencing technologies) and compared those sequences to 21 previously published mitochondrial genomes from various engraulid taxa. The phylogenetic results showed that the genus Encrasicholina is monophyletic, and it is the sister group to the more-diverse "New World anchovy" clade. The mitogenome-based dating results indicated that the crown group Encrasicholina originated about 33.7 million years ago (nearby the limit Eocene/Oligocene), and each species of Encrasicholina has been reproductively isolated from the others for more than 20 million years, despite their morphological similarities. In contrast, preliminary population genetic analyses across the Northwest Pacific region using four mitogenomic sequences revealed very low levels of genetic differentiation within Encrasicholina punctifer. These molecular results combined with recent taxonomic revisions are important for designing further studies on the population structure and phylogeography of these anchovies.	[Lavoue, Sebastien; Bertrand, Joris A. M.; Wang, Hui-Yu; Chen, Wei-Jen] Natl Taiwan Univ, Inst Oceanog, Taipei, Taiwan; [Bertrand, Joris A. M.] Univ Lausanne, Dept Computat Biol, Biophore, Lausanne, Switzerland; [Bertrand, Joris A. M.] Swiss Inst Bioinformat Genopode, Quartier Sorge, Lausanne, Switzerland; [Ho, Hsuan-Ching] Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan; [Motomura, Hiroyuki] Kagoshima Univ Museum, 1-21-30 Korimoto, Kagoshima, Japan; [Hata, Harutaka] Kagoshima Univ, United Grad Sch Agr Sci, 1-21-24 Korimoto, Kagoshima, Japan; [Sado, Tetsuya; Miya, Masaki] Nat Hist Museum & Inst, Dept Ecol & Environm Sci, Chuo Ku, 955-2 Aoba Cho, Chiba, Japan	National Taiwan University; University of Lausanne; Swiss Institute of Bioinformatics; National Museum of Marine Biology & Aquarium; Kagoshima University; Kagoshima University	Lavoue, S (corresponding author), Natl Taiwan Univ, Inst Oceanog, Taipei, Taiwan.	microceb@hotmail.com	CHEN, Wei-Jen/A-2605-2008; Bertrand, Joris/C-1812-2014; Miya, Masaki/O-2664-2019; Lavoue, Sebastien/H-7118-2012	CHEN, Wei-Jen/0000-0003-4751-7632; Bertrand, Joris/0000-0002-3379-1019; Lavoue, Sebastien/0000-0003-4798-6666; Miya, Masaki/0000-0002-9791-9886; WANG, HUI-YU/0000-0002-9100-321X	Japan Society for Promoting Science [JSPS]; Ministry of Education, Culture, Sports, Science and Technology [MEXT] Kakenhi [26291083]; Ministry of Science and Technology of Taiwan [MOST103-2119-M-002-019-MY3]; JSPS/MEXT Kakenhi [26291083]	Japan Society for Promoting Science [JSPS](Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology [MEXT] Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); JSPS/MEXT Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Japan Society for Promoting Science [JSPS, https://www.jsps.go.jp/english/] Ministry of Education, Culture, Sports, Science and Technology [MEXT, www.mext.go.jp/en] Kakenhi (no. 26291083) to MM and the Ministry of Science and Technology of Taiwan [https://www.most.gov.tw/en/public] (MOST103-2119-M-002-019-MY3) to SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a research grant (MOST103-2119-M-002-019-MY3) from the Ministry of Science and Technology of Taiwan to S.L. and JSPS/MEXT Kakenhi (No. 26291083) to M.M. We thank the staff of the Office of the Vice-Chancellor for Research and Extension of the University of the Philippines Visayas (UPV), and UPV Museum of Natural Sciences, College of Fisheries, UPV, including R. P. Babaran, S. S. Garibay, U. B. Alama, V. G. Urbina, L. H. Mooc, C. J. N. Rubido, E. P. Abunal, A. M. T. Guzman, R. S. Cruz, A. C. Gaje, and R. F. M. Traifalgar, and graduate students of the College of Fisheries, UPV for their support of the field surveys. We thank staff of the Phuket Marine Biological Centre for donating the fish samples from Thailand. Prof. M.N. Siti Azizah (Universiti Sains Malaysia) kindly donated the tissue sample of Thryssa setirostris. We are grateful to all members of Hans Ho's lab, Hui Yu Wang's lab and Wei-Jen Chen's lab in helping us to collect and process some samples used in this study. Finally, we thank the two reviewers for their comments which helped to improve this manuscript.	Arratia Gloria, 2010, P247; Benton MJ, 1993, THE FOSSIL RECORD; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Bloom D. B., 2014, P ROYAL SOC B, V281, P2013, DOI DOI 10.1098/RSPB.2013.2081; Bloom DD, 2012, J EVOLUTION BIOL, V25, P701, DOI 10.1111/j.1420-9101.2012.02464.x; Bo Z, 2013, MITOCHONDR DNA, V24, P657, DOI 10.3109/19401736.2013.772599; BORNBUSCH AH, 1992, J MORPHOL, V214, P109, DOI 10.1002/jmor.1052140108; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; CHENG S, 1994, NAT GENET, V7, P350, DOI 10.1038/ng0794-350; Chiu T-S, 2000, J FISH SOC TAIWAN, V26, P183; De Figueiredo FJ, 2009, J VERTEBR PALEONTOL, V29, P993, DOI 10.1671/039.029.0402; De Figueiredo FJ, 2009, ZOOTAXA, P21, DOI 10.11646/zootaxa.2164.1.2; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eschmeyer WN, 2017, CATALOG FISHES ELECT; Fowler HW, 1937, ACAD NAT SCI PHILA M, V2, P1; GRANDE L, 1985, American Museum Novitates, P1; GRANDE L, 1985, B AM MUS NAT HIST, V181, P235; Hahn C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt371; Hata H, 2017, NEW ZEAL J ZOOL, V44, P122, DOI 10.1080/03014223.2016.1268177; Hata H, 2017, ICHTHYOL RES, V64, P18, DOI 10.1007/s10228-016-0529-4; Hata H, 2016, RAFFLES B ZOOL, V64, P79; Hata H, 2015, ZOOTAXA, V3941, P117, DOI 10.11646/zootaxa.3941.1.6; HIDA TS, 1973, FISH B-NOAA, V71, P135; Hsieh CH, 2009, FISH OCEANOGR, V18, P102, DOI 10.1111/j.1365-2419.2008.00498.x; Inoue JG, 2001, FISHERIES SCI, V67, P828, DOI 10.1046/j.1444-2906.2001.00329.x; Iwasaki W, 2013, MOL BIOL EVOL, V30, P2531, DOI 10.1093/molbev/mst141; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kottelat M, 2013, RAFFLES B ZOOL, P1; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lavoue S, 2005, MOL PHYLOGENET EVOL, V37, P165, DOI 10.1016/j.ympev.2005.03.024; Lavoue S, 2014, BIOL ECOLOGY ANCHOVI, P3; Lavoue S, 2017, ZOOTAXA IN PRESS; Lavoue S, 2007, MOL PHYLOGENET EVOL, V43, P1096, DOI 10.1016/j.ympev.2006.09.018; Lavoue S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056485; Lavoue S, 2010, MOL PHYLOGENET EVOL, V56, P480, DOI 10.1016/j.ympev.2009.11.022; Lewis AD, 1990, TUN BAITF IND REG P, P10; Li CH, 2007, MOL PHYLOGENET EVOL, V44, P386, DOI 10.1016/j.ympev.2006.10.030; Li Q, 2016, MITOCHONDRIAL DNA A, V27, P175, DOI 10.3109/19401736.2013.878931; Loytynoja A, 2003, BIOINFORMATICS, V19, P1505, DOI 10.1093/bioinformatics/btg193; Maack G, 1999, FISH RES, V44, P113, DOI 10.1016/S0165-7836(99)00084-3; Malabarba MC, 2017, ZOOL J LINN SOC-LOND, V180, P175, DOI 10.1111/zoj.12492; Marrama G, 2017, HIST BIOL, V29, P904, DOI 10.1080/08912963.2016.1262855; Marrama G, 2016, GEOL MAG, V153, P84, DOI 10.1017/S0016756815000278; Marrama G, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2015.1014490; Marrama G, 2015, ACTA PALAEONTOL POL, V60, P701, DOI 10.4202/app.00057.2014; Milton DA, 1996, FISH RES, V26, P239, DOI 10.1016/0165-7836(95)00434-3; Miya M, 1999, MAR BIOTECHNOL, V1, P416, DOI 10.1007/PL00011798; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; NELSON G, 1983, COPEIA, P48; Qiao HY, 2013, MITOCHONDR DNA, V24, P123, DOI 10.3109/19401736.2012.731405; Ronquist F, 2012, SYST BIOL, V61, P973, DOI 10.1093/sysbio/sys058; Satoh TP, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3054-y; Silva G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02945-0; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Taverne Louis, 2014, Bollettino del Museo Civico di Storia Naturale di Verona Geologia Paleontologia Preistoria, V38, P27; Taverne Louis, 2011, Bollettino del Museo Civico di Storia Naturale di Verona Geologia Paleontologia Preistoria, V35, P3; Taverne Louis, 2007, Bollettino del Museo Civico di Storia Naturale di Verona Geologia Paleontologia Preistoria, V31, P21; Taverne Louis, 2002, Bollettino del Museo Civico di Storia Naturale di Verona Geologia Paleontologia Preistoria, V26, P3; Tham AK, 1933, KUR S JAP CURR, P481; Tsai CF, 1997, FISH OCEANOGR, V6, P238; Wang SH, 2016, MITOCHONDRIAL DNA A, V27, P4084, DOI 10.3109/19401736.2014.1003855; Whitehead P.J.P., 1988, FAO FISH SYNOP, P305; WRIGHT PJ, 1992, J FISH BIOL, V40, P833, DOI 10.1111/j.1095-8649.1992.tb02630.x; YOUNG SS, 1994, ZOOL STUD, V33, P217; Zhang J, 2016, MITOCHONDRIAL DNA B, V1, P12, DOI 10.1080/23802359.2015.1137797; Zhao LL, 2016, MITOCHONDRIAL DNA A, V27, P1608, DOI 10.3109/19401736.2014.958691	67	9	10	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0181329	10.1371/journal.pone.0181329	http://dx.doi.org/10.1371/journal.pone.0181329			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753660	Green Published, gold, Green Submitted			2022-12-26	WOS:000406579300014
J	Wu, Y; Fortin, DA; Cochrane, VA; Chen, PC; Shyng, SL				Wu, Yi; Fortin, Dale A.; Cochrane, Veronica A.; Chen, Pei-Chun; Shyng, Show-Ling			NMDA receptors mediate leptin signaling and regulate potassium channel trafficking in pancreatic beta-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IONOTROPIC GLUTAMATE RECEPTORS; TRANSCRIPTION FACTOR; EXPRESSION; ISLETS; IDENTIFICATION; DIVERSITY; SECRETION; SUBTYPES; CURRENTS; RELEASE	NMDA receptors (NMDARs) are Ca2+-permeant, ligand-gated ion channels activated by the excitatory neurotransmitter glutamate and have well-characterized roles in the nervous system. The expression and function of NMDARs in pancreatic beta-cells, by contrast, are poorly understood. Here, we report a novel function of NMDARs in beta-cells. Using a combination of biochemistry, electrophysiology, and imaging techniques, we now show that NMDARs have a key role in mediating the effect of leptin to modulate beta-cells electrical activity by promoting AMP-activated protein kinase (AMPK)-dependent trafficking of KATP and Kv2.1 channels to the plasma membrane. Blocking NMDAR activity inhibited the ability of leptin to activate AMPK, induce KATP and Kv2.1 channel trafficking, and promote membrane hyperpolarization. Conversely, activation of NMDARs mimicked the effect of leptin, causing Ca2+ influx, AMPK activation, and increased trafficking of KATP and Kv2.1 channels to the plasma membrane, and triggered membrane hyperpolarization. Moreover, leptin potentiated NMDAR currents and triggered NMDAR-dependent Ca2+ influx. Importantly, NMDAR-mediated signaling was observed in rat insulinoma 832/13 cells and in human beta-cells, indicating that this pathway is conserved across species. The ability of NMDARs to regulate potassium channel surface expression and thus, beta-cells excitability provides mechanistic insight into the recently reported insulinotropic effects of NMDAR antagonists and therefore highlights the therapeutic potential of these drugs in managing type 2 diabetes.	[Wu, Yi; Fortin, Dale A.; Cochrane, Veronica A.; Shyng, Show-Ling] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Chen, Pei-Chun] Natl Cheng Kung Univ, Coll Med, Dept Physiol, 1 Univ Rd, Tainan 701, Taiwan	Oregon Health & Science University; National Cheng Kung University	Chen, PC (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Physiol, 1 Univ Rd, Tainan 701, Taiwan.; Shyng, SL (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Dept Biochem & Mol Biol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	pcchen@mail.ncku.edu.tw; shyngs@ohsu.edu		Chen, Pei-Chun/0000-0002-2550-6556	National Institutes of Health Grants [R01DK057699, 3R01DK057699-14S1]; Ministry of Science and Technology Grant [MOST105-2628-B-006-006-MY3]; National Institutes of Health T32 Training Grant [GM071338]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology Grant; National Institutes of Health T32 Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01DK057699 and 3R01DK057699-14S1 (to S.-L. S.) and by Ministry of Science and Technology Grant MOST105-2628-B-006-006-MY3 (to P.-C. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health T32 Training Grant GM071338.	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Aliprandi A, 2005, J CEREBR BLOOD F MET, V25, P513, DOI 10.1038/sj.jcbfm.9600039; Allison MB, 2014, J ENDOCRINOL, V223, pT25, DOI 10.1530/JOE-14-0404; ASHCROFT FM, 1994, J CELL BIOCHEM, V55, P54, DOI 10.1002/jcb.240550007; Atouf F, 1997, J BIOL CHEM, V272, P1929, DOI 10.1074/jbc.272.3.1929; Bai L., 2003, AM J PHYSL GASTEROIN, V284, pG808; Benninger RKP, 2008, BIOPHYS J, V95, P5048, DOI 10.1529/biophysj.108.140863; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Bruederle CE, 2011, TRAFFIC, V12, P1242, DOI 10.1111/j.1600-0854.2011.01227.x; Cabrera O, 2008, CELL METAB, V7, P545, DOI 10.1016/j.cmet.2008.03.004; Chen PC, 2013, J BIOL CHEM, V288, P34098, DOI 10.1074/jbc.M113.516880; Corless M, 2006, J ENDOCRINOL, V190, P719, DOI 10.1677/joe.1.06892; Di Cairano ES, 2011, J BIOL CHEM, V286, P14007, DOI 10.1074/jbc.M110.183517; DIVIRGILIO F, 1988, BIOCHEM J, V256, P959, DOI 10.1042/bj2560959; Feldmann N, 2011, MOL CELL ENDOCRINOL, V338, P46, DOI 10.1016/j.mce.2011.02.019; Gammelsaeter R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022960; GONOI T, 1994, J BIOL CHEM, V269, P16989; Gribble FM, 2003, DIABETOLOGIA, V46, P875, DOI 10.1007/s00125-003-1143-3; Harvey J, 1997, J PHYSIOL-LONDON, V504, P527, DOI 10.1111/j.1469-7793.1997.527bd.x; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; INAGAKI N, 1995, FASEB J, V9, P686, DOI 10.1096/fasebj.9.8.7768362; Irving AJ, 2006, NEUROSCIENCE, V138, P1137, DOI 10.1016/j.neuroscience.2005.11.042; Jacobson DA, 2007, CELL METAB, V6, P229, DOI 10.1016/j.cmet.2007.07.010; Lim A, 2009, DIABETES, V58, P2813, DOI 10.2337/db09-0600; Liu JSE, 2017, GENE DEV, V31, P228, DOI 10.1101/gad.294389.116; Luo X, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0007-15.2015; MacDonald PE, 2002, J BIOL CHEM, V277, P44938, DOI 10.1074/jbc.M205532200; Mairet-Coello G, 2013, NEURON, V78, P94, DOI 10.1016/j.neuron.2013.02.003; Marquard J, 2015, NAT MED, V21, P363, DOI 10.1038/nm.3822; Marroqui L, 2012, J MOL ENDOCRINOL, V49, pR9, DOI 10.1530/JME-12-0025; Mason MJ, 2005, BIOPHYS J, V88, P739, DOI 10.1529/biophysj.104.049866; Miller M, 2011, J BIOL CHEM, V286, P33436, DOI 10.1074/jbc.M111.274167; MOLNAR E, 1995, FEBS LETT, V371, P253, DOI 10.1016/0014-5793(95)00890-L; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Otters S, 2016, TRENDS ENDOCRIN MET, V27, P177, DOI 10.1016/j.tem.2015.12.004; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Park SH, 2013, P NATL ACAD SCI USA, V110, P12673, DOI 10.1073/pnas.1216351110; Patterson S, 2016, EUR J PHARMACOL, V771, P107, DOI 10.1016/j.ejphar.2015.12.015; Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; Shanley LJ, 2002, J PHYSIOL-LONDON, V545, P933, DOI 10.1113/jphysiol.2002.029488; Shanley LJ, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0001.2001; Shen KZ, 2014, NEUROSCIENCE, V274, P138, DOI 10.1016/j.neuroscience.2014.05.031; Shen KZ, 2010, J NEUROSCI, V30, P1882, DOI 10.1523/JNEUROSCI.3200-09.2010; Silva JR, 2014, BIOPHYS J, V107, P2016, DOI 10.1016/j.bpj.2014.09.037; SMOLEN P, 1993, BIOPHYS J, V64, P1668, DOI 10.1016/S0006-3495(93)81539-X; Thornton C, 2011, BIOCHEM J, V434, P503, DOI 10.1042/BJ20101485; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Weaver CD, 1996, J BIOL CHEM, V271, P12977, DOI 10.1074/jbc.271.22.12977; Wu Y, 2015, J BIOL CHEM, V290, P29676, DOI 10.1074/jbc.M115.670877; Wu ZY, 2012, TRAFFIC, V13, P1124, DOI 10.1111/j.1600-0854.2012.01373.x; Yang SN, 2007, CELL METAB, V6, P217, DOI 10.1016/j.cmet.2007.08.002	52	19	19	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15512	15524		10.1074/jbc.M117.802249	http://dx.doi.org/10.1074/jbc.M117.802249			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28768770	hybrid, Green Published			2022-12-26	WOS:000410809800030
J	Madsen, NAH; Aarsaether, KG; Herrmann, B				Madsen, Nina A. H.; Aarsaether, Karl G.; Herrmann, Bent			Predicting the effect of seine rope layout pattern and haul-in procedure on the effectiveness of demersal seine fishing: A Computer simulation-based approach	PLOS ONE			English	Article							MESH COD-ENDS; SELECTIVITY; MODEL; SIZE	Demersal Seining is an active fishing method applying two long seine ropes and a seine net. Demersal seining relies on fish responding to the seine rope as it moves during the fishing process. The seine ropes and net are deployed in a specific pattern encircling an area on the seabed. In some variants of demersal seining the haul-in procedure includes a towing phase where the fishing vessel moves forward before starting to winch in the seine ropes. The initial seine rope encircled area, the gradual change in it during the haul-in process and the fish's reaction to the moving seine ropes play an important role in the catch performance of demersal seine fishing. The current study investigates this subject by applying computer simulation models for demersal seine fishing. The demersal seine fishing is dynamic in nature and therefore a dynamic model, SeineSolver is applied for simulating the physical behaviour of the seine ropes during the fishing process. Information about the seine rope behaviour is used as input to another simulation tool, SeineFish that predicts the catch performance of the demersal seine fishing process. SeineFish implements a simple model for how fish at the seabed reacts to an approaching seine rope. Here, the SeineSolver and SeineFish tools are applied to investigate catching performance for a Norwegian demersal seine fishery targeting cod (Gadus morhua) in the coastal zone. The effect of seine rope layout pattern and the duration of the towing phase are investigated. Among the four different layout patterns investigated, the square layout pattern was predicted to perform best; catching 69%-86% more fish than would be obtained with the rectangular layout pattern. Inclusion of a towing phase in the fishing process was found to increase the catch performance for all layout patterns. For the square layout pattern, inclusion of a towing phase of 15 or 35 minutes increased the catch performance by respectively 37% and 48% compared to fishing without a towing phase. These results highlights the importance of the selected seine rope layout pattern and the duration of the towing phase when fishermen try to maximize the catch performance of their fishery. To our knowledge this is the first time the combination of models for the physical behaviour of seine ropes and for fish behaviour in response to seine rope movements have been applied to predict catch performance for demersal seining.	[Madsen, Nina A. H.; Herrmann, Bent] SINTEF Fisheries & Aquaculture, Hirtshals, Denmark; [Aarsaether, Karl G.] SINTEF Fisheries & Aquaculture, Trondheim, Norway; [Herrmann, Bent] Univ Tromso, Tromso, Norway	SINTEF; SINTEF; UiT The Arctic University of Tromso	Madsen, NAH (corresponding author), SINTEF Fisheries & Aquaculture, Hirtshals, Denmark.	nina.ah.madsen@gmail.com		Herrmann, Bent/0000-0003-1325-6198	Research Council of Norway [225193 (MAROFF-2)]; Norwegian Seafood Research Fund [900861]	Research Council of Norway(Research Council of Norway); Norwegian Seafood Research Fund	The investigations in this study were funded by the Research Council of Norway (project no. 225193 (MAROFF-2)) and the Norwegian Seafood Research Fund (project no. 900861 (FHF)). http://www.forskningsradet.no/ http://www.fhf.no/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The investigations in this study were funded by the Research Council of Norway (project no. 225193 (MAROFF-2)) and the Norwegian Seafood Research Fund (project no. 900861 (FHF)). We are grateful for their financial support.	[Anonymous], [No title captured]; Digre H, 2010, SFH80A105002; Egeland O., 2002, MODELING SIMULATION; Herrmann B, 2005, FISH RES, V71, P1, DOI 10.1016/j.fishres.2004.08.024; Herrmann B, 2006, FISH RES, V80, P148, DOI 10.1016/j.fishres.2006.04.018; Herrmann B, 2016, FISH RES, V184, P36, DOI 10.1016/j.fishres.2015.07.015; Herrmann B, 2016, MAR COAST FISH, V8, P277, DOI 10.1080/19425120.2016.1161682; Johansen V., 2007, THESIS; Madsen NAH, 2016, J OFFSHORE MECH ARCT, V138, DOI 10.1115/1.4033778; Madsen NAH, 2015, PROCEEDINGS OF THE ASME 34TH INTERNATIONAL CONFERENCE ON OCEAN, OFFSHORE AND ARCTIC ENGINEERING, 2015, VOL 7; O'Neill FG, 2007, ICES J MAR SCI, V64, P1558, DOI 10.1093/icesjms/fsm101; ONeill FG, 1997, J APPL MECH-T ASME, V64, P7, DOI 10.1115/1.2787297; Priour D, 1999, COMMUN NUMER METH EN, V15, P755, DOI 10.1002/(SICI)1099-0887(199910)15:10<755::AID-CNM299>3.0.CO;2-M; Reite KJ, 2014, ASME 2014 33 INT C O; Sainsbury J.C., 1996, COMMERCIAL FISHING M; Sala A, 2006, AQUAT LIVING RESOUR, V19, P317, DOI 10.1051/alr:2007002; Sistiaga M, 2015, FISH RES, V167, P164, DOI 10.1016/j.fishres.2015.01.015; Suuronen P, 2012, FISH RES, V119, P135, DOI 10.1016/j.fishres.2011.12.009; Thomson D., 1981, SEINE FISHING BOTTOM; Thrane Mikkel, 2004, Journal of Industrial Ecology, V8, P223, DOI 10.1162/1088198041269427; Walsh SJ, 2011, CAN TECH REP FISH AQ; Winger PD, 1999, ICES J MAR SCI, V56, P252, DOI 10.1006/jmsc.1999.0441	22	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182609	10.1371/journal.pone.0182609	http://dx.doi.org/10.1371/journal.pone.0182609			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771583	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000406853600147
J	Sim, SH; Bae, CD; Kwon, Y; Hwang, HL; Poojan, S; Hong, HI; Kim, K; Kang, SH; Kim, HS; Um, TH; Park, IH; Lee, KS; Jung, SY; Lee, S; Kang, HS; Lee, ES; Kim, MK; Hong, KM; Ro, J				Sim, Sung Hoon; Bae, Chang-Dae; Kwon, Youngmi; Hwang, Hai-Li; Poojan, Shiv; Hong, Hye-In; Kim, Kyungtae; Kang, Seo-Hee; Kim, Han-Seong; Um, Tae-Hyun; Park, In Hae; Lee, Keun Seok; Jung, So-Youn; Lee, Seeyoun; Kang, Han-Sung; Lee, Eun Sook; Kim, Mi-Kyung; Hong, Kyeong-Man; Ro, Jungsil			CKAP2 (cytoskeleton-associated protein2) is a new prognostic marker in HER2-negative luminal type breast cancer	PLOS ONE			English	Article							PROLIFERATION; TUMOR; KI67; EXPRESSION; SURVIVAL; INDEX	Background Recently, we reported cytoskeleton-associated protein2 (CKAP2) as a possible new prognostic breast cancer marker. However, it has not yet been applied in clinic. Therefore, clinical significance of CKAP2 was evaluated in comparison with that of Ki-67 in a cohort of breast cancer patients, and the expression difference was analyzed in cell cycle-arrested cancer and fibroblast cells. Methods A total of 579 early breast cancer patients who underwent surgery at the National Cancer Center Hospital in Korea between 2001 and 2005 were accrued. CKAP2-positive cell count (CPCC) and Ki-67 labeling index (Ki-67LI) were evaluated by immunohistochemcal staining. The immunocytochemical staining patterns of CKAP2 and Ki-67 were analyzed in HeLa and human fibroblast cells after synchronization by double thymidine block. Results Although there was a significant correlation (R = 0.754, P < 0.001) between CPCC and Ki-67LI, only CPCC was correlated with DFS in overall population (HR, 2.029; 95% CI, 1.012-4.068; P = 0.046) and HER2-negative luminal subgroup (HR, 3.984; 95% CI, 1.350-11.762; P = 0.012) by multivariate analysis. In immunocytochemical staining, more than 50% of serum-starved or non-mitotic cell phase HeLa cells were positive for Ki-67, in comparison to the low CKAP2-positivity, which might explain the prognostic difference between CPCC and Ki-67LI. Conclusions The current study showed that CPCC but not Ki-67LI is an independent prognostic indicator in early breast cancer, more specifically in HER2-negative luminal breast cancer. The difference between two markers may be related to the lower background expression of CKAP2 in cancer cells.	[Sim, Sung Hoon; Kwon, Youngmi; Park, In Hae; Lee, Keun Seok; Jung, So-Youn; Lee, Seeyoun; Kang, Han-Sung; Lee, Eun Sook; Ro, Jungsil] Natl Canc Ctr, Ctr Breast Canc, 111 Jungbalsan Ro, Goyang Si, Gyeonggi Do, South Korea; [Sim, Sung Hoon; Kwon, Youngmi; Hwang, Hai-Li; Poojan, Shiv; Hong, Hye-In; Kim, Kyungtae; Kang, Seo-Hee; Park, In Hae; Lee, Keun Seok; Jung, So-Youn; Lee, Seeyoun; Kang, Han-Sung; Lee, Eun Sook; Kim, Mi-Kyung; Hong, Kyeong-Man; Ro, Jungsil] Natl Canc Ctr, Res Inst, 111 Jungbalsan Ro, Goyang Si, Gyeonggi Do, South Korea; [Bae, Chang-Dae] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon, Gyeonggi Do, South Korea; [Kim, Han-Seong] Inje Univ, Ilsan Paik Hosp, Dept Pathol, Goyang Si, Gyeonggi Do, South Korea; [Um, Tae-Hyun] Inje Univ, Ilsan Paik Hosp, Dept Lab Med, Goyang Si, Gyeonggi Do, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); Sungkyunkwan University (SKKU); Inje University; Inje University	Ro, J (corresponding author), Natl Canc Ctr, Ctr Breast Canc, 111 Jungbalsan Ro, Goyang Si, Gyeonggi Do, South Korea.; Hong, KM; Ro, J (corresponding author), Natl Canc Ctr, Res Inst, 111 Jungbalsan Ro, Goyang Si, Gyeonggi Do, South Korea.	kmhong@ncc.re.kr; jungsro@ncc.re.kr		Poojan, Shiv/0000-0003-4702-5785	National Research Foundation, Korea [1230950]; National Cancer Center, Korea [1510121, 1410674]	National Research Foundation, Korea(National Research Foundation of Korea); National Cancer Center, Korea	This work was supported by the National Research Foundation, Korea (1230950) and the National Cancer Center, Korea (1510121 and 1410674). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; J.R. from the National Research Foundation, Korea (1230950) and K.-M. H. from National Cancer Center, Korea (1510121 and 1410674).	Amadori D, 2000, J CLIN ONCOL, V18, P3125, DOI 10.1200/JCO.2000.18.17.3125; Baak JPA, 2009, BREAST CANCER RES TR, V115, P241, DOI 10.1007/s10549-008-0126-y; Colozza M, 2005, ANN ONCOL, V16, P1723, DOI 10.1093/annonc/mdi352; Colozza M, 2010, LANCET ONCOL, V11, P414, DOI 10.1016/S1470-2045(10)70089-9; Ferguson NL, 2013, BREAST J, V19, P22, DOI 10.1111/tbj.12059; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Hong KU, 2008, EXP MOL MED, V40, P377, DOI 10.3858/emm.2008.40.4.377; Jeon SM, 2006, BIOCHEM BIOPH RES CO, V348, P222, DOI 10.1016/j.bbrc.2006.07.046; Jin Y, 2004, CANCER SCI, V95, P815, DOI 10.1111/j.1349-7006.2004.tb02187.x; Keam B, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2834; Kim HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098160; Kim HS, 2012, J CANCER RES CLIN, V138, P95, DOI 10.1007/s00432-011-1053-6; Nishimura R, 2014, MOL CLIN ONCOL, V2, P1062, DOI 10.3892/mco.2014.400; Penault-Llorca F, 2009, J CLIN ONCOL, V27, P2809, DOI 10.1200/JCO.2008.18.2808; Sparano JA, 2015, NEW ENGL J MED, V373, P2005, DOI 10.1056/NEJMoa1510764; van Diest PJ, 2004, J CLIN PATHOL, V57, P675, DOI 10.1136/jcp.2003.010777; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1	18	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182107	10.1371/journal.pone.0182107	http://dx.doi.org/10.1371/journal.pone.0182107			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771517	Green Published, Green Submitted, gold			2022-12-26	WOS:000406853600065
J	Weier, N; Thursky, K; Zaidi, STR				Weier, Naomi; Thursky, Karin; Zaidi, Syed Tabish R.			Antimicrobial knowledge and confidence amongst final year medical students in Australia	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; JUNIOR DOCTORS; PRESCRIBING ERRORS; PERCEPTIONS; STEWARDSHIP; CURRICULUM; PHARMACOTHERAPY; ATTITUDES; EDUCATION; INTERNS	Introduction Inappropriate use of antimicrobials is one of the major modifiable contributors to antimicrobial resistance. There is currently no validated survey tool available to assess knowledge and confidence of medical students in infectious diseases (ID) compared to other diseases states, and little is known about this topic. Materials and methods A cross-sectional survey of final year medical students attending universities around Australia was conducted between August and September, 2015. A survey unique from other published studies was developed to survey satisfaction in education, confidence and knowledge in ID, and how this compared to these factors in cardiovascular diseases. Results Reliability and validity was demonstrated in the survey tool used. Students were more likely to rate university education as sufficient for cardiovascular diseases (91.3%) compared to ID (72.5%), and were more confident in their knowledge of cardiovascular diseases compared to ID (74.38% vs. 53.76%). Students tended to answer more cardiovascular disease related clinical questions correctly (mean score 78%), compared to questions on antimicrobial use (mean score 45%). Conclusions Poor knowledge and confidence amongst final year medical students in Australia were observed in ID. Antimicrobial stewardship agenda should include the provision of additional training in antimicrobial prescribing to the future medical workforce.	[Weier, Naomi; Zaidi, Syed Tabish R.] Univ Tasmania, Div Pharm, Sch Med, Hobart, Tas, Australia; [Thursky, Karin] Doherty Inst, Melbourne, Vic, Australia; [Thursky, Karin] Royal Melbourne Hosp, Parkville, Vic, Australia	University of Tasmania; Royal Melbourne Hospital	Zaidi, STR (corresponding author), Univ Tasmania, Div Pharm, Sch Med, Hobart, Tas, Australia.	tabish.razizaidi@utas.edu.au	thursky, karin/AAV-4524-2021; Zaidi, Syed Tabish R./J-7336-2014	Weier, Naomi/0000-0001-9832-1846; thursky, karin/0000-0002-7400-232X; Zaidi, Syed Tabish R./0000-0002-2031-1055				Abbo LM, 2013, CLIN INFECT DIS, V57, P631, DOI 10.1093/cid/cit370; Ajemigbitse AA, 2013, ANN AFR MED, V12, P223, DOI 10.4103/1596-3519.122691; Akat PB, 2012, J PHARMACOL PHARMACO, V3, P56, DOI 10.4103/0976-500X.92519; Akici A, 2005, EUR J CLIN PHARMACOL, V61, P643, DOI 10.1007/s00228-005-0960-3; Australian Commission on Safety and Quality in Health Care (ACSQHC), 2014, ANT PRESCR PRACT AUS; Avent ML, 2014, AUST HEALTH REV, V38, P557, DOI 10.1071/AH13137; Broom A, 2014, SOC SCI MED, V110, P81, DOI 10.1016/j.socscimed.2014.03.030; Charani E, 2011, CLIN INFECT DIS, V53, P651, DOI 10.1093/cid/cir445; Coombes ID, 2008, MED J AUSTRALIA, V188, P89, DOI 10.5694/j.1326-5377.2008.tb01529.x; Dartnell J., 2001, AUS PRESCR, V2001, P2; De Clercq L, 2001, Educ Health (Abingdon), V14, P417; DeVellis R. F., 2012, SCALE DEV THEORY APP; Dyar OJ, 2014, J ANTIMICROB CHEMOTH, V69, P842, DOI 10.1093/jac/dkt440; Gupta Kanchan, 2014, Int J Appl Basic Med Res, V4, P90, DOI 10.4103/2229-516X.136786; Henning RH, 1994, GUIDE GOOD PRESCRIBI; Illing JC, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-34; Ingram PR, 2012, INTERN MED J, V42, P719, DOI 10.1111/j.1445-5994.2012.02809.x; Levy SB, 2002, J ANTIMICROB CHEMOTH, V49, P25, DOI 10.1093/jac/49.1.25; Martin AA, 2007, MED J AUSTRALIA, V186, P346, DOI 10.5694/j.1326-5377.2007.tb00934.x; Maxwell S, 2003, BRIT J CLIN PHARMACO, V55, P496, DOI 10.1046/j.1365-2125.2003.01878.x; Minen MT, 2010, MICROB DRUG RESIST, V16, P285, DOI 10.1089/mdr.2010.0009; Monrouxe L., 2014, PREPARED ARE UK MED; Pearson SA, 2002, MED EDUC, V36, P781, DOI 10.1046/j.1365-2923.2002.01267.x; Piddock LJV, 2012, LANCET INFECT DIS, V12, P249, DOI 10.1016/S1473-3099(11)70316-4; Pulcini C, 2011, CLIN MICROBIOL INFEC, V17, P80, DOI 10.1111/j.1469-0691.2010.03179.x; Pulcini C, 2013, VIRULENCE, V4, P192, DOI 10.4161/viru.23706; Rolfe IE, 2004, MED EDUC, V38, P778, DOI 10.1111/j.1365-2929.2004.01891.x; Slight SP, 2013, BRIT J GEN PRACT, V63, pE713, DOI 10.3399/bjgp13X673739; Srvinivasan A, 2004, ARCH INTERN MED, V164, P1451; Starmer K, 2013, EMERG MED AUSTRALAS, V25, P147, DOI 10.1111/1742-6723.12061; Stone S, 2000, ANN EMERG MED, V36, P320, DOI 10.1067/mem.2000.109341; T Dornan, 2009, DEPTH INVESTIGATION; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; The Department of Health, 2010, MED GRAD AUSTR GOV D; Vasundara K, 2010, INDIAN J PHARMACOL, V42, P420, DOI 10.4103/0253-7613.71901; Vollebregt JA, 2006, BRIT J CLIN PHARMACO, V61, P345, DOI 10.1111/j.1365-2125.2005.02571.x	36	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182460	10.1371/journal.pone.0182460	http://dx.doi.org/10.1371/journal.pone.0182460			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771549	Green Accepted, Green Published, gold			2022-12-26	WOS:000406853600119
J	Ximenez, C; Gonzalez, E; Nieves, M; Magana, U; Moran, P; Gudino-Zayas, M; Partida, O; Hernandez, E; Rojas-Velazquez, L; de Leon, MCG; Maldonado, H				Ximenez, Cecilia; Gonzalez, Enrique; Nieves, Miriam; Magana, Ulises; Moran, Patricia; Gudino-Zayas, Marco; Partida, Oswaldo; Hernandez, Eric; Rojas-Velazquez, Liliana; Garcia de Leon, Ma. Carmen; Maldonado, Hector			Differential expression of pathogenic genes of Entamoeba histolytica vs E. dispar in a model of infection using human liver tissue explants	PLOS ONE			English	Article							GALACTOSE-SPECIFIC ADHESIN; CYSTEINE PROTEINASE; PROTOZOAN PARASITE; AMEBIC PATHOGENESIS; OXIDATIVE STRESS; EPITHELIAL-CELLS; CALRETICULIN; VIRULENCE; SLICES; TROPHOZOITES	We sought to establish an ex vivo model for examining the interaction of E. histolytica with human tissue, using precision-cut liver slices (PCLS) from donated organs. E. histolytica-or E. dispar-infected PCLS were analyzed at different post-infection times (0, 1, 3, 24 and 48 h) to evaluate the relation between tissue damage and the expression of genes associated with three factors: a) parasite survival (peroxiredoxin, superoxide dismutase and 70 kDa heat shock protein), b) parasite virulence (EhGal/GalNAc lectin, amoebapore, cysteine proteases and calreticulin), and c) the host inflammatory response (various cytokines). Unlike E. dispar (non-pathogenic), E. histolytica produced some damage to the structure of hepatic parenchyma. Overall, greater expression of virulence genes existed in E. histolytica-infected versus E. dispar-infected tissue. Accordingly, there was an increased expression of EhGal/GalNAc lectin, Ehap-a and Ehcp-5, Ehcp-2, ehcp-1 genes with E. histolytica, and a decreased or lack of expression of Ehcp-2, and Ehap-a genes with E. dispar. E. histolytica-infected tissue also exhibited an elevated expression of genes linked to survival, principally peroxiredoxin, superoxide dismutase and Ehhsp-70. Moreover, E. histolytica-infected tissue showed an overexpression of some genes encoding for pro-inflammatory interleukins (ILs), such as il-8, ifn-gamma and tnf-alpha Contrarily, E. dispar-infected tissue displayed higher levels of il-10, the gene for the corresponding anti-inflammatory cytokine. Additionally, other genes were investigated that are important in the host-parasite relationship, including those encoding for the 20 kDa heat shock protein (HSP-20), the AIG-1 protein, and immune dominant variable surface antigen, as well as for proteins apparently involved in mechanisms for the protection of the trophozoites in different environments (e.g., thiore-doxin-reductase, oxido-reductase, and 9 hypothetical proteins). Some of the hypothetical proteins evidenced interesting overexpression rates, however we should wait to their characterization. This finding suggest that the present model could be advantageous for exploring the complex interaction between trophozoites and hepatocytes during the development of ALA, particularly in the initial stages of infection.	[Ximenez, Cecilia; Gonzalez, Enrique; Nieves, Miriam; Magana, Ulises; Moran, Patricia; Gudino-Zayas, Marco; Partida, Oswaldo; Hernandez, Eric; Rojas-Velazquez, Liliana] Univ Nacl Autonoma Mexico, Fac Med, Unit Expt Med, Lab Immunol, Mexico City, DF, Mexico; [Garcia de Leon, Ma. Carmen] UNAM INMEGEN, Fac Med, Unit Sci Vinculat, Mexico City, DF, Mexico; [Maldonado, Hector] Natl Inst Cancerol, Sub Direct Pathol, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Instituto Nacional de Medicina Genomica; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Cancerologia (INCAN)	Ximenez, C (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Unit Expt Med, Lab Immunol, Mexico City, DF, Mexico.	cximenez@unam.mx		Hernandez, Eric Gregorio/0000-0002-4188-2826; Gudino, Marco/0000-0003-3186-6854; Rojas-Velazquez, Liliana/0000-0001-7369-6262; XIMENEZ, CECILIA/0000-0003-0574-4538; GONZALEZ RIVAS, ENRIQUE/0000-0002-1144-9503	PAPITT (DGAPA) [IN2260511, IN218214]; National Autonomous University of Mexico (UNAM); CONACyT from the National Council for Science and Technology (CONACyT) [2010-C01-140990]; CONACYT	PAPITT (DGAPA); National Autonomous University of Mexico (UNAM)(Universidad Nacional Autonoma de Mexico); CONACyT from the National Council for Science and Technology (CONACyT); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors are grateful for the support provided to this study by the following grants: IN2260511 and IN218214 from PAPITT (DGAPA), National Autonomous University of Mexico (UNAM), and CONACyT 2010-C01-140990 from the National Council for Science and Technology (CONACyT). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Mario Nequiz-Avendafio for the axenic culture of E. histolytica (HM1:IMSS), and Dr. Adolfo Martinez-Palomo and Lizbeth Salazar-Villatoro for the axenic culture of E. dispar (SAW760). Liliana Rojas-Velazquez, a doctoral student from the Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico (UNAM), is grateful for having received fellowship 348424/239901 from CONACYT. We also appreciate the technical assistance of Martha Zaragoza and Ma. de los Angeles Padilla, and the secretarial assistance of Mrs. Ma Elena Ortiz.	AjueborM N, 2002, BIOCHEM PHARMACOL, V63, P191; Akbar MA, 2004, MOL BIOCHEM PARASIT, V133, P187, DOI 10.1016/j.molbiopara.2003.10.006; Andra J, 2003, DEV COMP IMMUNOL, V27, P291, DOI 10.1016/S0145-305X(02)00106-4; Andrin C, 1998, BIOCHEMISTRY-US, V37, P10386, DOI 10.1021/bi980595z; Bach PH, 1996, ATLA-ALTERN LAB ANIM, V24, P893; Bansal D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000551; Biller L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-63; Bracha R, 2003, EUKARYOT CELL, V2, P295, DOI 10.1128/EC.2.2.295-305.2003; BRACHA R, 1983, INFECT IMMUN, V40, P882, DOI 10.1128/IAI.40.3.882-887.1983; Bracha Rivka, 2006, PLoS Pathog, V2, pe48, DOI 10.1371/journal.ppat.0020048; BRAGA LL, 1992, J CLIN INVEST, V90, P1131, DOI 10.1172/JCI115931; BRENDEL K, 1993, METHODS TOXICOLOGY A, V1, P222; Bruchhaus I, 1998, BIOCHEM J, V330, P1217, DOI 10.1042/bj3301217; Bruchhaus I, 2003, EUKARYOT CELL, V2, P501, DOI 10.1128/EC.2.3.501-509.2003; Bruchhaus I, 1996, MOL MICROBIOL, V22, P255, DOI 10.1046/j.1365-2958.1996.00111.x; Carranza-Rosales P, 2012, EXP PARASITOL, V132, P424, DOI 10.1016/j.exppara.2012.09.012; Carranza-Rosales P, 2010, EXP PARASITOL, V126, P117, DOI 10.1016/j.exppara.2010.04.005; Davis PH, 2007, MOL BIOCHEM PARASIT, V151, P118, DOI 10.1016/j.molbiopara.2006.10.014; Davis PH, 2006, MOL MICROBIOL, V61, P1523, DOI 10.1111/j.1365-2958.2006.05344.x; Graaf IAM, 2007, EXPERT OPIN DRUG MET, V3, P879, DOI 10.1517/17425255.3.6.879; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; DIAMOND LS, 1993, J EUKARYOT MICROBIOL, V40, P340, DOI 10.1111/j.1550-7408.1993.tb04926.x; EGGLETON P, 1994, CLIN IMMUNOL IMMUNOP, V72, P405, DOI 10.1006/clin.1994.1160; Ehrenkaufer GM, 2007, CELL MICROBIOL, V9, P1426, DOI 10.1111/j.1462-5822.2006.00882.x; Evdokimova E, 2001, TOXICOL IN VITRO, V15, P683, DOI 10.1016/S0887-2333(01)00091-1; Fernandez-Lopez L, 2015, MEM 18 INT SEM AM; Ferreira V, 2004, J IMMUNOL, V172, P3042, DOI 10.4049/jimmunol.172.5.3042; Frederick JR, 2005, GLYCOBIOLOGY, V15, p53R, DOI 10.1093/glycob/cwj007; Garcia-Zepeda EA, 2007, PARASITE IMMUNOL, V29, P679, DOI 10.1111/j.1365-3024.2007.00990.x; Gold LI, 2010, FASEB J, V24, P665, DOI 10.1096/fj.09-145482; Gonzalez E, 2002, AM J TROP MED HYG, V67, P636, DOI 10.4269/ajtmh.2002.67.636; Gonzalez E, 2011, PARASITOL RES, V108, P439, DOI 10.1007/s00436-010-2085-6; Jaworski DC, 1996, J MED ENTOMOL, V33, P482, DOI 10.1093/jmedent/33.3.482; JAWORSKI DC, 1995, J INSECT PHYSIOL, V41, P369, DOI 10.1016/0022-1910(94)00107-R; KEENE WE, 1990, EXP PARASITOL, V71, P199, DOI 10.1016/0014-4894(90)90022-5; KHALIFE J, 1993, MOL BIOCHEM PARASIT, V57, P193, DOI 10.1016/0166-6851(93)90195-4; Lee J, 2008, KOREAN J PARASITOL, V46, P37, DOI 10.3347/kjp.2008.46.1.37; Leippe M, 1997, PARASITOL TODAY, V13, P178, DOI 10.1016/S0169-4758(97)01038-7; LEIPPE M, 1994, MOL MICROBIOL, V14, P895, DOI 10.1111/j.1365-2958.1994.tb01325.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Lohia A, 2003, MOL CELL BIOCHEM, V253, P217, DOI 10.1023/A:1026055631421; Lopez-Vancell R, 2000, PARASITOL RES, V86, P226, DOI 10.1007/s004360050035; MacFarlane RC, 2006, INFECT IMMUN, V74, P340, DOI 10.1128/IAI.74.1.340-351.2006; Meyer M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005853; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Min-Ho Choi, 2005, MOL BIOCHEM PARASIT, V144, P80; Mortimer L, 2010, EXP PARASITOL, V126, P366, DOI 10.1016/j.exppara.2010.03.005; Nuovo GJ, 2007, HUM PATHOL, V38, P1123, DOI 10.1016/j.humpath.2007.04.005; Ocadiz-Delgado R, 2008, GENESIS, V46, P19, DOI 10.1002/dvg.20357; Ocadiz-Delgado R, 2009, TRANSGENIC RES, V18, P513, DOI 10.1007/s11248-009-9243-6; Olivos A, 2005, EXP PARASITOL, V110, P309, DOI 10.1016/j.exppara.2005.03.020; Olivos-Garcia A, 2004, EXP MOL PATHOL, V77, P66, DOI 10.1016/j.yexmp.2003.09.003; Pacheco J, 2004, PARASITOL INT, V53, P35, DOI 10.1016/j.parint.2003.10.005; Pacheco-Yepez J, 2011, PARASITE IMMUNOL, V33, P56, DOI 10.1111/j.1365-3024.2010.01252.x; Pacheco-Yepez J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/324230; Papp S, 2004, J APPL BIOMED, V2, P1; PETRI WA, 1995, METHOD ENZYMOL, V253, P98; Petri WA, 2002, ANNU REV MICROBIOL, V56, P39, DOI 10.1146/annurev.micro.56.012302.160959; QUE X, 1991, NUCLEIC ACIDS RES, V19, P5438, DOI 10.1093/nar/19.19.5438; Que XC, 2000, CLIN MICROBIOL REV, V13, P196, DOI 10.1128/CMR.13.2.196-206.2000; Ralston KS, 2011, TRENDS PARASITOL, V27, P253, DOI 10.1016/j.pt.2011.02.006; Rastew E, 2012, INT J PARASITOL, V42, P1007, DOI 10.1016/j.ijpara.2012.08.006; REED SL, 1989, J CLIN MICROBIOL, V27, P2772, DOI 10.1128/JCM.27.12.2772-2777.1989; Santos F, 2015, CELL MICROBIOL, V17, P1037, DOI 10.1111/cmi.12419; SARGEAUNT PG, 1978, T ROY SOC TROP MED H, V72, P519, DOI 10.1016/0035-9203(78)90174-8; Seydel KB, 1997, INFECT IMMUN, V65, P1631, DOI 10.1128/IAI.65.5.1631-1639.1997; Sharma M, 2005, PARASITOLOGY, V131, P783, DOI 10.1017/S0031182005008541; Singh D, 2004, PARASITOLOGY, V129, P127, DOI 10.1017/S0031182004005451; Talvani A, 2004, CLIN INFECT DIS, V38, P943, DOI 10.1086/381892; Thohan S, 2001, DRUG METAB DISPOS, V29, P1337; Tillack M, 2006, MOL BIOCHEM PARASIT, V149, P58, DOI 10.1016/j.molbiopara.2006.04.009; TSUTSUMI V, 1992, T ROY SOC TROP MED H, V86, P170, DOI 10.1016/0035-9203(92)90555-Q; Tsutsumi V, 2006, ARCH MED RES, V37, P210, DOI 10.1016/j.arcmed.2005.09.011; TSUTSUMI V, 1984, AM J PATHOL, V117, P81; Vaithilingam A, 2012, INFECT IMMUN, V80, P2008, DOI 10.1128/IAI.06287-11; van Midwoud PM, 2011, ANAL CHEM, V83, P84, DOI 10.1021/ac1018638; Vicente JB, 2009, CELL MICROBIOL, V11, P51, DOI 10.1111/j.1462-5822.2008.01236.x; WHO, 1997, WKLY EPIDEMIOL REC R, V72, P97; Wilson IW, 2012, PARASITE IMMUNOL, V34, P90, DOI 10.1111/j.1365-3024.2011.01325.x; Ximenez C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/127453; Ximenez C, 2010, INT J ENV RES PUB HE, V7, P1105, DOI 10.3390/ijerph7031105; Yalcin A, 2004, ACTA BIOCHIM POL, V51, P1059	83	17	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0181962	10.1371/journal.pone.0181962	http://dx.doi.org/10.1371/journal.pone.0181962			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771523	Green Published, Green Submitted, gold			2022-12-26	WOS:000406853600048
J	Beland, M; Biggs, TW; Roberts, DA; Peterson, SH; Kokaly, RF; Piazza, S				Beland, Michael; Biggs, Trent W.; Roberts, Dar A.; Peterson, Seth H.; Kokaly, Raymond F.; Piazza, Sarai			Oiling accelerates loss of salt marshes, southeastern Louisiana	PLOS ONE			English	Article							WATER-HORIZON SPILL; CRUDE-OIL; SPARTINA-ALTERNIFLORA; JUNCUS-ROEMERIANUS; MISSISSIPPI DELTA; COASTAL MARSHES; BARATARIA BASIN; LAND LOSS; VEGETATION; EROSION	The 2010 BP Deepwater Horizon (DWH) oil spill damaged thousands of km(2) of intertidal marsh along shorelines that had been experiencing elevated rates of erosion for decades. Yet, the contribution of marsh oiling to landscape-scale degradation and subsequent land loss has been difficult to quantify. Here, we applied advanced remote sensing techniques to map changes in marsh land cover and open water before and after oiling. We segmented the marsh shorelines into non-oiled and oiled reaches and calculated the land loss rates for each 10% increase in oil cover (e.g. 0% to >70%), to determine if land loss rates for each reach oiling category were significantly different before and after oiling. Finally, we calculated background land-loss rates to separate natural and oil-related erosion and land loss. Oiling caused significant increases in land losses, particularly along reaches of heavy oiling (>20% oil cover). For reaches with >= 20% oiling, land loss rates increased abruptly during the 2010-2013 period, and the loss rates during this period are significantly different from both the pre-oiling (p < 0.0001) and 2013-2016 post-oiling periods (p < 0.0001). The pre-oiling and 2013-2016 post-oiling periods exhibit no significant differences in land loss rates across oiled and non-oiled reaches (p = 0.557). We conclude that oiling increased land loss by more than 50%, but that land loss rates returned to background levels within 3-6 years after oiling, suggesting that oiling results in a large but temporary increase in land loss rates along the shoreline.	[Beland, Michael; Biggs, Trent W.] San Diego State Univ, Dept Geog, San Diego, CA 92182 USA; [Beland, Michael; Roberts, Dar A.; Peterson, Seth H.] Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA; [Kokaly, Raymond F.] US Geol Survey, Box 25046, Denver, CO 80225 USA; [Piazza, Sarai] US Geol Survey, Wetland & Aquat Res Ctr, Baton Rouge, LA USA	California State University System; San Diego State University; University of California System; University of California Santa Barbara; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Beland, M (corresponding author), San Diego State Univ, Dept Geog, San Diego, CA 92182 USA.; Beland, M (corresponding author), Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA.	mbeland2@calstatela.edu			National Aeronautics and Space Administration Earth and Space Sciences Fellowship [13-EARTH13F-0052]; NASA Earth and Space Sciences Fellowship [13-EARTH13F-0052]	National Aeronautics and Space Administration Earth and Space Sciences Fellowship; NASA Earth and Space Sciences Fellowship	This work was funded by the National Aeronautics and Space Administration Earth and Space Sciences Fellowship (13-EARTH13F-0052), https://science.nasa.gov/researchers/sara/grant-stats/nasa-earth-and-space-science-fellowship-nessf-selections to MB.; We thank Digital Globe and Aerometric, Inc. (Quantum Spatial) for their efforts in collecting and preprocessing the large volume of data that made this and other post-spill studies possible. USGS team for their assistance in field campaigns to collect data used in map validation. The inital stages of this research was supported by a NASA Earth and Space Sciences Fellowship (13-EARTH13F-0052). Any use of trade, product, or firm names is for descriptive purposes only and does not imply endorsement by the U.S. Government.	Adams R. D., 1976, SEA GRAND PUBL LA ST, P111; Alexander Steve K., 1987, INT OIL SPILL C P, V1987, P445, DOI [10.7901/2169-3358-1987-1-445., DOI 10.7901/2169-3358-1987-1-445]; [Anonymous], 2010, OIL BUDGET CALCULATO; Atlas RM, 2015, ENVIRON SCI TECHNOL, V49, P8356, DOI 10.1021/acs.est.5b00413; Baker J.M., 1993, INT OIL SPILL C WASH, P395; Barras J., 2003, HIST PROJECTED COAST; Barrett B., 1970, WATER MEASUREMENTS C, P196; Beland M, 2016, REMOTE SENS ENVIRON, V182, P192, DOI 10.1016/j.rse.2016.04.024; Bernhard A. E., 2016, FRONTIERS MICROBIOLO, V7; BERTNESS MD, 1993, AM NAT, V142, P718, DOI 10.1086/285567; BRITSCH LD, 1993, J COASTAL RES, V9, P324; Chabreck RH., 1972, VEGETATION WATER SOI; CHUANG WS, 1983, J GEOPHYS RES-OCEANS, V88, P2615, DOI 10.1029/JC088iC04p02615; CRAIG NJ, 1979, ENVIRON MANAGE, V3, P133, DOI 10.1007/BF01867025; Culbertson JB, 2008, J APPL ECOL, V45, P1284, DOI 10.1111/j.1365-2664.2008.01477.x; Day JW, 2007, SCIENCE, V315, P1679, DOI 10.1126/science.1137030; Day JW, 2000, ESTUARIES, V23, P425, DOI 10.2307/1353136; DEEGAN LA, 1984, ENVIRON MANAGE, V8, P519, DOI 10.1007/BF01871577; DELAUNE RD, 1994, J COASTAL RES, V10, P1021; DeLaune RD, 2003, AQUAT ECOL, V37, P351, DOI 10.1023/B:AECO.0000007047.42636.96; Evers D.E., 1992, WETLANDS ECOLOGY MAN, V2, P103, DOI [10.1007/BF00215318, DOI 10.1007/BF00215318]; Feagin RA, 2009, P NATL ACAD SCI USA, V106, P10109, DOI 10.1073/pnas.0901297106; FitzGerald D., 2007, P COAST SED 07 MAY 1, V7, P179; Francalanci S, 2013, GEOMORPHOLOGY, V195, P53, DOI 10.1016/j.geomorph.2013.04.026; Gabet EJ, 1998, ESTUARIES, V21, P745, DOI 10.2307/1353278; Gagliano S. M., 1981, SPECIAL REPORT MARSH; Gagliano S. M., 1970, COASTAL ENG P, V1; Gedan KB, 2009, ANNU REV MAR SCI, V1, P117, DOI 10.1146/annurev.marine.010908.163930; HATTON RS, 1983, LIMNOL OCEANOGR, V28, P494, DOI 10.4319/lo.1983.28.3.0494; HERSHNER C, 1980, MAR BIOL, V56, P163, DOI 10.1007/BF00397133; Hester MW, 2016, ENVIRON POLLUT, V216, P361, DOI 10.1016/j.envpol.2016.05.065; Hester MW, 2001, ENVIRON EXP BOT, V46, P277, DOI 10.1016/S0098-8472(01)00100-9; Hester MW, 2000, MAR ENVIRON RES, V49, P233, DOI 10.1016/S0141-1136(99)00071-9; Hoff R., 2010, 961 HAZMAT NOAA, P70; HOFF RZ, 1993, P 1993 INT OIL SPILL, P307; Iredale H, 1995, S123 NOAA NMF US DEP; Jensen J.R., 1993, GEOCARTO INT, V8, P87, DOI [10.1080/10106049309354432, DOI 10.1080/10106049309354432]; Khanna S, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9020169; Khanna S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078989; Ko JY, 2004, OCEAN COAST MANAGE, V47, P597, DOI 10.1016/j.ocecoaman.2004.12.004; Kokaly RF, 2013, REMOTE SENS ENVIRON, V129, P210, DOI 10.1016/j.rse.2012.10.028; Li CY, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006566; Lin QX, 2016, SCI TOTAL ENVIRON, V557, P369, DOI 10.1016/j.scitotenv.2016.03.049; Lin QX, 2012, ENVIRON SCI TECHNOL, V46, P3737, DOI 10.1021/es203552p; Lin QX, 2009, ECOL ENG, V35, P85, DOI 10.1016/j.ecoleng.2008.09.010; Lin QX, 1996, MAR POLLUT BULL, V32, P202, DOI 10.1016/0025-326X(95)00118-7; Lin QX, 2002, MAR POLLUT BULL, V44, P897, DOI 10.1016/S0025-326X(02)00118-2; Marton JM, 2015, ESTUAR COAST, V38, P1824, DOI 10.1007/s12237-015-9943-5; McClenachan G, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044030; MENDELSSOHN IA, 1990, OIL CHEM POLLUT, V7, P1, DOI 10.1016/S0269-8579(05)80031-0; Mendelssohn IA, 2012, BIOSCIENCE, V62, P562, DOI 10.1525/bio.2012.62.6.7; Michel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065087; Micheli ER, 2002, EARTH SURF PROC LAND, V27, P687, DOI 10.1002/esp.340; Mishra DR, 2012, REMOTE SENS ENVIRON, V118, P176, DOI 10.1016/j.rse.2011.11.007; Morton RA, 2010, J COASTAL RES, V26, P555, DOI 10.2112/JCOASTRES-D-09-00014R1.1; NIERING W A, 1977, Connecticut Arboretum Bulletin, V22, P2; NYMAN JA, 1994, EARTH SURF PROC LAND, V19, P69, DOI 10.1002/esp.3290190106; PENLAND S, 1990, J COASTAL RES, V6, P323; Pennings SC, 2005, J ECOL, V93, P159, DOI 10.1111/j.1365-2745.2004.00959.x; Pennings SC, 2001, MARINE COMMUNITY ECOLOGY, P289; Peterson SH, 2015, REMOTE SENS ENVIRON, V159, P222, DOI 10.1016/j.rse.2014.12.009; PEZESHKI SR, 1993, WATER AIR SOIL POLL, V68, P461, DOI 10.1007/BF00478469; Pezeshki SR, 2000, ENVIRON POLLUT, V108, P129, DOI 10.1016/S0269-7491(99)00244-4; Rabalais NN, 2016, OCEANOGRAPHY, V29, P150, DOI 10.5670/oceanog.2016.79; Ramsey E, 2016, REMOTE SENS ENVIRON, V186, P350, DOI 10.1016/j.rse.2016.08.001; Rangoonwala A., 2016, GEOPHYS RES LETT; Roth KL, 2012, REMOTE SENS ENVIRON, V127, P139, DOI 10.1016/j.rse.2012.08.030; SASSER CE, 1986, ENVIRON MANAGE, V10, P671, DOI 10.1007/BF01866771; SASSER CE, 1995, WETLANDS ECOLOGY, V3, P171, DOI DOI 10.1007/BF00180023; Sell D., 1995, INT OIL SPILL C, P595; Shapiro K, 2016, J MAR SCI ENG, V4, DOI 10.3390/jmse4020033; Silliman BR, 2002, P NATL ACAD SCI USA, V99, P10500, DOI 10.1073/pnas.162366599; Silliman BR, 2012, P NATL ACAD SCI USA, V109, P11234, DOI 10.1073/pnas.1204922109; SMART RM, 1978, ESTUAR COAST MAR SCI, V7, P487, DOI 10.1016/0302-3524(78)90125-1; Somers B, 2009, INT J REMOTE SENS, V30, P139, DOI 10.1080/01431160802304625; Somers B, 2010, INT J REMOTE SENS, V31, P5549, DOI 10.1080/01431160903311305; Stedman S.M., 2008, STATUS TRENDS WETLAN; Turner RE, 2016, MAR POLLUT BULL, V110, P316, DOI 10.1016/j.marpolbul.2016.06.046; Turner RE, 2016, WETL ECOL MANAG, V24, P373, DOI 10.1007/s11273-015-9457-8; Turner RE, 2011, ESTUAR COAST, V34, P1084, DOI 10.1007/s12237-010-9341-y; TURNER RE, 1990, AM ZOOL, V30, P89; TURNER RE, 1976, CONTRIB MAR SCI, V20, P47; van de Koppel J, 2005, AM NAT, V165, pE1; VANEERDT MM, 1985, EARTH SURF PROC LAND, V10, P95, DOI 10.1002/esp.3290100203; Visser JM, 1998, ESTUARIES, V21, P818, DOI 10.2307/1353283; Weis JS, 2004, ENVIRON INT, V30, P685, DOI 10.1016/j.envint.2003.11.002; Wilson CA, 2008, ESTUAR COAST SHELF S, V80, P483, DOI 10.1016/j.ecss.2008.09.004; Wu TH, 2013, CAN GEOTECH J, V50, P259, DOI 10.1139/cgj-2012-0160; Zengel S., 2013, 42 NOAA NOS OR R US; Zengel S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132324	90	17	18	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0181197	10.1371/journal.pone.0181197	http://dx.doi.org/10.1371/journal.pone.0181197			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767649	gold, Green Submitted, Green Published			2022-12-26	WOS:000406768200019
J	Haymerle, G; Janik, S; Fochtmann, A; Pammer, J; Schachner, H; Nemec, L; Mildner, M; Houben, R; Grasl, MC; Erovic, BM				Haymerle, Georg; Janik, Stefan; Fochtmann, Alexandra; Pammer, Johannes; Schachner, Helga; Nemec, Lucas; Mildner, Michael; Houben, Roland; Grasl, Matthaeus Ch.; Erovic, Boban M.			Expression of Merkelcell polyomavirus (MCPyV) large T-antigen in Merkel cell carcinoma lymph node metastases predicts poor outcome	PLOS ONE			English	Article							VIRUS; SKIN; ORIGIN	Background The aim of this study was to determine the prevalence of MCPyV in Merkel cell carcinoma (MCC) primaries versus lymph node metastasis and to evaluate possible prognostic factors. Methods Samples of MCC primaries and lymph node metastases were stained immunohistochemically for the MCPyV large T-antigen and expression was compared to patients A clinical outcome. Results 41 MCC patients were included. 33 (61%) out of 54 specimens were MCPyV-positive in the immunohistochemistry. 15 (47%) out of 32 primary tumors were positive compared to 18 (82%) out of 22 lymph node metastases. Eleven patients with positive polyomavirus expression died from the carcinoma compared to 4 patients without virus expression. Cox regression analysis showed worse disease-free survival in patients with MCPyV compared to virus-negative lymph nodes (p = 0.002). Conclusions To our knowledge this is the first study to describe a negative prognostic effect of the MCPyV expression in lymph node metastasis in MCC patients.	[Haymerle, Georg; Janik, Stefan; Grasl, Matthaeus Ch.; Erovic, Boban M.] Med Univ Vienna, Dept Otolaryngol Head & Neck Surg, Vienna, Austria; [Fochtmann, Alexandra] Med Univ Vienna, Clin Div Plast & Reconstruct Surg, Dept Surg, Vienna, Austria; [Pammer, Johannes; Schachner, Helga] Med Univ Vienna, Dept Clin Pathol, Vienna, Austria; [Nemec, Lucas; Mildner, Michael] Med Univ Vienna, Res Div Biol & Pathobiol Skin, Dept Dermatol, Vienna, Austria; [Houben, Roland] Med Univ Wuerzburg, Dept Dermatol, Wurzburg, Germany	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Wurzburg	Erovic, BM (corresponding author), Med Univ Vienna, Dept Otolaryngol Head & Neck Surg, Vienna, Austria.	boban.erovic@meduniwien.ac.at	Erovic, Boban/S-7824-2018	Erovic, Boban/0000-0002-7404-2583; Houben, Roland/0000-0003-4538-2324; Mildner, Michael/0000-0002-6892-925X				Becker JC, 2009, J INVEST DERMATOL, V129, P248, DOI 10.1038/jid.2008.198; Chen TT, 2011, J CLIN VIROL, V50, P125, DOI 10.1016/j.jcv.2010.10.015; Deneve JL, 2012, ANN SURG ONCOL, V19, P2360, DOI 10.1245/s10434-011-2213-2; Edge S. B., 2010, AJCC CANC STAGING MA, P315; Erovic BM, 2013, HEAD NECK-J SCI SPEC, V35, P184, DOI 10.1002/hed.22942; Erovic I, 2013, J SKIN CANCER, V2013, DOI 10.1155/2013/929364; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; FRIGERIO B, 1983, HISTOPATHOLOGY, V7, P229, DOI 10.1111/j.1365-2559.1983.tb02238.x; Garneski KM, 2009, J INVEST DERMATOL, V129, P246, DOI 10.1038/jid.2008.229; Haymerle G, 2015, EUR ARCH OTO-RHINO-L, V272, P425, DOI 10.1007/s00405-014-2974-x; Kuwamoto S, 2011, HUM PATHOL, V42, P1063, DOI 10.1016/j.humpath.2011.01.020; Leroux-Kozal V, 2015, HUM PATHOL, V46, P443, DOI 10.1016/j.humpath.2014.12.001; Loyo M, 2012, BRIT J CANCER, V106, P1314, DOI 10.1038/bjc.2012.73; Moens U, 2015, VIRUSES-BASEL, V7, P1871, DOI 10.3390/v7041871; MOLL I, 1990, ARCH DERMATOL RES, V282, P213, DOI 10.1007/BF00371638; Popp S, 2002, INT J CANCER, V99, P352, DOI 10.1002/ijc.10321; Schneider S, 2013, J SKIN CANCER, V2013, DOI 10.1155/2013/189342; Spurgeon ME, 2013, VIROLOGY, V435, P118, DOI 10.1016/j.virol.2012.09.029; TOKER C, 1972, ARCH DERMATOL, V105, P107, DOI 10.1001/archderm.105.1.107; Tolstov YL, 2009, INT J CANCER, V125, P1250, DOI 10.1002/ijc.24509; Viscidi RP, 2011, CLIN VACCINE IMMUNOL, V18, P1737, DOI 10.1128/CVI.05175-11	21	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0180426	10.1371/journal.pone.0180426	http://dx.doi.org/10.1371/journal.pone.0180426			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763479	Green Published, gold, Green Submitted			2022-12-26	WOS:000406766500005
J	Jee, J; Mourya, R; Shivakumar, P; Fei, L; Wagner, M; Bezerra, JA				Jee, Junbae; Mourya, Reena; Shivakumar, Pranavkumar; Fei, Lin; Wagner, Michael; Bezerra, Jorge A.			Cxcr2 signaling and the microbiome suppress inflammation, bile duct injury, and the phenotype of experimental biliary atresia	PLOS ONE			English	Article							NKP46(+) CELLS; DISEASE; COLITIS; INFANTS; DIFFERENTIATION; INTERLEUKIN-8; PATHOGENESIS; RESPONSES; DEFENSE; INNATE	Biliary atresia is progressive fibro-inflammatory cholangiopathy of young children. Central to pathogenic mechanisms of injury is the tissue targeting by the innate and adaptive immune cells. Among these cells, neutrophils and the IL-8/Cxcl-8 signaling via its Cxcr2 receptor have been linked to bile duct injury. Here, we aimed to investigate whether the intestinal microbiome modulates Cxcr2-dependent bile duct injury and obstruction. Adult wild-type (WT) and Cxcr2(-/-) mice were fed a diet supplemented with sulfamethoxazole/trimethoprim (SMZ/TMP) during pregnancy and lactation, and their pups were injected intraperitoneally with rhesus rotavirus (RRV) within 24 hours of life to induce experimental biliary atresia. The maternal exposure to SMZ/TMP significantly lowered the incidence of jaundice and bile duct obstruction and resulted in improved survival, especially in Cxcr2(-/-) mice. Analyses of the microbiome by deep sequencing of 16S rRNA of the neonatal colon showed a delay in bacterial colonization of WT mice induced by SMZ/TMP, with a notable switch from Proteobacteria to Firmicutes. Interestingly, the genetic inactivation of Cxcr2 alone produced a similar bacterial shift. When treated with SMZ/TMP, Cxcr2(-/-) mice infected with RRV to induce experimental biliary atresia showed further enrichment of Corynebacterium, Anaerococcus and Streptococcus. Among these, Anaerococcus lactolyticus was significantly associated with a suppression of biliary injury, cholestasis, and survivability. These results suggest that the postnatal development of the intestinal microbiota is an important susceptibility factor for experimental biliary atresia.	[Jee, Junbae; Mourya, Reena; Shivakumar, Pranavkumar; Bezerra, Jorge A.] Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol, Cincinnati, OH 45229 USA; [Jee, Junbae; Mourya, Reena; Shivakumar, Pranavkumar; Bezerra, Jorge A.] Cincinnati Childrens Hosp Med Ctr, Div Hepatol, Cincinnati, OH 45229 USA; [Jee, Junbae; Mourya, Reena; Shivakumar, Pranavkumar; Bezerra, Jorge A.] Cincinnati Childrens Hosp Med Ctr, Div Nutr, Cincinnati, OH 45229 USA; [Fei, Lin] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Wagner, Michael] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Bezerra, JA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol, Cincinnati, OH 45229 USA.; Bezerra, JA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Hepatol, Cincinnati, OH 45229 USA.; Bezerra, JA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Nutr, Cincinnati, OH 45229 USA.	jorge.bezerra@cchmc.org	Shivakumar, Pranav/A-4229-2011	Mourya, Reena/0000-0003-4525-0196	NIH [DK-64008, DK-83781]; Integrative Morphology and the Gene Analysis Cores of the Digestive Health Center [DK-78392]; Junior Co-Operative Society of Cincinnati Children's Hospital Medical Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392, R01DK083781, R01DK064008] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Integrative Morphology and the Gene Analysis Cores of the Digestive Health Center; Junior Co-Operative Society of Cincinnati Children's Hospital Medical Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the NIH grants DK-64008 and DK-83781 to JAB and by the Integrative Morphology and the Gene Analysis Cores of the Digestive Health Center (DK-78392). The studies were also supported by the generous support of the Junior Co-Operative Society of Cincinnati Children's Hospital Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the NIH grants DK-64008 and DK-83781 to JAB and by the Integrative Morphology and the Gene Analysis Cores of the Digestive Health Center (DK-78392). The studies were also supported by the generous support of the Junior Co-Operative Society of Cincinnati Children's Hospital Medical Center. The authors thank Jillian Ellis for technical consulting.	Arrieta MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00427; Asai A, 2015, NAT REV GASTRO HEPAT, V12, P342, DOI 10.1038/nrgastro.2015.74; Asnicar F, 2015, PEERJ, V3, DOI 10.7717/peerj.1029; Backhed F, 2015, CELL HOST MICROBE, V17, P852, DOI 10.1016/j.chom.2015.05.012; Bessho K, 2014, HEPATOLOGY, V60, P211, DOI 10.1002/hep.27045; Bessho K, 2011, ANNU REV MED, V62, P171, DOI 10.1146/annurev-med-042909-093734; Bezerra JA, 2005, PEDIATR TRANSPLANT, V9, P646, DOI 10.1111/j.1399-3046.2005.00350.x; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang TW, 2012, J BIOL CHEM, V287, P418, DOI 10.1074/jbc.M111.290361; Dasgupta S, 2014, CELL HOST MICROBE, V15, P413, DOI 10.1016/j.chom.2014.03.006; Duplantier AJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00143; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ezaki T, 2001, INT J SYST EVOL MICR, V51, P1521, DOI 10.1099/00207713-51-4-1521; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Farooq SM, 2009, J PHARMACOL EXP THER, V329, P123, DOI 10.1124/jpet.108.145862; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gibbons D, 2014, NAT MED, V20, P1206, DOI 10.1038/nm.3670; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hansen CHF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034043; Houghteling PD, 2015, J PEDIATR GASTR NUTR, V60, P294, DOI 10.1097/MPG.0000000000000597; Kim JM, 2014, INTEST RES, V12, P20, DOI [10.5217/ir.2014.12.1.20, 10.5217/ir.2014.12.4.266]; KOBAYASHI A, 1988, AM J CLIN NUTR, V48, P1211, DOI 10.1093/ajcn/48.5.1211; Lien TH, 2015, J PEDIATR GASTR NUTR, V60, P654, DOI 10.1097/MPG.0000000000000676; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; McMurtry VE, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0075-8; MIYANO T, 1977, J PEDIATR SURG, V12, P19, DOI 10.1016/0022-3468(77)90291-3; Mohanty SK, 2010, PEDIATR RES, V67, P345, DOI 10.1203/PDR.0b013e3181d22a73; Myers B, 1923, Proc R Soc Med, V16, P17; Petersen C, 1997, J PEDIATR SURG, V32, P1190, DOI 10.1016/S0022-3468(97)90680-1; Preidis GA, 2012, J PEDIATR GASTR NUTR, V55, P299, DOI 10.1097/MPG.0b013e31824d2548; Renz H, 2012, NAT REV IMMUNOL, V12, P9, DOI 10.1038/nri3112; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Saxena V, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002069; Segain JP, 2000, GUT, V47, P397, DOI 10.1136/gut.47.3.397; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shivakumar P, 2004, J CLIN INVEST, V114, P322, DOI 10.1172/jci200421153; Shivakumar P, 2014, J HEPATOL, V60, P370, DOI 10.1016/j.jhep.2013.09.021; Spehlmann ME, 2009, J IMMUNOL, V183, P3332, DOI 10.4049/jimmunol.0900600; Squires JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127191; Torri F, 2012, GENES-BASEL, V3, P545, DOI 10.3390/genes3030545; Zindl CL, 2013, P NATL ACAD SCI USA, V110, P12768, DOI 10.1073/pnas.1300318110	44	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0182089	10.1371/journal.pone.0182089	http://dx.doi.org/10.1371/journal.pone.0182089			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763485	gold, Green Published, Green Submitted			2022-12-26	WOS:000406766500042
J	Lin, TS; Hsu, PY; Chang, CH; Ko, CL; Kuo, YM; Wu, YW; Yen, RF; Wu, CH; Li, KJ; Hsein, YC; Hsieh, SC				Lin, Ting-Syuan; Hsu, Pei-Ying; Chang, Chin-Hao; Ko, Chi-Lun; Kuo, Yu-Min; Wu, Yen-Wen; Yen, Ruoh-Fang; Wu, Cheng-Han; Li, Ko-Jen; Hsein, Yenh-Chen; Hsieh, Song-Chou			Increased heterogeneity of brain perfusion is an early marker of central nervous system involvement in antiphospholipid antibody carriers	PLOS ONE			English	Article							SUBARACHNOID HEMORRHAGE; CLASSIFICATION; PATHOGENESIS; DIAGNOSIS; THERAPY; EVENT; SPECT	Objective The non-criteria neuropsychiatric manifestations of antiphospholipid syndrome include headache, dizziness, vertigo, seizure, depression and psychosis. There were still no objective methods qualified to detect the early central nervous system involvement in non-criteria antiphospholipid syndrome. We evaluated the effectiveness of Tc-99m ECD SPECT in assessing circulatory insufficiency in the brains of patients with antiphospholipid antibodies and neuropsychiatric symptoms but without thromboembolism. Materials and methods Patients with a history of positive antiphospholipid antibodies and neuropsychiatric symptoms composed the case group; patients without antiphospholipid antibody served as the control group. Subjects with a history of thromboembolism or autoantibodies to extractable nuclear antigens were excluded. All patients received Tc-99m ECD SPECT studies and were classified by the number of positive antiphospholipid antibodies they carried. The heterogeneity of brain perfusion was defined as the coefficient of variation of the SPECT signals. Analysis of variance (ANOVA) was applied to evaluate the differences between the groups. Results Total 60 adult patients were included in this study. There were 54 patients in the case group and 6 patients in the control group. The mean age was 38.3 +/- 11.5 years. There were 52 women and 8 men. There was no significant difference in the mean brain perfusion between groups (P = 0.69). However, Tc-99m ECD SPECT demonstrated significant heterogeneity of brain perfusion in relation to the number of antiphospholipid antibodies (P = 0.01). Conclusions This is the first study demonstrating that Tc-99m ECD SPECT can early detect the increased heterogeneity of brain circulation in non-criteria antiphospholipid antibody carriers.	[Lin, Ting-Syuan] Natl Taiwan Univ Hosp, Dept Internal Med, Yun Lin Branch, Yunlin, Taiwan; [Lin, Ting-Syuan; Kuo, Yu-Min; Wu, Cheng-Han] Natl Taiwan Univ, Coll Med, Inst Clin Med, Taipei, Taiwan; [Hsu, Pei-Ying; Ko, Chi-Lun] Natl Taiwan Univ Hosp, Dept Nucl Med, Yun Lin Branch, Yunlin, Taiwan; [Hsu, Pei-Ying; Ko, Chi-Lun; Wu, Yen-Wen; Yen, Ruoh-Fang] Natl Taiwan Univ Hosp, Dept Nucl Med, Taipei, Taiwan; [Hsu, Pei-Ying; Ko, Chi-Lun; Wu, Yen-Wen; Yen, Ruoh-Fang] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Chang, Chin-Hao] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan; [Kuo, Yu-Min; Wu, Yen-Wen; Wu, Cheng-Han; Li, Ko-Jen; Hsieh, Song-Chou] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Wu, Yen-Wen] Far Eastern Mem Hosp, Cardiovasc Med Ctr, Cardiol Div, New Taipei, Taiwan; [Wu, Yen-Wen] Far Eastern Mem Hosp, Dept Nucl Med, New Taipei, Taiwan; [Wu, Yen-Wen] Yang Ming Univ, Sch Med, Taipei, Taiwan; [Hsein, Yenh-Chen] Natl Taiwan Univ Hosp, Dept Lab Med, Yun Lin Branch, Yunlin, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital	Hsieh, SC (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan.	hsiehsc@ntu.edu.tw		LI, KO-JEN/0000-0002-4544-4620; YEN, RUOH-FANG/0000-0003-1648-6482; WU, YEN-WEN/0000-0003-1520-1166; Lin, Ting-Syuan/0000-0002-2101-0887	National Taiwan University Hospital, Yun-Lin Branch [NTUHYL104.I004]	National Taiwan University Hospital, Yun-Lin Branch	Funded by research grant from National Taiwan University Hospital, Yun-Lin Branch Grant number:NTUHYL104.I004 to TSL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alic L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110300; Brey RL, 2011, LUPUS, V20, P153, DOI 10.1177/0961203310396748; Buvat I, 2015, J NUCL MED, V56, P1642, DOI 10.2967/jnumed.115.163469; CHANG LT, 1978, IEEE T NUCL SCI, V25, P638, DOI 10.1109/TNS.1978.4329385; Chapman J, 2003, LUPUS, V12, P514, DOI 10.1191/0961203303lu392oa; Clark CA, 2001, J RHEUMATOL, V28, P1939; Erkan D, 2014, NAT REV RHEUMATOL, V10, P266, DOI 10.1038/nrrheum.2014.39; Erkan D, 2013, ARTHRITIS RHEUM-US, V65, P464, DOI 10.1002/art.37759; Espinosa G, 2015, NAT REV RHEUMATOL, V11, P586, DOI 10.1038/nrrheum.2015.88; Giannakopoulos B, 2013, NEW ENGL J MED, V368, P1033, DOI 10.1056/NEJMra1112830; Giannakopoulos B, 2009, BLOOD, V113, P985, DOI 10.1182/blood-2007-12-129627; Gomez-Puerta JA, 2014, J AUTOIMMUN, V48-49, P20, DOI 10.1016/j.jaut.2014.01.006; Kim DH, 2015, CLIN NUCL MED, V40, P708, DOI 10.1097/RLU.0000000000000867; Kozora E, 2014, CLIN EXP RHEUMATOL, V32, P34; Lim W, 2011, CURR OPIN HEMATOL, V18, P361, DOI 10.1097/MOH.0b013e3283497f3e; Meroni PL, 2011, NAT REV RHEUMATOL, V7, P330, DOI 10.1038/nrrheum.2011.52; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Modzelewski R, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-40; Mustonen T, 2008, J NEUROL NEUROSUR PS, V79, P1128, DOI 10.1136/jnnp.2007.142851; Mustonen T, 2006, NUCL MED COMMUN, V27, P157, DOI 10.1097/01.mnm.0000194399.04820.31; Oku K, 2014, LUPUS, V23, P1269, DOI 10.1177/0961203314537361; Pengo V, 2011, BLOOD, V118, P4714, DOI 10.1182/blood-2011-03-340232; Rand JH, 2011, BLOOD, V117, P6743, DOI 10.1182/blood-2011-04-346734; Roldan Jose F, 2007, Curr Rheumatol Rep, V9, P109, DOI 10.1007/s11926-007-0004-3; Romanowicz G, 2000, Nucl Med Rev Cent East Eur, V3, P17; Rovaris M, 2001, Curr Rheumatol Rep, V3, P301, DOI 10.1007/s11926-001-0034-1; Ruffatti A, 2011, ANN RHEUM DIS, V70, P1083, DOI 10.1136/ard.2010.142042; Sanna G, 2003, RHEUMATOLOGY, V42, P200, DOI 10.1093/rheumatology/keg080; Sciascia S, 2013, RHEUMATOLOGY, V52, P1397, DOI 10.1093/rheumatology/kes388; Sun SS, 2003, RHEUMATOL INT, V23, P301, DOI 10.1007/s00296-003-0314-3; Urbanus RT, 2009, LANCET NEUROL, V8, P998, DOI 10.1016/S1474-4422(09)70239-X; Volkow ND, 2002, PSYCHIAT RES-NEUROIM, V114, P39, DOI 10.1016/S0925-4927(01)00130-5; Ziessman HA., 2013, NUCL MED REQUISITES, V4th ed., P350	33	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0182344	10.1371/journal.pone.0182344	http://dx.doi.org/10.1371/journal.pone.0182344			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763503	Green Published, Green Submitted, gold			2022-12-26	WOS:000406766500062
J	Castillo, DS; Cassola, A				Castillo, Daniela S.; Cassola, Alejandro			Novel sensitive monoclonal antibody based competitive enzyme-linked immunosorbent assay for the detection of raw and processed bovine beta-casein	PLOS ONE			English	Article							COWS MILK ALLERGY; PROTEIN ALLERGY; FOOD ALLERGY; ALLERGENICITY; DIAGNOSIS; EXTRACTION; CHILDREN; ELISA; IDENTIFICATION; VALIDATION	Cow milk protein allergy (CMPA) is the most common childhood food allergy, which can sometimes persist or can newly develop in adulthood with severe symptoms. CMPA's treatment is complete dietary avoidance of milk proteins. To achieve this task, patients have to be aware of milk proteins found as "hidden allergens" in food commodities. In regard to milk proteins, it has been reported that allergenicity of caseins remains unaffected upon heat treatment. For these reasons, we aimed to obtain monoclonal antibodies (mAbs) against native and denatured beta-casein, one of the most abundant and antigenic caseins, in order to develop an indirect competitive ELISA (icELISA) to detect and quantify traces of this milk allergen in raw and processed foodstuffs. We developed two specific hybridoma clones, 1H3 and 6A12, which recognized beta-casein in its denatured and native conformations by indirect ELISA (iELISA). Cross-reaction analysis by Western blot and iELISA indicated that these mAbs specifically recognized beta-casein from bovine and goat milk extracts, while they did not cross-react with proteins present in other food matrixes. These highly specific mAbs enabled the development of sensitive, reliable and reproducible icELISAs to detect and quantify this milk protein allergen in food commodities. The extraction of beta-casein from foodstuff was efficiently carried out at 60 degrees C for 15 minutes, using an extraction buffer containing 1% SDS. The present study establishes a valid 1H3 based-icELISA, which allows the detection and quantification -0.29 ppm and 0.80 ppm, respectively-of small amounts of beta-casein in raw and processed foods. Furthermore, we were able to detect milk contamination in incurred food samples with the same sensitivity as a commercial sandwich ELISA thus showing that this icELISA constitutes a reliable analytical method for control strategies in food industry and allergy prevention.	[Castillo, Daniela S.; Cassola, Alejandro] Univ Nacl San Martin UNSAM, Consejo Nacl Invest Cient & Tecn CONICET, Inst Tecnol Chascomus IIB INTECH, Inst Invest Biotecnol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Cassola, A (corresponding author), Univ Nacl San Martin UNSAM, Consejo Nacl Invest Cient & Tecn CONICET, Inst Tecnol Chascomus IIB INTECH, Inst Invest Biotecnol, Buenos Aires, DF, Argentina.	acassola@iibintech.com.ar		Cassola, Alejandro/0000-0001-7366-5327	Fondo para la Investigacion Cientifica y Tecnologica [2013-1707]	Fondo para la Investigacion Cientifica y Tecnologica	This study was supported by Fondo para la Investigacion Cientifica y Tecnologica, award number 2013-1707 to Alejandro Cassola. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott M, 2010, J AOAC INT, V93, P442; Andersen KK, 2009, J MOL BIOL, V391, P207, DOI 10.1016/j.jmb.2009.06.019; Baker M, 2015, NATURE, V521, P274, DOI 10.1038/521274a; Bengtsson U, 1996, GUT, V39, P130, DOI 10.1136/gut.39.1.130; Bernard H, 1998, INT ARCH ALLERGY IMM, V115, P235, DOI 10.1159/000023906; Besler M, 2001, J CHROMATOGR B, V756, P207, DOI 10.1016/S0378-4347(01)00110-4; Bloom KA, 2014, PEDIAT ALLERG IMM-UK, V25, P740, DOI 10.1111/pai.12283; Caffarelli C, 2010, ITAL J PEDIATR, V36, DOI 10.1186/1824-7288-36-5; Docena GH, 1996, ALLERGY, V51, P412, DOI 10.1111/j.1398-9995.1996.tb04639.x; DREBORG S, 1995, PEDIAT ALLERG IMM-UK, V6, P22, DOI 10.1111/j.1399-3038.1995.tb00380.x; du Toit G, 2010, ARCH DIS CHILDHOOD-E, V95, P134, DOI 10.1136/adc.2007.118018; Farrell HM, 2001, FOOD HYDROCOLLOID, V15, P341, DOI 10.1016/S0268-005X(01)00080-7; Fiocchi A, 2010, J ALLERGY CLIN IMMUN, V126, P1119, DOI 10.1016/j.jaci.2010.10.011; Goding J.W., 1996, MONOCLONAL ANTIBODIE; Hochwallner H, 2014, METHODS, V66, P22, DOI 10.1016/j.ymeth.2013.08.005; Holt C, 2013, J DAIRY SCI, V96, P6127, DOI 10.3168/jds.2013-6831; Isolauri E, 1996, J ALLERGY CLIN IMMUN, V97, P9, DOI 10.1016/S0091-6749(96)70277-4; Ito K, 2016, ANAL BIOANAL CHEM, V408, P5973, DOI 10.1007/s00216-016-9438-7; Jimenez-Saiz R, 2015, CRIT REV FOOD SCI, V55, P1902, DOI 10.1080/10408398.2012.736435; Koppelman SJ, 2006, WOODHEAD PUBL FOOD S, P1; Lam HY, 2008, CLIN EXP ALLERGY, V38, P995, DOI 10.1111/j.1365-2222.2008.02968.x; Lamothe S, 2007, J DAIRY SCI, V90, P5380, DOI 10.3168/jds.2007-0488; Ludman S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5424; Mills ENC, 2008, CURR OPIN ALLERGY CL, V8, P249, DOI 10.1097/ACI.0b013e3282ffb123; Nation U., GLOBALLY HARMONIZED; Norgaard A, 1996, J ALLERGY CLIN IMMUN, V97, P218; Ossowski S, 2012, LANGMUIR, V28, P13577, DOI 10.1021/la302416p; Parker CH, 2015, J AGR FOOD CHEM, V63, P10669, DOI 10.1021/acs.jafc.5b04287; Patrick W, 2009, J AGR FOOD CHEM, V57, P8399, DOI 10.1021/jf9013982; Pelto L, 1999, EUR J CLIN NUTR, V53, P620, DOI 10.1038/sj.ejcn.1600819; Prado M, 2016, CRIT REV FOOD SCI, V56, P2511, DOI 10.1080/10408398.2013.873767; Restani P, 1999, CLIN EXP ALLERGY, V29, P997, DOI 10.1046/j.1365-2222.1999.00563.x; Restani P, 2009, ANAL BIOANAL CHEM, V395, P47, DOI 10.1007/s00216-009-2909-3; Saarinen KM, 2005, J ALLERGY CLIN IMMUN, V116, P869, DOI 10.1016/j.jaci.2005.06.018; Sharma S, 2001, J CHROMATOGR B, V756, P183, DOI 10.1016/S0378-4347(01)00107-4; Sicherer SH, 2014, J ALLERGY CLIN IMMUN, V133, P291, DOI 10.1016/j.jaci.2013.11.020; Solinas C, 2010, J MATERN-FETAL NEO M, V23, P76, DOI 10.3109/14767058.2010.512103; Steinhoff M, 2011, FOOD ADDIT CONTAM A, V28, P373, DOI 10.1080/19440049.2010.545957; Thomas K, 2007, FOOD CHEM TOXICOL, V45, P1116, DOI 10.1016/j.fct.2006.12.016; Tsabouri S, 2014, ENDOCR METAB IMMUNE, V14, P16, DOI 10.2174/1871530314666140121144224; Turnbull JL, 2015, ALIMENT PHARM THER, V41, P3, DOI 10.1111/apt.12984; Uhlen M, 2016, NAT METHODS, V13, P823, DOI [10.1038/nmeth.3995, 10.1038/NMETH.3995]; Vandenplas Y, 2007, EUR J PEDIATR, V166, P1211, DOI 10.1007/s00431-007-0497-9; Watanabe Y, 2005, J IMMUNOL METHODS, V300, P115, DOI 10.1016/j.jim.2005.02.014; Yousefi R, 2009, BIOPOLYMERS, V91, P623, DOI 10.1002/bip.21190	45	14	14	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0182447	10.1371/journal.pone.0182447	http://dx.doi.org/10.1371/journal.pone.0182447			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759641	Green Published, Green Submitted, gold			2022-12-26	WOS:000406761600076
J	Ip, FCF; Ng, YP; Or, TCT; Sun, PR; Fu, GM; Li, JYH; Ye, WC; Cheung, TH; Ip, NY				Ip, Fanny C. F.; Ng, Yu Pong; Or, Terry C. T.; Sun, Peiran; Fu, Guangmiao; Li, Jessica Y. H.; Ye, Wen-Cai; Cheung, Tom H.; Ip, Nancy Y.			Anemoside A(3) ameliorates experimental autoimmune encephalomyelitis by modulating T helper 17 cell response	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; TANDEM MASS-SPECTROMETRY; CENTRAL-NERVOUS-SYSTEM; CHINENSIS BUNGE REGEL; MULTIPLE-SCLEROSIS; PULSATILLA-CHINENSIS; MOUSE MODELS; T(H)17 CELL; TH17 CELLS; IN-VITRO	Anemoside A(3) (AA3) is a natural triterpenoid glycoside isolated from the root of Pulsatilla chinensis (Bunge) Regel. We previously showed that AA3 exhibits cognitive-enhancing and neuroprotective properties. In the present study, we demonstrated that AA3 modulates inflammatory responses by regulating prostaglandin E receptor 4 signaling. Because prostaglandin E receptor 4 is involved in the pathophysiology of experimental autoimmune encephalomyelitis (EAE), an animal model of human multiple sclerosis (MS), we assessed the beneficial effect of AA3 in EAE mice. AA3 treatment significantly reduced clinical severity and inflammatory infiltrates in the spinal cord of EAE mice. In vitro studies revealed that AA3 inhibited the T cell response toward the encephalitogenic epitope of myelin oligodendrocyte glycoprotein (MOG). AA3 significantly downregulated the expressions of certain Th1 and Th17 cytokines in activated T cells re-stimulated by MOG. Moreover, AA3 inhibited the activation of STAT4 and STAT3, which are the transcription factors pivotal for Th1 and Th17 lineage differentiation, respectively, in activated T cells. Pharmacological analysis further suggested that AA3 reduced Th17 cell differentiation and expansion. In conclusion, AA3 exerts an immunomodulatory effect in EAE, demonstrating its potential as a therapeutic agent for MS in humans.	[Ip, Fanny C. F.; Ng, Yu Pong; Or, Terry C. T.; Sun, Peiran; Fu, Guangmiao; Li, Jessica Y. H.; Cheung, Tom H.; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; [Ip, Fanny C. F.; Sun, Peiran; Fu, Guangmiao; Cheung, Tom H.; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Hong Kong, Hong Kong, Peoples R China; [Ip, Fanny C. F.; Ng, Yu Pong; Or, Terry C. T.; Sun, Peiran; Cheung, Tom H.; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Hong Kong, Hong Kong, Peoples R China; [Ip, Fanny C. F.; Ip, Nancy Y.] HKUST Shenzhen Res Inst, Guangdong Prov Key Lab Brain Sci Dis & Drug Dev, Shenzhen, Guangdong, Peoples R China; [Ip, Fanny C. F.; Ye, Wen-Cai; Ip, Nancy Y.] Jinan Univ, HKUST Jinan Joint Lab Innovat Drug Discovery, Guangzhou, Guangdong, Peoples R China; [Ye, Wen-Cai] Jinan Univ, Coll Pharm, Inst Tradit Chinese Med & Nat Prod, Guangzhou, Guangdong, Peoples R China; [Ye, Wen-Cai] Jinan Univ, Guangdong Prov Key Lab Pharmacodynam Constituents, Guangzhou, Guangdong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Jinan University; Jinan University; Jinan University	Ip, NY (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China.; Ip, NY (corresponding author), Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Hong Kong, Hong Kong, Peoples R China.; Ip, NY (corresponding author), Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Hong Kong, Hong Kong, Peoples R China.; Ip, NY (corresponding author), HKUST Shenzhen Res Inst, Guangdong Prov Key Lab Brain Sci Dis & Drug Dev, Shenzhen, Guangdong, Peoples R China.; Ip, NY (corresponding author), Jinan Univ, HKUST Jinan Joint Lab Innovat Drug Discovery, Guangzhou, Guangdong, Peoples R China.	boip@ust.hk		Ip, Nancy Yuk-Yu/0000-0002-2763-8907	National Key Basic Research Program of China [2013CB530900]; Hong Kong Research Grants Council Theme-based Research Scheme [T13-607/12R]; Innovation and Technology Fund [ITS/179/11FP]; Shenzhen Peacock Plan; S. H. Ho Foundation	National Key Basic Research Program of China(National Basic Research Program of China); Hong Kong Research Grants Council Theme-based Research Scheme(Hong Kong Research Grants Council); Innovation and Technology Fund; Shenzhen Peacock Plan; S. H. Ho Foundation	This study was supported in part by the National Key Basic Research Program of China (2013CB530900), the Hong Kong Research Grants Council Theme-based Research Scheme (T13-607/12R), the Innovation and Technology Fund (ITS/179/11FP), the Shenzhen Peacock Plan, and the S. H. Ho Foundation to NYI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JI, 2011, BBA-MOL BASIS DIS, V1812, P252, DOI 10.1016/j.bbadis.2010.06.017; Anderton SM, 2015, BIOMED J, V38, P206, DOI 10.4103/2319-4170.158510; Ano S, 2013, J IMMUNOL, V190, P1056, DOI 10.4049/jimmunol.1202386; Baker D, 2015, CURR PHARM DESIGN, V21, P2440, DOI 10.2174/1381612821666150316122706; Bridel C, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.14012; Butti E, 2008, GENE THER, V15, P504, DOI 10.1038/gt.2008.10; Chamberlain KA, 2016, NEUROPHARMACOLOGY, V110, P633, DOI 10.1016/j.neuropharm.2015.10.010; Cheng L, 2008, RAPID COMMUN MASS SP, V22, P3783, DOI 10.1002/rcm.3801; Cheng Y, 2017, J NEUROSCI RES; Chitnis T, 2001, J CLIN INVEST, V108, P739, DOI 10.1172/JCI200112563; Cudaback E, 2014, BIOCHEM PHARMACOL, V88, P565, DOI 10.1016/j.bcp.2013.12.014; Degenhardt A, 2009, NAT REV NEUROL, V5, P672, DOI 10.1038/nrneurol.2009.178; DeLuca GC, 2015, BRAIN PATHOL, V25, P79, DOI 10.1111/bpa.12220; El-behi M, 2010, J NEUROIMMUNE PHARM, V5, P189, DOI 10.1007/s11481-009-9188-9; English C, 2015, CLIN THER, V37, P691, DOI 10.1016/j.clinthera.2015.03.001; Esaki Y, 2010, P NATL ACAD SCI USA, V107, P12233, DOI 10.1073/pnas.0915112107; Farooq SM, 2013, CNS NEUROSCI THER, V19, P503, DOI 10.1111/cns.12087; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; Fletcher JM, 2009, J IMMUNOL, V183, P7602, DOI 10.4049/jimmunol.0901881; Forbes E, 2010, IMMUNOL CELL BIOL, V88, P240, DOI 10.1038/icb.2009.101; Franklin RJM, 2012, NAT REV NEUROL, V8, P624, DOI 10.1038/nrneurol.2012.200; Gao XD, 2003, PLANTA MED, V69, P171, DOI 10.1055/s-2003-37705; Gharibi T, 2015, CELL IMMUNOL, V293, P113, DOI 10.1016/j.cellimm.2015.01.002; Hemmer B, 2002, NAT REV NEUROSCI, V3, P291, DOI 10.1038/nrn784; Hirahara K, 2010, CYTOKINE GROWTH F R, V21, P425, DOI 10.1016/j.cytogfr.2010.10.006; Ip FCF, 2015, NEUROPSYCHOPHARMACOL, V40, P1877, DOI 10.1038/npp.2015.37; Kawahara K, 2015, BBA-MOL CELL BIOL L, V1851, P414, DOI 10.1016/j.bbalip.2014.07.008; Kihara Y, 2009, P NATL ACAD SCI USA, V106, P21807, DOI 10.1073/pnas.0906891106; Kipp M, 2012, MULT SCLER RELAT DIS, V1, P15, DOI 10.1016/j.msard.2011.09.002; Kohm AP, 2005, J IMMUNOL, V174, P4525, DOI 10.4049/jimmunol.174.8.4525; Lovett-Racke AE, 2011, BBA-MOL BASIS DIS, V1812, P246, DOI 10.1016/j.bbadis.2010.05.012; Mahad DH, 2015, LANCET NEUROL, V14, P183, DOI 10.1016/S1474-4422(14)70256-X; Maier E, 2012, EUR J IMMUNOL, V42, P2827, DOI 10.1002/eji.201242433; Mirza A., 2017, CLIN IMMUNOL; Miyamoto K, 2006, BRAIN, V129, P1984, DOI 10.1093/brain/awl170; MORA JS, 1984, NEW ENGL J MED, V310, P126; Morishima N, 2009, BIOCHEM BIOPH RES CO, V386, P105, DOI 10.1016/j.bbrc.2009.05.140; Muthian G, 2006, J CLIN IMMUNOL, V26, P73, DOI 10.1007/s10875-006-8787-y; Nagashima H, 2014, NAT IMMUNOL, V15, P449, DOI 10.1038/ni.2863; Ni J, 2007, J NEUROIMMUNOL, V186, P94, DOI 10.1016/j.jneuroim.2007.03.012; Olsen JA, 2015, J NEUROSCI RES, V93, P687, DOI 10.1002/jnr.23493; Palumbo S, 2013, PROSTAG LEUKOTR ESS, V89, P273, DOI 10.1016/j.plefa.2013.08.008; Pinheiro MAL, 2016, BBA-MOL BASIS DIS, V1862, P461, DOI 10.1016/j.bbadis.2015.10.018; Popescu Bogdan F Gh, 2013, Continuum (Minneap Minn), V19, P901, DOI 10.1212/01.CON.0000433291.23091.65; Reess J, 2002, MULT SCLER, V8, P15; Rio J, 2004, NEUROLOGY, V63, P525, DOI 10.1212/01.WNL.0000133206.44931.25; Rostami A, 2013, J NEUROL SCI, V333, P76, DOI 10.1016/j.jns.2013.03.002; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Tutuncu M, 2015, PLOS ONE, V10; Ulges A, 2016, P NATL ACAD SCI USA, V113, P10145, DOI 10.1073/pnas.1523869113; Xu HJ, 2011, ANAL BIOCHEM, V419, P323, DOI 10.1016/j.ab.2011.08.045; Xu HJ, 2011, J SEP SCI, V34, P308, DOI 10.1002/jssc.201000660; Yadav SK, 2015, CURR OPIN NEUROL, V28, P206, DOI 10.1097/WCO.0000000000000205; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; Ye WC, 1996, PHYTOCHEMISTRY, V42, P799, DOI 10.1016/0031-9422(96)00043-X; Zhang DM, 2010, PLANTA MED, V76, P1814, DOI 10.1055/s-0030-1250003; Zheng YT, 2010, J ETHNOPHARMACOL, V128, P615, DOI 10.1016/j.jep.2010.02.004	58	13	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0182069	10.1371/journal.pone.0182069	http://dx.doi.org/10.1371/journal.pone.0182069			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759648	Green Published, Green Submitted, gold			2022-12-26	WOS:000406761600048
J	Liu, MM; Farkas, M; Spinnhirny, P; Pevet, P; Pierce, E; Hicks, D; Zack, DJ				Liu, Melissa M.; Farkas, Michael; Spinnhirny, Perrine; Pevet, Paul; Pierce, Eric; Hicks, David; Zack, Donald J.			De novo assembly and annotation of the retinal transcriptome for the Nile grass rat (Arvicanthis ansorgei)	PLOS ONE			English	Article							RNA-SEQ DATA; RODENT MODEL; SEQUENCE; DIVERSITY; MURIDAE	Cone photoreceptors are required for color vision and high acuity vision, and they die in a variety of retinal degenerations, leading to irreversible vision loss and reduced quality of life. To date, there are no approved therapies that promote the health and survival of cones. The development of novel treatments targeting cones has been challenging and impeded, in part, by the limitations inherent in using common rodent model organisms, which are nocturnal and rod-dominant, to study cone biology. The African Nile grass rat (Arvicanthis ansorgei), a diurnal animal whose photoreceptor population is more than 30% cones, offers significant potential as a model organism for the study of cone development, biology, and degeneration. However, a significant limitation in using the A. ansorgei retina for molecular studies is that A. ansorgei does not have a sequenced genome or transcriptome. Here we present the first de novo assembled and functionally annotated transcriptome for A. ansorgei. We performed RNA sequencing for A. ansorgei whole retina to a depth of 321 million pairs of reads and assembled 400,584 Trinity transcripts. Transcriptome-wide analyses and annotations suggest that our data set confers nearly full length coverage for the majority of retinal transcripts. Our high quality annotated transcriptome is publicly available, and we hope it will facilitate wider usage of A. ansorgei as a model organism for molecular studies of cone biology and retinal degeneration.	[Liu, Melissa M.; Zack, Donald J.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA; [Farkas, Michael] Univ Buffalo, Dept Ophthalmol, Jacobs Sch Med & Biomed Sci, Buffalo, NY USA; [Farkas, Michael] Vet Adm Western New York Healthcare Syst, Res Serv, Buffalo, NY USA; [Spinnhirny, Perrine; Pevet, Paul; Hicks, David] CNRS, UPR3212, Inst Neurosci Cellulaires & Integrat, Strasbourg, France; [Pierce, Eric] Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Ocular Genom Inst, Boston, MA 02114 USA; [Zack, Donald J.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Zack, Donald J.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Zack, Donald J.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Zack, Donald J.] Univ Paris 06, Inst Vis, Paris, France	Johns Hopkins University; Johns Hopkins Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Harvard University; Massachusetts Eye & Ear Infirmary; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; UDICE-French Research Universities; Sorbonne Universite	Zack, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA.; Hicks, D (corresponding author), CNRS, UPR3212, Inst Neurosci Cellulaires & Integrat, Strasbourg, France.; Zack, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.; Zack, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.; Zack, DJ (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.; Zack, DJ (corresponding author), Univ Paris 06, Inst Vis, Paris, France.	photoreceptor67@hotmail.com; donzack@gmail.com		Liu, Melissa/0000-0002-4385-9507	National Institutes of Health [EY009769, EY020902, P30EY001765, P30EY014104, T32EY007143]; Foundation Fighting Blindness; Prevent Blindness, Inc.; Guerrieri Family Foundation; State of Maryland through The Institute for Data Intensive Engineering and Science (IDIES); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); Guerrieri Family Foundation; State of Maryland through The Institute for Data Intensive Engineering and Science (IDIES); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (EY009769, EY020902, P30EY001765, P30EY014104, and T32EY007143, https://www.nih.gov/) and the Foundation Fighting Blindness (http://www.blindriess.org/), unrestricted funds from Research to Prevent Blindness, Inc. (https://www.rpbusa.org), and generous gifts from the Guerrieri Family Foundation and from Mr. and Mrs. Robert and Clarice Smith. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Some of the computation work was performed on the Maryland Advanced Research Computing Center (MARCC), which is supported by a State of Maryland grant to Johns Hopkins University through The Institute for Data Intensive Engineering and Science (IDIES). The authors would also like to thank the members of the Genomics Core of the Ocular Genomics Institute at Mass Eye and Ear for their experimental assistance.	Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Bobu C, 2006, INVEST OPHTH VIS SCI, V47, P3109, DOI 10.1167/iovs.05-1397; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boudard DL, 2010, NEUROSCIENCE, V169, P1815, DOI 10.1016/j.neuroscience.2010.06.037; Caldelas I, 2003, NEUROSCIENCE, V116, P583, DOI 10.1016/S0306-4522(02)00654-1; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Castiglia R, 2006, J ZOOL SYST EVOL RES, V44, P223, DOI 10.1111/j.1439-0469.2006.00356.x; Dobigny G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077815; Ducroz JF, 1998, MOL PHYLOGENET EVOL, V10, P104, DOI 10.1006/mpev.1997.0477; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Farkas MH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-486; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Merriman DK, 2012, LAB ANIMAL, V41, P315, DOI 10.1038/laban.150; Mustafi D, 2016, HUM MOL GENET, V25, P4376, DOI 10.1093/hmg/ddw268; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Powell S, 2014, NUCLEIC ACIDS RES, V42, pD231, DOI 10.1093/nar/gkt1253; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; SZEL A, 1992, EXP EYE RES, V55, P47; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Van Hooser SD, 2006, VISUAL NEUROSCI, V23, P765, DOI 10.1017/S0952523806230098	31	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0179061	10.1371/journal.pone.0179061	http://dx.doi.org/10.1371/journal.pone.0179061			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759564	Green Submitted, Green Published, gold			2022-12-26	WOS:000406761600004
J	Vitale, ML; Garcia, CJ; Akpovi, CD; Pelletier, RM				Vitale, Maria Leiza; Garcia, Christopher J.; Akpovi, Casimir D.; Pelletier, R. -Marc			Distinctive actions of connexin 46 and connexin 50 in anterior pituitary folliculostellate cells	PLOS ONE			English	Article							INTERCELLULAR COMMUNICATION; GAP-JUNCTION; STELLATE CELLS; POSTNATAL-DEVELOPMENT; SEASONAL BREEDER; GROWTH-HORMONE; GERM-CELL; EXPRESSION; PROTEIN; LEPTIN	Folliculostellate cell gap junctions establish a network for the transmission of information within the anterior pituitary. Connexins make up gap junction channels. Changes in connexin (Cx) turnover modify gap junction-mediated intercellular communication. We have reported that cytokines and hormones influence Cx43 turnover and coupling in folliculostellate cells and in the folliculostellate cell line TtT/GF. In addition, the expression of different connexins alters intercellular communication and connexins may have functions besides cell coupling. Here we assessed the expression, turnover and subcellular localization of Cx46 and Cx50 in the anterior pituitary and TtT/GF cells. Then, we assessed the impact of various natural (lactation, annual reproductive cycle, bFGF) and pathological (autoimmune orchitis, diabetes/obesity) conditions associated with altered anterior pituitary hormone secretion on Cx46 and Cx50. Anterior pituitary Cx46 and Cx50 expression and subcellular distribution were cell-dependent. Cx46 was expressed by folliculostellate, TtT/GF and endocrine cells. In the cytoplasm, Cx46 was chiefly associated with lysosomes. Variously sized Cx46 molecules were recovered exclusively in the TtT/GF cell nuclear fraction. In the nucleus, Cx46 co-localized with Nopp-140, a nucleolar factor involved in rRNA processing. Neither cytoplasmic nor nuclear Cx46 and Cx43 co-localized. Cx50 localized to folliculostellate and TtT/GF cells, and to the walls of blood capillaries, not to endocrine cells. Cx50 was cytoplasmic and associated with the cell membrane, not nuclear. Cx50 did not co-localize with Cx46 but it co-localized in the cytoplasm and co-immunoprecipitated with Cx43. Cx46 and Cx50 responses to various physiological and pathological challenges were different, often opposite. Cx46 and Cx43 expression and phosphorylation profiles differed in the anterior pituitary, whereas Cx50 and Cx43 were similar. The data suggest that Cx46 participates to cellular growth and proliferation and that Cx50, together with Cx43, contributes to folliculostellate cell coupling.	[Vitale, Maria Leiza; Garcia, Christopher J.; Akpovi, Casimir D.; Pelletier, R. -Marc] Univ Montreal, Fac Med, Dept Pathol & Biol Cellulaire, Montreal, PQ, Canada	Universite de Montreal	Vitale, ML (corresponding author), Univ Montreal, Fac Med, Dept Pathol & Biol Cellulaire, Montreal, PQ, Canada.	maria.leiza.vitale@umontreal.ca			Natural Sciences and Engineering Research Council of Canada [OGP0194652, OGP0041653]; Diabete Quebec	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Diabete Quebec	This work was supported by Natural Sciences and Engineering Research Council of Canada Grants OGP0194652 (to M. L. Vitale) and OGP0041653 (to R.-M. Pelletier): www.nserc-crsng.ca. R.-M Pelletier and ML Vitale received start up funds from Diabete Quebec: www.diabete.gc.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham V, 2001, AM J PHYSIOL-LUNG C, V280, pL1085, DOI 10.1152/ajplung.2001.280.6.L1085; Accorsi PA, 2007, J DAIRY SCI, V90, P1683, DOI 10.3168/jds.2006-611; Allaerts W, 2005, EUR J ENDOCRINOL, V153, P1, DOI 10.1530/eje.1.01949; Avanzo JL, 2006, LIFE SCI, V79, P2202, DOI 10.1016/j.lfs.2006.07.033; Banerjee D, 2011, J BIOL CHEM, V286, P24519, DOI 10.1074/jbc.M110.217208; Banerjee D, 2010, INT J CANCER, V127, P839, DOI 10.1002/ijc.25107; Barash IA, 1996, ENDOCRINOLOGY, V137, P3144, DOI 10.1210/en.137.7.3144; Bellini M, 1999, MOL BIOL CELL, V10, P3425, DOI 10.1091/mbc.10.10.3425; Cardin J, 2000, GEN COMP ENDOCR, V120, P75, DOI 10.1006/gcen.2000.7535; Chi NC, 2010, P NATL ACAD SCI USA, V107, P14662, DOI 10.1073/pnas.0909432107; Comninos AN, 2014, HUM REPROD UPDATE, V20, P153, DOI 10.1093/humupd/dmt033; Console GM, 1999, APPL IMMUNOHISTO M M, V7, P142, DOI 10.1097/00129039-199906000-00007; Culjkovic B, 2006, J CELL BIOL, V175, P415, DOI 10.1083/jcb.200607020; Das Sarma J, 2001, J CELL SCI, V114, P4013; Das S, 2011, CURR EYE RES, V36, P620, DOI 10.3109/02713683.2011.573899; Dbouk HA, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-4; deFeijter AW, 1996, MOL CARCINOGEN, V16, P203, DOI 10.1002/(SICI)1098-2744(199608)16:4<203::AID-MC4>3.3.CO;2-F; Dermietzel R, 2000, BRAIN RES REV, V32, P45, DOI 10.1016/S0165-0173(99)00067-3; DeRosa AM, 2005, GAP JUNCTIONS IN DEVELOPMENT AND DISEASE, P173, DOI 10.1007/3-540-28621-7_8; Dunia I, 2006, EUR J CELL BIOL, V85, P729, DOI 10.1016/j.ejcb.2006.03.006; Ernst A, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.42; Evans WH, 2002, MOL MEMBR BIOL, V19, P121, DOI 10.1080/09687680210139839; FARQUHAR MG, 1957, ANAT REC, V127, P291; FLETCHER WH, 1975, J CELL BIOL, V67, P469, DOI 10.1083/jcb.67.2.469; Fortin ME, 2006, BIOL REPROD, V74, P2, DOI 10.1095/biolreprod.105.044313; Ganesan S, 2015, TOXICOL APPL PHARM, V282, P1, DOI 10.1016/j.taap.2014.10.020; Haedo MR, 2009, HORM RES, V72, P266, DOI 10.1159/000245928; He F, 2011, OLSON MOJ, P253; Herve JC, 2007, J MEMBRANE BIOL, V217, P21, DOI 10.1007/s00232-007-9054-8; Hoang QV, 2010, MOL VIS, V16, P1343; Huang RP, 1998, CANCER RES, V58, P5089; Inoue K, 1999, ARCH HISTOL CYTOL, V62, P205, DOI 10.1679/aohc.62.205; INOUE K, 1992, ENDOCRINOLOGY, V131, P3110, DOI 10.1210/en.131.6.3110; Kabbaj O, 2003, BIOL REPROD, V68, P722, DOI 10.1095/biolreprod.102.008169; Kardami E, 2007, PROG BIOPHYS MOL BIO, V94, P245, DOI 10.1016/j.pbiomolbio.2007.03.009; Koval M, 1997, J CELL BIOL, V137, P847, DOI 10.1083/jcb.137.4.847; Laird DW, 2010, TRENDS CELL BIOL, V20, P92, DOI 10.1016/j.tcb.2009.11.001; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; LARSON BA, 1976, ENDOCRINOLOGY, V98, P139, DOI 10.1210/endo-98-1-139; Lin D, 2004, MOL VIS, V10, P688; Liu JL, 2011, J BIOL CHEM, V286, P16914, DOI 10.1074/jbc.M111.218735; Lyles D, 2010, J NEUROENDOCRINOL, V22, P1267, DOI 10.1111/j.1365-2826.2010.02084.x; McLeod T, 2014, BIOCHEM SOC T, V42, P1224, DOI 10.1042/BST20140062; Meilleur MA, 2007, ENDOCRINOLOGY, V148, P5913, DOI 10.1210/en.2007-0767; Mennecier G, 2011, MOL CARCINOG, V47, P391; Morand I, 1996, ENDOCRINOLOGY, V137, P3356, DOI 10.1210/en.137.8.3356; Morris J., 2011, OPEN NEUROENDOCRINOL, V4, P77; NAKAJIMA T, 1980, BRAIN RES, V191, P523, DOI 10.1016/0006-8993(80)91300-1; Olsnes S, 2003, PHYSIOL REV, V83, P163, DOI 10.1152/physrev.00021.2002; Oyamada M, 2005, BBA-BIOMEMBRANES, V1719, P6, DOI 10.1016/j.bbamem.2005.11.002; Pelletier RM, 2015, AM J PHYSIOL-REG I, V309, pR255, DOI 10.1152/ajpregu.00152.2015; Pelletier RM, 2011, AM J PHYSIOL-REG I, V300, pR121, DOI 10.1152/ajpregu.00500.2010; Pelletier RM, 2009, AM J PHYSIOL-REG I, V296, pR743, DOI 10.1152/ajpregu.90751.2008; PELLETIER RM, 1995, J ANDROL, V16, P400; Pelletier RM, 1999, BIOL REPROD, V60, P1128, DOI 10.1095/biolreprod60.5.1128; PELLETIER RM, 1988, AM J ANAT, V183, P68, DOI 10.1002/aja.1001830105; PELLETIER RM, 1986, AM J ANAT, V175, P91, DOI 10.1002/aja.1001750109; Ponsaerts R, 2010, EXTRACELLULAR ATP AND ADENOSINE AS REGULATORS OF ENDOTHELIAL CELL FUNCTION, P161, DOI 10.1007/978-90-481-3435-9_10; Puller C, 2009, J NEUROSCI, V29, P6266, DOI 10.1523/JNEUROSCI.5867-08.2009; Sakuma E, 2002, ARCH HISTOL CYTOL, V65, P269, DOI 10.1679/aohc.65.269; Sanches DS, 2009, VET PATHOL, V46, P846, DOI 10.1354/vp.08-VP-0263-S-FL; Shearer D, 2008, INVEST OPHTH VIS SCI, V49, P1553, DOI 10.1167/iovs.07-1193; Shirasawa N, 2004, ANAT REC PART A, V278A, P462, DOI 10.1002/ar.a.20040; SHIRASAWA N, 1983, CELL TISSUE RES, V231, P235; SOJI T, 1989, ANAT RECORD, V224, P523, DOI 10.1002/ar.1092240410; SOJI T, 1990, ANAT REC, V226, P337, DOI 10.1002/ar.1092260310; SOJI T, 1991, ANAT REC, V231, P351, DOI 10.1002/ar.1092310309; Solinet S, 2011, HISTOCHEM CELL BIOL, V136, P245, DOI 10.1007/s00418-011-0840-0; STRAUS W, 1982, J HISTOCHEM CYTOCHEM, V30, P491, DOI 10.1177/30.5.6176617; Tartaglia LA, 1997, J BIOL CHEM, V272, P6093, DOI 10.1074/jbc.272.10.6093; Teleki I, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-50; Tipsmark CK, 2008, J ENDOCRINOL, V196, P275, DOI 10.1677/JOE-07-0540; VILAPORCILE E, 1972, Z ZELLFORSCH MIK ANA, V129, P328, DOI 10.1007/BF00307293; Vinken M, 2015, BIOCHIM BIOPHYS ACTA, V1815, P13; Vitale ML, 2015, J NEUROENDOCRINOL, V27, P787, DOI 10.1111/jne.12308; Vitale ML, 2009, MICROSC RES TECHNIQ, V72, P856, DOI 10.1002/jemt.20771; Vitale ML, 2001, BIOL REPROD, V64, P625, DOI 10.1095/biolreprod64.2.625; Vlotides G, 2009, ENDOCRINOLOGY, V150, P3252, DOI 10.1210/en.2008-1625; Wang Z, 2009, EXP EYE RES, V89, P898, DOI 10.1016/j.exer.2009.07.015; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; WILFINGER WW, 1984, TISSUE CELL, V16, P483, DOI 10.1016/0040-8166(84)90026-0; Wright JA, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/496904; YAMAMOTO T, 1993, HISTOCHEMISTRY, V100, P53, DOI 10.1007/BF00268878; Yamasaki H, 1999, C R ACCAD SCI PARIS, V399, P151; Yu WH, 1997, P NATL ACAD SCI USA, V94, P1023, DOI 10.1073/pnas.94.3.1023; Zheng GF, 2005, J MOL HISTOL, V36, P461, DOI 10.1007/s10735-006-9021-1	86	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0182495	10.1371/journal.pone.0182495	http://dx.doi.org/10.1371/journal.pone.0182495			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759642	Green Published, gold, Green Submitted			2022-12-26	WOS:000406761600077
J	Fossion, R; Rivera, AL; Toledo-Roy, JC; Ellis, J; Angelova, M				Fossion, Ruben; Leonor Rivera, Ana; Toledo-Roy, Juan C.; Ellis, Jason; Angelova, Maia			Multiscale adaptive analysis of circadian rhythms and intradaily variability: Application to actigraphy time series in acute insomnia subjects	PLOS ONE			English	Article							EMPIRICAL MODE DECOMPOSITION; ULTRADIAN RHYTHMS; PRACTICE PARAMETERS; ALZHEIMERS-DISEASE; SLEEP-MEDICINE; MOTOR-ACTIVITY; SOCIAL STRESS; DYNAMICS; UPDATE; TEMPERATURE	Circadian rhythms become less dominant and less regular with chronic-degenerative disease, such that to accurately assess these pathological conditions it is important to quantify not only periodic characteristics but also more irregular aspects of the corresponding time series. Novel data-adaptive techniques, such as singular spectrum analysis (SSA), allow for the decomposition of experimental time series, in a model-free way, into a trend, quasiperiodic components and noise fluctuations. We compared SSA with the traditional techniques of cosinor analysis and intradaily variability using 1-week continuous actigraphy data in young adults with acute insomnia and healthy age-matched controls. The findings suggest a small but significant delay in circadian components in the subjects with acute insomnia, i.e. a larger acrophase, and alterations in the day-to-day variability of acrophase and amplitude. The power of the ultradian components follows a fractal 1/f power law for controls, whereas for those with acute insomnia this power law breaks down because of an increased variability at the 90min time scale, reminiscent of Kleitman's basic rest-activity (BRAC) cycles. This suggests that for healthy sleepers attention and activity can be sustained at whatever time scale required by circumstances, whereas for those with acute insomnia this capacity may be impaired and these individuals need to rest or switch activities in order to stay focused. Traditional methods of circadian rhythm analysis are unable to detect the more subtle effects of day-to-day variability and ultradian rhythm fragmentation at the specific 90min time scale.	[Fossion, Ruben; Leonor Rivera, Ana; Toledo-Roy, Juan C.] Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Mexico City 04510, DF, Mexico; [Fossion, Ruben; Leonor Rivera, Ana; Toledo-Roy, Juan C.] Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad, Mexico City 04510, DF, Mexico; [Ellis, Jason] Northumbria Univ, Fac Hlth & Life Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Angelova, Maia] Deakin Univ, Sch Informat Technol, Melbourne Burwood Campus, Burwood, Vic 3125, Australia	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Northumbria University; Deakin University	Fossion, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Mexico City 04510, DF, Mexico.; Fossion, R (corresponding author), Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad, Mexico City 04510, DF, Mexico.	ruben.fossion@nucleares.unam.mx	Angelova, Maia/AAJ-2123-2020; Toledo-Roy, Juan Claudio/N-6666-2019; Rivera, Ana Leonor/B-5062-2010; Toledo-Roy, Juan/G-6071-2019; Fossion, Ruben/X-1682-2019; Nucleares, Instituto/AAK-6270-2020; Rivera, Ana Leonor/L-4433-2019; Ellis, Jason/E-7783-2013	Toledo-Roy, Juan Claudio/0000-0002-0267-3378; Rivera, Ana Leonor/0000-0002-0296-7966; Toledo-Roy, Juan/0000-0002-0267-3378; Fossion, Ruben/0000-0001-8456-2075; Rivera, Ana Leonor/0000-0002-0296-7966; Ellis, Jason/0000-0002-8496-520X; Angelova, Maia/0000-0002-0931-0916	DGAPA-PAPIIT of the Universidad Nacional Autonoma de Mexico [IN106215, IV100116, IA105017]; Consejo Nacional de Ciencia y Tecnologia [2011-01-167441]; Academy of Medical Sciences, through the UK Government's Newton Fund program; Academy of Medical Sciences (AMS) [AMS-NAF1-Fossion] Funding Source: researchfish	DGAPA-PAPIIT of the Universidad Nacional Autonoma de Mexico; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Academy of Medical Sciences, through the UK Government's Newton Fund program; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS))	We acknowledge financial support from DGAPA-PAPIIT of the Universidad Nacional Autonoma de Mexico (project numbers IN106215, IV100116 and IA105017), the Consejo Nacional de Ciencia y Tecnologia (project number CB-2011-01-167441) and the Newton Advanced Fellowship awarded to R.F. by the Academy of Medical Sciences, through the UK Government's Newton Fund program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonmati-Carrion MA, 2014, CHRONOBIOL INT, V31, P37, DOI 10.3109/07420528.2013.820740; Cornelissen G, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-16; Dowse HB, 2009, METHOD ENZYMOL, V454, P141, DOI 10.1016/S0076-6879(08)03806-8; Elsner JB, SINGULAR SPECTRUM AN; Endo Y, 2000, PHYSIOL BEHAV, V71, P263, DOI 10.1016/S0031-9384(00)00339-5; Ericsson KA, 2015, ACAD MED, V90, P1471, DOI 10.1097/ACM.0000000000000939; Fossion R, 2014, AIP CONF PROC, V1575, P89, DOI 10.1063/1.4861700; Frank E, 2014, ANN NY ACAD SCI, V1334, P1, DOI 10.1111/nyas.12600; Ghil M, 2002, REV GEOPHYS, V40, DOI 10.1029/2000RG000092; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Golyandina N., ANAL TIME SERIES STR; Golyandina N, SPRINGER BRIEFS STAT; Goncalves BSB, 2015, SLEEP MED REV, V20, P84, DOI 10.1016/j.smrv.2014.06.002; Goncalves BSB, 2014, NONPARAMETRIC METHOD, P158; Gorka Z, 1996, PHARMACOL BIOCHEM BE, V54, P229, DOI 10.1016/0091-3057(95)02173-6; GRAU C, 1995, PHYSIOL BEHAV, V57, P411, DOI 10.1016/0031-9384(94)00274-9; Halberg F., 1967, CELLULAR ASPECTS BIO, P20, DOI DOI 10.1007/978-3-642-88394-1; Halberg Franz, 2003, J Circadian Rhythms, V1, P2, DOI 10.1186/1740-3391-1-2; Hall M, 2004, PSYCHOSOM MED, V66, P56, DOI 10.1097/01.PSY.0000106884.58744.09; Hall Martica, 2007, Behav Sleep Med, V5, P178; Harper DG, 1996, PHYSIOL BEHAV, V59, P409, DOI 10.1016/0031-9384(95)02012-8; Hassani H., 2007, DATA SCI J, V5, P239, DOI DOI 10.6339/JDS.2007.05(2).396; HAYASHI M, 1994, PERCEPT MOTOR SKILL, V79, P791, DOI 10.2466/pms.1994.79.2.791; Holloway PM, 2014, INTERFACE, V11; Hu K, 2009, P NATL ACAD SCI USA, V106, P2490, DOI 10.1073/pnas.0806087106; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Iatsenko D, 2015, SPRINGER THESES-RECO, P1, DOI 10.1007/978-3-319-20016-3; Iatsenko D, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.032916; Ivanov PC, 2007, P NATL ACAD SCI USA, V104, P20702, DOI 10.1073/pnas.0709957104; Iyengar N, 1996, AM J PHYSIOL-REG I, V271, pR1078, DOI 10.1152/ajpregu.1996.271.4.R1078; Kleitman N., 1939, SLEEP WAKEFULNESS; Krampe Ralf Th., 1995, PRACTICE PERFORMANCE, P84; Kripke Daniel F, 2008, J Circadian Rhythms, V6, P6, DOI 10.1186/1740-3391-6-6; Krishnan B, 2001, NATURE, V411, P313, DOI 10.1038/35077094; LACK L, 1993, SLEEP, V16, P436, DOI 10.1093/sleep/16.5.436; LAVIE P, 1989, CHRONOBIOL INT, V6, P21, DOI 10.3109/07420528909059139; Lavie P., 1992, ULTRADIAN CYCLES SLE; Leise TL, 2011, J BIOL RHYTHM, V26, P454, DOI 10.1177/0748730411416330; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; Lichstein KL, 2006, SLEEP, V29, P232; Littner M, 2003, SLEEP, V26, P754, DOI 10.1093/sleep/26.6.754; McClung CA, 2011, EUR NEUROPSYCHOPHARM, V21, pS683, DOI 10.1016/j.euroneuro.2011.07.008; Meeker K, 2011, J BIOL RHYTHM, V26, P353, DOI 10.1177/0748730411409863; Morgenthaler T, 2006, SLEEP, V29, P1415; MORRIS M, 1990, SLEEP, V13, P1; Natale V, 2009, SLEEP, V32, P767, DOI 10.1093/sleep/32.6.767; Niggemyer KA, 2004, SLEEP, V27, P1535, DOI 10.1093/sleep/27.8.1535; OKUDAIRA N, 1984, PHYSIOL BEHAV, V32, P843, DOI 10.1016/0031-9384(84)90203-8; Peng C-K, 2004, PHYSICA A, V337, P307; Refinetti R, 2007, BIOL RHYTHM RES, V38, P275, DOI 10.1080/09291010600903692; Sadeh A, 2011, SLEEP MED REV, V15, P259, DOI 10.1016/j.smrv.2010.10.001; Sing HC, 1992, ULTRADIAN RHYTHMS LI; TORNATZKY W, 1993, PHYSIOL BEHAV, V53, P983, DOI 10.1016/0031-9384(93)90278-N; WITTING W, 1990, BIOL PSYCHIAT, V27, P563, DOI 10.1016/0006-3223(90)90523-5; Yamazaki S, 1998, J NEUROSCI, V18, P10709; Yu W, 2007, METHODS MOL BIOL, V362; Zee Phyllis C, 2013, Continuum (Minneap Minn), V19, P132, DOI 10.1212/01.CON.0000427209.21177.aa	58	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0181762	10.1371/journal.pone.0181762	http://dx.doi.org/10.1371/journal.pone.0181762			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753669	Green Accepted, Green Published, gold			2022-12-26	WOS:000406579300026
J	Heldbjerg, H; Fox, AD; Thellesen, PV; Dalby, L; Sunde, P				Heldbjerg, Henning; Fox, Anthony D.; Thellesen, Peder V.; Dalby, Lars; Sunde, Peter			Common Starlings (Sturnus vulgaris) increasingly select for grazed areas with increasing distance-to-nest	PLOS ONE			English	Article							FARMLAND BIRD POPULATIONS; HABITAT USE; AGRICULTURAL INTENSIFICATION; EUROPEAN STARLINGS; RESOURCE SELECTION; ATHENE-NOCTUA; BRITAIN; LANDSCAPE; AVAILABILITY; CONSERVATION	The abundant and widespread Common Starling (Sturnus vulgaris) is currently declining across much of Europe due to landscape changes caused by agricultural intensification. The proximate mechanisms causing adverse effects to breeding Starlings are unclear, hampering our ability to implement cost-efficient agri-environmental schemes to restore populations to former levels. This study aimed to show how this central foraging farmland bird uses and selects land cover types in general and how use of foraging habitat changes in relation to distance from the nest. We attached GPS-loggers to 17 breeding Starlings at a Danish dairy cattle farm in 2015 and 2016 and analysed their use of different land cover types as a function of distance intervals from the nest and their relative availability. As expected for a central place forager, Starlings increasingly avoided potential foraging areas with greater distance-to-nest: areas >= 500 m were selected > 100 times less frequently than areas within 100 m. On average, Starlings selected the land cover category Grazed most frequently, followed by Short Grass, Bare Ground, Meadow and Winter Crops. Starlings compensated for elevated travel costs by showing increasing habitat selection the further they foraged from the nest. Our results highlight the importance of Grazed foraging habitats close to the nest site of breeding Starlings. The ecological capacity of intensively managed farmlands for insectivorous birds like the Starling is decreasing through conversion of the most strongly selected land cover type (Grazed) to the least selected (Winter Crops) which may be further exacerbated through spatial segregation of foraging and breeding habitats.	[Heldbjerg, Henning; Fox, Anthony D.; Dalby, Lars; Sunde, Peter] Aarhus Univ, Dept Biosci Wildlife Ecol, Kalo, Ronde, Denmark; [Heldbjerg, Henning] DOF BirdLife Denmark, Copenhagen, Denmark; [Thellesen, Peder V.] Hjortkaer, Arre, Denmark	Aarhus University	Heldbjerg, H (corresponding author), Aarhus Univ, Dept Biosci Wildlife Ecol, Kalo, Ronde, Denmark.; Heldbjerg, H (corresponding author), DOF BirdLife Denmark, Copenhagen, Denmark.	hh@dof.dk	Sunde, Peter/AAE-8995-2021; Sunde, Peter/E-9132-2013; Heldbjerg, Henning/GRF-3351-2022; Dalby, Lars/D-2281-2013	Sunde, Peter/0000-0002-7485-037X; Sunde, Peter/0000-0002-7485-037X; Dalby, Lars/0000-0002-7270-6999; Heldbjerg, Henning/0000-0003-4268-2671	Danish Nature Agency; Innovationsfonden; Aage V Jensen Naturfond; 15. Juni Fonden	Danish Nature Agency; Innovationsfonden; Aage V Jensen Naturfond; 15. Juni Fonden	The Danish Nature Agency funded the project: "Agerlandets almindelige og sjaeldne fugle" for HH and ADF. HH acknowledges the support of an industrial PhD stipend awarded by Innovationsfonden, which, together with Aage V Jensen Naturfond and 15. Juni Fonden also supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; [Anonymous], 2006, SAS MIXED MODELS; Beyer HL, 2010, PHILOS T R SOC B, V365, P2245, DOI 10.1098/rstb.2010.0083; Boyce MS, 2016, J ANIM ECOL, V85, P11, DOI 10.1111/1365-2656.12359; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Bruun M, 2003, BIOL CONSERV, V114, P179, DOI 10.1016/S0006-3207(03)00021-1; Bruun M., 2002, THESIS; Butler SJ, 2010, AGR ECOSYST ENVIRON, V137, P348, DOI 10.1016/j.agee.2010.03.005; Butler SJ, 2004, IBIS, V146, P123, DOI 10.1111/j.1474-919X.2004.00352.x; Carrete M, 2005, BIOL CONSERV, V126, P582, DOI 10.1016/j.biocon.2005.06.031; Chamberlain DE, 2000, J APPL ECOL, V37, P771, DOI 10.1046/j.1365-2664.2000.00548.x; Cunningham MA, 2006, ECOL APPL, V16, P1062, DOI 10.1890/1051-0761(2006)016[1062:PALFIG]2.0.CO;2; Danish Ministry of Food and Fisheries, 1999, DIR DIG DAN AGR REG; Devereux CL, 2004, IBIS, V146, P115, DOI 10.1111/j.1474-919X.2004.00355.x; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Duchesne T, 2010, J ANIM ECOL, V79, P548, DOI 10.1111/j.1365-2656.2010.01670.x; EBCC, TRENDS COMM BIRDS EU; Fenger M, 2016, ANN REPORT; Fox AD, 2004, J APPL ECOL, V41, P427, DOI 10.1111/j.0021-8901.2004.00917.x; Fuller RJ, 1995, CONSERV BIOL, V9, P1425, DOI 10.1046/j.1523-1739.1995.09061425.x; Gustin M., 2017, BIRD STUDY; Heldbjerg H, 2017, BIRD CONSERV IN 0306; Heldbjerg H, 2016, AGR ECOSYST ENVIRON, V230, P24, DOI 10.1016/j.agee.2016.05.025; KACELNIK A, 1990, J ANIM ECOL, V59, P655, DOI 10.2307/4887; Lele SR, 2013, J ANIM ECOL, V82, P1183, DOI 10.1111/1365-2656.12141; Newton I, 2004, IBIS, V146, P579, DOI 10.1111/j.1474-919X.2004.00375.x; Northrup JM, 2013, ECOLOGY, V94, P1456, DOI 10.1890/12-1688.1; Patenaude-Monette M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102162; Reif J, 2016, AGR ECOSYST ENVIRON, V232, P208, DOI 10.1016/j.agee.2016.08.007; Robinson RA, 2002, J APPL ECOL, V39, P157, DOI 10.1046/j.1365-2664.2002.00695.x; Salek M, 2010, BIRD STUDY, V57, P495, DOI 10.1080/00063657.2010.494717; Schekkerman H, 2007, ARDEA, V95, P39, DOI 10.5253/078.095.0105; Smith HG, 2002, AGR ECOSYST ENVIRON, V92, P107, DOI 10.1016/S0167-8809(01)00266-3; Technosmart, 2015, TECHN GYPS 5 MICR GP; Thellesen PV, DANISH ENGL IN PRESS; Thorup K, 2010, IBIS, V152, P803, DOI 10.1111/j.1474-919X.2010.01046.x; TINBERGEN JM, 1981, ARDEA, V69, P1; Vickery JA, 2001, J APPL ECOL, V38, P647, DOI 10.1046/j.1365-2664.2001.00626.x; Ward S, 2004, J EXP BIOL, V207, P4291, DOI 10.1242/jeb.01281; WESTERTERP K, 1982, ARDEA, V70, P153; Wiersma P, 2005, J EXP BIOL, V208, P4099, DOI 10.1242/jeb.01855; WILLIAMSON P, 1975, CONDOR, V77, P84, DOI 10.2307/1366761	42	13	16	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182504	10.1371/journal.pone.0182504	http://dx.doi.org/10.1371/journal.pone.0182504			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771556	Green Published, Green Submitted, gold			2022-12-26	WOS:000406853600128
J	Kim, BH; Choi, HY; Ki, M; Kim, KA; Jang, ES; Jeong, SH				Kim, Bo Hyun; Choi, Hwa Young; Ki, Moran; Kim, Kyung-Ah; Jang, Eun Sun; Jeong, Sook-Hyang			Population-based prevalence, incidence, and disease burden of autoimmune hepatitis in South Korea	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; LIVER-DISEASE; FOLLOW-UP; EPIDEMIOLOGY; NATIONWIDE; CRITERIA; WOMEN; AREA	Background and aim Little is known about population-based epidemiology and disease burden of autoimmune hepatitis (AIH). The aim of this study was to investigate the prevalence, incidence, comorbidity and direct medical cost of AIH in South Korea. Methods The data was from the nationwide, population-based National Health Insurance Service claims database and the Rare Intractable Disease registration program. Age and gender-specific prevalence rates were calculated, and data on comorbidity, diagnostic tests, prescribed drugs, and medical costs were retrieved for patients registered under the disease code K75.4 (AIH) from 2009 to 2013. Results A total of 4,085 patients with AIH were identified between 2009 and 2013 with a female-tomale ratio of 6.4. The age-adjusted prevalence rate was 4.82/100,000 persons and gender adjusted prevalence rates were 8.35 in females and 1.30 in males. The age-adjusted calculated incidence rate was 1.07/100,000 persons (gender-adjusted 1.83 in females and 0.31 in males). Ascites, variceal bleeding, and hepatocellular carcinoma were found in 1.4%, 1.3%, and 2.2% of the patients, respectively. Forty-six patients (1.1%) underwent liver transplantation during the study period. Case-fatality was 2.18%. Corticosteroid and azathioprine were prescribed in 44.1% and 38.0% of prevalent patients with AIH in 2013, respectively. The nationwide total direct medical cost was less than 4.0 million USD, and the average cost for each patient was 1,174 USD in 2013. Conclusion This is the first report on the nationwide epidemiology of AIH in Korea, and it showed a lower prevalence than that of Western countries with considerable disease burden.	[Kim, Bo Hyun] Natl Canc Ctr, Ctr Liver Canc, Goyang, South Korea; [Choi, Hwa Young; Ki, Moran] Grad Sch Canc Sci, Dept Canc Control & Policy, Goyang, South Korea; [Choi, Hwa Young; Ki, Moran] Policy Natl Canc Ctr, Goyang, South Korea; [Kim, Kyung-Ah] Inje Univ, Dept Internal Med, Ilsan Paik Hosp, Goyang, South Korea; [Jang, Eun Sun; Jeong, Sook-Hyang] Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Coll Med, Seoul, South Korea	National Cancer Center - Korea (NCC); Inje University; Seoul National University (SNU); Seoul National University Hospital	Jeong, SH (corresponding author), Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Coll Med, Seoul, South Korea.	jsh@snubh.org		Ki, Moran/0000-0002-8892-7104	Korean Association for the Study of the Liver (KASL); National Cancer Center, Korea [NCC-1410860]	Korean Association for the Study of the Liver (KASL); National Cancer Center, Korea	This work was supported in part by a research grant from Korean Association for the Study of the Liver (KASL academic research fund 2013), and from the National Cancer Center, Korea (NCC-1410860). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boberg Kirsten Muri, 2002, Clin Liver Dis, V6, P635; Boberg KM, 1998, SCAND J GASTROENTERO, V33, P99; Borssen AD, 2015, SCAND J GASTROENTERO, V50, P217, DOI 10.3109/00365521.2014.983154; Czaja AJ, 2013, DIGEST DIS SCI, V58, P1459, DOI 10.1007/s10620-012-2525-5; Delgado JS, 2013, J DIGEST DIS, V14, P611, DOI 10.1111/1751-2980.12085; Groribaek L, 2014, J HEPATOL, V60, P612, DOI 10.1016/j.jhep.2013.10.020; Haider AS, 2010, INTERN MED J, V40, P281, DOI 10.1111/j.1445-5994.2009.02041.x; Hurlburt KJ, 2002, AM J GASTROENTEROL, V97, P2402, DOI 10.1111/j.1572-0241.2002.06019.x; Jalihal A, 2009, HEPATOB PANCREAT DIS, V8, P602; JOHNSON PJ, 1993, HEPATOLOGY, V18, P998, DOI 10.1002/hep.1840180435; Kim BH, 2013, J GASTROEN HEPATOL, V28, P128, DOI 10.1111/j.1440-1746.2012.07292.x; Koay LB, 2006, DIGEST DIS SCI, V51, P1978, DOI 10.1007/s10620-005-9068-y; Lee SS, 2012, CLIN MOL HEPATOL, V18, P309, DOI 10.3350/cmh.2012.18.3.309; Lee YM, 2001, J GASTROEN HEPATOL, V16, P1384, DOI 10.1046/j.1440-1746.2001.02646.x; Migita K, 2012, LIVER INT, V32, P837, DOI 10.1111/j.1478-3231.2011.02734.x; Ministry of the Interior (MOI), 2015, POP STAT; Ngu JH, 2010, J GASTROEN HEPATOL, V25, P1681, DOI 10.1111/j.1440-1746.2010.06384.x; Primo J, 2009, ACTA GASTRO-ENT BELG, V72, P402; van Gerven NMF, 2014, SCAND J GASTROENTERO, V49, P1245, DOI 10.3109/00365521.2014.946083; Werner M, 2008, SCAND J GASTROENTERO, V43, P1232, DOI 10.1080/00365520802130183; Whalley S, 2007, CLIN MED, V7, P119, DOI 10.7861/clinmedicine.7-2-119; Wong GW, 2015, DIGEST DIS, V33, P25, DOI 10.1159/000440707; Wong RJ, 2011, DIGEST DIS SCI, V56, P578, DOI 10.1007/s10620-010-1444-6; Yeoman AD, 2008, HEPATOLOGY, V48, P863, DOI 10.1002/hep.22432; Yoshizawa K, 2016, HEPATOL RES, V46, P878, DOI 10.1111/hepr.12639	25	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182391	10.1371/journal.pone.0182391	http://dx.doi.org/10.1371/journal.pone.0182391			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771543	Green Published, Green Submitted, gold			2022-12-26	WOS:000406853600099
J	Leong, CG; Bloomfield, RA; Boyd, CA; Dornbusch, AJ; Lieber, L; Liu, F; Owen, A; Slay, E; Lang, KM; Lostroh, CP				Leong, Colleen G.; Bloomfield, Rebecca A.; Boyd, Caroline A.; Dornbusch, Amber J.; Lieber, Leah; Liu, Flora; Owen, Amie; Slay, Erin; Lang, Kristine M.; Lostroh, C. Phoebe			The role of core and accessory type IV pilus genes in natural transformation and twitching motility in the bacterium Acinetobacter baylyi	PLOS ONE			English	Article							SP STRAIN BD413; DNA-UPTAKE; NEISSERIA-MENINGITIDIS; COMPETENCE GENE; PATHOGENIC NEISSERIA; GENOME SEQUENCE; PROTEIN; IDENTIFICATION; MEMBRANE; PILIN	Here we present an examination of type IV pilus genes associated with competence and twitching in the bacterium Acinetobacter baylyi (strain ADP1, BD413). We used bioinformatics to identify potential competence and twitching genes and their operons. We measured the competence and twitching phenotypes of the bioinformatically-identified genes. These results demonstrate that competence and twitching in A. baylyi both rely upon a core of the same type IV pilus proteins. The core includes the inner membrane assembly platform (PilC), a periplasmic assemblage connecting the inner membrane assembly platform to the secretin (ComM), a secretin (ComQ) and its associated pilotin (PilF) that assists with secretin assembly and localization, both cytoplasmic pilus retraction ATPases (PilU, PilT), and pilins (ComP, ComB, PilX). Proteins not needed for both competence and twitching are instead found to specialize in either of the two traits. The pilins are varied in their specialization with some required for either competence (FimT) and others for twitching (ComE). The protein that transports DNA across the inner membrane (ComA) specializes in competence, while signal transduction proteins (PilG, PilS, and PilR) specialize in twitching. Taken together our results suggest that the function of accessory proteins should not be based on homology alone. In addition the results suggest that in A. baylyi the mechanisms of natural transformation and twitching are mediated by the same set of core Type IV pilus proteins with distinct specialized proteins required for each phenotype. Finally, since competence requires multiple pilins as well as both pilus retraction motors PilU and PilT, this suggests that A. baylyi employs a pilus in natural transformation.	[Leong, Colleen G.; Bloomfield, Rebecca A.; Boyd, Caroline A.; Dornbusch, Amber J.; Lieber, Leah; Liu, Flora; Owen, Amie; Slay, Erin; Lostroh, C. Phoebe] Colorado Coll, Dept Mol Biol, Colorado Springs, CO 80903 USA; [Lang, Kristine M.] Colorado Coll, Dept Phys, Colorado Springs, CO 80903 USA	Colorado College; Colorado College	Lostroh, CP (corresponding author), Colorado Coll, Dept Mol Biol, Colorado Springs, CO 80903 USA.	plostroh@coloradocollege.edu		Boyd, Caroline/0000-0002-3966-9276; Lostroh, Phoebe/0000-0002-7956-9536; Bloomfield, Rebecca/0000-0001-6185-4358	National Science Foundation Biology Directorate [MCB-1330511]	National Science Foundation Biology Directorate	This research was made possible by grant support from the National Science Foundation Biology Directorate (MCB-1330511, Lang & Lostroh). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm RA, 1996, MOL MICROBIOL, V22, P161; Averhoff B, 2008, ACINETOBACTER MOL MI; Ayers M, 2009, J MOL BIOL, V394, P128, DOI 10.1016/j.jmb.2009.09.034; Barbe V, 2004, NUCLEIC ACIDS RES, V32, P5766, DOI 10.1093/nar/gkh910; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berry JL, 2015, FEMS MICROBIOL REV, V39, P134, DOI 10.1093/femsre/fuu001; Berry JL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004014; Bertrand JJ, 2010, J BACTERIOL, V192, P994, DOI 10.1128/JB.01390-09; Bohn YST, 2009, MOL MICROBIOL, V71, P730, DOI 10.1111/j.1365-2958.2008.06559.x; BOYD JM, 1994, MOL GEN GENET, V243, P565, DOI 10.1007/BF00284205; BRADLEY DE, 1980, CAN J MICROBIOL, V26, P146, DOI 10.1139/m80-022; Burkhardt J, 2011, J BIOL CHEM, V286, P9977, DOI 10.1074/jbc.M110.212688; Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055; Busch S, 1999, APPL ENVIRON MICROB, V65, P4568; Cehovin A, 2013, P NATL ACAD SCI USA, V110, P3065, DOI 10.1073/pnas.1218832110; Chavez-Dozal A, 2012, FEMS MICROBIOL ECOL; Chen I, 2005, SCIENCE, V310, P1456, DOI 10.1126/science.1114021; Chen I, 2001, J BACTERIOL, V183, P3160, DOI 10.1128/JB.183.10.3160-3168.2001; Cheng Y, 2013, INFECT IMMUN, V81, P4280, DOI 10.1128/IAI.00493-13; Chiang P, 2005, J BACTERIOL, V187, P829, DOI 10.1128/JB.187.3.829-839.2005; Collins RF, 2004, J BIOL CHEM, V279, P39750, DOI 10.1074/jbc.M405971200; Comolli JC, 1999, INFECT IMMUN, V67, P3625, DOI 10.1128/IAI.67.7.3625-3630.1999; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; Eriksson J, 2012, INFECT IMMUN, V80, P2538, DOI 10.1128/IAI.06354-11; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Friedrich A, 2001, APPL ENVIRON MICROB, V67, P3140, DOI 10.1128/AEM.67.7.3140-3148.2001; Georgiadou M, 2012, MOL MICROBIOL, V84, P857, DOI 10.1111/j.1365-2958.2012.08062.x; Giltner CL, 2012, MICROBIOL MOL BIOL R, V76, P740, DOI 10.1128/MMBR.00035-12; Graupner S, 2000, J BACTERIOL, V182, P2184, DOI 10.1128/JB.182.8.2184-2190.2000; Hamilton HL, 2006, MOL MICROBIOL, V59, P376, DOI 10.1111/j.1365-2958.2005.04964.x; Harding CM, 2015, MOL MICROBIOL, V96, P1023, DOI 10.1111/mmi.12986; Heiniger RW, 2010, CELL MICROBIOL, V12, P1158, DOI 10.1111/j.1462-5822.2010.01461.x; HENRICHSEN J, 1983, ANNU REV MICROBIOL, V37, P81, DOI 10.1146/annurev.mi.37.100183.000501; Hepp C, 2016, P NATL ACAD SCI USA, V113, P12467, DOI 10.1073/pnas.1608110113; Herzberg C, 2000, ARCH MICROBIOL, V173, P220, DOI 10.1007/s002039900134; Hospenthal MK, 2017, NAT REV MICROBIOL, V15, P365, DOI 10.1038/nrmicro.2017.40; Johnson MDL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029629; Johnston C, 2014, NAT REV MICROBIOL, V12, P181, DOI 10.1038/nrmicro3199; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Karuppiah V, 2011, J BIOL CHEM, V286, P24434, DOI 10.1074/jbc.M111.243535; Kehl-Fie TE, 2008, J BACTERIOL, V190, P7157, DOI 10.1128/JB.00884-08; Koo J, 2008, J BACTERIOL, V190, P6961, DOI 10.1128/JB.00996-08; Koo J, 2016, STRUCTURE, V24, P1778, DOI 10.1016/j.str.2016.08.007; Korotkov KV, 2011, TRENDS BIOCHEM SCI, V36, P433, DOI 10.1016/j.tibs.2011.04.002; Kurre R, 2012, MOL MICROBIOL, V86, P857, DOI 10.1111/mmi.12022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laurenceau R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004835; LAUTROP H, 1962, ACTA PATHOL MIC SC, P303; Leighton TL, 2015, J BACTERIOL, V197, P2229, DOI 10.1128/JB.00220-15; Link C, 1998, J BACTERIOL, V180, P1592, DOI 10.1128/JB.180.6.1592-1595.1998; Maier B, 2015, TRENDS MICROBIOL, V23, P775, DOI 10.1016/j.tim.2015.09.002; Matthey N, 2016, TRENDS MICROBIOL, V24, P98, DOI 10.1016/j.tim.2015.10.008; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; Morand PC, 2004, EMBO J, V23, P2009, DOI 10.1038/sj.emboj.7600200; Morand PC, 2001, MOL MICROBIOL, V40, P846, DOI 10.1046/j.1365-2958.2001.02452.x; Morand PC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006834; Orans J, 2010, P NATL ACAD SCI USA, V107, P1065, DOI 10.1073/pnas.0911616107; PALMEN R, 1993, J GEN MICROBIOL, V139, P295, DOI 10.1099/00221287-139-2-295; Porstendorfer D, 1997, APPL ENVIRON MICROB, V63, P4150; Porstendorfer D, 2000, J BACTERIOL, V182, P3673, DOI 10.1128/JB.182.13.3673-3680.2000; Price MN, 2005, NUCLEIC ACIDS RES, V33, P3224, DOI 10.1093/nar/gki638; Price MN, 2005, NUCLEIC ACIDS RES, V33, P880, DOI 10.1093/nar/gki232; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; RUDEL T, 1995, P NATL ACAD SCI USA, V92, P7986, DOI 10.1073/pnas.92.17.7986; Sampaleanu LM, 2009, J MOL BIOL, V394, P143, DOI 10.1016/j.jmb.2009.09.037; SANDKVIST M, 1995, EMBO J, V14, P1664, DOI 10.1002/j.1460-2075.1995.tb07155.x; Seitz P, 2014, MBIO, V5, DOI 10.1128/mBio.01409-14; Seitz P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004066; Seitz P, 2013, P NATL ACAD SCI USA, V110, P17987, DOI 10.1073/pnas.1315647110; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Soderholm N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024353; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Sun H, 2000, CURR BIOL, V10, P1143, DOI 10.1016/S0960-9822(00)00705-3; Taha MK, 1998, MOL MICROBIOL, V28, P1153, DOI 10.1046/j.1365-2958.1998.00876.x; Takhar HK, 2013, J BIOL CHEM, V288, P9721, DOI 10.1074/jbc.M113.453506; Wang J, 2011, J BACTERIOL, V193, P2122, DOI 10.1128/JB.00041-11; Watnick PI, 1999, MOL MICROBIOL, V34, P586, DOI 10.1046/j.1365-2958.1999.01624.x; Wilharm G, 2013, J BACTERIOL, V195, P4146, DOI 10.1128/JB.00754-13; Wolfgang M, 1998, P NATL ACAD SCI USA, V95, P14973, DOI 10.1073/pnas.95.25.14973; Nguyen Y, 2015, J BIOL CHEM, V290, P601, DOI 10.1074/jbc.M114.616904	81	25	25	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182139	10.1371/journal.pone.0182139	http://dx.doi.org/10.1371/journal.pone.0182139			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771515	gold, Green Published, Green Submitted			2022-12-26	WOS:000406853600067
J	Mullan, F; Austin, RS; Parkinson, CR; Hasan, A; Bartlett, DW				Mullan, Francesca; Austin, Rupert S.; Parkinson, Charles R.; Hasan, Adam; Bartlett, David W.			Measurement of surface roughness changes of unpolished and polished enamel following erosion	PLOS ONE			English	Article							SCANNING-ELECTRON-MICROSCOPY; NATURAL HUMAN ENAMEL; TOOTH WEAR; IN-VITRO; TEXTURE CHARACTERIZATION; DENTAL EROSION; HIGH FLUORIDE; ABRASION; DEMINERALIZATION; REMINERALIZATION	Objectives To determine if Sa roughness data from measuring one central location of unpolished and polished enamel were representative of the overall surfaces before and after erosion. Methods Twenty human enamel sections (4x4 mm) were embedded in bis-acryl composite and randomised to either a native or polishing enamel preparation protocol. Enamel samples were subjected to an acid challenge (15 minutes 100 mL orange juice, pH 3.2, titratable acidity 41.3mmol OH/L, 62.5 rpm agitation, repeated for three cycles). Median (IQR) surface roughness [Sa] was measured at baseline and after erosion from both a centralised cluster and four peripheral clusters. Within each cluster, five smaller areas (0.04 mm 2) provided the Sa roughness data. Results For both unpolished and polished enamel samples there were no significant differences between measuring one central cluster or four peripheral clusters, before and after erosion. For unpolished enamel the single central cluster had a median (IQR) Sa roughness of 1.45 (2.58) mu m and the four peripheral clusters had a median (IQR) of 1.32 (4.86) mu m before erosion; after erosion there were statistically significant reductions to 0.38 (0.35) mu m and 0.34 (0.49) mu m respectively (p< 0.0001). Polished enamel had a median (IQR) Sa roughness 0.04 (0.17) mu m for the single central cluster and 0.05 (0.15) mu m for the four peripheral clusters which statistically significantly increased after erosion to 0.27 (0.08) mu m for both (p< 0.0001). Conclusion Measuring one central cluster of unpolished and polished enamel was representative of the overall enamel surface roughness, before and after erosion.	[Mullan, Francesca; Austin, Rupert S.; Hasan, Adam; Bartlett, David W.] Kings Coll London, Dent Inst, Guys Hosp, London, England; [Mullan, Francesca; Austin, Rupert S.; Hasan, Adam; Bartlett, David W.] Kings Coll London, Dent Inst, Kings Hosp, London, England; [Mullan, Francesca; Austin, Rupert S.; Hasan, Adam; Bartlett, David W.] Kings Coll London, Dent Inst, St Thomas Hosp, London, England; [Parkinson, Charles R.] GSK Consumer Healthcare, Weybridge, Surrey, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; GlaxoSmithKline	Mullan, F (corresponding author), Kings Coll London, Dent Inst, Guys Hosp, London, England.; Mullan, F (corresponding author), Kings Coll London, Dent Inst, Kings Hosp, London, England.; Mullan, F (corresponding author), Kings Coll London, Dent Inst, St Thomas Hosp, London, England.	francesca.mullan@kcl.ac.uk	Parkinson, Charlie/Y-3880-2019	Austin, Rupert/0000-0003-2782-1020; Parkinson, Charles/0000-0001-5087-4468	GSK Consumer Healthcare, Weybridge, UK; GSK Consumer Healthcare; Academy of Medical Sciences (AMS) [AMS-SGCL6-Austin] Funding Source: researchfish; National Institute for Health Research [CL-2011-17-015] Funding Source: researchfish	GSK Consumer Healthcare, Weybridge, UK; GSK Consumer Healthcare; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by GSK Consumer Healthcare, Weybridge, UK, http://www.gsk.com/en-gb/reseamh/randd-locations/uk/weybridge/. The funding source had involvement in the writing of the report and the decision to submit the article for publication. The funder provided support in the form of salaries for author [CP] and PhD funding for author [FM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This study was funded by GSK Consumer Healthcare.	ARNOLD WH, 2015, HEAD FACE MED, V11; Austin RS, 2016, DENT MATER, V32, P278, DOI 10.1016/j.dental.2015.11.016; Austin RS, 2015, SURF TOPOGR-METROL, V3, DOI 10.1088/2051-672X/3/2/023002; Austin RS, 2011, J DENT, V39, P648, DOI 10.1016/j.jdent.2011.07.006; Bajaj D, 2009, ACTA BIOMATER, V5, P3045, DOI 10.1016/j.actbio.2009.04.013; Bartlett DW, 2005, INT DENT J, V55, P277; Carvalho TS, 2014, J DENT, V42, P450, DOI 10.1016/j.jdent.2014.01.004; Creeth JE, 2015, J DENT, V43, P823, DOI 10.1016/j.jdent.2015.03.008; Cuy JL, 2002, ARCH ORAL BIOL, V47, P281, DOI 10.1016/S0003-9969(02)00006-7; DigitalSurf, 2013, MOUNTAINSMAP REF MAN; Field J, 2010, J DENT, V38, P182, DOI 10.1016/j.jdent.2010.01.002; Ganss C, 2000, ARCH ORAL BIOL, V45, P897, DOI 10.1016/S0003-9969(00)00041-8; Giusca CL, 2012, MEAS SCI TECHNOL, V23, DOI 10.1088/0957-0233/23/3/035008; Goodall RH, 2015, SCI REP-UK, V5, DOI 10.1038/srep10800; Gracia LH, 2010, J DENT, V38, pS12, DOI 10.1016/S0300-5712(11)70004-5; Hara AT, 2016, J DENT RES, V95, P537, DOI 10.1177/0022034516629941; Hara AT, 2014, EUR J ORAL SCI, V122, P161, DOI 10.1111/eos.12108; HEWLETT ER, 1992, DENT MATER, V8, P49, DOI 10.1016/0109-5641(92)90053-F; Huysmans MCDNJM, 2011, CARIES RES, V45, P60, DOI 10.1159/000325947; ISO, 1997, ISO 4287 1997 WRITT; Kashkosh LT, EGYPTIAN DENT J, V62, P514; Leach R, 2008, MEASUREMENT GOOD PRA, V108, P17; Leach R., 2014, CHARACTERISATION ARE; Leach RK, 2014, FUNDAMENTAL PRINCIPL, V2nd ed.; Limandri S, 2016, MICRON, V84, P54, DOI 10.1016/j.micron.2016.02.001; Mann C, 2014, J DENT, V42, P1411, DOI 10.1016/j.jdent.2014.06.011; Mistry M, 2015, CARIES RES, V49, P508, DOI 10.1159/000438725; Mullan F, 2017, DENT MATER, V33, pE273, DOI 10.1016/j.dental.2017.04.004; Mullan F, 2017, J DENT, V60, P50, DOI 10.1016/j.jdent.2017.02.015; Rakhmatullina E, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.11.117009; Rakhmatullina E, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3631791; Ranjitkar S, 2017, J DENT RES, V96, P300, DOI 10.1177/0022034516680585; Rodriguez JM, 2012, CARIES RES, V46, P9, DOI 10.1159/000334786; Rodriguez JM, 2012, DENT MATER, V28, P245, DOI 10.1016/j.dental.2011.10.002; Sancakli HS, 2015, AUST DENT J, V60, P38, DOI 10.1111/adj.12271; Seong J, 2015, J DENT, V43, P1013, DOI 10.1016/j.jdent.2015.04.002; SILVERSTONE LM, 1975, CARIES RES, V9, P373, DOI 10.1159/000260179; Specifications GP, 1997, SURF TEXT PROF METH; Tantbirojn D, 2012, J AM DENT ASSOC, V143, P278, DOI 10.14219/jada.archive.2012.0153; Zavala-Alonso V, 2010, MICROSC MICROANAL, V16, P531, DOI 10.1017/S1431927610093748	40	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182406	10.1371/journal.pone.0182406	http://dx.doi.org/10.1371/journal.pone.0182406			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771562	Green Published, Green Submitted, gold			2022-12-26	WOS:000406853600104
J	Shewell, LK; Jen, FEC; Jennings, MP				Shewell, Lucy K.; Jen, Freda E. -C; Jennings, Michael P.			Refinement of immunizing antigens to produce functional blocking antibodies against the AniA nitrite reductase of Neisseria gonorrhoeae	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; CERVICAL EPITHELIAL-CELLS; PATHOGENIC NEISSERIA; INFECTIONS; EXPRESSION; RESPONSES; VACCINE; LIPOOLIGOSACCHARIDE; CEFTRIAXONE; VARIANTS	The emergence of multi-drug resistant Neisseria gonorrhoeae has generated an urgent need for novel therapies or a vaccine to prevent gonococcal disease. In this study we investigate the potential of targeting the surface exposed nitrite reductase, AniA, to block activity by producing functional blocking antibodies. AniA activity is essential for anaerobic growth and biofilm formation of N. gonorrhoeae and functional blocking antibodies may prevent colonisation and disease. Seven peptides covering regions adjacent to the active site were designed based on the AniA structure. Six of the seven peptide conjugates generated immune responses. Peptide 7, GALGQLKVEGAEN, was able to elicit antibodies capable of blocking AniA activity. Antiserum raised against the peptide 7 conjugate detected AniA in 20 N. gonorrhoeae clinical isolates. Recombinant AniA protein antigens were also assessed in this study and generated high-titre, functional blocking antibody responses. Peptide 7 conjugates or truncated recombinant AniA antigens have potential for inclusion in a vaccine against N. gonorrhoeae.	[Shewell, Lucy K.; Jen, Freda E. -C; Jennings, Michael P.] Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia	Griffith University	Jennings, MP (corresponding author), Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia.	m.jennings@griffith.edu.au	Jennings, Michael P/G-4822-2013	Jennings, Michael P/0000-0002-1027-4684; Shewell, Lucy/0000-0002-8847-0503	Australian National Health and Medical Research Council Program [565526, APP1071659]; Australian Research Council [130103141]; Queensland Government Women's Academic Fund; JSPS KAKENHI [JP 24580291]; Project of the Bio-oriented Technology Research Advancement Institution, NARO	Australian National Health and Medical Research Council Program(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Queensland Government Women's Academic Fund; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Project of the Bio-oriented Technology Research Advancement Institution, NARO	This work was funded by the Australian National Health and Medical Research Council Program Grant 565526 and APP1071659 to M.P. J., Australian Research Council Discovery Project Grant 130103141 to M.P.J., and Queensland Government Women's Academic Fund to F.E.-C.J.; Part of this his work was supported by JSPS KAKENHI Grant Number JP 24580291 and by a grant from the Project of the Bio-oriented Technology Research Advancement Institution, NARO (the special scheme project on advanced research and development for next-generation technology). We thank Dr S. Miwa and Dr. M. Okauchi of Japan Fisheries Research and Education Agency, National Research Institute of Aquaculture, for their technical support.	APICELLA MA, 1987, INFECT IMMUN, V55, P1755, DOI 10.1128/IAI.55.8.1755-1761.1987; APICELLA MA, 1974, J INFECT DIS, V130, P619, DOI 10.1093/infdis/130.6.619; BOSLEGO JW, 1991, VACCINE, V9, P154, DOI 10.1016/0264-410X(91)90147-X; Boulanger MJ, 2002, J MOL BIOL, V315, P1111, DOI 10.1006/jmbi.2001.5251; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; Brito LA, 2014, J CONTROL RELEASE, V190, P563, DOI 10.1016/j.jconrel.2014.06.027; Camara J, 2012, J ANTIMICROB CHEMOTH, V67, P1858, DOI 10.1093/jac/dks162; CLARK VL, 1987, INFECT IMMUN, V55, P1359, DOI 10.1128/IAI.55.6.1359-1364.1987; CLARK VL, 1988, MICROB PATHOGENESIS, V5, P381, DOI 10.1016/0882-4010(88)90038-1; Craig AP, 2015, VACCINE, V33, P4520, DOI 10.1016/j.vaccine.2015.07.015; DANAHER RJ, 1995, J BACTERIOL, V177, P7275, DOI 10.1128/jb.177.24.7275-7279.1995; Edwards JL, 2006, CELL MICROBIOL, V8, P1253, DOI 10.1111/j.1462-5822.2006.00707.x; Edwards JL, 2003, INFECT IMMUN, V71, P6381, DOI 10.1128/IAI.71.11.6381-6391.2003; Edwards JL, 2015, CRITICAL RE IN PRESS; Eyre JWH, 1909, LANCET, V2, P76; Falsetta ML, 2009, INFECT IMMUN, V77, P3522, DOI 10.1128/IAI.00036-09; Fox KK, 1999, AM J EPIDEMIOL, V149, P353, DOI 10.1093/oxfordjournals.aje.a009820; GREENBERG L, 1974, CAN J PUBLIC HEALTH, V65, P29; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hedges SR, 1999, INFECT IMMUN, V67, P3937, DOI 10.1128/IAI.67.8.3937-3946.1999; Hedges SR, 1998, J INFECT DIS, V178, P742, DOI 10.1086/515372; HOEHN GT, 1992, INFECT IMMUN, V60, P4704, DOI 10.1128/IAI.60.11.4704-4708.1992; JERSE AE, 1994, J EXP MED, V179, P911, DOI 10.1084/jem.179.3.911; Johnson MB, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00077; Ku SC, 2009, BIOCHEM BIOPH RES CO, V378, P84, DOI 10.1016/j.bbrc.2008.11.025; Liu Y, 2014, MUCOSAL IMMUNOL, V7, P165, DOI 10.1038/mi.2013.36; Liu YR, 2011, MBIO, V2, DOI 10.1128/mBio.00095-11; Mellies J, 1997, MOL GEN GENET, V256, P525, DOI 10.1007/s004380050597; Ohnishi M, 2011, ANTIMICROB AGENTS CH, V55, P3538, DOI 10.1128/AAC.00325-11; Peak IR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072003; Phillips NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038303; Ray TD, 2011, J IMMUNOL, V186, P4881, DOI 10.4049/jimmunol.1003623; ROSS DC, 1995, GENITOURIN MED, V71, P367; Scharbaai-Vazquez R, 2014, SEX TRANSM INFECT; SEIFERT HS, 1994, J CLIN INVEST, V93, P2744, DOI 10.1172/JCI117290; Shewell LK, 2013, BIOCHEM BIOPH RES CO, V431, P215, DOI 10.1016/j.bbrc.2012.12.132; Steichen CT, 2008, J INFECT DIS, V198, P1856, DOI 10.1086/593336; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; SWANSON J, 1987, J EXP MED, V165, P1344, DOI 10.1084/jem.165.5.1344; SWANSON J, 1988, J EXP MED, V168, P2121, DOI 10.1084/jem.168.6.2121; US Department of Health and Human Services Centers for Disease Control and Prevention., 2013, ANT RES THREATS US; WHO, 2012, GLOB INC PREV SEL CU; Zughaier SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087688	43	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182555	10.1371/journal.pone.0182555	http://dx.doi.org/10.1371/journal.pone.0182555			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771632	Green Published, gold, Green Submitted			2022-12-26	WOS:000406853600141
J	Alvarez-Silva, MC; Alvarez-Yela, AC; Gomez-Cano, F; Zambrano, MM; Husserl, J; Danies, G; Restrepo, S; Gonzalez-Barrios, AF				Camila Alvarez-Silva, Maria; Catalina Alvarez-Yela, Astrid; Gomez-Cano, Fabio; Mercedes Zambrano, Maria; Husserl, Johana; Danies, Giovanna; Restrepo, Silvia; Fernando Gonzalez-Barrios, Andres			Compartmentalized metabolic network reconstruction of microbial communities to determine the effect of agricultural intervention on soils	PLOS ONE			English	Article							FLUX BALANCE ANALYSIS; BIOGEOCHEMICAL CYCLES; GENES	Soil microbial communities are responsible for a wide range of ecological processes and have an important economic impact in agriculture. Determining the metabolic processes performed by microbial communities is crucial for understanding and managing ecosystem properties. Metagenomic approaches allow the elucidation of the main metabolic processes that determine the performance of microbial communities under different environmental conditions and perturbations. Here we present the first compartmentalized metabolic reconstruction at a metagenomics scale of a microbial ecosystem. This systematic approach conceives a meta-organism without boundaries between individual organisms and allows the in silico evaluation of the effect of agricultural intervention on soils at a metagenomics level. To characterize the microbial ecosystems, topological properties, taxonomic and metabolic profiles, as well as a Flux Balance Analysis (FBA) were considered. Furthermore, topological and optimization algorithms were implemented to carry out the curation of the models, to ensure the continuity of the fluxes between the metabolic pathways, and to confirm the metabolite exchange between subcellular compartments. The proposed models provide specific information about ecosystems that are generally overlooked in non-compartmentalized or non-curated networks, like the influence of transport reactions in the metabolic processes, especially the important effect on mitochondrial processes, as well as provide more accurate results of the fluxes used to optimize the metabolic processes within the microbial community.	[Camila Alvarez-Silva, Maria; Catalina Alvarez-Yela, Astrid; Fernando Gonzalez-Barrios, Andres] Univ Los Andes, GDPP, Dept Chem Engn, Bogota, Colombia; [Gomez-Cano, Fabio; Danies, Giovanna; Restrepo, Silvia] Univ Los Andes, Lab Micol & Fitopatol LAMFU, Dept Biol Sci, Bogota, Colombia; [Mercedes Zambrano, Maria] Ctr Genom & Bioinformat Extreme Environm Gebix, Bogota, Colombia; [Mercedes Zambrano, Maria] Corp Corpogen Res Ctr, Bogota, Colombia; [Husserl, Johana] Univ Los Andes, Ctr Invest Ingn Ambiental, Dept Environm Engn, Bogota, Colombia	Universidad de los Andes (Colombia); Universidad de los Andes (Colombia); Universidad de los Andes (Colombia)	Gonzalez-Barrios, AF (corresponding author), Univ Los Andes, GDPP, Dept Chem Engn, Bogota, Colombia.	andgonza@uniandes.edu.co	Zambrano, Maria Mercedes/AAD-2805-2019	Zambrano, Maria Mercedes/0000-0002-0796-4473; Alvarez Yela, Astrid Catalina/0000-0002-2911-1690; Gonzalez Barrios, Andres Fernando/0000-0003-2517-2020	Colciencias [573-2012, 6492013]; MCAS	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); MCAS	This work received funding from Colciencias (contract Nos. 573-2012 and 6492013). The funder provided support in the form of salaries for authors MCAS and MY but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; [Anonymous], PLOS COMPUT BIOL; Arita M, 2004, P NATL ACAD SCI USA, V101, P1543, DOI 10.1073/pnas.0306458101; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Caspi R, 2014, NUCLEIC ACIDS RES, V42; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004; Ganter M, 2013, BIOINFORMATICS, p2 ; Gianchandani EP, 2010, WIRES SYST BIOL MED, V2, P372, DOI 10.1002/wsbm.60; Glass Elizabeth M, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5368; Hao T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-393; Henry CS, 2007, BIOPHYS J, V92, P1792, DOI 10.1529/biophysj.106.093138; Henson MA, 2014, IET SYST BIOL, V8, P214, DOI 10.1049/iet-syb.2013.0021; Jacquiod S, 2014, J BIOTECHNOL, V190, P18, DOI 10.1016/j.jbiotec.2014.03.036; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Klitgord N, 2011, CURR OPIN BIOTECH, V22, P541, DOI 10.1016/j.copbio.2011.04.018; Kneip C, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-55; Konwar KM, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-202; Kumar VS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-212; Lee JM, 2006, BRIEF BIOINFORM, V7, P140, DOI 10.1093/bib/bbl007; Llorens- Mares T, 2015, ISME J, P1; Moriya Y, 2007, NUCL ACIDS RES S2, V35, pW182; Nacke H, 2014, MICROB ECOL, P1; Nazaries L, 2013, APPL ENVIRON MICROB, V79, P4031, DOI 10.1128/AEM.00095-13; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Pavlopoulos GA, 2011, BIODATA MIN, V4, DOI 10.1186/1756-0381-4-10; Raman K, 2009, BRIEF BIOINFORM, V10, P435, DOI 10.1093/bib/bbp011; Reed JL, 2006, NAT REV GENET, V7, P130, DOI 10.1038/nrg1769; Roling WFM, 2010, CURR OPIN BIOTECH, V21, P532, DOI 10.1016/j.copbio.2010.06.007; Scardoni G, 2009, BIOINFORMATICS, V25, P2857, DOI 10.1093/bioinformatics/btp517; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; Seauencina H., 2011, WORKBENCH, P1; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sorokin DY, 2011, ISME J, V2; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; Vieites JM, 2009, FEMS MICROBIOL REV, V33, P236, DOI 10.1111/j.1574-6976.2008.00152.x; Xu ZF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093445; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604; Zamora MA, 2015, ECOL MODEL, V313, P259, DOI 10.1016/j.ecolmodel.2015.06.041; ZHANG ZH, 2009, PLOS ONE, V4; Zomorrodi AR, 2014, ACS SYNTH BIOL, V3, P247, DOI 10.1021/sb4001307	43	4	4	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0181826	10.1371/journal.pone.0181826	http://dx.doi.org/10.1371/journal.pone.0181826			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767679	Green Published, Green Submitted, gold			2022-12-26	WOS:000406768200036
J	Li, P; Xiao, ZT; Braciak, TA; Ou, QJ; Chen, G; Oduncu, FS				Li, Pan; Xiao, Zhitao; Braciak, Todd A.; Ou, Qingjian; Chen, Gong; Oduncu, Fuat S.			Systematic immunohistochemical screening for mismatch repair and ERCC1 gene expression from colorectal cancers in China: Clinicopathological characteristics and effects on survival	PLOS ONE			English	Article							MICROSATELLITE INSTABILITY; DNA-REPAIR; SENSITIVITY; CELLS	Background We performed a systematic screening of colorectal cancer (CRC) tissues to investigate whether mismatch repair (MMR) status and ERCC1 protein expression could be predictive of clinical outcomes for these patients following the recommendation of The Evaluation of Genomic Applications in Practice of Prevention (EGAPP). Methods The expression of four MMR genes and ERCC1 were assessed by immunohistochemistry (IHC) from cancer tissue samples of 2233 consecutive CRC patients. Results We observed that most CRC patients with a proficient MMR (pMMR) status tended to have simultaneous ERCC1 protein expression (P< 0.001). Stage III CRC patients with deficient MMR (dMMR) had higher prognoses than the same stage patients with pMMR (DFS: 74% vs 65%, P = 0.04; OS: 79% vs 69%, P = 0.04). Here, dMMR is also associated with poorer survival for stage II patients after chemotherapy (DFS: 66% vs 78%, P = 0.04). Stage II and III patients that were shown to express ERCC1 protein had higher DFS and OS than those that were deficient in expression (stage II, DFS: 83% vs 70%, P = 0.006; OS 85% vs 73%, P = 0.02. Stage III, DFS: 67% vs56%, P = 0.03; OS: 71% vs 57%, P = 0.04). Conclusions Our results indicate that dMMR appeared to predictive of a survival benefit for stage III CRC patients. We also found the determination of ERCC1 expression to be useful for predicting DFS or OS for stage II and III CRC patients. In addition, the expression of MMR genes and ERCC1 showed a significant relationship.	[Li, Pan; Braciak, Todd A.; Oduncu, Fuat S.] Ludwig Maximilians Univ Munchen, Dept Hematol & Oncol, Med Klin & Poliklin 4, Munich, Germany; [Xiao, Zhitao; Ou, Qingjian; Chen, Gong] Sun Yat Sen Univ, Canc Ctr, Dept Colorectal Surg, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China	University of Munich; State Key Lab Oncology South China; Sun Yat Sen University	Oduncu, FS (corresponding author), Ludwig Maximilians Univ Munchen, Dept Hematol & Oncol, Med Klin & Poliklin 4, Munich, Germany.; Ou, QJ; Chen, G (corresponding author), Sun Yat Sen Univ, Canc Ctr, Dept Colorectal Surg, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.	ouqj@sysucc.org.cn; chengong@sysucc.org.cn; fuat.oduncu@med.uni-muenchen.de						Arnould S, 2003, EUR J CANCER, V39, P112, DOI 10.1016/S0959-8049(02)00411-2; Berg AO, 2009, GENET MED, V11, P35, DOI [10.1097/GIM.0b013e318181fa2ff, 10.1097/GIM.0b013e31818fa2ff]; Bertagnolli MM, 2011, J CLIN ONCOL, V29, P3153, DOI 10.1200/JCO.2010.33.0092; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Chang IY, 2005, BIOCHEM BIOPH RES CO, V327, P225, DOI 10.1016/j.bbrc.2004.12.008; Goode EL, 2002, CANCER EPIDEM BIOMAR, V11, P1513; Hall G, 2010, PATHOLOGY, V42, P409, DOI 10.3109/00313025.2010.493871; Jass JR, 1998, GUT, V42, P673, DOI 10.1136/gut.42.5.673; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jenkins MA, 2007, GASTROENTEROLOGY, V133, P48, DOI 10.1053/j.gastro.2007.04.044; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kumar K, 2009, CLIN CANCER RES, V15, P1155, DOI 10.1158/1078-0432.CCR-08-1029; Lanza G, 2006, J CLIN ONCOL, V24, P2359, DOI 10.1200/JCO.2005.03.2433; Malesci A, 2007, CLIN CANCER RES, V13, P3831, DOI 10.1158/1078-0432.CCR-07-0366; Nishina T, 2013, JPN J CLIN ONCOL, V43, P1080, DOI 10.1093/jjco/hyt127; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Southey MC, 2005, J CLIN ONCOL, V23, P6524, DOI 10.1200/JCO.2005.04.671; Sylvester BE, 2012, CLIN CANCER RES, V18, P350, DOI 10.1158/1078-0432.CCR-11-1397; Viguier J, 2005, CLIN CANCER RES, V11, P6212, DOI 10.1158/1078-0432.CCR-04-2216; Youn CK, 2004, CANCER RES, V64, P4849, DOI 10.1158/0008-5472.CAN-04-0348; Zaanan A, 2014, CURR COLORECT CANC R, V10, P346, DOI 10.1007/s11888-014-0237-2; Zaanan A, 2011, CLIN CANCER RES, V17, P7470, DOI 10.1158/1078-0432.CCR-11-1048	23	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0181615	10.1371/journal.pone.0181615	http://dx.doi.org/10.1371/journal.pone.0181615			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767665	Green Published, Green Submitted, gold			2022-12-26	WOS:000406768200033
J	Washburn, N; Meccariello, R; Hu, SH; Hains, M; Bhatnagar, N; Sarvaiya, H; Kapoor, B; Schaeck, J; Pino, I; Manning, A; Lansing, JC; Bosques, CJ				Washburn, Nathaniel; Meccariello, Robin; Hu, Shaohui; Hains, Maurice; Bhatnagar, Naveen; Sarvaiya, Hetal; Kapoor, Bulbul; Schaeck, John; Pino, Ignacio; Manning, Anthony; Lansing, Jonathan C.; Bosques, Carlos J.			High-resolution physicochemical characterization of different intravenous immunoglobulin products	PLOS ONE			English	Article							ANTIINFLAMMATORY ACTIVITY; FC SIALYLATION; DIMERIC IGG; ANTIBODY; IVIG; GLYCOSYLATION; PROTEIN; IDENTIFICATION; ASSOCIATION; MECHANISMS	Intravenous immunoglobulin (IVIg) is a complex mixture drug comprising diverse immunoglobulins and non-IgG proteins purified from the plasma of thousands of healthy donors. Approved IVIg products on the market differ regarding source of plasma, isolation process, and formulation. These products are used widely, and often interchangeably, for the treatment of immunodeficiency and autoimmune and inflammatory diseases, but their mechanisms of action in different indications are not well understood. A primary limitation to understanding the therapeutic relevance of specific components within IVIg has been the limited resolution of analytics historically implemented to characterize its complex mixture. In this study, high-resolution analytics were applied to better understand the composition of IVIg and product variations. We characterized three approved IVIg products: Gammagard (R), Privigen (R), and Octagam (R). Differences in the distribution of molecular weight species, IgG sequence variants, isoforms, glycoforms, and the repertoire of previously reported antibody specificities were identified. We also compared the effect of aging on these products to identify changes in size distribution and posttranslational modifications. This type of characterization may provide insights into the specific factors and components of IVIg that may influence its activity and ultimately lead to optimization of IVIg products for use in autoimmune diseases.	[Washburn, Nathaniel; Meccariello, Robin; Hains, Maurice; Bhatnagar, Naveen; Sarvaiya, Hetal; Kapoor, Bulbul; Schaeck, John; Manning, Anthony; Lansing, Jonathan C.; Bosques, Carlos J.] Momenta Pharmaceut, Res, Cambridge, MA 02142 USA; [Hu, Shaohui] CDI Labs, Res, Baltimore, MD USA; [Pino, Ignacio] CDI Labs, Res, Mayaguez, PR USA		Bosques, CJ (corresponding author), Momenta Pharmaceut, Res, Cambridge, MA 02142 USA.	cbosques@momentapharma.com	Hu, Shaohui/AAE-4433-2020		Momenta Pharmaceuticals Inc.	Momenta Pharmaceuticals Inc.	Momenta Pharmaceuticals Inc. funded the study. The funder provided support in the form of salaries for authors NW, RM, MH, NB, HS, BK, JS, AM, JL, and CJB but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'Author Contributions' section of the online submission. Momenta Pharmaceuticals Inc. provided funding for medical writing and editorial support.	Andya JD, 1999, PHARMACEUT RES, V16, P350, DOI 10.1023/A:1018805232453; Anthony RM, 2008, P NATL ACAD SCI USA, V105, P19571, DOI 10.1073/pnas.0810163105; Bartelds GM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3208; Basta G, 2004, CARDIOVASC RES, V63, P582, DOI 10.1016/j.cardiores.2004.05.001; Bondt A, 2014, MOL CELL PROTEOMICS, V13, P3029, DOI 10.1074/mcp.M114.039537; Bouma B, 2003, J BIOL CHEM, V278, P41810, DOI 10.1074/jbc.M303925200; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; Bussone G, 2009, PROTEOMICS, V9, P2253, DOI 10.1002/pmic.200800819; Durandy A, 2009, CLIN EXP IMMUNOL, V158, P2, DOI [10.1111/j.1365-2249.2009.04022.X, 10.1111/j.1365-2249.2009.04022.x]; FEHR J, 1982, NEW ENGL J MED, V306, P1254, DOI 10.1056/NEJM198205273062102; FRENCH MAH, 1984, CLIN EXP IMMUNOL, V56, P473; Goetze AM, 2012, GLYCOBIOLOGY, V22, P221, DOI 10.1093/glycob/cwr141; Ha S, 2011, GLYCOBIOLOGY, V21, P1087, DOI 10.1093/glycob/cwr047; Hartung HP, 2009, CLIN EXP IMMUNOL, V158, P23, DOI [10.1111/j.1365-2249.2009.04024.X, 10.1111/j.1365-2249.2009.04024.x]; Hawe A, 2008, ANAL BIOCHEM, V378, P115, DOI 10.1016/j.ab.2008.03.050; HUIZINGA TWJ, 1989, J IMMUNOL, V142, P2359; Jefferis R, 2009, MABS, V1, P332, DOI 10.4161/mabs.1.4.9122; Jeong JS, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016253; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Karsten CM, 2012, NAT MED, V18, P1401, DOI 10.1038/nm.2862; KING DJ, 1992, BIOCHEM J, V281, P317, DOI 10.1042/bj2810317; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; Lackner F, 2014, ELECTROPHORESIS, V35, P515, DOI 10.1002/elps.201300319; Magdelaine-Beuzelin C, 2009, PHARMACOGENET GENOM, V19, P383, DOI 10.1097/FPC.0b013e32832a06bf; MALHOTRA R, 1995, NAT MED, V1, P237, DOI 10.1038/nm0395-237; Martin TD, 2006, INT IMMUNOPHARMACOL, V6, P517, DOI 10.1016/j.intimp.2005.11.005; Negi VS, 2007, J CLIN IMMUNOL, V27, P233, DOI 10.1007/s10875-007-9088-9; Neron S, 2014, OPEN J IMMUNOL, V4, p68 ; Neron S, 2012, BIOCH ANAL BIOCH, pS8; Nimmerjahn F, 2008, ANNU REV IMMUNOL, V26, P513, DOI 10.1146/annurev.immunol.26.021607.090232; Orbach H, 2005, CLIN REV ALLERG IMMU, V29, P173, DOI 10.1385/CRIAI:29:3:173; Radosevich M, 2010, VOX SANG, V98, P12, DOI 10.1111/j.1423-0410.2009.01226.x; Rombouts Y, 2016, ANN RHEUM DIS, V75, P578, DOI 10.1136/annrheumdis-2014-206598; Rosenberg AS, 2006, AAPS J, V8, pE501, DOI 10.1208/aapsj080359; Schwab I, 2013, NAT REV IMMUNOL, V13, P176, DOI 10.1038/nri3401; Seifner A, 2014, TRANSFUSION, V54, P376, DOI 10.1111/trf.12280; Sridhar G, 2014, TRANSFUSION, V54, P2553, DOI 10.1111/trf.12663; Tobon-Velasco JC, 2014, CNS NEUROL DISORD-DR, V13, P1615, DOI 10.2174/1871527313666140806144831; US Department of Health and Human Services Food and Drug Administration and Center for Drug Evaluation and Research, 2014, GUID IND IMM ASS THE; Washburn N, 2015, P NATL ACAD SCI USA, V112, pE1297, DOI 10.1073/pnas.1422481112; Wymann S, 2008, MOL IMMUNOL, V45, P2621, DOI 10.1016/j.molimm.2007.12.020	41	1	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0181251	10.1371/journal.pone.0181251	http://dx.doi.org/10.1371/journal.pone.0181251			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759653	Green Published, Green Submitted, gold			2022-12-26	WOS:000406761600014
J	Chao, TK; Huang, TS; Liao, YP; Huang, RL; Su, PH; Shen, HY; Lai, HC; Wang, YC				Chao, Tai-Kuang; Huang, Tien-Shuo; Liao, Yu-Ping; Huang, Rui-Lan; Su, Po-Hsuan; Shen, Hueng-Yuan; Lai, Hung-Cheng; Wang, Yu-Chi			Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer	PLOS ONE			English	Article							ANTITUMOR-ACTIVITY; SHIKONIN; CELL; APOPTOSIS; ISOFORM; GROWTH; ENERGY	Pyruvate kinase M2 (PKM2) regulates glycolysis and oxidative phosphorylation; however, the role of PKM2 in ovarian cancer remains largely unknown. We investigated whether ovarian cancer metabolism could provide insight into the development of therapeutic strategies. We performed immunohistochemical staining for PKM2 on a tissue microarray for multivariate analysis. It revealed that patients exhibiting higher PKM2 expression were significantly associated with malignancy groups (p < 0.001) and pathogenesis models (p < 0.001), had poor progression-free survival rates (p = 0.01) as compared with patients exhibiting lower PKM2 levels, and yielded a hazard ratio of death of 2.02 (95% confidence interval: 0.70-5.85). In cell lines, PKM2 inhibitor significantly inhibited the glycolytic rate according to cellular glucose consumption (p < 0.001). We also utilized Seahorse assays to assess metabolism- related cell-specific factors and the impact of PKM2 inhibitors. Energy shifts as per Seahorse analysis showed attenuation of the extracellular acidification rate (p < 0.05) and no significant difference in oxygen-consumption rate in SKOV3 cells. Treatment with PKM2 inhibitor suppressed ovarian cancer growth and cell migration in vitro and inhibited tumor growth without significant toxicity in a xenograft study. PKM2 inhibition disturbed Warburg effects and inhibited ovarian cancer cell growth. Targeting PKM2 may constitute a promising therapy for patients with ovarian cancer, and clinical trials involving shikonin are warranted.	[Chao, Tai-Kuang; Lai, Hung-Cheng; Wang, Yu-Chi] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Chao, Tai-Kuang] Triserv Gen Hosp, Dept Pathol, Natl Def Med Ctr, Taipei, Taiwan; [Chao, Tai-Kuang; Huang, Tien-Shuo; Liao, Yu-Ping; Huang, Rui-Lan; Su, Po-Hsuan; Lai, Hung-Cheng; Wang, Yu-Chi] Natl Def Med Ctr, Lab Epigenet & Canc Stem Cells, Taipei, Taiwan; [Huang, Tien-Shuo; Liao, Yu-Ping; Huang, Rui-Lan; Su, Po-Hsuan; Lai, Hung-Cheng] Taipei Med Univ, Shuang Ho Hosp, Dept Obstet & Gynecol, New Taipei, Taiwan; [Huang, Tien-Shuo; Liao, Yu-Ping; Huang, Rui-Lan; Su, Po-Hsuan; Lai, Hung-Cheng] Taipei Med Univ, Sch Med, Dept Obstet & Gynecol, Coll Med, Taipei, Taiwan; [Shen, Hueng-Yuan] Triserv Gen Hosp, Dept Nucl Med, Natl Def Med Ctr, Taipei, Taiwan; [Shen, Hueng-Yuan] Triserv Gen Hosp, PET Ctr, Natl Def Med Ctr, Taipei, Taiwan; [Wang, Yu-Chi] Triserv Gen Hosp, Dept Obstet & Gynecol, Natl Def Med Ctr, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital	Wang, YC (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.; Wang, YC (corresponding author), Natl Def Med Ctr, Lab Epigenet & Canc Stem Cells, Taipei, Taiwan.; Wang, YC (corresponding author), Triserv Gen Hosp, Dept Obstet & Gynecol, Natl Def Med Ctr, Taipei, Taiwan.	yuchitsgh@ndmctsgh.edu.tw		Huang, Rui Lan/0000-0001-6458-4672	 [TSGH-C103-076];  [TSGH-C104-071];  [TSGH-C105-072];  [TSGH-C106-059];  [TSGH-C104-006-006-008-S01];  [TSGH-C104-006-006-008-S02];  [TSGH-C104-006-006-008-S03];  [TMU-NDMC-104-05];  [104TMU-SHH-07];  [NHRI-EX104-1040661];  [NHRI-EX105-1040661]	; ; ; ; ; ; ; ; ; ; 	The work was supported by the following: TSGH-C103-076, TSGH-C104-071, TSGH-C105-072, TSGH-C106-059, TSGH-C104-006-006-008-S01, TSGH-C104-006-006-008-S02, TSGH-C104-006-006-008-S03, TMU-NDMC-104-05, 104TMU-SHH-07, NHRI-EX104-1040661, NHRI-EX105-1040661. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Wahab Z, 2015, ONCOTARGET, V6, P10908, DOI 10.18632/oncotarget.3434; Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Chen J, 2011, ONCOGENE, V30, P4297, DOI 10.1038/onc.2011.137; Chen X, 2002, PHYTOTHER RES, V16, P199, DOI 10.1002/ptr.1100; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Guo X P, 1991, Zhong Xi Yi Jie He Za Zhi, V11, P598; Hao ZF, 2015, ONCOL LETT, V9, P629, DOI 10.3892/ol.2014.2771; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Lai HC, 2014, GYNECOL ONCOL, V135, P552, DOI 10.1016/j.ygyno.2014.10.018; Lengyel E, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.10.026; Li WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094079; Li WJ, 2014, MOL CARCINOGEN, V53, P403, DOI 10.1002/mc.21988; Lim JY, 2012, WORLD J GASTROENTERO, V18, P4037, DOI 10.3748/wjg.v18.i30.4037; Liu LD, 2012, NATURE, V483, P608, DOI 10.1038/nature10927; Martirosyan A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-103; Matthaiou EI, 2014, INT J NANOMED, V9, P1855, DOI 10.2147/IJN.S51880; Meng E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107142; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; NOGUCHI T, 1986, J BIOL CHEM, V261, P3807; SANKAWA U, 1977, CHEM PHARM BULL, V25, P2392; SANKAWA U, 1981, CHEM PHARM BULL, V29, P116; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Teicher BA, 2012, CLIN CANCER RES, V18, P5537, DOI 10.1158/1078-0432.CCR-12-2587; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Wang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074538; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yeh CC, 2007, IN VIVO, V21, P1011; Zhao Z, 2016, TUMOR BIOL, V37, P4223, DOI 10.1007/s13277-015-4121-8	32	35	39	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0182166	10.1371/journal.pone.0182166	http://dx.doi.org/10.1371/journal.pone.0182166			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753677	Green Submitted, Green Published, gold			2022-12-26	WOS:000406579300054
J	Ochocka, R; Hering, A; Hajduk, JS; Cal, K; Baranska, H				Ochocka, Renata; Hering, Anna; Hajduk, Justyna Stefanowicz; Cal, Krzysztof; Baranska, Helena			The effect of mangiferin on skin: Penetration, permeation and inhibition of ECM enzymes	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE-1; FLUORESCENCE; SOLUBILITY; ELASTASE; PLANT	Mangiferin (2-C-beta-D-glucopyranosyl-1,3,6,7-tetrahydroxyxanthone) is a polyphenol with strong antioxidant properties. Mangiferin is obtained from the mango tree (Mangifera indica L., Anacardiaceae). It has been proven that mangiferin exhibits many pharmacological activities. The aim of this study was to analyze the penetration of mangiferin into the human skin and through the skin. According to our knowledge, skin penetration and permeation studies of mangiferin have not been analyzed so far. Additionally, the influence of mangiferin on two Extracellular Matrix Enzymes (ECM): collagenase and elastase, was evaluated for the first time. It has been indicated that mangiferin is able to permeate the stratum corneum and penetrate into the epidermis and dermis in comparable amounts. For confirmation of the obtained results, fluorescence microscopy was successfully utilized. The analysis revealed the capability of mangiferin to reversibly inhibit elastase and collagenase activity. The mechanism of mangiferin interaction with both enzymes was estimated as a noncompetitive inhibition.	[Ochocka, Renata; Hering, Anna; Hajduk, Justyna Stefanowicz] Med Univ Gdansk, Dept Biol & Pharmaceut Bot, Gdansk, Poland; [Cal, Krzysztof; Baranska, Helena] Med Univ Gdansk, Dept Pharmaceut Technol, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk	Ochocka, R (corresponding author), Med Univ Gdansk, Dept Biol & Pharmaceut Bot, Gdansk, Poland.	renata@gumed.edu.pl		hering, anna/0000-0003-1060-5380	Ministry of Science and Higher Education of the Republic of Poland, under Leading National Research Centre (KNOW)	Ministry of Science and Higher Education of the Republic of Poland, under Leading National Research Centre (KNOW)	This project was supported by the Ministry of Science and Higher Education of the Republic of Poland, from the quality - promoting subsidy, under the Leading National Research Centre (KNOW) program for the years 2012-2017.	Acosta J, 2016, J PHARM PHARMACOGN R, V4, P49; Afaq F, 2006, EXP DERMATOL, V15, P678, DOI 10.1111/j.1600-0625.2006.00466.x; Bartoszewski R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092128; Baud Stephanie, 2013, Biomol Concepts, V4, P65, DOI 10.1515/bmc-2011-0062; Chae S, 2011, BIOSCI BIOTECH BIOCH, V75, P2321, DOI 10.1271/bbb.110465; CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354; De Nysschen AM, 1996, BIOCHEM SYST ECOL, V24, P243, DOI 10.1016/0305-1978(95)00100-X; Doose S, 2009, CHEMPHYSCHEM, V10, P1389, DOI 10.1002/cphc.200900238; Garg AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034475; Ghosal S, 1996, INDIAN J CHEM B, V35, P561; Gold-Smith F, 2016, NUTRIENTS, V8, DOI 10.3390/nu8070396; Joubert E, 2012, S AFR J BOT, V82, P113, DOI 10.1016/j.sajb.2012.07.019; Kim JH, 2009, J MED PLANTS RES, V3, P914; KLIGMAN AM, 1963, ARCH DERMATOL, V88, P702, DOI 10.1001/archderm.1963.01590240026005; Kokotkiewicz A, 2012, Z NATURFORSCH C, V67, P65, DOI 10.5560/ZNC.2012.67c0065; Lahmann C, 2001, LANCET, V357, P935, DOI 10.1016/S0140-6736(00)04220-3; Lim SH, 2011, PHOTOCHEM PHOTOBIOL, V87, P1152, DOI 10.1111/j.1751-1097.2011.00939.x; Lin H, 2009, SPECTROCHIM ACTA A, V73, P936, DOI 10.1016/j.saa.2009.04.025; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Marti-Mestres G, 2007, INT J PHARMACEUT, V331, P139, DOI 10.1016/j.ijpharm.2006.09.020; Masibo M, 2008, COMPR REV FOOD SCI F, V7, P309, DOI 10.1111/j.1541-4337.2008.00047.x; Muruganandan S, 2002, TOXICOLOGY, V176, P165, DOI 10.1016/S0300-483X(02)00069-0; Naylor EC, 2011, MATURITAS, V69, P249, DOI 10.1016/j.maturitas.2011.04.011; NOTT PE, 1967, PHYTOCHEMISTRY, V6, P741, DOI 10.1016/S0031-9422(00)86015-X; Nunez-Selles AJ, 2005, J BRAZIL CHEM SOC, V16, P699, DOI 10.1590/S0103-50532005000500004; Prado Y, 2015, J PHARM PHARMACOGN R, V3, P13; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Quan TH, 2009, J INVEST DERM SYMP P, V14, P20, DOI 10.1038/jidsymp.2009.8; Sethiya N. K., 2008, ASIAN J TRAD MED, V3, P224; Shi Y, 2005, FOOD CHEM, V92, P707, DOI 10.1016/j.foodchem.2004.08.031; Shoji K, 2011, ARCH PHARM RES, V34, P469, DOI 10.1007/s12272-011-0316-8; Thring TSA, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-27; Valentine RM, 2013, PHOTOCH PHOTOBIO SCI, V12, P203, DOI 10.1039/c2pp25271f; Wang JJ, 2005, CHROMATOGRAPHIA, V61, P633, DOI 10.1365/s10337-005-0563-2; Wang SQ, 2010, DERMATOL THER, V23, P31, DOI 10.1111/j.1529-8019.2009.01289.x; Yue YY, 2009, J PHARMACEUT BIOMED, V49, P753, DOI 10.1016/j.jpba.2008.12.017	36	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181542	10.1371/journal.pone.0181542	http://dx.doi.org/10.1371/journal.pone.0181542			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750062	Green Published, gold, Green Submitted			2022-12-26	WOS:000406575700056
J	Yoshioka, N; Dowdy, SF				Yoshioka, Naohisa; Dowdy, Steven F.			Enhanced generation of iPSCs from older adult human cells by a synthetic five-factor self-replicative RNA	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; INDUCTION; VIRUS; VECTOR	We previously devised a polycistronic, synthetic self-replicating RNA (srRNA) to generate human induced Pluripotent Stem Cells (iPSCs) that simultaneously expresses four reprogramming factors (4F). However, while the best 4F srRNA efficiently generated iPSCs from young fibroblasts, it was inefficient on adult human fibroblasts (> 50 years). To increase the iPSC generation efficiency, we included additional reprogramming factors. We found that a single transfection of a five factor (5F) srRNA, containing OCT4, KLF4, SOX2, GLIS1 and cMYC, robustly generated iPSCs from adult human fibroblasts aged 54 to 77 and from a 24 year old cardiomyopathy patient donor. Interestingly, 5F-srRNA induced LIN28A, which was one of the original reprogramming factors. 5F-srRNA also accelerated the generation of iPSCs by seven days compared to 4F-srRNAs. Further improvements include phosphatase treatment to remove 5' phosphate and use of Lipofectamine MessengerMAX that increased transfection efficiency to similar to 90%. Together, these improvements enabled us to efficiently generate iPSCs from human fibroblasts using 5F-srRNA while eliminating both puromycin selection and feeder cells.	[Yoshioka, Naohisa; Dowdy, Steven F.] UCSD Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Yoshioka, Naohisa] EMD Millipore, Hayward, CA USA	University of California System; University of California San Diego; Merck KGaA; MilliporeSigma	Dowdy, SF (corresponding author), UCSD Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	sdowdy@ucsd.edu			Keck Foundation	Keck Foundation(W.M. Keck Foundation)	This work was supported by Keck Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alateeq S, 2015, CURR STEM CELL RES T, V10, P193, DOI 10.2174/1574888X10666150220154820; Alcami A, 2000, J VIROL, V74, P11230, DOI 10.1128/JVI.74.23.11230-11239.2000; Angel M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011756; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Gonzalez F, 2011, NAT REV GENET, V12, P231, DOI 10.1038/nrg2937; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hu KJ, 2014, STEM CELLS DEV, V23, P1285, DOI 10.1089/scd.2013.0620; Hussein SMI, 2011, CLIN PHARMACOL THER, V89, P741, DOI 10.1038/clpt.2011.37; KINNEY RM, 1989, VIROLOGY, V170, P19, DOI 10.1016/0042-6822(89)90347-4; Liu XP, 2013, NAT CELL BIOL, V15, P829, DOI 10.1038/ncb2765; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Mayr F, 2013, INT J MOL SCI, V14, P16532, DOI 10.3390/ijms140816532; Nallagatla SR, 2008, RNA BIOL, V5, P140, DOI 10.4161/rna.5.3.6839; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Rosa A, 2013, INT J MOL SCI, V14, P14346, DOI 10.3390/ijms140714346; Schlaeger TM, 2015, NAT BIOTECHNOL, V33, P58, DOI 10.1038/nbt.3070; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yoshioka N, 2013, CELL STEM CELL, V13, P246, DOI 10.1016/j.stem.2013.06.001; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	26	17	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0182018	10.1371/journal.pone.0182018	http://dx.doi.org/10.1371/journal.pone.0182018			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750082	Green Submitted, Green Published, gold			2022-12-26	WOS:000406575700114
J	Crossland, H; Timmons, JA; Atherton, PJ				Crossland, Hannah; Timmons, James A.; Atherton, Philip J.			A dynamic ribosomal biogenesis response is not required for IGF-1-mediated hypertrophy of human primary myotubes	FASEB JOURNAL			English	Article						RNA; skeletal muscle; mTOR	SKELETAL-MUSCLE HYPERTROPHY; RNA-POLYMERASE-I; C-MYC; RESISTANCE EXERCISE; RDNA TRANSCRIPTION; PROTEIN-SYNTHESIS; UBIQUITIN LIGASES; EXPRESSION; GROWTH; CELLS	Increased ribosomal DNA transcription has been proposed to limit muscle protein synthesis, making ribosome biogenesis central to skeletal muscle hypertrophy. We examined the relationship between ribosomal RNA (rRNA) production and IGF-n/1-n/mediated myotube hypertrophy in vitro. Primary skeletal myotubes were treated with IGF-n/1 (50 ng/ml) with or without 0.5 mu MCX-n/5461 (CX), an inhibitor of RNA polymerase I. Myotube diameter, total protein, and RNA and DNA levels were measured along with markers of RNA polymerase I regulatory factors and regulators of protein synthesis. CX treatment reduced 45S pre-n/rRNA expression (-64 +/- 5% vs. IGF-n/1; P < 0.001) and total RNA content (-16 +/- 2% vs. IGF-n/1; P < 0.001) in IGF-n/1-n/treated myotubes. IGF-n/1-n/mediated increases in myotube diameter (1.27 +/- 0.09-n/fold, P < 0.05 vs. control) and total protein (+20 +/- 2%; P < 0.001 vs. control) were not prevented by CX treatment. Suppression of rRNAsynthesis during IGF-n/1 treatment did not prevent early increases in AKT (+203 +/- 39% vs. CX; P < 0.001) and p70 S6K1 (269 +/- 41% vs. CX; P < 0.001) phosphorylation. Despite robust inhibition of the dynamic ribosomal biogenesis response to IGF-n/1, myotube diameter and protein accretion were sustained. Thus, while ribosome biogenesis represents a potential site for the regulation of skeletal muscle protein synthesis and muscle mass, it does not appear to be a prerequisite for IGF-n/1-n/induced myotube hypertrophy in vitro.-n/Crossland, H., Timmons, J. A., Atherton, P. J. A dynamic ribosomal biogenesis response is not required for IGF-n/1-n/mediated hypertrophy of human primary myotubes.	[Crossland, Hannah; Timmons, James A.] Kings Coll London, Guys Hosp, Div Genet & Mol Med, London, England; [Crossland, Hannah; Atherton, Philip J.] Univ Nottingham, Royal Derby Hosp, Sch Med, Derby, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Nottingham	Atherton, PJ (corresponding author), Univ Nottingham, Clin Metab & Mol Physiol, Med Sch, Royal Derby Hosp, Uttoxeter Rd, Derby DE22 3DT, England.	philip.atherton@nottingham.ac.uk	Crossland, Hannah/GMW-8128-2022; Timmons, James A/J-4698-2014; Timmons, James A/M-6350-2019	Timmons, James A/0000-0002-2255-1220; Timmons, James A/0000-0002-2255-1220; Atherton, Philip/0000-0002-7286-046X	UK Medical Research Council (MRC) [G1100015]; MRC-Arthritis Research UK (ARUK) Centre for Musculoskeletal Ageing Research [MR/K00414X/1, 19891]; Medical Research Council [G1100015] Funding Source: researchfish; MRC [G1100015] Funding Source: UKRI	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC-Arthritis Research UK (ARUK) Centre for Musculoskeletal Ageing Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in part, by the UK Medical Research Council (MRC; Grant G1100015). The MRC-Arthritis Research UK (ARUK) Centre for Musculoskeletal Ageing Research was funded through MRC Grant MR/K00414X/1 and ARUK Grant 19891 awarded to the Universities of Nottingham and Birmingham. The primary cells used were provided by T. Gustafsson (Karolinska Institutet, Solna, Sweden). The authors declare no conflicts of interest.	Adams GR, 1999, J APPL PHYSIOL, V87, P1705, DOI 10.1152/jappl.1999.87.5.1705; Albert B, 2012, GENET RES INT, V2012, DOI 10.1155/2012/276948; Baar K, 1999, AM J PHYSIOL-CELL PH, V276, pC120, DOI 10.1152/ajpcell.1999.276.1.C120; Beckouet F, 2008, MOL CELL BIOL, V28, P1596, DOI 10.1128/MCB.01464-07; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Boon K, 2001, EMBO J, V20, P1383, DOI 10.1093/emboj/20.6.1383; Brook MS, 2016, J PHYSIOL-LONDON, V594, P7399, DOI 10.1113/JP272857; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; Campbell KJ, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a018408; Chen YW, 2002, J PHYSIOL-LONDON, V545, P27, DOI 10.1113/jphysiol.2002.021220; Crossland H, 2013, AM J PHYSIOL-ENDOC M, V305, pE183, DOI 10.1152/ajpendo.00541.2012; ENDO T, 1986, MOL CELL BIOL, V6, P1412, DOI 10.1128/MCB.6.5.1412; Figueiredo VC, 2015, AM J PHYSIOL-ENDOC M, V309, pE72, DOI 10.1152/ajpendo.00050.2015; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Hannan KM, 2003, MOL CELL BIOL, V23, P8862, DOI 10.1128/MCB.23.23.8862-8877.2003; HANZLIKOVA V, 1975, CELL TISSUE RES, V160, P411; Kim S, 2000, P NATL ACAD SCI USA, V97, P11198, DOI 10.1073/pnas.200372597; Kuhn CD, 2007, CELL, V131, P1260, DOI 10.1016/j.cell.2007.10.051; Kusnadi EP, 2015, GENE, V556, P27, DOI 10.1016/j.gene.2014.11.010; Li LM, 2016, ONCOTARGETS THER, V9, P5985, DOI 10.2147/OTT.S104513; Mammucari C, 2008, AUTOPHAGY, V4, P524, DOI 10.4161/auto.5905; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504; Milan G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7670; Nader GA, 2005, AM J PHYSIOL-CELL PH, V289, pC1457, DOI 10.1152/ajpcell.00165.2005; Nakada S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147284; Olsson K, 2016, ENDOCRINOLOGY, V157, P98, DOI 10.1210/en.2015-1685; Poortinga G, 2004, EMBO J, V23, P3325, DOI 10.1038/sj.emboj.7600335; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Stec MJ, 2016, AM J PHYSIOL-ENDOC M, V310, pE652, DOI 10.1152/ajpendo.00486.2015; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Tamaki T, 2009, HISTOCHEM CELL BIOL, V132, P71, DOI 10.1007/s00418-009-0584-2; von Walden F, 2016, AM J PHYSIOL-CELL PH, V311, pC663, DOI 10.1152/ajpcell.00144.2016; von Walden F, 2012, AM J PHYSIOL-CELL PH, V302, pC1523, DOI 10.1152/ajpcell.00460.2011; Wen Y, 2016, EXERC SPORT SCI REV, V44, P110, DOI 10.1249/JES.0000000000000082; West DWD, 2016, J PHYSIOL-LONDON, V594, P453, DOI 10.1113/JP271365; Xu H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14432	42	8	8	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5196	5207		10.1096/fj.201700329R	http://dx.doi.org/10.1096/fj.201700329R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28774889	Green Published			2022-12-26	WOS:000416588300007
J	Wei, J; Ding, DX; Wang, T; Liu, Q; Lin, Y				Wei, Jie; Ding, Dongxiao; Wang, Tao; Liu, Qiong; Lin, Yi			MiR-338 controls BPA-triggered pancreatic islet insulin secretory dysfunction from compensation to decompensation by targeting Pdx-1	FASEB JOURNAL			English	Article						glucose homeostasis; estrogen receptor; Gpr30; Glp1; diabetes	ENDOCRINE-DISRUPTING CHEMICALS; GLUCAGON-LIKE PEPTIDE-1; BETA-CELL FUNCTION; HIGH-FAT DIET; BREAST-CANCER CELLS; COUPLED RECEPTOR 30; BISPHENOL-A; DIABETES-MELLITUS; GENE-EXPRESSION; DOWN-REGULATION	Bisphenol A (BPA) can disrupt glucose homeostasis and impair pancreatic islet function; however, the mechanisms behind these effects are poorly understood. Malemice (4wk old) were treated with BPA(50 or 500mg/kg/d) for 8 wk. Whole-body glucose homeostasis, pancreatic islet morphology and function, and miR-338-mediated molecular signal transduction analyses were examined. We showed that BPA treatment ledto a disruption of glucose tolerance and a compensatory increase of pancreatic islets insulin secretion and pancreatic and duodenal homeobox 1 (Pdx1) expression in mice. Inhibition of Pdx1 reduced glucose-stimulated insulin secretion and ATP production in the islets of BPA-exposed mice. Based on primary pancreatic islets, we also confirmed that miR-338 regulated Pdx1 and thus contributed to BPA-induced insulin secretory dysfunction from compensation to decompensation. Shortterm BPA exposure downregulated miR-338 through activation of G-protein-coupled estrogen receptor 1 (Gpr30), whereas long-term BPA exposure upregulated miR-338 through suppression of glucagon-like peptide 1 receptor (Glp1r). Taken together, our results reveal a molecular mechanism, whereby BPA regulates Gpr30/Glp1r to mediate the expression of miR-338, which acts to control Pdx1-dependent insulin secretion. The Gpr30/Glp1r-miR-338-Pdx1 axis should be represented as a novel mechanismby which BPA induces insulin secretory dysfunction in pancreatic islets.-Wei, J., Ding, D., Wang, T., Liu, Q., Lin, Y. MiR-338 controls BPA-triggered pancreatic islet insulin secretory dysfunction from compensation to decompensation by targeting Pdx-1.	[Wei, Jie; Liu, Qiong] Xiamen Univ, Med Coll, Dept Basic Med Sci, Xiamen, Peoples R China; [Wang, Tao] Xiamen Univ, State Key Lab Cellular Stress Biol, Xiamen, Peoples R China; [Wang, Tao] Xiamen Univ, Dept Biomed Sci, Sch Life Sci, Xiamen, Peoples R China; [Ding, Dongxiao; Lin, Yi] Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm & Hlth, Xiamen 361021, Peoples R China	Xiamen University; Xiamen University; Xiamen University; Chinese Academy of Sciences; Institute of Urban Environment, CAS	Lin, Y (corresponding author), Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm & Hlth, Xiamen 361021, Peoples R China.; Wei, J (corresponding author), Xiamen Univ, Dept Basic Med Sci, Med Coll, Xiamen Na 361102, Fujian, Peoples R China.	jiewei@xmu.edu.cn; ylin@iue.ac.cn	CAS, KLUEH/T-5743-2019		National Natural Science Foundation of China [81502782, 21677140]; Natural Science Foundation of Fujian [2015J01351, 2017J01028]; Fundamental Research Funds for the Central Universities [20720150113]; Youth Innovation Promotion Association, Chinese Academy of Sciences [217349]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian(Natural Science Foundation of Fujian Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Youth Innovation Promotion Association, Chinese Academy of Sciences	The authors thank the Xiamen University Laboratory Animal Center for providing animal management and care and Shaopeng Yu of the Center for helping to perform the animal experiments. This work was supported by Grants 81502782 and 21677140 from the National Natural Science Foundation of China; Grants 2015J01351 and 2017J01028 from the Natural Science Foundation of Fujian; Grant 20720150113 from the Fundamental Research Funds for the Central Universities; and Grant 217349 from the Youth Innovation Promotion Association, Chinese Academy of Sciences. The authors declare no conflicts of interest.	Ahren J, 2010, ISLETS, V2, P353, DOI 10.4161.islets.2.6.13619; Alonso-Magdalena P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002069; Alonso-Magdalena P, 2011, NAT REV ENDOCRINOL, V7, P346, DOI 10.1038/nrendo.2011.56; Aschrafi A, 2012, CELL MOL LIFE SCI, V69, P4017, DOI 10.1007/s00018-012-1064-8; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Carchia E, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.319; D'Cruz SC, 2012, FOOD CHEM TOXICOL, V50, P1124, DOI 10.1016/j.fct.2011.11.041; Damsch S, 2011, TOXICOL PATHOL, V39, P348, DOI 10.1177/0192623310388431; Dong S, 2011, ENVIRON POLLUT, V159, P212, DOI 10.1016/j.envpol.2010.09.004; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; El Ouaamari A, 2008, DIABETES, V57, P2708, DOI 10.2337/db07-1614; Farilla L, 2002, ENDOCRINOLOGY, V143, P4397, DOI 10.1210/en.2002-220405; Filios SR, 2015, DIABETES, V64, P3631, DOI 10.2337/db15-0831; Garofano A, 1998, DIABETOLOGIA, V41, P1114, DOI 10.1007/s001250051038; Gauthier BR, 2004, J BIOL CHEM, V279, P31121, DOI 10.1074/jbc.M405030200; Ge LC, 2014, TOXICOL LETT, V226, P81, DOI 10.1016/j.toxlet.2014.01.035; Gifford R, 2015, LANCET DIABETES ENDO, V3, P925, DOI 10.1016/S2213-8587(15)00423-4; Holst JJ, 2004, AM J PHYSIOL-ENDOC M, V287, pE199, DOI 10.1152/ajpendo.00545.2003; Huygh J, 2015, ENVIRON INT, V81, P64, DOI 10.1016/j.envint.2015.04.008; Jacovetti C, 2012, J CLIN INVEST, V122, P3541, DOI 10.1172/JCI64151; Kang HS, 2014, J PHYSIOL PHARMACOL, V65, P273; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Latreille M, 2014, J CLIN INVEST, V124, P2722, DOI 10.1172/JCI73066; Lin Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.206; Lin Y, 2017, BBA-MOL CELL BIOL L, V1862, P869, DOI 10.1016/j.bbalip.2017.05.001; Marmugi A, 2014, TOXICOLOGY, V325, P133, DOI 10.1016/j.tox.2014.08.006; Moon MK, 2015, J ENDOCRINOL, V226, P35, DOI 10.1530/JOE-14-0714; Nadal A, 2018, J STEROID BIOCHEM, V176, P16, DOI 10.1016/j.jsbmb.2017.01.014; Nesca V, 2013, DIABETOLOGIA, V56, P2203, DOI 10.1007/s00125-013-2993-y; Perreault L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069991; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Pupo M, 2012, ENVIRON HEALTH PERSP, V120, P1177, DOI 10.1289/ehp.1104526; Quesada I, 2002, FASEB J, V16, P1671, DOI 10.1096/fj.02-0313fje; Saura M, 2014, FASEB J, V28, P4719, DOI 10.1096/fj.14-252460; Schneyer A, 2011, ENDOCRINOLOGY, V152, P3301, DOI 10.1210/en.2011-1301; Sharma G, 2011, ENDOCRINOLOGY, V152, P3030, DOI 10.1210/en.2011-0091; Sheng ZG, 2011, ENVIRON HEALTH PERSP, V119, P1775, DOI 10.1289/ehp.1103781; Sieli PT, 2011, ENVIRON HEALTH PERSP, V119, P1260, DOI 10.1289/ehp.1003385; Silver MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026868; Smith EP, 2014, CELL METAB, V19, P1050, DOI 10.1016/j.cmet.2014.04.005; Song LQ, 2012, J ENDOCRINOL, V215, P303, DOI 10.1530/JOE-12-0219; Song Y, 2016, J DIABETES, V8, P516, DOI 10.1111/1753-0407.12325; Soriano S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031109; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Tao SF, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0489-x; Taylor JA, 2011, ENVIRON HEALTH PERSP, V119, P422, DOI 10.1289/ehp.1002514; Teng Y, 2015, J BIOL CHEM, V290, P15799, DOI 10.1074/jbc.M115.641167; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Thomas P, 2006, J STEROID BIOCHEM, V102, P175, DOI 10.1016/j.jsbmb.2006.09.017; Tiano JP, 2012, NAT REV ENDOCRINOL, V8, P342, DOI 10.1038/nrendo.2011.242; Vandenberg LN, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-46; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Veiga-Lopez A, 2013, ENDOCRINOLOGY, V154, P1873, DOI 10.1210/en.2012-2129; Walker MK, 2012, TOXICOL APPL PHARM, V260, P65, DOI 10.1016/j.taap.2012.01.025; Wei J, 2014, FREE RADICAL BIO MED, V67, P91, DOI 10.1016/j.freeradbiomed.2013.10.811; Wei J, 2011, ENDOCRINOLOGY, V152, P3049, DOI 10.1210/en.2011-0045; Welshons WV, 2006, ENDOCRINOLOGY, V147, pS56, DOI 10.1210/en.2005-1159; Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010; Xu G, 2007, DIABETES, V56, P1551, DOI 10.2337/db06-1033	59	28	28	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5184	5195		10.1096/fj.201700282R	http://dx.doi.org/10.1096/fj.201700282R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28774890				2022-12-26	WOS:000416588300006
J	Galuppo, P; Vettorazzi, S; Hovelmann, J; Scholz, CJ; Tuckermann, JP; Bauersachs, J; Fraccarollo, D				Galuppo, Paolo; Vettorazzi, Sabine; Hoevelmann, Julian; Scholz, Claus-Juergen; Tuckermann, Jan Peter; Bauersachs, Johann; Fraccarollo, Daniela			The glucocorticoid receptor in monocyte-derived macrophages is critical for cardiac infarct repair and remodeling	FASEB JOURNAL			English	Article						fibroblast; myeloid cells; myocardial infarction; wound healing	ACUTE MYOCARDIAL-INFARCTION; INFLAMMATORY RESPONSE; CELLULAR COMPOSITION; SUPPRESSION; ANGIOGENESIS; FIBROBLASTS; ACTIVATION; EXPRESSION	Cell-and tissue-specific actions of glucocorticoids are mediated by the glucocorticoid receptor. Here, we demonstrate that the glucocorticoid receptor (GR) in macrophages is essential for cardiac healing after myocardial infarction. Compared with GR(flox) (wild-type controls), GR(LysMCre) mice that lacked GR in myeloid cells showed increased acute mortality as a result of cardiac rupture. Seven days after left coronary artery ligation, GRLysMCre mice exhibited worse cardiac function and adverse remodeling associated with impaired scar formation and angiogenic response to ischemic injury. Inactivation of GR altered the functional differentiation/maturation of monocyte-derived macrophages in the infarcted myocardium. Mechanistically, CD45(+)/CD11b(+)/Ly6G(-)/F4/80(+) macrophages isolated from GRLysMCre infarcts showed deregulation of factors that control inflammation, neovascularization, collagen degradation, and scar tissue formation. Moreover, we demonstrate that cardiac fibroblasts sorted from the ischemic myocardium of GR(LysMCre) mice compared with cells isolated from injured GRflox hearts displayed higher matrix metalloproteinase 2 expression, and we provide evidence that the macrophage GR regulates myofibroblast differentiation in the infarct microenvironment during the early phase of wound healing. In summary, GR signaling in macrophages, playing a crucial role in tissue-repairing mechanisms, could be a potential therapeutic target during wound healing after ischemic myocardial injury.-Galuppo, P., Vettorazzi, S., Hovelmann, J., Scholz, C.-J., Tuckermann, J. P., Bauersachs, J., Fraccarollo, D. The glucocorticoid receptor in monocyte-derived macrophages is critical for cardiac infarct repair and remodeling.	[Galuppo, Paolo; Hoevelmann, Julian; Bauersachs, Johann; Fraccarollo, Daniela] Hannover Med Sch, Dept Cardiol & Angiol, Carl Neuberg St 1, D-30625 Hannover, Germany; [Vettorazzi, Sabine; Tuckermann, Jan Peter] Univ Ulm, Inst Comparat Mol Endocrinol, Ulm, Germany; [Scholz, Claus-Juergen] Univ Bonn, Life & Med Sci Inst LIMES, Bonn, Germany	Hannover Medical School; Ulm University; University of Bonn	Fraccarollo, D (corresponding author), Hannover Med Sch, Dept Cardiol & Angiol, Carl Neuberg St 1, D-30625 Hannover, Germany.	fraccarollo.daniela@mh-hannover.de	Scholz, Claus Jürgen/H-3202-2019; Hoevelmann, Julian/AAP-3995-2021	Scholz, Claus Jürgen/0000-0002-6406-7859; Hoevelmann, Julian/0000-0002-2023-3026; Vettorazzi, Dr. Sabine/0000-0001-8667-9488	German Cardiac Society	German Cardiac Society	The authors thank Margarete Gobel from the Core Unit Systems Medicine (University of Wurzburg) for excellent technical assistance. J.H. was supported by a research grant from the German Cardiac Society. The authors declare no conflicts of interest.	Bujak M, 2008, AM J PATHOL, V173, P57, DOI 10.2353/ajpath.2008.070974; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; Cao J, 2015, MACROMOL RES, V23, P485, DOI 10.1007/s13233-015-3065-6; Chen BJ, 2017, MICROCIRCULATION, V24, DOI 10.1111/micc.12305; Desmet SJ, 2017, J CLIN INVEST, V127, P1136, DOI 10.1172/JCI88886; Dutta P, 2015, ARTERIOSCL THROM VAS, V35, P1066, DOI 10.1161/ATVBAHA.114.304652; Fraccarollo D., 2017, METHODS MOL BIOL FIB; Fraccarollo D, 2008, HYPERTENSION, V51, P905, DOI 10.1161/HYPERTENSIONAHA.107.100941; Fraccarollo D, 2015, ESC HEART FAIL, V2, P150, DOI 10.1002/ehf2.12053; Fraccarollo D, 2012, CARDIOVASC RES, V94, P293, DOI 10.1093/cvr/cvs109; Fraccarollo D, 2011, CIRCULATION, V123, P400, DOI 10.1161/CIRCULATIONAHA.110.983023; Frangogiannis NG, 2001, FASEB J, V15, P1428, DOI 10.1096/fj.00-0745fje; Frangogiannis NG, 2016, CIRC RES, V119, P1049, DOI 10.1161/CIRCRESAHA.116.309926; Frantz S, 2013, FASEB J, V27, P871, DOI 10.1096/fj.12-214049; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Giugliano GR, 2003, AM J CARDIOL, V91, P1055, DOI 10.1016/S0002-9149(03)00148-6; Gray GA, 2017, J MOL ENDOCRINOL, V58, pR1, DOI 10.1530/JME-16-0128; Hafezi-Moghadam A, 2002, NAT MED, V8, P473, DOI 10.1038/nm0502-473; Hilgendorf I, 2014, CIRC RES, V114, P1611, DOI 10.1161/CIRCRESAHA.114.303204; Hubner S, 2015, BIOL CHEM, V396, P1223, DOI 10.1515/hsz-2015-0106; MANNISI JA, 1987, J CLIN INVEST, V79, P1431, DOI 10.1172/JCI112971; Minutti CM, 2017, SEMIN CELL DEV BIOL, V61, P3, DOI 10.1016/j.semcdb.2016.08.006; Montecucco F, 2012, EUR HEART J, V33, P1964, DOI 10.1093/eurheartj/ehr127; Pentecost A. E., 2016, MICROSCALE TECHNOLOG, P292; Pinto AR, 2016, CIRC RES, V118, P400, DOI 10.1161/CIRCRESAHA.115.307778; Prabhu SD, 2016, CIRC RES, V119, P91, DOI 10.1161/CIRCRESAHA.116.303577; Ridiandries A, 2017, FASEB J, V31, P1179, DOI 10.1096/fj.201600540R; Ridiandries A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111856; Sanchez-Martin L, 2011, BLOOD, V117, P88, DOI 10.1182/blood-2009-12-258186; Saxena A, 2013, J IMMUNOL, V191, P4838, DOI 10.4049/jimmunol.1300725; Seropian IM, 2014, J AM COLL CARDIOL, V63, P1593, DOI 10.1016/j.jacc.2014.01.014; Snyder RJ, 2016, WOUND REPAIR REGEN, V24, P613, DOI 10.1111/wrr.12444; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Tillmanns J, 2015, J MOL CELL CARDIOL, V87, P194, DOI 10.1016/j.yjmcc.2015.08.016; Tuckermann JP, 2007, J CLIN INVEST, V117, P1381, DOI 10.1172/JCI28034; Vettorazzi S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8796; Weinberger T, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00107; Zhou PZ, 2016, CIRC RES, V118, P368, DOI 10.1161/CIRCRESAHA.116.308139	38	21	21	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					5122	5132		10.1096/fj.201700317R	http://dx.doi.org/10.1096/fj.201700317R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28768721	Green Published			2022-12-26	WOS:000413398500039
J	Torres, P; Diaz, J; Arce, M; Silva, P; Mendoza, P; Lois, P; Molina-Berrios, A; Owen, GI; Palma, V; Torres, VA				Torres, Pedro; Diaz, Jorge; Arce, Maximiliano; Silva, Patricio; Mendoza, Pablo; Lois, Pablo; Molina-Berrios, Alfredo; Owen, Gareth I.; Palma, Veronica; Torres, Vicente A.			The salivary peptide histatin-1 promotes endothelial cell adhesion, migration, and angiogenesis	FASEB JOURNAL			English	Article						signaling; GTPase; saliva; Rab5; wound healing	WOUND-CLOSURE; RICH PROTEINS; GROWTH-FACTOR; RAC; MORPHOGENESIS; MUCOSAL; RAB5	Saliva is a key factor that contributes to the high efficiency of wound healing in the oral mucosa. This is not only attributed to physical cues but also to the presence of specific peptides in the saliva, such as histatins. Histatin-1 is a 38 aa antimicrobial peptide, highly enriched in human saliva, which has been previously reported to promote the migration of oral keratinocytes and fibroblasts in vitro. However, the participation of histatin-1 in other crucial events required for wound healing, such as angiogenesis, is unknown. Here we demonstrate that histatin-1 promotes angiogenesis, as shown in vivo, using the chick chorioallantoic membrane model, and by an in vitro tube formation assay, using both human primary cultured endothelial cells (HUVECs) and the EA. hy926 cell line. Specifically, histatin-1 promoted endothelial cell adhesion and spreading onto fibronectin, as well as endothelial cell migration in the wound closure and Boyden chamber assays. These actions required the activation of the Ras and Rab interactor 2 (RIN2)/Rab5/Rac1 signaling axis, as histatin-1 increased the recruitment of RIN2, a Rab5-guanine nucleotide exchange factor (GEF) to early endosomes, leading to sequential Rab5/Rac1 activation. Accordingly, interfering with either Rab5 or Rac1 activities prevented histatin-1-dependent endothelial cell migration. Finally, by immunodepletion assays, we showed that salivary histatin-1 is required for the promigratory effects of saliva on endothelial cells. In conclusion, we report that salivary histatin-1 is a novel proangiogenic factor that may contribute to oral wound healing.-Torres, P., Diaz, J., Arce, M., Silva, P., Mendoza, P., Lois, P., Molina-Berrios, A., Owen, G. I., Palma, V., Torres, V. A. The salivary peptide histatin-1 promotes endothelial cell adhesion, migration, and angiogenesis.	[Torres, Pedro; Silva, Patricio; Mendoza, Pablo; Molina-Berrios, Alfredo; Torres, Vicente A.] Univ Chile, Fac Dent, Inst Res Dent Sci, Calle Sergio Livingstone 943, Santiago 8380492, Chile; [Diaz, Jorge; Arce, Maximiliano; Owen, Gareth I.; Torres, Vicente A.] Univ Chile, Adv Ctr Chron Dis ACCDiS, Santiago, Chile; [Lois, Pablo; Palma, Veronica] Univ Chile, Fac Sci, Lab Stem Cells & Dev Biol, Santiago, Chile; [Arce, Maximiliano; Owen, Gareth I.] Pontificia Univ Catolica Chile, Fac Biol Sci, Santiago, Chile; [Arce, Maximiliano; Owen, Gareth I.] Pontificia Univ Catolica Chile, Fac Med, Santiago, Chile; [Owen, Gareth I.] Pontificia Univ Catolica Chile, Millennium Inst Immunol & Immunotherapy, Santiago, Chile; [Silva, Patricio] Univ Cent Chile, Fac Hlth Sci, Santiago, Chile	Universidad de Chile; Universidad de Chile; Universidad de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Universidad Central de Chile	Torres, VA (corresponding author), Univ Chile, Fac Dent, Inst Res Dent Sci, Calle Sergio Livingstone 943, Santiago 8380492, Chile.	vatorres@med.uchile.cl		Torres, Vicente A/0000-0002-5973-7248; Molina-Berrios, Alfredo/0000-0001-8351-3239; Palma, Veronica/0000-0002-4320-7525	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1140907, 1140970, 1140697, 11140227]; Comision Nacional de Investigacion Cientifica y Tecnologica-Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias (CONICYT-FONDAP) [15130011]; Fondo de Fomento al Desarrollo Cientifico y Tecnologico (Fondef) [D09E1047]; Biomedical Research Consortium of Chile (BMRC) [13CTI-21526-P6]; Instituto Milenio en Inmunologia e Inmunoterapia (IMII) [P09/016-F]	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Comision Nacional de Investigacion Cientifica y Tecnologica-Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias (CONICYT-FONDAP); Fondo de Fomento al Desarrollo Cientifico y Tecnologico (Fondef)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDEF); Biomedical Research Consortium of Chile (BMRC); Instituto Milenio en Inmunologia e Inmunoterapia (IMII)	The authors acknowledge C. Pizarro (Faculty of Sciences, Universidad de Chile) for help with the chick CAM analysis. This work was supported, in part, by Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) Grants 1140907 (to V.A.T.), 1140970 (to G.I.O.), 1140697 (to V.P.), and 11140227 (to A.M.-B.); Comision Nacional de Investigacion Cientifica y Tecnologica-Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias (CONICYT-FONDAP) 15130011 (to V.A.T. and G.I.O.); Fondo de Fomento al Desarrollo Cientifico y Tecnologico (Fondef) D09E1047; and Biomedical Research Consortium of Chile (BMRC) 13CTI-21526-P6 and Instituto Milenio en Inmunologia e Inmunoterapia (IMII) P09/016-F (to G.I.O.). The authors declare no conflicts of interest.	Ahmad M, 2004, J HISTOCHEM CYTOCHEM, V52, P361, DOI 10.1177/002215540405200307; Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; Barbieri MA, 2004, EUR J CELL BIOL, V83, P305, DOI 10.1078/0171-9335-00381; Bid HK, 2013, MOL CANCER THER, V12, P1925, DOI 10.1158/1535-7163.MCT-13-0164; Boink MA, 2016, WOUND REPAIR REGEN, V24, P100, DOI 10.1111/wrr.12380; Brand HS, 2013, CHIN J DENT RES, V16, P7; Campese M, 2009, ARCH ORAL BIOL, V54, P345, DOI 10.1016/j.archoralbio.2008.11.010; Connolly JO, 2002, MOL BIOL CELL, V13, P2474, DOI 10.1091/mbc.E02-01-0006; Fernandez-Borja M, 2012, CELL RES, V22, P1426, DOI 10.1038/cr.2012.118; Glim JE, 2013, WOUND REPAIR REGEN, V21, P648, DOI 10.1111/wrr.12072; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Gusman H, 2004, ARCH ORAL BIOL, V49, P11, DOI 10.1016/S0003-9969(03)00182-1; Keswani SG, 2013, WOUND REPAIR REGEN, V21, P554, DOI 10.1111/wrr.12065; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lange S, 2014, J CELL PHYSIOL, V229, P1673, DOI 10.1002/jcp.24612; MACARAK EJ, 1983, J CELL PHYSIOL, V116, P76, DOI 10.1002/jcp.1041160112; Melino S, 2014, FEBS J, V281, P657, DOI 10.1111/febs.12612; Mendoza P, 2013, J CELL SCI, V126, P3835, DOI 10.1242/jcs.119727; OPPENHEIM FG, 1988, J BIOL CHEM, V263, P7472; OPPENHEIM FG, 1986, J BIOL CHEM, V261, P1177; Oudhoff MJ, 2009, J DENT RES, V88, P846, DOI 10.1177/0022034509342951; Oudhoff MJ, 2008, FASEB J, V22, P3805, DOI 10.1096/fj.08-112003; Oudhoff MJ, 2009, FASEB J, V23, P3928, DOI 10.1096/fj.09-137588; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Sandri C, 2012, CELL RES, V22, P1479, DOI 10.1038/cr.2012.110; Silva P, 2016, ONCOTARGET, V7, P29548, DOI 10.18632/oncotarget.8794; Storgard Chris, 2004, V294, P123; Sun XL, 2009, FASEB J, V23, P2691, DOI 10.1096/fj.09-131045; Szpaderska AM, 2003, J DENT RES, V82, P621, DOI 10.1177/154405910308200810; van Dijk IA, 2017, J DENT RES, V96, P423, DOI 10.1177/0022034516681761; van Dijk IA, 2017, FASEB J, V31, P3922, DOI 10.1096/fj.201700180R; van Dijk IA, 2015, FASEB J, V29, P3124, DOI 10.1096/fj.14-266825; VANSETTEN GB, 1995, LARYNGOSCOPE, V105, P610, DOI 10.1288/00005537-199506000-00009; XU T, 1991, INFECT IMMUN, V59, P2549, DOI 10.1128/IAI.59.8.2549-2554.1991	34	42	45	1	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4946	4958		10.1096/fj.201700085R	http://dx.doi.org/10.1096/fj.201700085R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28751526				2022-12-26	WOS:000413398500025
J	Shi, SJ; Buck, TM; Kinlough, CL; Marciszyn, AL; Hughey, RP; Chalfie, M; Brodsky, JL; Kleyman, TR				Shi, Shujie; Buck, Teresa M.; Kinlough, Carol L.; Marciszyn, Allison L.; Hughey, Rebecca P.; Chalfie, Martin; Brodsky, Jeffrey L.; Kleyman, Thomas R.			Regulation of the epithelial Na+ channel by paraoxonase-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL EXPRESSION; SODIUM-CHANNELS; SURFACE EXPRESSION; OXIDATIVE STRESS; GAMMA-SUBUNIT; ION CHANNELS; ENAC; PROTEIN; FAMILY; HSC70	Paraoxonase-2 (PON-2) is a membrane-bound lactonase with unique anti-oxidative and anti-atherosclerotic properties. PON-2 shares key structural elements with MEC-6, an endoplasmic reticulum-resident molecular chaperone in Caenorhabditis elegans. MEC-6 modulates the expression of a mechanotransductive ion channel comprising MEC-4 and MEC-10 in touch-receptor neurons. Because pon-2 mRNA resides in multiple rat nephron segments, including the aldosterone-sensitive distal nephron where the epithelial Na+ channel (ENaC) is expressed, we hypothesized that PON-2 would similarly regulate ENaC expression. We observed PON-2 expression in aquaporin 2-positive principal cells of the distal nephron of adult human kidney. PON-2 also co-immunoprecipitated with ENaC when co-expressed in HEK293 cells. When PON-2 was co-expressed with ENaC in Xenopus oocytes, ENaC activity was reduced, reflecting a reduction in ENaC surface expression. MEC-6 also reduced ENaC activity when co-expressed in Xenopus oocytes. The PON-2 inhibitory effect was ENaC-specific, as PON-2 had no effect on functional expression of the renal outer medullary potassium channel. PON-2 did not alter the response of ENaC to extracellular Na+, mechanical shear stress, or alpha-chymotrypsin-mediated proteolysis, suggesting that PON-2 did not alter the regulation of ENaC by these factors. Together, our data suggest that PON-2 regulates ENaC activity by modulating its intracellular trafficking and surface expression.	[Shi, Shujie; Kinlough, Carol L.; Marciszyn, Allison L.; Hughey, Rebecca P.; Kleyman, Thomas R.] Univ Pittsburgh, Renal Electrolyte Div, Dept Med, Pittsburgh, PA 15261 USA; [Buck, Teresa M.; Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15261 USA; [Hughey, Rebecca P.; Kleyman, Thomas R.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Hughey, Rebecca P.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15261 USA; [Kleyman, Thomas R.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Chalfie, Martin] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Columbia University	Kleyman, TR (corresponding author), Univ Pittsburgh, Renal Electrolyte Div, 3550 Terrace St, Pittsburgh, PA 15261 USA.	kleyman@pitt.edu		Buck, Teresa/0000-0002-9013-9756	National Institutes of Health [DK103834, DK090195, GM075061, GM030997, DK051391, DK079307]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051391, R37DK051391, P30DK079307, K01DK090195, K01DK103834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030997, R01GM075061, R37GM030997, R35GM122522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part by National Institutes of Health Grants DK103834 (to S.S.) DK090195 (to T.M.B.), GM075061 (to J.L.B.), GM030997 (to M.C.), DK051391 (to T.R.K.), and DK079307 (Pittsburgh Center for Kidney Research). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altenhofer S, 2010, J BIOL CHEM, V285, P24398, DOI 10.1074/jbc.M110.118604; Althaus M, 2007, FASEB J, V21, P2389, DOI 10.1096/fj.06-7694com; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Brown D, 1996, HISTOCHEM CELL BIOL, V105, P261, DOI 10.1007/BF01463929; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Buck TM, 2017, BIOCHEM J, V474, P357, DOI 10.1042/BCJ20160760; Buck TM, 2013, J BIOL CHEM, V288, P18366, DOI 10.1074/jbc.M113.469882; Buck TM, 2010, MOL BIOL CELL, V21, P1047, DOI 10.1091/mbc.E09-11-0944; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Carattino MD, 2014, AM J PHYSIOL-RENAL, V307, pF1080, DOI 10.1152/ajprenal.00157.2014; Carattino MD, 2003, J BIOL CHEM, V278, P36202, DOI 10.1074/jbc.M300312200; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; Chanoux RA, 2013, AM J PHYSIOL-CELL PH, V305, pC776, DOI 10.1152/ajpcell.00059.2013; Chanoux RA, 2012, J BIOL CHEM, V287, P19255, DOI 10.1074/jbc.M112.357756; Chelur DS, 2002, NATURE, V420, P669, DOI 10.1038/nature01205; Chen YS, 2016, MOL BIOL CELL, V27, P1272, DOI 10.1091/mbc.E15-08-0561; Chen YS, 2015, P NATL ACAD SCI USA, V112, P11690, DOI 10.1073/pnas.1515968112; Cortes-Gonzalez C, 2010, CELL PHYSIOL BIOCHEM, V26, P657, DOI 10.1159/000322333; Devarajan A, 2014, ADV EXP MED BIOL, V824, P33, DOI 10.1007/978-3-319-07320-0_5; Devarajan A, 2011, ANTIOXID REDOX SIGN, V14, P341, DOI 10.1089/ars.2010.3430; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; DUC C, 1994, J CELL BIOL, V127, P1907, DOI 10.1083/jcb.127.6.1907; FUSHIMI K, 1993, NATURE, V361, P549, DOI 10.1038/361549a0; Goldfarb SB, 2006, P NATL ACAD SCI USA, V103, P5817, DOI 10.1073/pnas.0507903103; Grifoni SC, 2008, AM J PHYSIOL-HEART C, V294, pH2022, DOI 10.1152/ajpheart.01271.2007; Grumbach Y, 2014, AM J PHYSIOL-CELL PH, V307, pC701, DOI 10.1152/ajpcell.00134.2014; Gu GQ, 1996, P NATL ACAD SCI USA, V93, P6577, DOI 10.1073/pnas.93.13.6577; Hagmann H, 2014, FASEB J, V28, P1769, DOI 10.1096/fj.13-240309; Harel M, 2004, NAT STRUCT MOL BIOL, V11, P412, DOI 10.1038/nsmb767; Hoger JH, 2002, P NATL ACAD SCI USA, V99, P7780, DOI 10.1073/pnas.102184999; Horke S, 2007, CIRCULATION, V115, P2055, DOI 10.1161/CIRCULATIONAHA.106.681700; Horke S, 2008, BIOCHEM J, V416, P395, DOI 10.1042/BJ20080775; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Johnson JL, 2012, BBA-MOL CELL RES, V1823, P607, DOI 10.1016/j.bbamcr.2011.09.020; Kashlan OB, 2007, J BIOL CHEM, V282, P28149, DOI 10.1074/jbc.M703409200; Kashlan OB, 2012, EXP CELL RES, V318, P1011, DOI 10.1016/j.yexcr.2012.02.024; Kashlan OB, 2011, AM J PHYSIOL-RENAL, V301, pF684, DOI 10.1152/ajprenal.00259.2011; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kellenberger S, 2015, PHARMACOL REV, V67, P1, DOI 10.1124/pr.114.009225; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Lee JW, 2015, J AM SOC NEPHROL, V26, P2669, DOI 10.1681/ASN.2014111067; Levy E, 2007, AM J PHYSIOL-GASTR L, V293, pG1252, DOI 10.1152/ajpgi.00369.2007; Ma HP, 2002, J BIOL CHEM, V277, P7641, DOI 10.1074/jbc.C100737200; Maarouf AB, 2009, J BIOL CHEM, V284, P7756, DOI 10.1074/jbc.M807060200; Mack KL, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00008; Mackness MI, 1996, CURR OPIN LIPIDOL, V7, P69, DOI 10.1097/00041433-199604000-00004; Mochizuki H, 1998, GENE, V213, P149, DOI 10.1016/S0378-1119(98)00193-0; Morimoto T, 2006, AM J PHYSIOL-RENAL, V291, pF663, DOI 10.1152/ajprenal.00514.2005; Ng CJ, 2006, J BIOL CHEM, V281, P29491, DOI 10.1074/jbc.M605379200; Ng CJ, 2001, J BIOL CHEM, V276, P44444, DOI 10.1074/jbc.M105660200; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Passero CJ, 2012, AM J PHYSIOL-RENAL, V302, pF1, DOI 10.1152/ajprenal.00330.2011; Pochynyuk O, 2005, J BIOL CHEM, V280, P37565, DOI 10.1074/jbc.M509071200; Prince LS, 1998, BIOCHEM J, V336, P705, DOI 10.1042/bj3360705; Shi Shujie, 2013, Curr Mol Pharmacol, V6, P28; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Stockand JD, 2008, IUBMB LIFE, V60, P620, DOI 10.1002/iub.89; Stoltz DA, 2009, J BIOL CHEM, V284, P35564, DOI 10.1074/jbc.M109.051706; Valentijn JA, 1998, J BIOL CHEM, V273, P30344, DOI 10.1074/jbc.273.46.30344; Vila-Carriles WH, 2007, J BIOL CHEM, V282, P34381, DOI 10.1074/jbc.M705354200; Vuagniaux G, 2002, J GEN PHYSIOL, V120, P191, DOI 10.1085/jgp.20028598; Warnock DG, 2014, NAT REV NEPHROL, V10, P146, DOI 10.1038/nrneph.2013.275; Yang Y, 2012, FREE RADICAL BIO MED, V53, P437, DOI 10.1016/j.freeradbiomed.2012.05.015; You H, 2017, J CELL SCI, V130, P1027, DOI 10.1242/jcs.198242; Zhou H, 1996, AM J PHYSIOL-CELL PH, V271, pC1949, DOI 10.1152/ajpcell.1996.271.6.C1949	68	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15927	15938		10.1074/jbc.M117.785253	http://dx.doi.org/10.1074/jbc.M117.785253			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28768768	Green Published, hybrid			2022-12-26	WOS:000411512200029
J	Kampmeyer, C; Karakostova, A; Schenstrom, SM; Abildgaard, AB; Lauridsen, AM; Jourdain, I; Hartmann-Petersen, R				Kampmeyer, Caroline; Karakostova, Antonina; Schenstrom, Signe M.; Abildgaard, Amanda B.; Lauridsen, Anne-Marie; Jourdain, Isabelle; Hartmann-Petersen, Rasmus			The exocyst subunit Sec3 is regulated by a protein quality control pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MISFOLDED CYTOSOLIC PROTEINS; UBIQUITIN LIGASE; MOLECULAR CHAPERONES; PROTEASOMAL DEGRADATION; CELL-SEPARATION; COMPLEX; TARGETS; GENE; MEMBRANE; RSP5	Exocytosis involves fusion of secretory vesicles with the plasma membrane, thereby delivering membrane proteins to the cell surface and releasing material into the extracellular space. The tethering of the secretory vesicles before membrane fusion is mediated by the exocyst, an essential phylogenetically conserved octameric protein complex. Exocyst biogenesis is regulated by several processes, but the mechanisms by which the exocyst is degraded are unknown. Here, to unravel the components of the exocyst degradation pathway, we screened for extragenic suppressors of a temperature-sensitive fission yeast strain mutated in the exocyst subunit Sec3 (sec3-913). Oneof the suppressing DNAs encoded a truncated dominant-negative variant of the 26S proteasome subunit, Rpt2, indicating that exocyst degradation is controlled by the ubiquitin-proteasome system. The temperature-dependent growth defect of the sec3-913 strain was gene dosage-dependent and suppressed by blocking the proteasome, Hsp70-type molecular chaperones, the Pib1 E3 ubiquitin-protein ligase, and the deubiquitylating enzyme Ubp3. Moreover, defects in cell septation, exocytosis, and endocytosis in sec3 mutant strains were similarly alleviated by mutation of components in this pathway. We also found that, particularly under stress conditions, wild-type Sec3 degradation is regulated by Pib1 and the 26S proteasome. In conclusion, our results suggest that a cytosolic protein quality control pathway monitors folding and proteasome-dependent turnover of an exocyst subunit and, thereby, controls exocytosis in fission yeast.	[Kampmeyer, Caroline; Karakostova, Antonina; Schenstrom, Signe M.; Abildgaard, Amanda B.; Lauridsen, Anne-Marie; Hartmann-Petersen, Rasmus] Univ Copenhagen, Dept Biol, Linderstrom Lang Ctr, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark; [Jourdain, Isabelle] Univ Exeter, Coll Life & Environm Sci, Geoffrey Pope Bldg,Stocker Rd, Exeter EX4 4QD, Devon, England	University of Copenhagen; University of Exeter	Hartmann-Petersen, R (corresponding author), Univ Copenhagen, Dept Biol, Linderstrom Lang Ctr, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.; Jourdain, I (corresponding author), Univ Exeter, Coll Life & Environm Sci, Geoffrey Pope Bldg,Stocker Rd, Exeter EX4 4QD, Devon, England.	i.jourdain@exeter.ac.uk; rhpetersen@bio.ku.dk	Hartmann-Petersen, Rasmus/K-4434-2014	Hartmann-Petersen, Rasmus/0000-0002-4155-7791; Karakostova, Antonina/0000-0002-1309-5323	Lundbeck Foundation; Danish Cancer Society; Novo Nordisk Foundation; A. P. Moller Foundation; Aase and Ejnar Danielsens Foundation; Danish Rheumatism Association; Danish Council for Independent Research (Natural Sciences); Novo Nordisk Fonden [NNF15OC0017100] Funding Source: researchfish; The Danish Cancer Society [R124-A7466] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Danish Cancer Society(Danish Cancer Society); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); A. P. Moller Foundation; Aase and Ejnar Danielsens Foundation; Danish Rheumatism Association; Danish Council for Independent Research (Natural Sciences)(Det Frie Forskningsrad (DFF)); Novo Nordisk Fonden(Novo Nordisk Foundation); The Danish Cancer Society(Danish Cancer Society)	This work was supported by the Lundbeck Foundation (to R. H. P.), the Danish Cancer Society (to R. H. P.), the Novo Nordisk Foundation (to R. H. P.), the A. P. Moller Foundation (to R. H. P.), the Aase and Ejnar Danielsens Foundation (to R. H. P.), the Danish Rheumatism Association (to R. H. P.), and the Danish Council for Independent Research (Natural Sciences) (to R. H. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahner A, 2007, MOL BIOL CELL, V18, P806, DOI 10.1091/mbc.E06-05-0458; Amm I, 2016, FEBS LETT, V590, P1765, DOI 10.1002/1873-3468.12213; Amm I, 2014, BBA-MOL CELL RES, V1843, P182, DOI 10.1016/j.bbamcr.2013.06.031; Andersen KM, 2011, ANTIOXID REDOX SIGN, V14, P1601, DOI 10.1089/ars.2010.3329; Arlow T, 2013, P NATL ACAD SCI USA, V110, P246, DOI 10.1073/pnas.1215510110; Arndt V, 2007, CELL MOL LIFE SCI, V64, P2525, DOI 10.1007/s00018-007-7188-6; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bendezu FO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040248; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Boyd C, 2004, J CELL BIOL, V167, P889, DOI 10.1083/jcb.200408124; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; CAPECCHI MR, 1974, P NATL ACAD SCI USA, V71, P4732, DOI 10.1073/pnas.71.12.4732; Christianson JC, 2014, NAT STRUCT MOL BIOL, V21, P325, DOI 10.1038/nsmb.2793; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; Drummond DA, 2009, CURR BIOL, V19, pR740, DOI 10.1016/j.cub.2009.07.039; Dunn R, 2001, MOL BIOL CELL, V12, P421, DOI 10.1091/mbc.12.2.421; Duttler S, 2013, MOL CELL, V50, P379, DOI 10.1016/j.molcel.2013.03.010; Fang NN, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12907; Fang NN, 2014, NAT CELL BIOL, V16, P1227, DOI 10.1038/ncb3054; Fang NN, 2011, NAT CELL BIOL, V13, P1344, DOI 10.1038/ncb2343; Fang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085238; Finley D, 2011, NAT CELL BIOL, V13, P1290, DOI 10.1038/ncb2371; Gachet Y, 2005, J CELL SCI, V118, P4231, DOI 10.1242/jcs.02530; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Geffen Y, 2016, MOL CELL, V63, P1055, DOI 10.1016/j.molcel.2016.08.005; GORDON C, 1993, NATURE, V366, P355, DOI 10.1038/366355a0; Guerriero CJ, 2013, J BIOL CHEM, V288, P18506, DOI 10.1074/jbc.M113.475905; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hartmann-Petersen R, 2004, CURR BIOL, V14, P824, DOI 10.1016/j.cub.2004.04.029; He B, 2007, EMBO J, V26, P4053, DOI 10.1038/sj.emboj.7601834; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Heider MR, 2016, NAT STRUCT MOL BIOL, V23, P59, DOI 10.1038/nsmb.3146; Huibregtse JM, 1997, P NATL ACAD SCI USA, V94, P3656, DOI 10.1073/pnas.94.8.3656; Jantti J, 1999, P NATL ACAD SCI USA, V96, P909, DOI 10.1073/pnas.96.3.909; Jin Y, 2011, DEV CELL, V21, P1156, DOI 10.1016/j.devcel.2011.10.009; Jourdain I, 2012, TRAFFIC, V13, P1481, DOI 10.1111/j.1600-0854.2012.01408.x; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kono K, 2012, CELL, V150, P151, DOI 10.1016/j.cell.2012.05.030; Kragelund BB, 2016, TRENDS BIOCHEM SCI, V41, P446, DOI 10.1016/j.tibs.2016.02.004; Kriegenburg F, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004140; Kriegenburg F, 2012, FEBS J, V279, P532, DOI 10.1111/j.1742-4658.2011.08456.x; Le Goff X, 2016, J CELL SCI, V129, P2638, DOI 10.1242/jcs.184846; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Liu JL, 2007, MOL BIOL CELL, V18, P4483, DOI 10.1091/mbc.E07-05-0461; Liu XM, 2015, MOL CELL, V59, P1035, DOI 10.1016/j.molcel.2015.07.034; Lucocq JM, 2013, AUTOPHAGY, V9, P1443, DOI 10.4161/auto.25570; Mao P, 2010, J BIOL CHEM, V285, P37542, DOI 10.1074/jbc.M110.170175; Martin-Cuadrado AB, 2003, J CELL SCI, V116, P1689, DOI 10.1242/jcs.00377; Martin-Cuadrado AB, 2005, MOL BIOL CELL, V16, P4867, DOI 10.1091/mbc.E04-12-1114; Martin-Urdiroz M, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00024; Mathiassen SG, 2015, J BIOL CHEM, V290, P21141, DOI 10.1074/jbc.M115.662312; Matsuyama A, 2004, YEAST, V21, P1289, DOI 10.1002/yea.1181; Maurer MJ, 2016, G3-GENES GENOM GENET, V6, P1853, DOI 10.1534/g3.116.027953; Mazumdar T, 2010, P NATL ACAD SCI USA, V107, P13854, DOI 10.1073/pnas.0913495107; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nakashima A, 2014, BIOL OPEN, V3, P542, DOI 10.1242/bio.20148367; Nielsen SV, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006739; Nielsen SV, 2014, BIOMOLECULES, V4, P646, DOI 10.3390/biom4030646; Nishino K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141796; Paraskevopoulos K, 2014, MOL CELL, V56, P453, DOI 10.1016/j.molcel.2014.09.008; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; Penney M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050796; Pleskot R, 2015, BBA-BIOMEMBRANES, V1848, P1481, DOI 10.1016/j.bbamem.2015.03.026; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rosenbaum JC, 2011, MOL CELL, V41, P93, DOI 10.1016/j.molcel.2010.12.004; Sangster TA, 2008, P NATL ACAD SCI USA, V105, P2963, DOI 10.1073/pnas.0712200105; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; Shcherbik N, 2011, RNA, V17, P1422, DOI 10.1261/rna.2615311; Shin ME, 2001, J BIOL CHEM, V276, P41388, DOI 10.1074/jbc.M105665200; Tamai KK, 2002, J CELL SCI, V115, P1847; Theodoraki MA, 2012, J BIOL CHEM, V287, P23911, DOI 10.1074/jbc.M112.341164; VANDYK TK, 1989, NATURE, V342, P451, DOI 10.1038/342451a0; Wang HY, 2002, MOL BIOL CELL, V13, P515, DOI 10.1091/mbc.01-11-0542; Wu B, 2015, J CELL SCI, V128, P2957, DOI 10.1242/jcs.156398; Wu H, 2008, TRENDS CELL BIOL, V18, P397, DOI 10.1016/j.tcb.2008.06.007; Yamamoto A, 2005, J BIOL CHEM, V280, P11911, DOI 10.1074/jbc.M411256200	80	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15240	15253		10.1074/jbc.M117.789867	http://dx.doi.org/10.1074/jbc.M117.789867			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28765280	Green Published, hybrid			2022-12-26	WOS:000410809800007
J	Li, LT; Kaplan, J; Ward, DM				Li, Liangtao; Kaplan, Jerry; Ward, Diane M.			The glucose sensor Snf1 and the transcription factors Msn2 and Msn4 regulate transcription of the vacuolar iron importer gene CCC1 and iron resistance in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; TRANSPORTER; EXPRESSION; PATHWAYS; METABOLISM; MECHANISM	The budding yeast Saccharomyces cerevisiae stores iron in the vacuole, which is a major resistance mechanism against iron toxicity. One key protein involved in vacuolar iron storage is the iron importer Ccc1, which facilitates iron entry into the vacuole. Transcription of the CCC1 gene is largely regulated by the binding of iron-sulfur clusters to the activator domain of the transcriptional activator Yap5. Additional evidence, however, suggests that Yap5-independent transcriptional activation of CCC1 also contributes to iron resistance. Here, we demonstrate that components of the signaling pathway involving the low-glucose sensor Snf1 regulate CCC1 transcription and iron resistance. We found that SNF1 deletion acts synergistically with YAP5 deletion to regulate CCC1 transcription and iron resistance. A kinase-dead mutation of Snf1 lowered iron resistance as did deletion of SNF4, which encodes a partner protein of Snf1. Deletion of all three alternative partners of Snf1 encoded by SIT1, SIT2, and GAL83 decreased both CCC1 transcription and iron resistance. The Snf1 complex is known to activate the general stress transcription factors Msn2 and Msn4. We show that Msn2 and Msn4 contribute to Snf1-mediated CCC1 transcription. Of note, SNF1 deletion in combination with MSN2 and MSN4 deletion resulted in additive effects on CCC1 transcription, suggesting that other activators contribute to the regulation of CCC1 transcription. In conclusion, we show that yeast have developed multiple transcriptional mechanisms to regulate Ccc1 expression and to protect against high cytosolic iron toxicity.	[Li, Liangtao; Kaplan, Jerry; Ward, Diane M.] Univ Utah, Sch Med, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Ward, DM (corresponding author), Univ Utah, Sch Med, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84132 USA.	diane.mcveyward@path.utah.edu			National Institutes of Health Grant [DK030534]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030534, U54DK110858, R37DK030534] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK030534 (to D. M. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Caetano SM, 2015, J BIOL CHEM, V290, P18584, DOI 10.1074/jbc.M114.600742; Crisp RJ, 2006, EMBO J, V25, P512, DOI 10.1038/sj.emboj.7600961; Du Y, 2012, MOL CELLS, V34, P127, DOI 10.1007/s10059-012-2242-0; ESTRUCH F, 1993, MOL CELL BIOL, V13, P3872, DOI 10.1128/MCB.13.7.3872; Fernandes L, 1997, MOL CELL BIOL, V17, P6982, DOI 10.1128/MCB.17.12.6982; Haurie V, 2003, J BIOL CHEM, V278, P45391, DOI 10.1074/jbc.M307447200; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Kim SA, 2006, SCIENCE, V314, P1295, DOI 10.1126/science.1132563; Kumanovics A, 2008, J BIOL CHEM, V283, P10276, DOI 10.1074/jbc.M801160200; Li L, 2008, MOL CELL BIOL, V28, P1326, DOI 10.1128/MCB.01219-07; Li LT, 2012, J BIOL CHEM, V287, P35709, DOI 10.1074/jbc.M112.395533; Li LT, 2011, J BIOL CHEM, V286, P38488, DOI 10.1074/jbc.M111.286666; Li LT, 2010, J BIOL CHEM, V285, P10232, DOI 10.1074/jbc.M109.096859; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Lin HL, 2011, J BIOL CHEM, V286, P3851, DOI 10.1074/jbc.M110.190959; Ohdate T, 2010, GENES CELLS, V15, P59, DOI 10.1111/j.1365-2443.2009.01365.x; Outten CE, 2013, CURR OPIN MICROBIOL, V16, P662, DOI 10.1016/j.mib.2013.07.020; Petrenko N, 2013, MOL BIOL CELL, V24, P2045, DOI 10.1091/mbc.E12-12-0870; Pimentel C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037434; Poor CB, 2014, P NATL ACAD SCI USA, V111, P4043, DOI 10.1073/pnas.1318869111; Portillo F, 2005, FEBS LETT, V579, P512, DOI 10.1016/j.febslet.2004.12.019; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Rietzschel N, 2015, MOL CELL BIOL, V35, P370, DOI 10.1128/MCB.01033-14; Ruiz A, 2011, P NATL ACAD SCI USA, V108, P6349, DOI 10.1073/pnas.1102758108; Schilke B, 1999, P NATL ACAD SCI USA, V96, P10206, DOI 10.1073/pnas.96.18.10206; Slavic K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10403; Martinez-Pastor MT, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-017-2215-8; Thorsen M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-105; Treitel MA, 1998, MOL CELL BIOL, V18, P6273, DOI 10.1128/MCB.18.11.6273; Yun CW, 2000, J BIOL CHEM, V275, P10709, DOI 10.1074/jbc.275.14.10709	30	16	17	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15577	15586		10.1074/jbc.M117.802504	http://dx.doi.org/10.1074/jbc.M117.802504			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28760824	Green Published, hybrid			2022-12-26	WOS:000410809800035
J	Carlson, AR; Sibold, JS; Assal, TJ; Negron, JF				Carlson, Amanda R.; Sibold, Jason S.; Assal, Timothy J.; Negron, Jose F.			Evidence of compounded disturbance effects on vegetation recovery following high-severity wildfire and spruce beetle outbreak	PLOS ONE			English	Article							MOUNTAIN PINE-BEETLE; WESTERN UNITED-STATES; COLORADO FRONT RANGE; SUB-ALPINE FORESTS; BARK BEETLE; FIRE SEVERITY; TREE MORTALITY; BURN SEVERITY; CLIMATE-CHANGE; NORTH-AMERICA	Spruce beetle (Dendroctonus rufipennis) outbreaks are rapidly spreading throughout subalpine forests of the Rocky Mountains, raising concerns that altered fuel structures may increase the ecological severity of wildfires. Although many recent studies have found no conclusive link between beetle outbreaks and increased fire size or canopy mortality, few studies have addressed whether these combined disturbances produce compounded effects on short-term vegetation recovery. We tested for an effect of spruce beetle outbreak severity on vegetation recovery in the West Fork Complex fire in southwestern Colorado, USA, where much of the burn area had been affected by severe spruce beetle outbreaks in the decade prior to the fire. Vegetation recovery was assessed using the Landsat-derived Normalized Difference Vegetation Index (NDVI) two years after the fire, which occurred in 2013. Beetle outbreak severity, defined as the basal area of beetle-killed trees within Landsat pixels, was estimated using vegetation index differences (dVls) derived from pre outbreak and post-outbreak Landsat images. Of the seven dVls tested, the change in Normalized Difference Moisture Index (dNDMI) was most strongly correlated with field measurements of beetle-killed basal area (R-2 = 0.66). dNDMI was included as an explanatory variable in sequential autoregressive (SAR) models of NDVI2015. Models also included pre disturbance NDVI, topography, and weather conditions at the time of burning as covariates. SAR results showed a significant correlation between NDVI2015 and dNDMI, with more severe spruce beetle outbreaks corresponding to reduced post-fire vegetation cover. The correlation was stronger for models which were limited to locations in the red stage of outbreak (outbreak <= 5 years old at the time of fire) than for models of gray-stage locations (outbreak >5 years old at the time of fire). These results indicate that vegetation recovery processes may be negatively impacted by severe spruce beetle outbreaks occurring within a decade of stand-replacing wildfire.	[Carlson, Amanda R.] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Carlson, Amanda R.; Sibold, Jason S.] Colorado State Univ, Dept Anthropol, Ft Collins, CO 80523 USA; [Assal, Timothy J.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO USA; [Negron, Jose F.] US Forest Serv, Rocky Mt Res Stn, Ft Collins, CO USA	Colorado State University; Colorado State University; United States Department of the Interior; United States Geological Survey; United States Department of Agriculture (USDA); United States Forest Service	Carlson, AR (corresponding author), Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA.; Carlson, AR (corresponding author), Colorado State Univ, Dept Anthropol, Ft Collins, CO 80523 USA.	Amanda.Carlson@colostate.edu	negron, jose/AAE-1935-2020; Assal, Timothy/ABE-1349-2021	Assal, Timothy/0000-0001-6342-2954	US Forest Service Forest Health Program [14-JV-11221633-097]	US Forest Service Forest Health Program	This research was supported by a grant from the US Forest Service Forest Health Program (http://www.fs.us/foresthealth/), Grant No. 14-JV-11221633-097. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agee J.K., 1998, NW SCI, V72, P24; Agee JK, 2005, FOREST ECOL MANAG, V211, P83, DOI 10.1016/j.foreco.2005.01.034; Agne MC, 2016, FOREST ECOL MANAG, V366, P73, DOI 10.1016/j.foreco.2016.02.004; Andrus RA, 2016, ECOL APPL, V26, P700, DOI 10.1890/15-1121; APLET GH, 1988, ECOLOGY, V69, P312, DOI 10.2307/1940429; ARNO SF, 1980, J FOREST, V78, P460; Assal TJ, 2016, FOREST ECOL MANAG, V365, P137, DOI 10.1016/j.foreco.2016.01.017; Assal TJ, 2014, REMOTE SENS ENVIRON, V155, P275, DOI 10.1016/j.rse.2014.09.002; Bebi P, 2003, ECOLOGY, V84, P362, DOI 10.1890/0012-9658(2003)084[0362:IBFASB]2.0.CO;2; Bentz B, 2009, BARK BEETLE OUTBREAK, P6; Bentz BJ, 2010, BIOSCIENCE, V60, P602, DOI 10.1525/bio.2010.60.8.6; BESSIE WC, 1995, ECOLOGY, V76, P747, DOI 10.2307/1939341; Bigler C, 2005, ECOLOGY, V86, P3018, DOI 10.1890/05-0011; BIVAND R., 2014, SPDEP SPATIAL DEPEND; Buma B, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00058.1; Buma B, 2012, ENVIRON MONIT ASSESS, V184, P3849, DOI 10.1007/s10661-011-2228-y; Cawson JG, 2013, FOREST ECOL MANAG, V310, P219, DOI 10.1016/j.foreco.2013.08.016; Certini G, 2005, OECOLOGIA, V143, P1, DOI 10.1007/s00442-004-1788-8; Cohen WB, 2016, FOREST ECOL MANAG, V360, P242, DOI 10.1016/j.foreco.2015.10.042; Collins BJ, 2011, FOREST ECOL MANAG, V261, P2168, DOI 10.1016/j.foreco.2011.03.016; CRIST EP, 1984, IEEE T GEOSCI REMOTE, V22, P256, DOI 10.1109/TGRS.1984.350619; Dale VH, 2001, BIOSCIENCE, V51, P723, DOI 10.1641/0006-3568(2001)051[0723:CCAFD]2.0.CO;2; Debano L.F., 1998, FIRE EFFECTS ECOSYST; DeRose RJ, 2012, FOREST SCI, V58, P1, DOI 10.5849/forsci.10-079; Derose RJ, 2009, ECOSCIENCE, V16, P28, DOI 10.2980/16-1-3160; Donato DC, 2013, FOREST ECOL MANAG, V303, P160, DOI 10.1016/j.foreco.2013.04.022; Dzwonko Z, 2015, FOREST ECOL MANAG, V342, P56, DOI 10.1016/j.foreco.2015.01.013; ESRI, 2010, ARCGIS DESKT REL 10; Falk DA, 2007, ECOSYSTEMS, V10, P809, DOI 10.1007/s10021-007-9070-7; Gao BC, 1996, REMOTE SENS ENVIRON, V58, P257, DOI 10.1016/S0034-4257(96)00067-3; Goodwin NR, 2008, REMOTE SENS ENVIRON, V112, P3680, DOI 10.1016/j.rse.2008.05.005; Hais M, 2009, REMOTE SENS ENVIRON, V113, P835, DOI 10.1016/j.rse.2008.12.012; Hansen EM, 2003, CAN ENTOMOL, V135, P687; Hart SJ, 2015, REMOTE SENS ENVIRON, V168, P134, DOI 10.1016/j.rse.2015.06.015; Harvey BJ, 2014, ECOL APPL, V24, P1608, DOI 10.1890/13-1851.1; Harvey BJ, 2013, ECOLOGY, V94, P2475, DOI 10.1890/13-0188.1; Havasova M, 2015, ANN FOR RES, V58, P295; Healey SP, 2006, REMOTE SENS ENVIRON, V101, P115, DOI 10.1016/j.rse.2005.12.006; Healey SP, 2005, REMOTE SENS ENVIRON, V97, P301, DOI 10.1016/j.rse.2005.05.009; Hicke JA, 2012, FOREST ECOL MANAG, V271, P81, DOI 10.1016/j.foreco.2012.02.005; Hope A, 2007, INT J REMOTE SENS, V28, P1339, DOI 10.1080/01431160600908924; Ireland G, 2015, APPL GEOGR, V56, P232, DOI 10.1016/j.apgeog.2014.11.016; Jakubauskas ME, 2000, GEOCARTO INT, V15, P21; Jenkins MJ, 2008, FOREST ECOL MANAG, V254, P16, DOI 10.1016/j.foreco.2007.09.045; Jenkins MJ, 2012, FOREST ECOL MANAG, V275, P23, DOI 10.1016/j.foreco.2012.02.036; Jin SM, 2005, REMOTE SENS ENVIRON, V94, P364, DOI 10.1016/j.rse.2004.10.012; Jonasova M, 2008, BIOL CONSERV, V141, P1525, DOI 10.1016/j.biocon.2008.03.013; Keeley JE, 2009, INT J WILDLAND FIRE, V18, P116, DOI 10.1071/WF07049; Key C.H., 1999, NORMALIZED BURN RATI; Kulakowski D, 2003, J BIOGEOGR, V30, P1445, DOI 10.1046/j.1365-2699.2003.00912.x; Kulakowski D, 2007, ECOLOGY, V88, P759, DOI 10.1890/06-0124; Kulakowski D, 2013, J VEG SCI, V24, P168, DOI 10.1111/j.1654-1103.2012.01437.x; Lennon JJ, 2000, ECOGRAPHY, V23, P101, DOI 10.1034/j.1600-0587.2000.230111.x; Liu QS, 2014, INT GEOSCI REMOTE SE, P541, DOI 10.1109/IGARSS.2014.6946479; Masek JG, 2006, IEEE GEOSCI REMOTE S, V3, P68, DOI 10.1109/LGRS.2005.857030; McCarley TR, 2017, REMOTE SENS ENVIRON, V191, P419, DOI 10.1016/j.rse.2016.12.022; Meddens AJH, 2013, REMOTE SENS ENVIRON, V132, P49, DOI 10.1016/j.rse.2013.01.002; Meddens AJH, 2012, ECOL APPL, V22, P1876, DOI 10.1890/11-1785.1; Meigs GW, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/4/045008; Meigs GW, 2011, REMOTE SENS ENVIRON, V115, P3707, DOI 10.1016/j.rse.2011.09.009; Meng R, 2015, REMOTE SENS ENVIRON, V171, P311, DOI 10.1016/j.rse.2015.10.024; Negron JF, 2008, J FOREST, V106, P325; Negron JF, 2014, FOREST SCI, V60, P409, DOI 10.5849/forsci.13-169; Odion DC, 2000, ECOL MONOGR, V70, P149, DOI 10.1890/0012-9615(2000)070[0149:FSHATF]2.0.CO;2; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; Parks SA, 2011, INT J WILDLAND FIRE, V20, P815, DOI 10.1071/WF10051; PEET RK, 1978, VEGETATIO, V37, P65, DOI 10.1007/BF00126830; Petropoulos GP, 2014, APPL GEOGR, V50, P120, DOI 10.1016/j.apgeog.2014.02.006; Prichard SJ, 2014, ECOL APPL, V24, P571, DOI 10.1890/13-0343.1; R Core Development Team, 2013, R LANG ENV STAT COMP; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; ROMME WH, 1981, ECOLOGY, V62, P319, DOI 10.2307/1936706; RYAN KC, 1988, CAN J FOREST RES, V18, P1291, DOI 10.1139/x88-199; Schoennagel T, 2004, BIOSCIENCE, V54, P661, DOI 10.1641/0006-3568(2004)054[0661:TIOFFA]2.0.CO;2; SCHOTT JR, 1988, REMOTE SENS ENVIRON, V26, P1, DOI 10.1016/0034-4257(88)90116-2; Sibold JS, 2006, J BIOGEOGR, V33, P631, DOI 10.1111/j.1365-2699.2005.01404.x; Simard M, 2011, ECOL MONOGR, V81, P3, DOI 10.1890/10-1176.1; Stephens SL, 2013, SCIENCE, V342, P41, DOI 10.1126/science.1240294; Turner MG, 2011, ECOSYSTEMS, V14, P1081, DOI 10.1007/s10021-011-9465-3; Turner MG, 2010, ECOLOGY, V91, P2833, DOI 10.1890/10-0097.1; US Forest Service Remote Sensing Applications Center, BURN AR EM RESP BAER; US Geological Survey, GEOMAC WILDL FIR SUP; US Geological Survey Gap Analysis Program, LAND COV DAT; VOGELMANN JE, 1990, INT J REMOTE SENS, V11, P2281, DOI 10.1080/01431169008955175; Walter JA, 2013, FOREST ECOL MANAG, V302, P308, DOI 10.1016/j.foreco.2013.03.038; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Wilson EH, 2002, REMOTE SENS ENVIRON, V80, P385, DOI 10.1016/S0034-4257(01)00318-2; Wilson JP., 2000, TERRAIN ANAL PRINCIP, P87; Wimberly MC, 2009, ECOL APPL, V19, P1377, DOI 10.1890/08-1685.1	89	25	25	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0181778	10.1371/journal.pone.0181778	http://dx.doi.org/10.1371/journal.pone.0181778			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28777802	Green Published, Green Submitted, gold			2022-12-26	WOS:000406944300012
J	Kim, EK; Park, HYL; Park, CK				Kim, Eun Kyoung; Park, Hae-Young Lopilly; Park, Chan Kee			Segmented inner plexiform layer thickness as a potential biomarker to evaluate open-angle glaucoma: Dendritic degeneration of retinal ganglion cell	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NERVE-FIBER LAYER; VISUAL-FIELD SENSITIVITY; EARLY-STAGE GLAUCOMA; INTRAOCULAR-PRESSURE; MOUSE MODEL; DAMAGE; PROGRESSION; PROJECTION; TRANSPORT	Purpose To evaluate the changes of retinal nerve fiber layer (RNFL), ganglion cell layer (GCL), inner plexiform layer (IPL), and ganglion cell-inner plexiform layer (GCIPL) thicknesses and compare structure-function relationships of 4 retinal layers using spectral-domain optical coherence tomography (SD-OCT) in macular region of glaucoma patients. Methods In cross-sectional study, a total of 85 eyes with pre-perimetric to advanced glaucoma and 26 normal controls were enrolled. The glaucomatous eyes were subdivided into three groups according to the severity of visual field defect: a preperimetric glaucoma group, an early glaucoma group, and a moderate to advanced glaucoma group. RNFL, GCL, IPL, and GCIPL thicknesses were measured at the level of the macula by the Spectralis (Heidelberg Engineering, Heidelberg, Germany) SD-OCT with automated segmentation software. For functional evaluation, corresponding mean sensitivity (MS) values were measured using 24-2 standard automated perimetry (SAP). Results RNFL, GCL, IPL, and GCIPL thicknesses were significantly different among 4 groups (P <.001). Macular structure losses were positively correlated with the MS values of the 24-2 SAP for RNFL, GCL, IPL, and GCIPL (R = 0.553, 0.636, 0.648 and 0.646, respectively, P <.001). In regression analysis, IPL and GCIPL thicknesses showed stronger association with the corresponding MS values of 24-2 SAP compared with RNFL and GCL thicknesses (R 2 = 0.420, P <.001 for IPL; R 2 = 0.417, P<.001 for GCIPL thickness). Conclusions Segmented IPL thickness was significantly associated with the degree of glaucoma. Segmental analysis of the inner retinal layer including the IPL in macular region may provide valuable information for evaluating glaucoma.	[Kim, Eun Kyoung; Park, Hae-Young Lopilly; Park, Chan Kee] Catholic Univ Korea, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea; [Kim, Eun Kyoung; Park, Hae-Young Lopilly; Park, Chan Kee] Seoul St Marys Hosp, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital	Park, CK (corresponding author), Catholic Univ Korea, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea.; Park, CK (corresponding author), Seoul St Marys Hosp, Seoul, South Korea.	ckpark@catholic.ac.kr						Agostinone J, 2015, PROG BRAIN RES, V220, P199, DOI 10.1016/bs.pbr.2015.04.012; Bao ZZ, 2008, BRAIN RES, V1192, P165, DOI 10.1016/j.brainres.2007.01.116; Berry RH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144341; Campbell JP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42201; Choi JH, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-29; Della Santina L, 2013, J NEUROSCI, V33, P17444, DOI 10.1523/JNEUROSCI.5461-12.2013; Dysli C, 2015, TRANSL VIS SCI TECHN, V4, DOI 10.1167/tvst.4.4.9; El-Danaf RN, 2015, J NEUROSCI, V35, P2329, DOI 10.1523/JNEUROSCI.1419-14.2015; Frankfort BJ, 2013, INVEST OPHTH VIS SCI, V54, P762, DOI 10.1167/iovs.12-10581; Garway-Heath DF, 2000, OPHTHALMOLOGY, V107, P1809, DOI 10.1016/S0161-6420(00)00284-0; Greschner M, 2011, J PHYSIOL-LONDON, V589, P75, DOI 10.1113/jphysiol.2010.193888; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Hood DC, 2007, PROG RETIN EYE RES, V26, P688, DOI 10.1016/j.preteyeres.2007.08.001; Hood DC, 2013, PROG RETIN EYE RES, V32, P1, DOI 10.1016/j.preteyeres.2012.08.003; Hood DC, 2011, INVEST OPHTH VIS SCI, V52, P940, DOI 10.1167/iovs.10-5803; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Jacoby WG, 2000, ELECT STUD, V19, P577, DOI 10.1016/S0261-3794(99)00028-1; Li ZW, 2011, INVEST OPHTH VIS SCI, V52, P7205, DOI 10.1167/iovs.10-6868; Martinez-De-La-Casa JM, 2014, INVEST OPHTH VIS SCI, V55, P8343, DOI 10.1167/iovs.14-15501; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; Mayama C, 2015, INVEST OPHTH VIS SCI, V56, P5681, DOI 10.1167/iovs.15-17208; Morgan JE, 2004, EYE, V18, P1089, DOI 10.1038/sj.eye.6701574; Moura ALD, 2012, EYE, V26, P1188, DOI 10.1038/eye.2012.110; Mwanza JC, 2012, OPHTHALMOLOGY, V119, P1151, DOI 10.1016/j.ophtha.2011.12.014; Nuschke AC, 2015, EXP EYE RES, V141, P111, DOI 10.1016/j.exer.2015.06.006; Rao HL, 2011, ARCH OPHTHALMOL-CHIC, V129, P864, DOI 10.1001/archophthalmol.2011.145; Raza AS, 2011, ARCH OPHTHALMOL-CHIC, V129, P1529, DOI 10.1001/archophthalmol.2011.352; Shin HY, 2013, INVEST OPHTH VIS SCI, V54, P7344, DOI 10.1167/iovs.13-12667; Su D, 2013, OPHTHALMOLOGY, V120, P520, DOI 10.1016/j.ophtha.2012.08.018; Tan O, 2009, OPHTHALMOLOGY, V116, P2305, DOI 10.1016/j.ophtha.2009.05.025; Wang M, 2009, ARCH OPHTHALMOL-CHIC, V127, P875, DOI 10.1001/archophthalmol.2009.145; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Wheat JL, 2012, J GLAUCOMA, V21, P95, DOI 10.1097/IJG.0b013e31820bcfbe; Zeimer R, 1998, OPHTHALMOLOGY, V105, P224, DOI 10.1016/S0161-6420(98)92743-9	34	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182404	10.1371/journal.pone.0182404	http://dx.doi.org/10.1371/journal.pone.0182404			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771565	Green Submitted, gold, Green Published			2022-12-26	WOS:000406853600103
J	Soldano, A; Klinke, S; Otero, LH; Rivera, M; Catalano-Dupuy, DL; Ceccarelli, EA				Soldano, Anabel; Klinke, Sebastian; Otero, Lisandro H.; Rivera, Mario; Catalano-Dupuy, Daniela L.; Ceccarelli, Eduardo A.			Structural and mutational analyses of the Leptospira interrogans virulence-related heme oxygenase provide insights into its catalytic mechanism	PLOS ONE			English	Article							SYNECHOCYSTIS SP PCC-6803; HYDROGEN-BONDING NETWORK; CRYSTAL-STRUCTURE; CORYNEBACTERIUM-DIPHTHERIAE; COMPLEX; VERDOHEME; IRON; REQUIRES; SUBSTRATE; FORMS	Heme oxygenase from Leptospira interrogans is an important virulence factor. During catalysis, redox equivalents are provided to this enzyme by the plastidic-type ferredoxin-NADP(+) reductase also found in L. interrogans. This process may have evolved to aid this bacterial pathogen to obtain heme-iron from their host and enable successful colonization. Herein we report the crystal structure of the heme oxygenase-heme complex at 1.73 angstrom resolution. The structure reveals several distinctive features related to its function. A hydrogen bonded network of structural water molecules that extends from the catalytic site to the protein surface was cleared observed. A depression on the surface appears to be the H+ network entrance from the aqueous environment to the catalytic site for O-2 activation, a key step in the heme oxygenase reaction. We have performed a mutational analysis of the F157, located at the above-mentioned depression. The mutant enzymes were unable to carry out the complete degradation of heme to biliverdin since the reaction was arrested at the verdoheme stage. We also observed that the stability of the oxyferrous complex, the efficiency of heme hydroxylation and the subsequent conversion to verdoheme was adversely affected. These findings underscore a long-range communication between the outer fringes of the hydrogen-bonded network of structural waters and the heme active site during catalysis. Finally, by analyzing the crystal structures of ferredoxin-NADP(+) reductase and heme oxygenase, we propose a model for the productive association of these proteins.	[Soldano, Anabel; Catalano-Dupuy, Daniela L.; Ceccarelli, Eduardo A.] Univ Nacl Rosario, Inst Biol Mol & Celular Rosario IBR, Fac Ciencias Bioquim & Farmaceut, CONICET, Rosario, Santa Fe, Argentina; [Klinke, Sebastian; Otero, Lisandro H.] Fdn Inst Leloir, IIBBA CONICET, Buenos Aires, DF, Argentina; [Klinke, Sebastian; Otero, Lisandro H.] Plataforma Argentina Biol Estruct & Metab PLABEM, Buenos Aires, DF, Argentina; [Rivera, Mario] Univ Kansas, Dept Chem, Lawrence, KS 66045 USA; [Rivera, Mario] Univ Kansas, Ralph N Adams Inst Bioanalyt Chem, Lawrence, KS 66045 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of Kansas; University of Kansas	Ceccarelli, EA (corresponding author), Univ Nacl Rosario, Inst Biol Mol & Celular Rosario IBR, Fac Ciencias Bioquim & Farmaceut, CONICET, Rosario, Santa Fe, Argentina.	ceccarelli@ibr-conicet.gov.ar	Ceccarelli, Eduardo A./M-8699-2014; Ceccarelli, Eduardo A./V-2600-2019; Klinke, Sebastián/N-6174-2018	Ceccarelli, Eduardo A./0000-0001-5776-3306; Ceccarelli, Eduardo A./0000-0001-5776-3306; Klinke, Sebastián/0000-0002-8777-0870; Otero, Lisandro/0000-0002-5448-5483; Catalano-Dupuy, Daniela L./0000-0003-2864-0133	Ministerio de Ciencia, Tecnologia e Innovacion Productiva, Argentina; ANPCYT [PICT-2012-1841]; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina; CONICET [PIP 0345]	Ministerio de Ciencia, Tecnologia e Innovacion Productiva, Argentina; ANPCYT(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by the Ministerio de Ciencia, Tecnologia e Innovacion Productiva, Argentina, ANPCYT, PICT-2012-1841 (www.mincyt.gob.ar/); and Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina, CONICET, PIP 0345 (http://www.conicet.gov.ar/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beers EP, 2001, CURR OPIN PLANT BIOL, V4, P561, DOI 10.1016/S1369-5266(00)00216-8; Benson DR, 2013, METAL IONS LIFE SCI, V12, P279, DOI 10.1007/978-94-007-5561-1_9; Bricogne G, 2014, BUSTER VERSION 2 10; Caignan GA, 2002, OXIDATION HEME VERDI, V9, P14879; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898; Damaso CO, 2004, INORG CHEM, V43, P8470, DOI 10.1021/ic049029k; Davydov R, 2002, J AM CHEM SOC, V124, P1798, DOI 10.1021/ja0122391; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Friedman J, 2004, BIOCHEMISTRY-US, V43, P5239, DOI 10.1021/bi049687g; Friedman J, 2003, J BIOL CHEM, V278, P34654, DOI 10.1074/jbc.M302985200; Furci LM, 2007, INHIBITION BACTERIAL, P3804; Harada E, 2015, BIOCHEMISTRY-US, V54, P340, DOI 10.1021/bi5009694; Heinzl GA, 2016, J MED CHEM, V59, P6929, DOI 10.1021/acs.jmedchem.6b00757; HERNANDEZ G, 1994, BIOCHEMISTRY-US, V33, P6631, DOI 10.1021/bi00187a033; Higashimoto Y, 2005, J BIOL CHEM, V280, P729, DOI 10.1074/jbc.M406203200; Hirotsu S, 2004, J BIOL CHEM, V279, P11937, DOI 10.1074/jbc.M311631200; Hom K, 2013, J MED CHEM, V56, P2097, DOI 10.1021/jm301819k; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keegan RM, 2007, ACTA CRYSTALLOGR D, V63, P447, DOI 10.1107/S0907444907002661; Kumar R, 2016, BIOCHEMISTRY-US, V55, P2622, DOI 10.1021/acs.biochem.6b00239; Lad L, 2005, J BIOL INORG CHEM, V10, P138, DOI 10.1007/s00775-004-0620-6; Lad L, 2004, J INORG BIOCHEM, V98, P1686, DOI 10.1016/j.jinorgbio.2004.07.004; Lad L, 2003, J BIOL CHEM, V278, P7834, DOI 10.1074/jbc.M211450200; Lightning LK, 2001, J BIOL CHEM, V276, P10612, DOI 10.1074/jbc.M010349200; Liu Y, 2000, J BIOL CHEM, V275, P34501, DOI 10.1074/jbc.M004245200; Matera KM, 1996, J BIOL CHEM, V271, P6618, DOI 10.1074/jbc.271.12.6618; Matsui T, 2005, J BIOL CHEM, V280, P36833, DOI 10.1074/jbc.M503529200; Matsui T, 2010, ACCOUNTS CHEM RES, V43, P240, DOI 10.1021/ar9001685; Medina M, 2004, PHOTOSYNTH RES, V79, P113, DOI 10.1023/B:PRES.0000015386.67746.2c; Murray GL, 2008, MICROBES INFECT, V10, P791, DOI 10.1016/j.micinf.2008.04.010; Murray GL, 2009, MICROBES INFECT, V11, P311, DOI 10.1016/j.micinf.2008.11.014; Nascimento AS, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-69; Rivera M, 2005, J INORG BIOCHEM, V99, P337, DOI 10.1016/j.jinorgbio.2004.09.016; Rivera Mario, 2009, V6, P241, DOI [10.1039/9781847559159-00241, 10.1039/BK9781847559159-00241]; Rodriguez JC, 2007, J AM CHEM SOC, V129, P11730, DOI 10.1021/ja072405q; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sakamoto H, 2000, J INORG BIOCHEM, V82, P113, DOI 10.1016/S0162-0134(00)00149-5; Sato H, 2007, J INORG BIOCHEM, V101, P1394, DOI 10.1016/j.jinorgbio.2007.05.016; Schuller DJ, 1999, NAT STRUCT BIOL, V6, P860; Schuller DJ, 2001, BIOCHEMISTRY-US, V40, P11552, DOI 10.1021/bi0110239; Smirnov VV, 2014, J BIOL INORG CHEM, V19, P1137, DOI 10.1007/s00775-014-1169-7; Soldano A, 2014, BBA-GEN SUBJECTS, V1840, P3208, DOI 10.1016/j.bbagen.2014.07.021; Sugishima M, 2005, BIOCHEMISTRY-US, V44, P4257, DOI 10.1021/bi0480483; Sugishima M, 2004, EUR J BIOCHEM, V271, P4517, DOI 10.1111/j.1432-1033.2004.04411.x; Sugishima M, 2002, J BIOL CHEM, V277, P45086, DOI 10.1074/jbc.M207267200; Sugishima M, 2002, BIOCHEMISTRY-US, V41, P7293, DOI 10.1021/bi025662a; Unno M, 2013, J BIOL CHEM, V288, P34443, DOI 10.1074/jbc.M113.486936; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Wilks A, 1996, BIOCHEMISTRY-US, V35, P930, DOI 10.1021/bi952405f; Wilks A, 1998, J BIOL CHEM, V273, P837, DOI 10.1074/jbc.273.2.837; Wilks A, 2002, ANTIOXID REDOX SIGN, V4, P603, DOI 10.1089/15230860260220102; WILKS A, 1993, J BIOL CHEM, V268, P22357; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yu J, 2010, BIOINFORMATICS, V26, P46, DOI 10.1093/bioinformatics/btp599; Zhu WM, 2000, J BACTERIOL, V182, P6783, DOI 10.1128/JB.182.23.6783-6790.2000	61	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182535	10.1371/journal.pone.0182535	http://dx.doi.org/10.1371/journal.pone.0182535			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771589	gold, Green Published, Green Submitted			2022-12-26	WOS:000406853600135
J	Chua, JS; Tran, VM; Kalita, M; Quintero, MV; Antelope, O; Muruganandam, G; Saijoh, Y; Kuberan, B				Chua, Jie Shi; Tran, Vy M.; Kalita, Mausam; Quintero, Maritza V.; Antelope, Orlando; Muruganandam, Geethu; Saijoh, Yukio; Kuberan, Balagurunathan			A glycan-based approach to therapeutic angiogenesis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HEPARAN-SULFATE; PROMOTES ANGIOGENESIS; ALZHEIMERS-DISEASE; GEOMETRIC CONTROL; BETA-XYLOSIDES; IN-VITRO; VEGF; CHONDROITIN; ANGIOPOIETIN-1	Angiogenesis, the sprouting of new blood vessels from existing vasculature, involves multiple complex biological processes, and it is an essential step for hemostasis, tissue healing and regeneration. Angiogenesis stimulants can ameliorate human disease conditions including limb ischemia, chronic wounds, heart disease, and stroke. The current strategies to improve the bioavailability of pro-angiogenic growth factors, including VEGF and FGF2, have remained largely unsuccessful. This study demonstrates that small molecules, termed click-xylosides, can promote angiogenesis in the in vitro matrigel tube formation assay and the ex ovo chick chorioallantoic membrane assay, depending on their aglycone moieties. Xyloside treatment enhances network connectivity and cell survivability, thereby, maintaining the network structures on matrigel culture for an extended period of time. These effects were achieved via the secreted xyloside-primed glycosaminoglycans (GAG) chains that in part, act through an ERK1/2 mediated signaling pathway. Through the remodeling of GAGs in the extracellular matrix of endothelial cells, the glycan approach, involving xylosides, offers great potential to effectively promote therapeutic angiogenesis.	[Chua, Jie Shi; Tran, Vy M.; Muruganandam, Geethu; Kuberan, Balagurunathan] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Chua, Jie Shi; Tran, Vy M.; Kalita, Mausam; Quintero, Maritza V.; Antelope, Orlando; Kuberan, Balagurunathan] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA; [Saijoh, Yukio] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT USA; [Kuberan, Balagurunathan] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Kuberan, B (corresponding author), Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.; Kuberan, B (corresponding author), Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA.; Kuberan, B (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	kuby.balagurunathan@utah.edu	Tran, Vy/GWC-8836-2022	Kalita, Mausam/0000-0002-4847-2678; Quintero, Maritza/0000-0001-8879-7867; Saijoh, Yukio/0000-0002-7548-4789; Balagurunathan, Kuberan/0000-0001-9203-8118	NIH/National Heart, Lung and Blood Institute (Programs of Excellence in Glycosciences Grant, NHLBI) [HL107152]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [HD066121]	NIH/National Heart, Lung and Blood Institute (Programs of Excellence in Glycosciences Grant, NHLBI); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the NIH/National Heart, Lung and Blood Institute (Programs of Excellence in Glycosciences Grant, NHLBI, HL107152 to B.K.) and Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD, HD066121 to Y.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Blau HM, 2001, NAT MED, V7, P532, DOI 10.1038/87850; Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carpentier G, 2012, IMAGE J NEWS, V5, P71; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Chiodelli P, 2015, MOLECULES, V20, P6342, DOI 10.3390/molecules20046342; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; de la Torre JC, 2004, NEUROL RES, V26, P517, DOI 10.1179/016164104225016254; Denholm EM, 2001, EUR J PHARMACOL, V416, P213, DOI 10.1016/S0014-2999(01)00884-6; Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441; Ergul A, 2012, STROKE, V43, P2270, DOI 10.1161/STROKEAHA.111.642710; Francescone R.A., 2011, JOVE-J VIS EXP, V55, P3040; FRITZ TA, 1994, J BIOL CHEM, V269, P300; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Hausman MR, 2004, AM J SURG, V187, p44S, DOI 10.1016/S0002-9610(03)00304-0; Huang HG, 2012, CELL REP, V2, P695, DOI 10.1016/j.celrep.2012.08.015; ISHIHARA M, 1995, J BIOCHEM-TOKYO, V118, P1255, DOI 10.1093/oxfordjournals.jbchem.a125015; KRUPINSKI J, 1994, STROKE, V25, P1794, DOI 10.1161/01.STR.25.9.1794; Kuberan B, 2008, CHEMBIOCHEM, V9, P198, DOI 10.1002/cbic.200700494; Le Jan S, 2012, ARTERIOSCL THROM VAS, V32, P1255, DOI 10.1161/ATVBAHA.111.240622; MACCARANA M, 1993, J BIOL CHEM, V268, P23898; Murphy S, 2006, CIRC RES, V99, P257, DOI 10.1161/01.RES.0000233316.17882.33; Nguyen TKN, 2013, ACS CHEM BIOL, V8, P939, DOI 10.1021/cb400132r; Nishiguchi KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013493; OKAYAMA M, 1973, J BIOCHEM-TOKYO, V74, P1069; Oki S, 2007, DEVELOPMENT, V134, P3893, DOI 10.1242/dev.009464; Ono K, 1999, GLYCOBIOLOGY, V9, P705, DOI 10.1093/glycob/9.7.705; Penc SF, 1998, J BIOL CHEM, V273, P28116, DOI 10.1074/jbc.273.43.28116; Persson A, 2016, J BIOL CHEM, V291, P14871, DOI 10.1074/jbc.M116.716829; Prydz K, 2000, J CELL SCI, V113, P193; Prydz K, 2009, GLYCOCONJUGATE J, V26, P1117, DOI 10.1007/s10719-009-9232-2; Pufe T, 2003, BONE, V33, P869, DOI 10.1016/j.bone.2003.08.002; Raman K, 2011, BIOCHEM BIOPH RES CO, V404, P86, DOI 10.1016/j.bbrc.2010.11.069; Raman K, 2010, BIOCHEM BIOPH RES CO, V398, P191, DOI 10.1016/j.bbrc.2010.06.055; Rinsch C, 2001, GENE THER, V8, P523, DOI 10.1038/sj.gt.3301436; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Salmon AHJ, 2009, CARDIOVASC RES, V83, P24, DOI 10.1093/cvr/cvp093; SCHWARTZ NB, 1977, J BIOL CHEM, V252, P6316; SCHWARTZ NB, 1976, BIOCHEM BIOPH RES CO, V71, P851, DOI 10.1016/0006-291X(76)90909-8; Sefcik Lauren S, 2008, Organogenesis, V4, P215; Shen CJ, 2011, EXP CELL RES, V317, P1860, DOI 10.1016/j.yexcr.2011.05.006; Shintani Y, 2006, EMBO J, V25, P3045, DOI 10.1038/sj.emboj.7601188; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Shriver Z, 2002, TRENDS CARDIOVAS MED, V12, P71, DOI 10.1016/S1050-1738(01)00150-5; Siegbahn A, 2015, ORG BIOMOL CHEM, V13, P3351, DOI 10.1039/c4ob02632b; Stefanini MO, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000622; Tao ZX, 2011, P NATL ACAD SCI USA, V108, P2064, DOI 10.1073/pnas.1018925108; ten Dam GB, 2007, AM J PATHOL, V171, P1324, DOI 10.2353/ajpath.2007.070111; Thurston G, 2002, J ANAT, V200, P575, DOI 10.1046/j.1469-7580.2002.00061.x; VERTEL BM, 1993, J BIOL CHEM, V268, P11105; Victor XV, 2009, J BIOL CHEM, V284, P25842, DOI 10.1074/jbc.M109.043208; YANG EY, 1990, J CELL BIOL, V111, P731, DOI 10.1083/jcb.111.2.731; Yin GY, 2002, MOL THER, V5, P547, DOI 10.1006/mthe.2002.0590; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	56	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0182301	10.1371/journal.pone.0182301	http://dx.doi.org/10.1371/journal.pone.0182301			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763512	Green Published, Green Submitted, gold			2022-12-26	WOS:000406766500059
J	Kasarapu, P; Porto-Neto, LR; Fortes, MRS; Lehnert, SA; Mudadu, MA; Coutinho, L; Regitano, L; George, A; Reverter, A				Kasarapu, Parthan; Porto-Neto, Laercio R.; Fortes, Marina R. S.; Lehnert, Sigrid A.; Mudadu, Mauricio A.; Coutinho, Luiz; Regitano, Luciana; George, Andrew; Reverter, Antonio			The Bos taurus-Bos indicus balance in fertility and milk related genes	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; GENOME-WIDE ASSOCIATION; MEAT QUALITY TRAITS; LINKAGE DISEQUILIBRIUM; REPRODUCTIVE EFFICIENCY; CANDIDATE GENE; CATTLE; SNP; SELECTION; IDENTIFICATION	Numerical approaches to high-density single nucleotide polymorphism (SNP) data are often employed independently to address individual questions. We linked independent approaches in a bioinformatics pipeline for further insight. The pipeline driven by heterozygosity and Hardy-Weinberg equilibrium (HWE) analyses was applied to characterize Bos taurus and Bos indicus ancestry. We infer a gene co-heterozygosity network that regulates bovine fertility, from data on 18,363 cattle with genotypes for 729,068 SNP. Hierarchical clustering separated populations according to Bos taurus and Bos indicus ancestry. The weights of the first principal component were subjected to Normal mixture modelling allowing the estimation of a gene's contribution to the Bos taurus-Bos indicus axis. We used deviation from HWE, contribution to Bos indicus content and association to fertility traits to select 1,284 genes. With this set, we developed a co-heterozygosity network where the group of genes annotated as fertility-related had significantly higher Bos indicus content compared to other functional classes of genes, while the group of genes associated with milk production had significantly higher Bos taurus content. The network analysis resulted in capturing novel gene associations of relevance to bovine domestication events. We report transcription factors that are likely to regulate genes associated with cattle domestication and tropical adaptation. Our pipeline can be generalized to any scenarios where population structure requires scrutiny at the molecular level, particularly in the presence of a priori set of genes known to impact a phenotype of evolutionary interest such as fertility.	[Kasarapu, Parthan; Porto-Neto, Laercio R.; Lehnert, Sigrid A.; Reverter, Antonio] CSIRO Agr & Food, Queensland Biosci Precinct, Brisbane, Qld, Australia; [Fortes, Marina R. S.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Mudadu, Mauricio A.] Embrapa Agr Informat, Campinas, SP, Brazil; [Coutinho, Luiz] Univ Sao Paulo, Ctr Genom Func ESALQ, Piracicaba, SP, Brazil; [Regitano, Luciana] Embrapa Southeast Livestock, Rodovia Washington Luiz, Sao Carlos, SP, Brazil; [George, Andrew] CSIRO, DATA61, Ecosci Precinct Brisbane, Brisbane, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Reverter, A (corresponding author), CSIRO Agr & Food, Queensland Biosci Precinct, Brisbane, Qld, Australia.	Toni.Reverter-Gomez@csiro.au	de Alvarenga Mudadu, Maurício/B-6524-2014; Fortes, Marina/AAN-6815-2020; Reverter, Antonio/C-9699-2013; Fortes, Marina R S/G-2302-2012; Porto-Neto, Laercio R/D-2594-2012; Coutinho, Luiz L/C-8455-2012; Lehnert, Sigrid A/A-3676-2013; Coutinho, Luiz/P-5233-2019; Regitano, Luciana/C-7002-2012	de Alvarenga Mudadu, Maurício/0000-0002-2767-2507; Fortes, Marina/0000-0002-7254-1960; Reverter, Antonio/0000-0002-4681-9404; Fortes, Marina R S/0000-0002-7254-1960; Porto-Neto, Laercio R/0000-0002-3536-8265; Coutinho, Luiz L/0000-0002-7266-8881; Lehnert, Sigrid A/0000-0003-4891-9094; Coutinho, Luiz/0000-0002-7266-8881; Regitano, Luciana/0000-0001-9242-8351	Embrapa Southeast Livestock	Embrapa Southeast Livestock	Embrapa Southeast Livestock has provided support in the form of salaries for authors [MM and LR]. They provided the Nelore data and contributed to the drafting of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams HA, 2016, J DAIRY SCI, V99, P6693, DOI 10.3168/jds.2015-10517; Ariyoshi M, 2003, GENE DEV, V17, P1909, DOI 10.1101/gad.266203; Bertolini F, 2015, J ANIM BREED GENET, V132, P346, DOI 10.1111/jbg.12155; Blott SC, 1999, HEREDITY, V82, P613, DOI 10.1046/j.1365-2540.1999.00521.x; Boitard S, 2016, GENETICS, V203, P433, DOI 10.1534/genetics.115.181594; Bolormaa S, 2013, J ANIM SCI, V91, P3088, DOI 10.2527/jas.2012-5827; Bolormaa S, 2011, J ANIM SCI, V89, P2050, DOI 10.2527/jas.2010-3363; Bomba L, 2015, GENETICS SELECTION E, V47; Canas-Alvarez JJ, 2016, J ANIM SCI, V94, P2779, DOI 10.2527/jas.2016-0425; Canovas A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102551; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Charlier C, 2008, NAT GENET, V40, P449, DOI 10.1038/ng.96; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Cohen-Zinder M, 2005, GENOME RES, V15, P936, DOI 10.1101/gr.3806705; Cole JB, 2009, J DAIRY SCI, V92, P2931, DOI 10.3168/jds.2008-1762; Costa RB, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0150-4; Costa RB, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0146-0; DALEY DR, 1987, J ANIM SCI, V64, P373, DOI 10.2527/jas1987.642373x; DAVIS CS, 1982, BIOMETRICS, V38, P279; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Edwards SM, 2016, GENETICS, V203, P1871, DOI 10.1534/genetics.116.187161; Espigolan R, 2015, GENET MOL RES, V14, P11133, DOI 10.4238/2015.September.22.7; Flori L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006595; Fortes MRS, 2013, ANDROLOGY-US, V1, P644, DOI 10.1111/j.2047-2927.2013.00101.x; Fortes MRS, 2016, THERIOGENOLOGY, V86, P333, DOI 10.1016/j.theriogenology.2016.04.046; Fortes MRS, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101089; Fortes MRS, 2010, P NATL ACAD SCI USA, V107, P13642, DOI 10.1073/pnas.1002044107; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Hu ZL, 2016, NUCLEIC ACIDS RES, V44, pD827, DOI 10.1093/nar/gkv1233; Hudson NJ, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0158-9; Hudson NJ, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-66; Hyeong KE, 2014, ASIAN AUSTRAL J ANIM, V27, P1406, DOI 10.5713/ajas.2014.14273; Kapila N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157237; Kaupe B, 2004, J DAIRY RES, V71, P182, DOI 10.1017/S0022029904000032; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Kishore A, 2014, CELL STRESS CHAPERON, V19, P613, DOI 10.1007/s12192-013-0486-z; Koufariotis L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-436; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Lewis J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018007; Liu X, 2008, BMC BIOINFORMATICS, V9; Looft C, 2001, MAMM GENOME, V12, P646, DOI 10.1007/s003350020003; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; MacEachern S, 2009, BMC GENOMICS, P10; MACHUGH DE, 1994, P ROY SOC B-BIOL SCI, V256, P25, DOI 10.1098/rspb.1994.0044; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marques E, 2011, J ANIM BREED GENET, V128, P305, DOI 10.1111/j.1439-0388.2010.00910.x; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; McDaneld TG, 2014, J ANIM SCI, V92, P1378, DOI 10.2527/jas.2013-6821; McLachlan G., 1999, J STAT SOFTW, V4, P1, DOI DOI 10.18637/jss.v004.i02; Morgan A, 1993, GENEREVIEWS R; Mudadu MA, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2535-3; Page BT, 2002, J ANIM SCI, V80, P3077; Pan DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060440; Pegolo S, 2016, J DAIRY SCI, V99, P4558, DOI 10.3168/jds.2015-10420; Porto-Neto LR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113284; Porto-Neto LR, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-22; Porto-Neto LR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-876; Psaros KM, 2015, J ANIM SCI, V93, P978, DOI 10.2527/jas.2014-8509; Purfield DC, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-70; Qanbari S, 2010, ANIM GENET, V41, P377, DOI 10.1111/j.1365-2052.2009.02016.x; Randhawa IAS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153013; Reverter A, 2016, J ANIM SCI, V94, P4096, DOI 10.2527/jas.2016-0675; Reverter A, 2013, J ANIM SCI, V91, P530, DOI 10.2527/jas.2012-5780; Reverter A, 2008, BIOINFORMATICS, V24, P2491, DOI 10.1093/bioinformatics/btn482; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Samuels DC, 2016, GENETICS; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shepherd C, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0254-2; St-Pierre B, 2004, DEV DYNAM, V230, P124, DOI 10.1002/dvdy.20013; Tambasco-Talhari D, 2005, GENET MOL BIOL, V28, P218, DOI 10.1590/S1415-47572005000200007; Tantia Madhu S, 2006, BMC Vet Res, V2, P32, DOI 10.1186/1746-6148-2-32; Thomas M., PLANT ANIMAL GENOME; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; VanderWielen BD, 2011, J BIOL CHEM, V286, P14892, DOI 10.1074/jbc.M110.181156; Vignal A, 2002, GENET SEL EVOL, V34, P275, DOI [10.1186/1297-9686-34-3-275, 10.1051/gse:2002009]; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1; Wibowo Tito A, 2008, Int J Biol Sci, V4, P406; Wiener P, 2004, HEREDITY, V93, P597, DOI 10.1038/sj.hdy.6800566; Yuan ZR, 2012, GENE, V505, P190, DOI 10.1016/j.gene.2012.05.010; Yuan ZR, 2012, MOL BIOL REP, V39, P6625, DOI 10.1007/s11033-012-1467-5; Zhang HM, 2012, NUCLEIC ACIDS RES, V40, pD144, DOI 10.1093/nar/gkr965; Zhang K, 2004, GENOME RES, V14, P908, DOI 10.1101/gr.1837404	84	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0181930	10.1371/journal.pone.0181930	http://dx.doi.org/10.1371/journal.pone.0181930			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763475	Green Published, gold, Green Submitted			2022-12-26	WOS:000406766500028
J	Messina, S; Solaro, C; Righini, I; Bergamaschi, R; Bonavita, S; Bossio, RB; Morra, VB; Costantino, G; Cavalla, P; Centonze, D; Comi, G; Cottone, S; Danni, MC; Francia, A; Gajofatto, A; Gasperini, C; Zaffaroni, M; Petrucci, L; Signoriello, E; Maniscalco, GT; Spinicci, G; Matta, M; Mirabella, M; Peda, G; Castelli, L; Rovaris, M; Sessa, E; Spitaleri, D; Paolicelli, D; Granata, A; Zappia, M; Patti, F				Messina, Silvia; Solaro, Claudio; Righini, Isabella; Bergamaschi, Roberto; Bonavita, Simona; Bossio, Roberto Bruno; Morra, Vincenzo Brescia; Costantino, Gianfranco; Cavalla, Paola; Centonze, Diego; Comi, Giancarlo; Cottone, Salvatore; Danni, Maura Chiara; Francia, Ada; Gajofatto, Alberto; Gasperini, Claudio; Zaffaroni, Mauro; Petrucci, Loredana; Signoriello, Elisabetta; Maniscalco, Giorgia Teresa; Spinicci, Gabriella; Matta, Manuela; Mirabella, Massimiliano; Peda, Graziella; Castelli, Letizia; Rovaris, Marco; Sessa, Edoardo; Spitaleri, Daniele; Paolicelli, Damiano; Granata, Alfredo; Zappia, Mario; Patti, Francesco		SAFE Study Grp	Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study)	PLOS ONE			English	Article							CANNABIS-BASED MEDICINE; DOUBLE-BLIND; SYMPTOMS; MANAGEMENT; IMPACT	Background The approval of Sativex for the management of multiple sclerosis (MS) spasticity opened a new opportunity to many patients. In Italy, the healthcare payer can be fully reimbursed by the involved pharma company with the cost of treatment for patients not responding after a 4 week (28 days) trial period (Payment by Results, PbR), and 50% reimbursed with the cost of 6 weeks (42 days) treatment for other patients discontinuing (Cost Sharing, CS). The aim of our study was to describe the Sativex discontinuation profile from a large population of spasticity treated Italian MS patients. Methods We collected data of patients from 30 MS centres across the country starting Sativex between January 2014 and February 2015. Data were collected from the mandatory Italian Medicines Agency (AIFA) web-registry. Predictors of treatment discontinuation were assessed using a multivariate Cox proportional regression analysis. Results During the observation period 631 out of 1597 (39.5%) patients discontinued Sativex. The Kaplan-Meier estimates curve showed that 333 patients (20.8%) discontinued treatment at 4 weeks while 422 patients (26.4%) discontinued at 6 weeks. We found after adjusted modeling that a higher NRS score at T1 (adjHR 2.23, 95% 2.07-2.41, p<0.001) and a lower baseline NRS score (adjHR 0.51 95% CI 0.46-0.56, p<0.001) were predictive of treatment discontinuation. Conclusion These data show that the first 6 weeks are useful in identifying those patients in which Sativex could be effective, thus avoiding the cost of longer term evaluation.	[Messina, Silvia; Zappia, Mario; Patti, Francesco] Univ Catania, Dept Med Surg Sci & Adv Technol GF Ingrassia, Catania, Italy; [Solaro, Claudio] Dept Head & Neck, Neurol Unit, ASL3, Genoa, Italy; [Righini, Isabella] Univ Florence, Dept NEUROFARBA, Florence, Italy; [Bergamaschi, Roberto] Neurol Inst C Mondino, Dept Neurol, Pavia, Italy; [Bonavita, Simona] II Univ Naples, Clin Neurol 1, Naples, Italy; [Bossio, Roberto Bruno] Neurol Operating Unit, Cosenza, Italy; [Bossio, Roberto Bruno] Multiple Sclerosis Ctr, Prov Hlth Author Cosenza, Cosenza, Italy; [Morra, Vincenzo Brescia] Univ Federico II, Multiple Sclerosis Ctr, Naples, Italy; [Costantino, Gianfranco] Foggia Hosp, Demyelinating Dis Ctr, Foggia, Italy; [Cavalla, Paola] Cittadella Salute & Sci Torino, AOU, Turin, Italy; [Centonze, Diego] Univ Tor Vegata, Neurosci Dept, Rome, Italy; [Centonze, Diego] IRCCS, Neuromed, Unit Neurol & Neurorehabil, Pozzilli, IS, Italy; [Centonze, Diego] Osped San Raffaele, Dept Neurol, Milan, Italy; [Cottone, Salvatore] Villa Sofia Cervello Hosp, Neuroimmunol Unit, Palermo, Italy; [Danni, Maura Chiara] Ancona Hosp, Neurol Clin, Ancona, Italy; [Francia, Ada] Psich Sapienza Univ, Dept Neurol, Multiple Sclerosis Ctr, Rome, Italy; [Gajofatto, Alberto] Univ Verona, Dept Neurosci, Biomed & Movement Multiple Sclerosis Ctr, Verona, Italy; [Gasperini, Claudio] San Camillo Hosp, Neurol Div, Rome, Italy; [Zaffaroni, Mauro] Sant Antonio Abate Hosp, Multiple Sclerosis Ctr, Gallarate, Italy; [Petrucci, Loredana] Univ Hosp Pisa, Multiple Sclerosis Ctr, Pisa, Italy; [Signoriello, Elisabetta] Univ Naples 2, Multiple Sclerosis Ctr, Naples, Italy; [Maniscalco, Giorgia Teresa] Cardarelli Hosp, Multiple Sclerosis Ctr, Naples, Italy; [Spinicci, Gabriella] Univ Cagliari, Dept Med Sci, Cagliari, Italy; [Matta, Manuela] San Luigi Gonzaga Hosp, Multiple Sclerosis Ctr CRESM, Orbassano, Italy; [Mirabella, Massimiliano] Cattol Univ, Multiple Sclerosis Ctr, Rome, Italy; [Peda, Graziella] Vaio Hosp, Multiple Sclerosis Ctr, Fidenza, Italy; [Castelli, Letizia] S Andrea Hosp, Multiple Sclerosis Ctr, Rome, Italy; [Rovaris, Marco] IRCCS, Don Gnocchi Fdn, Multiple Sclerosis Ctr, Milan, Italy; [Sessa, Edoardo] IRCCS, Bonino Pulejo Ctr, Multiple Sclerosis Ctr, Messina, Italy; [Spitaleri, Daniele] San G Moscati Hosp, Multiple Sclerosis Ctr, Avellino, Italy; [Paolicelli, Damiano] Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy; [Granata, Alfredo] Magna Graecia Univ Catanzaro, Inst Neurol, Dept Med Sci, Catanzaro, Italy	University of Catania; University of Florence; IRCCS Fondazione Casimiro Mondino; Universita della Campania Vanvitelli; University of Naples Federico II; A.O.U. Citta della Salute e della Scienza di Torino; IRCCS Neuromed; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Verona; University of Pisa; Azienda Ospedaliero Universitaria Pisana; Universita della Campania Vanvitelli; Antonio Cardarelli Hospital; University of Cagliari; Azienda Ospedaliero-Universitaria San Luigi Gonzaga; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; IRCCS Fondazione Don Carlo Gnocchi Onlus; San Giuseppe Moscati Hospital; Universita degli Studi di Bari Aldo Moro; Magna Graecia University of Catanzaro	Patti, F (corresponding author), Univ Catania, Dept Med Surg Sci & Adv Technol GF Ingrassia, Catania, Italy.	patti@unict.it	Sessa, Edoardo/AAB-8544-2020; Solaro, Claudio Marcello/AAL-2402-2021; MIRABELLA, Massimiliano/AAC-4016-2020; Signoriello, Elisabetta/ABG-1289-2020; Castelli, Letizia/AAC-2441-2019; Rovaris, Marco/AAA-6040-2020; Centonze, Diego/J-7767-2016; Bonavita, Simona/AGN-5124-2022; Messina, Silvia/ABC-8780-2020; Castelli, Letizia/AAL-7701-2020; Zappia, Mario/AAB-7800-2019; Signoriello, Elisabetta/AAL-9069-2021	Solaro, Claudio Marcello/0000-0002-6713-4623; MIRABELLA, Massimiliano/0000-0002-7783-114X; Signoriello, Elisabetta/0000-0001-5753-6752; Rovaris, Marco/0000-0001-9691-1957; Centonze, Diego/0000-0002-8390-8545; Bonavita, Simona/0000-0002-8561-9720; patti, francesco/0000-0002-6923-0846				Arroyo R, 2014, J COMP EFFECT RES, V3, P435, DOI [10.2217/CER.14.30, 10.2217/cer.14.30]; Arroyo R, 2011, EXPERT REV PHARM OUT, V11, P205, DOI [10.1586/ERP.11.6, 10.1586/erp.11.6]; Beard S., 2003, HEALTH TECHNOL ASSES, V7, P1, DOI DOI 10.3310/HTA7400; Collin C, 2007, EUR J NEUROL, V14, P290, DOI 10.1111/j.1468-1331.2006.01639.x; Collin C, 2010, NEUROL RES, V32, P451, DOI 10.1179/016164109X12590518685660; Farrar JT, 2008, CLIN THER, V30, P974, DOI 10.1016/j.clinthera.2008.05.011; Garrison LP, 2013, VALUE HEALTH, V16, P703, DOI 10.1016/j.jval.2013.04.011; Meuth SG, 2015, EXPERT REV NEUROTHER, V15, P909, DOI 10.1586/14737175.2015.1067607; Novotna A, 2011, EUR J NEUROL, V18, P1122, DOI 10.1111/j.1468-1331.2010.03328.x; Oreja-Guevara C., 2015, CLIN EXP PHARM, V5, DOI [10.4172/2161-1459.1000184, DOI 10.4172/2161-1459.1000184]; Otero-Romero S, 2016, MULT SCLER J, V22, P1386, DOI 10.1177/1352458516643600; Patti F, 2016, J NEUROL NEUROSUR PS, V87, P944, DOI 10.1136/jnnp-2015-312591; Patti F, 2014, NEUROEPIDEMIOLOGY, V42, P211, DOI 10.1159/000360423; Pozzilli C, 2014, EUR NEUROL, V71, P1, DOI 10.1159/000357739; Shakespeare D T, 2001, Cochrane Database Syst Rev, pCD001332, DOI 10.1002/14651858.CD001332; Slof J, 2015, EXPERT REV PHARM OUT, V15, P379, DOI 10.1586/14737167.2015.1025759; Wade DT, 2006, MULT SCLER J, V12, P639, DOI 10.1177/1352458505070618; Wade DT, 2004, MULT SCLER, V10, P434, DOI 10.1191/1352458504ms1082oa	18	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0180651	10.1371/journal.pone.0180651	http://dx.doi.org/10.1371/journal.pone.0180651			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763462	Green Published, Green Submitted, gold			2022-12-26	WOS:000406766500006
J	Tang, XH; Yu, PM; Ding, D; Ge, Y; Shi, YB; Wang, P; Zhu, GX; Hong, Z				Tang, XingHua; Yu, Peimin; Ding, Ding; Ge, Yan; Shi, Yunbo; Wang, Ping; Zhu, Guoxing; Hong, Zhen			Risk factors for seizure reoccurrence after withdrawal from antiepileptic drugs in individuals who have been seizure-free for over 2 years	PLOS ONE			English	Article							RECURRENCE; EPILEPSY; CHILDREN; EEG; IDENTIFICATION; ABNORMALITIES; RELAPSE	Purpose To observe risk factors for recurrence after withdrawal from antiepileptic drugs. Methods We assessed 1282 patients with a definite diagnosis of epilepsy. Results In total, 292 patients between 14 and 80 years of age were grouped according to risk factors for recurrence. Of these individuals, 119 discontinued AED(s) and relapsed. The relapse rate was 34.4 per 100 person-years. We used a Cox regression for multivariate analysis to investigate the influence of the following on seizure recurrence: receiving more than one type of AED (HR = 2.53, 95% CI 1.24-5.16) and more than 6 months prior to initiation of AED treatment (HR 1.47, 95% CI = 1.004-2.15). Conclusions Although the decision to discontinue AED treatment necessitates an individual evaluation of each patient, our study suggests that there may be a high risk of recurrence in individuals who: were receiving more than one AEDs and had initiated their AED treatment more than 6 months after the initial appearance of epilepsy symptoms.	[Tang, XingHua; Yu, Peimin; Ding, Ding; Ge, Yan; Shi, Yunbo; Wang, Ping; Zhu, Guoxing; Hong, Zhen] Fudan Univ, Huashan Hosp, Inst Neurol, Shanghai, Peoples R China	Fudan University	Yu, PM (corresponding author), Fudan Univ, Huashan Hosp, Inst Neurol, Shanghai, Peoples R China.	tracypmyu@163.com	Wang, Ping/GZB-2001-2022		National Natural Science Foundation of China [81501121]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (Grant No. 81501121).	Acharya UR, 2011, INT J NEURAL SYST, V21, P199, DOI 10.1142/S0129065711002808; Aktekin B, 2006, EPILEPSY BEHAV, V8, P616, DOI 10.1016/j.yebeh.2006.01.018; Beghi E, 2013, EPILEPSIA, V54, P2, DOI 10.1111/epi.12305; BERG AT, 1994, NEUROLOGY, V44, P601, DOI 10.1212/WNL.44.4.601; Bonnett LJ, 2011, J NEUROL NEUROSUR PS, V82, P1328, DOI 10.1136/jnnp.2010.222885; Bouma PA, 2012, J NEUROL NEUROSUR PS, V72, P507; Britton JW, 2010, J CLIN NEUROPHYSIOL, V27, P249, DOI 10.1097/WNP.0b013e3181eaa620; Brodie MJ, 2012, NEUROLOGY, V78, P1548, DOI 10.1212/WNL.0b013e3182563b19; Callaghan B, 2011, EPILEPSIA, V52, P619, DOI 10.1111/j.1528-1167.2010.02929.x; Callaghan N, 1988, NEW ENGL J MED, V319, P188; Camfield P, 2008, EPILEPSIA, V49, P25, DOI 10.1111/j.1528-1167.2008.01923.x; Cardoso TAM, 2006, NEUROLOGY, V67, P134, DOI 10.1212/01.wnl.0000223350.08394.06; CHADWICK D, 1991, LANCET, V337, P1175; Chen YJ, 2001, EPILEPSY RES, V44, P65, DOI 10.1016/S0920-1211(00)00204-7; Kazibutowska Z, 1992, Neurol Neurochir Pol, V26, P304; Khan RB, 2006, EPILEPSIA, V47, P375, DOI 10.1111/j.1528-1167.2006.00431.x; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Lossius MI, 2008, EPILEPSIA, V49, P455, DOI 10.1111/j.1528-1167.2007.01323.x; Olmez A, 2009, SEIZURE-EUR J EPILEP, V18, P251, DOI 10.1016/j.seizure.2008.10.011; OVERWEG J, 1987, EPILEPSY RES, V1, P272, DOI 10.1016/0920-1211(87)90002-7; Ramos-Lizana J, 2010, EUR J PAEDIATR NEURO, V14, P116, DOI 10.1016/j.ejpn.2009.05.006; Specchio LM, 2004, CNS DRUGS, V18, P201, DOI 10.2165/00023210-200418040-00001; SPERBER EF, 1991, DEV BRAIN RES, V60, P88, DOI 10.1016/0165-3806(91)90158-F; Verrotti A, 2003, ANN MED, V35, P207, DOI 10.1080/07853890310008260; Wang L, 2012, EPILEPSY RES, V98, P116, DOI 10.1016/j.eplepsyres.2011.06.008	25	10	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0181710	10.1371/journal.pone.0181710	http://dx.doi.org/10.1371/journal.pone.0181710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763466	Green Published, Green Submitted, gold			2022-12-26	WOS:000406766500017
J	Huang, CH; Huang, YTA; Lai, YC; Sun, CK				Huang, Chi-Hsien; Huang, Yu-Tung Anton; Lai, Yu-Cheng; Sun, Cheuk-Kwan			Prevalence and predictors of hypovitaminosis D among the elderly in subtropical region	PLOS ONE			English	Review							VITAMIN-D DEFICIENCY; CARDIOVASCULAR RISK-FACTORS; D INADEQUACY; COLORECTAL-CANCER; D SUPPLEMENTATION; D INSUFFICIENCY; OSTEOPOROSIS; CALCIUM; WOMEN; METAANALYSIS	The prevalence of low vitamin D status in the elderly population of subtropical area and the potential risk/protective factors have not been addressed. This cross-sectional question-naire-based study, which collected demographic/anthropometric data and information on diet habit and sun exposure, recruited 170 subjects with mean age 70.9 +/- 5.6 in rural areas of southern Taiwan. Serum 25-OH vitamin D, calcium, and intact parathyroid hormone were also measured. Using cut-off level of 30 ng/mL, subjects were divided into low (n = 95) and normal (n = 75) serum vitamin D groups. The results demonstrated a low vitamin D status in 30.6% of men and 57.7% of women. Dietary vitamin D intake was another factor associated with vitamin D status (p = 0.02). Logistic regression identified inadequate intake of vitamin D-rich food as the only risk factor for low vitamin D status in men (OR = 4.55, p = 0.01), whereas inadequate sun exposure was the only predictable risk with dose-response relationship in women (low vs. high sun exposure, OR = 6.84, p = 0.018; moderate vs. high sun exposure, OR = 6.67, p = 0.005). In conclusion, low vitamin D status was common in the elderly of subtropical rural areas. Low sun exposure and inadequate dietary vitamin D consumption were associated with a low vitamin D status in females and males, respectively.	[Huang, Chi-Hsien; Lai, Yu-Cheng] E Da Hosp, Dept Family Med, Kaohsiung, Taiwan; [Huang, Chi-Hsien] E Da Hosp, Ctr Evidence Based Med, Kaohsiung, Taiwan; [Huang, Chi-Hsien; Sun, Cheuk-Kwan] I Shou Univ, Sch Med Int Students, Kaohsiung, Taiwan; [Huang, Yu-Tung Anton] Kaohsiung Med Univ, Coll Nursing, Master Program Long Term Care Aging, Kaohsiung, Taiwan; [Huang, Yu-Tung Anton] Kaohsiung Med Univ, Dept Med Res, Kaohsiung, Taiwan; [Huang, Yu-Tung Anton] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Sun, Cheuk-Kwan] E Da Hosp, Dept Emergency Med, Kaohsiung, Taiwan	E-Da Hospital; E-Da Hospital; I Shou University; Kaohsiung Medical University; Kaohsiung Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; E-Da Hospital	Sun, CK (corresponding author), I Shou Univ, Sch Med Int Students, Kaohsiung, Taiwan.; Sun, CK (corresponding author), E Da Hosp, Dept Emergency Med, Kaohsiung, Taiwan.	lawrence.c.k.sun@gmail.com	Sun, Cheuk-Kwan/K-5723-2012; Huang, Yu-Tung/S-4026-2018	Huang, Yu-Tung/0000-0003-3224-7238				Adams JS, 2010, J CLIN ENDOCR METAB, V95, P471, DOI 10.1210/jc.2009-1773; Aggarwal Sameer, 2013, Indian J Endocrinol Metab, V17, pS618, DOI 10.4103/2230-8210.123549; Al-Musharaf S, 2012, EUR J PEDIATR, V171, P1081, DOI 10.1007/s00431-012-1686-8; Babu US, 2010, MOL NUTR FOOD RES, V54, P1134, DOI 10.1002/mnfr.200900480; Bhan A, 2010, ENDOCRIN METAB CLIN, V39, P321, DOI 10.1016/j.ecl.2010.02.001; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Bjelakovic G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007470.pub2; Bulathsinghala P, 2010, J NUTR METAB, V2010, DOI 10.1155/2010/721365; Chailurkit LO, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-853; Chan HLY, 2015, J HEPATOL, V63, P1086, DOI 10.1016/j.jhep.2015.06.025; Chang CI, 2010, ARCH GERONTOL GERIAT, V50, pS17, DOI 10.1016/S0167-4943(10)70006-6; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; Choi HS, 2008, J CLIN ENDOCR METAB, V96, P643, DOI DOI 10.1210/JC.2010-2133; Christakos S, 2016, PHYSIOL REV, V96, P365, DOI 10.1152/physrev.00014.2015; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; Garland CF, 2006, AM J PUBLIC HEALTH, V96, P252, DOI 10.2105/AJPH.2004.045260; Giovannucci E, 2006, JNCI-J NATL CANCER I, V98, P451, DOI 10.1093/jnci/djj101; Giovannucci E, 2009, J CLIN ENDOCR METAB, V94, P418, DOI 10.1210/jc.2008-2695; Gordon CM, 2004, ARCH PEDIAT ADOL MED, V158, P531, DOI 10.1001/archpedi.158.6.531; Grubler M.R., 2017, REV ENDOCR METAB DIS; HOLICK MF, 1992, NEW ENGL J MED, V326, P1178, DOI 10.1056/NEJM199204303261802; Holick MF, 2006, MAYO CLIN PROC, V81, P353, DOI 10.4065/81.3.353; Holick MF, 2005, J CLIN ENDOCR METAB, V90, P3215, DOI 10.1210/jc.2004-2364; HOLICK MF, 1989, LANCET, V2, P1104; HOLICK MF, 1994, AM J CLIN NUTR, V60, P619, DOI 10.1093/ajcn/60.4.619; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2006, PROG BIOPHYS MOL BIO, V92, P49, DOI 10.1016/j.pbiomolbio.2006.02.014; Holick MF, 2006, J CLIN INVEST, V116, P2062, DOI 10.1172/JCI29449; Hwang JS, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-257; Judd SE, 2009, AM J MED SCI, V338, P40, DOI 10.1097/MAJ.0b013e3181aaee91; Kung AWC, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-226; Lee JE, 2011, CANCER PREV RES, V4, P735, DOI 10.1158/1940-6207.CAPR-10-0289; Liou Yiing Mei, 2008, J Nurs Res, V16, P252; Lips P, 2006, J INTERN MED, V260, P245, DOI 10.1111/j.1365-2796.2006.01685.x; Liu EJ, 2010, AM J CLIN NUTR, V91, P1627, DOI 10.3945/ajcn.2009.28441; LO CW, 1985, AM J CLIN NUTR, V42, P644, DOI 10.1093/ajcn/42.4.644; Looker AC, 2011, NCHS DATA BRIEF, V59, P1; Lu L, 2009, DIABETES CARE, V32, P1278, DOI 10.2337/dc09-0209; Ma YL, 2011, J CLIN ONCOL, V29, P3775, DOI 10.1200/JCO.2011.35.7566; MACLAUGHLIN J, 1985, J CLIN INVEST, V76, P1536, DOI 10.1172/JCI112134; Malabanan A, 1998, LANCET, V351, P805, DOI 10.1016/S0140-6736(05)78933-9; Martineau AR, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6583; Martineau AR, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011511.pub2; Mitchell DM, 2012, ENDOCR PRACT, V18, P914, DOI 10.4158/EP12072.OR; Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6; Mondul AM, 2017, EPIDEMIOL REV, P1; Moy FM, 2011, J PHOTOCH PHOTOBIO B, V104, P444, DOI 10.1016/j.jphotobiol.2011.05.002; MYRUP B, 1992, ARCH INTERN MED, V152, P2265, DOI 10.1001/archinte.152.11.2265; Nimitphong H, 2013, DERM-ENDOCRINOL, V5, DOI 10.4161/derm.24054; Otani T, 2007, BRIT J CANCER, V97, P446, DOI 10.1038/sj.bjc.6603892; Penna G, 2005, BLOOD, V106, P3490, DOI 10.1182/blood-2005-05-2044; Pfeifer M, 2001, J CLIN ENDOCR METAB, V86, P1633, DOI 10.1210/jc.86.4.1633; Pludowski P, 2013, ENDOKRYNOL POL, V64, P319, DOI 10.5603/EP.2013.0012; REID IR, 1986, AGE AGEING, V15, P35, DOI 10.1093/ageing/15.1.35; Robien K, 2013, BRIT J NUTR, V109, P493, DOI 10.1017/S0007114512001675; Rucker D, 2002, CAN MED ASSOC J, V166, P1517; SCRAGG R, 1995, EUR J CLIN NUTR, V49, P640; Van Horn LV, 2011, NUTR RES, V31, P579, DOI 10.1016/j.nutres.2011.07.003; van Schoor NM, 2011, BEST PRACT RES CL EN, V25, P671, DOI 10.1016/j.beem.2011.06.007; Vierucci F, 2014, ITAL J PEDIATR, V40, DOI 10.1186/1824-7288-40-54; Weaver CM, 2016, OSTEOPOROSIS INT, V27, P367, DOI 10.1007/s00198-015-3386-5; Wranicz Julia, 2014, Rocz Panstw Zakl Hig, V65, P273; Yu Areum, 2013, Clin Nutr Res, V2, P107, DOI 10.7762/cnr.2013.2.2.107; Yu SL, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000585	64	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0181063	10.1371/journal.pone.0181063	http://dx.doi.org/10.1371/journal.pone.0181063			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759618	Green Submitted, Green Published, gold			2022-12-26	WOS:000406761600010
J	Tomita, S; Saito, K; Nakamura, T; Sekiyama, Y; Kikuchi, J				Tomita, Satoru; Saito, Katsuichi; Nakamura, Toshihide; Sekiyama, Yasuyo; Kikuchi, Jun			Rapid discrimination of strain-dependent fermentation characteristics among Lactobacillus strains by NMR-based metabolomics of fermented vegetable juice	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; DIVERSITY; FOODS; MICROORGANISMS; METABOLISM; PYRUVATE	In this study, we investigated the applicability of NMR-based metabolomics to discriminate strain-dependent fermentation characteristics of lactic acid bacteria (LAB), which are important microorganisms for fermented food production. To evaluate the discrimination capability, six type strains of Lactobacillus species and six additional L. brevis strains were used focusing on i) the difference between homo-and hetero-lactic fermentative species and ii) strain-dependent characteristics within L. brevis. Based on the differences in the metabolite profiles of fermented vegetable juices, non-targeted principal component analysis (PCA) clearly separated the samples into those inoculated with homo-and hetero-lactic fermentative species. The separation was primarily explained by the different levels of dominant metabolites (lactic acid, acetic acid, ethanol, and mannitol). Orthogonal partial least squares discrimination analysis, based on a regions-of-interest (ROIs) approach, revealed the contribution of low-abundance metabolites: acetoin, phenyllactic acid, p-hydroxyphenyllactic acid, glycerophosphocholine, and succinic acid for homolactic fermentation; and ornithine, tyramine, and.-aminobutyric acid (GABA) for heterolactic fermentation. Furthermore, ROIs-based PCA of seven L. brevis strains separated their strain-dependent fermentation characteristics primarily based on their ability to utilize sucrose and citric acid, and convert glutamic acid and tyrosine into GABA and tyramine, respectively. In conclusion, NMR metabolomics successfully discriminated the fermentation characteristics of the tested strains and provided further information on metabolites responsible for these characteristics, which may impact the taste, aroma, and functional properties of fermented foods.	[Tomita, Satoru; Saito, Katsuichi; Nakamura, Toshihide; Sekiyama, Yasuyo] Natl Agr & Food Res Org NARO, Food Res Inst, Tsukuba, Ibaraki, Japan; [Sekiyama, Yasuyo; Kikuchi, Jun] RIKEN, Ctr Sustainable Resource Sci, Yokohama, Kanagawa, Japan; [Kikuchi, Jun] Yokohama City Univ, Grad Sch Med Life Sci, Yokohama, Kanagawa, Japan; [Kikuchi, Jun] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi, Japan; [Kikuchi, Jun] Nagoya Univ, Sch Agr Sci, Nagoya, Aichi, Japan; [Saito, Katsuichi] Natl Agr & Food Res Org NARO, Tsukuba, Ibaraki, Japan	National Agriculture & Food Research Organization - Japan; RIKEN; Yokohama City University; Nagoya University; Nagoya University; National Agriculture & Food Research Organization - Japan	Tomita, S (corresponding author), Natl Agr & Food Res Org NARO, Food Res Inst, Tsukuba, Ibaraki, Japan.	satorutomita@affrc.go.jp	Kikuchi, Jun/O-4725-2019; Kikuchi, Jun/M-5512-2015; Tomita, Satoru/D-6127-2017	Kikuchi, Jun/0000-0002-6809-394X; Kikuchi, Jun/0000-0002-6809-394X; Tomita, Satoru/0000-0002-9212-9113	Ministry of Agriculture, Forestry and Fisheries of Japan	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	The research was supported financially by the Ministry of Agriculture, Forestry and Fisheries of Japan, within the project "The special scheme to deploy highly advanced technology for agriculture forestry and fisheries". The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bringel F, 2001, SYST APPL MICROBIOL, V24, P561, DOI 10.1078/0723-2020-00061; Ebrahimi P, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-0996-7; Ferain T, 1996, J BACTERIOL, V178; Fukuda S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004893; Ganzle MG, 2007, FOOD MICROBIOL, V24, P128, DOI 10.1016/j.fm.2006.07.006; Hagi T, 2016, J DAIRY SCI, V99, P994, DOI 10.3168/jds.2015-9945; HICKEY MW, 1983, AUST J BIOL SCI, V36, P487; Higuchi T, 1997, J BACTERIOL, V179, P3362, DOI 10.1128/JB.179.10.3362-3364.1997; Hong YS, 2011, MAGN RESON CHEM, V49, pS13, DOI 10.1002/mrc.2832; Honore AH, 2016, ANAL BIOANAL CHEM, V408, P83, DOI 10.1007/s00216-015-9103-6; KANEUCHI C, 1988, APPL ENVIRON MICROB, V54, P3053, DOI 10.1128/AEM.54.12.3053-3056.1988; Lewis IA, 2009, MAGN RESON CHEM, V47, pS123, DOI 10.1002/mrc.2526; Li HX, 2010, AMINO ACIDS, V39, P1107, DOI 10.1007/s00726-010-0582-7; Liu SQ, 1996, J APPL BACTERIOL, V81, P486; Lu Y, 2016, METABOLITES, V6, DOI 10.3390/metabo6020019; McMillan A, 2015, SCI REP-UK, V5, DOI 10.1038/srep14174; Meyers SA, 1996, FOOD MICROBIOL, V13, P383, DOI 10.1006/fmic.1996.0044; Mozzi F, 2013, FOOD RES INT, V54, P1152, DOI 10.1016/j.foodres.2012.11.010; Novak L, 2000, J BACTERIOL, V182, P1136, DOI 10.1128/JB.182.4.1136-1143.2000; Ochi H, 2012, J BIOSCI BIOENG, V113, P751, DOI 10.1016/j.jbiosc.2012.02.006; Palama TL, 2016, ANALYST, V141, P4558, DOI [10.1039/C6AN00393A, 10.1039/c6an00393a]; Ravyts F, 2012, ENG LIFE SCI, V12, P356, DOI 10.1002/elsc.201100119; Rivas-Ubach A, 2013, METHODS ECOL EVOL, V4, P464, DOI 10.1111/2041-210X.12028; Settachaimongkon S, 2014, INT J FOOD MICROBIOL, V177, P29, DOI 10.1016/j.ijfoodmicro.2014.02.008; Shalaby AR, 1996, FOOD RES INT, V29, P675, DOI 10.1016/S0963-9969(96)00066-X; Smid EJ, 2014, ANNU REV FOOD SCI T, V5, P313, DOI 10.1146/annurev-food-030713-092339; Smit G, 2005, FEMS MICROBIOL REV, V29, P591, DOI 10.1016/j.femsre.2005.04.002; Steinkraus KH, 1997, FOOD CONTROL, V8, P311, DOI 10.1016/S0956-7135(97)00050-9; Tamang JP, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00578; Tamang JP, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00377; Tomita S, 2015, FOOD CHEM, V174, P163, DOI 10.1016/j.foodchem.2014.11.028; TSAU JL, 1992, APPL ENVIRON MICROB, V58, P891, DOI 10.1128/AEM.58.3.891-894.1992; Vivek N, 2016, BIORESOURCE TECHNOL, V213, P222, DOI 10.1016/j.biortech.2016.02.020; Vrancken G, 2009, INT J FOOD MICROBIOL, V135, P216, DOI 10.1016/j.ijfoodmicro.2009.07.035; Wegkamp A, 2010, LETT APPL MICROBIOL, V50, P57, DOI 10.1111/j.1472-765X.2009.02752.x; Wisselink HW, 2002, INT DAIRY J, V12, P151, DOI 10.1016/S0958-6946(01)00153-4; Wu QL, 2017, CRIT REV FOOD SCI, V57, P3661, DOI 10.1080/10408398.2016.1147418; Zayed G, 2004, PROCESS BIOCHEM, V39, P1081, DOI 10.1016/S0032-9592(03)00222-X	38	23	23	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0182229	10.1371/journal.pone.0182229	http://dx.doi.org/10.1371/journal.pone.0182229			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759594	Green Submitted, Green Published, gold			2022-12-26	WOS:000406761600065
J	Kortz, TB; Axelrod, DM; Chisti, MJ; Kache, S				Kortz, Teresa Bleakly; Axelrod, David M.; Chisti, Mohammod J.; Kache, Saraswati			Clinical outcomes and mortality before and after implementation of a pediatric sepsis protocol in a limited resource setting: A retrospective cohort study in Bangladesh	PLOS ONE			English	Article							INTERNATIONAL CONSENSUS DEFINITIONS; EARLY FLUID RESUSCITATION; GOAL-DIRECTED THERAPY; SEPTIC SHOCK; AFRICAN CHILDREN; MANAGEMENT; TRANSFUSION; GUIDELINES; DIARRHEA; CRITERIA	Background Pediatric sepsis has a high mortality rate in limited resource settings. Sepsis protocols have been shown to be a cost-effective strategy to improve morbidity and mortality in a variety of populations and settings. At Dhaka Hospital in Bangladesh, mortality from pediatric sepsis in high-risk children previously approached 60%, which prompted the implementation of an evidenced-based protocol in 2010. The clinical effectiveness of this protocol had not been measured. We hypothesized that implementation of a pediatric sepsis protocol improved clinical outcomes, including reducing mortality and length of hospital stay. Materials and methods This was a retrospective cohort study of children 1-59 months old with a diagnosis of sepsis, severe sepsis or septic shock admitted to Dhaka Hospital from 10/25/2009-10/25/2011. The primary outcome was inpatient mortality pre-and post-protocol implementation. Secondary outcomes included fluid overload, heart failure, respiratory insufficiency, length of hospital stay, and protocol compliance, as measured by antibiotic and fluid bolus administration within 60 minutes of hospital presentation. Results 404 patients were identified by a key-word search of the electronic medical record; 328 patients with a primary diagnosis of sepsis, severe sepsis, or septic shock were included (143 pre- and 185 post-protocol) in the analysis. Pre- and post-protocol mortality were similar and not statistically significant (32.17% vs. 34.59%, p = 0.72). The adjusted odds ratio (AOR) for post-protocol mortality was 1.55 (95% CI, 0.88-2.71). The odds for developing fluid overload were significantly higher post-protocol (AOR 3.45, 95% CI, 2.04-5.85), as were the odds of developing heart failure (AOR 4.52, 95% CI, 1.43-14.29) and having a longer median length of stay (AOR 1.81, 95% CI 1.10-2.96). There was no statistically significant difference in respiratory insufficiency (pre- 65.7% vs. post- 70.3%, p = 0.4) or antibiotic administration between the cohorts (pre- 16.08% vs. post- 12.43%, p = 0.42). Conclusions Implementation of a pediatric sepsis protocol did not improve all-cause mortality or length of stay and may have been associated with increased fluid overload and heart failure during the study period in a large, non-governmental hospital in Bangladesh. Similar rates of early antibiotic administration may indicate poor protocol compliance. Though evidenced-based protocols are a potential cost-effective strategy to improve outcomes, future studies should focus on optimal implementation of context-relevant sepsis protocols in limited resource settings.	[Kortz, Teresa Bleakly] Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA 94143 USA; [Axelrod, David M.; Kache, Saraswati] Stanford Sch Med, Dept Pediat, Stanford, CA USA; [Chisti, Mohammod J.] Int Ctr Diarrhoeal Dis Res, Nutr & Clin Serv Div, Dhaka, Bangladesh	University of California System; University of California San Francisco; Stanford University; International Centre for Diarrhoeal Disease Research (ICDDR)	Kortz, TB (corresponding author), Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA 94143 USA.	Teresa.Bleakly@ucsf.edu	Chisti, Mohammod J/A-7216-2018	Axelrod, David M./0000-0002-3355-8532	Mary Duke Biddle Clinical Scholars Program	Mary Duke Biddle Clinical Scholars Program	This project was funded by a Mary Duke Biddle Clinical Scholars Program Grant (http://globalhealth.stanford.edu/field-service/mary-duke.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Ahmed T, 1999, LANCET, V353, P1919, DOI 10.1016/S0140-6736(98)07499-6; Aquina CT, 2016, ANN SURG; Baelani I, 2011, CRIT CARE, V15, DOI 10.1186/cc9410; Bhaskar P, 2015, INTENS CARE MED, V41, P1445, DOI 10.1007/s00134-015-3851-9; Brierley J, 2009, CRIT CARE MED, V37, P666, DOI 10.1097/CCM.0b013e31819323c6; CARCILLO JA, 1991, JAMA-J AM MED ASSOC, V266, P1242, DOI 10.1001/jama.266.9.1242; Chisti MJ, 2011, ACTA PAEDIATR, V100, pE275, DOI 10.1111/j.1651-2227.2011.02368.x; Chisti MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051376; Chisti MJ, 2009, ACTA PAEDIATR, V98, P873, DOI 10.1111/j.1651-2227.2008.01196.x; Crowe CA, 2010, AM J EMERG MED, V28, P689, DOI 10.1016/j.ajem.2009.03.007; de Oliveira CF, 2008, INTENS CARE MED, V34, P1065, DOI 10.1007/s00134-008-1085-9; de Oliveira CF, 2010, SHOCK, V34, P44, DOI 10.1097/SHK.0b013e3181e7e6d5; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Dunser MW, 2012, INTENS CARE MED, V38, P557, DOI [10.1007/s00134-012-2468-5, 10.1007/s00134-012-2521-4]; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Han YY, 2003, PEDIATRICS, V112, P793, DOI 10.1542/peds.112.4.793; Holst LB, 2014, NEW ENGL J MED, V371, P1381, DOI 10.1056/NEJMoa1406617; Hsu CY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002601; Jacob ST, 2009, PLOS ONE, V4, pA115, DOI 10.1371/journal.pone.0007782; Jawad Issrah, 2012, J Glob Health, V2, P010404, DOI 10.7189/jogh.02.010404; Ketharanathan N, 2014, J TROP PEDIATRICS, V60, P428, DOI 10.1093/tropej/fmu041; Kiguli S, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0246-7; Kissoon N, 2011, PEDIATR CRIT CARE ME, V12, P494, DOI 10.1097/PCC.0b013e318207096c; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Maitland K, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-68; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Mangia CMF, 2009, J PEDIAT INF DIS-GER, V4, P71, DOI 10.3233/JPI-2009-0157; Mouncey PR, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19970; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Sarmin M, 2014, ACTA PAEDIATR, V103, pe306, DOI 10.1111/apa.12640; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Shankar-Hari M, 2016, JAMA-J AM MED ASSOC, V315, P775, DOI 10.1001/jama.2016.0289; Shorr AF, 2007, CRIT CARE MED, V35, P1257, DOI 10.1097/01.CCM.0000261886.65063.CC; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Slater A, 2003, INTENS CARE MED, V29, P278, DOI 10.1007/s00134-002-1601-2; Sutherland SM, 2010, AM J KIDNEY DIS, V55, P316, DOI 10.1053/j.ajkd.2009.10.048; UNICEF, 2015, COMMITTING CHILD SUR; Wang JL, 2009, J FORMOS MED ASSOC, V108, P778, DOI 10.1016/S0929-6646(09)60405-8; Watson RS, 2005, PEDIATR CRIT CARE ME, V6, pS3, DOI DOI 10.1097/01.PCC.0000161289.22464.C3; Weiss SL, 2015, AM J RESP CRIT CARE, V191, P1147, DOI 10.1164/rccm.201412-2323OC; Wiens MO, 2016, PEDIATR CRIT CARE ME, V17, P400, DOI 10.1097/PCC.0000000000000708; Wiens Matthew O, 2012, Clin Epidemiol, V4, P319, DOI 10.2147/CLEP.S35693; World Health Organization, 2013, HOSP CAR CHILDR GUID; World Health Organization (WHO), 2004, SEV MALN REP CONS RE; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602	48	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0181160	10.1371/journal.pone.0181160	http://dx.doi.org/10.1371/journal.pone.0181160			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753618	Green Published, gold, Green Submitted			2022-12-26	WOS:000406579300012
J	Mate-Munoz, JL; Lougedo, JH; Barba, M; Garcia-Fernandez, P; Garnacho-Castano, MV; Dominguez, R				Luis Mate-Munoz, Jose; Lougedo, Juan H.; Barba, Manuel; Garcia-Fernandez, Pablo; Garnacho-Castano, Manuel V.; Dominguez, Raul			Muscular fatigue in response to different modalities of CrossFit sessions	PLOS ONE			English	Article							SHORTENING CYCLE EXERCISE; CREATINE SUPPLEMENTATION; AEROBIC FITNESS; PERFORMANCE; LACTATE; FORCE; POWER; COORDINATION; ENDURANCE; RECOVERY	Background CrossFit is a new strength and conditioning regimen involving short intense daily workouts called workouts of the day (WOD). This study assesses muscular fatigue levels induced by the three modalities of CrossFit WOD; gymnastics (G), metabolic conditioning (M) and weightlifting (W). Material and methods 34 healthy subjects undertook three WOD (one per week): a G WOD consisting of completing the highest number of sets of 5 pull-ups, 10 push-ups and 15 air squats in 20 min; an M WOD, in which the maximum number of double skipping rope jumps was executed in 8 sets (20 s), resting (10 s) between sets; and finally, a W WOD in which the maximum number of power cleans was executed in 5 min, lifting a load equivalent to 40% of the individual's 1RM. Before and after each WOD, blood lactate concentrations were measured. Also, before, during, and after each WOD, muscular fatigue was assessed in a countermovement jump test (CMJ). Results Significant reductions were produced in the mechanical variables jump height, average power and maximum velocity in response to G; and in jump height, mean and peak power, maximum velocity and maximum force in response to W (P<0.01). However, in M, significant reductions in mechanical variables were observed between pre- and mid session (after sets 2, 4, 6 and 8), but not between pre- and post session. Conclusions Muscular fatigue, reflected by reduced CMJ variables, was produced following the G and W sessions, while recovery of this fatigue was observed at the end of M, likely attributable to rest intervals allowing for the recovery of phosphocreatine stores. Our findings also suggest that the high intensity and volume of exercise in G and W WODs could lead to reduced muscular-tendon stiffness causing a loss of jump ability, related here to a longer isometric phase during the CMJ.	[Luis Mate-Munoz, Jose; Lougedo, Juan H.; Barba, Manuel; Garcia-Fernandez, Pablo; Dominguez, Raul] Alfonso X Sabio Univ, Dept Phys Act & Sport Sci, Madrid, Spain; [Garnacho-Castano, Manuel V.] Pompeu Fabra Univ, Coll Hlth Sci, TecnoCampus, Barcelona, Spain	Pompeu Fabra University	Mate-Munoz, JL (corresponding author), Alfonso X Sabio Univ, Dept Phys Act & Sport Sci, Madrid, Spain.	jmatmuo@uax.es	Garnacho-Castaño, Manuel Vicente/AAE-4620-2020; Domínguez, Raúl/AAX-1068-2021	Garnacho-Castaño, Manuel Vicente/0000-0003-3180-4629; Dominguez, Raul/0000-0002-6891-391X; Mate-Munoz, Jose Luis/0000-0003-3282-1455; Garcia Fernandez, Pablo/0000-0002-6604-9136				Abdessemed D, 1999, INT J SPORTS MED, V20, P368, DOI 10.1055/s-2007-971146; Bobbert M F, 2001, Exerc Sport Sci Rev, V29, P95, DOI 10.1097/00003677-200107000-00002; Bompa TO, 1999, HUMAN KINETICS; BOSCO C, 1979, EUR J APPL PHYSIOL O, V41, P275, DOI 10.1007/BF00429744; Bosquet L, 2010, J SPORT SCI MED, V9, P459; Brown LE, 2003, J STRENGTH COND RES, V17, P88; Butcher SJ, 2015, OPEN ACCESS J SPORTS, V6, P241, DOI 10.2147/OAJSM.S88265; Cooper R, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-33; Dong-Hoon Yoo，, 2015, [Exercise Science, 운동과학], V24, P109, DOI 10.15857/ksep.2015.24.2.117; Farley CT, 1999, J BIOMECH, V32, P267, DOI 10.1016/S0021-9290(98)00170-5; Garnacho-Castano MV, 2015, J STRENGTH COND RES, V29, P2867, DOI 10.1519/JSC.0000000000000956; Garnacho-Castano MV, 2015, J SPORT SCI MED, V14, P128; Glassman G., 2007, CROSSFIT J, V56, P1; Goins J, 2014, MED SCI SPORT EXER, V46, P270, DOI 10.1249/01.mss.0000493998.84691.5d; Gorostiaga EM, 2010, J STRENGTH COND RES, V24, P1138, DOI 10.1519/JSC.0b013e3181cf769f; Gutierrez M, 2006, BIOMECANICA DEPORTIV; Hadeed MJ, 2011, MED SCI SPORT EXER, V43, P224, DOI 10.1249/01.MSS.0000400606.24620.bc; Hak PT, 2013, J STRENGTH IN PRESS; Horita T, 2003, EUR J APPL PHYSIOL, V88, P527, DOI 10.1007/s00421-002-0716-z; Ishikawa M, 2006, EUR J APPL PHYSIOL, V97, P298, DOI 10.1007/s00421-006-0180-2; Ishikawa M, 2006, J ELECTROMYOGR KINES, V16, P423, DOI 10.1016/j.jelekin.2005.08.006; Joondeph SA, 2013, RETINAL DETACHMENT D; Khamoui AV, 2011, J STRENGTH COND RES, V25, P198, DOI 10.1519/JSC.0b013e3181b94a7b; Kliszczewicz B., 2014, J SPORT HUMAN PERF, V2, P1, DOI [10.12922/jshp.0038.2014, DOI 10.12922/JSHP.V2I2.38]; Kliszczewicz B, 2015, J HUM KINET, V47, P81, DOI 10.1515/hukin-2015-0064; Korhonen MT, 2006, J APPL PHYSIOL, V101, P906, DOI 10.1152/japplphysiol.00299.2006; Mc Naughton LR, 2002, INT J SPORTS MED, V23, P130, DOI 10.1055/s-2002-20133; McCully KK, 2002, CAN J APPL PHYSIOL, V27, P70, DOI 10.1139/h02-005; McLean S.R., 2004, INT J APPL SPORTS SC, V16, P22; Millet GY, 2004, SPORTS MED, V34, P105, DOI 10.2165/00007256-200434020-00004; Moreira Reis AJL, 2014, APUNTS MED SPORT, V49, P53; Murray DP, 2007, J STRENGTH COND RES, V21, P870; Pereira Gleber, 2014, Motriz: rev. educ. fis., V20, P303, DOI 10.1590/S1980-65742014000300009; Perez M, 2003, BRIT J SPORT MED, V37, P140, DOI 10.1136/bjsm.37.2.140; Rodacki ALF, 2002, MED SCI SPORT EXER, V34, P105, DOI 10.1097/00005768-200201000-00017; Rodacki ALF, 2001, MED SCI SPORT EXER, V33, P1157; Romero D., 2010, PREVENCION LESIONES; Sanchez-Medina L, 2011, MED SCI SPORT EXER, V43, P1725, DOI 10.1249/MSS.0b013e318213f880; Skare OC, 2001, SCAND J MED SCI SPOR, V11, P96, DOI 10.1034/j.1600-0838.2001.011002096.x; Smilios I, 2010, J STRENGTH COND RES, V24, P2122, DOI 10.1519/JSC.0b013e3181a5bc44; Smith MM, 2013, J STRENGTH COND RES, V27, P3159, DOI 10.1519/JSC.0b013e318289e59f; Tabata I, 1996, MED SCI SPORT EXER, V28, P1327, DOI 10.1097/00005768-199610000-00018; Tibana RA, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00260; Tomlin DL, 2001, SPORTS MED, V31, P1, DOI 10.2165/00007256-200131010-00001; Weisenthal BM, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114531177	45	54	58	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0181855	10.1371/journal.pone.0181855	http://dx.doi.org/10.1371/journal.pone.0181855			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753624	Green Published, gold, Green Submitted			2022-12-26	WOS:000406579300029
J	van Dyke, AL; Kuhs, KAL; Shiels, MS; Koshiol, J; Trabert, B; Loftfield, E; Purdue, MP; Wentzensen, N; Pfeiffer, RM; Katki, HA; Hildesheim, A; Kemp, TJ; Pinto, LA; Chaturvedi, AK; Safaeian, M				van Dyke, Alison L.; Kuhs, Krystle A. Lang; Shiels, Meredith S.; Koshiol, Jill; Trabert, Britton; Loftfield, Erikka; Purdue, Mark P.; Wentzensen, Nicolas; Pfeiffer, Ruth M.; Katki, Hormuzd A.; Hildesheim, Allan; Kemp, Troy J.; Pinto, Ligia A.; Chaturvedi, Anil K.; Safaeian, Mahboobeh			Associations between self-reported diabetes and 78 circulating markers of inflammation, immunity, and metabolism among adults in the United States	PLOS ONE			English	Article							C-REACTIVE PROTEIN; INSULIN-RESISTANCE; MONICA/KORA AUGSBURG; SYSTEMIC IMMUNE; CANCER-RISK; TNF-ALPHA; TYPE-2; HEALTH; POPULATION; LUNG	Inflammation is increasingly thought to be associated with diabetes; however, only a few inflammation markers have been assessed concurrently in relation to history of diabetes. In the most comprehensive evaluation of inflammation markers and diabetes to date using a Luminex bead-based assay, we measured 78 inflammation-, immune-, and metabolicrelated markers detectable in at least 10% of serum samples collected from participants from the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) screening trial (n = 1,814). At baseline, 6.6% (n = 120) of PLCO participants self-reported a history of diabetes. Crosssectional associations between these markers and self-reported diabetes were assessed using weighted logistic regression adjusting for sex, smoking status, blood draw age and year, body mass index, and cohort sub-study. Including chemokines [C-C motif ligand (CCL) 19, CCL20, CCL21, C-X-C motif ligand (CXCL) 6, CXCL10, and CXCL11] and soluble cytokine and chemokine receptors [soluble (s) interleukin (IL) 6 receptor (R), soluble tumor necrosis factor receptor (sTNFR) 1, sTNFR2, and sIL-R2], ten inflammation-related markers, were nominally associated with diabetes (P<0.05). In addition to these associations, higher levels of insulin, gastric inhibitory polypeptide, and pancreatic polypeptide remained significantly associated with self-reported diabetes with a false discovery rate <5%, indicating that the assay was able to detect markers associated with diabetes. In summary, selfreported diabetes was nominally associated with circulating cytokines, chemokines, and soluble cytokine and chemokine receptors in the most expansive examination of diabetes and inflammation-and immune-related markers to date. These results highlight the need to explore in future prospective studies the role of inflammation markers in diabetes.	[van Dyke, Alison L.; Kuhs, Krystle A. Lang; Shiels, Meredith S.; Koshiol, Jill; Trabert, Britton; Loftfield, Erikka; Purdue, Mark P.; Wentzensen, Nicolas; Pfeiffer, Ruth M.; Katki, Hormuzd A.; Hildesheim, Allan; Chaturvedi, Anil K.; Safaeian, Mahboobeh] NCI, Div Canc Epidemiol & Genet, NIH, Rockville, MD 20850 USA; [Kemp, Troy J.; Pinto, Ligia A.] Leidos Biomed Res Inc, Human Papilloma Virus Immunol Lab, Frederick Natl Lab Canc Res, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	van Dyke, AL (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Rockville, MD 20850 USA.	alison.vandyke@nih.gov	Trabert, Britton/F-8051-2015; koshiol, Jill/L-8686-2014; Wentzensen, Nicolas/AAG-8522-2019; Loftfield, Erikka/Z-2121-2018	Trabert, Britton/0000-0002-1539-6090; koshiol, Jill/0000-0002-3832-6204; Loftfield, Erikka/0000-0002-3573-8748	Intramural Research Program of the National Cancer Institute, National Institutes of Health; federal funds from the National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZIACP010150] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); federal funds from the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project received funding from the Intramural Research Program of the National Cancer Institute, part of the National Institutes of Health. This project also has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.	Abbatecola AM, 2004, J AM GERIATR SOC, V52, P399, DOI 10.1111/j.1532-5415.2004.52112.x; Arcidiacono B, 2012, EXP DIABETES RES, DOI 10.1155/2012/789174; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Chao C, 2010, ARCH INTERN MED, V170, P1557, DOI 10.1001/archinternmed.2010.312; Chaturvedi AK, 2011, CANCER EPIDEM BIOMAR, V20, P1902, DOI 10.1158/1055-9965.EPI-11-0221; Chia CW, 2014, J CLIN ENDOCR METAB, V99, P2477, DOI 10.1210/jc.2013-3994; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Creutzfeldt W, 2001, EXP CLIN ENDOCR DIAB, V109, pS288, DOI 10.1055/s-2001-18589; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Eguchi K, 2013, DIABETES OBES METAB, V15, P152, DOI 10.1111/dom.12168; Federation ID, 2015, IDF DIABETES ATLAS; Ford ES, 2002, AM J EPIDEMIOL, V155, P57, DOI 10.1093/aje/155.1.57; Hameed I, 2015, WORLD J DIABETES, V6, P598, DOI 10.4239/wjd.v6.i4.598; Han TS, 2002, DIABETES CARE, V25, P2016, DOI 10.2337/diacare.25.11.2016; Herder C, 2006, DIABETOLOGIA, V49, P921, DOI 10.1007/s00125-006-0190-y; Herder C, 2005, GESUNDHEITSWESEN, V67, pS115, DOI 10.1055/s-2005-858252; Herder C, 2013, DIABETES OBES METAB, V15, P39, DOI 10.1111/dom.12155; Herder C, 2009, DIABETOLOGIA, V52, P433, DOI 10.1007/s00125-008-1243-1; Herder C, 2006, DIABETES, V55, P2340, DOI 10.2337/db05-1320; Hernandez AV, 2015, EUR J CANCER, V51, P2747, DOI 10.1016/j.ejca.2015.08.031; Holst JJ, 2009, MOL CELL ENDOCRINOL, V297, P127, DOI 10.1016/j.mce.2008.08.012; Huth C, 2006, DIABETES, V55, P2915, DOI 10.2337/db06-0600; Jackson JM, 2014, MENOPAUSE, V21, P861, DOI [10.1097/GME.0000000000000189, 10.1097/gme.0000000000000189]; Kahleova H, 2012, J DIABETES COMPLICAT, V26, P442, DOI 10.1016/j.jdiacomp.2012.05.003; Kahn SE, 2010, DIABETES CARE, V33, P177, DOI 10.2337/dc09-1661; Kitahara CM, 2014, CANCER EPIDEM BIOMAR, V23, P2840, DOI 10.1158/1055-9965.EPI-14-0699-T; Korn E. L., 1999, ANAL HLTH SURVEYS; Koshiol J, 2016, CYTOKINE, V83, P217, DOI 10.1016/j.cyto.2016.05.003; Krakoff J, 2003, DIABETES CARE, V26, P1745, DOI 10.2337/diacare.26.6.1745; Laaksonen DE, 2004, DIABETOLOGIA, V47, P1403, DOI 10.1007/s00125-004-1472-x; Ley SH, 2008, DIABETES CARE, V31, P1410, DOI 10.2337/dc08-0036; Lin J, 2009, DIABETES-METAB RES, V25, P219, DOI 10.1002/dmrr.923; Liu CX, 2016, CYTOKINE, V86, P100, DOI 10.1016/j.cyto.2016.06.028; Loftfield E, 2015, CANCER EPIDEM BIOMAR, V24, P1052, DOI 10.1158/1055-9965.EPI-15-0038-T; Margolis KL, 2008, CLIN TRIALS, V5, P240, DOI 10.1177/1740774508091749; Muggah E, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-16; Muller S, 2002, DIABETOLOGIA, V45, P805, DOI 10.1007/s00125-002-0829-2; Nakanishi N, 2005, INTERNAL MED, V44, P542, DOI 10.2169/internalmedicine.44.542; Pradhan AD, 2003, ARTERIOSCL THROM VAS, V23, P650, DOI 10.1161/01.ATV.0000065636.15310.9C; Pradhan AD, 2009, JAMA-J AM MED ASSOC, V302, P1186, DOI 10.1001/jama.2009.1347; Prevention CfDCa, 2014, NAT DIAB STAT REP ES; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; Purdue MP, 2013, BLOOD, V122, P951, DOI 10.1182/blood-2013-01-481077; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Schulze MB, 2005, AM J CLIN NUTR, V82, P675, DOI 10.1093/ajcn/82.3.675; Shanik MH, 2008, DIABETES CARE, V31, pS262, DOI 10.2337/dc08-s264; Shiels MS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju294; Shiels MS, 2013, JNCI-J NATL CANCER I, V105, P1871, DOI 10.1093/jnci/djt309; Shiels MS, 2015, J NATL CANC I, V107; Starup-Linde J, 2013, CURR DRUG SAF, V8, P296, DOI 10.2174/15748863113086660071; Stoer NC, 2013, STAT MED, V32, P5328, DOI 10.1002/sim.6019; Temelkova-Kurktschiev T, 2002, METABOLISM, V51, P743, DOI 10.1053/meta.2002.32804; Thorand B, 2007, DIABETES CARE, V30, P854, DOI 10.2337/dc06-1693; Trabert B, 2014, GYNECOL ONCOL, V135, P297, DOI 10.1016/j.ygyno.2014.08.025; Tsilidis KK, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7607; Vozarova B, 2001, OBES RES, V9, P414, DOI 10.1038/oby.2001.54; Wang X, 2013, DIABETES CARE, V36, P166, DOI 10.2337/dc12-0702; Yoon YS, 2015, METABOLISM, V64, P1324, DOI 10.1016/j.metabol.2015.06.013	58	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0182359	10.1371/journal.pone.0182359	http://dx.doi.org/10.1371/journal.pone.0182359			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753646	Green Published, Green Submitted, gold			2022-12-26	WOS:000406579300062
J	Ko, Y; Song, J; Lee, SY; Moon, JW; Mo, EK; Park, JY; Kim, JH; Park, S; Hwang, YI; Jang, SH; Jhun, BW; Sim, YS; Shin, TR; Kim, DG; Hong, JY; Lee, CY; Lee, MG; Kim, CH; Hyun, IG; Park, YB				Ko, Yousang; Song, Jinkyung; Lee, Suh-Young; Moon, Jin-Wook; Mo, Eun-Kyung; Park, Ji Young; Kim, Joo-Hee; Park, Sunghoon; Hwang, Yong Il; Jang, Seung Hun; Jhun, Byung Woo; Sim, Yun Su; Shin, Tae Rim; Kim, Dong-Gyu; Hong, Ji Young; Lee, Chang Youl; Lee, Myung Goo; Kim, Cheol-Hong; Hyun, In Gyu; Park, Yong Bum			Does repeated pleural culture increase the diagnostic yield of Mycobacterium tuberculosis from tuberculous pleural effusion in HIV-negative individuals?	PLOS ONE			English	Article							FLUID; LIQUID; MEDIA; PERFORMANCE; PULMONARY; SYSTEM	Background Despite recent advances in methods for culturing Mycobacterium tuberculosis (MTB), the diagnostic yield of tuberculous pleural effusion (TBPE) remains unsatisfactory. However, unlike repeated sputum cultures of pulmonary tuberculosis, little is known about the role of repeated pleural cultures. We examined whether repeated pleural cultures are associated with increased MTB yield from TBPE. Methods A multicenter, retrospective cohort study was performed from January 2012 to December 2015 in South Korea. Patients were categorized into two groups: single-or repeated-culture groups. The diagnostic yield of MTB and clinical, radiological, and pleural fluid characteristics were evaluated. Results Among the 329 patients with TBPE, 77 (23.4%) had repeated cultures and 252 (76.5%) had a single culture. Pleural culture was performed twice in all 77 patients in the repeated-culture group at a 1-day interval (inter-quartile range, 1.0-2.0). In the repeated-culture group, the yield of MTB from the first culture was 31.2%, which was similar to that in the single-culture group (31.2% vs. 29.8%, P = 0.887). However, the yield of MTB from the second culture (10/77, 13.0%) was more than that from the first. These results may be attributable to the insufficient immune clearance for MTB invasion into the pleural space between the first and second cultures. Over time, the yield of the second cultures decreased from 17.4% to 6.7% and then 6.3%. Finally, the overall yield of MTB in the repeated-and single-culture groups was 44.2% and 29.8% respectively (P < 0.001). Conclusions The results showed that repeated pleural cultures increased MTB yield from TBPE in human immunodeficiency virus-negative individuals. Furthermore, repeated cultures may increase yield when carried out for two consecutive days.	[Ko, Yousang; Song, Jinkyung; Lee, Suh-Young; Moon, Jin-Wook; Mo, Eun-Kyung; Park, Yong Bum] Hallym Univ, Coll Med, Kangdong Sacred Heart Hosp, Div Pulm Allergy & Crit Care Med,Dept Internal Me, Seoul, South Korea; [Ko, Yousang; Lee, Suh-Young; Moon, Jin-Wook; Mo, Eun-Kyung; Park, Ji Young; Kim, Joo-Hee; Park, Sunghoon; Hwang, Yong Il; Jang, Seung Hun; Jhun, Byung Woo; Sim, Yun Su; Shin, Tae Rim; Kim, Dong-Gyu; Hong, Ji Young; Lee, Chang Youl; Lee, Myung Goo; Kim, Cheol-Hong; Hyun, In Gyu; Park, Yong Bum] Hallym Univ, Coll Med, Lung Res Inst, Chunchon, South Korea; [Park, Ji Young; Kim, Joo-Hee; Park, Sunghoon; Hwang, Yong Il; Jang, Seung Hun] Hallym Univ, Sacred Heart Hosp, Div Pulm Allergy & Crit Care Med, Anyang, South Korea; [Jhun, Byung Woo; Sim, Yun Su; Shin, Tae Rim; Kim, Dong-Gyu] Kangnam Sacred Heart Hosp, Div Pulm Allergy & Crit Care Med, Seoul, South Korea; [Hong, Ji Young; Lee, Chang Youl; Lee, Myung Goo] Chuncheon Sacred Heart Hosp, Div Pulm Allergy & Crit Care Med, Chunchon, South Korea; [Kim, Cheol-Hong; Hyun, In Gyu] Dongtan Sacred Heart Hosp, Div Pulm Allergy & Crit Care Med, Hwaseong, South Korea	Hallym University; Hallym University; Hallym University	Park, YB (corresponding author), Hallym Univ, Coll Med, Kangdong Sacred Heart Hosp, Div Pulm Allergy & Crit Care Med,Dept Internal Me, Seoul, South Korea.; Park, YB (corresponding author), Hallym Univ, Coll Med, Lung Res Inst, Chunchon, South Korea.	bfspark2@gmail.com		Park, Ji Young/0000-0002-6533-4656; Park, Yong Bum/0000-0002-5814-6104				Bae E, 2008, KOREAN J LAB MED, V28, P299, DOI 10.3343/kjlm.2008.28.4.299; Bai K J, 1998, Respirology, V3, P261, DOI 10.1111/j.1440-1843.1998.tb00132.x; Bielsa S, 2013, INT J TUBERC LUNG D, V17, P85, DOI 10.5588/ijtld.12.0236; Choi H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165428; Chung CL, 2005, CHEST, V128, P690, DOI 10.1016/S0012-3692(15)50413-3; Conde MB, 2003, AM J RESP CRIT CARE, V167, P723, DOI 10.1164/rccm.2111019; Diacon AH, 2003, EUR RESPIR J, V22, P589, DOI 10.1183/09031936.03.00017103a; ETSTEN B, 1951, N Engl J Med, V245, P959; Harries A., 2004, TOMANS TUBERCULOSIS, V46; Kim CH, 2015, J KOREAN MED SCI, V30, P1922, DOI 10.3346/jkms.2015.30.12.1922; Ko Y, 2017, TUBERC RESPIR DIS, V80, P35, DOI 10.4046/trd.2017.80.1.35; Koh WJ, 2017, TUBERC RESPIR DIS, V80, P90, DOI 10.4046/trd.2017.80.1.90; Lee BH, 2015, J KOREAN MED SCI, V30, P871, DOI 10.3346/jkms.2015.30.7.871; Lee HY, 2015, KOREAN J INTERN MED, V30, P325, DOI 10.3904/kjim.2015.30.3.325; Lee J, 2016, J THORAC DIS, V8, P1935, DOI 10.21037/jtd.2016.06.54; Light RW, 2010, RESPIROLOGY, V15, P451, DOI 10.1111/j.1440-1843.2010.01723.x; Liu SF, 2005, INT J TUBERC LUNG D, V9, P111; Luzze H, 2001, INT J TUBERC LUNG D, V5, P746; Mase SR, 2007, INT J TUBERC LUNG D, V11, P485; Paulson T, 2013, NATURE, V502, pS2, DOI 10.1038/502S2a; Porcel JM, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.07.23; Rageade F, 2014, EUR J CLIN MICROBIOL, V33, P867, DOI 10.1007/s10096-014-2105-z; Raviglione M, 2001, INT J TUBERC LUNG D, V5, P213; Ruan SY, 2012, THORAX, V67, P822, DOI 10.1136/thoraxjnl-2011-201363; Sehgal IS, 2016, J CLIN MICROBIOL, V54, P1133, DOI 10.1128/JCM.03205-15; Tovar M, 2008, CLIN INFECT DIS, V46, P909, DOI 10.1086/527447; von Groote-Bidlingmaier F, 2013, THORAX, V68, P290, DOI 10.1136/thoraxjnl-2012-202338; Vorster MJ, 2015, J THORAC DIS, V7, P981, DOI 10.3978/j.issn.2072-1439.2015.02.18; World Health Organization, TREATM TUB GUID, V4th; World Health Organization, 2014, GLOB TUB REP	30	4	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e181798	10.1371/journal.pone.0181798	http://dx.doi.org/10.1371/journal.pone.0181798			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750069	gold, Green Published, Green Submitted			2022-12-26	WOS:000406575700082
J	Chen, YR; Chou, HC; Yang, CH; Chen, HY; Liu, YW; Lin, TY; Yeh, CL; Chao, WT; Tsou, HH; Chuang, HC; Tan, TH				Chen, Y-R; Chou, H-C; Yang, C-H; Chen, H-Y; Liu, Y-W; Lin, T-Y; Yeh, C-L; Chao, W-T; Tsou, H-H; Chuang, H-C; Tan, T-H			Deficiency in VHR/DUSP3, a suppressor of focal adhesion kinase, reveals its role in regulating cell adhesion and migration	ONCOGENE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; DUAL-SPECIFICITY PHOSPHATASE; SRC FAMILY KINASES; DOWN-REGULATION; CANCER CELLS; VHR; ACTIVATION; EXPRESSION; JNK; MAP	Vaccinia H1-related phosphatase (VHR/DUSP3) is a member of the dual-specificity phosphatase family. Deregulation of VHR is observed in various malignant diseases. We identified focal adhesion kinase (FAK) as a VHR-interacting molecule. Over-expression of VHR decreased tyrosine phosphorylation of FAK and decreasing VHR promoted FAK tyrosine phosphorylation. In vitro assays proved that recombinant VHR directly dephosphorylated FAK and paxillin. VHR-knockout mice did not have obvious abnormality; however, VHR-knockout cells showed decreased expression of integrins and FAK but stronger FAK and paxillin phosphorylation upon attachment to fibronectin. Additionally, VHR-knockout fibroblast and lung epithelial cells had elevated ligand-induced epidermal growth factor receptor (EGFR) phosphorylation. Inducible expression of VHR suppressed directional cell migration, and VHR deficiency resulted in a higher cell migratory ability. VHR-knockout cells have stronger FAK phosphorylation in cell adhesions, long-lasting trailing ends and slower turnover of focal adhesions. These collective data indicate that VHR is a FAK phosphatase and participates in regulating the formation and disassembly of focal adhesions.	[Chen, Y-R; Chou, H-C; Yang, C-H; Chen, H-Y; Liu, Y-W; Lin, T-Y; Yeh, C-L] Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan 35053, Taiwan; [Chen, H-Y; Chao, W-T] Tunghai Univ, Dept Life Sci, Taichung, Taiwan; [Tsou, H-H] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Zhunan, Taiwan; [Chao, W-T] China Med Univ, Coll Publ Hlth, Grad Inst Biostat, Taichung, Taiwan; [Chuang, H-C; Tan, T-H] Natl Hlth Res Inst, Immunol Res Ctr, Zhunan 35053, Taiwan; [Tan, T-H] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX USA	National Health Research Institutes - Taiwan; Tunghai University; National Health Research Institutes - Taiwan; China Medical University Taiwan; National Health Research Institutes - Taiwan; Baylor College of Medicine	Chen, YR (corresponding author), Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan 35053, Taiwan.; Tan, TH (corresponding author), Natl Hlth Res Inst, Immunol Res Ctr, Zhunan 35053, Taiwan.	yrchen@nhri.org.tw; ttan@nhri.org.tw	Chuang, Huai-Chia/E-9486-2016; Chen, Yi-Rong/CAH-7991-2022; Chen, Yi-Rong/E-3991-2010; Tan, Tse-Hua/E-3983-2010; Chen, Yi-Rong/CAF-2186-2022; Tan, Tse-Hua/ABD-7080-2021	Chen, Yi-Rong/0000-0002-4307-3002; Chen, Yi-Rong/0000-0002-4307-3002; Tan, Tse-Hua/0000-0003-4969-3170; Chen, Yi-Rong/0000-0002-4307-3002; Tan, Tse-Hua/0000-0003-4969-3170	National Health Research Institutes, Taiwan [MG-102-PP-03, MG-103-PP-03, 105-IMPP01, 105-IMSP01]; Ministry of Science and Technology, Taiwan [102-2628-B-400-003, 105-2314-B-400-027]	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	We thank National Health Research Institutes Transgenic Animal Core for assistance in the mouse blastocyst injection and Optical Biology Core for the assistance in confocal microscopy and time-lapsed photography analyses. This work was supported by grants from National Health Research Institutes, Taiwan (MG-102-PP-03 and MG-103-PP-03 to Y-R Chen; 105-IMPP01 and 105-IMSP01 to T-H Tan), and grants from Ministry of Science and Technology, Taiwan (102-2628-B-400-003 to Y-R Chen and 105-2314-B-400-027 to T-H Tan).	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Alonso A, 2001, J BIOL CHEM, V276, P4766, DOI 10.1074/jbc.M006497200; Amand M, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-108; Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; Arnoldussen YJ, 2008, CANCER RES, V68, P9255, DOI 10.1158/0008-5472.CAN-08-1224; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Chen AJ, 2002, J BIOL CHEM, V277, P36592, DOI 10.1074/jbc.M200453200; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Davidson D, 2001, EMBO J, V20, P3414, DOI 10.1093/emboj/20.13.3414; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Gallegos LL, 2016, SCI REP-UK, V6, DOI 10.1038/srep27114; Hao L, 2007, INT J CANCER, V121, P39, DOI 10.1002/ijc.22597; Henkens R, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-147; Hood KL, 2002, BIOCHEM BIOPH RES CO, V298, P545, DOI 10.1016/S0006-291X(02)02488-9; Hoyt R, 2007, J IMMUNOL, V179, P3402, DOI 10.4049/jimmunol.179.6.3402; Huang CY, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-24; ILLC D, 1995, NATURE, V377, P539; ISHIBASHI T, 1992, P NATL ACAD SCI USA, V89, P12170, DOI 10.1073/pnas.89.24.12170; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Lee J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12296; Li JP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4618; Li JP, 2010, J BIOL CHEM, V285, P5472, DOI 10.1074/jbc.M109.060186; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Musumeci L, 2015, CIRCULATION, V131, P656, DOI 10.1161/CIRCULATIONAHA.114.010186; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Pavic K, 2015, FEBS J, V282, P1871, DOI 10.1111/febs.13263; Rahmouni S, 2006, NAT CELL BIOL, V8, P524, DOI 10.1038/ncb1398; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schumacher MA, 2002, BIOCHEMISTRY-US, V41, P3009, DOI 10.1021/bi015799l; Sieg DJ, 1999, J CELL SCI, V112, P2677; Singh P, 2015, J IMMUNOL, V194, P4951, DOI 10.4049/jimmunol.1402431; Todd JL, 2002, ONCOGENE, V21, P2573, DOI 10.1038/sj.onc.1205344; Todd JL, 1999, J BIOL CHEM, V274, P13271, DOI 10.1074/jbc.274.19.13271; Wang JY, 2006, J NEUROCHEM, V98, P89, DOI 10.1111/j.1471-4159.2006.03852.x; Wang JY, 2011, J BIOL CHEM, V286, P10177, DOI 10.1074/jbc.M110.163295; Wang XH, 2012, J BIOL CHEM, V287, P11037, DOI 10.1074/jbc.M111.310946; Xiao Q, 2013, J AM CHEM SOC, V135, P9760, DOI 10.1021/ja401692t; Yang CH, 2015, BBA-MOL BASIS DIS, V1852, P1540, DOI 10.1016/j.bbadis.2015.04.020; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125	40	15	17	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 23	2017	36	47					6509	6517		10.1038/onc.2017.255	http://dx.doi.org/10.1038/onc.2017.255			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FN5LN	28759036				2022-12-26	WOS:000416049200001
J	Zhang, B; Lu, W				Zhang, Bin; Lu, Wen			Src homology 2 domain-containing phosphotyrosine phosphatase 2 (Shp2) controls surface GluA1 protein in synaptic homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMPA RECEPTOR TRAFFICKING; TYROSINE-PHOSPHATASE; CANCER PROGRESSION; NOONAN-SYNDROME; PLASTICITY; PHOSPHORYLATION; MEMORY; ACTIVATION; MECHANISMS; PATHWAY	Src Homology 2 domain-containing phosphotyrosine phosphatase 2 (Shp2) functions in synaptic plasticity, learning, and memory. However, the precise mechanisms by which this multifunctional protein contributes to synaptic function remains largely unknown. Homeostatic plasticity may be viewed as a process of bidirectional synaptic scaling, up or down. Through this process, neuronal circuitry stability is maintained so that changes in synaptic strength may be preserved under changing conditions. Abetter understanding of these processes is needed. In this regard, we report that phosphorylation of Shp2 at tyrosine 542 and its translocation to the postsynaptic compartment are integral processes in synaptic scaling. Furthermore, we show, using both pharmacological and genetic approaches, that Shp2 phosphatase activity is critical to the regulation of Ser(P)(845) GluA1 and surface expression of this AMPA receptor subunit during synaptic scaling. Thus, Shp2 may contribute meaningfully to synaptic homeostasis.	[Lu, Wen] Hainan Med Univ, Dept Biochem & Mol Biol, Haikou 571199, Hainan, Peoples R China; [Zhang, Bin] Hangzhou Normal Univ, Inst Life Sci, Zhejiang Key Lab Organ Dev & Regenerat, Hangzhou 310036, Zhejiang, Peoples R China	Hainan Medical University; Hangzhou Normal University	Lu, W (corresponding author), Hainan Med Univ, Dept Biochem & Mol Biol, Haikou 571199, Hainan, Peoples R China.; Zhang, B (corresponding author), Hangzhou Normal Univ, Inst Life Sci, Zhejiang Key Lab Organ Dev & Regenerat, Hangzhou 310036, Zhejiang, Peoples R China.	zhangbin890124@163.com; swkxlw@163.com	Lu, Wen/AAL-8524-2020		National Natural Science Foundation of China Grant [31600863]; Hainan Medical University	National Natural Science Foundation of China Grant(National Natural Science Foundation of China (NSFC)); Hainan Medical University	This work was supported by National Natural Science Foundation of China Grant 31600863 (to W.L.) and a start-up fund of Hainan Medical University (to W.L.). The authors declare that they have no conflicts of interest with the contents of this article.	Aceto N, 2012, NAT MED, V18, P529, DOI 10.1038/nm.2645; Anggono V, 2012, CURR OPIN NEUROBIOL, V22, P461, DOI 10.1016/j.conb.2011.12.006; Anggono V, 2011, J NEUROSCI, V31, P2188, DOI 10.1523/JNEUROSCI.5633-10.2011; Bateup HS, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00028; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; Dance M, 2008, CELL SIGNAL, V20, P453, DOI 10.1016/j.cellsig.2007.10.002; Diering GH, 2014, NEURON, V84, P790, DOI 10.1016/j.neuron.2014.09.024; Han T, 2015, J HEPATOL, V63, P651, DOI 10.1016/j.jhep.2015.03.036; Hanafusa H, 2004, J BIOL CHEM, V279, P22992, DOI 10.1074/jbc.M312498200; Hellmuth K, 2008, P NATL ACAD SCI USA, V105, P7275, DOI 10.1073/pnas.0710468105; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kusakari S, 2015, MOL CELL BIOL, V35, P1557, DOI 10.1128/MCB.01339-14; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lee YS, 2014, NAT NEUROSCI, V17, P1736, DOI 10.1038/nn.3863; Lu W, 2015, J BIOL CHEM, V290, P22945, DOI 10.1074/jbc.M115.663450; Meng SS, 2010, J MOL CELL BIOL, V2, P223, DOI 10.1093/jmcb/mjq017; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Pagani MR, 2009, CELL, V139, P186, DOI 10.1016/j.cell.2009.08.033; Park CY, 1999, J BIOL CHEM, V274, P7583, DOI 10.1074/jbc.274.11.7583; Poole AW, 2005, CELL SIGNAL, V17, P1323, DOI 10.1016/j.cellsig.2005.05.016; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Prahallad A, 2015, CELL REP, V12, P1978, DOI 10.1016/j.celrep.2015.08.037; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Yan XY, 2017, MOL NEUROBIOL, V54, P7235, DOI 10.1007/s12035-016-0222-7; Zhang B, 2016, J BIOL CHEM, V291, P18856, DOI 10.1074/jbc.M116.714501; Zhang XM, 2015, CELL RES, V25, P818, DOI 10.1038/cr.2015.75	30	10	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15481	15488		10.1074/jbc.M117.775239	http://dx.doi.org/10.1074/jbc.M117.775239			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28768764	Green Published, hybrid			2022-12-26	WOS:000410809800027
J	Isari, S; Pearman, JK; Casas, L; Michell, CT; Curdia, J; Berumen, ML; Irigoien, X				Isari, Stamatina; Pearman, John K.; Casas, Laura; Michell, Craig T.; Curdia, Joao; Berumen, Michael L.; Irigoien, Xabier			Exploring the larval fish community of the central Red Sea with an integrated morphological and molecular approach	PLOS ONE			English	Article							GREAT-BARRIER-REEF; OFFSHORE DISTRIBUTIONAL PATTERNS; MESOSCALE DISTRIBUTION PATTERNS; LIFE-HISTORY TRAITS; CORAL-REEF; VERTICAL-DISTRIBUTION; TUNA BAITFISH; ASSEMBLAGES; ICHTHYOPLANKTON; SPRATELLOIDES	An important aspect of population dynamics for coral reef fishes is the input of new individuals from the pelagic larval pool. However, the high biodiversity and the difficulty of identifying larvae of closely related species represent obstacles to more fully understanding these populations. In this study, we combined morphology and genetic barcoding (Cytochrome Oxidase I gene) to characterize the seasonal patterns of the larval fish community at two sites in close proximity to coral reefs in the central-north Red Sea: one shallower inshore location (50 m depth) and a nearby site located in deeper and more offshore waters (similar to 500 m depth). Fish larvae were collected using oblique tows of a 60 cm-bongo net (500 mu m mesh size) every month for one year (2013). During the warmer period of the year (June-November), the larval fish stock was comparable between sampling sites. However, during the colder months, abundances were higher in the inshore than in the offshore waters. Taxonomic composition and temporal variation of community structure differed notably between sites, potentially reflecting habitat differences, reproductive patterns of adults, and/or advective processes in the area. Eleven out of a total of 62 recorded families comprised 69-94% of the fish larval community, depending on sampling site and month. Richness of taxa was notably higher in the inshore station compared to the offshore, particularly during the colder period of the year and especially for the gobiids and apogonids. Two mesopelagic taxa (Vin-ciguerria sp. and Benthosema spp.) comprised an important component of the larval community at the deeper site with only a small and sporadic occurrence in the shallower inshore waters. Our data provide an important baseline reference for the larval fish communities of the central Red Sea, representing the first such study from Saudi Arabian waters.	[Isari, Stamatina; Pearman, John K.; Casas, Laura; Michell, Craig T.; Curdia, Joao; Berumen, Michael L.; Irigoien, Xabier] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Biol & Environm Sci & Engn Div, Thuwal, Saudi Arabia; [Irigoien, Xabier] AZTI Marine Res, Pasaia, Gipuzkoa, Spain; [Irigoien, Xabier] Basque Fdn Sci, Ikerbasque, Bilbao, Spain	King Abdullah University of Science & Technology; AZTI; Basque Foundation for Science	Isari, S (corresponding author), King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Biol & Environm Sci & Engn Div, Thuwal, Saudi Arabia.	stamatina.isari@kaust.edu.sa	Irigoien, Xabier/B-8171-2009; Isari, Stamatina/J-6987-2014; Casas, Laura/G-9347-2015; Berumen, Michael/F-7745-2011	Irigoien, Xabier/0000-0002-5411-6741; Isari, Stamatina/0000-0003-3457-0274; Casas, Laura/0000-0001-6617-8731; Michell, Craig/0000-0003-4706-7256; Pearman, John Kenneth/0000-0002-2237-9723; Berumen, Michael/0000-0003-2463-2742	King Abdullah University of Science and Technology; Red Sea Research Center Competitive Funding project (CCF)	King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); Red Sea Research Center Competitive Funding project (CCF)	The research was supported by baseline funding provided by King Abdullah University of Science and Technology to XI. SI was co-funded by the Red Sea Research Center Competitive Funding project (CCF). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Almany GR, 2013, CURR BIOL, V23, P626, DOI 10.1016/j.cub.2013.03.006; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2016, INT C MAR ENV RED SE; Ardura A, 2016, PEERJ, V4, DOI 10.7717/peerj.2438; Ayala D, 2016, FISH OCEANOGR, V25, P85, DOI 10.1111/fog.12136; Baier CT, 1997, MAR ECOL PROG SER, V146, P43, DOI 10.3354/meps146043; Ben-Tzvi O, 2008, MAR ECOL PROG SER, V359, P229, DOI 10.3354/meps07343; Berumen ML, 2013, CORAL REEFS, V32, P737, DOI 10.1007/s00338-013-1055-8; Berumen ML, 2005, MAR ECOL PROG SER, V287, P217, DOI 10.3354/meps287217; BOEHLERT GW, 1994, MAR ECOL PROG SER, V107, P1, DOI 10.3354/meps107001; Botsford LW, 2009, CORAL REEFS, V28, P327, DOI 10.1007/s00338-009-0466-z; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Cao L, 2015, HYDROBIOLOGIA, V754, P135, DOI 10.1007/s10750-014-1984-4; CHOAT JH, 1993, FISH B-NOAA, V91, P195; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; Clarke KR, 2015, PRIMER V7 USER MANUA; COUGHLIN DJ, 1990, ENVIRON BIOL FISH, V29, P35, DOI 10.1007/BF00000566; COWEN RK, 1994, B MAR SCI, V54, P228; DALZELL P, 1985, J FISH BIOL, V27, P229, DOI 10.1111/j.1095-8649.1985.tb04023.x; Depczynski M, 2003, MAR ECOL PROG SER, V256, P183, DOI 10.3354/meps256183; Depczynski M, 2006, ECOLOGY, V87, P3119, DOI 10.1890/0012-9658(2006)87[3119:EPAIIV]2.0.CO;2; DiBattista JD, 2016, J BIOGEOGR, V43, P423, DOI 10.1111/jbi.12649; DiBattista JD, 2016, J BIOGEOGR, V43, P13, DOI 10.1111/jbi.12631; Fahay M.P., 2007, EARLY STAGES FISHES; Fisher R, 2015, CURR BIOL, V25, P500, DOI 10.1016/j.cub.2014.12.022; FROESE R., 2022, US; Golani D, 2010, ZOOTAXA, P1; Hoey AS, 2016, MAR POLLUT BULL, V105, P524, DOI 10.1016/j.marpolbul.2015.11.035; HOSIE GW, 1994, MAR ECOL PROG SER, V106, P21, DOI 10.3354/meps106021; Hubert N, 2015, MOL ECOL RESOUR, V15, P57, DOI 10.1111/1755-0998.12293; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Ivanova NV, 2007, MOL ECOL NOTES, V7, P544, DOI 10.1111/j.1471-8286.2007.01748.x; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; John JS, 2001, CORAL REEFS, V20, P163, DOI 10.1007/s003380100152; Johnson RK, 1984, NEW SPEICES VINCIGUE; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Khalil M., 2015, THESIS; Khalil MT, 2017, PEER J; Klevjer TA, 2012, MAR BIOL, V159, P1833, DOI 10.1007/s00227-012-1973-y; Ko HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053451; Kruskal J, 1978, MULTIDIMENSIONAL SCA; Lefevre CD, 2016, CORAL REEFS, V35, P399, DOI 10.1007/s00338-016-1406-3; Leis J.M., 1991, P183; Leis Jeffrey L., 2002, P171, DOI 10.1016/B978-012615185-5/50011-6; Leis JM, 2015, ICHTHYOL RES, V62, P9, DOI 10.1007/s10228-014-0426-7; LEIS JM, 1976, MAR BIOL, V36, P359, DOI 10.1007/BF00389198; LEIS JM, 1991, MAR BIOL, V109, P157, DOI 10.1007/BF01320243; LEIS JM, 1993, B MAR SCI, V53, P362; LEIS JM, 1987, AUST J MAR FRESH RES, V38, P211; LEIS JM, 2004, LARVAE INDOPACIFIC C; McCook LJ, 2009, CORAL REEFS, V28, P353, DOI 10.1007/s00338-008-0463-7; MILTON DA, 1991, J FISH BIOL, V39, P849, DOI 10.1111/j.1095-8649.1991.tb04414.x; MILTON DA, 1991, FISH B-NOAA, V89, P221; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Moser GH, 1996, EARLY STAGES FISHES, P33; Muhling BA, 2013, FISH OCEANOGR, V22, P409, DOI 10.1111/fog.12031; Munch K, 2008, SYST BIOL, V57, P750, DOI 10.1080/10635150802422316; Mwaluma JM, 2011, ENVIRON BIOL FISH, V90, P393, DOI 10.1007/s10641-010-9749-z; Nanninga GB, 2015, CORAL REEFS, V34, P383, DOI 10.1007/s00338-015-1266-2; Nanninga GB, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00071; OLIVAR M-P, 1991, Scientia Marina, V55, P1; Olney J.E., 2006, EARLY STAGES ATLANTI, P1019; Pegg GG, 2006, SCI MAR, V70, P7, DOI 10.3989/scimar.2006.70s27; Olivar MP, 2014, J MARINE SYST, V138, P127, DOI 10.1016/j.jmarsys.2013.10.009; Pinsky ML, 2017, CURR BIOL, V27, P149, DOI 10.1016/j.cub.2016.10.053; Puncher GN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130407; Rabbaniha M, 2015, MAR POLLUT BULL, V97, P105, DOI 10.1016/j.marpolbul.2015.06.028; Raitsos DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064909; Roberts M.L., 2014, THESIS; Robitzch VSN, 2016, MAR POLLUT BULL, V105, P566, DOI 10.1016/j.marpolbul.2015.11.045; Robitzch VSN, 2017, THESIS; Rodriguez JM, 2006, MAR BIOL, V149, P885, DOI 10.1007/s00227-006-0270-z; Roik A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163939; ROPKE A, 1993, MAR ECOL PROG SER, V101, P223, DOI 10.3354/meps101223; Sassa C, 2015, J MAR BIOL ASSOC UK, V95, P161, DOI 10.1017/S0025315414001209; SMITH P E, 1977, FAO (Food and Agriculture Organization of the United Nations) Fisheries Technical Paper, V175, P1; Somarakis S, 2002, J PLANKTON RES, V24, P339, DOI 10.1093/plankt/24.4.339; Sponaugle S, 2003, MAR BIOL, V143, P175, DOI 10.1007/s00227-003-1059-y; Stucky Brian J, 2012, J Biomol Tech, V23, P90, DOI 10.7171/jbt.12-2303-004; Thorrold SR, 1996, MAR ECOL PROG SER, V145, P17, DOI 10.3354/meps145017; Titelman J, 2006, MAR BIOL, V149, P297, DOI 10.1007/s00227-005-0200-5; Valdez-Moreno M, 2010, MAR FRESHWATER RES, V61, P665, DOI 10.1071/MF09222; Vasquez-Yeomans L, 2000, ENVIRON BIOL FISH, V58, P379, DOI 10.1023/A:1007695717652; Vasquez-Yeomans L, 2011, BIODIVERS CONSERV, V20, P2379, DOI 10.1007/s10531-011-9990-6; Vasquez-Yeomans L, 1998, B MAR SCI, V62, P229; Vaughan GO, 2016, MAR POLLUT BULL, V105, P441, DOI 10.1016/j.marpolbul.2015.10.052; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; WILLIAMS DM, 1992, CONT SHELF RES, V12, P923, DOI 10.1016/0278-4343(92)90052-L; YOUNG PC, 1986, MAR ECOL PROG SER, V31, P209, DOI 10.3354/meps031209	89	27	27	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182503	10.1371/journal.pone.0182503	http://dx.doi.org/10.1371/journal.pone.0182503			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771590	gold, Green Submitted, Green Published			2022-12-26	WOS:000406853600127
J	Ozimek, M; Rokowski, R; Draga, P; Ljakh, V; Ambrozy, T; Krawczyk, M; Regwelski, T; Stanula, A; Gorner, K; Jurczak, A; Mucha, D				Ozimek, Mariusz; Rokowski, Robert; Draga, Pawel; Ljakh, Vladimir; Ambrozy, Tadeusz; Krawczyk, Marcin; Regwelski, Tomasz; Stanula, Arkadiusz; Gorner, Karol; Jurczak, Adam; Mucha, Dariusz			The role of physique, strength and endurance in the achievements of elite climbers	PLOS ONE			English	Article							SPORT ROCK CLIMBERS; SKINFOLD THICKNESS; PHYSIOLOGY; EXERCISE	Purpose The primary aim of this study is to determine the principal somatic and motor determinants for elite climbers. Methods Twenty climbers were examined [age: 28.5 +/- 6.1 years]. The runners were divided into two groups based on their climbing level, according to the International Rock Climbing Research Association (IRCRA). Elite climbers represented a 8b-8c Rotpunkt (RP) climbing level (n = 6), and advanced climbers represented an 7c+-8a RP level (n = 14). The following measurements were assessed: height, weight, lean body mass, upper limb length, arm span, and forearm, arm, thigh and calf circumference. The BMI, Rohrer ratio, and Ape Index were also measured. The following motor tests were assessed: a specific test for finger strength, an arm strength test, and a test of muscle endurance (hanging from 2.5 and 4 cm ledges). In addition, pull ups were used to measure muscle resistance to fatigue. Results Elite climbers recorded significantly higher values for finger strength than advanced climbers (129.08 vs. 111.54 kg; t((18)) = 2.35, p = 0.03) and arm endurance (33.17 vs. 25.75 pull ups; t((18)) = 2.54, p = 0.02). In addition, the calf circumference was significantly lower in elite climbers than that in advanced climbers (34.75 vs. 36.93 cm; t((18)) = 3.50, p = 0.003). Conclusion The results suggest that elite climbers have greater finger strength and arm endurance than advanced climbers.	[Ozimek, Mariusz] Univ Sch Phys Educ, Inst Sport, Dept Track & Field Sports, Krakow, Poland; [Rokowski, Robert; Regwelski, Tomasz] Univ Phys Educ, Fac Tourism & Recreat, Dept Alpinism & Tourism, Krakow, Poland; [Draga, Pawel] Univ Warsaw, Dept Phys & Sport Educ, Warsaw, Poland; [Ljakh, Vladimir] Univ Sch Phys Educ, Inst Sport, Dept Sports Theory & Anthropometr, Krakow, Poland; [Ambrozy, Tadeusz] Univ Sch Phys Educ, Dept Gymnast, Inst Sport, Krakow, Poland; [Krawczyk, Marcin] Univ Sch Phys Educ, Inst Sport, Krakow, Poland; [Stanula, Arkadiusz] Jerzy Kukuczka Acad Phys Educ, Dept Individual Sports, Katowice, Poland; [Gorner, Karol] Matej Bel Univ, Dept Phys Educ & Sports, Filozoficka Fac, Banska Bystrica, Slovakia; [Jurczak, Adam] Univ Sch Phys Educ, Dept Theory & Methodol Phys Educ, Krakow, Poland; [Mucha, Dariusz] Univ Sch Phys Educ, Dept Biol Renovat & Correct Defects Attitudes, Inst Biomed, Krakow, Poland	Institute of Sport - National Research Institute; University of Warsaw; Institute of Sport - National Research Institute; Institute of Sport - National Research Institute; Institute of Sport - National Research Institute; Akademia Wychowania Fizycznego im. Jerzego Kukuczki w Katowicach; Matej Bel University	Mucha, D (corresponding author), Univ Sch Phys Educ, Dept Biol Renovat & Correct Defects Attitudes, Inst Biomed, Krakow, Poland.	nauka.autograf@gmail.com	Ambroży, Tadeusz/AAZ-4796-2021; Stanula, Arkadiusz/W-5066-2018	Ambroży, Tadeusz/0000-0001-7361-9478; Stanula, Arkadiusz/0000-0003-1759-6456; Mucha, Dariusz/0000-0001-8361-8663; Krawczyk, Marcin/0000-0003-0599-2435; Lyakh, Vladimir/0000-0001-6257-0488; Jurczak, Adam/0000-0002-4935-9829; Rokowski, Robert/0000-0003-1849-2587				Balas J, 2012, EUR J SPORT SCI, V12, P16, DOI 10.1080/17461391.2010.546431; BILLAT V, 1995, J SPORT MED PHYS FIT, V35, P20; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Romero VE, 2009, J SPORT SCI, V27, P469, DOI 10.1080/02640410802603863; Ferguson RA, 1997, EUR J APPL PHYSIOL O, V76, P174, DOI 10.1007/s004210050231; Giles LV, 2006, SPORTS MED, V36, P529, DOI 10.2165/00007256-200636060-00006; Grant S, 1996, J SPORT SCI, V14, P301, DOI 10.1080/02640419608727715; Ozimek M, 2016, J HUM KINET, V53, P249, DOI 10.1515/hukin-2016-0027; Rokowski R, 2007, ANTROPOMOTORYKA, V17, P81; Schoffl VR, 2009, MED SPORTIVA, V13, P231; Sheel AW, 2004, BRIT J SPORT MED, V38, P355, DOI 10.1136/bjsm.2003.008169; SIRI W E, 1956, Adv Biol Med Phys, V4, P239; Sterkowicz S., 2014, MED SPORTIVA, V18, P16; Tomaszewski P, 2011, J HUM KINET, V29, P107, DOI 10.2478/v10078-011-0044-7; Vigouroux L, 2006, J SPORT SCI, V24, P181, DOI 10.1080/02640410500127785; Watts PB, 2004, EUR J APPL PHYSIOL, V91, P361, DOI 10.1007/s00421-003-1036-7; Watts PB, 1993, J SPORT SCI, V11, P113, DOI 10.1080/02640419308729974	17	11	11	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182026	10.1371/journal.pone.0182026	http://dx.doi.org/10.1371/journal.pone.0182026			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771525	Green Submitted, Green Published, gold			2022-12-26	WOS:000406853600058
J	Tzikas, S; Palapies, L; Bakogiannis, C; Zeller, T; Sinning, C; Baldus, S; Bickel, C; Vassilikos, V; Lackner, KJ; Zeiher, A; Munzel, T; Blankenberg, S; Keller, T				Tzikas, Stergios; Palapies, Lars; Bakogiannis, Constantinos; Zeller, Tanja; Sinning, Christoph; Baldus, Stephan; Bickel, Christoph; Vassilikos, Vassilios; Lackner, Karl J.; Zeiher, Andreas; Muenzel, Thomas; Blankenberg, Stefan; Keller, Till			GDF-15 predicts cardiovascular events in acute chest pain patients	PLOS ONE			English	Article							GROWTH-DIFFERENTIATION FACTOR-15; RISK STRATIFICATION; EARLY-DIAGNOSIS; HEART-DISEASE; BIOMARKERS; MEMBER; REVASCULARIZATION; ASSOCIATION; POPULATION; MORTALITY	Background Treatment of patients presenting with possible acute myocardial infarction (AMI) is based on timely diagnosis and proper risk stratification aided by biomarkers. We aimed at evaluating the predictive value of GDF-15 in patients presenting with symptoms suggestive of AMI. Methods Consecutive patients presenting with suspected AMI were enrolled in three study centers. Cardiovascular events were assessed during a follow-up period of 6 months with a combined endpoint of death or MI. Results From the 1818 enrolled patients (m/f = 1208/610), 413 (22.7%) had an acute MI and 63 patients reached the combined endpoint. Patients with MI and patients with adverse outcome had higher GDF-15 levels compared with non-MI patients (967.1pg/mL vs. 692.2 pg/L, p<0.001) and with event-free patients (1660 pg/mL vs. 756.6 pg/L, p< 0.001). GDF-15 levels were lower in patients with SYNTAX score <= 22 (797.3 pg/mL vs. 947.2 pg/L, p = 0.036). Increased GDF-15 levels on admission were associated with a hazard ratio of 2.1 for death or MI (95% CI: 1.67-2.65, p< 0.001) in a model adjusted for age and sex and of 1.57 (1.13-2.19, p = 0.008) adjusted for the GRACE score variables. GDF-15 showed a relevant reclassification with regards to the GRACE score with an overall net reclassification index (NRI) of 12.5% and an integrated discrimination improvement (IDI) of 14.56% (p = 0.006). Conclusion GDF-15 is an independent predictor of future cardiovascular events in patients presenting with suspected MI. GDF-15 levels correlate with the severity of CAD and can identify and risk-stratify patients who need coronary revascularization.	[Tzikas, Stergios; Muenzel, Thomas] Aristotle Univ Thessaloniki, Ippokrateio Hosp, Dept Cardiol 3, Thessaloniki, Greece; [Tzikas, Stergios] Univ Med Ctr, Johannes Gutenberg Univ, Dept Internal Med 2, Mainz, Germany; [Palapies, Lars] Goethe Univ Frankfurt, Div Cardiol, Dept Med III, Frankfurt, Germany; [Bakogiannis, Constantinos; Zeller, Tanja; Sinning, Christoph] Univ Heart Ctr Hamburg, Clin Gen & Intervent Cardiol, Hamburg, Germany; [Baldus, Stephan] German Ctr Cardiovasc Res DZHK, Berlin, Germany; [Baldus, Stephan] Univ Cologne, Dept Internal Med 3, Cologne, Germany; [Baldus, Stephan] Fed Armed Forces Hosp, Dept Internal Med, Koblenz, Germany; [Bickel, Christoph] Univ Med Ctr Mainz, Inst Clin Chem & Lab Med, Mainz, Germany	Aristotle University of Thessaloniki; Johannes Gutenberg University of Mainz; Goethe University Frankfurt; University of Hamburg; University Medical Center Hamburg-Eppendorf; German Centre for Cardiovascular Research; University of Cologne; Johannes Gutenberg University of Mainz	Tzikas, S (corresponding author), Aristotle Univ Thessaloniki, Ippokrateio Hosp, Dept Cardiol 3, Thessaloniki, Greece.; Tzikas, S (corresponding author), Univ Med Ctr, Johannes Gutenberg Univ, Dept Internal Med 2, Mainz, Germany.	tzikas@gmail.com	Tzikas, Stergios/A-2234-2010; Munzel, Thomas/A-2912-2014; Tzikas, Stergios/AAW-2673-2020	Tzikas, Stergios/0000-0002-7811-5620; Munzel, Thomas/0000-0001-5503-4150; Tzikas, Stergios/0000-0002-7811-5620; Zeller, Tanja/0000-0003-3379-2641; Bakogiannis, Constantinos/0000-0002-1132-9835	Johannes Gutenberg University of Mainz research program "Wissen schafft Zukunft"; Johannes Gutenberg University of Mainz research program "Schwerpunkt Vaskulare Prevention"; BRAHMS AG Germany	Johannes Gutenberg University of Mainz research program "Wissen schafft Zukunft"; Johannes Gutenberg University of Mainz research program "Schwerpunkt Vaskulare Prevention"; BRAHMS AG Germany	The present study was supported by unrestricted grants of Johannes Gutenberg University of Mainz research programs "Wissen schafft Zukunft" and "Schwerpunkt Vaskulare Prevention" as well as the BRAHMS AG Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonaca MP, 2011, ARTERIOSCL THROM VAS, V31, P203, DOI 10.1161/ATVBAHA.110.213512; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Daniels LB, 2011, CIRCULATION, V123, P2101, DOI 10.1161/CIRCULATIONAHA.110.979740; de Winter RJ, 2005, NEW ENGL J MED, V353, P1095, DOI 10.1056/NEJMoa044259; Eggers KM, 2008, EUR HEART J, V29, P2327, DOI 10.1093/eurheartj/ehn339; Eggers KM, 2010, CIRC-CARDIOVASC GENE, V3, P88, DOI 10.1161/CIRCGENETICS.109.877456; Fairlie WD, 1999, J LEUKOCYTE BIOL, V65, P2, DOI 10.1002/jlb.65.1.2; Filippatos G, 2014, J AM COLL CARDIOL, V63, P1654, DOI 10.1016/j.jacc.2013.11.055; Fox KAA, 2006, BMJ-BRIT MED J, V333, P1091, DOI 10.1136/bmj.38985.646481.55; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Hsiao EC, 2000, MOL CELL BIOL, V20, P3742, DOI 10.1128/MCB.20.10.3742-3751.2000; Keller T, 2013, INT J CARDIOL, V167, P1423, DOI 10.1016/j.ijcard.2012.04.063; Keller T, 2010, J AM COLL CARDIOL, V55, P2096, DOI 10.1016/j.jacc.2010.01.029; Kempf T, 2006, CIRC RES, V98, P351, DOI 10.1161/01.RES.0000202805.73038.48; Kempf T, 2007, EUR HEART J, V28, P2858, DOI 10.1093/eurheartj/ehm465; Kempf T, 2007, J AM COLL CARDIOL, V50, P1054, DOI 10.1016/j.jacc.2007.04.091; Kempf T, 2011, NAT MED, V17, P581, DOI 10.1038/nm.2354; Khan SQ, 2009, EUR HEART J, V30, P1057, DOI 10.1093/eurheartj/ehn600; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Lind L, 2009, EUR HEART J, V30, P2346, DOI 10.1093/eurheartj/ehp261; Lindholm D, 2017, CLIN CHEM, V63, P573, DOI 10.1373/clinchem.2016.261271; Mehta SR, 2009, NEW ENGL J MED, V360, P2165, DOI 10.1056/NEJMoa0807986; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; Morrow DA, 2007, CIRCULATION, V115, P949, DOI 10.1161/CIRCULATIONAHA.106.683110; Rohatgi A, 2012, CLIN CHEM, V58, P172, DOI 10.1373/clinchem.2011.171926; Schaub N, 2012, CLIN CHEM, V58, P441, DOI 10.1373/clinchem.2011.173310; Schopfer DW, 2014, AM HEART J, V167, P186, DOI 10.1016/j.ahj.2013.09.013; Thygesen K, 2007, EUR HEART J, V28, P2525; Tzikas S, 2013, HEART, V99, P388, DOI 10.1136/heartjnl-2012-302956; Wallentin L, 2014, CIRCULATION, V129, P293, DOI 10.1161/CIRCULATIONAHA.113.004420; Widera C, 2012, EUR HEART J, V33, P1095, DOI 10.1093/eurheartj/ehr444; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/ejcts/ezu366, 10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224]; Wollert KC, 2007, CIRCULATION, V116, P1540, DOI 10.1161/CIRCULATIONAHA.107.697714; Wollert KC, 2007, BASIC RES CARDIOL, V102, P412, DOI 10.1007/s00395-007-0662-3; Xu J, 2006, CIRC RES, V98, P342, DOI 10.1161/01.RES.0000202804.84885.d0	36	19	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182314	10.1371/journal.pone.0182314	http://dx.doi.org/10.1371/journal.pone.0182314			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771550	Green Published, Green Submitted, gold			2022-12-26	WOS:000406853600088
J	Drewry, DH; Wells, CI; Andrews, DM; Angell, R; Al-Ali, H; Axtman, AD; Capuzzi, SJ; Elkins, JM; Ettmayer, P; Frederiksen, M; Gileadi, O; Gray, N; Hooper, A; Knapp, S; Laufer, S; Luecking, U; Michaelides, M; Muller, S; Muratov, E; Denny, RA; Saikatendu, KS; Treiber, DK; Zuercher, WJ; Willson, TM				Drewry, David H.; Wells, Carrow I.; Andrews, David M.; Angell, Richard; Al-Ali, Hassan; Axtman, Alison D.; Capuzzi, Stephen J.; Elkins, Jonathan M.; Ettmayer, Peter; Frederiksen, Mathias; Gileadi, Opher; Gray, Nathanael; Hooper, Alice; Knapp, Stefan; Laufer, Stefan; Luecking, Ulrich; Michaelides, Michael; Mueller, Susanne; Muratov, Eugene; Denny, R. Aldrin; Saikatendu, Kumar S.; Treiber, Daniel K.; Zuercher, William J.; Willson, Timothy M.			Progress towards a public chemogenomic set for protein kinases and a call for contributions	PLOS ONE			English	Article							CANCER-CELLS; INHIBITOR; IDENTIFICATION; INTERROGATION; SENSITIVITY; SELECTIVITY; DEPENDENCY; TARGETS	Protein kinases are highly tractable targets for drug discovery. However, the biological function and therapeutic potential of the majority of the 500+ human protein kinases remains unknown. We have developed physical and virtual collections of small molecule inhibitors, which we call chemogenomic sets, that are designed to inhibit the catalytic function of almost half the human protein kinases. In this manuscript we share our progress towards generation of a comprehensive kinase chemogenomic set (KCGS), release kinome profiling data of a large inhibitor set (Published Kinase Inhibitor Set 2 (PKIS2)), and outline a process through which the community can openly collaborate to create a KCGS that probes the full complement of human protein kinases.	[Drewry, David H.; Wells, Carrow I.; Axtman, Alison D.; Zuercher, William J.; Willson, Timothy M.] Univ North Carolina Chapel Hill, Struct Genom Consortium, UNC Eshelman Sch Pharm, Chapel Hill, NC 27599 USA; [Andrews, David M.] AstraZeneca, Darwin Bldg,Cambridge Sci Pk, Cambridge, England; [Angell, Richard; Hooper, Alice] UCL, Sch Pharm, Drug Discovery Grp, Translat Res Off, 29-39 Brunswick Sq, London, England; [Al-Ali, Hassan] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Al-Ali, Hassan] Univ Miami, Miller Sch Med, Peggy & Harold Katz Family Drug Discovery Ctr, Miami, FL 33136 USA; [Capuzzi, Stephen J.; Muratov, Eugene] Univ North Carolina Chapel Hill Chapel, Lab Mol Modeling, Div Chem Biol & Med Chem, UNC Eshelman Sch Pharm, Chapel Hill, NC USA; [Elkins, Jonathan M.] Univ Estadual Campinas UNICAMP, Struct Genom Consortium, Campinas, SP, Brazil; [Ettmayer, Peter] Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria; [Frederiksen, Mathias] Novartis Inst BioMed Res, Novartis Campus, Basel, Switzerland; [Gileadi, Opher] Univ Oxford, Struct Genom Consortium, Oxford, England; [Gileadi, Opher] Univ Oxford, Nuffield Dept Clin Med, Target Discovery Inst, Oxford, England; [Gray, Nathanael] Harvard Med Sch, Harvard Dept Biol Chem & Mol Pharmacol, Boston, MA USA; [Gray, Nathanael] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Knapp, Stefan; Mueller, Susanne] Goethe Univ Frankfurt, Struct Genom Consortium, Buchmann Inst Mol Life Sci, Max von Laue Str 15, Frankfurt, Germany; [Knapp, Stefan; Mueller, Susanne] Goethe Univ Frankfurt, Inst Pharmaceut Chem, Max von Laue Str 15, Frankfurt, Germany; [Laufer, Stefan] Eberhard Karls Univ Tubingen, Dept Pharmaceut Chem, Inst Pharmaceut Sci, Morgenstelle 8, Tubingen, Germany; [Luecking, Ulrich] Bayer Pharma AG, Drug Discovery, Mullerstr 178, Berlin, Germany; [Michaelides, Michael] AbbVie, Oncol Chem, 1 North Waukegan Rd, N Chicago, IL USA; [Denny, R. Aldrin] Pfizer Inc, Worldwide Med Chem, Cambridge, MA USA; [Saikatendu, Kumar S.] Takeda Calif Inc, Global Res Externalizat, 10410 Sci Ctr Dr, San Diego, CA USA; [Treiber, Daniel K.] DiscoverX Corp, Fremont, CA USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; AstraZeneca; University of London; University College London; University of London School of Pharmacy; University of Miami; University of Miami; Universidade Estadual de Campinas; Boehringer Ingelheim; Novartis; University of Oxford; University of Oxford; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Goethe University Frankfurt; Goethe University Frankfurt; Eberhard Karls University of Tubingen; Bayer AG; Bayer Healthcare Pharmaceuticals; AbbVie; Pfizer; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals USA Inc. (TPUSA); Takeda California Inc	Drewry, DH (corresponding author), Univ North Carolina Chapel Hill, Struct Genom Consortium, UNC Eshelman Sch Pharm, Chapel Hill, NC 27599 USA.	David.Drewry@unc.edu	feinstein, doug/M-9414-2019; Muratov, Eugene/C-4454-2014; Knapp, Stefan/AAG-2347-2019	Muratov, Eugene/0000-0003-4616-7036; Knapp, Stefan/0000-0001-5995-6494; Hooper, Alice/0000-0002-8826-0960; Andrews, David/0000-0002-6716-6270; Al-Ali, Hassan/0000-0002-8899-3443; Drewry, David Harold/0000-0001-5973-5798; Muller-Knapp, Susanne/0000-0003-2402-4157; Laufer, Stefan/0000-0001-6952-1486; Axtman, Alison/0000-0003-4779-9932; Elkins, Jon/0000-0003-2858-8929	Eshelman Institute for Innovation; AstraZeneca; Boehringer Ingelheim; Novartis Institute; Bayer Pharma; AbbVie; Pfizer Inc.; Takeda California Inc.; DiscoverX Corporation; UNC Eshelman Institute for Innovation; Bayer Pharma AG; Canada Foundation for Innovation; Genome Canada; Innovative Medicines Initiative (EU/EFPIA); Janssen [115766]; Merck Co.; AbbVie [1097737]; Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer; Sao Paulo Research Foundation-FAPESP; Takeda; Wellcome Trust [092809/Z/10/Z]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK116204] Funding Source: NIH RePORTER	Eshelman Institute for Innovation; AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); Novartis Institute; Bayer Pharma; AbbVie(AbbVie); Pfizer Inc.(Pfizer); Takeda California Inc.(Takeda Pharmaceutical Company Ltd); DiscoverX Corporation; UNC Eshelman Institute for Innovation; Bayer Pharma AG; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada(Genome Canada); Innovative Medicines Initiative (EU/EFPIA); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck Co.(Merck & Company); AbbVie(AbbVie); Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Sao Paulo Research Foundation-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Our work was funded by the Eshelman Institute for Innovation (http://unceii.org/). The funder (Eshelman Institute for Innovation) provided support in the form of salaries for authors (DHD, CIW, ADA, WJZ, TMW), but did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors arearticulated in the author contributions section. David M. Andrews is an employee of the commercial company AstraZeneca. AstraZeneca did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, and only provided financial support in the form of author salary. Peter Ettmayer is an employee of the commercial company Boehringer Ingelheim. Boehringer Ingelheim did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, and only provided financial support in the form of author salary. Mathias Frederiksen is an employee of the commercial company Novartis Institute for Biomedical Research. Novartis Institute for Biomedical Research did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, and only provided financial support in the form of author salary. Ulrich Luecking is an employee of the commercial company Bayer Pharma. Bayer Pharma did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, and only provided financial support in the form of author salary. Michael Michaelides is an employee of the commercial company AbbVie. AbbVie did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, and only provided financial support in the form of author salary. R. Aldrin Denny is an employee of the commercial company Pfizer Inc. Pfizer Inc did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, and only provided financial support in the form of author salary and research materials. Kumar Saikatendu is an employee of the commercial company Takeda California, Inc. Takeda California Inc did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, and only provided financial support in the form of author salary and research materials. Dan Treiber is an employee of the commercial company DiscoverX Corporation. DiscoverX Corporation did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, and only provided financial support in the form of author salary.; This work was funded by the UNC Eshelman Institute for Innovation.; The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada, Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck & Co., Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, Sao Paulo Research Foundation-FAPESP, Takeda, and Wellcome Trust [092809/Z/10/Z].	Al-Ali H, 2015, ACS CHEM BIOL, V10, P1939, DOI 10.1021/acschembio.5b00289; Amata E, 2016, ACS INFECT DIS, V2, P180, DOI 10.1021/acsinfecdis.5b00136; Arrowsmith CH, 2015, NAT CHEM BIOL, V11, P536, DOI 10.1038/nchembio.1867; Atkinson Jennifer M, CANC CELL, V20, P384; Bamborough P, 2008, J MED CHEM, V51, P7898, DOI 10.1021/jm8011036; Bogen D, 2015, ONCOTARGET, V6, P35247, DOI 10.18632/oncotarget.6208; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Breinig M, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156400; Christmann-Franck S, 2016, J CHEM INF MODEL, V56, P1654, DOI 10.1021/acs.jcim.6b00122; Crowther GJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149996; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Derbyshire ER, 2014, CHEMBIOCHEM, V15, P1920, DOI 10.1002/cbic.201400025; Drewry DH, 2014, CURR TOP MED CHEM, V14, P340, DOI 10.2174/1568026613666131127160819; Eckhart AD, 2002, MOL PHARMACOL, V61, P749, DOI 10.1124/mol.61.4.749; Edwards A, 2017, SCI TRANS M IN PRESS; Edwards AM, 2011, NATURE, V470, P163, DOI 10.1038/470163a; Elkins JM, 2016, NAT BIOTECHNOL, V34, P95, DOI 10.1038/nbt.3374; Ember SWJ, 2014, ACS CHEM BIOL, V9, P1160, DOI 10.1021/cb500072z; Fabbro D, 2015, BRIT J PHARMACOL, V172, P2675, DOI 10.1111/bph.13096; Fabbro D, 2015, MOL PHARMACOL, V87, P766, DOI 10.1124/mol.114.095489; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Fedorov O, 2010, NAT CHEM BIOL, V6, P166, DOI 10.1038/nchembio.297; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Fink LS, 2015, MOL CANCER THER, V14, P298, DOI 10.1158/1535-7163.MCT-14-0529; Graczyk PP, 2007, J MED CHEM, V50, P5773, DOI 10.1021/jm070562u; Gross S, 2015, J CLIN INVEST, V125, P1780, DOI 10.1172/JCI76094; Guo KX, 2014, J BIOMOL SCREEN, V19, P538, DOI 10.1177/1087057113520325; Hildebrand JM, 2014, P NATL ACAD SCI USA, V111, P15072, DOI 10.1073/pnas.1408987111; Homan KT, 2015, ACS CHEM BIOL, V10, P310, DOI 10.1021/cb5006323; Hong AL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11987; Iorio F, 2016, CELL, V166, P740, DOI 10.1016/j.cell.2016.06.017; Jones LH, 2017, NAT REV DRUG DISCOV; King AJ, 2006, CANCER RES, V66, P11100, DOI 10.1158/0008-5472.CAN-06-2554; Knapp S, 2013, NAT CHEM BIOL, V9, P3, DOI 10.1038/nchembio.1113; Lipchik AM, 2015, J AM CHEM SOC, V137, P2484, DOI 10.1021/ja507164a; Liu F, 2016, ACS CHEM BIOL, V11, P1537, DOI 10.1021/acschembio.6b00250; Long T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004356; Luo TP, 2012, P NATL ACAD SCI USA, V109, P2860, DOI 10.1073/pnas.1120589109; Manago F, 2012, SCI REP-UK, V2, DOI 10.1038/srep00301; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mardilovich K, 2015, ONCOTARGET, V6, P38469, DOI 10.18632/oncotarget.6288; Markowitz D, 2016, MOL CANCER THER, V15, P1799, DOI 10.1158/1535-7163.MCT-15-0849; Marshall A, 2012, PLANT CELL, V24, P2262, DOI 10.1105/tpc.112.096677; Mason JM, 2014, CANCER CELL, V26, P163, DOI 10.1016/j.ccr.2014.05.006; Maurice DH, 2014, NAT REV DRUG DISCOV, V13, P290, DOI 10.1038/nrd4228; Metz JT, 2011, NAT CHEM BIOL, V7, P200, DOI 10.1038/NCHEMBIO.530; Preston S, 2015, INT J PARASITOL, V45, P333, DOI 10.1016/j.ijpara.2015.01.007; Roskoski R, 2015, PHARMACOL RES, V100, P1, DOI 10.1016/j.phrs.2015.07.010; Roth BL, 2015, J BIOL CHEM, V290, P19471, DOI 10.1074/jbc.R115.654764; Ryall KA, 2015, BIOINFORMATICS, V31, P3799, DOI 10.1093/bioinformatics/btv427; Scheipl S, 2016, J PATHOL, V239, P320, DOI 10.1002/path.4729; Seashore-Ludlow B, 2015, CANCER DISCOV, V5, P1210, DOI 10.1158/2159-8290.CD-15-0235; Simpson C, 2016, ACS INFECT DIS, V2, P194, DOI 10.1021/acsinfecdis.5b00102; Smyth Lynette A, 2009, J Chem Biol, V2, P131, DOI 10.1007/s12154-009-0023-9; Szwajda A, 2015, CHEM BIOL, V22, P1144, DOI 10.1016/j.chembiol.2015.06.021; Tang J, 2014, J CHEM INF MODEL, V54, P735, DOI 10.1021/ci400709d; Thorne CA, 2015, NAT CHEM BIOL, V11, P58, DOI 10.1038/nchembio.1690; Tiedemann RE, 2010, BLOOD, V115, P1594, DOI 10.1182/blood-2009-09-243980; Tyner JW, 2013, CANCER RES, V73, P285, DOI 10.1158/0008-5472.CAN-12-1906; Uitdehaag JCM, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-94; Urick AK, 2015, ACS CHEM BIOL, V10, P2246, DOI 10.1021/acschembio.5b00483; Wu P, 2015, TRENDS PHARMACOL SCI, V36, P422, DOI 10.1016/j.tips.2015.04.005; Zulawski M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-548	63	82	82	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0181585	10.1371/journal.pone.0181585	http://dx.doi.org/10.1371/journal.pone.0181585			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767711	Green Published, gold, Green Submitted			2022-12-26	WOS:000406768200031
J	Lima, DLF; Carneiro, SDRM; Barbosa, FTD; Saintrain, MVD; Moizan, JAH; Doucet, J				Ferreira Lima, Danilo Lopes; Rocha Mendes Carneiro, Sandro Dias; de Sousa Barbosa, Fladia Taciana; de Lima Saintrain, Maria Vieira; Herve Moizan, Jean Andre; Doucet, Jean			Salivary flow and xerostomia in older patients with type 2 diabetes mellitus	PLOS ONE			English	Article							DISEASE	Objectives To assess salivary flow in older patients with type 2 diabetes mellitus (DM2) and its association with xerostomia. Methods Cross-sectional clinical study conducted with older patients diagnosed with type 2 diabetes for at least one year receiving treatment at the Integrated Center for Diabetes and Hypertension of Ceara A (CIHD) in the city of Fortaleza, Ceara A, Northeastern Brazil. Oral clinical examination was carried out to assess the decayed, missing and filled teeth index (DMFT). Perception of the presence of xerostomia/dry mouth was assessed using the Visual Analogue Scale. Stimulated salivary flow was measured and samples were obtained using an extra-soft silicone device. Results 120 older patients with diabetes (60 insulin-dependent and 60 non-insulin-dependent) aged 65-91 years, with a mean age of 72.26 +/- 6.53 years, were assessed. Of these, 111 (92.5%) presented a decrease in salivary flow while 59 (49.2%) reported moderate to severe xerostomia/dry mouth. The DMFT Index presented a mean of 27.53 +/- 4.86 teeth. Conclusions Reduced salivary flow was found in the group assessed in the present research; however, this finding is not in accordance with the perception of xerostomia/dry mouth reported by the patients.	[Ferreira Lima, Danilo Lopes] Univ Fortaleza Unifor, Dent Sch, Undergrad Program, Fortaleza, Ceara, Brazil; [Ferreira Lima, Danilo Lopes; de Sousa Barbosa, Fladia Taciana] Univ Fortaleza Unifor, Dent Sch, Grad Program, Fortaleza, Ceara, Brazil; [Rocha Mendes Carneiro, Sandro Dias] Univ Fortaleza Unifor, Dent Sch, Fortaleza, Ceara, Brazil; [de Lima Saintrain, Maria Vieira] Univ Fortaleza Unifor, Publ Hlth Grad Program, Fortaleza, Ceara, Brazil; [Herve Moizan, Jean Andre] Rouen Univ Hosp, St Julien Hosp, Dent Care Dept, Rouen, France; [Doucet, Jean] Rouen Univ Hosp, St Julien Hosp, Dept Internal Med Geriatr & Therapeut, Rouen, France	Universidade Fortaleza; Universidade Fortaleza; Universidade Fortaleza; Universidade Fortaleza; CHU de Rouen; CHU de Rouen	Saintrain, MVD (corresponding author), Univ Fortaleza Unifor, Publ Hlth Grad Program, Fortaleza, Ceara, Brazil.	mvlsaintrain@yahoo.com.br		Saintrain, Maria/0000-0003-1514-3218	Diretoria de Pesquisa, Desenvolvimento e Inovacao - DPDI of the Universidade de Fortaleza [1987]	Diretoria de Pesquisa, Desenvolvimento e Inovacao - DPDI of the Universidade de Fortaleza	The present research is funded by the Diretoria de Pesquisa, Desenvolvimento e Inovacao - DPDI of the Universidade de Fortaleza (Grant No. 1987). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, DIABETES CARE, V34, pS11; Brokelman Roy B G, 2012, Eur Orthop Traumatol, V3, P101; Carboni AMG, 2000, DIABETES CLIN, V4, P62; Carper MM, 2014, J BEHAV MED, V37, P501, DOI 10.1007/s10865-013-9505-x; Collin HL, 2000, ORAL SURG ORAL MED O, V90, P299, DOI 10.1067/moe.2000.107536; Colussi Claudia Flemming, 2004, Rev. bras. epidemiol., V7, P88; Conceicao MD, 2013, BOM HALITO SEGURANCA, P105; Costa KL, 2016, J PERIODONTOL, V26, P1; Barros MBD, 2011, CIENC SAUDE COLETIVA, V16, P3755, DOI 10.1590/S1413-81232011001000012; Guimaraes KB, 2007, REV ODONTO CIENC, V22, P124; Islas-Granillo H, 2014, W INDIAN MED J, V63, P758, DOI 10.7727/wimj.2014.036; Koromantzos PA, 2011, J CLIN PERIODONTOL, V38, P142, DOI 10.1111/j.1600-051X.2010.01652.x; Lima A.A.S., 2004, REV ODONTO CIENC, V19, P238; Lima DLF, 2014, J DENT REST, V1; Lin CC, 2002, J DIABETES COMPLICAT, V16, P176, DOI 10.1016/S1056-8727(01)00174-X; Malinowska K., 2014, ADV CLIN EXP MED, V23, P225; Ministerio da Saude (BR), 2011, PROJ SB BRAS 2010 PE; MURRAH VA, 1985, J ORAL PATHOL MED, V14, P236, DOI 10.1111/j.1600-0714.1985.tb00487.x; Narhi T O, 1996, Spec Care Dentist, V16, P116; Negrato CA, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-27; Noboru Kuroiwa D, 2014, Minerva Stomatol, V63, P421; Oliveira JEP, 2014, DIRETRIZES SOCIEDADE; Panarotto D, 2005, REV AMRIGS, V49, P137; Peters SAE, 2014, DIABETOLOGIA, V57, P1542, DOI 10.1007/s00125-014-3260-6; Ricci P, 2010, B EPIDEMIOL HEBD PAR, V43, P425; Samnieng P, 2012, COMMUNITY DENT HLTH, V29, P117, DOI 10.1922/CDH_2690Ueno07; de Freitas LRS, 2012, EPIDEMIOL SERV SAUDE, V21, P7, DOI 10.5123/S1679-49742012000100002; Cabrera MAS, 2007, REV ASSOC MED BRAS, V53, P178, DOI 10.1590/S0104-42302007000200026; Schara Rok, 2006, J Int Acad Periodontol, V8, P61; Shi YK, 2014, LANCET, V383, P1947, DOI 10.1016/S0140-6736(14)60886-2; Silva AM, 2010, CIENC SAUDE COLETIVA, V15, P2197, DOI 10.1590/S1413-81232010000400034; Skaleric Uros, 2004, J Int Acad Periodontol, V6, P160; Soares MSM, 2004, ARQ ODONTOL, V40, P49; Takeuchi K, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/381821; World Health Organization, 2013, ORAL HLTH SURVEYS BA, V5th edn, p., P19; World Health Organization- WHO, 2012, GLOB HLTH DAT REP GH; Xerostomia Coimbra F., 2009, R PORT ESTOMATOL CIR, V50, P159	37	16	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0180891	10.1371/journal.pone.0180891	http://dx.doi.org/10.1371/journal.pone.0180891			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767676	gold, Green Published, Green Submitted			2022-12-26	WOS:000406768200013
J	Pani, D; Usai, I; Cosseddu, P; Melis, M; Sollai, G; Crnjar, R; Barbarossa, IT; Raffo, L; Bonfiglio, A				Pani, Danilo; Usai, Ilenia; Cosseddu, Piero; Melis, Melania; Sollai, Giorgia; Crnjar, Roberto; Barbarossa, Iole Tomassini; Raffo, Luigi; Bonfiglio, Annalisa			An automated system for the objective evaluation of human gustatory sensitivity using tongue biopotential recordings	PLOS ONE			English	Article							RECEPTOR GENE TAS2R38; BODY-MASS INDEX; BITTER-TASTE; 6-N-PROPYLTHIOURACIL PROP; PERCEPTION; POLYMORPHISMS; ASSOCIATIONS; ANATOMY; LOCUS; TRAIT	The goal of this work is to develop an automatic system for the evaluation of the gustatory sensitivity of patients using an electrophysiological recording of the response of bud cells to taste stimuli. In particular, the study aims to evaluate the effectiveness and limitations of supervised classifiers in the discrimination between subjects belonging to the three 6-n-propylthiouracil (PROP) taster categories (supertasters, medium tasters, and non-tasters), exploiting features extracted from electrophysiological recordings of the tongue. Thirty-nine subjects (equally divided into the three PROP status classes by standard non-objective scaling methods) underwent a non-invasive, differential, biopotential recording of their tongues during stimulation with PROP by using a custom-made, flexible, silver electrode. Two different classifiers were trained to recognize up to seven different features extracted from the recorded depolarization signal. The classification results indicate that the identified set of features allows to distinguish between PROP tasters and non-tasters (average accuracy of 80% +/- 18% and up to 94% +/- 15% when only supertasters and non-tasters are considered), but medium tasters were difficult to identify. However, these apparent classification errors are related to uncertainty in the labeling procedures, which are based on non-objective tests, in which the subjects provided borderline evaluations. Thus, using the proposed method, it is possible, for the first time, to automatically achieve objective PROP taster status identification with high accuracy. The simplicity of the recording technique allows for easy reproduction of the experimental setting; thus the technique can be used in future studies to evaluate other gustatory stimuli. The proposed approach represents the first objective and automatic method to directly measure human gustatory responses and a milestone for physiological taste studies, with applications ranging from basic science to food tasting evaluations.	[Pani, Danilo; Usai, Ilenia; Cosseddu, Piero; Raffo, Luigi; Bonfiglio, Annalisa] Univ Cagliari, Dept Elect & Elect Engn, Cagliari, Italy; [Melis, Melania; Sollai, Giorgia; Crnjar, Roberto; Barbarossa, Iole Tomassini] Univ Cagliari, Dept Biomed Sci, Monserrato, Italy	University of Cagliari; University of Cagliari	Pani, D (corresponding author), Univ Cagliari, Dept Elect & Elect Engn, Cagliari, Italy.	danilo.pani@diee.unica.it	Pani, Danilo/C-6832-2009; Cosseddu, Piero/ACC-2341-2022; RAFFO, LUIGI/E-9713-2012; SOLLAI, GIORGIA/AAR-1130-2021	Pani, Danilo/0000-0003-1924-0875; RAFFO, LUIGI/0000-0001-9683-009X; SOLLAI, GIORGIA/0000-0001-7341-582X; MELIS, MELANIA/0000-0003-3410-3158	Regione Autonoma della Sardegna [CRP 59490]; University of Cagliari (Progetti di Ricerca di Interesse Dipartimentale, PRID); FIR	Regione Autonoma della Sardegna(Regione Sardegna); University of Cagliari (Progetti di Ricerca di Interesse Dipartimentale, PRID); FIR(Ministry of Education, Universities and Research (MIUR))	This work was supported by Regione Autonoma della Sardegna L.R. 7/2007, 2012 (grant number CRP 59490) and grants from University of Cagliari (Progetti di Ricerca di Interesse Dipartimentale, PRID 2015) and FIR 2016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbarossa IT, 2015, PHYSIOL BEHAV, V138, P6, DOI 10.1016/j.physbeh.2014.09.011; Bartoshuk L. M., 1993, Food Quality and Preference, V4, P21, DOI 10.1016/0950-3293(93)90310-3; BARTOSHUK LM, 1988, CHEM SENSES, V13, P517, DOI 10.1093/chemse/13.4.517; BARTOSHUK LM, 1994, PHYSIOL BEHAV, V56, P1165, DOI 10.1016/0031-9384(94)90361-1; Bartoshuk LM, 2004, PHYSIOL BEHAV, V82, P109, DOI 10.1016/j.physbeh.2004.02.033; Bishop C. M, 2006, PATTERN RECOGNITION; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Cabras T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030962; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Drayna D, 2003, HUM GENET, V112, P567, DOI 10.1007/s00439-003-0911-y; Drewnowski A, 2016, J AM DIET ASSOC, V107, P1340; Duffy VB, 2000, J AM DIET ASSOC, V100, P647, DOI 10.1016/S0002-8223(00)00191-7; Duffy VB, 2004, ALCOHOL CLIN EXP RES, V28, P1629, DOI 10.1097/01.ALC.0000145789.55183.D4; Feeney EL, 2014, PHYSIOL BEHAV, V128, P148, DOI 10.1016/j.physbeh.2014.02.013; Fox AL, 1932, P NATL ACAD SCI USA, V18, P115, DOI 10.1073/pnas.18.1.115; Genick UK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027745; GLANVILL.EV, 1965, NATURE, V205, P930, DOI 10.1038/205930a0; HARRIS H, 1950, ANN EUGENIC, V15, P32; Hayes JE, 2008, CHEM SENSES, V33, P255, DOI 10.1093/chemse/bjm084; Hayes JE, 2007, CHEM SENSES, V32, P225, DOI 10.1093/chemse/bjl050; Huang TK, 2006, J MACH LEARN RES, V7, P85; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Lofhede J, 2012, SENSORS-BASEL, V12, P16907, DOI 10.3390/s121216907; Melis M, 2013, PLOS ONE, V8; Melis M, 2017, PHYSIOL BEHAV, V173, P163, DOI 10.1016/j.physbeh.2017.01.031; Melis M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131104; Melis M, 2015, NUTRIENTS, V7, P2068, DOI 10.3390/nu7032068; Mennella JA, 2005, PEDIATRICS, V115, pE216, DOI 10.1542/peds.2004-1582; Mennella JA, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-60; Padiglia A, 2010, AM J CLIN NUTR, V92, P539, DOI 10.3945/ajcn.2010.29418; Reed DR, 1999, AM J HUM GENET, V64, P1478, DOI 10.1086/302367; Sollai G, 2017, SCI REP-UK, V7, DOI 10.1038/srep40353; Tepper BJ, 2008, OBESITY, V16, P2289, DOI 10.1038/oby.2008.357; Tepper BJ, 2008, ANNU REV NUTR, V28, P367, DOI 10.1146/annurev.nutr.28.061807.155458; Tepper BJ, 2014, NUTRIENTS, V6, P3363, DOI 10.3390/nu6093363; Tepper BJ, 1998, AM J HUM GENET, V63, P1271, DOI 10.1086/302124; Tepper BJ, 1998, ANN NY ACAD SCI, V855, P802, DOI 10.1111/j.1749-6632.1998.tb10662.x; Tepper BJ, 2001, PHYSIOL BEHAV, V73, P571, DOI 10.1016/S0031-9384(01)00500-5; Tomassini Barbarossa I, 2016, ELSEVIER, V29, P531; Valencia E, 2016, COMPUT BIOL MED, V76, P168, DOI 10.1016/j.compbiomed.2016.07.002; Vapnik V., 1995, NATURE STAT LEARNING, P188; Wooding S, 2004, AM J HUM GENET, V74, P637, DOI 10.1086/383092; Yeomans MR, 2009, Q J EXP PSYCHOL, V62, P1648, DOI 10.1080/17470210802557793; Zhao LQ, 2003, PHYSIOL BEHAV, V78, P625, DOI 10.1016/S0031-9384(03)00057-X	45	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0177246	10.1371/journal.pone.0177246	http://dx.doi.org/10.1371/journal.pone.0177246			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767651	Green Published, Green Submitted, gold			2022-12-26	WOS:000406768200002
J	Wang, CQ; Hong, F; Lu, Y; Li, XN; Liu, HM				Wang, Chuqiao; Hong, Feng; Lu, Yong; Li, Xianning; Liu, Hengming			Improved biogas production and biodegradation of oilseed rape straw by using kitchen waste and duck droppings as co-substrates in two-phase anaerobic digestion	PLOS ONE			English	Article							FOOD WASTE; CHICKEN MANURE; METHANE PRODUCTION; VEGETABLE WASTE; CATTLE MANURE; SWINE MANURE; PERFORMANCE; HYDROLYSIS; STOVER; FRUIT	Oilseed rape straw (ORS) is a kind of biorefractory waste widely existing in the rural area of China, which is highly suitable to mix with kitchen waste (KW) and duck droppings (DD) in two-phase anaerobic digestion (AD). This research introduced the importance of KW and DD addition to improve the biogas production and biodegradation of ORS. A set of comparative experiments were conducted on two-phase mono-and co-digestion with organic load of 60 g VS/L. The total methane yield (TMY) and the biodegradation of ORS of co-digestions were obviously improving, and the synergistic effect found in the two-phase co-digestions. The optimum mixing ratio of ORS, KW and DD was 50:40:10, and the corresponding TMY and VS degradation rate of ORS were 374.5 mL/g VS and 49.7%, respectively. Addition of KW and DD maintained the pH within the optimal range for the hydrolyzing-acidification, improved the phase separation and buffering capacity of AD system.	[Wang, Chuqiao; Hong, Feng; Lu, Yong; Li, Xianning] Southeast Univ, Sch Energy & Environm, Nanjing, Jiangsu, Peoples R China; [Liu, Hengming] Dalian Ocean Univ, Ocean Sci & Environm Coll, Dalian, Peoples R China	Southeast University - China; Dalian Ocean University	Li, XN (corresponding author), Southeast Univ, Sch Energy & Environm, Nanjing, Jiangsu, Peoples R China.	lxnseu@163.com	wang, chu/GYJ-2191-2022		National Key Technology R&D Program of China [2013BAJ10612-02]; National Twelfth Five-Year Major Projects [2012ZX07101-005]; Environmental Scientific Research Programs of Jiangsu Province [2016029]	National Key Technology R&D Program of China(National Key Technology R&D Program); National Twelfth Five-Year Major Projects; Environmental Scientific Research Programs of Jiangsu Province	The National Key Technology R&D Program of China (grant number: 2013BAJ10612-02). National Twelfth Five-Year Major Projects (grant number: 2012ZX07101-005). Environmental Scientific Research Programs of Jiangsu Province (grant number: 2016029).; The present work was supported by the National Key Technology R&D Program of China (2013BAJ10B12-02), National Twelfth Five-Year Major Projects (2012ZX07101-005) and Environmental Scientific Research Programs of Jiangsu Province (2016029). One part of this research was conducted at field laboratory located in a village in Anhui Province, and another part was conducted at the Southeast University. Thanks you very much for your consideration.	American Public Health Association (APHA), 1998, AM PHYS ED REV, V20th; Beccari M, 1996, WATER RES; Bouallagui H, 2004, BIOCHEM ENG J, V21, P193, DOI 10.1016/j.bej.2004.05.001; Castrillon L, 2013, BIORESOURCE TECHNOL, V136, P73, DOI 10.1016/j.biortech.2013.02.076; Chen YG, 2007, WATER RES, V41, P683, DOI 10.1016/j.watres.2006.07.030; El-Mashad HM, 2010, BIORESOURCE TECHNOL, V101, P4021, DOI 10.1016/j.biortech.2010.01.027; Hansen KH, 1998, WATER RES, V32, P5, DOI 10.1016/S0043-1354(97)00201-7; Ji WC, 2014, BIOENERG RES, V7, P1392, DOI 10.1007/s12155-014-9468-y; KIVAISI AK, 1995, BIOMASS BIOENERG, V8, P45, DOI 10.1016/0961-9534(94)00075-5; Labatut RA, 2011, BIORESOURCE TECHNOL, V102, P2255, DOI 10.1016/j.biortech.2010.10.035; Lehtomaki A, 2007, RESOUR CONSERV RECY, V51, P591, DOI 10.1016/j.resconrec.2006.11.004; Li YQ, 2013, BIORESOURCE TECHNOL, V149, P565, DOI 10.1016/j.biortech.2013.09.063; Li YQ, 2013, BIORESOURCE TECHNOL, V149, P406, DOI 10.1016/j.biortech.2013.09.091; Li YQ, 2013, APPL BIOCHEM BIOTECH, V171, P117, DOI 10.1007/s12010-013-0335-7; Li YQ, 2013, ENERG FUEL, V27, P2085, DOI 10.1021/ef400117f; Maranon E, 2012, WASTE MANAGE, V32, P1821, DOI 10.1016/j.wasman.2012.05.033; Martinez EJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153139; Mohan S, 2008, J ENVIRON ENG SCI, V7, P91, DOI 10.1139/S07-039; Nair S, 2005, ENVIRON TECHNOL, V26, P1003, DOI 10.1080/09593332608618488; Nayono SE, 2010, BIORESOURCE TECHNOL, V101, P6987, DOI 10.1016/j.biortech.2010.03.123; Niu QG, 2014, CHEM ENG J, V244, P587, DOI 10.1016/j.cej.2013.11.074; Petersson A, 2007, BIOMASS BIOENERG, V31, P812, DOI 10.1016/j.biombioe.2007.06.001; Pullammanappallil PC, 2001, BIORESOURCE TECHNOL, V78, P165, DOI 10.1016/S0960-8524(00)00187-5; Shen F, 2013, BIORESOURCE TECHNOL, V144, P80, DOI 10.1016/j.biortech.2013.06.099; Svensson LM, 2007, BIORESOURCE TECHNOL, V98, P46, DOI 10.1016/j.biortech.2005.11.023; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Vedrenne F, 2008, BIORESOURCE TECHNOL, V99, P146, DOI 10.1016/j.biortech.2006.11.043; Vivekanand V, 2012, BIORESOURCE TECHNOL, V123, P608, DOI 10.1016/j.biortech.2012.06.088; Wang XW, 2015, BIORESOURCE TECHNOL, V180, P192, DOI 10.1016/j.biortech.2014.12.023; Xia A, 2016, BIOTECHNOL ADV, V34, P451, DOI 10.1016/j.biotechadv.2015.12.009; Yang YQ, 2013, ENVIRON SCI POLLUT R, V20, P2162, DOI 10.1007/s11356-012-1414-y; Yao Y, 2016, BIOTECHNOL BIOFUELS, P9; Ye JQ, 2013, WASTE MANAGE, V33, P2653, DOI 10.1016/j.wasman.2013.05.014; Yong ZH, 2015, RENEW ENERG, V78, P527, DOI 10.1016/j.renene.2015.01.033; Zahedi S, 2013, BIORESOURCE TECHNOL, V148, P443, DOI 10.1016/j.biortech.2013.09.002; Zhang B, 2005, ENVIRON TECHNOL, V26, P329, DOI 10.1080/09593332608618563; Zhang B, 2014, ENVIRON TECHNOL, V35, P1277, DOI 10.1080/09593330.2013.866169; Zhang CS, 2013, BIORESOURCE TECHNOL, V145, P10, DOI 10.1016/j.biortech.2013.03.030; Zhang RH, 2007, BIORESOURCE TECHNOL, V98, P929, DOI 10.1016/j.biortech.2006.02.039; Zhang T, 2015, WASTE MANAGE, V35, P119, DOI 10.1016/j.wasman.2014.09.004; Zhang T, 2014, ENERG FUEL, V28, P2490, DOI 10.1021/ef500262m; Zhao C, 2016, IND CROP PROD, V83, P86, DOI 10.1016/j.indcrop.2015.12.018; Zhao C, 2016, ENERG FUEL, V30, P1154, DOI 10.1021/acs.energyfuels.5b02817; Zhao MX, 2013, ENERG CONVERS MANAGE, V75, P21, DOI 10.1016/j.enconman.2013.05.037; Zhu BN, 2010, BIORESOURCE TECHNOL, V101, P6374, DOI 10.1016/j.biortech.2010.03.075	45	22	22	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182361	10.1371/journal.pone.0182361	http://dx.doi.org/10.1371/journal.pone.0182361			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767709	gold, Green Published, Green Submitted			2022-12-26	WOS:000406768200072
J	Hennessy, RS; Go, JL; Hennessy, RR; Tefft, BJ; Jana, S; Stoyles, NJ; Al-Hijji, MA; Thaden, JJ; Pislaru, SV; Simari, RD; Stulak, JM; Young, MD; Lerman, A				Hennessy, Ryan S.; Go, Jason L.; Hennessy, Rebecca R.; Tefft, Brandon J.; Jana, Soumen; Stoyles, Nicholas J.; Al-Hijji, Mohammed A.; Thaden, Jeremy J.; Pislaru, Sorin V.; Simari, Robert D.; Stulak, John M.; Young, Melissa D.; Lerman, Amir			Recellularization of a novel off-the-shelf valve following xenogenic implantation into the right ventricular outflow tract	PLOS ONE			English	Article							DECELLULARIZED HEART-VALVES; IN-VIVO; ALPHA-GAL; TISSUE; SHEEP; PORCINE; VITRO; REPOPULATION; CIRCULATION; CONDUITS	Current research on valvular heart repair has focused on tissue-engineered heart valves (TEHV) because of its potential to grow similarly to native heart valves. Decellularized xenografts are a promising solution; however, host recellularization remains challenging. In this study, decellularized porcine aortic valves were implanted into the right ventricular outflow tract (RVOT) of sheep to investigate recellularization potential. Porcine aortic valves, decellularized with sodium dodecyl sulfate (SDS), were sterilized by supercritical carbon dioxide (scCO(2)) and implanted into the RVOT of five juvenile polypay sheep for 5 months (n = 5). During implantation, functionality of the valves was assessed by serial echocardiography, blood tests, and right heart pulmonary artery catheterization measurements. The explanted valves were characterized through gross examination, mechanical characterization, and immunohistochemical analysis including cell viability, phenotype, proliferation, and extracellular matrix generation. Gross examination of the valve cusps demonstrated the absence of thrombosis. Bacterial and fungal stains were negative for pathogenic microbes. Immunohistochemical analysis showed the presence of myofibroblast-like cell infiltration with formation of new collagen fibrils and the existence of an endothelial layer at the surface of the explant. Analysis of cell phenotype and morphology showed no lymphoplasmacytic infiltration. Tensile mechanical testing of valve cusps revealed an increase in stiffness while strength was maintained during implantation. The increased tensile stiffness confirms the recellularization of the cusps by collagen synthesizing cells. The current study demonstrated the feasibility of the trans-species implantation of a non-fixed decellularized porcine aortic valve into the RVOT of sheep. The implantation resulted in recellularization of the valve with sufficient hemodynamic function for the 5-month study. Thus, the study supports a potential role for use of a TEHV for the treatment of valve disease in humans.	[Hennessy, Ryan S.; Go, Jason L.; Hennessy, Rebecca R.; Tefft, Brandon J.; Jana, Soumen; Stoyles, Nicholas J.; Al-Hijji, Mohammed A.; Thaden, Jeremy J.; Pislaru, Sorin V.; Young, Melissa D.; Lerman, Amir] Mayo Clin, Dept Cardiovasc Dis, Rochester, MN 55905 USA; [Simari, Robert D.] Univ Kansas, Sch Med, Dept Internal Med, Kansas City, KS USA; [Stulak, John M.] Mayo Clin, Div Cardiovasc Surg, Rochester, MN USA	Mayo Clinic; University of Kansas; University of Kansas Medical Center; Mayo Clinic	Lerman, A (corresponding author), Mayo Clin, Dept Cardiovasc Dis, Rochester, MN 55905 USA.	lerman.amir@mayo.edu	Al-Hijji, Mohammed/AAX-1700-2020	Al-Hijji, Mohammed/0000-0002-9572-7688; Go, Jason/0000-0002-5652-5338; Pislaru, Sorin/0000-0002-5256-3150	NIH [T32 HL007111-38]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007111] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH (T32 HL007111-38).	[Anonymous], 2013, F215013 ASTM; Brown W M 3rd, 1991, ASAIO Trans, V37, pM445; Buchanan RM, 2014, BIOMECH MODEL MECHAN, V13, P813, DOI 10.1007/s10237-013-0536-6; Butcher JT, 2011, ADV DRUG DELIVER REV, V63, P242, DOI 10.1016/j.addr.2011.01.008; Cheung DY, 2015, EXPERT OPIN BIOL TH, V15, P1155, DOI 10.1517/14712598.2015.1051527; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; CURRIE PJ, 1985, CIRCULATION, V71, P1162, DOI 10.1161/01.CIR.71.6.1162; Della Barbera M, 2015, CARDIOVASC PATHOL, V24, P102, DOI 10.1016/j.carpath.2014.10.001; DiVincenti L, 2014, J AM ASSOC LAB ANIM, V53, P439; Galili U, 2001, BIOCHIMIE, V83, P557, DOI 10.1016/S0300-9084(01)01294-9; Gilbert TW, 2012, J CELL BIOCHEM, V113, P2217, DOI 10.1002/jcb.24130; Gupta B, 2015, ANN THORAC SURG, V100, P599, DOI 10.1016/j.athoracsur.2015.03.120; Gutierrez JRP, 2015, TISSUE ENG PT A, V21, P332, DOI [10.1089/ten.tea.2014.0003, 10.1089/ten.TEA.2014.0003]; Helder MRK, 2016, ANN THORAC SURG, V101, P667, DOI 10.1016/j.athoracsur.2015.07.080; Hennessy R., 2016, J JACC BASIC TRANSLA; Honge JL, 2011, EUR J CARDIO-THORAC, V39, P829, DOI 10.1016/j.ejcts.2010.08.054; Iop L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099593; Kajbafzadeh AM, 2016, INT J SURG, V28, P97, DOI 10.1016/j.ijsu.2016.02.061; Ketchedjian A, 2005, ANN THORAC SURG, V79, P888, DOI 10.1016/j.athoracsur.2004.09.033; Kitahara H, 2016, INTERACT CARDIOV TH, V22, P571, DOI 10.1093/icvts/ivw022; Konakci KZ, 2005, EUR J CLIN INVEST, V35, P17; Leyh RG, 2003, ANN THORAC SURG, V75, P1457, DOI 10.1016/S0003-4975(02)04845-2; Moroni F, 2014, AM J STEM CELLS, V3, P1; Parnell A, 2009, HEART LUNG VESSEL, V1, P7; Perea-Gil I, 2015, AM J TRANSL RES, V7, P558; Quinn RW, 2011, ANN THORAC SURG, V92, P131, DOI 10.1016/j.athoracsur.2011.03.039; Rabkin-Aikawa E, 2004, J HEART VALVE DIS, V13, P841; Rana D, 2015, J TISSUE ENG REGEN M; Reimer JM, 2015, BIOMATERIALS, V62, P88, DOI 10.1016/j.biomaterials.2015.05.009; Sacks MS, 2009, J BIOMECH, V42, P1804, DOI 10.1016/j.jbiomech.2009.05.015; Schopka S, 2009, J BIOMED MATER RES B, V88B, P130, DOI 10.1002/jbm.b.31159; Sugimoto Hiroatsu, 2013, Cardiovasc Eng Technol, V4, P2; Syedain Z, 2015, BIOMATERIALS, V73, P175, DOI 10.1016/j.biomaterials.2015.09.016; Syedain ZH, 2013, TISSUE ENG PT A, V19, P759, DOI [10.1089/ten.tea.2012.0365, 10.1089/ten.TEA.2012.0365]; Takagi K, 2006, ARTIF ORGANS, V30, P233, DOI 10.1111/j.1525-1594.2006.00210.x; THUBRIKAR MJ, 1986, AM J CARDIOL, V58, P304, DOI 10.1016/0002-9149(86)90067-6; Tudorache I, 2007, J HEART VALVE DIS, V16, P567; White A, 2006, J BIOTECHNOL, V123, P504, DOI 10.1016/j.jbiotec.2005.12.033; Zhao Dong-e, 2003, Asian Cardiovasc Thorac Ann, V11, P153; Zoghbi WA, 2009, J AM SOC ECHOCARDIOG, V22, P975, DOI 10.1016/j.echo.2009.07.013	40	25	27	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0181614	10.1371/journal.pone.0181614	http://dx.doi.org/10.1371/journal.pone.0181614			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763463	Green Published, gold, Green Submitted			2022-12-26	WOS:000406766500015
J	Reinmuth, E; Parker, P; Aurbacher, J; Hogy, P; Dabbert, S				Reinmuth, Evelyn; Parker, Phillip; Aurbacher, Joachim; Hoegy, Petra; Dabbert, Stephan			Modeling perceptions of climatic risk in crop production	PLOS ONE			English	Article							LAND-USE; MANAGEMENT; IMPACTS; WATER; AGRICULTURE; IRRIGATION; ADAPTATION; AVERSION; INSIGHTS; SUPPORT	In agricultural production, land-use decisions are components of economic planning that result in the strategic allocation of fields. Climate variability represents an uncertainty factor in crop production. Considering yield impact, climatic influence is perceived during and evaluated at the end of crop production cycles. In practice, this information is then incorporated into planning for the upcoming season. This process contributes to attitudes toward climate-induced risk in crop production. In the literature, however, the subjective valuation of risk is modeled as a risk attitude toward variations in (monetary) outcomes. Consequently, climatic influence may be obscured by political and market influences so that risk perceptions during the production process are neglected. We present a utility concept that allows the inclusion of annual risk scores based on mid-season risk perceptions that are incorporated into field-planning decisions. This approach is exemplified and implemented for winter wheat production in the Kraichgau, a region in Southwest Germany, using the integrated bio-economic simulation model FARMACTOR and empirical data from the region. Survey results indicate that a profitability threshold for this crop, the level of "still-good yield" (sgy), is 69 dt ha-1 (regional mean Kraichgau sample) for a given season. This threshold governs the monitoring process and risk estimators. We tested the modeled estimators against simulation results using ten projected future weather time series for winter wheat production. The mid-season estimators generally proved to be effective. This approach can be used to improve the modeling of planning decisions by providing a more comprehensive evaluation of field-crop response to climatic changes from an economic risk point of view. The methodology further provides economic insight in an agrometeorological context where prices for crops or inputs are lacking, but farmer attitudes toward risk should still be included in the analysis.	[Reinmuth, Evelyn; Dabbert, Stephan] Univ Hohenheim, Sect Prod Theory & Resource Econ, Inst Farm Management, Stuttgart, Germany; [Parker, Phillip; Aurbacher, Joachim] Justus Liebig Univ Giessen, Inst Farm & Agribusiness Management, Giessen, Germany; [Hoegy, Petra] Univ Hohenheim, Inst Landscape & Plant Ecol, Stuttgart, Germany	University Hohenheim; Justus Liebig University Giessen; University Hohenheim	Reinmuth, E (corresponding author), Univ Hohenheim, Sect Prod Theory & Resource Econ, Inst Farm Management, Stuttgart, Germany.	evelyn_reinmuth@uni-hohenheim.de	Aurbacher, Joachim/G-5233-2014	Reinmuth, Evelyn/0000-0001-5281-2287; Hogy, Petra/0000-0002-4833-1381	Deutsche Forschungsgemeinschaft (DFG) as part of the Research Unit Agricultural Landscapes under Global Climate Change Processes and Feedbacks on a Regional Scale [FOR 1695]	Deutsche Forschungsgemeinschaft (DFG) as part of the Research Unit Agricultural Landscapes under Global Climate Change Processes and Feedbacks on a Regional Scale(German Research Foundation (DFG))	The scientific research is (was) supported by Deutsche Forschungsgemeinschaft (DFG) as part of the Research Unit Agricultural Landscapes under Global Climate Change Processes and Feedbacks on a Regional Scale (FOR 1695). Website: http://www.dfg.de/; Project website: https://klimawandel/uni-hohenheirn.de/.	[Anonymous], 2015, LEL STRUKTURDATEN LA; Antle JM, 2010, AM J AGR EC; ARROW KJ, 1964, REV ECON STUD, V31, P91, DOI 10.2307/2296188; Aurbacher J, 2013, AGR SYST, V119, P44, DOI 10.1016/j.agsy.2013.04.005; Aurbacher J, 2011, AGR SYST, V104, P470, DOI 10.1016/j.agsy.2011.03.004; Beddow JM, 2015, J ECON HIST, V75, P219, DOI 10.1017/S002205071500008X; Berger T, 2014, J AGR ECON, V65, P323, DOI 10.1111/1477-9552.12045; Biernath C, 2013, EUR J AGRON, V48, P74, DOI 10.1016/j.eja.2013.02.008; Biernath C, 2011, EUR J AGRON, V35, P71, DOI 10.1016/j.eja.2011.04.001; Bloomfield JP, 2006, SCI TOTAL ENVIRON, V369, P163, DOI 10.1016/j.scitotenv.2006.05.019; Crane TA, 2011, NJAS-WAGEN J LIFE SC, V57, P179, DOI 10.1016/j.njas.2010.11.002; Dorward A., 1997, Quarterly Journal of International Agriculture, V36, P317; Dorward A, 1999, AGR ECON-BLACKWELL, V21, P191, DOI 10.1016/S0169-5150(99)00018-3; Dury J, 2012, AGRON SUSTAIN DEV, V32, P567, DOI 10.1007/s13593-011-0037-x; DWD Climate Data Center (CDC), 2016, HIST DAIL STAT OBS T; Ewert F, 2015, ENVIRON MODELL SOFTW, V72, P287, DOI 10.1016/j.envsoft.2014.12.003; Finger R, 2013, ENVIRON MODELL SOFTW, V43, P169, DOI 10.1016/j.envsoft.2013.02.001; Finger R, 2012, GER J AGR ECON, V61, P30; Flichman G, 2014, BIOECONOMIC MODELING; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Gbetibouo GA, 2009, 00849 IFPRI ENV PROD; Godwin D, 1990, USERS GUIDE CERES WH; Groom B, 2008, APPL ECON, V40, P315, DOI 10.1080/00036840600592916; Hardaker J. B., 2004, Coping with risk in agriculture, DOI 10.1079/9780851998312.0000; Hardaker J. B., 1991, Review of Marketing and Agricultural Economics, V59, P9; Henseler M, 2009, AGR SYST, V100, P31, DOI 10.1016/j.agsy.2008.12.002; Hogy P, 2013, ENVIRON EXP BOT, V88, P11, DOI 10.1016/j.envexpbot.2011.12.007; HOEGY P, 2013, FOOD CHEM, V136, P1470, DOI DOI 10.1016/J.F00DCHEM.2012.09.056; Hogy P, 2008, J CEREAL SCI, V48, P580, DOI 10.1016/j.jcs.2008.01.006; Ingwersen J, 2011, AGR FOREST METEOROL, V151, P345, DOI 10.1016/j.agrformet.2010.11.010; Just DR, 2010, ANNU REV RESOUR ECON, V2, P13, DOI 10.1146/annurev.resource.012809.103902; Just DR, 2003, AM J AGR ECON, V85, P1234, DOI 10.1111/j.0092-5853.2003.00536.x; Just RE, 2003, AM J AGR ECON, V85, P1249, DOI 10.1111/j.0092-5853.2003.00538.x; Kahneman Daniel, 2000, CHOICES VALUES FRAME, P673, DOI DOI 10.1017/CBO9780511803475.038; Keating BA, 2003, EUR J AGRON, V18, P267, DOI 10.1016/S1161-0301(02)00108-9; Kellner U, 2012, GER J AGR ECON, V61, P1; Kreienkamp F, 2010, WR2010 EH5 1 A1B UBA; Lehmann N, 2013, LAND USE POLICY, V35, P119, DOI 10.1016/j.landusepol.2013.05.008; Lehmann N, 2013, AGR SYST, V117, P55, DOI 10.1016/j.agsy.2012.12.011; McCown RL, 2012, AGR SYST, V106, P33, DOI 10.1016/j.agsy.2011.10.005; MCCOWN RL, 1991, CLIMATIC RISK IN CROP PRODUCTION : MODELS AND MANAGEMENT FOR THE SEMIARID TROPICS AND SUBTROPICS, P383; Meier U, 2001, BBCH MONOGRAPH; Mirzaeitalarposhti R, 2017, CATENA, V149, P283, DOI 10.1016/j.catena.2016.10.001; Musssshoff O, 2011, MODERNES AGRAR MANAG; Nelson GC, 2014, AGR ECON-BLACKWELL, V45, P85, DOI 10.1111/agec.12091; Ortiz-Bobea A, 2013, AM J AGR ECON, V95, P244, DOI 10.1093/ajae/aas035; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Park P, 2015, J NEUROSURG-SPINE, V22, P374, DOI 10.3171/2014.9.SPINE131004; Parker PS, 2017, J AGRON CROP SCI, V203, P227, DOI 10.1111/jac.12182; PRATT JW, 1964, ECONOMETRICA, V32, P122, DOI 10.2307/1913738; Priesack E, 2006, NUTR CYCL AGROECOSYS, V75, P1, DOI 10.1007/s10705-006-9006-1; Reinmuth E, 2017, COMPUT ELECTRON AGR, V138, P29, DOI 10.1016/j.compag.2017.04.007; Ritchie J.T., 1991, AGRONOMY MONOGRAPH, V31, P31, DOI [10.2134/agronmonogr31.c3, DOI 10.2134/AGR0NM0N0GR31.C3]; Schmitz C, 2014, AGR ECON-BLACKWELL, V45, P69, DOI 10.1111/agec.12090; Schonhart M, 2011, AGR SYST, V104, P122, DOI 10.1016/j.agsy.2010.03.014; Schreinemachers P, 2011, ENVIRON MODELL SOFTW, V26, P845, DOI 10.1016/j.envsoft.2011.02.004; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; StataCorp, 2013, STATA STAT SOFTW REL; Stockle CO, 2003, EUR J AGRON, V18, P289, DOI 10.1016/S1161-0301(02)00109-0; Troost C, 2015, AM J AGR ECON, V97, P833, DOI 10.1093/ajae/aau076; White JW, 2011, FIELD CROP RES, V124, P357, DOI 10.1016/j.fcr.2011.07.001; WILLIAMS JR, 1989, T ASAE, V32, P497; Wizemann HD, 2015, METEOROL Z, V24, P39, DOI 10.1127/metz/2014/0618	63	1	1	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0181954	10.1371/journal.pone.0181954	http://dx.doi.org/10.1371/journal.pone.0181954			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC3VC	28763471	Green Published, Green Submitted, gold			2022-12-26	WOS:000406766500030
J	Punchik, B; Komarov, R; Gavrikov, D; Semenov, A; Freud, T; Kagan, E; Goldberg, Y; Press, Y				Punchik, Boris; Komarov, Roman; Gavrikov, Dmitry; Semenov, Anna; Freud, Tamar; Kagan, Ella; Goldberg, Yury; Press, Yan			Can home care for homebound patients with chronic heart failure reduce hospitalizations and costs?	PLOS ONE			English	Article							DISEASE MANAGEMENT PROGRAMS; TRANSITIONAL CARE; EPIDEMIOLOGY; READMISSIONS; STRATEGIES; MULTIDISCIPLINARY; INTERVENTION; RISK	Background Congestive heart failure (CHF), a common problem in adults, is associated with multiple hospitalizations, high mortality rates and high costs. Purpose To evaluate whether home care for homebound patients with CHF reduces healthcare service utilization and overall costs. Methods A retrospective study of healthcare utilization among homebound patients who received home care for CHF from 2012-1015. The outcome measures were number of hospital admissions per month, total number of hospitalization days and days for CHF only, emergency room visits, and overall costs. A comparison was conducted between the 6-month period prior to entry into home care and the time in home care. Results Over the study period 196 patients were treated by home care for CHF with a mean age of 79.4 +/- 9.5 years. 113 (57.7%) were women. Compared to the six months prior to home care, there were statistically significant decreases in hospitalizations (46.3%), in the number of total in-hospital days (28.7%), in the number of in-hospital days for CHF (66.7%), in emergency room visits (47%), and in overall costs (23.9%). Conclusion Home care for homebound adults with CHF can reduce healthcare utilization and healthcare costs.	[Punchik, Boris; Gavrikov, Dmitry; Semenov, Anna; Kagan, Ella; Goldberg, Yury; Press, Yan] Yasski Clin, Home Care Unit, Clalit Hlth Serv, Beer Sheva, Israel; [Punchik, Boris; Kagan, Ella] Ben Gurion Univ Negev, Div Hlth Community, Unit Community Geriatr, Beer Sheva, Israel; [Komarov, Roman; Gavrikov, Dmitry; Semenov, Anna] Clalit Hlth Serv, Kenion Ha Negev Towers, Beer Sheva, Israel; [Freud, Tamar; Press, Yan] Ben Gurion Univ Negev, Dept Family Med, Siaal Family Med & Primary Care Res Ctr, Fac Hlth Sci, Beer Sheva, Israel	Clalit Health Services; Ben Gurion University; Clalit Health Services; Ben Gurion University	Press, Y (corresponding author), Yasski Clin, Home Care Unit, Clalit Hlth Serv, Beer Sheva, Israel.; Press, Y (corresponding author), Ben Gurion Univ Negev, Dept Family Med, Siaal Family Med & Primary Care Res Ctr, Fac Hlth Sci, Beer Sheva, Israel.	yanpr@clalit.org.il	Freud, Tamar/D-7276-2016; Komarov, Roman/AAB-7631-2020	Punchik, Boris/0000-0002-1346-9874	Israel Association of Family Physicians	Israel Association of Family Physicians	This work was supported by the Israel Association of Family Physicians (htlp //www. woncaeurope.org/content/israel-association-family-physicians). There is no grant number. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosy AP, 2014, J AM COLL CARDIOL, V63, P1123, DOI 10.1016/j.jacc.2013.11.053; Bradley EH, 2013, CIRC-CARDIOVASC QUAL, V6, P444, DOI 10.1161/CIRCOUTCOMES.111.000101; Brannstrom M, 2014, EUR J HEART FAIL, V16, P1142, DOI 10.1002/ejhf.151; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Community- based care for the specialized management of heart failure, 2009, ONT HLTH TECHNOL ASS, V9, P1; Criteria Committee of the New York Heart Association, 1994, NOMENCLATURE CRITERI, V9th, P253; Curtis LH, 2008, ARCH INTERN MED, V168, P418, DOI 10.1001/archinternmed.2007.80; Dharmarajan K, 2013, JAMA-J AM MED ASSOC, V309, P355, DOI 10.1001/jama.2012.216476; Eastwood CA, 2014, CAN J CARDIOL, V30, P612, DOI 10.1016/j.cjca.2014.02.017; Eilat-Tsanani S, 2016, EUR J CARDIOVASC NUR, V15, pE78, DOI 10.1177/1474515115602677; Feltner C, 2014, ANN INTERN MED, V160, P774, DOI 10.7326/M14-0083; Fergenbaum Jennifer, 2015, J Cardiovasc Nurs, V30, pS44, DOI 10.1097/JCN.0000000000000235; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Jeon YH, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-77; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Kimmelstiel C, 2004, CIRCULATION, V110, P1450, DOI 10.1161/01.CIR.0000141562.22216.00; Maru S, 2015, INT J CARDIOL, V201, P368, DOI 10.1016/j.ijcard.2015.08.066; McAlister FA, 2004, J AM COLL CARDIOL, V44, P810, DOI 10.1016/j.jacc.2004.05.055; McAlister FA, 2001, AM J MED, V110, P378, DOI 10.1016/S0002-9343(00)00743-9; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x; Norton C, 2011, PROG CARDIOVASC DIS, V54, P78, DOI 10.1016/j.pcad.2011.04.002; Ponikowski P, 2014, ESC HEART FAIL, V1, P4, DOI 10.1002/ehf2.12005; Psotka MA, 2013, HEART FAIL CLIN, V9, P303, DOI 10.1016/j.hfc.2013.04.005; Roger VL, 2013, CIRC RES, V113, P646, DOI 10.1161/CIRCRESAHA.113.300268; Savard LA, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-194; Stewart S, 1999, LANCET, V354, P1077, DOI 10.1016/S0140-6736(99)03428-5; Takeda A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002752.pub3; Thomas R, 2013, HEART, V99, P233, DOI 10.1136/heartjnl-2012-302313; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Young JB, 2004, MED CLIN N AM, V88, P1135, DOI 10.1016/j.mcna.2004.06.001; Zhang B, 2013, J NEUROSCI, V33, P2639, DOI 10.1523/JNEUROSCI.4377-12.2013	32	8	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0182148	10.1371/journal.pone.0182148	http://dx.doi.org/10.1371/journal.pone.0182148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753675	gold, Green Submitted, Green Published			2022-12-26	WOS:000406579300052
J	Qin, C; Sun, YQ; Dong, YD				Qin, Chao; Sun, Yongqi; Dong, Yadong			A new computational strategy for identifying essential proteins based on network topological properties and biological information	PLOS ONE			English	Article							ESSENTIAL GENE IDENTIFICATION; SUBCELLULAR-LOCALIZATION; CENTRALITY; ORTHOLOGY; GENOME; INTERACTOME; INTEGRATION; PREDICTION; DATABASE	Essential proteins are the proteins that are indispensable to the survival and development of an organism. Deleting a single essential protein will cause lethality or infertility. Identifying and analysing essential proteins are key to understanding the molecular mechanisms of living cells. There are two types of methods for predicting essential proteins: experimental methods, which require considerable time and resources, and computational methods, which overcome the shortcomings of experimental methods. However, the prediction accuracy of computational methods for essential proteins requires further improvement. In this paper, we propose a new computational strategy named CoTB for identifying essential proteins based on a combination of topological properties, subcellular localization information and orthologous protein information. First, we introduce several topological properties of the protein-protein interaction (PPI) network. Second, we propose new methods for measuring orthologous information and subcellular localization and a new computational strategy that uses a random forest prediction model to obtain a probability score for the proteins being essential. Finally, we conduct experiments on four different Saccharomyces cerevisiae datasets. The experimental results demonstrate that our strategy for identifying essential proteins outperforms traditional computational methods and the most recently developed method, SON. In particular, our strategy improves the prediction accuracy to 89, 78, 79, and 85 percent on the YDIP, YMIPS, YMBD and YHQ datasets at the top 100 level, respectively.	[Qin, Chao; Sun, Yongqi; Dong, Yadong] Beijing Jiaotong Univ, Sch Comp & Informat Technol, Beijing Key Lab Traff Data Anal & Min, Beijing, Peoples R China	Beijing Jiaotong University	Sun, YQ (corresponding author), Beijing Jiaotong Univ, Sch Comp & Informat Technol, Beijing Key Lab Traff Data Anal & Min, Beijing, Peoples R China.	yqsun@bjtu.edu.cn	sun, yq/HGD-4468-2022; Dong, Yadong/GXG-3093-2022		National Natural Science Foundation of China [61572005, 61272004]; Fundamental Research Funds for the Central Universities [K17JB00220]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by NO.61572005, National Natural Science Foundation of China, www.nsfc.gov.cn, YQS CQ; NO.61272004, National Natural Science Foundation of China, www.nsfc.gov.cn, YQS; NO. K17JB00220, Fundamental Research Funds for the Central Universities, CQ YQS YDD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acencio ML, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-290; Binder JX, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau012; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cullen LM, 2005, IMMUNOL CELL BIOL, V83, P217, DOI 10.1111/j.1440-1711.2005.01332.x; Estrada E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056103; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Friedel CC, 2009, J COMPUT BIOL, V16, P971, DOI 10.1089/cmb.2009.0023; Furney SJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-3; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hu WQ, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030024; Issel-Tarver L, 2002, METHOD ENZYMOL, V350, P329, DOI 10.1016/S0076-6879(02)50972-1; Li GS, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1115-5; Li M, 2017, IEEE ACM T COMPUT BI, V14, P370, DOI 10.1109/TCBB.2015.2394487; Li M, 2016, TSINGHUA SCI TECHNOL, V21, P668, DOI 10.1109/TST.2016.7787009; Li M, 2016, CURR BIOINFORM, V11, P195, DOI 10.2174/1574893611666160125220905; Li M, 2015, IEEE ACM T COMPUT BI, V12, P372, DOI 10.1109/TCBB.2014.2361350; Li M, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-15; Li M, 2011, COMPUT BIOL CHEM, V35, P143, DOI 10.1016/j.compbiolchem.2011.04.002; Luo JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131418; Mewes HW, 2006, NUCLEIC ACIDS RES, V34, pD169, DOI 10.1093/nar/gkj148; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Peng W, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-87; Peng XQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130743; Proctor C.H., 1951, RES METHODS SOCIAL R, P561; Pu SY, 2007, PROTEOMICS, V7, P944, DOI 10.1002/pmic.200600636; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Qi XQ, 2012, INFORM SCIENCES, V194, P240, DOI 10.1016/j.ins.2011.12.027; Qin C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161042; Roemer T, 2003, MOL MICROBIOL, V50, P167, DOI 10.1046/j.1365-2958.2003.03697.x; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Tang XW, 2014, IEEE ACM T COMPUT BI, V11, P407, DOI 10.1109/TCBB.2013.2295318; Tang Y, 2015, BIOSYSTEMS, V127, P67, DOI 10.1016/j.biosystems.2014.11.005; Wang JX, 2012, IEEE ACM T COMPUT BI, V9, P1070, DOI 10.1109/TCBB.2011.147; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Yu HY, 2004, TRENDS GENET, V20, P227, DOI 10.1016/j.tig.2004.04.008; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858; Zhao BH, 2016, METHODS, V110, P54, DOI 10.1016/j.ymeth.2016.07.005; Zhong JC, 2015, TSINGHUA SCI TECHNOL, V20, P491, DOI 10.1109/TST.2015.7297748; Zhong JC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S4-S7	42	13	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0182031	10.1371/journal.pone.0182031	http://dx.doi.org/10.1371/journal.pone.0182031			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753682	Green Published, Green Submitted, gold			2022-12-26	WOS:000406579300043
J	Reddy, VB; Lerner, EA				Reddy, Vemuri B.; Lerner, Ethan A.			Activation of mas-related G-protein-coupled receptors by the house dust mite cysteine protease Der p1 provides a new mechanism linking allergy and inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELLS	Cysteine and serine proteases function via protease-activated and mas-related G-protein-coupled receptors (Mrgprs) to contribute to allergy and inflammation. Der p1 is a cysteine protease and major allergen from the house dust mite and is associated with allergic rhinitis and allergic asthma. Der p1 activates protease-activated receptor 2 and induces the release of the pro-inflammatory cytokine IL-6 from cells. However, the possibility that Der p1 acts on Mrgprs has not been considered. We report here that ratiometric calcium imaging reveals that Der p1 activates the human receptor MRGPRX1 and the mouse homolog MrgprC11, implicated previously in itch. Der p1 cleavage of N-terminal receptor peptides followed by site-directed mutagenesis of the cleavage sites links receptor activation to specific amino acid residues. Der p1 also induced the release of IL-6 from heterologous cells expressing MRGPRX1. In summary, activation of Mrgprs by the allergen Der p1 may contribute to inflammation.	[Lerner, Ethan A.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, 149,13th St, Charlestown, MA 02129 USA; Harvard Med Sch, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Lerner, EA (corresponding author), Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, 149,13th St, Charlestown, MA 02129 USA.	elerner@mgh.harvard.edu		Lerner, Ethan/0000-0001-5480-4133	NIAMS, National Institutes of Health [R01AR057744, R21AR067399]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057744, R21AR067399] Funding Source: NIH RePORTER	NIAMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIAMS, National Institutes of Health Grants R01AR057744 and R21AR067399. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Asokananthan N, 2002, J IMMUNOL, V169, P4572, DOI 10.4049/jimmunol.169.8.4572; Azimi E, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.89362; Elmariah SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099702; Kauffman Henk F, 2006, Clin Mol Allergy, V4, P5, DOI 10.1186/1476-7961-4-5; Liu Q, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001925; McNeil BD, 2015, NATURE, V519, P237, DOI 10.1038/nature14022; Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118; Reddy VB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8864; Sharlow ER, 2000, J CELL SCI, V113, P3093; Shi JB, 2010, ORL-J OTO-RHIN-LARYN, V72, P256, DOI 10.1159/000312687; Talbot S, 2015, NEURON, V87, P341, DOI 10.1016/j.neuron.2015.06.007	11	18	19	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17399	17406		10.1074/jbc.M117.787887	http://dx.doi.org/10.1074/jbc.M117.787887			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28768771	hybrid, Green Published			2022-12-26	WOS:000414009300021
J	Abdi, K; Chen, T; Klein, BA; Tai, AK; Coursen, J; Liu, XD; Skinner, J; Periasamy, S; Choi, Y; Kessler, BM; Palmer, RJ; Gittis, A; Matzinger, P; Duncan, MJ; Singh, NJ				Abdi, Kaveh; Chen, Tsute; Klein, Brian A.; Tai, Albert K.; Coursen, Jill; Liu, Xiangdong; Skinner, Jeff; Periasamy, Saravanan; Choi, Youngnim; Kessler, Benedikt M.; Palmer, Robert J.; Gittis, Apostolos; Matzinger, Polly; Duncan, Margaret J.; Singh, Nevil J.			Mechanisms by which Porphyromonas gingivalis evades innate immunity	PLOS ONE			English	Article							GINGIPAIN ADHESIN DOMAINS; OUTER-MEMBRANE PROTEIN; PERIODONTAL PATHOGEN; DENDRITIC CELLS; IN-VIVO; FUSOBACTERIUM-NUCLEATUM; SUBGINGIVAL PLAQUE; EPITHELIAL-CELLS; GUT MICROBIOTA; DIRECT REPEATS	The oral cavity is home to unique resident microbial communities whose interactions with host immunity are less frequently studied than those of the intestinal microbiome. We examined the stimulatory capacity and the interactions of two oral bacteria, Porphyromonas gingivalis (P. gingivalis) and Fusobacterium nucleatum (F. nucleatum), on Dendritic Cell (DC) activation, comparing them to the effects of the well-studied intestinal microbe Escherichia coli (E. coli). Unlike F. nucleatum and E. coli, P. gingivalis failed to activate DCs, and in fact silenced DC responses induced by F. nucleatum or E. coli. We identified a variant strain of P. gingivalis (W50) that lacked this immunomodulatory activity. Using biochemical approaches and whole genome sequencing to compare the two substrains, we found a point mutation in the hagA gene. This protein is though to be involved in the alteration of the PorSS/gingipain pathway, which regulates protein secretion into the extracellular environment. A proteomic comparison of the secreted products of the two substrains revealed enzymatic differences corresponding to this phenotype. We found that P. gingivalis secretes gingipain(s) that inactivate several key proinflammatory mediators made by DCs and/or T cells, but spare Interleukin-1 (IL-1) and GM-CSF, which can cause capillary leaks that serve as a source of the heme that P. gingivalis requires for its survival, and GM-CSF, which can cause epithelial-cell growth. Taken together, our results suggest that P. gingivalis has evolved potent mechanisms to modulate its virulence factors and dampen the innate immune response by selectively inactivating most proinflammatory cytokines.	[Abdi, Kaveh; Coursen, Jill; Skinner, Jeff; Matzinger, Polly] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Chen, Tsute; Klein, Brian A.; Duncan, Margaret J.] Forsyth Inst, Dept Microbiol, Cambridge, MA USA; [Tai, Albert K.] Tufts Univ, Sch Med, TUCF Genom, Boston, MA 02111 USA; [Liu, Xiangdong] NIAID, Immunoregulat Lab, NIH, Bldg 10, Bethesda, MD 20892 USA; [Periasamy, Saravanan] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD USA; [Choi, Youngnim] Seoul Natl Univ, Sch Dent & Dent Res Inst, Dept Oromaxillofacial Infect Immun, Seoul, South Korea; [Kessler, Benedikt M.] Univ Oxford, Nuffield Dept Clin Med, Target Discovery Inst, Oxford, England; [Gittis, Apostolos] NIAID, Res Technol Branch, NIH, Rockville, MD USA; [Singh, Nevil J.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Periasamy, Saravanan] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore, Singapore	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Forsyth Institute; Tufts University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Seoul National University (SNU); University of Oxford; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University System of Maryland; University of Maryland Baltimore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Abdi, K (corresponding author), NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA.	kabdi@niaid.nih.gov	periasamy, saravanan/AAF-2860-2020; Kessler, Benedikt/AAY-8614-2021; Palmer, Robert/L-6601-2019; Chen, Tsute/ABC-2676-2020; Choi, Youngnim/AAL-8140-2020	Kessler, Benedikt/0000-0002-8160-2446; Choi, Youngnim/0000-0002-6496-5560; Skinner, Jeff/0000-0001-5697-0442; Singh, Nevil/0000-0002-8384-9290	Intramural Research Program at the National Institutes of Health, National Institute of Allergy and Infectious Diseases; NIAID [R21A1126184, R01A1110719]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000581, R01AI110719, ZICAI001051] Funding Source: NIH RePORTER	Intramural Research Program at the National Institutes of Health, National Institute of Allergy and Infectious Diseases; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Intramural Research Program at the National Institutes of Health, National Institute of Allergy and Infectious Diseases supported this work. N.J.S. is funded by the NIAID extramural grants R21A1126184 and R01A1110719. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Abdi K, 2006, SCAND J IMMUNOL, V64, P83, DOI 10.1111/j.1365-3083.2006.01767.x; Abdi K, 2014, J IMMUNOL, V192, P6028, DOI 10.4049/jimmunol.1400159; Abdi K, 2012, J IMMUNOL, V188, P5981, DOI 10.4049/jimmunol.1102868; Abe N, 2004, BIOL CHEM, V385, P1041, DOI 10.1515/BC.2004.135; Belanger M, 2012, ANAEROBE, V18, P128, DOI 10.1016/j.anaerobe.2011.10.005; BRAUNSTEIN S, 1994, J INVEST DERMATOL, V103, P601, DOI 10.1111/1523-1747.ep12396936; Brook I, 2000, J MED MICROBIOL, V49, P827, DOI 10.1099/0022-1317-49-9-827; Bucht A, 1996, CLIN EXP IMMUNOL, V103, P357; Calkins CC, 1998, J BIOL CHEM, V273, P6611, DOI 10.1074/jbc.273.12.6611; CHAIM W, 1992, ARCH GYNECOL OBSTET, V251, P1, DOI 10.1007/BF02718272; Chen T, 2004, MICROB PATHOGENESIS, V36, P205, DOI 10.1016/j.micpath.2003.12.001; Darveau RP, 2009, DNA CELL BIOL, V28, P389, DOI 10.1089/dna.2009.0864; Dashper SG, 2004, ORAL MICROBIOL IMMUN, V19, P50, DOI 10.1046/j.0902-0055.2003.00113.x; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Fitzpatrick RE, 2009, FUTURE MICROBIOL, V4, P471, DOI 10.2217/FMB.09.18; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Gibson FC, 2005, J PERIODONTOL, V76, P1629, DOI 10.1902/jop.2005.76.10.1629; Haffajee AD, 1998, J CLIN PERIODONTOL, V25, P346, DOI 10.1111/j.1600-051X.1998.tb02454.x; Hajishengallis G, 2007, J IMMUNOL, V179, P2359, DOI 10.4049/jimmunol.179.4.2359; Hajishengallis G, 2016, TRENDS MICROBIOL, V24, P477, DOI 10.1016/j.tim.2016.02.010; Hajishengallis G, 2014, EUR J IMMUNOL, V44, P328, DOI 10.1002/eji.201344202; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Han NM, 1996, INFECT IMMUN, V64, P4000, DOI 10.1128/IAI.64.10.4000-4007.1996; Jotwani R, 2003, EUR J IMMUNOL, V33, P2980, DOI 10.1002/eji.200324392; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Koornstra JJ, 1998, BRIT J RHEUMATOL, V37, P1249; Kozarov E, 1998, INFECT IMMUN, V66, P4721, DOI 10.1128/IAI.66.10.4721-4725.1998; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Manichanh C, 2012, NAT REV GASTRO HEPAT, V9, P599, DOI 10.1038/nrgastro.2012.152; NAKAYAMA K, 1995, J BIOL CHEM, V270, P23619, DOI 10.1074/jbc.270.40.23619; Nguyen KA, 2004, INFECT IMMUN, V72, P1374, DOI 10.1128/IAI.72.3.1374-1382.2004; Olczak T, 2005, FEMS MICROBIOL REV, V29, P119, DOI 10.1016/j.femsre.2004.09.001; Palm E, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-155; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Periasamy S, 2009, J BACTERIOL, V191, P6804, DOI 10.1128/JB.01006-09; PIKE R, 1994, J BIOL CHEM, V269, P406; POTEMPA J, 1995, INFECT IMMUN, V63, P1176, DOI 10.1128/IAI.63.4.1176-1182.1995; Pulendran B, 2001, J IMMUNOL, V167, P5067, DOI 10.4049/jimmunol.167.9.5067; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Rangarajan M, 2008, J BACTERIOL, V190, P2920, DOI 10.1128/JB.01868-07; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Reed J. A. Huffman, 1997, AM J PHYSIOL, V273, pL715; Roberts GL, 2000, BRIT J BIOMED SCI, V57, P156; Saiki K, 2014, MOL ORAL MICROBIOL, V29, P32, DOI 10.1111/omi.12043; Sandros J, 2000, J DENT RES, V79, P1808, DOI 10.1177/00220345000790101301; Shin JE, 2013, IMMUNOL CELL BIOL, V91, P503, DOI 10.1038/icb.2013.35; Slakeski N, 2002, ORAL MICROBIOL IMMUN, V17, P150, DOI 10.1034/j.1399-302X.2002.170303.x; SMITH JW, 1993, NEW ENGL J MED, V328, P756, DOI 10.1056/NEJM199303183281103; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Stathopoulou PG, 2010, J CLIN PERIODONTOL, V37, P24, DOI 10.1111/j.1600-051X.2009.01505.x; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Veith PD, 2002, BIOCHEM J, V363, P105, DOI 10.1042/0264-6021:3630105; WOOLDRIDGE KG, 1993, FEMS MICROBIOL REV, V12, P325, DOI 10.1016/0168-6445(93)90011-W; Yasaki-Inagaki Y, 2006, FEMS IMMUNOL MED MIC, V47, P287, DOI 10.1111/j.1574-695X.2006.00091.x; YI ES, 1992, AM J PATHOL, V140, P659	57	19	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182164	10.1371/journal.pone.0182164	http://dx.doi.org/10.1371/journal.pone.0182164			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771533	gold, Green Published, Green Submitted			2022-12-26	WOS:000406853600071
J	Tikhomirova, VE; Kost, OA; Kryukova, OV; Golukhova, EZ; Bulaeva, NI; Zholbaeva, AZ; Bokeria, LA; Garcia, JGN; Danilov, SM				Tikhomirova, Victoria E.; Kost, Olga A.; Kryukova, Olga V.; Golukhova, Elena Z.; Bulaeva, Naida I.; Zholbaeva, Aigerim Z.; Bokeria, Leo A.; Garcia, Joe G. N.; Danilov, Sergei M.			ACE phenotyping in human heart	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; MONOCLONAL-ANTIBODIES; ATRIAL-FIBRILLATION; INHIBITION; GLYCOSYLATION; EXPRESSION; SYSTEM; DOMAIN; SITES	Aims Angiotensin-converting enzyme (ACE), which metabolizes many peptides and plays a key role in blood pressure regulation and vascular remodeling, is expressed as a type-1 membrane glycoprotein on the surface of different cells, including endothelial cells of the heart. We hypothesized that the local conformation and, therefore, the properties of heart ACE could differ from lung ACE due to different microenvironment in these organs. Methods and results We performed ACE phenotyping (ACE levels, conformation and kinetic characteristics) in the human heart and compared it with that in the lung. ACE activity in heart tissues was 10-15 lower than that in lung. Various ACE effectors, LMW endogenous ACE inhibitors and HMW ACE-binding partners, were shown to be present in both heart and lung tissues. "Conformational fingerprint" of heart ACE (i.e., the pattern of 17 mAbs binding to different epitopes on the ACE surface) significantly differed from that of lung ACE, which reflects differences in the local conformations of these ACEs, likely controlled by different ACE glycosylation in these organs. Substrate specificity and pH-optima of the heart and lung ACEs also differed. Moreover, even within heart the apparent ACE activities, the local ACE conformations, and the content of ACE inhibitors differ in atria and ventricles. Conclusions Significant differences in the local conformations and kinetic properties of heart and lung ACEs demonstrate tissue specificity of ACE and provide a structural base for the development of mAbs able to distinguish heart and lung ACEs as a potential blood test for predicting atrial fibrillation risk.	[Tikhomirova, Victoria E.; Kost, Olga A.; Kryukova, Olga V.] Moscow MV Lomonosov State Univ, Chem Fac, Moscow, Russia; [Tikhomirova, Victoria E.; Kost, Olga A.; Kryukova, Olga V.; Golukhova, Elena Z.; Bulaeva, Naida I.; Zholbaeva, Aigerim Z.; Bokeria, Leo A.] Bakulev Ctr Cardiovasc Surg, Moscow, Russia; [Garcia, Joe G. N.; Danilov, Sergei M.] Univ Arizona Hlth Sci, Tucson, AZ 85721 USA; [Danilov, Sergei M.] Univ Illinois, Dept Anesthesiol, Chicago, IL 60607 USA	Lomonosov Moscow State University; Russian Academy of Medical Sciences; Bakulev Scientific Center for Cardiovascular Surgery; University of Arizona; University of Arizona Health Sciences; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kost, OA (corresponding author), Moscow MV Lomonosov State Univ, Chem Fac, Moscow, Russia.; Kost, OA (corresponding author), Bakulev Ctr Cardiovasc Surg, Moscow, Russia.; Danilov, SM (corresponding author), Univ Arizona Hlth Sci, Tucson, AZ 85721 USA.; Danilov, SM (corresponding author), Univ Illinois, Dept Anesthesiol, Chicago, IL 60607 USA.	olga.a.kost@gmail.com; danilov@uic.edu	Bulaeva, Naida/L-6748-2018; Tikhomirova, Victoria/E-4966-2019; Golukhova, Elena/Q-1768-2015	Tikhomirova, Victoria/0000-0003-4368-3430; Golukhova, Elena/0000-0002-6252-0322; Bulaeva, Naida/0000-0002-5091-0518	Ministry of Science and Education of Russian Federation [14.Z50.31.0026]	Ministry of Science and Education of Russian Federation(Ministry of Education and Science, Russian Federation)	This work was supported by the Ministry of Science and Education of Russian Federation [grant number 14.Z50.31.0026].; This work was supported by the Ministry of Science and Education of Russian Federation (grant number 14.Z50.31.0026).	ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; Balyasnikova IV, 2007, J PROTEOME RES, V6, P1580, DOI 10.1021/pr060658x; Bernstein KE, 2013, PHARMACOL REV, V65, P1, DOI 10.1124/pr.112.006809; Brogren H, 2008, THROMB RES, V122, P271, DOI 10.1016/j.thromres.2008.04.008; CALDWELL PRB, 1976, SCIENCE, V191, P1050, DOI 10.1126/science.175444; Csato A V, 2014, PLOS ONE, V9; DANILOV S, 1994, J BIOL CHEM, V269, P26806; Danilov SM, 2008, J CARDIOVASC PHARM, V52, P90, DOI 10.1097/FJC.0b013e31817fd3bc; Danilov SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep34913; Danilov SM, 2010, J PROTEOME RES, V9, P5782, DOI 10.1021/pr100564r; DANSER AHJ, 1995, CIRCULATION, V92, P1387, DOI 10.1161/01.CIR.92.6.1387; Ehrlich JR, 2006, EUR HEART J, V27, P512, DOI 10.1093/eurheartj/ehi668; FABRIS B, 1990, BRIT J PHARMACOL, V100, P651, DOI 10.1111/j.1476-5381.1990.tb15862.x; FALKENHAHN M, 1995, HYPERTENSION, V25, P219, DOI 10.1161/01.HYP.25.2.219; Ferrario CM, 2010, HYPERTENSION, V55, P445, DOI 10.1161/HYPERTENSIONAHA.109.145839; Fleming I, 2006, CIRC RES, V98, P887, DOI 10.1161/01.RES.0000217340.40936.53; Garats EV, 2001, BIOCHEMISTRY-MOSCOW+, V66, P429, DOI 10.1023/A:1010205614096; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Goette A, 2000, J AM COLL CARDIOL, V35, P1669, DOI 10.1016/S0735-1097(00)00611-2; HARRIS RB, 1985, PEPTIDES, V6, P393, DOI 10.1016/0196-9781(85)90102-0; Hennig R, 2016, BBA-GEN SUBJECTS, V1860, P1728, DOI 10.1016/j.bbagen.2016.03.035; HOLMQUIST B, 1979, ANAL BIOCHEM, V95, P540, DOI 10.1016/0003-2697(79)90769-3; IKEMOTO F, 1989, BIOCHEM BIOPH RES CO, V159, P1093, DOI 10.1016/0006-291X(89)92221-3; Iravanian S, 2008, HEART RHYTHM, V5, pS12, DOI 10.1016/j.hrthm.2008.02.025; JASPARD E, 1993, J BIOL CHEM, V268, P9496; Kalinska M, 2016, BIOCHIMIE, V122, P270, DOI 10.1016/j.biochi.2015.09.023; Kasi VS, 2007, AM J PHYSIOL-HEART C, V293, pH182, DOI 10.1152/ajpheart.00684.2006; Kryukova OV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143455; Metzger R, 2011, MICROVASC RES, V81, P206, DOI 10.1016/j.mvr.2010.12.003; Naperova IA, 2008, J PROTEOME RES, V7, P3396, DOI 10.1021/pr800142w; Orth T, 1998, FEBS LETT, V431, P255, DOI 10.1016/S0014-5793(98)00767-4; Rasoul S, 2004, J HYPERTENS, V22, P593, DOI 10.1097/00004872-200403000-00023; Rice GI, 2004, BIOCHEM J, V383, P45, DOI 10.1042/BJ20040634; Ryan J W, 1979, Adv Exp Med Biol, V120B, P599; SAKHAROV IY, 1988, BIOCHEM BIOPH RES CO, V151, P109, DOI 10.1016/0006-291X(88)90565-7; Salvesen G., 2012, HDB PROTEOLYTIC ENZY, V3rd, P480; Shen XZ, 2007, AM J PATHOL, V170, P2122, DOI 10.2353/ajpath.2007.061205; SOUBRIER F, 1988, P NATL ACAD SCI USA, V85, P9386, DOI 10.1073/pnas.85.24.9386; STUDER R, 1994, J CLIN INVEST, V94, P301, DOI 10.1172/JCI117322; Thevananther S, 1999, CAN J PHYSIOL PHARM, V77, P216, DOI 10.1139/cjpp-77-3-216; VAGO T, 1992, BRIT J PHARMACOL, V107, P821, DOI 10.1111/j.1476-5381.1992.tb14530.x; Yu XC, 1997, J BIOL CHEM, V272, P3511, DOI 10.1074/jbc.272.6.3511	42	11	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0181976	10.1371/journal.pone.0181976	http://dx.doi.org/10.1371/journal.pone.0181976			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771512	Green Submitted, Green Published, gold			2022-12-26	WOS:000406853600051
J	Govindaraju, VK; Bodas, M; Vij, N				Govindaraju, Viren Kumar; Bodas, Manish; Vij, Neeraj			Cigarette smoke induced autophagy-impairment regulates AMD pathogenesis mechanisms in ARPE-19 cells	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME PATHWAY; PIGMENTED EPITHELIAL-CELLS; MACULAR DEGENERATION; OXIDATIVE-STRESS; EMPHYSEMA PATHOGENESIS; THERAPEUTIC STRATEGIES; PROTEIN AGGREGATION; SENESCENCE; EXPOSURE; DISEASES	Age related macular degeneration ( AMD) is one of the leading causes of blindness. Genetics, environmental insult, and age-related factors all play a key role in altering proteostasis, the homeostatic process regulating protein synthesis, degradation and processing. These factors also play a role in the pathogenesis of AMD and it has been well established that cigarette smoking (CS) initiates AMD pathogenic mechanisms. The primary goal of this study is to elucidate whether CS can induce proteostasis/autophagy-impairment in retinal pigment epithelial (RPE) cells. In our preliminary analysis, it was found that cigarette smoke extract (CSE) induces accumulation of ubiquitinated proteins in the insoluble protein fraction (p < 0.01), which was subsequently mitigated through cysteamine (p < 0.01) or fisetin (p < 0.05) treatment. Further, it was verified that these CSE induced ubiquitinated proteins accumulated in the peri-nuclear spaces (p < 0.05) that were cleared-off with cysteamine (p < 0.05) or fisetin (p < 0.05). Moreover, CSE-induced aggresome-formation (LC3B-GFP and Ub-RFP co-localization) and autophagy-flux impairment was significantly (p < 0.01) mitigated by cysteamine (p < 0.05) or fisetin (p < 0.05) treatment, indicating the restoration of CSE-mediated autophagy-impairment. CSE treatment was also found to induce intracellular reactive oxygen species (ROS, p < 0.001) while impacting cell viability (p < 0.001), which was quantified using CMH(2)DCFDA-dye (ROS) and MTS (proliferation) or propodium iodide staining (cell viability) assays, respectively. Moreover, cysteamine and fisetin treatment ameliorated CS-mediated ROS production (p < 0.05) and diminished cell viability (p < 0.05). Lastly, CSE was found to induce cellular senescence (p < 0.001), which was significantly ameliorated by cysteamine (p < 0.001) or fisetin (p < 0.001). In conclusion, our study indicates that CS induced proteostasis/autophagy-impairment regulates mechanisms associated with AMD pathogenesis. Moreover, autophagy-inducing drugs such as cysteamine or fisetin can ameliorate AMD pathogenesis mechanisms that warrant further investigation in pre-clinical murine models.	[Govindaraju, Viren Kumar; Bodas, Manish; Vij, Neeraj] Cent Michigan Univ, Coll Med, Mt Pleasant, MI 48859 USA; [Vij, Neeraj] Johns Hopkins Univ, Sch Med, Dept Pediat & Pulm Med, Baltimore, MD 21218 USA	Central Michigan University; Johns Hopkins University	Vij, N (corresponding author), Cent Michigan Univ, Coll Med, Mt Pleasant, MI 48859 USA.; Vij, N (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat & Pulm Med, Baltimore, MD 21218 USA.	neeraj.vij@cmich.edu	Bodas, Manish/AAE-4016-2020	Bodas, Manish/0000-0002-1046-9799				Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Aryan Nona, 2016, Open Neurol J, V10, P83, DOI 10.2174/1874205X01610010083; Athanasiou D, 2013, FEBS LETT, V587, P2008, DOI 10.1016/j.febslet.2013.05.020; Bodas M, 2012, CURR MOL MED, V12, P807, DOI 10.2174/156652412801318809; Bodas M, 2017, ANTIOXID REDOX SIGNA; Bodas M, 2016, ANTIOXIDANTS REDOX S; Bodas M, 2016, FREE RADICAL BIO MED, V97, P441, DOI 10.1016/j.freeradbiomed.2016.06.017; Boya P, 2016, PROG RETIN EYE RES, V55, P206, DOI 10.1016/j.preteyeres.2016.08.001; Dantuma NP, 2014, FRONT MOL NEUROSCI, V7, DOI [10.3389/fnmo1.2014.00070, 10.3389/fnmol.2014.00070]; Ehrlich R, 2008, CLIN INTERV AGING, V3, P473; Ferrington DA, 2016, PROG RETIN EYE RES, V51, P69, DOI 10.1016/j.preteyeres.2015.09.002; Fujihara M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003119; Golestaneh N, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.453; Hanneken A, 2006, INVEST OPHTH VIS SCI, V47, P3164, DOI 10.1167/iovs.04-1369; Hytti M, 2017, J NUTR BIOCHEM, V42, P37, DOI 10.1016/j.jnutbio.2016.12.014; Hytti M, 2015, SCI REP-UK, V5, DOI 10.1038/srep17645; Tran I, 2015, AM J RESP CELL MOL, V53, P159, DOI 10.1165/rcmb.2014-0107OC; Kaarniranta K., 2016, CELL BIOL TOXICOL; Kaarniranta K, 2013, AUTOPHAGY, V9, P973, DOI 10.4161/auto.24546; Khan JC, 2006, BRIT J OPHTHALMOL, V90, P75, DOI 10.1136/bjo.2005.073643; Kim YS, 2016, INTEGR MED RES, V5, P22, DOI 10.1016/j.imr.2016.01.001; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kozlowski MR, 2012, MED HYPOTHESES, V78, P505, DOI 10.1016/j.mehy.2012.01.018; Liu ZZ, 2014, ADV EXP MED BIOL, V801, P237, DOI 10.1007/978-1-4614-3209-8_31; Martini-Stoica H, 2016, TRENDS NEUROSCI, V39, P221, DOI 10.1016/j.tins.2016.02.002; ME, 2011, INVEST OPHTH VIS SCI, V52, P3842; Min T, 2011, J MOL MED, V89, P577, DOI 10.1007/s00109-011-0732-8; Mitter SK, 2014, AUTOPHAGY, V10, P1989, DOI 10.4161/auto.36184; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Myers CE, 2014, OPHTHALMOLOGY, V121, P1949, DOI 10.1016/j.ophtha.2014.04.040; Park JS, 2016, FREE RADICAL RES, V50, P1408, DOI 10.1080/10715762.2016.1253073; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Shivalingappa PC, 2015, ANTIOXIDANTS REDOX S; Sigler EJ, 2014, EYE, V28, P838, DOI 10.1038/eye.2014.100; Tanida I, 2010, METHODS MOL BIOL, V648, P193, DOI 10.1007/978-1-60761-756-3_13; van Rijt SH, 2012, AM J PHYSIOL-LUNG C, V303, pL814, DOI 10.1152/ajplung.00128.2012; Vij N, 2016, AM J RESP CRIT CARE, V193; Wang L, 2014, FREE RADICAL BIO MED, V70, P155, DOI 10.1016/j.freeradbiomed.2014.01.015; Woodell A, 2014, ADV EXP MED BIOL, V801, P301, DOI 10.1007/978-1-4614-3209-8_38; Yu AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048501; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zhan J, 2016, CURR MOL MED, V16, P487, DOI 10.2174/1566524016666160429121606; Zhang XJ, 2013, ACTA PHARMACOL SIN, V34, P595, DOI 10.1038/aps.2012.184; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhu DH, 2009, J BIOL CHEM, V284, P9529, DOI 10.1074/jbc.M809393200	47	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182420	10.1371/journal.pone.0182420	http://dx.doi.org/10.1371/journal.pone.0182420			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767736	Green Published, Green Submitted, gold			2022-12-26	WOS:000406768200081
J	Janovick, JA; Spicer, TP; Bannister, TD; Scampavia, L; Conn, PM				Janovick, Jo Ann; Spicer, Timothy P.; Bannister, Thomas D.; Scampavia, Louis; Conn, P. Michael			Pharmacoperone rescue of vasopressin 2 receptor mutants reveals unexpected constitutive activity and coupling bias	PLOS ONE			English	Article							NEPHROGENIC DIABETES-INSIPIDUS; UNFOLDED PROTEIN RESPONSE; 2ND INTRACELLULAR LOOP; HORMONE RECEPTOR; PHARMACOLOGICAL CHAPERONES; ENDOPLASMIC-RETICULUM; MOLECULAR-BASIS; GNRHR MUTANTS; HELA-CELLS; ACTIVATION	Pharmacoperones are small molecules that diffuse into cells and rescue misfolded, mistrafficked protein mutants, restoring their function. These substances act with high target specificity, serving as templates to fold (or refold) receptors, enzymes, ion channels or other proteins and enable them to pass the scrutiny of the cellular quality control system ("rescue"). In the present study we demonstrate that a rescued mutant (L83Q) of the vasopressin type 2 receptor (V2R), shows a strong bias for Gs coupling unlike the WT V2 receptor, which couples to both Gs and Gq/11. Failure of the mutant to couple to Gq/11 was not due to a limiting quantity of G-proteins since other Gq/11-coupled receptors (WT V2R, histamine receptor and muscarinic receptor) responded appropriately to their ligands. Transfection with DNA encoding Gq enabled the V2 receptor mutant to couple to this G protein, but only modestly compared with the WT receptor. Fourteen V2R mutant pharmacoperones, of multiple chemical classes, obtained from a high throughput screen of a 660,000 structure library, and one V2R peptidomimetic antagonist rescues L83Q. The rescued mutant shows similar bias with all pharmacoperones identified, suggesting that the bias is intrinsic to the mutant protein's structure, rather than due to the chemical class of the pharmacoperone. In the case of V2R mutant Y128S, rescue with a pharmacoperone revealed constitutive activity, also with bias for Gs, although both IP and cAMP were produced in response to agonist. These results suggest that particular rescued receptor mutants show functional characteristics that differ from the WT receptor; a finding that may be important to consider as pharmacoperones are developed as therapeutic agents.	[Janovick, Jo Ann; Conn, P. Michael] Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, Lubbock, TX 79430 USA; [Janovick, Jo Ann; Conn, P. Michael] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol Biochem, Lubbock, TX 79430 USA; [Spicer, Timothy P.; Scampavia, Louis] Scripps Res Inst, Lead Identificat Div, Translat Res Inst, Jupiter, FL USA; [Spicer, Timothy P.; Scampavia, Louis] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL USA; [Bannister, Thomas D.] Scripps Res Inst, Dept Chem, Jupiter, FL USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Janovick, JA (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, Lubbock, TX 79430 USA.; Janovick, JA (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol Biochem, Lubbock, TX 79430 USA.	jody.janovick@ttuhsc.edu			National Institutes of Health (NIDDK) [DK099090]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099090] Funding Source: NIH RePORTER	National Institutes of Health (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (NIDDK) DK099090, https:// www.niddk.nih.gov (PMC, LS). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ala Y, 1998, J AM SOC NEPHROL, V9, P1861; Armstrong SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065885; Arora KK, 1997, MOL ENDOCRINOL, V11, P1203, DOI 10.1210/me.11.9.1203; Bartoszewski R, 2008, AM J RESP CELL MOL, V39, P448, DOI 10.1165/rcmb.2008-0065OC; Beaumont KA, 2007, HUM MOL GENET, V16, P2249, DOI 10.1093/hmg/ddm177; Bernier V, 2006, J AM SOC NEPHROL, V17, P232, DOI 10.1681/ASN.2005080854; Bichet DG, 2006, ADV CHRONIC KIDNEY D, V13, P96, DOI 10.1053/j.ackd.2006.01.006; Biebermann H, 2003, DIABETES, V52, P2984, DOI 10.2337/diabetes.52.12.2984; Birnbaumer R, 1999, ARCH MED RES, V30, P465, DOI 10.1016/S0188-4409(99)00063-6; Brothers SP, 2004, MOL ENDOCRINOL, V18, P1787, DOI 10.1210/me.2004-0091; CHEUNG AH, 1991, FEBS LETT, V279, P277, DOI 10.1016/0014-5793(91)80167-2; Chini B, 2007, BIOCHEM SOC T, V35, P737, DOI 10.1042/BST0350737; Conn PM, 2007, PHARMACOL REV, V59, P225, DOI 10.1124/pr.59.3.2; Conn PM, 2011, ADV PHARMACOL, V62, P109, DOI 10.1016/B978-0-12-385952-5.00008-7; Conn PM, 2009, TRENDS PHARMACOL SCI, V30, P228, DOI 10.1016/j.tips.2009.02.002; Conn PM, 2009, MOL CELL ENDOCRINOL, V299, P137, DOI 10.1016/j.mce.2008.10.051; Duvernay MT, 2009, TRAFFIC, V10, P552, DOI 10.1111/j.1600-0854.2009.00890.x; Gehret AU, 2006, J BIOL CHEM, V281, P20698, DOI 10.1074/jbc.M513642200; HARPER JF, 1975, J CYCLIC NUCL PROT, V1, P207; HAZAMA A, 1985, BIOCHIM BIOPHYS ACTA, V845, P249, DOI 10.1016/0167-4889(85)90183-1; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; HUCKLE WR, 1987, METHOD ENZYMOL, V141, P149; Ibrahim S, 2010, ARTERIOSCL THROM VAS, V30, P1802, DOI 10.1161/ATVBAHA.110.208900; Janovick JA, 2003, J PHARMACOL EXP THER, V305, P608, DOI 10.1124/jpet.102.048454; Janovick JA, 2007, MOL CELL ENDOCRINOL, V272, P77, DOI 10.1016/j.mce.2007.04.012; Janovick JA, 2016, MOL CELL ENDOCRINOL, V434, P176, DOI 10.1016/j.mce.2016.07.003; Janovick JA, 2013, P NATL ACAD SCI USA, V110, P21030, DOI 10.1073/pnas.1315194110; Janovick JA, 2012, MOL ENDOCRINOL, V26, P1179, DOI 10.1210/me.2012-1089; Janovick JA, 2011, J PHARMACOL EXP THER, V338, P430, DOI 10.1124/jpet.111.180869; Janovick JA, 2010, METHOD ENZYMOL, V485, P277, DOI [10.1016/S0076-6879(10)85016-5, 10.1016/B978-0-12-381296-4.00016-6]; Janovick JA, 2010, P NATL ACAD SCI USA, V107, P4454, DOI 10.1073/pnas.0914261107; Janovick JA, 2009, MOL ENDOCRINOL, V23, P157, DOI 10.1210/me.2008-0384; Jean-Alphonse F, 2009, J AM SOC NEPHROL, V20, P2190, DOI 10.1681/ASN.2008121289; Kamsteeg EJ, 1999, EMBO J, V18, P2394, DOI 10.1093/emboj/18.9.2394; Knoers NVAM, 2001, PEDIATR NEPHROL, V16, P1146, DOI 10.1007/s004670100051; Koenig JA, 1996, MOL PHARMACOL, V49, P351; Krestel HE, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e39; Krumins AM, 2006, J BIOL CHEM, V281, P10250, DOI 10.1074/jbc.M511551200; Leanos-Miranda A, 2003, J CLIN ENDOCR METAB, V88, P3360, DOI 10.1210/jc.2003-030084; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Liu J, 1996, J BIOL CHEM, V271, P8772, DOI 10.1074/jbc.271.15.8772; Lykke K, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12519; Martin NP, 2003, J BIOL CHEM, V278, P45954, DOI 10.1074/jbc.M308285200; Noorwez SM, 2003, J BIOL CHEM, V278, P14442, DOI 10.1074/jbc.M300087200; Parnell EA, 2012, LIFE SCI, V91, P1093, DOI 10.1016/j.lfs.2012.02.020; Robben JH, 2009, P NATL ACAD SCI USA, V106, P12195, DOI 10.1073/pnas.0900130106; Sanchez-Laorden BL, 2006, J INVEST DERMATOL, V126, P172, DOI 10.1038/sj.jid.5700036; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Smith E, 2016, J BIOMOL SCREEN, V21, P824, DOI 10.1177/1087057116653925; STANISLAUS D, 1994, ENDOCRINOLOGY, V135, P2220, DOI 10.1210/en.135.5.2220; Takahashi K, 2012, J BIOL CHEM, V287, P2099, DOI 10.1074/jbc.M111.268797; Tao YX, 2014, ENDOCR REV, V35, P602, DOI 10.1210/er.2013-1121; Tao Ya-Xiong, 2014, Adv Pharmacol, V70, P135, DOI 10.1016/B978-0-12-417197-8.00005-5; TILLY BC, 1990, BIOCHEM J, V266, P235, DOI 10.1042/bj2660235; Timossi C, 2002, MOL CELL ENDOCRINOL, V189, P157, DOI 10.1016/S0303-7207(01)00720-1; Tiulpakov A, 2016, MOL ENDOCRINOL, V30, P889, DOI 10.1210/me.2016-1002; Ulloa-Aguirre A, 2006, ACS CHEM BIOL, V1, P631, DOI 10.1021/cb600360h; Ulloa-Aguirre A, 2011, RECENT PATENTS ENDOC, V5, P13, DOI 10.2174/187221411794351851; VOLPI M, 1988, J CELL BIOL, V107, P2533, DOI 10.1083/jcb.107.6.2533; Witte I, 2011, METHOD ENZYMOL, V489, P127, DOI 10.1016/B978-0-12-385116-1.00008-X; Zarinan T, 2010, MOL CELL ENDOCRINOL, V321, P112, DOI 10.1016/j.mce.2010.02.027; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhu XY, 1998, BIOCHEMISTRY-US, V37, P15773, DOI 10.1021/bi981162z	63	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0181830	10.1371/journal.pone.0181830	http://dx.doi.org/10.1371/journal.pone.0181830			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767678	Green Published, gold, Green Submitted			2022-12-26	WOS:000406768200037
J	Mattison, CP; Khurana, T; Tarver, MR; Florane, CB; Grimm, CC; Pakala, SB; Cottone, CB; Riegel, C; Bren-Mattison, Y; Slater, JE				Mattison, Christopher P.; Khurana, Taruna; Tarver, Matthew R.; Florane, Christopher B.; Grimm, Casey C.; Pakala, Suman B.; Cottone, Carrie B.; Riegel, Claudia; Bren-Mattison, Yvette; Slater, Jay E.			Cross-reaction between Formosan termite (Coptotermes formosanus) proteins and cockroach allergens	PLOS ONE			English	Article							MAJOR SHRIMP ALLERGEN; IN-VITRO DIGESTION; SUBTERRANEAN TERMITE; IGE BINDING; DUST-MITE; ANTIBODY; TROPOMYOSIN; ASTHMA; ISOPTERA; INSECTS	Cockroach allergens can lead to serious allergy and asthma symptoms. Termites are evolutionarily related to cockroaches, cohabitate in human dwellings, and represent an increasing pest problem in the United States. The Formosan subterranean termite (Coptotermes formosanus) is one of the most common species in the southern United States. Several assays were used to determine if C. formosanus termite proteins cross-react with cockroach allergens. Expressed sequence tag and genomic sequencing results were searched for homology to cockroach allergens using BLAST 2.2.21 software. Whole termite extracts were analyzed by mass-spectrometry, immunoassay with IgG and scFv antibodies to cockroach allergens, and human IgE from serum samples of cockroach allergic patients. Expressed sequence tag and genomic sequencing results indicate greater than 60% similarity between predicted termite proteins and German and American cockroach allergens, including Bla g 2/Per a 2, Bla g 3/Per a 3, Bla g 5, Bla g 6/Per a 6, Bla g 7/Per a 7, Bla g 8, Per a 9, and Per a 10. Peptides from whole termite extract were matched to those of the tropomyosin (Bla g 7), arginine kinase (Per a 9), and myosin (Bla g 8) cockroach allergens by mass-spectrometry. Immunoblot and ELISA testing revealed cross-reaction between several proteins with IgG and IgE antibodies to cockroach allergens. Several termite proteins, including the hemocyanin and tropomyosin orthologs of Blag 3 and Bla g 7, were shown to cross-react with cockroach allergens. This work presents support for the hypothesis that termite proteins may act as allergens and the findings could be applied to future allergen characterization, epitope analysis, and clinical studies.	[Mattison, Christopher P.; Tarver, Matthew R.; Florane, Christopher B.; Grimm, Casey C.] ARS, Southern Reg Res Ctr, USDA, New Orleans, LA 70124 USA; [Khurana, Taruna] US FDA, Div Vaccines & Related Prod Applicat, Silver Spring, MD USA; [Pakala, Suman B.] J Craig Venter Inst, Rockville, MD USA; [Cottone, Carrie B.; Riegel, Claudia] New Orleans Mosquito Termite & Rodent Control Boa, New Orleans, LA USA; [Bren-Mattison, Yvette] BioMed Bridge LLC, Denver, CO USA; [Slater, Jay E.] US FDA, Div Bacterial Parasit & Allergen Prod, Silver Spring, MD USA; [Tarver, Matthew R.] Bayer CropSci, Biol, West Sacramento, CA USA; [Pakala, Suman B.] Univ Georgia, Paul D Coverdell Ctr, Athens, GA 30602 USA	United States Department of Agriculture (USDA); US Food & Drug Administration (FDA); J. Craig Venter Institute; US Food & Drug Administration (FDA); Bayer AG; Bayer CropScience; University System of Georgia; University of Georgia	Mattison, CP (corresponding author), ARS, Southern Reg Res Ctr, USDA, New Orleans, LA 70124 USA.	chris.mattison@ars.usda.gov	Bren-Mattison, Yvette/AAC-1137-2022	Pakala, Suman/0000-0001-5156-0823	U.S. Department of Agriculture-Agricultural Research Service; Center for Biologics Evaluation and Research, FDA; Bayer CropScience; BioMed Bridge, LLC	U.S. Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Center for Biologics Evaluation and Research, FDA; Bayer CropScience(Bayer AG); BioMed Bridge, LLC	This research was supported by funds from the U.S. Department of Agriculture-Agricultural Research Service and intramural funding from the Center for Biologics Evaluation and Research, FDA. The funders (Bayer CropScience and BioMed Bridge, LLC) have provided support in the form of salaries for authors [MRT, YBM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Mention of trade names, commercial products, or companies in this paper is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the U.S. Department of Agriculture.	Arruda L K, 2001, Curr Opin Pulm Med, V7, P14, DOI 10.1097/00063198-200101000-00003; Arruda LK, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0428-6; Arruda LK, 1995, J BIOL CHEM, V270, P31196, DOI 10.1074/jbc.270.52.31196; Ayuso R, 2002, INT ARCH ALLERGY IMM, V127, P27, DOI 10.1159/000048166; Ayuso R, 2010, J ALLERGY CLIN IMMUN, V125, P1286, DOI 10.1016/j.jaci.2010.03.010; Blackwell D., 2015, TABLES SUMMARY HLTH; Bloom B, 2010, VITAL HLTH STAT, V10; Busse WW, 2007, J ALLERGY CLIN IMMUN, V119, P43, DOI 10.1016/j.jaci.2006.10.021; Chapman MD, 2007, J ALLERGY CLIN IMMUN, V119, P414, DOI 10.1016/j.jaci.2006.11.001; Cookson W, 2011, J ALLERGY CLIN IMMUN, V128, P266, DOI 10.1016/j.jaci.2011.06.026; Dobrovolskaia E, 2006, CLIN EXP ALLERGY, V36, P525, DOI 10.1111/j.1365-2222.2006.02466.x; Fernandes J, 2003, CLIN EXP ALLERGY, V33, P956, DOI 10.1046/j.1365-2222.2003.01722.x; Gern JE, 2010, J ALLERGY CLIN IMMUN, V125, P545, DOI 10.1016/j.jaci.2010.01.037; Gore JC, 2007, ANNU REV ENTOMOL, V52, P439, DOI 10.1146/annurev.ento.52.110405.091313; Inward D, 2007, BIOL LETTERS, V3, P331, DOI 10.1098/rsbl.2007.0102; Jenkins JA, 2007, J ALLERGY CLIN IMMUN, V120, P1399, DOI 10.1016/j.jaci.2007.08.019; Khurana T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140225; Khurana T, 2014, J ALLERGY CLIN IMMUN, V133, pAB220, DOI 10.1016/j.jaci.2013.12.785; Khurana Taruna, 2013, Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess, V97, P37; Khurana T, 2014, ANN ALLERG ASTHMA IM, V112, P140, DOI 10.1016/j.anai.2013.11.007; Lopata AL, 2010, CLIN EXP ALLERGY, V40, P850, DOI 10.1111/j.1365-2222.2010.03513.x; Mattison CP, 2014, J AGR FOOD CHEM, V62, P6746, DOI 10.1021/jf501117p; Mattison CP, 2014, MOL NUTR FOOD RES, V58, P884, DOI 10.1002/mnfr.201300299; McGrew WC, 2014, J HUM EVOL, V71, P4, DOI 10.1016/j.jhevol.2013.07.016; Mueller GA, 2014, MOL IMMUNOL, V59, P200, DOI 10.1016/j.molimm.2014.02.003; Ntukuyoh A.I., 2012, INT J FOOD NUTR SAF, V1, P60; O'Malley RC, 2014, J HUM EVOL, V71, P46, DOI 10.1016/j.jhevol.2013.09.014; Olmedo O, 2011, J ALLERGY CLIN IMMUN, V128, P284, DOI 10.1016/j.jaci.2011.02.044; Paoletti MG, 2003, ECOL FOOD NUTR, V42, P177, DOI 10.1080/036702403902-2255177; Patterson ML, 2002, CLIN EXP ALLERGY, V32, P721, DOI 10.1046/j.1365-2222.2002.01397.x; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pomes A, 2007, PROTEIN PEPTIDE LETT, V14, P960, DOI 10.2174/092986607782541178; Rabito FA, 2007, J URBAN HEALTH, V84, P782, DOI 10.1007/s11524-007-9216-0; Rabito FA, 2011, ANN ALLERG ASTHMA IM, V106, P103, DOI 10.1016/j.anai.2010.10.013; Raubenheimer D, 2013, ANNU REV ENTOMOL, V58, P141, DOI 10.1146/annurev-ento-120710-100713; Renand A, 2014, J ALLERGY CLIN IMMUN, V134, P1456, DOI 10.1016/j.jaci.2014.07.048; Rothman JM, 2014, J HUM EVOL, V71, P59, DOI 10.1016/j.jhevol.2014.02.016; Rumpold BA, 2013, MOL NUTR FOOD RES, V57, P802, DOI 10.1002/mnfr.201200735; Santiago HC, 2011, J ALLERGY CLIN IMMUN, V127, P479, DOI 10.1016/j.jaci.2010.11.007; Sereda MJ, 2008, TRENDS PARASITOL, V24, P272, DOI 10.1016/j.pt.2008.03.006; Sereda MJ, 2010, ACTA TROP, V116, P61, DOI 10.1016/j.actatropica.2010.05.010; Slater JE, 2007, CLIN EXP ALLERGY, V37, P1033, DOI 10.1111/j.1365-2222.2007.02751.x; Srinroch C, 2015, FOOD CHEM, V184, P160, DOI 10.1016/j.foodchem.2015.03.094; SU NY, 1984, ENVIRON ENTOMOL, V13, P1466, DOI 10.1093/ee/13.6.1466; Su NY, 2003, SOCIOBIOLOGY, V41, P7; Su NY, 2002, SOCIOBIOLOGY, V40, P95; Szalanski AL, 2003, J ECON ENTOMOL, V96, P1514, DOI 10.1603/0022-0493-96.5.1514; Tan HSG, 2015, FOOD QUAL PREFER, V42, P78, DOI 10.1016/j.foodqual.2015.01.013; Tarver Matthew R., 2012, Insects, V3, P1190, DOI 10.3390/insects3041190; van Broekhoven S, 2016, FOOD CHEM, V196, P1075, DOI 10.1016/j.foodchem.2015.10.033; Verhoeckx KCM, 2014, FOOD CHEM TOXICOL, V65, P364, DOI 10.1016/j.fct.2013.12.049; Zhang D, 2012, INSECT MOL BIOL, V21, P235, DOI 10.1111/j.1365-2583.2011.01130.x; Zhang DH, 2009, INSECT BIOCHEM MOLEC, V39, P516, DOI 10.1016/j.ibmb.2009.03.006; Zheng LN, 2011, FOOD CHEM TOXICOL, V49, P2954, DOI 10.1016/j.fct.2011.07.043	54	7	7	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182260	10.1371/journal.pone.0182260	http://dx.doi.org/10.1371/journal.pone.0182260			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC3VT	28767688	Green Submitted, gold, Green Published			2022-12-26	WOS:000406768200060
J	Miret, M; Horvath-Puho, E; Deruaz-Luyet, A; Sorensen, HT; Ehrenstein, V				Miret, Montserrat; Horvath-Puho, Erzsebet; Deruaz-Luyet, Anouk; Sorensen, Henrik Toft; Ehrenstein, Vera			Potential paraneoplastic syndromes and selected autoimmune conditions in patients with non-small cell lung cancer and small cell lung cancer: A population-based cohort study	PLOS ONE			English	Article							NEUROLOGIC DISORDERS; NEUROENDOCRINE DIFFERENTIATION; CONSECUTIVE PATIENTS; ONCOLOGY; REGISTRY	Background Little is known about the occurrence and distribution of types of paraneoplastic syndromes (PNS) in patients with lung cancer. Identification of autoimmune PNS is particularly important for discerning them from immune-related adverse events of novel immunotherapies. We estimated the occurrence of PNS among patients with lung cancer and compared it with that in the general population. Methods In this registry-based cohort study in Denmark, we identified all patients with incident primary lung cancer between 1997 and 2010, and in a general-population comparison cohort matched on calendar time, sex, age, and residence. Among patients with non-small cell lung cancer (NSCLC) and small-cell lung cancer (SCLC), we estimated prevalence of potential PNS and selected autoimmune conditions and compared their incidence rates with those of equivalent conditions in the general population cohort, using hazard ratios (HRs) adjusted for baseline comorbidity. Results There were 35,319 patients with NSCLC and 6,711 patients with SCLC. The incidence rates per 1000 person-years (95% confidence interval) of any potential PNS or selected autoimmune disorders were 135.4 (131.9-139.1) among NSCLC patients and 237.3 (224.4-250.5) among SCLC patients. Adjusted HRs for any potential PNS or selected autoimmune disorders were 4.8 (4.7-5.0) for NSCLC and 8.2 (7.6-8.8) for SCLC. Conclusion Incidence rate of any potential PNS or selected autoimmune disorders among patients with lung cancer was greater than that in the general population and was greater after SCLC than after NSCLC.	[Miret, Montserrat] Nestle Hlth Sci, Vevey, Switzerland; [Horvath-Puho, Erzsebet; Sorensen, Henrik Toft; Ehrenstein, Vera] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark; [Deruaz-Luyet, Anouk] Boehringer Ingelheim GmbH & Co KG, Global Epidemiol, Ingelheim, Germany	Nestle SA; Aarhus University; Boehringer Ingelheim	Ehrenstein, V (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark.	ve@clin.au.dk	Sorensen, Henrik Toft/Z-6181-2019	Sorensen, Henrik Toft/0000-0003-4299-7040; Ehrenstein, Vera/0000-0002-3415-3254; Horvath-Puho, Erzsebet/0000-0002-3594-2212	Merck Serono S.A., Geneva, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany; Merck Serono S.A.; Program for Clinical Research Infrastructure (PROCRIN); Novo Nordisk Foundation	Merck Serono S.A., Geneva, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany; Merck Serono S.A.; Program for Clinical Research Infrastructure (PROCRIN); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This study was funded in part by a grant from Merck Serono S.A., Geneva, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany, to and administered by Aarhus University. Merck Serono S.A. provided support in the form of salaries for MM and ADL and in the form of institutional grants for VE, HTS, and EHP. While this study was in perpetration, MM became an employee of Nestle Health Science and received support in the form of salary. While this study was in perpetration, ADL became an employee of Boehringer Ingelheim and received support in the form of salary. HTS received support by the Program for Clinical Research Infrastructure (PROCRIN), established by the Lundbeck Foundation (Lundbeckfonden) and the Novo Nordisk Foundation, and administered by the Danish Regions. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Beasley MB, 2005, SEMIN ROENTGENOL, V40, P90, DOI 10.1053/j.ro.2005.01.001; Bertino EM, 2009, CANCER-AM CANCER SOC, V115, P4434, DOI 10.1002/cncr.24498; Bilynsky B. T., 2015, Experimental Oncology, V37, P82; Bishop AE, 2010, OXFORD TXB MED; Brahmer JR, 2013, CANCER IMMUNOL RES, V1, P85, DOI 10.1158/2326-6066.CIR-13-0078; Darnell RB, 2011, CONT NEUROLOGY SERIE, V79; Darnell RB, 2006, SEMIN ONCOL, V33, P270, DOI 10.1053/j.seminoncol.2006.03.008; DeVita VT., 2019, DEVITA HELLMAN ROSEN; Gandhi Leena, 2006, J Natl Compr Canc Netw, V4, P631; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Gozzard P, 2015, NEUROLOGY, V85, P235, DOI 10.1212/WNL.0000000000001721; Graus F, 2004, J NEUROL NEUROSUR PS, V75, P1135, DOI 10.1136/jnnp.2003.034447; Hauber H-P, 2011, Pneumologie, V65, P347, DOI 10.1055/s-0030-1256118; Heinemann S, 2008, CANC THER, V6, P687; Honnorat J, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-22; Howe MC, 2005, HISTOPATHOLOGY, V46, P195, DOI 10.1111/j.1365-2559.2005.02047.x; Jordan JT, 2016, JAMA NEUROL, V73, P907, DOI 10.1001/jamaneurol.2016.1564; Lahita R., 2000, TXB AUTOIMMUNE DIS; PATEL AM, 1993, MAYO CLIN PROC, V68, P278, DOI 10.1016/S0025-6196(12)60050-0; Pelosof LC, 2010, MAYO CLIN PROC, V85, P838, DOI 10.4065/mcp.2010.0099; RICHARDSON G E, 1992, Current Opinion in Oncology, V4, P323, DOI 10.1097/00001622-199204000-00014; Santacroce L, 2016, PARANEOPLASTIC SYNDR; Schleusener JT, 1996, CANCER-AM CANCER SOC, V77, P1284, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1284::AID-CNCR9>3.0.CO;2-I; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; SCULIER JP, 1987, CANCER, V60, P2275, DOI 10.1002/1097-0142(19871101)60:9<2275::AID-CNCR2820600929>3.0.CO;2-3; Seute T, 2004, CANCER-AM CANCER SOC, V100, P801, DOI 10.1002/cncr.20043; Spiro SG, 2007, CHEST, V132, p149S, DOI 10.1378/chest.07-1358; Suzuki H, 2013, J GASTROENTEROL, V48, P574, DOI 10.1007/s00535-013-0787-0; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Titulaer MJ, 2011, EUR J NEUROL, V18, P19, DOI 10.1111/j.1468-1331.2010.03220.x; Travis WD, 2010, ANN ONCOL, V21, P65, DOI 10.1093/annonc/mdq380; vanOosterhout AGM, 1996, CANCER, V77, P1434, DOI 10.1002/(SICI)1097-0142(19960415)77:8<1434::AID-CNCR3>3.0.CO;2-C; Zell JA, 2005, SUPPORT CARE CANCER, V13, P870, DOI 10.1007/s00520-005-0825-4	35	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0181564	10.1371/journal.pone.0181564	http://dx.doi.org/10.1371/journal.pone.0181564			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767671	Green Published, Green Submitted, gold			2022-12-26	WOS:000406768200028
J	van Esdonk, MJ; Tai, BN; Cotterill, A; Charles, B; Hennig, S				van Esdonk, Michiel Joost; Tai, Bonnie; Cotterill, Andrew; Charles, Bruce; Hennig, Stefanie			Prediction of glycaemic control in young children and adolescents with type 1 diabetes mellitus using mixed-effects logistic regression modelling	PLOS ONE			English	Article							METABOLIC-CONTROL; GROWTH-HORMONE; ADHERENCE; EDUCATION; HBA(1C)	Objectives Glycaemic control in children and adolescents with type 1 diabetes mellitus can be challenging, complex and influenced by many factors. This study aimed to identify patient characteristics that were predictive of satisfactory glycaemic control in the paediatric population using a logistic regression mixed-effects (population) modelling approach. Methods The data were obtained from 288 patients aged between 1 and 22 years old recorded retrospectively over 3 years (1852 HbA1c observations). HbA1c status was categorised as 'satisfactory' or 'unsatisfactory' glycaemic control, using an a priori cut-off value of HbA1c >= 9% (75 mmol/mol), as used routinely by the hospital's endocrine paediatricians. Patients' characteristics were tested as covariates in the model as potential predictors of glycaemic control. Results There were three patient characteristics identified as having a significant influence on glycaemic control: HbA1c measurement at the beginning of the observation period (Odds Ratio (OR) = 0.30 per 1% HbA1c increase, 95% confidence interval (CI) = 0.20-0.41); Age (OR = 0.88 per year increase, 95% CI = 0.80-0.94), and fractional disease duration (disease duration/age, OR = 0.80 per 0.10 increase, 95% CI = 0.66-0.93) were collectively identified as factors contributing significantly to lower the probability of satisfactory glycaemic control. Conclusions The study outcomes may prove useful for identifying paediatric patients at risk of having unsatisfactory glycaemic control, and who could require more extensive monitoring, support, or targeted interventions.	[van Esdonk, Michiel Joost; Charles, Bruce; Hennig, Stefanie] Univ Queensland, PACE, Sch Pharm, Woolloongabba, Qld, Australia; [Tai, Bonnie] Prince Charles Hosp, Pharm Dept, Chermside, Qld, Australia; [Cotterill, Andrew] Lady Cilento Childrens Hosp, South Brisbane & Queensland Paediat Endocrinol, Woolloongabba, Qld, Australia; [van Esdonk, Michiel Joost] Leiden Univ, Leiden Acad Ctr Drug Res, Cluster Syst Pharmacol, Div Pharmacol, Leiden, Netherlands	University of Queensland; Prince Charles Hospital; Leiden University; Leiden University - Excl LUMC	van Esdonk, MJ (corresponding author), Univ Queensland, PACE, Sch Pharm, Woolloongabba, Qld, Australia.; van Esdonk, MJ (corresponding author), Leiden Univ, Leiden Acad Ctr Drug Res, Cluster Syst Pharmacol, Div Pharmacol, Leiden, Netherlands.	m.j.van.esdonk@lacdr.leidenuniv.nl	Hennig, Stefanie/E-4426-2011; van Esdonk, Michiel Joost/Y-7595-2019	Hennig, Stefanie/0000-0001-5972-3711; van Esdonk, Michiel Joost/0000-0001-8159-0273				[Anonymous], 2000, BMC MED RES METHODOL; Bagley SC, 2001, J CLIN EPIDEMIOL, V54, P979, DOI 10.1016/S0895-4356(01)00372-9; Beal S, 1989, NONMEM USERS GUIDES; Bewick V, 2005, CRIT CARE, V9, P112, DOI 10.1186/cc3045; Borus JS, 2010, CURR OPIN PEDIATR, V22, P405, DOI 10.1097/MOP.0b013e32833a46a7; Chemtob CM, 2011, J DIABETES, V3, P153, DOI 10.1111/j.1753-0407.2011.00116.x; Clements MA, 2014, BMJ OPEN DIAB RES CA, V2, DOI 10.1136/bmjdrc-2014-000039; Couch Robert, 2008, Evid Rep Technol Assess (Full Rep), P1; DCCT Res Grp, 1994, J PEDIATR-US, V125, P177, DOI 10.1016/S0022-3476(94)70190-3; Duncan I, 2009, DIABETES EDUCATOR, V35, P752, DOI 10.1177/0145721709343609; Eeg-Olofsson K, 2007, DIABETES CARE, V30, P496, DOI 10.2337/dc06-1406; Ellis SE, 2004, PATIENT EDUC COUNS, V52, P97, DOI 10.1016/S0738-3991(03)00016-8; Ette EL, 2003, J CLIN PHARMACOL, V43, P610, DOI 10.1177/0091270003253624; FOWELIN J, 1995, DIABETIC MED, V12, P990, DOI 10.1111/j.1464-5491.1995.tb00411.x; Goodall I, 2010, RECOMMENDED CHANGES; Higgins T, 2012, CLIN BIOCHEM, V45, P1038, DOI 10.1016/j.clinbiochem.2012.06.006; Hosmer D. W., 2013, APPL LOGISTIC REGRES; IBM Corp, 2013, IBM SPSS STAT WINDOW; Jack L, 2003, DIABETES SPECTRUM, V16, P154, DOI DOI 10.2337/DIASPECT.16.3.154; Jones GRD, 2011, MED J AUSTRALIA, V195, P45, DOI 10.5694/j.1326-5377.2011.tb03190.x; Jorde R, 2000, DIABETIC MED, V17, P451, DOI 10.1046/j.1464-5491.2000.00295.x; Kalil AC, 2010, AM J TRANSPLANT, V10, P1686, DOI 10.1111/j.1600-6143.2010.03141.x; Kim H, 2012, J CLIN RES PEDIATR E, V4, P82, DOI [10.4274/Jcrpe.663, 10.4274/jcrpe.663]; LAURITZEN T, 1985, DIABETES, V34, P74, DOI 10.2337/diab.34.3.S74; Lindbom L, 2004, COMPUT METH PROG BIO, V75, P85, DOI 10.1016/j.cmpb.2003.11.003; Loveman E, 2003, HEALTH TECHNOL ASSES, V7, P1, DOI DOI 10.3310/HTA7220; McHugh ML, 2013, BIOCHEM MEDICA, V23, P143, DOI 10.11613/BM.2013.018; Mohammad Hanaa A, 2012, Indian J Endocrinol Metab, V16, P796, DOI 10.4103/2230-8210.100679; Mortensen HB, 1997, DIABETES CARE, V20, P714, DOI 10.2337/diacare.20.5.714; Motta M, 2010, ARCH GERONTOL GERIAT, V50, P60, DOI 10.1016/j.archger.2009.01.012; Mould DR, 2012, CPT-PHARMACOMET SYST, V1, DOI 10.1038/psp.2012.4; Patterson CC, 2012, DIABETOLOGIA, V55, P2142, DOI 10.1007/s00125-012-2571-8; R Core Team, 2014, LANG ENV STAT COMP; Rausch JR, 2012, DIABETES CARE, V35, P1219, DOI 10.2337/dc11-2163; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; ROSE SR, 1991, J CLIN ENDOCR METAB, V73, P428, DOI 10.1210/jcem-73-2-428; Rosenbauer J, 2012, DIABETES CARE, V35, P80, DOI 10.2337/dc11-0993; Rosilio M, 1998, DIABETES CARE, V21, P1146, DOI 10.2337/diacare.21.7.1146; RStudio, 2015, RSTUDIO INT DEV ENV; SHERWIN RS, 1984, NEW ENGL J MED, V311, P365, DOI 10.1056/NEJM198408093110604; Svensson M, 2004, DIABETES CARE, V27, P955, DOI 10.2337/diacare.27.4.955; Sweenie R, 2014, FAM SYST HEALTH, V32, P31, DOI 10.1037/fsh0000001; WHO, 2006, WHO CHILD GROWTH STA; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zou KH, 2007, CIRCULATION, V115, P654, DOI 10.1161/CIRCULATIONAHA.105.594929	45	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182181	10.1371/journal.pone.0182181	http://dx.doi.org/10.1371/journal.pone.0182181			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767734	gold, Green Published, Green Submitted			2022-12-26	WOS:000406768200052
J	Drumm, K; Liebst-Olsen, M; Daugbjerg, N; Moestrup, O; Hansen, PJ				Drumm, Kirstine; Liebst-Olsen, Mette; Daugbjerg, Niels; Moestrup, Ojvind; Hansen, Per Juel			Effects of irradiance and prey deprivation on growth, cell carbon and photosynthetic activity of the freshwater kleptoplastidic dinoflagellate Nusuttodinium (= Gymnodinium) aeruginosum (Dinophyceae)	PLOS ONE			English	Article							CILIATE MYRIONECTA-RUBRA; MESODINIUM-RUBRUM; AMYLAX-TRIACANTHA; GREEN NOCTILUCA; ENDOSYMBIONT; RETENTION; LIGHT; CHLOROPLASTS; PERFORMANCE; CILIOPHORA	The freshwater dinoflagellate Nusuttodinium aeruginosum lacks permanent chloroplasts. Rather it sequesters chloroplasts as well as other cell organelles, like mitochondria and nuclei, from ingested cryptophyte prey. In the present study, growth rates, cell production and photosynthesis were measured at seven irradiances, ranging from 10 to 140 pmol photons r(-2)S(-1), when fed the cryptophyte Chroomonas sp. Growth rates were positively influenced by irradiance and increased from 0.025 eat 10 pmol photons r(-2)S(-1) to maximum growth rates of similar to 0.3 d(-1) at irradiances > 40 pmol photons r(-2)S(-1). Similarly, photosynthesis ranged from 1.84 to 36.9 pg C cell(-1) h(-1) at 10 and 140 pmol photons r(-2)S(-1), respectively. The highest rates of photosynthesis in N. aeruginosum only corresponded to similar to 25% of its own cell carbon content and estimated biomass production. The measured rates of photosynthesis could not explain the observed growth rates at high irradiances. Cultures of N. aeruginosum subjected to prey starvation were able to survive for at least 27 days in the light. The sequestered chloroplasts maintained their photosynthetic activity during the entire period of starvation, during which the population underwent 4 cell divisions. This indicates that N. aeruginosum has some control of the chloroplasts, which may be able to replicate. In conclusion, N. aeruginosum seems to be in an early stage of chloroplast acquisition with some control of its ingested chloroplasts.	[Drumm, Kirstine; Liebst-Olsen, Mette; Daugbjerg, Niels; Moestrup, Ojvind; Hansen, Per Juel] Univ Copenhagen, Dept Biol, Marine Biol Sect, Copenhagen, Denmark	University of Copenhagen	Drumm, K (corresponding author), Univ Copenhagen, Dept Biol, Marine Biol Sect, Copenhagen, Denmark.	kirstinedrumm@bio.ku.dk	Hansen, Per J/E-9969-2011; Daugbjerg, Niels/D-3521-2014; Hansen, Per Juel/AAX-6193-2020; Drumm, Kirstine/D-4357-2016	Hansen, Per J/0000-0003-0228-9621; Daugbjerg, Niels/0000-0002-0397-3073; Hansen, Per Juel/0000-0003-0228-9621; Drumm, Kirstine/0000-0003-2287-9231	Carlsberg Foundation; Danish Council for Independent Research [4181-00484]	Carlsberg Foundation(Carlsberg Foundation); Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	ND thanks the Carlsberg Foundation for an equipment grant. This study was partly supported by the Danish Council for Independent Research, grant number 4181-00484 to PJH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cannella D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11134; Daugbjerg N, 2013, PROTIST, V164, P411, DOI 10.1016/j.protis.2012.10.001; Eriksen Niels T., 2002, Harmful Algae, V1, P191, DOI 10.1016/S1568-9883(02)00011-2; FIELDS SD, 1991, J PHYCOL, V27, P525, DOI 10.1111/j.0022-3646.1991.00525.x; Foster RA, 2006, J PHYCOL, V42, P453, DOI 10.1111/j.1529-8817.2006.00206.x; Gast RJ, 2007, ENVIRON MICROBIOL, V9, P39, DOI 10.1111/j.1462-2920.2006.01109.x; Guo ZV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101397; Hansen PJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00785; Hansen PJ, 2006, MAR BIOL RES, V2, P169, DOI 10.1080/17451000600719577; Hansen PJ, 2004, MAR ECOL PROG SER, V275, P79, DOI 10.3354/meps275079; Horiguchi Takeo, 1992, Japanese Journal of Phycology, V40, P353; Jakobsen HH, 2000, MAR ECOL PROG SER, V201, P121, DOI 10.3354/meps201121; Johnson MD, 2006, J PHYCOL, V42, P1235, DOI 10.1111/j.1529-8817.2006.00275.x; Johnson MD, 2007, NATURE, V445, P426, DOI 10.1038/nature05496; Johnson MD, 2005, AQUAT MICROB ECOL, V39, P303, DOI 10.3354/ame039303; Kim M, 2014, J EUKARYOT MICROBIOL, V61, P354, DOI 10.1111/jeu.12115; Kim M, 2012, J PHYCOL, V48, P569, DOI 10.1111/j.1529-8817.2012.01150.x; KLEIN B, 1986, J PLANKTON RES, V8, P827, DOI 10.1093/plankt/8.5.827; Koike K, 2008, PHYCOL RES, V56, P301, DOI 10.1111/j.1440-1835.2008.00512.x; LARSEN J, 1988, PHYCOLOGIA, V27, P366, DOI 10.2216/i0031-8884-27-3-366.1; Lewitus AJ, 1999, J PHYCOL, V35, P303, DOI 10.1046/j.1529-8817.1999.3520303.x; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; Moeller HV, 2011, J PHYCOL, V47, P324, DOI 10.1111/j.1529-8817.2010.00954.x; Nielsen LT, 2007, MAR BIOL RES, V3, P446, DOI 10.1080/17451000701711820; Onuma R, 2015, PROTIST, V166, P177, DOI 10.1016/j.protis.2015.01.004; PORRA RJ, 1997, PHYTOPLANKTON PIGMEN; Riisgaard K, 2009, MAR ECOL PROG SER, V381, P51, DOI 10.3354/meps07953; SCHNEPF E, 1989, PLANT SYST EVOL, V164, P75, DOI 10.1007/BF00940431; Skovgaard A, 1998, AQUAT MICROB ECOL, V15, P293, DOI 10.3354/ame015293; Skovgaard A, 2000, MAR ECOL PROG SER, V201, P129, DOI 10.3354/meps201129; Smith M, 2007, MAR ECOL PROG SER, V338, P61, DOI 10.3354/meps338061; STOECKER DK, 1991, MAR ECOL PROG SER, V73, P245, DOI 10.3354/meps073245; STOECKER DK, 1988, MAR BIOL, V99, P415, DOI 10.1007/BF02112135; Strom SL, 2001, AQUAT MICROB ECOL, V23, P253, DOI 10.3354/ame023253; SWEENEY BM, 1976, J PHYCOL, V12, P460, DOI 10.1111/j.0022-3646.1976.00460.x; SWEENEY BM, 1971, J PHYCOL, V7, P53, DOI 10.1111/j.1529-8817.1971.tb01478.x; Takano Y, 2014, PROTIST, V165, P759, DOI 10.1016/j.protis.2014.09.001; Tarangkoon W, 2011, AQUAT MICROB ECOL, V62, P25, DOI 10.3354/ame01455; Tarangkoon W, 2010, AQUAT MICROB ECOL, V58, P197, DOI 10.3354/ame01356; WILCOX LW, 1985, SCIENCE, V227, P192, DOI 10.1126/science.227.4683.192; Wisecaver JH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-366; Yamaguchi H, 2011, PROTIST, V162, P650, DOI 10.1016/j.protis.2011.01.002	42	1	1	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0181751	10.1371/journal.pone.0181751	http://dx.doi.org/10.1371/journal.pone.0181751			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763480	Green Published, Green Submitted, gold			2022-12-26	WOS:000406766500019
J	Henke, A; Thuss-Patience, P; Behzadi, A; Henke, O				Henke, Antje; Thuss-Patience, Peter; Behzadi, Asita; Henke, Oliver			End-of-life care for immigrants in Germany. An epidemiological appraisal of Berlin	PLOS ONE			English	Article							PALLIATIVE CARE; HEALTH-CARE; DISEASES; HOSPICE; TURKISH	Background Since the late 1950' s, a steadily increasing immigrant population in Germany is resulting in a subpopulation of aging immigrants. The German health care system needs to adjust its services-linguistically, culturally, and medically-for this subpopulation of patients. Immigrants make up over 20% of the population in Germany, yet the majority receive inadequate medical care. As many of the labor immigrants of the 1960s and 1970s are in need of hospice and palliative care (HPC), little is known about this specialized care for immigrants. This epidemiological study presents utilization of HPC facilities in Berlin with a focus on different immigrant groups. Methods A validated questionnaire was used to collect data from patients at 34 HPC institutions in Berlin over 20 months. All newly admitted patients were recruited. Anonymized data were coded and analyzed by using SPSS and compared with the population statistics of Berlin. Results 4118 questionnaires were completed and included in the analysis. At 11.4% the proportion of immigrants accessing HPC was significantly (p<0,001) below their proportion in the general Berlin population. This difference was especially seen in the age groups of 51-60 (21.46% immigrants in Berlin population, 17.7% immigrants in HPC population) and 61-70 years (16,9% vs. 13,1%). The largest ethnic groups are Turks, Russians, and Poles, with a different weighting than in the general population: Turkish immigrants were 24% of all Berlin immigrants, but only 13.6% of the study immigrant population (OR: 0.23, 95% CI: 0.18-0.29, p<0.001). Russian and Polish immigrants account for 5.6% and 9.2% in the population, but 11.5% and 24.8% in the study population respectively (Russian: OR 0.88, 95% CI: 0.66-1.16; Polish: OR 1.17, 95% CI: 0.97-1.42). Palliative care wards (PC) were used most often (16.7% immigrants of all PC patients); outpatient hospice services were used least often by immigrants (11.4%). Median age at first admission to HPC was younger in immigrants than non-immigrants: 61-70 vs. 71-80, p = 0.03. Conclusions Immigrants are underrepresented in Berlin's HPC and immigrants on average make use of care at a younger age than non-immigrants. In this regard, Turkish immigrants in particular have the poorest utilization of HPC. These results should prompt research on Turkish immigrants, regarding access barriers, since they represent the largest immigrant group. This may be due to a lack of cultural sensitivity of the care-providers and a lack of knowledge about HPC among immigrants. In the comparison of the kinds of institutions, immigrants are less likely to access outpatient hospice services compared to PC. Apparently, PC appear to be a smaller hurdle for utilization. These results show a non-existent, but oft-cited "healthy immigrant effect" of the first generation of work immigrants, now entering old age. These findings correspond with studies suggesting increased health concerns in immigrants. Focused research is needed to promote efforts in providing adequate and fair access to HPC for all people in Berlin.	[Henke, Antje; Thuss-Patience, Peter; Behzadi, Asita; Henke, Oliver] Charite, Div Palliat Med, Dept Hematol & Oncol, Virchow Campus, Berlin, Germany; [Henke, Antje] Charite, Berlin Sch Publ Hlth, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Henke, O (corresponding author), Charite, Div Palliat Med, Dept Hematol & Oncol, Virchow Campus, Berlin, Germany.	oliver.henke@charite.de	Henke, Oliver/HGA-7260-2022	Behzadi, Asita/0000-0002-8568-0644	Foundation Paula-Kubitscheck-Vogel from Ravenburg, Germany	Foundation Paula-Kubitscheck-Vogel from Ravenburg, Germany	The study poject "Immigrants in End-Of-Life Care in Berlin 2013-2016", was supported by the Foundation Paula-Kubitscheck-Vogel from Ravenburg, Germany with 24,000 Euros. This epidemiologic study was part of the project, https://www.pkv-stiftung.det/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberer M, 2016, DEUT MED WOCHENSCHR, V141, pE8, DOI 10.1055/s-0041-106907; Anderson P, 2008, SOZIALREFERAT LANDES, P40; [Anonymous], 2012, 18 BUND MIGR FLUCHTL, V18; Borde T, 2002, GESUNDHEITSWESEN, V64, P476, DOI 10.1055/s-2002-33775; Bozorgmehr K, 2016, BUNDESGESUNDHEITSBLA, V59, P545, DOI 10.1007/s00103-016-2329-4; Bundesamt Statistisches, 2015, BEV ERW; Bundesamt Statistisches, 2014, BEV ERW; Crawley LaVera M, 2005, J Palliat Med, V8 Suppl 1, pS58; David M, 2006, EUR J EMERG MED, V13, P352, DOI 10.1097/01.mej.0000228451.15103.89; de Graaff FM, 2012, ETHNIC HEALTH, V17, P363, DOI 10.1080/13557858.2011.645152; Domnich A, 2012, EPIDEMIOL BIOSTAT PU, V9, DOI 10.2427/7532; Evans N, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-141; Henke O, 2012, Z PALLIATMEDIZIN, V13, P191, DOI 10.1055/s-0032-1305060; Henke O, 2015, Z PALLIATMEDIZIN, V16, P254, DOI 10.1055/s-0035-1552726; Jansky M, 2017, BUNDESGESUNDHEITSBLA, V60, P89, DOI 10.1007/s00103-016-2476-7; Koffman J, 2007, PALLIATIVE MED, V21, P145, DOI 10.1177/0269216306074639; Kohls M., 2012, 12 BUND MIGR FLUCHTL, V12; Lampert T, 2005, ARMUTS UND REICHTUMS, P127; Paal P, 2017, PLOS ONE, V12; Razum O., 2006, MIGRATION MORTALITAT, P255; Schenk L, 2006, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V49, P853, DOI 10.1007/s00103-006-0018-4; Schenk L., 2008, ALTER GESUNDHEIT KRA, P156; Schimany P, 2012, 18 BUND MIGR FLUCHTL, V18; Selby P, 1996, BRIT J CANCER, V74, pS54; Stich A, 2016, INTERNIST, V57, P409, DOI 10.1007/s00108-016-0057-3; Tezcan-Guntekin H, 2015, DTSCH ARZTEBL, V112; TNS Infratest Sozialforschung, 2011, TNS INFR SOZ; Woellert F, 2009, UNGENUTZTE POTENZIAL	28	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0182033	10.1371/journal.pone.0182033	http://dx.doi.org/10.1371/journal.pone.0182033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763469	Green Submitted, Green Published, gold			2022-12-26	WOS:000406766500035
J	Qiao, JP; Wang, ZS; Zhao, GH; Huo, YK; Herder, CL; Sikora, CO; Peterson, BS				Qiao, Jianping; Wang, Zhishun; Zhao, Guihu; Huo, Yuankai; Herder, Carl L.; Sikora, Chamonix O.; Peterson, Bradley S.			Functional neural circuits that underlie developmental stuttering	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; BASAL GANGLIA; BRAIN; CHILDREN; MOTOR; SPEECH; ADULTS; SPEAKERS; CORTEX; CLASSIFICATION	The aim of this study was to identify differences in functional and effective brain connectivity between persons who stutter (PWS) and typically developing (TD) fluent speakers, and to assess whether those differences can serve as biomarkers to distinguish PWS from TD controls. We acquired resting-state functional magnetic resonance imaging data in 44 PWS and 50 TD controls. We then used Independent Component Analysis (ICA) together with Hierarchical Partner Matching (HPM) to identify networks of robust, functionally connected brain regions that were highly reproducible across participants, and we assessed whether connectivity differed significantly across diagnostic groups. We then used Granger Causality (GC) to study the causal interactions (effective connectivity) between the regions that ICA and HPM identified. Finally, we used a kernel support vector machine to assess how well these measures of functional connectivity and granger causality discriminate PWS from TD controls. Functional connectivity was stronger in PWS compared with TD controls in the supplementary motor area (SMA) and primary motor cortices, but weaker in inferior frontal cortex (IFG, Broca's area), caudate, putamen, and thalamus. Additionally, causal influences were significantly weaker in PWS from the IFG to SMA, and from the basal ganglia to IFG through the thalamus, compared to TD controls. ICA and GC indices together yielded an accuracy of 92.7% in classifying PWS from TD controls. Our findings suggest the presence of dysfunctional circuits that support speech planning and timing cues for the initiation and execution of motor sequences in PWS. Our high accuracy of classification further suggests that these aberrant brain features may serve as robust biomarkers for PWS.	[Qiao, Jianping] Shandong Normal Univ, Inst Data Sci & Technol, Sch Phys & Elect, Shandong Prov Key Lab Med Phys & Image Proc Techn, Jinan, Shandong, Peoples R China; [Qiao, Jianping; Wang, Zhishun; Huo, Yuankai] Columbia Univ, Dept Psychiat, New York, NY 10027 USA; [Zhao, Guihu] Cent S Univ, Sch Informat Sci & Engn, Changsha, Hunan, Peoples R China; [Herder, Carl L.; Sikora, Chamonix O.] Amer Inst Stuttering, New York, NY USA; [Peterson, Bradley S.] Childrens Hosp Los Angeles, Inst Developing Mind, Los Angeles, CA 90027 USA; [Peterson, Bradley S.] Univ Southern Calif, Keck Sch Med, Dept Psychiat, Los Angeles, CA USA	Shandong Normal University; Columbia University; Central South University; Children's Hospital Los Angeles; University of Southern California	Wang, ZS (corresponding author), Columbia Univ, Dept Psychiat, New York, NY 10027 USA.; Zhao, GH (corresponding author), Cent S Univ, Sch Informat Sci & Engn, Changsha, Hunan, Peoples R China.	wangz@nyspi.columbia.edu; zhaoguihu@foxmail.com			McGue Millhiser Family Trust; National Natural Science Foundation of China [61603225]; Natural Science Foundation of Shandong Province [ZR2016FQ04]; China Postdoctoral Science Foundation [2016M602182]	McGue Millhiser Family Trust; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the McGue Millhiser Family Trust, National Natural Science Foundation of China (61603225) (http://ww.nsfc.gov.cn/), Natural Science Foundation of Shandong Province (ZR2016FQ04), and China Postdoctoral Science Foundation (2016M602182). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm PA, 2004, J COMMUN DISORD, V37, P325, DOI 10.1016/j.jcomdis.2004.03.001; [Anonymous], [No title captured]; Beal DS, 2007, NEUROREPORT, V18, P1257, DOI 10.1097/WNR.0b013e3282202c4d; Beal DS, 2013, CORTEX, V49, P2151, DOI 10.1016/j.cortex.2012.08.013; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Bloodstein O., 1995, HDB STUTTERING SINGU; Boecker H, 1998, J NEUROPHYSIOL, V79, P1070, DOI 10.1152/jn.1998.79.2.1070; Braun AR, 1997, BRAIN, V120, P761, DOI 10.1093/brain/120.5.761; Cahana-Amitay D, 2014, BEHAV NEUROL, V2014, DOI 10.1155/2014/260381; Cai SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041830; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Chan SH, 2013, BRAIN LANG, V125, P283, DOI 10.1016/j.bandl.2011.11.005; Chang SE, 2008, NEUROIMAGE, V39, P1333, DOI 10.1016/j.neuroimage.2007.09.067; Chang SE, 2013, BRAIN, V136, P3709, DOI 10.1093/brain/awt275; Chang SE, 2011, CEREB CORTEX, V21, P2507, DOI 10.1093/cercor/bhr028; Choo AL, 2011, J COMMUN DISORD, V44, P470, DOI 10.1016/j.jcomdis.2011.03.001; Chu C, 2011, NEUROIMAGE, V58, P560, DOI 10.1016/j.neuroimage.2011.06.053; Cykowski MD, 2010, NEUROIMAGE, V52, P1495, DOI 10.1016/j.neuroimage.2010.05.011; Cykowski MD, 2008, CEREB CORTEX, V18, P571, DOI 10.1093/cercor/bhm093; Dai ZJ, 2012, NEUROIMAGE, V59, P2187, DOI 10.1016/j.neuroimage.2011.10.003; Desai J, 2017, HUM BRAIN MAPP, V38, P1865, DOI 10.1002/hbm.23487; Eggers K, 2013, J FLUENCY DISORD, V38, P1, DOI 10.1016/j.jfludis.2012.10.001; Etchell AC, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00467; First MB, 2002, STRUCTURED CLIN INTE; Foundas AL, 2004, NEUROLOGY, V63, P1640, DOI 10.1212/01.WNL.0000142993.33158.2A; Foundas AL, 2003, NEUROLOGY, V61, P1378, DOI 10.1212/01.WNL.0000094320.44334.86; Foundas AL, 2013, PERCEPT MOTOR SKILL, V116, P528, DOI 10.2466/15.10.PMS.116.2.528-543; Fox PT, 1996, NATURE, V382, P158, DOI 10.1038/382158a0; Fridriksson J, 2009, J SPEECH LANG HEAR R, V52, P812, DOI 10.1044/1092-4388(2008/06-0197); Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Giraud AL, 2008, BRAIN LANG, V104, P190, DOI 10.1016/j.bandl.2007.04.005; Gordon N, 2002, DEV MED CHILD NEUROL, V44, P278, DOI 10.1017/S0012162201002067; Gray KR, 2013, NEUROIMAGE, V65, P167, DOI 10.1016/j.neuroimage.2012.09.065; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Hardwick RM, 2013, NEUROIMAGE, V67, P283, DOI 10.1016/j.neuroimage.2012.11.020; Howell P, 2012, BRAIN LANG, V123, P211, DOI 10.1016/j.bandl.2012.09.010; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Ingham RJ, 1996, J SPEECH HEAR RES, V39, P1208, DOI 10.1044/jshr.3906.1208; Ingham RJ, 2012, BRAIN LANG, V122, P11, DOI 10.1016/j.bandl.2012.04.002; Ip ML, 2012, INT J SPEECH-LANG PA, V14, P543, DOI 10.3109/17549507.2012.712158; Jancke L, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-23; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kell CA, 2009, BRAIN, V132, P2747, DOI 10.1093/brain/awp185; Liu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089891; Lu CM, 2012, NEUROLOGY, V79, P625, DOI 10.1212/WNL.0b013e31826356d2; Lu CM, 2010, CORTEX, V46, P49, DOI 10.1016/j.cortex.2009.02.017; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Nieuwenhuis M, 2012, NEUROIMAGE, V61, P606, DOI 10.1016/j.neuroimage.2012.03.079; Nottebohm F, 2010, BRAIN LANG, V115, P3, DOI 10.1016/j.bandl.2010.05.002; O'Neill J, 2017, JAMA PSYCHIAT, V74, P85, DOI 10.1001/jamapsychiatry.2016.3199; Qiao JP, 2015, IEEE T BIO-MED ENG, V62, P1272, DOI 10.1109/TBME.2014.2385151; Smits-Bandstra S, 2007, J FLUENCY DISORD, V32, P251, DOI 10.1016/j.jfludis.2007.06.001; Sommer M, 2002, LANCET, V360, P380, DOI 10.1016/S0140-6736(02)09610-1; Taniwaki T, 2003, J NEUROSCI, V23, P3432; Tyler LK, 2011, BRAIN, V134, P415, DOI 10.1093/brain/awq369; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Wang ZH, 2008, HUM BRAIN MAPP, V29, P875, DOI 10.1002/hbm.20434; Wang ZS, 2011, AM J PSYCHIAT, V168, P1326, DOI 10.1176/appi.ajp.2011.09111692; Watkins KE, 2008, BRAIN, V131, P50, DOI 10.1093/brain/awm241; Wiese H, 2004, NEUROSCI LETT, V371, P220, DOI 10.1016/j.neulet.2004.08.078; WINGATE ME, 1964, J SPEECH HEAR DISORD, V29, P484, DOI 10.1044/jshd.2904.484; WU JC, 1995, NEUROREPORT, V6, P501, DOI 10.1097/00001756-199502000-00024; Xuan Y., 2012, PLOS ONE, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0030570; YAIRI E, 1992, J SPEECH HEAR RES, V35, P782, DOI 10.1044/jshr.3504.782; Yaruss JS, 2006, J FLUENCY DISORD, V31, P90, DOI 10.1016/j.jfludis.2006.02.002; Ye Z, 2011, HUM BRAIN MAPP, V32, P1081, DOI 10.1002/hbm.21093	67	16	16	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0179255	10.1371/journal.pone.0179255	http://dx.doi.org/10.1371/journal.pone.0179255			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC3TH	28759567	Green Submitted, Green Published, gold			2022-12-26	WOS:000406761600005
J	Demirel, O; Ballo, O; Reddy, PNG; Vakhrusheva, O; Zhang, J; Eichler, A; Fernandes, R; Badura, S; Serve, H; Brandts, C				Demirel, Ozlem; Ballo, Olivier; Reddy, Pavankumar N. G.; Vakhrusheva, Olesya; Zhang, Jing; Eichler, Astrid; Fernandes, Ramona; Badura, Susanne; Serve, Hubert; Brandts, Christian			SOCS1 function in BCR-ABL mediated myeloproliferative disease is dependent on the cytokine environment	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; HUMAN-MELANOMA; C-ABL; IMATINIB; SUPPRESSOR; CELLS; GENE; RESISTANCE; METHYLATION; SIGNALING-1	Treatment with tyrosine kinase inhibitors is the standard of care for Philadelphia chromosome positive leukemias. However the eradication of leukemia initiating cells remains a challenge. Circumstantial evidence suggests that the cytokine microenvironment may play a role in BCR-ABL mediated leukemogenesis and in imatinib resistance. Gene expression analyses of BCR-ABL positive ALL long-term cultured cells revealed strong reduction of SOCS mRNA expression after imatinib treatment, thereby demonstrating a strong inhibition of cytokine signaling. In this study we employed SOCS1-a strong inhibitor of cytokine signaling-as a tool to terminate external cytokine signals in BCR-ABL transformed cells in vitro and in vivo. In colony formation assays with primary bone marrow cells, expression of SOCS1 decreased colony numbers under pro-proliferative cytokines, while it conferred growth resistance to anti-proliferative cytokines. Importantly, co-expression of SOCS1 with BCR-ABL led to the development of a MPD phenotype with a prolonged disease latency compared to BCR-ABL alone in a murine bone marrow transplantation model. Interestingly, SOCS1 co-expression protected 20% of mice from MPD development. In summary, we conclude that under pro-proliferative cytokine stimulation at the onset of myeloproliferative diseases SOCS1 acts as a tumor suppressor, while under anti-proliferative conditions it exerts oncogenic function. Therefore SOCS1 can promote opposing functions depending on the cytokine environment.	[Demirel, Ozlem; Ballo, Olivier; Reddy, Pavankumar N. G.; Vakhrusheva, Olesya; Zhang, Jing; Eichler, Astrid; Fernandes, Ramona; Badura, Susanne; Serve, Hubert; Brandts, Christian] Goethe Univ, Dept Med, Hematol Oncol, Frankfurt, Germany; [Demirel, Ozlem; Zhang, Jing; Serve, Hubert; Brandts, Christian] German Canc Consortium DKTK, Heidelberg, Germany; [Demirel, Ozlem; Zhang, Jing; Serve, Hubert; Brandts, Christian] German Canc Res Ctr, Heidelberg, Germany; [Reddy, Pavankumar N. G.] Harvard Med Sch, Childrens Hosp Boston, Hematol Oncol, Boston, MA USA	Goethe University Frankfurt; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Harvard University; Boston Children's Hospital; Harvard Medical School	Brandts, C (corresponding author), Goethe Univ, Dept Med, Hematol Oncol, Frankfurt, Germany.; Brandts, C (corresponding author), German Canc Consortium DKTK, Heidelberg, Germany.; Brandts, C (corresponding author), German Canc Res Ctr, Heidelberg, Germany.	brandts@em.uni-frankfurt.de	; Reddy, Pavankumar N.G./C-2315-2009	Brandts, Christian H./0000-0003-1732-2535; Reddy, Pavankumar N.G./0000-0001-5980-110X; Olesya, Buzikova/0000-0001-9462-2502	German Cancer Aid [108688, 108400]; LOEWE Center [IIIL4-518/17.004(2013)]; German Cancer Consortium (DKTK)	German Cancer Aid(Deutsche Krebshilfe); LOEWE Center; German Cancer Consortium (DKTK)	Funded by German Cancer Aid (108688 and 108400 to CHB), LOEWE Center (IIIL4-518/17.004(2013) to CHB), and German Cancer Consortium (DKTK, to OD, JZ, HS and CHB).; The authors would like to thank Martin Ruthardt and Afsar Ali Mian for helpful discussions and experimental suggestions, the German Cancer Aid (108688 and 108400 to CHB), LOEWE Center (IIIL4-518/17.004(2013) to CHB) and the German Cancer Consortium (DKTK, to OD, JZ, HS and CHB) for financial support.	Baker SJ, 2007, ONCOGENE, V26, P6724, DOI 10.1038/sj.onc.1210757; Beissert T, 2008, INT J CANCER, V122, P2744, DOI 10.1002/ijc.23467; Branford S, 2003, BLOOD, V102, P276, DOI 10.1182/blood-2002-09-2896; Centlivre M, 2010, GENE THER, V17, P14, DOI 10.1038/gt.2009.109; Chen CY, 2003, GENE CHROMOSOME CANC, V37, P300, DOI 10.1002/gcc.10222; Chu PY, 2010, SWISS MED WKLY, V140, DOI 10.4414/smw.2010.13065; Cilloni D, 2012, CLIN CANCER RES, V18, P930, DOI 10.1158/1078-0432.CCR-10-1613; Corbin AS, 2011, J CLIN INVEST, V121, P396, DOI 10.1172/JCI35721; Galm O, 2003, BLOOD, V101, P2784, DOI 10.1182/blood-2002-06-1735; Grignani F, 1998, CANCER RES, V58, P14; Hansen N, 2013, LEUKEMIA, V27, P130, DOI 10.1038/leu.2012.169; Hantschel Oliver, 2012, Genes Cancer, V3, P436, DOI 10.1177/1947601912458584; Hantschel O, 2012, NAT CHEM BIOL, V8, P285, DOI [10.1038/NCHEMBIO.775, 10.1038/nchembio.775]; Hatirnaz M, 2007, AM J HEMATOL, V82, P729, DOI 10.1002/ajh.20886; Hazlehurst LA, 2009, CANCER CONTROL, V16, P100, DOI 10.1177/107327480901600202; Hochhaus A, 2002, LEUKEMIA, V16, P2190, DOI 10.1038/sj.leu.2402741; Hoelbl A, 2006, BLOOD, V107, P4898, DOI 10.1182/blood-2005-09-3596; Hoelbl A, 2010, EMBO MOL MED, V2, P98, DOI 10.1002/emmm.201000062; Inagaki-Ohara Kyoko, 2013, JAKSTAT, V2, pe24053, DOI 10.4161/jkst.24053; Jatiani Shashidhar S, 2010, Genes Cancer, V1, P979, DOI 10.1177/1947601910397187; Kovacic B, 2012, EMBO MOL MED, V4, P283, DOI 10.1002/emmm.201100208; Li Z, 2004, J INVEST DERMATOL, V123, P737, DOI 10.1111/j.0022-202X.2004.23408.x; Limnander A, 2004, MOL CELL, V15, P329, DOI 10.1016/j.molcel.2004.06.041; Linossi EM, 2013, CYTOKINE GROWTH F R, V24, P241, DOI 10.1016/j.cytogfr.2013.03.005; Liu SH, 2008, PIGM CELL MELANOMA R, V21, P545, DOI 10.1111/j.1755-148X.2008.00484.x; Liu TC, 2003, BRIT J HAEMATOL, V123, P654, DOI 10.1046/j.1365-2141.2003.04660.x; Mehta AK, 2009, GENE, V428, P20, DOI 10.1016/j.gene.2008.09.033; Melo JV, 1996, BLOOD, V88, P2375, DOI 10.1182/blood.V88.7.2375.bloodjournal8872375; Mottok A, 2009, BLOOD, V114, P4503, DOI 10.1182/blood-2009-06-225839; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Nijimeijer BA, 2009, EXP HEMATOL, V37, P376, DOI 10.1016/j.exphem.2008.11.002; NOWELL PC, 1961, JNCI-J NATL CANCER I, V27, P1013; Qiu XX, 2012, NEOPLASIA, V14, P547, DOI 10.1596/neo.12230; Quintes-Cardama A, 2009, CANCER CONTROL, V16, P122, DOI 10.1177/107327480901600204; Raccurt M, 2003, BRIT J CANCER, V89, P524, DOI 10.1038/sj.bjc.6601115; Reddy PNG, 2012, BLOOD, V120, P1691, DOI 10.1182/blood-2010-08-301416; Roman-Gomez J, 2004, HAEMATOLOGICA, V89, P42; Rottapel R, 2002, ONCOGENE, V21, P4351, DOI 10.1038/sj.onc.1205537; Sirvent A, 2008, BIOL CELL, V100, P617, DOI 10.1042/BC20080020; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Sutherland KD, 2004, ONCOGENE, V23, P7726, DOI 10.1038/sj.onc.1207787; TOUGH IM, 1961, LANCET, V1, P411; Trengove MC, 2013, AM J CLIN EXP IMMUNO, V2, P1; Van Etten RA, 2002, ONCOGENE, V21, P8643, DOI 10.1038/sj.onc.1206091; Van Etten RA, 1999, TRENDS CELL BIOL, V9, P179, DOI 10.1016/S0962-8924(99)01549-4; Warsch W, 2011, BLOOD, V117, P3409, DOI 10.1182/blood-2009-10-248211; Watanabe D, 2004, BRIT J HAEMATOL, V126, P726, DOI 10.1111/j.1365-2141.2004.05107.x; Williams RT, 2007, GENE DEV, V21, P2283, DOI 10.1101/gad.1588607; Zhang J, 2012, INT J CANCER, V130, P1971, DOI 10.1002/ijc.27318; Zhang XW, 1998, BLOOD, V92, P3829, DOI 10.1182/blood.V92.10.3829	50	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0180401	10.1371/journal.pone.0180401	http://dx.doi.org/10.1371/journal.pone.0180401			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753604	Green Published, Green Submitted, gold			2022-12-26	WOS:000406579300005
J	Gao, WL; Wu, Z; Sun, JY; Ni, XP; Xia, HZ				Gao, Wenli; Wu, Zheng; Sun, Junyang; Ni, Xianpu; Xia, Huanzhang			Modulation of kanamycin B and kanamycin A biosynthesis in Streptomyces kanamyceticus via metabolic engineering	PLOS ONE			English	Article							GENE-CLUSTER; OTOTOXICITY; INTEGRATION; IMPROVEMENT; SITES	Both kanamycin A and kanamycin B, antibiotic components produced by Streptomyces kanamyceticus, have medical value. Two different pathways for kanamycin biosynthesis have been reported by two research groups. In this study, to obtain an optimal kanamycin A-producing strain and a kanamycin B-high-yield strain, we first examined the native kanamycin biosynthetic pathway in vivo. Based on the proposed parallel biosynthetic pathway, kanN disruption should lead to kanamycin A accumulation; however, the kanN-disruption strain produced neither kanamycin A nor kanamycin B. We then tested the function of kanJ and kanK. The main metabolite of the kanJ-disruption strain was identified as kanamycin B. These results clarified that kanamycin biosynthesis does not proceed through the parallel pathway and that synthesis of kanamycin A from kanamycin B is catalyzed by KanJ and KanK in S. kanamyceticus. As expected, the kanamycin B yield of the kanJ-disruption strain was 3268 +/- 255 mu g/mL, 12-fold higher than that of the original strain. To improve the purity of kanamycin A and reduce the yield of kanamycin B in the fermentation broth, four different kanJ-and kanK-overexpressing strains were constructed through either homologous recombination or site-specific integration. The overexpressing strain containing three copies of kanJ and kanK in its genome exhibited the lowest kanamycin B yield (128 +/- 20 mu g/mL), which was 54% lower than that of the original strain. Our experimental results demonstrate that kanamycin A is derived from KanJ-and-KanK-catalyzed conversion of kanamycin B in S. kanamyceticus. Moreover, based on the clarified biosynthetic pathway, we obtained a kanamycin B-high-yield strain and an optimized kanamycin A-producing strain with minimal byproduct.	[Gao, Wenli; Wu, Zheng; Sun, Junyang; Ni, Xianpu; Xia, Huanzhang] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, 103 Wenhua Rd, Shenyang, Liaoning, Peoples R China	Shenyang Pharmaceutical University	Ni, XP; Xia, HZ (corresponding author), Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, 103 Wenhua Rd, Shenyang, Liaoning, Peoples R China.	nixianpu126@126.com; xiahz612@sina.com			National Natural Science Foundation of China [81502965, 81273410]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81502965, 81273410).; This work was supported by the National Natural Science Foundation of China (81502965, 81273410). We would like to thank the Microbial Medicine Innovative Research Team of Jinan.	Chen Y, 2008, APPL ENVIRON MICROB, V74, P1820, DOI 10.1128/AEM.02770-07; Combes P, 2002, J BACTERIOL, V184, P5746, DOI 10.1128/JB.184.20.5746-5752.2002; Commission EP, 2008, EUROPEAN PHARMACOPOE; Du D, 2013, APPL MICROBIOL BIOT, V97, P6383, DOI 10.1007/s00253-013-4836-7; ENEVA GI, 1991, SPECTROCHIM ACTA A, V47, P875, DOI 10.1016/0584-8539(91)80274-M; Gu PF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09684; Gu YW, 2015, CHEMBIOCHEM, V16, P1933, DOI 10.1002/cbic.201500258; Hsu BH, 1999, J CHROMATOGR B, V725, P103, DOI 10.1016/S0378-4347(98)00529-5; JANSSEN GR, 1993, GENE, V124, P133, DOI 10.1016/0378-1119(93)90774-W; Kharel MK, 2004, ARCH BIOCHEM BIOPHYS, V429, P204, DOI 10.1016/j.abb.2004.06.009; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kondo S., 1999, J Infect Chemother, V5, P1, DOI 10.1007/s101560050001; KONDO S, 1973, J ANTIBIOT, V26, P412, DOI 10.7164/antibiotics.26.412; Kudo F, 2009, J ANTIBIOT, V62, P471, DOI 10.1038/ja.2009.76; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACNEIL DJ, 1992, GENE, V111, P61, DOI 10.1016/0378-1119(92)90603-M; Nepal KK, 2009, MOL CELLS, V27, P601, DOI 10.1007/s10059-009-0080-5; Ni XP, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-015-0402-6; Ni XP, 2011, APPL MICROBIOL BIOT, V89, P723, DOI 10.1007/s00253-010-2908-5; Parekh S, 2000, APPL MICROBIOL BIOT, V54, P287, DOI 10.1007/s002530000403; Park JW, 2011, NAT CHEM BIOL, V7, P843, DOI 10.1038/nchembio.671; Rowley PA, 2008, NUCLEIC ACIDS RES, V36, P3879, DOI 10.1093/nar/gkn269; RUSSELL NJ, 1979, ACTA OTO-LARYNGOL, V88, P369, DOI 10.3109/00016487909137181; Sambrook J., 2001, MOL CLONING LAB MANU; Shimizu Y, 2005, NEUROSCI LETT, V380, P243, DOI 10.1016/j.neulet.2005.01.066; Sucipto H, 2012, ANGEW CHEM INT EDIT, V51, P3428, DOI 10.1002/anie.201108122; Yanai K, 2004, J ANTIBIOT, V57, P351, DOI 10.7164/antibiotics.57.351; YUNG MW, 1987, ACTA OTO-LARYNGOL, V103, P73, DOI 10.3109/00016488709134700	28	12	12	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0181971	10.1371/journal.pone.0181971	http://dx.doi.org/10.1371/journal.pone.0181971			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753625	Green Published, Green Submitted, gold			2022-12-26	WOS:000406579300037
J	Garcia-Gudino, D; Landa, E; Mendoza-Temis, J; Albarado-Ibanez, A; Toledo-Roy, JC; Morales, IO; Frank, A				Garcia-Gudino, David; Landa, Emmanuel; Mendoza-Temis, Joel; Albarado-Ibanez, Alondra; Toledo-Roy, Juan C.; Morales, Irving O.; Frank, Alejandro			Enhancement of early warning properties in the Kuramoto model and in an atrial fibrillation model due to an external perturbation of the system	PLOS ONE			English	Article							SIGNAL	When a complex dynamical system is externally disturbed, the statistical moments of signals associated to it can be affected in ways that depend on the nature and amplitude of the perturbation. In systems that exhibit phase transitions, the statistical moments can be used as Early Warnings (EW) of the transition. A natural question is thus to wonder what effect external disturbances have on the EWs of system. In this work we study the impact of external noise added to the system on the EWs, with particular focus on understanding the importance of the amplitude and complexity of the noise. We do this by analyzing the EWs of two computational models related to biology: the Kuramoto model, which is a paradigm of synchronization for biological systems, and a cellular automaton model of cardiac dynamics which has been used as a model for atrial fibrillation. For each model we first characterize the EWs. Then, we introduce external noise of varying intensity and nature to observe what effect this has on the EWs. In both cases we find that the introduction of noise amplified the EWs, with more complex noise having a greater effect. This both offers a way to improve the chance of detection of EWs in real systems and suggests that natural variability in the real world does not have a detrimental effect on EWs, but the opposite.	[Garcia-Gudino, David; Landa, Emmanuel; Mendoza-Temis, Joel; Albarado-Ibanez, Alondra; Toledo-Roy, Juan C.; Morales, Irving O.; Frank, Alejandro] Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad, Mexico City, DF, Mexico; [Garcia-Gudino, David; Mendoza-Temis, Joel; Morales, Irving O.; Frank, Alejandro] Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Mexico City, DF, Mexico; [Garcia-Gudino, David; Landa, Emmanuel; Mendoza-Temis, Joel; Albarado-Ibanez, Alondra; Toledo-Roy, Juan C.; Morales, Irving O.; Frank, Alejandro] Lab Nacl Ciencias Complejidad, Mexico City, DF, Mexico; [Albarado-Ibanez, Alondra] Benemerita Univ Autonoma Puebla, Inst Fisiol Celular, Puebla, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Benemerita Universidad Autonoma de Puebla	Garcia-Gudino, D (corresponding author), Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad, Mexico City, DF, Mexico.; Garcia-Gudino, D (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Mexico City, DF, Mexico.; Garcia-Gudino, D (corresponding author), Lab Nacl Ciencias Complejidad, Mexico City, DF, Mexico.	davisggn@ciencias.unam.mx	Nucleares, Instituto/AAK-6270-2020; Toledo-Roy, Juan Claudio/N-6666-2019; Toledo-Roy, Juan/G-6071-2019	Toledo-Roy, Juan Claudio/0000-0002-0267-3378; Toledo-Roy, Juan/0000-0002-0267-3378	Consejo Nacional de Ciencia y Tecnologia through Laboratorio Nacional de Ciencias de la Complejidad; Universidad Nacional Autonoma de Mexico through UNAM/DGAPA; Universidad Nacional Autonoma de Mexico through UNAM/DGAPA [PAPIITIV100116, PAPIITIN106215, PAPIIT IV100116, PAPIIT IN106215]	Consejo Nacional de Ciencia y Tecnologia through Laboratorio Nacional de Ciencias de la Complejidad; Universidad Nacional Autonoma de Mexico through UNAM/DGAPA; Universidad Nacional Autonoma de Mexico through UNAM/DGAPA	This work was supported by Consejo Nacional de Ciencia y Tecnologia through Laboratorio Nacional de Ciencias de la Complejidad and Universidad Nacional Autonoma de Mexico for financial support through grants UNAM/DGAPA (DG JM), UNAM/DGAPA / PAPIITIV100116 (EL IM AF), and UNAM/DGAPA / PAPIITIN106215 (JT AF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Consejo Nacional de Ciencia y Tecnologia through Laboratorio Nacional de Ciencias de la Complejidad, and Universidad Nacional Autonoma de Mexico for financial support through grants: UNAM/DGAPA / PAPIIT IV100116 and PAPIIT IN106215. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebron JA, 2005, REV MOD PHYS, V77, P137, DOI 10.1103/RevModPhys.77.137; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Chandra Bag Bidhan, 2007, PHYS REV E, V76; Christensen K, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.028104; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; Dakos V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041010, 10.1371/journal.pone.0045586]; Daniels B.C., 2005, OHIO WESLEYAN PHYS D, V7, P2; Guttal V, 2008, ECOL LETT, V11, P450, DOI 10.1111/j.1461-0248.2008.01160.x; Henning T., 2009, THESIS; Iyengar N, 1996, AM J PHYSIOL-REG I, V271, pR1078, DOI 10.1152/ajpregu.1996.271.4.R1078; Kefi S, 2013, OIKOS, V122, P641, DOI 10.1111/j.1600-0706.2012.20838.x; Kleinen T, 2003, OCEAN DYNAM, V53, P53, DOI DOI 10.1007/S10236-002-0023-6; Landa IO, PLOS ONE, V10; Moro E., EDP SCI EPL EUROPHYS, V44; Narayan SM, 2012, J AM COLL CARDIOL, V60, P628, DOI 10.1016/j.jacc.2012.05.022; Quail Thomas, PREDICTING ONSET PER; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227	17	5	5	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0181953	10.1371/journal.pone.0181953	http://dx.doi.org/10.1371/journal.pone.0181953			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753631	gold, Green Published, Green Submitted			2022-12-26	WOS:000406579300036
J	Martin-Ortega, J; Glenk, K; Byg, A				Martin-Ortega, Julia; Glenk, Klaus; Byg, Anja			How to make complexity look simple? Conveying ecosystems restoration complexity for socio-economic research and public engagement	PLOS ONE			English	Article							SERVICES; ECOLOGY; PARTICIPATION; SCIENCE; BIODIVERSITY; PEATLANDS	Ecosystems degradation represents one of the major global challenges at the present time, threating people's livelihoods and well-being worldwide. Ecosystem restoration therefore seems no longer an option, but an imperative. Restoration challenges are such that a dialogue has begun on the need to re-shape restoration as a science. A critical aspect of that reshaping process is the acceptance that restoration science and practice needs to be coupled with socio-economic research and public engagement. This inescapably means conveying complex ecosystem's information in a way that is accessible to the wider public. In this paper we take up this challenge with the ultimate aim of contributing to making a step change in science's contribution to ecosystems restoration practice. Using peatlands as a paradigmatically complex ecosystem, we put in place a transdisciplinary process to articulate a description of the processes and outcomes of restoration that can be understood widely by the public. We provide evidence of the usefulness of the process and tools in addressing four key challenges relevant to restoration of any complex ecosystem: (1) how to represent restoration outcomes; (2) how to establish a restoration reference; (3) how to cope with varying restoration time-lags and (4) how to define spatial units for restoration. This evidence includes the way the process resulted in the creation of materials that are now being used by restoration practitioners for communication with the public and in other research contexts. Our main contribution is of an epistemological nature: while ecosystem services-based approaches have enhanced the integration of academic disciplines and non-specialist knowledge, this has so far only followed one direction (from the biophysical underpinning to the description of ecosystem services and their appreciation by the public). We propose that it is the mix of approaches and epistemological directions (including from the public to the biophysical parameters) what will make a definitive contribution to restoration practice.	[Martin-Ortega, Julia] Univ Leeds, Sustainabil Res Inst, Sch Earth & Environm, Leeds, W Yorkshire, England; [Glenk, Klaus] Scottish Rural Coll, Land Econ Unit, Edinburgh, Midlothian, Scotland; [Byg, Anja] James Hutton Inst Aberdeen, Social Econ & Geog Sci Grp, Aberdeen, Scotland	University of Leeds; James Hutton Institute	Martin-Ortega, J (corresponding author), Univ Leeds, Sustainabil Res Inst, Sch Earth & Environm, Leeds, W Yorkshire, England.	j.martinortega@leeds.ac.uk	Glenk, Klaus/B-8743-2014	Glenk, Klaus/0000-0002-2472-0235; Martin-Ortega, Julia/0000-0003-0002-6772	Scottish Government Strategic Research Programme; Valuing Nature Network project "Valuing Peatlands: Assessing and valuing peatland ecosystem services for sustainable management"; Natural Environment Research Council (UK); University of Leeds Social Sciences Impact Acceleration Account in association; Economic and Social Research Council; water@leeds	Scottish Government Strategic Research Programme; Valuing Nature Network project "Valuing Peatlands: Assessing and valuing peatland ecosystem services for sustainable management"; Natural Environment Research Council (UK)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); University of Leeds Social Sciences Impact Acceleration Account in association; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); water@leeds	This research was mainly funded by the Scottish Government Strategic Research Programme (2011-2016). Part of the work reported here was also partially funded by the Valuing Nature Network project "Valuing Peatlands: Assessing and valuing peatland ecosystem services for sustainable management" funded by the Natural Environment Research Council (UK) (2011-2012) and the Scottish Government Strategic Research Programme (2016-2021), the University of Leeds Social Sciences Impact Acceleration Account in association with the Economic and Social Research Council (2016) and water@leeds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. General website for Scottish Government Strategic Research Programme: http://www.gov.scot/Topics/Research/About/EBAR/StrategicResearch/future-research-strategy/Themes. Website NERC's Valuing Network programme: http://www.nerc.ac.uk/research/funded/programmes/valuingnature/. University of Leeds Social Sciences Impact Acceleration Account: http.//www.esrc.ac.uk/funding/funding-opportunities/impact-acceleration-accounts/. Water@leeds: www.wateratleeds.org.	Aitkenhead MJ, 2016, GEODERMA, V262, P187, DOI 10.1016/j.geoderma.2015.08.034; [Anonymous], 2012, UNEP YB EM ISS GLOB; [Anonymous], 2006, JOINT NATURE CONSERV; Aronson J, 2010, RESTOR ECOL, V18, P143, DOI 10.1111/j.1526-100X.2009.00638.x; Artz R., 2016, WISE PEATLAND CHOICE; Artz R., 2012, POTENTIAL ABATEMENT; Babbie E., 2005, BASICS SOCIAL RES, P1; Bain C., 2011, IUCN UK COMMISSION I; Baird AJ, 2012, ECOHYDROLOGY, V5, P242, DOI 10.1002/eco.230; Bilotta GS, 2008, WATER RES, V42, P2849, DOI 10.1016/j.watres.2008.03.018; Bruneau P., 2014, COMMISSIONED REPORT, P62; Bullock J. M., 2011, TRENDS ECOLOGY EVOLU, V26; Byg A, 2017, BIOL CONSERV, V206, P181, DOI 10.1016/j.biocon.2016.12.022; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; CBD Secretariat of the Convention on Biological Diversity, 2010, GLOB BIOD OUTL, V3; CBD Secretariat of the Convention on Biological Diversity, 2014, GLOB BIOD OUTL, V4; Chambers P., 1983, RURAL DEV PUTTING LA; Cooke C., 2001, PARTICIPATION NEW TY; Cris R., 2014, GLOBAL PEATLAND REST; D'Astous A, 2013, ECOL ENG, V61, P519, DOI 10.1016/j.ecoleng.2012.09.002; Dise NB, 2009, SCIENCE, V326, P810, DOI 10.1126/science.1174268; Duckett D., 2016, TACKLING WICKED ENV; Dunlap RE, 2000, J SOC ISSUES, V56, P425, DOI 10.1111/0022-4537.00176; Evans CD, 2014, ECOSYST SERV, V9, P5, DOI 10.1016/j.ecoser.2014.06.013; Frolking S, 2011, ENVIRON REV, V19, P371, DOI [10.1139/A11-014, 10.1139/a11-014]; Glenk K, 2014, ECOSYST SERV, V9, P20, DOI 10.1016/j.ecoser.2014.02.008; Haines-Young R., 2010, ECOSYSTEM ECOLOGY NE, DOI DOI 10.1017/CBO9780511750458.007; Helford R., RESTORING NATURE PER, V1, P119; Hensher D., 2005, APPL CHOICE ANAL PRI, DOI 10.1017/CBO9780511610356; Hobbs RJ, 2011, BIOSCIENCE, V61, P442, DOI 10.1525/bio.2011.61.6.6; Holden J, 2005, PHILOS T R SOC A, V363, P2891, DOI 10.1098/rsta.2005.1671; Holden J, 2004, PROG PHYS GEOG, V28, P95, DOI 10.1191/0309133304pp403ra; Ingram J, 2016, J RURAL STUD, V48, P115, DOI 10.1016/j.jrurstud.2016.10.005; Jensen RJ, 2007, MANAGE SCI, V53, P1716, DOI 10.1287/mnsc.1070.0740; Joosten H., 2009, The Global Peatland CO2 Picture: peatland status and drainage related emissions in all countries of the world; Lawrence RJ, 2004, FUTURES, V36, P397, DOI 10.1016/j.futures.2003.10.005; Liu JG, 2007, SCIENCE, V317, P1513, DOI 10.1126/science.1144004; Martin-Ortega J., 2015, WATER ECOSYSTEM SERV; Martin-Ortega J, 2014, ECOSYST SERV, V9, P34, DOI 10.1016/j.ecoser.2014.06.007; Mauerhofer V, 2016, LAND USE POLICY, V52, P481, DOI 10.1016/j.landusepol.2014.12.012; McVittie A, 2015, ECOL ECON, V110, P15, DOI 10.1016/j.ecolecon.2014.12.004; Mobjork M, 2010, FUTURES, V42, P866, DOI 10.1016/j.futures.2010.03.003; National Peatland Plan, 2000, WORK OUR FUT; Nelleman C., 2010, RAPID RESPONSE ASSES; PRETTY JN, 1995, WORLD DEV, V23, P1247, DOI 10.1016/0305-750X(95)00046-F; Reed MS, 2008, BIOL CONSERV, V141, P2417, DOI 10.1016/j.biocon.2008.07.014; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Roberts L, 2009, SCIENCE, V325, P555, DOI 10.1126/science.325_555; ROSENFIELD PL, 1992, SOC SCI MED, V35, P1343, DOI 10.1016/0277-9536(92)90038-R; Rotherham Ian D., 2011, PEAT PEAT CUTTING; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; SNH, 2014, SCOTL NAT HER SNHS M; SNH, 2014, SCOTL NAT HER MAPP S; STAR SL, 1989, SOC STUD SCI, V19, P387, DOI 10.1177/030631289019003001; Strauss A., 2008, BASICS QUALITATIVE R; Strutzel E., 1968, DISCOVERY GROUNDED T, V17, P364, DOI [10.1097/00006199-196807000-00014, DOI 10.1097/00006199-196807000-00014]; Tress G, 2005, LANDSCAPE ECOL, V20, P479, DOI 10.1007/s10980-004-3290-4; Turnhout E, 2013, CONSERV LETT, V6, P154, DOI 10.1111/j.1755-263X.2012.00307.x; Van Tatenhove JPM, 2003, ENVIRON VALUE, V12, P155, DOI 10.3197/096327103129341270; Waylen KA, 2014, CONSERV BIOL, V28, P1215, DOI 10.1111/cobi.12331; Wilson L, 2011, SCI TOTAL ENVIRON, V409, P2010, DOI 10.1016/j.scitotenv.2011.02.036; Wright R.F., 1994, BIOSCIENCE, V45, P4; Yang W, 2015, ASCE-ASME J RISK U B, V1, DOI 10.1115/1.4029751; Yu ZC, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043584	64	13	13	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0181686	10.1371/journal.pone.0181686	http://dx.doi.org/10.1371/journal.pone.0181686			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1ED	28753629	Green Published, gold			2022-12-26	WOS:000406579300022
J	Romagnuolo, R; Scipione, CA; Marcovina, SM; Gemin, M; Seidah, NG; Boffa, MB; Koschinsky, ML				Romagnuolo, Rocco; Scipione, Corey A.; Marcovina, Santica M.; Gemin, Matthew; Seidah, Nabil G.; Boffa, Michael B.; Koschinsky, Marlys L.			Roles of the low density lipoprotein receptor and related receptors in inhibition of lipoprotein(a) internalization by proprotein convertase subtilisin/kexin type 9	PLOS ONE			English	Article							EVOLOCUMAB AMG 145; MONOCLONAL-ANTIBODY; LP(A) LIPOPROTEIN; PRIMARY HYPERCHOLESTEROLEMIA; MYOCARDIAL-INFARCTION; HUMAN-FIBROBLASTS; PCSK9 INHIBITION; POOLED ANALYSIS; PHASE-2 TRIALS; LDL RECEPTOR	Elevated plasma concentrations of lipoprotein(a) (Lp(a)) are a causal risk factor for cardiovascular disease. The mechanisms underlying Lp(a) clearance from plasma remain unclear, which is an obvious barrier to the development of therapies to specifically lower levels of this lipoprotein. Recently, it has been documented that monoclonal antibody inhibitors of proprotein convertase subtilisin/kexin type 9 (PCSK9) can lower plasma Lp(a) levels by 30%. Since PCSK9 acts primarily through the low density lipoprotein receptor (LDLR), this result is in conflict with the prevailing view that the LDLR does not participate in Lp(a) clearance. To support our recent findings in HepG2 cells that the LDLR can act as a bona fide receptor for Lp(a) whose effects are sensitive to PCSK9, we undertook a series of Lp(a) internalization experiments using different hepatic cells, with different variants of PCSK9, and with different members of the LDLR family. We found that PCSK9 decreased Lp(a) and/or apo(a) internalization by Huh7 human hepatoma cells and by primary mouse and human hepatocytes. Overexpression of human LDLR appeared to enhance apo(a)/Lp(a) internalization in both types of primary cells. Importantly, internalization of Lp(a) by LDLR-deficient mouse hepatocytes was not affected by PCSK9, but the effect of PCSK9 was restored upon overexpression of human LDLR. In HepG2 cells, Lp(a) internalization was decreased by gain-of-function mutants of PCSK9 more than by wild-type PCSK9, and a loss-of function variant had a reduced ability to influence Lp(a) internalization. Apo(a) internalization by HepG2 cells was not affected by apo(a) isoform size. Finally, we showed that very low density lipoprotein receptor (VLDLR), LDR-related protein (LRP)-8, and LRP-1 do not play a role in Lp(a) internalization or the effect of PCSK9 on Lp(a) internalization. Our findings are consistent with the idea that PCSK9 inhibits Lp(a) clearance through the LDLR, but do not exclude other effects of PCSK9 such as on Lp(a) biosynthesis.	[Romagnuolo, Rocco; Scipione, Corey A.; Gemin, Matthew] Univ Windsor, Dept Chem & Biochem, Windsor, ON, Canada; [Marcovina, Santica M.] Univ Washington, Dept Med, Northwest Lipid Res Labs, Seattle, WA USA; [Seidah, Nabil G.] IRCM, Lab Biochem Neuroendocrinol, Montreal, PQ, Canada; [Boffa, Michael B.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Biochem, London, ON, Canada; [Koschinsky, Marlys L.] Univ Western Ontario, Schulich Sch Med & Dent, Robarts Res Inst, London, ON, Canada; [Koschinsky, Marlys L.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON, Canada	University of Windsor; University of Washington; University of Washington Seattle; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Koschinsky, ML (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Robarts Res Inst, London, ON, Canada.; Koschinsky, ML (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON, Canada.	mlk@robarts.ca	Seidah, Nabil/I-3596-2013; Scipione, Corey A/AAH-2200-2019	Seidah, Nabil/0000-0001-6503-9342; Scipione, Corey A/0000-0002-0052-8038; Koschinsky, Marlys/0000-0002-2643-2288	Regeneron Pharmaceuticals, Inc.	Regeneron Pharmaceuticals, Inc.(Regeneron)	The work was funded through a research contract from Regeneron Pharmaceuticals, Inc. The funders had no role in study design or data collection and analysis. The funders reviewed the manuscript and approved it for submission.; This study was funded by Regeneron Pharmaceuticals, Inc.	Abifadel M, 2009, HUM MUTAT, V30, P520, DOI 10.1002/humu.20882; Alonso R, 2014, J AM COLL CARDIOL, V63, P1983, DOI 10.1016/j.jacc.2014.01.063; Argraves KM, 1997, J CLIN INVEST, V100, P2170, DOI 10.1172/JCI119753; Becker L, 2004, BIOCHEMISTRY-US, V43, P9978, DOI 10.1021/bi049536d; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; BOERWINKLE E, 1992, J CLIN INVEST, V90, P52, DOI 10.1172/JCI115855; Cain WJ, 2005, J LIPID RES, V46, P2681, DOI 10.1194/jlr.M500249-JLR200; Canuel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064145; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Croyal M, 2015, ARTERIOSCL THROM VAS, V35, P2042, DOI 10.1161/ATVBAHA.115.305835; Desai NR, 2013, CIRCULATION, V128, P962, DOI 10.1161/CIRCULATIONAHA.113.001969; Fitzgerald K, 2015, AM HEART ASS SESS 20; FLOREN CH, 1981, BIOCHEM BIOPH RES CO, V102, P636, DOI 10.1016/S0006-291X(81)80179-9; FRYKMAN PK, 1995, P NATL ACAD SCI USA, V92, P8453, DOI 10.1073/pnas.92.18.8453; Gaudet D, 2014, AM J CARDIOL, V114, P711, DOI 10.1016/j.amjcard.2014.05.060; HAVEKES L, 1981, FEBS LETT, V132, P169, DOI 10.1016/0014-5793(81)81153-2; HOFMANN SL, 1990, J CLIN INVEST, V85, P1542, DOI 10.1172/JCI114602; Kamstrup PR, 2009, JAMA-J AM MED ASSOC, V301, P2331, DOI 10.1001/jama.2009.801; Khera AV, 2014, CIRCULATION, V129, P635, DOI 10.1161/CIRCULATIONAHA.113.004406; KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P913; Koschinsky M, 2014, EXPERT OPIN THER TAR, V18, P747, DOI 10.1517/14728222.2014.920326; Koschinsky ML, 2014, ENDOCRIN METAB CLIN, V43, P949, DOI 10.1016/j.ecl.2014.08.002; Kosenko T, 2013, J BIOL CHEM, V288, P8279, DOI 10.1074/jbc.M112.421370; Kraft HG, 2000, ARTERIOSCL THROM VAS, V20, P522, DOI 10.1161/01.ATV.20.2.522; KREMPLER F, 1987, J CLIN INVEST, V80, P401, DOI 10.1172/JCI113086; Kronenberg F, 2013, J INTERN MED, V273, P6, DOI 10.1111/j.1365-2796.2012.02592.x; LACKNER C, 1993, HUM MOL GENET, V2, P933, DOI 10.1093/hmg/2.7.933; Lambert G, 2012, J LIPID RES, V53, P2515, DOI 10.1194/jlr.R026658; Langsted A, 2016, J CLIN ENDO IN PRESS; Marcovina SM, 1996, J LIPID RES, V37, P2569; MARZ W, 1993, FEBS LETT, V325, P271, DOI 10.1016/0014-5793(93)81087-G; Mayne J, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-22; McKenney JM, 2012, J AM COLL CARDIOL, V59, P2344, DOI 10.1016/j.jacc.2012.03.007; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Niemeier A, 1999, ARTERIOSCL THROM VAS, V19, P552, DOI 10.1161/01.ATV.19.3.552; Ooi EM, 2015, ARTERIOSCL THROM VAS, V35, P2686, DOI 10.1161/ATVBAHA.115.306136; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Raal FJ, 2016, J LIPID RES, V57, P1086, DOI 10.1194/jlr.P065334; Raal FJ, 2014, J AM COLL CARDIOL, V63, P1278, DOI 10.1016/j.jacc.2014.01.006; RADER DJ, 1994, J CLIN INVEST, V93, P2758, DOI 10.1172/JCI117292; RADER DJ, 1995, J CLIN INVEST, V95, P1403, DOI 10.1172/JCI117794; Reblin T, 1997, J LIPID RES, V38, P2103; Reyes-Soffer G, 2017, CIRCULATION, V135, P352, DOI 10.1161/CIRCULATIONAHA.116.025253; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Romagnuolo R, 2015, J BIOL CHEM, V290, P11649, DOI 10.1074/jbc.M114.611988; Roth EM, 2012, NEW ENGL J MED, V367, P1891, DOI 10.1056/NEJMoa1201832; Saavedra YGL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072113; Shapiro MD, 2016, CIRC RES, V118, P732, DOI 10.1161/CIRCRESAHA.115.306471; Stein EA, 2014, EUR HEART J, V35, P2249, DOI 10.1093/eurheartj/ehu085; Strong A, 2012, J CLIN INVEST, V122, P2807, DOI 10.1172/JCI63563; Tam SP, 1996, J LIPID RES, V37, P518; Tavori H, 2016, CIRC RES, V119, P29, DOI 10.1161/CIRCRESAHA.116.308811; VANDERHOEK YY, 1993, HUM MOL GENET, V2, P361, DOI 10.1093/hmg/2.4.361; Villard Elise F, 2016, JACC Basic Transl Sci, V1, P419, DOI 10.1016/j.jacbts.2016.06.006; White AL, 1997, J BIOL CHEM, V272, P5048, DOI 10.1074/jbc.272.8.5048; Yang XP, 2013, J LIPID RES, V54, P2450, DOI 10.1194/jlr.M038877	57	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0180869	10.1371/journal.pone.0180869	http://dx.doi.org/10.1371/journal.pone.0180869			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750079	Green Submitted, Green Published, gold			2022-12-26	WOS:000406575700020
J	Maier, A; Wu, H; Cordasic, N; Oefner, P; Dietel, B; Thiele, C; Weidemann, A; Eckardt, KU; Warnecke, C				Maier, Anja; Wu, Hao; Cordasic, Nada; Oefner, Peter; Dietel, Barbara; Thiele, Christoph; Weidemann, Alexander; Eckardt, Kai-Uwe; Warnecke, Christina			Hypoxia-inducible protein 2 Hig2/Hilpda mediates neutral lipid accumulation in macrophages and contributes to atherosclerosis in apolipoprotein E-deficient mice	FASEB JOURNAL			English	Article						foam cell; lipid droplets; hypoxia-inducible factor-1	DROPLET PROTEIN; CELLS; GENE; LIPOLYSIS; TARGET; CANCER; CYCLOOXYGENASE-2; MICROENVIRONMENT; OVEREXPRESSION; INFLAMMATION	Recently we identified hypoxia-inducible protein 2 (HIG2)/hypoxia-inducible lipid droplet-associated (HILPDA) as lipid droplet (LD) protein. Because HILPDA is highly expressed in atherosclerotic plaques, we examined its regulation and function in murine macrophages, compared it to the LD adipose differentiation-related protein (Adrp)/perilipin 2 (Plin2), and investigated its effects on atherogenesis in apolipoprotein E-deficient (ApoE(-/-)) mice. Tie2-Cre-driven Hilpda conditional knockout (cKO) did not affect viability, proliferation, and ATP levels in macrophages. Hilpda proved to be a target of hypoxia-inducible factor 1 (Hif-1) andperoxisomeproliferator-activated receptors. In contrast, Adrp/Plin2 was not induced by Hif-1. Hilpda localized to the endoplasmic reticulum-LD interface, the site of LD formation. Hypoxic lipid accumulation and storage of oxidized LDL, cholesteryl esters and triglycerides were abolished in Hilpda cKO macrophages, independent of the glycolytic switch, fatty acid or lipoprotein uptake. Hilpda depletion reduced resistance against lipid overload and increased production of reactive oxygen species after reoxygenation. LPS-stimulated prostaglandin-E2 production was dysregulated in macrophages, demonstrating the substrate buffer and reservoir function of LDs for eicosanoid production. In ApoE(-/-) Hilpda cKO mice, total aortic plaque area, plaque macrophages and vascular Vegf expression were reduced. Thus, macrophage Hilpda is crucial to foam-cell formation and lipid deposition, and to controlled prostaglandin-E2 production. By these means Hilpda promotes lesion formation and progression of atherosclerosis.-Maier, A., Wu, H., Cordasic, N., Oefner, P., Dietel, B., Thiele, C., Weidemann, A., Eckardt, K.-U., Warnecke, C. Hypoxia-inducible protein 2 Hig2/Hilpda mediates neutral lipid accumulation in macrophages and contributes to atherosclerosis in apolipoprotein E-deficient mice.	[Maier, Anja; Cordasic, Nada; Weidemann, Alexander; Eckardt, Kai-Uwe; Warnecke, Christina] Friedrich Alexander Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, Erlangen, Germany; [Dietel, Barbara] Friedrich Alexander Univ Erlangen Nurnberg, Dept Mol Cardiol & Angiol, Erlangen, Germany; [Wu, Hao] Johns Hopkins Univ Sch Med, Dept Mol Biol & Genet, Baltimore, MD USA; [Wu, Hao] Johns Hopkins Univ Sch Med, Howard Hughes Med Inst, Baltimore, MD USA; [Oefner, Peter] Univ Regensburg, Inst Funct Genom, Regensburg, Germany; [Thiele, Christoph] Univ Bonn, Life & Med Sci LIMES Inst, Bonn, Germany; [Weidemann, Alexander] Univ Witten Herdecke, Med Ctr Cologne Merheim, Dept Med Nephrol Transplantat & Med Intens Care 1, Cologne, Germany; [Wu, Hao] MIT, Whitehead Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; University of Regensburg; University of Bonn; Witten Herdecke University; Massachusetts Institute of Technology (MIT); Whitehead Institute	Warnecke, C (corresponding author), Univ Hosp Erlangen, Translat Res Ctr, Labs Med Clin 4, Schwabachanlage 12, D-91054 Erlangen, Germany.	christina.warnecke@uk-erlangen.de			Interdisciplinary Center for Clinical Research (IZKF) Erlangen [A56]; Doktor-Robert-Pfleger Foundation, Bamberg; Human Frontier Science Program fellowship [LT000125/2009-L]; National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator award fellowship [22950]	Interdisciplinary Center for Clinical Research (IZKF) Erlangen; Doktor-Robert-Pfleger Foundation, Bamberg; Human Frontier Science Program fellowship(Human Frontier Science Program); National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator award fellowship	The authors thank E. Schefler and J. Baumgartl (both from Friedrich-Alexander-University Erlangen-Nurnberg) for excellent technical assistance. C.W. was supported by the Interdisciplinary Center for Clinical Research (IZKF) Erlangen (Project A56) and the Doktor-Robert-Pfleger Foundation, Bamberg. H.W. was supported by a Human Frontier Science Program fellowship (LT000125/2009-L) and a National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator award fellowship (Grant 22950). The authors declare no conflicts of interest.	Accioly MT, 2008, CANCER RES, V68, P1732, DOI 10.1158/0008-5472.CAN-07-1999; Bensaad K, 2014, CELL REP, V9, P349, DOI 10.1016/j.celrep.2014.08.056; Bozza PT, 2009, BBA-MOL CELL BIOL L, V1791, P540, DOI 10.1016/j.bbalip.2009.01.005; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Chaudhari SM, 2015, ARTERIOSCL THROM VAS, V35, P2316, DOI 10.1161/ATVBAHA.115.306171; Cipollone F, 2001, CIRCULATION, V104, P921, DOI 10.1161/hc3401.093152; Crucet M, 2013, ATHEROSCLEROSIS, V229, P110, DOI 10.1016/j.atherosclerosis.2013.04.034; Dehne N, 2009, EXP CELL RES, V315, P1791, DOI 10.1016/j.yexcr.2009.03.019; Dietel B, 2013, ATHEROSCLEROSIS, V230, P92, DOI 10.1016/j.atherosclerosis.2013.06.014; DiStefano MT, 2016, MOL METAB, V5, P1149, DOI 10.1016/j.molmet.2016.09.009; DiStefano MT, 2015, J BIOL CHEM, V290, P15175, DOI 10.1074/jbc.M115.650184; Gimm T, 2010, FASEB J, V24, P4443, DOI 10.1096/fj.10-159806; Gomez I, 2013, PROSTAG LEUKOTR ESS, V89, P55, DOI 10.1016/j.plefa.2013.04.004; GORDON GB, 1977, AM J PATHOL, V88, P663; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Hulbert AJ, 2005, BIOL REV, V80, P155, DOI 10.1017/S1464793104006578; Jacobi J, 2010, AM J PATHOL, V176, P2559, DOI 10.2353/ajpath.2010.090614; Kaushik S, 2015, NAT CELL BIOL, V17, P759, DOI 10.1038/ncb3166; Kim SH, 2013, CANCER LETT, V341, P159, DOI 10.1016/j.canlet.2013.07.028; Lee K, 2013, ATHEROSCLEROSIS, V226, P74, DOI 10.1016/j.atherosclerosis.2012.09.037; Marsch E, 2013, CURR OPIN LIPIDOL, V24, P393, DOI 10.1097/MOL.0b013e32836484a4; Mattijssen F, 2014, J BIOL CHEM, V289, P19279, DOI 10.1074/jbc.M114.570044; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Parathath S, 2013, TRENDS CARDIOVAS MED, V23, P80, DOI 10.1016/j.tcm.2012.09.004; Richard D, 2008, PHARMACOL RES, V57, P451, DOI 10.1016/j.phrs.2008.05.002; Sankaranarayanan S, 2011, J LIPID RES, V52, P2332, DOI 10.1194/jlr.D018051; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen GM, 2015, MOL MED REP, V12, P8055, DOI 10.3892/mmr.2015.4488; Spandl J, 2009, TRAFFIC, V10, P1579, DOI 10.1111/j.1600-0854.2009.00980.x; Takeda N, 2010, GENE DEV, V24, P491, DOI 10.1101/gad.1881410; Thiele C, 2012, ACS CHEM BIOL, V7, P2004, DOI 10.1021/cb300414v; Togashi A, 2005, CANCER RES, V65, P4817, DOI 10.1158/0008-5472.CAN-05-0120; Warnecke C, 2003, FASEB J, V17, P1186, DOI 10.1096/fj.02-1062fje; Weller Peter F, 2016, Trans Am Clin Climatol Assoc, V127, P328; Xu SW, 2010, CYTOTECHNOLOGY, V62, P473, DOI 10.1007/s10616-010-9290-0	36	34	35	3	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4971	4984		10.1096/fj.201700235R	http://dx.doi.org/10.1096/fj.201700235R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28760743				2022-12-26	WOS:000413398500027
J	Zeng, SC; Liu, LJ; Sun, Y; Lu, GX; Lin, G				Zeng, Sicong; Liu, Lvjun; Sun, Yi; Lu, Guangxiu; Lin, Ge			Role of telomeric repeat-containing RNA in telomeric chromatin remodeling during the early expansion of human embryonic stem cells	FASEB JOURNAL			English	Article						histone demethylation; telomere length; TERRA; TRF1	HUMAN BLASTOCYSTS; SELF-RENEWAL; IN-VITRO; LENGTH; TERRA; ELONGATION; DIFFERENTIATION; TRANSCRIPTION; PLURIPOTENCY; ASSOCIATION	This study aimed to explore the role of telomeric repeat-containing RNA (TERRA) in telomeric chromatin remodeling during the early expansion of human embryonic stem cells (hESCs). During the derivation of hESCs, histone demethylation in the telomeric region facilitates telomerase-mediated telomere elongation. An adequate telomere repeat is essential for hESCs to acquire and/or maintain the unlimited symmetric division, which suggests that there is a link between pluripotency and telomere maintenance. The present study found that the gradual decrease in TERRA levels and related TERRA foci were correlated with telomeric length elongation in the early expansion of hESCs. In addition, TERRA participated in telomeric chromatin remodeling by cooperating with SUV39H1 (suppressor of variegation 3-9 homolog 1/2) to propagate telomeric heterochromatin marker, histone H3 trimethylation of lysine 9. Moreover, the fibroblast growth factor signaling pathway, which is activated in hESCs, could suppress TERRA levels via telomeric repeat factor 1, which results in reduced SUV39H1 recruitment by TERRA at the telomere. Taken together, these results highlight the role of TERRA in hESC telomere elongation and homeostasis in the acquisition and/or maintenance of stem cell pluripotency.	[Zeng, Sicong; Liu, Lvjun; Sun, Yi; Lin, Ge] Cent S Univ, Inst Reprod & Stem Cell Engn, Sch Basic Med Sci, 110 Xiangya St, Changsha 410001, Hunan, Peoples R China; [Zeng, Sicong; Liu, Lvjun; Sun, Yi; Lu, Guangxiu; Lin, Ge] Natl Engn & Res Ctr Human Stem Cell, Changsha, Hunan, Peoples R China	Central South University	Lin, G (corresponding author), Cent S Univ, Inst Reprod & Stem Cell Engn, Sch Basic Med Sci, 110 Xiangya St, Changsha 410001, Hunan, Peoples R China.	2670162908@qq.com		Sun, Yi/0000-0001-9238-976X	postdoctoral research station of Central South University - China Postdoctoral Science Foundation [2014M560650]; National Natural Science Foundation of China [31401248]; Natural Science Foundation of Hunan Province [14JJ2004, 2014SK3066]	postdoctoral research station of Central South University - China Postdoctoral Science Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province)	The authors thank Dr. Pingyuan Xie for data analysis and Dr. Di Zhou and Lamei Cheng for proofreading. This work was supported by the postdoctoral research station of Central South University and funded by the China Postdoctoral Science Foundation (2014M560650; to S.Z.), the National Natural Science Foundation of China (Grant 31401248; to S.Z.), and the Natural Science Foundation of Hunan Province (Grants 14JJ2004 and 2014SK3066; to Y.S.). The authors declare no conflicts of interest.	Agarwal S, 2010, NATURE, V464, P292, DOI 10.1038/nature08792; Arnoult N, 2012, NAT STRUCT MOL BIOL, V19, P948, DOI 10.1038/nsmb.2364; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Bartman CM, 2015, EXP CELL RES, V330, P178, DOI 10.1016/j.yexcr.2014.07.020; Benetti R, 2007, J CELL BIOL, V178, P925, DOI 10.1083/jcb.200703081; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 2005, EMBO J, V24, P1095, DOI 10.1038/sj.emboj.7600598; Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38; Cusanelli E, 2013, MOL CELL, V51, P780, DOI 10.1016/j.molcel.2013.08.029; Dai C, 2015, J BIOL CHEM, V290, P22423, DOI 10.1074/jbc.M115.642710; Deng Z, 2009, MOL CELL, V35, P403, DOI 10.1016/j.molcel.2009.06.025; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Garcia-Cao M, 2004, NAT GENET, V36, P94, DOI 10.1038/ng1278; Gil ME, 2004, MOL BIOTECHNOL, V27, P169, DOI 10.1385/MB:27:2:169; Ginis I, 2004, DEV BIOL, V269, P360, DOI 10.1016/j.ydbio.2003.12.034; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Hiyama E, 2007, BRIT J CANCER, V96, P1020, DOI 10.1038/sj.bjc.6603671; Huang JJ, 2011, CELL RES, V21, P779, DOI 10.1038/cr.2011.16; Le RR, 2014, CELL STEM CELL, V14, P27, DOI 10.1016/j.stem.2013.11.005; Lin G, 2009, CELL STEM CELL, V5, P461, DOI 10.1016/j.stem.2009.10.009; Liu L, 2017, TRENDS GENET, V33, P16, DOI 10.1016/j.tig.2016.10.007; Marion RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025680; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Moravec M, 2016, EMBO REP, V17, P999, DOI 10.15252/embr.201541708; Niida H, 1998, NAT GENET, V19, P203, DOI 10.1038/580; Nishikawa T, 2001, STRUCTURE, V9, P1237, DOI 10.1016/S0969-2126(01)00688-8; Porro A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6379; Porro A, 2014, CELL REP, V6, P765, DOI 10.1016/j.celrep.2014.01.022; Porro A, 2010, MOL CELL BIOL, V30, P4808, DOI 10.1128/MCB.00460-10; Pucci F, 2013, CELL STEM CELL, V12, P479, DOI 10.1016/j.stem.2013.01.018; Scheibe M, 2013, GENOME RES, V23, P2149, DOI 10.1101/gr.151878.112; Schneider RP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2946; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Song XP, 2015, ONCOTARGET, V6, P5263, DOI 10.18632/oncotarget.3029; Dang-Nguyen TQ, 2013, J REPROD DEVELOP, V59, P27; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Varela E, 2011, P NATL ACAD SCI USA, V108, P15207, DOI 10.1073/pnas.1105414108; Xie CQ, 2003, CHINESE SCI BULL, V48, P354, DOI 10.1360/03tb9075; Xie PY, 2014, STEM CELLS, V32, P391, DOI 10.1002/stem.1558; Yang CB, 2008, STEM CELLS, V26, P850, DOI 10.1634/stemcells.2007-0677; Zeng SC, 2014, J CELL SCI, V127, P752, DOI 10.1242/jcs.131433; Zhang LF, 2009, GENETICS, V182, P685, DOI 10.1534/genetics.109.103093	44	5	6	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4783	4795		10.1096/fj.201600939RR	http://dx.doi.org/10.1096/fj.201600939RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28765174				2022-12-26	WOS:000413398500011
J	Hino, T; Hamamoto, H; Suzuki, H; Yagi, H; Ohshiro, T; Nagano, S				Hino, Tomoya; Hamamoto, Haruka; Suzuki, Hirokazu; Yagi, Hisashi; Ohshiro, Takashi; Nagano, Shingo			Crystal structures of TdsC, a dibenzothiophene monooxygenase from the thermophile Paenibacillus sp A11-2, reveal potential for expanding its substrate selectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLAVIN-DEPENDENT MONOOXYGENASE; DESULFURIZING ENZYMES; HYDROXYBENZOATE HYDROXYLASE; SULFONE MONOOXYGENASE; OXYGENASE COMPONENT; DBT DESULFURIZATION; FUNCTIONAL-ANALYSIS; PURIFICATION; DSZC; C4A-HYDROPEROXYFLAVIN	Sulfur compounds in fossil fuels are a major source of environmental pollution, and microbial desulfurization has emerged as a promising technology for removing sulfur under mild conditions. The enzyme TdsC from the thermophile Paenibacillus sp. A11-2 is a two-component flavin-dependent monooxygenase that catalyzes the oxygenation of dibenzothiophene (DBT) to its sulfoxide (DBTO) and sulfone (DBTO2) during microbial desulfurization. The crystal structures of the apo and flavin mononucleotide (FMN)-bound forms of DszC, an ortholog of TdsC, were previously determined, although the structure of the ternary substrate-FMN-enzyme complex remains unknown. Herein, we report the crystal structures of the DBT-FMN-TdsC and DBTO-FMN-TdsC complexes. These ternary structures revealed many hydrophobic and hydrogen-bonding interactions with the substrate, and the position of the substrate could reasonably explain the two-step oxygenation of DBT by TdsC. Wealso determined the crystal structure of the indole-bound enzyme because TdsC, but not DszC, can also oxidize indole, and we observed that indole binding did not induce global conformational changes in TdsC with or without bound FMN. We also found that the two loop regions close to the FMN-binding site are disordered in apo-TdsC and become structured upon FMN binding. Alanine substitutions of Tyr-93 and His-388, which are located close to the substrate and FMNbound to TdsC, significantly decreased benzothiophene oxygenation activity, suggesting their involvement in supplying protons to the active site. Interestingly, these substitutions increased DBT oxygenation activity by TdsC, indicating that expanding the substrate-binding site can increase the oxygenation activity of TdsConlargersulfur-containingsubstrates, apropertythatshould prove useful for future microbial desulfurization applications.	[Hino, Tomoya; Hamamoto, Haruka; Suzuki, Hirokazu; Yagi, Hisashi; Ohshiro, Takashi; Nagano, Shingo] Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, 4-101 Koyamacho Minami, Tottori 6808552, Japan	Tottori University	Ohshiro, T; Nagano, S (corresponding author), Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, 4-101 Koyamacho Minami, Tottori 6808552, Japan.	ohshiro@bio.tottori-u.ac.jp; snagano@bio.tottori-u.ac.jp	Suzuki, Hirokazu/AAG-2285-2020	Suzuki, Hirokazu/0000-0002-9507-6467				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alfieri A, 2007, P NATL ACAD SCI USA, V104, P1177, DOI 10.1073/pnas.0608381104; [Anonymous], 2015, PYMOL MOL GRAPH SYST; Ballou DP, 2005, BIOCHEM BIOPH RES CO, V338, P590, DOI 10.1016/j.bbrc.2005.09.081; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Chaiyen P, 2004, BIOCHEMISTRY-US, V43, P3933, DOI 10.1021/bi035734d; Chaiyen P, 2012, TRENDS BIOCHEM SCI, V37, P373, DOI 10.1016/j.tibs.2012.06.005; Chenprakhon P, 2014, BIOCHEMISTRY-US, V53, P4084, DOI 10.1021/bi500480n; Duan X, 2013, ACTA CRYSTALLOGR F, V69, P597, DOI 10.1107/S1744309113011172; Ellis HR, 2010, ARCH BIOCHEM BIOPHYS, V497, P1, DOI 10.1016/j.abb.2010.02.007; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Entsch B, 2005, ARCH BIOCHEM BIOPHYS, V433, P297, DOI 10.1016/j.abb.2004.09.029; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gonzalez-Osorio L, 2016, BIOCHEM BIOPH RES CO, V481, P189, DOI 10.1016/j.bbrc.2016.10.145; Gray KA, 2003, CURR OPIN MICROBIOL, V6, P229, DOI 10.1016/S1369-5274(03)00065-1; Guan LJ, 2015, FEBS J, V282, P3126, DOI 10.1111/febs.13216; Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005; Ishii Y, 2000, BIOCHEM BIOPH RES CO, V270, P81, DOI 10.1006/bbrc.2000.2370; JONES KC, 1986, J BIOL CHEM, V261, P2553; Joosten V, 2007, CURR OPIN CHEM BIOL, V11, P195, DOI 10.1016/j.cbpa.2007.01.010; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim JJP, 2004, EUR J BIOCHEM, V271, P483, DOI 10.1046/j.1432-1033.2003.03948.x; Kim SH, 2007, J BIOL CHEM, V282, P33107, DOI 10.1074/jbc.M703440200; Kirimura K, 2004, APPL MICROBIOL BIOT, V65, P703, DOI 10.1007/s00253-004-1652-0; Kirimura K, 2001, J BIOSCI BIOENG, V91, P262, DOI 10.1263/jbb.91.262; Konishi J, 2003, APPL MICROBIOL BIOT, V62, P356, DOI 10.1007/s00253-003-1331-6; Konishi J, 2002, APPL MICROBIOL BIOT, V60, P128, DOI 10.1007/s00253-002-1096-3; Konishi J, 1997, APPL ENVIRON MICROB, V63, P3164, DOI 10.1128/AEM.63.8.3164-3169.1997; Konishi J, 2000, J BIOSCI BIOENG, V90, P607, DOI 10.1263/jbb.90.607; Li JC, 2009, BIORESOURCE TECHNOL, V100, P2594, DOI 10.1016/j.biortech.2008.12.009; Liu SH, 2014, PROTEINS, V82, P1708, DOI 10.1002/prot.24525; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mohebali G, 2008, MICROBIOL-SGM, V154, P2169, DOI 10.1099/mic.0.2008/017608-0; Nakayama N, 2002, BBA-PROTEINS PROTEOM, V1598, P122, DOI 10.1016/S0167-4838(02)00365-5; Ohshiro T, 2005, J BIOSCI BIOENG, V100, P266, DOI 10.1263/jbb.100.266; Ohshiro T, 1997, J FERMENT BIOENG, V83, P233, DOI 10.1016/S0922-338X(97)80985-3; Ohshiro T, 1999, J BIOSCI BIOENG, V88, P610, DOI 10.1016/S1389-1723(00)87088-7; Ohshiro T., 2003, ENCY ENV MICROBIOLOG, P1041; Ohshiro T, 2009, BIOSCI BIOTECH BIOCH, V73, P2128, DOI 10.1271/bbb.90284; Ortiz-Maldonado M, 1999, BIOCHEMISTRY-US, V38, P8124, DOI 10.1021/bi990560e; PIDDINGTON CS, 1995, APPL ENVIRON MICROB, V61, P468, DOI 10.1128/AEM.61.2.468-475.1995; SCHREUDER HA, 1990, BIOCHEMISTRY-US, V29, P3101, DOI 10.1021/bi00464a029; Terwilliger TC, 2012, ACTA CRYSTALLOGR D, V68, P861, DOI 10.1107/S0907444912015636; Thotsaporn K, 2011, J BIOL CHEM, V286, P28170, DOI 10.1074/jbc.M111.241836; Ueno G, 2016, AIP CONF PROC, V1741, DOI 10.1063/1.4952941; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; Visitsatthawong S, 2015, J AM CHEM SOC, V137, P9363, DOI 10.1021/jacs.5b04328; Zhang L, 2014, PROTEINS, V82, P2733, DOI 10.1002/prot.24638	49	10	10	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15804	15813		10.1074/jbc.M117.788513	http://dx.doi.org/10.1074/jbc.M117.788513			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28768765	Green Published, hybrid			2022-12-26	WOS:000411512200018
J	Kang, MY; Hong, YC				Kang, Mo-Yeol; Hong, Yun-Chul			Crossover effect of spouse weekly working hours on estimated 10-years risk of cardiovascular disease	PLOS ONE			English	Article							DUAL-EARNER COUPLES; FAMILY CONFLICT; SPILLOVER; STRESSORS; HEALTH; HOME	Objectives To investigate the association between spouse weekly working hours (SWWH) and the estimated 10-years risk of cardiovascular disease (CVD). Methods This cross-sectional study was based on the data obtained from the Korean National Health and Nutrition Examination Survey 2007-2012. Data of 16,917 participants (8,330 husbands, 8,587 wives) were used for this analysis. The participants' clinical data were collected to estimate the 10-years risk of CVD, as well as weekly working hours. Multiple logistic regression was conducted to investigate the association between SWWH and the estimated 10-years risk of CVD. We also performed a stratified analysis according to each participant's and their spouse's employment status. Results Compared to those whose spouses worked 30 hours per week, estimated 10-years risk of CVD was significantly higher as SWWH increase among those whose spouses worked >30 hours per week. After adjusting for covariates, the odds ratio for high CVD risk was found to increase as SWWH increased, up to 2.52 among husbands and 2.43 among wives. We also found that the association between SWWH and the estimated 10-years risk of CVD varied according to the employment status. Analysis of each component included in the CVD appraisal model showed that SWWH had close relationship with diabetes in men, and smoking habits in women. Conclusions Spouse's long working hours are associated with individual's risk of CVD in future, especially among husbands.	[Kang, Mo-Yeol; Hong, Yun-Chul] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Hong, Yun-Chul] Seoul Natl Univ, Inst Environm Med, Med Res Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Hong, YC (corresponding author), Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.; Hong, YC (corresponding author), Seoul Natl Univ, Inst Environm Med, Med Res Ctr, Seoul, South Korea.	ychong1@snu.ac.kr	Hong, Yun-Chul/J-5725-2012	Hong, Yun-Chul/0000-0001-9010-7271				ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Bianchi SM, 2010, J MARRIAGE FAM, V72, P705, DOI 10.1111/j.1741-3737.2010.00726.x; Caruso CC, 2004, DHHS NIOSH PUBLICATI, DOI 10.26616/NIOSHPUB2004143; Demerouti E, 2005, J VOCAT BEHAV, V67, P266, DOI 10.1016/j.jvb.2004.07.001; Dewe P, 2004, PERSONNEL PSYCHOL, V57; Golden L., 2006, J SOCIO-ECON, V35, P382, DOI DOI 10.1016/J.S0CEC.2005.11.039; Grzywacz JG, 2013, CURR ISS WORK ORGAN, P110; Hammer LB, 2005, J OCCUP HEALTH PSYCH, V10, P138, DOI 10.1037/1076-8998.10.2.138; Jee SH, 2013, EUROPEAN J PREVENTIV; Jee SH, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005025; Kivimaki M, 2015, LANCET, V386, P1739, DOI 10.1016/S0140-6736(15)60295-1; Matthews RA, 2006, J OCCUP HEALTH PSYCH, V11, P228, DOI 10.1037/1076-8998.11.3.228; Newman DA, 2014, ORGAN RES METHODS, V17, P372, DOI 10.1177/1094428114548590; Raley S, 2012, AM J SOCIOL, V117, P1422, DOI 10.1086/663354; Repetti R, 2009, CURR DIR PSYCHOL SCI, V18, P106, DOI 10.1111/j.1467-8721.2009.01618.x; Rodriguez-Munoz A, 2014, J HAPPINESS STUD, V15, P271, DOI 10.1007/s10902-013-9421-3; Saxbe D, 2010, J PERS SOC PSYCHOL, V98, P92, DOI 10.1037/a0016959; Shimazu A, 2013, J OCCUP HEALTH, V55, P234, DOI 10.1539/joh.12-0252-OA; Song ZL, 2008, J APPL PSYCHOL, V93, P443, DOI 10.1037/0021-9010.93.2.443; SPITZE G, 1988, J MARRIAGE FAM, V50, P595, DOI 10.2307/352633; Vaananen A, 2005, J PERS SOC PSYCHOL, V89, P176, DOI 10.1037/0022-3514.89.2.176; Westman M, 2001, J ORGAN BEHAV, V22, P467, DOI 10.1002/job.91; Westman M, 2001, HUM RELAT, V54, P717, DOI 10.1177/0018726701546002; Westman M, 1998, HUM RELAT, V51, P137, DOI 10.1023/A:1016910118568; Westman M, 2008, J OCCUP HEALTH PSYCH, V13, P168, DOI 10.1037/1076-8998.13.2.168; Westman M, 2009, J ORGAN BEHAV, V30, P587, DOI 10.1002/job.616	26	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182010	10.1371/journal.pone.0182010	http://dx.doi.org/10.1371/journal.pone.0182010			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC5AR	28771506	Green Published, Green Submitted, gold			2022-12-26	WOS:000406853600055
J	Li, YQ; Pei, L; Li, J; Wang, YQ; Yuan, J; Ning, TG				Li, Yueqin; Pei, Li; Li, Jing; Wang, Yiqun; Yuan, Jin; Ning, Tigang			Photonic instantaneous frequency measurement of wideband microwave signals	PLOS ONE			English	Article							ADJUSTABLE MEASUREMENT RANGE; DOPED FIBER LASER; SINGLE-POLARIZATION; PERFORMANCE ANALYSIS; PHASE MODULATION; TUNABLE RANGE; RESOLUTION; CHANNELIZER; FILTER	We propose a photonic system for instantaneous frequency measurement (IFM) of wideband microwave signals with a tunable measurement range and resolution based on a polarization-maintaining fiber Bragg grating (PM-FBG). Firstly, in order to be insensitive to laser power fluctuation, we aim at generating two different frequency to amplitude characteristics so that we can normalize them to obtain an amplitude comparison function (ACF). Then we encode these two different wavelengths in two perpendicular polarizations by using the PM-FBG which shows different transmission profiles at two polarizations. The ACF is capable of being adjusted by tuning polarization angle, therefore the measurement range and resolution are tunable. By theoretical analyses and simulated verification, a frequency measurement range of 0 similar to 17.2 GHz with average resolution of +/- 0.12 GHz can be achieved, which signifies a wide measurement range with relatively high resolution. Our system does not require large optical bandwidth for the components because the wavelength spacing can be small, making the system affordable, stable, and reliable with more consistent characteristics due to the narrowband nature of the optical parts. PM-FBG with high integration can be potentially used for more polarization manipulating systems and the use of a single-polarization dual-wavelength laser can simplify the architecture and enhance the stability.	[Li, Yueqin; Pei, Li; Li, Jing; Wang, Yiqun; Yuan, Jin; Ning, Tigang] Beijing Jiaotong Univ, Inst Lightwave Technol, Key Lab All Opt Network & Adv Telecommun Network, Minist Educ, Beijing, Peoples R China; [Li, Yueqin] Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90024 USA; [Li, Yueqin] Calif NanoSyst Inst, Los Angeles, CA USA	Beijing Jiaotong University; University of California System; University of California Los Angeles	Pei, L (corresponding author), Beijing Jiaotong Univ, Inst Lightwave Technol, Key Lab All Opt Network & Adv Telecommun Network, Minist Educ, Beijing, Peoples R China.	lipei@bjtu.edu.cn			National Natural Science Foundation of China [61525501, 61405007]; Fundamental Research Funds for the Central Universities [2016YJS020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was jointly supported by the National Natural Science Foundation of China, http://www.nsfc.gov.cn/, (Grant No. 61525501 and 61405007) and the Fundamental Research Funds for the Central Universities (Grant No. 2016YJS020).	Attygalle M, 2009, IEEE PHOTONIC TECH L, V21, P206, DOI 10.1109/LPT.2008.2010000; Chi H, 2008, IEEE PHOTONIC TECH L, V20, P1249, DOI 10.1109/LPT.2008.926025; Feng SC, 2008, OPT EXPRESS, V16, P11830, DOI 10.1364/OE.16.011830; Li JQ, 2009, OPT LETT, V34, P743, DOI 10.1364/OL.34.000743; Li J, 2014, OPT LASER TECHNOL, V63, P54, DOI 10.1016/j.optlastec.2014.04.003; Li J, 2013, OPT LASER TECHNOL, V48, P210, DOI 10.1016/j.optlastec.2012.08.038; Li W, 2012, IEEE PHOTONICS J, V4, P427, DOI 10.1109/JPHOT.2012.2189102; Li W, 2012, OPT LETT, V37, P166, DOI 10.1364/OL.37.000166; Li YQ, 2015, OPT COMMUN, V354, P140, DOI 10.1016/j.optcom.2015.05.050; Li Z, 2010, OPT COMMUN, V283, P396, DOI 10.1016/j.optcom.2009.10.036; Nguyen LVT, 2009, IEEE PHOTONIC TECH L, V21, P642, DOI 10.1109/LPT.2009.2015890; Pan SL, 2010, IEEE PHOTONIC TECH L, V22, P1437, DOI 10.1109/LPT.2010.2059004; Vidal B, 2011, OPT COMMUN, V284, P3996, DOI 10.1016/j.optcom.2011.04.044; Wang WS, 2001, IEEE T MICROW THEORY, V49, P1996, DOI 10.1109/22.954820; Winnall ST, 2006, IEEE T MICROW THEORY, V54, P868, DOI 10.1109/TMTT.2005.863052; Yin B, 2014, OPT EXPRESS, V22, P22528, DOI 10.1364/OE.22.022528; Yin B, 2014, IEEE PHOTONIC TECH L, V26, P1227, DOI 10.1109/LPT.2014.2318773; Zhang HL, 2013, IEEE MICROW WIREL CO, V23, P623, DOI 10.1109/LMWC.2013.2280638; Zhang HL, 2013, ELECTRON LETT, V49, P277, DOI 10.1049/el.2012.3552; Zhang WF, 2012, IEEE PHOTONICS J, V4, P889, DOI 10.1109/JPHOT.2012.2199481; Zhang XM, 2009, IEEE MICROW WIREL CO, V19, P422, DOI 10.1109/LMWC.2009.2020046; Zhou JQ, 2009, OPT EXPRESS, V17, P7217, DOI 10.1364/OE.17.007217; Zou XH, 2009, J LIGHTWAVE TECHNOL, V27, P5314, DOI 10.1109/JLT.2009.2030695; Zou XH, 2008, IEEE PHOTONIC TECH L, V20, P1989, DOI 10.1109/LPT.2008.2005505	24	9	9	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182231	10.1371/journal.pone.0182231	http://dx.doi.org/10.1371/journal.pone.0182231			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771636	Green Submitted, gold, Green Published			2022-12-26	WOS:000406853600079
J	Moon, KA; Navas-Acien, A; Grau-Perez, M; Francesconi, KA; Goessler, W; Guallar, E; Umans, JG; Best, LG; Newman, JD				Moon, Katherine A.; Navas-Acien, Ana; Grau-Perez, Maria; Francesconi, Kevin A.; Goessler, Walter; Guallar, Eliseo; Umans, Jason G.; Best, Lyle G.; Newman, Jonathan D.			Low-moderate urine arsenic and biomarkers of thrombosis and inflammation in the Strong Heart Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; PLASMINOGEN-ACTIVATOR; AMERICAN-INDIANS; DRINKING-WATER; RISK-FACTORS; EXPOSURE; POPULATION; ASSOCIATION; PLASMA	The underlying pathology of arsenic-related cardiovascular disease (CVD) is unknown. Few studies have evaluated pathways through thrombosis and inflammation for arsenic-related CVD, especially at low-moderate arsenic exposure levels (<100 mu g/L in drinking water). We evaluated the association of chronic low-moderate arsenic exposure, measured as the sum of inorganic and methylated arsenic species in urine (Sigma As), with plasma biomarkers of thrombosis and inflammation in American Indian adults (45-74 years) in the Strong Heart Study. We evaluated the cross-sectional and longitudinal associations between baseline Sigma As with fibrinogen at three visits (baseline, 1989-91; Visit 2, 1993-95, Visit 3, 1998-99) using mixed models and the associations between baseline Sigma As and Visit 2 plasminogen activator inhibitor-1 (PAI-1) and high sensitivity C-reactive protein (hsCRP) using linear regression. Median (interquartile range) concentrations of baseline Sigma As and fibrinogen, and Visit 2 hsCRP and PAI-1 were 8.4 (5.1, 14.3) mu g/g creatinine, 346 (304, 393) mg/dL, 44 (30, 67) mg/L, and 3.8 (2.0, 7.0) ng/mL, respectively. Comparing the difference between the 75th and the 25th percentile of Sigma As (14.3 vs. 5.1 mu g/g creatinine), Sigma As was positively associated with baseline fibrinogen among those with diabetes (adjusted geometric mean ratio (GMR): 1.05, 95% CI: 1.02, 1.07) not associated among those without diabetes (GMR: 1.01, 95% CI: 0.99, 1.02) (p-interaction for diabetes = 0.014), inversely associated with PAI-1 (GMR: 0.94, 95% CI: 0.90, 0.99), and not associated with hsCRP (GMR: 1.00, 95% CI: 0.93, 1.08). We found no evidence for an association between baseline Sigma As and annual change in fibrinogen over follow-up (p-interaction = 0.28 and 0.12 for diabetes and non-diabetes, respectively). Low-moderate arsenic exposure was positively associated with baseline fibrinogen in participants with diabetes and unexpectedly inversely associated with PAI-1. Further research should evaluate the role of prothrombotic factors in arsenic-related cardiovascular disease.	[Moon, Katherine A.; Navas-Acien, Ana; Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Navas-Acien, Ana; Grau-Perez, Maria] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; [Francesconi, Kevin A.; Goessler, Walter] Karl Franzens Univ Graz, Inst Chem Analyt Chem, Graz, Austria; [Umans, Jason G.] MedStar Hlth Res Inst, Hyattsville, MD USA; [Best, Lyle G.] Missouri Breaks Ind Res, Timber Lake, SD USA; [Newman, Jonathan D.] NYU, Sch Med, New York, NY USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Graz; MedStar Health Research Institute; New York University	Moon, KA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.	kmoon9@jhu.edu	Goessler, Walter/A-1084-2016	Goessler, Walter/0000-0002-0142-9373; Grau Perez, Maria/0000-0003-1660-9972; Newman, Jonathan/0000-0001-6855-7305	National Institute of Environmental Health Sciences [1R01E5025216, R01ES021367, 5P42ES10349]; National Heart Lung and Blood Institute [5T32HL007024]; National Heart, Lung, and Blood Institute (NHBLI) [K23HL125991]; American Heart Association Mentored Clinical and Population Research Award [15MCPRP24480132]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001409] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109284] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung, and Blood Institute (NHBLI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Mentored Clinical and Population Research Award(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the National Institute of Environmental Health Sciences (1R01E5025216, R01ES021367, and 5P42ES10349) to ANA, JGU, and LGB. K. A. Moon was supported by the National Heart Lung and Blood Institute (5T32HL007024). Dr. Newman was partially funded by the National Heart, Lung, and Blood Institute (NHBLI) (K23HL125991) and the American Heart Association Mentored Clinical and Population Research Award (15MCPRP24480132). Missouri Breaks Industries provided support in the form of compensation for Dr. Lyle Best, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles are articulated in the author contributions section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhyankar LN, 2012, ENVIRON HEALTH PERSP, V120, P494, DOI 10.1289/ehp.1103988; ALDERMAN MH, 1993, AM J HYPERTENS, V6, P896, DOI 10.1093/ajh/6.10.896; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; American Diabetes Association, 2002, CLIN DIABETES, V20, P53; ANGLETON P, 1989, CIRCULATION, V79, P101, DOI 10.1161/01.CIR.79.1.101; Avogaro A, 2011, DIABETES CARE, V34, pS285, DOI 10.2337/dc11-s239; Ayotte J.D., 2011, TRACE ELEMENTS RADON; Balakumar P, 2009, CARDIOVASC TOXICOL, V9, P169, DOI 10.1007/s12012-009-9050-6; Best LG, 2004, HUM HERED, V58, P112, DOI 10.1159/000083032; Best LG, 2005, CIRCULATION, V112, P1289, DOI 10.1161/CIRCULATIONAHA.104.489260; Brohall G, 2006, DIABETIC MED, V23, P609, DOI 10.1111/j.1464-5491.2005.01725.x; Centers for Disease Control and Prevention, 2009, 4 REP HUM EXP ENV CH; Chen Y, 2013, ENVIRON HEALTH PERSP, V121, P832, DOI 10.1289/ehp.1205797; Chen Y, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2431; CLAUSS A., 1957, ACTA HAEMATOL, V17, P237; Dandona P, 2003, J CLIN ENDOCR METAB, V88, P2422, DOI 10.1210/jc.2003-030178; Danesh J, 2005, JAMA-J AM MED ASSOC, V294, P1799, DOI 10.1001/jama.294.14.1799; Davalos D, 2012, SEMIN IMMUNOPATHOL, V34, P43, DOI 10.1007/s00281-011-0290-8; DECLERCK P J, 1988, Blood, V71, P220; Druwe IL, 2012, TOXICOL APPL PHARM, V261, P263, DOI 10.1016/j.taap.2012.04.005; Dubin R, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-3; Farzan SF, 2015, TOXICOL APPL PHARM, V287, P93, DOI 10.1016/j.taap.2015.05.013; FOLSOM A R, 1992, Ethnicity and Disease, V2, P35; FOLSOM AR, 1995, EUR HEART J, V16, P21, DOI 10.1093/eurheartj/16.suppl_A.21; Folsom AR, 2001, ARTERIOSCL THROM VAS, V21, P611, DOI 10.1161/01.ATV.21.4.611; Fonseca V, 2004, ENDOCR REV, V25, P153, DOI 10.1210/er.2002-0034; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gilbert-Diamond D, 2011, P NATL ACAD SCI USA, V108, P20656, DOI 10.1073/pnas.1109127108; Gribble MO, 2012, AM J EPIDEMIOL, V176, P865, DOI 10.1093/aje/kws153; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Howard BV, 1999, CIRCULATION, V99, P2389, DOI 10.1161/01.CIR.99.18.2389; HOWARD BV, 1992, DIABETES, V41, P4, DOI 10.2337/diab.41.2.S4; Hutson SS, ESTIMATED USE WATER; Ibrahim JG, 2009, TEST-SPAIN, V18, P1, DOI 10.1007/s11749-009-0138-x; James KA, 2015, ENVIRON HEALTH PERSP, V123, P128, DOI 10.1289/ehp.1307839; Jiang SJ, 2002, THROMB RES, V105, P55, DOI 10.1016/S0049-3848(01)00397-8; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Karas MG, 2012, STROKE, V43, P720, DOI 10.1161/STROKEAHA.111.631168; Ken-Dror G, 2012, EUR J EPIDEMIOL, V27, P267, DOI 10.1007/s10654-012-9666-x; Kizer JR, 2009, AM J CARDIOL, V104, P247, DOI 10.1016/j.amjcard.2009.03.026; Kuo C-C, CARDIOVASCU IN PRESS; Laakso M, 2010, DIABETES CARE, V33, P442, DOI 10.2337/dc09-0749; LEE ET, 1990, AM J EPIDEMIOL, V132, P1141, DOI 10.1093/oxfordjournals.aje.a115757; Lee MY, 2002, TOXICOL APPL PHARM, V179, P83, DOI 10.1006/taap.2001.9356; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Macy EM, 1997, CLIN CHEM, V43, P52; Martin-Timon I, 2014, WORLD J DIABETES, V5, P444, DOI 10.4239/wjd.v5.i4.444; Moon KA, 2013, ANN INTERN MED, V159, P649, DOI 10.7326/0003-4819-159-10-201311190-00719; National Research Council, 2013, CRIT ASP EPAS IRIS A; Navas-Acien A, 2013, JAMA INTERN MED, V173, P1395, DOI 10.1001/jamainternmed.2013.6405; Navas-Acien A, 2009, ENVIRON HEALTH PERSP, V117, P1428, DOI 10.1289/ehp.0800509; Nermell B, 2008, ENVIRON RES, V106, P212, DOI 10.1016/j.envres.2007.08.005; North KE, 2003, AM J EPIDEMIOL, V157, P303, DOI 10.1093/aje/kwf208; Okafor ON, 2015, J AM COLL CARDIOL, V65, P1683, DOI 10.1016/j.jacc.2015.02.040; Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360; Palmieri V, 2003, AM HEART J, V145, P467, DOI 10.1067/mhj.2003.144; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Peters BA, 2015, FREE RADICAL BIO MED, V85, P174, DOI 10.1016/j.freeradbiomed.2015.04.020; Ridker PM, 2016, CIRC RES, V118, P145, DOI 10.1161/CIRCRESAHA.115.306656; Ridker PM, 2004, CIRCULATION, V109, P6, DOI 10.1161/01.CIR.0000133444.17867.56; Rudnicka AR, 2007, CIRCULATION, V115, P996, DOI 10.1161/CIRCULATIONAHA.106.635169; Ryan PB, 2000, ENVIRON HEALTH PERSP, V108, P731, DOI 10.2307/3434726; Scheer J, 2012, ANAL METHODS-UK, V4, P406, DOI 10.1039/c2ay05638k; Shara NM, 2012, AM J KIDNEY DIS, V60, P795, DOI 10.1053/j.ajkd.2012.06.015; Shen M C, 1983, Taiwan Yi Xue Hui Za Zhi, V82, P816; Sohel N, 2009, EPIDEMIOLOGY, V20, P824, DOI 10.1097/EDE.0b013e3181bb56ec; Stanton Bruce A, 2015, Curr Environ Health Rep, V2, P329, DOI 10.1007/s40572-015-0057-9; Stec JJ, 2000, CIRCULATION, V102, P1634, DOI 10.1161/01.CIR.102.14.1634; Stoddart M L, 2000, Am Indian Alsk Native Ment Health Res, V9, P20; Szmitko PE, 2003, CIRCULATION, V108, P1917, DOI 10.1161/01.CIR.0000089190.95415.9F; Tofler GH, 2016, THROMB RES, V140, P30, DOI 10.1016/j.thromres.2016.02.002; Van de Craen B, 2012, THROMB RES, V130, P576, DOI 10.1016/j.thromres.2012.06.023; Wang CCL, 2016, CIRCULATION, V133, P2459, DOI 10.1161/CIRCULATIONAHA.116.022194; Wang CH, 2007, TOXICOL APPL PHARM, V222, P315, DOI 10.1016/j.taap.2006.12.022; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Wu F., 2014, ADV METEOROL, V2014, P1; Wu F, 2012, AM J EPIDEMIOL, V175, P1252, DOI 10.1093/aje/kwr464; WU HL, 1993, THROMB RES, V72, P211, DOI 10.1016/0049-3848(93)90188-T; Xue JP, 2010, ENVIRON HEALTH PERSP, V118, P345, DOI 10.1289/ehp.0901205; Zheng LY, 2015, EPIDEMIOLOGY, V26, P601, DOI 10.1097/EDE.0000000000000313; Zheng LY, 2013, AM J KIDNEY DIS, V61, P385, DOI 10.1053/j.ajkd.2012.09.011	82	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182435	10.1371/journal.pone.0182435	http://dx.doi.org/10.1371/journal.pone.0182435			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771557	Green Published, Green Submitted, gold			2022-12-26	WOS:000406853600114
J	Xi, Y; Jiao, WX; Cao, JK; Jiang, WB				Xi, Yu; Jiao, Wenxiao; Cao, Jiankang; Jiang, Weibo			Effects of chlorogenic acid on capacity of free radicals scavenging and proteomic changes in postharvest fruit of nectarine	PLOS ONE			English	Article							ANTIOXIDANT CAPACITY; TOMATO FRUIT; PEACH FRUIT; STORAGE; PURIFICATION; PEROXIDASE; COMPONENTS; PROTEINS; QUALITY; PROFILE	To study how chlorogenic acid affects changes of reactive oxygen species (ROS) and the proteins involved in ROS scavenging of nectarine during storage time, the fruits were treated with chlorogenic acid (CHA) then stored at 25 degrees C for further studies. The CHA-treatment significantly reduced O-2(-). production rate, H2O2 content, and membrane permeability of nectarine fruit during storage. The key proteins related the nectarine fruit senescence during storage were identified by two-dimensional electrophoresis and MALDI-TOF/TOF. Level and enzymatic activity of peroxidase were reduced, while both the protein levels and the enzymatic activities of superoxide dismutase, glutathione reductase, glutathione-s-transferase and monodehydroascorbate reductase were enhanced in nectarine fruit treated with CHA. In addition, levels of several pathogen-related proteins were also enhanced by CHA-treatment. Taking together, the present study showed that CHA could influence changes in defense related proteins and reduced oxidative damage in nectarine fruit during postharvest ripening.	[Xi, Yu; Jiao, Wenxiao; Cao, Jiankang; Jiang, Weibo] China Agr Univ, Coll Food Sci & Nutr Engn, 17 Qinghua Donglu, Beijing, Peoples R China	China Agricultural University	Jiang, WB (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, 17 Qinghua Donglu, Beijing, Peoples R China.	jwb@cau.edu.cn			National Basic Research Program (973) of China [2013CB127106]	National Basic Research Program (973) of China(National Basic Research Program of China)	This work was supported by the National Basic Research Program (973) of China (2013CB127106) http://www.most.gov.cn/index.htm to Weibo Jiang. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	BEERS RF, 1952, J BIOL CHEM, V195, P133; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chan ZL, 2007, J PROTEOME RES, V6, P1677, DOI 10.1021/pr060483r; Ding CK, 2001, PLANT SCI, V161, P1153, DOI 10.1016/S0168-9452(01)00521-0; Dixit V, 2001, J EXP BOT, V52, P1101, DOI 10.1093/jexbot/52.358.1101; Giraldo E, 2012, J PROTEOMICS, V75, P5774, DOI 10.1016/j.jprot.2012.08.005; Huang GJ, 2008, J AGR FOOD CHEM, V56, P2989, DOI 10.1021/jf072994j; Jimenez A, 2002, PLANTA, V214, P751, DOI 10.1007/s004250100667; Jing GX, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-19; Mdluli KM, 2005, FOOD CHEM, V92, P311, DOI 10.1016/j.foodchem.2004.07.026; NAKANO Y, 1987, PLANT CELL PHYSIOL, V28, P131; Ozkaya O, 2016, SCI HORTIC-AMSTERDAM, V198, P454, DOI 10.1016/j.scienta.2015.12.016; Scattino C, 2014, FOOD CHEM, V163, P51, DOI 10.1016/j.foodchem.2014.04.077; Shi JY, 2009, LWT-FOOD SCI TECHNOL, V42, P477, DOI 10.1016/j.lwt.2008.09.008; Speranza A, 2012, PLANT BIOLOGY, V14, P64, DOI 10.1111/j.1438-8677.2011.00479.x; Stojanovic BT, 2016, NOT BOT HORTI AGROBO, V44, P175, DOI 10.15835/nbha44110192; Tian SP, 2013, PLANT MOL BIOL, V82, P593, DOI 10.1007/s11103-013-0035-2; Toivonen PMA, 1998, J AGR FOOD CHEM, V46, P20, DOI 10.1021/jf970490n; Veal EA, 2004, MOL CELL, V15, P129, DOI 10.1016/j.molcel.2004.06.021; Velikova V, 2000, PLANT SCI, V151, P59, DOI 10.1016/S0168-9452(99)00197-1; Wang JH, 2015, POSTHARVEST BIOL TEC, V101, P1, DOI 10.1016/j.postharvbio.2014.11.004; Wang LJ, 2014, SCI HORTIC-AMSTERDAM, V178, P14, DOI 10.1016/j.scienta.2014.07.038; Wang SY, 2001, J AGR FOOD CHEM, V49, P4977, DOI 10.1021/jf0106244; Xi Y., 2016, PLOS ONE, V11; Xi Y, 2017, LWT-FOOD SCI TECHNOL, V75, P537, DOI 10.1016/j.lwt.2016.10.004; Zhang L, 2011, J PROTEOMICS, V74, P1135, DOI 10.1016/j.jprot.2011.04.012; Zhang ZK, 2015, FOOD CHEM, V171, P191, DOI 10.1016/j.foodchem.2014.09.001	27	16	16	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182494	10.1371/journal.pone.0182494	http://dx.doi.org/10.1371/journal.pone.0182494			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771559	gold, Green Published, Green Submitted			2022-12-26	WOS:000406853600126
J	Karade, SK; Kulkarni, SS; Ghate, MV; Patil, AA; Londhe, R; Salvi, SP; Kadam, DB; Joshi, RK; Rewari, BB; Gangakhedkar, RR				Karade, Santosh K.; Kulkarni, Smita S.; Ghate, Manisha V.; Patil, Ajit A.; Londhe, Rajkumar; Salvi, Sonali P.; Kadam, Dileep B.; Joshi, Rajneesh K.; Rewari, Bharat B.; Gangakhedkar, Raman R.			Antiretroviral resistance following immunological monitoring in a resource-limited setting of western India: A cross-sectional study	PLOS ONE			English	Article							HIV DRUG-RESISTANCE; HIV-1-INFECTED INDIVIDUALS; FAILURE IMPLICATIONS; VIROLOGICAL FAILURE; THERAPY; MUTATIONS; FREQUENCY; CRITERIA	Background The free antiretroviral therapy (ART) program in India still relies on the clinico-immunological monitoring for diagnosis of treatment failure. As the nucleoside reverse transcriptase inhibitor (NRTI) backbone is shared in first-and second-line regimens, accumulation of drug resistant mutations (DRMs) can compromise the efficacy of NRTI. This study was undertaken to describe the pattern of HIV DRMs following immunological monitoring and investigate its impact on the cycling of NRTI between first-and second-line ART. Methods and findings This cross-sectional study was performed at a state-sponsored ART clinic of Pune city in western India between January and June 2016. Consecutive adults receiving first-line ART with immunological failure (IF) were recruited for plasma viral load (PVL) estimation. Randomly selected 80 participants with PVL > 1000 copies/mL underwent HIV drug resistance genotyping. Of these, 75 plasma sample were successfully genotyped. The median CD4 count and duration of ART at the time of failure were 98 (IQR: 61.60-153.50) cells/mu L and 4.62 (IQR: 3.17-6.15) years, respectively. The prevalence of NRTI, non-NRTI, and major protease inhibitor resistance mutations were 89.30%, 96%, and 1.33%, respectively. Following first-line failure, sequences from 56.67% of individuals indicated low-to high-level resistance to all available NRTI. The proportion of sequences with >= 2 thymidine analogue mutations (TAMs) and >= 3 TAMs were 62.12% and 39.39%, respectively. An average of 1.98 TAMs per sequence were observed following IF as compared to 0.37 TAMs per sequence following targeted PVL monitoring at 12 months of ART from a prior study; this difference was significant (p< 0.001). Conclusion The option of cycling of NRTI analogues between first-and second-line regimens would no longer be effective if individuals are followed-up by immunological monitoring due to accumulation of mutations. Introduction of routine PVL monitoring is a priority for the long-term sustainability of free ART program in India.	[Karade, Santosh K.; Patil, Ajit A.] Natl AIDS Res Inst ICMR, HIV Drug Resistance Lab, Pune, Maharashtra, India; [Karade, Santosh K.] Armed Forces Med Coll, Dept Microbiol, Pune, Maharashtra, India; [Kulkarni, Smita S.; Londhe, Rajkumar] Natl AIDS Res Inst ICMR, Dept Virol, Pune, Maharashtra, India; [Ghate, Manisha V.; Gangakhedkar, Raman R.] Natl AIDS Res Inst ICMR, Dept Clin Sci, Pune, Maharashtra, India; [Salvi, Sonali P.; Kadam, Dileep B.] BJ Med Coll & Sasoon Gen Hosp, Dept Med, Pune, Maharashtra, India; [Joshi, Rajneesh K.] Natl AIDS Res Inst ICMR, Dept Epidemiol & Biostat, Pune, Maharashtra, India; [Joshi, Rajneesh K.] Armed Forces Med Coll, Dept Community Med, Pune, Maharashtra, India; [Rewari, Bharat B.] Natl AIDS Control Org, Dept AIDS Control, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); Armed Forces Medical College; Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); B.J. Govt. Medical College & Sassoon General Hospitals, Pune; Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); Armed Forces Medical College	Gangakhedkar, RR (corresponding author), Natl AIDS Res Inst ICMR, Dept Clin Sci, Pune, Maharashtra, India.	rgangakhedkar@nariindia.org		Joshi, Rajneesh/0000-0001-6275-7269; Londhe, Rajkumar/0000-0002-1184-7667; KARADE, SANTOSH/0000-0002-0427-3909; Patil, Ajit/0000-0002-6976-0978	intramural grant of Indian Council for Medical Research (ICMR), New Delhi; office of Director General Armed Forces Medical Services, New Delhi	intramural grant of Indian Council for Medical Research (ICMR), New Delhi; office of Director General Armed Forces Medical Services, New Delhi	The work was partially funded by intramural grant of Indian Council for Medical Research (ICMR), New Delhi. Dr Santosh Karade, PhD research scholar was sponsored by the office of Director General Armed Forces Medical Services, New Delhi. The funding agency and sponsors have no role in planning or implementation of the study.	Anquetil D, 2012, AIDS RES HUM RETROV, V28, P1793, DOI [10.1089/aid.2012.0060, 10.1089/AID.2012.0060]; Chaturbhuj DN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087441; Cozzi-Lepri A, 2009, J INFECT DIS, V200, P687, DOI 10.1086/604731; Department of AIDS Control NACO Ministry of Health and family Welfare Government of India, 2013, ANT THER GUID HIV IN; Ekstrand ML, 2011, INT HEALTH, V3, P27, DOI 10.1016/j.inhe.2010.11.003; Hamers RL, 2012, CLIN INFECT DIS, V54, P1660, DOI 10.1093/cid/cis254; Hingankar NK, 2012, CLIN INFECT DIS, V54, pS348, DOI 10.1093/cid/cis005; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; Huang A, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofv158; Kandathil AJ, 2009, INDIAN J MED MICROBI, V27, P231, DOI 10.4103/0255-0857.53205; Kannangai R, 2015, MOL DIAGN THER, V19, P273, DOI 10.1007/s40291-015-0160-5; Kantor R, 2015, PRETREATMENT HIV DRU; Karade S, 2015, LTD HIV PRETREATMENT; Karade SK, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004886; Kumarasamy N, 2009, CLIN INFECT DIS, V49, P306, DOI 10.1086/600044; Mehta Kedar G, 2016, J Family Med Prim Care, V5, P266; National AIDS Control Organisation. Department of Health and Family Welfare, 2013, NAT GUID 2 LIN ALT 1; National AIDS Control Organization and National Institute of Medical Statistics (ICMR), 2015, TECHNICAL REPORT; National AIDS Control Organization Department of AIDS Control Ministry of Health and Family Welfare. Government of India, 201415 MIN HLTH FAM; Ndembi N, 2010, J INFECT DIS, V201, P106, DOI 10.1086/648590; Patil RT, 2014, ISRN AIDS, V2014; Reynolds SJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-381; Rutherford GW, 2014, AIDS, V28, pS161, DOI 10.1097/QAD.0000000000000236; Sinha S, 2012, CURR HIV RES, V10, P532, DOI 10.2174/157016212802429785; Sivamalar S, 2016, ACCUMULATION HIV 1 D; Vallabhaneni S, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18449; Vidya M, 2009, ANTIVIR THER, V14, P1005, DOI 10.3851/IMP1411; World Health Organization, 2016, CONS GUID US ANT DRU	28	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0181889	10.1371/journal.pone.0181889	http://dx.doi.org/10.1371/journal.pone.0181889			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763465	Green Published, gold, Green Submitted			2022-12-26	WOS:000406766500026
J	Xue, FZ; Li, Q; Li, XM				Xue, Fangzheng; Li, Qian; Li, Xiumin			The combination of circle topology and leaky integrator neurons remarkably improves the performance of echo state network on time series prediction	PLOS ONE			English	Article							SELF-ORGANIZATION; NEURAL ENERGY	Recently, echo state network (ESN) has attracted a great deal of attention due to its high accuracy and efficient learning performance. Compared with the traditional random structure and classical sigmoid units, simple circle topology and leaky integrator neurons have more advantages on reservoir computing of ESN. In this paper, we propose a new model of ESN with both circle reservoir structure and leaky integrator units. By comparing the prediction capability on Mackey-Glass chaotic time series of four ESN models: classical ESN, circle ESN, traditional leaky integrator ESN, circle leaky integrator ESN, we find that our circle leaky integrator ESN shows significantly better performance than other ESNs with roughly 2 orders of magnitude reduction of the predictive error. Moreover, this model has stronger ability to approximate nonlinear dynamics and resist noise than conventional ESN and ESN with only simple circle structure or leaky integrator neurons. Our results show that the combination of circle topology and leaky integrator neurons can remarkably increase dynamical diversity and meanwhile decrease the correlation of reservoir states, which contribute to the significant improvement of computational performance of Echo state network on time series prediction.	[Xue, Fangzheng; Li, Qian; Li, Xiumin] Chongqing Univ, Minist Educ, Key Lab Dependable Serv Comp Cyber Phys Soc, Chongqing 400044, Peoples R China; [Xue, Fangzheng; Li, Qian; Li, Xiumin] Chongqing Univ, Coll Automat, Chongqing 400044, Peoples R China	Chongqing University; Chongqing University	Li, XM (corresponding author), Chongqing Univ, Minist Educ, Key Lab Dependable Serv Comp Cyber Phys Soc, Chongqing 400044, Peoples R China.; Li, XM (corresponding author), Chongqing Univ, Coll Automat, Chongqing 400044, Peoples R China.	xmli@cqu.edu.cn	Li, Xiumin/ABA-5948-2020	Li, Xiumin/0000-0002-2398-4757	National Natural Science Foundation of China [61473051, 61304165]; Natural Science Foundation of Chongqing [cstc2016jcyjA0015]; Fundamental Research Funds for the Central Universities [106112017CDJXY170004, CQDXWL-2012-172]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Chongqing(Natural Science Foundation of Chongqing); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is supported by the National Natural Science Foundation of China (Nos. 61473051), Natural Science Foundation of Chongqing (No. cstc2016jcyjA0015) and Fundamental Research Funds for the Central Universities (No. 106112017CDJXY170004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by the National Natural Science Foundation of China (Nos. 61473051 and 61304165), Natural Science Foundation of Chongqing (No. cstc2016jcyjA0015) and Fundamental Research Funds for the Central Universities (No. 106112017CDJXY170004 and Nos. CQDXWL-2012-172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchi FM, 2015, NEURAL NETWORKS, V71, P204, DOI 10.1016/j.neunet.2015.08.010; Bo Yang, 2012, Frontiers of Electrical and Electronic Engineering in China, V7, P200, DOI 10.1007/s11460-011-0176-5; Chrol-Cannon J, 2014, BIOSYSTEMS, V125, P43, DOI 10.1016/j.biosystems.2014.04.003; Cui HY, 2014, NEURAL NETWORKS, V57, P141, DOI 10.1016/j.neunet.2014.05.013; Deng ZD, 2007, IEEE T NEURAL NETWOR, V18, P1364, DOI 10.1109/TNN.2007.894082; Gao ZK, 2017, INT J NEURAL SYST, V27, DOI 10.1142/S0129065717500058; Gao ZK, 2016, EPL-EUROPHYS LETT, V116, DOI 10.1209/0295-5075/116/50001; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Gao ZK, 2016, IEEE T INSTRUM MEAS, V65, P1690, DOI 10.1109/TIM.2016.2540862; Holzmann G, 2010, NEURAL NETWORKS, V23, P244, DOI 10.1016/j.neunet.2009.07.004; Jaeger H, 2005, IEEE IJCNN, P1460; Jaeger H, 2004, SCIENCE, V304, P78, DOI 10.1126/science.1091277; Jaeger H., 2002, TUTORIAL TRAINING RE, V5; Jaeger H., 2007, DISCOVERING MULTISCA; Jaeger H., 2001, TECH REP 148, V148; Jaeger H, 2003, ADV NEURAL INFORM PR, P609; Jaegera H, 2007, NEURAL NETWORKS, V20, P335, DOI 10.1016/j.neunet.2007.04.016; Li DC, 2012, IEEE T NEUR NET LEAR, V23, P787, DOI 10.1109/TNNLS.2012.2188414; Li XM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120750; Lin XW, 2009, EXPERT SYST APPL, V36, P7313, DOI 10.1016/j.eswa.2008.09.049; Liu Xiang, 2012, Journal of China Universities of Posts and Telecommunications, V19, P87, DOI 10.1016/S1005-8885(11)60232-X; Lukosevicius M, 2009, COMPUT SCI REV, V3, P127, DOI 10.1016/j.cosrev.2009.03.005; Lun SX, 2015, NEUROCOMPUTING, V159, P58, DOI 10.1016/j.neucom.2015.02.029; Rodan A, 2011, IEEE T NEURAL NETWOR, V22, P131, DOI 10.1109/TNN.2010.2089641; Shi Zhi-wei, 2007, Control and Decision, V22, P258; Shutin D, 2012, NEURAL COMPUT, V24, P967, DOI 10.1162/NECO_a_00253; Skowronski MD, 2007, IEEE T AUDIO SPEECH, V15, P1724, DOI 10.1109/TASL.2007.896669; Skowronski MD, 2006, IEEE INT SYMP CIRC S, P3153, DOI 10.1109/ISCAS.2006.1693294; Strauss T, 2012, NEURAL COMPUT, V24, P3246, DOI 10.1162/NECO_a_00374; Tong MH, 2007, NEURAL NETWORKS, V20, P424, DOI 10.1016/j.neunet.2007.04.013; Wang L, 2016, EXPERT SYST APPL, V43, P237, DOI 10.1016/j.eswa.2015.08.055; Wang RB, 2016, COGN NEURODYNAMICS, V10, P1, DOI 10.1007/s11571-015-9354-0; Wang S, 2006, WCICA 2006: SIXTH WORLD CONGRESS ON INTELLIGENT CONTROL AND AUTOMATION, VOLS 1-12, CONFERENCE PROCEEDINGS, P3014; Wang YH, 2017, COGN NEURODYNAMICS, V11, P99, DOI 10.1007/s11571-016-9412-2; Wang ZY, 2015, COGN NEURODYNAMICS, V9, P129, DOI 10.1007/s11571-014-9311-3; Wang ZY, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00014; Xue YB, 2007, NEURAL NETWORKS, V20, P365, DOI 10.1016/j.neunet.2007.04.014; Yin J, 2012, IEEE T AUTON MENT DE, V4, P273, DOI 10.1109/TAMD.2012.2182765; Yu P, 2011, IEEE IMTC P, P670	40	8	8	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0181816	10.1371/journal.pone.0181816	http://dx.doi.org/10.1371/journal.pone.0181816			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759581	Green Published, gold, Green Submitted			2022-12-26	WOS:000406761600030
J	Dahl, V; Wallensten, A				Dahl, Viktor; Wallensten, Anders			Self-reported infections during international travel and notifiable infections among returning international travellers, Sweden, 2009-2013	PLOS ONE			English	Article							FINNISH NATIONWIDE DATA; RISK; ABROAD; OUTBREAK; ILLNESS; REGIONS	We studied food and water-borne diseases (FWDs), sexually transmitted diseases (STDs), vector-borne diseases (VBDs) and diseases vaccinated against in the Swedish childhood vaccination programme among Swedish international travellers, in order to identify countries associated with a high number of infections. We used the national database for notifiable infections to estimate the number of FWDs (campylobacteriosis, salmonellosis, giardiasis, shigellosis, EHEC, Entamoeba histolytica, yersinosis, hepatitis A, paratyphoid fever, typhoid fever, hepatitis E, listeriosis, cholera), STIs (chlamydia, gonorrhoea and acute hepatitis B), VBDs (dengue fever, malaria, West Nile fever, Japanese encephalitis and yellow fever) and diseases vaccinated against in the Swedish childhood vaccination programme (pertussis, measles, mumps, rubella, diphtheria) acquired abroad 2009-2013. We obtained number and duration of trips to each country from a database that monthly collects travel data from a randomly selected proportion of the Swedish population. We calculated number of infections per country 2009-2013 and incidence/million travel days for the five countries with the highest number of infections. Thailand had the highest number of FWDs (7,697, incidence 191/million travel days), STIs (1,388, incidence 34/million travel days) and VBDs (358, incidence 9/million travel days). France had the highest number of cases of diseases vaccinated against in the Swedish childhood vaccination programme (8, 0.4/million travel days). Swedish travellers contracted most infections in Thailand. Special focus should be placed on giving advice to travellers to this destination.	[Dahl, Viktor; Wallensten, Anders] Publ Hlth Agcy Sweden, Stockholm, Sweden; [Dahl, Viktor] European Ctr Dis Prevent & Control ECDC, EPIET, Stockholm, Sweden; [Wallensten, Anders] Uppsala Univ, Dept Med Sci, Uppsala, Sweden	Public Health Agency of Sweden; European Centre for Disease Prevention & Control; Uppsala University	Dahl, V (corresponding author), Publ Hlth Agcy Sweden, Stockholm, Sweden.; Dahl, V (corresponding author), European Ctr Dis Prevent & Control ECDC, EPIET, Stockholm, Sweden.	viktor.dahl@folkhalsomyndigheten.se		Dahl, Viktor/0000-0001-9921-5172				AHLM C, 1994, SCAND J INFECT DIS, V26, P711, DOI 10.3109/00365549409008640; [Anonymous], 2014, ANN EP REP 2014 FOOD; Askling HH, 2009, J TRAVEL MED, V16, P233, DOI 10.1111/j.1708-8305.2009.00307.x; Askling HH, 2005, EMERG INFECT DIS, V11, P436, DOI 10.3201/eid1103.040677; Bruni, 1997, J Travel Med, V4, P61, DOI 10.1111/j.1708-8305.1997.tb00781.x; Crim SM, 2015, MMWR-MORBID MORTAL W, V64, P495; Ekdahl K, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-54; Ekdahl K, 2005, J TRAVEL MED, V12, P197, DOI 10.2310/7060.2005.12405; Ekdahl K, 2005, CLIN MICROBIOL INFEC, V11, P138, DOI 10.1111/j.1469-0691.2004.01045.x; Ekdahl L, 2005, J INFECTION, V51, P222, DOI 10.1016/j.jinf.2005.02.002; Evans MR, 2001, J INFECTION, V43, P140, DOI 10.1053/jinf.2001.0876; Freedman DO, 2006, NEW ENGL J MED, V354, P119, DOI 10.1056/NEJMoa051331; KLONTZ KC, 1989, AM J EPIDEMIOL, V129, P341, DOI 10.1093/oxfordjournals.aje.a115137; Leder K, 2013, ANN INTERN MED, V158, P456, DOI 10.7326/0003-4819-158-6-201303190-00005; Lindback H, 2003, EMERG INFECT DIS, V9, P438, DOI 10.3201/eid0904.020267; MOSER MR, 1979, AM J EPIDEMIOL, V110, P1; Schlagenhauf P, 2015, LANCET INFECT DIS, V15, P55, DOI 10.1016/S1473-3099(14)71000-X; Scoville SL, 1997, MIL MED, V162, P172, DOI 10.1093/milmed/162.3.172; Siikamaki H, 2015, EUROSURVEILLANCE, V20, P15, DOI 10.2807/1560-7917.ES2015.20.19.21128; Siikamaki H, 2017, TRAVEL MED INFECT DI, V15, P29, DOI 10.1016/j.tmaid.2016.10.007; Steffen R, 2015, JAMA-J AM MED ASSOC, V313, P71, DOI 10.1001/jama.2014.17006; Steffen R, 2015, J TRAVEL MED, V22, P1, DOI 10.1111/jtm.12171; Sundbeck M, 2016, TRAVEL MED INFECT DI, V14, P233, DOI 10.1016/j.tmaid.2016.03.014; United Nations World Tourism Organization (UNWTO), 2015, TOUR HIGHL; Warne B, 2014, J TRAVEL MED, V21, P248, DOI 10.1111/jtm.12120; World Health Organization, 2013, GLOB VIEW COMP; World Health Organization, VACC PREV DIS MON SY	27	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0181625	10.1371/journal.pone.0181625	http://dx.doi.org/10.1371/journal.pone.0181625			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753671	Green Published, gold, Green Submitted			2022-12-26	WOS:000406579300021
J	McDaid, A; Logette, E; Buchillier, V; Muriset, M; Suchon, P; Pache, TD; Tanackovic, G; Kutalik, Z; Michaud, J				McDaid, Aaron; Logette, Emmanuelle; Buchillier, Valerie; Muriset, Maude; Suchon, Pierre; Pache, Thierry Daniel; Tanackovic, Goranka; Kutalik, Zoltan; Michaud, Joelle			Risk prediction of developing venous thrombosis in combined oral contraceptive users	PLOS ONE			English	Article							ASSOCIATION; THROMBOEMBOLISM; SUSCEPTIBILITY; VARIANTS; MIGRAINE; GENETICS; UPDATE	Background Venous thromboembolism (VTE) is a complex multifactorial disease influenced by genetic and environmental risk factors. An example for the latter is the regular use of combined oral contraceptives (CC), which increases the risk to develop VTE by 3 to 7 fold, depending on estrogen dosage and the type of progestin present in the pill. One out of 1'000 women using CC develops thrombosis, often with life-long consequences; a risk assessment is therefore necessary prior to such treatment. Currently known clinical risk factors associated with VTE development in general are routinely checked by medical doctors, however they are far from being sufficient for risk prediction, even when combined with genetic tests for Factor V Leiden and Factor II G20210A variants. Thus, clinical and notably genetic risk factors specific to the development of thrombosis associated with the use of CC in particular should be identified. Methods and findings Step-wise (logistic) model selection was applied to a population of 1622 women using CC, half of whom (794) had developed a thromboembolic event while using contraceptives. 46 polymorphisms and clinical parameters were tested in the model selection and a specific combination of 4 clinical risk factors and 9 polymorphisms were identified. Among the 9 polymorphisms, there are two novel genetic polymorphisms (rs1799853 and rs4379368) that had not been previously associated with the development of thromboembolic event. This new prediction model outperforms (AUC 0.71, 95% CI 0.69-0.74) previously published models for general thromboembolic events in a cross-validation setting. Further validation in independent populations should be envisaged. Conclusion We identified two new genetic variants associated to VTE development, as well as a robust prediction model to assess the risk of thrombosis for women using combined oral contraceptives. This model outperforms current medical practice as well as previously published models and is the first model specific to CC use.	[McDaid, Aaron; Kutalik, Zoltan] Univ Hosp Lausanne, Inst Social & Prevent Med, Lausanne, Switzerland; [McDaid, Aaron; Kutalik, Zoltan] SIB, Lausanne, Switzerland; [Logette, Emmanuelle; Buchillier, Valerie; Muriset, Maude; Pache, Thierry Daniel; Tanackovic, Goranka; Michaud, Joelle] Gene Predictis SA, EPFL Innovat Pk, CH-1015 Lausanne, Switzerland; [Suchon, Pierre] Alx Marseille Univ, INSERM, INRA, NORT, Marseille, France; [Suchon, Pierre] Hop la Timone, AP HM, Serv Hematol Biol, Marseille, France	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Institute of Bioinformatics; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Michaud, J (corresponding author), Gene Predictis SA, EPFL Innovat Pk, CH-1015 Lausanne, Switzerland.	jam@genepredictis.com	Colaus, PsyColaus/K-6607-2013; Kutalik, Zoltan/HHZ-5697-2022	Kutalik, Zoltan/0000-0001-8285-7523; Suchon, Pierre/0000-0001-8845-9163	Canton de Vaud, Service de promotion economique et du commerce; Gene Predictis SA	Canton de Vaud, Service de promotion economique et du commerce; Gene Predictis SA	This study was funded by Canton de Vaud, Service de promotion economique et du commerce (https://www.vd.ch/themes/economie/developpement-econornique/prornotioneconomique/): EL, VB, MM, GT, JM. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. It was also funded by Gene Predictis SA: AM, ZK. Authors EL, VB, MM, GT and JM are employed by Gene Predictis SA. TDP is President of the Board of directors of Gene Predictis SA. Gene Predictis SA provided support in the form of salaries for authors (EL, VB, MM, GT and JM) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	[Anonymous], 2011, INT J GYNECOL OBSTET, V112, P252, DOI 10.1016/j.ijgo.2010.12.003; Anttila V, 2013, NAT GENET, V45, P912, DOI 10.1038/ng.2676; Auton A., 2015, NATURE, V7571, P68, DOI 10.1038/nature15393; Bruzelius M, 2015, J THROMB HAEMOST, V13, P219, DOI 10.1111/jth.12808; Cushman Mary, 2005, Hematology Am Soc Hematol Educ Program, P452; de Haan HG, 2012, BLOOD, V120, P656, DOI 10.1182/blood-2011-12-397752; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Heit JA, 2012, J THROMB HAEMOST, V10, P1521, DOI 10.1111/j.1538-7836.2012.04810.x; Kutalik Z, 2011, BIOSTATISTICS, V12, P1, DOI 10.1093/biostatistics/kxq039; Li Y, 2009, J THROMB HAEMOST, V7, P1802, DOI 10.1111/j.1538-7836.2009.03544.x; Millar DS, 2000, HUM GENET, V106, P646, DOI 10.1007/s004390050038; Morange PE, 2015, THROMB HAEMOSTASIS, V114, P910, DOI 10.1160/TH15-05-0410; Morange PE, 2011, BLOOD, V117, P3692, DOI 10.1182/blood-2010-11-319053; Peng KP, 2016, HEADACHE, V56, P1290, DOI 10.1111/head.12885; Rosendaal FR, 2016, THROMB J, V14, DOI 10.1186/s12959-016-0108-y; Rosendaal FR, 2009, J THROMB HAEMOST, V7, P301, DOI 10.1111/j.1538-7836.2009.03394.x; Sacco S, 2015, CEPHALALGIA, V35, P146, DOI 10.1177/0333102414559551; Saposnik B, 2004, BLOOD, V103, P1311, DOI 10.1182/blood-2003-07-2520; Seligsohn U, 2001, NEW ENGL J MED, V344, P1222, DOI 10.1056/NEJM200104193441607; Suchon P, 2017, CLIN GENET, V91, P131, DOI 10.1111/cge.12833; Suchon P, 2016, THROMB HAEMOSTASIS, V115, P135, DOI 10.1160/TH15-01-0045; Vinogradova Y, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2135; Wang B, 2004, DRUG METAB DISPOS, V32, P1209, DOI 10.1124/dmd.104.000182	24	18	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0182041	10.1371/journal.pone.0182041	http://dx.doi.org/10.1371/journal.pone.0182041			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750087	Green Published, gold, Green Submitted			2022-12-26	WOS:000406575700120
J	Keeley, TP; Siow, RCM; Jacob, R; Mann, GE				Keeley, Thomas P.; Siow, Richard C. M.; Jacob, Ron; Mann, Giovanni E.			A PP2A-mediated feedback mechanism controls Ca2+-dependent NO synthesis under physiological oxygen	FASEB JOURNAL			English	Article						endothelial cells; normoxia; hypoxia	ENDOTHELIAL NITRIC-OXIDE; PROTEIN PHOSPHATASE 2A; NEURAL PRECURSOR CELLS; FLUID SHEAR-STRESS; DOWN-REGULATION; STEM-CELLS; SYNTHASE; PHOSPHORYLATION; HYPOXIA; O-2	Intracellular O-2 is a key regulator of NO signaling, yet most in vitro studies are conducted in atmospheric O-2 levels, hyperoxic with respect to the physiologic milieu. We investigated NO signaling in endothelial cells cultured in physiologic (5%) O-2 and stimulated with histamine or shear stress. Culture of cells in 5% O-2 (> 5 d) decreased histamine but not shear stress-stimulated endothelial (e) NOSactivity. Unlike cells adapted to a hypoxic environment(1% O-2), those cultured in 5% O-2 still mobilized sufficient Ca2+ to activate AMPK. Enhanced expression and membrane targeting of PP2A-C was observed in 5% O-2, resulting in greater interaction with eNOS in response to histamine. Moreover, increased dephosphorylation of eNOS in 5% O-2 was Ca2+-sensitive and reversed by okadaic acid or PP2A-C siRNA. The present findings establish that Ca2+ mobilization stimulates both NO synthesis and PP2A-mediated eNOS dephosphorylation, thus constituting a novel negative feedback mechanism regulating eNOS activity not present in response to shear stress. This, coupled with enhanced NO bioavailability, underpins differences in NO signaling induced by inflammatory and physiologic stimuli that are apparent only in physiologic O-2 levels. Furthermore, an explicit delineation between physiologic normoxia and genuine hypoxia is defined here, with implications for our understanding of pathophysiological hypoxia.-Keeley, T. P., Siow, R. C. M., Jacob, R., Mann, G. E. A PP2A-mediated feedback mechanism controls Ca2+-dependent NO synthesis under physiological oxygen.	[Keeley, Thomas P.; Siow, Richard C. M.; Jacob, Ron; Mann, Giovanni E.] Kings Coll London, Fac Life Sci & Med, Cardiovasc Div, Kings British Heart Fdn,Ctr Res Excellence, 150 Stamford St,Franklin Wilkins Bldg,Room 3-01, London SE1 9NH, England	University of London; King's College London	Mann, GE (corresponding author), Kings Coll London, Fac Life Sci & Med, Cardiovasc Div, Kings British Heart Fdn,Ctr Res Excellence, 150 Stamford St,Franklin Wilkins Bldg,Room 3-01, London SE1 9NH, England.	giovanni.mann@kcl.ac.uk		Mann, Giovanni/0000-0001-7311-2044; Keeley, Thomas/0000-0002-0334-7144	British Heart Foundation [FS/13/66/30445]; Heart Research UK [NET01/13]	British Heart Foundation(British Heart Foundation); Heart Research UK	The authors thank Dr. Kalwant Authi for assistance with ultracentrifugation, Paraskevi-Maria Psefteli for experimental assistance, and Prof. Jeremy Pearson and Dr. Sarah J. Chapple (all from King's College) for helpful discussions, and the midwives of St. Thomas' Hospital (London, United Kingdom) for assistance in the collection of umbilical cords. This work was supported by Grant FS/13/66/30445 from the British Heart Foundation and NET01/13 from Heart Research UK. The authors declare no conflicts of interest.	ANDO J, 1988, IN VITRO CELL DEV B, V24, P871; Atkuri KR, 2007, P NATL ACAD SCI USA, V104, P4547, DOI 10.1073/pnas.0611732104; Atkuri KR, 2005, P NATL ACAD SCI USA, V102, P3756, DOI 10.1073/pnas.0409910102; Ayajiki K, 1996, CIRC RES, V78, P750, DOI 10.1161/01.RES.78.5.750; Baharians Z, 1998, J BIOL CHEM, V273, P19019, DOI 10.1074/jbc.273.30.19019; BALIN AK, 1977, J CELL BIOL, V74, P58, DOI 10.1083/jcb.74.1.58; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BOKKALA S, 1995, BIOCHEM J, V306, P837, DOI 10.1042/bj3060837; BUSSE R, 1990, FEBS LETT, V265, P133, DOI 10.1016/0014-5793(90)80902-U; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chapple SJ, 2016, FREE RADICAL BIO MED, V92, P152, DOI 10.1016/j.freeradbiomed.2015.12.013; Davis AJ, 2008, J BIOL CHEM, V283, P16104, DOI 10.1074/jbc.M710313200; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; El Alami M, 2014, STEM CELL REP, V3, P566, DOI 10.1016/j.stemcr.2014.08.002; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Fleming I, 1998, CIRC RES, V82, P686, DOI 10.1161/01.RES.82.6.686; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Fulton D, 2002, J BIOL CHEM, V277, P4277, DOI 10.1074/jbc.M106302200; Garcia C, 2008, J CLIN INVEST, V118, P2291, DOI [10.1172/JC134508, 10.1172/JCI34508]; Grallert A, 2015, NATURE, V517, P94, DOI 10.1038/nature14019; Harris MB, 2001, J BIOL CHEM, V276, P16587, DOI 10.1074/jbc.M100229200; Janssens V, 2003, J BIOL CHEM, V278, P10697, DOI 10.1074/jbc.M211717200; Kou RQ, 2002, J BIOL CHEM, V277, P29669, DOI 10.1074/jbc.M204519200; KOUREMBANAS S, 1993, J CLIN INVEST, V92, P99, DOI 10.1172/JCI116604; Lantoine F, 1998, BIOCHEM J, V330, P695, DOI 10.1042/bj3300695; Li TS, 2011, CARDIOVASC RES, V89, P157, DOI 10.1093/cvr/cvq251; Liu XP, 1998, P NATL ACAD SCI USA, V95, P2175, DOI 10.1073/pnas.95.5.2175; Lorenz M, 2015, ATHEROSCLEROSIS, V240, P61, DOI 10.1016/j.atherosclerosis.2015.02.018; MCQUILLAN LP, 1994, AM J PHYSIOL-HEART C, V267, pH1921; Moreno CS, 2000, J BIOL CHEM, V275, P5257, DOI 10.1074/jbc.275.8.5257; Murata T, 2002, J BIOL CHEM, V277, P44085, DOI 10.1074/jbc.M205934200; Olszewska-Pazdrak B, 2009, AM J PHYSIOL-CELL PH, V296, pC1162, DOI 10.1152/ajpcell.00533.2008; Ostergaard L, 2007, AM J PHYSIOL-HEART C, V293, pH2894, DOI 10.1152/ajpheart.01230.2006; Ostergaard L, 2009, PROTEOMICS, V9, P4457, DOI 10.1002/pmic.200800130; Palacios-Callender M, 2007, P NATL ACAD SCI USA, V104, P18508, DOI 10.1073/pnas.0709440104; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Persechini A, 2002, TRENDS CARDIOVAS MED, V12, P32, DOI 10.1016/S1050-1738(01)00144-X; Qing L, 2004, P NATL ACAD SCI USA, V101, P17126, DOI 10.1073/pnas.0407492101; RILEY RJ, 1993, CLIN OBSTET GYNECOL, V36, P13, DOI 10.1097/00003081-199303000-00005; Rowlands DJ, 2011, HYPERTENSION, V57, P833, DOI 10.1161/HYPERTENSIONAHA.110.162198; SANDERS SP, 1993, J CLIN INVEST, V91, P46, DOI 10.1172/JCI116198; Schmidt K, 1998, METH MOL B, V100, P281; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stacpoole SRL, 2011, CELL DEATH DIFFER, V18, P1016, DOI 10.1038/cdd.2010.171; Stacpoole SRL, 2013, STEM CELL TRANSL MED, V2, P464, DOI 10.5966/sctm.2012-0144; Takemoto M, 2002, CIRCULATION, V106, P57, DOI 10.1161/01.CIR.0000020682.73694.AB; Thomas DD, 2001, P NATL ACAD SCI USA, V98, P355, DOI 10.1073/pnas.98.1.355; Thors B, 2003, ATHEROSCLEROSIS, V168, P245, DOI 10.1016/S0021-9150(03)00127-8; Tiede LM, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.128; Toporsian M, 2000, CIRC RES, V86, P671, DOI 10.1161/01.RES.86.6.671; Tsai AG, 2003, PHYSIOL REV, V83, P933, DOI 10.1152/physrev.00034.2002; Urbich C, 2002, FASEB J, V16, P706, DOI 10.1096/fj.01-0637fje; Victor VM, 2009, CIRC RES, V104, P1178, DOI 10.1161/CIRCRESAHA.109.197228; Wei Q, 2006, J BIOL CHEM, V281, P21652, DOI 10.1074/jbc.M602105200; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Yamamoto K, 2000, AM J PHYSIOL-HEART C, V279, pH285, DOI 10.1152/ajpheart.2000.279.1.H285; Zhang QJ, 2012, DIABETES, V61, P1848, DOI 10.2337/db11-1399	59	14	15	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5172	+		10.1096/fj.201700211R	http://dx.doi.org/10.1096/fj.201700211R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28760745	Green Published			2022-12-26	WOS:000416588300005
J	Tynan, A; Mawhinney, L; Armstrong, ME; O'Reilly, C; Kennedy, S; Caraher, E; Julicher, K; O'Dwyer, D; Maher, L; Schaffer, K; Fabre, A; McKone, EF; Leng, L; Bucala, R; Bernhagen, J; Cooke, G; Donnelly, SC				Tynan, Aisling; Mawhinney, Leona; Armstrong, Michelle E.; O'Reilly, Ciaran; Kennedy, Sarah; Caraher, Emma; Julicher, Karen; O'Dwyer, David; Maher, Lewena; Schaffer, Kirsten; Fabre, Aurelie; McKone, Edward F.; Leng, Lin; Bucala, Richard; Bernhagen, Juergen; Cooke, Gordon; Donnelly, Seamas C.			Macrophage migration inhibitory factor enhances Pseudomonas aeruginosa biofilm formation, potentially contributing to cystic fibrosis pathogenesis	FASEB JOURNAL			English	Article						cytokine; bacteria; respiratory infections	TAUTOMERASE ACTIVE-SITE; FACTOR MIF; ENZYMATIC-ACTIVITY; DISEASE SEVERITY; INFLAMMATION; MODULATOR	Macrophage migration inhibitory factor (MIF) is a key proinflammatory mediator that we have previously shown to be associated with an aggressive clinical phenotype in cystic fibrosis. It possesses unique tautomerase enzymatic activity. However, todate, nohuman-derived substrate has been identified that has the capacity to interact with this cytokine's unique tautomerase activity. This led us to hypothesize that MIF may have the capacity to interact with external substrates. We describe for the first time how Pseudomonas aeruginosa can utilize human recombinant MIF (rMIF) to significantly (P < 0.01) enhance its endogenous biofilm formation. Our in vivo studies demonstrate that utilizing a small-molecular-weight inhibitor targeting MIF's tautomerase activity (SCD-19) significantly reduces the inflammatory response in a murine pulmonary chronic P. aeruginosa model. In addition, we show that in in vitro experiments, pretreatment of P. aeruginosa with rMIF is associated with reduced bacterial killing by tobramycin. Our novel findings support the concept of an anti-MIF strategy that targets this enzymatic activity as a potential future antibacterial therapeutic approach.-Tynan, A., Mawhinney, L., Armstrong, M. E., O'Reilly, C., Kennedy, S., Caraher, E., Julicher, K., O'Dwyer, D., Maher, L., Schaffer, K., Fabre, A., McKone, E. F., Leng, L., Bucala, R., Bernhagen, J., Cooke, G., Donnelly, S. C. Macrophage migration inhibitory factor enhances Pseudomonas aeruginosa biofilm formation, potentially contributing to cystic fibrosis pathogenesis.	[Tynan, Aisling; Mawhinney, Leona; Armstrong, Michelle E.; O'Reilly, Ciaran; Julicher, Karen; Donnelly, Seamas C.] Trinity Coll Dublin, Tallaght Hosp, Dept Med, Dublin, Ireland; [Kennedy, Sarah; Caraher, Emma; Cooke, Gordon] Inst Technol Tallaght, Dept Sci, Ctr Microbial Host Interact, Dublin, Ireland; [O'Dwyer, David; Maher, Lewena; Schaffer, Kirsten; Fabre, Aurelie; McKone, Edward F.] Univ Coll Dublin, St Vincents Univ Hosp, Dublin, Ireland; [O'Dwyer, David; Maher, Lewena; Schaffer, Kirsten; Fabre, Aurelie; McKone, Edward F.] Univ Coll Dublin, Sch Med, Dublin, Ireland; [O'Dwyer, David; Maher, Lewena; Schaffer, Kirsten; Fabre, Aurelie; McKone, Edward F.] Univ Coll Dublin, UCD Conway Inst Biomol & Biomed Res, Dublin, Ireland; [Leng, Lin; Bucala, Richard] Yale Sch Med, Internal Med, New Haven, CT USA; [Bernhagen, Juergen] Rhein Westfal TH Aachen, Inst Biochem & Mol Cell Biol, Aachen, Germany; [Bernhagen, Juergen] Ludwig Maximilians Univ Munchen, Klinikum Univ Munchen, Inst Stroke & Dementia Res, Vasc Biol, Munich, Germany	Trinity College Dublin; Technological University Dublin; University College Dublin; Saint Vincent's University Hospital; University College Dublin; University College Dublin; Yale University; RWTH Aachen University; University of Munich	Donnelly, SC (corresponding author), Trinity Coll Dublin, Trinity Ctr, Trinity Biomed Sci Inst, Dept Clin Med,Sch Med, 152-160 Pearse St, Dublin 24, Ireland.	seamas.donnelly@tcd.ie	Cooke, Gordon/E-3743-2010	Cooke, Gordon/0000-0003-0366-3603; fabre, aurelie/0000-0001-8176-1386; Leng, Lin/0000-0002-0605-358X; Tynan, Aisling/0000-0002-6856-2259; Donnelly, Seamas/0000-0001-7145-1843; O'Reilly, Ciaran/0000-0001-8926-1853; Armstrong, Michelle E./0000-0001-7729-755X	Science Foundation Ireland (SFI); Health Research Board (HRB); Irish Lung Foundation (ILF); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130669] Funding Source: NIH RePORTER	Science Foundation Ireland (SFI)(Science Foundation Ireland); Health Research Board (HRB); Irish Lung Foundation (ILF); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	S.C.D. was supported by grants from Science Foundation Ireland (SFI), the Health Research Board (HRB), and the Irish Lung Foundation (ILF). The authors thank G.A. O'Toole (Dartmouth School of Medicine, Hanover, NH, USA) for his kind donation of PA14-and GFP-tagged PA01. G.C. and S.C.D. share senior authorship. The authors declare no conflicts of interest.	Adamali H, 2012, AM J RESP CRIT CARE, V186, P162, DOI 10.1164/rccm.201110-1864OC; Al-Abed Y, 2005, J BIOL CHEM, V280, P36541, DOI 10.1074/jbc.C500243200; Baugh JA, 2002, GENES IMMUN, V3, P170, DOI 10.1038/sj.gene.6363867; Bendrat K, 1997, BIOCHEMISTRY-US, V36, P15356, DOI 10.1021/bi971153a; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Deschaght P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-244; Donnelly SC, 1997, NAT MED, V3, P320, DOI 10.1038/nm0397-320; Gadjeva M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000826; Ghafoor A, 2011, APPL ENVIRON MICROB, V77, P5238, DOI 10.1128/AEM.00637-11; Gregory JL, 2004, ARTHRITIS RHEUM-US, V50, P3023, DOI 10.1002/art.20470; Gregory JL, 2006, J IMMUNOL, V177, P8072, DOI 10.4049/jimmunol.177.11.8072; Hopkins N, 2001, J APPL PHYSIOL, V91, P919, DOI 10.1152/jappl.2001.91.2.919; KRUGER TF, 1987, ARCH ANDROLOGY, V18, P275, DOI 10.3109/01485018708988493; Leigh R, 2002, AM J RESP CELL MOL, V27, P526, DOI 10.1165/rcmb.2002-0048OC; Lobo J, 2012, CLIN CHEST MED, V33, P307, DOI 10.1016/j.ccm.2012.02.006; Lubetsky JB, 2002, J BIOL CHEM, V277, P24976, DOI 10.1074/jbc.M203220200; Mawhinney L, 2014, MOL MED, V20, P729, DOI 10.2119/molmed.2014.00136; Merritt Judith H, 2005, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b01s00; Moreau-Marquis S, 2008, PULM PHARMACOL THER, V21, P595, DOI 10.1016/j.pupt.2007.12.001; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nielsen MW, 2011, JOVE-J VIS EXP, DOI 10.3791/2383; Parks QM, 2009, J MED MICROBIOL, V58, P492, DOI 10.1099/jmm.0.005728-0; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Plant BJ, 2005, AM J RESP CRIT CARE, V172, P1412, DOI 10.1164/rccm.200412-1714OC; Reber LL, 2012, J IMMUNOL, V188, P3478, DOI 10.4049/jimmunol.1004227; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; Rossi AG, 1998, J CLIN INVEST, V101, P2869, DOI 10.1172/JCI1524; Santos LL, 2011, ARTHRITIS RHEUM-US, V63, P960, DOI 10.1002/art.30203; Song XJ, 2014, LIFE SCI, V119, P9, DOI 10.1016/j.lfs.2014.10.006; Sugimoto H, 1996, FEBS LETT, V389, P145, DOI 10.1016/0014-5793(96)00553-4; Zaidi T, 2011, SCI REP-UK, V1, DOI 10.1038/srep00058; Zhou L, 2012, CLIN VACCINE IMMUNOL, V19, P1065, DOI 10.1128/CVI.05715-11	36	8	9	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					5102	5110		10.1096/fj.201700463R	http://dx.doi.org/10.1096/fj.201700463R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28768722	Green Published, Green Submitted			2022-12-26	WOS:000413398500037
J	Jayathilake, PG; Gupta, P; Li, BW; Madsen, C; Oyebamiji, O; Gonzalez-Cabaleiro, R; Rushton, S; Bridgens, B; Swailes, D; Allen, B; McGough, AS; Zuliani, P; Ofiteru, ID; Wilkinson, D; Chen, JJ; Curtis, T				Jayathilake, Pahala Gedara; Gupta, Prashant; Li, Bowen; Madsen, Curtis; Oyebamiji, Oluwole; Gonzalez-Cabaleiro, Rebeca; Rushton, Steve; Bridgens, Ben; Swailes, David; Allen, Ben; McGough, A. Stephen; Zuliani, Paolo; Ofiteru, Irina Dana; Wilkinson, Darren; Chen, Jinju; Curtis, Tom			A mechanistic Individual-based Model of microbial communities	PLOS ONE			English	Article							CELLULAR-AUTOMATON APPROACH; DETACHMENT MECHANISMS; MULTISPECIES BIOFILMS; DYNAMICS; GROWTH; NANOINDENTATION; SIMULATIONS; TRANSPORT; SURFACES; PROTOCOL	Accurate predictive modelling of the growth of microbial communities requires the credible representation of the interactions of biological, chemical and mechanical processes. However, although biological and chemical processes are represented in a number of Individual-based Models (IbMs) the interaction of growth and mechanics is limited. Conversely, there are mechanically sophisticated IbMs with only elementary biology and chemistry. This study focuses on addressing these limitations by developing a flexible IbM that can robustly combine the biological, chemical and physical processes that dictate the emergent properties of a wide range of bacterial communities. This IbM is developed by creating a microbiological adaptation of the open source Large-scale Atomic/Molecular Massively Parallel Simulator (LAMMPS). This innovation should provide the basis for "bottom up" prediction of the emergent behaviour of entire microbial systems. In the model presented here, bacterial growth, division, decay, mechanical contact among bacterial cells, and adhesion between the bacteria and extracellular polymeric substances are incorporated. In addition, fluid-bacteria interaction is implemented to simulate biofilm deformation and erosion. The model predicts that the surface morphology of biofilms becomes smoother with increased nutrient concentration, which agrees well with previous literature. In addition, the results show that increased shear rate results in smoother and more compact biofilms. The model can also predict shear rate dependent biofilm deformation, erosion, streamer formation and breakup.	[Jayathilake, Pahala Gedara; Swailes, David; Chen, Jinju] Newcastle Univ, Sch Mech & Syst Engn, Newcastle Upon Tyne, Tyne & Wear, England; [Gupta, Prashant; Rushton, Steve] Newcastle Univ, Sch Biol, Newcastle Upon Tyne, Tyne & Wear, England; [Li, Bowen; Madsen, Curtis; McGough, A. Stephen; Zuliani, Paolo] Newcastle Univ, Sch Comp Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Oyebamiji, Oluwole; Wilkinson, Darren] Newcastle Univ, Sch Math & Stat, Newcastle Upon Tyne, Tyne & Wear, England; [Gonzalez-Cabaleiro, Rebeca; Ofiteru, Irina Dana] Newcastle Univ, Sch Chem Engn & Adv Mat, Newcastle Upon Tyne, Tyne & Wear, England; [Bridgens, Ben; Allen, Ben; Curtis, Tom] Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne, Tyne & Wear, England; [Gupta, Prashant] Procter & Gamble Tech Ctr Ltd, Newcastle Upon Tyne, Tyne & Wear, England; [Madsen, Curtis] Boston Univ, Dept Elect & Comp Engn, Boston, MA 02215 USA	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Procter & Gamble; Boston University	Jayathilake, PG; Chen, JJ (corresponding author), Newcastle Univ, Sch Mech & Syst Engn, Newcastle Upon Tyne, Tyne & Wear, England.; Rushton, S (corresponding author), Newcastle Univ, Sch Biol, Newcastle Upon Tyne, Tyne & Wear, England.; Curtis, T (corresponding author), Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne, Tyne & Wear, England.	jayathilake.pahala-gedara@ncl.ac.uk; steven.rushton@ncl.ac.uk; jinju.chen@ncl.ac.uk; tom.curtis@ncl.ac.uk	Oyebamiji, Oluwole/ABF-8407-2020; Cabaleiro, Rebeca Gonzalez/AAA-6733-2020	Oyebamiji, Oluwole/0000-0002-6561-9459; Cabaleiro, Rebeca Gonzalez/0000-0002-4000-5928; chen, jinju/0000-0002-9792-6285; Bridgens, Benjamin/0000-0002-9461-100X; Jayathilake, Pahala Gedara/0000-0001-7691-0949; McGough, Stephen/0000-0001-5626-0934; Ofiteru, Dana/0000-0002-1492-3709; Allen, Ben/0000-0001-5978-0812; Wilkinson, Darren James/0000-0003-0736-802X	UK Engineering and Physical Sciences Research Council (EPSRC) as part of the Newcastle University Frontiers in Engineering Biology (NUFEB) [EP/K039083/1]; Engineering and Physical Sciences Research Council [EP/K039083/1] Funding Source: researchfish; EPSRC [EP/K039083/1] Funding Source: UKRI	UK Engineering and Physical Sciences Research Council (EPSRC) as part of the Newcastle University Frontiers in Engineering Biology (NUFEB); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors would like to thank the UK Engineering and Physical Sciences Research Council (EPSRC) for funding this work as part of the Newcastle University Frontiers in Engineering Biology (NUFEB) project (EP/K039083/1). This work would not have been possible without the multi-disciplinary collaboration that has been enabled by this award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the UK Engineering and Physical Sciences Research Council (EPSRC) for funding this work as part of the Newcastle University Frontiers in Engineering Biology (NUFEB) project (EP/K039083/1). This work would not have been possible without the multi-disciplinary collaboration that has been enabled by this award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpkvist E, 2007, WATER SCI TECHNOL, V55, P265, DOI 10.2166/wst.2007.267; Alpkvist E, 2006, BIOTECHNOL BIOENG, V94, P961, DOI 10.1002/bit.20917; Beech WB, 2004, CURR OPIN BIOTECH, V15, P181, DOI 10.1016/j.copbio.2004.05.001; Blanchard AE, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0188-5; Brilliantov NV, 1996, PHYS REV E, V53, P5382, DOI 10.1103/PhysRevE.53.5382; Brindle ER, 2011, BIOTECHNOL BIOENG, V108, P2968, DOI 10.1002/bit.23245; Celler K, 2014, SCI REP-UK, V4, DOI 10.1038/srep03649; Chambless JD, 2007, BIOTECHNOL BIOENG, V97, P1573, DOI 10.1002/bit.21363; Chen C, 2015, MATH METHOD APPL SCI, V38, P4461, DOI 10.1002/mma.2828; Chen J, 2007, THIN SOLID FILMS, V516, P128, DOI 10.1016/j.tsf.2007.08.131; Chen JJ, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2013.0055; Chen JJ, 2012, J BIOMECH, V45, P2810, DOI 10.1016/j.jbiomech.2012.08.037; CUNDALL PA, 1979, GEOTECHNIQUE, V29, P47, DOI 10.1680/geot.1979.29.1.47; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226; Farrell FDC, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.168101; Fratamico PM, 2009, WOODHEAD PUBL FOOD S, P1; Freitas R, 2016, COMP MATER SCI, V112, P333, DOI 10.1016/j.commatsci.2015.10.050; Giao MS, 2013, J APPL MICROBIOL, V114, P256, DOI 10.1111/jam.12032; Gorochowski TE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042790; Gorokh AA, 2016, MOSC U PHYS B+, V71, P114, DOI 10.3103/S0027134916010070; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Guelon T, 2011, SPRINGER SER BIOFILM, V5, P111, DOI 10.1007/978-3-642-19940-0_6; Head DA, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.032702; Horn H, 2014, ADV BIOCHEM ENG BIOT, V146, P53, DOI 10.1007/10_2014_275; HUSTON M, 1988, BIOSCIENCE, V38, P682, DOI 10.2307/1310870; Knutson CE, 2005, WATER RESOUR RES, V41, DOI 10.1029/2004WR003459; Kragh KN, 2016, MBIO, V7, DOI 10.1128/mBio.00237-16; Kreft JU, 1998, MICROBIOL-UK, V144, P3275, DOI 10.1099/00221287-144-12-3275; Kreft JU, 2001, MICROBIOL-SGM, V147, P2897, DOI 10.1099/00221287-147-11-2897; Lardon LA, 2011, ENVIRON MICROBIOL, V13, P2416, DOI 10.1111/j.1462-2920.2011.02414.x; Li C, 2015, RSC ADV, V5, P79001, DOI 10.1039/c5ra11041f; Li ZL, 2016, SEP PURIF TECHNOL, V162, P91, DOI 10.1016/j.seppur.2016.02.011; Nadell CD, 2015, ISME J, V9, P1700, DOI 10.1038/ismej.2014.246; Nadell CD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000716; Ni BJ, 2009, WATER RES, V43, P1350, DOI 10.1016/j.watres.2008.12.004; Noguera DR, 2004, WATER SCI TECHNOL, V49, P169, DOI 10.2166/wst.2004.0833; Ofiteru ID, 2014, WATER RES, V50, P382, DOI 10.1016/j.watres.2013.10.053; Picioreanu C, 2000, BIOTECHNOL BIOENG, V69, P504, DOI 10.1002/1097-0290(20000905)69:5<504::AID-BIT5>3.0.CO;2-S; Picioreanu C, 1998, BIOTECHNOL BIOENG, V57, P718, DOI 10.1002/(SICI)1097-0290(19980320)57:6<718::AID-BIT9>3.0.CO;2-O; Picioreanu C, 2004, APPL ENVIRON MICROB, V70, P3024, DOI 10.1128/AEM.70.5.3024-3040.2004; Picioreanu C, 1998, BIOTECHNOL BIOENG, V58, P101, DOI 10.1002/(SICI)1097-0290(19980405)58:1<101::AID-BIT11>3.0.CO;2-M; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Radu AI, 2010, J MEMBRANE SCI, V365, P1, DOI 10.1016/j.memsci.2010.07.036; Schluter J, 2015, ISME J, V9, P139, DOI 10.1038/ismej.2014.174; Silbert LE, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051302; STEWART PS, 1993, BIOTECHNOL BIOENG, V41, P111, DOI 10.1002/bit.260410115; Sun R, 2016, COMPUT GEOSCI-UK, V89, P207, DOI 10.1016/j.cageo.2016.01.011; Tang YN, 2013, WATER RES, V47, P5729, DOI 10.1016/j.watres.2013.06.055; Walter M, 2013, CHEM ENG J, V228, P1140, DOI 10.1016/j.cej.2013.05.071; Wang Q, 2010, SOLID STATE COMMUN, V150, P1009, DOI 10.1016/j.ssc.2010.01.021; Wanner O, 1996, BIOTECHNOL BIOENG, V49, P172; Xavier JB, 2005, ENVIRON MICROBIOL, V7, P1085, DOI 10.1111/j.1462-2920.2005.00787.x; Xavier JD, 2005, BIOTECHNOL BIOENG, V91, P651, DOI 10.1002/bit.20544; Xu ZJ, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066702; Zhang T, 2008, COMMUN COMPUT PHYS, V4, P72	57	46	47	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0181965	10.1371/journal.pone.0181965	http://dx.doi.org/10.1371/journal.pone.0181965			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771505	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000406853600050
J	Jermacz, L; Kobak, J				Jermacz, Lukasz; Kobak, Jaroslaw			Keep calm and don't stop growing: Non-consumptive effects of a sympatric predator on two invasive Ponto-Caspian gammarids Dikerogammarus villosus and Pontogammarus robustoides	PLOS ONE			English	Article							MEDIATED INDIRECT INTERACTIONS; PREY INTERACTIONS; KILLER SHRIMP; INTERSPECIFIC COMPETITION; ZEBRA MUSSELS; LIFE-HISTORY; AMPHIPOD; RISK; IMPACT; FISH	Predators shape prey populations by elimination of individuals (consumptive effects) and by inducing modifications in prey behaviour, physiology or morphology (NCE-non-consumptive effects). Due to the resource allocation to defence, decreased feeding and higher stress, the costs of predator NCEs can be considerable. Therefore, the resistance to NCEs may be crucial for population growth and interspecific competition. We tested the resistance of Ponto-Caspian gammarids Dikerogammarus villosus and Pontogammarus robustoides to NCEs imposed by their predator, the racer goby Babka gymnotrachelus. As D. villosus is often avoided by predators in the presence of alternative food, we hypothesised that it would bear lower behavioural and physiological costs of anti-predator responses. We tested gammarid feeding in short-time experiments (2-4 h) with food (chironomid larvae) located at various distances from the stony shelter (to enforce food searching, Experiment I) or in the direct gammarid proximity (no searching needed, Experiment II). Moreover, we checked the predator effect on gammarid growth in a 2-week Experiment III. Both gammarids exposed to predators reduced feeding efficiency outside the shelter (Experiment I). Contrary to our expectations, the response of D. villosus was stronger. When food was provided in their direct proximity (Experiment II), the feeding of both species was unaffected by predators, indicating that a shelter supplied with food can reduce predator NCEs. The growth of P. robustoides was reduced in the presence of predators (Experiment III), whereas that of D. villosus was unaffected. Although D. villosus has a more effective defence strategy than P. robustoides, it bears similar or even higher behavioural costs of NCEs. However, it exhibits the higher resistance to the long-term predator presence, sustaining its growth rate under such conditions. This may be one of the factors contributing to the great invasion success of D. villosus, currently taking place in European fresh waters.	[Jermacz, Lukasz; Kobak, Jaroslaw] Nicolaus Copernicus Univ, Dept Invertebrate Zool, Torun, Poland	Nicolaus Copernicus University	Jermacz, L (corresponding author), Nicolaus Copernicus Univ, Dept Invertebrate Zool, Torun, Poland.	lukasjermacz@gmail.com	Kobak, Jaroslaw/F-2796-2013; Jermacz, Łukasz/B-8728-2017	Kobak, Jaroslaw/0000-0001-7660-9240; Jermacz, Łukasz/0000-0001-9182-116X	grant of the National Science Centre, Poland [2016/21/B/NZ8/00418]	grant of the National Science Centre, Poland	Our study was supported by the grant of the National Science Centre, Poland No. 2016/21/B/NZ8/00418.	ABRAMS PA, 1991, ECOLOGY, V72, P1242, DOI 10.2307/1941098; Abrams PA, 2007, ECOLOGY, V88, P2555, DOI 10.1890/06-1381.1; Bacela-Spychalska K, 2013, FRESHWATER BIOL, V58, P730, DOI 10.1111/fwb.12078; Bacela-Spychalska K, 2012, BIOL INVASIONS, V14, P1831, DOI 10.1007/s10530-012-0193-1; BARRY MJ, 1994, OECOLOGIA, V97, P278, DOI 10.1007/BF00323161; Benard MF, 2004, ANNU REV ECOL EVOL S, V35, P651, DOI 10.1146/annurev.ecolsys.35.021004.112426; Blonska D, 2016, LIMNOLOGICA, V61, P1, DOI 10.1016/j.limno.2016.06.003; Blonska D, 2015, FRESHWATER BIOL, V60, P2187, DOI 10.1111/fwb.12647; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Bolnick DI, 2005, ECOLOGY, V86, P2771, DOI 10.1890/04-1249; Bourdeau PE, 2013, ECOLOGY, V94, P1449, DOI 10.1890/12-2116.1; Bowler DE, 2013, J ZOOL, V289, P52, DOI 10.1111/j.1469-7998.2012.00961.x; Brandner J, 2013, HYDROBIOLOGIA, V703, P113, DOI 10.1007/s10750-012-1349-9; Bruijs MCM, 2001, ARCH HYDROBIOL, V152, P633; Clinchy M, 2013, FUNCT ECOL, V27, P56, DOI 10.1111/1365-2435.12007; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; Dick JTA, 2000, P ROY SOC B-BIOL SCI, V267, P977, DOI 10.1098/rspb.2000.1099; Dick JTA, 2002, CAN J FISH AQUAT SCI, V59, P1078, DOI 10.1139/F02-074; Gergs R, 2008, J N AM BENTHOL SOC, V27, P541, DOI 10.1899/07-151.1; Grabowska J, 2016, LIMNOLOGICA, V56, P30, DOI 10.1016/j.limno.2015.11.004; Grabowski M, 2007, HYDROBIOLOGIA, V590, P75, DOI 10.1007/s10750-007-0759-6; Hellmann C, 2015, AQUAT INVASIONS, V10, P385, DOI 10.3391/ai.2015.10.4.03; Hesselschwerdt J, 2008, FUND APPL LIMNOL, V173, P177, DOI 10.1127/1863-9135/2008/0173-0177; Hesselschwerdt J, 2009, BIOL INVASIONS, V11, P2133, DOI 10.1007/s10530-009-9492-6; Hill JM, 2013, OECOLOGIA, V172, P79, DOI 10.1007/s00442-012-2488-4; Horppila J, 2005, HYDROBIOLOGIA, V545, P167, DOI 10.1007/s10750-005-2677-9; Janssens L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088247; Jermacz L, 2017, HYDROBIOLOGIA, V785, P173, DOI 10.1007/s10750-016-2917-1; Jermacz L, 2015, BEHAV ECOL, V26, P656, DOI 10.1093/beheco/arv009; Jermacz L, 2015, HYDROBIOLOGIA, V746, P209, DOI 10.1007/s10750-014-1963-9; Kakareko T, 2005, J APPL ICHTHYOL, V21, P292, DOI 10.1111/j.1439-0426.2005.00683.x; Karatayev AY, 2002, INVASIVE AQUATIC SPECIES OF EUROPE: DISTRIBUTION, IMPACTS AND MANAGEMENT, P433; Kley Axel, 2005, Journal of Limnology, V64, P85; Kobak J, 2015, J ZOOL, V297, P66, DOI 10.1111/jzo.12252; Kobak J, 2016, PEERJ, V4, DOI 10.7717/peerj.2672; Kobak J, 2016, BIOL INVASIONS, V18, P1953, DOI 10.1007/s10530-016-1140-3; Kobak J, 2014, AQUAT ECOL, V48, P397, DOI 10.1007/s10452-014-9492-1; Koester M, 2016, HYDROBIOLOGIA, V768, P299, DOI 10.1007/s10750-015-2558-9; Lagrue C, 2015, OIKOS, V124, P1589, DOI 10.1111/oik.02272; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; MacNeil C, 2005, J ZOOL, V267, P31, DOI 10.1017/S0952836905007351; MacNeil Calum, 2013, NeoBiota, V19, P1; McCauley SJ, 2011, ECOLOGY, V92, P2043, DOI 10.1890/11-0455.1; Naddafi R, 2007, OIKOS, V116, P1289, DOI 10.1111/j.2007.0030-1299.15695.x; Naddafi R, 2014, FRESHWATER BIOL, V59, P703, DOI 10.1111/fwb.12297; Naddafi R, 2013, ANIM BEHAV, V86, P1275, DOI 10.1016/j.anbehav.2013.09.032; Peckarsky BL, 2008, ECOLOGY, V89, P2416, DOI 10.1890/07-1131.1; Pinchuk VI, 2003, FRESHWATER FISHES EU, V1, P264; Pockl M, 2007, FRESHWATER BIOL, V52, P50, DOI 10.1111/j.1365-2427.2006.01671.x; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Preisser EL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002465; Preisser EL, 2007, ECOLOGY, V88, P2744, DOI 10.1890/07-0260.1; Preisser EL, 2009, ECOL LETT, V12, P315, DOI 10.1111/j.1461-0248.2009.01290.x; Rewicz T, 2014, AQUAT INVASIONS, V9, P267, DOI 10.3391/ai.2014.9.3.04; Ruehl CB, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00065.1; Rupert E. E., 2004, INVERTEBRATE ZOOLOGY; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; Siepielski AM, 2014, EVOLUTION, V68, P696, DOI 10.1111/evo.12294; Slos S, 2008, FUNCT ECOL, V22, P637, DOI 10.1111/j.1365-2435.2008.01424.x; Slos S, 2009, OECOLOGIA, V161, P461, DOI 10.1007/s00442-009-1401-2; Stewart TW, 1999, J N AM BENTHOL SOC, V18, P274, DOI 10.2307/1468465; Van Dievel M, 2016, OECOLOGIA, V181, P347, DOI 10.1007/s00442-015-3440-1; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; Wisenden BD, 2009, BEHAVIOUR, V146, P1423, DOI 10.1163/156853909X440998	64	15	15	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182481	10.1371/journal.pone.0182481	http://dx.doi.org/10.1371/journal.pone.0182481			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771578	gold, Green Submitted, Green Published			2022-12-26	WOS:000406853600120
J	Matossian, MD; Elliott, S; Hoang, VT; Burks, HE; Phamduy, TB; Chrisey, DB; Zuercher, WJ; Drewry, DH; Wells, C; Collins-Burow, B; Burow, ME				Matossian, Margarite D.; Elliott, Steven; Hoang, Van T.; Burks, Hope E.; Phamduy, Theresa B.; Chrisey, Douglas B.; Zuercher, William J.; Drewry, David H.; Wells, Carrow; Collins-Burow, Bridgette; Burow, Matthew E.			Novel application of the published kinase inhibitor set to identify therapeutic targets and pathways in triple negative breast cancer subtypes	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH; EMT; PROGRESSION; EXPRESSION; KINOME; SHAPE	Triple negative breast cancers (TNBCs) have high recurrence and metastasis rates. Acquisition of a mesenchymal morphology and phenotype in addition to driving migration is a consequential process that promotes metastasis. Although some kinases are known to regulate a mesenchymal phenotype, the role for a substantial portion of the human kinome remains uncharacterized. Here we evaluated the Published Kinase Inhibitor Set (PKIS) and screened a panel of TNBC cell lines to evaluate the compounds' effects on a mesenchymal phenotype. Our screen identified 36 hits representative of twelve kinase inhibitor chemotypes based on reversal of the mesenchymal cell morphology, which was then prioritized to twelve compounds based on gene expression and migratory behavior analyses. We selected the most active compound and confirmed mesenchymal reversal on transcript and protein levels with qRT-PCR and Western Blot. Finally, we utilized a kinase array to identify candidate kinases responsible for the EMT reversal. This investigation shows the novel application to identify previously unrecognized kinase pathways and targets in acquisition of a mesenchymal TNBC phenotype that warrant further investigation. Future studies will examine specific roles of the kinases in mechanisms responsible for acquisition of the mesenchymal and/or migratory phenotype.	[Matossian, Margarite D.; Elliott, Steven; Hoang, Van T.; Burks, Hope E.; Collins-Burow, Bridgette; Burow, Matthew E.] Tulane Univ, Dept Med, Sect Hematol & Oncol, New Orleans, LA 70118 USA; [Phamduy, Theresa B.; Chrisey, Douglas B.] Tulane Univ, Dept Phys, New Orleans, LA 70118 USA; [Zuercher, William J.; Drewry, David H.; Wells, Carrow] Univ North Carolina Chapel Hill, Eshelman Sch Pharm, Chapel Hill, NC USA	Tulane University; Tulane University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Burow, ME (corresponding author), Tulane Univ, Dept Med, Sect Hematol & Oncol, New Orleans, LA 70118 USA.	mburow@tulane.edu			National Institutes of Health [1R15CA176496-01A1, R01-CA174785-A1, R01-CA125806-05]; AbbVie; Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; Eshelman Institute for Innovation; Genome Canada; Innovative Medicines Initiative (EU/EFPIA); Janssen, Merck Co.; Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer; Sao Paulo Research Foundation-FAPESP; Takeda; Wellcome Trust; Biospecimen Core Laboratory of the Louisiana Cancer Research Consortium; NATIONAL CANCER INSTITUTE [R01CA174785] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AbbVie(AbbVie); Bayer Pharma AG; Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Eshelman Institute for Innovation; Genome Canada(Genome Canada); Innovative Medicines Initiative (EU/EFPIA); Janssen, Merck Co.; Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Sao Paulo Research Foundation-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); Biospecimen Core Laboratory of the Louisiana Cancer Research Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded with the following grants awarded by National Institutes of Health: 1R15CA176496-01A1 (MEB), R01-CA174785-A1 (BC-B) and R01-CA125806-05 (MEB). The funders both had important roles in study design, data collection and analysis and decision to publish. MEB had an important role in preparation of the manuscript.; We would like to thank GlaxoSmithKline for the generous donation of PKIS and PKIS2 compounds for these studies. The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada, Innovative Medicines Initiative (EU/EFPIA), Janssen, Merck & Co., Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, Sao Paulo Research Foundation-FAPESP, Takeda, and Wellcome Trust. We would like to thank our collaborators at the Eshelman School of Pharmacy at the University of North Carolina for their invaluable contribution, discussion and revisions to the manuscript. Furthermore, this work has been supported in part by the Biospecimen Core Laboratory of the Louisiana Cancer Research Consortium. We would also like to acknowledge Matthew Ducot of Tulane University Department of Physics for his assistance developing a method to quantify aspects of cellular morphology. Finally, the results in S4 Fig are based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov.	Al-Ali H, 2015, ACS CHEM BIOL, V10, P1939, DOI 10.1021/acschembio.5b00289; Alderton GK, 2013, NAT REV CANCER, V13, P3, DOI 10.1038/nrc3428; American Cancer Society, 2016, CANC FACTS FIGURES 2; Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Anders CK, 2009, CLIN BREAST CANCER, V9, pS73, DOI 10.3816/CBC.2009.s.008; Bae YK, 2015, J BREAST CANCER, V18, P256, DOI 10.4048/jbc.2015.18.3.256; Ball SG, 2012, STEM CELLS, V30, P548, DOI 10.1002/stem.1015; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chua KN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033183; Collins I, 2006, NAT CHEM BIOL, V2, P689, DOI 10.1038/nchembio840; D'Amato NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045684; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Elkins JM, 2016, NAT BIOTECHNOL, V34, P95, DOI 10.1038/nbt.3374; Evans MJ, 2005, NAT BIOTECHNOL, V23, P1303, DOI 10.1038/nbt1149; Fedorov O, 2010, NAT CHEM BIOL, V6, P166, DOI 10.1038/nchembio.297; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Goswami CP, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-970; Goswami Chirayu Pankaj, 2013, J Clin Bioinforma, V3, P22, DOI 10.1186/2043-9113-3-22; He YP, 2015, MOL BIOL CELL, V26, P3229, DOI 10.1091/mbc.E15-03-0142; Heldin CH, 2012, FEBS LETT, V586, P1959, DOI 10.1016/j.febslet.2012.02.037; Kim HJ, 2015, J BREAST CANCER, V18, P371, DOI 10.4048/jbc.2015.18.4.371; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lee WC, 2014, P NATL ACAD SCI USA, V111, pE4409, DOI 10.1073/pnas.1402306111; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Midland AA, 2012, CELL RES, V22, P620, DOI 10.1038/cr.2012.25; Nero TL, 2014, NAT REV CANCER, V14, P248, DOI 10.1038/nrc3690; Ocana A, 2013, CANCER TREAT REV, V39, P68, DOI 10.1016/j.ctrv.2012.05.004; Paul Manash K, 2004, Int J Med Sci, V1, P101; Poage GM, 2013, CANCER RES, V73, P557; Poh AR, 2015, ONCOTARGET, V6, P15752, DOI 10.18632/oncotarget.4199; Rakha EA, 2011, CLIN ONCOL-UK, V23, P587, DOI 10.1016/j.clon.2011.03.013; Rhodes LV, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-295; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Sakurai K, 2014, CELL STEM CELL, V14, P523, DOI 10.1016/j.stem.2014.03.001; Tate CR, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3192; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Tevaarwerk AJ, 2013, CANCER-AM CANCER SOC, V119, P1140, DOI 10.1002/cncr.27819; Thiery JP, 2010, B CANCER, V97, P1285, DOI 10.1684/bdc.2010.1206; Wang J, 2016, GENES DIS, V3, P3, DOI 10.1016/j.gendis.2016.01.002; Wong IY, 2014, NAT MATER, V13, P1063, DOI [10.1038/nmat4062, 10.1038/NMAT4062]; Yu HY, 2013, ADV HEALTHC MATER, V2, P1188, DOI 10.1002/adhm.201300053	41	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0177802	10.1371/journal.pone.0177802	http://dx.doi.org/10.1371/journal.pone.0177802			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771473	Green Published, Green Submitted, gold			2022-12-26	WOS:000406853600002
J	Ross, A; Rankin, J; Beaman, J; Murray, K; Sinnett, P; Riddle, R; Haskins, J; Vassar, M				Ross, Andrew; Rankin, Justin; Beaman, Jason; Murray, Kelly; Sinnett, Philip; Riddle, Ross; Haskins, Jordan; Vassar, Matt			Methodological quality of systematic reviews referenced in clinical practice guidelines for the treatment of opioid use disorder	PLOS ONE			English	Article							DRUG-MONITORING PROGRAMS; IMPROVING PRIMARY-CARE; CONFLICTS-OF-INTEREST; MEASUREMENT TOOL; INDUSTRY SPONSORSHIP; DEATH RATES; ABUSE; BIAS; RECOMMENDATIONS; IMPACT	Introduction With efforts to combat opioid use disorder, there is an increased interest in clinical practice guidelines (CPGs) for opioid use disorder treatments. No literature exists examining the quality of systematic reviews used in opioid use disorder CPGs. This study aims to describe the methodological quality and reporting clarity of systematic reviews (SRs) used to create CPGs for opioid use disorder. Methods From June to July 2016 guideline clearinghouses and medical literature databases were searched for relevant CPGs used in the treatment of opioid use disorder. Included CPGs must have been recognized by a national organization. SRs from the reference section of each CPG was scored by using AMSTAR (a measurement tool to assess the methodological quality of systematic reviews) tool and PRISMA (preferred reporting items for systematic reviews and meta-analyses) checklist. Results Seventeen CPGs from 2006-2016 were included in the review. From these, 57 unique SRs were extracted. SRS comprised 0.28% to 17.92% of all references found in the CPGs. All SRs obtained moderate or high methodological quality score on the AMSTAR tool. All reviews met at least 70% of PRISMA criteria. In PRISMA, underperforming areas included accurate title labeling, protocol registration, and risk of bias. Underperforming areas in AMSTAR included conflicts of interest, funding, and publication bias. A positive correlation was found between AMSTAR and PRISMA scores (r = .79). Conclusion Although the SRs in the CPGs were of good quality, there are still areas for improvement. Systematic reviewers should consult PRISMA and AMSTAR when conducting and reporting reviews. It is important for CPG developers to consider methodological quality as a factor when developing CPG recommendations, recognizing that the quality of systematic reviews underpinning guidelines does not necessarily correspond to the quality of the guideline itself.	[Ross, Andrew; Rankin, Justin; Beaman, Jason; Murray, Kelly; Sinnett, Philip; Riddle, Ross; Haskins, Jordan; Vassar, Matt] Oklahoma State Univ, Ctr Hlth Sci, Tulsa, OK 74106 USA	Oklahoma State University System; Oklahoma State University Center for Health Sciences	Ross, A (corresponding author), Oklahoma State Univ, Ctr Hlth Sci, Tulsa, OK 74106 USA.	aeross@okstate.edu	Vassar, Matt/AAD-5385-2020	Vassar, Ben Matthew/0000-0003-2859-6152				Amato L, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004147.pub4; American Society of Addiction Medicine, 2015, NAT PRACT GUID US ME; Andrews J, 2013, J CLIN EPIDEMIOL, V66, P719, DOI 10.1016/j.jclinepi.2012.03.013; Andrews JC, 2013, J CLIN EPIDEMIOL, V66, P726, DOI 10.1016/j.jclinepi.2013.02.003; [Anonymous], 2011, METH MAINT TREATM PR; Atakpo P, 2016, J DERMATOL SCI, V82, P69, DOI 10.1016/j.jdermsci.2016.02.005; Bero L, 2013, JAMA INTERN MED, V173, P580, DOI 10.1001/jamainternmed.2013.4190; Birnbaum HG, 2011, PAIN MED, V12, P657, DOI 10.1111/j.1526-4637.2011.01075.x; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; Boyd Elizabeth A, 2012, Proc Am Thorac Soc, V9, P234, DOI 10.1513/pats.201208-057ST; Bryce S, 2016, J PSYCHIATR RES, V75, P91, DOI 10.1016/j.jpsychires.2016.01.004; Burda BU, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0237-1; California Society of Addiction Medicine, 2008, GUID PHYS WORK CAL O; Campsall P, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002029; Choudhry NK, 2002, JAMA-J AM MED ASSOC, V287, P612, DOI 10.1001/jama.287.5.612; Cluzeau F, 2003, QUAL SAF HEALTH CARE, V12, P18; Cosgrove L, 2009, PSYCHOTHER PSYCHOSOM, V78, P228, DOI 10.1159/000214444; Detweiler BN, 2016, ANAESTHESIA, V71, P955, DOI 10.1111/anae.13520; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr6501e1, 10.1001/jama.2016.1464, 10.15585/mmwr.rr7103a1]; Ford C., 2011, ROYAL COLL GEN PRACT; Gowing L, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002025.pub3; Graham Ian D, 2005, Evid Based Nurs, V8, P68, DOI 10.1136/ebn.8.3.68; Green TC, 2011, PAIN MED, V12, P982, DOI 10.1111/j.1526-4637.2011.01136.x; Grilli R, 2000, LANCET, V355, P103, DOI 10.1016/S0140-6736(99)02171-6; Handford CKM., 2012, BUPRENORPHINE NALOXO; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Institute of Medicine Board on Health Care Services Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, 2011, CLIN PRACTICE GUIDEL; Knopf A, 2016, ALCOHOLISM DRUG ABUS, V28, P1, DOI DOI 10.1002/adaw.30537; Lang TA, 2013, BASIC STAT REPORTING, P23; Levi-Minzi MA, 2016, HEALTH CARE WOMEN IN, V37, P744, DOI 10.1080/07399332.2016.1158262; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Li TJ, 2015, ANN INTERN MED, V162, P287, DOI 10.7326/M14-1603; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Licurse A, 2010, ARCH INTERN MED, V170, P675, DOI 10.1001/archinternmed.2010.39; Lingford-Hughes AR, 2012, J PSYCHOPHARMACOL, V26, P899, DOI 10.1177/0269881112444324; Magellan Healthcare Clinical Practice Guideline Task Force, 2015, INTR MAG AD CLIN PRA; Manchikanti L, 2008, PAIN PHYSICIAN, V11, pS63; Mattick RP, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002207.pub3; Mattick RP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002209.pub2; Meyer R, 2014, POPUL HEALTH MANAG, V17, P372, DOI 10.1089/pop.2013.0098; Ministry of Health, 2014, NZ PRACT GUID OP SUB; Minozzi S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001333.pub3; Moher D., 2015, STATEMENT SYSTEMATIC, V4, DOI [10.1186/2046-4053-4-1, DOI 10.1186/2046-4053-4-12-S2.0-84920780781, DOI 10.14306/RENHYD.20.2.223]; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; MULROW CD, 1994, BRIT MED J, V309, P597, DOI 10.1136/bmj.309.6954.597; National Institute for Health and Care Excellence, 2007, METH BUPR MAN OP DEP; Onishi A, 2014, J CLIN EPIDEMIOL, V67, P1320, DOI 10.1016/j.jclinepi.2014.07.002; Paulozzi LJ, 2011, PAIN MED, V12, P747, DOI 10.1111/j.1526-4637.2011.01062.x; Pieper D, 2015, J CLIN EPIDEMIOL, V68, P574, DOI 10.1016/j.jclinepi.2014.12.009; Popovich I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050403; Reifler LM, 2012, PAIN MED, V13, P434, DOI 10.1111/j.1526-4637.2012.01327.x; Riaz H, 2015, AM J CARDIOL, V116, P1944, DOI 10.1016/j.amjcard.2015.09.034; Roest AM, 2015, JAMA PSYCHIAT, V72, P500, DOI 10.1001/jamapsychiatry.2015.15; Rudd RA, 2016, MMWR-MORBID MORTAL W, V64, P1378, DOI 10.15585/mmwr.mm6450a3; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7647; Sharif Mohammad O, 2013, Oral Health Dent Manag, V12, P9; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Shea BJ, 2009, J CLIN EPIDEMIOL, V62, P1013, DOI 10.1016/j.jclinepi.2008.10.009; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; The Management of Substance Use Disorders Work Group, 2015, VA DID CLIN PRACT GU; Tzoulaki I, 2013, JAMA INTERN MED, V173, P664, DOI 10.1001/jamainternmed.2013.3018; Van der Wees P, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-3; Waller R., 2014, MED ASSISTED TREATME; Zee AV, 2009, AM J PUBLIC HEALTH, V99, P221, DOI 10.2105/AJPH.2007.131714	65	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0181927	10.1371/journal.pone.0181927	http://dx.doi.org/10.1371/journal.pone.0181927			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771633	Green Submitted, gold, Green Published			2022-12-26	WOS:000406853600044
J	Couderc, JL; Richard, G; Vachias, C; Mirouse, V				Couderc, Jean-Louis; Richard, Graziella; Vachias, Caroline; Mirouse, Vincent			Drosophila LKB1 is required for the assembly of the polarized actin structure that allows spermatid individualization	PLOS ONE			English	Article							TUMOR-SUPPRESSOR LKB1; PEUTZ-JEGHERS-SYNDROME; TRANSGENIC RNAI; SPLICE VARIANT; MYOSIN-V; MELANOGASTER; KINASE; GENOME; SPERMATOGENESIS; SPERMIOGENESIS	In mammals, a testis-specific isoform of the protein kinase LKB1 is required for spermiogenesis, but its exact function and specificity are not known. Human LKB1 rescues the functions of Drosophila Lkb1 essential for viability, but these males are sterile, revealing a new function for this genes in fly. We also identified a testis-specific transcript generated by an alternative promoter and that only differs by a longer 5'UTR. We show that dLKB1 is required in the germline for the formation of the actin cone, the polarized structure that allows spermatid individualization and cytoplasm excess extrusion during spermiogenesis. Three of the nine LKB1 classical targets in the Drosophila genome ( AMPK, NUAK and KP78b) are required for proper spermiogenesis, but later than dLKB1. dLkb1 mutant phenotype is reminiscent of that of myosin V mutants, and both proteins show a dynamic localization profile before actin cone formation. Together, these data highlight a new dLKB1 function and suggest that dLKB1 posttranscriptional regulation in testis and involvement in spermatid morphogenesis are evolutionarily conserved features.	[Couderc, Jean-Louis; Richard, Graziella; Vachias, Caroline; Mirouse, Vincent] Univ Clermont Auvergne, CNRS, INSERM, GReD, Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA)	Mirouse, V (corresponding author), Univ Clermont Auvergne, CNRS, INSERM, GReD, Clermont Ferrand, France.	vincent.mirouse@udamail.fr		Vachias, Caroline/0000-0001-6292-4266; MIrouse, Vincent/0000-0001-5823-342X	ATIP-Avenir program; Association pour la Recherche Contre le Cancer; Region Auvergne; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	ATIP-Avenir program; Association pour la Recherche Contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Region Auvergne(Region Auvergne-Rhone-Alpes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the ATIP-Avenir program, the Association pour la Recherche Contre le Cancer and the Region Auvergne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Bloomington Drosophila Stock Center (NIH P40OD018537), NIG-fly facility, VDRC Stock Center and Harvard Medical School (NIH/NIGMS R01-GM084947), for providing the transgenic RNAi fly stocks used in this study; E. Knust for the gift of the anti-myosin V antibody, R. Renkawitz-Pohl, A. Ephrussi, B. Loppin, D. McKearin, D St Johnston for fly stocks, M. Billaud for hLKB1 cDNAs and T. David for the drawings. This work was supported by the ATIP-Avenir program, the Association pour la Recherche Contre le Cancer and the Region Auvergne.	Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Barckmann B, 2013, DEV BIOL, V377, P33, DOI 10.1016/j.ydbio.2013.02.018; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Bertoldo MJ, 2016, MOL CELL ENDOCRINOL, V423, P96, DOI 10.1016/j.mce.2016.01.001; BRAUN RE, 1989, GENE DEV, V3, P793, DOI 10.1101/gad.3.6.793; Denison FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028306; Denison FC, 2009, J BIOL CHEM, V284, P67, DOI 10.1074/jbc.M806153200; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Fabian Lacramioara, 2012, Spermatogenesis, V2, P197; Fabrizio JJ, 1998, DEVELOPMENT, V125, P1833; Fukuda N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003858; Fuller MT, 1993, SPERMATOGENESIS, P71; Ghosh-Roy A, 2005, MOL BIOL CELL, V16, P3107, DOI 10.1091/mbc.E05-02-0103; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Hammer JA, 2012, NAT REV MOL CELL BIO, V13, P13, DOI 10.1038/nrm3248; Isaji M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022755; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Krauss J, 2009, CURR BIOL, V19, P1058, DOI 10.1016/j.cub.2009.04.062; Lee JH, 2006, CELL DEATH DIFFER, V13, P1110, DOI 10.1038/sj.cdd.4401790; Lindsley D.T., 1980, SPERMATOGENESIS, P225; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Martin SG, 2003, NATURE, V421, P379, DOI 10.1038/nature01296; Mermall V, 2005, DEV BIOL, V286, P238, DOI 10.1016/j.ydbio.2005.07.028; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Noguchi T, 2006, MOL BIOL CELL, V17, P2559, DOI 10.1091/mbc.E06-01-0031; Noguchi T, 2003, DEVELOPMENT, V130, P1805, DOI 10.1242/dev.00406; Noguchi T, 2008, MOL BIOL CELL, V19, P2363, DOI 10.1091/mbc.E07-08-0840; Pocha SM, 2011, J CELL BIOL, V195, P827, DOI 10.1083/jcb.201105144; Raja SJ, 2005, MOL CELL BIOL, V25, P6165, DOI 10.1128/MCB.25.14.6165-6177.2005; Sanchez-Cespedes M, 2007, ONCOGENE, V26, P7825, DOI 10.1038/sj.onc.1210594; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Steinhauer J., 2015, SPERMATOGENESIS, V5, DOI [10.1080/21565562.2015.1041345, DOI 10.1080/21565562.2015.1041345]; Tanwar PS, 2012, HUM MOL GENET, V21, P4394, DOI 10.1093/hmg/dds272; TOKUYASU KT, 1972, Z ZELLFORSCH MIK ANA, V124, P479, DOI 10.1007/BF00335253; Towler MC, 2008, BIOCHEM J, V416, P1, DOI 10.1042/BJ20081447	37	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182279	10.1371/journal.pone.0182279	http://dx.doi.org/10.1371/journal.pone.0182279			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767695	Green Submitted, Green Published, gold			2022-12-26	WOS:000406768200064
J	Tian, GL; Gao, LM; Kong, YL; Hu, XY; Xie, KL; Zhang, RQ; Ling, N; Shen, QR; Guo, SW				Tian, Guangli; Gao, Limin; Kong, Yali; Hu, Xiangyu; Xie, Kailiu; Zhang, Ruiqing; Ling, Ning; Shen, Qirong; Guo, Shiwei			Improving rice population productivity by reducing nitrogen rate and increasing plant density	PLOS ONE			English	Article							LEAF-AREA INDEX; GRAIN-YIELD; USE EFFICIENCY; WHEAT; MANAGEMENT; NUMBER	In terms of tillering potential, the aboveground portions of rice are significantly influenced by the nitrogen level (NL) and transplant density (TD). To obtain a suitable combination of NL and TD, five NLs (0, 90, 180, 270 and 360 kg ha(-1)) and two TDs [high density (HD), 32.5x10(4) hills ha(-1); low density (LD), 25.5x10(4) hills ha(-1)] were used in the rice experiments during 2012 to 2014, in Jiangsu, China. The results showed the highest grain yield of rice obtained at HD and LD when N supply was 180 and 270 kg ha(-1), respectively. That's because there are more tillers per unit area, a larger leaf biomass fraction of total aboveground biomass, a larger leaf area index (LAI) and a larger canopy photosynthesis potential (CPP) at HD. It can be concluded that, higher rice planting densities resulted in less N inputs, while more N is needed to improve single plant actual tiller ability under low density to offset the reduced planting density. When the NL was more than 180 kg ha(-1), the actual tillering ability of a single plant at LD was 20% more than that at HD. Based on these results, the supply of 1 kg N can be replaced by adding approximately 1000 planting hills per hectare. Therefore, adjusting the transplant density could be an efficient method to reduce the amount of nitrogen fertilizer and increase the nitrogen fertilizer use efficiency, which is very conducive to the sustainable development of agriculture.	[Tian, Guangli; Gao, Limin; Kong, Yali; Hu, Xiangyu; Xie, Kailiu; Zhang, Ruiqing; Ling, Ning; Shen, Qirong; Guo, Shiwei] Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Solid Organ Waste, Jiangsu Prov Key Lab Organ Waste Utilizat, Natl Engn Res Ctr Organ Based Fertilizers, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Guo, SW (corresponding author), Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Solid Organ Waste, Jiangsu Prov Key Lab Organ Waste Utilizat, Natl Engn Res Ctr Organ Based Fertilizers, Nanjing, Jiangsu, Peoples R China.	sguo@njau.edu.cn	Ling, Ning/AAF-3633-2019; Zhang, Rui/GXN-3801-2022; Shen, Qirong/AAB-6531-2020	Ling, Ning/0000-0003-1250-4073; 	National Basic Research Program of China [2013CB127403]; National Natural Science Foundation of China [31172020, 31272236]; Special Fund for Agriculture Profession of China [201103003,20150312205, 201103003, 20150312205]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agriculture Profession of China	Funded by The National Basic Research Program of China (2013CB127403) (for experiment implement), The National Natural Science Foundation of China (31172020 and 31272236) (for travel and living allowances, and sample collection), and The Special Fund for Agriculture Profession of China (201103003,20150312205) (for sample analysis).; This works were supported by the National Basic Research Program of China (2013CB127403), the National Natural Science Foundation of China (31172020 and 31272236), and the Special Fund for Agriculture Profession of China (201103003, 20150312205).	Ali E. A., 2010, American-Eurasian Journal of Agricultural and Environmental Science, V7, P327; Arduini I, 2006, EUR J AGRON, V25, P309, DOI 10.1016/j.eja.2006.06.009; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Banwart S, 2011, NATURE, V474, P151, DOI 10.1038/474151a; Chen XP, 2014, NATURE, V514, P486, DOI 10.1038/nature13609; Ciampitti IA, 2011, FIELD CROP RES, V121, P2, DOI 10.1016/j.fcr.2010.10.009; COUNCE PA, 1990, J PROD AGRIC, V3, P390, DOI 10.2134/jpa1990.0390; Evers JB, 2006, ANN BOT-LONDON, V97, P649, DOI 10.1093/aob/mcl020; FAGADE SO, 1971, AGRON J, V63, P503, DOI 10.2134/agronj1971.00021962006300030047x; Fageria NK, 2007, J PLANT NUTR, V30, P843, DOI 10.1080/15226510701374831; Gabrielle B, 1998, 16 INT SOC SOIL SCI; Gastal F, 2002, J EXP BOT, V53, P789, DOI 10.1093/jexbot/53.370.789; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Habtegebrial K, 2007, SOIL TILL RES, V94, P55, DOI 10.1016/j.still.2006.07.002; HASEGAWA T, 1994, AGRON J, V86, P673, DOI 10.2134/agronj1994.00021962008600040016x; Horie T, 1997, FIELD CROP RES, V52, P55, DOI 10.1016/S0378-4290(96)03458-2; Huang M, 2013, FIELD CROP RES, V149, P187, DOI 10.1016/j.fcr.2013.04.029; JONGKAEWWATTANA S, 1991, J AGRON CROP SCI, V167, P43, DOI 10.1111/j.1439-037X.1991.tb00932.x; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Kiniry JR, 2001, AGRON J, V93, P1354, DOI 10.2134/agronj2001.1354; KIRBY EJM, 1972, J AGR SCI, V78, P281, DOI 10.1017/S0021859600069124; Lawlor DW, 2002, J EXP BOT, V53, P773, DOI 10.1093/jexbot/53.370.773; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Makino A, 2011, PLANT PHYSIOL, V155, P125, DOI 10.1104/pp.110.165076; Miao YX, 2011, AGRON SUSTAIN DEV, V31, P397, DOI 10.1051/agro/2010034; NANGJU D, 1970, AGRON J, V62, P468, DOI 10.2134/agronj1970.00021962006200040011x; NGUU NV, 1978, FIELD CROP RES, V2, P19, DOI 10.1016/0378-4290(79)90003-0; NOVOA R, 1981, PLANT SOIL, V58, P177, DOI 10.1007/BF02180053; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Sakamoto T, 2008, CURR OPIN PLANT BIOL, V11, P209, DOI 10.1016/j.pbi.2008.01.009; SHADCHINA TM, 1995, J PLANT NUTR, V18, P1427, DOI 10.1080/01904169509364992; Sinclair TR, 2006, FIELD CROP RES, V98, P60, DOI 10.1016/j.fcr.2005.12.006; Sui BA, 2013, FIELD CROP RES, V150, P99, DOI 10.1016/j.fcr.2013.06.012; VERGARA B. S., 1964, Soil and Plant Food, V10, P15; Wu GW, 1998, AGRON J, V90, P317, DOI 10.2134/agronj1998.00021962009000030001x; Yang JC, 2006, J EXP BOT, V57, P149, DOI 10.1093/jxb/erj018; Yang JC, 2001, PLANT PHYSIOL, V127, P315, DOI 10.1104/pp.127.1.315; Zhong X, 2002, J AGR SCI, V138, P269, DOI 10.1017/S0021859601001903; Zhong XH, 2003, J PLANT NUTR, V26, P1203, DOI 10.1081/PLN-120020365	39	51	55	7	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182310	10.1371/journal.pone.0182310	http://dx.doi.org/10.1371/journal.pone.0182310			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767723	Green Submitted, Green Published, gold			2022-12-26	WOS:000406768200070
J	Anastasiou, CA; Yannakoulia, M; Kosmidis, MH; Dardiotis, E; Hadjigeorgiou, GM; Sakka, P; Arampatzi, X; Bougea, A; Labropoulos, I; Scarmeas, N				Anastasiou, Costas A.; Yannakoulia, Mary; Kosmidis, Mary H.; Dardiotis, Efthimios; Hadjigeorgiou, Giorgos M.; Sakka, Paraskevi; Arampatzi, Xanthi; Bougea, Anastasia; Labropoulos, Ioannis; Scarmeas, Nikolaos			Mediterranean diet and cognitive health: Initial results from the Hellenic Longitudinal Investigation of Ageing and Diet	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; CARDIOVASCULAR-DISEASE; DEPRESSION SCALE; NORMATIVE DATA; LEWY BODIES; AGED 65; DEMENTIA; RISK; ADHERENCE; DECLINE	Background The Mediterranean dietary pattern has been associated with a decreased risk of many degenerative diseases and cognitive function in particular; however, relevant information from Mediterranean regions, where the prototype Mediterranean diet is typically adhered to, have been very limited. Additionally, predefined Mediterranean diet (MeDi) scores with use of a priori cut-offs have been used very rarely, limiting comparisons between different populations and thus external validity of the associations. Finally, associations between individual components of MeDi (i.e., food groups, macronutrients) and particular aspects of cognitive performance have rarely been explored. We evaluated the association of adherence to an a priori defined Mediterranean dietary pattern and its components with dementia and specific aspects of cognitive function in a representative population cohort in Greece. Methods Participants from the Hellenic Longitudinal Investigation of Ageing and Diet (HELIAD), an on-going population-based study, exploring potential associations between diet and cognitive performance in a representative sample from Greek regions, were included in this analysis. Diagnosis of dementia was made by a full clinical and neuropsychological evaluation, while cognitive performance was assessed according to five cognitive domains (memory, language, attention-speed, executive functioning, visuospatial perception) and a composite cognitive score. Adherence to MeDi was evaluated by an a priori score (range 0-55), derived from a detailed food frequency questionnaire. Results Among 1,865 individuals (mean age 73 +/- 6 years, 41% male), 90 were diagnosed with dementia and 223 with mild cognitive impairment. Each unit increase in the Mediterranean dietary score (MedDietScore) was associated with a 10% decrease in the odds for dementia. Adherence to the MeDi was also associated with better performance in memory, language, visuospatial perception and the composite cognitive score; the associations were strongest for memory. Fish consumption was negatively associated with dementia and cognitive performance positively associated with non-refined cereal consumption. Conclusions Our results suggest that adherence to the MeDi is associated with better cognitive performance and lower dementia rates in Greek elders. Thus, the MeDi in its a priori constructed prototype form may have cognitive benefits in traditional Mediterranean populations.	[Anastasiou, Costas A.; Yannakoulia, Mary] Harokopio Univ, Dept Nutr & Dietet, Athens, Greece; [Anastasiou, Costas A.; Scarmeas, Nikolaos] Univ Athens, Dept Social Med Psychiat & Neurol, Neurol Clin 1, Eginit Hosp, Athens, Greece; [Kosmidis, Mary H.; Arampatzi, Xanthi] Aristotle Univ Thessaloniki, Sch Psychol, Lab Cognit Neurosci, Thessaloniki, Greece; [Dardiotis, Efthimios; Hadjigeorgiou, Giorgos M.] Univ Thessaly, Sch Med, Larisa, Greece; [Sakka, Paraskevi] Athens Assoc Alzheimers Dis & Related Disorders, Maroussi, Greece; [Bougea, Anastasia] Eginit Hosp, Neurol Clin 1, Athens, Greece; [Labropoulos, Ioannis] Biomed Diagnost Lab, Athens, Greece; [Scarmeas, Nikolaos] Columbia Univ, Dept Neurol, Taub Inst Res Alzheimers Dis & Aging Brain, Gertrude H Sergievsky Ctr, New York, NY USA	Harokopio University Athens; National & Kapodistrian University of Athens; Aristotle University of Thessaloniki; University of Thessaly; Columbia University	Scarmeas, N (corresponding author), Univ Athens, Dept Social Med Psychiat & Neurol, Neurol Clin 1, Eginit Hosp, Athens, Greece.; Scarmeas, N (corresponding author), Columbia Univ, Dept Neurol, Taub Inst Res Alzheimers Dis & Aging Brain, Gertrude H Sergievsky Ctr, New York, NY USA.	ns257@columbia.edu	BOUGEA, ANASTASIA/P-8197-2017; Scarmeas, Nikolaos/AAD-2512-2020; Stefanadis, Christodoulos/ABH-2232-2020; Scarmeas, Nikolaos/AAD-2517-2020; Kosmidis, Mary H/AAN-2104-2021	Scarmeas, Nikolaos/0000-0001-6453-8908; Stefanadis, Christodoulos/0000-0001-5974-6454; Scarmeas, Nikolaos/0000-0001-6453-8908; Kosmidis, Mary/0000-0001-8790-1220; Dardiotis, Efthimios/0000-0003-2957-641X; Yannakoulia, Mary/0000-0003-2171-7337; Anastasiou, Costas/0000-0002-3536-3034	Alzheimers Association [IIRG-09-133014]; ESPA-EU program Excellence Grant (ARISTEIA) [189 10276/8/9/2011]; European Social Fund; Greek National resources; Ministry for Health and Social Solidarity (Greece) [DY2b/oik.51657/14.4.2009]; Greek State Scholarships Foundation [MIS: 5001552]	Alzheimers Association(Alzheimer's Association); ESPA-EU program Excellence Grant (ARISTEIA); European Social Fund(European Social Fund (ESF)); Greek National resources(Greek Ministry of Development-GSRT); Ministry for Health and Social Solidarity (Greece); Greek State Scholarships Foundation(Greek Ministry of Development-GSRT)	This study was supported by the following grants: IIRG-09-133014 from the Alzheimers Association; 189 10276/8/9/2011 from the ESPA-EU program Excellence Grant (ARISTEIA), which is co-funded by the European Social Fund and Greek National resources, and DY2b/oik.51657/14.4.2009 from the Ministry for Health and Social Solidarity (Greece). Costas A. Anastasiou has received financial support from the Greek State Scholarships Foundation (MIS: 5001552).	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; American Psychiatric Association, 2000, DIAGNOSTIC AND STATI; Benton AL, 1994, CONTRIBUTIONS TO NEU; Berr C, 2009, DEMENT GERIATR COGN, V28, P357, DOI 10.1159/000253483; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; Bountziouka V, 2012, NUTR METAB CARDIOVAS, V22, P659, DOI 10.1016/j.numecd.2010.10.015; Bozikas VP, 2008, J CLIN EXP NEUROPSYC, V30, P199, DOI 10.1080/13803390701346113; Broe GA, 1998, AUST NZ J PUBL HEAL, V22, P621, DOI 10.1111/j.1467-842X.1998.tb01449.x; Cherbuin N, 2012, AM J GERIAT PSYCHIAT, V20, P635, DOI 10.1097/JGP.0b013e31823032a9; Christensen K, 2013, LANCET, V382, P1507, DOI 10.1016/S0140-6736(13)60777-1; Corley J, 2013, INT PSYCHOGERIATR, V25, P1393, DOI 10.1017/S1041610213000793; Cummings JL, 1997, NEUROLOGY, V48, pS10, DOI 10.1212/WNL.48.5_Suppl_6.10S; Dardiotis E, 2014, NEUROEPIDEMIOLOGY, V43, P9, DOI 10.1159/000362723; DEVANAND DP, 1992, ARCH NEUROL-CHICAGO, V49, P371, DOI 10.1001/archneur.1992.00530280051022; Dewey ME, 2001, INT J GERIATR PSYCH, V16, P751, DOI 10.1002/gps.397.abs; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Feart C, 2013, P NUTR SOC, V72, P140, DOI 10.1017/S0029665112002959; Feart C, 2009, JAMA-J AM MED ASSOC, V302, P638, DOI 10.1001/jama.2009.1146; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fotuhi M, 2009, NAT CLIN PRACT NEURO, V5, P140, DOI 10.1038/ncpneuro1044; Fountoulakis KN, 1999, AGING-CLIN EXP RES, V11, P367, DOI 10.1007/BF03339814; Gardener H, 2015, AM J CARDIOL, V115, P510, DOI 10.1016/j.amjcard.2014.11.038; Gardener H, 2012, ARCH NEUROL-CHICAGO, V69, P251, DOI 10.1001/archneurol.2011.548; Gardener S, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.91; Gardener SL, 2015, MOL PSYCHIATR, V20, P860, DOI 10.1038/mp.2014.79; Giaglis G, 2010, JOURNAL OF THE INTER, V15; Gosche KM, 2002, NEUROLOGY, V58, P1476, DOI 10.1212/WNL.58.10.1476; Gu Y, 2011, CURR ALZHEIMER RES, V8, P510, DOI 10.2174/156720511796391836; Gu Y, 2015, NEUROLOGY, V85, P1744, DOI 10.1212/WNL.0000000000002121; HACHINSKI VC, 1975, ARCH NEUROL-CHICAGO, V32, P632, DOI 10.1001/archneur.1975.00490510088009; Jacka FN, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0461-x; Kesse-Guyot E, 2013, AM J CLIN NUTR, V97, P369, DOI 10.3945/ajcn.112.047993; Knight A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8090579; Kosmidis MH, 2010, BEHAV NEUROL, V23, P245, DOI [10.3233/BEN-2010-0306, 10.1155/2010/956709]; Kosmidis MH, 2004, J INT NEUROPSYCH SOC, V10, P164, DOI 10.1017/S1355617704102014; Koyama A, 2015, J GERONTOL A-BIOL, V70, P352, DOI 10.1093/gerona/glu097; Langa KM, 2017, JAMA INTERN MED, V177, P51, DOI 10.1001/jamainternmed.2016.6807; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Martinez-Lapiscina EH, 2013, J NUTR HEALTH AGING, V17, P544, DOI 10.1007/s12603-013-0027-6; Matthews Dawn C, 2014, Adv J Mol Imaging, V4, P43; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Michopoulos Ioannis, 2008, Ann Gen Psychiatry, V7, P4, DOI 10.1186/1744-859X-7-4; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Panagiotakos DB, 2006, NUTR METAB CARDIOVAS, V16, P559, DOI 10.1016/j.numecd.2005.08.006; Pitsavos C, 2005, AM J CLIN NUTR, V82, P694, DOI 10.1093/ajcn/82.3.694; Psaltopoulou T, 2008, PUBLIC HEALTH NUTR, V11, P1054, DOI 10.1017/S1368980007001607; Psaltopoulou T, 2013, ANN NEUROL, V74, P580, DOI 10.1002/ana.23944; Roberts RO, 2010, DEMENT GERIATR COGN, V29, P413, DOI 10.1159/000305099; ROSEN WG, 1980, ANN NEUROL, V7, P486, DOI 10.1002/ana.410070516; Salas-Salvado J, 2008, EUR J CLIN NUTR, V62, P651, DOI 10.1038/sj.ejcn.1602762; Samieri C, 2013, EPIDEMIOLOGY, V24, P490, DOI 10.1097/EDE.0b013e318294a065; Samieri C, 2013, J NUTR, V143, P493, DOI 10.3945/jn.112.169896; Sastre M, 2006, INT J DEV NEUROSCI, V24, P167, DOI 10.1016/j.ijdevneu.2005.11.014; Satizabal CL, 2016, NEW ENGL J MED, V374, P523, DOI 10.1056/NEJMoa1504327; Scarmeas N, 2011, ANN NEUROL, V69, P257, DOI 10.1002/ana.22317; Scarmeas N, 2009, ARCH NEUROL-CHICAGO, V66, P216, DOI 10.1001/archneurol.2008.536; Scarmeas N, 2006, ANN NEUROL, V59, P912, DOI 10.1002/ana.20854; Singh B, 2014, J ALZHEIMERS DIS, V39, P271, DOI 10.3233/JAD-130830; Sofi F, 2010, AM J CLIN NUTR, V92, P1189, DOI 10.3945/ajcn.2010.29673; Solfrizzi V, 1999, NEUROLOGY, V52, P1563, DOI 10.1212/WNL.52.8.1563; Stakias N, 2006, J GERONTOL A-BIOL, V61, P1228, DOI 10.1093/gerona/61.12.1228; Supreme Scientific Health Council, 1999, ARCH HELLENIC MED, V16, P516; Tangney CC, 2011, AM J CLIN NUTR, V93, P601, DOI 10.3945/ajcn.110.007369; Titova OE, 2013, EXP GERONTOL, V48, P1443, DOI 10.1016/j.exger.2013.10.002; Toole JF, 1996, AM J EPIDEMIOL, V144, P849; Tsapkini K, 2009, BEHAV NEUROL, V22, P111, DOI [10.3233/BEN-2009-0256, 10.3233/ben-2009-0256]; Tsivgoulis G, 2013, NEUROLOGY, V80, P1684, DOI 10.1212/WNL.0b013e3182904f69; Valls-Pedret C, 2015, JAMA INTERN MED, V175, P1094, DOI 10.1001/jamainternmed.2015.1668; Vercambre MN, 2012, J ACAD NUTR DIET, V112, P816, DOI 10.1016/j.jand.2012.02.023; Vlahou CH., 2002, PSYCHOL J HELL PSYCH, V9, P336; Vlahou CH, 2013, ARCH CLIN NEUROPSYCH, V28, P52, DOI 10.1093/arclin/acs099; Walker MP, 2000, BRIT J PSYCHIAT, V177, P252, DOI 10.1192/bjp.177.3.252; Wengreen H, 2013, AM J CLIN NUTR, V98, P1263, DOI 10.3945/ajcn.112.051276; World Health Organisation, 2012, DEMENTIA A PUBLIC HE; World Health Organization (WHO), 2015, WORLD REPORT ON AGEI; Yannakoulia M, 2015, AGEING RES REV, V20, P74, DOI 10.1016/j.arr.2014.10.003; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	84	122	125	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0182048	10.1371/journal.pone.0182048	http://dx.doi.org/10.1371/journal.pone.0182048			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC3VC	28763509	gold, Green Published, Green Submitted			2022-12-26	WOS:000406766500037
J	Andrade, PHS; Lobo, IMF; da Silva, WB				Santos Andrade, Paulo Henrique; Fraga Lobo, Iza Maria; da Silva, Wellington Barros			Risk factors for adverse drug reactions in pediatric inpatients: A cohort study	PLOS ONE			English	Article							HOSPITALIZED CHILDREN; EPIDEMIOLOGY; DOCUMENTATION; ALLERGY; PATIENT	Purpose The present study aims to identify the risk factors for adverse drug reactions (ADR) in pediatric inpatients. Methods A prospective cohort study in one general pediatric ward in a hospital in Northeast Brazil was conducted in two stages: the first stage was conducted between August 17th and November 6th, 2015, and the second one between March 1st and August 25th, 2016. We included children aged 014 years 11 months hospitalized with a minimum stay of 48 hours. Observed outcomes were the ADR occurrence and the time until the first ADR observed. In the univariate analysis, the time to the first ADR was compared among groups using a log-rank test. For the multivariate analysis, the Cox regression model was used. Results A total of 173 children (208 admissions) and 66 ADR classified as definite and probable were identified. The incidence rate was 3/100 patient days. The gastro-intestinal system disorders were the main ADR observed (28.8%). In addition, 22.7% of the ADR were related to antibacterials for systemic use and 15.2% to general anesthesia. Prior history of ADR of the child [hazard ratio (HR) 2.44; 95% confidence interval (CI) 1.195.00], the use of meglumine antimonate (HR 4.98; 95% CI 1.2120.54), antibacterial for systemic use (HR 2.75; 95% CI 1.086.98) and antiepileptic drugs (HR 3.84; 95% CI 1.4010.56) were identified risk factors for ADR. Conclusions We identified as risk factors the prior history of ADR of the child and the use of meglumine antimonate, antibacterial for systemic use and antiepileptic drugs.	[Santos Andrade, Paulo Henrique; da Silva, Wellington Barros] Univ Fed Sergipe, Sao Cristovao, Sergipe, Brazil; [Fraga Lobo, Iza Maria] Hosp Univ Sergipe, Aracaju, Sergipe, Brazil	Universidade Federal de Sergipe	Andrade, PHS (corresponding author), Univ Fed Sergipe, Sao Cristovao, Sergipe, Brazil.	paulo_henrique0@hotmail.com	Silva, Wellington B./A-4250-2015; Andrade, Paulo Henrique Santos/K-9110-2019	Andrade, Paulo Henrique Santos/0000-0002-8824-459X	Fellowship of the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fellowship of the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by a Fellowship of the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) awarded to Paulo Henrique Santos Andrade.	Alomar MJ, 2014, SAUDI PHARM J, V22, P83, DOI 10.1016/j.jsps.2013.02.003; Andrade PHS, 2017, THER ADV DRUG SAF; Andrade PHS, 2017, PROTOCOL DATA COLLEC, DOI [10.17504/protocols.io.iqqcdvw, DOI 10.17504/PROTOCOLS.IO.IQQCDVW]; Barton L, 2012, CLIN MED, V12, P119, DOI 10.7861/clinmedicine.12-2-119; Dai DW, 2016, PEDIATR CRIT CARE ME, V17, pE218, DOI 10.1097/PCC.0000000000000684; dos Santos DB, 2006, PHARMACOEPIDEM DR S, V15, P635, DOI 10.1002/pds.1187; Drugs.com, 2016, MICR HEALTHC SER; Eshetie TC, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0401-0; Farooq M, 2008, IRISH J MED SCI, V177, P243, DOI 10.1007/s11845-008-0166-7; HARTWIG SC, 1992, AM J HOSP PHARM, V49, P2229, DOI 10.1093/ajhp/49.9.2229; Hazell L, 2006, DRUG SAFETY, V29, P385, DOI 10.2165/00002018-200629050-00003; Impicciatore P, 2001, BRIT J CLIN PHARMACO, V52, P77, DOI 10.1046/j.0306-5251.2001.01407.x; Kelly AM, 2016, INT J TUBERC LUNG D, V20, P442, DOI 10.5588/ijtld.15.0318; Lopez-Gonzalez E, 2009, DRUG SAFETY, V32, P19, DOI 10.2165/00002018-200932010-00002; Matos C, 2016, DRUG SAFETY, V39, P1105, DOI 10.1007/s40264-016-0453-6; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Rashed AN, 2014, BRIT J CLIN PHARMACO, V77, P873, DOI 10.1111/bcp.12270; Rashed AN, 2012, EUR J CLIN PHARMACOL, V68, P1657, DOI 10.1007/s00228-012-1302-x; Rashed AN, 2012, EUR J CLIN PHARMACOL, V68, P801, DOI 10.1007/s00228-011-1183-4; Silva DCB, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001868; Smyth RMD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0024061; Sultana J, 2013, J PHARMACOL PHARMACO, V4, pS73, DOI 10.4103/0976-500X.120957; Thiesen S, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-237; Turner S, 1999, ACTA PAEDIATR, V88, P965, DOI 10.1080/08035259950168469; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; WHO, 2016, AN THER CHEM CLASS; WHO, 2015, WHO ADV REACT TERM; WHO, 2002, IMP PHARM SAF MON ME; WHO, 2010, INT CLASS DIS VERS 1	29	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0182327	10.1371/journal.pone.0182327	http://dx.doi.org/10.1371/journal.pone.0182327			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763499	Green Submitted, Green Published, gold			2022-12-26	WOS:000406766500061
J	Chen, XZ; Peng, Y; Peng, S; Yao, S; Chen, C; Xu, P				Chen, Xuanzhen; Peng, Yong; Peng, Shan; Yao, Song; Chen, Chao; Xu, Ping			Flow and fracture behavior of aluminum alloy 6082-T6 at different tensile strain rates and triaxialities	PLOS ONE			English	Article							STRESS TRIAXIALITY; CONSTITUTIVE MODELS; DUCTILE FRACTURE; STEEL; TEMPERATURES; STRENGTH; FAILURE; GROWTH	This study aims to investigate the flow and fracture behavior of aluminum alloy 6082-T6 (AA6082-T6) at different strain rates and triaxialities. Two groups of Charpy impact tests were carried out to further investigate its dynamic impact fracture property. A series of tensile tests and numerical simulations based on finite element analysis (FEA) were performed. Experimental data on smooth specimens under various strain rates ranging from 0.0001 similar to 3400 s(-1) shows that AA6082-T6 is rather insensitive to strain rates in general. However, clear rate sensitivity was observed in the range of 0.001 similar to 1 s(-1) while such a characteristic is counteracted by the adiabatic heating of specimens under high strain rates. A Johnson-Cook constitutive model was proposed based on tensile tests at different strain rates. In this study, the average stress triaxiality and equivalent plastic strain at facture obtained from numerical simulations were used for the calibration of J-C fracture model. Both of the J-C constitutive model and fracture model were employed in numerical simulations and the results was compared with experimental results. The calibrated J-C fracture model exhibits higher accuracy than the J-C fracture model obtained by the common method in predicting the fracture behavior of AA6082-T6. Finally, the Scanning Electron Microscope (SEM) of fractured specimens with different initial stress triaxialities were analyzed. The magnified fractographs indicate that high initial stress triaxiality likely results in dimple fracture.	[Chen, Xuanzhen; Peng, Yong; Peng, Shan; Yao, Song; Xu, Ping] Cent S Univ, Key Lab Traff Safety Track, Sch Traff & Transportat Engn, Minist Educ, Changsha, Hunan, Peoples R China; [Peng, Yong] Cent S Univ, State Key Lab High Performance Complex Mfg, Changsha, Hunan, Peoples R China; [Chen, Chao] Hunan Ind Polytech, Changsha, Hunan, Peoples R China	Central South University; Central South University; Hunan Industry Polytechnic	Peng, Y (corresponding author), Cent S Univ, Key Lab Traff Safety Track, Sch Traff & Transportat Engn, Minist Educ, Changsha, Hunan, Peoples R China.; Peng, Y (corresponding author), Cent S Univ, State Key Lab High Performance Complex Mfg, Changsha, Hunan, Peoples R China.; Chen, C (corresponding author), Hunan Ind Polytech, Changsha, Hunan, Peoples R China.	yong_peng@csu.edu.cn; hngyzycc@163.com		PENG, Yong/0000-0003-0101-0342; Chen, Xuanzhen/0000-0001-7787-8661	National Natural Science Foundation of China [51405517, U1334208]; Natural Science Foundation of Hunan [2015JJ3155]; Central South University [ZLXD2017002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan(Natural Science Foundation of Hunan Province); Central South University	This work was supported by the National Natural Science Foundation of China (No. 51405517 and U1334208), the Natural Science Foundation of Hunan (2015JJ3155) and Strategic Leading Science and Technology Project of Central South University (ZLXD2017002).	Bao YB, 2004, INT J MECH SCI, V46, P81, DOI 10.1016/j.ijmecsci.2004.02.006; Borvik T, 2005, INT J IMPACT ENG, V32, P35, DOI 10.1016/j.ijimpeng.2005.05.001; Borvik T, 2005, ENG FRACT MECH, V72, P1071, DOI 10.1016/j.engfracmech.2004.07.007; Bridgman P.W., 1964, STUDIES LARGE PLASTI; Chen Y, 2009, INT J SOLIDS STRUCT, V46, P3825, DOI 10.1016/j.ijsolstr.2009.07.013; Choung J, 2014, OCEAN ENG, V91, P218, DOI 10.1016/j.oceaneng.2014.09.019; Choung J, 2012, MAR STRUCT, V29, P1, DOI 10.1016/j.marstruc.2012.08.001; Clausen AH, 2004, MAT SCI ENG A-STRUCT, V364, P260, DOI 10.1016/j.msea.2003.08.027; Erice B, 2012, ENG FRACT MECH, V79, P1, DOI 10.1016/j.engfracmech.2011.08.023; Feng F, 2014, MATER DESIGN, V57, P10, DOI 10.1016/j.matdes.2013.12.031; HANCOCK JW, 1976, J MECH PHYS SOLIDS, V24, P147, DOI 10.1016/0022-5096(76)90024-7; Hou QY, 2010, COMP MATER SCI, V50, P147, DOI 10.1016/j.commatsci.2010.07.018; Hu DY, 2015, MATER DESIGN, V87, P759, DOI 10.1016/j.matdes.2015.08.063; JOHNSON GR, 1985, ENG FRACT MECH, V21, P31, DOI 10.1016/0013-7944(85)90052-9; Johnson GR, 1983, P 7 INT S BALL NETH, P541, DOI DOI 10.1038/NRM3209; Kolsky H., 1949, P PHYS SOC B; LEROY G, 1981, ACTA METALL MATER, V29, P1509, DOI 10.1016/0001-6160(81)90185-1; Li HY, 2013, MATER DESIGN, V49, P493, DOI 10.1016/j.matdes.2012.12.083; Ludwik P., 1923, STAHL EISEN, V43, P999; Majzoobi GH, 2016, ENG FRACT MECH, V158, P179, DOI 10.1016/j.engfracmech.2016.03.001; Malcher L, 2012, INT J PLASTICITY, V30-31, P81, DOI 10.1016/j.ijplas.2011.10.005; Oosterkamp LD, 2000, MAT SCI ENG A-STRUCT, V278, P225, DOI 10.1016/S0921-5093(99)00570-5; Pardoen T, 2000, J MECH PHYS SOLIDS, V48, P2467, DOI 10.1016/S0022-5096(00)00019-3; Peng Y, 2015, THIN WALL STRUCT, V94, P663, DOI 10.1016/j.tws.2015.05.016; Singh NK, 2014, MECH ADV MATER STRUC, V21, P531, DOI 10.1080/15376494.2012.699594; Spigarelli S, 2003, SCRIPTA MATER, V49, P179, DOI 10.1016/S1359-6462(03)00206-9; TAYLOR G, 1948, PROC R SOC LON SER-A, V194, P289, DOI 10.1098/rspa.1948.0081; Trajkovski J, 2015, MATER DESIGN, V66, P37, DOI 10.1016/j.matdes.2014.10.030; Trana E, 2015, J MATER PROCESS TECH, V216, P59, DOI 10.1016/j.jmatprotec.2014.08.032; VANDENBEUKEL A, 1975, PHYS STATUS SOLIDI A, V30, P197, DOI 10.1002/pssa.2210300120; Wierzbicki T, 2005, INT J MECH SCI, V47, P719, DOI 10.1016/j.ijmecsci.2005.03.003	31	28	29	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0181983	10.1371/journal.pone.0181983	http://dx.doi.org/10.1371/journal.pone.0181983			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759617	gold, Green Submitted, Green Published			2022-12-26	WOS:000406761600041
J	Muhammad, IF; Borne, Y; Ostling, G; Kennback, C; Gottsater, M; Persson, M; Nilsson, PM; Engstrom, G				Muhammad, Iram Faqir; Borne, Yan; Ostling, Gerdo; Kennback, Cecilia; Gottsater, Mikael; Persson, Margaretha; Nilsson, Peter M.; Engstrom, Gunnar			Acute phase proteins as prospective risk markers for arterial stiffness: The Malmo Diet and Cancer cohort	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; C-REACTIVE PROTEIN; INTIMA-MEDIA THICKNESS; AORTIC STIFFNESS; CARDIOVASCULAR MORTALITY; BLOOD-PRESSURE; FOLLOW-UP; ALL-CAUSE; INFLAMMATION; PLASMA	Background and objectives Arterial stiffness plays a significant role in the development and progression of adverse cardiovascular events and all-cause mortality. This observational study aims to explore the relationship between six acute phase proteins namely, ceruloplasmin, alpha-1-antitrypsin, orosomucoid, haptoglobin, complement C3 and C-reactive protein (CRP), and carotid-femoral pulse wave velocity (c-f PWV) in a population-based cohort, and to also explore the effect of low-grade inflammation on the relationship between diabetes and c-f PWV. Method The study consisted of participants from the Malmo Diet and Cancer study with data from baseline examinations (1991-1994) and follow-up examinations (2007-2012). Arterial stiffness was measured at follow-up by determining c-f PWV. After excluding participants with missing data, the total study population included 2338 subjects. General linear models were used to assess the relationship between baseline acute phase proteins and c-f PWV. Results After adjusting for traditional risk factors the participants in the 4th quartile vs 1st quartile of alpha-1-antitrypsin (geometric mean: 10.32 m/s vs 10.04 m/s) (p<0.05), C3 (10.35 m/s vs 10.06 m/s) (p<0.05) and CRP (10.37 m/s vs 9.96 m/s) (p<0.001) showed significant association with c-f PWV. Diabetes at follow-up was also associated with high c-f PWV, however, this relationship was independent of low grade inflammation. Conclusion Alpha-1-antitrypsin, C3 and CRP are associated with arterial stiffness. The results indicate that low grade inflammation is associated with arterial stiffness in addition to established cardiovascular risk factors.	[Muhammad, Iram Faqir; Borne, Yan; Ostling, Gerdo; Gottsater, Mikael; Persson, Margaretha; Nilsson, Peter M.; Engstrom, Gunnar] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Ostling, Gerdo; Kennback, Cecilia; Gottsater, Mikael; Persson, Margaretha; Nilsson, Peter M.] Skane Univ Hosp, Malmo, Sweden	Lund University; Lund University; Skane University Hospital	Muhammad, IF (corresponding author), Lund Univ, Dept Clin Sci, Malmo, Sweden.	iram.faqir_muhammad@med.lu.se	b, y/AAG-3349-2019; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Persson, Margaretha/0000-0001-8188-5792	Medical Research Council of Sweden [K2011-65X-20752-04-6, 2014-2265]; Region Skake County Council (ALF); Swedish Heart and Lung foundation [20150469]; Ernhold Lundstrom Foundation	Medical Research Council of Sweden(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Region Skake County Council (ALF); Swedish Heart and Lung foundation(Swedish Heart-Lung Foundation); Ernhold Lundstrom Foundation	This MDC Re-exam study was supported by the Medical Research Council of Sweden (grant K2011-65X-20752-04-6; 2014-2265), the Region Skake County Council (ALF), the Swedish Heart and Lung foundation (grant 20150469) and Ernhold Lundstrom Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Amar J, 2004, J HYPERTENS, V22, P349, DOI 10.1097/00004872-200402000-00019; Ben-Shlomo Y, 2014, J AM COLL CARDIOL, V63, P636, DOI 10.1016/j.jacc.2013.09.063; Benetos A, 2002, CIRCULATION, V105, P1202, DOI 10.1161/hc1002.105135; Bjarnegard N, 2006, LUPUS, V15, P644, DOI 10.1177/0961203306071402; Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434; Cecelja M, 2009, HYPERTENSION, V54, P1328, DOI 10.1161/HYPERTENSIONAHA.109.137653; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; Cunha RS, 1997, J HYPERTENS, V15, P1423, DOI 10.1097/00004872-199715120-00009; Dahl M, 2003, CIRCULATION, V107, P747, DOI 10.1161/01.CIR.0000049642.20484.5D; Duckers JM, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-173; Duprez DA, 2005, J HUM HYPERTENS, V19, P515, DOI 10.1038/sj.jhh.1001860; Engstrom G, 2007, J HUM HYPERTENS, V21, P276, DOI 10.1038/sj.jhh.1002129; Engstrom G, 2003, ARTERIOSCL THROM VAS, V23, P2247, DOI 10.1161/01.ATV.0000102924.11767.8D; Engstrom G, 2002, ARTERIOSCL THROM VAS, V22, P2054, DOI 10.1161/01.ATV.0000041842.43905.F3; Enhorning S, 2016, EUR J ENDOCRINOL, V174, P69, DOI 10.1530/EJE-15-0781; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gottsater M, 2015, J HYPERTENS, V33, P957, DOI 10.1097/HJH.0000000000000520; Hedblad B, 2000, DIABETIC MED, V17, P299, DOI 10.1046/j.1464-5491.2000.00280.x; Henry RMA, 2003, CIRCULATION, V107, P2089, DOI 10.1161/01.CIR.0000065222.34933.FC; Jain S, 2014, ATHEROSCLEROSIS, V237, P381, DOI 10.1016/j.atherosclerosis.2014.09.011; Johansen NB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037165; KELLY RP, 1992, CIRC RES, V71, P490, DOI 10.1161/01.RES.71.3.490; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; London GM, 2003, KIDNEY INT, V63, pS88; Maki-Petaja KM, 2006, CIRCULATION, V114, P1185, DOI 10.1161/CIRCULATIONAHA.105.601641; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Manjer J, 2001, EUR J CANCER PREV, V10, P489, DOI 10.1097/00008469-200112000-00003; Mattace-Raso FUS, 2004, ATHEROSCLEROSIS, V176, P111, DOI 10.1016/j.atherosclerosis.2004.04.014; McEniery CM, 2010, HYPERTENSION, V56, P36, DOI 10.1161/HYPERTENSIONAHA.110.150896; McEniery CM, 2005, J AM COLL CARDIOL, V46, P1753, DOI 10.1016/j.jacc.2005.07.037; Meaume S, 2001, ARTERIOSCL THROM VAS, V21, P2046, DOI 10.1161/hq1201.100226; Moyssakis I, 2005, RHEUMATOLOGY, V44, P251, DOI 10.1093/rheumatology/keh478; Muhammad IF, 2016, ACTA DIABETOL, V53, P981, DOI 10.1007/s00592-016-0903-8; MUSCARI A, 1995, AM J MED, V98, P357, DOI 10.1016/S0002-9343(99)80314-3; Nitta K, 2004, HYPERTENS RES, V27, P47, DOI 10.1291/hypres.27.47; O'Rourke MF, 2010, VASC MED, V15, P461, DOI 10.1177/1358863X10382946; Ockene IS, 2001, CLIN CHEM, V47, P444; Pasceri V, 2000, CIRCULATION, V102, P2165; Prenner SB, 2015, ATHEROSCLEROSIS, V238, P370, DOI 10.1016/j.atherosclerosis.2014.12.023; Rosvall M, 2015, ATHEROSCLEROSIS, V239, P615, DOI 10.1016/j.atherosclerosis.2015.01.030; Sacre K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094511; Schram MT, 2004, HYPERTENSION, V43, P176, DOI 10.1161/01.HYP.0000111829.46090.92; Schumacher W, 2009, HYPERTENSION, V53, P150, DOI 10.1161/HYPERTENSIONAHA.108.117622; Sebastian-Gambaro MA, 1997, EUR J CLIN CHEM CLIN, V35, P845; Shen L, 2013, BIOMED ENVIRON SCI, V26, P717, DOI 10.3967/0895-3988.2013.09.002; Shields KJ, 2011, CTS-CLIN TRANSL SCI, V4, P146, DOI 10.1111/j.1752-8062.2011.00304.x; Strasser B, 2015, NUTR METAB CARDIOVAS, V25, P495, DOI 10.1016/j.numecd.2015.01.002; Townsend RR, 2015, J CLIN HYPERTENS, V17, P503, DOI 10.1111/jch.12574; Vanfleteren LEGW, 2014, EUR RESPIR J, V43, P1306, DOI 10.1183/09031936.00169313; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Weir-McCall JR, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0546-x; Yasmin, 2004, ARTERIOSCL THROM VAS, V24, P969, DOI 10.1161/01.ATV.zhq0504.0173; Zanoli L, 2012, J HYPERTENS, V30, P1775, DOI 10.1097/HJH.0b013e3283568abd	55	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0181718	10.1371/journal.pone.0181718	http://dx.doi.org/10.1371/journal.pone.0181718			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759613	Green Submitted, gold, Green Published			2022-12-26	WOS:000406761600023
J	Upadhyay, K; Hiregoudar, B; Meals, E; English, BK; Talati, AJ				Upadhyay, Kirtikumar; Hiregoudar, Basu; Meals, Elizabeth; English, Boyce Keith; Talati, Ajay J.			Combination therapy with ampicillin and azithromycin improved outcomes in a mouse model of group B streptococcal sepsis	PLOS ONE			English	Article							BACTEREMIC PNEUMOCOCCAL PNEUMONIA; BACTERIAL-MENINGITIS; MACROLIDE ANTIBIOTICS; MURINE MACROPHAGES; ILL PATIENTS; DISEASE; MORTALITY; CLARITHROMYCIN; PNEUMOLYSIN; INFECTION	Background Evidence suggests that beta-lactam monotherapy of streptococcal infections may incite stronger inflammation and is inferior to combination therapy with macrolides. We hypothesized that use of macrolides alone or in combination with a beta-lactam for group B streptococcal (GBS) sepsis would improve outcomes by reducing inflammation. Methods TNF-alpha was measured from supernatants of RAW 264.7 cells stimulated with GBS isolates, in presence of four treatment regimens: ampicillin alone, azithromycin alone, or combination of azithromycin plus ampicillin. Mouse model of GBS sepsis was developed and treated with same four regimens. Clinical sepsis scores were monitored; serum cytokines (TNF-alpha, IL-6, IL-10) and chemokines (MIP-1 alpha) were measured at the end. Results GBS isolates exposed to azithromycin or combination (compared to ampicillin alone) stimulated less TNF production in vitro. In the murine sepsis model, mortality was lower along with decreased sepsis scores in mice treated with combination therapy. Mean serum IL-6 was lower in mice treated with azithromycin alone (66 +/- 52 pg/ml) or combination of ampicillin plus azithromycin (52 +/- 22 pg/ml) compared to ampicillin alone (260 +/- 160 pg/ml) (p < 0.005). Conclusions Combination therapy of ampicillin+azithromycin improved outcomes in a murine GBS sepsis model; this therapeutic approach deserves additional study.	[Upadhyay, Kirtikumar; Meals, Elizabeth; Talati, Ajay J.] Univ Tennessee, Hlth Sci Ctr, Childrens Fdn Res Ctr, Le Bonheur Childrens Hosp, Memphis, TN 38163 USA; [Upadhyay, Kirtikumar; Talati, Ajay J.] Univ Tennessee, Hlth Sci Ctr, Div Neonatal Perinatal Med, Memphis, TN 38163 USA; [Upadhyay, Kirtikumar; Meals, Elizabeth; Talati, Ajay J.] Univ Tennessee, Hlth Sci Ctr, Dept Pediat, Memphis, TN 38163 USA; [Hiregoudar, Basu] Cheyenne Reg Med Ctr, Cheyenne, WY USA; [English, Boyce Keith] Michigan State Univ, Coll Human Med, Dept Pediat & Human Dev, Lansing, MI USA; [Talati, Ajay J.] Univ Tennessee, Hlth Sci Ctr, Dept Obstet Gynecol, Memphis, TN USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Michigan State University; Michigan State University College of Human Medicine; University of Tennessee System; University of Tennessee Health Science Center	Upadhyay, K (corresponding author), Univ Tennessee, Hlth Sci Ctr, Childrens Fdn Res Ctr, Le Bonheur Childrens Hosp, Memphis, TN 38163 USA.; Upadhyay, K (corresponding author), Univ Tennessee, Hlth Sci Ctr, Div Neonatal Perinatal Med, Memphis, TN 38163 USA.; Upadhyay, K (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Pediat, Memphis, TN 38163 USA.	kupadhya@uthsc.edu	Talati, Ajay/AGY-6999-2022	Talati, Ajay/0000-0003-1798-9970; Upadhyay, Kirtikumar/0000-0002-5951-8686	Children Foundation Research Institute; Le Bonheur Children's Hospital; University of Tennessee Health Science Center [65-0505]	Children Foundation Research Institute; Le Bonheur Children's Hospital; University of Tennessee Health Science Center	This work was supported by Children Foundation Research Institute in partnership with Le Bonheur Children's Hospital and University of Tennessee Health Science Center (grant 65-0505) to KU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTRIAN R, 1964, ANN INTERN MED, V60, P759, DOI 10.7326/0003-4819-60-5-759; Baddour LM, 2004, AM J RESP CRIT CARE, V170, P440, DOI 10.1164/rccm.200311-1578OC; Brinkmann KC, 2005, PEDIATR RES, V57, P419, DOI 10.1203/01.PDR.0000153946.97159.79; Cornacchione P, 1998, IMMUNOLOGY, V93, P86; Crosbie PAJ, 2009, EUR RESPIR J, V33, P171, DOI 10.1183/09031936.00042208; Cusumano V, 1996, INFECT IMMUN, V64, P2850, DOI 10.1128/IAI.64.7.2850-2852.1996; Edmond KM, 2012, LANCET, V379, P547, DOI 10.1016/S0140-6736(11)61651-6; FELDMAN WE, 1976, J PEDIATR-US, V88, P549, DOI 10.1016/S0022-3476(76)80003-0; FOULDS G, 1990, J ANTIMICROB CHEMOTH, V25, P73, DOI 10.1093/jac/25.suppl_A.73; Giamarellos-Bourboulis EJ, 2014, J ANTIMICROB CHEMOTH, V69, P1111, DOI 10.1093/jac/dkt475; Hiwatashi Y, 2011, J PHARM PHARMACOL, V63, P1320, DOI 10.1111/j.2042-7158.2011.01343.x; Jiang Jia-Horng, 2004, Journal of Microbiology Immunology and Infection, V37, P301; Karlstrom A, 2009, J INFECT DIS, V199, P1, DOI DOI 10.1086/595568; Klein O.J., 2001, INFECT DIS FETUS NEW, P943; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Krohn MA, 1999, J INFECT DIS, V179, P1410, DOI 10.1086/314756; Libster R, 2012, PEDIATRICS, V130, pE8, DOI 10.1542/peds.2011-3453; MANCUSO G, 1994, INFECT IMMUN, V62, P4997, DOI 10.1128/IAI.62.11.4997-5002.1994; MANCUSO G, 1994, FEMS IMMUNOL MED MIC, V9, P49, DOI 10.1016/0928-8244(94)90080-9; Mancuso G, 2004, J IMMUNOL, V172, P6324, DOI 10.4049/jimmunol.172.10.6324; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Marriott HM, 2008, CURR MOL MED, V8, P497, DOI 10.2174/156652408785747924; Martinez JA, 2003, CLIN INFECT DIS, V36, P389, DOI 10.1086/367541; Mufson MA, 1999, AM J MED, V107, P34, DOI 10.1016/S0002-9343(99)00098-4; Murphy DM, 2010, EXPERT OPIN INV DRUG, V19, P401, DOI 10.1517/13543781003636480; Nau R, 1999, J INFECT DIS, V179, P1557, DOI 10.1086/314760; ODIO CM, 1991, NEW ENGL J MED, V324, P1525, DOI 10.1056/NEJM199105303242201; Orman KL, 2000, J INFECT DIS, V182, P1561, DOI 10.1086/315861; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; QUAGLIARELLO V, 1992, NEW ENGL J MED, V327, P864, DOI 10.1056/NEJM199209173271208; Schrag SJ, 2000, NEW ENGL J MED, V342, P15, DOI 10.1056/NEJM200001063420103; Sligl WI, 2013, CAN J INFECT DIS MED, V24, pE107, DOI 10.1155/2013/652512; Smith MW, 2007, COMPARATIVE MED, V57, P82; Spreer A, 2003, ANTIMICROB AGENTS CH, V47, P2649, DOI 10.1128/AAC.47.8.2649-2654.2003; Talati AJ, 2001, MICROBES INFECT, V3, P267, DOI 10.1016/S1286-4579(01)01379-X; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319; Velaphi S, 2003, PEDIATRICS, V111, P541, DOI 10.1542/peds.111.3.541; Walkey AJ, 2012, CHEST, V141, P1153, DOI 10.1378/chest.11-1908; Waterer GW, 2001, ARCH INTERN MED, V161, P1837, DOI 10.1001/archinte.161.15.1837; Zuckerman JM, 2011, MED CLIN N AM, V95, P761, DOI 10.1016/j.mcna.2011.03.012	40	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0182023	10.1371/journal.pone.0182023	http://dx.doi.org/10.1371/journal.pone.0182023			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759625	Green Published, gold, Green Submitted			2022-12-26	WOS:000406761600044
J	Usmani, SS; Bedi, G; Samuel, JS; Singh, S; Kalra, S; Kumar, P; Ahuja, AA; Sharma, M; Gautam, A; Raghava, GPS				Usmani, Salman Sadullah; Bedi, Gursimran; Samuel, Jesse S.; Singh, Sandeep; Kalra, Sourav; Kumar, Pawan; Ahuja, Anjuman Arora; Sharma, Meenu; Gautam, Ankur; Raghava, Gajendra P. S.			THPdb: Database of FDA-approved peptide and protein therapeutics	PLOS ONE			English	Article							STRUCTURE PREDICTION; FUTURE	THPdb (http://crdd.osdd.net/raghava/thpdb/) is a manually curated repository of Food and Drug Administration (FDA) approved therapeutic peptides and proteins. The information in THPdb has been compiled from 985 research publications, 70 patents and other resources like DrugBank. The current version of the database holds a total of 852 entries, providing comprehensive information on 239 US-FDA approved therapeutic peptides and proteins and their 380 drug variants. The information on each peptide and protein includes their sequences, chemical properties, composition, disease area, mode of activity, physical appearance, category or pharmacological class, pharmacodynamics, route of administration, toxicity, target of activity, etc. In addition, we have annotated the structure of most of the protein and peptides. A number of user-friendly tools have been integrated to facilitate easy browsing and data analysis. To assist scientific community, a web interface and mobile App have also been developed.	[Usmani, Salman Sadullah; Bedi, Gursimran; Samuel, Jesse S.; Singh, Sandeep; Kalra, Sourav; Kumar, Pawan; Ahuja, Anjuman Arora; Sharma, Meenu; Gautam, Ankur; Raghava, Gajendra P. S.] CSIR, Inst Microbial Technol, Bioinformat Ctr, Chandigarh, India; [Raghava, Gajendra P. S.] IIIT, Ctr Computat Biol, Okhla Phase 3, New Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Indraprastha Institute of Information Technology Delhi	Gautam, A; Raghava, GPS (corresponding author), CSIR, Inst Microbial Technol, Bioinformat Ctr, Chandigarh, India.; Raghava, GPS (corresponding author), IIIT, Ctr Computat Biol, Okhla Phase 3, New Delhi, India.	ankurgautam@imtech.res.in; raghava@imtech.res.in	Usmani, Salman Sadullah/GNP-3395-2022; Raghava, Gajendra P.S./AAA-2413-2022; Raghava, Gajendra/B-1717-2009; Sharma, Meenu/GWM-5030-2022; Kalra, Sourav/F-2273-2019; Sharma, Meenu/C-6232-2019	Usmani, Salman Sadullah/0000-0001-6624-4428; Raghava, Gajendra P.S./0000-0002-8902-2876; Kalra, Sourav/0000-0002-0651-4825; Sharma, Meenu/0000-0001-8836-9272; Singh, Sandeep/0000-0001-5361-4303	Council of Scientific and Industrial Research (CSIR) [GENESIS BSC0121]; Department of Biotechnology, (BTISNET), Govt. of India	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, (BTISNET), Govt. of India	Authors are thankful to funding agencies, Council of Scientific and Industrial Research (CSIR) (project Open Source Drug discovery and GENESIS BSC0121), and Department of Biotechnology (project BTISNET), Govt. of India for financial support and fellowships.; Authors are thankful to funding agencies, Council of Scientific and Industrial Research (CSIR) (project Open Source Drug discovery and GENESIS BSC0121), and Department of Biotechnology (project BTISNET), Govt. of India for financial support and fellowships.	Agrawal P, 2016, NUCLEIC ACIDS RES, V44, pD1098, DOI 10.1093/nar/gkv1266; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antosova Z, 2009, TRENDS BIOTECHNOL, V27, P628, DOI 10.1016/j.tibtech.2009.07.009; Boohaker RJ, 2012, CURR MED CHEM, V19, P3794; Bruno BJ, 2013, THER DELIV, V4, P1443, DOI [10.4155/TDE.13.104, 10.4155/tde.13.104]; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Dhanda SK, 2016, BRIEF BIOINFORM; Di L, 2015, AAPS J, V17, P134, DOI 10.1208/s12248-014-9687-3; Fosgerau K, 2015, DRUG DISCOV TODAY, V20, P122, DOI 10.1016/j.drudis.2014.10.003; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; GOEDDEL DV, 1979, P NATL ACAD SCI USA, V76, P106, DOI 10.1073/pnas.76.1.106; Kaur H, 2007, PROTEIN PEPTIDE LETT, V14, P626; Kumar R, 2015, NUCLEIC ACIDS RES, V43, pD956, DOI 10.1093/nar/gku1141; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399; Otvos L, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00062; Pirtskhalava M, 2016, NUCLEIC ACIDS RES, V44, pD1104, DOI 10.1093/nar/gkv1174; Rose PW, 2015, NUCLEIC ACIDS RES, V43, pD345, DOI 10.1093/nar/gku1214; Singh S, 2016, NUCLEIC ACIDS RES, V44, pD1119, DOI 10.1093/nar/gkv1114; Singh S, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0103-4; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Tyagi A, 2015, NUCLEIC ACIDS RES, V43, pD837, DOI 10.1093/nar/gku892; Van Dorpe S, 2012, BRAIN STRUCT FUNCT, V217, P687, DOI 10.1007/s00429-011-0375-0; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Waghu FH, 2016, NUCLEIC ACIDS RES, V44, pD1094, DOI 10.1093/nar/gkv1051; Wynendaele E, 2013, NUCLEIC ACIDS RES, V41, pD655, DOI 10.1093/nar/gks1137; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213	27	255	255	4	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0181748	10.1371/journal.pone.0181748	http://dx.doi.org/10.1371/journal.pone.0181748			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759605	gold, Green Published, Green Submitted			2022-12-26	WOS:000406761600026
J	Biswas, T; Uddin, MJ; Al Mamun, A; Pervin, S; Garnett, SP				Biswas, Tuhin; Uddin, Md. Jasim; Al Mamun, Abdullah; Pervin, Sonia; Garnett, Sarah P.			Increasing prevalence of overweight and obesity in Bangladeshi women of reproductive age: Findings from 2004 to 2014	PLOS ONE			English	Article							EXCEEDS UNDERWEIGHT; MATERNAL OBESITY; DOUBLE BURDEN; HEALTH; TRENDS	Background Overweight and obesity are a particular concern for women of reproductive age. They not only increase the risk of chronic diseases but they are also associated with adverse perinatal, neonatal, infant and child outcomes. The objective of this study was to examine the trend of overweight and obesity among Bangladeshi women of reproductive age between 2004 and 2014. Method This is a secondary data analysis of the 2004, 2007, 2011 and 2014 Bangladesh Demographic and Health Surveys ( BDHS). We determined the age standardized prevalence of overweight and obesity of women aged 15-49 years, who had their weight and height measured. Overweight and obesity were determined using the Asian specific BMI cut-offs criteria. Result The prevalence of overweight increased from 11.4% [95% CI: 10.4to 12.5] in 2004 to 25.2% [95% CI: 24.0 to 26.4] in 2014. The prevalence of obesity increased from 3.5% [95% CI: 3.0to4.2] to 11.2% [95% CI: 10.1to12.5%] over the same period of time. This was seen in all age groups. However, the greatest increase was observed in women aged 35 to 49 years. The highest prevalence of overweight and obesity were observed in those women with the highest education level and wealth, larger family size, living in urban areas and not being in paid employment. Conclusion The prevalence of overweight and obesity among women of reproductive age in Bangladesh is high and increasing. We speculate that this has the potential to jeopardize the improvements that have been made in maternal and infant health over the last two decades. Evidence based prevention strategies are required to address this serious public health issue.	[Biswas, Tuhin; Uddin, Md. Jasim; Pervin, Sonia] Icddr B, Hlth Syst & Populat Studies Div, Dhaka, Bangladesh; [Biswas, Tuhin; Al Mamun, Abdullah] Univ Queensland, Social Sci Res Inst, Indooroopilly, Qld, Australia; [Garnett, Sarah P.] Univ Sydney, Westmead Clin Sch, Childrens Hosp, Sydney, NSW, Australia; [Garnett, Sarah P.] Childrens Hosp Westmead, Inst Endocrinol & Diabet, Locked Bag 4001, Westmead, NSW, Australia	International Centre for Diarrhoeal Disease Research (ICDDR); University of Queensland; University of Sydney; University of Sydney	Biswas, T (corresponding author), Icddr B, Hlth Syst & Populat Studies Div, Dhaka, Bangladesh.; Biswas, T (corresponding author), Univ Queensland, Social Sci Res Inst, Indooroopilly, Qld, Australia.	tuhin.biswas@icddrb.org	Mamun, Abdullah A/A-4673-2011; Mamun, Abdullah/HHM-9898-2022; Garnett, Sarah/D-8067-2012	Mamun, Abdullah A/0000-0002-1535-8086; Garnett, Sarah/0000-0001-7552-0789; Biswas, Tuhin/0000-0002-7837-0306; Uddin, Dr. Md. Jashim/0000-0002-3243-3455				Angkurawaranon C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113547; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Biswas T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167140; Bonita R, 2013, LANCET, V381, P575, DOI 10.1016/S0140-6736(12)61993-X; Catalano PM, 2012, DIABETES CARE, V35, P780, DOI 10.2337/dc11-1790; Cervantes VGA, 2016, REV MEXICANA TRASTOR, V7, P46; Dastgiri S, 2006, PUBLIC HEALTH NUTR, V9, P996, DOI 10.1017/PHN2006982; Du SF, 2004, SOC SCI MED, V59, P1505, DOI 10.1016/j.socscimed.2004.01.021; Godfrey KM, 2017, LANCET DIABETES ENDO, V5, P53, DOI 10.1016/S2213-8587(16)30107-3; Hanson M, 2016, LANCET DIABETES ENDO, V4, P966, DOI 10.1016/S2213-8587(16)30098-5; Islam A, 2014, CHRONIC NONCOMMUNICA, V1, P6; Janghorbani M, 2007, OBESITY, V15, P2797, DOI 10.1038/oby.2007.332; Karar ZA, 2009, GLOBAL HEALTH ACTION, V2, DOI 10.3402/gha.v2i0.1904; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Ly KA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-35; Mamun AA, 2015, OBES RES CLIN PRACT, V9, P75, DOI 10.1016/j.orcp.2014.03.001; Mendez MA, 2005, AM J CLIN NUTR, V81, P714; *NAT I POP RES TRA, 2005, BANGL DEM HLTH SURV; National Institute of Population Research and Training, 2013, BANGL HLTH SURV 2011; National Institute of Population Research and Training, 2015, BANGL HLTH SURV 2014; National Institute of Population Research and Training Mitra and Associates & Macro International, 2009, BANGL DEM HLTH SURV; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Poston L, 2016, LANCET DIABETES ENDO, V4, P1025, DOI 10.1016/S2213-8587(16)30217-0; Puska P, 2007, WHO STRATEGY DIET PH; Ramesh P., 2009, Journal of Human Ecology, V25, P93; Sarma Haribondhu, 2016, BMC Obes, V3, P13, DOI 10.1186/s40608-016-0093-5; Shafique S, 2007, INT J EPIDEMIOL, V36, P449, DOI 10.1093/ije/dyl306; Stupin JH, 2014, GEBURTSH FRAUENHEILK, V74, P639, DOI 10.1055/s-0034-1368486; Subramanian SV, 2007, J EPIDEMIOL COMMUN H, V61, P802, DOI 10.1136/jech.2006.053801; Subramanian SV, 2011, AM J CLIN NUTR, V93, P413, DOI 10.3945/ajcn.110.004820; Subramanian SV, 2009, AM J CLIN NUTR, V90, P369, DOI 10.3945/ajcn.2009.27487	31	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0181080	10.1371/journal.pone.0181080	http://dx.doi.org/10.1371/journal.pone.0181080			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753680	Green Submitted, Green Published, gold			2022-12-26	WOS:000406579300011
J	Gabriel, TL; Mirzaian, M; Hooibrink, B; Ottenhoff, R; van Roomen, C; Aerts, JMFG; van Eijk, M				Gabriel, Tanit L.; Mirzaian, Mina; Hooibrink, Berend; Ottenhoff, Roelof; van Roomen, Cindy; Aerts, Johannes M. F. G.; van Eijk, Marco			Induction of Sphk1 activity in obese adipose tissue macrophages promotes survival	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; INSULIN-RESISTANCE; SPHINGOLIPID METABOLISM; T-CELLS; FUNCTIONAL-CHARACTERIZATION; MOLECULAR-CLONING; KINASE; CERAMIDE; INFLAMMATION; SPHINGOSINE-1-PHOSPHATE	During obesity, adipose tissue macrophages (ATM) are increased in concert with local inflammation and insulin resistance. Since the levels of sphingolipid (SLs) in adipose tissue (AT) are altered during obesity we investigated the potential impact of SLs on ATMs. For this, we first analyzed expression of SL metabolizing genes in ATMs isolated from obese mice. A marked induction of sphingosine kinase 1 (Sphk1) expression was observed in obese ATM when compared to lean ATM. This induction was observed in both MGL-ve (M1) and MGL1+ve (M2) macrophages from obese WAT. Next, RAW264.7 cells were exposed to excessive palmitate, resulting in a similar induction of Sphk1. This Sphk1 induction was also observed when cells were treated with chloroquine, a lysosomotropic amine impacting lysosome function. Simultaneous incubation of RAW cells with palmitate and the Sphk1 inhibitor SK1-I promoted cell death, suggesting a protective role of Sphk1 during lipotoxic conditions. Interestingly, a reduction of endoplasmic reticulum (ER) stress related genes was detected in obese ATM and was found to be associated with elevated Sphk1 expression. Altogether, our data suggest that lipid overload in ATM induces Sphk1, which promotes cell viability.	[Gabriel, Tanit L.; Ottenhoff, Roelof; van Roomen, Cindy; van Eijk, Marco] Acad Med Ctr, Dept Med Biochem, Amsterdam, Netherlands; [Mirzaian, Mina; Aerts, Johannes M. F. G.; van Eijk, Marco] Leiden Univ, Leiden Inst Chem, Dept Biochem, Leiden, Netherlands; [Hooibrink, Berend] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam	van Eijk, M (corresponding author), Acad Med Ctr, Dept Med Biochem, Amsterdam, Netherlands.; van Eijk, M (corresponding author), Leiden Univ, Leiden Inst Chem, Dept Biochem, Leiden, Netherlands.	m.c.van.eijk@LIC.leidenuniv.nl	Aerts, Johannes/A-1028-2009	Aerts, Johannes/0000-0001-8168-2565; van Eijk, Marco/0000-0001-7751-4112; Mirzaian, Mina/0000-0001-9404-2903	Dutch Diabetes Foundation [2009.80.016]	Dutch Diabetes Foundation	This work was supported by the Dutch Diabetes Foundation (grant number 2009.80.016).	Becker KP, 2005, J BIOL CHEM, V280, P2606, DOI 10.1074/jbc.M409066200; Berg JM, 2002, BIOCHEMISTRY-US, V5th; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boslem E, 2011, BIOCHEM J, V435, P267, DOI 10.1042/BJ20101867; Bruce CR, 2012, DIABETES, V61, P3148, DOI 10.2337/db12-0029; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Christoffersen C, 2011, P NATL ACAD SCI USA, V108, P9613, DOI 10.1073/pnas.1103187108; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Egawa J, 2016, J PHYSIOL-LONDON, V594, P4565, DOI 10.1113/JP270590; Elbein SC, 2011, DIABETES, V60, P1019, DOI 10.2337/db10-1270; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Festa A, 2000, CIRCULATION, V102, P42, DOI 10.1161/01.CIR.102.1.42; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Frayn KN, 2003, INT J OBESITY, V27, P875, DOI 10.1038/sj.ijo.0802326; Fujii S, 2012, CIRCULATION, V126; Gabriel TL, 2014, DIABETES, V63, P3310, DOI 10.2337/db13-1720; Gao P, 2011, MOL CANCER RES, V9, P1509, DOI 10.1158/1541-7786.MCR-11-0336; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; Geng TY, 2015, J LIPID RES, V56, P2359, DOI 10.1194/jlr.M063511; Groener JEM, 2007, CLIN CHEM, V53, P742, DOI 10.1373/clinchem.2006.079012; Hill AA, 2015, MOL METAB, V4, P665, DOI 10.1016/j.molmet.2015.07.005; Hu W, 2009, J LIPID RES, V50, P1852, DOI 10.1194/jlr.M800635-JLR200; Ikeda M, 2004, BIOCHEM BIOPH RES CO, V325, P338, DOI 10.1016/j.bbrc.2004.10.036; Kewalramani G, 2011, PLOS ONE, P6; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Kolak M, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-115; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Kramer G, 2016, FEBS OPEN BIO, V6, P902, DOI 10.1002/2211-5463.12078; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Mandala SM, 1998, P NATL ACAD SCI USA, V95, P150, DOI 10.1073/pnas.95.1.150; Marques ARA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147208; Mirzaian M, 2015, BLOOD CELL MOL DIS, V54, P307, DOI 10.1016/j.bcmd.2015.01.006; Mistry PK, 2012, P NATL ACAD SCI USA, V109, P9220, DOI 10.1073/pnas.1207533109; Mullen TD, 2011, J LIPID RES, V52, P68, DOI 10.1194/jlr.M009142; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Odegaard JI, 2008, NAT CLIN PRACT ENDOC, V4, P619, DOI 10.1038/ncpendmet0976; Olivera A, 2000, METHOD ENZYMOL, V311, P215; Prieur X, 2011, DIABETES, V60, P797, DOI 10.2337/db10-0705; Qi YF, 2013, FASEB J, V27, P4294, DOI 10.1096/fj.13-230052; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Samad F, 2006, DIABETES, V55, P2579, DOI 10.2337/db06-0330; Schipper HS, 2012, J CLIN INVEST, V122, P3343, DOI 10.1172/JCI62739; Schwiebs A, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00094; Veret J, 2013, BBA-MOL CELL BIOL L, V1831, P251, DOI 10.1016/j.bbalip.2012.10.003; Wang J, 2014, AM J PHYSIOL-ENDOC M, V306, pE756, DOI 10.1152/ajpendo.00549.2013; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Won Cho Kae, 2014, METHOD ENZYMOL, V537, p297 ; Wu WC, 2004, MOL CELL BIOL, V24, P7359, DOI 10.1128/MCB.24.17.7359-7369.2004; Xiong YQ, 2013, J BIOL CHEM, V288, P32563, DOI 10.1074/jbc.M113.483750; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu XY, 2013, CELL METAB, V18, P816, DOI 10.1016/j.cmet.2013.11.001; Xuan Pham Tho, 2011, FASEB J, P25	63	10	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0182075	10.1371/journal.pone.0182075	http://dx.doi.org/10.1371/journal.pone.0182075			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753653	Green Published, gold, Green Submitted			2022-12-26	WOS:000406579300047
J	Li, JY; Liu, LS; Fong, S; Wong, RK; Mohammed, S; Fiaidhi, J; Sung, Y; Wong, KKL				Li, Jinyan; Liu, Lian-Sheng; Fong, Simon; Wong, Raymond K.; Mohammed, Sabah; Fiaidhi, Jinan; Sung, Yunsick; Wong, Kelvin K. L.			Adaptive Swarm Balancing Algorithms for rare-event prediction in imbalanced healthcare data	PLOS ONE			English	Article							CLASSIFICATION	Clinical data analysis and forecasting have made substantial contributions to disease control, prevention and detection. However, such data usually suffer from highly imbalanced samples in class distributions. In this paper, we aim to formulate effective methods to rebalance binary imbalanced dataset, where the positive samples take up only the minority. We investigate two different meta-heuristic algorithms, particle swarm optimization and bat algorithm, and apply them to empower the effects of synthetic minority over-sampling technique ( SMOTE) for pre-processing the datasets. One approach is to process the full dataset as a whole. The other is to split up the dataset and adaptively process it one segment at a time. The experimental results reported in this paper reveal that the performance improvements obtained by the former methods are not scalable to larger data scales. The latter methods, which we call Adaptive Swarm Balancing Algorithms, lead to significant efficiency and effectiveness improvements on large datasets while the first method is invalid. We also find it more consistent with the practice of the typical large imbalanced medical datasets. We further use the meta-heuristic algorithms to optimize two key parameters of SMOTE. The proposed methods lead to more credible performances of the classifier, and shortening the run time compared to brute-force method.	[Li, Jinyan; Fong, Simon] Univ Macau, Dept Comp & Informat Sci, Taipa, Macao, Peoples R China; [Liu, Lian-Sheng] Guangzhou Univ TCM, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Wong, Raymond K.] Univ New South Wales, Sch Comp Sci & Engn, Sydney, NSW, Australia; [Mohammed, Sabah; Fiaidhi, Jinan] Lakehead Univ, Dept Comp Sci, Thunder Bay, ON, Canada; [Sung, Yunsick] Keimyung Univ, Comp Engn Div, Daegu, South Korea; [Wong, Kelvin K. L.] Univ Western Sydney, Sch Med, Campbelltown, NSW, Australia	University of Macau; Guangzhou University of Chinese Medicine; University of New South Wales Sydney; Lakehead University; Keimyung University; Western Sydney University	Fong, S (corresponding author), Univ Macau, Dept Comp & Informat Sci, Taipa, Macao, Peoples R China.; Wong, KKL (corresponding author), Univ Western Sydney, Sch Med, Campbelltown, NSW, Australia.	ccfong@umac.mo; Kelvin.Wong@westernsydney.edu.au	Mohammed, Sabah/AAA-6307-2020; Wong, Kelvin/AAL-8636-2021; Wong, Kelvin Kian Loong/ABA-3915-2021; Fiaidhi, Jinan/AAN-2023-2020; Fong, Simon/C-9388-2009	Mohammed, Sabah/0000-0002-7639-0696; Wong, Kelvin Kian Loong/0000-0002-8600-1105; Li, Jinyan/0000-0003-1833-7413; Fiaidhi, Jinan/0000-0001-7063-6061; Fong, Simon/0000-0002-1848-7246				Brown I, 2012, EXPERT SYST APPL, V39, P3446, DOI 10.1016/j.eswa.2011.09.033; Chawla N.V., 2003, EUR C PRINC DAT MIN; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Drummond Chris, 2003, WORKSH LEARN IMB DAT, V11, P1; Fawcett T., 1996, COMBINING DATA MININ; FISTER I, 2014, ARXIV13036310, DOI DOI 10.1155/2014/709738; Fister I, 2014, SCI WORLD J, DOI 10.1155/2014/709738; Fong S., 2015, IMPROVING KNOWLEDGE, p75 ; Fong S, 2016, IEEE T SERV COMPUT, V9, P33, DOI 10.1109/TSC.2015.2439695; Fong S, 2014, IT PROF, V16, P24, DOI 10.1109/MITP.2014.50; Frank A., 2010, UCI MACHINE LEARNING; Gandomi AH, 2014, J COMPUT SCI-NETH, V5, P224, DOI 10.1016/j.jocs.2013.10.002; Ichikawa T, 2007, AM J ROENTGENOL, V188, P409, DOI 10.2214/AJR.05.1918; Jee K, 2013, HEALTHC INFORM RES, V19, P79, DOI 10.4258/hir.2013.19.2.79; Kennedy J., 1995, 1995 IEEE International Conference on Neural Networks Proceedings (Cat. No.95CH35828), P1942, DOI 10.1109/ICNN.1995.488968; Krink T., 2002, EV COMP 2002 CEC 02; Kusiak A., 2000, IND ENG RES C; Li C, 2007, P 45; Li J., 2015, COMP BUS INT ISCBI 3; Li J., 2016, ADV DAT MIN APPL 12; Li J., INFORM FUSION, V39, P1; Li JY, 2016, BIODATA MIN, V9, DOI 10.1186/s13040-016-0117-1; Li JY, 2016, J SUPERCOMPUT, V72, P3708, DOI 10.1007/s11227-015-1541-6; Peram T., 2003, SWARM INT S 2003 SIS; Reiner BI, 2011, J AM COLL RADIOL, V8, P768, DOI 10.1016/j.jacr.2011.04.021; Song L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-298; Viera AJ, 2005, FAM MED, V37, P360; Wang CY, 2015, GENET MOL RES, V14, P123, DOI 10.4238/2015.January.15.15; Yang XB, 2010, ADV INFORM KNOWL PRO, P65, DOI 10.1007/978-1-84882-628-1_4; Zou Q, 2016, BIG DATA RES, V5, P2, DOI 10.1016/j.bdr.2015.12.001	30	25	25	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0180830	10.1371/journal.pone.0180830	http://dx.doi.org/10.1371/journal.pone.0180830			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753613	gold, Green Published, Green Submitted			2022-12-26	WOS:000406579300007
J	Parkin, L; Sharples, KJ; Barson, DJ; Blank, ML				Parkin, Lianne; Sharples, Katrina J.; Barson, David J.; Blank, Mei-Ling			Simvastatin dose and acute kidney injury without concurrent serious muscle injury: A nationwide nested case-control study	PLOS ONE			English	Article							HIGH-POTENCY STATINS; RISK; ATORVASTATIN; DISEASE; HEALTH; IDEAL	Background Inconsistent findings from four observational studies suggest that the risk of acute kidney injury (AKI) may increase with increasing statin dose or potency, but none of the studies took statin-related severe muscle injury, including rhabdomyolysis, into account. We undertook a nationwide nested case-control study in New Zealand to examine the risk of AKI without concurrent serious muscle injury according to simvastatin dose in two cohorts: people without a history of renal disease and people with non-dialysis dependent chronic kidney disease. Materials and methods A total of 334,710 people aged >= 18 years without a history of renal disease (cohort 1) and 5,437 with non-dialysis dependent chronic kidney disease (cohort 2) who initiated simvastatin therapy between 1 January 2006 and 31 December 2013 were identified using national pharmaceutical dispensing and hospital discharge data. Patients who developed AKI without concurrent serious muscle injury during follow-up (cases) were ascertained using hospital discharge and mortality data (n = 931 from cohort 1, n = 160 from cohort 2). Up to 10 controls per case, matched by date of birth, sex, and cohort entry date were randomly selected from the relevant cohort using risk set sampling. Results Relative to current use of 20mg simvastatin daily, the adjusted odds ratios and 95% confidence intervals (95% CI) in cohort 1 for current use of 40mg and 80mg were 0.9 (95% CI 0.7-1.2) and 1.3 (95% CI 0.7-2.3), respectively. The adjusted odds ratio for 40mg in cohort 2 was 1.1 (95% CI 0.7-1.9); the numbers taking 80mg were very small and the confidence interval was correspondingly wide. Conclusion The findings of this study suggest that a relationship between statin dose and AKI may not exist independent of serious muscle injury.	[Parkin, Lianne; Barson, David J.; Blank, Mei-Ling] Univ Otago, Dunedin Sch Med, Div Hlth Sci, Dept Prevent & Social Med, Dunedin, New Zealand; [Sharples, Katrina J.] Univ Otago, Div Sci, Dept Math & Stat, Dunedin, New Zealand; [Sharples, Katrina J.] Univ Otago, Dunedin Sch Med, Div Hlth Sci, Dept Med, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago	Parkin, L (corresponding author), Univ Otago, Dunedin Sch Med, Div Hlth Sci, Dept Prevent & Social Med, Dunedin, New Zealand.	lianne.parkin@otago.ac.nz		Blank, Mei-Ling/0000-0003-0728-4598; Parkin, Lianne/0000-0002-6824-6176	Department of Preventive and Social Medicine, University of Otago	Department of Preventive and Social Medicine, University of Otago	A Strategic Research Grant of $10,000 (NZD) was received from the Department of Preventive and Social Medicine, University of Otago, to cover the costs of data acquisition and management. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya T, 2016, AM J CARDIOL, V117, P647, DOI 10.1016/j.amjcard.2015.11.031; Analytical Services, 2009, MORT COLL DAT DICT; [Anonymous], 2004, ETHN DAT PROT HLTH D; Armitage J, 2007, LANCET, V370, P1781, DOI 10.1016/S0140-6736(07)60716-8; Armitage J, 2010, LANCET, V376, P1658, DOI 10.1016/S0140-6736(10)60310-8; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bangalore S, 2014, AM J CARDIOL, V113, P2018, DOI 10.1016/j.amjcard.2014.03.046; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; Blank ML, 2014, KIDNEY INT, V86, P837, DOI 10.1038/ki.2014.74; British Medical Association and Royal Pharmaceutical Society of Great Britain, 2013, BRIT NAT FORM; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Chawla LS, 2014, NEW ENGL J MED, V371, P58, DOI 10.1056/NEJMra1214243; Corrao G, 2014, ATHEROSCLEROSIS, V234, P224, DOI 10.1016/j.atherosclerosis.2014.02.022; de Lemos JA, 2004, JAMA-J AM MED ASSOC, V292, P1307, DOI 10.1001/jama.292.11.1307; Dean AG, OPENEPI OPEN SOURCE; Desai Chintan S, 2014, BMJ, V349, pg3743, DOI 10.1136/bmj.g3743; Dormuth CR, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f880; Fassett RG, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1531; Goldacre B, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4745; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2197; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Lameire NH, 2013, LANCET, V382, P170, DOI 10.1016/S0140-6736(13)60647-9; LAPI F, 2013, BMJ-BRIT MED J, V346, pe8525, DOI DOI 10.1136/BMJ.E8525; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Manitoba Centre for Health Policy, CONC CHARLS COM IND; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Ministry of Health, PHARM COLL; Ministry of Health, 2013, CARD DIS RISK ASS; Ministry of Health, NZ CANC REG NZCR; Ministry of Health, ICD 10 AM ACHI ACS; Ministry of Health, NAT HLTH IND; Ministry of Health, MORT COLL; Ministry of Health. National Minimum Dataset (hospital events), NAT MIN DAT; National Health Board, 2014, NAT MIN DAT HOSP EV; Parkin L, 2014, INT J CARDIOL, V174, P83, DOI 10.1016/j.ijcard.2014.03.150; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Salmond C., 2007, NZDEP2006 INDEX DEPR; Sathasivam S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2286; Smeeth L, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3802; StataCorp, 2013, STATA STAT SOFTW REL; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R	44	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0182066	10.1371/journal.pone.0182066	http://dx.doi.org/10.1371/journal.pone.0182066			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753656	Green Published, gold, Green Submitted			2022-12-26	WOS:000406579300044
J	Banerjee, V; Oren, O; Ben-Zeev, E; Taube, R; Engel, S; Papo, N				Banerjee, Victor; Oren, Ofek; Ben-Zeev, Efrat; Taube, Ran; Engel, Stanislav; Papo, Niv			A computational combinatorial approach identifies a protein inhibitor of superoxide dismutase 1 misfolding, aggregation, and cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ALS-LINKED SOD1; MOTOR-NEURON DISEASE; IN-VITRO EVOLUTION; FAMILIAL ALS; DELIVERY; STABILITY; ANTIBODY; DOCKING; DESIGN	Molecular agents that specifically bind and neutralize misfolded and toxic superoxide dismutase 1 (SOD1) mutant proteins may find application in attenuating the disease progression of familial amyotrophic lateral sclerosis. However, high structural similarities between the wild-type and mutant SOD1 proteins limit the utility of this approach. Here we addressed this challenge by converting a promiscuous natural human IgG-binding domain, the hyperthermophilic variant of protein G (HTB1), into a highly specific aggregation inhibitor (designated HTB1M) of two familial amyotrophic lateral sclerosis-linked SOD1 mutants, SOD1(G93A) and SOD1(G85R). We utilized a computational algorithm for mapping protein surfaces predisposed to HTB1 intermolecular interactions to construct a focused HTB1 library, complemented with an experimental platform based on yeast surface display for affinity and specificity screening. HTB1M displayed high binding specificity toward SOD1 mutants, inhibited their amyloid aggregation in vitro, prevented the accumulation of misfolded proteins in living cells, and reduced the cytotoxicity of SOD1(G93A) expressed in motor neuron-like cells. Competition assays and molecular docking simulations suggested that HTB1M binds to SOD1 via both its alpha -helical and beta -sheet domains at the native dimer interface that becomes exposed upon mutated SOD1 misfolding and monomerization. Our results demonstrate the utility of computational mapping of the protein-protein interaction potential for designing focused protein libraries to be used in directed evolution. They also provide new insight into the mechanism of conversion of broad-spectrum immunoglobulin-binding proteins, such as HTB1, into target-specific proteins, thereby paving the way for the development of new selective drugs targeting the amyloidogenic proteins implicated in a variety of human diseases.	[Banerjee, Victor; Oren, Ofek; Papo, Niv] Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-8410501 Beer Sheva, Israel; [Banerjee, Victor; Oren, Ofek; Papo, Niv] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-8410501 Beer Sheva, Israel; [Engel, Stanislav] Ben Gurion Univ Negev, Dept Clin Biochem & Pharmacol, IL-84105 Beer Sheva, Israel; [Engel, Stanislav] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Oren, Ofek; Taube, Ran] Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol Immunol & Genet, IL-84105 Beer Sheva, Israel; [Ben-Zeev, Efrat] Weizmann Inst Sci, Nancy & Stephen Grand Israel Natl Ctr Personalize, IL-76100 Rehovot, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; Ben Gurion University; Ben Gurion University; Weizmann Institute of Science	Papo, N (corresponding author), Ben Gurion Univ Negev, Dept Biotechnol Engn, POB 653, IL-84105 Beer Sheva, Israel.; Papo, N (corresponding author), Ben Gurion Univ Negev, Natl Inst Biotechnol, POB 653, IL-84105 Beer Sheva, Israel.	papo@bgu.ac.il	Engel, Stanislav/G-2799-2013; Papo, Niv/R-3946-2017; TAUBE, RAN/F-2029-2012; Banerjee, Victor/N-8427-2014; BANERJEE, VICTOR/J-9581-2019	Engel, Stanislav/0000-0001-5916-5190; TAUBE, RAN/0000-0002-2062-4537; Banerjee, Victor/0000-0002-3906-3362; BANERJEE, VICTOR/0000-0002-3906-3362				Abel O, 2012, HUM MUTAT, V33, P1345, DOI 10.1002/humu.22157; Al-Chalabi Ammar, 2000, Current Opinion in Neurology, V13, P397, DOI 10.1097/00019052-200008000-00006; Banerjee V, 2016, ACS CHEM NEUROSCI, V7, P1595, DOI 10.1021/acschemneuro.6b00227; Banerjee V, 2014, LANGMUIR, V30, P4775, DOI 10.1021/la5007007; Banerjee V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072318; Banerjee V, 2012, COLLOID SURFACE B, V92, P142, DOI 10.1016/j.colsurfb.2011.11.036; Battistini S, 2005, J NEUROL, V252, P782, DOI 10.1007/s00415-005-0742-y; Benmohamed R, 2011, AMYOTROPH LATERAL SC, V12, P87, DOI 10.3109/17482968.2010.522586; Berry JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061177; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Bidhendi EE, 2016, J CLIN INVEST, V126, P2249, DOI 10.1172/JCI84360; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Brettschneider J, 2015, NAT REV NEUROSCI, V16, P109, DOI 10.1038/nrn3887; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chen R, 2003, PROTEINS, V51, P397, DOI 10.1002/prot.10334; Chen T, 2012, J MED CHEM, V55, P515, DOI 10.1021/jm2014277; Cohen I, 2016, BIOCHEM J, V473, P1329, DOI 10.1042/BJ20151410; Colby DW, 2004, METHOD ENZYMOL, V388, P348; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Cudkowicz M, 2011, NAT MED, V17, P1652, DOI 10.1038/nm.2579; Cudkowicz ME, 2014, LANCET NEUROL, V13, P1083, DOI 10.1016/S1474-4422(14)70222-4; Das KP, 1996, J BIOL CHEM, V271, P10449, DOI 10.1074/jbc.271.18.10449; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; Fujisawa T, 2012, ANN NEUROL, V72, P739, DOI 10.1002/ana.23668; Furukawa Y., 2012, PROTEIN AGGREGATES I, P335; Gera N, 2013, METHODS, V60, P15, DOI 10.1016/j.ymeth.2012.03.014; Ghadge GD, 2013, NEUROBIOL DIS, V56, P74, DOI 10.1016/j.nbd.2013.04.007; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Israelson A, 2015, NEURON, V86, P218, DOI 10.1016/j.neuron.2015.02.034; Israelson A, 2010, NEURON, V67, P575, DOI 10.1016/j.neuron.2010.07.019; Ivanova MI, 2014, P NATL ACAD SCI USA, V111, P197, DOI 10.1073/pnas.1320786110; Janson C, 2002, HUM GENE THER, V13, P1391, DOI 10.1089/104303402760128612; Khare SD, 2006, AMYLOID, V13, P226, DOI 10.1080/13506120600960486; Khare SD, 2004, P NATL ACAD SCI USA, V101, P15094, DOI 10.1073/pnas.0406650101; Kuttner YY, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003028; Kuttner YY, 2012, J MOL BIOL, V415, P419, DOI 10.1016/j.jmb.2011.11.009; Leal SS, 2013, J BIOL CHEM, V288, P25219, DOI 10.1074/jbc.M113.470740; Lee S, 2015, EXP NEUROBIOL, V24, P1, DOI 10.5607/en.2015.24.1.1; LEIGH PN, 1991, CURR OPIN NEUROL NEU, V4, P586; Li QA, 2010, P NATL ACAD SCI USA, V107, P21146, DOI 10.1073/pnas.1014862107; Limpert AS, 2013, BEILSTEIN J ORG CHEM, V9, P717, DOI 10.3762/bjoc.9.82; Liu HN, 2012, J NEUROSCI, V32, P8791, DOI 10.1523/JNEUROSCI.5053-11.2012; Lorenzen S, 2007, PROTEINS, V68, P187, DOI 10.1002/prot.21442; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Malakauskas SM, 1998, NAT STRUCT BIOL, V5, P470, DOI 10.1038/nsb0698-470; Marks WJ, 2008, LANCET NEUROL, V7, P400, DOI 10.1016/S1474-4422(08)70065-6; Messori A, 1999, PHARMACOECONOMICS, V16, P153, DOI 10.2165/00019053-199916020-00004; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; Osman R, 2016, J COMPUT CHEM, V37, P913, DOI 10.1002/jcc.24276; Papo N, 2011, P NATL ACAD SCI USA, V108, P14067, DOI 10.1073/pnas.1016635108; Parone PA, 2013, J NEUROSCI, V33, P4657, DOI 10.1523/JNEUROSCI.1119-12.2013; Patel P, 2014, MOL THER, V22, P498, DOI 10.1038/mt.2013.239; Pepper LR, 2008, COMB CHEM HIGH T SCR, V11, P127; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pierce B, 2007, PROTEINS, V67, P1078, DOI 10.1002/prot.21373; Pratt AJ, 2014, P NATL ACAD SCI USA, V111, pE4568, DOI 10.1073/pnas.1308531111; Rajagopal S, 2004, BIOORG MED CHEM LETT, V14, P1389, DOI 10.1016/j.bmcl.2003.09.098; Ray SS, 2005, P NATL ACAD SCI USA, V102, P3639, DOI 10.1073/pnas.0408277102; Rodriguez JA, 2002, J BIOL CHEM, V277, P15932, DOI 10.1074/jbc.M112088200; Rosenfeld L, 2016, TRENDS BIOCHEM SCI, V41, P421, DOI 10.1016/j.tibs.2016.03.002; Rosenfeld L, 2015, J BIOL CHEM, V290, P26180, DOI 10.1074/jbc.M115.671271; Russell AJ, 2012, NAT MED, V18, P452, DOI 10.1038/nm.2618; Saccon RA, 2013, BRAIN, V136, P2342, DOI 10.1093/brain/awt097; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shibata N, 1996, J NEUROPATH EXP NEUR, V55, P481, DOI 10.1097/00005072-199604000-00011; Smith TJ, 2006, J AM CHEM SOC, V128, P14456, DOI 10.1021/ja065557e; Snyder BR, 2011, HUM GENE THER, V22, P1129, DOI 10.1089/hum.2011.008; Sugaya K, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00359; Wang LJ, 2014, NEUROBIOL DIS, V71, P317, DOI 10.1016/j.nbd.2014.08.010; Wang Q, 2008, PLOS BIOL, V6, P1508, DOI 10.1371/journal.pbio.0060170; Williams JR, 2016, NEUROBIOL DIS, V89, P1, DOI 10.1016/j.nbd.2016.01.020; Woerner AC, 2016, SCIENCE, V351, P173, DOI 10.1126/science.aad2033; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Worgall S, 2008, HUM GENE THER, V19, P463, DOI 10.1089/hum.2008.022; Wunderlich M, 2007, J MOL BIOL, V373, P775, DOI 10.1016/j.jmb.2007.08.004; Zetterstrom P, 2011, J BIOL CHEM, V286, P20130, DOI 10.1074/jbc.M111.218842; Zhao XY, 2015, J NANOMATER, V2015, DOI 10.1155/2015/104193	82	11	11	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15777	15788		10.1074/jbc.M117.789610	http://dx.doi.org/10.1074/jbc.M117.789610			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28768772	hybrid, Green Published			2022-12-26	WOS:000411512200016
J	Anda, S; Zach, R; Grallert, B				Anda, Silje; Zach, Robert; Grallert, Beata			Activation of Gcn2 in response to different stresses	PLOS ONE			English	Article							POLYMERASE-III TRANSCRIPTION; TRANSFER-RNA-BINDING; PROTEIN-KINASE GCN2; TRANSLATIONAL CONTROL; FISSION YEAST; INITIATION FACTOR-2-ALPHA; PHOSPHORYLATION; DEPHOSPHORYLATION; MECHANISM; ASSOCIATION	All organisms have evolved pathways to respond to different forms of cellular stress. The Gcn2 kinase is best known as a regulator of translation initiation in response to starvation for amino acids. Work in budding yeast has showed that the molecular mechanism of GCN2 activation involves the binding of uncharged tRNAs, which results in a conformational change and GCN2 activation. This pathway requires GCN1, which ensures delivery of the uncharged tRNA onto GCN2. However, Gcn2 is activated by a number of other stresses which do not obviously involve accumulation of uncharged tRNAs, raising the question how Gcn2 is activated under these conditions. Here we investigate the requirement for ongoing translation and tRNA binding for Gcn2 activation after different stresses in fission yeast. We find that mutating the tRNA-binding site on Gcn2 or deleting Gcn1 abolishes Gcn2 activation under all the investigated conditions. These results suggest that tRNA binding to Gcn2 is required for Gcn2 activation not only in response to starvation but also after UV irradiation and oxidative stress.	[Anda, Silje; Zach, Robert; Grallert, Beata] Oslo Univ Hosp, Inst Canc Res, Dept Radiat Biol, Oslo, Norway; [Zach, Robert] Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague, Czech Republic	University of Oslo; Charles University Prague	Grallert, B (corresponding author), Oslo Univ Hosp, Inst Canc Res, Dept Radiat Biol, Oslo, Norway.	Beata.Grallert@rr-research.no		Grallert, Beata/0000-0001-5917-0555; Zach, Robert/0000-0002-7604-1648	Norwegian Research Council; South-Eastern Norwegian Health Authorities; Erasmus program	Norwegian Research Council(Research Council of NorwayEuropean Commission); South-Eastern Norwegian Health Authorities; Erasmus program	The Norwegian Research Council and the South-Eastern Norwegian Health Authorities supported this work. Robert Zach was supported by the Erasmus program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Norwegian Research Council and the South-Eastern Norwegian Health Authorities for financial support and Marit Haugli and Lilian Lindbergsengen for excellent technical assistance. Robert Zach was supported by the Erasmus program.	Berlanga JJ, 2009, EUKARYOT CELL; Cambiaghi TD, 2014, BIOCHEM BIOPH RES CO, V443, P592, DOI 10.1016/j.bbrc.2013.12.021; Caspari T, 2000, MOL CELL BIOL, V20, P1254, DOI 10.1128/MCB.20.4.1254-1262.2000; Castilho BA, 2014, BBA-MOL CELL RES, V1843, P1948, DOI 10.1016/j.bbamcr.2014.04.006; Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003; Deng J, 2002, CURR BIOL, V12, P1279, DOI 10.1016/S0960-9822(02)01037-0; DEVER TE, 1993, P NATL ACAD SCI USA, V90, P4616, DOI 10.1073/pnas.90.10.4616; Dieterich DC, 2010, NAT NEUROSCI, V13, P897, DOI 10.1038/nn.2580; Do AND, 2009, PHYSIOL GENOMICS, V38, P328, DOI 10.1152/physiolgenomics.90396.2008; Dong JS, 2000, MOL CELL, V6, P269, DOI 10.1016/S1097-2765(00)00028-9; Garcia-Barrio M, 2000, EMBO J, V19, P1887, DOI 10.1093/emboj/19.8.1887; Gerlitz G, 2002, EUR J BIOCHEM, V269, P2810, DOI 10.1046/j.1432-1033.2002.02974.x; Goodfellow SJ, 2008, J MOL BIOL, V378, P481, DOI 10.1016/j.jmb.2008.02.060; Grallert B, 2007, CELL CYCLE, V6, P2768, DOI 10.4161/cc.6.22.4933; Grallert B, 2013, BIOCHEM SOC T, V41, P1687, DOI 10.1042/BST20130210; HINNEBUSCH AG, 1993, MOL MICROBIOL, V10, P215, DOI 10.1111/j.1365-2958.1993.tb01947.x; Kearsey SE, 2000, EMBO J, V19, P1681, DOI 10.1093/emboj/19.7.1681; Kimball SR, 1999, INT J BIOCHEM CELL B, V31, P25, DOI 10.1016/S1357-2725(98)00128-9; Kirchner S, 2015, NAT REV GENET, V16, P98, DOI 10.1038/nrg3861; Knutsen JHJ, 2015, J CELL SCI, V128, P4420, DOI 10.1242/jcs.176545; Krohn M, 2008, J CELL SCI, V121, P4047, DOI 10.1242/jcs.035428; Lageix S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004991; Lu W, 2009, J BIOL CHEM, V284, P24281, DOI 10.1074/jbc.M109.008821; Marton MJ, 1997, MOL CELL BIOL, V17, P4474, DOI 10.1128/MCB.17.8.4474; MARTON MJ, 1993, MOL CELL BIOL, V13, P3541, DOI 10.1128/MCB.13.6.3541; Moir RD, 2006, P NATL ACAD SCI USA, V103, P15044, DOI 10.1073/pnas.0607129103; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nemoto N, 2010, J MOL BIOL, V404, P183, DOI 10.1016/j.jmb.2010.09.016; Nilssen EA, 2003, P NATL ACAD SCI USA, V100, P10758, DOI 10.1073/pnas.1833769100; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Oficjalska-Pham D, 2006, MOL CELL, V22, P623, DOI 10.1016/j.molcel.2006.04.008; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Powley IR, 2009, GENE DEV, V23, P1207, DOI 10.1101/gad.516509; Qiu H, 2001, EMBO J, V20, P1425, DOI 10.1093/emboj/20.6.1425; Qiu HF, 2002, GENE DEV, V16, P1271, DOI 10.1101/gad.979402; RAMIREZ M, 1991, MOL CELL BIOL, V11, P3027, DOI 10.1128/MCB.11.6.3027; Rodland GE, 2014, CELL CYCLE, V13, P453, DOI 10.4161/cc.27270; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; Sattlegger E, 2000, EMBO J, V19, P6622, DOI 10.1093/emboj/19.23.6622; Sattlegger E, 2005, J BIOL CHEM, V280, P16514, DOI 10.1074/jbc.M414566200; Tvegard T, 2007, GENE DEV, V21, P649, DOI 10.1101/gad.421807; Udagawa T, 2008, J BIOL CHEM, V283, P22063, DOI 10.1074/jbc.M710017200; Valbuena N, 2012, J CELL SCI, V125, P5955, DOI 10.1242/jcs.105395; WEK RC, 1989, P NATL ACAD SCI USA, V86, P4579, DOI 10.1073/pnas.86.12.4579; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Zhan K, 2004, GENETICS, V168, P1867, DOI 10.1534/genetics.104.031443	46	43	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182143	10.1371/journal.pone.0182143	http://dx.doi.org/10.1371/journal.pone.0182143			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771613	gold, Green Published, Green Submitted			2022-12-26	WOS:000406853600068
J	Florek, NW; Kamlangdee, A; Mutschler, JP; Kingstad-Bakke, B; Schultz-Darken, N; Broman, KW; Osorio, JE; Friedrich, TC				Florek, Nicholas W.; Kamlangdee, Attapon; Mutschler, James P.; Kingstad-Bakke, Brock; Schultz-Darken, Nancy; Broman, Karl W.; Osorio, Jorge E.; Friedrich, Thomas C.			A modified vaccinia Ankara vaccine vector expressing a mosaic H5 hemagglutinin reduces viral shedding in rhesus macaques	PLOS ONE			English	Article							DEPENDENT CELLULAR CYTOTOXICITY; INACTIVATED INFLUENZA VACCINES; FC-GAMMA-R; NONHUMAN-PRIMATES; VIRUS-ANKARA; DNA VACCINES; IMMUNE-RESPONSES; ANIMAL-MODELS; PLASMA-CELLS; ANTIBODIES	The rapid antigenic evolution of influenza viruses requires frequent vaccine reformulations. Due to the economic burden of continuous vaccine reformulation and the threat of new pandemics, there is intense interest in developing vaccines capable of eliciting broadly cross-reactive immunity to influenza viruses. We recently constructed a "mosaic" hemagglutinin (HA) based on subtype 5 HA (H5) and designed to stimulate cellular and humoral immunity to multiple influenza virus subtypes. Modified vaccinia Ankara (MVA) expressing this H5 mosaic (MVA-H5M) protected mice against multiple homosubtypic H5N1 strains and a heterosubtypic H1N1 virus. To assess its potential as a human vaccine we evaluated the ability of MVA-H5M to provide heterosubtypic immunity to influenza viruses in a non-human primate model. Rhesus macaques received an initial dose of either MVA-H5M or plasmid DNA encoding H5M, followed by a boost of MVA-H5M, and then were challenged, together with naive controls, with the heterosubtypic virus A/California/04/2009 (H1N1pdm). Macaques receiving either vaccine regimen cleared H1N1pdm challenge faster than naive controls. Vaccination with H5M elicited antibodies that bound H1N1pdm HA, but did not neutralize the H1N1pdm challenge virus. Plasma from vaccinated macaques activated NK cells in the presence of H1N1pdm HA, suggesting that vaccination elicited cross-reactive antibodies capable of mediating antibody-dependent cell-mediated cytotoxicity (ADCC). Although HA-specific T cell responses to the MVA-H5M vaccine were weak, responses after challenge were stronger in vaccinated macaques than in control animals. Together these data suggest that mosaic HA antigens may provide a means for inducing broadly cross-reactive immunity to influenza viruses.	[Florek, Nicholas W.; Kamlangdee, Attapon; Mutschler, James P.; Kingstad-Bakke, Brock; Osorio, Jorge E.; Friedrich, Thomas C.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Kamlangdee, Attapon] Kasetsart Univ, Dept Vet Med, Bangkok, Thailand; [Schultz-Darken, Nancy; Friedrich, Thomas C.] Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA; [Broman, Karl W.] Univ Wisconsin, Dept Biostat & Med Informat, Sch Med & Publ Hlth, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; Kasetsart University; University of Wisconsin System; University of Wisconsin Madison	Osorio, JE; Friedrich, TC (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA.; Friedrich, TC (corresponding author), Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA.	osorio@svm.vetmed.wisc.edu; thomasf@primate.wisc.edu		Broman, Karl/0000-0002-4914-6671	Wisconsin National Primate Research Center base grant National Institutes of Health [P51 OD011106]; National Institutes of Health National Research Service Award [T32 GM07215]; National Institutes of Health Research Facilities Improvement Program Grants [RR015459, RR020141]; WNPRC [NIH P51 OD011106]; NIH [T32 GM07215, RR015459, RR020141]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR020141, C06RR015459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	Wisconsin National Primate Research Center base grant National Institutes of Health; National Institutes of Health National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Research Facilities Improvement Program Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WNPRC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a supplement to the Wisconsin National Primate Research Center base grant National Institutes of Health, https://www.nih.gov/, P51 OD011106, awarded to TCF. NWF was supported by National Institutes of Health National Research Service Award, https://www.nih.gov/, T32 GM07215. This research was conducted with support from National Institutes of Health Research Facilities Improvement Program Grants, https://www.nih.gov/, RR015459 and RR020141. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Dr. David Evans for supplying the CD16 expressing KHYG-1 NK cells for use in our ADCC assay. Thanks to Benjamin von Bredow for assisting with KHYG-1 cell cultures. This work was supported by a supplement to the WNPRC base grant NIH P51 OD011106, awarded to TCF. NWF was supported by a fellowship from NIH National Research Service Award T32 GM07215. This research was conducted with support from NIH Research Facilities Improvement Program Grants RR015459 and RR020141.	Air G M, 1987, Contrib Microbiol Immunol, V8, P20; Alonso PL, 2013, VACCINE, V31, pB3, DOI 10.1016/j.vaccine.2013.02.035; Alpert MD, 2012, J VIROL, V86, P12039, DOI 10.1128/JVI.01650-12; [Anonymous], 1996, GUIDE CARE USE LAB A; [Anonymous], 2002, MANUAL ANIMAL INFLUE; Belongia EA, 2009, J INFECT DIS, V199, P159, DOI 10.1086/595861; Berthoud TK, 2011, CLIN INFECT DIS, V52, P1, DOI 10.1093/cid/ciq015; Black S, 2011, PEDIATR INFECT DIS J, V30, P1081, DOI 10.1097/INF.0b013e3182367662; Bodewes R, 2010, EXPERT REV VACCINES, V9, P59, DOI [10.1586/erv.09.148, 10.1586/ERV.09.148]; Bouvier NM, 2010, VIRUSES-BASEL, V2, P1530, DOI 10.3390/v20801530; Boyden AW, 2014, IMMUNOL RES, V59, P73, DOI 10.1007/s12026-014-8541-0; Brewoo JN, 2013, VACCINE, V31, P1848, DOI 10.1016/j.vaccine.2013.01.038; Burrage LC, 2010, MAMM GENOME, V21, P115, DOI 10.1007/s00335-010-9247-9; Chakrabarti S, 1997, BIOTECHNIQUES, V23, P1094, DOI 10.2144/97236st07; Coudeville L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-18; de Jong JC, 2000, J INFECTION, V40, P218, DOI 10.1053/jinf.2000.0652; DiLillo DJ, 2016, J CLIN INVEST, V126, P605, DOI 10.1172/JCI84428; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Donnelly JJ, 2005, J IMMUNOL, V175, P633, DOI 10.4049/jimmunol.175.2.633; DONNELLY JJ, 1995, NAT MED, V1, P583, DOI 10.1038/nm0695-583; Dudoit S, 2008, SPRINGER SER STAT, P1; Dunand CJH, 2016, CELL HOST MICROBE, V19, P800, DOI 10.1016/j.chom.2016.05.014; Ellebedy AH, 2014, P NATL ACAD SCI USA, V111, P13133, DOI 10.1073/pnas.1414070111; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Florek KR, 2014, J VIROL, V88, P13418, DOI 10.1128/JVI.01219-14; Gilbert SC, 2006, VACCINE, V24, P4554, DOI 10.1016/j.vaccine.2005.08.048; Gomaa MR, 2015, J INFECT DIS, V211, P1399, DOI 10.1093/infdis/jiu529; Hannoun C, 2004, VIRUS RES, V103, P133, DOI 10.1016/j.virusres.2004.02.025; Hessel A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088340; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Hogarth PM, 2014, CURR TOP MICROBIOL, V382, P321, DOI 10.1007/978-3-319-07911-0_15; Jegaskanda S, 2016, J INFECT DIS, V214, P945, DOI 10.1093/infdis/jiw262; Jegaskanda S, 2013, J VIROL, V87, P13706, DOI 10.1128/JVI.01666-13; Jegaskanda S, 2013, J VIROL, V87, P5512, DOI 10.1128/JVI.03030-12; Kamlangdee A, 2016, J VIROL, V90, P6771, DOI 10.1128/JVI.00730-16; Kamlangdee A, 2014, J VIROL, V88, P13300, DOI 10.1128/JVI.01532-14; Kaur K, 2011, TRENDS IMMUNOL, V32, P524, DOI 10.1016/j.it.2011.08.007; Krammer F, 2015, CELL HOST MICROBE, V18, P395, DOI 10.1016/j.chom.2015.10.003; Krammer F, 2015, NAT REV DRUG DISCOV, V14, P167, DOI 10.1038/nrd4529; Krammer F, 2013, J VIROL, V87, P6542, DOI [10.1128/JVI.00641-13, 10.1128/JVI.03183-13]; Kreijtz JHCM, 2014, LANCET INFECT DIS, V14, P1196, DOI [10.1016/s1473-3099(14)70963-6, 10.1016/S1473-3099(14)70963-6]; Kutzler MA, 2008, NAT REV GENET, V9, P776, DOI 10.1038/nrg2432; Laddy DJ, 2009, J VIROL, V83, P4624, DOI 10.1128/JVI.02335-08; Lemke A, 2016, MUCOSAL IMMUNOL, V9, P83, DOI 10.1038/mi.2015.38; Liu MA, 1997, VACCINE, V15, P909, DOI 10.1016/S0264-410X(96)00280-0; McConkey SJ, 2003, NAT MED, V9, P729, DOI 10.1038/nm881; MEYER H, 1991, J GEN VIROL, V72, P1031, DOI 10.1099/0022-1317-72-5-1031; Moncla LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078750; MORELL A, 1970, J CLIN INVEST, V49, P673, DOI 10.1172/JCI106279; Mullin J, 2016, VACCINE, V34, P1688, DOI 10.1016/j.vaccine.2016.02.028; Odendahl M, 2005, BLOOD, V105, P1614, DOI 10.1182/blood-2004-07-2507; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Pica N, 2012, P NATL ACAD SCI USA, V109, P2573, DOI 10.1073/pnas.1200039109; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Tan GS, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005578; Wang TT, 2011, SCIENCE, V333, P834, DOI 10.1126/science.1210724; Weatherall D., 2006, USE NONHUMAN PRIMATE; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Weinfurter JT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002381; WHO, 2014, INFL SEAS; Wiersma LCM, 2015, VACCINES, V3, P239, DOI 10.3390/vaccines3020239; Zaraket H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7553	62	9	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0181738	10.1371/journal.pone.0181738	http://dx.doi.org/10.1371/journal.pone.0181738			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771513	Green Published, Green Submitted, gold			2022-12-26	WOS:000406853600031
J	Hanifa, Y; Fielding, KL; Chihota, VN; Adonis, L; Charalambous, S; Foster, N; Karstaedt, A; McCarthy, K; Nicol, MP; Ndlovu, NT; Sinanovic, E; Sahid, F; Stevens, W; Vassall, A; Churchyard, GJ; Grant, AD				Hanifa, Yasmeen; Fielding, Katherine L.; Chihota, Violet N.; Adonis, Lungiswa; Charalambous, Salome; Foster, Nicola; Karstaedt, Alan; McCarthy, Kerrigan; Nicol, Mark P.; Ndlovu, Nontobeko T.; Sinanovic, Edina; Sahid, Faieza; Stevens, Wendy; Vassall, Anna; Churchyard, Gavin J.; Grant, Alison D.			A clinical scoring system to prioritise investigation for tuberculosis among adults attending HIV clinics in South Africa	PLOS ONE			English	Article							MULTIVARIABLE PREDICTION MODEL; HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; RISK-FACTORS; INFECTED PATIENTS; INDIVIDUAL PROGNOSIS; DIAGNOSIS TRIPOD; IMPACT; PEOPLE	Background The World Health Organization (WHO) recommendation for regular tuberculosis (TB) screening of HIV-positive individuals with Xpert MTB/RIF as the first diagnostic test has major resource implications. Objective To develop a diagnostic prediction model for TB, for symptomatic adults attending for routine HIV care, to prioritise TB investigation. Design Cohort study exploring a TB testing algorithm. Setting HIV clinics, South Africa. Participants Representative sample of adult HIV clinic attendees; data from participants reporting >= 1 symptom on the WHO screening tool were split 50: 50 to derive, then internally validate, a prediction model. Outcome TB, defined as "confirmed" if Xpert MTB/RIF, line probe assay or M. tuberculosis culture were positive; and "clinical" if TB treatment started without microbiological confirmation, within six months of enrolment. Results Overall, 79/2602 (3.0%) participants on ART fulfilled TB case definitions, compared to 65/906 (7.2%) pre-ART. Among 1133/3508 (32.3%) participants screening positive on the WHO tool, 1048 met inclusion criteria for this analysis: 52/515 (10.1%) in the derivation and 58/533 (10.9%) in the validation dataset had TB. Our final model comprised ART status (on ART > 3 months vs. pre-ART or ART < 3 months); body mass index (continuous); CD4 (continuous); number of WHO symptoms (1 vs. > 1 symptom). We converted this to a clinical score, using clinically-relevant CD4 and BMI categories. A cut-off score of >= 3 identified those with TB with sensitivity and specificity of 91.8% and 34.3% respectively. If investigation was prioritised for individuals with score of >= 3, 68% (717/1048) symptomatic individuals would be tested, among whom the prevalence of TB would be 14.1% (101/717); 32% (331/1048) of tests would be avoided, but 3% (9/331) with TB would be missed amongst those not tested. Conclusion Our clinical score may help prioritise TB investigation among symptomatic individuals.	[Hanifa, Yasmeen; Fielding, Katherine L.; Vassall, Anna; Churchyard, Gavin J.; Grant, Alison D.] London Sch Hyg & Trop Med, London, England; [Chihota, Violet N.; Charalambous, Salome; McCarthy, Kerrigan; Ndlovu, Nontobeko T.; Churchyard, Gavin J.] Aurum Inst, Johannesburg, South Africa; [Chihota, Violet N.; Charalambous, Salome; Churchyard, Gavin J.; Grant, Alison D.] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Adonis, Lungiswa] Mamelodi Hosp, Pretoria, South Africa; [Foster, Nicola; Sinanovic, Edina] Univ Cape Town, Sch Publ Hlth & Family Med, Hlth Econ Unit, Cape Town, South Africa; [Karstaedt, Alan; Sahid, Faieza] Chris Hani Baragwanath Hosp, Dept Med, Johannesburg, South Africa; [Karstaedt, Alan; Sahid, Faieza] Univ Witwatersrand, Johannesburg, South Africa; [Nicol, Mark P.] Univ Cape Town, Div Med Microbiol, Fac Hlth Sci, Cape Town, South Africa; [Nicol, Mark P.; Stevens, Wendy] Natl Hlth Lab Serv, Johannesburg, South Africa; [Stevens, Wendy] Univ Witwatersrand, Sch Pathol, Dept Mol Med & Haematol, Fac Hlth Sci, Johannesburg, South Africa; [Churchyard, Gavin J.] South African Med Res Council, Adv Treatment & Care TB HIV, Collaborating Ctr HIV & TB, Johannesburg, South Africa; [Grant, Alison D.] Univ KwaZulu Natal, Africa Hlth Res Inst, Sch Nursing & Publ Hlth, Durban, South Africa	University of London; London School of Hygiene & Tropical Medicine; University of Witwatersrand; University of Cape Town; University of Witwatersrand; University of Cape Town; National Health Laboratory Service; University of Witwatersrand; South African Medical Research Council; Africa Health Research Institute; University of Kwazulu Natal	Hanifa, Y (corresponding author), London Sch Hyg & Trop Med, London, England.	yasmeen.hanifa@lshtm.ac.uk	Sinanovic, Edina/AAR-2590-2020; Nicol, Mark/W-4149-2019; Chihota, Violet/DWH-9372-2022; Foster, Nicola/AAA-9040-2020	Nicol, Mark/0000-0002-1366-4805; Foster, Nicola/0000-0003-4630-6243; McCarthy, Kerrigan/0000-0001-8958-9795; HANIFA, YASMEEN/0000-0002-1677-0697; Charalambous, Salome/0000-0001-7143-1009; Vassall, Anna/0000-0002-2911-1375; Churchyard, Gavin/0000-0002-4269-3699; Chihota, Violet/0000-0003-1444-9266	Bill and Melinda Gates Foundation [OPP1034523]; Medical Research Council [MR/K012126/1] Funding Source: researchfish	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	GC received funding for the study from the Bill and Melinda Gates Foundation, grant number OPP1034523 (Churchyard). URL: http://www.gatestoundation.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Amoakwa K, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofu120; Balcha TT, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu095; Balcha TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085478; Baussano I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000381; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Claassens MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076272; Collins GS, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7594; Corbett EL, 2009, INT J TUBERC LUNG D, V13, P1231; Corbett EL, 2000, AIDS, V14, P2759, DOI 10.1097/00002030-200012010-00016; Department of Health D Republic of South Africa, 2015, NAT TUB MAN GUID 201; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Gupta RK, 2013, INT J TUBERC LUNG D, V17, P1014, DOI 10.5588/ijtld.13.0032; Hanrahan CF, 2010, AIDS, V24, P1501, DOI 10.1097/QAD.0b013e32833a2a4a; Hermans SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010527; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Kerkhoff AD, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0702-1; Khan FA, 2014, AIDS, V28, P1463, DOI 10.1097/QAD.0000000000000278; Kibret KT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064488; Ku NS, 2013, INT J TUBERC LUNG D, V17, P777, DOI 10.5588/ijtld.12.0607; Kufa T, 2012, JAIDS-J ACQ IMM DEF, V60, pE22, DOI 10.1097/QAI.0b013e318251ae0b; Lawn SD, 2012, CLIN INFECT DIS, V54, P1071, DOI 10.1093/cid/cir1039; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Liu EJ, 2015, AIDS, V29, P1391, DOI 10.1097/QAD.0000000000000705; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Ndlovu N, 2014, 4 SA TB C 2014 DURB; Nicholas S, 2011, JAIDS-J ACQ IMM DEF, V57, P311, DOI 10.1097/QAI.0b013e318218a713; Peck RN, 2012, INT J TUBERC LUNG D, V16, P1047, DOI 10.5588/ijtld.11.0772; Rangaka MX, 2012, CLIN INFECT DIS, V55, P1698, DOI 10.1093/cid/cis775; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; Rudolf F, 2014, INT J TUBERC LUNG D, V18, P277, DOI 10.5588/ijtld.13.0517; Shisana O, 2012, S AFRICAN NATL HIV P; Steyerberg E., 2009, CLIN PREDICTION MODE; Van Rie A, 2011, JAIDS-J ACQ IMM DEF, V56, P349, DOI 10.1097/QAI.0b013e3181f9fb39; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2015, DEF REP FRAM TUB 201; World Health Organization, 2013, WHO POL COLL TB HIV	39	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0181519	10.1371/journal.pone.0181519	http://dx.doi.org/10.1371/journal.pone.0181519			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771504	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000406853600024
J	Mademont-Soler, I; Mates, J; Yotti, R; Espinosa, MA; Perez-Serra, A; Fernandez-Avila, AI; Coll, M; Mendez, I; Iglesias, A; del Olmo, B; Riuro, H; Cuenca, S; Allegue, C; Campuzano, O; Pico, F; Ferrer-Costa, C; Alvarez, P; Castillo, S; Garcia-Pavia, P; Gonzalez-Lopez, E; Padron-Barthe, L; de Bustamante, AD; Darnaude, MT; Gonzalez-Hevia, JI; Brugada, J; Fernandez-Aviles, F; Brugada, R				Mademont-Soler, Irene; Mates, Jesus; Yotti, Raquel; Angeles Espinosa, Maria; Perez-Serra, Alexandra; Isabel Fernandez-Avila, Ana; Coll, Monica; Mendez, Irene; Iglesias, Anna; del Olmo, Bernat; Riuro, Helena; Cuenca, Sofia; Allegue, Catarina; Campuzano, Oscar; Pico, Ferran; Ferrer-Costa, Carles; Alvarez, Patricia; Castillo, Sergio; Garcia-Pavia, Pablo; Gonzalez-Lopez, Esther; Padron-Barthe, Laura; Diaz de Bustamante, Aranzazu; Teresa Darnaude, Maria; Ignacio Gonzalez-Hevia, Jose; Brugada, Josep; Fernandez-Aviles, Francisco; Brugada, Ramon			Additional value of screening for minor genes and copy number variants in hypertrophic cardiomyopathy	PLOS ONE			English	Article							HEAVY-CHAIN GENE; DILATED CARDIOMYOPATHY; MOLECULAR DIAGNOSIS; PHOSPHOLAMBAN GENE; SEQUENCE CAPTURE; LOW-PREVALENCE; MUTATION; PHENOTYPE; GENOTYPE; MYBPC3	Introduction Hypertrophic cardiomyopathy (HCM) is the most prevalent inherited heart disease. Next-generation sequencing (NGS) is the preferred genetic test, but the diagnostic value of screening for minor and candidate genes, and the role of copy number variants (CNVs) deserves further evaluation. Methods Three hundred and eighty-seven consecutive unrelated patients with HCM were screened for genetic variants in the 5 most frequent genes (MYBPC3, MYH7, TNNT2, TNNI3 and TPM1) using Sanger sequencing (N = 84) or NGS (N = 303). In the NGS cohort we analyzed 20 additional minor or candidate genes, and applied a proprietary bioinformatics algorithm for detecting CNVs. Additionally, the rate and classification of TTN variants in HCM were compared with 427 patients without structural heart disease. Results The percentage of patients with pathogenic/likely pathogenic (P/LP) variants in the main genes was 33.3%, without significant differences between the Sanger sequencing and NGS cohorts. The screening for 20 additional genes revealed LP variants in ACTC1, MYL2, MYL3, TNNC1, GLA and PRKAG2 in 12 patients. This approach resulted in more inconclusive tests (36.0% vs. 9.6%, p<0.001), mostly due to variants of unknown significance (VUS) in TTN. The detection rate of rare variants in TTN was not significantly different to that found in the group of patients without structural heart disease. In the NGS cohort, 4 patients (1.3%) had pathogenic CNVs: 2 deletions in MYBPC3 and 2 deletions involving the complete coding region of PLN. Conclusions A small percentage of HCM cases without point mutations in the 5 main genes are explained by P/LP variants in minor or candidate genes and CNVs. Screening for variants in TTN in HCM patients drastically increases the number of inconclusive tests, and shows a rate of VUS that is similar to patients without structural heart disease, suggesting that this gene should not be analyzed for clinical purposes in HCM.	[Mademont-Soler, Irene; Mates, Jesus; Perez-Serra, Alexandra; Coll, Monica; Iglesias, Anna; del Olmo, Bernat; Riuro, Helena; Allegue, Catarina; Campuzano, Oscar; Pico, Ferran; Brugada, Ramon] Univ Girona IDIBGI, Cardiovasc Genet Ctr, Girona, Spain; [Mademont-Soler, Irene; Yotti, Raquel; Angeles Espinosa, Maria; Perez-Serra, Alexandra; Isabel Fernandez-Avila, Ana; Coll, Monica; Mendez, Irene; Iglesias, Anna; Cuenca, Sofia; Campuzano, Oscar; Garcia-Pavia, Pablo; Gonzalez-Lopez, Esther; Padron-Barthe, Laura; Brugada, Josep; Fernandez-Aviles, Francisco; Brugada, Ramon] Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain; [Yotti, Raquel; Angeles Espinosa, Maria; Isabel Fernandez-Avila, Ana; Mendez, Irene; Cuenca, Sofia; Fernandez-Aviles, Francisco] Univ Complutense, Dept Cardiol, Hosp Gen Univ Gregorio Maranon, Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain; [Campuzano, Oscar; Brugada, Ramon] Univ Girona, Dept Med Sci, Sch Med, Girona, Spain; [Alvarez, Patricia; Castillo, Sergio] Gendiag Exe SL, Barcelona, Spain; [Garcia-Pavia, Pablo; Gonzalez-Lopez, Esther; Padron-Barthe, Laura] Francisco De Vitoria Univ, Inherited Cardiac Dis Unit, Dept Cardiol, Hosp Univ Puerta Hierro, Madrid, Spain; [Diaz de Bustamante, Aranzazu; Teresa Darnaude, Maria] Hosp Univ Mostoles, Genet Unit, Madrid, Spain; [Ignacio Gonzalez-Hevia, Jose] Hosp Univ Miguel Servet, Zaragoza, Spain; [Brugada, Josep] Univ Barcelona, Arrhythmia Unit, Hosp Clin Barcelona, Barcelona, Spain; [Brugada, Ramon] Hosp Univ Dr Josep Trueta, Cardiovasc Genet Unit, Girona, Spain	Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Complutense University of Madrid; General University Gregorio Maranon Hospital; Universitat de Girona; Hospital Puerta de Hierro-Majadahonda; Universidad Francisco de Vitoria; Miguel Servet University Hospital; University of Barcelona; Hospital Clinic de Barcelona; Universitat de Girona; Girona University Hospital Dr. Josep Trueta	Yotti, R (corresponding author), Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain.; Yotti, R (corresponding author), Univ Complutense, Dept Cardiol, Hosp Gen Univ Gregorio Maranon, Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain.	raquel.yotti@salud.madrid.org	Garcia-Pavia, Pablo/T-9100-2019; Gonzalez-Lopez, Esther/AAG-1404-2021; Fernández, Ana Isabel/J-3265-2012; campuzano, oscar/J-1968-2014	Fernández, Ana Isabel/0000-0002-1509-5191; campuzano, oscar/0000-0001-5298-5276; Yotti, Raquel/0000-0002-5551-7408; Mates, Jesus/0000-0002-3822-745X; Fernandez-Aviles, Francisco/0000-0001-5501-5275; Mademont-Soler, Irene/0000-0002-6501-9250; ALLEGUE TOSCANO, CATARINA/0000-0002-5121-3159; Ferrer-Costa, CARLES/0000-0002-3779-8808; del Olmo Cabestre, Bernat/0000-0002-7109-7626; Mendez, Irene/0000-0002-5117-4794	io "Obra social La Caixa"; Institute de Salud Carlos III (Fondo Investigacion Sanitaria -FIS-) [PI14/01773, PI15/02222, BA16/00032]; Sociedad Espanola de Cardiologia (Proyecto Investigacion Basica Cardiologia de los Socios Estratagicos SEC)	io "Obra social La Caixa"; Institute de Salud Carlos III (Fondo Investigacion Sanitaria -FIS-); Sociedad Espanola de Cardiologia (Proyecto Investigacion Basica Cardiologia de los Socios Estratagicos SEC)	This work was supported by: io "Obra social La Caixa": Ramon Brugada; Institute de Salud Carlos III (Fondo Investigacion Sanitaria -FIS- (PI14/01773): Ramon Brugada; Sociedad Espanola de Cardiologia (Proyecto Investigacion Basica Cardiologia 2015 de los Socios Estratagicos SEC): Oscar Campuzano; Institute de Salud Carlos III (Fondo Investigacion Sanitaria -FIS- (PI15/02222; BA16/00032): Raquel Yotti. The funder provided support in the form of salaries for authors CF-C, PA and SC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alfares AA, 2015, GENET MED, V17, P880, DOI [10.1038/gim.2014.205, 10.1038/gim.2015.16]; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; [Anonymous], 2016, DATABASE GENOMIC VAR; [Anonymous], 2016, CLINGEN CLIN GENOME; [Anonymous], 2016, HUMAN GENE MUTATION; Bagnall RD, 2010, INT J CARDIOL, V145, P150, DOI 10.1016/j.ijcard.2009.07.009; Berge KE, 2014, CLIN GENET, V86, P355, DOI 10.1111/cge.12286; Bottillo I, 2016, GENE, V577, P227, DOI 10.1016/j.gene.2015.11.048; Marsiglia JDC, 2013, AM HEART J, V166, P775, DOI 10.1016/j.ahj.2013.07.029; Cecconi M, 2016, INT J MOL MED, V38, P1111, DOI 10.3892/ijmm.2016.2732; Ceyhan-Birsoy O, 2016, MOL GENET GENOM MED, V4, P143, DOI 10.1002/mgg3.187; Chanavat V, 2012, EUR J MED GENET, V55, P163, DOI 10.1016/j.ejmg.2012.01.002; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Cobo-Marcos M, 2013, REV ESP CARDIOL, V66, P746, DOI 10.1016/j.rec.2013.04.003; Coto E, 2012, J MOL DIAGN, V14, P518, DOI 10.1016/j.jmoldx.2012.04.001; D'Argenio V, 2014, J MOL DIAGN, V16, P32, DOI 10.1016/j.jmoldx.2013.07.008; Das KJ, 2014, GENET MED, V16, P286, DOI 10.1038/gim.2013.138; Duzkale H, 2013, CLIN GENET, V84, P453, DOI 10.1111/cge.12257; Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Friedrich FW, 2012, HUM MOL GENET, V21, P3237, DOI 10.1093/hmg/dds157; Garcia-Pavia P, 2011, EUR J HEART FAIL, V13, P1193, DOI 10.1093/eurjhf/hfr110; Gigli M, 2016, FRONT CARDIOVASC MED, V3, DOI 10.3389/fcvm.2016.00021; Glotov AS, 2015, CLIN CHIM ACTA, V446, P132, DOI 10.1016/j.cca.2015.04.014; Gomez J, 2014, CIRC J, V78, P2963, DOI 10.1253/circj.CJ-14-0628; Gruner C, 2013, CIRC-CARDIOVASC GENE, V6, P19, DOI 10.1161/CIRCGENETICS.112.963363; Haghighi K, 2006, P NATL ACAD SCI USA, V103, P1388, DOI 10.1073/pnas.0510519103; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Herman DS, 2009, NAT METHODS, V6, P507, DOI 10.1038/nmeth.1343; Jouven X, 2002, HEART, V88, P153, DOI 10.1136/heart.88.2.153; Kapplinger JD, 2014, J CARDIOVASC TRANSL, V7, P347, DOI 10.1007/s12265-014-9542-z; Kassem HS, 2013, J CARDIOVASC TRANSL, V6, P65, DOI 10.1007/s12265-012-9425-0; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li ZZ, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-173; Liu XX, 2015, SCI REP-UK, V5, DOI 10.1038/srep11411; Lopes LR, 2015, EUR J MED GENET, V58, P611, DOI 10.1016/j.ejmg.2015.10.001; Lopes LR, 2015, HEART, V101, P294, DOI 10.1136/heartjnl-2014-306387; Lopes LR, 2013, J MED GENET, V50, P228, DOI 10.1136/jmedgenet-2012-101270; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; MARIAN AJ, 1992, J CLIN INVEST, V90, P2156, DOI 10.1172/JCI116101; Maron BJ, 2012, HEART RHYTHM, V9, P57, DOI 10.1016/j.hrthm.2011.08.009; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; Meder B, 2011, CIRC-CARDIOVASC GENE, V4, P110, DOI 10.1161/CIRCGENETICS.110.958322; Medin M, 2007, EUR J HEART FAIL, V9, P37, DOI 10.1016/j.ejheart.2006.04.007; Millat G, 2010, EUR J MED GENET, V53, P261, DOI 10.1016/j.ejmg.2010.07.007; Mook ORF, 2013, J MED GENET, V50, P614, DOI 10.1136/jmedgenet-2012-101231; Nannenberg EA, 2011, J AM COLL CARDIOL, V58, P2406, DOI 10.1016/j.jacc.2011.07.044; Olivotto I, 2008, MAYO CLIN PROC, V83, P630, DOI 10.4065/83.6.630; Pezzoli L, 2012, GENE, V507, P165, DOI 10.1016/j.gene.2012.06.097; Reguero JR, 2013, INT J CARDIOL, V168, P4555, DOI 10.1016/j.ijcard.2013.06.085; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Roberts AM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010134; Rubattu S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081239; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Server Exome Variant, 2016, NHLBI GO EX SEQ PROJ; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Tian T, 2015, HEART VESSELS, V30, P258, DOI 10.1007/s00380-014-0503-x; Valdes-Mas R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6326; Van Driest SL, 2005, MAYO CLIN PROC, V80, P463, DOI 10.4065/80.4.463; Veselka J, 2016, LANCET; Villard E, 2005, EUR HEART J, V26, P794, DOI 10.1093/eurheartj/ehi193; Waldmuller S, 2011, EUR J HEART FAIL, V13, P1185, DOI 10.1093/eurjhf/hfr074; Walsh R, 2017, EUR HEART J	67	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0181465	10.1371/journal.pone.0181465	http://dx.doi.org/10.1371/journal.pone.0181465			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771489	Green Published, Green Submitted, gold			2022-12-26	WOS:000406853600021
J	Zhang, YY; Su, XY; Kong, Z; Fu, FQ; Zhang, P; Wang, D; Wu, H; Wan, XC; Li, Y				Zhang, Yingyi; Su, Xinya; Kong, Zhe; Fu, Fangqiu; Zhang, Pu; Wang, Dan; Wu, Hai; Wan, Xuechao; Li, Yao			An androgen reduced transcript of LncRNA GAS5 promoted prostate cancer proliferation	PLOS ONE			English	Article							LONG NONCODING RNA; INHIBITS PROLIFERATION; TUMOR-SUPPRESSOR; RECEPTOR; APOPTOSIS; MECHANISMS; INVASION; PROGRAM	Prostate cancer (PCa) becomes a leading cause of death in males nowadays. Recent reports showed that androgen-responsive long non-coding RNAs played important roles in tumorigenesis and progression of PCa. In this study, we focused on a special transcript of GAS5 (ENST00000456293.5, GAS5-007), which was reported as a tumor suppressor. Here, we demonstrated GAS5-007 was reduced by androgen treatment and inhibited by AR. Next, we explored the expression level of GAS, finding the expression of it in PCa tissue was higher than normal tissue in both public databases and human tissue samples. Functional analysis of GAS5 showed it was related to regulating translational elongation, protein biosynthesis, and transcription. Moreover, we observed GAS5-007 knockdown inhibited the proliferation, cell cycle and promoted cell apoptosis of PCa. We also constructed a GAS5-miRNA network to explain the different roles of different GAS5 transcripts in PCa. This study provides novel insights to identify potential diagnostic biomarker and therapy target for prostate cancer in clinical treatment.	[Zhang, Yingyi] Second Mil Med Univ, Changhai Hosp, Dept Oncol, 168 Changhai Rd, Shanghai, Peoples R China; [Su, Xinya; Kong, Zhe; Fu, Fangqiu; Zhang, Pu; Wang, Dan; Wu, Hai; Wan, Xuechao; Li, Yao] Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, Shanghai, Peoples R China	Naval Medical University; Fudan University	Wan, XC; Li, Y (corresponding author), Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, Shanghai, Peoples R China.	wanxuechaosu@126.com; yaoli@fudan.edu.cn	Li, Yao/AAE-3550-2019; Fu, Fangqiu/AAZ-7904-2020; Zhang, Yingyi/AAD-4718-2019	Kong, Zhe/0000-0001-7430-534X	National Natural Science Foundation of China [31571330, 81672558]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by grants 31571330 and 81672558 from the National Natural Science Foundation of China.	Arredouani MS, 2009, CLIN CANCER RES, V15, P5794, DOI 10.1158/1078-0432.CCR-09-0911; Aryee MJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005211; Bawa P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122143; Cao QF, 2016, MOL MED REP, V13, P27, DOI 10.3892/mmr.2015.4503; Chang L, 2016, MOL MED REP, V13, P1541, DOI 10.3892/mmr.2015.4716; Fang ZY, 2016, CANCER LETT, V374, P62, DOI 10.1016/j.canlet.2016.01.033; Hu LT, 2016, TUMOR BIOL, V37, P2691, DOI 10.1007/s13277-015-4111-x; Li LJ, 2016, TUMOR BIOL, V37, P299, DOI 10.1007/s13277-015-3750-2; Li TW, 2016, ONCOTARGET, V7, P8601, DOI 10.18632/oncotarget.6926; Liu YC, 2015, SCI REP-UK, V5, DOI 10.1038/srep10159; Min WJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160451; Misawa A, 2016, J BIOL CHEM, V291, P17861, DOI 10.1074/jbc.M116.718536; Parolia A, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0314-4; Pickard MR, 2013, BBA-MOL BASIS DIS, V1832, P1613, DOI 10.1016/j.bbadis.2013.05.005; Pickard MR, 2015, GENES-BASEL, V6, P484, DOI 10.3390/genes6030484; Sakurai K, 2015, MOL CANCER RES, V13, P828, DOI 10.1158/1541-7786.MCR-15-0016-T; Shi SJ, 2015, ONCOTARGET, V6, P11652, DOI 10.18632/oncotarget.3457; Shi XF, 2015, MOL CARCINOGEN, V54, pE1, DOI 10.1002/mc.22120; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sun M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-319; Takayama K, 2013, EMBO J, V32, P1665, DOI 10.1038/emboj.2013.99; Wan L, 2016, ONCOL RES, V24, P161, DOI 10.3727/096504016X14618564639178; Wan X, 2016, ONCOTARGET; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Xue D, 2016, TUMOR BIOL, V37, P16187, DOI 10.1007/s13277-016-5429-8; Ylipaa A, 2015, CANCER RES, V75, P4026, DOI 10.1158/0008-5472.CAN-15-0217; Zhang A, 2015, CELL REP, V13, P209, DOI 10.1016/j.celrep.2015.08.069; Zhao XH, 2015, MOL THER, V23, P1899, DOI 10.1038/mt.2015.170	28	35	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182305	10.1371/journal.pone.0182305	http://dx.doi.org/10.1371/journal.pone.0182305			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771526	Green Submitted, gold, Green Published			2022-12-26	WOS:000406853600087
J	Okin, GS				Okin, Gregory S.			Environmental impacts of food consumption by dogs and cats	PLOS ONE			English	Article							TOXOPLASMA-GONDII; DOMESTIC CATS; FELIS-CATUS; WATER; OWNERSHIP; MEAT; SUSTAINABILITY; DIGESTIBILITY; PREDATION; ANIMALS	In the US, there are more than 163 million dogs and cats that consume, as a significant portion of their diet, animal products and therefore potentially constitute a considerable dietary footprint. Here, the energy and animal-derived product consumption of these pets in the US is evaluated for the first time, as are the environmental impacts from the animal products fed to them, including feces production. In the US, dogs and cats consume about 19% +/- 2% of the amount of dietary energy that humans do (203 +/- 15 PJ yr(-1) vs. 1051 +/- 9 PJ yr(-1)) and 33% +/- 9% of the animal-derived energy (67 +/- 17 PJ yr(-1) vs. 206 +/- 2 PJ yr(-1)). They produce about 30% +/- 13%, by mass, as much feces as Americans (5.1 +/- Tg yr(-1) vs. 17.2 Tg yr(-1)), and through their diet, constitute about 25 +/- 30% of the environmental impacts from animal production in terms of the use of land, water, fossil fuel, phosphate, and biocides. Dog and cat animal product consumption is responsible for release of up to 64 +/- 16 million tons CO2-equivalent methane and nitrous oxide, two powerful greenhouse gasses (GHGs). Americans are the largest pet owners in the world, but the tradition of pet ownership in the US has considerable costs. As pet ownership increases in some developing countries, especially China, and trends continue in pet food toward higher content and quality of meat, globally, pet ownership will compound the environmental impacts of human dietary choices. Reducing the rate of dog and cat ownership, perhaps in favor of other pets that offer similar health and emotional benefits would considerably reduce these impacts. Simultaneous industry-wide efforts to reduce overfeeding, reduce waste, and find alternative sources of protein will also reduce these impacts.	[Okin, Gregory S.] Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Okin, GS (corresponding author), Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90024 USA.	okin@ucla.edu	Okin, Greg/D-3226-2019	Okin, Gregory/0000-0002-0484-3537				Aitchison J, 1986, STAT ANAL COMPOSITIO, DOI DOI 10.1007/978-94-009-4109-0; American Pet Products Association, 2015, 2015 2016 APPA NAT P; [Anonymous], 2014, DOG BREED WEIGHT CHA; [Anonymous], 2013, WBOC TV; [Anonymous], 2014, AKC DOG REGISTRATION; [Anonymous], 2015, FOOD AV PER CAP DAT; Aramini JJ, 1999, EPIDEMIOL INFECT, V122, P305, DOI 10.1017/S0950268899002113; Archer J, 1997, EVOL HUM BEHAV, V18, P237, DOI 10.1016/S0162-3095(99)80001-4; Barratt DG, 1998, WILDLIFE RES, V25, P475, DOI 10.1071/WR97026; Bermingham EN, 2013, J ANIM PHYSIOL AN N, V97, P522, DOI 10.1111/j.1439-0396.2012.01293.x; Beverland MB, 2008, J BUS RES, V61, P490, DOI 10.1016/j.jbusres.2006.08.009; Blue G.F., 1986, CHILDHOOD ED, V63, DOI [10.1080/00094056.1986.10521747, DOI 10.1080/00094056.1986.10521747]; Boya U. O., 2012, J TARGET MEAS ANAL M, V20, P133; Bradley T, 2012, ATLANTIC, DOI 10.2994/1808-9798(2006)1[185:TOOBDI]2.0.CO;2; Burros M., 1975, WASHINGTON POST; CHURCHER PB, 1987, J ZOOL, V212, P439, DOI 10.1111/j.1469-7998.1987.tb02915.x; CLEMENS R, 2014, FOOD TECHNOL CHICAGO, V68, P20; Covert A.M., 1985, MARRIAGE FAM REV, V8, P95, DOI DOI 10.1300/J002V08N03_08; Cutt H, 2007, HEALTH PLACE, V13, P261, DOI 10.1016/j.healthplace.2006.01.003; Daly B, 2006, ANTHROZOOS, V19, P113, DOI 10.2752/089279306785593801; De-Oliveira LD, 2008, J ANIM SCI, V86, P2237, DOI 10.2527/jas.2007-0354; Dotson MJ, 2008, J BUS RES, V61, P457, DOI 10.1016/j.jbusres.2007.07.019; Eshel G, 2006, EARTH INTERACT, V10, DOI 10.1175/EI167.1; Eshel G, 2014, P NATL ACAD SCI USA, V111, P11996, DOI 10.1073/pnas.1402183111; Friedmann E., 1985, PETS AND THE FAMILY, V8, P191, DOI [10.1300/J002v08n03_14, DOI 10.1300/J002V08N03_14]; GELDREICH EE, 1968, J WATER POLLUT CON F, V40, P1861; GELDREICH EE, 1969, J WATER POLLUT CON F, V41, pR336; Gillies C, 2003, J ZOOL, V259, P309, DOI 10.1017/S095283690200328X; Grocery Headquarters, 2015, MARK SHAR LEAD BRAND; Hill D, 2002, CLIN MICROBIOL INFEC, V8, P634, DOI 10.1046/j.1469-0691.2002.00485.x; Egozcue JJ, 2011, COMPOSITIONAL DATA ANALYSIS: THEORY AND APPLICATIONS, P12; Kempson KM, J AM DIETETIC ASS, V102, P1795; Keyzer MA, 2005, ECOL ECON, V55, P187, DOI 10.1016/j.ecolecon.2004.12.002; Kidd AH, 1998, PSYCHOL REP, V83, P131, DOI 10.2466/PR0.83.5.131-138; Kumcu A, 2014, J FOOD PROD MARK, P1; LAMPE JW, 1993, GUT, V34, P531, DOI 10.1136/gut.34.4.531; Larson C., 2014, BLOOMBERG BUSINESS W; Lund E. M., 2006, International Journal of Applied Research in Veterinary Medicine, V4, P177; Lund E. M., 2005, International Journal of Applied Research in Veterinary Medicine, V3, P88; Mallin MA, 2000, ECOL APPL, V10, P1047, DOI 10.2307/2641016; Meyer H, 1999, J VET MED A, V46, P155, DOI 10.1046/j.1439-0442.1999.00201.x; Miller MA, 2008, INT J PARASITOL, V38, P1319, DOI 10.1016/j.ijpara.2008.02.005; Mugford RA., 1975, PET ANIMALS SOC, P54; National Research Council, 2006, NUTR REQ DOGS CATS, V10th; NRC, 2003, NUTR REQ DOGS CATS; Oppenheimer GM, 2014, AM J PUBLIC HEALTH, V104, P59, DOI 10.2105/AJPH.2013.301464; Overmyer JP, 2007, J ENVIRON SCI HEAL B, V42, P471, DOI 10.1080/03601230701391823; Pet Food Institute, 2016, CAT FOOD SAL US 2000; Pet Food Institute, 2016, DOG FOOD SAL US 2000; Pimentel D, 2003, AM J CLIN NUTR, V78, p660S, DOI 10.1093/ajcn/78.3.660S; Poleman TT, 1994, INCOME DIETARY CHANG; Reijnders L, 2003, AM J CLIN NUTR, V78, p664S, DOI 10.1093/ajcn/78.3.664S; Rosegrant MW, 1999, P NUTR SOC, V58, P219, DOI 10.1017/S0029665199000312; RYDER EL, 1985, VET CLIN N AM-SMALL, V15, P333, DOI 10.1016/S0195-5616(85)50305-8; Swanson KS, 2013, ADV NUTR, V4, P141, DOI 10.3945/an.112.003335; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Tilman D, 2014, NATURE, V515, P518, DOI 10.1038/nature13959; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; U. S. Census Bureau, 2015, ANN EST RES POP US R; U. S. Environmental Protection Agency, 2013, ADV SUST MAT MAN FAC; US Census Bureau, 2016, US WORLD POP CLOCK U; USDA Agricultural Research Service, 2012, WHAT WE EAT AM NHANE; Vale R., 2009, TIME EAT DOG REAL GU; VANHOUTTE BA, 1995, J APPL DEV PSYCHOL, V16, P463, DOI 10.1016/0193-3973(95)90030-6; Walker Ashby F, 2015, J Patient Exp, V2, P21, DOI 10.1177/237437431500200105; Wirsenius S, 2010, AGR SYST, V103, P621, DOI 10.1016/j.agsy.2010.07.005; Wood L, 2005, SOC SCI MED, V61, P1159, DOI 10.1016/j.socscimed.2005.01.017	67	52	53	22	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0181301	10.1371/journal.pone.0181301	http://dx.doi.org/10.1371/journal.pone.0181301			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC3VT	28767700	Green Published, gold, Green Submitted			2022-12-26	WOS:000406768200022
J	Pahil, S; Taneja, N; Ansari, HR; Raghava, GPS				Pahil, Sapna; Taneja, Neelam; Ansari, Hifzur Rahman; Raghava, G. P. S.			In silico analysis to identify vaccine candidates common to multiple serotypes of Shigella and evaluation of their immunogenicity	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE O-ANTIGEN; B-CELL EPITOPES; FLEXNERI 2A; SUBCELLULAR-LOCALIZATION; PEPTIDE VACCINE; CLINICAL-TRIAL; ANTIBODY-RESPONSE; IPA PROTEINS; PREDICTION; SONNEI	Shigellosis or bacillary dysentery is an important cause of diarrhea, with the majority of the cases occurring in developing countries. Considering the high disease burden, increasing antibiotic resistance, serotype-specific immunity and the post-infectious sequelae associated with shigellosis, there is a pressing need of an effective vaccine against multiple serotypes of the pathogen. In the present study, we used bio-informatics approach to identify antigens shared among multiple serotypes of Shigella spp. This approach led to the identification of many immunogenic peptides. The five most promising peptides based on MHC binding efficiency were a putative lipoprotein (EL PGI I), a putative heat shock protein (EL PGI II), Spa32 (EL PGI III), IcsB (EL PGI IV) and a hypothetical protein (EL PGI V). These peptides were synthesized and the immunogenicity was evaluated in BALB/c mice by ELISA and cytokine assays. The putative heat shock protein (HSP) and the hypothetical protein elicited good humoral response, whereas putative lipoprotein, Spa32 and IcsB elicited good T-cell response as revealed by increased IFN-gamma and TNF-alpha cytokine levels. The patient sera from confirmed cases of shigellosis were also evaluated for the presence of peptide specific antibodies with significant IgG and IgA antibodies against the HSP and the hypothetical protein, bestowing them as potential future vaccine candidates. The antigens reported in this study are novel and have not been tested as vaccine candidates against Shigella. This study offers time and cost-effective way of identifying unprecedented immunogenic antigens to be used as potential vaccine candidates. Moreover, this approach should easily be extendable to find new potential vaccine candidates for other pathogenic bacteria.	[Pahil, Sapna; Taneja, Neelam] Postgrad Inst Med Educ & Res, Dept Med Microbiol, Chandigarh, India; [Ansari, Hifzur Rahman; Raghava, G. P. S.] Inst Microbial Technol, Bioinformat Ctr, Chandigarh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Taneja, N (corresponding author), Postgrad Inst Med Educ & Res, Dept Med Microbiol, Chandigarh, India.	drneelampgi@yahoo.com	Raghava, Gajendra/B-1717-2009; Raghava, Gajendra P.S./AAA-2413-2022	Raghava, Gajendra P.S./0000-0002-8902-2876; Pahil, Sapna/0000-0002-7395-3991; TANEJA, NEELAM/0000-0003-1198-6138; Ansari, Hifzur Rahman/0000-0002-0646-1743	Council of Medical Research (ICM R), New Delhi; Department of Medical Microbiology, PGIMER, Chandigarh, India; Indian Council of Medical Research (ICMR), New Delhi, India; WIPO (World Intellectual Property Organization) in collaboration with ICMR	Council of Medical Research (ICM R), New Delhi(Indian Council of Medical Research (ICMR)); Department of Medical Microbiology, PGIMER, Chandigarh, India; Indian Council of Medical Research (ICMR), New Delhi, India(Indian Council of Medical Research (ICMR)); WIPO (World Intellectual Property Organization) in collaboration with ICMR	The Indian Council of Medical Research (ICM R), New Delhi, provided research fellowship to SP for carrying out this work as a part of her PhD thesis. The Department of Medical Microbiology, PGIMER, Chandigarh, India also funded a part of this work.; We wish to thank the Indian Council of Medical Research (ICMR), New Delhi, India. The work has been granted an international patent by WIPO (World Intellectual Property Organization) in collaboration with ICMR.	Ashkenazi S, 1999, J INFECT DIS, V179, P1565, DOI 10.1086/314759; Bai Y, 2003, WORLD J GASTROENTERO, V9, P2711; Barrios K, 2012, CANCER IMMUNOL IMMUN, V61, P1307, DOI 10.1007/s00262-012-1259-8; Belyakov IM, 2009, J IMMUNOL, V183, P6883, DOI 10.4049/jimmunol.0901466; Bhasin M, 2005, BIOINFORMATICS, V21, P2522, DOI 10.1093/bioinformatics/bti309; Bhasin M, 2007, J BIOSCIENCES, V32, P31, DOI 10.1007/s12038-007-0004-5; Bingrui W, 1984, Arch Roum Pathol Exp Microbiol, V43, P285; Bins A, 2007, J IMMUNOTHER, V30, P234, DOI 10.1097/01.cji.0000211333.06762.47; Boumghar-Bourtchai L, 2008, EMERG INFECT DIS, V14, P1297, DOI 10.3201/eid1408.080147; Brennan RE, 2004, INFECT IMMUN, V72, P6666, DOI 10.1128/IAI.72.11.6666-6675.2004; Cerdeno-Tarraga AM, 2003, NUCLEIC ACIDS RES, V31, P6516, DOI 10.1093/nar/gkg874; Chen C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017712; Chitradevi STS, 2016, VACCINE, V34, P5376, DOI 10.1016/j.vaccine.2016.08.034; COHEN D, 1989, J CLIN MICROBIOL, V27, P162, DOI 10.1128/JCM.27.1.162-167.1989; COHEN D, 1991, J CLIN MICROBIOL, V29, P386, DOI 10.1128/JCM.29.2.386-389.1991; Cohen D, 1996, CLIN DIAGN LAB IMMUN, V3, P451, DOI 10.1128/CDLI.3.4.451-455.1996; Cubillos C, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-66; Dakshinamoorthy G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034077; DAMJANOVIC V, 1973, CRYOBIOLOGY, V10, P171, DOI 10.1016/0011-2240(73)90024-2; DESILVA DGH, 1993, GUT, V34, P194, DOI 10.1136/gut.34.2.194; Dutta P, 1987, J Assoc Physicians India, V35, P195; FERRECCIO C, 1991, AM J EPIDEMIOL, V134, P614, DOI 10.1093/oxfordjournals.aje.a116134; Folster JP, 2011, ANTIMICROB AGENTS CH, V55, P1758, DOI 10.1128/AAC.01463-10; Gohara R, 2002, J IMMUNOTHER, V25, P439, DOI 10.1097/00002371-200209000-00008; Goldman SE, 2016, INT J MOL MED, V37, P1127, DOI 10.3892/ijmm.2016.2512; Gupta A, PLOS ONE, V9; Hackbarth C, 2010, CHEM BIOL DRUG DES, V76, P293, DOI 10.1111/j.1747-0285.2010.01021.x; HERRINGTON DA, 1990, VACCINE, V8, P353, DOI 10.1016/0264-410X(90)90094-3; HIRABAYASHI Y, 1990, VACCINE, V8, P243, DOI 10.1016/0264-410X(90)90053-O; Hua SJ, 2001, BIOINFORMATICS, V17, P721, DOI 10.1093/bioinformatics/17.8.721; Hueman MT, 2005, CLIN CANCER RES, V11, P7470, DOI 10.1158/1078-0432.CCR-05-0235; ISLAM D, 1995, INFECT IMMUN, V63, P2054, DOI 10.1128/IAI.63.5.2054-2061.1995; ISLAM D, 1995, INFECT IMMUN, V63, P2941, DOI 10.1128/IAI.63.8.2941-2949.1995; Izumoto S, 2008, J NEUROSURG, V108, P963, DOI 10.3171/JNS/2008/108/5/0963; Kaminski RW, 2009, EXPERT REV VACCINES, V8, P1693, DOI 10.1586/ERV.09.127; Karlsson MS, 2013, ANTIMICROB AGENTS CH, V57, P1559, DOI 10.1128/AAC.02360-12; Kelly DF, 2005, ADV EXP MED BIOL, V568, P217; Klade CS, 2002, CURR OPIN MOL THER, V4, P216; Korber B, 2006, PLOS COMPUT BIOL, V2, P484, DOI 10.1371/journal.pcbi.0020071; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; KOTLOFF KL, 1995, VACCINE, V13, P1488, DOI 10.1016/0264-410X(95)00102-7; Kotloff KL, 1996, INFECT IMMUN, V64, P4542, DOI 10.1128/IAI.64.11.4542-4548.1996; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Kweon MN, 2008, CURR OPIN INFECT DIS, V21, P313, DOI 10.1097/QCO.0b013e3282f88b92; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Levine MM, 2007, NAT REV MICROBIOL, V5, P540, DOI 10.1038/nrmicro1662; Lin SW, 2007, VACCINE, V25, P2187, DOI 10.1016/j.vaccine.2006.11.044; Lindsay B, 2013, J CLIN MICROBIOL, V51, P1740, DOI 10.1128/JCM.02713-12; Liu J, 2016, LANCET, V388, P1291, DOI 10.1016/S0140-6736(16)31529-X; Livio S, 2014, CLIN INFECT DIS, V59, P933, DOI 10.1093/cid/ciu468; Miyazawa M, 2010, CANCER SCI, V101, P433, DOI 10.1111/j.1349-7006.2009.01416.x; Morello CS, 2005, J VIROL, V79, P159, DOI 10.1128/JVI.79.1.159-175.2005; Naheed A, 2004, LANCET INFECT DIS, V4, P607, DOI 10.1016/S1473-3099(04)01143-0; Nair GB, 2010, GUT PATHOG, V2, DOI 10.1186/1757-4749-2-4; Niyogi SK, 2005, J MICROBIOL, V43, P133; Oaks EV, 2006, VACCINE, V24, P2290, DOI 10.1016/j.vaccine.2005.11.040; OAKS EV, 1986, INFECT IMMUN, V53, P57, DOI 10.1128/IAI.53.1.57-63.1986; Obeid OE, 1996, VIRUS RES, V42, P173, DOI 10.1016/0168-1702(96)01311-1; OBERHELMAN RA, 1991, INFECT IMMUN, V59, P2341, DOI 10.1128/IAI.59.7.2341-2350.1991; PAL SC, 1984, LANCET, V1, P1462, DOI 10.1016/S0140-6736(84)91948-2; Phalipon A, 2002, IMMUNITY, V17, P107, DOI 10.1016/S1074-7613(02)00341-2; Phalipon A, 2007, IMMUNOL CELL BIOL, V85, P119, DOI 10.1038/sj.icb7100025; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Pore D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022663; RAHAMAN MM, 1975, J INFECT DIS, V131, P700, DOI 10.1093/infdis/132.1.15; RAQIB R, 1995, INFECT IMMUN, V63, P289, DOI 10.1128/IAI.63.1.289-296.1995; Rasolofo-Razanamparany V, 2001, INFECT IMMUN, V69, P5230, DOI 10.1128/IAI.69.9.5230-5234.2001; Riddle MS, 2006, AM J TROP MED HYG, V74, P891, DOI 10.4269/ajtmh.2006.74.891; Riddle MS, 2011, VACCINE, V29, P7009, DOI 10.1016/j.vaccine.2011.07.033; Ross AG, N ENGL J MED, V368, P1817; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Scarselli M, 2005, TRENDS BIOTECHNOL, V23, P84, DOI 10.1016/j.tibtech.2004.12.008; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; SEN D, 1986, Journal of Diarrhoeal Diseases Research, V4, P161; Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236; Sivapalasingam S, 2006, ANTIMICROB AGENTS CH, V50, P49, DOI 10.1128/AAC.50.1.49-54.2006; Soria-Guerra RE, 2015, J BIOMED INFORM, V53, P405, DOI 10.1016/j.jbi.2014.11.003; Taneja N, 2005, INDIAN J MED RES, V122, P348; Taneja N, 2007, J CLIN MICROBIOL, V45, P678, DOI 10.1128/JCM.02247-06; Taneja N, 2012, J ANTIMICROB CHEMOTH, V67, P1347, DOI 10.1093/jac/dks061; Teng XD, 2015, HUM VACC IMMUNOTHER, V11, P1456, DOI 10.1080/21645515.2015.1037057; Tribble D, 2010, VACCINE, V28, P6076, DOI 10.1016/j.vaccine.2010.06.086; Tuteja R, 1999, IMMUNOLOGY, V97, P1, DOI 10.1046/j.1365-2567.1999.00743.x; Venkatesan MM, 2006, EXPERT REV VACCINES, V5, P669, DOI 10.1586/14760584.5.5.669; Vita R, NUCL ACIDS RES, V38, pD854; von Seidlein L, 2006, PLOS MED, V3, P1556, DOI 10.1371/journal.pmed.0030353; WATARAI M, 1995, P NATL ACAD SCI USA, V92, P4927, DOI 10.1073/pnas.92.11.4927; Woodward DL, 2005, J MED MICROBIOL, V54, P741, DOI 10.1099/jmm.0.46095-0; Yamada A, 2011, EXP THER MED, V2, P109, DOI 10.3892/etm.2010.177; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604; Yu J, 2000, INFECT IMMUN, V68, P6449, DOI 10.1128/IAI.68.11.6449-6456.2000; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zhang LJ, 2013, ONCOL RES, V21, P193, DOI 10.3727/096504014X13887748696789	93	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0180505	10.1371/journal.pone.0180505	http://dx.doi.org/10.1371/journal.pone.0180505			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767653	Green Published, Green Submitted, gold			2022-12-26	WOS:000406768200009
J	Tolesa, Z; Bekele, E; Tesfaye, K; Ben Slimen, H; Valqui, J; Getahun, A; Hartl, GB; Suchentrunk, F				Tolesa, Zelalem; Bekele, Endashaw; Tesfaye, Kassahun; Ben Slimen, Hichem; Valqui, Juan; Getahun, Abebe; Hartl, Guenther B.; Suchentrunk, Franz			Mitochondrial and nuclear DNA reveals reticulate evolution in hares (Lepus spp., Lagomorpha, Mammalia) from Ethiopia	PLOS ONE			English	Article							POLYMORPHIC MICROSATELLITE LOCI; GENUS LEPUS; INTROGRESSIVE HYBRIDIZATION; POPULATION-STRUCTURE; HAPLOTYPE RECONSTRUCTION; EUROPAEUS PALLAS; SARDINIAN HARES; CAPENSIS; TIMIDUS; DIFFERENTIATION	For hares (Lepus spp., Leporidae, Lagomorpha, Mammalia) from Ethiopia no conclusive molecular phylogenetic data are available. To provide a first molecular phylogenetic model for the Abyssinian Hare (Lepus habessinicus), the Ethiopian Hare (L. fagani), and the Ethiopian Highland Hare (L. starcki) and their evolutionary relationships to hares from Africa, Eurasia, and North America, we phylogenetically analysed mitochondrial ATPase subunit 6 (ATP6; n = 153/416bp) and nuclear transferrin (TF; n = 155/434bp) sequences of phenotypically determined individuals. For the hares from Ethiopia, genotype composition at twelve microsatellite loci (n = 107) was used to explore both interspecific gene pool separation and levels of current hybridization, as has been observed in some other Lepus species. For phylogenetic analyses ATP6 and TF sequences of Lepus species from South and North Africa (L. capensis, L. saxatilis), the Anatolian peninsula and Europe (L. europaeus, L. timidus) were also produced and additional TF sequences of 18 Lepus species retrieved from GenBank were included as well. Median joining networks, neighbour joining, maximum likelihood analyses, as well as Bayesian inference resulted in similar models of evolution of the three species from Ethiopia for the ATP6 and TF sequences, respectively. The Ethiopian species are, however, not monophyletic, with signatures of contemporary uni- and bidirectional mitochondrial introgression and/ or shared ancestral polymorphism. Lepus habessinicus carries mtDNA distinct from South African L. capensis and North African L. capensis sensu lato; that finding is not in line with earlier suggestions of its conspecificity with L. capensis. Lepus starcki has mtDNA distinct from L. capensis and L. europaeus, which is not in line with earlier suggestions to include it either in L. capensis or L. europaeus. Lepus fagani shares mitochondrial haplotypes with the other two species from Ethiopia, despite its distinct phenotypic and microsatellite differences; moreover, it is not represented by a species-specific mitochondrial haplogroup, suggesting considerable mitochondrial capture by the other species from Ethiopia or species from other parts of Africa. Both mitochondrial and nuclear sequences indicate close phylogenetic relationships among all three Lepus species from Ethiopia, with L. fagani being surprisingly tightly connected to L. habessinicus. TF sequences suggest close evolutionary relationships between the three Ethiopian species and Cape hares from South and North Africa; they further suggest that hares from Ethiopia hold a position ancestral to many Eurasian and North American species.	[Tolesa, Zelalem] Hawassa Univ, Dept Biol, Hawassa, Ethiopia; [Tolesa, Zelalem; Valqui, Juan; Hartl, Guenther B.] Christian Albrechts Univ Kiel, Zool Inst, Kiel, Germany; [Tolesa, Zelalem; Suchentrunk, Franz] Univ Vet Med Vienna, Res Inst Wildlife Ecol, Vienna, Austria; [Bekele, Endashaw; Tesfaye, Kassahun] Addis Ababa Univ, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia; [Tesfaye, Kassahun] Addis Ababa Univ, Ctr Biotechnol, Addis Ababa, Ethiopia; [Ben Slimen, Hichem] Inst Super Biotechnol Beja, Ave Habib Bourguiba, Beja, Tunisia; [Getahun, Abebe] Addis Ababa Univ, Dept Zool Sci, Addis Ababa, Ethiopia	Hawassa University; University of Kiel; University of Veterinary Medicine Vienna; Addis Ababa University; Addis Ababa University; Universite de Jendouba; Addis Ababa University	Tolesa, Z (corresponding author), Hawassa Univ, Dept Biol, Hawassa, Ethiopia.; Tolesa, Z (corresponding author), Christian Albrechts Univ Kiel, Zool Inst, Kiel, Germany.; Tolesa, Z (corresponding author), Univ Vet Med Vienna, Res Inst Wildlife Ecol, Vienna, Austria.	aslnp2000@yahoo.com		Ben Slimen, Hichem/0000-0002-7351-9028	Wildlife Research - Franz Suchentrunk/Vienna [4/2009]	Wildlife Research - Franz Suchentrunk/Vienna	Substantial financial support was provided by Wildlife Research - Franz Suchentrunk/Vienna nr. 4/2009. In addition FS was involved in the conceptualization, study design, data analysis, decision to publish and preparation of the manuscript.	Alves PC, 2008, MOL PHYLOGENET EVOL, V46, P1191, DOI 10.1016/j.ympev.2007.11.010; Alves Paulo C., 2008, P395; Alves PC, 2008, PHILOS T R SOC B, V363, P2831, DOI 10.1098/rstb.2008.0053; Alves PC, 2006, MOL PHYLOGENET EVOL, V40, P640, DOI 10.1016/j.ympev.2006.02.016; Alves PC, 2003, MOL PHYLOGENET EVOL, V27, P70, DOI 10.1016/S1055-7903(02)00417-7; Andersson AC, 1999, HEREDITAS, V130, P309, DOI 10.1111/j.1601-5223.1999.00309.x; ANGERMANN R, 1988, Zoologische Abhandlungen (Dresden), V43, P149; Angermann R, 1983, ACTA ZOOL FENN, V174, P17; Angermann R, 1965, THESIS; [Anonymous], 2005, MAMM BIOL, V70, P171; Arnason U, 2002, P NATL ACAD SCI USA, V99, P8151, DOI 10.1073/pnas.102164299; Awadi A, 2016, GENETICA; Azzaroli Puccetti M. L., 1996, Mammalia, V60, P223, DOI 10.1515/mamm.1996.60.2.223; AZZAROLI-PUCCETTI M L, 1987, Cimbebasia Series A, V9, P1; Azzaroli-Puccetti M.L., 1987, Atti della Accademia Nazionale dei Lincei Memorie Classe di Scienze Fisiche Matematiche e Naturali Sezione IIIA, V19, P1; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Belhhir K., 2004, GENETIX V 4 0 LOGICI; Belkhir K, 2002, MOL ECOL NOTES, V2, P611, DOI 10.1046/j.1471-8286.2002.00273.x; Ben Slimen H, 2008, MAMM BIOL, V73, P25, DOI 10.1016/j.mambio.2007.02.003; Ben Slimen H, 2007, MAMM BIOL, V72, P224, DOI 10.1016/j.mambio.2006.03.002; Ben Slimen H, 2006, J ZOOL SYST EVOL RES, V44, P88, DOI 10.1111/j.1439-0469.2005.00345.x; Ben Slimen H, 2005, BIOCHEM GENET, V43, P577, DOI 10.1007/s10528-005-9115-6; Ben Slimen H, 2008, BIOCHEM SYST ECOL, V36, P22, DOI 10.1016/j.bse.2007.06.014; BONHOMME F, 1986, MAMMALIA, V50, P495, DOI 10.1515/mamm.1986.50.4.495; Campos JL, 2011, MAMM BIOL, V76, P251, DOI 10.1016/j.mambio.2010.05.001; Canu A, 2012, J ZOOL SYST EVOL RES, V50, P328, DOI 10.1111/j.1439-0469.2012.00671.x; Chantry-Darmon U, 2005, MAMM GENOME, V16, P442, DOI 10.1007/s00335-005-2471-z; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Collins L., 2005, MAMMALS SO AFRICAN S, P63; Cornuet JM, 1996, GENETICS, V144, P2001; Coyne J.A., 2004, SPECIATION; Degnan JH, 2006, PLOS GENET, V2, P762, DOI 10.1371/journal.pgen.0020068; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Felsenstein J., 2013, PHYLIP PHYLOGENY INF; Flot JF, 2006, MOL ECOL NOTES, V6, P627, DOI 10.1111/j.1471-8286.2006.01355.x; Flux J.E., 1983, Acta Zoologica Fennica, P41; Flux J.E.C., 1990, P61; Fredsted Tina, 2006, BMC Ecology, V6, P17, DOI 10.1186/1472-6785-6-17; Garrick RC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-118; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Garza JC, 1996, GENOME RES, V6, P211, DOI 10.1101/gr.6.3.211; Ge DY, 2012, MAMM BIOL, V77, P113, DOI 10.1016/j.mambio.2011.09.009; Halanych KM, 1999, MOL PHYLOGENET EVOL, V11, P213, DOI 10.1006/mpev.1998.0581; Hall B.G., 2016, PHYLOGENETIC TREES M; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Happold DCD, 1817, MEM SOC IMP NAT MOSC, V5, P372; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Hoffman R, 2005, MAMMAL SPECIES WORLD, P185; Huelsenbeck JP, 2001, SYST BIOL, V50, P351, DOI 10.1080/106351501300317978; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kasapidis P, 2005, MOL PHYLOGENET EVOL, V34, P55, DOI 10.1016/j.ympev.2004.09.007; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Koutsogiannouli EA, 2012, MAMM BIOL, V77, P428, DOI 10.1016/j.mambio.2012.01.005; Kryger U., 2002, THESIS; Kumar S., 1993, MEGA MOL EVOLUTIONAR; Leache AD, 2002, SYST BIOL, V51, P44, DOI 10.1080/106351502753475871; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu J, 2011, ZOOTAXA, P47, DOI 10.11646/zootaxa.3010.1.4; Liu J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-223; Lopez-Martinez Nieves, 2008, P27, DOI 10.1007/978-3-540-72446-9_3; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Matthee CA, 2004, SYST BIOL, V53, P433, DOI 10.1080/10635150490445715; Melo-Ferreira J, 2007, MOL ECOL, V16, P605, DOI 10.1111/j.1365-294X.2006.03166.x; Melo-Ferreira J, 2005, MOL ECOL, V14, P2459, DOI 10.1111/j.1365-294X.2005.02599.x; Melo-Ferreira J, 2012, SYST BIOL, V61, P367, DOI 10.1093/sysbio/syr114; Melo-Ferreira J, 2014, MOL ECOL, V23, P4617, DOI 10.1111/mec.12886; Melo-Ferreira J, 2014, GENOME BIOL EVOL, V6, P886, DOI 10.1093/gbe/evu059; Mengoni C, 2015, CONSERV GENET, V16, P477, DOI 10.1007/s10592-014-0674-0; Morrison DA, 2011, INTRO PHYLOGENETIC N; Mougel F, 1997, ANIM GENET, V28, P58, DOI 10.1111/j.1365-2052.1997.00047.x; Nei M., 2000, MOL EVOLUTION PHYLOG; Nunome M, 2014, BIOL J LINN SOC, V111, P761, DOI 10.1111/bij.12245; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; PALACIOS F, 1989, MAMMALIA, V53, P227, DOI 10.1515/mamm.1989.53.2.227; PALACIOS F, 1996, BONNER ZOOL BEITR, V46, P59; Palacios F, 2008, MAMM BIOL, V73, P358, DOI 10.1016/j.mambio.2007.10.013; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Petter F., 1959, Mammalia Paris, V23, P41, DOI 10.1515/mamm.1959.23.1.41; Petter F., 1963, MAMMALIA, V27, P238; Pierpaoli M, 1999, MOL ECOL, V8, P1805, DOI 10.1046/j.1365-294x.1999.00766.x; Pietri C, 2011, EUR J WILDLIFE RES, V57, P313, DOI 10.1007/s10344-010-0430-9; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Posada D., 2012, PHYLOGENETIC HDB PRA, P345; Pritchard JK, 2000, GENETICS, V155, P945; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Rambaut A, 2012, FIGTREE V 1 4 2 TREE; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; RICO C, 1994, ANIM GENET, V25, P367, DOI 10.1111/j.1365-2052.1994.tb00379.x; Riga F, 2001, J ZOOL, V253, P241, DOI 10.1017/S0952836901000218; ROBINSON T J, 1987, Annals of the Transvaal Museum, V34, P379; Robinson TJ, 2005, MAMMAL REV, V35, P231, DOI 10.1111/j.1365-2907.2005.00073.x; ROBINSON TJ, 1982, S AFR J ZOOL, V17, P220; ROBINSON TJ, 1983, CAN J GENET CYTOL, V25, P540, DOI 10.1139/g83-081; Robinson TJ, 2002, CYTOGENET GENOME RES, V96, P223, DOI 10.1159/000063034; Ronquist F., 2011, MRBAYES V 3 IN PRESS; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scandura M, 2007, BIOCHEM GENET, V45, P305, DOI 10.1007/s10528-007-9076-z; Sert H, 2009, MAMM BIOL, V74, P286, DOI 10.1016/j.mambio.2008.05.008; Smith AT, 2008, IUCN RED LIST THREAT; Smith S, 2010, MOL ECOL, V19, P36, DOI 10.1111/j.1365-294X.2009.04444.x; Stamatis C, 2009, J BIOGEOGR, V36, P515, DOI 10.1111/j.1365-2699.2008.02013.x; Stamatis C, 2008, GENE, V410, P154, DOI 10.1016/j.gene.2007.12.010; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Suchentrunk F, 2000, J ZOOL, V252, P503, DOI 10.1017/S0952836900000261; Suchentrunk Franz, 2008, P65, DOI 10.1007/978-3-540-72446-9_5; Suchentrunk F, 2009, MAMM BIOL, V74, P325, DOI 10.1016/j.mambio.2009.05.005; Surridge AK, 1997, ANIM GENET, V28, P302, DOI 10.1111/j.1365-2052.1997.00137.x; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thulin CG, 2006, HEREDITAS, V143, P68, DOI 10.1111/j.2006.0018-0661.01952.x; Thulin CG, 1997, MOL ECOL, V6, P463, DOI 10.1046/j.1365-294X.1997.t01-1-00199.x; Thulin CG, 2006, WILDLIFE BIOL, V12, P29, DOI 10.2981/0909-6396(2006)12[29:SAAHIA]2.0.CO;2; Thulin CG, 2002, J ZOOL, V258, P299, DOI 10.1017/S0952836902001425; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Waltari E, 2005, MOL ECOL, V14, P3005, DOI 10.1111/j.1365-294X.2005.02625.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; Winkler Alisa J., 2010, P305; Wright S, 1931, GENETICS, V16, P0097; Wu CH, 2005, MOL PHYLOGENET EVOL, V37, P45, DOI 10.1016/j.ympev.2005.05.006; Wu YH, 2011, MOL PHYLOGENET EVOL, V59, P545, DOI 10.1016/j.ympev.2011.03.027; Yalden DW, 1996, TROP ZOOL, V9, P73, DOI 10.1080/03946975.1996.10539304; YALDEN DW, 1986, MONIT ZOOL ITAL, V21, P31, DOI 10.1080/03749444.1986.10736707; YOM-TOV Y., 1967, MAMMALIA, V31, P246, DOI 10.1515/mamm.1967.31.2.246; Zachos FE, 2010, J ZOOL, V282, P47, DOI 10.1111/j.1469-7998.2010.00710.x	134	12	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0180137	10.1371/journal.pone.0180137	http://dx.doi.org/10.1371/journal.pone.0180137			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767659	Green Published, Green Submitted, gold			2022-12-26	WOS:000406768200005
J	Gouveia, LR; Santos, JC; Silva, RD; Batista, AD; Domingues, ALC; Lopes, EPD; Silva, RO				Gouveia, Liana Ribeiro; Santos, Joelma Carvalho; Silva, Ronaldo Dionisio; Batista, Andrea Doria; Coutinho Domingues, Ana Lucia; de Almeida Lopes, Edmundo Pessoa; Silva, Ricardo Oliveira			Diagnosis of coinfection by schistosomiasis and viral hepatitis B or C using H-1 NMR-based metabonomics	PLOS ONE			English	Article							MANSONI; METABOLOMICS	Background Diagnosis of liver involvement due to schistosomiasis in asymptomatic patients from endemic areas previously diagnosed with chronic hepatitis B (HBV) or C (HCV) and periportal fibrosis is challenging. H-1 Nuclear Magnetic Resonance (NMR)-based metabonomics strategy is a powerful tool for providing a profile of endogenous metabolites of low molecular weight in biofluids in a non-invasive way. The aim of this study was to diagnose periportal fibrosis due to schistosomiasis mansoni in patients with chronic HBV or HCV infection through NMR-based metabonomics models. Methodology/Principal findings The study included 40 patients divided into two groups: (i) 18 coinfected patients with schistosomiasis mansoni and HBV or HCV; and (ii) 22 HBV or HCV monoinfected patients. The serum samples were analyzed through H-1 NMR spectroscopy and the models were based on Principal Component Analysis (PCA) and Partial Least Squares-Discriminant Analysis (PLS-DA). Ultrasonography examination was used to ascertain the diagnosis of periportal fibrosis. Exploratory analysis showed a clear separation between coinfected and monoinfected samples. The supervised model built from PLS-DA showed accuracy, R-2 and Q(2) values equal to 100%, 98.1% and 97.5%, respectively. According to the variable importance in the projection plot, lactate serum levels were higher in the coinfected group, while the signals attributed to HDL serum cholesterol were more intense in the monoinfected group. Conclusions/Significance The metabonomics models constructed in this study are promising as an alternative tool for diagnosis of periportal fibrosis by schistosomiasis in patients with chronic HBV or HCV infection from endemic areas for Schistosoma mansoni.	[Gouveia, Liana Ribeiro; Silva, Ronaldo Dionisio; Silva, Ricardo Oliveira] Univ Fed Pernambuco UFPE, Ctr Exact & Nat Sci, Fundamental Chem Dept, Postgrad Program Chem, Recife, PE, Brazil; [Santos, Joelma Carvalho; Batista, Andrea Doria; Coutinho Domingues, Ana Lucia; de Almeida Lopes, Edmundo Pessoa] Univ Fed Pernambuco UFPE, Ctr Hlth Sci, Postgrad Program Trop Med, Recife, PE, Brazil; [Batista, Andrea Doria; de Almeida Lopes, Edmundo Pessoa] Univ Fed Pernambuco UFPE, Hosp Clin, Dept Internal Med, Recife, PE, Brazil	Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Universidade Federal de Pernambuco	Gouveia, LR (corresponding author), Univ Fed Pernambuco UFPE, Ctr Exact & Nat Sci, Fundamental Chem Dept, Postgrad Program Chem, Recife, PE, Brazil.	lianargouveia@gmail.com	Lopes, Edmundo/R-5159-2017; Silva, Ricardo Oliveira/ABF-2093-2021; Silva, Ricardo O/A-9461-2013	Lopes, Edmundo/0000-0002-3470-1564; Silva, Ricardo Oliveira/0000-0001-8090-7320; Silva, Ricardo O/0000-0001-8090-7320				Araujo L, 2017, BR J MED MED RES, V19, P1; Balog CIA, 2011, MOL BIOSYST, V7, P1473, DOI 10.1039/c0mb00262c; Barsoum RS, 2013, J ADV RES, V4, P433, DOI 10.1016/j.jare.2013.01.005; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de DST Aids e Hepatites Virais, 2015, PROT CLIN DIR HEP CO; Van-Lume DSD, 2013, REV SAUDE PUBL, V47, P414, DOI 10.1590/S0034-910.2013047004247; Elbaz T, 2013, J ADV RES, V4, P445, DOI 10.1016/j.jare.2012.12.001; Embade N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155094; Gao HC, 2009, CANCER SCI, V100, P782, DOI 10.1111/j.1349-7006.2009.01086.x; Gasim GI, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0251-2; Githui EK, 2006, EXP PARASITOL, V114, P180, DOI 10.1016/j.exppara.2006.03.007; Godoy MMG, 2010, J VIRAL HEPATITIS, V17, P854, DOI 10.1111/j.1365-2893.2009.01252.x; Gray DJ, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2651; Guimaraes Cavalcanti Marta, 2015, Clin Liver Dis (Hoboken), V6, P59, DOI 10.1002/cld.495; Guleria A, 2015, ARTICLE NMR BASED SE; Hewer R, 2006, J PHARMACEUT BIOMED, V41, P1442, DOI 10.1016/j.jpba.2006.03.006; Holmes E, 2015, NAT REV GASTRO HEPAT, V12, P458, DOI 10.1038/nrgastro.2015.114; Lambertucci JR, 2014, REV SOC BRAS MED TRO, V47, P130, DOI 10.1590/0037-8682-0186-2013; Li JV, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-179; Li J, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-115; Manzella A, 2012, AM J TROP MED HYG, V86, P982, DOI 10.4269/ajtmh.2012.11-0419; da Fonseca CSM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101964; Pinto J, 2015, J PROTEOME RES, V14, P2696, DOI 10.1021/acs.jproteome.5b00260; Richter J, 1996, 2 INT WORKSH NIAM NI, P49; Ruiz-Guevara R, 2007, REV SOC BRAS MED TRO, V40, P505, DOI 10.1590/S0037-86822007000500003; Sah V.K., 2015, RADIOL INFECT DIS, V2, P150, DOI DOI 10.1016/j.jrid.2015.11.007; Sands CJ, 2015, AM J GASTROENTEROL, V110, P159, DOI 10.1038/ajg.2014.370; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Wang YL, 2004, P NATL ACAD SCI USA, V101, P12676, DOI 10.1073/pnas.0404878101; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Worley B, 2015, CURR METABOLOMICS, V1, P92, DOI DOI 10.2174/2213235X11301010092.MULTIVARIATE; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yu MQ, 2017, CAN J GASTROENTEROL, V2017, DOI 10.1155/2017/8467192	33	7	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0182196	10.1371/journal.pone.0182196	http://dx.doi.org/10.1371/journal.pone.0182196			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763497	Green Published, gold, Green Submitted			2022-12-26	WOS:000406766500049
J	Mijalkov, M; Kakaei, E; Pereira, JB; Westman, E; Volpe, G				Mijalkov, Mite; Kakaei, Ehsan; Pereira, Joana B.; Westman, Eric; Volpe, Giovanni		Alzheimer's Dis Neuroimaging	BRAPH: A graph theory software for the analysis of brain connectivity	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; TIME-VARYING CONNECTIVITY; SMALL-WORLD; FUNCTIONAL CONNECTIVITY; ALZHEIMERS-DISEASE; NETWORK TOPOLOGY; HUMAN CONNECTOME; TOOLBOX; PARCELLATION; ORGANIZATION	The brain is a large-scale complex network whose workings rely on the interaction between its various regions. In the past few years, the organization of the human brain network has been studied extensively using concepts from graph theory, where the brain is represented as a set of nodes connected by edges. This representation of the brain as a connectome can be used to assess important measures that reflect its topological architecture. We have developed a freeware MatLab-based software (BRAPH-BRain Analysis using graPH theory) for connectivity analysis of brain networks derived from structural magnetic resonance imaging (MRI), functional MRI (fMRI), positron emission tomography (PET) and electroencephalogram (EEG) data. BRAPH allows building connectivity matrices, calculating global and local network measures, performing non-parametric permutations for group comparisons, assessing the modules in the network, and comparing the results to random networks. By contrast to other toolboxes, it allows performing longitudinal comparisons of the same patients across different points in time. Furthermore, even though a user-friendly interface is provided, the architecture of the program is modular (object-oriented) so that it can be easily expanded and customized. To demonstrate the abilities of BRAPH, we performed structural and functional graph theory analyses in two separate studies. In the first study, using MRI data, we assessed the differences in global and nodal network topology in healthy controls, patients with amnestic mild cognitive impairment, and patients with Alzheimer's disease. In the second study, using resting-state fMRI data, we compared healthy controls and Parkinson's patients with mild cognitive impairment.	[Mijalkov, Mite; Kakaei, Ehsan; Volpe, Giovanni] Bilkent Univ, UNAM, Natl Nanotechnol Res Ctr, Ankara, Turkey; [Mijalkov, Mite; Kakaei, Ehsan; Volpe, Giovanni] Bilkent Univ, Dept Phys, Ankara, Turkey; [Pereira, Joana B.; Westman, Eric] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Volpe, Giovanni] Gothenburg Univ, Dept Phys, Gothenburg, Sweden	Ihsan Dogramaci Bilkent University; Ihsan Dogramaci Bilkent University; Karolinska Institutet; University of Gothenburg	Volpe, G (corresponding author), Bilkent Univ, UNAM, Natl Nanotechnol Res Ctr, Ankara, Turkey.; Volpe, G (corresponding author), Bilkent Univ, Dept Phys, Ankara, Turkey.; Volpe, G (corresponding author), Gothenburg Univ, Dept Phys, Gothenburg, Sweden.	giovanni.volpe@physics.gu.se	Pereira, Joana/AAR-4466-2020; Kakaei, Ehsan/K-9106-2017; Pereira, Joana/AAL-9244-2020; Volpe, Giovanni/B-1862-2008; Mijalkov, Mite/AHB-3132-2022; Westman, Eric/H-5771-2011	Kakaei, Ehsan/0000-0001-7396-0967; Volpe, Giovanni/0000-0001-5057-1846; Westman, Eric/0000-0002-3115-2977	National Institutes of Health [U01 AG024904]; Department of Defense [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd; GE Healthcare; Genentech, Inc.; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer I mmunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.; Takeda Pharmaceutical Company; Canadian Institutes of Health Research; Michael J. Fox Foundation; Abbott; Avid Radiopharmaceuticals; Biogen Idec; Bristol-Myers Squibb; Covance; Elan; Genentech; GSK-GlaxoSmithKline; Lilly; Merck; MSD-Meso Scale Discovery; Pfizer; Roche; UCB; Swedish Foundation for Strategic Research (SSF) [4-3193/2014]; Strategic Research Programme in Neuroscience at Karolinska Institutet (StratNeuro), Hjarnfonden [F02015-0173]; Vetenskapsradet [2016-02282 2017-2020]; Birgitta och Sten Westerberg; TUBITAK [2215]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Alzheimer's Association(Alzheimer's Association); Alzheimer's Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.(Biogen); Bristol-Myers Squibb Company(Bristol-Myers Squibb); Eisai Inc.(Eisai Co Ltd); Elan Pharmaceuticals, Inc.; Eli Lilly and Company(Eli Lilly); F. Hoffmann-La Roche Ltd(Hoffmann-La Roche); GE Healthcare(General ElectricGE Healthcare); Genentech, Inc.(Roche HoldingGenentech); Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer I mmunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.(Johnson & JohnsonJohnson & Johnson USA); Medpace, Inc.; Merck Co., Inc.(Merck & Company); Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation(Novartis); Pfizer Inc.(Pfizer); Piramal Imaging; Servier(Servier); Synarc Inc.; Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael J. Fox Foundation; Abbott(Abbott Laboratories); Avid Radiopharmaceuticals; Biogen Idec(Biogen); Bristol-Myers Squibb(Bristol-Myers Squibb); Covance; Elan; Genentech(Roche HoldingGenentech); GSK-GlaxoSmithKline; Lilly(Eli Lilly); Merck(Merck & Company); MSD-Meso Scale Discovery; Pfizer(Pfizer); Roche(Roche Holding); UCB(UCB Pharma SA); Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Strategic Research Programme in Neuroscience at Karolinska Institutet (StratNeuro), Hjarnfonden; Vetenskapsradet(Swedish Research Council); Birgitta och Sten Westerberg; TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	Data used in the preparation of this article were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) and the Parkinson's Progression Markers Initiative (PPMI). Data collection and sharing of ADNI was funded by the National Institutes of Health Grant U01 AG024904 and Department of Defense award number W81XWH-12-2-0012. ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Alzheimer's Association; Alzheimer's Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer I mmunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. PPMI a public-private partnership is funded by the Michael J. Fox Foundation for Parkinson's Research and funding partners, including Abbott, Avid Radiopharmaceuticals, Biogen Idec, Bristol-Myers Squibb, Covance, Elan, GE Healthcare, Genentech, GSK-GlaxoSmithKline, Lilly, Merck, MSD-Meso Scale Discovery,Pfizer, Roche, UCB (www.ppmi-info.org/fundingpartners). For up-to-date information on the PPMI database visit wm. ppmi-info.org. We would also like to thank the Swedish Foundation for Strategic Research (SSF) grant number 4-3193/2014, the Strategic Research Programme in Neuroscience at Karolinska Institutet (StratNeuro), Hjarnfonden grant number F02015-0173, Vetenskapsradet grant number 2016-02282 2017-2020, and Birgitta och Sten Westerberg for additional financial support. We would also like to thank TUBITAK 2215 Graduate Programme for their support.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Baggio HC, 2015, CNS NEUROSCI THER, V21, P793, DOI 10.1111/cns.12417; Barabasi A.-L., 2016, NETWORK SCI; Barttfeld P, 2012, NEUROPSYCHOLOGIA, V50, P3653, DOI 10.1016/j.neuropsychologia.2012.09.047; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Calhoun VD, 2014, NEURON, V84, P262, DOI 10.1016/j.neuron.2014.10.015; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Crossley NA, 2014, BRAIN, V137, P2382, DOI 10.1093/brain/awu132; Cui J, 2008, NEURAL NETWORKS, V21, P1094, DOI 10.1016/j.neunet.2008.05.007; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Dimitriadis SI, 2010, J NEUROSCI METH, V193, P145, DOI 10.1016/j.jneumeth.2010.08.027; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Fornito A, 2013, NEUROIMAGE, V80, P426, DOI 10.1016/j.neuroimage.2013.04.087; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; He B, 2011, J NEUROSCI METH, V195, P261, DOI 10.1016/j.jneumeth.2010.11.015; Hosseini SMH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040709; Ji GJ, 2017, RADIOLOGY, V283, P186, DOI 10.1148/radiol.2016160422; Kruschwitz JD, 2015, J NEUROSCI METH, V245, P107, DOI 10.1016/j.jneumeth.2015.02.021; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Liao W, 2014, BRAIN STRUCT FUNCT, V219, P2001, DOI 10.1007/s00429-013-0619-2; Liao W, 2014, BRAIN CONNECT, V4, P780, DOI 10.1089/brain.2014.0253; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Marek K, 2011, PROG NEUROBIOL, V95, P629, DOI 10.1016/j.pneurobio.2011.09.005; Meunier D, 2014, NEUROBIOL AGING, V35, P42, DOI 10.1016/j.neurobiolaging.2013.07.003; Pereira JB, 2016, CEREB CORTEX, V26, P3476, DOI 10.1093/cercor/bhw128; Pereira JB, 2015, HUM BRAIN MAPP, V36, P2980, DOI 10.1002/hbm.22822; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2009, HUM BRAIN MAPP, V30, P403, DOI 10.1002/hbm.20517; Shu N, 2011, CEREB CORTEX, V21, P2565, DOI 10.1093/cercor/bhr039; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Sporns O, 2013, NEUROIMAGE, V80, P53, DOI 10.1016/j.neuroimage.2013.03.023; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Svenningsson P, 2012, LANCET NEUROL, V11, P697, DOI 10.1016/S1474-4422(12)70152-7; Tijms BM, 2013, NEUROBIOL AGING, V34, P2023, DOI 10.1016/j.neurobiolaging.2013.02.020; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Voevodskaya O, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00264; Wang JH, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3389/fnhum.2015.00386, 10.3389/fnhum.2015.00458]; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weintraub D, 2015, MOVEMENT DISORD, V30, P919, DOI 10.1002/mds.26170; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Winblad B, 2016, LANCET NEUROL, V15, P455, DOI 10.1016/S1474-4422(16)00062-4; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yu QB, 2015, NEUROIMAGE, V107, P345, DOI 10.1016/j.neuroimage.2014.12.020; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223	56	101	102	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0178798	10.1371/journal.pone.0178798	http://dx.doi.org/10.1371/journal.pone.0178798			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763447	Green Published, gold, Green Submitted			2022-12-26	WOS:000406766500001
J	Petri, RM; Pourazad, P; Khiaosa-Ard, R; Klevenhusen, F; Metzler-Zebeli, BU; Zebeli, Q				Petri, Renee M.; Pourazad, Poulad; Khiaosa-Ard, Ratchaneewan; Klevenhusen, Fenja; Metzler-Zebeli, Barbara U.; Zebeli, Qendrim			Temporal dynamics of in-situ fiber-adherent bacterial community under ruminal acidotic conditions determined by 16S rRNA gene profiling	PLOS ONE			English	Article							DAIRY-COWS; SP-NOV; RUMEN; DIVERSITY; ACIDOSIS; POPULATIONS; HOST; DIET	Subacute rumen acidotic (SARA) conditions are a consequence of high grain feeding. Recent work has shown that the pattern of grain feeding can significantly impact the rumen epimural microbiota. In a continuation of these works, the objective of this study was to determine the role of grain feeding patterns on the colonization and associated changes in predicted functional properties of the fiber-adherent microbial community over a 48 h period. Eight rumen-cannulated Holstein cows were randomly assigned to interrupted or continuous 60%-grain challenge model (n = 4 per model) to induce SARA conditions. Cows in the continuous model were challenged for 4 weeks, whereas cows of interrupted model had a 1-wk break in between challenges. To determine dynamics of rumen fiber-adherent microbial community we incubated the same hay from the diet samples for 24 and 48 h in situ during the baseline (no grain fed), week 1 and 4 of the continuous grain feeding model as well as during the week 1 following the break in the interrupted model. Microbial DNA was extracted and 16SrRNA amplicon (V3-V5 region) sequencing was done with the Illumina MiSeq platform. A significant decrease (P < 0.001) in fiber-adherent rumen bacterial species richness and diversity was observed at the end of a 4 week continuous SARA challenge in comparison to the baseline. A total of 159 operational taxonominc units (OTUs) were identified from the microbial population representing > 0.1% relative abundance in the rumen, 18 of which were significantly impacted by the feeding challenge model. Correlation analysis of the significant OTUs to rumen pH as an indicator of SARA showed genus Succiniclasticum had a positive correlation to SARA conditions regardless of treatment. Predictive analysis of functional microbial properties suggested that the glyoxylate/dicarboxylate pathway was increased in response to SARA conditions, decreased between 24h to 48h of incubation, negatively correlated with propanoate metabolism and positively correlated to members of the Veillonellaceae family including Succiniclasticum spp. This may indicate an adaptive response in bacterial metabolism under SARA conditions. This research clearly indicates that changes to the colonizing fiber-adherent rumen microbial population and their predicted functional genes occur in both the short (48 h) and long term (4 wk) under both continuous and interrupted SARA challenge models.	[Petri, Renee M.; Pourazad, Poulad; Khiaosa-Ard, Ratchaneewan; Klevenhusen, Fenja; Zebeli, Qendrim] Univ Vet Med Vienna, Dept Farm Anim & Vet Publ Hlth, Inst Anim Nutr & Funct Plant Cpds, Vienna, Austria; [Metzler-Zebeli, Barbara U.] Univ Vet Med Vienna, Dept Farm Anim & Vet Publ Hlth, Clin Swine, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Zebeli, Q (corresponding author), Univ Vet Med Vienna, Dept Farm Anim & Vet Publ Hlth, Inst Anim Nutr & Funct Plant Cpds, Vienna, Austria.	qendrim.zebeli@vetmeduni.ac.at	Petri, Renee Maxine/J-6102-2019; Khiaosa-ard, Ratchaneewan/Y-1733-2019	Petri, Renee Maxine/0000-0002-8209-8261; Khiaosa-ard, Ratchaneewan/0000-0003-3359-5787; Klevenhusen, Fenja/0000-0001-6015-5459; Pourazad, Poulad/0000-0001-9744-3868	Vienna Science and Technology fund (WWTF) [LS12-010]; R Petri was funded by Vetmeduni Vienna, PostDoc Programme	Vienna Science and Technology fund (WWTF); R Petri was funded by Vetmeduni Vienna, PostDoc Programme	Funding for this research was provided by the project "D-LINFLACOW, LS12-010" of Vienna Science and Technology fund (WWTF) www.wwtf.at/. R Petri was funded by Vetmeduni Vienna, PostDoc Programme https://www.vetmeduni.ac.at/en/research/young-scientists/.	Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dohme F, 2008, J DAIRY SCI, V91, P3554, DOI 10.3168/jds.2008-1264; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; GrechMora I, 1996, INT J SYST BACTERIOL, V46, P512, DOI 10.1099/00207713-46-2-512; Henderson G, 2015, SCI REP-UK, V5, DOI 10.1038/srep14567; Khafipour E, 2009, J DAIRY SCI, V92, P1712, DOI 10.3168/jds.2008-1656; Khafipour E, 2009, APPL ENVIRON MICROB, V75, P7115, DOI 10.1128/AEM.00739-09; Khiaosa-ard R., 2016, Proceedings of the Society of Nutrition Physiology, V25, P68; Kleen JL, 2003, J VET MED A, V50, P406, DOI 10.1046/j.1439-0442.2003.00569.x; Klieve AV, 2003, J APPL MICROBIOL, V95, P621, DOI 10.1046/j.1365-2672.2003.02024.x; Kong YH, 2010, FEMS MICROBIOL ECOL, V74, P612, DOI 10.1111/j.1574-6941.2010.00977.x; Lagkouvardos I, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.131, 10.1038/nmicrobiol.2016.131]; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Littell RC, 1998, J ANIM SCI, V76, P1216; MCALLISTER TA, 1994, J ANIM SCI, V72, P3004, DOI 10.2527/1994.72113004x; Metzler-Zebeli BU, 2013, ANAEROBE, V20, P65, DOI 10.1016/j.anaerobe.2013.02.005; Myer PR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129174; OErskov E. R., 1980, Tropical Animal Production, V5, P195; Petri RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083424; Piao H, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00307; Pourazad P, 2016, J ANIM SCI, V94, P726, DOI 10.2527/jas.2015-9605; Pourazad P, 2017, ANIMAL UNPUB; Qumar M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164192; Tajima K, 2001, APPL ENVIRON MICROB, V67, P2766, DOI 10.1128/AEM.67.6.2766-2774.2001; VANGYLSWYK NO, 1970, J GEN MICROBIOL, V64, P11, DOI 10.1099/00221287-64-1-11; VANGYLSWYK NO, 1995, INT J SYST BACTERIOL, V45, P297, DOI 10.1099/00207713-45-2-297; Wetzels SU, 2017, J DAIRY SCI, V100, P1829, DOI 10.3168/jds.2016-11620; Zebeli Q, 2008, ANIM FEED SCI TECH, V140, P307, DOI 10.1016/j.anifeedsci.2007.04.002; Zheng H, 2016, ENVIRON MICROBIOL, V18, P191, DOI 10.1111/1462-2920.12960	32	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0182271	10.1371/journal.pone.0182271	http://dx.doi.org/10.1371/journal.pone.0182271			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763489	Green Published, Green Submitted, gold			2022-12-26	WOS:000406766500056
J	Alshehri, S; Shakeel, F; Ibrahim, M; Elzayat, E; Altamimi, M; Shazly, G; Mohsin, K; Alkholief, M; Alsulays, B; Alshetaili, A; Alshahrani, A; Almalki, B; Alanazi, F				Alshehri, Sultan; Shakeel, Faiyaz; Ibrahim, Mohamed; Elzayat, Ehab; Altamimi, Mohammad; Shazly, Gamal; Mohsin, Kazi; Alkholief, Musaed; Alsulays, Bader; Alshetaili, Abdullah; Alshahrani, Abdulaziz; Almalki, Bander; Alanazi, Fars			Influence of the microwave technology on solid dispersions of mefenamic acid and flufenamic acid	PLOS ONE			English	Article							DRUG-POLYMER INTERACTION; BIOAVAILABILITY ENHANCEMENT; BETA-CYCLODEXTRIN; DELIVERY SYSTEM; SOLUBILITY; WATER; DISSOLUTION; POLYVINYLPYRROLIDONE; NANOEMULSION; STABILITY	The present studies were undertaken to develop solvent-free solid dispersions (SDs) for poorly soluble anti-inflammatory drugs mefenamic acid (MA) and flufenamic acid (FFA) in order to enhance their in vitro dissolution rate and in vivo anti-inflammatory effects. The SDs of MA and FFA were prepared using microwaves irradiation (MW) technique. Different carriers such as Pluronic F127 (R) (PL), Eudragit EPO (R) (EPO), polyethylene glycol 4000 (PEG 4000) and Gelucire 50/13 (GLU) were used for the preparation of SDs. Prepared MW irradiated SDs were characterized physicochemically using differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), Fourier transform infra-red (FT-IR) spectroscopy, powder X-ray diffraction (PXRD) and scanning electron microscopy (SEM). The physicochemical characteristics and drug release profile of SDs were compared with pure drugs. The results of DSC, TGA, FT-IR, PXRD and SEM showed that SDs were successfully prepared. In vitro dissolution rate of MA and FFA was remarkably enhanced by SDs in comparison with pure MA and FFA. The SDs of MA and FFA prepared using PEG 400 showed higher drug release profile in comparison with those prepared using PL, EPO or GLU. The dissolution efficiency for MA-PEG SD and FFA-PEG SD was obtained as 61.40 and 59.18%, respectively. Optimized SDs were also evaluated for in vivo anti-inflammatory effects in male Wistar rats. The results showed significant % inhibition by MA-PEG (87.74% after 4 h) and FFA-PEG SDs (81.76% after 4 h) in comparison with pure MA (68.09% after 4 h) and pure FFA (55.27% after 4 h) (P < 0.05). These results suggested that MW irradiated SDs of MA and FFA could be successfully used for the enhancement of in vitro dissolution rate and in vivo therapeutic efficacy of both drugs.	[Alshehri, Sultan; Shakeel, Faiyaz; Ibrahim, Mohamed; Elzayat, Ehab; Altamimi, Mohammad; Shazly, Gamal; Mohsin, Kazi; Alkholief, Musaed; Alshahrani, Abdulaziz; Almalki, Bander; Alanazi, Fars] King Saud Univ, Dept Pharmaceut, Coll Pharm, Riyadh, Saudi Arabia; [Shazly, Gamal] Assiut Univ, Dept Pharmaceut, Fac Pharm, Assiut, Egypt; [Alsulays, Bader; Alshetaili, Abdullah] Prince Sattam Bin Abdulaziz Univ, Dept Pharmaceut, Coll Pharm, Al Kharj, Saudi Arabia	King Saud University; Egyptian Knowledge Bank (EKB); Assiut University; Prince Sattam Bin Abdulaziz University	Alshehri, S (corresponding author), King Saud Univ, Dept Pharmaceut, Coll Pharm, Riyadh, Saudi Arabia.	salshehri1@ksu.edu.sa	Elzayat, Ehab/AAZ-6628-2021; Ibrahim, Mohamed Fahmy/AAP-7467-2021; Elzayat, Ehab/GRY-0433-2022; Kazi, Mohsin/B-4417-2010; Alanazi, Fars/D-1558-2015; Altamimi, Mohammad A./AAH-8244-2020; Alshehri/AAD-6312-2019; Shakeel, Faiyaz/ABF-2218-2020; Kazi, Mohsin/ABC-8141-2020	Elzayat, Ehab/0000-0001-5177-4477; Kazi, Mohsin/0000-0002-5611-0378; Alanazi, Fars/0000-0002-0757-3245; Altamimi, Mohammad A./0000-0003-4877-864X; Shakeel, Faiyaz/0000-0002-6109-0885; Kazi, Mohsin/0000-0002-5611-0378; Ibrahim, Mohamed/0000-0001-7535-5453	King Saud University; King Saud University [RGP-1438-013]	King Saud University(King Saud University); King Saud University(King Saud University)	This work was supported by Deanship of Scientific Research, King Saud University.; The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for funding the research through research group project number RGP-1438-013.	Aitipamula S, 2014, CRYSTENGCOMM, V16, P5793, DOI 10.1039/c3ce42182a; Alshehri SM, 2017, PHARM DEV TECHNOL, V22, P740, DOI 10.3109/10837450.2016.1138129; Alshehri SM, 2015, J DRUG DELIV SCI TEC, V27, P18, DOI 10.1016/j.jddst.2015.03.003; Altamimi MA, 2017, SAUDI PHARM J, V25, P419, DOI 10.1016/j.jsps.2016.09.013; Arafa MF, 2016, DRUG DEV IND PHARM, V42, P1225, DOI 10.3109/03639045.2015.1118495; Aso Y, 2009, CHEM PHARM BULL, V57, P61, DOI 10.1248/cpb.57.61; Avachat A, 2012, ASIAN J PHARM SCI, V7, P337; Bali DE, 2016, EUR J DRUG METAB PH, V41, P807, DOI 10.1007/s13318-015-0311-4; Barreiro-Iglesias R, 2003, INT J PHARM, V258, P165, DOI 10.1016/S0378-5173(03)00181-9; Boghra RJ, 2011, CHEM PHARM BULL, V59, P438, DOI 10.1248/cpb.59.438; Dong BX, 2017, DRUG DEV IND PHARM, V43, P996, DOI 10.1080/03639045.2017.1287721; Fatima MT, 2016, BIOMACROMOLECULES, V17, P2375, DOI 10.1021/acs.biomac.6b00417; Fulop I, 2015, ACTA PHARMACEUT, V65, P453, DOI 10.1515/acph-2015-0035; Ganguly R, 2017, COLLOID SURFACE B, V152, P176, DOI 10.1016/j.colsurfb.2017.01.023; Greenhalgh DJ, 1999, J PHARM SCI, V88, P1182, DOI 10.1021/js9900856; Huang JJ, 2008, J PHARM SCI-US, V97, P251, DOI 10.1002/jps.21072; Insel PA, 1990, PHARM BASIS THERAPEU; Jelvehgari M, 2011, IRAN J PHARM RES, V10, P457; Kang N, 2015, DRUG DEV IND PHARM, V41, P978, DOI 10.3109/03639045.2014.920024; Kojima T, 2012, PHARM RES-DORDR, V29, P2777, DOI 10.1007/s11095-011-0655-7; Lin C., 2004, DRUG DEVELOP RES, V63, P181; Martindale in, 1996, EXTRA PHARMACOPOEIA; Maurya D, 2010, J PHARM PHARMACOL, V62, P1599, DOI 10.1111/j.2042-7158.2010.01187.x; Menendez JA, 2010, FUEL PROCESS TECHNOL, V91, P1, DOI 10.1016/j.fuproc.2009.08.021; Michel D, 2016, INT J NANOMED, V11, P6703, DOI 10.2147/IJN.S121156; Moneghini M, 2008, INT J PHARMACEUT, V361, P125, DOI 10.1016/j.ijpharm.2008.05.026; Moneghini M, 2009, POWDER TECHNOL, V195, P259, DOI 10.1016/j.powtec.2009.06.006; Perlovich GL, 2007, J PHARMACEUT BIOMED, V45, P679, DOI 10.1016/j.jpba.2007.01.039; Qadir A, 2016, J MOL LIQ, V214, P7, DOI 10.1016/j.molliq.2015.11.050; Rao KRSS, 2011, INDIAN J PHARM SCI, V73, P243; Sathigari SK, 2012, J PHARM SCI-US, V101, P3456, DOI 10.1002/jps.23125; Savjani KT, 2012, INT SCH RES NOT, V2012; Serajuddin ATM, 1999, J PHARM SCI-US, V88, P1058, DOI 10.1021/js980403l; Shakeel F, 2009, PHARMAZIE, V64, P258, DOI 10.1691/ph.2009.8282; Shakeel F, 2016, J PHARM PHARMACOL, V68, P772, DOI 10.1111/jphp.12550; Shakeel F, 2013, J CHEM ENG DATA, V58, P3551, DOI 10.1021/je4008525; Shakeel F, 2013, J MOL LIQ, V180, P89, DOI 10.1016/j.molliq.2013.01.008; Shazly GA, 2012, DRUG DEVELOP RES, V73, P299, DOI 10.1002/ddr.21013; Sridevi S, 2002, EUR J PHARM BIOPHARM, V54, P151, DOI 10.1016/S0939-6411(02)00056-5; Su YL, 2003, MOL SIMULAT, V29, P803, DOI 10.1080/0892702031000121888; Tanno F, 2004, DRUG DEV IND PHARM, V30, P9, DOI 10.1081/DDC-120027506; Tantishaiyakul V, 1999, INT J PHARM, V181, P143, DOI 10.1016/S0378-5173(99)00070-8; Thakral S, 2013, EXPERT OPIN DRUG DEL, V10, P131, DOI 10.1517/17425247.2013.736962; Van Eerdenbrugh B, 2010, MOL PHARMACEUT, V7, P1328, DOI 10.1021/mp1001153; Wang WL, 2015, ENERGY, V87, P678, DOI 10.1016/j.energy.2015.05.036; Watson D.G., 2005, PHARM ANAL; Winter C. A., 1965, NONSTEROIDAL ANTIINF, P190; Xiqiang Z, 2014, J ANAL APPL PYROL, V107, P59; YOSHIOKA M, 1995, J PHARM SCI, V84, P983, DOI 10.1002/jps.2600840814	49	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0182011	10.1371/journal.pone.0182011	http://dx.doi.org/10.1371/journal.pone.0182011			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759638	Green Published, Green Submitted, gold			2022-12-26	WOS:000406761600043
J	Jastrebski, SF; Lamont, SJ; Schmidt, CJ				Jastrebski, Sara F.; Lamont, Susan J.; Schmidt, Carl J.			Chicken hepatic response to chronic heat stress using integrated transcriptome and metabolome analysis	PLOS ONE			English	Article							GLUTATHIONE SYNTHESIS; IDENTIFICATION; GLYCOSYLATION; HOMEOSTASIS; BLOOD	The liver plays a central role in metabolism and is important in maintaining homeostasis throughout the body. This study integrated transcriptomic and metabolomic data to understand how the liver responds under chronic heat stress. Chickens from a rapidly growing broiler line were heat stressed for 8 hours per day for one week and liver samples were collected at 28 days post hatch. Transcriptome analysis reveals changes in genes responsible for cell cycle regulation, DNA replication, and DNA repair along with immune function. Integrating the metabolome and transcriptome data highlighted multiple pathways affected by heat stress including glucose, amino acid, and lipid metabolism along with glutathione production and beta-oxidation.	[Jastrebski, Sara F.; Schmidt, Carl J.] Univ Delaware, Dept Anim & Food Sci, Newark, DE 19716 USA; [Lamont, Susan J.] Iowa State Univ, Dept Anim Sci, Ames, IA USA	University of Delaware; Iowa State University	Jastrebski, SF (corresponding author), Univ Delaware, Dept Anim & Food Sci, Newark, DE 19716 USA.	sjas@udel.edu		Schmidt, Carl/0000-0002-8386-4781	Agriculture and Food Research Initiative Competitive Grant from the United States Department of Agriculture National Institute of Food and Agriculture [2011-67003-30228]	Agriculture and Food Research Initiative Competitive Grant from the United States Department of Agriculture National Institute of Food and Agriculture	This project was supported by Agriculture and Food Research Initiative Competitive Grant 2011-67003-30228 from the United States Department of Agriculture National Institute of Food and Agriculture. CJS and SJL received funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruce A., 2002, MOL BIOL CELL, V4th ed.; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; CHUNG TK, 1990, J NUTR, V120, P158, DOI 10.1093/jn/120.2.158; Coble DJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1084; Council NR, 1994, NUTR REQ POULTR, V9; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Gu XH, 2012, POULTRY SCI, V91, P790, DOI 10.3382/ps.2011-01628; HENLE KJ, 1993, EXP CELL RES, V207, P245, DOI 10.1006/excr.1993.1190; Horvath TL, 2006, INT J OBESITY, V30, pS30, DOI 10.1038/sj.ijo.0803275; Ippolito Danielle L., 2014, BMC Physiology, V14, P14, DOI 10.1186/s12899-014-0014-0; JETHMALANI SM, 1994, J BIOL CHEM, V269, P23603; Juhnke H, 1996, MOL GEN GENET, V252, P456, DOI 10.1007/BF02173011; Kuhl NM, 2000, CELL MOL LIFE SCI, V57, P450, DOI 10.1007/PL00000707; Lara Lucas J, 2013, Animals (Basel), V3, P356, DOI 10.3390/ani3020356; LAUTERBURG BH, 1984, HEPATOLOGY, V4, P586, DOI 10.1002/hep.1840040402; Hai L, 2006, COMP BIOCHEM PHYS A, V144, P11, DOI 10.1016/j.cbpa.2006.01.032; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Lyons J, 2000, P NATL ACAD SCI USA, V97, P5071, DOI 10.1073/pnas.090083297; Mahmoud KZ, 2003, COMP BIOCHEM PHYS B, V136, P921, DOI 10.1016/S1096-4959(03)00288-4; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; Sun L, UNPUB; Sun L, 2015, CELL STRESS CHAPERON, V20, P939, DOI 10.1007/s12192-015-0621-0; Tamaru T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024521; Velichko AK, 2015, NUCLEIC ACIDS RES, V43, P6309, DOI 10.1093/nar/gkv573; Voet D., 1995, BIOCHEMISTRY; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Zhang XF, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0591-3; Zhang ZY, 2012, POULTRY SCI, V91, P2931, DOI 10.3382/ps.2012-02255	31	70	74	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0181900	10.1371/journal.pone.0181900	http://dx.doi.org/10.1371/journal.pone.0181900			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759571	Green Submitted, gold, Green Published			2022-12-26	WOS:000406761600037
J	Rezaee, F; Harford, TJ; Linfield, DT; Altawallbeh, G; Midura, RJ; Ivanov, AI; Piedimonte, G				Rezaee, Fariba; Harford, Terri J.; Linfield, Debra T.; Altawallbeh, Ghaith; Midura, Ronald J.; Ivanov, Andrei I.; Piedimonte, Giovanni			cAMP-dependent activation of protein kinase A attenuates respiratory syncytial virus-induced human airway epithelial barrier disruption	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; TIGHT JUNCTION; DISEASE SEVERITY; ASTHMA ATTACKS; INFECTION; INFLAMMATION; REPLICATION; CELLS; EPAC; RNA	Airway epithelium forms a barrier to the outside world and has a crucial role in susceptibility to viral infections. Cyclic adenosine monophosphate (cAMP) is an important second messenger acting via two intracellular signaling molecules: protein kinase A (PKA) and the guanidine nucleotide exchange factor, Epac. We sought to investigate effects of increased cAMP level on the disruption of model airway epithelial barrier caused by RSV infection and the molecular mechanisms underlying cAMP actions. Human bronchial epithelial cells were infected with RSV-A2 and treated with either cAMP releasing agent, forskolin, or cAMP analogs. Structure and functions of the Apical Junctional Complex (AJC) were evaluated by measuring transepithelial electrical resistance and permeability to FITC-dextran, and determining localization of AJC proteins by confocal microscopy. Increased intracellular cAMP level significantly attenuated RSV-induced disassembly of AJC. These barrier-protective effects of cAMP were due to the activation of PKA signaling and did not involve Epac activity. Increased cAMP level reduced RSV-induced reorganization of the actin cytoskeleton, including apical accumulation of an essential actin-binding protein, cortactin, and inhibited expression of the RSV F protein. These barrier-protective and antiviral-function of cAMP signaling were evident even when cAMP level was increased after the onset of RSV infection. Taken together, our study demonstrates that cAMP/PKA signaling attenuated RSV-induced disruption of structure and functions of the model airway epithelial barrier by mechanisms involving the stabilization of epithelial junctions and inhibition of viral biogenesis. Improving our understanding of the mechanisms involved in RSV-induced epithelial dysfunction and viral pathogenesis will help to develop novel anti-viral therapeutic approaches.	[Rezaee, Fariba; Harford, Terri J.; Linfield, Debra T.; Altawallbeh, Ghaith; Piedimonte, Giovanni] Cleveland Clin Childrens, Pediat Res Ctr, Cleveland, OH 44104 USA; [Rezaee, Fariba; Harford, Terri J.; Linfield, Debra T.; Altawallbeh, Ghaith; Piedimonte, Giovanni] Cleveland Clin Childrens, Pediat Inst, Cleveland, OH 44104 USA; [Rezaee, Fariba; Harford, Terri J.; Linfield, Debra T.; Altawallbeh, Ghaith; Piedimonte, Giovanni] Lerner Res Inst, Pathobiol Dept, Cleveland, OH 44195 USA; [Midura, Ronald J.] Lerner Res Inst, Biomed Engn Dept, Cleveland, OH USA; [Ivanov, Andrei I.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Virginia Inst Mol Med, Richmond, VA USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Virginia Commonwealth University	Rezaee, F (corresponding author), Cleveland Clin Childrens, Pediat Res Ctr, Cleveland, OH 44104 USA.; Rezaee, F (corresponding author), Cleveland Clin Childrens, Pediat Inst, Cleveland, OH 44104 USA.; Rezaee, F (corresponding author), Lerner Res Inst, Pathobiol Dept, Cleveland, OH 44195 USA.	rezaeef@ccf.org	Rezaee, Fariba/AAI-1437-2021; Ivanov, Andrei/V-1672-2019	Rezaee, Fariba/0000-0002-7625-3341; Harford, Terri/0000-0001-6590-0673	NIH [K12HD068373, K08 AI112781]; NIH-NIDDK [R01DK108278]; NIH-NHLBI [RO1HL061007]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD068373, T32HD057821] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI112781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK108278] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH K12HD068373 (F.R.), NIH K08 AI112781 (F.R.), NIH-NIDDK R01DK108278 (A.I.I.), and NIH-NHLBI RO1HL061007 (G.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeffner F, 2011, AM J PHYSIOL-LUNG C, V301, pL99, DOI 10.1152/ajplung.00398.2010; Baranwal S, 2012, MOL BIOL CELL, V23, P3542, DOI 10.1091/mbc.E12-02-0162; Bauer G, 2009, ARCH ARGENT PEDIATR, V107, P111, DOI 10.1590/S0325-00752009000200004; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Becker S, 1997, AM J PHYSIOL-LUNG C, V272, pL512, DOI 10.1152/ajplung.1997.272.3.L512; BEUSHAUSEN S, 1987, J VIROL, V61, P3795, DOI 10.1128/JVI.61.12.3795-3803.1987; BIRON KK, 1973, VIROLOGY, V56, P383, DOI 10.1016/0042-6822(73)90317-6; Bochkov YA, 2015, P NATL ACAD SCI USA, V112, P5485, DOI 10.1073/pnas.1421178112; Bonnelykke K, 2014, NAT GENET, V46, P51, DOI 10.1038/ng.2830; Bougneres L, 2004, J CELL BIOL, V166, P225, DOI 10.1083/jcb.200402073; Buckingham SC, 2000, PEDIATR INFECT DIS J, V19, P113, DOI 10.1097/00006454-200002000-00006; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Cheng XD, 2008, ACTA BIOCH BIOPH SIN, V40, P651, DOI 10.1111/j.1745-7270.2008.00438.x; Chiba H, 2008, BBA-BIOMEMBRANES, V1778, P588, DOI 10.1016/j.bbamem.2007.08.017; Choudhary S, 2005, J VIROL, V79, P8948, DOI 10.1128/JVI.79.14.8948-8959.2005; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DeVincenzo JP, 2010, AM J RESP CRIT CARE, V182, P1305, DOI 10.1164/rccm.201002-0221OC; Di Pasquale G, 2003, EMBO J, V22, P1716, DOI 10.1093/emboj/cdg153; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Georas SN, 2014, J ALLERGY CLIN IMMUN, V134, P509, DOI 10.1016/j.jaci.2014.05.049; Gerlo S, 2011, CELL MOL LIFE SCI, V68, P3823, DOI 10.1007/s00018-011-0757-8; Gonzalez-Sanchez R, 2006, J INT MED RES, V34, P200, DOI 10.1177/147323000603400210; Groskreutz DJ, 2006, J IMMUNOL, V176, P1733, DOI 10.4049/jimmunol.176.3.1733; Hallak LK, 2000, J VIROL, V74, P10508, DOI 10.1128/JVI.74.22.10508-10513.2000; Hayes MM, 2002, CELL IMMUNOL, V215, P61, DOI 10.1016/S0008-8749(02)00017-5; Huerta M, 2010, J INT MED RES, V38, P661, DOI 10.1177/147323001003800229; Clemente MI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085230; Itzhaki I, 2012, J AM COLL CARDIOL, V60, P990, DOI 10.1016/j.jacc.2012.02.066; Ivanov AI, 2013, INT REV CEL MOL BIO, V303, P27, DOI 10.1016/B978-0-12-407697-6.00002-7; Ivanov AI, 2010, AM J PATHOL, V177, P512, DOI 10.2353/ajpath.2010.100168; Jagtap Madhavi, 2011, Ayu, V32, P59, DOI 10.4103/0974-8520.85729; Juven T, 2000, PEDIATR INFECT DIS J, V19, P293, DOI 10.1097/00006454-200004000-00006; Kato A, 2007, CURR OPIN IMMUNOL, V19, P711, DOI 10.1016/j.coi.2007.08.004; King KA, 2001, AM J RESP CELL MOL, V24, P101, DOI 10.1165/ajrcmb.24.2.4264; Koppelman GH, 2009, AM J RESP CRIT CARE, V180, P929, DOI 10.1164/rccm.200810-1621OC; Kugelmann D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126213; Lawrence DW, 2002, AM J PHYSIOL-CELL PH, V282, pC1235, DOI 10.1152/ajpcell.00288.2001; Li Z, 2016, J MOL NEUROSCI, V58, P153, DOI 10.1007/s12031-015-0649-8; Do LAH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160606; Martinez I, 2002, J GEN VIROL, V83, P1445, DOI [10.1099/0022-1317-83-6-1445, 10.1099/vir.0.18337-0]; Masaki T, 2011, MOL BIOL CELL, V22, P2144, DOI 10.1091/mbc.E10-11-0875; Masuyama K, 2003, J ALLERGY CLIN IMMUN, V112, P208, DOI 10.1067/mai.2003.1526; McCullers JA, 2003, J INFECT DIS, V187, P1000, DOI 10.1086/368163; Naqvi S, 2014, BIOCHEM J, V458, P469, DOI 10.1042/BJ20131115; Nascimento-Carvalho CM, 2008, PEDIATR INFECT DIS J, V27, P939, DOI 10.1097/INF.0b013e3181723751; Netherton SJ, 2007, CIRC RES, V101, P768, DOI 10.1161/CIRCRESAHA.106.146159; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Overgaard CE, 2011, ANTIOXID REDOX SIGN, V15, P1179, DOI 10.1089/ars.2011.3893; Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT; Piedimonte G, 2004, PEDIATR RES, V55, P657, DOI 10.1203/01.PDR.0000112244.72924.26; Piedimonte G, 2003, PEDIATR INFECT DIS J, V22, pS66, DOI 10.1097/00006454-200302001-00010; Raymond DR, 2007, CELL SIGNAL, V19, P2507, DOI 10.1016/j.cellsig.2007.08.005; Rezaee F, 2013, J VIROLOGY; Rezaee F, 2014, AM J RESP CELL MOL, V50, P857, DOI 10.1165/rcmb.2013-0541RT; Rezaee F, 2011, J ALLERGY CLIN IMMUN, V128, P1216, DOI 10.1016/j.jaci.2011.08.035; Rezaee F, 2011, AM J RESP CELL MOL, V45, P277, DOI 10.1165/rcmb.2010-0121OC; Rios-Silva M, 2014, INT J MED SCI, V11, P448, DOI 10.7150/ijms.8034; Rodrigues SF, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.978720; Saatian B, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24333; Sajjan U, 2008, AM J RESP CRIT CARE, V178, P1271, DOI 10.1164/rccm.200801-136OC; Schlegel N, 2009, AM J PHYSIOL-CELL PH, V296, pC453, DOI 10.1152/ajpcell.00360.2008; Schleimer RP, 2007, J ALLERGY CLIN IMMUN, V120, P1279, DOI 10.1016/j.jaci.2007.08.046; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Shivanna M, 2010, MOL VIS, V16, P1781; Skjerven HO, 2016, J INFECT DIS, V213, P915, DOI 10.1093/infdis/jiv513; Smalley-Freed WG, 2010, J CLIN INVEST, V120, P1824, DOI 10.1172/JCI41414; Soong G, 2011, J BIOL CHEM, V286, P35891, DOI 10.1074/jbc.M111.295386; Stahl-Hennig C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000373; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; Stensballe LG, 2009, J ALLERGY CLIN IMMUN, V123, P131, DOI 10.1016/j.jaci.2008.10.042; Surapisitchat J, 2011, HANDB EXP PHARMACOL, V204, P193, DOI 10.1007/978-3-642-17969-3_8; Takahashi N, 2002, EUR J BIOCHEM, V269, P4559, DOI 10.1046/j.1432-1033.2002.03157.x; Tao XR, 2014, J VIROL, V88, P3902, DOI 10.1128/JVI.03001-13; Thomsen SF, 2009, AM J RESP CRIT CARE, V179, P1091, DOI 10.1164/rccm.200809-1471OC; Torres JP, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-125; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Villenave R, 2012, P NATL ACAD SCI USA, V109, P5040, DOI 10.1073/pnas.1110203109; Wan H, 2000, EUR RESPIR J, V15, P1058, DOI 10.1034/j.1399-3003.2000.01514.x; Wang DS, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15017453; Waschke J, 2006, HISTOCHEM CELL BIOL, V125, P397, DOI 10.1007/s00418-005-0080-2; Watsky MA, 1996, INVEST OPHTH VIS SCI, V37, P1924; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Yan XL, 2016, J MED VIROLOGY; Zhang YH, 2001, J VIROL, V75, P9044, DOI 10.1128/JVI.75.19.9044-9058.2001; Zimmerman NP, 2012, INFLAMM BOWEL DIS, V18, P1081, DOI 10.1002/ibd.21898	87	17	17	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0181876	10.1371/journal.pone.0181876	http://dx.doi.org/10.1371/journal.pone.0181876			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759570	gold, Green Published, Green Submitted			2022-12-26	WOS:000406761600034
J	Wang, WX; Shao, Y; Hou, HB; Zhou, M				Wang, Weixing; Shao, Yan; Hou, Haobo; Zhou, Min			Synthesis and thermodynamic properties of arsenate and sulfate-arsenate ettringite structure phases	PLOS ONE			English	Article							CENTER-DOT 26H(2)O; SPECTROSCOPIC CHARACTERIZATION; PORTLAND-CEMENT; WATER; SOLUBILITY	Arsenic is a toxic and carcinogenic contaminant of potential concern. Ettringite [Ca6Al2(-SO4)(3)(OH)(12)center dot 26H(2)O] has the ability to incorporate oxyanions as a solid solution with SO42-, which could lower the soluble oxyanion concentrations. Therefore, ettringite containing SO42- and AsO43- has been synthesized. Results indicated that AsO43- could substitute for SO42- inside the channels of ettringite in the form of HAsO42-, and a linear correlation existed between X-initial solution and X-solid. The thermodynamic characterization of the solid samples was investigated by means of Visual MINTEQ, a freeware chemical equilibrium model, and the solubility product logK of -48.4 +/- 0.4 was calculated for HAsO4-ettringite at 25 degrees C. The Lippmann phase diagram and X-HAsO4-X-HAsO4,X-aq plot showed that the solid solution series containing arsenate has HAsO4-poor aqueous solutions in equilibrium. These findings can be helpful to arsenate solidification and arsenate leaching modeling projects.	[Wang, Weixing; Shao, Yan; Hou, Haobo; Zhou, Min] Wuhan Univ, Sch Resource & Environm Sci, Wuhan, Hubei, Peoples R China; [Wang, Weixing; Hou, Haobo; Zhou, Min] Hubei Environm Remediat Mat Engn Technol Res Ctr, Wuhan, Hubei, Peoples R China; [Shao, Yan] China City Environm Protect Engn Ltd Co, Wuhan, Hubei, Peoples R China	Wuhan University	Hou, HB; Zhou, M (corresponding author), Wuhan Univ, Sch Resource & Environm Sci, Wuhan, Hubei, Peoples R China.; Hou, HB; Zhou, M (corresponding author), Hubei Environm Remediat Mat Engn Technol Res Ctr, Wuhan, Hubei, Peoples R China.	houhb@whu.edu.cn; zhoumin@whu.edu.cn			Science and Technology Department of Hubei Province [2016ACA162]	Science and Technology Department of Hubei Province	This work was funded by Science and Technology Department of Hubei Province (URL: http://www.hbstd.gov.cn/), grant number: 2016ACA162. Two authors, MZ and HH, received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bothe JV, J HAZARDOUS MAT; Choi WH, 2012, J HAZARD MATER, V227, P402, DOI 10.1016/j.jhazmat.2012.05.082; Cornelis G, 2006, WASCON2006 SCI ENG R; Frost RL, 2013, VIB SPECTROSC, V68, P266, DOI 10.1016/j.vibspec.2013.08.011; Garry MR, 2015, REGUL TOXICOL PHARM, V73, P378, DOI 10.1016/j.yrtph.2015.07.023; GLYNN PD, 1991, COMPUT GEOSCI, V17, P907, DOI 10.1016/0098-3004(91)90090-Z; GLYNN PD, 1990, AM J SCI, V290, P164, DOI 10.2475/ajs.290.2.164; HASSETT DJ, 1990, MATER RES BULL, V25, P1347, DOI 10.1016/0025-5408(90)90216-O; Henke K., 2009, ARSENIC ENV CHEM HLT, DOI DOI 10.1002/9780470741122.CH3; Iwaida T., 2001, J NUCL FUEL CYCLE EN, V7, P57; KTH Department of Sustainable Development Environmental Science and Engine, 2010, VIS MINTEQ VER 3 0 0; KTH Department of Sustainable Development Environmental Science and Engine, MINTEQAE DAT BAS AQ; Kumarathasan P., 1990, RES SOC S P, V178, P83; Leisinger SM, ENV SCI TECHNOLOGY; Lothenbach B, 2008, CEMENT CONCRETE RES, V38, P1, DOI 10.1016/j.cemconres.2007.08.017; Mollah MYA, 1998, SCI TOTAL ENVIRON, V224, P57, DOI 10.1016/S0048-9697(98)00318-0; Moon DH, 2009, J HAZARD MATER, V168, P944, DOI 10.1016/j.jhazmat.2009.02.125; Moon DH, 2004, SCI TOTAL ENVIRON, V330, P171, DOI 10.1016/j.scitotenv.2004.03.016; Myneni SCB, 1997, ENVIRON SCI TECHNOL, V31, P1761, DOI 10.1021/es9607594; Myneni SCB, 1998, GEOCHIM COSMOCHIM AC, V62, P3285, DOI 10.1016/S0016-7037(98)00222-1; Nordstrom D.K., 1996, ENV CHEM ALUMINUM, P29; NORDSTROM DK, 1990, ACS SYM SER, V416, P398; Ochs M, 2002, RADIOCHIM ACTA, V90, P639, DOI 10.1524/ract.2002.90.9-11_2002.639; OECD Nuclear Energy Agency, 2007, CHEM THERM CHEM THER; Perkins RB, 1999, GEOCHIM COSMOCHIM AC, V63, P1969, DOI 10.1016/S0016-7037(99)00078-2; Perkins RB, 2000, APPL GEOCHEM, V15, P1203, DOI 10.1016/S0883-2927(99)00109-2; Poellmann H, CEMENT CONCRETE RES, V199, P422; Prasanna SV, 2009, J COLLOID INTERF SCI, V331, P439, DOI 10.1016/j.jcis.2008.11.054; Prieto M, 2000, AQUAT GEOCHEM, V6, P133, DOI 10.1023/A:1009642619137; REDLICH O, 1948, IND ENG CHEM, V40, P345, DOI 10.1021/ie50458a036; Reig FB, 2002, TALANTA, V58, P811, DOI 10.1016/S0039-9140(02)00372-7; Rudnai T, 2014, INT J HYG ENVIR HEAL, V217, P813, DOI 10.1016/j.ijheh.2014.05.002; Scholtzova E, 2015, J MOL STRUCT, V1100, P215, DOI 10.1016/j.molstruc.2015.06.075; Shock EL, 1997, GEOCHIM COSMOCHIM AC, V61, P907, DOI 10.1016/S0016-7037(96)00339-0; Siebert H., 1966, ANWENDUNGEN SCHWINGU, DOI [10.1007/978-3-642-85629-7, DOI 10.1007/978-3-642-85629-7]; Suksomrana W, 2017, NARESUAN U J SCI TEC, V25, P57; Zhang M, 2003, ENVIRON SCI TECHNOL, V37, P2947, DOI 10.1021/es020969i	37	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0182160	10.1371/journal.pone.0182160	http://dx.doi.org/10.1371/journal.pone.0182160			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759655	Green Submitted, gold, Green Published			2022-12-26	WOS:000406761600057
J	Schwanekamp, JA; Lorts, A; Sargent, MA; York, AJ; Grimes, KM; Fischesser, DM; Gokey, JJ; Whitsett, JA; Conway, SJ; Molkentin, JD				Schwanekamp, Jennifer A.; Lorts, Angela; Sargent, Michelle A.; York, Allen J.; Grimes, Kelly M.; Fischesser, Demetria M.; Gokey, Jason J.; Whitsett, Jeffrey A.; Conway, Simon J.; Molkentin, Jeffery D.			TGFBI functions similar to periostin but is uniquely dispensable during cardiac injury	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; EXPRESSION; PROTEIN; FIBROSIS; GROWTH; CANCER; MICE; FIBRILLOGENESIS; FIBROBLASTS; DYSTROPHY	Extracellular matrix production and accumulation stabilize the heart under normal conditions as well as form a protective scar after myocardial infarction injury, although excessive extracellular matrix accumulation with long-standing heart disease is pathological. In the current study we investigate the role of the matricellular protein, transforming growth factor betainduced (TGFBI), which is induced in various forms of heart disease. Additionally, we sought to understand whether TGFBI is functionally redundant to its closely related family member periostin, which is also induced in the diseased heart. Surgical models of myocardial infarction and cardiac pressure overload were used in mice with genetic loss of Postn and/or Tgfbi to examine the roles of these genes during the fibrotic response. Additionally, cardiac-specific TGFBI transgenic mice were generated and analyzed. We observed that deletion of Tgfbi did not alter cardiac disease after myocardial infarction in contrast to greater ventricular wall rupture in Postn gene-deleted mice. Moreover, Tgfbi and Postn double gene-deleted mice showed a similar post-myocardial infarction disease phenotype as Postn-deleted mice. Over-expression of TGFBI in the hearts of mice had a similar effect as previously shown in mice with periostin over-expression. Thus, TGFBI and periostin act similarly in the heart in affecting fibrosis and disease responsiveness, although TGFBI is not seemingly necessary in the heart after myocardial infarction injury and is fully compensated by the more prominently expressed effector periostin.	[Schwanekamp, Jennifer A.; Lorts, Angela; Sargent, Michelle A.; York, Allen J.; Grimes, Kelly M.; Fischesser, Demetria M.; Gokey, Jason J.; Whitsett, Jeffrey A.; Molkentin, Jeffery D.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45220 USA; [Conway, Simon J.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Molkentin, Jeffery D.] Cincinnati Childrens Hosp Med Ctr, Howard Hughes Med Inst, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Indiana University System; Indiana University Bloomington; Cincinnati Children's Hospital Medical Center; Howard Hughes Medical Institute	Molkentin, JD (corresponding author), Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45220 USA.; Molkentin, JD (corresponding author), Cincinnati Childrens Hosp Med Ctr, Howard Hughes Med Inst, Cincinnati, OH 45229 USA.	Jeff.Molkentin@cchmc.org	Gokey, Jason/AAB-1739-2019	Gokey, Jason/0000-0001-8244-7831; Molkentin, Jeffery/0000-0002-3558-6529; Schwanekamp, Jennifer/0000-0002-0329-5786	NIH [R01HL105924, R01HL69779, R01HL115619]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105924, T32HL007752, T32HL125204] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NIH grants to JDM include: R01HL105924 and R01HL69779. NIH grants to SJC include: R01HL115619.	Ahlfeld SK, 2016, AM J PATHOL, V186, P777, DOI 10.1016/j.ajpath.2015.11.024; Ahmed AA, 2007, CANCER CELL, V12, P514, DOI 10.1016/j.ccr.2007.11.014; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Bozyk PD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031336; Calaf GM, 2008, INT J MOL MED, V21, P561; Conway SJ, 2014, CELL MOL LIFE SCI, V71, P1279, DOI 10.1007/s00018-013-1494-y; Correll RN, 2015, J MOL CELL CARDIOL, V87, P38, DOI 10.1016/j.yjmcc.2015.07.032; Fan D, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-15; Guan J, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0084-3; Han KE, 2016, PROG RETIN EYE RES, V50, P67, DOI 10.1016/j.preteyeres.2015.11.002; Hoersch S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-30; Holmberg C, 2012, CARCINOGENESIS, V33, P1553, DOI 10.1093/carcin/bgs180; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Kanisicak O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12260; Kannabiran C, 2006, HUM MUTAT, V27, P615, DOI 10.1002/humu.20334; Kaur H, 2016, CIRC RES, V118, P1906, DOI 10.1161/CIRCRESAHA.116.308643; Kii I, 2010, J BIOL CHEM, V285, P2028, DOI 10.1074/jbc.M109.051961; Kim BY, 2009, J BIOL CHEM, V284, P19580, DOI 10.1074/jbc.M109.013607; Kudo A, 2011, CELL MOL LIFE SCI, V68, P3201, DOI 10.1007/s00018-011-0784-5; Lawson WE, 2005, AM J PATHOL, V167, P1267, DOI 10.1016/S0002-9440(10)61214-X; Lee JH, 2011, CIRC RES, V109, P1332, DOI 10.1161/CIRCRESAHA.111.249433; Limjunyawong N, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.249; Litvin J, 2005, ANAT REC PART A, V287A, P1205, DOI 10.1002/ar.a.20237; Liu AY, 2014, MATRIX BIOL, V37, P150, DOI 10.1016/j.matbio.2014.04.007; Lorts A, 2012, P NATL ACAD SCI USA, V109, P10978, DOI 10.1073/pnas.1204708109; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Morra L, 2011, VIRCHOWS ARCH, V459, P465, DOI 10.1007/s00428-011-1151-5; Mosher DF, 2015, CRIT REV BIOCHEM MOL, V50, P427, DOI 10.3109/10409238.2015.1069791; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Pajares MJ, 2014, BRIT J CANCER, V110, P1545, DOI 10.1038/bjc.2014.33; Pinto AR, 2016, CIRC RES, V118, P400, DOI 10.1161/CIRCRESAHA.115.307778; Sanbe A, 2003, CIRC RES, V92, P609, DOI 10.1161/01.RES.0000065442.64694.9F; Schwanekamp JA, 2016, ARTERIOSCL THROM VAS, V36, P60, DOI 10.1161/ATVBAHA.115.306397; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; SKONIER J, 1992, DNA CELL BIOL, V11, P511, DOI 10.1089/dna.1992.11.511; Takayama G, 2006, J ALLERGY CLIN IMMUN, V118, P98, DOI 10.1016/j.jaci.2006.02.046; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; Thapa N, 2007, INT J BIOCHEM CELL B, V39, P2183, DOI 10.1016/j.biocel.2007.06.004; van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Xie M, 2013, CIRCULATION, V128, P1021, DOI 10.1161/CIRCULATIONAHA.113.001879; Zhao S, 2014, J CARDIOL, V63, P373, DOI 10.1016/j.jjcc.2013.09.013; Zhu J, 2015, INT J CLIN EXP PATHO, V8, P702	44	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181945	10.1371/journal.pone.0181945	http://dx.doi.org/10.1371/journal.pone.0181945			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750100	Green Submitted, gold, Green Published			2022-12-26	WOS:000406575700105
J	Van Leuvenhaege, C; Vandelannoote, K; Affolabi, D; Portaels, F; Sopoh, G; de Jong, BC; Eddyani, M; Meehan, CJ				Van Leuvenhaege, Chloe; Vandelannoote, Koen; Affolabi, Dissou; Portaels, Francoise; Sopoh, Ghislain; de Jong, Bouke C.; Eddyani, Miriam; Meehan, Conor J.			Bacterial diversity in Buruli ulcer skin lesions: Challenges in the clinical microbiome analysis of a skin disease	PLOS ONE			English	Article							MYCOBACTERIUM-ULCERANS; EPIDEMIOLOGY; INFECTIONS; IDENTIFICATION	Background Buruli ulcer (BU) is an infectious disease caused by Mycobacterium ulcerans and considered the third most prevalent mycobacterial disease in humans. Secondary bacterial infections in open BU lesions are the main cause of pain, delayed healing and systemic illness, resulting in prolonged hospital stay. Thus, understanding the diversity of bacteria, termed the microbiome, in these open lesions is important for proper treatment. However, adequately studying the human microbiome in a clinical setting can prove difficult when investigating a neglected tropical skin disease due to its rarity and the setting. Methodology/Principal findings Using 16S rRNA sequencing, we determined the microbial composition of 5 BU lesions, 3 non-BU lesions and 3 healthy skin samples. Although no significant differences in diversity were found between BU and non-BU lesions, the former were characterized by an increase of Bacteroidetes compared to the non-BU wounds and the BU lesions also contained significantly more obligate anaerobes. With this molecular-based study, we were also able to detect bacteria that were missed by culture-based methods in previous BU studies. Conclusions/Significance Our study suggests that BU may lead to changes in the skin bacterial community within the lesions. However, in order to determine if such changes hold true across all BU cases and are either a cause or consequence of a specific wound environment, further microbiome studies are necessary. Such skin microbiome analysis requires large sample sizes and lesions from the same body site in many patients, both of which can be difficult for a rare disease. Our study proposes a pipeline for such studies and highlights several drawbacks that must be considered if microbiome analysis is to be utilized for neglected tropical diseases.	[Van Leuvenhaege, Chloe; Vandelannoote, Koen; Portaels, Francoise; de Jong, Bouke C.; Eddyani, Miriam; Meehan, Conor J.] Inst Trop Med, Dept Biomed Sci, Mycobacteriol Unit, Antwerp, Belgium; [Affolabi, Dissou] Lab Reference Mycobacteries, Cotonou, Benin; [Sopoh, Ghislain] CDTUB Allada, Inst Reg Sante Publ, Allada, Benin	Institute of Tropical Medicine (ITM)	Meehan, CJ (corresponding author), Inst Trop Med, Dept Biomed Sci, Mycobacteriol Unit, Antwerp, Belgium.	cmeehan@itg.be	Vandelannoote, Koen/AGK-5719-2022; Sopoh, Ghislain Emmanuel/AAP-2220-2021; de Jong, Bouke/A-3636-2013	Vandelannoote, Koen/0000-0001-8367-4083; de Jong, Bouke/0000-0002-1017-4675; Meehan, Conor/0000-0003-0724-8343	Medicor UBS Optim us Foundations; Department of Economy, Science and Innovation of the Flemish Government	Medicor UBS Optim us Foundations; Department of Economy, Science and Innovation of the Flemish Government	This work was supported by the Medicor UBS Optim us Foundations and the Department of Economy, Science and Innovation of the Flemish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Amissah NA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003421; Andrews S., 2010, FASTQC QUALITY CONTR; Barogui YT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002010; Bowler PG, 2001, CLIN MICROBIOL REV, V14, P244, DOI 10.1128/CMR.14.2.244-269.2001; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHAO A, 1984, SCAND J STAT, V11, P265; Cheung MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054574; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Crisp JG, 2015, CLIN INFECT DIS, V61, P1679, DOI 10.1093/cid/civ655; Davies CE, 2001, WOUND REPAIR REGEN, V9, P332, DOI 10.1046/j.1524-475x.2001.00332.x; Decuypere S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004470; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Eddyani M, 2015, WHO M BUR ULC GEN; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fahlen A, 2012, ARCH DERMATOL RES, V304, P15, DOI 10.1007/s00403-011-1189-x; Gao Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002719; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2012, ADV EXP MED BIOL, V946, P55, DOI 10.1007/978-1-4614-0106-3_4; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hospodsky D, 2014, MICROBIOL-SGM, V160, P1144, DOI 10.1099/mic.0.075390-0; Huang GKL, 2014, EXPERT REV ANTI-INFE, V12, P855, DOI 10.1586/14787210.2014.910113; Jervis-Bardy J, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0083-8; Kazadi WM, 2014, CLIN EPIDEMIOL, V6, P119, DOI 10.2147/CLEP.S44553; Kembel SW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002743; Kibadi K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000736; Kirkup BC, 2015, ADV WOUND CARE, V4, P12, DOI 10.1089/wound.2014.0560; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Langille MG, 2014, MICROBIOME, V2, DOI 10.1186/s40168-014-0050-9; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; McInnes P., 2010, MANUAL PROCEDURES HU; Merritt RW, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000911; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Mueller YK, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004593; Organisation mondiale de la Sante A, 2012, TRA INF MYC ULC ULC; Organisation WH, 2016, BUR ULC FACT SHEET; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Price LB, 2011, WOUND REPAIR REGEN, V19, P80, DOI 10.1111/j.1524-475X.2010.00628.x; Rhoads DD, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-321; Rideout JR, 2014, PEERJ, V2, DOI 10.7717/peerj.545; Rodrigues LC, 2011, LANCET INFECT DIS, V11, P464, DOI 10.1016/S1473-3099(11)70006-8; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Silva PES, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0955-1; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Stinear T, 1999, J CLIN MICROBIOL, V37, P1018, DOI 10.1128/JCM.37.4.1018-1023.1999; Tagami H., 2008, International Journal of Cosmetic Science, V30, P413, DOI 10.1111/j.1468-2494.2008.00459.x; Team RC, 2014, R LANG ENV STAT COMP; van der Werf TS, 2005, B WORLD HEALTH ORGAN, V83, P785; Walsh DS, 2011, DERMATOL CLIN, V29, P1, DOI 10.1016/j.det.2010.09.006; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Wortman J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-S1-O13; Wu JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082763, 10.1371/journal.pone.0081986, 10.1371/journal.pone.0081982]; Yeboah-Manu D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002191; Zeeuwen PLJM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r101; Zhou YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124194	62	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181994	10.1371/journal.pone.0181994	http://dx.doi.org/10.1371/journal.pone.0181994			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750103	Green Published, Green Submitted, gold			2022-12-26	WOS:000406575700110
J	Callizo, J; Feltgen, N; Ammermann, A; Ganser, J; Bemme, S; Bertelmann, T; Pfeiffer, S; Duvinage, A; Groschel, K; Hoerauf, H; Wachter, R				Callizo, Josep; Feltgen, Nicolas; Ammermann, Antje; Ganser, Janina; Bemme, Sebastian; Bertelmann, Thomas; Pfeiffer, Sebastian; Duvinage, Andre; Groeschel, Klaus; Hoerauf, Hans; Wachter, Rolf			Atrial fibrillation in retinal vascular occlusion disease and non-arteritic anterior ischemic optic neuropathy	PLOS ONE			English	Article							VEIN OCCLUSION; ARTERY-OCCLUSION; CAROTID STENOSIS; RISK-FACTOR; CRYPTOGENIC STROKE; MORTALITY; THROMBOEMBOLISM; TRANSIENT; COHORT; EYE	Background Patients with retinal vascular occlusion disease have an increased risk for ischemic stroke and share some risk factors with cerebrovascular disease. The purpose of this study was to analyze the prevalence of atrial fibrillation (AF) in subjects with retinal vascular occlusive disease and anterior ischemic optic neuropathy and to compare these data to an ischemic stroke group. Methods Prospective, observational single-center trial. Subjects with retinal artery occlusion (RAO), retinal vein occlusion (RVO) and anterior ischemic optic neuropathy (AION) were included. Patients with ischemic stroke (IS) from a previous observational trial were used as control. Investigation included 7-day Holter ECG, echocardiography, duplex ultrasonography of the carotid arteries, and 24-hour blood pressure monitoring. Further vascular risk factors were documented. Results During the 1-year study period, 101 patients were recruited. The control group with ischemic stroke consisted of 272 subjects. At inclusion, the prevalence of AF was 12% (RAO), 10.2% (RVO), 11.1% (NAION) and 15.8% (IS). The final prevalence after Holter ECG rose to 16% (RAO), 18.4% (RVO), 14.8% (NAION) and 26.5% (IS). No significant difference was measured between groups. Conclusions We detected a similar prevalence of AF in all groups. RVO patients tended to exhibit a higher AF detection rate and lower number needed to screen than RAO and NAION. The detection of AF rose considerably via Holter ECG. As a consequence, we recommend prolonged ECG monitoring in patients with acute ophthalmic vascular diseases.	[Callizo, Josep; Feltgen, Nicolas; Ammermann, Antje; Ganser, Janina; Bemme, Sebastian; Bertelmann, Thomas; Hoerauf, Hans] Univ Gottingen, Clin Ophthalmol, Gottingen, Germany; [Pfeiffer, Sebastian] Georg August Univ, Inst Clin Res GmbH, Gottingen, Germany; [Duvinage, Andre] Tech Univ Munich, Clin Prevent Rehabil & Sports Med, Munich, Germany; [Groeschel, Klaus] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Neurol, Mainz, Germany; [Wachter, Rolf] Univ Gottingen, Clin Cardiol & Pneumol, Gottingen, Germany	University of Gottingen; University of Gottingen; Technical University of Munich; Johannes Gutenberg University of Mainz; University of Gottingen	Callizo, J (corresponding author), Univ Gottingen, Clin Ophthalmol, Gottingen, Germany.	josep.callizo@med.uni-goettingen.de	Gröschel, Klaus/ABC-4777-2021; Wachter, Rolf/AAA-4037-2020	Gröschel, Klaus/0000-0002-0244-6116; Wachter, Rolf/0000-0003-2231-2200				Anderson DC, 2002, STROKE, V33, P1963, DOI 10.1161/01.STR.0000023445.20454.A8; Bertelsen M, 2014, OPHTHALMOLOGY, V121, P637, DOI 10.1016/j.ophtha.2013.07.025; Biousse V, 2015, NEW ENGL J MED, V372, P2428, DOI 10.1056/NEJMra1413352; Cairns JA, 2011, CAN J CARDIOL, V27, P74, DOI 10.1016/j.cjca.2010.11.007; Callizo J, 2015, OPHTHALMOLOGY; Cestari DM, 2016, OPHTHALMOLOGY, V123, P2446, DOI 10.1016/j.ophtha.2016.08.017; Chang YS, 2015, BRIT J OPHTHALMOL, V99, P227, DOI 10.1136/bjophthalmol-2014-305451; Chang YS, 2012, AM J OPHTHALMOL, V154, P645, DOI 10.1016/j.ajo.2012.03.046; Christiansen CB, 2013, J THROMB HAEMOST, V11, P1485, DOI 10.1111/jth.12297; Divya KP, 2015, J STROKE CEREBROVASC, V24, P2149, DOI 10.1016/j.jstrokecerebrovasdis.2015.05.030; Dussault C, 2015, CIRC-ARRHYTHMIA ELEC, V8, P263, DOI 10.1161/CIRCEP.114.002521; Ehlers JP, 2011, SURV OPHTHALMOL, V56, P281, DOI 10.1016/j.survophthal.2010.11.006; Gladstone DJ, 2014, NEW ENGL J MED, V370, P2467, DOI 10.1056/NEJMoa1311376; Grotta JC, 2013, NEW ENGL J MED, V369, P1143, DOI 10.1056/NEJMcp1214999; Hayreh SS, 2017, OPHTHALMOL RETINA, V1, P12, DOI 10.1016/j.oret.2016.08.003; Healey JS, 2012, NEW ENGL J MED, V366, P120, DOI 10.1056/NEJMoa1105575; Helenius J, 2012, ANN NEUROL, V72, P286, DOI 10.1002/ana.23597; Hohnloser SH, 2007, J AM COLL CARDIOL, V50, P2156, DOI 10.1016/j.jacc.2007.07.076; Kirwan C, 2008, IRISH J MED SCI, V177, P277, DOI 10.1007/s11845-008-0141-3; Koizumi H, 2007, AM J OPHTHALMOL, V144, P858, DOI 10.1016/j.ajo.2007.07.036; Lee J, 2014, AM J OPHTHALMOL, V157, P1231, DOI 10.1016/j.ajo.2014.01.033; Lee YC, 2016, AM J OPHTHALMOL, V170, P183, DOI 10.1016/j.ajo.2016.08.006; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Mead GE, 2002, STROKE, V33, P2383, DOI 10.1161/01.STR.0000029827.93497.97; Miyasaka Y, 2008, AM J CARDIOL, V102, P568, DOI 10.1016/j.amjcard.2008.04.025; Park SJ, 2015, NEUROLOGY, V85, P1578, DOI 10.1212/WNL.0000000000002085; Park SJ, 2015, OPHTHALMOLOGY, V122, P2336, DOI 10.1016/j.ophtha.2015.07.018; Plunkett O, 2014, BRIT J OPHTHALMOL, V98, P1141, DOI 10.1136/bjophthalmol-2013-304646; Ponto KA, 2015, J THROMB HAEMOST, V13, P1254, DOI 10.1111/jth.12982; Rim TH, 2015, OPHTHALMOLOGY, V122, P1187, DOI 10.1016/j.ophtha.2015.01.020; Sanna T, 2014, NEW ENGL J MED, V370, P2478, DOI 10.1056/NEJMoa1313600; Siantar RG, 2015, SCI REP-UK, V5, DOI 10.1038/srep16304; Stahrenberg R, 2010, STROKE, V41, P2884, DOI 10.1161/STROKEAHA.110.591958; Tsaloumas MD, 2000, EYE, V14, P821, DOI 10.1038/eye.2000.230; Wachter R, 2017, LANCET NEUROL; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Wong TY, 2001, SURV OPHTHALMOL, V46, P59, DOI 10.1016/S0039-6257(01)00234-X; Woo SCY, 2016, EYE LOND ENGL	38	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0181766	10.1371/journal.pone.0181766	http://dx.doi.org/10.1371/journal.pone.0181766			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771491	Green Published, Green Submitted, gold			2022-12-26	WOS:000406853600032
J	Niang, M; Thiam, LG; Sane, R; Diagne, N; Talla, C; Doucoure, S; Faye, J; Diop, F; Badiane, A; Diouf, B; Camara, D; Diene-Sarr, F; Sokhna, C; Richard, V; Toure-Balde, A				Niang, Makhtar; Thiam, Laty Gaye; Sane, Rokhaya; Diagne, Nafissatou; Talla, Cheikh; Doucoure, Souleymane; Faye, Joseph; Diop, Fode; Badiane, Abdoulaye; Diouf, Babacar; Camara, Diogop; Diene-Sarr, Fatoumata; Sokhna, Cheikh; Richard, Vincent; Toure-Balde, Aissatou			Substantial asymptomatic submicroscopic Plasmodium carriage during dry season in low transmission areas in Senegal: Implications for malaria control and elimination	PLOS ONE			English	Article							FALCIPARUM; INFECTIONS; PCR; DETECTABILITY; PARASITEMIA; COMMUNITY; DIELMO	Background In the progress towards malaria elimination, the accurate diagnosis of low-density asymptomatic infections is critical. Low-density asymptomatic submicroscopic malaria infections may act as silent reservoirs that maintain low-level residual malaria transmission in the community. Light microscopy, the gold standard in malaria diagnosis lacks the sensitivity to detect low-level parasitaemia. In this study, the presence and prevalence of submicroscopic Plasmodium carriage were investigated to estimate the parasites reservoir among asymptomatic individuals living in low transmission areas in Dielmo and Ndiop, Senegal during the dry season. Methods A total of 2,037 blood samples were collected during cross-sectional surveys prior the malaria transmission season in July 2013 (N = 612), June 2014 (N = 723) and June 2015 (N = 702) from asymptomatic individuals living in Dielmo and Ndiop, Senegal. Samples were used to determine the prevalence of submicroscopic Plasmodium carriage by real time PCR (qPCR) in comparison to microscopy considered as gold standard. Results The prevalence of submicroscopic Plasmodium carriage was 3.75% (23/612), 12.44% (90/723) and 6.41% (45/702) in 2013, 2014 and 2015, respectively. No Plasmodium carriage was detected by microscopy in 2013 while microscopy-based prevalence of Plasmodium carriage accounted for only 0.27% (2/723) and 0.14% (1/702) in 2014 and 2015, respectively. Plasmodium falciparum accounted for the majority of submicroscopic infections and represented 86.95% (20/23), 81.11% (73/90) and 95.55 (43/45) of infections in 2013, 2014 and 2015 respectively. Conclusion Low-density submicroscopic asymptomatic Plasmodium carriage is common in the study areas during the dry season indicating that traditional measures are insufficient to assess the scale of parasite reservoir when transmission reaches very low level. Control and elimination strategies may wish to consider using molecular methods to identify parasites carriers to guide Mass screening and Treatment strategies.	[Niang, Makhtar; Thiam, Laty Gaye; Sane, Rokhaya; Diop, Fode; Diouf, Babacar; Camara, Diogop; Toure-Balde, Aissatou] Inst Pasteur, Immunol Unit, Dakar, Senegal; [Diagne, Nafissatou; Doucoure, Souleymane; Sokhna, Cheikh] French Natl Res Inst Sustainable Dev, URMITE, URMITE UMR 198, Dakar, Senegal; [Talla, Cheikh; Faye, Joseph; Diene-Sarr, Fatoumata; Richard, Vincent] Inst Pasteur, Epidemiol Unit, Dakar, Senegal	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar	Niang, M (corresponding author), Inst Pasteur, Immunol Unit, Dakar, Senegal.	mniang@pasteur.sn	Talla, Cheikh/AAZ-5134-2020	Talla, Cheikh/0000-0003-0678-1226; Thiam, Laty Gaye/0000-0001-7086-4726; Vincent, RICHARD/0000-0002-6961-1753	Institute Pasteur de Dakar; Institute de Recherche pour le Developpement de Dakar	Institute Pasteur de Dakar; Institute de Recherche pour le Developpement de Dakar	The study was funded by Institute Pasteur de Dakar and Institute de Recherche pour le Developpement de Dakar. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrane YA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054305; Baltzell KA, 2013, AM J TROP MED HYG, V88, P289, DOI 10.4269/ajtmh.2012.12-0095; Baum E, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0611-9; Bousema T, 2014, NAT REV MICROBIOL, V12, P833, DOI 10.1038/nrmicro3364; Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10; Brenner H, 1997, STAT MED, V16, P981, DOI 10.1002/(SICI)1097-0258(19970515)16:9<981::AID-SIM510>3.0.CO;2-N; Canier L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-405; Coleman RE, 2004, J MED ENTOMOL, V41, P201, DOI 10.1603/0022-2585-41.2.201; Diallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031100; Diop F, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-83; Farrugia C, 2011, J CLIN MICROBIOL, V49, P2191, DOI 10.1128/JCM.02156-10; Fontenille D, 1997, T ROY SOC TROP MED H, V91, P647, DOI 10.1016/S0035-9203(97)90506-X; Golassa L, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1070-1; Golassa L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-352; Harris I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-254; Lin JT, 2014, TRENDS PARASITOL, V30, P183, DOI 10.1016/j.pt.2014.02.004; Lindblade KA, 2013, EXPERT REV ANTI-INFE, V11, P623, DOI [10.1586/eri.13.45, 10.1586/ERI.13.45]; Lo E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121763; Manjurano A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-370; Murphy SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097398; Murphy SC, 2012, AM J TROP MED HYG, V86, P383, DOI 10.4269/ajtmh.2012.10-0658; Niang M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0808-y; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Proietti C, 2011, AM J TROP MED HYG, V84, P830, DOI 10.4269/ajtmh.2011.10-0498; Rogier C, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P255; Roucher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046188; Sama W, 2006, PARASITOLOGY, V132, P13, DOI 10.1017/S0031182005008607; Schneider P, 2007, AM J TROP MED HYG, V76, P470, DOI 10.4269/ajtmh.2007.76.470; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Steenkeste N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-108; Stresman GH, 2014, AM J TROP MED HYG, V91, P1101, DOI 10.4269/ajtmh.14-0355; Tadesse FG, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0821-1; The malEra Consultative Group on Monitoring Surveillance and Evaluation, 2011, PLOS MED, V8; Trape JF, 2014, LANCET INFECT DIS, V14, P476, DOI 10.1016/S1473-3099(14)70712-1; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; World Health Organization, 2015, WHO WORLD MAL REP 20	37	29	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182189	10.1371/journal.pone.0182189	http://dx.doi.org/10.1371/journal.pone.0182189			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771615	gold, Green Published, Green Submitted			2022-12-26	WOS:000406853600074
J	Blagden, S; Seddon, D; Hungerford, D; Stanistreet, D				Blagden, Sarah; Seddon, Daniel; Hungerford, Daniel; Stanistreet, Debbi			Uptake of a new meningitis vaccination programme amongst first-year undergraduate students in the United Kingdom: A cross-sectional study	PLOS ONE			English	Article							HEALTH BELIEF MODEL; COLLEGE-AGE WOMEN; MENINGOCOCCAL DISEASE; INFLUENZA VACCINATION; UNIVERSITY-STUDENTS; HUMAN-PAPILLOMAVIRUS; SOCIAL DEPRIVATION; ATTITUDES; STATISTICS; INTENTIONS	Background In 2015 meningococcal group W was declared endemic in the UK, with the meningococcal ACWY vaccination(MenACWY) subsequently introduced amongst adolescents and first-year university students. This study aimed to determine MenACWY uptake amongst students and to evaluate how this was influenced by demographics and via the Health Belief Model(HBM). Methods This was a cross-sectional study conducted at a British university amongst first-year undergraduate students aged 18-25 years. Data collection was via an electronic questionnaire encompassing demographics, the HBM and vaccination status. Univariable analysis of the associations between demographics, health beliefs and vaccination was performed, followed by multiple logistic regression. Results 401 participants were included in analysis. Vaccine uptake was 68.1%. Variables independently associated with vaccination upon multiple regression were age, gap-year, perceived effectiveness of the vaccine and knowledge about risk of meningitis. Compared to 18 yearolds, the odds of vaccination were reduced for 19 year-olds(aOR = 0.087, 95% CI = 0.010-0.729), 20 year-olds(aOR = 0.019, 95% CI = 0.002-0.161) and 21-25 year-olds(aOR = 0.003, 95% CI = < 0.001-0.027). In contrast, taking a gap year(aOR = 2.939, 95% CI = 1.329-6.501), higher perceived vaccine effectiveness(aOR = 3.555, 95% CI = 1.787-7.073) and knowledge about meningitis risk(aOR = 2.481, 95% CI = 1.165-5.287) were independently associated with increased uptake. Conclusions MenACWY uptake amongst students in this study and in other sources is above the national coverage for all adolescents (35.3%), indicating that this vaccination programme may be increasing health inequalities. Older students are less likely to become vaccinated due to differing vaccination policy in this age-group. In future, strategies that focus on specific student cohorts and that highlight vaccine effectiveness and the risk of meningitis should be considered. National evaluation of this vaccination programme is recommended to clarify its impact on health inequalities.	[Blagden, Sarah; Stanistreet, Debbi] Univ Liverpool, Dept Publ Hlth & Policy, Inst Psychol Hlth & Soc, Liverpool, Merseyside, England; [Seddon, Daniel] NHS England, Regatta Pl,Brunswick Business Pk, Liverpool, Merseyside, England; [Seddon, Daniel; Hungerford, Daniel] Univ Liverpool, Ctr Global Vaccine Res, Inst Infect & Global Hlth, Liverpool, Merseyside, England; [Hungerford, Daniel] Publ Hlth England North West, Liverpool, Merseyside, England	University of Liverpool; University of Liverpool; Public Health England	Blagden, S (corresponding author), Univ Liverpool, Dept Publ Hlth & Policy, Inst Psychol Hlth & Soc, Liverpool, Merseyside, England.	s.blagden@nhs.net	Hungerford, Daniel/AAA-8805-2019	Hungerford, Daniel/0000-0002-9770-0163; Stanistreet, Debbi/0000-0003-3738-1727				Al-Khashan HI, 2011, SAUDI MED J, V32, P159; Bennett KK, 2012, J SOC PSYCHOL, V152, P480, DOI 10.1080/00224545.2011.639408; Coe AB, 2012, INOV PHARM, V3; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Department for Business, 2015, 186 BIS; Department of Health, 2015, THE GREEN BOOK; Department of Health, 2015, THE GREEN BOOK; Donadiki EM, 2014, PUBLIC HEALTH, V128, P268, DOI 10.1016/j.puhe.2013.12.004; Edmunds MR, 2001, BRIT MED J, V322, P102, DOI 10.1136/bmj.322.7278.102; Fone DL, 2003, EPIDEMIOL INFECT, V130, P53, DOI 10.1017/S095026880200794X; Goodman AL, 2014, AM J TROP MED HYG, V91, P281, DOI 10.4269/ajtmh.13-0763; Heyderman RS, 2004, ARCH DIS CHILD, V89, P1064, DOI 10.1136/adc.2003.036004; ImmForm, 2016, MEN DAT COLL; Jones IR, 1997, BRIT MED J, V314, P794, DOI 10.1136/bmj.314.7083.794; Krawczyk AL, 2012, HEALTH PSYCHOL, V31, P685, DOI 10.1037/a0027012; Levin Kate Ann, 2006, Evid Based Dent, V7, P24, DOI 10.1038/sj.ebd.6400375; Liau A, 2000, INT J STD AIDS, V11, P445, DOI 10.1258/0956462001916227; Lin WC, 1997, J ADV NURS, V25, P709, DOI 10.1046/j.1365-2648.1997.1997025709.x; Matsui D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-149; Moore PJ, 2017, INT J ADOLESC MED HL; NHS Choices, 2015, TRAV VACC; NHS England, 2016, ENH SERV SPEC MEN FR; Office for National Statistics, 2016, SOC2010, V3; Painter JE, 2011, J SCHOOL HEALTH, V81, P304, DOI 10.1111/j.1746-1561.2011.00595.x; Paneth N, 2000, J AM COLL HEALTH, V49, P7, DOI 10.1080/07448480009596276; Pielak KL, 2003, CAN J PUBLIC HEALTH, V94, P193, DOI 10.1007/BF03405065; Public Health England, 2016, VACC COV EST 1 URG C; Public Health England, 2015, MEN ACWY CONJ VACC M; Public Health England, 2015, CONT INCR MEN GROUP; Richards K, 2016, SAGE OPEN, V6, DOI 10.1177/2158244016629709; Roberts CL, 1996, AM J PUBLIC HEALTH, V86, P1155, DOI 10.2105/AJPH.86.8_Pt_1.1155; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Stuart J M, 2002, Commun Dis Public Health, V5, P327; Sundstrom B, 2015, SOC MARK Q, V21, P173, DOI 10.1177/1524500415598984; SurveyMonkey, 2016, SURVEYMONKEY FREE ON; The Deputy Prime Minister's Office, 2015, RES AN SOC MOB IND; Thirlaway K, 2003, Commun Dis Public Health, V6, P157; Tho SLN, 2015, VACCINE, V33, P3463, DOI 10.1016/j.vaccine.2015.05.073; Turner DP, 2017, PUBLIC HLTH; University and Colleges Admission Services (UCAS), 2017, MAT UND STUD; University of Liverpool Student Administration Department, 2016, PERS COMM REG STUD D; Wheldon CW, 2013, J HEALTH PSYCHOL, V18, P1177, DOI 10.1177/1359105312459875; Williams CJ, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-30; Yang ZJ, 2015, J HEALTH COMMUN, V20, P69, DOI 10.1080/10810730.2014.904023; Zhang GS, 2009, PROCEEDINGS OF 2009 INTERNATIONAL CONFERENCE OF NATURAL PRODUCT AND TRADITIONAL MEDICINE, VOLS 1 AND 2, P308	46	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0181817	10.1371/journal.pone.0181817	http://dx.doi.org/10.1371/journal.pone.0181817			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC3VT	28767667	Green Submitted, Green Published, gold			2022-12-26	WOS:000406768200035
J	Koroiva, R; Pepinelli, M; Rodrigues, ME; Roque, FD; Lorenz-Lemke, AP; Kvist, S				Koroiva, Ricardo; Pepinelli, Mateus; Rodrigues, Marciel Elio; Roque, Fabio de Oliveira; Lorenz-Lemke, Aline Pedroso; Kvist, Sebastian			DNA barcoding of odonates from the Upper Plata basin: Database creation and genetic diversity estimation	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; DIPTERA-SIMULIIDAE; CLASSIFICATION; IDENTIFICATION; CONSERVATION; DRAGONFLIES; HISTORY; LIBRARY; TAXA; LIFE	We present a DNA barcoding study of Neotropical odonates from the Upper Plata basin, Brazil. A total of 38 species were collected in a transition region of "Cerrado" and Atlantic Forest, both regarded as biological hotspots, and 130 cytochrome c oxidase subunit I (COI) barcodes were generated for the collected specimens. The distinct gap between intraspecific (0-2%) and interspecific variation (15% and above) in COI, and resulting separation of Barcode Index Numbers (BIN), allowed for successful identification of specimens in 94% of cases. The 6% fail rate was due to a shared BIN between two separate nominal species. DNA barcoding, based on COI, thus seems to be a reliable and efficient tool for identifying Neotropical odonate specimens down to the species level. These results underscore the utility of DNA barcoding to aid specimen identification in diverse biological hotspots, areas that require urgent action regarding taxonomic surveys and biodiversity conservation.	[Koroiva, Ricardo] Univ Fed Mato Grosso do Sul, Ecol & Conservat Grad Program, Campo Grande, MS, Brazil; [Koroiva, Ricardo; Roque, Fabio de Oliveira] Univ Fed Mato Grosso do Sul, Lab Ecol, Campo Grande, MS, Brazil; [Pepinelli, Mateus; Kvist, Sebastian] Royal Ontario Museum, Dept Nat Hist, Toronto, ON, Canada; [Pepinelli, Mateus; Kvist, Sebastian] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Rodrigues, Marciel Elio] Univ Estadual Santa Cruz, Lab Organismos Aquat, Ilheus, BA, Brazil; [Lorenz-Lemke, Aline Pedroso] Univ Fed Mato Grosso do Sul, Lab Evolucao & Biodiversidade, Campo Grande, MS, Brazil	Universidade Federal de Mato Grosso do Sul; Universidade Federal de Mato Grosso do Sul; Royal Ontario Museum; University of Toronto; Universidade Estadual de Santa Cruz; Universidade Federal de Mato Grosso do Sul	Koroiva, R (corresponding author), Univ Fed Mato Grosso do Sul, Ecol & Conservat Grad Program, Campo Grande, MS, Brazil.; Koroiva, R (corresponding author), Univ Fed Mato Grosso do Sul, Lab Ecol, Campo Grande, MS, Brazil.	ricardo.koroiva@gmail.com	Rodrigues, Marciel E/D-6826-2013; Lorenz, Aline Pedroso/I-1743-2012; Koroiva, Ricardo/F-5767-2015; Pepinelli, Mateus/A-4817-2013	Lorenz, Aline Pedroso/0000-0002-2810-2282; Koroiva, Ricardo/0000-0002-6658-0824; Pepinelli, Mateus/0000-0002-9815-4774; Rodrigues, Marciel/0000-0001-8161-6234; Kvist, Sebastian/0000-0003-3200-6207	Doctorate Sandwich Abroad Program (CAPES/PDSE) Scholarship [88881.134428/2016-01]; Rufford Foundation (Dragonflies of Serra da Bodoquena Project [RSGF 19689-1]; NSERC discovery grant; Doctorate Sandwich Abroad Program (CAPES/PDSE) Scholarship	Doctorate Sandwich Abroad Program (CAPES/PDSE) Scholarship; Rufford Foundation (Dragonflies of Serra da Bodoquena Project; NSERC discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Doctorate Sandwich Abroad Program (CAPES/PDSE) Scholarship	RK received CAPES/Social Demand (CAPES/DS) scholarship, Doctorate Sandwich Abroad Program (CAPES/PDSE) Scholarship (Process n. 88881.134428/2016-01) and a grant from the Rufford Foundation (Dragonflies of Serra da Bodoquena Project, RSGF 19689-1). SK was funded by a NSERC discovery grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmann T, 2013, MOL ECOL RESOUR, V13, P1069, DOI 10.1111/1755-0998.12125; Borges Pedro Paulino, 2015, Neotropical Biology and Conservation, V10, P2, DOI 10.4013/nbc.2015.101.01; Carle FL, 2015, ARTHROPOD SYST PHYLO, V73, P281; CCDB, 2011, PRIM SETS SEQ PCR PR; Chan A, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0569-4; De Marco Paulo Jr, 2005, Lundiana, V6, P13; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; de Vivo M, 2011, BIOTA NEOTROP, V11, P111, DOI 10.1590/S1676-06032011000500007; Diaz J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157419; Dijkstra KDB, 2013, ZOOTAXA, V3703, P36; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ely CV, 2017, J NAT CONSERV, V36, P10, DOI 10.1016/j.jnc.2017.01.003; Fisher BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001787; Garrison R.W., 2010, DAMSELFLY GENERA NEW, P490; Garrison Rosser W., 2006, P1; Garrison RW, 2016, SYNONYMIC LIST NEW W; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hawlitschek O, 2016, MOL ECOL RESOUR, V16, P242, DOI 10.1111/1755-0998.12416; Hebert PDN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068535; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heckman C. W, 2008, SECTION 3 ODONATA EN, P11; Heckman Charles W., 2006, P1; Hernandez-Triana LM, 2014, MOL ECOL RESOUR, V14, P508, DOI 10.1111/1755-0998.12208; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; Kalkman VJ, 2008, HYDROBIOLOGIA, V595, P351, DOI 10.1007/s10750-007-9029-x; Kim MJ, 2014, ENTOMOL RES, V44, P65, DOI 10.1111/1748-5967.12051; Klink CA, 2005, CONSERV BIOL, V19, P707, DOI 10.1111/j.1523-1739.2005.00702.x; Knebelsberger T, 2014, MOL ECOL RESOUR, V14, P1060, DOI 10.1111/1755-0998.12238; Ko HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053451; Koroiva R, 2016, CIENCIA PANTANAL, V2, P26; Kumar S., 2016, MOL BIOL EVOLUTION, V33, DOI [DOI 10.1093/M0LBEV/MSW054, https://doi.org/10.1093/molbev/msw054, 10.1093/molbev/msw054]; Kvist S, 2016, MITOCHONDRIAL DNA A, V27, P2241, DOI 10.3109/19401736.2014.984166; Lencioni FAA, 2006, DAMSELFLIES BRAZIL I, V2; Lencioni FAA, 2005, DAMSELFLIES BRAZIL I; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Mittermeier RA, 2005, CONSERV BIOL, V19, P601, DOI 10.1111/j.1523-1739.2005.00709.x; Monteiro CD, 2015, ECOL INDIC, V48, P303, DOI 10.1016/j.ecolind.2014.08.021; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nava-Bolanos A, 2016, BIOL J LINN SOC; Pramual P, 2014, MOL ECOL RESOUR, V14, P262, DOI 10.1111/1755-0998.12174; Pritchard G., 1982, Advances in Odonatology, V1, P227; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Raupach MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106940; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Slowik Jozef, 2012, Insecta Mundi, V0251, P1; Smith MA, 2009, MOL ECOL RESOUR, V9, P208, DOI 10.1111/j.1755-0998.2009.02646.x; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Trivinho-Strixino S, 2012, ANN LIMNOL-INT J LIM, V48, P411, DOI 10.1051/limn/2012032; Valente-Neto F, 2016, ECOL INDIC, V61, P952, DOI 10.1016/j.ecolind.2015.10.052; von Ellenrieder N., 2009, AGRION, V13, P58; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Zhou X, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-30	53	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0182283	10.1371/journal.pone.0182283	http://dx.doi.org/10.1371/journal.pone.0182283			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763495	Green Submitted, Green Published, gold			2022-12-26	WOS:000406766500058
J	Masalia, RR; Bewick, AJ; Burke, JM				Masalia, Rishi R.; Bewick, Adam J.; Burke, John M.			Connectivity in gene coexpression networks negatively correlates with rates of molecular evolution in flowering plants	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORK; GUILT-BY-ASSOCIATION; MICROARRAY DATA SETS; POSITIVE SELECTION; ARABIDOPSIS-THALIANA; BIOSYNTHETIC-PATHWAY; EXPRESSION ANALYSIS; FUNCTIONAL MODULES; RNA-SEQ; REVEALS	Gene coexpression networks are a useful tool for summarizing transcriptomic data and providing insight into patterns of gene regulation in a variety of species. Though there has been considerable interest in studying the evolution of network topology across species, less attention has been paid to the relationship between network position and patterns of molecular evolution. Here, we generated coexpression networks from publicly available expression data for seven flowering plant taxa (Arabidopsis thaliana, Glycine max, Oryza sativa, Populusspp., Solanum lycopersicum, Vitisspp., and Zea mays) to investigate the relationship between network position and rates of molecular evolution. We found a significant negative correlation between network connectivity and rates of molecular evolution, with more highly connected (i.e., "hub") genes having significantly lower nonsynonymous substitution rates and dAlicIS ratios compared to less highly connected (i.e., "peripheral") genes across the taxa surveyed. These findings suggest that more centrally located hub genes are, on average, subject to higher levels of evolutionary constraint than are genes located on the periphery of gene coexpression networks. The consistency of this result across disparate taxa suggests that it holds for flowering plants in general, as opposed to being a species specific phenomenon.	[Masalia, Rishi R.; Burke, John M.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Bewick, Adam J.] Univ Georgia, Dept Genet, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Masalia, RR (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	masalia@uga.com	Burke, John M/A-3502-2013	Burke, John M/0000-0002-1412-5539; Masalia, Rishi/0000-0003-3661-690X	National Science Foundation Plant Genome Research Program [DBI-1444522]; Direct For Biological Sciences [1444522] Funding Source: National Science Foundation	National Science Foundation Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was funded by a grant from the National Science Foundation Plant Genome Research Program (DBI-1444522; https://nsf.gov/funding/pgm_sum.jsp?pims_id=5338) received by John M. Burke. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Ponce D, 2012, GENOME BIOL EVOL, V4, P1263, DOI 10.1093/gbe/evs101; Alvarez-Ponce D, 2011, GENOME BIOL EVOL, V3, P87, DOI 10.1093/gbe/evq084; Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; Atias O, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-86; Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Cork JM, 2004, BIOESSAYS, V26, P479, DOI 10.1002/bies.20026; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ficklin SP, 2011, PLANT PHYSIOL, V156, P1244, DOI 10.1104/pp.111.173047; Ficklin SP, 2010, PLANT PHYSIOL, V154, P13, DOI 10.1104/pp.110.159459; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Fraser HB, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-11; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Guerrero C., 2016, 2016 INT S COMP ED S, P1, DOI [10.1109/SIIE.2016.7751857, DOI 10.1109/SIIE.2016.7751857]; Hahn MW, 2004, J MOL EVOL, V58, P203, DOI 10.1007/s00239-003-2544-0; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; HOLM S, 1979, SCAND J STAT, V6, P65; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Josephs EB, 2017, GENOME BIOL EVOL; Kim PM, 2007, P NATL ACAD SCI USA, V104, P20274, DOI 10.1073/pnas.0710183104; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lee I, 2010, NAT BIOTECHNOL, V28, P149, DOI 10.1038/nbt.1603; Lee TH, 2009, PLANT PHYSIOL, V151, P16, DOI 10.1104/pp.109.139030; Livingstone K, 2009, J HERED, V100, P754, DOI 10.1093/jhered/esp026; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Lu YQ, 2003, MOL BIOL EVOL, V20, P1844, DOI 10.1093/molbev/msg197; Luisi P, 2015, GENOME BIOL EVOL, V7, P1141, DOI 10.1093/gbe/evv055; MacLennan NK, 2009, MOL GENET METAB, V98, P203, DOI 10.1016/j.ymgme.2009.05.004; Mahler N, 2017, BIORXIV; Mao LY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-346; Movahedi S, 2011, PLANT PHYSIOL, V156, P1316, DOI 10.1104/pp.111.177865; Mutwil M, 2010, PLANT PHYSIOL, V152, P29, DOI 10.1104/pp.109.145318; Oliver S, 2000, NATURE, V403, P601, DOI 10.1038/35001165; Persson S, 2005, P NATL ACAD SCI USA, V102, P8633, DOI 10.1073/pnas.0503392102; Pighucci M, 2009, ANN NY ACAD SCI, V1168, P218, DOI 10.1111/j.1749-6632.2009.04578.x; Promislow DEL, 2004, P ROY SOC B-BIOL SCI, V271, P1225, DOI 10.1098/rspb.2004.2732; Proost S, 2016, CURR OPIN PLANT BIOL, V30, P143, DOI 10.1016/j.pbi.2016.02.010; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; R Core team. R Core Team, 2015, LANGUAGE ENV STAT CO, V55, P275; Ramsay H, 2009, MOL BIOL EVOL, V26, P1045, DOI 10.1093/molbev/msp021; Rausher MD, 2008, J MOL EVOL, V67, P137, DOI 10.1007/s00239-008-9105-5; Rausher MD, 1999, MOL BIOL EVOL, V16, P266, DOI 10.1093/oxfordjournals.molbev.a026108; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Ruprecht C, 2017, PLANT J, V90, P447, DOI 10.1111/tpj.13502; Saito K, 2008, TRENDS PLANT SCI, V13, P36, DOI 10.1016/j.tplants.2007.10.006; Schulze A, 2001, NAT CELL BIOL, V3, pE190, DOI 10.1038/35087138; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1633, DOI 10.1111/j.1365-3040.2009.02040.x; Vitkup D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r39; Wang Y, 2009, INT J MOL SCI, V10, P116, DOI 10.3390/ijms10010116; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wolfe CJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-227; Wong DCJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-882; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang JC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23805	58	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0182289	10.1371/journal.pone.0182289	http://dx.doi.org/10.1371/journal.pone.0182289			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759647	Green Submitted, Green Published, gold			2022-12-26	WOS:000406761600071
J	Sonthon, P; Promthet, S; Changsirikulchai, S; Rangsin, R; Thinkhamrop, B; Rattanamongkolgul, S; Hurst, CP				Sonthon, Paithoon; Promthet, Supannee; Changsirikulchai, Siribha; Rangsin, Ram; Thinkhamrop, Bandit; Rattanamongkolgul, Suthee; Hurst, Cameron P.			The impact of the quality of care and other factors on progression of chronic kidney disease in Thai patients with Type 2 Diabetes Mellitus: A nationwide cohort study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; DENSITY-LIPOPROTEIN CHOLESTEROL; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; GLYCEMIC CONTROL; PREVALENCE; RISK; ASSOCIATION; DECLINE; OUTCOMES	Objective The present study investigates the impact of quality of care (QoC) and other factors on chronic kidney disease (CKD) stage progression among Type 2 Diabetes Mellitus (T2DM) patients. Methods This study employed a retrospective cohort from a nationwide Diabetes and Hypertension study involving 595 Thai hospitals. T2DM patients who were observed at least 2 times in the 3 years follow-up (between 2011-2013) were included in our study. Ordinal logistic mixed effect regression modeling was used to investigate the association between the QoC and other factors with CKD stage progression. Results After adjusting for covariates, we found that the achievement of the HbA1c clinical targets (<= 7%) was the only QoC indicator protective against the CKD stage progression (adjusted OR = 0.76; 95% CI = 0.59-0.98; p<0.05). In terms of other covariates, age, occupation, type of health insurance, region of residence, HDL-C, triglyceride, hypertension and insulin sensitizer were also strongly associated with CKD stage progression. Conclusions This cohort study demonstrates the achievement of the HbA1c clinical target (<= 7%) is the only QoC indicator protective against progression of CKD stage. Neither of the other clinical targets (BP and LDL-C) nor any process of care targets could be shown to be associated with CKD stage progression. Therefore, close monitoring of blood sugar control is important to slow CKD progression, but long-term prospective cohorts are needed to gain better insights into the impact of QoC indicators on CKD progression.	[Sonthon, Paithoon] Khon Kaen Univ, Fac Publ Hlth, Publ Hlth Program, Khon Kaen, Thailand; [Sonthon, Paithoon] Minist Publ Hlth, Phetchabun Prov Publ Hlth Off, Phetchabun, Thailand; [Promthet, Supannee; Thinkhamrop, Bandit] Khon Kaen Univ, Fac Publ Hlth, Khon Kaen, Thailand; [Changsirikulchai, Siribha; Rattanamongkolgul, Suthee] Srinakharinwirot Univ, Fac Med, Nakhon Nayok, Thailand; [Rangsin, Ram] Phramongkutklao Coll Med, Dept Mil & Community Med, Bangkok, Thailand; [Hurst, Cameron P.] Chulalongkorn Univ, Ctr Excellence Biostat, Fac Med, Bangkok, Thailand	Khon Kaen University; Khon Kaen University; Srinakharinwirot University; Phramongkutklao College of Medicine; Chulalongkorn University	Hurst, CP (corresponding author), Chulalongkorn Univ, Ctr Excellence Biostat, Fac Med, Bangkok, Thailand.	cameron.h@chula.ac.th	Rangsin, Ram/AAW-9527-2020; Rangsin, Ram/AAR-9082-2021; Hurst, Cameron/AAD-5753-2019; Hurst, Cameron P/P-5175-2017	Rangsin, Ram/0000-0002-7175-0963; Hurst, Cameron/0000-0002-4577-8962; Hurst, Cameron P/0000-0002-4577-8962	Research Group for Prevention and Control of Diabetes Mellitus in the Northeast of Thailand	Research Group for Prevention and Control of Diabetes Mellitus in the Northeast of Thailand	This study was supported by The Medical Research Network of the Consortium of Thai Medical Schools (MedResNet) Thailand who provided permission to use the Diabetes and Hypertension dataset in this study. We also gratefully acknowledge the support of the Research Group for Prevention and Control of Diabetes Mellitus in the Northeast of Thailand.	Afkarian M, 2013, J AM SOC NEPHROL, V24, P302, DOI 10.1681/ASN.2012070718; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Bailey Robert A, 2014, BMC Res Notes, V7, P415, DOI 10.1186/1756-0500-7-415; Bayer FJ, 2014, AM J MANAG CARE, V20, P41; Bowe B, 2016, KIDNEY INT, V89, P886, DOI 10.1016/j.kint.2015.12.034; Soriano LC, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0204-5; Cheng DF, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-195; Christensen R.H.B., 2015, R PACKAGE VERSION, DOI DOI 10.1016/S0022-5371(72)80001-X; Coll-de-Tuero G, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-87; Cosmo SD, 2015, NEPHROL DIAL TRANSPL; Cruz MC, 2011, CLINICS, V66, P991, DOI 10.1590/S1807-59322011000600012; Cummings DM, 2011, J AM BOARD FAM MED, V24, P391, DOI 10.3122/jabfm.2011.04.100186; Dyck RF, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-57; Eriksen BO, 2016, KIDNEY INT, V90, P404, DOI 10.1016/j.kint.2016.03.021; Goderis G, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004029; Imai E, 2016, NEPHROL DIAL TRANSPL, V31, P447, DOI 10.1093/ndt/gfv272; Inker LA, 2014, AM J KIDNEY DIS, V63, P713, DOI 10.1053/j.ajkd.2014.01.416; Kosachunhanun N, COMP EFFECT STICKY R; Krairittichai Udom, 2011, J Med Assoc Thai, V94 Suppl 2, pS1; Lee CL, 2013, AM J NEPHROL, V38, P19, DOI 10.1159/000351803; Liao LN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130828; Lou QL, 2012, DIABETES METAB J, V36, P433, DOI 10.4093/dmj.2012.36.6.433; Luk AOY, 2013, DIABETES-METAB RES, V29, P384, DOI 10.1002/dmrr.2404; Metsarinne K, PRIM CARE DIABETES; Nicholas SB, 2015, ADV CHRONIC KIDNEY D, V22, P6, DOI 10.1053/j.ackd.2014.07.002; Do OH, 2013, INT J DIABETES DEV C, V33, P96, DOI 10.1007/s13410-013-0112-8; Ong-Ajyooth L, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-35; R Core Team, 2016, R LANG ENV STAT COMP; Rodriguez-Poncelas A, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-150; Rodriguez-Poncelas A, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-46; Sacks FM, 2014, CIRCULATION, V129, P999, DOI 10.1161/CIRCULATIONAHA.113.002529; Salinero-Fort MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122030; Sheen YJ, 2014, J DIABETES COMPLICAT, V28, P779, DOI 10.1016/j.jdiacomp.2014.08.002; Shurraw S, 2011, ARCH INTERN MED, V171, P1920, DOI 10.1001/archinternmed.2011.537; Sieng S, 2015, EPIDEMIOL OPEN ACCES, P1, DOI [10.4172/2161-1165.S2-004, DOI 10.4172/2161-1165.S2-004]; Sieng S, 2015, DIABETES RES CLIN PR, V108, P265, DOI 10.1016/j.diabres.2015.02.005; Swinnen SG, 2009, DIABETES CARE, V32, pS253, DOI 10.2337/dc09-S318; Toyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071810; Vupputuri S, 2014, J DIABETES COMPLICAT, V28, P10, DOI 10.1016/j.jdiacomp.2013.09.014; Worswick J, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-26	40	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0180977	10.1371/journal.pone.0180977	http://dx.doi.org/10.1371/journal.pone.0180977			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753611	Green Published, Green Submitted, gold			2022-12-26	WOS:000406579300009
J	Wei, BH; Yang, ZG; Wang, JY; Chen, AQ; Shi, QY; Cheng, YX				Wei, Banghong; Yang, Zhigang; Wang, Jianyi; Chen, Aqin; Shi, Qiuyan; Cheng, Yongxu			Effects of dietary lipids on the hepatopancreas transcriptome of Chinese mitten crab (Eriocheir sinensis)	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; ACYL-COA SYNTHETASES; SINGLE-STRANDED RNA; SALMON SALMO-SALAR; FISH-OIL; FUNCTIONAL-CHARACTERIZATION; GROWTH-PERFORMANCE; REFERENCE GENOME; IMMUNE-RESPONSE; SOYBEAN OIL	Fish oil supplies worldwide have declined sharply over the years. To reduce the use of fish oil in aquaculture, many studies have explored the effects of fish oil substitutions on aquatic animals. To illustrate the effects of dietary lipids on Chinese mitten crab and to improve the use of vegetable oils in the diet of the crabs, 60 male juvenile Chinese mitten crabs were fed one of five diets for 116 days: fish oil (FO), soybean oil (SO), linseed oil (LO), FO + SO (1:1, FSO), and FO + LO (1:1, FLO). Changes in the crab hepatopancreas transcriptome were analyzed using RNA sequencing. There were a total 55,167 unigenes obtained from the transcriptome, of which the expression of 3030 was significantly altered in the FLO vs. FO groups, but the expression of only 412 unigenes was altered in the FSO vs. FO groups. The diets significantly altered the expression of many enzymes involved in lipid metabolism, such as pancreatic lipase, long-chain acyl-CoA synthetases, carnitine palmitoyltransferase I, acetyl-CoA carboxylase, fatty acid synthase, and fatty acyl.9-desaturase. The dietary lipids also affected the Toll-like receptor and Janus activated kinase-signal transducers and activators of transcription signaling pathways. Our results indicate that substituting fish oil with vegetable oils in the diet of Chinese mitten crabs might decrease the digestion and absorption of dietary lipids, fatty acids biosynthesis, and immunologic viral defense, and increase beta-oxidation by altering the expression of the relevant genes. Our results lay the foundation for further understanding of lipid nutrition in Chinese mitten crab.	[Wei, Banghong; Yang, Zhigang; Wang, Jianyi; Chen, Aqin; Shi, Qiuyan; Cheng, Yongxu] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai, Peoples R China	Shanghai Ocean University	Yang, ZG (corresponding author), Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai, Peoples R China.	zgyang@shou.edu.cn	Wei, Banghong/AAT-5451-2020		National Natural Science Foundation of China [31472287, 31402272]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China [grant numbers 31472287 (ZGY), 31402272 (AQC)].	Agaba M, 2004, MAR BIOTECHNOL, V6, P251, DOI 10.1007/s10126-003-0029-1; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Birk RZ, 2004, PEDIATR RES, V55, P921, DOI 10.1203/01.PDR.0000127430.04127.4F; Caballero MJ, 2002, AQUACULTURE, V214, P253, DOI 10.1016/S0044-8486(01)00852-3; Campbell I, 2009, ANAEST INTENS CARE M, V10, P342, DOI 10.1016/j.mpaic.2009.04.007; Castro LFC, 2016, PROG LIPID RES, V62, P25, DOI 10.1016/j.plipres.2016.01.001; Chatelain F, 1996, EUR J BIOCHEM, V235, P789, DOI 10.1111/j.1432-1033.1996.00789.x; Chen K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144889; Chen WY, 2008, DEV COMP IMMUNOL, V32, P1142, DOI 10.1016/j.dci.2008.03.003; Chen YL, 2016, AQUAC RES, V47, P1984, DOI 10.1111/are.12654; [陈彦良 Chen Yanliang], 2014, [中国水产科学, Journal of Fishery Sciences of China], V21, P511; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Eaton S, 1996, BIOCHEM J, V320, P345, DOI 10.1042/bj3200345; Field FJ, 2002, BIOCHEM J, V368, P855, DOI 10.1042/BJ20020731; Francis G, 2001, AQUACULTURE, V199, P197, DOI 10.1016/S0044-8486(01)00526-9; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo ZH, 2013, AQUACULTURE, V402, P58, DOI 10.1016/j.aquaculture.2013.03.033; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Huang S, 2015, SCI REP-UK, V5, DOI 10.1038/srep14015; Hui M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114187; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; JEFFCOAT R, 1977, BIOCHEM J, V161, P431, DOI 10.1042/bj1610431; Jiang H, 2009, COMP BIOCHEM PHYS D, V4, P227, DOI 10.1016/j.cbd.2009.05.001; Kang MJ, 1997, P NATL ACAD SCI USA, V94, P2880, DOI 10.1073/pnas.94.7.2880; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kerner J, 2000, BBA-MOL CELL BIOL L, V1486, P1, DOI 10.1016/S1388-1981(00)00044-5; Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.01.06.db05-0982; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Kitazawa H, 2009, LIPIDS, V44, P765, DOI 10.1007/s11745-009-3320-8; Kuah MK, 2015, BBA-MOL CELL BIOL L, V1851, P248, DOI 10.1016/j.bbalip.2014.12.012; Leonard AE, 2004, PROG LIPID RES, V43, P36, DOI 10.1016/S0163-7827(03)00040-7; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li LO, 2006, J BIOL CHEM, V281, P37246, DOI 10.1074/jbc.M604427200; Li XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068233; Li YD, 2015, COMP BIOCHEM PHYS D, V13, P1, DOI 10.1016/j.cbd.2014.10.002; Mashek DG, 2007, FUTURE LIPIDOL, V2, P465, DOI 10.2217/17460875.2.4.465; Morais S, 2015, BBA-MOL CELL BIOL L, V1851, P588, DOI 10.1016/j.bbalip.2015.01.014; Noordin NM, 2015, J SHELLFISH RES, V34, P1065, DOI 10.2983/035.034.0333; Ouraji H, 2010, J FOOD QUALITY, V33, P405, DOI 10.1111/j.1745-4557.2010.00336.x; Peng XH, 2016, AQUACULT INT, V24, P145, DOI 10.1007/s10499-015-9914-7; Qiu Ren-Jie, 2012, Chinese Journal of Zoology, V47, P78; Qu Q, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.132; Rosenlund G, 2001, AQUAC RES, V32, P323, DOI 10.1046/j.1355-557x.2001.00025.x; ROWLEY AF, 1995, FISH SHELLFISH IMMUN, V5, P549, DOI 10.1016/S1050-4648(95)80041-7; Samocha TM, 2009, AQUAC RES, V41, P961; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sheen SS, 1999, AQUACULTURE, V175, P143, DOI 10.1016/S0044-8486(99)00027-7; SHEEN SS, 1991, AQUACULTURE, V93, P121, DOI 10.1016/0044-8486(91)90211-O; Shi QiuYan, 2016, Journal of Fisheries of China, V40, P844; Soller F, 2015, AQUACULT NUTR, V23, P63; Soupene E, 2008, EXP BIOL MED, V233, P507, DOI 10.3181/0710-MR-287; Sun C, 2011, MOL BIOL REP, V38, P5313, DOI 10.1007/s11033-011-0681-x; Sun Y, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/214841; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Turchini GM, 2009, BRIT J NUTR, V102, P69, DOI 10.1017/S0007114508137874; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; VOGT G, 1994, ZOOMORPHOLOGY, V114, P83, DOI 10.1007/BF00396642; Wang CH, 2008, MOL ECOL, V17, P3515, DOI 10.1111/j.1365-294X.2008.03850.x; Wang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084921; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Watkins PA, 2007, J LIPID RES, V48, P2736, DOI 10.1194/jlr.M700378-JLR200; Wen XB, 2001, COMP BIOCHEM PHYS B, V130, P95, DOI 10.1016/S1096-4959(01)00411-0; Xu HG, 2015, J WORLD AQUACULT SOC, V46, P349, DOI 10.1111/jwas.12205; Yang JY, 2016, IMMUNITY, V44, P889, DOI 10.1016/j.immuni.2016.03.009; Yang ZG, 2013, COMP BIOCHEM PHYS B, V165, P99, DOI 10.1016/j.cbpb.2013.03.010; [姚琴琴 Yao Qinqin], 2015, [中国水产科学, Journal of Fishery Sciences of China], V22, P1177; Zhao Lei, 2016, Chinese Journal of Zoology, V51, P1071, DOI 10.13859/j.cjz.201606015; Zhao Lei, 2016, Chinese Journal of Animal Nutrition, V28, P455; Zheng XZ, 2004, AQUACULTURE, V236, P467, DOI 10.1016/j.aquaculture.2004.02.003	74	11	12	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0182087	10.1371/journal.pone.0182087	http://dx.doi.org/10.1371/journal.pone.0182087			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753670	gold, Green Submitted, Green Published			2022-12-26	WOS:000406579300048
J	Yokoyama, T; Lee, JK; Miwa, K; Opthof, T; Tomoyama, S; Nakanishi, H; Yoshida, A; Yasui, H; Iida, T; Miyagawa, S; Okabe, S; Sawa, Y; Sakata, Y; Komuro, I				Yokoyama, Teruki; Lee, Jong-Kook; Miwa, Keiko; Opthof, Tobias; Tomoyama, Satoki; Nakanishi, Hiroyuki; Yoshida, Akira; Yasui, Haruyo; Iida, Tadatsune; Miyagawa, Shigeru; Okabe, Shigeo; Sawa, Yoshiki; Sakata, Yasushi; Komuro, Issei			Quantification of sympathetic hyperinnervation and denervation after myocardial infarction by three-dimensional assessment of the cardiac sympathetic network in cleared transparent murine hearts	PLOS ONE			English	Article							SINGLE-CELL RESOLUTION; NERVE-FIBERS; WHOLE-BRAIN; INNERVATION; TISSUE; PREDICTS; CANINE; SUPERSENSITIVITY; MECHANISMS; PROGNOSIS	Background The sympathetic nervous system is critical in maintaining the normal physiological function of the heart. Its dysfunction in pathological states may exacerbate the substrate for arrhythmias. Obviously, knowledge of its three-dimensional (3D) structure is important, however, it has been revealed by conventional methods only to a limited extent. In this study, a new method of tissue clearance in combination with immunostaining unravels the 3D structure of the sympathetic cardiac network as well as its changes after myocardial infarction. Methods and results Hearts isolated from adult male mice were optically cleared using the CUBIC-perfusion protocol. After making the hearts transparent, sympathetic nerves and coronary vessels were immunofluorescently labeled, and then images were acquired. The spatial distribution of sympathetic nerves was visualized not only along the epicardial surface, but also transmurally. They were distributed over the epicardial surface and penetrated into the myocardium to twist around coronary vessels, but also independent from the coronary vasculature. At 2 weeks after myocardial infarction, we were able to quantify both denervation distal from the site of infarction and nerve sprouting (hyperinnervation) at the ischemic border zone of the hearts in a 3D manner. The nerve density at the ischemic border zone was more than doubled in hearts with myocardial infarction compared to intact mice hearts (3D analyses; n = 5, p<0.05). Conclusions There is both sympathetic hyperinnervation and denervation after myocardial infarction. Both can be visualized and quantified by a new imaging technique in transparent hearts and thereby become a useful tool in elucidating the role of the sympathetic nervous system in arrhythmias associated with myocardial infarction.	[Yokoyama, Teruki; Tomoyama, Satoki; Nakanishi, Hiroyuki; Yoshida, Akira; Yasui, Haruyo; Sakata, Yasushi] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka, Japan; [Lee, Jong-Kook; Miwa, Keiko] Osaka Univ, Dept Adv Cardiovasc Regenerat Med, Grad Sch Med, Suita, Osaka, Japan; [Opthof, Tobias] Acad Med Ctr, Dept Clin & Expt Cardiol, Heart Grp, Amsterdam, Netherlands; [Opthof, Tobias] Univ Med Ctr Utrecht, Dept Med Physiol, Utrecht, Netherlands; [Iida, Tadatsune; Okabe, Shigeo] Univ Tokyo, Dept Cellular Neurobiol, Grad Sch Med, Tokyo, Japan; [Miyagawa, Shigeru; Sawa, Yoshiki] Osaka Univ, Dept Cardiovasc Surg, Grad Sch Med, Suita, Osaka, Japan; [Komuro, Issei] Univ Tokyo, Dept Cardiovasc Med, Grad Sch Med, Tokyo, Japan	Osaka University; Osaka University; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; University of Tokyo; Osaka University; University of Tokyo	Lee, JK (corresponding author), Osaka Univ, Dept Adv Cardiovasc Regenerat Med, Grad Sch Med, Suita, Osaka, Japan.	jlee@cardiology.med.osaka-u.ac.jp	Nakanishi, Hiroyuki/AAD-9324-2020	Nakanishi, Hiroyuki/0000-0003-3982-3314; Sakata, Yasushi/0000-0002-5618-4721; Miyagawa, Shigeru/0000-0003-0015-6569; Okabe, Shigeo/0000-0003-1216-8890; LEE, Jong-Kook/0000-0001-9053-7781	New Energy and Industrial Technology Development Organization [P10004]; Japan Society for the Promotion of Science [26293188]; Grants-in-Aid for Scientific Research [17H01387, 25117006] Funding Source: KAKEN	New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in part, by research grants from New Energy and Industrial Technology Development Organization (P10004, http://www.nedo.go.jp/english/index.html) and Japan Society for the Promotion of Science (26293188, http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBER MJ, 1983, CIRCULATION, V67, P787, DOI 10.1161/01.CIR.67.4.787; Boogers MJ, 2010, J AM COLL CARDIOL, V55, P2769, DOI 10.1016/j.jacc.2009.12.066; Cao JM, 2000, CIRC RES, V86, P816, DOI 10.1161/01.RES.86.7.816; Cao JM, 2000, CIRCULATION, V101, P1960, DOI 10.1161/01.CIR.101.16.1960; Chen PS, 2001, CARDIOVASC RES, V50, P409, DOI 10.1016/S0008-6363(00)00308-4; Christensen TE, 2016, JACC-CARDIOVASC IMAG, V9, P982, DOI 10.1016/j.jcmg.2016.01.028; Chung K, 2013, NAT METHODS, V10, P508, DOI [10.1038/nmeth.2481, 10.1038/NMETH.2481]; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; Dewald O, 2004, AM J PATHOL, V164, P665, DOI 10.1016/S0002-9440(10)63154-9; Dobaczewski M, 2006, CELL TISSUE RES, V324, P475, DOI 10.1007/s00441-005-0144-6; Fallavollita JA, 2014, J AM COLL CARDIOL, V63, P141, DOI 10.1016/j.jacc.2013.07.096; Freeman K, 2014, J NEUROSCI METH, V221, P48, DOI 10.1016/j.jneumeth.2013.09.005; INOUE H, 1987, CIRCULATION, V75, P877, DOI 10.1161/01.CIR.75.4.877; Jacobson AF, 2010, J AM COLL CARDIOL, V55, P2212, DOI 10.1016/j.jacc.2010.01.014; KAMMERLING JJ, 1987, CIRCULATION, V76, P383, DOI 10.1161/01.CIR.76.2.383; Kawashima T, 2011, ANAT SCI INT, V86, P30, DOI 10.1007/s12565-010-0096-0; KAYE DM, 1995, J AM COLL CARDIOL, V26, P1257, DOI 10.1016/0735-1097(95)00332-0; Kolesova H, 2016, HISTOCHEM CELL BIOL, V146, P141, DOI 10.1007/s00418-016-1441-8; Mahmoud AI, 2015, DEV CELL, V34, P387, DOI 10.1016/j.devcel.2015.06.017; Makita T, 2008, NATURE, V452, P759, DOI 10.1038/nature06859; Manousiouthakis E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4918; MERLET P, 1992, J NUCL MED, V33, P471; Nakata T, 2013, JACC-CARDIOVASC IMAG, V6, P772, DOI 10.1016/j.jcmg.2013.02.007; Nam J, 2013, DEVELOPMENT, V140, P1475, DOI 10.1242/dev.087601; Nehrhoff I, 2016, BIOMED OPT EXPRESS, V7, P3716, DOI 10.1364/BOE.7.003716; Oh YS, 2006, HEART RHYTHM, V3, P728, DOI 10.1016/j.hrthm.2006.02.005; Susaki EA, 2015, NAT PROTOC, V10, P1709, DOI 10.1038/nprot.2015.085; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Swissa M, 2004, J AM COLL CARDIOL, V43, P858, DOI 10.1016/j.jacc.2003.07.053; Tainaka K, 2014, CELL, V159, P911, DOI 10.1016/j.cell.2014.10.034; Tamaki S, 2009, J AM COLL CARDIOL, V53, P426, DOI 10.1016/j.jacc.2008.10.025; VRACKO R, 1991, HUM PATHOL, V22, P138, DOI 10.1016/0046-8177(91)90035-N; VRACKO R, 1990, LAB INVEST, V63, P490; White IA, 2015, CIRC RES, V117, P990, DOI 10.1161/CIRCRESAHA.115.307465; Wittstein IS, 2012, CELL MOL NEUROBIOL, V32, P847, DOI 10.1007/s10571-012-9804-8; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017; Zhou SM, 2004, CIRC RES, V95, P76, DOI 10.1161/01.RES.0000133678.22968.e3; ZIPES DP, 1983, PACE, V6, P1210, DOI 10.1111/j.1540-8159.1983.tb04459.x	39	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0182072	10.1371/journal.pone.0182072	http://dx.doi.org/10.1371/journal.pone.0182072			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753665	Green Submitted, Green Published, gold			2022-12-26	WOS:000406579300046
J	Steffen, W; Ko, FC; Patel, J; Lyamichev, V; Albert, TJ; Benz, J; Rudolph, MG; Bergmann, F; Streidl, T; Kratzsch, P; Boenitz-Dulat, M; Oelschlaegel, T; Schraeml, M				Steffen, Wojtek; Ko, Fu Chong; Patel, Jigar; Lyamichev, Victor; Albert, Thomas J.; Benz, Jorg; Rudolph, Markus G.; Bergmann, Frank; Streidl, Thomas; Kratzsch, Peter; Boenitz-Dulat, Mara; Oelschlaegel, Tobias; Schraeml, Michael			Discovery of a microbial transglutaminase enabling highly site-specific labeling of proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOMYCES-MOBARAENSIS; PRO-TRANSGLUTAMINASE; BACTERIAL TRANSGLUTAMINASE; ESCHERICHIA-COLI; PEPTIDE; PURIFICATION; ACTIVATION; EXPRESSION; SUBSTRATE; SEQUENCE	Microbial transglutaminases (MTGs) catalyze the formation of Gln-Lys isopeptide bonds and are widely used for the crosslinking of proteins and peptides in food and biotechnological applications (e. g.to improve the texture of protein-rich foods or in generating antibody-drug conjugates). Currently used MTGs have low substrate specificity, impeding their biotechnological use as enzymes that do not cross-react with nontarget substrates (i.e. as bio-orthogonal labeling systems). Here, we report the discovery of an MTG from Kutzneria albida (KalbTG), which exhibited no cross-reactivity with known MTG substrates or commonly used target proteins, such as antibodies. KalbTG was produced in Escherichia coli as soluble and active enzyme in the presence of its natural inhibitor ammonium to prevent potentially toxic cross-linking activity. The crystal structure of KalbTG revealed a conserved core similar to other MTGs but very short surface loops, making it the smallestMTGcharacterized to date. Ultra-dense peptide array technology involving a pool of 1.4 million unique peptides identified specific recognition motifs for KalbTG in these peptides. We determined that the motifs YRYRQ and RYESK are the best Gln and Lys substrates of KalbTG, respectively. By first reacting a bifunctionalized peptide with the more specific KalbTG and in a second step with the less specific MTG from Streptomyces mobaraensis, a successful bio-orthogonal labeling system was demonstrated. Fusing the KalbTG recognition motif to an antibody allowed for site-specific and ratio-controlled labeling using low label excess. Its site specificity, favorable kinetics, ease of use, and cost-effective production render KalbTG an attractive tool for a broad range of applications, including production of therapeutic antibody-drug conjugates.	[Steffen, Wojtek; Ko, Fu Chong; Bergmann, Frank; Streidl, Thomas; Kratzsch, Peter; Boenitz-Dulat, Mara; Oelschlaegel, Tobias; Schraeml, Michael] Roche Diagnost GmbH, CPS, Nonnenwald 2, D-82377 Penzberg, Germany; [Patel, Jigar; Lyamichev, Victor; Albert, Thomas J.] NimbleGen, Roche Sequencing, Madison, WI 53719 USA; [Benz, Jorg; Rudolph, Markus G.] F Hoffmann Roche Ltd, pRED, Grenzacherstr 124, CH-4070 Basel, Switzerland	Roche Holding; Roche Holding; Roche NimbleGen; Roche Holding	Steffen, W (corresponding author), Roche Diagnost GmbH, CPS, Nonnenwald 2, D-82377 Penzberg, Germany.	wojtek.steffen@roche.com		Rudolph, Markus/0000-0003-0447-1101	Roche Diagnostics GmbH, Penzberg, Germany	Roche Diagnostics GmbH, Penzberg, Germany	W. S., F. C. K., F. Bergmann, T. Streidl, P. Kratzsch, M. Boenitz-Dulat, T. Oelschlaegel, and M. Schraeml are employees of Roche Diagnostics GmbH, Penzberg, Germany. J. Patel, V. Lyamichev, and T. J. Albert are employees of Roche Sequencing, NimbleGen, Madison, USA. J. Benz and M. G. Rudolph are employed by F. Hoffmann-La Roche Ltd, pRED, Basel, Switzerland. The authors have filed patent applications on aspects of this research. This study was sponsored and designed by Roche Diagnostics GmbH, Penzberg, Germany.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ANDO H, 1989, AGR BIOL CHEM TOKYO, V53, P2613, DOI 10.1080/00021369.1989.10869735; Andres H., 2012, International Patent, Patent No. [WO/2012/150321, 2012150321]; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Date M, 2004, J BIOTECHNOL, V110, P219, DOI 10.1016/j.jbiotec.2004.02.011; Dennler P, 2014, BIOCONJUGATE CHEM, V25, P569, DOI 10.1021/bc400574z; Du K, 2014, APPL ENVIRON MICROB, V80, P723, DOI 10.1128/AEM.02820-13; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandes CG, 2015, BIOCHEMISTRY-US, V54, P5723, DOI 10.1021/acs.biochem.5b00661; FOLK JE, 1966, BIOCHIM BIOPHYS ACTA, V122, P244, DOI 10.1016/0926-6593(66)90066-X; Forsstrom B, 2014, MOL CELL PROTEOMICS, V13, P1585, DOI 10.1074/mcp.M113.033308; Geertsma ER, 2011, BIOCHEMISTRY-US, V50, P3272, DOI 10.1021/bi200178z; Gerber P., 1986, MOLOC MOLECULAR MODE; Green MR, 2012, MOL CLONING LAB MANU, V1; Jawa V, 2013, CLIN IMMUNOL, V149, P534, DOI 10.1016/j.clim.2013.09.006; Jeger S, 2010, ANGEW CHEM INT EDIT, V49, P9995, DOI 10.1002/anie.201004243; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Josten AE, 2000, J IMMUNOL METHODS, V240, P47, DOI 10.1016/S0022-1759(00)00172-1; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamiya N, 2007, J BIOSCI BIOENG, V104, P195, DOI 10.1263/jbb.104.195; Kashiwagi T, 2002, J BIOL CHEM, V277, P44252, DOI 10.1074/jbc.M203933200; Kieliszek M, 2014, FOLIA MICROBIOL, V59, P241, DOI 10.1007/s12223-013-0287-x; Lee JH, 2013, BIOTECHNOL BIOENG, V110, P2865, DOI 10.1002/bit.24970; Lin SJ, 2007, BIOTECHNOL LETT, V29, P111, DOI 10.1007/s10529-006-9205-5; Liu S, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-112; Malesevic M, 2015, CHEMBIOCHEM, V16, P1169, DOI 10.1002/cbic.201402709; Martins IM, 2014, APPL MICROBIOL BIOT, V98, P6957, DOI 10.1007/s00253-014-5894-1; Marx CK, 2008, J BIOTECHNOL, V136, P156, DOI 10.1016/j.jbiotec.2008.06.005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mori Y, 2011, BIOCHEM BIOPH RES CO, V410, P829, DOI 10.1016/j.bbrc.2011.06.073; Oteng-Pabi SK, 2013, ANAL BIOCHEM, V441, P169, DOI 10.1016/j.ab.2013.07.014; Pasternack R, 1998, EUR J BIOCHEM, V257, P570, DOI 10.1046/j.1432-1327.1998.2570570.x; Pfleiderer C, 2005, MICROBIOL RES, V160, P265, DOI 10.1016/j.micres.2005.01.001; Rashidian M, 2013, BIOCONJUGATE CHEM, V24, P1277, DOI 10.1021/bc400102w; Rebets Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-885; Rickert M, 2016, PROTEIN SCI, V25, P442, DOI 10.1002/pro.2833; Sarafeddinov A, 2011, J MICROBIOL BIOTECHN, V21, P617, DOI 10.4014/jmb.1012.12004; Scholz C, 2005, J MOL BIOL, V345, P1229, DOI 10.1016/j.jmb.2004.10.091; Seguro K, 1996, ACS SYM SER, V650, P271; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sommer C, 2012, AMINO ACIDS, V42, P997, DOI 10.1007/s00726-011-1016-x; Sommer C, 2011, PROTEIN EXPRES PURIF, V77, P9, DOI 10.1016/j.pep.2010.12.005; Strop P, 2015, NAT BIOTECHNOL, V33, P694, DOI 10.1038/nbt.3274; Strop P, 2014, BIOCONJUGATE CHEM, V25, P855, DOI 10.1021/bc500099v; Sugimura Y, 2008, ARCH BIOCHEM BIOPHYS, V477, P379, DOI 10.1016/j.abb.2008.06.014; Thiele A, 2011, MOL BIOTECHNOL, V49, P283, DOI 10.1007/s12033-011-9402-x; Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938; Wang K, 2013, BIOTECHNOL LETT, V35, P383, DOI 10.1007/s10529-012-1090-5; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang HL, 2009, BIOSCI BIOTECH BIOCH, V73, P2531, DOI 10.1271/bbb.90422; Yang MT, 2011, J BIOL CHEM, V286, P7301, DOI 10.1074/jbc.M110.203315; Zhou Q, 2015, ANTI-CANCER AGENT ME, V15, P828, DOI 10.2174/1871520615666150302125448; Zotzel J, 2003, EUR J BIOCHEM, V270, P4149, DOI 10.1046/j.1432-1033.2003.03809.x	54	30	32	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15622	15635		10.1074/jbc.M117.797811	http://dx.doi.org/10.1074/jbc.M117.797811			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28751378	Green Published, hybrid			2022-12-26	WOS:000411512200004
J	Hsieh, WH; Lin, CY; Te, ALD; Lo, MT; Wu, CI; Chung, FP; Chang, YC; Chang, SL; Lin, C; Lo, LW; Hu, YF; Liao, JN; Chen, YY; Jhuo, SJ; Raharjo, SB; Lin, YJ; Chen, SA				Hsieh, Wan-Hsin; Lin, Chin-Yu; Te, Abigail Louise D.; Lo, Men-Tzung; Wu, Cheng-I; Chung, Fa-Po; Chang, Yi-Chung; Chang, Shih-Lin; Lin, Chen; Lo, Li-Wei; Hu, Yu-Feng; Liao, Jo-Nan; Chen, Yun-Yu; Jhuo, Shih-Jie; Raharjo, Sunu Budhi; Lin, Yenn-Jiang; Chen, Shih-Ann			A novel noninvasive surface ECG analysis using interlead QRS dispersion in arrhythmogenic right ventricular cardiomyopathy	PLOS ONE			English	Article							T-WAVE MORPHOLOGY; RISK STRATIFICATION; OUTFLOW TRACT; ELECTROPHYSIOLOGIC CHARACTERISTICS; DYSPLASIA-CARDIOMYOPATHY; MAGNETIC-RESONANCE; CATHETER ABLATION; DYSPLASIA/CARDIOMYOPATHY; TACHYCARDIA; DIAGNOSIS	Background This study investigated the feasibility of using the precordial surface ECG lead interlead QRS dispersion (IQRSD) in the identification of abnormal ventricular substrate in arrhythmogenic right ventricular cardiomyopathy (ARVC). Methods Seventy-one consecutive patients were enrolled and reclassified into 4 groups: definite ARVC with epicardial ablation (Group 1), ARVC with ventricular tachycardia (VT, Group 2), idiopathic right ventricular outflow tract VT without ARVC (Group 3), and controls without VT (Group 4). IQRSD was quantified by the angular difference between the reconstruction vectors obtained from the QRS-loop decomposition, based on a principal component analysis (PCA). Electroanatomic mapping and simulated ECGs were used to investigate the relationship between QRS dispersion and abnormal substrate. Results The percentage of the QRS loop area in the Group 1-2 was smaller than the controls (P = 0.01). The IQRSD between V1-V2 could differentiate all VTs from control (P<0.01). Group 1-2 had a greater IQRSD than the Group 3-4 (V4-V5, P = 0.001), and Group 1 had a greater IQRSD than Group 3-4 (V6-Lead I, P< 0.001). Both real and simulated data had a positive correlation between the maximal IQRSD (y= 0.62) and the extent of corresponding abnormal substrate (y= 0.71, both P< 0.001). Conclusions The IQRSD of the surface ECG precordial leads successfully differentiated ARVC from controls, and could be used as a noninvasive marker to identify the abnormal substrate and the status of ARVC patients who can benefit from epicardial ablation.	[Hsieh, Wan-Hsin; Lin, Chin-Yu; Te, Abigail Louise D.; Wu, Cheng-I; Chung, Fa-Po; Chang, Yi-Chung; Chang, Shih-Lin; Lo, Li-Wei; Hu, Yu-Feng; Liao, Jo-Nan; Chen, Yun-Yu; Jhuo, Shih-Jie; Raharjo, Sunu Budhi; Lin, Yenn-Jiang; Chen, Shih-Ann] Taipei Vet Gen Hosp, Div Cardiol, Dept Med, Taipei, Taiwan; [Hsieh, Wan-Hsin; Lo, Men-Tzung; Lin, Chen] Natl Cent Univ, Inst Translat & Interdisciplinary Med, Chungli, Taiwan; [Hsieh, Wan-Hsin; Lo, Men-Tzung; Lin, Chen] Natl Cent Univ, Dept Biomed Sci & Engn, Chungli, Taiwan; [Lin, Chin-Yu; Chung, Fa-Po; Chang, Shih-Lin; Lo, Li-Wei; Hu, Yu-Feng; Liao, Jo-Nan; Lin, Yenn-Jiang; Chen, Shih-Ann] Natl Yang Ming Univ, Fac Med, Taipei, Taiwan; [Lin, Chin-Yu; Chung, Fa-Po; Chang, Shih-Lin; Lo, Li-Wei; Hu, Yu-Feng; Liao, Jo-Nan; Lin, Yenn-Jiang; Chen, Shih-Ann] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Lin, Chin-Yu] Taipei Vet Gen Hosp, Dept Med, Yuan Shan Branch, Ilan, Taiwan; [Te, Abigail Louise D.] St Lukes Med Ctr, HB Calleja Heart & Vasc Inst, Quezon City, Philippines	Taipei Veterans General Hospital; National Central University; National Central University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Saint Lukes Medical Center - Philippines	Lin, YJ; Chen, SA (corresponding author), Taipei Vet Gen Hosp, Div Cardiol, Dept Med, Taipei, Taiwan.; Lin, YJ; Chen, SA (corresponding author), Natl Yang Ming Univ, Fac Med, Taipei, Taiwan.; Lin, YJ; Chen, SA (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan.	linyennjiang@gmail.com; epsachen@ms41.hinet.net	Hu, Yu-Feng/V-1401-2019; huang, yuting/T-4341-2019; Chang, Shih-Lin/AGT-1191-2022	Hu, Yu-Feng/0000-0001-5715-2070; Te, Abigail Louise/0000-0002-7461-2793; Jhuo, Shih-Jie/0000-0001-8008-9671; Lin, Chin-Yu/0000-0003-3282-7523; Lin, Chen/0000-0001-6261-8509; raharjo, sunu budhi/0000-0001-5749-8231	Ministry of Science and Technology of Taiwan [MOST 104-2314-B-010-063-MY2]; Grant of Taipei Veterans General Hospital [V106C-158]; Joint foundation of Taipei Veterans General Hospital and National Taiwan University Hospital [105AC-D710, VGHUST105-G7-4-1]; Clinical trial in Taipei Veterans General Hospital [C13-092]; Biosense Webster [IIS 290]; Research Foundation of Cardiovascular Medicine [105-01-007, 105-02-008, 105-02-028]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Grant of Taipei Veterans General Hospital(Taipei Veterans General Hospital); Joint foundation of Taipei Veterans General Hospital and National Taiwan University Hospital; Clinical trial in Taipei Veterans General Hospital; Biosense Webster; Research Foundation of Cardiovascular Medicine	This work was supported by Ministry of Science and Technology of Taiwan (MOST 104-2314-B-010-063-MY2); Grant of Taipei Veterans General Hospital (V106C-158); Joint foundation of Taipei Veterans General Hospital and National Taiwan University Hospital (105AC-D710, VGHUST105-G7-4-1); Clinical trial in Taipei Veterans General Hospital (C13-092) supported by Biosense Webster (IIS 290); Research Foundation of Cardiovascular Medicine (105-01-007, 105-02-008, 105-02-028).	Acar B, 1999, MED BIOL ENG COMPUT, V37, P574, DOI 10.1007/BF02513351; Awad MM, 2006, AM J HUM GENET, V79, P136, DOI 10.1086/504393; Basso C, 2009, LANCET, V373, P1289, DOI 10.1016/S0140-6736(09)60256-7; Calkins H, 2015, CIRC J, V79, P901, DOI 10.1253/circj.CJ-15-0288; Chung FP, 2015, J CARDIOL, V65, P441, DOI 10.1016/j.jjcc.2014.12.023; Corrado D, 1997, J AM COLL CARDIOL, V30, P1512, DOI 10.1016/S0735-1097(97)00332-X; Fontaine G, 1999, ANNU REV MED, V50, P17, DOI 10.1146/annurev.med.50.1.17; Galeotti L, 2009, J ELECTROCARDIOL, V42, P204, DOI 10.1016/j.jelectrocard.2008.12.007; Hoffmayer KS, 2013, HEART RHYTHM, V10, P477, DOI 10.1016/j.hrthm.2012.12.009; Kazmierczak J, 1998, HEART, V79, P388, DOI 10.1136/hrt.79.4.388; KLEBER AG, 1978, CIRC RES, V42, P603, DOI 10.1161/01.RES.42.5.603; Liao YC, 2014, INT J CARDIOL, V174, P628, DOI 10.1016/j.ijcard.2014.04.169; Lin CY, 2016, JACC CLIN ELECTROPHY, V2; Mandal S., 1985, Gegenbaurs Morphologisches Jahrbuch, V131, P81; Marcus FI, 2005, AM J CARDIOL, V95, P1070, DOI 10.1016/j.amjcard.2004.12.060; MARCUS FI, 1982, CIRCULATION, V65, P384, DOI 10.1161/01.CIR.65.2.384; Marcus FI, 2010, CIRCULATION, V121, P1533, DOI 10.1161/CIRCULATIONAHA.108.840827; Marra MP, 2012, CIRC-ARRHYTHMIA ELEC, V5, P91, DOI 10.1161/CIRCEP.111.964635; MILLER WT, 1978, CIRC RES, V43, P315, DOI 10.1161/01.RES.43.2.315; Morin DP, 2010, AM J CARDIOL, V105, P1821, DOI 10.1016/j.amjcard.2010.01.365; Nasir K, 2004, CIRCULATION, V110, P1527, DOI 10.1161/01.CIR.0000142293.60725.18; Peters S, 2003, ANN NONINVAS ELECTRO, V8, P238, DOI 10.1046/j.1542-474X.2003.08312.x; Peters S, 1999, INT J CARDIOL, V71, P243, DOI 10.1016/S0167-5273(99)00142-4; Peters S, 2007, J ELECTROCARDIOL, V40, P34, DOI 10.1016/j.jelectrocard.2006.10.002; Platonov PG, 2016, HEART RHYTHM, V13, P208, DOI 10.1016/j.hrthm.2015.08.031; Polin GM, 2011, HEART RHYTHM, V8, P76, DOI 10.1016/j.hrthm.2010.09.088; RAMPAZZO A, 1994, HUM MOL GENET, V3, P959, DOI 10.1093/hmg/3.6.959; Saberniak J, 2017, EUR HEART J-CARD IMG, V18, P62, DOI 10.1093/ehjci/jew014; Saguner AM, 2015, CIRC J, V79, P447, DOI 10.1253/circj.CJ-14-1234; Saguner AM, 2014, CIRC J, V78, P2854, DOI 10.1253/circj.CJ-14-0474; Sallam K, 2014, CIRC J, V78, P784, DOI 10.1253/circj.CJ-14-0182; Shimizu W, 2009, HEART RHYTHM, V6, P1507, DOI 10.1016/j.hrthm.2009.06.017; Tandri H, 2008, AM HEART J, V155, P147, DOI 10.1016/j.ahj.2007.08.011; Tandri H, 2009, HEART RHYTHM, V6, P769, DOI 10.1016/j.hrthm.2009.02.031; te Riele ASJM, 2014, J AM COLL CARDIOL, V64, P293, DOI 10.1016/j.jacc.2014.04.044; te Riele ASJM, 2013, HEART RHYTHM, V10, P1484, DOI [10.1016/j.hrthm.2013.06.022, 10.1016/j.hrthm.20l3.06.022]; Tsai CF, 1997, INT J CARDIOL, V62, P143, DOI 10.1016/S0167-5273(97)00198-8; Turrini P, 2001, CIRCULATION, V103, P3075, DOI 10.1161/01.CIR.103.25.3075; van Oosterom A, 2004, HEART, V90, P165, DOI 10.1136/hrt.2003.014662; Wen JY, 2015, CIRC J, V79, P1402, DOI 10.1253/circj.CJ-15-0363; Zabel M, 2000, CIRCULATION, V102, P1252, DOI 10.1161/01.CIR.102.11.1252	41	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182364	10.1371/journal.pone.0182364	http://dx.doi.org/10.1371/journal.pone.0182364			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771538	gold, Green Published, Green Submitted			2022-12-26	WOS:000406853600097
J	Novinec, M				Novinec, Marko			Computational investigation of conformational variability and allostery in cathepsin K and other related peptidases	PLOS ONE			English	Article							HEPARIN-LIKE GLYCOSAMINOGLYCANS; COLLAGENOLYTIC ACTIVITY; CYSTEINE CATHEPSINS; PROTEASE; INHIBITION; SULFATE; SPECIFICITIES; COLLAGENASE; ODANACATIB; DYNAMICS	Allosteric targeting is progressively gaining ground as a strategy in drug design. Its success, however, depends on our knowledge of the investigated system. In the case of the papain-like cysteine peptidase cathepsin K, a major obstacle in our understanding of allostery is represented by the lack of observable conformational change at the active site. This makes it difficult to understand how binding of effectors at known allosteric sites translates into modified enzyme activity. Herein, we address this issue by a computational approach based on experimental data. We analyze the conformational space of the papain-like family and the positioning of cathepsin K within it using principal component analysis and molecular dynamics simulations. We show that human cathepsin L-like endopeptidases (cathepsins L, K, S and V) adopt similar conformations which are distinct from their non-animal counterparts and other related peptidases. Molecular dynamics simulations show that the conformation of cathepsin K is influenced by known allosteric effectors, chondroitin sulfate and the small molecules NSC13345 and NSC94914. Importantly, all effectors affect the geometry of the active site around sites S1 and S2 that represent the narrowest part of the active site cleft and the major specificity determinant in papain-like endopeptidases. The effectors act by stabilizing pre-existing conformational states according to a two-state model and thereby facilitate or hinder the binding of substrate into the active site, as shown by molecular docking simulations. Comparison with other related enzymes shows that similar conformational variability and, by implication, allostery also exist in other papain-like endopeptidases.	[Novinec, Marko] Univ Ljubljana, Dept Chem & Biochem, Fac Chem & Chem Technol, Ljubljana, Slovenia	University of Ljubljana	Novinec, M (corresponding author), Univ Ljubljana, Dept Chem & Biochem, Fac Chem & Chem Technol, Ljubljana, Slovenia.	marko.novinec@fkkt.uni-lj.si	Novinec, Marko/J-9789-2019	Novinec, Marko/0000-0003-1824-1649	Slovenian Research Agency [P1-0140]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The author acknowledges the financial support from the Slovenian Research Agency (research core funding No. P1-0140).	Aguda AH, 2014, P NATL ACAD SCI USA, V111, P17474, DOI 10.1073/pnas.1414126111; Almeida PC, 2001, J BIOL CHEM, V276, P944, DOI 10.1074/jbc.M003820200; Almeida PC, 1999, J BIOL CHEM, V274, P30433, DOI 10.1074/jbc.274.43.30433; Biniossek ML, 2011, J PROTEOME RES, V10, P5363, DOI 10.1021/pr200621z; Bone HG, 2015, OSTEOPOROSIS INT, V26, P699, DOI 10.1007/s00198-014-2944-6; Bradshaw WJ, 2014, ACTA CRYSTALLOGR D, V70, P1983, DOI 10.1107/S1399004714009997; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Costa TFR, 2012, BBA-PROTEINS PROTEOM, V1824, P493, DOI 10.1016/j.bbapap.2011.12.006; Duong LT, 2016, CALCIFIED TISSUE INT, V98, P381, DOI 10.1007/s00223-015-0051-0; Garnero P, 1998, J BIOL CHEM, V273, P32347, DOI 10.1074/jbc.273.48.32347; Gauthier JY, 2008, BIOORG MED CHEM LETT, V18, P923, DOI 10.1016/j.bmcl.2007.12.047; Gelb BD, 1996, SCIENCE, V273, P1236, DOI 10.1126/science.273.5279.1236; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Judice WAS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080153; LaLonde JM, 1999, BIOCHEMISTRY-US, V38, P862, DOI 10.1021/bi9822271; Li ZQ, 2008, J MOL BIOL, V383, P78, DOI 10.1016/j.jmb.2008.07.038; Li ZQ, 2004, J BIOL CHEM, V279, P5470, DOI 10.1074/jbc.M310349200; Li ZQ, 2000, BIOCHEMISTRY-US, V39, P529, DOI 10.1021/bi992251u; Lima APCA, 2002, J BIOL CHEM, V277, P5875, DOI 10.1074/jbc.M108518200; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Michel D, 2016, BIOCHIMIE, V128, P48, DOI 10.1016/j.biochi.2016.06.012; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Nogaroto V, 2006, FEMS MICROBIOL LETT, V261, P187, DOI 10.1111/j.1574-6968.2006.00348.x; Novinec M, 2016, FEBS LETT, V590, P4507, DOI 10.1002/1873-3468.12495; Novinec M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106642; Novinec Marko, 2013, Biomol Concepts, V4, P287, DOI 10.1515/bmc-2012-0054; Novinec M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4287; Novinec M, 2010, BIOCHEM J, V429, P379, DOI 10.1042/BJ20100337; Nussinov R, 2015, CURR OPIN STRUC BIOL, V30, P17, DOI 10.1016/j.sbi.2014.11.005; Ong PC, 2007, J BIOL CHEM, V282, P36980, DOI 10.1074/jbc.M706991200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sage J, 2013, BIOCHEMISTRY-US, V52, P6487, DOI 10.1021/bi400925g; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Seeber M, 2011, J COMPUT CHEM, V32, P1183, DOI 10.1002/jcc.21688; Sharma V, 2015, BIOCHEM J, V465, P163, DOI 10.1042/BJ20140809; Skjrven L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0399-6; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Turk D, 1998, BIOL CHEM, V379, P137, DOI 10.1515/bchm.1998.379.2.137; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Vizovisek M, 2015, PROTEOMICS, V15, P2479, DOI 10.1002/pmic.201400460; Wex T, 1999, BIOCHEM BIOPH RES CO, V259, P401, DOI 10.1006/bbrc.1999.0700; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	46	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182387	10.1371/journal.pone.0182387	http://dx.doi.org/10.1371/journal.pone.0182387			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771551	gold, Green Published, Green Submitted			2022-12-26	WOS:000406853600098
J	Drolle, E; Negoda, A; Hammond, K; Pavlov, E; Leonenko, Z				Drolle, Elizabeth; Negoda, Alexander; Hammond, Keely; Pavlov, Evgeny; Leonenko, Zoya			Changes in lipid membranes may trigger amyloid toxicity in Alzheimer's disease	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; BETA-PROTEIN; PEPTIDE; GANGLIOSIDE; CHOLESTEROL; AGGREGATION; MECHANISMS; FIBRILS; DOMAINS; FIBRILLOGENESIS	Amyloid-beta peptides (A beta), implicated in Alzheimer's disease (AD), interact with the cellular membrane and induce amyloid toxicity. The composition of cellular membranes changes in aging and AD. We designed multi-component lipid models to mimic healthy and diseased states of the neuronal membrane. Using atomic force microscopy (AFM), Kelvin probe force microscopy (KPFM) and black lipid membrane (BLM) techniques, we demonstrated that these model membranes differ in their nanoscale structure and physical properties, and interact differently with A beta(1-42). Based on our data, we propose a new hypothesis that changes in lipid membrane due to aging and AD may trigger amyloid toxicity through electrostatic mechanisms, similar to the accepted mechanism of antimicrobial peptide action. Understanding the role of the membrane changes as a key activating amyloid toxicity may aid in the development of a new avenue for the prevention and treatment of AD.	[Drolle, Elizabeth; Leonenko, Zoya] Univ Waterloo, Dept Biol, Waterloo, ON, Canada; [Drolle, Elizabeth; Leonenko, Zoya] Univ Waterloo, Waterloo Inst Nanotechnol, Waterloo, ON, Canada; [Negoda, Alexander; Pavlov, Evgeny] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS, Canada; [Hammond, Keely; Leonenko, Zoya] Univ Waterloo, Dept Phys & Astron, Waterloo, ON, Canada; [Pavlov, Evgeny] NYU, Coll Dent, Dept Basic Sci, New York, NY USA	University of Waterloo; University of Waterloo; Dalhousie University; University of Waterloo; New York University	Leonenko, Z (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON, Canada.; Leonenko, Z (corresponding author), Univ Waterloo, Waterloo Inst Nanotechnol, Waterloo, ON, Canada.; Leonenko, Z (corresponding author), Univ Waterloo, Dept Phys & Astron, Waterloo, ON, Canada.	zleonenk@uwaterloo.ca			Natural Science and Engineering Council of Canada (NSERC); Heart and Stroke Foundation of Canada grant; American Heart Association; WIN; NSERC	Natural Science and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Heart and Stroke Foundation of Canada grant; American Heart Association(American Heart Association); WIN; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Natural Science and Engineering Council of Canada (NSERC) grant to ZL, Heart and Stroke Foundation of Canada grant and American Heart Association grant to EP, an NSERC Canada Graduate Scholarship and WIN Fellowship to ED, and an NSERC Undergraduate Student Research Award to KH.	Abramov AY, 2011, AGING CELL, V10, P595, DOI 10.1111/j.1474-9726.2011.00685.x; An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B; Ariga T, 2008, J LIPID RES, V49, P1157, DOI 10.1194/jlr.R800007-JLR200; BEITINGER H, 1989, BIOCHIM BIOPHYS ACTA, V984, P293, DOI 10.1016/0005-2736(89)90296-4; Bennett SAL, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00168; BROCKMAN H, 1994, CHEM PHYS LIPIDS, V73, P57, DOI 10.1016/0009-3084(94)90174-0; Burke KA, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00017; CALDERON RO, 1995, J NEUROCHEM, V64, P424; Chi EY, 2007, BIOCHEMISTRY-US, V46, P1913, DOI 10.1021/bi062177x; Choucair A, 2007, BBA-BIOMEMBRANES, V1768, P146, DOI 10.1016/j.bbamem.2006.09.005; Connelly L, 2012, J PHYS CHEM B, V116, P1728, DOI 10.1021/jp2108126; Cunnane SC, 2012, J ALZHEIMERS DIS, V29, P691, DOI 10.3233/JAD-2012-110629; Drolle E, 2014, DRUG METAB REV, V46, P207, DOI 10.3109/03602532.2014.882354; Drolle E, 2012, BIOPHYS J, V103, pL27, DOI 10.1016/j.bpj.2012.06.053; Eckert GP, 2010, CURR PROTEIN PEPT SC, V11, P319, DOI 10.2174/138920310791330668; Elman JA, 2014, NAT NEUROSCI, V17, P1316, DOI 10.1038/nn.3806; Fantini J, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001602; Fezoui Y, 2000, AMYLOID, V7, P166, DOI 10.3109/13506120009146831; Friedman R, 2009, J MOL BIOL, V387, P407, DOI 10.1016/j.jmb.2008.12.036; Hane F, 2011, J ALZHEIMERS DIS, V26, P485, DOI 10.3233/JAD-2011-102112; He XX, 2010, NEUROBIOL AGING, V31, P398, DOI 10.1016/j.neurobiolaging.2008.05.010; Jang H, 2011, BIOPHYS J, V100, P1775, DOI 10.1016/j.bpj.2011.01.072; KRACUN I, 1991, International Journal of Developmental Biology, V35, P289; Kumar DKV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1059; Lau TL, 2006, J MOL BIOL, V356, P759, DOI 10.1016/j.jmb.2005.11.091; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Maltseva E, 2004, CHEMPHYSCHEM, V5, P1185, DOI 10.1002/cphc.200400045; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; Matsuzaki K, 2007, BBA-BIOMEMBRANES, V1768, P1935, DOI 10.1016/j.bbamem.2007.02.009; Mlinac K, 2010, TRANSL NEUROSCI, V1, P300, DOI 10.2478/v10134-010-0043-6; Moores B, 2010, ULTRAMICROSCOPY, V110, P708, DOI 10.1016/j.ultramic.2010.02.036; Moores B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025954; Mouritsen OG, 1998, PHARM RES-DORDR, V15, P1507, DOI 10.1023/A:1011986613392; Paiva D, 2013, LANGMUIR, V29, P1920, DOI 10.1021/la304012e; Pavlov E, 2005, FEBS LETT, V579, P5187, DOI 10.1016/j.febslet.2005.08.032; Pettegrew JW, 2001, NEUROCHEM RES, V26, P771, DOI 10.1023/A:1011603916962; Prenner E, 2007, CHEM PHYS LIPIDS, V145, P106, DOI 10.1016/j.chemphyslip.2006.11.002; Prinetti A, 2001, J BIOL CHEM, V276, P21136, DOI 10.1074/jbc.M010666200; Puglielli L, 2003, NAT NEUROSCI, V6, P345, DOI 10.1038/nn0403-345; Qiu LM, 2009, BIOPHYS J, V96, P4299, DOI 10.1016/j.bpj.2009.02.036; Rushworth JV, 2011, INT J ALZHEIMERS DIS, V2011, DOI [10.4061/2011/603052, DOI 10.4061/2011/603052]; Sasahara K, 2013, PHYS CHEM CHEM PHYS, V15, P8929, DOI 10.1039/c3cp44517h; SODERBERG M, 1991, LIPIDS, V26, P421, DOI 10.1007/BF02536067; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; SVENNERHOLM L, 1994, J NEUROCHEM, V62, P1039; Terzi E, 1997, BIOCHEMISTRY-US, V36, P14845, DOI 10.1021/bi971843e; Tofoleanu F, 2012, PRION, V6, P339, DOI 10.4161/pri.21022; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; van de Waterbeemd H, 2001, J MED CHEM, V44, P1313, DOI 10.1021/jm000407e; Vestergaard M, 2010, MICR HUM SCI MHS 201; Vestergaard M, 2008, BIOTECHNOL BIOENG, V99, P753, DOI 10.1002/bit.21731; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; Williams TL, 2011, BIOCHEM J, V439, P67, DOI 10.1042/BJ20110750; Winterhalter M, 2000, CURR OPIN COLLOID IN, V5, P250, DOI 10.1016/S1359-0294(00)00063-7; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Yanagisawa K, 1998, NEUROBIOL AGING, V19, pS65, DOI 10.1016/S0197-4580(98)00032-3; Yanagisawa K, 2011, J NEUROCHEM, V116, P806, DOI 10.1111/j.1471-4159.2010.07006.x	57	61	60	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182194	10.1371/journal.pone.0182194	http://dx.doi.org/10.1371/journal.pone.0182194			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767712	gold, Green Published, Green Submitted			2022-12-26	WOS:000406768200053
J	Somasundaram, R; Fernandes, S; Deuring, JJ; de Haar, C; Kuipers, EJ; Vogelaar, L; Middleton, FA; van der Woude, CJ; Peppelenbosch, MP; Kerr, WG; Fuhler, GM				Somasundaram, Rajesh; Fernandes, Sandra; Deuring, Jasper J.; de Haar, Colin; Kuipers, Ernst J.; Vogelaar, Lauran; Middleton, Frank A.; van der Woude, C. Janneke; Peppelenbosch, Maikel P.; Kerr, William G.; Fuhler, Gwenny M.			Analysis of SHIP1 expression and activity in Crohn's disease patients	PLOS ONE			English	Article							INFLAMMATION; DEFICIENCY; EXPANSION; REPRESSES; GENE	Background SH2 domain containing inositol-5-phosphatase (SHIP1) is an important modulator of innate and adaptive immunity. In mice, loss of SHIP1 provokes severe ileitis resembling Crohn's disease (CD), as a result of deregulated immune responses, altered cytokine production and intestinal fibrosis. Recently, SHIP1 activity was shown to be correlated to the presence of a CD-associated single nucleotide polymorphism in ATG16L1. Here, we studied SHIP1 activity and expression in an adult cohort of CD patients. Methods SHIP1 activity, protein and mRNA expression in peripheral blood mononuclear cells from CD patients in clinical remission were determined by Malachite green assay, Western blotting and qRT-PCR respectively. Genomic DNA was genotyped for ATG16L1 rs2241880. Results SHIP1 protein levels are profoundly diminished in a subset of patients; however, SHIP1 activity and expression are not correlated to ATG16L1 SNP status in this adult cohort. Conclusions Aberrant SHIP1 activity can contribute to disease in a subset of adult CD patients, and warrants further investigation.	[Somasundaram, Rajesh; Deuring, Jasper J.; de Haar, Colin; Kuipers, Ernst J.; Vogelaar, Lauran; van der Woude, C. Janneke; Peppelenbosch, Maikel P.; Fuhler, Gwenny M.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Gastroenterol & Hepatol, S Gravendijkwal 230, Rotterdam, Netherlands; [Fernandes, Sandra; Kerr, William G.] SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA; [Middleton, Frank A.] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA; [Kerr, William G.] SUNY Upstate Med Univ, Dept Pediat, Syracuse, NY 13210 USA	Erasmus University Rotterdam; Erasmus MC; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Fuhler, GM (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Gastroenterol & Hepatol, S Gravendijkwal 230, Rotterdam, Netherlands.	g.fuhler@erasmusmc.nl	Peppelenbosch, Maikel P./U-5304-2019; Fuhler, Gwenny/AAC-7122-2019; Kuipers, Ernst J/H-3293-2019; Kerr, William/B-8616-2015	Fuhler, Gwenny/0000-0001-9221-4855; Kuipers, Ernst J/0000-0002-0633-3098; Fernandes Denney, Sandra/0000-0003-0919-8925; de Haar, Colin/0000-0003-4358-2410; Middleton, Frank/0000-0002-3107-7188; van der Woude, C.Janneke/0000-0003-3875-6957; Kerr, William/0000-0002-4720-7135; Peppelenbosch, Maikel/0000-0001-9112-6028	Dutch Cancer Society [2010-4737]; ECCO; Crohn's & Colitis Foundation of America; National Institutes of Health [R01 HL72523, R01 HL085580, R01 HL107127]; Paige Arnold Butterfly Run; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072523, R01HL107127, R01HL085580] Funding Source: NIH RePORTER	Dutch Cancer Society(KWF Kankerbestrijding); ECCO; Crohn's & Colitis Foundation of America; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paige Arnold Butterfly Run; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Dutch Cancer Society (2010-4737 to G.M.F.), the ECCO (personal grant to M.P.P.), the Crohn's & Colitis Foundation of America (W.G.K. & S.F.), National Institutes of Health (R01 HL72523, R01 HL085580, R01 HL107127 to W.G.K.), and the Paige Arnold Butterfly Run (to W.G.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank all patients and healthy volunteers who participated in this study. WGK is the Murphy Family Professor of Children's Oncology Research, an Empire Scholar of the State University of NY and was a Senior Scholar of the Crohn's and Colitis Foundation of America during this study. SF is a Fellow of Crohn's and Colitis Foundation of America. This work was supported by the Dutch Cancer Society [2010-4737 to G.M.F.], the ECCO (personal grant to M.P.P.), National Institutes of Health [R01 HL72523, R01 HL085580, R01 HL107127 to W.G.K.) and the Paige Arnold Butterfly Run [to W.G.K.	Arijs I, 2012, GUT, V61, P956, DOI 10.1136/gutjnl-2011-301256; Brooks R, 2010, J IMMUNOL, V184, P3582, DOI 10.4049/jimmunol.0902844; Fuhler GM, 2009, EURJHAEMATOL; Geier SJ, 1997, BLOOD, V89, P1876, DOI 10.1182/blood.V89.6.1876; Ghansah T, 2004, J IMMUNOL, V173, P7324, DOI 10.4049/jimmunol.173.12.7324; Henderson P, 2011, INFLAMM BOWEL DIS, V17, P346, DOI 10.1002/ibd.21283; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kerr WG, 2011, ANN NY ACAD SCI, V1217, P1, DOI 10.1111/j.1749-6632.2010.05869.x; Kerr WG, 2011, GUT, V60, P177, DOI 10.1136/gut.2009.202283; Maxwelll MJ, 2014, GENES IMMUN, V15, P233, DOI 10.1038/gene.2014.9; McLarren KW, 2011, AM J PATHOL, V179, P180, DOI 10.1016/j.ajpath.2011.03.018; Muise AM, 2012, GUT, V61, P1028, DOI 10.1136/gutjnl-2011-300078; Ngoh EN, 2015, GENES IMMUN, V16, P452, DOI 10.1038/gene.2015.30; Ngoh EN, 2015, GASTROENTEROLOGY; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Rauh MJ, 2005, IMMUNITY, V23, P361, DOI 10.1016/j.immuni.2005.09.003; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032	17	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182308	10.1371/journal.pone.0182308	http://dx.doi.org/10.1371/journal.pone.0182308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767696	Green Published, Green Submitted, gold			2022-12-26	WOS:000406768200069
J	Bogdanska, MU; Bodnar, M; Piotrowska, MJ; Murek, M; Schucht, P; Back, J; Martinez-Gonzalez, A; Perez-Garcia, VM				Bogdanska, Magdalena U.; Bodnar, Marek; Piotrowska, Monika J.; Murek, Michael; Schucht, Philippe; Back, Jurgen; Martinez-Gonzalez, Alicia; Perez-Garcia, Victor M.			A mathematical model describes the malignant transformation of low grade gliomas: Prognostic implications	PLOS ONE			English	Article							RANDOMIZED-TRIAL; EUROPEAN ORGANIZATION; RADIATION-THERAPY; GROWTH; RADIOTHERAPY; TEMOZOLOMIDE; PROGRESSION; EFFICACY; EXPANSION; RESECTION	Gliomas are the most frequent type of primary brain tumours. Low grade gliomas (LGGs, WHO grade II gliomas) may grow very slowly for the long periods of time, however they inevitably cause death due to the phenomenon known as the malignant transformation. This refers to the transition of LGGs to more aggressive forms of high grade gliomas (HGGs, WHO grade III and IV gliomas). In this paper we propose a mathematical model describing the spatio-temporal transition of LGGs into HGGs. Our modelling approach is based on two cellular populations with transitions between them being driven by the tumour microenvironment transformation occurring when the tumour cell density grows beyond a critical level. We show that the proposed model describes real patient data well. We discuss the relationship between patient prognosis and model parameters. We approximate tumour radius and velocity before malignant transformation as well as estimate the onset of this process.	[Bogdanska, Magdalena U.; Bodnar, Marek; Piotrowska, Monika J.] Univ Warsaw, Fac Math Informat & Mech, Warsaw, Poland; [Bogdanska, Magdalena U.; Martinez-Gonzalez, Alicia; Perez-Garcia, Victor M.] Univ Castilla La Mancha, Dept Math, Ciudad Real, Spain; [Murek, Michael; Schucht, Philippe; Back, Jurgen] Univ Klin Neurochirurgie, Bern Univ Hosp, Bern, Switzerland	University of Warsaw; Universidad de Castilla-La Mancha; University of Bern; University Hospital of Bern	Bogdanska, MU (corresponding author), Univ Warsaw, Fac Math Informat & Mech, Warsaw, Poland.; Bogdanska, MU (corresponding author), Univ Castilla La Mancha, Dept Math, Ciudad Real, Spain.	m.bogdanska@mimuw.edu.pl	Pérez-García, Víctor M./C-8892-2011; Martínez-González, Alicia/Q-5117-2017	Pérez-García, Víctor M./0000-0002-6575-495X; Martínez-González, Alicia/0000-0002-6938-0932; Piotrowska, Monika/0000-0003-0156-8290; Bodnar, Marek/0000-0001-5571-2476	National Science Centre (Poland) [2015/17/N/ST1/02564, 2015/19/B/ST1/01163]; Ministerio de Economia y Competitividad and FEDER (Spain) [MTM2015-71200-R]; Junta de Comunidades de Castilla-La Mancha (Spain) [PEII-2014-031-P]; James S. Mc. Donnell Foundation (USA) within 21st Century Science Initiative in Mathematical and Complex Systems Approaches for Brain Cancer [220020450]	National Science Centre (Poland); Ministerio de Economia y Competitividad and FEDER (Spain); Junta de Comunidades de Castilla-La Mancha (Spain)(Junta de Comunidades de Castilla-La Mancha); James S. Mc. Donnell Foundation (USA) within 21st Century Science Initiative in Mathematical and Complex Systems Approaches for Brain Cancer	MUB was supported by National Science Centre (Poland), grant number 2015/17/N/ST1/02564. MB and MJP were supported by National Science Centre (Poland), grant number 2015/19/B/ST1/01163. AMG and VMPG were supported by Ministerio de Economia y Competitividad and FEDER (Spain), grant number MTM2015-71200-R, Junta de Comunidades de Castilla-La Mancha (Spain), grant number PEII-2014-031-P and by the James S. Mc. Donnell Foundation (USA) within 21st Century Science Initiative in Mathematical and Complex Systems Approaches for Brain Cancer (Collaborative award 220020450).	Barazzuol L, 2010, J THEOR BIOL, V262, P553, DOI 10.1016/j.jtbi.2009.10.021; Bobek-Billewicz B, 2014, FOLIA NEUROPATHOL, V52, P128, DOI 10.5114/fn.2014.43784; Bondiau PY, 2008, PHYS MED BIOL, V53, P879, DOI 10.1088/0031-9155/53/4/004; Chaichana KL, 2010, J NEUROSURG, V112, P10, DOI 10.3171/2008.10.JNS08608; Clerc M, 2002, IEEE T EVOLUT COMPUT, V6, P58, DOI 10.1109/4235.985692; Danchaivijitr N, 2008, RADIOLOGY, V247, P170, DOI 10.1148/radiol.2471062089; Dong X, 2016, NEURO-ONCOL PRACT, V3, P29; Ellingson BM, 2010, J MAGN RESON IMAGING, V31, P538, DOI 10.1002/jmri.22068; Frazier JL, 2010, WORLD NEUROSURG, V73, P53, DOI 10.1016/j.surneu.2009.05.010; Galochkina T, 2015, MATH BIOSCI, V267, P1, DOI 10.1016/j.mbs.2015.05.006; GANNETT DE, 1994, INT J RADIAT ONCOL, V30, P567, DOI 10.1016/0360-3016(92)90942-B; Gerin C, 2012, CELL PROLIFERAT, V45, P76, DOI 10.1111/j.1365-2184.2011.00790.x; Gerin C, 2013, NEURO-ONCOLOGY, V15, P1379, DOI 10.1093/neuonc/not072; Grier JT, 2006, ONCOLOGIST, V11, P681, DOI 10.1634/theoncologist.11-6-681; Harpold HLP, 2007, J NEUROPATH EXP NEUR, V66, P1, DOI 10.1097/nen.0b013e31802d9000; Hathout Leith, 2015, CNS Oncol, V4, P247, DOI 10.2217/cns.15.16; Jakola AS, 2012, JAMA-J AM MED ASSOC, V308, P1881, DOI 10.1001/jama.2012.12807; Jalbert LE, 2016, NEURO-ONCOLOGY, P1; Jung TY, 2011, CLIN NEUROL NEUROSUR, V113, P752, DOI 10.1016/j.clineuro.2011.08.002; Kaloshi G, 2007, NEUROLOGY, V68, P1831, DOI 10.1212/01.wnl.0000262034.26310.a2; Karim ABMF, 1996, INT J RADIAT ONCOL, V36, P549, DOI 10.1016/S0360-3016(96)00352-5; Karim ABMF, 2002, INT J RADIAT ONCOL, V52, P316, DOI 10.1016/S0360-3016(01)02692-X; Keles G., 2011, J NEUROSURG, V95, P735; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Kesari S, 2009, CLIN CANCER RES, V15, P330, DOI 10.1158/1078-0432.CCR-08-0888; Law M, 2006, RADIOLOGY, V238, P658, DOI 10.1148/radiol.2382042180; Leighton C, 1997, J CLIN ONCOL, V15, P1294, DOI 10.1200/JCO.1997.15.4.1294; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Macaulay RJ, 2015, CANCER CONTROL, V22, P200, DOI 10.1177/107327481502200211; Mandonnet E, 2003, ANN NEUROL, V53, P524, DOI 10.1002/ana.10528; Mangiola A, 2010, EXPERT REV NEUROTHER, V10, P507, DOI [10.1586/ern.09.158, 10.1586/ERN.09.158]; Martinez-Gonzalez A, 2012, B MATH BIOL, V74; Martinez-Gonzalez A, 2016, ADV EXP MED BIOL, V936, P11, DOI 10.1007/978-3-319-42023-3_2; Martinez-Gonzalez A, 2015, MATH MED BIOL, V32, P239, DOI 10.1093/imammb/dqu002; Mazzocco P, 2015, CPT-PHARMACOMET SYST, V4, P728, DOI 10.1002/psp4.54; Mazzocco P, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/297903; Murray, 2002, MATH BIOL I INTRO IN; Ohgaki H, 2013, CLIN CANCER RES, V19, P764, DOI 10.1158/1078-0432.CCR-12-3002; Ostrom QT, 2014, NEUROONCOL S4, V16, piv1; Pallud J, 2006, ANN NEUROL, V60, P380, DOI 10.1002/ana.20946; Pallud J, 2013, NEURO-ONCOLOGY, V15, P595, DOI 10.1093/neuonc/nos331; Pallud J, 2012, NEUROSURGERY, V71, P729, DOI 10.1227/NEU.0b013e31826213de; Pardo R, 2016, COMMUN NONLINEAR SCI, V39, P360, DOI 10.1016/j.cnsns.2016.03.014; Perez-Garcia VM, 2015, MATH MED BIOL, V32, P307, DOI 10.1093/imammb/dqu009; Perez-Garcia VM, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.021921; Perez-Garcia VM, 2015, MATH MED BIOL; PIEPMEIER JM, 1987, J NEUROSURG, V67, P177, DOI 10.3171/jns.1987.67.2.0177; Poon E, 2009, EXPERT REV MOL MED, P11; Pouratian N, 2007, J NEURO-ONCOL, V82, P281, DOI 10.1007/s11060-006-9280-4; Pouratian N, 2010, CURR NEUROL NEUROSCI, V10, P224, DOI 10.1007/s11910-010-0105-7; Rockne R, 2010, PHYS MED BIOL, V55, P3271, DOI 10.1088/0031-9155/55/12/001; Romanowski CAJ, 2008, NEURORADIOL J, V21, P47, DOI 10.1177/19714009080210S109; Sakarunchai Ittichai, 2013, Journal of the Medical Association of Thailand, V96, P1542; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shaw E, 2002, J CLIN ONCOL, V20, P2267, DOI 10.1200/JCO.2002.09.126; Shi YH, 1998, IEEE C EVOL COMPUTAT, P69, DOI 10.1109/ICEC.1998.699146; SKELLAM JG, 1951, BIOMETRIKA, V38, P196, DOI 10.2307/2332328; Smith JS, 2008, J CLIN ONCOL, V26, P1338, DOI 10.1200/JCO.2007.13.9337; Swanson KR, 2008, CLIN ONCOL-UK, V20, P301, DOI 10.1016/j.clon.2008.01.006; Swanson KR, 2011, CANCER RES, V71, P7366, DOI 10.1158/0008-5472.CAN-11-1399; TOVI M, 1994, ACTA RADIOL, V35, P495; Wang CH, 2009, CANCER RES, V69, P9133, DOI 10.1158/0008-5472.CAN-08-3863; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wessels PH, 2003, LANCET NEUROL, V2, P395, DOI 10.1016/S1474-4422(03)00434-4; Woodward DE, 1996, CELL PROLIFERAT, V29, P269, DOI 10.1111/j.1365-2184.1996.tb01580.x	65	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0179999	10.1371/journal.pone.0179999	http://dx.doi.org/10.1371/journal.pone.0179999			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763450	gold, Green Submitted, Green Published			2022-12-26	WOS:000406766500002
J	Ellis, M; Astell, A				Ellis, Maggie; Astell, Arlene			Communicating with people living with dementia who are nonverbal: The creation of Adaptive Interaction	PLOS ONE			English	Article							NURSING-HOME; CARE; BURNOUT; SUPPORT; NURSES	Loss of verbal language production makes people with dementia appear unreachable. We previously presented a case study applying nonverbal communication techniques with a lady with dementia who could no longer speak, which we termed Adaptive Interaction. The current small-n study examines the applicability of Adaptive Interaction as a general tool for uncovering the communication repertoires of non-verbal individuals living with dementia. Communicative responses of 30 interaction sessions were coded and analysed in two conditions: Standard (Baseline) and Adaptive Interaction (Intervention). All participants retained the ability to interact plus a unique communication repertoire comprising a variety of nonverbal components, spanning eye gaze, emotion expression, and movement. In comparison to Baseline sessions, Intervention sessions were characterised by more smiling, looking at ME and imitation behaviour from the people with dementia. These findings allude to the potential of Adaptive Interaction as the basis for interacting with people living with dementia who can no longer speak.	[Ellis, Maggie] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland; [Astell, Arlene] Univ Sheffield, ScHARR, Sheffield, S Yorkshire, England; [Astell, Arlene] Ontario Shores Ctr Mental Hlth Sci, Res & Acad, Whitby, ON, Canada	University of St Andrews; University of Sheffield	Ellis, M (corresponding author), Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland.	mpe@st-andrews.ac.uk	Astell, Arlene J/G-1625-2014	Astell, Arlene J/0000-0002-6822-9472; Ellis, Maggie/0000-0002-7957-022X				Abad V., 2002, VOICES WORLD FORUM M, V2; Astell AJ, 2006, INFANT CHILD DEV, V15, P311, DOI 10.1002/icd.455; ASTROM S, 1991, INT J NURS STUD, V28, P65, DOI 10.1016/0020-7489(91)90051-4; BERG A, 1994, J ADV NURS, V20, P742, DOI 10.1046/j.1365-2648.1994.20040742.x; BOWIE P, 1993, INT J GERIATR PSYCH, V8, P857, DOI 10.1002/gps.930081009; BURGIO LD, 1990, GERONTOLOGIST, V30, P107, DOI 10.1093/geront/30.1.107; Caldwell P., 2005, FINDING YOU FINDING; Carstensen L., 1995, J CLIN GEROPSYCHOLOG, V1, P207; CHAPPELL NL, 1992, GERONTOLOGIST, V32, P351, DOI 10.1093/geront/32.3.351; CONSTABLE JF, 1986, J HUM STRESS, V12, P20, DOI 10.1080/0097840X.1986.9936762; Ellis M., 2008, TECHNIQUES PROMOTING; Feil N., 1999, HDB COUNSELING PSYCH, P590; Hewett D., 1996, INTERACTIVE APPROACH; Kempler D., 1995, DEMENTIA COMMUNICATI, P98; Kitwood T, 1990, AGEING SOC, V10, P177, DOI [10.1017/S0144686X00008060, DOI 10.1017/S0144686X00008060]; Kitwood Tom, 1997, DEMENTIA RECONSIDERE, P7; Klimova B, 2016, J APPL BIOMED, V14, P97, DOI 10.1016/j.jab.2016.02.002; Kraijo H, 2014, J ALZHEIMERS DIS, V40, P631, DOI 10.3233/JAD-132420; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Launer LJ, 1999, NEUROLOGY, V52, P78, DOI 10.1212/WNL.52.1.78; Nind M., 1996, EUROPEAN J SPECIAL N, V11, P48; Noldus Information Technology, 2003, OBS VID PRO VERS 5; Samuel J, 1998, INTRO INTENSIVE INTE; Stokes G., 2000, CHALLENGING BEHAV DE; Stothard V., 1998, GRADUAL DEV INTENSIV, P149; Sweeting H, 1997, SOCIOL HEALTH ILL, V19, P93; Talbot R, 2015, DEMENTIA; Todman JB., 2001, SINGLE CASE SMALL N; Torke AM, 2014, PALLIATIVE MED, V28, P195, DOI 10.1177/0269216314521354; Watson J, 1997, BRIT J SPECIAL ED, V24, P80, DOI DOI 10.1111/1467-8527.00020; Woods RT, 1999, PSYCHOL PROBLEMS AGE	31	27	27	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0180395	10.1371/journal.pone.0180395	http://dx.doi.org/10.1371/journal.pone.0180395			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC3VC	28763445	gold, Green Published, Green Accepted			2022-12-26	WOS:000406766500004
J	Jana, S; Patel, D; Patel, S; Upadhyay, K; Thadani, J; Mandal, R; Das, S; Devkar, R				Jana, Sarmita; Patel, Dipak; Patel, Shweta; Upadhyay, Kapil; Thadani, Jaymesh; Mandal, Rahul; Das, Santasabuj; Devkar, Ranjitsinh			Anthocyanin rich extract of Brassica oleracea L. alleviates experimentally induced myocardial infarction	PLOS ONE			English	Article							INDUCED CARDIAC-FAILURE; OXIDATIVE STRESS; FREE-RADICALS; IDENTIFICATION; CALCIUM; RATS; ANTIOXIDANTS; VEGETABLES; RECEPTOR; ATPASE	Cardioprotective potential of anthocyanin rich red cabbage extract (ARCE) was assessed in H2O2 treated rat neonatal cardiomyoblasts (H9c2 cells) and isoproterenol (ISO) induced rodent model of myocardial infarction. H2O2 treated H9c2 cells recorded cytotoxicity (48-50%) and apoptosis (57.3%), the same were reduced in presence of ARCE (7-10% & 12.3% respectively). Rats pretreated with ARCE for 30 days followed by ISO treatment recorded favourable heart: body weight ratio as compared to ISO treated group. Also, the mRNA levels of enzymatic antioxidants (sod and catalase) and apoptotic genes (bax and bcl-2) in ARCE+ISO treated group were similar to the control group suggesting that ARCE pretreatment prevents ISO induced depletion of enzymatic antioxidants and apoptosis. Histoarchitecture of ventricular tissue of ISO treated group was marked by infracted areas (10%) and derangement of myocardium whereas, ARCE+ISO treated group (4.5%) recorded results comparable to control (0%). ARCE+ISO treated group accounted for upregulation of caveolin-3 and SERCA2a expression as compared to the ISO treated group implying towards ARCE mediated reduction in membrane damage and calcium imbalance. Molecular docking scores and LigPlot analysis of cyanidin-3-glucoside (-8.7 Kcal/mol) and delphinidin-3-glucoside (-8.5 Kcal/mol) showed stable hydrophobic and electrostatic interactions with beta(1) adrenergic receptor. Overall this study elucidates the mechanism of ARCE mediated prevention of experimentally induced myocardial damage.	[Jana, Sarmita; Patel, Dipak; Patel, Shweta; Upadhyay, Kapil; Thadani, Jaymesh; Devkar, Ranjitsinh] Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Zool, Phytotherapeut & Metab Endocrinol Div, Vadodara, India; [Patel, Dipak] Jai Res Fdn, Ecotoxicol Lab, Vapi, India; [Mandal, Rahul; Das, Santasabuj] Natl Inst Cholera & Enter Dis, Biomed Informat Ctr, Kolkata, India	Maharaja Sayajirao University Baroda; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Devkar, R (corresponding author), Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Zool, Phytotherapeut & Metab Endocrinol Div, Vadodara, India.	rv.devkar-zoo@msubaroda.ac.in	Upadhyay, Kapil/AAU-2192-2020	Upadhyay, Kapil/0000-0002-0000-5085; Devkar, Ranjitsinh/0000-0002-9863-7418	University Grant Commission [41-89/2012/SR]	University Grant Commission(University Grants Commission, India)	The authors are thankful to University Grant Commission for providing financial assistance in form of Major Research Project (F.No. 41-89/2012/SR). We are also thankful to the Co-ordinator, DBTMSUB-ILSPARE, for technical support. Help rendered by Dr. Kishore Rajput for microscopy, Ms. Ramadevi Pulipaka and Ms. Kavita Shirsath is also duly acknowledged.	Afroz R, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6437641; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; BLOOM S, 1972, AM J PATHOL, V69, P459; Cassidy A, 2013, CIRCULATION, V127, P188, DOI 10.1161/CIRCULATIONAHA.112.122408; Charron CS, 2007, J AGR FOOD CHEM, V55, P5354, DOI 10.1021/jf0710736; Christopher JA, 2013, J MED CHEM, V56, P3446, DOI 10.1021/jm400140q; Devkar RV, 2012, FOOD FUNCT, V3, P837, DOI 10.1039/c2fo00001f; Draghici G, 2013, MAGNESIUM, V28, P26; Duchnowicz P, 2012, ENVIRON TOXICOL PHAR, V34, P783, DOI 10.1016/j.etap.2012.09.008; Glinska S, 2011, ECOTOX ENVIRON SAFE, V74, P93, DOI 10.1016/j.ecoenv.2010.06.018; Grishko V, 2003, AM J PHYSIOL-HEART C, V285, pH2364, DOI 10.1152/ajpheart.00408.2003; Guo HH, 2012, FOOD CHEM TOXICOL, V50, P3040, DOI 10.1016/j.fct.2012.06.015; Hidalgo M, 2012, GENES NUTR, V7, P295, DOI 10.1007/s12263-011-0263-5; Igarashi K, 2000, BIOSCI BIOTECH BIOCH, V64, P1600, DOI 10.1271/bbb.64.1600; Jadeja RN, 2010, CARDIOVASC TOXICOL, V10, P174, DOI 10.1007/s12012-010-9076-9; Jennings A, 2012, AM J CLIN NUTR, V96, P781, DOI 10.3945/ajcn.112.042036; Jing L, 2015, HEART LUNG CIRC, V24, P602, DOI 10.1016/j.hlc.2014.11.018; Joseph DR, 1908, J EXP MED, V10, P521, DOI 10.1084/jem.10.4.521; Kataya HAH, 2008, EVID-BASED COMPL ALT, V5, P281, DOI 10.1093/ecam/nem029; Lee Y, 2009, APOPTOSIS, V14, P536, DOI 10.1007/s10495-008-0302-x; Li CL, 2006, BIOCHEM BIOPH RES CO, V344, P1135, DOI 10.1016/j.bbrc.2006.04.024; Li CM, 2011, FOOD CHEM TOXICOL, V49, P2090, DOI 10.1016/j.fct.2011.05.022; Lipskaia L, 2010, EXPERT OPIN BIOL TH, V10, P29, DOI 10.1517/14712590903321462; Lipskaia L, 2009, PFLUG ARCH EUR J PHY, V457, P673, DOI 10.1007/s00424-007-0428-7; Lo Scalzo R, 2008, FOOD CHEM, V107, P136, DOI 10.1016/j.foodchem.2007.07.072; Nimse SB, 2015, RSC ADV, V5, P27986, DOI 10.1039/c4ra13315c; Ostrom RS, 2000, MOL PHARMACOL, V57, P1075; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Padmanabhan M, 2006, TOXICOLOGY, V224, P128, DOI 10.1016/j.tox.2006.04.039; Qin Y, 2009, AM J CLIN NUTR, V90, P485, DOI 10.3945/ajcn.2009.27814; Roth DM, 2011, PEDIATR CARDIOL, V32, P329, DOI 10.1007/s00246-010-9881-8; Sankhari JM, 2012, J SCI FOOD AGR, V92, P1688, DOI 10.1002/jsfa.5532; Santos CXC, 2011, FREE RADICAL BIO MED, V50, P777, DOI 10.1016/j.freeradbiomed.2011.01.003; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shih PH, 2010, J NUTR BIOCHEM, V21, P598, DOI 10.1016/j.jnutbio.2009.03.008; Shim SH, 2012, J MED FOOD, V15, P818, DOI 10.1089/jmf.2012.2241; SINGAL PK, 1982, CAN J PHYSIOL PHARM, V60, P1390, DOI 10.1139/y82-207; Sun X, 2011, J CELL BIOCHEM, V112, P2019, DOI 10.1002/jcb.23121; Thounaojam MC, 2011, J FOOD SCI, V76, pT35, DOI 10.1111/j.1750-3841.2010.01962.x; Thounaojam MC, 2010, J HEALTH SCI, V56, P92, DOI 10.1248/jhs.56.92; Wagner H., 1996, PLANT DRUG ANAL THIN; Wiczkowski W, 2013, FOOD RES INT, V51, P303, DOI 10.1016/j.foodres.2012.12.015; Wu XL, 2005, J AGR FOOD CHEM, V53, P3101, DOI 10.1021/jf0478861; YEAGER JC, 1982, LIFE SCI, V30, P299, DOI 10.1016/0024-3205(82)90512-4; YEAGER JC, 1981, CIRC SHOCK, V8, P151	45	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0182137	10.1371/journal.pone.0182137	http://dx.doi.org/10.1371/journal.pone.0182137			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763488	Green Submitted, Green Published, gold			2022-12-26	WOS:000406766500045
J	Martinez-Useros, J; Georgiev-Hristov, T; Fernandez-Acenero, MJ; Borrero-Palacios, A; Indacochea, A; Guerrero, S; Li, WY; Cebrian, A; del Pulgar, TG; Puime-Otin, A; del Puerto-Nevado, L; Rodriguez-Remirez, M; Perez, N; Celdran, A; Gebauer, F; Garcia-Foncillas, J				Martinez-Useros, Javier; Georgiev-Hristov, Tihomir; Jesus Fernandez-Acenero, Maria; Borrero-Palacios, Aurea; Indacochea, Alberto; Guerrero, Santiago; Li, Weiyao; Cebrian, Arancha; Gomez del Pulgar, Teresa; Puime-Otin, Alberto; del Puerto-Nevado, Laura; Rodriguez-Remirez, Maria; Perez, Nuria; Celdran, Angel; Gebauer, Fatima; Garcia-Foncillas, Jesus			UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: A proof-of-concept	PLOS ONE			English	Article							RNA-BINDING PROTEIN; NUCLEIC-ACID-BINDING; UNR; CANCER; METAANALYSIS; TRANSLATION; CONSUMPTION; CA-19-9; HEPSIN; CELLS	Pancreatic ductal adenocarcinoma is an aggressive form of pancreatic cancer and the fourth leading cause of cancer-related death. When possible, curative approaches are based on surgical resection, though not every patient is a candidate for surgery. There are clinical guidelines for the management of these patients that offer different treatment options depending on the clinical and pathologic characteristics. However, the survival rates seen in this kind of patients are still low. The CDSE1 gene is located upstream of NRAS and encodes an RNA-binding protein termed UNR. The aim of this study was to analyze UNR expression and its correlation with outcome in patients with resectable pancreatic ductal adenocarcinoma (PDAC). For this, samples from resectable PDAC patients who underwent duodenopancreatectomy were used to evaluate UNR protein expression by immunohistochemistry using a tissue microarray. Here, we observed that low UNR expression was significantly associated with shorter progression-free survival after surgery (P = 0.010). Moreover, this prognostic marker remained significant after Cox proportional hazards model (P = 0.036). We further studied the role of CDSE1 expression in patient's prognosis using data from public repositories (GEO and TGCA), confirming our results. Interestingly, CDSE1 expression correlated with that of genes characteristic of an immunogenic molecular subtype of pancreatic cancer. Based on these findings, UNR may be considered a potential prognostic biomarker for resectable PDAC and may serve to guide subsequent adjuvant treatment decisions.	[Martinez-Useros, Javier; Borrero-Palacios, Aurea; Li, Weiyao; Cebrian, Arancha; Gomez del Pulgar, Teresa; del Puerto-Nevado, Laura; Rodriguez-Remirez, Maria; Garcia-Foncillas, Jesus] Univ Hosp Fdn Jimenez Diaz FJD, OncoHlth Inst, Translat Oncol Div, Madrid, Spain; [Georgiev-Hristov, Tihomir] Hosp Villalba, Surg Dept, Collado Villalba, Spain; [Jesus Fernandez-Acenero, Maria] Clin San Carlos Univ Hosp, Dept Pathol, Madrid, Spain; [Indacochea, Alberto; Guerrero, Santiago; Gebauer, Fatima] Barcelona Inst Sci & Technol, Ctr Genom Regulat CRG, Gene Regulat Stem Cells & Canc Programme, Barcelona, Spain; [Indacochea, Alberto] Vall Hebron Hosp, Vall Hebron Inst Rec, Oncol & Mol Pathol Res Group, Barcelona, Spain; [Guerrero, Santiago; Gebauer, Fatima] Univ Pompeu Fabra, Barcelona, Spain; [Puime-Otin, Alberto; Perez, Nuria] Univ Hosp Fdn Jimenez Diaz, Dept Pathol, Madrid, Spain; [Celdran, Angel] Fdn Jimenez Diaz Univ Hosp, Gen & Digest Tract Surg Dept, Hepatobiliary & Pancreat Surg Unit, Madrid, Spain	Hospital Clinico San Carlos; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Hospital Universitari Vall d'Hebron; Pompeu Fabra University; Fundacion Jimenez Diaz	Martinez-Useros, J; Garcia-Foncillas, J (corresponding author), Univ Hosp Fdn Jimenez Diaz FJD, OncoHlth Inst, Translat Oncol Div, Madrid, Spain.	javier.museros@oncohealth.eu; jgfoncillas@gmail.com	Gebauer, Fatima/E-7725-2015; Gomez del Pulgar, Teresa/GXV-5256-2022; Guerrero, Santiago/H-7382-2015; Aceñero, M Jesús Fernández/ABC-5904-2020; LI, WEIYAO/ABB-7090-2020; Guerrero, Santiago/M-4500-2019; Rodríguez Remírez, María/AAD-8321-2022; Georgiev-Hristov, Tihomir/B-2606-2009; Indacochea Cusirramos, Alberto/L-2574-2016	Gebauer, Fatima/0000-0001-7563-0013; Guerrero, Santiago/0000-0003-3473-7214; Aceñero, M Jesús Fernández/0000-0002-2439-3553; Guerrero, Santiago/0000-0003-3473-7214; Rodríguez Remírez, María/0000-0002-2831-2132; Georgiev-Hristov, Tihomir/0000-0002-4428-6413; Cebrian Aranda, Arancha/0000-0002-6260-1376; J, Garcia-Foncillas/0000-0002-7591-8006; LI, WEIYAO/0000-0003-0262-8945; Indacochea Cusirramos, Alberto/0000-0003-2643-9807	RNA-Reg CONSOLIDER Network of the Spanish Ministry of Economy, Industry and Competitiveness [CSD2009-00080]; Spanish Health Research Project from Instituto de Salud Carlos III of the Spanish Ministry of Economy, Industry and Competitiveness [PI16/01468]	RNA-Reg CONSOLIDER Network of the Spanish Ministry of Economy, Industry and Competitiveness; Spanish Health Research Project from Instituto de Salud Carlos III of the Spanish Ministry of Economy, Industry and Competitiveness	This work has been carried out with the support of the RNA-Reg CONSOLIDER Network CSD2009-00080 (J.M.-U. and J.G.-F.), and Spanish Health Research Project Funds PI16/01468 from Instituto de Salud Carlos III (A.C. and J.G.-F.), both of the Spanish Ministry of Economy, Industry and Competitiveness.	Adsay NV, 2005, AM J SURG PATHOL, V29, P724, DOI 10.1097/01.pas.0000163360.40357.f1; Ariyama J, 1998, PANCREAS, V16, P396, DOI 10.1097/00006676-199804000-00030; Assifi MM, 2011, SURGERY, V150, P466, DOI 10.1016/j.surg.2011.07.006; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Bosman F. T., 2010, WHO CLASSIFICATION T; Boussadia O, 1997, FEBS LETT, V420, P20, DOI 10.1016/S0014-5793(97)01479-8; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cohen L.H., 1988, LIFE EVENTS PSYCHOL, P11; Cornelis S, 2005, NUCLEIC ACIDS RES, V33, P3095, DOI 10.1093/nar/gki611; Crane CH, 2012, J CLIN ONCOL, V30, P4049, DOI 10.1200/JCO.2012.45.1799; Dormoy-Raclet V, 2007, ONCOGENE, V26, P2595, DOI 10.1038/sj.onc.1210068; Ducreux M, 2015, ANN ONCOL, V56; Egawa S, 2004, PANCREAS, V28, P235, DOI 10.1097/00006676-200404000-00004; Elatmani H, 2011, STEM CELLS, V29, P1504, DOI 10.1002/stem.712; Evans JR, 2003, ONCOGENE, V22, P8012, DOI 10.1038/sj.onc.1206645; Ferrer N, 1999, DNA CELL BIOL, V18, P209, DOI 10.1089/104454999315420; Fong ZV, 2012, CANCER J, V18, P530, DOI 10.1097/PPO.0b013e31827654ea; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Goonetilleke KS, 2007, EJSO-EUR J SURG ONC, V33, P266, DOI 10.1016/j.ejso.2006.10.004; Grosset C, 2000, CELL, V103, P29, DOI 10.1016/S0092-8674(00)00102-1; Hariharan D, 2008, HPB, V10, P58, DOI 10.1080/13651820701883148; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; JACQUEMINSABLON H, 1994, NUCLEIC ACIDS RES, V22, P2643, DOI 10.1093/nar/22.13.2643; JEFFERS M, 1990, NUCLEIC ACIDS RES, V18, P4891; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang TH, 2015, ONCOTARGET, V6, P27751, DOI 10.18632/oncotarget.4859; Kawai S, 2008, INT J CANCER, V123, P2880, DOI 10.1002/ijc.23907; Kelsen DP, 1997, SURGERY, V122, P53, DOI 10.1016/S0039-6060(97)90264-6; Kim JE, 2004, J GASTROEN HEPATOL, V19, P182, DOI 10.1111/j.1440-1746.2004.03219.x; Kloppel G HR, 2000, PATHOLOGY GENETICS T; Kobayashi H, 2013, NEUROSCIENCE, V253, P292, DOI 10.1016/j.neuroscience.2013.08.055; Larsson SC, 2012, BRIT J CANCER, V106, P603, DOI 10.1038/bjc.2011.585; Larsson SC, 2006, AM J CLIN NUTR, V84, P1171, DOI 10.1093/ajcn/84.5.1171; Lee J, 2015, AM J TRANSPLANT, V15; Maithel SK, 2008, ANN SURG ONCOL, V15, P3512, DOI 10.1245/s10434-008-0134-5; Martinez-Useros J, 2016, BIOMED RES INT, V2016, DOI DOI 10.1155/2016/1869304; Martinez-Useros J, 2017, J CLIN MED, V6, DOI 10.3390/jcm6030029; Martinez-Useros J, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4873089; Mihailovich M, 2012, RNA, V18, P53, DOI 10.1261/rna.029603.111; Mitchell SA, 2003, MOL CELL, V11, P757, DOI 10.1016/S1097-2765(03)00093-5; Pawlik TM, 2008, ANN SURG ONCOL, V15, P2081, DOI 10.1245/s10434-008-9929-7; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Reddy D N, 2001, Trop Gastroenterol, V22, P149; Schepens B, 2007, EMBO J, V26, P158, DOI 10.1038/sj.emboj.7601468; Scholch S, 2015, ONCOTARGET, V6, P4663, DOI 10.18632/oncotarget.3081; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Tempero MA MM, 2016, NCCN CLIN PRACTICE G; Triqueneaux G, 1999, NUCLEIC ACIDS RES, V27, P1926, DOI 10.1093/nar/27.8.1926; van Kouwenhove M, 2011, NAT REV CANCER, V11, P644, DOI 10.1038/nrc3107; Verbeke CS, 2012, BRIT J SURG, V99, P1036, DOI 10.1002/bjs.8734; WHIPPLE AO, 1945, ANN SURG, V121, P847, DOI 10.1097/00000658-194506000-00008; Wu QY, 2007, FRONT BIOSCI-LANDMRK, V12, P5052, DOI 10.2741/2447; Wurth L, 2016, CANCER CELL, V30, P694, DOI 10.1016/j.ccell.2016.10.004; Wurth L, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/178525; Zhang CY, 2015, CELL SIGNAL, V27, P789, DOI 10.1016/j.cellsig.2014.12.020	55	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0182044	10.1371/journal.pone.0182044	http://dx.doi.org/10.1371/journal.pone.0182044			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763470	Green Published, Green Submitted, gold			2022-12-26	WOS:000406766500036
J	Miller, AD; Chama, A; Louw, TM; Subramanian, A; Viljoen, HJ				Miller, April D.; Chama, Abdoulkadri; Louw, Tobias M.; Subramanian, Anuradha; Viljoen, Hendrik J.			Frequency sensitive mechanism in low intensity ultrasound enhanced bioeffects	PLOS ONE			English	Article							CELL-MATRIX INTERACTIONS; PULSED ULTRASOUND; VISCOELASTIC PROPERTIES; CARTILAGE REPAIR; CHONDROCYTES; MECHANOTRANSDUCTION; OSTEOARTHRITIS; REGENERATION; BIOREACTOR; CAVITATION	This study presents two novel theoretical models to elucidate frequency sensitive nuclear mechanisms in low-intensity ultrasound enhanced bioeffects. In contrast to the typical 1.5 MHz pulsed ultrasound regime, our group previously experimentally confirmed that ultrasound stimulation of anchored chondrocytes at resonant frequency maximized gene expression of load inducible genes which are regulatory markers for cellular response to external stimuli. However, ERK phosphorylation displayed no frequency dependency, suggesting that the biochemical mechanisms involved in enhanced gene expression is downstream of ERK phosphorylation. To elucidate such underlying mechanisms, this study presents a theoretical model of an anchored cell, representing an in vitro chondrocyte, in an ultrasound field. The model results showed that the mechanical energy storage is maximized at the chondrocyte's resonant frequency and the energy density in the nucleus is almost twice as high as in the cytoplasm. Next, a mechanochemical model was developed to link the mechanical stimulation of ultrasound and the increased mechanical energy density in the nucleus to the downstream targets of the ERK pathway. This study showed for the first time that ultrasound stimulation induces frequency dependent gene expression as a result of altered rates of transcription factors binding to chromatin.	[Miller, April D.; Chama, Abdoulkadri; Louw, Tobias M.; Subramanian, Anuradha; Viljoen, Hendrik J.] Univ Nebraska Lincoln, Dept Chem & Biomol Engn, Lincoln, NE 68588 USA; [Chama, Abdoulkadri; Louw, Tobias M.] Stellenbosch Univ, Dept Chem Engn, Stellenbosch, South Africa	University of Nebraska System; University of Nebraska Lincoln; Stellenbosch University	Viljoen, HJ (corresponding author), Univ Nebraska Lincoln, Dept Chem & Biomol Engn, Lincoln, NE 68588 USA.	hviljoen1@unl.edu	Chama, Abdoulkadri/AGP-7797-2022	Chama, Abdoulkadri/0000-0001-5572-5250; Louw, Tobias/0000-0002-4166-0799				Atalla N, 2009, PROPAGATION SOUND PO; Bidhendi AJ, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/192618; Claes L, 2007, PROG BIOPHYS MOL BIO, V93, P384, DOI 10.1016/j.pbiomolbio.2006.07.021; COMSOL, 2014, COMSOL 5 0 AC MOD US, P45; Cook SD, 2001, CLIN ORTHOP RELAT R, pS231; Dalecki D, 2004, ANNU REV BIOMED ENG, V6, P229, DOI 10.1146/annurev.bioeng.6.040803.140126; Demirel Y., 2014, NONEQUILIBRIUM THE E; Duda GN, 2004, J BIOMED MATER RES B, V68B, P21, DOI 10.1002/jbm.b.10075; Duvshani-Eshet M, 2006, GENE THER, V13, P163, DOI 10.1038/sj.gt.3302642; Guilak F, 2000, BIOCHEM BIOPH RES CO, V269, P781, DOI 10.1006/bbrc.2000.2360; Guilak F, 2000, J BIOMECH, V33, P1663, DOI 10.1016/S0021-9290(00)00105-6; Haider MA, 2007, COMPUT METHOD APPL M, V196, P2999, DOI 10.1016/j.cma.2006.08.020; Harrington HA, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/3/036001; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; KESTIN J, 1978, J PHYS CHEM REF DATA, V7, P941, DOI 10.1063/1.555581; Kim EJ, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2978991; Krasovitski B, 2011, P NATL ACAD SCI USA, V108, P3258, DOI 10.1073/pnas.1015771108; Kuhn T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022962; Leipzig ND, 2005, J BIOMECH, V38, P77, DOI 10.1016/j.jbiomech.2004.03.013; Lemmon E., 2011, NIST CHEM WEBBOOK; Louw TM, 2013, ULTRASOUND MED BIOL, V39, P1303, DOI 10.1016/j.ultrasmedbio.2013.01.015; Sanchez AL, 2009, REUMATOL CLIN, V5, P163, DOI 10.1016/j.reuma.2008.09.005; de Albornoz PM, 2011, BRIT MED BULL, V100, P39, DOI 10.1093/bmb/ldr006; Miller AD, 2017, J BIOMECH, V56, P83, DOI 10.1016/j.jbiomech.2017.03.007; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Namazi H, 2012, ARCH PHYS MED REHAB, V93, P1882, DOI 10.1016/j.apmr.2012.01.028; Noriega S, 2012, INT J BIOCHEM CELL B, V44, P1331, DOI 10.1016/j.biocel.2012.04.027; Rowat AC, 2008, BIOESSAYS, V30, P226, DOI 10.1002/bies.20720; Rubin C, 2001, J BONE JOINT SURG AM, V83A, P259, DOI 10.2106/00004623-200102000-00015; Subramanian A, 2013, TISSUE ENG PART C-ME, V19, P244, DOI [10.1089/ten.tec.2012.0199, 10.1089/ten.TEC.2012.0199]; Takeuchi R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2451; Taylor R., 1993, MULTICOMPONENT MASS; Thakurta SG, 2014, ACTA BIOMATER, V10, P4798, DOI 10.1016/j.actbio.2014.07.013; Trickey WR, 2006, J BIOMECH, V39, P78, DOI 10.1016/j.jbiomech.2004.11.006; Trickey WR, 2000, J ORTHOPAED RES, V18, P891, DOI 10.1002/jor.1100180607; Vaziri A, 2007, J BIOMECH, V40, P2053, DOI 10.1016/j.jbiomech.2006.09.023; Whitney NP, 2012, ULTRASOUND MED BIOL, V38, P1734, DOI 10.1016/j.ultrasmedbio.2012.06.002; Xin ZC, 2016, TRANSL ANDROL UROL, V5, P255, DOI 10.21037/tau.2016.02.04; Zura R, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0498-1	39	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0181717	10.1371/journal.pone.0181717	http://dx.doi.org/10.1371/journal.pone.0181717			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763448	gold, Green Published, Green Submitted			2022-12-26	WOS:000406766500018
J	Moreira, CMD; Batista, CM; Fernandes, JC; Kessler, RL; Soares, MJ; Fragoso, SP				do Nascimento Moreira, Claudia Maria; Batista, Cassiano Martin; Fernandes, Jessica Chimenes; Kessler, Rafael Luis; Soares, Maurilio Jose; Fragoso, Stenio Perdigao			Knockout of the gamma subunit of the AP-1 adaptor complex in the human parasite Trypanosoma cruzi impairs infectivity and differentiation and prevents the maturation and targeting of the major protease cruzipain	PLOS ONE			English	Article							CYSTEINE PROTEINASE; VIRULENCE FACTORS; CLATHRIN-ADAPTER; GOLGI-COMPLEX; CELL INVASION; IDENTIFICATION; HOST; METACYCLOGENESIS; LOCALIZATION; GLYCOPROTEIN	The AP-1 Adaptor Complex assists clathrin-coated vesicle assembly in the trans-Golgi network (TGN) of eukaryotic cells. However, the role of AP-1 in the protozoan Trypanosoma cruzi-the Chagas disease parasite-has not been addressed. Here, we studied the function and localization of AP-1 in different T. cruzi life cycle forms, by generating a gene knockout of the large AP-1 subunit gamma adaptin (TcAP1-gamma), and raising a monoclonal antibody against TcAP1-gamma. Co-localization with a Golgi marker and with the clathrin light chain showed that TcAP1-gamma is located in the Golgi, and it may interact with clathrin in vivo, at the TGN. Epimastigote (insect form) parasites lacking TcAP1-gamma (Tc gamma KO) have reduced proliferation and differentiation into infective metacyclic trypomastigotes (compared with wild-type parasites). Tc gamma KO parasites have also displayed significantly reduced infectivity towards mammalian cells. Importantly, TcAP1-gamma knockout impaired maturation and transport to lysosome-related organelles (reservosomes) of a key cargo-the major cysteine protease cruzipain, which is important for parasite nutrition, differentiation and infection. In conclusion, the defective processing and transport of cruzipain upon AP-1 ablation may underlie the phenotype of Tc gamma KO parasites.	[do Nascimento Moreira, Claudia Maria; Fragoso, Stenio Perdigao] Fiocruz MS, Inst Carlos Chagas, Lab Mol Biol Trypanosomatids, Curitiba, Parana, Brazil; [Batista, Cassiano Martin; Fernandes, Jessica Chimenes; Soares, Maurilio Jose] Fiocruz MS, Inst Carlos Chagas, Lab Cell Biol, Curitiba, Parana, Brazil; [Kessler, Rafael Luis] Fiocruz MS, Inst Carlos Chagas, Lab Funct Genom, Curitiba, Parana, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Fragoso, SP (corresponding author), Fiocruz MS, Inst Carlos Chagas, Lab Mol Biol Trypanosomatids, Curitiba, Parana, Brazil.	sfragoso@fiocruz.br	Soares, Maurilio J/I-4627-2016; Fragoso, Stenio/AAB-4703-2019; Batista, C.M./D-1396-2013; Kessler, Rafael/E-9291-2018	Soares, Maurilio J/0000-0001-9701-836X; Fragoso, Stenio/0000-0002-0909-7940; Batista, C.M./0000-0002-3947-5914; Kessler, Rafael/0000-0002-6365-8251	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Oswaldo Cruz (Fiocruz)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Oswaldo Cruz (Fiocruz)	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao Oswaldo Cruz (Fiocruz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CL, 2007, MOL BIOCHEM PARASIT, V156, P175, DOI 10.1016/j.molbiopara.2007.07.020; Alvarez VE, 2012, BBA-PROTEINS PROTEOM, V1824, P195, DOI 10.1016/j.bbapap.2011.05.011; Aparicio IM, 2004, INFECT IMMUN, V72, P5892, DOI 10.1128/IAI.72.10.5892-5902.2004; Auxiliadora de Sousa M., 1983, Memorias do Instituto Oswaldo Cruz, V78, P317, DOI 10.1590/S0074-02761983000300009; Batista CM, 2013, EXP PARASITOL, V134, P52, DOI 10.1016/j.exppara.2013.01.023; Batista CM, 2014, BIOMED RES INT, V2014; Batista M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-259; Boehm M, 2001, MOL BIOL CELL, V12, P2907, DOI 10.1091/mbc.12.10.2907; BONALDO MC, 1988, J CELL BIOL, V106, P1349, DOI 10.1083/jcb.106.4.1349; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Branquinha MH, 2015, CURR MED CHEM, V22, P2225, DOI 10.2174/0929867322666150521091652; Canagarajah BJ, 2013, PROTEIN SCI, V22, P517, DOI 10.1002/pro.2235; CAZZULO JJ, 1990, BIOCHIM BIOPHYS ACTA, V1037, P186, DOI 10.1016/0167-4838(90)90166-D; Cazzulo JJ, 1997, BIOL CHEM, V378, P1; Cazzulo Juan Jose, 2002, Current Topics in Medicinal Chemistry, V2, P1261, DOI 10.2174/1568026023392995; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V14, P83, DOI 10.1016/0166-6851(85)90108-2; Corre JR, 2007, J EUKARYOT MICROBIOL, V54, P297, DOI 10.1111/j.1550-7408.2007.00258.x; Cunha-e-Silva N, 2006, PARASITOL RES, V99, P325, DOI 10.1007/s00436-006-0190-3; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; de Souza W, 2009, PROG HISTOCHEM CYTO, V44, P67, DOI 10.1016/j.proghi.2009.01.001; DECAZZULO BMF, 1994, FEMS MICROBIOL LETT, V124, P81; Doray B, 2001, MOL BIOL CELL, V12, P1925, DOI 10.1091/mbc.12.7.1925; Duschak VG, 2009, CURR MED CHEM, V16, P3174, DOI 10.2174/092986709788802971; Engel JC, 1998, J CELL SCI, V111, P597; Figueiredo RCBQ, 2004, PARASITOLOGY, V129, P431, DOI 10.1017/S0031182004005797; Girard-Dias W, 2012, HISTOCHEM CELL BIOL, V138, P821, DOI 10.1007/s00418-012-1002-8; Gokool S, 2003, J BIOL CHEM, V278, P29400, DOI 10.1074/jbc.M304572200; Gradia DF, 2009, INT J PARASITOL, V39, P49, DOI 10.1016/j.ijpara.2008.05.019; Guo YS, 2014, ANNU REV CELL DEV BI, V30, P169, DOI 10.1146/annurev-cellbio-100913-013012; Hirst J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001170; Kalb LC, 2016, CONSERVATION DIVERGE, V6, P1; Kalb LC, 2014, BMC CELL BIOL, V15, DOI 10.1186/1471-2121-15-23; Kent HM, 2002, STRUCTURE, V10, P1139, DOI 10.1016/S0969-2126(02)00801-8; Kessler RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067441; Kugeratski FG, 2015, MEM I OSWALDO CRUZ, V110, P687, DOI 10.1590/0074-02760150074; LeBorgne R, 1997, J CELL BIOL, V137, P335; Lefkir Y, 2003, MOL BIOL CELL, V14, P1835, DOI 10.1091/mbc.E02-10-0627; Manna PT, 2013, MOL PHYLOGENET EVOL, V67, P123, DOI 10.1016/j.ympev.2013.01.002; Mazzarotto GCA, 2009, J VIROL METHODS, V162, P96, DOI 10.1016/j.jviromet.2009.07.022; MEIRELLES MNL, 1992, MOL BIOCHEM PARASIT, V52, P175, DOI 10.1016/0166-6851(92)90050-T; MURTA ACM, 1990, MOL BIOCHEM PARASIT, V43, P27, DOI 10.1016/0166-6851(90)90127-8; Osorio L, 2012, MICROBES INFECT, V14, P1390, DOI 10.1016/j.micinf.2012.09.003; Park SY, 2014, BIOSCIENCE REP, V34, P381, DOI 10.1042/BSR20140069; Pavani RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005181; de Souza FSP, 2010, MOL BIOCHEM PARASIT, V172, P90, DOI 10.1016/j.molbiopara.2010.03.014; Sambrok J., 1989, MOL CLONING LAB MANU; Sant'Anna C, 2004, MICROSC MICROANAL, V10, P637, DOI 10.1017/S1431927604040863; Sant'Anna C, 2008, HISTOCHEM CELL BIOL, V130, P1187, DOI 10.1007/s00418-008-0486-8; Santos CC, 2005, J CELL SCI, V118, P901, DOI 10.1242/jcs.01677; Schimanski B, 2005, EUKARYOT CELL, V4, P1942, DOI 10.1128/EC.4.11.1942-1950.2005; SOARES MJ, 1992, J CELL SCI, V102, P157; SOARES MJ, 1989, PARASITOL RES, V75, P522, DOI 10.1007/BF00931160; Soares MJ, 1999, MEM I OSWALDO CRUZ, V94, P139, DOI 10.1590/S0074-02761999000700015; SOUTOPADRON T, 1990, J CELL SCI, V96, P485; Tazeh NN, 2009, EUKARYOT CELL, V8, P1352, DOI 10.1128/EC.00156-09; Ter Haar E, 1999, P NATL ACAD SCI USA, V97, P1096; Tomas AM, 1997, EUR J BIOCHEM, V244, P596, DOI 10.1111/j.1432-1033.1997.t01-1-00596.x; Touz MC, 2004, MOL BIOL CELL, V15, P3053, DOI 10.1091/mbc.E03-10-0744; Tyler K.M., 2003, P1; Vidal JC, 2017, PARASITOLOGY, P1; Vince JE, 2008, EUKARYOT CELL, V7, P1256, DOI 10.1128/EC.00090-08; Yeung BG, 2001, TRAFFIC, V2, P565, DOI 10.1034/j.1600-0854.2001.20806.x; YOKOYAMAYASUNAKA JKU, 1994, ACTA TROP, V57, P307, DOI 10.1016/0001-706X(94)90076-0	65	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0179615	10.1371/journal.pone.0179615	http://dx.doi.org/10.1371/journal.pone.0179615			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759609	gold, Green Published, Green Submitted			2022-12-26	WOS:000406761600006
J	Grant, JF; Chittleborough, CR; Shi, ZM; Taylor, AW				Grant, Janet F.; Chittleborough, Catherine R.; Shi, Zumin; Taylor, Anne W.			The association between A Body Shape Index and mortality: Results from an Australian cohort	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; MASS INDEX; WAIST CIRCUMFERENCE; OBESITY PARADOX; FOLLOW-UP; RISK; OVERWEIGHT; WEIGHT; DISEASE; HEALTH	It is well recognised that obesity increases the risk of premature death. A Body Shape Index (ABSI) is a formula that uses waist circumference (WC), body mass index (BMI) and height to predict risk of premature mortality, where a high score (Quartile 4) indicates that a person's WC is more than expected given their height and weight. Our study examines the association between ABSI quartiles and all-cause-, cardiovascular- and cancer-related mortality, and primary cause of death. Self-reported demographic and biomedically measured health-related risk factor and weight data was from the baseline stage of the North West Adelaide Health Study (1999-2003, n = 4056), a longitudinal cohort of Australian adults. Death-related information was obtained from the National Death Index. Primary cause of death across ABSI quartiles was examined. The association between mortality and ABSI (quartile and continuous scores) was investigated using a Cox proportional hazards survival model and adjusting for socioeconomic, and self-reported and biomedical risk factors. The proportion of all three types of mortality steadily increased from ABSI Quartile 1 through to Quartile 4. After adjusting for demographic and health-related risk factors, the risk of all-cause mortality was higher for people in ABSI Quartile 4 (HR 2.64, 95% CI 01.56-4.47), and ABSI Quartile 3 (HR 1.95, 95% CI 1.15-3.33), with a moderate association for the continuous ABSI score (HR 1.32, 95% CI 1.18-1.48). ABSI is therefore positively associated with mortality in Australian adults. Different combined measures of obesity such as the ABSI are useful in examining mortality risk.	[Grant, Janet F.; Chittleborough, Catherine R.] Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia; [Grant, Janet F.; Chittleborough, Catherine R.] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia; [Shi, Zumin; Taylor, Anne W.] Univ Adelaide, Populat Res & Outcome Studies, Discipline Med, Adelaide, SA, Australia	University of Adelaide; Robinson Research Institute; University of Adelaide; University of Adelaide	Grant, JF (corresponding author), Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia.; Grant, JF (corresponding author), Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia.	janet.grant@adelaide.edu.au	Chittleborough, Catherine/A-7436-2011; Shi, Zumin/A-1093-2009; Taylor, Anne w/F-5708-2010; Grant, Janet F/B-9577-2011	Chittleborough, Catherine/0000-0003-3196-7137; Shi, Zumin/0000-0002-3099-3299; Taylor, Anne w/0000-0002-4422-7974; Grant, Janet/0000-0002-3421-5603				Abdullah A, 2011, INT J EPIDEMIOL, V40, P985, DOI 10.1093/ije/dyr018; [Anonymous], 2015, CAUS OF DEATH; Australian Bureau of Statistics. National Health Survey: Users Guide, 2001, NAT HLTH SURV US GUI; Australian Institute of Health & Welfare Heart, 2001, STROK VASC DIS AUSTR; Australian Institute of Health & Welfare Risk Factor Prevalence Study, 1990, CAT NO AIHW; Borrell LN, 2014, AM J PUBLIC HEALTH, V104, P512, DOI 10.2105/AJPH.2013.301597; Cameron AJ, 2009, MED J AUSTRALIA, V191, P202, DOI 10.5694/j.1326-5377.2009.tb02753.x; Carmienke S, 2013, EUR J CLIN NUTR, V67, P573, DOI 10.1038/ejcn.2013.61; Childers DK, 2010, INT J OBESITY, V34, P1231, DOI 10.1038/ijo.2010.71; Colagiuri S, 2009, NATL EVIDENCE BASED; Corrada MM, 2006, AM J EPIDEMIOL, V163, P938, DOI 10.1093/aje/kwj114; Dhana K, 2016, J EPIDEMIOL COMMUN H, V70, P90, DOI 10.1136/jech-2014-205257; Faeh D, 2011, EUR J EPIDEMIOL, V26, P647, DOI 10.1007/s10654-011-9593-2; Flanders WD, 2008, INT J OBESITY, V32, pS42, DOI 10.1038/ijo.2008.84; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Grant Janet F, 2006, Epidemiol Perspect Innov, V3, P4, DOI 10.1186/1742-5573-3-4; Grant JF, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-6; Gray L, 2011, ARCH INTERN MED, V171, P1768, DOI 10.1001/archinternmed.2011.486; Greenberg JA, 2013, OBESITY, V21, P405, DOI 10.1002/oby.20023; HAN TS, 1995, BRIT MED J, V311, P1401, DOI 10.1136/bmj.311.7017.1401; Heron M., 2014, DEATHS LEADING CAUSE; Hu FB, 2007, ARCH INTERN MED, V167, P875, DOI 10.1001/archinte.167.9.875; International Diabetes, 2006, FED IDF CONS WORLDW; Katzmarzyk PT, 2002, INT J OBESITY, V26, P1054, DOI 10.1038/sj.ijo.0802057; Krakauer NY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088793; Krakauer NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039504; Kuk JL, 2009, J AM GERIATR SOC, V57, P2077, DOI 10.1111/j.1532-5415.2009.02486.x; Lenz M, 2009, DTSCH ARZTEBL INT, V106, P641, DOI 10.3238/arztebl.2009.0641; Masters RK, 2013, AM J EPIDEMIOL, V177, P431, DOI 10.1093/aje/kws325; Matheson EM, 2012, J AM BOARD FAM MED, V25, P9, DOI 10.3122/jabfm.2012.01.110164; Mehta NK, 2009, DEMOGRAPHY, V46, P851, DOI 10.1353/dem.0.0077; Ponce-Garcia Isabel, 2015, PLoS One, V10, pe0127369, DOI 10.1371/journal.pone.0127369; Preston SH, 2014, EPIDEMIOLOGY, V25, P454, DOI 10.1097/EDE.0000000000000075; Reis JP, 2009, OBESITY, V17, P1232, DOI 10.1038/oby.2008.664; Roberson LL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-14; Sahakyan KR, 2015, ANN INTERN MED, V163, P827, DOI 10.7326/M14-2525; Sardarinia M, 2017, NUTRITION, V33, P105, DOI 10.1016/j.nut.2016.05.004; Stevens J, 1998, NEW ENGL J MED, V338, P1, DOI 10.1056/NEJM199801013380101; Stevens J, 2005, ENCY HUMAN NUTR, p392 ; Taylor A, 2006, BMC PUBLIC HEALTH, P6; Taylor AW, 2006, AUST NZ J PUBL HEAL, V30, P238, DOI 10.1111/j.1467-842X.2006.tb00864.x; Vanltallie TB, 1998, NUTR REV, V56, P300, DOI 10.1111/j.1753-4887.1998.tb01663.x; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Welborn TA, 2007, EUR J CLIN NUTR, V61, P1373, DOI 10.1038/sj.ejcn.1602656; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Zhang XL, 2007, ARCH INTERN MED, V167, P886, DOI 10.1001/archinte.167.9.886; Zheng H, 2013, AM J EPIDEMIOL, V178, P1591, DOI 10.1093/aje/kwt179	47	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0181244	10.1371/journal.pone.0181244	http://dx.doi.org/10.1371/journal.pone.0181244			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC3TH	28759582	Green Published, gold, Green Submitted			2022-12-26	WOS:000406761600013
J	Hardie, DR; Korsman, SN; Hsiao, NY; Morobadi, MD; Vawda, S; Goedhals, D				Hardie, Diana Ruth; Korsman, Stephen N.; Hsiao, Nei-Yuan; Morobadi, Molefi Daniel; Vawda, Sabeehah; Goedhals, Dominique			Contamination with HIV antibody may be responsible for false positive results in specimens tested on automated platforms running HIV 4th generation assays in a region of high HIV prevalence	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; PERFORMANCE EVALUATION; COMBO ASSAY	Introduction In South Africa where the prevalence of HIV infection is very high, 4th generation HIV antibody/ p24 antigen combo immunoassays are the tests of choice for laboratory based screening. Testing is usually performed in clinical pathology laboratories on automated analysers. To investigate the cause of false positive results on 4th generation HIV testing platforms in public sector laboratories, the performance of two automated platforms was compared in a clinical pathology setting, firstly on routine diagnostic specimens and secondly on known sero-negative samples. Methods Firstly, 1181 routine diagnostic specimens were sequentially tested on Siemens and Roche automated 4th generation platforms. HIV viral load, western blot and follow up testing were used to determine the true status of inconclusive specimens. Subsequently, known HIV seronegative samples from a single donor were repeatedly tested on both platforms and an analyser was tested for surface contamination with HIV positive serum to identify how suspected specimen contamination could be occurring. Results Serial testing of diagnostic specimens yielded 163 weakly positive or discordant results. Only 3 of 163 were conclusively shown to indicate true HIV infection. Specimen contamination with HIV antibody was suspected, based on the following evidence: the proportion of positive specimens increased on repeated passage through the analysers; viral loads were low or undetectable and western blots negative or indeterminate on problem specimens; screen negative, 2 nd test positive specimens tested positive when reanalysed on the screening assay; follow up specimens (where available) were negative. Similarly, an increasing number of known negative specimens became (repeatedly) sero-positive on serial passage through one of the analysers. Internal and external analyser surfaces were contaminated with HIV serum, evidence that sample splashes occur during testing. Conclusions Due to the extreme sensitivity of these assays, contamination with minute amounts of HIV antibody can cause a negative sample to test positive. Better contamination control measures are needed on analysers used in clinical pathology environments, especially in regions where HIV sero-prevalence is high.	[Hardie, Diana Ruth; Korsman, Stephen N.; Hsiao, Nei-Yuan] Univ Cape Town, Div Virol, Dept Pathol, Cape Town, South Africa; [Hardie, Diana Ruth; Korsman, Stephen N.; Hsiao, Nei-Yuan; Morobadi, Molefi Daniel; Vawda, Sabeehah; Goedhals, Dominique] Natl Hlth Lab Serv, Johannesburg, South Africa; [Morobadi, Molefi Daniel; Vawda, Sabeehah; Goedhals, Dominique] Univ Free State, Dept Med Microbiol & Virol, Bloemfontein, South Africa	University of Cape Town; National Health Laboratory Service; University of the Free State	Hardie, DR (corresponding author), Univ Cape Town, Div Virol, Dept Pathol, Cape Town, South Africa.; Hardie, DR (corresponding author), Natl Hlth Lab Serv, Johannesburg, South Africa.	Diana.Hardie@uct.ac.za	hardie, diana/R-6870-2019	Hardie, Diana/0000-0002-0056-7547	Quality Assurance Division of the National Health Laboratory Service	Quality Assurance Division of the National Health Laboratory Service	The cost of reagents was covered by the Quality Assurance Division of the National Health Laboratory Service. Apart from this, the authors received no specific funding for this work.	Alexander TS, 2016, CLIN VACCINE IMMUNOL, V23, P249; Begg K, 2012, ANAL POCT VCT PERFOR, P1; Branson BM, 2014, GUIDELINES RECOMMEND, P4; Buckner CM, 2016, J INFECT DIS, V214, P390, DOI 10.1093/infdis/jiw163; Hancock DB, 2015, AIDS, V29, P767, DOI 10.1097/QAD.0000000000000604; Hare CB, 2006, CLIN INFECT DIS, V42, P700, DOI 10.1086/500215; Klarkowski D, 2014, EXPERT REV ANTI-INFE, V12, P49, DOI 10.1586/14787210.2014.866516; Lee K, 2013, ANN LAB MED, V33, P420, DOI 10.3343/alm.2013.33.6.420; Min C, 2014, J CLIN VIROL, V58, P221; Muhlbacher A, 2013, MED MICROBIOL IMMUN, V202, P77, DOI 10.1007/s00430-012-0250-5; Payne H, 2015, LANCET INFECT DIS, V15, P803, DOI 10.1016/S1473-3099(15)00087-0; Pumarola T, 2010, J VIROL METHODS, V170, P16, DOI 10.1016/j.jviromet.2010.08.012; Rosenberg NE, 2015, CURR OPIN HIV AIDS, V10, P61, DOI 10.1097/COH.0000000000000121; Simbayi L., 2014, AFRICAN NATL HIV P; Wolpaw BJ, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-73; World Health Organization, 1997, WKLY EPIDEMIOL REC, V72, P81	16	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0182167	10.1371/journal.pone.0182167	http://dx.doi.org/10.1371/journal.pone.0182167			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759622	Green Submitted, Green Published, gold			2022-12-26	WOS:000406761600059
J	Armstrong, NM; Gitlin, LN; Parisi, JM; Carlson, MC; Rebok, GW; Gross, AL				Armstrong, Nicole M.; Gitlin, Laura N.; Parisi, Jeanine M.; Carlson, Michelle C.; Rebok, George W.; Gross, Alden L.			E pluribus unum: Harmonization of physical functioning across intervention studies of middle-aged and older adults	PLOS ONE			English	Article							ITEM RESPONSE THEORY; QUALITY-OF-LIFE; RANDOMIZED-TRIAL; HOME INTERVENTION; DEMENTIA; HEALTH; SCALE; ADL; INDIVIDUALS; RASCH	Common scales for physical functioning are not directly comparable without harmonization techniques, complicating attempts to pool data across studies. Our aim was to provide a standardized metric for physical functioning in adults based on basic and instrumental activities of daily living scaled to NIH PROMIS norms. We provide an item bank to compare the difficulty of various physical functioning activities. We used item response theory methods to place 232 basic and instrumental activities of daily living questions, administered across eight intervention studies of middle-aged and older adults (N = 2,556), on a common metric. We compared the scale's precision to an average z-score of items and evaluated criterion validity based on objective measures of physical functioning and Fried's frailty criteria. Model-estimated item thresholds were widely distributed across the range of physical functioning. From test information plots, the lowest precision in each dataset was 0.80. Using power calculations, the sample size needed to detect 25% physical functional decline with 80% power based on the physical functioning factor was less than half of what would be needed using an average z-score. The physical functioning factor correlated in expected directions with objective measurements from the Timed Up and Go task, tandem balance, gait speed, chair stands, grip strength, and frailty status. Item-level harmonization enables direct comparison of physical functioning measures across existing and potentially future studies and across levels of function using a nationally representative metric. We identified key thresholds of physical functioning items in an item bank to facilitate clinical and epidemiologic decision-making.	[Armstrong, Nicole M.; Gross, Alden L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Armstrong, Nicole M.; Carlson, Michelle C.; Rebok, George W.; Gross, Alden L.] Johns Hopkins Univ, Ctr Aging & Hlth, Baltimore, MD 21218 USA; [Gitlin, Laura N.] Johns Hopkins Sch Med, Div Geriatr & Gerontol, Dept Med, Baltimore, MD USA; [Gitlin, Laura N.; Parisi, Jeanine M.] Johns Hopkins Sch Nursing, Ctr Innovat Care Aging, Baltimore, MD USA; [Parisi, Jeanine M.; Carlson, Michelle C.; Rebok, George W.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Armstrong, NM (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.; Armstrong, NM (corresponding author), Johns Hopkins Univ, Ctr Aging & Hlth, Baltimore, MD 21218 USA.	narmstr2@jhu.edu			Johns Hopkins School of Nursing Center for Innovative Care in Aging; Epidemiology and Biostatistics of Aging Training Program, Johns Hopkins Center on Aging and Health [T32AG000247]; National Institute on Aging [R01AG13687, R01 AG041781-01A, P01 AG027735-03, P30-AG021134, P30-AG02113, R37-AG19905]; National Institute on Aging; National Institute on Nursing Research [R01AG22254, AG13305, AG13289, AG13313, AG20277, AG13265, NR004261]; Alzheimer's Association [NPSASA-10-174265]; National Institute of Mental Health [R01 MH079814, RC1MH090770, R21MH069425]; Pennsylvania Department of Health and Tobacco Funds [41000272]; John A. Hartford Foundation; NATIONAL INSTITUTE ON AGING [T32AG000247, P50AG005146] Funding Source: NIH RePORTER	Johns Hopkins School of Nursing Center for Innovative Care in Aging; Epidemiology and Biostatistics of Aging Training Program, Johns Hopkins Center on Aging and Health; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); Alzheimer's Association(Alzheimer's Association); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Pennsylvania Department of Health and Tobacco Funds; John A. Hartford Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a Pilot Award from the Johns Hopkins School of Nursing Center for Innovative Care in Aging (PI: Gross) and T32AG000247 (Epidemiology and Biostatistics of Aging Training Program, Johns Hopkins Center on Aging and Health) (Armstrong). ABLE was funded by the National Institute on Aging (Grant Number: R01AG13687, PI, Gitlin). ACT was funded by the National Institute on Aging and the National Institute on Nursing Research (Grant Number: R01AG22254, PI, Gitlin). ALZQOL was funded by Alzheimer's Association (Grant Number: NPSASA-10-174265, PI, Gitlin). Beat the Blues (BTB) was funded by the National Institute of Mental Health (Grant Numbers: R01 MH079814, RC1MH090770, PI, Gitlin). COPE was funded by the Pennsylvania Department of Health and Tobacco Funds (Grant Number: SAP#41000272, PI, Gitlin). REACH II was funded by the National Institute on Aging and the National Institute on Nursing Research (AG13305, AG13289, AG13313, AG20277, AG13265, NR004261, PI, Gitlin). TAP was funded by the National Institute of Mental Health (Grant Number: R21MH069425) and currently by the National Institute on Aging (Grant Number: R01 AG041781-01A). BECT was funded by the National Institute on Aging (P01 AG027735-03 and P30-AG021134), the John A. Hartford Foundation, and the Johns Hopkins Older Americans Independence Center under the National Institute on Aging (P30-AG02113 and R37-AG19905). Role of Sponsors/Funders: The contents do not necessarily represent views of the funding entities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASBERG KH, 1989, SCAND J REHABIL MED, V21, P171; Belle SH, 2006, ANN INTERN MED, V145, P727, DOI 10.7326/0003-4819-145-10-200611210-00005; Bjorner JB, 1998, J CLIN EPIDEMIOL, V51, P1189, DOI 10.1016/S0895-4356(98)00111-5; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BORTZ WM, 1993, J AM GERIATR SOC, V41, P1004; BUJA A, 1992, MULTIVAR BEHAV RES, V27, P509, DOI 10.1207/s15327906mbr2704_2; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Ettinger WH, 1997, JAMA-J AM MED ASSOC, V277, P25, DOI 10.1001/jama.277.1.25; Fieo RA, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-42; Fisher W P Jr, 1997, J Outcome Meas, V1, P329; Fried LP, 2013, CONTEMP CLIN TRIALS, V36, P1, DOI 10.1016/j.cct.2013.05.003; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gitlin L., 2005, PHYS FUNCTION OLDER; Gitlin LN, 2006, J AM GERIATR SOC, V54, P809, DOI 10.1111/j.1532-5415.2006.00703.x; Gitlin LN, 2014, AM J GERIAT PSYCHIAT, V22, P587, DOI 10.1016/j.jagp.2012.11.005; Gitlin LN, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-4; Gitlin LN, 2010, JAMA-J AM MED ASSOC, V304, P983, DOI 10.1001/jama.2010.1253; Gitlin LN, 2009, GERONTOLOGIST, V49, P428, DOI 10.1093/geront/gnp087; Gitlin LN, 2009, J AM GERIATR SOC, V57, P476, DOI 10.1111/j.1532-5415.2008.02147.x; Gitlin LN, 2005, J AGING HEALTH, V17, P148, DOI 10.1177/0898264304274184; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; Gross AL, 2015, PSYCHOL AGING, V30, P863, DOI 10.1037/pag0000032; HALEY SM, 1994, J CLIN EPIDEMIOL, V47, P671, DOI 10.1016/0895-4356(94)90215-1; Hambleton R. K., 1991, FUNDAMENTALS ITEM RE; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Jenkinson C, 2001, J NEUROL NEUROSUR PS, V71, P220, DOI 10.1136/jnnp.71.2.220; JORESKOG KG, 1975, J AM STAT ASSOC, V70, P631, DOI 10.2307/2285946; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; KEMPEN GIJM, 1990, GERONTOLOGIST, V30, P497, DOI 10.1093/geront/30.4.497; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Liu H., 2009, J CLIN EPIDEMIOL, V63, P1169, DOI DOI 10.1016/J.JCLINEPI.2009.11.021]; Lord FM, 1953, EDUC PSYCHOL MEAS, V13, P517, DOI 10.1177/001316445301300401; Mathews CE, 2012, EXERC SPORT SCI REV, V40, P118, DOI 10.1097/JES.0b013e31825b34a0; Muthen B., 2010, MPLUS USERS GUIDE; Raczek AE, 1998, J CLIN EPIDEMIOL, V51, P1203, DOI 10.1016/S0895-4356(98)00112-7; Rose M, 2008, J CLIN EPIDEMIOL, V61, P17, DOI 10.1016/j.jclinepi.2006.06.025; Rose M, 2014, J CLIN EPIDEMIOL, V67, P516, DOI 10.1016/j.jclinepi.2013.10.024; Stewart AL, 1992, MEASURING FUNCTIONIN, P86; TAKANE Y, 1987, PSYCHOMETRIKA, V52, P393, DOI 10.1007/BF02294363; Tonner M Christine, 2004, Home Health Care Serv Q, V22, P65, DOI 10.1300/J027v22n04_04; Tsuji T, 1995, AM J PHYS MED REHAB, V74, P432, DOI 10.1097/00002060-199511000-00007; VANDERHEIDE A, 1993, ANN RHEUM DIS, V52, P497, DOI 10.1136/ard.52.7.497; Woods CM, 2009, APPL PSYCH MEAS, V33, P42, DOI 10.1177/0146621607314044	45	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0181746	10.1371/journal.pone.0181746	http://dx.doi.org/10.1371/journal.pone.0181746			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1ED	28753644	gold, Green Submitted, Green Published			2022-12-26	WOS:000406579300024
J	Wang, Q; He, HJ; Li, B; Lin, HC; Zhang, YM; Zhang, J; Wang, ZY				Wang, Qi; He, Haijun; Li, Bing; Lin, Hancheng; Zhang, Yinming; Zhang, Ji; Wang, Zhenyuan			UV-Vis and ATR-FTIR spectroscopic investigations of postmortem interval based on the changes in rabbit plasma	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; OXIDATIVE STRESS; INFRARED-SPECTROSCOPY; FEATURE-SELECTION; DETERMINING TIME; IR SPECTROSCOPY; PLS-REGRESSION; DEATH; BLOOD; RAT	Estimating PMI is of great importance in forensic investigations. Although many methods are used to estimate the PMI, a few investigations focus on the postmortem redistribution. In this study, ultraviolet-visible (UV-Vis) measurement combined with visual inspection indicated a regular diffusion of hemoglobin into plasma after death showing the redistribution of postmortem components in blood. Thereafter, attenuated total reflection-Fourier transform infrared (ATR-FTIR) spectroscopy was used to confirm the variations caused by this phenomenon. First, full-spectrum partial least-squares (PLS) and genetic algorithm combined with PLS (GA-PLS) models were constructed to predict the PMI. The performance of GA-PLS model was better than that of full-spectrum PLS model based on its root mean square error (RMSE) of cross-validation of 3.46 h (R-2 = 0.95) and the RMSE of prediction of 3.46 h (R-2 = 0.94). The investigation on the similarity of spectra between blood plasma and formed elements also supported the role of redistribution of components in spectral changes in postmortem plasma. These results demonstrated that ATR-FTIR spectroscopy coupled with the advanced mathematical methods could serve as a convenient and reliable tool to study the redistribution of postmortem components and estimate the PMI.	[Wang, Qi; He, Haijun; Li, Bing; Lin, Hancheng; Zhang, Yinming; Zhang, Ji; Wang, Zhenyuan] Xi An Jiao Tong Univ, Dept Forens Pathol, Coll Forens Med, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University	Wang, ZY (corresponding author), Xi An Jiao Tong Univ, Dept Forens Pathol, Coll Forens Med, Xian, Shaanxi, Peoples R China.	wzy218@xjtu.edu.cn	wang, zhenyuan/AAB-4874-2021	Wang, zhenyuan/0000-0003-3561-6414	Council of National Natural Science Foundation of China [81471819, 81273335]	Council of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the Council of National Natural Science Foundation of China (Nos. 81471819, 81273335).	Alves A, 2012, WOOD SCI TECHNOL, V46, P157, DOI 10.1007/s00226-010-0383-x; Amendt J, 2007, INT J LEGAL MED, V121, P90, DOI 10.1007/s00414-006-0086-x; Andersen CM, 2010, J CHEMOMETR, V24, P728, DOI 10.1002/cem.1360; Appierto V, 2014, BIOANALYSIS, V6, P1215, DOI 10.4155/bio.13.344; Baker MJ, 2014, NAT PROTOC, V9, P1771, DOI 10.1038/nprot.2014.110; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Bauer Martin, 2003, Leg Med (Tokyo), V5, P220, DOI 10.1016/j.legalmed.2003.08.001; Bras LP, 2008, J CHEMOMETR, V22, P695, DOI 10.1002/cem.1153; CARRUTHERS A, 1990, PHYSIOL REV, V70, P1135, DOI 10.1152/physrev.1990.70.4.1135; Costa I, 2015, TOXICOL RES-UK, V4, P1443, DOI 10.1039/c5tx00209e; Couteaux MM, 2005, SOIL BIOL BIOCHEM, V37, P795, DOI 10.1016/j.soilbio.2004.08.028; Dokgoz H, 2001, FORENSIC SCI INT, V124, P25, DOI 10.1016/S0379-0738(01)00559-X; Donaldson AE, 2015, METABOLOMICS, V11, P237, DOI 10.1007/s11306-014-0691-5; Donaldson AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082011; Donaldson AE, 2014, AUST J FORENSIC SCI, V46, P8, DOI 10.1080/00450618.2013.784356; Elkins KM, 2011, J FORENSIC SCI, V56, P1580, DOI 10.1111/j.1556-4029.2011.01870.x; Gall JAM, 2003, J ROY SOC MED, V96, P556; Gumu fx M.D.A, 2015, J FORENSIC SCI; HARBOE M, 1959, SCAND J CLIN LAB INV, V11, P66, DOI 10.3109/00365515909060410; Hasegawa K, 1998, THEOCHEM-J MOL STRUC, V425, P255, DOI 10.1016/S0166-1280(97)00205-4; Henssge C, 2004, FORENSIC SCI INT, V144, P167, DOI 10.1016/j.forsciint.2004.04.051; Henssge C, 2007, FORENSIC SCI INT, V165, P182, DOI 10.1016/j.forsciint.2006.05.017; Huang P, 2008, SPECTROSC-INT J, V22, P21, DOI 10.1155/2008/870871; Huang P, 2009, SPECTROSC LETT, V42, P108, DOI 10.1080/00387010802375362; Hyde ER, 2015, INT J LEGAL MED, V129, P661, DOI 10.1007/s00414-014-1128-4; Jetter W. W., 1943, AMER JOUR CLIN PATH, V13, P178; Jiang CP, 2009, J CHROMATOGR A, V1216, P5849, DOI 10.1016/j.chroma.2009.06.013; Katsumata Y, 1983, Nihon Hoigaku Zasshi, V37, P75; Ke Y, 2012, J FORENSIC SCI, V57, P794, DOI 10.1111/j.1556-4029.2011.02036.x; Kikuchi K, 2010, EXP THER MED, V1, P109, DOI 10.3892/etm_00000019; Kirschner MB, 2011, PLOS ONE, V6, P270; Kurtulus A, 2012, LEGAL MED-TOKYO, V14, P214, DOI 10.1016/j.legalmed.2012.03.002; Leardi R, 1998, CHEMOMETR INTELL LAB, V41, P195, DOI 10.1016/S0169-7439(98)00051-3; Leardi R, 2000, J CHEMOMETR, V14, P643, DOI 10.1002/1099-128X(200009/12)14:5/6<643::AID-CEM621>3.0.CO;2-E; Leardi R, MANUAL PLS GENETIC A; Leardi R., 2004, PLS GENETIC ALGORITH; LEE DC, 1990, BIOCHEMISTRY-US, V29, P9185, DOI 10.1021/bi00491a012; Machaalani R, 2010, NEUROCHEM INT, V57, P655, DOI 10.1016/j.neuint.2010.08.002; MADEA B, 1994, FORENSIC SCI INT, V69, P221, DOI 10.1016/0379-0738(94)90386-7; Madea B, 2005, FORENSIC SCI INT, V151, P139, DOI 10.1016/j.forsciint.2005.01.013; Maeda H, 2011, LEGAL MED-TOKYO, V13, P55, DOI 10.1016/j.legalmed.2010.12.005; Mao SW, 2013, LEGAL MED-TOKYO, V15, P235, DOI 10.1016/j.legalmed.2013.03.004; Mao SW, 2011, SCI JUSTICE, V51, P135, DOI 10.1016/j.scijus.2010.11.003; Martin FL, 2010, NAT PROTOC, V5, P1748, DOI 10.1038/nprot.2010.133; Mehmood T, 2016, J CHEMOMETR, V30, P4, DOI 10.1002/cem.2762; Movasaghi Z, 2008, APPL SPECTROSC REV, V43, P134, DOI 10.1080/05704920701829043; Mukhopadhyay R, 2004, ANAL CHEM, V76, p369A, DOI 10.1021/ac041652z; Olsztynska-Janus S, 2012, ACTA BIOENG BIOMECH, V14, P101, DOI 10.5277/abb120314; Oussama A, 2012, J AM OIL CHEM SOC, V89, P1807, DOI 10.1007/s11746-012-2091-1; Petibois C, 2006, ANALYST, V131, P640, DOI 10.1039/b518076g; Petibois C, 2005, CELL BIOL INT, V29, P709, DOI 10.1016/j.cellbi.2005.04.007; Petibois C, 2004, ANALYST, V129, P912, DOI 10.1039/b408931f; Petibois C, 2000, J LAB CLIN MED, V135, P210, DOI 10.1067/mlc.2000.104460; Petibois C, 2008, INT J SPORT PHYSIOL, V3, P119, DOI 10.1123/ijspp.3.2.119; Poloz YO, 2009, INT J LEGAL MED, V123, P305, DOI 10.1007/s00414-009-0343-x; Rein AJ, 2013, AM LAB, V45, P16; Rinnan A, 2009, TRAC-TREND ANAL CHEM, V28, P1201, DOI 10.1016/j.trac.2009.07.007; Sato T, 2015, ANAL BIOANAL CHEM, V407, P3659, DOI 10.1007/s00216-015-8584-7; SCHONING P, 1980, AM J VET RES, V41, P955; Severcan M, 2001, J MOL STRUCT, V565, P383, DOI 10.1016/S0022-2860(01)00505-1; Sowemimo-Coker SO, 2002, TRANSFUS MED REV, V16, P46, DOI 10.1053/tmrv.2002.29404; Staniszewska E, 2014, SPECTROCHIM ACTA A, V118, P981, DOI 10.1016/j.saa.2013.09.131; Staniszewska-Slezak E, 2015, ANALYST, V140, P2273, DOI 10.1039/c4an01864h; Tuo Y, 2010, APPL SPECTROSC, V64, P268, DOI 10.1366/000370210790918382; Vass AA, 2002, J FORENSIC SCI, V47, P542; Warther S, 2012, INT J LEGAL MED, V126, P399, DOI 10.1007/s00414-011-0665-3; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Yang HY, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2015.024; Ziegel E. R., 2002, TECHNORNETRICS, V17, P108	69	21	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0182161	10.1371/journal.pone.0182161	http://dx.doi.org/10.1371/journal.pone.0182161			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753641	Green Published, Green Submitted, gold			2022-12-26	WOS:000406579300053
J	Jansson, AM; Csiszar, A; Maier, J; Nystrom, AC; Ax, E; Johansson, P; Schiavone, LH				Jansson, Anna M.; Csiszar, Agnes; Maier, Joachim; Nystrom, Ann-Christin; Ax, Elisabeth; Johansson, Patrik; Schiavone, Lovisa Holmberg			The interleukin-like epithelial-mesenchymal transition inducer ILEI exhibits a non-interleukin-like fold and is active as a domain-swapped dimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; GAMMA-SECRETASE; PROGRESSION; CANCER; TGF-BETA-1; CARCINOMA; PATHOLOGY; FAM3C; CELLS; RAS	Production and secretion of pro-metastatic proteins is a feature of many tumor cells. The FAM3C interleukin-like epithelialto-mesenchymal-transition (EMT) inducer (ILEI) has been shown to be strongly up-regulated in several cancers and to be essential for tumor formation and metastasis in epithelial cells, correlating with a significant decrease in overall survival in colon and breast cancer patients. ILEI has been seen to interact with the gamma-secretase presenilin 1 subunit (PS1). However, not much is known about the mechanism-of-action or the detailed ILEI structure. We present here the crystal structures of FAM3C ILEI and show that it exists as monomers but also as covalent dimers. The observed ILEI beta-beta-alpha fold confirmed previous indications that the FAM3C proteins do not form classical four-helix-bundle structures as was initially predicted. This provides the first experimental evidence that the interleukin-like EMT inducers are not evolutionarily related to the interleukins. However, more surprisingly, the ILEI dimer structure was found to feature a trans-linked domain swap, converting an intramolecular disulfide to intermolecular. Interestingly, dimeric but not monomeric ILEI was subsequently found to cause a dose-dependent increase in EpRas cell invasiveness comparable with TGF-alpha, indicating that the dimer might be the active ILEI species. This is in line with a parallel study showing that covalent oligomerization of ILEI is essential for EMT and tumor progression in vivo. The structures and the activity data give some first insight into the relationship between dimerization and ILEI function as well as indicate an intriguing link between ILEI, the PS1-protease, TGF-beta, and the TGF-beta receptor 1.	[Jansson, Anna M.; Maier, Joachim; Ax, Elisabeth; Schiavone, Lovisa Holmberg] AstraZeneca, Discovery Sci Dept, Reagents & Assay Dev Div, Pepparedsleden 1, S-43183 Molndal, Sweden; [Nystrom, Ann-Christin] AstraZeneca, Cardiovas & Metab Dis Dept, Translat Sci Div, Pepparedsleden 1, S-43183 Molndal, Sweden; [Johansson, Patrik] AstraZeneca, Discovery Sci Dept, Struct & Biophys Div, Pepparedsleden 1, S-43183 Molndal, Sweden; [Csiszar, Agnes] Med Univ Vienna, Dept Med 1, Inst Canc Res, Borschkegasse 8a, A-1090 Vienna, Austria	AstraZeneca; AstraZeneca; AstraZeneca; Medical University of Vienna	Johansson, P (corresponding author), AstraZeneca, Discovery Sci Dept, Struct & Biophys Div, Pepparedsleden 1, S-43183 Molndal, Sweden.; Schiavone, LH (corresponding author), AstraZeneca R&D, Reagents & Assay Dev, Discovery Sci, Pepparedsleden 1, S-43183 Molndal, Sweden.	patrik.johansson@astrazeneca.com; lovisa.holmberg.schiavone@astrazeneca.com	Csiszar, Agnes/I-2747-2019	Csiszar, Agnes/0000-0001-7911-3427; Ax, Elisabeth/0000-0001-7553-5059	Discovery Sciences, AstraZeneca; Austrian Science Foundation (FWF) [P25834-B23]; Austrian Science Fund (FWF) [P 25834] Funding Source: researchfish	Discovery Sciences, AstraZeneca; Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Discovery Sciences, AstraZeneca. This work was also supported by the Austrian Science Foundation (FWF) Grant P25834-B23) (to A.C.). A. M. J., J. M., A.-C. N., E. A., P. J., and L. H. S. are employees of AstraZeneca, which provided funding.	Bai XC, 2015, NATURE, V525, P212, DOI 10.1038/nature14892; Bettye T. G., 2017, ACTA CRYSTALLOGR D, V67, P271; Bolduc DM, 2016, P NATL ACAD SCI USA, V113, pE509, DOI 10.1073/pnas.1512952113; Bricogne G., 2016, BUSTER VERSION 2 11; Caraci F, 2012, EUR NEUROPSYCHOPHARM, V22, P281, DOI 10.1016/j.euroneuro.2011.08.006; Caraci F, 2011, CNS NEUROSCI THER, V17, P237, DOI 10.1111/j.1755-5949.2009.00115.x; Chaudhury A, 2010, NAT CELL BIOL, V12, P286, DOI 10.1038/ncb2029; Csiszar A, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0433-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gao ZH, 2014, HISTOPATHOLOGY, V65, P527, DOI 10.1111/his.12435; Halberg N, 2016, CANCER CELL, V29, P339, DOI 10.1016/j.ccell.2016.02.013; Hasegawa H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4917; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hussey GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052624; Johansson P, 2013, STRUCTURE, V21, P306, DOI 10.1016/j.str.2012.12.009; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2005, COMP LIF SCI 1 INT S; Lahsnig C, 2009, ONCOGENE, V28, P638, DOI 10.1038/onc.2008.418; Liu L, 2016, NEUROSCIENCE, V330, P236, DOI 10.1016/j.neuroscience.2016.05.050; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Song Q, 2014, TUMOR BIOL, V35, P1377, DOI 10.1007/s13277-013-1188-y; Stewart R, 2011, PROTEIN ENG DES SEL, V24, P671, DOI 10.1093/protein/gzr015; Tesseur I, 2006, J CLIN INVEST, V116, P3060, DOI 10.1172/JCI27341; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; Waerner T, 2006, CANCER CELL, V10, P227, DOI 10.1016/j.ccr.2006.07.020; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhu Y, 2002, GENOMICS, V80, P144, DOI 10.1006/geno.2002.6816; Zhu YH, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0424-8	30	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15501	15511		10.1074/jbc.M117.782904	http://dx.doi.org/10.1074/jbc.M117.782904			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28751379	hybrid, Green Published			2022-12-26	WOS:000410809800029
J	Jaime-Gonzalez, C; Acebes, P; Mateos, A; Mezquida, ET				Jaime-Gonzalez, Carlos; Acebes, Pablo; Mateos, Ana; Mezquida, Eduardo T.			Bridging gaps: On the performance of airborne LiDAR to model wood mouse-habitat structure relationships in pine forests	PLOS ONE			English	Article							SMALL MAMMALS; BOREAL FORESTS; SPECIES RICHNESS; LANDSCAPE; ABUNDANCE; RODENTS; TREE; TEMPERATE; PATTERN; LIGHT	LiDAR technology has firmly contributed to strengthen the knowledge of habitat structure-wildlife relationships, though there is an evident bias towards flying vertebrates. To bridge this gap, we investigated and compared the performance of LiDAR and field data to model habitat preferences of wood mouse (Apodemus sylvaticus) in a Mediterranean high mountain pine forest (Pinus sylvestris). We recorded nine field and 13 LiDAR variables that were summarized by means of Principal Component Analyses (PCA). We then analyzed wood mouse's habitat preferences using three different models based on: (i) field PCs predictors, (ii) LiDAR PCs predictors; and (iii) both set of predictors in a combined model, including a variance partitioning analysis. Elevation was also included as a predictor in the three models. Our results indicate that LiDAR derived variables were better predictors than field-based variables. The model combining both data sets slightly improved the predictive power of the model. Field derived variables indicated that wood mouse was positively influenced by the gradient of increasing shrub cover and negatively affected by elevation. Regarding LiDAR data, two LiDAR PCs, i.e. gradients in canopy openness and complexity in forest vertical structure positively influenced wood mouse, although elevation interacted negatively with the complexity in vertical structure, indicating wood mouse's preferences for plots with lower elevations but with complex forest vertical structure. The combined model was similar to the LiDAR-based model and included the gradient of shrub cover measured in the field. Variance partitioning showed that LiDAR-based variables, together with elevation, were the most important predictors and that part of the variation explained by shrub cover was shared. LiDAR derived variables were good surrogates of environmental characteristics explaining habitat preferences by the wood mouse. Our LiDAR metrics represented structural features of the forest patch, such as the presence and cover of shrubs, as well as other characteristics likely including time since perturbation, food availability and predation risk. Our results suggest that LiDAR is a promising technology for further exploring habitat preferences by small mammal communities.	[Jaime-Gonzalez, Carlos; Acebes, Pablo; Mateos, Ana; Mezquida, Eduardo T.] Univ Autonoma Madrid, Dept Ecol, Fac Sci, Madrid, Spain	Autonomous University of Madrid	Jaime-Gonzalez, C (corresponding author), Univ Autonoma Madrid, Dept Ecol, Fac Sci, Madrid, Spain.	carlos.jaime.g@gmail.com	Acebes, Pablo/L-6444-2014	Acebes Vives, Pablo/0000-0003-1880-7841	Universidad Autonoma de Madrid (Spain)	Universidad Autonoma de Madrid (Spain)	CJ was partially funded by the Universidad Autonoma de Madrid (Spain) for performing the field work, thanks to an aid program for postgraduates students. This paper is a contribution to the REMEDINAL 3 (S2013/MAE-2719) network of the CAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackers SH, 2015, REMOTE SENS ENVIRON, V156, P361, DOI 10.1016/j.rse.2014.09.025; AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; [Anonymous], 1993, ECOGRAPHY, V16, P47; Arnan X, 2014, J NAT HIST, V48, P481, DOI 10.1080/00222933.2013.800611; Barbeito I, 2011, CAN J FOREST RES, V41, P341, DOI 10.1139/X10-214; Barbeito I, 2009, APPL VEG SCI, V12, P488, DOI 10.1111/j.1654-109X.2009.01043.x; Bartemucci P, 2006, CAN J FOREST RES, V36, P2065, DOI 10.1139/X06-088; Bergen KM, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000883; Bertolino S, 2015, HYSTRIX, V26, P25, DOI 10.4404/hystrix-26.1-10263; Bogdziewicz M, 2014, EUR J FOREST RES, V133, P1, DOI 10.1007/s10342-013-0726-x; Briggs JS, 2009, ECOLOGY, V90, P675, DOI 10.1890/07-0542.1; Castro J, 2004, J ECOL, V92, P266, DOI 10.1111/j.0022-0477.2004.00870.x; CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; Davies AB, 2014, TRENDS ECOL EVOL, V29, P681, DOI 10.1016/j.tree.2014.10.005; Ecke F, 2002, J APPL ECOL, V39, P781, DOI 10.1046/j.1365-2664.2002.00759.x; Fedriani JM, 2005, BEHAV ECOL, V16, P1018, DOI 10.1093/beheco/ari082; Froidevaux JSP, 2016, REMOTE SENS ENVIRON, V175, P242, DOI 10.1016/j.rse.2015.12.038; Fuller AK, 2004, FOREST ECOL MANAG, V191, P373, DOI 10.1016/j.foreco.2004.01.014; Garcia FJ, 1998, ACTA THERIOL, V43, P255, DOI 10.4098/AT.arch.98-20; Goetz S, 2007, REMOTE SENS ENVIRON, V108, P254, DOI 10.1016/j.rse.2006.11.016; Gurnell J., 2006, LIVE TRAPPING SMALL, VFourth edition, revised ed.; Gustafson EJ, 1998, ECOSYSTEMS, V1, P143, DOI 10.1007/s100219900011; Hirsch BT, 2012, ECOL LETT, V15, P1423, DOI 10.1111/ele.12000; Holloway GL, 2012, FOREST ECOL MANAG, V285, P187, DOI 10.1016/j.foreco.2012.08.025; Jung K, 2012, J APPL ECOL, V49, P523, DOI 10.1111/j.1365-2664.2012.02116.x; Latifi H, 2016, FORESTRY, V89, P69, DOI 10.1093/forestry/cpv032; Lefsky MA, 2002, BIOSCIENCE, V52, P19, DOI 10.1641/0006-3568(2002)052[0019:LRSFES]2.0.CO;2; Lone K, 2014, OIKOS, V123, P641, DOI 10.1111/j.1600-0706.2013.00938.x; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; Maltamo M, 2005, FOREST ECOL MANAG, V216, P41, DOI 10.1016/j.foreco.2005.05.034; Marsh ACW, 2000, BIOL CONSERV, V92, P275, DOI 10.1016/S0006-3207(99)00071-3; Martinuzzi S, 2009, REMOTE SENS ENVIRON, V113, P2533, DOI 10.1016/j.rse.2009.07.002; McCay TS, 2000, J MAMMAL, V81, P527, DOI 10.1644/1545-1542(2000)081&lt;0527:UOWDBC&gt;2.0.CO;2; McGaughey R. J., 2003, P TERR DAT APPL VIS, P28; Melin M, 2016, REMOTE SENS ENVIRON, V173, P238, DOI 10.1016/j.rse.2015.07.025; Montgomery WI., 1999, ATLAS EUROPEAN MAMMA, P274; Moran-Lopez T, 2016, OIKOS, V125, P1445, DOI 10.1111/oik.02884; Moreira-Arce D, 2016, FOREST ECOL MANAG, V369, P135, DOI 10.1016/j.foreco.2016.03.024; Morris DW, 2003, OECOLOGIA, V136, P1, DOI 10.1007/s00442-003-1241-4; Muller J, 2014, MANAG FOR ECOSYST, V27, P357, DOI 10.1007/978-94-017-8663-8_18; Muller J, 2009, J APPL ECOL, V46, P897, DOI 10.1111/j.1365-2664.2009.01677.x; Naxara L, 2009, J MAMMAL, V90, P404, DOI 10.1644/08-MAMM-A-100.1; Nelson R, 2005, REMOTE SENS ENVIRON, V96, P292, DOI 10.1016/j.rse.2005.02.012; Palminteri S, 2012, REMOTE SENS ENVIRON, V127, P98, DOI 10.1016/j.rse.2012.08.014; Petty SJ, 1999, J ZOOL, V248, P451, DOI 10.1111/j.1469-7998.1999.tb01045.x; RIITTERS KH, 1995, LANDSCAPE ECOL, V10, P23, DOI 10.1007/BF00158551; Ruiz-Capillas P, 2013, BIOL CONSERV, V158, P223, DOI 10.1016/j.biocon.2012.09.025; Skowronski N, 2007, REMOTE SENS ENVIRON, V108, P123, DOI 10.1016/j.rse.2006.09.032; Sullivan TP, 2000, ECOL APPL, V10, P1367, DOI 10.1890/1051-0761(2000)010[1367:SMASSI]2.0.CO;2; Team RC, 2013, R FDN STAT COMP; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Torre I., 2002, Galemys, V14, P1; Torre I, 2004, ACTA OECOL, V25, P137, DOI 10.1016/j.actao.2003.10.007; Torre I, 2009, VIE MILIEU, V59, P199; Torre I, 2014, ACTA THERIOL, V59, P139, DOI 10.1007/s13364-013-0128-y; Vierling KT, 2008, FRONT ECOL ENVIRON, V6, P90, DOI 10.1890/070001; Walsh C., 2013, PACKAGE HIER PART HI; Zuur Alain F., 2009, P1; Zwolak R, 2016, FOREST ECOL MANAG, V359, P268, DOI 10.1016/j.foreco.2015.10.017	59	9	9	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182451	10.1371/journal.pone.0182451	http://dx.doi.org/10.1371/journal.pone.0182451			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771566	Green Published, gold, Green Submitted			2022-12-26	WOS:000406853600117
J	Nagy, E; Pilling, K; Watt, R; Pal, A; Orvos, H				Nagy, Emese; Pilling, Karen; Watt, Rachel; Pal, Attila; Orvos, Hajnalka			Neonates' responses to repeated exposure to a still face	PLOS ONE			English	Article							MOTHER-INFANT INTERACTION; FOLLOW-UP; FULL-TERM; CESAREAN CHILDBIRTH; 6-MONTH-OLD INFANTS; EMOTION REGULATION; SOCIAL COMPETENCE; NEWBORN-INFANTS; PRETERM INFANTS; HOMO PROVOCANS	Aim The main aims of the study were to examine whether human neonates' responses to communication disturbance modelled by the still-face paradigm were stable and whether their responses were affected by their previous experience with the still-face paradigm. Methods The still face procedure, as a laboratory model of interpersonal stress, was administered repeatedly, twice, to 84 neonates (0 to 4 day olds), with a delay of an average of 1.25 day. Results Frame-by-frame analysis of the frequency and duration of gaze, distressed face, crying, sleeping and sucking behaviours showed that the procedure was stressful to them both times, that is, the still face effect was stable after repeated administration and newborns consistently responded to such nonverbal violation of communication. They averted their gaze, showed distress and cried more during the still-face phase in both the first and the second administration. They also showed a carry-over effect in that they continued to avert their gaze and displayed increased distress and crying in the first reunion period, but their gaze behaviour changed with experience, in the second administration. While in the first administration the babies continued averting their gaze even after the stressful still-face phase was over, this carry-over effect disappeared in the second administration, and the babies significantly increased their gaze following the still-face phase. Conclusion After excluding explanations of fatigue, habituation and random effects, a self-other regulatory model is discussed as a possible explanation for this pattern.	[Nagy, Emese; Pilling, Karen; Watt, Rachel] Univ Dundee, Psychol, Pk Pl, Dundee DD1 4HN, Scotland; [Pal, Attila; Orvos, Hajnalka] Univ Szeged, Dept Obstet & Gynaecol, Szeged, Hungary	University of Dundee; Szeged University	Nagy, E (corresponding author), Univ Dundee, Psychol, Pk Pl, Dundee DD1 4HN, Scotland.	E.Nagy@dundee.ac.uk			Economic & Social Research Council [RES-062-23-1779]; Economic and Social Research Council [ES/G029202/1] Funding Source: researchfish; ESRC [ES/G029202/1] Funding Source: UKRI	Economic & Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The study was supported by grant RES-062-23-1779 from the Economic & Social Research Council to EN.; The Authors thank Jozsefne Varga for her help in recruitment, to Dezsone Nagy for her help in managing the database, to John Morris for his technical assistance. The study was supported by grant RES-062-23-1779 from the Economic & Social Research Council to E.N.	Adamson LB, 2003, INFANCY, V4, P451, DOI 10.1207/S15327078IN0404_01; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 1973, NEONATAL BEHAV ASSES; Bazhenova OV, 2001, CHILD DEV, V72, P1314, DOI 10.1111/1467-8624.00350; Bertin E, 2006, INFANT BEHAV DEV, V29, P294, DOI 10.1016/j.infbeh.2005.12.003; Bigelow AE, 2012, INFANT BEHAV DEV, V35, P240, DOI 10.1016/j.infbeh.2011.12.008; Brazelton T.B., 1974, MOTHER INFANT INTERA; Bushnell IWR, 2001, INFANT CHILD DEV, V10, P67, DOI 10.1002/icd.248; BUSHNELL IWR, 1984, BRIT J DEV PSYCHOL, V2, P11, DOI 10.1111/j.2044-835X.1984.tb00530.x; COHN JF, 1983, CHILD DEV, V54, P185, DOI 10.2307/1129876; Conradt E, 2010, INFANT BEHAV DEV, V33, P251, DOI 10.1016/j.infbeh.2010.01.001; Cossette L, 1996, SEX ROLES, V35, P693, DOI 10.1007/BF01544087; CULP RE, 1989, BIRTH-ISS PERINAT C, V16, P53, DOI 10.1111/j.1523-536X.1989.tb00860.x; DECASPER AJ, 1986, INFANT BEHAV DEV, V9, P133, DOI 10.1016/0163-6383(86)90025-1; FIELD T, 1988, CHILD DEV, V59, P1569, DOI 10.1111/j.1467-8624.1988.tb03684.x; Field T, 2007, INFANT MENT HEALTH J, V28, P314, DOI 10.1002/imhj.20138; Field T, 2009, INFANT BEHAV DEV, V32, P239, DOI 10.1016/j.infbeh.2009.03.005; FIELD TM, 1981, INFANT BEHAV DEV, V4, P307, DOI 10.1016/S0163-6383(81)80032-X; FIELD TM, 1980, INFANT BEHAV DEV, V3, P253, DOI 10.1016/S0163-6383(80)80031-2; Forbes EE, 2004, INFANCY, V5, P61, DOI 10.1207/s15327078in0501_3; GAREL M, 1988, EARLY HUM DEV, V16, P271, DOI 10.1016/0378-3782(88)90108-9; GAREL M, 1990, EARLY HUM DEV, V21, P105, DOI 10.1016/0378-3782(90)90039-L; Geva R, 2008, J CHILD PSYCHOL PSYC, V49, P1031, DOI 10.1111/j.1469-7610.2008.01918.x; GOTTLIEB SE, 1986, J DEV BEHAV PEDIATR, V7, P180; GUSELLA JL, 1988, CHILD DEV, V59, P1111; Haley DW, 2003, CHILD DEV, V74, P1534, DOI 10.1111/1467-8624.00621; Heimann M, 2001, EMERGING COGNITIVE ABILITIES IN EARLY INFANCY, P231; Heimann M., 2002, IMITATIVE MIND DEV E, P74, DOI DOI 10.1017/CB09780511489969.005; Hsu HC, 2008, INFANT BEHAV DEV, V31, P194, DOI 10.1016/j.infbeh.2007.10.008; Jean ADL, 2012, INFANT BEHAV DEV, V35, P779, DOI 10.1016/j.infbeh.2012.07.023; KEEN RE, 1965, PSYCHON SCI, V2, P265, DOI 10.3758/BF03343442; Kisilevsky BS, 1998, DEV PSYCHOL, V34, P629, DOI 10.1037/0012-1649.34.4.629; Kogan N, 1996, INFANT BEHAV DEV, V19, P359, DOI 10.1016/S0163-6383(96)90034-X; Koole S. L., 2011, HDB SELF REGULATION, V2nd, P22; LAMB ME, 1987, MERRILL PALMER QUART, V33, P241; Mangelsdorf SC, 1995, CHILD DEV, V66, P1817, DOI 10.2307/1131912; Melinder A, 2010, INFANT BEHAV DEV, V33, P472, DOI 10.1016/j.infbeh.2010.05.003; Mesman J, 2009, DEV REV, V29, P120, DOI 10.1016/j.dr.2009.02.001; Montirosso R, 2010, BRIT J DEV PSYCHOL, V28, P347, DOI 10.1348/026151009X416429; Moore GA, 2004, DEV PSYCHOL, V40, P1068, DOI 10.1037/0012-1649.40.6.1068; Moore GA, 2001, DEV PSYCHOL, V37, P706, DOI 10.1037//0012-1649.37.5.706; Murray L, 1997, PSYCHOL MED, V27, P253, DOI 10.1017/S0033291796004564; MURRAY L., 1985, SOCIAL PERCEPTION IN, P177; Nadel J, 1999, DEVELOPMENTAL SCI, V2, P164, DOI 10.1111/1467-7687.00065; Nagy E, 2004, INFANT BEHAV DEV, V27, P54, DOI 10.1016/j.infbeh.2003.06.004; NAGY E, 1994, INT J PSYCHOPHYSIOL, V18, P128; Nagy E, 2008, DEV PSYCHOL, V44, P1779, DOI 10.1037/a0012665; Nagy E, 2006, INFANT CHILD DEV, V15, P223, DOI 10.1002/icd.460; Nagy E, 2011, INFANT CHILD DEV, V20, P3, DOI 10.1002/icd.683; Noldus Information Technology, 2009, OBS XT REF MAN VERS; Noldus Information Technology, 2003, OBS REF MAN VERS 5 0; Olson G, 1983, HDB CHILD PSYCHOL FO; PASCALIS O, 1995, INFANT BEHAV DEV, V18, P79, DOI 10.1016/0163-6383(95)90009-8; PelaezNogueras M, 1996, CHILD DEV, V67, P1780, DOI 10.1111/j.1467-8624.1996.tb01827.x; Reddy V, 2003, TRENDS COGN SCI, V7, P397, DOI 10.1016/S1364-6613(03)00191-8; Rochat P, 2002, INFANT CHILD DEV, V11, P289, DOI 10.1002/icd.259; Rosenblith JF, 1985, BEGINNING DEV 1 2 YE; Rosenblum KL, 2002, CHILD DEV, V73, P999, DOI 10.1111/1467-8624.00453; Segal LB, 1995, CHILD DEV, V66, P1829; Shapiro B, 1998, INFANT BEHAV DEV, V21, P299, DOI 10.1016/S0163-6383(98)90008-X; Slater A, 1989, INFANT DEV, P43; Stanley C, 2004, DEV PSYCHOPATHOL, V16, P1, DOI 10.1017/S0954579404044384; STIFTER CA, 1995, DEV PSYCHOL, V31, P448, DOI 10.1037/0012-1649.31.3.448; Striano T, 1999, BRIT J DEV PSYCHOL, V17, P551, DOI 10.1348/026151099165474; SWAIN IU, 1993, DEV PSYCHOL, V29, P312, DOI 10.1037/0012-1649.29.2.312; Tarabulsy GM, 2003, INFANT BEHAV DEV, V26, P421, DOI 10.1016/S0163-6383(03)00039-0; THOMAN EB, 1990, NEUROSCI BIOBEHAV R, V14, P93, DOI 10.1016/S0149-7634(05)80165-4; TODA S, 1993, DEV PSYCHOL, V29, P532, DOI 10.1037/0012-1649.29.3.532; TRONICK E, 1978, J AM ACAD CHILD PSY, V17, P1, DOI 10.1016/S0002-7138(09)62273-1; TRONICK EZ, 1989, CHILD DEV, V60, P85, DOI 10.2307/1131074; TRONICK EZ, 1989, AM PSYCHOL, V44, P112, DOI 10.1037/0003-066X.44.2.112; Weinberg MK, 1996, CHILD DEV, V67, P905, DOI 10.2307/1131869; Weinberg MK, 2006, J CHILD PSYCHOL PSYC, V47, P670, DOI 10.1111/j.1469-7610.2005.01545.x; Werner JS, 1978, INFANT BEHAV DEV, V1, P79	74	11	11	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0181688	10.1371/journal.pone.0181688	http://dx.doi.org/10.1371/journal.pone.0181688			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC5AR	28771555	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000406853600029
J	Nandakumar, P; Tin, A; Grove, ML; Ma, JZ; Boerwinkle, E; Coresh, J; Chakravarti, A				Nandakumar, Priyanka; Tin, Adrienne; Grove, Megan L.; Ma, Jianzhong; Boerwinkle, Eric; Coresh, Josef; Chakravarti, Aravinda			MicroRNAs in the miR-17 and miR-15 families are downregulated in chronic kidney disease with hypertension	PLOS ONE			English	Article							STAGE RENAL-DISEASE; T-CELLS; EXPRESSION; RISK; INFECTION; ROLES	Background In older adults (aged 70-74 years), African-Americans have 4-fold higher risk of developing hypertension-attributed end-stage renal disease (ESRD) than European-Americans. A hypothesized mechanism linking hypertension and progressive chronic kidney disease (CKD) is the innate immune response and inflammation. Persons with CKD are also more susceptible to infection. Gene expression in peripheral blood can provide a view of the innate immune activation profile. We aimed to identify differentially expressed genes, microRNAs, and pathways in peripheral blood between cases with CKD and high blood pressure under hypertension treatment versus controls without CKD and with controlled blood pressure in African Americans. Methods Case and control pairs (N = 15x2) were selected from those without diabetes and were matched for age, sex, body mass index, APOL1 risk allele count, and hypertension medication use. High blood pressure under hypertension treatment was defined as hypertension medication use and systolic blood pressure (SBP) >= 145 mmHg. CKD was defined as estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73m(2). Cases were selected from those with CKD and high blood pressure under hypertension treatment, and controls were selected from those without CKD (eGFR: 75-120 mL/min/1.73m(2) and urine albumin-to-creatinine ratio < 30mg/g) and with blood pressure controlled by hypertension medication use (SBP < 135 mmHg and D(diastolic) BP < 90 mm Hg). We perform RNA sequencing of mRNA and microRNA and conducted differential expression and co-expression network analysis. Results Of 347 miRNAs included in the analysis, 14 were significantly associated with case status (Benjamini-Hochberg adjusted p-value [BH p] < 0.05). Of these, ten were downregulated in cases: three of each belong to the miR-17 and miR-15 families. In co-expression network analysis of miRNA, one module, which included 13 of the 14 significant miRNAs, had significant association with case status. Of the 14,488 genes and 41,739 transcripts included in the analysis, none had significant association with case status. Gene co-expression network analyses did not yield any significant associations for mRNA. Conclusion We have identified 14 differentially expressed miRNAs in the peripheral blood of CKD cases with high blood pressure under hypertension treatment as compared to appropriate controls. Most of the significant miRNAs were downregulated and have critical roles in immune cell functions. Future studies are needed to replicate our findings and determine whether the downregulation of these miRNAs in immune cells may influence CKD progression or complications.	[Nandakumar, Priyanka; Chakravarti, Aravinda] Johns Hopkins Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Nandakumar, Priyanka] Johns Hopkins Univ, Sch Med, Predoctoral Training Program Human Genet & Mol Bi, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Tin, Adrienne; Coresh, Josef] Johns Hopkins Bloomberg Sch Publ Hlth, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Grove, Megan L.; Ma, Jianzhong; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Ctr Human Genet, Dept Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA; [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Baylor College of Medicine	Chakravarti, A (corresponding author), Johns Hopkins Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	aravinda@jhmi.edu			Maryland Genetics Epidemiology and Medicine (MD-GEM) Training Program from the Burroughs-Wellcome Fund; National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [R01DK076770]; National Heart, Lung, and Blood Institute [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, HHSN268201700001I]; A Genome-Wide Association Study in Essential Hypertension (FEHGAS2) [R01HL086694]; NIH/NIDDK National Research Service Award (NRSA) Renal Disease Epidemiology Training Program [T32DK007732]; NIH/NHLBI Cardiovascular Epidemiology Training Grant [T32HL007024]; National Human Genome Research Institute [U54 HG003273, UM1 HG008898]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK112087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER	Maryland Genetics Epidemiology and Medicine (MD-GEM) Training Program from the Burroughs-Wellcome Fund; National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); A Genome-Wide Association Study in Essential Hypertension (FEHGAS2); NIH/NIDDK National Research Service Award (NRSA) Renal Disease Epidemiology Training Program; NIH/NHLBI Cardiovascular Epidemiology Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the Maryland Genetics Epidemiology and Medicine (MD-GEM) Training Program through support from the Burroughs-Wellcome Fund (PN and AT) and National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases grant R01DK076770. The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C). Priyanka Nandakumar has received support from A Genome-Wide Association Study in Essential Hypertension (FEHGAS2) (R01HL086694). Adrienne Tin has received support from the NIH/NIDDK National Research Service Award (NRSA) Renal Disease Epidemiology Training Program (T32DK007732) and NIH/NHLBI T32HL007024 Cardiovascular Epidemiology Training Grant. National Human Genome Research Institute grants U54 HG003273 and UM1 HG008898 National Heart, Lung, and Blood Institute HHSN268201700001I. The funders had no role in study design,data collection and analysis, decision to publish, or preparation of the manuscript.	Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bash LD, 2009, AM J KIDNEY DIS, V53, P596, DOI 10.1053/j.ajkd.2008.10.044; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bleazard T, 2015, BIOINFORMATICS, V31, P1592, DOI 10.1093/bioinformatics/btv023; Chonchol M, 2006, SEMIN DIALYSIS, V19, P291, DOI 10.1111/j.1525-139X.2006.00175.x; Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258; Dalrymple LS, 2012, AM J KIDNEY DIS, V59, P356, DOI 10.1053/j.ajkd.2011.07.012; de Kouchkovsky D, 2013, J IMMUNOL, V191, P1594, DOI 10.4049/jimmunol.1203567; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Enright AJ, 2004, GENOME BIOL, V5; Erlinger TP, 2003, AM J KIDNEY DIS, V42, P256, DOI 10.1016/S0272-6386(03)00650-4; Fan PC, 2016, HUM GENOMICS, V10, DOI 10.1186/s40246-016-0085-z; Fehlmann T, 2016, RNA BIOL, V13, P1084, DOI 10.1080/15476286.2016.1234658; Frazee AC, 2015, NAT BIOTECHNOL, V33, P243, DOI 10.1038/nbt.3172; Fu JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002431; Grigoryev YA, 2011, J IMMUNOL, V187, P2233, DOI 10.4049/jimmunol.1101233; Harrison DG, 2011, HYPERTENSION, V57, P132, DOI 10.1161/HYPERTENSIONAHA.110.163576; Ichii O, 2012, KIDNEY INT, V81, P280, DOI 10.1038/ki.2011.345; James MT, 2008, ARCH INTERN MED, V168, P2333, DOI 10.1001/archinte.168.21.2333; Jiang S, 2011, BLOOD, V118, P5487, DOI 10.1182/blood-2011-05-355644; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Kopp JB, 2013, CURR OPIN NEPHROL HY, V22, P266, DOI 10.1097/MNH.0b013e3283600f8c; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Leek JT, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku864; Li SQ, 2011, CIRCULATION, V124, P175, DOI 10.1161/CIRCULATIONAHA.110.012237; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ludwig N, 2016, NUCLEIC ACIDS RES, V44, P3865, DOI 10.1093/nar/gkw116; Marketou ME, 2014, J HUM HYPERTENS, V28, P450, DOI 10.1038/jhh.2013.133; Mattace-Raso FUS, 2010, J HYPERTENS, V28, P892, DOI 10.1097/HJH.0b013e328336ed26; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; Murtagh F, 2014, J CLASSIF, V31, P274, DOI 10.1007/s00357-014-9161-z; Napoleone E, 2000, CIRC RES, V86, P139, DOI 10.1161/01.RES.86.2.139; Parsa A, 2013, NEW ENGL J MED, V369, P2183, DOI 10.1056/NEJMoa1310345; Qi JN, 2012, FEBS LETT, V586, P1201, DOI 10.1016/j.febslet.2012.03.011; Rodwell GEJ, 2004, PLOS BIOL, V2, P2191, DOI 10.1371/journal.pbio.0020427; Sesso HD, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001802; Sharma A, 2009, P NATL ACAD SCI USA, V106, P5761, DOI 10.1073/pnas.0808743106; Singh Y, 2015, J IMMUNOL, V195, P5667, DOI 10.4049/jimmunol.1401875; Tang SW, 2009, CANCER LETT, V273, P35, DOI 10.1016/j.canlet.2008.07.038; Trionfini P, 2015, NAT REV NEPHROL, V11, P23, DOI 10.1038/nrneph.2014.202; U. S. Renal Data System, 2012, USRDS 2012 ANN DAT R; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; VANHOLDER R, 1993, J AM SOC NEPHROL, V3, P1541; Wang H, 2016, ONCOL LETT, V11, P3821, DOI 10.3892/ol.2016.4476; Wang HL, 2012, RENAL FAILURE, V34, P685, DOI 10.3109/0886022X.2012.676491; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Zaza G, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-17	48	29	29	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0176734	10.1371/journal.pone.0176734	http://dx.doi.org/10.1371/journal.pone.0176734			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771472	Green Published, Green Submitted, gold			2022-12-26	WOS:000406853600001
J	Moutinho, TJ; Panagides, JC; Biggs, MB; Medlock, GL; Kolling, GL; Papin, JA				Moutinho, Thomas J., Jr.; Panagides, John C.; Biggs, Matthew B.; Medlock, Gregory L.; Kolling, Glynis L.; Papin, Jason A.			Novel co-culture plate enables growth dynamic-based assessment of contact-independent microbial interactions	PLOS ONE			English	Article							CYSTIC-FIBROSIS; PSEUDOMONAS-AERUGINOSA; BURKHOLDERIA-MULTIVORANS; METABOLIC INTERACTIONS; COMMUNITIES; COOPERATION; MIXTURES; BACTERIA; CEPACIA; COLI	Interactions between microbes are central to the dynamics of microbial communities. Understanding these interactions is essential for the characterization of communities, yet challenging to accomplish in practice. There are limited available tools for characterizing diffusion-mediated, contact-independent microbial interactions. A practical and widely implemented technique in such characterization involves the simultaneous co-culture of distinct bacterial species and subsequent analysis of relative abundance in the total population. However, distinguishing between species can be logistically challenging. In this paper, we present a low-cost, vertical membrane, co-culture plate to quantify contact-independent interactions between distinct bacterial populations in co-culture via real-time optical density measurements. These measurements can be used to facilitate the analysis of the interaction between microbes that are physically separated by a semipermeable membrane yet able to exchange diffusible molecules. We show that diffusion across the membrane occurs at a sufficient rate to enable effective interaction between physically separate cultures. Two bacterial species commonly found in the cystic fibrotic lung, Pseudomonas aeruginosa and Burkholderia cenocepacia, were co-cultured to demonstrate how this plate may be implemented to study microbial interactions. We have demonstrated that this novel co-culture device is able to reliably generate real-time measurements of optical density data that can be used to characterize interactions between microbial species.	[Moutinho, Thomas J., Jr.; Panagides, John C.; Biggs, Matthew B.; Medlock, Gregory L.; Kolling, Glynis L.; Papin, Jason A.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22903 USA	University of Virginia	Papin, JA (corresponding author), Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22903 USA.	papin@virginia.edu		Biggs, Matthew/0000-0001-6492-8180; Papin, Jason/0000-0002-2769-5805; Moutinho Jr., Thomas/0000-0002-8940-4970; Medlock, Gregory/0000-0002-1571-0801; Panagides, John/0000-0002-8008-7649; Kolling, Glynis/0000-0001-8871-8129	National Institutes of Health [GM108501, T32LM012416]; National Science Foundation Graduate Research Fellowship [DDGE-1315231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108501] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T32LM012416] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	TJM, JCP, MBB, GLM, GLK, and JAP are supported by R01 grant GM108501 from the National Institutes of Health (www.nih.gov). GLM is also supported by National Institute of Health on grant T32LM012416. TJM is also supported by National Science Foundation Graduate Research Fellowship Program DDGE-1315231 (www.nsfgrfp.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biggs MB, 2017, ISME J, V11, P426, DOI 10.1038/ismej.2016.130; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Braga RM, 2016, BRAZ J MICROBIOL, V47, P86, DOI 10.1016/j.bjm.2016.10.005; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Chen CY, 2003, J MICROBIOL METH, V55, P475, DOI 10.1016/S0167-7012(03)00194-5; Cope EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028523; Costello A, 2014, MICROBIOL-SGM, V160, P1474, DOI 10.1099/mic.0.074203-0; DALGAARD P, 1994, INT J FOOD MICROBIOL, V23, P391, DOI 10.1016/0168-1605(94)90165-1; Eberl L, 2004, INT J MED MICROBIOL, V294, P123, DOI 10.1016/j.ijmm.2004.06.022; Goers L, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0065; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Hanly TJ, 2012, APPL MICROBIOL BIOT, V93, P2529, DOI 10.1007/s00253-011-3628-1; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Jensen PA, 2015, JALA-J LAB AUTOM, V20, P51, DOI 10.1177/2211068214555414; Jones AM, 2004, THORAX, V59, P948, DOI 10.1136/thx.2003.017210; Jung PP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119807; Junicke H, 2014, AMB EXPRESS, V4, DOI 10.1186/s13568-014-0035-x; Leinweber A, 2017, ISME J, V11, P1179, DOI 10.1038/ismej.2016.195; Liao BQ, 2004, WATER ENVIRON RES, V76, P425, DOI 10.2175/106143004X151527; Linares JF, 2006, P NATL ACAD SCI USA, V103, P19484, DOI 10.1073/pnas.0608949103; Liu A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0164919; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Morris BE, 2013, FEMS MICROBIOL REV, V37, P384, DOI 10.1111/1574-6976.12019; Mytilinaios I, 2015, J APPL MICROBIOL, V118, P161, DOI 10.1111/jam.12695; Nakagawa A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1327; NURMIKKO V, 1957, APPL MICROBIOL, V5, P160, DOI 10.1128/AEM.5.3.160-165.1957; Oliveira NM, 2014, P NATL ACAD SCI USA, V111, P17941, DOI 10.1073/pnas.1412673111; Phelan VV, 2012, NAT CHEM BIOL, V8, P26, DOI 10.1038/nchembio.739; Ponomarova O, 2015, CURR OPIN MICROBIOL, V27, P37, DOI 10.1016/j.mib.2015.06.014; Ramsey MM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002012; Salimi F, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-95; Savichtcheva O, 2011, INT J HYDROGEN ENERG, V36, P7530, DOI 10.1016/j.ijhydene.2011.03.097; Schalk IJ, 2013, ENVIRON MICROBIOL, V15, P1661, DOI 10.1111/1462-2920.12013; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Stadie J, 2013, FOOD MICROBIOL, V35, P92, DOI 10.1016/j.fm.2013.03.009; Traxler MF, 2013, MBIO, V4, DOI 10.1128/mBio.00459-13; Wintermute EH, 2010, GENE DEV, V24, P2603, DOI 10.1101/gad.1985210; Wintermute EH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.66; Wright CJ, 2013, MOL ORAL MICROBIOL, V28, P83, DOI 10.1111/omi.12012; Xavier JB, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.16; Zhou K, 2015, NAT BIOTECHNOL, V33, P377, DOI 10.1038/nbt.3095	41	9	10	6	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182163	10.1371/journal.pone.0182163	http://dx.doi.org/10.1371/journal.pone.0182163			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767660	Green Submitted, gold, Green Published			2022-12-26	WOS:000406768200048
J	Thongbai, B; Miller, SL; Stadler, M; Wittstein, K; Hyde, KD; Lumyong, S; Raspe, O				Thongbai, Benjarong; Miller, Steven L.; Stadler, Marc; Wittstein, Kathrin; Hyde, Kevin D.; Lumyong, Saisamorn; Raspe, Olivier			Study of three interesting Amanita species from Thailand: Morphology, multiple-gene phylogeny and toxin analysis	PLOS ONE			English	Article							LETHAL AMANITAS; DIVERSITY	Amanita ballerina and A. brunneitoxicaria spp. nov. are introduced from Thailand. Amanita fuligineoides is also reported for the first time from Thailand, increasing the known distribution of this taxon. Together, those findings support our view that many taxa are yet to be discovered in the region. While both morphological characters and a multiple-gene phylogeny clearly place A. brunneitoxicaria and A. fuligineoides in sect. Phalloideae (Fr.) Quel., the placement of A. ballerina is problematic. On the one hand, the morphology of A. ballerina shows clear affinities with stirps Limbatula of sect. Lepidella. On the other hand, in a multiple- gene phylogeny including taxa of all sections in subg. Lepidella, A. ballerina and two other species, including A. zangii, form a well-supported clade sister to the Phalloideae sensu Bas 1969, which include the lethal "death caps" and "destroying angels". Together, the A. ballerina-A. zangii clade and the Phalloideae sensu Bas 1969 also form a well-supported clade. We therefore screened for two of the most notorious toxins by HPLC-MS analysis of methanolic extracts from the basidiomata. Interestingly, neither alpha-amanitin nor phalloidin was found in A. ballerina, whereas Amanita fuligineoides was confirmed to contain both alpha-amanitin and phalloidin, and A. brunneitoxicaria contained only alpha-amanitin. Together with unique morphological characteristics, the position in the phylogeny indicates that A. ballerina is either an important link in the evolution of the deadly Amanita sect. Phalloideae species, or a member of a new section also including A. zangii.	[Thongbai, Benjarong; Hyde, Kevin D.] Mae Fah Luang Univ, Ctr Excellence Fungal Res, Chiang Rai, Thailand; [Thongbai, Benjarong; Hyde, Kevin D.] Mae Fah Luang Univ, Sch Sci, Chiang Rai, Thailand; [Miller, Steven L.] Univ Wyoming, Dept Bot, Laramie, WY 82071 USA; [Stadler, Marc; Wittstein, Kathrin] Helmholtz Ctr Infect Res, Dept Microbial Drugs, Braunschweig, Germany; [Stadler, Marc; Wittstein, Kathrin] German Ctr Infect Res DZIF, Partner Site Hannover Braunschweig, Braunschweig, Germany; [Lumyong, Saisamorn; Raspe, Olivier] Chiang Mai Univ, Dept Biol, Fac Sci, Chiang Mai, Thailand; [Raspe, Olivier] Bot Garden Meise, Meise, Belgium; [Raspe, Olivier] Serv Gen Enseignement Univ & Rech Sci, Federat Wallonie Bruxelles, Brussels, Belgium	Mae Fah Luang University; Mae Fah Luang University; University of Wyoming; Helmholtz Association; Helmholtz-Center for Infection Research; German Center for Infection Research; Chiang Mai University	Raspe, O (corresponding author), Chiang Mai Univ, Dept Biol, Fac Sci, Chiang Mai, Thailand.; Raspe, O (corresponding author), Bot Garden Meise, Meise, Belgium.; Raspe, O (corresponding author), Serv Gen Enseignement Univ & Rech Sci, Federat Wallonie Bruxelles, Brussels, Belgium.	olivier.raspe@botanicgardenmeise.be	Stadler, Marc/AHB-7016-2022; Hyde, Kevin D/F-7890-2010; Raspé, Olivier/I-5176-2019; Stadler, Marc/P-8882-2014	Stadler, Marc/0000-0002-7284-8671; Raspé, Olivier/0000-0002-8426-2133; Stadler, Marc/0000-0002-7284-8671	Thai Royal Golden Ph.D. Jubilee-Industry (RGJ) program, Thailand [Ph.D./0072/2553 in 4.S.M.F./53/A.2]; National Science Foundation, USA [DEB-1050292]; National Research Council of Thailand [RTA-5880006]; Fonds National de la Recherche Scientifique, Belgium [2014/V3/5/215 - IB/MF]	Thai Royal Golden Ph.D. Jubilee-Industry (RGJ) program, Thailand; National Science Foundation, USA(National Science Foundation (NSF)); National Research Council of Thailand(National Research Council of Thailand (NRCT)); Fonds National de la Recherche Scientifique, Belgium(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the Thai Royal Golden Ph.D. Jubilee-Industry (RGJ) program, Thailand (URL: rgi.trf.or.th/rnain/home/) Grant number Ph.D./0072/2553 in 4.S.M.F./53/A.2 to BT; National Science Foundation, USA (URL: www.nsf.gov) Grant number DEB-1050292 to SLM; National Research Council of Thailand (URL: en.nrct.go.th) Grant number RTA-5880006 to SL and OR and Fonds National de la Recherche Scientifique, Belgium (URL: fnrs.be) Grant number: 2014/V3/5/215 - IB/MF to OR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bas C, 1969, PERSOONIA, V5, P285, DOI DOI 10.3852/09-288; ber U die Inhaltsstoffe des gru E nen Knollenbla E tterpilzes LI, 1977, EUR J ORG CHEM, P859; Cai Q, 2016, MYCOLOGIA, V108, P993, DOI 10.3852/16-008; Cai Q, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-143; Cai Qing, 2012, Plant Diversity and Resources, V34, P614, DOI 10.3724/SP.J.1143.2012.12140; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Hallen HE, 2007, P NATL ACAD SCI USA, V104, P19097, DOI 10.1073/pnas.0707340104; Helfer AG, 2014, J CHROMATOGR A, V1325, P92, DOI 10.1016/j.chroma.2013.11.054; Hosen MI, 2015, MYCOL PROG, V14, DOI 10.1007/s11557-015-1058-7; Jayasiri SC, 2015, FUNGAL DIVERS, V74, P3, DOI 10.1007/s13225-015-0351-8; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kim CS, 2013, MYCOBIOLOGY, V41, P131, DOI 10.5941/MYCO.2013.41.3.131; Li GJ, 2016, FUNGAL DIVERS, V78, P1, DOI 10.1007/s13225-016-0366-9; Li HJ, 2015, MYCOL PROG, V14, DOI 10.1007/s11557-015-1055-x; Li P, 2014, TOXICON, V83, P59, DOI 10.1016/j.toxicon.2014.02.020; Miller MA, 2009, THE CIPRES PORTAL; Miller SL, 2004, MYCOTAXON, V89, P31; Nayak AP, 2013, MED MYCOL, V51, P1, DOI 10.3109/13693786.2012.698025; Oda Takashi, 1999, Mycoscience, V40, P57, DOI 10.1007/BF02465674; Rambaut A., 2018, FIGTREE; RodrAoguez-Caycedo C, 2016, STUDIES AMANITACEAE; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Saccardo PA, 1887, SYLLOGE FUNGORUM, V9; Sanchez-Ramirez S, 2015, MOL ECOL, V24, P5938, DOI 10.1111/mec.13413; Sanmee R, 2008, FUNGAL DIVERS, V32, P97; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tang SS, 2016, TOXICON, V120, P78, DOI 10.1016/j.toxicon.2016.07.018; Thiers B., 2017, INDEX HERBARIORUM; Thongbai B, 2016, PHYTOTAXA, V286, P211, DOI 10.11646/phytotaxa.286.4.1; Tulloss R., 2016, AMANITACEAE, V1, P1; TULLOSS R E, 1992, Memoirs of the New York Botanical Garden, V66, P1; Tulloss R. E., 2017, STUDIES AMANITACEAE; Tulloss RE, MUTABLE TEXT; U ber die Giftstoffe des gru E nen Knollenbla E tterpilzes 13, 1957, ANGEW CHEM, V69, P389; WIELAND T, 1967, LIEBIGS ANN CHEM, V704, P226; Yang Z. L., 2015, ATLAS CHINESE SPECIE; Yang ZL, 1997, BIBLIOTHECA MYCOLOGI, V170, P1; Yarze JC, 2012, AM J GASTROENTEROL, V107, P790, DOI 10.1038/ajg.2012.29; Zhang LF, 2004, FUNGAL DIVERS, V17, P219; Zhang P, 2010, FUNGAL DIVERS, V42, P119, DOI 10.1007/s13225-010-0018-4; Zhang Ping, 2015, Mycology-An International Journal On Fungal Biology, V6, P86, DOI 10.1080/21501203.2015.1042536	42	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182131	10.1371/journal.pone.0182131	http://dx.doi.org/10.1371/journal.pone.0182131			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767681	gold, Green Published, Green Submitted			2022-12-26	WOS:000406768200046
J	Liu, NC; Troconis, EL; Kalmar, L; Price, DJ; Wright, HE; Adams, VJ; Sargan, DR; Ladlow, JF				Liu, Nai-Chieh; Troconis, Eileen L.; Kalmar, Lajos; Price, David J.; Wright, Hattie E.; Adams, Vicki J.; Sargan, David R.; Ladlow, Jane F.			Conformational risk factors of brachycephalic obstructive airway syndrome (BOAS) in pugs, French bulldogs, and bulldogs	PLOS ONE			English	Article							UPPER RESPIRATORY SYNDROME; SLEEP-APNEA; NECK CIRCUMFERENCE; METABOLIC SYNDROME; CLINICAL SIGNS; DOGS; BREEDS; FLOW; DIMENSIONS; LONGEVITY	Extremely brachycephalic, or short-muzzled, dog breeds such as pugs, French bulldogs, and bulldogs are prone to the conformation-related respiratory disorder-brachycephalic obstructive airway syndrome (BOAS). Affected dogs present with a wide range of clinical signs from snoring and exercise intolerance, to life-threatening events such as syncope. In this study, conformational risk factors for BOAS that could potentially aid in breeding away from BOAS were sought. Six hundred and four pugs, French bulldogs, and bulldogs were included in the study. Soft tape measurements of the head and body were used and the inter-observer reproducibility was evaluated. Breed-specific models were developed to assess the associations between the conformational factors and BOAS status based on functional grading. The models were further validated by means of a BOAS index, which is an objective measurement of respiratory function using whole-body barometric plethysmography. The final models have good predictive power for discriminating BOAS (-) and BOAS (+) phenotypes indicated by the area under the curve values of >80% on the receiver operating curves. When other factors were controlled, stenotic nostrils were associated with BOAS in all three breeds; pugs and bulldogs with higher body condition scores (BCS) had a higher risk of developing BOAS. Among the standardized conformational measurements (i.e. craniofacial ratio (CFR), eye width ratio (EWR), skull index (SI), neck girth ratio (NGR), and neck length ratio (NLR)), for pugs EWR and SI, for French bulldogs NGR and NLR, and for bulldogs SI and NGR showed significant associations with BOAS status. However, the NGR in bulldogs was the only significant predictor that also had satisfactory inter-observer reproducibility. A NGR higher than 0.71 in male bulldogs was predictive of BOAS with approximately 70% sensitivity and specificity. In conclusion, stenotic nostrils, BCS, and NGR were found to be valid, easily applicable predictors for BOAS (+).	[Liu, Nai-Chieh; Troconis, Eileen L.; Kalmar, Lajos; Price, David J.; Wright, Hattie E.; Sargan, David R.; Ladlow, Jane F.] Univ Cambridge, Dept Vet Med, Cambridge, Cambs, England; [Adams, Vicki J.] Vet Epi, Mildenhall, Suffolk, England	University of Cambridge	Ladlow, JF (corresponding author), Univ Cambridge, Dept Vet Med, Cambridge, Cambs, England.	jfl1001@cam.ac.uk	Kalmar, Lajos/C-3040-2014; Ladlow, Jane/AAM-1595-2020; Liu, Nai-Chieh/D-6625-2013	Kalmar, Lajos/0000-0003-3691-8350; Ladlow, Jane/0000-0002-8076-4021; Price, David/0000-0003-0076-3123; Sargan, David Richard/0000-0001-9897-2489; Liu, Nai-Chieh/0000-0002-1919-1412; Adams, Vicki/0000-0001-5427-251X	Kennel Club Charitable Trust [RG71960]; Cambridge Overseas Trust	Kennel Club Charitable Trust; Cambridge Overseas Trust	The Kennel Club Charitable Trust (RG71960, https://kcchantabletrust.org.uk) provided financial support and sources for data collection to DRS, LK. NCL, and JFL. Cambridge Overseas Trust (https://www.cambridgetrust.org/ about/cambridge-overseas-trust/) supported NCL for her PhD. The current study was conducted during her PhD but was not included in her thesis. VJA runs her own commercial consultancy company, Vet Epi. VJA was involved in data acquisition and manuscript preparation and was remunerated for her work on the project from the research grants. Vet Epi did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; AMIS TC, 1986, AM J VET RES, V47, P2200; Asher L, 2009, VET J, V182, P402, DOI 10.1016/j.tvjl.2009.08.033; Bateson P., 2016, INDEPENDENT INQUIRY; Caccamo R, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-12; Cassidy KM, 2007, BREED WEIGHT LIFESPA; Cizza G, 2014, METAB SYNDR RELAT D, V12, P231, DOI 10.1089/met.2013.0093; Evans H., 1993, SKELETON MUSCULAR SY, P122; Gamer M, 2012, IRR VARIOUS COEFFICI; GOLDBERG MB, 1981, RESP PHYSIOL, V43, P327, DOI 10.1016/0034-5687(81)90113-4; Grand JGR, 2011, J SMALL ANIM PRACT, V52, P232, DOI 10.1111/j.1748-5827.2011.01047.x; Heidenreich D, 2016, VET SURG, V45, P83, DOI 10.1111/vsu.12418; HENDRICKS JC, 1987, J APPL PHYSIOL, V63, P1344, DOI 10.1152/jappl.1987.63.4.1344; HENDRICKS JC, 1992, VET CLIN N AM-SMALL, V22, P1145, DOI 10.1016/S0195-5616(92)50306-0; Hoareau G, 2015, J SMALL ANIM PRACT, V56, P103, DOI 10.1111/jsap.12299; Hoareau GL, 2012, J VET INTERN MED, V26, P897, DOI 10.1111/j.1939-1676.2012.00941.x; HOFFSTEIN V, 1992, EUR RESPIR J, V5, P377; Katz SL, 2014, J CLIN SLEEP MED, V10, P1303, DOI 10.5664/jcsm.4284; Kaye BM, 2015, VET RADIOL ULTRASOUN, V56, P609, DOI 10.1111/vru.12277; Knecht CD., 1979, COMPENDIUM, V1, P25; Koch D, 2015, KURZMITTEILUNGEN, V157, P1; Laflamme D, 1997, CANINE PRACT, V22, P10; Liu NC, 2016, J VET INTERN MED, V30, P853, DOI 10.1111/jvim.13933; Liu NC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130741; Manens J, 2014, J VET INTERN MED, V28, P371, DOI 10.1111/jvim.12260; Manens J, 2012, VET J, V193, P217, DOI 10.1016/j.tvjl.2011.10.013; Mellema MS, 2014, J VET INTERN MED, V28, P1418, DOI 10.1111/jvim.12393; Meola SD, 2013, TOP COMPANION ANIM M, V28, P91, DOI 10.1053/j.tcam.2013.06.004; Michell AR, 1999, VET REC, V145, P625, DOI 10.1136/vr.145.22.625; Mortimore IL, 1998, AM J RESP CRIT CARE, V157, P280, DOI 10.1164/ajrccm.157.1.9703018; O'Neill DG, 2013, VET J, V198, P638, DOI 10.1016/j.tvjl.2013.09.020; O'Neill Dan G, 2016, Canine Genet Epidemiol, V3, P5, DOI 10.1186/s40575-016-0035-z; O'Neill Dan G, 2015, Canine Genet Epidemiol, V2, P10, DOI 10.1186/s40575-015-0023-8; Oechtering G., 2010, Veterinary Focus, V20, P2; Onat A, 2009, CLIN NUTR, V28, P46, DOI 10.1016/j.clnu.2008.10.006; Packer RMA, 2012, ANIM WELFARE, V21, P81, DOI 10.7120/096272812X13345905673809; Packer RMA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137496; Poncet CM, 2006, J SMALL ANIM PRACT, V47, P137, DOI 10.1111/j.1748-5827.2006.00057.x; Poncet CM, 2005, J SMALL ANIM PRACT, V46, P273, DOI 10.1111/j.1748-5827.2005.tb00320.x; SCHMIDTNIELSEN K, 1970, SCIENCE, V169, P1102, DOI 10.1126/science.169.3950.1102; Schuenemann R, 2014, J AM ANIM HOSP ASSOC, V50, P149, DOI 10.5326/JAAHA-MS-5991; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; SMITH PL, 1988, J APPL PHYSIOL, V64, P789, DOI 10.1152/jappl.1988.64.2.789; Sutter NB, 2008, MAMM GENOME, V19, P713, DOI 10.1007/s00335-008-9153-6; The_Kennel_Club_UK, 2016, DOG BREEDS REG STAT; Watkins, 2007, FDN CLIN RES APPL PR	46	40	40	4	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0181928	10.1371/journal.pone.0181928	http://dx.doi.org/10.1371/journal.pone.0181928			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763490	gold, Green Published, Green Submitted			2022-12-26	WOS:000406766500027
J	Zhang, SS; Kang, HM; Yang, WZ				Zhang, Shanshan; Kang, Hongmei; Yang, Wenzhong			Climate change-induced water stress suppresses the regeneration of the critically endangered forest tree Nyssa yunnanensis	PLOS ONE			English	Article							EARLY SEEDLING GROWTH; MORTALITY-RATES; SEVERE DROUGHT; GERMINATION; TEMPERATURE; DYNAMICS; ESTABLISHMENT; SURVIVAL; MOISTURE; PLANTS	Climatic change-induced water stress has been found to threaten the viability of trees, especially endangered species, through inhibiting their recruitment. Nyssa yunnanensis, a plant species with extremely small populations (PSESP), consists of only two small populations of eight mature individuals remaining in southwestern China. In order to determine the barriers to regeneration, both in situ and laboratory experiments were performed to examine the critical factors hindering seed germination and seedling establishment. The results of in situ field experiments demonstrated that soil water potentials lower than -5.40 MPa (experienced in December) had significantly inhibitory effects on seedling survival, and all seedlings perished at a soil water potential of -5.60 MPa (January). Laboratory experiments verified that N. yunnanensis seedlings could not survive at a 20% PEG 6000 concentration (-5.34 MPa) or 1/5 water-holding capacity (WHC; -5.64 MPa), and seed germination was inhibited in the field from September (-1.10 MPa) to November (-4.30 MPa). Our results suggested that soil water potentials between -5.34 and -5.64 MPa constituted the range of soil water potentials in which N. yunnanensis seedlings could not survive. In addition to water deficit, intensified autotoxicity, which is concentration-dependent, resulted in lower seed germination and seedling survival. Thus, seed establishment was probably simultaneously impacted by water deficit and aggravated autotoxicity. Meteorological records from the natural distribution areas of N. yunnanensis indicated that mean annual rainfall and relative humidity have declined by 21.7% and 6.3% respectively over past 55 years, while the temperature has increased by 6.0%. Climate change-induced drought, along with a poor resistance and adaptability to drought stress, has severely impacted the natural regeneration of N. yunnanensis. In conclusion, climate change-induced drought has been implicated as a regulating factor in the natural regeneration of N. yunnanensis through suppressing seed germination and screening out seedlings in the dry season. Based on the experimental findings, habitat restoration and microclimate improvement should both be highlighted in the conservation of this particular plant species.	[Zhang, Shanshan; Kang, Hongmei; Yang, Wenzhong] Yunnan Acad Forestry, Key Lab Yunnan Rare & Endangered Species Conserva, State Forestry Adm, Yunnan Key Lab Forest Plant Cultivat & Utilizat, Kunming, Yunnan, Peoples R China; [Zhang, Shanshan; Kang, Hongmei; Yang, Wenzhong] Yunnan Acad Forestry, Kunming, Yunnan, Peoples R China		Yang, WZ (corresponding author), Yunnan Acad Forestry, Key Lab Yunnan Rare & Endangered Species Conserva, State Forestry Adm, Yunnan Key Lab Forest Plant Cultivat & Utilizat, Kunming, Yunnan, Peoples R China.; Yang, WZ (corresponding author), Yunnan Acad Forestry, Kunming, Yunnan, Peoples R China.	wzyang2004@126.com			National Natural Science Foundation of China [NSFC-31460119, NSFC-31660164]; State Forestry Administration of China [2014YB1004, 2015YB1021, 2016YB1038]; Yunnan Provincial Natural Science Foundation [2013FD074]; Yunnan Forestry Department [2015SX1001, 2016SX1018, 2017SX1012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Forestry Administration of China; Yunnan Provincial Natural Science Foundation(Natural Science Foundation of Yunnan Province); Yunnan Forestry Department	We gratefully acknowledge funding for this project provided by the National Natural Science Foundation of China (NSFC-31460119 and NSFC-31660164), State Forestry Administration of China (2014YB1004, 2015YB1021, 2016YB1038), Yunnan Provincial Natural Science Foundation (2013FD074), and Yunnan Forestry Department (2015SX1001, 2016SX1018 and 2017SX1012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge funding for this project provided by the National Natural Science Foundation of China (NSFC-31460119 and NSFC-31660164), State Forestry Administration of China (2014YB1004, 2015YB1021, 2016YB1038), Yunnan Provincial Natural Science Foundation (2013FD074), and Yunnan Forestry Department (2015SX1001, 2016SX1018 and 2017SX1012).	AAVV, 2000, CONSERVACION VEGETAL, V6, P1; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Almansouri M, 2001, PLANT SOIL, V231, P243, DOI 10.1023/A:1010378409663; Barbera AC, 2014, WATER RES, V52, P275, DOI 10.1016/j.watres.2013.11.004; Barbeta A, 2013, GLOBAL CHANGE BIOL, V19, P3133, DOI 10.1111/gcb.12269; Bartholomeus RP, 2011, J GEOPHYS RES, V116, pG4; Breshears DD, 2009, FRONT ECOL ENVIRON, V7, P185, DOI 10.1890/080016; Caron MM, 2015, PLANT BIOLOGY, V17, P52, DOI 10.1111/plb.12177; Cavallaro V, 2016, ECOL ENG, V95, P557, DOI 10.1016/j.ecoleng.2016.06.040; Cavallaro V, 2014, ECOL ENG, V71, P113, DOI 10.1016/j.ecoleng.2014.07.055; Chen W, 2011, J NE FOREST U, V39, P17; Clark DA, 2003, P NATL ACAD SCI USA, V100, P5852, DOI 10.1073/pnas.0935903100; Clark DB, 2010, GLOBAL CHANGE BIOL, V16, P747, DOI 10.1111/j.1365-2486.2009.02004.x; Cochrane A, 2011, AUSTRAL ECOL, V36, P923, DOI 10.1111/j.1442-9993.2010.02211.x; Dalgleish HJ, 2010, J ECOL, V98, P209, DOI 10.1111/j.1365-2745.2009.01585.x; DEKA RN, 1995, EUR J SOIL SCI, V46, P233, DOI 10.1111/j.1365-2389.1995.tb01831.x; El Midaoui Mohammed, 2002, Helia, V25, P51, DOI 10.2298/HEL0237051M; Engelbrecht BMJ, 2003, OECOLOGIA, V136, P383, DOI 10.1007/s00442-003-1290-8; Fay PA, 2009, ACTA OECOL, V35, P679, DOI 10.1016/j.actao.2009.06.007; Huang CY, 2012, GLOBAL CHANGE BIOL, V18, P1016, DOI 10.1111/j.1365-2486.2011.02592.x; Jeltsch F, 2008, PERSPECT PLANT ECOL, V9, P171, DOI 10.1016/j.ppees.2007.11.004; Camarero JJ, 2015, J ECOL, V103, P44, DOI 10.1111/1365-2745.12295; Jump AS, 2005, ECOL LETT, V8, P1010, DOI 10.1111/j.1461-0248.2005.00796.x; KHAZAIE H, 2013, PROENVIRONMENT, V6, P496; Khurana E, 2001, ENVIRON CONSERV, V28, P39, DOI 10.1017/S0376892901000042; KNIPE OD, 1973, J RANGE MANAGE, V26, P68, DOI 10.2307/3896892; Kouba Y, 2012, FOREST ECOL MANAG, V274, P143, DOI 10.1016/j.foreco.2012.02.033; Liu WJ, 1997, NAT RESOUR, V2, P62; Lloret F, 2005, J VEG SCI, V16, P67, DOI 10.1111/j.1654-1103.2005.tb02339.x; Ma YP, 2013, BIODIVERS CONSERV, V22, P803, DOI 10.1007/s10531-013-0434-3; Mainiero R, 2006, FOREST ECOL MANAG, V237, P135, DOI 10.1016/j.foreco.2006.09.034; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; McLaren KP, 2003, FOREST ECOL MANAG, V183, P61, DOI 10.1016/S0378-1127(03)00100-2; Milbau A, 2009, ANN BOT-LONDON, V104, P287, DOI 10.1093/aob/mcp117; Mostafavi K., 2011, Advances in Environmental Biology, V5, P3307; Mueller RC, 2005, J ECOL, V93, P1085, DOI 10.1111/j.1365-2745.2005.01042.x; Murillo-Amador B, 2002, J AGRON CROP SCI, V188, P235, DOI 10.1046/j.1439-037X.2002.00563.x; Nepstad DC, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000360; Okcu Gamze, 2005, Turkish Journal of Agriculture and Forestry, V29, P237; Parry ML, 2007, CLIMATE CHANGE 2007; Penuelas J, 2001, FOREST SCI, V47, P214; Penuelas J, 2007, GLOBAL CHANGE BIOL, V13, P2563, DOI 10.1111/j.1365-2486.2007.01464.x; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Poorter L, 2000, J TROP ECOL, V16, P481, DOI 10.1017/S026646740000153X; Rawal DS, 2015, INT J BIOMETEOROL, V59, P1237, DOI 10.1007/s00484-014-0935-0; Rolim SG, 2005, OECOLOGIA, V142, P238, DOI 10.1007/s00442-004-1717-x; Sadeghian S. Y., 2000, Journal of Sugar Beet Research, V37, P55, DOI 10.5274/jsbr.37.3.55; Sadeghian SY, 2004, J AGRON CROP SCI, V190, P138, DOI 10.1111/j.1439-037X.2004.00087.x; SHARMA ML, 1976, AGRON J, V68, P390, DOI 10.2134/agronj1976.00021962006800020048x; SHARMA ML, 1973, AGRON J, V65, P982, DOI 10.2134/agronj1973.00021962006500060041x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Springer TL, 2005, CROP SCI, V45, P2075, DOI 10.2135/cropsci2005.0061; Stone C, 2012, FOREST ECOL MANAG, V265, P94, DOI 10.1016/j.foreco.2011.10.008; Sun BL, 2009, ANN MO BOT GARD, V96, P672, DOI 10.3417/2008015; Sun Bao-Ling, 2007, Acta Botanica Yunnanica, V29, P351; Sun Bao-Ling, 2007, Acta Botanica Yunnanica, V29, P173; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; Walck JL, 2011, GLOBAL CHANGE BIOL, V17, P2145, DOI 10.1111/j.1365-2486.2010.02368.x; Wang ML, 2005, ACTA PHYTOECOLOGICA, V9, P697; Williams AP, 2013, NAT CLIM CHANGE, V3, P292, DOI [10.1038/nclimate1693, 10.1038/NCLIMATE1693]; Yuan Rui-ling, 2013, Forest Research, V26, P384; Zhang SS, 2015, ISR J PLANT SCI, V62, P187, DOI 10.1080/07929978.2015.1064630	62	6	10	7	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0182012	10.1371/journal.pone.0182012	http://dx.doi.org/10.1371/journal.pone.0182012			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763476	gold, Green Published, Green Submitted			2022-12-26	WOS:000406766500034
J	Eneman, B; Elmonem, MA; van den Heuvel, LP; Khodaparast, L; Khodaparast, L; van Geet, C; Freson, K; Levtchenko, E				Eneman, Benedicte; Elmonem, Mohamed A.; van den Heuvel, Lambertus P.; Khodaparast, Laleh; Khodaparast, Ladan; van Geet, Chris; Freson, Kathleen; Levtchenko, Elena			Pituitary adenylate cyclase-activating polypeptide (PACAP) in zebrafish models of nephrotic syndrome	PLOS ONE			English	Article							DOXORUBICIN-INDUCED CARDIOMYOPATHY; FUNCTIONAL EXPRESSION; SLIT DIAPHRAGM; NEPHRIN; MUTATIONS; IDENTIFICATION; RECEPTOR; PROTEIN; CLONING; KIDNEY	Pituitary adenylate cyclase-activating polypeptide (PACAP) is an inhibitor of megakaryopoiesis and platelet function. Recently, PACAP deficiency was observed in children with nephrotic syndrome (NS), associated with increased platelet count and aggregability and increased risk of thrombosis. To further study PACAP deficiency in NS, we used transgenic Tg(cd41:EGFP) zebrafish with GFP-labeled thrombocytes. We generated two models for congenital NS, a morpholino injected model targeting nphsl (nephrin), which is mutated in the Finnish-type congenital NS. The second model was induced by exposure to the nephrotoxic compound adriamycin. Nephrin RNA expression was quantified and zebrafish embryos were live-screened for proteinuria and pericardial edema as evidence of renal impairment. Protein levels of PACAP and its binding-protein ceruloplasmin were measured and GFPlabeled thrombocytes were quantified. We also evaluated the effects of PACAP morpholino injection and the rescue effects of PACAP-38 peptide in both congenital NS models. Nephrin downregulation and pericardial edema were observed in both nephrin morpholino injected and adriamycin exposed congenital NS models. However, PACAP deficiency was demonstrated only in the adriamycin exposed condition. Ceruloplasmin levels and the number of GFP-labeled thrombocytes remained unchanged in both models. PACAP morpholino injections worsened survival rates and the edema phenotype in both congenital NS models while injection with human PACAP-38 could only rescue the adriamycin exposed model. We hereby report, for the first time, PACAP deficiency in a NS zebrafish model as a consequence of adriamycin exposure. However, distinct from the human congenital NS, both zebrafish models retained normal levels of ceruloplasmin and thrombocytes. We further extend the renoprotective effects of the PACAP-38 peptide against adriamycin toxicity in zebrafish.	[Eneman, Benedicte; Elmonem, Mohamed A.; van den Heuvel, Lambertus P.; Levtchenko, Elena] KU Leuven Univ Leuven, Dept Pediat Nephrol & Growth & Regenerat, Univ Hosp Leuven, Leuven, Belgium; [Elmonem, Mohamed A.] Cairo Univ, Dept Clin & Chem Pathol, Fac Med, Cairo, Egypt; [van den Heuvel, Lambertus P.] Radboud Univ Nijmegen, Dept Pediat Nephrol, Med Ctr, Nijmegen, Netherlands; [Khodaparast, Laleh; Khodaparast, Ladan] KU Leuven Univ Leuven, Dept Cellular & Mol Med, Switch Lab, VIB,Univ Hosp Leuven, Leuven, Belgium; [van Geet, Chris; Freson, Kathleen] KU Leuven Univ Leuven, Dept Cardiovasc Sci, Ctr Mol & Vasc Biol, Leuven, Belgium	KU Leuven; University Hospital Leuven; Egyptian Knowledge Bank (EKB); Cairo University; Radboud University Nijmegen; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; KU Leuven	Levtchenko, E (corresponding author), KU Leuven Univ Leuven, Dept Pediat Nephrol & Growth & Regenerat, Univ Hosp Leuven, Leuven, Belgium.	elena.levtchenko@uzleuven.be	Levtchenko, Elena/AAO-7125-2020; van den Heuvel, Lambertus/AAM-1772-2021; van den Heuvel, L.P.W.J./H-8044-2014; Elmonem, Mohamed A/G-2939-2017	van den Heuvel, Lambertus/0000-0003-3917-6727; van den Heuvel, L.P.W.J./0000-0003-3917-6727; Elmonem, Mohamed A/0000-0002-3154-1948; freson, kathleen/0000-0002-4381-2442; Khodaparast, Laleh/0000-0002-5865-7748; Levtchenko, Elena/0000-0002-8352-7312; Khodaparast, ladan/0000-0001-6373-8019	Fund for Scientific Research, Flanders (F. W. O. Vlaanderen) [EVB-C1911-ASP/10, 1801110N]	Fund for Scientific Research, Flanders (F. W. O. Vlaanderen)(FWO)	This work was supported by grants from the Fund for Scientific Research, Flanders (F. W. O. Vlaanderen) to BE (grant EVB-C1911-ASP/10), and E.L (grant 1801110N). URL: http//wwwtwobe/. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aapro MS, 2003, ANN ONCOL, V14, P441, DOI 10.1093/annonc/mdg112; Alexandre D, 2011, J MOL NEUROSCI, V43, P94, DOI 10.1007/s12031-010-9397-y; Chatterjee K, 2010, CARDIOLOGY, V115, P155, DOI 10.1159/000265166; Di Michele M, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.007625; Ding YH, 2011, CIRC RES, V109, P658, DOI 10.1161/CIRCRESAHA.111.248260; Drummond IA, 1998, DEVELOPMENT, V125, P4655; Eneman B, 2015, J THROMB HAEMOST, V13, P755, DOI 10.1111/jth.12891; Eneman B, 2016, PEDIATR NEPHROL, V31, P1267, DOI 10.1007/s00467-015-3173-8; Freson K, 2004, J CLIN INVEST, V113, P905, DOI 10.1172/JCI200419252; Freson K, 2008, BLOOD, V111, P1885, DOI 10.1182/blood-2007-06-098558; Gbadegesin R, 2008, NEPHROL DIAL TRANSPL, V23, P1291, DOI 10.1093/ndt/gfm759; Hentschel DM, 2007, AM J PHYSIOL-RENAL, V293, pF1746, DOI 10.1152/ajprenal.00009.2007; Hinkes BG, 2007, PEDIATRICS, V119, pE907, DOI 10.1542/peds.2006-2164; Jagadeeswaran P, 1999, BRIT J HAEMATOL, V107, P731, DOI 10.1046/j.1365-2141.1999.01763.x; Jeansson M, 2009, J AM SOC NEPHROL, V20, P114, DOI 10.1681/ASN.2007111205; Juhila J, 2010, AM J PATHOL, V176, P51, DOI 10.2353/ajpath.2010.080843; Kerlin BA, 2012, CLIN J AM SOC NEPHRO, V7, P513, DOI 10.2215/CJN.10131011; Khan AM, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.163; Khandekar Gauri, 2012, Adv Hematol, V2012, P857058, DOI 10.1155/2012/857058; Kramer-Zucker AG, 2005, DEV BIOL, V285, P316, DOI 10.1016/j.ydbio.2005.06.038; Li M, 2011, J MOL NEUROSCI, V43, P58, DOI 10.1007/s12031-010-9394-1; Lin HF, 2005, BLOOD, V106, P3803, DOI 10.1182/blood-2005-01-0179; LUTZ EM, 1993, FEBS LETT, V334, P3, DOI 10.1016/0014-5793(93)81668-P; Maduna T, 2016, J NEUROSCI RES, V94, P1472, DOI 10.1002/jnr.23915; Mahmoodi BK, 2008, CIRCULATION, V117, P224, DOI 10.1161/CIRCULATIONAHA.107.716951; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; Mori H, 2010, CIRC J, V74, P1183, DOI 10.1253/circj.CJ-09-1024; Octavia Y, 2012, J MOL CELL CARDIOL, V52, P1213, DOI 10.1016/j.yjmcc.2012.03.006; Orth SR, 1998, NEW ENGL J MED, V338, P1202, DOI 10.1056/NEJM199804233381707; Patrakka J, 2007, TRENDS MOL MED, V13, P396, DOI 10.1016/j.molmed.2007.06.006; Peeters K, 2010, BRIT J HAEMATOL, V151, P54, DOI 10.1111/j.1365-2141.2010.08327.x; PISEGNA JR, 1993, P NATL ACAD SCI USA, V90, P6345, DOI 10.1073/pnas.90.13.6345; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Racz B, 2010, J MOL NEUROSCI, V42, P419, DOI 10.1007/s12031-010-9349-6; Rudecki AP, 2016, TRENDS ENDOCRIN MET, V27, P620, DOI 10.1016/j.tem.2016.04.008; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; Sakamoto K, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/727152; Shioda S, 2015, PEPTIDES, V72, P202, DOI 10.1016/j.peptides.2015.08.006; Simic I, 2013, PEDIATR NEPHROL, V28, P2079, DOI 10.1007/s00467-012-2376-5; SREEDHARAN SP, 1993, BIOCHEM BIOPH RES CO, V193, P546, DOI 10.1006/bbrc.1993.1658; Stackley KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025652; Tams JW, 1999, BIOCHEM J, V341, P271, DOI 10.1042/0264-6021:3410271; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Zennaro C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098131	45	6	6	11	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0182100	10.1371/journal.pone.0182100	http://dx.doi.org/10.1371/journal.pone.0182100			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759637	Green Submitted, gold, Green Published			2022-12-26	WOS:000406761600052
J	Landskron, J; Kraggerud, SM; Wik, E; Dorum, A; Bjornslett, M; Melum, E; Helland, O; Bjorge, L; Lothe, RA; Salvesen, HB; Tasken, K				Landskron, Johannes; Kraggerud, Sigrid M.; Wik, Elisabeth; Dorum, Anne; Bjornslett, Merete; Melum, Espen; Helland, Oystein; Bjorge, Line; Lothe, Ragnhild A.; Salvesen, Helga B.; Tasken, Kjetil			C77G in PTPRC (CD45) is no risk allele for ovarian cancer, but associated with less aggressive disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MULTIPLE-SCLEROSIS; T-CELLS; EXON-A; REGULATORY POLYMORPHISM; HEALTHY-INDIVIDUALS; ISOFORM EXPRESSION; SYSTEMIC-SCLEROSIS; PHOSPHATASE GENE; POINT MUTATION	The pan lymphocyte marker CD45 exists in various isoforms arising from alternative splicing of the exons 4, 5 and 6. While naive T cells express CD45RA translated from an mRNA containing exon 4, exons 4-6 are spliced out to encode the shorter CD45R0 in antigen-experienced effector/memory T cells. The SNP C77G (rs17612648) is located in exon 4 and blocks the exon's differential splicing from the pre-mRNA, enforcing expression of CD45RA. Several studies have linked C77G to autoimmune diseases but lack of validation in other cohorts has left its role elusive. An incidental finding in an ovarian cancer patient cohort from West Norway (Bergen region, n = 312), suggested that the frequency of C77G was higher among ovarian cancer patients than in healthy Norwegians (n = 1,357) (3.0% vs. 1.8% allele frequency). However, this finding could not be validated in a larger patient cohort from South-East Norway (Oslo region, n = 1,198) with 1.2% allele frequency. Hence, C77G is not associated with ovarian cancer in the Norwegian population. However, its frequency was increased in patients with FIGO stage II, endometrioid histology or an age at diagnosis of 60 years or older indicating a possible association with a less aggressive cancer type.	[Landskron, Johannes; Tasken, Kjetil] Univ Oslo, Ctr Mol Med Norway, Nordic EMBL Partnership, Oslo, Norway; [Landskron, Johannes; Tasken, Kjetil] Oslo Univ Hosp, Oslo, Norway; [Landskron, Johannes; Tasken, Kjetil] Univ Oslo, KG Jebsen Ctr Canc Immunotherapy, Oslo, Norway; [Kraggerud, Sigrid M.; Bjornslett, Merete; Lothe, Ragnhild A.] Oslo Univ Hosp, Dept Mol Oncol, Inst Canc Res, Norwegian Radium Hosp, Oslo, Norway; [Kraggerud, Sigrid M.; Bjornslett, Merete; Lothe, Ragnhild A.] Univ Oslo, Ctr Canc Biomed, Fac Med, Oslo, Norway; [Kraggerud, Sigrid M.; Bjornslett, Merete; Lothe, Ragnhild A.] Oslo Univ Hosp, KG Jebsen Colorectal Canc Res Ctr, Oslo, Norway; [Wik, Elisabeth] Haukeland Hosp, Dept Pathol, Bergen, Norway; [Wik, Elisabeth] Univ Bergen, Ctr Canc Biomarkers CCBIO, Dept Clin Med, Sect Pathol, Bergen, Norway; [Dorum, Anne] Oslo Univ Hosp, Dept Gynaecol Oncol, Norwegian Radium Hosp, Oslo, Norway; [Melum, Espen] Oslo Univ Hosp, Norwegian PSC Res Ctr, Dept Transplantat Med, Div Surg Inflammatory Med & Transplantat,Natl Hos, Oslo, Norway; [Melum, Espen; Tasken, Kjetil] Univ Oslo, KG Jebsen Inflammat Res Ctr, Oslo, Norway; [Helland, Oystein; Bjorge, Line; Salvesen, Helga B.] Haukeland Hosp, Dept Obstet & Gynaecol, Bergen, Norway; [Helland, Oystein; Bjorge, Line; Salvesen, Helga B.] Univ Bergen, Dept Clin Sci, Ctr Canc Biomarkers, Bergen, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Bergen; Haukeland University Hospital; University of Bergen; University of Oslo; University of Oslo; University of Oslo; University of Bergen; Haukeland University Hospital; University of Bergen	Tasken, K (corresponding author), Univ Oslo, Ctr Mol Med Norway, Nordic EMBL Partnership, Oslo, Norway.; Tasken, K (corresponding author), Oslo Univ Hosp, Oslo, Norway.; Tasken, K (corresponding author), Univ Oslo, KG Jebsen Ctr Canc Immunotherapy, Oslo, Norway.; Tasken, K (corresponding author), Univ Oslo, KG Jebsen Inflammat Res Ctr, Oslo, Norway.	kjetil.tasken@ncmm.uio.no	Bjorge, Line/AAD-6179-2021; Wik, E./AAA-9105-2020; Bjorge, Line/C-1307-2017	Bjorge, Line/0000-0002-0240-2770; Bjorge, Line/0000-0002-0240-2770; Dorum, Anne/0000-0002-6274-2398; Tasken, Kjetil/0000-0003-2841-4697; Lothe, Ragnhild A./0000-0002-1693-1032	Research Council of Norway [187615, 179571]; Norwegian Cancer Society [419544]; South-Eastern Norway Regional Health Authority [2015031]; Western Norway Regional Health Authority; K. G. Jebsen Foundation	Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); South-Eastern Norway Regional Health Authority; Western Norway Regional Health Authority; K. G. Jebsen Foundation	This work was supported by the Research Council of Norway, http://www.forskningsradet. no,187615 (KT), 179571 (SMK and RAL); The Norwegian Cancer Society, https://kreftforeningen.no/en/main-priorities/, 419544 (KT); The South-Eastern Norway Regional Health Authority, http://www.helse-sorost.no/, 2015031 (KT); The Western Norway Regional Health Authority, https://helse-vest.no/, (LB and HBS) and K. G. Jebsen Foundation, http:www.stiftkgj.no/, (JL and KT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKBAR AN, 1988, J IMMUNOL, V140, P2171; Ballerini C, 2002, NEUROSCI LETT, V328, P325, DOI 10.1016/S0304-3940(02)00565-7; Barcellos LF, 2001, NAT GENET, V29, P23, DOI 10.1038/ng722; Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Do HT, 2006, J IMMUNOL, V176, P931, DOI 10.4049/jimmunol.176.2.931; Earp MA, 2014, HUM GENET, V133, P481, DOI 10.1007/s00439-013-1383-3; Ebell MH, 2016, AM J PREV MED, V50, P384, DOI 10.1016/j.amepre.2015.09.023; Ferlay J, 2014, INT J CANC; Gomez-Lira M, 2003, J NEUROIMMUNOL, V140, P216, DOI 10.1016/S0165-5728(03)00208-X; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; Jacobsen M, 2000, NAT GENET, V26, P495, DOI 10.1038/82659; Ju H, 2009, NEOPLASIA, V11, P1340, DOI 10.1593/neo.91132; Kirsten H, 2008, J RHEUMATOL, V35, P1817; Knappskog S, 2011, CANCER CELL, V19, P273, DOI 10.1016/j.ccr.2010.12.019; Landskron J, 2014, CANC IMMUNOLOGY IMMU; Liu JZ, 2013, NAT GENET, V45, P670, DOI 10.1038/ng.2616; Lynch KW, 2001, J BIOL CHEM, V276, P24341, DOI 10.1074/jbc.M102175200; Miterski Bianca, 2002, BMC Med Genet, V3, P3, DOI 10.1186/1471-2350-3-3; Motoya S, 1999, J BIOL CHEM, V274, P1407, DOI 10.1074/jbc.274.3.1407; Motta-Mena LB, 2011, J BIOL CHEM, V286, P20043, DOI 10.1074/jbc.M111.218727; Nicholas RS, 2003, J NEUROL NEUROSUR PS, V74, P944, DOI 10.1136/jnnp.74.7.944; Pharoah PDP, 2013, NAT GENET, V45, P362, DOI 10.1038/ng.2564; Pokoyski C, 2015, GENES IMMUN, V16, P519, DOI 10.1038/gene.2015.39; Quaye L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005983; SCHWINZER R, 1992, EUR J IMMUNOL, V22, P1095, DOI 10.1002/eji.1830220433; SCHWINZER R, 1990, J EXP MED, V171, P1803, DOI 10.1084/jem.171.5.1803; Schwinzer R, 2003, GENES IMMUN, V4, P168, DOI 10.1038/sj.gene.6363894; Song HL, 2009, NAT GENET, V41, P996, DOI 10.1038/ng.424; Stanton T, 2003, P NATL ACAD SCI USA, V100, P5997, DOI 10.1073/pnas.0931490100; Szvetko AL, 2009, BRAIN RES, V1255, P148, DOI 10.1016/j.brainres.2008.12.017; Tchilian EZ, 2006, TRENDS IMMUNOL, V27, P146, DOI 10.1016/j.it.2006.01.001; Tchilian EZ, 2002, IMMUNOGENETICS, V53, P980, DOI 10.1007/s00251-001-0410-z; Tchilian EZ, 2001, J IMMUNOL, V166, P6144, DOI 10.4049/jimmunol.166.10.6144; THUDE H, 1995, EUR J IMMUNOL, V25, P2101, DOI 10.1002/eji.1830250745; Veillette A, 1999, J BIOL CHEM, V274, P14392, DOI 10.1074/jbc.274.20.14392; Vogel A, 2003, GENES IMMUN, V4, P79, DOI 10.1038/sj.gene.6363918; Vorechovsky I, 2001, NAT GENET, V29, P22, DOI 10.1038/ng723; Windhagen A, 2007, CLIN EXP IMMUNOL, V150, P509, DOI 10.1111/j.1365-2249.2007.03508.x	40	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0182030	10.1371/journal.pone.0182030	http://dx.doi.org/10.1371/journal.pone.0182030			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759630	Green Published, Green Submitted, gold			2022-12-26	WOS:000406761600045
J	Lee, JK; Lee, S; Kim, KT; Lee, MC				Lee, Joon Kyu; Lee, Sahnghoon; Kim, Ki Tae; Lee, Myung Chul			Anatomic tunnel placement can be achieved with a modification to transtibial technique in single bundle anterior cruciate ligament reconstruction: A cadaver study	PLOS ONE			English	Article							3-DIMENSIONAL COMPUTED-TOMOGRAPHY; ANTEROMEDIAL PORTAL TECHNIQUE; FEMORAL TUNNEL; ACL RECONSTRUCTION; CORONAL PLANE; TIBIAL TUNNEL; POSTEROLATERAL BUNDLES; INSERTION SITE; KNEE LAXITY; POSITION	Placing the tunnels in the anatomic positions is important for successful restoration of knee function after anterior cruciate ligament reconstruction (ACLR). It has been shown that it is difficult to place the tunnels in the anatomic position using the transtibial technique. The purpose of this study was to evaluate the effect of each step of our modified transtibial technique (mTT) on the positioning of the femoral tunnel so as to assess whether the mTT could achieve anatomic placements of the tunnels without tibial tunnel expansion. Ten fresh-frozen cadaveric knees were used. First, the tibial tunnel was created in the center of ACL footprint. Then, a pin was inserted through the tibial tunnel using a femoral guide by four stepwise techniques: transtibial technique, additional anterior drawer force applied to the proximal tibia, another additional varus force applied to the tibia and finally, additional external rotation of the tibia and the femoral guide (mTT). Then, tibial tunnel was re-reamed using mTT with 10mm-diameter reamer. The pin positions in each technique on the femur were evaluated by the quadrant method and shapes of the tibial tunnel apertures were evaluated. Femoral pin positions in the four techniques were 23.6 +/- 4.5%, 28.4 +/- 3.4%, 30.1 +/- 3.8%, 33.2 +/- 4.5% in the superior-inferior position, and 23.9 +/- 4.3%, 26.2 +/- 3.7%, 32.0 +/- 4.3%, 36.9 +/- 4.8% in the anterior-posterior position, respectively. Pin position shifted to more inferior and posterior position with each step of mTT (all p values comparing superior-inferior and anterior-posterior positions of each step with positions of previous step were 0.008 or less). Using mTT, tibial tunnel aperture was 10.5 +/- 0.3mm wide and 12.9 +/- 1.1mm long. In conclusion, anatomic placements of femoral tunnels in ACLR without excessive tibial tunnel expansion could be achieved using the mTT.	[Lee, Joon Kyu; Kim, Ki Tae] Hallym Univ, Dept Orthopaed Surg, Sacred Heart Hosp, Anyang, South Korea; [Lee, Sahnghoon; Lee, Myung Chul] Seoul Natl Univ Hosp, Dept Orthopaed Surg, Seoul, South Korea	Hallym University; Seoul National University (SNU); Seoul National University Hospital	Lee, MC (corresponding author), Seoul Natl Univ Hosp, Dept Orthopaed Surg, Seoul, South Korea.	leemc@snu.ac.kr						Arnold MP, 2001, KNEE SURG SPORT TR A, V9, P194, DOI 10.1007/s001670100198; Bedi A, 2011, ARTHROSCOPY, V27, P380, DOI 10.1016/j.arthro.2010.07.018; Bedi A, 2010, ARTHROSCOPY, V26, P342, DOI 10.1016/j.arthro.2009.12.006; Bedi A, 2009, ARTHROSCOPY, V25, P1128, DOI 10.1016/j.arthro.2009.03.008; Chhabra A, 2004, ARTHROSCOPY, V20, P328, DOI 10.1016/j.arthro.2003.11.034; Colombet P, 2006, ARTHROSCOPY, V22, P984, DOI 10.1016/j.arthro.2006.04.102; Dargel J, 2009, KNEE SURG SPORT TR A, V17, P220, DOI 10.1007/s00167-008-0639-2; Forsythe B, 2010, J BONE JOINT SURG AM, V92A, P1418, DOI 10.2106/JBJS.I.00654; Guo L, 2009, INT ORTHOP, V33, P133, DOI 10.1007/s00264-008-0523-1; Harner CD, 2008, ARTHROSCOPY, V24, P113, DOI 10.1016/j.arthro.2007.07.019; Heming JF, 2007, AM J SPORT MED, V35, P1708, DOI 10.1177/0363546507304137; Howell SM, 2001, AM J SPORT MED, V29, P567, DOI 10.1177/03635465010290050801; Iriuchishima T, 2010, KNEE SURG SPORT TR A, V18, P1226, DOI 10.1007/s00167-010-1128-y; Jepsen CF, 2007, ARTHROSCOPY, V23, P1326, DOI 10.1016/j.arthro.2007.09.010; Kaseta MK, 2008, CLIN ORTHOP RELAT R, V466, P1467, DOI 10.1007/s11999-008-0238-z; Kopf S, 2010, J BONE JOINT SURG AM, V92A, P1427, DOI 10.2106/JBJS.I.00655; Lamy T, 1997, AM J MED, V102, P14, DOI 10.1016/S0002-9343(96)00351-8; Lee JK, 2014, J BONE JOINT SURG AM, V96A, P664, DOI 10.2106/JBJS.M.00088; Lee MC, 2007, ARTHROSCOPY, V23, P771, DOI 10.1016/j.arthro.2007.04.016; Musahl V, 2003, ARTHROSCOPY, V19, P154, DOI 10.1053/jars.2003.50001; Pietrini SD, 2011, KNEE SURG SPORT TR A, V19, P792, DOI 10.1007/s00167-010-1372-1; Raffo CS, 2008, ARTHROSCOPY, V24, P843, DOI 10.1016/j.arthro.2007.12.005; Rue JPH, 2008, AM J SPORT MED, V36, P73, DOI 10.1177/0363546507311093; Scopp JM, 2004, ARTHROSCOPY, V20, P294, DOI 10.1016/j.arthro.2004.01.001; Steiner ME, 2009, AM J SPORT MED, V37, P1912, DOI 10.1177/0363546509340407; Strauss EJ, 2011, AM J SPORT MED, V39, P1263, DOI 10.1177/0363546510395488; Takahashi M, 2006, AM J SPORT MED, V34, P787, DOI 10.1177/0363546505282625; Tashiro Y, 2014, OPEN ACCESS J SPORTS, V5, P65, DOI 10.2147/OAJSM.S59297; Tsuda E, 2010, AM J SPORT MED, V38, P698, DOI 10.1177/0363546509351561; Tsukada H, 2008, J ORTHOP SCI, V13, P122, DOI 10.1007/s00776-007-1203-5; Youm YS, 2014, AM J SPORT MED, V42, P2941, DOI 10.1177/0363546514551922; Zantop T, 2008, AM J SPORT MED, V36, P65, DOI 10.1177/0363546507308361	32	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0180860	10.1371/journal.pone.0180860	http://dx.doi.org/10.1371/journal.pone.0180860			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759600	gold, Green Published, Green Submitted			2022-12-26	WOS:000406761600008
J	Heilmann, K; Toth, R; Bossmann, C; Klimo, K; Plass, C; Gerhauser, C				Heilmann, K.; Toth, R.; Bossmann, C.; Klimo, K.; Plass, C.; Gerhauser, C.			Genome-wide screen for differentially methylated long noncoding RNAs identifies Esrp2 and lncRNA Esrp2-as regulated by enhancer DNA methylation with prognostic relevance for human breast cancer	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MAMMALIAN EXPRESSION ATLAS; ENGINEERED MOUSE MODELS; TUMOR-SUPPRESSOR GENE; MAMMARY ADENOCARCINOMA; CPG METHYLATION; BONE METASTASIS; SEQUENCING DATA; SEQ EXPERIMENTS; STEM-CELLS	The majority of long noncoding RNAs (lncRNAs) is still poorly characterized with respect to function, interactions with protein-coding genes, and mechanisms that regulate their expression. As for protein-coding RNAs, epigenetic deregulation of lncRNA expression by alterations in DNA methylation might contribute to carcinogenesis. To provide genome-wide information on lncRNAs aberrantly methylated in breast cancer we profiled tumors of the C3(1) SV40TAg mouse model by MCIp-seq (Methylated CpG Immunoprecipitation followed by sequencing). This approach detected 69 lncRNAs differentially methylated between tumor tissue and normal mammary glands, with 26 located in antisense orientation of a protein-coding gene. One of the hypomethylated lncRNAs, 1810019D21Rik (now called Esrp2-antisense (as)) was identified in proximity to the epithelial splicing regulatory protein 2 (Esrp2) that is significantly elevated in C3(1) tumors. ESRPs were shown previously to have a dual role in carcinogenesis. Both gain and loss have been associated with poor prognosis in human cancers, but the mechanisms regulating expression are not known. Indepth analyses indicate that coordinate overexpression of Esrp2 and Esrp2-as inversely correlates with DNA methylation. Luciferase reporter gene assays support co-expression of Esrp2 and the major short Esrp2-as variant from a bidirectional promoter, and transcriptional regulation by methylation of a proximal enhancer. Ultimately, this enhancer-based regulatory mechanism provides a novel explanation for tissue-specific expression differences and upregulation of Esrp2 during carcinogenesis. Knockdown of Esrp2-as reduced Esrp2 protein levels without affecting mRNA expression and resulted in an altered transcriptional profile associated with extracellular matrix (ECM), cell motility and reduced proliferation, whereas overexpression enhanced proliferation. Our findings not only hold true for the murine tumor model, but led to the identification of an unannotated human homolog of Esrp2-as which is significantly upregulated in human breast cancer and associated with poor prognosis.	[Heilmann, K.; Toth, R.; Bossmann, C.; Klimo, K.; Plass, C.; Gerhauser, C.] German Canc Res Ctr, Div Epigen & Canc Risk Factors, Neuenheimer Feld 280, D-69120 Heidelberg, BW, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Gerhauser, C (corresponding author), German Canc Res Ctr, Div Epigen & Canc Risk Factors, Neuenheimer Feld 280, D-69120 Heidelberg, BW, Germany.	c.gerhauser@dkfz.de	Toth, Reka/AAB-1695-2020	Toth, Reka/0000-0002-6096-1052; Plass, Christoph/0000-0003-2554-3952; Gerhauser, Clarissa/0000-0002-5792-3901	DKFZ Helmholtz International Graduate School for Cancer Research	DKFZ Helmholtz International Graduate School for Cancer Research	KH was supported by a Ph.D. scholarship provided by the DKFZ Helmholtz International Graduate School for Cancer Research. We are grateful to Megumio Onishi Seebacher for providing barcoded oligonucleotide sequences, the Genome and Proteome core facility of the DKFZ for providing technical support and excellent MCIp-seq and RNA-seq services, and Lorena Salgueiro and Rocio Sotillo Roman for their instant support in isolating murine mammary epithelial cells and fibroblasts. We further want to thank Oliver Mucke and Monika Helf for excellent technical assistance, and Thomas Risch, Maiwen Caudron-Herger, Odilia Popanda and Dieter Weichenhan for helpful discussion. The results reported here are in part based upon data generated by The Cancer Genome Atlas managed by the NCI and NHGRI. Information about TCGA can be found at http://cancergenome.nih.gov.	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Ades F, 2014, J CLIN ONCOL, V32, P2794, DOI 10.1200/JCO.2013.54.1870; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arab K, 2014, MOL CELL, V55, P604, DOI 10.1016/j.molcel.2014.06.031; Aran D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r21; Asch-Kendrick R, 2016, HUM PATHOL, V48, P37, DOI 10.1016/j.humpath.2015.09.035; Baer C, 2015, INT J CANCER, V137, P1352, DOI 10.1002/ijc.29491; Bai YG, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0079-7; Bashir M, 2015, NPJ BREAST CANCER, V1, DOI 10.1038/npjbcancer.2015.7; Batts TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027841; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bennett CN, 2010, TOXICOL PATHOL, V38, P88, DOI 10.1177/0192623309357074; Bennett CN, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2125; Bertucci F, 2012, CURR MOL MED, V12, P96, DOI 10.2174/156652412798376134; Blaas L, 2016, NAT CELL BIOL, V18, P1346, DOI 10.1038/ncb3434; Bock C, 2012, MOL CELL, V47, P633, DOI 10.1016/j.molcel.2012.06.019; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Carrieri C, 2012, NATURE, V491, P454, DOI 10.1038/nature11508; Chau YM, 2002, J CLIN ENDOCR METAB, V87, P2674, DOI 10.1210/jc.87.6.2674; Darlington G J, 1987, Methods Enzymol, V151, P19, DOI 10.1016/S0076-6879(87)51006-0; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; Deeb KK, 2007, CANCER RES, V67, P8065, DOI 10.1158/0008-5472.CAN-07-1515; Deloria AJ, 2016, ONCOTARGET, V7, P73800, DOI 10.18632/oncotarget.12070; Di Palma T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.262; Diederichs S, 2014, TRENDS GENET, V30, P121, DOI 10.1016/j.tig.2014.01.004; Drake LE, 2014, J PATHOL, V232, P283, DOI 10.1002/path.4298; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Faryna M, 2012, FASEB J, V26, P4937, DOI 10.1096/fj.12-209502; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Gebhard C, 2006, CANCER RES, V66, P6118, DOI 10.1158/0008-5472.CAN-06-0376; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Gottgens EL, 2016, INT REV CEL MOL BIO, V327, P163, DOI 10.1016/bs.ircmb.2016.06.003; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; Green JE, 2000, ONCOGENE, V19, P1020, DOI 10.1038/sj.onc.1203280; Grote P, 2013, DEV CELL, V24, P206, DOI 10.1016/j.devcel.2012.12.012; Guil S, 2012, NAT STRUCT MOL BIOL, V19, P1068, DOI 10.1038/nsmb.2428; Gumireddy K, 2013, EMBO J, V32, P2672, DOI 10.1038/emboj.2013.188; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hayakawa A, 2016, ADV EXP MED BIOL, V925, P33; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Holzer RG, 2003, BREAST CANCER RES TR, V77, P65, DOI 10.1023/A:1021175931177; Horiguchi K, 2012, ONCOGENE, V31, P3190, DOI 10.1038/onc.2011.493; Hu GZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107016; Hu XW, 2014, CANCER CELL, V26, P344, DOI 10.1016/j.ccr.2014.07.009; Huang HY, 2013, CLIN CANCER RES, V19, P2861, DOI 10.1158/1078-0432.CCR-12-2641; Hwang JA, 2013, ONCOTARGET, V4, P2317, DOI 10.18632/oncotarget.1464; Hynes RO, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a004903; Ishii H, 2014, J BIOL CHEM, V289, P27386, DOI 10.1074/jbc.M114.589432; Iwakiri M, 2009, NEUROPATHOLOGY, V29, P263, DOI 10.1111/j.1440-1789.2008.00978.x; Jaeger J, 2007, CLIN CANCER RES, V13, P806, DOI 10.1158/1078-0432.CCR-06-1820; Jechlinger M, 2009, GENE DEV, V23, P1677, DOI 10.1101/gad.1801809; Johnsson P, 2014, BBA-GEN SUBJECTS, V1840, P1063, DOI 10.1016/j.bbagen.2013.10.035; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kersten K, 2017, EMBO MOL MED, V9, P137, DOI 10.15252/emmm.201606857; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Lee C, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-37; Li AM, 2013, BIOCHEM BIOPH RES CO, V436, P486, DOI 10.1016/j.bbrc.2013.05.131; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LI Y, 2015, SCI REP UK, V5; Lienhard M, 2014, BIOINFORMATICS, V30, P284, DOI 10.1093/bioinformatics/btt650; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lizio M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0560-6; MAROULAKOU IG, 1994, P NATL ACAD SCI USA, V91, P11236, DOI 10.1073/pnas.91.23.11236; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Minden Audrey, 2012, ISRN Oncol, V2012, P694201, DOI 10.5402/2012/694201; Mizutani A, 2016, ONCOGENE, V35, P3514, DOI 10.1038/onc.2015.412; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Naba A, 2016, MATRIX BIOL, V49, P10, DOI 10.1016/j.matbio.2015.06.003; Nikolsky Y, 2008, CANCER RES, V68, P9532, DOI 10.1158/0008-5472.CAN-08-3082; Okonechnikov K, 2016, BIOINFORMATICS, V32, P292, DOI 10.1093/bioinformatics/btv566; Pappa G, 2007, CARCINOGENESIS, V28, P1471, DOI 10.1093/carcin/bgm044; Pelechano V, 2013, NAT REV GENET, V14, P880, DOI 10.1038/nrg3594; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Pradella D, 2017, MOL CANCER, V16, DOI 10.1186/s12943-016-0579-2; Punj V, 2010, CLIN CANCER RES, V16, P1140, DOI 10.1158/1078-0432.CCR-09-2463; Qin D, 2015, CELL MOL BIOL LETT, V20, P323, DOI 10.1515/cmble-2015-0021; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Reaves DK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091747; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roring M, 2012, EMBO J, V31, P2629, DOI 10.1038/emboj.2012.100; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Sahu A, 2015, TRENDS CANCER, V1, P93, DOI 10.1016/j.trecan.2015.08.010; Schilling E, 2007, GENOMICS, V90, P314, DOI 10.1016/j.ygeno.2007.04.011; Shapiro IM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002218; Smalley MJ, 2010, METHODS MOL BIOL, V633, P139, DOI 10.1007/978-1-59745-019-5_11; Sonnet Miriam, 2013, Methods Mol Biol, V971, P201, DOI 10.1007/978-1-62703-269-8_11; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun H, 2016, J CELL MOL MED, V20, P1234, DOI 10.1111/jcmm.12783; Tommasi S, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2233; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Tseng YY, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.974467; Tseng YY, 2014, NATURE, V512, P82, DOI 10.1038/nature13311; Visvader JE, 2014, GENE DEV, V28, P1143, DOI 10.1101/gad.242511.114; Walrath JC, 2010, ADV CANCER RES, V106, P113, DOI 10.1016/S0065-230X(10)06004-5; Wang DS, 2015, NATURE, V517, P81, DOI 10.1038/nature13851; Wang W, 2005, ONCOGENE, V24, P2705, DOI 10.1038/sj.onc.1208464; Warzecha CC, 2012, SEMIN CANCER BIOL, V22, P417, DOI 10.1016/j.semcancer.2012.04.003; Warzecha CC, 2010, EMBO J, V29, P3286, DOI 10.1038/emboj.2010.195; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Xu Z, 2014, ONCOGENE, V33, P2836, DOI 10.1038/onc.2013.243; Yang F, 2017, CELL MOL LIFE SCI, V74, P951, DOI 10.1007/s00018-016-2334-7; Yao Y, 2010, CARCINOGENESIS, V31, P382, DOI 10.1093/carcin/bgp308; Yarmishyn AA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S9-S7; Yoon JH, 2012, MOL CELL, V47, P648, DOI 10.1016/j.molcel.2012.06.027; Yu HS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-251; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011; Zhu M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r77	119	50	54	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 16	2017	36	46					6446	6461		10.1038/onc.2017.246	http://dx.doi.org/10.1038/onc.2017.246			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FM9WN	28759043	hybrid, Green Published			2022-12-26	WOS:000415622900008
J	Peters, AA; Jamaludin, SYN; Yapa, KTDS; Chalmers, S; Wiegmans, AP; Lim, HF; Milevskiy, MJG; Azimi, I; Davis, FM; Northwood, KS; Pera, E; Marcial, DL; Dray, E; Waterhouse, NJ; Cabot, PJ; Gonda, TJ; Kenny, PA; Brown, MA; Khanna, KK; Roberts-Thomson, SJ; Monteith, GR				Peters, A. A.; Jamaludin, S. Y. N.; Yapa, K. T. D. S.; Chalmers, S.; Wiegmans, A. P.; Lim, H. F.; Milevskiy, M. J. G.; Azimi, I.; Davis, F. M.; Northwood, K. S.; Pera, E.; Marcial, D. L.; Dray, E.; Waterhouse, N. J.; Cabot, P. J.; Gonda, T. J.; Kenny, P. A.; Brown, M. A.; Khanna, K. K.; Roberts-Thomson, S. J.; Monteith, G. R.			Oncosis and apoptosis induction by activation of an overexpressed ion channel in breast cancer cells	ONCOGENE			English	Article							NEURONAL DEGENERATION; MOLECULAR-MECHANISMS; PROSTATE-CANCER; CALCIUM; DEATH; EXPRESSION; NECROSIS; TUMORS; CONSEQUENCES; HOMEOSTASIS	The critical role of calcium signalling in processes related to cancer cell proliferation and invasion has seen a focus on pharmacological inhibition of overexpressed ion channels in specific cancer subtypes as a potential therapeutic approach. However, despite the critical role of calcium in cell death pathways, pharmacological activation of overexpressed ion channels has not been extensively evaluated in breast cancer. Here we define the overexpression of transient receptor potential vanilloid 4 (TRPV4) in a subgroup of breast cancers of the basal molecular subtype. We also report that pharmacological activation of TRPV4 with GSK1016790A reduced viability of two basal breast cancer cell lines with pronounced endogenous overexpression of TRPV4, MDA-MB-468 and HCC1569. Pharmacological activation of TRPV4 produced pronounced cell death through two mechanisms: apoptosis and oncosis in MDA-MB-468 cells. Apoptosis was associated with PARP-1 cleavage and oncosis was associated with a rapid decline in intracellular ATP levels, which was a consequence of, rather than the cause of, the intracellular ion increase. TRPV4 activation also resulted in reduced tumour growth in vivo. These studies define a novel therapeutic strategy for breast cancers that overexpress specific calcium permeable plasmalemmal ion channels with available selective pharmacological activators.	[Peters, A. A.; Jamaludin, S. Y. N.; Yapa, K. T. D. S.; Chalmers, S.; Lim, H. F.; Azimi, I.; Davis, F. M.; Pera, E.; Marcial, D. L.; Cabot, P. J.; Gonda, T. J.; Roberts-Thomson, S. J.; Monteith, G. R.] Univ Queensland, Sch Pharm, 20 Cornwall St, Brisbane, Qld 4102, Australia; [Wiegmans, A. P.] QIMR Berghofer Med Res Inst, Tumour Microenvironm Lab, Brisbane, Qld, Australia; [Milevskiy, M. J. G.; Northwood, K. S.; Brown, M. A.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Azimi, I.; Davis, F. M.; Monteith, G. R.] Univ Queensland, Translat Res Inst, Mater Res Inst, Brisbane, Qld, Australia; [Dray, E.] Queensland Univ Technol, Translat Res Inst, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Dray, E.] Queensland Univ Technol, Translat Res Inst, Sch Biomed Sci, Brisbane, Qld, Australia; [Waterhouse, N. J.; Khanna, K. K.] QIMR Berghofer Med Res Inst, Signal Transduct Lab, Brisbane, Qld, Australia; [Kenny, P. A.] Gunderson Med Fdn, Kabara Canc Res Inst, La Crosse, WI USA; [Jamaludin, S. Y. N.] Univ Sultan Zainal Abidin, Fac Med, Kuala Terengganu, Terengganu, Malaysia	University of Queensland; QIMR Berghofer Medical Research Institute; University of Queensland; Mater Research; University of Queensland; Queensland University of Technology (QUT); Queensland University of Technology (QUT); QIMR Berghofer Medical Research Institute; Universiti Sultan Zainal Abidin	Monteith, GR (corresponding author), Univ Queensland, Sch Pharm, 20 Cornwall St, Brisbane, Qld 4102, Australia.	gregm@uq.edu.au	Dray, Eloise/AAD-5147-2021; Brown, Melissa A/F-1451-2010; Roberts-Thomson, Sarah J/B-4282-2011; Peters, Amelia/AAP-3886-2021; Roberts-Thomson, Sarah/W-5676-2019; Davis, Felicity M/P-1387-2016; Cabot, Peter John/B-2424-2013; Peters, Amelia A/E-4254-2010; Chalmers, Silke/Q-5731-2019; Monteith, Gregory/B-1626-2008; Chalmers, Silke/GQH-6183-2022; Dray, Eloise/E-3938-2012; Azimi, Iman/E-2043-2011	Roberts-Thomson, Sarah J/0000-0001-8202-5786; Peters, Amelia/0000-0002-0700-7817; Roberts-Thomson, Sarah/0000-0001-8202-5786; Davis, Felicity M/0000-0001-9112-118X; Cabot, Peter John/0000-0003-1778-3753; Monteith, Gregory/0000-0002-4345-530X; Dray, Eloise/0000-0001-6793-9838; Chalmers, Silke/0000-0002-5874-7540; Northwood, Korinne/0000-0001-6268-547X; Brown, Melissa/0000-0002-2830-9259; Jamaludin, Siti Yusrina Nadihah/0000-0002-8006-1406; Gonda, Thomas/0000-0002-8792-3021; Azimi, Iman/0000-0001-9477-9999; Khanna, Kum Kum/0000-0001-8650-5381	National Health and Medical Research Council of Australia [1079671]; Cancer Council Queensland [1042819]; Mater Foundation; Australian Government; Ministry of Higher Education Malaysia Scholarship; NBCF fellowship [ECR13-04]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Queensland(Cancer Council Queensland); Mater Foundation; Australian Government(Australian GovernmentCGIAR); Ministry of Higher Education Malaysia Scholarship; NBCF fellowship	This work was supported by the National Health and Medical Research Council of Australia (1079671) and Cancer Council Queensland (1042819). We are grateful to Sunil Lakhani and The Brisbane Breast Bank (The University of Queensland Centre for Clinical Research, Brisbane, Australia) for providing the MDA-MB-468 and BT-20 cell lines and RNA from 184A1, 184B5, MCF10A and Bre-80-hTERT cells for this study. GM is supported by the Mater Foundation. The Translational Research Institute is supported by a grant from the Australian Government. SYNJ was funded by the Ministry of Higher Education Malaysia Scholarship. ED is the recipient of a NBCF fellowship (ECR13-04).	Adapala RK, 2016, ONCOGENE, V35, P314, DOI 10.1038/onc.2015.83; Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Aung CS, 2009, CARCINOGENESIS, V30, P1962, DOI 10.1093/carcin/bgp223; Aydar E, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-23; Azimi I, 2016, MOL ONCOL, V10, P166, DOI 10.1016/j.molonc.2015.09.006; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Cardaci S, 2012, J BIOENERG BIOMEMBR, V44, P17, DOI 10.1007/s10863-012-9422-7; Chen RB, 2014, UROL ONCOL-SEMIN ORI, V32, P524, DOI 10.1016/j.urolonc.2013.05.011; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Clarke C, 2013, CARCINOGENESIS, V34, P2300, DOI 10.1093/carcin/bgt208; Curry MC, 2012, J BIOL CHEM, V287, P28598, DOI 10.1074/jbc.M112.364737; Czifra G, 2009, J CANCER RES CLIN, V135, P507, DOI 10.1007/s00432-008-0482-3; Del Nagro C, 2014, J BIOL CHEM, V289, P35182, DOI 10.1074/jbc.M114.580159; Ding X, 2010, JNCI-J NATL CANCER I, V102, P1052, DOI 10.1093/jnci/djq217; Dubois C, 2014, CANCER CELL, V26, P19, DOI 10.1016/j.ccr.2014.04.025; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; Feng MY, 2010, CELL, V143, P84, DOI 10.1016/j.cell.2010.08.040; Frandsen SK, 2012, CANCER RES, V72, P1336, DOI 10.1158/0008-5472.CAN-11-3782; Franken J, 2014, BRIT J PHARMACOL, V171, P2537, DOI 10.1111/bph.12502; Garcia-Elias A, 2014, HANDB EXP PHARMACOL, V222, P293, DOI 10.1007/978-3-642-54215-2_12; GOLDSBY RA, 1963, BIOCHEMISTRY-US, V2, P1142, DOI 10.1021/bi00905a041; Gradilone SA, 2010, GASTROENTEROLOGY, V139, P304, DOI 10.1053/j.gastro.2010.04.010; Haas BE, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-61; HARTLEY DM, 1993, J NEUROSCI, V13, P1993; Jo AO, 2016, P NATL ACAD SCI USA, V113, P3885, DOI 10.1073/pnas.1515895113; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Laing RJ, 2016, NEUROSCIENTIST, V22, P171, DOI 10.1177/1073858414567884; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee WH, 2016, SCI REP-UK, V6, DOI 10.1038/srep27903; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Mahieu F, 2007, J BIOL CHEM, V282, P3325, DOI 10.1074/jbc.M605213200; MAJNO G, 1995, AM J PATHOL, V146, P3; Middelbeek J, 2012, CANCER RES, V72, P4250, DOI 10.1158/0008-5472.CAN-11-3863; Monteith GR, 2012, J BIOL CHEM, V287, P31666, DOI 10.1074/jbc.R112.343061; Peters AA, 2012, MOL CANCER THER, V11, P2158, DOI 10.1158/1535-7163.MCT-11-0965; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Presson AP, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-230; Rivenbark AG, 2013, AM J PATHOL, V183, P1113, DOI 10.1016/j.ajpath.2013.08.002; Sattler R, 2001, MOL NEUROBIOL, V24, P107, DOI 10.1385/MN:24:1-3:107; Shi Y, 2009, GUT, V58, P1443, DOI 10.1136/gut.2009.181735; Solvang HK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-197; Thorneloe KS, 2008, J PHARMACOL EXP THER, V326, P432, DOI 10.1124/jpet.108.139295; Thorneloe KS, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004276; Trump BF, 1997, TOXICOL PATHOL, V25, P82, DOI 10.1177/019262339702500116; Weerasinghe P, 2012, EXP MOL PATHOL, V93, P302, DOI 10.1016/j.yexmp.2012.09.018; Willette RN, 2008, J PHARMACOL EXP THER, V326, P443, DOI 10.1124/jpet.107.134551; Wojda U, 2008, IUBMB LIFE, V60, P575, DOI 10.1002/iub.91; Wu TTL, 2014, CELL CALCIUM, V56, P59, DOI 10.1016/j.ceca.2014.04.006; Yang SL, 2009, ONCOGENE, V28, P1320, DOI 10.1038/onc.2008.475; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Zhang L, 2004, CANCER RES, V64, P8365, DOI 10.1158/0008-5472.CAN-04-2146; Zhuang LY, 2002, LAB INVEST, V82, P1755, DOI 10.1097/01.LAB.0000043910.41414.E7; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	58	48	51	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 16	2017	36	46					6490	6500		10.1038/onc.2017.234	http://dx.doi.org/10.1038/onc.2017.234			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FM9WN	28759041				2022-12-26	WOS:000415622900012
J	Csoka, B; Toro, G; Vindeirinho, J; Varga, ZV; Koscso, B; Nemeth, ZH; Kokai, E; Antonioli, L; Suleiman, M; Marchetti, P; Cseri, K; Deak, A; Virag, L; Pacher, P; Bai, P; Hasko, G				Csoka, Balazs; Toro, Gabor; Vindeirinho, Joana; Varga, Zoltan V.; Koscso, Balazs; Nemeth, Zoltan H.; Kokai, Endre; Antonioli, Luca; Suleiman, Mara; Marchetti, Piero; Cseri, Karolina; Deak, Adam; Virag, Laszlo; Pacher, Pal; Bai, Peter; Hasko, Gyorgy			A(2A) adenosine receptors control pancreatic dysfunction in high-fat-diet-induced obesity	FASEB JOURNAL			English	Article						diabetes; islet; beta-cell; beta-cell dedifferentiation	BETA-CELL DEDIFFERENTIATION; ENDOPLASMIC-RETICULUM STRESS; CHRONIC OXIDATIVE STRESS; INSULIN-SECRETION; ADIPOSE-TISSUE; GLUCOSE TOXICITY; MACROPHAGES; INFLAMMATION; SURVIVAL; MICE	Adenosine, a key extracellular signaling mediator, regulates several aspects of metabolism by activating 4 G-protein-coupled receptors, the A(1), A(2A), A(2B), and A(3) adenosine receptors (ARs). The role of A(2A)ARs in regulating high-fat-diet (HFD)-induced metabolic derangements is unknown. To evaluate the role of A(2A)ARs in regulating glucose and insulin homeostasis in obesity, we fed A(2A)AR-knockout (KO) and control mice an HFD for 16 wk to initiate HFD-induced metabolic disorder. We found that genetic deletion of A(2A)ARs caused impaired glucose tolerance in mice fed an HFD. This impaired glucose tolerance was caused by a decrease in insulin secretion but not in insulin sensitivity. Islet size and insulin content in pancreata of A(2A)AR-deficient micewere decreased compared with control mice after consuming an HFD. A(2A)AR-KO mice had decreased expression of the beta-cell-specific markers pdx1, glut2, mafA, and nkx6.1 and increased expression of the dedifferentiation markers sox2 and hes1. Ex vivo islet experiments confirmed the role of A(2A)ARs in protecting against decreased insulin content and release caused by HFD. Other experiments with bone marrow chimeras revealed that inflammation was not the primary cause of decreased insulin secretion in A(2A)AR-KO mice. Altogether, our data showed that A(2A)ARs control pancreatic dysfunction in HFD-induced obesity.-Csoka, B., Toro, G., Vindeirinho, J., Varga, Z. V., Koscso, B., Nemeth, Z. H., Kokai, E., Antonioli, L., Suleiman, M., Marchetti, P., Cseri, K., Deak, A., Virag, L., Pacher, P., Bai, P., Hasko ', G. A(2A) adenosine receptors control pancreatic dysfunction in high- fat-diet-induced obesity.	[Csoka, Balazs; Toro, Gabor; Vindeirinho, Joana; Nemeth, Zoltan H.; Hasko, Gyorgy] Rutgers New Jersey Med Sch, Dept Surg, Newark, NJ USA; [Csoka, Balazs; Toro, Gabor; Hasko, Gyorgy] Rutgers New Jersey Med Sch, Ctr Immun & Inflammat, Newark, NJ USA; [Varga, Zoltan V.; Pacher, Pal] NIAAA, NIH, Bethesda, MD USA; [Koscso, Balazs] Penn State Univ Coll Med, Dept Microbiol & Immunol, Hershey, PA USA; [Nemeth, Zoltan H.] Morristown Mem Med Ctr, Dept Surg, Morristown, NJ USA; [Kokai, Endre; Cseri, Karolina; Virag, Laszlo; Bai, Peter; Hasko, Gyorgy] Univ Debrecen, Dept Med Chem, Fac Med, Debrecen, Hungary; [Deak, Adam] Univ Debrecen, Dept Operat Tech & Surg Res, Inst Surg, Debrecen, Hungary; [Antonioli, Luca; Suleiman, Mara; Marchetti, Piero] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy; [Virag, Laszlo; Bai, Peter] Hungarian Acad Sci, Cell Biol & Signalling Res Grp, Debrecen, Hungary	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Debrecen; University of Debrecen; University of Pisa; Hungarian Academy of Sciences	Csoka, B; Hasko, G (corresponding author), Rutgers New Jersey Med Sch, Dept Surg, Ctr Immun & Inflammat, 185 South Orange Ave, Newark, NJ 07103 USA.	csokaba@njms.rutgers.edu; haskoge@njms.rutgers.edu	Suleiman, Mara/AAB-9841-2019; Varga, Zoltan V/J-9264-2017; Pacher, Pal/B-6378-2008	Suleiman, Mara/0000-0002-2478-8782; Varga, Zoltan V/0000-0002-2758-0784; Pacher, Pal/0000-0001-7036-8108; Koscso, Balazs/0000-0001-9676-2066; Virag, Laszlo/0000-0002-7099-6718	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences [R01GM66189]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [R01DK113790]; U.S. Army Medical Research and Materiel Command [09065004]; Hungarian Scientific Research Fund (OTKA) [CK 78275, PD83473]; Intramural Research Program of the NIH National Institute on Alcohol Abuse and Alcoholism; Bolyai fellowship; Hungarian National Innovation Office (Baross Program Seahorse) [TeT_09-2010-0023, TAMOP-4.2.2.A-11/1/KONV-2012-0025, TAMOP4.2.1./B-09/KONV-2010-0007, TAMOP-4.2.2/B-10/1-2010-0024]; Medical and Health Science Center [Mec-8/2011]; National Research, Development and Innovation Office [GINOP-2.3.2-15-201600020 TUMORDNS, GINOP-2.3.2-15-2016-00048-STAYALIVE, OTKA K112336]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK113790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066189] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences; NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Intramural Research Program of the NIH National Institute on Alcohol Abuse and Alcoholism; Bolyai fellowship(Hungarian Academy of Sciences); Hungarian National Innovation Office (Baross Program Seahorse); Medical and Health Science Center; National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Katalin Erdelyi (University of Debrecen) for technical assistance. This work was supported by U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences Grant R01GM66189 (to G.H.), NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant R01DK113790, U.S. Army Medical Research and Materiel Command Grant 09065004 (to G.H.), Hungarian Scientific Research Fund (OTKA) Grants CK 78275 (to G.H.) and PD83473 (to P.B.), the Intramural Research Program of the NIH National Institute on Alcohol Abuse and Alcoholism (to P.P.), a Bolyai fellowship (to P.B.), the Hungarian National Innovation Office (Baross Program Seahorse Grants TeT_09-2010-0023), TAMOP-4.2.2.A-11/1/KONV-2012-0025, TAMOP4.2.1./B-09/KONV-2010-0007, TAMOP-4.2.2/B-10/1-2010-0024), and the Medical and Health Science Center (Mecenatura Mec-8/2011). L.V. is supported by National Research, Development and Innovation Office Grants GINOP-2.3.2-15-201600020 TUMORDNS, GINOP-2.3.2-15-2016-00048-STAYALIVE, and OTKA K112336. The authors declare no conflicts of Interest.	Ahren B, 2005, CURR MOL MED, V5, P275, DOI 10.2174/1566524053766004; ANAND BK, 1951, P SOC EXP BIOL MED, V77, P323, DOI 10.3181/00379727-77-18766; Andersson O, 2014, EXP CELL RES, V321, P3, DOI 10.1016/j.yexcr.2013.11.019; Andersson O, 2012, CELL METAB, V15, P885, DOI 10.1016/j.cmet.2012.04.018; Antonioli L, 2015, NAT REV ENDOCRINOL, V11, P228, DOI 10.1038/nrendo.2015.10; Antonioli L, 2013, NAT REV CANCER, V13, P842, DOI 10.1038/nrc3613; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Bai P, 2011, CELL METAB, V13, P450, DOI 10.1016/j.cmet.2011.03.013; Bensellam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029807; Burkart V, 1999, NAT MED, V5, P314, DOI 10.1038/6535; Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Centers for Disease Control and Prevention, 2014, NATIONAL DIABETES ST; Chen JF, 2014, INT REV NEUROBIOL, V119, P257, DOI 10.1016/B978-0-12-801022-8.00012-X; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Csoka B, 2007, BLOOD, V110, P2685, DOI 10.1182/blood-2007-01-065870; Csoka B, 2015, FASEB J, V29, P25, DOI 10.1096/fj.14-253567; Csoka B, 2014, DIABETES, V63, P850, DOI 10.2337/db13-0573; Csoka B, 2012, FASEB J, V26, P376, DOI 10.1096/fj.11-190934; Csoka B, 2010, J IMMUNOL, V185, P542, DOI 10.4049/jimmunol.0901295; Eckle T, 2014, J IMMUNOL, V192, P1249, DOI 10.4049/jimmunol.1100593; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Eisenstein A, 2014, J CELL PHYSIOL, V229, P414, DOI 10.1002/jcp.24473; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Eltzschig HK, 2009, EXPERT OPIN THER TAR, V13, P1267, DOI 10.1517/14728220903241666; Fiori JL, 2013, DIABETES, V62, P3500, DOI 10.2337/db13-0266; Fredholm BB, 2000, N-S ARCH PHARMACOL, V362, P364, DOI 10.1007/s002100000313; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Gao T, 2014, CELL METAB, V19, P259, DOI 10.1016/j.cmet.2013.12.002; Gehl Z, 2012, HISTOL HISTOPATHOL, V27, P651, DOI 10.14670/HH-27.651; Girgis CM, 2012, TRENDS ENDOCRIN MET, V23, P372, DOI 10.1016/j.tem.2012.05.003; Gnad T, 2014, NATURE, V516, P395, DOI 10.1038/nature13816; Grden M, 2007, EXP MOL PATHOL, V83, P392, DOI 10.1016/j.yexmp.2007.03.005; Grenz A, 2012, CURR OPIN CRIT CARE, V18, P178, DOI 10.1097/MCC.0b013e3283514bd0; Guo SL, 2013, J CLIN INVEST, V123, P3305, DOI 10.1172/JCI65390; Hart ML, 2011, J IMMUNOL, V186, P4367, DOI 10.4049/jimmunol.0903617; Hasko G, 2000, FASEB J, V14, P2065, DOI 10.1096/fj.99-0508com; Hasko G, 2008, J LEUKOCYTE BIOL, V83, P447, DOI 10.1189/jlb.0607359; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Hull R, 2005, DIABETOLOGIA, V48, P1350, DOI 10.1007/s00125-005-1772-9; Johnston-Cox H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098775; Jourdan T, 2013, NAT MED, V19, P1132, DOI 10.1038/nm.3265; Kaneto H, 2005, INT J BIOCHEM CELL B, V37, P1595, DOI 10.1016/j.biocel.2005.04.003; Koupenova Milka, 2013, J Cell Physiol, DOI 10.1002/jcp.24352; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Linnemann AK, 2014, ADV NUTR, V5, P278, DOI 10.3945/an.113.005488; Masini M, 2009, DIABETOLOGIA, V52, P1083, DOI 10.1007/s00125-009-1347-2; Nemeth ZH, 2006, J IMMUNOL, V176, P5616, DOI 10.4049/jimmunol.176.9.5616; Ohtani M, 2013, GEN COMP ENDOCR, V187, P86, DOI 10.1016/j.ygcen.2013.02.011; Peng Z, 2009, J CLIN INVEST, V119, P582, DOI 10.1172/JCI37409; Pinhal-Enfield G, 2003, AM J PATHOL, V163, P711, DOI 10.1016/S0002-9440(10)63698-X; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Puri S, 2013, GENE DEV, V27, P2563, DOI 10.1101/gad.227785.113; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Robertson RP, 2004, J BIOL CHEM, V279, P42351, DOI 10.1074/jbc.R400019200; Sitkovsky MV, 2014, CANCER IMMUNOL RES, V2, P598, DOI 10.1158/2326-6066.CIR-14-0075; Sitkovsky MV, 2009, TRENDS IMMUNOL, V30, P102, DOI 10.1016/j.it.2008.12.002; Stull ND, 2012, JOVE-J VIS EXP, DOI 10.3791/4137; Szot G. L., 2007, J VIS EXP, V25; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Wang ZY, 2014, CELL METAB, V19, P872, DOI 10.1016/j.cmet.2014.03.010; Weinberg N, 2007, DIABETES, V56, P1299, DOI 10.2337/db06-1654; Zehetner J, 2008, GENE DEV, V22, P3135, DOI 10.1101/gad.496908	65	21	21	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4985	4997		10.1096/fj.201700398R	http://dx.doi.org/10.1096/fj.201700398R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28765173	Green Published			2022-12-26	WOS:000413398500028
J	Gupta, AK; Ghosh, K; Palit, S; Barua, J; Das, PK; Ukil, A				Gupta, Anand Kumar; Ghosh, Kuntal; Palit, Shreyasi; Barua, Jayita; Das, Pijush K.; Ukil, Anindita			Leishmania donovani inhibits inflammasome-dependent macrophage activation by exploiting the negative regulatory proteins A20 and UCP2	FASEB JOURNAL			English	Article						IL-1 beta; caspase-1; NF-kappa B; ROS	EXPERIMENTAL VISCERAL LEISHMANIASIS; HOST IMMUNE-RESPONSE; NLRP3 INFLAMMASOME; UNCOUPLING PROTEIN-2; PATTERN-RECOGNITION; MYCOBACTERIUM-TUBERCULOSIS; MURINE MACROPHAGES; ENZYME A20; GENE; EXPRESSION	In visceral leishmaniasis, we found that the antileishmanial drug Amp B produces a higher level of IL-1 beta over the infected control. Moreover, administering anti-IL-1 beta antibody to infected Amp B-treated mice showed significantly less parasite clearance. Investigation revealed that Leishmania inhibits stimuli-induced expression of a multiprotein signaling platform, NLRP3 inflammasome, which in turn inhibits caspase-1 activation mediated maturation of IL-1 beta from its pro form. Attenuation of NLRP3 and pro-IL-1 beta in infection was found to result from decreased NF-kappa B activity. Transfecting infected cells with constitutively active NF-kappa B plasmid increased NLRP3 and pro-IL-1 beta expression but did not increase mature IL-1 beta, suggesting that IL-1 beta maturation requires a second signal, which was found to be reactive oxygen species (ROS). Decreased NF-kappa B was attributed to increased expression of A20, a negative regulator of NF-kappa B signaling. Silencing A20 in infected cells restored NLRP3 and pro-IL-1 beta expression, but also increased matured IL-1 beta, implying an NF-kappa B-independent A20-modulated IL-1 beta maturation. Macrophage ROS is primarily regulated by mitochondrial uncoupling protein 2 (UCP2), and UCP2-silencedinfected cells showed an increased IL-1 beta level. Shorthairpin RNA-mediated knockdown of A20 and UCP2 in infected mice independently documented decreased liver and spleen parasite burden and increased IL-1 beta production. These results suggest that Leishmania exploits A20 and UCP2 to impair inflammasome activation for disease propagation.-Gupta, A. K., Ghosh, K., Palit, S., Barua, J., Das, P. K., Ukil, A. Leishmania donovani inhibits inflammasome-dependent macrophage activation by exploiting the negative regulatory proteins A20 and UCP2.	[Gupta, Anand Kumar; Palit, Shreyasi; Das, Pijush K.] Indian Inst Chem Biol, CSIR, Infect Dis & Immunol Div, 4 Raja SC Mullick Rd, Kolkata 700032, India; [Ghosh, Kuntal; Barua, Jayita; Ukil, Anindita] Univ Calcutta, Dept Biochem, 35 Ballygunge Circular Rd, Kolkata 700019, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); University of Calcutta	Das, PK (corresponding author), Indian Inst Chem Biol, CSIR, Infect Dis & Immunol Div, 4 Raja SC Mullick Rd, Kolkata 700032, India.; Ukil, A (corresponding author), Univ Calcutta, Dept Biochem, 35 Ballygunge Circular Rd, Kolkata 700019, India.	pijushdas@iicb.res.in; aninditau@yahoo.com		Gupta, Anand/0000-0001-7917-9194; Gupta, Purnima/0000-0003-4389-3024	Government of West Bengal, Department of Biotechnology [221/BT(Estt)/RD-40/2014]; Indo Israel Grant [F.6-10/2016(IC)]; University Grants Commission, University with Potential for Excellence II Grant [UGC/148/UPE/ST1]; Department of Science and Technology [EMR/2014/000287]; Department of Biotechnology Grant [BT/PR10289/BRB/10/1257/2013]; National Academy of Sciences, India (NASI) Senior Scientist Fellowship; University Grants Commission; Council of Scientific and Industrial Research	Government of West Bengal, Department of Biotechnology; Indo Israel Grant; University Grants Commission, University with Potential for Excellence II Grant(University Grants Commission, India); Department of Science and Technology(Department of Science & Technology (India)); Department of Biotechnology Grant; National Academy of Sciences, India (NASI) Senior Scientist Fellowship; University Grants Commission(University Grants Commission, India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Government of West Bengal, Department of Biotechnology Grant 221/BT(Estt)/RD-40/2014, Indo Israel Grant F.6-10/2016(IC), University Grants Commission, University with Potential for Excellence II Grant UGC/148/UPE/ST1, Department of Science and Technology Grant EMR/2014/000287, Department of Biotechnology Grant BT/PR10289/BRB/10/1257/2013, a National Academy of Sciences, India (NASI) Senior Scientist Fellowship, University Grants Commission, and the Council of Scientific and Industrial Research. The authors declare no conflicts of interest.	Abais JM, 2015, ANTIOXID REDOX SIGN, V22, P1111, DOI 10.1089/ars.2014.5994; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Apte RN, 2002, SEMIN CANCER BIOL, V12, P277, DOI 10.1016/S1044-579X(02)00014-7; Arsenescu R, 2005, J IMMUNOL, V174, P3906, DOI 10.4049/jimmunol.174.7.3906; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Ball WB, 2011, J IMMUNOL, V187, P1322, DOI 10.4049/jimmunol.1004237; Bauernfeind F, 2013, EMBO MOL MED, V5, P814, DOI 10.1002/emmm.201201771; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; CHANG KP, 1976, SCIENCE, V193, P678, DOI 10.1126/science.948742; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Darisipudi MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019588; Delbridge LM, 2007, CURR OPIN IMMUNOL, V19, P10, DOI 10.1016/j.coi.2006.11.005; Dowling JK, 2012, CRIT REV BIOCHEM MOL, V47, P424, DOI 10.3109/10409238.2012.694844; Duong BH, 2015, IMMUNITY, V42, P55, DOI 10.1016/j.immuni.2014.12.031; Eder C, 2009, IMMUNOBIOLOGY, V214, P543, DOI 10.1016/j.imbio.2008.11.007; Eklund D, 2014, J INFECT DIS, V209, P749, DOI 10.1093/infdis/jit572; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Gavrilin MA, 2009, J IMMUNOL, V182, P7982, DOI 10.4049/jimmunol.0803073; Ghosh K, 2013, J INFECT DIS, V207, P1016, DOI 10.1093/infdis/jis771; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Gurung P, 2015, J CLIN INVEST, V125, P1329, DOI 10.1172/JCI79526; Gurung P, 2014, J IMMUNOL, V192, P1835, DOI 10.4049/jimmunol.1302839; Heyninck K, 1999, J CELL BIOL, V145, P1471, DOI 10.1083/jcb.145.7.1471; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Hu ZZ, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.363; Jin CC, 2010, J CLIN IMMUNOL, V30, P628, DOI 10.1007/s10875-010-9440-3; Kankkunen P, 2010, J IMMUNOL, V184, P6335, DOI 10.4049/jimmunol.0903019; Kanneganti TD, 2010, NAT REV IMMUNOL, V10, P688, DOI 10.1038/nri2851; Kar S, 2010, J LEUKOCYTE BIOL, V88, P9, DOI 10.1189/jlb.0909644; Kedzierski L, 2010, J GLOB INFECT DIS, V2, P177, DOI 10.4103/0974-777X.62881; Kole L, 1999, J INFECT DIS, V180, P811, DOI 10.1086/314929; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Lima DS, 2013, NAT MED, V19, P909, DOI 10.1038/nm.3221; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Nishitsuji H, 2004, MICROBES INFECT, V6, P76, DOI 10.1016/j.micinf.2003.10.009; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; Ozoren N, 2006, J IMMUNOL, V176, P4337, DOI 10.4049/jimmunol.176.7.4337; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pei Y, 2006, NAT METHODS, V3, P670, DOI 10.1038/NMETH911; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Rahman MM, 2011, J VIROL, V85, P12505, DOI 10.1128/JVI.00410-11; Santhosh CV, 2008, BIOCHEM BIOPH RES CO, V371, P546, DOI 10.1016/j.bbrc.2008.04.106; Shio MT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003868; Shio MT, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/819512; Shio MT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000559; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; Srivastav S, 2012, J IMMUNOL, V189, P924, DOI 10.4049/jimmunol.1102845; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; van de Veerdonk Frank L, 2011, Trends Immunol, V32, P110, DOI 10.1016/j.it.2011.01.003; Vande Walle L, 2014, NATURE, V512, P69, DOI 10.1038/nature13322; Vela JM, 2002, MOL CELL NEUROSCI, V20, P489, DOI 10.1006/mcne.2002.1127; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Yeon SH, 2017, J LEUKOCYTE BIOL, V101, P205, DOI 10.1189/jlb.3VMA1215-579RR; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305	65	36	36	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					5087	5101		10.1096/fj.201700407R	http://dx.doi.org/10.1096/fj.201700407R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28765172				2022-12-26	WOS:000413398500036
J	Beier, E; Bernal, G; Ruiz-Ochoa, M; Barton, ED				Beier, Emilio; Bernal, Gladys; Ruiz-Ochoa, Mauricio; Desmond Barton, Eric			Freshwater exchanges and surface salinity in the Colombian basin, Caribbean Sea	PLOS ONE			English	Article							LOW-LEVEL JET; GUAJIRA UPWELLING SYSTEM; INTRA-AMERICA SEA; INTERANNUAL VARIABILITY; TROPICAL ATLANTIC; MAGDALENA RIVER; SOUTH-AMERICA; CIRCULATION; PRECIPITATION; MODEL	Despite the heavy regional rainfall and considerable discharge of many rivers into the Colombian Basin, there have been few detailed studies about the dilution of Caribbean Surface Water and the variability of salinity in the southwestern Caribbean. An analysis of the precipitation, evaporation and runoff in relation to the climate variability demonstrates that although the salt balance in the Colombian Basin overall is in equilibrium, the area south of 12 N is an important dilution sub-basin. In the southwest of the basin, in the region of the Panama-Colombia Gyre, Caribbean Sea Water is diluted by precipitation and runoff year round, while in the northeast, off La Guajira, its salinity increases from December to May by upwelling. At the interannual scale, continental runoff is related to El Nino Southern Oscillation, and precipitation and evaporation south of 12 N are related to the Caribbean Low Level Jet. During El Nino years the maximum salinification occurs in the dry season (December February) while in La Nina years the maximum dilution (or freshening), reaching La Guajira Coastal Zone, occurs in the wet season (September-November).	[Beier, Emilio] Ctr Invest Cient & Educ Super Ensenada, Unidad La Paz, La Paz, Baja Calif Sur, Mexico; [Bernal, Gladys; Ruiz-Ochoa, Mauricio] Univ Nacl Colombia, Dept Geociencias & Medio Ambiente, Medellin, Colombia; [Ruiz-Ochoa, Mauricio] Univ Manuela Beltran, Fac Ingn, Programa Ingn Ambiental, Bucaramanga, Colombia; [Desmond Barton, Eric] CSIC, Dept Oceanog Inst Invest Marinas, Vigo, Spain	CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Universidad Nacional de Colombia; Universidad Manuela Beltran - UMB; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Bernal, G (corresponding author), Univ Nacl Colombia, Dept Geociencias & Medio Ambiente, Medellin, Colombia.	gbernal@unal.edu.co		Bernal, Gladys/0000-0001-6333-6028; Ruiz-Ochoa, Mauricio/0000-0002-8374-4165; barton, eric/0000-0002-5315-5968; Beier, Emilio/0000-0001-8478-7709	COLCIENCIAS [1118-13-17721]; CONACYT [SEP-2008-103898]; Universidad Nacional de Colombia; CICESE, Mexico; Campus do Mar, University of Vigo, Spain; Universidad Manuela Beltran, Colombia	COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Universidad Nacional de Colombia; CICESE, Mexico; Campus do Mar, University of Vigo, Spain; Universidad Manuela Beltran, Colombia	This study was supported by COLCIENCIAS, 1118-13-17721, http://www.colciencias.gov.co/; CONACYT, SEP-2008-103898, http://www.conacyt.gob.rnx/; Universidad Nacional de Colombia, http://www.unal.edu.co; CICESE, Mexico, http://www.cicese.edu.mx; Campus do Mar, University of Vigo, Spain, http://www.campusdornas.es; Universidad Manuela Beltran, Colombia, http://www.umb.edu.co/bucaramanga/.	Alvera-Azcarate A, 2009, J PHYS OCEANOGR, V39, P640, DOI 10.1175/2008JPO3765.1; Amador JA, 2008, ANN NY ACAD SCI, V1146, P153, DOI 10.1196/annals.1446.012; Andrade C.A., 2009, GEOS, V29, P85; Andrade CA, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001549; Andrade CA, 2005, CONT SHELF RES, V25, P1003, DOI 10.1016/j.csr.2004.12.012; Andrade CA, 2013, B CIENT CIOH, V31, P73; [Anonymous], 2013, NOAA ATLAS NESDIS; Beron-Vera FJ, 2000, J GEOPHYS RES-OCEANS, V105, P11441, DOI 10.1029/2000JC900038; Boyer T, 2015, CHANGES CALCULATION; Restrepo JC, 2014, J HYDROL, V509, P266, DOI 10.1016/j.jhydrol.2013.11.045; Canon-Paez M., 2003, B CIENTIFICO CIOH, P66, DOI [10.26640/22159045.116, DOI 10.26640/22159045.116]; Centurioni LR, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016231; Cherubin LM, 2007, DEEP-SEA RES PT I, V54, P1451, DOI 10.1016/j.dsr.2007.04.021; Cook KH, 2010, J CLIMATE, V23, P1477, DOI 10.1175/2009JCLI3210.1; Corredor-Garcia J.E., 1981, B CIENT CIOH, V3, P3; Draper N.R., 1998, APPL REGRESSION ANAL, P79; ETTER PC, 1987, J PHYS OCEANOGR, V17, P1232, DOI 10.1175/1520-0485(1987)017<1232:HAFBOT>2.0.CO;2; Fratantoni DM, 2001, J GEOPHYS RES-OCEANS, V106, P22067, DOI 10.1029/2000JC000730; Gill A., 1982, INT GEOPHYS SER, V30; GORDON AL, 1967, J GEOPHYS RES, V72, P6207, DOI 10.1029/JZ072i024p06207; Grant A., 2004, COMISION PROBLEMATIC; Grodsky SA, 2015, J GEOPHYS RES-OCEANS, V120, P1375, DOI 10.1002/2014JC010625; Hidalgo HG, 2015, GEOGR ANN A, V97, P41, DOI 10.1111/geoa.12085; Hu CM, 2004, DEEP-SEA RES PT II, V51, P1151, DOI 10.1016/j.dsr2.2004.04.001; Jouanno J, 2008, OCEAN MODEL, V23, P82, DOI 10.1016/j.ocemod.2008.04.002; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kelly PS, 2000, J GEOPHYS RES-OCEANS, V105, P19699, DOI 10.1029/1999JC900328; Lagerloef G, 2008, OCEANOGRAPHY, V21, P68, DOI 10.5670/oceanog.2008.68; Locarnini RA, 2013, NOAA ATLAS NESDIS, V73, P1; Lonin SA, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2008JC005100; Matano R, 2008, J PHYS OCEANOGR, V32, P1228; Matano RP, 2008, J MARINE SYST, V74, P315, DOI 10.1016/j.jmarsys.2008.01.007; Mesa O.J., 1997, INTRO CLIMA COLOMBIA; Milliman J. D., 2011, RIVER DISCHARGE COAS, DOI 10.1017/CBO9780511781247; Mooers CNK, 1998, GLOBAL COASTAL OCEAN, V11, P183; MORRISON JM, 1982, J GEOPHYS RES-OCEANS, V87, P4207, DOI 10.1029/JC087iC06p04207; MORRISON JM, 1990, J GEOPHYS RES-OCEANS, V95, P699, DOI 10.1029/JC095iC01p00699; Munoz E, 2008, J CLIMATE, V21, P1260, DOI 10.1175/2007JCLI1855.1; Paramo J, 2011, REV BIOL MAR OCEANOG, V46, P421, DOI 10.4067/S0718-19572011000300011; Petus C., 2007, REV TELEDETECTION, V7, P143; Poveda G, 2001, WATER RESOUR RES, V37, P2169, DOI 10.1029/2000WR900395; Poveda G., 2010, CLIM DYNAM, V36, P2233, DOI [10.1007/s00382-010-0931-y, DOI 10.1007/s00382-010-0931-y]; Poveda G., 2004, REV ACAD COLOMB CIEN, V28, P201; Poveda G, 2006, PALAEOGEOGR PALAEOCL, V234, P3, DOI 10.1016/j.palaeo.2005.10.031; Restrepo JD, 2000, J HYDROL, V235, P137, DOI 10.1016/S0022-1694(00)00269-9; Restrepo JD, 2006, GLOBAL PLANET CHANGE, V50, P33, DOI 10.1016/j.gloplacha.2005.09.002; Restrepo JD, 2004, ENVIRONM SCI, P169; Rhein M, 2005, DEEP-SEA RES PT I, V52, P2234, DOI 10.1016/j.dsr.2005.08.003; Richardson PL, 2005, DEEP-SEA RES PT II, V52, P429, DOI 10.1016/j.dsr2.2004.11.001; Ripa P, 2002, CIENC MAR, V28, P79; Rueda-Roa DT, 2013, DEEP-SEA RES PT I, V78, P102, DOI 10.1016/j.dsr.2013.04.008; Ruiz-Ochoa M, 2012, DEEP-SEA RES PT I, V64, P43, DOI 10.1016/j.dsr.2012.01.013; Schmidt MW, 2004, NATURE, V428, P160, DOI 10.1038/nature02346; SEMTNER AJ, 1992, J GEOPHYS RES-OCEANS, V97, P5493, DOI 10.1029/92JC00095; Smith R, 2010, THESIS; Tokmakian R, 1998, INT WOCE NEWS, V32, P26; Tomczak M., 2003, REGIONAL OCEANOGRAPH, V2; Tootle GA, 2008, J HYDROL, V349, P268, DOI 10.1016/j.jhydrol.2007.10.058; TRENBERTH KE, 1984, MON WEATHER REV, V112, P326, DOI 10.1175/1520-0493(1984)112<0326:SVNITS>2.0.CO;2; Wang CZ, 2007, CLIM DYNAM, V29, P411, DOI 10.1007/s00382-007-0243-z; Whyte FS, 2008, INT J CLIMATOL, V28, P119, DOI 10.1002/joc.1510; Xie PP, 1997, B AM METEOROL SOC, V78, P2539, DOI 10.1175/1520-0477(1997)078<2539:GPAYMA>2.0.CO;2; YOO JM, 1990, J PHYS OCEANOGR, V20, P831, DOI 10.1175/1520-0485(1990)020<0831:AAIVOT>2.0.CO;2; Yueh S., 2014, AQUARIUS CAP ALGORIT	64	17	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0182116	10.1371/journal.pone.0182116	http://dx.doi.org/10.1371/journal.pone.0182116			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28777801	Green Published, Green Submitted, gold			2022-12-26	WOS:000406944300020
J	Jouhet, J; Lupette, J; Clerc, O; Magneschi, L; Bedhomme, M; Collin, S; Roy, S; Marechal, E; Rebeille, F				Jouhet, Juliette; Lupette, Josselin; Clerc, Olivier; Magneschi, Leonardo; Bedhomme, Mariette; Collin, Severine; Roy, Sylvaine; Marechal, Eric; Rebeille, Fabrice			LC-MS/MS versus TLC plus GC methods: Consistency of glycerolipid and fatty acid profiles in microalgae and higher plant cells and effect of a nitrogen starvation	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; ELECTROSPRAY-IONIZATION; FRAGMENTATION PROCESSES; MEMBRANE-LIPIDS; ARABIDOPSIS; TRIACYLGLYCEROL; QUADRUPOLE; GALACTOLIPIDS; ACCUMULATION; PHOSPHATIDYLCHOLINE	Methods to analyze lipidomes have considerably evolved, more and more based on mass spectrometry technics (LC-MS/MS). However, accurate quantifications using these methods require 13 C-labeled standards for each lipid, which is not feasible because of the very large number of molecules. Thus, quantifications rely on standard molecules representative of a whole class of lipids, which might lead to false estimations of some molecular species. Here, we determined and compared glycerolipid distributions from three different types of cells, two microalgae (Phaeodactylum tricornutum, Nannochloropsis gaditana) and one higher plant (Arabidopsis thaliana), using either LC-MS/MS or Thin Layer Chromatography coupled with Gas Chromatography (TLC-GC), this last approach relying on the precise quantification of the fatty acids present in each glycerolipid class. Our results showed that the glycerolipid distribution was significantly different depending on the method used. How can one reconcile these two analytical methods? Here we propose that the possible bias with MS data can be circumvented by systematically running in tandem with the sample to be analyzed a lipid extract from a qualified control (QC) of each type of cells, previously analyzed by TLC-GC, and used as an external standard to quantify the MS results. As a case study, we applied this method to compare the impact of a nitrogen deficiency on the three types of cells.	[Jouhet, Juliette; Lupette, Josselin; Clerc, Olivier; Magneschi, Leonardo; Bedhomme, Mariette; Collin, Severine; Roy, Sylvaine; Marechal, Eric; Rebeille, Fabrice] Univ Grenoble Alpes, Lab Physiol Cellulaire Vegetale, Biosci & Biotechnol Inst Grenoble, CNRS,CEA,INRA,UMR 5168,CEA Grenoble, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Rebeille, F (corresponding author), Univ Grenoble Alpes, Lab Physiol Cellulaire Vegetale, Biosci & Biotechnol Inst Grenoble, CNRS,CEA,INRA,UMR 5168,CEA Grenoble, Grenoble, France.	fabrice.rebeille@cea.fr	LUPETTE, Josselin/ABF-6919-2020	LUPETTE, Josselin/0000-0002-7842-575X	TOTAL-CEA; Flagship program from the CEA High Commissioner	TOTAL-CEA; Flagship program from the CEA High Commissioner	This work was partly supported by a TOTAL-CEA partnership and a Flagship program from the CEA High Commissioner.; We wish to thank Mathilde Cussac, Valerie Gros, Catherine Albrieux, Camille Rak and Guil-laume Tourcier for skilled technical assistance. We are grateful to Maryse Block for attentive reviewing of the manuscript. This work was partly supported by a TOTAL-CEA partnership and a Flagship program from the CEA High Commissioner.	Abida H, 2015, PLANT PHYSIOL, V167, P118, DOI 10.1104/pp.114.252395; Amara S, 2010, BBA-MOL CELL BIOL L, V1801, P508, DOI 10.1016/j.bbalip.2010.01.003; Amara S, 2009, BBA-MOL CELL BIOL L, V1791, P983, DOI 10.1016/j.bbalip.2009.05.002; Anandarajah K, 2012, APPL ENERG, V96, P371, DOI 10.1016/j.apenergy.2012.02.057; Bates PD, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00147; Bates PD, 2011, PLANT J, V68, P387, DOI 10.1111/j.1365-313X.2011.04693.x; Berges JA, 2004, J PHYCOL, V40, P619, DOI 10.1111/j.1529-8817.2004.40301.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Buseman CM, 2006, PLANT PHYSIOL, V142, P28, DOI 10.1104/pp.106.082115; Camera E, 2010, J LIPID RES, V51, P3377, DOI 10.1194/jlr.D008391; Courchesne NMD, 2009, J BIOTECHNOL, V141, P31, DOI 10.1016/j.jbiotec.2009.02.018; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; Deme B, 2014, FASEB J, V28, P3373, DOI 10.1096/fj.13-247395; Devaiah SP, 2006, PHYTOCHEMISTRY, V67, P1907, DOI 10.1016/j.phytochem.2006.06.005; Dodds ED, 2005, LIPIDS, V40, P419, DOI 10.1007/s11745-006-1399-8; Durrett TP, 2008, PLANT J, V54, P593, DOI 10.1111/j.1365-313X.2008.03442.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Guella G, 2003, RAPID COMMUN MASS SP, V17, P1982, DOI 10.1002/rcm.1142; HARRISON PJ, 1980, J PHYCOL, V16, P28, DOI 10.1111/j.1529-8817.1980.tb02994.x; Horn PJ, 2016, SCIENCE, V353, P1228, DOI 10.1126/science.aaf6206; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P797, DOI 10.1016/S1044-0305(00)00151-3; Hsu FF, 2005, J AM SOC MASS SPECTR, V16, P491, DOI 10.1016/j.jasms.2004.12.015; Hsu FF, 2000, J MASS SPECTROM, V35, P596; Hsu FF, 2001, J AM SOC MASS SPECTR, V12, P1036, DOI 10.1016/S1044-0305(01)00285-9; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P986, DOI 10.1016/S1044-0305(00)00172-0; Hsu FF, 2003, J AM SOC MASS SPECTR, V14, P352, DOI 10.1016/S1044-0305(03)00064-3; Hsu FF, 2010, J AM SOC MASS SPECTR, V21, P657, DOI 10.1016/j.jasms.2010.01.007; Jouhet J, 2004, J CELL BIOL, V167, P863, DOI 10.1083/jcb.200407022; Jouhet J, 2003, FEBS LETT, V544, P63, DOI 10.1016/S0014-5793(03)00477-0; Joyard J, 2010, PROG LIPID RES, V49, P128, DOI 10.1016/j.plipres.2009.10.003; Koivusalo M, 2001, J LIPID RES, V42, P663; Li MY, 2014, PLANT J, V77, P160, DOI 10.1111/tpj.12365; Lu CF, 2011, CURR OPIN BIOTECH, V22, P252, DOI 10.1016/j.copbio.2010.11.006; Mei C, 2015, SCI REP-UK, V5, DOI 10.1038/srep15207; Mei CE, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.02014; Petroutsos D, 2014, PROG LIPID RES, V54, P68, DOI 10.1016/j.plipres.2014.02.001; Rainteau D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041985; Scala S, 2001, CELL MOL LIFE SCI, V58, P1666, DOI 10.1007/PL00000804; Shockey J, 2016, PLANT PHYSIOL, V170, P163, DOI 10.1104/pp.15.01563; Simionato D, 2013, EUKARYOT CELL, V12, P665, DOI 10.1128/EC.00363-12; Trentacoste EM, 2013, P NATL ACAD SCI USA, V110, P19748, DOI 10.1073/pnas.1309299110; Vigeolas H, 2012, J BIOTECHNOL, V162, P3, DOI 10.1016/j.jbiotec.2012.03.017; Welti R, 2004, CURR OPIN PLANT BIOL, V7, P337, DOI 10.1016/j.pbi.2004.03.011; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Zianni R, 2013, J MASS SPECTROM, V48, P205, DOI 10.1002/jms.3149	46	50	51	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182423	10.1371/journal.pone.0182423	http://dx.doi.org/10.1371/journal.pone.0182423			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771624	Green Published, Green Submitted, gold			2022-12-26	WOS:000406853600110
J	Li, DC; Hu, SC; Lin, LS; Yeh, CW				Li, Der-Chiang; Hu, Susan C.; Lin, Liang-Sian; Yeh, Chun-Wu			Detecting representative data and generating synthetic samples to improve learning accuracy with imbalanced data sets	PLOS ONE			English	Article							NEURAL-NETWORK; CLASSIFICATION; INFORMATION	It is difficult for learning models to achieve high classification performances with imbalanced data sets, because with imbalanced data sets, when one of the classes is much larger than the others, most machine learning and data mining classifiers are overly influenced by the larger classes and ignore the smaller ones. As a result, the classification algorithms often have poor learning performances due to slow convergence in the smaller classes. To balance such data sets, this paper presents a strategy that involves reducing the sizes of the majority data and generating synthetic samples for the minority data. In the reducing operation, we use the box-and-whisker plot approach to exclude outliers and the Mega-Trend-Diffusion method to find representative data from the majority data. To generate the synthetic samples, we propose a counterintuitive hypothesis to find the distributed shape of the minority data, and then produce samples according to this distribution. Four real datasets were used to examine the performance of the proposed approach. We used paired t-tests to compare the Accuracy, G-mean, and F-measure scores of the proposed data pre-processing (PPDP) method merging in the D3C method (PPDP+D3C) with those of the one-sided selection (OSS), the well-known SMOTEBoost (SB) study, and the normal distribution-based over-sampling (NDO) approach, and the proposed data pre-processing (PPDP) method. The results indicate that the classification performance of the proposed approach is better than that of above-mentioned methods.	[Li, Der-Chiang] Natl Cheng Kung Univ, Coll Management, Dept Ind & Informat Management, Tainan, Taiwan; [Hu, Susan C.] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan, Taiwan; [Lin, Liang-Sian] Ind Technol Res Inst, Informat & Commun Res Labs, Hsinchu, Taiwan; [Yeh, Chun-Wu] Kun Shan Univ, Dept Informat Management, Coll Informat Technol, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University; Industrial Technology Research Institute - Taiwan; Kun Shan University	Yeh, CW (corresponding author), Kun Shan Univ, Dept Informat Management, Coll Informat Technol, Tainan, Taiwan.	davidyeh929@gmail.com	Hu, Susan C./AFU-5419-2022; Li, Der-Chiang/K-6214-2013	Hu, Susan C./0000-0003-2437-5918; Li, Der-Chiang/0000-0002-0887-1308	MOST [104-2221-E-006-105]	MOST	The work was supported by MOST 104-2221-E-006-105, https://www.most.gov.tw/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asuncion A, 2007, UCI MACHINE LEARNING, P12; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chawla NV, 2003, LECT NOTES ARTIF INT, V2838, P107, DOI 10.1007/978-3-540-39804-2_12; Chen MC, 2008, INFORM SCIENCES, V178, P3214, DOI 10.1016/j.ins.2008.03.018; Cohen G, 2006, ARTIF INTELL MED, V37, P7, DOI 10.1016/j.artmed.2005.03.002; Estabrooks A, 2004, COMPUT INTELL-US, V20, P18, DOI 10.1111/j.0824-7935.2004.t01-1-00228.x; Farquad MAH, 2012, DECIS SUPPORT SYST, V53, P226, DOI 10.1016/j.dss.2012.01.016; Fernandez-Navarro F, 2011, PATTERN RECOGN, V44, P1821, DOI 10.1016/j.patcog.2011.02.019; Freund Y., 1996, P 13 INT C MACH LEAR, V96, P148, DOI DOI 10.5555/3091696.3091715; GAIL MH, 1978, J ROY STAT SOC B MET, V40, P350; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; Hong X, 2007, IEEE T NEURAL NETWOR, V18, P28, DOI 10.1109/TNN.2006.882812; Kubat M, 1997, ADDRESSING CURSE IMB; Li DC, 2007, COMPUT OPER RES, V34, P966, DOI 10.1016/j.cor.2005.05.019; Li DC, 2014, DECIS SUPPORT SYST, V66, P71, DOI 10.1016/j.dss.2014.06.004; Li DC, 2011, ARTIF INTELL MED, V52, P45, DOI 10.1016/j.artmed.2011.02.001; Li DC, 2010, COMPUT BIOL MED, V40, P509, DOI 10.1016/j.compbiomed.2010.03.005; Lin C, 2014, NEUROCOMPUTING, V123, P424, DOI 10.1016/j.neucom.2013.08.004; LITTLE SN, 1983, CAN J FOREST RES, V13, P85, DOI 10.1139/x83-012; Lo HY, 2008, ACM SIGKDD EXPLORATI, V10, P43, DOI [10.1145/1540276.1540290, DOI 10.1145/1540276.1540290]; Mazurowski MA, 2008, NEURAL NETWORKS, V21, P427, DOI 10.1016/j.neunet.2007.12.031; Murphey YL, 2004, APPL INTELL, V21, P117, DOI 10.1023/B:APIN.0000033632.42843.17; Nelson W, 1982, APPL LIFE DATA ANAL; Nguwi Y-Y, 2009, NEUR NETW 2009 IJCNN; Peng X, 2008, NEURAL NETWORKS, V21, P450, DOI 10.1016/j.neunet.2007.12.051; Piras L, 2012, PATTERN RECOGN LETT, V33, P2198, DOI 10.1016/j.patrec.2012.08.003; Song L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-298; Sun YM, 2007, PATTERN RECOGN, V40, P3358, DOI 10.1016/j.patcog.2007.04.009; Sun YM, 2009, INT J PATTERN RECOGN, V23, P687, DOI 10.1142/S0218001409007326; Tahir MA, 2012, PATTERN RECOGN, V45, P3738, DOI 10.1016/j.patcog.2012.03.014; Tukey JW, 1977, EXPLORATORY DATA ANA; Wahed AS, 2009, STAT MED, V28, P2077, DOI 10.1002/sim.3598; Wang CY, 2015, GENET MOL RES, V14, P123, DOI 10.4238/2015.January.15.15; Williamson JM, 2008, STAT MED, V27, P543, DOI 10.1002/sim.3003; Xie JG, 2007, PATTERN RECOGN, V40, P557, DOI 10.1016/j.patcog.2006.01.009; Yen SJ, 2006, LECT NOTES CONTR INF, V344, P731; Zhang H, 2011, INT C ADV DAT MIN AP; Zhao ZQ, 2009, PATTERN RECOGN LETT, V30, P783, DOI 10.1016/j.patrec.2008.06.002; Zou Q, 2016, BIG DATA RES, V5, P2, DOI 10.1016/j.bdr.2015.12.001	40	33	38	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0181853	10.1371/journal.pone.0181853	http://dx.doi.org/10.1371/journal.pone.0181853			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771522	Green Published, Green Submitted, gold			2022-12-26	WOS:000406853600041
J	Krause, AR; Speacht, TL; Zhang, Y; Lang, CH; Donahue, HJ				Krause, Andrew R.; Speacht, Toni L.; Zhang, Yue; Lang, Charles H.; Donahue, Henry J.			Simulated space radiation sensitizes bone but not muscle to the catabolic effects of mechanical unloading	PLOS ONE			English	Article							LONG-TERM INCREASE; SKELETAL-MUSCLE; RODENT MODEL; RISK; COUNTERMEASURES; HOSPITALIZATION; METABOLISM; MODULATION; FRACTURE; ATROPHY	Deep space travel exposes astronauts to extended periods of space radiation and mechanical unloading, both of which may induce significant muscle and bone loss. Astronauts are exposed to space radiation from solar particle events (SPE) and background radiation referred to as galactic cosmic radiation (GCR). To explore interactions between skeletal muscle and bone under these conditions, we hypothesized that decreased mechanical load, as in the microgravity of space, would lead to increased susceptibility to space radiation-induced bone and muscle loss. We evaluated changes in bone and muscle of mice exposed to hind limb suspension (HLS) unloading alone or in addition to proton and high (H) atomic number (Z) and energy (E) (HZE) (O-16) radiation. Adult male C57Bl/6J mice were randomly assigned to six groups: No radiation +/- HLS, 50 cGy proton radiation +/- HLS, and 50 cGy proton radiation + 10 cGy O-16 radiation +/- HLS. Radiation alone did not induce bone or muscle loss, whereas HLS alone resulted in both bone and muscle loss. Absolute trabecular and cortical bone volume fraction (BV/TV) was decreased 24% and 6% in HLS-no radiation vs the normally loaded no-radiation group. Trabecular thickness and mineral density also decreased with HLS. For some outcomes, such as BV/TV, trabecular number and tissue mineral density, additional bone loss was observed in the HLS+proton+HZE radiation group compared to HLS alone. In contrast, whereas HLS alone decreased muscle mass (19% gastrocnemius, 35% quadriceps), protein synthesis, and increased proteasome activity, radiation did not exacerbate these catabolic outcomes. Our results suggest that combining simulated space radiation with HLS results in additional bone loss that may not be experienced by muscle.	[Krause, Andrew R.; Speacht, Toni L.] Penn State Coll Med, Dept Orthopaed, Hershey, PA USA; [Zhang, Yue; Donahue, Henry J.] Virginia Commonwealth Univ, Sch Engn, Dept Biomed Engn, Richmond, VA 23284 USA; [Lang, Charles H.] Penn State Coll Med, Dept Cellular & Mol Physiol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Virginia Commonwealth University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Donahue, HJ (corresponding author), Virginia Commonwealth Univ, Sch Engn, Dept Biomed Engn, Richmond, VA 23284 USA.	hjdonahue@vcu.edu		Speacht, Toni/0000-0001-9239-995X	National Space Biomedical Research Institute [MA02802]; NIH [R01Ar068132-18, R01AG13097]	National Space Biomedical Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Space Biomedical Research Institute grant MA02802, and NIH grant R01Ar068132-18. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Space Biomedical Research Institute grant MA02802, and NIH grant R01AG13097. We would like to thank the scientist and technicians who staff the NSRL for their expertise in running our simulated space radiation. Finally, we are grateful for the members of the Lang lab and Donahue lab, past and present, for their help and guidance.	Alwood JS, 2010, BONE, V47, P248, DOI 10.1016/j.bone.2010.05.004; Attaix D, 2005, ESSAYS BIOCHEM, V41, P173, DOI 10.1042/EB0410173; BADHWAR GD, 1992, ADV SPACE RES-SERIES, V12, P195, DOI 10.1016/0273-1177(92)90108-A; BADHWAR GD, 1994, ADV SPACE RES, V14, P749, DOI 10.1016/0273-1177(94)90537-1; Belavy DL, 2010, J APPL PHYSIOL, V109, P1801, DOI 10.1152/japplphysiol.00707.2010; Beller G, 2011, BONE, V49, P858, DOI 10.1016/j.bone.2011.06.021; Bonewald LF, 2013, J BONE MINER RES, V28, P1857, DOI 10.1002/jbmr.1980; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brotto M., 2012, IBMS BONEKEY, V9; Chowdhury P, 2016, ANN CLIN LAB SCI, V46, P190; DiGirolamo DJ, 2013, J BONE MINER RES, V28, P1509, DOI 10.1002/jbmr.1969; Ferron M, 2014, ARCH BIOCHEM BIOPHYS, V561, P137, DOI 10.1016/j.abb.2014.05.022; Frost RA, 2011, PHYSIOLOGY, V26, P83, DOI 10.1152/physiol.00044.2010; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Goodman CA, 2013, EXERC SPORT SCI REV, V41, P107, DOI 10.1097/JES.0b013e3182798a95; Govey PM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167673; Grimston SK, 2007, ANN NY ACAD SCI, V1116, P444, DOI 10.1196/annals.1402.009; Halloran BP, 2002, J BONE MINER RES, V17, P1044, DOI 10.1359/jbmr.2002.17.6.1044; Hamrick MW, 2010, J MUSCULOSKEL NEURON, V10, P64; Hanson AM, 2005, BIOMED SCI INSTRUM, V41, P92; Hellweg CE, 2007, NATURWISSENSCHAFTEN, V94, P517, DOI 10.1007/s00114-006-0204-0; Johnell O, 2001, OSTEOPOROSIS INT, V12, P207, DOI 10.1007/s001980170131; Kaji H, 2016, BONEKEY REP, V5, DOI 10.1038/bonekey.2016.48; Kanis J, 2001, STROKE, V32, P702, DOI 10.1161/01.STR.32.3.702; Ng KW, 2011, CLIN ENDOCRINOL, V75, P147, DOI 10.1111/j.1365-2265.2011.04133.x; La Tessa C, 2016, LIFE SCI SPACE RES, V11, P18, DOI 10.1016/j.lssr.2016.10.002; Lang SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038910; Lang TF, 2011, J OSTEOPOROS, V2011, DOI 10.4061/2011/702735; LeBlanc A, 2000, J APPL PHYSIOL, V89, P2158, DOI 10.1152/jappl.2000.89.6.2158; LEBLANC A, 1995, AVIAT SPACE ENVIR MD, V66, P1151; LEBLANC A, 1992, ACTA ASTRONAUT, V27, P89, DOI 10.1016/0094-5765(92)90182-I; Lloyd SA, 2014, J BONE MINER RES, V29, P1118, DOI 10.1002/jbmr.2113; Lloyd SA, 2013, BONE, V57, P76, DOI 10.1016/j.bone.2013.07.022; Lloyd SA, 2012, J BONE MINER RES, V27, P2359, DOI 10.1002/jbmr.1687; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; Ohshima Hiroshi, 2006, Clin Calcium, V16, P81; Orwoll ES, 2013, J BONE MINER RES, V28, P1243, DOI 10.1002/jbmr.1948; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Scott JM, 2011, SPINAL CORD, V49, P4, DOI 10.1038/sc.2010.53; Slaba TC, 2016, LIFE SCI SPACE RES, V8, P52, DOI 10.1016/j.lssr.2016.01.001; Steiner JL, 2015, PHYSL REP, V3, DOI 10.14814/phy2.12333; Tamma R, 2009, FASEB J, V23, P2549, DOI 10.1096/fj.08-127951; Townsend LW, 2002, ADV SPACE RES, V30, P957, DOI 10.1016/S0273-1177(02)00160-6; Yumoto K, 2010, RADIAT RES, V173, P494, DOI 10.1667/RR1754.1	44	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182403	10.1371/journal.pone.0182403	http://dx.doi.org/10.1371/journal.pone.0182403			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767703	Green Published, gold, Green Submitted			2022-12-26	WOS:000406768200078
J	Lipczynska, M; Szymanski, P; Kumor, M; Klisiewicz, A; Hoffman, P				Lipczynska, Magdalena; Szymanski, Piotr; Kumor, Magdalena; Klisiewicz, Anna; Hoffman, Piotr			Collagen turnover biomarkers and systemic right ventricle remodeling in adults with previous atrial switch procedure for transposition of the great arteries	PLOS ONE			English	Article							DIFFUSE MYOCARDIAL FIBROSIS; CHRONIC HEART-FAILURE; MAGNETIC-RESONANCE; UNNATURAL HISTORY; MUSTARD; METALLOPROTEINASES; ASSOCIATION; DISEASE; SURGERY; MATRIX	Background Myocardial fibrosis is a potential pathophysiological mechanism leading to systemic right ventricular (SRV) deterioration. We hypothesize that circulating levels of collagen deposition markers are elevated in patients with SRV remodeling and this elevation may have a predictive value. Methods We prospectively evaluated 56 patients with D-TGA after the atrial switch procedure (mean age 25.6 +/- 4.8, range 18-37 years; 67% males). Serum levels of procollagen type III aminoterminal propeptide (PIIINP), collagen type I carboxy-terminal telopeptide (CITP), procollagen type I N-terminal propeptide (PINP), matrix metalloproteinase (MMP 1, MMP 9) and a tissue inhibitor of matrix metalloproteinase (TIMP 1) and N-terminal pro-brain natriuretic peptide (NT-pro-BNP) were measured and compared with healthy controls. The relationship between these serum markers, echocardiographic and cardiac magnetic resonance parameters and the outcome at a follow-up of 61 months (range, 24-85 months) was determined. Results Compared with the healthy control group, the study group had significantly higher levels of TIMP1, PIIINP, CITP, PINP and NT-pro-BNP (p<0.05, each). The levels of PIIINP and CITP were significantly higher among patients with an SRV mass index above the mean value. The level of PIIINP was significantly higher among patients with an SRV EDV index above the mean value. CITP was significantly elevated in SRV late gadolinium enhanced (LGE) positive patients, compared to patients without SRV LGE. MMP9 and TIMP1 predicted an adverse clinical outcome on univariate Cox proportional hazard survival analysis in addition to well proven predictors of outcome (SRV EF and NYHA). Conclusions We demonstrated a pattern of altered collagen turnover adversely related with the indices of SRV remodeling and an adverse clinical outcome in patients with SRV.	[Lipczynska, Magdalena; Kumor, Magdalena; Klisiewicz, Anna; Hoffman, Piotr] Inst Cardiol, Adult Congenital Heart Dis Dept, Warsaw, Poland; [Szymanski, Piotr] Inst Cardiol, Acquired Valve Dis Dept, Warsaw, Poland	Institute of Cardiology - Poland; Institute of Cardiology - Poland	Lipczynska, M (corresponding author), Inst Cardiol, Adult Congenital Heart Dis Dept, Warsaw, Poland.	mlipczynska@ikard.pl		Klisiewicz, Anna/0000-0001-5439-7443; Szymanski, Piotr/0000-0001-9486-7892; , Piotr/0000-0002-4860-0967; Lipczynska, Magdalena/0000-0001-8584-4744	Polish Ministry of Science and Higher Education [2.22/VI/11]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	Financial support for the study was provided by the Polish Ministry of Science and Higher Education for the statutory activities of the Institute of Cardiology (2.22/VI/11).	Ahmed SH, 2006, CIRCULATION, V113, P2089, DOI 10.1161/CIRCULATIONAHA.105.573865; Babu-Narayan SV, 2005, CIRCULATION, V111, P2091, DOI 10.1161/01.CIR.0000162463.61626.3B; Bolger AP, 2002, CIRCULATION, V106, P92, DOI 10.1161/01.CIR.0000020009.30736.3F; Broberg CS, 2010, CIRC-CARDIOVASC IMAG, V3, P727, DOI 10.1161/CIRCIMAGING.108.842096; Catalano O, 2007, J CARDIOVASC MED, V8, P807, DOI 10.2459/JCM.0b013e32801105ef; Chalikias GK, 2015, CLIN CHIM ACTA, V443, P39, DOI 10.1016/j.cca.2014.06.028; Cuypers JAAE, 2014, EUR HEART J, V35, P1666, DOI 10.1093/eurheartj/ehu102; Diller GP, 2014, EUR HEART J, V35, P1637, DOI 10.1093/eurheartj/ehu132; Diller GP, 2012, AM HEART J, V163, P859, DOI 10.1016/j.ahj.2012.01.038; Dobson R, 2013, J THORAC CARDIOV SUR, V145, P1493, DOI 10.1016/j.jtcvs.2013.02.030; Dos L, 2005, HEART, V91, P652, DOI 10.1136/hrt.2003.029769; Dos L, 2013, INT J CARDIOL, V168, P5167, DOI 10.1016/j.ijcard.2013.07.163; Eindhoven JA, 2012, J AM COLL CARDIOL, V60, P2140, DOI 10.1016/j.jacc.2012.02.092; Frantz S, 2008, EUR J HEART FAIL, V10, P388, DOI 10.1016/j.ejheart.2008.02.015; Fratz S, 2006, HEART, V92, P1673, DOI 10.1136/hrt.2005.086579; Giardini A, 2006, AM J CARDIOL, V98, P1277, DOI 10.1016/j.amjcard.2006.05.062; Haas F, 1999, ANN THORAC SURG, V68, P1692, DOI 10.1016/S0003-4975(99)01039-5; Hartke Lopa P, 2006, Congenit Heart Dis, V1, P192, DOI 10.1111/j.1747-0803.2006.00035.x; HOFFMAN JIE, 1995, PEDIATR CARDIOL, V16, P155; HOST NB, 1995, AM J CARDIOL, V76, P869, DOI 10.1016/S0002-9149(99)80251-3; Lipczynska M, 2015, CAN J CARDIOL, V31, P760, DOI 10.1016/j.cjca.2015.02.028; Lombardi R, 2003, CIRCULATION, V108, P1455, DOI 10.1161/01.CIR.0000090687.97972.10; Lopez B, 2001, HYPERTENSION, V38, P1222, DOI 10.1161/hy1101.098549; Lopez B, 2010, CIRCULATION, V121, P1645, DOI 10.1161/CIRCULATIONAHA.109.912774; Michalek PM, 2009, AM J CARDIOL, V104, P414; MUSTARD WT, 1964, SURGERY, V55, P469; Plymen CM, 2013, EUR HEART J-CARD IMG, V14, P963, DOI 10.1093/ehjci/jet014; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Rydman R, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.002628; Safdar Z, 2014, JACC-HEART FAIL, V2, P412, DOI 10.1016/j.jchf.2014.03.013; SENNING A, 1959, SURGERY, V45, P966; Sugimoto M, 2009, HEART, V95, P2023, DOI 10.1136/hrt.2009.170241; Szymanski P, 2005, INT J CARDIOL, V101, P59, DOI 10.1016/j.ijcard.2004.03.019; TURINA MI, 1989, CIRCULATION, V80, P162; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; Vejlstrup N, 2015, CIRCULATION, V132, P633, DOI 10.1161/CIRCULATIONAHA.114.010770; Winter MM, 2009, HEART, V95, P960, DOI 10.1136/hrt.2008.156265	37	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0180629	10.1371/journal.pone.0180629	http://dx.doi.org/10.1371/journal.pone.0180629			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767656	Green Published, gold, Green Submitted			2022-12-26	WOS:000406768200011
J	Qing, YL; Gerson, SL				Qing, Yulan; Gerson, Stanton L.			Mismatch repair deficient hematopoietic stem cells are preleukemic stem cells	PLOS ONE			English	Article							NONPOLYPOSIS COLON-CANCER; ACUTE MYELOID-LEUKEMIA; MICROSATELLITE INSTABILITY; MSH2 GENE; HEMATOLOGICAL MALIGNANCY; MYELOGENOUS LEUKEMIA; GENOMIC INSTABILITY; MUTATION FREQUENCY; COLORECTAL-CANCER; TARGET GENES	Whereas transformation events in hematopoietic malignancies may occur at different developmental stages, the initial mutation originates in hematopoietic stem cells (HSCs), creating a preleukemic stem cell (PLSC). Subsequent mutations at either stem cell or progenitor cell levels transform the PLSC into lymphoma/leukemia initiating cells (LIC). Thymic lymphomas have been thought to develop from developing thymocytes. T cell progenitors are generated from HSCs in the bone marrow (BM), but maturation and proliferation of T cells as well as T-lymphomagenesis depends on both regulatory mechanisms and microenvironment within the thymus. We studied PLSC linked to thymic lymphomas. In this study, we use MSH2-/-mice as a model to investigate the existence of PLSC and the evolution of PLSC to LIC. Following BM transplantation, we found that MSH2-/- BM cells from young mice are able to fully reconstitute multiple hematopoietic lineages of lethally irradiated wild-type recipients. However, all recipients developed thymic lymphomas within three and four months post transplantation. Transplantation of different fractions of BM cells or thymocytes from young health MSH2-/- mice showed that an HSC enriched fraction always reconstituted hematopoiesis followed by lymphoma development. In addition, lymphomas did not occur in thymectomized recipients of MSH2-/- BM. These results suggest that HSCs with DNA repair defects such as MSH2-/- are PLSCs because they retain hematopoietic function, but also carry an obligate lymphomagenic potential within their T-cell progeny that is dependent on the thymic microenvironment.	[Qing, Yulan; Gerson, Stanton L.] Case Western Reserve Univ, Natl Ctr Regenerat Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA	Case Western Reserve University	Gerson, SL (corresponding author), Case Western Reserve Univ, Natl Ctr Regenerat Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.	slg5@case.edu			Cytometry & Imaging Microscopy Core Facility of the Case Comprehensive Cancer Center [P30 CA43703]; National Institute of Health [RO1CA063193]	Cytometry & Imaging Microscopy Core Facility of the Case Comprehensive Cancer Center; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by the Cytometry & Imaging Microscopy Core Facility of the Case Comprehensive Cancer Center (P30 CA43703) (SLG) and by National Institute of Health (nih.gov) grant RO1CA063193 (SLG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Baross-Francis A, 1998, P NATL ACAD SCI USA, V95, P8739, DOI 10.1073/pnas.95.15.8739; Baross-Francis A, 2000, CARCINOGENESIS, V21, P1259, DOI 10.1093/carcin/21.6.1259; Belcheva A, 2010, LEUKEMIA LYMPHOMA, V51, P1777, DOI 10.3109/10428194.2010.516377; BONIVER J, 1981, CANCER RES, V41, P390; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bougeard L, 2003, AM J HUM GENET, V72, P213, DOI 10.1086/345297; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Campbell MR, 2005, CANCER RES, V65, P2626, DOI 10.1158/0008-5472.CAN-04-3158; Chalastanis A, 2010, J NATL CANCER I, V102, P1731, DOI 10.1093/jnci/djq389; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; De Vos M, 2004, AM J HUM GENET, V74, P954, DOI 10.1086/420796; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; Diouf B, 2011, NAT MED, V17, P1298, DOI 10.1038/nm.2430; Duval A, 2002, CANCER RES, V62, P2447; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Fujiwara T, 1998, AM J PATHOL, V153, P1063, DOI 10.1016/S0002-9440(10)65651-9; FURTH J, 1946, J GERONTOL, V1, P46; HARANGHERA N, 1978, J NATL CANCER I, V60, P707, DOI 10.1093/jnci/60.3.707; HARANGHERA N, 1987, LEUKEMIA, V1, P442; HAYS EF, 1989, CANCER RES, V49, P4225; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Hirano K, 2002, DIS COLON RECTUM, V45, P273, DOI 10.1007/s10350-004-6161-9; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; KAPLAN HS, 1950, J NATL CANCER I, V11, P83; KATO A, 1985, J NATL CANCER I, V75, P491; Kim N, 1998, J EXP MED, V187, P1729, DOI 10.1084/jem.187.11.1729; Kim TM, 2013, CELL, V155, P858, DOI 10.1016/j.cell.2013.10.015; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Ladi E, 2006, NAT IMMUNOL, V7, P338, DOI 10.1038/ni1323; Larson RC, 1996, EMBO J, V15, P1021, DOI 10.1002/j.1460-2075.1996.tb00439.x; Leveen P, 2005, BLOOD, V106, P4234, DOI 10.1182/blood-2005-05-1871; Licht JD, 2001, ONCOGENE, V20, P5660, DOI 10.1038/sj.onc.1204593; Liu B, 1996, NAT MED, V2, P169, DOI 10.1038/nm0296-169; Lowsky R, 2000, BLOOD, V95, P1767, DOI 10.1182/blood.V95.5.1767.005k07_1767_1772; Lowsky R, 1997, BLOOD, V89, P2276, DOI 10.1182/blood.V89.7.2276; Mayle A, 2013, CYTOM PART A, V83A, P27, DOI 10.1002/cyto.a.22093; Metcalf D, 1966, THE THYMUS; Miyamoto T, 2000, P NATL ACAD SCI USA, V97, P7521, DOI 10.1073/pnas.97.13.7521; Peltomaki P, 2001, HUM MOL GENET, V10, P735, DOI 10.1093/hmg/10.7.735; Reese JS, 2003, BLOOD, V102, P1626, DOI 10.1182/blood-2002-10-3035; Reiss C, 2010, LEUKEMIA LYMPHOMA, V51, P1875, DOI 10.3109/10428194.2010.510360; Reitmair AH, 1997, CANCER RES, V57, P3765; REITMAIR AH, 1995, NAT GENET, V11, P64, DOI 10.1038/ng0995-64; Ricciardone MD, 1999, CANCER RES, V59, P290; ROBLEDO M, 1995, LEUKEMIA, V9, P960; Rosty C, 2000, MODERN PATHOL, V13, P586, DOI 10.1038/modpathol.3880100; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781; WADA C, 1994, BLOOD, V83, P3449, DOI 10.1182/blood.V83.12.3449.bloodjournal83123449; Wang Q, 1999, CANCER RES, V59, P294; Whiteside D, 2002, CANCER RES, V62, P359; Woerner SM, 2005, ONCOGENE, V24, P2525, DOI 10.1038/sj.onc.1208456; Yuan YZ, 2001, P NATL ACAD SCI USA, V98, P10398, DOI 10.1073/pnas.171321298; Zhang SL, 2002, MUTAT RES-FUND MOL M, V500, P67, DOI 10.1016/S0027-5107(01)00297-4; Zhu YM, 1999, BLOOD, V94, P733, DOI 10.1182/blood.V94.2.733.414k03_733_740	59	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182175	10.1371/journal.pone.0182175	http://dx.doi.org/10.1371/journal.pone.0182175			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767666	gold, Green Submitted, Green Published			2022-12-26	WOS:000406768200051
J	Amarasinghe, A; Abdul-Cader, MS; Nazir, S; Senapathi, UD; van der Meer, F; Cork, SC; Gomis, S; Abdul-Careem, MF				Amarasinghe, Aruna; Abdul-Cader, Mohamed Sarjoon; Nazir, Sadiya; Senapathi, Upasama De Silva; van der Meer, Frank; Cork, Susan Catherine; Gomis, Susantha; Abdul-Careem, Mohamed Faizal			Infectious bronchitis corona virus establishes productive infection in avian macrophages interfering with selected antimicrobial functions	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; NITRIC-OXIDE PRODUCTION; INFLAMMATORY CYTOKINES; DISEASE VIRUS; DC-SIGN; REPLICATION; PROTEIN; INDUCTION; TROPISM; CELLS	Infectious bronchitis virus (IBV) causes respiratory disease leading to loss of egg and meat production in chickens. Although it is known that macrophage numbers are elevated in the respiratory tract of IBV infected chickens, the role played by macrophages in IBV infection, particularly as a target cell for viral replication, is unknown. In this study, first, we investigated the ability of IBV to establish productive replication in macrophages in lungs and trachea in vivo and in macrophage cell cultures in vitro using two pathogenic IBV strains. Using a double immunofluorescent technique, we observed that both IBV Massachusetts -type 41 (M41) and Connecticut A5968 (Conn A5968) strains replicate in avian macrophages at a low level in vivo. This in vivo observation was substantiated by demonstrating IBV antigens in macrophages following in vitro IBV infection. Further, IBV productive infection in macrophages was confirmed by demonstrating corona viral particles in macrophages and IBV ribonucleic acid (RNA) in culture supernatants. Evaluation of the functions of macrophages following infection of macrophages with IBV M41 and Conn A5968 strains revealed that the production of antimicrobial molecule, nitric oxide (NO) is inhibited. It was also noted that replication of IBV M41 and Conn A5968 strains in macrophages does not interfere with the induction of type 1 IFN activity by macrophages. In conclusion, both M41 and Con A5968 IBV strains infect macrophages in vivo and in vitro resulting productive replications. During the replication of IBV in macrophages, their ability to produce NO can be affected without affecting the ability to induce type 1 IFN activity. Further studies are warranted to uncover the significance of macrophage infection of IBV in the pathogenesis of IBV infection in chickens.	[Amarasinghe, Aruna; Abdul-Cader, Mohamed Sarjoon; Nazir, Sadiya; Senapathi, Upasama De Silva; van der Meer, Frank; Cork, Susan Catherine; Abdul-Careem, Mohamed Faizal] Univ Calgary, Hlth Res Innovat Ctr 2C53, Fac Vet Med, Dept Ecosyst & Publ Hlth, Calgary, AB, Canada; [Gomis, Susantha] Univ Saskatchewan, Dept Vet Pathol, Western Coll Vet Med, Saskatoon, SK, Canada	University of Calgary; University of Saskatchewan	Abdul-Careem, MF (corresponding author), Univ Calgary, Hlth Res Innovat Ctr 2C53, Fac Vet Med, Dept Ecosyst & Publ Hlth, Calgary, AB, Canada.	faizal.abdulcareem@ucalgary.ca	Cork, Susan/AAG-8820-2020; van der Meer, Frank/AAX-3784-2020; Careem, Faizal/H-8005-2019; van der Meer, Frank/T-3497-2019	Cork, Susan/0000-0002-8200-3584; van der Meer, Frank/0000-0003-3785-9639; Careem, Faizal/0000-0002-9974-7600; 	Saskatchewan Agriculture Development Fund [20140185]; Natural Sciences and Engineering Research Council of Canada [RT736458]	Saskatchewan Agriculture Development Fund; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	SG received funding from Saskatchewan Agriculture Development Fund (grant number, 20140185; URL-https://www.saskatchewanca./business/agriculture-natural-resources-and-industry/agribusiness-farmers-and-ranchers/agricultural-research-programs/knowledge-creation/agnculture-development-fund) and MFAC received funding from Natural Sciences and Engineering Research Council of Canada (grant number RT736458; URL-http://www.nserc-crsng.gc.ca/index_eng.asp).	Abdul-Cader MS, 2017, J GEN VIROLOGY; Akerstrom S, 2005, J VIROL, V79, P1966, DOI 10.1128/JVI.79.3.1966-1969.2005; Akerstrom S, 2009, VIROLOGY, V395, P1, DOI 10.1016/j.virol.2009.09.007; Barrow AD, 2003, J GEN VIROL, V84, P2635, DOI 10.1099/vir.0.19206-0; Bray M, 2005, INT J BIOCHEM CELL B, V37, P1560, DOI 10.1016/j.biocel.2005.02.018; Cavanagh D, 2007, VET RES, V38, P281, DOI 10.1051/vetres:2006055; Chen YS, 2015, CAN J VET RES, V79, P87; Cheng JH, 2014, ARCH VIROL, V159, P2937, DOI 10.1007/s00705-014-2148-6; Cheung CY, 2005, J VIROL, V79, P7819, DOI 10.1128/JVI.79.12.7819-7826.2005; Crippen TL, 2006, VET IMMUNOL IMMUNOP, V109, P127, DOI 10.1016/j.vetimm.2005.08.024; Ding Z, 2014, J VIROL, V88, P8936, DOI 10.1128/JVI.00700-14; Gillespie L, 2016, SCI REP-UK, V6, DOI 10.1038/srep19428; Gotoh T, 2002, J BIOL CHEM, V277, P12343, DOI 10.1074/jbc.M107988200; Haddadi S, 2013, VET IMMUNOL IMMUNOP, V155, P270, DOI 10.1016/j.vetimm.2013.08.005; Hodgson T, 2004, J VIROL, V78, P13804, DOI 10.1128/JVI.78.24.13804-13811.2004; Honeycutt JB, 2016, J CLIN INVEST, V126, P1353, DOI 10.1172/JCI84456; Kameka AM, 2014, VIROLOGY, V450, P114, DOI 10.1016/j.virol.2013.12.001; Khatri M, 2007, VET IMMUNOL IMMUNOP, V117, P106, DOI 10.1016/j.vetimm.2007.02.002; Khatri M, 2009, J VIROL METHODS, V160, P197, DOI 10.1016/j.jviromet.2009.05.008; Kint J, 2016, J VIROL, V90, P7519, DOI 10.1128/JVI.00627-16; Kint J, 2015, J VIROL, V89, P12047, DOI 10.1128/JVI.01057-15; Kint J, 2015, J VIROL, V89, P1156, DOI 10.1128/JVI.02671-14; Klepper Arielle, 2015, EC Microbiol, V2, P328; LAUDE H, 1984, J GEN VIROL, V65, P327, DOI 10.1099/0022-1317-65-2-327; Lee CW, 2002, J VET DIAGN INVEST, V14, P377, DOI 10.1177/104063870201400503; Lin AF, 2009, J IMMUNOL, V183, P7398, DOI 10.4049/jimmunol.0803955; Liniger M, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-7; Lui PY, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.33; Luo JY, 2016, VIROLOGY, V495, P10, DOI 10.1016/j.virol.2016.04.025; Marvin SA, 2017, J VIROL, V91, DOI 10.1128/JVI.01417-16; Montassier HJ, 2010, BRAZ J POULTRY SCI, V12, P87, DOI 10.1590/S1516-635X2010000200003; Park JE, 2014, VIRUS RES, V191, P143, DOI 10.1016/j.virusres.2014.07.038; PATTERSON S, 1982, J GEN VIROL, V60, P307, DOI 10.1099/0022-1317-60-2-307; Pedersen NC, 2012, VIRUS RES, V165, P17, DOI 10.1016/j.virusres.2011.12.020; Pertile L, 1996, AVIAN DIS, V40, P342, DOI 10.2307/1592230; QURESHI MA, 1990, VET IMMUNOL IMMUNOP, V26, P237, DOI 10.1016/0165-2427(90)90094-9; Raj GD, 1997, AVIAN PATHOL, V26, P677, DOI 10.1080/03079459708419246; Ramakrishnan Muthannan Andavar, 2016, World J Virol, V5, P85, DOI 10.5501/wjv.v5.i2.85; Reddy VRAP, 2016, VET RES, V47, DOI 10.1186/s13567-016-0354-9; REED L. J., 1938, AMER JOUR HYG, V27, P493; Regan AD, 2008, J VIROL, V82, P11992, DOI 10.1128/JVI.01094-08; Sainz B, 2004, VIROLOGY, V329, P11, DOI 10.1016/j.virol.2004.08.011; Steurbaut S, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-89; Takano T, 2011, VIRUS RES, V156, P72, DOI 10.1016/j.virusres.2010.12.020; VONBULOW V, 1983, AVIAN PATHOL, V12, P179, DOI 10.1080/03079458308436162; Wang GG, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/323171; Yilla M, 2005, VIRUS RES, V107, P93, DOI 10.1016/j.virusres.2004.09.004; Yip MS, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-82; Zaffuto KM, 2007, J GEN VIROL, V88, P3007, DOI 10.1099/vir.0.83042-0; Zhang YT, 2012, VET MICROBIOL, V157, P285, DOI 10.1016/j.vetmic.2012.01.011; Zhou J, 2014, J INFECT DIS, V209, P1331, DOI 10.1093/infdis/jit504	51	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0181801	10.1371/journal.pone.0181801	http://dx.doi.org/10.1371/journal.pone.0181801			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763472	gold, Green Published, Green Submitted			2022-12-26	WOS:000406766500023
J	Tsui, PH; Zhou, ZH; Lin, YH; Hung, CM; Chung, SJ; Wan, YL				Tsui, Po-Hsiang; Zhou, Zhuhuang; Lin, Ying-Hsiu; Hung, Chieh-Ming; Chung, Shih-Jou; Wan, Yung-Liang			Effect of ultrasound frequency on the Nakagami statistics of human liver tissues	PLOS ONE			English	Article							ACOUSTIC STRUCTURE QUANTIFICATION; HOMODYNED K-DISTRIBUTION; MAGNETIC-RESONANCE ELASTOGRAPHY; CHRONIC HEPATITIS-B; BACKSCATTERED STATISTICS; CIRRHOTIC LIVER; FIBROSIS; STEATOSIS; DISEASE; SPECTROSCOPY	The analysis of the backscattered statistics using the Nakagami parameter is an emerging ultrasound technique for assessing hepatic steatosis and fibrosis. Previous studies indicated that the echo amplitude distribution of a normal liver follows the Rayleigh distribution (the Nakagami parameter m is close to 1). However, using different frequencies may change the backscattered statistics of normal livers. This study explored the frequency dependence of the backscattered statistics in human livers and then discussed the sources of ultrasound scattering in the liver. A total of 30 healthy participants were enrolled to undergo a standard care ultrasound examination on the liver, which is a natural model containing diffuse and coherent scatterers. The liver of each volunteer was scanned from the right intercostal view to obtain image raw data at different central frequencies ranging from 2 to 3.5 MHz. Phantoms with diffuse scatterers only were also made to perform ultrasound scanning using the same protocol for comparisons with clinical data. The Nakagami parameter -frequency correlation was evaluated using Pearson correlation analysis. The median and interquartile range of the Nakagami parameter obtained from livers was 1.00 (0.98-1.05) for 2 MHz, 0.93 (0.89-0.98) for 2.3 MHz, 0.87 (0.84-0.92) for 2.5 MHz, 0.82 (0.77-0.88) for 3.3 MHz, and 0.81 (0.76-0.88) for 3.5 MHz. The Nakagami parameter decreased with the increasing central frequency (r=-0.67, p < 0.0001). However, the effect of ultrasound frequency on the statistical distribution of the backscattered envelopes was not found in the phantom results (r=-0.147, p = 0.0727). The current results demonstrated that the backscattered statistics of normal livers is frequency -dependent. Moreover, the coherent scatterers may be the primary factor to dominate the frequency dependence of the backscattered statistics in a liver.	[Tsui, Po-Hsiang; Lin, Ying-Hsiu; Wan, Yung-Liang] Chang Gung Univ, Coll Med, Dept Med Imaging & Radiol Sci, Taoyuan, Taiwan; [Tsui, Po-Hsiang; Wan, Yung-Liang] Chang Gung Univ, Inst Radiol Res, Med Imaging Res Ctr, Taoyuan, Taiwan; [Tsui, Po-Hsiang; Wan, Yung-Liang] Chang Gung Mem Hosp Linkou, Taoyuan, Taiwan; [Tsui, Po-Hsiang; Hung, Chieh-Ming; Wan, Yung-Liang] Chang Gung Mem Hosp Linkou, Dept Med Imaging & Intervent, Taoyuan, Taiwan; [Tsui, Po-Hsiang; Chung, Shih-Jou] Chang Gung Univ, Dept Elect Engn, Taoyuan, Taiwan; [Zhou, Zhuhuang] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing, Peoples R China; [Zhou, Zhuhuang] Beijing Univ Technol, Fac Informat Technol, Beijing, Peoples R China	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Beijing University of Technology; Beijing University of Technology	Tsui, PH; Wan, YL (corresponding author), Chang Gung Univ, Coll Med, Dept Med Imaging & Radiol Sci, Taoyuan, Taiwan.; Tsui, PH; Wan, YL (corresponding author), Chang Gung Univ, Inst Radiol Res, Med Imaging Res Ctr, Taoyuan, Taiwan.; Tsui, PH; Wan, YL (corresponding author), Chang Gung Mem Hosp Linkou, Taoyuan, Taiwan.; Tsui, PH; Wan, YL (corresponding author), Chang Gung Mem Hosp Linkou, Dept Med Imaging & Intervent, Taoyuan, Taiwan.; Tsui, PH (corresponding author), Chang Gung Univ, Dept Elect Engn, Taoyuan, Taiwan.	tsuiph@mail.cgu.edu.tw; ylw0518@cgmh.org.tw	Tsui, Po-Hsiang/AHE-7426-2022; Zhou, Zhuhuang/M-3301-2019	Zhou, Zhuhuang/0000-0003-0570-8473; Tsui, Po-Hsiang/0000-0002-5604-1800	Ministry of Science and Technology (Taiwan) [MOST 103-2221-E-182-001-MY3]; Chang Gung Memorial Hospital (Linkou, Taiwan) [CIRPD1E0023, CMRPD1C0711, CMRPD1F0311]	Ministry of Science and Technology (Taiwan)(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital (Linkou, Taiwan)(Chang Gung Memorial Hospital)	This work was supported by the Ministry of Science and Technology (Taiwan) under Grant No. MOST 103-2221-E-182-001-MY3. This work was also supported by the Chang Gung Memorial Hospital (Linkou, Taiwan) under Grant Nos. CIRPD1E0023, CMRPD1C0711, and CMRPD1F0311.	Alqahtani M. A., 2010, 2010 International Conference of Medical Image Analysis and Clinical Application (MIACA), P63, DOI 10.1109/MIACA.2010.5528423; Arena U, 2008, HEPATOLOGY, V47, P380, DOI 10.1002/hep.22007; Barr RG, 2015, RADIOLOGY, V276, P845, DOI 10.1148/radiol.2015150619; Berzigotti A, 2013, J HEPATOL, V59, P180, DOI 10.1016/j.jhep.2012.12.028; BURCKHARDT CB, 1978, IEEE T SON ULTRASON, V25, P1, DOI 10.1109/T-SU.1978.30978; Castera L, 2012, GASTROENTEROLOGY, V142, P1293, DOI 10.1053/j.gastro.2012.02.017; Chan DFY, 2004, INT J OBESITY, V28, P1257, DOI 10.1038/sj.ijo.0802734; Choong CC, 2012, J CLIN IMAG SCI, V2, DOI 10.4103/2156-7514.101000; Choudhry S, 2000, RADIOGRAPHICS, V20, P1127, DOI 10.1148/radiographics.20.4.g00jl371127; Cowin GJ, 2008, J MAGN RESON IMAGING, V28, P937, DOI 10.1002/jmri.21542; Destrempes F, 2013, SIAM J IMAGING SCI, V6, P1499, DOI 10.1137/120875727; DUTT V, 1994, ULTRASONIC IMAGING, V16, P265, DOI 10.1006/uimg.1994.1016; FEI DY, 1985, J ACOUST SOC AM, V78, P871, DOI 10.1121/1.393115; FELLINGHAM LL, 1984, IEEE T SON ULTRASON, V31, P418, DOI 10.1109/T-SU.1984.31522; FERRAL H, 1992, GASTROINTEST RADIOL, V17, P74, DOI 10.1007/BF01888512; GARRA BS, 1989, INVEST RADIOL, V24, P196, DOI 10.1097/00004424-198903000-00004; Gerstenmaier JF, 2014, INSIGHTS IMAGING, V5, P441, DOI 10.1007/s13244-014-0336-2; Haider L, 2004, BIOPHYS J, V87, P2322, DOI 10.1529/biophysj.104.041665; Han AG, 2013, J ACOUST SOC AM, V134, P686, DOI 10.1121/1.4807576; Hara T, 2000, JPN J APPL PHYS 1, V39, P3262, DOI 10.1143/JJAP.39.3262; Ho MC, 2014, ULTRASOUND MED BIOL, V40, P2272, DOI 10.1016/j.ultrasmedbio.2014.04.019; Ho MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063543; Ho MC, 2012, ULTRASONICS, V52, P215, DOI 10.1016/j.ultras.2011.08.005; Hruska DP, 2009, IEEE T ULTRASON FERR, V56, P2471, DOI 10.1109/TUFFC.2009.1334; Huang Y, 2016, EUR RADIOL, V26, P2344, DOI 10.1007/s00330-015-4056-x; Huang Y, 2015, ULTRASOUND MED BIOL, V41, P2360, DOI 10.1016/j.ultrasmedbio.2015.05.006; Huber A, 2015, EUR J RADIOL OPEN, V2, P90, DOI 10.1016/j.ejro.2015.05.002; Hung CH, 2003, J GASTROENTEROL, V38, P153, DOI 10.1007/s005350300025; Huwart L, 2008, GASTROENTEROLOGY, V135, P32, DOI 10.1053/j.gastro.2008.03.076; Igarashi Y, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.07HF17; INSANA MF, 1986, ULTRASONIC IMAGING, V8, P165, DOI 10.1016/0161-7346(86)90007-6; Karlas T, 2015, WORLD J GASTROENTERO, V21, P4894, DOI 10.3748/wjg.v21.i16.4894; Keller J, 2015, BMC MED IMAGING, V15, DOI 10.1186/s12880-015-0100-1; Kolios MC, 2001, ULTRASON, P1257, DOI 10.1109/ULTSYM.2001.991948; Kramer C, 2014, ULTRASOUND MED BIOL, V40, P2811, DOI 10.1016/j.ultrasmedbio.2014.07.020; Kubota K, 2000, ONCOL REP, V7, P767; Kuroda H, 2012, WORLD J GASTROENTERO, V18, P3889, DOI 10.3748/wjg.v18.i29.3889; Larrue A, 2011, I S BIOMED IMAGING, P887, DOI 10.1109/ISBI.2011.5872546; Liang XE, 2011, J VIRAL HEPATITIS, V18, P884, DOI 10.1111/j.1365-2893.2010.01389.x; LIN DY, 1993, J CLIN ULTRASOUND, V21, P303, DOI 10.1002/jcu.1870210502; Lin JJ, 2017, ULTRASONICS, V77, P133, DOI 10.1016/j.ultras.2017.02.006; Lodish H, 2000, MOL CELL BIOL; Mamou J, 2013, QUANTITATIVE ULTRASO; McPherson S, 2009, J HEPATOL, V51, P389, DOI 10.1016/j.jhep.2009.04.012; NICHOLAS D, 1982, ULTRASOUND MED BIOL, V8, P17, DOI 10.1016/0301-5629(82)90065-5; Nishiura T, 2005, BRIT J RADIOL, V78, P189, DOI 10.1259/bjr/75208448; Oelze ML, 2016, IEEE T ULTRASON FERR, V63, P336, DOI 10.1109/TUFFC.2015.2513958; OOSTERVELD BJ, 1985, ULTRASONIC IMAGING, V7, P142, DOI 10.1016/0161-7346(85)90073-2; Pfeifer L, 2014, ULTRASCHALL MED, V35, P44, DOI 10.1055/s-0033-1350170; Pike R., 2001, SCATTERING INVERSE S; RAPPAPORT AM, 1958, ANAT REC, V130, P673, DOI 10.1002/ar.1091300405; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Ricci P, 2013, RADIOL MED, V118, P995, DOI 10.1007/s11547-013-0940-0; Rubert N, 2013, IEEE T ULTRASON FERR, V60, P1061, DOI 10.1109/TUFFC.2013.2670; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Shankar PM, 2000, IEEE T ULTRASON FERR, V47, P727, DOI 10.1109/58.842062; Shankar PM, 2002, J ACOUST SOC AM, V111, P2463; Shung K., 1993, ULTRASONIC SCATTERIN; Son JY, 2016, RADIOLOGY, V278, P257, DOI 10.1148/radiol.2015141779; THOMSEN C, 1994, MAGN RESON IMAGING, V12, P487, DOI 10.1016/0730-725X(94)92543-7; Toyoda H, 2009, AM J ROENTGENOL, V193, P1037, DOI 10.2214/AJR.07.4047; Tsui PH, 2008, PHYS MED BIOL, V53, P6027, DOI 10.1088/0031-9155/53/21/009; Tsui PH, 2007, ULTRASOUND MED BIOL, V33, P608, DOI 10.1016/j.ultrasmedbio.2006.10.005; Tsui PH, 2015, ULTRASOUND MED BIOL, V41, P2240, DOI 10.1016/j.ultrasmedbio.2015.04.003; Tsui PH, 2014, ULTRASONICS, V54, P1448, DOI 10.1016/j.ultras.2014.04.024; Tsui PH, 2008, J MED BIOL ENG, V28, P197; Tunis AS, 2005, ULTRASOUND MED BIOL, V31, P1041, DOI 10.1016/j.ultrasmedbio.2005.04.020; TUTHILL TA, 1988, ULTRASONIC IMAGING, V10, P81, DOI 10.1016/0161-7346(88)90051-X; Venkatesh SK, 2013, J MAGN RESON IMAGING, V37, P544, DOI 10.1002/jmri.23731; WAGNER RF, 1983, IEEE T SON ULTRASON, V30, P156, DOI 10.1109/T-SU.1983.31404; Wan YL, 2015, P I MECH ENG H, V229, P419, DOI 10.1177/0954411915585864; Yamada H, 2006, J HEPATOL, V44, P68, DOI 10.1016/j.jhep.2005.08.009; Yamaguchi T, 1999, JPN J APPL PHYS 1, V38, P3388, DOI 10.1143/JJAP.38.3388; Yoneda M, 2010, RADIOLOGY, V256, P640, DOI 10.1148/radiol.10091662; Young B, 2006, WHEATERS FUNCTIONAL; Yu X, 2015, PHYS MED BIOL, V60, P7513, DOI 10.1088/0031-9155/60/19/7513; Zagzebski JA, 1999, IEEE T ULTRASON FERR, V46, P35, DOI 10.1109/58.741421; Zhang SY, 2014, J ULTRAS MED, V33, P959, DOI 10.7863/ultra.33.6.959; Zhou ZH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118030	80	23	23	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0181789	10.1371/journal.pone.0181789	http://dx.doi.org/10.1371/journal.pone.0181789			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763461	Green Published, Green Submitted, gold			2022-12-26	WOS:000406766500022
J	Chambal, LM; Gudo, ES; Carimo, A; Real, RC; Mabunda, N; Mauela, C; Vubil, A; Zicai, AF; Bhatt, N; Antunes, F				Chambal, Lucia Mabalane; Gudo, Eduardo Samo; Carimo, Awa; Real, Rita Corte; Mabunda, Nedio; Mauela, Cremildo; Vubil, Adolfo; Zicai, Ana Flora; Bhatt, Nilesh; Antunes, Francisco			HBV infection in untreated HIV-infected adults in Maputo, Mozambique	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; LAMIVUDINE-RESISTANCE; LIVER-DISEASE; HEPATOCELLULAR-CARCINOMA; VIRAL-HEPATITIS; COINFECTION; MORTALITY; COHORT	Background HIV/HBV coinfected patients are at high risk of developing chronic HBV infection, liver cirrhosis and hepatocellular carcinoma. In Mozambique, where HIV prevalence is one of the highest in the world, HIV-infected patients are scarcely characterized in terms of HBV coinfection and 3TC-resistance mutations profile. Methods To characterize ART-naive HIV- infected adults, with and without HBV coinfection, a cross-sectional study was conducted between May and November 2012 in two health centers from Maputo city, Mozambique. Subjects were consecutively enrolled in the study and, then, tested for hepatitis B surface antigen (HBsAg). Moreover, CD4(+) T cells count, HBV DNA in plasma, HBV genotyping and 3TC-resistance mutations profile of HBV were assessed in HIV/HBV coinfected patients. Results In total, 518 patients were enrolled in the study. The median age was 33 years old and 66.8% were women. The median CD4+ T cells count was 361 cells/mm 3 and 47 (9.1%) were coinfected with HBV. Out of 46 coinfected patients, 24 (55.2%) had HBV DNA >= 20 - < 20 000 and 12 (26.1%) had HBV-DNA >= 20 000. APRI >2.0 was reported in 4.3% of coinfected and 1.7% of monoinfected patients (p = 0.228), while FIB-4 > 3.25 was reported in 4.4% of coinfected and 1.3% of monoinfected patients (p = 0.112). Genotype A was the most frequent, identified in 25/27 (92.6%) patients, whereas genotype E was present in 2/27 (7.4%) patients. No patient had 3TC-resistance mutations. Conclusions This study showed that HBV coinfection was prevalent among ART-naive HIV-infected adults in Mozambique. Overall, these data highlight the importance of screening HBV coinfection as an integrated measure of HIV routine care to improve health conditions and treatment of HIV/HBV coinfected patients.	[Chambal, Lucia Mabalane; Carimo, Awa] Hosp Cent Maputo, Maputo, Mozambique; [Gudo, Eduardo Samo; Mabunda, Nedio; Mauela, Cremildo; Vubil, Adolfo; Zicai, Ana Flora; Bhatt, Nilesh] Inst Nacl Saude, Maputo, Mozambique; [Gudo, Eduardo Samo] Univ Eduardo Mondlane, Fac Med, Maputo, Mozambique; [Real, Rita Corte] Ctr Hosp Lisboa Cent, Lab Biol Mol, Lisbon, Portugal; [Antunes, Francisco] Univ Lisbon, Fac Med, Inst Saude Ambiental, Lisbon, Portugal	Eduardo Mondlane University; Centro Hospitalar de Lisboa Central, EPE; Universidade de Lisboa; Universidade de Lisboa	Chambal, LM (corresponding author), Hosp Cent Maputo, Maputo, Mozambique.	luciachambal@gmail.com		Maueia, Cremildo Gomes/0000-0002-1511-6175	Ministry of Health of Mozambique; ViiV Healthcare Portugal	Ministry of Health of Mozambique; ViiV Healthcare Portugal	This work was supported by funds from Ministry of Health of Mozambique and ViiV Healthcare Portugal.; The authors would like to thank to all participants for their valuable contribution. Also, the authors thank to the entire field-work team for their efforts in completing this investigation, especially the staff members of the Polana Canico Health and Training Center (CISPOC) of Instituto Nacional de Saude (INS), the Serology and Molecular Virology Laboratory of INS and the Mavalane General Hospital. We also would like to thank Catarina Silva and Luis Veloso for their medical writting support. This work was funded by Ministry of Health of Mozambique and by ViiV Healthcare Portugal.	Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Aoudjane S, 2014, CLIN INFECT DIS, V59, P1618, DOI 10.1093/cid/ciu630; Benhamou Y, 1999, HEPATOLOGY, V30, P1302, DOI 10.1002/hep.510300525; Burnett RJ, 2005, LIVER INT, V25, P201, DOI 10.1111/j.1478-3231.2005.01054.x; Calisti G, 2015, T ROY SOC TROP MED H, V109, P723, DOI 10.1093/trstmh/trv077; Cao GW, 2009, WORLD J GASTROENTERO, V15, P5761, DOI 10.3748/wjg.15.5761; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chun HM, 2012, J INFECT DIS, V205, P185, DOI 10.1093/infdis/jir720; Colin JF, 1999, HEPATOLOGY, V29, P1306, DOI 10.1002/hep.510290447; Cunha L, 2007, J MED VIROL, V79, P1832, DOI 10.1002/jmv.21010; Di Bisceglie AM, 2010, ANTIVIR THER, V15, P499, DOI 10.3851/IMP1494; Easterbrook P, 2012, SEMIN LIVER DIS, V32, P147, DOI 10.1055/s-0032-1316476; Europe WROf, 2011, MAN HEP B HIV COINF; Germer JJ, 2003, AM J TRANSPLANT, V3, P743, DOI 10.1034/j.1600-6143.2003.00149.x; Hamers RL, 2013, JAIDS-J ACQ IMM DEF, V64, P174, DOI 10.1097/QAI.0b013e3182a60f7d; Hoffmann CJ, 2007, LANCET INFECT DIS, V7, P402, DOI 10.1016/S1473-3099(07)70135-4; Joshi D, 2011, LANCET, V377, P1198, DOI 10.1016/S0140-6736(10)62001-6; Kessler HH, 2003, CLIN CHEM, V49, P989, DOI 10.1373/49.6.989; Kim HN, 2011, J VIRAL HEPATITIS, V18, pE447, DOI 10.1111/j.1365-2893.2011.01466.x; Konopnicki D, 2005, AIDS, V19, P593, DOI 10.1097/01.aids.0000163936.99401.fe; Kumar Ramesh, 2008, Trop Gastroenterol, V29, P136; LAURE F, 1985, SCIENCE, V229, P561, DOI 10.1126/science.2410981; Law WP, 2003, AIDS, V17, P2191, DOI 10.1097/00002030-200310170-00007; Li YJ, 2016, JAIDS-J ACQ IMM DEF, V72, P39, DOI 10.1097/QAI.0000000000000927; Lurie Y, 2015, WORLD J GASTROENTERO, V21, P11567, DOI 10.3748/wjg.v21.i41.11567; Mendy ME, 2010, J VIRAL HEPATITIS, V17, P115, DOI 10.1111/j.1365-2893.2009.01168.x; Modi AA, 2007, AIDS REV, V9, P25; Naniche D, 2011, AM J TROP MED HYG, V85, P776, DOI 10.4269/ajtmh.2011.10-0713; Nikolopoulos GK, 2009, CLIN INFECT DIS, V48, P1763, DOI 10.1086/599110; Ocama P, 2015, AFR HEALTH SCI, V15, P328, DOI 10.4314/ahs.v15i2.4; Organization WH, 2015, GUID PREV CAR TREATM; Puoti M, 2000, J ACQ IMMUN DEF SYND, V24, P211; Puoti M, 2006, J HEPATOL, V44, pS65, DOI 10.1016/j.jhep.2005.11.015; Ramanlal NA, 2008, SEROLOGICAL MARKERS; Salmon-Ceron D, 2005, J HEPATOL, V42, P799, DOI 10.1016/j.jhep.2005.01.022; Sanchez-Tapias JM, 2002, GASTROENTEROLOGY, V123, P1848, DOI 10.1053/gast.2002.37041; Saude INd Estatistica INd, 2010, INQ NAC HIV SIDA MOC; Selabe SG, 2007, J MED VIROL, V79, P1650, DOI 10.1002/jmv.20974; Selabe SG, 2009, J MED VIROL, V81, P996, DOI 10.1002/jmv.21479; Sinicco A, 1997, SCAND J INFECT DIS, V29, P111, DOI 10.3109/00365549709035869; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Tremeau-Bravard A, 2012, AFR HEALTH SCI, V12, P312, DOI 10.4314/ahs.v12i3.10; UNAIDS, 2015, AIDSINFO 2015 2015; UNAIDS, 2014, UND FAST TRACK ACC A; United Nations GA, 2016, 65 SESS POL DECL HIV; Wandeler G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152043; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; World Health Organization, 2015, GLOB HLTH SECT STRAT; Xiao GQ, 2015, HEPATOLOGY, V61, P292, DOI 10.1002/hep.27382; Xie J, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20659	50	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0181836	10.1371/journal.pone.0181836	http://dx.doi.org/10.1371/journal.pone.0181836			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759595	Green Submitted, Green Published, gold			2022-12-26	WOS:000406761600032
J	Fisher, CJ; Niu, C; Foltz, W; Chen, YH; Sidorova-Darmos, E; Eubanks, JH; Lilge, L				Fisher, Carl J.; Niu, Carolyn; Foltz, Warren; Chen, Yonghong; Sidorova-Darmos, Elena; Eubanks, James H.; Lilge, Lothar			ALA-PpIX mediated photodynamic therapy of malignant gliomas augmented by hypothermia	PLOS ONE			English	Article							NEWLY-DIAGNOSED GLIOBLASTOMA; PROTOPORPHYRIN IX FLUORESCENCE; BRAIN-BARRIER DISRUPTION; ACUTE ISCHEMIC-STROKE; 5-AMINOLEVULINIC ACID; MILD HYPOTHERMIA; GABA(B) RECEPTORS; CLINICAL ARTICLE; GUIDED RESECTION; TREATED RATS	Background Malignant gliomas are highly invasive, difficult to treat, and account for 2% of cancer deaths worldwide. Glioblastoma Multiforme (GBM) comprises the most common and aggressive intracranial tumor. The study hypothesis is to investigate the modification of Photodynamic Therapy (PDT) efficacy by mild hypothermia leads to increased glioma cell kill while protecting normal neuronal structures. Methods Photosensitizer accumulation and PDT efficacy in vitro were quantified in various glioma cell lines, primary rat neurons, and astrocytes. In vivo studies were carried out in healthy brain and RG2 glioma of naive Fischer rats. Hypothermia was induced at 1 hour pre-to 2 hours post-PDT, with ALA-PpIX accumulation and PDT treatments effects on tumor and normal brain PDT quantified using optical spectroscopy, histology, immunohistochemistry, MRI, and survival studies, respectively. Findings In vitro studies demonstrated significantly improved post-PDT survival in primary rat neuronal cells. Rat in vivo studies confirmed a neuroprotective effect to hypothermia following PpIX mediated PDT by T-2 mapping at day 10, reflecting edema/inflammation volume reduction. Mild hypothermia increased PpIX fluorescence in tumors five-fold, and the median post-PDT rat survival time (8.5 days normothermia; 14 days hypothermia). Histology and immunohistochemistry show close to complete cellular protection in normal brain structures under hypothermia. Conclusions The benefits of hypothermia on both normal neuronal tissue as well as increased PpIX fluorescence and RG2 induced rat survival strongly suggest a role for hypothermia in photonics-based surgical techniques, and that a hypothermic intervention could lead to considerable patient outcome improvements.	[Fisher, Carl J.; Lilge, Lothar] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Niu, Carolyn; Chen, Yonghong; Lilge, Lothar] Princess Margaret Canc Ctr, Div Mol Imaging, Toronto, ON, Canada; [Foltz, Warren] Univ Hlth Network, Dept Radiat Oncol, Toronto, ON, Canada; [Sidorova-Darmos, Elena; Eubanks, James H.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Eubanks, James H.] Toronto Western Hosp, Krembil Res Inst, Div Genet & Dev, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Lilge, L (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.; Lilge, L (corresponding author), Princess Margaret Canc Ctr, Div Mol Imaging, Toronto, ON, Canada.	llilge@uhnresearch.ca		lilge, lothar/0000-0001-5533-0005; Eubanks, James/0000-0001-8595-2024; Fisher, Carl/0000-0002-7412-8133	Institute of Cancer Research of the Canadian Institutes of Health Research [MOP 93567]; UHN Advanced Optical Microscopy Facility; UHN STTARR imaging facility	Institute of Cancer Research of the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); UHN Advanced Optical Microscopy Facility; UHN STTARR imaging facility	The study was funded by the Institute of Cancer Research of the Canadian Institutes of Health Research under grant #MOP 93567. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Authors want to express their thanks to the UHN Advanced Optical Microscopy Facility for their support in microscopic studies and the UHN STTARR imaging facility for their support in the in vivo imaging studies.	Akimoto J, 2016, NEUROL MED-CHIR, V56, P151, DOI 10.2176/nmc.ra.2015-0296; Amelio D, 2010, RADIOTHER ONCOL, V97, P361, DOI 10.1016/j.radonc.2010.08.018; Arican N, 2006, INT J NEUROSCI, V116, P1249, DOI 10.1080/00207450600550303; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Chang CN, 2003, J NEURO-ONCOL, V61, P45, DOI 10.1023/A:1021270201988; Chi OZ, 2001, ANESTHESIOLOGY, V95, P933, DOI 10.1097/00000542-200110000-00023; Crowley R Webster, 2006, Neurosurg Focus, V20, pE17; DERESKI MO, 1995, NEUROSURGERY, V36, P141, DOI 10.1227/00006123-199501000-00018; Eljamel MS, 2008, LASER MED SCI, V23, P361, DOI 10.1007/s10103-007-0494-2; Eljamel S, 2010, PHOTODIAGN PHOTODYN, V7, P76, DOI 10.1016/j.pdpdt.2010.02.002; Ennis SR, 2003, BRAIN RES, V959, P226, DOI 10.1016/S0006-8993(02)03749-6; Fisher CJ, 2013, LASER SURG MED, V45, P460, DOI 10.1002/lsm.22161; Fritzell S, 2013, J NEUROIMMUNOL, V258, P91, DOI 10.1016/j.jneuroim.2013.02.017; Gao DP, 2015, MOL MED REP, V11, P3009, DOI 10.3892/mmr.2014.3111; Gerard CS, 2014, SEMIN ONCOL, V41, P458, DOI 10.1053/j.seminoncol.2014.06.008; Gu XH, 2015, EXP NEUROL, V267, P135, DOI 10.1016/j.expneurol.2015.02.029; Gunther HS, 2008, ONCOGENE, V27, P2897, DOI 10.1038/sj.onc.1210949; Hammer MD, 2003, NEUROLOGIST, V9, P280, DOI 10.1097/01.nrl.0000094628.29312.2b; Hemmen TM, 2009, J NEUROTRAUM, V26, P387, DOI 10.1089/neu.2008.0574; Hess KR, 2004, CANCER, V101, P2293, DOI 10.1002/cncr.20621; Huang Z, 2010, PROTEIN CELL, V1, P638, DOI 10.1007/s13238-010-0078-y; Johansson A, 2013, LASER SURG MED, V45, P225, DOI 10.1002/lsm.22126; Jones OD, 2015, NEUROSCIENCE, V309, P113, DOI 10.1016/j.neuroscience.2015.08.035; Kim A, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3523616; Kim A, 2010, OPT EXPRESS, V18, P5580, DOI 10.1364/OE.18.005580; Kostaras X, 2014, CURR ONCOL, V21, pE493, DOI 10.3747/co.21.1769; Lee KM, 2009, GENES GENOM, V31, P89, DOI 10.1007/BF03191142; Li B, 2016, ONCOL LETT, V11, P2084, DOI 10.3892/ol.2016.4210; Lilge L, 1998, J CLIN LASER MED SUR, V16, P81, DOI 10.1089/clm.1998.16.81; Lilge L, 1997, J PHOTOCH PHOTOBIO B, V39, P229, DOI 10.1016/S1011-1344(97)00010-9; Lun XQ, 2009, CLIN CANCER RES, V15, P2777, DOI 10.1158/1078-0432.CCR-08-2342; Masubuchi T, 2013, PHOTOMED LASER SURG, V31, P428, DOI 10.1089/pho.2012.3469; Mathews MS, 2011, LASER SURG MED, V43, P892, DOI 10.1002/lsm.21135; Mineharu Y, 2012, NEUROTHERAPEUTICS, V9, P827, DOI 10.1007/s13311-012-0144-7; Moan J, 1999, PHOTOCHEM PHOTOBIOL, V70, P669, DOI 10.1562/0031-8655(1999)070<0669:TTDOPI>2.3.CO;2; MULLER PJ, 1987, PHOTOCHEM PHOTOBIOL, V46, P929, DOI 10.1111/j.1751-1097.1987.tb04871.x; Muragaki Y, 2013, J NEUROSURG, V119, P845, DOI 10.3171/2013.7.JNS13415; Niu CJ, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.9.098002; Olivo M, 2004, INT J ONCOL, V25, P37; Ostojic ZS, 2013, NEUROSCIENCE, V238, P39, DOI 10.1016/j.neuroscience.2013.01.072; Paez-Martinez N, 2013, EUR J PHARMACOL, V698, P178, DOI 10.1016/j.ejphar.2012.10.004; Schreer A, 2005, ANAL BIOCHEM, V344, P76, DOI 10.1016/j.ab.2005.06.009; Shaw E G, 1993, Oncology (Williston Park), V7, P97; Shaw EG, 1993, ONCOLOGY, V7, p8 ; Shaw EG, 1993, ONCOLOGY, V7, p[7, 8 ]; Stepp H, 2007, J ENVIRON PATHOL TOX, V26, P157, DOI 10.1615/JEnvironPatholToxicolOncol.v26.i2.110; Stummer W, 1998, NEUROSURGERY, V42, P518, DOI 10.1097/00006123-199803000-00017; Stummer W, 2003, ACT NEUR S, V88, P9; Stummer W, 2011, ACTA NEUROCHIR, V153, P1211, DOI 10.1007/s00701-011-1001-x; Stupp R, 2002, J CLIN ONCOL, V20, P1375, DOI 10.1200/JCO.20.5.1375; Stylli SS, 2006, J CLIN NEUROSCI, V13, P709, DOI 10.1016/j.jocn.2005.11.012; Valdes PA, 2011, J NEUROSURG, V115, P11, DOI 10.3171/2011.2.JNS101451; Voelzke WR, 2008, CURR TREAT OPTION ON, V9, P23, DOI 10.1007/s11864-008-0053-5; Willey A, 2014, DERMATOL SURG, V40, P1094, DOI 10.1097/01.DSS.0000452662.69539.57; Wong MLH, 2007, J CLIN NEUROSCI, V14, P301, DOI 10.1016/j.jocn.2006.11.005; Yemisci M, 2006, NEUROSURGERY, V59, P1296, DOI 10.1227/01.NEU.0000245607.99946.8F; Yordanova YN, 2011, J NEUROSURG, V115, P232, DOI 10.3171/2011.3.JNS101333; Zagorac D, 2008, J CEREBR BLOOD F MET, V28, P1431, DOI 10.1038/jcbfm.2008.31; Zgavc T, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-105; Zhang XF, 2014, LASER SURG MED, V46, P422, DOI 10.1002/lsm.22248	60	19	20	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0181654	10.1371/journal.pone.0181654	http://dx.doi.org/10.1371/journal.pone.0181654			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759636	Green Published, gold, Green Submitted			2022-12-26	WOS:000406761600021
J	Ford, TC; Nibbs, R; Crewther, DP				Ford, Talitha C.; Nibbs, Richard; Crewther, David P.			Glutamate/GABA plus ratio is associated with the psychosocial domain of autistic and schizotypal traits	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; GAMMA-AMINOBUTYRIC-ACID; FUNCTIONING AUTISM; ANTERIOR CINGULATE; SPECTRUM QUOTIENT; GLUTAMINE CYCLE; HUMAN BRAIN; SCHIZOPHRENIA; GABA; EXCITATION/INHIBITION	Background The autism and schizophrenia spectra overlap to a large degree in the social and interpersonal domains. Similarly, abnormal excitatory glutamate and inhibitory gamma-aminobutyric acid (GABA) neurotransmitter concentrations have been reported for both spectra, with the interplay of these neurotransmitters important for cortical excitation to inhibition regulation. This study investigates whether these neurotransmitter abnormalities are specific to the shared symptomatology, and whether the degree of abnormality increases with increasing symptom severity. Hence, the relationship between the glutamate/GABA ratio and autism and schizophrenia spectrum traits in an unmedicated, subclinical population was investigated. Methods A total of 37 adults (19 female, 18 male) aged 18-38 years completed the Autism Spectrum Quotient (AQ) and Schizotypal Personality Questionnaire (SPQ), and participated in the resting state proton magnetic resonance spectroscopy study in which sequences specific for quantification of glutamate and GABA+ concentration were applied to a right and left superior temporal voxel. Results There were significant, moderate, positive relationships between right superior temporal glutamate/GABA+ ratio and AQ, SPQ and AQ+ SPQ total scores (p<0.05), SPQ subscales Social Anxiety, No Close Friend, Constricted Affect, Odd Behaviour, Odd Speech, Ideas of Reference and Suspiciousness, and AQ subscales Social Skills, Communication and Attention Switching (p< 0.05); increased glutamate/GABA+ coinciding with higher scores on these subscales. Only the relationships between glutamate/GABA+ ratio and Social Anxiety, Constricted Affect, Social Skills and Communication survived multiple comparison correction (p< 0.004). Left superior temporal glutamate/GABA+ ratio reduced with increasing restricted imagination (p< 0.05). Conclusion These findings demonstrate evidence for an association between excitatory/inhibitory neurotransmitter concentrations and symptoms that are shared between the autism and schizophrenia spectra.	[Ford, Talitha C.; Crewther, David P.] Swinburne Univ Technol, Fac Heath Arts & Design, Ctr Human Psychopharmacol, Melbourne, Vic, Australia; [Nibbs, Richard] Swinburne Univ Technol, Swinburne Neuroimaging, Fac Heath Arts & Design, Melbourne, Vic, Australia	Swinburne University of Technology; Swinburne University of Technology	Ford, TC (corresponding author), Swinburne Univ Technol, Fac Heath Arts & Design, Ctr Human Psychopharmacol, Melbourne, Vic, Australia.	tcford@swin.edu.au	Ford, Talitha/H-6641-2019	Ford, Talitha/0000-0001-5400-2659	Swinburne University Neuroimaging Grant; The National Health and Medical Research Council of Australia [APP1004740]	Swinburne University Neuroimaging Grant; The National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Funding for this study was provided by a Swinburne University Neuroimaging Grant and The National Health and Medical Research Council of Australia, APP1004740.	ARTHUR W, 1994, EDUC PSYCHOL MEAS, V54, P394, DOI 10.1177/0013164494054002013; Bak LK, 2006, J NEUROCHEM, V98, P641, DOI 10.1111/j.1471-4159.2006.03913.x; Barneveld PS, 2011, SCHIZOPHR RES, V126, P231, DOI 10.1016/j.schres.2010.09.004; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Brix MK, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00365; Brown MS, 2013, AUTISM RES, V6, P1, DOI 10.1002/aur.1260; Cochran DM, 2015, J CHILD ADOL PSYCHOP, V25, P314, DOI 10.1089/cap.2014.0112; COOLIDGE FL, 1992, J PERS ASSESS, V59, P223, DOI 10.1207/s15327752jpa5902_1; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dinsdale NL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063316; Edden RAE, 2014, J MAGN RESON IMAGING, V40, P1445, DOI 10.1002/jmri.24478; Egerton A, 2012, NEUROPSYCHOPHARMACOL, V37, P2515, DOI 10.1038/npp.2012.113; EYSENCK SBG, 1985, PERS INDIV DIFFER, V6, P21, DOI 10.1016/0191-8869(85)90026-1; Ford TC, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00117; Ford TC, 2017, UNDER REV; Gaetz W, 2014, NEUROIMAGE, V86, P1, DOI 10.1016/j.neuroimage.2013.05.068; HAASE A, 1986, MAGNET RESON MED, V3, P963, DOI 10.1002/mrm.1910030619; Harada M, 2011, J AUTISM DEV DISORD, V41, P447, DOI 10.1007/s10803-010-1065-0; Harris AD, 2015, J MAGN RESON IMAGING, V42, P1431, DOI 10.1002/jmri.24903; Homayoun H, 2007, J NEUROSCI, V27, P11496, DOI 10.1523/JNEUROSCI.2213-07.2007; Horder J, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.53; Hurst RM, 2007, J AUTISM DEV DISORD, V37, P1711, DOI 10.1007/s10803-006-0302-z; Kanai C, 2011, RES AUTISM SPECT DIS, V5, P185, DOI 10.1016/j.rasd.2010.03.008; LeBlanc JJ, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/921680; Lindell AK, 2006, NEUROPSYCHOL REV, V16, P131, DOI 10.1007/s11065-006-9011-9; Lisman JE, 2008, TRENDS NEUROSCI, V31, P234, DOI 10.1016/j.tins.2008.02.005; Marsman A, 2014, NEUROIMAGE-CLIN, V6, P398, DOI 10.1016/j.nicl.2014.10.005; McKenna MC, 2007, J NEUROSCI RES, V85, P3347, DOI 10.1002/jnr.21444; Mescher M, 1996, J MAGN RESON SER A, V123, P226, DOI 10.1006/jmra.1996.0242; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Mullins PG, 2014, NEUROIMAGE, V86, P43, DOI 10.1016/j.neuroimage.2012.12.004; Near J, 2015, MAGN RESON MED, V73, P44, DOI 10.1002/mrm.25094; ObjectPlanet, 1998, OPINIO, V6, P8; Posse S, 2007, MAGN RESON MED, V58, P236, DOI 10.1002/mrm.21287; RAINE A, 1991, SCHIZOPHRENIA BULL, V17, P555, DOI 10.1093/schbul/17.4.555; Rojas DC, 2014, NEUROIMAGE, V86, P28, DOI 10.1016/j.neuroimage.2013.01.045; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Russell-Smith SN, 2011, PERS INDIV DIFFER, V51, P128, DOI 10.1016/j.paid.2011.03.027; Schubert F, 2004, NEUROIMAGE, V21, P1762, DOI 10.1016/j.neuroimage.2003.11.014; Spek AA, 2010, RES AUTISM SPECT DIS, V4, P709, DOI 10.1016/j.rasd.2010.01.009; Szulc A, 2005, PHARMACOPSYCHIATRY, V38, P214, DOI 10.1055/s-2005-873156; Theberge J, 2003, AM J PSYCHIAT, V160, P2231, DOI 10.1176/appi.ajp.160.12.2231; van Elst LT, 2014, MOL PSYCHIATR, V19, P1314, DOI 10.1038/mp.2014.62; Wakabayashi A, 2012, RES AUTISM SPECT DIS, V6, P717, DOI 10.1016/j.rasd.2011.09.008; Wilson M, 2011, MAGN RESON MED, V65, P1, DOI 10.1002/mrm.22579; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360	46	22	22	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0181961	10.1371/journal.pone.0181961	http://dx.doi.org/10.1371/journal.pone.0181961			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC3TH	28759626	Green Published, Green Submitted, gold			2022-12-26	WOS:000406761600040
J	Guillot, X; Martin, H; Seguin-Py, S; Maguin-Gate, K; Moretto, J; Totoson, P; Wendling, D; Demougeot, C; Tordi, N				Guillot, Xavier; Martin, Helene; Seguin-Py, Stephanie; Maguin-Gate, Katy; Moretto, Johnny; Totoson, Perle; Wendling, Daniel; Demougeot, Celine; Tordi, Nicolas			Local cryotherapy improves adjuvant-induced arthritis through down-regulation of IL-6/IL-17 pathway but independently of TNF alpha	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; NF-KAPPA-B; RHEUMATOID-ARTHRITIS; INFLAMMATORY RESPONSE; SYNOVIAL INFLAMMATION; ARTICULAR-CARTILAGE; JOINT INFLAMMATION; MESSENGER-RNA; LYMPH-NODES; IN-VIVO	Objectives Local cryotherapy is widely and empirically used in the adjuvant setting in rheumatoid arthritis treatment, however its own therapeutic and anti-inflammatory effects are poorly characterized. We aimed to evaluate the effects of local cryotherapy on local and systemic inflammation in Adjuvant-induced arthritis, a murine model of rheumatoid arthritis. Methods The effects of mild hypothermia (30 degrees C for 2 hours) on cytokine protein levels (Multiplex/ELISA) were evaluated in vitro in cultured rat adjuvant-induced arthritis patellae. In vivo, local cryotherapy was applied twice a day for 14 days in arthritic rats (ice: n = 10, cold gas: n = 9, non-treated: n = 10). At day 24 after the induction of arthritis, cytokine expression levels were measured in grinded hind paws (Q-RT-PCR) and in the plasma (Multiplex/ELISA). Results In vitro, punctual mild hypothermia down-regulated IL-6 protein expression. In vivo, ice showed a better efficacy profile on the arthritis score and joint swelling and was better tolerated, while cold gas induced a biphasic response profile with initial, transient arthritis worsening. Local cryotherapy also exerted local and systemic anti-inflammatory effects, both at the gene and the protein levels: IL- 6, IL-17A and IL-1 beta gene expression levels were significantly down-regulated in hind paws. Both techniques decreased plasma IL-17A while ice decreased plasma IL- 6 protein levels. By contrast, we observed no effect on local/systemic TNF-alpha pathway. Conclusions We demonstrated for the first time that sub-chronically applied local cryotherapy (ice and cold gas) is an effective and well-tolerated treatment in adjuvant-induced arthritis. Furthermore, we provided novel insights into the cytokine pathways involved in Local cryotherapy's local and systemic anti-inflammatory effects, which were mainly IL-6/IL-17A-driven and TNF-alpha independent in this model.	[Guillot, Xavier; Martin, Helene; Maguin-Gate, Katy; Moretto, Johnny; Totoson, Perle; Demougeot, Celine; Tordi, Nicolas] Univ Bourgogne Franche Comte, PEPITE EA4267, FHU INCREASE, Besancon, France; [Guillot, Xavier; Wendling, Daniel] CHRU Besancon, Serv Rhumatol, Besancon, France; [Seguin-Py, Stephanie] FHU INCREASE, INSERM CIC 1431, Besancon, France; [Wendling, Daniel] Univ Bourgogne Franche Comte, EA 4266, Besancon, France	Universite de Franche-Comte; CHU Besancon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Guillot, X (corresponding author), Univ Bourgogne Franche Comte, PEPITE EA4267, FHU INCREASE, Besancon, France.; Guillot, X (corresponding author), CHRU Besancon, Serv Rhumatol, Besancon, France.	xguillot@chu-besancon.fr	; Tordi, Nicolas/K-2137-2017	MARTIN, helene/0000-0001-8318-3858; Demougeot, Celine/0000-0003-0639-9756; GUILLOT, Xavier/0000-0002-1217-7351; Tordi, Nicolas/0000-0002-8459-9465; Totoson, Perle/0000-0002-5012-4330				Anderson GD, 1996, J CLIN INVEST, V97, P2672, DOI 10.1172/JCI118717; Ayer LM, 2000, INFLAMMATION, V24, P447, DOI 10.1023/A:1007064212462; Banfi G, 2010, SPORTS MED, V40, P509, DOI 10.2165/11531940-000000000-00000; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bolon B, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/569068; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Chatap G, 2007, JOINT BONE SPINE, V74, P617, DOI 10.1016/j.jbspin.2006.10.011; de Punder YMR, 2011, NAT REV RHEUMATOL, V7, P261, DOI 10.1038/nrrheum.2011.49; Diestel A, 2008, CRYOBIOLOGY, V57, P216, DOI 10.1016/j.cryobiol.2008.08.005; Dugue B, 2005, SCAND J CLIN LAB INV, V65, P395, DOI 10.1080/00365510510025728; Earp JC, 2008, J PHARMACOL EXP THER, V326, P532, DOI 10.1124/jpet.108.137372; Fujimoto K, 2008, PANCREAS, V37, P176, DOI 10.1097/MPA.0b013e318162cb26; Gibbons H, 2003, MOL BRAIN RES, V110, P63, DOI 10.1016/S0169-328X(02)00585-5; Guillot X, 2016, ANN RHEUM DIS, V75, P896, DOI 10.1136/annrheumdis-2016-eular.1699; Guillot X, 2016, JT BONE SPINE REV RH; Guillot X, 2014, EXPERT REV CLIN IMMU, V10, P281, DOI 10.1586/1744666X.2014.870036; Gundersen Y, 2001, ACTA ANAESTH SCAND, V45, P994, DOI 10.1034/j.1399-6576.2001.450812.x; HARRIS ED, 1974, NEW ENGL J MED, V290, P1, DOI 10.1056/NEJM197401032900101; Hildebrand F, 2005, CYTOKINE, V31, P382, DOI 10.1016/j.cyto.2005.06.008; Hu W, 2012, INFLAMM RES, V61, P827, DOI 10.1007/s00011-012-0477-z; Huizinga TWJ, 2015, ANN RHEUM DIS, V74, P35, DOI 10.1136/annrheumdis-2014-205752; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Leppaluoto J, 2008, SCAND J CLIN LAB INV, V68, P145, DOI 10.1080/00365510701516350; Lloyd M., HUMANE ENDPOINT ANIM, V43, P1300; Lubahn CL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00346; Lubberts E, 2000, ARTHRITIS RHEUM-US, V43, P1300, DOI 10.1002/1529-0131(200006)43:6<1300::AID-ANR12>3.0.CO;2-D; Lubberts E, 2001, J IMMUNOL, V167, P1004, DOI 10.4049/jimmunol.167.2.1004; Lubberts E, 1998, CYTOKINE, V10, P361, DOI 10.1006/cyto.1997.0298; Lubberts E, 2015, NAT REV RHEUMATOL, V11, P415, DOI 10.1038/nrrheum.2015.53; Lubberts E, 2010, SEMIN IMMUNOPATHOL, V32, P43, DOI 10.1007/s00281-009-0189-9; Luo JG, 2014, ARTHRITIS RHEUMATOL, V66, P896, DOI 10.1002/art.38328; Lupa A, 2013, RHEUMATOLINT, V33, P2053; Matsui T, 2015, NEUROCRIT CARE, V23, P116, DOI 10.1007/s12028-014-0094-5; Oliver SJ, 1996, J RHEUMATOL, V23, P56; OOSTERVELD FGJ, 1994, ARTHRITIS RHEUM, V37, P1578, DOI 10.1002/art.1780371104; Paquet J, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3774; Paulissen SMJ, 2013, J IMMUNOL, V191, P1364, DOI 10.4049/jimmunol.1300274; Portanova JP, 1996, J EXP MED, V184, P883, DOI 10.1084/jem.184.3.883; Pournot H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022748; Rioja I, 2004, CLIN EXP IMMUNOL, V137, P65, DOI 10.1111/j.1365-2249.2004.02499.x; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Schmidt-Weber CB, 1999, CELL IMMUNOL, V195, P53, DOI 10.1006/cimm.1999.1509; Snekhalatha U, 2013, Z RHEUMATOL, V72, P375, DOI 10.1007/s00393-012-1083-8; Straub RH, 2009, ANN RHEUM DIS, V68, P572, DOI 10.1136/ard.2008.089458; Tortorici MA, 2009, CRIT CARE MED, V37, P263, DOI 10.1097/CCM.0b013e3181931ed3; Truettner JS, 2005, J CEREBR BLOOD F MET, V25, P1505, DOI 10.1038/sj.jcbfm.9600150; van Hamburg JP, 2012, ANN RHEUM DIS, V71, P606, DOI 10.1136/annrheumdis-2011-200424; van Hamburg JP, 2009, ARTHRITIS RHEUM-US, V60, P750, DOI 10.1002/art.24329; VANDENBERG WB, 1982, RHEUMATOL INT, V1, P165, DOI 10.1007/BF00541171; WAKIM K G, 1951, Arch Phys Med Rehabil, V32, P714; Webster CM, 2009, NEUROBIOL DIS, V33, P301, DOI 10.1016/j.nbd.2008.11.001; Weinberger Abraham, 1995, Arthritis and Rheumatism, V38, pS242; Welch V, 2001, COCHRANE DB SYST REV; Wojtecka- Lukasic E, 2002, ANN RHEUM DIS S, V61; Wright HL, 2015, RHEUMATOLOGY, V54, P188, DOI 10.1093/rheumatology/keu299; Yenari MA, 2006, NEUROCHEM INT, V49, P164, DOI 10.1016/j.neuint.2006.03.016; Zampeli E, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3757	58	14	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0178668	10.1371/journal.pone.0178668	http://dx.doi.org/10.1371/journal.pone.0178668			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759646	Green Submitted, gold, Green Published			2022-12-26	WOS:000406761600003
J	Rius, B; Duran-Guell, M; Flores-Costa, R; Lopez-Vicario, C; Lopategi, A; Alcaraz-Quiles, J; Casulleras, M; Lozano, JJ; Titos, E; Claria, J				Rius, Bibiana; Duran-Guell, Marta; Flores-Costa, Roger; Lopez-Vicario, Cristina; Lopategi, Aritz; Alcaraz-Quiles, Jose; Casulleras, Mireia; Jose Lozano, Juan; Titos, Esther; Claria, Joan			The specialized proresolving lipid mediator maresin 1 protects hepatocytes from lipotoxic and hypoxia-induced endoplasmic reticulum stress	FASEB JOURNAL			English	Article						NAFLD; UPR; miRNA; liver cells	FATTY LIVER; CELL-DEATH; ER STRESS; ACUTE-INFLAMMATION; ADIPOSE-TISSUE; RESOLVIN D1; RESOLUTION; DISEASE; ROLES; AUTOPHAGY	Endoplasmic reticulum(ER) stress and activation of the unfolded protein response (UPR) are hallmarks of nonalcoholic fatty liver disease (NAFLD), which is the hepatic manifestation of the metabolic syndrome associated with obesity. The specialized proresolving lipid mediator maresin 1 (MaR1) preserves tissue homeostasis by exerting cytoprotective actions, dampening inflammation, and expediting its timely resolution. Here, we explored whether MaR1 protects liver cells from lipotoxic and hypoxia-induced ER stress. Mice were rendered obese by high fat diet feeding, and experiments were performed in primary hepatocytes, Kupffer cells, and precision-cut liver slices (PCLSs). Palmitate-induced lipotoxicity increased ER stress and altered autophagy in hepatocytes, effects that were prevented by MaR1. MaR1 protected hepatocytes against lipotoxicity-induced apoptosis by activating the UPR prosurvival mechanisms and preventing the excessive up-regulation of proapoptotic pathways. Protective MaR1 effects were also seen in hepatocytes challenged with hypoxia and TNF-alpha-induced cell death. High-throughput microRNA (miRNA) sequencing revealed that MaR1 actions were associated with specific miRNA signatures targeting both protein folding and apoptosis. MaR1 also prevented lipotoxic-triggered ER stress and hypoxia-induced inflammation in PCLSs and enhanced Kupffer cell phagocytic capacity. Together, these findings describe the ability of MaR1 to oppose ER stress in liver cells under conditions frequently encountered in NAFLD.	[Rius, Bibiana; Duran-Guell, Marta; Flores-Costa, Roger; Lopez-Vicario, Cristina; Lopategi, Aritz; Alcaraz-Quiles, Jose; Casulleras, Mireia; Titos, Esther; Claria, Joan] IDIBAPS, Hosp Clin, Dept Biochem & Mol Genet, Barcelona, Spain; [Lopez-Vicario, Cristina; Jose Lozano, Juan; Titos, Esther; Claria, Joan] CIBERehd, Barcelona, Spain; [Claria, Joan] European Fdn Study Chron Liver Failure EF CLIF, Barcelona, Spain; [Claria, Joan] Univ Barcelona, Dept Biomed Sci, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona	Claria, J (corresponding author), Hosp Clin Barcelona, Dept Biochem & Mol Genet, Villarroel 170, E-08036 Barcelona, Spain.	jclaria@clinic.ub.es	Claria, Joan/M-7772-2019; Titos, Esther/AAA-5394-2019	Titos, Esther/0000-0002-2543-2243; Duran, Marta/0000-0002-3265-395X; Lopez-Vicario, Cristina/0000-0002-6609-8501; Lozano, Juan Jose/0000-0001-7613-3908; Casulleras, Mireia/0000-0002-2899-5826	Spanish Ministerio de Economia y Competitividad (MEC) under European Regional Development Funds [SAF15-63674-R, PIE14/00045]; Instituto de Salud Carlos III; MEC [BES-2013-063705]; Agaur/BFU (FI-DGR); Marie Curie Action	Spanish Ministerio de Economia y Competitividad (MEC) under European Regional Development Funds; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); MEC(European Commission); Agaur/BFU (FI-DGR); Marie Curie Action(European Commission)	The authors thank Ana Isabel Martinez-Puchol [Institut d'Investigacions Biomediques, August Pi i Sunyer (IDIBAPS)] for technical assistance. This work was supported by grants from the Spanish Ministerio de Economia y Competitividad (MEC) (SAF15-63674-R and PIE14/00045) under European Regional Development Funds. CIBERehd is funded by the Instituto de Salud Carlos III. This study was carried out at the Center Esther Koplowitz (IDIBAPs), which is a member of the Centres de Recerca de Catalunya (CERCA) Programme/Generalitat de Catalunya. B.R. is a recipient of a MEC fellowship (BES-2013-063705). J.A.-Q. is a recipient of an Agaur/BFU fellowship (FI-DGR 2015). A.L. was funded by a Marie Curie Action. The authors declare no conflicts of interest.	Abdulnour REE, 2014, P NATL ACAD SCI USA, V111, P16526, DOI 10.1073/pnas.1407123111; Airley RE, 2003, INT J CANCER, V104, P85, DOI 10.1002/ijc.10904; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Boden Guenther, 1998, Frontiers in Bioscience, V3, pD169; Borgeson E, 2015, CELL METAB, V22, P125, DOI 10.1016/j.cmet.2015.05.003; Buckley CD, 2013, NAT REV IMMUNOL, V13, P59, DOI 10.1038/nri3362; Carabelli J, 2011, J CELL MOL MED, V15, P1329, DOI 10.1111/j.1582-4934.2010.01128.x; Dalli J, 2013, FASEB J, V27, P2573, DOI 10.1096/fj.13-227728; Dalli J, 2013, CHEM BIOL, V20, P188, DOI 10.1016/j.chembiol.2012.11.010; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gidalevitz T, 2013, BBA-MOL CELL RES, V1833, P2410, DOI 10.1016/j.bbamcr.2013.03.007; Grootjans J, 2016, NAT REV IMMUNOL, V16, P469, DOI 10.1038/nri.2016.62; Han J, 2013, DIABETOLOGIA, V56, P911, DOI 10.1007/s00125-012-2809-5; Han J, 2016, J LIPID RES, V57, P1329, DOI 10.1194/jlr.R067595; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Jewell UR, 2001, FASEB J, V15, P1312, DOI 10.1096/fj.00-0732fje; Jungermann K, 2000, HEPATOLOGY, V31, P255, DOI 10.1002/hep.510310201; Kaluz S, 2009, BBA-REV CANCER, V1795, P162, DOI 10.1016/j.bbcan.2009.01.001; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Klassen LW, 2008, BIOCHEM PHARMACOL, V76, P426, DOI 10.1016/j.bcp.2008.05.012; Li J, 2008, CELL DEATH DIFFER, V15, P1460, DOI 10.1038/cdd.2008.81; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lopez-Vicario C, 2015, P NATL ACAD SCI USA, V112, P536, DOI 10.1073/pnas.1422590112; Lopez-Vicario C, 2014, GUT, V63, P344, DOI 10.1136/gutjnl-2012-303179; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Mantena SK, 2009, BIOCHEM J, V417, P183, DOI 10.1042/BJ20080868; Marcon R, 2013, J IMMUNOL, V191, P4288, DOI 10.4049/jimmunol.1202743; Muller S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/948408; Nath B, 2012, HEPATOLOGY, V55, P622, DOI 10.1002/hep.25497; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Pastorekova S, 2006, ADV CLIN CHEM, V42, P167, DOI 10.1016/S0065-2423(06)42005-9; Pfaffenbach KT, 2010, AM J PHYSIOL-ENDOC M, V298, pE1027, DOI 10.1152/ajpendo.00642.2009; Recchiuti A, 2011, FASEB J, V25, P544, DOI 10.1096/fj.10-169599; Rius B, 2014, FASEB J, V28, P836, DOI 10.1096/fj.13-235614; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rubinstein AD, 2011, MOL CELL, V44, P698, DOI 10.1016/j.molcel.2011.10.014; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Sanyal AJ, 2005, NAT CLIN PRACT GASTR, V2, P46, DOI 10.1038/ncpgasthep0084; Savransky V, 2007, HEPATOLOGY, V45, P1007, DOI 10.1002/hep.21593; Serhan CN, 2015, SEMIN IMMUNOL, V27, P200, DOI 10.1016/j.smim.2015.03.004; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2012, FASEB J, V26, P1755, DOI 10.1096/fj.11-201442; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Spite M, 2014, CELL METAB, V19, P21, DOI 10.1016/j.cmet.2013.10.006; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Trauner M, 2010, BBA-MOL CELL BIOL L, V1801, P299, DOI 10.1016/j.bbalip.2009.10.007; Upton JP, 2012, SCIENCE, V338, P818, DOI 10.1126/science.1226191; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wenger RH, 1997, KIDNEY INT, V51, P560, DOI 10.1038/ki.1997.79; Willy JA, 2015, MOL BIOL CELL, V26, P2190, DOI 10.1091/mbc.E15-01-0036; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yang Z., 2014, PLOS ONE, V9, P1, DOI [10.1371/journal.pone.011598925551561, DOI 10.1371/JOURNAL.PONE.011598925551561, DOI 10.1371/J0URNAL.P0NE.0115989]	60	40	41	3	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5384	+		10.1096/fj.201700394R	http://dx.doi.org/10.1096/fj.201700394R			25	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28768719	Green Submitted			2022-12-26	WOS:000416588300022
J	Bush, KT; Wu, W; Lun, C; Nigam, SK				Bush, Kevin T.; Wu, Wei; Lun, Christina; Nigam, Sanjay K.			The drug transporter OAT3 (SLC22A8) and endogenous metabolite communication via the gut-liver-kidney axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGANIC ANION TRANSPORTER; BASOLATERAL MEMBRANE-VESICLES; KNOCKOUT MICE; OLFACTORY MUCOSA; SYSTEMS BIOLOGY; FAMILY-MEMBERS; CHOROID-PLEXUS; UREMIC TOXINS; URIC-ACID; METABOLOMICS	The organic anion transporters OAT1 (SLC22A6) and OAT3 (SLC22A8) have similar substrate specificity for drugs, but it is far from clear whether this holds for endogenous substrates. By analysis of more than 600 metabolites in the Oat3KO (Oat3 knockout) by LC/MS, we demonstrateOAT3involvement in the movement of gut microbiome products, key metabolites, and signaling molecules, including those flowing through the gutliver-kidney axis. Major pathways affected included those involved in metabolism of bile acids, flavonoids, nutrients, amino acids (including tryptophan-derivatives that are uremic toxins), and lipids. OAT3 is also critical in elimination of liverderived phase II metabolites, particularly those undergoing glucuronidation. Analysis of physicochemical features revealed nine distinct metabolite groups; at least one member of most clusters has been previously validated in transport assays. In contrast to drugs interacting with the OATs, endogenous metabolites accumulating in the Oat1KO (Oat1 knockout) versus Oat3KO have distinct differences in their physicochemical properties; they are very different in size, number of rings, hydrophobicity, and molecular complexity. Consistent with the Remote Sensing and Signaling Hypothesis, the data support the importance of the OAT transporters in inter-organ and interorganismal remote communication via transporter-mediated movement of key metabolites and signaling molecules (e. g. gut microbiome-to-intestine-to-blood-to-liver-to-kidney-tourine). We discuss the possibility of an intimate connection between OATs and metabolite sensing and signaling pathways (e. g. bile acids). Furthermore, the metabolomics and pathway analysis support the view that OAT1 plays a greater role in kidney proximal tubule metabolism and OAT3 appears relatively more important in systemic metabolism, modulating levels of metabolites flowing through intestine, liver, and kidney.	[Bush, Kevin T.; Nigam, Sanjay K.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Wu, Wei] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Lun, Christina] Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Nigam, SK (corresponding author), Univ Calif San Diego, 9500 Gilman Dr MC0693, La Jolla, CA 92093 USA.	snigam@ucsd.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090259, P50HD090259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK109392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098449, R01GM104098] Funding Source: NIH RePORTER; NICHD NIH HHS [P50 HD090259, U54 HD090259] Funding Source: Medline; NIDDK NIH HHS [R01 DK109392] Funding Source: Medline; NIGMS NIH HHS [R01 GM104098, R01 GM098449] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn SY, 2011, J BIOL CHEM, V286, P31522, DOI 10.1074/jbc.M111.272534; Ahn SY, 2009, J BIOL CHEM, V284, P31422, DOI 10.1074/jbc.M109.024489; Ahn SY, 2009, MOL PHARMACOL, V76, P481, DOI 10.1124/mol.109.056564; Badawy AAB, 2017, INT J TRYPTOPHAN RES, V10, DOI 10.1177/1178646917691938; Badenhorst CPS, 2014, DRUG METAB REV, V46, P343, DOI 10.3109/03602532.2014.908903; Beebe K., 2016, METABOLON; BENDER DA, 1983, MOL ASPECTS MED, V6, P101, DOI 10.1016/0098-2997(83)90005-5; Bhatnagar V, 2016, CLIN KIDNEY J, V9, P444, DOI 10.1093/ckj/sfw010; Brady KP, 1999, GENOMICS, V56, P254, DOI 10.1006/geno.1998.5722; Chen J, 2008, AM J PHYSIOL-RENAL, V295, pF247, DOI 10.1152/ajprenal.00139.2008; Chiang JYL, 2013, COMPR PHYSIOL, V3, P1191, DOI 10.1002/cphy.c120023; Chu L, 2015, INT UROL NEPHROL, V47, P345, DOI 10.1007/s11255-014-0901-0; Deng HY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00373; Eraly SA, 2006, J BIOL CHEM, V281, P5072, DOI 10.1074/jbc.M508050200; Eraly SA, 2004, PHYSIOL GENOMICS, V18, P12, DOI 10.1152/physiolgenomics.00014.2004; Eraly SA, 2008, PHYSIOL GENOMICS, V33, P180, DOI 10.1152/physiolgenomics.00207.2007; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Flydal MI, 2013, IUBMB LIFE, V65, P341, DOI 10.1002/iub.1150; Food and Drug Administration Guidance for Industry, 2012, STUD DES DAT AN IMPL; Gallegos TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040796; GIBSON DT, 1968, SCIENCE, V161, P1093, DOI 10.1126/science.161.3846.1093; Guo C, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00646; Husted AS, 2017, CELL METAB, V25, P777, DOI 10.1016/j.cmet.2017.03.008; Jimenez F, 2002, DIGEST DIS SCI, V47, P2398, DOI 10.1023/A:1020575001944; Kaler G, 2007, J BIOL CHEM, V282, P23841, DOI 10.1074/jbc.M703467200; Kaler G, 2006, BIOCHEM BIOPH RES CO, V351, P872, DOI 10.1016/j.bbrc.2006.10.136; Keszthelyi D, 2009, NEUROGASTROENT MOTIL, V21, P1239, DOI 10.1111/j.1365-2982.2009.01370.x; Konishi Y, 2004, J AGR FOOD CHEM, V52, P6418, DOI 10.1021/jf049560y; Legette LL, 2014, J AGR FOOD CHEM, V62, P1294, DOI 10.1021/jf400097m; Lennerz BS, 2015, MOL GENET METAB, V114, P73, DOI 10.1016/j.ymgme.2014.11.010; Liu HC, 2016, J PHARMACOL EXP THER, V359, P215, DOI 10.1124/jpet.116.232660; Liu HC, 2016, J BIOL CHEM, V291, P19474, DOI 10.1074/jbc.M116.745216; LopezNieto CE, 1996, NAT BIOTECHNOL, V14, P857, DOI 10.1038/nbt0796-857; LopezNieto CE, 1997, J BIOL CHEM, V272, P6471, DOI 10.1074/jbc.272.10.6471; LopezNieto CE, 1996, J AM SOC NEPHROL, V7, pA0277; Mackenzie AE, 2017, NEUROPHARMACOLOGY, V113, P661, DOI 10.1016/j.neuropharm.2015.07.035; Martinot E, 2017, MOL ASPECTS MED, V56, P2, DOI 10.1016/j.mam.2017.01.006; Martovetsky G, 2016, DRUG METAB DISPOS, V44, P1050, DOI 10.1124/dmd.115.068254; Martovetsky G, 2013, MOL PHARMACOL, V84, P808, DOI 10.1124/mol.113.088229; Mazerska Z, 2016, PHARMACOL THERAPEUT, V159, P35, DOI 10.1016/j.pharmthera.2016.01.009; Monte JC, 2004, BIOCHEM BIOPH RES CO, V323, P429, DOI 10.1016/j.bbrc.2004.08.112; Nagle MA, 2013, NEUROSCI LETT, V534, P133, DOI 10.1016/j.neulet.2012.11.027; Nagle MA, 2011, J BIOL CHEM, V286, P243, DOI 10.1074/jbc.M110.139949; Namkung J, 2015, MOL CELLS, V38, P1023, DOI 10.14348/molcells.2015.0258; Ney DM, 2014, CURR OPIN CLIN NUTR, V17, P61, DOI 10.1097/MCO.0000000000000002; Nicholson JK, 2003, NAT REV DRUG DISCOV, V2, P668, DOI 10.1038/nrd1157; Nigam SK, 2015, CLIN J AM SOC NEPHRO, V10, P2039, DOI 10.2215/CJN.02440314; Nigam SK, 2015, PHYSIOL REV, V95, P83, DOI 10.1152/physrev.00025.2013; Nigam SK, 2015, NAT REV DRUG DISCOV, V14, P29, DOI 10.1038/nrd4461; Ohta T, 2009, TOXICOL PATHOL, V37, P521, DOI 10.1177/0192623309336152; Pavlova A, 2000, AM J PHYSIOL-RENAL, V278, pF635, DOI 10.1152/ajprenal.2000.278.4.F635; Peters J C, 1991, Adv Exp Med Biol, V294, P345; Prentice KJ, 2014, CELL METAB, V19, P653, DOI 10.1016/j.cmet.2014.03.008; PRITCHARD JB, 1995, J PHARMACOL EXP THER, V274, P1278; PRITCHARD JB, 1988, AM J PHYSIOL, V255, pF597, DOI 10.1152/ajprenal.1988.255.4.F597; Rechner AR, 2002, FREE RADICAL BIO MED, V33, P220, DOI 10.1016/S0891-5849(02)00877-8; Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057; Sahu M., 2013, COMP ENG INTELL SYST, V4, P22; Saito H, 2010, PHARMACOL THERAPEUT, V125, P79, DOI 10.1016/j.pharmthera.2009.09.008; Sharma K, 2013, J AM SOC NEPHROL, V24, P1901, DOI 10.1681/ASN.2013020126; SHIMADA H, 1987, AM J PHYSIOL, V253, pF795, DOI 10.1152/ajprenal.1987.253.5.F795; Sweeney DE, 2011, MOL PHARMACOL, V80, P147, DOI 10.1124/mol.110.070680; Sweet DH, 2002, J BIOL CHEM, V277, P26934, DOI 10.1074/jbc.M203803200; Tan JK, 2017, ANNU REV IMMUNOL, V35, P371, DOI 10.1146/annurev-immunol-051116-052235; Thorburn AN, 2014, IMMUNITY, V40, P833, DOI 10.1016/j.immuni.2014.05.014; Torres AM, 2011, J BIOL CHEM, V286, P26391, DOI 10.1074/jbc.M111.249292; Truong DM, 2008, J BIOL CHEM, V283, P8654, DOI 10.1074/jbc.M708615200; Vallon V, 2008, J AM SOC NEPHROL, V19, P1732, DOI 10.1681/ASN.2008020180; Vallon V, 2008, AM J PHYSIOL-RENAL, V294, pF867, DOI 10.1152/ajprenal.00528.2007; Vallon V, 2012, AM J PHYSIOL-RENAL, V302, pF1293, DOI 10.1152/ajprenal.00013.2012; VANBERGEHENEGOUWEN GP, 1976, GUT, V17, P861, DOI 10.1136/gut.17.11.861; VanWert AL, 2008, PHARM RES-DORDR, V25, P453, DOI 10.1007/s11095-007-9407-0; VanWert AL, 2008, MOL PHARMACOL, V74, P122, DOI 10.1124/mol.107.042853; VanWert AL, 2007, AM J PHYSIOL-RENAL, V293, pF1332, DOI 10.1152/ajprenal.00319.2007; VanWert AL, 2010, BIOPHARM DRUG DISPOS, V31, P1, DOI 10.1002/bdd.693; Wikoff WR, 2011, J PROTEOME RES, V10, P2842, DOI 10.1021/pr200093w; Wolman AT, 2013, DRUG METAB DISPOS, V41, P791, DOI 10.1124/dmd.112.049569; Wu W, 2015, DRUG METAB DISPOS, V43, P1855, DOI 10.1124/dmd.115.065250; Wu W, 2013, DRUG METAB DISPOS, V41, P1825, DOI 10.1124/dmd.113.052647; Wu W, 2011, MOL PHARMACOL, V79, P795, DOI 10.1124/mol.110.070607; Wu W, 2009, PHYSIOL GENOMICS, V38, P116, DOI 10.1152/physiolgenomics.90309.2008; WU WT, 2017, SCI REP, V7; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; You G, 2014, WILEY SER DRUG DISC, P1, DOI 10.1002/9781118705308; Zhu C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140569	85	62	62	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15789	15803		10.1074/jbc.M117.796516	http://dx.doi.org/10.1074/jbc.M117.796516			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28765282	hybrid, Green Published			2022-12-26	WOS:000411512200017
J	Li, Q; Zhang, ZH; Xie, B; Ji, XW; Lu, JH; Jiang, RL; Lei, S; Mao, SH; Ying, LJ; Lu, D; Si, XS; Ji, MX; He, JX; Chen, MY; Zheng, WJ; Wang, J; Huang, J; Wang, JF; Ji, YL; Chen, GD; Zhu, JH; Shao, YD; Lin, RH; Zhang, C; Zhang, WW; Luo, J; Lou, TZ; He, XW; Chen, K; Peng, W; Sun, RH				Li, Qian; Zhang, Zhongheng; Xie, Bo; Ji, Xiaowei; Lu, Jiahong; Jiang, Ronglin; Lei, Shu; Mao, Shihao; Ying, Lijun; Lu, Di; Si, Xiaoshui; Ji, Mingxia; He, Jianxing; Chen, Mengyan; Zheng, Wenjuan; Wang, Jiao; Huang, Jing; Wang, Junfeng; Ji, Yaling; Chen, Guodong; Zhu, Jianhua; Shao, Yadi; Lin, Ronghai; Zhang, Chao; Zhang, Weiwen; Luo, Jian; Lou, Tianzheng; He, Xuwei; Chen, Kun; Peng, Wei; Sun, Renhua			Effectiveness of enteral feeding protocol on clinical outcomes in critically ill patients: A before and after study	PLOS ONE			English	Article							BIG DATA; PARENTERAL-NUTRITION; MULTICENTER; METAANALYSIS; VOLUME; ROUTE; RISK	Background and objective Enteral nutrition (EN) feeding protocol was proposed to have positive impact on critically ill patients. However, current studies showed conflicting results. The present study aimed to investigate whether enteral feeding protocol was able to improve clinical outcomes in critically ill patients. Methods A before (stage 1) and after (stage 2) interventional study was performed in 10 tertiary care hospitals. All patients expected to stay in the intensive care unit (ICU) for over three days were potentially eligible. Clinical outcomes such as 28-day mortality, ICU length of stay, duration of mechanical ventilation (MV), and nosocomial infection were compared between the two stages. Main results A total of 410 patients were enrolled during the study period, including 236 in stage 1 and 174 in stage 2. EN feeding protocol was able to increase the proportion of EN in day 2 (41.8 +/- 22.3 vs. 50.0 +/- 28.3%; p = 0.006) and day 6 (70.3 +/- 25.2 vs. 77.6 +/- 25.8%; p = 0.006). EN percentages tended to be higher in stage 1 than that in stage 2 on other days, but statistical significance was not reached. There was no difference in 28-day mortality between stage 1 and 2 (0.14 vs. 0.14; p = 0.984). Implementation of EN feeding protocol marginally reduced ICU length of stay (19.44 +/- 18.48 vs. 16.29 +/- 16.19 days; p = 0.077). There was no difference in the duration of MV between stage a and stage 2 (14.24 +/- 14.49 vs. 14.51 +/- 17.55 days; p = 0.877). Conclusions The study found that the EN feeding protocol was able to increase the proportion of EN feeding, but failed to reduce 28-day mortality, incidence of nosocomial infection or duration of MV.	[Li, Qian; Sun, Renhua] Zhejiang Prov Peoples Hosp, Dept Crit Care Med, Hangzhou, Zhejiang, Peoples R China; [Zhang, Zhongheng] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Emergency Med, Hangzhou, Zhejiang, Peoples R China; [Xie, Bo; Ji, Xiaowei; Lu, Jiahong] Huzhou Cent Hosp, Dept Crit Care Med, Huzhou, Zhejiang, Peoples R China; [Jiang, Ronglin; Lei, Shu; Mao, Shihao] Zhejiang Prov Hosp TCM, Dept Crit Care Med, Hangzhou, Zhejiang, Peoples R China; [Ying, Lijun; Lu, Di] Shaoxing Peoples Hosp, Dept Crit Care Med, Shaoxing, Zhejiang, Peoples R China; [Si, Xiaoshui; Ji, Mingxia; He, Jianxing; Chen, Mengyan; Zheng, Wenjuan; Wang, Jiao; Huang, Jing; Wang, Junfeng; Ji, Yaling] YiWu Cent Hosp, Dept Crit Care Med, Jinhua, Zhejiang, Peoples R China; [Chen, Guodong; Zhu, Jianhua; Shao, Yadi] NingBo First Hosp, Dept Crit Care Med, Ningbo, Zhejiang, Peoples R China; [Lin, Ronghai; Zhang, Chao] TaiZhou Hosp, Dept Crit Care Med, Taizhou, Zhejiang, Peoples R China; [Zhang, Weiwen; Luo, Jian] QuZhou Peoples Hosp, Dept Crit Care Med, Quzhou, Zhejiang, Peoples R China; [Lou, Tianzheng; He, Xuwei] LiShui Peoples Hosp, Dept Crit Care Med, Lishui, Zhejiang, Peoples R China; [Chen, Kun; Peng, Wei] Zhejiang Univ, Jinhua Hosp, Jinhua Municipal Cent Hosp, Dept Crit Care Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang Provincial People's Hospital; Zhejiang University; Huzhou University; Zhejiang Chinese Medical University; Zhejiang University	Sun, RH (corresponding author), Zhejiang Prov Peoples Hosp, Dept Crit Care Med, Hangzhou, Zhejiang, Peoples R China.	zjpphicu@126.com	zhang, zh/GWV-4677-2022; Zhang, Zhongheng/E-1282-2011	Zhang, Zhongheng/0000-0002-2336-5323; Li, Qian/0000-0001-7311-105X				Al-Dorzi HM, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1539-3; Arabi YM, 2011, AM J CLIN NUTR, V93, P569, DOI 10.3945/ajcn.110.005074; Compton F, 2014, AM J CRIT CARE, V23, P396, DOI 10.4037/ajcc2014140; Ventura AMC, 2015, NUTR CLIN PRACT, V30, P351, DOI 10.1177/0884533614547765; Cunningham CA, 2017, JPEN J PARENTER ENTE, V170; Declercq B, 2016, ANAESTH INTENS CARE, V44, P93, DOI 10.1177/0310057X1604400114; Desachy A, 2008, INTENS CARE MED, V34, P1054, DOI 10.1007/s00134-007-0983-6; Elke G, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1298-1; Franzosi OS, 2017, NUTR HOSP, V34, P19, DOI [10.20960/nh.971, 10.20960/nh.443]; Gavri C, 2016, CLIN NUTR ESPEN, V12, pE14, DOI 10.1016/j.clnesp.2016.01.002; Gramlich L, 2004, NUTRITION, V20, P843, DOI 10.1016/j.nut.2004.06.003; Haskins IN, 2015, JPEN J PARENTER ENTE, V42; Havens JM, 2016, JPEN J PARENTER ENTE, V43; Heyland DK, 2015, CLIN NUTR, V34, P659, DOI 10.1016/j.clnu.2014.07.008; Heyland DK, 2010, CRIT CARE, V14, DOI 10.1186/cc8991; Heyland DK, 2003, JPEN-PARENTER ENTER, V27, P355, DOI 10.1177/0148607103027005355; Hofman Z, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0220-y; Kim SH, 2017, ASIA PAC J CLIN NUTR, V26, P27, DOI 10.6133/apjcn.122015.01; Kuppinger DD, 2013, NUTRITION, V29, P1075, DOI 10.1016/j.nut.2013.01.025; Kuslapuu M, 2015, INTENS CRIT CARE NUR, V31, P309, DOI 10.1016/j.iccn.2015.03.001; Lew CCH, 2016, JPEN J PARENTER ENTE, V5; McClave SA, 2016, JPEN-PARENTER ENTER, V40, P159, DOI [10.1097/CCM.0000000000001525, 10.1177/0148607115621863]; McClave SA, 2015, JPEN-PARENTER ENTER, V39, P707, DOI 10.1177/0148607114540004; Mehta NM, 2012, CRIT CARE MED, V40, P2204, DOI 10.1097/CCM.0b013e31824e18a8; Ming-Chao F, 2016, CHIN MED SCI J, V31, P213; Padar Martin, 2017, World J Crit Care Med, V6, P56, DOI 10.5492/wjccm.v6.i1.56; Rice TW, 2012, JAMA-J AM MED ASSOC, V307, P795, DOI 10.1001/jama.2012.137; Stewart ML, 2014, WORLDV EVID-BASED NU, V11, P194, DOI 10.1111/wvn.12036; Su YY, 2016, ASIA PAC J CLIN NUTR, V25, P521, DOI 10.6133/apjcn.092015.20; Wang D, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0094-0; Wilson Sara, 2016, World J Crit Care Med, V5, P180, DOI 10.5492/wjccm.v5.i3.180; Zhang Z., 2017, J EMERGENCY CRITICAL, V1; Zhang ZH, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.07.15; Zhang ZH, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.02.15; Zhang ZH, 2016, ANN TRANSL MED, V4, DOI 10.3978/j.issn.2305-5839.2015.12.38; Zhang ZH, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.12.11; Zhang ZH, 2015, J THORAC DIS, V7, P238, DOI 10.3978/j.issn.2072-1439.2015.02.14; Zhang ZH, 2014, J THORAC DIS, V6, P1659, DOI 10.3978/j.issn.2072-1439.2014.12.12; Zhang ZH, 2014, QUANT IMAGING MED SU, V4, P426, DOI 10.3978/j.issn.2223-4292.2014.09.03; Zhang ZH, 2014, J CRIT CARE, V29, P865, DOI 10.1016/j.jcrc.2014.06.015; Zhang ZH, 2014, J THORAC DIS, V6, P995, DOI 10.3978/j.issn.2072-1439.2014.07.01	41	11	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182393	10.1371/journal.pone.0182393	http://dx.doi.org/10.1371/journal.pone.0182393			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771622	Green Published, gold, Green Submitted			2022-12-26	WOS:000406853600100
J	Llano, DA; Bundela, S; Mudar, RA; Devanarayan, V				Llano, Daniel A.; Bundela, Saurabh; Mudar, Raksha A.; Devanarayan, Viswanath		Alzheimer's Dis Neuroimaging Init	A multivariate predictive modeling approach reveals a novel CSF peptide signature for both Alzheimer's Disease state classification and for predicting future disease progression	PLOS ONE			English	Article							FATTY-ACID-BINDING; MILD COGNITIVE IMPAIRMENT; CEREBROSPINAL-FLUID BIOMARKERS; MASS-SPECTROMETRY; BRAIN-TYPE; PROTEOMICS; PROTEIN; DEMENTIA; DISCOVERY; SERUM	To determine if a multi-analyte cerebrospinal fluid (CSF) peptide signature can be used to differentiate Alzheimer's Disease (AD) and normal aged controls (NL), and to determine if this signature can also predict progression from mild cognitive impairment (MCI) to AD, analysis of CSF samples was done on the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset. The profiles of 320 peptides from baseline CSF samples of 287 subjects over a 3-6 year period were analyzed. As expected, the peptide most able to differentiate between AD vs. NL was found to be Apolipoprotein E. Other peptides, some of which are not classically associated with AD, such as heart fatty acid binding protein, and the neuronal pentraxin receptor, also differentiated disease states. A sixteen-analyte signature was identified which differentiated AD vs. NL with an area under the receiver operating characteristic curve of 0.89, which was better than any combination of amyloid beta (1-42), tau, and phospho-181 tau. This same signature, when applied to a new and independent data set, also strongly predicted both probability and rate of future progression of MCI subjects to AD, better than traditional markers. These data suggest that multivariate peptide signatures from CSF predict MCI to AD progression, and point to potentially new roles for certain proteins not typically associated with AD.	[Llano, Daniel A.] Univ Illinois, Dept Mol & Integrat Physiol, Champaign, IL 61820 USA; [Bundela, Saurabh; Devanarayan, Viswanath] AbbVie Inc, Exploratory Stat, N Chicago, IL USA; [Mudar, Raksha A.] Univ Illinois, Dept Speech & Hearing Sci, Champaign, IL USA; [Bundela, Saurabh] Excelra, Hyderabad, Andhra Pradesh, India	University of Illinois System; University of Illinois Urbana-Champaign; AbbVie; University of Illinois System; University of Illinois Urbana-Champaign	Llano, DA (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Champaign, IL 61820 USA.	d-llano@illinois.edu	Llano, Daniel/X-8184-2019	Llano, Daniel/0000-0003-0933-1837	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; AbbVie; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; BioClinica, Inc.;Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; Eurolmmun; F. Hoffmann-La Roche Ltd; Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck Co., Inc; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; Transition Therapeutics; Canadian Institutes of Health Research; NATIONAL INSTITUTE ON AGING [U01AG024904] Funding Source: NIH RePORTER	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DOD ADNI (Department of Defense); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); AbbVie(AbbVie); Alzheimer's Association(Alzheimer's Association); Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; BioClinica, Inc.;Biogen; Bristol-Myers Squibb Company(Bristol-Myers Squibb); CereSpir, Inc.; Eisai Inc.(Eisai Co Ltd); Elan Pharmaceuticals, Inc.; Eli Lilly and Company(Eli Lilly); Eurolmmun; F. Hoffmann-La Roche Ltd(Hoffmann-La Roche); Genentech, Inc.(Roche HoldingGenentech); Fujirebio; GE Healthcare(General ElectricGE Healthcare); IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.(Johnson & JohnsonJohnson & Johnson USA); Lumosity; Lundbeck(Lundbeck Corporation); Merck Co., Inc(Merck & Company); Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation(Novartis); Pfizer Inc.(Pfizer); Piramal Imaging; Servier(Servier); Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Transition Therapeutics; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.;Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; Eurolmmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.;Biogen; BristolMyers Squibb Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; Eurolmmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (wwwfnihorg). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.	Abdi F, 2006, J ALZHEIMERS DIS, V9, P293; Addona TA, 2009, NAT BIOTECHNOL, V27, P633, DOI 10.1038/nbt.1546; Asano T, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-101; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carrette O, 2003, PROTEOMICS, V3, P1486, DOI 10.1002/pmic.200300470; Chiasserini D, 2010, J ALZHEIMERS DIS, V22, P1281, DOI 10.3233/JAD-2010-101293; Choi YS, 2013, J CHROMATOGR B, V930, P129, DOI 10.1016/j.jchromb.2013.05.003; Cocco C, 2010, J ANAT, V217, P683, DOI 10.1111/j.1469-7580.2010.01309.x; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Craig-Schapiro R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018850; Csernansky JG, 2002, ALZ DIS ASSOC DIS, V16, P144, DOI 10.1097/00002093-200207000-00003; Dakna M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-594; Dickerson BC, 2005, NEUROLOGY, V65, P404, DOI 10.1212/01.wnl.0000171450.97464.49; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Dukart J., 2015, J ALZHEIMERS DIS, P1; Efron B., 1994, INTRO BOOTSTRAP; Ferreira D, 2014, FRONTIERS AGING NEUR, V6; Ferreira D, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00287; Fliser D, 2007, J AM SOC NEPHROL, V18, P1057, DOI 10.1681/ASN.2006090956; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Fukuyama R, 2000, EUR NEUROL, V43, P155, DOI 10.1159/000008156; Guo LH, 2013, EUR ARCH PSY CLIN N, V263, P553, DOI 10.1007/s00406-013-0405-4; Harari O, 2014, BIOL PSYCHIAT, V75, P723, DOI 10.1016/j.biopsych.2013.11.032; Hirtz C, 2016, CLIN CHIM ACTA, V454, P33, DOI 10.1016/j.cca.2015.12.020; Holtta M, 2015, J PROTEOME RES, V14, P654, DOI 10.1021/pr501076j; Hu WT, 2010, ACTA NEUROPATHOL, V119, P669, DOI 10.1007/s00401-010-0667-0; Jahn H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026540; Kalaria R, 1991, CEREBRO VASCULAR BRA, V4, P226; Khan W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134368; Kim Y, 2016, NATURE COMMUNICATION, V7; Lagerstedt L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175572; Lehallier B, 2015, JAMA NEUROL, V2015, P1, DOI DOI 10.1001/JAMANEUROL.2015.3135; Leth-Larsen R, 2010, MOL CELL PROTEOMICS, V9, P1369, DOI 10.1074/mcp.R900006-MCP200; Llano DA, 2013, ALZ DIS ASSOC DIS, V27, P233, DOI 10.1097/WAD.0b013e31826d597a; Maarouf CL, 2009, CURR ALZHEIMER RES, V6, P399, DOI 10.2174/156720509788929318; Makridakis M, 2010, J PROTEOMICS, V73, P2291, DOI 10.1016/j.jprot.2010.07.001; Matsui Y, 2010, CELL MOL NEUROBIOL, V30, P991, DOI 10.1007/s10571-010-9529-5; Mischak H, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001249; Ohrfelt A, 2011, DEMENT GER COGN D EX, V1, P31, DOI 10.1159/000323417; Olah Z, 2014, J ALZHEIMERS DIS; Olsson B, 2013, J ALZHEIMERS DIS, V34, P673, DOI 10.3233/JAD-121384; Parnetti L, 2006, MECH AGEING DEV, V127, P129, DOI 10.1016/j.mad.2005.09.022; Pelsers MMAL, 2004, CLIN CHEM, V50, P1568, DOI 10.1373/clinchem.2003.030361; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Phan JH, 2006, PROG BRAIN RES, V158, P83, DOI 10.1016/S0079-6123(06)58004-5; Puchades M, 2003, MOL BRAIN RES, V118, P140, DOI 10.1016/j.molbrainres.2003.08.005; Ringman JM, 2012, ARCH NEUROL-CHICAGO, V69, P96, DOI 10.1001/archneurol.2011.642; Ritchie C, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008782.pub4; Roher AE, 2009, BIOMARKERS, V14, P493, DOI 10.3109/13547500903108423; Rosen C, 2013, CURR OPIN PSYCHIATR, V26, P276, DOI 10.1097/YCO.0b013e32835f6747; Ruetschi U, 2005, EXP NEUROL, V196, P273, DOI 10.1016/j.expneurol.2005.08.002; Selle H, 2005, COMB CHEM HIGH T SCR, V8, P801, DOI 10.2174/138620705774962391; Serada S, 2014, METHODS MOL BIOL, V1142, P99, DOI 10.1007/978-1-4939-0404-4_12; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Shioda N, 2014, J BIOL CHEM, V289, P18957, DOI 10.1074/jbc.M113.527341; Simon R, 2012, MOL CELL PROTEOMICS, V11, P1389, DOI 10.1074/mcp.M112.018861; Simonsen AH, 2007, ARCH NEUROL-CHICAGO, V64, P366, DOI 10.1001/archneur.64.3.366; Spellman DS, 2015, DEV EVALUATION MULTI; Stalmach A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104625; Sun Y, 2013, ALZHEIMERS DEMENT, V9, pP555; Sunderland T, 2003, JAMA-J AM MED ASSOC, V289, P2094, DOI 10.1001/jama.289.16.2094; TANAKA T, 1991, CLIN BIOCHEM, V24, P195, DOI 10.1016/0009-9120(91)90571-U; Torsetnes SB, 2014, ANAL CHEM, V86, P6983, DOI 10.1021/ac500986t; Wildsmith KR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-22; Wunderlich MT, 2005, J NEUROL, V252, P718, DOI 10.1007/s00415-005-0725-z; Yang J, 2013, SCI WORLD J, DOI [10.1155/2013/812469, 10.1155/2013/829067]; Yin GN, 2009, BRAIN RES, V1265, P158, DOI 10.1016/j.brainres.2009.01.058; Zanier ER, 2013, BRIT J ANAESTH, V111, P424, DOI 10.1093/bja/aet149; Zetterberg H, 2007, J ALZHEIMERS DIS, V12, P255, DOI 10.3233/jad-2007-12307; Zhang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015573	71	33	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182098	10.1371/journal.pone.0182098	http://dx.doi.org/10.1371/journal.pone.0182098			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771542	gold, Green Published, Green Submitted			2022-12-26	WOS:000406853600063
J	Moss, TJ; Clark, MT; Calland, JF; Enfield, KB; Voss, JD; Lake, DE; Moorman, JR				Moss, Travis J.; Clark, Matthew T.; Calland, James Forrest; Enfield, Kyle B.; Voss, John D.; Lake, Douglas E.; Moorman, J. Randall			Cardiorespiratory dynamics measured from continuous ECG monitoring improves detection of deterioration in acute care patients: A retrospective cohort study	PLOS ONE			English	Article							EARLY WARNING SCORE; ATRIAL-FIBRILLATION; PERFORMANCE EVALUATION; MORTALITY REDUCTION; CLASSIFICATION; VALIDATION; ARRHYTHMIA; APACHE; RHYTHM; TRACK	Background Charted vital signs and laboratory results represent intermittent samples of a patient's dynamic physiologic state and have been used to calculate early warning scores to identify patients at risk of clinical deterioration. We hypothesized that the addition of cardiorespiratory dynamics measured from continuous electrocardiography (ECG) monitoring to intermittently sampled data improves the predictive validity of models trained to detect clinical deterioration prior to intensive care unit (ICU) transfer or unanticipated death. Methods and findings We analyzed 63 patient-years of ECG data from 8,105 acute care patient admissions at a tertiary care academic medical center. We developed models to predict deterioration resulting in ICU transfer or unanticipated death within the next 24 hours using either vital signs, laboratory results, or cardiorespiratory dynamics from continuous ECG monitoring and also evaluated models using all available data sources. We calculated the predictive validity (C-statistic), the net reclassification improvement, and the probability of achieving the difference in likelihood ratio chi(2) for the additional degrees of freedom. The primary outcome occurred 755 times in 586 admissions (7%). We analyzed 395 clinical deteriorations with continuous ECG data in the 24 hours prior to an event. Using only continuous ECG measures resulted in a C-statistic of 0.65, similar to models using only laboratory results and vital signs (0.63 and 0.69 respectively). Addition of continuous ECG measures to models using conventional measurements improved the C-statistic by 0.01 and 0.07; a model integrating all data sources had a C-statistic of 0.73 with categorical net reclassification improvement of 0.09 for a change of 1 decile in risk. The difference in likelihood ratio chi(2) between integrated models with and without cardiorespiratory dynamics was 2158 (p value: <0.001). Conclusions Cardiorespiratory dynamics from continuous ECG monitoring detect clinical deterioration in acute care patients and improve performance of conventional models that use only laboratory results and vital signs.	[Moss, Travis J.; Lake, Douglas E.; Moorman, J. Randall] Univ Virginia, Sch Med, Dept Med, Div Cardiovasc Med, Charlottesville, VA 22908 USA; [Moss, Travis J.; Clark, Matthew T.; Calland, James Forrest; Enfield, Kyle B.; Lake, Douglas E.; Moorman, J. Randall] Univ Virginia, Ctr Adv Med Analyt, Charlottesville, VA 22903 USA; [Clark, Matthew T.] Adv Med Predict Devices Diagnost & Displays Inc, Charlottesville, VA USA; [Calland, James Forrest] Univ Virginia, Sch Med, Dept Surg, Div Acute Care & Trauma Surg, Charlottesville, VA USA; [Enfield, Kyle B.] Univ Virginia, Sch Med, Dept Med, Div Pulm & Crit Care, Charlottesville, VA 22908 USA; [Voss, John D.] Univ Virginia, Dept Med, Charlottesville, VA USA; [Lake, Douglas E.] Univ Virginia, Dept Stat, Charlottesville, VA USA; [Moorman, J. Randall] Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA; [Moorman, J. Randall] Univ Virginia, Dept Mol Physiol, Charlottesville, VA USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia	Moss, TJ (corresponding author), Univ Virginia, Sch Med, Dept Med, Div Cardiovasc Med, Charlottesville, VA 22908 USA.; Moss, TJ (corresponding author), Univ Virginia, Ctr Adv Med Analyt, Charlottesville, VA 22903 USA.	moss@virginia.edu	Moorman, J Randall/ABG-9946-2020; Enfield, Kyle/J-1840-2019; Calland, James/AAR-8664-2021	Enfield, Kyle/0000-0003-4624-0176; Clark, Matthew/0000-0002-4161-7897; Moss, Travis/0000-0002-9997-6075	NIH GO [1RC2HD064488]; Wallace H. Coulter Foundation; University of Virginia Health System	NIH GO; Wallace H. Coulter Foundation; University of Virginia Health System	The study was sponsored by the University of Virginia Health System, NIH GO Grant 1RC2HD064488, and the Wallace H. Coulter Foundation. The sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	ANGELONE A, 1964, J APPL PHYSIOL, V19, P479, DOI 10.1152/jappl.1964.19.3.479; Bailey TC, 2013, J HOSP MED, V8, P236, DOI 10.1002/jhm.2009; Ben-Ari J., 2010, Journal of Medical Engineering & Technology, V34, P393, DOI 10.3109/03091902.2010.503308; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brown H, 2014, AM J MED, V127, P226, DOI 10.1016/j.amjmed.2013.12.004; Cardoso LTQ, 2011, CRIT CARE, V15, DOI 10.1186/cc9975; Carrara M, 2015, J ELECTROCARDIOL, V48, P943, DOI 10.1016/j.jelectrocard.2015.08.002; Carrara M, 2015, PHYSIOL MEAS, V36, P1873, DOI 10.1088/0967-3334/36/9/1873; Churpek MM, 2014, AM J RESP CRIT CARE, V190, P649, DOI 10.1164/rccm.201406-1022OC; Churpek MM, CRIT CARE MED, V201, P841; Clark MT, 2012, J APPL PHYSIOL, V112, P859, DOI 10.1152/japplphysiol.01152.2011; DeMazumder D, 2013, CIRC-ARRHYTHMIA ELEC, V6, P555, DOI 10.1161/CIRCEP.113.000034; Fairchild KD, 2013, PEDIATR RES, V74, P570, DOI 10.1038/pr.2013.136; Gardner-Thorpe J, 2006, ANN ROY COLL SURG, V88, P571, DOI 10.1308/003588406X130615; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Harrell FE, 2001, REGRESSION MODELING; Henry KE, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3719; Hu X, 2012, J BIOMED INFORM, V45, P913, DOI 10.1016/j.jbi.2012.03.001; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lake DE, 2014, J CLIN MONIT COMPUT, V28, P329, DOI 10.1007/s10877-013-9530-x; Lake DE, 2011, AM J PHYSIOL-HEART C, V300, pH319, DOI 10.1152/ajpheart.00561.2010; Li Q, 2008, PHYSIOL MEAS, V29, P15, DOI 10.1088/0967-3334/29/1/002; Moody G. B., 1985, Computers in Cardiology (Cat. No.85CH2217-8), P113; Moody GA, 2001, IEEE ENG MED BIOL, V20, P45, DOI 10.1109/51.932724; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Moorman JR, 2011, J PEDIATR-US, V159, P900, DOI 10.1016/j.jpeds.2011.06.044; Morgan R., 1997, CLIN INTENSIVE CARE, V8, P100, DOI DOI 10.3109/TCIC.8.2.93.110; Moss TJ, 2017, CRIT CARE MED; Moss TJ, 2016, CRIT CARE MED, V44, P1639, DOI 10.1097/CCM.0000000000001738; Moss TJ, 2015, J ELECTROCARDIOL, V48, P1075, DOI 10.1016/j.jelectrocard.2015.08.007; Moss TJ, 2014, PHYSIOL MEAS, V35, P1929, DOI 10.1088/0967-3334/35/10/1929; Nemati S, 2010, EURASIP J ADV SIG PR, DOI 10.1155/2010/926305; Pena MA, 2009, MED BIOL ENG COMPUT, V47, P709, DOI 10.1007/s11517-009-0436-1; Prytherch DR, 2010, RESUSCITATION, V81, P932, DOI 10.1016/j.resuscitation.2010.04.014; Royal College of Physicians, 2012, NAT EARL WARN SCOR N; Saria S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001304; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Smith GB, 2008, RESUSCITATION, V79, P11, DOI 10.1016/j.resuscitation.2008.05.004; Smith GB, 2008, RESUSCITATION, V77, P170, DOI 10.1016/j.resuscitation.2007.12.004; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Tarassenko L, 2006, BRIT J ANAESTH, V97, P64, DOI 10.1093/bja/ael113; Young MP, 2003, J GEN INTERN MED, V18, P77, DOI 10.1046/j.1525-1497.2003.20441.x; Zimlichman E, 2012, J HOSP MED, V7, P628, DOI 10.1002/jhm.1963	44	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0181448	10.1371/journal.pone.0181448	http://dx.doi.org/10.1371/journal.pone.0181448			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771487	Green Published, Green Submitted, gold			2022-12-26	WOS:000406853600019
J	Sadighi, S; Zokaasadi, M; Kasaeian, A; Maghsudi, S; Jahanzad, I; Fumani, HK				Sadighi, Sanambar; Zokaasadi, Mohammad; Kasaeian, Amir; Maghsudi, Somaye; Jahanzad, Issa; Fumani, Hosein Kamranzadeh			The effect of immunohistochemically detected p53 accumulation in prognosis of breast cancer; A retrospective survey of outcome	PLOS ONE			English	Article							GENE; MORTALITY; GRADE	Background P53; a tumor suppressor gene has known to have a role in a group of human cancers. Its role in breast cancer; one of the most prevalent malignancies worldwide, is still controversial. The current study is designed to evaluate the prognostic role of p53 mutation in breast cancer. Methods one hundred and eighty five breast cancer patients were studied in this retrospective study. P53 mutation was detected by accumulation of p53 protein in the patients' pathology samples. Immunohistochemistry (IHC) was used to detect the protein. The effect of p53 on the final outcome was assessed using Kaplan-Meier estimate of survival and compared by log-rank test. Prognostic effects analyzed by cox proportional hazard models. Results while the stage of the disease at presentation was not significantly different between p53 positive and negative patients, those with p53 mutation had a significantly poorer outcome in terms of overall and disease-free survival rates (OS and DFS). In a multivariate analysis hazard ratio of p53 mutation was about 5 and 3.8 for OS and DFS respectively. They also had a higher cumulative incidence of relapse. Conclusion It seems that p53 mutation is an independent prognostic factor for breast cancer. Although larger prospective studies are needed to clarify the importance of such a conclusion.	[Sadighi, Sanambar] Univ Tehran Med Sci, Canc Inst Iran, Canc Res Ctr, Dept Med Oncol, Tehran, Iran; [Zokaasadi, Mohammad; Kasaeian, Amir; Maghsudi, Somaye; Fumani, Hosein Kamranzadeh] Univ Tehran Med Sci, Hematol Oncol & Stem Cell Transplantat Res Ctr, Tehran, Iran; [Jahanzad, Issa] Univ Tehran Med Sci, Canc Inst Iran, Canc Res Ctr, Dept Pathol, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences	Fumani, HK (corresponding author), Univ Tehran Med Sci, Hematol Oncol & Stem Cell Transplantat Res Ctr, Tehran, Iran.	Dr.kamranzadeh@gmail.com	zokaasadi, mohammad/ABA-5524-2020; Kasaeian, Amir/C-8290-2017; Fumani, Hosein Kamranzadeh/ABD-1136-2020	zokaasadi, mohammad/0000-0001-8957-0541; Kasaeian, Amir/0000-0003-2018-9368; Fumani, Hosein Kamranzadeh/0000-0002-6227-8994				Blaszyk H, 2000, INT J CANCER, V89, P32, DOI 10.1002/(SICI)1097-0215(20000120)89:1<32::AID-IJC6>3.0.CO;2-G; Elston C W, 2002, Histopathology, V41, P154; Falette N, 1998, CANCER RES, V58, P1451; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gasparini G, 1998, INT J ONCOL, V12, P1117; Global Burden of Disease Cancer Collaboration, 2017, JAMA Oncol, V3, P524, DOI 10.1001/jamaoncol.2016.5688; Harirchi Iraj, 2004, Asian Pac J Cancer Prev, V5, P24; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jung SY, 2011, J SURG ONCOL, V103, P207, DOI 10.1002/jso.21819; Korkolis DP, 2004, ANTICANCER RES, V24, P2061; Kroger N, 2006, CLIN CANCER RES, V12, P159, DOI 10.1158/1078-0432.CCR-05-1340; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Liu CG, 2010, MED ONCOL, V27, P747, DOI 10.1007/s12032-009-9279-8; Mirza AN, 2002, ANN SURG, V235, P10, DOI 10.1097/00000658-200201000-00003; Mousavi SM, 2009, ANN ONCOL, V20, P556, DOI 10.1093/annonc/mdn642; Mylonas I, 2005, VERSUS INVASIVE BREA, P25; Sadjadi Alireza, 2005, Asian Pac J Cancer Prev, V6, P359; Sana M, 2015, J CANCER RES THER, V11, P508, DOI 10.4103/0973-1482.163698; Shokouh TZ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001359; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; SILVESTRINI R, 1993, J NATL CANCER I, V85, P965, DOI 10.1093/jnci/85.12.965; Sjogren S, 1996, J NATL CANCER I, V88, P173, DOI 10.1093/jnci/88.3-4.173; Skibinski A, 2015, ONCOGENE, V34, P5309, DOI 10.1038/onc.2014.475; Soontrapornchai Prinya, 2007, Journal of the Medical Association of Thailand, V90, P1833; Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578; Vegran F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055103	26	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182444	10.1371/journal.pone.0182444	http://dx.doi.org/10.1371/journal.pone.0182444			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771563	Green Submitted, Green Published, gold			2022-12-26	WOS:000406853600116
J	Sundarrajan, L; Yeung, C; Hahn, L; Weber, LP; Unniappan, S				Sundarrajan, Lakshminarasimhan; Yeung, Chanel; Hahn, Logan; Weber, Lynn P.; Unniappan, Suraj			Irisin regulates cardiac physiology in zebrafish	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; HUMAN SKELETAL-MUSCLE; ADIPOSE-TISSUE; ENDOCRINE ORGAN; IN-VIVO; MYOSTATIN; EXERCISE; FNDC5; FAT; OBESITY	Irisin is a myokine encoded in its precursor fibronectin type III domain containing 5 (FNDC5). It is abundantly expressed in cardiac and skeletal muscle, and is secreted upon the activation of peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1 alpha). We aimed to study the role of irisin on cardiac function and muscle protein regulation in zebrafish. Western blot analyses detected the presence of irisin protein (23 kDa) in zebrafish heart and skeletal muscle, and irisin immunoreactivity was detected in both tissues. Irisin siRNA treated samples did not show bands corresponding to irisin in zebrafish. In vitro studies found that treatment with irisin (0.1 nM) downregulated the expression of PGC-1 alpha, myostatin a, and b, while upregulating troponin C mRNA expression in zebrafish heart and skeletal muscle. Exogenous irisin (0.1 and 1 ng/g B.W) increased diastolic volume, heart rate and cardiac output, while knockdown of irisin (10 ng/g B.W) showed opposing effects on cardiovascular function. Irisin (1 and 10 ng/g B.W) downregulated PGC-1 alpha, myostatin a and b, and upregulated troponin C and troponin T2D mRNA expression. Meanwhile, knockdown of irisin showed opposing effects on troponin C, troponin T2D and myostatin a and b mRNAs in zebrafish heart and skeletal muscle. Collectively, these results identified muscle proteins as novel targets of irisin, and added irisin to the list of peptide modulators of cardiovascular physiology in zebrafish.	[Sundarrajan, Lakshminarasimhan; Yeung, Chanel; Hahn, Logan; Weber, Lynn P.; Unniappan, Suraj] Univ Saskatchewan, Dept Vet Biomed Sci, Western Coll Vet Med, Lab Integrat Neuroendocrinol, Saskatoon, SK, Canada	University of Saskatchewan	Unniappan, S (corresponding author), Univ Saskatchewan, Dept Vet Biomed Sci, Western Coll Vet Med, Lab Integrat Neuroendocrinol, Saskatoon, SK, Canada.	suraj.unniappan@usask.ca		Weber, Lynn/0000-0002-9631-464X	Discovery Grant from the Natural Sciences and Engineering Research Council of Canada; Establishment Grant from the Saskatchewan Health Research Foundation (SHRF); Canada Foundation for Innovation (CFI)	Discovery Grant from the Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Establishment Grant from the Saskatchewan Health Research Foundation (SHRF); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation)	This research was funded by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada. SU is a recipient of an Establishment Grant from the Saskatchewan Health Research Foundation (SHRF). The ultrasound machine was purchased using a Leaders Opportunities Fund from the Canada Foundation for Innovation (CFI) to Lynn Weber. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SU is a recipient of an an Establishment Grant from the Saskatchewan Health Research Foundation (SHRF). The ultrasound machine was purchased using a Leaders Opportunities Fund from the Canada Foundation for Innovation (CFI) to Lynn Weber.	Aydin S, 2014, PEPTIDES, V61, P130, DOI 10.1016/j.peptides.2014.09.014; Aydin S, 2013, PEPTIDES, V50, P13, DOI 10.1016/j.peptides.2013.09.011; Aydin S, 2014, PEPTIDES, V52, P68, DOI 10.1016/j.peptides.2013.11.024; Bayliss CR, 2013, CARDIOVASC RES, V97, P500, DOI 10.1093/cvr/cvs322; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Brailoiu E, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12419; Carlson CJ, 1999, AM J PHYSIOL-REG I, V277, pR601, DOI 10.1152/ajpregu.1999.277.2.R601; Dong J, 2016, INT J OBESITY, V40, P434, DOI 10.1038/ijo.2015.200; Dun SL, 2013, NEUROSCIENCE, V240, P155, DOI 10.1016/j.neuroscience.2013.02.050; Eisele PS, 2015, BIOCHEM BIOPH RES CO, V464, P692, DOI 10.1016/j.bbrc.2015.06.166; Ferrante MI, 2011, J CELL SCI, V124, P565, DOI 10.1242/jcs.071274; Ferrer-Martinez A, 2002, DEV DYNAM, V224, P154, DOI 10.1002/dvdy.10099; Frontera WR, 2015, CALCIFIED TISSUE INT, V96, P183, DOI 10.1007/s00223-014-9915-y; Gao YP, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00088; Gerger CJ, 2015, AQUAT TOXICOL, V165, P19, DOI 10.1016/j.aquatox.2015.05.008; Hartwig S, 2014, BBA-PROTEINS PROTEOM, V1844, P1011, DOI 10.1016/j.bbapap.2013.08.004; Hashemi MS, 2013, NEUROSCIENCE, V231, P296, DOI 10.1016/j.neuroscience.2012.11.041; Hendriks SH, 2016, AM HEART J, V174, P43, DOI 10.1016/j.ahj.2015.12.015; Hofmann T, 2014, PEPTIDES, V54, P89, DOI 10.1016/j.peptides.2014.01.016; Hou NN, 2016, J MOL CELL CARDIOL, V99, P188, DOI 10.1016/j.yjmcc.2016.09.005; Huang W, 2009, DEV BIOL, V331, P237, DOI 10.1016/j.ydbio.2009.04.039; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Jedrychowski MP, 2015, CELL METAB, V22, P734, DOI 10.1016/j.cmet.2015.08.001; Joulia-Ekaza D, 2007, CURR OPIN PHARMACOL, V7, P310, DOI 10.1016/j.coph.2006.11.011; Kapilevich LV, 2015, GENES DIS, V2, P328, DOI 10.1016/j.gendis.2015.10.001; Kurdiova T, 2014, J PHYSIOL-LONDON, V592, P1091, DOI 10.1113/jphysiol.2013.264655; Lecker SH, 2012, CIRC-HEART FAIL, V5, P812, DOI 10.1161/CIRCHEARTFAILURE.112.969543; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Moreno-Navarrete JM, 2013, J CLIN ENDOCR METAB, V98, pE769, DOI 10.1210/jc.2012-2749; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; Moon HS, 2013, METABOLISM, V62, P1131, DOI 10.1016/j.metabol.2013.04.007; Na I, 2016, BIOL CHEM, V397, P731, DOI 10.1515/hsz-2015-0303; Nair N, 2016, GEN COMP ENDOCR, V234, P142, DOI 10.1016/j.ygcen.2016.02.015; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pedersen BK, 2013, COMPR PHYSIOL, V3, P1337, DOI 10.1002/cphy.c120033; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pedersen BK, 2007, J APPL PHYSIOL, V103, P1093, DOI 10.1152/japplphysiol.00080.2007; Piya MK, 2014, AM J PHYSIOL-ENDOC M, V306, pE512, DOI 10.1152/ajpendo.00308.2013; Shan TZ, 2013, FASEB J, V27, P1981, DOI 10.1096/fj.12-225755; Shettigar V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10794; Teufel A, 2002, GENE, V297, P79, DOI 10.1016/S0378-1119(02)00828-4; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Tiano JP, 2015, J BIOL CHEM, V290, P11431, DOI 10.1074/jbc.A114.617399; Timmons JA, 2012, NATURE, V488, pE9, DOI 10.1038/nature11364; Wu F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134662; Xin C, 2016, INT J OBESITY, V40, P443, DOI 10.1038/ijo.2015.199; Xu RY, 2013, J GERIATR CARDIOL, V10, P102, DOI [10.3969/j.issn.1671-5411.2013.01.015, 10.3724/SP.J.1263.2012.11101]; Yang ZG, 2015, INT J CLIN EXP PATHO, V8, P6490; Zhang WZ, 2015, CARDIOVASC DRUG THER, V29, P121, DOI 10.1007/s10557-015-6580-y; Zhao L, 2015, ENDOCR J, V62, P921, DOI 10.1507/endocrj.EJ15-0230	50	26	26	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0181461	10.1371/journal.pone.0181461	http://dx.doi.org/10.1371/journal.pone.0181461			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771499	Green Submitted, Green Published, gold			2022-12-26	WOS:000406853600020
J	Tillmann, S; Pereira, VS; Liebenberg, N; Christensen, AK; Wegener, G				Tillmann, Sandra; Pereira, Vitor Silva; Liebenberg, Nico; Christensen, Anne Karina; Wegener, Gregers			ZL006, a small molecule inhibitor of PSD-95/nNOS interaction, does not induce antidepressant-like effects in two genetically predisposed rat models of depression and control animals	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; GUANOSINE-MONOPHOSPHATE PATHWAY; SENSITIVE LINE RAT; FORCED SWIMMING TEST; TAIL SUSPENSION TEST; WISTAR-KYOTO RATS; NMDA RECEPTORS; DOUBLE-BLIND; KETAMINE; INVOLVEMENT	N-methyl-D-aspartate receptor (NMDA-R) antagonists and nitric oxide inhibitors have shown promising efficacy in depression but commonly induce adverse events. To circumvent these, a more indirect disruption of the nitric oxide synthase/postsynaptic density protein 95 kDa complex at the NMDA-R has been proposed. This disruption can be achieved using small molecule inhibitors such as ZL006, which has attracted attention as ischemic stroke therapy in rodents and has been proposed as a potential novel treatment for depression. Based on this, our aim was to translate these findings to animal models of depression to elucidate antidepressant-like properties in more detail. In the present study, we administered ZL006 to two established animal models of depression and control rodents. Following treatment, we measured locomotion in the Open Field and depressive-like behavior in the Forced Swim Test and Tail Suspension Test. Our experimental designs included the use of different species (rats, mice), strains (Flinders Sensitive Line rats, Flinders Resistant Line rats, Wistar Kyoto rats, Wistar Hanover rats, Sprague Dawley rats, B6NTac mice), routes of administration (intraperitoneal, intracerebroventricular), times of administration (single injection, repeated injections), treatment regimens (acute, sustained), and doses (5, 10, 15, 50 mg/kg). ZL006 did not affect behavior in any of the described settings. On a molecular level, ZL006 significantly reduced total nitrate/nitrite concentrations in the cerebellum, supporting that it is capable of reducing nitric oxide metabolites in the brain. Future studies using different experimental parameters are needed to further investigate the behavioral profile of ZL006.	[Tillmann, Sandra; Pereira, Vitor Silva; Liebenberg, Nico; Christensen, Anne Karina; Wegener, Gregers] Aarhus Univ, Translat Neuropsychiat Unit, Dept Clin Med, Aarhus, Denmark	Aarhus University	Tillmann, S (corresponding author), Aarhus Univ, Translat Neuropsychiat Unit, Dept Clin Med, Aarhus, Denmark.	sti@clin.au.dk	Wegener, Gregers/Z-3945-2019; Wegener, Gregers/A-1019-2011; Tillmann, Sandra/F-1076-2018; Pereira, Vitor/F-4283-2010	Wegener, Gregers/0000-0002-0081-0068; Tillmann, Sandra/0000-0003-2387-2947; Pereira, Vitor/0000-0002-9051-3154	eMOOD (AU Ideas Initiative); Conselho Nacional de Pesquisa-CNPq [PDE-203647/2014-9]	eMOOD (AU Ideas Initiative); Conselho Nacional de Pesquisa-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by eMOOD (AU Ideas Initiative). Vitor Silva Pereira received funding from Conselho Nacional de Pesquisa-CNPq (PDE-203647/2014-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Bach A, 2015, SCI REP-UK, V5, DOI 10.1038/srep12157; Bai F, 2001, PHARMACOL BIOCHEM BE, V70, P187, DOI 10.1016/S0091-3057(01)00599-8; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Chatterjee M., 2012, ISRN PSYCHIAT, V2012, DOI DOI 10.5402/2012/595141; Chen DY, 2016, BIOORG MED CHEM LETT, V26, P2152, DOI 10.1016/j.bmcl.2016.03.074; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; de Sa-Calcada D, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00335; DeVos SL, 2013, JOVE-J VIS EXP, DOI 10.3791/50326; Dhir A, 2011, NITRIC OXIDE-BIOL CH, V24, P125, DOI 10.1016/j.niox.2011.02.002; Doucet MV, 2013, NEUROPSYCHOPHARMACOL, V38, P1575, DOI 10.1038/npp.2013.57; Duman RS, 2014, DIALOGUES CLIN NEURO, V16, P11; Florio SK, 2009, BRIT J PHARMACOL, V158, P494, DOI 10.1111/j.1476-5381.2009.00300.x; FORSTERMANN U, 1990, BIOCHEM BIOPH RES CO, V168, P727, DOI 10.1016/0006-291X(90)92382-A; Garcia LSB, 2008, PROG NEURO-PSYCHOPH, V32, P140, DOI 10.1016/j.pnpbp.2007.07.027; Gould TD, 2009, NEUROMETHODS, V42, P1, DOI 10.1007/978-1-60761-303-9_1; Griebel G, 1999, PHYSIOL BEHAV, V67, P315, DOI 10.1016/S0031-9384(98)00298-4; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Hu W, 2014, NEUROCHEM INT, V79, P57, DOI 10.1016/j.neuint.2014.10.005; Jaffrey SR, 1998, NEURON, V20, P115, DOI 10.1016/S0896-6273(00)80439-0; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Lahmame A, 1997, EUR J PHARMACOL, V337, P115, DOI 10.1016/S0014-2999(97)01276-4; Lai TW, 2014, PROG NEUROBIOL, V115, P157, DOI 10.1016/j.pneurobio.2013.11.006; Lee WH, 2015, NEUROPHARMACOLOGY, V97, P464, DOI 10.1016/j.neuropharm.2015.05.038; Li LL, 2013, J NEUROSCI, V33, P8185, DOI 10.1523/JNEUROSCI.4578-12.2013; Liebenberg N, 2015, ACTA NEUROPSYCHIATR, V27, P90, DOI 10.1017/neu.2014.39; Lucki I, 1997, BEHAV PHARMACOL, V8, P523, DOI 10.1097/00008877-199711000-00010; Luo CX, 2014, J NEUROSCI, V34, P13535, DOI 10.1523/JNEUROSCI.1305-14.2014; MACKENZIE GM, 1994, NEUROREPORT, V5, P1993, DOI 10.1097/00001756-199410000-00039; Mercadante S, 2000, J PAIN SYMPTOM MANAG, V20, P246, DOI 10.1016/S0885-3924(00)00194-9; Mossner LD, 2011, AM J VET RES, V72, P1505, DOI 10.2460/ajvr.72.11.1505; Mutlu O, 2009, PHARMACOL BIOCHEM BE, V92, P82, DOI 10.1016/j.pbb.2008.10.013; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Ostadhadi S, 2016, BIOMED PHARMACOTHER, V82, P713, DOI 10.1016/j.biopha.2016.05.035; Ostadhadi S, 2016, BRAIN RES BULL, V122, P62, DOI 10.1016/j.brainresbull.2016.03.004; Overstreet DH, 2013, PHARMACOL REV, V65, P143, DOI 10.1124/pr.111.005397; OVERSTREET DH, 1993, NEUROSCI BIOBEHAV R, V17, P51, DOI 10.1016/S0149-7634(05)80230-1; Overstreet DH, 2005, NEUROSCI BIOBEHAV R, V29, P739, DOI 10.1016/j.neubiorev.2005.03.015; Paxinos G, 2007, RAT BRAIN STEREOTAXI, V6; Roberts RE, 2014, NEUROPSYCHOPHARMACOL, V39, P329, DOI 10.1038/npp.2013.195; Rosenzweig-Lipson S, 2007, PHARMACOL THERAPEUT, V113, P134, DOI 10.1016/j.pharmthera.2006.07.002; Sales AJ, 2011, BRIT J PHARMACOL, V164, P1711, DOI 10.1111/j.1476-5381.2011.01489.x; Salter M, 1996, J NEUROCHEM, V66, P1683; Sanacora G, 2008, NAT REV DRUG DISCOV, V7, P426, DOI 10.1038/nrd2462; Slattery DA, 2012, NAT PROTOC, V7, P1009, DOI 10.1038/nprot.2012.044; Smith AE, 2016, BEHAV BRAIN RES, V305, P23, DOI 10.1016/j.bbr.2016.02.021; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Suzuki E, 2001, J AFFECT DISORDERS, V63, P221, DOI 10.1016/S0165-0327(00)00164-6; Thase ME, 2001, BRIT J PSYCHIAT, V178, P234, DOI 10.1192/bjp.178.3.234; Ulak G, 2010, PHARMACOL BIOCHEM BE, V95, P308, DOI 10.1016/j.pbb.2010.02.006; Veilleux-Lemieux D, 2013, J AM ASSOC LAB ANIM, V52, P567; Wang CM, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00023; Wegener G, 2016, MELATONIN NEUROPROTE, P765; Wegener G, 2010, PHARMACEUTICALS, V3, P273, DOI 10.3390/ph3010273; Will CC, 2003, MOL PSYCHIATR, V8, P925, DOI 10.1038/sj.mp.4001345; World Health Organization, 2008, The global burden of disease: 2004 update; Zarate CA, 2006, AM J PSYCHIAT, V163, P153, DOI 10.1176/appi.ajp.163.1.153; Zhou L, 2010, NAT MED, V16, P1439, DOI 10.1038/nm.2245; Zomkowski ADE, 2012, PHARMACOL BIOCHEM BE, V103, P408, DOI 10.1016/j.pbb.2012.09.011; Zomkowski ADE, 2010, EUR NEUROPSYCHOPHARM, V20, P793, DOI 10.1016/j.euroneuro.2010.07.011	60	14	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182698	10.1371/journal.pone.0182698	http://dx.doi.org/10.1371/journal.pone.0182698			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771575	Green Published, gold, Green Submitted			2022-12-26	WOS:000406853600151
J	Koppelmans, V; Bloomberg, JJ; De Dios, YE; Wood, SJ; Reuter-Lorenz, PA; Kofman, IS; Riascos, R; Mulavara, AP; Seidler, RD				Koppelmans, Vincent; Bloomberg, Jacob J.; De Dios, Yiri E.; Wood, Scott J.; Reuter-Lorenz, Patricia A.; Kofman, Igor S.; Riascos, Roy; Mulavara, Ajitkumar P.; Seidler, Rachael D.			Brain plasticity and sensorimotor deterioration as a function of 70 days head down tilt bed rest	PLOS ONE			English	Article							DURATION SPACE-FLIGHT; CEREBRAL-CORTEX; STRUCTURAL PLASTICITY; CEREBROSPINAL-FLUID; SPACEFLIGHT ANALOG; OLDER-ADULTS; MICROGRAVITY; EXERCISE; ORIENTATION; WALKING	Background Adverse effects of spaceflight on sensorimotor function have been linked to altered somatosensory and vestibular inputs in the microgravity environment. Whether these spaceflight sequelae have a central nervous system component is unknown. However, experimental studies have shown spaceflight-induced brain structural changes in rodents' sensorimotor brain regions. Understanding the neural correlates of spaceflight-related motor performance changes is important to ultimately develop tailored countermeasures that ensure mission success and astronauts' health. Method Head down-tilt bed rest (HDBR) can serve as a microgravity analog because it mimics body unloading and headward fluid shifts of microgravity. We conducted a 70-day 6 E HDBR study with 18 right-handed males to investigate how microgravity affects focal gray matter ( GM) brain volume. MRI data were collected at 7 time points before, during and post-HDBR. Standing balance and functional mobility were measured pre and post-HDBR. The same metrics were obtained at 4 time points over similar to 90 days from 12 control subjects, serving as reference data. Results HDBR resulted in widespread increases GM in posterior parietal regions and decreases in frontal areas; recovery was not yet complete by 12 days post-HDBR. Additionally, HDBR led to balance and locomotor performance declines. Increases in a cluster comprising the precuneus, precentral and postcentral gyrus GM correlated with less deterioration or even improvement in standing balance. This association did not survive Bonferroni correction and should therefore be interpreted with caution. No brain or behavior changes were observed in control subjects. Conclusions Our results parallel the sensorimotor deficits that astronauts experience post-flight. The widespread GM changes could reflect fluid redistribution. Additionally, the association between focal GM increase and balance changes suggests that HDBR also may result in neuroplastic adaptation. Future studies are warranted to determine causality and underlying mechanisms.	[Koppelmans, Vincent; Seidler, Rachael D.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA; [Bloomberg, Jacob J.; Wood, Scott J.] NASA, Johnson Space Ctr, Houston, TX USA; [De Dios, Yiri E.; Kofman, Igor S.; Mulavara, Ajitkumar P.] KBRwyle, Houston, TX USA; [Reuter-Lorenz, Patricia A.; Seidler, Rachael D.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Riascos, Roy] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Seidler, Rachael D.] Univ Michigan, Neurosci Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; National Aeronautics & Space Administration (NASA); University of Michigan System; University of Michigan; University of Texas System; University of Texas Health Science Center Houston; University of Michigan System; University of Michigan	Seidler, RD (corresponding author), Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA.; Seidler, RD (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA.; Seidler, RD (corresponding author), Univ Michigan, Neurosci Program, Ann Arbor, MI 48109 USA.	rseidler@umich.edu	Koppelmans, Vincent/V-2604-2019; Riascos, Roy/AAE-3822-2019	Koppelmans, Vincent/0000-0003-2036-7603; Riascos, Roy/0000-0002-3081-0413; Seidler, Rachael/0000-0003-2452-9024	National Space Biomedical Research Institute: NASA cooperative agreement NCC [9-58, MA02701, PF04101]; National Aeronautics and Space Administration: NASA [NNX11AR02G]; National Aeronautics and Space Administration: NASA Flight Analogs Project; National Institutes of Health, National Center for Advancing Translational Sciences, NASA Flight Analogs Project [1UL1RR029876-01]; NASA [MA02701, PF04101, NCC 9-58]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029876] Funding Source: NIH RePORTER	National Space Biomedical Research Institute: NASA cooperative agreement NCC; National Aeronautics and Space Administration: NASA(National Aeronautics & Space Administration (NASA)); National Aeronautics and Space Administration: NASA Flight Analogs Project; National Institutes of Health, National Center for Advancing Translational Sciences, NASA Flight Analogs Project; NASA(National Aeronautics & Space Administration (NASA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work is supported by grants from the following institutions: 1) the National Space Biomedical Research Institute (http://nsbri.org/funding/): a. NASA cooperative agreement NCC 9-58 awarded to RDS, b. MA02701 awarded to RDS, c. PF04101 awarded to VK; 2) the National Aeronautics and Space Administration (https://www.nasa.gov/about/research/index.html): a. NASA; NNX11AR02G awarded to RDS, b. NASA Flight Analogs Project; and 3) National Institutes of Health (https://www.nih.gov), National Center for Advancing Translational Sciences (https://ncats.nih.gov), NASA Flight Analogs Project (1UL1RR029876-01) awarded to AR Brasier. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. YED and APM are employed by KBRwyle. The funder provided support in the form of salaries for authors YED and APM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This work is supported by grants from the following institutions:; 1. the National Space Biomedical Research Institute (http://nsbri.org/funding/):; a. NASA cooperative agreement NCC 9-58 awarded to RDS; b. MA02701 awarded to RDS; c. PF04101 awarded to VK; 2. the National Aeronautics and Space Administration (https://www.nasa.gov/about/research/index.html):; a. NASA; NNX11AR02G awarded to RDS; b. NASA Flight Analogs Project; 3. National Institutes of Health (https://www.nih.gov), National Center for Advancing Translational Sciences (https://ncats.nih.gov), NASA Flight Analogs Project (1UL1RR029876-01) awarded to AR Brasier.	Alperin N, 2005, ACT NEUR S, V95, P177; [Anonymous], 2010, VBM8 TOOLBOX MANUAL; Bherer Louis, 2013, J Aging Res, V2013, P197326, DOI [10.1155/2013/657508, 10.1155/2013/197326]; Bijsterbosch JD, 2013, PHYSIOL MEAS, V34, pN9, DOI 10.1088/0967-3334/34/3/N9; Bloomberg JJ, 1997, J VESTIBUL RES-EQUIL, V7, P161, DOI 10.1016/S0957-4271(96)00169-3; Bloomberg JJ, 2003, IEEE ENG MED BIOL, V22, P58, DOI 10.1109/MEMB.2003.1195697; Caceres A, 2015, ICC TOOLBOX SPM5 KIN; Cai LY, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00031; Caprihan A, 1999, EUR J APPL PHYSIOL O, V79, P367, DOI 10.1007/s004210050522; Cassady K, 2016, NEUROIMAGE, V141, P18, DOI 10.1016/j.neuroimage.2016.07.029; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cohen HS, 2012, J VESTIBUL RES-EQUIL, V22, P191, DOI 10.3233/VES-2012-0456; Crestini A, 2004, IN VITRO CELL DEV-AN, V40, P159; D'Amelio F, 1998, ADV SPACE RES-SERIES, V22, P235, DOI 10.1016/S0273-1177(98)80015-X; D'iachkova L N, 2007, Izv Akad Nauk Ser Biol, P372; Dayan E, 2011, NEURON, V72, P443, DOI 10.1016/j.neuron.2011.10.008; DeFelipe J, 2002, CEREB CORTEX, V12, P883, DOI 10.1093/cercor/12.8.883; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045; Eickhoff SB, 2006, HUM BRAIN MAPP, V27, P611, DOI 10.1002/hbm.20205; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Eriksson SH, 2009, J NEUROSCI METH, V181, P111, DOI 10.1016/j.jneumeth.2009.05.001; Eulenburg PZ, 2012, NEUROIMAGE, V60, P162, DOI 10.1016/j.neuroimage.2011.12.032; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Fjell AM, 2014, PROG NEUROBIOL, V117, P20, DOI 10.1016/j.pneurobio.2014.02.004; Friedman L, 2008, HUM BRAIN MAPP, V29, P958, DOI 10.1002/hbm.20440; Gill TM, 2004, J GERONTOL A-BIOL, V59, P755; Gottlieb J, 2010, CURR OPIN NEUROBIOL, V20, P731, DOI 10.1016/j.conb.2010.09.015; Grabherr L, 2010, J VESTIBUL RES-EQUIL, V20, P53, DOI 10.3233/VES-2010-0364; Gregory MA, 2013, CURR SPORT MED REP, V12, P256, DOI 10.1249/JSR.0b013e31829a74fd; Gryga M, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00037; Holstein G.R, 1999, J GRAVIT PHYSL, V6, P47; Kawai Yasuaki, 2003, Yonago Acta Medica, V46, P1; Koppelmans V, 2016, NPJ MICROGRAVITY, V2, DOI 10.1038/s41526-016-0001-9; Koppelmans V, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00121; Koppelmans V, 2015, HUM BRAIN MAPP, V36, P2352, DOI 10.1002/hbm.22775; Koppelmans V, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-205; Kramer LA, 2012, RADIOLOGY, V263, P819, DOI 10.1148/radiol.12111986; Langer N, 2012, NEUROLOGY, V78, P182, DOI 10.1212/WNL.0b013e31823fcd9c; Layne CS, 2001, J APPL PHYSIOL, V90, P997, DOI 10.1152/jappl.2001.90.3.997; Li K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135835; Li W, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00023; Liao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052558; Manor B, 2012, DIABETES CARE, V35, P1907, DOI 10.2337/dc11-2463; May A, 2007, CEREB CORTEX, V17, P205, DOI 10.1093/cercor/bhj138; May A, 2011, TRENDS COGN SCI, V15, P475, DOI 10.1016/j.tics.2011.08.002; Miller CA, 2010, AVIAT SPACE ENVIR MD, V81, P919, DOI 10.3357/ASEM.2680.2010; Muir J, 2011, GAIT POSTURE, V33, P429, DOI 10.1016/j.gaitpost.2010.12.019; Mulavara AP, 2012, J VESTIBUL RES-EQUIL, V22, P153, DOI 10.3233/VES-2011-0435; Mulavara AP, 2010, EXP BRAIN RES, V202, P649, DOI 10.1007/s00221-010-2171-0; Mulder E, 2014, J MUSCULOSKEL NEURON, V14, P359; NeuroCom International, 2003, SMART EQUITEST SYST; Newberg AB, 1998, ADV SPACE RES-SERIES, V22, P185, DOI 10.1016/S0273-1177(98)80010-0; O'Brien LM, 2011, PSYCHIAT RES-NEUROIM, V193, P113, DOI 10.1016/j.pscychresns.2011.01.007; O'Brien LM, 2006, HARVARD REV PSYCHIAT, V14, P141, DOI 10.1080/10673220600784119; PAGE LK, 1985, CHILD NERV SYST, V1, P12, DOI 10.1007/BF00706724; Peer M, 2015, P NATL ACAD SCI USA, V112, P11072, DOI 10.1073/pnas.1504242112; Pierson R, 2011, NEUROIMAGE, V54, P328, DOI 10.1016/j.neuroimage.2010.06.047; Pioneering Space, 2014, PION SPAC NASAS NEXT; Ploutz-Snyder LL, 2014, MED SCI SPORT EXER, V46, P358, DOI 10.1249/MSS.0b013e3182a62f85; Reschke MF, 2009, AVIAT SPACE ENVIR MD, V80, pA45, DOI 10.3357/ASEM.BR06.2009; Roberts DR, 2015, AM J NEURORADIOL, V36, P2048, DOI 10.3174/ajnr.A4406; Roberts DR, 2010, AVIAT SPACE ENVIR MD, V81, P30, DOI 10.3357/ASEM.2532.2009; Sarabon N, 2013, J ELECTROMYOGR KINES, V23, P1505, DOI 10.1016/j.jelekin.2013.09.002; Shoemaker JK, 2012, EXP PHYSIOL, V97, P1249, DOI 10.1113/expphysiol.2012.065557; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; van Dongen S, 2001, J EVOLUTIONARY BIOL, V12, P94; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; YOUNG LR, 1984, SCIENCE, V225, P205, DOI 10.1126/science.6610215; Yuan P, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00071; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	74	45	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182236	10.1371/journal.pone.0182236	http://dx.doi.org/10.1371/journal.pone.0182236			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC3VT	28767698	gold, Green Published, Green Submitted			2022-12-26	WOS:000406768200057
J	Takano, K; Kakuki, T; Kaneko, Y; Kohno, T; Kikuchi, S; Himi, T; Kojima, T				Takano, Kenichi; Kakuki, Takuya; Kaneko, Yakuto; Kohno, Takayuki; Kikuchi, Shin; Himi, Tetsuo; Kojima, Takashi			Histone deacetylase inhibition prevents cell death induced by loss of tricellular tight junction proteins in temperature-sensitive mouse cochlear cells	PLOS ONE			English	Article							CISPLATIN-INDUCED OTOTOXICITY; BARRIER; EXPRESSION; DEAFNESS; CANCER; HDAC6	Tricellular tight junctions (tTJs) are specialized structures that occur where the corners of three cells meet to seal adjacent intercellular space. The molecular components of tTJs include tricellulin (TRIC) and lipolysis-stimulated lipoprotein receptor (LSR) which recruits TRIC, are required for normal hearing. Although loss of TRIC causes hearing loss with degeneration of cochlear cells, the detailed mechanisms remains unclear. In the present study, by using temperature-sensitive mouse cochlear cells, US/VOT-E36 cell line, we investigated the changes of TRIC and LSR during cochlear cell differentiation and the effects of histone deacetylase (HDAC) inhibitors against cell degeneration induced by loss of TRIC and LSR. During cell differentiation induced by the temperature change, expression of TRIC and LSR were clearly induced. Treatment with metformin enhanced expression TRIC and LSR via AMPK during cell differentiation. Loss of TRIC and LSR by the siRNAs induced cell death in differentiated cells. Treatment with HDAC inhibitors trichostatin A and HDAC6 inhibitor prevented the cell death induced by loss of TRIC and LSR. Collectively, these findings suggest that both tTJ proteins TRIC and LSR have crucial roles for the differentiated cochlear cell survival, and that HDAC inhibitors may be potential therapeutic agents to prevent hearing loss.	[Takano, Kenichi; Kakuki, Takuya; Kaneko, Yakuto; Himi, Tetsuo] Sapporo Med Univ, Sch Med, Dept Otolaryngol, Sapporo, Hokkaido, Japan; [Kakuki, Takuya; Kaneko, Yakuto; Kohno, Takayuki; Kojima, Takashi] Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Dept Cell Sci, Sapporo, Hokkaido, Japan; [Kikuchi, Shin] Sapporo Med Univ, Sch Med, Dept Anat, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University	Takano, K (corresponding author), Sapporo Med Univ, Sch Med, Dept Otolaryngol, Sapporo, Hokkaido, Japan.	ktakashi@sapmed.ac.jp		Takano, Kenichi/0000-0001-8706-6384; Kohno, Takayuki/0000-0002-1782-3578	Ministry of Education, Culture, Sports, Science, and Technology, Japan [25861575, 15K08350]; Grants-in-Aid for Scientific Research [15K01419] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partially supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (No. 25861575 and 15K08350). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borck G, 2011, AM J HUM GENET, V88, P127, DOI 10.1016/j.ajhg.2010.12.011; Bordin M, 2004, MOL CANCER RES, V2, P692; Chang J, 2014, JARO-J ASSOC RES OTO, V15, P149, DOI 10.1007/s10162-013-0431-y; Chang ZG, 2016, J TRAUMA ACUTE CARE, V81, P512, DOI 10.1097/TA.0000000000001137; Chen J, 2016, JARO-J ASSOC RES OTO, V17, P289, DOI 10.1007/s10162-016-0567-7; Chishti MS, 2008, J HUM GENET, V53, P101, DOI 10.1007/s10038-007-0209-3; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; GULLEY RL, 1976, J NEUROCYTOL, V5, P479, DOI 10.1007/BF01181652; Helyer R, 2007, EUR J NEUROSCI, V25, P957, DOI 10.1111/j.1460-9568.2007.05338.x; Higashi T, 2013, J CELL SCI, V126, P966, DOI 10.1242/jcs.116442; Huang J, 2015, INT J MOL MED, V36, P493, DOI 10.3892/ijmm.2015.2249; Ikenouchi J, 2005, J CELL BIOL, V171, P939, DOI 10.1083/jcb.200510043; Ikenouchi J, 2008, MOL BIOL CELL, V19, P4687, DOI 10.1091/mbc.E08-05-0530; Jung HH, 2011, HEARING RES, V282, P92, DOI 10.1016/j.heares.2011.09.005; Kamitani T, 2015, SCI REP-UK, V5, DOI 10.1038/srep18402; Kitajiri S, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6137541; Kitajiri S, 2014, BIOL OPEN, V3, P759, DOI 10.1242/bio.20147799; Kojima T, 2010, J CELL PHYSIOL, V225, P720, DOI 10.1002/jcp.22273; Krishnan M, 2010, ONCOGENE, V29, P305, DOI 10.1038/onc.2009.324; Krug SM, 2009, MOL BIOL CELL, V20, P3713, DOI 10.1091/mbc.E09-01-0080; Masuda S, 2011, J CELL SCI, V124, P548, DOI 10.1242/jcs.072058; Nayak G, 2013, J CLIN INVEST, V123, P4036, DOI 10.1172/JCI69031; Ran J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12917; Riazuddin S, 2006, AM J HUM GENET, V79, P1040, DOI 10.1086/510022; Rivieccio MA, 2009, P NATL ACAD SCI USA, V106, P19599, DOI 10.1073/pnas.0907935106; Shakespear MR, 2011, TRENDS IMMUNOL, V32, P335, DOI 10.1016/j.it.2011.04.001; Shimada H, 2016, ONCOTARGET, V7, P27735, DOI 10.18632/oncotarget.8408; Takano K, 2014, EXCLI J, V13, P1145; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; Wang J, 2015, AM J OTOLARYNG, V36, P242, DOI 10.1016/j.amjoto.2014.11.003; Wen LT, 2015, INT J MOL MED, V36, P534, DOI 10.3892/ijmm.2015.2236; Yoon Somy, 2016, Chonnam Med J, V52, P1, DOI 10.4068/cmj.2016.52.1.1; Zhang J, 2014, CELL MOL LIFE SCI, V71, P3885, DOI 10.1007/s00018-014-1656-6	35	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182291	10.1371/journal.pone.0182291	http://dx.doi.org/10.1371/journal.pone.0182291			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767685	Green Published, Green Submitted, gold			2022-12-26	WOS:000406768200065
J	Gupta, SK; Srivastava, SK; Sharma, A; Nalage, VHH; Salvi, D; Kushwaha, H; Chitnis, NB; Shukla, P				Gupta, Sanjeev Kumar; Srivastava, Santosh K.; Sharma, Ankit; Nalage, Vaibhav H. H.; Salvi, Darshita; Kushwaha, Hiralal; Chitnis, Nikhil B.; Shukla, Pratyoosh			Metabolic engineering of CHO cells for the development of a robust protein production platform	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY PRODUCTION; HAMSTER OVARY CELLS; YEAST PYRUVATE-CARBOXYLASE; FC-FUSION PROTEINS; FED-BATCH CULTURES; N-GLYCOSYLATION; EXPRESSION; LACTATE; REDUCTION; GROWTH	Chinese hamster ovary (CHO) cells are the most preferred mammalian host used for the bio-pharmaceutical production. A major challenge in metabolic engineering is to balance the flux of the tuned heterogonous metabolic pathway and achieve efficient metabolic response in a mammalian cellular system. Pyruvate carboxylase is an important network element for the cytoplasmic and mitochondrial metabolic pathway and efficiently contributes in enhancing the energy metabolism. The lactate accumulation in cell culture can be reduced by rewiring of the pyruvate flux in engineered cells. In the present work, we over-expressed the yeast cytosolic pyruvate carboxylase (PYC2) enzyme in CHO cells to augment pyruvate flux towards the TCA cycle. The dual selection strategy is adopted for the screening and isolation of CHO clones containing varying number of PYC2 gene load and studied their cellular kinetics. The enhanced PYC2 expression has led to enhanced pyruvate flux which, thus, allowed reduced lactate accumulation up to 4 folds and significant increase in the cell density and culture longevity. With this result, engineered cells have shown a significant enhanced antibody expression up to 70% with improved product quality (similar to 3 fold) as compared to the parental cells. The PYC2 engineering allowed overall improved cell performance with various advantages over parent cells in terms of pyruvate, glucose, lactate and cellular energy metabolism. This study provides a potential expression platform for a biotherapeutic protein production in a controlled culture environment.	[Gupta, Sanjeev Kumar; Srivastava, Santosh K.; Sharma, Ankit; Nalage, Vaibhav H. H.; Salvi, Darshita; Kushwaha, Hiralal; Chitnis, Nikhil B.] Ipca Labs Ltd, Adv Biotech Lab, Plot 125,Kandivli Ind Estate,Kandivli West, Bombay, Maharashtra, India; [Gupta, Sanjeev Kumar; Shukla, Pratyoosh] Maharshi Dayanand Univ, Dept Microbiol, Enzyme Technol & Prot Bioinformat Lab, Rohtak, Haryana, India	Maharshi Dayanand University	Shukla, P (corresponding author), Maharshi Dayanand Univ, Dept Microbiol, Enzyme Technol & Prot Bioinformat Lab, Rohtak, Haryana, India.	pratyoosh.shukla@gmail.com	Shukla, Pratyoosh/N-8039-2013	Shukla, Pratyoosh/0000-0002-9307-4126	Ipca Laboratories Ltd.	Ipca Laboratories Ltd.	Ipca Laboratories Ltd. provided support in the form of salaries for authors SKG, SKS, AS, VHN, DS, HK, NBC. The specific roles of these authors are articulated in the 'author contributions' section. The funder did not have a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Ipca Laboratories Ltd. provided support in the form of salaries for authors SKG, SKS, AS, VHN, DS, HK, NBC. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Akbarzadeh-Sharbaf Soudabeh, 2013, Avicenna Journal of Medical Biotechnology, V5, P87; Altamirano C, 2004, J BIOTECHNOL, V110, P171, DOI 10.1016/j.jbiotec.2004.02.004; Bollati-Fogolin M, 2005, BIOTECHNOL PROGR, V21, P17, DOI 10.1021/bp049825t; Calo-Fernandez B, 2012, PHARMACEUTICALS-BASE, V5, P1393, DOI 10.3390/ph5121393; Chen KQ, 2001, BIOTECHNOL BIOENG, V72, P55, DOI 10.1002/1097-0290(20010105)72:1<55::AID-BIT8>3.0.CO;2-4; Chusainow J, 2009, BIOTECHNOL BIOENG, V102, P1182, DOI 10.1002/bit.22158; Cruz HJ, 2000, ENZYME MICROB TECH, V27, P43, DOI 10.1016/S0141-0229(00)00151-4; CUMMING D A, 1991, Glycobiology, V1, P115, DOI 10.1093/glycob/1.2.115; Dorai H, 2010, BIOTECHNOL PROGR, V26, P1367, DOI 10.1002/btpr.426; Dorka P, 2009, BIOPROC BIOSYST ENG, V32, P183, DOI 10.1007/s00449-008-0236-2; Fogolin MB, 2004, J BIOTECHNOL, V109, P179, DOI 10.1016/j.jbiotec.2003.10.035; Fogolin MB, 2001, ESACT PROCEED, V1, P241; Genzel Y, 2005, BIOTECHNOL PROGR, V21, P58, DOI 10.1021/bp049827d; Goetze AM, 2011, GLYCOBIOLOGY, V21, P949, DOI 10.1093/glycob/cwr027; Gupta SK, 2017, CRIT REV MICROBIOL, V43, P31, DOI 10.3109/1040841X.2016.1150959; Harrison RL, 2006, ADV VIRUS RES, V68, P159, DOI 10.1016/S0065-3527(06)68005-6; HASSELL T, 1990, J CELL SCI, V96, P501; Henry O, 2011, METAB ENG, V13, P499, DOI 10.1016/j.ymben.2011.05.004; Higel F, 2016, EUR J PHARM BIOPHARM, V100, P94, DOI 10.1016/j.ejpb.2016.01.005; Huang YM, 2010, BIOTECHNOL PROGR, V26, P1400, DOI 10.1002/btpr.436; Irani N, 2002, J BIOTECHNOL, V93, P269, DOI 10.1016/S0168-1656(01)00409-6; Jefferis R, 2005, BIOTECHNOL PROGR, V21, P11, DOI 10.1021/bp040016j; Jeong DW, 2006, MOL CELL BIOCHEM, V284, P1, DOI 10.1007/s11010-005-9004-7; Jiang Z, 2006, BIOTECHNOL PROGR, V22, P313, DOI 10.1021/bp0501524; Jitrapakdee S, 1999, BIOCHEM J, P1; Kim JY, 2012, APPL MICROBIOL BIOT, V93, P917, DOI 10.1007/s00253-011-3758-5; Kim SH, 2007, APPL MICROBIOL BIOT, V74, P152, DOI 10.1007/s00253-006-0654-5; KURANO N, 1990, J BIOTECHNOL, V15, P113, DOI 10.1016/0168-1656(90)90055-G; Lao MS, 1997, BIOTECHNOL PROGR, V13, P688, DOI 10.1021/bp9602360; LeFloch F, 2006, CYTOTECHNOLOGY, V52, P39, DOI 10.1007/s10616-006-9039-y; Lim Y, 2010, BIOTECHNOL APPL BIOC, V55, P175, DOI 10.1042/BA20090363; Liu LM, 2015, J PHARM SCI-US, V104, P1866, DOI 10.1002/jps.24444; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez VS, 2013, BIOTECHNOL BIOENG, V110, P660, DOI 10.1002/bit.24728; Niu HX, 2013, CHEM ENG SCI, V102, P461, DOI 10.1016/j.ces.2013.07.034; Nolan RP, 2011, METAB ENG, V13, P108, DOI 10.1016/j.ymben.2010.09.003; Shao L, 2002, GLYCOBIOLOGY, V12, P763, DOI 10.1093/glycob/cwf085; Stork R, 2008, J BIOL CHEM, V283, P7804, DOI 10.1074/jbc.M709179200; Templeton N, 2013, BIOTECHNOL BIOENG, V110, P2013, DOI 10.1002/bit.24858; Thomann M, 2016, MOL IMMUNOL, V73, P69, DOI 10.1016/j.molimm.2016.03.002; Toussaint C, 2016, J BIOTECHNOL, V217, P122, DOI 10.1016/j.jbiotec.2015.11.010; Vallee C, 2014, J BIOTECHNOL, V169, P63, DOI 10.1016/j.jbiotec.2013.11.002; Walsh G, 2014, NAT BIOTECHNOL, V32, P992, DOI 10.1038/nbt.3040; Wilkens CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119053; Xu JF, 2011, BIOTECHNOL ADV, V29, P278, DOI 10.1016/j.biotechadv.2011.01.002; Young JD, 2013, CURR OPIN BIOTECH, V24, P1108, DOI 10.1016/j.copbio.2013.04.016; Zhang YX, 2009, ADV BIOCHEM ENG BIOT, V113, P177, DOI 10.1007/10_2008_19; Zhou MX, 2011, J BIOTECHNOL, V153, P27, DOI 10.1016/j.jbiotec.2011.03.003; Zhu JW, 2012, BIOTECHNOL ADV, V30, P1158, DOI 10.1016/j.biotechadv.2011.08.022	49	42	44	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0181455	10.1371/journal.pone.0181455	http://dx.doi.org/10.1371/journal.pone.0181455			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763459	Green Published, gold, Green Submitted			2022-12-26	WOS:000406766500013
J	Zanet, S; Miglio, G; Ferrari, C; Bassano, B; Ferroglio, E; von Hardenberg, A				Zanet, Stefania; Miglio, Giacomo; Ferrari, Caterina; Bassano, Bruno; Ferroglio, Ezio; von Hardenberg, Achaz			Higher risk of gastrointestinal parasite infection at lower elevation suggests possible constraints in the distributional niche of Alpine marmots	PLOS ONE			English	Article							ECOLOGICAL IMMUNOLOGY; ASCARIS-SUUM; TRADE-OFFS; OCCUPANCY; PREVALENCE; MALARIA; EPIZOOTIOLOGY; MODELS; BIRDS	Alpine marmots Marmota marmota occupy a narrow altitudinal niche within high elevation alpine environments. For animals living at such high elevations where resources are limited, parasitism represents a potential major cost in life history. Using occupancy models, we tested if marmots living at higher elevation have a reduced risk of being infected with gastrointestinal helminths, possibly compensating the lower availability of resources (shorter feeding season, longer snow cover and lower temperature) than marmots inhabiting lower elevations. Detection probability of eggs and oncospheres of two gastro-intestinal helminthic parasites, Ascaris laevis and Ctenotaenia marmotae, sampled in marmot feces, was used as a proxy of parasite abundance. As predicted, the models showed a negative relationship between elevation and parasite detectability (i.e. abundance) for both species, while there appeared to be a negative effect of solar radiance only for C. marmotae. Site-occupancy models are used here for the first time to model the constrains of gastrointestinal parasitism on a wild species and the relationship existing between endoparasites and environmental factors in a population of free-living animals. The results of this study suggest the future use of site-occupancy models as a viable tool to account for parasite imperfect detection in eco-parasitological studies, and give useful insights to further investigate the hypothesis of the contribution of parasite infection in constraining the altitudinal niche of Alpine marmots.	[Zanet, Stefania; Miglio, Giacomo; Ferroglio, Ezio] Univ Turin, Dept Vet Sci, Grugliasco, To, Italy; [Ferrari, Caterina; Bassano, Bruno; von Hardenberg, Achaz] Alpine Wildlife Res Ctr, Gran Paradiso Natl Pk, Valsavarenche, Aosta, Italy; [von Hardenberg, Achaz] Univ Chester, Dept Biol Sci, Conservat Biol Res Grp, Chester, Cheshire, England	University of Turin; University of Chester	Zanet, S (corresponding author), Univ Turin, Dept Vet Sci, Grugliasco, To, Italy.	stefania.zanet@unito.it	von Hardenberg, Achaz/C-7313-2008; Zanet, Stefania/AAD-1969-2020	von Hardenberg, Achaz/0000-0002-9899-1687; Zanet, Stefania/0000-0002-7543-399X	Ente Parco Nazionale Gran Paradiso, as part of the "Marmot Project"; Surveillance service of the Gran Paradiso National Park; Park wardens of Orvieilles	Ente Parco Nazionale Gran Paradiso, as part of the "Marmot Project"; Surveillance service of the Gran Paradiso National Park; Park wardens of Orvieilles	The project was funded by Ente Parco Nazionale Gran Paradiso, as part of the "Marmot Project". The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the precious help of all the graduate and undergraduate students whose contribution over the years is fundamental for the sustainability of the "Alpine marmot Research Project". We wish to thank also the support of the Surveillance service of the Gran Paradiso National Park and in particular the Park wardens of Orvieilles, Martino Nicolino and Edi Chenal.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; ALLAINE D, 1994, CAN J ZOOL, V72, P2193, DOI 10.1139/z94-293; ANDERSON DC, 1976, ECOLOGY, V57, P552, DOI 10.2307/1936439; [Anonymous], 2008, QUANT GIS VERS 3 4 4; ARENE FOI, 1986, J THERM BIOL, V11, P9, DOI 10.1016/0306-4565(86)90011-2; Armitage K. B., 2013, Natural Science, V5, P36; Armitage K. B., 2000, Oecologia Montana, V9, P1; Armitage KB, 2017, J MAMMAL, V98, P321, DOI 10.1093/jmammal/gyw159; ARNOLD W, 1990, BEHAV ECOL SOCIOBIOL, V27, P229; Ashley N. T., 2012, ECOIMMUNOLOGY, P45; Atkinson CT, 2010, J AVIAN BIOL, V41, P357, DOI 10.1111/j.1600-048X.2009.04915.x; Auld SKJR, 2013, J EVOLUTION BIOL, V26, P2479, DOI 10.1111/jeb.12243; BABERO BERT B., 1960, TRANS AMER MICROSC SOC, V79, P439, DOI 10.2307/3224127; BABERO BERT B., 1960, AMER MIDLAND NAT, V64, P349, DOI 10.2307/2422668; BARASH DP, 1976, ANIM BEHAV, V24, P27, DOI 10.1016/S0003-3472(76)80096-6; Bassano B., 1992, P13; Borgo A, 2003, ACTA THERIOL, V48, P557, DOI 10.1007/BF03192501; Bozick BA, 2015, Q REV BIOL, V90, P361, DOI 10.1086/683698; Brambilla A, 2013, ANIM BEHAV, V86, P153, DOI 10.1016/j.anbehav.2013.05.006; Callait MP, 2000, LIFE IN THE COLD, P139; Callait MP, 1999, THESIS; CHUTE RM, 1960, J PARASITOL, V46, P539, DOI 10.2307/3274933; CHUTE RM, 1961, J PARASITOL, V47, P25, DOI 10.2307/3274969; Colvin ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116605; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; Dean A, 2011, EPI INFO DATABASE ST; DOBSON AP, 1988, Q REV BIOL, V63, P139, DOI 10.1086/415837; Eads David A., 2013, International Journal for Parasitology Parasites and Wildlife, V2, P246, DOI 10.1016/j.ijppaw.2013.09.002; Euzeby J., 1963, MALADIES VERMINEUSES, V1; Ferrari C, 2013, ANIM BEHAV, V85, P1385, DOI 10.1016/j.anbehav.2013.03.030; Fiske IJ, 2011, J STAT SOFTW, V43, P1; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; FORD BR, 1972, EXP PARASITOL, V32, P62, DOI 10.1016/0014-4894(72)90010-0; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Guillera-Arroita G, 2010, METHODS ECOL EVOL, V1, P131, DOI 10.1111/j.2041-210X.2010.00017.x; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; HAUSFATER G, 1982, Primates, V23, P287, DOI 10.1007/BF02381167; Heaselgrave W, 2011, ACTA TROP, V119, P138, DOI 10.1016/j.actatropica.2011.05.004; HERRERO J, 1994, ARCTIC ALPINE RES, V26, P328, DOI 10.2307/1551793; Herrero J, 2008, IUCN RED LIST THREAT; HUGOT JP, 1980, ANN PARASIT HUM COMP, V55, P97, DOI 10.1051/parasite/1980551097; Hume ID, 2002, J COMP PHYSIOL B, V172, P197, DOI 10.1007/s00360-001-0240-1; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Lachish S, 2012, METHODS ECOL EVOL, V3, P339, DOI 10.1111/j.2041-210X.2011.00156.x; Larsen MN, 1999, PARASITOLOGY, V119, P209, DOI 10.1017/S0031182099004503; Le Berre M., 1993, ETHOLOGY, V93, P21; Lenti Boero D., 1992, P95; Lopez BC, 2009, ETHOL ECOL EVOL, V21, P225, DOI 10.1080/08927014.2009.9522477; Lopez J, 2013, J ZOOL, V291, P296, DOI 10.1111/jzo.12076; Macchi E., 1992, P123; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Manfredi M.T., 1992, P203; Martinez-Mota R, 2015, DEV PRIMATOL-PROG PR, P259, DOI 10.1007/978-1-4939-1957-4_10; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; Oribatiden Ebermann E., 1976, Z PARASITENKUNDEN, V50, P303; Ortega A., 2011, THESIS; Polly P. D., 2015, EVOLUTION RODENTS AD, P246, DOI DOI 10.1017/CBO9781107360150.010; Preleuthner M, 1996, BIODIVERSITY MARMOTS, P111; R Development Core Team, 2015, R LANG ENV STAT COMP; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; Schuster R, 2000, ONDERSTEPOORT J VET, V67, P49; Sears BF, 2015, J ANIM ECOL, V84, P625, DOI 10.1111/1365-2656.12333; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Siraj AS, 2014, SCIENCE, V343, P1154, DOI 10.1126/science.1244325; SOMME L, 1989, BIOL REV, V64, P367, DOI 10.1111/j.1469-185X.1989.tb00681.x; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Taylor M. A., 2015, VET PARASITOL; Urquhart G.M., 1996, VET PARASITOL, V2nd; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; VANVUREN D, 1991, CAN J ZOOL, V69, P1755, DOI 10.1139/z91-244; VanVuren D, 1996, ETHOLOGY, V102, P686; Zamora-Vilchis I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039208	72	9	9	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0182477	10.1371/journal.pone.0182477	http://dx.doi.org/10.1371/journal.pone.0182477			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763517	gold, Green Published, Green Submitted			2022-12-26	WOS:000406766500069
J	Lindbom, SJA; Larsson, M; Agardh, A				Lindbom, Sigrid J. A.; Larsson, Markus; Agardh, Anette			The naked truth about HIV and risk taking in Swedish prisons: A qualitative study	PLOS ONE			English	Article							SEXUAL VIOLENCE; INMATES; PREVALENCE; BEHAVIORS; INCARCERATION; INFECTION; INJECTION; RATES	Background This qualitative study explores former prison inmates' perceptions and attitudes towards HIV risk inside Swedish prisons. Method In 2014, eight semi-structured interviews were conducted with former male prisoners to gain a deeper understanding of situations perceived to be associated with risk of HIV transmission. The material gathered from the interviews was analyzed by manifest and latent qualitative content analysis. Results The findings revealed that risky behavioral practices, such as sharing needles, unprotected sexual activity, and lack of openness about HIV status represented potential health threats with regard to the risk of HIV transmission. Conclusions Evidence from the study indicates that educational interventions regarding HIV and the transmission routes are required for HIV prevention in Swedish prisons.	[Lindbom, Sigrid J. A.; Larsson, Markus; Agardh, Anette] Lund Univ, Dept Clin Sci, Social Med & Global Hlth, Malmo, Sweden	Lund University	Larsson, M (corresponding author), Lund Univ, Dept Clin Sci, Social Med & Global Hlth, Malmo, Sweden.	markus.larsson@med.lu.se		Larsson, Markus/0000-0001-6336-3245				Abiona TC, 2010, AM J INFECT CONTROL, V38, P121, DOI 10.1016/j.ajic.2009.06.006; Adams LM, 2013, AIDS BEHAV, V17, P2685, DOI 10.1007/s10461-011-9990-2; [Anonymous], 2009, HIV TESTING COUNSELL, P3; Awofeso Niyi, 2002, Aust Health Rev, V25, P162; Ayanwale Lekan, 2008, Am J Health Stud, V23, P179; Backlin E., 2010, THESIS; Braithwaite RL, 2003, AM J PUBLIC HEALTH, V93, P759, DOI 10.2105/AJPH.93.5.759; Butler T, 2013, SEX TRANSM INFECT, V89, P377, DOI 10.1136/sextrans-2012-050856; Christensen PB, 2000, EUR J EPIDEMIOL, V16, P1043, DOI 10.1023/A:1010833917242; Comfort M, 2005, J SEX RES, V42, P3, DOI 10.1080/00224490509552251; Fetherston J, 2013, J SUBST USE, V18, P65, DOI 10.3109/14659891.2012.760008; Folkhalsomyndigheten, 2017, INF HIV; Gagnon H, 2007, CAN J PUBLIC HEALTH, V98, P297, DOI 10.1007/BF03405407; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Grinstead O., 1997, J HLTH ED S1, pS, DOI [10.1080/10556699.1997.10608630, DOI 10.1080/10556699.1997.10608630]; Hammett TM, 2006, AM J PUBLIC HEALTH, V96, P974, DOI 10.2105/AJPH.2005.066993; Hellard M E, 2004, Sex Health, V1, P107, DOI 10.1071/SH03018; Hellard ME, 2007, AM J INFECT CONTROL, V35, P477, DOI 10.1016/j.ajic.2006.08.002; Hensley C., 2001, J MENS STUDIES, V10, P59, DOI [DOI 10.3149/JMS.1001.59, 10.3149/jms.1001.59]; Hill T., 2014, UCLA WOMENS LAW J, V21, P89; Jones TR, 2008, INT J OFFENDER THER, V52, P280, DOI 10.1177/0306624X07307631; Jurgens R, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-26; Jurgens R., 2007, INTERVENTIONS ADDRES; Jurgens R, 2009, LANCET INFECT DIS, V9, P57, DOI 10.1016/S1473-3099(08)70305-0; Keene J., 1997, HOWARD J CRIM JUST, V36, P28, DOI [DOI 10.1111/1468-2311.00037, 10.1111/1468-2311.00037]; Krienert J, 2014, CRIM JUSTICE STUD, V27, P387, DOI 10.1080/1478601X.2014.938740; Larsen Kari, 2008, J Contemp Health Law Policy, V24, P251; Lonnaeus O., 2013, SVENSKA FANGELSER MA; McLemore Megan, 2008, HIV AIDS Policy Law Rev, V13, P20; Noaks Ark Syd, UNPUB; Patenaude AL, 2004, PRISON J, V84, p69S, DOI 10.1177/0032885504269898; Pena-Orellana M, 2011, J HEALTH CARE POOR U, V22, P962, DOI 10.1353/hpu.2011.0084; Pinkerton SD, 2007, PRISON J, V87, P295, DOI 10.1177/0032885507304525; Razzaghi Emran M, 2006, Harm Reduct J, V3, P12; Richters J, 2012, ARCH SEX BEHAV, V41, P517, DOI 10.1007/s10508-010-9667-3; Rotily M, 2001, EUR J PUBLIC HEALTH, V11, P243, DOI 10.1093/eurpub/11.3.243; Scott D.P., 2004, J CORRECT HEALTH CAR, V10, P151, DOI DOI 10.1177/107834580301000203; Sieck CJ, 2011, J URBAN HEALTH, V88, P690, DOI 10.1007/s11524-011-9565-6; Slutgiltig statistik for, 2014, STOCKH BROTTSF; Smittskyddsinstitutet, 2012, EP ARS 2012; Snow KJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-830; Titilayo A, 2015, INT J PRISON HLTH, V11, P196; Wolff N, 2006, J URBAN HEALTH, V83, P835, DOI 10.1007/s11524-006-9065-2; World Health Organization Regional Office for Europe, PRIS HLTH FACT SHEET	44	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0182237	10.1371/journal.pone.0182237	http://dx.doi.org/10.1371/journal.pone.0182237			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC3TH	28759572	Green Published, gold, Green Submitted			2022-12-26	WOS:000406761600066
J	Montesantos, S; Katz, I; Venegas, J; Pichelin, M; Caillibotte, G				Montesantos, Spyridon; Katz, Ira; Venegas, Jose; Pichelin, Marine; Caillibotte, Georges			The effect of disease and respiration on airway shape in patients with moderate persistent asthma	PLOS ONE			English	Article							RESOLUTION COMPUTED-TOMOGRAPHY; 3-DIMENSIONAL MODEL; AEROSOL DEPOSITION; FLOW LIMITATION; HELIUM-OXYGEN; REGIONAL VENTILATION; MULTIDETECTOR CT; HEALTHY-SUBJECTS; LUNG-INFLATION; DISTENSIBILITY	Computational models of gas transport and aerosol deposition frequently utilize idealized models of bronchial tree structure, where airways are considered a network of bifurcating cylinders. However, changes in the shape of the lung during respiration affect the geometry of the airways, especially in disease conditions. In this study, the internal airway geometry was examined, concentrating on comparisons between mean lung volume (MLV) and total lung capacity (TLC). A set of High Resolution CT images were acquired during breath hold on a group of moderate persistent asthmatics at MLV and TLC after challenge with a broncho-constrictor (methacholine) and the airway trees were segmented and measured. The airway hydraulic diameter (Dh) was calculated through the use of average lumen area (Ai) and average internal perimeter (Pi) at both lung volumes and was found to be systematically higher at TLC by 13.5 9% on average, with the lower lobes displaying higher percent change in comparison to the lower lobes. The average internal diameter (Din) was evaluated to be 12.4 6.8% (MLV) and 10.8 6.3% (TLC) lower than the Dh, for all the examined bronchi, a result displaying statistical significance. Finally, the airway distensibility per bronchial segment and per generation was calculated to have an average value of 0.45 0.28, exhibiting high variability both between and within lung regions and generations. Mixed constriction/dilation patterns were recorded between the lung volumes, where a number of airways either failed to dilate or even constricted when observed at TLC. We conclude that the Dh is higher than Din, a fact that may have considerable effects on bronchial resistance or airway loss at proximal regions. Differences in caliber changes between lung regions are indicative of asthma-expression variability in the lung. However, airway distensibility at generation 3 seems to predict distensibility more distally.	[Montesantos, Spyridon; Katz, Ira; Pichelin, Marine; Caillibotte, Georges] Paris Saclay, Med R&D, Air Liquide Sante Int, Paris, France; [Katz, Ira] Lafayette Coll, Dept Mech Engn, Easton, PA 18042 USA; [Venegas, Jose] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Venegas, Jose] Harvard Med Sch, Boston, MA USA	Air Liquide; UDICE-French Research Universities; Universite Paris Saclay; Lafayette College; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Montesantos, S (corresponding author), Paris Saclay, Med R&D, Air Liquide Sante Int, Paris, France.	Spyridon.montesantos@airliquide.com						[Anonymous], 1994, ICRP PUBL; Aysola RS, 2008, CHEST, V134, P1183, DOI 10.1378/chest.07-2779; Bai TR, 2005, CLIN SCI, V108, P463, DOI 10.1042/CS20040342; Bakker ME, 2012, RESP MED, V106, P677, DOI 10.1016/j.rmed.2011.11.013; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Benfante A, 2013, COPD, V10, P560, DOI 10.3109/15412555.2013.773304; Bokov P, 2010, RESP PHYSIOL NEUROBI, V173, P1, DOI 10.1016/j.resp.2010.05.011; Bordas R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144105; Borojeni AAT, 2015, J BIOMECH, V48, P1988, DOI 10.1016/j.jbiomech.2015.03.035; Brown N, 2007, AM J RESP CRIT CARE, V176, P129, DOI 10.1164/rccm.200609-1317OC; Brown RH, 2001, AM J RESP CRIT CARE, V163, P994, DOI 10.1164/ajrccm.163.4.2007119; Brown RH, 2016, J APPL PHYSL BETHESD, V1985; Busse William W., 2000, Journal of Allergy and Clinical Immunology, V106, P1033; Chae EJ, 2011, ALLERGY ASTHMA IMMUN, V3, P111, DOI 10.4168/aair.2011.3.2.111; Choi S, 2015, J APPL PHYSL BETHESD, V118, P1286, DOI DOI 10.1152/JAPPLPHYSI0L.01094.2014; Diaz AA, 2012, CHEST, V141, P736, DOI 10.1378/chest.11-1026; Donohue KM, 2013, J ALLERGY CLIN IMMUN, V131, P361, DOI 10.1016/j.jaci.2012.11.036; Eskandari M, 2015, ANN BIOMED ENG, P1; Fain S, 2009, D28 IMAGING OBSTRUCT, pA5575; FLEMING JS, 1995, J AEROSOL MED, V8, P341, DOI 10.1089/jam.1995.8.341; Florens M, 1985, J APPL PHYSL BETHESD, V110, P756, DOI DOI 10.1152/JAPPLPHYSI0L; Grebenkov DS, 2007, J MAGN RESON, V184, P143, DOI 10.1016/j.jmr.2006.09.026; Greenblatt EE, 2015, J AEROSOL MED PULM D; Greenblatt EE, 2016, J AEROSOL MED PULM D, V29, P260, DOI 10.1089/jamp.2014.1204; Gupta S, 2014, J ALLERGY CLIN IMMUN, V133, P729, DOI 10.1016/j.jaci.2013.09.039; Gupta S, 2010, THORAX, V65, P775, DOI 10.1136/thx.2010.136374; Hartley RA, 2016, J ALLERGY CLIN IMMUN, V137, P1413, DOI 10.1016/j.jaci.2016.02.001; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Holinger P., 1950, THORAX, V5, P222; HORSFIELD K, 1968, J APPL PHYSIOL, V24, P373, DOI 10.1152/jappl.1968.24.3.373; Hoshino M, 2010, RESP MED, V104, P794, DOI 10.1016/j.rmed.2009.12.005; Katz I, 2014, J AEROSOL MED PULM D, V27, P71, DOI 10.1089/jamp.2013.1072; Katz I, 2016, AEROSOL SCI TECHNOL; Katz IM, 2011, J BIOMECH, V44, P1137, DOI 10.1016/j.jbiomech.2011.01.022; Kelly VJ, 2012, J APPL PHYSIOL, V112, P1494, DOI 10.1152/japplphysiol.01259.2011; Kermode JA, 2011, RESP MED, V105, P1798, DOI 10.1016/j.rmed.2011.07.010; Kim M, 2015, INT J NUMER METH BIO, V31, DOI 10.1002/cnm.2730; Kitaoka H, 1999, J APPL PHYSIOL, V87, P2207, DOI 10.1152/jappl.1999.87.6.2207; KOBLINGER L, 1990, J AEROSOL SCI, V21, P661, DOI 10.1016/0021-8502(90)90121-D; Kotaru C, 1985, J APPL PHYSL BETHESD, V98, P1028; Kundu S, 2013, EUR RADIOL, V23, P1564, DOI 10.1007/s00330-012-2746-1; Lee DY, 2002, J AEROSOL SCI, V33, P1219, DOI 10.1016/S0021-8502(02)00053-8; Liang L, 2007, MED PHYS, V34, P1013, DOI 10.1118/1.2437284; MACKLEM P T, 1989, European Respiratory Journal, V2, p516S; MACKLEM PT, 1967, J APPL PHYSIOL, V22, P395, DOI 10.1152/jappl.1967.22.3.395; MARTONEN TB, 1995, INT J BIOMED COMPUT, V40, P5, DOI 10.1016/0020-7101(95)01106-O; Montaudon M, 2007, J ANAT, V211, P579, DOI 10.1111/j.1469-7580.2007.00811.x; Montaudon M, 2009, RADIOLOGY, V253, P844, DOI 10.1148/radiol.2533090303; Montesantos S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168026; Montesantos S, 2013, ANAT REC, V296, P852, DOI 10.1002/ar.22695; Petersen J, 2014, EUR RADIOL, V24, P2319, DOI 10.1007/s00330-014-3261-3; Pozin N, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2873; Pyrgos G, 2011, J APPL PHYSIOL, V110, P472, DOI 10.1152/japplphysiol.00603.2010; Rembold CM, 2014, J PHYSIOL-LONDON, V592, P3831, DOI 10.1113/jphysiol.2014.272302; Sauret V, 1999, PHYS MED BIOL, V44, P1625, DOI 10.1088/0031-9155/44/7/304; Shaughnessy EJ., 2005, INTRO FLUID MECH; Shimizu K, 2010, RESP MED, V104, P1809, DOI 10.1016/j.rmed.2010.06.013; Swan AJ, 2012, J THEOR BIOL, V300, P222, DOI 10.1016/j.jtbi.2012.01.042; Tawhai Merryn H., 2003, Anatomical Record, V275B, P207, DOI 10.1002/ar.b.10034; Tawhai MH, 2000, ANN BIOMED ENG, V28, P793, DOI 10.1114/1.1289457; Tawhai MH, 2004, J APPL PHYSIOL, V97, P2310, DOI 10.1152/japplphysiol.00520.2004; Tgavalekos NT, 2003, ANN BIOMED ENG, V31, P363, DOI 10.1114/1.1557972; Tian G, 2015, PHARM RES-DORDR, V32, P3170, DOI 10.1007/s11095-015-1695-1; Venegas JG, 2005, RESP PHYSIOL NEUROBI, V148, P57, DOI 10.1016/j.resp.2005.05.023; Venegas JG, 2005, NATURE, V434, P777, DOI 10.1038/nature03490; Venegas J, 2007, THORAX, V62, P653, DOI 10.1136/thx.2006.073239; Vial Laurence, 2005, Computer Methods in Biomechanics and Biomedical Engineering, V8, P267, DOI 10.1080/10255840500289772; Walenga RL, 2014, J AEROSOL SCI, V78, P11, DOI 10.1016/j.jaerosci.2014.08.003; Wongviriyawong C, 2013, J APPL PHYSIOL, V114, P504, DOI 10.1152/japplphysiol.00273.2012; Wongviriyawong C, 2012, J APPL PHYSIOL, V112, P237, DOI 10.1152/japplphysiol.01400.2010; Yin YB, 2013, J COMPUT PHYS, V244, P168, DOI 10.1016/j.jcp.2012.12.007	71	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0182052	10.1371/journal.pone.0182052	http://dx.doi.org/10.1371/journal.pone.0182052			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759656	Green Published, Green Submitted, gold			2022-12-26	WOS:000406761600047
J	Schlegel, P; Reinkober, J; Meinhardt, E; Tscheschner, H; Gao, E; Schumacher, SM; Yuan, A; Backs, J; Most, P; Wieland, T; Koch, WJ; Katus, HA; Raake, PW				Schlegel, Philipp; Reinkober, Julia; Meinhardt, Eric; Tscheschner, Henrike; Gao, Erhe; Schumacher, Sarah M.; Yuan, Ancai; Backs, Johannes; Most, Patrick; Wieland, Thomas; Koch, Walter J.; Katus, Hugo A.; Raake, Philip W.			G protein-coupled receptor kinase 2 promotes cardiac hypertrophy	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE; FAILURE; GRK2; ABLATION; MYOCYTES; INHIBITION; ACTIVATION; EXPRESSION; MEMBRANE; PREVENTS	The increase in protein activity and upregulation of G-protein coupled receptor kinase 2 (GRK2) is a hallmark of cardiac stress and heart failure. Inhibition of GRK2 improved cardiac function and survival and diminished cardiac remodeling in various animal heart failure models. The aim of the present study was to investigate the effects of GRK2 on cardiac hypertrophy and dissect potential molecular mechanisms. In mice we observed increased GRK2 mRNA and protein levels following transverse aortic constriction (TAC). Conditional GRK2 knockout mice showed attenuated hypertrophic response with preserved ventricular geometry 6 weeks after TAC operation compared to wild-type animals. In isolated neonatal rat ventricular cardiac myocytes stimulation with angiotensin II and phenylephrine enhanced GRK2 expression leading to enhanced signaling via protein kinase B (PKB or Akt), consecutively inhibiting glycogen synthase kinase 3 beta (GSK3(3), such promoting nuclear accumulation and activation of nuclear factor of activated T-cells (NFAT). Cardiac myocyte hypertrophy induced by in vitro GRK2 overexpression increased the cytosolic interaction of GRK2 and phosphoinositide 3-kinase y (PI3Ky). Moreover, inhibition of PI3Ky as well as GRK2 knock down prevented Akt activation resulting in halted NFAT activity and reduced cardiac myocyte hypertrophy. Our data show that enhanced GRK2 expression triggers cardiac hypertrophy by GRK2-PI3Ky mediated Akt phosphorylation and subsequent inactivation of GSK36, resulting in enhanced NFAT activity.	[Schlegel, Philipp; Reinkober, Julia; Meinhardt, Eric; Tscheschner, Henrike; Most, Patrick; Katus, Hugo A.; Raake, Philip W.] Heidelberg Univ, Dept Internal Med 3, Cardiol, Univ Hosp Heidelberg, Heidelberg, Germany; [Schlegel, Philipp; Backs, Johannes; Most, Patrick; Wieland, Thomas; Katus, Hugo A.] DZHK German Ctr Cardiovasc Res, Partner Site Heidelberg Mannheim, Berlin, Germany; [Gao, Erhe; Schumacher, Sarah M.; Yuan, Ancai; Koch, Walter J.] Temple Univ, Ctr Translat Med, Dept Pharmacol, Sch Med, Philadelphia, PA 19122 USA; [Backs, Johannes] Heidelberg Univ, Dept Mol Cardiol & Epigenet, Heidelberg, Germany; [Wieland, Thomas] Heidelberg Univ, Inst Expt & Clin Pharmacol & Toxicol, Med Fac Mannheim, Mannheim, Germany	Ruprecht Karls University Heidelberg; German Centre for Cardiovascular Research; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Raake, PW (corresponding author), Heidelberg Univ, Dept Internal Med 3, Cardiol, Univ Hosp Heidelberg, Heidelberg, Germany.	philip.raake@med.uni-heidelberg.de	Wieland, Thomas/Q-1506-2019; Wieland, Thomas/G-1772-2012	Wieland, Thomas/0000-0001-8262-8261; Wieland, Thomas/0000-0001-8262-8261; Schumacher, Sarah/0000-0002-4941-7267	Deutsche Forschungsgemeinschaft [1668/6-1, RA 1668/3-1, RA 1668/1-1]; Deutsche Herzstiftung; Novartis Foundation scholarship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL061690] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Herzstiftung; Novartis Foundation scholarship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grants from the Deutsche Forschungsgemeinschaft (http://www.dfg.de/; RA 1668/6-1, RA 1668/3-1 and RA 1668/1-1) to PWR, Deutsche Herzstiftung (http://www.herzstiftung.de/; F/43/13) to PWR and the Novartis Foundation scholarship to PS. The funders had no role in study	Akhter SA, 1998, SCIENCE, V280, P574, DOI 10.1126/science.280.5363.574; Aoyagi T, 2011, CURR PHARM DESIGN, V17, P1818, DOI 10.2174/138161211796390976; Benjamin EJ, 1999, AM J MED SCI, V317, P168, DOI 10.1097/00000441-199903000-00006; Brinks H, 2010, CIRC RES, V107, P1140, DOI 10.1161/CIRCRESAHA.110.221010; Cannavo A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00264; Chen M, 2013, CIRC RES, V112, P1121, DOI 10.1161/CIRCRESAHA.112.300754; Choi DJ, 1997, J BIOL CHEM, V272, P17223, DOI 10.1074/jbc.272.27.17223; Ciccarelli M, 2011, CIRCULATION, V123, P1953, DOI 10.1161/CIRCULATIONAHA.110.988642; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Hall RA, 2002, CIRC RES, V91, P672, DOI 10.1161/01.RES.0000037000.74258.03; Kamal FA, 2014, J AM COLL CARDIOL, V63, P2549, DOI 10.1016/j.jacc.2014.02.587; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Matkovich SJ, 2006, CIRC RES, V99, P996, DOI 10.1161/01.RES.0000247932.71270.2c; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Most P, 2003, J BIOL CHEM, V278, P48404, DOI 10.1074/jbc.M308587200; Noor N, 2011, J MOL CELL CARDIOL, V51, P534, DOI 10.1016/j.yjmcc.2010.11.005; Penela P, 2010, BRIT J PHARMACOL, V160, P821, DOI 10.1111/j.1476-5381.2010.00727.x; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Prasad SVN, 2000, J BIOL CHEM, V275, P4693, DOI 10.1074/jbc.275.7.4693; Prasad SVN, 2001, J BIOL CHEM, V276, P18953, DOI 10.1074/jbc.M102376200; Premont RT, 1996, J BIOL CHEM, V271, P6403, DOI 10.1074/jbc.271.11.6403; Raake PW, 2008, CIRC RES, V103, P413, DOI 10.1161/CIRCRESAHA.107.168336; Raake PW, 2012, CIRCULATION, V125, P2108, DOI 10.1161/CIRCULATIONAHA.111.044255; Raake PWJ, 2013, EUR HEART J, V34, P1437, DOI 10.1093/eurheartj/ehr447; Ramos-Ruiz R, 2000, CIRCULATION, V101, P2083, DOI 10.1161/01.CIR.101.17.2083; Rockman HA, 1998, P NATL ACAD SCI USA, V95, P7000, DOI 10.1073/pnas.95.12.7000; Salcedo A, 2006, EMBO J, V25, P4752, DOI 10.1038/sj.emboj.7601351; Shiojima I, 2006, GENE DEV, V20, P3347, DOI 10.1101/gad.1492806; Sorriento D, 2015, J CARDIOVASC TRANSL, V8, P493, DOI 10.1007/s12265-015-9646-0; Sussman MA, 2011, PHYSIOL REV, V91, P1023, DOI 10.1152/physrev.00024.2010; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; UNGERER M, 1993, CIRCULATION, V87, P454, DOI 10.1161/01.CIR.87.2.454; Volkers M, 2011, CIRC RES, V108, P27, DOI 10.1161/CIRCRESAHA.110.225201; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Zhou YY, 2000, AM J PHYSIOL-HEART C, V279, pH429	39	22	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0182110	10.1371/journal.pone.0182110	http://dx.doi.org/10.1371/journal.pone.0182110			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759639	Green Submitted, Green Published, gold			2022-12-26	WOS:000406761600053
J	Silva-Vilches, C; Pletinckx, K; Lohnert, M; Pavlovic, V; Ashour, D; John, V; Vendelova, E; Kneitz, S; Zhou, J; Chen, R; Reinheckel, T; Mueller, TD; Bodem, J; Lutz, MB				Silva-Vilches, Cinthia; Pletinckx, Katrien; Lohnert, Miriam; Pavlovic, Vladimir; Ashour, Diyaaeldin; John, Vini; Vendelova, Emilia; Kneitz, Susanne; Zhou, Jie; Chen, Rena; Reinheckel, Thomas; Mueller, Thomas D.; Bodem, Jochen; Lutz, Manfred B.			Low doses of cholera toxin and its mediator cAMP induce CTLA-2 secretion by dendritic cells to enhance regulatory T cell conversion	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CATHEPSIN-L; IN-VIVO; TOLERANCE INDUCTION; CYSTEINE PROTEASES; BYSTANDER ANTIGENS; ADJUVANT ACTIVITY; SEMI-MATURE; TH17 CELLS; ACTIVATION	Immature or semi-mature dendritic cells (DCs) represent tolerogenic maturation stages that can convert naive T cells into Foxp3(+) induced regulatory T cells (iTreg). Here we found that murine bone marrow-derived DCs (BM-DCs) treated with cholera toxin (CT) matured by up-regulating MHC-II and costimulatory molecules using either high or low doses of CT (CThi, CTlo) or with cAMP, a known mediator CT signals. However, all three conditions also induced mRNA of both isoforms of the tolerogenic molecule cytotoxic T lymphocyte antigen 2 (CTLA-2 alpha and CTLA-2 beta). Only DCs matured under CThi conditions secreted IL-1 beta, IL-6 and IL-23 leading to the instruction of Th17 cell polarization. In contrast, CTlo - or cAMP-DCs resembled semi-mature DCs and enhanced TGF-beta-dependent Foxp3(+) iTreg conversion. iTreg conversion could be reduced using siRNA blocking of CTLA-2 and reversely, addition of recombinant CTLA-2 alpha increased iTreg conversion in vitro. Injection of CTlo - or cAMP-DCs exerted MOG peptide-specific protective effects in experimental autoimmune encephalomyelitis (EAE) by inducing Foxp3(+) Tregs and reducing Th17 responses. Together, we identified CTLA-2 production by DCs as a novel tolerogenic mediator of TGF-beta-mediated iTreg induction in vitro and in vivo. The CT-induced and cAMP-mediated up-regulation of CTLA-2 also may point to a novel immune evasion mechanism of Vibrio cholerae.	[Silva-Vilches, Cinthia; Pletinckx, Katrien; Lohnert, Miriam; Pavlovic, Vladimir; Ashour, Diyaaeldin; John, Vini; Vendelova, Emilia; Kneitz, Susanne; Bodem, Jochen; Lutz, Manfred B.] Univ Wurzburg, Inst Virol & Immunobiol, Wurzburg, Germany; [Kneitz, Susanne] Univ Wurzburg, Dept Physiol Chem, Wurzburg, Germany; [Zhou, Jie; Chen, Rena] BioLegend Inc, San Diego, CA USA; [Reinheckel, Thomas] Univ Freiburg, Inst Mol Med & Cell Res, Freiburg, Germany; [Reinheckel, Thomas] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, Freiburg, Germany; [Mueller, Thomas D.] Univ Wurzburg, Dept Mol Plant Physiol & Biophys, Wurzburg, Germany; [Silva-Vilches, Cinthia] Heidelberg Univ, Dept Dermatol, Heidelberg, Germany; [Pletinckx, Katrien] Grunenthal GmbH, Cellular Biol, Drug Discovery, Aachen, Germany	University of Wurzburg; University of Wurzburg; University of Freiburg; University of Freiburg; University of Wurzburg; Ruprecht Karls University Heidelberg; Grunenthal Group	Lutz, MB (corresponding author), Univ Wurzburg, Inst Virol & Immunobiol, Wurzburg, Germany.	m.lutz@vim.uni-wuerzburg.de	Reinheckel, Thomas/AAL-9761-2021; Bodem, Jochen/H-9122-2019; John, Vini/GLU-7078-2022	Reinheckel, Thomas/0000-0001-9866-9105; Bodem, Jochen/0000-0003-1908-4091; John, Vini/0000-0001-9714-7268; Mueller, Thomas/0000-0003-1862-7357; Lutz, Manfred B./0000-0001-9193-1772	German Research Foundation (DFG); University of Wuerzburg in the funding programme Open Access Publishing; DAAD; collaborative research centre of the DFG [TR52]	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg in the funding programme Open Access Publishing; DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); collaborative research centre of the DFG(German Research Foundation (DFG))	This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The Stibet program of the DAAD and the collaborative research centre TR52 of the DFG provided support in the form of salaries for author CSV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Abe Y, 2004, GROWTH FACTORS, V22, P105, DOI 10.1080/08977190410001704688; Akira S, 2004, CR BIOL, V327, P581, DOI 10.1016/j.crvi.2004.04.002; Apte SH, 2013, EUR J IMMUNOL, V43, P2707, DOI 10.1002/eji.201343475; Azukizawa H, 2011, EUR J IMMUNOL, V41, P1420, DOI 10.1002/eji.201040930; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Braun MC, 1999, J EXP MED, V189, P541, DOI 10.1084/jem.189.3.541; Bromme D, 1999, BIOCHEMISTRY-US, V38, P2377, DOI 10.1021/bi982175f; BRUNET JF, 1988, IMMUNOL REV, V103, P21, DOI 10.1111/j.1600-065X.1988.tb00747.x; Campo MA, 1996, AM J OBSTET GYNECOL, V174, P1605, DOI 10.1016/S0002-9378(96)70614-2; Datta SK, 2010, P NATL ACAD SCI USA, V107, P10638, DOI 10.1073/pnas.1002348107; de Haan L, 2004, MOL MEMBR BIOL, V21, P77, DOI 10.1080/09687680410001663267; DELARIA K, 1994, J BIOL CHEM, V269, P25172; DENIZOT F, 1989, EUR J IMMUNOL, V19, P631, DOI 10.1002/eji.1830190409; Deussing J, 2002, GENOMICS, V79, P225, DOI 10.1006/geno.2002.6696; Gagliardi MC, 2000, EUR J IMMUNOL, V30, P2394, DOI 10.1002/1521-4141(2000)30:8<2394::AID-IMMU2394>3.0.CO;2-Y; Grdic D, 2005, J IMMUNOL, V175, P5192, DOI 10.4049/jimmunol.175.8.5192; Gregori S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00030; Gustafsson T, 2013, EUR J IMMUNOL, V43, P1779, DOI 10.1002/eji.201242867; Heufler C, 1996, EUR J IMMUNOL, V26, P659, DOI 10.1002/eji.1830260323; Hilkens CMU, 2010, INT REV IMMUNOL, V29, P156, DOI 10.3109/08830180903281193; Iezzi G, 1999, EUR J IMMUNOL, V29, P4092, DOI 10.1002/(SICI)1521-4141(199912)29:12<4092::AID-IMMU4092>3.3.CO;2-1; Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kasabova M, 2014, J BIOL CHEM, V289, P16239, DOI 10.1074/jbc.M113.542407; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kurata M, 2003, PROTEIN EXPRES PURIF, V32, P119, DOI 10.1016/S1046-5928(03)00222-5; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Lavelle EC, 2003, J IMMUNOL, V171, P2384, DOI 10.4049/jimmunol.171.5.2384; Lee JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005190; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Lutz MB, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22796; Lutz MB, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00123; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Luziga C, 2008, BRAIN RES, V1204, P40, DOI 10.1016/j.brainres.2008.01.067; LYONS RM, 1988, J CELL BIOL, V106, P1659, DOI 10.1083/jcb.106.5.1659; MARINARO M, 1995, J IMMUNOL, V155, P4621; Menges M, 2002, J EXP MED, V195, P15, DOI 10.1084/jem.20011341; Min B, 2008, NAT IMMUNOL, V9, P223, DOI 10.1038/ni0308-223; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097; O'Garra A, 2011, NAT IMMUNOL, V12, P288, DOI 10.1038/ni.2003; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Olvera-Gomez I, 2012, P NATL ACAD SCI USA, V109, P2072, DOI 10.1073/pnas.1105771109; Phythian-Adams AT, 2010, J EXP MED, V207, P2089, DOI 10.1084/jem.20100734; Pletinckx K, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00039; Pletinckx K, 2011, EUR J IMMUNOL, V41, P3479, DOI 10.1002/eji.201141631; Ram SJ, 2004, BIOPHOTONICS INT; Roediger B, 2015, ADV IMMUNOL, V125, P111, DOI 10.1016/bs.ai.2014.09.004; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; Rothenbacher FP, 2014, GUT MICROBES, V5, P120, DOI 10.4161/gmic.26944; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Somanna A, 2002, J BIOL CHEM, V277, P25305, DOI 10.1074/jbc.M203034200; Stanford M, 2004, CLIN EXP IMMUNOL, V137, P201, DOI 10.1111/j.1365-2249.2004.02520.x; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Su SB, 2004, J IMMUNOL, V173, P755, DOI 10.4049/jimmunol.173.2.755; Sugita S, 2008, J IMMUNOLOGY, V181; Sugita S, 2011, INVEST OPHTH VIS SCI, V52, P2598, DOI 10.1167/iovs.10-6322; Sugita S, 2009, J IMMUNOL, V183, P5013, DOI 10.4049/jimmunol.0901623; Sun JB, 2010, SCAND J IMMUNOL, V71, P1, DOI 10.1111/j.1365-3083.2009.02321.x; Thomson AW, 2009, TRANSPLANTATION, V87, pS86, DOI 10.1097/TP.0b013e3181a2dcec; Todorovic V, 2012, J CELL BIOCHEM, V113, P410, DOI 10.1002/jcb.23385; Tolosa E, 2003, J CLIN INVEST, V112, P517, DOI 10.1172/JCI200318028; Van Meirvenne S, 2002, CANCER GENE THER, V9, P787, DOI 10.1038/sj.cgt.7700499; van Panhuys N, 2014, IMMUNITY, V41, P63, DOI 10.1016/j.immuni.2014.06.003; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; Wille A, 2004, BIOL CHEM, V385, P665, DOI 10.1515/BC.2004.082; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737; Yura M, 2001, VACCINE, V20, P134, DOI 10.1016/S0264-410X(01)00278-X; ZAL T, 1994, J EXP MED, V180, P2089, DOI 10.1084/jem.180.6.2089; Zhang LZ, 2011, CELL SIGNAL, V23, P1611, DOI 10.1016/j.cellsig.2011.05.014; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	75	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0178114	10.1371/journal.pone.0178114	http://dx.doi.org/10.1371/journal.pone.0178114			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759565	gold, Green Published, Green Submitted			2022-12-26	WOS:000406761600002
J	Alexander, KL; Katz, J; Elson, CO				Alexander, Katie L.; Katz, Jannet; Elson, Charles O.			CBirTox is a selective antigen-specific agonist of the Treg-IgA-microbiota homeostatic pathway	PLOS ONE			English	Article							REGULATORY T-CELLS; TOXIN-B-SUBUNIT; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CHOLERA-TOXIN; DENDRITIC CELLS; GUT MICROBIOME; RETINOIC ACID; IMMUNE-RESPONSES; PRESENTING CELLS; SMALL-INTESTINE	Cultivating an environment of mutualism between host cells and the microbiota is vital, and dysregulation of this relationship is associated with multiple immune disorders including metabolic and skin diseases, asthma, allergy, and Inflammatory Bowel Disease (IBD). One prominent mechanism for maintaining homeostasis is the protective regulatory T cell (Treg)-Immunoglobulin A (IgA) pathway toward microbiota antigens, in which Tregs maintain homeostasis and provide critical survival factors to IgA(+) B cells. In order to amplify the Treg-IgA pathway, we have generated a fusion protein, CBirTox, comprised of a portion of the carboxy terminus of CBir1, a microbiota flagellin, genetically coupled to Cholera Toxin B subunit (CTB) via the A2 linker of CT. Both dendritic cells (DCs) and B cells pulsed with CBirTox selectively induced functional CD4(+)Foxp3(+) Tregs in vitro, and CBirTox augmented CD4(+)Foxp3(+) cell numbers in vivo. The induced Foxp3 expression was independent of retinoic acid (RA) signaling but was inhibited by neutralization of TGF-beta. CBirTox treatment of B cells downregulated mammalian target of rapamycin (mTOR) signaling. Furthermore, CBirTox-pulsed DCs induced substantial production of IgA from naive B cells. Collectively these data demonstrate that CBirTox represents a novel approach to bolstering the Treg-IgA pathway at the host-microbiota interface.	[Alexander, Katie L.; Elson, Charles O.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Katz, Jannet] Univ Alabama Birmingham, Dept Pediat Dent, Birmingham, AL USA; [Elson, Charles O.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Elson, CO (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.; Elson, CO (corresponding author), Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA.	coelson@uabmc.edu		Elson, Charles/0000-0001-8873-1534	NIH [DK071176]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant DK071176. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basset C, 2010, TOXINS, V2, P1774, DOI 10.3390/toxins2071774; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Carbone J, 2011, EXPERT REV ANTI-INFE, V9, P405, DOI [10.1586/eri.10.178, 10.1586/ERI.10.178]; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Corthay A, 2009, SCAND J IMMUNOL, V70, P326, DOI 10.1111/j.1365-3083.2009.02308.x; Dawson RM, 2005, J APPL TOXICOL, V25, P30, DOI 10.1002/jat.1015; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Dertzbaugh MT, 1998, PROTEIN ENG, V11, P577, DOI 10.1093/protein/11.7.577; Dubinsky MC, 2006, AM J GASTROENTEROL, V101, P360, DOI 10.1111/j.1572-0241.2006.00456.x; Elson CO, 2006, ANN NY ACAD SCI, V1072, P39, DOI 10.1196/annals.1326.010; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Feng T, 2010, J IMMUNOL, V185, P5915, DOI 10.4049/jimmunol.1001233; Feuerer M, 2010, P NATL ACAD SCI USA, V107, P5919, DOI 10.1073/pnas.1002006107; George-Chandy A, 2001, INFECT IMMUN, V69, P5716, DOI 10.1128/IAI.69.9.5716-5725.2001; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gloudemans AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059822; Gordon JR, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00007; Haidinger M, 2010, J IMMUNOL, V185, P3919, DOI 10.4049/jimmunol.1000296; HAJISHENGALLIS G, 1995, J IMMUNOL, V154, P4322; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Holmgren J, 2005, IMMUNOL LETT, V97, P181, DOI 10.1016/j.imlet.2004.11.009; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; HOLMGREN J, 1973, INFECT IMMUN, V8, P208, DOI 10.1128/IAI.8.2.208-214.1973; Kaetzel CS, 2005, IMMUNOL REV, V206, P83, DOI 10.1111/j.0105-2896.2005.00278.x; Kelly JR, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00392; Konrad A, 2006, GASTROENTEROLOGY, V130, P2050, DOI 10.1053/j.gastro.2006.02.055; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Limon JJ, 2014, P NATL ACAD SCI USA, V111, pE5076, DOI 10.1073/pnas.1407104111; Macedo C, 2012, TRANSPLANT RES, V1, DOI 10.1186/2047-1440-1-16; Mantis NJ, 2011, MUCOSAL IMMUNOL, V4, P603, DOI 10.1038/mi.2011.41; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; MCKENZIE SJ, 1984, J IMMUNOL, V133, P1818; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Pollizzi KN, 2014, NAT REV IMMUNOL, V14, P435, DOI 10.1038/nri3701; Schmidt A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00051; Schnitzler AC, 2007, INFECT IMMUN, V75, P3150, DOI 10.1128/IAI.00581-06; Sharma MD, 2007, J CLIN INVEST, V117, P2570, DOI 10.1172/JCI31911; Strober W, 1997, IMMUNOL TODAY, V18, P61, DOI 10.1016/S0167-5699(97)01000-1; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Sun JB, 2010, SCAND J IMMUNOL, V71, P1, DOI 10.1111/j.1365-3083.2009.02321.x; Sun JB, 2000, INT IMMUNOL, V12, P1449, DOI 10.1093/intimm/12.10.1449; SUN JB, 1994, P NATL ACAD SCI USA, V91, P10795, DOI 10.1073/pnas.91.23.10795; Sun JB, 2012, J IMMUNOL, V188, P1686, DOI 10.4049/jimmunol.1101771; Tarkowski A, 1999, ARTHRITIS RHEUM, V42, P1628, DOI 10.1002/1529-0131(199908)42:8<1628::AID-ANR10>3.0.CO;2-T; Thaiss CA, 2014, CELL HOST MICROBE, V15, P662, DOI 10.1016/j.chom.2014.05.016; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnquist HR, 2007, J IMMUNOL, V178, P7018, DOI 10.4049/jimmunol.178.11.7018; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; WOOGEN SD, 1987, J IMMUNOL, V139, P3764; Workman CJ, 2009, CELL MOL LIFE SCI, V66, P2603, DOI 10.1007/s00018-009-0026-2; Xu XJ, 2012, SEMIN IMMUNOL, V24, P429, DOI 10.1016/j.smim.2012.12.005; Zeng H, 2015, TRENDS IMMUNOL, V36, P3, DOI 10.1016/j.it.2014.08.003	57	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181866	10.1371/journal.pone.0181866	http://dx.doi.org/10.1371/journal.pone.0181866			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750075	gold, Green Submitted, Green Published			2022-12-26	WOS:000406575700094
J	Beczek, M; Ryzak, M; Sochan, A; Mazur, R; Polakowski, C; Bieganowski, A				Beczek, Michal; Ryzak, Magdalena; Sochan, Agata; Mazur, Rafal; Polakowski, Cezary; Bieganowski, Andrzej			The differences in crown formation during the splash on the thin water layers formed on the saturated soil surface and model surface	PLOS ONE			English	Article							DROP IMPACT; SINGLE DROP; LIQUID SURFACE; EROSION; FILM; DYNAMICS; DETACHMENT; TENSION; LAND; SUSPENSIONS	Splash is the first stage of a negative phenomenon-soil erosion. The aim of this work was to describe the crown formation quantitatively (as part of the splash erosion) and compare the course of this phenomenon on the thin water film formed on a smooth glass surface and on the surface of saturated soil. The height of the falling water drop was 1.5 m. The observation of the crowns was carried out by high-speed cameras. The static and dynamic parameters of crown formation were analysed. It was found that the crowns formed on the water film covering the saturated soil surface were smaller and the time intervals of their existence were shorter. In addition, the shapes of the crowns were different from those created on the water layer covering the glass surface. These differences can be explained by the slightly different values of surface tension and viscosity of the soil solution, the greater roughness of the soil surface and the lower thickness of the water film on the soil surface.	[Beczek, Michal; Ryzak, Magdalena; Sochan, Agata; Mazur, Rafal; Polakowski, Cezary; Bieganowski, Andrzej] Inst Agrophys PAS, Lublin, Poland	Polish Academy of Sciences; Bohdan Dobrzanski Institute of Agrophysics of the Polish Academy of Sciences	Beczek, M (corresponding author), Inst Agrophys PAS, Lublin, Poland.	m.beczek@ipan.lublin.pl	Polakowski, Cezary/H-7294-2013	Polakowski, Cezary/0000-0002-1658-8334; Bieganowski, Andrzej/0000-0002-3571-3241; Sochan, Agata/0000-0002-1987-0220; Beczek, Michal/0000-0002-8851-0982; Ryzak, Magdalena/0000-0002-6400-5375; Mazur, Rafal/0000-0002-5520-3863	National Science Centre, Poland [2014/14/E/ST10/00851]; Statutory Research of Institute of Agrophysics Polish Academy of Sciences	National Science Centre, Poland(National Science Centre, Poland); Statutory Research of Institute of Agrophysics Polish Academy of Sciences	This work was partially financed from: 1) National Science Centre, Poland in the frame of project no. 2014/14/E/ST10/00851; 2) Statutory Research of Institute of Agrophysics Polish Academy of Sciences. The authors declare that all the funding or sources of support (whether external or internal) were listed and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2013, LANDFORMS; ALDURRAH M, 1981, SOIL SCI SOC AM J, V45, P949, DOI 10.2136/sssaj1981.03615995004500050026x; [Anonymous], 992007 ISOIEC; Bandura L, 2015, FUEL, V147, P100, DOI 10.1016/j.fuel.2015.01.067; Bargiel D, 2013, J ENVIRON MANAGE, V124, P82, DOI 10.1016/j.jenvman.2013.03.049; Bogacz A., 2013, Soil Science Annual, V64, P88; CAI YK, 1989, EXP FLUIDS, V7, P388; Cheng M, 2015, COMPUT FLUIDS, V115, P11, DOI 10.1016/j.compfluid.2015.03.019; Coghe A, 1999, C MAT ILASS EUR 99; Cossali GE, 1997, EXP FLUIDS, V22, P463, DOI 10.1007/s003480050073; Cossali GE, 2004, EXP FLUIDS, V36, P888, DOI 10.1007/s00348-003-0772-0; Dadashev RK, 2015, RUSS J PHYS CHEM A+, V89, P1504, DOI 10.1134/S0036024415080075; Dong LC, 2003, LANGMUIR, V19, P10205, DOI 10.1021/la035128j; Fernandez-Raga M, 2010, ATMOS RES, V96, P225, DOI 10.1016/j.atmosres.2009.07.013; Funk R, 2016, SPRINGER WATER, P425, DOI 10.1007/978-3-319-24409-9_18; Furbish DJ, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000498; GOLDSACK DE, 1977, CAN J CHEM, V55, P1062, DOI 10.1139/v77-148; Hakansson I, 2000, SOIL TILL RES, V53, P71, DOI 10.1016/S0167-1987(99)00095-1; Imerson AC, 1981, CATENA, V8, P83; Jezierska-Tys S, 2010, J TOXICOL ENV HEAL A, V73, P1194, DOI 10.1080/15287394.2010.491777; Korbiel T, 2015, MEAS CONTROL-UK, V48, P149, DOI 10.1177/0020294015572667; Krechetnikov R, 2009, J COLLOID INTERF SCI, V331, P555, DOI 10.1016/j.jcis.2008.11.079; Kubota Y, 2011, J VISUAL-JAPAN, V14, P111, DOI 10.1007/s12650-011-0071-4; Lamorski K, 2014, J PLANT NUTR SOIL SC, V177, P803, DOI 10.1002/jpln.201300594; Legout C, 2005, GEODERMA, V124, P279, DOI 10.1016/j.geoderma.2004.05.006; Liang GT, 2014, THEOR COMP FLUID DYN, V28, P159, DOI 10.1007/s00162-013-0308-z; Long EJ, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.032201; Manzello SL, 2002, EXP FLUIDS, V32, P580, DOI 10.1007/S00348-001-0401-8; Marzen M, 2015, CATENA, V127, P135, DOI 10.1016/j.catena.2014.12.023; Menta C., 2012, BIODIVERS CONSERV UT, DOI [10.5772/51091, DOI 10.5772/51091]; Moghadam BK, 2015, GEODERMA, V241, P210, DOI 10.1016/j.geoderma.2014.11.025; Mouzai L, 2003, J HYDRAUL RES, V41, P61, DOI 10.1080/00221680309499929; Musztyfaga E, 2015, ENV PROTECTION NATUR, V25, P45; Naderi-Boldaji M, 2016, SOIL TILL RES, V159, P41, DOI 10.1016/j.still.2016.01.010; Nakonieczna A, 2015, SENSORS-BASEL, V15, P8464, DOI 10.3390/s150408464; Nikolopoulos N, 2005, INT J HEAT FLUID FL, V26, P119, DOI 10.1016/j.ijheatfluidflow.2004.06.002; Nosalewicz A, 2014, PLANT SOIL, V375, P229, DOI 10.1007/s11104-013-1961-0; Paluszek J, 2013, SOIL SCI ANNU, V64, P41, DOI 10.2478/ssa-2013-0008; Panagos P, 2015, ENVIRON SCI POLICY, V54, P438, DOI 10.1016/j.envsci.2015.08.012; Poesen J., 1988, Catena Supplement, P113; Quinton JN, 2010, NAT GEOSCI, V3, P311, DOI [10.1038/NGEO838, 10.1038/ngeo838]; Raman KA, 2015, COMPUT FLUIDS, V107, P285, DOI 10.1016/j.compfluid.2014.11.007; Rejman J, 2014, SOIL TILL RES, V143, P77, DOI 10.1016/j.still.2014.05.011; Rekasi M, 2013, CHEM ECOL, V29, P709, DOI 10.1080/02757540.2013.817568; Rioboo R, 2003, EXP FLUIDS, V35, P648, DOI 10.1007/s00348-003-0719-5; Ryzak M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158472; Ryzak M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119269; Ryzak M, 2012, SENSORS-BASEL, V12, P11527, DOI 10.3390/s120911527; Sarapatka B, 2015, J ENVIRON QUAL, V44, P154, DOI 10.2134/jeq2014.05.0233; Seeger M., 2015, EGU GEN ASS C, P17; Siczek A, 2015, SOIL TILL RES, V153, P175, DOI 10.1016/j.still.2015.06.006; Tuo D, 2015, J SOIL SEDIMENT, V2, P1; Vander Wal RL, 2006, EXP FLUIDS, V40, P33, DOI 10.1007/s00348-005-0044-2; Vander Wal RL, 2006, EXP FLUIDS, V40, P23, DOI 10.1007/s00348-005-0043-3; Viswanath DS., 2007, VISCOSITY LIQUIDS TH; Walkiewicz A, 2016, ENVIRON POLLUT, V213, P403, DOI 10.1016/j.envpol.2016.02.048; Weissenborn PK, 1996, J COLLOID INTERF SCI, V184, P550, DOI 10.1006/jcis.1996.0651; Wolinska A, 2015, POL J ENVIRON STUD, V24, P2677, DOI 10.15244/pjoes/59323; Worthington A. M., 1895, THE SPLASH OF A DROP; Yarin AL, 2006, ANNU REV FLUID MECH, V38, P159, DOI 10.1146/annurev.fluid.38.050304.092144; YARIN AL, 1995, J FLUID MECH, V283, P141, DOI 10.1017/S0022112095002266; Zhang LV, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3526743	62	16	16	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181974	10.1371/journal.pone.0181974	http://dx.doi.org/10.1371/journal.pone.0181974			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750072	Green Published, Green Submitted, gold			2022-12-26	WOS:000406575700108
J	Bohm, A; Wagner, R; Machicao, F; Holst, JJ; Gallwitz, B; Stefan, N; Fritsche, A; Haring, HU; Staiger, H				Boehm, Anja; Wagner, Robert; Machicao, Fausto; Holst, Jens Juul; Gallwitz, Baptist; Stefan, Norbert; Fritsche, Andreas; Haering, Hans-Ulrich; Staiger, Harald			DPP4 gene variation affects GLP-1 secretion, insulin secretion, and glucose tolerance in humans with high body adiposity	PLOS ONE			English	Article							DIPEPTIDYL-PEPTIDASE-IV; TYPE-2 DIABETES-MELLITUS; GLUCAGON-LIKE PEPTIDE-1; DEFICIENT FISCHER RATS; OBESITY; DEGRADATION; RESISTANCE; SITAGLIPTIN; SENSITIVITY; HEALTHY	Objective Dipeptidyl-peptidase 4 (DPP-4) cleaves and inactivates the insulinotropic hormones glucagon-like peptide 1 (GLP-1) and gastric inhibitory polypeptide, collectively termed incretins. DPP-4 inhibitors entered clinical practice as approved therapeutics for type-2 diabetes in 2006. However, inter-individual variance in the responsiveness to DPP-4 inhibitors was reported. Thus, we asked whether genetic variation in the DPP4 gene affects incretin levels, insulin secretion, and glucose tolerance in participants of the TUbingen Family study for type-2 diabetes (TUF). Research design and methods Fourteen common (minor allele frequencies >= 0.05) DPP4 tagging single nucleotide polymorphisms (SNPs) were genotyped in 1,976 non-diabetic TUF participants characterized by oral glucose tolerance tests and bioimpedance measurements. In a subgroup of 168 subjects, plasma incretin levels were determined. Results We identified a variant, i.e., SNP rs6741949, in intron 2 of the DPP4 gene that, after correction for multiple comparisons and appropriate adjustment, revealed a significant genotype-body fat interaction effect on glucose-stimulated plasma GLP-1 levels (p = 0.0021). Notably, no genotype-BMI interaction effects were detected (p = 0.8). After stratification for body fat content, the SNP negatively affected glucose-stimulated GLP-1 levels (p = 0.0229), insulin secretion (p = 0.0061), and glucose tolerance (p = 0.0208) in subjects with high body fat content only. Conclusions A common variant, i.e., SNP rs6741949, in the DPP4 gene interacts with body adiposity and negatively affects glucose-stimulated GLP-1 levels, insulin secretion, and glucose tolerance. Whether this SNP underlies the reported inter-individual variance in responsiveness to DPP-4 inhibitors, at least in subjects with high body fat content, remains to be shown.	[Boehm, Anja; Wagner, Robert; Gallwitz, Baptist; Stefan, Norbert; Fritsche, Andreas; Haering, Hans-Ulrich] Eberhard Karls Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, Tubingen, Germany; [Boehm, Anja; Wagner, Robert; Machicao, Fausto; Stefan, Norbert; Fritsche, Andreas; Haering, Hans-Ulrich; Staiger, Harald] German Ctr Diabet Res DZD, Tubingen, Germany; [Boehm, Anja; Wagner, Robert; Machicao, Fausto; Stefan, Norbert; Fritsche, Andreas; Haering, Hans-Ulrich; Staiger, Harald] Univ Tubingen, Helmholtz Ctr Munich, Inst Diabet Res & Metab Dis, Tubingen, Germany; [Holst, Jens Juul] Univ Copenhagen, Sect Translat Metab Physiol, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Fritsche, Andreas] Eberhard Karls Univ Tubingen, Div Nutr & Prevent Med, Dept Internal Med, Tubingen, Germany; [Haering, Hans-Ulrich; Staiger, Harald] Eberhard Karls Univ Tubingen, Interfac Ctr Pharmacogen & Pharma Res, Tubingen, Germany; [Staiger, Harald] Eberhard Karls Univ Tubingen, Dept Biochem & Pharm, Inst Pharmaceut Sci, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Novo Nordisk Foundation; University of Copenhagen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Staiger, H (corresponding author), German Ctr Diabet Res DZD, Tubingen, Germany.; Staiger, H (corresponding author), Univ Tubingen, Helmholtz Ctr Munich, Inst Diabet Res & Metab Dis, Tubingen, Germany.; Staiger, H (corresponding author), Eberhard Karls Univ Tubingen, Interfac Ctr Pharmacogen & Pharma Res, Tubingen, Germany.; Staiger, H (corresponding author), Eberhard Karls Univ Tubingen, Dept Biochem & Pharm, Inst Pharmaceut Sci, Tubingen, Germany.	harald.staiger@med.uni-tuebingen.de	Gallwitz, Baptist/AAQ-2051-2020; Holst, Jens/AAA-8022-2022; Wagner, Robert/B-3689-2012	Gallwitz, Baptist/0000-0002-8880-6409; Wagner, Robert/0000-0002-6120-0191; Stefan, Norbert/0000-0002-2186-9595; Staiger, Harald/0000-0002-9507-5333; Moller, Anja/0000-0002-5344-8533; Holst, Jens Juul/0000-0001-6853-3805	German Federal Ministry of Education and Research (BMBF) [01G10925]; Deutsche Forschungsgemeinschaft [STE 1096/3-1]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported in part by a grant (01G10925) from the German Federal Ministry of Education and Research (BMBF) to the German Centre for Diabetes Research (DZD e.V.). N.S. is supported by a Heisenberg professorship from the Deutsche Forschungsgemeinschaft (STE 1096/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSORGE S, 1987, ACTA HISTOCHEM, V82, P41, DOI 10.1016/S0065-1281(87)80049-1; Aschner P, 2012, LANCET, V379, P2262, DOI 10.1016/S0140-6736(12)60439-5; Aso Y, 2012, TRANSL RES, V159, P25, DOI 10.1016/j.trsl.2011.09.005; Bouchard L, 2009, ACTA DIABETOL, V46, P13, DOI 10.1007/s00592-008-0049-4; Carr RD, 2010, J CLIN ENDOCR METAB, V95, P872, DOI 10.1210/jc.2009-2054; Conarello SL, 2003, P NATL ACAD SCI USA, V100, P6825, DOI 10.1073/pnas.0631828100; Deacon CF, 2000, J CLIN ENDOCR METAB, V85, P3575, DOI 10.1210/jc.85.10.3575; Deacon CF, 2004, HORM METAB RES, V36, P761, DOI 10.1055/s-2004-826160; DEACON CF, 1995, J CLIN ENDOCR METAB, V80, P952, DOI 10.1210/jc.80.3.952; Gallwitz B, 2011, DRUGS, V71, P1675, DOI 10.2165/11592810-000000000-00000; Gallwitz B, 2011, EXPERT OPIN INV DRUG, V20, P723, DOI 10.1517/13543784.2011.576667; Garber AJ, 2011, J AM OSTEOPATH ASSOC, V111, pS20; Herzberg-Schafer SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014194; Kirino Y, 2012, ENDOCR J, V59, P949, DOI 10.1507/endocrj.EJ12-0158; Kirino Y, 2011, AM J PHYSIOL-ENDOC M, V300, pE372, DOI 10.1152/ajpendo.00319.2010; Lambeir AM, 2003, CRIT REV CL LAB SCI, V40, P209, DOI 10.1080/713609354; Lamers D, 2011, DIABETES, V60, P1917, DOI 10.2337/db10-1707; Lencioni C, 2008, CURR DIABETES REP, V8, P179, DOI 10.1007/s11892-008-0031-0; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Matteucci E, 2009, CURR MED CHEM, V16, P2943, DOI 10.2174/092986709788803114; Mentlein R, 1999, REGUL PEPTIDES, V85, P9, DOI 10.1016/S0167-0115(99)00089-0; Monami M, 2011, DIABETES-METAB RES, V27, P362, DOI 10.1002/dmrr.1184; Muscelli E, 2008, DIABETES, V57, P1340, DOI 10.2337/db07-1315; Nagakura T, 2001, BIOCHEM BIOPH RES CO, V284, P501, DOI 10.1006/bbrc.2001.4999; Nauck MA, 2011, AM J MED, V124, pS19, DOI 10.1016/j.amjmed.2010.11.002; Reinehr T, 2010, J PEDIATR ENDOCR MET, V23, P101; Schweizer Anja, 2012, Diabetes Ther, V3, P8, DOI 10.1007/s13300-012-0008-5; Staiger H, 2009, ENDOCR REV, V30, P557, DOI 10.1210/er.2009-0017; Stefan N, 2005, DIABETOLOGIA, V48, P2282, DOI 10.1007/s00125-005-1948-3; Toft-Nielsen MB, 2001, J CLIN ENDOCR METAB, V86, P3717, DOI 10.1210/jc.86.8.3717; VANHOOF G, 1992, EUR J CLIN CHEM CLIN, V30, P333; Yasuda N, 2002, LIFE SCI, V71, P227, DOI 10.1016/S0024-3205(02)01637-5	32	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181880	10.1371/journal.pone.0181880	http://dx.doi.org/10.1371/journal.pone.0181880			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750074	Green Submitted, gold, Green Published			2022-12-26	WOS:000406575700096
J	Dudek, CA; Dannheim, H; Schomburg, D				Dudek, Christian-Alexander; Dannheim, Henning; Schomburg, Dietmar			BrEPS 2.0: Optimization of sequence pattern prediction for enzyme annotation	PLOS ONE			English	Article							PROTEIN-SEQUENCE; PROFILES; FAMILY	The prediction of gene functions is crucial for a large number of different life science areas. Faster high throughput sequencing techniques generate more and larger datasets. The manual annotation by classical wet-lab experiments is not suitable for these large amounts of data. We showed earlier that the automatic sequence pattern-based BrEPS protocol, based on manually curated sequences, can be used for the prediction of enzymatic functions of genes. The growing sequence databases provide the opportunity for more reliable patterns, but are also a challenge for the implementation of automatic protocols. We reimplemented and optimized the BrEPS pattern generation to be applicable for larger datasets in an acceptable timescale. Primary improvement of the new BrEPS protocol is the enhanced data selection step. Manually curated annotations from Swiss-Prot are used as reliable source for function prediction of enzymes observed on protein level. The pool of sequences is extended by highly similar sequences from TrEMBL and SwissProt. This allows us to restrict the selection of Swiss-Prot entries, without losing the diversity of sequences needed to generate significant patterns. Additionally, a supporting pattern type was introduced by extending the patterns at semi-conserved positions with highly similar amino acids. Extended patterns have an increased complexity, increasing the chance to match more sequences, without losing the essential structural information of the pattern. To enhance the usability of the database, we introduced enzyme function prediction based on consensus EC numbers and IUBMB enzyme nomenclature. BrEPS is part of the Braunschweig Enzyme Database (BRENDA) and is available on a completely redesigned website and as download. The database can be downloaded and used with the BrEPScmd command line tool for large scale sequence analysis. The BrEPS website and downloads for the database creation tool, command line tool and database are freely accessible at http://breps.tu-bs.de.	[Dudek, Christian-Alexander; Dannheim, Henning; Schomburg, Dietmar] Tech Univ Carolo Wilhelmina Braunschweig, Dept Bioinformat & Biochem, Braunschweig Integrated Ctr Syst Biol BRICS, D-38106 Braunschweig, Germany	Braunschweig University of Technology	Schomburg, D (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Dept Bioinformat & Biochem, Braunschweig Integrated Ctr Syst Biol BRICS, D-38106 Braunschweig, Germany.	d.schomburg@tu-braunschweig.de	Dudek, Christian-Alexander/ABA-9276-2021	Dudek, Christian-Alexander/0000-0001-9117-7909	Federal State of Lower Saxony, Niedersachsisches Vorab [VWZN3215]	Federal State of Lower Saxony, Niedersachsisches Vorab	HD was funded by the Federal State of Lower Saxony, Niedersachsisches Vorab (VWZN3215) (https://www.volkswagenstiftung.de/en/fundng/our-funding-portfolio-at-a-glance/niedersaechsisches-vorab.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiva E, 2014, NUCLEIC ACIDS RES, V42, pD521, DOI 10.1093/nar/gkt1130; Attwood TK, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas019; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Bannert C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-589; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Claudel-Renard C, 2003, NUCLEIC ACIDS RES, V31, P6633, DOI 10.1093/nar/gkg847; DAY WHE, 1984, J CLASSIF, V1, P7, DOI 10.1007/BF01890115; DEFAYS D, 1977, COMPUT J, V20, P364, DOI 10.1093/comjnl/20.4.364; Finn RD, 2017, NUCLEIC ACIDS RES, V45, pD190, DOI 10.1093/nar/gkw1107; Friedberg I, 2006, BRIEF BIOINFORM, V7, P225, DOI 10.1093/bib/bbl004; GONNET GH, 1992, SCIENCE, V256, P1443, DOI 10.1126/science.1604319; Haft DH, 2013, NUCLEIC ACIDS RES, V41, pD387, DOI 10.1093/nar/gks1234; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; McDonald AG, 2009, NUCLEIC ACIDS RES, V37, pD593, DOI 10.1093/nar/gkn582; Pedruzzi I, 2015, NUCLEIC ACIDS RES, V43, pD1064, DOI 10.1093/nar/gku1002; Placzek S, 2016, NUCLEIC ACIDS RES, DOI DOI 10.1093/NAR/GKW952; Servant Florence, 2002, Brief Bioinform, V3, P246, DOI 10.1093/bib/3.3.246; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Whisstock JC, 2003, Q REV BIOPHYS, V36, P307, DOI 10.1017/S0033583503003901	23	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0182216	10.1371/journal.pone.0182216	http://dx.doi.org/10.1371/journal.pone.0182216			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750104	Green Published, gold			2022-12-26	WOS:000406575700142
J	Fatti, G; Shaikh, N; Jackson, D; Goga, A; Nachega, JB; Eley, B; Grimwood, A				Fatti, Geoffrey; Shaikh, Najma; Jackson, Debra; Goga, Ameena; Nachega, Jean B.; Eley, Brian; Grimwood, Ashraf			Low HIV incidence in pregnant and postpartum women receiving a community-based combination HIV prevention intervention in a high HIV incidence setting in South Africa	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; YOUNG-WOMEN; FOLLOW-UP; TENOFOVIR; PROPHYLAXIS; OUTCOMES; INFECTIONS; PREVALENCE; EPIDEMIC; SERVICES	Background Young Southern African women have the highest HIV incidence globally. Pregnancy doubles the risk of HIV acquisition further, and maternal HIV acquisition contributes significantly to the paediatric HIV burden. Little data on combination HIV prevention interventions during pregnancy and lactation are available. We measured HIV incidence amongst pregnant and postpartum women receiving a community-based combination HIV prevention intervention in a high HIV incidence setting in South Africa. Methods A cohort study that included HIV-uninfected pregnant women was performed. Lay community-based workers provided individualized HIV prevention counselling and performed three-monthly home and clinic-based individual and couples HIV testing. Male partners were referred for circumcision, sexually transmitted infections or HIV treatment as appropriate. Kaplan-Meier analyses and Cox's regression were used to estimate HIV incidence and factors associated with HIV acquisition. Results The 1356 women included (median age 22.5 years) received 5289 HIV tests. Eleven new HIV infections were detected over 828.3 person-years (PY) of follow-up, with an HIV incidence rate of 1.33 infections/100 PY (95% CI: 0.74-2.40). Antenatally, the HIV incidence rate was 1.49 infections/100 PY (95% CI: 0.64-2.93) and postnatally the HIV incidence rate was 1.03 infections/100 PY (95% CI: 0.33-3.19). 53% of male partners received HIV testing and 66% of eligible partners received referral for circumcision. Women within known serodiscordant couples, and women with newly diagnosed HIV-infected partners, adjusted hazard ratio (aHR) = 32.7 (95% CI: 3.8-282.2) and aHR = 126.4 (95% CI: 33.8-472.2) had substantially increased HIV acquisition, respectively. Women with circumcised partners had a reduced risk of incident HIV infection, aHR = 0.22 (95% CI: 0.03-1.86). Conclusions Maternal HIV incidence was substantially lower than previous regional studies. Community-based combination HIV prevention interventions may reduce high maternal HIV incidence in resource-poor settings. Expanded roll-out of home-based couples HIV testing and initiating pre-exposure prophylaxis for pregnant women within serodiscordant couples is needed in Southern Africa.	[Fatti, Geoffrey; Jackson, Debra] KhethImpilo, Cape Town, South Africa; [Goga, Ameena] Univ Stellenbosch, SACEMA, Stellenbosch, South Africa; [Jackson, Debra; Goga, Ameena] UNICEF, New York, NY USA; [Goga, Ameena] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa; [Jackson, Debra; Eley, Brian] South African Med Res Council, Hlth Syst Res Unit, Pretoria, South Africa; [Nachega, Jean B.] Univ Pretoria, Dept Paediat, Pretoria, South Africa; [Jackson, Debra] Dept Epidemiol, Infect Dis & Microbiol, Pittsburgh, PA USA; [Goga, Ameena] Univ Stellenbosch, Dept Med & Ctr Infect Dis, Fac Med & Hlth Sci, Cape Town, South Africa; [Goga, Ameena; Eley, Brian] Johns Hopkins Univ, Dept Epidemiol & Int Hlth, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Goga, Ameena] Univ Cape Town, Red Cross War Mem Childrens Hosp, Dept Paediat & Child Hlth, Cape Town, South Africa	Stellenbosch University; UNICEF; University of the Western Cape; South African Medical Research Council; University of Pretoria; Stellenbosch University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Cape Town	Fatti, G (corresponding author), KhethImpilo, Cape Town, South Africa.	geoffrey.fatti@khethimpilo.org	Fatti, Geoffrey/AAA-9217-2019	Fatti, Geoffrey/0000-0002-6467-662X; Jackson, Debra/0000-0003-3307-632X; Nachega, Jean/0000-0002-2862-4443	Positive Action for Children's Fund, ViiV Healthcare	Positive Action for Children's Fund, ViiV Healthcare	The Positive Action for Children's Fund, ViiV Healthcare, funded the implementation of the program that was evaluated in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuelezam NN, 2016, AM J EPIDEMIOL, V184, P239, DOI 10.1093/aje/kwv344; Actuarial Society of South Africa, 2011, ASSA2008 AIDS DEM MO; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Barin F, 2006, J INFECT DIS, V193, P1504, DOI 10.1086/503778; Barnighausen T, 2007, AIDS PATIENT CARE ST, V21, P799, DOI 10.1089/apc.2007.0193; Baxter C, 2016, AJAR-AFR J AIDS RES, V15, P109, DOI 10.2989/16085906.2016.1196224; Bekker LG, 2016, S AFR J HIV MED, V17, DOI 10.4102/sajhivmed.v17i1.455; Bunge K BJ, 2015, INT AIDS C JUL 2015; Chen HL, 2015, HEPATOLOGY, V62, P375, DOI 10.1002/hep.27837; De Schacht C, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18808; Dellar RC, 2015, J INT AIDS SOC, V18, P64, DOI 10.7448/IAS.18.2.19408; Dinh TH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125525; Drake AL, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001608; Egbe TO, 2016, J PREGNANCY, V2016, DOI 10.1155/2016/7397695; Fatti G, 2012, J INT AIDS SOC, V15, P265, DOI 10.7448/IAS.15.2.17381; Fatti G, 2012, JAIDS-J ACQ IMM DEF, V61, pE50, DOI 10.1097/QAI.0b013e31826a6aee; Friedman B, 2016, CLIN MICROBIOL INFEC; Gray RH, 2005, LANCET, V366, P1182, DOI 10.1016/S0140-6736(05)67481-8; Greenup AJ, 2014, J HEPATOL, V61, P502, DOI 10.1016/j.jhep.2014.04.038; Harrison A, 2015, CURR HIV-AIDS REP, V12, P207, DOI 10.1007/s11904-015-0261-0; HertPicciotto I, 1997, BIOMETRICS, V53, P1151, DOI 10.2307/2533573; Johnson LF, 2012, JAIDS-J ACQ IMM DEF, V59, P417, DOI 10.1097/QAI.0b013e3182432f27; Kaplan R, 2008, AIDS, V22, P1679, DOI 10.1097/QAD.0b013e32830ebcee; Karim QA, 2011, INT J EPIDEMIOL, V40, P922, DOI 10.1093/ije/dyq176; Kieffer MP, 2011, JAIDS-J ACQ IMM DEF, V57, pE85, DOI 10.1097/QAI.0b013e31821acc6e; Kinuthia J, 2015, AIDS, V29, P2025, DOI 10.1097/QAD.0000000000000793; Krubiner CB, 2016, AIDS, V30, P2261, DOI 10.1097/QAD.0000000000001214; Ladur AN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133239; le Roux SM, 2017, AIDS, V31, P97, DOI 10.1097/QAD.0000000000001302; Mofenson LM, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002133; Mohlala BKF, 2011, AIDS, V25, P1535, DOI 10.1097/QAD.0b013e328348fb85; Moodley D, 2015, SEX TRANSM DIS, V42, P43, DOI 10.1097/OLQ.0000000000000219; Moodley D, 2011, J INFECT DIS, V203, P1231, DOI 10.1093/infdis/jir017; Moodley D, 2009, AIDS, V23, P1255, DOI 10.1097/QAD.0b013e32832a5934; Msuya SE, 2008, AIDS CARE, V20, P700, DOI 10.1080/09540120701687059; Mugo NR, 2014, JAMA-J AM MED ASSOC, V312, P362, DOI 10.1001/jama.2014.8735; Mugo NR, 2011, AIDS, V25, P1887, DOI 10.1097/QAD.0b013e32834a9338; Mugwanya KK, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002132; Munjoma MW, 2010, BMC PUBLIC HEALTH, V10, P1; National Department of Health of South Africa, 2011, HUM RES HLTH S AFR H; National Department of Health of South Africa, 2014, NAT CONS GUID PREV M; National Department of Health South Africa, 2015, NAT CONS GUID PREV M; National Department of Health South Africa, 2016, GUID EXP COMB PREV T; National Department of Health South Africa, 2013, S AFR ANT TREATM GUI; National Department of Health South Africa, 2015, GUID MAT CAR S AFR, V4th; Nyondo AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119273; Palombi L, 2016, J ANTIMICROB CHEMOTH, V71, P1027, DOI 10.1093/jac/dkv435; Pan CQ, 2016, NEW ENGL J MED, V374, P2324, DOI 10.1056/NEJMoa1508660; Price JT, 2016, JAIDS-J ACQ IMM DEF, V72, pS145, DOI 10.1097/QAI.0000000000001063; Ross DA, 2010, AIDS, V24, pS4, DOI 10.1097/01.aids.0000390703.35642.89; Shanaube K, 2015, CURR HIV-AIDS REP, V12, P231, DOI 10.1007/s11904-015-0262-z; Skar H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060906; South African National AIDS Council, 2012, NAT STRAT PLAN HIV S; South African National Department of Health, 2013, NAT ANT SENT HIV PRE; UNAIDS, 2014, THE GAP REP; Wang BX, 2011, SAMJ S AFR MED J, V101, P253, DOI 10.7196/SAMJ.4078; World Health Organisation, 2008, TASK SHIFT GLOB REC; World Health Organization, 2015, POL BRIEF PREEXP PRO; Wouters E, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-194	59	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181691	10.1371/journal.pone.0181691	http://dx.doi.org/10.1371/journal.pone.0181691			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750070	gold, Green Published, Green Submitted			2022-12-26	WOS:000406575700072
J	Wang, JP; Tang, C; Wang, Q; Su, J; Ni, T; Yang, WJ; Wang, YS; Chen, W; Liu, XQ; Wang, S; Zhang, JJ; Song, HL; Zhu, J; Wang, Y				Wang, Junpeng; Tang, Chao; Wang, Qian; Su, Jun; Ni, Ting; Yang, Wenjing; Wang, Yongsheng; Chen, Wei; Liu, Xiqiang; Wang, Shuai; Zhang, Jingjing; Song, Huili; Zhu, Jun; Wang, Yuan			NRF1 coordinates with DNA methylation to regulate spermatogenesis	FASEB JOURNAL			English	Article						ASZ1; germline gene regulation; mitochondria	GERM-CELL DEVELOPMENT; EMBRYONIC STEM-CELLS; MITOCHONDRIAL BIOGENESIS; HUMAN GENOME; DAZL GENE; PROMOTER; PROTEIN; MICE; GASZ; SPECIFICATION	Spermatogenesis is a highly coordinated process that requires tightly regulated gene expression programmed by transcription factors and epigenetic modifiers. In this study, we found that nuclear respiratory factor (NRF)-1, a key transcription factor for mitochondrial biogenesis, cooperated with DNA methylation to directly regulate the expression of multiple germ cell-specific genes, including Asz1. In addition, conditional ablation of NRF1 in gonocytes dramatically down-regulated these germline genes, blocked germ cell proliferation, and subsequently ledtomale infertility in mice. Our data highlight a precise crosstalk between transcriptional regulation by NRF1 and epigenetic modulation during germ cell development and unequivocally demonstrate a novel role of NRF1 in spermatogenesis.-Wang, J., Tang, C., Wang, Q., Su, J., Ni, T., Yang, W., Wang, Y., Chen, W., Liu, X., Wang, S., Zhang, J., Song, H., Zhu, J., Wang, Y. NRF1 coordinates with DNA methylation to regulate spermatogenesis.	[Wang, Junpeng; Tang, Chao; Wang, Qian; Su, Jun; Wang, Yongsheng; Chen, Wei; Liu, Xiqiang; Wang, Shuai; Zhang, Jingjing; Song, Huili; Wang, Yuan] East China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai, Peoples R China; [Wang, Junpeng; Tang, Chao; Wang, Qian; Su, Jun; Wang, Yongsheng; Chen, Wei; Liu, Xiqiang; Wang, Shuai; Zhang, Jingjing; Song, Huili; Wang, Yuan] East China Normal Univ, Sch Life Sci, 500 Dongchuan Rd, Shanghai 200241, Peoples R China; [Ni, Ting] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Minist Educ MOE, Shanghai, Peoples R China; [Ni, Ting] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Collaborat Innovat Ctr Genet & Dev, Shanghai, Peoples R China; [Yang, Wenjing; Zhu, Jun] NHLBI, Syst Biol Ctr, NIH, Bethesda, MD USA; [Wang, Yuan] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA	East China Normal University; East China Normal University; Fudan University; Fudan University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Michigan State University	Wang, Y (corresponding author), East China Normal Univ, Sch Life Sci, 500 Dongchuan Rd, Shanghai 200241, Peoples R China.	ywang@bio.ecnu.edu.cn		wang, Yuan/0000-0002-0939-1269; Tang, Chao/0000-0002-2091-3355; Zhang, Jingjing/0000-0002-7953-1159	Ministry of Science and Technology of China [2016YFA0100300, 2014CB964800]; National Natural Science Foundation of China [31471347, 31271589, 16JC1404200, 11DZ2260300]; Science and Technology Commission of Shanghai Municipality, China [1ZICHL006058]; Intramural Research Program of the U.S. National Institutes of Health, National Heart Lung Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006230, ZICHL006058] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality, China(Science & Technology Commission of Shanghai Municipality (STCSM)); Intramural Research Program of the U.S. National Institutes of Health, National Heart Lung Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Richard Mailman from Penn State College of Medicine (State College, PA, USA) for help in manuscript preparation. This work was supported by Grants 2016YFA0100300 and 2014CB964800 (to Yu.W.) from the Ministry of Science and Technology of China, Grants 31471347 and 31271589 (to Yu.W.) from the National Natural Science Foundation of China, Grants 16JC1404200 (to Yu.W.) and 11DZ2260300 from the Science and Technology Commission of Shanghai Municipality, China, and Grant 1ZICHL006058 (to J.Z.) from the Intramural Research Program of the U.S. National Institutes of Health, National Heart Lung Blood Institute. The authors declare no conflicts of interest.	Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Azhikina TL, 2005, BIOCHEMISTRY-MOSCOW+, V70, P596, DOI 10.1007/s10541-005-0153-9; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Domcke S, 2015, NATURE, V528, P575, DOI 10.1038/nature16462; EVANS MJ, 1989, J BIOL CHEM, V264, P14361; Ewen KA, 2010, MOL CELL ENDOCRINOL, V323, P76, DOI 10.1016/j.mce.2009.12.013; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Hammoud SS, 2014, CELL STEM CELL, V15, P239, DOI 10.1016/j.stem.2014.04.006; Hayashi K, 2007, SCIENCE, V316, P394, DOI 10.1126/science.1137545; HOFMANN MC, 1992, EXP CELL RES, V201, P417, DOI 10.1016/0014-4827(92)90291-F; Huo L, 2001, MOL CELL BIOL, V21, P644, DOI 10.1128/MCB.21.2.644-654.2001; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Linher K, 2009, DIFFERENTIATION, V77, P335, DOI 10.1016/j.diff.2008.08.001; Ma L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000635; Maatouk DM, 2006, DEVELOPMENT, V133, P3411, DOI 10.1242/dev.02500; Miranda TB, 2007, J CELL PHYSIOL, V213, P384, DOI 10.1002/jcp.21224; Qiu LL, 2016, J REPROD DEVELOP, V62, P367, DOI 10.1262/jrd.2016-003; Ramalho-Santos J, 2009, HUM REPROD UPDATE, V15, P553, DOI 10.1093/humupd/dmp016; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Sada A, 2009, SCIENCE, V325, P1394, DOI 10.1126/science.1172645; Saga Y, 2008, CURR OPIN GENET DEV, V18, P337, DOI 10.1016/j.gde.2008.06.003; Saitou M, 2009, CURR OPIN GENET DEV, V19, P386, DOI 10.1016/j.gde.2009.06.003; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Shen L, 2007, PLOS GENET, V3, P2023, DOI 10.1371/journal.pgen.0030181; Song HW, 2014, SEMIN CELL DEV BIOL, V30, P14, DOI 10.1016/j.semcdb.2014.02.005; Teng YN, 2012, HUM REPROD, V27, P2857, DOI 10.1093/humrep/des227; Tsai-Morris CH, 2004, P NATL ACAD SCI USA, V101, P6373, DOI 10.1073/pnas.0401855101; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Wang Q, 2013, STEM CELL RES, V11, P845, DOI 10.1016/j.scr.2013.05.012; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wylie C, 1999, CELL, V96, P165, DOI 10.1016/S0092-8674(00)80557-7; Yan W, 2002, MOL ENDOCRINOL, V16, P1168, DOI 10.1210/me.16.6.1168; Zhang JJ, 2016, EMBO REP, V17, P220, DOI 10.15252/embr.201540846; Zhang XL, 2014, STEM CELL REP, V3, P460, DOI 10.1016/j.stemcr.2014.07.004	41	28	28	1	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4959	4970		10.1096/fj.201700093R	http://dx.doi.org/10.1096/fj.201700093R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28754714	Green Published			2022-12-26	WOS:000413398500026
J	Elam, MB; Majumdar, G; Mozhui, K; Gerling, IC; Vera, SR; Fish-Trotter, H; Williams, RW; Childress, RD; Raghow, R				Elam, Marshall B.; Majumdar, Gipsy; Mozhui, Khyobeni; Gerling, Ivan C.; Vera, Santiago R.; Fish-Trotter, Hannah; Williams, Robert W.; Childress, Richard D.; Raghow, Rajendra			Patients experiencing statin-induced myalgia exhibit a unique program of skeletal muscle gene expression following statin re-challenge	PLOS ONE			English	Article							CALCIUM-RELEASE CHANNELS; INDUCED MYOPATHY; MYOSITIS-MYALGIA; P53; CALCINEURIN; THERAPY; RISK; APOPTOSIS; TOXICITY; VARIANTS	Statins, the 3-hydroxy-3-methyl-glutaryl (HMG)-CoA reductase inhibitors, are widely prescribed for treatment of hypercholesterolemia. Although statins are generally well tolerated, up to ten percent of statin-treated patients experience myalgia symptoms, defined as muscle pain without elevated creatinine phosphokinase (CPK) levels. Myalgia is the most frequent reason for discontinuation of statin therapy. The mechanisms underlying statin myalgia are not clearly understood. To elucidate changes in gene expression associated with statin myalgia, we compared profiles of gene expression in skeletal muscle biopsies from patients with statin myalgia who were undergoing statin re-challenge (cases) versus those of statin-tolerant controls. A robust separation of case and control cohorts was revealed by Principal Component Analysis of differentially expressed genes (DEGs). To identify putative gene expression and metabolic pathways that may be perturbed in skeletal muscles of patients with statin myalgia, we subjected DEGs to Ingenuity Pathways (IPA) and DAVID (Database for Annotation, Visualization and Integrated Discovery) analyses. The most prominent pathways altered by statins included cellular stress, apoptosis, cell senescence and DNA repair (TP53, BARD1, Mre11 and RAD51); activation of pro-inflammatory immune response (CXCL12, CST5, POU2F1); protein catabolism, cholesterol biosynthesis, protein prenylation and RAS-GTPase activation (FDFT1, LSS, TP53, UBD, ATF2, H-ras). Based on these data we tentatively conclude that persistent myalgia in response to statins may emanate from cellular stress underpinned by mechanisms of post-inflammatory repair and regeneration. We also posit that this subset of individuals is genetically predisposed to eliciting altered statin metabolism and/or increased end-organ susceptibility that lead to a range of statin-induced myopathies. This mechanistic scenario is further bolstered by the discovery that a number of single nucleotide polymorphisms (e.g., SLCO1B1, SLCO2B1 and RYR2) associated with statin myalgia and myositis were observed with increased frequency among patients with statin myalgia.	[Elam, Marshall B.; Majumdar, Gipsy; Gerling, Ivan C.; Vera, Santiago R.; Childress, Richard D.; Raghow, Rajendra] Dept Vet Affairs Med Ctr Memphis, Memphis, TN 38104 USA; [Elam, Marshall B.; Majumdar, Gipsy; Raghow, Rajendra] Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, Memphis, TN 38163 USA; [Elam, Marshall B.; Gerling, Ivan C.; Fish-Trotter, Hannah; Childress, Richard D.] Univ Tennessee, Dept Med, Hlth Sci Ctr, Memphis, TN 38104 USA; [Mozhui, Khyobeni] Univ Tennessee, Hlth Sci Ctr, Dept Prevent Med, Memphis, TN USA; [Williams, Robert W.] Univ Tennessee, Hlth Sci Ctr, Coll Med, Dept Genet Genom & Informat, Memphis, TN USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Elam, MB; Raghow, R (corresponding author), Dept Vet Affairs Med Ctr Memphis, Memphis, TN 38104 USA.; Elam, MB; Raghow, R (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, Memphis, TN 38163 USA.; Elam, MB (corresponding author), Univ Tennessee, Dept Med, Hlth Sci Ctr, Memphis, TN 38104 USA.	melam@uthsc.edu; rraghow@uthsc.edu	Williams, Robert W./H-8789-2016	Williams, Robert W./0000-0001-8924-4447	University of Tennessee Clinical and Translational Research Initiative; Memphis VA Research Foundation-Research Incorporated; Department of Veteran's Affairs Merit Review; VA Merit Review Grants	University of Tennessee Clinical and Translational Research Initiative; Memphis VA Research Foundation-Research Incorporated; Department of Veteran's Affairs Merit Review(US Department of Veterans Affairs); VA Merit Review Grants(US Department of Veterans Affairs)	This work was supported by the University of Tennessee Clinical and Translational Research Initiative (MBE, RR); Memphis VA Research Foundation-Research Incorporated (MBE,RR); Department of Veteran's Affairs Merit Review (RR). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; We gratefully acknowledge the assistance of Sheronda Peeples, Janelle Turner and Mark Heckle in the conduct of this research. We also express our sincere appreciation to the patients who volunteered to participate in this study. These studies were partially funded by the University of Tennessee Clinical and Translational Research Initiative, the Memphis VA Research Foundation, Research Incorporated and VA Merit Review Grants.	Ahmed W, 2009, TRANSL RES, V153, P11, DOI 10.1016/j.trsl.2008.11.002; Baker SK, 2005, MUSCLE NERVE, V31, P572, DOI 10.1002/mus.20291; Bays H, 2006, AM J CARDIOL, V97, p6C, DOI 10.1016/j.amjcard.2005.12.006; Beharry AW, 2015, MUSCLE NERVE, V52, P1098, DOI 10.1002/mus.24912; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Cao PR, 2009, FASEB J, V23, P2844, DOI 10.1096/fj.08-128843; Carr DF, 2014, NATURE, V513, pE1, DOI 10.1038/nature13628; Cho L, 2016, CARDIOVASC DRUG THER, V30, P297, DOI 10.1007/s10557-016-6655-4; Coon TA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3881; Dennis RA, 2009, PHYSIOL GENOMICS, V38, P169, DOI 10.1152/physiolgenomics.00056.2009; Donnelly LA, 2011, CLIN PHARMACOL THER, V89, P210, DOI 10.1038/clpt.2010.255; Draeger A, 2006, J PATHOL, V210, P94, DOI 10.1002/path.2018; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Elam MB, 2009, OBESITY, V17, P1563, DOI 10.1038/oby.2009.49; Erb M, 2009, J PHARMACOL EXP THER, V331, P787, DOI 10.1124/jpet.109.160754; Feferman T, 2005, J IMMUNOL, V174, P5324, DOI 10.4049/jimmunol.174.9.5324; Feki A, 2005, ONCOGENE, V24, P3726, DOI 10.1038/sj.onc.1208491; Feng QP, 2012, PHARMACOGENOMICS, V13, P579, DOI [10.2217/PGS.12.11, 10.2217/pgs.12.11]; Ficenec David, 2003, Briefings in Bioinformatics, V4, P260, DOI 10.1093/bib/4.3.260; Fiegenbaum M, 2005, CLIN PHARMACOL THER, V78, P551, DOI 10.1016/j.clpt.2005.08.003; Floyd JS, 2014, NATURE, V513, pE1, DOI 10.1038/nature13629; Fox DK, 2014, AM J PHYSIOL-ENDOC M, V307, pE245, DOI 10.1152/ajpendo.00010.2014; Ghatak A, 2010, ATHEROSCLEROSIS, V210, P337, DOI 10.1016/j.atherosclerosis.2009.11.033; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Glueck CJ, 2011, CURR MED RES OPIN, V27, P1683, DOI 10.1185/03007995.2011.598144; Golomb BA, 2007, DRUG SAFETY, V30, P669, DOI 10.2165/00002018-200730080-00003; Goodman CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128398; Hall AM, 2012, J LIPID RES, V53, P990, DOI 10.1194/jlr.P025536; Hanai JI, 2007, J CLIN INVEST, V117, P3940, DOI 10.1172/JCI32741; Harris LJ, 2011, J CLIN LIPIDOL, V5, P299, DOI 10.1016/j.jacl.2011.05.005; Hernandez-Ochoa EO, 2016, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00420; Hoenig MR, 2011, J CLIN LIPIDOL, V5, P91, DOI 10.1016/j.jacl.2011.01.001; Hsiang BN, 1999, J BIOL CHEM, V274, P37161, DOI 10.1074/jbc.274.52.37161; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hudson MB, 2013, INT J BIOCHEM CELL B, V45, P2173, DOI 10.1016/j.biocel.2013.06.029; Hunten S, 2015, ONCOTARGET, V6, P15842; Irminger-Finger I, 2006, ONCOL REP, V15, P1425; Johnson TE, 2004, TOXICOL APPL PHARM, V200, P237, DOI 10.1016/j.taap.2004.04.010; Knauer MJ, 2010, CIRC RES, V106, P297, DOI 10.1161/CIRCRESAHA.109.203596; Laaksonen R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000097; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Lin SB, 2013, J BIOL CHEM, V288, P6238, DOI 10.1074/jbc.M112.429605; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Loganathan P, 2016, EXPERT REV CLIN IMMU, V12, P33, DOI 10.1586/1744666X.2016.1103181; Luzum JA, 2015, CELL METAB, V21, P622, DOI 10.1016/j.cmet.2015.03.003; Magni P, 2015, EUR J INTERN MED, V26, P82, DOI 10.1016/j.ejim.2015.01.002; Majumdar G, 2015, ANAL BIOCH; Majumdar G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-709; Mammen AL, 2016, NEW ENGL J MED, V374, P664, DOI 10.1056/NEJMra1515161; MANDARINO LJ, 1987, J CLIN INVEST, V80, P655, DOI 10.1172/JCI113118; Mangravite LM, 2013, NATURE, V502, P377, DOI 10.1038/nature12508; Marciante KD, 2011, PHARMACOGENET GENOM, V21, P280, DOI 10.1097/FPC.0b013e328343dd7d; Marcoff L, 2007, J AM COLL CARDIOL, V49, P2231, DOI 10.1016/j.jacc.2007.02.049; Matzno S, 2005, J PHARM PHARMACOL, V57, P1475, DOI 10.1211/jpp.57.11.0014; Morikawa S, 2005, J ATHEROSCLER THROMB, V12, P121, DOI 10.5551/jat.12.121; Moylan JS, 2014, REDOX BIOL, V2, P910, DOI 10.1016/j.redox.2014.07.006; Mukhtar RYA, 2005, CURR OPIN LIPIDOL, V16, P640; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; Needham M, 2014, NEUROMUSCULAR DISORD, V24, P4, DOI 10.1016/j.nmd.2013.09.011; Nichols GA, 2007, CLIN THER, V29, P1761, DOI 10.1016/j.clinthera.2007.08.022; Noel B, 2007, J EUR ACAD DERMATOL, V21, P17, DOI 10.1111/j.1468-3083.2006.01838.x; Norata GD, 2014, PHARMACOL RES, V88, P107, DOI 10.1016/j.phrs.2014.04.012; Oh J, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-7; Ohta M, 2012, BIOCHEM BIOPH RES CO, V424, P301, DOI 10.1016/j.bbrc.2012.06.111; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Pance A, 2016, BBA-GENE REGUL MECH, V1859, P820, DOI 10.1016/j.bbagrm.2016.04.003; Pasternak RC, 2002, CIRCULATION, V106, P1024, DOI 10.1161/01.CIR.0000032466.44170.44; Phillips PS, 2002, ANN INTERN MED, V137, P581, DOI 10.7326/0003-4819-137-7-200210010-00009; Radic M, 2004, J IMMUNOL, V172, P6692, DOI 10.4049/jimmunol.172.11.6692; Ravasz Erzsebet, 2009, V541, P145, DOI 10.1007/978-1-59745-243-4_7; Ruano G, 2007, MUSCLE NERVE, V36, P329, DOI 10.1002/mus.20871; Saloniemi T, 2012, J ENDOCRINOL, V212, P27, DOI 10.1530/JOE-11-0315; Santulli G, 2015, CURR MOL PHARMACOL, V8, P206, DOI 10.2174/1874467208666150507105105; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; Schirris TJJ, 2015, CELL METAB, V22, P399, DOI 10.1016/j.cmet.2015.08.002; Semsarian C, 1999, NATURE, V400, P576, DOI 10.1038/23054; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SHARP GC, 1972, AM J MED, V52, P148, DOI 10.1016/0002-9343(72)90064-2; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Stewart A., 2013, PLOS CURR, V5; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Stone NJ, 2014, ANN INTERN MED, V160, P339, DOI 10.7326/M14-0126; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Tsamandouras N, 2014, CLIN PHARMACOL THER, V96, P90, DOI 10.1038/clpt.2014.55; Urso ML, 2005, ARTERIOSCL THROM VAS, V25, P2560, DOI 10.1161/01.ATV.0000190608.28704.71; Vladutiu GD, 2008, CURR OPIN RHEUMATOL, V20, P648, DOI 10.1097/BOR.0b013e328314b7b4; Vladutiu GD, 2006, MUSCLE NERVE, V34, P153, DOI 10.1002/mus.20567; Wang JX, 2011, NAT MED, V17, P71, DOI 10.1038/nm.2282; Watanabe R, 2005, VIRCHOWS ARCH, V447, P643, DOI 10.1007/s00428-004-1183-1; Wiel C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4792; Zhu CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003716	94	18	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0181308	10.1371/journal.pone.0181308	http://dx.doi.org/10.1371/journal.pone.0181308			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771594	Green Submitted, Green Published, gold			2022-12-26	WOS:000406853600014
J	Hale, AL; White, PM; Webber, CL; Todd, JR				Hale, Anna L.; White, Paul M.; Webber, Charles L., III; Todd, James R.			Effect of growing media and fertilization on sugarcane flowering under artificial photoperiod	PLOS ONE			English	Article							FERTILITY	The USDA-ARS Sugarcane Variety Development Program in Houma, LA aims to maximize the number of panicles available for crossing through artificial manipulation of the environment. In a three-year study, the effect of growing media, fertilizer treatment, and their interaction on sugarcane flowering (% of panicles emerged), and number of days to flowering (DTF) under an artificial photoperiod treatment were assessed. The commercially-available sugarcane cultivar, 'HoCP 96-540' was planted in 2.8-L pots and subjected to the standard local photoperiod treatment. The cultivar was planted in four growing media (RediEarth Seedling and Germination Mix, Fafard, Metro-Mix (R) 902, and Metro-Mix (R) 900) and subjected to three different fertilizer applications. In the control treatment, fertilizer application was stopped prior to the commencement of the photoperiod treatment as practiced in some sugarcane breeding programs. The continuous treatment consisted of an application of a 10 ml solution of a NPK three times a week between June and October. The partial treatment consisted of applications of the same NPK solution applied post-initiation between September and October. Nitrogen starvation prior to the commencement of the photoperiod treatment is generally accepted to improve flower initiation; thus the standard practice is to cease nitrogen application two weeks prior to beginning a photoperiod regime. The growing media used in this study did not have a significant effect on days to flowering or percent panicle emergence. In our study, the control fertilizer treatment showed a flowering percentage across all growing media types of 21.2% less than a continuous fertilization regime. Furthermore, a significant trend was observed between fertilization treatments and days to flowering, with the continuous treatment producing panicles, on average across growing media, four days earlier than the control treatment, and six days earlier than the partial treatment. Evidence across this three-year experiment indicates that we should consider modifying plant nutrition management as soil fertility was found to be inadequate.	[Hale, Anna L.; White, Paul M.; Webber, Charles L., III; Todd, James R.] ARS, USDA, Southeast Area, Sugarcane Res Unit, Houma, LA 70360 USA	United States Department of Agriculture (USDA)	Hale, AL (corresponding author), ARS, USDA, Southeast Area, Sugarcane Res Unit, Houma, LA 70360 USA.	Anna.Hale@ars.usda.gov		Hale, Anna/0000-0002-0329-3430; White, Paul/0000-0003-0545-3618	committee of American Sugar Cane League of U.S.A., Inc	committee of American Sugar Cane League of U.S.A., Inc	The authors funding from the dedicated funding committee of the American Sugar Cane League of the U.S.A., Inc. to help fund this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam A. I., 1978, Proceedings 16th Congress International Society of Sugar Cane Technologists, Brazil 1977., P875; Allard H., 1938, J AGR RES; Berding, 2005, P INT SOC SUGAR CANE, V25, P515; Berding N., 2010, Proceedings of the 2010 Conference of the Australian Society of Sugar Cane Technologists held at Bundaberg, Queensland, Australia, 11-14 May 2010, P234; BERDING N, 1980, CROP SCI, V20, P463, DOI 10.2135/cropsci1980.0011183X002000040011x; Berding N, 2004, P AUST SOC SUGAR CAN, V26, P1; Brett P. G. C., 1951, Proceedings of the Seventh Congress of the International Society of Sugar Cane Technologists, Brisbane, 25th August-15th September, 1950., P43; Brunkhorst M. J., 2003, Proceedings of the Annual Congress - South African Sugar Technologists' Association, P306; Brunkhorst M. J., 2001, Proceedings of the Annual Congress - South African Sugar Technologists' Association, P143; CHILTON S. J. P., 1954, Sugar Bulletin, V32, P165; Clements HF, 1965, P INT SOC SUGAR CANE, V12, P795; COLEMAN R. E., 1963, International Sugar Journal, V65, P351; Dunckelman P, 1975, P AM SOC SUGAR CANE, V4, P80; Dunckelman P., 1974, P AM SOC SUGAR CANE, V3, P40; Dunckelman P. H., 1973, Sugar Bulletin, V52, P7; Dunckelman PH, 1973, ISSCT SUGARCANE BREE, V31, P8; Garner WW., 1920, MON WEATHER REV, V48, P415, DOI [10.1175/1520-0493(1920)482.0.CO;2, DOI 10.1175/1520-0493(1920)48<415B:EOTRLO>2.0.CO;2]; Gosnell J. M., 1973, Proceedings of the 47th Annual Congress, South African Sugar Technologists' Association., P144; Lee S, 1968, P INT SOC SUGAR CANE, V13, P1001; MIDMORE DJ, 1980, FIELD CROP RES, V3, P65, DOI 10.1016/0378-4290(80)90008-8; Nuss K. J., 1982, South African Sugar Technologists' Association. Proceedings of the fifty-sixth annual congress., P140; Nuss K. J., 1977, South Africa, South African Sugar Technologists' Association: Proceedings of the fifty-first annual congress, 1977., P27; Nuss K. J., 1999, Proceedings of the XXIII ISSCT Congress, New Delhi, India, 22-26 February, 1999. Volume 2, P504; Paliatseas E, 1953, SUGARCANE SEEDLINGS, P2; Paliatseas E, 1955, FLOWERING SUGARCANE, P2; Paliatseas ED, 1971, P INT SOC SUGAR CANE, V14, P354; Sartoris G, 1938, P INT SOC SUGARCANE, V6, P796; Shanmugavadivu R., 2009, Sugar Tech, V11, P401, DOI 10.1007/s12355-009-0070-0; Stevenson GC, 1965, GENETICS BREEDING SU; Van Dillewijn C, 1952, BOT OF SUGARCANE; Ven Katraman TS, 1932, P INT SOC SUGAR CANE, V44, P1	31	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0181639	10.1371/journal.pone.0181639	http://dx.doi.org/10.1371/journal.pone.0181639			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771490	Green Published, gold, Green Submitted			2022-12-26	WOS:000406853600028
J	Heiss, AG; Antolin, F; Bleicher, N; Harb, C; Jacomet, S; Kuhn, M; Marinova, E; Stika, HP; Valamoti, SM				Heiss, Andreas G.; Antolin, Ferran; Bleicher, Niels; Harb, Christian; Jacomet, Stefanie; Kuhn, Marlu; Marinova, Elena; Stika, Hans-Peter; Valamoti, Soultana Maria			State of the (t) art. Analytical approaches in the investigation of components and production traits of archaeological bread-like objects, applied to two finds from the Neolithic lakeshore settlement Parkhaus Opera (Zurich, Switzerland)	PLOS ONE			English	Article							WILD CEREAL-GRAINS; OHALO-II; REMAINS	The site of Parkhaus Opera is located on the north-eastern shore of Lake Zurich (Switzerland) and was documented during a rescue excavation in 2010 and 2011 by the Office for Urbanism, City of Zurich. Two charred bread-like objects were found in late Neolithic Layer 13 of the pile-dwelling, and are investigated using a novel set of analyses for cereal-based foodstuffs. Tissue remains of barley and wheat were identified, as well as a schizocarp of celery (cf. Apium graveolens), providing the first evidence for the use of bread condiments in the Neolithic. Cereal particle sizes were recorded and used to draw conclusions regarding milling and sieving of the raw material. Gas bubbles in the charred objects were measured in order to evaluate possible leavening of the dough. The outcomes of this research significantly advance the understanding of the production traits of cereal-based food during the Neolithic. The analytical techniques proposed by this study open up new possibilities for systematic and consistent investigations of cereal-based archaeological foodstuffs.	[Heiss, Andreas G.] Austrian Acad Sci OAW, Austrian Archaeol Inst OAI, Vienna, Austria; [Antolin, Ferran; Jacomet, Stefanie; Kuhn, Marlu] Univ Basel, Integrat Prehist & Archaeol Sci IPAS IPNA, Basel, Switzerland; [Bleicher, Niels] Off Urbanism Zurich, Underwater Archaeol & Lab Dendrochronol, Zurich, Switzerland; [Harb, Christian] Cantonal Archaeol Zurich, Dubendorf, Switzerland; [Marinova, Elena] Katholieke Univ Leuven, Ctr Archaeol Sci, Leuven, Belgium; [Marinova, Elena] RBINS, Brussels, Belgium; [Stika, Hans-Peter] Univ Hohenheim, Inst Bot 210, Stuttgart, Germany; [Valamoti, Soultana Maria] Aristotle Univ Thessaloniki, Sch Hist & Archaeol, Thessaloniki, Greece	Austrian Academy of Sciences; University of Basel; KU Leuven; University Hohenheim; Aristotle University of Thessaloniki	Heiss, AG (corresponding author), Austrian Acad Sci OAW, Austrian Archaeol Inst OAI, Vienna, Austria.	andreas.g.heiss@oeai.at	Heiss, Andreas/K-5393-2013; Antolín, Ferran/N-3508-2019; Marinova, Elena/E-9935-2010	Heiss, Andreas/0000-0002-2989-7259; Antolín, Ferran/0000-0002-0533-5788; Marinova, Elena/0000-0003-3793-3317	Cantonal Archaeology of Zurich; H European Research Council in the project PLANTCULT [ERC-2015-CoG 682529]; European Research Council in the project PLANTCULT [ERC-2015-CoG 682529]; Swiss National Science Foundation (SNSF)	Cantonal Archaeology of Zurich; H European Research Council in the project PLANTCULT; European Research Council in the project PLANTCULT; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	This work was supported by the Cantonal Archaeology of Zurich (http://www.are.zh.ch/internet/baudirektion/are/de/service/international.html) to CH, NB, FA, MK, and AGH. Data evaluation and manuscript production was funded by the H2020 European Research Council in the project PLANTCULT (ERC-2015-CoG 682529, http://cordis.europa.eu/project/rcn/20260_en.html) to SMV, AGH, FA, SJ, and HPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are most grateful to the Cantonal Archaeology of Zurich for funding the analysis which this paper is based on. Data evaluation and manuscript production was funded by the European Research Council in the project PLANTCULT (ERC-2015-CoG 682529, PI Soultana-Maria Valamoti). We would also like to thank the Swiss National Science Foundation (SNSF) for their financial support of the workshop "Groats, bulgur, flour and semolina: archaeobotanical identification of cereal meals" held in Basel in 2015, where this research was first presented and discussed. We thank Veronique Zech-Matterne (MNHM Paris) and Nicolas Monteix (Universite de Rouen) for their valuable input to the evaluation of the finds. We are also grateful to Ursula Thanheiser and Mathias Mehofer (both VIAS, University of Vienna) for their support during the initial stage of the analysis, and to Alfred Galik (OAI, OAW) for his kind assistance in data processing. The authors thank Margaret L. Janke (University of Hohenheim, Stuttgart) for language editing, and for this manuscript's headline.	A-M Hansson, 1997, PLANT FOOD SCANDINAV; Ahrens M, 2001, THESIS; Anderberg A.-L., 1994, ATLAS SEEDS SMALL FR; [Anonymous], ARCHAOBOTANIK ZURICH; Antolin F, 2016, JB ARCHAOL SCHWEIZ, V99, P143, DOI DOI 10.5281/3888318.894128; Antolin F, 2017, ZURICH PARKHAUS OPER, V3, P50; Antolin F, 2017, J ARCHAEOL SCI-REP, V12, P323, DOI 10.1016/j.jasrep.2017.02.008; Antolin F, 2016, QUATERN INT, V404, P56, DOI 10.1016/j.quaint.2015.08.003; Arranz-Otaegui A., 2016, QUATERNARY INT; Auger F, 2008, J CEREAL SCI, V48, P349, DOI 10.1016/j.jcs.2007.10.006; Berggren G., 1981, ATLAS SEEDS SMALL 3; Berggren G, 1969, ATLAS SEEDS SMALL 2; Billamboz A, 2010, VERNETZUNGEN ASPEKTE, V60, P253; Bleicher N, 2017, ZURICH PARKHAUS OPER, V3; Bleicher N., 2015, ZURICH PARKHAUS OPER, V1; Bleicher N, 2015, ZURICH PARKHAUS OPER; Bojnansky V, 2007, ATLAS SEEDS FRUITS C; Braadbaart F, 2005, ARCHAEOMETRY, V47, P103, DOI 10.1111/j.1475-4754.2005.00190.x; Britton K, 2011, VEG HIST ARCHAEOBOT, V20, P41, DOI 10.1007/s00334-010-0245-3; Brockner W., 1994, ARCHAOL KORRESPONDEN, V24, P399; Brombacher C, 2011, VOIE ROMAINE STRUCTU, P83; Capparelli A, 2011, ARCHAEOL ANTHROP SCI, V3, P1, DOI 10.1007/s12520-011-0063-2; Cappers R. T. J, 2006, DIGITAL SEED ATLAS N; Cappers R.T.J., 2016, DIGITAL ATLAS TRADIT DIGITAL ATLAS TRADIT; Chen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045137; College S., 1988, SCANNING ELECT MICRO, P225; Cosack E, 2011, ARCHAOL KORRESPONDEN, V41, P507; Datta AK, 2007, J FOOD ENG, V79, P106, DOI 10.1016/j.jfoodeng.2006.01.046; Dickson C., 1987, CIRCAEA, V4, P95; Ebersbach R, 2015, ZURICH MOZARTSTRASSE, V5; Eiselen H, 2000, MAX WAHREN GESAMMELT; Fechner K., 1992, CORRES CIVILISATIONS, V2, P43; Fuller D.Q., 2006, MILLET ATLAS SOME ID; Gale R., 2000, PLANTS ARCHAEOLOGY; GAN Z, 1995, J CEREAL SCI, V21, P215, DOI 10.1006/jcrs.1995.0025; Gassner G., 1989, MIKROSKOPISCHE UNTER; Gong YW, 2011, J ARCHAEOL SCI, V38, P470, DOI 10.1016/j.jas.2010.10.006; Gonzalez Carretero L., 2017, VEGETATION HIST ARCH; Goodfellow P. N., 2002, RETHINK MARXISM, P25, DOI DOI 10.1007/978-94-010-0593-7_1; GREIG J, 1981, J ARCHAEOL SCI, V8, P265, DOI 10.1016/0305-4403(81)90003-0; Hahn H., 1996, MIKROSKOPISCHE DIAGN; Hall MJ, 1997, J AM CERAM SOC, V80, P1298, DOI 10.1111/j.1151-2916.1997.tb02981.x; Hansson A.-M., 1994, LAB ARKEOL, V7, P5; Hansson A-M, 1996, LABORATIV ARKEOLOGI, V9, P61; Hansson A-M., 1994, LAB ARKEOL, V7, P21; Hansson A-M, 2012, EXCAVATIONS AT HELGO, V18, P53; Hansson A-M, 2014, PLANTS PEOPLE CHOICE, P335; Hansson A-M, 1995, LAB ARKEOL, V8, P38; Hansson Ann-Marie, 2014, PLANTS PEOPLE CHOICE, V1, P311; Heer O., 1865, NEUJAHRSBL NATURFORS, V1866, P1; Heiss A.G., 2010, ALPINE BRANDOPFERPLA, V5, P781; Heiss AG., 2014, PLANTS PEOPLE CHOICE, P343; Heiss AG., 2008, WEIZEN LINSEN OPFERB; Heiss AG, 2015, J ARCHAEOL SCI, V55, P71, DOI 10.1016/j.jas.2014.12.014; Herbig C., 2016, AUSGRABUNGEN SACHSEN, V5, P519; Herbig C., 2009, ARCHAOBOTANISCHE UNT; HILLMAN G, 1993, WORLD ARCHAEOL, V25, P94, DOI 10.1080/00438243.1993.9980230; Hofmann E., 1924, SITZUNGSBERICHTE MN, V133, P379; Jacomet S., 1988, PRA HIST MENSCH SEIN, P205; Jacomet S., 2006, ROMISCHE VILLA BIVER, V2, P579; Jacomet S., 2007, ENCY QUATERNARY SCI, V3, P2384; Jacomet S, 2004, JUNGSTEINZEITLICHE S; Junkelmann M., 2006, PANIS MILITARIS ERNA; K-E Behre, 1991, BERICHTE DENKMALPFLE, V11, P9; Katz S.H., 2003, ENCY FOOD CULTURE; KORBERGROHNE U, 1980, FLORA, V170, P189; Kozub D, 2000, HELICON FOCUS 5 3 7; Kreuz A., 2003, DENKMALPFLEGE KULTUR, V1, P20; Kreuz A, 2006, ARCHAOBOTANISCHES DA; Kubiak-Martens L, 2014, VEGETATION HIST ARCH; Lannoy S., 2002, PAIN, P119; LUND D, 1984, CRC CR REV FOOD SCI, V20, P249, DOI 10.1080/10408398409527391; Maier U, 2004, ARCHAOBOTANISCHE UNT; Martinez Straumann S., 2004, JUNGSTEINZEITLICHE S, P277; Maurizio A., 1916, GETREIDE NAHRUNG WAN; Mehofer M, ARCHAOLOGIE OSTERREI, V16, P56; Mehofer M, ARCHAOLOGIE OSTERREI, V16, P55; Messikommer H., 1913, PFAHLBAUTEN ROBENHAU; Metcalfe CR, 1960, ANATOMY MONOCOTYLEDO, V1; Metheny K.B., 2015, ARCHAEOLOGY FOOD ENC, VVolume 1, P70; Motuzaite-Matuzeviciute G, 2013, ANTIQUITY, V87, P1073, DOI 10.1017/S0003598X00049875; Nadel D, 2012, ANTIQUITY, V86, P990, DOI 10.1017/S0003598X00048201; Netolitzky F., 1914, SITZUNGSBERICHTE MN, V123, P725; Oeggl K., 1996, P 9 INT PAL C HOUST, P511; Piperno DR, 2004, NATURE, V430, P670, DOI 10.1038/nature02734; Popova T., 2016, SE EUROPE ANATOLIA P; Procopiou H., 2003, TRAITEMENT RECOLTES, P115; Procopiou H., 2002, MOUDRE BROYER INTERP; Proudfoot B., 1983, BAR INT SERIES, P85; Rasband W., 2009, IMAGE J; Rosch M., 1985, THESIS, P164; Samuel D., 1999, FOOD IN THE ARTS, P173; Samuel D., 1993, CAMB ARCHAEOL J, V3, P276, DOI [10.1017/S0959774300000883, DOI 10.1017/S0959774300000883]; Samuel D., 2001, PEUPLEMENT RURAL AME, P347; Samuel D., 1996, PETITS PROPOS CULINA, V54, P12; Samuel D, 1999, ARCHAEOLOGY INT, V3, P28; Samuel D., 1994, ARCHAEOLOGICAL STUDY; Samuel D., 2002, CIVILISATIONS REV IN, P27, DOI DOI 10.4000/CIVILISATIONS.1353; Scanlon MG, 2001, FOOD RES INT, V34, P841, DOI 10.1016/S0963-9969(01)00109-0; Schmidt E., 1963, AUSGRABUNGEN FUNDE N, V8, P86; Seibel W., 2005, WARENKUNDE GETREIDE; SHEWRY PR, 1995, BIO-TECHNOL, V13, P1185, DOI 10.1038/nbt1195-1185; Steiner BL, 2015, J ARCHAEOL SCI-REP, V2, P310, DOI 10.1016/j.jasrep.2015.02.012; Steiner BL, 2017, THESIS; Thury GE, 2001, CONDIMENTA GEWURZPFL; Valamoti S. M., 2009, PLANTS CULTURE SEEDS, V3, P25; Valamoti SM, 2002, VEG HIST ARCHAEOBOT, V11, P17, DOI 10.1007/s003340200002; Valamoti SM, 2013, ARCHAEOL ANTHROP SCI, P1; Valamoti SM, PLANTCULT P IN PRESS; Valamoti SM, 2011, ARCHAEOL ANTHROP SCI, V3, P19, DOI 10.1007/s12520-011-0058-z; Valamoti SM, 2008, VEG HIST ARCHAEOBOT, V17, pS265, DOI 10.1007/s00334-008-0190-6; vonGroller-Mildensee M., 1902, ROMISCHE LIMES OSTER, V3, P31; Wahren M, 2000, MAX WAHREN GESAMMELT, P9; Wahren M, 2000, MAX WAHREN GESAMMELT, P705; Wahren M, 2000, MAX WAHREN GESAMMELT, P51; Wahren M., 2000, MAX WAHREN GESAMMELT, P223; Wahren M., 2000, MAX WAHREN GESAMMELT, P189; Wahren M., 1984, ARCHAOLOGIE SCHWEIZ, V7, P2, DOI 10.5169/seals-6409; Wang S, 2011, J CEREAL SCI, V54, P203, DOI 10.1016/j.jcs.2011.05.004; Weiss E, 2008, J ARCHAEOL SCI, V35, P2400, DOI 10.1016/j.jas.2008.03.012; Wiethold J., 2013, HAGEVILLE SAINT JULI, P244; WINTON A. L., 1932, STRUCTURE COMPOSITIO; Winton AL, 1935, STRUCTURE COMPOSITIO, VII	123	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182401	10.1371/journal.pone.0182401	http://dx.doi.org/10.1371/journal.pone.0182401			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	FC5AR	28771539	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000406853600101
J	Lin, CH; Chen, DY; Chao, WC; Liao, TL; Chen, YM; Chen, HH				Lin, Ching-Heng; Chen, Der-Yuan; Chao, Wen-Cheng; Liao, Tsai-Ling; Chen, Yi-Ming; Chen, Hsin-Hua			Association between periodontitis and the risk of palindromic rheumatism: A nationwide, population-based, case-control study	PLOS ONE			English	Article							CITRULLINATED PEPTIDE ANTIBODIES; ARTHRITIS; DISEASE; PROGRESSION; MICROBIOME; PREVALENCE; PROTEINS; HEALTH; NHANES	Objective To estimate the association between a history of periodontitis (PD) and the risk of incident palindromic rheumatism (PR). Methods Using a nationwide, administrative database, this study identified 4,421 newly-diagnosed PR cases from 2007 to 2012 and randomly selected 44,210 non-PR controls matched (1: 10) for sex, age and the year of the index date. After adjusting for comorbid diabetes mellitus, we estimated the odds ratios (ORs) with 95% confidence intervals (CIs) using conditional logistic regression analysis to quantify the association between a history of PD and the risk of PR. The influences of the lag time and severity of PD were examined by calculating ORs for subgroups of patients based on the time interval between the last PD-related visit and the index date and PD-related cumulative cost and number of visit. Results This study showed an association between a history of PD and incident PR (OR, 1.51; 95% CI, 1.41-1.61). The association remained significant after variation of PD definitions. The magnitude of the association was greater in those with shorter lag time between the latest date of PD diagnosis and PR index date and those who had a higher number of visits for PD or a greater cumulative cost for PD-related visits. After excluding 569 PR patients who developed rheumatoid arthritis after the index date, we found a consistent time- and dose-dependent association between PD and PR risk. Conclusion This study demonstrated a time- and dose-dependent association between PD exposure and PR risk.	[Lin, Ching-Heng; Chen, Der-Yuan; Chao, Wen-Cheng; Liao, Tsai-Ling; Chen, Yi-Ming; Chen, Hsin-Hua] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Chen, Der-Yuan; Chao, Wen-Cheng; Liao, Tsai-Ling; Chen, Yi-Ming] Natl Taipei Univ Nursing & Hlth Sci, Dept Healthcare Management, Taipei, Taiwan; [Lin, Ching-Heng; Chen, Der-Yuan; Chen, Yi-Ming; Chen, Hsin-Hua] Taichung Vet Gen Hosp, Div Allergy, Dept Internal Med, Immunol, Taichung, Taiwan; [Chen, Der-Yuan; Chao, Wen-Cheng; Liao, Tsai-Ling; Chen, Yi-Ming] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chen, Der-Yuan; Liao, Tsai-Ling; Chen, Yi-Ming] Chung Hsing Univ, Inst Biomed Sci & Rong Hsing Res, Ctr Translat Med, Taichung, Taiwan; [Chen, Der-Yuan; Liao, Tsai-Ling; Chen, Yi-Ming; Chen, Hsin-Hua] Taichung Vet Gen Hosp, Dept Med Educ, Taichung, Taiwan; [Liao, Tsai-Ling] Taichung Vet Gen Hosp, Div Chest Med, Dept Internal Med, Taichung, Taiwan; [Chao, Wen-Cheng; Liao, Tsai-Ling; Chen, Yi-Ming] Natl Yang Ming Univ, Inst Publ Hlth & Community Med Res Ctr, Taipei, Taiwan	Taichung Veterans General Hospital; National Taipei University of Nursing & Health Science (NTUNHS); Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Chung Hsing University; Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University	Chen, HH (corresponding author), Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan.	shc5555@hotmail.com	Chen, Yi-Ming/AAV-3806-2021	Chen, Yi-Ming/0000-0001-7593-3065				Albandar JM, 2011, J PERIODONTOL, V82, P337, DOI 10.1902/jop.2011.100638; Antoniazzi RP, 2009, J PERIODONTOL, V80, P429, DOI [10.1902/jop.2009.080350, 10.1902/jop.2009.080350 ]; Borrell LN, 2005, J DENT RES, V84, P924, DOI 10.1177/154405910508401010; Brusca SB, 2014, CURR OPIN RHEUMATOL, V26, P101, DOI 10.1097/BOR.0000000000000008; Canete JD, 2007, ARTHRITIS RHEUM, V56, P2784, DOI 10.1002/art.22755; Chen HH, 2015, SCI REP-UK, V5, DOI 10.1038/srep18288; Chen HH, 2010, J MED ULTRASOUND, V18, P17; Chen HH, 2013, ANN RHEUM DIS, V72, P1206, DOI 10.1136/annrheumdis-2012-201593; Chen HH, 2009, J ULTRAS MED, V28, P1193, DOI 10.7863/jum.2009.28.9.1193; Chen W, 2016, CAN J PHYSIOL PHARM, V94, P28, DOI 10.1139/cjpp-2015-0230; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Chou YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139693; COPELAND KT, 1977, AM J EPIDEMIOL, V105, P488, DOI 10.1093/oxfordjournals.aje.a112408; Gonzalez-Lopez L, 1999, J RHEUMATOL, V26, P540; GUERNE PA, 1992, AM J MED, V93, P451, DOI 10.1016/0002-9343(92)90177-D; HANNONEN P, 1987, SCAND J RHEUMATOL, V16, P413, DOI 10.3109/03009748709165412; Hench PR, 1944, ARCH INTERN MED, V73, P28; Kaur Sushil, 2012, JBI Libr Syst Rev, V10, P1; KCHIR MM, 1992, ANN MED INTERNE, V143, P347; Kim SK, 2006, ANN RHEUM DIS, V65, P1539, DOI 10.1136/ard.2006.052928; Klareskog L, 2008, ANNU REV IMMUNOL, V26, P651, DOI 10.1146/annurev.immunol.26.021607.090244; Koskinen E, 2009, J RHEUMATOL, V36, P1873, DOI 10.3899/jrheum.090025; Lee HS, 2004, ARTHRITIS RHEUM-US, V50, P3468, DOI 10.1002/art.20608; Maksymowych WP, 2002, J RHEUMATOL, V29, P2319; MATTINGLY S, 1966, ANN RHEUM DIS, V25, P307, DOI 10.1136/ard.25.4.307; McGraw WT, 1999, INFECT IMMUN, V67, P3248, DOI 10.1128/IAI.67.7.3248-3256.1999; Podhorecka M, 2017, POSTEP HIG MED DOSW, V71, P170; Potikuri D, 2012, ANN RHEUM DIS, V71, P1541, DOI 10.1136/annrheumdis-2011-200380; Russell AS, 2006, J RHEUMATOL, V33, P1240; Sanmarti R, 2004, BEST PRACT RES CL RH, V18, P647, DOI 10.1016/j.berh.2004.05.005; Schiodt M, 2001, ORAL DIS, V7, P106, DOI 10.1034/j.1601-0825.2001.70207.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Tentolouris N, 2008, DIABETIC MED, V25, P1010, DOI 10.1111/j.1464-5491.2008.02487.x; Wade WG, 2013, PHARMACOL RES, V69, P137, DOI 10.1016/j.phrs.2012.11.006; WAJED MA, 1977, ANN RHEUM DIS, V36, P56, DOI 10.1136/ard.36.1.56; Wegner N, 2010, IMMUNOL REV, V233, P34, DOI 10.1111/j.0105-2896.2009.00850.x; WILLIAMS MH, 1971, ANN RHEUM DIS, V30, P375, DOI 10.1136/ard.30.4.375; YOUSSEF W, 1991, J RHEUMATOL, V18, P35	38	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182284	10.1371/journal.pone.0182284	http://dx.doi.org/10.1371/journal.pone.0182284			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771535	Green Published, gold, Green Submitted			2022-12-26	WOS:000406853600084
J	Marcelino-Rodriguez, I; Gonzalez, DA; Aleman-Sanchez, JJ; Diaz, BB; Perez, MD; Gannar, F; Coello, SD; Fernandez, FJC; de Leon, AC				Marcelino-Rodriguez, Itahisa; Almeida Gonzalez, Delia; Juan Aleman-Sanchez, Jose; Brito Diaz, Buenaventura; del Rodriguez Perez, Maria; Gannar, Fadoua; Dominguez Coello, Santiago; Cuevas Fernandez, Francisco J.; Cabrera de Leon, Antonio			Inverse association of resistin with physical activity in the general population	PLOS ONE			English	Article							INFLAMMATORY RESPONSE; INSULIN SENSITIVITY; AEROBIC EXERCISE; SLEEP DURATION; SERUM RESISTIN; CHOLESTEROL; ADIPOKINE	Aim Resistin is a cytokine related with inflammation and ischemic heart disease. Physical activity (PA) prevents chronic inflammation and ischemic heart disease. We studied the relationship of serum concentration of resistin with HDL cholesterol, a known biomarker of PA, and with different measures of PA, in a large sample of the general adult population in the Canary Islands. Methods Cross-sectional study of 6636 adults recruited randomly. We analyzed the correlation of resistin and HDL cholesterol with PA (as metabolic equivalent level [MET]), and fitted the results with linear and logistic regression models using adjustment for age, alcohol consumption and smoking. Results Mean resistin level was higher in women (p<0.001), correlated inversely with age, HDL cholesterol (p<0.001) and alcohol consumption (p<0.001 in men), and correlated directly with smoking (p<0.001). Resistin correlated inversely with the duration of leisure time PA (p<0.001), leisure time MET (p<0.001) and moderate leisure time PA (p<0.001), with some differences between sexes. Men (OR = 0.78 [0.61-0.99; p<0.05]) and women (OR = 0.75 [0.61-0.92; p<0.01]) in the upper quintile of leisure time PA had a lower risk of elevated resistin. In contrast, a high degree of sedentarism was associated with an increased risk elevated resistin in women (OR = 1.24 [1.04-1.47; p<0.05] and in men (OR = 1.40 [1.01-1.82; p<0.05]). Conclusions In our sample of the general population, resistin was inversely associated with measures and levels of PA and HDL cholesterol. The association of resistin with PA was stronger than the association of HDL cholesterol with PA, making resistin a potentially useful biomarker of PA.	[Marcelino-Rodriguez, Itahisa; Almeida Gonzalez, Delia; Juan Aleman-Sanchez, Jose; Brito Diaz, Buenaventura; del Rodriguez Perez, Maria; Gannar, Fadoua; Dominguez Coello, Santiago; Cuevas Fernandez, Francisco J.; Cabrera de Leon, Antonio] Unidad Invest Atenc Primaria, Santa Cruz De Tenerife, Spain; [Marcelino-Rodriguez, Itahisa; Almeida Gonzalez, Delia; Juan Aleman-Sanchez, Jose; Brito Diaz, Buenaventura; del Rodriguez Perez, Maria; Gannar, Fadoua; Dominguez Coello, Santiago; Cuevas Fernandez, Francisco J.; Cabrera de Leon, Antonio] Hosp Univ Nuestra Senora Candelaria, Santa Cruz De Tenerife, Spain; [Marcelino-Rodriguez, Itahisa; Almeida Gonzalez, Delia; Juan Aleman-Sanchez, Jose; Brito Diaz, Buenaventura; del Rodriguez Perez, Maria; Dominguez Coello, Santiago; Cabrera de Leon, Antonio] Inst Salud Carlos III, Red Invest Cardiovasc, Madrid, Spain; [Almeida Gonzalez, Delia] Hosp Univ Nuestra Senora Candelaria, Unidad Inmunol, Santa Cruz De Tenerife, Spain; [Gannar, Fadoua] Carthage Univ, Fac Sci Bizerte, Tunis, Tunisia; [Cabrera de Leon, Antonio] Univ La Laguna, Area Med Prevent & Salud Publ, San Cristobal la Laguna, Spain	Instituto de Salud Carlos III; Universite de Carthage; Universidad de la Laguna	de Leon, AC (corresponding author), Unidad Invest Atenc Primaria, Santa Cruz De Tenerife, Spain.; de Leon, AC (corresponding author), Hosp Univ Nuestra Senora Candelaria, Santa Cruz De Tenerife, Spain.; de Leon, AC (corresponding author), Inst Salud Carlos III, Red Invest Cardiovasc, Madrid, Spain.; de Leon, AC (corresponding author), Univ La Laguna, Area Med Prevent & Salud Publ, San Cristobal la Laguna, Spain.	acableon@gmail.com	Marcelino-RodrÃguez, Itahisa/AGE-3176-2022; Marcelino-Rodríguez, Itahisa/AAH-1469-2021	Marcelino-Rodríguez, Itahisa/0000-0003-3645-3207; DOMINGUEZ COELLO, SANTIAGO/0000-0003-1974-1936; Cuevas Fernandez, Francisco Javier/0000-0002-0918-7698	Canary Islands Health Service; Spanish Government (Instituto de Salud Carlos III) [0901314, PI12/01855, RD12/0042/0031]; Spanish Government (FEDER)	Canary Islands Health Service; Spanish Government (Instituto de Salud Carlos III)(Instituto de Salud Carlos III); Spanish Government (FEDER)(European Commission)	Canary Islands Health Service. Spanish Government (Instituto de Salud Carlos III, projects 0901314, PI12/01855, and RD12/0042/0031. FEDER).	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Al-Disi D, 2010, ENDOCR J, V57, P915, DOI 10.1507/endocrj.K10E-145; Balducci S, 2010, NUTR METAB CARDIOVAS, V20, P608, DOI 10.1016/j.numecd.2009.04.015; Botero JP, 2013, J SPORT MED PHYS FIT, V53, P289; de Leon AC, 2007, REV ESP CARDIOL, V60, P244, DOI 10.1157/13100275; de Leon AC, 2014, J ATHEROSCLER THROMB, V21, P454, DOI 10.5551/jat.22103; de Leon AC, 2014, J ATHEROSCLER THROMB, V21, P273, DOI 10.5551/jat.19273; Camus G, 1997, CLIN SCI, V92, P415, DOI 10.1042/cs0920415; Casella A, 2011, AM J CARDIOL, V107, P1168, DOI 10.1016/j.amjcard.2010.12.014; de Leon AC, 2008, REV ESP SALUD PUBLIC, V82, P519, DOI 10.1590/S1135-57272008000500007; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Elosua R, 2000, MED SCI SPORT EXER, V32, P1431, DOI 10.1097/00005768-200008000-00011; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Hayashino Y, 2014, METABOLISM, V63, P431, DOI 10.1016/j.metabol.2013.08.018; Hopps E, 2011, ACTA DIABETOL, V48, P183, DOI 10.1007/s00592-011-0278-9; Kadoglou NP, 2007, DIABETES CARE, V30, P719, DOI 10.2337/dc06-1149; Kim DY, 2014, J PHYS THER SCI, V26, P275, DOI 10.1589/jpts.26.275; Kodama S, 2007, ARCH INTERN MED, V167, P999, DOI 10.1001/archinte.167.10.999; Lee TS, 2009, LIFE SCI, V84, P97, DOI 10.1016/j.lfs.2008.11.004; Lehrke M, 2004, PLOS MED, V1, P161, DOI 10.1371/journal.pmed.0010045; Mandal P, 2011, J BIOL CHEM, V286, P13460, DOI 10.1074/jbc.M110.204644; Many G, 2013, PEDIATR EXERC SCI, V25, P12, DOI 10.1123/pes.25.1.12; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Morris CJ, 2016, P NATL ACAD SCI USA, V113, pE1402; Northcott JM, 2012, CAN J PHYSIOL PHARM, V90, P1029, DOI [10.1139/Y2012-053, 10.1139/y2012-053]; Oliveira AG, 2011, DIABETES, V60, P784, DOI 10.2337/db09-1907; Ozcan O, 2015, ARCH PHYSIOL BIOCHEM, V121, P50, DOI 10.3109/13813455.2014.1003567; Perseghin G, 2006, DIABETOLOGIA, V49, P1893, DOI 10.1007/s00125-006-0267-7; Rosa JC, 2011, J CELL PHYSIOL, V226, P1604, DOI 10.1002/jcp.22490; Roupas ND, 2013, HORM-INT J ENDOCRINO, V12, P275, DOI 10.14310/horm.2002.1411; Rutters F, 2016, J CLIN ENDOCR METAB, V101, P3272, DOI 10.1210/jc.2016-1045; Shek PN, 1998, CAN J PHYSIOL PHARM, V76, P589, DOI 10.1139/cjpp-76-5-589; Smith MM, 2012, J PHYSIOL-LONDON, V590, P1787, DOI 10.1113/jphysiol.2011.221036; Song G, SCI REPORTS, V6, P30889; Vuolteenaho K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110481; Walsh NP, 2011, EXERC IMMUNOL REV, V17, P64; Wenning P, 2013, EXP CLIN ENDOCR DIAB, V121, P475, DOI 10.1055/s-0033-1343395	37	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182493	10.1371/journal.pone.0182493	http://dx.doi.org/10.1371/journal.pone.0182493			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771611	Green Published, Green Submitted, gold			2022-12-26	WOS:000406853600125
J	Saarela, C; Joutsa, J; Laine, M; Parkkola, R; Rinne, JO; Karrasch, M				Saarela, Carina; Joutsa, Juho; Laine, Matti; Parkkola, Riitta; Rinne, Juha O.; Karrasch, Mira			Regional gray matter correlates of memory for emotion-laden words in middle-aged and older adults: A voxel-based morphometry study	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBES; ALZHEIMERS-DISEASE; PREFRONTAL CORTEX; EPISODIC MEMORY; FUNCTIONAL NEUROANATOMY; COGNITIVE PERFORMANCE; AMYGDALA ACTIVITY; NEURAL PROCESSES; HUMAN CEREBELLUM; LONG-TERM	Emotional content is known to enhance memory in a content-dependent manner in healthy populations. In middle-aged and older adults, a reduced preference for negative material, or even an enhanced preference for positive material has been observed. This preference seems to be modulated by the emotional arousal that the material evokes. The neuroanatomical basis for emotional memory processes is, however, not well understood in middle-aged and older healthy people. Previous research on local gray matter correlates of emotional memory in older populations has mainly been conducted with patients suffering from various neurodegenerative diseases. To our knowledge, this is the first study to examine regional gray matter correlates of immediate free recall and recognition memory of intentionally encoded positive, negative, and emotionally neutral words using voxel-based morphometry (VBM) in a sample of 50-to-79-year-old cognitively intact normal adults. The behavioral analyses yielded a positivity bias in recognition memory, but not in immediate free recall. No associations with memory performance emerged from the region-of-interest (ROI) analyses using amygdalar and hippocampal volumes. Controlling for total intracranial volume, age, and gender, the whole-brain VBM analyses showed statistically significant associations between immediate free recall of negative words and volumes in various frontal regions, between immediate free recall of positive words and cerebellar volume, and between recognition memory of positive words and primary visual cortex volume. The findings indicate that the neural areas subserving memory for emotion-laden information encompass posterior brain areas, including the cerebellum, and that memory for emotion-laden information may be driven by cognitive control functions.	[Saarela, Carina; Laine, Matti; Karrasch, Mira] Abo Akad Univ, Dept Psychol, Turku, Finland; [Saarela, Carina] Univ Turku, Ctr Cognit Neurosci, Turku, Finland; [Joutsa, Juho; Rinne, Juha O.] Turku Univ Hosp, Turku PET Ctr, Turku, Finland; [Joutsa, Juho] Univ Turku, Dept Neurol, Turku, Finland; [Joutsa, Juho] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA 02114 USA; [Joutsa, Juho] Harvard Med Sch, Boston, MA USA; [Joutsa, Juho] Beth Israel Deaconess Med Ctr, Berenson Allen Ctr Noninvas Brain Stimulat, Boston, MA 02215 USA; [Laine, Matti] Univ Turku, Turku Brain & Mind Ctr, Turku, Finland; [Parkkola, Riitta] Univ Tampere, Dept Radiol, Tampere, Finland; [Parkkola, Riitta] Tampere Univ Hosp, Dept Radiol, Tampere, Finland; [Rinne, Juha O.] Turku Univ Hosp, Div Clin Neurosci, Turku, Finland; [Parkkola, Riitta] Univ Turku, Dept Radiol, Turku, Finland; [Parkkola, Riitta] Turku Univ Hosp, Turku, Finland	Abo Akademi University; University of Turku; University of Turku; University of Turku; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; University of Turku; Tampere University; Tampere University; Tampere University Hospital; University of Turku; University of Turku; University of Turku	Saarela, C (corresponding author), Abo Akad Univ, Dept Psychol, Turku, Finland.; Saarela, C (corresponding author), Univ Turku, Ctr Cognit Neurosci, Turku, Finland.	carina.saarela@abo.fi	Parkkola, Riitta/AAZ-1341-2020	Karrasch, Mira/0000-0002-6996-9157	Victoria Foundation (FIN); Swedish Cultural Foundation in Finland (FIN); Professor Jan Magnus Jansson's Foundation for Geriatric Research (FIN); Abo Akademi University Endowment (FIN); former Department of Psychology and Logopedics at the Abo Akademi University (FIN); Margaretha Foundation (FIN); Paivikki and Sakari Sohlberg Foundation (FIN); Miina Sillanpaa Foundation (FIN); Sigrid Juselius Foundation (FIN); Academy of Finland [295580]; Finnish Medical Foundation (FIN); Orion Research Foundation (FIN)	Victoria Foundation (FIN); Swedish Cultural Foundation in Finland (FIN); Professor Jan Magnus Jansson's Foundation for Geriatric Research (FIN); Abo Akademi University Endowment (FIN); former Department of Psychology and Logopedics at the Abo Akademi University (FIN); Margaretha Foundation (FIN); Paivikki and Sakari Sohlberg Foundation (FIN); Miina Sillanpaa Foundation (FIN); Sigrid Juselius Foundation (FIN); Academy of Finland(Academy of Finland); Finnish Medical Foundation (FIN); Orion Research Foundation (FIN)	The Victoria Foundation (FIN) http://victoriastiftelsen.fi/start (CS). The Swedish Cultural Foundation in Finland (FIN) http://www.kulturfonden.fi/in-english/ (CS). Professor Jan Magnus Jansson's Foundation for Geriatric Research (FIN) (CS). The Abo Akademi University Endowment (FIN) http://stiftelsenabo.fi/en/ (CS). The former Department of Psychology and Logopedics at the Abo Akademi University (FIN) (CS). The Margaretha Foundation (FIN) http://www.margarethasaatio.fi/ (CS). The Paivikki and Sakari Sohlberg Foundation(FIN)http://www.pss-saatio.fi/english.htm (CS). The Miina Sillanpaa Foundation (FIN) https://www.miinasillanpaa.fi/eng/ (CS). The Sigrid Juselius Foundation (FIN) http://www.sigridjuselius.fi/foundation (JOR). Academy of Finland (grant number 295580) (FIN) http://www.aka.fi/en/ (JJ). The Finnish Medical Foundation (FIN) http://www.laakatieteensaatio.fi/fin/inenglish/ (JJ). Orion Research Foundation (FIN) www.orion.fi/en/rd/ (JJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 1997, LEARN MEMORY, V4, P291, DOI 10.1101/lm.4.3.291; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Allen PA, 2008, HBK BEHAV NEUROSCI, V18, P115, DOI 10.1016/S1569-7339(08)00208-7; Amaral DG, 2003, NEUROSCIENCE, V118, P1099, DOI 10.1016/S0306-4522(02)01001-1; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Andreasen NC, 1999, HUM BRAIN MAPP, V8, P226, DOI 10.1002/(SICI)1097-0193(1999)8:4<226::AID-HBM6>3.3.CO;2-W; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Baillieux H, 2008, CLIN NEUROL NEUROSUR, V110, P763, DOI 10.1016/j.clineuro.2008.05.013; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Benton AL., 1983, MULTILINGUAL APHASIA; Bostan AC, 2013, TRENDS COGN SCI, V17, P241, DOI 10.1016/j.tics.2013.03.003; Brooks BL, 2011, ASSESSMENT, V18, P156, DOI 10.1177/1073191110385316; Buckner RL, 2011, J NEUROPHYSIOL, V106, P2322, DOI 10.1152/jn.00339.2011; Cabeza R, 1997, J COGNITIVE NEUROSCI, V9, P254, DOI 10.1162/jocn.1997.9.2.254; Cacioppo JT., 2011, SOCIAL NEUROSCIENCE, P249, DOI [DOI 10.1093/ACPROF:OSO/9780195316872.003.0017, 10.1093/acprof:oso/9780195316872.003.0017]; Cahill L, 1996, P NATL ACAD SCI USA, V93, P8016, DOI 10.1073/pnas.93.15.8016; Canli T, 1999, PSYCHOBIOLOGY, V27, P441; CARSTENSEN LL, 1995, CURR DIR PSYCHOL SCI, V4, P151, DOI 10.1111/1467-8721.ep11512261; Champod AS, 2007, P NATL ACAD SCI USA, V104, P14837, DOI 10.1073/pnas.0607101104; Charles ST, 2003, J EXP PSYCHOL GEN, V132, P310, DOI 10.1037/0096-3445.132.2.310; Cohen MS, MODIFIED VERSION EDI; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Cuadra MB, 2005, IEEE T MED IMAGING, V24, P1548, DOI 10.1109/TMI.2005.857652; D'Angelo E, 2013, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00116; DODRILL CB, 1978, EPILEPSIA, V19, P611, DOI 10.1111/j.1528-1157.1978.tb05041.x; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Dolan RS, 2000, NEUROIMAGE, V11, P203, DOI 10.1006/nimg.2000.0538; Dolcos F, 2005, P NATL ACAD SCI USA, V102, P2626, DOI 10.1073/pnas.0409848102; Ebner NC, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00223; Ellfolk U, 2013, J PARKINSON DIS, V3, P593, DOI 10.3233/JPD-130276; Entis JJ, 2012, NEUROIMAGE, V60, P1226, DOI 10.1016/j.neuroimage.2011.12.073; Fischer H, 2010, CORTEX, V46, P490, DOI 10.1016/j.cortex.2009.05.011; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fjell AM, 2013, NEUROBIOL AGING, V34, P2239, DOI 10.1016/j.neurobiolaging.2013.04.006; Fjell AM, 2009, J NEUROSCI, V29, P15223, DOI 10.1523/JNEUROSCI.3252-09.2009; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fossati P, 2004, NEUROIMAGE, V22, P1596, DOI 10.1016/j.neuroimage.2004.03.034; Fossati P, 2012, EUR NEUROPSYCHOPHARM, V22, pS487, DOI 10.1016/j.euroneuro.2012.07.008; Gautam P, 2011, NEUROIMAGE, V55, P845, DOI 10.1016/j.neuroimage.2011.01.015; Ghashghaei H, 2007, NEUROIMAGE, V34, P905, DOI 10.1016/j.neuroimage.2006.09.046; Grieve SM, 2005, HUM BRAIN MAPP, V25, P391, DOI 10.1002/hbm.20115; Gronholm P, 2005, COGNITIVE BRAIN RES, V25, P359, DOI 10.1016/j.cogbrainres.2005.06.010; Gruhn D, 2005, PSYCHOL AGING, V20, P579, DOI 10.1037/0882-7974.20.4.579; Gunning-Dixon FM, 2003, NEUROBIOL AGING, V24, P285, DOI 10.1016/S0197-4580(02)00099-4; Guzman-Velez E, 2015, HIPPOCAMPUS; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; Hamann S, 2003, NAT NEUROSCI, V6, P106, DOI 10.1038/nn0203-106; Hamann S, 2001, TRENDS COGN SCI, V5, P394, DOI 10.1016/S1364-6613(00)01707-1; Hamann SB, 1999, NAT NEUROSCI, V2, P289, DOI 10.1038/6404; HEATH RG, 1982, BIOL PSYCHIAT, V17, P569; Herold D, 2015, BRAIN STRUCT FUNCT; Hogan MJ, 2011, CORTEX, V47, P441, DOI 10.1016/j.cortex.2010.01.001; Jernigan TL, 2001, NEUROBIOL AGING, V22, P581, DOI 10.1016/S0197-4580(01)00217-2; Jokinen P, 2009, PARKINSONISM RELAT D, V15, P88, DOI 10.1016/j.parkreldis.2008.03.005; Kalenzaga S, 2016, EMOTION, V16, P602, DOI 10.1037/emo0000170; Kalpouzos G, 2012, NEUROBIOL AGING, V33, P623, DOI DOI 10.1016/J.NEUR0BI0LAGING.2011.02.021; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Kennedy Q, 2004, PSYCHOL SCI, V15, P208, DOI 10.1111/j.0956-7976.2004.01503011.x; Kensinger E.A., 2008, HDB EMOTIONS, V3rd ed., P601; Kensinger EA, 2004, REV NEUROSCIENCE, V15, P241, DOI 10.1515/REVNEURO.2004.15.4.241; Kensinger EA, 2004, P NATL ACAD SCI USA, V101, P3310, DOI 10.1073/pnas.0306408101; Kensinger EA, 2008, J COGNITIVE NEUROSCI, V20, P1161, DOI 10.1162/jocn.2008.20080; Kensinger EA, 2008, J GERONTOL B-PSYCHOL, V63, pP13, DOI 10.1093/geronb/63.1.P13; Kensinger EA, 2002, EMOTION, V2, P118, DOI 10.1037//1528-3542.2.2.118; Kensinger EA, 2011, NEUROPSYCHOLOGIA, V49, P663, DOI 10.1016/j.neuropsychologia.2011.01.017; Kumfor F, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00225; Kumfor F, 2013, BRAIN, V136, P2992, DOI 10.1093/brain/awt185; Labouvie-Vief G., 2010, HDB LIFE SPAN DEV SO, V2, P79; Laine M, 1987, FINNISH VERSION BOST; Landre L, 2013, J ALZHEIMERS DIS, V36, P535, DOI 10.3233/JAD-130170; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Maillet D, 2013, AGEING RES REV, V12, P479, DOI 10.1016/j.arr.2012.11.001; Majerus S, 2011, J MEM LANG, V64, P181, DOI 10.1016/j.jml.2010.10.003; Mather M, 2005, TRENDS COGN SCI, V9, P496, DOI 10.1016/j.tics.2005.08.005; Mather M, 2016, ANNU REV PSYCHOL, V67, P213, DOI 10.1146/annurev-psych-122414-033540; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miquel M, 2016, NEUROSCI BIOBEHAV R, V60, P1, DOI 10.1016/j.neubiorev.2015.11.005; Mistridis P, 2014, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00939; Mori E, 1999, AM J PSYCHIAT, V156, P216; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Murphy NA, 2008, PSYCHOL AGING, V23, P263, DOI 10.1037/0882-7974.23.2.263; Nyberg L, 2012, TRENDS COGN SCI, V16, P292, DOI 10.1016/j.tics.2012.04.005; Ochsner KN, 2012, ANN NY ACAD SCI, V1251, pE1, DOI 10.1111/j.1749-6632.2012.06751.x; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Osterrieth P., 1944, ARCH PSYCHOL-GENEVE, V30, P206; Paul R, 2009, NEUROBIOL AGING, V30, P457, DOI 10.1016/j.neurobiolaging.2007.07.017; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phelps EA, 1997, BRAIN COGNITION, V35, P85, DOI 10.1006/brcg.1997.0929; Philippi N, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00021; Picazio S, 2015, CEREBELLUM, V14, P47, DOI 10.1007/s12311-014-0609-9; Pollock JW, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00060; PORTIN R, 1995, PSYCHOL MED, V25, P1295, DOI 10.1017/S0033291700033262; Posner J, 2009, HUM BRAIN MAPP, V30, P883, DOI 10.1002/hbm.20553; Poutiainen E, 2010, TRAIL MAKING TEST HD; Price JL, 2003, ANN NY ACAD SCI, V985, P50; Reed AE, 2014, PSYCHOL AGING, V29, P1, DOI 10.1037/a0035194; Reed AE, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00339; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Russell JA, 1999, J PERS SOC PSYCHOL, V76, P805, DOI 10.1037/0022-3514.76.5.805; Sacchetti B, 2009, NEUROSCIENCE, V162, P756, DOI 10.1016/j.neuroscience.2009.01.064; Salat DH, 2002, CEREB CORTEX, V12, P494, DOI 10.1093/cercor/12.5.494; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; Schmahmann JD, 2006, BRAIN, V129, P290, DOI 10.1093/brain/awh729; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schmahmann JD, 1996, HUM BRAIN MAPP, V4, P174, DOI 10.1002/(SICI)1097-0193(1996)4:3<174::AID-HBM3>3.0.CO;2-0; Schmitz TW, 2007, NEUROSCI BIOBEHAV R, V31, P585, DOI 10.1016/j.neubiorev.2006.12.003; Schultz RR, 2009, ACTA NEUROL SCAND, V120, P101, DOI 10.1111/j.1600-0404.2008.01132.x; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Soderholm C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072859; Sollberger M, 2009, NEUROPSYCHOLOGIA, V47, P2812, DOI 10.1016/j.neuropsychologia.2009.06.006; Stern Y, 2005, CEREB CORTEX, V15, P394, DOI 10.1093/cercor/bhh142; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Tabert MH, 2001, NEUROPSYCHOLOGIA, V39, P556, DOI 10.1016/S0028-3932(00)00157-3; Tehan G, 2007, J MEM LANG, V56, P35, DOI 10.1016/j.jml.2006.08.015; Turner BM, 2007, NEUROPSYCHOLOGIA, V45, P1331, DOI 10.1016/j.neuropsychologia.2006.09.023; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Petten C, 2004, NEUROPSYCHOLOGIA, V42, P1394, DOI 10.1016/j.neuropsychologia.2004.04.006; VICTOROFF J, 1994, NEUROLOGY, V44, P2267, DOI 10.1212/WNL.44.12.2267; Virtanen, 1999, WORDMILL LEXICAL SEA; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wechsler D, 1987, WMS R WECHSLER MEMOR; Williams LM, 2006, J NEUROSCI, V26, P6422, DOI 10.1523/JNEUROSCI.0022-06.2006	131	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182541	10.1371/journal.pone.0182541	http://dx.doi.org/10.1371/journal.pone.0182541			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC5AR	28771634	Green Published, gold			2022-12-26	WOS:000406853600138
J	Burse, M; Shi, J; Aiken, C				Burse, Mallori; Shi, Jiong; Aiken, Christopher			Cyclophilin A potentiates TRIM5 alpha inhibition of HIV-1 nuclear import without promoting TRIM5 alpha binding to the viral capsid	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; A-DEPENDENT RESTRICTION; OLD-WORLD MONKEY; REVERSE TRANSCRIPTION; RETROVIRUS RESTRICTION; PREINTEGRATION COMPLEX; SIGNALING PATHWAYS; RHESUS TRIM5-ALPHA; TRIM5 PROTEINS; INFECTED-CELLS	The host immunophilin cyclophilin A (CypA) binds to the capsid protein (CA) of HIV-1 and regulates its infectivity. Depending on the target cell type, CypA can either promote or inhibit HIV-1 infection. The ability of CypA to promote HIV-1 infection has been extensively studied and linked to several steps in early replication including uncoating, reverse transcription and nuclear import. By contrast, the mechanism by which CypA inhibits infection is less well understood. We investigated the mechanism by which CypA potentiates restriction of HIV-1 by the tripartite motif-containing protein 5 (TRIM5 alpha). Depletion of TRIM5 alpha in the African green monkey cell line Vero, resulted in a loss of inhibition of infection by CypA, demonstrating that inhibition by CypA is mediated by TRIM5 alpha. Complementary genetic and biochemical assays failed to demonstrate an ability of CypA to promote binding of TRIM5 alpha to the viral capsid. TRIM5 alpha inhibits HIV-1 reverse transcription in a proteasome-dependent manner; however, we observed that inhibition of proteasome activity did not reduce the ability of CypA to inhibit infection, suggesting that CypA acts at a step after reverse transcription. Accordingly, we observed a CypA-dependent reduction in the accumulation of nuclear HIV-1 DNA, indicating that CypA specifically promotes TRIM5 alpha inhibition of HIV-1 nuclear import. We also observed that the ability of CypA to inhibit HIV-1 infection is abolished by amino acid substitutions within the conserved CPSF6-binding surface in CA. Our results indicate that CypA inhibits HIV-1 infection in Vero cells not by promoting TRIM5 alpha binding to the capsid but by blocking nuclear import of the HIV-1 preintegration complex.	[Burse, Mallori; Shi, Jiong; Aiken, Christopher] Vanderbilt Univ, Med Ctr, Dept Pathol Immunol & Microbiol, Nashville, TN 37232 USA	Vanderbilt University	Aiken, C (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Immunol & Microbiol, Nashville, TN 37232 USA.	chris.aiken@vanderbilt.edu	Aiken, Christopher/Y-9252-2019		NIH [R01 AI076121, F31 AI108481]; Vanderbilt Molecular Virology Training Grant [5T32 AI08955]; CTSA [5UL1 RR024975-03]; Vanderbilt Ingram Cancer Center [P30 CA68485]; Vanderbilt Vision Center [P30 EY08126]; NIH/NCRR [G20 RR030956]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076121] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Molecular Virology Training Grant; CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Vanderbilt Ingram Cancer Center; Vanderbilt Vision Center; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH R01 AI076121. MB was supported in part by NIH Individual Predoctoral Fellowship F31 AI108481 and by the Vanderbilt Molecular Virology Training Grant 5T32 AI08955. The Vanderbilt VANTAGE Core provided technical assistance for this work. VANTAGE is supported in part by CTSA Grant (5UL1 RR024975-03), the Vanderbilt Ingram Cancer Center (P30 CA68485), the Vanderbilt Vision Center (P30 EY08126), and NIH/NCRR (G20 RR030956). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberham C, 1996, J VIROL, V70, P3536, DOI 10.1128/JVI.70.6.3536-3544.1996; Ambrose Z, 2012, J VIROL, V86, P4708, DOI 10.1128/JVI.05887-11; Anderson JL, 2006, J VIROL, V80, P9754, DOI 10.1128/JVI.01052-06; Berthoux L, 2005, P NATL ACAD SCI USA, V102, P14849, DOI 10.1073/pnas.0505659102; Braaten D, 1996, J VIROL, V70, P3551, DOI 10.1128/JVI.70.6.3551-3560.1996; Braaten D, 1996, J VIROL, V70, P4220, DOI 10.1128/JVI.70.7.4220-4227.1996; BUKRINSKY MI, 1992, P NATL ACAD SCI USA, V89, P6580, DOI 10.1073/pnas.89.14.6580; Campbell EM, 2008, J CELL BIOL, V180, P549, DOI 10.1083/jcb.200706154; De Iaco A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-11; De Iaco A, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-20; Diaz-Griffero F, 2009, J VIROL, V83, P10737, DOI 10.1128/JVI.01307-09; Dietrich EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014019; Dismuke DJ, 2006, J VIROL, V80, P3712, DOI 10.1128/JVI.80.8.3712-3720.2006; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1; Hatziioannou T, 2004, P NATL ACAD SCI USA, V101, P10774, DOI 10.1073/pnas.0402361101; He JL, 1997, NATURE, V385, P645, DOI 10.1038/385645a0; Henning MS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003868; Hulme AE, 2015, J VIROL, V89, P643, DOI 10.1128/JVI.03043-14; Kawai T, 2011, EMBO MOL MED, V3, P513, DOI 10.1002/emmm.201100160; Keckesova Z, 2006, J VIROL, V80, P4683, DOI 10.1128/JVI.80.10.4683-4690.2006; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; Li X, 2007, VIROLOGY, V366, P234, DOI 10.1016/j.virol.2007.04.022; Li Y, 2009, J VIROL, V83, P10951, DOI 10.1128/JVI.00682-09; Lienlaf M, 2011, J VIROL, V85, P8725, DOI 10.1128/JVI.00497-11; Lin TY, 2008, VIROLOGY, V379, P335, DOI 10.1016/j.virol.2008.06.037; Lin TY, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-70; Liu ZL, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-014-0129-1; Matreyek KA, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0090-z; Matreyek KA, 2013, VIRUSES-BASEL, V5, P2483, DOI 10.3390/v5102483; Matreyek KA, 2011, J VIROL, V85, P7818, DOI 10.1128/JVI.00325-11; Newman RM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000003; PAUZA CD, 1994, VIROLOGY, V205, P470, DOI 10.1006/viro.1994.1667; Price AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002896; Qi ML, 2008, J VIROL, V82, P12001, DOI 10.1128/JVI.01518-08; Reicin AS, 1996, J VIROL, V70, P8645, DOI 10.1128/JVI.70.12.8645-8652.1996; Roa A, 2012, J VIROL, V86, P1717, DOI 10.1128/JVI.05811-11; Rold CJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000074; Saito A, 2016, J VIROL, V90, P5808, DOI 10.1128/JVI.03116-15; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Schaller T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002439; Shah VB, 2013, J VIROL, V87, P422, DOI 10.1128/JVI.07177-11; Shi J, 2006, VIROLOGY, V350, P493; Shi J, 2006, VIROLOGY, V350, P493, DOI 10.1016/j.virol.2006.03.013; Shi J, 2013, J VIROL, V87, P9271, DOI 10.1128/JVI.00713-13; Shi J, 2011, J VIROL, V85, P542, DOI 10.1128/JVI.01406-10; Sowd GA, 2016, P NATL ACAD SCI USA, V113, pE1054, DOI 10.1073/pnas.1524213113; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2005, J VIROL, V79, P3139, DOI 10.1128/JVI.79.5.3139-3145.2005; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Stremlau M, 2006, VIROLOGY, V351, P112, DOI 10.1016/j.virol.2006.03.015; Tang SX, 2001, J VIROL, V75, P9357, DOI 10.1128/JVI.75.19.9357-9366.2001; Towers G, 2002, J VIROL, V76, P2548, DOI 10.1128/JVI.76.5.2548-2550.2002; Towers G, 2000, P NATL ACAD SCI USA, V97, P12295, DOI 10.1073/pnas.200286297; Veillette M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-25; Versteeg GA, 2013, IMMUNITY, V38, P384, DOI 10.1016/j.immuni.2012.11.013; Wehrly K, 1997, METHODS, V12, P288, DOI 10.1006/meth.1997.0481; Wilson SJ, 2008, P NATL ACAD SCI USA, V105, P3557, DOI 10.1073/pnas.0709003105; Wu XL, 2006, P NATL ACAD SCI USA, V103, P7465, DOI 10.1073/pnas.0510483103; Yoo SH, 1997, J MOL BIOL, V269, P780, DOI 10.1006/jmbi.1997.1051; Yufenyuy EL, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-29; Zhou LH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002194; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	63	8	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182298	10.1371/journal.pone.0182298	http://dx.doi.org/10.1371/journal.pone.0182298			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767697	gold, Green Published, Green Submitted			2022-12-26	WOS:000406768200067
J	Fois, M; Fenu, G; Canadas, EM; Bacchetta, G				Fois, Mauro; Fenu, Giuseppe; Maria Canadas, Eva; Bacchetta, Gianluigi			Disentangling the influence of environmental and anthropogenic factors on the distribution of endemic vascular plants in Sardinia	PLOS ONE			English	Article							SPECIES RICHNESS; DISTRIBUTION PATTERNS; DIVERSITY; ISLANDS; FLORA; EXTINCTION; MAP	Due to the impelling urgency of plant conservation and the increasing availability of high resolution spatially interpolated (e.g. climate variables) and categorical data (e.g. land cover and vegetation type), many recent studies have examined relationships among plant species distributions and a diversified set of explanatory factors; nevertheless, global and regional patterns of endemic plant richness remain in many cases unexplained. One such pattern is the 294 endemic vascular plant taxa recorded on a 1 km resolution grid on the environmentally heterogeneous island of Sardinia. Sixteen predictors, including topographic, geological, climatic and anthropogenic factors, were used to model local (number of taxa inside each 1 km grid cell) Endemic Vascular Plant Richness (EVPR). Generalized Linear Models were used to evaluate how each factor affected the distribution of local EVPR. Significant relationships with local EVPR and topographic, geological, climatic and anthropogenic factors were found. In particular, elevation explained the larger fraction of variation in endemic richness but other environmental factors (e.g. precipitation seasonality and slope) and human-related factors (e.g. the Human Influence Index (HII) and the proportion of anthropogenic land uses) were, respectively, positively and negatively correlated with local EVPR. Regional EVPR (number of endemic taxa inside each 100 m elevation interval) was also measured to compare local and regional EVPR patterns along the elevation gradient. In contrast to local, regional EVPR tended to decrease with altitude partly due to the decreasing area covered along altitude. The contrasting results between local and regional patterns suggest that local richness increases as a result of increased interspecific aggregation along altitude, whereas regional richness may depend on the interaction between area and altitude. This suggests that the shape and magnitude of the species-area relationship might vary with elevation. This work provides-for the first time in Sardinia-a comprehensive analysis of the influence of environmental factors on the pattern of EVPR in the entire territory, from sea level to the highest peaks. Elevation, as well as other environmental and human-related variables, were confirmed to be influencing factors. In addition, variations of EVPR patterns at regional-to-local spatial scales inspire next investigations on the possible interaction between elevation and area in explaining patterns of plant species richness.	[Fois, Mauro; Fenu, Giuseppe; Bacchetta, Gianluigi] Univ Cagliari, CCB, Dipartimento Sci Vita & Ambiente, Cagliari, Italy; [Fenu, Giuseppe] Sapienza Univ Roma, Dipartimento Biol Ambientale, Rome, Italy; [Maria Canadas, Eva] Univ Granada, Fac Ciencias, Dept Bot, Granada, Spain	University of Cagliari; Sapienza University Rome; University of Granada	Fenu, G (corresponding author), Univ Cagliari, CCB, Dipartimento Sci Vita & Ambiente, Cagliari, Italy.; Fenu, G (corresponding author), Sapienza Univ Roma, Dipartimento Biol Ambientale, Rome, Italy.	giuseppe.fenu@uniroma1.it	Fois, Mauro/T-7059-2019; Fenu, Giuseppe/AAR-8439-2021; Cañadas, Eva M./A-8928-2011; Bacchetta, Gianluigi/AAD-5329-2020	Fois, Mauro/0000-0002-4178-0790; Cañadas, Eva M./0000-0003-1348-553X; Fenu, Giuseppe/0000-0003-4762-5043; BACCHETTA, GIANLUIGI/0000-0002-1714-3978				Abdelaal M, 2017, PLANT BIOSYST; [Anonymous], 2011, GLOBAL ECOL BIOGEOGR, V20, P218; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; Anselin L, 1996, REG SCI URBAN ECON, V26, P77, DOI 10.1016/0166-0462(95)02111-6; Araujo MB, 2003, GLOBAL ECOL BIOGEOGR, V12, P5, DOI 10.1046/j.1466-822X.2003.00314.x; Bacchetta G., 2014, SYSTEM BIODIVERS; Bacchetta G, 2014, PHYTOTAXA, V186, P279, DOI 10.11646/phytotaxa.186.5.5; Bacchetta G, 2012, PHYTOTAXA, V56, P59, DOI 10.11646/phytotaxa.56.1.9; Bachetta G., 2009, Fitosociologia (Pavia), V46, P3; Balmford A, 1996, TRENDS ECOL EVOL, V11, P193, DOI 10.1016/0169-5347(96)10026-4; Barbosa AM, 2017, MODEVA MODEL EVALUAT; Birnbaum P, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv075; Bonanno G, 2016, FLORA, V224, P230, DOI 10.1016/j.flora.2016.09.001; Bosso L, 2016, HYSTRIX, V27; Canu S, 2015, J MAPS, V11, P711, DOI 10.1080/17445647.2014.988187; Caperta AD, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu032; Carmignani L, 2016, J MAPS, V12, P826, DOI 10.1080/17445647.2015.1084544; Cespedes B, 2014, APPL VEG SCI, V17, P86, DOI 10.1111/avsc.12053; Cogoni D, 2017, ENV CONSERV; Concepcion ED, 2015, OIKOS, V124, P1571, DOI 10.1111/oik.02166; Conti F, 2007, NATURA VICENTINA, V10, p[2006, 5]; Fenu G, 2010, CANDOLLEA, V65, P347, DOI 10.15553/c2010v652a10; FERNANDEZCALZADO R, 2013, PIRINEOS, V168, P7, DOI DOI 10.3989/Pirineos.2013.168001; Fois M, 2017, J ENVIRON PLANN MAN; Fois M, 2016, J NAT CONSERV, V33, P1, DOI 10.1016/j.jnc.2016.06.001; Fois M, 2016, BIODIVERS CONSERV, V25, P1091, DOI 10.1007/s10531-016-1110-1; Grill Andrea, 2002, Journal for Nature Conservation (Jena), V10, P51, DOI 10.1078/1617-1381-00006; Groemping U., 2006, J STAT SOFTW, V17, P1, DOI DOI 10.18637/JSS.V017.I01; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Harrison S, 2008, CONSERV LETT, V1, P65, DOI 10.1111/j.1755-263X.2008.00010.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Irl SDH, 2015, J ECOL, V103, P1621, DOI 10.1111/1365-2745.12463; Kallimanis AS, 2011, ACTA OECOL, V37, P65, DOI 10.1016/j.actao.2010.11.008; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Lecis R, 2004, BIOL CONSERV, V119, P263, DOI 10.1016/j.biocon.2003.11.011; Li JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054839; Lorite J, BIOL CONSERV; MAC ARTHUR ROBERT H., 1967; Mansion G, 2008, SYST BIOL, V57, P269, DOI 10.1080/10635150802044029; Mazziotta A, 2016, CLIMATIC CHANGE, V135, P585, DOI 10.1007/s10584-015-1591-z; Medail F, 2009, J BIOGEOGR, V36, P1333, DOI 10.1111/j.1365-2699.2008.02051.x; Normand S, GLOB ECOL BIOGEOGR; Ohlemuller R, 2008, BIOL LETTERS, V4, P568, DOI 10.1098/rsbl.2008.0097; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Panitsa M, 2006, J BIOGEOGR, V33, P1223, DOI 10.1111/j.1365-2699.2006.01481.x; Panitsa M, 2010, ACTA OECOL, V36, P431, DOI 10.1016/j.actao.2010.04.004; Perez-Garcia FJ, 2012, ANN BOT FENN, V49, P43, DOI 10.5735/085.049.0106; plant richness, 2014, BIOL CONSERV, V170, P282; Porceddu M, 2017, SYST BIODIVERS, V15, P480, DOI 10.1080/14772000.2016.1271058; Real R, 2003, J BIOGEOGR, V30, P939, DOI 10.1046/j.1365-2699.2003.00871.x; Sfenthourakis S, 2012, J BIOGEOGR, V39, P750, DOI 10.1111/j.1365-2699.2011.02639.x; Smiraglia D, 2013, J MAPS, V9, P239, DOI 10.1080/17445647.2013.771290; Steinbauer MJ, 2013, ACTA OECOL, V47, P52, DOI 10.1016/j.actao.2012.11.004; Steinbauer MJ, GLOB ECOL BIOGEOGR, V25, P1097; Stuessy TF, 2006, J BIOGEOGR, V33, P1259, DOI 10.1111/j.1365-2699.2006.01504.x; Thompson JD., 2005, PLANT EVOLUTION MEDI, DOI DOI 10.1093/ACPROF:OSO/9780198515340.001.0001; Trigas P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059425; Trigas P, 2012, FOLIA GEOBOT, V47, P421, DOI 10.1007/s12224-012-9130-4; Voda R, 2016, SCI REP-UK, V6, DOI 10.1038/srep28828; Wildlife Conservation Society (WCS), 2005, LAST WILD PROJECT VE; Wulff AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073371	62	26	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182539	10.1371/journal.pone.0182539	http://dx.doi.org/10.1371/journal.pone.0182539			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767717	Green Submitted, Green Published, gold			2022-12-26	WOS:000406768200085
J	Prabhu, VV; Lulla, AR; Madhukar, NS; Ralff, MD; Zhao, D; Kline, CLB; Van den Heuvel, APJ; Lev, A; Garnett, MJ; McDermott, U; Benes, CH; Batchelor, TT; Chi, AS; Elemento, O; Allen, JE; El-Deiry, WS				Prabhu, Varun V.; Lulla, Amriti R.; Madhukar, Neel S.; Ralff, Marie D.; Zhao, Dan; Kline, Christina Leah B.; Van den Heuvel, A. Pieter J.; Lev, Avital; Garnett, Mathew J.; McDermott, Ultan; Benes, Cyril H.; Batchelor, Tracy T.; Chi, Andrew S.; Elemento, Olivier; Allen, Joshua E.; El-Deiry, Wafik S.			Cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumors	PLOS ONE			English	Article							INTEGRATED STRESS-RESPONSE; INITIATING CELLS; PROSTATE-CANCER; MALIGNANCIES; METASTASIS	Cancer stem cells (CSCs) correlate with recurrence, metastasis and poor survival in clinical studies. Encouraging results from clinical trials of CSC inhibitors have further validated CSCs as therapeutic targets. ONC201 is a first-in-class small molecule imipridone in Phase I/II clinical trials for advanced cancer. We have previously shown that ONC201 targets self-renewing, chemotherapy-resistant colorectal CSCs via Akt/ERK inhibition and DR5/TRAIL induction. In this study, we demonstrate that the anti-CSC effects of ONC201 involve early changes in stem cell-related gene expression prior to tumor cell death induction. A targeted network analysis of gene expression profiles in colorectal cancer cells revealed that ONC201 downregulates stem cell pathways such as Wnt signaling and modulates genes (ID1, ID2, ID3 and ALDH7A1) known to regulate self-renewal in colorectal, prostate cancer and glioblastoma. ONC201-mediated changes in CSC-related gene expression were validated at the RNA and protein level for each tumor type. Accordingly, we observed inhibition of self-renewal and CSC markers in prostate cancer cell lines and patient-derived glioblastoma cells upon ONC201 treatment. Interestingly, ONC201-mediated CSC depletion does not occur in colorectal cancer cells with acquired resistance to ONC201. Finally, we observed that basal expression of CSC-related genes (ID1, CD44, HES7 and TCF3) significantly correlate with ONC201 efficacy in > 1000 cancer cell lines and combining the expression of multiple genes leads to a stronger overall prediction. These proof-of-concept studies provide a rationale for testing CSC expression at the RNA and protein level as a predictive and pharmacodynamic biomarker of ONC201 response in ongoing clinical studies.	[Prabhu, Varun V.; Allen, Joshua E.] Oncoceutics Inc, Philadelphia, PA 19104 USA; [Lulla, Amriti R.; Ralff, Marie D.; Kline, Christina Leah B.; Lev, Avital; El-Deiry, Wafik S.] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Lulla, Amriti R.; Van den Heuvel, A. Pieter J.] Penn State Coll Med, Hershey, PA USA; [Madhukar, Neel S.; Elemento, Olivier] Weill Cornell Med, New York, NY USA; [Zhao, Dan; Benes, Cyril H.; Batchelor, Tracy T.; Chi, Andrew S.] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA USA; [Garnett, Mathew J.; McDermott, Ultan] Wellcome Trust Sanger Inst, Hinxton, England; [Van den Heuvel, A. Pieter J.] Johnson & Johnson, Spring House, PA USA; [Chi, Andrew S.] NYU, Langone Med Ctr, New York, NY USA	Fox Chase Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Cornell University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Wellcome Trust Sanger Institute; Johnson & Johnson; Johnson & Johnson USA; New York University; NYU Langone Medical Center	Prabhu, VV (corresponding author), Oncoceutics Inc, Philadelphia, PA 19104 USA.; El-Deiry, WS (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	varun.prabhu@oncoceutics.com; wafik.eldeiry@fccc.edu	El-Deiry, Wafik/AAJ-6080-2020; Lulla, Amriti R./AAI-4167-2020; van den Heuvel, Antonius PJ/J-8145-2012	El-Deiry, Wafik/0000-0002-9577-8266; Zhao, Dan/0000-0001-7066-9058; McDermott, Ultan/0000-0001-9032-4700	NIH [R01 CA173453]; American Cancer Society Research Professorship; Oncoceutics	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Research Professorship(American Cancer Society); Oncoceutics	The authors acknowledge NIH grant R01 CA173453 (Wafik S. EI-Deiry) and support from an American Cancer Society Research Professorship (Wafik S. EI-Deiry). Oncoceutics provided partial support for this work in the form of salaries for authors WP and JEA (during the later portions of the research while they were employed by Oncoceutics), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allen JE, 2016, ONCOTARGET; Allen JE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004828; Cheng J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115339; Clements WK, 2011, NATURE, V474, P220, DOI 10.1038/nature10107; Gujral TS, 2014, CELL, V159, P844, DOI 10.1016/j.cell.2014.10.032; Hitron M, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.2530; Ishizawa J, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aac4380; Jin X, 2011, CANCER RES, V71, P3066, DOI 10.1158/0008-5472.CAN-10-1495; Jones RJ, 2004, JNCI-J NATL CANCER I, V96, P583, DOI 10.1093/jnci/djh095; Kline CLB, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aac4374; Lasorella A, 2014, NAT REV CANCER, V14, P77, DOI 10.1038/nrc3638; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; O'Brien CA, 2012, CANCER CELL, V21, P777, DOI 10.1016/j.ccr.2012.04.036; Prabhu VV, 2015, CANCER RES, V75, P1423, DOI 10.1158/0008-5472.CAN-13-3451; Rudin CM, 2016, J CLIN ONCOL S, P34; Smith DC, 2014, CLIN CANCER RES, V20, P6295, DOI 10.1158/1078-0432.CCR-14-1373; Stein M. N., 2017, CLIN CANC RES; Sun Y, 2012, NAT MED, V18, P1359, DOI 10.1038/nm.2890; van den Hoogen C, 2010, CANCER RES, V70, P5163, DOI 10.1158/0008-5472.CAN-09-3806; Ying MY, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.588988; Zeppernick F, 2008, CLIN CANCER RES, V14, P123, DOI 10.1158/1078-0432.CCR-07-0932; Zhang XJ, 2017, CELL SIGNAL, V29, P12, DOI 10.1016/j.cellsig.2016.09.009	22	21	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0180541	10.1371/journal.pone.0180541	http://dx.doi.org/10.1371/journal.pone.0180541			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767654	gold, Green Published, Green Submitted			2022-12-26	WOS:000406768200010
J	Han, YM; Koh, J; Kim, JW; Lee, C; Koh, SJ; Kim, B; Lee, KL; Im, JP; Kim, JS				Han, Yoo Min; Koh, Jaemoon; Kim, Ji Won; Lee, Changhyun; Koh, Seong-Joon; Kim, ByeongGwan; Lee, Kook Lae; Im, Jong Pil; Kim, Joo Sung			NF-kappa B activation correlates with disease phenotype in Crohn's disease	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; INHIBITS ACTIVATION; CLINICAL-FEATURES; GRANULOMAS; PREDICTORS; RECURRENCE; SURGERY	Background/Aims Unregulated activation of nuclear factor-kappa B (NF-kappa B) plays a critical role in the pathogenesis of Crohn's disease. In this study, we investigated the clinical characteristics and disease outcome of Crohn's disease patients with varying levels of the NF-kappa B activation. Methods Crohn's disease patients who underwent surgical bowel resection were divided into two groups, based on the activation status of NF-kappa B. NF-kappa B activation was assessed by the immunoreactivity of nuclear NF-kappa B during immunohistochemical staining of bowel resection specimens. We compared the demographic, clinical and histologic characteristics between groups. Furthermore, the occurrence of reoperation, readmission, and medication change due to disease flare-up were investigated according to NF-kappa B activation status. Results Among 83 Crohn's disease patients, 47 (56%) showed high NF-kappa B activity and 36 (44%) showed low NF-kappa B activity. Patients with high NF-kappa B activity had higher frequency of ileocolonic involvement (P = 0.028) and lower frequency of perianal involvement (P = 0.042) relative to those with low NF-kappa B activity. Total histologic scores were significantly higher in patients with high NF-kappa B activity than those with low NF-kappa B activity (P = 0.044). There was no significant difference in the frequency of reoperation, readmission, and medication change in relation to NF-kappa B activation status. Conclusions Crohn's disease patients with high NF-kappa B activation showed specific clinical manifestations of higher frequency of ileocolonic involvement and lower frequency of perianal involvement relative to those with low NF-kappa B activation. High NF-kappa B activity was associated with higher histologic scores. However, the NF-kappa B activity did not affect the outcome and disease course after surgery.	[Han, Yoo Min; Lee, Changhyun; Kim, Joo Sung] Seoul Natl Univ Hosp, Dept Internal Med, Healthcare Syst Gangnam Ctr, Seoul, South Korea; [Han, Yoo Min; Lee, Changhyun; Kim, Joo Sung] Seoul Natl Univ Hosp, Healthcare Res Inst, Healthcare Syst Gangnam Ctr, Seoul, South Korea; [Koh, Jaemoon] Seoul Natl Univ, Dept Pathol, Coll Med, Seoul, South Korea; [Kim, Ji Won; Koh, Seong-Joon; Kim, ByeongGwan; Lee, Kook Lae; Im, Jong Pil; Kim, Joo Sung] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Kim, Ji Won; Koh, Seong-Joon; Kim, ByeongGwan; Lee, Kook Lae] Seoul Natl Univ, Dept Internal Med, Boramae Hosp, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Kim, JW (corresponding author), Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea.; Kim, JW (corresponding author), Seoul Natl Univ, Dept Internal Med, Boramae Hosp, Seoul, South Korea.	kjwjor@snu.ac.kr	Han, Yoo Min/AAC-5661-2022	Lee, Changhyun/0000-0002-5839-6576	SNUH Research Fund [04-2014-3110]	SNUH Research Fund	This study was supported by grant no. 04-2014-3110 from the SNUH Research Fund, and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All aspects of the analysis and its writing were carried out by the authors.	Anseline PF, 1997, BRIT J SURG, V84, P78; Bantel H, 2000, AM J GASTROENTEROL, V95, P3452; Beaugerie L, 2006, GASTROENTEROLOGY, V130, P650, DOI 10.1053/j.gastro.2005.12.019; Bernell O, 2000, ANN SURG, V231, P38, DOI 10.1097/00000658-200001000-00006; D'Haens GR, 1998, GASTROENTEROLOGY, V114, P262, DOI 10.1016/S0016-5085(98)70476-7; Danese S, 2006, WORLD J GASTROENTERO, V12, P4807; De Cruz P, 2012, INFLAMM BOWEL DIS, V18, P758, DOI 10.1002/ibd.21825; Dias CC, 2013, WORLD J GASTROENTERO, V19, P3866, DOI 10.3748/wjg.v19.i24.3866; Ellis RD, 1998, INFLAMM RES, V47, P440, DOI 10.1007/s000110050358; Gan HT, 2005, J GASTROEN HEPATOL, V20, P1016, DOI 10.1111/j.1440-1746.2005.03862.x; Geboes K, 2002, GUT, V50, P37; Henriksen M, 2007, SCAND J GASTROENTERO, V42, P602, DOI 10.1080/00365520601076124; Heresbach D, 2005, GUT, V54, P215, DOI 10.1136/gut.2004.041715; Heresbach D, 2004, EUR J GASTROEN HEPAT, V16, P55, DOI 10.1097/00042737-200401000-00009; Jung JY, 2015, INTEST RES, V13, P68, DOI 10.5217/ir.2015.13.1.68; KALTSCHMIDT C, 1995, BIOL CHEM H-S, V376, P9; Koga H, 1999, HEPATOLOGY, V29, P688, DOI 10.1002/hep.510290355; Lee EJ, 2016, INTEST RES, V14, P30, DOI 10.5217/ir.2016.14.1.30; Loly C, 2008, SCAND J GASTROENTERO, V43, P948, DOI 10.1080/00365520801957149; MARKOWITZ J, 1989, J PEDIATR GASTR NUTR, V9, P182, DOI 10.1097/00005176-198908000-00009; Nagao-Kitamoto H, 2016, INTEST RES, V14, P127, DOI 10.5217/ir.2016.14.2.127; Ng WK, 2016, INTEST RES, V14, P111, DOI 10.5217/ir.2016.14.2.111; OKADA M, 1987, J CLIN GASTROENTEROL, V9, P165, DOI 10.1097/00004836-198704000-00011; RUTGEERTS P, 1990, GASTROENTEROLOGY, V99, P956, DOI 10.1016/0016-5085(90)90613-6; Schreiber S, 1998, GUT, V42, P477, DOI 10.1136/gut.42.4.477; Shih DQ, 2008, WORLD J GASTROENTERO, V14, P390, DOI 10.3748/wjg.14.390; Van Assche G, 2010, J CROHNS COLITIS, V4, P7, DOI 10.1016/j.crohns.2009.12.003; Vora Puja, 2012, Front Biosci (Elite Ed), V4, P1451; Zhang C, 2015, J HUAZHONG U SCI-MED, V35, P368, DOI 10.1007/s11596-015-1439-9	29	36	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0182071	10.1371/journal.pone.0182071	http://dx.doi.org/10.1371/journal.pone.0182071			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753650	Green Published, Green Submitted, gold			2022-12-26	WOS:000406579300045
J	Zhang, JF; Sun, J; Ma, BB; Du, WP				Zhang, Jifei; Sun, Jian; Ma, Baibing; Du, Wenpeng			Assessing the ecological vulnerability of the upper reaches of the Minjiang River	PLOS ONE			English	Article							LAND-USE CHANGE; GLOBAL SENSITIVITY-ANALYSIS; CLIMATE-CHANGE; ECOSYSTEM VULNERABILITY; FOREST; CARBON; CHINA; SOIL; DYNAMICS; REGION	The upper reaches of the Minjiang River (URMR), located on the eastern edge of the Tibetan Plateau in southwestern China, are an important component of the ecological barrier of the Upper Yangtze River Basin. Climate change and human activities have increased the ecological sensitivity and vulnerability of the region, which may pose a threat to the ecological security of the Yangtze River Basin and have negative impacts on local social and economic development. In this study, we analyzed land use and cover change (LUCC) of the URMR between 2000 and 2010, and found that the total rate of LUCC was less than 0.50% during this period. In addition, net primary production (NPP) was employed to describe the changes in ecosystem sensitivity and vulnerability, and the results demonstrated that slightly and moderately sensitive and vulnerable zones occupied the largest area, distributed mainly in forest, shrub, and grassland ecosystems. However, compared with the period from 2000 to 2005, the ecological sensitivity and vulnerability showed a worsening trend in the period 2005-2010. Exploring the relationship between vulnerability/sensitivity and environmental factors, we found that sensitivity and vulnerability were positively correlated with precipitation (>700 mm) and aridity index (>36 mm/degrees C). The results highlight that the future ecological sensitivity and vulnerability of URMR should be further investigated, and that the LUCC induced by human activities and climate change have caused alteration of in ecosystem vulnerability.	[Zhang, Jifei] Chinese Acad Sci, Inst Mt Hazards & Environm, Ctr Mt Dev Res, Chengdu, Sichuan, Peoples R China; [Sun, Jian; Ma, Baibing] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Synth Res Ctr Chinese Ecosyst Res Network, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China; [Ma, Baibing; Du, Wenpeng] Changan Univ, Sch Earth Sci & Resource, Xian, Shaanxi, Peoples R China	Chinese Academy of Sciences; Institute of Mountain Hazards & Environment, CAS; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chang'an University	Sun, J (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Synth Res Ctr Chinese Ecosyst Res Network, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China.	sunjian@igsnrr.ac.cn	Sun, Jian/I-9740-2016; Du, Wenpeng/AAQ-3269-2021	Sun, Jian/0000-0001-8765-5015; 	National Science Foundation of China [41301193, 41501057]; West Light Foundation of The Chinese Academy of Sciences	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); West Light Foundation of The Chinese Academy of Sciences(Chinese Academy of Sciences)	This research is funded by the National Science Foundation of China (Grant no. 41301193, 41501057), and West Light Foundation of The Chinese Academy of Sciences. The funders provided financial support in data collection and publish. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger WN, 2006, GLOBAL ENVIRON CHANG, V16, P268, DOI 10.1016/j.gloenvcha.2006.02.006; Amundrud SL, 2015, ECOLOGY, V96, P1957, DOI 10.1890/14-1828.1; [Anonymous], 2015, SICHUAN STAT YB 2014; [Anonymous], 2008, PHYS GEOGRAPHY; Arevalo CBM, 2011, AGR ECOSYST ENVIRON, V141, P342, DOI 10.1016/j.agee.2011.03.013; Barber VA, 2000, NATURE, V405, P668, DOI 10.1038/35015049; Beroya-Eitner MA, 2016, ECOL INDIC, V60, P329, DOI 10.1016/j.ecolind.2015.07.001; Chen G, 2006, THEROIES PRACTICES E; Cheng GW, 2014, J MT SCI-ENGL, V11, P1560, DOI 10.1007/s11629-013-2722-5; Cinner JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074321; Clark DA, 2003, P NATL ACAD SCI USA, V100, P5852, DOI 10.1073/pnas.0935903100; Coulson D, 2006, ECOL INDIC, V6, P749, DOI 10.1016/j.ecolind.2005.09.008; De Lange HJ, 2010, SCI TOTAL ENVIRON, V408, P3871, DOI 10.1016/j.scitotenv.2009.11.009; Dong XB, 2007, OUTLOOK AGR, V36, P247, DOI 10.5367/000000007783418561; Eakin H, 2006, ANNU REV ENV RESOUR, V31, P365, DOI 10.1146/annurev.energy.30.050504.144352; Erb KH, 2009, ECOL ECON, V69, P250, DOI 10.1016/j.ecolecon.2009.07.001; Fagre DB, 2000, US FOR SERV RMRS-P, V3, P74; Farhan AR, 2012, OCEAN COAST MANAGE, V65, P1, DOI 10.1016/j.ocecoaman.2012.04.015; Folland CK, 2001, GEOPHYS RES LETT, V28, P2621, DOI 10.1029/2001GL012877; Gallopin GC, 2006, GLOBAL ENVIRON CHANG, V16, P293, DOI 10.1016/j.gloenvcha.2006.02.004; Giardina CP, 2000, NATURE, V404, P858, DOI 10.1038/35009076; Guo B, 2016, J ARID LAND, V8, P23, DOI 10.1007/s40333-015-0055-7; [国志兴 GUO Zhixing], 2008, [资源科学, Resources Science], V30, P1226; He XY, 2006, PEDOSPHERE, V16, P398, DOI 10.1016/S1002-0160(06)60068-4; Hong WY, 2016, ECOL INDIC, V69, P540, DOI 10.1016/j.ecolind.2016.05.028; Hou K, 2016, ENVIRON SCI POLLUT R, V23, P4670, DOI 10.1007/s11356-015-5679-9; [侯文娟 Hou Wenjuan], 2016, [地理科学进展, Progress in Geography], V35, P320; IPCC, 2013, PHYS SCI BAS WORK GO, V1, P535; IPCC, 2014, CLIMATE CHANGE 201 A, V1, P32; Janssen MA, 2006, GLOBAL ENVIRON CHANG, V16, P240, DOI 10.1016/j.gloenvcha.2006.04.001; Jin Yi, 2011, Shengtaixue Zazhi, V30, P2646; Karl TR, 1995, AM MET SOC AMS S GLO; Kelly PM, 2000, CLIMATIC CHANGE, V47, P325, DOI 10.1023/A:1005627828199; Laterra P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155019; Li AN, 2006, ECOL MODEL, V192, P175, DOI 10.1016/j.ecolmodel.2005.07.005; [李平星 Li Pingxing], 2014, [自然资源学报, Journal of Natural Resources], V29, P779; [李双成 Li Shuangcheng], 2005, [生态学报, Acta Ecologica Sinica], V25, P621; Li Y, 2005, INT GEOSCI REMOTE SE, P5361; Liu HL, 2016, GLOBAL PLANET CHANGE, V137, P1, DOI 10.1016/j.gloplacha.2015.12.014; Liu M, 2014, CHINESE GEOGR SCI, V24, P471, DOI 10.1007/s11769-014-0706-1; Lobo A, 2006, HYDROL EARTH SYST SC, V10, P151, DOI 10.5194/hess-10-151-2006; Long X, 2016, ENERG POLICY, P100; Ma KM, 2004, LAND DEGRAD DEV, V15, P75, DOI 10.1002/ldr.584; Mann ME, 1999, GEOPHYS RES LETT, V26, P759, DOI 10.1029/1999GL900070; McCarthy JJ, 2001, IPCC CLIMATE CHANGE, P81; Mekonnen ZA, 2016, ECOL MODEL, V320, P241, DOI 10.1016/j.ecolmodel.2015.10.004; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Miller MP, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR012312; Morris DJ, 2014, ECOL MODEL, V273, P251, DOI 10.1016/j.ecolmodel.2013.11.019; PAHLWOSTL C, 1994, ECOL MODEL, V75, P51, DOI 10.1016/0304-3800(94)90006-X; Pandey R, 2015, APPL GEOGR, V64, P74, DOI 10.1016/j.apgeog.2015.09.008; Preston BL, 2011, SUSTAIN SCI, V6, P177, DOI 10.1007/s11625-011-0129-1; Qiao Qing, 2008, Research of Environmental Sciences, V21, P117; Safta C, 2015, GEOSCI MODEL DEV, V8, P1899, DOI 10.5194/gmd-8-1899-2015; Salinger M, 2005, CLIMATIC CHANGE, V70, P9, DOI 10.1007/s10584-005-5936-x; Shen CC, 2016, ECOL INDIC, V61, P822, DOI 10.1016/j.ecolind.2015.10.035; Singh R, 2014, WATER RESOUR RES, V50, P3409, DOI 10.1002/2013WR014988; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Song GB, 2015, ECOL INDIC, V52, P57, DOI 10.1016/j.ecolind.2014.11.032; Sun J, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-015-5014-4; Sun JN, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-016-5440-9; Tang C, 2011, LANDSLIDES, V8, P485, DOI 10.1007/s10346-011-0269-5; Tang GP, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00087.1; Tang JY, 2009, J GEOPHYS RES, V114, P4427; Tang Q, 2013, HYDROL PROCESS, V27, P3547, DOI 10.1002/hyp.9472; Temperli C, 2013, LANDSCAPE ECOL, V28, P1337, DOI 10.1007/s10980-013-9882-0; Tian SJ, 2013, APPL MECH MATER, V353-356, P1236, DOI 10.4028/www.scientific.net/AMM.353-356.1236; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Villa F, 2002, ENVIRON MANAGE, V29, P335, DOI 10.1007/s00267-001-0030-2; Wagner PD, 2016, SCI TOTAL ENVIRON, V539, P153, DOI 10.1016/j.scitotenv.2015.08.148; Wang JY, 2004, SHANDONG AGR SCI, V2, P9; Wang RuiYan, 2008, Transactions of the Chinese Society of Agricultural Engineering, V24, P215; Wilcox KR, 2016, ECOLOGY, V97, P561, DOI 10.1890/15-1437.1; Wu SH, 2007, CHINESE SCI BULL, V52, P1379, DOI 10.1007/s11434-007-0197-x; [肖桐 XIAO Tong], 2010, [资源科学, Resources Science], V32, P323; [姚建 Yao Jian], 2004, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V13, P380; Yu Li, 2008, Zhiwu Shengtai Xuebao, V32, P521, DOI 10.3773/j.issn.1005-264x.2008.03.001; Yuan QZ, 2014, J GEOGR SCI, V24, P3, DOI 10.1007/s11442-014-1069-3; Zhang MH, 2012, J ANAL METHODS CHEM, V2012, DOI 10.1155/2012/709656; Zhang Wen-guang, 2007, Shengtaixue Zazhi, V26, P1063; Zhang Wen-guang, 2007, Journal of Forestry Research (Harbin), V18, P97, DOI 10.1007/s11676-007-0019-7; Zhang WG, 2008, LANDSCAPE URBAN PLAN, V85, P195, DOI 10.1016/j.landurbplan.2007.11.006; [张文辉 Zhang Wenhui], 2003, [西北植物学报, Acta Botanica Boreali-Occidentalla Sinica], V23, P888; [张镱锂 Zhang Yili], 2013, [地理学报, Acta Geographica Sinica], V68, P1197; Zhang YX, 2015, THEOR APPL CLIMATOL, V121, P157, DOI 10.1007/s00704-014-1213-0; Zhang Z., 2010, P IEEE C ENG MED BIO, P1, DOI DOI 10.1016/J.RSE.2014.04.004; [朱渊 Zhu Yuan], 2014, [吉林大学学报. 地球科学版, Journal of Jilin University. Earth Science Edition], V44, P268	87	17	20	5	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0181825	10.1371/journal.pone.0181825	http://dx.doi.org/10.1371/journal.pone.0181825			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1ED	28753635	Green Published, Green Submitted, gold			2022-12-26	WOS:000406579300028
J	Gallagher, EJ; Zelenko, Z; Neel, BA; Antoniou, IM; Rajan, L; Kase, N; LeRoith, D				Gallagher, E. J.; Zelenko, Z.; Neel, B. A.; Antoniou, I. M.; Rajan, L.; Kase, N.; LeRoith, D.			Elevated tumor LDLR expression accelerates LDL cholesterol-mediated breast cancer growth in mouse models of hyperlipidemia	ONCOGENE			English	Article							MESSENGER-RNA; CELL-GROWTH; RECEPTOR; DENSITY; MICE; HYPERCHOLESTEROLEMIA; ATHEROSCLEROSIS; SURVIVAL; GENE; PROGRESSION	Obesity is associated with an increase in cancer-specific mortality in women with breast cancer. Elevated cholesterol, particularly low-density lipoprotein cholesterol (LDL-C), is frequently seen in obese women. Here, we aimed to determine the importance of elevated circulating LDL, and LDL receptor (LDLR) expression in tumor cells, on the growth of breast cancer using mouse models of hyperlipidemia. We describe two novel immunodeficient mouse models of hyperlipidemia (Rag1(-/-)/LDLR-/- and Rag1(-/-)/ApoE (apolipoprotein E)(-/-) mice) in addition to established immunocompetent LDLR-/- and ApoE(-/-) mice. The mice were used to study the effects of elevated LDL-C in human triple-negative (MDA-MB-231) and mouse Her2/Neu-overexpressing (MCNeuA) breast cancers. Tumors derived from MCNeuA and MDA-MB-231 cells had high LDLR expression and formed larger tumors in mice with high circulating LDL-C concentrations than in mice with lower LDL-C. Silencing the LDLR in the tumor cells led to decreased growth of Her2/Neu-overexpressing tumors in LDLR-/- and ApoE(-/-) mice, with increased Caspase 3 cleavage. Additionally, in vitro, silencing the LDLR led to decreased cell survival in serum-starved conditions, associated with Caspase 3 cleavage. Examining publically available human data sets, we found that high LDLR expression in human breast cancers was associated with decreased recurrence-free survival, particularly in patients treated with systemic therapies. Overall, our results highlight the importance of the LDLR in the growth of triple-negative and HER2-overexpressing breast cancers in the setting of elevated circulating LDL-C, which may be important contributing factors to the increased recurrence and mortality in obese women with breast cancer.	[Gallagher, E. J.; Zelenko, Z.; Neel, B. A.; Antoniou, I. M.; Rajan, L.; Kase, N.; LeRoith, D.] Icahn Sch Med Mt Sinai, Div Endocrinol Diabet & Bone Dis, Dept Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Gallagher, EJ (corresponding author), Icahn Sch Med Mt Sinai, Div Endocrinol Diabet & Bone Dis, Dept Med, New York, NY 10029 USA.	Emily.Gallagher@mssm.edu			NCI/NIH [K08 CA190779, R01 CA200553]; Tisch Cancer Institute at Mount Sinai Junior Scientist Award; NATIONAL CANCER INSTITUTE [K08CA190770, R01CA190779, R01CA200553] Funding Source: NIH RePORTER	NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Tisch Cancer Institute at Mount Sinai Junior Scientist Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research in this study was funded by NCI/NIH K08 CA190779 to EJG, NCI/NIH R01 CA200553 to DLR and Tisch Cancer Institute at Mount Sinai Junior Scientist Award to EJG. We would like to acknowledge the Icahn School of Medicine at Mount Sinai Mouse Genetics and Gene Targeting Core Facility, Translational and Molecular Imaging Core facility and the Biorepository and Pathology Core Facility.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Alikhani N, 2013, ONCOGENE, V32, P961, DOI 10.1038/onc.2012.113; Antalis CJ, 2011, CLIN EXP METASTAS, V28, P733, DOI 10.1007/s10585-011-9405-9; Badana A, 2016, J BREAST CANCER, V19, P372, DOI 10.4048/jbc.2016.19.4.372; Bahl M, 2005, BREAST CANCER RES TR, V94, P135, DOI 10.1007/s10549-005-6654-9; Bieghs V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030668; BROWN MS, 1974, SCIENCE, V185, P61, DOI 10.1126/science.185.4145.61; Buffa FM, 2011, CANCER RES, V71, P5635, DOI 10.1158/0008-5472.CAN-11-0489; Campbell MJ, 2002, IN VITRO CELL DEV-AN, V38, P326; Chahil TJ, 2006, ENDOCRIN METAB CLIN, V35, P491, DOI 10.1016/j.ecl.2006.06.002; Chanrion M, 2008, CLIN CANCER RES, V14, P1744, DOI 10.1158/1078-0432.CCR-07-1833; Choudhury RP, 2004, ARTERIOSCL THROM VAS, V24, P1904, DOI 10.1161/01.ATV.0000142808.34602.25; Dansky HM, 1999, ARTERIOSCL THROM VAS, V19, P1960, DOI 10.1161/01.ATV.19.8.1960; de Gonzalo-Calvo D, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1469-5; Demark-Wahnefried W, 2012, CANCER EPIDEM BIOMAR, V21, P1244, DOI 10.1158/1055-9965.EPI-12-0485; dos Santos CR, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-132; Ferguson RD, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3089; Goswami Chirayu Pankaj, 2013, J Clin Bioinforma, V3, P22, DOI 10.1186/2043-9113-3-22; Grossmann ME, 2008, BRIT J CANCER, V98, P370, DOI 10.1038/sj.bjc.6604166; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hogarth CA, 2003, COMP BIOCHEM PHYS B, V135, P219, DOI 10.1016/S1096-4959(03)00046-0; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Kuzu OF, 2016, CANCER RES, V76, P2063, DOI 10.1158/0008-5472.CAN-15-2613; Lamas B, 2015, MOL CARCINOGEN, V54, P58, DOI 10.1002/mc.22074; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Liu J, 2013, ONCOTARGET, V4, P1804, DOI 10.18632/oncotarget.1364; Liu X, 2015, INT J OBESITY, V39, P1548, DOI 10.1038/ijo.2015.93; Llaverias G, 2011, AM J PATHOL, V178, P402, DOI 10.1016/j.ajpath.2010.11.005; Loi S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-239; Mansourian M, 2016, J PHARM PHARM SCI, V19, P72, DOI 10.18433/J3202B; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Mulder M, 2007, NEUROSCI RES, V59, P251, DOI 10.1016/j.neures.2007.07.004; Nelson ER, 2013, SCIENCE, V342, P1094, DOI 10.1126/science.1241908; Pelton K, 2014, AM J PATHOL, V184, P2099, DOI 10.1016/j.ajpath.2014.03.006; Pires LA, 2012, BRAZ J MED BIOL RES, V45, P557, DOI 10.1590/S0100-879X2012007500068; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Ribas V, 2016, CLIN TRANSL MED, V5, DOI 10.1186/s40169-016-0106-5; RUDLING MJ, 1986, BRIT MED J, V292, P580, DOI 10.1136/bmj.292.6520.580; Stranzl A, 1997, BREAST CANCER RES TR, V42, P195, DOI 10.1023/A:1005754026205; Suarez Y, 2004, CARDIOVASC RES, V64, P346, DOI 10.1016/j.cardiores.2004.06.024; Szasz AM, 2016, ONCOTARGET, V7, P49322, DOI 10.18632/oncotarget.10337; Teupser D, 2003, ARTERIOSCL THROM VAS, V23, P1907, DOI 10.1161/01.ATV.0000090126.34881.B1; Wang SH, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-175; Weitman ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070703; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Yin W, 2012, J LIPID RES, V53, P51, DOI 10.1194/jlr.M019927; Zelenko Z, 2017, ONCOGENE, V36, P1394, DOI 10.1038/onc.2016.305; Zeng XK, 2009, CLIN CANCER RES, V15, P2840, DOI 10.1158/1078-0432.CCR-08-1401; Zhao WN, 2016, CANCER RES, V76, P2037, DOI 10.1158/0008-5472.CAN-15-1970	49	97	102	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 16	2017	36	46					6462	6471		10.1038/onc.2017.247	http://dx.doi.org/10.1038/onc.2017.247			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FM9WN	28759039	Green Accepted			2022-12-26	WOS:000415622900009
J	Kaneko, A; Uenishi, K; Maruyama, Y; Mizuno, N; Baba, S; Kumasaka, T; Mikami, B; Murata, K; Hashimoto, W				Kaneko, Ai; Uenishi, Kasumi; Maruyama, Yukie; Mizuno, Nobuhiro; Baba, Seiki; Kumasaka, Takashi; Mikami, Bunzo; Murata, Kousaku; Hashimoto, Wataru			A solute-binding protein in the closed conformation induces ATP hydrolysis in a bacterial ATP-binding cassette transporter involved in the import of alginate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHINGOMONAS SP A1; MACROMOLECULE (ALGINATE)-BINDING PROTEIN; ABC TRANSPORTER; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MECHANISM; SYSTEM; TRANSLOCATION; RECOGNITION; SUBSTRATE	The Gram-negative bacterium Sphingomonas sp. A1 incorporates alginate into cells via the cell-surface pit without prior depolymerization by extracellular enzymes. Alginate import across cytoplasmic membranes thereby depends on the ATPbinding cassette transporter AlgM1M2SS (a heterotetramer of AlgM1, AlgM2, and AlgS), which cooperates with the periplasmic solute-binding protein AlgQ1 or AlgQ2; however, several details of AlgM1M2SS-mediated alginate import are not wellunderstood. Herein, we analyzed ATPase and transport activities of AlgM1M2SS after reconstitution into liposomes with AlgQ2 and alginate oligosaccharide substrates having different polymerization degrees (PDs). Longer alginate oligosaccharides (PD >= 5) stimulated the ATPase activity of AlgM1M2SS but were inert as substrates of AlgM1M2SS-mediated transport, indicating that AlgM1M2SS-mediated ATP hydrolysis can be stimulated independently of substrate transport. Using X-ray crystallography in the presence of AlgQ2 and long alginate oligosaccharides (PD 6-8) and with the humid air and glue-coating method, we determined the crystal structure of AlgM1M2SS in complex with oligosaccharide-bound AlgQ2 at 3.6 angstrom resolution. The structure of the ATP-binding cassette transporter in complex with non-transport ligand-bound periplasmic solutebinding protein revealed that AlgM1M2SS and AlgQ2 adopt inward-facing and closed conformations, respectively. These in vitro assays and structural analyses indicated that interactions between AlgM1M2SS in the inward-facing conformation and periplasmic ligand-bound AlgQ2 in the closed conformation induce ATP hydrolysis by the ATP-binding protein AlgS. We conclude that substrate-bound AlgQ2 in the closed conformation initially interacts with AlgM1M2SS, the AlgM1M2SS-AlgQ2 complex then forms, and this formation is followed by ATP hydrolysis.	[Kaneko, Ai; Uenishi, Kasumi; Hashimoto, Wataru] Kyoto Univ, Lab Basic & Appl Mol Biotechnol, Div Food Sci & Biotechnol, Grad Sch Agr, Kyoto 6110011, Japan; [Mikami, Bunzo] Kyoto Univ, Lab Appl Struct Biol, Div Appl Life Sci, Grad Sch Agr, Kyoto 6110011, Japan; [Maruyama, Yukie; Murata, Kousaku] Setsunan Univ, Fac Sci & Engn, Dept Life Sci, Food Microbiol Lab, Neyagawa, Osaka 5728508, Japan; [Mizuno, Nobuhiro; Baba, Seiki; Kumasaka, Takashi] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan	Kyoto University; Kyoto University; Setsunan University; Japan Synchrotron Radiation Research Institute	Hashimoto, W (corresponding author), Kyoto Univ, Lab Basic & Appl Mol Biotechnol, Div Food Sci & Biotechnol, Grad Sch Agr, Kyoto 6110011, Japan.	whasimot@kais.kyoto-u.ac.jp	Kumasaka, Takashi/D-7428-2018	Kumasaka, Takashi/0000-0001-9289-1557; baba, seiki/0000-0002-2589-232X	Japan Society for the Promotion of Science; Targeted Proteins Research Program; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid Scientific Research from the Japan Society for the Promotion of Science (to K. M., Y. M., and W. H.) and the Targeted Proteins Research Program (to W. H.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baba S, 2013, ACTA CRYSTALLOGR D, V69, P1839, DOI 10.1107/S0907444913018027; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bao H, 2015, J BIOL CHEM, V290, P25452, DOI 10.1074/jbc.M115.671826; Beis K, 2015, BIOCHEM SOC T, V43, P889, DOI 10.1042/BST20150047; Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gould AD, 2010, J BIOL CHEM, V285, P11290, DOI 10.1074/jbc.M109.089078; Hashimoto W, 2000, J BACTERIOL, V182, P4572, DOI 10.1128/JB.182.16.4572-4577.2000; Hayashi C, 2014, J BACTERIOL, V196, P2691, DOI 10.1128/JB.01666-14; Hisano T, 1996, BIOCHEM BIOPH RES CO, V220, P979, DOI 10.1006/bbrc.1996.0526; JACKSON P, 1994, METHOD ENZYMOL, V230, P250; Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Locher KP, 2004, FEBS LETT, V564, P264, DOI 10.1016/S0014-5793(04)00289-3; Maruyama Y, 2015, STRUCTURE, V23, P1643, DOI 10.1016/j.str.2015.06.021; Mishima Y, 2003, J BIOL CHEM, V278, P6552, DOI 10.1074/jbc.M209932200; Momma K, 2000, J BACTERIOL, V182, P3998, DOI 10.1128/JB.182.14.3998-4004.2000; Momma K, 2005, BIOCHEMISTRY-US, V44, P5053, DOI 10.1021/bi047781r; Momma K, 2002, J MOL BIOL, V316, P1051, DOI 10.1006/jmbi.2001.5393; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishitani Y, 2012, BIOCHEMISTRY-US, V51, P3622, DOI 10.1021/bi300194f; Oldham ML, 2013, P NATL ACAD SCI USA, V110, P18132, DOI 10.1073/pnas.1311407110; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766	28	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15681	15690		10.1074/jbc.M117.793992	http://dx.doi.org/10.1074/jbc.M117.793992			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28768763	Green Published, hybrid			2022-12-26	WOS:000411512200009
J	Quintana, J; Novoa-Aponte, L; Arguello, JM				Quintana, Julia; Novoa-Aponte, Lorena; Arguello, Jose M.			Copper homeostasis networks in the bacterium Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; TRANSPOSON MUTANT LIBRARY; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; TRANSCRIPTIONAL RESPONSE; TRANSPORTING ATPASES; 2-COMPONENT SYSTEM; FUNCTIONAL ROLES; METAL TRANSPORT; ION-SELECTIVITY	Bacterial copper (Cu+) homeostasis enables both precise metallation of diverse cuproproteins and control of variable metal levels. To this end, protein networks mobilize Cu+ to cellular targets with remarkable specificity. However, the understanding of these processes is rather fragmented. Here, we use genome-wide transcriptomic analysis by RNA-Seq to characterize the response of Pseudomonas aeruginosa to external 0.5 mM CuSO4, a condition that did not generate pleiotropic effects. Pre-steady-state (5-min) and steady-state (2-h) Cu+ fluxes resulted in distinct transcriptome landscapes. Cells quickly responded to Cu2+ stress by slowing down metabolism. This was restored once steady state was reached. Specific Cu+ homeostasis genes were strongly regulated in both conditions. Our system-wide analysis revealed induction of three Cu+ efflux systems (a P-1B-ATPase, a porin, and a resistance-nodulationdivision (RND) system) and of a putative Cu+ -binding periplasmic chaperone and the unusual presence of two cytoplasmic CopZ proteins. Both CopZ chaperones could bind Cu+ with high affinity. Importantly, novel transmembrane transporters probably mediating Cu+ influx were among those largely repressed upon Cu+ stress. Compartmental Cu+ levels appear independently controlled; the cytoplasmic Cu+ sensor CueR controls cytoplasmic chaperones and plasma membrane transporters, whereas CopR/S responds to periplasmic Cu+. Analysis of Delta copR and Delta cueR mutant strains revealed a CopR regulon composed of genes involved in periplasmic Cu+ homeostasis and its putative DNA recognition sequence. In conclusion, our study establishes a system-wide model of a network of sensors/regulators, soluble chaperones, and influx/efflux transporters that control the Cu+ levels in P. aeruginosa compartments.	[Quintana, Julia; Novoa-Aponte, Lorena; Arguello, Jose M.] Worcester Polytech Inst, Dept Chem & Biochem, 60 Prescott St, Worcester, MA 01609 USA	Worcester Polytechnic Institute	Arguello, JM (corresponding author), Worcester Polytech Inst, Dept Chem & Biochem, 60 Prescott St, Worcester, MA 01609 USA.	arguello@wpi.edu	Quintana, Julia/AAE-5099-2020; Arguello, Jose/D-1997-2012	Quintana, Julia/0000-0002-5145-3590; Arguello, Jose/0000-0003-3940-6297; Novoa-Aponte, Lorena/0000-0003-3348-8383	NIGMS, National Institutes of Health [R01 GM114949]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114949] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant R01 GM114949 (to J. M. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arguello JM, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00073; Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Arnesano F, 2002, GENOME RES, V12, P255, DOI 10.1101/gr.196802; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Banci L, 2001, BIOCHEMISTRY-US, V40, P15660, DOI 10.1021/bi0112715; Blaby-Haas CE, 2014, P NATL ACAD SCI USA, V111, pE5480, DOI 10.1073/pnas.1421545111; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNER AJ, 1995, ANAL BIOCHEM, V226, P80, DOI 10.1006/abio.1995.1194; Caille O, 2007, J BACTERIOL, V189, P4561, DOI 10.1128/JB.00095-07; CHA JS, 1991, P NATL ACAD SCI USA, V88, P8915, DOI 10.1073/pnas.88.20.8915; Chacon KN, 2014, P NATL ACAD SCI USA, V111, P15373, DOI 10.1073/pnas.1411475111; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Cobine PA, 2006, BBA-MOL CELL RES, V1763, P759, DOI 10.1016/j.bbamcr.2006.03.002; Comolli JC, 2004, MOL MICROBIOL, V51, P1193, DOI 10.1046/j.1365-2958.2003.03904.x; Conesa A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0881-8; Corbett D, 2011, MOL MICROBIOL, V81, P457, DOI 10.1111/j.1365-2958.2011.07705.x; Cubillas C, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.452; Djoko KY, 2008, CHEMBIOCHEM, V9, P1579, DOI 10.1002/cbic.200800100; Dupont CL, 2011, METALLOMICS, V3, P1109, DOI 10.1039/c1mt00107h; Ekici S, 2012, MBIO, V3, DOI 10.1128/mBio.00293-11; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Elsen S, 2011, J BACTERIOL, V193, P3376, DOI 10.1128/JB.00159-11; Frausto da Silva J, 2001, BIOL CHEM ELEMENTS, P418; Gonzalez-Guerrero M, 2008, P NATL ACAD SCI USA, V105, P5992, DOI 10.1073/pnas.0711446105; Gonzalez-Guerrero M, 2010, MOL MICROBIOL, V78, P1246, DOI 10.1111/j.1365-2958.2010.07402.x; Gudipaty SA, 2012, FEMS MICROBIOL LETT, V330, P30, DOI 10.1111/j.1574-6968.2012.02529.x; Haas BJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-734; Harrison MD, 1999, BBA-MOL BASIS DIS, V1453, P254, DOI 10.1016/S0925-4439(98)00110-0; Helbig K, 2008, J BACTERIOL, V190, P5431, DOI 10.1128/JB.00271-08; Held K, 2012, J BACTERIOL, V194, P6387, DOI 10.1128/JB.01479-12; Hernandez-Montes G, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-249; Huffman DL, 2002, BIOCHEMISTRY-US, V41, P10046, DOI 10.1021/bi0259960; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kershaw CJ, 2005, MICROBIOL-SGM, V151, P1187, DOI 10.1099/mic.0.27650-0; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim EH, 2011, J BACTERIOL, V193, P2381, DOI 10.1128/JB.01323-10; Kim EH, 2010, NAT PROD REP, V27, P711, DOI 10.1039/b906681k; Lee BWK, 2007, BIOCHEMISTRY-US, V46, P12844, DOI 10.1021/bi701265r; Lee SM, 2002, BIOCHEM BIOPH RES CO, V295, P616, DOI 10.1016/S0006-291X(02)00726-X; Lewinson O, 2009, P NATL ACAD SCI USA, V106, P4677, DOI 10.1073/pnas.0900666106; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Lohmeyer E, 2012, BBA-BIOENERGETICS, V1817, P2005, DOI 10.1016/j.bbabio.2012.06.621; Long F, 2010, NATURE, V467, P484, DOI 10.1038/nature09395; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Munson GP, 2000, J BACTERIOL, V182, P5864, DOI 10.1128/JB.182.20.5864-5871.2000; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; Osman D, 2013, MOL MICROBIOL, V87, P466, DOI 10.1111/mmi.12107; Osman D, 2008, ADV APPL MICROBIOL, V65, P217, DOI 10.1016/S0065-2164(08)00608-4; Outten FW, 2001, J BIOL CHEM, V276, P30670, DOI 10.1074/jbc.M104122200; Outten FW, 2000, J BIOL CHEM, V275, P31024, DOI 10.1074/jbc.M006508200; Padilla-Benavides T, 2014, J BIOL CHEM, V289, P20492, DOI 10.1074/jbc.M114.577668; Padilla-Benavides T, 2013, J BIOL CHEM, V288, P69, DOI 10.1074/jbc.M112.420810; Pezza A, 2016, P NATL ACAD SCI USA, V113, P11573, DOI 10.1073/pnas.1603192113; Pontel LB, 2014, MICROBIOL-SGM, V160, P1659, DOI 10.1099/mic.0.080473-0; Quaranta D, 2007, J BACTERIOL, V189, P5361, DOI 10.1128/JB.00377-07; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Ray A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-224; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; Rosenzweig AC, 2012, CURR TOP MEMBR, V69, P113, DOI 10.1016/B978-0-12-394390-3.00005-7; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schelder S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022143; Shafeeq S, 2011, MOL MICROBIOL, V81, P1255, DOI 10.1111/j.1365-2958.2011.07758.x; Smaldone GT, 2007, MICROBIOL-SGM, V153, P4123, DOI 10.1099/mic.0.2007/011742-0; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Strausak D, 1997, J BIOL CHEM, V272, P8932; Tavares P, 2006, J INORG BIOCHEM, V100, P2087, DOI 10.1016/j.jinorgbio.2006.09.003; Teitzel GM, 2006, J BACTERIOL, V188, P7242, DOI 10.1128/JB.00837-06; Thaden JT, 2010, J BACTERIOL, V192, P2557, DOI 10.1128/JB.01528-09; Trasnea PI, 2016, MOL MICROBIOL, V100, P345, DOI 10.1111/mmi.13321; Vita N, 2016, SCI REP-UK, V6, DOI 10.1038/srep39065; Vita N, 2015, NATURE, V525, P140, DOI 10.1038/nature14854; Wagner S, 2016, J MED CHEM, V59, P5929, DOI 10.1021/acs.jmedchem.5b01698; Ward SK, 2008, J BACTERIOL, V190, P2939, DOI 10.1128/JB.01847-07; Wernimont AK, 2000, NAT STRUCT BIOL, V7, P766; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Winsor GL, 2016, NUCLEIC ACIDS RES, V44, pD646, DOI 10.1093/nar/gkv1227; Winsor GL, 2005, NUCLEIC ACIDS RES, V33, pD338, DOI 10.1093/nar/gki047; Wunsch P, 2003, J BACTERIOL, V185, P887, DOI 10.1128/JB.185.3.887-896.2003; Xiao ZG, 2011, J BIOL CHEM, V286, P11047, DOI 10.1074/jbc.M110.213074; Yamamoto K, 2005, MOL MICROBIOL, V56, P215, DOI 10.1111/j.1365-2958.2005.04532.x; Yeats C, 2004, TRENDS BIOCHEM SCI, V29, P169, DOI 10.1016/j.tibs.2004.02.004; Yoneyama H, 1996, MICROBIOL-UK, V142, P2137, DOI 10.1099/13500872-142-8-2137	90	59	61	3	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15691	15704		10.1074/jbc.M117.804492	http://dx.doi.org/10.1074/jbc.M117.804492			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28760827	hybrid, Green Published			2022-12-26	WOS:000411512200010
J	Schaefer, MK; Kossl, M; Hechavarria, JC				Schaefer, Markus K.; Koessl, Manfred; Hechavarria, Julio C.			Laminar differences in response to simple and spectro-temporally complex sounds in the primary auditory cortex of ketamine-anesthetized gerbils	PLOS ONE			English	Article							CURRENT-SOURCE-DENSITY; SPECIES-SPECIFIC VOCALIZATION; STIMULUS-SPECIFIC ADAPTATION; LOCAL-FIELD POTENTIALS; INFERIOR COLLICULUS; MONGOLIAN GERBIL; MOUSTACHED BAT; TOPOGRAPHICAL DISTRIBUTION; ULTRASONIC VOCALIZATIONS; FUNCTIONAL-ORGANIZATION	In mammals, acoustic communication plays an important role during social behaviors. Despite their ethological relevance, the mechanisms by which the auditory cortex represents different communication call properties remain elusive. Recent studies have pointed out that communication-sound encoding could be based on discharge patterns of neuronal populations. Following this idea, we investigated whether the activity of local neuronal networks, such as those occurring within individual cortical columns, is sufficient for distinguishing between sounds that differed in their spectro-temporal properties. To accomplish this aim, we analyzed simple pure-tone and complex communication call elicited multi-unit activity (MUA) as well as local field potentials (LFP), and current source density (CSD) waveforms at the single-layer and columnar level from the primary auditory cortex of anesthetized Mongolian gerbils. Multi-dimensional scaling analysis was used to evaluate the degree of "call-specificity" in the evoked activity. The results showed that whole laminar profiles segregated 1.82-6 times better across calls than single-layer activity. Also, laminar LFP and CSD profiles segregated better than MUA profiles. Significant differences between CSD profiles evoked by different sounds were more pronounced at mid and late latencies in the granular and infragranular layers and these differences were based on the absence and/or presence of current sinks and on sink timing. The stimulus-specific activity patterns observed within cortical columns suggests that the joint activity of local cortical populations (as local as single columns) could indeed be important for encoding sounds that differ in their acoustic attributes.	[Schaefer, Markus K.; Koessl, Manfred; Hechavarria, Julio C.] Goethe Univ, AK Neurobiol & Biosensor, Inst Cell Biol & Neurosci, Frankfurt, Germany	Goethe University Frankfurt	Schaefer, MK (corresponding author), Goethe Univ, AK Neurobiol & Biosensor, Inst Cell Biol & Neurosci, Frankfurt, Germany.	markus.sbio@web.de		Schaefer, Markus/0000-0002-0422-7523; Hechavarria, Julio C./0000-0001-9277-2339	Hans-Bockler-Stiftung; German Research Foundation (DFG)	Hans-Bockler-Stiftung; German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the Hans-Bockler-Stiftung (scholarship to Markus K. Schaefer) and the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Alexander Lehmann for technical support, Mona Lebner for call recordings of newborn gerbils, Gisa Prange for histological assistance, Maurice Groh for his support on the electrophysiological recordings, Bernhard Gaese for support with the statistical analysis and the Hans-Bockler-Stiftung for the scholarship to Markus K. Schaefer.	Altmann SA, 1967, STRUCTURE PRIMATE CO; ANDREW R. J., 1963, BEHAVIOUR, V20, P1, DOI 10.1163/156853963X00220; ARMSTRONGJAMES M, 1988, EXP NEUROL, V99, P369, DOI 10.1016/0014-4886(88)90155-0; Beetz MJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep35991; Beetz MJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep29102; BOBBIN RP, 1979, ARCH OTOLARYNGOL, V105, P467; BRUNSOBECHTOLD JK, 1981, J COMP NEUROL, V197, P705, DOI 10.1002/cne.901970410; Budinger E, 2000, EUR J NEUROSCI, V12, P2425, DOI 10.1046/j.1460-9568.2000.00142.x; Casseday JH, 2002, SPR HDB AUD, V15, P238; CHURCH MW, 1987, ELECTROEN CLIN NEURO, V67, P570, DOI 10.1016/0013-4694(87)90060-5; COHEN MS, 1982, ANESTH ANALG, V61, P338; DAFNY N, 1978, NEUROPHARMACOLOGY, V17, P851, DOI 10.1016/0028-3908(78)90073-4; deCharms RC, 1998, SCIENCE, V280, P1439, DOI 10.1126/science.280.5368.1439; DELGUTTE B, 1980, J ACOUST SOC AM, V68, P843, DOI 10.1121/1.384824; EGGERMONT JJ, 1994, J NEUROPHYSIOL, V71, P246, DOI 10.1152/jn.1994.71.1.246; Ehret G, 2002, P NATL ACAD SCI USA, V99, P479, DOI 10.1073/pnas.012361999; EHRET G, 1987, NATURE, V325, P249, DOI 10.1038/325249a0; Erulkar S D, 1968, Contrib Sens Physiol, V3, P149; Fishman YI, 2013, J NEUROSCI, V33, P10312, DOI 10.1523/JNEUROSCI.0020-13.2013; Foeller E, 2001, JARO, V2, P279; Fries P, 2015, NEURON, V88, P220, DOI 10.1016/j.neuron.2015.09.034; Fuster JM, 2000, EXP BRAIN RES, V133, P66, DOI 10.1007/s002210000401; Gaese BH, 2001, J NEUROPHYSIOL, V86, P1062, DOI 10.1152/jn.2001.86.2.1062; Garcia R, 1996, EUR J NEUROSCI, V8, P809, DOI 10.1111/j.1460-9568.1996.tb01266.x; Gehr DD, 2000, HEARING RES, V150, P27, DOI 10.1016/S0378-5955(00)00170-2; GOSSSAMPSON MA, 1991, LAB ANIM, V25, P360, DOI 10.1258/002367791780810074; Green S., 1975, VARIATIONS VOCAL PAT; Happel MFK, 2010, J NEUROSCI, V30, P11114, DOI 10.1523/JNEUROSCI.0689-10.2010; Hashimoto H, 2004, EXP ANIM TOKYO, V53, P409, DOI 10.1538/expanim.53.409; Hechavarria JC, 2016, SCI REP-UK, V6, DOI 10.1038/srep39226; HIENZ RD, 1988, J ACOUST SOC AM, V84, P186, DOI 10.1121/1.396963; HOLMAN SD, 1991, DEV PSYCHOBIOL, V24, P103, DOI 10.1002/dev.420240204; Huang CL, 2000, J COMP NEUROL, V427, P302, DOI 10.1002/1096-9861(20001113)427:2<302::AID-CNE10>3.0.CO;2-J; Hunter MD, 2010, NEUROIMAGE, V53, P611, DOI 10.1016/j.neuroimage.2010.06.053; Jacobs J, 2010, P NATL ACAD SCI USA, V107, P6487, DOI 10.1073/pnas.0911213107; Kajikawa Y, 2011, NEURON, V72, P847, DOI 10.1016/j.neuron.2011.09.029; Kanwal JS, 2007, FRONT BIOSCI-LANDMRK, V12, P4621, DOI 10.2741/2413; Kanwal JS, 2000, NEUROREPORT, V11, P367, DOI 10.1097/00001756-200002070-00029; Kanwal JS, 2005, DISTRIBUTED CORTICAL; Kaur S, 2004, J NEUROPHYSIOL, V91, P2551, DOI 10.1152/jn.01121.2003; Klein C, 2014, BRAIN TOPOGR, V27, P599, DOI 10.1007/s10548-014-0376-4; Kobayasi KI, 2012, J ACOUST SOC AM, V131, P1622, DOI 10.1121/1.3672693; Kocsis B, 1999, J NEUROSCI, V19, P6200, DOI 10.1523/JNEUROSCI.19-14-06200.1999; Kolmogorov A. N., 1965, PROBL PEREDACHI INF, V1, P3; Kruskal J, 1978, MULTIDIMENSIONAL SCA; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; KUHL PK, 1983, J ACOUST SOC AM, V73, P1003, DOI 10.1121/1.389148; KUHL PK, 1978, J ACOUST SOC AM, V63, P905, DOI 10.1121/1.381770; KUWADA S, 1989, J NEUROPHYSIOL, V61, P269, DOI 10.1152/jn.1989.61.2.269; Linden JF, 2003, CEREB CORTEX, V13, P83, DOI 10.1093/cercor/13.1.83; Maier A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00031; MANLEY JA, 1978, EXP BRAIN RES, V32, P171; Mardia K. V., 1979, MULTIVARIATE ANAL, Vxv; Medvedev AV, 2004, J NEUROPHYSIOL, V92, P52, DOI 10.1152/jn.01253.2003; Medvedev AV, 2002, BIOL CYBERN, V86, P497, DOI 10.1007/s00422-002-0316-3; Mitchell BD, 2005, J COMP NEUROL, V482, P17, DOI 10.1002/cne.20428; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; MITZDORF U, 1987, INT J NEUROSCI, V33, P33, DOI 10.3109/00207458708985928; Moore BCJ, 2008, JARO-J ASSOC RES OTO, V9, P399, DOI 10.1007/s10162-008-0143-x; Nelken I, 2003, BIOL CYBERN, V89, P397, DOI 10.1007/s00422-003-0445-3; NEWMAN JD, 1973, BRAIN RES, V54, P287, DOI 10.1016/0006-8993(73)90050-4; NICHOLSON C, 1975, J NEUROPHYSIOL, V38, P356, DOI 10.1152/jn.1975.38.2.356; Norena A, 2002, HEARING RES, V166, P202, DOI 10.1016/S0378-5955(02)00329-5; Pettersen KH, 2006, J NEUROSCI METH, V154, P116, DOI 10.1016/j.jneumeth.2005.12.005; Portfors CV, 2004, AN ACAD BRAS CIENC, V76, P253, DOI 10.1590/S0001-37652004000200010; Portfors CV, 2001, HEARING RES, V151, P95, DOI 10.1016/S0378-5955(00)00214-8; RADTKESCHULLER S, 1995, EUR J NEUROSCI, V7, P570, DOI 10.1111/j.1460-9568.1995.tb00662.x; RAPPELSBERGER P, 1981, PFLUG ARCH EUR J PHY, V389, P159, DOI 10.1007/BF00582108; Rauschecker JP, 1997, ACTA OTO-LARYNGOL, P34; Rauschecker JP, 1998, CURR OPIN NEUROBIOL, V8, P516, DOI 10.1016/S0959-4388(98)80040-8; Ray S, 2015, CURR OPIN NEUROBIOL, V31, P111, DOI 10.1016/j.conb.2014.09.004; Sakamoto K, 2015, NEURAL NETWORKS, V62, P67, DOI 10.1016/j.neunet.2014.06.009; Schaefer MK, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00052; SINEX DG, 1991, J ACOUST SOC AM, V90, P2441, DOI 10.1121/1.402048; SINEX DG, 1988, J ACOUST SOC AM, V83, P1817, DOI 10.1121/1.396516; SINNOTT JM, 1991, J ACOUST SOC AM, V89, P2421, DOI 10.1121/1.400974; SINNOTT JM, 1989, J ACOUST SOC AM, V86, P557, DOI 10.1121/1.398235; SINNOTT JM, 1987, J ACOUST SOC AM, V82, P1539, DOI 10.1121/1.395144; Sloan TB, 1998, J CLIN NEUROPHYSIOL, V15, P217, DOI 10.1097/00004691-199805000-00005; SOVIJARVI ARA, 1975, ACTA PHYSIOL SCAND, V93, P318, DOI 10.1111/j.1748-1716.1975.tb05821.x; STEINSCHNEIDER M, 1982, BRAIN RES, V252, P353, DOI 10.1016/0006-8993(82)90403-6; STEINSCHNEIDER M, 1992, ELECTROEN CLIN NEURO, V84, P196, DOI 10.1016/0168-5597(92)90026-8; STEINSCHNEIDER M, 1994, ELECTROEN CLIN NEURO, V92, P30, DOI 10.1016/0168-5597(94)90005-1; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; SUGA N, 1965, J PHYSIOL-LONDON, V181, P671, DOI 10.1113/jphysiol.1965.sp007791; Sugimoto S, 1997, HEARING RES, V112, P175, DOI 10.1016/S0378-5955(97)00119-6; Szymanski FD, 2009, J NEUROPHYSIOL, V102, P1483, DOI 10.1152/jn.00240.2009; Ter-Mikaelian M, 2013, J NEUROPHYSIOL, V110, P1190, DOI 10.1152/jn.00645.2012; Ter-Mikaelian M, 2012, BEHAVIOUR, V149, P461, DOI 10.1163/156853912X639778; Theunissen FE, 2000, J NEUROSCI, V20, P2315; THOMAS H, 1993, EUR J NEUROSCI, V5, P882, DOI 10.1111/j.1460-9568.1993.tb00940.x; VAKNIN G, 1988, J NEUROSCI METH, V24, P131, DOI 10.1016/0165-0270(88)90056-8; Filha VAVD, 2010, BRAZ J OTORHINOLAR, V76, P263; Wallace MN, 2008, EXP BRAIN RES, V184, P179, DOI 10.1007/s00221-007-1092-z; Wang XQ, 1995, J NEUROPHYSIOL, V74, P2685, DOI 10.1152/jn.1995.74.6.2685; Wang XQ, 2001, J NEUROPHYSIOL, V86, P2616, DOI 10.1152/jn.2001.86.5.2616; Wenstrup JJ, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-03-j0002.2001; WINTER P, 1973, EXP BRAIN RES, V18, P489; ZURITA P, 1994, NEUROSCI RES, V19, P303, DOI 10.1016/0168-0102(94)90043-4	99	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e082514	10.1371/journal.pone.0182514	http://dx.doi.org/10.1371/journal.pone.0182514			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771568	Green Published, Green Submitted, gold			2022-12-26	WOS:000406853600131
J	Shi, SS; Zhang, XC; Mandel, MA; Zhang, P; Zhang, YL; Ferguson, M; Amuge, T; Rounsley, S; Liu, ZX; Xiong, ZG				Shi, Shanshan; Zhang, Xiuchun; Mandel, M. Alejandra; Zhang, Peng; Zhang, Yuliang; Ferguson, Morag; Amuge, Teddy; Rounsley, Steve; Liu, Zhixin; Xiong, Zhongguo			Variations of five eIF4E genes across cassava accessions exhibiting tolerant and susceptible responses to cassava brown streak disease	PLOS ONE			English	Article							EUKARYOTIC TRANSLATION INITIATION; GENOME-LINKED PROTEIN; CAP-BINDING PROTEIN; RECESSIVE RESISTANCE; PLANT-VIRUSES; FACTOR 4E; GROWTH; EXPRESSION; MECHANISM; GENETICS	Cassava (Manihot esculenta) is an important tropical subsistence crop that is severely affected by cassava brown streak disease (CBSD) in East Africa. The disease is caused by Cassava brown streak virus (CBSV) and Ugandan cassava brown streak virus (UCBSV). Both have a (+)-sense single-stranded RNA genome with a 5' covalently-linked viral protein, which functionally resembles the cap structure of mRNA, binds to eukaryotic translation initiation factor 4E (eIF4E) or its analogues, and then enable the translation of viral genomic RNA in host cells. To characterize cassava eIF4Es and their potential role in CBSD tolerance and susceptibility, we cloned five eIF4E transcripts from cassava (accession TMS60444). Sequence analysis indicated that the cassava eIF4E family of proteins consisted of one eIF4E, two eIF(iso) 4E, and two divergent copies of novel cap-binding proteins (nCBPs). Our data demonstrated experimentally the coding of these five genes as annotated in the published cassava genome and provided additional evidence for refined annotations. Illumina resequencing data of the five eIF4E genes were analyzed from 14 cassava lines tolerant or susceptible to CBSD. Abundant single nucleotide polymorphisms (SNP) and biallelic variations were observed in the eIF4E genes; however, most of the SNPs were located in the introns and non-coding regions of the exons. Association studies of non-synonymous SNPs revealed no significant association between any SNP of the five eIF4E genes and the tolerance or susceptibility to CBSD. However, two SNPs in two genes were weakly associated with the CBSD responses but had no direct causal-effect relationship. SNPs in an intergenic region upstream of eIF4E_me showed a surprising strong association with CBSD responses. Digital expression profile analysis showed differential expression of different eIF4E genes but no significant difference in gene expression was found between susceptible and tolerant cassava accessions despite the association of the intergenic SNPs with CBSD responses.	[Shi, Shanshan; Zhang, Xiuchun; Zhang, Yuliang; Liu, Zhixin] Chinese Acad Trop Agr Sci, Inst Trop Biol & Biotechnol, Haikou, Hainan, Peoples R China; [Shi, Shanshan; Mandel, M. Alejandra; Xiong, Zhongguo] Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA; [Shi, Shanshan; Mandel, M. Alejandra; Xiong, Zhongguo] Univ Arizona, Inst BIO5, Tucson, AZ 85721 USA; [Zhang, Peng] Chinese Acad Sci, Inst Plant Physiol & Ecol, CAS Ctr Excellence Mol Plant Sci, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China; [Ferguson, Morag; Amuge, Teddy] IITA, Nairobi, Kenya; [Rounsley, Steve] Genus Plc, De Forest, WI USA	Chinese Academy of Tropical Agricultural Sciences; University of Arizona; University of Arizona; Chinese Academy of Sciences	Liu, ZX (corresponding author), Chinese Acad Trop Agr Sci, Inst Trop Biol & Biotechnol, Haikou, Hainan, Peoples R China.; Xiong, ZG (corresponding author), Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA.; Xiong, ZG (corresponding author), Univ Arizona, Inst BIO5, Tucson, AZ 85721 USA.	liuzhixin@itbb.org.cn; zxiong@email.arizona.edu	Amuge, Teddy/AAD-1564-2022; Peng Zhang, Dr./A-6423-2008	Peng Zhang, Dr./0000-0002-4868-1306; Shi, Shanshan/0000-0001-5702-6963; Xiong, Zhongguo/0000-0002-2999-0840	Bill and Melinda Gates Foundation [OPP1068522]; Natural Science Foundation of China [31461143016]; Genus plc	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Genus plc	This project is supported in part by Bill and Melinda Gates Foundation Challenge Exploration Grant OPP1068522 to ZX and Natural Science Foundation of China Grant 31461143016 to ZL, ZX, and XZ. One of the coauthors (SR) is affiliated with Genus plc, DeForest, WI, USA. Genus plc provided support only in the form of salaries for author SR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.; This project is supported in part by Bill and Melinda Gates Foundation Challenge Exploration Grant OPP1068522 to ZX and Natural Science Foundation of China Grant 31461143016 to ZL, ZX, and XZ. We thank Drs. Ming Peng and Wenquan Wang at the Institute of Tropical Biology and Biotechnology, Chinese Academy of Tropical Agricultural Sciences for stimulating discussions and comments, and Dr. Shengqiang Shu at DOE Joint Genome Institute for technical assistance.	Acosta-Leal R, 2008, VIROLOGY, V379, P275, DOI 10.1016/j.virol.2008.06.026; Acosta-Leal R, 2013, VIROLOGY, V437, P39, DOI 10.1016/j.virol.2012.12.001; Anjanappa RB, 2016, MOL PLANT MICROBE IN, V29, P527, DOI 10.1094/MPMI-01-16-0027-R; Barah P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058987; Bredeson JV, 2016, NAT BIOTECHNOL, V34, P562, DOI 10.1038/nbt.3535; Callard D, 1996, PLANT PHYSIOL, V112, P705, DOI 10.1104/pp.112.2.705; Chandrasekaran J, 2016, MOL PLANT PATHOL, V17, P1140, DOI 10.1111/mpp.12375; Combe JP, 2005, PLANT MOL BIOL, V57, P749, DOI 10.1007/s11103-005-3098-x; Duprat A, 2002, PLANT J, V32, P927, DOI 10.1046/j.1365-313X.2002.01481.x; Ferguson M., 2015, African Journal of Biotechnology, V14, P96; Goodfellow I, 2011, CURR OPIN VIROL, V1, P355, DOI 10.1016/j.coviro.2011.09.003; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Ji GL, 2015, BIOINFORMATICS, V31, P1671, DOI 10.1093/bioinformatics/btv004; Jiang J, 2011, CURR OPIN VIROL, V1, P347, DOI 10.1016/j.coviro.2011.09.010; Joshi B, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-48; Kang BC, 2005, ANNU REV PHYTOPATHOL, V43, P581, DOI 10.1146/annurev.phyto.43.011205.141140; Kanyuka K, 2005, MOL PLANT PATHOL, V6, P449, DOI [10.1111/j.1364-3703.2005.00294.x, 10.1111/J.1364-3703.2005.00294.X]; Kaweesi T, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0216-x; Kawuki RS, 2016, BREEDING SCI, V66, P560, DOI 10.1270/jsbbs.16005; Kulembeka HP, 2012, EUPHYTICA, V187, P277, DOI 10.1007/s10681-012-0730-0; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kuwata S, 2016, J GEN PLANT PATHOL, V82, P318, DOI 10.1007/s10327-016-0684-5; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Maruthi MN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096642; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; Mayberry LK, 2009, PLANT PHYSIOL, V150, P1844, DOI 10.1104/pp.109.138438; Mazier M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029595; Mbanzibwa DR, 2009, J VIROL, V83, P6934, DOI 10.1128/JVI.00537-09; Merrick WC, 2015, J BIOL CHEM, V290, P24091, DOI 10.1074/jbc.R115.675280; Monger WA, 2010, ARCH VIROL, V155, P429, DOI 10.1007/s00705-009-0581-8; Nishimura MT, 2003, SCIENCE, V301, P969, DOI 10.1126/science.1086716; Pati BL, 2015, J GEN VIROL, V96, P956, DOI 10.1099/vir.0.000014; Patrick RM, 2012, COMP FUNCT GENOM, V2012; Pennisi E, 2010, SCIENCE, V327, P804, DOI 10.1126/science.327.5967.804; Prochnik S, 2012, TROP PLANT BIOL, V5, P88, DOI 10.1007/s12042-011-9088-z; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Pyott DE, 2016, MOL PLANT PATHOL, V17, P1276, DOI 10.1111/mpp.12417; Rhoads RE, 2009, J BIOL CHEM, V284, P16711, DOI 10.1074/jbc.R900002200; Ruud KA, 1998, J BIOL CHEM, V273, P10325, DOI 10.1074/jbc.273.17.10325; Samac DA, 2011, MOL PLANT PATHOL, V12, P786, DOI [10.1111/j.1364-3703.2011.00712.x, 10.1111/J.1364-3703.2011.00712.X]; Sanfacon H, 2015, VIRUSES-BASEL, V7, P3392, DOI 10.3390/v7072778; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tomoo K, 2002, BIOCHEM J, V362, P539, DOI 10.1042/0264-6021:3620539; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Truniger V, 2009, ADV VIRUS RES, V75, P119, DOI 10.1016/S0065-3527(09)07504-6; Martinez-Silva AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031606; Van de Poel B, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00640; van Loon LC, 2006, TRENDS PLANT SCI, V11, P184, DOI 10.1016/j.tplants.2006.02.005; Wang AM, 2012, MOL PLANT PATHOL, V13, P795, DOI 10.1111/j.1364-3703.2012.00791.x; Wang WQ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6110; Weng ZM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000917; Whitham SA, 2003, PLANT J, V33, P271, DOI 10.1046/j.1365-313X.2003.01625.x; Winter S, 2010, J GEN VIROL, V91, P1365, DOI 10.1099/vir.0.014688-0; Yeam I, 2007, PLANT CELL, V19, P2913, DOI 10.1105/tpc.107.050997	57	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0181998	10.1371/journal.pone.0181998	http://dx.doi.org/10.1371/journal.pone.0181998			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771520	Green Submitted, Green Published, gold			2022-12-26	WOS:000406853600054
J	Song, JB; Mo, XW; Yang, HQ; Yue, LM; Song, J; Mo, BX				Song, Jianbo; Mo, Xiaowei; Yang, Haiqi; Yue, Luming; Song, Jun; Mo, Beixin			The U-box family genes in Medicago truncatula: Key elements in response to salt, cold, and drought stresses	PLOS ONE			English	Article							E3 UBIQUITIN LIGASE; ABSCISIC-ACID; CELL-DEATH; PROTEIN-DEGRADATION; ARABIDOPSIS; RICE; DEFENSE; PROTEASOME; EXPRESSION; TOLERANCE	The ubiquitination pathway regulates growth, development, and stress responses in plants, and the U-box protein family of ubiquitin ligases has important roles in this pathway. Here, 64 putative U-box proteins were identified in the Medicago truncatula genome. In addition to the conserved U-box motif, other functional domains, such as the ARM, kinase, KAP, and WD40 domains, were also detected. Phylogenetic analysis of the M. truncatula U-box proteins grouped them into six subfamilies, and chromosomal mapping and synteny analyses indicated that tandem and segmental duplications may have contributed to the expansion and evolution of the U-box gene family in this species. Using RNA-seq data from M. truncatula seedlings subjected to three different abiotic stresses, we identified 33 stress-inducible plant U-box genes (MtPUBs). Specifically, 25 salinity-, 15 drought-, and 16 cold-regulated MtPUBs were detected. Among them, MtPUB10, MtPUB17, MtPUB18, MtPUB35, MtPUB42, and MtPUB44 responded to all three stress conditions. Expression profiling by qRT-PCR was consistent with the RNA-seq data, and stress-related elements were identified in the promoter regions. The present findings strongly indicate that U-box proteins play critical roles in abiotic stress response in M. truncatula.	[Song, Jianbo; Mo, Xiaowei; Yang, Haiqi; Yue, Luming; Mo, Beixin] Shenzhen Univ, Coll Life Sci & Oceanog, Guangdong Prov Key Lab Plant Epigenet, Shenzhen, Peoples R China; [Song, Jianbo] Jiang Xi Agr Univ, Coll Sci, Dept Biochem & Mol Biol, Nanchang, Jiangxi, Peoples R China; [Song, Jun] Shenzhen Univ, Coll Optoelect Engn, Key Lab Optoelect Devices & Syst, Minist Educ & Guangdong Prov, Shenzhen, Peoples R China	Shenzhen University; Shenzhen University	Mo, BX (corresponding author), Shenzhen Univ, Coll Life Sci & Oceanog, Guangdong Prov Key Lab Plant Epigenet, Shenzhen, Peoples R China.	bmo@szu.edu.cn	Song, Jun/M-2196-2017	Song, Jun/0000-0002-2321-7064; Song, Jianbo/0000-0003-0158-2527	National Natural Science Foundation of China [31560076, 91440105, 31571332]; Guangdong Innovation Research Team Fund [2014ZT05S078]; China Postdoctoral Science Foundation [2016M592523]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Innovation Research Team Fund; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was supported by the National Natural Science Foundation of China, grant number 31560076 (https://isisn.nsfc.gov.cn/egrantindex/funcindex/pnsearch-list) to JIANBO SONG. The role of the sponsors was RNA sequencing and data analysis related fee. This study was also supported by the National Natural Science Foundation of China, grant number 91440105 (https://isisn.nsfc.gov.cn/egrantindex/funcindex/prisearch-list) to XIAOWEI MO, LUMING YUE. The role of the sponsors was study design and RNA sequencing. This study was also supported by the National Natural Science Foundation of China, grant number 31571332 (https.//isisn.nsfc.gov.cn/egrantindex/funcindex/prisearch-list) to BEIXIN MO. The role of the sponsors was data collection and analysis. This study was also supported by the Guangdong Innovation Research Team Fund, grant number 2014ZT05S078 (http://cxtd_gdstc.gov.cn) to BEIXIN MO, JUN SONG. The role of the sponsors was decision to publish and data collection and analysis. This study was also supported by the China Postdoctoral Science Foundation, grant number 2016M592523 (http://jj.chinapostdoctor.org.cn/V1/Program3/Default.aspx) to JIANBO SONG, HAIQI YANG. The role of the sponsors was preparation of the manuscript.	Azevedo C, 2001, TRENDS PLANT SCI, V6, P354, DOI 10.1016/S1360-1385(01)01960-4; Bae H, 2014, BIOCHEM BIOPH RES CO, V444, P575, DOI 10.1016/j.bbrc.2014.01.098; Cho SK, 2008, PLANT CELL, V20, P1899, DOI 10.1105/tpc.108.060699; Cho SK, 2006, PLANT PHYSIOL, V142, P1664, DOI 10.1104/pp.106.087965; Cho SK, 2015, BIOCHEM BIOPH RES CO, V464, P994, DOI 10.1016/j.bbrc.2015.07.030; Ciechanover A, 2005, CELL DEATH DIFFER, V12, P1178, DOI 10.1038/sj.cdd.4401692; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; DOLFERUS R, 1994, PLANT PHYSIOL, V105, P1075, DOI 10.1104/pp.105.4.1075; Gonzalez-Lamothe R, 2006, PLANT CELL, V18, P1067, DOI 10.1105/tpc.106.040998; Gu ZL, 2002, MOL BIOL EVOL, V19, P256, DOI 10.1093/oxfordjournals.molbev.a004079; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Hur YJ, 2012, MOL BIOL REP, V39, P5883, DOI 10.1007/s11033-011-1399-5; Hwang JH, 2015, PLANT CELL REP, V34, P277, DOI 10.1007/s00299-014-1706-4; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Li W, 2012, PLANT PHYSIOL, V159, P239, DOI 10.1104/pp.111.192617; Liu YC, 2011, MOL PLANT, V4, P938, DOI 10.1093/mp/ssr030; Loscher M, 2005, BIOCHEM J, V388, P593, DOI 10.1042/BJ20041517; Luo JH, 2006, PLANT J, V46, P649, DOI 10.1111/j.1365-313X.2006.02730.x; Luo QL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122600; MUNDY J, 1990, P NATL ACAD SCI USA, V87, P1406, DOI 10.1073/pnas.87.4.1406; Ohi MD, 2002, RNA, V8, P798, DOI 10.1017/S1355838202025050; Park JJ, 2011, PLANT J, V65, P194, DOI 10.1111/j.1365-313X.2010.04416.x; Patterson Cam, 2002, Sci STKE, V2002, ppe4; RIGGLEMAN B, 1989, GENE DEV, V3, P96, DOI 10.1101/gad.3.1.96; Rosser MFN, 2007, J BIOL CHEM, V282, P22267, DOI 10.1074/jbc.M700513200; Sahara N, 2005, J NEUROCHEM, V94, P1254, DOI 10.1111/j.1471-4159.2005.03272.x; Shen GX, 2007, PLANT J, V52, P309, DOI 10.1111/j.1365-313X.2007.03239.x; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Wang J, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0442-4; Wiborg J, 2008, BIOCHEM J, V413, P447, DOI 10.1042/BJ20071568; Xu DP, 1996, PLANT PHYSIOL, V110, P249, DOI 10.1104/pp.110.1.249; Yan JQ, 2003, PLANT PHYSIOL, V132, P861, DOI 10.1104/pp.103.020800; Yang CW, 2006, PLANT CELL, V18, P1084, DOI 10.1105/tpc.105.039198; Yang XH, 2008, PLANT PHYSIOL, V148, P1189, DOI 10.1104/pp.108.121921; Yee D, 2009, J EXPT BOT; Zeng LR, 2008, MOL PLANT, V1, P800, DOI 10.1093/mp/ssn044; Zeng LR, 2004, PLANT CELL, V16, P2795, DOI 10.1105/tpc.104.025171; Zhou ZS, 2013, J HAZARD MATER, V252, P123, DOI 10.1016/j.jhazmat.2013.02.011	42	25	27	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182402	10.1371/journal.pone.0182402	http://dx.doi.org/10.1371/journal.pone.0182402			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771553	Green Submitted, gold, Green Published			2022-12-26	WOS:000406853600102
J	van Gisbergen, MW; Voets, AM; Biemans, R; Hoffmann, RF; Drittij-Reijnders, MJ; Haenen, GRMM; Heijink, IH; Rouschop, KMA; Dubois, LJ; Lambin, P				van Gisbergen, Marike W.; Voets, An M.; Biemans, Rianne; Hoffmann, Roland F.; Drittij-Reijnders, Marie-Jose; Haenen, Guido R. M. M.; Heijink, Irene H.; Rouschop, Kasper M. A.; Dubois, Ludwig J.; Lambin, Philippe			Distinct radiation responses after in vitro mtDNA depletion are potentially related to oxidative stress	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; IONIZING-RADIATION; TUMOR RESPONSE; CELL-DEATH; METABOLISM; RADIOSENSITIVITY; GLUTATHIONE; GENERATION; RESISTANCE; METFORMIN	Several clinically used drugs are mitotoxic causing mitochondrial DNA (mtDNA) variations, and thereby influence cancer treatment response. We hypothesized that radiation responsiveness will be enhanced in cellular models with decreased mtDNA content, attributed to altered reactive oxygen species (ROS) production and antioxidant capacity. For this purpose BEAS-2B, A549, and 143B cell lines were depleted from their mtDNA (rho(0)). Overall survival after irradiation was increased (p<0.001) for BEAS-2B rho(0) cells, while decreased for both tumor rho(0) lines (p<0.05). In agreement, increased residual DNA damage was observed after mtDNA depletion for A549 and 143B cells. Intrinsic radiosensitivity (surviving fraction at 2Gy) was not influenced. We investigated whether ROS levels, oxidative stress and/or antioxidant responses were responsible for altered radiation responses. Baseline ROS formation was similar between BEAS-2B parental and rho(0) cells, while reduced in A549 and 143B rho(0) cells, compared to their parental counterparts. After irradiation, ROS levels significantly increased for all parental cell lines, while levels for rho(0) cells remained unchanged. In order to investigate the presence of oxidative stress upon irradiation reduced glutathione: oxidized glutathione (GSH: GSSG) ratios were determined. Irradiation reduced GSH: GSSG ratios for BEAS-2B parental and 143B rho(0), while for A549 this ratio remained equal. Additionally, changes in antioxidant responses were observed. Our results indicate that mtDNA depletion results in varying radiation responses potentially involving variations in cellular ROS and antioxidant defence mechanisms. We therefore suggest when mitotoxic drugs are combined with radiation, in particular at high dose per fraction, the effect of these drugs on mtDNA copy number should be explored.	[van Gisbergen, Marike W.; Voets, An M.; Biemans, Rianne; Rouschop, Kasper M. A.; Dubois, Ludwig J.; Lambin, Philippe] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Dept Radiat Oncol,MaastRO Lab, Maastricht, Netherlands; [Voets, An M.] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Dept Clin Genom, Maastricht, Netherlands; [Hoffmann, Roland F.; Heijink, Irene H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Drittij-Reijnders, Marie-Jose; Haenen, Guido R. M. M.] Maastricht Univ, Med Ctr, NUTRIM Sch Nutr Toxicol & Metab, Dept Toxicol, Maastricht, Netherlands; [Heijink, Irene H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands; [Heijink, Irene H.] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma & COPD, Groningen, Netherlands	Maastricht University; Maastricht University; University of Groningen; Maastricht University; Maastricht University Medical Centre (MUMC); University of Groningen; University of Groningen	van Gisbergen, MW (corresponding author), Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Dept Radiat Oncol,MaastRO Lab, Maastricht, Netherlands.	m.vangisbergen@maastrichtuniversity.nl	van Gisbergen, Marike/N-9751-2018	van Gisbergen, Marike/0000-0001-8318-7787; Rouschop, Kasper/0000-0002-4208-5415; Voets, An/0000-0002-3127-6179; Haenen, Guido/0000-0001-6986-290X; Lambin, Philippe/0000-0001-7961-0191	Netherlands Genomics Initiative [93612005]	Netherlands Genomics Initiative	This research was financially supported the Netherlands Genomics Initiative (pre-seed grant 2012, 93612005).	Ashley N, 2009, BIOCHEM BIOPH RES CO, V378, P450, DOI 10.1016/j.bbrc.2008.11.059; Bernstein C, 2002, MUTAT RES-REV MUTAT, V511, P145, DOI 10.1016/S1383-5742(02)00009-1; Birsoy K, 2014, NATURE, V508, P108, DOI 10.1038/nature13110; Bol V, 2015, ACTA ONCOL, V54, P266, DOI 10.3109/0284186X.2014.932006; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Chandel NS, 1999, FEBS LETT, V454, P173, DOI 10.1016/S0014-5793(99)00783-8; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Cloos CR, 2009, RADIAT RES, V171, P581, DOI 10.1667/RR1395.1; Das KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073358; Dubois L, 2013, RADIOTHER ONCOL, V108, P523, DOI 10.1016/j.radonc.2013.06.018; FERTIL B, 1985, INT J RADIAT ONCOL, V11, P1699, DOI 10.1016/0360-3016(85)90223-8; Garrido N, 2008, BIOCHEM J, V414, P93, DOI 10.1042/BJ20071615; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Halliwell B, 2003, FEBS LETT, V540, P3, DOI 10.1016/S0014-5793(03)00235-7; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hosoki A, 2012, J RADIAT RES, V53, P58, DOI 10.1269/jrr.11034; Kennedy KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075154; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Koritzinsky M, 2015, INT J RADIAT ONCOL, V93, P454, DOI 10.1016/j.ijrobp.2015.06.003; Kulkarni R, 2011, ENVIRON MOL MUTAGEN, V52, DOI 10.1002/em.20605; Kuwahara Y, 2016, INT J RADIAT ONCOL, V96, P556, DOI 10.1016/j.ijrobp.2016.07.002; Leach JK, 2001, CANCER RES, V61, P3894; Lee S, 2012, FREE RADICAL BIO MED, V53, P807, DOI 10.1016/j.freeradbiomed.2012.05.038; Leist P, 1996, FREE RADICAL BIO MED, V21, P297, DOI 10.1016/0891-5849(96)00045-7; Li XR, 2016, ONCOTARGET, V7, P40297, DOI 10.18632/oncotarget.9610; Liu JF, 2012, ONCOL REP, V28, P1406, DOI 10.3892/or.2012.1932; Mari M, 2009, ANTIOXID REDOX SIGN, V11, P2685, DOI [10.1089/ars.2009.2695, 10.1089/ARS.2009.2695]; Marin JJG, 2016, FREE RADICAL BIO MED, V101, P71, DOI 10.1016/j.freeradbiomed.2016.09.025; Menegakis A, 2009, INT J RADIAT BIOL, V85, P1032, DOI 10.3109/09553000903242149; Mineri R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005713; Moran M, 2010, BBA-MOL BASIS DIS, V1802, P443, DOI 10.1016/j.bbadis.2010.02.001; Nicholls DG, 2010, J VISUALIZED EXPT JO; Park SY, 2004, J BIOL CHEM, V279, P7512, DOI 10.1074/jbc.M307677200; Parks SK, 2013, NAT REV CANCER, V13, P611, DOI 10.1038/nrc3579; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Porporato PE, 2014, CELL REP, V8, P754, DOI 10.1016/j.celrep.2014.06.043; Quennet V, 2006, RADIOTHER ONCOL, V81, P130, DOI 10.1016/j.radonc.2006.08.012; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Robertson JD, 2000, J BIOL CHEM, V275, P32438, DOI 10.1074/jbc.C000518200; Rouschop KMA, 2011, RADIOTHER ONCOL, V99, P385, DOI 10.1016/j.radonc.2011.05.047; Singh KK, 1999, ONCOGENE, V18, P6641, DOI 10.1038/sj.onc.1203056; SUGIOKA K, 1988, BIOCHIM BIOPHYS ACTA, V936, P377, DOI 10.1016/0005-2728(88)90014-X; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Tang JT, 1999, ANTICANCER RES, V19, P4959; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; van Gisbergen MW, 2015, MUTAT RES-REV MUTAT, V764, P16, DOI 10.1016/j.mrrev.2015.01.001; Vergani L, 2004, EUR J BIOCHEM, V271, P3646, DOI 10.1111/j.1432-1033.2004.04298.x; Voets AM, 2012, BBA-BIOENERGETICS, V1817, P1971, DOI 10.1016/j.bbabio.2012.07.001; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Williams MD, 1998, J BIOL CHEM, V273, P28510, DOI 10.1074/jbc.273.43.28510; Xu H, 2013, ONCOL REP, V30, P3006, DOI 10.3892/or.2013.2783; Zannella VE, 2013, CLIN CANCER RES, V19, P6741, DOI 10.1158/1078-0432.CCR-13-1787	53	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182508	10.1371/journal.pone.0182508	http://dx.doi.org/10.1371/journal.pone.0182508			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771582	Green Published, Green Submitted, gold			2022-12-26	WOS:000406853600130
J	Leutz-Schmidt, P; Weinheimer, O; Jobst, BJ; Dinkel, J; Biederer, J; Kauczor, HU; Puderbach, MU; Wielputz, MO				Leutz-Schmidt, Patricia; Weinheimer, Oliver; Jobst, Bertram J.; Dinkel, Julien; Biederer, Juergen; Kauczor, Hans-Ulrich; Puderbach, Michael U.; Wielpuetz, Mark O.			Influence of exposure parameters and iterative reconstruction on automatic airway segmentation and analysis on MDCT-An ex vivo phantom study	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; FILTERED BACK-PROJECTION; COMPUTED-TOMOGRAPHY; WALL THICKNESS; FLOW LIMITATION; CT; EMPHYSEMA; COPD; DIMENSIONS; VOLUMETRY	Objectives To evaluate the influence of exposure parameters and raw-data-based iterative reconstruction (IR) on computer-aided segmentation and quantitative analysis of the tracheobronchial tree on multidetector computed tomography (MDCT). Material and methods 10 porcine heart-lung-explants were mounted inside a dedicated chest phantom. MDCT was performed at 120kV and 80kV with 120, 60, 30 and 12 mAs each. All scans were reconstructed with filtered back projection (FBP) or IR, resulting in a total of 160 datasets. The maximum number of detected airway segments, most peripheral airway generation detected, generation-specific airway wall thickness (WT), total diameter (TD) and normalized wall thickness (pi10) were compared. Results The number of detected airway segments decreased slightly with dose (324.8 +/- 118 at 120kV/120mAs vs. 288.9 +/- 130 at 80kV/30mAs with FBP, p<0.05) and was not changed by IR. The 20(th) generation was constantly detected as most peripheral. WT did not change significantly with exposure parameters and reconstruction algorithm across all generations: range 1(st) generation 2.4-2.7mm, 5(th) 1.0-1.1mm, and 10(th) 0.7mm with FBP; 1(st) 2.3-2.4mm, 5(th) 1.0-1.1mm, and 10(th) 0.7-0.8mm with IR. pi10 was not affected as well (range 0.32-0.34mm). Conclusions Exposure parameters and IR had no relevant influence on measured airway parameters even for WT <1mm. Thus, no systematic errors would be expected using automatic airway analysis with low-dose MDCT and IR.	[Leutz-Schmidt, Patricia; Weinheimer, Oliver; Jobst, Bertram J.; Dinkel, Julien; Biederer, Juergen; Kauczor, Hans-Ulrich; Puderbach, Michael U.; Wielpuetz, Mark O.] Univ Hosp Heidelberg, Dept Diagnost & Intervent Radiol, Heidelberg, Germany; [Leutz-Schmidt, Patricia; Weinheimer, Oliver; Jobst, Bertram J.; Dinkel, Julien; Biederer, Juergen; Kauczor, Hans-Ulrich; Puderbach, Michael U.; Wielpuetz, Mark O.] German Ctr Lung Res DZL, Translat Lung Res Ctr TLRC Heidelberg, Heidelberg, Germany; [Leutz-Schmidt, Patricia; Weinheimer, Oliver; Jobst, Bertram J.; Dinkel, Julien; Kauczor, Hans-Ulrich; Puderbach, Michael U.; Wielpuetz, Mark O.] Heidelberg Univ, Thoraxklin, Dept Diagnost & Intervent Radiol Nucl Med, Heidelberg, Germany; [Biederer, Juergen] Gross Gerau Cty Hosp, Radiol Darmstadt, Gross Gerau, Germany; [Biederer, Juergen; Puderbach, Michael U.; Wielpuetz, Mark O.] German Canc Res Ctr, Dept Radiol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Leutz-Schmidt, P (corresponding author), Univ Hosp Heidelberg, Dept Diagnost & Intervent Radiol, Heidelberg, Germany.; Leutz-Schmidt, P (corresponding author), German Ctr Lung Res DZL, Translat Lung Res Ctr TLRC Heidelberg, Heidelberg, Germany.; Leutz-Schmidt, P (corresponding author), Heidelberg Univ, Thoraxklin, Dept Diagnost & Intervent Radiol Nucl Med, Heidelberg, Germany.	Patricia.Leutz@med.uni-heidelberg.de	Wielpütz, Mark Oliver/ADP-0499-2022; Wielpuetz, Mark/ABE-1790-2020; Kauczor, Hans-Ulrich/AAU-5955-2021; Kauczor, HU/AAX-6033-2021; Weinheimer, Oliver/AAN-3652-2021	Wielpütz, Mark Oliver/0000-0001-6962-037X; Wielpuetz, Mark/0000-0001-6962-037X; 	German Center for Lung Research through a grant from the Federal Ministry of Education and Research (BMBF) Germany	German Center for Lung Research through a grant from the Federal Ministry of Education and Research (BMBF) Germany	This work has been supported by the German Center for Lung Research (DZL) through a grant from the Federal Ministry of Education and Research (BMBF) Germany (http://www.dzl.de/index.php/de/standorte/ueberblick/tlrc-heidelberg). All authors declare that they have no competing interests with regard to the work submitted. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T, 2008, EUR RADIOL, V18, P2731, DOI 10.1007/s00330-008-1089-4; Achenbach T, 2012, EUR J RADIOL, V81, P183, DOI 10.1016/j.ejrad.2010.09.012; Baumueller S, 2012, EUR RADIOL, V22, P2597, DOI 10.1007/s00330-012-2524-0; Biederer J, 2003, RADIOLOGY, V226, P250, DOI 10.1148/radiol.2261011275; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Botelho MPF, 2013, EUR J RADIOL, V82, pE726, DOI 10.1016/j.ejrad.2013.07.011; Choo JY, 2014, EUR RADIOL, V24, P799, DOI 10.1007/s00330-013-3078-5; Christe A, 2013, WORLD J RADIOL, V5, P421, DOI 10.4329/wjr.v5.i11.421; Coxson Harvey O, 2009, Proc Am Thorac Soc, V6, P439, DOI 10.1513/pats.200904-015AW; Coxson HO, 2009, AM J RESP CRIT CARE, V180, P588, DOI 10.1164/rccm.200901-0159PP; European COPD Coalition, 2015, PREV IN EU; GOLD, GLOB STRAT DIAGN MAN; Gomez-Cardona D, 2015, MED PHYS, V42, P5919, DOI 10.1118/1.4930797; Grydeland TB, 2009, EUR RESPIR J, V34, P858, DOI 10.1183/09031936.00167908; Han MLK, 2011, RADIOLOGY, V261, P274, DOI 10.1148/radiol.11110173; Hasegawa M, 2009, THORAX, V64, P332, DOI 10.1136/thx.2008.103671; Hasegawa M, 2006, AM J RESP CRIT CARE, V173, P1309, DOI 10.1164/rccm.200601-037OC; Heussel CP, 2006, ROFO-FORTSCHR RONTG, V178, P987, DOI 10.1055/s-2006-926823; HOLM S, 1979, SCAND J STAT, V6, P65; Kauczor HU, 2011, J THORAC IMAG, V26, P290, DOI 10.1097/RTI.0b013e3182277113; Kim SS, 2013, RADIOLOGY, V266, P626, DOI 10.1148/radiol.12120385; Kiml V, 2013, AM J RESP CRIT CARE, V187, P228, DOI 10.1164/rccm.201210-1843CI; Lee SW, 2014, EUR RADIOL, V24, P817, DOI 10.1007/s00330-013-3090-9; Little MP, 1996, INT J RADIAT BIOL, V70, P83, DOI 10.1080/095530096145364; Lynch DA, 2015, RADIOLOGY, V277, P192, DOI 10.1148/radiol.2015141579; McCollough CH, 2015, RADIOLOGY, V276, P499, DOI 10.1148/radiol.15142047; Mets OM, 2012, EUR RADIOL, V22, P2103, DOI 10.1007/s00330-012-2489-z; Monteiro A, 2014, INT J MORPHOL, V32, P312, DOI 10.4067/s0717-95022014000100050; Patel BD, 2008, AM J RESP CRIT CARE, V178, P500, DOI 10.1164/rccm.200801-059OC; Pontana F, 2011, EUR RADIOL, V21, P636, DOI 10.1007/s00330-010-1991-4; Sieren JP, 2016, AM J RESP CRIT CARE; Singh S, 2010, RADIOLOGY, V257, P373, DOI 10.1148/radiol.10092212; Streffer C, 2003, Ann ICRP, V33, P5; Weinheimer O, 2017, SPIE MED IMAGING; Weinheimer O, 2009, P 2 INT WORKSH PULM; Weinheimer O, 2008, IEEE T MED IMAGING, V27, P64, DOI 10.1109/TMI.2007.902798; Wielputz MO, 2015, EUR J RADIOL, V84, P1005, DOI 10.1016/j.ejrad.2015.01.025; Wielputz MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112898; Wielputz MO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073142; Wielputz MO, 2013, EUR J RADIOL, V82, P1577, DOI 10.1016/j.ejrad.2013.04.035; Wielputz MO, 2013, J THORAC IMAG, V28, P104, DOI 10.1097/RTI.0b013e3182765785; Willemink MJ, 2012, AM J ROENTGENOL, V199, P1241, DOI 10.2214/AJR.12.8727	42	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182268	10.1371/journal.pone.0182268	http://dx.doi.org/10.1371/journal.pone.0182268			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767732	Green Published, Green Submitted, gold			2022-12-26	WOS:000406768200062
J	Orsztynowicz, M; Lechniak, D; Pawlak, P; Kociucka, B; Kubickova, S; Cernohorska, H; Madeja, ZE				Orsztynowicz, Maciej; Lechniak, Dorota; Pawlak, Piotr; Kociucka, Beata; Kubickova, Svatava; Cernohorska, Halina; Madeja, Zofia Eliza			Changes in chromosome territory position within the nucleus reflect alternations in gene expression related to embryonic lineage specification	PLOS ONE			English	Article							BOVINE PREIMPLANTATION EMBRYOS; EARLY MOUSE DEVELOPMENT; STEM-CELLS; X-CHROMOSOME; GENOME ORGANIZATION; FATE SPECIFICATION; SELF-RENEWAL; ES CELLS; DIFFERENTIATION; PLURIPOTENCY	Loss of totipotentcy in an early embryo is directed by molecular processes responsible for cell fate decisions. Three dimensional genome organisation is an important factor linking chromatin architecture with stage specific gene expression patterns. Little is known about the role of chromosome organisation in gene expression regulation of lineage specific factors in mammalian embryos. Using bovine embryos as a model we have described these interactions at key developmental stages. Three bovine chromosomes (BTA) that differ in size, number of carried genes, and contain loci for key lineage regulators OCT4, NANOG and CDX2, were investigated. The results suggest that large chromosomes regardless of their gene density (BTA12 gene-poor, BTA5 gene-rich) do not significantly change their radial position within the nucleus. Gene loci however, may change its position within the chromosome territory (CT) and relocate its periphery, when stage specific process of gene activation is required. Trophectoderm specific CDX2 and epiblast precursor NANOG loci tend to locate on the surface or outside of the CTs, at stages related with their high expression. We postulate that the observed changes in CT shape reflect global alternations in gene expression related to differentiation.	[Orsztynowicz, Maciej; Lechniak, Dorota; Pawlak, Piotr; Kociucka, Beata; Madeja, Zofia Eliza] Poznan Univ Life Sci, Dept Genet & Anim Breeding, Poznan, Poland; [Kubickova, Svatava; Cernohorska, Halina] Vet Res Inst, Brno, Czech Republic	Poznan University of Life Sciences; Czech Veterinary Research Institute	Madeja, ZE (corresponding author), Poznan Univ Life Sci, Dept Genet & Anim Breeding, Poznan, Poland.	zmadeja@up.poznan.pl	Pawlak, Piotr/AAX-7094-2020; Kubickova, Svatava/GZL-5927-2022; Černohorská, Halina/GZM-9624-2022	Pawlak, Piotr/0000-0003-3489-1684; Kubickova, Svatava/0000-0002-1006-9453; Madeja, Zofia Eliza/0000-0001-9649-2422; LECHNIAK, DOROTA Marta/0000-0001-8543-0752	National Science Centre (NCN, Poland) [PRO.2011/01N/N/NZ9/00792]	National Science Centre (NCN, Poland)	This study was funded by The National Science Centre (NCN, Poland) grant number: PRO.2011/01N/N/NZ9/00792; https://www.ncn.gov.pl. MO and PP are a grant holders of the European Social Fund (Human Capital Program). DL is a member of the Management Committee of the Cost Action "Epiconcept" (FA1201).; DL is a member of the Management Committee of the COST Action "Epiconcept (FA1201)". This study was funded by The National Science Centre (NCN, Poland) grant number: PRO.2011/01N/N/NZ9/00792.	Ahmed K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010531; Albiez H, 2006, CHROMOSOME RES, V14, P707, DOI 10.1007/s10577-006-1086-x; Artus J, 2012, CURR STEM CELL RES T, V7, P78, DOI 10.2174/157488812798483403; Berg DK, 2011, DEV CELL, V20, P244, DOI 10.1016/j.devcel.2011.01.003; Bonev B, 2016, NAT REV GENET, V17, P661, DOI 10.1038/nrg.2016.112; Borsos M, 2016, GENE DEV, V30, P611, DOI 10.1101/gad.273805.115; Bou G, 2016, DEV BIOL, V410, P36, DOI 10.1016/j.ydbio.2015.12.014; Cauffman G, 2005, MOL HUM REPROD, V11, P173, DOI 10.1093/molehr/gah155; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Deng WL, 2014, CELL, V158, P849, DOI 10.1016/j.cell.2014.05.050; Di Stefano M, 2016, SCI REP-UK, V6, DOI 10.1038/srep35985; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Eils R, 1996, J CELL BIOL, V135, P1427, DOI 10.1083/jcb.135.6.1427; Goetze S, 2007, SEMIN CELL DEV BIOL, V18, P707, DOI 10.1016/j.semcdb.2007.08.007; Goossens K, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-27; Goossens K, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-64; Graf A, 2014, P NATL ACAD SCI USA, V111, P4139, DOI 10.1073/pnas.1321569111; Guest DJ, 2007, STEM CELLS DEV, V16, P789, DOI 10.1089/scd.2007.0032; Iannuccelli E, 2010, BIOINFORMATICS, V26, P696, DOI 10.1093/bioinformatics/btq013; JOHNSON MH, 1981, CELL, V24, P71, DOI 10.1016/0092-8674(81)90502-X; Khan DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034110; Kobolak J, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-88; Kociucka B, 2012, CYTOGENET GENOME RES, V136, P295, DOI 10.1159/000338255; Koehler D, 2009, EXP CELL RES, V315, P2053, DOI 10.1016/j.yexcr.2009.02.016; Kuijk EW, 2008, DEV DYNAM, V237, P918, DOI 10.1002/dvdy.21480; Kuijk EW, 2012, DEVELOPMENT, V139, P871, DOI 10.1242/dev.071688; Latos PA, 2015, GENE DEV, V29, P2435, DOI 10.1101/gad.268821.115; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Madeja ZE, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-32; Madeja ZE, 2015, STEM CELLS DEV, V24, P2437, DOI 10.1089/scd.2015.0053; Maitre JL, 2016, NATURE, V536, P344, DOI 10.1038/nature18958; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Mamo S, 2012, ANIM REPROD SCI, V134, P56, DOI 10.1016/j.anireprosci.2012.08.011; Meister P, 2011, CURR OPIN GENET DEV, V21, P167, DOI 10.1016/j.gde.2011.01.023; Memili E, 1999, BIOL REPROD, V61, P1198, DOI 10.1095/biolreprod61.5.1198; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Plusa B, 2008, DEVELOPMENT, V135, P3081, DOI 10.1242/dev.021519; Ragoczy T, 2003, CHROMOSOME RES INT J, V11; Saiz N, 2013, REPRODUCTION, V145, pR65, DOI 10.1530/REP-12-0381; Sehgal N, 2014, CHROMOSOMA, V123, P499, DOI 10.1007/s00412-014-0480-y; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Sritanaudomchai H, 2009, DEV BIOL, V335, P179, DOI 10.1016/j.ydbio.2009.08.025; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Talamas JA, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00095; TARKOWSKI AK, 1967, J EMBRYOL EXP MORPH, V18, P155; VanSoom A, 1997, MOL REPROD DEV, V47, P47, DOI 10.1002/(SICI)1098-2795(199705)47:1&lt;47::AID-MRD7&gt;3.0.CO;2-Q; Wiblin AE, 2005, J CELL SCI, P118; Wu X, 2016, SCI REP-UK, V6, DOI 10.1038/srep28343; Yuzyuk T, 2009, DEV CELL, V16, P699, DOI 10.1016/j.devcel.2009.03.008; Zeng FY, 2005, DEV BIOL, V283, P40, DOI 10.1016/j.ydbio.2005.03.038; Zuccotti M, 2012, INT J DEV BIOL, V56, P853, DOI 10.1387/ijdb.120174mz	58	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182398	10.1371/journal.pone.0182398	http://dx.doi.org/10.1371/journal.pone.0182398			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767705	Green Published, gold, Green Submitted			2022-12-26	WOS:000406768200077
J	Bernhardt, A; Schamel, M; Gbureck, U; Gelinsky, M				Bernhardt, Anne; Schamel, Martha; Gbureck, Uwe; Gelinsky, Michael			Osteoclastic differentiation and resorption is modulated by bioactive metal ions Co2+, Cu2+ and Cr3+ incorporated into calcium phosphate bone cements	PLOS ONE			English	Article							IN-VITRO RESORPTION; HIP-REPLACEMENT; COBALT; ANGIOGENESIS; SCAFFOLDS; CHROMIUM; FAILURE; RELEASE; COPPER; ASSAYS	Biologically active metal ions in low doses have the potential to accelerate bone defect healing. For successful remodelling the interaction of bone graft materials with both bone-forming osteoblasts and bone resorbing osteoclastsis crucial. In the present study brushite forming calcium phosphate cements (CPC) were doped with Co2+, Cu2+ and Cr3+ and the influence of these materials on osteoclast differentiation and activity was examined. Human osteoclasts were differentiated from human peripheral blood mononuclear cells (PBMC) both on the surface and in indirect contact to the materials on dentin discs. Release of calcium, phosphate and bioactive metal ions was determined using ICP-MS both in the presence and absence of the cells. While Co2+ and Cu2+ showed a burst release, Cr3+ was released steadily at very low concentrations (below 1 mu M) and both calcium and phosphate release of the cements was considerably changed in the Cr3+ modified samples. Direct cultivation of PBMC/osteoclasts on Co2+ cements showed lower attached cell number compared to the reference but high activity of osteoclast specific enzymes tartrate resistant acid phosphatase (TRAP), carbonic anhydrase II (CAII) and cathepsin K (CTSK) and significantly increased gene expression of vitronectin receptor. Indirect cultivation with diluted Co2+ cement extracts revealed highest resorbed area compared to all other modifications and the reference. Cu2+ cements had cytotoxic effect on PBMC/osteoclasts during direct cultivation, while indirect cultivation with diluted extracts from Cu2+ cements did not provoke cytotoxic effects but a strictly inhibited resorption. Cr3+ doped cements did not show cytotoxic effects at all. Gene expression and enzyme activity of CTSK was significantly increased in direct culture. Indirect cultivation with Cr3+ doped cements revealed significantly higher resorbed area compared to the reference. In conclusion Cr3+ doped calcium phosphate cements are an innovative cement modification because of their high cytocompatibility and support of active resorption by osteoclasts.	[Bernhardt, Anne; Gelinsky, Michael] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Joint & Soft Tissue Res, Ctr Translat Bone, Dresden, Germany; [Bernhardt, Anne; Gelinsky, Michael] Tech Univ Dresden, Fac Med, Dresden, Germany; [Schamel, Martha; Gbureck, Uwe] Univ Wurzburg, Dept Funct Mat Med & Dent, Wurzburg, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; University of Wurzburg	Bernhardt, A (corresponding author), Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Joint & Soft Tissue Res, Ctr Translat Bone, Dresden, Germany.; Bernhardt, A (corresponding author), Tech Univ Dresden, Fac Med, Dresden, Germany.	anne.bernhardt@tu-dresden.de	Gelinsky, Michael/A-9680-2012	Gelinsky, Michael/0000-0001-9075-5121	DFG [GB 1/12-2, GE 1133/13-2]; TU Dresden	DFG(German Research Foundation (DFG)); TU Dresden(European Commission)	Funding provided by DFG Grant No. GB 1/12-2 and GE 1133/13-2, Open Access Publication Funds of the TU Dresden, Dr. Anne Bernhardt. The funders had no role in study design, data collection and anal ysis, decision to publish, or preparation of the manuscript.	Alatalo SL, 2000, CLIN CHEM, V46, P1751; Andrews RE, 2011, BONE, V49, P717, DOI 10.1016/j.bone.2011.06.007; Athanasou NA, 2016, BONE JOINT RES, V5, P162, DOI 10.1302/2046-3758.55.BJR-2016-0086; Barralet J, 2009, TISSUE ENG PT A, V15, P1601, DOI 10.1089/ten.tea.2007.0370; Bernhardt A, 2017, EUR CELLS MATER, V33, P28, DOI 10.22203/eCM.v033a03; Bernhardt A, 2015, TISSUE ENG PART C-ME, V21, P160, DOI [10.1089/ten.tec.2014.0187, 10.1089/ten.TEC.2014.0187]; Birgani ZT, 2016, BIOMED MATER, V11, DOI 10.1088/1748-6041/11/1/015020; Bohner M, 2008, J BIOMED MATER RES B, V84B, P375, DOI 10.1002/jbm.b.30881; Bose S, 2013, TRENDS BIOTECHNOL, V31, P594, DOI 10.1016/j.tibtech.2013.06.005; Chen ZT, 2015, BIOMATERIALS, V61, P126, DOI 10.1016/j.biomaterials.2015.04.044; de Groot FYF, 2010, BIOMATERIALS, V31, P2976; Dutta DK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124389; Grossardt C, 2010, TISSUE ENG PT A, V16, P3687, DOI [10.1089/ten.tea.2010.0281, 10.1089/ten.TEA.2010.0281]; Gupta R, 2015, AM J CASE REP, V16, P542, DOI 10.12659/AJCR.893609; Gustafson K, 2014, ACTA ORTHOP, V85, P348, DOI 10.3109/17453674.2014.922730; Habibovic P, 2011, ACTA BIOMATER, V7, P3013, DOI 10.1016/j.actbio.2011.03.027; Kulanthaivel S, 2016, MAT SCI ENG C-MATER, V58, P648, DOI 10.1016/j.msec.2015.08.052; Kwon YM, 2011, J ARTHROPLASTY, V26, P511, DOI 10.1016/j.arth.2010.05.030; Lange T, 2011, BIOMATERIALS, V32, P4067, DOI 10.1016/j.biomaterials.2011.02.039; Long T, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/4/045012; Mabilleau G, 2012, SCI REP, V219; Montazerolghaem M, 2015, MAT SCI ENG C-MATER, V52, P212, DOI 10.1016/j.msec.2015.03.038; Morimoto S, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/4/045020; Mourino V, 2012, J R SOC INTERFACE, V9, P401, DOI 10.1098/rsif.2011.0611; Neutzsky-Wulff AV, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-109; Patntirapong S, 2009, BIOMATERIALS, V30, P548, DOI 10.1016/j.biomaterials.2008.09.062; Rissanen JP, 2009, J BONE MINER METAB, V27, P105, DOI 10.1007/s00774-008-0002-1; Schamel M, 2017, MAT SCI ENG C; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shah KM, 2015, J ORTHOP RES, V33, P114, DOI 10.1002/jor.22729; Sheikh Z, 2015, ACTA BIOMATER, V26, P338, DOI 10.1016/j.actbio.2015.08.031; WILSON T, 1981, CALCIFIED TISSUE INT, V33, P35, DOI 10.1007/BF02409410; Zhang ZY, 2012, ACTA BIOMATER, V8, P13, DOI 10.1016/j.actbio.2011.09.020	33	20	20	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0182109	10.1371/journal.pone.0182109	http://dx.doi.org/10.1371/journal.pone.0182109			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763481	Green Submitted, gold, Green Published			2022-12-26	WOS:000406766500044
J	Hooijmans, MT; Doorenweerd, N; Baligand, C; Verschuuren, JJGM; Ronen, I; Niks, EH; Webb, AG; Kan, HE				Hooijmans, M. T.; Doorenweerd, N.; Baligand, C.; Verschuuren, J. J. G. M.; Ronen, I.; Niks, E. H.; Webb, A. G.; Kan, H. E.			Spatially localized phosphorous metabolism of skeletal muscle in Duchenne muscular dystrophy patients: 24-month follow-up	PLOS ONE			English	Article							NUCLEAR MAGNETIC-RESONANCE; PHOSPHOLIPID METABOLITES; ENERGY-METABOLISM; FOREARM MUSCLE; IN-VIVO; BOYS; MRI; AGE; PHOSPHATIDYLCHOLINE; SPECTROSCOPY	Objectives To assess the changes in phosphodiester (PDE)-levels, detected by P-31 magnetic resonance spectroscopy (MRS), over 24-months to determine the potential of PDE as marker for muscle tissue changes in Duchenne Muscular Dystrophy (DMD) patients. Methods Spatially resolved phosphorous datasets were acquired in the right lower leg of 18 DMD patients (range: 5-15.4 years) and 12 age-matched healthy controls (range: 5-14 years) at three time-points (baseline, 12-months, and 24-months) using a 7T MR-System (Philips Achieva). 3-point Dixon images were acquired at 3T (Philips Ingenia) to determine muscle fat fraction. Analyses were done for six muscles that represent different stages of muscle wasting. Differences between groups and time-points were assessed with non-parametric tests with correction for multiple comparisons. Coefficient of variance (CV) were determined for PDE in four healthy adult volunteers in high and low signal-to-noise ratio (SNR) datasets. Results PDE-levels were significantly higher (two-fold) in DMD patients compared to controls in all analyzed muscles at almost every time point and did not change over the study period. Fat fraction was significantly elevated in all muscles at all time points compared to healthy controls, and increased significantly over time, except in the tibialis posterior muscle. The mean within subject CV for PDE-levels was 4.3% in datasets with high SNR (>10:1) and 5.7% in datasets with low SNR. Discussion and conclusion The stable two-fold increase in PDE-levels found in DMD patients in muscles with different levels of muscle wasting over 2-year time, including DMD patients as young as 5.5 years-old, suggests that PDE-levels may increase very rapidly early in the disease process and remain elevated thereafter. The low CV values in high and low SNR datasets show that PDE-levels can be accurately and reproducibly quantified in all conditions. Our data confirms the great potential of PDE as a marker for muscle tissue changes in DMD patients.	[Hooijmans, M. T.; Doorenweerd, N.; Baligand, C.; Ronen, I.; Webb, A. G.; Kan, H. E.] Leiden Univ, Med Ctr, CJ Gorter Ctr High Field MRI, Dept Radiol, Leiden, Netherlands; [Doorenweerd, N.] Newcastle Univ, John Walton Muscular Dystrophy Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Verschuuren, J. J. G. M.; Niks, E. H.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Newcastle University - UK; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Hooijmans, MT (corresponding author), Leiden Univ, Med Ctr, CJ Gorter Ctr High Field MRI, Dept Radiol, Leiden, Netherlands.	m.t.hooijmans@amc.uva.nl	Webb, Andrew/G-9642-2016; Kan, Hermien/L-2385-2013; Niks, Erik H/M-3520-2016	Webb, Andrew/0000-0003-4045-9732; Kan, Hermien/0000-0002-5772-7177; Niks, Erik H/0000-0001-5892-5143; Verschuuren, Jan/0000-0002-4572-1501; Ronen, Itamar/0000-0002-6872-4895	Netherlands Organization for Health Research and Development (ZonMW) [113302001]; European Union (FP7-HEALTH-INNOVATION-1) [602485]; Gratama Foundation (University of Leiden) [10.13]	Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); European Union (FP7-HEALTH-INNOVATION-1); Gratama Foundation (University of Leiden)	MTH reports a grant from the Netherlands Organization for Health Research and Development (ZonMW) (grant number 113302001) and a grant from the European Union (FP7-HEALTH-2013-INNOVATION-1, grant agreement no. 602485) during conduct of the research. JJGMV and EHN report grants from Duchenne Parent Project, ZonMW and AFM, and trial support from BioMarin, GSK, Lilly and Santhera, outside the submitted work. JJGMV reports grants from European Union and consultancy for Biomarin. EHN reports consultancies for BioMarin and Summit. HEK reports grants from ZonMW, AFM, Duchenne Parent Project, and Gratama Stichting, and consultancy for BioMarin and aTyr Pharma, outside the submitted work. AGW reports grants from NWO and a European Advanced Grant. ND reports a grant from Dutch Duchenne Parent Project (grant Brain imaging and cognition in Duchenne muscular dystrophy-2010) and a grant from Gratama Foundation (University of Leiden, grant number nr 10.13) CB reports a grant from the European Union (FP7-HEALTH-2013-INNOVATION-1, grant agreement no. 602485). No personal financial benefits were received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akima H, 2012, NEUROMUSCULAR DISORD, V22, P16, DOI 10.1016/j.nmd.2011.06.750; Arpan I, 2014, NEUROLOGY, V83, P974, DOI 10.1212/WNL.0000000000000775; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Banerjee B, 2010, MAGN RESON IMAGING, V28, P698, DOI 10.1016/j.mri.2010.03.008; Bogner W, 2009, MAGN RESON MED, V62, P574, DOI 10.1002/mrm.22057; BURT CT, 1976, BIOCHEMISTRY-US, V15, P4850, DOI 10.1021/bi00667a015; Deoni SCL, 2008, NEUROIMAGE, V40, P662, DOI 10.1016/j.neuroimage.2007.11.052; Fallbrook A, 1999, BRAIN RES, V834, P207, DOI 10.1016/S0006-8993(99)01570-X; Farber SA, 2000, FASEB J, V14, P2198, DOI 10.1096/fj.99-0853; Fischmann A, 2012, J NEUROL, V259, P1648, DOI 10.1007/s00415-011-6393-2; Forbes SC, 2013, RADIOLOGY, V269, P198, DOI 10.1148/radiol.13121948; GRIFFITHS RD, 1985, MUSCLE NERVE, V8, P760, DOI 10.1002/mus.880080904; Hogrel JY, 2016, NEUROLOGY, V86, P1022, DOI 10.1212/WNL.0000000000002464; Hollingsworth KG, 2013, MUSCLE NERVE, V48, P586, DOI 10.1002/mus.23879; Hooijmans MT, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3667; IJWPJ MdG, 2014, J NEUROMUSCULAR DIS, P99; Jelenc MT, 2016, NMR BIOMED, V29, P57, DOI 10.1002/nbm.3445; Kan HE, 2010, NMR BIOMED, V23, P563, DOI 10.1002/nbm.1494; KEMP GJ, 1993, J NEUROL SCI, V116, P201, DOI 10.1016/0022-510X(93)90326-T; Kinali M, 2011, NEUROLOGY, V76, P346, DOI 10.1212/WNL.0b013e318208811f; Lanza IR, 2011, J MAGN RESON IMAGING, V34, P1143, DOI 10.1002/jmri.22733; Le Guiner C, 2014, MOL THER, V22, P1923, DOI 10.1038/mt.2014.151; McCully KK, 2011, J APPL PHYSIOL, V111, P143, DOI 10.1152/japplphysiol.00094.2011; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; NEWMAN RJ, 1982, BRIT MED J, V284, P1072, DOI 10.1136/bmj.284.6322.1072; NEWMAN RJ, 1982, CLIN SCI, V63, pP36, DOI 10.1042/cs063036Pa; Rosenberg AS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa7322; RUIZCABELLO J, 1992, NMR BIOMED, V5, P226, DOI 10.1002/nbm.1940050506; Rzanny R, 2016, Z MED PHYS, V26, P323, DOI 10.1016/j.zemedi.2016.06.006; SATRUSTEGUI J, 1988, MECH AGEING DEV, V42, P105, DOI 10.1016/0047-6374(88)90066-8; Sleigh A, 2012, J CLIN ENDOCR METAB, V97, pE438, DOI 10.1210/jc.2011-2587; Smeulders MJC, 2010, J MAGN RESON IMAGING, V31, P1252, DOI 10.1002/jmri.22153; Sterin M, 2001, CANCER RES, V61, P7536; Straub V, 2016, LANCET NEUROL, V15, P882, DOI 10.1016/S1474-4422(16)30035-7; Szendroedi J, 2007, PLOS MED, V4, P858, DOI 10.1371/journal.pmed.0040154; Szendroedi J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021846; Taylor D J, 1983, Mol Biol Med, V1, P77; Valkovic L, 2016, SCI REP-UK, V6, DOI 10.1038/srep20087; Wary C, 2015, NMR BIOMED, V28, P1150, DOI 10.1002/nbm.3352; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1; Willcocks RJ, 2016, ANN NEUROL, V79, P535, DOI 10.1002/ana.24599; Wokke BH, 2014, NMR BIOMED, V27, P1371, DOI 10.1002/nbm.3199; Wokke BH, 2014, NEUROMUSCULAR DISORD, V24, P409, DOI 10.1016/j.nmd.2014.01.015; YOUNKIN DP, 1987, NEUROLOGY, V37, P165, DOI 10.1212/WNL.37.1.165	44	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0182086	10.1371/journal.pone.0182086	http://dx.doi.org/10.1371/journal.pone.0182086			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763477	Green Published, gold, Green Submitted			2022-12-26	WOS:000406766500041
J	Khan, S; Malla, AM; Zafar, A; Naseem, I				Khan, Saman; Malla, Ali Mohammed; Zafar, Atif; Naseem, Imrana			Synthesis of novel coumarin nucleus-based DPA drug-like molecular entity: In vitro DNA/Cu(II) binding, DNA cleavage and pro-oxidant mechanism for anticancer action	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; N-ALKYL SULFATES; COPPER-COMPLEXES; METAL-COMPLEXES; CANCER-CELLS; CYCLOPHOSPHAMIDE HYDROCHLORIDE; FLUORESCENCE-SPECTRA; DERIVATIVES; LIGAND; APOPTOSIS	Despite substantial research on cancer therapeutics, systemic toxicity and drug-resistance limits the clinical application of many drugs like cisplatin. Therefore, new chemotherapeutic strategies against different malignancies are needed. Targeted cancer therapy is a new paradigm for cancer therapeutics which targets pathways or chemical entities specific to cancer cells than normal ones. Unlike normal cells, cancer cells contain elevated copper which plays an integral role in angiogenesis. Copper is an important metal ion associated with chromatin DNA, particularly with guanine. Thus, targeting copper via copper-specific chelators in cancer cells can serve as an effective anticancer strategy. New pharmacophore di(2picolyl)amine (DPA)-3(bromoacetyl) coumarin (ligand-L) was synthesized and characterized by IR, ESI-MS, H-1- and C-13-NMR. Binding ability of ligand-L to DNA/Cu(II) was evaluated using a plethora of biophysical techniques which revealed ligand-L-DNA and ligand-LCu(II) interaction. Competitive displacement assay and docking confirmed non-intercalative binding mode of ligand-L with ctDNA. Cyclic voltammetry confirmed ligand-L causes quasi reversible Cu(II)/Cu(I) conversion. Further, acute toxicity studies revealed no toxic effects of ligand-L on mice. To evaluate the chemotherapeutic potential and anticancer mechanism of ligand-L, DNA damage via pBR322 cleavage assay and reactive oxygen species (ROS) generation were studied. Results demonstrate that ligand-L causes DNA cleavage involving ROS generation in the presence of Cu(II). In conclusion, ligand-L causes redox cycling of Cu(II) to generate ROS which leads to oxidative DNA damage and pro-oxidant cancer cell death. These findings will establish ligand-L as a lead molecule to synthesize new molecules with better copper chelating and pro-oxidant properties against different malignancies.	[Khan, Saman; Zafar, Atif; Naseem, Imrana] Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh, Uttar Pradesh, India; [Malla, Ali Mohammed] Govt Degree Coll, Dept Chem, Sopore, Kashmir, India	Aligarh Muslim University	Naseem, I (corresponding author), Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh, Uttar Pradesh, India.	imrananaseem2009@gmail.com			UGC-MANFJR Fellowship	UGC-MANFJR Fellowship	SK received financial support from the UGC-MANFJR Fellowship. No additional funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acilan C, 2017, BBA-GEN SUBJECTS, V1861, P218, DOI 10.1016/j.bbagen.2016.10.014; ADDISON AW, 1981, INORG CHEM, V20, P103, DOI 10.1021/ic50215a024; Agudelo D, 2016, J PHOTOCH PHOTOBIO B, V158, P274, DOI 10.1016/j.jphotobiol.2016.02.032; Ahsan H, 1998, CANCER LETT, V124, P23, DOI 10.1016/S0304-3835(97)00442-4; [Anonymous], PROG CLIN BIOL RES; Antonioli B, 2009, DALTON T, P4795, DOI 10.1039/b901832h; Beillerot A, 2008, BIOORG MED CHEM LETT, V18, P1102, DOI 10.1016/j.bmcl.2007.12.004; BHAT R, 1994, MUTAT RES-ENVIR MUTA, V313, P39, DOI 10.1016/0165-1161(94)90031-0; Blagosklonny MV, 2003, DRUG DISCOV TODAY, V8, P1104, DOI 10.1016/S1359-6446(03)02806-X; Boerner LJK, 2005, CURR OPIN CHEM BIOL, V9, P135, DOI 10.1016/j.cbpa.2005.02.010; Bonincontro A, 2008, LANGMUIR, V24, P1973, DOI 10.1021/la701730h; Boulikas T, 2003, ONCOL REP, V10, P1663; Brewer GJ, 2005, CURR CANCER DRUG TAR, V5, P195, DOI 10.2174/1568009053765807; Burger RM, 1998, CHEM REV, V98, P1153, DOI 10.1021/cr960438a; Chamani J, 2003, J CHEM THERMODYN, V35, P199, DOI 10.1016/S0021-9614(02)00312-9; Chanphai P, 2017, INT J BIOL MACROMOL, V95, P850, DOI 10.1016/j.ijbiomac.2016.09.090; Chen QG, 1999, ANALYST, V124, P901, DOI 10.1039/a901174i; Crowe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073684; Curir P, 2007, J NAT PROD, V70, P1668, DOI 10.1021/np070295v; DeLano WL, 1997, PYMOL MOL GRAPHIC SY; Denoyer D, 2015, METALLOMICS, V7, P1459, DOI 10.1039/c5mt00149h; Dobbelstein M, 2014, NAT REV DRUG DISCOV, V13, P179, DOI 10.1038/nrd4201; Donnelly AC, 2008, J ORG CHEM, V73, P8901, DOI 10.1021/jo801312r; Elshemy HAH, 2017, BIOORGAN MED CHEM, V25, P1066, DOI 10.1016/j.bmc.2016.12.019; Guan Y, 2006, ANAL CHIM ACTA, V570, P21, DOI 10.1016/j.aca.2006.03.106; Gupte A, 2007, FREE RADICAL BIO MED, V43, P1271, DOI 10.1016/j.freeradbiomed.2007.07.003; Hafez OMA, 2014, ACTA POL PHARM, V71, P593; Haq I, 2002, ARCH BIOCHEM BIOPHYS, V403, P1, DOI 10.1016/S0003-9861(02)00202-3; Haris P, 2017, SPECTROCHIM ACTA A, V175, P155, DOI 10.1016/j.saa.2016.11.049; Hassan I, 2010, FOOD CHEM TOXICOL, V48, P2052, DOI 10.1016/j.fct.2010.05.004; HINMAN JW, 1957, J AM CHEM SOC, V79, P3789, DOI 10.1021/ja01571a047; Holm AIS, 2010, PHYS CHEM CHEM PHYS, V12, P9581, DOI 10.1039/c003446k; Hurley LH, 2002, NAT REV CANCER, V2, P188, DOI 10.1038/nrc749; Hwu JR, 2008, ANTIVIR RES, V77, P157, DOI 10.1016/j.antiviral.2007.09.003; Ibrahim MM, 2011, J MOL STRUCT, V998, P1, DOI 10.1016/j.molstruc.2011.04.009; IVANOV VI, 1973, BIOPOLYMERS, V12, P89, DOI 10.1002/bip.1973.360120109; Jain SS, 2003, NUCLEIC ACIDS RES, V31, P4608, DOI 10.1093/nar/gkg648; Jashari A, 2014, BIOORGAN MED CHEM, V22, P2655, DOI 10.1016/j.bmc.2014.03.026; KAGAWA TF, 1991, J BIOL CHEM, V266, P20175; Kakkar R, 2002, J MOL STRUC-THEOCHEM, V579, P109, DOI 10.1016/S0166-1280(01)00721-7; Karthick V, 2013, CELL BIOCHEM BIOPHYS, V66, P657, DOI 10.1007/s12013-012-9510-7; Kashanian S, 2010, EUR FOOD RES TECHNOL, V230, P821, DOI 10.1007/s00217-010-1226-6; KASHMAN Y, 1992, J MED CHEM, V35, P2735, DOI 10.1021/jm00093a004; KUMAR CV, 1993, J AM CHEM SOC, V115, P8547, DOI 10.1021/ja00072a004; Lacy A, 2004, CURR PHARM DESIGN, V10, P3797, DOI 10.2174/1381612043382693; Lee HP, 2012, INT IMMUNOPHARMACOL, V13, P163, DOI 10.1016/j.intimp.2012.04.002; LERMAN LS, 1961, J MOL BIOL, V3, P18, DOI 10.1016/S0022-2836(61)80004-1; Li Y, 2014, SENSOR ACTUAT B-CHEM, V191, P464, DOI 10.1016/j.snb.2013.10.022; Li ZX, 2009, MOL CELLS, V27, P283, DOI 10.1007/s10059-009-0036-9; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu HK, 2011, ACCOUNTS CHEM RES, V44, P349, DOI 10.1021/ar100140e; Lowndes SA, 2005, J MAMMARY GLAND BIOL, V10, P299, DOI 10.1007/s10911-006-9003-7; Maheswari PU, 2004, J INORG BIOCHEM, V98, P219, DOI 10.1016/j.jinorgbio.2003.09.003; Mati SS, 2013, J PHYS CHEM B, V117, P14655, DOI 10.1021/jp4090553; MERGNY JL, 1992, SCIENCE, V256, P1681, DOI 10.1126/science.256.5064.1681; Moghaddam MM, 2014, LUMINESCENCE, V29, P314, DOI 10.1002/bio.2546; Mohareb RM, 2015, MOLECULES, V20, P11535, DOI 10.3390/molecules200611535; Mohareba RM, 2015, CHEM PHARM BULL, V63, P678, DOI 10.1248/cpb.c15-00115; Moosavi-Movahedi AA, 2004, THERMOCHIM ACTA, V414, P233, DOI 10.1016/j.tca.2004.01.007; Moosavi-Movahedi AA, 2003, J PROTEIN CHEM, V22, P23, DOI 10.1023/A:1023011609931; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; NAKAYAMA T, 1983, CARCINOGENESIS, V4, P765, DOI 10.1093/carcin/4.6.765; Nasulewiez A, 2004, J TRACE ELEM MED BIO, V18, P1, DOI 10.1016/j.jtemb.2004.02.004; Nogueira V, 2013, CLIN CANCER RES, V19, P4309, DOI 10.1158/1078-0432.CCR-12-1424; Omidvar Z, 2013, J SOLUTION CHEM, V42, P1005, DOI 10.1007/s10953-013-0009-7; Omidvar Z, 2011, J BIOMOL STRUCT DYN, V29, P181, DOI 10.1080/07391102.2011.10507382; Pan Q, 2002, CANCER RES, V62, P4854; Peng CY, 1996, J COMPUT CHEM, V17, P49, DOI 10.1002/(SICI)1096-987X(19960115)17:1<49::AID-JCC5>3.0.CO;2-0; Peng FY, 2006, J NUCL MED, V47, P1649; Piazzi L, 2008, BIOORG MED CHEM LETT, V18, P423, DOI 10.1016/j.bmcl.2007.09.100; Prisecaru A, 2013, J MED CHEM, V56, P8599, DOI 10.1021/jm401465m; PYLE AM, 1989, J AM CHEM SOC, V111, P3051, DOI 10.1021/ja00190a046; QUINLAN GJ, 1987, BIOCHEM PHARMACOL, V36, P3629, DOI 10.1016/0006-2952(87)90012-8; RAHMAN A, 1990, CARCINOGENESIS, V11, P2001, DOI 10.1093/carcin/11.11.2001; RAISTRICK H, 1953, BIOCHEM J, V55, P421, DOI 10.1042/bj0550421; Rehman MT, 2014, MOL PHARMACEUT, V11, P1785, DOI 10.1021/mp500116c; Salem MAI, 2016, MOLECULES, V21, DOI 10.3390/molecules21020249; Santini C, 2014, CHEM REV, V114, P815, DOI 10.1021/cr400135x; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Shahabadi N, 2014, MOL BIOSYST, V10, P338, DOI 10.1039/c3mb70340a; Shakir M, 2011, J PHOTOCH PHOTOBIO B, V104, P449, DOI 10.1016/j.jphotobiol.2011.05.003; Shamsi A, 2018, J BIOMOL STRUCT DYN, V36, P1479, DOI 10.1080/07391102.2017.1326320; Siddiqi ZA, 2012, EUR J MED CHEM, V57, P102, DOI 10.1016/j.ejmech.2012.08.043; Song YM, 2000, SPECTROCHIM ACTA A, V56, P2491, DOI 10.1016/S1386-1425(00)00340-1; Southan C, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-20; Stanway SJ, 2006, CLIN CANCER RES, V12, P1585, DOI 10.1158/1078-0432.CCR-05-1996; Stern O, 1919, PHYS Z, V20, P183; Subasinghe A, 2016, BIOINORG CHEM APPL, V2016, DOI 10.1155/2016/2675937; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Trejo-Solis C, 2005, NEOPLASIA, V7, P563, DOI 10.1593/neo.04607; Trejo-Solis C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-156; Yoshi J, 2001, INT J CANCER, V94, P768, DOI 10.1002/ijc.1537; YOSHIDA D, 1993, J NEURO-ONCOL, V16, P109, DOI 10.1007/BF01324697; Zafar A, 2017, FOOD CHEM TOXICOL, V99, P149, DOI 10.1016/j.fct.2016.11.034; Zaki M, 2016, J PHOTOCH PHOTOBIO B, V161, P318, DOI 10.1016/j.jphotobiol.2016.05.030; Zhang CX, 2003, CURR OPIN CHEM BIOL, V7, P481, DOI 10.1016/S1367-5931(03)00081-4; Zowczak M, 2001, BIOL TRACE ELEM RES, V82, P1, DOI 10.1385/BTER:82:1-3:001	99	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0181783	10.1371/journal.pone.0181783	http://dx.doi.org/10.1371/journal.pone.0181783			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763458	Green Submitted, Green Published, gold			2022-12-26	WOS:000406766500021
J	Kwon, E; Pathak, D; Chang, HW; Kim, DY				Kwon, Eunju; Pathak, Deepak; Chang, Hyeun Wook; Kim, Dong Young			Crystal structure of mimivirus uracil-DNA glycosylase	PLOS ONE			English	Article							BASE-EXCISION-REPAIR; MUTATIONAL ANALYSIS; FLIPPING MECHANISM; INHIBITOR PROTEIN; VIRUS; COMPLEX; SEQUENCE; REPLICATION; MIMICRY; ENZYMES	Cytosine deamination induced by stresses or enzymatic catalysis converts deoxycytidine into deoxyuridine, thereby introducing a G to A mutation after DNA replication. Base-excision repair to correct uracil to cytosine is initiated by uracil-DNA glycosylase (UDG), which recognizes and eliminates uracil from DNA. Mimivirus, one of the largest known viruses, also encodes a distinctive UDG gene containing a long N-terminal domain (N-domain; residues 1-130) and a motif-I (residues 327-343), in addition to the canonical catalytic domain of family I UDGs (also called UNGs). To understand the structural and functional features of the additional segments, we have determined the crystal structure of UNG from Acanthamoeba polyphaga mimivirus (mvUNG). In the crystal structure of mvUNG, residues 95-130 in the N-domain bind to a hydrophobic groove in the catalytic domain, and motif-I forms a short beta-sheet with a positively charged surface near the active site. Circular dichroism spectra showed that residues 1-94 are in a random coil conformation. Deletion of the three additional fragments reduced the activity and thermal stability, compared to full-length mvUNG. The results suggested that the mvUNG N-domain and motif-I are required for its structural and functional integrity.	[Kwon, Eunju; Pathak, Deepak; Chang, Hyeun Wook; Kim, Dong Young] Yeungnam Univ, Coll Pharm, Gyongsan, Gyeongbuk, South Korea	Yeungnam University	Kim, DY (corresponding author), Yeungnam Univ, Coll Pharm, Gyongsan, Gyeongbuk, South Korea.	dyokim@ynu.ac.kr		Kim, Dong Young/0000-0001-7594-9083	Basic Science Research Programs through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2014R1A1A1002064, 2014R1A4A1071040]	Basic Science Research Programs through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	DYK (2014R1A1A1002064) and HWC (2014R1A4A1071040) were supported by Basic Science Research Programs through the National Research Foundation of Korea (NRF; www.nrf.re.kr) funded by the Ministry of Science, ICT & Future Planning. The funder had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Aherfi S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00349; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Bulgar AD, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.135; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Handa P, 2001, J BIOL CHEM, V276, P17324, DOI 10.1074/jbc.M011166200; Hegde ML, 2013, J MOL BIOL, V425, P2359, DOI 10.1016/j.jmb.2013.03.030; Hegde ML, 2010, CELL MOL LIFE SCI, V67, P3573, DOI 10.1007/s00018-010-0485-5; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Banos-Sanz JI, 2013, NUCLEIC ACIDS RES, V41, P6761, DOI 10.1093/nar/gkt395; Jiang YL, 2002, BIOCHEMISTRY-US, V41, P11236, DOI 10.1021/bi026226r; La Scola B, 2003, SCIENCE, V299, P2033; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LINDAHL T, 1982, ANNU REV BIOCHEM, V51, P61, DOI 10.1146/annurev.bi.51.070182.000425; Lu CC, 2007, J VIROL, V81, P1195, DOI 10.1128/JVI.01518-06; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mer G, 2000, CELL, V103, P449, DOI 10.1016/S0092-8674(00)00136-7; MOL CD, 1995, CELL, V80, P869, DOI 10.1016/0092-8674(95)90290-2; MOL CD, 1995, CELL, V82, P701, DOI 10.1016/0092-8674(95)90467-0; Nagelhus TA, 1997, J BIOL CHEM, V272, P6561, DOI 10.1074/jbc.272.10.6561; Otterlei M, 1998, NUCLEIC ACIDS RES, V26, P4611, DOI 10.1093/nar/26.20.4611; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panayotou G, 1998, J BIOL CHEM, V273, P45, DOI 10.1074/jbc.273.1.45; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; Parikh SS, 2000, MUTAT RES-DNA REPAIR, V460, P183, DOI 10.1016/S0921-8777(00)00026-4; Pearl LH, 2000, MUTAT RES-DNA REPAIR, V460, P165, DOI 10.1016/S0921-8777(00)00025-2; Putnam CD, 1999, J MOL BIOL, V287, P331, DOI 10.1006/jmbi.1999.2605; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Raoult D, 2007, CLIN INFECT DIS, V45, P95, DOI 10.1086/518608; SANCAR A, 1988, ANNU REV BIOCHEM, V57, P29, DOI 10.1146/annurev.bi.57.070188.000333; SAVVA R, 1995, NAT STRUCT BIOL, V2, P752, DOI 10.1038/nsb0995-752; SAVVA R, 1995, NATURE, V373, P487, DOI 10.1038/373487a0; Scaramozzino N, 2003, NUCLEIC ACIDS RES, V31, P4950, DOI 10.1093/nar/gkg672; Schormann N, 2014, PROTEIN SCI, V23, P1667, DOI 10.1002/pro.2554; Schormann N, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-45; Schrodinger L. L. C., 2015, THE PYMOL MOLECULAR; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; SLUPPHAUG G, 1995, BIOCHEMISTRY-US, V34, P128, DOI 10.1021/bi00001a016; UPTON C, 1993, P NATL ACAD SCI USA, V90, P4518, DOI 10.1073/pnas.90.10.4518; Wong I, 2002, J BIOL CHEM, V277, P19424, DOI 10.1074/jbc.M201198200; WORRAD DM, 1988, J VIROL, V62, P4774, DOI 10.1128/JVI.62.12.4774-4777.1988; Xiao GY, 1999, PROTEINS, V35, P13	43	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0182382	10.1371/journal.pone.0182382	http://dx.doi.org/10.1371/journal.pone.0182382			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763516	Green Submitted, gold, Green Published			2022-12-26	WOS:000406766500064
J	Yu, WH				Yu, Wenhao			Regional co-location pattern scoping on a street network considering distance decay effects of spatial interaction	PLOS ONE			English	Article							COLOCATION PATTERNS; LOCAL INDICATORS; ASSOCIATION; DISCOVERY; CLUSTERS; SERVICES; POINTS	Regional co-location scoping intends to identify local regions where spatial features of interest are frequently located together. Most of the previous researches in this domain are conducted on a global scale and they assume that spatial objects are embedded in a 2-D space, but the movement in urban space is actually constrained by the street network. In this paper we refine the scope of co-location patterns to 1-D paths consisting of nodes and segments. Furthermore, since the relations between spatial events are usually inversely proportional to their separation distance, the proposed method introduces the "Distance Decay Effects" to improve the result. Specifically, our approach first subdivides the street edges into continuous small linear segments. Then a value representing the local distribution intensity of events is estimated for each linear segment using the distance-decay function. Each kind of geographic feature can lead to a tessellated network with density attribute, and the generated multiple networks for the pattern of interest will be finally combined into a composite network by calculating the co-location prevalence measure values, which are based on the density variation between different features. Our experiments verify that the proposed approach is effective in urban analysis.	[Yu, Wenhao] China Univ Geosci, Fac Informat Engn, Wuhan, Hubei, Peoples R China; [Yu, Wenhao] Natl Engn Res Ctr Geog Informat Syst, Wuhan, Hubei, Peoples R China	China University of Geosciences	Yu, WH (corresponding author), China Univ Geosci, Fac Informat Engn, Wuhan, Hubei, Peoples R China.; Yu, WH (corresponding author), Natl Engn Res Ctr Geog Informat Syst, Wuhan, Hubei, Peoples R China.	wenhao_yu@whu.edu.cn			Fundamental Research Funds for the Central Universities; China University of Geosciences (Wuhan) [CUG170640]; National Key Research and Development Program of China [2017YFB0503601]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China University of Geosciences (Wuhan); National Key Research and Development Program of China	The project was supported by the Fundamental Research Funds for the Central Universities, China University of Geosciences (Wuhan) (No.CUG170640), and by the National Key Research and Development Program of China (No.2017YFB0503601). The URLs of the funders' website are http://www.moe.edu.cn/ and http://www.most.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R., 1994, P 20 INT C VER LARG, P487; Ai TH, 2015, COMPUT ENVIRON URBAN, V51, P83, DOI 10.1016/j.compenvurbsys.2015.02.001; Appice A., 2003, Intelligent Data Analysis, V7, P541; Beatty C, 2002, J NAVIGATION, V55, P241, DOI 10.1017/S0373463302001790; Bembenik R, 2009, J INTELL INF SYST, V33, P41, DOI 10.1007/s10844-008-0076-1; Chen YG, 2015, CHAOS SOLITON FRACT, V77, P174, DOI 10.1016/j.chaos.2015.05.022; Chen YG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126158; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Ding W, 2007, REGIONAL ASS RULE SC, P595; Ding W, 2011, GEOINFORMATICA, V15, P1, DOI 10.1007/s10707-010-0111-6; Flouvat F, 2015, GEOINFORMATICA, V19, P147, DOI 10.1007/s10707-014-0209-3; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Guo L, 2013, INT J APPL EARTH OBS, V21, P384, DOI 10.1016/j.jag.2011.11.003; Huang Y, 2004, IEEE T KNOWL DATA EN, V16, P1472, DOI 10.1109/TKDE.2004.90; Huang Y, 2006, GEOINFORMATICA, V10, P239, DOI 10.1007/s10707-006-9827-8; Koperski K, 1995, DISCOVERY SPATIAL AS, P47, DOI [10.1007/3-540-60159-7_4, DOI 10.1007/3-540-60159-7_4]; Liu Y. L., 2013, J NANOMATER, V2013, P9, DOI DOI 10.1016/J.RESS.2013.09.001; McGrail MR, 2009, APPL GEOGR, V29, P533, DOI 10.1016/j.apgeog.2008.12.003; Mennis J., 2003, T GIS, V7, P371; Mennis J., 2005, T GIS, V9, P5, DOI DOI 10.1016/J.ADAJ.2018.05.034; Mennis J, 2009, COMPUT ENVIRON URBAN, V33, P403, DOI 10.1016/j.compenvurbsys.2009.11.001; Miller H.J., 1994, GEOGRAPHICAL SYSTEMS, V1, P157; Miller HJ, 2009, CH CRC DATA MIN KNOW, P1; O'Sullivan D., 2010, GEOGRAPHIC INFORM AN; Okabe A, 1996, GEOGR ANAL, V28, P330; Okabe A., 2000, SPATIAL TESSELLATION, P43, DOI 10.1002/9780470317013.ch2; Okabe A., 2006, T GIS, V10, P535, DOI [10.1111/j.1467-9671.2006.01011.x, DOI 10.1111/J.1467-9671.2006.01011.X, 10.1111/j.1467- 9671.2006.01011.x]; OPENSHAW S, 1995, STATISTICIAN, V44, P3, DOI 10.2307/2348611; Qian F, 2012, KNOWL INF SYST, V33, P419, DOI 10.1007/s10115-012-0506-9; Santos MY, 2005, SOFT COMPUT, V9, P374, DOI 10.1007/s00500-004-0417-0; Schabenberger O., 2005, STAT METHODS SPATIAL; Shekhar S, 2001, LECT NOTES COMPUT SC, V2121, P236; Shiode S, 2009, INT J GEOGR INF SCI, V23, P75, DOI 10.1080/13658810801949843; Sierra R, 2012, INT J GEOGR INF SCI, V26, P441, DOI 10.1080/13658816.2011.594799; Thurstain-Goodwin M., 2000, T GIS, V4, P305, DOI [10.1111/1467-9671.00058, DOI 10.1111/1467-9671.00058]; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Wang F., 2006, QUANTITATIVE METHODS, DOI 10.1071/PY10021; Wang F., 2016, PROF GEOGR, V69, P22; Xia ZX, 2008, COMPUT ENVIRON URBAN, V32, P396, DOI 10.1016/j.compenvurbsys.2008.05.001; Yamada I., 2004, J TRANSP GEOGR, V12, DOI [10.1016/j.jtrangeo.2003.10.006, DOI 10.1016/J.JTRANGEO.2003.10.006, DOI 10.1016/j.jtrangeo.2003.10.006]; Yamada I, 2007, GEOGR ANAL, V39, P268, DOI 10.1111/j.1538-4632.2007.00704.x; Yoo J.S., P 12 ANN ACM INT WOR, P241; Yoo JS, 2006, IEEE T KNOWL DATA EN, V18, P1323, DOI 10.1109/TKDE.2006.150; Yoo JS, 2012, DATA MIN KNOWL DISC, V24, P159, DOI 10.1007/s10618-011-0223-0; You Wan, 2008, International Journal of Business Intelligence and Data Mining, V3, P375, DOI 10.1504/IJBIDM.2008.022735; Yu WH, 2017, INT J GEOGR INF SCI, V31, P280, DOI 10.1080/13658816.2016.1194423; Yu WH, 2016, EXPERT SYST APPL, V46, P324, DOI 10.1016/j.eswa.2015.10.010	47	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0181959	10.1371/journal.pone.0181959	http://dx.doi.org/10.1371/journal.pone.0181959			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC3VC	28763496	Green Submitted, Green Published, gold			2022-12-26	WOS:000406766500031
J	Pathak, S; Regmi, S; Gupta, B; Pham, TT; Yong, CS; Kim, JO; Yook, S; Kim, JR; Park, MH; Bae, YK; Jeong, JH				Pathak, Shiva; Regmi, Shobha; Gupta, Biki; Tung Thanh Pham; Yong, Chul Soon; Kim, Jong Oh; Yook, Simmyung; Kim, Jae-Ryong; Park, Min Hui; Bae, Young Kyung; Jeong, Jee-Heon			Engineered islet cell clusters transplanted into subcutaneous space are superior to pancreatic islets in diabetes	FASEB JOURNAL			English	Article						pseudoislets; hypoxia; apoptosis; transplantation	BIOARTIFICIAL PANCREAS; RAT ISLETS; DEVICE; REVASCULARIZATION; SURVIVAL; SITE	An alternative route for pancreatic islet transplantation is the subcutaneous space; however, inadequate vascularization in the subcutaneous space limits the availability of oxygen and nutrients to the subcutaneously transplanted islets, which leads to the development of a necrotic core in the islets, thereby causing islet dysfunction. Thus, we aimed to prevent the early apoptosis of pancreatic islets after transplantation into subcutaneous space by preparing islet clusters of appropriate size. We prepared fully functional islet cell clusters (ICCs) by using the hanging-drop technique. We optimized the size of ICCs on the basis of viability and functionality after culture in an hypoxic environment. We transplanted ICCs into the subcutaneous space of diabetic mice and evaluated the viability of the islets at the transplantation site. In an hypoxic environment, ICCs exhibited improved viability and functionality compared with control islets. ICCs, upon transplantation into the hypoxic subcutaneous space of diabetic mice, showed better glycemic control compared with control islets. Live/dead imaging of the islets after retrieval fromthe transplanted area revealed significantly reduced apoptosis in ICCs. Transplantation of ICCsmay be an attractive strategy to prevent islet cell apoptosis that results from nonimmune-mediated physiologic stress at the transplantation site.-Pathak, S., Regmi, S., Gupta, B., Pham, T. T., Yong, C. S., Kim, J. O., Yook, S., Kim, J.-R., Park, M. H., Bae, Y. K., Jeong, J.-H. Engineeredislet cell clusters transplanted into subcutaneous space are superior to pancreatic islets in diabetes.	[Pathak, Shiva; Regmi, Shobha; Gupta, Biki; Tung Thanh Pham; Yong, Chul Soon; Kim, Jong Oh; Jeong, Jee-Heon] Yeungnam Univ, Coll Pharm, Gyongsan, South Korea; [Yook, Simmyung] Keimyung Univ, Coll Pharm, Daegu, South Korea; [Kim, Jae-Ryong] Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, Daegu, South Korea; [Kim, Jae-Ryong] Yeungnam Univ, Coll Med, Smart Aging Convergence Res Ctr, Daegu, South Korea; [Park, Min Hui; Bae, Young Kyung] Yeungnam Univ, Dept Pathol, Coll Med, Daegu, South Korea	Yeungnam University; Keimyung University; Yeungnam University; Yeungnam University; Yeungnam University	Jeong, JH (corresponding author), Yeungnam Univ, Coll Pharm, 280 Daehak Ro, Gyongsan 38541, Gyeongbuk Do, South Korea.	jeeheon@yu.ac.kr	Gupta, Biki/AAF-6859-2020; Pathak, Shiva/AAY-2052-2021; Pham, Tung/AAC-9514-2020; Pham, Tung/GPT-1655-2022	Bae, Young Kyung/0000-0002-6689-9413; Pham, Tung/0000-0002-3961-8268; Gupta, Biki/0000-0002-2315-1026; Gupta, Biki/0000-0001-8158-6813	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, Information and Communications Technology (ICT), and Future Planning [2015R1A2A2A04005616, 2015R1A5A2009124]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute; Ministry of Health and Welfare [HI16C1767]; Creative Economy Leading Technology Development Program through the Gyeongsangbuk-Do [SF316001A]; Creative Economy Leading Technology Development Program through Gyeongbuk Science and Technology Promotion Center of Korea [SF316001A]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, Information and Communications Technology (ICT), and Future Planning; Korea Health Technology R&D Project through the Korea Health Industry Development Institute; Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Creative Economy Leading Technology Development Program through the Gyeongsangbuk-Do; Creative Economy Leading Technology Development Program through Gyeongbuk Science and Technology Promotion Center of Korea	The authors thank the members of the Department of Pathology (College of Medicine, Yeungnam University) for their assistance during the immunohistochemical studies. The authors also thank the members of laboratory animal center of Yeungnam University for their assistance with animal care. This work was supported by the Basic Science Research Program through the National Research Foundation of Korea, funded by the Ministry of Science, Information and Communications Technology (ICT), and Future Planning (Grants 2015R1A2A2A04005616 and 2015R1A5A2009124), Korea Health Technology R&D Project through the Korea Health Industry Development Institute and the Ministry of Health and Welfare (Grant HI16C1767), and the Creative Economy Leading Technology Development Program through the Gyeongsangbuk-Do and Gyeongbuk Science and Technology Promotion Center of Korea (SF316001A). The authors declare no conflicts of interests.	Balamurugan AN, 2003, PANCREAS, V26, P279, DOI 10.1097/00006676-200304000-00012; Barkai U, 2013, CELL TRANSPLANT, V22, P1463, DOI 10.3727/096368912X657341; Bennet W, 2000, UPSALA J MED SCI, V105, P125, DOI 10.1517/03009734000000059; Bloch K, 2006, TISSUE ENG, V12, P337, DOI 10.1089/ten.2006.12.337; Brissova M, 2006, DIABETES, V55, P2974, DOI 10.2337/db06-0690; Carlsson PO, 2001, DIABETES, V50, P489, DOI 10.2337/diabetes.50.3.489; Cavallari G, 2007, TRANSPL P, V39, P2018, DOI 10.1016/j.transproceed.2007.05.016; CIRULLI V, 1994, J CELL SCI, V107, P1429; Cui W, 2004, TRANSPL P, V36, P1206, DOI 10.1016/j.transproceed.2004.04.059; Evron Y, 2015, HORM METAB RES, V47, P24, DOI 10.1055/s-0034-1394375; Hauge-Evans AC, 1999, DIABETES, V48, P1402, DOI 10.2337/diabetes.48.7.1402; Head WS, 2012, DIABETES, V61, P1700, DOI 10.2337/db11-1312; Henriksnas J, 2012, DIABETES, V61, P665, DOI 10.2337/db10-0895; Kawakami Y, 2001, PANCREAS, V23, P375, DOI 10.1097/00006676-200111000-00007; Kim HJ, 2013, TRANSPL P, V45, P605, DOI 10.1016/j.transproceed.2012.11.014; Lehmann R, 2007, DIABETES, V56, P594, DOI 10.2337/db06-0779; MacGregor RR, 2006, AM J PHYSIOL-ENDOC M, V290, pE771, DOI 10.1152/ajpendo.00097.2005; O'Sullivan ES, 2010, DIABETOLOGIA, V53, P937, DOI 10.1007/s00125-009-1653-8; Olsson R, 2011, DIABETES, V60, P2350, DOI 10.2337/db09-0490; Pathak S, 2016, ACS APPL MATER INTER, V8, P25702, DOI 10.1021/acsami.6b07897; Pedraza E, 2012, P NATL ACAD SCI USA, V109, P4245, DOI 10.1073/pnas.1113560109; Pepper AR, 2015, NAT BIOTECHNOL, V33, P518, DOI 10.1038/nbt.3211; Pileggi A, 2006, TRANSPLANTATION, V81, P1318, DOI 10.1097/01.tp.0000203858.41105.88; Rajab A, 2010, CURR DIABETES REP, V10, P332, DOI 10.1007/s11892-010-0130-6; Regmi S, 2017, INT J PHARMACEUT, V520, P163, DOI 10.1016/j.ijpharm.2017.02.014; Riopel M, 2014, FRONT BIOSCI-LANDMRK, V19, P77, DOI 10.2741/4196; Sakata N, 2010, PEDIATR DIABETES, V11, P471, DOI 10.1111/j.1399-5448.2009.00629.x; SHAPIRO AMJ, 1995, TRANSPLANTATION, V59, P1060, DOI 10.1097/00007890-199504150-00027; Zuellig RA, 2017, J TISSUE ENG REGEN M, V11, P109, DOI 10.1002/term.1891	29	17	17	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					5111	5121		10.1096/fj.201700490R	http://dx.doi.org/10.1096/fj.201700490R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28754712				2022-12-26	WOS:000413398500038
J	Yan, D; Kowal, J; Akkari, L; Schuhmacher, AJ; Huse, JT; West, BL; Joyce, JA				Yan, D.; Kowal, J.; Akkari, L.; Schuhmacher, A. J.; Huse, J. T.; West, B. L.; Joyce, J. A.			Inhibition of colony stimulating factor-1 receptor abrogates microenvironment-mediated therapeutic resistance in gliomas	ONCOGENE			English	Article							KINASE INHIBITOR; TUMOR-GROWTH; GLIOBLASTOMA; CONSORTIUM; RESPONSES; BLOCKADE; CHIR-258; CANCER	Glioblastomas represent the most aggressive glioma grade and are associated with a poor patient prognosis. The current standard of care, consisting of surgery, radiation and chemotherapy, only results in a median survival of 14 months, underscoring the importance of developing effective new therapeutic strategies. Among the challenges in treating glioblastomas are primary resistance and the rapid emergence of recurrent disease, which can result from tumor cell-intrinsic mechanisms in addition to tumor microenvironment (TME)-mediated extrinsic resistance. Using a PDGF-B-driven proneural glioma mouse model, we assessed a panel of tyrosine kinase inhibitors with different selectivity profiles. We found that PLX3397, an inhibitor of colony stimulating factor-1 receptor (CSF-1R), blocks glioma progression, markedly suppresses tumor cell proliferation and reduces tumor grade. By contrast, the multi-targeted tyrosine kinase inhibitors dovitinib and vatalanib, which directly target tumor cells, exert minimal anti-tumoral effects in vivo, despite killing glioma cells in vitro, suggesting a TME-mediated resistance mechanism may be involved. Interestingly, PLX3397 interferes with tumor-mediated education of macrophages and consequently restores the sensitivity of glioma cells to tyrosine kinase inhibitors in vivo in preclinical combination trials. Our findings thus demonstrate that microenvironmental alteration by CSF-1R blockade renders tumor cells more susceptible to receptor tyrosine kinase inhibition in a preclinical glioblastoma model, which may have important translational relevance.	[Yan, D.; Akkari, L.; Schuhmacher, A. J.; Joyce, J. A.] Mem Sloan Kettering Canc Ctr, Cancer Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA; [Kowal, J.; Akkari, L.; Joyce, J. A.] Univ Lausanne, Ludwig Inst Canc Res, Lausanne, Switzerland; [Kowal, J.; Akkari, L.; Joyce, J. A.] Univ Lausanne, Dept Oncol, CH-1066 Lausanne, Switzerland; [Huse, J. T.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Huse, J. T.] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [West, B. L.] Plexxikon Inc, Berkeley, CA USA	Memorial Sloan Kettering Cancer Center; Ludwig Institute for Cancer Research; University of Lausanne; University of Lausanne; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Plexxikon	Joyce, JA (corresponding author), Univ Lausanne, Dept Oncol, CH-1066 Lausanne, Switzerland.	johanna@joycelab.org	Schuhmacher, Alberto J./R-6765-2019	Schuhmacher, Alberto J./0000-0002-0136-1049; West, Brian/0000-0002-5320-3691; Akkari, Leila/0000-0001-5479-641X; Kowal, Joanna/0000-0001-7849-6040	US National Cancer Institute (NCI) [R01CA181355]; Swiss Cancer League [KFS 3990-08-2016]; Ludwig Institute for Cancer Research; NCI Support Grant [P30 CA008748]; American Brain Tumor Association; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA181355] Funding Source: NIH RePORTER	US National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swiss Cancer League; Ludwig Institute for Cancer Research; NCI Support Grant; American Brain Tumor Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Florian Klemm and all members of the Joyce laboratory for insightful comments and experimental advice. We are grateful to Kenishana Simpson, Xiaoping Chen and Nisarg Shah for excellent technical support. We thank Dr Eric Holland for scientific discussion, and for generously providing the Nestin-Tv-a Ink4a/Arf<SUP>-/-</SUP> mouse line. This research was supported by the US National Cancer Institute (NCI) (R01CA181355, JAJ), the Swiss Cancer League (KFS 3990-08-2016, JAJ), the Ludwig Institute for Cancer Research (JAJ), NCI Support Grant for the MSKCC core facilities used (P30 CA008748), and the American Brain Tumor Association (LA).	Agarwal S, 2012, MOL CANCER THER, V11, P2183, DOI 10.1158/1535-7163.MCT-12-0552; Beier D, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-128; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bowman RL, 2016, CELL REP, V17, P2445, DOI 10.1016/j.celrep.2016.10.052; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Butowski N, 2016, NEURO-ONCOLOGY, V18, P557, DOI 10.1093/neuonc/nov245; Charles NA, 2012, GLIA, V60, P502, DOI 10.1002/glia.21264; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Engler JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043339; Geng L, 2006, INT J RADIAT ONCOL, V64, P263, DOI 10.1016/j.ijrobp.2005.08.025; Hallett Penelope J, 2008, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0116s42; Hussain SF, 2006, NEURO-ONCOLOGY, V8, P261, DOI 10.1215/15228517-2006-008; Kennedy BC, 2013, J ONCOL, V2013, DOI 10.1155/2013/486912; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; Lee SH, 2005, CLIN CANCER RES, V11, P3633, DOI 10.1158/1078-0432.CCR-04-2129; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mellinghoff IK, 2012, CURR TOP MICROBIOL, V355, P135, DOI 10.1007/82_2011_178; Paul Indranil, 2013, Genes Cancer, V4, P427, DOI 10.1177/1947601913503341; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Quail DF, 2017, CANCER CELL, V31, P326, DOI 10.1016/j.ccell.2017.02.009; Quail DF, 2016, SCIENCE, V352, DOI 10.1126/science.aad3018; Reardon DA, 2014, NEURO-ONCOLOGY, V16, P1441, DOI 10.1093/neuonc/nou212; Ruffell B, 2015, CANCER CELL, V27, P462, DOI 10.1016/j.ccell.2015.02.015; Schafer N, 2016, J CANCER RES CLIN, V142, P1581, DOI 10.1007/s00432-016-2161-0; Shi HB, 2014, CANCER DISCOV, V4, P80, DOI 10.1158/2159-8290.CD-13-0642; Shih AH, 2004, CANCER RES, V64, P4783, DOI 10.1158/0008-5472.CAN-03-3831; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tap WD, 2015, NEW ENGL J MED, V373, P428, DOI 10.1056/NEJMoa1411366; Trudel S, 2005, BLOOD, V105, P2941, DOI 10.1182/blood-2004-10-3913; Uhrbom L, 2004, NAT MED, V10, P1257, DOI 10.1038/nm1120; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wen PY, 2006, CLIN CANCER RES, V12, P4899, DOI 10.1158/1078-0432.CCR-06-0773; Wood JM, 2000, CANCER RES, V60, P2178; Ziegler DS, 2008, J CLIN INVEST, V118, P3109, DOI 10.1172/JCI34120	38	117	118	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 26	2017	36	43					6049	6058		10.1038/onc.2017.261	http://dx.doi.org/10.1038/onc.2017.261			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FK9OT	28759044	Green Published, hybrid			2022-12-26	WOS:000413841400013
J	Fujii, M; Yoneda, A; Takei, N; Sakai-Sawada, K; Kosaka, M; Minomi, K; Yokoyama, A; Tamura, Y				Fujii, Mizuki; Yoneda, Akihiro; Takei, Norio; Sakai-Sawada, Kaori; Kosaka, Marina; Minomi, Kenjiro; Yokoyama, Atsuro; Tamura, Yasuaki			Endoplasmic reticulum oxidase 1 alpha is critical for collagen secretion from and membrane type 1-matrix metalloproteinase levels in hepatic stellate cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; MATRIX-METALLOPROTEINASE; LIVER FIBROSIS; INHIBITS PROLIFERATION; MISFOLDED PROCOLLAGEN; EXTRACELLULAR-MATRIX; MOLECULAR CHAPERONE; SELECTIVE AUTOPHAGY; MAP KINASE; GROWTH	Upon liver injury, excessive deposition of collagen from activated hepatic stellate cells (HSCs) is a leading cause of liver fibrosis. An understanding of the mechanism by which collagen biosynthesis is regulated in HSCs will provide important clues for practical anti-fibrotic therapy. Endoplasmic reticulum oxidase 1 alpha (ERO1 alpha) functions as an oxidative enzyme of protein disulfide isomerase, which forms intramolecular disulfide bonds of membrane and secreted proteins. However, the role of ERO1 alpha in HSCs remains unclear. Here, we show that ERO1 alpha is expressed and mainly localized in the endoplasmic reticulum in human HSCs. When HSCs were transfected with ERO1 alpha siRNA or an ERO1 alpha shRNA-expressing plasmid, expression of ERO1 alpha was completely silenced. Silencing of ERO1 alpha expression in HSCs markedly suppressed their proliferation but did not induce apoptosis, which was accompanied by impaired secretion of collagen type 1. Silencing of ERO1 alpha expression induced impaired disulfide bond formation and inhibited autophagy via activation of the Akt/mammalian target of rapamycin signaling pathway, resulting in intracellular accumulation of collagen type 1 in HSCs. Furthermore, silencing of ERO1 alpha expression also promoted proteasome-dependent degradation of membrane type 1-matrix metalloproteinase (MT1-MMP), which stimulates cell proliferation through cleavage of secreted collagens. The inhibition of HSC proliferation was reversed by treatment with MT1-MMP-cleaved collagen type 1. The results suggest that ERO1 alpha plays a crucial role in HSC proliferation via posttranslational modification of collagen and MT1-MMP and, therefore, may be a suitable therapeutic target for managing liver fibrosis.	[Fujii, Mizuki; Yokoyama, Atsuro] Hokkaido Univ, Grad Sch Dent Med, Div Oral Funct Sci, Dept Oral Funct Prosthodont,Kita Ku, Nishi 7,Kita 13, Sapporo, Hokkaido 0608486, Japan; [Fujii, Mizuki; Yoneda, Akihiro; Takei, Norio; Sakai-Sawada, Kaori; Kosaka, Marina; Minomi, Kenjiro; Tamura, Yasuaki] Hokkaido Univ, Dept Mol Therapeut, Ctr Food & Med Innovat, Inst Promot Business Reg Collaborat,Kita Ku, Nishi 11,Kita 21, Sapporo, Hokkaido 0010021, Japan; [Kosaka, Marina; Minomi, Kenjiro] Nitto Denko Corp, Dept Res & Dev, Nucle Acid Med Business Div, Kita Ku, Nishi 11,Kita 21, Sapporo, Hokkaido 0010021, Japan	Hokkaido University; Hokkaido University; Nitto Denko Corporation	Yoneda, A (corresponding author), Hokkaido Univ, Dept Mol Therapeut, Ctr Food & Med Innovat, Inst Promot Business Reg Collaborat,Kita Ku, Nishi 11,Kita 21, Sapporo, Hokkaido 0010021, Japan.	ayoneda@fmi.hokudai.ac.jp			Center of Innovation Program from the Ministry and Education, Culture, Sports, Science and Technology of Japan (MEXT); Japan Science and Technology Agency (JST); Nitto Denko Corporation (Osaka, Japan)	Center of Innovation Program from the Ministry and Education, Culture, Sports, Science and Technology of Japan (MEXT); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Nitto Denko Corporation (Osaka, Japan)	This work was supported in part by grants from the Center of Innovation Program from the Ministry and Education, Culture, Sports, Science and Technology of Japan (MEXT) and Japan Science and Technology Agency (JST). This work was supported in part by Nitto Denko Corporation (Osaka, Japan). The authors declare that they have no conflicts of interest with the contents of this article.	Adachi M, 2008, HEPATOLOGY, V47, P677, DOI 10.1002/hep.21991; Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Araki K, 2013, J CELL BIOL, V202, P861, DOI 10.1083/jcb.201303027; Birukawa NK, 2014, J BIOL CHEM, V289, P20209, DOI 10.1074/jbc.M113.544494; Bottomley MJ, 2001, CURR BIOL, V11, P1114, DOI 10.1016/S0960-9822(01)00317-7; Cabibbo A, 2000, J BIOL CHEM, V275, P4827, DOI 10.1074/jbc.275.7.4827; Caligiuri A, 2008, HEPATOLOGY, V47, P668, DOI 10.1002/hep.21995; Calvente CJ, 2015, HEPATOLOGY, V62, P1285, DOI 10.1002/hep.27936; Carloni V, 2002, HEPATOLOGY, V36, P582, DOI 10.1053/jhep.2002.35277; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Gao RP, 2004, J HEPATOL, V40, P431, DOI 10.1016/j.jhep.2003.11.012; Handy JA, 2011, BIOCHEM J, V440, P385, DOI 10.1042/BJ20102148; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282; Hudson DA, 2015, FREE RADICAL BIO MED, V80, P171, DOI 10.1016/j.freeradbiomed.2014.07.037; Hulmes DJS, 2002, J STRUCT BIOL, V137, P2, DOI 10.1006/jsbi.2002.4450; Ishida Y, 2009, AUTOPHAGY, V5, P1217, DOI 10.4161/auto.5.8.10168; Ishida Y, 2009, MOL BIOL CELL, V20, P2744, DOI 10.1091/mbc.E08-11-1092; Karsdal MA, 2015, AM J PHYSIOL-GASTR L, V308, pG807, DOI 10.1152/ajpgi.00447.2014; Kawasaki K, 2015, J BIOL CHEM, V290, P3639, DOI 10.1074/jbc.M114.592139; Khaminets A, 2015, NATURE, V522, P354, DOI 10.1038/nature14498; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kinoshita T, 1998, J BIOL CHEM, V273, P16098, DOI 10.1074/jbc.273.26.16098; Kumar P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110405; Lilienbaum Alain, 2013, Int J Biochem Mol Biol, V4, P1; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Mehal WZ, 2015, SEMIN LIVER DIS, V35, P184, DOI 10.1055/s-0035-1550055; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nedelsky NB, 2008, BBA-MOL BASIS DIS, V1782, P691, DOI 10.1016/j.bbadis.2008.10.002; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; Pagani M, 2000, J BIOL CHEM, V275, P23685, DOI 10.1074/jbc.M003061200; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Reif S, 2003, J BIOL CHEM, V278, P8083, DOI 10.1074/jbc.M212927200; Sato Y, 2008, NAT BIOTECHNOL, V26, P431, DOI 10.1038/nbt1396; Schuck S, 2014, J CELL SCI, V127, P4078, DOI 10.1242/jcs.154716; Shen HM, 2014, TRENDS BIOCHEM SCI, V39, P61, DOI 10.1016/j.tibs.2013.12.001; Tsai M, 2002, J CELL BIOL, V159, P207, DOI 10.1083/jcb.200207120; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; Wake K, 1980, Int Rev Cytol, V66, P303; Wilson R, 1998, J BIOL CHEM, V273, P9637, DOI 10.1074/jbc.273.16.9637; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhou XY, 2006, J BIOL CHEM, V281, P39757, DOI 10.1074/jbc.M605621200; Zhou XY, 2004, J BIOL CHEM, V279, P23996, DOI 10.1074/jbc.M311668200; Zito E, 2012, MOL CELL, V48, P39, DOI 10.1016/j.molcel.2012.08.010; Zito E, 2010, J CELL BIOL, V188, P821, DOI 10.1083/jcb.200911086; Zucker S, 1998, J BIOL CHEM, V273, P1216, DOI 10.1074/jbc.273.2.1216	52	5	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15649	15660		10.1074/jbc.M117.783126	http://dx.doi.org/10.1074/jbc.M117.783126			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28774960	Green Published, hybrid			2022-12-26	WOS:000411512200006
J	Gil-Pulido, J; Cochain, C; Lippert, MA; Schneider, N; Butt, E; Amezaga, N; Zernecke, A				Gil-Pulido, Jesus; Cochain, Clement; Lippert, Malte A.; Schneider, Nicole; Butt, Elke; Amezaga, Nuria; Zernecke, Alma			Deletion of Batf3-dependent antigen-presenting cells does not affect atherosclerotic lesion formation in mice	PLOS ONE			English	Article							CD8-ALPHA(+) DENDRITIC CELLS; LEISHMANIA-MAJOR INFECTION; RECEPTOR-DEFICIENT MICE; REGULATORY T-CELLS; IMMUNE-RESPONSE; MACROPHAGES; PLAQUE; INTERLEUKIN-12; ATHEROGENESIS; SPECIFICITY	Atherosclerosis is the main underlying cause for cardiovascular events such as myocardial infarction and stroke and its development might be influenced by immune cells. Dendritic cells (DCs) bridge innate and adaptive immune responses by presenting antigens to T cells and releasing a variety of cytokines. Several subsets of DCs can be discriminated that engage specific transcriptional pathways for their development. Basic leucine zipper transcription factor ATF-like 3 (Batf3) is required for the development of classical CD8 alpha(+) and CD103(+) DCs. By crossing mice deficient in Batf3 with atherosclerosis-prone low density lipoprotein receptor (Ldlr(-/-))-deficient mice we here aimed to further address the contribution of Batf3-dependent CD8a(+) and CD103(+) antigen-presenting cells to atherosclerosis. We demonstrate that deficiency in Batf3 entailed mild effects on the immune response in the spleen but did not alter atherosclerotic lesion formation in the aorta or aortic root, nor affected plaque phenotype in low density lipoprotein receptor-deficient mice fed a high fat diet. We thus provide evidence that Batf3-dependent antigen-presenting cells do not have a prominent role in atherosclerosis.	[Gil-Pulido, Jesus; Cochain, Clement; Lippert, Malte A.; Schneider, Nicole; Butt, Elke; Amezaga, Nuria; Zernecke, Alma] Univ Hosp Wurzburg, Inst Expt Biomed, Wurzburg, Germany	University of Wurzburg	Zernecke, A (corresponding author), Univ Hosp Wurzburg, Inst Expt Biomed, Wurzburg, Germany.	alma.zernecke@uni-wuerzburg.de		Zernecke, Alma/0000-0001-8551-4729	Deutsche Forschungsgemeinschaft [SFB688, TPA22]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This project was supported by the Deutsche Forschungsgemeinschaft (SFB688, TPA22).	Abram CL, 2014, J IMMUNOL METHODS, V408, P89, DOI 10.1016/j.jim.2014.05.009; Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Aparicio-Vergara M, 2010, ATHEROSCLEROSIS, V213, P335, DOI 10.1016/j.atherosclerosis.2010.05.030; Ashok D, 2014, EUR J IMMUNOL, V44, P1422, DOI 10.1002/eji.201344242; Buono C, 2004, CIRCULATION, V109, P2009, DOI 10.1161/01.CIR.0000127121.16815.F1; Busch M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088452; Carbone FR, 2010, J IMMUNOL, V185, P1353, DOI 10.4049/jimmunol.1090065; Choi JH, 2011, IMMUNITY, V35, P819, DOI 10.1016/j.immuni.2011.09.014; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Darrasse-Jeze G, 2009, J EXP MED, V206, P1853, DOI 10.1084/jem.20090746; Ensan S, 2016, NAT IMMUNOL, V17, P159, DOI 10.1038/ni.3343; Ferris ST, 2014, IMMUNITY, V41, P657, DOI 10.1016/j.immuni.2014.09.012; Gautier EL, 2009, CIRCULATION, V119, P2367, DOI 10.1161/CIRCULATIONAHA.108.807537; Getz GS, 2016, ARTERIOSCL THROM VAS, V36, P1734, DOI 10.1161/ATVBAHA.116.306874; Gimbrone MA, 2016, CIRC RES, V118, P620, DOI 10.1161/CIRCRESAHA.115.306301; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Habets KLL, 2010, CARDIOVASC RES, V85, P622, DOI 10.1093/cvr/cvp338; Haddad Y, 2017, CIRC RES; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; HUME DA, 1983, J CELL PHYSIOL, V117, P189, DOI 10.1002/jcp.1041170209; JONASSON L, 1986, ARTERIOSCLEROSIS, V6, P131, DOI 10.1161/01.ATV.6.2.131; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Legein B, 2015, SCI REP-UK, V5, DOI 10.1038/srep15414; Li YL, 2017, EBIOMEDICINE, V18, P188, DOI 10.1016/j.ebiom.2017.04.008; Lutgens E, 2010, J EXP MED, V207, P391, DOI 10.1084/jem.20091293; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Mallat Z, 2003, CIRCULATION, V108, P1232, DOI 10.1161/01.CIR.0000089083.61317.A1; Maraskovsky E, 1996, J EXP MED, V184, P1953, DOI 10.1084/jem.184.5.1953; Martinez-Lopez M, 2015, EUR J IMMUNOL, V45, P119, DOI 10.1002/eji.201444651; Mashayekhi M, 2011, IMMUNITY, V35, P249, DOI 10.1016/j.immuni.2011.08.008; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; Murphy TL, 2013, NAT REV IMMUNOL, V13, P499, DOI 10.1038/nri3470; Paulson KE, 2010, CIRC RES, V106, P383, DOI 10.1161/CIRCRESAHA.109.210781; Schieffer B, 2004, CIRCULATION, V110, P3493, DOI 10.1161/01.CIR.0000148135.08582.97; Song L, 2004, ATHEROSCLEROSIS, V177, P43, DOI 10.1016/j.atherosclerosis.2004.06.018; Vorlova S, 2017, THROMB HAEMOSTASIS, V117, P176, DOI 10.1160/TH16-06-0466; Zernecke A, 2008, ARTERIOSCL THROM VAS, V28, P1897, DOI 10.1161/ATVBAHA.107.161174; Zernecke A, 2015, ARTERIOSCL THROM VAS, V35, P763, DOI 10.1161/ATVBAHA.114.303566; Zirlik A, 2007, CIRCULATION, V115, P1571, DOI 10.1161/CIRCULATIONAHA.106.683201; Zitvogel L, 2014, CANCER CELL, V26, P591, DOI 10.1016/j.ccell.2014.10.008	41	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0181947	10.1371/journal.pone.0181947	http://dx.doi.org/10.1371/journal.pone.0181947			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771609	Green Published, gold, Green Submitted			2022-12-26	WOS:000406853600045
J	Lakiotaki, K; Kanterakis, A; Kartsaki, E; Katsila, T; Patrinos, GP; Potamias, G				Lakiotaki, Kleanthi; Kanterakis, Alexandros; Kartsaki, Evgenia; Katsila, Theodora; Patrinos, George P.; Potamias, George			Exploring public genomics data for population pharmacogenomics	PLOS ONE			English	Article							DRUG RESPONSE; GENETIC DIVERSITY; RESEARCH NETWORK; CLINICAL IMPLEMENTATION; ALLELE NOMENCLATURE; BREAST-CANCER; VARIANTS; CONSORTIUM; CHALLENGES	Racial and ethnic differences in drug responses are now well studied and documented. Pharmacogenomics research seeks to unravel the genetic underpinnings of inter-individual variability with the aim of tailored-made theranostics and therapeutics. Taking into account the differential expression of pharmacogenes coding for key metabolic enzymes and transporters that affect drug pharmacokinetics and pharmacodynamics, we advise that data interpretation and analysis need to occur in light of geographical ancestry, if implications for drug development and global health are to be considered. Herein, we exploit ePGA, a web-based electronic Pharmacogenomics Assistant and publicly available genetic data from the 1000 Genomes Project to explore genotype to phenotype associations among the 1000 Genomes Project populations.	[Lakiotaki, Kleanthi; Kanterakis, Alexandros; Kartsaki, Evgenia; Potamias, George] Fdn Res & Technol, Inst Comp Sci, Iraklion, Crete, Greece; [Katsila, Theodora; Patrinos, George P.] Univ Patras, Sch Hlth Sci, Dept Pharm, Patras, Greece; [Patrinos, George P.] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Pathol, Al Ain, U Arab Emirates	University of Patras; United Arab Emirates University	Patrinos, GP (corresponding author), Univ Patras, Sch Hlth Sci, Dept Pharm, Patras, Greece.; Patrinos, GP (corresponding author), United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Pathol, Al Ain, U Arab Emirates.	gpatrinos@upatras.gr	Kanterakis, Alexandros/ABC-1705-2021; Katsila, Theodora/O-3228-2015; Patrinos, George/C-2845-2009	Kanterakis, Alexandros/0000-0003-4276-0115; Katsila, Theodora/0000-0002-6263-4231; Patrinos, George/0000-0002-0519-7776	European Commission [FP7-305444, H2020-668353 (U-PGx)]; OPCE II; Greek-EU operational program [11SigmaYN_10_145]	European Commission(European CommissionEuropean Commission Joint Research Centre); OPCE II; Greek-EU operational program	Part of this work was funded by grants from the European Commission [FP7-305444 (RD-Connect); H2020-668353 (U-PGx)] and the OPCE II; Greek-EU operational program (11 Sigma YN_10_145; eMoDiA) to GPP.; Part of this work was funded by grants from the European Commission [FP7-305444 (RD-Connect); H2020-668353 (U-PGx)] and the OPCE II; Greek-EU operational program (11 Sigma YN_10_145; eMoDiA) to GPP.	Administration UF and D, 2013, GUIDANCE IND CLIN PH; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altman RB, 2013, CLIN PHARMACOL THER, V94, P211, DOI 10.1038/clpt.2013.111; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Bachtiar M, 2013, GENETICS POPULATION, P162; CARSON PE, 1956, SCIENCE, V124, P484, DOI 10.1126/science.124.3220.484-a; Chan SL, 2016, PHARMACOGENET GENOM, V26, P28, DOI 10.1097/FPC.0000000000000182; Cho SK, 2012, PHARMACOGENET GENOM, V22, P598, DOI 10.1097/FPC.0b013e3283544085; Dong NN, 2012, J CANCER RES CLIN, V138, P1197, DOI 10.1007/s00432-012-1183-5; Giacomini KM, 2007, CLIN PHARMACOL THER, V81, P328, DOI 10.1038/sj.clpt.6100087; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Hildebrandt MAT, 2007, PHARMACOGENOMICS J, V7, P133, DOI 10.1038/sj.tpj.6500404; Hiratsuka M, 2006, MUTAT RES-FUND MOL M, V599, P98, DOI 10.1016/j.mrfmmm.2006.02.008; Hoskins JM, 2009, NAT REV CANCER, V9, P576, DOI 10.1038/nrc2683; HUGHES HB, 1954, AM REV TUBERC PULM, V70, P266; Johnson JA, 2008, CIRCULATION, V118, P1383, DOI 10.1161/CIRCULATIONAHA.107.704023; KALOW W, 1956, LANCET, V271, P576; Katsila T, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00061; Kubo K, 2016, PHARMACOGENOMICS J, P1; Lakiotaki K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162801; Li J, 2011, HUM MOL GENET, V20, P528, DOI 10.1093/hmg/ddq498; Limaye N, 2013, APPL TRANSL GENOM, V2, P17, DOI 10.1016/j.atg.2013.05.002; Lin G. G., 2012, J NEUROSCI METH, V100, P130, DOI DOI 10.1016/J.PESTBP.2011.02.012.INVESTIGATI0NS; Liu BH, 2016, METHOD MOL BIOL, P93; McLaren W, 2016, GENOME BIOL, P42374; Mizzi C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162866; Motsinger-Reif AA, 2013, PHARMACOGENET GENOM, V23, P383, DOI 10.1097/FPC.0b013e32833d7b45; Nebert D. W., 2001, Pharmacogenomics Journal, V1, P19; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; O'Donnell PH, 2012, CLIN PHARMACOL THER, V92, P446, DOI 10.1038/clpt.2012.117; Padmanabhan S., 2014, HDB PHARMACOGENOMICS; Pereira NL, 2015, NAT REV CARDIOL; Potamias G, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140071; Prowell TM, 2016, NEW ENGL J MED, V374, P2001, DOI 10.1056/NEJMp1603747; Ramamoorthy A, 2015, CLIN PHARMACOL THER, V97, P263, DOI 10.1002/cpt.61; Ramos E, 2014, PHARMACOGENOMICS J, V14, P217, DOI 10.1038/tpj.2013.24; Relling MV, 2011, CLIN PHARMACOL THER, V89, P464, DOI 10.1038/clpt.2010.279; Richards-Waugh LL, 2014, J ANAL TOXICOL, V38, P541, DOI 10.1093/jat/bku091; Robarge J, 2007, CLIN PHARMACOL THER, V82, P244, DOI 10.1038/sj.clpt.6100284; Salleh MZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071554; Samwald M, 2015, PHARMACOGENOMICS, V16, P1713, DOI 10.2217/pgs.15.108; Shuldiner AR, 2013, CLIN PHARMACOL THER, V94, P207, DOI 10.1038/clpt.2013.59; Sim Sarah C., 2010, Human Genomics, V4, P278; Smedley D, 2015, NUCLEIC ACIDS RES, V43, pW589, DOI 10.1093/nar/gkv350; Temple R, 2007, ANN INTERN MED, V146, P57, DOI 10.7326/0003-4819-146-1-200701020-00010; van der Wouden CH, 2017, CLIN PHARMACOL THER, V101, P341, DOI [10.1002/cpt.725, 10.1002/cpt.602]; Vetrans Administration Cooperative Study Group on Antihypertensive Agents, 1981, JAMA-J AM MED ASSOC, V248, P1996; Whirl-Carrillo M, 2012, CLIN PHARMACOL THER, V92, P414, DOI 10.1038/clpt.2012.96; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761; Zhou Y., 2017, CLIN PHARM THER	50	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182138	10.1371/journal.pone.0182138	http://dx.doi.org/10.1371/journal.pone.0182138			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771511	Green Submitted, gold, Green Published			2022-12-26	WOS:000406853600066
J	Song, FH; Qian, Y; Peng, X; Li, XH; Xing, PQ; Ye, DQ; Lei, HX				Song, Fuhai; Qian, Ying; Peng, Xing; Li, Xiuhui; Xing, Peiqi; Ye, Dongqing; Lei, Hongxing			The frontline of immune response in peripheral blood	PLOS ONE			English	Article							RESISTANT PROSTATE-CANCER; GENE-EXPRESSION; PROGNOSTIC BIOMARKER; SIGNATURE; TRANSCRIPTOME; HAPTOGLOBIN; INFECTION; INDIVIDUALS; ASSOCIATION; METABOLISM	Peripheral blood is an attractive source for the discovery of disease biomarkers. Gene expression profiling of whole blood or its components has been widely conducted for various diseases. However, due to population heterogeneity and the dynamic nature of gene expression, certain biomarkers discovered from blood transcriptome studies could not be replicated in independent studies. In the meantime, it's also important to know whether a reliable biomarker is shared by several diseases or specific to certain health conditions. We hypothesized that common mechanism of immune response in blood may be shared by different diseases. Under this hypothesis, we surveyed publicly available transcriptome data on infectious and autoimmune diseases derived from peripheral blood. We examined to which extent common gene dys-regulation existed in different diseases. We also investigated whether the commonly dys-regulated genes could serve as reliable biomarkers. First, we found that a limited number of genes are frequently dys-regulated in infectious and autoimmune diseases, from which we selected 10 genes co-dysregulated in viral infections and another set of 10 genes co-dysregulated in bacterial infections. In addition to its ability to distinguish viral infections from bacterial infections, these 20 genes could assist in disease classification and monitoring of treatment effect for several infectious and autoimmune diseases. In some cases, a single gene is sufficient to serve this purpose. It was interesting that dys-regulation of these 20 genes were also observed in other types of diseases including cancer and stroke where certain genes could also serve as biomarkers for diagnosis or prognosis. Furthermore, we demonstrated that this set of 20 genes could also be used in continuous monitoring of personal health. The rich information from these commonly dys-regulated genes may find its wide application in clinical practice and personal healthcare. More validation studies and in-depth investigations are warranted in the future.	[Song, Fuhai; Qian, Ying; Peng, Xing; Li, Xiuhui; Xing, Peiqi; Ye, Dongqing; Lei, Hongxing] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Song, Fuhai; Qian, Ying; Peng, Xing; Li, Xiuhui; Xing, Peiqi; Lei, Hongxing] Univ Chinese Acad Sci, Cunji Med Sch, Beijing, Peoples R China; [Lei, Hongxing] Beijing Inst Brain Disorders, Ctr Alzheimers Dis, Beijing, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Lei, HX (corresponding author), Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China.; Lei, HX (corresponding author), Univ Chinese Acad Sci, Cunji Med Sch, Beijing, Peoples R China.; Lei, HX (corresponding author), Beijing Inst Brain Disorders, Ctr Alzheimers Dis, Beijing, Peoples R China.	leihx@big.ac.cn		Lei, Hongxing/0000-0003-0496-0386	National High Technology Program of China (863 Program) [2015AA020108]; National Basic Research Program of China (973 Program) - Ministry of Science and Technology of China [2014CB964901]; National Key Research and Development Program of China - Ministry of Science and Technology of China [2016YFC0901700]; National Basic Research Program of China (973 Program) [2014CB964901]	National High Technology Program of China (863 Program); National Basic Research Program of China (973 Program) - Ministry of Science and Technology of China; National Key Research and Development Program of China - Ministry of Science and Technology of China; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by grants from the National High Technology Program of China (863 Program; grant no. 2015AA020108), the National Basic Research Program of China (973 Program; grant no. 2014CB964901) awarded to H Lei by the Ministry of Science and Technology of China, and the National Key Research and Development Program of China (grant no. 2016YFC0901700) awarded to H Lei by the Ministry of Science and Technology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the National High Technology Program of China (863 Program; Grant No. 2015AA020108), the National Basic Research Program of China (973 Program; Grant No. 2014CB964901), and the National Key Research and Development Program of China (Grant No. 2016YFC0901700) awarded to H Lei by the Ministry of Science and Technology of China.	Aaroe J, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2472; Ahn SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048979; Araki H, 2015, CANCER IMMUNOL IMMUN, V64, P1565, DOI 10.1007/s00262-015-1756-7; Banchereau R, 2012, HOST IMMUNE TRANSCRI, V7; Barnes MG, 2009, ARTHRITIS RHEUM-US, V60, P2102, DOI 10.1002/art.24601; Barr TL, 2010, NEUROLOGY, V75, P1009, DOI 10.1212/WNL.0b013e3181f2b37f; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bloom CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046191; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; Chiche L, 2014, ARTHRITIS RHEUMATOL, V66, P1583, DOI 10.1002/art.38628; Cliff JM, 2013, J INFECT DIS, V207, P18, DOI 10.1093/infdis/jis499; Feenstra B, 2014, NAT GENET, V46, P1274, DOI 10.1038/ng.3129; Galamb O, 2008, CANCER EPIDEM BIOMAR, V17, P2835, DOI 10.1158/1055-9965.EPI-08-0231; Garvin P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138290; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Haas B, 2011, J PROTEOMICS, V75, P229, DOI 10.1016/j.jprot.2011.06.028; Han GC, 2013, J ALZHEIMERS DIS, V35, P373, DOI 10.3233/JAD-121963; He YY, 2015, CLIN BIOCHEM, V48, P329, DOI 10.1016/j.clinbiochem.2014.11.016; Heinonen S, 2015, AM J RESP CRITICAL C; Herberg JA, 2016, JAMA-J AM MED ASSOC, V316, P835, DOI 10.1001/jama.2016.11236; Herberg JA, 2013, J INFECT DIS, V208, P1664, DOI 10.1093/infdis/jit348; Hoang LT, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0102-6; Hyrcza MD, 2007, J VIROL, V81, P3477, DOI 10.1128/JVI.01552-06; Idaghdour Y, 2012, P NATL ACAD SCI USA, V109, P16786, DOI 10.1073/pnas.1204945109; James K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143970; Kaforou M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001538; Koth LL, 2011, AM J RESP CRIT CARE, V184, P1153, DOI 10.1164/rccm.201106-1143OC; Kuhn A, 2011, NAT METHODS, V8, P945, DOI [10.1038/NMETH.1710, 10.1038/nmeth.1710]; Lee HM, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3317; Luo HB, 2016, MOL NEUROBIOL, V53, P3596, DOI 10.1007/s12035-015-9288-x; Massanella M, 2013, ANTIVIR RES, V100, P420, DOI 10.1016/j.antiviral.2013.07.017; Morris CR, 2005, JAMA-J AM MED ASSOC, V294, P81, DOI 10.1001/jama.294.1.81; Napolioni V, 2011, CLIN CHIM ACTA, V412, P574, DOI 10.1016/j.cca.2010.12.006; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Okada Y, 2012, NAT GENET, V44, P511, DOI 10.1038/ng.2231; Olmos D, 2012, LANCET ONCOL, V13, P1114, DOI 10.1016/S1470-2045(12)70372-8; Ottenhoff THM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045839; Pankla R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r127; Preininger M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003362; Quartier P, 2011, ANN RHEUM DIS, V70, P747, DOI 10.1136/ard.2010.134254; Ruderfer DM, 2014, MOL PSYCHIATR, V19, P1017, DOI 10.1038/mp.2013.138; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Song FH, 2016, CURR OPIN PHARMACOL, V26, P47, DOI 10.1016/j.coph.2015.09.015; Stamova B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102550; Stathopoulos GP, 2009, INT J MOL MED, V24, P613, DOI 10.3892/ijmm_00000272; Streicher K, 2014, ARTHRITIS RHEUMATOL, V66, P173, DOI 10.1002/art.38194; Suarez NM, 2015, J INFECT DIS, V212, P213, DOI 10.1093/infdis/jiv047; Sun JY, 2012, J ALZHEIMERS DIS, V28, P389, DOI 10.3233/JAD-2011-111313; Swami A, 2013, J MACH LEARN RES, V12, P2825; Sweeney TE, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5993; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Wang L, 2016, SCI REP-UK, V6, DOI 10.1038/srep32976; Warren HS, 2009, MOL MED, V15, P220, DOI 10.2119/molmed.2009.00027; Wong HR, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-34; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Xu X, 2014, J IMMUNOL, V193, P4125, DOI 10.4049/jimmunol.1401249; Yan XD, 2010, CANCER RES, V70, P1616, DOI 10.1158/0008-5472.CAN-09-3215; Yoon D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075214; Zaatar AM, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-76; Zhai YJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004869; Zhou BY, 2010, P NATL ACAD SCI USA, V107, P9923, DOI 10.1073/pnas.1002757107	62	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182294	10.1371/journal.pone.0182294	http://dx.doi.org/10.1371/journal.pone.0182294			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771541	Green Published, Green Submitted, gold			2022-12-26	WOS:000406853600085
J	Ying, G; Wang, J; Kumar, V; Zajonc, DM				Ying, Ge; Wang, Jing; Kumar, Vipin; Zajonc, Dirk M.			Crystal structure of Qa-1(a) with bound Qa-1 determinant modifier peptide	PLOS ONE			English	Article							KILLER-CELL RECEPTORS; CLASS IB MOLECULES; HLA-E; T-CELLS; BINDING-SPECIFICITY; LEADER SEQUENCE; RECOGNITION; ANTIGEN; CD94/NKG2A; LYMPHOCYTES	Qa-1 is a non-classical Major Histocompatibility (MHC) class I molecule that generally presents hydrophobic peptides including Qdm derived from the leader sequence of classical MHC I molecules for immune surveillance by NK cells. Qa-1 bound peptides derived from the TCR V beta 8.2 of activated T cells also activates CD8(+) regulatory T cells to control autoimmunity and maintain self-tolerance. Four allotypes of Qa-1 (Qa-1(a-d)) are expressed that are highly conserved in sequence but have several variations that could affect peptide binding to Qa-1 or TCR recognition. Here, we determined the structure of Qa-1(a) with bound Qdm peptide. While the overall structure is very similar to that of Qa-1(b), there are several amino acid differences around the peptide binding platform that could affect TCR recognition. Most notably, two amino acid substitutions are found in the pocket P2, which binds the anchor residue Met2 of the Qdm peptide. These residues affect both the size and shape of the binding pocket, as well as affect the charge at physiologic pH, suggesting Qa-1(a) and Qa-1(b) could present slightly distinct peptide reservoirs, which could presumably be recognized by different populations of CD8(+) T cells.	[Ying, Ge; Wang, Jing; Zajonc, Dirk M.] La Jolla Inst Allergy & Immunol LJI, Div Cell Biol, La Jolla, CA 92037 USA; [Kumar, Vipin] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Zajonc, Dirk M.] Univ Ghent, Dept Internal Med, Fac Med & Hlth Sci, Ghent, Belgium	University of California System; University of California San Diego; Ghent University	Zajonc, DM (corresponding author), La Jolla Inst Allergy & Immunol LJI, Div Cell Biol, La Jolla, CA 92037 USA.; Zajonc, DM (corresponding author), Univ Ghent, Dept Internal Med, Fac Med & Hlth Sci, Ghent, Belgium.	dzajonc@lji.org		Zajonc, Dirk/0000-0001-7215-1981	National Institute of Health [R01-AI05227]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project was funded in part by the National Institute of Health (www.nih.gov) grant R01-AI05227 to V.K. Use of the Stanford Synchrotron Radiation Lightsource, SLAG National Accelerator Laboratory, is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams EJ, 2013, ANNU REV IMMUNOL, V31, P529, DOI 10.1146/annurev-immunol-032712-095912; ALDRICH CJ, 1994, CELL, V79, P649, DOI 10.1016/0092-8674(94)90550-9; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Carrillo-Bustamante P, 2016, IMMUNOGENETICS, V68, P3, DOI 10.1007/s00251-015-0869-7; Chen LL, 2014, J IMMUNOL, V193, P1427, DOI 10.4049/jimmunol.1302048; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Davies A, 2003, J IMMUNOL, V170, P5027, DOI 10.4049/jimmunol.170.10.5027; DeCloux A, 1997, J IMMUNOL, V158, P2183; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hansen SG, 2016, SCIENCE, V351, P714, DOI 10.1126/science.aac9475; He Y, 2016, CELLULAR MOL IMMUNOL; Iannello A, 2013, COLD SH Q B, V78, P249, DOI 10.1101/sqb.2013.78.020255; JENKINS RN, 1983, J IMMUNOL, V131, P2147; JIANG H, 1995, IMMUNITY, V2, P185, DOI 10.1016/S1074-7613(95)80079-4; Kaiser BK, 2008, P NATL ACAD SCI USA, V105, P6696, DOI 10.1073/pnas.0802736105; Kim HJ, 2011, SEMIN IMMUNOL, V23, P446, DOI 10.1016/j.smim.2011.06.001; KOLLER BH, 1988, J IMMUNOL, V141, P897; Kraft JR, 2000, J EXP MED, V192, P613, DOI 10.1084/jem.192.5.613; Lampen MH, 2013, MOL IMMUNOL, V53, P126, DOI 10.1016/j.molimm.2012.07.009; Lo WF, 2000, NAT MED, V6, P215, DOI 10.1038/72329; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Miller JD, 2003, J IMMUNOL, V171, P1369, DOI 10.4049/jimmunol.171.3.1369; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Petrie EJ, 2008, J EXP MED, V205, P725, DOI 10.1084/jem.20072525; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Schuren ABC, 2016, CURR OPIN IMMUNOL, V40, P43, DOI 10.1016/j.coi.2016.02.007; Smith TRF, 2008, TRENDS IMMUNOL, V29, P337, DOI 10.1016/j.it.2008.04.002; Tang X, 2006, J IMMUNOL, V177, P7645, DOI 10.4049/jimmunol.177.11.7645; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; Vance RE, 1998, J EXP MED, V188, P1841, DOI 10.1084/jem.188.10.1841	34	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182296	10.1371/journal.pone.0182296	http://dx.doi.org/10.1371/journal.pone.0182296			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767728	Green Published, Green Submitted, gold			2022-12-26	WOS:000406768200066
J	Yu, XY; Shi, YB; Wang, T; Sun, X				Yu, Xiaoyu; Shi, Yunbo; Wang, Tian; Sun, Xu			Dust-concentration measurement based on Mie scattering of a laser beam	PLOS ONE			English	Article							DIFFRACTION	To realize automatic measurement of the concentration of dust particles in the air, a theory for dust concentration measurement was developed, and a system was designed to implement the dust concentration measurement method based on laser scattering. In the study, the principle of dust concentration detection using laser scattering is studied, and the detection basis of Mie scattering theory is determined. Through simulation, the influence of the incident laser wavelength, dust particle diameter, and refractive index of dust particles on the scattered light intensity distribution are obtained for determining the scattered light intensity curves of single suspended dust particles under different characteristic parameters. A genetic algorithm was used to study the inverse particle size distribution, and the reliability of the measurement system design is proven theoretically. The dust concentration detection system, which includes a laser system, computer circuitry, air flow system, and control system, was then implemented according to the parameters obtained from the theoretical analysis. The performance of the designed system was evaluated. Experimental results show that the system performance was stable and reliable, resulting in high-precision automatic dust concentration measurement with strong anti-interference ability.	[Yu, Xiaoyu; Shi, Yunbo; Wang, Tian; Sun, Xu] Harbin Univ Sci & Technol, Higher Educ Key Lab Measuring & Control Technol &, Sch Measurement Control Technol & Commun Engn, Harbin, Heilongjiang, Peoples R China	Harbin University of Science & Technology	Yu, XY (corresponding author), Harbin Univ Sci & Technol, Higher Educ Key Lab Measuring & Control Technol &, Sch Measurement Control Technol & Commun Engn, Harbin, Heilongjiang, Peoples R China.	13904808427@163.com						Cyr M, 2001, MATER STRUCT, V34, P342, DOI 10.1007/BF02486485; HAYAKAWA O, 1995, ADV POWDER TECHNOL, V6, P47, DOI 10.1016/S0921-8831(08)60547-6; Heinisch RL, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.243903; Huang S, 2013, J CHINA U MINING TEC, V42, P133; [黄三 Huang San], 2013, [中国矿业大学学报. 自然科学版, Journal of China University of Mining & Technology], V42, P117; Pan Qi, 2007, Chinese Journal of Scientific Instrument, V28, P1070; PROBERTJONES JR, 1984, J OPT SOC AM A, V1, P822, DOI 10.1364/JOSAA.1.000822; Stephen A, 2010, LIMNOLOGY OCEANOGRAP, V8, P507; Vladutescu DV, 2012, IEEE T INSTRUM MEAS, V61, P1733, DOI 10.1109/TIM.2011.2178664; YU AB, 1990, POWDER TECHNOL, V62, P101, DOI 10.1016/0032-5910(90)80073-8; Zhao PS, 2011, ATMOS RES, V101, P711, DOI 10.1016/j.atmosres.2011.04.019	11	12	13	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0181575	10.1371/journal.pone.0181575	http://dx.doi.org/10.1371/journal.pone.0181575			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767662	Green Submitted, gold, Green Published			2022-12-26	WOS:000406768200029
J	Tokunaga, E; Akiyama, H; Soloshonok, VA; Inoue, Y; Hara, H; Shibata, N				Tokunaga, Etsuko; Akiyama, Hidehiko; Soloshonok, Vadim A.; Inoue, Yuki; Hara, Hideaki; Shibata, Norio			Biological evaluation of both enantiomers of fluoro-thalidomide using human myeloma cell line H929 and others	PLOS ONE			English	Article							CYTOCHROME-P450 3A ENZYMES; SELF-DISPROPORTIONATION; MULTIPLE-MYELOMA; IN-VITRO; ACHIRAL CHROMATOGRAPHY; OPTICAL PURIFICATIONS; ASYMMETRIC-SYNTHESIS; ANALOGS; ANGIOGENESIS; APOPTOSIS	Over the last few years, thalidomide has become one of the most important anti-tumour drugs for the treatment of relapsed-refractory multiple myeloma. However, besides its undesirable teratogenic side effect, its configurational instability critically limits any further therapeutic improvements of this drug. In 1999, we developed fluoro-thalidomide which is a bioisostere of thalidomide, but, in sharp contrast to the latter, it is configurationally stable and readily available in both enantiomeric forms. The biological activity of fluoro-thalidomide however, still remains virtually unstudied, with the exception that fluoro-thalidomide is not teratogenic. Herein, we report the first biological evaluation of fluoro-thalidomide in racemic and in both (R)- and (S)-enantiomerically pure forms against (in vitro) H929 cells of multiple myeloma (MM) using an annexin V assay. We demonstrate that all fluoro-thalidomides inhibited the growth of H929 MM cells without any in-vivo activation. Furthermore, we report that the enantiomeric forms of fluoro-thalidomide display different anti-tumour activities, with the (S)-enantiomer being noticeably more potent. The angiogenesis of fluoro-thalidomides is also investigated and compared to thalidomide. The data obtained in this study paves the way towards novel pharmaceutical research on fluoro-thalidomides.	[Tokunaga, Etsuko; Shibata, Norio] Nagoya Inst Technol, Dept Nanopharmaceut Sci, Nagoya, Aichi, Japan; [Akiyama, Hidehiko] Fujita Hlth Univ, Fac Med Technol, Toyoake, Aichi, Japan; [Soloshonok, Vadim A.] Univ Basque Country, UPV EHU, Fac Chem, Dept Organ Chem 1, San Sebastian, Spain; [Soloshonok, Vadim A.] Basque Fdn Sci Maria Diaz Haro, Ikerbasque, Bilbao, Spain; [Inoue, Yuki; Hara, Hideaki] Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Mol Pharmacol, Gifu, Japan	Nagoya Institute of Technology; Fujita Health University; University of Basque Country; Basque Foundation for Science; Gifu Pharmaceutical University	Shibata, N (corresponding author), Nagoya Inst Technol, Dept Nanopharmaceut Sci, Nagoya, Aichi, Japan.	nozshiba@nitech.ac.jp	Shibata, Norio/A-9628-2008	Shibata, Norio/0000-0002-3742-4064; Hara, Hideaki/0000-0003-2046-9001	Kobayashi International Foundation; Takeda Science Foundation, Japan; Japan Agency for Medical Research and Development (AMED); Advanced Catalytic Transformation (ACT-C) from the Japan Science and Technology (JST) Agency	Kobayashi International Foundation; Takeda Science Foundation, Japan(Takeda Science Foundation (TSF)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Advanced Catalytic Transformation (ACT-C) from the Japan Science and Technology (JST) Agency	This research is (partially) supported by Kobayashi International Foundation, a specific research grant from Takeda Science Foundation, Japan, the Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from Japan Agency for Medical Research and Development (AMED), the Advanced Catalytic Transformation (ACT-C) from the Japan Science and Technology (JST) Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Mr. Okiya Matsubara for kind assistance with the submission of this manuscript, and Mr. Hiroki Doi for his help of biological assay. Funding Statement: This research is (partially) supported by Kobayashi International Foundation, a specific research grant from Takeda Science Foundation, Japan, the Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from Japan Agency for Medical Research and Development (AMED), the Advanced Catalytic Transformation (ACT-C) from the Japan Science and Technology (JST) Agency.	Akiyama Hidehiko, 2003, Rinsho Byori, V51, P733; Bartlett JB, 2004, NAT REV CANCER, V4, P314, DOI 10.1038/nrc1323; BLASCHKE G, 1989, ARZNEIMITTEL-FORSCH, V39-1, P293; BRAUN AG, 1986, TOXICOL APPL PHARM, V82, P175, DOI 10.1016/0041-008X(86)90449-7; Burkle A, 2005, INT J BIOCHEM CELL B, V37, P1043, DOI 10.1016/j.biocel.2004.10.006; Cevatemre B, 2016, CHEM-BIOL INTERACT, V260, P248, DOI 10.1016/j.cbi.2016.10.001; Chikaraishi Y, 2008, EXP EYE RES, V86, P131, DOI 10.1016/j.exer.2007.10.003; Chowdhury G, 2010, CHEM RES TOXICOL, V23, P1018, DOI 10.1021/tx900367p; Chung F, 2003, ONCOL RES, V14, P75, DOI 10.3727/000000003108748621; Cornelissen M, 2002, APOPTOSIS, V7, P41; Creagh EM, 2014, TRENDS IMMUNOL, V35, P631, DOI 10.1016/j.it.2014.10.004; Dalvit C, 2013, J FLUORINE CHEM, V152, P129, DOI 10.1016/j.jfluchem.2013.01.017; Diggle GE, 2001, INT J CLIN PRACT, V55, P627; Einsele H, 2017, LEUKEMIA, V31, P1463, DOI 10.1038/leu.2017.83; Engelhardt M, 2014, RECENT RESULTS CANC, V201, P359, DOI 10.1007/978-3-642-54490-3_22; ERIKSSON T, 1995, CHIRALITY, V7, P44, DOI 10.1002/chir.530070109; Feng N, 2016, SCI REP-UK, V6, DOI 10.1038/srep27280; Gockel HR, 2004, J IMMUNOL, V172, P5103, DOI 10.4049/jimmunol.172.8.5103; GORDON GB, 1981, P NATL ACAD SCI-BIOL, V78, P2545, DOI 10.1073/pnas.78.4.2545; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Guirguis AA, 2015, CURR OPIN CELL BIOL, V37, P61, DOI 10.1016/j.ceb.2015.10.004; Han JL, 2011, CURR ORG SYNTH, V8, P310, DOI 10.2174/157017911794697303; HENDRICKX AG, 1990, J MED PRIMATOL, V19, P81; Ito T, 1997, J BIOL CHEM, V272, P11671, DOI 10.1074/jbc.272.18.11671; Izawa K, 2016, EUR J ORG CHEM, V2016, P8, DOI 10.1002/ejoc.201501158; Kim DH, 2006, NUCL MED BIOL, V33, P255, DOI 10.1016/j.nucmedbio.2005.12.003; Kukhar VP, 2009, FUTURE MED CHEM, V1, P793, DOI 10.4155/FMC.09.70; Lee CJJ, 2011, TOXICOL SCI, V122, P157, DOI 10.1093/toxsci/kfr086; Liu WM, 2004, HEMATOL J, V5, P247, DOI 10.1038/sj.thj.6200351; Lu J, 2003, CLIN CANCER RES, V9, P1680; Maeno M, 2015, CHEM SCI, V6, P1043, DOI 10.1039/c4sc03047h; Majumder S, 2009, BRIT J PHARMACOL, V158, P1720, DOI 10.1111/j.1476-5381.2009.00446.x; Man HW, 2009, J MED CHEM, V52, P1522, DOI 10.1021/jm900210d; Man HW, 2003, BIOORG MED CHEM LETT, V13, P3415, DOI 10.1016/S0960-894X(03)00778-9; Meyring M, 2002, ANAL CHEM, V74, P3726, DOI 10.1021/ac0203138; Miller MT, 2011, CURR OPIN OPHTHALMOL, V22, P356, DOI 10.1097/ICU.0b013e3283499f24; Muller GW, 1996, J MED CHEM, V39, P3238, DOI 10.1021/jm9603328; Murayama N, 2014, CHEM RES TOXICOL, V27, P304, DOI 10.1021/tx4004374; Nakamura S, 2011, ARTERIOSCL THROM VAS, V31, P1041, DOI 10.1161/ATVBAHA.111.223594; Ng SSW, 2003, CANCER RES, V63, P3189; Nishiyama S, 2015, CHEM RES TOXICOL, V28, P2088, DOI 10.1021/acs.chemrestox.5b00381; Ogawa S, 2010, J FLUORINE CHEM, V131, P521, DOI 10.1016/j.jfluchem.2009.12.002; Ogbomo H, 2008, NEOPLASIA, V10, P1402, DOI 10.1593/neo.08972; Osipov SN, 2004, TETRAHEDRON, V60, P271, DOI 10.1016/j.tet.2003.11.027; Powell RJ, 1999, BIODRUGS, V11, P409, DOI 10.2165/00063030-199911060-00005; Rajkumar SV, 2001, LEUKEMIA, V15, P1274, DOI 10.1038/sj.leu.2402183; Shalini S, 2015, CELL DEATH DIFFER, V22, P526, DOI 10.1038/cdd.2014.216; Sherbet GV, 2015, ANTICANCER RES, V35, P5767; Smart BE, 2001, J FLUORINE CHEM, V109, P3, DOI 10.1016/S0022-1139(01)00375-X; Soloshonok VA, 2012, CHEM SOC REV, V41, P4180, DOI 10.1039/c2cs35006h; Soloshonok VA, 2009, FUTURE MED CHEM, V1, P897, DOI 10.4155/FMC.09.63; Sorochinsky AE, 2013, CHIRALITY, V25, P365, DOI 10.1002/chir.22180; Sorochinsky AE, 2013, SYNTHESIS-STUTTGART, V45, P141, DOI 10.1055/s-0032-1316812; Stephens TD, 2000, BIOCHEM PHARMACOL, V59, P1489, DOI 10.1016/S0006-2952(99)00388-3; Suzuki E, 2001, ENANTIOMER, V6, P275; Takeuchi Y, 1999, ORG LETT, V1, P1571, DOI 10.1021/ol9902172; Teo SK, 2004, CLIN PHARMACOKINET, V43, P311, DOI 10.2165/00003088-200443050-00004; Thomas FXC, 2006, CURR PHARM DESIGN, V12, P1449; Ueki H, 2010, TETRAHEDRON-ASYMMETR, V21, P1396, DOI 10.1016/j.tetasy.2010.04.040; Vermes I, 2000, J IMMUNOL METHODS, V243, P167, DOI 10.1016/S0022-1759(00)00233-7; vom Hagen F, 2010, BRIT J OPHTHALMOL, V94, P504, DOI 10.1136/bjo.2009.158790; Wang J, 2014, CHEM REV, V114, P2432, DOI 10.1021/cr4002879; Weber D, 2003, J CLIN ONCOL, V21, P16, DOI 10.1200/JCO.2003.03.139; Weinlich R, 2011, TRENDS CELL BIOL, V21, P630, DOI 10.1016/j.tcb.2011.09.002; Wilkinson SM, 2015, AUST J CHEM, V68, P4, DOI 10.1071/CH14198; Yamada T, 2006, ORG LETT, V8, P5625, DOI 10.1021/ol0623668; Yamamoto T, 2011, ORG LETT, V13, P470, DOI 10.1021/ol102818g; Yamazaki H, 2011, CHEM RES TOXICOL, V24, P287, DOI 10.1021/tx200005g; Zhou Y, 2016, CHEM REV, V116, P422, DOI 10.1021/acs.chemrev.5b00392; Zhu W, 2014, J FLUORINE CHEM, V167, P37, DOI 10.1016/j.jfluchem.2014.06.026	70	16	16	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0182152	10.1371/journal.pone.0182152	http://dx.doi.org/10.1371/journal.pone.0182152			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763493	Green Published, gold			2022-12-26	WOS:000406766500047
J	Dong, B; Wu, B; Hong, WH; Li, XP; Li, Z; Xue, L; Huang, YF				Dong, Bin; Wu, Bin; Hong, Wenhong; Li, Xiuping; Li, Zhuo; Xue, Li; Huang, Yongfang			Transcriptome analysis of the tea oil camellia (Camellia oleifera) reveals candidate drought stress genes	PLOS ONE			English	Article							PHYSIOLOGICAL-RESPONSES; MICROSATELLITE MARKERS; IMPROVES DROUGHT; LOW-TEMPERATURE; ABSCISIC-ACID; WATER-STRESS; TOLERANCE; EXPRESSION; PLANT; IDENTIFICATION	Background The tea-oil camellia (Camellia oleifera) is the most important oil plant in southern China, and has a strong resistance to drought and barren soil. Understanding the molecular mechanisms of drought tolerance would greatly promote its cultivation and molecular breeding. Results In total, we obtained 76,585 unigenes with an average length of 810 bp and an N50 of 1,092 bp. We mapped all the unigenes to the NCBI 'nr' (non-redundant), SwissProt, KEGG, and clusters of orthologous groups (COG) databases, where 52,531 (68.6%) unigenes were functionally annotated. According to the annotation, 46,171 (60.8%) unigenes belong to 338 KEGG pathways. We identified a series of unigenes that are related to the synthesis and regulation of abscisic acid (ABA), the activity of protective enzymes, vitamin B6 metabolism, the metabolism of osmolytes, and pathways related to the biosynthesis of secondary metabolites. After exposed to drought for 12 hours, the number of differentially-expressed genes (DEGs) between treated plants and control plants increased in the G4 cultivar, while there was no significant increase in the drought-tolerant C3 cultivar. DEGs associated with drought stress responsive pathways were identified by KEGG pathway enrichment analysis. Moreover, we found 789 DEGs related to transcription factors. Finally, according to the results of qRT-PCR, the expression levels of the 20 unigenes tested were consistent with the results of next-generation sequencing. Conclusions In the present study, we identified a large set of cDNA unigenes from C. oleifera annotated using public databases. Further studies of DEGs involved in metabolic pathways related to drought stress and transcription will facilitate the discovery of novel genes involved in resistance to drought stress in this commercially important plant.	[Dong, Bin; Hong, Wenhong; Li, Xiuping; Xue, Li; Huang, Yongfang] South China Agr Univ, Guangzhou, Guangdong, Peoples R China; [Dong, Bin; Li, Xiuping] Guangdong Agr Ind Business Polytech, Guangzhou, Guangdong, Peoples R China; [Wu, Bin] DRIGEN Co Ltd, Shenzhen, Guangdong, Peoples R China; [Li, Zhuo] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China	South China Agricultural University; Chinese University of Hong Kong	Xue, L; Huang, YF (corresponding author), South China Agr Univ, Guangzhou, Guangdong, Peoples R China.	forxue@scau.edu.cn; hyfang@scau.edu.cn						Arunyanark A, 2008, J AGRON CROP SCI, V194, P113, DOI 10.1111/j.1439-037X.2008.00299.x; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bai ZY, 2017, SCI REP-UK, V7, DOI 10.1038/srep41700; Bhaskara GB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00484; Budak H, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01012; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chen YZ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00189; Chen YF, 2010, INT J MOL SCI, V11, P4417, DOI 10.3390/ijms11114417; Cheng LX, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0871-8; Cheng YT, 2014, J AGR FOOD CHEM, V62, P642, DOI 10.1021/jf404614k; Coello P, 2011, J EXP BOT, V62, P883, DOI 10.1093/jxb/erq331; de Zelicourt A, 2016, TRENDS PLANT SCI, V21, P677, DOI 10.1016/j.tplants.2016.04.004; Silvestre WVD, 2017, ACTA PHYSIOL PLANT, V39, DOI 10.1007/s11738-016-2301-9; Dubrovina AS, 2017, PLANT GROWTH REGUL, V82, P79, DOI 10.1007/s10725-016-0240-5; Elagib NA, 2014, ECOL INDIC, V43, P114, DOI 10.1016/j.ecolind.2014.02.033; Fiorentino A, 2007, MOLECULES, V12, P263, DOI 10.3390/12020263; Chu HD, 2016, INT J GENOMICS, V2016, DOI 10.1155/2016/5427062; Hamanishi ET, 2011, FORESTRY, V84, P273, DOI 10.1093/forestry/cpr012; Han BC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166975; Hayano-Kanashiro C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007531; Hu JJ, 2016, PAK J BOT, V48, P899; Hu Y, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1831-x; Izanloo A, 2008, J EXP BOT, V59, P3327, DOI 10.1093/jxb/ern199; Jaleel CA, 2009, INT J AGRIC BIOL, V11, P100; Jia BG, 2015, GENET MOL RES, V14, P6906, DOI 10.4238/2015.June.18.33; Kudo M, 2017, PLANT BIOTECHNOL J, V15, P458, DOI 10.1111/pbi.12644; Lee CP, 2006, J AGR FOOD CHEM, V54, P779, DOI 10.1021/jf052325a; Li J, 2015, BIOCHEM BIOPH RES CO, V459, P208, DOI 10.1016/j.bbrc.2015.02.052; Li KQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149352; Li L, 2015, SCI REP-UK, V5, DOI 10.1038/srep13033; Liang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep24265; Lu J, 2014, URBAN FOR URBAN GREE, V13, P682, DOI 10.1016/j.ufug.2014.08.003; Ma JL, 2011, J VERBRAUCH LEBENSM, V6, P9, DOI 10.1007/s00003-010-0581-3; Ma J, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00592; Mafakheri A, 2010, AUST J CROP SCI, V4, P580; Mohammadi MHS, 2017, PLANT PHYSIOL BIOCH, V111, P129, DOI 10.1016/j.plaphy.2016.11.014; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ng LM, 2011, P NATL ACAD SCI USA, V108, P21259, DOI 10.1073/pnas.1118651109; Nuccio ML, 2015, NAT BIOTECHNOL, V33, P862, DOI 10.1038/nbt.3277; Ogbaga CC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154423; Pang T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-488; Paul A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05932; Reddy MP, 2002, EUPHYTICA, V128, P9, DOI 10.1023/A:1020691618797; Redillas MCFR, 2012, PLANT BIOTECHNOL REP, V6, P89, DOI 10.1007/s11816-011-0210-3; Rosero C., 2011, BMC P, V5, P178; Ruszkowski M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00869; Shen JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep32005; Sheoran S, 2015, APPL BIOCHEM BIOTECH, V177, P1282, DOI 10.1007/s12010-015-1813-x; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Song H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35245; Sperdouli I, 2012, J PLANT PHYSIOL, V169, P577, DOI 10.1016/j.jplph.2011.12.015; Sperlich D., QUERCUS ILEX L J EXP; Tai YL, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0574-6; Tang S, 2015, PLANT MOL BIOL REP, V33, P424, DOI 10.1007/s11105-014-0759-4; VASQUEZTELLO A, 1990, J EXP BOT, V41, P827, DOI 10.1093/jxb/41.7.827; Vukosavljev M, 2015, MOL ECOL RESOUR, V15, P17, DOI 10.1111/1755-0998.12289; Wan J, 2009, CROP SCI, V49; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu XL, 2016, IND CROP PROD, V94, P385, DOI 10.1016/j.indcrop.2016.08.041; Xiong HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092913; Xu ZZ, 2010, PLANT SIGNAL BEHAV, V5, P649, DOI 10.4161/psb.5.6.11398; Yang GY, 2014, PLANT CELL TISS ORG, V117, P99, DOI 10.1007/s11240-014-0424-5; Ye YY, 2017, PLANT CELL REP, V36, P235, DOI 10.1007/s00299-016-2084-x; Ye Y, 2014, INT J NANOMED, V9, P4475, DOI 10.2147/IJN.S64313; Zeng XQ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2685-3; Zhang WX, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-S1-S7; Zhang XF, 2014, MOLECULES, V19, P7568, DOI 10.3390/molecules19067568; Zhou G, 2011, GLOBAL CHANGE BIOL, V17; Zivcak M, 2013, PHOTOSYNTH RES, V117, P529, DOI 10.1007/s11120-013-9885-3	70	29	33	9	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0181835	10.1371/journal.pone.0181835	http://dx.doi.org/10.1371/journal.pone.0181835			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759610	Green Submitted, Green Published, gold			2022-12-26	WOS:000406761600031
J	Hua, MC; Su, HM; Yao, TC; Kuo, ML; Lai, MW; Tsai, MH; Huang, JL				Hua, Man-Chin; Su, Hui-Min; Yao, Tsung-Chieh; Kuo, Ming-Ling; Lai, Ming-Wei; Tsai, Ming-Han; Huang, Jing-Long			Alternation of plasma fatty acids composition and desaturase activities in children with liver steatosis	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; METABOLIC SYNDROME; INSULIN-RESISTANCE; PALMITOLEIC ACID; ACTIVITY INDEXES; ADIPOSE-TISSUE; LIFE-STYLE; DISEASE; OBESITY; ASSOCIATION	Objective The aim of this study was to investigate changes in plasma fatty acids proportions and estimated desaturase activities for variable grading of liver steatosis in children. Methods In total, 111 schoolchildren (aged 8-18 years) were included in the analysis from March 2015 to August 2016. Anthropometric evaluation, liver ultrasound examination and scoring for nonalcoholic fatty liver disease (NAFLD score = 0-6), and biochemical and plasma fatty acids analysis were performed. We compared the composition ratio of fatty acids between children with high-grade liver steatosis (NAFLD score = 4-6), low-grade liver steatosis (NAFLD score = 1-3), and healthy controls (NAFLD score = 0). In addition, correlation coefficients (r) between NAFLD score, metabolic variables, and estimated activity of desaturase indices (stearoyl-coenzyme A desaturase-1 (SCD1), delta -5 and delta -6 desaturase) were calculated. Results Compared with healthy controls, children with liver steatosis showed a higher proportion of monounsaturated fatty acids (21.16 2.81% vs. 19.68 2.71%, p= 0.024). In addition, children with high- grade liver steatosis exhibited higher proportions of palmitic acid (C16:0), palmitoleic acid (C16:1 n-7), dihomo-y-linolenic acid (C20:3n-6), adrenic acid (C22:4n-6), and docosapentaenoic acid (C22:5n-6); and lower proportions of eicosapentaenoic acid (C20:5n-3) (P< 0.05). In all subjects, the NAFLD score was positively correlated with body mass index (BMI) (kg/m(2)) (r = 0.696), homeostasis model of assessment ratio index(HOMA-IR) (r = 0.510), SCD1 (16) (r = 0.273), and the delta-6 index (r = 0.494); and inversely associated with the delta-5 index (r = -0.443). Conclusion Our current data suggested that children with liver steatosis was highly associated with obesity, and insulin resistance. In addition, increased endogenous lipogenesis through altered desaturase activity may contribute to the progression of liver steatosis in children.	[Hua, Man-Chin; Tsai, Ming-Han] Chang Gung Mem Hosp, Dept Pediat, Keelung, Taiwan; [Hua, Man-Chin; Yao, Tsung-Chieh; Lai, Ming-Wei; Tsai, Ming-Han; Huang, Jing-Long] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Su, Hui-Min] Natl Taiwan Univ, Coll Med, Dept Physiol, Taipei, Taiwan; [Yao, Tsung-Chieh; Kuo, Ming-Ling; Huang, Jing-Long] Chang Gung Mem Hosp, Dept Pediat, Div Allergy Asthma & Rheumatol, Taoyuan, Taiwan; [Kuo, Ming-Ling] Chang Gung Univ, Dept Microbiol & Immunol, Grad Inst Biomed Sci, Coll Med, Taoyuan, Taiwan; [Lai, Ming-Wei] Chang Gung Mem Hosp, Linkou Branch, Dept Pediat, Div Gastroenterol, Taoyuan, Taiwan; [Lai, Ming-Wei] Chang Gung Mem Hosp, Linkou Branch, Liver Res Ctr, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Taiwan University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Hua, MC (corresponding author), Chang Gung Mem Hosp, Dept Pediat, Keelung, Taiwan.; Hua, MC; Huang, JL (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.; Huang, JL (corresponding author), Chang Gung Mem Hosp, Dept Pediat, Div Allergy Asthma & Rheumatol, Taoyuan, Taiwan.	menchin@cgmh.org.tw; long@cgmh.org.tw		Huang, Jing-Long/0000-0001-9280-920X; SU, HUI-MIN/0000-0002-9970-4459; Huang, Jing-Long/0000-0002-3530-7753	Chang Gung Memorial Hospital, Keelung, Taiwan [CMRPG 2E0131-32]	Chang Gung Memorial Hospital, Keelung, Taiwan(Chang Gung Memorial Hospital)	This study was funded by grants from Chang Gung Memorial Hospital, Keelung, Taiwan (CMRPG 2E0131-32). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araya J, 2004, CLIN SCI, V106, P635, DOI 10.1042/CS20030326; Berardis S, 2014, EUR J PEDIATR, V173, P131, DOI 10.1007/s00431-013-2157-6; Boden G, 2008, ENDOCRIN METAB CLIN, V37, P635, DOI 10.1016/j.ecl.2008.06.007; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Chen W, 2010, PEDIATR NEONATOL, V51, P69, DOI 10.1016/S1875-9572(10)60014-9; Day CP, 2011, CLIN MED, V11, P176, DOI 10.7861/clinmedicine.11-2-176; De Almeida IT, 2002, CLIN NUTR, V21, P219, DOI 10.1054/clnu.2001.0529; Dimopoulos N, 2006, BIOCHEM J, V399, P473, DOI 10.1042/BJ20060244; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Giorgio V, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-40; Graif M, 2000, INVEST RADIOL, V35, P319, DOI 10.1097/00004424-200005000-00006; Hamaguchi M, 2007, AM J GASTROENTEROL, V102, P2708, DOI 10.1111/j.1572-0241.2007.01526.x; He XX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162368; Hofacer R, 2012, PROSTAG LEUKOTR ESS, V86, P71, DOI 10.1016/j.plefa.2011.10.003; Hofacer R, 2011, NUTR RES, V31, P715, DOI 10.1016/j.nutres.2011.08.007; Ibrahim SH, 2011, J PEDIATR GASTR NUTR, V53, P109, DOI 10.1097/MPG.0b013e31820e82a1; JOSEPH AEA, 1991, CLIN RADIOL, V43, P26, DOI 10.1016/S0009-9260(05)80350-2; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kelishadi R, 2009, DIABETOL METAB SYNDR, V1, DOI 10.1186/1758-5996-1-29; Lee JJ, 2015, AM J CLIN NUTR, V101, P34, DOI 10.3945/ajcn.114.092262; Lopez-Vicario C, 2014, GUT, V63, P344, DOI 10.1136/gutjnl-2012-303179; Mangravite LM, 2007, AM J CLIN NUTR, V86, P759, DOI 10.1093/ajcn/86.3.759; Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5; Marzuillo P, 2014, WORLD J HEPATOL, V6, P217, DOI 10.4254/wjh.v6.i4.217; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moser AB, 1999, NEUROCHEM RES, V24, P187, DOI 10.1023/A:1022549618333; Nehra V, 2001, DIGEST DIS SCI, V46, P2347, DOI 10.1023/A:1012338828418; Nobili V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088005; Okada T, 2005, AM J CLIN NUTR, V82, P747, DOI 10.1093/ajcn/82.4.747; Peter A, 2009, CLIN CHEM, V55, P2113, DOI 10.1373/clinchem.2009.127274; Reynoso R, 2003, MOL CELL BIOCHEM, V246, P155, DOI 10.1023/A:1023423005187; Schwimmer JB, 2006, PEDIATRICS, V118, P1388, DOI 10.1542/peds.2006-1212; Schwimmer JB, 2008, CIRCULATION, V118, P277, DOI 10.1161/CIRCULATIONAHA.107.739920; Simopoulos AP, 2011, WORLD REV NUTR DIET, V102, P10, DOI 10.1159/000327785; Smith BW, 2011, CRIT REV CL LAB SCI, V48, P97, DOI 10.3109/10408363.2011.596521; Spahis S, 2015, PROSTAG LEUKOTR ESS, V99, P25, DOI 10.1016/j.plefa.2015.04.010; Steffen LM, 2008, INT J OBESITY, V32, P1297, DOI 10.1038/ijo.2008.89; Tanaka N, 2008, J CLIN GASTROENTEROL, V42, P413, DOI 10.1097/MCG.0b013e31815591aa; Vinknes KJ, 2013, OBESITY, V21, pE294, DOI 10.1002/oby.20011; Walle P, 2016, METABOLISM, V65, P655, DOI 10.1016/j.metabol.2016.01.011; Warensjo E, 2006, NUTR METAB CARDIOVAS, V16, P128, DOI 10.1016/j.numecd.2005.06.001; Yamada K, 2015, LIVER INT, V35, P582, DOI 10.1111/liv.12685; Yao TC, 2011, J ASTHMA, V48, P503, DOI 10.3109/02770903.2011.576743; Zong G, 2013, AM J CLIN NUTR, V98, P319, DOI 10.3945/ajcn.113.061218	46	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0182277	10.1371/journal.pone.0182277	http://dx.doi.org/10.1371/journal.pone.0182277			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759573	Green Published, gold, Green Submitted			2022-12-26	WOS:000406761600070
J	Staveteig, S				Staveteig, Sarah			Fear, opposition, ambivalence, and omission: Results from a follow-up study on unmet need for family planning in Ghana	PLOS ONE			English	Article							FERTILITY PREFERENCES; QUALITATIVE METHODS; CONTRACEPTIVE USE; TIME DYNAMICS; WOMEN	Introduction Despite a relatively strong family planning program and regionally modest levels of fertility, Ghana recorded one of the highest levels of unmet need for family planning on the African continent in 2008. Unmet need for family planning is a composite measure based on apparent contradictions between women's reproductive preferences and practices. Women who want to space or limit births but are not using contraception are considered to have an unmet need for family planning. The study sought to understand the reasons behind high levels of unmet need for family planning in Ghana. Methods A mixed methods follow-up study was embedded within the stratified, two-stage cluster sample of the 2014 Ghana Demographic and Health Survey (GDHS). Women in 13 survey clusters who were identified as having unmet need, along with a reference group of current family planning users, were approached to be reinterviewed within an average of three weeks from their GDHS interview. Follow-up respondents were asked a combination of closed- and open-ended questions about fertility preferences and contraceptive use. Closed-ended responses were compared against the original survey; transcripts were thematically coded and analyzed using qualitative analysis software. Results Among fecund women identified by the 2014 GDHS as having unmet need, follow-up interviews revealed substantial underreporting of method use, particularly traditional methods. Complete postpartum abstinence was sometimes the intended method of family planning but was overlooked during questions about method use. Other respondents classified as having unmet need had ambivalent fertility preferences. In several cases, respondents expressed revised fertility preferences upon follow-up that would have made them ineligible for inclusion in the unmet need category. The reference group of family planning users also expressed unstable fertility preferences. Aversion to modern method use was generally more substantial than reported in the GDHS, particularly the risk of menstrual side effects, personal or partner opposition to family planning, and religious opposition to contraception.	[Staveteig, Sarah] Avenir Hlth, Glastonbury, CT 06033 USA; [Staveteig, Sarah] Demog & Hlth Surveys DHS Program, Rockville, MD 20850 USA		Staveteig, S (corresponding author), Avenir Hlth, Glastonbury, CT 06033 USA.; Staveteig, S (corresponding author), Demog & Hlth Surveys DHS Program, Rockville, MD 20850 USA.	sstaveteig@avenirhealth.org		Staveteig Ford, Sarah/0000-0003-4330-2917	United States Agency for International Development (USAID) through The Demographic and Health Surveys (DHS) Program [AIDOAA-C-13-00095]	United States Agency for International Development (USAID) through The Demographic and Health Surveys (DHS) Program(United States Agency for International Development (USAID))	This study was funded by the United States Agency for International Development (USAID) through The Demographic and Health Surveys (DHS) Program (#AIDOAA-C-13-00095). The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Adanu R M, 2012, Ghana Med J, V46, P58; Agadjanian V, 2005, POPUL RES POLICY REV, V24, P617, DOI 10.1007/s11113-005-5096-8; Andro A, 2001, POPULATION, V56, P721, DOI 10.2307/1534884; [Anonymous], 2015, UPTAKE DISCONTINUATI; Arnold, 1994, EVALUATION PAKISTAN; Aryeetey R, 2010, AFRICAN J REPROD HLT, V14; Bankole A, 1999, POPUL RES POLICY REV, V18, P579, DOI 10.1023/A:1006373106870; Becker S, 1999, INT FAM PLAN PERSPEC, V25, P172, DOI 10.2307/2991881; Bignami- Van Assche S, 2003, INDIVIDUAL CONSISTEN, pS1; Blanc AK, 2002, J BIOSOC SCI, V34, P475, DOI 10.1017/S0021932002004753; Bradley SEK, 2014, STUD FAMILY PLANN, V45, P123, DOI 10.1111/j.1728-4465.2014.00381.x; Bradley SarahE.K., 2012, DHS ANAL STUDIES; Brown W, 2014, STUD FAMILY PLANN, V45, P73, DOI 10.1111/j.1728-4465.2014.00377.x; Carr B, 2012, LANCET, V380, P80, DOI 10.1016/S0140-6736(12)60905-2; Casterline JB, 2003, INT FAM PLAN PERSPEC, V29, P158, DOI 10.2307/3181044; Casterline JB, 2000, POPUL DEV REV, V26, P691, DOI 10.1111/j.1728-4457.2000.00691.x; Cleland J, 2014, STUD FAMILY PLANN, V45, P105, DOI 10.1111/j.1728-4465.2014.00380.x; Crissman HP, 2012, STUD FAMILY PLANN, V43, P201, DOI 10.1111/j.1728-4465.2012.00318.x; DIXONMUELLER R, 1992, STUD FAMILY PLANN, V23, P330, DOI 10.2307/1966531; Eliason S, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-65; Finlay Jocelyn E, 2013, Int J Gynaecol Obstet, V123 Suppl 1, pe24, DOI 10.1016/j.ijgo.2013.07.008; Freedman R., 1974, CROSS CULTURAL COMP; Ghana Statistical Service Ghana Health Service and ICF International, 2015, GHAN DEM HLTH SURV 2; Ghana Statistical Service Ghana Health Service Macro International, 2009, GHAN MAT HLTH SURV 2; Ghana Statistical Service Research, 2008, GHAN DEM HLTH SURV 2; Hindin MJ, 2014, J FAM PLAN REPROD H, V40, P30, DOI 10.1136/jfprhc-2012-100464; Irwin S., 2010, HDB EMERGENT METHODS, P427; JOHNSON R. B., 2004, EDUC RESEARCHER, V33, P14, DOI 10.3102/0013189X033007014; Johnson-Hanks J, 2002, POPUL DEV REV, V28, P229, DOI 10.1111/j.1728-4457.2002.00229.x; Johnson- Hanks J., 2005, CURRENT ANTHR; Knodel J, 1997, POPUL DEV REV, V23, P847, DOI 10.2307/2137386; Kodzi IA, 2010, DEMOGR RES, V22, P965, DOI 10.4054/DemRes.2010.22.30; Kodzi IA, 2010, STUD FAMILY PLANN, V41, P45, DOI 10.1111/j.1728-4465.2010.00223.x; Machiyama K, 2014, STUD FAMILY PLANN, V45, P203, DOI 10.1111/j.1728-4465.2014.00385.x; Obermeyer CM, 1997, POPUL DEV REV, V23, P813, DOI 10.2307/2137381; Osei I, 2005, Afr J Reprod Health, V9, P76; Page HJ., 1981, CHILD SPACING TROPIC; Robey B, 1996, Popul Rep J, P1; Rossier C, 2014, STUD FAMILY PLANN, V45, P171, DOI 10.1111/j.1728-4465.2014.00383.x; SCHATZ E, 2003, DEMOGRAPHIC RES S, V0001; Schatz E, 2012, CULT HEALTH SEX, V14, P811, DOI 10.1080/13691058.2012.698309; Schatz E, 2012, POP STUD-J DEMOG, V66, P183, DOI 10.1080/00324728.2012.658851; Sedgh G, 2014, STUD FAMILY PLANN, V45, P301, DOI 10.1111/j.1728-4465.2014.00393.x; Sedgh G, 2014, STUD FAMILY PLANN, V45, P151, DOI 10.1111/j.1728-4465.2014.00382.x; Sennott C, 2012, INT PERSPECT SEX R H, V38, P34, DOI 10.1363/3803412; Singh S, 2012, ADDING IT COSTS BENE; Speizer IS, 2013, CONTRACEPTION, V88, P553, DOI 10.1016/j.contraception.2013.04.006; Stash S, 1999, STUD FAMILY PLANN, V30, P267, DOI 10.1111/j.1728-4465.1999..x; STAVETEIG S, 2017, GLOBAL HLTH ACTION, V10; TAN PC, 1994, STUD FAMILY PLANN, V25, P222, DOI 10.2307/2137905; Westoff C. F., 1988, International Family Planning Perspectives, V14, P45, DOI 10.2307/2947679; Westoff CF, 1998, INT FAM PLAN PERSPEC, V24, P12, DOI 10.2307/2991914; Westoff CF, 1991, UNMET NEED DEMAND FA	53	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0182076	10.1371/journal.pone.0182076	http://dx.doi.org/10.1371/journal.pone.0182076			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC3TH	28759624	Green Published, Green Submitted, gold			2022-12-26	WOS:000406761600049
J	Reis, MB; Pereira, PAT; Caetano, GF; Leite, MN; Galvao, AF; Paula-Silva, FWG; Frade, MAC; Faccioli, LH				Reis, Mouzarllem Barros; Tartari Pereira, Priscilla Aparecida; Caetano, Guilherme Ferreira; Leite, Marcel Nani; Galvao, Alyne Favero; Garcia Paula-Silva, Francisco Wanderley; Cipriani Frade, Marco Andrey; Faccioli, Lucia Helena			Lipoxin A(4) encapsulated in PLGA microparticles accelerates wound healing of skin ulcers	PLOS ONE			English	Article							HUMAN KERATINOCYTES; ARACHIDONIC-ACID; FIBRIN-GLUE; IN-VITRO; NEUTROPHILS; INFLAMMATION; MEDIATORS; MICROSPHERES; PHAGOCYTOSIS; MACROPHAGES	Lipoxin A(4) (LXA(4)) is involved in the resolution of inflammation and wound healing; however, it is extremely unstable. Thus, to preserve its biological activities and confer stability, we encapsulated LXA(4) in poly-lactic-co-glycolic acid (PLGA) microparticles (LXA(4)-MS) and assessed its application in treating dorsal rat skin lesions. Ulcers were sealed with fibrin adhesive and treated with either LXA(4)-MS, unloaded microparticles (Un-MS), soluble LXA(4), or PBS/glue (vehicle). All groups were compared at 0, 2, 7, and 14 days post-lesions. Our results revealed that LXA(4)-MS accelerated wound healing from day 7 and reduced initial ulcer diameters by 80%. Soluble LXA(4), Un-MS, or PBS closed wounds by 60%, 45%, and 39%, respectively. LXA(4)-MS reduced IL-1 beta and TNF-alpha, but increased TGF-beta, collagen deposition, and the number of blood vessels. Compared to other treatments, LXA(4)-MS reduced inflammatory cell numbers, myeloperoxidase (MPO) concentration, and metalloproteinase- 8 (MMP8) mRNA in scar tissue, indicating decreased neutrophil chemotaxis. In addition, LXA(4)-MS treatment increased macrophages and IL-4, suggesting a positive impact on wound healing. Finally, we demonstrated that WRW4, a selective LXA(4) receptor (ALX) antagonist, reversed healing by 50%, indicating that LXA(4) must interact with ALX to induce wound healing. Our results show that LXA(4)-MS could be used as a pharmaceutical formulation for the treatment of skin ulcers.	[Reis, Mouzarllem Barros; Tartari Pereira, Priscilla Aparecida; Galvao, Alyne Favero; Garcia Paula-Silva, Francisco Wanderley; Faccioli, Lucia Helena] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Anal Clin Toxicol & Bromatol, Ribeirao Preto, SP, Brazil; [Caetano, Guilherme Ferreira; Leite, Marcel Nani; Cipriani Frade, Marco Andrey] Univ Sao Paulo, Fac Med Ribeirao Preto, Div Dermatol, Dept Clin Med, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Faccioli, LH (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Anal Clin Toxicol & Bromatol, Ribeirao Preto, SP, Brazil.	faccioli@fcfrp.usp.br	Leite, Marcel Nani/D-1135-2015; Caetano, Guilherme/V-8978-2019; Pereira, Priscilla/AAA-5867-2020; de Paula e Silva, Francisco Wanderley Garcia Garcia/D-1712-2012; Frade, Marco Andrey Cipriani/G-1165-2012; Caetano, Guilherme F/D-8223-2013; Reis, Mouzarllem Barros/O-7635-2017; Faccioli, Lúcia Helena/AGH-5297-2022	Leite, Marcel Nani/0000-0002-2121-8688; Pereira, Priscilla/0000-0002-6659-2163; de Paula e Silva, Francisco Wanderley Garcia Garcia/0000-0001-8559-532X; Frade, Marco Andrey Cipriani/0000-0003-2700-5971; Reis, Mouzarllem Barros/0000-0002-7074-6532; Faccioli, Lúcia Helena/0000-0002-4999-8305	Sao Paulo Research Foundation (FAPESP) [2014/07125-6]; Conselho Nacional de Desenvolvimento Gientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/07125-6]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Gientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grants from Sao Paulo Research Foundation (FAPESP; grant #2014/07125-6) and Conselho Nacional de Desenvolvimento Gientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; grant #2014/07125-6) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). We would like to thank Dr. Celio Lopes Silva for providing PLGA and Ana Paula Masson, Izaira Tincani Brandao, Wendy Martin Rios and Guilherme Gelfuso for technical support.	Andrade TAM, 2011, BRAZ J MED BIOL RES, V44, P1036, DOI 10.1590/S0100-879X2011007500116; Bosanquet DC, 2014, WOUND REPAIR REGEN, V22, P143, DOI 10.1111/wrr.12149; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Caetano G. F., 2016, PHARM BIOL, P1; Caetano GF, 2015, J BIOMED MATER RES B, V103, P1013, DOI 10.1002/jbm.b.33277; Chiang N., 2017, MOL ASPECTS MED; Chiang N, 2006, PHARMACOL REV, V58, P463, DOI 10.1124/pr.58.3.4; Clish CB, 2000, J BIOL CHEM, V275, P25372, DOI 10.1074/jbc.M002863200; de Jalon EG, 2001, INT J PHARM, V226, P181, DOI 10.1016/S0378-5173(01)00811-0; DEAN RT, 1979, BIOCHIM BIOPHYS ACTA, V584, P57, DOI 10.1016/0304-4165(79)90235-6; dos Santos DF, 2011, EUR J PHARM SCI, V44, P580, DOI 10.1016/j.ejps.2011.10.005; dos Santos DF, 2009, EUR J PHARM SCI, V38, P548, DOI 10.1016/j.ejps.2009.10.003; Dovi JV, 2003, J LEUKOCYTE BIOL, V73, P448, DOI 10.1189/jlb.0802406; Fronza M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112297; Godson C, 2000, J IMMUNOL, V164, P1663, DOI 10.4049/jimmunol.164.4.1663; Gronert K, 2005, PROSTAG LEUKOTR ESS, V73, P221, DOI 10.1016/j.plefa.2005.05.009; HASTY KA, 1990, J BIOL CHEM, V265, P11421; Herrera BS, 2015, BIOCHEM BIOPH RES CO, V464, P1072, DOI 10.1016/j.bbrc.2015.07.076; Horch RE, 1998, CELL TRANSPLANT, V7, P309, DOI 10.1016/S0963-6897(98)00005-0; Horch RE, 2001, TRANSPLANT P, V33, P642, DOI 10.1016/S0041-1345(00)02181-3; Hu F, 2015, J DERMATOL SCI, V78, P181, DOI 10.1016/j.jdermsci.2015.03.009; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; Karlsson J, 2006, BIOCHEM PHARMACOL, V71, P1488, DOI 10.1016/j.bcp.2006.02.010; La Flamme AC, 2012, PLOS ONE, V7; Nicolete R, 2007, PROSTAG OTH LIPID M, V83, P121, DOI 10.1016/j.prostaglandins.2006.10.007; Nicolete R, 2011, INT IMMUNOPHARMACOL, V11, P1557, DOI 10.1016/j.intimp.2011.05.014; Nicolete R, 2009, INT J ANTIMICROB AG, V34, P365, DOI 10.1016/j.ijantimicag.2009.06.009; Nicolete R, 2008, EUR J PHARM BIOPHARM, V70, P784, DOI 10.1016/j.ejpb.2008.06.019; RONFARD V, 1991, BURNS, V17, P181, DOI 10.1016/0305-4179(91)90099-3; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Serhan CN, 2017, FASEB J, V31, P1273, DOI [10.1096/fj.201601222R, 10.1096/fj.201601222r]; Serhan CN, 2015, SEMIN IMMUNOL, V27, P200, DOI 10.1016/j.smim.2015.03.004; Serhan CN, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016311; SERHAN CN, 1990, J CLIN INVEST, V85, P772, DOI 10.1172/JCI114503; SERHAN CN, 1984, BIOCHEM BIOPH RES CO, V118, P943, DOI 10.1016/0006-291X(84)91486-4; SERHAN CN, 1984, P NATL ACAD SCI-BIOL, V81, P5335, DOI 10.1073/pnas.81.17.5335; Serhan CN, 2017, MOL ASPECTS MED; Shibata H, 1996, CLIN CHIM ACTA, V251, P53, DOI 10.1016/0009-8981(96)06292-4; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Sivamani RK, 2014, ADV WOUND CARE, V3, P476, DOI 10.1089/wound.2014.0523; Weinberger B, 2008, PEDIATR RES, V64, P393, DOI 10.1203/PDR.0b013e318180e4af; Wilgus TA, 2003, WOUND REPAIR REGEN, V11, P25, DOI 10.1046/j.1524-475X.2003.11106.x; Wong SL, 2015, NAT MED, V21, P815, DOI 10.1038/nm.3887	43	25	26	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0182381	10.1371/journal.pone.0182381	http://dx.doi.org/10.1371/journal.pone.0182381			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753648	gold, Green Published, Green Submitted			2022-12-26	WOS:000406579300063
J	Nakata, K; Sugi, Y; Narabayashi, H; Kobayakawa, T; Nakanishi, Y; Tsuda, M; Hosono, A; Kaminogawa, S; Hanazawa, S; Takahashi, K				Nakata, Kazuaki; Sugi, Yutaka; Narabayashi, Hikari; Kobayakawa, Tetsuro; Nakanishi, Yusuke; Tsuda, Masato; Hosono, Akira; Kaminogawa, Shuichi; Hanazawa, Shigemasa; Takahashi, Kyoko			Commensal microbiota-induced microRNA modulates intestinal epithelial permeability through the small GTPase ARF4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL; COLITIS; PATHWAY; PDCD4; HOST	The intestinal tract contains many commensal bacteria that modulate various physiological host functions. Dysbiosis of commensal bacteria triggers dysfunction of the intestinal epithelial barrier, leading to the induction or aggravation of intestinal inflammation. Toelucidate whether microRNA plays a role in commensal microbiome-dependent intestinal epithelial barrier regulation, we compared transcripts in intestinal epithelial cells (IECs) from conventional and germ-free mice and found that commensal bacteria induced the expression of miR-21-5p in IECs. miR-21-5p increased intestinal epithelial permeability and up-regulated ADP ribosylation factor 4 (ARF4), a small GTPase, in the IEC line Caco-2. We also found that ARF4 expression was up-regulated upon suppression of phosphatase and tensin homolog (PTEN) and programmed cell death 4 (PDCD4), which are known miR-21-5p targets, by RNAi. Furthermore, ARF4 expression in epithelial cells of the large intestine was higher in conventional mice than in germ-free mice. ARF4 suppression in the IEC line increased the expression of tight junction proteins and decreased intestinal epithelial permeability. These results indicate that commensal microbiomedependent miR-21-5p expression in IECs regulates intestinal epithelial permeability via ARF4, which may therefore represent a target for preventing or managing dysfunction of the intestinal epithelial barrier.	[Nakata, Kazuaki; Sugi, Yutaka; Narabayashi, Hikari; Kobayakawa, Tetsuro; Nakanishi, Yusuke; Tsuda, Masato; Hosono, Akira; Kaminogawa, Shuichi; Hanazawa, Shigemasa; Takahashi, Kyoko] Nihon Univ, Coll Bioresource Sci, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan	Nihon University	Takahashi, K (corresponding author), Nihon Univ, Coll Bioresource Sci, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan.	ktaka@brs.nihon-u.ac.jp			Japan Society for the Promotion of Science [KAKENHI 26450165]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by a grant from the Japan Society for the Promotion of Science (KAKENHI 26450165 to K. T.).	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Aggarwal S, 2011, BIOCHEM J, V433, P51, DOI 10.1042/BJ20100249; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bitomsky N, 2004, ONCOGENE, V23, P7484, DOI 10.1038/sj.onc.1208064; Biton M, 2011, NAT IMMUNOL, V12, P239, DOI 10.1038/ni.1994; Dalmasso G, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019293, 10.1371/journal.pone.0023806]; Citalan-Madrid AF, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.26938; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Langlois MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015742; Lee J. H., 2015, SCI REP, V5; Maudet C, 2014, FEBS LETT, V588, P4140, DOI 10.1016/j.febslet.2014.08.002; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Ohland CL, 2010, AM J PHYSIOL-GASTR L, V298, pG807, DOI 10.1152/ajpgi.00243.2009; Pruteanu M, 2013, AM J PHYSIOL-GASTR L, V305, pG740, DOI 10.1152/ajpgi.00316.2012; Pruteanu M, 2011, INFLAMM BOWEL DIS, V17, P1189, DOI 10.1002/ibd.21475; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Shi CZ, 2016, GUT, V65, P1470, DOI 10.1136/gutjnl-2014-308455; Singh N, 2012, INT J BIOL SCI, V8, P171, DOI 10.7150/ijbs.8.171; Smyth D, 2012, CELL MICROBIOL, V14, P1257, DOI 10.1111/j.1462-5822.2012.01796.x; Staedel C, 2013, CELL MICROBIOL, V15, P1496, DOI 10.1111/cmi.12159; Sugi V., 2016, PLOS ONE, V11; Takahashi K, 2009, J IMMUNOL, V183, P6522, DOI 10.4049/jimmunol.0901271; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tlaskalova-Hogenova H, 2011, CELL MOL IMMUNOL, V8, P110, DOI 10.1038/cmi.2010.67; Wu F, 2010, INFLAMM BOWEL DIS, V16, P1729, DOI 10.1002/ibd.21267; Ye DM, 2011, GASTROENTEROLOGY, V141, P1323, DOI 10.1053/j.gastro.2011.07.005; Zhang L, 2015, CELL BIOCHEM FUNCT, V33, P235, DOI 10.1002/cbf.3109; Zhang Y., 2015, BARRIERS, V3; Zhou QQ, 2015, GASTROENTEROLOGY, V148, P158, DOI 10.1053/j.gastro.2014.09.037; Zhou X, 2010, LAB INVEST, V90, P144, DOI 10.1038/labinvest.2009.126	33	61	66	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15426	15433		10.1074/jbc.M117.788596	http://dx.doi.org/10.1074/jbc.M117.788596			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28760826	Green Published, hybrid			2022-12-26	WOS:000410809800022
J	Kim, JG; Bae, SJ; Lee, HS; Park, JH; Kim, KW				Kim, Jeong-gyun; Bae, Sung-Jin; Lee, Hye Shin; Park, Ji-Hyeon; Kim, Kyu-Won			Claudin5a is required for proper inflation of Kupffer's vesicle lumen and organ laterality	PLOS ONE			English	Article							LEFT-RIGHT ASYMMETRY; BLOOD-BRAIN-BARRIER; CAPILLARY ENDOTHELIAL-CELLS; LEFT-RIGHT AXIS; ZEBRAFISH EMBRYO; CILIATED ORGAN; FLUID-FLOW; EXPRESSION; MORPHOGENESIS; MECHANISMS	Left-right asymmetric organ development is critical to establish a proper body plan of vertebrates. In zebrafish, the Kupffer's vesicle (KV) is a fluid-filled sac which controls asymmetric organ development, and a properly inflated KV lumen by means of fluid influx is a prerequisite for the asymmetric signal transmission. However, little is known about the components that support the paracellular tightness between the KV luminal epithelial cells to sustain hydrostatic pressure during KV lumen expansion. Here, we identified that the claudin5a (cldn5a) is highly expressed at the apical surface of KV epithelial cells and tightly seals the KV lumen. Downregulation of cldn5a in zebrafish showed a failure in organ laterality that resulted from malformed KV. In addition, accelerated fluid influx into KV by combined treatment of forskolin and 3-isobutyl-1-methylxanthine failed to expand the partially-formed KV lumen in cldn5a morphants. However, malformed KV lumen and defective heart laterality in cldn5a morphants were significantly rescued by exogenous cldn5a mRNA, suggesting that the tightness between the luminal epithelial cells is important for KV lumen formation. Taken together, these findings suggest that cldn5a is required for KV lumen inflation and left-right asymmetric organ development.	[Kim, Jeong-gyun] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea; [Bae, Sung-Jin; Lee, Hye Shin; Park, Ji-Hyeon; Kim, Kyu-Won] Seoul Natl Univ, SNU Harvard NeuroVasc Protect Res Ctr, Coll Pharm, Seoul, South Korea; [Bae, Sung-Jin; Lee, Hye Shin; Park, Ji-Hyeon; Kim, Kyu-Won] Seoul Natl Univ, Res Inst Pharmaceut Sci, Seoul, South Korea; [Kim, Kyu-Won] Seoul Natl Univ, Crop Biotechnol Inst, GreenBio Sci & Technol, Pyeongchang, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, KW (corresponding author), Seoul Natl Univ, SNU Harvard NeuroVasc Protect Res Ctr, Coll Pharm, Seoul, South Korea.; Kim, KW (corresponding author), Seoul Natl Univ, Res Inst Pharmaceut Sci, Seoul, South Korea.; Kim, KW (corresponding author), Seoul Natl Univ, Crop Biotechnol Inst, GreenBio Sci & Technol, Pyeongchang, South Korea.	qwonkim@snu.ac.kr	Bae, Sung-Jin/AAX-9144-2021; Kim, Kyu Won/AAJ-7213-2020	Bae, Sung-Jin/0000-0001-8975-0876	Global Research Laboratory (GRL) [2011-0021874]; Global Core Research Center (GCRC) [2011-0030001]; Bio & Medical Technology Development Program [NRF-2015M3A9E6028949]; NRF - Korean Ministry of Science, ICT and Future Planning [2015R1C1A2A01054446]; NRF - Ministry of Education [NRF-2017R1A6A3A11032239]	Global Research Laboratory (GRL); Global Core Research Center (GCRC); Bio & Medical Technology Development Program; NRF - Korean Ministry of Science, ICT and Future Planning; NRF - Ministry of Education	This work was supported by the Global Research Laboratory (GRL) Program (2011-0021874), the Global Core Research Center (GCRC) Program (2011-0030001), the Bio & Medical Technology Development Program (NRF-2015M3A9E6028949) and the NRF grant (2015R1C1A2A01054446) through the National Research Foundation (NRF; http://www.nrf.re.kr) funded by the Korean Ministry of Science, ICT and Future Planning, and Basic Science Research Program through the NRF funded by the Ministry of Education (NRF-2017R1A6A3A11032239). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamar E, 2010, DEV DYNAM, V239, P2980, DOI 10.1002/dvdy.22431; Ablooglu AJ, 2010, DEVELOPMENT, V137, P3449, DOI 10.1242/dev.045310; Amack JD, 2004, CURR BIOL, V14, P685, DOI 10.1016/j.cub.2004.04.002; Baker K, 2008, P NATL ACAD SCI USA, V105, P13924, DOI 10.1073/pnas.0802159105; Bisgrove BW, 2012, DEV BIOL, V363, P166, DOI 10.1016/j.ydbio.2011.12.030; Bisgrove BW, 2005, DEV BIOL, V287, P274, DOI 10.1016/j.ydbio.2005.08.047; Ceccaldi P-F, 2004, J Gynecol Obstet Biol Reprod (Paris), V33, P192; Compagnon J, 2014, DEV CELL, V31, P774, DOI 10.1016/j.devcel.2014.11.003; Cooper I, 2011, METHODS MOL BIOL, V762, P347, DOI 10.1007/978-1-61779-185-7_25; de Campos-Baptista MIM, 2008, DEV DYNAM, V237, P3624, DOI 10.1002/dvdy.21777; Ellertsdottir E, 2006, DEV DYNAM, V235, P1794, DOI 10.1002/dvdy.20800; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Francescatto L, 2010, DEVELOPMENT, V137, P2753, DOI 10.1242/dev.049627; Gokey JJ, 2016, DEV DYNAM, V245, P22, DOI [10.1002/dvdy.24355, 10.1002/DVDY.24355]; Hashimoto H, 2004, DEVELOPMENT, V131, P1741, DOI 10.1242/dev.01070; Horne-Badovinac S, 2003, SCIENCE, V302, P662, DOI 10.1126/science.1085397; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jeong JY, 2008, BRAIN RES BULL, V75, P619, DOI 10.1016/j.brainresbull.2007.10.043; Jia W, 2014, MOL MED REP, V9, P779, DOI 10.3892/mmr.2013.1875; Jurynec MJ, 2008, P NATL ACAD SCI USA, V105, P12485, DOI 10.1073/pnas.0806015105; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Krock BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104661; Lenhart KF, 2011, DEVELOPMENT, V138, P4405, DOI 10.1242/dev.071092; Lin AE, 2014, AM J MED GENET A, V164, P2581, DOI 10.1002/ajmg.a.36695; Liu DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021793; Long S, 2003, DEVELOPMENT, V130, P2303, DOI 10.1242/dev.00436; Lopes SS, 2010, DEVELOPMENT, V137, P3625, DOI 10.1242/dev.054452; Matsui T, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00027; Matsui T, 2012, CELL MOL LIFE SCI, V69, P3069, DOI 10.1007/s00018-012-0985-6; MCCOMB P, 1986, FERTIL STERIL, V46, P412; Nakamura T, 2012, DEVELOPMENT, V139, P3257, DOI 10.1242/dev.061606; Navis A, 2013, DEVELOPMENT, V140, P1703, DOI 10.1242/dev.091819; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Novodvorsky P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141611; Ohtsuki S, 2008, J NEUROCHEM, V104, P147, DOI 10.1111/j.1471-4159.2007.05008.x; Ohtsuki S, 2007, J CELL PHYSIOL, V210, P81, DOI 10.1002/jcp.20823; Oishi I, 2006, NAT GENET, V38, P1316, DOI 10.1038/ng1892; Oteiza P, 2008, DEVELOPMENT, V135, P2807, DOI 10.1242/dev.022228; Oteiza P, 2010, DEVELOPMENT, V137, P3459, DOI 10.1242/dev.049981; Pintado P, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.161102; Place ES, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171143; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Roxo-Rosa M, 2015, BIOL OPEN, V4, P1356, DOI 10.1242/bio.014076; Sakaguchi T, 2006, DEVELOPMENT, V133, P4063, DOI 10.1242/dev.02581; Sampaio P, 2014, DEV CELL, V29, P716, DOI 10.1016/j.devcel.2014.04.030; Schottenfeld J, 2007, DEVELOPMENT, V134, P1605, DOI 10.1242/dev.02827; Smith D J, 2014, Bioarchitecture, V4, P119, DOI 10.4161/19490992.2014.956593; Smith KA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002289; Wang GL, 2012, DEV BIOL, V370, P52, DOI 10.1016/j.ydbio.2012.07.019; Wang GL, 2011, DEVELOPMENT, V138, P45, DOI 10.1242/dev.052985; Wang XH, 2008, DEV DYNAM, V237, P3640, DOI 10.1002/dvdy.21771; Xie J, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-76; Yost HJ, 1999, CURR OPIN GENET DEV, V9, P422; Zhang JJ, 2010, P NATL ACAD SCI USA, V107, P1425, DOI 10.1073/pnas.0911996107; Zhang JF, 2016, DEVELOPMENT, V143, P2603, DOI 10.1242/dev.132969; Zhang M, 2012, DEVELOPMENT, V139, P2009, DOI 10.1242/dev.074435	58	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182047	10.1371/journal.pone.0182047	http://dx.doi.org/10.1371/journal.pone.0182047			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771527	Green Published, gold, Green Submitted			2022-12-26	WOS:000406853600059
J	Kumar, S; Subbarao, BL; Kumari, R; Hallan, V				Kumar, Surender; Subbarao, Burra L.; Kumari, Reenu; Hallan, Vipin			Molecular characterization of a novel cryptic virus infecting pigeonpea plants	PLOS ONE			English	Article							DEPENDENT RNA-POLYMERASE; DE-NOVO INITIATION; COMPLETE NUCLEOTIDE-SEQUENCES; DOUBLE-STRANDED-RNA; ACTIVE-SITE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; DISEASE VIRUS; CAJANUS-CAJAN; I-TASSER	A new member of the genus Deltapartitivirus was identified containing three dsRNAs with an estimated size of 1.71, 1.49 and 1.43 kb. The dsRNAs were extracted from symptomless pigeonpea [Cajanus cajan (L.) Millspaugh] plants cv. Erra Kandulu. This new virus with 4.64 kb genome was tentatively named Arhar cryptic virus-1 (ArCV-1). The genomic RNAs were amplified and characterized by sequence independent single primer amplification. The dsRNAs shared a highly conserved 16 nt 5' non-coding region (5'-GATAATGATCCAAGGA-3'). The largest dsRNA (dsRNA-1) was identified as the viral RNA dependent RNA polymerase (replicase), predicted to encode a putative 55.34 kDa protein (P1). The two other smaller dsRNAs (dsRNA-2 and dsRNA-3) predicted to encode for putative capsid proteins of 38.50kDa (P2) and 38.51kDa (P3), respectively. Phylogenetic analysis indicated that ArCV-1 formed a clade together with Fragaria chiloensis cryptic virus, Rosa multiflora cryptic virus and Rose cryptic virus-1, indicating that ArCV-1 could be a new member of the genus Deltapartitivirus. ArCV-1 3D(poi) structure revealed several interesting features. The 3D(poi) in its full-length shares structural similarities with members of the family Caliciviridaeand family Picornaviridae. In addition, fourth dsRNA molecule (dsRNA-2A), not related to ArCV-1 genome, was found in the same plant tissue. The dsRNA-2A (1.6 kb) encodes a protein (P4), with a predicted size of 44.5 kDa. P4 shares similarity with coat protein genes of several cryptic viruses, in particular the bipartite cryptic viruses including Raphanus sativus cryptic virus-3. This is the first report of occurrence of a cryptic virus in pigeonpea plants.	[Kumar, Surender] Acad Sci & Innovat Res AcSIR, CSIR IHBT Campus, Palampur, Himachal Prades, India; [Kumar, Surender; Kumari, Reenu; Hallan, Vipin] CSIR, Inst Himalayan Bioresource Technol, Dept Biotechnol, Plant Virus Lab, Palampur, Himachal Prades, India	Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT)	Hallan, V (corresponding author), CSIR, Inst Himalayan Bioresource Technol, Dept Biotechnol, Plant Virus Lab, Palampur, Himachal Prades, India.	hallan@ihbt.res.in	Kumari, Reenu/AAR-1044-2021	Kumari, Reenu/0000-0003-0213-9121; Hallan, Vipin/0000-0002-5189-7327	Indian Council of Medical research (ICMR), Govt. of India [45/59/2012PHA/BMS]; Council of Scientific & Industrial Research	Indian Council of Medical research (ICMR), Govt. of India(Indian Council of Medical Research (ICMR)); Council of Scientific & Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	A fellowship to SK from the Indian Council of Medical research (ICMR), Govt. of India; grant number 45/59/2012PHA/BMS and financial support from Council of Scientific & Industrial Research are duly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUELNASR MA, 1985, J GEN VIROL, V66, P2453, DOI 10.1099/0022-1317-66-11-2453; Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200; AHLQUIST P, 1985, J VIROL, V53, P536, DOI 10.1128/JVI.53.2.536-542.1985; Appleby TC, 2005, J VIROL, V79, P277, DOI 10.1128/JVI.79.1.277-288.2005; ARGOS P, 1988, NUCLEIC ACIDS RES, V16, P9909, DOI 10.1093/nar/16.21.9909; Arnold JJ, 1999, J BIOL CHEM, V274, P37060, DOI 10.1074/jbc.274.52.37060; BHATTIPROLU SL, 1993, J PHYTOPATHOL, V137, P55, DOI 10.1111/j.1439-0434.1993.tb01325.x; Blawid R, 2007, ARCH VIROL, V152, P1477, DOI 10.1007/s00705-007-0966-5; BLUMENTHAL T, 1980, P NATL ACAD SCI-BIOL, V77, P2601, DOI 10.1073/pnas.77.5.2601; BOCCARDO G, 1987, ADV VIRUS RES, V32, P171, DOI 10.1016/S0065-3527(08)60477-7; BURNS CC, 1989, J VIROL, V63, P4866, DOI 10.1128/JVI.63.11.4866-4874.1989; Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653; Castro C, 2009, NAT STRUCT MOL BIOL, V16, P212, DOI 10.1038/nsmb.1540; Chen L, 2006, ARCH VIROL, V151, P2077, DOI 10.1007/s00705-006-0765-4; Chen L, 2006, ARCH VIROL, V151, P849, DOI 10.1007/s00705-005-0685-8; Crotty S, 2003, J VIROL, V77, P5378, DOI 10.1128/JVI.77.9.5378-5388.2003; DEHAAN P, 1991, J GEN VIROL, V72, P2207, DOI 10.1099/0022-1317-72-9-2207; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461; DIAMOND SE, 1994, J VIROL, V68, P863, DOI 10.1128/JVI.68.2.863-876.1994; Elbeaino T, 2015, ARCH VIROL, V160, P2019, DOI 10.1007/s00705-015-2479-y; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferrer-Orta C, 2006, EMBO J, V25, P880, DOI 10.1038/sj.emboj.7600971; Ferrer-Orta C, 2006, CURR OPIN STRUC BIOL, V16, P27, DOI 10.1016/j.sbi.2005.12.002; Ferrer-Orta C, 2004, J BIOL CHEM, V279, P47212, DOI 10.1074/jbc.M405465200; Ferrer-Orta C, 2007, P NATL ACAD SCI USA, V104, P9463, DOI 10.1073/pnas.0700518104; Ferrer-Orta C, 2015, VIRUSES-BASEL, V7, P4438, DOI 10.3390/v7082829; Fullerton SWB, 2007, J VIROL, V81, P1858, DOI 10.1128/JVI.01462-06; Garriga D, 2007, P NATL ACAD SCI USA, V104, P20540, DOI 10.1073/pnas.0704447104; Ghabrial SA, 2005, VIRUS TAXONOMY, P580; GOELET P, 1982, P NATL ACAD SCI-BIOL, V79, P5818, DOI 10.1073/pnas.79.19.5818; Gohara DW, 2000, J BIOL CHEM, V275, P25523, DOI 10.1074/jbc.M002671200; Gong P, 2013, PLOS ONE; Gong P, 2010, P NATL ACAD SCI USA, V107, P22505, DOI 10.1073/pnas.1007626107; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; Gorbalenya AE, 2002, J MOL BIOL, V324, P47, DOI 10.1016/S0022-2836(02)01033-1; Graham SC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002085; Hansen JL, 1997, STRUCTURE, V5, P1109, DOI 10.1016/S0969-2126(97)00261-X; Hogbom M, 2009, J GEN VIROL, V90, P281, DOI 10.1099/vir.0.005629-0; HONDA A, 1986, J BIOL CHEM, V261, P5987; INOKUCHI Y, 1987, J VIROL, V61, P3946, DOI 10.1128/JVI.61.12.3946-3949.1987; JABLONSKI SA, 1991, J VIROL, V65, P4565, DOI 10.1128/JVI.65.9.4565-4572.1991; JABLONSKI SA, 1995, J VIROL, V69, P1532, DOI 10.1128/JVI.69.3.1532-1539.1995; KAMER G, 1984, NUCLEIC ACIDS RES, V12, P7269, DOI 10.1093/nar/12.18.7269; Kao CC, 2001, VIROLOGY, V287, P251, DOI 10.1006/viro.2001.1039; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440; KOONIN EV, 1991, J GEN VIROL, V72, P2197, DOI 10.1099/0022-1317-72-9-2197; KRONER P, 1989, J VIROL, V63, P5302, DOI 10.1128/JVI.63.12.5302-5309.1989; LARDER BA, 1987, NATURE, V327, P716, DOI 10.1038/327716a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee JH, 2011, J GEN VIROL, V92, P1607, DOI 10.1099/vir.0.031104-0; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; LONGSTAFF M, 1993, EMBO J, V12, P379, DOI 10.1002/j.1460-2075.1993.tb05669.x; Luque D, 2009, P NATL ACAD SCI USA, V106, P2148, DOI 10.1073/pnas.0808498106; Maan S, 2007, J VIROL METHODS, V143, P132, DOI 10.1016/j.jviromet.2007.02.016; Mielke N, 2007, J GEN VIROL, V88, P1337, DOI 10.1099/vir.0.82715-0; Mielke-Ehret N, 2012, VIRUSES-BASEL, V4, P1515, DOI 10.3390/v4091515; MORRIS TJ, 1979, PHYTOPATHOLOGY, V69, P854, DOI 10.1094/Phyto-69-854; NATSUAKI T, 1986, INTERVIROLOGY, V25, P69, DOI 10.1159/000149658; Nene YL, 1906, ANNOTATED BIBLIO PIG; Ng KKS, 2008, CURR TOP MICROBIOL, V320, P137; Ng KKS, 2004, J BIOL CHEM, V279, P16638, DOI 10.1074/jbc.M400584200; Ng KKS, 2002, J BIOL CHEM, V277, P1381, DOI 10.1074/jbc.M109261200; Nibert ML, 2014, VIRUS RES, V188, P128, DOI 10.1016/j.virusres.2014.04.007; O'Reilly EK, 1998, VIROLOGY, V252, P287, DOI 10.1006/viro.1998.9463; Pan JH, 2007, P NATL ACAD SCI USA, V104, P7385, DOI 10.1073/pnas.0611599104; Paul AV, 1998, NATURE, V393, P280, DOI 10.1038/30529; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Potgieter AC, 2009, J GEN VIROL, V90, P1423, DOI 10.1099/vir.0.009381-0; Ranjith-Kumar CT, 2002, J VIROL, V76, P12526, DOI 10.1128/JVI.76.24.12526-12536.2002; Ranjith-Kumar CT, 2002, J VIROL, V76, P12513, DOI 10.1128/JVI.76.24.12513-12525.2002; Rong R, 2002, VIRUS RES, V90, P217, DOI 10.1016/S0168-1702(02)00178-8; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sabanadzovic S, 2008, J PLANT PATHOL, V90, P287; Sabanadzovic S, 2011, VIRUS GENES, V43, P307, DOI 10.1007/s11262-011-0634-4; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANKAR S, 1992, J BIOL CHEM, V267, P10168; Sholders AJ, 2014, J MOL BIOL, V426, P1407, DOI 10.1016/j.jmb.2013.12.031; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; STEITZ TA, 1994, SCIENCE, V266, P2022, DOI 10.1126/science.7528445; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tao YZ, 2002, CELL, V111, P733, DOI 10.1016/S0092-8674(02)01110-8; Thompson AA, 2004, EMBO J, V23, P3462, DOI 10.1038/sj.emboj.7600357; TRAYNOR P, 1991, J VIROL, V65, P2807, DOI 10.1128/JVI.65.6.2807-2815.1991; Tzanetakis IE, 2008, VIRUS GENES, V36, P267, DOI 10.1007/s11262-007-0186-9; van Dijk AA, 2004, J GEN VIROL, V85, P1077, DOI 10.1099/vir.0.19731-0; Vemana K, 2014, PLANT DIS, V98, P287, DOI 10.1094/PDIS-07-13-0731-PDN; Verdaguer N, 2012, STRUCTURE, V20, P1448, DOI 10.1016/j.str.2012.08.014; Vives-Adrian L, 2014, J VIROL, V88, P5595, DOI 10.1128/JVI.03502-13; Willighagen E, 2007, NATURE P; Xu X, 2003, NUCLEIC ACIDS RES, V31, P7117, DOI 10.1093/nar/gkg916; Yang XR, 2012, STRUCTURE, V20, P1519, DOI 10.1016/j.str.2012.06.012; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	96	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0181829	10.1371/journal.pone.0181829	http://dx.doi.org/10.1371/journal.pone.0181829			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771507	Green Published, Green Submitted, gold			2022-12-26	WOS:000406853600038
J	Kwon, MJ; Yun, ST; Ham, B; Lee, JH; Oh, JS; Jheong, WW				Kwon, Man Jae; Yun, Seong-Taek; Ham, Baknoon; Lee, Jeong-Ho; Oh, Jun-Seop; Jheong, Weon-Wha			Impacts of leachates from livestock carcass burial and manure heap sites on groundwater geochemistry and microbial community structure	PLOS ONE			English	Article							WATER-QUALITY; BACTERIA; CONTAMINATION; KOREA; SOIL	We investigated the impacts of leachates from a swine carcass burial site and a cow manure heap on the geochemical and microbiological properties of agricultural water samples, including leachate, groundwater from monitoring wells and background wells, and stream water. The leachate from the livestock burial site showed extremely high electrical conductivity, turbidity, and major ion concentrations, but low redox potential and dissolved oxygen levels. The groundwater in the monitoring wells adjacent to both sites showed severe contamination from the leachate, as indicated by the increases in EC, turbidity, Cl-, and SO42-. Bacteria from the phylum Firmicutes and Bacteriodetes and Archaea from the phylum Euryarchaeota were the major phyla in both the leachates and manure heap. However, the class-or genus-level components of these phyla differed markedly between the leachate and manure heap samples. The relative abundance of Firmicutes decreased from 35% to 0.3 similar to 13.9% in the monitoring wells and background wells at both sites. The Firmicutes in these wells was unlikely to have originated from the transportation of leachate to the surrounding environment because Firmicutes genera differed drastically between the leachate and monitoring wells. Meanwhile, sulfate-reducing bacteria (SRB) from the livestock carcass burial site were detected in the monitoring wells close to the leachate. This was likely because the release of carcass decomposition products, such as organic acids, to adjacent areas improved the suitability of the local environments for SRB, which were not abundant in the leachate. This study highlights the need to better understand microbial community dynamics along groundwater flow paths to evaluate bacterial transport in subsurface environments and provides new insights into the effective management of groundwater quality at both farm and regional scales.	[Kwon, Man Jae; Ham, Baknoon] Korea Inst Sci & Technol, Kangnung, South Korea; [Kwon, Man Jae; Yun, Seong-Taek; Ham, Baknoon] Korea Univ, KU KIST Green Sch, Seoul, South Korea; [Yun, Seong-Taek; Lee, Jeong-Ho; Oh, Jun-Seop] Korea Univ, Dept Earth & Environm Sci, Seoul, South Korea; [Jheong, Weon-Wha] Natl Inst Environm Res, Incheon, South Korea	Korea Institute of Science & Technology (KIST); Korea University; Korea University; National Institute of Environmental Research (NIER), Republic of Korea	Kwon, MJ (corresponding author), Korea Inst Sci & Technol, Kangnung, South Korea.; Kwon, MJ; Yun, ST (corresponding author), Korea Univ, KU KIST Green Sch, Seoul, South Korea.; Yun, ST (corresponding author), Korea Univ, Dept Earth & Environm Sci, Seoul, South Korea.	mkwon@kist.re.kr; styun@korea.ac.kr		Yun, Seong-Taek/0000-0001-9443-2872; Weon-Hwa, Jheong/0000-0001-8752-607X	NIER; National Research Foundation of Korea - Ministry of Science and Technology of Korea (University Institute cooperation program); KIST-Gangneung Institute [2Z04221]	NIER; National Research Foundation of Korea - Ministry of Science and Technology of Korea (University Institute cooperation program); KIST-Gangneung Institute	This work was initially supported by the NIER project on the "Investigation of pathogenic microorganisms in groundwater around livestock burial sites." BNH was supported by a National Research Foundation of Korea Grant funded by the Ministry of Science and Technology of Korea (2016, University Institute cooperation program). This work was partially supported by the KIST-Gangneung Institute (Grant no. 2Z04221). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Armstrong P, 2016, HELIYON, V2, DOI 10.1016/j.heliyon.2016.e00070; Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Choi NC, 2013, ECON ENVIRON GEOL, V46, P345, DOI 10.9719/EEG.2013.46.4.345; Christian G, 2002, AQUAT MICROB ECOL, V28, P117; DAVIS SN, 1980, GROUND WATER, V18, P14, DOI 10.1111/j.1745-6584.1980.tb03366.x; DeFlaun MF, 1997, FEMS MICROBIOL REV, V20, P473, DOI 10.1016/S0168-6445(97)00027-2; Dekeirsschieter J, 2009, FORENSIC SCI INT, V189, P46, DOI 10.1016/j.forsciint.2009.03.034; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ferguson AS, 2007, J APPL MICROBIOL, V102, P1227, DOI 10.1111/j.1365-2672.2007.03398.x; Freedman R., 2003, WATER QUALITY IMPACT; Glanville TD, 2009, WATER AIR SOIL POLL, V198, P285, DOI 10.1007/s11270-008-9845-2; GRAN G, 1952, ANALYST, V77, P661, DOI 10.1039/an9527700661; Gwyther CL, 2011, WASTE MANAGE, V31, P767, DOI 10.1016/j.wasman.2010.12.005; Han YC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00989; Hobson P. N., 2012, RUMEN MICROBIAL ECOS, V2nd; Howard GT, 2010, INT BIODETER BIODEGR, V64, P300, DOI 10.1016/j.ibiod.2010.02.006; Hutchison ML, 2004, LETT APPL MICROBIOL, V39, P207, DOI 10.1111/j.1472-765X.2004.01564.x; JEFFREY DJ, 1995, REV SCI TECH OIE, V14, P57, DOI 10.20506/rst.14.1.828; Joung HK, 2013, INT J ENV RES PUB HE, V10, P7126, DOI 10.3390/ijerph10127126; Keener HM, 2000, APPL ENG AGRIC, V16, P681; Kim HS, 2012, GEOSCI J, V16, P479, DOI 10.1007/s12303-012-0036-1; Knight-Jones TJD, 2013, PREV VET MED, V112, P161, DOI 10.1016/j.prevetmed.2013.07.013; Kwon MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146689; Li XD, 2015, J ENVIRON QUAL, V44, P1435, DOI 10.2134/jeq2015.03.0139; Mao SY, 2015, SCI REP-UK, V5, DOI 10.1038/srep16116; Nelson WC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00713; Oliver DM, 2007, WATER AIR SOIL POLL, V185, P369, DOI 10.1007/s11270-007-9451-8; Palacios OA, 2017, AGR WATER MANAGE, V184, P19, DOI 10.1016/j.agwat.2017.01.001; 최낙철, 2013, [The journal of Engineering Geology, 지질공학], V23, P37; POMMEPUY M, 1992, WATER SCI TECHNOL, V25, P93, DOI 10.2166/wst.1992.0341; Pratt DL, 2010, ASABE CSBE N CENTR I, P10; Stefani FOP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128272; Stotzky G, 2000, SOIL BIOCH; Thayalakumaran T, 2008, AGR WATER MANAGE, V95, P103, DOI 10.1016/j.agwat.2007.09.003; Weiss S, 2016, INT J LEGAL MED, V130, P253, DOI 10.1007/s00414-015-1206-2; Yang H, 2016, SCI REP-UK, V6, DOI 10.1038/srep27427; Yang SH, 2015, GENET MOL BIOL, V38, P373, DOI 10.1590/S1415-475738320140252; Yuan Q, 2013, SCI TOTAL ENVIRON, V456, P246, DOI 10.1016/j.scitotenv.2013.03.083; Yuan Q, 2012, WASTE MANAGE, V32, P939, DOI 10.1016/j.wasman.2011.11.015	41	5	5	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182579	10.1371/journal.pone.0182579	http://dx.doi.org/10.1371/journal.pone.0182579			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771598	Green Published, gold, Green Submitted			2022-12-26	WOS:000406853600144
J	Montoliu-Gaya, L; Esquerda-Canals, G; Bronsoms, S; Villegas, S				Montoliu-Gaya, Laia; Esquerda-Canals, Gisela; Bronsoms, Silvia; Villegas, Sandra			Production of an anti-A beta antibody fragment in Pichia pastoris and in vitro and in vivo validation of its therapeutic effect	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; AMYLOID PEPTIDE; MONOCLONAL-ANTIBODIES; ENDOTOXIN REMOVAL; 3XTG-AD MICE; MOUSE MODEL; BRAIN; AGGREGATION; EXPRESSION; EPITOPE	ScFv-h3D6 has been shown as an efficient therapy in the 3xTg-AD mouse model of Alzheimer's Disease. Because one of the major bottlenecks for the therapeutic uses of proteins produced in Escherichia coli is their potential contamination with endotoxins, LPS were extensively removed by a rather low-efficient, expensive, and time-consuming purification step. In addition, disulfide scrambling is favored in the reducing bacterial cytoplasm albeit the use of reductase deficient strains. To overcome these hurdles, as well as to improve the yield, the yeast Pichia pastoris, an endotoxin-free host system for recombinant protein production, has been used to produce scFv-h3D6, both in flask and in a fed-batch bioreactor. Comparison of the thermal stability of the obtained protein with that from E. coli showed no differences. Opposite to the case of the protein obtained from E. coli, no disulfide scrambled conformations or LPS traces were detected in that produced in P. pastoris. Cytotoxicity assays in SH-SY5Y neuroblastoma cell-cultures demonstrated that proteins from both expression systems were similarly efficient in precluding A beta-induced toxicity. Finally, the 3xTg-AD mouse model was used to test the therapeutic effect of both proteins. Quantification of A beta levels from cortex and hippocampus protein extracts by ELISA, and A beta-immuno-histochemistry, showed that both proteins reduced A beta burden. This work demonstrates that scFv-h3D6 obtained from P. pastoris shows the same benefits as those already known for that obtained from E. coli, with multiple advantages in terms of recombinant production and safety.	[Montoliu-Gaya, Laia; Esquerda-Canals, Gisela; Villegas, Sandra] Univ Autonoma Barcelona, Prot Folding & Stabil Grp, Dept Bioquim & Biol Mol, Barcelona, Spain; [Esquerda-Canals, Gisela] Univ Autonoma Barcelona, Unitat Citol & Histol, Dept Biol Cel Lular Fisiol & Immunol, Barcelona, Spain; [Bronsoms, Silvia] Univ Autonoma Barcelona, Serv Proteom & Biol Estruct, Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona	Villegas, S (corresponding author), Univ Autonoma Barcelona, Prot Folding & Stabil Grp, Dept Bioquim & Biol Mol, Barcelona, Spain.	sandra.villegas@uab.cat	Villegas, Sandra/ABF-8206-2021; Villegas, Sandra/D-8789-2011	Villegas, Sandra/0000-0001-8644-4304; Villegas, Sandra/0000-0001-8644-4304; Bronsoms, Silvia/0000-0001-9763-762X	Institute de Salud Carlos III [FIS-PI113-01330]; Generalitat de Catalunya [2014-PROD00032]; FEDER; PIF-UAB student grants	Institute de Salud Carlos III(Instituto de Salud Carlos III); Generalitat de Catalunya(Generalitat de Catalunya); FEDER(European Commission); PIF-UAB student grants	This research was supported by grants Institute de Salud Carlos III [FIS-PI113-01330] (SV) and Generalitat de Catalunya [2014-PROD00032] (SV), both grants co-funded by FEDER. PIF-UAB student grants (LMG, GEC).	[Anonymous], PICH FERM PROC GUID; Arakawa T, 2014, ANTIBODIES, V3, P232, DOI 10.3390/antib3020232; Arias CAD, 2017, PLOS ONE, V12; Bacskai BJ, 2002, J NEUROSCI, V22, P7873; Bard F, 2003, P NATL ACAD SCI USA, V100, P2023, DOI 10.1073/pnas.0436286100; Birch JR, 2006, ADV DRUG DELIVER REV, V58, P671, DOI 10.1016/j.addr.2005.12.006; BRAKE AJ, 1984, P NATL ACAD SCI-BIOL, V81, P4642, DOI 10.1073/pnas.81.15.4642; Cao XD, 2015, BIOTECHNOL LETT, V37, P1347, DOI 10.1007/s10529-015-1804-6; Check E, 2002, NATURE, V415, P462, DOI 10.1038/415462a; Chen LH, 2006, PROTEIN EXPRES PURIF, V46, P495, DOI 10.1016/j.pep.2005.09.002; Daly R, 2005, J MOL RECOGNIT, V18, P119, DOI 10.1002/jmr.687; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Esquerda-Canals G, 2013, MABS-AUSTIN, V5, P660, DOI 10.4161/mabs.25428; Frenkel D, 1998, J NEUROIMMUNOL, V88, P85, DOI 10.1016/S0165-5728(98)00098-8; Frenkel D, 1999, J NEUROIMMUNOL, V95, P136, DOI 10.1016/S0165-5728(99)00003-X; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; Gimenez-Llort L, 2013, MABS-AUSTIN, V5, P665, DOI 10.4161/mabs.25424; GRINNA LS, 1989, YEAST, V5, P107, DOI 10.1002/yea.320050206; Gupta SK, 2017, CRIT REV MICROBIOL, V43, P31, DOI 10.3109/1040841X.2016.1150959; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hardy J, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P151; Higgins DR, 1995, CURRENT PROTOCOLS PR; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Hoogenboom HR, 1998, IMMUNOTECHNOLOGY, V4, P1, DOI 10.1016/S1380-2933(98)00007-4; JULIUS D, 1984, CELL, V37, P1075, DOI 10.1016/0092-8674(84)90442-2; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; Liu SG, 1997, CLIN BIOCHEM, V30, P455, DOI 10.1016/S0009-9120(97)00049-0; Magalhaes PO, 2007, J PHARM PHARM SCI, V10, P388; Marin-Argany M, 2011, BIOCHEM J, V437, P25, DOI 10.1042/BJ20101712; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Montoliu-Gaya L, 2017, PROTEIN SCI; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Nielsen HM, 2010, GLIA, V58, P1235, DOI 10.1002/glia.21004; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Petsch D, 2000, J BIOTECHNOL, V76, P97, DOI 10.1016/S0168-1656(99)00185-6; Research C for DE and. Guidances (Drugs), GUID DRUGS GUID IND; Rivera-Hernandez G, 2013, MABS-AUSTIN, V5, P678, DOI 10.4161/mabs.25382; Solomon B, 1996, P NATL ACAD SCI USA, V93, P452, DOI 10.1073/pnas.93.1.452; Solomon B, 1997, P NATL ACAD SCI USA, V94, P4109, DOI 10.1073/pnas.94.8.4109; Song HN, 2014, INT J MOL SCI, V15, P23658, DOI 10.3390/ijms151223658; Spencer B, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00114; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Waldmann TA, 2003, NAT MED, V9, P269, DOI 10.1038/nm0303-269; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang J, 1999, EXP NEUROL, V158, P328, DOI 10.1006/exnr.1999.7085; Wilcock DM, 2004, J NEUROSCI, V24, P6144, DOI 10.1523/JNEUROSCI.1090-04.2004; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245	50	17	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0181480	10.1371/journal.pone.0181480	http://dx.doi.org/10.1371/journal.pone.0181480			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771492	Green Published, Green Submitted, gold			2022-12-26	WOS:000406853600022
J	Park, G; Kim, SY; Song, YJ				Park, Gayoung; Kim, Sun Yeou; Song, Yoon-Jae			Ester alkaloids from Cephalotaxus interfere with the 2'3'-cGAMP-induced type I interferon pathway in vitro	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; INFLAMMATORY DISEASE; SELF-DNA; HOMOHARRINGTONINE; CELLS; APOPTOSIS; KOREANA; SENSOR	Dysregulated activation of the cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) pathway by self-DNA contributes to interferonopathy and promotes autoimmune diseases. To identify potential suppressors of STING-induced type I interferon (IFN) induction, ethanol extracts of medicinal plants were screened for inhibitory activity against IFN-beta promoter activation. Notably, 70% ethanol extract of Cephalotaxus koreana specifically down-regulated STING-induced, but not TBK1-or IRF3-induced, IFN-beta promoter activity. The compounds exerting inhibitory activity specifically against STING-mediated IFN-beta promoter activation were identified as ester alkaloids isolated from the genus, Cephalotaxus, homoharringtonine and harringtonine. Furthermore, these two compounds inhibited 2'3'-cGAMP-induced IFN-stimulated gene expression and interaction between STING and TBK1. These suppressive effects were not observed with cephalotaxine devoid of the ester side-chain. Our data support the potential utility of homoharringtonine and harringtonine to treat STING-associated interferonopathy and autoimmune diseases.	[Park, Gayoung; Song, Yoon-Jae] Gachon Univ, Dept Life Sci, Seongnam Si, Kyeonggi Do, South Korea; [Kim, Sun Yeou] Gachon Univ, Coll Pharm, Lab Pharmacognosy, Incheon, South Korea	Gachon University; Gachon University	Song, YJ (corresponding author), Gachon Univ, Dept Life Sci, Seongnam Si, Kyeonggi Do, South Korea.	songyj@gachon.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education of Korea [2014R1A1A2056381]; Bio & Medical Technology Development Program through the NRF - Ministry of Science, ICT & Future Planning [2014M3A9B6069336]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education of Korea; Bio & Medical Technology Development Program through the NRF - Ministry of Science, ICT & Future Planning	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education of Korea (2014R1A1A2056381) and the Bio & Medical Technology Development Program through the NRF funded by the Ministry of Science, ICT & Future Planning (2014M3A9B6069336). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Seung-Chul Kim (Sungkyunkwan University, Korea) for collecting and providing the plant material. This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education of Korea (2014R1A1A2056381) and the Bio & Medical Technology Development Program through the NRF funded by the Ministry of Science, ICT & Future Planning (2014M3A9B6069336).	Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640; Ahn J, 2014, CURR OPIN IMMUNOL, V31, P121, DOI 10.1016/j.coi.2014.10.009; Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Barber GN, 2014, TRENDS IMMUNOL, V35, P88, DOI 10.1016/j.it.2013.10.010; Burdette DL, 2013, NAT IMMUNOL, V14, P19, DOI 10.1038/ni.2491; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cao W, 2015, SCI REP-UK, V5, DOI 10.1038/srep08477; Chen R, 2011, BLOOD, V117, P156, DOI 10.1182/blood-2010-01-262808; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Grieves JL, 2015, P NATL ACAD SCI USA, V112, P5117, DOI 10.1073/pnas.1423804112; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kang SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082688; Kantarjian HM, 2001, CANCER-AM CANCER SOC, V92, P1591, DOI 10.1002/1097-0142(20010915)92:6<1591::AID-CNCR1485>3.0.CO;2-U; Kim JE, 2014, MOL CELL BIOL, V34, P325, DOI 10.1128/MCB.00912-13; Kim WK, 2010, BIOTECHNOL BIOPROC E, V15, P481, DOI 10.1007/s12257-010-0053-8; Lau L, 2015, SCIENCE, V350, P568, DOI 10.1126/science.aab3291; Liu Q, 2007, J ORG CHEM, V72, P7352, DOI 10.1021/jo0710883; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Lu SQ, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-2; ODWYER PJ, 1986, J CLIN ONCOL, V4, P1563, DOI 10.1200/JCO.1986.4.10.1563; POWELL RG, 1972, J PHARM SCI-US, V61, P1227, DOI 10.1002/jps.2600610812; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; TUJEBAJEVA RM, 1992, BIOCHIM BIOPHYS ACTA, V1129, P177, DOI 10.1016/0167-4781(92)90484-H; Xiao TS, 2013, MOL CELL, V51, P135, DOI 10.1016/j.molcel.2013.07.004; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yoon KD, 2010, B KOREAN CHEM SOC, V31, P495, DOI 10.5012/bkcs.2010.31.02.495; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146	28	4	4	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182701	10.1371/journal.pone.0182701	http://dx.doi.org/10.1371/journal.pone.0182701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771599	gold, Green Submitted, Green Published			2022-12-26	WOS:000406853600152
J	Pelaez, R; Morales, X; Salvo, E; Garasa, S; de Solorzano, CO; Martinez, A; Larrayoz, IM; Rouzaut, A				Pelaez, Rafael; Morales, Xabier; Salvo, Elizabeth; Garasa, Saray; Ortiz de Solorzano, Carlos; Martinez, Alfredo; Larrayoz, Ignacio M.; Rouzaut, Ana			beta 3 integrin expression is required for invadopodia-mediated ECM degradation in lung carcinoma cells	PLOS ONE			English	Article							HUMAN BREAST-CANCER; ACTIN POLYMERIZATION; ADHESION; PODOSOMES; ALPHA-V-BETA-3; ACTIVATION; ALPHA(V)BETA(3); METASTASIS; MATURATION; INVASION	Cancer related deaths are primarily due to tumor metastasis. To facilitate their dissemination to distant sites, cancer cells develop invadopodia, actin-rich protrusions capable of degrading the surrounding extracellular matrix (ECM). We aimed to determine whether beta 3 integrin participates in invadopodia formed by lung carcinoma cells, based on our previous findings of specific TGF-beta induction of beta 3 integrin dependent metastasis in animal models of lung carcinoma. In this study, we demonstrate that lung carcinoma cells form invadopodia in response to TGF-beta exposure. Invadopodia formation and degradation activity is dependent on beta 3 integrin expression since beta 3 integrin deficient cells are not able to degrade gelatin-coated surfaces. Even more, transient over-expression of SRC did not restore invadopodia formation in beta 3 integrin deficient cells. Finally, we observed that blockade of PLC-dependent signaling leads to more intense labeling for beta 3 integrin in invadopodia. Our results suggest that beta 3 integrin function, and location, in lung cancer cells are essential for invadopodia formation, and this integrin regulates the activation of different signal pathways necessary for the invasive structure. beta 3 integrin has been associated with poor prognosis and increased metastasis in several carcinoma types, including lung cancer. Our findings provide new evidence to support the use of targeted therapies against this integrin to combat the onset of metastases.	[Pelaez, Rafael; Morales, Xabier; Salvo, Elizabeth; Garasa, Saray; Rouzaut, Ana] Ctr Appl Med Res CIMA, Dept Oncol, Pamplona, Spain; [Pelaez, Rafael; Larrayoz, Ignacio M.] CIBIR, Biomarkers & Mol Signaling Grp, Neurodegenerat Dis Area, Ctr Biomed Res La Rioja, Logrono, Spain; [Morales, Xabier; Ortiz de Solorzano, Carlos] Ctr Appl Med Res, Div Solid Tumors & Biomarkers, Lab Preclin Models & Analyt Tools, Pamplona, Navarra, Spain; [Morales, Xabier; Ortiz de Solorzano, Carlos] CIBERONC, Pamplona, Navarra, Spain; [Garasa, Saray; Rouzaut, Ana] CIMA, Dept Immunol & Immunotherapy, Pamplona, Navarra, Spain; [Martinez, Alfredo] CIBIR, Ctr Biomed Res La Rioja, Oncol Area, Logrono, Spain; [Rouzaut, Ana] Univ Navarra, Dept Biochem & Genet, Pamplona, Spain; [Salvo, Elizabeth] NYU, Coll Dent, Bluestone Ctr Clin Res, New York, NY USA	CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; University of Navarra; University of Navarra; New York University	Pelaez, R; Rouzaut, A (corresponding author), Ctr Appl Med Res CIMA, Dept Oncol, Pamplona, Spain.; Pelaez, R; Larrayoz, IM (corresponding author), CIBIR, Biomarkers & Mol Signaling Grp, Neurodegenerat Dis Area, Ctr Biomed Res La Rioja, Logrono, Spain.; Rouzaut, A (corresponding author), CIMA, Dept Immunol & Immunotherapy, Pamplona, Navarra, Spain.; Rouzaut, A (corresponding author), Univ Navarra, Dept Biochem & Genet, Pamplona, Spain.	rpelaez@riojasalud.es; ilarrayoz@riojasalud.es; arouzaut@unav.es	Peláez, Rafael/R-9458-2019; Ortiz-de-Solorzano, Carlos/G-3278-2010; Martinez, Alfredo/GQH-5998-2022; Larrayoz, Ignacio M/I-5613-2012; Garasa, Saray/J-6602-2017; Rouzaut, Ana/I-2576-2017	Peláez, Rafael/0000-0002-4047-6017; Ortiz-de-Solorzano, Carlos/0000-0001-8720-0205; Martinez, Alfredo/0000-0003-4882-4044; Larrayoz, Ignacio M/0000-0003-1629-152X; Morales, Xabier/0000-0003-0303-9958; Garasa, Saray/0000-0001-5192-2599; Rouzaut, Ana/0000-0003-3226-9162	Spanish Ministry of Economy and Competitiveness /Torres Quevedo program [PTQ-11-04778]; Institute of Health Carlos III grant [PI10/02131, PI13/02313]; Spanish Ministry of Economy and Competitiveness [DPI2012-38090-C03-02, DPI2015-64221-C2-2]	Spanish Ministry of Economy and Competitiveness /Torres Quevedo program; Institute of Health Carlos III grant; Spanish Ministry of Economy and Competitiveness(Spanish Government)	RP was supported by Spanish Ministry of Economy and Competitiveness /Torres Quevedo program PTQ-11-04778. This work was funded by Institute of Health Carlos III grants [PI10/02131 (AR) and PI13/02313 (AR)] and Spanish Ministry of Economy and Competitiveness grants [DPI2012-38090-C03-02(COS) and DPI2015-64221-C2-2 (COS)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert JM, 2006, INT J RADIAT ONCOL, V65, P1536, DOI 10.1016/j.ijrobp.2006.04.036; Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; Anguiano M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171417; Artym VV, 2015, J CELL BIOL, V208, P331, DOI 10.1083/jcb.201405099; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Ayala I, 2008, J CELL SCI, V121, P369, DOI 10.1242/jcs.008037; Balanis Nikolas, 2012, Cell Logist, V2, P46; Beaty BT, 2014, EUR J CELL BIOL, V93, P438, DOI 10.1016/j.ejcb.2014.07.003; Branch KM, 2012, BIOL OPEN, V1, P711, DOI 10.1242/bio.20121867; Burger KL, 2014, PROSTATE, V74, P134, DOI 10.1002/pros.22735; Chan KT, 2009, J CELL BIOL, V185, P357, DOI 10.1083/jcb.200809110; Deryugina EI, 2001, EXP CELL RES, V263, P209, DOI 10.1006/excr.2000.5118; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Destaing O, 2010, MOL BIOL CELL, V21, P4108, DOI 10.1091/mbc.E10-07-0580; Enderling H, 2008, BIOPHYS J, V95, P2203, DOI 10.1529/biophysj.108.133199; Faccio R, 2003, J CELL BIOL, V162, P499, DOI 10.1083/jcb.200212082; Frittoli E, 2014, J CELL BIOL, V206, P307, DOI 10.1083/jcb.201403127; Furger KA, 2003, MOL CANCER RES, V1, P810; Galvez BG, 2002, J CELL BIOL, V159, P509, DOI 10.1083/jcb.200205026; Geblinger D, 2010, J CELL SCI, V123, P1503, DOI 10.1242/jcs.060954; Geletu M, 2013, ANTICANCER RES, V33, P4401; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hoshino D, 2013, J CELL SCI, V126, P2979, DOI 10.1242/jcs.079475; Irigoyen M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-130; Kaverina I, 2003, J CELL SCI, V116, P4915, DOI 10.1242/jcs.00818; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li LX, 2010, J CEREBR BLOOD F MET, V30, P1031, DOI 10.1038/jcbfm.2009.276; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Linder S, 2011, ANNU REV CELL DEV BI, V27, P185, DOI 10.1146/annurev-cellbio-092910-154216; Luo K, 2016, COLD SPRING HARB PER; Maher PA, 2000, EXP CELL RES, V260, P189, DOI 10.1006/excr.2000.5009; Mamuya FA, 2012, J CELL MOL MED, V16, P445, DOI 10.1111/j.1582-4934.2011.01419.x; Mandal S, 2008, EXP CELL RES, V314, P3478, DOI 10.1016/j.yexcr.2008.09.013; Marchan S, 2010, ANAL CELL PATHOL AMS, V1043; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; Miranti CK, 1998, CURR BIOL, V8, P1289, DOI 10.1016/S0960-9822(07)00559-3; Mori S, 2008, J BIOL CHEM, V283, P18066, DOI 10.1074/jbc.M801213200; Mueller SC, 1999, J BIOL CHEM, V274, P24947, DOI 10.1074/jbc.274.35.24947; Mulari M, 2003, MICROSC RES TECHNIQ, V61, P496, DOI 10.1002/jemt.10371; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Osborne SL, 2007, MOL CELL PROTEOMICS, V6, P1158, DOI 10.1074/mcp.M600430-MCP200; Ponceau A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120781; Roca-Cusachs P, 2009, P NATL ACAD SCI USA, V106, P16245, DOI 10.1073/pnas.0902818106; Salvo E, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-112; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; Scheppke L, 2012, BLOOD, V119, P2149, DOI 10.1182/blood-2011-04-348706; Seguin L, 2014, NAT CELL BIOL, V16, P457, DOI 10.1038/ncb2953; Sharma VP, 2013, CURR BIOL, V23, P2079, DOI 10.1016/j.cub.2013.08.044; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Smerling C, 2007, EXP CELL RES, V313, P3153, DOI 10.1016/j.yexcr.2007.06.003; Spinardi L, 2004, EXP CELL RES, V295, P360, DOI 10.1016/j.yexcr.2004.01.007; Stylli SS, 2012, J CLIN NEUROSCI, V19, P436, DOI 10.1016/j.jocn.2011.11.013; Su S, 2009, ONCOGENE, V28, P3047, DOI 10.1038/onc.2009.163; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Takayama S, 2005, ANTICANCER RES, V25, P79; Takkunen M, 2010, J CELL MOL MED, V14, P1569, DOI 10.1111/j.1582-4934.2009.00868.x; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Tome Y, 2013, ANTICANCER RES, V33, P3623; Ward DT, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015623.73739.B8; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; Worthington JJ, 2011, TRENDS BIOCHEM SCI, V36, P47, DOI 10.1016/j.tibs.2010.08.002; Xie LH, 2005, J GEN PHYSIOL, V126, P541, DOI 10.1085/jgp.200509380; Yamaguchi H, 2012, EUR J CELL BIOL, V91, P902, DOI 10.1016/j.ejcb.2012.04.005; Yamaguchi H, 2010, ONCOTARGET, V1, P320; ZAMBONINZALLONE A, 1989, EXP CELL RES, V182, P645, DOI 10.1016/0014-4827(89)90266-8	65	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0181579	10.1371/journal.pone.0181579	http://dx.doi.org/10.1371/journal.pone.0181579			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767724	Green Published, gold, Green Submitted			2022-12-26	WOS:000406768200030
J	Zhang, MH				Zhang, Minghuan			Formation flight and collision avoidance for multiple UAVs based on modified tentacle algorithm in unstructured environments	PLOS ONE			English	Article							UNMANNED AERIAL VEHICLES; RECEDING HORIZON CONTROL; OPTIMIZATION; AIRCRAFT	This paper presents a method for formation flight and collision avoidance of multiple UAVs. Due to the shortcomings such as collision avoidance caused by UAV's high-speed and unstructured environments, this paper proposes a modified tentacle algorithm to ensure the high performance of collision avoidance. Different from the conventional tentacle algorithm which uses inverse derivation, the modified tentacle algorithm rapidly matches the radius of each tentacle and the steering command, ensuring that the data calculation problem in the conventional tentacle algorithm is solved. Meanwhile, both the speed sets and tentacles in one speed set are reduced and reconstructed so as to be applied to multiple UAVs. Instead of path iterative optimization, the paper selects the best tentacle to obtain the UAV collision avoidance path quickly. The simulation results show that the method presented in the paper effectively enhances the performance of flight formation and collision avoidance for multiple high-speed UAVs in unstructured environments.	[Zhang, Minghuan] Northwestern Polytech Univ, Sch Astronaut, Xian, Shaanxi, Peoples R China	Northwestern Polytechnical University	Zhang, MH (corresponding author), Northwestern Polytech Univ, Sch Astronaut, Xian, Shaanxi, Peoples R China.	zhangmh@nwpu.edu.cn			China Space Foundation [N2015KC0121]	China Space Foundation	This work was supported by China Space Foundation (N2015KC0121).	Alonso-Mora J, 2015, AUTON ROBOT, V39, P101, DOI 10.1007/s10514-015-9429-0; Ambroziak L, 2015, AEROSP SCI TECHNOL, V46, P221, DOI 10.1016/j.ast.2015.07.015; Brodecki M, 2015, J GUID CONTROL DYNAM, V38, P1083, DOI 10.2514/1.G000220; Cao ZQ, 2002, PROCEEDINGS OF THE 4TH WORLD CONGRESS ON INTELLIGENT CONTROL AND AUTOMATION, VOLS 1-4, P1270, DOI 10.1109/WCICA.2002.1020786; Chao Z, 2012, MATH PROBL ENG, V2012, DOI 10.1155/2012/261367; Chen J, 2014, CHIN CONTR CONF, P1150, DOI 10.1109/ChiCC.2014.6896790; Cho H, 2015, J MECH SCI TECHNOL, V29, P3691, DOI 10.1007/s12206-015-0814-6; [邓婉 Deng Wan], 2011, [计算机仿真, Computer Simulation], V28, P73; Dong W, 2008, IET CONTROL THEORY A, V2, P1077, DOI 10.1049/iet-cta:20080183; Duan HB, 2010, IET CONTROL THEORY A, V4, P2565, DOI 10.1049/iet-cta.2009.0256; Duan HB, 2013, SCI CHINA TECHNOL SC, V56, P1066, DOI 10.1007/s11431-013-5199-0; Gageik N., 2015, ACCESS IEEE, V3; Hundelshausen F.., 2008, INT J FIELD ROBOTICS, P393; Kang S, 2013, INT J AERONAUT SPACE, V14, P75, DOI 10.5139/IJASS.2013.14.1.75; Li MJ, 2015, POLIT ASIA, P1; Li W, 2009, J SOFTW MAINT EVOL-R, V21, P19, DOI 10.1002/smr.397; Liu C, 2016, INTERNATIONAL CONFERENCE ON CONTROL AND AUTOMATION (ICCA 2016), P263; Ma Peibei, 2010, Acta Aeronautica et Astronautica Sinica, V31, P1660; PACHTER M, 1994, J GUID CONTROL DYNAM, V17, P1380, DOI 10.2514/3.21364; Paul T, 2008, SIMUL MODEL PRACT TH, V16, P1453, DOI 10.1016/j.simpat.2008.08.005; Qiu HX, 2014, NONLINEAR DYNAM, V78, P1973, DOI 10.1007/s11071-014-1579-7; Rinaldi F, 2013, J INTELL ROBOT SYST, V70, P203, DOI 10.1007/s10846-012-9708-3; Ru CJ, 2014, MATH PROBL ENG, V2014, DOI 10.1155/2014/835301; Ruchti J., 2011, CSSE1103 AUB U; Seo J, 2012, P I MECH ENG G-J AER, V226, P817, DOI 10.1177/0954410011415157; Shan J, 2008, IET CONTROL THEORY A, V2, P930, DOI 10.1049/iet-cta:20080063; Shanmugavel M, 2010, 2010 15TH INTERNATIONAL CONFERENCE ON METHODS AND MODELS IN AUTOMATION AND ROBOTICS (MMAR), P218, DOI 10.1109/MMAR.2010.5587231; Tang J, 2014, ARAB J SCI ENG, V39, P8409, DOI 10.1007/s13369-014-1368-0; Wan Jing, 2009, Journal of System Simulation, V21, P4183; [韦常柱 WEI Chang-zhu], 2010, [宇航学报, Journal of Chinese Society of Astronautics], V31, P1043; Xia YQ, 2016, ISA T, V61, P287, DOI 10.1016/j.isatra.2015.12.010; Xu J, 2014, J AIRCRAFT, V51, P490, DOI 10.2514/1.C032154; Yang Xiaolin, 2013, Evid Based Complement Alternat Med, V2013, P926928, DOI 10.1155/2013/926928; Yao P, 2015, AEROSP SCI TECHNOL, V47, P269, DOI 10.1016/j.ast.2015.09.037; Zhang L, 2014, APPL MECH MATER, V541-542, P1473, DOI 10.4028/www.scientific.net/AMM.541-542.1473; Zhen ZY, 2015, P I MECH ENG G-J AER, V229, P1813, DOI 10.1177/0954410014561703; Zhu LH, 2016, MEASUREMENT, V77, P40, DOI 10.1016/j.measurement.2015.09.006	37	8	8	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0182006	10.1371/journal.pone.0182006	http://dx.doi.org/10.1371/journal.pone.0182006			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763498	gold, Green Published, Green Submitted			2022-12-26	WOS:000406766500032
J	Hakre, S; Jagodzinski, LL; Liu, Y; Pham, PT; Kijak, GH; Tovanabutra, S; McCutchan, FE; Scoville, SL; Cersovsky, SB; Michael, NL; Scott, PT; Peel, SA				Hakre, Shilpa; Jagodzinski, Linda L.; Liu, Ying; Pham, Peter T.; Kijak, Gustavo H.; Tovanabutra, Sodsai; McCutchan, Francine E.; Scoville, Stephanie L.; Cersovsky, Steven B.; Michael, Nelson L.; Scott, Paul T.; Peel, Sheila A.			Characteristics of HIV-infected US Army soldiers linked in molecular transmission clusters, 2001-2012	PLOS ONE			English	Article							COST-EFFECTIVENESS; UNITED-STATES; SURVEILLANCE; OUTCOMES	Objective Recent surveillance data suggests the United States (U.S.) Army HIV epidemic is concentrated among men who have sex with men. To identify potential targets for HIV prevention strategies, the relationship between demographic and clinical factors and membership within transmission clusters based on baseline po/sequences of HIV-infected Soldiers from 2001 through 2012 were analyzed. Methods We conducted a retrospective analysis of baseline partial po/sequences, demographic and clinical characteristics available for all Soldiers in active service and newly-diagnosed with HIV-1 infection from January 1, 2001 through December 31, 2012. HIV-1 subtype designations and transmission clusters were identified from phylogenetic analysis of sequences. Univariate and multivariate logistic regression models were used to evaluate and adjust for the association between characteristics and cluster membership. Results Among 518 of 995 HIV-infected Soldiers with available partial po/sequences, 29% were members of a transmission cluster. Assignment to a southern U.S. region at diagnosis and year of diagnosis were independently associated with cluster membership after adjustment for other significant characteristics (p<0.10) of age, race, year of diagnosis, region of duty assignment, sexually transmitted infections, last negative HIV test, antiretroviral therapy, and transmitted drug resistance. Subtyping of the po/fragment indicated HIV-1 subtype B infection predominated (94%) among HIV-infected Soldiers. Conclusion These findings identify areas to explore as HIV prevention targets in the U.S. Army. An increased frequency of current force testing may be justified, especially among Soldiers assigned to duty in installations with high local HIV prevalence such as southern U.S. states.	[Hakre, Shilpa; Jagodzinski, Linda L.; Liu, Ying; Pham, Peter T.; Kijak, Gustavo H.; Tovanabutra, Sodsai; Michael, Nelson L.; Scott, Paul T.; Peel, Sheila A.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA; [Hakre, Shilpa; Liu, Ying; Pham, Peter T.; Kijak, Gustavo H.; Tovanabutra, Sodsai; McCutchan, Francine E.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA; [Scoville, Stephanie L.; Cersovsky, Steven B.] US Army Publ Hlth Ctr, Aberdeen Proving Ground, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Hakre, S (corresponding author), Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA.; Hakre, S (corresponding author), Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA.	shakre@hivresearch.org			U.S. Army Medical Research and Materiel Command [W81XWH-16-C-0225]; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-11-2-0174]; U.S. Department of Defense (DoD)	U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense (DoD)(United States Department of Defense)	This work was supported by the U.S. Army Medical Research and Materiel Command under Contract No W81XWH-16-C-0225 and by a cooperative agreement (W81XWH-11-2-0174) between The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), and the U.S. Department of Defense (DoD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, CTR DIS CONTR PREV S; [Anonymous], FACT SHEET; Bradley H, 2014, MMWR-MORBID MORTAL W, V63, P1113; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Buot MLG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091711; Centers for Disease Control and Prevention, 2012, SURV REP; Department of Health and Human Services, 2016, SERV DOHAH; Department of the Army, 2014, ARM REG; Forsyth AD, 2015, AIDS EDUC PREV, V27, P493, DOI 10.1521/aeap.2015.27.6.493; Hakre S, 2015, JAIDS-J ACQ IMM DEF, V70, P456, DOI 10.1097/QAI.0000000000000778; Hakre S, 2012, MIL MED, V177, P609, DOI 10.7205/MILMED-D-11-00386; Hutchinson Angela B, 2016, J Acquir Immune Defic Syndr, V71, P323, DOI 10.1097/QAI.0000000000000838; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Lucas A, 2013, AIDS, V27, P795, DOI 10.1097/QAD.0b013e32835c54f9; Moore RD, 2011, CLIN INFECT DIS, V52, pS208, DOI 10.1093/cid/ciq044; Oster AM, 2017, ANN EPIDEMIOL, V27, P244, DOI [10.1016/j.annepidem.2017.02.002, 10.1016/j.annePidem.2017.02.002]; Oster AM, 2015, JAIDS-J ACQ IMM DEF, V70, P444, DOI 10.1097/QAI.0000000000000809; Pacha LA, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002093; Reif S, 2011, THE LAST DECADE; Reif S, 2015, J COMMUN HEALTH, V40, P642, DOI 10.1007/s10900-014-9979-7; Rubertone MV, 2002, AM J PUBLIC HEALTH, V92, P1900, DOI 10.2105/AJPH.92.12.1900; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Zhang M, 2006, NUCLEIC ACIDS RES, V34, pW463, DOI 10.1093/nar/gkl255	23	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0182376	10.1371/journal.pone.0182376	http://dx.doi.org/10.1371/journal.pone.0182376			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759645	gold, Green Submitted, Green Published			2022-12-26	WOS:000406761600075
J	Han, YL; Zhao, YP; Wang, QS				Han, Yulan; Zhao, Yongping; Wang, Qisong			Dictionary learning based noisy image super-resolution via distance penalty weight model	PLOS ONE			English	Article							SPARSE REPRESENTATION; REGULARIZATION; INTERPOLATION	In this study, we address the problem of noisy image super-resolution. Noisy low resolution (LR) image is always obtained in applications, while most of the existing algorithms assume that the LR image is noise-free. As to this situation, we present an algorithm for noisy image super-resolution which can achieve simultaneously image super-resolution and denoising. And in the training stage of our method, LR example images are noise-free. For different input LR images, even if the noise variance varies, the dictionary pair does not need to be retrained. For the input LR image patch, the corresponding high resolution (HR) image patch is reconstructed through weighted average of similar HR example patches. To reduce computational cost, we use the atoms of learned sparse dictionary as the examples instead of original example patches. We proposed a distance penalty model for calculating the weight, which can complete a second selection on similar atoms at the same time. Moreover, LR example patches removed mean pixel value are also used to learn dictionary rather than just their gradient features. Based on this, we can reconstruct initial estimated HR image and denoised LR image. Combined with iterative back projection, the two reconstructed images are applied to obtain final estimated HR image. We validate our algorithm on natural images and compared with the previously reported algorithms. Experimental results show that our proposed method performs better noise robustness.	[Han, Yulan; Zhao, Yongping; Wang, Qisong] Harbin Inst Technol, Dept Automat Test & Control, Harbin, Heilongjiang, Peoples R China	Harbin Institute of Technology	Han, YL; Zhao, YP (corresponding author), Harbin Inst Technol, Dept Automat Test & Control, Harbin, Heilongjiang, Peoples R China.	hanyulanbox@126.com; zhaoyp2590@126.com						Chang H, 2004, PROC CVPR IEEE, P275, DOI 10.1109/cvpr.2004.1315043; Chen CLP, 2015, IEEE T IMAGE PROCESS, V24, P4014, DOI 10.1109/TIP.2015.2456432; Dai D, 2015, COMPUT GRAPH FORUM, V34, P95, DOI 10.1111/cgf.12544; Trinh DH, 2014, IEEE T IMAGE PROCESS, V23, P1882, DOI 10.1109/TIP.2014.2308422; Dong C, 2014, LECT NOTES COMPUT SC, V8692, P184, DOI 10.1007/978-3-319-10593-2_13; Dong WS, 2013, IEEE T IMAGE PROCESS, V22, P1618, DOI 10.1109/TIP.2012.2235847; Dong WS, 2013, IEEE T IMAGE PROCESS, V22, P1382, DOI 10.1109/TIP.2012.2231086; Elad M, 2006, IEEE T IMAGE PROCESS, V15, P3736, DOI 10.1109/TIP.2006.881969; Feng ZZ, 2013, PATTERN RECOGN, V46, P2134, DOI 10.1016/j.patcog.2013.01.016; Freeman WT, 2002, IEEE COMPUT GRAPH, V22, P56, DOI 10.1109/38.988747; Gao X, 2014, IEEE T IMAGE PROCESS, V21, P3194; Gu S., 2014, ADV NEURAL INFORM PR, P793; Gu S, 2015, ICCV, V3; Huang JB, 2015, PROC CVPR IEEE, P5197, DOI 10.1109/CVPR.2015.7299156; Jiang WM, 2016, IEEE T IND INFORM, V12, P248, DOI 10.1109/TII.2015.2496272; Kim KI, 2008, LECT NOTES COMPUT SC, V5096, P456; Lee Hui Jung, 2015, J ELECTRON IMAGING, V24; Li X, 2001, IEEE T IMAGE PROCESS, V10, P1521, DOI 10.1109/83.951537; Li XY, 2015, NEUROCOMPUTING, V149, P940, DOI 10.1016/j.neucom.2014.07.040; Lin ZC, 2004, IEEE T PATTERN ANAL, V26, P83, DOI 10.1109/TPAMI.2004.1261081; Liu Y, 2015, IET IMAGE PROCESS, V9, P347, DOI 10.1049/iet-ipr.2014.0311; Marquina A, 2008, J SCI COMPUT, V37, P367, DOI 10.1007/s10915-008-9214-8; Ni KS, 2009, IEEE T IMAGE PROCESS, V18, P1976, DOI 10.1109/TIP.2009.2023706; Ni Karl S, 2007, IMAGE PROCESS, V16, P1596; Radu Timofte, 2016, CVPR; Singels A., 2014, Proceedings of the Annual Congress - South African Sugar Technologists' Association, P1; Sun J, 2008, PROC CVPR IEEE, P2471, DOI 10.1109/CVPR.2008.4587659; Tai YW, 2010, PROC CVPR IEEE, P2400, DOI 10.1109/CVPR.2010.5539933; Tang SZ, 2014, J ELECTRON IMAGING, V23, DOI 10.1117/1.JEI.23.3.033002; Timofte R, 2015, LECT NOTES COMPUT SC, V9006, P111, DOI 10.1007/978-3-319-16817-3_8; Timofte R, 2013, IEEE I CONF COMP VIS, P1920, DOI 10.1109/ICCV.2013.241; Wang S, 2012, CVPR; Wei Z, 2014, J ELECTRON IMAGING, V23, DOI 10.1117/1.JEI.23.1.013008; Xie J, 2015, IEEE T MULTIMEDIA, V17, P1525, DOI 10.1109/TMM.2015.2457678; Xu Jian, 2015, J ADV SIGNAL PROCESS, V41; Yang JC, 2010, IEEE T IMAGE PROCESS, V19, P2861, DOI 10.1109/TIP.2010.2050625; Yang MC, 2013, IEEE T MULTIMEDIA, V15, P498, DOI 10.1109/TMM.2012.2232646; Zeyde R., 2010, INT C CURVES SURFACE, P711, DOI DOI 10.1007/978-3-642-27413-8_47; Zhang KB, 2015, IEEE T IMAGE PROCESS, V24, P846, DOI 10.1109/TIP.2015.2389629; Zhang KB, 2013, IEEE T NEUR NET LEAR, V24, P1648, DOI 10.1109/TNNLS.2013.2262001; Zhang XJ, 2008, IEEE T IMAGE PROCESS, V17, P887, DOI 10.1109/TIP.2008.924279; Zhang Z, 2017, IEEE T IND INFORM, V13, P644, DOI 10.1109/TII.2017.2653184; Zhang Z, 2016, IEEE T SIGNAL PROCES, V64, P3790, DOI 10.1109/TSP.2016.2550016; Zhou F, 2015, IEEE SIGNAL PROC LET, V22, P336, DOI 10.1109/LSP.2014.2360038	46	0	0	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0182165	10.1371/journal.pone.0182165	http://dx.doi.org/10.1371/journal.pone.0182165			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759633	gold, Green Published, Green Submitted			2022-12-26	WOS:000406761600058
J	Peng, C; Engle, SE; Yan, YJ; Weera, MM; Berry, JN; Arvin, MC; Zhao, GQ; McIntosh, JM; Chester, JA; Drenan, RM				Peng, Can; Engle, Staci E.; Yan, Yijin; Weera, Marcus M.; Berry, Jennifer N.; Arvin, Matthew C.; Zhao, Guiqing; McIntosh, J. Michael; Chester, Julia A.; Drenan, Ryan M.			Altered nicotine reward-associated behavior following alpha 4 nAChR subunit deletion in ventral midbrain	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; LONG-TERM POTENTIATION; AMPA RECEPTOR FUNCTION; AREA DOPAMINE NEURONS; ACETYLCHOLINE-RECEPTORS; TEGMENTAL AREA; SYNAPTIC PLASTICITY; MICE LACKING; RELEASE; RATS	Nicotinic acetylcholine receptors containing alpha 4 subunits (alpha 4132* nAChRs) are critical for nicotinic cholinergic transmission and the addictive action of nicotine. To identify specific activities of these receptors in the adult mouse brain, we coupled targeted deletion of alpha 4 nAChR subunits with behavioral and and electrophysiological measures of nicotine sensitivity. A viral-mediated Cre/lox approach allowed us to delete alpha 4 from ventral midbrain (vMB) neurons. We used two behavioral assays commonly used to assess the motivational effects of drugs of abuse: home-cage oral self-administration, and place conditioning. Mice lacking alpha 4 subunits in vMB consumed significantly more nicotine at the highest offered nicotine concentration (200 mu g/mL) compared to control mice. Deletion of alpha 4 subunits in vMB blocked nicotine-induced conditioned place preference (CPP) without affecting locomotor activity. Acetylcholine-evoked currents as well as nicotine-mediated increases in synaptic potentiation were reduced in mice lacking mu 4 in vMB. Immunostaining verified that alpha 4 subunits were deleted from both dopamine and non-dopamine neurons in the ventral tegmental area (VTA). These results reveal that attenuation of alpha 4* nAChR function in reward-related brain circuitry of adult animals may increase nicotine intake by enhancing the rewarding effects and/or reducing the aversive effects of nicotine.	[Peng, Can; Yan, Yijin; Arvin, Matthew C.; Zhao, Guiqing; Drenan, Ryan M.] Northwestern Univ, Dept Pharmacol, Feinberg Sch Med, Chicago, IL 60611 USA; [Engle, Staci E.; Berry, Jennifer N.; Arvin, Matthew C.; Drenan, Ryan M.] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Weera, Marcus M.; Chester, Julia A.] Purdue Univ, Dept Psychol Sci, W Lafayette, IN 47907 USA; [McIntosh, J. Michael] Univ Utah, George E Wahlen Vet Affairs Med Ctr, Salt Lake City, UT USA; [McIntosh, J. Michael] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [McIntosh, J. Michael] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Northwestern University; Feinberg School of Medicine; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Drenan, RM (corresponding author), Northwestern Univ, Dept Pharmacol, Feinberg Sch Med, Chicago, IL 60611 USA.; Drenan, RM (corresponding author), Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA.	drenan@northwestern.edu	Weera, Marcus/AAI-6252-2020	Engle, Staci/0000-0002-8116-5063; Peng, Can/0000-0003-3576-9269	National Institutes of Health (NIH) grants [DA035942, DA030396, GM103801, GM48677]; Purdue Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA030396, R01DA035942] Funding Source: NIH RePORTER	National Institutes of Health (NIH) grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Purdue Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health (NIH) grants (DA035942 and DA030396 to R.M.D.; GM103801 and GM48677 to J.M.M.). J.A.C. was supported by a grant from the Purdue Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriani W, 2002, BEHAV BRAIN RES, V134, P21, DOI 10.1016/S0166-4328(01)00448-X; Azam L, 2002, J COMP NEUROL, V444, P260, DOI 10.1002/cne.10138; Azam L, 2010, FASEB J, V24, P5113, DOI 10.1096/fj.10-166272; Bardo MT, 2000, PSYCHOPHARMACOLOGY, V153, P31, DOI 10.1007/s002130000569; Barker DJ, 2016, J CHEM NEUROANAT, V73, P33, DOI 10.1016/j.jchemneu.2015.12.016; Barrenha GD, 2012, ALCOHOL CLIN EXP RES, V36, P2065, DOI 10.1111/j.1530-0277.2012.01839.x; Berry JN, 2015, NEUROSCIENCE, V304, P161, DOI 10.1016/j.neuroscience.2015.07.052; Brielmaier JM, 2008, PHARMACOL BIOCHEM BE, V89, P94, DOI 10.1016/j.pbb.2007.11.005; Brunzell DH, 2014, ANN NY ACAD SCI, V1327, P27, DOI 10.1111/nyas.12421; CALCAGNETTI DJ, 1994, PROG NEURO-PSYCHOPH, V18, P925, DOI 10.1016/0278-5846(94)90108-2; Champtiaux N, 2003, J NEUROSCI, V23, P7820; Champtiaux N, 2002, J NEUROSCI, V22, P1208, DOI 10.1523/JNEUROSCI.22-04-01208.2002; Chester JA, 2002, ALCOHOL, V26, P131, DOI 10.1016/S0741-8329(02)00199-4; Cohen BN, 2012, NEUROSCIENCE, V200, P31, DOI 10.1016/j.neuroscience.2011.10.047; CORRIGALL WA, 1989, PSYCHOPHARMACOLOGY, V99, P473, DOI 10.1007/BF00589894; Cunningham CL, 2006, NAT PROTOC, V1, P1662, DOI 10.1038/nprot.2006.279; DIXON WJ, 1950, ANN MATH STAT, V21, P488, DOI 10.1214/aoms/1177729747; Drenan RM, 2008, NEURON, V60, P123, DOI 10.1016/j.neuron.2008.09.009; Drenan RM, 2012, PHARMACOL REV, V64, P869, DOI 10.1124/pr.111.004671; Drenan RM, 2010, J NEUROSCI, V30, P9877, DOI 10.1523/JNEUROSCI.2056-10.2010; Engle SE, 2015, NEUROPHARMACOLOGY, V91, P13, DOI 10.1016/j.neuropharm.2014.11.014; Engle SE, 2013, MOL PHARMACOL, V84, P393, DOI 10.1124/mol.113.087346; Engle SE, 2012, JOVE-J VIS EXP, DOI 10.3791/50034; EXLEY R, 2007, NEUROPSYCHOPHARMACOL, V21, P21; Exley R, 2011, P NATL ACAD SCI USA, V108, P7577, DOI 10.1073/pnas.1103000108; Faget L, 2016, CELL REP, V15, P2796, DOI 10.1016/j.celrep.2016.05.057; Fowler CD, 2011, NATURE, V471, P597, DOI 10.1038/nature09797; Frahm S, 2011, NEURON, V70, P522, DOI 10.1016/j.neuron.2011.04.013; Gao M, 2010, J NEUROSCI, V30, P13814, DOI 10.1523/JNEUROSCI.1943-10.2010; Geuzaine A, 2014, BEHAV BRAIN RES, V262, P14, DOI 10.1016/j.bbr.2013.12.052; Glick SD, 1996, PSYCHOPHARMACOLOGY, V128, P426; Glick SD, 1998, PSYCHOPHARMACOLOGY, V139, P274, DOI 10.1007/s002130050716; Grabus SD, 2006, PSYCHOPHARMACOLOGY, V184, P456, DOI 10.1007/s00213-006-0305-7; Grady SR, 2012, NEUROPHARMACOLOGY, V62, P1935, DOI 10.1016/j.neuropharm.2011.12.026; Grady SR, 2010, NEUROPHARMACOLOGY, V58, P1054, DOI 10.1016/j.neuropharm.2010.01.013; Graupner M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003183; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lammel S, 2014, NEUROPHARMACOLOGY, V76, P351, DOI 10.1016/j.neuropharm.2013.03.019; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; Le Foll B, 2006, PSYCHOPHARMACOLOGY, V184, P367, DOI 10.1007/s00213-005-0155-8; Liu LW, 2012, MOL PHARMACOL, V81, P541, DOI 10.1124/mol.111.076661; Mackey EDW, 2012, J NEUROSCI, V32, P10226, DOI 10.1523/JNEUROSCI.0007-12.2012; Mao DY, 2011, J NEUROSCI, V31, P6710, DOI 10.1523/JNEUROSCI.5671-10.2011; Marks MJ, 2014, J NEUROCHEM, V130, P185, DOI 10.1111/jnc.12721; MARKS MJ, 1983, J PHARMACOL EXP THER, V226, P817; Marubio LM, 2003, EUR J NEUROSCI, V17, P1329, DOI 10.1046/j.1460-9568.2003.02564.x; McGranahan TM, 2011, J NEUROSCI, V31, P10891, DOI 10.1523/JNEUROSCI.0937-11.2011; Nashmi R, 2007, J NEUROSCI, V27, P8202, DOI 10.1523/JNEUROSCI.2199-07.2007; Natarajan R, 2011, PHARMACOL BIOCHEM BE, V99, P519, DOI 10.1016/j.pbb.2011.05.004; NEMETHCOSLETT R, 1986, PSYCHOPHARMACOLOGY, V88, P420; Ngolab J, 2015, J NEUROSCI, V35, P8570, DOI 10.1523/JNEUROSCI.4453-14.2015; Pogun S., 2012, J ADDICT RES THER, pS2; POMERLEAU CS, 1987, PSYCHOPHARMACOLOGY, V91, P391, DOI 10.1007/BF00518198; Pons S, 2008, J NEUROSCI, V28, P12318, DOI 10.1523/JNEUROSCI.3918-08.2008; Rauhut AS, 2008, PHYSIOL BEHAV, V93, P177, DOI 10.1016/j.physbeh.2007.08.011; RISINGER FO, 1995, PHARMACOL BIOCHEM BE, V51, P457, DOI 10.1016/0091-3057(95)00007-J; Robinson SF, 1996, PSYCHOPHARMACOLOGY, V124, P332, DOI 10.1007/BF02247438; ROSE JE, 1989, PHARMACOL BIOCHEM BE, V32, P933, DOI 10.1016/0091-3057(89)90061-0; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Salminen O, 2007, MOL PHARMACOL, V71, P1563, DOI 10.1124/mol.106.031492; Sanjakdar SS, 2015, NEUROPSYCHOPHARMACOL, V40, P350, DOI 10.1038/npp.2014.177; SCHWARTZ RD, 1983, SCIENCE, V220, P214, DOI 10.1126/science.6828889; Sparks JA, 1999, PSYCHOPHARMACOLOGY, V141, P145, DOI 10.1007/s002130050818; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Taylor SR, 2014, J COMP NEUROL, V522, P3308, DOI 10.1002/cne.23603; Tolu S, 2013, MOL PSYCHIATR, V18, P382, DOI 10.1038/mp.2012.83; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Wooltorton JRA, 2003, J NEUROSCI, V23, P3176; Xiao C, 2009, J NEUROSCI, V29, P12428, DOI 10.1523/JNEUROSCI.2939-09.2009; Yararbas G, 2010, NEUROPHARMACOLOGY, V58, P374, DOI 10.1016/j.neuropharm.2009.10.001	70	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0182142	10.1371/journal.pone.0182142	http://dx.doi.org/10.1371/journal.pone.0182142			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759616	gold, Green Published, Green Submitted			2022-12-26	WOS:000406761600055
J	Stucki, D; Freitak, D; Sundstrom, L				Stucki, Dimitri; Freitak, Dalial; Sundstrom, Liselotte			Survival and gene expression under different temperature and humidity regimes in ants	PLOS ONE			English	Article							ALFALFA LEAFCUTTING BEE; IMMUNE-RESPONSE; DROSOPHILA-MELANOGASTER; BEAUVERIA-BASSIANA; DESICCATION; RESISTANCE; TRANSCRIPTION; POPULATION; TOLERANCE; PROTEIN	Short term variation in environmental conditions requires individuals to adapt via changes in behavior and/or physiology. In particular variation in temperature and humidity are common, and the physiological adaptation to changes in temperature and humidity often involves alterations in gene expression, in particular that of heat-shock proteins. However, not only traits involved in the resistance to environmental stresses, but also other traits, such as immune defenses, may be influenced indirectly by changes in temperature and humidity. Here we investigated the response of the ant F. exsecta to two temperature regimes (20 degrees C & 25 degrees C), and two humidity regimes (50% & 75%), for two populations. We measured the survival and the expression of six metabolism- and immunity-related genes, and furthermore compared the expression levels in each condition with the pre-experiment expression levels. Both populations survived equally well at the two humidities, but one population showed higher mortality at 25 degrees C than 20 degrees, at 50% humidity. Similarly, the two populations showed striking differences in their gene expression before the experiment, and in their responses to the environmental conditions. Surprisingly, instead of converging to similar expression levels in the same environmental conditions, gene expression diverged further apart. This indicates different reaction norms to both temperature and humidity for the two populations. Furthermore, our results suggest that also immune defenses are indirectly affected by environmental conditions.	[Stucki, Dimitri; Freitak, Dalial; Sundstrom, Liselotte] Univ Helsinki, Ctr Excellence Biol Interact, Dept Biosci, Helsinki, Finland; [Stucki, Dimitri; Freitak, Dalial; Sundstrom, Liselotte] Univ Helsinki, Tvarminne Zool Stn, Hango, Finland; [Freitak, Dalial] Univ Jyvaskyla, Ctr Excellence Biol Interact, Jyvaskyla, Finland	University of Helsinki; University of Helsinki; University of Jyvaskyla	Stucki, D (corresponding author), Univ Helsinki, Ctr Excellence Biol Interact, Dept Biosci, Helsinki, Finland.; Stucki, D (corresponding author), Univ Helsinki, Tvarminne Zool Stn, Hango, Finland.	dimitri.stucki@helsinki.fi	Sundstrom, Liselotte/G-5080-2010	Sundstrom, Liselotte/0000-0002-6176-8940; Stucki, Dimitri/0000-0001-6663-6798	Academy of Finland [251337, 252411, 284666]; Societas pro Flora et Fauna Fennica; University of Helsinki; Doctoral Programme in Wildlife Biology Research	Academy of Finland(Academy of Finland); Societas pro Flora et Fauna Fennica; University of Helsinki; Doctoral Programme in Wildlife Biology Research	This work was supported by Academy of Finland (grants #251337, #252411, #284666) (http://www.aka.fi/en): Financial funding; University of Helsinki (https://www.helsinki.fi/en): Financial funding; Societas pro Flora et Fauna Fennica (http://www.societasfff.fi/?lang=en): Financial funding (Dimitri Stucki); and Doctoral Programme in Wildlife Biology Research (http://www.societasfff.fi/?lang=en): Financial funding (Dimitri Stucki). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Academy of Finland (grants #251337, #252411, #284666), the University of Helsinki, the Doctoral Programme in Wildlife Biology Research, and the Societas pro Flora et Fauna Fennica for funding. We would also like to thank our field assistants for their valuable help during the bioassay, and an anonymous reviewer for valuable comments on the manuscript.	Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benoit JB, 2010, J INSECT PHYSIOL, V56, P151, DOI 10.1016/j.jinsphys.2009.09.012; BHATKAR A, 1970, Florida Entomologist, V53, P229, DOI 10.2307/3493193; Cahan SH, 2017, COMP BIOCHEM PHYS A, V204, P113, DOI 10.1016/j.cbpa.2016.11.017; Clarke A, 2004, FUNCT ECOL, V18, P243, DOI 10.1111/j.0269-8463.2004.00841.x; Dekoninck W, 2014, J HYMENOPT RES, V41, P95, DOI 10.3897/JHR.41.8191; DiAngelo JR, 2009, P NATL ACAD SCI USA, V106, P20853, DOI 10.1073/pnas.0906749106; Ekesi S, 1999, BIOCONTROL SCI TECHN, V9, P177, DOI 10.1080/09583159929767; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Frouz J, 2000, INSECT SOC, V47, P229, DOI 10.1007/PL00001708; Frouz J, 2007, INSECT SOC, V54, P251, DOI 10.1007/s00040-007-0939-4; Haag-Liautard C, 2009, J EVOLUTION BIOL, V22, P134, DOI 10.1111/j.1420-9101.2008.01635.x; Heckmann LH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-250; Hoang A, 2001, EVOLUTION, V55, P2353, DOI 10.1111/j.0014-3820.2001.tb00748.x; Hoffmann AA, 1999, HEREDITY, V83, P637, DOI 10.1038/sj.hdy.6886490; Hoffmann AA, 2002, ECOL LETT, V5, P614, DOI 10.1046/j.1461-0248.2002.00367.x; HOOD WG, 1990, PHYSIOL ENTOMOL, V15, P23, DOI 10.1111/j.1365-3032.1990.tb00489.x; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; James RR, 2005, APIDOLOGIE, V36, P15, DOI 10.1051/apido:2004065; Johansson H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079777; Ju Z, 2002, MOL GENET GENOMICS, V268, P87, DOI 10.1007/s00438-002-0727-9; Kuznetsova A, 2014, IMERTEST TESTS LINEA; Lazzaro BP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000025; Lord JC, 2005, BIOL CONTROL, V34, P180, DOI 10.1016/j.biocontrol.2005.05.004; McClelland GB, 2006, J PHYSIOL-LONDON, V577, P739, DOI 10.1113/jphysiol.2006.119032; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Nijhout HF, 2003, EVOL DEV, V5, P9, DOI 10.1046/j.1525-142X.2003.03003.x; Nikoskelainen S, 2004, DEV COMP IMMUNOL, V28, P581, DOI 10.1016/j.dci.2003.10.003; R Core Team, 2021, R LANGUAGE ENV STAT; Raffel TR, 2006, FUNCT ECOL, V20, P819, DOI 10.1111/j.1365-2435.2006.01159.x; Schlichting CD, 1998, PHENOTYPIC EVOLUTION; Sim C, 2008, P NATL ACAD SCI USA, V105, P6777, DOI 10.1073/pnas.0802067105; Sinclair BJ, 2007, INSECT MOL BIOL, V16, P435, DOI 10.1111/j.1365-2583.2007.00739.x; Sorensen JG, 2007, J EVOLUTION BIOL, V20, P1624, DOI 10.1111/j.1420-9101.2007.01326.x; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Stanton J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010216; Tammariello SP, 1999, J INSECT PHYSIOL, V45, P933, DOI 10.1016/S0022-1910(99)00073-6; Teets NM, 2012, P NATL ACAD SCI USA, V109, P20744, DOI 10.1073/pnas.1218661109; Therneau T. M, 2015, SURVIVAL SURVIVAL AN; Therneau TM, 2015, IXED EFFECTS COX MOD; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vogt JT, 1999, J INSECT PHYSIOL, V45, P655, DOI 10.1016/S0022-1910(99)00036-0; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341; Xu J, 2012, INSECT MOL BIOL, V21, P269, DOI 10.1111/j.1365-2583.2012.01133.x; Zhu JY, 2009, INSECT SCI, V16, P227, DOI 10.1111/j.1744-7917.2009.01252.x	46	3	3	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0181137	10.1371/journal.pone.0181137	http://dx.doi.org/10.1371/journal.pone.0181137			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759608	Green Published, gold, Green Submitted			2022-12-26	WOS:000406761600011
J	Paredes, R; Tzou, PL; van Zyl, G; Barrow, G; Camacho, R; Carmona, S; Grant, PM; Gupta, RK; Hamers, RL; Harrigan, R; Jordan, MR; Kantor, R; Katzenstein, DA; Kuritzkes, DR; Maldarelli, F; Otelea, D; Wallis, CL; Schapiro, JM; Shafer, RW				Paredes, Roger; Tzou, Philip L.; van Zyl, Gert; Barrow, Geoff; Camacho, Ricardo; Carmona, Sergio; Grant, Philip M.; Gupta, Ravindra K.; Hamers, Raph L.; Harrigan, Richard; Jordan, Michael R.; Kantor, Rami; Katzenstein, David A.; Kuritzkes, Daniel R.; Maldarelli, Frank; Otelea, Dan; Wallis, Carole L.; Schapiro, Jonathan M.; Shafer, Robert W.			Collaborative update of a rule-based expert system for HIV-1 genotypic resistance test interpretation	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TENOFOVIR DISOPROXIL FUMARATE; TREATMENT-EXPERIENCED PATIENTS; REVERSE-TRANSCRIPTASE INHIBITORS; PATIENTS FAILING RALTEGRAVIR; DRUG-RESISTANCE; CROSS-RESISTANCE; VIROLOGICAL RESPONSE; VIRTUAL PHENOTYPE; ANTIRETROVIRAL TREATMENT	Introduction HIV-1 genotypic resistance test (GRT) interpretation systems (IS) require updates as new studies on HIV-1 drug resistance are published and as treatment guidelines evolve. Methods An expert panel was created to provide recommendations for the update of the Stanford HIV Drug Resistance Database (HIVDB) GRT-IS. The panel was polled on the ARVs to be included in a GRT report, and the drug-resistance interpretations associated with 160 drug-resistance mutation (DRM) pattern-ARV combinations. The DRM pattern-ARV combinations included 52 nucleoside RT inhibitor (NRTI) DRM pattern-ARV combinations (13 patterns x 4 NRTIs), 27 nonnucleoside RT inhibitor (NNRTI) DRM pattern-ARV combinations (9 patterns x 3 NNRTIs), 39 protease inhibitor (PI) DRM pattern-ARV combinations (13 patterns x 3 PIs) and 42 integrase strand transfer inhibitor (INSTI) DRM pattern-ARV combinations (14 patterns x 3 INSTIs). Results There was universal agreement that a GRT report should include the NRTIs lamivudine, abacavir, zidovudine, emtricitabine, and tenofovir disoproxil fumarate; the NNRTIs efavirenz, etravirine, nevirapine, and rilpivirine; the PIs atazanavir/r, darunavir/r, and lopinavir/r (with "/r" indicating pharmacological boosting with ritonavir or cobicistat); and the INSTIs dolutegravir, elvitegravir, and raltegravir. There was a range of opinion as to whether the NRTIs stavudine and didanosine and the PIs nelfinavir, indinavir/r, saquinavir/r, fosamprenavir/r, and tipranavir/r should be included. The expert panel members provided highly concordant DRM pattern-ARV interpretations with only 6% of NRTI, 6% of NNRTI, 5% of PI, and 3% of INSTI individual expert interpretations differing from the expert panel median by more than one resistance level. The expert panel median differed from the HIVDB 7.0 GRT-IS for 20 912.5%) of the 160 DRM pattern-ARV combinations including 12 NRTI, two NNRTI, and six INSTI pattern-ARV combinations. Eighteen of these differences were updated in HIVDB 8.1 GRT-IS to reflect the expert panel median. Additionally, HIVDB users are now provided with the option to exclude those ARVs not considered to be universally required. Conclusions The HIVDB GRT-IS was updated through a collaborative process to reflect changes in HIV drug resistance knowledge, treatment guidelines, and expert opinion. Such a process broadens consensus among experts and identifies areas requiring further study.	[Paredes, Roger] IrsiCaixa AIDS Res Inst, Badalona, Spain; [Tzou, Philip L.; Grant, Philip M.; Katzenstein, David A.; Shafer, Robert W.] Stanford Univ, Div Infect Dis, Stanford, CA 94305 USA; [van Zyl, Gert] Stellenbosch Univ, Div Med Virol, Cape Town, South Africa; [van Zyl, Gert] NHLS Tygerberg, Cape Town, South Africa; [Barrow, Geoff] Univ West Indies, Dept Med, Ctr HIV AIDS Res Educ & Serv CHARES, Kingston, Jamaica; [Camacho, Ricardo] Katholieke Univ Leuven, Rega Inst Med Res, Leuven, Belgium; [Carmona, Sergio] Univ Witwatersrand, Dept Mol Med & Haematol, Johannesburg, South Africa; [Gupta, Ravindra K.] UCL, Dept Infect, London WC1E 6BT, England; [Hamers, Raph L.] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Harrigan, Richard] BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Jordan, Michael R.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Kantor, Rami] Brown Univ, Div Infect Dis, Alpert Med Sch, Providence, RI 02912 USA; [Kuritzkes, Daniel R.] Harvard Med Sch, Brigham & Womens Hosp, Div Infect Dis, Boston, MA USA; [Maldarelli, Frank] NCI, HIV Dynam & Replicat Program, CCR, NIH,Translat Res Unit, Frederick, MD 21701 USA; [Otelea, Dan] Natl Inst Infect Dis, Mol Diagnost Lab, Bucharest, Romania; [Wallis, Carole L.] BARC SA, Johannesburg, South Africa; [Wallis, Carole L.] Lancet Labs, Johannesburg, South Africa; [Schapiro, Jonathan M.] Natl Hemophilia Ctr, Tel Hashomer, Israel	Institut de Recerca de la Sida - IrsiCaixa; Stanford University; Stellenbosch University; University West Indies Mona Jamaica; KU Leuven; University of Witwatersrand; University of London; University College London; University of Amsterdam; Academic Medical Center Amsterdam; B.C. Centre for Excellence in HIV/AIDS; Tufts University; Brown University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institute for Infectious Diseases "Matei Bals"; Victor Babes National Institute of Pathology	Shafer, RW (corresponding author), Stanford Univ, Div Infect Dis, Stanford, CA 94305 USA.	rshafer@stanford.edu	Tzou, Philip Lei/S-8654-2019; Maldarelli, Frank/O-2428-2016; Otelea, Dan/AAV-6467-2021; van Zyl, Gert/I-7357-2019; Gupta, Ravindra/G-5529-2015	Tzou, Philip Lei/0000-0002-2876-1552; van Zyl, Gert/0000-0003-3021-5101; Gupta, Ravindra/0000-0001-9751-1808; Hamers, Raph/0000-0002-5007-7896; Barrow, Geoffrey/0000-0002-0784-9440; Otelea, Dan/0000-0002-0821-6346; katzenstein, david/0000-0002-8593-4560; Carmona, Sergio/0000-0002-6792-4748; Wallis, Carole/0000-0001-8408-8772; Paredes, Roger/0000-0002-6553-691X	National Institutes of Health [RO1 A10658581]; NATIONAL CANCER INSTITUTE [ZIABC010819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068581, UM1AI106701, R01AI108441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health RO1 A10658581. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram ME, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172206; Altmann A, 2009, J INFECT DIS, V199, P999, DOI 10.1086/597305; [Anonymous], 2017, PHENOSENSE INTEGRASE; Anstett K, 2015, J VIROL, V89, P4681, DOI 10.1128/JVI.03485-14; Antinori A, 2002, AIDS RES HUM RETROV, V18, P835, DOI 10.1089/08892220260190308; Beerenwinkel N, 2003, NUCLEIC ACIDS RES, V31, P3850, DOI 10.1093/nar/gkg575; Blanco JL, 2017, 2017 C RETR OPP INF; Brenner BG, 2016, J ANTIMICROB CHEMOTH, V71, P1948, DOI 10.1093/jac/dkw071; Cahn P, 2013, LANCET, V382, P700, DOI 10.1016/S0140-6736(13)61221-0; Canducci F, 2011, J INFECT DIS, V204, P1811, DOI 10.1093/infdis/jir636; Danion F, 2015, J ANTIMICROB CHEMOTH, V70, P1921, DOI 10.1093/jac/dkv012; De Meyer S, 2005, ANTIMICROB AGENTS CH, V49, P2314, DOI 10.1128/AAC.49.6.2314-2321.2005; de Meyer S, 2008, AIDS RES HUM RETROV, V24, P379, DOI 10.1089/aid.2007.0173; Eron JJ, 2013, J INFECT DIS, V207, P740, DOI 10.1093/infdis/jis750; FDA, 2016, PREZ DAR PRESCR INF; FDA, 2015, TIV DOL PRESCR INF; Fransen S, 2012, J VIROL, V86, P7249, DOI 10.1128/JVI.06618-11; Frentz D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011505; Gallego O, 2004, J VIROL METHODS, V121, P115, DOI 10.1016/j.jviromet.2004.06.003; Jiamsakul Awachana, 2012, BMC Res Notes, V5, P582, DOI 10.1186/1756-0500-5-582; Kempf DJ, 2002, ANTIVIR THER, V7, P165; Kempf DJ, 2001, J VIROL, V75, P7462, DOI 10.1128/JVI.75.16.7462-7469.2001; King MS, 2007, ANTIMICROB AGENTS CH, V51, P3067, DOI 10.1128/AAC.00388-07; Kobayashi M, 2011, ANTIMICROB AGENTS CH, V55, P813, DOI 10.1128/AAC.01209-10; Lanier ER, 2004, ANTIVIR THER, V9, P37; Larder B, 2007, ANTIVIR THER, V12, P15; Lepik KJ, 2017, AIDS, V31, P1425, DOI 10.1097/QAD.0000000000001494; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Louie M, 2003, AIDS, V17, P1151, DOI 10.1097/00002030-200305230-00006; Mackie NE, 2013, AIDS, V27, P2245, DOI 10.1097/QAD.0b013e3283636179; Malet I, 2008, ANTIMICROB AGENTS CH, V52, P1351, DOI 10.1128/AAC.01228-07; Malet I, 2014, J ANTIMICROB CHEMOTH, V69, P2118, DOI 10.1093/jac/dku095; Margot NA, 2017, J INFECT DIS, V215, P920, DOI 10.1093/infdis/jix015; Margot NA, 2016, ANTIVIR RES, V132, P50, DOI 10.1016/j.antiviral.2016.05.012; Margot NA, 2015, ANTIMICROB AGENTS CH, V59, P5917, DOI 10.1128/AAC.01151-15; Melikian GL, 2012, ANTIMICROB AGENTS CH, V56, P2305, DOI 10.1128/AAC.05487-11; Mesplede T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-22; Miller MD, 2004, J INFECT DIS, V189, P837, DOI 10.1086/381784; Molina JM, 2012, LANCET INFECT DIS, V12, P27, DOI 10.1016/S1473-3099(11)70249-3; Munir S, 2015, J ANTIMICROB CHEMOTH, V70, P739, DOI 10.1093/jac/dku474; Naeger LK, 2007, AIDS, V21, P179, DOI 10.1097/QAD.0b013e3280119213; Naeger LK, 2006, AIDS, V20, P847, DOI 10.1097/01.aids.0000218548.77457.76; Parkin NT, 2004, ANTIMICROB AGENTS CH, V48, P437, DOI 10.1128/AAC.48.2.437-443.2004; Petropoulos CJ, 2000, ANTIMICROB AGENTS CH, V44, P920, DOI 10.1128/AAC.44.4.920-928.2000; Picchio G, 2011, AIDS RES HUM RETROV, V27, P1272, DOI 10.1089/aid.2011.0049; Poonpiriya V, 2008, J VIROL METHODS, V151, P79, DOI 10.1016/j.jviromet.2008.03.017; Puchhammer-Stockl E, 2002, HIV Med, V3, P200, DOI 10.1046/j.1468-1293.2002.00116.x; Quashie PK, 2015, J VIROL, V89, P3163, DOI 10.1128/JVI.03353-14; Quashie PK, 2013, ANTIMICROB AGENTS CH, V57, P6223, DOI 10.1128/AAC.01835-13; Quashie PK, 2012, J VIROL, V86, P2696, DOI 10.1128/JVI.06591-11; Revell AD, 2011, AIDS, V25, P1855, DOI 10.1097/QAD.0b013e328349a9c2; Rhee SY, 2017, EBIOMEDICINE, V18, P225, DOI 10.1016/j.ebiom.2017.03.024; Rhee SY, 2016, J VIROL, V90, P6058, DOI 10.1128/JVI.00495-16; Rhee SY, 2010, ANTIMICROB AGENTS CH, V54, P4253, DOI 10.1128/AAC.00574-10; Rhee SY, 2009, J INFECT DIS, V200, P453, DOI 10.1086/600073; Rimsky L, 2012, JAIDS-J ACQ IMM DEF, V59, P39, DOI 10.1097/QAI.0b013e31823df4da; Saag MS, 1998, AIDS, V12, pF203, DOI 10.1097/00002030-199816000-00002; Sax PE, 2009, NEW ENGL J MED, V361, P2230, DOI 10.1056/NEJMoa0906768; Shulman NS, 2000, J ACQ IMMUN DEF SYND, V23, P221; Sturmer M, 2003, ANTIVIR THER, V8, P239; Tang MW, 2012, INTERVIROLOGY, V55, P98, DOI 10.1159/000331998; TenoRes Study G., 2016, LANCET INFECT DIS; Torti C, 2003, J INFECT DIS, V188, P194, DOI 10.1086/376512; U. S. Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents, 2016, GUIDELINES USE ANTIR; Underwood MR, 2012, JAIDS-J ACQ IMM DEF, V61, P297, DOI 10.1097/QAI.0b013e31826bfd02; Vandamme AM, 2011, AIDS REV, V13, P77; Vercauteren J, 2006, ANTIVIR RES, V71, P335, DOI 10.1016/j.antiviral.2006.05.003; Vercauteren J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061436; Vermeiren H, 2007, J VIROL METHODS, V145, P47, DOI 10.1016/j.jviromet.2007.05.009; Vingerhoets J, 2010, AIDS, V24, P503, DOI 10.1097/QAD.0b013e32833677ac; Walmsley SL, 2001, AIDS, V15, P1581, DOI 10.1097/00002030-200108170-00019; Whitcomb JM, 2003, J INFECT DIS, V188, P992, DOI 10.1086/378281; Winters B, 2008, JAIDS-J ACQ IMM DEF, V48, P26, DOI 10.1097/QAI.0b013e31816d9bf4; World Health Organization, 2013, CONGUID UANT DRU; Zazzi M, 2012, INTERVIROLOGY, V55, P123, DOI 10.1159/000332008	75	20	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0181357	10.1371/journal.pone.0181357	http://dx.doi.org/10.1371/journal.pone.0181357			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753637	Green Published, Green Submitted, gold			2022-12-26	WOS:000406579300015
J	Lin, YC; Xu, S; Zeng, D; Ni, XQ; Zhou, MJ; Zeng, Y; Wang, HS; Zhou, Y; Zhu, H; Pan, KC; Li, GY				Lin, Yicen; Xu, Shuai; Zeng, Dong; Ni, Xueqin; Zhou, Mengjia; Zeng, Yan; Wang, Hesong; Zhou, Yi; Zhu, Hui; Pan, Kangcheng; Li, Guangyao			Disruption in the cecal microbiota of chickens challenged with Clostridium perfringens and other factors was alleviated by Bacillus licheniformis supplementation	PLOS ONE			English	Article							NECROTIC ENTERITIS; BROILER-CHICKENS; GROWTH-PERFORMANCE; PREDISPOSING FACTORS; SUBTILIS; INHIBITION; ANTIBIOTICS; INFECTION; RESPONSES; HEALTH	Clostridium perfringens can induce necrotic enteritis of chickens, which causes large economic losses every year. Bacillus licheniformis, a probiotic, can inhibit the growth of pathogenic bacteria such as Clostridium perfringens, thereby improving the health status of chickens. However, from a microbial ecology perspective, the mechanisms by which alterations to the gut microbiota improve health remain unknown. In this study, we used Illumina MiSeq sequencing to investigate the cecal microbiota of a negative control group (NC), a C. perfringens and Eimeria challenge group with fishmeal supplementation (PC), a group supplemented with fishmeal and infected with coccidia (FC), and group PC with B. licheniformis supplementation (BL). We found that the health status of C. perfringens-challenged chickens was compromised, and that B. licheniformis improved the growth of the chickens challenged with pathogens. Microbial diversity analysis and taxonomic profiling of groups NC, PC, and FC revealed a disturbed cecal microflora of the birds with C. perfringens. We also characterized the microbiota of the chickens in the BL group using several methods. Principal coordinate analysis demonstrated that, compared with group PC, the bacterial community structure of group BL was more similar to that of group NC. Linear discriminant analysis with effect size revealed less differentially represented bacterial taxa between groups BL and NC than between groups PC and NC. In addition, groups BL and NC appeared to have similar overrepresented microbial taxa (such as Bacteroides, Helicobacter, Megamonas, and Akkermansia) compared with group PC. Finally, a phylogenetic investigation of communities by reconstruction of unobserved states analysis indicated that large differences existed between group PC and groups NC and BL. In conclusion, pre-treatment with B. licheniformis reduced the disturbance of the cecal microbiome induced by challenge with C. perfringens and other factors in broiler chickens.	[Lin, Yicen; Xu, Shuai; Zeng, Dong; Ni, Xueqin; Zhou, Mengjia; Zeng, Yan; Wang, Hesong; Zhou, Yi; Zhu, Hui; Pan, Kangcheng] Sichuan Agr Univ, Coll Vet Med, Anim Microecol Inst, Chengdu, Sichuan, Peoples R China; [Lin, Yicen; Xu, Shuai; Zeng, Dong; Ni, Xueqin; Zhou, Mengjia; Zeng, Yan; Wang, Hesong; Zhou, Yi; Zhu, Hui; Pan, Kangcheng] Sichuan Agr Univ, Key Lab Anim Dis & Human Hlth Sichuan Prov, Chengdu, Sichuan, Peoples R China; [Li, Guangyao] Boshan Developing Agr Technol Co Ltd, Yaan, Peoples R China	Sichuan Agricultural University; Key Laboratory of Animal Disease & Human Health of Sichuan Province; Sichuan Agricultural University	Ni, XQ (corresponding author), Sichuan Agr Univ, Coll Vet Med, Anim Microecol Inst, Chengdu, Sichuan, Peoples R China.; Ni, XQ (corresponding author), Sichuan Agr Univ, Key Lab Anim Dis & Human Hlth Sichuan Prov, Chengdu, Sichuan, Peoples R China.	xueqinni@foxmail.com			Key Laboratory of Animal Disease and Human Health of Sichuan Province at Sichuan Agricultural University	Key Laboratory of Animal Disease and Human Health of Sichuan Province at Sichuan Agricultural University	We would like to thank all the members of the Key Laboratory of Animal Disease and Human Health of Sichuan Province at Sichuan Agricultural University for their support. We also express our appreciation to Bo Zeng for his training on 16S rRNA sequencing and the use of QIIME.	Alam A, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2015.21, 10.1038/NMICROBIOL.2015.21]; Allaart JG, 2013, COMP IMMUNOL MICROB, V36, P449, DOI 10.1016/j.cimid.2013.05.001; Barbosa TM, 2005, APPL ENVIRON MICROB, V71, P968, DOI 10.1128/AEM.71.2.968-978.2005; Callaway TR, 2009, POULTRY SCI, V88, P298, DOI 10.3382/ps.2008-00222; Caly DL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01336; Cao L, 2012, POULTRY SCI, V91, P3065, DOI 10.3382/ps.2012-02548; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Chumpitazi BP, 2015, ALIMENT PHARM THER, V42, P418, DOI 10.1111/apt.13286; Cummings JH, 2001, AM J CLIN NUTR, V73, p415S, DOI 10.1093/ajcn/73.2.415s; da Costa SPF, 2013, VACCINE, V31, P4003, DOI 10.1016/j.vaccine.2013.05.063; Dec M, 2014, POULTRY SCI; DUCLUZEAU R, 1976, ANTIMICROB AGENTS CH, V9, P20, DOI 10.1128/AAC.9.1.20; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; FULLER R, 1989, J APPL BACTERIOL, V66, P365; Gillespie MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048363; Goldstein EJC, 2011, CURR OPIN INFECT DIS, V24, pS21, DOI 10.1097/01.qco.0000393485.17894.4c; Jayaraman S, 2013, POULTRY SCI, V92, P370, DOI 10.3382/ps.2012-02528; Jia W, 2009, POULTRY SCI, V88, P132, DOI 10.3382/ps.2008-00204; Kim JE, 2015, RES VET SCI, V102, P150, DOI 10.1016/j.rvsc.2015.07.022; Knap I, 2010, AVIAN DIS, V54, P931, DOI 10.1637/9106-101509-ResNote.1; La Ragione RM, 2003, VET MICROBIOL, V94, P245, DOI 10.1016/S0378-1135(03)00077-4; Lanckriet A, 2010, AVIAN PATHOL, V39, P63, DOI 10.1080/03079450903505771; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lee KW, 2014, RES VET SCI, V97, P304, DOI 10.1016/j.rvsc.2014.07.021; Liu YY, 2012, AM J PHYSIOL-GASTR L, V302, pG608, DOI 10.1152/ajpgi.00266.2011; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; McDonald D, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-7; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mikelsaar Marika, 2009, Microbial Ecology in Health and Disease, V21, P1, DOI 10.1080/08910600902815561; Moore RJ, 2015, MICROBIOL AUST, V36, P118, DOI 10.1071/MA15041; Oakley BB, 2014, FEMS MICROBIOL LETT, V360, P100, DOI 10.1111/1574-6968.12608; Olkowski AA, 2006, RES VET SCI, V81, P99, DOI 10.1016/j.rvsc.2005.10.006; Pourabedin M, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv122; Qu A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002945; Rychlik I, 2014, VET RES, V45, DOI 10.1186/s13567-014-0119-2; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sergeant MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091941; Shahir N, 2016, INFLAMM BOWEL DIS, V22, pS67, DOI 10.1097/01.MIB.0000480310.59187.c8; Shojadoost B, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-74; Songer JG, 1996, ANAEROBE, V2, P197, DOI 10.1006/anae.1996.0027; Stanley D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104739; Stanley D, 2012, APPL MICROBIOL BIOT, V96, P1361, DOI 10.1007/s00253-011-3847-5; Stanley D, 2012, VET MICROBIOL, V159, P155, DOI 10.1016/j.vetmic.2012.03.032; Tactacan GB, 2013, J APPL POULTRY RES, V22, P825, DOI 10.3382/japr.2013-00730; Takesue Y, 2002, SURG TODAY, V32, P581, DOI 10.1007/s005950200105; Timbermont L, 2009, VET MICROBIOL, V137, P388, DOI 10.1016/j.vetmic.2009.01.017; Wade B., 2015, World Poultry, V31, P16; Wei S, 2013, POULTRY SCI, V92, P671, DOI 10.3382/ps.2012-02822; Wrigley DM, 2004, ANAEROBE, V10, P295, DOI 10.1016/j.anaerobe.2004.05.006; Wu SB, 2014, VET MICROBIOL, V169, P188, DOI 10.1016/j.vetmic.2014.01.007; Wu SB, 2011, APPL ENVIRON MICROB, V77, P1135, DOI 10.1128/AEM.01803-10; Wu SB, 2010, AVIAN DIS, V54, P1058, DOI 10.1637/9338-032910-Reg.1; Zeng B, 2015, SCI REP-UK, V5, DOI 10.1038/srep09342; Zhou MJ, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0219-2	55	53	56	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182426	10.1371/journal.pone.0182426	http://dx.doi.org/10.1371/journal.pone.0182426			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771569	gold, Green Submitted, Green Published			2022-12-26	WOS:000406853600112
J	Burgess, PI; Harding, SP; Garcia-Finana, M; Beare, NAV; Glover, S; Cohen, DB; Msukwa, G; Allain, TJ				Burgess, Philip I.; Harding, Simon P.; Garcia-Finana, Marta; Beare, Nicholas A. V.; Glover, Simon; Cohen, Danielle B.; Msukwa, Gerald; Allain, Theresa J.			Incidence and progression of diabetic retinopathy in Sub-Saharan Africa: A five year cohort study	PLOS ONE			English	Article							SIGHT-THREATENING RETINOPATHY; RISK-FACTORS; VISUAL IMPAIRMENT; 4-YEAR INCIDENCE; PREVALENCE; POPULATION; AGE; EPIDEMIOLOGY; DIAGNOSIS; MELLITUS	Aims To describe the incidence and progression of retinopathy in people with diabetes in Southern Malawi over 5 years. To document visual loss in a setting where laser treatment is not available. Methods Subjects from a cohort sampled from a hospital-based, primary-care diabetes clinic in 2007 were traced in 2012. Laser treatment was not available. Modified Wisconsin grading of retinopathy was performed using slit lamp biomicroscopy by a single ophthalmologist in 2007 and using four-field mydriatic fundus photographs at an accredited reading centre in 2012. Visual acuity was measured by Snellen chart in 2007 and by 'Early Treatment of Diabetic Retinopathy Study' chart in 2012. HbA1c, blood pressure, HIV status, urine albumin-creatinine ratio, haemoglobin and lipids were measured. Results Of 281 subjects recruited in 2007, 135 (48%) were traced and assessed, 15 were confirmed dead. At follow-up (median 5.3 years) >= 2 step retinopathy progression was observed in 48 subjects (36.4%; 95% CI 28.2-44.6). Incidence of sight threatening diabetic retinopathy for those with level 10 (no retinopathy) and level 20 (background) retinopathy at baseline, was 19.4% (11.3-27.4) and 81.3% (62.1-100), respectively. In multivariate analysis 2 step progression was associated with HbA1c (OR 1.2495% CI 1.04-1.48), and haemoglobin level (0.77, 0.62-0.98). 25 subjects (18.8%) lost >= 5 letters, 7 (5.3%) lost >= 15 letters. Conclusions Progression to sight threatening diabetic retinopathy from no retinopathy and background retinopathy was approximately 5 and 3 times that reported in recent European studies, respectively. Incidence of visual loss was high in a location where treatment was not available.	[Burgess, Philip I.; Glover, Simon; Cohen, Danielle B.] Queen Elizabeth Cent Hosp, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Burgess, Philip I.; Harding, Simon P.; Beare, Nicholas A. V.] Univ Liverpool, Dept Eye & Vis Sci, Liverpool, Merseyside, England; [Garcia-Finana, Marta] Univ Liverpool, Dept Biostat, Liverpool, Merseyside, England; [Msukwa, Gerald] Queen Elizabeth Cent Hosp, Lions Sight Eye Unit 1, Blantyre, Malawi; [Allain, Theresa J.] Univ Malawi, Coll Med, Blantyre, Malawi	University of Malawi; University of Liverpool; University of Liverpool; University of Malawi; University of Malawi	Burgess, PI (corresponding author), Queen Elizabeth Cent Hosp, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi.; Burgess, PI (corresponding author), Univ Liverpool, Dept Eye & Vis Sci, Liverpool, Merseyside, England.	philipburgess@doctors.org.uk	Beare, Nicholas/AAG-4946-2019	Cohen, Danielle/0000-0002-8694-3522; Beare, Nicholas/0000-0001-8086-990X	Wellcome Trust via a Clinical PhD Fellowship [094015/Z/10/A]	Wellcome Trust via a Clinical PhD Fellowship(Wellcome Trust)	This work was funded by the Wellcome Trust via a Clinical PhD Fellowship (PIB Grant number 094015/Z/10/A). The funding body had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afkhami-Ardekani M, 2009, J DIABETES COMPLICAT, V23, P194, DOI 10.1016/j.jdiacomp.2007.11.006; Ajoy MVK, 2011, INDIAN J OPHTHALMOL, V59, P207, DOI 10.4103/0301-4738.81029; [Anonymous], 1991, OPHTHALMOLOGY, V98, P786; [Anonymous], 2011, MAL INT GUID PROV HI; Bo S, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.04.049; Burgess PI, 2014, DIABETIC MED, V31, P1643, DOI 10.1111/dme.12492; Burgess PI, 2013, DIABETIC MED, V30, P399, DOI 10.1111/j.1464-5491.2012.03756.x; Burgess PI, 2016, OPHTHALMOLOGY, V123, P1919, DOI 10.1016/j.ophtha.2016.05.042; Cohen DB, 2010, AM J TROP MED HYG, V83, P575, DOI 10.4269/ajtmh.2010.10-0104; Damkondwar DR, 2012, INDIAN J OPHTHALMOL, V60, P45, DOI 10.4103/0301-4738.91344; Dowse GK, 1998, AM J EPIDEMIOL, V147, P448, DOI 10.1093/oxfordjournals.aje.a009470; Falkenstein IA, 2008, OPHTHALMOLOGY, V115, P319, DOI 10.1016/j.ophtha.2007.05.028; Glover SJ, 2012, BRIT J OPHTHALMOL, V96, P156, DOI 10.1136/bjo.2010.196071; HARDING SP, 1995, BMJ-BRIT MED J, V311, P1131, DOI 10.1136/bmj.311.7013.1131; He BB, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/157940; International Diabetes Federation, 2009, DIABETES ATLAS; Jones CD, 2012, DIABETES CARE, V35, P592, DOI 10.2337/dc11-0943; Kaiser Peter K, 2009, Trans Am Ophthalmol Soc, V107, P311; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; KLEIN R, 1989, ARCH OPHTHALMOL-CHIC, V107, P244, DOI 10.1001/archopht.1989.01070010250031; KLEIN R, 1989, ARCH OPHTHALMOL-CHIC, V107, P237, DOI 10.1001/archopht.1989.01070010243030; Lim LA, 2010, EYE, V24, P673, DOI 10.1038/eye.2009.147; Msyamboza KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020316; Patel PJ, 2008, INVEST OPHTH VIS SCI, V49, P4347, DOI 10.1167/iovs.08-1935; Raman R, 2012, CURR EYE RES, V37, P513, DOI 10.3109/02713683.2012.669005; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stratton IM, 2001, DIABETOLOGIA, V44, P156, DOI 10.1007/s001250051594; Tapp RJ, 2006, DIABETES RES CLIN PR, V73, P298, DOI 10.1016/j.diabres.2006.02.009; World Health Organisation, 2013, COUNTR STAT MAL; World Health Organization, 2008, WORLDW PREV AN 1993; World Health Organization, 2005, INT WHO CLIN STAG HI; Younis N, 2003, DIABETIC MED, V20, P758, DOI 10.1046/j.1464-5491.2003.01035.x; Younis N, 2003, LANCET, V361, P195, DOI 10.1016/S0140-6736(03)12267-2	34	3	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0181359	10.1371/journal.pone.0181359	http://dx.doi.org/10.1371/journal.pone.0181359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767669	Green Published, Green Submitted, gold			2022-12-26	WOS:000406768200023
J	Puneeta, P; Vijai, D; Yamamoto, J; Adachi, K; Kato, Y; Sakurai, Y				Puneeta, Pandey; Vijai, Dharmamony; Yamamoto, Jun; Adachi, Kohsuke; Kato, Yoshiki; Sakurai, Yasunori			Structure and properties of the egg mass of the ommastrephid squid Todarodes pacificus	PLOS ONE			English	Article							NIDAMENTAL GLAND MUCOSUBSTANCE; ARTIFICIAL FERTILIZATION; PARALARVAL DEVELOPMENT; EMBRYONIC-DEVELOPMENT; DOSIDICUS-GIGAS; CEPHALOPODA; BEHAVIOR; HATCHLINGS; SURVIVAL; MOLLUSCA	The Japanese flying squid, Todarodes pacificus, is thought to spawn neutrally buoyant egg masses that retain a specific location in the water column by floating at the interface between water layers of slightly different densities. It is important to understand the physical process that determines the vertical distribution of the egg masses to predict their horizontal drift in relation to embryo survival and subsequent recruitment. Here, mesocosm experiments were conducted in a 300 m(3) tank by creating a thermally stratified (17-22 degrees C) water column to obtain egg masses. A cage net methodology was developed to sustain egg masses for detailed observation. We measured the density of the egg masses of T. pacificus, and used this information to infer the vertical distribution patterns of the egg masses at the spawning grounds (Tsushima Strait, Japan). When measured separately, the density of the outer jelly of each egg mass was 2.7 sigma units higher than that of the surrounding water. The outer jelly and the specific gravity of embedded individual eggs (similar to 1.10) cause the egg masses to have very slight negative buoyancy relative to the water in which they are formed. Analysis of the vertical profile of the spawning ground showed that water density (sigma theta) in-creased sharply at similar to 30 m depth; thus, egg masses might settle above the pycnocline layer. In conclusion, we suggest that T. pacificus egg masses might retain their location in the water column by floating at the interface between water layers of slightly different densities, which happen to be above the pycnocline layer (actual depth varies seasonally/annually) in the Tsushima Strait between Korea and Japan.	[Puneeta, Pandey; Vijai, Dharmamony; Sakurai, Yasunori] Hokkaido Univ, Sch Fisheries Sci, Dept Marine Bioresources & Ecol, Sapporo, Hokkaido, Japan; [Yamamoto, Jun] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Sapporo, Hokkaido, Japan; [Adachi, Kohsuke] Kochi Univ, Grad Sch Agr, Lab Aquat Prod Utilizat, Monobeotsu 200, Nankoku, Kochi, Japan; [Kato, Yoshiki] Japan Fisheries Res & Educ Agcy, Marine Fisheries Res & Dev Ctr JAMARC, Yokohama, Kanagawa, Japan; [Vijai, Dharmamony] Fisheries Res & Educ Agcy, Oceanog Div, Samemachi, Hachinohe, Aomori, Japan; [Sakurai, Yasunori] Fisheries & Oceans Hakodate, Hakodate Cephalopod Res Ctr, Benten Cho 20-5, Hakodate, Hokkaido, Japan	Hokkaido University; Hokkaido University; Kochi University; Japan Fisheries Research & Education Agency (FRA); Japan Fisheries Research & Education Agency (FRA)	Puneeta, P (corresponding author), Hokkaido Univ, Sch Fisheries Sci, Dept Marine Bioresources & Ecol, Sapporo, Hokkaido, Japan.	puneeta83@gmail.com	Dharmamony, Vijai/E-8824-2016; Pandey, Puneeta/AAL-3001-2021	Dharmamony, Vijai/0000-0002-9120-8880; Puneeta, Pandey/0000-0002-5798-1415	Hokkaido University, Japan	Hokkaido University, Japan	This study was funded by Hokkaido University, Japan.	Adachi K, 2016, INVERTEBR REPROD DEV; Arkhipkin AI, 2015, REV FISH SCI AQUAC, V23, P92, DOI 10.1080/23308249.2015.1026226; Birk MA, 2016, J NAT HIST; BOOTH DT, 1995, J EXP BIOL, V198, P241; Bower JR, 1996, AM MALACOL BULL, V13, P65; Boyle P. R., 2005, CEPHALOPODS ECOLOGY; CHAFFEE C, 1984, J EXP MAR BIOL ECOL, V84, P73, DOI 10.1016/0022-0981(84)90231-4; Chesalin M.V., 1993, OCEANOLOGY+, V33, P98; CLARKE MR, 1966, ADV MAR BIOL, V4, P91, DOI 10.1016/S0065-2881(08)60314-4; Denny M., 1983, P431; Durward RD, 1980, INT COMM NW ATL FISH, V6, P6; GIORGI AE, 1984, ENVIRON BIOL FISH, V10, P15, DOI 10.1007/BF00001659; Hamabe M., 1963, Bulletin of the Japanese Society of Scientific Fisheries, V29, P930; Hamabe M., 1961, Zoological Magazine Tokyo, V70, P385; IKEDA Y, 1995, J MAR BIOL ASSOC UK, V75, P495, DOI 10.1017/S0025315400018348; Ikeda Yuzuru, 1993, P179; KIMURA S, 1994, FISHERIES SCI, V60, P193, DOI 10.2331/fishsci.60.193; Kimura S, 2004, J MOLLUS STUD, V70, P117, DOI 10.1093/mollus/70.2.117; Kimura S, 2003, J TOKYO U FISH; Klussmann-Kolb A, 2001, ZOOL ANZ, V240, P101, DOI 10.1078/0044-5231-00010; Laptikhovsky V.V., 1990, Biologiya Morya (Vladivostok), V1990, P62; O'Dor RK, 1985, NAFO SCI COUN STUDIE, V9, P69; O'Shea S, 2004, NEW ZEAL J ZOOL, V31, P161, DOI 10.1080/03014223.2004.9518369; Ohizumi H, 2000, MAR ECOL PROG SER, V200, P265, DOI 10.3354/meps200265; Puneeta P, 2016, MAR ECOL PROG SER, V551, P277, DOI 10.3354/meps011776; Puneeta P, 2015, J EXP BIOL, V218, P3825, DOI 10.1242/jeb.127670; Sakai M, 1998, S AFR J MARINE SCI, V20, P255; Sakurai Y, 2000, ICES J MAR SCI, V57, P24, DOI 10.1006/jmsc.2000.0667; SAKURAI Y, 1995, VELIGER, V38, P185; Sakurai Y, 1996, AM MALACOL BULL, V13, P89; Sakurai Y., 2006, GLOBEC REPORT, V24, P33; Sakurai Y., 2013, ADV SQUID BIOL ECO 2, P249; Smith AM, 2002, INTEGR COMP BIOL, V42, P1164, DOI 10.1093/icb/42.6.1164; Staaf DJ, 2008, J MAR BIOL ASSOC UK, V88, P759, DOI 10.1017/S0025315408001422; Staaf DJ, 2011, MAR ECOL PROG SER, V441, P165, DOI 10.3354/meps09389; Sugiura Y, 1995, FISHERIES SCI, V61, P1009, DOI 10.2331/fishsci.61.1009; SUNDBY S, 1983, DEEP-SEA RES, V30, P645, DOI 10.1016/0198-0149(83)90042-0; Tanaka Yuji, 1992, Journal of Oceanography, V48, P461, DOI 10.1007/BF02234021; von Boletzky S, 1998, OCEANOGR MAR BIOL<D>, V36, P341; Vijai D, 2016, J SHELLFISH RES, V35, P1007, DOI 10.2983/035.035.0423; Vijai D, 2015, ZOOMORPHOLOGY, V134, P417, DOI 10.1007/s00435-015-0267-6; Villanueva R, 2012, AQUACULTURE, V342, P125, DOI 10.1016/j.aquaculture.2012.02.025; von Boletzky S, 1973, VELIGER, V15, P257; Wakeham WA, 2007, SPRINGER HDB EXPT FL, P85; Watanabe K, 1996, AM MALACOL BULL, V13, P73; Yamamoto Jun, 2012, Bulletin of the Japanese Society of Fisheries Oceanography, V76, P18; Yatsu A, 1999, FISHERIES SCI, V65, P904, DOI 10.2331/fishsci.65.904; YOUNG RE, 1985, PAC SCI, V39, P359	48	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182261	10.1371/journal.pone.0182261	http://dx.doi.org/10.1371/journal.pone.0182261			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767686	gold, Green Submitted, Green Published			2022-12-26	WOS:000406768200061
J	Hoover, KW; Tao, KL; Peters, PJ				Hoover, Karen W.; Tao, Kevin L.; Peters, Philip J.			Nationally representative prevalence estimates of gay, bisexual, and other men who have sex with men who have served in the US military	PLOS ONE			English	Article							DONT ASK	Objectives To estimate the number of men in the U.S. military who are gay, bisexual, or other men who have sex with men (MSM) to inform the development of military and other federal policies. Study design We analyzed data from the National Surveys of Family Growth to estimate the number of U.S. men who were gay, bisexual, or MSM, and who had served in the military, compared to those who did not serve. We stratified using hierarchical categories of gay, bisexual, and other MSM to compare proportions in the military and general population. Results We found that 4.23% of men self-reported as gay, bisexual, or other MSM among men who served in the military, compared to 4.14% among men who had not served (p = 0.93). When stratified, we found that 0.78% self-reported as gay among men who served in the military, compared to 2.12% among men who had not served (p<0.001). Conclusions The proportion of men who identified as a gay was lower in the military than in the general population. This finding might have been influenced by historical military policies related to sexual orientation.	[Hoover, Karen W.; Tao, Kevin L.; Peters, Philip J.] CDC, Div HIV AIDS Prevent, Ctr Dis Control & Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Hoover, KW (corresponding author), CDC, Div HIV AIDS Prevent, Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	khoover@cdc.gov						Affairs USDoV, LESBIAN GAY BISEXUAL; Armed Forces Health Surveillance Center (AFHSC), 2014, MSMR, V21, P16; Armed Forces Health Surveillance Center (AFHSC), 2012, MSMR, V19, P7; Biddix JM, 2013, MIL MED, V178, P1335, DOI 10.7205/MILMED-D-13-00044; Blosnich JR, 2014, AM J PUBLIC HEALTH, V104, pS535, DOI 10.2105/AJPH.2014.302100; Blosnich JR, 2014, AM J PREV MED, V46, P337, DOI 10.1016/j.amepre.2013.11.010; Burks DJ, 2011, AM PSYCHOL, V66, P604, DOI 10.1037/a0024609; Burrelli DF, 2010, DONT ASK DONT TELL T, P1; Carpenter R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002299; Centers for Disease Control and Prevention, 2014, HIV SURV REP; Centers for Disease Control and Prevention, 2014, PREEXP PROPH PREV HI; Centers For Disease Control and Prevention, 2015, SEX TRANSM DIS SURV; Chandra A, 2006, NATL HLTH STAT REPOR, V2011, P1; Clark Leslie L, 2015, MSMR, V22, P8; Gates GJ., 2010, LESBIAN GAY BISEXUAL; Gates GJ., 2004, GAY MEN LESBIANS US; Gaydos Joel C, 2013, MSMR, V20, P2; Hakre S, 2012, JAIDS-J ACQ IMM DEF, V61, P125, DOI [10.1097/QAI.0b013e31826a15db., 10.1097/QAI.0b013e31826a15db]; Hakre S, 2011, JAIDS-J ACQ IMM DEF, V56, P372, DOI 10.1097/QAI.0b013e31820a7f4d; Institute of Medicine (US) Committee on Lesbian Gay Bisexual and Transgender Health Issues and Research Gaps and Opportunities, 2011, HLTH LESB GAY BIS TR; Katz KA, 2010, NEW ENGL J MED, V363, P2380, DOI 10.1056/NEJMp1012496; Lepkowski JM, 2010, VITAL HLTH STAT, V2; Marconi VC, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-14; Miller K, 2013, BATTLES REMAIN MILIT; Mirza Raul A, 2012, MSMR, V19, P10; Mock SE, 2012, ARCH SEX BEHAV, V41, P641, DOI 10.1007/s10508-011-9761-1; Mosher W. D., 2002, ADV DATA, V362, P1; O'Reilly KB, AMA M DONT ASK DONT; Patten E, 2011, PEW RES CTR SOCIAL D; Rostker Bernard D., 1993, SEXUAL ORIENTATION U; Sinclair GD, 2009, J HOMOSEXUAL, V56, P701, DOI 10.1080/00918360903054137; Spaulding AB, 2012, SEX TRANSM INFECT, V88, P266, DOI 10.1136/sextrans-2011-050173; Tzeng JS, 2013, J SEX TRANSM DIS, V2013, P1; White House, 2010, PRES SIGNS REP DONT	34	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0182222	10.1371/journal.pone.0182222	http://dx.doi.org/10.1371/journal.pone.0182222			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC3VC	28763487	Green Published, Green Submitted, gold			2022-12-26	WOS:000406766500053
J	Viau, S; Chabrand, L; Eap, S; Lorant, J; Rouger, K; Goudaliez, F; Sumian, C; Delorme, B				Viau, Sabrina; Chabrand, Lucie; Eap, Sandy; Lorant, Judith; Rouger, Karl; Goudaliez, Francis; Sumian, Chryslain; Delorme, Bruno			Pathogen reduction through additive-free short-wave UV light irradiation retains the optimal efficacy of human platelet lysate for the expansion of human bone marrow mesenchymal stem cells	PLOS ONE			English	Article							WAVELENGTH ULTRAVIOLET-LIGHT; FETAL BOVINE SERUM; WHITE BLOOD-CELLS; STROMAL CELLS; IN-VITRO; PHOTOCHEMICAL TREATMENT; APHERESIS PLATELETS; PRT SYSTEM; TGF-BETA; C LIGHT	Background We recently developed and characterized a standardized and clinical grade human Platelet Lysate (hPL) that constitutes an advantageous substitute for fetal bovine serum (FBS) for human mesenchymal stem cell (hMSC) expansion required in cell therapy procedures, avoiding xenogenic risks (virological and immunological) and ethical issues. Because of the progressive use of pathogen-reduced (PR) labile blood components, and the requirement of ensuring the viral safety of raw materials for cell therapy products, we evaluated the impact of the novel procedure known as THERAFLEX UV-Platelets for pathogen reduction on hPL quality (growth factors content) and efficacy (as a medium supplement for hMSC expansion). This technology is based on short-wave ultraviolet light (UV-C) that induces non-reversible damages in DNA and RNA of pathogens while preserving protein structures and functions, and has the main advantage of not needing the addition of any photosensitizing additives (that might secondarily interfere with hMSCs). Methodology / Principal findings We applied the THERAFLEX UV-Platelets procedure on fresh platelet concentrates (PCs) suspended in platelet additive solution and prepared hPL from these treated PCs. We compared the quality and efficacy of PR-hPL with the corresponding non-PR ones. We found no impact on the content of five cytokines tested (EGF, bFGF, PDGF-AB, VEGF and IGF-1) but a significant decrease in TGF-beta 1 (-21%, n = 11, p<0.01). We performed large-scale culture of hMSCs from bone marrow (BM) during three passages and showed that hPL or PR-hPL at 8% triggered comparable BM-hMSC proliferation as FBS at 10% plus bFGF. Moreover, after proliferation of hMSCs in an hPL- or PR-hPL-containing medium, their profile of membrane marker expression, their clonogenic potential and immunosuppressive properties were maintained, in comparison with BM-hMSCs cultured under FBS conditions. The potential to differentiate towards the adipogenic and osteogenic lineages of hMSCs cultured in parallel in the three conditions also remained identical. Conclusion / Significance We demonstrated the feasibility of using UV-C-treated platelets to subsequently obtain pathogen-reduced hPL, while preserving its optimal quality and efficacy for hMSC expansion in cell therapy applications.	[Viau, Sabrina; Chabrand, Lucie; Eap, Sandy; Delorme, Bruno] Macopharma, Biotherapy Div, Mouvaux, France; [Lorant, Judith; Rouger, Karl] INRA, UMR PAnTher 703, Nantes, France; [Lorant, Judith; Rouger, Karl] LUNAM Univ, Oniris, Ecole Natl Vet Agroalimentaire & Alimentat Nantes, Nantes, France; [Goudaliez, Francis; Sumian, Chryslain] Macopharma, Transfus Div, Tourcoing, France	INRAE; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique	Viau, S (corresponding author), Macopharma, Biotherapy Div, Mouvaux, France.	sabrina.viau@macopharma.com		Lorant, Judith/0000-0002-9824-0955	Macopharma; Region Pays de la Loire; French government (National Research Agency), Nantes Metropole	Macopharma; Region Pays de la Loire(Region Pays de la Loire); French government (National Research Agency), Nantes Metropole	Macopharma provided support in the form of salaries for authors Sabrina VIAU, Lucie CHABRAND, Sandy EAP, Francis GOUDALIEZ, Chryslain SUMIAN and Bruno DELORME, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are described in the 'author contributions' section. Judith LORANT received financial support from French government (National Research Agency), Nantes Metropole and the Region Pays de la Loire.	Abdelrazik H, 2011, EUR J IMMUNOL, V41, P3281, DOI 10.1002/eji.201141542; Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Andreu G, 2002, TRANSFUSION, V42, P1356, DOI 10.1046/j.1537-2995.2002.00202.x; Apelseth TO, 2007, TRANSFUSION, V47, P653, DOI 10.1111/j.1537-2995.2007.01167.x; AuBuchon JP, 2005, TRANSFUSION, V45, P1335, DOI 10.1111/j.1537-2995.2005.00202.x; Bernardo ME, 2007, J CELL PHYSIOL, V211, P121, DOI 10.1002/jcp.20911; Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139; Blumel J, 2010, BUNDESGESUNDHEITSBLA, V53, P38, DOI 10.1007/s00103-009-0996-0; Burnouf T, 2016, BIOMATERIALS, V76, P371, DOI 10.1016/j.biomaterials.2015.10.065; Caillet-Fauquet P, 2004, J VIROL METHODS, V118, P131, DOI 10.1016/j.jviromet.2004.02.002; Capelli C, 2007, BONE MARROW TRANSPL, V40, P785, DOI 10.1038/sj.bmt.1705798; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Castiglia S, 2014, CYTOTHERAPY, V16, P750, DOI 10.1016/j.jcyt.2013.12.008; Cazenave JP, 2010, TRANSFUSION, V50, P2362, DOI 10.1111/j.1537-2995.2010.02694.x; Ciaravino V, 2001, HUM EXP TOXICOL, V20, P533, DOI 10.1191/096032701718120319; Delorme Bruno, 2007, V140, P67; Delorme B, 2008, BLOOD, V111, P2631, DOI 10.1182/blood-2007-07-099622; Delorme B, 2006, REGEN MED, V1, P497, DOI 10.2217/17460751.1.4.497; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Doucet C, 2005, J CELL PHYSIOL, V205, P228, DOI 10.1002/jcp.20391; Douki T, 2003, NUCLEIC ACIDS RES, V31, P3134, DOI 10.1093/nar/gkg408; Drawz SM, 2015, TRANSFUSION, V55, P1745, DOI 10.1111/trf.13026; Faddy HM, 2016, TRANSFUSION, V56, P1548, DOI 10.1111/trf.13519; Faddy HM, 2016, VOX SANG; Fast LD, 2006, TRANSFUSION, V46, P642, DOI 10.1111/j.1537-2995.2006.00777.x; Fekete N, 2014, TISSUE ENG PART C-ME, V20, P129, DOI [10.1089/ten.tec.2013.0061, 10.1089/ten.TEC.2013.0061]; Fekete N, 2012, CYTOTHERAPY, V14, P540, DOI 10.3109/14653249.2012.655420; Francois M, 2012, J CELL PHYSIOL, V227, P3535, DOI 10.1002/jcp.24081; FRYSTYK J, 1994, FEBS LETT, V348, P185, DOI 10.1016/0014-5793(94)00602-4; Funk MB, 2011, TRANSFUS MED HEMOTH, V38, P266, DOI 10.1159/000330372; Goodrich RP, 2006, TRANSFUS APHER SCI, V35, P5, DOI 10.1016/j.transci.2006.01.007; Grass JA, 1998, BLOOD, V91, P2180, DOI 10.1182/blood.V91.6.2180.2180_2180_2188; Gurung S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15042; Han GW, 2012, INT J BIOL SCI, V8, P228, DOI 10.7150/ijbs.8.228; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Infanti L, 2011, TRANSFUS APHER SCI, V45, P175, DOI 10.1016/j.transci.2011.07.013; Iudicone P, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-28; Jing DH, 2012, HAEMATOL-HEMATOL J, V97, P331, DOI 10.3324/haematol.2011.050815; Jonsdottir-Buch SM, 2015, CELL TRANSPLANT, V24, P1545, DOI 10.3727/096368914X683043; Jonsdottir-Buch SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068984; Krause K, 2009, HEART, V95, P1145, DOI 10.1136/hrt.2008.155077; Kuehnert MJ, 2001, TRANSFUSION, V41, P1493, DOI 10.1046/j.1537-2995.2001.41121493.x; Kwon SY, 2014, VOX SANG, V107, P254, DOI 10.1111/vox.12158; Lepelletier Y, 2010, STEM CELLS DEV, V19, P1075, DOI 10.1089/scd.2009.0212; Lin L, 2004, TRANSFUSION, V44, P1496, DOI 10.1111/j.1537-2995.2004.04125.x; Lin LL, 2005, TRANSFUSION, V45, P580, DOI 10.1111/j.0041-1132.2005.04316.x; Lindholm Paul F., 2011, Infectious Disorders - Drug Targets, V11, P45; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Lucarelli E, 2003, BIOMATERIALS, V24, P3095, DOI 10.1016/S0142-9612(03)00114-5; Menard C, 2013, STEM CELLS DEV, V22, P1789, DOI 10.1089/scd.2012.0594; Mohr H, 2009, TRANSFUSION, V49, P2612, DOI 10.1111/j.1537-2995.2009.02334.x; Mohr H, 2009, TRANSFUSION, V49, P1956, DOI 10.1111/j.1537-2995.2009.02228.x; Ng F, 2008, BLOOD, V112, P295, DOI 10.1182/blood-2007-07-103697; Oikonomopoulos A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16570; Pohler P, 2015, TRANSFUSION, V55, P337, DOI 10.1111/trf.12836; PUCHTLER H, 1978, HISTOCHEMISTRY, V56, P177, DOI 10.1007/BF00495978; PUCHTLER H, 1969, J HISTOCHEM CYTOCHEM, V17, P110, DOI 10.1177/17.2.110; Reddy HL, 2008, TRANSFUS MED REV, V22, P133, DOI 10.1016/j.tmrv.2007.12.003; Romieu-Mourez R, 2007, J IMMUNOL, V179, P1549, DOI 10.4049/jimmunol.179.3.1549; Ruane PH, 2004, TRANSFUSION, V44, P877, DOI 10.1111/j.1537-2995.2004.03355.x; Sanjabi S, 2009, CURR OPIN PHARMACOL, V9, P447, DOI 10.1016/j.coph.2009.04.008; Schlenke P, 2014, TRANSFUS MED HEMOTH, V41, P309, DOI 10.1159/000365646; Schrezenmeier H, 2007, TRANSFUSION, V47, P644, DOI 10.1111/j.1537-2995.2007.01166.x; Seltsam A, 2011, TRANSFUS MED HEMOTH, V38, P43, DOI 10.1159/000323845; Sensebe L, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt217; Shih DTB, 2015, NEW BIOTECHNOL, V32, P199, DOI 10.1016/j.nbt.2014.06.001; Spees JL, 2004, MOL THER, V9, P747, DOI 10.1016/j.ymthe.2004.02.012; Squillaro T, 2015, CELL TRANSPLANT; te Boome LCJ, 2015, LEUKEMIA, V29, P1839, DOI 10.1038/leu.2015.89; Thiele T, 2015, VOX SANG, V109, P44, DOI 10.1111/vox.12247; van Rhenen D, 2003, BLOOD, V101, P2426, DOI 10.1182/blood-2002-03-0932	72	27	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0181406	10.1371/journal.pone.0181406	http://dx.doi.org/10.1371/journal.pone.0181406			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763452	Green Published, gold, Green Submitted			2022-12-26	WOS:000406766500012
J	Sang, Q; Cai, B; Chen, H				Sang, Qiang; Cai, Biao; Chen, Hao			Contour detection improved by context-adaptive surround suppression	PLOS ONE			English	Article							SALIENT CONTOURS; INTEGRATION; INHIBITION; MODEL; EXTRACTION	Recently, many image processing applications have taken advantage of a psychophysical and neurophysiological mechanism, called "surround suppression" to extract object contour from a natural scene. However, these traditional methods often adopt a single suppression model and a fixed input parameter called "inhibition level", which needs to be manually specified. To overcome these drawbacks, we propose a novel model, called "context-adaptive surround suppression", which can automatically control the effect of surround suppression according to image local contextual features measured by a surface estimator based on a local linear kernel. Moreover, a dynamic suppression method and its stopping mechanism are introduced to avoid manual intervention. The proposed algorithm is demonstrated and validated by a broad range of experimental results.	[Sang, Qiang] Chengdu Univ Technol, Coll Informat Sci & Technol, Chengdu, Sichuan, Peoples R China; [Cai, Biao] Chengdu Univ Technol, Dept Digital Media Technol, Chengdu, Sichuan, Peoples R China; [Chen, Hao] Southwest Univ Nationalities, Dept Comp Sci & Technol, Chengdu, Sichuan, Peoples R China	Chengdu University of Technology; Chengdu University of Technology; Southwest Minzu University	Cai, B (corresponding author), Chengdu Univ Technol, Dept Digital Media Technol, Chengdu, Sichuan, Peoples R China.	caibiao@cdut.edu.cn		Cai, Biao/0000-0002-0609-1914	Chengdu University of Technology [KYGG201529, 10912kytd201510]; Education Department of SiChuan Province [15Z60076]; China's ministry of education [13zxzk01]	Chengdu University of Technology; Education Department of SiChuan Province; China's ministry of education(Ministry of Education, China)	This work was supported by grant number: KYGG201529, funder: Chengdu University of Technology, http://www.jcc.cdut.edu.cn/, receiver: QS; grant number: 15Z60076, funder: Education Department of SiChuan Province, http://www.scedu.net/, receiver: QS; grant number: 10912kytd201510, funder: Chengdu University of Technology, http://www.jcc.cdut.edu.cn, receiver: BC; and grant number: 13zxzk01, funder: China's ministry of education http://en.moe.gov.cn/, receiver: BC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAKEMORE C, 1972, EXP BRAIN RES, V15, P439; Bonneh Y, 1998, VISION RES, V38, P3541, DOI 10.1016/S0042-6989(98)00045-5; Gijbels I, 2002, IEEE T, V28, P1075; Gijbels I, 2007, ANN I STAT MATH, V59, P235, DOI 10.1007/s10463-006-0045-9; Grigorescu C, 2004, IMAGE VISION COMPUT, V22, P609, DOI 10.1016/j.imavis.2003.12.004; Grigorescu C, 2003, IEEE T IMAGE PROCESS, V12, P729, DOI 10.1109/TIP.2003.814250; Grossberg S, 1997, TRENDS NEUROSCI, V20, P106, DOI 10.1016/S0166-2236(96)01002-8; Hess R, 1999, TRENDS COGN SCI, V3, P480, DOI 10.1016/S1364-6613(99)01410-2; Jones HE, 2001, J NEUROPHYSIOL, V86, P2011, DOI 10.1152/jn.2001.86.4.2011; Lee TS, 2003, J PHYSIOL-PARIS, V97, P121, DOI 10.1016/j.jphysparis.2003.09.015; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; Li ZP, 1998, NEURAL COMPUT, V10, P903, DOI 10.1162/089976698300017557; Papari G, 2007, EURASIP J ADV SIG PR, DOI 10.1155/2007/71828; Papari G, 2006, PROC SPIE, V6064, DOI 10.1117/12.643700; Papari G, 2011, PATTERN RECOGN, V44, P1999, DOI 10.1016/j.patcog.2010.08.013; RIZZOLATTI G, 1975, BRAIN RES, V88, P357, DOI 10.1016/0006-8993(75)90399-6; Simmers AJ, 2001, INVEST OPHTH VIS SCI, V42, P2737; Tang QL, 2007, PATTERN RECOGN, V40, P3100, DOI 10.1016/j.patcog.2007.02.009; Tang QL, 2007, IMAGE VISION COMPUT, V25, P1282, DOI 10.1016/j.imavis.2006.08.007; Ursino M, 2004, NEURAL NETWORKS, V17, P719, DOI 10.1016/j.neunet.2004.03.007; Wei H, 2013, NEUROCOMPUTING, V103, P247, DOI 10.1016/j.neucom.2012.09.027; Yen SC, 1998, VISION RES, V38, P719, DOI 10.1016/S0042-6989(97)00197-1; Zeng C, 2011, NEUROCOMPUTING, V74, P1527, DOI 10.1016/j.neucom.2010.12.022; Zeng C, 2011, NEUROIMAGE, V55, P49, DOI 10.1016/j.neuroimage.2010.11.067	24	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0181792	10.1371/journal.pone.0181792	http://dx.doi.org/10.1371/journal.pone.0181792			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759589	Green Published, Green Submitted, gold			2022-12-26	WOS:000406761600028
J	Adam, I; Salih, MM; Mohmmed, AA; Rayis, DA; Elbashir, MI				Adam, Ishag; Salih, Magdi M.; Mohmmed, Ahmed A.; Rayis, Duria A.; Elbashir, Mustafa I.			Pregnant women carrying female fetuses are at higher risk of placental malaria infection	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; MATERNAL ASTHMA; EASTERN SUDAN; OFFSPRING SEX; FETAL SEX; TRANSMISSION; PATHOLOGY; AREA; EPIDEMIOLOGY; EPIGENETICS	Background The pathophysiology of the placental malaria is not fully understood. If there is a fetal sex-specific susceptibility to malaria infection, this might add to the previous knowledge on the immunology, endocrinology and pathophysiology of placental malaria infections. Aims This study was conducted to assess whether the sex of the fetus was associated with placental malaria infections. Subjects and methods A cross-sectional study was performed including a secondary analysis of a cohort of women who were investigated for prevalence and risk factors (including fetal sex) for placental malaria in eastern Sudan. Placental histology was used to diagnose placental malaria infections. Results Among 339 women enrolled, the mean (SD) age was 25.8 (6.7) years and parity was 2.7 (2.2). Among the new born babies, 157 (46.3%) were male and 182 (53.7%) were female. Five (1.5%), 9 (2.7%) and 103 (30.4%) of the 339 placentas had active, active-chronic, pastchronic malaria infection on histopathology examination respectively, while 222 (65.5%) of them showed no malaria infection. Logistic regression analyses showed no associations between maternal age or parity and placental malaria infections. Women who have blood group O (OR = 1.95, 95% CI = 1.19-3.10; P = 0.007) and women who had female new born were at higher risk for placental malaria infections (OR = 2.55, 95% CI = 1.57-4.13; P<0.001). Conclusion Fetal gender may be a novel risk factor for placental malaria. In this work the female placentas were at higher risk for malaria infections than the male placentas.	[Adam, Ishag; Rayis, Duria A.; Elbashir, Mustafa I.] Fac Med Univ Khartoum, Khartoum, Sudan; [Salih, Magdi M.] Univ Khartoum, Fac Med Lab Sci, Khartoum, Sudan; [Mohmmed, Ahmed A.] Ribat Univ, Fac Med, Khartoum, Sudan	University of Khartoum	Adam, I (corresponding author), Fac Med Univ Khartoum, Khartoum, Sudan.	ishagadam@hotmail.com	Salih, Magdi/AAW-2050-2021; Salih, Magdi M/ABE-4905-2021	Salih, Magdi/0000-0003-1827-3659; Adam, Ishag/0000-0001-5031-7741				Adam I, 2005, ANN TROP MED PARASIT, V99, P339, DOI 10.1179/136485905X36244; Adam I, 2011, J INFECT DEV COUNTR, V5, P83, DOI 10.3855/jidc.1282; Adam I, 2009, J PARASITOL, V95, P751, DOI 10.1645/GE-1912.1; Adam I, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-110; Bayoumi NK, 2009, ANN TROP MED PARASIT, V103, P111, DOI 10.1179/136485909X385045; BULMER JN, 1993, HISTOPATHOLOGY, V22, P211, DOI 10.1111/j.1365-2559.1993.tb00110.x; Clifton V, 2009, REPROD FERTIL; Clifton VL, 2010, PLACENTA, V31, pS33, DOI 10.1016/j.placenta.2009.11.010; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Diouf I, 2004, J INFECT DIS, V189, P2235, DOI 10.1086/420791; Gabory A, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-5; Himeidan YE, 2004, ANN TROP MED PARASIT, V98, P631, DOI 10.1179/000349804225021307; JAMES WH, 1995, HUM REPROD, V10, P1403, DOI 10.1093/HUMREP/10.6.1403; James WH, 2001, HUM REPROD, V16, P2246, DOI 10.1093/humrep/16.10.2246; James WH, 2001, HUM REPROD, V16, P2031, DOI 10.1093/humrep/16.9.2031; John R, 2012, REPROD BIOMED ONLINE, V25, P5, DOI 10.1016/j.rbmo.2012.03.018; Laar Amos K, 2013, BMC Res Notes, V6, P350, DOI 10.1186/1756-0500-6-350; Murji A, 2012, AM J; Myers JE, 2015, REPROD SCI, V22, P235, DOI 10.1177/1933719114537713; Ordi J, 1998, AM J SURG PATHOL, V22, P1006, DOI 10.1097/00000478-199808000-00011; Panchenko Polina E., 2015, Biologie Aujourd hui, V209, P175, DOI 10.1051/jbio/2015021; Rayis DA, 2016, ASIAN PACIFIC J TROP, V6, P2014; Redd SC, 1996, AM J TROP MED HYG, V55, P57, DOI 10.4269/ajtmh.1996.55.57; Reeder JC, 2000, INFECT IMMUN, V68, P3923, DOI 10.1128/IAI.68.7.3923-3926.2000; Saif Z, 2014, PLACENTA, V35, P260, DOI 10.1016/j.placenta.2014.01.012; Schalekamp-Timmermans S, 2016, INT J HYDROGEN ENERG, P1; Scott NM, 2009, J IMMUNOL, V182, P1411, DOI 10.4049/jimmunol.182.3.1411; Seneviratne SN, 2016, J OBSTET GYNAECOL, P1; Thornburg KL, 2010, PLACENTA, V31, pS54, DOI 10.1016/j.placenta.2010.01.002; Vatten LJ, 2004, EARLY HUM DEV, V76, P47, DOI 10.1016/j.earlhumdev.2003.10.006; Walker MG, 2012, PLACENTA, V33, P568, DOI 10.1016/j.placenta.2012.03.011; Walsh JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137215	32	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0182394	10.1371/journal.pone.0182394	http://dx.doi.org/10.1371/journal.pone.0182394			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753649	Green Published, Green Submitted, gold			2022-12-26	WOS:000406579300065
J	Beamish, CA; Zhang, LH; Szlapinski, SK; Strutt, BJ; Hill, DJ				Beamish, Christine A.; Zhang, Linhao; Szlapinski, Sandra K.; Strutt, Brenda J.; Hill, David J.			An increase in immature beta-cells lacking Glut2 precedes the expansion of beta-cell mass in the pregnant mouse	PLOS ONE			English	Article							GESTATIONAL DIABETES-MELLITUS; PROLACTIN RECEPTOR; INSULIN-SECRETION; PANCREATIC-ISLETS; ADULT-MOUSE; ADAPTATION; LANGERHANS; GROWTH; IDENTIFICATION; PROLIFERATION	A compensatory increase in beta-cell mass occurs during pregnancy to counter the associated insulin resistance, and a failure in adaptation is thought to contribute to gestational diabetes. Insulin-expressing but glucose-transporter-2-low (Ins (+)Glut2(LO)) progenitor cells are present in mouse and human pancreas, being predominantly located in extra-islet beta-cell clusters, and contribute to the regeneration of the endocrine pancreas following induced ablation. We therefore sought to investigate the contribution of Ins (+)Glut2(LO) cells to beta-cell mass expansion during pregnancy. Female C57Bl/ 6 mice were time mated and pancreata were collected at gestational days (GD) 6, 9, 12, 15, and 18, and postpartum D7 (n = 4/time-point) and compared to control (non-pregnant) animals. Beta cell mass, location, proliferation (Ki67(+)), and proportion of Ins(+)Glut2(LO) cells were measured using immunohistochemistry and bright field or confocal microscopy. Beta cell mass tripled by GD18 and beta-cell proliferation peaked at GD12 in islets (>= 6 beta-cells) and small beta-cell clusters (1-5 beta-cells). The proportion and fraction of Ins(+)Glut2(LO) cells undergoing proliferation increased significantly at GD9 in both islets and clusters, preceding the increase in beta-cell mass and proliferation, and their proliferation within clusters persisted until GD15. The overall number of clusters increased significantly at GD9. Quantitative PCR showed a significant increase in Pdx1 presence at GD9 vs. GD18 or control pancreas, and Pdx1 was visualized by immunohistochemistry within both Ins(+)Glut2(LO) and Ins(+)Glut2(HI) cells within clusters. These results indicate that Ins+Glut2(LO) cells are likely to contribute to beta-cell mass expansion during pregnancy.	[Beamish, Christine A.; Szlapinski, Sandra K.; Hill, David J.] Western Univ, Dept Physiol & Pharmacol, London, ON, Canada; [Beamish, Christine A.; Strutt, Brenda J.; Hill, David J.] Childrens Hlth Res Inst, London, ON, Canada; [Beamish, Christine A.; Zhang, Linhao; Szlapinski, Sandra K.; Hill, David J.] St Joseph Hlth Care, Lawson Hlth Res Inst, London, ON, Canada; [Zhang, Linhao] Sichuan Univ, West China Sch Med, Chengdu, Sichuan, Peoples R China; [Hill, David J.] Western Univ, Dept Med, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Sichuan University; Western University (University of Western Ontario)	Hill, DJ (corresponding author), Western Univ, Dept Physiol & Pharmacol, London, ON, Canada.; Hill, DJ (corresponding author), Childrens Hlth Res Inst, London, ON, Canada.; Hill, DJ (corresponding author), St Joseph Hlth Care, Lawson Hlth Res Inst, London, ON, Canada.; Hill, DJ (corresponding author), Western Univ, Dept Med, London, ON, Canada.	david.hill@lhrionhealth.ca	Hill, David J/G-3302-2011	Hill, David J/0000-0002-2490-5678	Canadian Institute of Health Research [MOP-15263]; Alan Thicke Centre for Juvenile Diabetes Research; Program of Experimental Medicine, Department of Medicine, Schulich School of Medicine and Dentistry, Western University [R0362A06]; Program of Experimental Medicine through the Department of Medicine at the Schulich School of Medicine, Western University, London ON, Canada [R0362A06]; China Scholarship Council (CSC)	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Alan Thicke Centre for Juvenile Diabetes Research; Program of Experimental Medicine, Department of Medicine, Schulich School of Medicine and Dentistry, Western University; Program of Experimental Medicine through the Department of Medicine at the Schulich School of Medicine, Western University, London ON, Canada; China Scholarship Council (CSC)(China Scholarship Council)	Funded by Canadian Institutes of Health Research (MOP-15263) http://www.cihr-irsc.gc.ca. Alan Thicke Centre for Juvenile Diabetes Research. Program of Experimental Medicine (R0362A06), Department of Medicine, Schulich School of Medicine and Dentistry, Western University.; This work was supported by grants from the Canadian Institute of Health Research (MOP-15263), the Alan Thicke Centre for Juvenile Diabetes Research, and from the Program of Experimental Medicine (R0362A06) through the Department of Medicine at the Schulich School of Medicine, Western University, London ON, Canada. Linhao Zhang (MD candidate) was the recipient of a scholarship from the China Scholarship Council (CSC).	Abouna S, 2010, ORGANOGENESIS, V6, P125, DOI 10.4161/org.6.2.10374; Artner I, 2006, DIABETES, V55, P297, DOI 10.2337/diabetes.55.02.06.db05-0946; Bader E, 2016, NATURE, V535, P430, DOI 10.1038/nature18624; Banerjee RR, 2016, DIABETES, V65, P2331, DOI 10.2337/db15-1527; Beamish CA, 2016, ISLETS, V8, P65, DOI 10.1080/19382014.2016.1162367; Brelje TC, 2004, ENDOCRINOLOGY, V145, P4162, DOI 10.1210/en.2004-0201; Butler AE, 2010, DIABETOLOGIA, V53, P2167, DOI 10.1007/s00125-010-1809-6; Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538; Chamson-Reig A, 2010, DIABETOLOGIA, V53, P2188, DOI 10.1007/s00125-010-1835-4; Demirci C, 2012, DIABETES, V61, P1143, DOI 10.2337/db11-1154; Freemark M, 2002, ENDOCRINOLOGY, V143, P1378, DOI 10.1210/en.143.4.1378; Guo LL, 2013, DIABETES, V62, P3459, DOI 10.2337/db12-1833; Huang C, 2009, ENDOCRINOLOGY, V150, P1618, DOI 10.1210/en.2008-1003; Hughes E, 2011, ENDOCRINOLOGY, V152, P847, DOI 10.1210/en.2010-1250; Moffett RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096863; Newbern D, 2011, CURR OPIN ENDOCRINOL, V18, P409, DOI 10.1097/MED.0b013e32834c800d; PARSONS JA, 1992, ENDOCRINOLOGY, V130, P1459, DOI 10.1210/en.130.3.1459; Pechhold S, 2009, NAT BIOTECHNOL, V27, P1038, DOI 10.1038/nbt.1579; Razavi R, 2015, DIABETES, V64, P1311, DOI 10.2337/db14-0070; Rieck S, 2010, TRENDS ENDOCRIN MET, V21, P151, DOI 10.1016/j.tem.2009.11.001; Roscioni SS, 2016, NAT REV ENDOCRINOL, V12, P695, DOI 10.1038/nrendo.2016.147; Seaberg RM, 2004, NAT BIOTECHNOL, V22, P1115, DOI 10.1038/nbt1004; Smukler SR, 2011, CELL STEM CELL, V8, P281, DOI 10.1016/j.stem.2011.01.015; Sorenson RL, 1997, HORM METAB RES, V29, P301, DOI 10.1055/s-2007-979040; Sostrup B, 2014, ACTA OBSTET GYN SCAN, V93, P1190, DOI 10.1111/aogs.12495; Toselli C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100398; van der Meulen T, 2017, CELL METAB, V25, P911, DOI 10.1016/j.cmet.2017.03.017; VANASSCHE FA, 1978, BRIT J OBSTET GYNAEC, V85, P818; Vasavada RC, 2000, J BIOL CHEM, V275, P15399, DOI 10.1074/jbc.275.20.15399; Xiang AH, 2013, DIABETOLOGIA, V56, P2753, DOI 10.1007/s00125-013-3048-0; Xu YL, 2015, DIABETOLOGIA, V58, P2064, DOI 10.1007/s00125-015-3670-0; Xue Y, 2010, ENDOCRINE, V37, P83, DOI 10.1007/s12020-009-9273-0	32	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0182256	10.1371/journal.pone.0182256	http://dx.doi.org/10.1371/journal.pone.0182256			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753672	Green Published, gold, Green Submitted			2022-12-26	WOS:000406579300060
J	Almeida, FM; Saraiva-Romanholo, BM; Vieira, RP; Moriya, HT; Ligeiro-De-Oliveira, AP; Lopes, FDTQS; Castro-Faria-Neto, HC; Mauad, T; Martins, MA; Pazetti, R				Almeida, Francine Maria; Saraiva-Romanholo, Beatriz Mangueira; Vieira, Rodolfo Paula; Moriya, Henrique Takachi; Ligeiro-de-Oliveira, Ana Paula; Lopes, Fernanda D. T. Q. S.; Castro-Faria-Neto, Hugo C.; Mauad, Thais; Martins, Milton Arruda; Pazetti, Rogerio			Compensatory lung growth after bilobectomy in emphysematous rats	PLOS ONE			English	Article							VOLUME-REDUCTION SURGERY; OBSTRUCTIVE PULMONARY-DISEASE; ELASTASE-INDUCED EMPHYSEMA; EXPERIMENTAL-MODELS; OXIDATIVE STRESS; CIGARETTE-SMOKE; TREATMENT TRIAL; ANIMAL-MODELS; HE-3 MRI; TRANSPLANTATION	Lung volume reduction surgery (LVRS) is an option for emphysematous patients who are awaiting lung transplantation. LVRS reduces nonfunctional portions of lung tissues and favors the compensatory lung growth (CLG) of the remaining lobes. This phenomenon diminishes dyspnea and improves both the respiratory mechanics and quality of life for the patients. An animal model of elastase-induced pulmonary emphysema was used to investigate the structural and functional lung response after LVRS. Bilobectomy was performed six weeks after elastase instillation. Two weeks after bilobectomy, CLG effects were evaluated by lung mechanics and histomorphometric analysis. After bilobectomy, the emphysematous animals presented decreased mean linear intercepts, increased elastic fiber proportion, and increased alveolar surface density, total volumes of airspace, tissue and respiratory region and absolute surface area. We conclude that bilobectomy promoted CLG in emphysematous animals, resulting in alveolar architecture repair.	[Almeida, Francine Maria; Saraiva-Romanholo, Beatriz Mangueira; Lopes, Fernanda D. T. Q. S.; Martins, Milton Arruda] Univ Sao Paulo, Fac Med, LIM20, Sao Paulo, Brazil; [Saraiva-Romanholo, Beatriz Mangueira] IAMSPE UNICID, Sao Paulo, Brazil; [Vieira, Rodolfo Paula; Ligeiro-de-Oliveira, Ana Paula] Sch Med Sci Sao Jose dos Campos Humanitas & Univ, Brazilian Inst Teaching & Res Pulm & Exercise Imm, Sao Paulo, Brazil; [Moriya, Henrique Takachi] Univ Sao Paulo, LEB, Sao Paulo, Brazil; [Castro-Faria-Neto, Hugo C.] Inst Oswaldo Cruz, Lab Immunopharmacol, Rio De Janeiro, Brazil; [Mauad, Thais] FMUSP, Pathol LIM05, Sao Paulo, Brazil; [Pazetti, Rogerio] Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, Cardiopneumol LIM61, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Fundacao Oswaldo Cruz; Universidade de Sao Paulo; Universidade de Sao Paulo	Pazetti, R (corresponding author), Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, Cardiopneumol LIM61, Sao Paulo, Brazil.	rogerpaz@usp.br	de Almeida, Francine Maria/S-2314-2019; Almeida, Francine Maria/H-3733-2013; Saraiva-Romanholo, Beatriz Mangueira/I-5482-2013; Moriya, Henrique Takachi/B-5661-2011; de Paula Vieira, Rodolfo/E-9315-2011; Pazetti, Rogerio/D-6294-2012	de Almeida, Francine Maria/0000-0001-9755-5034; Almeida, Francine Maria/0000-0001-9755-5034; Saraiva-Romanholo, Beatriz Mangueira/0000-0003-0853-9708; Moriya, Henrique Takachi/0000-0002-1595-1779; de Paula Vieira, Rodolfo/0000-0001-6379-1143; DTQS Lopes, Fernanda/0000-0002-6402-3055; Ligeiro de Oliveira, Ana Paula/0000-0001-6089-5107	CAPES MSc fellowship; European Respiratory Society/Marie Curie Actions/European Union - 7th Framework Program	CAPES MSc fellowship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); European Respiratory Society/Marie Curie Actions/European Union - 7th Framework Program	FMA holds a CAPES MSc fellowship. RPV holds a Post-doctoral fellowship from European Respiratory Society/Marie Curie Actions/European Union - 7th Framework Program.	Agzarian J, 2013, ANN THORAC SURG, V96, P1217, DOI 10.1016/j.athoracsur.2013.04.077; Antunes MA, 2011, AN ACAD BRAS CIENC, V83, P1385, DOI 10.1590/S0001-37652011005000039; Bates JHT, 2009, LUNG MECHANICS: AN INVERSE MODELING APPROACH, P1, DOI 10.1017/CBO9780511627156; Braber S, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-99; Brewer KK, 2003, J APPL PHYSIOL, V95, P1926, DOI 10.1152/japplphysiol.00102.2003; CAGLE PT, 1990, AM J RESP CELL MOL, V3, P153, DOI 10.1165/ajrcmb/3.2.153; Emami K, 2008, J APPL PHYSIOL, V104, P773, DOI 10.1152/japplphysiol.00482.2007; Fernandez LG, 2007, J THORAC CARDIOV SUR, V134, P1300, DOI 10.1016/j.jtcvs.2007.07.005; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fishman A, 2003, NEW ENGL J MED, V348, P2059; Fishman A, 2001, NEW ENGL J MED, V345, P1075; Fusco LBF M.H., 2005, J BRAS PNEUMOL, P76; Gelb AF, 1999, CHEST, V116, P1608, DOI 10.1378/chest.116.6.1608; GOLD, GLOB STRAT DIAGN MAN; Han WH, 2011, ANTIOXID REDOX SIGN, V15, P2121, DOI 10.1089/ars.2010.3821; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Inoue K, 2010, J CLIN BIOCHEM NUTR, V46, P168, DOI 10.3164/jcbn.09-87; Kaza AK, 2002, CIRCULATION, V106, pI120, DOI 10.1161/01.cir.0000032918.33237.04; Kaza AK, 2001, ANN THORAC SURG, V71, P1645, DOI 10.1016/S0003-4975(01)02478-X; Kelleher CM, 2005, AM J RESP CELL MOL, V33, P355, DOI 10.1165/rcmb.2005-0206OC; Kim DK, 2003, RESP RES, V4, DOI 10.1186/rr196; Konerding MA, 2012, ANGIOGENESIS, V15, P23, DOI 10.1007/s10456-011-9236-y; Kuraki T, 2002, AM J RESP CRIT CARE, V166, P496, DOI 10.1164/rccm.2103118; Le Cras TD, 2005, J APPL PHYSIOL, V98, P1140, DOI 10.1152/japplphysiol.00479.2004; Mahadeva R, 2002, THORAX, V57, P908, DOI 10.1136/thorax.57.10.908; Marcus NY, 2012, EXP BIOL MED, V237, P1163, DOI 10.1258/ebm.2012.012106; MASSARO D, 1985, J CLIN INVEST, V76, P1297, DOI 10.1172/JCI112103; Miller J D, 1999, Can Respir J, V6, P26; Miller JD, 2006, ANN THORAC SURG, V81, P314, DOI 10.1016/j.athoracsur.2005.07.055; Mineo D, 2010, AM J RESP CRIT CARE, V181, P806, DOI 10.1164/rccm.200910-1476OC; National Research Council, 2011, GUIDE CARE USE LAB A; Naunheim KS, 2006, J THORAC CARDIOV SUR, V131, P43, DOI 10.1016/j.jtcvs.2005.09.006; Onclinx C, 2006, RADIOLOGY, V241, P763, DOI 10.1148/radiol.2413051456; Peces-Barba G, 2003, EUR RESPIR J, V22, P14, DOI 10.1183/09031936.03.00084402; Polonio IB, 2012, J BRAS PNEUMOL, V38, P452, DOI 10.1590/S1806-37132012000400007; Quintana HK, 2006, MAGN RESON MED, V56, P1242, DOI 10.1002/mrm.21051; Ramos DS, 2010, MED SCI SPORT EXER, V42, P113, DOI 10.1249/MSS.0b013e3181ad1c72; Ramsey S, 2007, CHEST, V131, P823, DOI 10.1378/chest.06-1790; SALDIVA PHN, 1989, CHEST, V95, P953, DOI 10.1378/chest.95.5.953; Sanchez PG, 2010, J THORAC CARDIOV SUR, V140, P564, DOI 10.1016/j.jtcvs.2010.03.050; Shigemura N, 2005, AM J RESP CRIT CARE, V171, P1237, DOI 10.1164/rccm.200411-1518OC; Shigemura N, 2006, AM J RESP CRIT CARE, V174, P1199, DOI 10.1164/rccm.200603-406OC; Shigemura N, 2013, TRANSPLANTATION, V96, P421, DOI 10.1097/TP.0b013e31829853ac; Stenmark KR, 2003, AM J RESP CELL MOL, V28, P133, DOI 10.1165/rcmb.F259; Toledo AC, 2012, EUR RESPIR J, V39, P254, DOI 10.1183/09031936.00003411; Vieira RP, 2008, AM J PHYSIOL-LUNG C, V295, pL670, DOI 10.1152/ajplung.00465.2007; Wada H, 2012, J THORAC CARDIOV SUR, V143, P711, DOI 10.1016/j.jtcvs.2011.09.024; Wright JL, 2008, AM J PHYSIOL-LUNG C, V295, pL1, DOI 10.1152/ajplung.90200.2008; Zhang WH, 2010, EUR J PHARMACOL, V647, P178, DOI 10.1016/j.ejphar.2010.08.028	49	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e181819	10.1371/journal.pone.0181819	http://dx.doi.org/10.1371/journal.pone.0181819			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750097	Green Published, gold, Green Submitted			2022-12-26	WOS:000406575700084
J	Shea, DJ; Li, YW; Stebe, KJ; Konstantopoulos, K				Shea, Daniel J.; Li, Yi W.; Stebe, Kathleen J.; Konstantopoulos, Konstantinos			E-selectin-mediated rolling facilitates pancreatic cancer cell adhesion to hyaluronic acid	FASEB JOURNAL			English	Article						PODXL; CD44v; cell rolling	COLON-CARCINOMA CELLS; SHEAR-FLOW; VASCULAR INTERACTIONS; TUMOR-CELLS; P-SELECTIN; MUCIN 16; CD44; BINDING; KINETICS; LIGAND	Tumor cell extravasation is a multistep process preceded by cell rolling and arrest on the vessel wall via the formation of specific receptor-ligand bonds. The strength, availability, and number of receptor-ligand bonds regulate the rate by which tumor cells tether, roll, and adhere to vascular walls. Although the mechanics of selectin mediated rolling have been extensively studied, little is known regarding how tumor cell rolling on selectins facilitates adhesion toa distinct substrate-bound protein with different kinetic properties. By using multicomponent protein patterning and a microfluidic system, we evaluated how E-selectin-dependent rolling modulates hyaluronic acid ( HA) adhesion as a function of fluid shear, contact time, and the spacing between E-selectin and HA regions patterned on the substrate. We show that tumor cells rolling on E-selectinwere similar to 40-fold more likely to bind to HA than nonrolling cells in shear flow. Furthermore, E-selectin-dependent rolling promotes adhesion to HA by both physically slowing cells and enabling them to position proximal to the surface, thereby increasing the on rate of adhesion. Abetter understanding of tumor cell adhesion under physiologic shear would lead to the development of new diagnostic assays and pave the way to clinical approaches aimed ultimately to halt metastasis.-Shea, D. J., Li, Y. W., Stebe, K. J., Konstantopoulos, K. E-selectin-mediated rolling facilitates pancreatic cancer cell adhesion to hyaluronic acid.	[Konstantopoulos, Konstantinos] Johns Hopkins Univ, Johns Hopkins Inst NanoBioTechnol, Baltimore, MD USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Dept Oncol, Baltimore, MD USA; [Stebe, Kathleen J.] Univ Penn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Pennsylvania	Konstantopoulos, K (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, 3400 N Charles St, Baltimore, MD 21218 USA.	konstant@jhu.edu			National Science Foundation [NSF-CBET-1159823]; U.S. National Institutes of Health, National Cancer Institute [R01CA186286]; NATIONAL CANCER INSTITUTE [R01CA186286] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Science Foundation Grant NSF-CBET-1159823 (to K.K. and K.J.S.) and the U.S. National Institutes of Health, National Cancer Institute Grant R01CA186286 (to K.K.). The authors declare no conflicts of interest.	Alon R, 1998, P NATL ACAD SCI USA, V95, P11631, DOI 10.1073/pnas.95.20.11631; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Burdick MM, 2004, AM J PHYSIOL-CELL PH, V287, pC539, DOI 10.1152/ajpcell.00450.2003; Burdick MM, 2003, AM J PHYSIOL-CELL PH, V284, pC977, DOI 10.1152/ajpcell.00423.2002; Chang KC, 2000, P NATL ACAD SCI USA, V97, P11262, DOI 10.1073/pnas.200240897; Chen SH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01870; Chen SH, 2012, FASEB J, V26, P1349, DOI 10.1096/fj.11-195669; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; Cheung LSL, 2011, BIOPHYS J, V100, P2338, DOI 10.1016/j.bpj.2011.04.013; Cheung LSL, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015013; Christophis C, 2011, BIOPHYS J, V101, P585, DOI 10.1016/j.bpj.2011.05.045; Clark RA, 1996, J CELL BIOL, V134, P1075, DOI 10.1083/jcb.134.4.1075; Dallas MR, 2012, AM J PHYSIOL-CELL PH, V303, pC616, DOI 10.1152/ajpcell.00149.2012; Ghosh M, 2008, LANGMUIR, V24, P8134, DOI 10.1021/la8006525; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; HAMMER DA, 1992, BIOPHYS J, V63, P35, DOI 10.1016/S0006-3495(92)81577-1; Hanley WD, 2004, J CELL SCI, V117, P2503, DOI 10.1242/jcs.01088; Hanley WD, 2006, FASEB J, V20, P337, DOI 10.1096/fj.05-4574fje; Jablonska A, 2018, J CEREBR BLOOD F MET, V38, P835, DOI 10.1177/0271678X17703888; Kim HR, 2004, CANCER RES, V64, P4569, DOI 10.1158/0008-5472.CAN-04-0202; Konstantopoulos K, 2009, ANNU REV BIOMED ENG, V11, P177, DOI 10.1146/annurev-bioeng-061008-124949; Launiere C, 2012, ANAL CHEM, V84, P4022, DOI 10.1021/ac2033408; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; McCarty OJT, 2002, BIOPHYS J, V83, P836, DOI 10.1016/S0006-3495(02)75212-0; Mohamadzadeh M, 1998, J CLIN INVEST, V101, P97, DOI 10.1172/JCI1604; Myung JH, 2014, ANAL CHEM, V86, P6088, DOI 10.1021/ac501243a; Nalayanda DD, 2007, BIOMED MICRODEVICES, V9, P207, DOI 10.1007/s10544-006-9022-6; Nandi A, 2000, J BIOL CHEM, V275, P14939, DOI 10.1074/jbc.275.20.14939; Napier SL, 2007, J BIOL CHEM, V282, P3433, DOI 10.1074/jbc.M607219200; Ogino S, 2010, STRUCTURE, V18, P649, DOI 10.1016/j.str.2010.02.010; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Raman PS, 2012, BIOPHYS J, V103, P415, DOI 10.1016/j.bpj.2012.06.039; Raman PS, 2011, J CELL SCI, V124, P1903, DOI 10.1242/jcs.079814; Schmidt BJ, 2008, ANAL CHEM, V80, P944, DOI 10.1021/ac071529i; Shea DJ, 2015, ONCOTARGET, V6, P24842, DOI 10.18632/oncotarget.4704; Streppel MM, 2012, HUM PATHOL, V43, P1755, DOI 10.1016/j.humpath.2012.01.005; TAKADA M, 1994, PANCREAS, V9, P748, DOI 10.1097/00006676-199411000-00013; Thomas SN, 2009, BIORHEOLOGY, V46, P207, DOI 10.3233/BIR-2009-0534; Tong ZQ, 2012, INTEGR BIOL-UK, V4, P847, DOI 10.1039/c2ib20036h; Wu L, 2007, J BIOL CHEM, V282, P9846, DOI 10.1074/jbc.M609219200; Yago T, 2004, J CELL BIOL, V166, P913, DOI 10.1083/jcb.200403144; Yu Q, 1997, J EXP MED, V186, P1985, DOI 10.1084/jem.186.12.1985; Zhu C, 2000, BIOPHYS J, V79, P1850, DOI 10.1016/S0006-3495(00)76434-4	43	12	12	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					5078	5086		10.1096/fj.201700331R	http://dx.doi.org/10.1096/fj.201700331R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28765175	Green Published			2022-12-26	WOS:000413398500035
J	Wang, Y; Chen, FQ; Zhao, M; Yang, Z; Li, J; Zhang, SQ; Zhang, WY; Ye, LH; Zhang, XD				Wang, Yuan; Chen, Fuquan; Zhao, Man; Yang, Zhe; Li, Jiong; Zhang, Shuqin; Zhang, Weiying; Ye, Lihong; Zhang, Xiaodong			The long noncoding RNA HULC promotes liver cancer by increasing the expression of the HMGA2 oncogene via sequestration of the microRNA-186	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOMA-CELLS; HEPATOCELLULAR-CARCINOMA; GASTRIC-CANCER; BREAST-CANCER; PROLIFERATION; PROTEIN; MIR-186; OVEREXPRESSION; TUMORIGENICITY; METASTASIS	The long noncoding RNA highly up-regulated in liver cancer (HULC) is aberrantly elevated in hepatocellular carcinoma (HCC), and this up-regulation is crucial for HCC pathogenesis. However, the underlying mechanism in HULC up-regulation is poorly understood. We hypothesized that HULC might modulate the oncogene high mobility group A2 (HMGA2) to promote hepatocarcinogenesis. Quantitative real-time PCR analysis showed that the expression levels of HULC were positively correlated with those of HMGA2 in clinical HCC tissues. Interestingly, we also observed that HULC could up-regulate HMGA2 in HCC cells. Mechanistically, we found that the microRNA-186 inhibited HMGA2 expression by targeting the 3'-untranslated region (3'-UTR) of HMGA2m RNA. Strikingly, HULC acted as a competing noncoding RNA to sequester miR-186 and thereby relieved miR-186-mediated HMGA2 repression. Functionally, HMGA2 knockdown decreased the HULC-enhanced growth of HCC cells both in vitro and in vivo. We conclude that the long noncoding RNA HULC increases HMGA2 expression by sequestering miR-186 post-transcriptionally and thereby promotes liver cancer growth, providing new insights into the mechanism by which HULC enhances hepatocarcinogenesis.	[Wang, Yuan; Chen, Fuquan; Zhao, Man; Yang, Zhe; Li, Jiong; Zhang, Shuqin; Zhang, Weiying] Nankai Univ, Coll Life Sci, Dept Canc Res, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Ye, Lihong; Zhang, Xiaodong] Nankai Univ, Dept Biochem, Coll Life Sci, State Key Lab Med Chem Biol, 94 Weijin Rd, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Ye, LH; Zhang, XD (corresponding author), Nankai Univ, Dept Biochem, Coll Life Sci, State Key Lab Med Chem Biol, 94 Weijin Rd, Tianjin 300071, Peoples R China.	yelihong@nankai.edu.cn; zhangxd@nankai.edu.cn	Lv, Yuanjie/AER-0767-2022; Wang, Yuan/HHC-1520-2022; wangwangwang, yuanyaun/HHN-6432-2022		National Basic Research Program of China 973 Program [2015CB553703, 2015CB553905]; National Natural Science Foundation of China [81272218, 81372186, 31670769, 31670771]; Project of Prevention and Treatment of Key Infectious Diseases Grant [2014ZX0002002-005]; Project of Prevention and Control of Key Chronic Non-infectious Diseases Grant [2016YFC130340]	National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Prevention and Treatment of Key Infectious Diseases Grant; Project of Prevention and Control of Key Chronic Non-infectious Diseases Grant	This work was supported by National Basic Research Program of China 973 Program Grants 2015CB553703 and 2015CB553905; National Natural Science Foundation of China Grants 81272218, 81372186, 31670769, and 31670771; Project of Prevention and Treatment of Key Infectious Diseases Grant 2014ZX0002002-005; and Project of Prevention and Control of Key Chronic Non-infectious Diseases Grant 2016YFC130340. The authors declare that they have no conflicts of interest with the contents of this article.	Agostini A, 2016, ONCOTARGET, V7, P85058, DOI 10.18632/oncotarget.13187; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Cao CH, 2016, ONCOTARGET, V7, P79956, DOI 10.18632/oncotarget.13182; Cui M, 2015, NEOPLASIA, V17, P79, DOI 10.1016/j.neo.2014.11.004; Cui NI., 2015, CANC RES, V75; Du YM, 2012, J BIOL CHEM, V287, P26302, DOI 10.1074/jbc.M112.342113; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Hua X, 2016, AM J CANCER RES, V6, P1650; Kaur H, 2016, CANCER LETT, V377, P55, DOI 10.1016/j.canlet.2016.04.020; Khanduja JS, 2016, MOL CELL, V63, P7, DOI 10.1016/j.molcel.2016.06.011; Li C, 2015, CELL PHYSIOL BIOCHEM, V36, P423, DOI 10.1159/000430109; Li HL, 2013, CARCINOGENESIS, V34, P2145, DOI 10.1093/carcin/bgt158; Liu L, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.35; Liu YW, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0588-9; Lu ZP, 2016, ONCOTARGET, V7, P241, DOI 10.18632/oncotarget.6280; Morishita A, 2013, CANCER RES, V73, P4289, DOI 10.1158/0008-5472.CAN-12-3848; Palumbo A, 2016, ONCOTARGET, V7, P25872, DOI 10.18632/oncotarget.8288; Panzitt K, 2007, GASTROENTEROLOGY, V132, P330, DOI 10.1053/j.gastro.2006.08.026; Parasramka MA, 2016, PHARMACOL THERAPEUT, V161, P67, DOI 10.1016/j.pharmthera.2016.03.004; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Ruan TY, 2016, ONCOL LETT, V11, P2941, DOI 10.3892/ol.2016.4312; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shan CL, 2011, CARCINOGENESIS, V32, P1190, DOI 10.1093/carcin/bgr106; Shan CL, 2010, CELL RES, V20, P563, DOI 10.1038/cr.2010.49; Shi H, 2016, CANCER LETT, V382, P147, DOI 10.1016/j.canlet.2016.08.025; Shi XF, 2013, CANCER LETT, V339, P159, DOI 10.1016/j.canlet.2013.06.013; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Wang XC, 2011, CLIN CANCER RES, V17, P2570, DOI 10.1158/1078-0432.CCR-10-2542; Wang Y, 2016, BIOCHEM BIOPH RES CO, V480, P455, DOI 10.1016/j.bbrc.2016.10.070; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Wend P, 2013, EMBO MOL MED, V5, P264, DOI 10.1002/emmm.201201320; Wu I., 2016, CARCINOGENESIS, V37; Wu JJ, 2016, CANCER LETT, V376, P284, DOI 10.1016/j.canlet.2016.04.005; Wu JJ, 2013, J MOL MED, V91, P1155, DOI 10.1007/s00109-013-1055-8; Wu JJ, 2011, CANCER RES, V71, P349, DOI 10.1158/0008-5472.CAN-10-2550; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919; Yang X, 2015, CANCER LETT, V360, P119, DOI 10.1016/j.canlet.2015.02.035; You X, 2014, ONCOGENE, V33, P449, DOI 10.1038/onc.2012.618; You XN, 2013, CARCINOGENESIS, V34, P1644, DOI 10.1093/carcin/bgt089; Young ARJ, 2007, GENE DEV, V21, P1005, DOI 10.1101/gad.1554707; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu X, 2017, J CELL MOL MED, V21, P410, DOI 10.1111/jcmm.12956; Yuan, 2014, CANCER CELL, V25, P666, DOI DOI 10.1016/J.CCR.2014.03.010; Zhang T, 2012, HEPATOLOGY, V56, P2051, DOI 10.1002/hep.25899; Zhang W, 2012, PLOS ONE, V7; Zhao XP, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0777-0; Zhu X, 2016, ONCOGENE, V35, P323, DOI 10.1038/onc.2015.84	50	104	107	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15395	15407		10.1074/jbc.M117.783738	http://dx.doi.org/10.1074/jbc.M117.783738			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28765279	Green Published, hybrid			2022-12-26	WOS:000410809800020
J	Anel-Lopez, L; Ortega-Ferrusola, C; Martinez-Rodriguez, C; Alvarez, M; Borragan, S; Chamorro, C; Pena, FJ; Anel, L; de Paz, P				Anel-Lopez, L.; Ortega-Ferrusola, C.; Martinez-Rodriguez, C.; Alvarez, M.; Borragan, S.; Chamorro, C.; Pena, F. J.; Anel, L.; de Paz, P.			Analysis of seminal plasma from brown bear (Ursus arctos) during the breeding season: Its relationship with testosterone levels	PLOS ONE			English	Article							SEMEN CHARACTERISTICS; BINDING PROTEINS; RAM SPERMATOZOA; SPERM MOTILITY; MAJOR PROTEINS; CAPACITATION; PROTEOME; QUALITY; ZINC; CRYOPRESERVATION	Seminal plasma (SP) plays an important role in the motility, viability and maintenance of the fertilizing capacity of mammalian spermatozoa. This study is the first on brown bear (Ursus arctos) SP components, and has two main objectives: 1) to define the SP composition in bear ejaculate and 2) to identify variations in SP composition in relation to high and low levels of testosterone in serum during the breeding season. Forty-eight sperm samples from 30 sexually mature male brown bears (Ursus arctos) were obtained by electroejaculation, and their serum testosterone levels were assessed to sort the animals into 2 groups (high and low testosterone levels, threshold 5 ng/dl). The biochemical and protein compositions of the SP samples were assessed, and sperm motility was analyzed. We found that lactate dehydrogenase was significantly higher in the low-serum-testosterone samples, while concentrations of lipase and Mg+ values were significantly higher in the high-serum-testosterone samples. In contrast, sperm motility did not significantly differ (P>0.05) between the testosterone level groups (total motility: 74.42.8% in the high-level group vs. 77.1 +/- 4.7% in the low-level group). A reference digital model was constructed since there is no information for this wild species. To do this, all gel images were added in a binary multidimensional image and thirty-three spots were identified as the most-repeated spots. An analysis of these proteins was done by qualitative equivalency (isoelectric point and molecular weight) with published data for a bull. SP protein composition was compared between bears with high and low serum testosterone, and three proteins (binder of sperm and two enzymes not identified in the reference bull) showed significant (P<0.05) quantitative differences. We conclude that male bears with high or low serum testosterone levels differs only in some properties of their SP, differences in enzyme LDIP2, energy source LACT2, one protein (similar to BSP1) and Mg ion were identified between these two groups. These data may inform the application of SP to improve bear semen extenders.	[Anel-Lopez, L.; Ortega-Ferrusola, C.; Alvarez, M.; Anel, L.] Univ Leon, Anim Reprod & Obstet, Leon, Spain; [Anel-Lopez, L.; Ortega-Ferrusola, C.; Martinez-Rodriguez, C.; Alvarez, M.; Chamorro, C.; Anel, L.; de Paz, P.] Univ Leon, ITRA ULE, INDEGSAL, Leon, Spain; [Martinez-Rodriguez, C.; de Paz, P.] Univ Leon, Mol Biol Cell Biol, Leon, Spain; [Borragan, S.] Cabarceno Pk, Cantabria, Spain; [Chamorro, C.] Univ Leon, Vet Anat, Leon, Spain; [Pena, F. J.] Univ Extremadura, Vet Teaching Hosp, Lab Equine Reprod & Equine Spermatol, Caceres, Spain	Universidad de Leon; Universidad de Leon; Universidad de Leon; Universidad de Leon; Universidad de Extremadura	Anel-Lopez, L (corresponding author), Univ Leon, Anim Reprod & Obstet, Leon, Spain.; Anel-Lopez, L (corresponding author), Univ Leon, ITRA ULE, INDEGSAL, Leon, Spain.	luis.anel86@gmail.com	Anel, Luis/K-6573-2017; Ortega-Ferrusola, Cristina/AGI-8478-2022; Peña, Fernando J/D-8450-2012; Anel-Lopez, Luis/K-6546-2017; ANEL-LÓPEZ, LUIS/AAP-2438-2020; de Paz, Paulino/K-8776-2014	Anel, Luis/0000-0003-2423-4031; Ortega-Ferrusola, Cristina/0000-0002-7698-8735; Peña, Fernando J/0000-0002-1311-2947; Anel-Lopez, Luis/0000-0001-7179-5742; ANEL-LÓPEZ, LUIS/0000-0001-7179-5742; Martinez-Rodriguez, Carmen/0000-0001-5773-6455; de Paz, Paulino/0000-0003-2531-595X	MINECO [CGL2013-48255-R]; Ministerio de Economia y Competitividad "Juan de la Cierva [IJCI-2014-21671]	MINECO(Spanish Government); Ministerio de Economia y Competitividad "Juan de la Cierva(Spanish Government)	This work was supported in part by MINECO (CGL2013-48255-R) and Cantur S.A. Luis Anel-Lopez was supported by MINECO (CGL2013-48255-R). C. Ortega Ferrusola is supported by a postdoctoral grant from "Ministerio de Economia y Competitividad "Juan de la Cierva" IJCI-2014-21671.	Alvarez-Rodriguez M, 2013, REPROD FERT DEVELOP, V25; BAAS JW, 1983, J REPROD FERTIL, V68, P275, DOI 10.1530/jrf.0.0680275; Barrios B, 2000, BIOL REPROD, V63, P1531, DOI 10.1095/biolreprod63.5.1531; Bellin ME, 1998, J ANIM SCI, V76, P2032; Caballero I, 2008, THERIOGENOLOGY, V70, P1352, DOI 10.1016/j.theriogenology.2008.07.013; Caballero I, 2012, REPROD DOMEST ANIM, V47, P12, DOI 10.1111/j.1439-0531.2012.02028.x; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Carreau S, 2011, REPROD BIOL, V11, P174, DOI 10.1016/S1642-431X(12)60065-5; Casao A, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-59; Colagar AH, 2009, NUTR RES, V29, P82, DOI 10.1016/j.nutres.2008.11.007; Colas C, 2009, MICROSC RES TECHNIQ, V72, P566, DOI 10.1002/jemt.20710; Darr CR, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.140707; de Paz P, 2012, REPROD DOMEST ANIM, V47, P105, DOI 10.1111/j.1439-0531.2011.01808.x; Del Giudice PT, 2013, FERTIL STERIL, V100, P667, DOI 10.1016/j.fertnstert.2013.04.036; Diaconescu C, 2014, SCI PAP-SER D-ANIM S, V57, P141; Garner DL, 2001, THERIOGENOLOGY, V56, P31, DOI 10.1016/S0093-691X(01)00540-4; Gomes-Alves S, 2014, THERIOGENOLOGY, V82, P469, DOI 10.1016/j.theriogenology.2014.05.015; Gonzales GF, 2012, HORM METAB RES, V44, P987, DOI 10.1055/s-0032-1321854; Hermo L, 2008, MOL REPROD DEV, V75, P565, DOI 10.1002/mrd.20800; Kawano N, 2004, THERIOGENOLOGY, V61, P351, DOI 10.1016/S0093-691X(03)00218-8; KILLIAN GJ, 1993, BIOL REPROD, V49, P1202, DOI 10.1095/biolreprod49.6.1202; Kirkwood RN, 2008, THERIOGENOLOGY, V70, P1364, DOI 10.1016/j.theriogenology.2008.07.018; Kumar P, 2013, J APPL ANIM RES, V41, P382, DOI 10.1080/09712119.2013.783482; La Falci VSN, 2002, THERIOGENOLOGY, V57, P1035, DOI 10.1016/S0093-691X(01)00714-2; Lambard S, 2003, MOL HUM REPROD, V9, P117, DOI 10.1093/molehr/gag020; Leahy T, 2010, REPROD FERT DEVELOP, V22, P1131, DOI 10.1071/RD09286; Ledesma A, 2016, ANIM REPROD SCI, V173, P35, DOI 10.1016/j.anireprosci.2016.08.007; Mahsud T, 2013, SMALL RUMINANT RES, V113, P175, DOI 10.1016/j.smallrumres.2013.04.004; Manjunath P, 2002, J REPROD IMMUNOL, V53, P109, DOI 10.1016/S0165-0378(01)00098-5; Manjunath P, 2002, BIOL REPROD, V67, P1250, DOI 10.1095/biolreprod67.4.1250; Mann T., 1981, MALE REPROD FUNCTION, Vsecond, P28, DOI [10.1007/978-1-4471-1300-3_1, DOI 10.1007/978-1-4471-1300-3_1]; Mann T, 1981, MALE REPROD FUNCTION; Maxwell WMC, 1999, REPROD FERT DEVELOP, V11, P123, DOI 10.1071/RD99046; Mendoza N, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105650; MILLER DJ, 1990, BIOL REPROD, V42, P899, DOI 10.1095/biolreprod42.6.899; Moore AI, 2005, THERIOGENOLOGY, V63, P2372, DOI 10.1016/j.theriogenology.2004.05.032; Muino-Blanco T, 2008, REPROD DOMEST ANIM, V43, P18, DOI 10.1111/j.1439-0531.2008.01228.x; Murase T, 2007, J REPROD DEVELOP, V53, P853, DOI 10.1262/jrd.19026; Perez-Patino C, 2016, J PROTEOMICS, V142, P15, DOI 10.1016/j.jprot.2016.04.026; Perez-Pe R, 2001, J CHROMATOGR B, V760, P113, DOI 10.1016/S0378-4347(01)00259-6; Pesch S, 2006, THERIOGENOLOGY, V66, P307, DOI 10.1016/j.theriogenology.2005.11.015; Rigau T, 2001, THERIOGENOLOGY, V56, P801, DOI 10.1016/S0093-691X(01)00609-4; Rigby SL, 2001, ANIM REPROD SCI, V68, P171, DOI 10.1016/S0378-4320(01)00154-3; Rodriguez AL, 2013, SYST BIOL REPROD MED, V59, P5, DOI 10.3109/19396368.2012.725120; Rodriguez-Martinez H, 2011, AM J REPROD IMMUNOL, V66, P11, DOI 10.1111/j.1600-0897.2011.01033.x; Sarsaifi K, 2015, THERIOGENOLOGY, V84, P956, DOI 10.1016/j.theriogenology.2015.05.035; Smith J. F., 1999, Proceedings of the New Zealand Society of Animal Production, V59, P223; TABERLET P, 1994, P ROY SOC B-BIOL SCI, V255, P195, DOI 10.1098/rspb.1994.0028; Talluri TR, 2017, VET WORLD, V10, P214, DOI 10.14202/vetworld.2017.214-220; Tang HH, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.107011; Vadnais ML, 2011, THERIOGENOLOGY, V76, P1508, DOI 10.1016/j.theriogenology.2011.06.021; Waddington B, 2017, REPROD DOMEST ANIM, V52, P335, DOI 10.1111/rda.12918; Walker WH, 2009, STEROIDS, V74, P602, DOI 10.1016/j.steroids.2008.11.017; Wong WY, 2001, REPROD TOXICOL, V15, P131, DOI 10.1016/S0890-6238(01)00113-7; Zaidi SK, 2017, CHIN J INTEGR MED; Zaja IZ, 2016, ANIM REPROD SCI, V164, P169, DOI 10.1016/j.anireprosci.2015.11.027	56	9	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0181776	10.1371/journal.pone.0181776	http://dx.doi.org/10.1371/journal.pone.0181776			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771486	Green Published, gold, Green Submitted			2022-12-26	WOS:000406853600034
J	Dutta, J; Thakur, D				Dutta, Jintu; Thakur, Debajit			Evaluation of multifarious plant growth promoting traits, antagonistic potential and phylogenetic affiliation of rhizobacteria associated with commercial tea plants grown in Darjeeling, India	PLOS ONE			English	Article							GENETIC DIVERSITY; BACTERIAL; BIOCONTROL; INFECTION; RHIZOSPHERE; PSEUDOMONAS; CHITINASES; DISEASE; DESERT; FIELDS	Plant growth promoting rhizobacteria (PGPR) are studied in different agricultural crops but the interaction of PGPR of tea crop is not yet studied well. In the present study, the indigenous tea rhizobacteria were isolated from seven tea estates of Darjeeling located in West Bengal, India. A total of 150 rhizobacterial isolates were screened for antagonistic activity against six different fungal pathogens i.e. Nigrospora sphaerica (KJ767520), Pestalotiopsis theae (ITCC 6599), Curvularia eragostidis (ITCC 6429), Glomerella cingulata (MTCC 2033), Rhizoctonia Solani (MTCC 4633) and Fusarium oxysporum (MTCC 284), out of which 48 isolates were antagonist to at least one fungal pathogen used. These 48 isolates exhibited multifarious antifungal properties like the production of siderophore, chitinase, protease and cellulase and also plant growth promoting (PGP) traits like IAA production, phosphate solubilization, ammonia and ACC deaminase production. Amplified ribosomal DNA restriction analysis (ARDRA) and BOX-PCR analysis based genotyping clustered the isolates into different groups. Finally, four isolates were selected for plant growth promotion study in two tea commercial cultivars TV-1 and Teenali-17 in nursery conditions. The plant growth promotion study showed that the inoculation of consortia of these four PGPR isolates significantly increased the growth of tea plant in nursery conditions. Thus this study underlines the commercial potential of these selected PGPR isolates for sustainable tea cultivation.	[Dutta, Jintu; Thakur, Debajit] Inst Adv Study Sci & Technol, Life Sci Div, Microbial Biotechnol Lab, Gauhati, Assam, India	Department of Science & Technology (India); Institute of Advanced Study in Science & Technology (IASST)	Thakur, D (corresponding author), Inst Adv Study Sci & Technol, Life Sci Div, Microbial Biotechnol Lab, Gauhati, Assam, India.	debajitthakur@yahoo.co.uk		Thakur, Debajit/0000-0001-5942-4818	Department of Biotechnology (DBT), Govt. of India under RGYI scheme [BT/PR6011/GBD/27/379/2012]	Department of Biotechnology (DBT), Govt. of India under RGYI scheme	This work was supported by the Department of Biotechnology (DBT), Govt. of India under RGYI scheme (Grant No. BT/PR6011/GBD/27/379/2012). The funder had no role in study, design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Department of Biotechnology (DBT), Govt. of India under RGYI scheme (Grant No. BT/PR6011/GBD/27/379/2012). The authors wish to thank Director, IASST, Guwahati, Assam, India, for providing facilities for this work. The authors are thankful to Dr. Romi Wahengbam, DST-Inspire faculty, Life Sciences Division, IASST and Professor Nandana Dutta, Department of English, Gauhati University, Guwahati, India for thoroughly reviewing and correcting English language of the manuscript.	Ahmadzadeh M, 2009, BIOL CONTROL, V48, P101, DOI 10.1016/j.biocontrol.2008.10.012; Baby UI, 2002, J PLANTATION CROPS, V30, P1; Beneduzi A, 2008, RES MICROBIOL, V159, P244, DOI 10.1016/j.resmic.2008.03.003; Beneduzi A, 2008, APPL SOIL ECOL, V39, P311, DOI 10.1016/j.apsoil.2008.01.006; Bharathi R, 2004, CROP PROT, V23, P835, DOI 10.1016/j.cropro.2004.01.007; Calvo P, 2014, PLANT SOIL, V383, P3, DOI [10.1007/s11104-014-2131-8, 10.1109/BigData.2014.7004461]; Cappuccino J. C., 1992, MICROBIOLOGY LAB MAN, Vthird, P125, DOI DOI 10.2307/1309615; Chakraborty U, 2013, INDIAN J BIOTECHNOL, V12, P20; Chakraborty U., 2012, World Journal of Agricultural Sciences, V8, P104; Chakraborty U, 2006, J BASIC MICROB, V46, P186, DOI 10.1002/jobm.200510050; CHET I, 1994, APPL BIOCHEM BIOTECH, V48, P37, DOI 10.1007/BF02825358; Chithrashree, 2011, BIOL CONTROL, V59, P114, DOI 10.1016/j.biocontrol.2011.06.010; Chu WH, 2007, J IND MICROBIOL BIOT, V34, P241, DOI 10.1007/s10295-006-0192-2; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; Cordero P, 2012, SYST APPL MICROBIOL, V35, P342, DOI 10.1016/j.syapm.2012.04.005; Daz K, 2009, WORLD J MICROB BIOT, V25, P867; Dutta J, 2015, PLANT DIS, V99, P417, DOI 10.1094/PDIS-05-14-0545-PDN; Dutta J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01252; DWORKIN M, 1958, J BACTERIOL, V75, P592, DOI 10.1128/JB.75.5.592-603.1958; El-Sayed WS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00651; Fan ZY, 2016, J GINSENG RES, V40, P97, DOI 10.1016/j.jgr.2015.05.003; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fiske CH, 1925, J BIOL CHEM, V66, P375; Franca L, 2016, EXTREMOPHILES, V20, P855, DOI 10.1007/s00792-016-0874-2; Garazzino S, 2005, J CLIN MICROBIOL, V43, P1459, DOI 10.1128/JCM.43.3.1459-1461.2005; George P, 2013, WORLD J MICROB BIOT, V29, P109, DOI 10.1007/s11274-012-1163-6; Glick BR, 2007, EUR J PLANT PATHOL, V119, P329, DOI 10.1007/s10658-007-9162-4; Glick BR, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/963401; GOLDMAN GH, 1994, TRENDS BIOTECHNOL, V12, P478, DOI 10.1016/0167-7799(94)90055-8; GORDON SA, 1951, PLANT PHYSIOL, V26, P192, DOI 10.1104/pp.26.1.192; Goswami D, 2014, MICROBIOL RES, V169, P66, DOI 10.1016/j.micres.2013.07.004; Gyaneshwar P, 1999, FEMS MICROBIOL LETT, V171, P223, DOI 10.1111/j.1574-6968.1999.tb13436.x; Hammami I, 2013, CR BIOL, V336, P557, DOI 10.1016/j.crvi.2013.10.006; Hertle R, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-16; Jha CK, 2012, WORLD J MICROB BIOT, V28, P891, DOI 10.1007/s11274-011-0886-0; Jin FL, 2011, INT J MOL SCI, V12, P3055, DOI 10.3390/ijms12053055; Kasana RC, 2008, CURR MICROBIOL, V57, P503, DOI 10.1007/s00284-008-9276-8; KATZNELSON H, 1959, CAN J MICROBIOL, V5, P79, DOI 10.1139/m59-010; Khan MS, 2014, PHOSPHATE SOLUBILIZI, P34; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kisand V, 2003, APPL ENVIRON MICROB, V69, P3607, DOI 10.1128/AEM.69.6.3607-3616.2003; KLOEPPER JW, 1980, NATURE, V286, P885, DOI 10.1038/286885a0; Langley JM, 2001, AM J INFECT CONTROL, V29, P94, DOI 10.1067/mic.2001.111537; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Majumder A. Basu, 2010, INC J TEA SCI, V8, P121; Marques APGC, 2010, SOIL BIOL BIOCHEM, V42, P1229, DOI 10.1016/j.soilbio.2010.04.014; Martin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036911; Mishra RK, 2015, BIOCATAL AGR BIOTECH, V4, P25, DOI 10.1016/j.bcab.2014.09.012; Nakkeeran S, 2006, PGPR: BIOCONTROL AND BIOFERTILIZATION, P257, DOI 10.1007/1-4020-4152-7_10; Nehra V, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2584-8; OSULLIVAN DJ, 1992, MICROBIOL REV, V56, P662, DOI 10.1128/MMBR.56.4.662-676.1992; Passardi A, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0139468, 10.1371/journal.pone.0134732]; Patel AK, 2009, BIORESOURCE TECHNOL, V100, P368, DOI 10.1016/j.biortech.2008.05.008; Penrose DM, 2003, PHYSIOL PLANTARUM, V118, P10, DOI 10.1034/j.1399-3054.2003.00086.x; Puente ME, 2004, PLANT BIOLOGY, V6, P629, DOI 10.1055/s-2004-821100; Remans R, 2008, PLANT SOIL, V302, P149, DOI 10.1007/s11104-007-9462-7; Ribeiro CM, 2012, MICROBIOL RES, V167, P69, DOI 10.1016/j.micres.2011.03.003; ROBERTS WK, 1988, J GEN MICROBIOL, V134, P169; Ryu RJ, 2008, J BACTERIOL, V190, P7200, DOI 10.1128/JB.00804-08; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Siddiqui ZA, 2007, WORLD J MICROB BIOT, V23, P435, DOI 10.1007/s11274-006-9244-z; Singh RP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155026; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Trabelsi D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/863240; Upadhyay SK, 2009, CURR MICROBIOL, V59, P489, DOI 10.1007/s00284-009-9464-1; USDA, 2010, BAS SYST SOIL CLASS; Vejan P, 2016, MOLECULES, V21, DOI 10.3390/molecules21050573; Verma VC, 2007, MICROB ECOL, V54, P119, DOI 10.1007/s00248-006-9179-9; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Williamson N, 2000, ANTON LEEUW INT J G, V78, P315, DOI 10.1023/A:1010225909148; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xu SJ, 2016, TROP PLANT PATHOL, V41, P162, DOI 10.1007/s40858-016-0077-5	72	49	52	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182302	10.1371/journal.pone.0182302	http://dx.doi.org/10.1371/journal.pone.0182302			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771547	Green Published, gold, Green Submitted			2022-12-26	WOS:000406853600086
J	Suzuki, H; Ahuja, CS; Salewski, RP; Li, LJ; Satkunendrarajah, K; Nagoshi, N; Shibata, S; Fehlings, MG				Suzuki, Hidenori; Ahuja, Christopher S.; Salewski, Ryan P.; Li, Lijun; Satkunendrarajah, Kajana; Nagoshi, Narihito; Shibata, Shinsuke; Fehlings, Michael G.			Neural stem cell mediated recovery is enhanced by Chondroitinase ABC pretreatment in chronic cervical spinal cord injury	PLOS ONE			English	Article							FUNCTIONAL RECOVERY; GLIAL SCAR; ADULT-RAT; SPONDYLOTIC MYELOPATHY; LOCOMOTOR RECOVERY; NEURITE OUTGROWTH; GAIT ANALYSIS; GRADED MODEL; TRANSPLANTATION; CONTUSION	Traumatic spinal cord injuries (SCIs) affect millions of people worldwide; the majority of whom are in the chronic phase of their injury. Unfortunately, most current treatments target the acute/subacute injury phase as the microenvironment of chronically injured cord consists of a well-established glial scar with inhibitory chondroitin sulfate proteoglycans (CSPGs) which acts as a potent barrier to regeneration. It has been shown that CSPGs can be degraded in vivo by intrathecal Chondroitinase ABC (ChABC) to produce a more permissive environment for regeneration by endogenous cells or transplanted neural stem cells (NSCs) in the subacute phase of injury. Using a translationally-relevant clip-contusion model of cervical spinal cord injury in mice we sought to determine if ChABC pretreatment could modify the harsh chronic microenvironment to enhance subsequent regeneration by induced pluripotent stem cell-derived NSCs (iPS-NSC). Seven weeks after injury D during the chronic phase D we delivered ChABC by intrathecal osmotic pump for one week followed by intraparenchymal iPS-NSC transplant rostral and caudal to the injury epicenter. ChABC administration reduced chronic-injury scar and resulted in significantly improved iPSC-NSC survival with clear differentiation into all three neuroglial lineages. Neurons derived from transplanted cells also formed functional synapses with host circuits on patch clamp analysis. Furthermore, the combined treatment led to recovery in key functional muscle groups including forelimb grip strength and measures of forelimb/hindlimb locomotion assessed by Catwalk. This represents important proof-of-concept data that the chronically injured spinal cord can be 'unlocked' by ChABC pretreatment to produce a microenvironment conducive to regenerative iPS-NSC therapy.	[Suzuki, Hidenori; Ahuja, Christopher S.; Salewski, Ryan P.; Li, Lijun; Satkunendrarajah, Kajana; Nagoshi, Narihito; Fehlings, Michael G.] Krembil Res Inst, Div Genet & Dev, Toronto, ON, Canada; [Suzuki, Hidenori] Yamaguchi Univ, Dept Orthoped Surg, Grad Sch Med, Ube, Yamaguchi, Japan; [Ahuja, Christopher S.; Salewski, Ryan P.; Fehlings, Michael G.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Ahuja, Christopher S.; Fehlings, Michael G.] Univ Toronto, Div Neurosurg, Toronto, ON, Canada; [Salewski, Ryan P.; Fehlings, Michael G.] Univ Toronto, Fac Med, Toronto, ON, Canada; [Nagoshi, Narihito] Keio Univ, Dept Orthoped Surg, Tokyo, Japan; [Shibata, Shinsuke] Keio Univ, Dept Physiol, Tokyo, Japan; [Fehlings, Michael G.] Univ Hlth Network, Toronto Western Hosp, Spinal Program, Toronto, ON, Canada	Krembil Research Institute; Yamaguchi University; University of Toronto; University of Toronto; University of Toronto; Keio University; Keio University; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Fehlings, MG (corresponding author), Krembil Res Inst, Div Genet & Dev, Toronto, ON, Canada.; Fehlings, MG (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.; Fehlings, MG (corresponding author), Univ Toronto, Div Neurosurg, Toronto, ON, Canada.; Fehlings, MG (corresponding author), Univ Toronto, Fac Med, Toronto, ON, Canada.; Fehlings, MG (corresponding author), Univ Hlth Network, Toronto Western Hosp, Spinal Program, Toronto, ON, Canada.	Michael.Fehlings@uhn.ca	Shibata, Shinsuke/AAM-6620-2020	Fehlings, Michael/0000-0002-5722-6364; Shibata, Shinsuke/0000-0002-1185-9043	Krembil Foundation; Phillip and Peggy DeZwirek; University of Toronto Spine Program; Canadian Institutes of Health Research; Brain/MINDS initiative from the Japan Agency for Medical Research and Development (AMED); Grants-in-Aid for Scientific Research [17K10932] Funding Source: KAKEN	Krembil Foundation; Phillip and Peggy DeZwirek; University of Toronto Spine Program; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Brain/MINDS initiative from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was generously supported by the Krembil Foundation, Phillip and Peggy DeZwirek, the University of Toronto Spine Program, and the Canadian Institutes of Health Research. In addition, this work was also supported by the Brain/MINDS initiative from the Japan Agency for Medical Research and Development (AMED) to S.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thank you to Drs. Nicole Forgione and Paul Bradshaw for copyediting this work and technical advice. This work was generously supported by the Krembil Foundation, Phillip and Peggy DeZwirek, the University of Toronto Spine Program, and the Canadian Institutes of Health Research. In addition, this work was also supported by the Brain/MINDS initiative from the Japan Agency for Medical Research and Development (AMED) to S.S.	Ahuja C, 2016, AO SPINE MA IN PRESS; Ahuja C, 2016, F1000 FACUL IN PRESS; Ahuja C, 2016, STEM CELLS IN PRESS; Ahuja Christopher S, 2016, F1000Res, V5, DOI 10.12688/f1000research.7586.1; Ahuja CS, 2016, STEM CELL TRANSL MED, V5, P914, DOI 10.5966/sctm.2015-0381; Barritt AW, 2006, J NEUROSCI, V26, P10856, DOI 10.1523/JNEUROSCI.2980-06.2006; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Basso DM, 2004, J NEUROTRAUM, V21, P395, DOI 10.1089/089771504323004548; Bazley FA, 2012, J NEUROSURG-SPINE, V16, P414, DOI 10.3171/2012.1.SPINE11684; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Caggiano AO, 2005, J NEUROTRAUM, V22, P226, DOI 10.1089/neu.2005.22.226; Cao QL, 2005, EXP NEUROL, V191, pS3, DOI 10.1016/j.expneurol.2004.08.026; Carter LM, 2011, EXP NEUROL, V228, P149, DOI 10.1016/j.expneurol.2010.12.023; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Forgione N, 2014, J NEUROTRAUM, V31, P1776, DOI 10.1089/neu.2014.3388; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; Hawryluk GWJ, 2012, STEM CELLS DEV, V21, P2222, DOI 10.1089/scd.2011.0596; Iwasaki M, 2014, BIOMATERIALS, V35, P2617, DOI 10.1016/j.biomaterials.2013.12.019; Joshi M, 2002, J NEUROTRAUM, V19, P175, DOI 10.1089/08977150252806947; Joshi M, 2002, J NEUROTRAUM, V19, P191, DOI 10.1089/08977150252806956; Karadimas SK, 2013, NEUROBIOL DIS, V54, P43, DOI 10.1016/j.nbd.2013.02.013; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Karimi-Abdolrezaee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037589; Kawabata S, 2016, STEM CELL REP, V6, P1, DOI 10.1016/j.stemcr.2015.11.013; Kumamaru H, 2013, STEM CELLS, V31, P1535, DOI 10.1002/stem.1404; Lu P, 2014, CURR OPIN NEUROBIOL, V27, P103, DOI 10.1016/j.conb.2014.03.010; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; Moon ES, 2014, NEUROBIOL DIS, V62, P394, DOI 10.1016/j.nbd.2013.10.020; Moon LDF, 2002, NEUROSCIENCE, V109, P101, DOI 10.1016/S0306-4522(01)00457-2; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nicholas CR, 2013, CELL STEM CELL, V12, P573, DOI 10.1016/j.stem.2013.04.005; Nishimura S, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-3; Onifer SM, 1997, RESTOR NEUROL NEUROS, V11, P211, DOI 10.3233/RNN-1997-11405; Piltti KM, 2013, STEM CELL TRANSL MED, V2, P961, DOI 10.5966/sctm.2013-0064; Popovic MR, 2011, NEUROREHAB NEURAL RE, V25, P433, DOI 10.1177/1545968310392924; Salazar DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012272; Salewski RP, 2015, STEM CELL TRANSL MED, V4, P743, DOI 10.5966/sctm.2014-0236; Salewski RP, 2015, STEM CELLS DEV, V24, P36, DOI 10.1089/scd.2014.0096; Salewski RP, 2013, STEM CELLS DEV, V22, P383, DOI 10.1089/scd.2012.0218; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; Statistical CNSCI, 2015, SPIN CORD INJ SCI FA; Wilcox JT, 2014, STEM CELL TRANSL MED, V3, P1148, DOI 10.5966/sctm.2014-0029; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yuan YM, 2013, NEUROSCI BULL, V29, P421, DOI 10.1007/s12264-013-1358-3; Zweckberger K., 2016, ACTA BIOMATER	48	53	55	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182339	10.1371/journal.pone.0182339	http://dx.doi.org/10.1371/journal.pone.0182339			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771534	Green Published, gold, Green Submitted			2022-12-26	WOS:000406853600092
J	Krystosik, AR; Curtis, A; Buritica, P; Ajayakumar, J; Squires, R; Davalos, D; Pacheco, R; Bhatta, MP; James, MA				Krystosik, Amy R.; Curtis, Andrew; Buritica, Paola; Ajayakumar, Jayakrishnan; Squires, Robert; Davalos, Diana; Pacheco, Robinson; Bhatta, Madhav P.; James, Mark A.			Community context and sub-neighborhood scale detail to explain dengue, chikungunya and Zika patterns in Cali, Colombia	PLOS ONE			English	Article							GOOGLE STREET VIEW; AEDES-AEGYPTI; INFORMATION-SYSTEMS; SEXUAL TRANSMISSION; VIRUS TRANSMISSION; PUBLIC-HEALTH; MAPPING ZIKA; BURDEN; SURVEILLANCE; INFECTION	Background Cali, Colombia has experienced chikungunya and Zika outbreaks and hypoendemic dengue. Studies have explained Cali's dengue patterns but lack the sub-neighborhood-scale detail investigated here. Methods Spatial-video geonarratives (SVG) with Ministry of Health officials and Community Health Workers were collected in hotspots, providing perspective on perceptions of why dengue, chikungunya and Zika hotspots exist, impediments to control, and social outcomes. Using spatial video and Google Street View, sub-neighborhood features possibly contributing to incidence were mapped to create risk surfaces, later compared with dengue, chikungunya and Zika case data. Results SVG captured insights in 24 neighborhoods. Trash and water risks in Calipso were mapped using SVG results. Perceived risk factors included proximity to standing water, canals, poverty, invasions, localized violence and military migration. These risks overlapped case density maps and identified areas that are suitable for transmission but are possibly under-reporting to the surveillance system. Conclusion Resulting risk maps with local context could be leveraged to increase vector-control efficiency-targeting key areas of environmental risk.	[Krystosik, Amy R.; Bhatta, Madhav P.; James, Mark A.] Kent State Univ, Coll Publ Hlth, Dept Biostat Environm Hlth Sci & Epidemiol, Kent, OH 44242 USA; [Curtis, Andrew; Ajayakumar, Jayakrishnan; Squires, Robert] Kent State Univ, Dept Geog, Hlth & Hazards Lab, Kent, OH 44242 USA; [Buritica, Paola; Pacheco, Robinson] Univ Libre, Grp Invest Epidemiol & Serv GRIEPIS, Cali, Colombia; [Davalos, Diana; Pacheco, Robinson] Univ ICESI, Dept Publ Hlth & Community Med, Cali, Valle Del Cauca, Colombia; [Davalos, Diana; Pacheco, Robinson] FVL, Ctr Clin Res, Cali, Valle Del Cauca, Colombia; [Krystosik, Amy R.] Stanford Univ, Sch Med, Dept Pediat Infect Dis, Stanford, CA 94305 USA	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Universidad ICESI; Stanford University	Krystosik, AR (corresponding author), Kent State Univ, Coll Publ Hlth, Dept Biostat Environm Hlth Sci & Epidemiol, Kent, OH 44242 USA.; Krystosik, AR (corresponding author), Stanford Univ, Sch Med, Dept Pediat Infect Dis, Stanford, CA 94305 USA.	akrystos@stanford.edu	Curtis, Andrew/U-8674-2019					Adhvaryu A, 2015, AM ECON J-ECON POLIC, V7, P29, DOI 10.1257/pol.20120262; Villar LA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003499; Armitage Cadavid M, 2015, CALI IN NUMBERS; Aviles G, 1999, EMERG INFECT DIS, V5, P575, DOI 10.3201/eid0504.990424; Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2; Cardona-Ospina JA, 2015, J CLIN VIROL, V70, P14, DOI 10.1016/j.jcv.2015.07.001; Casas I, 2016, J TRANSPORT HLTH; Rodriguez RC, 2016, AM J TROP MED HYG, V94, P1065, DOI 10.4269/ajtmh.15-0280; Centers for Disease Control and Prevention, 2016, FREQ ASK QUEST; Centers for Disease Control and Prevention, 2016, GEOGR DISTR CHIK VIR; Chaikoolvatana A., 2013, Dengue Bulletin, V37, P123; Chretien JP, 2007, AM J TROP MED HYG, V76, P405, DOI 10.4269/ajtmh.2007.76.405; Curtis A., 2016, ANN AM ASSOC GEOGR, P1; Curtis A, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13020187; Curtis A, 2015, INT J HEALTH GEOGR, V14, DOI 10.1186/s12942-015-0014-8; Curtis A, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-21; Curtis A, 2012, APPL GEOGR, V32, P393, DOI 10.1016/j.apgeog.2011.06.002; Curtis A, 2011, URBAN GEOGR, V32, P488, DOI 10.2747/0272-3638.32.4.488; Curtis JW, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-53; Delmelle E, 2016, ACTA TROP, V164, P169, DOI 10.1016/j.actatropica.2016.08.028; Delmelle EM, 2014, APPL GEOGR, V52, P144, DOI 10.1016/j.apgeog.2014.05.007; Dickin SK, 2014, APPL GEOGR, V46, P71, DOI 10.1016/j.apgeog.2013.11.003; Ferreira-de-Brito A, 2016, MEMORIAS I O CRUZ; Fredericks AC, 2014, ANN GLOB HEALTH, V80, P466, DOI 10.1016/j.aogh.2015.02.006; Freour T, 2016, EURO SURVEILL, V21; Garcia-Rejon J, 2008, AM J TROP MED HYG, V79, P940, DOI 10.4269/ajtmh.2008.79.940; Globovision, 2015, COL ANN END CHIK EP; Griew P., 2013, INT J BEHAV NUTR PHY, V10, P1; Gualberto Danny, 2015, Advances in Environmental Biology, V9, P1; Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013; Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; Hagenlocher M, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-36; Hamer GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023767; Hernandez M, 2016, BIOMEDICA, V36, P98, DOI 10.7705/biomedica.v36i0.2934; Instituto Nacional de Salud, 2016, B EP SEM; Instituto Nacional de Salud, 2016, B EP SEM 30, V30; Instituto National de Salud, 2015, EP B; Jeelani S, 2015, PUBLIC HEALTH, V129, P790, DOI 10.1016/j.puhe.2015.02.026; Jimenez-Canizales Carlos E, 2015, Recent Pat Antiinfect Drug Discov, V10, P64; Kienberger S, 2013, GEOSPATIAL HEALTH, V8, P313, DOI 10.4081/gh.2013.76; LaBeaud AD, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-1; Laiton-Donato K, 2016, BIOMEDICA, V36, P25, DOI 10.7705/biomedica.v36i0.2990; Lee VJ, 2012, PLOS NEGL TROP DIS, V6, DOI 10.1371/journal.pntd.0001786; Lourenco-de-Oliveira R, 2002, MEM I OSWALDO CRUZ, V97, P799, DOI 10.1590/S0074-02762002000600009; Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205; Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272; Ministerio de Salud y Proteccio A n Social, 2015, MIN SAL PROT SOC 201; Ministerio de Salud y Proteccio A n Social, PATT END DENG 2008 2; Morrison AC, 2004, J MED ENTOMOL, V41, P1123, DOI 10.1603/0022-2585-41.6.1123; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; Ndeffo-Mbah ML, 2016, SCI REPORTS, P6; NNBaR Sultana, 2013, ENTOMOLOGICAL INVEST; Nsoesie EO, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.20.30234; Pan American Health Organization, 2015, PAIS TERR CON CAS CO; Paniz-Mondolfi AE, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0157-x; Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7; PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001; Pontes RJS, 2000, AM J TROP MED HYG, V62, P378, DOI 10.4269/ajtmh.2000.62.378; Powers AM, 2015, J GEN VIROL, V96, P1, DOI 10.1099/vir.0.070136-0; Quintero J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-38; Restrepo AC, 2014, TROP MED INT HEALTH, V19, P863, DOI 10.1111/tmi.12325; Rodriguez-Morales AJ, 2017, INFECTION, V45, P93, DOI 10.1007/s15010-016-0948-1; Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P286, DOI 10.1016/j.tmaid.2016.03.018; Rodriguez-Morales AJ, 2016, INT J INFECT DIS, V48, P70, DOI 10.1016/j.ijid.2016.05.012; Rodriguez-Morales Alfonso J, 2016, F1000Res, V5, P568, DOI 10.12688/f1000research.8436.1; Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P62, DOI 10.1016/j.tmaid.2015.06.009; Rodriguez-Morales AJ, 2015, TRAVEL MED INFECT DI, V13, P256, DOI 10.1016/j.tmaid.2015.05.007; Ruiz-Moreno D., 2012, PLoS Neglected Tropical Diseases, V6, pe1918, DOI 10.1371/journal.pntd.0001918; Rundle AG, 2011, AM J PREV MED, V40, P94, DOI 10.1016/j.amepre.2010.09.034; Sarti E, 2016, INT J INFECT DIS, V44, P44, DOI 10.1016/j.ijid.2016.01.015; Secretaria de Salud, 2016, VIR ZIK CAL DESC SUS; Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495; Smiley LS, 2017, TROPICAL MED INFECT, V2; Soumahoro M-K, 2010, EMERGING INFECT DIS, V16; Spiegel Jerry, 2005, EcoHealth, V2, P273, DOI 10.1007/s10393-005-8388-x; Staples E, 2011, PREPAREDNESS RESPONS; Tami A, 2016, TRAVEL MED INFECT DI, V14, P9, DOI 10.1016/j.tmaid.2016.01.002; Tapia-Conyer R, 2009, J CLIN VIROL, V46, pS3, DOI 10.1016/S1386-6532(09)70286-0; Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002; Thiboutot MM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000623; Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016; Wen TH, 2015, APPL GEOGR, V62, P256, DOI 10.1016/j.apgeog.2015.05.003; WHO, 2015, CHIK FACT SHEET, V17, P50; WHO, WHO DIR GEN SUMM OUT, V32, P43; WHO, 2016, ZIK SIT REP, V15, P41; Yoon IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001730; Zambrano LI, 2016, J INFECT PUBLIC HLTH	90	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0181208	10.1371/journal.pone.0181208	http://dx.doi.org/10.1371/journal.pone.0181208			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC3VT	28767730	Green Published, Green Submitted, gold			2022-12-26	WOS:000406768200020
J	Yu, DH; Lv, L; Fang, L; Zhang, B; Wang, JN; Zhan, G; Zhao, L; Zhao, X; Li, BX				Yu, Dahai; Lv, Lin; Fang, Li; Zhang, Bo; Wang, Junnan; Zhan, Ge; Zhao, Lei; Zhao, Xin; Li, Baoxin			Inhibitory effects and mechanism of dihydroberberine on hERG channels expressed in HEK293 cells	PLOS ONE			English	Article							LONG QT SYNDROME; TRAFFICKING INHIBITION; QUALITY-CONTROL; BERBERINE; CHAPERONES; DERIVATIVES; DEFICIENCY; RESCUE; HSP70; ER	The human ether-a-go-go-related gene (hERG) potassium channel conducts rapid delayed rectifier potassium currents (l(Kr)) and contributes to phase III cardiac action potential repolarization. Drugs inhibit hERG channels by binding to aromatic residues in hERG helixes. Berberine (BBR) has multiple actions, and its hydrogenated derivative dihydroberberine (DHB) is a potential candidate for developing new drugs. Previous studies have demonstrated that BBR blocks hERG channels and prolongs action potential duration (APD). Our present study aimed to investigate the effects and mechanism of DHB on hERG channels. Protein expression and the hERG current were analyzed using western blotting and patch-clamp, respectively. DHB inhibited the hERG current concentration-dependently after instantaneous perfusion, accelerated channel inactivation by directly binding tyrosine (Tyr652) and phenylalanine (Phe656), and decreased mature (155-kDa) and simultaneously increased immature (135-kDa) hERG expression, respectively. This suggests disruption of forward trafficking of hERG channels. Besides, DHB remarkably reduced heat shock protein 90 (Hsp90) expression and its interaction with hERG, indicating that DHB disrupted hERG trafficking by impairing channel folding. Meanwhie, DHB enhanced the expression of cleaved activating transcription factor-6 (ATF-6), a biomarker of unfolded protein response (UPR). Expression of calnexin and calreticulin, chaperones activated by ATF-6 to facilitate channel folding, were also increased, which indicating UPR activation. Additionally, the degradation rate of mature 155-kDa hERG increased following DHB exposure. In conclusion, we demonstrated that DHB acutely blocked hERG channels by binding the aromatic Tyr652 and Phe656. DHB may decrease hERG plasma membrane expression through two pathways involving disruption of forward trafficking of immature hERG channels and enhanced degradation of mature hERG channels. Furthermore, forward trafficking was disrupted by impaired channel folding associated with altered interactions between hERG proteins and chaperones. Finally, trafficking inhibition activated UPR, and mature hERG channel degradation was increased by DHB.	[Yu, Dahai; Lv, Lin; Fang, Li; Zhang, Bo; Wang, Junnan; Zhan, Ge; Zhao, Lei; Zhao, Xin; Li, Baoxin] Harbin Med Univ, Coll Pharm, Dept Pharmacol, Harbin, Heilongjiang, Peoples R China	Harbin Medical University	Li, BX (corresponding author), Harbin Med Univ, Coll Pharm, Dept Pharmacol, Harbin, Heilongjiang, Peoples R China.	libx64@hotmail.com			National Natural Science Foundation of China [81673636, 81173050]; Major Program of the National Natural Science Foundation of Heilongjiang [ZD2015015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Program of the National Natural Science Foundation of Heilongjiang	This work is supported by grants from the National Natural Science Foundation of China (No. 81673636, 81173050), Major Program of the National Natural Science Foundation of Heilongjiang (No. ZD2015015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen JW, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0326-7; Christians ES, 2014, CURR PROTEIN PEPT SC, V15, P189, DOI 10.2174/1389203715666140331111518; Dennis AT, 2012, MOL PHARMACOL, V81, P198, DOI 10.1124/mol.111.075135; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Foo B, 2016, J PHYSIOL-LONDON, V594, P2469, DOI 10.1113/JP270531; Guo J, 2011, MOL PHARMACOL, V79, P806, DOI 10.1124/mol.110.069419; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Herrendorff R, 2016, J BIOL CHEM, V291, P17165, DOI 10.1074/jbc.M115.710616; Jin Y, 2016, EXPERT OPIN THER PAT, V26, P229, DOI 10.1517/13543776.2016.1118060; Kannankeril P, 2010, PHARMACOL REV, V62, P760, DOI 10.1124/pr.110.003723; Kong WJ, 2008, METABOLISM, V57, P1029, DOI 10.1016/j.metabol.2008.01.037; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Kratz JM, 2017, NAT PROD REP; Li BX, 2001, ACTA PHARMACOL SIN, V22, P125; Li ZH, 2016, J PHARMACOL TOX MET, V81, P233, DOI 10.1016/j.vascn.2016.05.005; Lynch JM, 2012, CELL, V149, P1257, DOI 10.1016/j.cell.2012.03.050; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Mayer MP, 2013, TRENDS BIOCHEM SCI, V38, P507, DOI 10.1016/j.tibs.2013.08.001; Melgari D, 2015, J MOL CELL CARDIOL, V86, P42, DOI 10.1016/j.yjmcc.2015.06.021; Pan Y, 2015, MOL PHARMACOL, V87, P378, DOI 10.1124/mol.114.094425; Pugsley MK, 2015, HANDB EXP PHARMACOL, V229, P149, DOI 10.1007/978-3-662-46943-9_7; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Saxena P, 2016, SCI REP-UK, V6, DOI 10.1038/srep24182; Schramm A, 2011, PLANTA MED, V77, P692, DOI 10.1055/s-0030-1270920; Smith JL, 2011, AM J PHYSIOL-CELL PH, V301, pC75, DOI 10.1152/ajpcell.00494.2010; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029885; Waring MJ, 2015, NAT REV DRUG DISCOV, V14, P475, DOI 10.1038/nrd4609; Yan M, 2015, DRUG DES DEV THER, V9, P5737, DOI 10.2147/DDDT.S91561; Zhang H, 2010, METABOLISM, V59, P285, DOI 10.1016/j.metabol.2009.07.029; Zhang KP, 2014, ACTA PHARMACOL SIN, V35, P1473, DOI 10.1038/aps.2014.101; Zhang KP, 2014, CELL PHYSIOL BIOCHEM, V34, P691, DOI 10.1159/000363034; Zhang YH, 2016, BIOCHEM PHARMACOL, V113, P24, DOI 10.1016/j.bcp.2016.05.013; Zhi D, 2015, EUR J PHARM SCI, V76, P149, DOI 10.1016/j.ejps.2015.05.009	35	8	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0181823	10.1371/journal.pone.0181823	http://dx.doi.org/10.1371/journal.pone.0181823			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763460	gold, Green Published, Green Submitted			2022-12-26	WOS:000406766500024
J	Gomez-Campos, R; Andruske, CL; de Arruda, M; Albornoz, CU; Cossio-Bolanos, M				Gomez-Campos, Rossana; Andruske, Cynthia Lee; de Arruda, Miguel; Albornoz, Camilo Urra; Cossio-Bolanos, Marco			Proposed equations and reference values for calculating bone health in children and adolescent based on age and sex	PLOS ONE			English	Article							CONCORDANCE CORRELATION-COEFFICIENT; MINERAL DENSITY; LUMBAR SPINE; REGRESSION; CURVES; GROWTH; MASS	Background The Dual Energy X-Ray Absorptiometry (DXA) is the gold standard for measuring BMD and bone mineral content (BMC). In general, DXA is ideal for pediatric use. However, the development of specific standards for particular geographic regions limits its use and application for certain socio-cultural contexts. Additionally, the anthropometry may be a low cost and easy to use alternative method in epidemiological contexts. The goal of our study was to develop regression equations for predicting bone health of children and adolescents based on anthropometric indicators to propose reference values based on age and sex. Methods 3020 students (1567 males and 1453 females) ranging in ages 4.0 to 18.9 were studied from the Maule Region (Chile). Anthropometric variables evaluated included: weight, standing height, sitting height, forearm length, and femur diameter. A total body scan (without the head) was conducted by means of the Dual Energy X-Ray Absorptiometry. Bone mineral density (BMD) and the bone mineral content (BMC) were also determined. Calcium consumption was controlled for by recording the intake of the three last days prior to the evaluation. Body Mass Index (BMI) was calculated, and somatic maturation was determined by using the years of peak growth rate (APHV). Results Four regression models were generated to calculate bone health: for males BMD = (R-2 = 0.79) and BMC = (R-2 = 0.84) and for the females BMD = (R-2 = 0.76) and BMC = (R2 = 0.83). Percentiles were developed by using the LMS method (p3, p5, p15, p25, p50, p75, p85, p95 and p97). Conclusions Regression equations and reference curves were developed to assess the bone health of Chilean children and adolescents. These instruments help identify children with potential underlying problems in bone mineralization during the growth stage and biological maturation.	[Gomez-Campos, Rossana; de Arruda, Miguel; Cossio-Bolanos, Marco] Univ Estadual Campinas, Fac Phys Educ, Campinas, Chile; [Gomez-Campos, Rossana] Univ Autonoma Chile, Talca, Chile; [Andruske, Cynthia Lee] Univ Talca, Escuela Pedagog Ingies, Fac Ciencias Educ, Campus Linares, Talca, Chile; [Andruske, Cynthia Lee] Res Network Human Biol Dev, Arequipa, Peru; [Albornoz, Camilo Urra] Univ Santo Tomas, Fac Salud, Escuela Kinesiol, Talca, Chile; [Cossio-Bolanos, Marco] Catholic Univ Maule, Dept Phys Activ Sci, Talca, Chile; [Cossio-Bolanos, Marco] Univ Nacl San Agustin, Arequipa, Peru	Universidad Autonoma de Chile; Universidad de Talca; Universidad Santo Tomas; Universidad Catolica del Maule; Universidad Nacional de San Agustin de Arequipa	Cossio-Bolanos, M (corresponding author), Univ Estadual Campinas, Fac Phys Educ, Campinas, Chile.; Cossio-Bolanos, M (corresponding author), Catholic Univ Maule, Dept Phys Activ Sci, Talca, Chile.; Cossio-Bolanos, M (corresponding author), Univ Nacl San Agustin, Arequipa, Peru.	mcossio1972@hotmail.com		Urra-Albornoz, Camilo/0000-0002-5936-359X	Conycit [1141295]	Conycit	This work was supported by Conycit 1141295.	Alwis G, 2010, ACTA PAEDIATR, V99, P1091, DOI 10.1111/j.1651-2227.2010.01713.x; Ancao MS, 2002, PROGRAMA DE APOIO; Bachrach LK, 2005, ENDOCRIN METAB CLIN, V34, P521, DOI 10.1016/j.ecl.2005.04.001; Baim S, 2008, J CLIN DENSITOM, V11, P6, DOI 10.1016/j.jocd.2007.12.002; Barnhart HX, 2002, BIOMETRICS, V58, P1020, DOI 10.1111/j.0006-341X.2002.01020.x; Baroncelli GI, 2000, HORM RES, V54, P2; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boot AM, 1997, J CLIN ENDOCR METAB, V82, P57, DOI 10.1210/jc.82.1.57; Butte NF, 2007, J NUTR, V137, P153, DOI 10.1093/jn/137.1.153; Cameron N, 2004, AM J CLIN NUTR, V80, P70; Fonseca RMC, 2008, PEDIATR EXERC SCI, V20, P40, DOI 10.1123/pes.20.1.40; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; DELRIO LD, 1994, PEDIATR RES, V35, P362, DOI 10.1203/00006450-199403000-00018; Faulkner RA, 1996, CALCIFIED TISSUE INT, V59, P344, DOI 10.1007/s002239900138; Fonseca ASM, 2001, BRAZ J MED BIOL RES, V34, P347, DOI 10.1590/S0100-879X2001000300008; Gartner A, 2004, EUR J CLIN NUTR, V58, P523, DOI 10.1038/sj.ejcn.1601839; Goncalves EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127294; Gordon CM, 2008, J CLIN DENSITOM, V11, P43, DOI 10.1016/j.jocd.2007.12.005; Gordon CM, 2005, CURR OPIN ENDOCRINOL, V12; Guo B, 2013, J BONE MINER METAB, V31, P304, DOI 10.1007/s00774-012-0401-1; Heaney RP, 2000, J AM COLL NUTR, V19, p83S, DOI 10.1080/07315724.2000.10718088; Henderson RC, 2004, DEV MED CHILD NEUROL, V46, P416, DOI 10.1017/S0012162204000672; Kalkwarf HJ, 2007, J CLIN ENDOCR METAB, V92, P2087, DOI 10.1210/jc.2006-2553; Khadilkar AV, 2011, BONE, V48, P810, DOI 10.1016/j.bone.2010.12.013; Kuczmarski RJ, 2000, ADV DATA VITAL HLTH; Lin L., 2000, BIOMETRICS, V56, P324, DOI [10.1111/j.0006-341X.2000.00324.x, DOI 10.1111/J.0006-341X.2000.00324.X]; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; MILLER JZ, 1991, BONE MINER, V14, P137, DOI 10.1016/0169-6009(91)90091-D; Minghelli B, 2013, N AM J MED SCI, V5, P653, DOI 10.4103/1947-2714.122309; Mirwald RL, 2002, MED SCI SPORT EXER, V34, P689, DOI 10.1097/00005768-200204000-00020; Molgaard C, 1997, ARCH DIS CHILD, V76, P9, DOI 10.1136/adc.76.1.9; Nakavachara P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097218; Rizzoli R, 2010, BONE, V46, P294, DOI 10.1016/j.bone.2009.10.005; Ross WD, 1991, PHYSL TESTING ELITEA, P223; RUBIN K, 1993, J PEDIATR-US, V123, P863, DOI 10.1016/S0022-3476(05)80381-6; Silva Carla C., 2006, Arq Bras Endocrinol Metab, V50, P105, DOI 10.1590/S0004-27302006000100015; SLINKER BK, 1985, AM J PHYSIOL, V249, pR1, DOI 10.1152/ajpregu.1985.249.1.R1; Vargas Deisi M., 2003, J. Pediatr. (Rio J.), V79, P253, DOI 10.1590/S0021-75572003000300012; Zemel BS, 2011, J CLIN ENDOCR METAB, V96, P3160, DOI 10.1210/jc.2011-1111	39	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0181918	10.1371/journal.pone.0181918	http://dx.doi.org/10.1371/journal.pone.0181918			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759569	Green Published, Green Submitted, gold			2022-12-26	WOS:000406761600038
J	Burr-Hersey, JE; Mooney, SJ; Bengough, AG; Mairhofer, S; Ritz, K				Burr-Hersey, Jasmine E.; Mooney, Sacha J.; Bengough, A. Glyn; Mairhofer, Stefan; Ritz, Karl			Developmental morphology of cover crop species exhibit contrasting behaviour to changes in soil bulk density, revealed by X-ray computed tomography	PLOS ONE			English	Article							ROOT-GROWTH; MECHANICAL IMPEDANCE; PLANT-GROWTH; COMPACTION; SYSTEMS; WHEAT; ELONGATION; MANAGEMENT; SEEDLINGS; PLATFORM	Plant roots growing through soil typically encounter considerable structural heterogeneity, and local variations in soil dry bulk density. The way the in situ architecture of root systems of different species respond to such heterogeneity is poorly understood due to challenges in visualising roots growing in soil. The objective of this study was to visualise and quantify the impact of abrupt changes in soil bulk density on the roots of three cover crop species with contrasting inherent root morphologies, viz. tillage radish (Raphanus sativus), vetch (Vicia sativa) and black oat (Avena strigosa). The species were grown in soil columns containing a two-layer compaction treatment featuring a 1.2 g cm(-3) (uncompacted) zone overlaying a 1.4 g cm(-3) (compacted) zone. Three-dimensional visualisations of the root architecture were generated via X-ray computed tomography, and an automated root-segmentation imaging algorithm. Three classes of behaviour were manifest as a result of roots encountering the compacted interface, directly related to the species. For radish, there was switch from a single tap-root to multiple perpendicular roots which penetrated the compacted zone, whilst for vetch primary roots were diverted more horizontally with limited lateral growth at less acute angles. Black oat roots penetrated the compacted zone with no apparent deviation. Smaller root volume, surface area and lateral growth were consistently observed in the compacted zone in comparison to the uncompacted zone across all species. The rapid transition in soil bulk density had a large effect on root morphology that differed greatly between species, with major implications for how these cover crops will modify and interact with soil structure.	[Burr-Hersey, Jasmine E.; Mooney, Sacha J.; Ritz, Karl] Univ Nottingham, Sch Biosci, Div Agr & Environm Sci, Sutton Bonington Campus, Loughborough, Leics, England; [Burr-Hersey, Jasmine E.; Bengough, A. Glyn] James Hutton Inst, Dundee, Scotland; [Bengough, A. Glyn] Univ Dundee, Sch Sci & Engn, Dundee, Scotland; [Mairhofer, Stefan] Univ Nottingham, Sch Comp Sci, Nottingham, England	University of Nottingham; James Hutton Institute; University of Dundee; University of Nottingham	Ritz, K (corresponding author), Univ Nottingham, Sch Biosci, Div Agr & Environm Sci, Sutton Bonington Campus, Loughborough, Leics, England.	karl.ritz@nottingham.ac.uk	Burr-Hersey, Jasmine/I-1166-2019; Mooney, Sacha J/G-4020-2010; Bengough, Anthony/AAH-5853-2020	Bengough, Anthony/0000-0001-5472-3077; Ritz, Karl/0000-0001-6584-0631	NERC; BBSRC; University of Nottingham [NE/M009106/1]; Scottish Government; Bangor University; British Geological Survey; Cranfield University; Centre for Ecology and Hydrology; Lancaster University; James Hutton Institute; Rothamsted Research	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Nottingham; Scottish Government; Bangor University; British Geological Survey; Cranfield University; Centre for Ecology and Hydrology; Lancaster University; James Hutton Institute; Rothamsted Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research is supported by the award of a studentship grant to JB-H by the NERC and BBSRC funded STARS (Soils Training And Research Studentships) Centre for Doctoral Training and Research Programme; a consortium consisting of Bangor University, British Geological Survey, Centre for Ecology and Hydrology, Cranfield University, James Hutton Institute, Lancaster University, Rothamsted Research and the University of Nottingham. Grant Ref: NE/M009106/1. The James Hutton Institute receives funding from the Scottish Government.; This research is supported by the award of a studentship grant to JB-H by the NERC and BBSRC funded STARS (Soils Training And Research Studentships) Centre for Doctoral Training and Research Programme; a consortium consisting of Bangor University, British Geological Survey, Centre for Ecology and Hydrology, Cranfield University, James Hutton Institute, Lancaster University, Rothamsted Research and the University of Nottingham. Grant Ref: NE/M009106/1. The James Hutton Institute receives funding from the Scottish Government. We thank Paul Brown of Frontier Agriculture for supplying seeds used in this study and useful discussions, and two anonymous reviewers plus the editor for helpful suggestions for improvement to the manuscript.	Abdollahi L, 2014, SOIL SCI SOC AM J, V78, P271, DOI 10.2136/sssaj2013.07.0302; Alameda D, 2012, ENVIRON EXP BOT, V79, P49, DOI 10.1016/j.envexpbot.2012.01.004; ATWELL BJ, 1993, ENVIRON EXP BOT, V33, P27, DOI 10.1016/0098-8472(93)90053-I; Ball BC, 1997, EUR J SOIL SCI, V48, P593, DOI 10.1046/j.1365-2389.1997.00120.x; Batey T, 2006, SOIL USE MANAGE, V22, P123, DOI 10.1111/j.1475-2743.2006.00017.x; Batey T, 2009, SOIL USE MANAGE, V25, P335, DOI 10.1111/j.1475-2743.2009.00236.x; Bengough AG, 2011, J EXP BOT, V62, P59, DOI 10.1093/jxb/erq350; BENGOUGH AG, 1990, J SOIL SCI, V41, P341, DOI 10.1111/j.1365-2389.1990.tb00070.x; Chen GH, 2010, PLANT SOIL, V331, P31, DOI 10.1007/s11104-009-0223-7; Clark LJ, 2003, PLANT SOIL, V255, P93, DOI 10.1023/A:1026140122848; Clark LJ, 1999, J EXP BOT, V50, P1263, DOI 10.1093/jexbot/50.336.1263; Clark RT, 2011, PLANT PHYSIOL, V156, P455, DOI 10.1104/pp.110.169102; Cresswell HP, 1995, SOIL RES, V33, P221, DOI [10.1071/SR9950221, DOI 10.1071/SR9950221]; Dunbabin VM, 2013, PLANT SOIL, V372, P93, DOI 10.1007/s11104-013-1769-y; Grzesiak S, 2013, ENVIRON EXP BOT, V88, P2, DOI 10.1016/j.envexpbot.2012.01.010; Hamza MA, 2005, SOIL TILL RES, V82, P121, DOI 10.1016/j.still.2004.08.009; Han E, 2015, BIOL FERT SOILS, V51, P847, DOI 10.1007/s00374-015-1032-1; IIJIMA M, 1991, ENVIRON EXP BOT, V31, P333, DOI 10.1016/0098-8472(91)90058-V; Ishaq M, 2001, SOIL TILL RES, V60, P153, DOI 10.1016/S0167-1987(01)00177-5; Iyer-Pascuzzi AS, 2010, PLANT PHYSIOL, V152, P1148, DOI 10.1104/pp.109.150748; Jin K, 2013, J EXP BOT, V64, P4761, DOI 10.1093/jxb/ert286; Kadziene G, 2011, GEODERMA, V166, P66, DOI 10.1016/j.geoderma.2011.07.013; Keyes SD, 2016, J BIOMECH, V49, P1802, DOI 10.1016/j.jbiomech.2016.04.023; Lewis J, 2010, J CONTAM HYDROL, V115, P1, DOI 10.1016/j.jconhyd.2010.04.001; Lipiec J., 2003, International Agrophysics, V17, P61; Lipiec J, 2003, GEODERMA, V116, P107, DOI 10.1016/S0016-7061(03)00097-1; Mairhofer S, 2015, FUNCT PLANT BIOL, V42, P460, DOI 10.1071/FP14071; Mairhofer S, 2012, PLANT PHYSIOL, V158, P561, DOI 10.1104/pp.111.186221; MATERECHERA SA, 1991, PLANT SOIL, V135, P31, DOI 10.1007/BF00014776; Mooney SJ, 2012, PLANT SOIL, V352, P1, DOI 10.1007/s11104-011-1039-9; PASSIOURA JB, 1991, AUST J SOIL RES, V29, P717, DOI 10.1071/SR9910717; Schmidt S, 2012, EUR J SOIL SCI, V63, P776, DOI 10.1111/j.1365-2389.2012.01487.x; Stirzaker RJ, 1996, PLANT SOIL, V185, P151, DOI 10.1007/BF02257571; TARDIEU F, 1994, SOIL TILL RES, V30, P217, DOI 10.1016/0167-1987(94)90006-X; TAYLOR HM, 1991, SOIL TILL RES, V19, P111, DOI 10.1016/0167-1987(91)90080-H; Tracy SR, 2012, PLANT SOIL, V353, P195, DOI 10.1007/s11104-011-1022-5; Tracy SR, 2011, J SCI FOOD AGR, V91, P1528, DOI 10.1002/jsfa.4424; Valentine TA, 2012, ANN BOT-LONDON, V110, P259, DOI 10.1093/aob/mcs118; VEPRASKAS MJ, 1988, SOIL SCI SOC AM J, V52, P1117, DOI 10.2136/sssaj1988.03615995005200040042x; White RE, 2006, PRINCIPLES PRACTICE, P59; White RG, 2010, PLANT CELL ENVIRON, V33, P133, DOI 10.1111/j.1365-3040.2009.02059.x	41	38	40	6	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0181872	10.1371/journal.pone.0181872	http://dx.doi.org/10.1371/journal.pone.0181872			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753645	Green Published, gold			2022-12-26	WOS:000406579300030
J	Hartley, DM; Giannini, CM; Wilson, S; Frieder, O; Margolis, PA; Kotagal, UR; White, DL; Connelly, BL; Wheeler, DS; Tadesse, DG; Macaluso, M				Hartley, David M.; Giannini, Courtney M.; Wilson, Stephanie; Frieder, Ophir; Margolis, Peter A.; Kotagal, Uma R.; White, Denise L.; Connelly, Beverly L.; Wheeler, Derek S.; Tadesse, Dawit G.; Macaluso, Maurizio			Coughing, sneezing, and aching online: Twitter and the volume of influenza-like illness in a pediatric hospital	PLOS ONE			English	Article							PUBLIC-HEALTH SURVEILLANCE; SOCIAL MEDIA; CLASSIFICATION	This study investigates the relation of the incidence of georeferenced tweets related to respiratory illness to the incidence of influenza-like illness (ILI) in the emergency department (ED) and urgent care clinics (UCCs) of a large pediatric hospital. We collected (1) tweets in English originating in our hospital's primary service area between 11/1/2014 and 5/1/2015 and containing one or more specific terms related to respiratory illness and (2) the daily number of patients presenting to our hospital's EDs and UCCs with ILI, as captured by ICD-9 codes. A Support Vector Machine classifier was applied to the set of tweets to remove those unlikely to be related to ILI. Time series of the pooled set of remaining tweets involving any term, of tweets involving individual terms, and of the ICD-9 data were constructed, and temporal cross-correlation between the social media and clinical data was computed. A statistically significant correlation (Spearman p = 0.23) between tweets involving the term flu and ED and UCC volume related to ILI 11 days in the future was observed. Tweets involving the terms coughing (Spearman. = 0.24) and headache (Spearman p = 0.19) individually were also significantly correlated to ILI-related clinical volume four and two days in the future, respectively. In the 2014-2015 cold and flu season, the incidence of local tweets containing the terms flu, coughing, and headache were early indicators of the incidence of ILI-related cases presenting to EDs and UCCs at our children's hospital.	[Hartley, David M.; Wilson, Stephanie; Margolis, Peter A.; Kotagal, Uma R.; White, Denise L.] Cincinnati Childrens Hosp Med Ctr, James M Anderson Ctr Hlth Syst Excellence, Cincinnati, OH 45229 USA; [Giannini, Courtney M.] Univ Cincinnati, Coll Med, Med Scientist Training Program, Cincinnati, OH USA; [Frieder, Ophir] Georgetown Univ, Dept Comp Sci, Washington, DC USA; [Connelly, Beverly L.] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA; [Wheeler, Derek S.] Cincinnati Childrens Hosp Med Ctr, Div Crit Care Med, Cincinnati, OH 45229 USA; [Tadesse, Dawit G.; Macaluso, Maurizio] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Georgetown University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Hartley, DM (corresponding author), Cincinnati Childrens Hosp Med Ctr, James M Anderson Ctr Hlth Syst Excellence, Cincinnati, OH 45229 USA.	David.Hartley@cchmc.org	Tadesse, Dawit/AAB-9024-2020	Hartley, David/0000-0003-2589-2538; Tadesse, Dawit/0000-0002-7892-0080	Place Outcomes Research Award program at Cincinnati Children's Hospital Medical Center	Place Outcomes Research Award program at Cincinnati Children's Hospital Medical Center	DMH acknowledges funding from the Place Outcomes Research Award program at Cincinnati Children's Hospital Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are indebted to anonymous reviewers for numerous suggestions strengthening the manuscript. DMH acknowledges funding from the Place Outcomes Research Award program at Cincinnati Children's Hospital Medical Center.	[Anonymous], 2014, R LANG ENV STAT COMP; Aslam AA, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3532; Batuwita R, 2013, IMBALANCED LEARNING: FOUNDATIONS, ALGORITHMS, AND APPLICATIONS, P83; Broniatowski DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083672; Broniatowski David Andre, 2015, JMIR Public Health Surveill, V1, pe5; Broniatowski DA, 2014, SCIENCE, V345, P148, DOI 10.1126/science.345.6193.148-a; Centers for Disease Control and Prevention, WHATS NEW UPD FLU NE; Centers for Disease Control and Prevention, 2016, SEAS INFL FLU 2016 2; Charles-Smith LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139701; Cheng Z., 2010, P 19 ACM INT C INF K, P759; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; Chunara R, 2015, SCI REP-UK, V5, DOI 10.1038/srep09540; Collier Nigel, 2011, J Biomed Semantics, V2 Suppl 5, pS9, DOI 10.1186/2041-1480-2-S5-S9; Culotta A, 2015, P 29 AAAI C ART INT; Culotta A., 2010, P 1 WORKSHOP SOCIAL, P115, DOI [10.1145/1964858.1964874, DOI 10.1145/1964858.1964874]; Dredze M, 2013, P AAAI WORKSH EXP BO; Duggan M., 2015, PEW RES CTR, V19, P1; Feinerer I, 2008, J STAT SOFTW, V25, P1; Gesualdo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082489; Hamilton Brady E, 2015, Natl Vital Stat Rep, V64, P1; Hartley DM, 2014, MILBANK Q, V92, P34, DOI 10.1111/1468-0009.12039; Marsden-Haug N, 2007, EMERG INFECT DIS, V13, P207, DOI 10.3201/eid1302.060557; Meyer D, 2017, E1071 MISC FUNCTIONS; Nagar R, 2014, J MED INTERNET RES, V16, P260, DOI 10.2196/jmir.3416; Nagel AC, 2013, J MED INTERNET RES, V15, P263, DOI 10.2196/jmir.2705; Nguyen D., 2014, P COLING 2014 25 INT, P1950; Parker J, 2015, SOC NETW ANAL MIN, V5, DOI 10.1007/s13278-014-0239-8; Prieto VM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086191; Sadilek A, 2012, P 26 AAAI C ART INT, P136; SAS, SAS ETS R 9 2 US GUI; Serfass DG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143051; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; Smolinski MS, 2015, AM J PUBLIC HEALTH, V105, P2124, DOI 10.2105/AJPH.2015.302696; Torii M, 2011, INT J MED INFORM, V80, P56, DOI 10.1016/j.ijmedinf.2010.10.015; Velasco E, 2014, MILBANK Q, V92, P7, DOI 10.1111/1468-0009.12038; Yates A, 2016, EFFECTS SAMPLING TWI	36	9	9	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0182008	10.1371/journal.pone.0182008	http://dx.doi.org/10.1371/journal.pone.0182008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1ED	28753678	Green Published, Green Submitted, gold			2022-12-26	WOS:000406579300041
J	Pagoulatou, S; Stergiopulos, N				Pagoulatou, Stamatia; Stergiopulos, Nikolaos			Evolution of aortic pressure during normal ageing: A model-based study	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; ONE-DIMENSIONAL MODEL; AGE-RELATED-CHANGES; ARTERIAL STIFFNESS; GENDER-DIFFERENCES; CARDIOVASCULAR EVENTS; VOLUME RELATION; BLOOD-PRESSURE; TRANSIT-TIME; RISK-FACTORS	Background The age-related increase in pulse pressure (PP) and systolic blood pressure (SBP) is often attributed to alterations in the wave reflection profile and augmented contributions of the reflected waves. However, clinical evidence shows that the stiffening of the proximal aorta with age and the consequent augmentation of the forward pressure wave plays an equally important role. The relative importance of the forward and reflected wave components in essential hypertension has not yet been fully elucidated. Objective The aim of the current investigation was to simulate the major ageing mechanisms in the arterial system and the heart using a mathematical one-dimensional model of the arterial tree and to assess the evolution of systolic and pulse pressure during normal (non-pathological) ageing. Methods and results Our state-of-the-art 1-D model was extended to include turbulence and inertial effects of the flow exiting the left ventricle. Literature data on the age-associated changes in arterial stiffness, peripheral resistance and cardiac contractility were gathered and used as an input for the simulations. The predicted evolution of pressure and augmentation index with age followed accurately the curves obtained in a number of large-scale clinical studies. Analysis of the relative contribution of the forward and backward wave components showed that the forward wave becomes the major determinant of the increase in central and peripheral SBP and PP with advancing age. Conclusions The 1-D model of the ageing tree and heart captures faithfully and with great accuracy the central pressure evolution with ageing. The stiffening of the proximal aorta and the resulting augmentation of the forward pressure wave is the major contributor of the systolic pressure augmentation with age.	[Pagoulatou, Stamatia; Stergiopulos, Nikolaos] Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol, Inst Bioengn, Lab Hemodynam & Cardiovasc Technol, Lausanne, Switzerland	Ecole Polytechnique Federale de Lausanne	Pagoulatou, S (corresponding author), Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol, Inst Bioengn, Lab Hemodynam & Cardiovasc Technol, Lausanne, Switzerland.	stamatia.pagoulatou@epfl.ch	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Stergiopulos, Nikolaos/0000-0002-0519-0160				Aslanidou L, 2016, ALTEX-ALTERN ANIM EX, V33, P13, DOI 10.14573/altex.1507071; AURIGEMMA GP, 1995, CARDIOLOGY, V86, P310, DOI 10.1159/000176895; Avolio AP, 2009, HYPERTENSION, V54, P375, DOI 10.1161/HYPERTENSIONAHA.109.134379; Baguet JP, 2003, J HUM HYPERTENS, V17, P407, DOI 10.1038/sj.jhh.1001566; BOUTOUYRIE P, 1992, J HYPERTENS, V10, pS87; Craiem D, 2012, IEEE ENG MED BIO, P4986, DOI 10.1109/EMBC.2012.6347112; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Ferrari AU, 2003, J APPL PHYSIOL, V95, P2591, DOI 10.1152/japplphysiol.00601.2003; Franklin SS, 1997, CIRCULATION, V96, P308; Gatzka CD, 2001, J HYPERTENS, V19, P2197, DOI 10.1097/00004872-200112000-00013; GERSTENBLITH G, 1977, CIRCULATION, V56, P273, DOI 10.1161/01.CIR.56.2.273; GILLER CA, 1994, ULTRASOUND MED BIOL, V20, P101, DOI 10.1016/0301-5629(94)90074-4; HAYASHI K, 1980, BIORHEOLOGY, V17, P211; Hayward CS, 1997, J AM COLL CARDIOL, V30, P1863, DOI 10.1016/S0735-1097(97)00378-1; HOLENSTEIN R, 1980, J BIOMECH ENG-T ASME, V102, P318, DOI 10.1115/1.3138229; Jani B, 2006, POSTGRAD MED J, V82, P357, DOI 10.1136/pgmj.2005.036053; Kamenskiy AV, 2015, J VASC SURG, V62, P1521, DOI 10.1016/j.jvs.2014.10.041; KATORI R, 1979, TOHOKU J EXP MED, V128, P377, DOI 10.1620/tjem.128.377; Kimoto E, 2003, DIABETES, V52, P448, DOI 10.2337/diabetes.52.2.448; LAKATTA EG, 1987, J AM COLL CARDIOL, V10, pA42, DOI 10.1016/S0735-1097(87)80447-3; Langewouters G. J., 1982, THESIS; LATHAM RD, 1985, CIRCULATION, V72, P1257, DOI 10.1161/01.CIR.72.6.1257; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lee HY, 2010, CIRC J, V74, P2257, DOI 10.1253/circj.CJ-10-0910; Lorell BH, 2000, CIRCULATION, V102, P470; LUCHSINGER PC, 1964, CIRC RES, V15, P503, DOI 10.1161/01.RES.15.6.503; Maksuti E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157493; McEniery CM, 2008, HYPERTENSION, V51, P1476, DOI 10.1161/HYPERTENSIONAHA.107.105445; McEniery CM, 2005, J AM COLL CARDIOL, V46, P1753, DOI 10.1016/j.jacc.2005.07.037; Meng LT, 2007, HYPERTENS RES, V30, P713, DOI 10.1291/hypres.30.713; Mitchell GF, 2008, HYPERTENSION, V51, P105, DOI 10.1161/HYPERTENSIONAHA.107.099721; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Mitchell GF, 2004, HYPERTENSION, V43, P1239, DOI 10.1161/01.HYP.0000128420.01881.aa; MURGO JP, 1980, CIRCULATION, V62, P105, DOI 10.1161/01.CIR.62.1.105; Mynard JP, 2012, INT J NUMER METH BIO, V28, P626, DOI 10.1002/cnm.1466; Najjar SS, 2008, J AM COLL CARDIOL, V51, P1377, DOI 10.1016/j.jacc.2007.10.065; O'Rourke MF, 2005, HYPERTENSION, V45, P652, DOI 10.1161/01.HYP.0000153793.84859.b8; OLIVETTI G, 1995, J AM COLL CARDIOL, V26, P1068, DOI 10.1016/0735-1097(95)00282-8; Redheuil A, 2011, J AM COLL CARDIOL, V58, P1262, DOI 10.1016/j.jacc.2011.06.012; Reymond P, 2012, ANN BIOMED ENG, V40, P742, DOI 10.1007/s10439-011-0443-x; Reymond P, 2011, AM J PHYSIOL-HEART C, V301, pH1173, DOI 10.1152/ajpheart.00821.2010; Reymond P, 2009, AM J PHYSIOL-HEART C, V297, pH208, DOI 10.1152/ajpheart.00037.2009; Rogers WJ, 2001, J AM COLL CARDIOL, V38, P1123, DOI 10.1016/S0735-1097(01)01504-2; Safar ME, 2002, HYPERTENSION, V39, P735, DOI 10.1161/hy0202.098325; SAGAWA K, 1981, CIRCULATION, V63, P1223, DOI 10.1161/01.CIR.63.6.1223; Sakurai M, 2007, J HYPERTENS, V25, P391, DOI 10.1097/HJH.0b013e3280115b7c; Senzaki H, 1996, CIRCULATION, V94, P2497, DOI 10.1161/01.CIR.94.10.2497; STERGIOPULOS N, 1992, J BIOMECH, V25, P1477, DOI 10.1016/0021-9290(92)90060-E; Strait JB, 2012, HEART FAIL CLIN, V8, P143, DOI 10.1016/j.hfc.2011.08.011; SUGA H, 1974, CIRC RES, V35, P117, DOI 10.1161/01.RES.35.1.117; SUGA H, 1973, CIRC RES, V32, P314, DOI 10.1161/01.RES.32.3.314; Torjesen AA, 2014, HYPERTENSION, V64, P259, DOI 10.1161/HYPERTENSIONAHA.114.03371; VAITKEVICIUS PV, 1993, CIRCULATION, V88, P1456, DOI 10.1161/01.CIR.88.4.1456; Vardoulis O, 2013, AM J PHYSIOL-HEART C, V304, pH1558, DOI 10.1152/ajpheart.00963.2012; Vardoulis O, 2012, ANN BIOMED ENG, V40, P2619, DOI 10.1007/s10439-012-0600-x; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; WESTERHOF N, 1972, CARDIOVASC RES, V6, P648, DOI 10.1093/cvr/6.6.648	57	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0182173	10.1371/journal.pone.0182173	http://dx.doi.org/10.1371/journal.pone.0182173			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753657	Green Published, Green Submitted, gold			2022-12-26	WOS:000406579300055
J	Wang, QJ; Han, NS; Dang, C; Lu, ZB; Wang, F; Yao, HW; Peng, YF; Stanley, D; Ye, GY				Wang, Qianjin; Han, Naishun; Dang, Cong; Lu, Zengbin; Wang, Fang; Yao, Hongwei; Peng, Yufa; Stanley, David; Ye, Gongyin			Combined influence of Bt rice and rice dwarf virus on biological parameters of a non-target herbivore, Nephotettix cincticeps (Uhler) (Hemiptera: Cicadellidae)	PLOS ONE			English	Article							TRANSGENIC INDICA RICE; SOGATELLA-FURCIFERA; CRY1C-ASTERISK GENE; FIELD CONDITIONS; INSECT PESTS; HOST-PLANT; VECTOR; PERFORMANCE; ARTHROPODS; INFECTION	The advent of genetically modified (GM) Bt rice creates the possibility of interactions among Bt crops, crop pathogens and non-target herbivores. In particular, information on how pathogen-infected Bt-expressing plants will influence non-target herbivores is necessary to predict the sustainability of GM cropping systems. Laboratory bioassays were conducted to evaluate the potential combined impacts of rice dwarf virus (RDV) and two Bt rice lines, T1C-19 (Cry1C) and T2A-1 (Cry2A), on non-target green rice leafhopper (GRLH), Nephotettix cincticeps (Uhler) (Hemiptera: Cicadellidae). In the first experiment, GRLHs feeding preference tests on Bt rice lines compared to a parental control rice line, MH63, were conducted. As rice plants were uninfected with RDV, GRLHs generally preferred the control MH63 line over the two Bt lines during the initial 8 h, with no significant preference during the following 64 h. As rice plants were infected with RDV, there were no clear preferences between the Bt rice lines and the control MH63 line. In the second experiment, we assessed the combined influence of RDV-infection status and Bt rice lines on GRLH biological parameters. Egg duration, adult weights, and male adult longevity were significantly affected on RDV-infected Bt rice. Other parameters, egg hatching rate, nymph survival and fecundity were not significantly influenced. We infer that interaction effect among two testing Bt rice lines and RDV will not lead to enlarged pest populations, thus demonstrating that growing these two Bt rice lines will poses negligible risk to GRLH in sustainable rice agroecosystems. Long-term field experiments to monitor the population dynamics of GRLHs at large scale need to be carried out to confirm the current results.	[Wang, Qianjin; Han, Naishun; Dang, Cong; Lu, Zengbin; Wang, Fang; Yao, Hongwei; Ye, Gongyin] Zhejiang Univ, State Key Lab Rice Biol, Inst Insect Sci, Minist Agr,Key Lab Mol Biol Crop Pathogens & Inse, Hangzhou, Zhejiang, Peoples R China; [Peng, Yufa] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing, Peoples R China; [Stanley, David] ARS, USDA, Biol Control Insects Res Lab, Columbia, MO USA	Ministry of Agriculture & Rural Affairs; Zhejiang University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia	Ye, GY (corresponding author), Zhejiang Univ, State Key Lab Rice Biol, Inst Insect Sci, Minist Agr,Key Lab Mol Biol Crop Pathogens & Inse, Hangzhou, Zhejiang, Peoples R China.	chu@zju.edu.cn	peng, yu/GXW-2071-2022	Ye, Gongyin/0000-0003-4937-8867	Special Research Projects for Developing Transgenic Plants, China [2016ZX08011-001, 2014ZX08011-001]; National Program on Key Basic Research Projects (973 Program) [2014CB138404]; Rice Pests Management Research Group of the Agricultural Science and Technology Innovation Program, China	Special Research Projects for Developing Transgenic Plants, China; National Program on Key Basic Research Projects (973 Program)(National Basic Research Program of China); Rice Pests Management Research Group of the Agricultural Science and Technology Innovation Program, China	Financial supports were provided by the Special Research Projects for Developing Transgenic Plants, China (2016ZX08011-001, and 2014ZX08011-001) and the National Program on Key Basic Research Projects (973 Program, 2014CB138404), as well as the Rice Pests Management Research Group of the Agricultural Science and Technology Innovation Program, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar ZR, 2010, ENVIRON ENTOMOL, V39, P715, DOI 10.1603/EN09095; Alcantara EP, 2004, ARCH INSECT BIOCHEM, V55, P169, DOI 10.1002/arch.10128; Chen H, 2005, THEOR APPL GENET, V111, P1330, DOI 10.1007/s00122-005-0062-8; CHEN M, 2003, ACTA PHYTOPHYL SIN, V30, P366, DOI DOI 10.3321/J.ISSN:0577; Chen Mao, 2006, Insect Science, V13, P409, DOI 10.1111/j.1744-7917.2006.00110.x; Chen M, 2011, ANNU REV ENTOMOL, V56, P81, DOI 10.1146/annurev-ento-120709-144810; Chen Y, 2012, TRANSGENIC RES, V21, P279, DOI 10.1007/s11248-011-9530-x; Chen Y, 2016, PLANT DIS, V100, P784, DOI 10.1094/PDIS-06-15-0713-RE; Cheng J., 1996, INSECT PESTS RICE, P103; Colvin J, 2006, ADV VIRUS RES, V67, P419, DOI 10.1016/S0065-3527(06)67011-5; Faria CA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000600; Han P, 2016, J PEST SCI, V89, P859, DOI 10.1007/s10340-016-0791-2; He XC, 2012, RICE SCI, V19, P335, DOI 10.1016/S1672-6308(12)60059-6; Hibino H, 1996, ANNU REV PHYTOPATHOL, V34, P249, DOI 10.1146/annurev.phyto.34.1.249; High SM, 2004, TRENDS PLANT SCI, V9, P286, DOI 10.1016/j.tplants.2004.04.002; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Honda K, 2007, PHYTOPATHOLOGY, V97, P712, DOI 10.1094/PHYTO-97-6-0712; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Jia SR, 2014, PLANT BIOTECHNOL J, V12, P1259, DOI 10.1111/pbi.12306; Jiao Xiao-Guo, 2006, Chinese Bulletin of Entomology, V43, P774; Lei WB, 2014, J ECON ENTOMOL, V107, P1721, DOI 10.1603/EC13569; Li W, 1995, CHINESE J VIROL, V11, P56; Li Y., 2016, SHOCK VIB, V2016, P14, DOI DOI 10.1111/PBI.12464; Liang L, 2010, J PLANT PROTECTION, V37, P375; Liu QS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15295; Liu Zhi-Cheng, 2003, Acta Entomologica Sinica, V46, P454; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Lu ZB, 2014, ENVIRON ENTOMOL, V43, P209, DOI 10.1603/EN13160; Lu Z. M., 2013, SCI CHINA INFORM SCI, V56, P1; Mouttet R, 2013, OECOLOGIA, V173, P1379, DOI 10.1007/s00442-013-2716-6; NAKASUJI F, 1970, Applied Entomology and Zoology, V5, P1; OMURA T, 1989, J GEN VIROL, V70, P2759, DOI 10.1099/0022-1317-70-10-2759; Roossinck MJ, 2015, VIROLOGY, V479, P271, DOI 10.1016/j.virol.2015.03.041; Ruan Y., 1981, ACTA PHYTOPHY SIN, V8, P27, DOI [10.13802/j.cnki.zwbhxb.1981.01.005, DOI 10.13802/J.CNKI.ZWBHXB.1981.01.005]; SAS Institute, 2003, SAS 9 1 HELP DOC GET; Stout MJ, 2006, ANNU REV ENTOMOL, V51, P663, DOI 10.1146/annurev.ento.51.110104.151117; Sun X, 2015, ECOTOX ENVIRON SAFE, V120, P449, DOI 10.1016/j.ecoenv.2015.06.034; Sun X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079032; Sun Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep26043; Tang W, 2006, MOL BREEDING, V18, P1, DOI 10.1007/s11032-006-9002-9; Tu Z, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-145; Wei TY, 2016, ANNU REV PHYTOPATHOL, V54, P99, DOI 10.1146/annurev-phyto-080615-095900; Whitehouse MEA, 2005, ENVIRON ENTOMOL, V34, P1224, DOI 10.1603/0046-225X(2005)034[1224:ACOACI]2.0.CO;2; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Xu HX, 2014, INSECT SCI, V21, P507, DOI 10.1111/1744-7917.12045; Yao YS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166771; Yoshida S., 1976, LAB MANUAL PHYSL STU, P61; Yu HL, 2011, J INTEGR PLANT BIOL, V53, P520, DOI 10.1111/j.1744-7909.2011.01047.x; Zhou Xia, 2005, Chinese Journal of Rice Science, V19, P74	49	9	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0181258	10.1371/journal.pone.0181258	http://dx.doi.org/10.1371/journal.pone.0181258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753622	Green Published, gold, Green Submitted			2022-12-26	WOS:000406579300013
J	Aucagne, R; Girard, S; Mayotte, N; Lehnertz, B; Lopes-Paciencia, S; Gendron, P; Boucher, G; Chagraoui, J; Sauvageau, G				Aucagne, Romain; Girard, Simon; Mayotte, Nadine; Lehnertz, Bernhard; Lopes-Paciencia, Stephane; Gendron, Patrick; Boucher, Genevieve; Chagraoui, Jalila; Sauvageau, Guy			UBAP2L is amplified in a large subset of human lung adenocarcinoma and is critical for epithelial lung cell identity and tumor metastasis	FASEB JOURNAL			English	Article						UBAP2L; EMT-like phenotype; non-small cell lung cancer; metastasis	MESENCHYMAL TRANSITION; PROTEIN 2-LIKE; CANCER GENOMICS; CARCINOMA CELLS; MIGRATION; GROWTH	The ubiquitin-associated protein 2-like (UBAP2L) gene remains poorly studied in human and mouse development. UBAP2L interacts with the Polycomb group protein B lymphoma Mo-MLV insertion region 1 homolog (BMI1) and determines the activity of mouse hematopoietic stem cells in vivo. Here we show that loss of Ubap2l leads to disorganized respiratory epithelium of mutant neonates, which die of respiratory failure. We also show that UBAP2L overexpression leads to epithelial-mesenchymal transition-like phenotype in a non-small cell lung carcinoma (NSCLC) cell line. UBAP2L is amplified in 15% of human primary lung adenocarcinoma specimens. Such patients express higher levels of UBAP2L and show a reduction in survival when compared with those who do not have this gene amplification. Supporting a possible role for UBAP2L in lung tumor progression, NSCLC cells engineered to express low levels of this gene produce much smaller tumors in vivo than wild-type control cells. Together, these results suggest that UBAP2L contributes to epithelial lung cell identity in mice and that it plays an important role in human lung adenocarcinoma.-Aucagne, R., Girard, S., Mayotte, N., Lehnertz, B., Lopes-Paciencia, S., Gendron, P., Boucher, G., Chagraoui, J., Sauvageau, G. UBAP2L is amplified in a large subset of human lung adenocarcinoma and is critical for epithelial lung cell identity and tumor metastasis.	[Aucagne, Romain; Girard, Simon; Mayotte, Nadine; Lehnertz, Bernhard; Lopes-Paciencia, Stephane; Chagraoui, Jalila; Sauvageau, Guy] Univ Montreal, Lab Mol Genet Stem Cells, Montreal, PQ, Canada; [Gendron, Patrick; Boucher, Genevieve] Univ Montreal, IRIC, Bioinformat Platform, Montreal, PQ, Canada; [Sauvageau, Guy] Univ Montreal, Dept Med, Montreal, PQ, Canada; [Sauvageau, Guy] Maisonneuve Rosemont Hosp, Div Hematol, Montreal, PQ, Canada; [Aucagne, Romain] Univ Bourgogne, UFR Sci Sante, UMR 1231, SAPHIHR Lab, Dijon, France	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Sauvageau, G (corresponding author), Univ Montreal, IRIC, Downtown Stn, POB 6128, Montreal, PQ H3C 3J7, Canada.	guy.sauvageau@umontreal.ca		Sauvageau, Guy/0000-0002-4333-7266; Aucagne, Romain/0000-0002-5644-3287; Boucher, Genevieve/0000-0001-6389-9007; Lopes-Paciencia, Stephane/0000-0002-0819-1572; Gendron, Patrick/0000-0001-9829-2600; Lehnertz, Bernhard/0000-0003-1523-1410	Canadian Institutes of Health Research [MOP-15064, FDN-143286]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The authors thank Melanie Frechette and Valerie Blouin-Chagnon [both from the Institute for Research in Immunology and Cancer (IRIC)] for technical assistance, Celine Moison and Camille Simon (IRIC) for scientific comments, and IRIC core facilities staff for flow cytometry (Daniele Gagne and Gael Dulude) and histology (Dr. Louis Gaboury) services. This work was supported by Canadian Institutes of Health Research operating Grant MOP-15064 and foundation Grant FDN-143286 awarded to G.S. G.S. holds a Canada Research Chair in Molecular Genetics of Stem Cells. The authors declare no conflicts of interest.	Baumgartner R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003598; Bordeleau ME, 2014, BLOOD, V124, P2362, DOI 10.1182/blood-2014-01-548651; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chai R, 2016, TUMOR BIOL, V37, P13225, DOI 10.1007/s13277-016-5159-y; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; De Rubeis S, 2010, MOL CELL NEUROSCI, V43, P43, DOI 10.1016/j.mcn.2009.09.013; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kuniyoshi H, 2002, GENETICS, V162, P1775; Kwon SC, 2013, NAT STRUCT MOL BIOL, V20, P1122, DOI 10.1038/nsmb.2638; Lavigne MC, 2004, BIOCHEM BIOPH RES CO, V324, P534, DOI 10.1016/j.bbrc.2004.09.080; Li D, 2014, ONCOL REP, V32, P1578, DOI 10.3892/or.2014.3360; Luca R, 2013, EMBO MOL MED, V5, P1523, DOI 10.1002/emmm.201302847; Maeda M, 2016, FASEB J, V30, P312, DOI 10.1096/fj.14-268987; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Naz RK, 2010, J REPROD IMMUNOL, V84, P24, DOI 10.1016/j.jri.2009.10.006; Qu P, 2009, CANCER RES, V69, P7252, DOI 10.1158/0008-5472.CAN-09-0577; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tirino V, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.144; Torr E., 2016, PHYSL REP, V4; Wilde IB, 2011, J PROTEOME RES, V10, P1062, DOI 10.1021/pr1008543; Ye T, 2017, CELL PHYSIOL BIOCHEM, V41, P1584, DOI 10.1159/000470824; Zhao B, 2015, INT J MOL MED, V36, P1012, DOI 10.3892/ijmm.2015.2323	24	10	10	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					5012	5018		10.1096/fj.201601219RRR	http://dx.doi.org/10.1096/fj.201601219RRR			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28754713				2022-12-26	WOS:000413398500030
J	Scholz, T; Weigert, A; Brune, B; Sadik, CD; Bohm, B; Burkhardt, H				Scholz, Tatjana; Weigert, Andreas; Bruene, Bernhard; Sadik, Christian D.; Boehm, Beate; Burkhardt, Harald			GM-CSF in murine psoriasiform dermatitis: Redundant and pathogenic roles uncovered by antibody-induced neutralization and genetic deficiency	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; COLONY-STIMULATING FACTOR; IMIQUIMOD-INDUCED PSORIASIS; INDUCED SKIN INFLAMMATION; TRANSCRIPTION FACTOR E2-2; MICROABSCESS FORMATION; RHEUMATOID-ARTHRITIS; EXPRESSION; IL-22; ACTIVATION	Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a pleiotropic, Th17-derived cytokine thought to critically contribute to the pathogenesis of diverse autoimmune diseases, including rheumatoid arthritis and psoriasis. Treatment with monoclonal antibodies that block GM-CSF activity is associated with favorable therapeutic effects in patients with rheumatoid arthritis. We evaluated the role of GM-CSF as a potential target for therapeutic interference in psoriasis using a combined pharmacologic and genetic approach and the mouse model of imiquimod-induced psoriasiform dermatitis (IMQPD). Neutralization of murine GM-CSF by an anti-GM-CSF antibody ameliorated IMQPD. In contrast, genetic deficiency in GM-CSF did not alter the course of IMQPD, suggesting the existence of mechanisms compensating for chronic, but not acute, absence of GM-CSF. Further investigation uncovered an alternative pathogenic pathway for IMQPD in the absence of GM-CSF characterized by an expanded plasmacytoid dendritic cell population and release of IFN alpha and IL-22. This pathway was not activated in wild-type mice during short-term anti-GM-CSF treatment. Our investigations support the potential value of GM-CSF as a therapeutic target in psoriatic disease. The discovery of an alternative pathogenic pathway for psoriasiform dermatitis in the permanent absence of GM-CSF, however, suggests the need for monitoring during therapeutic use of long-term GM-CSF blockade.	[Scholz, Tatjana; Burkhardt, Harald] Goethe Univ, Project Grp Translat Med & Pharmacol TMP, Fraunhofer Inst Mol Biol & Appl Ecol IME, Frankfurt, Germany; [Weigert, Andreas; Bruene, Bernhard] Goethe Univ, Fac Med, Inst Biochem Pathobiochem 1, Frankfurt, Germany; [Sadik, Christian D.] Univ Lubeck, Dept Dermatol Allergy & Venereol, Lubeck, Germany; [Boehm, Beate; Burkhardt, Harald] Goethe Univ, Univ Hosp Frankfurt, Div Rheumatol, Frankfurt, Germany	Fraunhofer Gesellschaft; Goethe University Frankfurt; Goethe University Frankfurt; University of Lubeck; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Burkhardt, H (corresponding author), Goethe Univ, Project Grp Translat Med & Pharmacol TMP, Fraunhofer Inst Mol Biol & Appl Ecol IME, Frankfurt, Germany.; Burkhardt, H (corresponding author), Goethe Univ, Univ Hosp Frankfurt, Div Rheumatol, Frankfurt, Germany.	Harald.Burkhardt@ime.fraunhofer.de	Sadik, Christian/M-9033-2019; Sadik, Christian David/G-9593-2014; Weigert, Andreas/E-6540-2010	Sadik, Christian/0000-0001-6701-048X; Sadik, Christian David/0000-0001-6701-048X; Weigert, Andreas/0000-0002-7529-1952	Landes-Offensive zur Entwickl ung Wissenschattlich-okonom ischer Exzellenz (LOEWE) of the Federal State of Hesse; Research Center for Translational Medicine and Pharmacology TMP; Else Kroner-Fresenius Foundation (EKFS); Research Training Group Translational Research Innovation-Pharma (TRIP); Federal Ministry of Education and Research of Germany (Arthromark TP4) [01 EC1401C]; Deutsche Forschungsgemeinschaft [Sal 960/5-1]; Galderma Fbrderkreis e.V.; Fraunhofer Institute I ME, Frankfurt am Main, Germany	Landes-Offensive zur Entwickl ung Wissenschattlich-okonom ischer Exzellenz (LOEWE) of the Federal State of Hesse; Research Center for Translational Medicine and Pharmacology TMP; Else Kroner-Fresenius Foundation (EKFS); Research Training Group Translational Research Innovation-Pharma (TRIP); Federal Ministry of Education and Research of Germany (Arthromark TP4); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Galderma Fbrderkreis e.V.; Fraunhofer Institute I ME, Frankfurt am Main, Germany	This research was supported by the research funding program Landes-Offensive zur Entwickl ung Wissenschattlich-okonom ischer Exzellenz (LOEWE) of the Federal State of Hesse, Research Center for Translational Medicine and Pharmacology TMP to Prof. Burkhardt; the Else Kroner-Fresenius Foundation (EKFS), Research Training Group Translational Research Innovation-Pharma (TRIP) to Dr. Scholz; the Federal Ministry of Education and Research of Germany (Arthromark TP4; 01 EC1401C) to Prof. Burkhardt; the Deutsche Forschungsgemeinschaft (Sal 960/5-1) and the Galderma Fbrderkreis e.V. (Theodar-Nasemann-Award 2014) to Dr. Sadik; and the Fraunhofer Institute I ME, Frankfurt am Main, Germany (editorial services). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATHERTON DJ, 1980, BRIT J DERMATOL, V102, P307, DOI 10.1111/j.1365-2133.1980.tb08145.x; Avitabile S, 2015, J INVEST DERMATOL, V135, P2862, DOI 10.1038/jid.2015.278; Behrens F, 2015, ANN RHEUM DIS, V74, P1058, DOI 10.1136/annrheumdis-2013-204816; Boehncke WH, 2015, LANCET, V386, P983, DOI 10.1016/S0140-6736(14)61909-7; Boniface K, 2007, CLIN EXP IMMUNOL, V150, P407, DOI 10.1111/j.1365-2249.2007.03511.x; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Burmester GR, 2013, ANN RHEUM DIS, V72, P1445, DOI 10.1136/annrheumdis-2012-202450; Campa M, 2016, DERMATOLOGY THER, V6, P1, DOI 10.1007/s13555-015-0092-3; Cho Seok Goo, 1998, Journal of Korean Medical Science, V13, P685; Christophers E, 2014, BRIT J DERMATOL, V170, P59, DOI 10.1111/bjd.12631; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Constantinescu CS, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000117; Croxford AL, 2014, J INVEST DERMATOL, V134, P728, DOI 10.1038/jid.2013.404; Dai JH, 2004, J IMMUNOL, V173, P1535, DOI 10.4049/jimmunol.173.3.1535; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Enzler T, 2003, J EXP MED, V197, P1213, DOI 10.1084/jem.20021258; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Gary-Gouy H, 2004, J INTERFERON CYTOKIN, V22, P653; Ghosh HS, 2010, IMMUNITY, V33, P905, DOI 10.1016/j.immuni.2010.11.023; Gibson SJ, 2002, CELL IMMUNOL, V218, P74, DOI 10.1016/S0008-8749(02)00517-8; Huang XF, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00526; KELLY R, 1993, BRIT J DERMATOL, V128, P468, DOI 10.1111/j.1365-2133.1993.tb00218.x; Kingston D, 2009, BLOOD, V114, P835, DOI 10.1182/blood-2009-02-206318; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Li HYS, 2012, BLOOD, V120, P4363, DOI 10.1182/blood-2012-07-441311; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; McGeachy MJ, 2011, NAT IMMUNOL, V12, P521, DOI 10.1038/ni.2044; Nestle FO, 2006, J EUR ACAD DERMATOL, V20, P24, DOI 10.1111/j.1468-3083.2006.01769.x; Perera GK, 2012, ANNU REV PATHOL-MECH, V7, P385, DOI 10.1146/annurev-pathol-011811-132448; Renauld JC, 2003, NAT REV IMMUNOL, V3, P667, DOI 10.1038/nri1153; Riol-Blanco L, 2014, NATURE, V510, P157, DOI 10.1038/nature13199; Sha LK, 2015, FREE RADICAL BIO MED, V83, P77, DOI 10.1016/j.freeradbiomed.2015.02.004; Sumida H, 2014, J IMMUNOL, V192, P4361, DOI 10.4049/jimmunol.1302959; Terhorst D, 2015, J IMMUNOL, V195, P4953, DOI 10.4049/jimmunol.1500551; Toichi E, 2000, J AM ACAD DERMATOL, V43, P391, DOI 10.1067/mjd.2000.103264; Ueyama A, 2014, J DERMATOL, V41, P135, DOI 10.1111/1346-8138.12367; Uribe-Herranz M, 2013, J INVEST DERMATOL, V133, P1541, DOI 10.1038/jid.2012.512; Van Belle AB, 2012, J IMMUNOL, V188, P462, DOI 10.4049/jimmunol.1102224; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Zuniga LA, 2013, IMMUNOL REV, V252, P78, DOI 10.1111/imr.12036	45	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0182646	10.1371/journal.pone.0182646	http://dx.doi.org/10.1371/journal.pone.0182646			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28777803	Green Submitted, gold, Green Published			2022-12-26	WOS:000406944300047
J	Chen, JT; Mao, SF; Li, HF; Zheng, MC; Yi, LG; Lin, JM; Lin, ZX				Chen, Jintao; Mao, Sifeng; Li, Haifang; Zheng, Mingcheng; Yi, Linglu; Lin, Jin-Ming; Lin, Zhi-xiong			The pathological structure of the perivascular niche in different microvascular patterns of glioblastoma	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; STEM-CELL NICHE; GROWTH; TUMORS; MICROENVIRONMENT; CLASSIFICATION; EPITHELIUM; PERICYTES; VESSELS; GLIOMAS	The perivascular niche is critical for intercellular communication between resident cell types in glioblastoma (GBM), and it plays a vital role in maintaining the glioma stem cell (GSC) microenvironment. It is shown in abundant research that different microvascular patterns exist in GBM; and it can be implied that different microvascular patterns are associated with different pathological structures in the perivascular niche. However, the pathological structure of the perivascular niche is still not clear. Here, we investigated the distribution and biological characteristics of different microvascular pattern niches (MVPNs) in GBM by detecting the expression of CD34, CD133, Nestin, alpha-SMA, GFAP and CD14 in the perivascular niche using multiple-fluorescence. The four basic microvascular patterns are microvascular sprouting (MS), vascular cluster (VC), vascular garland (VG), and glomeruloid vascular proliferation (GVP). By analyzing the proportion of the area of each marker in four types of formations, the results indicated that the expression of CD34, CD133 and Nestin in MS and VC was significantly lower than that in VG and GVP (P<0.05). Furthermore, the results showed that alpha-SMA expression different in the MS, VC, VG and GVP (P<0.05). However, the expression of GFAP and CD14 in each type of formation exhibited no significant difference (P>0.05). According to the area distributions of different markers, we mapped four precise simulation diagrams to provide an effective foundation for the accurate simulation of glioblastoma in vitro.	[Chen, Jintao; Zheng, Mingcheng] Fujian Med Univ, Affiliated Hosp 1, Dept Neurosurg, Fuzhou, Fujian, Peoples R China; [Chen, Jintao; Mao, Sifeng; Li, Haifang; Yi, Linglu; Lin, Jin-Ming] Tsinghua Univ, Beijing Key Lab Microanalyt Methods & Instrumenta, Dept Chem, Beijing, Peoples R China; [Lin, Zhi-xiong] Capital Med Univ, Beijing Sanbo Brain Hosp, Dept Neurosurg, Beijing, Peoples R China	Fujian Medical University; Tsinghua University; Capital Medical University	Lin, JM (corresponding author), Tsinghua Univ, Beijing Key Lab Microanalyt Methods & Instrumenta, Dept Chem, Beijing, Peoples R China.; Lin, ZX (corresponding author), Capital Med Univ, Beijing Sanbo Brain Hosp, Dept Neurosurg, Beijing, Peoples R China.	jmlin@mail.tsinghua.edu.cn; lzx1967@sina.com	Mao, Sifeng/M-4535-2018	Mao, Sifeng/0000-0002-8140-8379; Lin, Jin-Ming/0000-0001-8891-0655	National Natural Science Foundation of China [21435002, 81373373, 21621003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (NO. 21435002, 81373373, 21621003). The website is http://www.nsfc.gov.cn/publish/portal1/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (Nos. 21435002, 81373373, 21621003). The authors would like to thank the Department of Pathology, Beijing Sanbo Brain Hospital, Capital Medical University, China, for their help in immunohistochemistry design and assistance in data processing.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barcellos-de-Souza P, 2013, BBA-REV CANCER, V1836, P321, DOI 10.1016/j.bbcan.2013.10.004; Bexell D, 2009, MOL THER, V17, P183, DOI 10.1038/mt.2008.229; Birbrair A, 2014, AM J PHYSIOL-CELL PH, V307, pC25, DOI 10.1152/ajpcell.00084.2014; Birner P, 2003, BRAIN PATHOL, V13, P133, DOI 10.1111/j.1750-3639.2003.tb00013.x; Brooks Michael D, 2013, Curr Pathobiol Rep, V1, P101; Cao Y, 2013, CANCER-AM CANCER SOC, V119, P313, DOI 10.1002/cncr.27746; Chen L, 2015, HUM PATHOL, V46, P120, DOI 10.1016/j.humpath.2014.10.002; Chen QS, 2016, LAB CHIP, V16, P1346, DOI 10.1039/c6lc00231e; Cheng L, 2013, CELL, V153, P139, DOI 10.1016/j.cell.2013.02.021; Chepko G, 2005, TISSUE CELL, V37, P393, DOI 10.1016/j.tice.2005.06.005; Codrici E, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/5728438; Filatova A, 2013, BBA-GEN SUBJECTS, V1830, P2496, DOI 10.1016/j.bbagen.2012.10.008; Guichet PO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151274; Hayakawa Y, 2015, CANCER CELL, V28, P800, DOI 10.1016/j.ccell.2015.10.003; Hira VVV, 2017, BBA-MOL CELL RES, V1864, P594, DOI 10.1016/j.bbamcr.2016.12.021; Hottinger AF, 2016, NEURO-ONCOLOGY, V18, P1338, DOI 10.1093/neuonc/now182; Lapa C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122269; Lin CH, 2015, CHINESE CHEM LETT, V26, P1225, DOI 10.1016/j.cclet.2015.03.007; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Oh M, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00367; Ottone C, 2014, NAT CELL BIOL, V16, P1045, DOI 10.1038/ncb3045; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Pang YWY, 2016, J BONE MINER RES, V31, P514, DOI 10.1002/jbmr.2717; Schiffer D, 2015, TUMOR MICROENVIRONME, P49; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sun HQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114246; Svensson A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123553; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Zeppernick F, 2008, CLIN CANCER RES, V14, P123, DOI 10.1158/1078-0432.CCR-07-0932; Zhou WC, 2015, NAT CELL BIOL, V17, P170, DOI 10.1038/ncb3090; Zhu TS, 2011, CANCER RES, V71, P6061, DOI 10.1158/0008-5472.CAN-10-4269	33	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182183	10.1371/journal.pone.0182183	http://dx.doi.org/10.1371/journal.pone.0182183			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771552	Green Published, gold, Green Submitted			2022-12-26	WOS:000406853600073
J	Handy, LK; Maroudi, S; Powell, M; Nfila, B; Moser, C; Japa, I; Monyatsi, N; Tzortzi, E; Kouzeli, I; Luberti, A; Theodoridou, M; Offit, P; Steenhoff, A; Shea, JA; Feemster, KA				Handy, Lori K.; Maroudi, Stefania; Powell, Maura; Nfila, Bakanuki; Moser, Charlotte; Japa, Ingrid; Monyatsi, Ndibo; Tzortzi, Elena; Kouzeli, Ismini; Luberti, Anthony; Theodoridou, Maria; Offit, Paul; Steenhoff, Andrew; Shea, Judy A.; Feemster, Kristen A.			The impact of access to immunization information on vaccine acceptance in three countries	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; PUBLISHED LITERATURE; HESITANCY; VACCINATIONS; REASONS; COMMUNICATION; DETERMINANTS; CHILDREN; EUROPE; CRISIS	Introduction Vaccine acceptance is a critical component of sustainable immunization programs, yet rates of vaccine hesitancy are rising. Increased access to misinformation through media and anti-vaccine advocacy is an important contributor to hesitancy in the United States and other high-income nations with robust immunization programs. Little is known about the content and effect of information sources on attitudes toward vaccination in settings with rapidly changing or unstable immunization programs. Objective The objective of this study was to explore knowledge and attitudes regarding vaccines and vaccine-preventable diseases among caregivers and immunization providers in Botswana, the Dominican Republic, and Greece and examine how access to information impacts reported vaccine acceptance. Methods We conducted 37 focus groups and 14 semi-structured interviews with 96 providers and 153 caregivers in Botswana, the Dominican Republic, and Greece. Focus groups were conducted in Setswana, English, Spanish, or Greek; digitally recorded; and transcribed. Transcripts were translated into English, coded in qualitative data analysis software (NVivo 10, QSR International, Melbourne, Australia), and analyzed for common themes. Results Dominant themes in all three countries included identification of health care providers or medical literature as the primary source of vaccine information, yet participants reported insufficient communication about vaccines was available. Comments about level of trust in the health care system and government contrasted between sites, with the highest level of trust reported in Botswana but lower levels of trust in Greece. Conclusions In Botswana, the Dominican Republic, and Greece, participants expressed reliance on health care providers for information and demonstrated a need for more communication about vaccines. Trust in the government and health care system influenced vaccine acceptance differently in each country, demonstrating the need for country-specific data that focus on vaccine acceptance to fully understand which drivers can be leveraged to improve implementation of immunization programs.	[Handy, Lori K.] Thomas Jefferson Univ, Dept Pediat, Sidney Kimmel Med Ctr, Philadelphia, PA 19107 USA; [Handy, Lori K.] Nemours Alfred I duPont Hosp Children, Div Infect Dis, Wilmington, DC 19803 USA; [Handy, Lori K.; Moser, Charlotte; Offit, Paul; Feemster, Kristen A.] Childrens Hosp Philadelphia, Vaccine Educ Ctr, Philadelphia, PA 19104 USA; [Maroudi, Stefania; Tzortzi, Elena; Kouzeli, Ismini; Theodoridou, Maria] Collaborat Ctr Clin Epidemiol & Outcomes Res, Athens, Greece; [Powell, Maura; Japa, Ingrid; Steenhoff, Andrew] Childrens Hosp Philadelphia, Global Hlth Ctr, Philadelphia, PA 19104 USA; [Nfila, Bakanuki] Botswana UPenn Partnership, Gaborone, Botswana; [Moser, Charlotte; Offit, Paul; Steenhoff, Andrew; Feemster, Kristen A.] Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA; [Japa, Ingrid] Robert Reid Cabral Hosp, Santo Domingo, Dominican Rep; [Monyatsi, Ndibo] Minist Hlth, Child Hlth Div, Gaborone, Botswana; [Luberti, Anthony; Offit, Paul; Steenhoff, Andrew; Feemster, Kristen A.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Steenhoff, Andrew] Univ Botswana, Botswana UPenn Partnership, Gaborone, Botswana; [Steenhoff, Andrew] Univ Botswana, Dept Pediat & Adolescent Hlth, Gaborone, Botswana; [Shea, Judy A.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA	Jefferson University; Nemours Alfred I. duPont Hospital for Children; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Botswana; University of Botswana; University of Pennsylvania; Pennsylvania Medicine	Handy, LK (corresponding author), Thomas Jefferson Univ, Dept Pediat, Sidney Kimmel Med Ctr, Philadelphia, PA 19107 USA.; Handy, LK (corresponding author), Nemours Alfred I duPont Hosp Children, Div Infect Dis, Wilmington, DC 19803 USA.; Handy, LK (corresponding author), Childrens Hosp Philadelphia, Vaccine Educ Ctr, Philadelphia, PA 19104 USA.	handyl@email.chop.edu			Penn Center for AIDS Research (CFAR), an NIH-funded program [P30 AI 045008]; Mabel Freeman Fund; Vaccine Education Center at Children's Hospital of Philadelphia; Pincus Fellowship; Theoklis Zaoutis, MD, MSCE;  [T32-AI096345];  [L40-AI-107932]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055435] Funding Source: NIH RePORTER	Penn Center for AIDS Research (CFAR), an NIH-funded program; Mabel Freeman Fund; Vaccine Education Center at Children's Hospital of Philadelphia; Pincus Fellowship; Theoklis Zaoutis, MD, MSCE; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We acknowledge the work of Marc Callender, MD, Caitlin Fasano, and Rodney Finalle, MD; in addition to support from Theoklis Zaoutis, MD, MSCE. This publication was made possible through core services and support from the Penn Center for AIDS Research (CFAR), an NIH-funded program (P30 AI 045008). Lori K. Handy was supported by T32-AI096345 and L40-AI-107932. Additional funding was provided by Mabel Freeman Fund and the Vaccine Education Center at Childrens Hospital of Philadelphia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the work of Marc Callender, MD, Caitlin Fasano, and Rodney Finalle, MD; in addition to support from the Pincus Fellowship; the Vaccine Education Center at Children's Hospital of Philadelphia, and Theoklis Zaoutis, MD, MSCE.	[Anonymous], 2011, COV DISTR SEL ANT BO; [Anonymous], 2007, BOTSW EPI COV SURV 2; [Anonymous], 2012, YOUNG CHILD SURV DEV; BASTIEN JW, 1995, SOC SCI MED, V41, P77, DOI 10.1016/0277-9536(94)00297-7; BUKENYA GB, 1991, PAPUA NEW GUINEA MED, V34, P22; Dorell C, 2011, CLIN PEDIATR, V50, P1116, DOI 10.1177/0009922811415104; Dube E, 2015, VACCINE, V33, P4191, DOI 10.1016/j.vaccine.2015.04.041; Dube E, 2014, VACCINE, V32, P6649, DOI 10.1016/j.vaccine.2014.09.039; Goldstein S, 2015, VACCINE, V33, P4212, DOI 10.1016/j.vaccine.2015.04.042; GREENOUGH P, 1995, SOC SCI MED, V41, P605, DOI 10.1016/0277-9536(95)00032-3; Hinman Alan R, 2011, MMWR Suppl, V60, P49; Karafillakis E, 2016, VACCINE, V34, P5013, DOI 10.1016/j.vaccine.2016.08.029; Larson HJ, 2015, VACCINE, V33, P4165, DOI 10.1016/j.vaccine.2015.04.037; Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081; Larson HJ, 2011, LANCET, V378, P526, DOI 10.1016/S0140-6736(11)60678-8; Larson HJ, 2010, LANCET, V376, P572, DOI 10.1016/S0140-6736(10)60881-1; Laxminarayan R, 2011, HEALTH AFFAIR, V30, P1096, DOI 10.1377/hlthaff.2011.0405; Leung FH, 2009, CAN FAM PHYSICIAN, V55, P218; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; Maltezou HC, 2015, INFECT DIS-NOR, V47, P437, DOI 10.3109/23744235.2015.1018315; Mnookin S., 2011, PLOS BLOGS; Munoz DC, 2015, INT J PUBLIC HEALTH, V60, P767, DOI 10.1007/s00038-015-0715-6; Naugle DA, 2014, J HEALTH COMMUN, V19, P190, DOI 10.1080/10810730.2014.918217; Opel DJ, 2013, PEDIATRICS, V132, P1037, DOI 10.1542/peds.2013-2037; Panagiotopoulos T, 2013, REPORT NATL STUDY VA; Rainey JJ, 2011, VACCINE, V29, P8215, DOI 10.1016/j.vaccine.2011.08.096; Schaetti C, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-99; Sridhar S, 2014, VACCINE, V32, P6870, DOI 10.1016/j.vaccine.2014.10.063; Streefland PH, 1999, B WORLD HEALTH ORGAN, V77, P722; Sugerman DE, 2010, PEDIATRICS, V125, P747, DOI 10.1542/peds.2009-1653; The State of Vaccine Confidence 2015, 2015, STAT VACC CONF 2015; Thomson S., 2014, EC CRISIS HLTH SYSTE; UNAIDS, 2014, THE GAP REP; Vassiliki P, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1192; Willis N, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-23; World Health Organization, 2016, WHO VACC PREV DIS MO	36	24	24	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0180759	10.1371/journal.pone.0180759	http://dx.doi.org/10.1371/journal.pone.0180759			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771485	Green Submitted, Green Published, gold			2022-12-26	WOS:000406853600007
J	Michalik, M; Orwick-Rydmark, M; Habeck, M; Alva, V; Arnold, T; Linke, D				Michalik, Marcin; Orwick-Rydmark, Marcella; Habeck, Michael; Alva, Vikram; Arnold, Thomas; Linke, Dirk			An evolutionarily conserved glycine-tyrosine motif forms a folding core in outer membrane proteins	PLOS ONE			English	Article							DEPENDENT ANION CHANNEL; BARREL ASSEMBLY MACHINERY; 8-STRANDED BETA-BARREL; ESCHERICHIA-COLI; BACTERIAL PERIPLASM; OMPX; VDAC; MICELLES; MITOCHONDRIA; BIOGENESIS	An intimate interaction between a pair of amino acids, a tyrosine and glycine on neighboring beta-strands, has been previously reported to be important for the structural stability of auto-transporters. Here, we show that the conservation of this interacting pair extends to nearly all major families of outer membrane beta-barrel proteins, which are thought to have originated through duplication events involving an ancestral beta beta hairpin. We analyzed the function of this motif using the prototypical outer membrane protein OmpX. Stopped-flow fluorescence shows that two folding processes occur in the millisecond time regime, the rates of which are reduced in the tyrosine mutant. Folding assays further demonstrate a reduction in the yield of folded protein for the mutant compared to the wild-type, as well as a reduction in thermal stability. Taken together, our data support the idea of an evolutionarily conserved 'folding core' that affects the folding, membrane insertion, and thermal stability of outer membrane protein beta-barrels.	[Michalik, Marcin; Orwick-Rydmark, Marcella; Linke, Dirk] Univ Oslo, Dept Biosci, Oslo, Norway; [Michalik, Marcin; Arnold, Thomas; Linke, Dirk] Max Planck Inst Dev Biol, Dept Prot Evolut, Tubingen, Germany; [Habeck, Michael] Max Planck Inst Biophys Chem, Stat Inverse Problems Biophys, Gottingen, Germany; [Habeck, Michael] Univ Gottingen, Felix Bernstein Inst Math Stat Biosci, Gottingen, Germany; [Alva, Vikram] Max Planck Inst Dev Biol, Dept Prot Evolut, Tubingen, Germany; [Arnold, Thomas] Boehringer Ingelheim Vet Res Ctr, Hannover, Germany	University of Oslo; Max Planck Society; Max Planck Society; University of Gottingen; Max Planck Society; Boehringer Ingelheim	Linke, D (corresponding author), Univ Oslo, Dept Biosci, Oslo, Norway.; Linke, D (corresponding author), Max Planck Inst Dev Biol, Dept Prot Evolut, Tubingen, Germany.	dirk.linke@ibv.uio.no	Alva, Vikram/D-9378-2010; Linke, Dirk/F-9147-2010	Alva, Vikram/0000-0003-1188-473X; Linke, Dirk/0000-0003-3150-6752	German Science Foundation [DFG Li 1673/4-1]; Department of Biosciences, University of Oslo; Norwegian Research Council [NFR 240909]	German Science Foundation(German Research Foundation (DFG)); Department of Biosciences, University of Oslo; Norwegian Research Council(Research Council of NorwayEuropean Commission)	Funding to DL from the German Science Foundation (DFG Li 1673/4-1) and from the Department of Biosciences, University of Oslo, and funding to MOR from the Norwegian Research Council (NFR 240909), is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors want to thank Andrei Lupas for years of support and valuable discussions in the beginning of this project. Funding to DL from the German Science Foundation (DFG Li 1673/4-1) and from the Department of Biosciences, University of Oslo, and funding to MOR from the Norwegian Research Council (NFR 240909), is gratefully acknowledged.	Allen WJ, 2009, ADV PROTEIN CHEM STR, V78, P51, DOI [10.1016/S1876-1623(08)78003-9, 10.1016/S1876-1623(09)78003-9]; Alva V, 2015, ELIFE, V4, DOI 10.7554/eLife.09410; Arnold T, 2007, J MOL BIOL, V366, P1174, DOI 10.1016/j.jmb.2006.12.029; Arnold Thomas, 2008, Curr Protoc Protein Sci, VChapter 4, DOI 10.1002/0471140864.ps0408s53; Bakelar J, 2016, SCIENCE, V351, P180, DOI 10.1126/science.aad3460; Baldermann C, 1998, J BACTERIOL, V180, P3741, DOI 10.1128/JB.180.15.3741-3749.1998; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; BENZ R, 1994, BBA-REV BIOMEMBRANES, V1197, P167, DOI 10.1016/0304-4157(94)90004-3; Burmann BM, 2013, NAT STRUCT MOL BIOL, V20, P1265, DOI 10.1038/nsmb.2677; Calmettes C, 2015, ADV EXP MED BIOL, V883, P255, DOI 10.1007/978-3-319-23603-2_14; Chaturvedi D, 2014, FEBS LETT, V588, P4464, DOI 10.1016/j.febslet.2014.10.017; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Dupont M, 2004, FEBS LETT, V569, P27, DOI 10.1016/j.febslet.2004.05.047; Elsevier B.V., 2015, BIOCH BIOPHYS ACTA B, V1848, P1947; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; FISCHER K, 1994, J BIOL CHEM, V269, P25754; Gessmann D, 2011, J MOL BIOL, V413, P150, DOI 10.1016/j.jmb.2011.07.054; Gu YH, 2016, NATURE, V531, P64, DOI 10.1038/nature17199; Hammouda B, 2013, J RES NATL INST STAN, V118, P151, DOI 10.6028/jres.118.008; He LZ, 2002, J PHYS CHEM B, V106, P7596, DOI 10.1021/jp020034o; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hiller S, 2008, ANGEW CHEM INT EDIT, V47, P977, DOI 10.1002/anie.200703367; Hong HD, 2006, J BIOL CHEM, V281, P7568, DOI 10.1074/jbc.M512365200; Horne JE, 2016, BIOCHEM SOC T, V44, P802, DOI 10.1042/BST20160020; Kim KH, 2012, PROTEIN SCI, V21, P751, DOI 10.1002/pro.2069; Kleinschmidt JH, 1996, BIOCHEMISTRY-US, V35, P12993, DOI 10.1021/bi961478b; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Leyton DL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5239; Li SL, 1997, BIOTECHNIQUES, V23, P588, DOI 10.2144/97234bm05; Linke D, 2004, BIOPHYS J, V86, P1479, DOI 10.1016/S0006-3495(04)74216-2; MALLIARIS A, 1985, J PHYS CHEM-US, V89, P2709, DOI 10.1021/j100258a054; Miot M, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-4; Moon CP, 2013, P NATL ACAD SCI USA, V110, P4285, DOI 10.1073/pnas.1212527110; Moon CP, 2011, METHOD ENZYMOL, V492, P189, DOI 10.1016/B978-0-12-381268-1.00018-5; NESTERENKO MV, 1994, J BIOCHEM BIOPH METH, V28, P239, DOI 10.1016/0165-022X(94)90020-5; NEUWALD AF, 1995, PROTEIN SCI, V4, P1618, DOI 10.1002/pro.5560040820; Noinaj N, 2015, CURR OPIN STRUC BIOL, V31, P35, DOI 10.1016/j.sbi.2015.02.012; Noinaj N, 2014, STRUCTURE, V22, P1055, DOI 10.1016/j.str.2014.05.008; Noskov SY, 2016, BBA-BIOMEMBRANES, V1858, P1778, DOI 10.1016/j.bbamem.2016.02.026; Paramasivam N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-510; Pautsch A, 1999, PROTEINS, V34, P167, DOI 10.1002/(SICI)1097-0134(19990201)34:2<167::AID-PROT2>3.3.CO;2-8; Pavlova O, 2013, P NATL ACAD SCI USA, V110, pE938, DOI 10.1073/pnas.1219076110; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Raschle T, 2016, ANGEW CHEM INT EDIT, V55, P5952, DOI 10.1002/anie.201509910; Remmert M, 2010, MOL BIOL EVOL, V27, P1348, DOI 10.1093/molbev/msq017; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; Rollauer SE, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0023; ROSENBUSCH JP, 1974, J BIOL CHEM, V249, P8019; Rostovtseva TK, 2005, J BIOENERG BIOMEMBR, V37, P129, DOI 10.1007/s10863-005-6566-8; Schredelseker J, 2014, J BIOL CHEM, V289, P12566, DOI 10.1074/jbc.M113.497438; SCHWEIZER M, 1978, EUR J BIOCHEM, V82, P211, DOI 10.1111/j.1432-1033.1978.tb12013.x; Stanley AM, 2008, ARCH BIOCHEM BIOPHYS, V469, P46, DOI 10.1016/j.abb.2007.09.024; STRUYVE M, 1991, J MOL BIOL, V218, P141, DOI 10.1016/0022-2836(91)90880-F; Tafer H, 2004, BIOCHEMISTRY-US, V43, P860, DOI 10.1021/bi0356606; Tommassen J, 2010, MICROBIOL-SGM, V156, P2587, DOI 10.1099/mic.0.042689-0; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Ulrich T, 2015, INT J MED MICROBIOL, V305, P259, DOI 10.1016/j.ijmm.2014.12.009; Vogt J, 1999, STRUCTURE, V7, P1301, DOI 10.1016/S0969-2126(00)80063-5; Voigt CA, 2002, NAT STRUCT BIOL, V9, P553, DOI 10.1038/nsb805; Walser R, 2012, BIOL CHEM, V393, P1341, DOI 10.1515/hsz-2012-0234; Wimley WC, 2003, CURR OPIN STRUC BIOL, V13, P404, DOI 10.1016/S0959-440X(03)00099-X; Wimley WC, 2002, PROTEIN SCI, V11, P301, DOI 10.1110/ps.29402; Young JC, 2003, CELL, V113, P1, DOI 10.1016/S0092-8674(03)00192-2	64	13	13	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182016	10.1371/journal.pone.0182016	http://dx.doi.org/10.1371/journal.pone.0182016			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771529	Green Published, Green Submitted, gold			2022-12-26	WOS:000406853600056
J	Sun, HP; Li, F; Xu, ZJ; Sun, ML; Cong, HQ; Qiao, F; Zhong, XH				Sun, Huapeng; Li, Fang; Xu, Zijian; Sun, Mengli; Cong, Hanqing; Qiao, Fei; Zhong, Xiaohong			De novo leaf and root transcriptome analysis to identify putative genes involved in triterpenoid saponins biosynthesis in Hedera helix L.	PLOS ONE			English	Article							FUNCTIONAL-CHARACTERIZATION; GINSENOSIDE BIOSYNTHESIS; IVY LEAVES; IDENTIFICATION; SELECTION; EFFICACY; EXTRACT; PROTEIN	Hedera helix L. is an important traditional medicinal plant in Europe. The main active components are triterpenoid saponins, but none of the potential enzymes involved in triterpenoid saponins biosynthesis have been discovered and annotated. Here is reported the first study of global transcriptome analyses using the Illumina HiSeq(TM) 2500 platform for H. helix. In total, over 24 million clean reads were produced and 96,333 unigenes were assembled, with an average length of 1385 nt; more than 79,085 unigenes had at least one significant match to an existing gene model. Differentially Expressed Gene analysis identified 6,222 and 7,012 unigenes which were expressed either higher or lower in leaf samples when compared with roots. After functional annotation and classification, two pathways and 410 unigenes related to triterpenoid saponins biosynthesis were discovered. The accuracy of these de novo sequences was validated by RT-qPCR analysis and a RACE clone. These data will enrich our knowledge of triterpenoid saponin biosynthesis and provide a theoretical foundation for molecular research on H. helix.	[Sun, Huapeng; Cong, Hanqing; Qiao, Fei] Chinese Acad Trop Agr Sci, Minist Agr, Key Lab Crop Gene Resources & Germplasm Enhanceme, Trop Crops Genet Resources Inst, Danzhou, Peoples R China; [Li, Fang; Zhong, Xiaohong] Hunan Agr Univ, Hort & Landscape Coll, Changsha, Hunan, Peoples R China; [Xu, Zijian; Sun, Mengli] Hainan Univ, Inst Trop Agr & Forestry, Haikou, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Hunan Agricultural University; Hainan University	Qiao, F (corresponding author), Chinese Acad Trop Agr Sci, Minist Agr, Key Lab Crop Gene Resources & Germplasm Enhanceme, Trop Crops Genet Resources Inst, Danzhou, Peoples R China.; Zhong, XH (corresponding author), Hunan Agr Univ, Hort & Landscape Coll, Changsha, Hunan, Peoples R China.	qiaofeixn@gmail.com; xh-zhong@163.com						Achnine L, 2005, PLANT J, V41, P875, DOI 10.1111/j.1365-313X.2005.02344.x; Aharoni Asaph, 2006, Phytochemistry Reviews, V5, P49, DOI 10.1007/s11101-005-3747-3; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Carelli M, 2011, PLANT CELL, V23, P3070, DOI 10.1105/tpc.111.087312; Choi DW, 2005, PLANT CELL REP, V23, P557, DOI 10.1007/s00299-004-0845-4; Cwientzek U, 2011, PHYTOMEDICINE, V18, P1105, DOI 10.1016/j.phymed.2011.06.014; Dai ZB, 2011, J PLANT PHYSIOL, V168, P148, DOI 10.1016/j.jplph.2010.06.008; Fazio S, 2009, PHYTOMEDICINE, V16, P17, DOI 10.1016/j.phymed.2006.05.003; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gurkok T, 2015, PLANT MOL BIOL REP, V33, P673, DOI 10.1007/s11105-014-0772-7; Han JY, 2013, PLANT CELL PHYSIOL, V54, P2034, DOI 10.1093/pcp/pct141; Han JY, 2011, PLANT CELL PHYSIOL, V52, P2062, DOI 10.1093/pcp/pcr150; Han JY, 2010, PHYTOCHEMISTRY, V71, P36, DOI 10.1016/j.phytochem.2009.09.031; Haralampidis K, 2002, ADV BIOCHEM ENG BIOT, V75, P31; Hofmann D, 2003, PHYTOMEDICINE, V10, P213, DOI 10.1078/094471103321659979; Holzinger F, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/382789; Hussien SA, 2014, IRAQ J PHARM SCI, V23, P33; Irmler S, 2000, PLANT J, V24, P797, DOI 10.1046/j.1365-313x.2000.00922.x; Jayakodi M, 2014, J GINSENG RES, V38, P278, DOI 10.1016/j.jgr.2014.05.008; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Khdair A, 2010, INT J ANAL CHEM; Kumari A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-871; Landgrebe H., 1999, PHARM ZTG, V35, P11; Leopoldini M, 2010, J AGR FOOD CHEM, V58, P10768, DOI 10.1021/jf102576j; Li J, 2016, PLOS ONE, DOI 10.1371/journal.pone.0164235.g007; Liu MH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1477-5; Lutsenko Y., 2010, Herba Polonica, V56, P83; Marzian Olav, 2007, MMW Fortschr Med, V149, P69; Mendel M, 2013, J ETHNOPHARMACOL, V146, P423, DOI 10.1016/j.jep.2012.12.023; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Prescott TAK, 2014, PHYTOCHEMISTRY, V101, P116, DOI 10.1016/j.phytochem.2014.01.022; Qiao F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106900; Rasool S, 2016, PROTOPLASMA, V253, P1197, DOI 10.1007/s00709-015-0884-4; Rohdich F, 2006, FEBS J, V273, P4446, DOI 10.1111/j.1742-4658.2006.05446.x; Stauss-Grabo M, 2011, PHYTOMEDICINE, V18, P433, DOI 10.1016/j.phymed.2010.11.009; Sun HP, 2016, PLANT PHYSIOL BIOCH, V108, P286, DOI 10.1016/j.plaphy.2016.07.022; Suzuki H, 2002, PLANT J, V32, P1033, DOI 10.1046/j.1365-313X.2002.01497.x; Takahashi S, 2007, J BIOL CHEM, V282, P31744, DOI 10.1074/jbc.M703378200; Tian XJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131455; Tsaballa A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1738-3; Upadhyay S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-746; Vincken JP, 2007, PHYTOCHEMISTRY, V68, P275, DOI 10.1016/j.phytochem.2006.10.008; Wang GY, 2002, METAB ENG, V4, P193, DOI 10.1006/mben.2002.0225; Weitzel C, 2015, PHYTOCHEM REV, V14, P7, DOI 10.1007/s11101-013-9280-x; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang XD, 2015, INT J MOL SCI, V16, P11550, DOI 10.3390/ijms160511550; Zheng XS, 2014, INT J MOL SCI, V15, P5970, DOI 10.3390/ijms15045970	50	13	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182243	10.1371/journal.pone.0182243	http://dx.doi.org/10.1371/journal.pone.0182243			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771546	Green Published, gold, Green Submitted			2022-12-26	WOS:000406853600080
J	Winkler, MS; Rissiek, A; Priefler, M; Schwedhelm, E; Robbe, L; Bauer, A; Zahrte, C; Zoellner, C; Kluge, S; Nierhaus, A				Winkler, Martin Sebastian; Rissiek, Anne; Priefler, Marion; Schwedhelm, Edzard; Robbe, Linda; Bauer, Antonia; Zahrte, Corinne; Zoellner, Christian; Kluge, Stefan; Nierhaus, Axel			Human leucocyte antigen (HLA-DR) gene expression is reduced in sepsis and correlates with impaired TNF alpha response: A diagnostic tool for immunosuppression?	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; SEPTIC SHOCK; WHOLE-BLOOD; CYTOKINE RELEASE; HUMAN MONOCYTES; IMMUNOPARALYSIS; PROGNOSIS; SEVERITY; REVERSAL; OPTIONS	Background Sepsis is defined as a dysregulated immune response to infection. Impaired immune response in sepsis, often described as endotoxin tolerance, is characterized by unresponsiveness of monocytes on lipopolysaccharide (LPS) stimulation to release tumor necrosis factor a (TNF alpha). Furthermore, decreased monocyte surface protein expression of human leucocyte antigen DR (HLA-DR) is a marker for changes of the innate immune response during sepsis. Quantitative polymerase chain reaction (qPCR) and flow-cytometry (FACS) have been used to measure protein or gene expression of HLA-DR. We aimed to determine whether changes in mRNA expression of HLA-DR are associated with impaired TNF alpha response in human sepsis. Methods Surface protein together with mRNA expression of HLA-DR were measured by FACS and qPCR in a cohort of 9 sepsis patients and compared to 10 pre-operative control patients in a prospective study. In addition, 20 patients with post-surgical inflammation, 20 patients with sepsis or septic shock were included and TNF alpha was determined following ex vivo stimulation of whole blood with 500 pg/mL LPS. Total RNA was prepared from whole blood and subjected to qPCR analysis for expression analysis of HLA-DR alpha (HLA-DRA) to correlate TNF alpha response with HLA-DRA expression. Results Patients with sepsis presented higher numbers of monocytes in peripheral blood (P<0.001) but decreased surface protein and mRNA HLA-DR levels when compared to controls. In all patients mRNA expression of HLA-DRA was decreased by approximately 70% compared to controls (P<0.01) and was lowest in patients with sepsis or septic shock (P<0.01). TNF alpha response to LPS was decreased in all patients (median 319 pg/mL versus controls 1256 pg/mL; P<0.01) and lowest in patients with sepsis or septic shock (median 128 pg/mL; P<0.01). HLA-DRA correlated positively with TNF alpha response in all study participants (r +0.60, P<0.001) and within patients (r +0.67, P<0.001). The TNF alpha: HLA-DRA ratio correlated negatively with severity and the Sequential Organ Failure Assessment (SOFA) score (Spearman's rho -0.59, P<0.001) Conclusion In this study, HLA-DRA expression was associated with a functional assay of the innate immune response. Future interventional studies aimed at the immune response during sepsis could make use of these methods for optimizing target groups based on biological plausibility and intervention effectiveness.	[Winkler, Martin Sebastian; Robbe, Linda; Bauer, Antonia; Zoellner, Christian] Univ Med Ctr Hamburg Eppendorf, Dept Anaesthesiol, Hamburg, Germany; [Rissiek, Anne] Univ Med Ctr Hamburg Eppendorf, Dept Immunol, Hamburg, Germany; [Priefler, Marion; Zahrte, Corinne; Kluge, Stefan; Nierhaus, Axel] Univ Med Ctr Hamburg Eppendorf, Dept Intens Care Med, Hamburg, Germany; [Schwedhelm, Edzard] Univ Med Ctr Hamburg Eppendorf, Inst Clin Pharmacol & Toxicol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Nierhaus, A (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Intens Care Med, Hamburg, Germany.	nierhaus@uke.de	Winkler, Martin Sebastian/AGZ-1086-2022		University Medical Center Ham burg-Eppendorf,Hamburg, Germany	University Medical Center Ham burg-Eppendorf,Hamburg, Germany	We have not used any external financial sources to complete our study. Our work was supported by internal resources of the University Medical Center Ham burg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany. Dr. Winkler, Dr. Rissiek, Ms Priefler, Dr. Schwedhelm, Prof. Zoellner, Prof. Kluge and Dr. Nierhaus are employed at the University of Hamburg. The funding institution had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boomer JS, 2013, VIRULENCE, V5; Caille V, 2004, SHOCK, V22, P521, DOI 10.1097/01.shk.0000143410.63698.57; Cajander S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154690; Deutschman CS, 2014, IMMUNITY, V40, P464, DOI 10.1016/j.immuni.2014.04.001; Drewry AM, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1505-0; ERTEL W, 1995, BLOOD, V85, P1341, DOI 10.1182/blood.V85.5.1341.bloodjournal8551341; Gogos CA, 2000, J INFECT DIS, V181, P176, DOI 10.1086/315214; Hamers L, 2015, MINERVA ANESTESIOL, V81, P426; Heagy Wyrta, 2003, Surg Infect (Larchmt), V4, P171, DOI 10.1089/109629603766956960; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Hou TY, 2015, INT J CLIN EXP MED, V8, P15238; Leentjens J, 2012, AM J RESP CRIT CARE, V186, P838, DOI 10.1164/rccm.201204-0645OC; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lukaszewicz AC, 2009, CRIT CARE MED, V37, P2746, DOI 10.1097/CCM.0b013e3181ab858a; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Meisel C, 2009, AM J RESP CRIT CARE, V180, P640, DOI 10.1164/rccm.200903-0363OC; Monneret G, 2014, CRIT CARE, V18, DOI 10.1186/cc13179; MUNOZ C, 1991, J CLIN INVEST, V88, P1747, DOI 10.1172/JCI115493; Nierhaus A, 2003, INTENS CARE MED, V29, P646, DOI 10.1007/s00134-003-1666-6; Payen D, 2009, MINERVA ANESTESIOL, V75, P484; Ploder M, 2006, SHOCK, V25, P129, DOI 10.1097/01.shk.0000191379.62897.1d; Rigato O, 2003, SHOCK, V19, P113, DOI 10.1097/00024382-200302000-00004; Rimmele T, 2016, SHOCK, V45, P282, DOI 10.1097/SHK.0000000000000495; Segre E, 2016, SHOCK, V45, P490, DOI 10.1097/SHK.0000000000000557; Shalova IN, 2015, IMMUNITY, V42, P484, DOI 10.1016/j.immuni.2015.02.001; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Tang BMP, 2009, CRIT CARE MED, V37, P882, DOI 10.1097/CCM.0b013e31819b52fd; van der Bruggen T, 1999, INFECT IMMUN, V67, P3824, DOI 10.1128/IAI.67.8.3824-3829.1999; Venet F, 2007, CRIT CARE MED, V35, P1910, DOI 10.1097/01.CCM.0000275271.77350.B6; Wiedermann CJ, 2014, MED KLIN-INTENSIVMED, V109, P583, DOI 10.1007/s00063-014-0379-7	31	65	69	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182427	10.1371/journal.pone.0182427	http://dx.doi.org/10.1371/journal.pone.0182427			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771573	Green Published, gold, Green Submitted			2022-12-26	WOS:000406853600113
J	Yang, YR; He, CJ; Huang, L; Ban, YH; Tang, M				Yang, Yurong; He, Chuangjun; Huang, Li; Ban, Yihui; Tang, Ming			The effects of arbuscular mycorrhizal fungi on glomalin-related soil protein distribution, aggregate stability and their relationships with soil properties at different soil depths in lead-zinc contaminated area	PLOS ONE			English	Article							HEAVY-METAL ACCUMULATION; COMMUNITY STRUCTURE; ORGANIC-MATTER; SEQUESTRATION; INOCULATION; GROWTH; HYPHAE; PLANTS; ROOTS; MINE	Glomalin-related soil protein (GRSP), a widespread glycoprotein produced by arbuscular mycorrhizal fungi (AMF), is crucial for ecosystem functioning and ecological restoration. In the present study, an investigation was conducted to comprehensively analyze the effects of heavy metal (HM) contamination on AMF status, soil properties, aggregate distribution and stability, and their correlations at different soil depths (0-10, 10-20, 20-30, 30-40 cm). Our results showed that the mycorrhizal colonization (MC), hyphal length density (HLD), GRSP, soil organic matter (SOM) and soil organic carbon (SOC) were significantly inhibited by Pb compared to Zn at 0-20 cm soil depth, indicating that HM had significant inhibitory effects on AMF growth and soil properties, and that Pb exhibited greater toxicity than Zn at shallow layer of soil. Both the proportion of soil large macroaggregates (> 2000 mu m) and mean weight diameter (MWD) were positively correlated with GRSP, SOM and SOC at 0-20 cm soil depth (P < 0.05), proving the important contributions of GRSP, SOM and SOC for binding soil particles together into large macroaggregates and improving aggregate stability. Furthermore, MC and HLD had significantly positive correlation with GRSP, SOM and SOC, suggesting that AMF played an essential role in GRSP, SOM and SOC accumulation and subsequently influencing aggregate formation and particle-size distribution in HM polluted soils. Our study highlighted that the introduction of indigenous plant associated with AMF might be a successful biotechnological tool to assist the recovery of HM polluted soils, and that proper management practices should be developed to guarantee maximum benefits from plant-AMF symbiosis during ecological restoration.	[Yang, Yurong] Northeast Normal Univ, Key Lab Ecol Restorat & Ecosyst Management, Sch Environm, Changchun, Jilin, Peoples R China; [Yang, Yurong; He, Chuangjun] Northeast Normal Univ, Key Lab Vegetat Ecol, Minist Educ, Inst Grassland Sci, Changchun, Jilin, Peoples R China; [Huang, Li; Ban, Yihui; Tang, Ming] Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China; [Tang, Ming] South China Agr Univ, Coll Forestry & Landscape Architecture, Guangzhou, Guangdong, Peoples R China	Northeast Normal University - China; Northeast Normal University - China; Northwest A&F University - China; South China Agricultural University	Tang, M (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China.; Tang, M (corresponding author), South China Agr Univ, Coll Forestry & Landscape Architecture, Guangzhou, Guangdong, Peoples R China.	tangm@nwsuaf.edu.cn		Tang, Ming/0000-0002-8158-6300; Yang, Yurong/0000-0002-2053-2202	National Natural Science Foundation of China [41671268]; National Key Research and Development Program of China [2017YFC1101301]; Shaanxi Science and Technology Innovation Project Plan [2016KTCL02-07]; Fundamental Research Funds for the Central Universities [2412017QD022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Shaanxi Science and Technology Innovation Project Plan; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The study was supported by the National Natural Science Foundation of China (41671268), the National Key Research and Development Program of China (2017YFC1101301), Shaanxi Science and Technology Innovation Project Plan (2016KTCL02-07), and the Fundamental Research Funds for the Central Universities (2412017QD022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali H, 2013, CHEMOSPHERE, V91, P869, DOI 10.1016/j.chemosphere.2013.01.075; Alkorta I., 2004, Reviews in Environmental Science and Bio/Technology, V3, P71, DOI 10.1023/B:RESB.0000040059.70899.3d; Bainard LD, 2014, FEMS MICROBIOL ECOL, V88, P333, DOI 10.1111/1574-6941.12300; Ban YH, 2015, ANN MICROBIOL, V65, P503, DOI 10.1007/s13213-014-0886-z; Barthes B, 2002, CATENA, V47, P133, DOI 10.1016/S0341-8162(01)00180-1; Brar MS, 2002, P 17 WORLD C SOIL SC, V198, P1; Bremner J.M., 1982, METHODS SOIL ANAL, P575, DOI [DOI 10.2134/AGRONMONOGR9.2.2ED.C31, DOI 10.2134/AGR0NM0N0GR9.2.2ED.C31]; Bronick CJ, 2005, GEODERMA, V124, P3, DOI 10.1016/j.geoderma.2004.03.005; Cakmak I, 2000, NEW PHYTOL, V146, P185, DOI 10.1046/j.1469-8137.2000.00630.x; Chanclud E, 2016, MOL PLANT PATHOL, V17, P1289, DOI 10.1111/mpp.12393; Daniels B. A., 1982, Methods and principles of mycorrhizal research., P29; Dietz AC, 2001, ENVIRON HEALTH PERSP, V109, P163, DOI 10.2307/3434854; Fritsch C, 2010, CHEMOSPHERE, V81, P141, DOI 10.1016/j.chemosphere.2010.06.075; Gonzalez-Chavez MC, 2004, ENVIRON POLLUT, V130, P317, DOI 10.1016/j.envpol.2004.01.004; Gu HH, 2017, INT J PHYTOREMEDIAT, V19, P739, DOI 10.1080/15226514.2017.1284751; Horckmans L, 2007, SCI TOTAL ENVIRON, V376, P86, DOI 10.1016/j.scitotenv.2007.01.077; Ingleby K, 1997, FOREST ECOL MANAG, V90, P19, DOI 10.1016/S0378-1127(96)03875-3; Jackson M. L., 1985, SOIL CHEM ANAL ADV C; JAKOBSEN I, 1992, NEW PHYTOL, V120, P371, DOI 10.1111/j.1469-8137.1992.tb01077.x; Kemper W. D., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P425; KOSKE RE, 1989, MYCOL RES, V92, P486, DOI 10.1016/S0953-7562(89)80195-9; Li ZY, 2014, SCI TOTAL ENVIRON, V468, P843, DOI 10.1016/j.scitotenv.2013.08.090; Liu L, 2009, J HAZARD MATER, V163, P563, DOI 10.1016/j.jhazmat.2008.07.004; Liu RJ, 2000, ARBUSCULAR MYCORRHIZ; Liu ShuMing, 2005, Scientia Silvae Sinicae, V41, P174; Malekzadeh E, 2016, EUR J SOIL BIOL, V74, P45, DOI 10.1016/j.ejsobi.2016.03.003; Miransari M, 2011, APPL MICROBIOL BIOT, V89, P917, DOI 10.1007/s00253-010-3004-6; Nagajyoti PC, 2010, ENVIRON CHEM LETT, V8, P199, DOI 10.1007/s10311-010-0297-8; Nishi Mathur, 2007, Journal of Plant Sciences, V2, P127; Olaniran AO, 2013, INT J MOL SCI, V14, P10197, DOI 10.3390/ijms140510197; Rascio N, 2011, PLANT SCI, V180, P169, DOI 10.1016/j.plantsci.2010.08.016; Rillig MC, 2006, NEW PHYTOL, V171, P41, DOI 10.1111/j.1469-8137.2006.01750.x; Rillig MC, 2001, PLANT SOIL, V233, P167, DOI 10.1023/A:1010364221169; Rillig MC, 2004, CAN J SOIL SCI, V84, P355, DOI 10.4141/S04-003; Rillig MC, 2002, PLANT SOIL, V238, P325, DOI 10.1023/A:1014483303813; Rillig MC, 2003, PLANT SOIL, V253, P293, DOI 10.1023/A:1024807820579; Sharma RK, 2005, J ENVIRON BIOL, V26, P301; Smith S.E., 2010, MYCORRHIZAL SYMBIOSI, V3rd, DOI DOI 10.1097/00010694-198403000-00011; Smith SE, 2011, PLANT PHYSIOL, V156, P1050, DOI 10.1104/pp.111.174581; Staddon PL, 2003, SCIENCE, V300, P1138, DOI 10.1126/science.1084269; Steinberg PD, 2003, SOIL BIOL BIOCHEM, V35, P191, DOI 10.1016/S0038-0717(02)00249-3; Sundaray SK, 2011, J HAZARD MATER, V186, P1837, DOI 10.1016/j.jhazmat.2010.12.081; Trouvelot A, 1986, PHYSIOLOGICAL GENETI, P217, DOI DOI 10.1177/004057368303900411; Vodnik D, 2008, SCI TOTAL ENVIRON, V392, P130, DOI 10.1016/j.scitotenv.2007.11.016; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Wang FY, 2007, INT J PHYTOREMEDIAT, V9, P345, DOI 10.1080/15226510701476214; Wang FY, 2012, J PLANT GROWTH REGUL, V31, P549, DOI 10.1007/s00344-012-9265-9; Wang FY, 2016, CHEMOSPHERE, V147, P88, DOI 10.1016/j.chemosphere.2015.12.076; Wang Q, 2014, MYCORRHIZA, V24, P525, DOI 10.1007/s00572-014-0572-9; Wang Z, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0120482, 10.1371/journal.pone.0145726]; Wezowicz K, 2017, MYCORRHIZA, V27, P499, DOI 10.1007/s00572-017-0768-x; Wright SF, 1996, SOIL SCI, V161, P575, DOI 10.1097/00010694-199609000-00003; Wu FY, 2010, APPL SOIL ECOL, V44, P213, DOI 10.1016/j.apsoil.2009.12.008; Wu QS, 2014, SCI REP-UK, V4, DOI 10.1038/srep05823; Wu QS, 2008, EUR J SOIL BIOL, V44, P122, DOI 10.1016/j.ejsobi.2007.10.001; Wu ZP, 2014, SOIL BIOL BIOCHEM, V68, P283, DOI 10.1016/j.soilbio.2013.10.010; Xu ZY, 2012, SCI TOTAL ENVIRON, V435, P453, DOI 10.1016/j.scitotenv.2012.07.029; Yang YR, 2015, ENVIRON SCI POLLUT R, V22, P13179, DOI 10.1007/s11356-015-4521-8; Yang YR, 2015, SOIL BIOL BIOCHEM, V86, P146, DOI 10.1016/j.soilbio.2015.03.018; Yao YJ, 2004, MINER RESOUR GEOL, V18, P470; Zeng FR, 2011, ENVIRON POLLUT, V159, P84, DOI 10.1016/j.envpol.2010.09.019	61	45	49	7	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182264	10.1371/journal.pone.0182264	http://dx.doi.org/10.1371/journal.pone.0182264			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771531	Green Submitted, Green Published, gold			2022-12-26	WOS:000406853600082
J	Caporarello, N; Parrino, C; Trischitta, V; Frittitta, L				Caporarello, Nunzia; Parrino, Cristina; Trischitta, Vincenzo; Frittitta, Lucia			Insulin receptor signaling and glucagon-like peptide 1 effects on pancreatic beta cells	PLOS ONE			English	Article							TYPE-2 DIABETIC-PATIENTS; GROWTH; PROLIFERATION; POLYMORPHISM; EXENATIDE; SECRETION; TISSUE; GENES	Glucagon-like peptide-1 (GLP-1) is a potent gluco-incretin hormone, which plays a central role on pancreatic beta cell proliferation, survival and insulin secreting activity and whose analogs are used for treating hyperglycemia in type 2 diabetes mellitus. Notably, abnormal insulin signaling affects all the above-mentioned aspects on pancreatic beta cells. The aim of our study was to investigate whether the protective effects of GLP1-1 on beta cells are affected by altered insulin receptor signaling. To this end, several effects of GLP-1 were studied in INS-1E rat beta cells transfected either with an inhibitor of insulin receptor function (i.e., the Ectonucleotide Pyrophosphatase Phosphodiesterase 1, ENPP1), or with insulin receptor small interfering RNA, as well as in control cells. Crucial experiments were carried out also in a second cell line, namely the beta TC-1 mouse beta cells. Our data indicate that in insulin secreting beta cells in which either ENPP1 was up-regulated or insulin receptor was down-regulated, GLP-1 positive effects on several pancreatic beta cell activities, including glucose-induced insulin secretion, cell proliferation and cell survival, were strongly reduced. Further studies are needed to understand whether such a scenario occurs also in humans and, if so, if it plays a role of clinical relevance in diabetic patients with poor responsiveness to GLP-1 related treatments.	[Caporarello, Nunzia; Parrino, Cristina; Frittitta, Lucia] Univ Catania, Endocrine Unit, Dept Clin & Expt Med, Catania, Italy; [Trischitta, Vincenzo] IRCCS Casa Sollievo Sofferenza, Res Unit Diabet & Endocrine Dis, San Giovanni Rotondo, Italy; [Trischitta, Vincenzo] Sapienza Univ, Dept Expt Med, Rome, Italy; [Caporarello, Nunzia] Univ Catania, Dept Biomed & Biotechnol Sci, Catania, Italy	University of Catania; IRCCS Casa Sollievo Della Sofferenza; Sapienza University Rome; University of Catania	Frittitta, L (corresponding author), Univ Catania, Endocrine Unit, Dept Clin & Expt Med, Catania, Italy.	lfritti@unict.it	frittitta, Lucia/J-2334-2012; frittitta, lucia/AAA-4733-2019; Parrino, Cristina/ABA-7496-2020; Parrino, Cristina/H-4009-2018; TRISCHITTA, Vincenzo/K-1487-2016	frittitta, lucia/0000-0002-7941-5828; Parrino, Cristina/0000-0002-1367-6208; Parrino, Cristina/0000-0002-1367-6208; Caporarello, Nunzia/0000-0002-3183-2868; TRISCHITTA, Vincenzo/0000-0003-1174-127X				Anichini R, 2013, DIABETES METAB SYNDR, V6, P123, DOI 10.2147/DMSO.S42729; Brubaker PL, 2004, ENDOCRINOLOGY, V145, P2653, DOI 10.1210/en.2004-0015; Buteau J, 2003, DIABETES, V52, P124, DOI 10.2337/diabetes.52.1.124; Cornu M, 2010, J BIOL CHEM, V285, P10538, DOI 10.1074/jbc.M109.091116; Costanzo BV, 2001, DIABETES, V50, P831, DOI 10.2337/diabetes.50.4.831; Di Paola R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019462; Drucker DJ, 2015, DIABETES, V64, P317, DOI 10.2337/db14-1514; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Federici M, 2004, CIRCULATION, V109, P399, DOI 10.1161/01.CIR.0000109498.77895.6F; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Kahn C Ronald, 2003, Exp Diabesity Res, V4, P169, DOI 10.1155/EDR.2003.169; Khan M, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/162718; Kozawa J, 2012, J DIABETES INVEST, V3, P294, DOI 10.1111/j.2040-1124.2011.00168.x; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Kulkarni RN, 1999, J CLIN INVEST, V104, pR69, DOI 10.1172/JCI8339; Li YZ, 2003, J BIOL CHEM, V278, P471, DOI 10.1074/jbc.M209423200; Liew CW, 2010, J CLIN INVEST, V120, P2876, DOI 10.1172/JCI36849; Marchetti P, 2002, DIABETES, V51, P1419, DOI 10.2337/diabetes.51.5.1419; Moon MJ, 2011, MOL CELLS, V32, P389, DOI 10.1007/s10059-011-0157-9; Natarajan Kanchana, 2006, V332, P51; Nauck M, 2016, DIABETES OBES METAB, V18, P203, DOI 10.1111/dom.12591; Park S, 2006, J BIOL CHEM, V281, P1159, DOI 10.1074/jbc.M508307200; Patane G, 2013, ACTA DIABETOL, V50, P851, DOI 10.1007/s00592-013-0458-x; Pizzuti A, 1999, DIABETES, V48, P1881, DOI 10.2337/diabetes.48.9.1881; Prudente S, 2005, DIABETES, V54, P2807, DOI 10.2337/diabetes.54.9.2807; Prudente S, 2013, J CLIN ENDOCR METAB, V98, pE1143, DOI 10.1210/jc.2012-4282; Prudente S, 2009, NAT REV ENDOCRINOL, V5, P682, DOI 10.1038/nrendo.2009.215; Shin J, 2012, DIABETES METAB J, V36, P364, DOI 10.4093/dmj.2012.36.5.364; Song SO, 2014, J DIABETES INVEST, V5, P554, DOI 10.1111/jdi.12184	29	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0181190	10.1371/journal.pone.0181190	http://dx.doi.org/10.1371/journal.pone.0181190			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767692	Green Published, gold			2022-12-26	WOS:000406768200018
J	Petit, G; Luminet, O; Uva, MCD; Zorbas, A; Maurage, P; de Timary, P				Petit, Geraldine; Luminet, Olivier; Uva, Mariana Cordovil de Sousa; Zorbas, Alexis; Maurage, Pierre; de Timary, Philippe			Differential spontaneous recovery across cognitive abilities during detoxification period in alcohol-dependence	PLOS ONE			English	Article							COMPULSIVE DRINKING SCALE; WORKING-MEMORY CAPACITY; FRONTAL-LOBE; NEUROPSYCHOLOGICAL RECOVERY; NEUROCOGNITIVE FUNCTIONS; INTESTINAL PERMEABILITY; TC-99M-BICISATE SPECT; LONGITUDINAL CHANGES; EXECUTIVE FUNCTIONS; EMOTION REGULATION	Objective There is a lack of consensus regarding the extent to which cognitive dysfunctions may recover upon cessation of alcohol intake by alcohol-dependents (AD), and the divergent findings are most likely due to methodological differences between the various studies. The present study was aimed at conducting a very strict longitudinal study of cognitive recovery in terms of assessment points, the duration of abstinence, control of age and duration of the addiction, and by use of individual analyses in addition to mean group comparisons. Our study further focused on the 2-3 week phase of alcohol detoxification that is already known to positively affect many biological, emotional, motivational, as well as neural variables, followed by longer-term therapies for which good cognitive functioning is needed. Methods 41 AD inpatients undergoing a detoxification program, and 41 matched controls, were evaluated twice in terms of five cognitive functions (i.e., short-term memory, working memory, inhibition, cognitive flexibility, and verbal fluency) within a three-week interval [on the first day (T1) and the 18th day (T2) of abstinence for AD patients]. Emotional (positive and negative affectivity and depression) and motivational (craving) variables were also measured at both evaluation times. Results Although verbal fluency, short-term memory, and cognitive flexibility did not appear to be affected, the patients exhibited impaired inhibition and working memory at T1. While no recovery of inhibition was found to occur, the average working memory performance of the patients was comparable to that of the controls at T2. Improvements in emotional and motivational dimensions were also observed, although they did not correlate with the ones in working memory. Individual analysis showed that not all participants were impaired or recover the same functions. Conclusions While inhibition deficits appear to persist after 18 days of detoxification, deficits in working memory, which is a central component of cognition, are greatly reduced after alcohol detoxification. Individual differences in the trajectory of recovery do arise however, and it might be worth implementing individual assessments of impaired functions at the end of the detoxification phase in order to maximize the chances of success in longer-term treatments and abstinence.	[Petit, Geraldine; Luminet, Olivier; Uva, Mariana Cordovil de Sousa; Zorbas, Alexis; Maurage, Pierre] Catholic Univ Louvain, Res Inst Psychol Sci, Louvain La Neuve, Belgium; [Petit, Geraldine; Uva, Mariana Cordovil de Sousa; Zorbas, Alexis; de Timary, Philippe] Catholic Univ Louvain, Dept Adult Psychiat, St Luc Acad Hosp, Brussels, Belgium; [Petit, Geraldine; Maurage, Pierre; de Timary, Philippe] Catholic Univ Louvain, Lab Expt Psychopathol, Psychol Sci Res Inst, Louvain La Neuve, Belgium; [Petit, Geraldine; de Timary, Philippe] Catholic Univ Louvain, Inst Neurosci, Louvain La Neuve, Belgium; [Luminet, Olivier; Maurage, Pierre] Belgian Natl Fund Sci Res FRS FNRS, Brussels, Belgium; [de Timary, Philippe] Catholic Univ Louvain, St Luc Acad Hosp, Unite Integree Hepatol, Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Universite Catholique Louvain; Fonds de la Recherche Scientifique - FNRS; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Petit, G (corresponding author), Catholic Univ Louvain, Res Inst Psychol Sci, Louvain La Neuve, Belgium.; Petit, G; de Timary, P (corresponding author), Catholic Univ Louvain, Dept Adult Psychiat, St Luc Acad Hosp, Brussels, Belgium.; Petit, G; de Timary, P (corresponding author), Catholic Univ Louvain, Lab Expt Psychopathol, Psychol Sci Res Inst, Louvain La Neuve, Belgium.; Petit, G; de Timary, P (corresponding author), Catholic Univ Louvain, Inst Neurosci, Louvain La Neuve, Belgium.; de Timary, P (corresponding author), Catholic Univ Louvain, St Luc Acad Hosp, Unite Integree Hepatol, Brussels, Belgium.	geraldine.petit@uclouvain.be; Philippe.detimary@uclouvain.be	Petit, Geraldine/AAV-2334-2021	Maurage, Pierre/0000-0003-0197-0810	Belgian National Fund for Scientific Research (FNRS-FRS) [3.4585.07]; FNRS-FRS	Belgian National Fund for Scientific Research (FNRS-FRS)(Fonds de la Recherche Scientifique - FNRS); FNRS-FRS(Fonds de la Recherche Scientifique - FNRS)	PdT received financial support for this study from the Belgian National Fund for Scientific Research (FNRS-FRS; Grant Number: 3.4585.07; http://www1.frs-fnrs.be/). OL and PM received support in the form of salaries from FNRS-FRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Belgian National Fund for Scientific Research (FNRS-FRS; grant 3.4585.07). Olivier Luminet and Pierre Maurage are Senior Research Associate at the Belgian National Fund for Scientific Research (FNRS-FRS). The authors have declared that no competing interests exist.	Ambrose ML, 2001, ALCOHOL CLIN EXP RES, V25, P185, DOI 10.1111/j.1530-0277.2001.tb02197.x; Andersohn F., 2004, GER J PSYCHIAT, V7, P6; Ansseau M, 2000, EUR ADDICT RES, V6, P51, DOI 10.1159/000019010; ANTON RF, 1995, ALCOHOL CLIN EXP RES, V19, P92, DOI 10.1111/j.1530-0277.1995.tb01475.x; Anton RF, 1996, ARCH GEN PSYCHIAT, V53, P225; Baldo JV, 2006, J INT NEUROPSYCH SOC, V12, P896, DOI 10.1017/S1355617706061078; Bates ME, 2013, NEUROPSYCHOL REV, V23, P27, DOI 10.1007/s11065-013-9228-3; Bates ME, 2005, ALCOHOL CLIN EXP RES, V29, P367, DOI 10.1097/01.ALC.0000156131.88125.2A; Bates ME, 2004, J CONSULT CLIN PSYCH, V72, P1073, DOI 10.1037/0022-006X.72.6.1073; Bates ME, 2002, PSYCHOL ADDICT BEHAV, V16, P35, DOI 10.1037//0893-164X.16.1.35; Berking M, 2012, CURR OPIN PSYCHIATR, V25, P128, DOI 10.1097/YCO.0b013e3283503669; Berlucchi G, 2011, NEUROPSYCHOL REHABIL, V21, P560, DOI 10.1080/09602011.2011.573255; Bernardin F, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00078; Billieux J, 2012, PSYCHIAT RES, V198, P291, DOI 10.1016/j.psychres.2012.01.001; BROWN J, 1958, Q J EXP PSYCHOL, V10, P12, DOI 10.1080/17470215808416249; Bruffaerts R, 2007, SOC PSYCH PSYCH EPID, V42, P937, DOI 10.1007/s00127-007-0239-3; Casey BJ, 2010, J AM ACAD CHILD PSY, V49, P1189, DOI 10.1016/j.jaac.2010.08.017; Constant EL, 2006, J CLIN EXP NEUROPSYC, V28, P790, DOI 10.1080/13803390591000990; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; Cox WM, 2002, DRUG ALCOHOL DEPEN, V68, P237, DOI 10.1016/S0376-8716(02)00219-3; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; Curtin JJ, 2001, PSYCHOL SCI, V12, P527, DOI 10.1111/1467-9280.00397; Dao-Castellana MH, 1998, PSYCHOL MED, V28, P1039, DOI 10.1017/S0033291798006849; Davies SJC, 2005, ALCOHOL ALCOHOLISM, V40, P498, DOI 10.1093/alcalc/agh203; de Timary P, 2008, PSYCHIAT RES, V157, P105, DOI 10.1016/j.psychres.2006.12.008; de Timary P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071560; de Timary P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038682; Dingwall KM, 2011, ADDICTION, V106, P1419, DOI 10.1111/j.1360-0443.2011.03434.x; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Durazzo TC, 2007, ALCOHOL ALCOHOLISM, V42, P174, DOI 10.1093/alcalc/agm020; Durazzo TC, 2017, ALCOHOL CLIN EXP RES, V41, P107, DOI 10.1111/acer.13267; Durazzo TC, 2015, ADDICT BIOL, V20, P956, DOI 10.1111/adb.12180; EBBINGHAUS H, 1897, Z PSYCHOL, V13, P401; Engle RW, 2002, CURR DIR PSYCHOL SCI, V11, P19, DOI 10.1111/1467-8721.00160; Field M, 2008, DRUG ALCOHOL DEPEN, V97, P1, DOI 10.1016/j.drugalcdep.2008.03.030; First M.B., 1994, DIAGN STAT MAN MENT; Fujiwara E, 2008, J CLIN EXP NEUROPSYC, V30, P576, DOI 10.1080/13803390701557271; Gaudreau P., 2000, ACT C INT SOC FRANC, P61; Gazdzinski S, 2005, DRUG ALCOHOL DEPEN, V78, P263, DOI 10.1016/j.drugalcdep.2004.11.004; GLENN SW, 1991, J CLIN EXP NEUROPSYC, V13, P895, DOI 10.1080/01688639108405106; GLENN SW, 1991, ALCOHOL CLIN EXP RES, V15, P612, DOI 10.1111/j.1530-0277.1991.tb00569.x; GOLDMAN MS, 1995, ALCOHOL HEALTH RES W, V19, P148; Gorelick PB, 2010, ANN NY ACAD SCI, V1207, P155, DOI 10.1111/j.1749-6632.2010.05726.x; Goudriaan AE, 2006, ADDICTION, V101, P534, DOI 10.1111/j.1360-0443.2006.01380.x; Hildebrandt H, 2004, NEUROPSYCHOLOGY, V18, P203, DOI 10.1037/0894-4105.18.2.203; Houben K, 2011, PSYCHOL SCI, V22, P968, DOI 10.1177/0956797611412392; JOYCE EM, 1991, NEUROPSYCHOLOGIA, V29, P709, DOI 10.1016/0028-3932(91)90067-I; Kane M. J., 2005, WORKING MEMORY CAPAC; Kane MJ, 2007, PSYCHOL SCI, V18, P614, DOI 10.1111/j.1467-9280.2007.01948.x; Kiefer F, 2001, BIOL PSYCHIAT, V49, P782, DOI 10.1016/S0006-3223(01)01081-2; Kirschbaum C, 1996, LIFE SCI, V58, P1475, DOI 10.1016/0024-3205(96)00118-X; Leclercq S, 2014, P NATL ACAD SCI USA, V111, pE4485, DOI 10.1073/pnas.1415174111; Leclercq S, 2014, BIOL PSYCHIAT, V76, P725, DOI 10.1016/j.biopsych.2014.02.003; Leclercq S, 2012, BRAIN BEHAV IMMUN, V26, P911, DOI 10.1016/j.bbi.2012.04.001; Loeber S, 2010, ALCOHOL ALCOHOLISM, V45, P541, DOI 10.1093/alcalc/agq065; Mann K, 1999, ALCOHOL ALCOHOLISM, V34, P567, DOI 10.1093/alcalc/34.4.567; Manning V, 2008, EUR ADDICT RES, V14, P226, DOI 10.1159/000156479; McAfoose J, 2009, NEUROSCI BIOBEHAV R, V33, P355, DOI 10.1016/j.neubiorev.2008.10.005; Meulemans T, ADAPTATION VAL UNPUB; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Moriyama Y, 2006, PSYCHIAT CLIN NEUROS, V60, P85, DOI 10.1111/j.1440-1819.2006.01464.x; Munro CA, 2000, ALCOHOL CLIN EXP RES, V24, P1510, DOI 10.1111/j.1530-0277.2000.tb04569.x; Noel X, 2002, ALCOHOL ALCOHOLISM, V37, P347, DOI 10.1093/alcalc/37.4.347; Noel X, 2001, ALCOHOL ALCOHOLISM, V36, P556, DOI 10.1093/alcalc/36.6.556; Oberauer K, 2005, WORKING MEMORY INTEL; Parsons OA, 1998, ALCOHOL CLIN EXP RES, V22, P954, DOI 10.1097/00000374-199806000-00029; PARSONS OA, 1990, ADDICT BEHAV, V15, P297, DOI 10.1016/0306-4603(90)90073-7; PETERSON LR, 1959, J EXP PSYCHOL, V58, P193, DOI 10.1037/h0049234; Petit G, 2015, ALCOHOL CLIN EXP RES, V39, P2471, DOI 10.1111/acer.12914; Petit G, 2015, BEHAV BRAIN RES, V282, P84, DOI 10.1016/j.bbr.2014.12.057; PFEFFERBAUM A, 1995, ALCOHOL CLIN EXP RES, V19, P1177, DOI 10.1111/j.1530-0277.1995.tb01598.x; Ratti MT, 2002, ACTA NEUROL SCAND, V105, P276, DOI 10.1034/j.1600-0404.2002.0o315.x; Rosenbloom MJ, 2004, NEUROPSYCHOLOGY, V18, P589, DOI 10.1037/0894-4105.18.3.589; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Schneider W., 2002, E PRIME USERS GUIDE; Schottenbauer MA, 2007, NEUROPSYCHOLOGY, V21, P337, DOI 10.1037/0894-4105.21.3.337; Schulte MHJ, 2014, CLIN PSYCHOL REV, V34, P531, DOI 10.1016/j.cpr.2014.08.002; Speth A, COGNITIVE PROC UNPUB; Starkman MN, 2001, PSYCHOSOM MED, V63, P985, DOI 10.1097/00006842-200111000-00018; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sullivan EV, 2000, NEUROPSYCHOLOGY, V14, P178, DOI 10.1037//0894-4105.14.2.178; TEMPLER DI, 1975, INT J ADDICT, V10, P609, DOI 10.3109/10826087509026738; Teunissen CE, 2003, J NEUROIMMUNOL, V134, P142, DOI 10.1016/S0165-5728(02)00398-3; TRABERT W, 1995, ACTA PSYCHIAT SCAND, V92, P87, DOI 10.1111/j.1600-0447.1995.tb09548.x; Unsworth N, 2010, J MEM LANG, V62, P392, DOI 10.1016/j.jml.2010.02.001; Uva MCD, 2010, ALCOHOL ALCOHOLISM, V45, P241, DOI 10.1093/alcalc/agq012; Uva MCD, 2010, PERS INDIV DIFFER, V48, P16, DOI 10.1016/j.paid.2009.08.004; van Eijk J, 2013, ALCOHOL CLIN EXP RES, V37, P67, DOI 10.1111/j.1530-0277.2012.01853.x; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WEINSTEIN CS, 1993, PSYCHOTHER, V30, P317, DOI 10.1037/0033-3204.30.2.317	90	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0176638	10.1371/journal.pone.0176638	http://dx.doi.org/10.1371/journal.pone.0176638			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC3VT	28767647	gold, Green Published, Green Submitted			2022-12-26	WOS:000406768200001
J	Pikula, J; Amelon, SK; Bandouchova, H; Bartonicka, T; Berkova, H; Brichta, J; Hooper, S; Kokurewicz, T; Kolarik, M; Kollner, B; Kovacova, V; Linhart, P; Piacek, V; Turner, GG; Zukal, J; Martinkova, N				Pikula, Jiri; Amelon, Sybill K.; Bandouchova, Hana; Bartonicka, Tomas; Berkova, Hana; Brichta, Jiri; Hooper, Sarah; Kokurewicz, Tomasz; Kolarik, Miroslav; Koellner, Bernd; Kovacova, Veronika; Linhart, Petr; Piacek, Vladimir; Turner, Gregory G.; Zukal, Jan; Martinkova, Natalia			White-nose syndrome pathology grading in Nearctic and Palearctic bats	PLOS ONE			English	Article							PSEUDOGYMNOASCUS-DESTRUCTANS; GEOMYCES-DESTRUCTANS; MYOTIS-LUCIFUGUS; INFECTION; MORTALITY; SUGGESTS; WINGS	While white-nose syndrome (WNS) has decimated hibernating bat populations in the Nearctic, species from the Palearctic appear to cope better with the fungal skin infection causing WNS. This has encouraged multiple hypotheses on the mechanisms leading to differential survival of species exposed to the same pathogen. To facilitate intercontinental comparisons, we proposed a novel pathogenesis-based grading scheme consistent with WNS diagnosis histopathology criteria. UV light-guided collection was used to obtain single biopsies from Nearctic and Palearctic bat wing membranes non-lethally. The proposed scheme scores eleven grades associated with WNS on histopathology. Given weights reflective of grade severity, the sum of findings from an individual results in weighted cumulative WNS pathology score. The probability of finding fungal skin colonisation and single, multiple or confluent cupping erosions increased with increase in Pseudogymnoascus destructans load. Increasing fungal load mimicked progression of skin infection from epidermal surface colonisation to deep dermal invasion. Similarly, the number of UV-fluorescent lesions increased with increasing weighted cumulative WNS pathology score, demonstrating congruence between WNS-associated tissue damage and extent of UV fluorescence. In a case report, we demonstrated that UV-fluorescence disappears within two weeks of euthermy. Change in fluorescence was coupled with a reduction in weighted cumulative WNS pathology score, whereby both methods lost diagnostic utility. While weighted cumulative WNS pathology scores were greater in the Nearctic than Palearctic, values for Nearctic bats were within the range of those for Palearctic species. Accumulation of wing damage probably influences mortality in affected bats, as demonstrated by a fatal case of Myotis daubentonii with natural WNS infection and healing in Myotis myotis. The proposed semi-quantitative pathology score provided good agreement between experienced raters, showing it to be a powerful and widely applicable tool for defining WNS severity.	[Pikula, Jiri; Bandouchova, Hana; Brichta, Jiri; Kovacova, Veronika; Linhart, Petr; Piacek, Vladimir] Univ Vet & Pharmaceut Sci Brno, Dept Ecol & Dis Game, Fish & Bees, Brno, Czech Republic; [Pikula, Jiri] Univ Vet & Pharmaceut Sci Brno, CEITEC Cent European Inst Technol, Brno, Czech Republic; [Amelon, Sybill K.] ARS, USDA, Northern Res Stn, Columbia, MO USA; [Bartonicka, Tomas; Zukal, Jan] Masaryk Univ, Dept Bot & Zool, Brno, Czech Republic; [Berkova, Hana; Zukal, Jan; Martinkova, Natalia] Czech Acad Sci, Inst Vertebrate Biol, Brno, Czech Republic; [Hooper, Sarah] Univ Missouri, Dept Vet Pathobiol, Columbia, MO USA; [Kokurewicz, Tomasz] Wroclaw Univ Environm & Life Sci, Inst Biol, Dept Vertebrate Ecol & Palaeontol, Wroclaw, Poland; [Kolarik, Miroslav] Czech Acad Sci, Inst Microbiol, Lab Fungal Genet & Metab, Prague, Czech Republic; [Koellner, Bernd] Friedrich Loeffler Inst, Inst Immunol, Fed Res Inst Anim Hlth, Greifswald, Germany; [Turner, Gregory G.] Penn Game Commiss, Harrisburg, PA USA; [Martinkova, Natalia] Masaryk Univ, Inst Biostat & Anal, Brno, Czech Republic	University of Veterinary Sciences Brno; University of Veterinary Sciences Brno; United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia; Masaryk University Brno; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; University of Missouri System; University of Missouri Columbia; Wroclaw University of Environmental & Life Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Friedrich Loeffler Institute; Institute of Biostatistics & Analyses; Masaryk University Brno	Pikula, J (corresponding author), Univ Vet & Pharmaceut Sci Brno, Dept Ecol & Dis Game, Fish & Bees, Brno, Czech Republic.; Pikula, J (corresponding author), Univ Vet & Pharmaceut Sci Brno, CEITEC Cent European Inst Technol, Brno, Czech Republic.	pikulaj@vfu.cz	Berkova, Hana/G-1108-2014; Bartonička, Tomáš/J-2756-2014; Kolařík, Miroslav/A-1680-2008; Kokurewicz, Tomasz/C-7729-2017; Kovacova, Veronika/V-1815-2019; Piaček, Vladimír/AAI-1231-2020; Bandouchova, Hana/AAI-1213-2020; amelon, s/GYQ-7127-2022; Pikula, Jiri/V-8620-2018; Zukal, Jan/G-1180-2014; Martínková, Natália/C-2939-2008	Kolařík, Miroslav/0000-0003-4016-0335; Kokurewicz, Tomasz/0000-0002-3906-2124; Kovacova, Veronika/0000-0001-9362-125X; Piaček, Vladimír/0000-0003-0068-3801; Pikula, Jiri/0000-0001-8747-9365; Zukal, Jan/0000-0003-4967-6880; Martínková, Natália/0000-0003-4556-4363; Amelon, Sybill/0000-0003-3940-8153; Bandouchova, Hana/0000-0003-0373-7940; Hooper, Sarah/0000-0003-1150-2500	Czech Science Foundation [P506-12-1064, 17-20286S]; CEITEC project [LQ1601]; Ministry of Education, Youth and Sports of the Czech Republic under National Sustainability Programme II; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD011126] Funding Source: NIH RePORTER	Czech Science Foundation(Grant Agency of the Czech Republic); CEITEC project; Ministry of Education, Youth and Sports of the Czech Republic under National Sustainability Programme II; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the Czech Science Foundation (Grant No. P506-12-1064 and 17-20286S). This research was carried out as part of the CEITEC 2020 project (LQ1601), with further financial support from the Ministry of Education, Youth and Sports of the Czech Republic under National Sustainability Programme II.; This study was supported by the Czech Science Foundation (Grant No. P506-12-1064 and 17-20286S). This research was carried out as part of the CEITEC 2020 project (LQ1601), with further financial support from the Ministry of Education, Youth and Sports of the Czech Republic under National Sustainability Programme II. We thank the following students of the Veterinary Study Programme at the University of Veterinary and Pharmaceutical Sciences Brno for volunteering to participate in the study: Martina Balazova, Tereza Bartosova, Tereza Belkova, Martina Benesova, Miriam Birosova, Katerina Bohata, Denisa Bohusova, Klara Boryskova, Petra Buchnickova, Anna Casova, Ondrej Danek, Lenka Danielova, Anna Drahonovska, Marie Dvorakova, Anna Frumarova, Nella Fuchsova, Lenka Horakova, Vaclav Hulka, Patricie Janickova, Martina Jasanska, Miroslava Juranova, Lenka Kapustova, Lenka Klimesova, Magda Kohoutova, Katarina Kopalova, Lucie Kostalova,Tereza Kovarova, Jan Kovol, Barbora Krejci, Jan Krejci, Linda Kubastova, Marie Kubatova, Veronika Kvakova, Petra Lanikova, Barbora Lofflerova, Dobromila Malikova, Lenka Malinova, Jana Michalcova, Alena Mickova, Kristina Miklosovicova, Katerina Musalkova, Michaela Petrikova, Katerina Podrabska, Michaela Prokesova, Polina Rapekta, Nelly Reisova, Karel Slajs, Jiri Slavik, Marketa Sosnakova, Ivana Stahlavska, Veronika Starecka, Natalie Stefanakova, Vaclav Stellar, Sona Struharova, Monika Subrtova, Ondrej Taborsky, Ivana Timova, Klara Tlacbabova, Anita Turanska, Juraj Turna, Karel Tvrdon, Gabriela Vackova, Daniela Valvodova, Martina Vavrincova, Lenka Vecerkova, Lucie Veselkova, Lenka Vojtechovska, Michaela Vojtkova, Zuzana Volakova, Jakub Zalesky, Henrieta Zborilova and Anna Zemanova.	Bandouchova H, 2015, TRANSBOUND EMERG DIS, V62, P1, DOI 10.1111/tbed.12282; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Coleman JTH., 2014, OUTLOOKS PEST MANAGE, V25, P374; Court MH, 2017, AM J VET RES, V78, P90, DOI 10.2460/ajvr.78.1.90; Cross SS, 2011, DIAGNOSTIC HISTOPATH, V17, P263; Cryan PM, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-47; Cryan PM, 2013, J WILDLIFE DIS, V49, P398, DOI 10.7589/2012-04-121; Cryan PM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-135; Deem SL, 2001, CONSERV BIOL, V15, P1224, DOI 10.1046/j.1523-1739.2001.00336.x; Fey SB, 2015, P NATL ACAD SCI USA, V112, P1083, DOI 10.1073/pnas.1414894112; Field KA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005168; Flieger M, 2016, SCI REP-UK, V6, DOI 10.1038/srep33200; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Fuller NW, 2011, ECOHEALTH, V8, P154, DOI 10.1007/s10393-011-0705-y; Gamer M, 2012, IRR VARIOUS COEFFICI; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; Hoyt JR, 2016, EMERG INFECT DIS, V22, P140, DOI 10.3201/eid2201.151314; Ives AR, 2007, SYST BIOL, V56, P252, DOI 10.1080/10635150701313830; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Lucan RK, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1302-2; Martinkova N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013853; McGuire LP, 2016, ECOHEALTH, V13, P60, DOI 10.1007/s10393-016-1107-y; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Meteyer CU, 2012, VIRULENCE, V3, P583, DOI 10.4161/viru.22330; Meteyer CU, 2011, J WILDLIFE DIS, V47, P618, DOI 10.7589/0090-3558-47.3.618; Meteyer CU, 2009, J VET DIAGN INVEST, V21, P411, DOI 10.1177/104063870902100401; Minnis AM, 2013, FUNGAL BIOL-UK, V117, P638, DOI 10.1016/j.funbio.2013.07.001; Pikula J, 2012, J WILDLIFE DIS, V48, P207, DOI 10.7589/0090-3558-48.1.207; Puechmaille SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019167; RCore Team, 2020, R LANG ENV STAT COMP; Reeder DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038920; Reichard JD, 2009, ACTA CHIROPTEROL, V11, P457, DOI 10.3161/150811009X485684; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Rowlingson B, 2015, SPLANCS SPATIAL SPAC; Shuey MM, 2014, APPL ENVIRON MICROB, V80, P1726, DOI 10.1128/AEM.02897-13; Turner GG, 2014, J WILDLIFE DIS, V50, P566, DOI 10.7589/2014-03-058; Turner Gregory G., 2011, Bat Research News, V52, P13; Urbanek S, 2019, JPEG READ WRITE JPEG; Verant Michelle L., 2014, BMC Physiology, V14, P10, DOI 10.1186/s12899-014-0010-4; Voigt CC, 2013, J EXP BIOL, V216, P1516, DOI 10.1242/jeb.079509; Warnecke L, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0177; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; Zukal J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19829; Zukal J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097224	48	31	31	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0180435	10.1371/journal.pone.0180435	http://dx.doi.org/10.1371/journal.pone.0180435			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767673	gold, Green Published, Green Submitted			2022-12-26	WOS:000406768200008
J	Anyan, J; Verwey, M; Amir, S				Anyan, Jeffrey; Verwey, Michael; Amir, Shimon			Individual differences in circadian locomotor parameters correlate with anxiety- and depression-like behavior	PLOS ONE			English	Article							FORCED-SWIM TEST; HIGH TRAIT ANXIETY; BIPOLAR DISORDER; MOOD DISORDERS; RAT STRAINS; RHYTHMS; GENES; LIGHT; PHASE; MODEL	Disrupted circadian rhythms are a core feature of mood and anxiety disorders. Circadian rhythms are coordinated by a light-entrainable master clock located in the suprachiasmatic nucleus. Animal models of mood and anxiety disorders often exhibit blunted rhythms in locomotor activity and clock gene expression. Interestingly, the changes in circadian rhythms correlate with mood-related behaviours. Although animal models of depression and anxiety exhibit aberrant circadian rhythms in physiology and behavior, it is possible that the methodology being used to induce the behavioral phenotype (e.g., brain lesions, chronic stress, global gene deletion) affect behavior independently of circadian system. This study investigates the relationship between individual differences in circadian locomotor parameters and mood-related behaviors in healthy rats. The circadian phenotype of male Lewis rats was characterized by analyzing wheel running behavior under standard 12h:12h LD conditions, constant dark, constant light, and rate of re-entrainment to a phase advance. Rats were then tested on a battery of behavioral tests: activity box, restricted feeding, elevated plus maze, forced swim test, and fear conditioning. Under 12h: 12h LD conditions, percent of daily activity in the light phase and variability in activity onset were associated with longer latency to immobility in the forced swim test. Variability in onset also correlated positively with anxiety-like behavior in the elevated plus maze. Rate of re-entrainment correlated positively with measures of anxiety in the activity box and elevated plus maze. Lastly, we found that free running period under constant dark was associated with anxiety-like behaviors in the activity box and elevated plus maze. Our results provide a previously uncharacterized relationship between circadian locomotor parameters and mood-related behaviors in healthy rats and provide a basis for future examination into circadian clock functioning and mood.	[Anyan, Jeffrey; Verwey, Michael; Amir, Shimon] Concordia Univ, Dept Psychol, Ctr Studies Behav Neurobiol, Montreal, PQ, Canada	Concordia University - Canada	Amir, S (corresponding author), Concordia Univ, Dept Psychol, Ctr Studies Behav Neurobiol, Montreal, PQ, Canada.	shimon.amir@concordia.ca	Amir, Shimon/AAE-4635-2022	Amir, Shimon/0000-0003-1919-5023	Canadian Institutes of Health Research [M0P142458]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by a grant from the Canadian Institutes of Health Research received by SA (Grant Number: M0P142458). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study received no additional funding.	ASCHOFF J, 1972, NATURWISSENSCHAFTEN, V59, P276, DOI 10.1007/BF00610214; Berle Jan O, 2010, BMC Res Notes, V3, P149, DOI 10.1186/1756-0500-3-149; Carobrez AP, 2005, NEUROSCI BIOBEHAV R, V29, P1193, DOI 10.1016/j.neubiorev.2005.04.017; Cryan JF, 2002, TRENDS PHARMACOL SCI, V23, P238, DOI 10.1016/S0165-6147(02)02017-5; Dardente H, 2007, CHRONOBIOL INT, V24, P195, DOI 10.1080/07420520701283693; Dhabhar FS, 1997, NEUROENDOCRINOLOGY, V65, P360, DOI 10.1159/000127196; Duffy JF, 1996, J PHYSIOL-LONDON, V495, P289, DOI 10.1113/jphysiol.1996.sp021593; Evans JA, 2015, P BIOL SCI, P282; Goswami S, 2010, LEARN MEMORY, V17, P494, DOI 10.1101/lm.1948910; Griesauer I, 2014, ANN MED, V46, P148, DOI 10.3109/07853890.2013.866440; Gronli J, 2005, PHYSIOL BEHAV, V84, P571, DOI 10.1016/j.physbeh.2005.02.007; Harbour VL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076391; Hinojosa FR, 2006, BEHAV BRAIN RES, V168, P127, DOI 10.1016/j.bbr.2005.10.019; Jiang WG, 2011, BRAIN RES, V1399, P25, DOI 10.1016/j.brainres.2011.05.001; Jones N, 2001, PHYSIOL BEHAV, V72, P99, DOI 10.1016/S0031-9384(00)00388-7; Jones SG, 2015, SLEEP MED CLIN, V10, P481, DOI 10.1016/j.jsmc.2015.07.004; Kalsbeek A, 2006, J BIOL RHYTHM, V21, P458, DOI 10.1177/0748730406293854; Karatsoreos IN, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00162; Kelliher P, 2000, PHYSIOL BEHAV, V69, P531, DOI 10.1016/S0031-9384(00)00213-4; Kripke Daniel F, 2009, J Circadian Rhythms, V7, P2, DOI 10.1186/1740-3391-7-2; Lamont Elaine Waddington, 2007, Dialogues Clin Neurosci, V9, P333; Landgraf D, 2016, BIOL PSYCHIAT; LeGates TA, 2012, NATURE, V491, P594, DOI 10.1038/nature11673; Lewy AJ, 2006, P NATL ACAD SCI USA, V103, P7414, DOI 10.1073/pnas.0602425103; Martynhak BJ, 2015, CNS NEUROL DISORD-DR, V14, P963, DOI 10.2174/1871527314666150909115203; McClung CA, 2007, PHARMACOL THERAPEUT, V114, P222, DOI 10.1016/j.pharmthera.2007.02.003; Molendijk ML, 2015, PSYCHONEUROENDOCRINO, V62, P389, DOI 10.1016/j.psyneuen.2015.08.028; MONK TH, 1994, J SLEEP RES, V3, P196, DOI 10.1111/j.1365-2869.1994.tb00132.x; MROSOVSKY N, 1988, J COMP PHYSIOL A, V162, P35, DOI 10.1007/BF01342701; Nievergelt CM, 2006, AM J MED GENET B, V141B, P234, DOI 10.1002/ajmg.b.30252; NISHIMURA H, 1988, PHYSIOL BEHAV, V42, P93, DOI 10.1016/0031-9384(88)90266-1; Patel SD, 2010, AM J MED GENET B, V153B, P850, DOI 10.1002/ajmg.b.31087; Pickard BS, 2009, MOL PSYCHIATR, V14, P874, DOI 10.1038/mp.2008.24; Porsolt R D, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0810as14; Ramos A, 2002, BEHAV BRAIN RES, V129, P113, DOI 10.1016/S0166-4328(01)00337-0; Schaufler J, 2016, ANN MED, V48, P17, DOI 10.3109/07853890.2015.1122216; Sestakova Natalia, 2013, Interdiscip Toxicol, V6, P126, DOI 10.2478/intox-2013-0020; Soria V, 2010, NEUROPSYCHOPHARMACOL, V35, P1279, DOI 10.1038/npp.2009.230; Spencer S, 2013, EUR J NEUROSCI, V37, P242, DOI 10.1111/ejn.12010; Stevens RG, 2007, ENVIRON HEALTH PERSP, V115, P1357, DOI 10.1289/ehp.10200; Szelenberger Waldemar, 2005, World Psychiatry, V4, P186; Valentinuzzi VS, 1997, AM J PHYSIOL-REG I, V273, pR1957, DOI 10.1152/ajpregu.1997.273.6.R1957; WELSH DK, 1986, J COMP PHYSIOL A, V158, P827, DOI 10.1007/BF01324824; Wirz-Justice A, 2005, PSYCHOL MED, V35, P939, DOI 10.1017/S003329170500437X; WIRZJUSTICE A, 1993, ARCH GEN PSYCHIAT, V50, P929	45	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0181375	10.1371/journal.pone.0181375	http://dx.doi.org/10.1371/journal.pone.0181375			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763478	Green Published, gold, Green Accepted			2022-12-26	WOS:000406766500011
J	Castro, G; Liu, XJ; Ngo, K; De Leon-Tabaldo, A; Zhao, SR; Luna-Roman, R; Yu, JX; Cao, TH; Kuhn, R; Wilkinson, P; Herman, K; Nelen, MI; Blevitt, J; Xue, XH; Fourie, A; Fung-Leung, WP				Castro, Glenda; Liu, Xuejun; Ngo, Karen; De Leon-Tabaldo, Aimee; Zhao, Shanrong; Luna-Roman, Rosa; Yu, Jingxue; Cao, Tinghua; Kuhn, Robert; Wilkinson, Patrick; Herman, Krystal; Nelen, Marina I.; Blevitt, Jonathan; Xue, Xiaohua; Fourie, Anne; Fung-Leung, Wai-Ping			ROR gamma t and ROR alpha signature genes in human Th17 cells	PLOS ONE			English	Article							ORPHAN NUCLEAR RECEPTORS; GROWTH-FACTOR-BETA; HELPER-CELLS; DIFFERENTIATION; ISOFORM; BINDING; LIGAND; CHOLESTEROL; MECHANISMS; EXPRESSION	ROR gamma t and ROR alpha are transcription factors of the RAR-related orphan nuclear receptor (ROR) family. They are expressed in Th17 cells and have been suggested to play a role in Th17 differentiation. Although ROR gamma t signature genes have been characterized in mouse Th17 cells, detailed information on its transcriptional control in human Th17 cells is limited and even less is known about RORa signature genes which have not been reported in either human or mouse T cells. In this study, global gene expression of human CD4 T cells activated under Th17 skewing conditions was profiled by RNA sequencing. ROR gamma t and ROR alpha signature genes were identified in these Th17 cells treated with specific siRNAs to knock down ROR gamma t or ROR alpha expression. We have generated selective small molecule ROR gamma t modulators and they were also utilized as pharmacological tools in ROR gamma t signature gene identification. Our results showed that ROR gamma t controlled the expression of a very selective number of genes in Th17 cells and most of them were regulated by ROR alpha as well albeit a weaker influence. Key Th17 genes including IL -17A, IL -17F, IL -23R, CCL20 and CCR6 were shown to be regulated by both ROR gamma t and ROR alpha. Our results demonstrated an overlapping role of ROR gamma t and ROR alpha in human Th17 cell differentiation through regulation of a defined common set of Th17 genes. ROR gamma t as a drug target for treatment of Th17 mediated autoimmune diseases such as psoriasis has been demonstrated recently in clinical trials. Our results suggest that RORa could be involved in same disease mechanisms and gene signatures identified in this report could be valuable biomarkers for tracking the pharmacodynamic effects of compounds that modulate ROR gamma t or ROR alpha activities in patients.	[Castro, Glenda; Liu, Xuejun; Ngo, Karen; De Leon-Tabaldo, Aimee; Zhao, Shanrong; Luna-Roman, Rosa; Yu, Jingxue; Cao, Tinghua; Kuhn, Robert; Wilkinson, Patrick; Herman, Krystal; Nelen, Marina I.; Blevitt, Jonathan; Xue, Xiaohua; Fourie, Anne; Fung-Leung, Wai-Ping] Janssen R&D LLC, San Diego, CA 92121 USA	Johnson & Johnson; Janssen Pharmaceuticals	Fung-Leung, WP (corresponding author), Janssen R&D LLC, San Diego, CA 92121 USA.	wleung@its.jnj.com		Fung-Leung, Wai-Ping/0000-0001-7013-8855				Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; BECKERANDRE M, 1994, J BIOL CHEM, V269, P28531; CARLBERG C, 1994, MOL ENDOCRINOL, V8, P757, DOI 10.1210/me.8.6.757; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Clemente JC, 2012, J BIOMOL SCREEN, V17, P629, DOI 10.1177/1087057112441012; Dzhagalov I, 2004, J IMMUNOL, V173, P2952, DOI 10.4049/jimmunol.173.5.2952; Dzhagalov I, 2004, CELL MOL IMMUNOL, V1, P401; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Eberl G, 2003, IMMUNOL REV, V195, P81, DOI 10.1034/j.1600-065X.2003.00074.x; Fauber BP, 2014, J MED CHEM, V57, P5871, DOI 10.1021/jm401901d; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; He YW, 1998, IMMUNITY, V9, P797, DOI 10.1016/S1074-7613(00)80645-7; HIROSE T, 1994, BIOCHEM BIOPH RES CO, V205, P1976, DOI 10.1006/bbrc.1994.2902; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Ivanov II, 2007, SEMIN IMMUNOL, V19, P409, DOI 10.1016/j.smim.2007.10.011; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Kallen J, 2004, J BIOL CHEM, V279, P14033, DOI 10.1074/jbc.M400302200; Kallen JA, 2002, STRUCTURE, V10, P1697, DOI 10.1016/S0969-2126(02)00912-7; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; MatysiakScholze U, 1997, GENOMICS, V43, P78, DOI 10.1006/geno.1997.4757; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; ORTIZ MA, 1995, MOL ENDOCRINOL, V9, P1679, DOI 10.1210/me.9.12.1679; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Ruan QG, 2011, J EXP MED, V208, P2321, DOI 10.1084/jem.20110462; Santori FR, 2015, CELL METAB, V21, P286, DOI 10.1016/j.cmet.2015.01.004; Skepner J, 2014, J IMMUNOL, V192, P2564, DOI 10.4049/jimmunol.1302190; Soroosh P, 2014, P NATL ACAD SCI USA, V111, P12163, DOI 10.1073/pnas.1322807111; Villey I, 1999, EUR J IMMUNOL, V29, P4072, DOI 10.1002/(SICI)1521-4141(199912)29:12<4072::AID-IMMU4072>3.0.CO;2-E; Xiao S, 2014, IMMUNITY, V40, P477, DOI 10.1016/j.immuni.2014.04.004; Xue X, 2016, SCI REPORTS IN PRESS; Yang J, 2014, TRENDS PHARM SCI; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644	39	76	81	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0181868	10.1371/journal.pone.0181868	http://dx.doi.org/10.1371/journal.pone.0181868			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763457	gold, Green Published, Green Submitted			2022-12-26	WOS:000406766500025
J	Martin-Estebane, M; Navascues, J; Sierra-Martin, A; Martin-Guerrero, SM; Cuadros, MA; Carrasco, MC; Marin-Teva, JL				Martin-Estebane, Maria; Navascues, Julio; Sierra-Martin, Ana; Martin-Guerrero, Sandra M.; Cuadros, Miguel A.; Carrasco, Maria-Carmen; Marin-Teva, Jose L.			Onset of microglial entry into developing quail retina coincides with increased expression of active caspase-3 and is mediated by extracellular ATP and UDP	PLOS ONE			English	Article							FIND-ME SIGNAL; PURINERGIC RECEPTORS; CELL-DEATH; IMMUNOHISTOCHEMICAL LOCALIZATION; AMEBOID MICROGLIA; ADULT MICROGLIA; NEURONAL DEATH; MULLER CELLS; GLIAL-CELLS; IN-VITRO	Microglial cell precursors located in the area of the base of the pecten and the optic nerve head (BP/ONH) start to enter the retina of quail embryos at the 7 th day of incubation (E7), subsequently colonizing the entire retina by central-to-peripheral tangential migration, as previously shown by our group. The present study demonstrates a precise chronological coincidence of the onset of microglial cell entry into the retina with a striking increase in death of retinal cells, as revealed by their active caspase-3 expression and TUNEL staining, in regions dorsal to the BP/ONH area, suggesting that dying retinal cells would contribute to the microglial cell inflow into the retina. However, the molecular mechanisms involved in this inflow are currently unclear. Extracellular nucleotides, such as ATP and UDP, have previously been shown to favor migration of microglia towards brain injuries because they are released by apoptotic cells and stimulate both chemotaxis and chemokinesis in microglial cells via signaling through purinergic receptors. Hence, we tested here the hypothesis that ATP and UDP play a role in the entry and migration of microglial precursors into the developing retina. For this purpose, we used an experimental model system based on organotypic cultures of E6.5 quail embryo retina explants, which mimics the entry and migration of microglial precursors in the in situ developing retina. Inhibition of purinergic signaling by treating retina explants with either apyrase, a nucleotide-hydrolyzing enzyme, or suramin, a broad spectrum antagonist of purinergic receptors, significantly prevents the entry of microglial cells into the retina. In addition, treatment of retina explants with either exogenous ATP or UDP results in significantly increased numbers of microglial cells entering the retina. In light of these findings, we conclude that purinergic signaling by extracellular ATP and UDP is necessary for the entry and migration of microglial cells into the embryonic retina by inducing chemokinesis in these cells.	[Martin-Estebane, Maria; Navascues, Julio; Martin-Guerrero, Sandra M.; Cuadros, Miguel A.; Carrasco, Maria-Carmen; Marin-Teva, Jose L.] Univ Granada, Fac Ciencias, Dept Biol Celular, Granada, Spain; [Sierra-Martin, Ana] Univ Autonoma Barcelona, Dept Biol Celular Fisiol & Inmunol, Barcelona, Spain	University of Granada; Autonomous University of Barcelona	Marin-Teva, JL (corresponding author), Univ Granada, Fac Ciencias, Dept Biol Celular, Granada, Spain.	jlmarin@ugr.es	Cuadros, Miguel A/L-3954-2014; MARTÍN, ANA SIERRA/Q-6241-2016; Martín-Guerrero, Sandra María/P-9333-2018; ESTEBANÉ, MARÍA MARTÍN/AAR-5385-2020	Cuadros, Miguel A/0000-0003-4259-1649; MARTÍN, ANA SIERRA/0000-0002-9392-9374; Martín-Guerrero, Sandra María/0000-0003-1489-4757; ESTEBANÉ, MARÍA MARTÍN/0000-0002-9680-581X; Navascues, Julio/0000-0003-2958-2705; Marin Teva, Jose Luis/0000-0002-5829-4502	Ministerio de Economoia y Competitividad, Spain [BFU2010-19981]; Ministerio de Educacion, Cultura y Deporte, Spain [FPU14/02219]; National Institute of Child Health and Human Development	Ministerio de Economoia y Competitividad, Spain; Ministerio de Educacion, Cultura y Deporte, Spain; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from Ministerio de Economoia y Competitividad, Spain (BFU2010-19981) and Ministerio de Educacion, Cultura y Deporte, Spain (FPU14/02219). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The QH1 (developed by F. Dieterlen-Lievre), H5 (developed by J.R. Sanes) and 39.4D5 (developed by T.M. Jessell and S. Brenner-Morton) monoclonal antibodies were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the National Institute of Child Health and Human Development and maintained by the University of Iowa, Department of Biological Sciences. The authors thank Richard Davies for improving the English.	Abbracchio MP, 2009, TRENDS NEUROSCI, V32, P19, DOI 10.1016/j.tins.2008.10.001; Abiega O, 2016, PLOS BIOL, V14, DOI [10.1371/journal.pbio.1002508, 10.1371/journal.pbio.1002554, 10.1371/journal.pbio.1002466]; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Arno B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6611; ASHWELL K, 1991, DEV BRAIN RES, V58, P1, DOI 10.1016/0165-3806(91)90231-7; Askew K, 2017, CELL REP, V18, P391, DOI 10.1016/j.celrep.2016.12.041; Bernier LP, 2013, GLIA, V61, P2038, DOI 10.1002/glia.22574; Bianco F, 2005, BRAIN RES REV, V48, P144, DOI 10.1016/j.brainresrev.2004.12.004; Braun N, 2001, DRUG DEVELOP RES, V53, P208, DOI 10.1002/ddr.1189; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Caldero J, 2009, J NEUROSCI RES, V87, P2447, DOI 10.1002/jnr.22084; Carrasco MC, 2011, DEV NEUROBIOL, V71, P296, DOI 10.1002/dneu.20860; Casano AM, 2016, CELL REP, V16, P897, DOI 10.1016/j.celrep.2016.06.033; Casano AM, 2015, DEV CELL, V32, P469, DOI 10.1016/j.devcel.2015.01.018; Caserta TM, 2003, APOPTOSIS, V8, P345, DOI 10.1023/A:1024116916932; Chauvier D, 2007, CELL DEATH DIFFER, V14, P387, DOI 10.1038/sj.cdd.4402044; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Cuadros MA, 1998, PROG NEUROBIOL, V56, P173, DOI 10.1016/S0301-0082(98)00035-5; CUADROS MA, 1992, NEUROSCI LETT, V148, P11, DOI 10.1016/0304-3940(92)90792-6; Cunningham CL, 2013, J NEUROSCI, V33, P4216, DOI 10.1523/JNEUROSCI.3441-12.2013; Dalmau I, 1998, J COMP NEUROL, V398, P333, DOI 10.1002/(SICI)1096-9861(19980831)398:3<333::AID-CNE3>3.0.CO;2-0; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; De Simone R, 2010, J NEUROCHEM, V115, P450, DOI 10.1111/j.1471-4159.2010.06937.x; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Eyo UB, 2016, BRAIN BEHAV IMMUN, V55, P49, DOI 10.1016/j.bbi.2015.11.009; Farber K, 2008, GLIA, V56, P331, DOI 10.1002/glia.20606; Francisco-Morcillo J, 2014, DEV DYNAM, V243, P1203, DOI [10.1002/DVDY.24174, 10.1002/dvdy.24174]; Garceau V, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0121-9; Gendron FP, 2003, J NEUROCHEM, V87, P344, DOI 10.1046/j.1471-4159.2003.01995.x; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Hochreiter-Hufford A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008748; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Housley GD, 2009, TRENDS NEUROSCI, V32, P128, DOI 10.1016/j.tins.2009.01.001; HUME DA, 1983, J CELL BIOL, V97, P253, DOI 10.1083/jcb.97.1.253; Jo YH, 2002, J NEUROSCI, V22, P4794, DOI 10.1523/JNEUROSCI.22-12-04794.2002; Jo YH, 1999, NAT NEUROSCI, V2, P241, DOI 10.1038/6344; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; Koizumi S, 2013, GLIA, V61, P47, DOI 10.1002/glia.22358; Kurpius D, 2007, GLIA, V55, P873, DOI 10.1002/glia.20509; LING EA, 1993, GLIA, V7, P9, DOI 10.1002/glia.440070105; Loiola EC, 2011, NEUROCHEM INT, V58, P414, DOI 10.1016/j.neuint.2010.12.019; Madry C, 2015, J BIOL CHEM, V290, P12443, DOI 10.1074/jbc.R115.637157; Maeda T, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160054; Marin-Teva JL, 1999, J COMP NEUROL, V412, P255; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; Marin-Teva JL, 1998, GLIA, V22, P31, DOI 10.1002/(SICI)1098-1136(199801)22:1<31::AID-GLIA4>3.0.CO;2-B; Marin-Teva JL, 2014, MICROGLIA HLTH DIS, P175; Medina CB, 2016, CELL DEATH DIFFER, V23, P979, DOI 10.1038/cdd.2016.13; Miller AM, 2009, GLIA, V57, P875, DOI 10.1002/glia.20813; Mitchell CH, 2001, J PHYSIOL-LONDON, V534, P193, DOI 10.1111/j.1469-7793.2001.00193.x; Nasu-Tada K, 2005, GLIA, V52, P98, DOI 10.1002/glia.20224; NAVASCUES J, 1995, J COMP NEUROL, V354, P209, DOI 10.1002/cne.903540205; NEAL M, 1994, BRIT J PHARMACOL, V113, P1085, DOI 10.1111/j.1476-5381.1994.tb17106.x; Neher JJ, 2014, GLIA, V62, P1463, DOI 10.1002/glia.22693; Newman EA, 2005, J NEUROSCI, V25, P5502, DOI 10.1523/JNEUROSCI.1354-05.2005; Newman EA, 2001, J NEUROSCI, V21, P2215, DOI 10.1523/JNEUROSCI.21-07-02215.2001; Newman EA, 2004, NEURON GLIA BIOL, V1, P245, DOI 10.1017/S1740925X0500013X; Ohsawa K, 2007, GLIA, V55, P604, DOI 10.1002/glia.20489; Ohsawa K, 2011, GLIA, V59, P1793, DOI 10.1002/glia.21238; PARDANAUD L, 1987, DEVELOPMENT, V100, P339; Pearson RA, 2005, NEURON, V46, P731, DOI 10.1016/j.neuron.2005.04.024; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; PERRY VH, 1985, NEUROSCIENCE, V15, P313, DOI 10.1016/0306-4522(85)90215-5; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Pierre WC, 2017, BRAIN BEHAV IMMUN, V59, P333, DOI 10.1016/j.bbi.2016.08.018; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Rigato C, 2011, GLIA, V59, P675, DOI 10.1002/glia.21140; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Sanchez-Lopez A, 2004, GLIA, V46, P261, DOI 10.1002/glia.20007; Santos AM, 2008, J COMP NEUROL, V506, P224, DOI 10.1002/cne.21538; Santos PF, 1999, J NEUROBIOL, V41, P340, DOI 10.1002/(SICI)1097-4695(19991115)41:3<340::AID-NEU3>3.3.CO;2-#; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Shieh CH, 2014, GLIA, V62, P592, DOI 10.1002/glia.22628; Sierra A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00006; Sierra A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106048; Sperlagh B, 1998, NEUROSCIENCE, V86, P1195, DOI 10.1016/S0306-4522(98)00026-8; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Swinnen N, 2013, GLIA, V61, P150, DOI 10.1002/glia.22421; Tay TL, 2016, J PHYSL IN PRESS; Voigt J, 2015, NEUROCHEM RES, V40, P651, DOI 10.1007/s11064-014-1511-z; Wakselman S, 2008, J NEUROSCI, V28, P8138, DOI 10.1523/JNEUROSCI.1006-08.2008; Ward MM, 2010, ADV EXP MED BIOL, V664, P385, DOI 10.1007/978-1-4419-1399-9_44; Warny M, 2001, J BIOL CHEM, V276, P26051, DOI 10.1074/jbc.M102568200; White FA, 1998, J NEUROSCI, V18, P1428; Wilkinson PC, 1998, J IMMUNOL METHODS, V216, P139, DOI 10.1016/S0022-1759(98)00075-1; Wurm A, 2011, PROG RETIN EYE RES, V30, P324, DOI 10.1016/j.preteyeres.2011.06.001; Xu J, 2016, DEV CELL, V38, P214, DOI 10.1016/j.devcel.2016.06.018; Xu J, 2015, DEV CELL, V34, P632, DOI 10.1016/j.devcel.2015.08.018; YAMATO S, 1984, STAIN TECHNOL, V59, P113, DOI 10.3109/10520298409113840	95	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0182450	10.1371/journal.pone.0182450	http://dx.doi.org/10.1371/journal.pone.0182450			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763502	Green Published, gold, Green Submitted			2022-12-26	WOS:000406766500067
J	Garami, J; Haber, P; Myers, CE; Allen, MT; Misiak, B; Frydecka, D; Moustafa, AA				Garami, Julia; Haber, Paul; Myers, Catherine E.; Allen, Michael T.; Misiak, Blazej; Frydecka, Dorota; Moustafa, Ahmed A.			Intolerance of uncertainty in opioid dependency - Relationship with trait anxiety and impulsivity	PLOS ONE			English	Article							SUBSTANCE USE; USE DISORDERS; ALCOHOL; STRESS; WORRY; ACQUISITION; ADDICTION; HEROIN; ABUSE; RISK	Intolerance of uncertainty (IU) is the tendency to interpret ambiguous situations as threatening and having negative consequences, resulting in feelings of distress and anxiety. IU has been linked to a number of anxiety disorders, and anxiety felt in the face of uncertainty may result in maladaptive behaviors such as impulsive decision making. Although there is strong evidence that anxiety and impulsivity are risk factors for addiction, there is a paucity of research examining the role of IU in this disorder. The rate of opioid addiction, in particular, has been rising steadily in recent years, which necessitates deeper understanding of risk factors in order to develop effective prevention and treatment methods. The current study tested for the first time whether opioid-dependent adults are less tolerant of uncertainty compared to a healthy comparison group. Opioid dependent patients undergoing methadone maintenance therapy (n = 114) and healthy comparisons (n = 69) completed the following scales: Intolerance of Uncertainty Scale, the Barrett Impulsivity Scale, and the State Trait Anxiety Inventory. Analysis revealed that these measures were positively correlated with each other and that opioid-dependent patients had significantly higher IU scores. Regression analysis revealed that anxiety mediated the relationship between IU and impulsivity. Hierarchical moderation regression found an interaction between addiction status and impulsivity on IU scores in that the relationship between these variables was only observed in the patient group. Findings suggest that IU is a feature of addiction but does not necessarily play a unique role. Further research is needed to explore the complex relationship between traits and how they may contribute to the development and maintenance of addiction.	[Garami, Julia; Moustafa, Ahmed A.] Western Sydney Univ, Sch Social Sci & Psychol, Sydney, NSW, Australia; [Haber, Paul] Univ Sydney, Cent Clin Sch, Discipline Addict Med, Natl Hlth & Med Res Council,Ctr Res Excellence Me, Sydney, NSW, Australia; [Myers, Catherine E.] New Jersey Hlth Care Syst, Dept Vet Affairs, E Orange, NJ USA; [Myers, Catherine E.] Rutgers State Univ, New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ USA; [Allen, Michael T.] Univ Northern Colorado, Sch Psychol Sci, Greeley, CO 80639 USA; [Misiak, Blazej; Frydecka, Dorota] Wroclaw Med Univ, Dept & Clin Psychiat, Wroclaw, Poland; [Misiak, Blazej] Wroclaw Med Univ, Dept Genet, Wroclaw, Poland; [Moustafa, Ahmed A.] Western Sydney Univ, Marcs Inst Brain & Behaviour, Sydney, NSW, Australia	Western Sydney University; University of Sydney; New Jersey Department of Health & Senior Services; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Northern Colorado; Wroclaw Medical University; Wroclaw Medical University; Western Sydney University	Moustafa, AA (corresponding author), Western Sydney Univ, Sch Social Sci & Psychol, Sydney, NSW, Australia.; Moustafa, AA (corresponding author), Western Sydney Univ, Marcs Inst Brain & Behaviour, Sydney, NSW, Australia.	a.moustafa@westernsydney.edu.au	Frydecka, Dorota/ABD-8176-2021; Moustafa, Ahmed/AAM-2836-2021; Misiak, Błażej/ABA-2657-2021	Frydecka, Dorota/0000-0001-8582-9958; Misiak, Blazej/0000-0002-5392-6398; Moustafa, Ahmed/0000-0001-5971-273X				Allen MT, 2016, BEHAV BRAIN RES, V304, P86, DOI 10.1016/j.bbr.2016.02.007; Allen MT, 2014, FRONT BEHAV NEUROSCI, P8; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Barnes LLB, 2002, EDUC PSYCHOL MEAS, V62, P603, DOI 10.1177/0013164402062004005; BARRATT ES, 1965, PSYCHOL REP, V16, P547, DOI 10.2466/pr0.1965.16.2.547; Belzer KD, 2002, PERS INDIV DIFFER, V33, P573, DOI 10.1016/S0191-8869(01)00173-8; Blum J, 2013, AM J ADDICTION, V22, P598, DOI 10.1111/j.1521-0391.2013.12025.x; Buhr K, 2002, BEHAV RES THER, V40, P931, DOI 10.1016/S0005-7967(01)00092-4; Carleton RN, 2012, J ANXIETY DISORD, V26, P468, DOI 10.1016/j.janxdis.2012.01.011; Carpenter KM, 1999, J STUD ALCOHOL, V60, P694, DOI 10.15288/jsa.1999.60.694; Chamorro J, 2012, J PSYCHIATR RES, V46, P994, DOI 10.1016/j.jpsychires.2012.04.023; Cooper M.L., 1992, PSYCHOL ASSESS J CON, V4, P123, DOI DOI 10.1037/1040-3590.4.2.123; COOPER ML, 1995, J PERS SOC PSYCHOL, V69, P990, DOI 10.1037/0022-3514.69.5.990; Corr PJ, 2002, PERS INDIV DIFFER, V33, P511, DOI 10.1016/S0191-8869(01)00170-2; Cougle JR, 2012, PERS INDIV DIFFER, V52, P515, DOI 10.1016/j.paid.2011.11.017; Dugas MJ, 1998, BEHAV RES THER, V36, P215, DOI 10.1016/S0005-7967(97)00070-3; Dugas MJ, 2001, COGNITIVE THER RES, V25, P551, DOI 10.1023/A:1005553414688; Ersche KD, 2010, BIOL PSYCHIAT, V68, P770, DOI 10.1016/j.biopsych.2010.06.015; European Monitoring Centre for Drugs and Drug Addiction, 2015, EUR DRUG REP; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fishbain DA, 2008, PAIN MED, V9, P444, DOI 10.1111/j.1526-4637.2007.00370.x; FREESTON MH, 1994, PERS INDIV DIFFER, V17, P791, DOI 10.1016/0191-8869(94)90048-5; Gay P, 2011, COGNITIVE THER RES, V35, P293, DOI 10.1007/s10608-010-9317-z; Grant BF, 2009, MOL PSYCHIATR, V14, P1051, DOI 10.1038/mp.2008.41; Grant BF, 2006, ALCOHOL RES HEALTH, V29, P107; Holloway JL, 2014, BEHAV BRAIN RES, V261, P49, DOI 10.1016/j.bbr.2013.10.041; Jacobsen LK, 2001, AM J PSYCHIAT, V158, P1184, DOI 10.1176/appi.ajp.158.8.1184; Jones CM, 2015, MMWR-MORBID MORTAL W, V64, P719; Kashdan TB, 2008, DEPRESS ANXIETY, V25, P535, DOI 10.1002/da.20382; Khawaja NG., 2007, CLIN PSYCHOL-UK, V11, P24, DOI [10.1080/13284200601151778, DOI 10.1080/13284200601151778]; Kraemer KM, 2015, ADDICT BEHAV, V42, P162, DOI 10.1016/j.addbeh.2014.11.033; Kushner MG, 2008, SER ANXIETY RELAT DI, P3, DOI 10.1007/978-0-387-74290-8_1; Ladouceur R, 1997, BEHAV MODIF, V21, P355, DOI 10.1177/01454455970213006; Lai HMX, 2015, DRUG ALCOHOL DEPEN, V154, P1, DOI 10.1016/j.drugalcdep.2015.05.031; Leland DS, 2006, NEUROIMAGE, V33, P725, DOI 10.1016/j.neuroimage.2006.07.011; Litt MD, 2000, ADDICTION, V95, P889, DOI 10.1046/j.1360-0443.2000.9568896.x; Luhmann CC, 2011, BEHAV THER, V42, P378, DOI 10.1016/j.beth.2010.09.002; Mahoney Alison E. J., 2012, Cognitive Behaviour Therapy, V41, P212, DOI 10.1080/16506073.2011.622130; Maner JK, 2006, BEHAV THER, V37, P181, DOI 10.1016/j.beth.2005.11.003; McEvoy PM, 2012, BEHAV THER, V43, P533, DOI 10.1016/j.beth.2011.02.007; Meeten F, 2012, BEHAV RES THER, V50, P690, DOI 10.1016/j.brat.2012.08.003; Mehroof M, 2010, CYBERPSYCH BEH SOC N, V13, P313, DOI 10.1089/cyber.2009.0229; METZGER RL, 1990, J CLIN PSYCHOL, V46, P78, DOI 10.1002/1097-4679(199001)46:1<78::AID-JCLP2270460113>3.0.CO;2-R; Miller J, 2003, PERS INDIV DIFFER, V34, P1403, DOI 10.1016/S0191-8869(02)00122-8; Moeller FG, 2001, AM J PSYCHIAT, V158, P1783, DOI 10.1176/appi.ajp.158.11.1783; Myers CE, 2016, BEHAV BRAIN RES, V296, P240, DOI 10.1016/j.bbr.2015.09.018; Nelson BD, 2016, COGN AFFECT BEHAV NE, V16, P153, DOI 10.3758/s13415-015-0382-3; Oglesby ME, 2015, COGNITIVE THER RES, V39, P356, DOI 10.1007/s10608-014-9665-1; Park CL, 2002, J STUD ALCOHOL, V63, P486, DOI 10.15288/jsa.2002.63.486; Patak M, 2007, ADDICT BEHAV, V32, P351, DOI 10.1016/j.addbeh.2006.03.034; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pawluk EJ, 2013, PERS INDIV DIFFER, V54, P732, DOI 10.1016/j.paid.2012.11.027; Piazza PV, 2013, PSYCHOPHARMACOLOGY, V229, P387, DOI 10.1007/s00213-013-3224-4; Piazza PV, 1998, TRENDS PHARMACOL SCI, V19, P67, DOI 10.1016/S0165-6147(97)01115-2; Radell ML, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01175; Robinson J, 2009, J ANXIETY DISORD, V23, P38, DOI 10.1016/j.janxdis.2008.03.013; Roxburgh A, 2013, SYDNEY NATIONAL DRUG; SHER KJ, 1982, J ABNORM PSYCHOL, V91, P350, DOI 10.1037/0021-843X.91.5.350; Sheynin J, 2016, J CLIN PSYCHIAT, V77, P386, DOI 10.4088/JCP.14m09284; Sinha R, 2001, PSYCHOPHARMACOLOGY, V158, P343, DOI 10.1007/s002130100917; Spielberger C. D., 1977, STATE TRAIT ANXIETY; Stanford MS, 2009, PERS INDIV DIFFER, V47, P385, DOI 10.1016/j.paid.2009.04.008; TALLIS F, 1991, PERS INDIV DIFFER, V12, P21, DOI 10.1016/0191-8869(91)90128-X; Volkow N, 2004, ARCH NEUROL-CHICAGO, V9, P1575; Wilsey BL, 2008, PAIN MED, V9, P1107, DOI 10.1111/j.1526-4637.2007.00401.x; Winstanley CA, 2010, ALCOHOL CLIN EXP RES, V34, P1306, DOI 10.1111/j.1530-0277.2010.01215.x; Worthy DA, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00591	67	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0181955	10.1371/journal.pone.0181955	http://dx.doi.org/10.1371/journal.pone.0181955			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC3TH	28759635	Green Submitted, gold, Green Published			2022-12-26	WOS:000406761600039
J	Ng, PK; Lin, SM; Lim, PE; Hurtado, AQ; Phang, SM; Yow, YY; Sun, ZM				Ng, Poh-Kheng; Lin, Showe-Mei; Lim, Phaik-Eem; Hurtado, Anicia Q.; Phang, Siew-Moi; Yow, Yoon-Yen; Sun, Zhongmin			Genetic and morphological analyses of Gracilaria firma and G. changii (Gracilariaceae, Rhodophyta), the commercially important agarophytes in western Pacific	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; MITOCHONDRIAL COX1; COMPUTER-PROGRAM; PLASTID RBCL; ASIA; POPULATIONS; GELIDIALES	Many studies classifying Gracilaria species for the exploitation of agarophytes and the development of the agar industry were conducted before the prevalence of molecular tools, resulting in the description of many species based solely on their morphology. Gracilaria firma and G. changii are among the commercially important agarophytes from the western Pacific; both feature branches with basal constrictions that taper toward acute apices. In this study, we contrasted the morpho-anatomical circumscriptions of the two traditionally described species with molecular data from samples that included representatives of G. changii collected from its type locality. Concerted molecular analyses using the rbcL and cox1 gene sequences, coupled with morphological observations of the collections from the western Pacific, revealed no inherent differences to support the treatment of the two entities as distinct taxa. We propose merging G. changii (a later synonym) into G. firma and recognize G. firma based on thallus branches with abrupt basal constrictions that gradually taper toward acute (or sometimes broken) apices, cystocarps consisting of small gonimoblast cells and inconspicuous multinucleate tubular nutritive cells issuing from gonimoblasts extending into the inner pericarp at the cystocarp floor, as well as deep spermatangial conceptacles of the verrucosatype. The validation of specimens under different names as a single genetic species is useful to allow communication and knowledge transfer among groups from different fields. This study also revealed considerably low number of haplotypes and nucleotide diversity with apparent phylogeographic patterns for G. firma in the region. Populations from the Philippines and Taiwan were divergent from each other as well as from the populations from Malaysia, Thailand, Singapore and Vietnam. Establishment of baseline data on the genetic diversity of this commercially important agarophyte is relevant in the context of cultivation, as limited genetic diversity may jeopardize the potential for its genetic improvement over time.	[Ng, Poh-Kheng; Lin, Showe-Mei] Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung, Taiwan; [Lim, Phaik-Eem; Phang, Siew-Moi] Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur, Malaysia; [Hurtado, Anicia Q.] Integrated Serv Dev Aquaculture & Fisheries ISDA, Iloilo, Philippines; [Yow, Yoon-Yen] Sunway Univ, Dept Biol Sci, Sch Sci & Technol, Selangor, Malaysia; [Sun, Zhongmin] Chinese Acad Sci, Lab Marine Organism Taxon & Phylogeny, Inst Oceanol, Qingdao, Peoples R China	National Taiwan Ocean University; Universiti Malaya; Sunway University; Chinese Academy of Sciences; Institute of Oceanology, CAS	Lin, SM (corresponding author), Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung, Taiwan.; Lim, PE (corresponding author), Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur, Malaysia.	linsm@ntou.edu.tw; phaikeem@um.edu.my	LIM, Phaik Eem/B-5331-2010; Yow, Yoon Yen/AES-9633-2022; Phang, Siew Moi/A-7653-2008; Yow, Yoon Yen/E-1248-2016; Ng, Poh-Kheng/AAH-1976-2020	LIM, Phaik Eem/0000-0001-9186-1487; Yow, Yoon Yen/0000-0002-3859-2094; Yow, Yoon Yen/0000-0002-3859-2094; 	Taiwan Ministry of Science and Technology [102-2628-B-019-002-MY3, 105-2811-B-019-004]; Ministry of Higher Education, Malaysia, MoHE-HIR [H-50001-00-A000025]	Taiwan Ministry of Science and Technology; Ministry of Higher Education, Malaysia, MoHE-HIR	This study was funded by the Taiwan Ministry of Science and Technology (102-2628-B-019-002-MY3 and 105-2811-B-019-004 to SML) and the Ministry of Higher Education, Malaysia, MoHE-HIR Grant (H-50001-00-A000025 to PEL). The Integrated Services for the Development of Aquaculture and Fisheries (ISDA) Inc. did not provide any financial support in the conduct of the study. All funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abbot IA, 1988, TAXONOMY EC SEAWEEDS, VII, P137; ABBOTT I A, 1991, Pacific Science, V45, P12; Abbott IA, 1994, TAXONOMY EC SEAWEEDS, VIV, P111; AJISAKA T, 1993, HYDROBIOLOGIA, V261, P335; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Chan SW, 2014, MAR BIOL, V161, P785, DOI 10.1007/s00227-013-2377-3; Chang CF, 1976, STUDIA MAR SIN, V11, P91; Chiang YM, 1985, TAXONOMY EC SEAWEEDS, VI, P81; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; DOTY MS, 1983, AQUAT BOT, V15, P299, DOI 10.1016/0304-3770(83)90076-1; FREDERICQ S, 1990, HYDROBIOLOGIA, V204, P173, DOI 10.1007/BF00040230; FREDERICQ S, 1989, J PHYCOL, V25, P213, DOI 10.1111/j.1529-8817.1989.tb00116.x; Fredericq S, 1992, TAXONOMY EC SEAWEEDS, VIII, P211; FRESHWATER DW, 1994, PHYCOLOGIA, V33, P187, DOI 10.2216/i0031-8884-33-3-187.1; Gavio B, 2002, EUR J PHYCOL, V37, P349, DOI 10.1017/S0967026202003839; Geraldino Paul John L., 2006, Algae, V21, P417; Guillemin ML, 2008, EVOLUTION, V62, P1500, DOI 10.1111/j.1558-5646.2008.00373.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gulbransen DJ, 2012, J PHYCOL, V48, P1278, DOI 10.1111/j.1529-8817.2012.01218.x; Gurgel CFD, 2004, J PHYCOL, V40, P138, DOI 10.1111/j.0022-3646.2003.02-129.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Kim Myung Sook, 2008, Algae, V23, P209; Kraft GT, 1977, ALGA TYLOTUSGENUS GR, V15, P495; Krayesky DM, 2009, P BIOL SOC WASH, V122, P364, DOI 10.2988/08-43.1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le NH, 2005, VIETNAMESE J BIOTECH, V3, P373; LEWMANOMONT K., 1994, TAXONOMY EC SEAWEEDS, V4, P135; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin SM, 2006, CRYPTOGAMIE ALGOL, V27, P233; Lin SM, 2012, PHYCOLOGIA, V51, P421, DOI 10.2216/11-90.1; Lin SM, 2009, MARINE BENTHIC MACRO; Lyra GD, 2015, J PHYCOL, V51, P356, DOI 10.1111/jpy.12281; McHugh DJ, 2003, GUIDE SEAWEED IND; Ng PK, 2014, J APPL PHYCOL, V26, P1287, DOI 10.1007/s10811-013-0166-5; Phang SM, 1996, HYDROBIOLOGIA, V327, P347, DOI 10.1007/BF00047829; Phang SM, 1994, TAXONOMY EC SEAWEEDS, VIV, P125; SHANG YC, 1976, AQUACULTURE, V8, P1, DOI 10.1016/0044-8486(76)90014-4; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x; Terada R, 2000, BOT MAR, V43, P347, DOI 10.1515/BOT.2000.035; Terada Ryuta, 2000, Phycological Research, V48, P291; Titlyanov EA, 2012, RUSS J MAR BIOL+, V38, P285, DOI 10.1134/S1063074012040098; Trono GC, 1999, HYDROBIOLOGIA, V399, P1, DOI 10.1023/A:1017097226330; Tseng CK, 1999, BOT MAR, V42, P209, DOI 10.1515/BOT.1999.024; Valero M., 2017, PERSPECT PHYCOL, V4, P33, DOI [10.1127/pip/2017/0066, DOI 10.1127/PIP/2017/0066]; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Wiriyadamrikul J, 2010, BOT MAR, V53, P343, DOI 10.1515/BOT.2010.037; Withell Anne F., 1994, Australian Systematic Botany, V7, P281, DOI 10.1071/SB9940281; WITTMANN W, 1965, STAIN TECHNOL, V40, P161, DOI 10.3109/10520296509116398; Xia, 1999, FLORA ALGARUM MARINA; Xia B. M., 1987, PHYCOLOGIA, V26, P405; Xia BM, 1985, TAXONOMY EC SEAWEEDS, VI, P71; Yamamoto Hirotoshi, 1994, Japanese Journal of Phycology, V42, P331; Yang EC, 2008, J APPL PHYCOL, V20, P161, DOI 10.1007/s10811-007-9201-8; Yang HN, 1982, TAXONOMICAL STUDY GR, V9, P55; Yang MY, 2015, GENES GENOM, V37, P775, DOI 10.1007/s13258-015-0306-1; Yang MY, 2013, BOT STUD, V54, DOI 10.1186/1999-3110-54-27; Yow YY, 2013, J APPL PHYCOL, V25, P831, DOI 10.1007/s10811-012-9942-x; Yow YY, 2011, J APPL PHYCOL, V23, P219, DOI 10.1007/s10811-010-9535-5	59	9	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0182176	10.1371/journal.pone.0182176	http://dx.doi.org/10.1371/journal.pone.0182176			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759629	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000406761600060
J	Siao, MJ; Chen, GS; Lee, WC; Horng, JT; Chang, CW; Li, CH				Siao, Ming-Jhih; Chen, Gunng-Shinng; Lee, Wei-Cheng; Horng, Jorng-Tzong; Chang, Cheng-Wei; Li, Chung-Hsing			Increased risk of dental trauma in patients with allergic rhinitis: A nationwide population based cohort study	PLOS ONE			English	Article							MOUTH-BREATHING CHILDREN; PERMANENT INCISORS; SCHOOL-CHILDREN; FACIAL GROWTH; INJURIES; PREVALENCE; SCHOOLCHILDREN; EPIDEMIOLOGY; ETIOLOGY; BRAZIL	Allergic rhinitis (AR) is associated with various developmental issues that affecting dentition. We aimed to determine whether AR is associated with an increased risk of traumatic dental injuries (TDIs) in Taiwanese individuals. We used the Taiwan National Health Insurance Research Database (NHIRD) to conduct a nested case-control study. We compared an AR cohort with a matched cohort of patients without AR. New TDI cases were determined during our study period. To compare TDI risk between our study cohorts, we used Cox proportional regression analysis, and hazard ratios (HR) with 95% confidence intervals (CI) were calculated to quantify the association between AR exposure and TDI risk. In total, 76749 patients with AR (31715 male; 45034 female) were identified. In the AR and the non-AR cohorts, 312 patients in total had TDI. Patients with AR had a significantly higher risk of TDI than those without AR (aHR = 1.92; 95% CI = 1.459-2.525; P < 0.001). The risk of TDI was markedly higher in the AR cohort, except in the 3-12-year-old group, and with a CCI > 1. AR patients had a future risk of TDI, indicating a potentially linked disease pathophysiology. The association between AR and TDI is greater among general patients. Clinicians and caregivers should be aware of potential TDI co -morbidity in patients with AR.	[Siao, Ming-Jhih; Chen, Gunng-Shinng; Lee, Wei-Cheng; Li, Chung-Hsing] Triserv Gen Hosp, Dept Dent, Div Orthodont & Dentofacial Orthoped & Pediat Den, Taipei, Taiwan; [Siao, Ming-Jhih; Chen, Gunng-Shinng; Lee, Wei-Cheng; Li, Chung-Hsing] Natl Def Med Ctr, Sch Dent, Taipei, Taiwan; [Siao, Ming-Jhih; Chen, Gunng-Shinng; Lee, Wei-Cheng; Li, Chung-Hsing] Natl Def Med Ctr, Grad Inst Dent Sci, Taipei, Taiwan; [Horng, Jorng-Tzong] Natl Cent Univ, Dept Comp Sci & Informat Engn, Chungli, Taiwan; [Horng, Jorng-Tzong] Asia Univ, Dept Biomed Informat, Taichung, Taiwan; [Chang, Cheng-Wei] Hsing Wu Univ, Dept Informat Management, New Taipei, Taiwan	Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; National Central University; Asia University Taiwan	Li, CH (corresponding author), Triserv Gen Hosp, Dept Dent, Div Orthodont & Dentofacial Orthoped & Pediat Den, Taipei, Taiwan.; Li, CH (corresponding author), Natl Def Med Ctr, Sch Dent, Taipei, Taiwan.; Li, CH (corresponding author), Natl Def Med Ctr, Grad Inst Dent Sci, Taipei, Taiwan.; Chang, CW (corresponding author), Hsing Wu Univ, Dept Informat Management, New Taipei, Taiwan.	095010@mail.hwu.edu.tw; chiyenchli@yahoo.com.tw						Abreu RR, 2008, J PEDIAT-BRAZIL, V84, P529, DOI [10.1590/S0021-75572008000700010, 10.2223/JPED.1844]; Agostinho HA, 2015, ACTA MEDICA PORT, V28, P316, DOI 10.20344/amp.5556; Andersson L, 2013, J ENDODONT, V39, pS2, DOI 10.1016/j.joen.2012.11.021; Artun J, 2005, AM J ORTHOD DENTOFAC, V128, P347, DOI 10.1016/j.ajodo.2004.06.032; Basheer Bahija, 2014, J Int Oral Health, V6, P50; Bauss O, 2004, DENT TRAUMATOL, V20, P61, DOI 10.1111/j.1600-4469.2004.00230.x; Bellanti JA, 2000, ALLERGY ASTHMA PROC, V21, P367, DOI 10.2500/108854100778249088; BRESOLIN D, 1983, AM J ORTHOD DENTOFAC, V83, P334, DOI 10.1016/0002-9416(83)90229-4; Burden DJ, 1995, EUR J ORTHODONT, V17, P513, DOI 10.1093/ejo/17.6.513; CALISKAN MK, 1995, ENDOD DENT TRAUMATOL, V11, P210; CHENG MC, 1988, ANGLE ORTHOD, V58, P309; Cho SH, 2010, ARCH OTOLARYNGOL, V136, P610, DOI 10.1001/archoto.2010.75; Cortes MIS, 2001, DENT TRAUMATOL, V17, P22, DOI 10.1034/j.1600-9657.2001.170105.x; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dua R, 2012, CONTEMP CLIN DENT, V3, P38, DOI 10.4103/0976-237X.94544; Frasson Jussara Marinho Dias, 2006, Braz J Otorhinolaryngol, V72, P72; FRENG A, 1979, INT J PEDIATR OTORHI, V1, P249, DOI 10.1016/0165-5876(79)90019-3; Glendor U, 2009, DENT TRAUMATOL, V25, P19, DOI 10.1111/j.1600-9657.2008.00694.x; Guerra S, 2005, ALLERGY, V60, P343, DOI 10.1111/j.1398-9995.2005.00717.x; HARTGERINK DV, 1989, ANGLE ORTHOD, V59, P17; Hwang CY, 2010, ACTA DERM-VENEREOL, V90, P589, DOI 10.2340/00015555-0963; Jun- Jun Yeh, 2016, PLOS ONE, V11; Kowash MB, 1999, ITAL J PEDIAT DENT, V1, P25; Lin YT, 2016, PEDIATR RES, V80, P480, DOI 10.1038/pr.2016.111; Marcenes W, 2000, INT DENT J, V50, P87, DOI 10.1002/j.1875-595X.2000.tb00804.x; Marcenes W, 1999, ENDOD DENT TRAUMATOL, V15, P117; Principato JJ, 1989, P 6 INT COLL CRAN MA; RICKETTS RM, 1968, AMER J ORTHODONTICS, V54, P495, DOI 10.1016/0002-9416(68)90218-2; RUBIN RM, 1980, AM J ORTHOD DENTOFAC, V78, P504, DOI 10.1016/0002-9416(80)90301-2; SCHENDEL SA, 1976, AM J ORTHOD DENTOFAC, V70, P398, DOI 10.1016/0002-9416(76)90112-3; Sgan-Cohen HD, 2005, COMMUNITY DENT ORAL, V33, P174, DOI 10.1111/j.1600-0528.2005.00202.x; Skoner DR, 2001, J ALLERGY CLIN IMMUN, V108, pS2, DOI 10.1067/mai.2001.115569; Soriano EP, 2007, DENT TRAUMATOL, V23, P232, DOI 10.1111/j.1600-9657.2005.00426.x; Souki BQ, 2009, INT J PEDIATR OTORHI, V73, P767, DOI 10.1016/j.ijporl.2009.02.006; Traebert J, 2006, DENT TRAUMATOL, V22, P173, DOI 10.1111/j.1600-9657.2006.00359.x; Valera FCP, 2003, INT J PEDIATR OTORHI, V67, P761, DOI 10.1016/S0165-5876(03)00095-8; Vazquez Nava Francisco, 2007, Rev Alerg Mex, V54, P169; Yang MT, 2014, PEDIATR NEONATOL, V55, P168, DOI 10.1016/j.pedneo.2013.09.003	38	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0182370	10.1371/journal.pone.0182370	http://dx.doi.org/10.1371/journal.pone.0182370			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759627	Green Published, gold, Green Submitted			2022-12-26	WOS:000406761600074
J	Zhou, ZQ; Chen, TT; Wang, MR; Jin, L; Zhao, YY; Chen, SJ; Wang, CY; Zhang, GS; Wang, QL; Deng, QM; Liu, YB; Morgan, IG; He, MG; Liu, YZ; Congdon, N				Zhou, Zhongqiang; Chen, Tingting; Wang, Mengrui; Jin, Ling; Zhao, Yongyi; Chen, Shangji; Wang, Congyao; Zhang, Guoshan; Wang, Qilin; Deng, Qiaoming; Liu, Yubo; Morgan, Ian G.; He, Mingguang; Liu, Yizhi; Congdon, Nathan			Pilot study of a novel classroom designed to prevent myopia by increasing children's exposure to outdoor light	PLOS ONE			English	Article							REFRACTIVE-ERROR; SCHOOL-CHILDREN; TIME OUTDOORS; ULTRAVIOLET-RADIATION; DEPRIVATION MYOPIA; VISUAL IMPAIRMENT; BRIGHT LIGHT; RISK-FACTORS; EYE GROWTH; PROGRESSION	We sought to assess light characteristics and user acceptability of a prototype Bright Classroom (BC), designed to prevent children's myopia by exposing them to light conditions resembling the outdoors. Conditions were measured throughout the school year in the glass-constructed BC, a traditional classroom (TC) and outdoors. Teachers and children completed user questionnaires, and children rated reading comfort at different light intensities. A total of 230 children (mean age 10.2 years, 57.4% boys) and 13 teachers (36.8 years, 15.4% men) completed questionnaires. The median (Inter Quartile Range) light intensity in the BC (2,540 [1,330-4,060] lux) was greater than the TC (477 [245-738] lux, P < 0.001), though less than outdoors (19,500 [8,960-36,000] lux, P < 0.001). A prominent spectral peak at 490-560 nm was present in the BC and outdoors, but less so in the TC. Teachers and children gave higher overall ratings to the BC than TC, and light intensity in the BC in summer and on sunny days (> 5,000 lux) was at the upper limit of children's comfort for reading. In summary, light intensity in the BC exceeds TC, and is at the practical upper limit for routine use. Children and teachers prefer the BC.	[Zhou, Zhongqiang] Zhengzhou Univ, Henan Eye Inst, Henan Eye Hosp, Peoples Hosp,Henan Prov Peoples Hosp, Zhengzhou, Henan, Peoples R China; [Zhou, Zhongqiang; Chen, Tingting; Jin, Ling; Wang, Congyao; Zhang, Guoshan; Wang, Qilin; He, Mingguang; Liu, Yizhi; Congdon, Nathan] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Chen, Tingting] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Wang, Mengrui; Zhao, Yongyi; Deng, Qiaoming; Liu, Yubo] South China Univ Technol, Sch Architecture, Guangzhou, Guangdong, Peoples R China; [Chen, Shangji] Guangming Eye Hosp, Yangjiang, Peoples R China; [Morgan, Ian G.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [He, Mingguang] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Congdon, Nathan] ORBIS Int, New York, NY 10018 USA; [Congdon, Nathan] Queens Univ Belfast, Royal Victoria Hosp, Ctr Publ Hlth, Translat Res Equitable Eye Care, Belfast, Antrim, North Ireland	Zhengzhou University; Sun Yat Sen University; Sun Yat Sen University; South China University of Technology; Australian National University; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; Queens University Belfast	Congdon, N (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China.; Congdon, N (corresponding author), ORBIS Int, New York, NY 10018 USA.; Congdon, N (corresponding author), Queens Univ Belfast, Royal Victoria Hosp, Ctr Publ Hlth, Translat Res Equitable Eye Care, Belfast, Antrim, North Ireland.	ncongdon1@gmail.com	liu, yi/GXE-9662-2022; Morgan, Ian G/D-1190-2009; He, Mingguang/AAY-5239-2020	Morgan, Ian G/0000-0002-4548-3574; He, Mingguang/0000-0002-6912-2810	Chinese government; Ulverscroft Foundation	Chinese government; Ulverscroft Foundation	Dr Congdon is supported by a Thousand Man Plan grant from the Chinese government, and by the Ulverscroft Foundation. The funding organizations had no role in the design or conduct of this research.; Dr Congdon is supported by a Thousand Man Plan grant from the Chinese government, and by the Ulverscroft Foundation. The funding organizations had no role in the design or conduct of this research.	Adhami VM, 2008, PHOTOCHEM PHOTOBIOL, V84, P489, DOI 10.1111/j.1751-1097.2007.00293.x; [Anonymous], 2016, DAIL OUTD ACT OP NEW; [Anonymous], 2016, STUD SER SOUNDR INT; [Anonymous], 2016, INFR TRANSM HEAT ABS; Ashby R, 2009, INVEST OPHTH VIS SCI, V50, P5348, DOI 10.1167/iovs.09-3419; Ashby RS, 2010, INVEST OPHTH VIS SCI, V51, P5247, DOI 10.1167/iovs.09-4689; Backhouse S, 2013, OPHTHAL PHYSL OPT, V33, P563, DOI 10.1111/opo.12069; Chan TCY, 2014, AM J OPHTHALMOL, V158, P1130, DOI 10.1016/j.ajo.2014.08.026; Chia A, 2012, OPHTHALMOLOGY, V119, P347, DOI 10.1016/j.ophtha.2011.07.031; Congdon N, 2008, INVEST OPHTH VIS SCI, V49, P2888, DOI 10.1167/iovs.07-1160; Dharani R, 2012, EYE, V26, P911, DOI 10.1038/eye.2012.49; Esteso P, 2007, INVEST OPHTH VIS SCI, V48, P4949, DOI 10.1167/iovs.07-0052; Flitcroft DI, 2012, PROG RETIN EYE RES, V31, P622, DOI 10.1016/j.preteyeres.2012.06.004; French AN, 2013, OPHTHALMOLOGY, V120, P2100, DOI 10.1016/j.ophtha.2013.02.035; French AN, 2013, EXP EYE RES, V114, P58, DOI 10.1016/j.exer.2013.04.018; Gallagher RP, 2006, PROG BIOPHYS MOL BIO, V92, P119, DOI 10.1016/j.pbiomolbio.2006.02.011; He Ming-guang, 2008, Zhonghua Yan Ke Za Zhi, V44, P491; He MG, 2007, OPHTHALMOLOGY, V114, P374, DOI 10.1016/j.ophtha.2006.08.020; He MG, 2015, JAMA-J AM MED ASSOC, V314, P1142, DOI 10.1001/jama.2015.10803; Hua WJ, 2015, OPHTHAL PHYSL OPT, V35, P252, DOI 10.1111/opo.12207; Ji CY, 2008, OBES REV, V9, P78, DOI 10.1111/j.1467-789X.2007.00443.x; Jones LA, 2007, INVEST OPHTH VIS SCI, V48, P3524, DOI 10.1167/iovs.06-1118; Karouta C, 2015, INVEST OPHTH VIS SCI, V56, P299, DOI 10.1167/iovs.14-15499; Lam CSY, 2014, BRIT J OPHTHALMOL, V98, P40, DOI 10.1136/bjophthalmol-2013-303914; Li SM, 2016, CURR EYE RES, V41, P600, DOI 10.3109/02713683.2015.1050743; Li SM, 2015, INVEST OPHTH VIS SCI, V56, P4734, DOI 10.1167/iovs.14-15474; Li SM, 2013, OPHTHAL EPIDEMIOL, V20, P348, DOI 10.3109/09286586.2013.842596; Liu R, 2014, INVEST OPHTH VIS SCI, V55, P1901, DOI 10.1167/iovs.13-12276; Liu R, 2011, EXP EYE RES, V92, P447, DOI 10.1016/j.exer.2011.03.003; Lo J, 2016, EYE CONTACT LENS, V42, P61, DOI 10.1097/ICL.0000000000000130; Ma XC, 2015, AM J OPHTHALMOL, V160, P897, DOI 10.1016/j.ajo.2015.08.013; Ma XC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5740; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Morgan IG, 2010, ACTA OPHTHALMOL, V88, P877, DOI 10.1111/j.1755-3768.2009.01800.x; Mott MS, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-53; Pascolini D, 2010, BR J OPHTHALMOL, V96, P614, DOI DOI 10.1136/BJ0PHTHALM0L-2011-300539; Read SA, 2015, INVEST OPHTH VIS SCI, V56, P6779, DOI 10.1167/iovs.14-15978; Resnikoff S, 2008, B WORLD HEALTH ORGAN, V86, P63, DOI 10.2471/BLT.07.041210; Rose KA, 2008, ARCH OPHTHALMOL-CHIC, V126, P527, DOI 10.1001/archopht.126.4.527; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; Sankaridurg P, 2011, INVEST OPHTH VIS SCI, V52, P9362, DOI 10.1167/iovs.11-7260; Sankaridurg P, 2010, OPTOMETRY VISION SCI, V87, P631, DOI 10.1097/OPX.0b013e3181ea19c7; Saw SM, 2005, OPHTHAL PHYSL OPT, V25, P381, DOI 10.1111/j.1475-1313.2005.00298.x; Smith EL, 2014, EYE, V28, P180, DOI 10.1038/eye.2013.277; Smith EL, 2012, INVEST OPHTH VIS SCI, V53, P421, DOI 10.1167/iovs.11-8652; Wang XQ, 2015, JAMA OPHTHALMOL, V133, P1399, DOI 10.1001/jamaophthalmol.2015.3513; Wu JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082763, 10.1371/journal.pone.0081986, 10.1371/journal.pone.0081982]; Wu PC, 2013, OPHTHALMOLOGY, V120, P1080, DOI 10.1016/j.ophtha.2012.11.009; Yamaguchi N, 1999, J Epidemiol, V9, pS1; Yi Jun-Hui, 2011, Zhongguo Dang Dai Er Ke Za Zhi, V13, P32; You QS, 2014, ACTA OPHTHALMOL, V92, pE398, DOI 10.1111/aos.12299	51	25	25	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0181772	10.1371/journal.pone.0181772	http://dx.doi.org/10.1371/journal.pone.0181772			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759614	Green Published, Green Submitted, gold			2022-12-26	WOS:000406761600027
J	Neukam, K; Martinez, AP; Culasso, ACA; Ridruejo, E; Garcia, G; Di Lello, FA				Neukam, Karin; Martinez, Alfredo P.; Culasso, Andres C. A.; Ridruejo, Ezequiel; Garcia, Gabriel; Di Lello, Federico A.			NS3 genomic sequencing and phylogenetic analysis as alternative to a commercially available assay to reliably determine hepatitis C virus subtypes 1a and 1b	PLOS ONE			English	Article							LINE PROBE ASSAY; NS5B	Objective To evaluate the use of hepatitis C virus (HCV) NS3 sequencing as alternative to the comercially available Versant HCV 2.0 reverse hybridization line-probe assay (LiPA 2.0) to determine HCV genotype 1 (HCV-1) subtypes. Patients and methods A cohort of 104 patients infected by HCV-1 according to LiPA 2.0 was analyzed in a crosssectional study conducted in patients seen from January 2012 to June 2016 at an outpatient clinic in Buenos Aires, Argentina. Results The samples were included within well supported subtype clades: 64 with HCV-1b and 39 with HCV-1a infection. Twenty of the HCV-1a infected patientes were included in a supported sub-clade "1" and 19 individuals were among the basal sub-clade "2". LiPA 2.0 failed to subtype HCV-1 in 20 (19.2%) individuals. Subtype classification determined by NS3 direct sequencing showed that 2/18 (11.1%) of the HCV-1a-infected patients as determined by LiPA 2.0 were in fact infected by HCV-1b. Of the HCV-1b-infected according to LiPA 2.0, 10/66 (15.2%) patients showed HCV-1a infection according to NS3 sequencing. Overall misclassification was 14.3% (kappa-index for the concordance with NS3 sequencing = 0.635). One (1%) patient was erroneously genotyped as HCV-1 and was revealed as HCV genotype 4 infection. Conclusions Genomic sequencing of the HCV NS3 region represents an adequate alternative since it provides reliable genetic information. It even distinguishes between HCV-1a clades related to resistance-associated substitutions to HCV protease inhibitors, it provides reliable genetic information for genotyping/subgenotyping and simultaneously allows to determine the presence of resistance-associated substitutions to currently recommended DAAs.	[Neukam, Karin; Culasso, Andres C. A.; Garcia, Gabriel; Di Lello, Federico A.] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Virol, Buenos Aires, DF, Argentina; [Neukam, Karin] Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla,Unit Infect Dis Microbiol & P, Seville, Spain; [Neukam, Karin] Hosp Univ Valme, Unit Infect Dis & Mirobiol, Seville, Spain; [Martinez, Alfredo P.] Ctr Educ Med & Invest Clin Norberto Quirno CEMIC, Virol Sect, Buenos Aires, DF, Argentina; [Culasso, Andres C. A.; Ridruejo, Ezequiel; Di Lello, Federico A.] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Ridruejo, Ezequiel] Ctr Educ Med & Invest Clin Norbert Quirno CEMIC, Hepatol Sect, Dept Med, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Hospital Valme; Centro de Educacion Medica e Investigaciones Clinicas (CEMIC); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Centro de Educacion Medica e Investigaciones Clinicas (CEMIC)	Neukam, K; Di Lello, FA (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Catedra Virol, Buenos Aires, DF, Argentina.; Neukam, K (corresponding author), Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla,Unit Infect Dis Microbiol & P, Seville, Spain.; Neukam, K (corresponding author), Hosp Univ Valme, Unit Infect Dis & Mirobiol, Seville, Spain.; Di Lello, FA (corresponding author), Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.	karin.neukam@gmail.com; fadilello@ffyb.uba.ar	Neukam, Karin/D-9415-2018; Garcia, Gabriel/GWZ-5540-2022; Ridruejo, Ezequiel/H-7965-2019	Neukam, Karin/0000-0003-3875-1013; Ridruejo, Ezequiel/0000-0002-3321-0683; Di Lello, Federico Alejandro/0000-0001-9771-9705	Miguel Servet research grant from the Institute de Salud Carlos III [CP13/00187]; Agenda Nacional de Investigaciones Cientifica y Tecnicas [PICT 2013-1268]; Plan Nacional R+D+I [RD12/0017/0012]; ISCIII-Subdireccion General de Evaluacion; Fondo Europeo de Desarrollo Regional (FEDER)	Miguel Servet research grant from the Institute de Salud Carlos III; Agenda Nacional de Investigaciones Cientifica y Tecnicas; Plan Nacional R+D+I; ISCIII-Subdireccion General de Evaluacion; Fondo Europeo de Desarrollo Regional (FEDER)(European Commission)	ACAC, and FAD are members of the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) Research Career Program. KN is the recipient of a Miguel Servet research grant from the Institute de Salud Carlos III (grant number CP13/00187). This work was supported by the Agenda Nacional de Investigaciones Cientifica y Tecnicas (grant number PICT 2013-1268) and partially funded by the RD12/0017/0012 project as part of the Plan Nacional R+D+I and cofinanced by ISCIII-Subdireccion General de Evaluacion, the Fondo Europeo de Desarrollo Regional (FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Association for the Study of Liver Diseases-Infectious Diseases Society of American, 2016, REC TEST MAN TREAT H; Avo AP, 2013, J MED VIROL, V85, P815, DOI 10.1002/jmv.23545; Cantaloube JF, 2006, J CLIN MICROBIOL, V44, P2051, DOI 10.1128/JCM.02463-05; Chantratita W, 2017, J VIROL METHODS, V239, P1, DOI 10.1016/j.jviromet.2016.10.009; Chueca N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153754; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Di Maio V.C., 2017, LIVER INT; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; European Association for the Study of the Liver (EASL), 2015, EASL REC TREATM HEP; Falade-Nwulia O, 2017, ANN INTERN MED, V166, P637, DOI [10.7326/m16-2575, 10.7326/M16-2575]; Guelfo JR, 2014, J CLIN MICROBIOL, V52, P4027, DOI 10.1128/JCM.02209-14; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Larrat S, 2013, J CLIN MICROBIOL, V51, P2815, DOI 10.1128/JCM.00586-13; Liu CH, 2015, J CLIN MICROBIOL, V53, P1754, DOI 10.1128/JCM.03548-14; McCormick AL, 2015, J CLIN VIROL, V66, P56, DOI 10.1016/j.jcv.2015.03.006; Pickett BE, 2011, J VIRAL HEPATITIS, V18, P608, DOI 10.1111/j.1365-2893.2010.01342.x; Polilli E, 2016, CLINICOECONOMIC OUTC, V8, P467, DOI 10.2147/CEOR.S106238; Quer J, 2015, J CLIN MICROBIOL, V53, P219, DOI 10.1128/JCM.02093-14; sociacio A n Argentina para el Estudio de las Enfermedades del HAogado, ACT REC TRAT HEP CRO; Welzel T, 2017, J HEPATOL	20	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0182193	10.1371/journal.pone.0182193	http://dx.doi.org/10.1371/journal.pone.0182193			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753662	gold, Green Published, Green Submitted			2022-12-26	WOS:000406579300057
J	Niinimaki, M; Mentula, M; Jahangiri, R; Mannisto, J; Haverinen, A; Heikinheimo, O				Niinimaki, Maarit; Mentula, Maarit; Jahangiri, Reetta; Mannisto, Jaana; Haverinen, Annina; Heikinheimo, Oskari			Medical treatment of second-trimester fetal miscarriage; A retrospective analysis	PLOS ONE			English	Article							RANDOMIZED-CONTROLLED-TRIAL; PREGNANCY LOSS; MIFEPRISTONE; MISOPROSTOL; TERMINATION; ABORTION; INTERVALS	Objectives Research on the treatment of second-trimester miscarriages is scarce. We studied the outcomes, and the factors associated with adverse events and need for hospital resources in the medical treatment of second-trimester miscarriage. Materials and methods In these retrospective analyses we studied women treated for spontaneous fetal miscarriage with misoprostol-only (n = 24) or mifepristone and misoprostol (n = 177) in duration of gestation 12+ 1-21+ 6. Primary outcomes were the risk factors for surgical evacuation and excessive bleeding. Secondary outcomes were total misoprostol dose, time to expulsion and the length of hospital stay. Results History of surgical evacuation of the uterus increased the risk of surgical evacuation (p = 0.027). Excessive bleeding was not associated with any of the studied variables. More misoprostol was needed when the duration of gestation exceeded 17+0 weeks (p = 0.036). In multivariate analysis the time to fetal expulsion was shorter in women with history of 1-2 deliveries (hazard ratio [HR] 1.49, 95% confidence interval [CI]; 1.07-2.07), >= 3 deliveries (HR 1.63, 95% CI; 1.11-2.38) and with a two-day interval between mifepristone-misoprostol administration (HR 1.71, 95% CI; 1.05-2.81). Patients with symptoms (i.e. uterine bleeding or pain) at baseline had longer hospital stay (HR 0.66, 95% CI; 0.47-0.92). Conclusions The factors affecting the outcomes of medical treatment of second-trimester fetal miscarriage are similar to those of second-trimester induced abortion. Two-day interval between mifepristone-misoprostol administration might decrease the time to fetal expulsion and the need of hospital resources.	[Niinimaki, Maarit; Jahangiri, Reetta; Mannisto, Jaana] Univ Hosp Oulu, Dept Obstet & Gynecol, PEDEGO Res Unit, Med Res Ctr Oulu, Oulu, Finland; [Niinimaki, Maarit; Jahangiri, Reetta; Mannisto, Jaana] Univ Oulu, Oulu, Finland; [Mentula, Maarit; Haverinen, Annina; Heikinheimo, Oskari] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; [Mentula, Maarit; Haverinen, Annina; Heikinheimo, Oskari] Helsinki Univ Hosp, Katiloopisto Hosp, Helsinki, Finland	University of Oulu; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Niinimaki, M (corresponding author), Univ Hosp Oulu, Dept Obstet & Gynecol, PEDEGO Res Unit, Med Res Ctr Oulu, Oulu, Finland.; Niinimaki, M (corresponding author), Univ Oulu, Oulu, Finland.	maarit.niinimaki@oulu.fi	Heikinheimo, Oskari/ABC-7792-2020; Niinimäki, Maarit/DIZ-1888-2022; Dangal, Ganesh/O-1989-2017	Niinimäki, Maarit/0000-0003-0927-0472; Dangal, Ganesh/0000-0002-5834-5525				Abbas DF, 2016, OBSTET GYNECOL, V128, P1077, DOI 10.1097/AOG.0000000000001688; [Anonymous], 2012, NICE CLIN GUIDELINE; Dabash R, 2015, INT J GYNECOL OBSTET, V130, P40, DOI 10.1016/j.ijgo.2015.02.023; Elami-Suzin M, 2013, OBSTET GYNECOL, V122, P815, DOI 10.1097/AOG.0b013e3182a2dcb7; Gewell-Danielsson K, 2008, REPROD HEALTH MATTER, V16, P162, DOI 10.1016/S0968-8080(08)31371-8; Heikinheimo O, 2004, REPROD BIOMED ONLINE, V8, P236, DOI 10.1016/S1472-6483(10)60522-6; Joensuu-Manninen H, 2010, ACTA OBSTET GYN SCAN, V89, P1552, DOI 10.3109/00016349.2010.513427; Kapp N, 2007, OBSTET GYNECOL, V110, P1304, DOI 10.1097/01.AOG.0000289577.32274.a5; Kim C, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007223.pub4; Kolte AM, 2015, HUM REPROD, V30, P495, DOI 10.1093/humrep/deu299; Mark AG, 2015, INT J GYNECOL OBSTET, V129, P98, DOI 10.1016/j.ijgo.2014.11.011; McNamee KM, 2014, OBSTET GYN CLIN N AM, V41, P87, DOI 10.1016/j.ogc.2013.10.007; Mentula M, 2012, CONTRACEPTION, V86, P141, DOI 10.1016/j.contraception.2011.11.070; Mentula M, 2011, HUM REPROD, V26, P2690, DOI 10.1093/humrep/der218; Ngoc Nguyen Thi Nhu, 2011, Obstet Gynecol, V118, P601, DOI 10.1097/AOG.0b013e318227214e; Tang J, 2013, INT J GYNECOL OBSTET, V121, P186, DOI 10.1016/j.ijgo.2012.12.009; WHO Regional Strategy on Sexual and Reproductive Health, 2001, DEF IND FAM PLAN MAT; Wildschut H, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005216.pub2	18	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0182198	10.1371/journal.pone.0182198	http://dx.doi.org/10.1371/journal.pone.0182198			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753654	Green Published, gold			2022-12-26	WOS:000406579300058
J	Tani, H; Takeshita, J; Aoki, H; Nakamura, K; Abe, R; Toyoda, A; Endo, Y; Miyamoto, S; Gamo, M; Sato, H; Torimura, M				Tani, Hidenori; Takeshita, Jun-ichi; Aoki, Hiroshi; Nakamura, Kaoru; Abe, Ryosuke; Toyoda, Akinobu; Endo, Yasunori; Miyamoto, Sadaaki; Gamo, Masashi; Sato, Hiroaki; Torimura, Masaki			Identification of RNA biomarkers for chemical safety screening in mouse embryonic stem cells using RNA deep sequencing analysis	PLOS ONE			English	Article							LONG NONCODING RNAS; GENE-EXPRESSION; MICROARRAY ANALYSIS	Although it is not yet possible to replace in vivo animal testing completely, the need for a more efficient method for toxicity testing, such as an in vitro cell-based assay, has been widely acknowledged. Previous studies have focused on mRNAs as biomarkers; however, recent studies have revealed that non-coding RNAs (ncRNAs) are also efficient novel biomarkers for toxicity testing. Here, we used deep sequencing analysis (RNA-seq) to identify novel RNA biomarkers, including ncRNAs, that exhibited a substantial response to general chemical toxicity from nine chemicals, and to benzene toxicity specifically. The nine chemicals are listed in the Japan Pollutant Release and Transfer Register as class I designated chemical substances. We used undifferentiated mouse embryonic stem cells (mESCs) as a simplified cell-based toxicity assay. RNA-seq revealed that many mRNAs and ncRNAs responded substantially to the chemical compounds in mESCs. This finding indicates that ncRNAs can be used as novel RNA biomarkers for chemical safety screening.	[Tani, Hidenori; Aoki, Hiroshi; Nakamura, Kaoru; Torimura, Masaki] Natl Inst Adv Ind Sci & Technol, Environm Management Res Inst, Tsukuba, Ibaraki, Japan; [Takeshita, Jun-ichi; Gamo, Masashi] Natl Inst Adv Ind Sci & Technol, Res Inst Sci Safety & Sustainabil, Tsukuba, Ibaraki, Japan; [Abe, Ryosuke; Toyoda, Akinobu] Univ Tsukuba, Sch Sci & Engn, Coll Engn Syst, Tsukuba, Ibaraki, Japan; [Endo, Yasunori; Miyamoto, Sadaaki] Univ Tsukuba, Fac Syst & Informat Engn, Dept Risk Engn, Tsukuba, Ibaraki, Japan; [Sato, Hiroaki] Natl Inst Adv Ind Sci & Technol, Res Inst Sustainable Chem, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; University of Tsukuba; National Institute of Advanced Industrial Science & Technology (AIST)	Tani, H (corresponding author), Natl Inst Adv Ind Sci & Technol, Environm Management Res Inst, Tsukuba, Ibaraki, Japan.	h.tani@aist.go.jp	Tani, Hidenori/F-2042-2010; Gamo, Masashi/M-2883-2018; Takeshita, Jun-ichi/L-7806-2016; Aoki, Hiroshi/M-3255-2018; Sato, Hiroaki/AAC-3683-2019; Sato, Hiroaki/N-4160-2013; Torimura, Masaki/M-8401-2018	Tani, Hidenori/0000-0001-6390-4136; Gamo, Masashi/0000-0002-0515-6616; Takeshita, Jun-ichi/0000-0002-3471-1594; Aoki, Hiroshi/0000-0002-0975-2116; Sato, Hiroaki/0000-0003-2558-9248; Sato, Hiroaki/0000-0003-2558-9248; 				[Anonymous], 2015, INTERFACE REACH COSM; Anson BD, 2011, CLIN PHARMACOL THER, V89, P754, DOI 10.1038/clpt.2011.9; Aoki H, 2015, CHEM-ASIAN J, V10, P2560, DOI 10.1002/asia.201500449; Aung HH, 2011, PHYSIOL GENOMICS, V43, P917, DOI 10.1152/physiolgenomics.00051.2011; Bergmann JH, 2014, CURR OPIN CELL BIOL, V26, P10, DOI 10.1016/j.ceb.2013.08.005; Fukushima T, 2014, WATER RES, V52, P73, DOI 10.1016/j.watres.2014.01.006; Hara-Yamamura H, 2013, ENVIRON SCI TECHNOL, V47, P5425, DOI 10.1021/es4002955; Hirose T, 2014, EMBO REP, V15, P489, DOI 10.1002/embr.201338390; Hua YJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-214; Huang YCT, 2013, J TOXICOL ENV HEAL B, V16, P381, DOI 10.1080/10937404.2013.832649; Huang YCT, 2011, J TOXICOL ENV HEAL A, V74, P296, DOI 10.1080/15287394.2010.516238; Karoly ED, 2007, ENVIRON HEALTH PERSP, V115, P535, DOI 10.1289/ehp.9556; Kitani H, 1996, ZOOL SCI, V13, P865, DOI 10.2108/zsj.13.865; Koike E, 2004, TOXICOL APPL PHARM, V201, P178, DOI 10.1016/j.taap.2004.05.006; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Liebermann DA, 2002, LEUKEMIA, V16, P527, DOI 10.1038/sj.leu.2402477; Minami K, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.5; Omura S, 2009, TOXICOLOGY, V262, P65, DOI 10.1016/j.tox.2009.05.012; Poblete-Naredo I, 2016, BIOMEDICA, V36, P309, DOI 10.7705/biomedica.v36i3.2998; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Riechelmann H, 2007, ENVIRON HEALTH PERSP, V115, P1325, DOI 10.1289/ehp.9874; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Shinde V, 2015, JOVE-J VIS EXP, DOI 10.3791/52333; Suzuki N, 2012, J TOXICOL SCI, V37, P845, DOI 10.2131/jts.37.845; Tani H, 2016, J BIOSCI BIOENG, V122, P329, DOI 10.1016/j.jbiosc.2016.02.007; Tani H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106282; Tani H, 2013, BIOCHEM BIOPH RES CO, V439, P547, DOI 10.1016/j.bbrc.2013.09.006; Tsukue N, 2010, TOXICOL IN VITRO, V24, P363, DOI 10.1016/j.tiv.2009.11.004; Vijayan M, 2016, BBA-MOL BASIS DIS, V1862, P1984, DOI 10.1016/j.bbadis.2016.08.003; Wang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-29; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780	32	4	5	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0182032	10.1371/journal.pone.0182032	http://dx.doi.org/10.1371/journal.pone.0182032			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750099	Green Submitted, Green Published, gold			2022-12-26	WOS:000406575700116
J	Schenk, LK; Moller-Kerutt, A; Klosowski, R; Wolters, D; Schaffner-Reckinger, E; Weide, T; Pavenstadt, H; Vollenbroker, B				Schenk, Laura K.; Moeller-Kerutt, Annika; Klosowski, Rafael; Wolters, Dirk; Schaffner-Reckinger, Elisabeth; Weide, Thomas; Pavenstaedt, Hermann; Vollenbroeker, Beate			Angiotensin II regulates phosphorylation of actin-associated proteins in human podocytes	FASEB JOURNAL			English	Article						kidney; L-plastin; actin turnover; calcium	COLLECTING DUCT CELLS; L-PLASTIN; SIGNALING PATHWAYS; ALDOSTERONE SYSTEM; EPITHELIAL-CELLS; KIDNEY-DISEASE; KINASE-C; IN-VIVO; PROTEOME; DYNAMICS	Within the kidney, angiotensin II (AngII) targets different cell types in the vasculature, tubuli, and glomeruli. An important part of the renal filtration barrier is composed of podocytes with their actin-rich foot processes. In this study, we used stable isotope labeling with amino acids in cell culture coupled to mass spectrometry to characterize relative changes in the phosphoproteome of human podocytes in response to short-term treatment with AngII. In 4 replicates, we identified a total of 17,956 peptides that were traceable to 2081 distinct proteins. Bioinformatic analyses revealed that among the increasingly phosphorylated peptides are predominantly peptides that are related to actin filaments, cytoskeleton, lamellipodia, mammalian target of rapamycin, andMAPK signaling. Among others, this screening approach highlighted the increased phosphorylation of actin-bundling protein, L-plastin (LCP1). AngII-dependent phosphorylation of LCP1 in cultured podocytes was mediated by the kinases ERK, p90 ribosomal S6 kinase, PKA, or PKC. LCP1 phosphorylation increased filopodia formation. In addition, treatmentwith AngII led to LCP1 redistribution to the cell margins, membrane ruffling, and formation of lamellipodia. Our data highlight the importance of AngII-triggered actin cytoskeleton-associated signal transduction inpodocytes.-Schenk, L.K.,Moller-Kerutt, A., Klosowski, R.,Wolters, D.,Schaffner-Reckinger, E.,Weide, T.,Pavenstadt, H., Vollenbroker, B.Angiotensin II regulatesphosphorylation of actin-associatedproteins in human podocytes.	[Schenk, Laura K.; Moeller-Kerutt, Annika; Weide, Thomas; Pavenstaedt, Hermann; Vollenbroeker, Beate] Univ Klinikum Munster, Med Klin & Poliklin D, Munster, Germany; [Klosowski, Rafael; Wolters, Dirk] Ruhr Univ Bochum, Analyt Chem, Biomol Massenspektrometrie, Bochum, Germany; [Schaffner-Reckinger, Elisabeth] Univ Luxembourg, Life Sci Res Unit, Lab Cytoskeleton & Cell Plast, Esch Sur Alzette, Luxembourg	University of Munster; Ruhr University Bochum; University of Luxembourg	Vollenbroker, B (corresponding author), Med Klin & Poliklin D, Albert Schweitzer Campus 1,A14, D-48149 Munster, Germany.	beate.vollenbroeker@ukmuenster.de		Sievers, Laura Katharina/0000-0002-4677-5181	German Research Foundation (DFG) [PA 483/16-1, BU 1214/4-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by grants from the German Research Foundation (DFG; Grants PA 483/16-1 and BU 1214/4-1). The authors declare no conflicts of interest.	Al Tanoury Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009210; Ayoub MA, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00094; Azatov M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28805; Brahler S, 2016, J AM SOC NEPHROL, V27, P3285, DOI 10.1681/ASN.2015121303; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Christensen GL, 2010, MOL CELL PROTEOMICS, V9, P1540, DOI 10.1074/mcp.M900550-MCP200; Courcelles M, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.25; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Delanote V, 2010, FASEB J, V24, P105, DOI 10.1096/fj.09-134304; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Douglass J, 2012, AM J PHYSIOL-CELL PH, V303, pC715, DOI 10.1152/ajpcell.00166.2012; DWORKIN LD, 1983, AM J PHYSIOL, V244, pF95, DOI 10.1152/ajprenal.1983.244.2.F95; Eguchi S, 2003, BIOCHEM SOC T, V31, P1198; Famulski KS, 2013, AM J TRANSPLANT, V13, P634, DOI 10.1111/ajt.12080; Fukuda A, 2012, KIDNEY INT, V81, P40, DOI 10.1038/ki.2011.306; Gloy J, 1997, J CLIN INVEST, V99, P2772, DOI 10.1172/JCI119467; Greka A, 2012, SEMIN NEPHROL, V32, P319, DOI 10.1016/j.semnephrol.2012.06.003; Harding SD, 2011, DEVELOPMENT, V138, P2845, DOI 10.1242/dev.063594; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hsu HH, 2008, J MOL MED, V86, P1379, DOI 10.1007/s00109-008-0399-y; Huling JC, 2012, AM J PHYSIOL-RENAL, V302, pF401, DOI 10.1152/ajprenal.00457.2011; Humphrey SJ, 2015, NAT BIOTECHNOL, V33, P990, DOI 10.1038/nbt.3327; Ishida H, 2017, SCI REP-UK, V7, DOI 10.1038/srep40662; Janji B, 2006, J CELL SCI, V119, P1947, DOI 10.1242/jcs.02874; Khurana S, 2011, CELL ADHES MIGR, V5, P409, DOI 10.4161/cam.5.5.17644; Kobori H, 2013, CURR PHARM DESIGN, V19, P3033; Lommel MJ, 2016, FASEB J, V30, P1218, DOI 10.1096/fj.15-276311; McMahon AP, 2008, J AM SOC NEPHROL, V19, P667, DOI 10.1681/ASN.2007101078; MORGAN AJ, 1994, BIOCHEM J, V300, P665, DOI 10.1042/bj3000665; Morley SC, 2013, IMMUNOL REV, V256, P48, DOI 10.1111/imr.12102; NAMBA Y, 1992, J BIOCHEM-TOKYO, V112, P503, DOI 10.1093/oxfordjournals.jbchem.a123929; Nilufar S, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-66; Poppe H, 2008, NAT METHODS, V5, P277, DOI 10.1038/nmeth0408-277; Reiser J, 2004, J CLIN INVEST, V113, P1390, DOI 10.1172/JCI200420402; Remuzzi Giuseppe, 2005, Kidney Int Suppl, pS57; Rinschen MM, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aaf8165; Rinschen MM, 2016, AM J PHYSIOL-CELL PH, V311, pC404, DOI 10.1152/ajpcell.00121.2016; Rinschen MM, 2010, P NATL ACAD SCI USA, V107, P3882, DOI 10.1073/pnas.0910646107; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Ruster C, 2011, J AM SOC NEPHROL, V22, P1189, DOI 10.1681/ASN.2010040384; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Schenk LK, 2016, CELL PHYSIOL BIOCHEM, V38, P2452, DOI 10.1159/000445596; Schulze U, 2014, MOL CELL PROTEOMICS, V13, P1397, DOI 10.1074/mcp.M113.034108; Schweda F, 2015, PFLUG ARCH EUR J PHY, V467, P565, DOI 10.1007/s00424-014-1668-y; Scott RP, 2015, J CELL BIOL, V209, P199, DOI 10.1083/jcb.201410017; Shin SY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6777; Suzuki Hiroyuki, 2005, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V3, P305, DOI 10.2174/156801605774322355; Tchapyjnikov D, 2010, PHYSIOL GENOMICS, V40, P167, DOI 10.1152/physiolgenomics.00148.2009; Thingholm Tine E., 2009, V527, P57, DOI 10.1007/978-1-60327-834-8_5; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wennmann DO, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.476; Wennmann DO, 2012, SEMIN NEPHROL, V32, P377, DOI 10.1016/j.semnephrol.2012.06.009; Wisniewski JR, 2012, ANAL CHEM, V84, P2631, DOI 10.1021/ac300006b; Xiao KH, 2010, P NATL ACAD SCI USA, V107, P15299, DOI 10.1073/pnas.1008461107; Xie XF, 2016, AM J KIDNEY DIS, V67, P728, DOI 10.1053/j.ajkd.2015.10.011; Yao J, 2004, PLOS BIOL, V2, P787, DOI 10.1371/journal.pbio.0020167	59	14	14	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					5019	5035		10.1096/fj.201700142R	http://dx.doi.org/10.1096/fj.201700142R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28768720	Green Submitted			2022-12-26	WOS:000413398500031
J	Kumar, H; Singh, J; Kumari, P; Udgaonkar, JB				Kumar, Harish; Singh, Jogender; Kumari, Pratibha; Udgaonkar, Jayant B.			Modulation of the extent of structural heterogeneity in -synuclein fibrils by the small molecule thioflavin T	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alpha-synuclein (-synuclein); atomic force microscopy (AFM); hydrogen exchange mass spectrometry; neurodegenerative disease; toxicity; fibril heterogeneity; thioflavin T	HUMAN ALPHA-SYNUCLEIN; BETA-AMYLOID FIBRILS; SOLID-STATE NMR; MOUSE PRION PROTEIN; C-TERMINAL REGION; MASS-SPECTROMETRY; PARKINSONS-DISEASE; BINDING MODES; CONFORMATIONAL HETEROGENEITY; SECONDARY STRUCTURE	The transition of intrinsically disordered, monomeric -synuclein into -sheet-rich oligomers and fibrils is associated with multiple neurodegenerative diseases. Fibrillar aggregates possessing distinct structures that differ in toxicity have been observed in different pathological phenotypes. Understanding the mechanism of the formation of various fibril polymorphs with differing cytotoxic effects is essential for determining how the aggregation reaction could be modulated to favor nontoxic fibrils over toxic fibrils. In this study, two morphologically different -synuclein fibrils, one helical and the other ribbon-like, are shown to form together. Surprisingly, a widely used small molecule for probing aggregation reactions, thioflavin T (ThT), was found to tune the structural heterogeneity found in the fibrils. The ribbon-like fibrils formed in the presence of ThT were found to have a longer structural core than the helical fibrils formed in the absence of ThT. The ribbon-like fibrils are also more toxic to cells. By facilitating the formation of ribbon-like fibrils over helical fibrils, ThT reduced the extent of fibril polymorphism. This study highlights the role of a small molecule such as ThT in selectively favoring the formation of a specific type of fibril by binding to aggregates formed early on one of multiple pathways, thereby altering the structural core and external morphology of the fibrils formed.	[Kumar, Harish; Singh, Jogender; Kumari, Pratibha; Udgaonkar, Jayant B.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bengaluru 560065, India; [Singh, Jogender] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Kumari, Pratibha] Swiss Fed Inst Technol, Phys Chem Lab, Honggerberg Campus, CH-8093 Zurich, Switzerland	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Duke University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Udgaonkar, JB (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bengaluru 560065, India.	jayant@ncbs.res.in		Kumari, Pratibha/0000-0002-6696-9514; Singh, Jogender/0000-0002-7947-0405	Tata Institute of Fundamental Research; Department of Biotechnology, Ministry of Science and Technology, Government of India	Tata Institute of Fundamental Research(Tata Institute of Fundamental Research (TIFR)); Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This work was funded by the Tata Institute of Fundamental Research and the Department of Biotechnology, Ministry of Science and Technology, Government of India. The authors declare that they have no conflicts of interest with the contents of this article.	Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; Biancalana M, 2009, J MOL BIOL, V385, P1052, DOI 10.1016/j.jmb.2008.11.006; Bieschke J, 2012, NAT CHEM BIOL, V8, P93, DOI 10.1038/nchembio.719; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Burre J, 2012, J NEUROSCI, V32, P15227, DOI 10.1523/JNEUROSCI.3545-12.2012; Butterfield SM, 2010, ANGEW CHEM INT EDIT, V49, P5628, DOI 10.1002/anie.200906670; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chen M, 2007, J BIOL CHEM, V282, P24970, DOI 10.1074/jbc.M700368200; CHIRGADZE YN, 1976, BIOPOLYMERS, V15, P607, DOI 10.1002/bip.1976.360150402; Cho MK, 2011, PROTEIN SCI, V20, P387, DOI 10.1002/pro.570; Coelho-Cerqueira E, 2014, BIOORG MED CHEM LETT, V24, P3194, DOI 10.1016/j.bmcl.2014.04.072; Cohen SIA, 2015, NAT STRUCT MOL BIOL, V22, P207, DOI 10.1038/nsmb.2971; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 2000, ANN NY ACAD SCI, V920, P42; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; D'Amico M, 2012, J PHYS CHEM LETT, V3, P1596, DOI 10.1021/jz300412v; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dearborn AD, 2016, J BIOL CHEM, V291, P2310, DOI 10.1074/jbc.M115.698787; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; Del Mar C, 2005, P NATL ACAD SCI USA, V102, P15477, DOI 10.1073/pnas.0507405102; Der-Sarkissian A, 2003, J BIOL CHEM, V278, P37530, DOI 10.1074/jbc.M305266200; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Fandrich M., 2013, AMYLOID FIBRILS PREF, P321; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Fernandez CO, 2004, EMBO J, V23, P2039, DOI 10.1038/sj.emboj.7600211; Fitzpatrick AWP, 2013, P NATL ACAD SCI USA, V110, P5468, DOI 10.1073/pnas.1219476110; Frimpong AK, 2010, PROTEINS, V78, P714, DOI 10.1002/prot.22604; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Gurry T, 2013, J AM CHEM SOC, V135, P3865, DOI 10.1021/ja310518p; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Heise H, 2008, J MOL BIOL, V380, P444, DOI 10.1016/j.jmb.2008.05.026; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; Huang CJ, 2005, PROTEIN EXPRES PURIF, V42, P173, DOI 10.1016/j.pep.2005.02.014; Ivancic VA, 2016, CHEMPHYSCHEM, V17, P2461, DOI 10.1002/cphc.201600246; Jain S, 2010, BIOCHEMISTRY-US, V49, P7615, DOI 10.1021/bi100745j; Jameson LP, 2012, ACS CHEM NEUROSCI, V3, P807, DOI 10.1021/cn300076x; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jiang L, 2013, ELIFE, V2, DOI 10.7554/eLife.00857; Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002; Kumar S, 2007, J MOL BIOL, V367, P1186, DOI 10.1016/j.jmb.2007.01.039; Kumar S, 2009, BIOCHEMISTRY-US, V48, P6441, DOI 10.1021/bi900682w; Lam HT, 2016, BIOCHEMISTRY-US, V55, P675, DOI 10.1021/acs.biochem.5b01168; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Li S, 2016, ACTA PHYS-CHIM SIN, V32, P1391, DOI 10.3866/PKU.WHXB201603221; Lorenzen N, 2014, J AM CHEM SOC, V136, P3859, DOI 10.1021/ja411577t; Losasso V, 2011, BIOCHEMISTRY-US, V50, P6994, DOI 10.1021/bi2007564; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Mao XB, 2011, ACS CHEM NEUROSCI, V2, P281, DOI 10.1021/cn200006h; Marshall KE, 2014, PRION, V8, P192, DOI 10.4161/pri.28860; Meuvis J, 2010, BIOCHEMISTRY-US, V49, P9345, DOI 10.1021/bi1010927; Miake H, 2002, J BIOL CHEM, V277, P19213, DOI 10.1074/jbc.M110551200; Mirecka EA, 2014, ANGEW CHEM INT EDIT, V53, P4227, DOI 10.1002/anie.201309001; Mysling S, 2013, BIOCHEMISTRY-US, V52, P9097, DOI 10.1021/bi4009193; Okazaki H, 2013, FEBS LETT, V587, P3709, DOI 10.1016/j.febslet.2013.09.039; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Paslawski W, 2014, ANGEW CHEM INT EDIT, V53, P7560, DOI 10.1002/anie.201400491; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Pieri L, 2012, BIOPHYS J, V102, P2894, DOI 10.1016/j.bpj.2012.04.050; Qiang W, 2017, NATURE, V541, P217, DOI 10.1038/nature20814; Qiang W, 2013, J AM CHEM SOC, V135, P6860, DOI 10.1021/ja311963f; Rodriguez JA, 2015, NATURE, V525, P486, DOI 10.1038/nature15368; Rodriguez-Rodriguez C, 2010, CHEM COMMUN, V46, P1156, DOI 10.1039/b912396b; Sabate R, 2008, J STRUCT BIOL, V162, P387, DOI 10.1016/j.jsb.2008.02.002; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Sandal M, 2008, PLOS BIOL, V6, P99, DOI 10.1371/journal.pbio.0060006; Sekhar A, 2011, BIOCHEMISTRY-US, V50, P805, DOI 10.1021/bi101312h; Singh J, 2015, BIOCHEMISTRY-US, V54, P4431, DOI 10.1021/acs.biochem.5b00605; Singh J, 2013, J MOL BIOL, V425, P3510, DOI 10.1016/j.jmb.2013.06.009; Singh J, 2012, J MOL BIOL, V423, P217, DOI 10.1016/j.jmb.2012.06.040; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Stohr J, 2012, P NATL ACAD SCI USA, V109, P11025, DOI 10.1073/pnas.1206555109; Tanaka M, 2015, NAT CHEM BIOL, V11, P373, DOI 10.1038/nchembio.1818; Tuttle MD, 2016, NAT STRUCT MOL BIOL, V23, P409, DOI 10.1038/nsmb.3194; Tycko R, 2014, PROTEIN SCI, V23, P1528, DOI 10.1002/pro.2544; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; van Rooijen BD, 2009, J MOL BIOL, V394, P826, DOI 10.1016/j.jmb.2009.10.021; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Wu C, 2009, J MOL BIOL, V394, P627, DOI 10.1016/j.jmb.2009.09.056; Wu KP, 2010, J AM CHEM SOC, V132, P5546, DOI 10.1021/ja9105495; Xue WF, 2010, PRION, V4, P20, DOI 10.4161/pri.4.1.11378; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	91	20	20	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					16891	16903		10.1074/jbc.M117.795617	http://dx.doi.org/10.1074/jbc.M117.795617			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28760825	Green Published, hybrid			2022-12-26	WOS:000413140600011
J	Hamadani, KM; Howe, J; Jensen, MK; Wu, P; Cate, JHD; Marqusee, S				Hamadani, Kambiz M.; Howe, Jesse; Jensen, Madeleine K.; Wu, Peng; Cate, Jamie H. D.; Marqusee, Susan			An in vitro tag-and-modify protein sample generation method for single-molecule fluorescence resonance energy transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AZIDE-ALKYNE CYCLOADDITION; NONCANONICAL AMINO-ACIDS; CLICK CHEMISTRY; GENETIC-CODE; PURIFIED COMPONENTS; POLYPEPTIDE-CHAIN; FRET MEASUREMENTS; ESCHERICHIA-COLI; T4 LYSOZYME; DE-NOVO	Biomolecular systems exhibit many dynamic and biologically relevant properties, such as conformational fluctuations, multistep catalysis, transient interactions, folding, and allosteric structural transitions. These properties are challenging to detect and engineer using standard ensemble-based techniques. To address this drawback, single-molecule methods offer a way to access conformational distributions, transient states, and asynchronous dynamics inaccessible to these standard techniques. Fluorescence-based single-molecule approaches are parallelizable and compatible with multiplexed detection; to date, however, they have remained limited to serial screens of small protein libraries. This stems from the current absence of methods for generating either individual dual-labeled protein samples at high throughputs or protein libraries compatible with multiplexed screening platforms. Here, we demonstrate that by combining purified and reconstituted in vitro translation, quantitative unnatural amino acid incorporation via AUG codon reassignment, and copper-catalyzed azidealkyne cycloaddition, we can overcome these challenges for target proteins that are, or can be, methionine-depleted. We present an in vitro parallelizable approach that does not require laborious target-specific purification to generate dual-labeled proteins and ribosome-nascent chain libraries suitable for single-molecule FRET-based conformational phenotyping. We demonstrate the power of this approach by tracking the effects of mutations, C-terminal extensions, and ribosomal tethering on the structure and stability of three protein model systems: barnase, spectrin, and T4 lysozyme. Importantly, dual-labeled ribosome-nascent chain libraries enable single-molecule co-localization of genotypes with phenotypes, are well suited for multiplexed single-molecule screening of protein libraries, and should enable the in vitro directed evolution of proteins with designer single-molecule conformational phenotypes of interest.	[Hamadani, Kambiz M.; Cate, Jamie H. D.; Marqusee, Susan] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Jensen, Madeleine K.; Cate, Jamie H. D.; Marqusee, Susan] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Cate, Jamie H. D.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Hamadani, Kambiz M.; Howe, Jesse] Calif State Univ, Dept Chem & Biochem, San Marcos, CA 92096 USA; [Wu, Peng] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; California State University System; California State University San Marcos; Scripps Research Institute	Hamadani, KM; Cate, JHD; Marqusee, S (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA.; Cate, JHD; Marqusee, S (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.; Cate, JHD (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Hamadani, KM (corresponding author), Calif State Univ, Dept Chem & Biochem, San Marcos, CA 92096 USA.	khamadani@csusm.edu; jcate@lbl.gov; marqusee@berkeley.edu	Hamadani, Kambiz/AAM-4138-2020	Hamadani, Kambiz/0000-0002-2768-3361	National Institutes of Health (NIH) [GM50945]; NIH [GM65050]; CSUPERB New Investigator [20132014_522]; CSUSM Summer Scholar's Program award; National Science Foundation Graduate Research Fellowship [DGE 1106400]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050945, R01GM065050, T32GM007232] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CSUPERB New Investigator; CSUSM Summer Scholar's Program award; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) Grant GM50945 (to S. M.), NIH Grant GM65050 (to J. H. D. C.), a CSUPERB New Investigator Grant 20132014_522 (to K. M. H.), the CSUSM Summer Scholar's Program award (to J. H.), and a National Science Foundation Graduate Research Fellowship Grant DGE 1106400 (to M. K. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Instit utes of Health.	Albayrak C, 2014, ACS SYNTH BIOL, V3, P353, DOI 10.1021/sb400116x; Antonik M, 2006, J PHYS CHEM B, V110, P6970, DOI 10.1021/jp057257+; Baase WA, 2010, PROTEIN SCI, V19, P631, DOI 10.1002/pro.344; Back JW, 2005, ANGEW CHEM INT EDIT, V44, P7946, DOI 10.1002/anie.200502431; Batey S, 2006, BIOPHYS J, V90, P2120, DOI 10.1529/biophysj.105.072710; Besanceney-Webler C, 2011, ANGEW CHEM INT EDIT, V50, P8051, DOI 10.1002/anie.201101817; Best RB, 2015, BIOPHYS J, V108, P2721, DOI 10.1016/j.bpj.2015.04.038; Bhushan S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000581; Borgia A, 2016, J AM CHEM SOC, V138, P11714, DOI 10.1021/jacs.6b05917; Brustad EM, 2008, J AM CHEM SOC, V130, P17664, DOI 10.1021/ja807430h; Bundy BC, 2010, BIOCONJUGATE CHEM, V21, P255, DOI 10.1021/bc9002844; del Amo DS, 2010, J AM CHEM SOC, V132, P16893, DOI 10.1021/ja106553e; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; EIGEN M, 1994, P NATL ACAD SCI USA, V91, P5740, DOI 10.1073/pnas.91.13.5740; Ellis JP, 2008, ACS CHEM BIOL, V3, P555, DOI 10.1021/cb800059u; Forster AC, 2003, P NATL ACAD SCI USA, V100, P6353, DOI 10.1073/pnas.1132122100; Gu LC, 2014, NATURE, V515, P554, DOI 10.1038/nature13761; Ha T, 2014, NAT METHODS, V11, P1015, DOI 10.1038/nmeth.3107; Hamadani KM, 2008, BIOPHYS J, V95, P352, DOI 10.1529/biophysj.107.127431; Hein JE, 2010, CHEM SOC REV, V39, P1302, DOI 10.1039/b904091a; Hoffmann A, 2012, MOL CELL, V48, P63, DOI 10.1016/j.molcel.2012.07.018; Hong SH, 2014, ACS SYNTH BIOL, V3, P398, DOI 10.1021/sb400140t; Hong V, 2009, ANGEW CHEM INT EDIT, V48, P9879, DOI 10.1002/anie.200905087; Horiya S, 2014, J AM CHEM SOC, V136, P5407, DOI 10.1021/ja500678v; Ingargiola A, 2013, PROC SPIE, V8590, DOI 10.1117/12.2003704; Iwane Y, 2016, NAT CHEM, V8, P317, DOI [10.1038/NCHEM.2446, 10.1038/nchem.2446]; Jain A, 2011, NATURE, V473, P484, DOI 10.1038/nature10016; Jiang H, 2014, BIOCONJUGATE CHEM, V25, P698, DOI 10.1021/bc400502d; Johansson M, 2012, P NATL ACAD SCI USA, V109, P131, DOI 10.1073/pnas.1116480109; Josephson K, 2005, J AM CHEM SOC, V127, P11727, DOI 10.1021/ja0515809; Kaiser CM, 2011, SCIENCE, V334, P1723, DOI 10.1126/science.1209740; Kalinin S, 2012, NAT METHODS, V9, P1218, DOI [10.1038/nmeth.2222, 10.1038/NMETH.2222]; Kapanidis AN, 2004, P NATL ACAD SCI USA, V101, P8936, DOI 10.1073/pnas.0401690101; Kempe D, 2015, J PHYS CHEM B, V119, P4668, DOI 10.1021/acs.jpcb.5b02170; Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299; Kim S, 2011, NAT METHODS, V8, P242, DOI 10.1038/NMETH.1569; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Lemke EA, 2011, METHODS MOL BIOL, V751, P3, DOI 10.1007/978-1-61779-151-2_1; Lerner E, 2013, ANAL BIOANAL CHEM, V405, P5983, DOI 10.1007/s00216-013-7002-2; Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700; Llinas M, 1999, NAT STRUCT BIOL, V6, P1072; Llinas M, 1998, PROTEIN SCI, V7, P96, DOI 10.1002/pro.5560070110; Lu JL, 2005, NAT STRUCT MOL BIOL, V12, P1123, DOI 10.1038/nsmb1021; MARQUSEE S, 1987, P NATL ACAD SCI USA, V84, P8898, DOI 10.1073/pnas.84.24.8898; McKay CS, 2014, CHEM BIOL, V21, P1075, DOI 10.1016/j.chembiol.2014.09.002; Murakami H, 2006, NAT METHODS, V3, P357, DOI 10.1038/NMETH877; Muto H, 2006, MOL CELL, V22, P545, DOI 10.1016/j.molcel.2006.03.033; Nakatogawa H, 2001, MOL CELL, V7, P185, DOI 10.1016/S1097-2765(01)00166-6; Neira JL, 1999, J MOL BIOL, V285, P1309, DOI 10.1006/jmbi.1998.2249; Nettels D., 2011, SINGLE MOL FRET PROT, V146, DOI [10.1002/9781118131374.ch2, DOI 10.1002/9781118131374.CH2]; Nir E, 2006, J PHYS CHEM B, V110, P22103, DOI 10.1021/jp063483n; O'Donoghue P, 2013, NAT CHEM BIOL, V9, P594, DOI 10.1038/nchembio.1339; Ohashi H, 2007, BIOCHEM BIOPH RES CO, V352, P270, DOI 10.1016/j.bbrc.2006.11.017; Paredes E, 2011, CHEMBIOCHEM, V12, P125, DOI 10.1002/cbic.201000466; Passioura T, 2014, ANNU REV BIOCHEM, V83, P727, DOI 10.1146/annurev-biochem-060713-035456; Presolski SI, 2010, J AM CHEM SOC, V132, P14570, DOI 10.1021/ja105743g; Ratner V, 2002, BIOCONJUGATE CHEM, V13, P1163, DOI 10.1021/bc025537b; Riedel C, 2015, NATURE, V517, P227, DOI 10.1038/nature14043; Ruan BF, 2008, P NATL ACAD SCI USA, V105, P16502, DOI 10.1073/pnas.0809179105; Samelson AJ, 2016, P NATL ACAD SCI USA, V113, P13402, DOI 10.1073/pnas.1610272113; Scott KA, 2004, J MOL BIOL, V344, P207, DOI 10.1016/j.jmb.2004.09.023; Shi XH, 2012, NAT METHODS, V9, P499, DOI [10.1038/NMETH.1954, 10.1038/nmeth.1954]; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Spicer CD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5740; Terasaka N, 2015, INT J MOL SCI, V16, P6513, DOI 10.3390/ijms16036513; Tyagi S, 2014, NAT METHODS, V11, P297, DOI 10.1038/nmeth.2809; Vilfan ID, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-8; Vogelsang J, 2008, ANGEW CHEM INT EDIT, V47, P5465, DOI 10.1002/anie.200801518; Wang A, 2008, CHEMBIOCHEM, V9, P324, DOI 10.1002/cbic.200700379; Wang KH, 2007, NAT BIOTECHNOL, V25, P770, DOI 10.1038/nbt1314; Wang KH, 2014, NAT CHEM, V6, P393, DOI [10.1038/nchem.1919, 10.1038/NCHEM.1919]; Wang W, 2011, CHEM-ASIAN J, V6, P2796, DOI 10.1002/asia.201100385; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Worrell BT, 2013, SCIENCE, V340, P457, DOI 10.1126/science.1229506; Wu B, 2012, CHEMBIOCHEM, V13, P1405, DOI 10.1002/cbic.201200281; Xiao H, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a023945; Yang MY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5981; Yoo TY, 2012, J MOL BIOL, V418, P226, DOI 10.1016/j.jmb.2012.01.016; Zhang JJ, 2015, P NATL ACAD SCI USA, V112, P9602, DOI 10.1073/pnas.1506823112	79	3	3	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15636	15648		10.1074/jbc.M117.791723	http://dx.doi.org/10.1074/jbc.M117.791723			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28754692	hybrid, Green Published			2022-12-26	WOS:000411512200005
J	Johnson, NB; Deck, KM; Nizzi, CP; Eisenstein, RS				Johnson, Nathan B.; Deck, Kathryn M.; Nizzi, Christopher P.; Eisenstein, Richard S.			A synergistic role of IRP1 and FBXL5 proteins in coordinating iron metabolism during cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FE-S CLUSTER; ELEMENT-BINDING-PROTEIN; REGULATORY PROTEIN-1; SULFUR CLUSTER; RNA-BINDING; DEPENDENT DEGRADATION; CYTOSOLIC ACONITASE; IN-VIVO; HOMEOSTASIS; BIOGENESIS	Iron-regulatory protein 1 (IRP1) belongs to a family of RNAbinding proteins that modulate metazoan iron metabolism. Multiple mechanisms are employed to control the action of IRP1 in dictating changes in the uptake and metabolic fate of iron. Inactivation of IRP1 RNA binding by iron primarily involves insertion of a [4Fe-4S] cluster by the cytosolic ironsulfur cluster assembly (CIA) system, converting it into cytosolic aconitase (c-acon), but can also involve iron-mediated degradation of IRP1 by the E3 ligase FBXL5 that also targets IRP2. How CIA and FBXL5 collaborate to maintain cellular iron homeostasis through IRP1 and other pathways is poorly understood. Because impaired Fe-S cluster biogenesis associates with human disease, we determined the importance of FBXL5 for regulating IRP1 when CIA is impaired. Suppression of FBXL5 expression coupled with induction of an IRP1 mutant (IRPI3C>3S) that cannot insert the Fe-S cluster, or along with knockdown of the CIA factors NUBP2 or FAM96A, reduced cell viability. Iron supplementation reversed this growth defect and was associated with FBXL5-dependent polyubiquitination of IRP1. Phosphorylation of IRP1 at Ser-138 increased when CIA was inhibited and was required for iron rescue. Impaired CIA activity, as noted by reduced c-acon activity, was associated with enhanced FBXL5 expression and a concomitant reduction in IRP1 and IRP2 protein level and RNA-binding activity. Conversely, expression of either IRP induced FBXL5 protein level, demonstrating a negative feedback loop limiting excessive accumulation of ironresponse element RNA-binding activity, whose disruption reduces cell growth. We conclude that a regulatory circuit involving FBXL5 and CIA acts through both IRPs to control iron metabolism and promote optimal cell growth.	[Johnson, Nathan B.; Deck, Kathryn M.; Nizzi, Christopher P.; Eisenstein, Richard S.] Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Eisenstein, RS (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.	eisenste@nutrisci.wisc.edu			National Institutes of Health [RO1 DK66600]; United States Department of Agriculture Hatch Project [WIS01667]; Iron Metabolism Research Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture Hatch Project; Iron Metabolism Research Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant RO1 DK66600, United States Department of Agriculture Hatch Project WIS01667, and the Iron Metabolism Research Fund. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson CP, 2012, BBA-MOL CELL RES, V1823, P1468, DOI 10.1016/j.bbamcr.2012.05.010; Biederbick A, 2006, MOL CELL BIOL, V26, P5675, DOI 10.1128/MCB.00112-06; Brown NM, 2002, J BIOL CHEM, V277, P7246, DOI 10.1074/jbc.M110282200; Brown NM, 1998, P NATL ACAD SCI USA, V95, P15235, DOI 10.1073/pnas.95.26.15235; Camaschella C, 2007, BLOOD, V110, P1353, DOI 10.1182/blood-2007-02-072520; Chen OS, 1997, J NUTR, V127, P238, DOI 10.1093/jn/127.2.238; Clarke SL, 2006, EMBO J, V25, P544, DOI 10.1038/sj.emboj.7600954; Deck KM, 2009, J BIOL CHEM, V284, P12701, DOI 10.1074/jbc.M807717200; Drapier JC, 1996, METHOD ENZYMOL, V269, P26; EISENSTEIN RS, 1993, J BIOL CHEM, V268, P27363; Fillebeen C, 2003, MOL CELL BIOL, V23, P6973, DOI 10.1128/MCB.23.19.6973-6981.2003; GOESSLING LS, 1992, SCIENCE, V256, P670, DOI 10.1126/science.1316633; Goforth JB, 2010, RNA, V16, P154, DOI 10.1261/rna.1857210; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P7536, DOI 10.1073/pnas.89.16.7536; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P11735, DOI 10.1073/pnas.89.24.11735; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Ma CL, 2004, J BIOL CHEM, V279, P1533, DOI 10.1074/jbc.M310866200; Mabb AM, 2006, NAT CELL BIOL, V8, P986, DOI 10.1038/ncb1458; Martelli A, 2015, CELL METAB, V21, P311, DOI 10.1016/j.cmet.2015.01.010; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012; Moroishi T, 2011, CELL METAB, V14, P339, DOI 10.1016/j.cmet.2011.07.011; Paul VD, 2015, BBA-MOL CELL RES, V1853, P1528, DOI 10.1016/j.bbamcr.2014.12.018; Pondarre C, 2006, HUM MOL GENET, V15, P953, DOI 10.1093/hmg/ddl012; Rouault TA, 2012, DIS MODEL MECH, V5, P155, DOI 10.1242/dmm.009019; Roy CN, 2002, J CELL PHYSIOL, V190, P218, DOI 10.1002/JCP.10056; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Schalinske KL, 1997, P NATL ACAD SCI USA, V94, P10681, DOI 10.1073/pnas.94.20.10681; Shan YX, 2012, HUM MOL GENET, V21, P1457, DOI 10.1093/hmg/ddr582; Sharma AK, 2010, J BIOL CHEM, V285, P26745, DOI 10.1074/jbc.R110.122218; Sheftel A, 2010, TRENDS ENDOCRIN MET, V21, P302, DOI 10.1016/j.tem.2009.12.006; Sheftel AD, 2010, P NATL ACAD SCI USA, V107, P11775, DOI 10.1073/pnas.1004250107; Shi YB, 2009, HUM MOL GENET, V18, P3014, DOI 10.1093/hmg/ddp239; Song DS, 2008, J BIOL CHEM, V283, P9231, DOI 10.1074/jbc.M708077200; Song DS, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201731; Song DS, 2009, J BIOL CHEM, V284, P35297, DOI 10.1074/jbc.M109.040014; Stehling O, 2008, MOL CELL BIOL, V28, P5517, DOI 10.1128/MCB.00545-08; Stehling O, 2013, CELL METAB, V18, P187, DOI 10.1016/j.cmet.2013.06.015; Thompson JW, 2012, J BIOL CHEM, V287, P7357, DOI 10.1074/jbc.M111.308684; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Unden G, 2013, DALTON T, V42, P3082, DOI 10.1039/c2dt32089d; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Vinas-Castells R, 2014, NUCLEIC ACIDS RES, V42, P1079, DOI 10.1093/nar/gkt935; Wang J, 2007, MOL CELL BIOL, V27, P2423, DOI 10.1128/MCB.01111-06; Wingert RA, 2005, NATURE, V436, P1035, DOI 10.1038/nature03887; Zumbrennen KB, 2009, MOL CELL BIOL, V29, P2219, DOI 10.1128/MCB.00004-09	47	24	25	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15976	15989		10.1074/jbc.M117.785741	http://dx.doi.org/10.1074/jbc.M117.785741			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28768766	hybrid, Green Published			2022-12-26	WOS:000411512200034
J	Luo, WJ; Tan, P; Rodriguez, M; He, L; Tan, KR; Zeng, L; Siwko, S; Liu, MY				Luo, Weijia; Tan, Peng; Rodriguez, Melissa; He, Lian; Tan, Kunrong; Zeng, Li; Siwko, Stefan; Liu, Mingyao			Leucine-rich repeat-containing G protein-coupled receptor 4 (Lgr4) is necessary for prostate cancer metastasis via epithelial-mesenchymal transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOWN-REGULATION; TUMOR-GROWTH; EXPRESSION; GPR48; CELLS; SNAIL; GENE; KNOCKOUT; ANDROGEN; MARKER	Prostate cancer is a highly penetrant disease among men in industrialized societies, but the factors regulating the transition from indolent to aggressive and metastatic cancer remain poorly understood. We found that men with prostate cancers expressing high levels of the G protein-coupled receptor LGR4 had a significantly shorter recurrence-free survival compared with patients with cancers having low LGR4 expression. LGR4 expression was elevated in human prostate cancer cell lines with metastatic potential. We therefore generated a novel transgenic adenocarcinoma of the mouse prostate (TRAMP) mouse model to investigate the role of Lgr4 in prostate cancer development and metastasis in vivo. TRAMP Lgr4(-/-) mice exhibited an initial delay in prostate intraepithelial neoplasia formation, but the frequency of tumor formation was equivalent between TRAMP and TRAMP Lgr4(-/-) mice by 12 weeks. The loss of Lgr4 significantly improved TRAMP mouse survival and dramatically reduced the occurrence of lung metastases. LGR4 knockdown impaired the migration, invasion, and colony formation of DU145 cells and reversed epithelial-mesenchymal transition (EMT), as demonstrated by up-regulation of E-cadherin and decreased expression of the EMT transcription factors ZEB, Twist, and Snail. Overexpression of LGR4 in LNCaP cells had the opposite effects. Orthotopic injection of DU145 cells stably expressing shRNA targeting LGR4 resulted in decreased xenograft tumor size, reduced tumor EMT marker expression, and impaired metastasis, in accord with our findings in TRAMP Lgr4(-/-) mice. In conclusion, we propose that Lgr4 is a key protein necessary for prostate cancer EMT and metastasis.	[Luo, Weijia; Tan, Peng; Rodriguez, Melissa; He, Lian; Tan, Kunrong; Siwko, Stefan; Liu, Mingyao] Texas A&M Univ Syst Hlth Sci Ctr, Ctr Translat Canc Res, Inst Biosci & Technol, Dept Mol & Cellular Med, Houston, TX 77030 USA; [Tan, Peng; Zeng, Li; Liu, Mingyao] East China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200241, Peoples R China; [Tan, Peng; Zeng, Li; Liu, Mingyao] East China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; East China Normal University; East China Normal University	Liu, MY (corresponding author), Alkek Rm 526,2121 W Holcombe Blvd, Houston, TX 77030 USA.	mliu@ibt.tamhsc.edu	Tan, Peng/ABD-8190-2020; Tan, Peng/HGD-6812-2022; Tan, Peng/P-3825-2015	Tan, Peng/0000-0002-7005-1896; Tan, Peng/0000-0001-6992-9000; Luo, Weijia/0000-0002-4261-5084; He, Lian/0000-0002-8842-235X; Siwko, Stefan/0000-0003-4260-2985	National Basic Research Program of China Grant [2012CB910402]; National Natural Science Foundation of China Grant [81330049]; Department of Defense Grant [PC093061]; Cancer Prevention and Research Institute of Texas Grant [RP160235]; NCI, National Institutes of Health Grant [R01CA106479]; Department of Defense [PC424681, PC094495]; NATIONAL CANCER INSTITUTE [R01CA106479] Funding Source: NIH RePORTER	National Basic Research Program of China Grant(National Basic Research Program of China); National Natural Science Foundation of China Grant(National Natural Science Foundation of China (NSFC)); Department of Defense Grant(United States Department of Defense); Cancer Prevention and Research Institute of Texas Grant; NCI, National Institutes of Health Grant; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Basic Research Program of China Grant 2012CB910402, National Natural Science Foundation of China Grant 81330049, Department of Defense Grant PC093061 (to M. L.), Cancer Prevention and Research Institute of Texas Grant RP160235 (subaward to M. L.), and NCI, National Institutes of Health Grant R01CA106479 (to M. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Department of Defense predoctoral research award PC424681.; Supported by Department of Defense predoctoral research award PC094495.	Bisson I, 2009, CELL RES, V19, P683, DOI 10.1038/cr.2009.43; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Cervantes-Arias A, 2013, VET COMP ONCOL, V11, P169, DOI 10.1111/j.1476-5829.2011.00313.x; Chen XJ, 2007, CANCER SCI, V98, P68, DOI 10.1111/j.1349-7006.2006.00353.x; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Drake JM, 2010, J BIOL CHEM, V285, P33940, DOI 10.1074/jbc.M110.136044; Du B, 2013, J BIOL CHEM, V288, P15131, DOI 10.1074/jbc.M113.455535; Gao Y, 2006, CANCER RES, V66, P11623, DOI 10.1158/0008-5472.CAN-06-2629; GLEASON DONALD F., 1966, CANCER CHEMO THERAP REP, V50, P125; Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431; Heeboll S, 2009, APMIS, V117, P196, DOI 10.1111/j.1600-0463.2008.00007.x; Humphrey PA, 2007, J CLIN PATHOL, V60, P35, DOI 10.1136/jcp.2005.036442; Hurwitz A. A., 2001, CURR PROTOC IMMUNOL, DOI [10.1002/0471142735.1m2005s45, DOI 10.1002/0471142735.1M2005S45]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin Y, 2013, P NATL ACAD SCI USA, V110, pE2572, DOI 10.1073/pnas.1304318110; Jing J, 2015, NAT CELL BIOL, V17, P1339, DOI 10.1038/ncb3234; Kato S, 2006, NEPHRON EXP NEPHROL, V104, pE63, DOI 10.1159/000093999; Khamis ZI, 2012, MED RES REV, V32, P1026, DOI 10.1002/med.20232; Lang SH, 2009, J PATHOL, V217, P299, DOI 10.1002/path.2478; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lawson DA, 2007, J CLIN INVEST, V117, P2044, DOI 10.1172/JCI32810; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Li XY, 2010, DEVELOPMENT, V137, P151, DOI 10.1242/dev.040659; Liang F, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0486-1; Lucarelli G, 2013, J UROLOGY, V190, P2271, DOI 10.1016/j.juro.2013.05.004; Luo J, 2016, NAT MED, V22, P539, DOI 10.1038/nm.4076; Luo J, 2009, DEVELOPMENT, V136, P2747, DOI 10.1242/dev.033571; Luo WJ, 2013, STEM CELLS, V31, P2492, DOI 10.1002/stem.1484; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P2241, DOI 10.1210/me.2004-0133; Mendive F, 2006, DEV BIOL, V290, P421, DOI 10.1016/j.ydbio.2005.11.043; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Nakagawa T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002318; Oyama K, 2011, SEX DEV, V5, P205, DOI 10.1159/000329476; Pignon JC, 2013, P NATL ACAD SCI USA, V110, P8105, DOI 10.1073/pnas.1221216110; Qian Y, 2013, DEVELOPMENT, V140, P1751, DOI 10.1242/dev.093641; Russell Pamela J, 2003, Methods Mol Med, V81, P21; Signoretti S, 2000, AM J PATHOL, V157, P1769, DOI 10.1016/S0002-9440(10)64814-6; Smith BN, 2012, CELL ADHES MIGR, V6, P433, DOI 10.4161/cam.21687; Song HP, 2008, J BIOL CHEM, V283, P36687, DOI 10.1074/jbc.M800721200; Steffen JS, 2012, VIRCHOWS ARCH, V461, P355, DOI 10.1007/s00428-012-1292-1; Styrkarsdottir U, 2013, NATURE, V497, P517, DOI 10.1038/nature12124; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Wallerand H, 2010, UROL ONCOL-SEMIN ORI, V28, P473, DOI 10.1016/j.urolonc.2008.12.018; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang Y, 2013, STEM CELLS, V31, P1921, DOI 10.1002/stem.1438; Wen YC, 2014, CLIN CHIM ACTA, V431, P169, DOI 10.1016/j.cca.2014.01.036; Weng JS, 2008, P NATL ACAD SCI USA, V105, P6081, DOI 10.1073/pnas.0708257105; Whiteland H, 2013, EXP MOL PATHOL, V95, P220, DOI 10.1016/j.yexmp.2013.07.010; Whyte JL, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008078; Wu JH, 2013, CARCINOGENESIS, V34, P2861, DOI 10.1093/carcin/bgt229; Yamashita R, 2009, DEV DYNAM, V238, P993, DOI 10.1002/dvdy.21900; Yee DS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-162; Yi TF, 2014, J BIOL CHEM, V289, P8767, DOI 10.1074/jbc.M113.530816; Zhang L, 2016, EXPERT REV GASTROENT, V10, P595, DOI 10.1586/17474124.2016.1140036; Zi XL, 2005, CANCER RES, V65, P9762, DOI 10.1158/0008-5472.CAN-05-0103	58	19	20	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15525	15537		10.1074/jbc.M116.771931	http://dx.doi.org/10.1074/jbc.M116.771931			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28768769	hybrid, Green Published			2022-12-26	WOS:000410809800031
J	Martineau, X; Abed, E; Martel-Pelletier, J; Pelletier, JP; Lajeunesse, D				Martineau, Xavier; Abed, Elie; Martel-Pelletier, Johanne; Pelletier, Jean-Pierre; Lajeunesse, Daniel			Alteration of Wnt5a expression and of the non-canonical Wnt/PCP and Wnt/PKC-Ca2+ pathways in human osteoarthritis osteoblasts	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; GROWTH-FACTOR-BETA; BONE-COLLAGEN METABOLISM; SUBCHONDRAL BONE; SIGNALING PATHWAY; WNT/BETA-CATENIN; CANCELLOUS BONE; FEMORAL-HEAD; IN-VITRO; RECEPTORS	Objective Clinical and in vitro studies suggest that subchondral bone sclerosis due to abnormal osteoblasts (Ob) is involved in the progression and/or onset of osteoarthritis (OA). Human Ob isolated from sclerotic subchondral OA bone tissue show an altered phenotype, a decreased canonical Wnt/beta-catenin signaling pathway (cWnt), and a reduced mineralization in vitro. In addition to the cWnt pathway, at least two non-canonical signaling pathways, the Wnt/PKC and Wnt/PCP pathway have been described. However, there are no reports of either pathway in OA Ob. Here, we studied the two non-canonical pathways in OA Ob and if they influence their phenotype. Methods Human primary subchondral Ob were isolated from the subchondral bone plate of tibial plateaus of OA patients undergoing total knee arthroplasty, or of normal individuals at autopsy. The expression of genes involved in non-canonical Wnt signaling was evaluated by qRT-PCR and their protein production by Western blot analysis. Alkaline phosphatase activity and osteocalcin secretion (OC) were determined with substrate hydrolysis and EIA, respectively. Mineralization levels were evaluated with Alizarin Red Staining, Wnt/PKC and Wnt/PCP pathways by target gene expression and their respective activity using the NFAT and AP-1 luciferase reporter assays. Results OA Ob showed an altered phenotype as illustrated by an increased alkaline phosphatase activity and osteocalcin release compared to normal Ob. The expression of the non-canonical Wnt5a ligand was increased in OA Ob compared to normal. Whereas, the expression of LGR5 was significantly increased in OA Ob compared to normal Ob, the expression of LGR4 was similar. Wnt5a directly stimulated the expression and production of LGR5, contrasting, Wnt5a did not stimulate the expression of LGR4. Wnt5a also stimulated the phosphorylation of both JNK and PKC, as well as the activity of both NFAT and AP-1 transcription factors. The inhibition of Wnt5a expression partially corrects the abnormal mineralization, OC secretion and ALPase activity of OA Ob. Conclusion These data indicate that the alteration of Wnt5a, a non-canonical Wnt signaling activator, is implicated in the modified signalisation and phenotype observed in OA Ob.	[Martineau, Xavier; Abed, Elie; Martel-Pelletier, Johanne; Pelletier, Jean-Pierre; Lajeunesse, Daniel] CRCHUM, Unite Rech Arthrose, Montreal, PQ, Canada	Universite de Montreal	Lajeunesse, D (corresponding author), CRCHUM, Unite Rech Arthrose, Montreal, PQ, Canada.	daniel.laieunesse@umontreal.ca	Pelletier, Jean-Pierre/AAG-2896-2019; Martel-Pelletier, Johanne/AAG-2928-2019; Lajeunesse, Daniel/U-2223-2019		Canadian Institute for Health Research [MOP-49501]	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	Project grant from Canadian Institute for Health Research to DL.; Part of this study was presented at the 3rd World Congress on Controversies, Debate and Consensus in Bone, Muscle & Joint Diseases, Montreal, Canada, April 2015. This study was supported by grant MOP-49501 from the Canadian Institutes for Health Research to DL.	Abed E, 2014, BONE, V59, P28, DOI 10.1016/j.bone.2013.10.020; Abed E, 2011, ARTHRITIS RHEUM-US, V63, P3865, DOI 10.1002/art.30625; Alowolodu Oluwole, 2016, Intrinsically Disord Proteins, V4, pe1255295, DOI 10.1080/21690707.2016.1255295; Bailey AJ, 2002, INT J BIOCHEM CELL B, V34, P176, DOI 10.1016/S1357-2725(01)00107-8; Bouaziz W, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0540-6; Bradley EW, 2010, MOL ENDOCRINOL, V24, P1581, DOI 10.1210/me.2010-0037; Bruckner P, 2002, Z RHEUMATOL, V61, P263, DOI 10.1007/s00393-002-0407-5; Burr DB, 1997, MICROSC RES TECHNIQ, V37, P343, DOI 10.1002/(SICI)1097-0029(19970515)37:4<343::AID-JEMT9>3.0.CO;2-L; Chan TF, 2011, J BONE MINER RES, V26, P1399, DOI 10.1002/jbmr.358; Corr M, 2008, NAT CLIN PRACT RHEUM, V4, P550, DOI 10.1038/ncprheum0904; Couchourel D, 2009, ARTHRITIS RHEUM-US, V60, P1438, DOI 10.1002/art.24489; De A, 2011, ACTA BIOCH BIOPH SIN, V43, P745, DOI 10.1093/abbs/gmr079; de Lau WBM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-242; Dejmek J, 2006, MOL CELL BIOL, V26, P6024, DOI 10.1128/MCB.02354-05; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Fukuda T, 2010, DIFFERENTIATION, V80, P46, DOI 10.1016/j.diff.2010.05.002; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Gregory CA, 2005, ANN NY ACAD SCI, V1049, P97, DOI 10.1196/annals.1334.010; Griesmann H, 2013, NEOPLASIA, V15, P11, DOI 10.1593/neo.121312; Hilal G, 1998, ARTHRITIS RHEUM, V41, P891, DOI 10.1002/1529-0131(199805)41:5<891::AID-ART17>3.0.CO;2-X; Hsu SY, 2000, MOL ENDOCRINOL, V14, P1257, DOI 10.1210/me.14.8.1257; Kikuchi A, 2011, INT REV CEL MOL BIO, V291, P21, DOI 10.1016/B978-0-12-386035-4.00002-1; Kobayashi Y, 2016, J BIOCHEM, V159, P387, DOI 10.1093/jb/mvv124; Kuhl M, 2004, FRONT BIOSCI-LANDMRK, V9, P967; Laitinen M, 1999, LIFE SCI, V64, P847, DOI 10.1016/S0024-3205(99)00006-5; Lajeunesse D, 2003, Mod Rheumatol, V13, P7, DOI 10.3109/s101650300001; Lajeunesse D, 2003, CURR OPIN RHEUMATOL, V15, P628, DOI 10.1097/00002281-200309000-00018; Li BH, 1997, ANN RHEUM DIS, V56, P247, DOI 10.1136/ard.56.4.247; Li BH, 1997, J BONE MINER RES, V12, P641, DOI 10.1359/jbmr.1997.12.4.641; Li XF, 2005, NAT GENET, V37, P945, DOI 10.1038/ng1614; Liu GZ, 2009, J CELL BIOL, V185, P67, DOI 10.1083/jcb.200810137; Luo J, 2009, DEVELOPMENT, V136, P2747, DOI 10.1242/dev.033571; Mansell JP, 1997, BRIT J RHEUMATOL, V36, P16; Mansell JP, 1998, J CLIN INVEST, V101, P1596, DOI 10.1172/JCI867; Massicotte F, 2002, OSTEOARTHR CARTILAGE, V10, P491, DOI 10.1053/joca.2002.0528; Massicotte F, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2087; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P2241, DOI 10.1210/me.2004-0133; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Mutabaruka MS, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2925; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Peng YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056451; Ren DP, 2015, J CELL PHYSIOL, V230, P2426, DOI 10.1002/jcp.24972; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sai AJ, 2011, J CLIN ENDOCR METAB, V96, pE436, DOI 10.1210/jc.2010-1886; Sato A, 2010, EMBO J, V29, P41, DOI 10.1038/emboj.2009.322; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; Spater D, 2006, EUR CELLS MATER, V12, P71; Tang XL, 2012, ACTA PHARMACOL SIN, V33, P363, DOI 10.1038/aps.2011.210; Wang DL, 2013, GENE DEV, V27, P1339, DOI 10.1101/gad.219360.113; Wang YP, 2014, FRONT BIOSCI-LANDMRK, V19, P379, DOI 10.2741/4214; Weivoda MM, 2016, J BONE MINER RES, V31, P65, DOI 10.1002/jbmr.2599; Yamagata K, 2012, J BIOL CHEM, V287, P1588, DOI 10.1074/jbc.M111.315127; Zamurovic N, 2004, J BIOL CHEM, V279, P37704, DOI 10.1074/jbc.M403813200; Zhao W., 2015, J ORTHOP RES; Zhen GH, 2014, TRENDS PHARMACOL SCI, V35, P227, DOI 10.1016/j.tips.2014.03.005; Zhen GH, 2013, NAT MED, V19, P704, DOI 10.1038/nm.3143; Zhu M, 2008, ARTHRITIS RHEUM-US, V58, P2053, DOI 10.1002/art.23614	59	34	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0180711	10.1371/journal.pone.0180711	http://dx.doi.org/10.1371/journal.pone.0180711			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28777797	Green Published, Green Submitted, gold			2022-12-26	WOS:000406944300005
J	Bekker, MHJ; van Assen, MALM				Bekker, Marrie H. J.; van Assen, Marcel A. L. M.			Autonomy-connectedness mediates sex differences in symptoms of psychopathology	PLOS ONE			English	Article							GENDER-ROLE STRESS; LIFE-COURSE-PERSISTENT; DUAL PATHWAY MODEL; DSM-III-R; EATING-DISORDERS; ANTISOCIAL-BEHAVIOR; PERSONALITY-DISORDERS; INSECURE ATTACHMENT; MENTAL-DISORDERS; COMMUNITY SAMPLE	Objectives This study aimed to examine if autonomy-connectedness, capacity for self-governance under the condition of connectedness, would mediate sex differences in symptoms of various mental disorders (depression, anxiety, eating disorders, antisocial personality disorder). Method Participants (N = 5,525) from a representative community sample in the Netherlands filled out questionnaires regarding the variables under study. Results Autonomy-connectedness (self-awareness, SA; sensitivity to others, SO; capacity for managing new situations, CMNS) fully mediated the sex differences in depression and anxiety, and partly in eating disorder -(drive for thinness, bulimia, and body dissatisfaction) and antisocial personality disorder characteristics. The mediations followed the expected sex-specific patterns. SO related positively to the internalizing disorder indices, and negatively to the anti-social personality disorder. SA related negatively to all disorder indices; and CMNS to all internalizing disorder indices, but positively to the anti-social personality disorder. Conclusion Treatment of depression, anxiety, but also eating disorders and the antisocial personality disorder may benefit from a stronger focus on autonomy strengthening.	[Bekker, Marrie H. J.] Tilburg Univ, Dept Clin & Med Psychol, Tilburg, Netherlands; [van Assen, Marcel A. L. M.] Tilburg Univ, Dept Methodol & Stat, Tilburg, Netherlands	Tilburg University; Tilburg University	Bekker, MHJ (corresponding author), Tilburg Univ, Dept Clin & Med Psychol, Tilburg, Netherlands.	m.h.j.bekker@uvt.nl		van Assen, Marcel/0000-0002-7517-6081				Aiken L. S., 1991, MULTIPLE REGRESSION; Ainsworth M., 1978, PATTERNS ATTACHMENT; ALFORD BA, 1995, J CLIN PSYCHOL, V51, P190, DOI 10.1002/1097-4679(199503)51:2<190::AID-JCLP2270510207>3.0.CO;2-S; Allen JP, 2002, J CONSULT CLIN PSYCH, V70, P56, DOI 10.1037/0022-006X.70.1.56; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; Association AP DSM-IV APA on, 2000, DIAGN STAT MAN MENT; Bachrach N, 2013, J CLIN PSYCHOL, V69, P718, DOI 10.1002/jclp.21940; Bachrach N, 2012, J CLIN PSYCHOL, V68, P645, DOI 10.1002/jclp.21841; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Baron-Cohen S., 2007, ADV CLIN NEUROSCI RE, P7; Baron-Cohen S, 2008, Q J EXP PSYCHOL, V61, P64, DOI 10.1080/17470210701508749; BEATTIE HJ, 1988, INT J EAT DISORDER, V7, P453, DOI 10.1002/1098-108X(198807)7:4<453::AID-EAT2260070402>3.0.CO;2-2; Beck A.T., 2015, COGNITIVE THERAPY PE; Beck A. T., 1996, BDI 2 BECK DEPRESSIO; Bekker M., 2008, EMOTION REGULATION C, P170; Bekker M.H.J., 2016, BEHANDELPROTOCOL AUT; Bekker MHJ, 2008, SEX ROLES, V59, P532, DOI 10.1007/s11199-008-9447-x; Bekker MHJ, 2008, J CLIN PSYCHOL, V64, P747, DOI 10.1002/jclp.20486; Bekker MHJ, 2007, GENDER MED, V4, pS178, DOI 10.1016/S1550-8579(07)80057-X; Bekker MHJ, 2007, J CLIN PSYCHOL, V63, P507, DOI 10.1002/jclp.20363; Bekker MHJ, 2006, DEPRESS ANXIETY, V23, P274, DOI 10.1002/da.20178; Bekker MHJ, 2010, J SOC PERS RELAT, V27, P908, DOI 10.1177/0265407510377217; Bekker MHJ, 2006, J PERS ASSESS, V86, P51, DOI 10.1207/s15327752jpa8601_07; BEKKER MHJ, 1993, EUR J PERSONALITY, V7, P177, DOI 10.1002/per.2410070304; Bekker MHJ, 1996, CLIN PSYCHOL REV, V16, P129, DOI 10.1016/0272-7358(96)00012-8; Bekker MHJ., 2003, PSYCHOL HEALTH MED, V8, P231, DOI DOI 10.1080/1354850031000087618; Bekker MHJ, AUTONOMY CONNECTEDNE; Bieling PJ, 2000, COGNITIVE THER RES, V24, P763, DOI 10.1023/A:1005599714224; BIRTCHNELL J, 1984, BRIT J MED PSYCHOL, V57, P215, DOI 10.1111/j.2044-8341.1984.tb02581.x; Blair RJR, 2004, BRAIN COGNITION, V55, P198, DOI 10.1016/s0278-2626(03)00276-8; BOWLBY J, 1969, ATTACHMENT LOSS, V2; Bowlby J, 1969, ATTACHMENT LOSS SEPA; Braamhorst W, 2015, J NERV MENT DIS, V203, P804, DOI 10.1097/NMD.0000000000000371; Bruch H., 1973, PSYCHIAT ANN, V3, P6, DOI [10.3928/0048-5713-19730701-03, DOI 10.3928/0048-5713-19730701-03]; Burke A, 2001, J CLIN PSYCHOL, V57, P953, DOI 10.1002/jclp.1061; Cale EM, 2002, CLIN PSYCHOL REV, V22, P1179, DOI 10.1016/S0272-7358(01)00125-8; CHAMBLESS DL, 1986, BEHAV RES THER, V24, P231, DOI 10.1016/0005-7967(86)90098-7; Chodorow NancyJ., 1989, FEMINISM PSYCHOANALY; Crawford TN, 2006, J PERS DISORD, V20, P331, DOI 10.1521/pedi.2006.20.4.331; De Nooijer M, ATTACHMENT STYLE MAL; Derogatis LR, 1994, SCL90R NAT COMP SYST; Duijsens IJ, 1996, PERS INDIV DIFFER, V20, P171, DOI 10.1016/0191-8869(95)00161-1; Eaton NR, 2012, J ABNORM PSYCHOL, V121, P282, DOI 10.1037/a0024780; EISLER RM, 1987, BEHAV MODIF, V11, P123, DOI 10.1177/01454455870112001; Ellis JL, 2013, BEHAV RES METHODS, V45, P16, DOI 10.3758/s13428-012-0223-z; Eme RF, 2007, CLIN PSYCHOL REV, V27, P607, DOI 10.1016/j.cpr.2007.02.001; Erikson E.H, 1974, IDENTITY YOUTH CRISI; Fairbrother N, 1998, COGNITIVE THER RES, V22, P279, DOI 10.1023/A:1018796810260; FRANCHE RL, 1992, COGNITIVE THER RES, V16, P419, DOI 10.1007/BF01183166; GARNER DM, 1982, INT J EAT DISORDER, V1, P3, DOI 10.1002/1098-108X(198224)1:2<3::AID-EAT2260010202>3.0.CO;2-J; GILLESPIE BL, 1992, BEHAV MODIF, V16, P426, DOI 10.1177/01454455920163008; GOUGH HG, 1983, ADJECTIVE CHECKLIST; Hare RD, 1996, CRIM JUSTICE BEHAV, V23, P25, DOI 10.1177/0093854896023001004; Hare RD, 1994, CRIM JUSTICE BEHAV, V21, P481; HEATHERTON TF, 1991, PSYCHOL BULL, V110, P86, DOI 10.1037/0033-2909.110.1.86; Hmel BA, 2002, J PERS, V70, P277, DOI 10.1111/1467-6494.05006; Hoek HW, 2016, CURR OPIN PSYCHIATR, V29, P336, DOI 10.1097/YCO.0000000000000282; Hunt M, 2003, J PERS ASSESS, V80, P26, DOI 10.1207/S15327752JPA8001_10; Jack DC, 2011, PSYCHOL WOMEN QUART, V35, P523, DOI 10.1177/0361684311414824; Jackson D. N., 1967, PERSONALITY RES FORM; Karreman A, 2012, J ADOLESCENCE, V35, P407, DOI 10.1016/j.adolescence.2011.07.016; Keski-Rahkonen A, 2016, CURR OPIN PSYCHIATR, V29, P340, DOI 10.1097/YCO.0000000000000278; Kohlberg L, 1981, ESSAYS MORAL DEV PSY; Kramer MD, 2008, PSYCHOL MED, V38, P51, DOI 10.1017/S0033291707001572; Krueger RF, 1998, J ABNORM PSYCHOL, V107, P216, DOI 10.1037/0021-843X.107.2.216; Kuipers GS, 2016, ATTACH HUM DEV, V18, P250, DOI 10.1080/14616734.2015.1136660; Kuipers GS, 2012, CURR PSYCHIATRY REV, V8, P326, DOI 10.2174/157340012803520478; Lahey BB, 2006, J ABNORM CHILD PSYCH, V34, P737, DOI 10.1007/s10802-006-9064-5; Lee A, 2009, J CLIN CHILD ADOLESC, V38, P219, DOI 10.1080/15374410802698396; LUTEIJN F, 1984, HOPKINS SYMPTOM CHEC; Maas J, ENHANCING AUTONOMY C; MacKinnon D.P., 2012, INTRO STAT MEDIATION; Mahalik JR, 2005, J INTERPERS VIOLENCE, V20, P617, DOI 10.1177/0886260504269688; Mahler M, 1985, PSYCHOL BIRTH HUMAN; McLean CP, 2009, CLIN PSYCHOL REV, V29, P496, DOI 10.1016/j.cpr.2009.05.003; Moffitt T. E., 2001, SEX DIFFERENCES ANTI; Moffitt TE, 2003, CAUSES OF CONDUCT DISORDER AND JUVENILE DELINQUENCY, P49; Moffitt TE, 2007, CAMB HANDB PSYCHOL, P49; Nolen-Hoeksema S, 2001, PSYCHOL WOMEN QUART, V25, P37, DOI 10.1111/1471-6402.00005; Oakley A., 1993, SEX GENDER SOC; Olsen LR, 2004, ACTA PSYCHIAT SCAND, V110, P225, DOI 10.1111/j.1600-0447.2004.00399.x; Oosterveld P., 1989, ADJECTIVE CHECKLIST; Ouwens MA, 2009, APPETITE, V52, P234, DOI 10.1016/j.appet.2008.07.010; Piccinelli M, 2000, BRIT J PSYCHIAT, V177, P486, DOI 10.1192/bjp.177.6.486; Pokrajac-Bulian A, 2008, THIN IDEAL INTERNALI; ROBINS CJ, 1991, J ABNORM PSYCHOL, V100, P74, DOI 10.1037/0021-843X.100.1.74; Rutten EAP, ANXIETY DEPRESSION A; Rutter M, 2003, J CHILD PSYCHOL PSYC, V44, P1092, DOI 10.1111/1469-7610.00194; Samuel DB, 2009, PERSONAL MENT HEALTH, V3, P12, DOI 10.1002/pmh.61; SCHULKEN.J, 1974, GEDRAG GEZOND, V2, P65; Sentse M, 2010, INT J BEHAV DEV, V34, P159, DOI 10.1177/0165025409350949; Stice E, 2002, PSYCHOL BULL, V128, P825, DOI 10.1037//0033-2909.128.5.825; Stice E, 1998, J SOC CLIN PSYCHOL, V17, P129, DOI 10.1521/jscp.1998.17.2.129; Storch EA, 2004, DEPRESS ANXIETY, V19, P187, DOI 10.1002/da.20002; STRIEGELMOORE RH, 1986, AM PSYCHOL, V41, P246, DOI 10.1037/0003-066X.41.3.246; Strien Tv, 2002, EATING DISORDER INVE; Unger R. K., 1996, WOMEN GENDER FEMINIS; van Assen MALM, 2009, PERS INDIV DIFFER, V47, P12, DOI 10.1016/j.paid.2009.01.039; WELCH G, 1990, INT J EAT DISORDER, V9, P79, DOI 10.1002/1098-108X(199001)9:1<79::AID-EAT2260090109>3.0.CO;2-E; WIDIGER TA, 1991, CLIN PSYCHOL REV, V11, P1, DOI 10.1016/0272-7358(91)90135-H; Wittchen HU, 2005, EUR NEUROPSYCHOPHARM, V15, P357, DOI 10.1016/j.euroneuro.2005.04.012; Young J. E. S., 1994, COGNITIVE THERAPY PE; Zachrisson HD, 2010, EUR EAT DISORD REV, V18, P97, DOI 10.1002/erv.999; Zahn-Waxler C, 2008, ANNU REV CLIN PSYCHO, V4, P275, DOI 10.1146/annurev.clinpsy.3.022806.091358	105	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0181626	10.1371/journal.pone.0181626	http://dx.doi.org/10.1371/journal.pone.0181626			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC5AR	28771498	gold, Green Submitted, Green Published			2022-12-26	WOS:000406853600027
J	Grafeld, S; Oleson, KLL; Teneva, L; Kittinger, JN				Grafeld, Shanna; Oleson, Kirsten L. L.; Teneva, Lida; Kittinger, John N.			Follow that fish: Uncovering the hidden blue economy in coral reef fisheries	PLOS ONE			English	Article							SMALL-SCALE FISHERIES; ECOSYSTEM SERVICES; FOOD SECURITY; MANAGEMENT; SUSTAINABILITY; VALUATION; IMPACTS; DENSITY; POVERTY; TRENDS	Despite their importance for human well-being, nearshore fisheries are often data poor, undervalued, and underappreciated in policy and development programs. We assess the value chain for nearshore Hawaiian coral reef fisheries, mapping post-catch distribution and disposition, and quantifying associated monetary, food security, and cultural values. We estimate that the total annual value of the nearshore fishery in Hawai'i is $10.3-$16.4 million, composed of non-commercial ($7.2-$12.9 million) and commercial ($2.97 million licensed + $148,500-$445,500 unlicensed) catch. Hawaii's nearshore fisheries provide > 7 million meals annually, with most (> 5 million) from the non-commercial sector. Over a third (36%) of meals were planktivores, 26% piscivores, 21% primary consumers, and 18% secondary consumers. Only 62% of licensed commercial catch is accounted for in purchase reports, leaving 38% of landings unreported in sales. Value chains are complex, with major buyers for the commercial fishery including grocery stores (66%), retailers (19%), wholesalers (14%), and restaurants (< 1%), who also trade and sell amongst themselves. The bulk of total nearshore catch (72-74%) follows a short value chain, with non-commercial fishers keeping catch for household consumption or community sharing. A small amount (similar to 37,000kg) of reef fish-the equivalent of 1.8% of local catch-is imported annually into Hawai'i, 23,000kg of which arrives as passenger luggage on commercial flights from Micronesia. Evidence of exports to the US mainland exists, but is unquantifiable given existing data. Hawaiian nearshore fisheries support fundamental cultural values including subsistence, activity, traditional knowledge, and social cohesion. These small-scale coral reef fisheries provide large-scale benefits to the economy, food security, and cultural practices of Hawai'i, underscoring the need for sustainable management. This research highlights the value of information on the value chain for small-scale production systems, making the hidden economy of these fisheries visible and illuminating a range of conservation interventions applicable to Hawai'i and beyond.	[Grafeld, Shanna; Oleson, Kirsten L. L.] Univ Hawaii Manoa, Dept Nat Resources & Environm Management, Honolulu, HI 96822 USA; [Teneva, Lida; Kittinger, John N.] Conservat Int, Ctr Oceans, Honolulu, HI USA; [Kittinger, John N.] Arizona State Univ, Life Sci Ctr, Julie Ann Wrigley Global Inst Sustainabil, Ctr Biodivers Outcomes, Tempe, AZ USA	University of Hawaii System; University of Hawaii Manoa; Conservation International; Arizona State University; Arizona State University-Tempe	Grafeld, S (corresponding author), Univ Hawaii Manoa, Dept Nat Resources & Environm Management, Honolulu, HI 96822 USA.	grafeld@hawaii.edu	BITOUN, RACHEL Elisabeth/AAC-9538-2021; Oleson, Kirsten/M-7741-2015	BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Oleson, Kirsten/0000-0002-7992-5051	National Oceanicand Atmospheric Administration (NOAA) [NA15NMF4270332]	National Oceanicand Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA)	We are grateful for funding from the National Oceanicand Atmospheric Administration (NOAA) Saltonstall-Kennedy program, through award NA15NMF4270332, granted to JNK and LT of Conservation International. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, ECOL SOC, V15, P32; Ayers A, 2017, INT J COMMONS, P11; Bain D., 1996, GUIDE ESTIMATING VAL; Barnes-Mauthe M, 2015, ECOSYST SERV, V16, P283, DOI 10.1016/j.ecoser.2014.10.009; Barnes-Mauthe M, 2013, FISH RES, V147, P175, DOI 10.1016/j.fishres.2013.05.011; Barnes-Mauthe M, 2013, ECOL SOC, V18, DOI 10.5751/ES-05295-180123; Bell JD, 2009, MAR POLICY, V33, P64, DOI 10.1016/j.marpol.2008.04.002; Bene C, 2011, PROG DEV STUD, V11, P119, DOI 10.1177/146499341001100203; Bene C, 2010, DEV POLICY REV, V28, P325, DOI 10.1111/j.1467-7679.2010.00486.x; Berkes F., 2001, MANAGING SMALL SCALE; Birkeland C, 2004, BIOSCIENCE, V54, P1021, DOI 10.1641/0006-3568(2004)054[1021:RDTCR]2.0.CO;2; Brewer TD, 2011, CORAL REEF FISH VALU, P46; Brinson A, 2011, MAR POLICY, V35, P542, DOI 10.1016/j.marpol.2011.01.014; Brown E.O., 2010, VALUE CHAIN ANAL SEA; Bunse L, 2015, ECOSYST SERV, V14, P88, DOI 10.1016/j.ecoser.2015.05.004; California Environmental Associates, 2015, OC PROSP ROADM FISH; Cedric B., 2013, RONGEAD INT TRADE SU, P17; Cesar Herman S. J., 2004, Pacific Science, V58, P231, DOI 10.1353/psc.2004.0014; Chan KMA, 2012, ECOL ECON, V74, P8, DOI 10.1016/j.ecolecon.2011.11.011; Chang Kevin, 2016, FEASIBILITY NONCOMME; Chuenpagdee R, 2012, BOTTOM UP GLOBAL EST; Cinner JE, 2009, CONSERV BIOL, V23, P124, DOI 10.1111/j.1523-1739.2008.01041.x; Cinner JE, 2004, OCEAN COAST MANAGE, V47, P479, DOI 10.1016/j.ocecoaman.2004.09.002; Cinner JE, 2016, NATURE, V535, P416, DOI 10.1038/nature18607; Cinner JE, 2013, CONSERV BIOL, V27, P453, DOI 10.1111/j.1523-1739.2012.01933.x; Cinner JE, 2012, P NATL ACAD SCI USA, V109, P5219, DOI 10.1073/pnas.1121215109; Cisneros-Montemayor AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166681; Coin News LLC, COIN NEWS LLC; Conservation International Hawaii, 2016, LAW OH CAMP PROGR DE; Daily GC, 2009, FRONT ECOL ENVIRON, V7, P21, DOI 10.1890/080025; Daniel TC, 2012, P NATL ACAD SCI USA, V109, P8812, DOI 10.1073/pnas.1114773109; Darvill R, 2015, ECOSYST SERV, V13, P153, DOI 10.1016/j.ecoser.2014.10.004; de Groot RS, 2002, ECOL ECON, V41, P393, DOI 10.1016/S0921-8009(02)00089-7; Dible Max, 2016, W HAWAII TODAY  1203; Fafchamps M, 2005, AM J AGR ECON, V87, P717, DOI 10.1111/j.1467-8276.2005.00758.x; Fernandes da Costa PM, 2009, 2010 ANN M FEBR 6 9; Fishbase, THE EC TABL; Friedlander AM, 2013, PAC SCI, V67, P441, DOI 10.2984/67.3.10; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Geslani C., 2012, 1201 SOEST U HAW MAN; Gillett R., 2016, FISHERIES EC PACIFIC; Gillett R., 2001, CONTRIBUTION FISHERI; Glazier E, 2013, PAC SCI, V67, P345, DOI 10.2984/67.3.4; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; Hampton J, 2006, SC2SAWP2 WCPFC, V7, P18; Hannesson R, 2008, J NAT RESOUR POLICY, V1, P49; Harland C.M., 1996, BRIT J MANAGE, V7, pS63, DOI [10.1111/j.1467-8551.1996.tb00148.x, DOI 10.1111/J.1467-8551.1996.TB00148.X]; Hawaii Department of Business Economic Development & Tourism, 2013, 20132 HSDC HAW DEP B, P11; Hempel E., 2010, VALUE CHAIN ANAL FIS; Hernandez-Morcillo M, 2013, ECOL INDIC, V29, P434, DOI 10.1016/j.ecolind.2013.01.013; Hilborn R, 2014, ICES J MAR SCI, V71, P1040, DOI 10.1093/icesjms/fsu034; Hobbs J, 2000, WHAT ARE THEY; Hospital J, 2014, HAWAII RETAIL SEAFOO, DOI [10.7289/V53R0QSM, DOI 10.7289/V53R0QSM]; Houk P, 2012, CORAL REEFS, V31, P13, DOI 10.1007/s00338-011-0826-3; Ishida DN, 2001, CANCER, V91, P262, DOI 10.1002/1097-0142(20010101)91:1+<262::AID-CNCR16>3.0.CO;2-R; Jacinto ER, 2011, SMALL-SCALE FISHERIES MANAGEMENT: FRAMEWORKS AND APPROACHES FOR THE DEVELOPING WORLD, P160, DOI 10.1079/9781845936075.0160; Jacquet J, 2008, CONSERV BIOL, V22, P832, DOI 10.1111/j.1523-1739.2008.00978.x; Jokiel P., 2011, J MAR BIOL, V2011; Kittinger JN, 2013, HUMAN DIMENSIONS SMA; Kittinger JN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123856; Kittinger JN, 2013, PAC SCI, V67, P361, DOI 10.2984/67.3.5; Kohala Center, HLTH IMP ASS PROP MO; Kronen M, 2010, MAR POLICY, V34, P1135, DOI 10.1016/j.marpol.2010.03.013; Leung P, 2008, EC ISSUES, P13; Levine A, 2009, AM SAMOA FISHING COM; Liu JG, 2007, SCIENCE, V317, P1513, DOI 10.1126/science.1144004; Liu J, 2014, LANDSCAPE ECOL, V29, P1347, DOI 10.1007/s10980-014-0045-8; Loring PA, 2016, J AGR FOOD SYST COMM, V3, P13; Lovell SJ, 2011, EC CONTRIBUTION MARI; Madge L, 2016, NOAATMNMFSPIFSC58 US, P36; Marine Stewardship Council, 2017, CERT SUST SEAF; McClenachan L, 2013, FISH FISH, V14, P239, DOI 10.1111/j.1467-2979.2012.00465.x; McCoy K., 2015, ESTIMATING NEARSHORE; Meadows D., 1999, PLACES INTERV SYST; Mejia M, 2014, HAW CONS C; Millennium Ecosystem Assessment, 2005, ECOSYSTEMS HUMAN WEL; Miller ML, 2004, CROSS-CULT RES, V38, P289, DOI 10.1177/1069397104264278; Milne N., 2012, HAWAII CORAL REEF DE; Mora C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000131; Nadon MO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133960; Nangole E., 2011, REV GUIDELINES MANUA; National Marine Fisheries Service, 2011, SUMM 2011 VAL ADD MA; National Marine Fisheries Service Lowther, 2016, FISH US 2014; Nguyen NC, 2013, SYST RES BEHAV SCI, V30, P104, DOI 10.1002/sres.2145; Oleson KLL, 2015, ECOL ECON, V114, P104, DOI 10.1016/j.ecolecon.2015.02.028; OmniTrack Group, 2011, 2011 SEAF SEC STUD; Osterblom H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127533; Ostrom E., 2015, GOVERNING COMMONS; P'ala Pascua, 2015, ALA OLA KA PLACE BAS; PIFSC, 2016, BARBL CIRCL HOOK NEW; Plieninger T, 2015, CURR OPIN ENV SUST, V14, P28, DOI 10.1016/j.cosust.2015.02.006; Poepoe K., 2003, FISHERIES CTR RES RE, V11, P328; Rausser G, 2009, MAR POLICY, V33, P24, DOI 10.1016/j.marpol.2008.03.020; Reed M, 2013, MAR POLICY, V37, P62, DOI 10.1016/j.marpol.2012.04.009; Richmond L, 2015, OCEAN COAST MANAGE, V106, P87, DOI 10.1016/j.ocecoaman.2015.01.015; Sadovy YJ, 2003, WHILE STOCKS LAST LI; Schmitz H., 2005, VALUE CHAIN ANAL POL; Seafood Watch, 2017, MONT BAY AQ FDN; Severance C., 2010, PACIFIC ISLANDS FISH, P1; Smith MD, 2010, SCIENCE, V327, P784, DOI 10.1126/science.1185345; Soler GA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140270; State of Hawaii, 2017, NAT RES MAN TARG INC; State of Hawaii Department of Land and Natural Resources, COMM FISH; State of Hawaii Department of Land and Natural Resources, 2014, HAW COMM MAR LIC DEA; Thyresson M, 2013, MAR POLICY, V38, P246, DOI 10.1016/j.marpol.2012.05.041; Tissot BN, 2003, CONSERV BIOL, V17, P1759, DOI 10.1111/j.1523-1739.2003.00379.x; United States Department of Agriculture, GLOB AGR TRAD SYST; van den Berg M, 2009, MAKING VALUE CHAINS; Vaughan MB, 2013, PAC SCI, V67, P329, DOI 10.2984/67.3.3; Weijerman M, 2016, MAR POLICY, V63, P8, DOI 10.1016/j.marpol.2015.09.028; Welcomme RL, 2010, PHILOS T R SOC B, V365, P2881, DOI 10.1098/rstb.2010.0168; WELLMAN KF, 1992, APPL ECON, V24, P445, DOI 10.1080/00036849200000019; Western Pacific Regional Fishery Management Council, 2013, BOTT FISH HAW ARCH; Williams I, 2013, H1304 NOAA PAC ISL F, P61; Williams ID, 2008, ENVIRON CONSERV, V35, P261, DOI 10.1017/S0376892908004876; Zeller D, 2006, MAR RESOUR ECON, V21, P355; Zeller D, 2007, FISH B-NOAA, V105, P266	118	31	32	5	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182104	10.1371/journal.pone.0182104	http://dx.doi.org/10.1371/journal.pone.0182104			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC5AR	28771508	gold, Green Published			2022-12-26	WOS:000406853600064
J	Lin, JJ; Hsiao, HJ; Chan, OW; Wang, Y; Hsia, SH; Chiu, CH				Lin, Jainn-Jim; Hsiao, Hsiang-Ju; Chan, Oi-Wa; Wang, Yu; Hsia, Shao-Hsuan; Chiu, Cheng-Hsun			Increased serum thrombomodulin level is associated with disease severity and mortality in pediatric sepsis	PLOS ONE			English	Article							DISSEMINATED INTRAVASCULAR COAGULATION; MULTIORGAN DYSFUNCTION SYNDROME; SOLUBLE THROMBOMODULIN; PLASMA-LEVELS; CHILDREN	Background Endothelial dysfunction plays an important role in the pathophysiology of sepsis. As previously reported, the serum thrombomodulin is elevated in diseases associated with endothelial injury. Objective The aim of this study was to investigate the association of serum thrombomodulin level in different pediatric sepsis syndromes and evaluate the relationship with disease severity and mortality. Methods We prospectively collected cases of sepsis treated in a pediatric intensive care unit from June 2012 to July 2015 at Chang Gung Children's Hospital in Taoyuan, Taiwan. Clinical characteristics and serum thrombomodulin levels were analyzed. Results Increased serum thrombomodulin levels on days 1 and 3 of the diagnosis of sepsis were found in different pediatric sepsis syndromes. Patients with septic shock had significantly increased serum thrombomodulin levels on days 1 and 3 [day 1: median, 6.9 mU/ml (interquartile range (IQR): 5.8-12.8) and day 3: median, 5.8 mU/ml (IQR: 4.6-10.8)] compared to healthy controls [median, 3.4 mU/ml (IQR: 2.3-4.2)] (p = <0.001 and 0.001, respectively) and those with sepsis [day 1: median, 2.9 mU/ml (IQR: 1.8-4.7) and day 3: median, 3 mU/ml (IQR: 1.5-3.5)] and severe sepsis [day 1: median, 3.3 mU/ml (IQR: 1.3-8.6) and day 3: median, 4.4 mU/ml (IQR: 0.5-6)] (p = <0.001 and 0.001, respectively). There was also a significant positive correlation between serum thrombomodulin level on day 1 and day 1 PRISM-II, PELOD, PMOD and DIC scores. The patients who died had significantly higher serum thrombomodulin levels on days 1 and 3 [day 1: median, 9.9 mU/ml (IQR: 6.2-15.6) and day 3: median, 10.4 mU/ml (IQR: 9.2-11.7)] than the survivors [day 1; median, 4.4 mU/ml (IQR: 2.2-7.5) and day 3: [median, 3.5 mU/ml (IQR: 1.6-5.7)] (p = 0.046 and 0.012, respectively). Conclusion Increased serum thrombomodulin levels were found in different pediatric sepsis syndromes and correlated with disease severity and mortality.	[Lin, Jainn-Jim; Hsiao, Hsiang-Ju; Chan, Oi-Wa; Wang, Yu; Hsia, Shao-Hsuan] Chang Gung Univ, Coll Med, Chang Gung Childrens Hosp, Div Pediat Crit Care & Pediat Sepsis Study Grp, Taoyuan, Taiwan; [Lin, Jainn-Jim; Wang, Yu; Chiu, Cheng-Hsun] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan; [Lin, Jainn-Jim; Hsia, Shao-Hsuan; Chiu, Cheng-Hsun] Chang Gung Univ Coll Med, Chang Gung Childrens Hosp & Chang Gung Mem Hosp, Mol Infect Dis Res Ctr, Taoyuan, Taiwan; [Wang, Yu; Hsia, Shao-Hsuan] Chang Gung Mem Hosp, Dept Pediat, Keelung, Taiwan; [Hsiao, Hsiang-Ju; Chan, Oi-Wa; Wang, Yu] Chang Gung Mem Hosp, Dept Pediat, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Hsia, SH (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Childrens Hosp, Div Pediat Crit Care & Pediat Sepsis Study Grp, Taoyuan, Taiwan.; Chiu, CH (corresponding author), Chang Gung Univ Coll Med, Chang Gung Childrens Hosp & Chang Gung Mem Hosp, Mol Infect Dis Res Ctr, Taoyuan, Taiwan.	tw1picu002@gmail.com; chchiu@adm.cgmh.org.tw			Chang Gung Memorial Hospital, Taiwan [CMRPG3B0841, CMRPG3B0842, CMRPG3B0843]	Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This research was a part of an infection and immunity sepsis project, and was performed by the Pediatric Sepsis Study Group at Chang Gung Children's Hospital in Taoyuan, Taiwan. The work was supported in part by grants from Chang Gung Memorial Hospital (grant: CMRPG3B0841, CMRPG3B0842 and CMRPG3B0843), Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASAKURA H, 1991, AM J HEMATOL, V38, P281, DOI 10.1002/ajh.2830380406; Califano F, 2000, Eur Rev Med Pharmacol Sci, V4, P59; Dhainaut JF, 2002, CRIT CARE MED, V30, pS318, DOI 10.1097/00003246-200205001-00023; Faust SN, 2001, CRIT CARE MED, V29, pS62, DOI 10.1097/00003246-200107001-00022; Goldstein B, 2006, PEDIATR CRIT CARE ME, V7, P200, DOI 10.1097/01.PCC.0000217470.68764.36; Hartman ME, 2013, PEDIATR CRIT CARE ME, V14, P686, DOI 10.1097/PCC.0b013e3182917fad; IBA T, 1995, SURG TODAY, V25, P585, DOI 10.1007/BF00311430; Krafte-Jacobs B, 1998, CRIT CARE MED, V26, P933, DOI 10.1097/00003246-199805000-00032; Levi M, 2013, MINERVA ANESTESIOL, V79, P294; Lin JJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003374; Lin SM, 2008, CRIT CARE MED, V36, P683, DOI 10.1097/CCM.0B013E31816537D8; Mihajlovic DM, 2015, CLIN APPL THROMB-HEM, V21, P469, DOI 10.1177/1076029613508600; Ohlin AK, 2005, J THROMB HAEMOST, V3, P976, DOI 10.1111/j.1538-7836.2005.01267.x; Orwoll BE, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1145-9; Rivers EP, 2005, CAN MED ASSOC J, V173, P1054, DOI 10.1503/cmaj.050632; Sapru A, 2015, INTENS CARE MED, V41, P470, DOI 10.1007/s00134-015-3648-x; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327, DOI 10.1055/s-0037-1616068	17	14	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182324	10.1371/journal.pone.0182324	http://dx.doi.org/10.1371/journal.pone.0182324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771554	Green Published, gold, Green Submitted			2022-12-26	WOS:000406853600089
J	Matsuyama, T; Yasuike, M; Fujiwara, A; Nakamura, Y; Takano, T; Takeuchi, T; Satoh, N; Adachi, Y; Tsuchihashi, Y; Aoki, H; Odawara, K; Iwanaga, S; Kurita, J; Kamaishi, T; Nakayasu, C				Matsuyama, Tomomasa; Yasuike, Motoshige; Fujiwara, Atushi; Nakamura, Yoji; Takano, Tomokazu; Takeuchi, Takeshi; Satoh, Noriyuki; Adachi, Yoshikazu; Tsuchihashi, Yasushi; Aoki, Hideo; Odawara, Kazushi; Iwanaga, Shunsuke; Kurita, Jun; Kamaishi, Takashi; Nakayasu, Chihaya			A Spirochaete is suggested as the causative agent of Akoya oyster disease by metagenomic analysis	PLOS ONE			English	Article							JAPANESE PEARL OYSTER; PINCTADA-FUCATA-MARTENSII; MASS MORTALITIES; MARINE BIVALVES; BACTERIA; CRISTISPIRA; DIVERSITY; HEMOLYMPH; SEQUENCE; IDENTIFICATION	Mass mortality that is acompanied by reddish browning of the soft tissues has been occurring in cultured pearl oyster, Pinctada fucata martensii. The disease is called Akoya oyster disease (AOD). Although spreading pattern of the disease and transmission experiments suggest that the disease is infectious, the causative agent has not yet been identified. We used shotgun and 16S rRNA-based metagenomic analysis to identify genes that are present specifically in affected oysters. The genes found only in diseased oysters were mostly bacterial origin, suggesting that the causative agent was a bacterial pathogen. This hypothesis was supported by the inhibition of AOD development in naive oysters injected with the hemolymph of diseased animals followed immediately with penicillin bath-administration. Further analyses of the hemolymph and mantle specifically and universally detected genes of bacteria that belong to phylum Spirochaetes in diseased pearl oysters but not in healthy oysters. By in situ hybridization or immunostaining, a Brachyspira-like bacterium was observed in the smears of hemolymph from affected oysters, but not from healthy oysters. Phylogenetic analysis using 16S rRNA sequences showed that the presumptive causative bacterium was outside of but most closely related to family Brachyspiraceae. We propose 'Candidatus Maribrachyspira akoyae' gen. nov, sp nov., for this bacterium.	[Matsuyama, Tomomasa; Takano, Tomokazu; Kurita, Jun; Kamaishi, Takashi; Nakayasu, Chihaya] Japan Fisheries Res & Educ Agcy, Natl Res Inst Aquaculture, Res Ctr Fish Dis, Minamiise, Mie, Japan; [Yasuike, Motoshige; Fujiwara, Atushi; Nakamura, Yoji] Japan Fisheries Res & Educ Agcy, Res Ctr Bioinformat & Biosci, Natl Res Inst Fisheries Sci, Yokohama, Kanagawa, Japan; [Yasuike, Motoshige; Fujiwara, Atushi; Nakamura, Yoji] Grad Univ, Okinawa Inst Sci & Technol, Marine Genom Unit, Onna, Okinawa, Japan; [Tsuchihashi, Yasushi; Iwanaga, Shunsuke; Kurita, Jun] Ibaraki Univ, Dept Biol Prod Sci, Coll Agr, Ami, Ibaraki, Japan; [Nakamura, Yoji; Odawara, Kazushi; Kamaishi, Takashi] Mie Prefecture Fisheries Res Inst, Shima, Mie, Japan; [Takano, Tomokazu; Odawara, Kazushi; Kamaishi, Takashi] Ehime Prefecture Fisheries Res Ctr, Uwajima, Ehime, Japan; [Satoh, Noriyuki; Odawara, Kazushi; Kurita, Jun] Nagasaki Prefectural Inst Fisheries, Nagasaki, Japan	Japan Fisheries Research & Education Agency (FRA); Japan Fisheries Research & Education Agency (FRA); Okinawa Institute of Science & Technology Graduate University; Ibaraki University	Matsuyama, T (corresponding author), Japan Fisheries Res & Educ Agcy, Natl Res Inst Aquaculture, Res Ctr Fish Dis, Minamiise, Mie, Japan.	matsuym@fra.affrc.go.jp	Satoh, Nori/C-4123-2009	Satoh, Nori/0000-0002-4480-3572	JSPS KAKENHI [JP 24580291]; Project of the Bio-oriented Technology Research Advancement Institution; NARO	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Project of the Bio-oriented Technology Research Advancement Institution; NARO	Part of this his work was supported by JSPS KAKENHI Grant Number JP 24580291 and by a grant from the Project of the Bio-oriented Technology Research Advancement Institution, NARO (the special scheme project on advanced research and development for next-generation technology).	Abe Y, 2004, J VET MED SCI, V66, P773, DOI 10.1292/jvms.66.773; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bibby K, 2013, TRENDS BIOTECHNOL, V31, P11, DOI 10.1016/j.tibtech.2013.01.016; Bibby K, 2013, ENVIRON SCI TECHNOL, V47, P1945, DOI 10.1021/es305181x; CANALEPAROLA E, 1981, INT J SYST BACTERIOL, V31, P105, DOI 10.1099/00207713-31-1-105; Crochu S, 2004, J GEN VIROL, V85, P1971, DOI 10.1099/vir.0.79850-0; Dassanayake RP, 2005, ANTIMICROB AGENTS CH, V49, P1561, DOI 10.1128/AAC.49.4.1561-1563.2005; Fantham HB, 1908, Q J MICROSC SCI, V52, P1; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Garnier M, 2007, MICROB ECOL, V53, P187, DOI 10.1007/s00248-006-9061-9; Hahn MW, 2004, RES MICROBIOL, V155, P688, DOI 10.1016/j.resmic.2004.05.003; HARDY PH, 1961, J BACTERIOL, V82, P967, DOI 10.1128/JB.82.6.967-978.1961; HESPELL RB, 1970, ARCH MIKROBIOL, V74, P1, DOI 10.1007/BF00408683; Hirano M, 2002, FISHERIES SCI, V68, P700, DOI 10.1046/j.1444-2906.2002.00480.x; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; HUNTER RS, 1958, J OPT SOC AM, V48, P985, DOI 10.1364/JOSA.48.000985; Husmann G, 2010, J SHELLFISH RES, V29, P1069, DOI 10.2983/035.029.0409; Katzourakis A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001191; Kitamura SI, 2002, DIS AQUAT ORGAN, V50, P211, DOI 10.3354/dao050211; KOHLHEPP W, 1989, J NEUROL, V236, P464, DOI 10.1007/BF00328508; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kurokawa T, 1999, NIPPON SUISAN GAKK, V65, P241; LOESCHE WALTER J., 1962, SCIENCE, V138, P139, DOI 10.1126/science.138.3537.139; LOFGREN R, 1945, J BACTERIOL, V50, P679, DOI 10.1128/JB.50.6.679-690.1945; Lokmer A, 2015, ISME J, V9, P670, DOI 10.1038/ismej.2014.160; Lu XD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139582; Maeno Y, 2001, FISH PATHOL, V36, P225, DOI 10.3147/jsfp.36.225; MAYASICH SA, 1987, MICROBIAL ECOL, V14, P157, DOI 10.1007/BF02013020; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Miyazaki T, 1999, DIS AQUAT ORGAN, V37, P1, DOI 10.3354/dao037001; Miyazaki T, 2000, DIS AQUAT ORGAN, V43, P15, DOI 10.3354/dao043015; Morizane T, 2001, FISH PATHOL, V36, P207, DOI 10.3147/jsfp.36.207; Morizane T, 2002, FISH PATHOLOGY; Muroga K., 2002, DIS ASIAN AQUACULTUR, P197; MURRAY RGE, 1995, INT J SYST BACTERIOL, V45, P186, DOI 10.1099/00207713-45-1-186; Nagai K, 2013, ZOOL SCI, V30, P783, DOI 10.2108/zsj.30.783; Nakajima K., 1999, FISH PATHOL, V34, P227; Nakayasu C, 2004, FISH PATHOL, V39, P203, DOI 10.3147/jsfp.39.203; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Noguchi H, 1921, J EXP MED, V34, P295, DOI 10.1084/jem.34.3.295; Odawara K, 2011, FISH PATHOL, V46, P101, DOI 10.3147/jsfp.46.101; OLAFSEN JA, 1993, APPL ENVIRON MICROB, V59, P1848, DOI 10.1128/AEM.59.6.1848-1854.1993; Renault T., 2008, ENCY VIROLOGY, P560; Roiz D, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-93; Schmiedel D, 2009, J CLIN MICROBIOL, V47, P1393, DOI 10.1128/JCM.02469-08; Singh AE, 1999, CLIN MICROBIOL REV, V12, P187, DOI 10.1128/CMR.12.2.187; Starliper CE, 2008, J SHELLFISH RES, V27, P1311, DOI 10.2983/0730-8000-27.5.1311; Takeuchi T, 2012, DNA RES, V19, P117, DOI 10.1093/dnares/dss005; TALL BD, 1981, APPL ENVIRON MICROB, V42, P336, DOI 10.1128/AEM.42.2.336-343.1981; Tomaru Y, 2001, DIS AQUAT ORGAN, V44, P61, DOI 10.3354/dao044061; Fernandez NT, 2014, FEMS MICROBIOL ECOL, V88, P69, DOI 10.1111/1574-6941.12270; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wendling CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094256; Wile UJ, 1942, J AMER MED ASSOC, V119, P880, DOI 10.1001/jama.1942.02830280026008; Wu J, 2015, TROPICAL MED SURG, V2015; Yuszniahyati Y, 2015, Med J Malaysia, V70, P351	56	16	16	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182280	10.1371/journal.pone.0182280	http://dx.doi.org/10.1371/journal.pone.0182280			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771537	Green Submitted, Green Published, gold			2022-12-26	WOS:000406853600083
J	Nakamura, K; Miura, D; Saito, Y; Yunoki, K; Koyama, Y; Satoh, M; Kondo, M; Osawa, K; Hatipoglu, OF; Miyoshi, T; Yoshida, M; Morita, H; Ito, H				Nakamura, Kazufumi; Miura, Daiji; Saito, Yukihiro; Yunoki, Kei; Koyama, Yasushi; Satoh, Minoru; Kondo, Megumi; Osawa, Kazuhiro; Hatipoglu, Omer F.; Miyoshi, Toru; Yoshida, Masashi; Morita, Hiroshi; Ito, Hiroshi			Eicosapentaenoic acid prevents arterial calcification in klotho mutant mice	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; INHIBITS PROLIFERATION; CORONARY EVENTS; CALCIUM; DISEASE	Background The klotho gene was identified as an "aging-suppressor" gene that accelerates arterial calcification when disrupted. Serum and vascular klotho levels are reduced in patients with chronic kidney disease, and the reduced levels are associated with arterial calcification. Intake of eicosapentaenoic acid (EPA), an n-3 fatty acid, reduces the risk of fatal coronary artery disease. However, the effects of EPA on arterial calcification have not been fully elucidated. The aim of this study was to determine the effect of EPA on arterial calcification in klotho mutant mice. Methods and results Four-week-old klotho mutant mice and wild-type (WT) mice were given a diet containing 5% EPA (EPA food, klotho and WT: n = 12, each) or not containing EPA (control food, klotho and WT: n = 12, each) for 4 weeks. Calcium volume scores of thoracic and abdominal aortas assessed by computed tomography were significantly elevated in klotho mice after 4 weeks of control food, but they were not elevated in klotho mice after EPA food or in WT mice. Serum levels of EPA and resolvin E1, an active metabolite of EPA, in EPA food-fed mice were significantly increased compared to those in control food-fed mice. An oxidative stress PCR array followed by quantitative PCR revealed that NADPH oxidase-4 (NOX4), an enzyme that generates superoxide, gene expression was up-regulated in arterial smooth muscle cells (SMCs) of klotho mice. Activity of NOX was also significantly higher in SMCs of klotho mice than in those of WT mice. EPA decreased expression levels of the NOX4 gene and NOX activity. GPR120, a receptor of n-3 fatty acids, gene knockdown by siRNA canceled effects of EPA on NOX4 gene expression and NOX activity in arterial SMCs of klotho mice. Conclusions EPA prevents arterial calcification together with reduction of NOX gene expression and activity via GPR120 in klotho mutant mice.	[Nakamura, Kazufumi; Miura, Daiji; Saito, Yukihiro; Yunoki, Kei; Kondo, Megumi; Osawa, Kazuhiro; Hatipoglu, Omer F.; Miyoshi, Toru; Yoshida, Masashi; Morita, Hiroshi; Ito, Hiroshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Med, Okayama, Japan; [Miura, Daiji] Nagano Coll Nursing, Dept Basic Med, Komagane, Japan; [Koyama, Yasushi] Sakurabashi Watanabe Hosp, Dept Cardiol, Osaka, Japan; [Satoh, Minoru] Kawasaki Med Sch, Dept Nephrol & Hypertens, Kurashiki, Okayama, Japan; [Morita, Hiroshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Therapeut, Okayama, Japan	Okayama University; Kawasaki Medical School; Okayama University	Nakamura, K (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Med, Okayama, Japan.	ichibun@cc.okayama-u.ac.jp	Osawa, Kazuhiro/ABE-7537-2020; Hatipoglu, Omer Faruk/J-6706-2019	Hatipoglu, Omer Faruk/0000-0002-1012-001X; Saito, Yukihiro/0000-0001-7454-3102	Vascular Biology Innovation Conference (4th)	Vascular Biology Innovation Conference (4th)	Dr. Nakamura was supported by a grant from Vascular Biology Innovation Conference (4th).	Budoff MJ, 2007, J AM COLL CARDIOL, V49, P1860, DOI 10.1016/j.jacc.2006.10.079; Byon CH, 2008, J BIOL CHEM, V283, P15319, DOI 10.1074/jbc.M800021200; Callister TQ, 1998, NEW ENGL J MED, V339, P1972, DOI 10.1056/NEJM199812313392703; Callister TQ, 1998, RADIOLOGY, V208, P807, DOI 10.1148/radiology.208.3.9722864; Deng L, 2015, ARTERIOSCL THROM VAS, V35, P175, DOI 10.1161/ATVBAHA.114.304786; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Gao DS, 2016, HYPERTENSION, V68, P1191, DOI 10.1161/HYPERTENSIONAHA.116.07709; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Gyurko R, 2014, CRIT REV IMMUNOL, V34, P347, DOI 10.1615/CritRevImmunol.2014009982; Ikeda T, 2010, J CARDIOVASC PHARM, V55, P39, DOI 10.1097/FJC.0b013e3181c0419c; Itakura H, 2011, J ATHEROSCLER THROMB, V18, P99, DOI 10.5551/jat.5876; Kageyama A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068197; Kanai S, 2011, ATHEROSCLEROSIS, V215, P43, DOI 10.1016/j.atherosclerosis.2010.12.001; Kitagawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056695; Koh N, 2001, BIOCHEM BIOPH RES CO, V280, P1015, DOI 10.1006/bbrc.2000.4226; Kouchi H, 1999, BIOCHEM BIOPH RES CO, V264, P915, DOI 10.1006/bbrc.1999.1546; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Lim K, 2012, CIRCULATION, V125, P2243, DOI 10.1161/CIRCULATIONAHA.111.053405; Nagasu H, 2016, LAB INVEST, V96, P25, DOI 10.1038/labinvest.2015.128; Nakamura K, 2010, INT J CARDIOL, V140, P102, DOI 10.1016/j.ijcard.2008.11.022; Ogawa A, 2005, CIRCULATION, V112, P1806, DOI 10.1161/CIRCULATIONAHA.105.536169; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Osawa K, 2016, HEART VESSELS, V31, P499, DOI 10.1007/s00380-015-0645-5; Satoh M, 2006, P NATL ACAD SCI USA, V103, P7432, DOI 10.1073/pnas.0510444103; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Takamiya R, 2012, FEBS OPEN BIO, V2, P328, DOI 10.1016/j.fob.2012.10.001; Virmani R, 2014, ARTERIOSCL THROM VAS, V34, P1329, DOI 10.1161/ATVBAHA.114.304000; Wait JMS, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.003358; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3	30	20	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0181009	10.1371/journal.pone.0181009	http://dx.doi.org/10.1371/journal.pone.0181009			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771600	Green Published, gold, Green Submitted			2022-12-26	WOS:000406853600010
J	Suda, M; Shimizu, I; Yoshida, Y; Hayashi, Y; Ikegami, R; Katsuumi, G; Wakasugi, T; Yoshida, Y; Okuda, S; Soga, T; Minamino, T				Suda, Masayoshi; Shimizu, Ippei; Yoshida, Yohko; Hayashi, Yuka; Ikegami, Ryutaro; Katsuumi, Goro; Wakasugi, Takayuki; Yoshida, Yutaka; Okuda, Shujiro; Soga, Tomoyoshi; Minamino, Tohru			Inhibition of dipeptidyl peptidase-4 ameliorates cardiac ischemia and systolic dysfunction by up-regulating the FGF-2/EGR-1 pathway	PLOS ONE			English	Article							HEART-FAILURE; INSULIN-RESISTANCE; L-CITRULLINE; L-ARGININE; ORAL SUPPLEMENTATION; VENTRICULAR FUNCTION; ENERGY-METABOLISM; BLOOD-PRESSURE; GEL DIGESTION; MOUSE MODEL	Dipeptidyl peptidase 4 inhibitors are used worldwide in the management of diabetes, but their role in the prevention or treatment of cardiovascular disorders has yet to be defined. We found that linagliptin, a DPP-4 inhibitor, suppressed capillary rarefaction in the hearts of mice with dietary obesity. Metabolomic analysis performed with capillary electrophoresis/mass spectrometry (LC-MS/MS) showed that linagliptin promoted favorable metabolic remodeling in cardiac tissue, which was characterized by high levels of citrulline and creatine. DNA microarray analysis revealed that the cardiac tissue level of early growth response protein 1 (EGR-1), which activates angiogenesis, was significantly reduced in untreated mice with dietary obesity, while this decrease was inhibited by administration of linagliptin. Mature fibroblast growth factor 2 (FGF-2) has a putative truncation site for DPP-4 at the NH2-terminal, and LC-MS/MS showed that recombinant DPP-4 protein cleaved the NH2-terminal dipeptides of mature FGF-2. Incubation of cultured neonatal rat cardiomyocytes with FGF-2 increased Egr1 expression, while it was suppressed by recombinant DPP-4 protein. Furthermore, vascular endothelial growth factor-A had a critical role in mediating FGF-2/EGR-1 signaling. In conclusion, pharmacological inhibition of DPP-4 suppressed capillary rarefaction and contributed to favorable remodeling of cardiac metabolism in mice with dietary obesity.	[Suda, Masayoshi; Shimizu, Ippei; Yoshida, Yohko; Hayashi, Yuka; Ikegami, Ryutaro; Katsuumi, Goro; Wakasugi, Takayuki; Minamino, Tohru] Niigata Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Biol & Med, Niigata, Japan; [Shimizu, Ippei; Yoshida, Yohko] Niigata Univ, Grad Sch Med & Dent Sci, Div Mol Aging & Cell Biol, Niigata, Japan; [Yoshida, Yutaka] Niigata Univ, Grad Sch Med & Dent Sci, Inst Nephrol, Dept Struct Pathol, Niigata, Japan; [Okuda, Shujiro] Niigata Univ, Grad Sch Med & Dent Sci, Div Bioinformat, Niigata, Japan; [Soga, Tomoyoshi] Keio Univ, Inst Adv Biosci, Yamagata, Japan	Niigata University; Niigata University; Niigata University; Niigata University; Keio University	Minamino, T (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Biol & Med, Niigata, Japan.	tminamino@med.niigata-u.ac.jp	Minamino, Tohru/P-8145-2018	Minamino, Tohru/0000-0003-1627-6151; Shimizu, Ippei/0000-0003-3333-8131	Stem Cell Aging and Disease [17H04172, 26115008]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [15K15306]; Takeda Medical Research Foundation; Japan Foundation for Applied Enzymology; Takeda Science Foundation; SENSHIN Medical Research Foundation; Terumo Foundation; Manpei Suzuki Diabetes Foundation; Naito Foundation; NOVARITIS foundation; Boehringer Ingelheim, Inc.; JSPS KAKENHI [26893080, 16H06244, 16K19531]; Uehara Memorial Foundation; Kowa Life Science Foundation; Kanae Foundation; Japan Heart Foundation Research Grant; Senri Life Science Foundation; ONO Medical Research Foundation; Tsukada Grant for Niigata University Medical Research; Nakajima Foundation; SUZUKEN memorial foundation; Inamori Foundation; Mochida Memorial Foundation for Medical & Pharmaceutical Research; MSD Life Science Foundation; Public Interest Incorporated Foundation; Sumitomo Foundation; Japan Cardiovascular Research Foundation; Japan Diabetes Foundation; Kimura Memorial Heart Foundation; TERUMO FOUNDATION for LIFE SCIENCES and ARTS; Japan Heart Foundation Dr. Hiroshi Irisawa & Dr. Aya Irisawa Memorial Research Grant; Research Foundation for Community Medicine; Banyu Foundation Research Grant; Bourbon	Stem Cell Aging and Disease; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Medical Research Foundation; Japan Foundation for Applied Enzymology; Takeda Science Foundation(Takeda Science Foundation (TSF)); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Terumo Foundation; Manpei Suzuki Diabetes Foundation; Naito Foundation(Naito Memorial Foundation); NOVARITIS foundation; Boehringer Ingelheim, Inc.(Boehringer Ingelheim); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Uehara Memorial Foundation(Uehara Memorial Foundation); Kowa Life Science Foundation; Kanae Foundation; Japan Heart Foundation Research Grant; Senri Life Science Foundation; ONO Medical Research Foundation; Tsukada Grant for Niigata University Medical Research; Nakajima Foundation; SUZUKEN memorial foundation; Inamori Foundation; Mochida Memorial Foundation for Medical & Pharmaceutical Research; MSD Life Science Foundation; Public Interest Incorporated Foundation; Sumitomo Foundation; Japan Cardiovascular Research Foundation; Japan Diabetes Foundation; Kimura Memorial Heart Foundation; TERUMO FOUNDATION for LIFE SCIENCES and ARTS; Japan Heart Foundation Dr. Hiroshi Irisawa & Dr. Aya Irisawa Memorial Research Grant; Research Foundation for Community Medicine; Banyu Foundation Research Grant; Bourbon	This work was supported by a Grant-in -Aid for Scientific Research (Grant number 17H04172), a Grant-in-Aid for Scientific Research on Innovative Areas (Stem Cell Aging and Disease, Grant number 26115008), a Grant-in-Aid for Exploratory Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT, Grant number 15K15306) of Japan, grants from the Takeda Medical Research Foundation, the Japan Foundation for Applied Enzymology, the Takeda Science Foundation, the SENSHIN Medical Research Foundation, the Terumo Foundation, the Manpei Suzuki Diabetes Foundation, the Naito Foundation, and the NOVARITIS foundation, and the consigned research fund from Boehringer Ingelheim, Inc. (to T.M.) as well as by a Grants-in-Aid for Young Scientists (Start-up) (JSPS KAKENHI, Grant Number 26893080), and grants from the Uehara Memorial Foundation, Takeda Science Foundation, Kowa Life Science Foundation, Manpei Suzuki Diabetes Foundation, Kanae Foundation, Japan Heart Foundation Research Grant, The Senri Life Science Foundation, SENSHIN Medical Research Foundation, ONO Medical Research Foundation, Tsukada Grant for Niigata University Medical Research, The Nakajima Foundation, SUZUKEN memorial foundation, Inamori Foundation, Mochida Memorial Foundation for Medical & Pharmaceutical Research, MSD Life Science Foundation, Public Interest Incorporated Foundation, Grant for Basic Science Research Projects from The Sumitomo Foundation, Grants-in-Aid for Encouragement of Young Scientists (A) (JSPS KAKENHI Grant Number 16H06244), Grant From Japan Cardiovascular Research Foundation, Japan Diabetes Foundation, Kimura Memorial Heart Foundation, TERUMO FOUNDATION for LIFE SCIENCES and ARTS (to I.S.); by a Grants-in-Aid for Encouragement of Young Scientists (B) (JSPS KAKENHI Grant Number 16K19531), a Japan Heart Foundation Dr. Hiroshi Irisawa & Dr. Aya Irisawa Memorial Research Grant, Senshin Medical Research Foundation grant, SUZUKEN memorial foundation, Takeda Science Foundation, ONO Medical Research Foundation, Uehara Memorial Foundation, Research Foundation for Community Medicine, Kanae Foundation, Banyu Foundation Research Grant (to Y.Y.) and by a grant from Bourbon (to T.M., I.S. and Y.Y.). All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Boehringer Ingelheim supplied the DPP4 inhibitor, but was not involved in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop P, 2016, EUR J APPL PHYSIOL, V116, P1651, DOI 10.1007/s00421-016-3418-7; Arnlov J, 2001, AM HEART J, V142, P720, DOI 10.1067/mhj.2001.116957; Baumgardt SL, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.002424; Bostick B, 2014, METABOLISM, V63, P1000, DOI 10.1016/j.metabol.2014.04.002; Doenst T, 2013, CIRC RES, V113, P709, DOI 10.1161/CIRCRESAHA.113.300376; dos Santos L, 2013, CIRC-HEART FAIL, V6, P1029, DOI 10.1161/CIRCHEARTFAILURE.112.000057; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Filion KB, 2016, NEW ENGL J MED, V374, P1145, DOI 10.1056/NEJMoa1506115; Gilbert RE, 2015, LANCET, V385, P2107, DOI 10.1016/S0140-6736(14)61402-1; Gomez N, 2012, J VET INTERN MED, V26, P929, DOI 10.1111/j.1939-1676.2012.00942.x; Gomez N, 2012, EUR J HEART FAIL, V14, P14, DOI 10.1093/eurjhf/hfr146; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405; Ingelsson E, 2005, JAMA-J AM MED ASSOC, V294, P334, DOI 10.1001/jama.294.3.334; Orozco-Gutierrez JJ, 2010, CARDIOL J, V17, P612; Katayama H, 2001, RAPID COMMUN MASS SP, V15, P1416, DOI 10.1002/rcm.379; Lindbom M, 2008, J CARD FAIL, V14, P161, DOI 10.1016/j.cardfail.2007.10.020; Lu XN, 2005, MOL CELL PROTEOMICS, V4, P1948, DOI 10.1074/mcp.M500138-MCP200; Lygate CA, 2007, J MOL CELL CARDIOL, V42, P1129, DOI 10.1016/j.yjmcc.2007.03.899; Lygate CA, 2012, CARDIOVASC RES, V96, P466, DOI 10.1093/cvr/cvs272; MILLANVOYEVANBRUSSEL E, 1985, BIOCHEM PHARMACOL, V34, P145, DOI 10.1016/0006-2952(85)90114-5; Morita M, 2014, BIOCHEM BIOPH RES CO, V454, P53, DOI 10.1016/j.bbrc.2014.10.029; Mulvihill EE, 2014, ENDOCR REV, V35, P992, DOI 10.1210/er.2014-1035; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Ortega FB, 2016, CIRC RES, V118, P1752, DOI 10.1161/CIRCRESAHA.115.306883; Ou X, 2013, BLOOD, V122, P161, DOI 10.1182/blood-2013-02-487470; Passiatore G, 2011, J CELL PHYSIOL, V226, P1763, DOI 10.1002/jcp.22505; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Schwedhelm E, 2008, BRIT J CLIN PHARMACO, V65, P51, DOI 10.1111/j.1365-2125.2007.02990.x; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Sell H, 2013, DIABETES CARE, V36, P4083, DOI 10.2337/dc13-0496; Shigeta T, 2012, CIRCULATION, V126, P1838, DOI 10.1161/CIRCULATIONAHA.112.096479; Shimizu I, 2012, CELL METAB, V15, P51, DOI 10.1016/j.cmet.2011.12.006; Shimizu I, 2010, J CLIN INVEST, V120, P1506, DOI 10.1172/JCI40096; Shimoyamada H, 2010, AM J PATHOL, V177, P70, DOI 10.2353/ajpath.2010.091164; Silverman ES, 1999, AM J PATHOL, V154, P665, DOI 10.1016/S0002-9440(10)65312-6; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Takahashi A, 2013, AM J PHYSIOL-HEART C, V304, pH1361, DOI 10.1152/ajpheart.00454.2012; Ussher JR, 2014, CIRC RES, V114, P1788, DOI 10.1161/CIRCRESAHA.114.301958; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Witteles RM, 2008, J AM COLL CARDIOL, V51, P93, DOI 10.1016/j.jacc.2007.10.021; Yajima S, 2005, INT HEART J, V46, P289, DOI 10.1536/ihj.46.289; Zannad F, 2015, LANCET, V385, P2067, DOI 10.1016/S0140-6736(14)62225-X; Zhong JX, 2015, CIRC RES, V116, P1491, DOI 10.1161/CIRCRESAHA.116.305665	45	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182422	10.1371/journal.pone.0182422	http://dx.doi.org/10.1371/journal.pone.0182422			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771625	gold, Green Published, Green Submitted			2022-12-26	WOS:000406853600109
J	Fedida, J; Fressart, V; Charron, P; Surget, E; Hery, T; Richard, P; Donal, E; Keren, B; Duthoit, G; Hidden-Lucet, F; Villard, E; Gandjbakhch, E				Fedida, Joel; Fressart, Veronique; Charron, Philippe; Surget, Elodie; Hery, Tiphaine; Richard, Pascale; Donal, Erwan; Keren, Boris; Duthoit, Guillaume; Hidden-Lucet, Francoise; Villard, Eric; Gandjbakhch, Estelle			Contribution of exome sequencing for genetic diagnostic in arrhythmogenic right ventricular cardiomyopathy/dysplasia	PLOS ONE			English	Article							DILATED CARDIOMYOPATHY; CONSENSUS STATEMENT; HEART-FAILURE; MUTATIONS; DYSPLASIA/CARDIOMYOPATHY; DELETIONS; SPECTRUM; FAMILY; IMPACT	Background Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia (ARVC/D) is an inherited cardiomyopathy mainly caused by heterozygous desmosomal gene mutations, the major gene being PKP2. The genetic cause remains unknown in similar to 50% of probands with routine desmosomal gene screening. The aim of this study was to assess the diagnostic accuracy of whole exome sequencing (WES) in ARVC/D with negative genetic testing. Methods WES was performed in 22 patients, all without a mutation identified in desmosomal genes. Putative pathogenic variants were screened in 96 candidate genes associated with other cardiomyopathies/channelopathies. The sequencing coverage depth of PKP2, DSP, DSG2, DSC2, JUP and TMEM43 exons was compared to the mean coverage distribution to detect large insertions/deletions. All suspected deletions were verified by real-time qPCR, Multiplex- Ligation-dependent-Probe-Amplification (MLPA) and cGH-Array. MLPA was performed in 50 additional gene-negative probands. Results Coverage-depth analysis from the 22 WES data identified two large heterozygous PKP2 deletions: one from exon 1 to 14 and one restricted to exon 4, confirmed by qPCR and MLPA. MLPA identified 2 additional PKP2 deletions (exon 1-7 and exon 1-14) in 50 additional probands confirming a significant frequency of large PKP2 deletions (5.7%) in genenegative ARVC/D. Putative pathogenic heterozygous variants in EYA4, RBM20, PSEN1, and COX15 were identified in 4 unrelated probands. Conclusion A rather high frequency (5.7%) of large PKP2 deletions, undetectable by Sanger sequencing, was detected as the cause of ARVC/D. Coverage-depth analysis through next-generation sequencing appears accurate to detect large deletions at the same time than conventional putative mutations in desmosomal and cardiomyopathy-associated genes.	[Fedida, Joel; Surget, Elodie; Hery, Tiphaine; Villard, Eric; Gandjbakhch, Estelle] Hop La Pitie Salpetriere, INSERM, UMR S1166, ICAN, Paris, France; [Fedida, Joel; Duthoit, Guillaume; Hidden-Lucet, Francoise; Gandjbakhch, Estelle] Grp Hosp Pitie Salpetriere, AP HP, Inst Cardiol, Paris, France; [Fressart, Veronique; Richard, Pascale; Keren, Boris] Grp Hosp Pitie Salpetriere, AP HP, Serv Biochim Metabol, Unite Cardiogenet & Myogenet, Paris, France; [Charron, Philippe] Grp Hosp Ambroise Pare, AP HP, Dept Cardiol, Boulogne, France; [Charron, Philippe; Gandjbakhch, Estelle] Grp Hosp Pitie Salpetriere, AP HP, Ctr Reference Malad Cardiaques Hereditaires, Paris, France; [Donal, Erwan] Hop Pontchaillou, Dept Cardiol, Rennes, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Rennes	Gandjbakhch, E (corresponding author), Hop La Pitie Salpetriere, INSERM, UMR S1166, ICAN, Paris, France.; Gandjbakhch, E (corresponding author), Grp Hosp Pitie Salpetriere, AP HP, Inst Cardiol, Paris, France.; Gandjbakhch, E (corresponding author), Grp Hosp Pitie Salpetriere, AP HP, Ctr Reference Malad Cardiaques Hereditaires, Paris, France.	estelle.gandjbakhch@aphp.fr	Villard, Eric/AAI-2464-2021; villard, eric/AAH-2868-2021; donal, erwan/ABC-9736-2020	Villard, Eric/0000-0001-9801-7297; gandjbakhch, estelle/0000-0002-4846-5021; hidden-lucet, francoise/0000-0003-1257-5357; Charron, Philippe/0000-0002-1782-1118; Richard, Pascale/0000-0002-2390-3005	Assistance Publique-Hopitaux de Paris [05073]; "Federation Francaise de Cardiologie"/"Societe Frangaise de Cardiologie" and "Ligue contre la cardiomyopathie"; Federation Frangaise de Cardiologie	Assistance Publique-Hopitaux de Paris; "Federation Francaise de Cardiologie"/"Societe Frangaise de Cardiologie" and "Ligue contre la cardiomyopathie"; Federation Frangaise de Cardiologie	This work was supported by grants from Assistance Publique-Hopitaux de Paris [PHRC programme hospitalier de recherche AOM no 05073], "Federation Francaise de Cardiologie"/"Societe Frangaise de Cardiologie" and "Ligue contre la cardiomyopathie". J. Fedida was supported by a grant from the Federation Frangaise de Cardiologie. We thank Myobank - AFM (Institut de Myologie Hopital Pitie-Salpetriere, Paris, France) for the collection of heart samples from ARVC/D patients.	Ackerman MJ, 2011, EUROPACE, V13, P1077, DOI 10.1093/europace/eur245; Basso C, LANCET, V11, P1289; Bienengraeber M, 2004, NAT GENET, V36, P382, DOI 10.1038/ng1329; Brauch KM, 2009, J AM COLL CARDIOL, V54, P930, DOI 10.1016/j.jacc.2009.05.038; Christensen AH, 2011, CLIN GENET, V80, P256, DOI 10.1111/j.1399-0004.2011.01623.x; Christensen AH, 2010, J MED GENET, V47, P736, DOI 10.1136/jmg.2010.077891; Corrado D, 2015, CIRCULATION, V132, P441, DOI 10.1161/CIRCULATIONAHA.115.017944; Cox MGPJ, 2011, CIRCULATION, V123, P2690, DOI 10.1161/CIRCULATIONAHA.110.988287; Feng YM, 2015, GENET MED, V17, P99, DOI 10.1038/gim.2014.80; Fressart V, 2010, EUROPACE, V12, P861, DOI 10.1093/europace/euq104; Guo W, 2012, NAT MED, V18, P766, DOI 10.1038/nm.2693; Li DX, 2006, AM J HUM GENET, V79, P1030, DOI 10.1086/509900; Marcus FI, 2010, EUR HEART J, V31, P806, DOI [10.1093/eurheartj/ehq025, 10.1161/CIRCULATIONAHA.108.840827]; Mura IEAL, 2013, EUR J HUM GENET, V21, P1226, DOI 10.1038/ejhg.2013.39; Murray B, 2013, AM J MED GENET A, V161A, P371, DOI 10.1002/ajmg.a.35733; Ott P, 2003, PACE, V26, P1498, DOI 10.1046/j.1460-9592.2003.t01-1-00217.x; Otten E, 2010, HEART RHYTHM, V7, P1058, DOI 10.1016/j.hrthm.2010.04.023; Quarta G, 2011, EUR HEART J; Quarta G, 2011, CIRCULATION, V123, P2701, DOI 10.1161/CIRCULATIONAHA.110.976936; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rigato I, 2013, CIRC-CARDIOVASC GENE, V6, P533, DOI 10.1161/CIRCGENETICS.113.000288; Roberts JD, 2013, CLIN GENET, V83, P452, DOI 10.1111/j.1399-0004.2012.01950.x; Schonberger J, 2005, NAT GENET, V37, P418, DOI 10.1038/ng1527; Tiso N, 2001, HUM MOL GENET, V10, P189, DOI 10.1093/hmg/10.3.189; van der Zwaag PA, 2012, EUR J HEART FAIL, V14, P1199, DOI 10.1093/eurjhf/hfs119; Vite A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075082	26	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0181840	10.1371/journal.pone.0181840	http://dx.doi.org/10.1371/journal.pone.0181840			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767663	Green Submitted, Green Published, gold			2022-12-26	WOS:000406768200039
J	Gao, MH; Lai, NC; Giamouridis, D; Kim, YC; Guo, T; Hammond, HK				Gao, Mei Hua; Lai, N. Chin; Giamouridis, Dimosthenis; Kim, Young Chul; Guo, Tracy; Hammond, H. Kirk			Cardiac-directed expression of a catalytically inactive adenylyl cyclase 6 protects the heart from sustained beta-adrenergic stimulation	PLOS ONE			English	Article							LEFT-VENTRICULAR FUNCTION; HYPERTROPHIC RESPONSE; RECEPTOR STIMULATION; GENE-TRANSFER; FAILURE; MYOCYTES; MICE; CARDIOMYOPATHY; CONTRACTILITY; INHIBITION	Objectives Increased expression of adenylyl cyclase type 6 (AC6) has beneficial effects on the heart through cyclic adenosine monophosphate (cAMP)-dependent and cAMP-independent pathways. We previously generated a catalytically inactive mutant of AC6 (AC6mut) that has an attenuated response to beta-adrenergic receptor stimulation, and, consequently, exhibits reduced myocardial cAMP generation. In the current study we test the hypothesis that cardiac- directed expression of AC6mut would protect the heart from sustained beta-adrenergic receptor stimulation, a condition frequently encountered in patients with heart failure. Methods and results AC6mut mice and transgene negative siblings received osmotic mini-pumps to provide continuous isoproterenol infusion for seven days. Isoproterenol infusion caused deleterious effects that were attenuated by cardiac-directed AC6mut expression. Both groups showed reduced left ventricular (LV) ejection fraction, but the reduction was less in AC6mut mice (p = 0.047). In addition, AC6mut mice showed superior left ventricular function, manifested by higher values for LV peak +dP/dt (p = 0.03), LV peak -dP/dt (p = 0.008), end-systolic pressure-volume relationship (p = 0.003) and cardiac output (p<0.03). LV samples of AC6mut mice had more sarco/endoplasmic reticulum Ca2+-ATPase (SERCA2a) protein (p<0.01), which likely contributed to better LV function. AC6mut mice had lower rates of cardiac myocyte apoptosis (p = 0.016), reduced caspase 3/7 activity (p = 0.012) and increased B-cell lymphoma 2 (Bcl2) expression (p = 0.0001). Conclusion Mice with cardiac-directed AC6mut expression weathered the deleterious effects of continuous isoproterenol infusion better than control mice, indicating cardiac protection.	[Gao, Mei Hua; Lai, N. Chin; Giamouridis, Dimosthenis; Kim, Young Chul; Guo, Tracy; Hammond, H. Kirk] VA San Diego Healthcare Syst, Dept Med, Div Cardiol, San Diego, CA 92161 USA; [Gao, Mei Hua; Lai, N. Chin; Giamouridis, Dimosthenis; Kim, Young Chul; Guo, Tracy; Hammond, H. Kirk] Univ Calif San Diego, Dept Med, Div Cardiol, La Jolla, CA 92093 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego	Hammond, HK (corresponding author), VA San Diego Healthcare Syst, Dept Med, Div Cardiol, San Diego, CA 92161 USA.; Hammond, HK (corresponding author), Univ Calif San Diego, Dept Med, Div Cardiol, La Jolla, CA 92093 USA.	khammond@ucsd.edu		Kim, Young Chul/0000-0002-6782-2186; Hammond, H Kirk/0000-0002-6432-5934	National Institute of Health [P01 HL66941]; Merit grant from the Department of Veteran's Affairs [1101 BX001515-03, BX003774-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL066941] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003774, I01BX001515] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merit grant from the Department of Veteran's Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a National Institute of Health grant (P01 HL66941) and Merit grants from the Department of Veteran's Affairs (1101 BX001515-03, BX003774-01A1).	Baker DL, 1998, CIRC RES, V83, P1205, DOI 10.1161/01.RES.83.12.1205; Bhargava V, 1998, AM J CARDIOL, V81, P1130, DOI 10.1016/S0002-9149(98)00133-7; De Windt LJ, 2001, P NATL ACAD SCI USA, V98, P3322, DOI 10.1073/pnas.031371998; Fiedler B, 2004, CARDIOVASC RES, V63, P450, DOI 10.1016/j.cardiores.2004.04.002; Frantz S, 2013, EUR HEART J, V34, P1233, DOI 10.1093/eurheartj/ehr445; Gao Mei Hua, 2016, JACC Basic Transl Sci, V1, P617, DOI 10.1016/j.jacbts.2016.08.004; Gao MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072151; Gao MH, 2011, MOL PHARMACOL, V79, P381, DOI 10.1124/mol.110.067298; Gao MH, 2008, J BIOL CHEM, V283, P33527, DOI 10.1074/jbc.M805825200; Gao MH, 2004, J BIOL CHEM, V279, P38797, DOI 10.1074/jbc.M405701200; Hammond HK, 2016, JAMA CARDIOL, V1, P163, DOI 10.1001/jamacardio.2016.0008; Hare JM, 1998, CIRCULATION, V97, P161, DOI 10.1161/01.CIR.97.2.161; Hu AH, 2006, J PHARMACOL EXP THER, V318, P469, DOI 10.1124/jpet.106.102160; Kedzierski RM, 2003, MOL CELL BIOL, V23, P8226, DOI 10.1128/MCB.23.22.8226-8232.2003; Lai NC, 2008, J AM COLL CARDIOL, V51, P1490, DOI 10.1016/j.jacc.2008.01.015; Lai NC, 2004, CIRCULATION, V110, P330, DOI 10.1161/01.CIR.0000136033.21777.4D; MASON DT, 1971, CIRCULATION, V44, P47, DOI 10.1161/01.CIR.44.1.47; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; Nakayama H, 2009, J CLIN INVEST, V119, P3787, DOI 10.1172/JCI39724; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Ping PP, 1997, AM J PHYSIOL-HEART C, V273, pH707, DOI 10.1152/ajpheart.1997.273.2.H707; Senzaki H, 1996, CIRCULATION, V94, P2497, DOI 10.1161/01.CIR.94.10.2497; Sheikh F, 2008, J CLIN INVEST, V118, P3870, DOI 10.1172/JCI34472; Takahashi T, 2006, CIRCULATION, V114, P388, DOI 10.1161/CIRCULATIONAHA.106.632513; Tang T, 2008, CIRCULATION, V117, P61, DOI 10.1161/CIRCULATIONAHA.107.730069; Tang T, 2013, J MOL CELL CARDIOL, V60, P60, DOI 10.1016/j.yjmcc.2013.04.005; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664	27	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0181282	10.1371/journal.pone.0181282	http://dx.doi.org/10.1371/journal.pone.0181282			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767701	Green Published, gold, Green Submitted			2022-12-26	WOS:000406768200021
J	Lopez-Luna, J; Al-Jubouri, Q; Al-Nuaimy, W; Sneddon, LU				Lopez-Luna, Javier; Al-Jubouri, Qussay; Al-Nuaimy, Waleed; Sneddon, Lynne U.			Impact of stress, fear and anxiety on the nociceptive responses of larval zebrafish	PLOS ONE			English	Article							RAINBOW-TROUT; INDUCED ANALGESIA; ATLANTIC SALMON; BEHAVIORAL-RESPONSES; ONCORHYNCHUS-MYKISS; ALARM SUBSTANCE; PAIN; FISH; MODEL; STIMULATION	Both adult and larval zebrafish have been demonstrated to show behavioural responses to noxious stimulation but also to potentially stress- and fear or anxiety-eliciting situations. The pain or nociceptive response can be altered and modulated by these situations in adult fish through a mechanism called stress- induced analgesia. However, this phenomenon has not been described in larval fish yet. Therefore, this study explores the behavioural changes in larval zebrafish after noxious stimulation and exposure to challenges that can trigger a stress, fear or anxiety reaction. Five-day post fertilization zebrafish were exposed to either a stressor (air emersion), a predatory fear cue (alarm substance) or an anxiogenic (caffeine) alone or prior to immersion in acetic acid 0.1%. Pre- and post-stimulation behaviour (swimming velocity and time spent active) was recorded using a novel tracking software in 25 fish at once. Results show that larvae reduced both velocity and activity after exposure to the air emersion and alarm substance challenges and that these changes were attenuated using etomidate and diazepam, respectively. Exposure to acetic acid decreased velocity and activity as well, whereas air emersion and alarm substance inhibited these responses, showing no differences between pre- and post-stimulation. Therefore, we hypothesize that an antinociceptive mechanism, activated by stress and/or fear, occur in 5dpf zebrafish, which could have prevented the larvae to display the characteristic responses to pain.	[Lopez-Luna, Javier; Sneddon, Lynne U.] Univ Liverpool, Inst Integrat Biol, Dept Evolut Ecol & Behav, Liverpool, Merseyside, England; [Al-Jubouri, Qussay; Al-Nuaimy, Waleed] Univ Liverpool, Dept Elect Engn & Elect, Liverpool, Merseyside, England	University of Liverpool; University of Liverpool	Lopez-Luna, J (corresponding author), Univ Liverpool, Inst Integrat Biol, Dept Evolut Ecol & Behav, Liverpool, Merseyside, England.	jlopez@liverpool.ac.uk		Sneddon, Lynne/0000-0001-9787-3948; Al-Jubouri, Qussay Salim/0000-0002-9917-702X	EU Marie Curie Intra European Fellowship [FP7-PEOPLE-2013-430 IEF 628506]; NC3Rs UK [NC/K000888/1]; National Centre for the Replacement [NC/K000888/1] Funding Source: researchfish	EU Marie Curie Intra European Fellowship(European Commission); NC3Rs UK(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); National Centre for the Replacement	This project has been financed by a EU Marie Curie Intra European Fellowship (FP7-PEOPLE-2013-430 IEF 628506). LS is grateful for funding from NC3Rs UK (NC/K000888/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves FL, 2013, PHYSIOL BEHAV, V110, P58, DOI 10.1016/j.physbeh.2012.12.003; AMIT Z, 1986, PHYSIOL REV, V66, P1091, DOI 10.1152/physrev.1986.66.4.1091; Arends RJ, 1999, J ENDOCRINOL, V163, P149, DOI 10.1677/joe.0.1630149; Ashley PJ, 2009, ANIM BEHAV, V77, P403, DOI 10.1016/j.anbehav.2008.10.015; Bjorge MH, 2011, APPL ANIM BEHAV SCI, V133, P127, DOI 10.1016/j.applanim.2011.04.018; BODNAR RJ, 1979, PHYSIOL BEHAV, V23, P53, DOI 10.1016/0031-9384(79)90122-7; BOLLES RC, 1980, BEHAV BRAIN SCI, V3, P291, DOI 10.1017/S0140525X0000491X; Butler RK, 2009, PROG NEUROBIOL, V88, P184, DOI 10.1016/j.pneurobio.2009.04.003; Collymore C, 2014, J AM ASSOC LAB ANIM, V53, P198; Correia AD, 2011, PHARMACEUTICALS, V4, P665, DOI 10.3390/ph4040665; de Abreu MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103232; Dunlop R, 2005, J PAIN, V6, P561, DOI 10.1016/j.jpain.2005.02.010; Egan RJ, 2009, BEHAV BRAIN RES, V205, P38, DOI 10.1016/j.bbr.2009.06.022; Finn DP, 2004, EUR J NEUROSCI, V20, P848, DOI 10.1111/j.1460-9568.2004.03509.x; FINN IB, 1986, J PHARM EXP THER, V238, P33293; Flor H, 2002, EUR J PAIN-LONDON, V6, P395, DOI 10.1016/S1090-3801(02)00043-5; Gerlai R, 2010, BEHAV BRAIN RES, V207, P223, DOI 10.1016/j.bbr.2009.10.008; Gonzalez-Nunez V, 2009, ILAR J, V50, P373, DOI 10.1093/ilar.50.4.373; Gupta P., 2014, DRUG DEV THER, V5, P127, DOI [https://doi.org/10.4103/2394-2002.139626, DOI 10.4103/2394-2002.139626]; Hohmann AG, 2005, NATURE, V435, P1108, DOI 10.1038/nature03658; Kalueff AV, 2013, ZEBRAFISH, V10, P70, DOI 10.1089/zeb.2012.0861; Le Francois Nathalie R., 2013, Journal of Applied Aquaculture, V25, P248, DOI 10.1080/10454438.2013.815142; Liu Y, 2011, ECOL MODEL, V222, P2191, DOI 10.1016/j.ecolmodel.2011.02.010; Lopez-Luna J, 2017, J EXP BIOL, V220, P1451, DOI 10.1242/jeb.146969; Lopez -Luna J, 2017, APPL ANIM BEHAV SCI, V188, P97, DOI 10.1016/j.applanim.2017.01.002; MADDEN J, 1977, NATURE, V265, P358, DOI 10.1038/265358a0; Malafoglia V, 2014, J CELL PHYSIOL, V229, P300, DOI 10.1002/jcp.24447; MASSEE KC, 1995, AQUACULTURE, V134, P351, DOI 10.1016/0044-8486(95)00057-9; Maximino Caio, 2011, Psychol. Neurosci., V4, P149, DOI 10.3922/j.psns.2011.1.017; Maximino C, 2010, BEHAV BRAIN RES, V214, P157, DOI 10.1016/j.bbr.2010.05.031; Meagher MW, 2001, PSYCHOSOM MED, V63, P79, DOI 10.1097/00006842-200101000-00010; Mettam JJ, 2012, J EXP BIOL, V215, P685, DOI 10.1242/jeb.060350; Mettam JJ, 2011, APPL ANIM BEHAV SCI, V133, P265, DOI 10.1016/j.applanim.2011.06.009; MOSKOWITZ AS, 1985, PAIN, V23, P67, DOI 10.1016/0304-3959(85)90231-3; Mosley Craig, 2011, Veterinary Clinics of North America Exotic Animal Practice, V14, P45, DOI 10.1016/j.cvex.2010.09.009; Mourabit S, 2010, BIOL LETTERS, V6, P525, DOI 10.1098/rsbl.2009.0944; Nasr MAF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042420; Nordgreen J, 2007, J COMP PHYSIOL A, V193, P1235, DOI 10.1007/s00359-007-0283-1; Nordgreen J, 2009, APPL ANIM BEHAV SCI, V119, P101, DOI 10.1016/j.applanim.2009.03.015; OLSEN YA, 1995, AQUACULTURE, V134, P155, DOI 10.1016/0044-8486(95)00008-P; Ploghaus A, 2001, J NEUROSCI, V21, P9896, DOI 10.1523/JNEUROSCI.21-24-09896.2001; Ramsay JM, 2009, AQUACULTURE, V297, P157, DOI 10.1016/j.aquaculture.2009.08.035; Readman GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073773; Reilly SC, 2008, NEUROSCI LETT, V437, P135, DOI 10.1016/j.neulet.2008.03.075; Rhudy JL, 2000, PAIN, V84, P65, DOI 10.1016/S0304-3959(99)00183-9; Richendrfer H, 2012, BEHAV BRAIN RES, V228, P99, DOI 10.1016/j.bbr.2011.11.041; Roques JAC, 2012, FISH PHYSIOL BIOCHEM, V38, P1019, DOI 10.1007/s10695-011-9586-9; Schnorr SJ, 2012, BEHAV BRAIN RES, V228, P367, DOI 10.1016/j.bbr.2011.12.016; Sneddon LU, 2003, J PAIN, V4, P431, DOI 10.1067/S1526-5900(03)00717-X; Sneddon LU, 2003, APPL ANIM BEHAV SCI, V83, P153, DOI 10.1016/S0168-1591(03)00113-8; Sneddon LU, 2003, BRAIN RES, V972, P44, DOI 10.1016/S0006-8993(03)02483-1; Sneddon LU, 2014, ANIM BEHAV, V97, P201, DOI 10.1016/j.anbehav.2014.09.007; Sneddon LU, 2012, J EXOT PET MED, V21, P32, DOI 10.1053/j.jepm.2011.11.009; Sneddon LU, 2009, ILAR J, V50, P338, DOI 10.1093/ilar.50.4.338; Speedie N, 2008, BEHAV BRAIN RES, V188, P168, DOI 10.1016/j.bbr.2007.10.031; Steenbergen PJ, 2014, APPL ANIM BEHAV SCI, V152, P92, DOI 10.1016/j.applanim.2013.12.001; Steenbergen PJ, 2011, BEHAV BRAIN RES, V222, P15, DOI 10.1016/j.bbr.2011.03.025; Steimer Thierry, 2002, Dialogues Clin Neurosci, V4, P231; Valverde O, 2000, EUR J NEUROSCI, V12, P533, DOI 10.1046/j.1460-9568.2000.00929.x; Wisenden BD, 2000, PHILOS T ROY SOC B, V355, P1205, DOI 10.1098/rstb.2000.0668; Wolkers CPB, 2013, PLOS ONE, V8; Wong K, 2010, BRAIN RES, V1348, P209, DOI 10.1016/j.brainres.2010.06.012; Yilmaz P, 2010, PAIN, V151, P522, DOI 10.1016/j.pain.2010.08.016; Yue S, 2004, APPL ANIM BEHAV SCI, V87, P343, DOI 10.1016/j.applanim.2004.01.004	64	34	36	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0181010	10.1371/journal.pone.0181010	http://dx.doi.org/10.1371/journal.pone.0181010			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767661	Green Submitted, Green Published, gold			2022-12-26	WOS:000406768200014
J	Su, KC; Kou, YR; Lin, FC; Wu, CH; Feng, JY; Huang, SF; Shiung, TF; Chung, KC; Tung, YH; Yang, KY; Chang, SC				Su, Kang-Cheng; Kou, Yu Ru; Lin, Fang-Chi; Wu, Chieh-Hung; Feng, Jia-Yih; Huang, Shiang-Fen; Shiung, Tao-Fen; Chung, Kwei-Chun; Tung, Yu-Hsiu; Yang, Kuang-Yao; Chang, Shi-Chuan			A simplified prevention bundle with dual hand hygiene audit reduces early-onset ventilator-associated pneumonia in cardiovascular surgery units: An interrupted time-series analysis	PLOS ONE			English	Article							INTENSIVE-CARE UNITS; CONTROL CONSORTIUM INICC; CRITICALLY-ILL PATIENTS; MULTIDIMENSIONAL APPROACH; CHLORHEXIDINE GLUCONATE; MECHANICAL VENTILATION; NOSOCOMIAL PNEUMONIA; DEVELOPING-COUNTRIES; INFECTION-RATES; IMPACT	Background To investigate the effect of a simplified prevention bundle with alcohol-based, dual hand hygiene (HH) audit on the incidence of early-onset ventilation-associated pneumonia (VAP). Methods This 3-year, quasi-experimental study with interrupted time-series analysis was conducted in two cardiovascular surgery intensive care units in a medical center. Unaware external HH audit (eHH) performed by non-unit-based observers was a routine task before and after bundle implementation. Based on the realistic ICU settings, we implemented a 3-component bundle, which included: a compulsory education program, a knowing internal HH audit (iHH) performed by unit-based observers, and a standardized oral care (OC) protocol with 0.1% chlorhexidine gluconate. The study periods comprised 4 phases: 12-month pre-implementation phase 1 (eHH+/education-/iHH-/OC-), 3-month run-in phase 2 (eHH+/ education+/iHH +/OC+), 15-month implementation phase 3 (eHH+/education+/iHH+/OC+), and 6-month post-implementation phase 4 (eHH+/education-/iHH+/OC-). Results A total of 2553 ventilator-days were observed. VAP incidences (events/1000 ventilator days) in phase 1-4 were 39.1, 40.5, 15.9, and 20.4, respectively. VAP was significantlyreduced by 59% in phase 3 (vs. phase 1, incidence rate ratio [IRR] 0.41, P = 0.002), but rebounded in phase 4. Moreover, VAP incidence was inversely correlated to compliance of OC (r(2) = 0.531, P = 0.001) and eHH (r(2) = 0.878, P < 0.001), but not applied for iHH, despite iHH compliance was higher than eHH compliance during phase 2 to 4. Compared to eHH, iHH provided more efficient and faster improvements for standard HH practice. The minimal compliances required for significant VAP reduction were 85% and 75% for OC and eHH (both P < 0.05, IRR 0.28 and 0.42, respectively). Conclusions This simplified prevention bundle effectively reduces early-onset VAP incidence. An unaware HH compliance correlates with VAP incidence. A knowing HH audit provides better improvement in HH practice. Accordingly, we suggest dual HH audit and consistent bundle performance does matter in quality-of-care VAP prevention.	[Su, Kang-Cheng; Lin, Fang-Chi; Wu, Chieh-Hung; Feng, Jia-Yih; Yang, Kuang-Yao; Chang, Shi-Chuan] Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan; [Su, Kang-Cheng; Kou, Yu Ru] Natl Yang Ming Univ, Sch Med, Inst Physiol, Taipei, Taiwan; [Su, Kang-Cheng; Chang, Shi-Chuan] Taipei Vet Gen Hosp, Ctr Sleep Med, Taipei, Taiwan; [Huang, Shiang-Fen] Taipei Vet Gen Hosp, Dept Internal Med, Div Infect Dis, Taipei, Taiwan; [Shiung, Tao-Fen; Chung, Kwei-Chun; Tung, Yu-Hsiu] Taipei Vet Gen Hosp, Nursing Dept, Taipei, Taiwan; [Yang, Kuang-Yao] Natl Yang Ming Univ, Sch Med, Genome Res Ctr, Taipei, Taiwan; [Yang, Kuang-Yao; Chang, Shi-Chuan] Natl Yang Ming Univ, Sch Med, Inst Emergency & Crit Care Med, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Yang, KY (corresponding author), Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan.; Yang, KY (corresponding author), Natl Yang Ming Univ, Sch Med, Genome Res Ctr, Taipei, Taiwan.; Yang, KY (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Emergency & Crit Care Med, Taipei, Taiwan.	kyyang@vghtpe.gov.tw	Huang, Shiang-Fen/ABA-5375-2021	Huang, Shiang-Fen/0000-0003-0390-9108; Yang, Kuang-Yao/0000-0002-2803-980X; Kou, Yu Ru/0000-0002-4681-9009; Huang, Shiang-Fen/0000-0002-6685-8259	Taipei Veterans General Hospital [V106C-072]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	The authors received no specific funding for this work, except the manuscript processing fee, which was supported by the research grant from Taipei Veterans General Hospital (V106C-072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard R, 1998, B WORLD HEALTH ORGAN, V76, P327; Bouadma L, 2010, CRIT CARE MED, V38, P789, DOI 10.1097/CCM.0b013e3181ce21af; Boyce JM, 2002, AM J INFECT CONTROL, V30, pS1, DOI 10.1067/mic.2002.130391; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Chlebicki MN, 2007, CRIT CARE MED, V35, P595, DOI 10.1097/01.CCM.0000253395.70708.AC; Crnich Christopher J, 2005, Respir Care, V50, P813; Rosenthal VD, 2016, AM J INFECT CONTROL, V44, P1495, DOI 10.1016/j.ajic.2016.08.007; Dhar S, 2010, INFECT CONT HOSP EP, V31, P869, DOI 10.1086/655441; Drakulovic MB, 1999, LANCET, V354, P1851, DOI 10.1016/S0140-6736(98)12251-1; Fartoukh M, 2003, AM J RESP CRIT CARE, V168, P173, DOI 10.1164/rccm.200212-1449OC; Martinez-Resendez MF, 2014, AM J INFECT CONTROL, V42, P713, DOI 10.1016/j.ajic.2014.03.354; Fretheim A, 2015, BMJ QUAL SAF, V24, P748, DOI 10.1136/bmjqs-2014-003756; Gan CS, 2016, CAN J INFECT CONTROL, V31, P230; Guanche-Garcell H, 2013, J INFECT PUBLIC HEAL, V6, P98, DOI 10.1016/j.jiph.2012.11.009; Haessler S, 2014, BMJ QUAL SAF, V23, P965, DOI 10.1136/bmjqs-2014-003507; Hagel S, 2015, INFECT CONT HOSP EP, V36, P957, DOI 10.1017/ice.2015.93; Heo SM, 2008, CLIN INFECT DIS, V47, P1562, DOI 10.1086/593193; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Houston S, 2002, AM J CRIT CARE, V11, P567, DOI 10.4037/ajcc2002.11.6.567; Ibrahim EH, 2001, CHEST, V120, P555, DOI 10.1378/chest.120.2.555; Institute for Health Care Improvement, 2012, HOW TO IMPR; Ivers N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub3; Klompas M, 2014, INFECT CONT HOSP EP, V35, P915, DOI [10.1017/S0899823X00193894, 10.1086/677144]; Klompas M, 2014, JAMA INTERN MED, V174, P751, DOI 10.1001/jamainternmed.2014.359; Kohli E, 2009, INFECT CONT HOSP EP, V30, P222, DOI 10.1086/595692; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Leblebicioglu H, 2013, INFECTION, V41, P447, DOI 10.1007/s15010-013-0407-1; Liao YM, 2015, NURS CRIT CARE, V20, P89, DOI 10.1111/nicc.12037; Lin MY, 2012, CLIN INFECT DIS, V54, P1342, DOI 10.1093/cid/cis016; Marra AR, 2009, AM J INFECT CONTROL, V37, P619, DOI 10.1016/j.ajic.2009.03.009; Mehta S, 2012, JAMA-J AM MED ASSOC, V308, P1985, DOI 10.1001/jama.2012.13872; Mehta Y, 2013, EPIDEMIOL INFECT, V141, P2483, DOI 10.1017/S0950268813000381; Munro CL, 2009, AM J CRIT CARE, V18, P428, DOI 10.4037/ajcc2009792; Nelson BK, 1998, ACAD EMERG MED, V5, P739, DOI 10.1111/j.1553-2712.1998.tb02493.x; O'Grady NP, 2012, JAMA-J AM MED ASSOC, V307, P2534, DOI 10.1001/jama.2012.6445; Pan SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053746; Rello J, 2013, CLIN MICROBIOL INFEC, V19, P363, DOI 10.1111/j.1469-0691.2012.03808.x; Resar R, 2005, JT COMM J QUAL PATIE, V31, P243, DOI 10.1016/S1553-7250(05)31031-2; Rosenthal VD, 2006, AM J INFECT CONTROL, V34, P58, DOI 10.1016/j.ajic.2005.11.002; Rosenthal VD, 2008, AM J INFECT CONTROL, V36, P627, DOI [10.1016/j.ajic.2008.10.009, 10.1016/j.ajic.2008.06.003]; Rosenthal VD, 2012, CRIT CARE MED, V40, P3121, DOI 10.1097/CCM.0b013e3182657916; Rosenthal VD, 2012, AM J INFECT CONTROL, V40, P497, DOI 10.1016/j.ajic.2011.08.005; Rosenthal VD, 2012, INFECT CONT HOSP EP, V33, P704, DOI 10.1086/666342; Safdar N, 2005, CRIT CARE MED, V33, P2184, DOI 10.1097/01.CCM.0000181731.53912.D9; Safdar Nasia, 2005, Respir Care, V50, P725; Shi ZD, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008367.pub2; Su D, 2015, PUBLIC HEALTH, V129, P979, DOI 10.1016/j.puhe.2015.02.023; Svoronos T, 2015, BMJ QUAL SAF, V24, P475, DOI 10.1136/bmjqs-2015-004122; Tao LL, 2012, J CRIT CARE, V27, P440, DOI 10.1016/j.jcrc.2011.12.018; Tao LL, 2011, INT J INFECT DIS, V15, pE774, DOI 10.1016/j.ijid.2011.06.009; van Nieuwenhoven CA, 2006, CRIT CARE MED, V34, P396, DOI 10.1097/01.CCM.0000198529.76602.5E; World Health Organization, 2009, WHO GUID HAND HYG HL; Zack JE, 2002, CRIT CARE MED, V30, P2407, DOI 10.1097/00003246-200211000-00001	53	9	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182252	10.1371/journal.pone.0182252	http://dx.doi.org/10.1371/journal.pone.0182252			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767690	gold, Green Published, Green Submitted			2022-12-26	WOS:000406768200058
J	Swain, L; Key, G; Tauro, A; Ahonen, S; Wang, PX; Ackerley, C; Minassian, BA; Rusbridge, C				Swain, Lindsay; Key, Gill; Tauro, Anna; Ahonen, Saija; Wang, Peixiang; Ackerley, Cameron; Minassian, Berge A.; Rusbridge, Clare			Lafora disease in miniature Wirehaired Dachshunds	PLOS ONE			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; AGED DOGS; POLYGLUCOSAN BODIES; STORAGE DISEASE; BODY DISEASE; GLYCOGEN; ANIMALS; REPEAT	Lafora disease (LD) is an autosomal recessive late onset, progressive myoclonic epilepsy with a high prevalence in the miniature Wirehaired Dachshund. The disease is due to a mutation in the Epm2b gene which results in intracellular accumulation of abnormal glycogen (Lafora bodies). Recent breed-wide testing suggests that the carrier plus affected rate may be as high as 20%. A characteristic feature of the disease is spontaneous and reflex myoclonus; however clinical signs and disease progression are not well described. A survey was submitted to owners of MWHD which were homozygous for Epm2b mutation (breed club testing program) or had late onset reflex myoclonus and clinical diagnosis of LD. There were 27 dogs (11 male; 16 female) for analysis after young mutation-positive dogs that had yet to develop disease were excluded. Average age of onset of clinical signs was 6.94 years (3.5-12). The most common initial presenting sign was reflex and spontaneous myoclonus (77.8%). Other presenting signs included hypnic myoclonus (51.9%) and generalized seizures (40.7%). Less common presenting signs include focal seizures, "jaw smacking", "fly catching", "panic attacks", impaired vision, aggression and urinary incontinence. All these clinical signs may appear, and then increase in frequency and intensity over time. The myoclonus in particular becomes more severe and more refractory to treatment. Signs that developed later in the disease include dementia (51.9%), blindness (48.1%), aggression to people (25.9%) and dogs (33.3%), deafness (29.6%) and fecal (29.6%) and urinary (37.0%) incontinence as a result of loss of house training (disinhibited type behavior). Further prospective study is needed to further characterize the canine disease and to allow more specific therapeutic strategies and to tailor therapy as the disease progresses.	[Swain, Lindsay; Tauro, Anna; Rusbridge, Clare] Fitzpatrick Referrals Orthoped & Neurol, Godalming, Surrey, England; [Key, Gill] Dachshund Breed Council, Wrington, North Somerset, England; [Ahonen, Saija; Wang, Peixiang; Minassian, Berge A.] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON, Canada; [Ackerley, Cameron] Univ Toronto, Hosp Sick Children, Dept Pathol & Lab Med, Toronto, ON, Canada; [Minassian, Berge A.] Univ Toronto, Hosp Sick Children, Dept Pediat Neurol, Toronto, ON, Canada; [Rusbridge, Clare] Univ Surrey, Sch Vet Med, Fac Hlth & Med Sci, Guildford, Surrey, England; [Swain, Lindsay] BluePearl Vet Partners Michigan, Southfield, MI USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Surrey	Rusbridge, C (corresponding author), Fitzpatrick Referrals Orthoped & Neurol, Godalming, Surrey, England.; Rusbridge, C (corresponding author), Univ Surrey, Sch Vet Med, Fac Hlth & Med Sci, Guildford, Surrey, England.	rusbridge@surrey.ac.uk	Rusbridge, Clare/A-3794-2019; Rusbridge, Clare/K-6560-2019	Rusbridge, Clare/0000-0002-3366-2110; Rusbridge, Clare/0000-0002-3366-2110; Ahonen, Saija/0000-0003-3313-784X; Seath, Ian/0000-0003-3972-9547	Kennel Club Charitable Trust [327802]; Ontario Brain Institute; National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH) [P01 NS097197]; Fitzpatrick Referrals Ltd; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS097197] Funding Source: NIH RePORTER	Kennel Club Charitable Trust; Ontario Brain Institute; National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Fitzpatrick Referrals Ltd; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The Kennel Club Charitable Trust registered charity (No. 327802) partially subsidized the cost of genetic testing of many of the dogs in this study. The Dachshund Breed Council coordinated fundraising to contribute towards the cost of genetic testing. The genetic work was part funded by the Ontario Brain Institute and the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH) under award number P01 NS097197. Fitzpatrick Referrals Ltd, provided support in the form of salaries and materials for authors LS, AT and CR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript with the exception of the Dachshund Breed Council which has a Health and Welfare subcommittee which instigated the data collection but did not play a role in analysis.	Ahonen S, 2016, 2 BIENN INT LAF WORK, P15; [Anonymous], 2016, DACHSH MIN WIR HAIR; ANTAL M, 1982, J FR OPHTALMOL, V5, P615; Cardinali S, 2006, EPILEPSY RES, V69, P129, DOI 10.1016/j.eplepsyres.2006.01.007; DAVIS KE, 1990, AUST VET J, V67, P192, DOI 10.1111/j.1751-0813.1990.tb07754.x; Duran J, 2015, MOL ASPECTS MED, V46, P70, DOI 10.1016/j.mam.2015.08.007; Duran J, 2014, HUM MOL GENET, V23, P3147, DOI 10.1093/hmg/ddu024; Gabor LJ, 2010, J VET DIAGN INVEST, V22, P303, DOI 10.1177/104063871002200226; Gayarre J, 2014, BRAIN, V137, P806, DOI 10.1093/brain/awt353; Gredal H, 2003, J SMALL ANIM PRACT, V44, P511, DOI 10.1111/j.1748-5827.2003.tb00113.x; Hajek I, 2016, J SMALL ANIM PRACT, V57, P650, DOI 10.1111/jsap.12593; Hall DG, 1998, VET PATHOL, V35, P218, DOI 10.1177/030098589803500307; HOLLAND JM, 1970, AM J PATHOL, V58, P509; Honnold SP, 2010, J ZOO WILDLIFE MED, V41, P530, DOI 10.1638/2009-0090.1; Hulsmeyer VI, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0463-0; Ianzano Leonarda, 2005, Hum Mutat, V26, P397, DOI 10.1002/humu.9376; Kaiser E, 1991, Tierarztl Prax, V19, P290; Kalviainen R, 2015, SEMIN NEUROL, V35, P293, DOI 10.1055/s-0035-1552620; KAMIYA S, 1983, ACTA NEUROPATHOL, V60, P297, DOI 10.1007/BF00691880; Key G., 2013, PROGR SURVEY 2013; Key G., 2012, SURVEY RESULTS AUTUM; Kyllerman M, 1998, EPILEPSY RES, V29, P109, DOI 10.1016/S0920-1211(97)00069-7; Lohi H, 2005, SCIENCE, V307, P81, DOI 10.1126/science.1102832; LOUPAL G, 1985, ZBL VET MED A, V32, P502; Marquez M, 2010, VET J, V183, P222, DOI 10.1016/j.tvjl.2008.10.002; Minassian BA, 2001, PEDIATR NEUROL, V25, P21, DOI 10.1016/S0887-8994(00)00276-9; Mochel F, 2012, ANN NEUROL, V72, P433, DOI 10.1002/ana.23598; Nitschke F, 2013, CELL METAB, V17, P756, DOI 10.1016/j.cmet.2013.04.006; Pederson BA, 2013, ANN NEUROL, V74, P297, DOI 10.1002/ana.23899; Rusbridge C, 2004, EUR SOC VET NEUR 18; Schoeman T, 2002, J VET INTERN MED, V16, P201, DOI 10.1892/0891-6640(2002)016&lt;0201:PSDIAD&gt;2.3.CO;2; Seath I, 2014, LAFORA DIS DACHSHUND; SIMMONS MM, 1994, J COMP PATHOL, V110, P389, DOI 10.1016/S0021-9975(08)80316-7; Singh S, 2012, J HUM GENET, V57, P283, DOI 10.1038/jhg.2012.29; SUZUKI Y, 1980, ACTA NEUROPATHOL, V49, P159, DOI 10.1007/BF00690756; SUZUKI Y, 1979, ACTA NEUROPATHOL, V48, P77, DOI 10.1007/BF00691796; SUZUKI Y, 1978, ACTA NEUROPATHOL, V44, P217, DOI 10.1007/BF00691070; Turnbull J, 2016, EPILEPTIC DISORD, V18, pS38; Turnbull J, 2014, ANN NEUROL, V75, P442, DOI 10.1002/ana.24104; Turnbull J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002037; Webb AA, 2009, CAN VET J, V50, P963; Whitenack D, 1978, NEURONAL GLYCOPROTEI; YAMANAMI S, 1992, ACTA PATHOL JAPON, V42, P787	43	12	12	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182024	10.1371/journal.pone.0182024	http://dx.doi.org/10.1371/journal.pone.0182024			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767715	gold, Green Submitted, Green Published			2022-12-26	WOS:000406768200042
J	Carvallo, GO; Castro, SA				Carvallo, Gaston O.; Castro, Sergio A.			Invasions but not extinctions change phylogenetic diversity of angiosperm assemblage on southeastern Pacific Oceanic islands	PLOS ONE			English	Article							BIOTIC HOMOGENIZATION; GLOBAL PATTERNS; PLANT INVASIONS; RAIN-FOREST; CONSEQUENCES; BIOGEOGRAPHY; ARCHIPELAGO; EXAMPLE; TREE; BACTERIAL	We assessed changes in phylogenetic diversity of angiosperm flora on six oceanic islands located in the southeastern Pacific Ocean, by comparing flora from two periods: the pre-European colonization of islands and current times. We hypothesize that, in the time between these periods, extinction of local plant species and addition of exotic plants modified phylogenetic-alpha-diversity at different levels (deeper and terminal phylogeny) and increased phylo-beta-diversity among islands. Based on floristic studies, we assembled a phylogenetic tree from occurrence data that includes 921 species, of which 165 and 756 were native or exotic in origin, respectively. Then, we studied change in the phylo-alpha-diversity and phylo-beta-diversity (1-Phylosor) by comparing pre-European and current times. Despite extinction of 18 native angiosperm species, an increase in species richness and phylo-adiversity was observed for all islands studied, attributed to introduction of exotic plants (between 6 to 477 species per island). We did not observe significant variation of mean phylogenetic distance (MPD), a measure of the 'deeper' phylogenetic diversity of assemblages (e.g., orders, families), suggesting that neither extinctions nor introductions altered phylogenetic structure of the angiosperms of these islands. In regard to phylo-beta-diversity, we detected temporal turnover (variation in phylogenetic composition) between periods to flora (0.38 +/- 0.11). However, when analyses were performed only considering native plants, we did not observe significant temporal turnover between periods (0.07 +/- 0.06). These results indicate that introduction of exotic angiosperms has contributed more notably than extinctions to the configuration of plant assemblages and phylogenetic diversity on the studied islands. Because phylogenetic diversity is closely related to functional diversity (species trait variations and roles performed by organisms), our results suggests that the introduction of exotic plants to these islands could have detrimental impacts for ecosystem functions and ecosystem services that islands provide (e.g. productivity).	[Carvallo, Gaston O.] Pontificia Univ Catolica Valparaiso, Fac Ciencias, Inst Biol, Valparaiso, Chile; [Castro, Sergio A.] Univ Santiago, Fac Quim & Biol, Lab Ecol & Biodiversidad, Santiago, Chile; [Castro, Sergio A.] Ctr Desarrollo Nanociencia & Nanotecnol CEDENNA, Santiago, Chile	Pontificia Universidad Catolica de Valparaiso; Universidad de Santiago de Chile	Carvallo, GO (corresponding author), Pontificia Univ Catolica Valparaiso, Fac Ciencias, Inst Biol, Valparaiso, Chile.	gaston.carvallo@pucv.cl			FONDECYT [11150301]; Center for the Development of Nanoscience and Nanotechnology [CEDENNA FB0807]; Proyecto Basal USA [1555.48]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Center for the Development of Nanoscience and Nanotechnology(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); Proyecto Basal USA(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL)	FONDECYT 11150301 supported GOC. Center for the Development of Nanoscience and Nanotechnology CEDENNA FB0807 (Line 6) and Proyecto Basal USA 1555.48 (USACH) supported SAC. We declare that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez ME, 2002, ECOL APPL, V12, P1434, DOI 10.1890/1051-0761(2002)012[1434:CLCOAP]2.0.CO;2; Baeza Carlos M, 2007, Gayana Bot., V64, P125; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Beaulieu JM, 2012, ECOLOGY, V93, pS4, DOI 10.1890/11-0638.1; Bryant JA, 2008, P NATL ACAD SCI USA, V105, P11505, DOI 10.1073/pnas.0801920105; Cadotte MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019363; Castro SA, 2008, GLOBAL ECOL BIOGEOGR, V17, P524, DOI 10.1111/j.1466-8238.2008.00392.x; Castro SA, 2007, J BIOGEOGR, V34, P213, DOI 10.1111/j.1365-2699.2006.01605.x; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chittka L, 2001, NATURE, V411, P653, DOI 10.1038/35079676; Chown SL, 1998, AM NAT, V152, P562, DOI 10.1086/286190; Cuevas JG, 2004, REV CHIL HIST NAT, V77, P523; Danton P, 2006, ACTA BOT GALLICA, V153, P399, DOI 10.1080/12538078.2006.10515559; Diaz S, 2006, PLOS BIOL, V4, P1300, DOI 10.1371/journal.pbio.0040277; Dirnbock T, 2003, CONSERV BIOL, V17, P1650, DOI 10.1111/j.1523-1739.2003.00173.x; Etienne M, 1983, CIENCIAS AGRICOLAS U, V12, P1; Etienne M, 1982, B TECNICO U CHILE FA, V47; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fine PVA, 2011, ECOGRAPHY, V34, P552, DOI 10.1111/j.1600-0587.2010.06548.x; FLENLEY JR, 1984, NATURE, V307, P47, DOI 10.1038/307047a0; Gonzalez-Ferraan O, 1987, ISLAS OCEA NICAS CHI; Graham CH, 2008, ECOL LETT, V11, P1265, DOI 10.1111/j.1461-0248.2008.01256.x; Greimler Josef, 2002, Biological Invasions, V4, P73, DOI 10.1023/A:1020565510507; Greimler Josef, 2002, Pacific Science, V56, P263, DOI 10.1353/psc.2002.0022; Gunckel H, 1951, REV U, V36, P291; Haenke T, 1942, DESCRIPCIO REINO CHI; Harter DEV, 2015, PERSPECT PLANT ECOL, V17, P160, DOI 10.1016/j.ppees.2015.01.003; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; HOFFMANN A J, 1991, Gayana Botanica, V48, P89; Hulme PE, INSULAR ECOLOGY; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; JOHNSTON IVAN M., 1935, JOUR ARNOLD ARBORETUM, V16, P440; Johow F., 1896, ESTUDIOS FLORA ISLAS; Kembel S, 2016, PACKEGE PICANTE R T; Kembel SW, 2006, ECOLOGY, V87, pS86, DOI 10.1890/0012-9658(2006)87[86:TPSOAN]2.0.CO;2; Kueffer C, 2010, PERSPECT PLANT ECOL, V12, P145, DOI 10.1016/j.ppees.2009.06.002; Leprieur F, 2015, ECOGRAPHY, V38, P1; Lonsdale WM, 1999, ECOLOGY, V80, P1522, DOI 10.2307/176544; MacArthur R.H., 1967, THEORY ISLAND BIOGEO; Mace GM, 2004, PHILOS T R SOC B, V359, P711, DOI 10.1098/rstb.2003.1454; Mace GM, 2003, SCIENCE, V300, P1707, DOI 10.1126/science.1085510; Maherali H, 2007, SCIENCE, V316, P1746, DOI 10.1126/science.1143082; MANTEL N, 1967, CANCER RES, V27, P209; Marticorena C., 1998, Gayana Botanica, V55, P23; Marticorena C, 1998, GAYANA BOT, V55, P189; Marx HE, 2016, DIVERS DISTRIB, V22, P318, DOI 10.1111/ddi.12401; Matthei O., 1995, MANUAL MALEZAS QUE C; Matthei Oscar, 1993, Gayana Botanica, V50, P69; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Molina-Venegas R, 2015, J BIOGEOGR, V42, P507, DOI 10.1111/jbi.12398; Moreira-Munoz A, 2011, PLANT VEG, V5, P153, DOI 10.1007/978-90-481-8748-5_5; Naeem S, 2012, SCIENCE, V336, P1401, DOI 10.1126/science.1215855; Olden JD, 2004, TRENDS ECOL EVOL, V19, P18, DOI 10.1016/j.tree.2003.09.010; Olden JD, 2006, J BIOGEOGR, V33, P2027, DOI 10.1111/j.1365-2699.2006.01572.x; Ordonez A, 2014, ECOLOGY, V95, P1191, DOI 10.1890/13-1002.1; Philippi R, 1870, BOT ZEITUNG BERLIN, V28, P496; Proches S, 2008, GLOBAL ECOL BIOGEOGR, V17, P5, DOI 10.1111/j.1466-8238.2007.00333.x; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Richardson DM, 2006, PROG PHYS GEOG, V30, P409, DOI 10.1191/0309133306pp490pr; Richardson DM, 2010, DIVERS DISTRIB, V16, P313, DOI 10.1111/j.1472-4642.2010.00660.x; Rodrigues JLM, 2013, P NATL ACAD SCI USA, V110, P988, DOI 10.1073/pnas.1220608110; Sax DF, 2003, TRENDS ECOL EVOL, V18, P561, DOI 10.1016/S0169-5347(03)00224-6; Sax DF, 2002, AM NAT, V160, P766, DOI 10.1086/343877; Schaefer H, 2011, ECOL LETT, V14, P389, DOI 10.1111/j.1461-0248.2011.01600.x; Shooner S, 2015, J APPL ECOL, V52, P1509, DOI 10.1111/1365-2664.12517; Skottsberg C, 1956, NATURAL HIST JUAN FE; Skottsberg C, 1963, ARK BOT, V4, P465; Skottsberg C, 1957, P 8 PAC C, V4, P181; Skottsberg C, 1917, REV U CORDOVA, V4, P110; Skottsberg C, 1937, B MUSEO NACL HIST NA, V24, P1; SPARRE B., 1949, LILLOA, V20, P263; Strauss SY, 2006, P NATL ACAD SCI USA, V103, P5841, DOI 10.1073/pnas.0508073103; Swenson NG, 2014, J PLANT ECOL, V7, P166, DOI 10.1093/jpe/rtt074; Swenson NG, 2012, GLOBAL ECOL BIOGEOGR, V21, P798, DOI 10.1111/j.1466-8238.2011.00727.x; Swenson NG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004390; Swenson NG, 2014, USE R, P1, DOI 10.1007/978-1-4614-9542-0; Swenson Ulf, 1997, Pacific Science, V51, P233; Teillier Sebastian, 1997, Gayana Botanica, V54, P15; Ulrich W, 2014, OECOLOGIA, V175, P985, DOI 10.1007/s00442-014-2954-2; Valiente-Banuet A, 2013, ANNU REV ECOL EVOL S, V44, P347, DOI 10.1146/annurev-ecolsys-110512-135855; Verdu M, 2008, AM NAT, V172, P751, DOI 10.1086/593003; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Vitousek PM, 1996, AM SCI, V84, P468; VITOUSEK PM, 1987, SCIENCE, V238, P802, DOI 10.1126/science.238.4828.802; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Weigelt P, 2015, SCI REP-UK, V5, DOI 10.1038/srep12213; Weigelt P, 2013, P NATL ACAD SCI USA, V110, P15307, DOI 10.1073/pnas.1306309110; Whittaker RJ, 1998, ISLAND BIOGEOGRAPHY; Winter M, 2009, P NATL ACAD SCI USA, V106, P21721, DOI 10.1073/pnas.0907088106; Zizka G, 1991, PALMARUM HORTUS FRAN, V3, P1	93	7	7	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0182105	10.1371/journal.pone.0182105	http://dx.doi.org/10.1371/journal.pone.0182105			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763508	Green Published, Green Submitted, gold			2022-12-26	WOS:000406766500043
J	Murray, K; Godinez, DR; Brust-Mascher, I; Miller, EN; Gareau, MG; Reardon, C				Murray, Kaitlin; Godinez, Dayn Romero; Brust-Mascher, Ingrid; Miller, Elaine Nicole; Gareau, Melanie G.; Reardon, Colin			Neuroanatomy of the spleen: Mapping the relationship between sympathetic neurons and lymphocytes	PLOS ONE			English	Article							STROMAL CELLS; EXPERIMENTAL COLITIS; VOLUME TRANSMISSION; IMMUNE INTERACTIONS; LYMPHOID ORGANS; DENDRITIC CELLS; NERVE; VAGUS; INFLAMMATION; STIMULATION	The nervous system plays a profound regulatory role in maintaining appropriate immune responses by signaling to immune cells. These immune cells, including B- and T-cells, can further act as intermediary messengers, with subsets of B-and T-cells expressing choline acetyltransferase (ChAT), the enzyme required for acetylcholine (ACh) synthesis. Neural control of ACh release from ChAT(+) T-cells can have powerful immune implications, regulating lymphocyte trafficking, inflammation, and prevent death due to experimental septic shock. Although ACh release from T-cells has been proposed to occur following norepinephrine (NE) released from sympathetic nerve terminals in the spleen, it is unknown how this communication occurs. While it was proposed that tyrosine hydroxylase (TH+) axons form synapse-like structures with ChAT(+) T-cells, there is scant evidence to support or refute this phenomenon. With this in mind, we sought to determine the relative abundance of ChAT(+) B-and T-cells in close proximity to TH+ axons, and determine what factors contribute to their localization in the spleen. Using confocal microscopy of tissue sections and three-dimensional imaging of intact spleen, we confirmed that ChAT(+) B-cells exceed the number of ChAT(+) T-cells, and overall few ChAT(+) B-or T-cells are located close to TH+ fibers compared to total numbers. The organized location of ChAT(+) lymphocytes within the spleen suggested that these cells were recruited by chemokine gradients. We identified ChAT(+) B-and T-cells express the chemokine receptor CXCR5; indicating that these cells can respond to CXCL13 produced by stromal cells expressing the beta 2 adrenergic receptor in the spleen. Our findings suggest that sympathetic innervation contributes to organization of ChAT(+) immune cells in the white pulp of the spleen by regulating CXCL13. Supporting this contention, chemical sympathectomy significantly reduced expression of this chemokine. Together, we demonstrated that there does not appear to be a basis for synaptic neuro-immune communication, and that sympathetic innervation can modulate immune function through altering stromal cell chemokine production.	[Murray, Kaitlin; Godinez, Dayn Romero; Brust-Mascher, Ingrid; Miller, Elaine Nicole; Gareau, Melanie G.; Reardon, Colin] Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Reardon, C (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA.	creardon@ucdavis.edu		Reardon, Colin/0000-0003-2204-8091; Miller, Elaine/0000-0003-0348-8155	NIGMS NIH HHS [T32 GM099608] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agnati LF, 2006, ACTA PHYSIOL, V187, P329, DOI 10.1111/j.1748-1716.2006.01579.x; Bratton BO, 2012, EXP PHYSIOL, V97, P1180, DOI 10.1113/expphysiol.2011.061531; Broggi MAS, 2014, JOVE-J VIS EXP, DOI 10.3791/51803; Chung K, 2013, NAT METHODS, V10, P508, DOI [10.1038/nmeth.2481, 10.1038/NMETH.2481]; Chyou S, 2008, J IMMUNOL, V181, P3887, DOI 10.4049/jimmunol.181.6.3887; Cyster JG, 2000, IMMUNOL REV, V176, P181; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Emmenlauer M, 2009, J MICROSC-OXFORD, V233, P42, DOI 10.1111/j.1365-2818.2008.03094.x; Famm K, 2013, NATURE, V496, P159, DOI 10.1038/496159a; FELTEN SY, 1987, J NEUROSCI RES, V18, P37, DOI 10.1002/jnr.490180108; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Gabanyi I, 2016, CELL, V164, P378, DOI 10.1016/j.cell.2015.12.023; Gao V, 2016, P NATL ACAD SCI USA, V113, P8526, DOI 10.1073/pnas.1605063113; Ghia JE, 2007, AM J PHYSIOL-GASTR L, V293, pG560, DOI 10.1152/ajpgi.00098.2007; Gunn MD, 1998, P NATL ACAD SCI USA, V95, P258, DOI 10.1073/pnas.95.1.258; Inoue T, 2016, J CLIN INVEST, V126, P1939, DOI 10.1172/JCI83658; Ji H, 2014, MUCOSAL IMMUNOL, V7, P335, DOI 10.1038/mi.2013.52; Katakai T, 2008, J IMMUNOL, V181, P6189, DOI 10.4049/jimmunol.181.9.6189; Koopman FA, 2016, P NATL ACAD SCI USA, V113, P8284, DOI 10.1073/pnas.1605635113; Legler DF, 1998, J EXP MED, V187, P655, DOI 10.1084/jem.187.4.655; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; Lv TT, 2016, SCI REP-UK, V6, DOI 10.1038/srep32430; Mina-Osorio P, 2012, MOL MED, V18, P618, DOI 10.2119/molmed.2012.00027; Mionnet C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001672; Muller A, 2014, NAT METHODS, V11, P1245, DOI [10.1038/nmeth.3151, 10.1038/NMETH.3151]; Muller PA, 2014, CELL, V158, P300, DOI 10.1016/j.cell.2014.04.050; Munyaka P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109272; Nguyen QT, 2010, NAT NEUROSCI, V13, P127, DOI 10.1038/nn.2469; Olofsson PS, 2016, NAT BIOTECHNOL, V34, P1066, DOI 10.1038/nbt.3663; Peters A., 1991, FINE STRUCTURE NERVO; Reardon C, 2013, P NATL ACAD SCI US; Reardon C, 2016, IMMUNOL LETT, V178, P92, DOI 10.1016/j.imlet.2016.08.006; Riol-Blanco L, 2014, NATURE, V510, P157, DOI 10.1038/nature13199; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Salamone G, 2011, J NEUROIMMUNOL, V236, P47, DOI 10.1016/j.jneuroim.2011.05.007; Sarter M, 2009, NAT REV NEUROSCI, V10, P383, DOI 10.1038/nrn2635; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; STEAD RH, 1989, GASTROENTEROLOGY, V97, P575, DOI 10.1016/0016-5085(89)90627-6; Suzuki K, 2010, IMMUNITY, V33, P71, DOI 10.1016/j.immuni.2010.07.003; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Tournier JN, 2003, TRENDS IMMUNOL, V24, P114, DOI 10.1016/S1471-4906(03)00002-4; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; van de Pavert SA, 2009, NAT IMMUNOL, V10, P1193, DOI 10.1038/ni.1789; Vicente-Suarez I, 2015, MUCOSAL IMMUNOL, V8, P141, DOI 10.1038/mi.2014.51; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Xiao L, 2015, CIRC RES, V117, P547, DOI 10.1161/CIRCRESAHA.115.306010; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017	49	38	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0182416	10.1371/journal.pone.0182416	http://dx.doi.org/10.1371/journal.pone.0182416			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753658	Green Published, Green Submitted, gold			2022-12-26	WOS:000406579300067
J	Jin, W; Penington, CJ; Mccue, SW; Simpson, MJ				Jin, Wang; Penington, Catherine J.; Mccue, Scott W.; Simpson, Matthew J.			A computational modelling framework to quantify the effects of passaging cell lines	PLOS ONE			English	Article							IN-VITRO; SCRATCH ASSAYS; PROLIFERATION; MIGRATION; INVASION; TIME; REPRODUCIBILITY; PATHWAY; CULTURE; GROWTH	In vitro cell culture is routinely used to grow and supply a sufficiently large number of cells for various types of cell biology experiments. Previous experimental studies report that cell characteristics evolve as the passage number increases, and various cell lines can behave differently at high passage numbers. To provide insight into the putative mechanisms that might give rise to these differences, we perform in silico experiments using a random walk model to mimic the in vitro cell culture process. Our results show that it is possible for the average proliferation rate to either increase or decrease as the passaging process takes place, and this is due to a competition between the initial heterogeneity and the degree to which passaging damages the cells. We also simulate a suite of scratch assays with cells from near-homogeneous and heterogeneous cell lines, at both high and low passage numbers. Although it is common in the literature to report experimental results without disclosing the passage number, our results show that we obtain significantly different closure rates when performing in silico scratch assays using cells with different passage numbers. Therefore, we suggest that the passage number should always be reported to ensure that the experiment is as reproducible as possible. Furthermore, our modelling also suggests some avenues for further experimental examination that could be used to validate or refine our simulation results.	[Jin, Wang; Penington, Catherine J.; Mccue, Scott W.; Simpson, Matthew J.] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4000, Australia	Queensland University of Technology (QUT)	Simpson, MJ (corresponding author), Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4000, Australia.	matthew.simpson@qut.edu.au	Jin, Wang/AAD-4317-2020	Penington, Catherine/0000-0002-9344-0122; McCue, Scott/0000-0001-5304-2384	Australian Research Council [DP140100249, DP170100474]	Australian Research Council(Australian Research Council)	This work is funded by the Australian Research Council (Grants: DP140100249 to MJS and SWM, DP170100474 to MJS; http://www.arc.gov.au/). The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript.	Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a; Allegrucci C, 2007, HUM REPROD UPDATE, V13, P103, DOI 10.1093/humupd/dml041; ATCC, 2016, PASS NUMB EFF CELL L; ATCC, 2012, THAW PROP CRYOPR PRO; Cooley C, 2009, MOL BIOL CELL, V20, P2563, DOI 10.1091/mbc.E08-10-1019; DALE PD, 1994, MATH BIOSCI, V124, P127, DOI 10.1016/0025-5564(94)90040-X; Dunn SJ, 2016, MOL BIOL CELL, V27, P1863, DOI 10.1091/mbc.E15-12-0854; Foster SA, 1996, ONCOGENE, V12, P1773; Frascoli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059249; Gao Y, 2014, CARCINOGENESIS, V35, P923, DOI 10.1093/carcin/bgt407; Gough W, 2011, J BIOMOL SCREEN, V16, P155, DOI 10.1177/1087057110393340; Gracia JCM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175267; Gujral TS, 2014, CELL, V159, P844, DOI 10.1016/j.cell.2014.10.032; Haass NK, 2014, PIGM CELL MELANOMA R, V27, P764, DOI 10.1111/pcmr.12274; Haridas P, 2017, J THEOR BIOL, V423, P13, DOI 10.1016/j.jtbi.2017.04.017; Haridas P, 2016, SCI REP-UK, V6, DOI 10.1038/srep24569; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Jin W, 2017, B MATH BIOL, V79, P1028, DOI 10.1007/s11538-017-0267-4; Jin W, 2016, PHYS BIOL, V13, DOI 10.1088/1478-3975/13/5/056003; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lin HK, 2003, J BIOL CHEM, V278, P50902, DOI 10.1074/jbc.M300676200; Mahasa KJ, 2016, J THEOR BIOL, V404, P312, DOI 10.1016/j.jtbi.2016.06.012; MathWorks, 2016, MATHWORKS BOXPLOT; Petrovskii S, 2011, P NATL ACAD SCI USA, V108, P8704, DOI 10.1073/pnas.1015208108; Pfeiffer MJ, 2010, EUR UROL, V57, P246, DOI 10.1016/j.eururo.2009.01.015; Public Health England, 2017, PASS NUMB EXPL; Rubin H, 1997, MECH AGEING DEV, V98, P1, DOI 10.1016/S0047-6374(97)00067-5; Ruttala HB, 2015, COLLOID SURFACE B, V128, P419, DOI 10.1016/j.colsurfb.2015.02.040; SCHNEIDER EL, 1976, P NATL ACAD SCI USA, V73, P3584, DOI 10.1073/pnas.73.10.3584; Sengers BG, 2007, J R SOC INTERFACE, V4, P1107, DOI 10.1098/rsif.2007.0233; Simpson MJ, 2010, PHYSICA A, V389, P3779, DOI 10.1016/j.physa.2010.05.020; Simpson MJ, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.031920; Treloar KK, 2014, J THEOR BIOL, V356, P71, DOI 10.1016/j.jtbi.2014.04.026; Treloar KK, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-137; Treloar KK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067389; Tsoularis A, 2002, MATH BIOSCI, V179, P21, DOI 10.1016/S0025-5564(02)00096-2; Vasilevsky NA, 2013, PEERJ, V1, DOI 10.7717/peerj.148; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Vo BN, 2015, MATH BIOSCI, V263, P133, DOI 10.1016/j.mbs.2015.02.010; Yang QB, 2014, INT J CARDIOL, V177, P925, DOI 10.1016/j.ijcard.2014.09.204; Zhang H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167474	45	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181941	10.1371/journal.pone.0181941	http://dx.doi.org/10.1371/journal.pone.0181941			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750084	Green Submitted, Green Published, gold			2022-12-26	WOS:000406575700104
J	VanderDrift, LE; Vanable, PA; Bonafide, KE; Brown, JL; Bostwick, RA; Carey, MP				VanderDrift, Laura E.; Vanable, Peter A.; Bonafide, Katherine E.; Brown, Jennifer L.; Bostwick, Rebecca A.; Carey, Michael P.			Using actor-partner interdependence modeling to understand HPV vaccine acceptance	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; KNOWLEDGE; PARENT; COMMUNICATION; ACCEPTABILITY; PREDICTORS; BELIEFS	A wealth of scientific literature has been devoted to understanding what factors influence parents and their adolescent children to obtain the HPV vaccine. This literature is relatively uniform in its methodological approach of sampling individuals (i.e., either parents or adolescents) and examining the predictors of uptake for that individual. To improve understanding of HPV vaccination uptake, we sampled low-income, African American parent-child dyads with either a female (n = 93) or a male (n = 116) adolescent who had not been vaccinated. Both parents and children completed self-report measures that tapped intent to receive the vaccine and hypothesized predictors of intent (i.e., self-efficacy, beliefs about the vaccine, beliefs about HPV, knowledge of HPV). Using a dyadic analytic approach (i.e., the Actor-Partner Interdependence Model or APIM) [1], we found that parents and their adolescents have different structures of beliefs regarding HPV vaccination (i.e., they are empirically distinguishable). Consistent with prior research, the majority of predictors of an individual's own intention to vaccinate were individual-level variables; uniquely though, some predictors endorsed by one member of the dyad influenced the intentions held by the other member. Specifically, parents' reports of HPV severity and their self-efficacy were both associated with adolescents' intent to obtain the vaccine. Further, adolescents' beliefs that the vaccine will lead to greater promiscuity or be stigmatizing were associated with parents holding an increased intent to vaccinate. Use APIM improves understanding of HPV vaccination uptake and can be used to guide intervention efforts.	[VanderDrift, Laura E.; Vanable, Peter A.; Bonafide, Katherine E.; Bostwick, Rebecca A.] Syracuse Univ, Dept Psychol, Syracuse, NY 13210 USA; [Brown, Jennifer L.] Univ Cincinnati, Dept Psychiat & Behav Neurosci, Cincinnati, OH USA; [Carey, Michael P.] Miriam Hosp, Ctr Behav & Prevent Med, Providence, RI 02906 USA; [Carey, Michael P.] Brown Univ, Behav & Social Sci, Providence, RI 02912 USA; [Carey, Michael P.] Brown Univ, Psychiat & Human Behav, Med, Providence, RI 02912 USA	Syracuse University; University System of Ohio; University of Cincinnati; Lifespan Health Rhode Island; Miriam Hospital; Brown University; Brown University	VanderDrift, LE (corresponding author), Syracuse Univ, Dept Psychol, Syracuse, NY 13210 USA.	lvanderd@syr.edu		Machia, Laura/0000-0001-8725-1395	Merck HPV Investigator Initiated Studies Program	Merck HPV Investigator Initiated Studies Program	This research was funded by a Merck HPV Investigator Initiated Studies Program grant awarded to Peter A. Vanable. The authors wish to thank Noel Brewer for providing consultation and assistance with the development of our survey instrument. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AB, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-192; [Anonymous], 2006, ANAL DYADIC DATA; Brabin L, 2006, VACCINE, V24, P3087, DOI 10.1016/j.vaccine.2006.01.048; Brewer NT, 2007, PREV MED, V45, P107, DOI 10.1016/j.ypmed.2007.05.013; Cates JR, 2009, J RURAL HEALTH, V25, P93, DOI 10.1111/j.1748-0361.2009.00204.x; Curtis CR, 2013, MMWR-MORBID MORTAL W, V62, P685; Dickey S B, 2000, Pediatr Nurs, V26, P461; Hofman R, 2014, HEALTH EDUC RES, V29, P83, DOI 10.1093/her/cyt092; Holcomb B, 2004, J AM BOARD FAM PRACT, V17, P26, DOI 10.3122/jabfm.17.1.26; Holman DM, 2014, JAMA PEDIATR, V168, P76, DOI 10.1001/jamapediatrics.2013.2752; Johnson JW, 2000, MULTIVAR BEHAV RES, V35, P1, DOI 10.1207/S15327906MBR3501_1; Kenny DA, 2010, J FAM PSYCHOL, V24, P359, DOI 10.1037/a0019651; Krieger JL, 2011, HUM COMMUN RES, V37, P107, DOI 10.1111/j.1468-2958.2010.01395.x; McRee AL, 2011, J ADOLESCENT HEALTH, V48, P314, DOI 10.1016/j.jadohealth.2010.07.006; Mcree AL, 2010, PREV MED, V50, P213, DOI 10.1016/j.ypmed.2010.02.001; Moss JL, 2015, PREV MED, V78, P65, DOI 10.1016/j.ypmed.2015.07.002; Rand CM, 2011, VACCINE, V29, P7651, DOI 10.1016/j.vaccine.2011.08.002; Reagan-Steiner S, 2015, MMWR-MORBID MORTAL W, V64, P784, DOI 10.15585/mmwr.mm6429a3; Rhodes SD, 2004, HEALTH EDUC RES, V19, P272, DOI 10.1093/her/cyg026; Tonidandel S, 2009, PSYCHOL METHODS, V14, P387, DOI 10.1037/a0017735; Vietri JT, 2011, PREV MED, V52, P405, DOI 10.1016/j.ypmed.2011.03.002; Weinstein ND, 2007, HEALTH PSYCHOL, V26, P146, DOI 10.1037/0278-6133.26.2.146; Yacobi E, 1999, PREV MED, V28, P535, DOI 10.1006/pmed.1999.0486	23	2	2	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181662	10.1371/journal.pone.0181662	http://dx.doi.org/10.1371/journal.pone.0181662			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1CT	28750068	Green Published, gold, Green Submitted			2022-12-26	WOS:000406575700069
J	Ahmad, J; Sajjad, M; Mehmood, I; Baik, SW				Ahmad, Jamil; Sajjad, Muhammad; Mehmood, Irfan; Baik, Sung Wook			SiNC: Saliency-injected neural codes for representation and efficient retrieval of medical radiographs	PLOS ONE			English	Article							HISTOPATHOLOGICAL IMAGE-ANALYSIS; PATTERNS; SIMILARITY; NETWORKS	Medical image collections contain a wealth of information which can assist radiologists and medical experts in diagnosis and disease detection for making well-informed decisions. However, this objective can only be realized if efficient access is provided to semantically relevant cases from the ever-growing medical image repositories. In this paper, we present an efficient method for representing medical images by incorporating visual saliency and deep features obtained from a fine-tuned convolutional neural network (CNN) pre-trained on natural images. Saliency detector is employed to automatically identify regions of interest like tumors, fractures, and calcified spots in images prior to feature extraction. Neuronal activation features termed as neural codes from different CNN layers are comprehensively studied to identify most appropriate features for representing radiographs. This study revealed that neural codes from the last fully connected layer of the fine-tuned CNN are found to be the most suitable for representing medical images. The neural codes extracted from the entire image and salient part of the image are fused to obtain the saliency-injected neural codes (SiNC) descriptor which is used for indexing and retrieval. Finally, locality sensitive hashing techniques are applied on the SiNC descriptor to acquire short binary codes for allowing efficient retrieval in large scale image collections. Comprehensive experimental evaluations on the radiology images dataset reveal that the proposed framework achieves high retrieval accuracy and efficiency for scalable image retrieval applications and compares favorably with existing approaches.	[Ahmad, Jamil; Baik, Sung Wook] Sejong Univ, Dept Software, Coll Software & Convergence Technol, Seoul, South Korea; [Sajjad, Muhammad] Islamia Coll, Dept Comp Sci, Digital Image Proc Lab, Peshawar, Pakistan; [Mehmood, Irfan] Sejong Univ, Dept Comp Sci & Engn, Seoul, South Korea	Sejong University; University of Peshawar; Sejong University	Baik, SW (corresponding author), Sejong Univ, Dept Software, Coll Software & Convergence Technol, Seoul, South Korea.	sbaik@sejong.ac.kr	Ahmad, Jamil/G-6931-2015; Baik, Sung Wook/AAR-8236-2020	Ahmad, Jamil/0000-0001-8407-5971; Sajjad, Dr. Muhammmad/0000-0001-5646-0338; Mehmood, Irfan/0000-0001-7864-957X; Baik, Sung Wook/0000-0002-6678-7788	MISP (Ministry of Science, ICT & Future Planning), Korea [2015-0-00938]	MISP (Ministry of Science, ICT & Future Planning), Korea	This research was supported by the MISP (Ministry of Science, ICT & Future Planning), Korea, under National program for Excellence in SW (2015-0-00938) supervised by the IITP (Institute for Information & communications Technology Promation).	Ahmad J, 2015, NETW BAS INF SYST NB; Ahmad J, 2016, J REAL-TIME IMAGE PR, P1; Ahmad J, 2017, J VIS COMMUN IMAGE R, V45, P62, DOI 10.1016/j.jvcir.2017.02.010; Ahmad J, 2016, MULTIMED TOOLS APPL, V75, P12669, DOI 10.1007/s11042-016-3436-9; [Anonymous], 2012, UNSUPERVISED TRANSF; Antani S.K., 2002, ICVGIP; Arevalo J, 2015, 2015 37 ANN INT C IE; Avni U, 2011, IEEE T MED IMAGING, V30, P733, DOI 10.1109/TMI.2010.2095026; Azizpour H, 2015, IEEE COMPUT SOC CONF; Babenko A, 2014, LECT NOTES COMPUT SC, V8689, P584, DOI 10.1007/978-3-319-10590-1_38; Bar Y., 2015, SPIE MED IMAGING; Bueno JM, 2002, COMP BAS MED SYST 20; Burdescu DD, 2013, NEUROCOMPUTING, V109, P33, DOI 10.1016/j.neucom.2012.07.030; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Datar M., 2004, SOCG; Deng J, 2009, IEEE COMPUTVIS PATTE; Donahue J., 2014, P 31 INT C MACH LEAR; Fan Q, 2016, NEUROCOMPUTING, V175, P81, DOI 10.1016/j.neucom.2015.10.030; Furuya T, 2014, MULTIMEDIA MODELING; Gao MC, 2018, COMP M BIO BIO E-IV, V6, P1, DOI 10.1080/21681163.2015.1124249; Girshick R, 2014, PROC CVPR IEEE, P580, DOI 10.1109/CVPR.2014.81; Gong Y., 2011, COMP VIS PATT REC CV; Gong YC, 2014, LECT NOTES COMPUT SC, V8695, P392, DOI 10.1007/978-3-319-10584-0_26; Harel J., PROC, V733; He KM, 2014, LECT NOTES COMPUT SC, V8691, P346, DOI 10.1007/978-3-319-10578-9_23; Hou XD, 2012, IEEE T PATTERN ANAL, V34, P194, DOI 10.1109/TPAMI.2011.146; Huang YG, 2014, MULTIMED TOOLS APPL, V72, P2977, DOI 10.1007/s11042-013-1589-3; Iakovidis DK, 2009, IEEE T INF TECHNOL B, V13, P442, DOI 10.1109/TITB.2008.923144; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Kulis B, 2012, IEEE T PATTERN ANAL, V34, P1092, DOI 10.1109/TPAMI.2011.219; Kumar A, 2013, J DIGIT IMAGING, V26, P1025, DOI 10.1007/s10278-013-9619-2; Kwak DM, 2002, ANN NY ACAD SCI, V980, P212, DOI 10.1111/j.1749-6632.2002.tb04898.x; Lehmann TM, 2004, METHOD INFORM MED, V43, P354; Li Yang, 2015, COMP VIS PATT REC CV; Liu GH, 2015, PATTERN RECOGN, V48, P2554, DOI 10.1016/j.patcog.2015.02.005; Liu L., 2014, ADV NEURAL INFORM PR; Liu Y, 2007, PATTERN RECOGN, V40, P262, DOI 10.1016/j.patcog.2006.04.045; Long FH, 2003, SIG COM TEC, P1; Long J., 2015, P IEEE C COMP VIS PA, P3431; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Luo JW, 2016, ELECTRON LETT, V52, P276, DOI 10.1049/el.2015.3235; Mahmoudi F, 2003, PATTERN RECOGN, V36, P1725, DOI 10.1016/S0031-3203(03)000104; Muller H, 2004, INT J MED INFORM, V73, P1, DOI 10.1016/j.ijmedinf.2003.11.024; Muller Henning, 2003, Stud Health Technol Inform, V95, P480; Murala S, 2013, NEUROCOMPUTING, V119, P399, DOI 10.1016/j.neucom.2013.03.018; Rahman MM, 2007, IEEE T INF TECHNOL B, V11, P58, DOI 10.1109/TITB.2006.884364; Razavian A, 2014, P IEEE C COMP VIS PA; Razavian Ali Sharif, 2014, 2014 IEEE C COMP VIS; Seetharaman K, 2016, J KING SAUD UNIV-COM, V28, P110, DOI 10.1016/j.jksuci.2014.10.006; Shim S-O, 2003, AC SPEECH SIGN PROC; Simonyan Karen, ICLR 2015; Smeulders AWM, 2000, IEEE T PATTERN ANAL, V22, P1349, DOI 10.1109/34.895972; Song Y, 2015, P 5 ACM INT C MULT R; Srinivas M, 2015, NEUROCOMPUTING, V168, P880, DOI 10.1016/j.neucom.2015.05.036; Taigman Y., 2014, P IEEE C COMP VIS PA; Tajbakhsh N, 2016, IEEE T MED IMAGING, V35, P1299, DOI 10.1109/TMI.2016.2535302; van Ginneken B, 2015, 2015 IEEE 12 INT S B; Veltkamp R. C., 2013, STATE OF THE ART CON; Vikram TN, 2012, PATTERN RECOGN, V45, P3114, DOI 10.1016/j.patcog.2012.02.009; Wang J, 2011, IM GRAPH ICIG 2011 6; Wang JZ, 2000, P AMIA S AM MED INF; Wang W, 2002, LECT NOTES COMPUT SC, V2383, P29; Weiss Y., 2009, NIPS; Welter P, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-68; Xu K, 2015, PR MACH LEARN RES, V37, P2048; Yang W, 2012, J DIGIT IMAGING, V25, P708, DOI 10.1007/s10278-012-9495-1; Yang XY, 2015, IEEE T IMAGE PROCESS, V24, P1709, DOI 10.1109/TIP.2015.2411433; Zhang XF, 2015, MED IMAGE ANAL, V26, P306, DOI 10.1016/j.media.2015.10.005; Zhang XF, 2015, IEEE T MED IMAGING, V34, P496, DOI 10.1109/TMI.2014.2361481	69	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0181707	10.1371/journal.pone.0181707	http://dx.doi.org/10.1371/journal.pone.0181707			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771497	Green Published, Green Submitted, gold			2022-12-26	WOS:000406853600030
J	Cai, YC; He, YP; Lv, R; Chen, HC; Wang, Q; Pan, LW				Cai, Yicun; He, Yuping; Lv, Rong; Chen, Hongchao; Wang, Qiang; Pan, Liangwen			Detection and quantification of beef and pork materials in meat products by duplex droplet digital PCR	PLOS ONE			English	Article							REAL-TIME PCR; DNA COPY NUMBER; PROCESSED MEAT; D-LOOP; ADULTERATION; IDENTIFICATION; ASSAY; AMPLIFICATION; COMPONENTS; CHICKEN	Meat products often consist of meat from multiple animal species, and inaccurate food product adulteration and mislabeling can negatively affect consumers. Therefore, a cost-effective and reliable method for identification and quantification of animal species in meat products is required. In this study, we developed a duplex droplet digital PCR (dddPCR) detection and quantification system to simultaneously identify and quantify the source of meat in samples containing a mixture of beef (Bos taurus) and pork (Sus scrofa) in a single digital PCR reaction tube. Mixed meat samples of known composition were used to test the accuracy and applicability of this method. The limit of detection (LOD) and the limit of quantification (LOQ) of this detection and quantification system were also identified. We conclude that our dddPCR detection and quantification system is suitable for quality control and routine analyses of meat products.	[Cai, Yicun; He, Yuping; Lv, Rong; Chen, Hongchao; Wang, Qiang; Pan, Liangwen] Shanghai Entry Exit Inspect & Quarantine Bur Chin, Tech Ctr Anim Plant & Food Inspect & Quarantine, Pudong New Area, Shanghai, Peoples R China		Pan, LW (corresponding author), Shanghai Entry Exit Inspect & Quarantine Bur Chin, Tech Ctr Anim Plant & Food Inspect & Quarantine, Pudong New Area, Shanghai, Peoples R China.	panliangwen8@126.com			Shanghai science and technology commission [16DZ0501501]; Shanghai entry-exit inspection and quarantine bureau of science and technology plan projects fund [HK007-2016]	Shanghai science and technology commission(Science & Technology Commission of Shanghai Municipality (STCSM)Shanghai Science & Technology Committee); Shanghai entry-exit inspection and quarantine bureau of science and technology plan projects fund	This project was supported by Shanghai science and technology commission standard special fund (16DZ0501501) and Shanghai entry-exit inspection and quarantine bureau of science and technology plan projects fund (HK007-2016).	Ballin NZ, 2009, MEAT SCI, V83, P165, DOI 10.1016/j.meatsci.2009.06.003; Barakat H, 2014, APPL MICROBIOL BIOT, V98, P9805, DOI 10.1007/s00253-014-6084-x; Bertolini F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121701; Breitenmoser A, 2008, EUR FOOD RES TECHNOL, P227; Cai Y., 2014, BIOMED RES INT, V2014; Calvo JH, 2002, J AGR FOOD CHEM, V50, P5262, DOI 10.1021/jf020051a; Deb R, 2016, MOL BIOTECHNOL, V58, P850, DOI 10.1007/s12033-016-9984-4; Demarquoy J, 2013, MEAT SCI, V94, P164, DOI 10.1016/j.meatsci.2013.01.019; Druml B, 2015, FOOD CHEM, V178, P319, DOI 10.1016/j.foodchem.2015.01.003; Fang X, 2016, FOOD CHEM, V192, P485, DOI 10.1016/j.foodchem.2015.07.020; Floren C, 2015, FOOD CHEM, V173, P1054, DOI 10.1016/j.foodchem.2014.10.138; Giaretta N, 2013, FOOD CHEM, V141, P1814, DOI 10.1016/j.foodchem.2013.04.124; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hsieh YHP, 1998, J FOOD PROTECT, V61, P476, DOI 10.4315/0362-028X-61.4.476; Hsieh YHP, 2014, J AGR FOOD CHEM, V62, P12536, DOI 10.1021/jf504032j; Karabasanavar NS, 2014, FOOD CHEM, V145, P530, DOI 10.1016/j.foodchem.2013.08.084; Kesmen Z, 2012, J FOOD SCI, V77, pC167, DOI 10.1111/j.1750-3841.2011.02536.x; Kumar A, 2015, CRIT REV FOOD SCI, V55, P1340, DOI 10.1080/10408398.2012.693978; Lin CL, 2006, J ANIM BREED GENET, V123, P384, DOI 10.1111/j.1439-0388.2006.00622.x; Macedo-Silva A, 2000, MEAT SCI, V56, P189, DOI 10.1016/S0309-1740(00)00039-5; Morisset D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062583; Nau Jean-Yves, 2013, Rev Med Suisse, V9, P532; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Tanabe S, 2007, BIOSCI BIOTECH BIOCH, V71, P3131, DOI 10.1271/bbb.70683; Whale AS, 2017, ANAL CHEM, V89, P1724, DOI 10.1021/acs.analchem.6b03980	25	43	47	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0181949	10.1371/journal.pone.0181949	http://dx.doi.org/10.1371/journal.pone.0181949			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771608	Green Submitted, Green Published, gold			2022-12-26	WOS:000406853600046
J	Flint, J; Flint, M; Limpus, CJ; Mills, PC				Flint, Jaylene; Flint, Mark; Limpus, Colin J.; Mills, Paul C.			The impact of environmental factors on marine turtle stranding rates	PLOS ONE			English	Article							CLIMATE EVENTS; HERVEY-BAY; EXTREME; QUEENSLAND; CONSERVATION; VARIABILITY; AUSTRALIA; SEAGRASS; ECOLOGY; DUGONGS	Globally, tropical and subtropical regions have experienced an increased frequency and intensity in extreme weather events, ranging from severe drought to protracted rain depressions and cyclones, these coincided with an increased number of marine turtles subsequently reported stranded. This study investigated the relationship between environmental variables and marine turtle stranding. The environmental variables examined in this study, in descending order of importance, were freshwater discharge, monthly mean maximum and minimum air temperatures, monthly average daily diurnal air temperature difference and rainfall for the latitudinal hotspots (-27 degrees, -25 degrees, -23 degrees, -19 degrees) along the Queensland coast as well as for major embayments within these blocks. This study found that marine turtle strandings can be linked to these environmental variables at different lag times (3-12 months), and that cumulative (months added together for maximum lag) and non-cumulative (single month only) effects cause different responses. Different latitudes also showed different responses of marine turtle strandings, both in response direction and timing. Cumulative effects of freshwater discharge in all latitudes resulted in increased strandings 10-12 months later. For latitudes -27 degrees, -25 degrees and -23 degrees non-cumulative effects for discharge resulted in increased strandings 7-12 months later. Latitude - 19 degrees had different results for the non-cumulative bay with strandings reported earlier (3-6 months). Monthly mean maximum and minimum air temperatures, monthly average daily diurnal air temperature difference and rainfall had varying results for each examined latitude. This study will allow first responders and resource managers to be better equipped to deal with increased marine turtle stranding rates following extreme weather events.	[Flint, Jaylene; Flint, Mark; Limpus, Colin J.; Mills, Paul C.] Univ Queensland, Sch Vet Sci, Teaching & Invest Vet MARTI Unit, Vet Marine Anim Res, Gatton, Qld, Australia; [Flint, Mark] Ohio State Univ, Coll Vet Med, Dept Preventat Vet Med, Columbus, OH 43210 USA; [Limpus, Colin J.] Queensland Govt Brisbane, Queensland Dept Environm & Heritage Protect, Brisbane, Qld, Australia	University of Queensland; University System of Ohio; Ohio State University	Flint, J (corresponding author), Univ Queensland, Sch Vet Sci, Teaching & Invest Vet MARTI Unit, Vet Marine Anim Res, Gatton, Qld, Australia.	jaylene.flint@uq.net.au			Australian Research Council [LP 110100569]	Australian Research Council(Australian Research Council)	This study was partially funded by the Australian Research Council Link age Project Grant LP 110100569. There was no additional external funding received fort his study	AGUIRRE AA, 2004, ECOHEALTH, V1, P275, DOI DOI 10.1007/S10393-004-0097-3; [Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 2012, CHANGES CLIMATE EXTR; Bolker B., 2020, BBMLE TOOLS GEN MAXI; Bolker B., 2017, R COMPARE, V1; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Boschat G, 2015, CLIM DYNAM, V44, P1823, DOI 10.1007/s00382-014-2214-5; Brand-Gardner SJ, 1999, AUST J ZOOL, V47, P181, DOI 10.1071/ZO98065; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Coles R, 2012, EVALUATING RISK SEAG; Devlin MJ, 2012, 12 INT COR REEF S CA; Doherty PF, 2012, J ORNITHOL, V152, pS317, DOI 10.1007/s10336-010-0598-5; Easterling DR, 2000, B AM METEOROL SOC, V81, P417, DOI 10.1175/1520-0477(2000)081<0417:OVATIE>2.3.CO;2; Environmental Protection Agency, 2008, IND PAC MAR TURTL ID; Flint Jaylene, 2015, Journal of Marine Biology, P848923; Flint M, 2013, CRC MAR BIOL SER, P379; Geraci JR., 2005, MARINE MAMMALS ASHOR, V2; GREAT BARRIER REEF MARINE PARK AUTH, 2007, GREAT BARR REEF MAR, P2007; Great Barrier Reef Marine Park Authority, 2011, EXTR WEATH GREAT BAR; Hamann M., 2010, Endangered Species Research, V11, P245, DOI 10.3354/esr00279; Limpus C.J., 1985, P47; Limpus C. J., 2003, LOGGERHEAD SEA TURTL, P199; Limpus CJ, 2008, BIOLOGICAL REV AUSTR; Limpus CJ, 2011, HLTH ASSESSMENT GREE; Limpus Colin J., 1994, Memoirs of the Queensland Museum, V35, P139; Marsh H, 2008, CONT SHELF RES, V28, P2152, DOI 10.1016/j.csr.2008.03.023; McKenzie L. J., 2012, REEF RESCUE MARINE M; MCKENZIE LJ, 2000, POSTFLOOD MONITORING; Meager J. J., 2012, MARINE WILDLIFE STRA; Meager JJ, 2016, ECOL INDIC, V60, P987, DOI 10.1016/j.ecolind.2015.08.052; Meager JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094849; Meehl GA, 2000, B AM METEOROL SOC, V81, P427, DOI 10.1175/1520-0477(2000)081<0427:TIEWAC>2.3.CO;2; Nicholls N., EXTREMES CLIMATE CHA; Nicholls N, 2007, PROG PHYS GEOG, V31, P77, DOI 10.1177/0309133307073885; Norman SA, 2012, MAR MAMMAL SCI, V28, pE251, DOI 10.1111/j.1748-7692.2011.00507.x; Poiner IR, 1993, CSIRO MAR LAB REP, V5, P143; PREEN A, 1995, WILDLIFE RES, V22, P507, DOI 10.1071/WR9950507; PREEN AR, 1995, AQUAT BOT, V52, P3, DOI 10.1016/0304-3770(95)00491-H; Read MA, 2002, QUEENSLAND FEEDING E, P207; Shimada T, 2016, MAR ECOL PROG SER, V562, P163, DOI 10.3354/meps11972; Steffen W., 2013, CRITICAL DECADE EXTR; Tavares DC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168717; Wetz MS, 2013, MAR POLLUT BULL, V69, P7, DOI 10.1016/j.marpolbul.2013.01.020; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08; Zwiers F. W., 2013, CLIMATE SCI SERVING, P339, DOI [DOI 10.1007/978-94-007-6692-1_13, 10.1007/978-94-007-6692-1_13]	45	11	11	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182548	10.1371/journal.pone.0182548	http://dx.doi.org/10.1371/journal.pone.0182548			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771635	gold, Green Published			2022-12-26	WOS:000406853600139
J	Qayyum, S; Oves, M; Khan, AU				Qayyum, Shariq; Oves, Mohammad; Khan, Asad U.			Obliteration of bacterial growth and biofilm through ROS generation by facilely synthesized green silver nanoparticles	PLOS ONE			English	Article							EXTRACT; ANTIBIOFILM; AGENT	Mangifera indica inflorescence aqueous extract was utilized for production of green AgNPs. Synthesized AgNPs were characterized by UV-vis spectrophotometry, XRD, TEM, FESEM and particles size analyzer. AgNPs showed minimum inhibitory concentrations (MICs) of 8 mu g ml(-1) and 16 mu g ml(-1) for Gram negative (K. pneumoniae, P. aeruginosa and E. coli) and Gram positive (S. mutans and S. aureus) strains, respectively which was relatively quite low compared to chemically synthesized silver nanoparticles. AgNPs inhibited 80% and 75% biofilms of E. coli and S. mutans respectively as observed quantitatively by crystal violet assay. Qualitative biofilm inhibition was observed using SEM and CLSM. AgNPs adsorbed catheter also resisted the growth of biofilm on its surface displaying its possible future applications. AgNPs interaction with bacteria lead to bacterial membrane damage as observed by SEM and TEM. The membrane damage was confirmed by detecting leakage of proteins and reducing sugars from treated bacterial cells. AgNPs generated ROS on interaction with bacterial cells and this ROS production can be one of the possible reasons for their action. AgNPs exhibited no toxic effect on the cell viability of HeLa cell line.	[Qayyum, Shariq; Khan, Asad U.] Aligarh Muslim Univ, Med Microbiol & Mol Biol Lab, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India; [Oves, Mohammad] King Abdulaziz Univ, Ctr Excellence Environm Studies, Jeddah, Saudi Arabia	Aligarh Muslim University; King Abdulaziz University	Khan, AU (corresponding author), Aligarh Muslim Univ, Med Microbiol & Mol Biol Lab, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India.	asad.k@rediffmail.com	Khan, Asad U/K-8157-2013; qayyum, shariq/AAX-4820-2021; Oves, Mohammad/J-8804-2015	Khan, Asad U/0000-0001-9191-9423; qayyum, shariq/0000-0003-0777-1994; Oves, Mohammad/0000-0002-8513-6155				Abbasi E, 2016, CRIT REV MICROBIOL, V42, P173, DOI 10.3109/1040841X.2014.912200; Arokiyaraj S, 2014, INT J NANOMED, V9, P379, DOI 10.2147/IJN.S53546; Awwad AM, 2013, INT J IND CHEM, V4, DOI 10.1186/2228-5547-4-29; Bryaskova Rayna, 2011, J Chem Biol, V4, P185, DOI 10.1007/s12154-011-0063-9; Daghastanli NA, 2008, PHOTOCHEM PHOTOBIOL, V84, P1238, DOI 10.1111/j.1751-1097.2008.00345.x; Daglia M, 2012, CURR OPIN BIOTECH, V23, P174, DOI 10.1016/j.copbio.2011.08.007; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Gurunathan S, 2013, INT J NANOMED, V8, P4399, DOI 10.2147/IJN.S51881; Khan R, 2010, J APPL MICROBIOL, V109, P2151, DOI 10.1111/j.1365-2672.2010.04847.x; Khan S, 2012, INT J NANOMED, V7, P3245, DOI 10.2147/IJN.S31219; Kulshrestha S, 2014, BIOFOULING, V30, P1281, DOI 10.1080/08927014.2014.983093; Kumar A, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/29/295606; Li WR, 2010, APPL MICROBIOL BIOT, V85, P1115, DOI 10.1007/s00253-009-2159-5; Mittal AK, 2013, BIOTECHNOL ADV, V31, P346, DOI 10.1016/j.biotechadv.2013.01.003; Moulton MC, 2010, NANOSCALE, V2, P763, DOI 10.1039/c0nr00046a; Narayanan KB, 2008, MATER LETT, V62, P4588, DOI 10.1016/j.matlet.2008.08.044; Nayak D, 2016, ACS APPL MATER INTER, V8, P28538, DOI 10.1021/acsami.6b11391; Oves M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059140; Palanisamy NK, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/1477-3155-12-2; Parashar UK, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/41/415104; Patterson MJ, 1996, MED MICROBIOLOGY; Prathna TC, 2011, COLLOID SURFACE B, V82, P152, DOI 10.1016/j.colsurfb.2010.08.036; Qayyum S, 2016, IET NANOBIOTECHNOL, V10, P349, DOI 10.1049/iet-nbt.2015.0091; Qayyum S, 2016, MEDCHEMCOMM, V7, P1479, DOI 10.1039/c6md00124f; Raja K, 2012, SPECTROCHIM ACTA A, V97, P490, DOI 10.1016/j.saa.2012.06.038; Shah K A, 2010, Pharmacogn Rev, V4, P42, DOI 10.4103/0973-7847.65325; Shrivastava S, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/22/225103; Singh Amitabh, 2010, Archives of Phytopathology and Plant Protection, V43, P1254, DOI 10.1080/03235400802404759; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Stensberg MC, 2011, NANOMEDICINE-UK, V6, P879, DOI [10.2217/nnm.11.78, 10.2217/NNM.11.78]; Su HL, 2009, BIOMATERIALS, V30, P5979, DOI 10.1016/j.biomaterials.2009.07.030	31	67	69	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0181363	10.1371/journal.pone.0181363	http://dx.doi.org/10.1371/journal.pone.0181363			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771501	gold, Green Submitted, Green Published			2022-12-26	WOS:000406853600016
J	Endt, K; Goepfert, J; Omlin, A; Athanasiou, A; Tennstedt, P; Guenther, A; Rainisio, M; Engeler, DS; Steuber, T; Gillessen, S; Joos, T; Schiess, R				Endt, Kathrin; Goepfert, Jens; Omlin, Aurelius; Athanasiou, Alcibiade; Tennstedt, Pierre; Guenther, Anna; Rainisio, Maurizio; Engeler, Daniel S.; Steuber, Thomas; Gillessen, Silke; Joos, Thomas; Schiess, Ralph			Development and clinical testing of individual immunoassays for the quantification of serum glycoproteins to diagnose prostate cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; THROMBOSPONDIN-1 EXPRESSION; TUMOR ANGIOGENESIS; P53 ALTERATIONS; CATHEPSIN-D; BIOMARKERS; BENIGN; LUNG; ASSOCIATION; REGULATORS	Prostate Cancer (PCa) diagnosis is currently hampered by the high false-positive rate of PSA evaluations, which consequently may lead to overtreatment. Non-invasive methods with increased specificity and sensitivity are needed to improve diagnosis of significant PCa. We developed and technically validated four individual immunoassays for cathepsin D (CTSD), intercellular adhesion molecule 1 (ICAM1), olfactomedin 4 (OLFM4), and thrombospondin 1 (THBS1). These glycoproteins, previously identified by mass spectrometry using a Pten mouse model, were measured in clinical serum samples for testing the capability of discriminating PCa positive and negative samples. The development yielded 4 individual immunoassays with inter and intra-variability (CV) < 15% and linearity on dilution of the analytes. In serum, ex vivo protein stability (< 15% loss of analyte) was achieved for a duration of at least 24 hours at room temperature and 2 days at 4 degrees C. The measurement of 359 serum samples from PCa positive (n = 167) and negative (n = 192) patients with elevated PSA (2-10 ng/ml) revealed a significantly improved accuracy (P < 0.001) when two of the glycoproteins (CTSD and THBS1) were combined with %fPSA and age (AUC = 0.8109; P < 0.0001; 95% CI = 0.7673-0.8545). Conclusively, the use of CTSD and THBS1 together with commonly used parameters for PCa diagnosis such as %fPSA and age has the potential to improve the diagnosis of PCa.	[Endt, Kathrin; Athanasiou, Alcibiade; Schiess, Ralph] ProteoMediX Inc, Schlieren, Switzerland; [Goepfert, Jens; Guenther, Anna; Joos, Thomas] NMI Tubingen, Reutlingen, Germany; [Omlin, Aurelius; Engeler, Daniel S.; Gillessen, Silke] Cantonal Hosp St Gallen, St Gallen, Switzerland; [Tennstedt, Pierre; Steuber, Thomas] Martini Klin, Hamburg, Germany; [Rainisio, Maurizio] Abanovus LLC, San Remo, Italy	Kantonsspital St. Gallen	Schiess, R (corresponding author), ProteoMediX Inc, Schlieren, Switzerland.	schiess@proteomedix.com	Tennstedt, Pierre/E-9545-2011; Gillessen, Silke/C-6093-2019	Tennstedt, Pierre/0000-0001-9237-3442; Engeler, Daniel/0000-0003-1383-4701; Gillessen, Silke/0000-0001-5746-6555; Rainisio, Maurizio/0000-0002-4450-5751	ProteoMediX Inc.	ProteoMediX Inc.	The measurement of clinical samples was conducted at ProteoMediX Inc. and ProteoMediX Inc. funded the assay development at NMI Tilbingen. KE, M and RS are employed by ProteoMediX. MR is providing paid statistical consultancy to ProteoMediX through its company (Abanovus LLC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker HN, 2012, JOVE-J VIS EXP, DOI 10.3791/4084; Bangma CH, 1997, J UROLOGY, V157, P2191, DOI 10.1016/S0022-5347(01)64712-8; Bhindi B, 2015, J UROLOGY, V193, P1519, DOI 10.1016/j.juro.2014.11.096; Bryant RJ, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv095; Butler JE, 2000, METHODS, V22, P4, DOI 10.1006/meth.2000.1031; Center for Drug Evaluation and Research (CDER), 2001, GUID IND BIOAN METH; CHAMBON M, 1994, PROSTATE, V24, P320, DOI 10.1002/pros.2990240608; Cima I, 2011, P NATL ACAD SCI USA, V108, P3342, DOI 10.1073/pnas.1013699108; Craciun AM, 2000, CLIN CHEM, V46, P252; Crawford ED, 2012, J UROLOGY, V188, P1726, DOI 10.1016/j.juro.2012.07.023; Doll JA, 2001, PROSTATE, V49, P293, DOI 10.1002/pros.10025; Donovan MJ, 2015, PROSTATE CANCER P D, V18, P370, DOI 10.1038/pcan.2015.40; El Melegy NT, 2010, BRIT J BIOMED SCI, V67, P109; Fuzery AK, 2013, CLIN PROTEOM, V10, DOI 10.1186/1559-0275-10-13; Greenaway J, 2007, J CELL PHYSIOL, V210, P807, DOI 10.1002/jcp.20904; Gronberg H, 2015, LANCET ONCOL; Grossfeld GD, 1997, J NATL CANCER I, V89, P219, DOI 10.1093/jnci/89.3.219; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ioachim E, 2012, HISTOL HISTOPATHOL, V27, P209, DOI 10.14670/HH-27.209; Jemal A, 2015, JAMA-J AM MED ASSOC, V314, P2054, DOI 10.1001/jama.2015.14905; Kaygusuz G, 2007, INT UROL NEPHROL, V39, P841, DOI 10.1007/s11255-006-9144-z; Kwak C, 2002, BJU INT, V89, P303, DOI 10.1046/j.1464-4096.2001.01417.x; la Calle de C, 2015, J UROL; Lynch DF, 1997, PROSTATE, V32, P214, DOI 10.1002/(SICI)1097-0045(19970801)32:3<214::AID-PROS8>3.0.CO;2-K; Miyata Y, 2013, INT J MOL SCI, V14, P12249, DOI 10.3390/ijms140612249; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Papadaki C, 2009, CLIN CANCER RES, V15, P3827, DOI 10.1158/1078-0432.CCR-08-3027; Pruitt FL, 2013, PROSTATE, V73, P476, DOI 10.1002/pros.22589; Pry, 2008, CLIN BIOCHEM REV, V29, pS49; R Core Team, 2021, R LANGUAGE ENV STAT; Roobol MJ, 2011, ACTA ONCOL, V50, P85, DOI 10.3109/0284186X.2010.524935; Sammon JD, 2015, JAMA-J AM MED ASSOC, V314, P2075, DOI 10.1001/jama.2015.7273; Schiess R, 2009, MOL ONCOL, V3, P33, DOI 10.1016/j.molonc.2008.12.001; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Shafer MW, 2007, PROSTATE, V67, P255, DOI 10.1002/pros.20514; Shariat SF, 2011, ACTA ONCOL, V50, P61, DOI 10.3109/0284186X.2010.542174; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Tan Gong-Jun, 2013, World J Biol Chem, V4, P91, DOI 10.4331/wjbc.v4.i4.91; Tomlins SA, 2016, EUR UROL, V70, P45, DOI 10.1016/j.eururo.2015.04.039; Vetvicka V., 2012, J CANC THER RES, V1, P22, DOI DOI 10.7243/2049-7962-1-22; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Weissfeld JL, 2012, JNCI-J NATL CANCER I, V104, P280, DOI 10.1093/jnci/djr549; YANG Y, 1992, PROSTATE, V21, P201, DOI 10.1002/pros.2990210304; ZABRENETZKY V, 1994, INT J CANCER, V59, P191, DOI 10.1002/ijc.2910590209; Zhang XW, 2004, CANCER RES, V64, P2474, DOI 10.1158/0008-5472.CAN-03-3443	45	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0181557	10.1371/journal.pone.0181557	http://dx.doi.org/10.1371/journal.pone.0181557			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767721	Green Published, gold, Green Submitted			2022-12-26	WOS:000406768200027
J	Gaur, U; Tu, JB; Li, DY; Gao, Y; Lian, T; Sun, BY; Yang, DY; Fan, XL; Yang, MY				Gaur, Uma; Tu, Jianbo; Li, Diyan; Gao, Yue; Lian, Ting; Sun, Boyuan; Yang, Deying; Fan, Xiaolan; Yang, Mingyao			Molecular evolutionary patterns of NAD(+)/Sirtuin aging signaling pathway across taxa	PLOS ONE			English	Article							HIGH-FAT DIET; POLY(ADP-RIBOSE) POLYMERASE 1; LIFE-SPAN; CALORIE RESTRICTION; HUMAN LONGEVITY; NAD(+); METABOLISM; SIRTUINS; SIRT1; DISEASE	A deeper understanding of the conserved molecular mechanisms in different taxa have been made possible only because of the evolutionary conservation of crucial signaling pathways. In the present study, we explored the molecular evolutionary pattern of selection signatures in 51 species for 10 genes which are important components of NAD(+)/Sirtuin pathway and have already been directly linked to lifespan extension in worms and mice. Selection pressure analysis using PAML program revealed that MRPS5 and PPARGC1A were under significant constraints because of their functional significance. FOXO3a also displayed strong purifying selection. All three sirtuins, which were SIRT1, SIRT2 and SIRT6, displayed a great degree of conservation between taxa, which is consistent with the previous report. A significant evolutionary constraint is seen on the anti-oxidant gene, SOD3. As expected, TP53 gene was under significant selection pressure in mammals, owing to its major role in tumor progression. Poly-ADP-ribose polymerase (PARP) genes displayed the most sites under positive selection. Further 3D structural analysis of PARP1 and PARP2 protein revealed that some of these positively selected sites caused a change in the electrostatic potential of the protein structure, which may allow a change in its interaction with other proteins and molecules ultimately leading to difference in the function. Although the functional significance of the positively selected sites could not be established in the variants databases, yet it will be interesting to see if these sites actually affect the function of PARP1 and PARP2.	[Gaur, Uma; Tu, Jianbo; Li, Diyan; Gao, Yue; Lian, Ting; Sun, Boyuan; Yang, Deying; Fan, Xiaolan; Yang, Mingyao] Sichuan Agr Univ, Inst Anim Genet & Breeding, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University	Yang, MY (corresponding author), Sichuan Agr Univ, Inst Anim Genet & Breeding, Chengdu, Sichuan, Peoples R China.	yangmingyao@sicau.edu.cn	Yang, Mingyao/AAX-9927-2020	Yang, Mingyao/0000-0001-6508-2738	"Special postdoc grant" from Sichuan; National Natural Science Foundation of China [31471998]; Sichuan "Thousand Talents Program"	"Special postdoc grant" from Sichuan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan "Thousand Talents Program"	This work was supported by "Special postdoc grant" from Sichuan, The National Natural Science Foundation of China (31471998) and Sichuan "Thousand Talents Program."	Altmeyer M, 2009, AGING-US, V1, P458, DOI 10.18632/aging.100052; Asher G, 2010, CELL, V142, P943, DOI 10.1016/j.cell.2010.08.016; Atkovicaja R, 2014, DNA REPAIR, V23, P4; Bai P, 2011, CELL METAB, V13, P450, DOI 10.1016/j.cmet.2011.03.013; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Boamah EK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002442; Boehler C, 2011, METHODS MOL BIOL, V780, P313, DOI 10.1007/978-1-61779-270-0_19; Brunet FG, 2006, MOL BIOL EVOL, V23, P1808, DOI 10.1093/molbev/msl049; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Chalkiadaki A, 2012, NAT REV ENDOCRINOL, V8, P287, DOI 10.1038/nrendo.2011.225; Chenna BR, 2010, ADDICT BEHAV, V32, P1043; Daugherty MD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004403; Erener S, 2012, FASEB J, V26, P2631, DOI 10.1096/fj.11-200212; Fang EF, 2016, CELL METAB, V24, P566, DOI 10.1016/j.cmet.2016.09.004; Farres J, 2013, BLOOD, V122, P44, DOI 10.1182/blood-2012-12-472845; Fetterman CD, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-261; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Gossmann TI, 2014, DNA REPAIR, V23, P39, DOI 10.1016/j.dnarep.2014.07.005; Gossmann TI, 2012, FEBS J, V279, P3355, DOI 10.1111/j.1742-4658.2012.08559.x; Greiss S, 2009, MOL CELLS, V28, P407, DOI 10.1007/s10059-009-0169-x; GRUBE K, 1992, P NATL ACAD SCI USA, V89, P11759, DOI 10.1073/pnas.89.24.11759; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Herskovits AZ, 2013, CELL RES, V23, P746, DOI 10.1038/cr.2013.70; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Imai S, 2013, DIABETES OBES METAB, V15, P26, DOI 10.1111/dom.12171; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Imai S, 2011, FEBS LETT, V585, P1657, DOI 10.1016/j.febslet.2011.04.060; Jobson RW, 2010, MITOCHONDRION, V10, P540, DOI 10.1016/j.mito.2010.05.013; Kauppinen TM, 2007, NEUROSCIENCE, V145, P1267, DOI 10.1016/j.neuroscience.2006.09.034; Lehmann S, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.72; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lu WJ, 2009, NAT REV CANCER, V9, P758, DOI 10.1038/nrc2732; Mangerich A, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/321653; Mangerich A, 2010, MECH AGEING DEV, V131, P389, DOI 10.1016/j.mad.2010.05.005; McGaugh SE, 2015, P NATL ACAD SCI USA, V112, P7055, DOI 10.1073/pnas.1419659112; Merksamer PI, 2013, AGING-US, V5, P144, DOI 10.18632/aging.100544; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Mount D. W., 2001, BIOINFORMATICS SEQUE; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Pawlikowska L, 2009, AGING CELL, V8, P460, DOI 10.1111/j.1474-9726.2009.00493.x; Scheibye-Knudsen M, 2014, CELL METAB, V20, P840, DOI 10.1016/j.cmet.2014.10.005; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Szanto M, 2011, CARDIOVASC RES, V92, P430, DOI 10.1093/cvr/cvr246; Vassilopoulos Athanassios, 2011, Human Genomics, V5, P485; von Dassow G, 1999, J EXP ZOOL, V285, P307, DOI 10.1002/(SICI)1097-010X(19991215)285:4<307::AID-JEZ2>3.3.CO;2-M; Wang HC, 2009, BMC EVOLUTIONARY BIO, V9, P3246; Wang MH, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-222; Webb AE, 2016, AGING CELL, V15, P673, DOI 10.1111/acel.12479; Weidele K, 2010, BIOCHEM PHARMACOL, V80, P1103, DOI 10.1016/j.bcp.2010.06.010; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X	58	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182306	10.1371/journal.pone.0182306	http://dx.doi.org/10.1371/journal.pone.0182306			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767699	gold, Green Submitted, Green Published			2022-12-26	WOS:000406768200068
J	Smith, AJ; Higdon, JW; Richard, P; Orr, J; Bernhardt, W; Ferguson, SH				Smith, Alexander J.; Higdon, Jeff W.; Richard, Pierre; Orr, Jack; Bernhardt, Warren; Ferguson, Steven H.			Beluga whale summer habitat associations in the Nelson River estuary, western Hudson Bay, Canada	PLOS ONE			English	Article							DELPHINAPTERUS-LEUCAS; MARINE MAMMALS; WHITE WHALES; POPULATION; SEA; BEHAVIOR; ALASKA; IDENTITY	To understand beluga whale (Delphinapterus leucas) estuarine use in the Nelson River estuary, southwest Hudson Bay, we recorded and examined beluga movements and habitat associations for the July through August period in 2002-2005. We compared locations of belugas fitted with satellite transmitters ("tags") (2002-2005) and aerial-surveyed (2003 and 2005) belugas for years of differing freshwater flow from the Nelson River which is influenced by hydroelectric activity. Using the beluga telemetry location data, we estimated an early August behavioral shift in beluga distribution patterns from local estuarine use to a progressively more migratory behavior away from the estuary. The timing of this shift in behavior was also apparent in results of beluga aerial surveys from the 1940s-1960s, despite environmental changes including later freeze-up and warming ocean temperatures. Overall, during the higher than average discharge ("wet") year of 2005, the three tagged belugas ranged farther from the Nelson River but not farther from the nearest shore along southwestern Hudson Bay, compared to the 10 tagged belugas tracked during the "dry" years of 2002-2004 with below average discharges. Aerial survey data for 2003 and 2005 display a similar dry vs. wet year shift in spatial patterns, with no significant change in overall density of belugas within the study area. In the Nelson estuary, proximity to the fresh-salt water mixing area may be more important than the shallow waters of the upper estuary. Killer whales (Orcinus orca) were observed in the Churchill area (200 km northwest) during each year of study, 2002-05, and belugas may benefit from the proximity to shallow estuary waters that provide protection from the larger-bodied predator. Study results contribute to an understanding of the influence of environmental variation on how and why belugas use estuaries although considerable uncertainties exist and additional research is required.	[Smith, Alexander J.] Rambo Environ, Tampa, FL USA; [Higdon, Jeff W.] Higdon Wildlife Consulting, Winnipeg, MB, Canada; [Richard, Pierre; Orr, Jack; Ferguson, Steven H.] Fisheries & Oceans Canada, Winnipeg, MB, Canada; [Bernhardt, Warren] North South Consultants Inc, Winnipeg, MB, Canada	Fisheries & Oceans Canada	Ferguson, SH (corresponding author), Fisheries & Oceans Canada, Winnipeg, MB, Canada.	Steve.Ferguson@dfo-mpo.gc.ca			Manitoba Hydro Environmental Partnership Fund; NSERC Industrial Postgraduate Scholarship Fund; Fisheries and Oceans Canada; Manitoba Hydro	Manitoba Hydro Environmental Partnership Fund; NSERC Industrial Postgraduate Scholarship Fund; Fisheries and Oceans Canada; Manitoba Hydro	Research was funded by Manitoba Hydro Environmental Partnership Fund (https://www.hydro.mb.ca/communly/ervironmental_partnership_fund.shtml), NSERC Industrial Postgraduate Scholarship Fund to AJS (http://www.nserc-crsng.gc.ca/Students-Etudiants/PG-CS/IPS-BESII_eng.asp), Fisheries and Oceans Canada (http://www.dfo-mpo.gc.ca/index-eng.htm). The funder provided support in the form of salaries for authors AJS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We dedicate this manuscript our competent helicopter pilot Asbjorn (Ozzie) Erikson, who did not survive a helicopter crash during a forest fire rescue mission in northern Manitoba, 6 August 2013. Ozzie piloted a Bell 206L with Custom Helicopters Limited for many years ferrying hundreds of people and many tons of equipment safely back and forth to research field stations throughout northern Manitoba. We thank Manitoba Hydro for their generous support and funding for both the aerial surveys and beluga tagging. Hicks and Lawrence Aviation Ltd. (now Discovery Air Fire Services) provided support to conduct the aerial surveys in 2003 and 2005. We are grateful to the many people who assisted with the beluga tagging, especially Harold Funk of North South Consultants Inc., who safely piloted the jet boat up and down the Nelson River and throughout the capturing of the belugas in the estuary. Several First Nation individuals aided with the aerial surveys and beluga tagging. Clayton Flett, Russell Beardy, and Terry Neepin provided skill and knowledge towards the aerial surveys. John Beardy, John Hatley Jr., Jeromy Saunders, Darrin Chapmen, John Sinclair and Donald Beardy piloted the Zodiac chase boats and assisted with camp maintenance. Agnes Spence, Fanny Saunders, Andrea Hatley, and Elisabeth Neckoway cooked delicious, hardy, local foods for us. Daryl Hedman (Manitoba Conservation Operations Division) helped with the planning and logistics of the beluga tagging fieldwork. We thank Natalie Asselin, Eric Gaglione, Robert Hodgson, Dennis Litovka, Chris Malcom, Jim Orr, Denise Tenkula and Valeria Vergara for their help during the tagging fieldwork. The manuscript was improved considerably with the assistance of four anonymous reviewers.	*ARGOS, 1996, US MAN; Bailleul Frederic, 2012, Endangered Species Research, V17, P27, DOI 10.3354/esr00420; Barton K., 2013, MUMIN MULTIMODEL INT; BRODIE PF, 1971, J FISH RES BOARD CAN, V28, P1309, DOI 10.1139/f71-198; Brodie PF, 1970, THESIS; Brodie PF, 1967, THESIS; Calkins DG, 1983, SUSITNA HYDROELECTRI; Caron L.M.J., 1987, THESIS; Caron LMJ, 1990, CANADIAN B FISHERIES, P69; Citta JJ, 2016, MAR MAMMAL SCI, V32, P1272, DOI 10.1111/mms.12337; Corkeron PJ, 1999, MAR MAMMAL SCI, V15, P1228, DOI 10.1111/j.1748-7692.1999.tb00887.x; COSENS SE, 1990, ARCTIC, V43, P127; COSEWIC (Committee on the Status of Endangered Wildlife in Canada), 2015, COSEWIC ASS STAT REP; de March BGE, 2003, ARCTIC, V56, P111; Doan KH, 1953, FISHERIES RES BOARD, P98; Doidge DW, 2001, 12415 NUN RES CTR MA; FELTZ ET, 1966, CRYOBIOLOGY, V3, P261, DOI 10.1016/S0011-2240(66)80020-2; Ferguson Steven H, 2012, Aquat Biosyst, V8, P3, DOI 10.1186/2046-9063-8-3; Ferguson SH, 2012, POPUL ECOL, V54, P31, DOI 10.1007/s10144-011-0284-3; Finley K.J., 1982, Cetus, V4, P4; Fraker M. A., 1979, 863 DEP FISH ENV FIS; Fraker MA, 1978, BOWHEAD WHITE WHALES; FROST KJ, 1993, ARCTIC, V46, P8; Gagnon AS, 2005, ARCTIC, V58, P370, DOI 10.14430/arctic451; Goetz Kimberly T., 2012, Endangered Species Research, V16, P135, DOI 10.3354/esr00394; Gosselin JF, 2002, 2002042 FISH OC CAN; Gurarie E, 2009, ECOL LETT, V12, P395, DOI 10.1111/j.1461-0248.2009.01293.x; Hansen SE, 1988, THESIS; Hauser DDW, 2014, POLAR BIOL, V37, P1171, DOI 10.1007/s00300-014-1510-1; Heisterkamp S., 2016, COMPUTER SOFTWARE, V3, P1, DOI DOI 10.1016/J.CR0PR0.2007.08.015; Higdon JW, 2009, ECOL APPL, V19, P1365, DOI 10.1890/07-1941.1; HINZMAN LD, 1992, J GEOPHYS RES-ATMOS, V97, P2811, DOI 10.1029/91JD01752; Hooge P. N., 1997, ANIMAL MOVEMENT ANAL; Kelley TC, 2010, LITTLE LESS ARCTIC: TOP PREDATORS IN THE WORLDS LARGEST NORTHERN INLAND SEA, HUDSON BAY, P53, DOI 10.1007/978-90-481-9121-5_3; Kilabuk P, 1998, STUDY INUIT KNOWLEDG; Kleinenberg SE, 1969, BELUGA DELPHINAPTER; Laidre KL, 2008, ECOL APPL, V18, pS97, DOI 10.1890/06-0546.1; Ling JK, 1972, FUNCTIONAL ANATOMY M, P1; Litovka D.I., 2002, RUSSIAN J MARINE BIO, V28, P263; Martin AR, 1998, POLAR BIOL, V20, P218, DOI 10.1007/s003000050299; Moore S.E., 2000, MAR FISH REV, V62, P60; Mymrin NI, 1999, ARCTIC, V52, P62; Orr JR, 2001, ARCTIC, V54, P299; Peterson BJ, 2002, SCIENCE, V298, P2171, DOI 10.1126/science.1077445; Post E, 2013, SCIENCE, V341, P519, DOI 10.1126/science.1235225; Pranuthi G, 2014, INDIAN J SCI TECHNOL, V7, P1573; Prinsenberg SJ, 1991, JAMES BAY PUBLICATIO; Quakenbush Lori T., 2015, U S National Marine Fisheries Service Marine Fisheries Review, V77, P70; R CORE TEAM, 2016, R LANG ENV STAT COMP; Richard PR, 2001, ARCTIC, V54, P223, DOI 10.14430/arctic783; Richard PR, 2005, 2005017 CAN SCI ADV; SEAMAN GA, 1982, CETOLOGY, V44, P1; SERGEANT DE, 1975, J FISH RES BOARD CAN, V32, P1047, DOI 10.1139/f75-123; SERGEANT DE, 1973, J FISH RES BOARD CAN, V30, P1065, DOI 10.1139/f73-178; SERGEANT DE, 1969, J FISH RES BOARD CAN, V26, P2561, DOI 10.1139/f69-251; Silverman B.W., 1986, DENSITY ESTIMATION S; Simmonds MP, 2007, ORYX, V41, P19, DOI 10.1017/S0030605307001524; Smith A. L., 2007, THESIS; SMITH TG, 1986, CAN J FISH AQUAT SCI, V43, P1982, DOI 10.1139/f86-243; SMITH TG, 1992, CAN J ZOOL, V70, P2405, DOI 10.1139/z92-322; St Aubin DJ, 1990, CAN J ZOOL, V58, P359; Stewart DB, 2010, LITTLE LESS ARCTIC: TOP PREDATORS IN THE WORLDS LARGEST NORTHERN INLAND SEA, HUDSON BAY, P1, DOI 10.1007/978-90-481-9121-5_1; Stewart DG, 2005, CANADIAN TECHNICAL R; Swartz SL, 2006, MAMMAL REV, V36, P66, DOI 10.1111/j.1365-2907.2006.00082.x; Turgeon J, 2012, CONSERV GENET, V13, P419, DOI 10.1007/s10592-011-0294-x; Tynan CT, 1997, ARCTIC, V50, P308, DOI 10.14430/arctic1113; Vladkoy VD, 1944, ETUDES AQUATIQUES CH; Vos Daniel J., 2005, Northwestern Naturalist, V86, P59, DOI 10.1898/1051-1733(2005)086[0059:UMITDC]2.0.CO;2; WATTS PD, 1991, J THERM BIOL, V16, P57, DOI 10.1016/0306-4565(91)90053-5; WATTS PD, 1986, ARCTIC ALPINE RES, V18, P439, DOI 10.2307/1551093; Westdal Kristin H., 2016, Canadian Field-Naturalist, V130, P315, DOI 10.22621/cfn.v130i4.1925; Woodley TH, 1991, JAMES BAY; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; WXTide32, 2003, FREE WIND TID CURR P	74	24	26	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0181045	10.1371/journal.pone.0181045	http://dx.doi.org/10.1371/journal.pone.0181045			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767655	gold, Green Submitted, Green Published			2022-12-26	WOS:000406768200015
J	Hua, N; Takahashi, H; Yee, GM; Kitajima, Y; Katagiri, S; Kojima, M; Anzai, K; Eguchi, Y; Hamilton, JA				Hua, Ning; Takahashi, Hirokazu; Yee, Grace M.; Kitajima, Yoichiro; Katagiri, Sayaka; Kojima, Motoyasu; Anzai, Keizo; Eguchi, Yuichiro; Hamilton, James A.			Influence of muscle fiber type composition on early fat accumulation under high-fat diet challenge	PLOS ONE			English	Article							SKELETAL-MUSCLE; IN-VIVO; METABOLIC COMPLICATIONS; INSULIN-RESISTANCE; OBESITY; SPECTROSCOPY; TRIGLYCERIDE	Objective: To investigate whether differences in muscle fiber types affect early-stage fat accumulation, under high fat diet challenge in mice. Methods: Twelve healthy male C57BL/6 mice experienced with short-term (6 weeks) diet treatment for the evaluation of early pattern changes in muscular fat. The mice were randomly divided into two groups: high fat diet (n = 8) and normal control diet (n = 4). Extra- and intra-myocellular lipid (EMCL and IMCL) in lumbar muscles (type I fiber predominant) and tibialis anterior (TA) muscle (type II fiber predominant) were determined using magnetic resonance spectroscopy (MRS). Correlation of EMCL, IMCL and their ratio between TA and lumbar muscles was evaluated. Results: EMCL increased greatly in both muscle types after high fat diet. IMCL in TA and lumbar muscles increased to a much lower extent, with a slightly greater increase in TA muscles. EMCLs in the 2 muscles were positively correlated (r = 0.84, p = 0.01), but IMCLs showed a negative relationship (r = -0.84, p = 0.01). In lumbar muscles, high fat diet significantly decreased type I fiber while it increased type II fiber (all p <= 0.001). In TA muscle, there was no significant fiber type shifting (p>0.05). ConclusionS: Under short-time high fat diet challenge, lipid tends to initially accumulate extra-cellularly. In addition, compared to type II dominant muscle, Type I dominant muscle was less susceptible to IMCL accumulation but more to fiber type shifting. These phenomena might reflect compensative responses of skeletal muscle to dietary lipid overload in order to regulate metabolic homeostasis.	[Hua, Ning; Yee, Grace M.; Hamilton, James A.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; [Takahashi, Hirokazu; Katagiri, Sayaka] Harvard Med Sch, Joslin Diabet Ctr, Res Div, Boston, MA USA; [Takahashi, Hirokazu; Katagiri, Sayaka] Harvard Med Sch, Dept Med, Res Div, Boston, MA USA; [Takahashi, Hirokazu; Kitajima, Yoichiro; Kojima, Motoyasu; Anzai, Keizo] Saga Med Sch, Div Internal Med, Saga, Japan; [Kitajima, Yoichiro] Eguchi Hosp, Clin Gastroenterol, Saga, Japan; [Eguchi, Yuichiro] Saga Med Sch, Div Hepatol, Liver Ctr, Saga, Japan; [Hamilton, James A.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Boston University; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Saga University; Saga University; Boston University	Hamilton, JA (corresponding author), Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA.; Hamilton, JA (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.	jhamilt@bu.edu			Nobel from Boston University; Japanese Diabetes Foundation; NATIONAL INSTITUTE ON AGING [P30AG013846] Funding Source: NIH RePORTER	Nobel from Boston University; Japanese Diabetes Foundation(New Energy and Industrial Technology Development Organization (NEDO)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the Nobel from Boston University and also funded by the Japanese Diabetes Foundation.	[Anonymous], J BIOPHOTONICS INT, V11, P36; BJORNTORP P, 1991, DIABETES CARE, V14, P1132, DOI 10.2337/diacare.14.12.1132; Cameron-Smith D, 2003, AM J CLIN NUTR, V77, P313, DOI 10.1093/ajcn/77.2.313; Corcoran MP, 2007, SKELETAL MUSCLE LIPI; DeNies MS, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.204; Despres JP, 2012, CIRCULATION, V126, P1301, DOI 10.1161/CIRCULATIONAHA.111.067264; Fissoune R, 2009, ACAD RADIOL, V16, P890, DOI 10.1016/j.acra.2008.12.007; Hwang JH, 2007, AM J PHYSIOL-ENDOC M, V293, pE1663, DOI 10.1152/ajpendo.00590.2006; Jensen MD, 2008, J CLIN ENDOCR METAB, V93, pS57, DOI 10.1210/jc.2008-1585; JOHNSON MA, 1973, J NEUROL SCI, V18, P111, DOI 10.1016/0022-510X(73)90023-3; Kuhlmann J, 2003, DIABETES, V52, P138, DOI 10.2337/diabetes.52.1.138; Schilling N, 2009, ZOOLOGY, V112, P279, DOI 10.1016/j.zool.2008.09.007; Shortreed KE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007293; SIMONEAU JA, 1995, FASEB J, V9, P273, DOI 10.1096/fasebj.9.2.7781930; Sinha-Hikim I, 2014, ENDOCRINOLOGY, V155, P865, DOI 10.1210/en.2013-1795; Sitnick MT, 2013, DIABETES, V62, P3350, DOI 10.2337/db13-0500; Smith U, 2015, J CLIN INVEST, V125, P1790, DOI 10.1172/JCI81507; Stefan D, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/10/104035; Stuart CA, 2010, MED SCI SPORT EXER, V42, P96, DOI 10.1249/MSS.0b013e3181ad7f36; Szczepaniak LS, 1999, AM J PHYSIOL-ENDOC M, V276, pE977, DOI 10.1152/ajpendo.1999.276.5.E977; Trajcevski KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071747; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Wilson JM, 2012, J STRENGTH COND RES, V26, P1724, DOI 10.1519/JSC.0b013e318234eb6f	23	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0182430	10.1371/journal.pone.0182430	http://dx.doi.org/10.1371/journal.pone.0182430			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763507	Green Published, Green Submitted, gold			2022-12-26	WOS:000406766500066
J	Wang, L; Xiao, R; Andres-Mateos, E; Vandenberghe, LH				Wang, Li; Xiao, Ru; Andres-Mateos, Eva; Vandenberghe, Luk H.			Single stranded adeno-associated virus achieves efficient gene transfer to anterior segment in the mouse eye	PLOS ONE			English	Article							TRABECULAR MESHWORK CELLS; AAV; THERAPY; VECTORS; GLAUCOMA; TRANSDUCTION	Adeno-associated viruses (AAVs) are used extensively as a gene delivery vehicle for retinal gene therapy, yet its ability to target the anterior segment of the eye, critical to unlocking therapeutic opportunities, is less characterized. Previously, self-complimentary (sc) AAV was shown to be necessary for transduction of the cornea and trabecular meshwork (TM), limiting the size of the gene transfer cassette, likely due to a block in second strand synthesis thought to be required for functional transduction. Here, we evaluated several AAV capsids in a single stranded (ss) genome conformation for their ability to overcome the need for scAAV for targeting corneal endothelium and TM. AAV2, 8, and a recently synthetically developed AAV called Anc80L65 were evaluated in vitro and in vivo by intracameral injection in mice. Results show that although scAAV2 demonstrated superior infectivity in vitro including Human Trabecular meshwork (HTM) immortalized cell lines; Anc80L65 transduced following a single intracameral injection efficiently all components of the mouse anterior segment, including the TM, corneal stroma, and endothelial cells. These results suggest that Anc80L65 is able to overcome the requirement for scAAV genomes to enable TM and corneal targeting, expanding the potential experimental and therapeutic use of AAV gene transfer in the anterior segment of the eye.	[Wang, Li] Fudan Univ, Shanghai Med Coll, Eye & ENT Hosp, Dept Ophthalmol & Visual Sci, Shanghai, Peoples R China; [Wang, Li] Fudan Univ, Shanghai Med Coll, Eye & ENT Hosp, Eye Res Inst, Shanghai, Peoples R China; [Wang, Li] Fudan Univ, Minist Hlth, Key Lab Myopia, Shanghai, Peoples R China; [Wang, Li] Fudan Univ, Shanghai Key Lab Visual Impairment & Restorat, Shanghai, Peoples R China; [Wang, Li; Xiao, Ru; Andres-Mateos, Eva; Vandenberghe, Luk H.] Schepens Eye Res Inst, Grousbeck Gene Therapy Ctr, Boston, MA 02114 USA; [Wang, Li; Xiao, Ru; Andres-Mateos, Eva; Vandenberghe, Luk H.] Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA; [Wang, Li; Xiao, Ru; Andres-Mateos, Eva; Vandenberghe, Luk H.] Harvard Med Sch, Dept Ophthalmol, Ocular Genom Inst, Boston, MA 02115 USA; [Vandenberghe, Luk H.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Fudan University; Fudan University; Fudan University; Fudan University; Harvard University; Schepens Eye Research Institute; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Harvard University	Vandenberghe, LH (corresponding author), Schepens Eye Res Inst, Grousbeck Gene Therapy Ctr, Boston, MA 02114 USA.; Vandenberghe, LH (corresponding author), Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA.; Vandenberghe, LH (corresponding author), Harvard Med Sch, Dept Ophthalmol, Ocular Genom Inst, Boston, MA 02115 USA.; Vandenberghe, LH (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA.	luk_vandenberghe@meei.harvard.edu	VANDENBERGHE, LUC H./ABH-1765-2020; Vandenberghe, Luk H./J-6395-2014	VANDENBERGHE, LUC H./0000-0002-3508-4924; Vandenberghe, Luk H./0000-0002-3508-4924	Grousbeck Family Foundation; Lonza Houston; National Institutes of Health [5DP1EY023177]; NATIONAL EYE INSTITUTE [P30EY003790] Funding Source: NIH RePORTER	Grousbeck Family Foundation; Lonza Houston; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Grousbeck Family Foundation (L.H.V.), Lonza Houston, and National Institutes of Health 5DP1EY023177 (L.H.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Solinis MA, 2015, EUR J PHARM BIOPHARM, V95, P331, DOI 10.1016/j.ejpb.2014.12.022; Benjaminy S, 2015, AM J OPHTHALMOL, V160, P408, DOI 10.1016/j.ajo.2015.05.026; Bogner B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128759; Borras T, 2006, J GENE MED, V8, P589, DOI 10.1002/jgm.886; Borras T, 2003, EXP EYE RES, V76, P643, DOI 10.1016/S0014-4835(03)00030-7; Borras T, 2002, INVEST OPHTH VIS SCI, V43, P2513; Borras T, 2012, INVEST OPHTH VIS SCI, V53, P2506, DOI 10.1167/iovs.12-9483o; Buie LK, 2010, INVEST OPHTH VIS SCI, V51, P236, DOI 10.1167/iovs.09-3847; Buss DG, 2010, VET OPHTHALMOL, V13, P301, DOI 10.1111/j.1463-5224.2010.00813.x; Gruenert AK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152589; Hippert C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035318; Landegger L., 2017, NAT BIOTECHNOL; Liu J, 2008, MOL VIS, V14, P2087; Liu MM, 2011, BRIT J OPHTHALMOL, V95, P604, DOI 10.1136/bjo.2009.174912; Lock M, 2010, HUM GENE THER, V21, P1259, DOI 10.1089/hum.2010.055; McCarty DM, 2008, MOL THER, V16, P1648, DOI 10.1038/mt.2008.171; Mohan RR, 2003, EXP EYE RES, V76, P373, DOI 10.1016/S0014-4835(02)00275-0; Rivera VM, 2005, BLOOD, V105, P1424, DOI 10.1182/blood-2004-06-2501; Sharma A, 2010, EXP EYE RES, V91, P440, DOI 10.1016/j.exer.2010.06.020; Sharma A, 2010, BRAIN RES BULL, V81, P273, DOI 10.1016/j.brainresbull.2009.07.005; Strungaru MH, 2011, INVEST OPHTH VIS SCI, V52, P7625, DOI 10.1167/iovs.10-6967; Vance M, 2016, SCI REP-UK, V6, DOI 10.1038/srep22131; Zinn E, 2015, CELL REP, V12, P1056, DOI 10.1016/j.celrep.2015.07.019; Zinn E, 2014, CURR OPIN VIROL, V8, P90, DOI 10.1016/j.coviro.2014.07.008	24	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0182473	10.1371/journal.pone.0182473	http://dx.doi.org/10.1371/journal.pone.0182473			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763501	Green Published, gold, Green Submitted			2022-12-26	WOS:000406766500068
J	Jafarimoghaddam, A; Aberoumand, S				Jafarimoghaddam, Amin; Aberoumand, Sadegh			A Comparison between heat transfer performance of rectangular and semicircular tubes considering boundary effects on Brownian motions in the presence of Ag / water nanofluids: Applicable in the design of cooling system of photovoltaic cells	PLOS ONE			English	Article							REGIME	The present study aims to experimentally investigate heat transfer performance of rectangular and semicircular tubes in the presence of Ag / water nanofluids. The nanoparticles of Ag ( silver) were used in seven different volume concentrations of 0.03%, 0.07%, 0.1%, 0.2%, 0.4%, 1% and 2%. The experiment was conducted in relatively low Reynolds numbers of 301 to 740. A heater with the power of 200 W was used to keep the outer surface of the tubes under a constant heat flux condition. In addition, the rectangular tube has been designed within the same length as the semicircular one and also within the same hydraulic diameter. Moreover, the average nanoparticles size was 20 nm. The outcome results of the present empirical work indicate that, for all the examined Reynolds numbers, the semicircular tube has higher convective heat transfer coefficient for all the utilized volume concentrations of Ag nanoparticles. The possible reasons behind this advantage are discussed through the present work mainly by taking the boundary effect on Brownian motions into account. Coming to this point that the conventional design for cooling system of photovoltaic cells is a heat sink with the rectangular graves, it is discussed that using a semicircular design may have the advantage over the rectangular one in convective heat transfer coefficient enhancement and hence a better cooling performance for these solar cells.	[Jafarimoghaddam, Amin] KN Toosi Univ Technol, Dept Aerosp Engn, Tehran, Iran	K. N. Toosi University of Technology	Jafarimoghaddam, A (corresponding author), KN Toosi Univ Technol, Dept Aerosp Engn, Tehran, Iran.	a.jafarimoghaddam@gmail.com	Aberoumand, Sadegh/U-2385-2017	Aberoumand, Sadegh/0000-0002-2342-7563				Aberoumand S, 2016, APPL THERM ENG, V108, P967, DOI 10.1016/j.applthermaleng.2016.06.032; Aberoumand S, 2016, APPL THERM ENG, V101, P362, DOI 10.1016/j.applthermaleng.2016.01.148; Agrawal S, 2011, SOL ENERGY, V85, P356, DOI 10.1016/j.solener.2010.11.013; Ebrahimnia-Bajestan E, 2011, INT J HEAT MASS TRAN, V54, P4376, DOI 10.1016/j.ijheatmasstransfer.2011.05.006; Farajollahi B, 2010, INT J HEAT MASS TRAN, V53, P12, DOI 10.1016/j.ijheatmasstransfer.2009.10.019; Jafarimoghaddam A, 2016, ALEX ENG J, V55, P1047, DOI 10.1016/j.aej.2016.03.005; Jafarimoghaddam A, 2016, HEAT TRANS ASIAN RES; Karami N, 2014, INT COMMUN HEAT MASS, V55, P45, DOI 10.1016/j.icheatmasstransfer.2014.04.009; Karathanassis IK, 2013, APPL THERM ENG, V59, P733, DOI 10.1016/j.applthermaleng.2012.06.034; Leroy P, 2011, J COLLOID INTERF SCI, V356, P442, DOI 10.1016/j.jcis.2011.01.016; Mo JY, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.062106; Otanicar TP, 2010, J RENEW SUSTAIN ENER, V2, DOI 10.1063/1.3429737; Ramos-Alvarado B, 2011, APPL THERM ENG, V31, P2494, DOI 10.1016/j.applthermaleng.2011.04.015; Saidur R, 2012, INT J HEAT MASS TRAN, V55, P5899, DOI 10.1016/j.ijheatmasstransfer.2012.05.087; Taylor RA, 2011, J RENEW SUSTAIN ENER, V3, DOI 10.1063/1.3571565; Tyagi H, 2009, J SOL ENERG-T ASME, V131, DOI 10.1115/1.3197562; Vajjha RS, 2010, INT J HEAT MASS TRAN, V53, P4607, DOI 10.1016/j.ijheatmasstransfer.2010.06.032; Wen DS, 2005, MICROFLUID NANOFLUID, V1, P183, DOI 10.1007/s10404-004-0027-2; Xuan YM, 2000, INT J HEAT MASS TRAN, V43, P3701, DOI 10.1016/S0017-9310(99)00369-5	19	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0180883	10.1371/journal.pone.0180883	http://dx.doi.org/10.1371/journal.pone.0180883			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753603	gold, Green Submitted, Green Published			2022-12-26	WOS:000406579300008
J	Kim, JH; Lim, S; Park, KS; Jang, HC; Choi, SH				Kim, Jung Hee; Lim, Soo; Park, Kyong Soo; Jang, Hak Chul; Choi, Sung Hee			Total and differential WBC counts are related with coronary artery atherosclerosis and increase the risk for cardiovascular disease in Koreans	PLOS ONE			English	Article							BLOOD-CELL COUNT; AMERICAN-HEART-ASSOCIATION; LEUKOCYTE COUNT; COMPUTED-TOMOGRAPHY; MYOCARDIAL-INFARCTION; METABOLIC SYNDROME; PROGNOSTIC VALUE; ANGIOGRAPHY; EVENTS; WOMEN	Objective Inflammation is a key mechanism of atherosclerosis. White blood cells (WBCs) play a pivotal role in the inflammatory process. We investigated the relationships between total and differential WBC counts and multi-detector cardiac computed tomography (MDCT) findings, as well as the risk of cardiovascular disease in asymptomatic patients in Korea. Materials and methods We recruited asymptomatic men (n = 7274) and women (n = 5478) aged >= 30 years who were free of known coronary heart disease. All patients underwent MDCT during a routine health check-up in the Seoul National University Bundang Hospital between 2006 and 2007, and were followed-up for 5.6 years. We reviewed medical records for cardiovascular diseases (CVDs) and covariates. Results In covariate-adjusted logistic regression models for MDCT findings, subjects within the third tertile of all WBC subtypes had a higher risk for significant stenosis and noncalcified plaques compared with the first tertile of each subtype. In Cox proportional hazard regression models for the risk of CVDs, subjects within the third tertiles of lymphocytes and monocytes were at an increased risk of CVDs (total WBC, HR = 1.22 [1.02-1.44]; lymphocyte, HR = 1.47 [1.25-1.74]; monocytes, HR = 1.26 [1.02-1.35]) even after further adjustment for covariates and coronary artery stenosis. Conclusions Total WBC counts were related with the severity of coronary artery disease, and higher WBC counts increased the risk of CVDs in asymptomatic Koreans mainly by virtue of monocytes.	[Kim, Jung Hee; Lim, Soo; Park, Kyong Soo; Jang, Hak Chul; Choi, Sung Hee] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Lim, Soo; Jang, Hak Chul; Choi, Sung Hee] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Choi, SH (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.; Choi, SH (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea.	drshchoi@snu.ac.kr	Kim, Jung Hee/AAG-1191-2019; Park, Kyong Soo/C-2265-2008	Kim, Jung Hee/0000-0003-1932-0234; CHOI, SUNG HEE/0000-0003-0740-8116; Park, Kyong Soo/0000-0003-3597-342X				AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; [Anonymous], 1993, AM HEART J, V125, P855; Ates AH, 2011, CARDIOL J, V18, P371; Austen W G, 1975, Circulation, V51, P5; Budoff MJ, 2006, CIRCULATION, V114, P1761, DOI 10.1161/CIRCULATIONAHA.106.178458; Chun EJ, 2008, J COMPUT ASSIST TOMO, V32, P86, DOI 10.1097/rct.0b013e318059befa; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; FRIEDMAN GD, 1974, NEW ENGL J MED, V290, P1275, DOI 10.1056/NEJM197406062902302; Gillum RF, 2005, ANN EPIDEMIOL, V15, P266, DOI 10.1016/j.annepidem.2004.08.009; GILLUM RF, 1993, AM HEART J, V125, P855, DOI 10.1016/0002-8703(93)90181-8; Gkrania-Klotsas E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013405; Hausleiter J, 2006, J AM COLL CARDIOL, V48, P312, DOI 10.1016/j.jacc.2006.02.064; Hoffmann U, 2006, J AM COLL CARDIOL, V47, P1655, DOI 10.1016/j.jacc.2006.01.041; Horne BD, 2005, J AM COLL CARDIOL, V45, P1638, DOI 10.1016/j.jacc.2005.02.054; Ingelsson E, 2007, CIRCULATION, V116, P984, DOI 10.1161/CIRCULATIONAHA.107.708537; KANNEL WB, 1992, JAMA-J AM MED ASSOC, V267, P1253, DOI 10.1001/jama.267.9.1253; KOSTIS JB, 1984, AM J CARDIOL, V53, P997, DOI 10.1016/0002-9149(84)90624-6; Leng S, 2005, J GERONTOL A-BIOL, V60, P195, DOI 10.1093/gerona/60.2.195; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lim S, 2011, RADIOLOGY, V261, P437, DOI 10.1148/radiol.11101725; Madjid M, 2004, J AM COLL CARDIOL, V44, P1945, DOI 10.1016/j.jacc.2004.07.056; Margolis KL, 2005, ARCH INTERN MED, V165, P500, DOI 10.1001/archinte.165.5.500; Matsumoto N, 2007, CIRC J, V71, P1898, DOI 10.1253/circj.71.1898; Min JK, 2010, INT J CARDIOVAS IMAG, V26, P721, DOI 10.1007/s10554-010-9613-4; OLIVARES R, 1993, AM J EPIDEMIOL, V137, P49, DOI 10.1093/oxfordjournals.aje.a116601; PHILLIPS AN, 1992, AM J EPIDEMIOL, V136, P59, DOI 10.1093/oxfordjournals.aje.a116421; PRENTICE RL, 1982, AM J EPIDEMIOL, V116, P496, DOI 10.1093/oxfordjournals.aje.a113434; Rana JS, 2007, J INTERN MED, V262, P678, DOI 10.1111/j.1365-2796.2007.01864.x; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sabatine MS, 2002, J AM COLL CARDIOL, V40, P1761, DOI 10.1016/S0735-1097(02)02484-1; Sweetnam PM, 1997, AM J EPIDEMIOL, V145, P416; Takahashi Kiyoshi, 2002, Medical Electron Microscopy, V35, P179, DOI 10.1007/s007950200023; Wheeler JG, 2004, EUR HEART J, V25, P1287, DOI 10.1016/j.ehj.2004.05.002; ZALOKAR JB, 1981, NEW ENGL J MED, V304, P465, DOI 10.1056/NEJM198102193040806	35	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0180332	10.1371/journal.pone.0180332	http://dx.doi.org/10.1371/journal.pone.0180332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753607	Green Published, gold, Green Submitted			2022-12-26	WOS:000406579300004
J	Wallenhammar, A; Anandapadamanaban, M; Lemak, A; Mirabello, C; Lundstrom, P; Wallner, B; Sunnerhagen, M				Wallenhammar, Amelie; Anandapadamanaban, Madhanagopal; Lemak, Alexander; Mirabello, Claudio; Lundstroem, Patrik; Wallner, Bjoern; Sunnerhagen, Maria			Solution NMR structure of the TRIM21 B-box2 and identification of residues involved in its interaction with the RING domain	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; CHEMICAL-SHIFT; EVOLUTIONARY CONSERVATION; BACKBONE DYNAMICS; WEB SERVER; SEQUENCE; BINDING; RELAXATION; FINGER; MOTIF	Tripartite motif-containing (TRIM) proteins are defined by the sequential arrangement of RING, B-box and coiled-coil domains (RBCC), where the B-box domain is a unique feature of the TRIM protein family. TRIM21 is an E3 ubiquitin-protein ligase implicated in innate immune signaling by acting as an autoantigen and by modifying interferon regulatory factors. Here we report the three-dimensional solution structure of the TRIM21 B-box2 domain by nuclear magnetic resonance (NMR) spectroscopy. The structure of the B-box2 domain, comprising TRIM21 residues 86-130, consists of a short alpha-helical segment with an N-terminal short beta-strand and two anti-parallel beta-strands jointly found the core, and adopts a RING-like fold. This beta beta alpha beta core largely defines the overall fold of the TRIM21 B-box2 and the coordination of one Zn2+ ion stabilizes the tertiary structure of the protein. Using NMR titration experiments, we have identified an exposed interaction surface, a novel interaction patch where the B-box2 is likely to bind the N-terminal RING domain. Our structure together with comparisons with other TRIM B-box domains jointly reveal how its different surfaces are employed for various modular interactions, and provides extended understanding of how this domain relates to flanking domains in TRIM proteins.	[Wallenhammar, Amelie; Anandapadamanaban, Madhanagopal; Lundstroem, Patrik; Sunnerhagen, Maria] Linkoping Univ, Dept Phys Chem & Biol, Div Chem, Linkoping, Sweden; [Lemak, Alexander] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Lemak, Alexander] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Mirabello, Claudio; Wallner, Bjoern] Linkoping Univ, Div Bioinformat, Dept Phys Chem & Biol, Linkoping, Sweden; [Anandapadamanaban, Madhanagopal] MRC, Mol Biol Lab, Cambridge Biomed Campus, Cambridge, England	Linkoping University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Linkoping University; MRC Laboratory Molecular Biology	Sunnerhagen, M (corresponding author), Linkoping Univ, Dept Phys Chem & Biol, Div Chem, Linkoping, Sweden.	maria.sunnerhagen@liu.se	Mirabello, Claudio/AAF-2451-2020	Mirabello, Claudio/0000-0001-7868-034X; Sunnerhagen, Maria/0000-0002-0492-5890; Anandapadamanaban, Madhanagopal/0000-0002-4237-0048; Wallenhammar, Amelie/0000-0002-2867-8249	Swedish Science Council; Swedish Cancer Foundation; Swedish Foundation for International Cooperation in Research and Higher Education	Swedish Science Council; Swedish Cancer Foundation; Swedish Foundation for International Cooperation in Research and Higher Education	This project was supported by the Swedish Science Council (BW, MS), the Swedish Cancer Foundation (MS) and the Swedish Foundation for International Cooperation in Research and Higher Education (BW, MS).; This project was supported by the Swedish Science Council (BW, MS), the Swedish Cancer Foundation (MS) and the Swedish Foundation for International Cooperation in Research and Higher Education (BW, MS). The Swedish NMR Centre at the University of Gothenburg is acknowledged for instrument access and support. We thank Dr Maxim Mayzel and Dr Cecilia Persson for help with data recording. Structure calculations were performed at the University of Toronto and University Health Network (UHN) in Toronto, Canada. Modeling was performed on resources provided by the Swedish National Infrastructure for Computing (SNIC) at the National Supercomputer Centre (NSC) in Linkoping, Sweden.	Ahlner A, 2013, J BIOMOL NMR, V56, P191, DOI 10.1007/s10858-013-9737-7; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Beasley SA, 2007, P NATL ACAD SCI USA, V104, P3095, DOI 10.1073/pnas.0610548104; Berndsen CE, 2014, NAT STRUCT MOL BIOL, V21, P301, DOI 10.1038/nsmb.2780; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diaz-Griffero F, 2009, J VIROL, V83, P10737, DOI 10.1128/JVI.01307-09; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Espinosa A, 2011, J BIOL CHEM, V286, P36478, DOI 10.1074/jbc.M111.241786; Espinosa A, 2009, J EXP MED, V206, P1661, DOI 10.1084/jem.20090585; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FREEMONT PS, 1993, ANN NY ACAD SCI, V684, P174, DOI 10.1111/j.1749-6632.1993.tb32280.x; Ganser-Pornillos BK, 2011, P NATL ACAD SCI USA, V108, P534, DOI 10.1073/pnas.1013426108; Goldstone DC, 2014, P NATL ACAD SCI USA, V111, P9609, DOI 10.1073/pnas.1402448111; Grishin NV, 2001, NUCLEIC ACIDS RES, V29, P1703, DOI 10.1093/nar/29.8.1703; Grutter MG, 2012, CURR OPIN VIROL, V2, P142, DOI 10.1016/j.coviro.2012.02.003; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Gutmanas A, 2002, J BIOMOL NMR, V24, P191, DOI 10.1023/A:1021609314308; Hafsa NE, 2015, NUCLEIC ACIDS RES, V43, pW370, DOI 10.1093/nar/gkv494; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Hennig J, 2005, J BIOL CHEM, V280, P33250, DOI 10.1074/jbc.M503066200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang YJ, 2005, J AM CHEM SOC, V127, P1665, DOI 10.1021/ja047109h; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Keown JR, 2016, SCI REP-UK, V6, DOI 10.1038/srep26837; Keown JR, 2016, J STRUCT BIOL, V195, P282, DOI 10.1016/j.jsb.2016.07.004; Klose DP, 2010, BIOINFORMATICS, V26, P2624, DOI 10.1093/bioinformatics/btq480; Kong HJ, 2007, J IMMUNOL, V179, P26, DOI 10.4049/jimmunol.179.1.26; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kornhaber GJ, 2006, J BIOMOL NMR, V34, P259, DOI 10.1007/s10858-006-0027-5; Korzhnev DM, 2002, J AM CHEM SOC, V124, P10743, DOI 10.1021/ja0204776; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KRIZEK BA, 1993, INORG CHEM, V32, P937, DOI 10.1021/ic00058a030; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Laskowski RA, 1997, TRENDS BIOCHEM SCI, V22, P488, DOI 10.1016/S0968-0004(97)01140-7; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Maret W, 2015, METALLOMICS, V7, P202, DOI 10.1039/c4mt00230j; Massiah MA, 2007, J MOL BIOL, V369, P1, DOI 10.1016/j.jmb.2007.03.017; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Mrosek M, 2008, BIOCHEMISTRY-US, V47, P10722, DOI 10.1021/bi800733z; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Oke V, 2012, J AUTOIMMUN, P1; Orekhov VY, 2011, PROG NUCL MAG RES SP, V59, P271, DOI 10.1016/j.pnmrs.2011.02.002; Palmer AG, 2006, CHEM REV, V106, P1700, DOI 10.1021/cr0404287; Rajsbaum R, 2014, J MOL BIOL, V426, P1265, DOI 10.1016/j.jmb.2013.12.005; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Sheng Y, 2008, NAT STRUCT MOL BIOL, V15, P1334, DOI 10.1038/nsmb.1521; Short KM, 2006, J BIOL CHEM, V281, P8970, DOI 10.1074/jbc.M512755200; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Tamiola K, 2010, J AM CHEM SOC, V132, P18000, DOI 10.1021/ja105656t; Tao H, 2008, BIOCHEMISTRY-US, V47, P2450, DOI 10.1021/bi7018496; Torok M, 2001, DIFFERENTIATION, V67, P63, DOI 10.1046/j.1432-0436.2001.067003063.x; Wagner JM, ELIFE; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Yang K, 2009, J IMMUNOL, V182, P3782, DOI 10.4049/jimmunol.0803126	67	5	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0181551	10.1371/journal.pone.0181551	http://dx.doi.org/10.1371/journal.pone.0181551			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753623	Green Published, gold, Green Submitted			2022-12-26	WOS:000406579300020
J	Zeppenfeld, T; Balkenhol, N; Kovacs, K; Carminati, A				Zeppenfeld, Thorsten; Balkenhol, Niko; Kovacs, Kristof; Carminati, Andrea			Rhizosphere hydrophobicity: A positive trait in the competition for water	PLOS ONE			English	Article							HYDRAULIC CONDUCTIVITY; PATTERN-FORMATION; PLANT-ROOTS; SOIL; DYNAMICS; REPELLENCY; PROTOCOL; RELEASE; FLOW; FORM	The ability to acquire water from the soil is a major driver in interspecific plant competition and it depends on several root functional traits. One of these traits is the excretion of gel-like compounds (mucilage) that modify physical soil properties. Mucilage secreted by roots becomes hydrophobic upon drying, impedes the rewetting of the soil close to the root, the so called rhizosphere, and reduces water availability to plants. The function of rhizosphere hydrophobicity is not easily understandable when looking at a single plant, but it may constitute a competitive advantage at the ecosystem level. We hypothesize that by making the top soil hydrophobic, deep-rooted plants avoid competititon with shallow-rooted plants. To test this hypothesis we used an individual-based model to simulate water uptake and growth of two virtual plant species, one deep-rooted plant capable of making the soil hydrophobic and a shallow-rooted plant. We ran scenarios with different precipitation regimes ranging from dry to wet (350, 700, and 1400 mm total annual precipitation) and from high to low precipitation frequencies (1, 7, and 14 days). Plant species abundance and biomass were chosen as indicators for competitiveness of plant species. At constant precipitation frequency mucilage hydrophobicity lead to a benefit in biomass and abundance of the tap-rooted population. Under wet conditions this effect diminished and tap-rooted plants were less productive. Without this trait both species coexisted. The effect of root exudation trait remained constant under different precipitation frequencies. This study shows that mucilage secretion is a competitive trait for the acquisition of water. This advantage is achieved by the modification of the soil hydraulic properties and specifically by inducing water repellency in soil regions which are shared with other species.	[Zeppenfeld, Thorsten; Kovacs, Kristof] Univ Gottingen, Inst Geog, Dept Phys Geog, Gottingen, Germany; [Balkenhol, Niko] Univ Gottingen, Fac Forestry & Forest Ecol, Dept Wildlife Sci, Gottingen, Germany; [Carminati, Andrea] Univ Gottingen, Fac Agr Sci, Div Soil Hydrol, Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen	Zeppenfeld, T (corresponding author), Univ Gottingen, Inst Geog, Dept Phys Geog, Gottingen, Germany.	thorsten.zeppenfeld@geo.uni-goettingen.de	Carminati, Andrea/V-2336-2018; Carminati, Andrea/AAE-1926-2021	Carminati, Andrea/0000-0001-7415-0480; Zeppenfeld, Thorsten/0000-0001-9547-5524	Open Access Publication Funds of the Gottingen University	Open Access Publication Funds of the Gottingen University	We acknowledge support by the Open Access Publication Funds of the Gottingen University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge support by the Open Access Publication Funds of the Gottingen University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Gesellschaft fur Wissenschaftliche Datenverarbeitung Gottingen (GWDG) provided computational facilities for running simulations and point pattern statistics.	Ahmed MA, 2016, PLANT SOIL, V407, P161, DOI 10.1007/s11104-015-2749-1; [Anonymous], 2021, LANG ENV STAT COMP; Baddeley A, 2015, SPATIAL POINT PATTER; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Bardgett RD, 2014, TRENDS ECOL EVOL, V29, P692, DOI 10.1016/j.tree.2014.10.006; Benard P, 2016, ADV WATER RESOUR, V95, P190, DOI 10.1016/j.advwatres.2015.09.014; Brundrett MC, 2002, NEW PHYTOL, V154, P275, DOI 10.1046/j.1469-8137.2002.00397.x; Carminati A, 2016, Ann Bot, V118, P561, DOI 10.1093/aob/mcw113; Carminati A, 2016, VADOSE ZONE J, V15, DOI 10.2136/vzj2015.04.0060; Carminati A, 2013, ANN BOT-LONDON, V112, P277, DOI 10.1093/aob/mcs262; Carminati A, 2010, PLANT SOIL, V332, P163, DOI 10.1007/s11104-010-0283-8; Craine JM, 2013, FUNCT ECOL, V27, P833, DOI 10.1111/1365-2435.12081; Dennis PG, 2010, FEMS MICROBIOL ECOL, V72, P313, DOI 10.1111/j.1574-6941.2010.00860.x; Diehl D, 2013, COLLOID SURFACE A, V432, P8, DOI 10.1016/j.colsurfa.2013.05.011; Doerr SH, 2000, EARTH-SCI REV, V51, P33, DOI 10.1016/S0012-8252(00)00011-8; Esser DS, 2014, FEMS MICROBIOLOGY EC, V91; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Jones DL, 2009, PLANT SOIL, V321, P5, DOI 10.1007/s11104-009-9925-0; Kroener E, 2014, WATER RESOUR RES, V50, P6479, DOI 10.1002/2013WR014756; Kuzyakov Y, 2015, SOIL BIOL BIOCHEM, V83, P184, DOI 10.1016/j.soilbio.2015.01.025; Kuzyakov Y, 2010, SOIL BIOL BIOCHEM, V42, P1363, DOI 10.1016/j.soilbio.2010.04.003; LANDSBERG JJ, 1978, ANN BOT-LONDON, V42, P493, DOI 10.1093/oxfordjournals.aob.a085488; MacPherson B, 2016, ECOL MODEL, V323, P106, DOI 10.1016/j.ecolmodel.2015.12.013; Marschner P, 2011, SOIL BIOL BIOCHEM, V43, P883, DOI 10.1016/j.soilbio.2011.01.005; Meron E, 2012, ECOL MODEL, V234, P70, DOI 10.1016/j.ecolmodel.2011.05.035; Muller K, 2014, AGR WATER MANAGE, V143, P82, DOI 10.1016/j.agwat.2014.06.013; Muller K, 2011, AGR ECOSYST ENVIRON, V144, P208, DOI 10.1016/j.agee.2011.08.008; Naveed M, 2017, EGU GEN ASS C, V19, P14148; OADES JM, 1978, J SOIL SCI, V29, P1, DOI 10.1111/j.1365-2389.1978.tb02025.x; Osmont KS, 2007, ANNU REV PLANT BIOL, V58, P93, DOI 10.1146/annurev.arplant.58.032806.104006; Philippot L, 2013, NAT REV MICROBIOL, V11, P789, DOI 10.1038/nrmicro3109; Prieto I, 2012, NEW PHYTOL, V193, P830, DOI 10.1111/j.1469-8137.2011.04039.x; Ravi S, 2008, OECOLOGIA, V158, P545, DOI 10.1007/s00442-008-1164-1; Read DB, 2003, NEW PHYTOL, V157, P315, DOI 10.1046/j.1469-8137.2003.00665.x; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; Rietkerk M, 2008, TRENDS ECOL EVOL, V23, P169, DOI 10.1016/j.tree.2007.10.013; Shah VB, 2008, P 7 PYTH SCI C, P62; Sposito G, 2013, VADOSE ZONE J, V12, DOI 10.2136/vzj2013.02.0041; VANDENHONERT TH, 1948, DISCUSS FARADAY SOC, V3, P146, DOI 10.1039/df9480300146; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Walker TS, 2003, PLANT PHYSIOL, V132, P44, DOI 10.1104/pp.102.019661; Wilensky U., 1999, CTR CONNECTED LEARNI; York LM, 2016, J EXP BOT, V67, P3629, DOI 10.1093/jxb/erw108; Zarebanadkouki M, 2016, PLANT SOIL, V398, P267, DOI 10.1007/s11104-015-2668-1; Zickenrott IM, 2016, J PLANT NUTR SOIL SC, V179, P294, DOI 10.1002/jpln.201500511	46	12	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0182188	10.1371/journal.pone.0182188	http://dx.doi.org/10.1371/journal.pone.0182188			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753673	Green Submitted, Green Published, gold			2022-12-26	WOS:000406579300056
J	Kim, M; Furuzono, T; Yamakuni, K; Li, YJ; Kim, YI; Takahashi, H; Ohue-Kitano, R; Jheng, HF; Takahashi, N; Kano, Y; Yu, RN; Kishino, S; Ogawa, J; Uchida, K; Yamazaki, J; Tominaga, M; Kawada, T; Goto, T				Kim, Minji; Furuzono, Tomoya; Yamakuni, Kanae; Li, Yongjia; Kim, Young-Il; Takahashi, Haruya; Ohue-Kitano, Ryuji; Jheng, Huei-Fen; Takahashi, Nobuyuki; Kano, Yuriko; Yu, Rina; Kishino, Shigenobu; Ogawa, Jun; Uchida, Kunitoshi; Yamazaki, Jun; Tominaga, Makoto; Kawada, Teruo; Goto, Tsuyoshi			10-oxo-12(Z)-octadecenoic acid, a linoleic acid metabolite produced by gut lactic acid bacteria, enhances energy metabolism by activation of TRPV1	FASEB JOURNAL			English	Article						UCP1; beige cells; fatty acids; gut microbiota; obesity	BROWN ADIPOSE-TISSUE; DIET-INDUCED THERMOGENESIS; CAPSAICIN-RECEPTOR; WHITE FAT; MICROBIOTA; OBESITY; MICE; INFLAMMATION; ADIPOGENESIS; HOMEOSTASIS	Gutmicrobiota can regulate the host energymetabolism; however, the underlying mechanisms that could involve gut microbiota-derived compounds remain to be understood. Therefore, in this study, we investigated the effects ofKetoA [10-oxo-12(Z)-octadecenoic acid]-a linoleic acidmetaboliteproduced by gut lactic acid bacteria-on whole-body energy metabolism and found that dietary intake of KetoA could enhance energy expenditure in mice, thereby protecting mice from diet-induced obesity. By using Ca2+ imaging and whole-cell patch-clamp methods, KetoA was noted to potently activate transient receptor potential vanilloid 1 (TRPV1) and enhance noradrenalin turnover in adipose tissues. In addition, KetoA up-regulated genes that are related to brown adipocyte functions, including uncoupling protein 1 (UCP1) inwhite adipose tissue (WAT), whichwas later diminished in the presence of a b-adrenoreceptor blocker. By using obese and diabetic model KK-Ay mice, we further show that KetoA intake ameliorated obesity-associatedmetabolic disorders. In the absence of any observedKetoA-induced antiobesity effect or UCP1 up-regulation in TRPV1-deficient mice, we prove that the antiobesity effect of KetoAwas caused by TRPV1 activation-mediated browning inWAT. KetoA produced in the gut could therefore be involved in the regulation of host energy metabolism.-Kim, M., Furuzono, T., Yamakuni, K., Li, Y., Kim, Y.-I., Takahashi, H., Ohue-Kitano, R., Jheng, H.-F., Takahashi, N., Kano, Y., Yu, R., Kishino, S., Ogawa, J., Uchida, K., Yamazaki, J., Tominaga, M., Kawada, T., Goto, T. 10-oxo-12(Z)-octadecenoic acid, a linoleic acid metabolite produced by gut lactic acid bacteria, enhances energy metabolism by activation of TRPV1.	[Kim, Minji; Furuzono, Tomoya; Yamakuni, Kanae; Li, Yongjia; Kim, Young-Il; Takahashi, Haruya; Ohue-Kitano, Ryuji; Jheng, Huei-Fen; Takahashi, Nobuyuki; Kawada, Teruo; Goto, Tsuyoshi] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Lab Mol Funct Food, Kyoto, Japan; [Kishino, Shigenobu; Ogawa, Jun] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Lab Fermentat Physiol & Appl Microbiol, Kyoto, Japan; [Ohue-Kitano, Ryuji; Takahashi, Nobuyuki; Ogawa, Jun; Kawada, Teruo; Goto, Tsuyoshi] Kyoto Univ, Res Unit Physiol Chem, Ctr Promot Interdisciplinary Educ & Res, Kyoto, Japan; [Kano, Yuriko] Kobe Womens Univ, Fac Home Econ, Nutr Chem Lab, Kobe, Hyogo, Japan; [Yu, Rina] Univ Ulsan, Dept Food Sci & Nutr, Ulsan, South Korea; [Uchida, Kunitoshi; Tominaga, Makoto] Natl Inst Nat Sci, Natl Inst Physiol Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, Okazaki, Aichi, Japan; [Uchida, Kunitoshi; Tominaga, Makoto] Grad Univ Adv Studies, Dept Physiol Sci, Hayama, Japan; [Uchida, Kunitoshi; Yamazaki, Jun] Fukuoka Dent Coll, Dept Physiol Sci & Mol Biol, Fukuoka, Japan	Kyoto University; Kyoto University; Kyoto University; University of Ulsan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan; Fukuoka Dental College (FDC)	Goto, T (corresponding author), Kyoto Univ, Uji, Kyoto 6110011, Japan.	tgoto@kais.kyoto-u.ac.jp	Takahashi, Nobuyuki/AAX-8671-2021; Goto, Tsuyoshi/AAY-2344-2020	Takahashi, Nobuyuki/0000-0002-9705-662X; Goto, Tsuyoshi/0000-0003-1283-147X; Kim, Minji/0000-0003-2322-9900	Ministry of Education, Culture, Sports, Science and Technology of Japan [15H02441, 16H02551, 16K14927, 16K07734]; Bio-Oriented Technology Research Advancement Institution of Japan [26002A]; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry from the Ministry of Agriculture, Forestry and Fisheries of Japan [26002AB]; Advanced Low Carbon Technology Research and Development Program of Japan; NEDO Innovation Commercialization Venture Support Project [15101647]; program in the Science Research Center (Center for Food and Nutritional Genomics Research) of the National Research Foundation of Korea - Ministry of Education, Science, and Technology [2015R1A5A6001906]; Cooperative Study Program of the National Institute for Physiological Sciences; Grants-in-Aid for Scientific Research [16H02551] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Bio-Oriented Technology Research Advancement Institution of Japan; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry from the Ministry of Agriculture, Forestry and Fisheries of Japan; Advanced Low Carbon Technology Research and Development Program of Japan; NEDO Innovation Commercialization Venture Support Project; program in the Science Research Center (Center for Food and Nutritional Genomics Research) of the National Research Foundation of Korea - Ministry of Education, Science, and Technology; Cooperative Study Program of the National Institute for Physiological Sciences; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank M. Komori and N. Kitamura (Kyoto University) for their technical assistance. The authors thank S. Shinotoh (Kyoto University) for secretarial support. This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (15H02441, 16H02551, 16K14927, and 16K07734); the Bio-Oriented Technology Research Advancement Institution of Japan (26002A); the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry from the Ministry of Agriculture, Forestry and Fisheries of Japan (26002AB); the Advanced Low Carbon Technology Research and Development Program of Japan; and the NEDO Innovation Commercialization Venture Support Project (15101647). R.Y. was supported by a program in the Science Research Center (Center for Food and Nutritional Genomics Research, Grant 2015R1A5A6001906) of the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology. This work was supported by the Cooperative Study Program of the National Institute for Physiological Sciences. The authors declare no conflicts of interest.	Akiba Y, 2004, BIOCHEM BIOPH RES CO, V321, P219, DOI 10.1016/j.bbrc.2004.06.149; Aron-Wisnewsky J, 2016, NAT REV NEPHROL, V12, P169, DOI 10.1038/nrneph.2015.191; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Blad CC, 2012, NAT REV DRUG DISCOV, V11, P603, DOI 10.1038/nrd3777; Boulange CL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0303-2; BRODIE BB, 1966, J PHARMACOL EXP THER, V154, P493; Burant CF, 2013, DIABETES CARE, V36, pS175, DOI 10.2337/dcS13-2037; Cannon B, 1979, Methods Enzymol, V55, P65; Cao E, 2013, NEURON, V77, P667, DOI 10.1016/j.neuron.2012.12.016; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Cheung SY, 2015, ENDOCRINOLOGY, V156, P2074, DOI 10.1210/en.2014-1831; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; COUSIN B, 1992, J CELL SCI, V103, P931; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; DiBaise JK, 2012, AM J GASTROENTEROL S, V1, P22, DOI [10.1038/ajgsup.2012.5, DOI 10.1038/AJGSUP.2012.5]; Dorfman SE, 2009, OBESITY, V17, P1200, DOI 10.1038/oby.2008.662; Edvell A, 1998, AM J PHYSIOL-ENDOC M, V274, pE1034, DOI 10.1152/ajpendo.1998.274.6.E1034; Enos RT, 2013, J LIPID RES, V54, P152, DOI 10.1194/jlr.M030700; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; Goto T, 2017, J BIOL CHEM, V292, P9175, DOI 10.1074/jbc.M116.767590; Goto T, 2015, BIOCHEM BIOPH RES CO, V459, P597, DOI 10.1016/j.bbrc.2015.02.154; Jequier E, 2002, ANN NY ACAD SCI, V967, P379, DOI 10.1111/j.1749-6632.2002.tb04293.x; Julius D, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005991; Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252; Kawabata F, 2009, BIOSCI BIOTECH BIOCH, V73, P2690, DOI 10.1271/bbb.90555; Kim M, 2015, SCI REP-UK, V5, DOI 10.1038/srep18013; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Kishino S, 2013, P NATL ACAD SCI USA, V110, P17808, DOI 10.1073/pnas.1312937110; Kovatcheva-Datchary P, 2013, BEST PRACT RES CL GA, V27, P59, DOI 10.1016/j.bpg.2013.03.017; Labbe SM, 2016, AM J PHYSIOL-ENDOC M, V311, pE260, DOI 10.1152/ajpendo.00545.2015; Leonelli M, 2011, BRAZ J MED BIOL RES, V44, P1088, DOI [10.1590/S0100-879X2011007500124, 10.1590/S0100-879X2011001100003]; Miyamoto J, 2015, J BIOL CHEM, V290, P2902, DOI 10.1074/jbc.M114.610733; Morales-Lazaro SL, 2014, J BIOL CHEM, V289, P24079, DOI 10.1074/jbc.M114.572503; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; O'Neill S, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12229; Ohyama K, 2016, DIABETES, V65, P1410, DOI 10.2337/db15-0662; Oi-Kano Y, 2013, J NUTR BIOCHEM, V24, P887, DOI 10.1016/j.jnutbio.2012.06.003; Park JW, 2015, J NUCL MED, V56, P153, DOI 10.2967/jnumed.114.147603; Razavi R, 2006, CELL, V127, P1123, DOI 10.1016/j.cell.2006.10.038; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Rosenbaum M, 2015, TRENDS ENDOCRIN MET, V26, P493, DOI 10.1016/j.tem.2015.07.002; Rothwell NJ, 1997, OBES RES, V5, P650, DOI 10.1002/j.1550-8528.1997.tb00591.x; Sacks H, 2013, DIABETES, V62, P1783, DOI 10.2337/db12-1430; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Shintaku K, 2012, BRIT J PHARMACOL, V165, P1476, DOI 10.1111/j.1476-5381.2011.01634.x; Sun WP, 2016, EMBO REP, V17, P383, DOI 10.15252/embr.201540819; Suri A, 2008, TRENDS PHARMACOL SCI, V29, P29, DOI 10.1016/j.tips.2007.10.016; Tilg H, 2010, J CLIN GASTROENTEROL, V44, pS16, DOI 10.1097/MCG.0b013e3181dd8b64; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; VANDERTUIG JG, 1984, METABOLISM, V33, P26, DOI 10.1016/0026-0495(84)90158-6; Velagapudi VR, 2010, J LIPID RES, V51, P1101, DOI 10.1194/jlr.M002774; Wang YX, 2010, CELL RES, V20, P124, DOI 10.1038/cr.2010.13; World Health Organization, 2018, OB OV FACT SHEET 311; Woting A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040202; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005; Ye L, 2012, CELL, V151, P96, DOI 10.1016/j.cell.2012.08.034; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Yoo S, 2014, MOLECULES, V19, P4708, DOI 10.3390/molecules19044708; YOUNG JB, 1982, J CLIN INVEST, V69, P1061, DOI 10.1172/JCI110541; Zhang LL, 2007, CIRC RES, V100, P1063, DOI 10.1161/01.RES.0000262653.84850.8b	64	44	46	1	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					5036	5048		10.1096/fj.201700151R	http://dx.doi.org/10.1096/fj.201700151R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28754711				2022-12-26	WOS:000413398500032
J	Nie, Y; Littleton, B; Kavanagh, T; Abbate, V; Bansal, SS; Richards, D; Hylands, P; Sturzenbaum, SR				Nie, Yu; Littleton, Brad; Kavanagh, Thomas; Abbate, Vincenzo; Bansal, Sukhvinder S.; Richards, David; Hylands, Peter; Sturzenbaum, Stephen R.			Proanthocyanidin trimer gallate modulates lipid deposition and fatty acid desaturation in Caenorhabditis elegans	FASEB JOURNAL			English	Article						procyanidin; CARS; worm; triglyceride; natural product	GRAPE SEED EXTRACT; RAMAN-SCATTERING; RATS	The incidence of obesity is rising at an alarming rate. Despite its recognition as an urgent healthcare concern, obesity remains largely an unsolved medical problem. A comprehensive screen for functional dietary phytochemicals identified proanthocyanidins as putative targets to ameliorate obesity. A full-scale purification of oligomeric proanthocyanidins (OPCs) derived from grape seed extract yielded pure OPC dimer, trimer, tetramer, and their gallates (pOPCs). Forward chemical screening conducted in Caenorhabditis elegans suggested that pOPCs reduced the activity of lipase in vitro and triglyceride storage capacity in vivo. Proanthocyanidin trimer gallate in particular modified lipid desaturation in C. elegans, revealed by hyperspectral coherent anti-Stokes Raman scattering microscopy. Exposure to trimer gallate resulted in the transcriptional down-regulation of nhr-49 (an ortholog of the human peroxisome proliferator-activated receptor-alpha), and a key regulator of fat metabolism, and 2 downstream genes: fat-5 and acs-2. A combination exposure of 2 or 3 pOPCs (dimer gallate, trimer and/or trimer gallate) suggested the absence of synergistic potential. By using the whole-organism C. elegans coupled with versatile biochemical, biophysical, and genetic tools, we provide an account of the composition and bioactivity of individual OPCs and more generally highlight the potential of traditional Chinese medicine-derived drug leads.	[Nie, Yu; Sturzenbaum, Stephen R.] Kings Coll London, Analyt & Environm Sci Div, 3rd Floor,Franklin Wilkins Bldg,150 Stamford St, London SE1 9NH, England; [Abbate, Vincenzo; Bansal, Sukhvinder S.; Hylands, Peter] Kings Coll London, Inst Pharmaceut Sci, Fac Life Sci & Med, London, England; [Littleton, Brad; Kavanagh, Thomas; Richards, David] Kings Coll London, Dept Phys, Fac Nat & Math Sci, London, England	University of London; King's College London; University of London; King's College London; University of London; King's College London	Sturzenbaum, SR (corresponding author), Kings Coll London, Analyt & Environm Sci Div, 3rd Floor,Franklin Wilkins Bldg,150 Stamford St, London SE1 9NH, England.	stephen.sturzenbaum@kcl.ac.uk	Abbate, Vincenzo/K-6204-2019; Littleton, Brad/AAG-6345-2020; Littleton, Brad N/I-1463-2015	Littleton, Brad/0000-0002-1561-9688; Littleton, Brad N/0000-0002-1561-9688; Richards, David/0000-0001-8038-6860; Nie, Yu/0000-0001-7670-6411; Abbate, Vincenzo/0000-0002-3300-0520	King's-Chinese Scholarship Council scheme; Engineering and Physical Sciences Research Council [1252848] Funding Source: researchfish	King's-Chinese Scholarship Council scheme; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors thank Derives Resiniques et Terpeniques (DRT; Dax, France) for their kind donation of Vitaflavan and OPC-enriched samples, Dr. Norman Smith (King's College London) for the provision of semipreparative chromatography columns, Dr. Eugene Schuster (University College London) for assistance in the microarray data analysis, Prof. Robert Hider (King's College London) for additional technical support, and Dr. David Barlow (King's College London) for granting access to the Chem-TCM database. The authors thank Ms. Clinda Puvirajasinghe (King's College London) for her help in generating the glo-4:daf-22 double mutant. This work was supported by the King's-Chinese Scholarship Council scheme. The authors declare no conflicts of interest.	Appeldoorn MM, 2009, FOOD CHEM, V117, P713, DOI 10.1016/j.foodchem.2009.04.047; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; BRENNER S, 1974, GENETICS, V77, P71; Brooks KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007545; Camp CH, 2015, NAT PHOTONICS, V9, P295, DOI 10.1038/NPHOTON.2015.60; Del Bas JM, 2008, MOL NUTR FOOD RES, V52, P1172, DOI 10.1002/mnfr.200800054; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Hogan S, 2011, J AGR FOOD CHEM, V59, P3035, DOI 10.1021/jf1042773; Ibars M, 2017, INT J OBESITY, V41, P129, DOI 10.1038/ijo.2016.169; Kee TW, 2004, OPT LETT, V29, P2701, DOI 10.1364/OL.29.002701; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Lemieux GA, 2011, NAT CHEM BIOL, V7, P206, DOI [10.1038/nchembio.534, 10.1038/NCHEMBIO.534]; Littleton B, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.103902; Lizarraga D, 2007, FEBS J, V274, P4802, DOI 10.1111/j.1742-4658.2007.06010.x; Del Bas JM, 2009, MOL NUTR FOOD RES, V53, P805, DOI 10.1002/mnfr.200800364; Montagut G, 2010, J NUTR BIOCHEM, V21, P476, DOI 10.1016/j.jnutbio.2009.02.003; Moreno DA, 2003, NUTRITION, V19, P876, DOI 10.1016/S0899-9007(03)00167-9; Nie Y., 2017, ANIMAL MODELS STUDY; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Onakpoya IJ, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0735-y; Oprea TI, 2009, NAT CHEM BIOL, V5, P441, DOI 10.1038/nchembio0709-441; Rasmussen SE, 2005, MOL NUTR FOOD RES, V49, P159, DOI 10.1002/mnfr.200400082; Rothman JH, 2012, METHOD CELL BIOL, V107, P1; Schmidt BM, 2007, NAT CHEM BIOL, V3, P360, DOI 10.1038/nchembio0707-360; TimTec Compound Libraries, CHEM TCM DAT; Tomaru M, 2007, NUTRITION, V23, P351, DOI 10.1016/j.nut.2007.01.007; Tu YY, 2011, NAT MED, V17, P1217, DOI 10.1038/nm.2471; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; Wang P, 2014, ANGEW CHEM INT EDIT, V53, P11787, DOI 10.1002/anie.201406029; Wren AF, 2002, J AGR FOOD CHEM, V50, P2180, DOI 10.1021/jf011066w; Yamakoshi J, 2002, FOOD CHEM TOXICOL, V40, P599, DOI 10.1016/S0278-6915(02)00006-6; Yen K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012810; Zhang SBO, 2010, P NATL ACAD SCI USA, V107, P4640, DOI 10.1073/pnas.0912308107; Zhongzen Z., 2004, ILLUSTRATED CHINESE; Zhongzen Z., 2009, ENCY MED PLANTS, V1	36	4	5	2	37	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4891	4902		10.1096/fj.201700438R	http://dx.doi.org/10.1096/fj.201700438R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28760744				2022-12-26	WOS:000413398500020
J	Dias, AF; Rodrigues, TA; Pedrosa, AG; Barros-Barbosa, A; Francisco, T; Azevedo, JE				Dias, Ana F.; Rodrigues, Tony A.; Pedrosa, Ana G.; Barros-Barbosa, Aurora; Francisco, Tania; Azevedo, Jorge E.			The peroxisomal matrix protein translocon is a large cavity-forming protein assembly into which PEX5 protein enters to release its cargo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETING SIGNAL RECEPTOR; II SECRETION SYSTEM; HUMAN PTS1 RECEPTOR; IMPORT RECEPTOR; CYCLING RECEPTOR; MEMBRANE-PROTEIN; CONSERVED CYSTEINE; DOCKING PROTEIN; AAA PEROXINS; MACHINERY	A remarkable property of the machinery for import of peroxisomal matrix proteins is that it can accept already folded proteins as substrates. This import involves binding of newly synthesized proteins by cytosolic peroxisomal biogenesis factor 5 (PEX5) followed by insertion of the PEX5-cargo complex into the peroxisomal membrane at the docking/translocation module (DTM). However, how these processes occur remains largely unknown. Here, we used truncated PEX5 molecules to probe the DTM architecture. We found that the DTM can accommodate a larger number of truncated PEX5 molecules comprising amino acid residues 1-197 than full-length PEX5 molecules. A shorter PEX5 version (PEX5(1-125)) still interacted correctly with the DTM; however, this species was largely accessible to exogenously added proteinase K, suggesting that this protease can access the DTM occupied by a small PEX5 protein. Interestingly, the PEX5(1-125)-DTM interaction was inhibited by a polypeptide comprising PEX5 residues 138-639. Apparently, the DTM can recruit soluble PEX5 through interactions with different PEX5 domains, suggesting that the PEX5-DTM interactions are to some degree fuzzy. Finally, we found that the interaction between PEX5 and PEX14, a major DTM component, is stable at pH 11.5. Thus, there is no reason to assume that the hitherto intriguing resistance of DTM-bound PEX5 to alkaline extraction reflects its direct contact with the peroxisomal lipid bilayer. Collectively, these results suggest that the DTM is best described as a large cavity-forming protein assembly into which cytosolic PEX5 can enter to release its cargo.	[Dias, Ana F.; Rodrigues, Tony A.; Pedrosa, Ana G.; Barros-Barbosa, Aurora; Francisco, Tania; Azevedo, Jorge E.] Univ Porto, Inst Invest & Inovacao Saude i3S, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal; [Dias, Ana F.; Rodrigues, Tony A.; Pedrosa, Ana G.; Barros-Barbosa, Aurora; Francisco, Tania; Azevedo, Jorge E.] Univ Porto, IBMC, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal; [Dias, Ana F.; Rodrigues, Tony A.; Pedrosa, Ana G.; Azevedo, Jorge E.] Univ Porto, ICBAS, Rua Jorge Viterbo Ferreira 228, P-4050313 Oporto, Portugal	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto	Azevedo, JE (corresponding author), Univ Porto, Inst Invest & Inovacao Saude i3S, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal.; Azevedo, JE (corresponding author), Univ Porto, IBMC, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal.; Azevedo, JE (corresponding author), Univ Porto, ICBAS, Rua Jorge Viterbo Ferreira 228, P-4050313 Oporto, Portugal.	jazevedo@ibmc.up.pt	Barros-Barbosa, AR/L-1321-2014; Francisco, Tânia/AAK-9920-2020; Azevedo, Jorge E/A-4113-2008; Rodrigues, Tony/K-1141-2014	Barros-Barbosa, AR/0000-0003-4484-4427; Francisco, Tânia/0000-0003-3571-5164; Azevedo, Jorge E/0000-0001-7714-5302; Dias, Ana Filipa/0000-0002-6667-1961; Rodrigues, Tony/0000-0003-2311-8258; Pedrosa, Ana G/0000-0001-8887-2046	Fundo Europeu de Desenvolvimento Regional (FEDER) funds through the COMPETE Operational Programme for Competitiveness and Internationalization (POCI), Portugal; Portuguese funds through Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Inovacao [POCI-01-0145-FEDER-007274, PTDC/BEX-BCM/2311/2014]; Portuguese funds through Norte Programa Operacional Regional do Norte under the application of the "Porto Neurosciences and Neurologic Disease Research Initiative at i3S" [NORTE-01-0145-FEDER-000008]; Fundacao para a Ciencia e a Tecnologia; Programa Operacional Potencial Humano do Quadro de Referencia Estrategico Nacional; Fundo Social Europeu; FEDER funds through the COMPETE POCI, Portugal	Fundo Europeu de Desenvolvimento Regional (FEDER) funds through the COMPETE Operational Programme for Competitiveness and Internationalization (POCI), Portugal; Portuguese funds through Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Inovacao; Portuguese funds through Norte Programa Operacional Regional do Norte under the application of the "Porto Neurosciences and Neurologic Disease Research Initiative at i3S"; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Programa Operacional Potencial Humano do Quadro de Referencia Estrategico Nacional; Fundo Social Europeu; FEDER funds through the COMPETE POCI, Portugal	This work was supported in part by Fundo Europeu de Desenvolvimento Regional (FEDER) funds through the COMPETE 2020-Operational Programme for Competitiveness and Internationalization (POCI), Portugal 2020 and by Portuguese funds through Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Inovacao in the framework of the projects "Institute for Research and Innovation in Health Sciences" (Grant POCI-01-0145-FEDER-007274) and "The molecular mechanisms of peroxisome biogenesis" (Grant PTDC/BEX-BCM/2311/2014) and through Norte 2020-Programa Operacional Regional do Norte under the application of the "Porto Neurosciences and Neurologic Disease Research Initiative at i3S" (Grant NORTE-01-0145-FEDER-000008). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by Fundacao para a Ciencia e a Tecnologia, Programa Operacional Potencial Humano do Quadro de Referencia Estrategico Nacional, and Fundo Social Europeu.r Supported by FEDER funds through the COMPETE 2020-POCI, Portugal 2020.	Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Alencastre IS, 2009, J BIOL CHEM, V284, P27243, DOI 10.1074/jbc.M109.032565; Azevedo JE, 2004, CELL BIOCHEM BIOPHYS, V41, P451, DOI 10.1385/CBB:41:3:451; Azevedo JE, 2006, BBA-MOL CELL RES, V1763, P1574, DOI 10.1016/j.bbamcr.2006.09.002; Baker A, 2016, BIOCHEM SOC T, V44, P783, DOI 10.1042/BST20160036; Beck M, 2017, NAT REV MOL CELL BIO, V18, P73, DOI 10.1038/nrm.2016.147; Berks BC, 2015, ANNU REV BIOCHEM, V84, P843, DOI 10.1146/annurev-biochem-060614-034251; Bottger G, 2000, MOL BIOL CELL, V11, P3963, DOI 10.1091/mbc.11.11.3963; Braverman N, 1998, HUM MOL GENET, V7, P1195, DOI 10.1093/hmg/7.8.1195; Brocard C, 2006, BBA-MOL CELL RES, V1763, P1565, DOI 10.1016/j.bbamcr.2006.08.022; CARTER P, 1989, PROTEINS, V6, P240, DOI 10.1002/prot.340060306; Carvalho AF, 2006, J MOL BIOL, V356, P864, DOI 10.1016/j.jmb.2005.12.002; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; Carvalho AF, 2007, BBA-MOL CELL RES, V1773, P1141, DOI 10.1016/j.bbamcr.2007.04.011; Celedon JM, 2012, J CELL BIOL, V197, P523, DOI 10.1083/jcb.201201096; Costa-Rodrigues J, 2004, J BIOL CHEM, V279, P46573, DOI 10.1074/jbc.M406399200; Costa-Rodrigues J, 2005, J BIOL CHEM, V280, P24404, DOI 10.1074/jbc.M501985200; Dal Peraro M, 2016, NAT REV MICROBIOL, V14, P77, DOI 10.1038/nrmicro.2015.3; Dammai V, 2001, CELL, V105, P187, DOI 10.1016/S0092-8674(01)00310-5; Debelyy MO, 2011, J BIOL CHEM, V286, P28223, DOI 10.1074/jbc.M111.238600; Dias AF, 2016, BBA-MOL CELL RES, V1863, P814, DOI 10.1016/j.bbamcr.2015.09.025; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; Dodt G, 2001, J BIOL CHEM, V276, P41769, DOI 10.1074/jbc.M106932200; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Erdmann R, 2005, NAT REV MOL CELL BIO, V6, P738, DOI 10.1038/nrm1710; Francisco T, 2017, METHODS MOL BIOL, V1595, P27, DOI 10.1007/978-1-4939-6937-1_3; Francisco T, 2014, BIOCHIMIE, V98, P29, DOI 10.1016/j.biochi.2013.08.003; Francisco T, 2013, J BIOL CHEM, V288, P29151, DOI 10.1074/jbc.M113.487140; Fransen M, 1998, P NATL ACAD SCI USA, V95, P8087, DOI 10.1073/pnas.95.14.8087; FRANSEN M, 1995, J BIOL CHEM, V270, P7731, DOI 10.1074/jbc.270.13.7731; Fransen M, 2002, MOL CELL PROTEOMICS, V1, P243, DOI 10.1074/mcp.M100025-MCP200; Freitas MO, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.140236; Freitas MO, 2011, J BIOL CHEM, V286, P40509, DOI 10.1074/jbc.M111.287201; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Fujiki Y, 2006, BBA-MOL CELL RES, V1763, P1639, DOI 10.1016/j.bbamcr.2006.08.030; Gattiker A, 2002, PROTEOMICS, V2, P1435, DOI 10.1002/1615-9861(200210)2:10<1435::AID-PROT1435>3.0.CO;2-9; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; GLOVER JR, 1994, P NATL ACAD SCI USA, V91, P10541, DOI 10.1073/pnas.91.22.10541; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Gouveia AM, 2003, J BIOL CHEM, V278, P226, DOI 10.1074/jbc.M209498200; Gouveia AM, 2003, J BIOL CHEM, V278, P4389, DOI 10.1074/jbc.C200650200; Gouveia AMM, 2000, J BIOL CHEM, V275, P32444, DOI 10.1074/jbc.M004366200; Grou CP, 2009, CELL MOL LIFE SCI, V66, P254, DOI 10.1007/s00018-008-8415-5; Grou CP, 2008, J BIOL CHEM, V283, P14190, DOI 10.1074/jbc.M800402200; Grou CP, 2012, J BIOL CHEM, V287, P12815, DOI 10.1074/jbc.M112.340158; Grou CP, 2009, J BIOL CHEM, V284, P10504, DOI 10.1074/jbc.M808978200; Kerssen D, 2006, J BIOL CHEM, V281, P27003, DOI 10.1074/jbc.M509257200; Kim PK, 2015, J MOL BIOL, V427, P1176, DOI 10.1016/j.jmb.2015.02.005; Korotkov KV, 2012, NAT REV MICROBIOL, V10, P336, DOI 10.1038/nrmicro2762; Kunze M, 2011, J BIOL CHEM, V286, P45048, DOI 10.1074/jbc.M111.301853; Kurochkin IV, 2007, EMBO J, V26, P835, DOI 10.1038/sj.emboj.7601525; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Liu XQ, 2012, CURR OPIN CELL BIOL, V24, P484, DOI 10.1016/j.ceb.2012.05.003; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; MCNEW JA, 1994, J CELL BIOL, V127, P1245, DOI 10.1083/jcb.127.5.1245; Meinecke M, 2016, BBA-MOL CELL RES, V1863, P821, DOI 10.1016/j.bbamcr.2015.10.013; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Miyata N, 2012, TRAFFIC, V13, P168, DOI 10.1111/j.1600-0854.2011.01298.x; Neuhaus A, 2014, J BIOL CHEM, V289, P437, DOI 10.1074/jbc.M113.499707; Oliveira ME, 2003, J BIOL CHEM, V278, P39483, DOI 10.1074/jbc.M305089200; Oliveira MEM, 2002, BBA-BIOMEMBRANES, V1567, P13, DOI 10.1016/S0005-2736(02)00635-1; Otera H, 1998, MOL CELL BIOL, V18, P388, DOI 10.1128/MCB.18.1.388; Otera H, 2002, MOL CELL BIOL, V22, P1639, DOI 10.1128/MCB.22.6.1639-1655.2002; Pinto MP, 2006, J BIOL CHEM, V281, P34492, DOI 10.1074/jbc.M607183200; Pinto MP, 2009, BBA-MOL CELL RES, V1793, P1669, DOI 10.1016/j.bbamcr.2009.08.007; Platta HW, 2016, BBA-MOL CELL RES, V1863, P838, DOI 10.1016/j.bbamcr.2015.09.010; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Reguenga C, 2001, J BIOL CHEM, V276, P29935, DOI 10.1074/jbc.M104114200; Rodrigues TA, 2016, NAT PROTOC, V11, P2454, DOI 10.1038/nprot.2016.147; Rodrigues TA, 2015, SCI REP-UK, V5, DOI 10.1038/srep11806; Rodrigues TA, 2014, MOL CELL BIOL, V34, P2917, DOI 10.1128/MCB.01727-13; Romero, 1997, Genome Inform Ser Workshop Genome Inform, V8, P110; Saidowsky J, 2001, J BIOL CHEM, V276, P34524, DOI 10.1074/jbc.M104647200; Schliebs W, 1999, J BIOL CHEM, V274, P5666, DOI 10.1074/jbc.274.9.5666; Sharma R, 2015, FEBS LETT, V589, P2533, DOI 10.1016/j.febslet.2015.07.022; Shimizu N, 1999, J BIOL CHEM, V274, P12593, DOI 10.1074/jbc.274.18.12593; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; Tamura S, 2006, J BIOL CHEM, V281, P27693, DOI 10.1074/jbc.M605159200; TERLECKY SR, 1995, EMBO J, V14, P3627, DOI 10.1002/j.1460-2075.1995.tb00032.x; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Urquhart AJ, 2000, J BIOL CHEM, V275, P4127, DOI 10.1074/jbc.275.6.4127; WIEMER EAC, 1995, J CELL BIOL, V130, P51, DOI 10.1083/jcb.130.1.51; Will GK, 1999, MOL CELL BIOL, V19, P2265; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; Wojdyr M, 2010, J APPL CRYSTALLOGR, V43, P1126, DOI 10.1107/S0021889810030499; Yan ZF, 2017, NAT STRUCT MOL BIOL, V24, P177, DOI 10.1038/nsmb.3350	87	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15287	15300		10.1074/jbc.M117.805044	http://dx.doi.org/10.1074/jbc.M117.805044			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28765278	Green Published, hybrid			2022-12-26	WOS:000410809800011
J	Jin, CY; Zhang, GX; Zhang, YF; Hua, PY; Song, G; Sun, M; Li, X; Tong, T; Li, BJ; Zhang, XY				Jin, Chengyan; Zhang, Guangxin; Zhang, Yifan; Hua, Peiyan; Song, Ge; Sun, Mei; Li, Xin; Tong, Ti; Li, Bingjin; Zhang, Xingyi			Isoalantolactone induces intrinsic apoptosis through p53 signaling pathway in human lung squamous carcinoma cells	PLOS ONE			English	Article							CYCLE ARREST; CANCER; PROTEINS; GENES; ROLES; BCL-2; DEATH; PHASE	Isoalantolactone has recently been revealed to induce apoptosis in several types of cancer. However, little is reported on its anti-tumor potential on human lung cancer. Our present study was designed to investigate its effects on human lung squamous carcinoma SK-MES-1 cells. We found that Isoalantolactone induced cellular and DNA morphological changes and decreased the viability of SK-MES-1 cells. It significantly inhibited the growth of SK-MES-1 cells through apoptosis in a dose-dependent manner via activation of p53. It also induced cell cycle arrest at G1 phase. It can down-regulate Bcl-2 and up-regulate Bax, to induce dissipation of mitochondrial membrane potential and generation of reactive oxygen species. Caspase-3 was also activated by Isoalantolactone, with the cleavage of poly (ADPribose) polymerase. Our results reveal that Isoalantolactone induces intrinsic apoptosis in SK-MES-1 cells through p53 signaling pathway, which suggests that Isoalantolactone could be a potential leading compound for future development of anti-lung cancer drugs.	[Jin, Chengyan; Zhang, Guangxin; Zhang, Yifan; Hua, Peiyan; Song, Ge; Sun, Mei; Li, Xin; Tong, Ti; Li, Bingjin; Zhang, Xingyi] Jilin Univ, Hosp 2, Jilin Prov Key Lab Mol & Chem Genet, Changchun, Jilin, Peoples R China	Jilin University	Tong, T; Li, BJ; Zhang, XY (corresponding author), Jilin Univ, Hosp 2, Jilin Prov Key Lab Mol & Chem Genet, Changchun, Jilin, Peoples R China.	tti666@163.com; libingjin@jlu.edu.cn; xingyizhang@live.com	li, xin/HHS-9461-2022; Li, Lambert LL/F-7146-2015		Natural Science Foundation of China [81272472]; Technology Services of Jilin Province Scientific and Technological Project [20150414028GH, 20150520035JH]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Technology Services of Jilin Province Scientific and Technological Project	This study was supported by grants from the Natural Science Foundation of China (81272472) and Technology Services of Jilin Province Scientific and Technological Project (20150414028GH; 20150520035JH).	[Anonymous], SEER CANC STAT FACTS; Budram-Mahadeo V, 2002, ONCOGENE, V21, P6123, DOI 10.1038/sj.onc.1205842; Cragg GM, 2005, J ETHNOPHARMACOL, V100, P72, DOI 10.1016/j.jep.2005.05.011; Danial NN, 2007, CLIN CANCER RES, V13, P7254, DOI 10.1158/1078-0432.CCR-07-1598; Das SK, 2005, BBA-GEN SUBJECTS, V1726, P328, DOI 10.1016/j.bbagen.2005.09.007; Frenzel A, 2009, APOPTOSIS, V14, P584, DOI 10.1007/s10495-008-0300-z; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Greiner M, 2001, ENDOCRINE, V15, P323, DOI 10.1385/ENDO:15:3:323; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Khan M, 2012, INT J BIOL SCI, V8, P533, DOI 10.7150/ijbs.3753; King KL, 1998, ANNU REV PHYSIOL, V60, P601, DOI 10.1146/annurev.physiol.60.1.601; Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Rasul A, 2013, ARCH PHARM RES, V36, P1262, DOI 10.1007/s12272-013-0217-0; Rasul A, 2013, MOLECULES, V18, P9382, DOI 10.3390/molecules18089382; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wistuba II, 2000, CANCER RES, V60, P1949; Wu MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076000	20	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0181731	10.1371/journal.pone.0181731	http://dx.doi.org/10.1371/journal.pone.0181731			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28777796	gold, Green Submitted, Green Published			2022-12-26	WOS:000406944300010
J	Boccazzi, IV; Ottoboni, M; Martin, E; Comandatore, F; Vallone, L; Spranghers, T; Eeckhout, M; Mereghetti, V; Pinotti, L; Epis, S				Boccazzi, Ilaria Varotto; Ottoboni, Matteo; Martin, Elena; Comandatore, Francesco; Vallone, Lisa; Spranghers, Thomas; Eeckhout, Mia; Mereghetti, Valeria; Pinotti, Luciano; Epis, Sara			A survey of the mycobiota associated with larvae of the black soldier fly (Hermetia illucens) reared for feed production	PLOS ONE			English	Article							KILLER TOXIN; NUTRITIONAL COMPOSITION; EDIBLE INSECTS; FOOD; DIVERSITY; SAFETY; PURIFICATION; MICROBIOTA; MYCOTOXIN; NUMBER	Feed security, feed quality and issues surrounding the safety of raw materials are always of interest to all livestock farmers, feed manufacturers and competent authorities. These concerns are even more important when alternative feed ingredients, new product developments and innovative feeding trends, like insect-meals, are considered. The black soldier fly (Hermetia illucens) is considered a good candidate to be used as feed ingredient for aquaculture and other farm animals, mainly as an alternative protein source. Data on transfer of contaminants from different substrates to the insects, as well as the possible occurrence of toxin-producing fungi in the gut of non-processed insects are very limited. Accordingly, we investigated the impact of the substrate/diet on the intestinal mycobiota of H. illucens larvae using culture-dependent approaches (microbiological analyses, molecular identification through the typing of isolates and the sequencing of the 26S rRNA D1/D2 domain) and amplicon-based next-generation sequencing (454 pyrosequencing). We fed five groups of H. illucens larvae at the third growing stage on two substrates: chicken feed and/or vegetable waste, provided at different timings. The obtained results indicated that Pichia was the most abundant genus associated with the larvae fed on vegetable waste, whereas Trichosporon, Rhodotorula and Geotrichum were the most abundant genera in the larvae fed on chicken feed only. Differences in the fungal communities were highlighted, suggesting that the type of substrate selects diverse yeast and mold genera, in particular vegetable waste is associated with a greater diversity of fungal species compared to chicken feed only. A further confirmation of the significant influence of diet on the mycobiota is the fact that no operational taxonomic unit common to all groups of larvae was detected. Finally, the killer phenotype of isolated yeasts was tested, showing the inhibitory activity of just one species against sensitive strains, out of the 11 tested species.	[Boccazzi, Ilaria Varotto; Martin, Elena; Epis, Sara] Univ Milan, Dept Biosci, Milan, Italy; [Ottoboni, Matteo; Vallone, Lisa; Pinotti, Luciano] Univ Milan, Dept Hlth Anim Sci & Food Safety, Milan, Italy; [Comandatore, Francesco; Epis, Sara] Univ Milan, Pediat Clin Res Ctr Romeo & Enrica Invernizzi, Milan, Italy; [Spranghers, Thomas] Univ Ghent, Dept Crop Protect, Ghent, Belgium; [Eeckhout, Mia] Univ Ghent, Dept Appl Biosci, Ghent, Belgium; [Mereghetti, Valeria] Univ Milan, Dept Agr & Environm Sci Prod Landscape Agroenergy, Milan, Italy	University of Milan; University of Milan; University of Milan; Ghent University; Ghent University; University of Milan	Epis, S (corresponding author), Univ Milan, Dept Biosci, Milan, Italy.; Epis, S (corresponding author), Univ Milan, Pediat Clin Res Ctr Romeo & Enrica Invernizzi, Milan, Italy.	sara.epis@unimi.it	Vallone, Lisa/K-2846-2015; Spranghers, Thomas/AAP-1503-2020; Pinotti, Luciano/K-8236-2013; EPIS, SARA/B-7708-2017	Vallone, Lisa/0000-0001-6112-2229; Spranghers, Thomas/0000-0002-6789-3531; Pinotti, Luciano/0000-0003-0337-9426; EPIS, SARA/0000-0001-8807-4802; OTTOBONI, MATTEO/0000-0003-0123-3888; VAROTTO BOCCAZZI, ILARIA/0000-0002-8008-0025; MARTIN, ELENA/0000-0002-2253-3495	Italian Ministry of Education, University and Research FIRB [RBFR136GFF]; FEEDINSECT project Piano di Sostegno alla Ricerca University of Milan	Italian Ministry of Education, University and Research FIRB(Ministry of Education, Universities and Research (MIUR)); FEEDINSECT project Piano di Sostegno alla Ricerca University of Milan	This research was supported by the Italian Ministry of Education, University and Research FIRB 2013 [RBFR136GFF (to Sara Epis)] and by FEEDINSECT project Piano di Sostegno alla Ricerca 2015/17 University of Milan (to Luciano Pinotti). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, 638 WAG LIV RES; ASHIDA S, 1983, AGR BIOL CHEM TOKYO, V47, P2953, DOI 10.1080/00021369.1983.10866066; Bajaj BK, 2013, J BASIC MICROB, V53, P645, DOI 10.1002/jobm.201200187; Belluco S, 2013, COMPR REV FOOD SCI F, V12, P296, DOI 10.1111/1541-4337.12014; Bennett JW, 2003, CLIN MICROBIOL REV, V16, P497, DOI 10.1128/CMR.16.3.497-516.2003; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cappelli A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095988; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Choi WH, 2012, ENTOMOL RES, V42, P219, DOI 10.1111/j.1748-5967.2012.00465.x; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Coelho AR, 2009, FOOD ADDIT CONTAM A, V26, P73, DOI 10.1080/02652030802227227; Colombo AL, 2011, CLIN MICROBIOL REV, V24, P682, DOI 10.1128/CMR.00003-11; Deshpande V, 2016, MYCOLOGIA, V108, P1, DOI 10.3852/14-293; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Dragoni I, 1997, ALIMENTI MICOTOSSICO; DUPUY J, 1993, APPL ENVIRON MICROB, V59, P2864, DOI 10.1128/AEM.59.9.2864-2867.1993; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; EFSA Sci Comm, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4257; Ferreira N, 2010, CURR MICROBIOL, V60, P287, DOI 10.1007/s00284-009-9539-z; Garofalo C, 2017, FOOD MICROBIOL, V62, P15, DOI 10.1016/j.fm.2016.09.012; Genta FA, 2006, J INSECT PHYSIOL, V52, P593, DOI 10.1016/j.jinsphys.2006.02.007; Grabowski NT, 2017, INT J FOOD MICROBIOL, V243, P103, DOI 10.1016/j.ijfoodmicro.2016.11.005; Hatoum R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00421; HODGSON VJ, 1995, MICROBIOL-UK, V141, P2003, DOI 10.1099/13500872-141-8-2003; Huis A., 2013, EDIBLE INSECTS FUTUR; Jeon H, 2011, CURR MICROBIOL, V62, P1390, DOI 10.1007/s00284-011-9874-8; Klunder HC, 2012, FOOD CONTROL, V26, P628, DOI 10.1016/j.foodcont.2012.02.013; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; KURTZMAN CP, 2000, YEASTS TAXONOMIC STU; Labbani FZK, 2015, ANTON LEEUW INT J G, V107, P961, DOI 10.1007/s10482-015-0388-4; Lim SL, 2011, TROP BIOMED, V28, P438; Makkar HPS, 2014, ANIM FEED SCI TECH, V197, P1, DOI 10.1016/j.anifeedsci.2014.07.008; Manter DK, 2007, J MICROBIOL METH, V71, P7, DOI 10.1016/j.mimet.2007.06.016; Martin E, 2016, MED VET ENTOMOL, V30, P101, DOI 10.1111/mve.12149; Montagna M, 2016, ENVIRON MICROBIOL, V18, P4961, DOI 10.1111/1462-2920.13450; Montagna M, 2015, INSECT SCI, V22, P340, DOI 10.1111/1744-7917.12143; Muccilli Serena, 2015, Microorganisms, V3, P588, DOI 10.3390/microorganisms3040588; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; Pinotti L, 2016, TOXINS, V8, DOI 10.3390/toxins8020045; POLONELLI L, 1983, J CLIN MICROBIOL, V17, P774, DOI 10.1128/JCM.17.5.774-780.1983; Polonelli L, 1997, CLIN DIAGN LAB IMMUN, V4, P142, DOI 10.1128/CDLI.4.2.142-146.1997; Pottier I, 2008, INT J FOOD MICROBIOL, V126, P327, DOI 10.1016/j.ijfoodmicro.2007.08.021; Rumpold BA, 2013, MOL NUTR FOOD RES, V57, P802, DOI 10.1002/mnfr.201200735; Rumpold BA, 2013, INNOV FOOD SCI EMERG, V17, P1, DOI 10.1016/j.ifset.2012.11.005; Samson R. A., 2002, INTRO FOOD AIRBORNE; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shetaia Y. M., 2005, African Journal of Mycology and Biotechnology, V13, P73; Spranghers T, 2017, J SCI FOOD AGR, V97, P2594, DOI 10.1002/jsfa.8081; Vacchini V, 2017, ENV MICROBIOL REP, V9, P91, DOI 10.1111/1758-2229.12505; Vadkertiova Renata, 2007, Polish Journal of Microbiology, V56, P39; Vega FE, 2005, INSECT FUNGAL ASS EC, P230; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zhang E, 2011, MICROBIOL IMMUNOL, V55, P483, DOI 10.1111/j.1348-0421.2011.00341.x	55	58	58	4	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182533	10.1371/journal.pone.0182533	http://dx.doi.org/10.1371/journal.pone.0182533			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771577	Green Published, gold, Green Submitted			2022-12-26	WOS:000406853600134
J	Chiang, PH; Huang, LY; Lee, MS; Tsou, HC; Wahlqvist, ML				Chiang, Po-Huang; Huang, Lin-Yuan; Lee, Meei-Shyuan; Tsou, Hui-Chen; Wahlqvist, Mark L.			Fitness and food environments around junior high schools in Taiwan and their association with body composition: Gender differences for recreational, reading, food and beverage exposures	PLOS ONE			English	Article							LEISURE-TIME; OBESITY; NEIGHBORHOOD; PREVALENCE; CHILDREN; HEALTH; ADOLESCENTS; OVERWEIGHT; CHILDHOOD; NUTRITION	School environments may contribute to adolescent behavior, reproductive physiology and body composition (BC). The Nutritional and Health Survey in Taiwan (2010) for 1458 junior high school students was geo-mapped for 30 school environs. Facilities for physical activity (fitness centers, gymnasia and sports stadiums, activity centers and parks), sedentary activities (reading material rental shops (RMRS), internet cafes) and food and beverage outlets (FBOs) were calculated as weighted numbers within 1000m of schools. Multiple linear regressions were used to predict BC variable z-scores. For boys, higher fitness center densities and, for girls, gymnasia and sports stadiums were associated with less abdominal fatness. For girls, body mass index, waist circumference (WC) and triceps skinfold thickness (TSF) were greater when RMRS density was higher as was TSF with internet cafe A density. Where there were no FBOs, boys' WC and TSF were less with more parks, but girls were shorter and WC more adverse. With greater RMRS density and no FBOs, girls still had increased WC/Hip ratio, and less mid-arm muscle circumference. Boys' findings were more evident after considering puberty. Physical activity facilities (differently by gender), food and beverage outlets absence for boys and low reading material rental shop density for girls increase the likelihood of healthier body composition.	[Chiang, Po-Huang; Huang, Lin-Yuan; Tsou, Hui-Chen; Wahlqvist, Mark L.] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Prevent Med & Hlth Serv Res, Miaoli, Taiwan; [Chiang, Po-Huang] China Med Univ, Coll Publ Hlth, Taichung, Taiwan; [Lee, Meei-Shyuan; Wahlqvist, Mark L.] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Wahlqvist, Mark L.] Monash Univ, Monash Asia Inst, Melbourne, Vic, Australia; [Wahlqvist, Mark L.] Zhejiang Univ, Fuli Inst Food Sci & Nutr, Hangzhou, Zhejiang, Peoples R China	National Health Research Institutes - Taiwan; China Medical University Taiwan; National Defense Medical Center; Monash University; Zhejiang University	Wahlqvist, ML (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Prevent Med & Hlth Serv Res, Miaoli, Taiwan.; Wahlqvist, ML (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.; Wahlqvist, ML (corresponding author), Monash Univ, Monash Asia Inst, Melbourne, Vic, Australia.; Wahlqvist, ML (corresponding author), Zhejiang Univ, Fuli Inst Food Sci & Nutr, Hangzhou, Zhejiang, Peoples R China.	mark.wahlqvist@gmail.com			internal grant of National Health Research Institutes in Taiwan [04A1-PHPP21-014, 103-2410-H-400-001-MY2]	internal grant of National Health Research Institutes in Taiwan	The present study was supported by the internal grant of National Health Research Institutes in Taiwan (04A1-PHPP21-014 and 103-2410-H-400-001-MY2).	Abbassi V, 1998, PEDIATRICS, V102, P507; [Anonymous], 2011, J WORLD PUBLIC HLTH, V2, P3; Arroyo-Izaga M, 2008, INT J SPORT NUTR EXE, V18, P628, DOI 10.1123/ijsnem.18.6.628; Bjorntorp P, 1997, J ENDOCRINOL, V155, P193, DOI 10.1677/joe.0.1550193; Burnett S, 2011, LEARN INDIVID DIFFER, V21, P681, DOI 10.1016/j.lindif.2010.05.007; Cannon G., 2013, J WORLD PUBLIC H MAR; CDC, 2017, CHIDH OB FACTS HLTH; Chiang PH, 2013, ASIA PAC J CLIN NUTR, V22, P599, DOI 10.6133/apjcn.2013.22.4.19; Chiang PH, 2013, RES DEV DISABIL, V34, P3504, DOI 10.1016/j.ridd.2013.06.023; Chiang PH, 2011, PUBLIC HEALTH NUTR, V14, P1601, DOI 10.1017/S1368980011001042; Child Trends Databank, 2014, FOOD INS; Child Trends Databank, 2014, OV CHILDR YOUTH; Chou Dienfang, 2010, J INTERCULTURAL COMM, V19, P78; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Davis B, 2009, AM J PUBLIC HEALTH, V99, P505, DOI 10.2105/AJPH.2008.137638; Fakhouri T, 2012, NCHS DATA BRIEF, V2014, P1; Fox MK, 2009, J AM DIET ASSOC, V109, pS108, DOI 10.1016/j.jada.2008.10.065; FRAC, 2010, WHY LOW INC FOOD INS; Hills AP, 2014, ASIA PAC J CLIN NUTR, V23, P339, DOI 10.6133/apjcn.2014.23.3.07; Hou NQ, 2010, HEALTH PLACE, V16, P1206, DOI 10.1016/j.healthplace.2010.08.005; Hu FB, 2013, OBES REV, V14, P606, DOI 10.1111/obr.12040; Huang A., 1996, TAIWAN REV; Huang R., 2014, J HUM NUTR DIET; Izzo C, 2014, ONCOLOGY NURSIN 1003; Jago R, 2005, AM J PREV MED, V29, P98, DOI 10.1016/j.amepre.2005.04.002; Ji CY, 2009, INT J CARDIOL, V132, P1, DOI 10.1016/j.ijcard.2008.07.003; Karimi S, 2014, J SOC ISSUES HUMANIT, V2, P277; Laska MN, 2010, PUBLIC HEALTH NUTR, V13, P1757, DOI 10.1017/S1368980010001564; Lee CT, 2014, CONCERNED PHYS CHANG; Li YP, 2008, ASIA PAC J CLIN NUTR, V17, P131; Liou TH, 2009, ANN HUM BIOL, V36, P176, DOI 10.1080/03014460802691174; Liou YM, 2010, J ADV NURS, V66, P1246, DOI 10.1111/j.1365-2648.2010.05293.x; Ministry of the Interior, 2013, REP ED STAT TAIW; National Health Research Institute, 2012, NUTR HLTH SURV TAIW; OECD, 2014, OB UPD; Pratt C, 2008, RES Q EXERCISE SPORT, V79, P458, DOI 10.1080/02701367.2008.10599512; Robert Wood Johnson Foundation, 2010, FOOD INS RISK OB CHI; Robert Wood Johnson Foundation, 2012, F FAT OB THREAT AM F; Schaefer-McDaniel N, 2010, SOC SCI MED, V71, P651, DOI 10.1016/j.socscimed.2010.03.060; Scott KA, 2012, CURR OBES REP, V1, DOI 10.1007/s13679-011-0006-3; Shah BV., 2001, SUDDAN USERS MANUAL, V8th ed; Siahpush M, 2014, OBESITY, V22, P616, DOI 10.1002/oby.20572; Solomons N W, 1995, Asia Pac J Clin Nutr, V4, P59; Solomons NW, 2000, ASIA PAC J CLIN NUTR, V9, pS41, DOI 10.1046/j.1440-6047.2000.00165.x; Stang Jamie, 2005, GUIDELINES ADOLESCEN; Steinberg L., 2014, AGE OPPORTUNITY LESS; Steinberg L., 2014, CNN; Szalavitz M, 2010, TIME MAGAZINE; Timperio A, 2006, AM J PREV MED, V30, P45, DOI 10.1016/j.amepre.2005.08.047; Tirosh A, 2011, NEW ENGL J MED, V364, P1315, DOI 10.1056/NEJMoa1006992; Veldhuis JD, 2005, ENDOCR REV, V26, P114, DOI 10.1210/er.2003-0038; Wahlqvist ML, 2014, ASIA PAC J CLIN NUTR, V23, P1, DOI 10.6133/apjcn.2014.23.1.20; Wahlqvist ML, 2011, NUTR METAB; Wang SH, 2013, ADDICTION, V108, P2081, DOI 10.1111/add.12278	54	13	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182517	10.1371/journal.pone.0182517	http://dx.doi.org/10.1371/journal.pone.0182517			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC5AR	28771561	Green Submitted, Green Published, gold			2022-12-26	WOS:000406853600133
J	Chou, WC; Lin, SS; Yeh, SD; Li, SL; Peng, YC; Fan, YH; Chen, TC				Chou, Wan-Chen; Lin, Shih-Shun; Yeh, Shyi-Dong; Li, Siang-Ling; Peng, Ying-Che; Fan, Ya-Hsu; Chen, Tsung-Chi			Characterization of the genome of a phylogenetically distinct tospovirus and its interactions with the local lesion-induced host Chenopodium quinoa by whole-transcriptome analyses	PLOS ONE			English	Article							SPOTTED-WILT-VIRUS; CELL-DEATH; MOLECULAR CHARACTERIZATION; HYPERSENSITIVE RESPONSE; NICOTIANA-BENTHAMIANA; INNATE IMMUNITY; MOSAIC-VIRUS; RNA; GENE; EXPRESSION	Chenopodium quinoa is a natural local lesion host of numerous plant viruses, including tos-poviruses (family Bunyaviridae). Groundnut chlorotic fan-spot tospovirus (GCFSV) has been shown to consistently induce local lesions on the leaves of C. quinoa 4 days post-inoculation (dpi). To reveal the whole genome of GCFSV and its interactions with C. quinoa, RNA-seq was performed to determine the transcriptome profiles of C. quinoa leaves. The high-throughput reads from infected C. quinoa leaves were used to identify the whole genome sequence of GCFSV and its single nucleotide polymorphisms. Our results indicated that GCFSV is a phylogenetically distinct tospovirus. Moreover, 27,170 coding and 29,563 non-coding sequences of C. quinoa were identified through de novo assembly, mixing reads from mock and infected samples. Several key genes involved in the modulation of hypersensitive response (HR) were identified. The expression levels of 4,893 deduced complete genes annotated using the Arabidopsis genome indicated that several HR-related orthologues of pathogenesis-related proteins, transcription factors, mitogen-activated protein kinases, and defense proteins were significantly expressed in leaves that formed local lesions. Here, we also provide new insights into the replication progression of a tospovirus and the molecular regulation of the C. quinoa response to virus infection.	[Chou, Wan-Chen; Li, Siang-Ling; Fan, Ya-Hsu; Chen, Tsung-Chi] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Lin, Shih-Shun] Natl Taiwan Univ, Inst Biotechnol, Taipei, Taiwan; [Lin, Shih-Shun] Acad Sinica, Agr Biotechnol Res Ctr, Taipei, Taiwan; [Yeh, Shyi-Dong] Natl Chung Hsing Univ, Dept Plant Pathol, Taichung, Taiwan; [Yeh, Shyi-Dong] Natl Chung Hsing Univ, NCHU UCD Plant & Food Biotechnol Ctr, Taichung, Taiwan; [Peng, Ying-Che] Genetech Biotech Co Ltd, Taipei, Taiwan; [Chen, Tsung-Chi] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan	Asia University Taiwan; National Taiwan University; Academia Sinica - Taiwan; National Chung Hsing University; National Chung Hsing University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chen, TC (corresponding author), Asia Univ, Dept Biotechnol, Taichung, Taiwan.; Chen, TC (corresponding author), China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.	kikichenwolf@hotmail.com	Lin, Shih-Shun/HCH-9241-2022					Alazem M, 2015, MOL PLANT PATHOL, V16, P529, DOI 10.1111/mpp.12204; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barba M, 2014, VIRUSES-BASEL, V6, P106, DOI 10.3390/v6010106; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bucher E, 2003, J VIROL, V77, P1329, DOI 10.1128/JVI.77.2.1329-1336.2003; Caarls L, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00170; Chang JH, 2014, PLANT J, V77, P558, DOI 10.1111/tpj.12401; Chen C. C., 1996, Acta Horticulturae, P57; Chen TC, 2013, VIRUS GENES, V46, P487, DOI 10.1007/s11262-013-0880-8; Chu FH, 2001, PHYTOPATHOLOGY, V91, P856, DOI 10.1094/PHYTO.2001.91.9.856; Chu FH, 1998, PHYTOPATHOLOGY, V88, P351, DOI 10.1094/PHYTO.1998.88.4.351; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; De Oliveira AS, 2016, MOL PLANT PATHOL, V17, P1442, DOI 10.1111/mpp.12439; DEHAAN P, 1990, J GEN VIROL, V71, P1001, DOI 10.1099/0022-1317-71-5-1001; DEHAAN P, 1991, J GEN VIROL, V72, P2207, DOI 10.1099/0022-1317-72-9-2207; Duijsings D, 2001, EMBO J, V20, P2545, DOI 10.1093/emboj/20.10.2545; Dullemans AM, 2015, ARCH VIROL, V160, P605, DOI 10.1007/s00705-014-2282-1; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Gao MH, 2009, CELL HOST MICROBE, V6, P34, DOI 10.1016/j.chom.2009.05.019; Hagen C, 2011, ARCH VIROL, V156, P1209, DOI 10.1007/s00705-011-0979-y; Hallwass M, 2014, MOL PLANT PATHOL, V15, P871, DOI 10.1111/mpp.12144; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Huang CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126161; Jarvis DE, 2017, NATURE, V542, P307, DOI 10.1038/nature21370; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kang YC, 2014, EUR J PLANT PATHOL, V140, P815, DOI 10.1007/s10658-014-0511-9; Kikkert M, 1999, J VIROL, V73, P2288, DOI 10.1128/JVI.73.3.2288-2297.1999; KORMELINK R, 1994, VIROLOGY, V200, P56, DOI 10.1006/viro.1994.1162; Kung YJ, 2014, MOL PLANT MICROBE IN, V27, P944, DOI 10.1094/MPMI-04-14-0116-R; La Camera S, 2009, MOL PLANT MICROBE IN, V22, P469, DOI 10.1094/MPMI-22-4-0469; Lauring AS, 2013, NAT REV MICROBIOL, V11, P327, DOI 10.1038/nrmicro3003; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Li JT, 2011, ARCH VIROL, V156, P359, DOI 10.1007/s00705-010-0881-z; Lin SS, 2007, PHYTOPATHOLOGY, V97, P287, DOI 10.1094/PHYTO-97-3-0287; Liu LYD, 2014, PLANT CELL PHYSIOL, V55, P942, DOI 10.1093/pcp/pcu029; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Margaria P, 2016, VIRUS RES, V211, P38, DOI 10.1016/j.virusres.2015.09.019; Melcher U, 2000, J GEN VIROL, V81, P257, DOI 10.1099/0022-1317-81-1-257; Menzel W, 2002, J VIROL METHODS, V99, P81, DOI 10.1016/S0166-0934(01)00381-0; Pappu HR, 2009, VIRUS RES, V141, P219, DOI 10.1016/j.virusres.2009.01.009; Peiro A, 2014, MOL PLANT PATHOL, V15, P802, DOI 10.1111/mpp.12142; Plyusnin A, 2011, VIRUS TAXONOMY, P725; Ribeiro D, 2009, VIROLOGY, V383, P121, DOI 10.1016/j.virol.2008.09.028; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santamaria M, 2001, PLANT MOL BIOL, V47, P641, DOI 10.1023/A:1012410009930; Satyanarayana T, 1998, ARCH VIROL, V143, P353, DOI 10.1007/s007050050291; SCHAEFER BC, 1995, ANAL BIOCHEM, V227, P255, DOI 10.1006/abio.1995.1279; Shirasu K, 2000, PLANT MOL BIOL, V44, P371, DOI 10.1023/A:1026552827716; Song L, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00796; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Takeda A, 2002, FEBS LETT, V532, P75, DOI 10.1016/S0014-5793(02)03632-3; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; van Knippenberg I, 2002, VIROLOGY, V303, P278, DOI 10.1006/viro.2002.1632; Wylie SJ, 2012, ARCH VIROL, V157, P271, DOI 10.1007/s00705-011-1166-x; YEH SD, 1992, PLANT DIS, V76, P835, DOI 10.1094/PD-76-0835; Yeh SD, 1996, ACTA HORTIC, V431, P122; Zhang YC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044465, 10.1155/2012/583417]; Zvereva AS, 2012, VIRUSES-BASEL, V4, P2578, DOI 10.3390/v4112578	60	6	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182425	10.1371/journal.pone.0182425	http://dx.doi.org/10.1371/journal.pone.0182425			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771638	Green Submitted, Green Published, gold			2022-12-26	WOS:000406853600111
J	Heise, V; Zsoldos, E; Suri, S; Sexton, C; Topiwala, A; Filippini, N; Mahmood, A; Allan, CL; Singh-Manoux, A; Kivimaki, M; Mackay, CE; Ebmeier, KP				Heise, Verena; Zsoldos, Eniko; Suri, Sana; Sexton, Claire; Topiwala, Anya; Filippini, Nicola; Mahmood, Abda; Allan, Charlotte L.; Singh-Manoux, Archana; Kivimaki, Mika; Mackay, Clare E.; Ebmeier, Klaus P.			Uncoupling protein 2 haplotype does not affect human brain structure and function in a sample of community-dwelling older adults	PLOS ONE			English	Article							MITOCHONDRIAL; ACQUISITION; MODEL; UCP2	Uncoupling protein 2 (UCP2) is a mitochondrial membrane protein that plays a role in uncoupling electron transport from adenosine triphosphate (ATP) formation. Polymorphisms of the UCP2 gene in humans affect protein expression and function and have been linked to survival into old age. Since UCP2 is expressed in several brain regions, we investigated in this study whether UCP2 polymorphisms might 1) affect occurrence of neurodegenerative or mental health disorders and 2) affect measures of brain structure and function. We used structural magnetic resonance imaging (MRI), diffusion-weighted MRI and resting-state functional MRI in the neuroimaging sub-study of the Whitehall II cohort. Data from 536 individuals aged 60 to 83 years were analyzed. No association of UCP2 polymorphisms with the occurrence of neurodegenerative disorders or grey and white matter structure or resting-state functional connectivity was observed. However, there was a significant effect on occurrence of mood disorders in men with the minor alleles of -866G>A (rs659366) and Ala55Val (rs660339)) being associated with increasing odds of lifetime occurrence of mood disorders in a dose dependent manner. This result was not accompanied by effects of UCP2 polymorphisms on brain structure and function, which might either indicate that the sample investigated here was too small and underpowered to find any significant effects, or that potential effects of UCP2 polymorphisms on the brain are too subtle to be picked up by any of the neuroimaging measures used.	[Heise, Verena; Suri, Sana; Sexton, Claire; Mackay, Clare E.] Univ Oxford, Oxford Ctr Human Brain Act, OHBA, Oxford, England; [Heise, Verena; Zsoldos, Eniko; Suri, Sana; Sexton, Claire; Topiwala, Anya; Filippini, Nicola; Mahmood, Abda; Allan, Charlotte L.; Mackay, Clare E.; Ebmeier, Klaus P.] Univ Oxford, Dept Psychiat, Oxford, England; [Heise, Verena] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Allan, Charlotte L.] Newcastle Univ, Northumberland Tyne & Wear NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Allan, Charlotte L.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England; [Singh-Manoux, Archana; Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England; [Singh-Manoux, Archana] Hop Paul Brousse, Ctr Res Epidemiol & Populat Hlth, INSERM, U1018, Villejuif, France; [Ebmeier, Klaus P.] Warneford Hosp, Oxford Hlth NHS Fdn Trust, Oxford, England	University of Oxford; University of Oxford; University of Oxford; Newcastle University - UK; Newcastle University - UK; University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Heise, V (corresponding author), Univ Oxford, Oxford Ctr Human Brain Act, OHBA, Oxford, England.; Heise, V (corresponding author), Univ Oxford, Dept Psychiat, Oxford, England.; Heise, V (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England.	verena.heise@ndph.ox.ac.uk	Heise, Verena/AAE-2731-2021; Singh-Manoux, Archana/F-6804-2013; Sexton, Claire/W-3990-2019; Ebmeier, Klaus Peter/B-4789-2008; Filippini, Nicola/Q-5250-2019; Filippini, Nicola/H-6869-2013	Singh-Manoux, Archana/0000-0002-1244-5037; Sexton, Claire/0000-0002-3846-2986; Ebmeier, Klaus Peter/0000-0002-5190-7038; Filippini, Nicola/0000-0003-1513-5269; Filippini, Nicola/0000-0003-1513-5269; Kivimaki, Mika/0000-0002-4699-5627; Heise, Verena/0000-0002-5625-4128; Zsoldos, Eniko/0000-0002-0478-6165; Topiwala, Anya/0000-0002-8408-0372; Allan, Charlotte/0000-0001-6827-5420; Mackay, Clare/0000-0001-6111-8318	"Lifelong Health and Wellbeing" Programme Grant: "Predicting MRI abnormalities with longitudinal data of the Whitehall II Substudy" (UK Medical Research Council) [G1001354]; UK Medical Research Council [K013351]; ESRC professional fellowship scheme; US National Institutes of Health [R01AG013196, R01AG034454]; HDH Wills 1965 Charitable Trust [1117747]; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust; Oxford Health NHS Foundation Trust; University of Oxford; Medical Research Council [MC_EX_MR/N50192X/1, MR/M024962/1, MR/K013351/1, G1001354, MR/L023784/1] Funding Source: researchfish; Parkinson&quot;s UK [J-1403] Funding Source: researchfish; MRC [MR/K013351/1, MR/L023784/1, MC_EX_MR/N50192X/1, MR/M024962/1, G1001354] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [R01AG034454, R01AG013196] Funding Source: NIH RePORTER	"Lifelong Health and Wellbeing" Programme Grant: "Predicting MRI abnormalities with longitudinal data of the Whitehall II Substudy" (UK Medical Research Council)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ESRC professional fellowship scheme; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HDH Wills 1965 Charitable Trust; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust; Oxford Health NHS Foundation Trust; University of Oxford; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Work on this study was mainly funded by the Lifelong Health and Wellbeing Programme Grant: Predicting MRI abnormalities with longitudinal data of the Whitehall II Substudy (UK Medical Research Council: G1001354). Collection of blood and buccal mucosal samples for a characterization of immune function and associated measures is supported by the UK Medical Research Council grant K013351 and the ESRC professional fellowship scheme to MK. ASM receives research support from the US National Institutes of Health (R01AG013196, R01AG034454). NF, SS and AM are funded by the HDH Wills 1965 Charitable Trust (Nr: 1117747). VH, CS and CEM are supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust, Oxford Health NHS Foundation Trust and University of Oxford (The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank all participants and the Whitehall staff at UCL, who so helpfully collaborate with us. We are grateful to all FMRIB staff, in particular radiographers Jon Campbell, Michael Sanders, Caroline Young and David Parker, IT staff David Flitney, Christopher Gallagher, Duncan Mortimer and Matthew Webster, FMRIB administrative staff Sue Field and Marilyn Goulding, Barbora Krausova and especially KPE's PA Amanda Pipkin, for help with coordinating the appointments. We would like to thank Martin Turner and his colleagues for advising on incidental findings and taking over clinical responsibility for such participants. We are grateful for provision of the multiband pulse sequence and reconstruction algorithms to the Center for Magnetic Resonance Research, University of Minnesota, USA. We are grateful to Siemens Healthcare for the provision of the DTI and MEMPR sequences. The DTI sequence was a Works-in-Progress package for advanced EPI diffusion imaging, developed by Thorsten Feiweier, Siemens AG, Healthcare Sector, Erlangen, Germany. The Multi-Echo MPRAGE sequence is a Works-in-Progress package, developed by Siemens in collaboration with the Athinoula A. Martinos, Center for Biomedical Imaging, Massachusetts General Hospital. Work on this study was mainly funded by the "Lifelong Health and Wellbeing" Programme Grant: "Predicting MRI abnormalities with longitudinal data of the Whitehall II Substudy" (UK Medical Research Council: G1001354). Collection of blood and buccal mucosal samples for a characterization of immune function and associated measures is supported by the UK Medical Research Council grant K013351 and the ESRC professional fellowship scheme to MK. ASM receives research support from the US National Institutes of Health (R01AG013196, R01AG034454). NF, SS and AM are funded by the HDH Wills 1965 Charitable Trust (Nr: 1117747). VH, CS and CEM are supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust, Oxford Health NHS Foundation Trust and University of Oxford (The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health).	Andersen G, 2013, INT J OBESITY, V37, P175, DOI 10.1038/ijo.2012.22; Andrews ZB, 2005, J NEUROSCI, V25, P184, DOI 10.1523/JNEUROSCI.4269-04.2005; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Cardoso S, 2015, J BIOENERG BIOMEMBR, V47, P119, DOI 10.1007/s10863-014-9580-x; Diano S, 2000, ENDOCRINOLOGY, V141, P4226, DOI 10.1210/en.141.11.4226; Dietrich MO, 2008, J NEUROSCI, V28, P10766, DOI 10.1523/JNEUROSCI.2744-08.2008; Dietrich MO, 2010, PFLUG ARCH EUR J PHY, V459, P269, DOI 10.1007/s00424-009-0729-0; Donadelli M, 2014, CELL MOL LIFE SCI, V71, P1171, DOI 10.1007/s00018-013-1407-0; Douaud G, 2007, BRAIN, V130, P2375, DOI 10.1093/brain/awm184; Filippini N, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-159; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; First MB, 2002, USERS GUIDE STRUCTUR; Gaunt TR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-428; Gorgolewski KJ, 2015, FRONT NEUROINFORM, V9, DOI 10.3389/fninf.2015.00008; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Griffanti L, 2014, NEUROIMAGE, V95, P232, DOI 10.1016/j.neuroimage.2014.03.034; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Kivimaki M, 2012, BIOL PSYCHIAT, V72, P324, DOI 10.1016/j.biopsych.2012.02.005; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Manji H, 2012, NAT REV NEUROSCI, V13, P293, DOI 10.1038/nrn3229; Marmot M, 2005, INT J EPIDEMIOL, V34, P251, DOI 10.1093/ije/dyh372; Nakase T, 2007, NEUROPATHOLOGY, V27, P442, DOI 10.1111/j.1440-1789.2007.00815.x; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Qian L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058939; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rose G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029650; Salimi-Khorshidi G, 2014, NEUROIMAGE, V90, P449, DOI 10.1016/j.neuroimage.2013.11.046; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sotiropoulos SN, 2013, NEUROIMAGE, V80, P125, DOI 10.1016/j.neuroimage.2013.05.057; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; van der Kouwe AJW, 2008, NEUROIMAGE, V40, P559, DOI 10.1016/j.neuroimage.2007.12.025; Wechsler D., 2011, TEST PREMORBID FUNCT; Williams P, 2006, USERS GUIDE GEN HLTH; Wray NR, 2012, MOL PSYCHIATR, V17, P36, DOI 10.1038/mp.2010.109; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	41	0	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0181392	10.1371/journal.pone.0181392	http://dx.doi.org/10.1371/journal.pone.0181392			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771482	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000406853600018
J	Helsen, N; Roothans, D; Van den Heuvel, B; Van den Wyngaert, T; Van den Weyngaert, D; Carp, L; Stroobants, S				Helsen, Nils; Roothans, Dessie; Van den Heuvel, Bert; Van den Wyngaert, Tim; Van den Weyngaert, Danielle; Carp, Laurens; Stroobants, Sigrid			F-18-FDG-PET/CT for the detection of disease in patients with head and neck cancer treated with radiotherapy	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; SQUAMOUS-CELL CARCINOMA; LOCALLY ADVANCED HEAD; CONTRAST-ENHANCED CT; PET-CT; CONCOMITANT RADIOCHEMOTHERAPY; COMPUTED-TOMOGRAPHY; RADIATION-THERAPY; FDG-PET/CT; DISSECTION	Objective The aim of this study is to evaluate the diagnostic performance of FDG-PET/CT for the detection of residual disease after (chemo) radiotherapy in patients with head and neck squamous cell carcinoma (HNSCC) and to evaluate the prognostic value of the FDG-PET/CT findings. Methods Patients with HNSCC who underwent FDG-PET/CT after (chemo) radiotherapy were studied retrospectively. Results 104 FDG-PET/CT-scans were performed at a median of 13.2 weeks post-treatment (5.4-19.0 weeks). The diagnostic performance was time dependent with decreasing sensitivity and slightly increasing specificity over time. Sensitivity, specificity, PPV and NPV at 9 months after imaging were 91%, 87%, 77% and 95%, respectively. In a logistic regression model, the odds of a correct FDG-PET/CT increased with 33% every additional week after end of therapy (p = 0.01) and accuracy plateaued after 11 weeks (97%; p<0.001). A complete response on FDG-PET/CT was associated with an overall survival benefit (50.7 versus 10.3 months; p<0.001). Residual disease on FDG-PET/CT increased the risk of death 8fold (p<0.001). Conclusion FDG-PET/CT is able to detect residual disease after (chemo) radiotherapy, with an optimal time point for scanning between 11-12 weeks after therapy. However, a reevaluation is probably necessary 10-12 months after the FDG-PET/CT to detect late recurrences. In addition, FDG-PET/CT can guide decisions about neck dissection and identifies patients with poor prognosis.	[Helsen, Nils; Van den Wyngaert, Tim; Carp, Laurens; Stroobants, Sigrid] Antwerp Univ Hosp, Dept Nucl Med, Wilrijkstr 10, Edegem, Belgium; [Helsen, Nils; Roothans, Dessie; Van den Heuvel, Bert; Van den Wyngaert, Tim; Carp, Laurens; Stroobants, Sigrid] Univ Antwerp, Fac Med & Hlth Sci, Univ Pl 1, Antwerp, Belgium; [Van den Weyngaert, Danielle] ZNA Middelheim, Dept Radiotherapy, Lindendreef 1, Antwerp, Belgium	University of Antwerp; University of Antwerp; ZNA Middelheim Hospital	Helsen, N (corresponding author), Antwerp Univ Hosp, Dept Nucl Med, Wilrijkstr 10, Edegem, Belgium.; Helsen, N (corresponding author), Univ Antwerp, Fac Med & Hlth Sci, Univ Pl 1, Antwerp, Belgium.	Nils.Helsen@uza.be	Van den Wyngaert, Tim/C-7050-2017	Van den Wyngaert, Tim/0000-0002-0320-9075; Stroobants, Sigrid/0000-0002-6450-9944	Flemish agency for innovation by science and technology [IWT-90867]	Flemish agency for innovation by science and technology	This study was supported by a grant (IWT-90867) by the Flemish agency for innovation by science and technology. Funding was used to pay researchers but the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2008, OTOLARYNG CLIN N AM, V41, P23, DOI 10.1016/j.otc.2007.10.005; Andrade RS, 2006, INT J RADIAT ONCOL, V65, P1315, DOI 10.1016/j.ijrobp.2006.03.015; Argiris A, 2004, HEAD NECK-J SCI SPEC, V26, P447, DOI 10.1002/hed.10394; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Blanche P, 2013, STAT MED, V32, P5381, DOI 10.1002/sim.5958; Bombardieri E, 2003, EUR J NUCL MED MOL I, V30, pBP115, DOI 10.1007/s00259-003-1355-2; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Castaldi P, 2012, RADIOTHER ONCOL, V103, P63, DOI 10.1016/j.radonc.2012.03.001; CHAIKEN L, 1993, INT J RADIAT ONCOL, V27, P455, DOI 10.1016/0360-3016(93)90259-X; Chan JYK, 2012, ARCH OTOLARYNGOL, V138, P1040, DOI 10.1001/jamaoto.2013.607; Chen AY, 2006, HEAD NECK-J SCI SPEC, V28, P487, DOI 10.1002/hed.20362; Denis F, 2004, J CLIN ONCOL, V22, P69, DOI 10.1200/JCO.2004.08.021; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Frank DK, 2005, LARYNGOSCOPE, V115, P1015, DOI 10.1097/01.MLG.0000162648.37638.76; Goguen LA, 2010, ARCH OTOLARYNGOL, V136, P1071, DOI 10.1001/archoto.2010.188; Gregoire V, 2010, ANN ONCOL, V21, pv184, DOI 10.1093/annonc/mdq185; Gupta T, 2011, EUR J NUCL MED MOL I, V38, P2083, DOI 10.1007/s00259-011-1893-y; Hamoir M, 2012, ORAL ONCOL, V48, P203, DOI 10.1016/j.oraloncology.2011.10.015; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Leung AS, 2015, HEAD NECK S1, V38, pE853; Malone JP, 2009, ARCH OTOLARYNGOL, V135, P1119, DOI 10.1001/archoto.2009.152; Marur S, 2008, MAYO CLIN PROC, V83, P489, DOI 10.4065/83.4.489; McHam SA, 2003, HEAD NECK-J SCI SPEC, V25, P791, DOI 10.1002/hed.10293; Mehanna H, 2016, NEW ENGL J MED, V374, P1444, DOI 10.1056/NEJMoa1514493; Nayak JV, 2007, LARYNGOSCOPE, V117, P2129, DOI 10.1097/MLG.0b013e318149e6bc; Ong SC, 2008, J NUCL MED, V49, P532, DOI 10.2967/jnumed.107.044792; Passero VA, 2010, ANN ONCOL, V21, P2278, DOI 10.1093/annonc/mdq226; Pignon JP, 2009, RADIOTHER ONCOL, V92, P4, DOI 10.1016/j.radonc.2009.04.014; Pignon JP, 2000, LANCET, V355, P949, DOI 10.1016/S0140-6736(00)90011-4; Porceddu SV, 2011, HEAD NECK-J SCI SPEC, V33, P1675, DOI 10.1002/hed.21655; Rabalais AG, 2009, LARYNGOSCOPE, V119, P1120, DOI 10.1002/lary.20201; Rodrigues RS, 2009, J NUCL MED, V50, P1205, DOI 10.2967/jnumed.109.062075; SCHWARTZ LH, 1994, CANCER, V74, P1933, DOI 10.1002/1097-0142(19941001)74:7<1933::AID-CNCR2820740718>3.0.CO;2-X; Stenson KM, 2000, ARCH OTOLARYNGOL, V126, P950, DOI 10.1001/archotol.126.8.950; Yamamoto Y, 2007, RADIOLOGY, V244, P263, DOI 10.1148/radiol.2433060043; Yom SS, 2005, AM J CLIN ONCOL-CANC, V28, P385, DOI 10.1097/01.coc.0000162422.92095.9e; Zundel MT, 2011, INT J RADIAT ONCOL, V81, pE825, DOI 10.1016/j.ijrobp.2010.11.072	37	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182350	10.1371/journal.pone.0182350	http://dx.doi.org/10.1371/journal.pone.0182350			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771540	gold, Green Published, Green Submitted			2022-12-26	WOS:000406853600094
J	Land, J; Abdulahad, WH; Arends, S; Sanders, JSF; Stegeman, CA; Heeringa, P; Rutgers, A				Land, Judith; Abdulahad, Wayel H.; Arends, Suzanne; Sanders, Jan-Stephan F.; Stegeman, Coen A.; Heeringa, Peter; Rutgers, Abraham			Prospective monitoring of in vitro produced PR3-ANCA does not improve relapse prediction in granulomatosis with polyangiitis	PLOS ONE			English	Article							ANCA-ASSOCIATED VASCULITIS; ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; WEGENER GRANULOMATOSIS; DISEASE; PATHOGENESIS; REMISSION	Objectives Patients with granulomatosis with polyangiitis (GPA) are prone to disease relapse. Currently, no good biomarkers are available to predict relapses in individual patients. This study aimed to determine whether patients at risk for relapse can be distinguished based on increased in vitro autoantibody production. Methods Eighty-four proteinase 3 (PR3) anti-neutrophil cytoplasmic antibody (ANCA) positive GPA outpatients were prospectively monitored for up to two years and 32 healthy controls were included. At periodic intervals peripheral blood mononuclear cells were isolated, cultured and in vitro production of total and PR3-ANCA-specific IgG was determined. Moreover, serum ANCA titers were measured by indirect immunofluorescence. Results Sixteen patients (21%) relapsed during the follow-up period. At time of inclusion no significant differences were present for ANCA production between relapsing and non-relapsing patients. Samples before relapse exhibited increased serum ANCA titers and in vitro PR3-ANCA IgG levels compared with inclusion samples from non-relapsing patients. When evaluating changes over time, increasing serum ANCA titers were observed prior to relapse compared to a 1-year follow-up from non-relapsing patients. No significant change in in vitro PR3-ANCA levels occurred prior to relapse, compared to non-relapse patients. Conclusions While differences were observed for the serum ANCA titer in relapsing and non-relapsing patients, monitoring in vitro PR3-ANCA IgG production does not improve relapse prediction in GPA patients.	[Land, Judith; Abdulahad, Wayel H.; Arends, Suzanne; Rutgers, Abraham] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands; [Sanders, Jan-Stephan F.; Stegeman, Coen A.] Univ Groningen, Univ Med Ctr Groningen, Div Nephrol, Dept Internal Med, Groningen, Netherlands; [Heeringa, Peter] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Rutgers, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands.	a.rutgers@umcg.nl	Sanders, Jan-Stephan/ABC-6782-2021; Heeringa, Peter/A-6008-2009; Arends, Suzanne/M-5436-2015	Heeringa, Peter/0000-0001-8684-763X; Arends, Suzanne/0000-0002-4422-7640; /0000-0003-3109-4487; Stegeman, Coen/0000-0002-0224-0927; Land, Judith/0000-0001-5721-629X	Dutch Arthritis foundation [11-1-405]; Jan Kornelis de Cock foundation	Dutch Arthritis foundation; Jan Kornelis de Cock foundation	This work was supported by grants from the Dutch Arthritis foundation (Reumafonds project number 11-1-405, home.reumafonds.nl) and the Jan Kornelis de Cock foundation (decockstichting. nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boomsma MM, 2000, ARTHRITIS RHEUM-US, V43, P2025, DOI 10.1002/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O; de Joode AAE, 2015, NEPHROL DIAL TRANSPL, V30, pi150, DOI 10.1093/ndt/gfu397; Finkielman JD, 2007, ANN INTERN MED, V147, P611, DOI 10.7326/0003-4819-147-9-200711060-00005; Fussner LA, 2016, FACTORS DETERMINING; Guillevin L, 2014, NEW ENGL J MED, V371, P1771, DOI 10.1056/NEJMoa1404231; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Jennette JC, 2014, NAT REV RHEUMATOL, V10, P463, DOI 10.1038/nrrheum.2014.103; Kallenberg CGM, 2013, AM J KIDNEY DIS, V62, P1176, DOI 10.1053/j.ajkd.2013.05.009; Kemna MJ, 2015, J AM SOC NEPHROL, V26, P537, DOI 10.1681/ASN.2013111233; LEAVITT RY, 1990, ARTHRITIS RHEUM, V33, P1101, DOI 10.1002/art.1780330807; Lepse N, 2016, RHEUMATOLOGY, V55, P162, DOI 10.1093/rheumatology/kev293; Pagnoux C, 2008, ARTHRITIS RHEUM-US, V58, P2908, DOI 10.1002/art.23800; Sanders JSF, 2006, RHEUMATOLOGY, V45, P724, DOI 10.1093/rheumatology/kei272; Savige J, 1999, AM J CLIN PATHOL; STEGEMAN CA, 1994, ANN INTERN MED, V120, P12, DOI 10.7326/0003-4819-120-1-199401010-00003; Tadema H, 2011, RHEUMATOLOGY, V50, P689, DOI 10.1093/rheumatology/keq375; Tervaert JWC, 2009, APMIS, V117, P55, DOI 10.1111/j.1600-0463.2009.02478.x; TERVAERT JWC, 1993, ANN RHEUM DIS, V52, P115, DOI 10.1136/ard.52.2.115; Tomasson G, 2012, RHEUMATOLOGY, V51, P100, DOI 10.1093/rheumatology/ker280	19	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182549	10.1371/journal.pone.0182549	http://dx.doi.org/10.1371/journal.pone.0182549			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771641	Green Published, gold, Green Submitted			2022-12-26	WOS:000406853600140
J	Scott, D; Harrison, CL; Hutchison, S; de Courten, B; Stepto, NK				Scott, David; Harrison, Cheryce L.; Hutchison, Samantha; de Courten, Barbora; Stepto, Nigel K.			Exploring factors related to changes in body composition, insulin sensitivity and aerobic capacity in response to a 12-week exercise intervention in overweight and obese women with and without polycystic ovary syndrome	PLOS ONE			English	Article							RESISTANCE; FAT; THERAPY; MUSCLE; CLAMP	Objective To determine factors associated with differential changes in body fat, insulin resistance and aerobic capacity following a 12-week exercise intervention in overweight and obese women with and without polycystic ovary syndrome (PCOS). Methods 16 overweight and obese women (9 PCOS; 7 without PCOS) completed a supervised progressive 12-week exercise program. Primary outcomes included changes in indicators of insulin sensitivity (including glucose infusion rate relative to fat-free mass [GIR/FFM]), body composition, and aerobic capacity (VO2 peak; 12 participants only). Comparisons were made between women with and without PCOS, and between participants who lost >= 5% (classified as exercise responders) and <5% (non-responders) in body fat (assessed by dual-energy X-ray absorptiometry). Results Training decreased body fat percentage by (mean; 95% CI) -2.3%; -5.3, 0.7% in women with PCOS and by -6.4%; -10.9, -1.9% in women without PCOS (P = 0.08). Ten women (7 PCOS; 3 without PCOS) did not reduce body fat by >= 5%. All participants improved VO2 peak (mean change 27%; 16-39%) but four (2 PCOS; 2 without PCOS) demonstrated decreases in GIR/FFM (mean change for whole cohort: 37%; 3-71%). Android-gynoid fat ratio (0.58; 0.51, 0.66 vs 0.46; 0.40, 0.51; P<0.01) was significantly higher and GIR/FFM (6.69; 3.49, 9.90 vs 11.44; 9.15, 13.72 mg/kg/min; P = 0.01) was significantly lower in non-responders compared with responders at baseline, but non-responders had significant post-training decreases in android-gynoid ratio (-0.02; -0.04, -0.01; P = 0.03), and increases in VO2 peak (7.24; 2.28, 12.21 mL/kg/min; P = 0.01) and GIR/FFM (1.44; 0.27, 2.61 mg/kg/min; P = 0.02). In women with PCOS, pre-training VO2 peak was significantly negatively correlated with change in total body fat (r = -0.75; P = 0.02), and pre-training fasting glucose negatively correlated with changes in VO2 peak (r = -0.76; P = 0.04), but positively correlated with changes in GIR (r = 0.67; P = 0.046). Conclusion A high proportion of overweight and obese women with PCOS had small reductions in body fat following a 12-week exercise intervention, but nevertheless significantly reduced relative central adiposity and improved aerobic capacity and insulin sensitivity.	[Scott, David] Monash Univ, Dept Med, Fac Med Nursing & Hlth Sci, Sch Clin Sci,Monash Hlth, Clayton, Vic, Australia; [Scott, David; Stepto, Nigel K.] Univ Melbourne, Dept Med, Western Campus, St Albans, Vic, Australia; [Scott, David; Stepto, Nigel K.] Univ Melbourne, Australian Inst Musculoskeletal Sci, St Albans, Vic, Australia; [Harrison, Cheryce L.; Hutchison, Samantha; de Courten, Barbora; Stepto, Nigel K.] Monash Univ, Sch Publ Hlth & Prevent Med, Monash Ctr Hlth Res & Implementat, Clayton, Vic, Australia; [Hutchison, Samantha; de Courten, Barbora] Monash Hlth, Diabet & Vasc Med Unit, Clayton, Vic, Australia; [Stepto, Nigel K.] Victoria Univ, ISEAL, Melbourne, Vic, Australia	Monash University; University of Melbourne; University of Melbourne; Monash University; Victoria University	Scott, D (corresponding author), Monash Univ, Dept Med, Fac Med Nursing & Hlth Sci, Sch Clin Sci,Monash Hlth, Clayton, Vic, Australia.; Scott, D (corresponding author), Univ Melbourne, Dept Med, Western Campus, St Albans, Vic, Australia.; Scott, D (corresponding author), Univ Melbourne, Australian Inst Musculoskeletal Sci, St Albans, Vic, Australia.	david.scott@monash.edu	Scott, David/AAH-4641-2021; Harrison, Cheryce/AAC-3675-2019; Scott, David/AAE-5031-2021	Scott, David/0000-0001-5226-1972; Harrison, Cheryce/0000-0002-3154-4946; 	National Health and Medical Research Council Project [APP606553]; National Health and Medical Research Council RD Wright Biomedical Career Development Fellowship [APP1123014]; National Heart Foundation Fellowship [100864]	National Health and Medical Research Council Project(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council RD Wright Biomedical Career Development Fellowship; National Heart Foundation Fellowship(National Heart Foundation of Australia)	This study was supported by a National Health and Medical Research Council Project Grant (APP606553) awarded to NKS. DS is supported by a National Health and Medical Research Council RD Wright Biomedical Career Development Fellowship (APP1123014). BdC is supported by a National Heart Foundation Fellowship (100864). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohm A, 2016, DIABETES, V65, P2849, DOI 10.2337/db15-1723; Bouchard C, 1999, J APPL PHYSIOL, V87, P1003, DOI 10.1152/jappl.1999.87.3.1003; Bouchard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037887; Britton KA, 2011, CIRCULATION, V124, pE837, DOI 10.1161/CIRCULATIONAHA.111.077602; Cassar S, 2016, HUM REPROD, V31, P2619, DOI 10.1093/humrep/dew243; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Chmelo EA, 2015, J AM GERIATR SOC, V63, P462, DOI 10.1111/jgs.13322; DOUCHI T, 1995, OBSTET GYNECOL, V86, P516, DOI 10.1016/0029-7844(95)00250-U; Dumesic DA, 2016, J CLIN ENDOCR METAB; Giallauria F, 2009, CLIN ENDOCRINOL, V70, P394, DOI 10.1111/j.1365-2265.2008.03336.x; Harrison CL, 2012, CLIN ENDOCRINOL, V76, P351, DOI 10.1111/j.1365-2265.2011.04160.x; Harrison CL, 2011, HUM REPROD UPDATE, V17, P171, DOI 10.1093/humupd/dmq045; Hutchison SK, 2012, DIABETOLOGIA, V55, P1424, DOI 10.1007/s00125-011-2442-8; Hutchison SK, 2011, J CLIN ENDOCR METAB, V96, pE48, DOI 10.1210/jc.2010-0828; JAATINEN TA, 1993, FERTIL STERIL, V60, P262; Legro RS, 2015, J CLIN ENDOCR METAB, V100, P4048, DOI 10.1210/jc.2015-2778; Meyer C, 2007, DIABETES CARE, V30, P471, DOI 10.2337/dc06-0618; Montero D, 2017, J PHYSL; Moran LJ, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007506.pub2; Moran LJ, 2010, WOMENS HEALTH, V6, P271, DOI [10.2217/whe.09.89, 10.2217/WHE.09.89]; Randeva HS, 2002, J CLIN ENDOCR METAB, V87, P4496, DOI 10.1210/jc.2001-012056; Stephens NA, 2015, J CLIN ENDOCR METAB, V100, P43, DOI 10.1210/jc.2014-2545; Stepto NK, 2013, HUM REPROD, V28, P777, DOI 10.1093/humrep/des463; Teede HJ, 2011, MED J AUSTRALIA, V195, pS69, DOI 10.5694/mja11.10915	24	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182412	10.1371/journal.pone.0182412	http://dx.doi.org/10.1371/journal.pone.0182412			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771628	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000406853600107
J	Alvarez-Fraga, L; Rumbo-Feal, S; Perez, A; Gomez, MJ; Gayoso, C; Vallejo, JA; Ohneck, EJ; Valle, J; Actis, LA; Beceiro, A; Bou, G; Poza, M				Alvarez-Fraga, Laura; Rumbo-Feal, Soraya; Perez, Astrid; Gomez, Manuel J.; Gayoso, Carmen; Vallejo, Juan A.; Ohneck, Emily J.; Valle, Jaione; Actis, Luis A.; Beceiro, Alejandro; Bou, German; Poza, Margarita			Global assessment of small RNAs reveals a non-coding transcript involved in biofilm formation and attachment in Acinetobacter baumannii ATCC 17978	PLOS ONE			English	Article							SMALL REGULATORY RNAS; GENOME-WIDE IDENTIFICATION; SOLUBLE-RNAS; ABIOTIC SURFACES; LIFE-STYLE; DISCOVERY; PATHOGEN; VIRULENCE; MOTILITY; EXPRESSION	Many strains of Acinetobacter baumannii have been described as being able to form biofilm. Small non-coding RNAs (sRNAs) control gene expression in many regulatory circuits in bacteria. The aim of the present work was to provide a global description of the sRNAs produced both by planktonic and biofilm-associated (sessile) cells of A. baumannii ATCC 17978, and to compare the corresponding gene expression profiles to identify sRNAs molecules associated to biofilm formation and virulence. sRNA was extracted from both planktonic and sessile cells and reverse transcribed. cDNA was subjected to 454-pyrosequencing using the GS-FLX Titanium chemistry. The global analysis of the small RNA transcriptome revealed different sRNA expression patterns in planktonic and biofilm associated cells, with some of the transcripts only expressed or repressed in sessile bacteria. A total of 255 sRNAs were detected, with 185 of them differentially expressed in the different types of cells. A total of 9 sRNAs were expressed only in biofilm cells, while the expression of other 21 coding regions were repressed only in biofilm cells. Strikingly, the expression level of the sRNA 13573 was 120 times higher in biofilms than in planktonic cells, an observation that prompted us to further investigate the biological role of this non-coding transcript. Analyses of an isogenic mutant and over-expressing strains revealed that the sRNA 13573 gene is involved in biofilm formation and attachment to A549 human alveolar epithelial cells. The present work serves as a basis for future studies examining the complex regulatory network that regulate biofilm biogenesis and attachment to eukaryotic cells in A. baumannii ATCC 17978.	[Alvarez-Fraga, Laura; Rumbo-Feal, Soraya; Perez, Astrid; Gayoso, Carmen; Vallejo, Juan A.; Beceiro, Alejandro; Bou, German; Poza, Margarita] Complejo Hosp Univ CHUAC, Inst Invest Biomed INIBIC, Dept Microbiol, La Coruna, Spain; [Perez, Astrid; Ohneck, Emily J.; Actis, Luis A.] Miami Univ, Dept Microbiol, Oxford, OH 45056 USA; [Gomez, Manuel J.] INTA CSIC, Ctr Astrobiol, Dept Mol Evolut, Madrid, Spain; [Gomez, Manuel J.] Ctr Nacl Invest Cardiovasc Carlos III, Madrid, Spain; [Valle, Jaione] Inst Agrobiotecnol, Dept Biofilms Microbianos, Navarra, Spain	Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); University System of Ohio; Miami University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Centro Nacional de Investigaciones Cardiovasculares (CNIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB)	Bou, G; Poza, M (corresponding author), Complejo Hosp Univ CHUAC, Inst Invest Biomed INIBIC, Dept Microbiol, La Coruna, Spain.	german.bou.arevalo@sergas.es; margarita.poza.dominguez@sergas.es	M, Poza/AAA-2962-2021; PEREZ, ASTRID/AAB-2443-2020; jaione, valle/G-6213-2011; Gómez, Manuel J/F-8854-2016; Alvarez-Fraga, Laura/HGB-5957-2022; jaione, valle/N-8005-2019; Vallejo, Juan/B-8302-2012; Bou, German/H-6683-2015	jaione, valle/0000-0003-3115-0207; Gómez, Manuel J/0000-0002-4111-4835; jaione, valle/0000-0003-3115-0207; Beceiro Casas, Alejandro/0000-0002-6340-7815; Vallejo, Juan/0000-0002-7581-8654; Alvarez-Fraga, Laura/0000-0003-3920-5866; Rumbo-Feal, Soraya/0000-0002-1796-1815; Poza, Margarita/0000-0001-9423-7268; Bou, German/0000-0001-8837-0062	ISCIII - General Subdirection of Assessment and Promotion of the Research European Regional Development Fund (FEDER) A way of making Europe; European Development Regional Fund (EDRF) A Way to Achieve Europe [REIPI RD12/0015/0014]; Instituto de Salud Carlos III; Subdireccion General de Redes y Centros de Investigacion Cooperativa; Ministerio de Economia y Competitividad; Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica (SEIMC); Galician Plan for Research, Innovation and Growth (I2C Plan); Sara Borrell Programme (ISCIII, Spain) [CD13/00373]; Agusti Pumarola Grant (Societat Catalana de Malalties Infeccioses i Microbiologia Clinica, SCMIMC);  [PI12/00552];  [PI15/00860];  [PI11/01034];  [CP13/00226];  [P14/000059]	ISCIII - General Subdirection of Assessment and Promotion of the Research European Regional Development Fund (FEDER) A way of making Europe; European Development Regional Fund (EDRF) A Way to Achieve Europe; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Subdireccion General de Redes y Centros de Investigacion Cooperativa; Ministerio de Economia y Competitividad(Spanish Government); Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica (SEIMC); Galician Plan for Research, Innovation and Growth (I2C Plan); Sara Borrell Programme (ISCIII, Spain); Agusti Pumarola Grant (Societat Catalana de Malalties Infeccioses i Microbiologia Clinica, SCMIMC); ; ; ; ; 	This work has been funded by Projects PI12/00552 and PI15/00860 to GB, PI11/01034 to MP, CP13/00226 to AB, and P14/000059 to MP and AB, all integrated in the National Plan for Scientific Research, Development and Technological Innovation 2013-2016 and funded by the ISCIII - General Subdirection of Assessment and Promotion of the Research European Regional Development Fund (FEDER) A way of making Europe. Miami University Research Funds from the department of Microbiology supported this work. We also want to thank the Spanish Network for Research in Infectious Diseases (REIPI RD12/0015/0014 to GB), co-financed by the European Development Regional Fund (EDRF) A Way to Achieve Europe, Instituto de Salud Carlos III, Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Economia y Competitividad as well as Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica (SEIMC). A.P. was financially supported by the Galician Plan for Research, Innovation and Growth (I2C Plan 2012-2016). J.A. Vallejo was financially supported by the Sara Borrell Programme (ISCIII, Spain CD13/00373). S. Rumbo-Feal was financially supported by the Agusti Pumarola Grant (Societat Catalana de Malalties Infeccioses i Microbiologia Clinica, SCMIMC) and Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica (SEIMC).; This work has been funded by Projects PI12/00552 and PI15/00860 to GB, PI11/01034 to MP, CP13/00226 to AB, and P14/000059 to MP and AB, all integrated in the National Plan for Scientific Research, Development and Technological Innovation 2013-2016 and funded by the ISCIII General Subdirection of Assessment and Promotion of the Research European Regional Development Fund (FEDER) "A way of making Europe". Miami University Research Funds from the department of Microbiology supported this work. We also want to thank the Spanish Network for Research in Infectious Diseases (REIPI RD12/0015/0014 to GB), co financed by the European Development Regional Fund (EDRF) "A Way to Achieve Europe, Instituto de Salud Carlos III, Subdireccion General de Redes y Centros de InvestigaciOn Cooperativa, Ministerio de Economia y Competitividad as well as Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica (SEIMC). A.P. was financially supported by the Galician Plan for Research, Innovation and Growth (12C Plan 2012-2016). J.A. Vallejo was financially supported by the Sara Borrell Programme (ISCIII, Spain CD13/00373). S. RumboFeal was financially supported by the Agusti Pumarola Grant (Societat Catalana de Malalties Infeccioses i Microbiologia Clinica, SCMIMC) and Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica (SEIMC). Finally, we thank Chua Kim Lee (University of Singapore) for providing pMo130-Te1<SUP>R</SUP>.	Acosta J, 2011, EMERG INFECT DIS, V17, P1064, DOI [10.3201/eid1706.091866, 10.3201/eid/1706.091866]; Alvarez-Fraga L, 2016, VIRULENCE; Amarasinghe JJ, 2012, MOL ORAL MICROBIOL, V27, P327, DOI 10.1111/j.2041-1014.2012.00645.x; Aranda J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-279; Bak G, 2015, SCI REP-UK, V5, DOI 10.1038/srep15287; Bardill JP, 2012, RNA BIOL, V9, P392, DOI 10.4161/rna.19975; Barquist L, 2015, ANNU REV GENET, V49, P367, DOI 10.1146/annurev-genet-112414-054804; Bou G, 2000, CLIN MICROBIOL INFEC, V6, P635, DOI 10.1046/j.1469-0691.2000.00181.x; Cabral MP, 2011, J PROTEOME RES, V10, P3399, DOI 10.1021/pr101299j; Camarena L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000834; Canle D, 2005, CLIN MICROBIOL INFEC, V11, P540, DOI DOI 10.1111/J.1469-0691.2005.01184.X; Chambers JR, 2013, TRENDS MICROBIOL, V21, P39, DOI 10.1016/j.tim.2012.10.008; Corbella X, 2000, J CLIN MICROBIOL, V38, P4086, DOI 10.1128/JCM.38.11.4086-4095.2000; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; de Breij A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010732; de Celles MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045758; De Lay NR, 2016, CURR OPIN MICROBIOL, V30, P16, DOI 10.1016/j.mib.2015.12.006; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Dotsch A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031092; Eijkelkamp BA, 2011, FEMS MICROBIOL LETT, V323, P44, DOI 10.1111/j.1574-6968.2011.02362.x; Ferrara S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036553; Filiatrault MJ, 2010, J BACTERIOL, V192, P2359, DOI 10.1128/JB.01445-09; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; Gaddy JA, 2009, FUTURE MICROBIOL, V4, P273, DOI 10.2217/FMB.09.5; Ghaz-Jahanian MA, 2013, MOL BIOTECHNOL, V55, P288, DOI 10.1007/s12033-013-9700-6; Gomez-Lozano M, 2015, ENV MICROBIOL REP, V7, P227, DOI 10.1111/1758-2229.12233; Gomez-Lozano M, 2012, ENVIRON MICROBIOL, V14, P2006, DOI 10.1111/j.1462-2920.2012.02759.x; Guillier M, 2006, GENE DEV, V20, P2338, DOI 10.1101/gad.1457506; Hamad MA, 2009, GENE, V430, P123, DOI 10.1016/j.gene.2008.10.011; Higgins PG, 2010, J ANTIMICROB CHEMOTH, V65, P233, DOI 10.1093/jac/dkp428; Holmqvist E, 2010, EMBO J, V29, P1840, DOI 10.1038/emboj.2010.73; Jones Mark E, 2004, Ann Clin Microbiol Antimicrob, V3, P14, DOI 10.1186/1476-0711-3-14; Jorgensen MG, 2012, MOL MICROBIOL, V84, P36, DOI 10.1111/j.1365-2958.2012.07976.x; Khandige S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005109; Khoo JS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S13; Koo JT, 2011, P NATL ACAD SCI USA, V108, pE709, DOI 10.1073/pnas.1101655108; Kwenda S, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2376-0; Lee HW, 2008, CLIN MICROBIOL INFEC, V14, P49, DOI 10.1111/j.1469-0691.2007.01842.x; Lee HJ, 2012, FEMS MICROBIOL LETT, V326, P131, DOI 10.1111/j.1574-6968.2011.02441.x; Liu JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp080; Liu ZY, 2012, MOL MICROBIOL, V86, P140, DOI 10.1111/j.1365-2958.2012.08178.x; Livny J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003197; Loehfelm TW, 2008, J BACTERIOL, V190, P1036, DOI 10.1128/JB.01416-07; Majdalani N, 2002, MOL MICROBIOL, V46, P813, DOI 10.1046/j.1365-2958.2002.03203.x; Marti S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026030; Martinez LC, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00038; McConnell MJ, 2013, FEMS MICROBIOL REV, V37, P130, DOI 10.1111/j.1574-6976.2012.00344.x; Mika F, 2013, INT J MOL SCI, V14, P4560, DOI 10.3390/ijms14034560; Olson PD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001287; Ong CWM, 2009, RESPIROLOGY, V14, P1200, DOI 10.1111/j.1440-1843.2009.01630.x; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Perez A, 2017, VIRULENCE, V8, P959, DOI 10.1080/21505594.2016.1262313; Pitman S, 2015, INT J MOL SCI, V16, P29797, DOI 10.3390/ijms161226194; Raad II, 2011, BIOMATERIALS, V32, P2689, DOI 10.1016/j.biomaterials.2010.12.015; Rodriguez-Bano J, 2008, CLIN MICROBIOL INFEC, V14, P276, DOI 10.1111/j.1469-0691.2007.01916.x; Rumbo-Feal S, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00108; Rumbo-Feal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072968; Schilling D, 2010, ARCH MICROBIOL, V192, P691, DOI 10.1007/s00203-010-0592-6; Sharma R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093833; Shimoni Y, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100181; Sievers S, 2014, NUCLEIC ACIDS RES, V42, P9383, DOI 10.1093/nar/gku630; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Suar M, 2015, VIRULENCE, V6, P105, DOI 10.4161/21505594.2014.988543; Swiercz JP, 2008, NUCLEIC ACIDS RES, V36, P7240, DOI 10.1093/nar/gkn898; Thomason MK, 2012, MOL MICROBIOL, V84, P17, DOI 10.1111/j.1365-2958.2012.07965.x; Tjaden Brian, 2012, Methods Mol Biol, V905, P227, DOI 10.1007/978-1-61779-949-5_14; Tomaras AP, 2008, MICROBIOL-SGM, V154, P3398, DOI 10.1099/mic.0.2008/019471-0; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Tormo MA, 2005, J BACTERIOL, V187, P2348, DOI 10.1128/JB.187.7.2348-2356.2005; Vidal R, 1996, MICROBIOS, V86, P49; Villar M, 2014, MEDICINE, V93, P202, DOI 10.1097/MD.0000000000000036; Vogel J, 2005, BIOL CHEM, V386, P1219, DOI 10.1515/BC.2005.140; Wang LG, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00024; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Weilbacher T, 2003, MOL MICROBIOL, V48, P657, DOI 10.1046/j.1365-2958.2003.03459.x; Weiss A, 2016, MICROB GENOMICS, V2; Wenner N, 2014, ENVIRON MICROBIOL, V16, P1053, DOI 10.1111/1462-2920.12272; Yan YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074495; Yao Z, 2007, PLOS COMPUT BIOL, V3, P1212, DOI 10.1371/journal.pcbi.0030126; Zeng Q, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-414	80	8	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0182084	10.1371/journal.pone.0182084	http://dx.doi.org/10.1371/journal.pone.0182084			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763494	Green Submitted, Green Published, gold			2022-12-26	WOS:000406766500039
J	Kim, G; Kim, KJ; Rhee, Y; Lim, SK				Kim, Gyuri; Kim, Kwang Joon; Rhee, Yumie; Lim, Sung-Kil			Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease	PLOS ONE			English	Article							ATTENUATION PARAMETER CAP; NATIVE KOREAN POPULATION; CHRONIC HEPATITIS-C; STIFFNESS MEASUREMENT; ELDERLY CHINESE; OBESE CHILDREN; VITAMIN-D; OSTEOPOROSIS; CIRRHOSIS; STEATOSIS	Background Metabolic bone disorders frequently occur in patients with chronic liver disease; however, the association between liver fibrosis and bone mineral density in patients with non-alcoholic fatty liver disease (NAFLD) is unclear. Methods This is a cross-sectional analysis of 231 asymptomatic subjects (160 women, 61.6 years old) from a university hospital setting, between February 2012 and December 2014. Bone mineral density (BMD) was measured at the lumbar spine, femur neck, and total hip using dual-energy X-ray absorptiometry (DXA). Liver fibrosis and steatosis were assessed using transient elastography. Results Among a total of 231 individuals, 129 subjects (55.8%) had NAFLD. BMDs at lumbar spine, femur neck, and total hip were significantly lower in patients having NAFLD with significant fibrosis, compared with patients having NAFLD without significant fibrosis (Ps<0.005). In patients with NAFLD, significant liver fibrosis revealed marked negative correlations with BMD at the lumber spine (r = -0.19, P = 0.032), femur neck (r = -0.19, P = 0.034), and total hip (r = -0.21, P = 0.016). A multivariate linear regression analysis revealed that significant liver fibrosis was independently correlated with low BMD at the femur neck (beta = -0.18, P = 0.039) and total hip (beta = -0.21, P = 0.005) after adjustment for age, sex, BMI, fasting plasma glucose, alanine aminotransferase, high-density lipoprotein cholesterol, and liver steatosis among patients with NAFLD. Using multivariable logistic regression, significant liver fibrosis was independently associated with overall osteopenia and osteoporosis in subjects having NAFLD (OR = 4.10, 95% CI = 1.02-16.45). Conclusion The presence of significant liver fibrosis assessed via TE was independently associated with low BMD in NAFLD subjects.	[Kim, Gyuri; Kim, Kwang Joon; Rhee, Yumie; Lim, Sung-Kil] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Gyuri] Sungkyunkwan Univ, Sch Med, Div Endocrinol & Metab, Dept Med,Samsung Med Ctr, Seoul, South Korea	Yonsei University; Yonsei University Health System; Sungkyunkwan University (SKKU); Samsung Medical Center	Lim, SK (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	LSK@yuhs.ac	Rhee, Yumie/L-8020-2019; Kim, Gyuri/E-8992-2018	Rhee, Yumie/0000-0003-4227-5638; Kim, Gyuri/0000-0002-2242-2816				Arena U, 2008, GUT, V57, P1288, DOI 10.1136/gut.2008.149708; Arteh J, 2010, DIGEST DIS SCI, V55, P2624, DOI 10.1007/s10620-009-1069-9; Bertola A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013577; Bhatt SP, 2013, ATHEROSCLEROSIS, V230, P157, DOI 10.1016/j.atherosclerosis.2013.07.006; Binkley N, 2005, J BONE MINER RES, V20, P195, DOI 10.1359/JBMR.041115; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chang EJ, 2015, J KOREAN MED SCI, V30, P1821, DOI 10.3346/jkms.2015.30.12.1821; Chon YE, 2014, LIVER INT, V34, P102, DOI 10.1111/liv.12282; Clement S, 2008, HEPATOLOGY, V48, P799, DOI 10.1002/hep.22404; Cui R, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/396545; Culafic D, 2015, OSTEOPOROSIS INT, V26, P253, DOI 10.1007/s00198-014-2849-4; de Ledinghen V, 2014, J HEPATOL, V60, P1026, DOI 10.1016/j.jhep.2013.12.018; de Ledinghen V, 2012, LIVER INT, V32, P911, DOI 10.1111/j.1478-3231.2012.02820.x; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Fukuyama N, 2008, J CLIN BIOCHEM NUTR, V43, P1, DOI 10.3164/jcbn.2008036; Gallego-Rojo FJ, 1998, HEPATOLOGY, V28, P695, DOI 10.1002/hep.510280315; Gatta A, 2014, CLIN CASES MINER BON, V11, P185, DOI 10.11138/ccmbm/2014.11.3.185; Gaudio A, 2005, J ENDOCRINOL INVEST, V28, P677, DOI 10.1007/BF03347549; Giouleme OI, 2006, HEPATO-GASTROENTEROL, V53, P938; Goral V, 2010, WORLD J GASTROENTERO, V16, P1639, DOI 10.3748/wjg.v16.i13.1639; Hajiabbasi A, 2015, HEPAT MON, V15, DOI 10.5812/hepatmon.15(4)2015.26871; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Kanis JA, 2008, BONE, V42, P467, DOI 10.1016/j.bone.2007.11.001; Karlas T, 2017, J HEPATOL, V66, P1022, DOI 10.1016/j.jhep.2016.12.022; Keogh JB, 1999, NUTRITION, V15, P661, DOI 10.1016/S0899-9007(99)00121-5; Kim BK, 2012, J GASTROEN HEPATOL, V27, P781, DOI 10.1111/j.1440-1746.2011.06962.x; Kim SY, 2013, ENDOCRINOL METAB, V28, P280, DOI 10.3803/EnM.2013.28.4.280; Kim SU, 2009, J CLIN GASTROENTEROL, V43, P267, DOI 10.1097/MCG.0b013e31816f212e; Kim W, 2014, DIABETES METAB J, V38, P456, DOI 10.4093/dmj.2014.38.6.456; Larter CZ, 2010, J GASTROEN HEPATOL, V25, P672, DOI 10.1111/j.1440-1746.2010.06253.x; Li M, 2012, J CLIN ENDOCR METAB, V97, P2033, DOI 10.1210/jc.2011-3010; Lupoli R, 2015, CLIN ENDOCRINOL; Moon SS, 2012, ENDOCRINE, V42, P423, DOI 10.1007/s12020-012-9639-6; Musso G, 2016, NAT REV DRUG DISCOV, V15, P249, DOI 10.1038/nrd.2015.3; Nakchbandi IA, 2014, WORLD J GASTROENTERO, V20, P9427, DOI 10.3748/wjg.v20.i28.9427; Nakchbandi IA, 2009, NAT REV GASTRO HEPAT, V6, P660, DOI 10.1038/nrgastro.2009.166; Nascimbeni F, 2015, CLIN GASTROENTEROL H, V13, P763, DOI 10.1016/j.cgh.2014.07.037; Pacifico L, 2013, WORLD J GASTROENTERO, V19, P4007, DOI 10.3748/wjg.v19.i25.4007; Pardee PE, 2012, ALIMENT PHARM THER, V35, P248, DOI 10.1111/j.1365-2036.2011.04924.x; PERAZZO H, 2015, INT J HEPATOL, V2015, DOI DOI 10.1155/2015/624596; Perazzo H, 2015, LIVER INT, V35, P1533, DOI 10.1111/liv.12551; Petta S, 2017, HEPATOLOGY, V65, P1145, DOI 10.1002/hep.28843; Pirgon O, 2011, CLIN ENDOCRINOL, V75, P189, DOI 10.1111/j.1365-2265.2011.04038.x; Povero D, 2016, DIABETES METAB J, V40, P1, DOI 10.4093/dmj.2016.40.1.1; Purnak T, 2012, WIEN KLIN WOCHENSCHR, V124, P526, DOI 10.1007/s00508-012-0211-4; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Sasso M, 2012, CLIN RES HEPATOL GAS, V36, P13, DOI 10.1016/j.clinre.2011.08.001; Seo YS, 2015, LIVER INT; Talwalkar JA, 2007, CLIN GASTROENTEROL H, V5, P1214, DOI 10.1016/j.cgh.2007.07.020; Targher G, 2015, J ENDOCRINOL INVEST, V38, P817, DOI 10.1007/s40618-015-0315-6; Xia MF, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0766-3; Yadav A, 2013, NUTR CLIN PRACT, V28, P52, DOI 10.1177/0884533612470145; Yang HJ, 2016, EUR J GASTROEN HEPAT, V28, P338, DOI 10.1097/MEG.0000000000000535; You SC, 2015, J GASTROEN HEPATOL, V30, P1536, DOI 10.1111/jgh.12992; You SC, 2015, WORLD J GASTROENTERO, V21, P1158, DOI 10.3748/wjg.v21.i4.1158; Younossi ZM, 2011, HEPATOLOGY, V53, P1874, DOI 10.1002/hep.24268	57	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0182202	10.1371/journal.pone.0182202	http://dx.doi.org/10.1371/journal.pone.0182202			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759632	Green Submitted, Green Published, gold			2022-12-26	WOS:000406761600063
J	Sliwowski, R; Grygorowicz, M; Hojszyk, R; Jadczak, L				Sliwowski, Robert; Grygorowicz, Monika; Hojszyk, Radoslaw; Jadczak, Lukasz			The isokinetic strength profile of elite soccer players according to playing position	PLOS ONE			English	Article							MUSCLE STRENGTH; HAMSTRING STRAINS; QUADRICEPS; INJURY; FATIGUE; LEG; RELIABILITY; IMBALANCES; PREVENTION; ASYMMETRY	The aim of this study was to compare isokinetic strength performance profiles in elite soccer players across different field positions. A total of 111 elite international players of Polish Ekstraklasa (the top division in Poland) were examined during the 2010-2015 seasons. The players were classified into six positional roles: central defenders (CD), external defenders (ED), central midfielders (CM), external midfielders (EM), forwards (F), and goalkeepers (G). The concentric isokinetic strength (peak torque [PT] of quadriceps and hamstrings, H/Q ratios) was calculated for the dominant leg and the non-dominant leg at angular velocity of 1.05 rad.s(-1), whereas to assess isokinetic muscle endurance, the total work [TW] at angular velocity of 4.19 rad.s(-1), was taken into consideration. The results showed that isokinetic strength performance varies significantly among players in different playing positions. The analysis of PT for quadriceps (PT-Q) and hamstrings (PT-H) generally showed that the goalkeepers and central midfielders had lower strength levels compared to other playing positions. In the case of PT-H and hamstring/quadricep (H/Q) peak torque ratios, statistically significant differences were also noted for the legs, where mean values noted for the dominant leg were higher than for the non-dominant leg. For TW for quadriceps (TW-Q) and hamstrings (TW-H), statistically significant differences were noted only between playing positions. TW-Q values for goalkeepers were lower than for central defenders and external midfielders. TW-H values for goalkeepers were lower than for central midfielders, central defenders and external midfielders. This study showed that specific functional activity of players in individual positions on the field influences the varied profile of isokinetic strength performance.	[Sliwowski, Robert; Jadczak, Lukasz] Univ Sch Phys Educ Poznan, Dept Team Sports Games, Poznan, Poland; [Grygorowicz, Monika; Hojszyk, Radoslaw] Rehasport Clin FIFA Med Ctr Excellence, Dept Physiotherapy, Poznan, Poland		Sliwowski, R (corresponding author), Univ Sch Phys Educ Poznan, Dept Team Sports Games, Poznan, Poland.	robertsliwowski@wp.pl	Grygorowicz, Monika Małgorzata/A-1357-2012; Grygorowicz, Monika/GWU-5803-2022	Grygorowicz, Monika Małgorzata/0000-0002-9575-2074; Grygorowicz, Monika/0000-0002-9575-2074; Sliwowski, Robert/0000-0002-6689-9536; Jadczak, Lukasz/0000-0001-5418-7454				Aagaard P, 1998, AM J SPORT MED, V26, P231, DOI 10.1177/03635465980260021201; Amaral GM, 2014, BRAZ J PHYS THER, V18, P521, DOI 10.1590/bjpt-rbf.2014.0047; Andrade MD, 2012, J SPORT SCI, V30, P547, DOI 10.1080/02640414.2011.644249; Arnason A, 2008, SCAND J MED SCI SPOR, V18, P40, DOI 10.1111/j.1600-0838.2006.00634.x; Bogdanis GC, 2016, INT J SPORTS MED, V37, P119, DOI 10.1055/s-0035-1559686; Bosquet L, 2010, INT J SPORTS MED, V31, P82, DOI 10.1055/s-0029-1243168; Bradley PS, 2009, J SPORT SCI, V27, P159, DOI 10.1080/02640410802512775; Carling C, 2010, J SPORT SCI, V28, P319, DOI 10.1080/02640410903473851; Carvalho P., 2007, REV PORTUGUESA FISIO, V1, P4; Cometti G, 2001, INT J SPORTS MED, V22, P45, DOI 10.1055/s-2001-11331; Croisier JL, 2008, AM J SPORT MED, V36, P1469, DOI 10.1177/0363546508316764; Daneshjoo A, 2013, J HUM KINET, V39, P115, DOI 10.2478/hukin-2013-0074; Daneshjoo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050979; Dauty M, 2003, ISOKINET EXERC SCI, V11, P139; Camarda SRD, 2012, J SCI MED SPORT, V15, P355, DOI 10.1016/j.jsams.2011.11.257; Di Salvo V, 2007, INT J SPORTS MED, V28, P222, DOI 10.1055/s-2006-924294; English R, 2006, J SPORT REHABIL, V15, P95, DOI 10.1123/jsr.15.2.95; Forbes H, 2009, INT J SPORTS MED, V30, P592, DOI 10.1055/s-0029-1202817; Fousekis K, 2011, BRIT J SPORT MED, V45, P709, DOI 10.1136/bjsm.2010.077560; Fousekis K, 2010, J SPORT SCI MED, V9, P364; Goulart L. F., 2007, REV BRAS CINEANTROPO, V9, P165, DOI [10.1590/%25x, DOI 10.1590/%25X]; Greco CC, 2013, CLIN PHYSIOL FUNCT I, V33, P18, DOI 10.1111/j.1475-097X.2012.01160.x; Houweling TAW, 2009, ISOKINET EXERC SCI, V17, P213, DOI 10.3233/IES-2009-0356; Iga J, 2009, SCAND J MED SCI SPOR, V19, P714, DOI 10.1111/j.1600-0838.2008.00822.x; Jenkins NDM, 2013, J SPORT SCI, V31, P612, DOI 10.1080/02640414.2012.742958; Lehance C, 2009, SCAND J MED SCI SPOR, V19, P243, DOI 10.1111/j.1600-0838.2008.00780.x; Lehnert M, 2014, J HUM KINET, V42, P175, DOI 10.2478/hukin-2014-0072; Magalhaes J, 2004, J SPORT MED PHYS FIT, V44, P119; Manou V, 2002, ISOKINET EXERC SCI, V10, P177, DOI 10.3233/IES-2002-0101; MCLEAN BD, 1993, BRIT J SPORT MED, V27, P260, DOI 10.1136/bjsm.27.4.260; MOGNONI P, 1994, J SPORT MED PHYS FIT, V34, P357; MONTGOMERY L C, 1989, Journal of Orthopaedic and Sports Physical Therapy, V10, P315; OBERG B, 1984, INT J SPORTS MED, V5, P213, DOI 10.1055/s-2008-1025908; Rahnama N, 2005, ERGONOMICS, V48, P1568, DOI 10.1080/00140130500101585; Reilly T, 2000, J SPORT SCI, V18, P695, DOI 10.1080/02640410050120050; Ruas CV, 2015, J STRENGTH COND RES, V29, P1220, DOI 10.1519/JSC.0000000000000766; Sliwowski R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144021; Tourny-Chollet C, 2000, ISOKINET EXERC SCI, V8, P187, DOI 10.3233/IES-2000-0050; Weber FS, 2010, REV BRAS MED ESPORTE, V16, P264, DOI 10.1590/S1517-86922010000400006	39	18	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0182177	10.1371/journal.pone.0182177	http://dx.doi.org/10.1371/journal.pone.0182177			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759603	Green Published, gold, Green Submitted			2022-12-26	WOS:000406761600061
J	Hines, HM; Witkowski, P; Wilson, JS; Wakamatsu, K				Hines, Heather M.; Witkowski, Paige; Wilson, Joseph S.; Wakamatsu, Kazumasa			Melanic variation underlies aposematic color variation in two hymenopteran mimicry systems	PLOS ONE			English	Article							AMERICAN VELVET ANTS; OXIDATIVE STRESS; MIMETIC RADIATION; CHEMICAL-ANALYSIS; PHEOMELANIN; EUMELANIN; EVOLUTION; HAIR; IDENTIFICATION; ADAPTATION	The stinging hymenopteran velvet ants (Mutillidae) and bumble bees (Apidae: Bombus spp.) have both undergone extensive diversification in aposematic color patterns, including yellow-red hues and contrasting dark-light body coloration, as a result of Mullerian mimicry. Understanding the genetic and developmental mechanisms underlying shifts in these mimetic colors requires characterization of their pigmentation. In this study, a combination of solubility, spectrophotometry, and melanin degradation analysis are applied to several color forms and species of these lineages to determine that orange-red colors in both lineages are comprised of primarily dopamine-derived pheomelanins. Until a few recent studies, pheomelanins were thought not to occur in insects. These results support their potential to occur across insects and particularly among the Hymenoptera. Shifts between black and orange-red colors, such as between mimetic color forms of bumble bee Bombus melanopygus, are inferred to involve modification of the ratios of dark eumelanins to red pheomelanins, thus implicating the melanin pathway in mimetic diversification. This discovery highlights the need to focus on how pheomelanins are synthesized in the insect melanin pathway and the potential for new pigments to be found even in some of our most wellk-nown insect systems.	[Hines, Heather M.; Witkowski, Paige] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Wilson, Joseph S.] Utah State Univ, Dept Biol, Tooele, UT USA; [Wakamatsu, Kazumasa] Fujita Hlth Univ, Dept Chem, Sch Hlth Sci, Toyoake, Aichi, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Fujita Health University	Hines, HM (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	hmh19@psu.edu	Wakamatsu, Kazumasa/AAZ-5877-2020	Wakamatsu, Kazumasa/0000-0003-1748-9001	National Science Foundation Division of Environmental Biology CAREER grant [1453473]; Japan Society for the Promotion of Science (JSPS) [15K09794]	National Science Foundation Division of Environmental Biology CAREER grant; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This project was funded by a National Science Foundation Division of Environmental Biology CAREER grant to H. Hines (#1453473) and by a Japan Society for the Promotion of Science (JSPS) grant to K. Wakamatsu (No. 15K09794). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	d'Ischia M, 2013, PIGM CELL MELANOMA R, V26, P616, DOI 10.1111/pcmr.12121; Duennes MA, 2012, MOL PHYLOGENET EVOL, V64, P219, DOI 10.1016/j.ympev.2012.03.018; Franklin H.J, 1912, T AM ENTOMOL SOC, V38, P177; Galvan I, 2015, PIGM CELL MELANOMA R, V28, P599, DOI 10.1111/pcmr.12397; Galvan I, 2015, PHYSIOL BIOCHEM ZOOL, V88, P352, DOI 10.1086/680362; Galvan I, 2014, FUNCT ECOL, V28, P1387, DOI 10.1111/1365-2435.12283; Galvan I, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12140; Galvan I, 2011, OECOLOGIA, V165, P827, DOI 10.1007/s00442-010-1860-5; Hines HM, 2008, THESIS; Ito S, 1998, PIGM CELL RES, V11, P120, DOI 10.1111/j.1600-0749.1998.tb00721.x; Ito S, 2003, PIGM CELL RES, V16, P523, DOI 10.1034/j.1600-0749.2003.00072.x; ITO S, 1986, J CHROMATOGR, V375, P134, DOI 10.1016/S0378-4347(00)83700-7; Ito S, 2011, PIGM CELL MELANOMA R, V24, P605, DOI 10.1111/j.1755-148X.2011.00864.x; Garcia AJ, 2016, ARTHROPOD STRUCT DEV, V45, P311, DOI 10.1016/j.asd.2016.05.001; Kayser H., 1985, P367; Koch J., 2015, THESIS; Marek PE, 2009, P NATL ACAD SCI USA, V106, P9755, DOI 10.1073/pnas.0810408106; Napolitano A, 2014, PIGM CELL MELANOMA R, V27, P721, DOI 10.1111/pcmr.12262; Ozeki H, 1996, PIGM CELL RES, V9, P265, DOI 10.1111/j.1600-0749.1996.tb00116.x; Rapti Z, 2014, BIOL J LINN SOC, V113, P384, DOI 10.1111/bij.12356; Rodriguez J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112942; Roulin A, 2011, J EVOLUTION BIOL, V24, P2241, DOI 10.1111/j.1420-9101.2011.02353.x; Sanders KL, 2006, P ROY SOC B-BIOL SCI, V273, P1135, DOI 10.1098/rspb.2005.3418; Schmidt J.O., 1990, P387; SCHMIDT JO, 1984, ARCH INSECT BIOCHEM, V1, P155, DOI 10.1002/arch.940010205; SHEPPARD PM, 1985, PHILOS T R SOC B, V308, P433, DOI 10.1098/rstb.1985.0066; STARR CK, 1985, J ENTOMOL SCI, V20, P225, DOI 10.18474/0749-8004-20.2.225; Sugumaran H, 2002, PIGM CELL RES, V15, P2, DOI 10.1034/j.1600-0749.2002.00056.x; Symula R, 2001, P ROY SOC B-BIOL SCI, V268, P2415, DOI 10.1098/rspb.2001.1812; TURNER JRG, 1981, ANNU REV ECOL SYST, V12, P99, DOI 10.1146/annurev.es.12.110181.000531; Wakamatsu K, 2002, PIGM CELL RES, V15, P174, DOI 10.1034/j.1600-0749.2002.02017.x; Wakamatsu K, 2003, J NEUROCHEM, V86, P1015, DOI 10.1046/j.1471-4159.2003.01917.x; Wakamatsu K, 2002, PIGM CELL RES, V15, P225, DOI 10.1034/j.1600-0749.2002.02009.x; Wakamatsu K, 2009, PIGM CELL MELANOMA R, V22, P474, DOI 10.1111/j.1755-148X.2009.00580.x; Williams P, 2007, BIOL J LINN SOC, V92, P97, DOI 10.1111/j.1095-8312.2007.00878.x; Wilson JS, 2015, CURR BIOL, V25, pR704, DOI 10.1016/j.cub.2015.06.053; Wilson JS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2275	37	17	17	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0182135	10.1371/journal.pone.0182135	http://dx.doi.org/10.1371/journal.pone.0182135			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753659	gold, Green Published, Green Submitted			2022-12-26	WOS:000406579300050
J	Krieger, B; Qiao, M; Rousso, DL; Sanes, JR; Meister, M				Krieger, Brenna; Qiao, Mu; Rousso, David L.; Sanes, Joshua R.; Meister, Markus			Four alpha ganglion cell types in mouse retina: Function, structure, and molecular signatures	PLOS ONE			English	Article							TRANSCRIPTION FACTORS BRN3A; CAT RETINA; MAMMALIAN RETINAE; RECEPTIVE-FIELD; TRANSGENIC MICE; BRISK; IDENTIFICATION; EXCITATION; EXPRESSION; PATTERNS	The retina communicates with the brain using >= 30 parallel channels, each carried by axons of distinct types of retinal ganglion cells. In every mammalian retina one finds so-called "alpha" ganglion cells (alpha RGCs), identified by their large cell bodies, stout axons, wide and mono-stratified dendritic fields, and high levels of neurofilament protein. In the mouse, three alpha RGC types have been described based on responses to light steps: On-sustained, Off-sustained, and Off-transient. Here we employed a transgenic mouse line that labels alpha RGCs in the live retina, allowing systematic targeted recordings. We characterize the three known types and identify a fourth, with On-transient responses. All four alpha RGC types share basic aspects of visual signaling, including a large receptive field center, a weak antagonistic surround, and absence of any direction selectivity. They also share a distinctive waveform of the action potential, faster than that of other RGC types. Morphologically, they differ in the level of dendritic stratification within the IPL, which accounts for their response properties. Molecularly, each type has a distinct signature. A comparison across mammals suggests a common theme, in which four large-bodied ganglion cell types split the visual signal into four channels arranged symmetrically with respect to polarity and kinetics.	[Krieger, Brenna] Harvard Med Sch, Harvard Biophys Program, Boston, MA USA; [Qiao, Mu; Rousso, David L.; Sanes, Joshua R.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Qiao, Mu; Rousso, David L.; Sanes, Joshua R.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Meister, Markus] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; California Institute of Technology	Sanes, JR (corresponding author), Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA.; Sanes, JR (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.; Meister, M (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	sanesj@mcb.harvard.edu; meister@caltech.edu	Qiao, Mu/V-1213-2018	Qiao, Mu/0000-0001-7309-4237; Meister, Markus/0000-0003-2136-6506	NIH [1U01NS090562, NS029169, EY022073, EY025119]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS029169] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by NIH grants 1U01NS090562 to M.M., NS029169 and EY022073 to J.R.S, and EY025119 to D.L.R.	Badea TC, 2009, NEURON, V61, P852, DOI 10.1016/j.neuron.2009.01.020; Badea TC, 2011, VISION RES, V51, P269, DOI 10.1016/j.visres.2010.08.039; Baden T, 2016, NATURE, V529, P345, DOI 10.1038/nature16468; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Berson D., 2008, SENSES COMPREHENSIVE, P491, DOI DOI 10.1016/B978-012370880-9.00280-2; Berson DM, 1998, J COMP NEUROL, V399, P269, DOI 10.1002/(SICI)1096-9861(19980921)399:2<269::AID-CNE9>3.0.CO;2-Z; Bleckert A, 2014, CURR BIOL, V24, P310, DOI 10.1016/j.cub.2013.12.020; BOYCOTT BB, 1974, J PHYSIOL-LONDON, V240, P397, DOI 10.1113/jphysiol.1974.sp010616; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; CLELAND BG, 1975, J PHYSIOL-LONDON, V248, P151, DOI 10.1113/jphysiol.1975.sp010967; CLELAND BG, 1974, J PHYSIOL-LONDON, V240, P421, DOI 10.1113/jphysiol.1974.sp010617; Coombs J, 2006, NEUROSCIENCE, V140, P123, DOI 10.1016/j.neuroscience.2006.02.079; Della Santina L, 2016, CURR BIOL, V26, P2070, DOI 10.1016/j.cub.2016.06.016; Demb JB, 2001, J NEUROSCI, V21, P7447, DOI 10.1523/JNEUROSCI.21-19-07447.2001; Dhande OS, 2014, CURR OPIN NEUROBIOL, V24, P133, DOI 10.1016/j.conb.2013.08.006; Duan X, 2015, NEURON, V85, P1244, DOI 10.1016/j.neuron.2015.02.017; Duan X, 2014, CELL, V158, P793, DOI 10.1016/j.cell.2014.06.047; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; Estevez ME, 2012, J NEUROSCI, V32, P13608, DOI 10.1523/JNEUROSCI.1422-12.2012; Euler T, 2014, NAT REV NEUROSCI, V15, P507, DOI 10.1038/nrn3783; Famiglietti EV, 2004, J COMP NEUROL, V478, P323, DOI 10.1002/cne.20268; Farrow K, 2013, NEURON, V78, P325, DOI 10.1016/j.neuron.2013.02.014; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Kahles F, 2014, MOL METAB, V3, P384, DOI 10.1016/j.molmet.2014.03.004; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Kim IJ, 2010, J NEUROSCI, V30, P1452, DOI 10.1523/JNEUROSCI.4779-09.2010; Krishnaswamy A, 2015, NATURE, V524, P466, DOI 10.1038/nature14682; Lee MK, 1996, ANNU REV NEUROSCI, V19, P187, DOI 10.1146/annurev.ne.19.030196.001155; Lin B, 2004, NEURON, V43, P475, DOI 10.1016/j.neuron.2004.08.002; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Manookin MB, 2008, J NEUROSCI, V28, P4136, DOI 10.1523/JNEUROSCI.4274-07.2008; Muller D, 2014, SCIENCE, V343, P1264, DOI 10.1126/science.1246448; Munch TA, 2009, NAT NEUROSCI, V12, P1308, DOI 10.1038/nn.2389; MUMA NA, 1991, J NEUROCYTOL, V20, P844, DOI 10.1007/BF01191735; Pang JJ, 2003, J NEUROSCI, V23, P6063, DOI 10.1523/JNEUROSCI.23-14-06063.2003; PASTEELS B, 1990, VISUAL NEUROSCI, V5, P1, DOI 10.1017/S0952523800000031; PEICHL L, 1991, VISUAL NEUROSCI, V7, P155, DOI 10.1017/S0952523800011020; PEICHL L, 1981, PROC R SOC SER B-BIO, V212, P139, DOI 10.1098/rspb.1981.0030; PEICHL L, 1989, J COMP NEUROL, V286, P120, DOI 10.1002/cne.902860108; PEICHL L, 1987, PROC R SOC SER B-BIO, V231, P169, DOI 10.1098/rspb.1987.0040; Reese BE, 2015, BIOL REV, V90, P854, DOI 10.1111/brv.12139; RODIECK RW, 1991, VISUAL NEUROSCI, V6, P95, DOI 10.1017/S095252380001049X; Roska B, 2014, NEW VISUAL NEUROSCIENCES, P163; Roska B, 2006, J NEUROPHYSIOL, V95, P3810, DOI 10.1152/jn.00113.2006; Rousso DL, 2016, CELL REP, V15, P1930, DOI 10.1016/j.celrep.2016.04.069; Samuel MA, 2011, J NEUROSCI, V31, P16033, DOI 10.1523/JNEUROSCI.3580-11.2011; Sanes JR, 2015, ANNU REV NEUROSCI, V38, P221, DOI 10.1146/annurev-neuro-071714-034120; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Schwartz GW, 2012, NAT NEUROSCI, V15, P1572, DOI 10.1038/nn.3225; Siegert S, 2009, NAT NEUROSCI, V12, P1197, DOI 10.1038/nn.2370; Sumbul U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4512; Trenholm S, 2013, J NEUROSCI, V33, P14927, DOI 10.1523/JNEUROSCI.0808-13.2013; Van Wyk M, 2009, VISUAL NEUROSCI, V26, P297, DOI 10.1017/S0952523809990137; WASSLE H, 1981, PROC R SOC SER B-BIO, V212, P177, DOI 10.1098/rspb.1981.0033; Yi CW, 2012, ACTA HISTOCHEM CYTOC, V45, P201, DOI 10.1267/ahc.11061; Zhang YF, 2012, P NATL ACAD SCI USA, V109, pE2391, DOI 10.1073/pnas.1211547109	60	102	104	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0180091	10.1371/journal.pone.0180091	http://dx.doi.org/10.1371/journal.pone.0180091			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753612	Green Accepted, Green Published, gold			2022-12-26	WOS:000406579300003
J	Pearre, B; Perkins, LN; Markowitz, JE; Gardner, TJ				Pearre, Ben; Perkins, L. Nathan; Markowitz, Jeffrey E.; Gardner, Timothy J.			A fast and accurate zebra finch syllable detector	PLOS ONE			English	Article							GANGLIA-FOREBRAIN CIRCUIT; AUDITORY-FEEDBACK; ADULT BIRDSONG; SONGBIRD	The song of the adult male zebra finch is strikingly stereotyped. Efforts to understand motor output, pattern generation, and learning have taken advantage of this consistency by investigating the bird's ability to modify specific parts of song under external cues, and by examining timing relationships between neural activity and vocal output. Such experiments require that precise moments during song be identified in real time as the bird sings. Various syllable-detection methods exist, but many require special hardware, software, and know-how, and details on their implementation and performance are scarce. We present an accurate, versatile, and fast syllable detector that can control hardware at precisely timed moments during zebra finch song. Many moments during song can be isolated and detected with false negative and false positive rates well under 1% and 0.005% respectively. The detector can run on a stock Mac Mini with triggering delay of less than a millisecond and a jitter of sigma approximate to 2 milliseconds.	[Pearre, Ben; Perkins, L. Nathan; Gardner, Timothy J.] Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA; [Markowitz, Jeffrey E.] Harvard Med Sch, Dept Neurobiol, Boston, MA USA	Boston University; Harvard University; Harvard Medical School	Pearre, B (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	bwpearre@bu.edu	Markowitz, Jeffrey/GQP-3708-2022	Pearre, Benjamin W/0000-0001-9854-7183	NIH [5R01NS089679-02, 5U01NS090454-02]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089679] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by NIH grants 5R01NS089679-02 and 5U01NS090454-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andalman AS, 2009, P NATL ACAD SCI USA, V106, P12518, DOI 10.1073/pnas.0903214106; Canopoli A, 2014, J NEUROSCI, V34, P7018, DOI 10.1523/JNEUROSCI.0266-14.2014; Charlesworth JD, 2011, NAT NEUROSCI, V14, P373, DOI 10.1038/nn.2748; Hertz JA, 1991, THEORY NEURAL COMPUT; Jacobsen E, 2003, IEEE SIGNAL PROC MAG, V20, P74, DOI 10.1109/MSP.2003.1184347; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Keller GB, 2009, NATURE, V457, P187, DOI 10.1038/nature07467; Leonardo A, 1999, NATURE, V399, P466, DOI 10.1038/20933; Noll AM, 1970, P S COMP PROC COMM, V19, P779; Poole B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038173; Skocik M, 2013, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00111; Tchernichovski O., 2011, SOUND ANAL PROUSER M; Tumer EC, 2007, NATURE, V450, P1240, DOI 10.1038/nature06390; Wang CZH, 2008, PLOS BIOL, V6, P2154, DOI 10.1371/journal.pbio.0060250; Warren TL, 2011, J NEUROPHYSIOL, V106, P1806, DOI 10.1152/jn.00311.2011	15	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0181992	10.1371/journal.pone.0181992	http://dx.doi.org/10.1371/journal.pone.0181992			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753628	Green Published, Green Submitted, gold			2022-12-26	WOS:000406579300038
J	Foti, A; Dorendorf, F; Leimkuhler, S				Foti, Alessandro; Dorendorf, Frank; Leimkuehler, Silke			A single nucleotide polymorphism causes enhanced radical oxygen species production by human aldehyde oxidase	PLOS ONE			English	Article							XANTHINE-OXIDASE; SUPEROXIDE-PRODUCTION; NADH OXIDASE; ACTIVE-SITE; LIVER; OXIDOREDUCTASE; EXPRESSION; OXIDATION; BINDING	Aldehyde oxidases (AOXs) are molybdo-flavoenzymes characterized by broad substrate specificity, oxidizing aromatic/aliphatic aldehydes into the corresponding carboxylic acids and hydroxylating various heteroaromatic rings. The enzymes use oxygen as the terminal electron acceptor and produce reduced oxygen species during turnover. The physiological function of mammalian AOX isoenzymes is still unclear, however, human AOX (hAOX1) is an emerging enzyme in phase-I drug metabolism. Indeed, the number of xenobiotics acting as hAOX1 substrates is increasing. Further, numerous single-nucleotide polymorphisms (SNPs) have been identified within the hAOX1 gene. SNPs are a major source of inter-individual variability in the human population, and SNP-based amino acid exchanges in hAOX1 reportedly modulate the catalytic function of the enzyme in either a positive or negative fashion. In this report we selected ten novel SNPs resulting in amino acid exchanges in proximity to the FAD site of hAOX1 and characterized the purified enzymes after heterologous expression in Escherichia coli. The hAOX1 variants were characterized carefully by quantitative differences in their ability to produce superoxide radical. ROS represent prominent key molecules in physiological and pathological conditions in the cell. Our data reveal significant alterations in superoxide anion production among the variants. In particular the SNP-based amino acid exchange L438V in proximity to the isoalloxanzine ring of the FAD cofactor resulted in increased rate of superoxide radical production of 75%. Considering the high toxicity of the superoxide in the cell, the hAOX1-L438V SNP variant is an eventual candidate for critical or pathological roles of this natural variant within the human population.	[Foti, Alessandro; Dorendorf, Frank; Leimkuehler, Silke] Univ Potsdam, Inst Biochem & Biol, Dept Mol Enzymol, Potsdam, Germany	University of Potsdam	Leimkuhler, S (corresponding author), Univ Potsdam, Inst Biochem & Biol, Dept Mol Enzymol, Potsdam, Germany.	sleim@uni-potsdam.de		Leimkuhler, Silke/0000-0003-3238-2122	Deutsche Forschungsgemeinschaft [Le1171/8]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft, Grant #Le1171/8. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai R, 2007, J BIOCHEM, V141, P525, DOI 10.1093/jb/mvm054; Beedham C, 1997, PHARM WORLD SCI, V19, P255, DOI 10.1023/A:1008668913093; Bendotti C, 1997, NEUROREPORT, V8, P2343, DOI 10.1097/00001756-199707070-00048; BRANZOLI U, 1974, J BIOL CHEM, V249, P4339; Chakraborty S, 2002, J BIOL CHEM, V277, P41507, DOI 10.1074/jbc.M205432200; Choughule KV, 2015, BIOCHEM PHARMACOL, V96, P288, DOI 10.1016/j.bcp.2015.05.010; Coelho C, 2015, NAT CHEM BIOL, V11, P779, DOI [10.1038/NCHEMBIO.1895, 10.1038/nchembio.1895]; Foti A, 2016, DRUG METAB DISPOS, V44, P1277, DOI 10.1124/dmd.115.068395; Garattini E, 2008, CELL MOL LIFE SCI, V65, P1019, DOI 10.1007/s00018-007-7398-y; HARKNESS RA, 1986, J INHERIT METAB DIS, V9, P407, DOI 10.1007/BF01800499; Harris CM, 1997, J BIOL CHEM, V272, P8370, DOI 10.1074/jbc.272.13.8370; Hartmann T, 2012, DRUG METAB DISPOS, V40, P856, DOI 10.1124/dmd.111.043828; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Ishikita H, 2012, J AM CHEM SOC, V134, P999, DOI 10.1021/ja207173p; JOHNS DG, 1967, J CLIN INVEST, V46, P1492, DOI 10.1172/JCI105641; Kitamura S, 2014, XENOBIOTICA, V44, P123, DOI 10.3109/00498254.2013.868062; KRENITSKY TA, 1972, ARCH BIOCHEM BIOPHYS, V150, P585, DOI 10.1016/0003-9861(72)90078-1; Kundu TK, 2012, BIOCHEMISTRY-US, V51, P2930, DOI 10.1021/bi3000879; Kundu TK, 2007, ARCH BIOCHEM BIOPHYS, V460, P113, DOI 10.1016/j.abb.2006.12.032; Maia L, 2007, J BIOL INORG CHEM, V12, P777, DOI 10.1007/s00775-007-0229-7; MASSEY V, 1959, BIOCHIM BIOPHYS ACTA, V34, P255, DOI 10.1016/0006-3002(59)90259-8; Masuoka N, 2016, INT J FOOD SCI NUTR, V67, P283, DOI 10.3109/09637486.2016.1153609; Palmer T, 1996, MOL MICROBIOL, V20, P875, DOI 10.1111/j.1365-2958.1996.tb02525.x; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Srivastava S, 2017, PLANT PHYSIOL, V173, P1977, DOI 10.1104/pp.16.01939; Tayama Y, 2012, DRUG METAB PHARMACOK, V27, P543, DOI 10.2133/dmpk.DMPK-11-NT-124; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Yamaguchi Y, 2007, J BIOCHEM, V141, P513, DOI 10.1093/jb/mvm053	28	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0182061	10.1371/journal.pone.0182061	http://dx.doi.org/10.1371/journal.pone.0182061			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750088	gold, Green Published, Green Submitted			2022-12-26	WOS:000406575700128
J	Szymiczek, A; Carbone, M; Pastorino, S; Napolitano, A; Tanji, M; Minaai, M; Pagano, I; Mason, JM; Pass, HI; Bray, MR; Mak, TW; Yang, H				Szymiczek, A.; Carbone, M.; Pastorino, S.; Napolitano, A.; Tanji, M.; Minaai, M.; Pagano, I.; Mason, J. M.; Pass, H. I.; Bray, M. R.; Mak, T. W.; Yang, H.			Inhibition of the spindle assembly checkpoint kinase Mps-1 as a novel therapeutic strategy in malignant mesothelioma	ONCOGENE			English	Article							PLEURAL MESOTHELIOMA; CHROMOSOMAL INSTABILITY; ASBESTOS EXPOSURE; CANCER; BAP1; PROTEIN; ANEUPLOIDY; MUTATIONS; CFI-402257; MURINE	Malignant mesothelioma (MM) is an aggressive malignancy, highly resistant to current medical and surgical therapies, whose tumor cells characteristically show a high level of aneuploidy and genomic instability. We tested our hypothesis that targeting chromosomal instability in MM would improve response to therapy. Thr/Tyr kinase (TTK)/monopolar spindle 1 kinase (Mps-1) is a kinase of the spindle assembly checkpoint that controls cell division and cell fate. CFI-402257 is a novel, selective inhibitor of Mps-1 with antineoplastic activity. We found that CFI-402257 suppresses MM growth. We found that Mps-1 is overexpressed in MM and that its expression correlates with poor patients' outcome. In vitro, CFI-402257-mediated inhibition of Mps-1 resulted in abrogation of the mitotic checkpoint, premature progression through mitosis, marked aneuploidy and mitotic catastrophe. In vivo, CFI-402257 reduced MM growth in an orthotopic, syngeneic model, when used as a single agent, and more so when used in combination with cisplatin+pemetrexed, the current standard of care. Our preclinical findings indicate that CFI-402257 is a promising novel therapeutic agent to improve the efficacy of the current chemotherapeutic regimens for MM patients.	[Szymiczek, A.; Carbone, M.; Pastorino, S.; Napolitano, A.; Tanji, M.; Minaai, M.; Pagano, I.; Yang, H.] Univ Hawaii Manoa, Univ Hawaii, Ctr Canc, Thorac Oncol Program, Honolulu, HI 96822 USA; [Mason, J. M.; Bray, M. R.; Mak, T. W.] Univ Hlth Network, Campbell Family Inst Breast Canc Res, MaRS Ctr, TMDT East Tower, Toronto, ON, Canada; [Pass, H. I.] NYU, Langone Med Ctr, Dept Cardiothorac Surg, New York, NY USA	Cancer Research Center of Hawaii; University of Hawaii System; University of Hawaii Manoa; University of Toronto; University Toronto Affiliates; University Health Network Toronto; New York University; NYU Langone Medical Center	Carbone, M (corresponding author), Univ Hawaii Manoa, Univ Hawaii, Ctr Canc, 701 Ilalo St,Room 437, Honolulu, HI 96813 USA.; Yang, H (corresponding author), Univ Hawaii, Canc Biol Program, Ctr Canc, 701 Ilalo St,Room 439, Honolulu, HI 96813 USA.	mcarbone@cc.hawaii.edu; hyang@cc.hawaii.edu	Napolitano, Andrea/I-3146-2019	Napolitano, Andrea/0000-0002-7509-1555; Bray, Mark/0000-0003-4609-6127; Pass, Harvey/0000-0003-3222-3471	NCI-R01 [CA198138, CA160715]; University of Hawai'i Foundation; NATIONAL CANCER INSTITUTE [R01CA198138, R01CA160715, P30CA071789] Funding Source: NIH RePORTER	NCI-R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Hawai'i Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the NCI-R01 CA198138 to MC; by the NCI-R01 CA160715 to HY; and by the University of Hawai'i Foundation, which received an unrestricted gift to support MM research from Honeywell International Inc., to MC; and from United-4-a-Cure, to MC and HY CFI-402257 was synthesized and provided by our collaborators and co-authors at the Campbell Family Institute for Breast Cancer Research, Toronto, Canada.	Bononi A, 2017, CELL DEATH DIFFER, V24, P1694, DOI 10.1038/cdd.2017.95; Bononi A, 2017, NATURE, V546, P549, DOI 10.1038/nature22798; Bueno R, 2016, NAT GENET, V48, P407, DOI 10.1038/ng.3520; Carbone M, 2000, J CELL BIOCHEM, V76, P189, DOI 10.1002/(SICI)1097-4644(20000201)76:2<189::AID-JCB3>3.0.CO;2-J; Carbone M, 2016, J THORAC ONCOL, V11, P1246, DOI 10.1016/j.jtho.2016.04.028; Carbone M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005633; Carbone M, 2012, J CELL PHYSIOL, V227, P44, DOI 10.1002/jcp.22724; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Colombo R, 2010, CANCER RES, V70, P10255, DOI 10.1158/0008-5472.CAN-10-2101; Comertpay S, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0301-3; Daniel J, 2011, P NATL ACAD SCI USA, V108, P5384, DOI 10.1073/pnas.1007645108; Delgermaa V, 2011, B WORLD HEALTH ORGAN, V89, P716, DOI 10.2471/BLT.11.086678; Fisk HA, 2004, CELL CYCLE, V3, P439; Fisk HA, 2003, P NATL ACAD SCI USA, V100, P14875, DOI 10.1073/pnas.2434156100; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gazdar Adi F, 2003, Clin Lung Cancer, V5, P177, DOI 10.3816/CLC.2003.n.031; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; Guo GW, 2015, CANCER RES, V75, P264, DOI 10.1158/0008-5472.CAN-14-1008; HAGEMEIJER A, 1990, CANCER GENET CYTOGEN, V47, P1, DOI 10.1016/0165-4608(90)90258-C; Hao JQ, 2008, CHINESE MED J-PEKING, V121, P602, DOI 10.1097/00029330-200804010-00006; Henley SJ, 2013, INT J OCCUP ENV HEAL, V19, P1, DOI 10.1179/2049396712Y.0000000016; Hillegass JM, 2010, ANN NY ACAD SCI, V1203, P7, DOI 10.1111/j.1749-6632.2010.05554.x; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; ISOBE H, 1994, INT J CANCER, V57, P581, DOI 10.1002/ijc.2910570423; Janssen A, 2009, P NATL ACAD SCI USA, V106, P19108, DOI 10.1073/pnas.0904343106; Jean D, 2011, AM J PATHOL, V178, P881, DOI 10.1016/j.ajpath.2010.10.039; Jelluma N, 2008, CELL, V132, P233, DOI 10.1016/j.cell.2007.11.046; Jemaa M, 2013, CELL DEATH DIFFER, V20, P1532, DOI 10.1038/cdd.2013.105; Ji ZJ, 2015, SCIENCE, V348, P1260, DOI 10.1126/science.aaa4029; Jube S, 2012, CANCER RES, V72, P3290, DOI 10.1158/0008-5472.CAN-11-3481; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345; Ling YG, 2014, BIOCHEM BIOPH RES CO, V450, P1690, DOI 10.1016/j.bbrc.2014.07.071; Liu XD, 2012, ANNU REV BIOCHEM, V81, P561, DOI 10.1146/annurev-biochem-061611-090435; Liu Y, 2016, ACS MED CHEM LETT, V7, P671, DOI 10.1021/acsmedchemlett.5b00485; Lo Iacono M, 2015, J THORAC ONCOL, V10, P492, DOI 10.1097/JTO.0000000000000436; Mason JM, 2017, P NATL ACAD SCI USA, V114, P3127, DOI 10.1073/pnas.1700234114; Meyerhoff RR, 2015, J SURG RES, V196, P23, DOI 10.1016/j.jss.2015.01.043; Mezzapelle R, 2016, SCI REP-UK, V6, DOI 10.1038/srep22850; Napolitano A, 2016, ONCOGENE, V35, P1996, DOI 10.1038/onc.2015.243; Napolitano A, 2016, CLIN CANCER RES, V22, P3087, DOI 10.1158/1078-0432.CCR-15-1130; Nasu M, 2015, J THORAC ONCOL, V10, P565, DOI 10.1097/JTO.0000000000000471; Nijenhuis W, 2013, J CELL BIOL, V201, P217, DOI 10.1083/jcb.201210033; Ostroff RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046091; Singhi AD, 2016, MODERN PATHOL, V29, P14, DOI 10.1038/modpathol.2015.121; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; TAGUCHI T, 1993, CANCER RES, V53, P4349; Taniguchi T, 2007, CANCER SCI, V98, P438, DOI 10.1111/j.1349-7006.2006.00386.x; Tardif KD, 2011, MOL CANCER THER, V10, P2267, DOI 10.1158/1535-7163.MCT-11-0453; Testa JR, 2011, NAT GENET, V43, P1022, DOI 10.1038/ng.912; Ugurluer G, 2016, ANTICANCER RES, V36, P2331; van Jaarsveld RH, 2016, TRENDS CANCER, V2, P561, DOI 10.1016/j.trecan.2016.09.003; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Wei JH, 2005, J BIOL CHEM, V280, P7748, DOI 10.1074/jbc.M410152200; Yang HN, 2006, P NATL ACAD SCI USA, V103, P10397, DOI 10.1073/pnas.0604008103; Yoshikawa Y, 2016, P NATL ACAD SCI USA, V113, P13432, DOI 10.1073/pnas.1612074113; ZEIGER MA, 1994, GENE CHROMOSOME CANC, V11, P15, DOI 10.1002/gcc.2870110104	58	13	14	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 16	2017	36	46					6501	6507		10.1038/onc.2017.266	http://dx.doi.org/10.1038/onc.2017.266			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FM9WN	28759042	Green Accepted			2022-12-26	WOS:000415622900013
J	Oda, T; Hirabayashi, H; Shikauchi, G; Takamura, R; Hiraga, K; Minami, H; Hashimoto, H; Yamamoto, M; Wakabayashi, K; Shimizu, T; Sato, M				Oda, Takashi; Hirabayashi, Hirokazu; Shikauchi, Gen; Takamura, Ryouma; Hiraga, Kiyoshi; Minami, Hiroshi; Hashimoto, Hiroshi; Yamamoto, Masafumi; Wakabayashi, Keiji; Shimizu, Toshiyuki; Sato, Mamoru			Structural basis of autoinhibition and activation of the DNA-targeting ADP-ribosyltransferase pierisin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS-INDUCING PROTEIN; MOSQUITOCIDAL TOXIN; BACILLUS-SPHAERICUS; RIBOSYLATING TOXIN; STRUCTURE VALIDATION; MOLECULAR-CLONING; PURIFICATION; RECOGNITION; FAMILY; MONO(ADP-RIBOSYL)ATION	ADP-ribosyltransferases transfer the ADP-ribose moiety of beta NAD(+) to an acceptor molecule, usually a protein that modulates the function of the acceptor. Pierisin-1 is an ADP-ribosyltransferase from the cabbage butterfly Pieris rapae and is composed of N-terminal catalytic and C-terminal ricin B-like domains. Curiously, it ADP-ribosylates the DNA duplex, resulting in apoptosis of various cancer cells, which has raised interest in pierisin-1 as an anti-cancer agent. However, both the structure and the mechanism of DNA ADP-ribosylation are unclear. Here, we report the crystal structures of the N-terminal catalytic domain of pierisin-1, its complex with beta NAD(+), and the catalytic domain with the linker connecting it to the ricin B-like domains. We found that the catalytic domain possesses a defined, positively charged region on the molecular surface but that its overall structure is otherwise similar to those of proteintargeting ADP-ribosyltransferases. Electrophoretic mobility shift assays and site-directed mutagenesis indicated that pierisin- 1 binds double-stranded but not single-stranded DNA and that Lys(122), Lys(123), and Lys(124), which are found in a loop, and Arg(181) and Arg(187), located in a basic cleft near the loop, are required for DNA binding. Furthermore, the structure of the catalytic domain with the linker revealed an autoinhibitory mechanism in which the linker occupies and blocks both the beta NAD(+) - and DNA-binding sites, suggesting that proteolytic cleavage to remove the linker is necessary for enzyme catalysis. Our study provides a structural basis for the DNA-acceptor specificity of pierisin-1 and reveals that a self-regulatory mechanism is required for its activity.	[Oda, Takashi; Hirabayashi, Hirokazu; Shikauchi, Gen; Takamura, Ryouma; Hiraga, Kiyoshi; Minami, Hiroshi; Hashimoto, Hiroshi; Shimizu, Toshiyuki; Sato, Mamoru] Yokohama City Univ, Grad Sch Med Life Sci, Tsurumi Ku, 1-7-29 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan; [Hashimoto, Hiroshi] Univ Shizuoka, Sch Pharmaceut Sci, Shizuoka 4228526, Japan; [Wakabayashi, Keiji] Univ Shizuoka, Grad Div Nutr & Environm Sci, Shizuoka 4228526, Japan; [Yamamoto, Masafumi] Cent Inst Expt Anim, Kawasaki, Kanagawa 2100821, Japan; [Shimizu, Toshiyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan	Yokohama City University; University of Shizuoka; University of Shizuoka; University of Tokyo	Sato, M (corresponding author), Yokohama City Univ, Tsurumi Ku, 1-7-29 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	msato@tsurumi.yokohama-cu.ac.jp		Hashimoto, Hiroshi/0000-0003-1503-6789				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Carpusca I, 2006, MOL MICROBIOL, V62, P621, DOI 10.1111/j.1365-2958.2006.05401.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corda D, 2003, EMBO J, V22, P1953, DOI 10.1093/emboj/cdg209; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Han S, 2002, INT J MED MICROBIOL, V291, P523; Han SI, 2001, J MOL BIOL, V305, P95, DOI 10.1006/jmbi.2000.4292; Holbourn KP, 2006, FEBS J, V273, P4579, DOI 10.1111/j.1742-4658.2006.05442.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Jorgensen R, 2005, NATURE, V436, P979, DOI 10.1038/nature03871; Jorgensen R, 2008, EMBO REP, V9, P802, DOI 10.1038/embor.2008.90; Kanazawa T, 2001, P NATL ACAD SCI USA, V98, P2226, DOI 10.1073/pnas.051628898; Kono T, 1999, CANCER LETT, V137, P75, DOI 10.1016/S0304-3835(98)00346-2; Koyama K, 1996, JPN J CANCER RES, V87, P1259, DOI 10.1111/j.1349-7006.1996.tb03141.x; Lyons B, 2016, J BIOL CHEM, V291, P11198, DOI 10.1074/jbc.M115.707653; Matsumoto Y, 2008, P NATL ACAD SCI USA, V105, P2516, DOI 10.1073/pnas.0712221105; Matsushima-Hibiya Y, 2000, EUR J BIOCHEM, V267, P5742, DOI 10.1046/j.1432-1327.2000.01640.x; Matsushima-Hibiya Y, 2003, J BIOL CHEM, V278, P9972, DOI 10.1074/jbc.M212114200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakano T, 2006, P NATL ACAD SCI USA, V103, P13652, DOI 10.1073/pnas.0606140103; O'Neal CJ, 2005, SCIENCE, V309, P1093, DOI 10.1126/science.1113398; Orth JHC, 2011, TOXICON, V57, P199, DOI 10.1016/j.toxicon.2010.11.011; Otto H, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-139; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reinert DJ, 2006, J MOL BIOL, V357, P1226, DOI 10.1016/j.jmb.2006.01.025; Schirmer J, 2002, J BIOL CHEM, V277, P11941, DOI 10.1074/jbc.M108463200; Schirmer J, 2002, APPL ENVIRON MICROB, V68, P4894, DOI 10.1128/AEM.68.10.4894-4899.2002; Subbarayan S, 2016, INT J BIOL MACROMOL, V87, P16, DOI 10.1016/j.ijbiomac.2016.01.072; Takamura-Enya T, 2004, BIOCHEM BIOPH RES CO, V323, P579, DOI 10.1016/j.bbrc.2004.08.132; Takamura-Enya T, 2001, P NATL ACAD SCI USA, V98, P12414, DOI 10.1073/pnas.221444598; THANABALU T, 1992, J BACTERIOL, V174, P5051, DOI 10.1128/JB.174.15.5051-5056.1992; Treiber N, 2008, J MOL BIOL, V381, P150, DOI 10.1016/j.jmb.2008.05.067; Tsuge H, 2008, P NATL ACAD SCI USA, V105, P7399, DOI 10.1073/pnas.0801215105; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Watanabe M, 1999, P NATL ACAD SCI USA, V96, P10608, DOI 10.1073/pnas.96.19.10608; Watanabe M, 1998, JPN J CANCER RES, V89, P556, DOI 10.1111/j.1349-7006.1998.tb03297.x; Watanabe M, 2004, COMP BIOCHEM PHYS A, V139, P125, DOI 10.1016/j.cbpb.2004.07.010; Watanabe M, 2004, J BIOCHEM, V135, P471, DOI 10.1093/jb/mvh062; Yamamoto M, 2009, COMP BIOCHEM PHYS B, V154, P326, DOI 10.1016/j.cbpb.2009.07.007	41	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15445	15455		10.1074/jbc.M117.776641	http://dx.doi.org/10.1074/jbc.M117.776641			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28765284	Green Published, hybrid			2022-12-26	WOS:000410809800024
J	Arbour, KC; Naidoo, J; Steele, KE; Ni, A; Moreira, AL; Rekhtman, N; Robbins, PB; Karakunnel, J; Rimner, A; Huang, J; Riely, GJ; Hellmann, MD				Arbour, Kathryn C.; Naidoo, Jarushka; Steele, Keith E.; Ni, Ai; Moreira, Andre L.; Rekhtman, Natasha; Robbins, Paul B.; Karakunnel, Joyson; Rimner, Andreas; Huang, James; Riely, Gregory J.; Hellmann, Matthew D.			Expression of PD-L1 and other immunotherapeutic targets in thymic epithelial tumors	PLOS ONE			English	Article							CELL LUNG-CANCER; PHASE-II; CARCINOMA; THYMOMA; NIVOLUMAB; TRIAL; CLASSIFICATION; CHEMOTHERAPY	Introduction The thymus is a critical organ for the development of the adaptive immune system and thymic epithelial tumors (TETs; thymomas and thymic carcinomas) are often associated with auto-immune paraneoplastic conditions. However, the immunobiology of TETs is not well described. An evaluation of the tumor microenvironment, with particular focus on expression of immunotherapeutic targets, may facilitate and prioritize development of immunotherapy strategies for patients with TETs. Methods Tumor tissues from 23 patients with WHO Type B2/B3 thymoma (n = 12) and thymic carcinoma (n = 11) were identified and clinical outcomes were annotated. The expression of membranous PD-L1 on tumor cells, CD3+ and CD8+ tumor infiltrating lymphocytes (TILs), co-stimulatory (CD137, GITR, ICOS), and co-inhibitory immune checkpoint molecules (PD-1, CTLA-4, TIM-3) were assessed semi-quantitatively using immunohistochemistry. Results PD-L1 positivity (>= 25% of tumor membrane expression) was frequent in TETs (15/23, 65%), more common in thymomas compared to thymic carcinomas (p<0.01), and was associated with longer overall survival (p = 0.02). TIM-3 and GITR were expressed in all TETs, including 18/23 and 12/23 with at least moderate/high expression, respectively. Moderate/high CD137 expression correlated with CD8+ (p = 0.01) and moderate/high GITR expression co-associated with PD-1 (p = 0.043). Conclusions TETs are characterized by frequent PD-L1 expression and PD-L1 is associated with improved survival, suggesting PD-L1 signaling may be biologically important in TETs. Robust expression of markers of immune activation and immunotherapeutic target molecules in TETs emphasizes the potential for development of anti-PD-1/PD-L1 therapies.	[Arbour, Kathryn C.; Naidoo, Jarushka; Riely, Gregory J.; Hellmann, Matthew D.] Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Thorac Oncol Serv, 1275 York Ave, New York, NY 10021 USA; [Steele, Keith E.; Robbins, Paul B.; Karakunnel, Joyson] MedImmune LLC, Gaithersburg, MD USA; [Ni, Ai] Mem Sloan Kettering Canc Ctr, Dept Biostat, New York, NY 10021 USA; [Moreira, Andre L.; Rekhtman, Natasha] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Rimner, Andreas] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA; [Huang, James] Mem Sloan Kettering Canc Ctr, Dept Surg, Thorac Serv, 1275 York Ave, New York, NY 10021 USA; [Riely, Gregory J.; Hellmann, Matthew D.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Naidoo, Jarushka] Johns Hopkins Univ, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Moreira, Andre L.] NYU, Dept Pathol, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Robbins, Paul B.] Pfizer Inc, San Diego, CA USA	Memorial Sloan Kettering Cancer Center; AstraZeneca; Medimmune; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Johns Hopkins University; Johns Hopkins Medicine; New York University; NYU Langone Medical Center; Pfizer	Hellmann, MD (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Thorac Oncol Serv, 1275 York Ave, New York, NY 10021 USA.; Hellmann, MD (corresponding author), Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA.	hellmanm@mskcc.org	Riely, Gregory/AAF-4300-2019	Rimner, Andreas/0000-0002-1214-3856; Ni, Ai/0000-0003-3002-3556; Naidoo, Jarushka/0000-0002-3470-8686	National Cancer Institute at the National Institutes of Health: Memorial Sloan Kettering Cancer Center [P30 CA008748]; Medimmune LLC; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002384] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health: Memorial Sloan Kettering Cancer Center; Medimmune LLC(AstraZenecaMedimmune); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the National Cancer Institute at the National Institutes of Health: Memorial Sloan Kettering Cancer Center Support Grant/Core Grant [P30 CA008748]. Medimmune LLC provided support in the form of salaries for authors [KS, PR, JK] and support for reagents needed for immunopathologic analysis, but did not have any additional role in the study design, data analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bernard C, 2016, AUTOIMMUN REV, V15, P82, DOI 10.1016/j.autrev.2015.09.005; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Cooper WA, 2015, LUNG CANCER, V89, P181, DOI 10.1016/j.lungcan.2015.05.007; Farina G, 2007, LANCET ONCOL, V8, P449, DOI 10.1016/S1470-2045(07)70141-9; Fulop A, 2016, NEW ENGL J MED, V375, P1823; Giaccone G, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.8573; Giaccone G, 2011, J CLIN ONCOL, V29, P2052, DOI 10.1200/JCO.2010.32.4467; Hirsch FR, 2017, J THORAC ONCOL; Katsuya Y, 2015, LUNG CANCER, V88, P154, DOI 10.1016/j.lungcan.2015.03.003; Kondo K, 2004, ANN THORAC SURG, V77, P1183, DOI 10.1016/j.athoracsur.2003.07.042; Lemma GL, 2011, J CLIN ONCOL, V29, P2060, DOI 10.1200/JCO.2010.32.9607; Litvak AM, 2014, J THORAC ONCOL, V9, P1810, DOI 10.1097/JTO.0000000000000363; Loehrer PJ, 1997, J CLIN ONCOL, V15, P3093, DOI 10.1200/JCO.1997.15.9.3093; Massard C, 2016, J CLIN ONCOL; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Ngiow SF, 2011, CANCER RES, V71, P3540, DOI 10.1158/0008-5472.CAN-11-0096; Padda SK, 2015, J THORAC ONCOL, V10, P500, DOI 10.1097/JTO.0000000000000429; Park S, 2013, J THORAC ONCOL, V8, P959, DOI 10.1097/JTO.0b013e318292c41e; Parkhurst MR, 2016, CLIN CANC RES OFF J; Rebelatto MC, 2016, DIAGN PATHOL, V11, DOI 10.1186/s13000-016-0545-8; Rimm DL, 2017, JAMA ONCOL; Teng MWL, 2015, CANCER RES, V75, P2139, DOI 10.1158/0008-5472.CAN-15-0255; Thomas A, 2015, LANCET ONCOL, V16, P177, DOI 10.1016/S1470-2045(14)71181-7; Tiseo M, 2017, LUNG CANCER, V104, P24, DOI 10.1016/j.lungcan.2016.12.005; Travis WD, 2015, J THORAC ONCOL, V10, P1243, DOI 10.1097/JTO.0000000000000630; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Velcheti V, 2014, LAB INVEST, V94, P107, DOI 10.1038/labinvest.2013.130; Weissferdt A, 2017, MOD PATHOL; Yokoyama S, 2016, CLIN CANCER RES, V22, P4727, DOI 10.1158/1078-0432.CCR-16-0434	29	33	36	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182665	10.1371/journal.pone.0182665	http://dx.doi.org/10.1371/journal.pone.0182665			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771603	Green Submitted, gold, Green Published			2022-12-26	WOS:000406853600150
J	Bhandari, TR; Kutty, VR; Sarma, PS; Dangal, G				Bhandari, Tulsi Ram; Kutty, V. Raman; Sarma, P. Sankara; Dangal, Ganesh			Safe delivery care practices in western Nepal: Does women's autonomy influence the utilization of skilled care at birth?	PLOS ONE			English	Article							MATERNAL HEALTH-CARE; INEQUALITIES; MORTALITY; SERVICES; SCALE	Despite various efforts to increase the utilization of skilled birth attendants (SBA), nearly two-thirds of deliveries take place at home without the assistance of SBAs in Nepal. We hypothesized that the ability of women to take decisions about their own lives-women's autonomy-plays an important part in birth choices. To know this, we conducted a community-based cross-sectional study for assessing women's autonomy and utilization of safe delivery care service in Kapilvastu district of Nepal from June to October 2014. We used multivariate modeling to associate socioeconomic factors and women's autonomy with the utilization of safe delivery care services. Just over one-third of women sought institutional delivery care during the birth of their last child. Out of the total deliveries at health facilities, nearly 58% women visited health facility for self-reported emergency obstructive care. Only 6.2% home deliveries were handled by health workers and 14.7% women used the safe delivery kit for home delivery care. Higher levels of women's education had a strong positive association (odds ratio = 24.11, CI = 9.43-61.64) with institutional delivery care. Stratified analysis showed that when the husband is educated, women's education seems to work partly through their autonomy in decision making. Educational status of women emerged as one of the key predictors of the utilization of delivery care services in Kapilvastu district. Economic status of household and husband's education are other dominant predictors of the utilization of safe delivery care services. Improving the economic and educational status may be the way out for improving the proportion of institutional deliveries. Women's autonomy may be an important mediating factor in this pathway.	[Bhandari, Tulsi Ram] Pokhara Univ, Sch Hlth & Allied Sci, Dept Publ Hlth, Kaski, Nepal; [Bhandari, Tulsi Ram; Kutty, V. Raman; Sarma, P. Sankara] Sree Chitra Tirunal Inst Med Sci & Technol, AchuthaMenon Ctr Hlth Sci Studies, Trivandrum, Kerala, India; [Dangal, Ganesh] Kathmandu Model Hosp, Dept Obstet & Gynaecol, Kathmandu, Nepal	Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST)	Bhandari, TR (corresponding author), Pokhara Univ, Sch Hlth & Allied Sci, Dept Publ Hlth, Kaski, Nepal.; Bhandari, TR (corresponding author), Sree Chitra Tirunal Inst Med Sci & Technol, AchuthaMenon Ctr Hlth Sci Studies, Trivandrum, Kerala, India.	tulsib2004@gmail.com	Dangal, Ganesh/AAU-9082-2020; Dangal, Ganesh/O-1989-2017	Dangal, Ganesh/0000-0002-5834-5525; Bhandari, Tulsi/0000-0003-0774-0899				AbouZahr C, 2003, BRIT MED BULL, V67, P13, DOI 10.1093/bmb/ldg014; Allendorf K, 2007, STUD FAMILY PLANN, V38, P35, DOI 10.1111/j.1728-4465.2007.00114.x; [Anonymous], 2014, SPSS WIND 20 0 COMP; Bhandari TR, 2012, J OBSTET GYNAECOL, V7, P3, DOI DOI 10.3126/NJ0G.V7I2.11132; Bhandari TR, 2014, J NEPAL MED ASSOC, V52, P925; Borghi J, 2006, TROP MED INT HEALTH, V11, P228, DOI 10.1111/j.1365-3156.2005.01546.x; Chalmers B, 2012, BIRTH-ISS PERINAT C, V39, P276, DOI 10.1111/birt.12000; Dangal G., 2014, NEPAL J OBSTET GYNEC, V17, P8; Dangal G, 2014, GJMEDPH, V3, P1; Dean AG, 2015, OPENEPI OPEN SOURCE; Department of Health Services, 2013, ANN REP 2012 13; Dieltiens G, 2005, TOURS INT UNION SCI; Dudgeon MR, 2004, SOC SCI MED, V59, P1379, DOI 10.1016/j.socscimed.2003.11.035; Ensor T, 2009, HEALTH POLICY, V90, P247, DOI 10.1016/j.healthpol.2008.06.009; Gil-Gonzalez D, 2006, B WORLD HEALTH ORGAN, V84, P903; Govindasamy P, 1996, STUD FAMILY PLANN, V27, P328, DOI 10.2307/2138028; Govindasamy P., 1997, MATERNAL ED UTILIZAT; Hofmeyr GJ, 2005, BJOG-INT J OBSTET GY, V112, P1221, DOI 10.1111/j.1471-0528.2005.00725.x; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kruk Margaret E, 2012, Am J Public Health, V102, P645, DOI 10.2105/AJPH.2011.300462; Ministry of Health and Population Nepal New ERA and Macro International Inc, 2012, NEP DEM HLTH SURV 20; Powell-Jackson T, 2012, J HEALTH ECON, V31, P271, DOI 10.1016/j.jhealeco.2011.10.010; Prata N, 2011, J HEALTH POPUL NUTR, V29, P81; Raleigh VS, 2010, J ROY SOC MED, V103, P188, DOI 10.1258/jrsm.2010.090460; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Say L, 2007, B WORLD HEALTH ORGAN, V85, P812, DOI 10.2471/BLT.06.035659; Seward N, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001180; Sharma SK, 2007, J BIOSOC SCI, V39, P671, DOI 10.1017/S0021932007001952; Shrestha SK, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-25; Singh PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031666; Smits J, 2015, SOC INDIC RES, V122, P65, DOI 10.1007/s11205-014-0683-x; Suvedi B. K., 2009, NEPAL MATERNAL MORTA; Thapa DK, 2013, SOC SCI MED; Tuladhar J, 1997, NEPAL POPUL DEV J; Wagner Marsden, 2007, Midwifery Today Int Midwife, P55; Wanjira C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-360; World Health Organization (WHO), 2008, PROP BIRTHS ATT SKIL	37	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182485	10.1371/journal.pone.0182485	http://dx.doi.org/10.1371/journal.pone.0182485			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC5AR	28771579	gold, Green Submitted, Green Published			2022-12-26	WOS:000406853600121
J	Hassan, AS; Houston, K; Lahnstein, J; Shirley, N; Schwerdt, JG; Gidley, MJ; Waugh, R; Little, A; Burton, RA				Hassan, Ali Saleh; Houston, Kelly; Lahnstein, Jelle; Shirley, Neil; Schwerdt, Julian G.; Gidley, Michael J.; Waugh, Robbie; Little, Alan; Burton, Rachel A.			A Genome Wide Association Study of arabinoxylan content in 2-row spring barley grain	PLOS ONE			English	Article							CELL-WALL; GLUCURONOXYLAN BIOSYNTHESIS; GLYCOSIDE HYDROLASES; STARCHY ENDOSPERM; CELLULOSE BIOSYNTHESIS; XYLAN BIOSYNTHESIS; SYNTHASE COMPLEX; DIETARY FIBER; BETA-GLUCANS; ARABIDOPSIS	In barley endosperm arabinoxylan (AX) is the second most abundant cell wall polysaccharide and in wheat it is the most abundant polysaccharide in the starchy endosperm walls of the grain. AX is one of the main contributors to grain dietary fibre content providing several health benefits including cholesterol and glucose lowering effects, and antioxidant activities. Due to its complex structural features, AX might also affect the downstream applications of barley grain in malting and brewing. Using a high pressure liquid chromatography (HPLC) method we quantified AX amounts in mature grain in 128 spring 2-row barley accessions. Amounts ranged from similar to 5.2 mu g/g to similar to 9 mu g/g. We used this data for a Genome Wide Association Study (GWAS) that revealed three significant quantitative trait loci (QTL) associated with grain AX levels which passed a false discovery threshold (FDR) and are located on two of the seven barley chromosomes. Regions underlying the QTLs were scanned for genes likely to be involved in AX biosynthesis or turnover, and strong candidates, including glycosyltransferases from the GT43 and GT61 families and glycoside hydrolases from the GH10 family, were identified. Phylogenetic trees of selected gene families were built based on protein translations and were used to examine the relationship of the barley candidate genes to those in other species. Our data reaffirms the roles of existing genes thought to contribute to AX content, and identifies novel QTL (and candidate genes associated with them) potentially influencing the AX content of barley grain. One potential outcome of this work is the deployment of highly associated single nucleotide polymorphisms markers in breeding programs to guide the modification of AX abundance in barley grain.	[Hassan, Ali Saleh; Lahnstein, Jelle; Shirley, Neil; Schwerdt, Julian G.; Little, Alan; Burton, Rachel A.] Univ Adelaide, Sch Agr Food & Wine, ARC Ctr Excellence Plant Cell Walls, Waite Campus, Glen Osmond, SA, Australia; [Houston, Kelly] James Hutton Inst, Dundee, Scotland; [Gidley, Michael J.] Univ Queensland, ARC Ctr Excellence Plant Cell Walls, Ctr Nutr & Food Sci, Queensland Alliance Agr & Food Innovat, St Lucia, Qld, Australia; [Waugh, Robbie] Univ Dundee, Sch Life Sci, Div Plant Sci, Dundee, Scotland	University of Adelaide; James Hutton Institute; University of Queensland; University of Dundee	Burton, RA (corresponding author), Univ Adelaide, Sch Agr Food & Wine, ARC Ctr Excellence Plant Cell Walls, Waite Campus, Glen Osmond, SA, Australia.	rachel.burton@adelaide.edu.au	Little, Alan/S-2666-2016; Burton, Rachel A/C-4441-2011; Gidley, Mike/AAT-9543-2021	Little, Alan/0000-0003-0107-7643; Burton, Rachel A/0000-0002-0638-4709; , Kelly/0000-0003-2136-245X; Shirley, Neil/0000-0001-8114-9891; Schwerdt, Julian/0000-0002-0476-031X	University of Adelaide; Australian Research Council Centre of Excellence [CE110001007]; Scottish Rural and Environment Science and Analytical Services Division; Australian Research Council; Scottish Rural and Environment Science and Analytical Services Division (RESAS); BBSRC [BB/L026317/1, BB/J014869/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J014869/1, BB/L026317/1] Funding Source: researchfish	University of Adelaide; Australian Research Council Centre of Excellence(Australian Research Council); Scottish Rural and Environment Science and Analytical Services Division; Australian Research Council(Australian Research Council); Scottish Rural and Environment Science and Analytical Services Division (RESAS); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the University of Adelaide www.adelaide.edu.au ASH; Australian Research Council Centre of Excellence in Plant Cells Walls CE110001007 plantcellwalls.org.au -ASH, RAB, JL, NS, JGS, MJG, AL; Scottish Rural and Environment Science and Analytical Services Division http://www.gov. scot/Topics/Research/About/EBAR/StrategicResearchtfuture-research-strategy KH, RW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the Australian Research Council. We would like to acknowledge The Plant Accelerator, a National Collaborative Research Infrastructure Strategy facility, for the importation of plant lines through quarantine and the expert plant growth and care provided by its staff, particularly Dr. Bettina Berger, Lidia Mischis, Nicole Bond and Fiona Groskreutz. KH and RW would like to acknowledge funding from the Scottish Rural and Environment Science and Analytical Services Division (RESAS)	Adom KK, 2002, J AGR FOOD CHEM, V50, P6182, DOI 10.1021/jf0205099; Anders N, 2012, P NATL ACAD SCI USA, V109, P989, DOI 10.1073/pnas.1115858109; ASPINALL GO, 1959, ADV CARBOHYD CHEM, V14, P429; BACIC A, 1981, AUST J PLANT PHYSIOL, V8, P475, DOI 10.1071/PP9810475; Bamforth CW, 2001, J I BREWING, V107, P235, DOI 10.1002/j.2050-0416.2001.tb00095.x; Bartley LE, 2013, PLANT PHYSIOL, V161, P1615, DOI 10.1104/pp.112.208694; Basu D, 2013, J BIOL CHEM, V288, P10132, DOI 10.1074/jbc.M112.432609; BIELY P, 1993, BIOCHIM BIOPHYS ACTA, V1162, P246, DOI 10.1016/0167-4838(93)90288-3; Brown D, 2011, PLANT J, V66, P401, DOI 10.1111/j.1365-313X.2011.04501.x; Brown DM, 2009, PLANT J, V57, P732, DOI 10.1111/j.1365-313X.2008.03729.x; Buanafina MMD, 2009, MOL PLANT, V2, P861, DOI 10.1093/mp/ssp067; Burget EG, 1999, PLANT PHYSIOL, V121, P383, DOI 10.1104/pp.121.2.383; Burton RA, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00456; Carpita NC, 1996, ANNU REV PLANT PHYS, V47, P445, DOI 10.1146/annurev.arplant.47.1.445; Chen CC, 2015, ENZYME MICROB TECH, V71, P1, DOI 10.1016/j.enzmictec.2015.01.002; Chen XW, 2013, MOL PLANT, V6, P570, DOI 10.1093/mp/sss135; Chiniquy D, 2012, P NATL ACAD SCI USA, V109, P17117, DOI 10.1073/pnas.1202079109; Coelho E, 2016, CARBOHYD POLYM, V139, P167, DOI 10.1016/j.carbpol.2015.12.006; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Comino P, 2013, J AGR FOOD CHEM, V61, P12111, DOI 10.1021/jf403558u; Dabney A, 2011, QVALUE Q VALUE ESTIM; Faik A, 2010, PLANT PHYSIOL, V153, P396, DOI 10.1104/pp.110.154237; Fibriansah G, 2007, PROTEINS, V69, P683, DOI 10.1002/prot.21589; Frankova L, 2011, PLANT J, V67, P662, DOI 10.1111/j.1365-313X.2011.04625.x; Furtado GP, 2011, PROCESS BIOCHEM, V46, P1202, DOI 10.1016/j.procbio.2011.01.037; Gebruers K, 2010, J AGR FOOD CHEM, V58, P9353, DOI 10.1021/jf100447g; Gilkes NR, 1991, FEBS J, V202, P367; Hansen HB, 2002, EUR FOOD RES TECHNOL, V214, P33, DOI 10.1007/s00217-001-0417-6; Hoije A, 2005, CARBOHYD POLYM, V61, P266, DOI 10.1016/j.carbpol.2005.02.009; Hoije A, 2006, CARBOHYD RES, V341, P2959, DOI 10.1016/j.carres.2006.10.008; Houston K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-907; Hsieh YS, 2015, BIOCHEMISTRY; Izydorczyk MS, 2008, FOOD RES INT, V41, P850, DOI 10.1016/j.foodres.2008.04.001; Izydorczyk MS, 2000, CARBOHYD POLYM, V41, P417, DOI 10.1016/S0144-8617(99)00151-4; Jaaskelainen AS, 2013, J CEREAL SCI, V57, P543, DOI 10.1016/j.jcs.2013.02.007; Jensen JK, 2011, PLANT J, V66, P387, DOI 10.1111/j.1365-313X.2010.04475.x; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keppler BD, 2010, MOL PLANT, V3, P834, DOI 10.1093/mp/ssq028; Knudsen KEB, 2015, ADV NUTR, V6, P206, DOI 10.3945/an.114.007450; Kolenova K, 2006, J BIOTECHNOL, V121, P338, DOI 10.1016/j.jbiotec.2005.08.001; Kotake T, 2009, BIOCHEM J, V424, P169, DOI 10.1042/BJ20091025; Krawczyk H, 2008, FOOD BIOPROD PROCESS, V86, P31, DOI 10.1016/j.fbp.2007.10.018; Kulkarni AR, 2012, GLYCOBIOLOGY, V22, P439, DOI 10.1093/glycob/cwr117; Kuntothom T, 2009, ARCH BIOCHEM BIOPHYS, V491, P85, DOI 10.1016/j.abb.2009.09.004; Laidlaw HKC, 2012, J EXP BOT, V63, P3031, DOI 10.1093/jxb/ers019; Lee CH, 2007, PLANT CELL PHYSIOL, V48, P1624, DOI 10.1093/pcp/pcm135; Lee C, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27809; Lee C, 2012, PLANT CELL PHYSIOL, V53, P1934, DOI 10.1093/pcp/pcs138; Lee C, 2012, PLANT CELL PHYSIOL, V53, P135, DOI 10.1093/pcp/pcr158; Lee C, 2010, PLANT PHYSIOL, V153, P526, DOI 10.1104/pp.110.155309; Lee RC, 2001, BIOCHEM J, V356, P181, DOI 10.1042/0264-6021:3560181; Li SD, 2015, CURR OPIN PLANT BIOL, V28, P76, DOI 10.1016/j.pbi.2015.09.002; Lovegrove A, 2013, PLANT PHYSIOL, V163, P95, DOI 10.1104/pp.113.222653; Marcotuli I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132787; Mascher M, 2013, PLANT J, V76, P718, DOI 10.1111/tpj.12319; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Michikawa M, 2012, J BIOL CHEM, V287, P14069, DOI 10.1074/jbc.M112.346288; Minic Z, 2006, PLANT PHYSIOL BIOCH, V44, P435, DOI 10.1016/j.plaphy.2006.08.001; Mortimer JC, 2010, P NATL ACAD SCI USA, V107, P17409, DOI 10.1073/pnas.1005456107; Pellny TK, 2012, PLANT PHYSIOL, V158, P612, DOI 10.1104/pp.111.189191; Penning BW, 2009, PLANT PHYSIOL, V151, P1703, DOI 10.1104/pp.109.136804; Piston F, 2010, PLANTA, V231, P677, DOI 10.1007/s00425-009-1077-1; Polizeli MLTM, 2005, APPL MICROBIOL BIOT, V67, P577, DOI 10.1007/s00253-005-1904-7; Rakha A, 2011, CHARACTERISATION DIE; Ratke C, 2015, PLANT BIOTECHNOL J, V13, P26, DOI 10.1111/pbi.12232; Rautengarten C, 2011, PLANT CELL, V23, P1373, DOI 10.1105/tpc.111.083931; Remond C, 2008, CARBOHYD POLYM, V72, P424, DOI 10.1016/j.carbpol.2007.09.008; Rennie EA, 2014, CURR OPIN BIOTECH, V26, P100, DOI 10.1016/j.copbio.2013.11.013; Rennie EA, 2012, PLANT PHYSIOL, V159, P1408, DOI 10.1104/pp.112.200964; SAULNIER L, 1995, CARBOHYD RES, V272, P241, DOI 10.1016/0008-6215(95)00053-V; SAULNIER L, 1995, J CEREAL SCI, V22, P259, DOI 10.1006/jcrs.1995.0062; Schendel RR, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01249; Shang YL, 2015, J I BREWING, V121, P49, DOI 10.1002/jib.204; Shi YN, 2017, J INTEGR AGR, V16, P65, DOI [10.1016/S2095-3119(16)61389-8, 10.1016/s2095-3119(16)61389-8]; Singh A, 2010, PLANT SCI, V179, P114, DOI 10.1016/j.plantsci.2010.03.005; Slavin J, 2004, NUTR RES REV, V17, P99, DOI 10.1079/NRR200374; Song DL, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00493; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strohmeier M, 2004, PROTEIN SCI, V13, P3200, DOI 10.1110/ps.04828404; Suliman M, 2013, J PROTEOMICS, V78, P508, DOI 10.1016/j.jprot.2012.10.021; Sun XF, 2005, J AGR FOOD CHEM, V53, P860, DOI 10.1021/jf040456q; Szucs P, 2009, PLANT GENOME-US, V2, P134, DOI [10.3835/plantgenome2008.01.005, 10.3835/plantgenome2008.01.0005]; Tosh S.M., 2016, ENCY FOOD GRAINS, P236; Urbanowicz BR, 2012, P NATL ACAD SCI USA, V109, P14253, DOI 10.1073/pnas.1208097109; Nguyen VL, 2011, CROP SCI, V51, P1143, DOI 10.2135/cropsci2010.08.0484; Wang HZ, 2012, MOL PLANT, V5, P297, DOI 10.1093/mp/ssr098; Westendorf ML, 2002, VET CLIN N AM-FOOD A, V18, P233, DOI 10.1016/S0749-0720(02)00016-6; Wilkie K. C. B., 1979, Advances in Carbohydrate Chemistry and Biochemistry, V36, P215; Wu AM, 2009, PLANT J, V57, P718, DOI 10.1111/j.1365-313X.2008.03724.x; Xiong GY, 2013, MOL PLANT, V6, P1373, DOI 10.1093/mp/sst014; Yamaguchi M, 2010, PLANT BIOTECHNOL, V27, P237, DOI 10.5511/plantbiotechnology.27.237; Yang L, 2016, EUPHYTICA, V208, P205, DOI 10.1007/s10681-015-1576-z; Yoshida-Shimokawa T, 2001, PLANTA, V212, P470, DOI 10.1007/s004250000490; Yuan Y., 2016, PLOS ONE, V11; Yuan YF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01962; Yuan YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087370; Yuan YX, 2013, PLANT CELL PHYSIOL, V54, P1186, DOI 10.1093/pcp/pct070; Zeng W, 2016, PLANT PHYSIOL, V171, P93, DOI 10.1104/pp.15.01919; Zeng W, 2010, PLANT PHYSIOL, V154, P78, DOI 10.1104/pp.110.159749; Zheng H, 2011, APPL MICROBIOL BIOT, V90, P509, DOI 10.1007/s00253-011-3088-7; Zhong RQ, 2006, PLANT CELL, V18, P3158, DOI 10.1105/tpc.106.047399	102	16	18	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182537	10.1371/journal.pone.0182537	http://dx.doi.org/10.1371/journal.pone.0182537			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771585	Green Submitted, Green Published, gold			2022-12-26	WOS:000406853600136
J	Pepping, JK; Vandanmagsar, B; Fernandez-Kim, SO; Zhang, JY; Mynatt, RL; Bruce-Keller, AJ				Pepping, Jennifer K.; Vandanmagsar, Bolormaa; Fernandez-Kim, Sun-Ok; Zhang, Jingying; Mynatt, Randall L.; Bruce-Keller, Annadora J.			Myeloid-specific deletion of NOX2 prevents the metabolic and neurologic consequences of high fat diet	PLOS ONE			English	Article							ADIPOSE-TISSUE; NADPH-OXIDASE; INSULIN-RESISTANCE; OXIDATIVE STRESS; MACROPHAGE POLARIZATION; ENDOTHELIAL DYSFUNCTION; SUBCUTANEOUS FAT; RISK-FACTORS; OBESITY; INFLAMMATION	High fat diet-induced obesity is associated with inflammatory and oxidative signaling in macrophages that likely participates in metabolic and physiologic impairment. One key factor that could drive pathologic changes in macrophages is the pro-inflammatory, pro-oxidant enzyme NADPH oxidase. However, NADPH oxidase is a pleiotropic enzyme with both pathologic and physiologic functions, ruling out indiscriminant NADPH oxidase inhibition as a viable therapy. To determine if targeted inhibition of monocyte/macrophage NADPH oxidase could mitigate obesity pathology, we generated mice that lack the NADPH oxidase catalytic subunit NOX2 in myeloid lineage cells. C57Bl/6 control (NOX2-FL) and myeloid-deficient NOX2 (mNOX2-KO) mice were given high fat diet for 16 weeks, and subject to comprehensive metabolic, behavioral, and biochemical analyses. Data show that mNOX2-KO mice had lower body weight, delayed adiposity, attenuated visceral inflammation, and decreased macrophage infiltration and cell injury in visceral adipose relative to control NOX2-FL mice. Moreover, the effects of high fat diet on glucose regulation and circulating lipids were attenuated in mNOX2-KO mice. Finally, memory was impaired and markers of brain injury increased in NOX2-FL, but not mNOX2-KO mice. Collectively, these data indicate that NOX2 signaling in macrophages participates in the pathogenesis of obesity, and reinforce a key role for macrophage inflammation in diet-induced metabolic and neurologic decline. Development of macrophage/immune-specific NOX-based therapies could thus potentially be used to preserve metabolic and neurologic function in the context of obesity.	[Pepping, Jennifer K.; Vandanmagsar, Bolormaa; Fernandez-Kim, Sun-Ok; Zhang, Jingying; Mynatt, Randall L.; Bruce-Keller, Annadora J.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Bruce-Keller, AJ (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70803 USA.	annadora.bruce-keller@pbrc.edu	zhang, jingying R/R-4262-2018; Mynatt, Randall L/N-1980-2017; Bruce-Keller, Annadora/N-1954-2017; Vandanmagsar, Bolormaa/R-4565-2018	Mynatt, Randall L/0000-0003-4399-0019; 	National Institutes of Health [NS089092]; NIH [3P30-GM118430, 2P30 DK072476, P50AT002776-11]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the National Institutes of Health (NS089092). This work also utilized Transgenic, Imaging, and Animal Behavior/Phenotyping core facilities supported by NIH 3P30-GM118430, NIH 2P30 DK072476, and NIH P50AT002776-11. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2007, J HISTOCHEM CYTOCHEM, V55, P687, DOI 10.1369/jhc.6A7156.2007; Anilkumar N, 2008, ARTERIOSCL THROM VAS, V28, P1347, DOI 10.1161/ATVBAHA.108.164277; Ansari MA, 2011, FREE RADICAL BIO MED, V51, P171, DOI 10.1016/j.freeradbiomed.2011.03.025; Apovian CM, 2008, ARTERIOSCL THROM VAS, V28, P1654, DOI 10.1161/ATVBAHA.108.170316; Atzmon G, 2002, HORM METAB RES, V34, P622, DOI 10.1055/s-2002-38250; Bashir S, 2016, J NUTR BIOCHEM, V33, P82, DOI 10.1016/j.jnutbio.2016.02.011; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Beydoun MA, 2008, OBES REV, V9, P204, DOI 10.1111/j.1467-789X.2008.00473.x; Bingel SA, 2002, CONTEMP TOP LAB ANIM, V41, P33; Bruce-Keller A.J., 2011, NEUROBIOL DIS; Bruce-Keller AJ, 2015, BIOL PSYCHIAT, V77, P607, DOI 10.1016/j.biopsych.2014.07.012; Bruce-Keller AJ, 2010, FREE RADICAL BIO MED, V49, P22, DOI 10.1016/j.freeradbiomed.2010.03.006; Bruce-Keller AJ, 2009, BBA-MOL BASIS DIS, V1792, P395, DOI 10.1016/j.bbadis.2008.10.004; Chinen I, 2007, ENDOCRINOLOGY, V148, P160, DOI 10.1210/en.2006-1132; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Clark RA, 2004, MECH AGEING DEV, V125, P799, DOI 10.1016/j.mad.2004.08.009; Costford SR, 2014, AM J PHYSIOL-ENDOC M, V306, pE1341, DOI 10.1152/ajpendo.00089.2014; Dickinson BC, 2011, NAT CHEM BIOL, V7, P106, DOI 10.1038/NCHEMBIO.497; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Fillit H, 2008, AM J GERIATR PHARMAC, V6, P100, DOI 10.1016/j.amjopharm.2008.06.004; Freeman LR, 2013, FREE RADICAL BIO MED, V56, P226, DOI 10.1016/j.freeradbiomed.2012.08.577; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Garcia-Ruiz I, NADPH IMPLICATED PAT; Gil A, 2011, INT J PEDIATR OBES, V6, P13, DOI 10.3109/17477166.2011.604326; Grant Ryan, 2013, Methods Mol Biol, V1040, P195, DOI 10.1007/978-1-62703-523-1_15; Harman-Boehm I, 2007, J CLIN ENDOCR METAB, V92, P2240, DOI 10.1210/jc.2006-1811; Harrison IP, 2014, CLIN EXP PHARMACOL P, V41, P533, DOI 10.1111/1440-1681.12238; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Infanger DW, 2006, ANTIOXID REDOX SIGN, V8, P1583, DOI 10.1089/ars.2006.8.1583; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kishida KT, 2006, MOL CELL BIOL, V26, P5908, DOI 10.1128/MCB.00269-06; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Li Y, 2012, INT J OBES; Liu WL, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-22; Maddux BA, 2001, DIABETES, V50, P404, DOI 10.2337/diabetes.50.2.404; Matsuoka T, 1997, J CLIN INVEST, V99, P144, DOI 10.1172/JCI119126; Montezano AC, 2014, ANTIOXID REDOX SIGN, V20, P164, DOI 10.1089/ars.2013.5302; Morgenstern DE, 1997, J EXP MED, V185, P207, DOI 10.1084/jem.185.2.207; Murano I, 2008, J LIPID RES, V49, P1562, DOI 10.1194/jlr.M800019-JLR200; Navarro E, 2015, MOL NUTR FOOD RES, V59, P75, DOI 10.1002/mnfr.201400521; Ogden CL, 2013, NCHS DATA BRIEF, V131, P1; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Padwal RS, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004094.pub2, DOI 10.1002/14651858.CD004094.PUB2]; Pepping JK, 2013, AM J PHYSIOL-ENDOC M, V304, pE392, DOI 10.1152/ajpendo.00398.2012; Pepping JK, 2014, J NEUROIMMUNE PHARM; Roos CJ, 2012, BIOMARK MED, V6, P35, DOI [10.2217/BMM.11.105, 10.2217/bmm.11.105]; RUDERMAN NB, 1981, AM J CLIN NUTR, V34, P1617, DOI 10.1093/ajcn/34.8.1617; Schroeder K, 2009, ARTERIOSCL THROM VAS, V29, P239, DOI 10.1161/ATVBAHA.108.174219; Shan B, 2017, NAT IMMUNOL, V18, P519, DOI 10.1038/ni.3709; Shaw OM, 2014, RHEUMATOLOGY, V53, P1901, DOI 10.1093/rheumatology/keu174; Shibuya A, 2002, FEBS LETT, V525, P43, DOI 10.1016/S0014-5793(02)03059-4; Silver AE, 2007, CIRCULATION, V115, P627, DOI 10.1161/CIRCULATIONAHA.106.657486; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Sukumar P, 2013, DIABETES, V62, P2130, DOI 10.2337/db12-1294; Tan HY, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2795090; Trollor JN, 2012, ASS SYSTEMIC INFLAMM; Turchan-Cholewo J, 2009, ANTIOXID REDOX SIGN, V11, P193, DOI [10.1089/ars.2008.2097, 10.1089/ARS.2008.2097]; Vandanmagsar B, 2016, CELL REP, V15, P1686, DOI 10.1016/j.celrep.2016.04.057; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Zhang L, 2013, BIOCH BIOPHYS ACTA; Zhang XC, 2005, EXP NEUROL, V191, P318, DOI 10.1016/j.expneurol.2004.10.011	66	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0181500	10.1371/journal.pone.0181500	http://dx.doi.org/10.1371/journal.pone.0181500			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771483	Green Submitted, gold, Green Published			2022-12-26	WOS:000406853600023
J	Tshikudi, DM; Tripathi, MM; Hajjarian, Z; Van Cott, EM; Nadkarni, SK				Tshikudi, Diane M.; Tripathi, Markandey M.; Hajjarian, Zeinab; Van Cott, Elizabeth M.; Nadkarni, Seemantini K.			Optical sensing of anticoagulation status: Towards point-of-care coagulation testing	PLOS ONE			English	Article							DIFFUSING-WAVE SPECTROSCOPY; DIRECT THROMBIN INHIBITORS; IN-VITRO; HEPARIN; RIVAROXABAN; THERAPY; TEG; COAGULOPATHY; REPLACEMENT; ARGATROBAN	Anticoagulant overdose is associated with major bleeding complications. Rapid coagulation sensing may ensure safe and accurate anticoagulant dosing and reduce bleeding risk. Here, we report the novel use of Laser Speckle Rheology (LSR) for measuring anticoagulation and haemodilution status in whole blood. In the LSR approach, blood from 12 patients and 4 swine was placed in disposable cartridges and time-varying intensity fluctuations of laser speckle patterns were measured to quantify the viscoelastic modulus during clotting. Coagulation parameters, mainly clotting time, clot progression rate (a-angle) and maximum clot stiffness (MA) were derived from the clot viscoelasticity trace and compared with standard Thromboelastography (TEG). To demonstrate the capability for anticoagulation sensing in patients, blood samples from 12 patients treated with warfarin anticoagulant were analyzed. LSR clotting time correlated with prothrombin and activated partial thromboplastin time (r = 0.57-0.77, p < 0.04) and all LSR parameters demonstrated good correlation with TEG (r = 0.61-0.87, p < 0.04). To further evaluate the dose-dependent sensitivity of LSR parameters, swine blood was spiked with varying concentrations of heparin, argatroban and rivaroxaban or serially diluted with saline. We observed that anticoagulant treatments prolonged LSR clotting time in a dose-dependent manner that correlated closely with TEG (r = 0.99, p < 0.01). LSR angle was unaltered by anticoagulation whereas TEG angle presented dose-dependent diminution likely linked to the mechanical manipulation of the clot. In both LSR and TEG, MA was largely unaffected by anticoagulation, and LSR presented a higher sensitivity to increased haemodilution in comparison to TEG (p < 0.01). Our results establish that LSR rapidly and accurately measures the response of various anticoagulants, opening the opportunity for routine anticoagulation monitoring at the point-of-care or for patient self-testing.	[Tshikudi, Diane M.; Tripathi, Markandey M.; Hajjarian, Zeinab; Nadkarni, Seemantini K.] Harvard Med Sch, Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02115 USA; [Van Cott, Elizabeth M.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pathol, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Nadkarni, SK (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02115 USA.	snadkarni@mgh.harvard.edu			Air Force Office of Scientific Research and Blood coagulation monitoring at the point of care [FA9550-13-1-0068]; National Institute of Health;  [5RO1HL119867]	Air Force Office of Scientific Research and Blood coagulation monitoring at the point of care; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 	This work was supported by the research grant, A hand-held blood coagulation sensor, FA9550-13-1-0068, Seemantini K Nadkarni from the Air Force Office of Scientific Research and Blood coagulation monitoring at the point of care, 5RO1HL119867, Seemantini K Nadkarni from the National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolliger D, 2009, BRIT J ANAESTH, V102, P793, DOI 10.1093/bja/aep098; Bolliger D, 2010, ANESTHESIOLOGY, V113, P1205, DOI 10.1097/ALN.0b013e3181f22b5a; Brummel KE, 2002, BLOOD, V100, P148, DOI 10.1182/blood.V100.1.148; Burghardt WR, 1995, BIORHEOLOGY, V32, P621, DOI 10.1016/0006-355X(95)00041-7; Camenzind V, 2000, ANESTHESIOLOGY, V92, P1242, DOI 10.1097/00000542-200005000-00011; CARTEAUX JP, 1995, CIRCULATION, V91, P1568, DOI 10.1161/01.CIR.91.5.1568; Connolly SJ, 2007, CIRCULATION, V116, P449, DOI 10.1161/CIRCULATIONAHA.107.695163; Coppell JA, 2006, BLOOD COAGUL FIBRIN, V17, P97, DOI 10.1097/01.mbc.0000203859.62739.25; Crowther MA, 2008, BLOOD, V111, P4871, DOI 10.1182/blood-2007-10-120543; da Luz LT, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-29; De Lorenzo C, 2006, ANESTH ANALG, V102, P1194, DOI 10.1213/01.ane.0000200297.98089.ce; Di Nisio M, 2005, NEW ENGL J MED, V353, P1028, DOI 10.1056/NEJMra044440; Dias JD, 2015, ARCH PATHOL LAB MED, V139, P665, DOI 10.5858/arpa.2014-0170-OA; Douxfils J, 2012, THROMB RES, V130, P956, DOI 10.1016/j.thromres.2012.09.004; Eller T, 2014, CLIN CHEM LAB MED, V52, P835, DOI 10.1515/cclm-2013-0936; Evans JD., 1996, STRAIGHTFORWARD STAT; Evans P. A., 2006, RHEOLOGY REV, P255; Funk DM, 2012, HEMATOL-AM SOC HEMAT, P460, DOI 10.1182/asheducation-2012.1.460; Ganter MT, 2008, ANESTH ANALG, V106, P1366, DOI 10.1213/ane.0b013e318168b367; Gerotziafas GT, 2007, J THROMB HAEMOST, V5, P886, DOI 10.1111/j.1538-7836.2007.02429.x; Hajjarian Z, 2014, J BIOPHOTONICS, V10, P1; Hajjarian Z, 2013, PLOS ONE, V8, P1; Hajjarian Z, 2012, SCI REP-UK, V2, DOI 10.1038/srep00316; Harr JN, 2013, SHOCK, V39, P45, DOI 10.1097/SHK.0b013e3182787122; He S, 2010, THROMB HAEMOSTASIS, V103, P1076, DOI 10.1160/TH09-05-0306; HIIPPALA ST, 1995, ANESTH ANALG, V81, P360, DOI 10.1097/00000539-199508000-00026; Hillarp A, 2011, J THROMB HAEMOST, V9, P133, DOI 10.1111/j.1538-7836.2010.04098.x; Hirsh J, 2003, J AM COLL CARDIOL, V41, P1633, DOI 10.1016/S0735-1097(03)00416-9; Hirsh J, 2001, CIRCULATION, V103, P2994, DOI 10.1161/01.CIR.103.24.2994; HIRSH J, 1995, CHEST, V108, pS258, DOI 10.1378/chest.108.4_Supplement.258S; Johansson PI, 2012, CURR OPIN ANESTHESIO, V25, P235, DOI 10.1097/ACO.0b013e32834fab76; KAPLAN PD, 1993, APPL OPTICS, V32, P3828, DOI 10.1364/AO.32.003828; Katori N, 2005, ANESTH ANALG, V100, P1781, DOI 10.1213/01.ANE.0000149902.73689.64; Kirley K, 2012, CIRC-CARDIOVASC QUAL, V5, P615, DOI 10.1161/CIRCOUTCOMES.112.967299; Koepke JA, 2000, LAB MED, V31, P343, DOI 10.1309/2GM3-YJ04-FYGJ-QXR9; Lee CJ, 2011, BRIT J CLIN PHARMACO, V72, P581, DOI 10.1111/j.1365-2125.2011.03916.x; LEFKOVITS J, 1994, CIRCULATION, V90, P1522, DOI 10.1161/01.CIR.90.3.1522; Mani H, 2014, THER DRUG MONIT, V36, P624, DOI 10.1097/FTD.0000000000000064; MARET G, 1987, Z PHYS B CON MAT, V65, P409, DOI 10.1007/BF01303762; Nadkarni SK, 2005, CIRCULATION, V112, P885, DOI 10.1161/CIRCULATIONAHA.104.520098; Nielsen VG, 2006, J HEART LUNG TRANSPL, V25, P653, DOI 10.1016/j.healun.2006.02.010; Perzborn E, 2010, ARTERIOSCL THROM VAS, V30, P376, DOI 10.1161/ATVBAHA.110.202978; PINE DJ, 1990, J PHYS-PARIS, V51, P2101, DOI 10.1051/jphys:0199000510180210100; Rivard GE, 2005, J THROMB HAEMOST, V3, P2039, DOI 10.1111/j.1538-7836.2005.01513.x; ROSENBERG RD, 1984, J CLIN INVEST, V74, P1, DOI 10.1172/JCI111389; Samama MM, 2013, THROMB J, V11, DOI 10.1186/1477-9560-11-11; Schmidt DE, 2015, THROMB RES, V135, P1007, DOI 10.1016/j.thromres.2015.02.022; Services USD of H and H, 2014, NAT ACT PLAN ADV DRU; Solomon C, 2015, ANESTH ANALG, V121, P868, DOI 10.1213/ANE.0000000000000859; Solomon C, 2012, ANESTH ANALG, V114, P721, DOI 10.1213/ANE.0b013e31824724c8; Spiezia L, 2008, THROMB RES, V122, P568, DOI 10.1016/j.thromres.2008.04.006; Taketomi T, 2007, BLOOD COAGUL FIBRIN, V18, P761, DOI 10.1097/MBC.0b013e3282f102c6; ten Cate H, 2012, THROMB HAEMOSTASIS, V107, P803, DOI 10.1160/TH12-03-0130; Tripathi MM, 2014, BIOMED OPT EXPRESS, V5, P817, DOI 10.1364/BOE.5.000817; van Veen JJ, 2013, BRIT J HAEMATOL, V160, P859, DOI 10.1111/bjh.12173; Weitz D. A., 1993, DYNAMIC LIGHT SCATTE; WEITZ JI, 1990, J CLIN INVEST, V86, P385, DOI 10.1172/JCI114723; Whiting D, 2014, AM J HEMATOL, V89, P228, DOI 10.1002/ajh.23599; Wittkowsky AK, 2012, CLIN PHARMACOKINET, P351; Young G, 2007, BLOOD COAGUL FIBRIN, V18, P97, DOI 10.1097/MBC.0b013e3280116c4c; Zhu TN, 2009, ARTERIOSCL THROM VAS, V29, P298, DOI 10.1161/ATVBAHA.108.182428	61	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182491	10.1371/journal.pone.0182491	http://dx.doi.org/10.1371/journal.pone.0182491			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771571	Green Submitted, Green Published, gold			2022-12-26	WOS:000406853600123
J	Yang, NL; Baban, B; Isales, CM; Shi, XM				Yang, Nianlan; Baban, Babak; Isales, Carlos M.; Shi, Xing-Ming			Role of glucocorticoid-induced leucine zipper (GILZ) in inflammatory bone loss	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; RHEUMATOID-ARTHRITIS; TRANSGENIC MICE; FACTOR INHIBITORS; PROGENITOR CELLS; SYNOVIAL-FLUID; TNF-ALPHA; THERAPY; OSTEOARTHRITIS	TNF-alpha plays a key role in the development of rheumatoid arthritis (RA) and inflammatory bone loss. Unfortunately, treatment of RA with anti-inflammatory glucocorticoids (GCs) also causes bone loss resulting in osteoporosis. Our previous studies showed that overexpression of glucocorticoid-induced leucine zipper (GILZ), a mediator of GC's anti-inflammatory effect, can enhance osteogenic differentiation in vitro and bone acquisition in vivo. To investigate whether GILZ could antagonize TNF-alpha-induced arthritic inflammation and protect bone in mice, we generated a TNF-alpha-GILZ double transgenic mouse line (TNF-GILZ Tg) by crossbreeding a TNF-alpha Tg mouse, which ubiquitously expresses human TNF-alpha, with a GILZ Tg mouse, which expresses mouse GILZ under the control of a 3.6kb rat type I collagen promoter fragment. Results showed that overexpression of GILZ in bone marrow mesenchymal stem/progenitor cells protected mice from TNF-alpha-induced inflammatory bone loss and improved bone integrity (TNF-GILZ double Tg vs. TNF-alpha Tg, n = 12-15). However, mesenchymal cell lineage restricted GILZ expression had limited effects on TNF-alpha-induced arthritic inflammation as indicated by clinical scores and serum levels of inflammatory cytokines and chemokines.	[Yang, Nianlan; Isales, Carlos M.; Shi, Xing-Ming] Augusta Univ, Dept Neurosci, Augusta, GA 30912 USA; [Yang, Nianlan; Isales, Carlos M.; Shi, Xing-Ming] Augusta Univ, Dept Regenerat Med, Augusta, GA 30912 USA; [Baban, Babak] Augusta Univ, Dept Oral Biol, Augusta, GA USA; [Isales, Carlos M.; Shi, Xing-Ming] Augusta Univ, Dept Orthopaed Surg, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Shi, XM (corresponding author), Augusta Univ, Dept Neurosci, Augusta, GA 30912 USA.; Shi, XM (corresponding author), Augusta Univ, Dept Regenerat Med, Augusta, GA 30912 USA.; Shi, XM (corresponding author), Augusta Univ, Dept Orthopaed Surg, Augusta, GA 30912 USA.	xshi@augusta.edu	Isales, Carlos/J-9902-2013	Isales, Carlos/0000-0002-4480-3484; Shi, Xingming/0000-0003-4920-0989	National Institute on Aging of the National Institutes of Health [R01 AG046248, P01 AG 036675]; NATIONAL INSTITUTE ON AGING [R01AG046248, P01AG036675] Funding Source: NIH RePORTER	National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research reported in this publication was supported by the National Institute on Aging of the National Institutes of Health (https://www.nih.gov/about-nih/what-we-do/nih-almanac/national-institute-aging-nia) under Award Numbers R01 AG046248 and P01 AG 036675. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r Research reported in this publication was supported by the National Institute on Aging of the National Institutes of Health under Award Numbers R01 AG046248 and P01 AG 036675.	Amarasekara DS, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/832127; Armaka M, 2009, STANDARDIZED PROTOCO, DOI [10.1038/nprot.2009.102, DOI 10.1038/NPROT.2009.102]; Beaulieu E, 2010, ARTHRITIS RHEUM-US, V62, P2651, DOI 10.1002/art.27566; Berrebi D, 2003, BLOOD, V101, P729, DOI 10.1182/blood-2002-02-0538; Bostrom EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134608; Butler DM, 1997, J IMMUNOL, V159, P2867; Caetano-Lopes J, 2013, CLIN REV ALLERG IMMU, P38; Cenci S, 2000, J CLIN INVEST, V106, P1229, DOI 10.1172/JCI11066; Chopin F, 2008, ANN RHEUM DIS, V67, P353, DOI 10.1136/ard.2007.076604; Clay M, 2016, JOINT BONE SPINE REV; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; De Benedetti F, 2009, HORM RES, V72, P26, DOI 10.1159/000229760; Douni E, 2004, ARTHRITIS RES THER, V6, pR65, DOI 10.1186/ar1028; Eddleston J, 2007, J ALLERGY CLIN IMMUN, V119, P115, DOI 10.1016/j.jaci.2006.08.027; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Fine DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098541; Finzel S, 2011, ANN RHEUM DIS, V70, P1587, DOI 10.1136/ard.2010.148395; Ghabril M, 2013, CLIN GASTROENTEROL H, V11, P558, DOI 10.1016/j.cgh.2012.12.025; Hampel U, 2013, J IMMUNOL METHODS, V396, P134, DOI 10.1016/j.jim.2013.08.007; Hardy R, 2009, J ENDOCRINOL, V201, P309, DOI 10.1677/JOE-08-0568; Hastings R, 2010, ARTHRIT CARE RES, V62, P764, DOI 10.1002/acr.20037; He LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031717; HENCH PS, 1949, ANN RHEUM DIS, V8, P97, DOI 10.1136/ard.8.2.97; Jones EA, 2004, ARTHRITIS RHEUM-US, V50, P817, DOI 10.1002/art.20203; Jorgensen C, 2002, ANN RHEUM DIS, V61, P6, DOI 10.1136/ard.61.1.6; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Kirwan JR, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006356; Krieckaert CLM, 2013, RHEUMATOLOGY, V52, P547, DOI 10.1093/rheumatology/kes320; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Li XL, 2006, P NATL ACAD SCI USA, V103, P17432, DOI 10.1073/pnas.0607939103; Malysheva K, 2016, CROAT MED J, V57, P89, DOI 10.3325/cmj.2016.57.89; Manara M, 2015, RMD OPEN, V1, DOI 10.1136/rmdopen-2015-000065; Mateen S, 2016, CLIN CHIM ACTA, V455, P161, DOI 10.1016/j.cca.2016.02.010; Mohan N, 2001, ARTHRITIS RHEUM-US, V44, P2862, DOI 10.1002/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W; Pan GD, 2014, J BIOL CHEM, V289, P19373, DOI 10.1074/jbc.M113.535237; Raaschou P, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i262; Redlich K, 2012, NAT REV DRUG DISCOV, V11, P234, DOI 10.1038/nrd3669; Roman-Blas JA, 2006, OSTEOARTHR CARTILAGE, V14, P839, DOI 10.1016/j.joca.2006.04.008; Rousseau-Nepton I, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-012-0315-x; Saag KG, 2014, ANN NY ACAD SCI, V1318, P55, DOI 10.1111/nyas.12446; Saxne T, ARTHRITIS RHEUMATISM; Setoguchi S, 2008, AM HEART J, V156, P336, DOI 10.1016/j.ahj.2008.02.025; Singh JA, 2011, COCHRANE DATABASE SY, V2; Singh JA, 2016, ARTHRITIS RHEUMATOL, V68, P1, DOI 10.1002/art.39480; Siu S, 2015, ARTHRIT CARE RES, V67, P754, DOI 10.1002/acr.22519; Szekanecz Z, 2016, NAT REV RHEUMATOL, V12, P5, DOI 10.1038/nrrheum.2015.157; Tsatsanis C, 2006, INT J BIOCHEM CELL B, V38, P1654, DOI 10.1016/j.biocel.2006.03.021; van der Goes MC, 2016, CURRENT OPINION RHEU; van Everdingen AA, 2002, ANN INTERN MED, V136, P1, DOI 10.7326/0003-4819-136-1-200201010-00006; Vis M, 2006, ANN RHEUM DIS, V65, P1495, DOI 10.1136/ard.2005.044198; Vultaggio A, 2010, ALLERGY, V65, P657, DOI 10.1111/j.1398-9995.2009.02280.x; Woodworth TG, 2015, BEST PRACT RES CL RH, V29, P543, DOI 10.1016/j.berh.2015.10.001; Yang NL, 2008, J CELL BIOCHEM, V103, P1760, DOI 10.1002/jcb.21562; Yang NL, 2015, FASEB J, V29, P3954, DOI 10.1096/fj.15-273664; Zhang WX, 2008, J BIOL CHEM, V283, P4723, DOI 10.1074/jbc.M704147200; Zhao Q, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000851	56	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0181133	10.1371/journal.pone.0181133	http://dx.doi.org/10.1371/journal.pone.0181133			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771604	Green Submitted, Green Published, gold			2022-12-26	WOS:000406853600011
J	Zheng, F; Xia, ZA; Zeng, YF; Luo, JK; Sun, P; Cui, HJ; Wang, Y; Tang, T; Zhou, YT				Zheng, Fei; Xia, Zi-An; Zeng, Yi-Fu; Luo, Jie-Kun; Sun, Peng; Cui, Han-Jin; Wang, Yang; Tang, Tao; Zhou, Yan-Tao			Plasma metabolomics profiles in rats with acute traumatic brain injury	PLOS ONE			English	Article							NEURON-SPECIFIC ENOLASE; AMINO-ACIDS; BETA-HYDROXYBUTYRATE; ARACHIDONIC-ACID; PHOSPHORIC-ACID; LINOLEIC-ACID; BIOMARKER; GALACTOSE; DAMAGE; URINE	Traumatic brain injury (TBI) is a major cause of mortality and disability worldwide. We validated the utility of plasma metabolomics analysis in the clinical diagnosis of acute TBI in a rat model of controlled cortical impact (CCI) using gas chromatography/mass spectrometry (GC/MS). Thirty Sprague-Dawley rats were randomly divided into two groups of 15 rats each: the CCI group and sham group. Blood samples were obtained from the rats within the first 24 h after TBI injury. GC/MS measurements were performed to evaluate the profile of acute TBI-induced metabolic changes, resulting in the identification of 45 metabolites in plasma. Principal component analysis, partial least squares-discriminant analysis, orthogonal partial least square discriminant analysis using hierarchical clustering and univariate/multivariate analyses revealed clear differences in the plasma metabolome between the acute CCI group and the sham group. CCI induced distinctive changes in metabolites including linoleic acid metabolism, amino acid metabolism, galactose metabolism, and arachidonic acid metabolism. Specifically, the acute CCI group exhibited significant alterations in proline, phosphoric acid, beta-hydroxybutyric acid, galactose, creatinine, L-valine, linoleic acid and arachidonic acid. A receiver operating characteristic curve analysis showed that the above 8 metabolites in plasma could be used as the potential biomarkers for the diagnosis of acute TBI. Furthermore, this study is the first time to identify the galactose as a biomarker candidate for acute TBI. This comprehensive metabolic analysis complements target screening for potential diagnostic biomarkers of acute TBI and enhances predictive value for the therapeutic intervention of acute TBI.	[Zheng, Fei; Zeng, Yi-Fu; Zhou, Yan-Tao] Hunan Univ, Coll Elect & Informat Engn, Changsha, Hunan, Peoples R China; [Xia, Zi-An; Luo, Jie-Kun; Cui, Han-Jin; Wang, Yang; Tang, Tao] Cent S Univ, Xiangya Hosp, Dept Integrated Tradit Chinese & Western Med, Lab Ethnopharmacol, Changsha, Hunan, Peoples R China; [Sun, Peng] Shandong Univ Tradit Chinese Med, Coll Pharm, Jinan, Shandong, Peoples R China	Hunan University; Central South University; Shandong University of Traditional Chinese Medicine	Zhou, YT (corresponding author), Hunan Univ, Coll Elect & Informat Engn, Changsha, Hunan, Peoples R China.; Wang, Y; Tang, T (corresponding author), Cent S Univ, Xiangya Hosp, Dept Integrated Tradit Chinese & Western Med, Lab Ethnopharmacol, Changsha, Hunan, Peoples R China.	wangyang_xy87@163.com; falcontang@126.com; yantao_z@hnu.edu.cn			Natural Science Foundation of China [81673719, 61472126, 81473573, 81303074]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (Grant Nos. 81673719, 61472126, 81473573 and 81303074).	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Ali T, 2015, J PINEAL RES, V58, P71, DOI 10.1111/jpi.12194; Bahado-Singh RO, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1044-3; Bartnik-Olson Brenda L, 2013, Front Neuroenergetics, V5, P8, DOI 10.3389/fnene.2013.00008; Benjamini Y, 2014, BIOSTATISTICS, V15, P13, DOI 10.1093/biostatistics/kxt032; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Crack PJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-37; Darrah SD, 2013, EPILEPSY RES, V103, P180, DOI 10.1016/j.eplepsyres.2012.07.006; de Castro J, 2009, EXP MOL PATHOL, V87, P226, DOI 10.1016/j.yexmp.2009.08.002; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Eve DJ, 2016, NEUROPSYCH DIS TREAT, V12, P2689, DOI 10.2147/NDT.S110126; Faul M, 2011, BMJ J, P2002; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Frugier T, 2011, CELL MOL NEUROBIOL, V31, P569, DOI 10.1007/s10571-011-9650-0; Fu SP, 2015, J NEUROENDOCRINOL, V27, P212, DOI 10.1111/jne.12256; Glenn Thomas C, 2013, Acta Neurochir Suppl, V118, P115, DOI 10.1007/978-3-7091-1434-6_20; Gonzalez-Dominguez R, 2016, EBIOMEDICINE, V12, P8, DOI 10.1016/j.ebiom.2016.09.024; Haase-Fielitz A, 2009, CRIT CARE MED, V37, P553, DOI 10.1097/CCM.0b013e318195846e; Higuchi M, 2015, ALZ DIS ASSOC DIS, V29, P200, DOI 10.1097/WAD.0000000000000082; Jeter CB, 2013, J NEUROTRAUM, V30, P671, DOI 10.1089/neu.2012.2491; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Kathryn Beauchamp, 2016, METABOLOMICS, V12, P42; Kim K, 2009, MOL CELL PROTEOMICS, V8, P558, DOI 10.1074/mcp.M800165-MCP200; Knerr I, 2015, PEDIATR RES, V78, P272, DOI 10.1038/pr.2015.107; Lin X, 2014, CARBOHYD POLYM, V101, P533, DOI 10.1016/j.carbpol.2013.09.037; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Louin G, 2007, NITRIC OXIDE-BIOL CH, V17, P91, DOI 10.1016/j.niox.2007.05.006; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI 10.1089/neu.2008-0794; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; Melis GC, 2005, BRIT J NUTR, V94, P19, DOI 10.1079/BJN20051463; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Montero-Barrera D, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/615865; Movsesyan VA, 2001, EXP NEUROL, V167, P366, DOI 10.1006/exnr.2000.7567; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Oresic M, 2016, EBIOMEDICINE, V12, P118, DOI 10.1016/j.ebiom.2016.07.015; Orhan N, 2016, BRAIN RES, V1631, P113, DOI 10.1016/j.brainres.2015.11.038; Paixao L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121042; Pascual JM, 2007, J NEUROTRAUM, V24, P944, DOI 10.1089/neu.2006.0190; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/neu.2004.21.1553; Pilitsis JG, 2003, NEUROSCI LETT, V349, P136, DOI 10.1016/S0304-3940(03)00803-6; Prins ML, 2004, J NEUROCHEM, V90, P666, DOI 10.1111/j.1471-4159.2004.02542.x; Qin HQ, 2012, CHEM COMMUN, V48, P961, DOI 10.1039/c1cc15222j; Ragnarsson KT, 2002, RESTOR NEUROL NEUROS, V20, P103; Ross SA, 1996, BRIT J NEUROSURG, V10, P471, DOI 10.1080/02688699647104; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shen DS, 2016, WASTE MANAGE, V51, P65, DOI 10.1016/j.wasman.2016.02.027; Sheth SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129735; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Stover JF, 2004, ACTA NEUROCHIR, V146, P819, DOI 10.1007/s00701-004-0281-9; Sun M, 1997, PHYSIOL BEHAV, V61, P433, DOI 10.1016/S0031-9384(9X)00455-8; Thomas MH, 2016, BIOCHIMIE, V130, P168, DOI 10.1016/j.biochi.2016.07.013; Tomkins O, 2011, CARDIOVASC PSYCHIAT, V2011, DOI DOI 10.1155/2011/765923; Udy AA, 2017, J NEUROTRAUM, V34, P137, DOI 10.1089/neu.2015.4328; USUI A, 1989, CLIN CHEM, V35, P1942; Vazquez A, 2014, INT J BIOL SCI, V10, P909, DOI 10.7150/ijbs.9214; Veselkov KA, 2011, ANAL CHEM, V83, P5864, DOI 10.1021/ac201065j; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang XJ, 2012, MOL CELL PROTEOMICS, V11, P370, DOI 10.1074/mcp.M111.016006; Wang Y, 2016, MOL MED REP, V14, P3690, DOI 10.3892/mmr.2016.5720; Watts Dorraine D, 2004, Prehosp Emerg Care, V8, P254; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Winkler EA, 2016, NEUROGENETICS, V17, P31, DOI 10.1007/s10048-015-0467-8; Wolahan SM, 2016, NEUROSURG CLIN N AM, V27, P465, DOI 10.1016/j.nec.2016.05.006; Xie GX, 2012, J PROTEOME RES, V11, P3449, DOI 10.1021/pr300318m; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; YAMAZAKI Y, 1995, SURG NEUROL, V43, P267, DOI 10.1016/0090-3019(95)80012-6; Yang SG, 2012, J NEUROTRAUM, V29, P2696, DOI 10.1089/neu.2012.2442; Yi LZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21320; Yuan T, 2015, INT J CLIN EXP PATHO, V8, P5044; Zhang W, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006190; Zhang Y. D., 2016, SHOCK VIB, V2016, P1, DOI DOI 10.1155/2016/1317232; Zhao ZL, 2016, J NEUROL SCI, V364, P12, DOI 10.1016/j.jns.2016.03.007; Zhou YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132088	77	11	11	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182025	10.1371/journal.pone.0182025	http://dx.doi.org/10.1371/journal.pone.0182025			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771528	Green Published, Green Submitted, gold			2022-12-26	WOS:000406853600057
J	Zhou, YY; Wang, YY; Zhu, XF; Liu, R; Xiang, P; Chen, JS; Liu, XY; Duan, YX; Chen, LJ				Zhou, Yuanyuan; Wang, Yuanyuan; Zhu, Xiaofeng; Liu, Rui; Xiang, Peng; Chen, Jingsheng; Liu, Xiaoyu; Duan, Yuxi; Chen, Lijie			Management of the soybean cyst nematode Heterodera glycines with combinations of different rhizobacterial strains on soybean	PLOS ONE			English	Article							PLANT-PARASITIC NEMATODES; MELOIDOGYNE-INCOGNITA; BIOLOGICAL-CONTROL; PAECILOMYCES-LILACINUS; UNITED-STATES	Soybean cyst nematode (SCN) is the most damaging soybean pest worldwide. To improve soybean resistance to SCN, we employed a soybean seed-coating strategy through combination of three rhizobacterial strains, including Bacillus simple, B. megaterium and Sinarhizobium fredii at various ratios. We found seed coating by such rhizobacterial strains at a ratio of 3: 1: 1 (thereafter called SN101) produced the highest germination rate and the mortality of J2 of nematodes. Then, the role of soybean seed coating by SN101 in nematode control was evaluated under both greenhouse and two field conditions in Northeast China in 2013 and 2014. Our results showed that SN101 treatment greatly reduced SCN reproduction and significantly promoted plant growth and yield production in both greenhouse and field trials, suggesting that SN101 is a promising seed-coating agent that may be used as an alternative bio-nematicide for controlling SCN in soybean fields. Our findings also demonstrate that combination of multiple rhizobacterial strains needs to be considered in the seed coating for better management of plant nematodes.	[Zhou, Yuanyuan; Wang, Yuanyuan; Zhu, Xiaofeng; Liu, Rui; Chen, Jingsheng; Liu, Xiaoyu; Duan, Yuxi; Chen, Lijie] Shenyang Agr Univ, Nematol Inst Northern China, Shenyang, Liaoning, Peoples R China; [Xiang, Peng] Heilongjiang Acad Agr Sci, Heihe Branch, Heihe, Heilongjiang, Peoples R China; [Chen, Jingsheng] Heilongjiang Acad Agr Sci, Daqing Branch, Daqing, Heilongjiang, Peoples R China	Shenyang Agricultural University; Heilongjiang Academy of Agricultural Sciences; Heilongjiang Academy of Agricultural Sciences	Duan, YX; Chen, LJ (corresponding author), Shenyang Agr Univ, Nematol Inst Northern China, Shenyang, Liaoning, Peoples R China.	duanyx6407@163.com; chenlj-0210@syau.edu.cn	Zhu, Xiaofeng/AFT-5278-2022	Chen, Lijie/0000-0003-3122-9409	Special Fund for Agro-scientific Research in the Public Interest [201503114]; National Natural Science Foundation of China [31471748]; China Agriculture Research System [CARS-04-PS13]	Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System	This work was supported by the Special Fund for Agro-scientific Research in the Public Interest (201503114), National Natural Science Foundation of China (31471748), and China Agriculture Research System CARS-04-PS13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Special Fund for Agro-scientific Research in the Public Interest (201503114), National Natural Science Foundation of China (31471748), and China Agriculture Research System CARS-04-PS13. We also appreciate Shiyan Chen and Junbo Luan in Cornell University for comments and suggestions on the manuscript.	Abbasi MW, 2014, PLANT SOIL, V375, P159, DOI 10.1007/s11104-013-1931-6; ABDULBAK.AA, 1973, CROP SCI, V13, P630, DOI 10.2135/cropsci1973.0011183X001300060013x; Anastasiadis IA, 2008, CROP PROT, V27, P352, DOI 10.1016/j.cropro.2007.06.008; BECKER JO, 1988, PHYTOPATHOLOGY, V78, P1466, DOI 10.1094/Phyto-78-1466; Cabrera JA, 2010, BIODEGRADATION, V21, P1017, DOI 10.1007/s10532-010-9362-z; Dababat A, 2007, NEMATROPICA, V37, P267; [戴娟 DAI Juan], 2007, [安徽农业科学, Journal of Anhui Agricultural Sciences], V35, P3183; Duan Y, 2011, EUR SPINE J, P1; ELABYAD MS, 1993, PLANT SOIL, V149, P185, DOI 10.1007/BF00016608; Hallmann J, 2001, PHYTOPATHOLOGY, V91, P415, DOI 10.1094/PHYTO.2001.91.4.415; Hashem M, 2011, CROP PROT, V30, P285, DOI 10.1016/j.cropro.2010.12.009; Hussaini SSS A. R., 1975, INDIAN J NEMATOL, V5, P188; HUSSEY RS, 1973, PLANT DIS REP, V57, P1025; JONES MGK, 1981, ANN APPL BIOL, V97, P353, DOI 10.1111/j.1744-7348.1981.tb05122.x; Keawkham T., 2014, Australian Journal of Crop Science, V8, P1415; Khan A, 2006, BIOCONTROL, V51, P643, DOI 10.1007/s10526-005-4241-y; Riggs R.D., 1992, BIOL MANAGEMENT SOYB; RIGGS RD, 1988, J NEMATOL, V20, P392; Siddiqui I. A., 2003, Nematologia Mediterranea, V31, P111; [孙华 SUN Hua], 2009, [大豆科学, Soybean Science], V28, P507; Terefe M, 2009, J INVERTEBR PATHOL, V100, P94, DOI 10.1016/j.jip.2008.11.004; Tian B, 2007, FEMS MICROBIOL ECOL, V61, P197, DOI 10.1111/j.1574-6941.2007.00349.x; Wrather JA, 2006, J NEMATOL, V38, P173; Wrather JA, 2001, CAN J PLANT PATHOL, V23, P122, DOI 10.1080/07060660109506919; [项鹏 Xiang Peng], 2013, [中国生物防治学报, Chinese Journal of Biological Control], V29, P661; [于佰双 YU Bai-shuang], 2009, [大豆科学, Soybean Science], V28, P491; Zeng D, 2011, J YEAST FUNGAL RES, V2, P7; Zeng D., 2012, INT J CARBOHYDR CHEM, V2012, P1, DOI [10.1155/2012/104565, DOI 10.1155/2012/104565]; Zhao Y.S., 2009, SOYBEAN SCI, V28, P114	29	16	17	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182654	10.1371/journal.pone.0182654	http://dx.doi.org/10.1371/journal.pone.0182654			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771591	Green Published, gold, Green Submitted			2022-12-26	WOS:000406853600149
J	Zhu, CH; Song, WT; Tao, ZY; Liu, HX; Xu, WJ; Zhang, SJ; Li, HF				Zhu, Chunhong; Song, Weitao; Tao, Zhiyun; Liu, Hongxiang; Xu, Wenjuan; Zhang, Shuangjie; Li, Huifang			Deep RNA sequencing of pectoralis muscle transcriptomes during late-term embryonic to neonatal development in indigenous Chinese duck breeds	PLOS ONE			English	Article							BINDING-PROTEIN H; SKELETAL-MUSCLE; MESSENGER-RNA; GENE-EXPRESSION; SMOOTH-MUSCLE; IGF-I; GROWTH; ISOFORM; SYNEMIN; LOCALIZATION	Pectoral muscle (PM) comprises an important component of overall meat mass in ducks. However, PM has shown arrested or even reduced growth during late embryonic development, and the molecular mechanisms underlying PM growth during the late embryonic to neonatal period in ducks have not been addressed. In this study, we characterized potential candidate genes and signaling pathways related to PM development using RNA sequencing of PM samples selected at embryonic days (E) 21 and 27 and 5 days post-hatch (dph) in two duck breeds (Gaoyou and Jinding ducks). A total of 393 differentially expressed genes (DEGs) were identified, which showed higher or lower expression levels at E27 compared with E21 and 5 dph, reflecting the pattern of PM growth rates. Among these, 43 DEGs were common to all three time points in both duck breeds. These DEGs may thus be involved in regulating this developmental process. Specifically, KEGG pathway analysis of the 393 DEGs showed that genes involved with different metabolism pathways were highly expressed, while genes involved with cell cycle pathways showed lower expression levels at E27. These DEGs may thus be involved in the mechanisms responsible for the phenomenon of static or decreased breast muscle growth in duck breeds during the late embryonic period. These results increase the available genetic information for ducks and provide valuable resources for analyzing the mechanisms underlying the process of PM development.	[Zhu, Chunhong; Song, Weitao; Tao, Zhiyun; Liu, Hongxiang; Xu, Wenjuan; Zhang, Shuangjie; Li, Huifang] Jiangsu Inst Poultry Sci, Yangzhou, Jiangsu, Peoples R China		Li, HF (corresponding author), Jiangsu Inst Poultry Sci, Yangzhou, Jiangsu, Peoples R China.	zhuch_1304428@126.com			National Natural Science Foundation of China [31172194]; Agricultural science and technology independent innovation project of Jiangsu Province [CX(15)1010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agricultural science and technology independent innovation project of Jiangsu Province	This project was supported by the National Natural Science Foundation of China (31172194) (http://www.nsfc.gov.cn/), Agricultural science and technology independent innovation project of Jiangsu Province (CX(15)1010) (http://www.jsnyzzcx.cn/), received by HFL, CHZ, WTS, ZYT, HXL, WJX, SJZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brozzi F, 2012, MOL BIOL CELL, V23, P4444, DOI 10.1091/mbc.E12-05-0369; Chen L, 2015, ANIM GENET, V46, P299, DOI 10.1111/age.12294; Chen W, 2012, EXP PHYSIOL, V97, P861, DOI 10.1113/expphysiol.2011.01083.x; Clause KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040725; Conti A, 2014, BBA-MOL BASIS DIS, V1842, P99, DOI 10.1016/j.bbadis.2013.10.013; Dees E, 2012, DIS MODEL MECH, V5, P468, DOI 10.1242/dmm.008680; Frey N, 2008, J CLIN INVEST, V118, P3598, DOI 10.1172/JCI36277; Garcia-Pelagio KP, 2015, AM J PHYSIOL-CELL PH, V308, pC448, DOI 10.1152/ajpcell.00331.2014; Gizak A, 2005, J MOL HISTOL, V36, P243, DOI 10.1007/s10735-005-6523-1; Gizak A, 2004, FEBS LETT, V576, P445, DOI 10.1016/j.febslet.2004.09.050; GOODSON HV, 1994, J CELL SCI, V107, P1875; Guo ZX, 2016, ASIAN AUSTRALASIAN J; Hu Y, 2015, GENE, V567, P235, DOI 10.1016/j.gene.2015.05.001; Hu Y, 2015, GENE, V559, P38, DOI 10.1016/j.gene.2015.01.009; Huang YH, 2013, NAT GENET, V45, P776, DOI 10.1038/ng.2657; Indrakusuma I, 2015, CURR OBES REP, V4, P411, DOI 10.1007/s13679-015-0174-7; Jiang L, 2015, SCI REP-UK, V5, DOI 10.1038/srep08031; Jin JP, 2016, INT REV CEL MOL BIO, V321, P1, DOI 10.1016/bs.ircmb.2015.09.002; Jin JP, 1996, BIOCHEM BIOPH RES CO, V225, P883, DOI 10.1006/bbrc.1996.1267; Ju YW, 2013, GENESIS, V51, P667, DOI 10.1002/dvg.22407; Jung J, 1998, ARCH PHARM RES, V21, P712, DOI 10.1007/BF02976763; Kim DG, 2014, ENDOCRINOL METAB, V29, P185, DOI 10.3803/EnM.2014.29.2.185; Li HF, 2016, J INTEGR AGR, V15, P403, DOI 10.1016/S2095-3119(14)60949-7; Li MX, 2015, GENE, V571, P153, DOI 10.1016/j.gene.2015.07.074; Li X, 2015, GENE, V570, P221, DOI 10.1016/j.gene.2015.06.022; Li ZL, 2014, J CELL SCI, V127, P4589, DOI 10.1242/jcs.143164; Liao BS, 2005, J BIOL CHEM, V280, P18517, DOI 10.1074/jbc.M500270200; Liu C, 2010, AM J PHYSIOL-CELL PH, V298, pC1100, DOI 10.1152/ajpcell.00553.2009; Liu YL, 2016, POULTRY SCI, V95, P1396, DOI 10.3382/ps/pew043; Ma JJ, 2015, TRANSGENIC RES, V24, P409, DOI 10.1007/s11248-014-9849-1; Ma XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117294; Martins TS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139943; Mizuno Y, 2009, MUSCLE NERVE, V39, P634, DOI 10.1002/mus.21221; Moore D. T., 2005, International Journal of Poultry Science, V4, P138; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mullen AJ, 2000, GENE, V242, P313, DOI 10.1016/S0378-1119(99)00519-3; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Paul M, 2016, METHOD ENZYMOL, V568, P537, DOI 10.1016/bs.mie.2015.08.005; Picard B, 2002, REPROD NUTR DEV, V42, P415, DOI 10.1051/rnd:2002035; Piorkowska K, 2016, ANIM GENET, V47, P68, DOI 10.1111/age.12388; Rabiee F, 2014, GENE, V551, P127, DOI 10.1016/j.gene.2014.08.045; Rai M., 2016, MECH DEV; Robertson JB, 2008, DEV DYNAM, V237, P1424, DOI 10.1002/dvdy.21544; Shafqat N, 2013, J INHERIT METAB DIS, V36, P983, DOI 10.1007/s10545-013-9589-z; Sheng JJ, 2016, GENE, V576, P385, DOI 10.1016/j.gene.2015.10.052; Shu JT, 2015, DEV GENES EVOL, V225, P139, DOI 10.1007/s00427-015-0501-8; Srinivasa S, 2016, GROWTH HORM IGF RES, V26, P36, DOI 10.1016/j.ghir.2015.12.008; Su R, 2014, GENET MOL RES, V13, P10308, DOI 10.4238/2014.December.4.26; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wei B, 2016, GENE, V582, P1, DOI 10.1016/j.gene.2016.01.006; Xu TS, 2015, GENET MOL RES, V14, P4448, DOI 10.4238/2015.May.4.2; Xu TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107574; Yang H, 2011, MOL BIOL REP, V38, P827, DOI 10.1007/s11033-010-0172-5; Zhang RP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143378	55	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0180403	10.1371/journal.pone.0180403	http://dx.doi.org/10.1371/journal.pone.0180403			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771592	gold, Green Published, Green Submitted			2022-12-26	WOS:000406853600004
J	Vargas, A; Kim, HS; Baral, E; Yu, WQ; Craft, CM; Lee, EJ				Vargas, Andrew; Kim, Hwa Sun; Baral, Erika; Yu, Wan-Qing; Craft, Cheryl Mae; Lee, Eun-Jin			Protective effect of clusterin on rod photoreceptor in rat model of retinitis pigmentosa	PLOS ONE			English	Article							INDUCED RETINAL DEGENERATION; STRESS-INDUCED APOPTOSIS; FACTOR-BETA ISOFORMS; MOUSE RETINA; APOLIPOPROTEIN-J/CLUSTERIN; OXIDATIVE STRESS; GROWTH-FACTOR; CELL-DEATH; SULFATED GLYCOPROTEIN-2; SIGNALING PATHWAY	Retinitis Pigmentosa (RP) begins with the death of rod photoreceptors and is slowly followed by a gradual loss of cones and a rearrangement of the remaining retinal neurons. Clusterin is a chaperone protein that protects cells and is involved in various pathophysiological stresses, including retinal degeneration. Using a well-established transgenic rat model of RP (rhodopsin S334ter), we investigated the effects of clusterin on rod photoreceptor survival. To investigate the role of clusterin in S334ter-line3 retinas, Voronoi analysis and immunohistochemistry were used to evaluate the geometry of rod distribution. Additionally, immunoblot analysis, Bax activation, STAT3 and Akt phosphorylation were used to evaluate the pathway involved in rod cell protection. In this study, clusterin (10 mu g/ml) intravitreal treatment produced robust preservation of rod photoreceptors in S334ter-line3 retina. The mean number of rods in 1mm(2) was significantly greater in clusterin injected RP retinas (postnatal (P) 30, P45, P60, & P75) than in age-matched saline injected RP retinas (P<0.01). Clusterin activated Akt, STAT3 and significantly reduced Bax activity; in addition to inducing phosphorylated STAT3 in Muller cells, which suggests it may indirectly acts on photoreceptors. Thus, clusterin treatment may interferes with mechanisms leading to rod death by suppressing cell death through activation of Akt and STAT3, followed by Bax suppression. Novel insights into the pathway of how clusterin promotes the rod cell survival suggest this treatment may be a potential therapeutic strategy to slow progression of vision loss in human RP.	[Vargas, Andrew; Kim, Hwa Sun; Baral, Erika; Yu, Wan-Qing; Craft, Cheryl Mae; Lee, Eun-Jin] Univ Southern Calif, Keck Sch Med, Dept Ophthalmol, Mary Allen Lab Vis Res,USC Roski Eye Inst, Los Angeles, CA 90033 USA; [Yu, Wan-Qing] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Craft, Cheryl Mae] Univ Southern Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA; [Craft, Cheryl Mae] Univ Southern Calif, Neurosci Grad Program, Los Angeles, CA USA; [Lee, Eun-Jin] Univ Southern Calif, Dept Biomed Engn, Viterbi Sch Engn, Los Angeles, CA 90089 USA	University of Southern California; University of Washington; University of Washington Seattle; University of Southern California; University of Southern California; University of Southern California	Lee, EJ (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Ophthalmol, Mary Allen Lab Vis Res,USC Roski Eye Inst, Los Angeles, CA 90033 USA.; Lee, EJ (corresponding author), Univ Southern Calif, Dept Biomed Engn, Viterbi Sch Engn, Los Angeles, CA 90089 USA.	eunjinl@usc.edu		Yu, Wan-Qing/0000-0002-9275-391X	VSoE Research Innovation Fund [EY015851, EY03040]; Research to Prevent Blindness; Mary D. Allen Foundation; William Hansen Sandberg Memorial Foundation	VSoE Research Innovation Fund; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Mary D. Allen Foundation; William Hansen Sandberg Memorial Foundation	This study was supported by the VSoE Research Innovation Fund (data collection and analysis); EY015851 and EY03040 (data collection and analysis); Research to Prevent Blindness (data collection and analysis); Mary D. Allen Foundation, Dorie Miller, and the William Hansen Sandberg Memorial Foundation (preparation of the manuscript).	Agarwal N, 1996, BIOCHEM BIOPH RES CO, V225, P84, DOI 10.1006/bbrc.1996.1134; Ammar H, 2008, J BIOL CHEM, V283, P12851, DOI 10.1074/jbc.M800403200; ANDERSON DH, 1995, J NEUROSCI RES, V42, P63, DOI 10.1002/jnr.490420108; Arango-Gonzalez B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112142; ARONOW BJ, 1993, P NATL ACAD SCI USA, V90, P725, DOI 10.1073/pnas.90.2.725; Baig S, 2012, J ALZHEIMERS DIS, V28, P337, DOI 10.3233/JAD-2011-110473; Bajari TM, 2003, FASEB J, V17, P1505, DOI 10.1096/fj.02-1106fje; Bakbak Berker, 2016, Oman J Ophthalmol, V9, P44, DOI 10.4103/0974-620X.176100; Berger W, 2010, PROG RETIN EYE RES, V29, P335, DOI 10.1016/j.preteyeres.2010.03.004; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Buonfiglio DC, 2014, MOL VIS, V20, P742; Cao RH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002748; Carroll J, 2004, P NATL ACAD SCI USA, V101, P8461, DOI 10.1073/pnas.0401440101; Carver JA, 2003, IUBMB LIFE, V55, P661, DOI 10.1080/15216540310001640498; CHALAZONITIS A, 1992, J NEUROSCI, V12, P583; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; Choi SS, 2006, INVEST OPHTH VIS SCI, V47, P2080, DOI 10.1167/iovs.05-0997; Concepcion F, 2002, VISION RES, V42, P417, DOI 10.1016/S0042-6989(01)00195-X; Concepcion F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010904; Cregan SP, 1999, J NEUROSCI, V19, P7860; Delyfer MN, 2005, MOL VIS, V11, P688; DeMarco PJ, 2007, DOC OPHTHALMOL, V115, P155, DOI 10.1007/s10633-007-9078-5; Deming JD, 2015, INVEST OPHTH VIS SCI, V56, P7618, DOI 10.1167/iovs.15-17832; Deming JD, 2015, CELL SIGNAL, V27, P2002, DOI 10.1016/j.cellsig.2015.06.008; DESILVA HV, 1990, BIOCHEMISTRY-US, V29, P5380, DOI 10.1021/bi00474a025; Dorrell MI, 2009, J CLIN INVEST, V119, P611, DOI 10.1172/JCI35977; DRYJA TP, 1990, NATURE, V347, P614, DOI 10.1038/347614a0; DUGUID JR, 1989, P NATL ACAD SCI USA, V86, P7260, DOI 10.1073/pnas.86.18.7260; Duncan JL, 2007, INVEST OPHTH VIS SCI, V48, P3283, DOI 10.1167/iovs.06-1422; Er E, 2006, BBA-BIOENERGETICS, V1757, P1301, DOI 10.1016/j.bbabio.2006.05.032; FARBER DB, 1974, SCIENCE, V186, P449, DOI 10.1126/science.186.4162.449; FARNSWORTH CC, 1976, BIOCHIM BIOPHYS ACTA, V443, P556, DOI 10.1016/0005-2787(76)90517-7; Fujieda H, 2009, J NEUROCHEM, V108, P91, DOI 10.1111/j.1471-4159.2008.05739.x; Garcia-Ayuso D, 2013, INVEST OPHTH VIS SCI, V54, P5888, DOI 10.1167/iovs.13-12643; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; Gil SY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2896; Green ES, 2000, INVEST OPHTH VIS SCI, V41, P1546; Gwon JS, 2004, GLIA, V47, P35, DOI 10.1002/glia.20021; Hanhart J, 2014, EYE, V28, P646, DOI 10.1038/eye.2014.94; Harada T, 2000, NEURON, V26, P533, DOI 10.1016/S0896-6273(00)81185-X; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Heller AR, 2003, SHOCK, V20, P166, DOI 10.1097/01.shk.0000075569.93053.b3; HenrichNoack P, 1996, STROKE, V27, P1609, DOI 10.1161/01.STR.27.9.1609; Holtzman DM, 2001, NAT MED, V7, P977, DOI 10.1038/nm0901-977; JENNE DE, 1992, TRENDS BIOCHEM SCI, V17, P154, DOI 10.1016/0968-0004(92)90325-4; JENNE DE, 1989, P NATL ACAD SCI USA, V86, P7123, DOI 10.1073/pnas.86.18.7123; Jeong S, 2012, AM J PATHOL, V180, P2028, DOI 10.1016/j.ajpath.2012.01.025; Ji Y, 2015, INVEST OPHTH VIS SCI, V56, P352, DOI 10.1167/iovs.14-15398; Ji Y, 2012, J COMP NEUROL, V520, P874, DOI 10.1002/cne.22800; Joly S, 2008, J NEUROSCI, V28, P13765, DOI 10.1523/JNEUROSCI.5114-08.2008; JOMARY C, 1993, MOL BRAIN RES, V20, P279, DOI 10.1016/0169-328X(93)90053-R; JOMARY C, 1995, MOL BRAIN RES, V29, P172, DOI 10.1016/0169-328X(94)00252-A; Jomary C, 1999, J NEUROCHEM, V72, P1923, DOI 10.1046/j.1471-4159.1999.0721923.x; Jones BW, 2005, EXP EYE RES, V81, P123, DOI 10.1016/j.exer.2005.03.006; JONES SE, 1992, FEBS LETT, V300, P279, DOI 10.1016/0014-5793(92)80863-C; Jones SE, 2002, INT J BIOCHEM CELL B, V34, P427, DOI 10.1016/S1357-2725(01)00155-8; Jun HO, 2011, EXP MOL MED, V43, P53, DOI 10.3858/emm.2011.43.1.006; Kim JH, 2007, CURR EYE RES, V32, P693, DOI 10.1080/02713680701487871; Kim JH, 2010, INVEST OPHTH VIS SCI, V51, P561, DOI 10.1167/iovs.09-3774; Kim JH, 2010, INVEST OPHTH VIS SCI, V51, P1659, DOI 10.1167/iovs.09-3615; Kim YS, 2003, BRAIN RES, V976, P53, DOI 10.1016/S0006-8993(03)02636-2; KIRSZBAUM L, 1989, EMBO J, V8, P711, DOI 10.1002/j.1460-2075.1989.tb03430.x; Kitamura M, 1998, EXP NEPHROL, V6, P1; Klimaschewski L, 2001, CELL TISSUE RES, V306, P209, DOI 10.1007/s004410100431; Koltai T, 2014, ONCOTARGETS THER, V7, P447, DOI 10.2147/OTT.S58622; Kooragayala K, 2015, INVEST OPHTH VIS SCI, V56, P8428, DOI 10.1167/iovs.15-17901; LaVail MM, 1998, INVEST OPHTH VIS SCI, V39, P592; Lee ES, 2007, INVEST OPHTH VIS SCI, V48, P2868, DOI 10.1167/iovs.06-0035; Lee EJ, 2011, GLIA, V59, P1107, DOI 10.1002/glia.21183; Leeb C, 2014, J BIOL CHEM, V289, P4161, DOI 10.1074/jbc.M113.529271; Lehre KP, 1997, BRAIN RES, V744, P129, DOI 10.1016/S0006-8993(96)01022-0; Li N, 2013, ONCOGENE, V32, P1933, DOI 10.1038/onc.2012.212; Li W, 2010, NAT NEUROSCI, V13, P414, DOI 10.1038/nn.2507; Lin JH, 2010, ADV EXP MED BIOL, V664, P115, DOI 10.1007/978-1-4419-1399-9_14; Liu L, 1999, EXP NEUROL, V157, P69, DOI 10.1006/exnr.1999.7046; LOLLEY RN, 1994, INVEST OPHTH VIS SCI, V35, P358; LUTTY GA, 1993, INVEST OPHTH VIS SCI, V34, P477; Ma CY, 1998, P NATL ACAD SCI USA, V95, P9938, DOI 10.1073/pnas.95.17.9938; Machida S, 2000, INVEST OPHTH VIS SCI, V41, P3200; Marc RE, 2003, MOL NEUROBIOL, V28, P139, DOI 10.1385/MN:28:2:139; Marc RE, 2003, PROG RETIN EYE RES, V22, P607, DOI 10.1016/S1350-9462(03)00039-9; MAY PC, 1992, TRENDS NEUROSCI, V15, P391, DOI 10.1016/0166-2236(92)90190-J; MAY PC, 1990, NEURON, V5, P831, DOI 10.1016/0896-6273(90)90342-D; MCGEER PL, 1992, BRAIN RES, V579, P337, DOI 10.1016/0006-8993(92)90071-G; Mclaughlin L, 2000, J CLIN INVEST, V106, P1105, DOI 10.1172/JCI9037; MessmerJoudrier S, 1996, EUR J NEUROSCI, V8, P2652, DOI 10.1111/j.1460-9568.1996.tb01560.x; MICHEL D, 1992, SYNAPSE, V11, P105, DOI 10.1002/syn.890110203; Millis AJT, 2001, J CELL PHYSIOL, V186, P210, DOI 10.1002/1097-4652(200102)186:2<210::AID-JCP1019>3.0.CO;2-N; Miyata M, 2001, CIRCULATION, V104, P1407, DOI 10.1161/hc3701.095583; MOLDAY RS, 1987, J CELL BIOL, V105, P2589, DOI 10.1083/jcb.105.6.2589; Navab M, 1997, J CLIN INVEST, V99, P2005, DOI 10.1172/JCI119369; Nizard P, 2007, TRAFFIC, V8, P554, DOI 10.1111/j.1600-0854.2007.00549.x; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Price BA, 2011, INVEST OPHTH VIS SCI, V52, P9728, DOI 10.1167/iovs.11-8654; Pucci S, 2004, ONCOGENE, V23, P2298, DOI 10.1038/sj.onc.1207404; Pucci S, 2009, CELL CYCLE, V8, P473, DOI 10.4161/cc.8.3.7652; Punzo C, 2012, J BIOL CHEM, V287, P1642, DOI 10.1074/jbc.R111.304428; Rauen T, 1996, CELL TISSUE RES, V286, P325, DOI 10.1007/s004410050702; Ray A, 2010, CELL TISSUE RES, V339, P481, DOI 10.1007/s00441-009-0916-5; Reddy KB, 1996, BIOCHEMISTRY-US, V35, P6157, DOI 10.1021/bi952981b; Rey-Funes M, 2011, J NEUROSCI RES, V89, P729, DOI 10.1002/jnr.22556; Rohne P, 2014, CELL PHYSIOL BIOCHEM, V34, P1626, DOI 10.1159/000366365; Rohrer B, 2005, INVEST OPHTH VIS SCI, V46, P3876, DOI 10.1167/iovs.05-0533; Rosenberg ME, 2002, MOL CELL BIOL, V22, P1893, DOI 10.1128/MCB.22.6.1893-1902.2002; ROSENBERG ME, 1995, INT J BIOCHEM CELL B, V27, P633, DOI 10.1016/1357-2725(95)00027-M; Rossi EA, 2011, EYE, V25, P301, DOI 10.1038/eye.2010.221; Sadamitsu C, 2001, J BIOCHEM, V129, P813, DOI 10.1093/oxfordjournals.jbchem.a002924; Shen JK, 2005, J CELL PHYSIOL, V203, P457, DOI 10.1002/jcp.20346; Shim YJ, 2011, J LEUKOCYTE BIOL, V90, P761, DOI 10.1189/jlb.0311110; Shin JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167102; Shin JA, 2015, EXP EYE RES, V140, P41, DOI 10.1016/j.exer.2015.08.005; Song Y, 2003, INVEST OPHTH VIS SCI, V44, P4069, DOI 10.1167/iovs.02-1130; Stone J, 2008, BRAIN RES, V1189, P58, DOI 10.1016/j.brainres.2007.10.083; Strettoi E, 2004, J NEUROSCI, V24, P7576, DOI 10.1523/JNEUROSCI.2245-04.2004; Suzuki S, 2004, JPN J OPHTHALMOL, V48, P345, DOI 10.1007/s10384-004-0084-9; Trougakos IP, 2009, CLIN CANCER RES, V15, P48, DOI 10.1158/1078-0432.CCR-08-1805; Trougakos IP, 2002, INT J BIOCHEM CELL B, V34, P1430, DOI 10.1016/S1357-2725(02)00041-9; Tsuruta F, 2002, J BIOL CHEM, V277, P14040, DOI 10.1074/jbc.M108975200; Ueki Y, 2009, P NATL ACAD SCI USA, V106, P21389, DOI 10.1073/pnas.0906156106; UNSICKER K, 1991, NEUROSCIENCE, V44, P613, DOI 10.1016/0306-4522(91)90082-Y; Veleri S, 2015, DIS MODEL MECH, V8, P109, DOI 10.1242/dmm.017913; Wahlin KJ, 2000, INVEST OPHTH VIS SCI, V41, P927; Wang SM, 2008, INVEST OPHTH VIS SCI, V49, P3201, DOI 10.1167/iovs.08-1831; Wen R, 2008, ADV EXP MED BIOL, V613, P407, DOI 10.1007/978-0-387-74904-4_48; Wen R, 2006, J NEUROSCI, V26, P13523, DOI 10.1523/JNEUROSCI.4021-06.2006; Wilson MR, 2000, TRENDS BIOCHEM SCI, V25, P95, DOI 10.1016/S0968-0004(99)01534-0; WONG P, 1994, BIOCHEM CELL BIOL, V72, P489, DOI 10.1139/o94-066; WONG P, 1994, BIOCHEM CELL BIOL, V72, P499, DOI 10.1139/o94-067; WONG P, 1993, J BIOL CHEM, V268, P5021; Wong P, 2001, CURR EYE RES, V23, P157, DOI 10.1076/ceyr.23.3.157.5463; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717; Wu HM, 2006, AM J HUM GENET, V79, P574, DOI 10.1086/507568; Xia XA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016556; Xie MJ, 2001, PANCREAS, V22, P126, DOI 10.1097/00006676-200103000-00004; Yang CR, 2000, P NATL ACAD SCI USA, V97, P5907, DOI 10.1073/pnas.97.11.5907; Yu B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151542; Yu WQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151668; Yu WQ, 2017, J NEUROPHYSIOL; Zhang CH, 2016, DISCOV MED, V21, P227; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291; Zhao XF, 2014, CELL REP, V9, P272, DOI 10.1016/j.celrep.2014.08.047; Zhou Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099665; Zhu CL, 2013, CELL TISSUE RES, V351, P29, DOI 10.1007/s00441-012-1522-5	143	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182389	10.1371/journal.pone.0182389	http://dx.doi.org/10.1371/journal.pone.0182389			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767729	gold, Green Published, Green Submitted			2022-12-26	WOS:000406768200076
J	Adegboye, OA; Gayawan, E; Hanna, F				Adegboye, Oyelola A.; Gayawan, Ezra; Hanna, Fahad			Spatial modelling of contribution of individual level risk factors for mortality from Middle East respiratory syndrome coronavirus in the Arabian Peninsula	PLOS ONE			English	Article							BAYESIAN P-SPLINES; MERS-CORONAVIRUS; TRANSMISSION; DISEASE; CHINA; COV	Background Middle East respiratory syndrome coronavirus is a contagious respiratory pathogen that is contracted via close contact with an infected subject. Transmission of the pathogen has occurred through animal-to-human contact at first followed by human-to-human contact within families and health care facilities. Data and methods This study is based on a retrospective analysis of the Middle East respiratory syndrome coronavirus outbreak in the Kingdom of Saudi Arabia between June 2012 and July 2015. A Geoadditive variable model for binary outcomes was applied to account for both individual level risk factors as well spatial variation via a fully Bayesian approach. Results Out of 959 confirmed cases, 642 (67%) were males and 317 (33%) had died. Three hundred and sixty four (38%) cases occurred in Ar Riyad province, while 325 (34%) cases occurred in Makkah. Individuals with some comorbidity had a significantly higher likelihood of dying from MERS-CoV compared with those who did not suffer comorbidity [Odds ratio (OR) = 2.071; 95% confidence interval (CI): 1.307, 3.263]. Health-care workers were significantly less likely to die from the disease compared with non-health workers [OR = 0.372, 95% CI: 0.151, 0.827]. Patients who had fatal clinical experience and those with clinical and subclinical experiences were equally less likely to die from the disease compared with patients who did not have fatal clinical experience and those without clinical and subclinical experiences respectively. The odds of dying from the disease was found to increase as age increased beyond 25 years and was much higher for individuals with any underlying comorbidities. Conclusion Interventions to minimize mortality from the Middle East respiratory syndrome coronavirus should particularly focus individuals with comorbidity, non-health-care workers, patients with no clinical fatal experience, and patients without any clinical and subclinical experiences.	[Adegboye, Oyelola A.] Qatar Univ, Dept Math Stat & Phys, Coll Arts & Sci, Doha 2713, Qatar; [Gayawan, Ezra] Fed Univ Technol Akure, Dept Stat, Akure, Nigeria; [Hanna, Fahad] Qatar Univ, Dept Publ Hlth, Coll Hlth Sci, Doha 2713, Qatar	Qatar University; Qatar University	Hanna, F (corresponding author), Qatar Univ, Dept Publ Hlth, Coll Hlth Sci, Doha 2713, Qatar.	fhanna@qu.edu.qa	Gayawan, Ezra/H-4158-2019; Adegboye, Oyelola A/A-2987-2015; Hanna, Fahad/J-2602-2019	Adegboye, Oyelola A/0000-0002-9793-8024; Hanna, Fahad/0000-0002-0494-9585; Gayawan, Ezra/0000-0001-7702-4586				Adebayo SB, 2016, SPAT SPATIO-TEMPORAL, V17, P105, DOI 10.1016/j.sste.2016.04.011; Adegboye O. A., 2012, Asian Pacific Journal of Tropical Disease, V2, P253, DOI 10.1016/S2222-1808(12)60056-5; Adegboye OA, 2016, EPIDEMIOL INFECT, P1; Adegboye OA, 2018, APPL STAT, V67, P1; Agresti A., 2011, CATEGORICAL DATA ANA; Alqurashi KA, 2011, ANN SAUDI MED, V31, P19, DOI 10.4103/0256-4947.75773; Alraddadi B.M., 2016, EMERG INFECT DIS, V22; Assiri A, 2013, LANCET INFECT DIS, V13, P752, DOI 10.1016/S1473-3099(13)70204-4; Belitz C, 2009, BAYESX SOFTWARE BAYE; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Brezger A, 2006, COMPUT STAT DATA AN, V50, P967, DOI 10.1016/j.csda.2004.10.011; Brezger A., 2003, BAYESX ANAL BAYESIAN; Cauchemez S, 2013, EUROPEAN COMMUNICABL, V18; Centers for Disease Control and Prevention, 2014, CDC HLTH INF INT TRA; Chowell G, 2014, EPIDEMICS-NETH, V9, P40, DOI 10.1016/j.epidem.2014.09.011; Cowling BJ, 2015, EUROPEAN COMMUNICABL, V20; Drosten C, 2014, NEW ENGL J MED, V371, P828, DOI 10.1056/NEJMoa1405858; Fahrmeir L, 2004, STAT SINICA, V14, P731; Fahrmeir L, 2001, J ROY STAT SOC C-APP, V50, P201, DOI 10.1111/1467-9876.00229; Graham RL, 2013, NAT REV MICROBIOL, V11, P836, DOI 10.1038/nrmicro3143; Jackson MC, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-55; Khatab K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159173; Khatab K, 2009, AM J TROP MED HYG, V81, P116, DOI 10.4269/ajtmh.2009.81.116; Kucharski A, 2014, PLOS CURR, P6; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Lang S, 2004, J COMPUT GRAPH STAT, V13, P183, DOI 10.1198/1061860043010; Mackay IM, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0439-5; Ministry of Health SA, 2014, INT PREV CONTR MAN G; Oboho IK, 2015, NEW ENGL J MED, V372, P846, DOI 10.1056/NEJMoa1408636; Raj VS, 2014, CURR OPIN VIROL, V5, P58, DOI 10.1016/j.coviro.2014.01.010; Rambaut A., 2013, MERS COV SPATIAL TEM; Reusken CBEM, 2013, LANCET INFECT DIS, V13, P859, DOI 10.1016/S1473-3099(13)70164-6; Rivers CM, 2016, AM J EPIDEMIOL, V184, P460, DOI 10.1093/aje/kww013; SAS Institute Inc, 2011, BAS SAS 9 3 PROC GUI; Sep J, 2015, OUTBREAKS UNEXPLAINE, P61; Su S, 2015, LANCET, V385, P2349, DOI 10.1016/S0140-6736(15)60859-5; van Doremalen N, 2013, EUROSURVEILLANCE, V18, P7, DOI 10.2807/1560-7917.ES2013.18.38.20590; Wang JF, 2016, ECOL INDIC, V67, P250, DOI 10.1016/j.ecolind.2016.02.052; Wang JF, 2010, INT J GEOGR INF SCI, V24, P107, DOI 10.1080/13658810802443457; Watson JT, 2014, EMERG INFECT DIS, V20, P1054, DOI 10.3201/eid2006.140322; WHO MERS-CoV Research Group and others, 2013, PLOS CURRENTS OUTBRE; Yao YF, 2014, J INFECT DIS, V209, P236, DOI 10.1093/infdis/jit590	43	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0181215	10.1371/journal.pone.0181215	http://dx.doi.org/10.1371/journal.pone.0181215			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759623	gold, Green Published, Green Accepted			2022-12-26	WOS:000406761600012
J	Eggenberger, P; Tomovic, S; Munzer, T; de Bruin, ED				Eggenberger, Patrick; Tomovic, Sara; Munzer, Thomas; de Bruin, Eling D.			Older adults must hurry at pedestrian lights! A cross-sectional analysis of preferred and fast walking speed under single- and dual-task conditions	PLOS ONE			English	Article							MULTICOMPONENT PHYSICAL-EXERCISE; RANDOMIZED CONTROLLED-TRIAL; GAITRITE(R) WALKWAY SYSTEM; GAIT SPEED; COGNITIVE PERFORMANCE; COMMUNITY AMBULATION; MEANINGFUL CHANGE; ENOUGH TIME; PREDICTION; MORTALITY	Slow walking speed is strongly associated with adverse health outcomes, including cognitive impairment, in the older population. Moreover, adequate walking speed is crucial to maintain older pedestrians' mobility and safety in urban areas. This study aimed to identify the proportion of Swiss older adults that didn't reach 1.2 m/s, which reflects the requirements to cross streets within the green-yellow phase of pedestrian lights, when walking fast under cognitive challenge. A convenience sample, including 120 older women (65%) and men, was recruited from the community (88%) and from senior residences and divided into groups of 70-79 years (n = 59, 74.8 +/- 0.4 y; mean +/- SD) and >= 80 years (n = 61, 85.5 +/- 0.5 y). Steady state walking speed was assessed under single-and dual-task conditions at preferred and fast walking speed. Additionally, functional lower extremity strength (5-chair-rises test), subjective health rating, and retrospective estimates of fall frequency were recorded. Results showed that 35.6% of the younger and 73.8% of the older participants were not able to walk faster than 1.2 m/s under the fast dual-task walking condition. Fast dual-task walking speed was higher compared to the preferred speed single-and dual-task conditions (all p < .05, r = .31 to .48). Average preferred single-task walking speed was 1.19 +/- 0.24 m/s (70-79 y) and 0.94 +/- 0.27 m/s (>= 80 y), respectively, and correlated with performance in the 5-chairrises test (r(s) = -.49, p < .001), subjective health (tau = .27, p < .001), and fall frequency (tau = -.23, p = .002). We conclude that the fitness status of many older people is inadequate to safely cross streets at pedestrian lights and maintain mobility in the community's daily life in urban areas. Consequently, training measures to improve the older population's cognitive and physical fitness should be promoted to enhance walking speed and safety of older pedestrians.	[Eggenberger, Patrick; de Bruin, Eling D.] ETH, Dept Hlth Sci & Technol, Inst Human Movement Sci & Sport, Zurich, Switzerland; [Tomovic, Sara] Zurich Univ Appl Sci, Sch Hlth Profess, Inst Physiotherapy, Winterthur, Switzerland; [Tomovic, Sara; Munzer, Thomas] Geriatr Klin St Gallen, St Gallen, Switzerland; [de Bruin, Eling D.] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Epidemiol, Maastricht, Netherlands; [de Bruin, Eling D.] Maastricht Univ, Ctr Evidence Based Physiotherapy, Maastricht, Netherlands	Swiss Federal Institutes of Technology Domain; ETH Zurich; Zurich University of Applied Sciences; Maastricht University; Maastricht University	Eggenberger, P (corresponding author), ETH, Dept Hlth Sci & Technol, Inst Human Movement Sci & Sport, Zurich, Switzerland.	patrick.eggenberger@hest.ethz.ch	de Bruin, Eling D./A-4751-2011	de Bruin, Eling D./0000-0002-6542-7385	Zurcher Kantonalbank [ZKB-01 10-3]	Zurcher Kantonalbank	The work of PE and EDdB was supported by the Zurcher Kantonalbank (Grant Number: ZKB-01 10-3, Grant Recipient: EDdB) within the framework of sponsoring of movement sciences, sports and nutritional sciences at ETH Zurich. Zurcher Kantonalbank had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Yahya E, 2011, NEUROSCI BIOBEHAV R, V35, P715, DOI 10.1016/j.neubiorev.2010.08.008; Amosun S. L., 2007, Physiotherapy Theory and Practice, V23, P325, DOI 10.1080/09593980701593755; [Anonymous], 2016, FALLS FACT SHEET; [Anonymous], 2016, LOCATION FIGURES FAC; [Anonymous], 2014, STAT ALT PFLEG; [Anonymous], 1992, LICHTSIGNALANLAGEN U; Asher L, 2012, AGE AGEING, V41, P690, DOI 10.1093/ageing/afs076; Beurskens R, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/131608; Bilney B, 2003, GAIT POSTURE, V17, P68, DOI 10.1016/S0966-6362(02)00053-X; Bohannon RW, 2011, PHYSIOTHERAPY, V97, P182, DOI 10.1016/j.physio.2010.12.004; Bollard E, 2013, PHYSIOTHER THEOR PR, V29, P142, DOI 10.3109/09593985.2012.703760; Brown KC, 2015, GERONTOL GERIATR MED, V1; Brunnekreef JJ, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-17; Busch TD, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0031-2; Butler AA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152617; Chang YK, 2012, J AGING PHYS ACTIV, V20, P497, DOI 10.1123/japa.20.4.497; Chen PJ, 2012, J AM MED DIR ASSOC, V13, P517, DOI 10.1016/j.jamda.2012.02.002; Chu YH, 2013, GERIATR GERONTOL INT, V13, P289, DOI 10.1111/j.1447-0594.2012.00893.x; Cohen J.E., 1988, STAT POWER ANAL BEHA; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Corrigan R, 2008, DISABIL REHABIL, V30, P1411, DOI 10.1080/09638280701654542; de Bruin ED, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-59; Dommes A, 2013, ACCIDENT ANAL PREV, V59, P135, DOI 10.1016/j.aap.2013.05.017; Donoghue OA, 2016, J AGING HEALTH, V28, P850, DOI 10.1177/0898264315614004; Dumurgier Julien, 2009, BMJ, V339, pb4460, DOI 10.1136/bmj.b4460; Eggenberger P, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00066; Eggenberger P, 2015, CLIN INTERV AGING, V10, P1711, DOI 10.2147/CIA.S91997; Eggenberger P, 2015, CLIN INTERV AGING, V10, P1335, DOI 10.2147/CIA.S87732; Forte R, 2015, INT J ENV RES PUB HE, V12, P11328, DOI 10.3390/ijerph120911328; Franklin BA, 2015, AM J CARDIOL, V116, P313, DOI 10.1016/j.amjcard.2015.04.024; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fritz S, 2009, J GERIATR PHYS THER, V32, P2, DOI 10.1519/00139143-200932020-00002; Fuster J.M, 2003, CORTEX MIND UNIFYING; Gazzaley A, 2006, CORTEX, V42, P1037, DOI DOI 10.1016/S0010-9452(08)70211-9; Geraghty J, 2016, ACCIDENT ANAL PREV, V89, P151, DOI 10.1016/j.aap.2015.12.019; Goldberg A, 2011, AGING CLIN EXP RES, V23, P406, DOI 10.1007/BF03325236; Gonzales JU, 2016, GAIT POSTURE, V50, P89, DOI 10.1016/j.gaitpost.2016.08.021; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Guralnik JM, 2013, ASSESSING PHYS PERFO; Herman T, 2010, J GERONTOL A-BIOL, V65, P1086, DOI 10.1093/gerona/glq077; Hortobagyi T, 2015, SPORTS MED, V45, P1627, DOI 10.1007/s40279-015-0371-2; Kim Hee-Jae, 2016, J Exerc Nutrition Biochem, V20, P46; Kuh D, 2014, P NUTR SOC, V73, P237, DOI 10.1017/S0029665113003923; Kwon S, 2009, J NUTR HEALTH AGING, V13, P538, DOI 10.1007/s12603-009-0104-z; Langlois JA, 1997, AM J PUBLIC HEALTH, V87, P393, DOI 10.2105/AJPH.87.3.393; Leisman G, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00094; Liu B, 2016, GAIT POSTURE, V44, P172, DOI 10.1016/j.gaitpost.2015.12.008; Menant JC, 2014, AGEING RES REV, V16, P83, DOI 10.1016/j.arr.2014.06.001; Middleton A, 2015, J AGING PHYS ACTIV, V23, P314, DOI 10.1123/japa.2013-0236; Mirelman A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040297; Montero-Odasso M, 2012, J AM GERIATR SOC, V60, P2127, DOI 10.1111/j.1532-5415.2012.04209.x; Muir-Hunter SW, 2016, PHYSIOTHERAPY, V102, P29, DOI 10.1016/j.physio.2015.04.011; Nagamatsu LS, 2011, PSYCHOL AGING, V26, P253, DOI 10.1037/a0022929; Neider MB, 2011, PSYCHOL AGING, V26, P260, DOI 10.1037/a0021566; Ng SSM, 2013, AM J PHYS MED REHAB, V92, P776, DOI 10.1097/PHM.0b013e31828769d0; Peel NM, 2013, J GERONTOL A-BIOL, V68, P39, DOI 10.1093/gerona/gls174; Perera S, 2006, J AM GERIATR SOC, V54, P743, DOI 10.1111/j.1532-5415.2006.00701.x; Plummer P, 2015, GERONTOLOGY; Reve EV, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-134; Romero-Ortuno R, 2010, AGE AGEING, V39, P80, DOI 10.1093/ageing/afp206; Salbach NM, 2014, ARCH PHYS MED REHAB, V95, P117, DOI 10.1016/j.apmr.2013.06.017; Smith E, 2016, GAIT POSTURE, V44, P250, DOI 10.1016/j.gaitpost.2015.12.017; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Studenski S, 2009, J NUTR HEALTH AGING, V13, P878, DOI 10.1007/s12603-009-0245-0; Tournier I, 2016, ACCIDENT ANAL PREV, V91, P24, DOI 10.1016/j.aap.2016.02.031; Turner G, 2014, AGE AGEING, V43, P744, DOI 10.1093/ageing/afu138; Van Abbema R, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0061-9; van Kan GA, 2009, J NUTR HEALTH AGING, V13, P881; Voelcker-Rehage C, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00026; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Webster KE, 2005, GAIT POSTURE, V22, P317, DOI 10.1016/j.gaitpost.2004.10.005; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Zito GA, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0175-0	74	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0182180	10.1371/journal.pone.0182180	http://dx.doi.org/10.1371/journal.pone.0182180			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC3TH	28759587	Green Published, Green Submitted, gold			2022-12-26	WOS:000406761600062
J	Seri, B; Koffi, A; Danel, C; Ouassa, T; Blehoue, MA; Ouattara, E; Assemien, JD; Masumbuko, JM; Coffle, P; Cartier, N; Laurent, A; Raguin, G; Malvy, D; N'Dri-Yoman, T; Eholie, SP; Domoua, SK; Anglaret, X; Receveur, MC				Seri, Benjamin; Koffi, Ange; Danel, Christine; Ouassa, Timothee; Blehoue, Marcel-Angora; Ouattara, Eric; Assemien, Jeanne-d'Arc; Masumbuko, Jean-Marie; Coffle, Patrick; Cartier, Nathalie; Laurent, Arnaud; Raguin, Gilles; Malvy, Denis; N'Dri-Yoman, Therese; Eholie, Serge P.; Domoua, Serge K.; Anglaret, Xavier; Receveur, Marie-Catherine			Prevalence of pulmonary tuberculosis among prison inmates: A cross-sectional survey at the Correctional and Detention Facility of Abidjan, Cote d'Ivoire	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; SAHARAN AFRICAN PRISONS; NORTH GONDAR ZONE; HUMAN-RIGHTS; RISK-FACTORS; HIV; ETHIOPIA; TRANSMISSION; EXPERIENCE; COUNTRIES	Background In Cote d'Ivoire, a TB prison program has been developed since 1999. This program includes offering TB screening to prisoners who show up with TB symptoms at the infirmary. Our objective was to estimate the prevalence of pulmonary TB among inmates at the Correctional and Detention Facility of Abidjan, the largest prison of Cote d'Ivoire, 16 years after this TB program was implemented. Methods Between March and September 2015, inmates, were screened for pulmonary TB using systematic direct smear microscopy, culture and chest X-ray. All participants were also proposed HIV testing. TB was defined as either confirmed (positive culture), probable (positive microscopy and/or chest X-ray findings suggestive of TB) or possible (signs or symptoms suggestive of TB, no X-Ray or microbiological evidence). Factors associated with confirmed tuberculosis were analysed using multivariable logistic regression. Results Among the 943 inmates screened, 88 (9.3%) met the TB case definition, including 19 (2.0%) with confirmed TB, 40 (4.2%) with probable TB and 29 (3.1%) with possible TB. Of the 19 isolated TB strains, 10 (53%) were TB drug resistant, including 7 (37%) with multiresistance. Of the 10 patients with TB resistant strain, only one had a past history of TB treatment. HIV prevalence was 3.1% overall, and 9.6% among TB cases. Factors associated with confirmed TB were age >= 30 years (Odds Ratio 3.8; 95% CI 1.1-13.3), prolonged cough (Odds Ratio 3.6; 95% CI 1.3-9.5) and fever (Odds Ratio 2.7; 95% CI 1.0-7.5). Conclusion In the country largest prison, pulmonary TB is still 10 (confirmed) to 44 times (confirmed, probable or possible) as frequent as in the Cote d'Ivoire general population, despite a longtime running symptom-based program of TB detection. Decreasing TB prevalence and limiting the risk of MDR may require the implementation of annual in-cell TB screening campaigns that systematically target all prison inmates.	[Seri, Benjamin; Koffi, Ange; Danel, Christine; Ouattara, Eric; Masumbuko, Jean-Marie; Coffle, Patrick; N'Dri-Yoman, Therese; Eholie, Serge P.; Anglaret, Xavier] ANRS Res Site, Programme PAC CI, Abidjan, Cote Ivoire; [Seri, Benjamin; Danel, Christine; Ouattara, Eric; Malvy, Denis; Eholie, Serge P.; Anglaret, Xavier; Receveur, Marie-Catherine] Univ Bordeaux, INSERM, U1219, Bordeaux, France; [Ouassa, Timothee] CHU Treichville, Ctr Diagnost & Rech SIDA, Abidjan, Cote Ivoire; [Blehoue, Marcel-Angora] Maison Arret & Correct Abidjan, Abidjan, Cote Ivoire; [Ouattara, Eric; Malvy, Denis; Receveur, Marie-Catherine] Univ Hosp, Div Infect & Trop Dis, Dept Med, Interdept Ctr Trop Med & Clin Int Hlth, Bordeaux, France; [Assemien, Jeanne-d'Arc; Masumbuko, Jean-Marie] Expertise France Cote Ivoire, Abidjan, Cote Ivoire; [Cartier, Nathalie; Laurent, Arnaud; Raguin, Gilles] Expertise France, Dept Sante, Paris, France; [N'Dri-Yoman, Therese] CHU Yopougon, Serv Gastroenterohepatol, Abidjan, Cote Ivoire; [Eholie, Serge P.] CHU Treichville, Serv Malad Infect & Trop, Abidjan, Cote Ivoire; [Domoua, Serge K.] CHU Treichville, Serv Pneumol, Abidjan, Cote Ivoire	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux	Seri, B (corresponding author), ANRS Res Site, Programme PAC CI, Abidjan, Cote Ivoire.; Seri, B (corresponding author), Univ Bordeaux, INSERM, U1219, Bordeaux, France.	Benjamin.Seri@pacci.ci	Anglaret, Xavier/T-2757-2019; cartier, nathalie/C-3103-2012; Anglaret, Xavier/F-7333-2013; Ouattara, Eric/T-2833-2019; Eholie, Serge/T-6008-2019; MALVY, Denis/T-7930-2019	cartier, nathalie/0000-0003-2298-5261; Ouassa, Timothee Dieudonne/0000-0002-5456-3103; Anglaret, Xavier/0000-0003-3319-8423	French National Agency for AIDS and viral hepatitis research (ANRS, Paris, France) [ANRS 12310]; Expertise France	French National Agency for AIDS and viral hepatitis research (ANRS, Paris, France); Expertise France	This study is funded by French National Agency for AIDS and viral hepatitis research (ANRS, Paris, France; Grants ANRS 12310) and Expertise France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We also gratefully acknowledge the valuable contributions of the Ministere de la Justice, Ministere de la Sante et de l'Hygiene publique, Ministere des Droits de l'homme et des Libertes publiques, CeDReS, PNLT, CNACI, NPSP, PACCI teams and Bordeaux University Hospital, as well as to the French National Agency for AIDS and viral hepatitis research (ANRS, Paris, France; Grants ANRS 12310) and Expertise France which funded the study.	Abebe DS, 2011, INT J TUBERC LUNG D, V15, P668, DOI 10.5588/ijtld.10.0363; Adane K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149453; Addis Z, 2015, ASIAN PAC J TROP MED, V8, P127, DOI 10.1016/S1995-7645(14)60302-3; Agrawal M, 2016, J CLIN DIAGN RES, V10, pDC9, DOI 10.7860/JCDR/2016/18837.7755; Alavi SM, 2014, JUNDISHAPUR J MICROB, V7, DOI 10.5812/jjm.18872; Ali S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144040; Assemien J, 2010, 18 INT AIDS C JUL 18; Basu S, 2011, AM J TROP MED HYG, V84, P30, DOI 10.4269/ajtmh.2011.10-0472; Beggs CB, 2003, INT J TUBERC LUNG D, V7, P1015; Ben Amor Y, 2008, EMERG INFECT DIS, V14, P1345, DOI 10.3201/eid1409.061524; Biadglegne F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106869; Cobelens FGJ, 2008, PLOS MED, V5, P1037, DOI 10.1371/journal.pmed.0050150; Coninx R, 2000, BRIT MED J, V320, P440, DOI 10.1136/bmj.320.7232.440; Corbett EL, 2004, AM J RESP CRIT CARE, V170, P673, DOI 10.1164/rccm.200405-590OC; Foundation for Innovative New Diagnostics (FIND), MGIT PROC MAN; Gebrecherkos T, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3761-y; Harris JB, 2014, INT J TUBERC LUNG D, V18, P774, DOI 10.5588/ijtld.13.0732; Henostroza G, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1460-z; Henostroza G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067338; Institue for Criminal Policy Research (ICPS), 2003, PRISON HEALTHCARE NE, P5; Koffi N, 1997, INT J TUBERC LUNG D, V1, P250; Larouze B, 2008, T ROY SOC TROP MED H, V102, P841, DOI 10.1016/j.trstmh.2008.04.020; Marais BJ, 2010, LANCET, V375, P2179, DOI 10.1016/S0140-6736(10)60554-5; Mauro S, 2012, MANUAL ENV INTERVENT, P13; Moges B, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-352; Lemos ACM, 2009, J BRAS PNEUMOL, V35, P63, DOI 10.1590/S1806-37132009000100009; Noeske J, 2011, INT J TUBERC LUNG D, V15, P223; PNLT (Co A te d'Ivoire), 2009, GUID TECHN TUB DIR E; Rasolofo-Razanamparany V, 2000, RES MICROBIOL, V151, P785, DOI 10.1016/S0923-2508(00)01144-X; Reid SE, 2012, J INFECT DIS, V205, pS265, DOI 10.1093/infdis/jis029; Rubenstein LS, 2016, LANCET, V388, P1202, DOI 10.1016/S0140-6736(16)30663-8; Sanchez A, 2009, INT J TUBERC LUNG D, V13, P1247; Schwitters A, 2014, INT J TUBERC LUNG D, V18, P781, DOI 10.5588/ijtld.13.0934; Singh S, 1999, INT J STD AIDS, V10, P475, DOI 10.1258/0956462991914357; Telisinghe L, 2016, LANCET, V388, P1215, DOI 10.1016/S0140-6736(16)30578-5; Telisinghe L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087262; Todrys KW, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-8; Valenca MS, 2015, INT J TUBERC LUNG D, V19, P1182, DOI 10.5588/ijtld.15.0126; Van Deun A, 2010, AM J RESP CRIT CARE, V182, P684, DOI 10.1164/rccm.201001-0077OC; Rueda ZV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080592; Winetsky DE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086046; World Health Organization, 2014, STAT SAN MON 2014; World Health Organization, 2012, WHOHTMTB20121; World Health Organization (WHO), COT IV TUB PROF	44	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0181995	10.1371/journal.pone.0181995	http://dx.doi.org/10.1371/journal.pone.0181995			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759620	Green Submitted, Green Published, gold			2022-12-26	WOS:000406761600042
J	Martin, Y; Li, ZL; Cutter, SL				Martin, Yago; Li, Zhenlong; Cutter, Susan L.			Leveraging Twitter to gauge evacuation compliance: Spatiotemporal analysis of Hurricane Matthew	PLOS ONE			English	Article							SOCIAL MEDIA; MODEL; UNDERSTAND; PATTERNS; BEHAVIOR; TIME	Hurricane Matthew was the deadliest Atlantic storm since Katrina in 2005 and prompted one of the largest recent hurricane evacuations along the Southeastern coast of the United States. The storm and its projected landfall triggered a massive social media reaction. Using Twitter data, this paper examines the spatiotemporal variability in social media response and develops a novel approach to leverage geotagged tweets to assess the evacuation responses of residents. The approach involves the retrieval of tweets from the Twitter Stream, the creation and filtering of different datasets, and the statistical and spatial processing and treatment to extract, plot and map the results. As expected, peak Twitter response was reached during the pre-impact and preparedness phase, and decreased abruptly after the passage of the storm. A comparison between two time periods-pre-evacuation (October 2th-4th) and post-evacuation (October 7th-9 th)-indicates that 54% of Twitter users moved away from the coast to a safer location, with observed differences by state on the timing of the evacuation. A specific sub-state analysis of South Carolina illustrated overall compliance with evacuation orders and detailed information on the timing of departure from the coast as well as the destination location. These findings advance the use of big data and citizen-as-sensor approaches for public safety issues, providing an effective and near real-time alternative for measuring compliance with evacuation orders.	[Li, Zhenlong] Univ South Carolina, Dept Geog, Columbia, SC 29208 USA; Univ South Carolina, Hazards & Vulnerabil Res Inst, Columbia, SC USA	University of South Carolina System; University of South Carolina Columbia; University of South Carolina System; University of South Carolina Columbia	Li, ZL (corresponding author), Univ South Carolina, Dept Geog, Columbia, SC 29208 USA.	zhenlong@sc.edu	Li, Zhenlong/M-1065-2017	Li, Zhenlong/0000-0002-8938-5466; Martin, Yago/0000-0002-0375-8971	University of South Carolina [13540-16-40838]	University of South Carolina	This study was partially funded by the University of South Carolina through the 2015 SCFloods Research Initiative [grant no. 13540-16-40838]. The first author of this paper wants to express its gratitude to the Fulbright Program and the Spanish Fulbright Commission and lberdrola, as sponsoring company, for the educational funding for the doctoral degree at the University of South Carolina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald E, 2012, IATSS RES, V36, P1, DOI 10.1016/j.iatssr.2012.06.002; Baker E. J., 2000, STORMS, V1, P306; Baker E.J., 1991, INT J MASS EMERGENCI, V9, P287; Baker E.J., 1997, HURRICANES BERTHA FR; Bowser GC, 2015, ENVIRONMENT, V57, P28, DOI 10.1080/00139157.2015.1089145; Bukvic A, 2015, INT J DISAST RISK RE, V13, P215, DOI 10.1016/j.ijdrr.2015.06.008; Chae J, 2014, COMPUT GRAPH-UK, V38, P51, DOI 10.1016/j.cag.2013.10.008; Chen XN, 2016, GEOJOURNAL, V81, P863, DOI 10.1007/s10708-016-9745-8; Crooks A, 2013, T GIS, V17, P124, DOI 10.1111/j.1467-9671.2012.01359.x; Crossett K., 2013, NATL COASTAL POPULAT; Cutter S. L., 2011, S CAROLINA HURRICANE; Cutter SL, 2009, ENVIRONMENT, V51, P26, DOI 10.3200/ENVT.51.2.26-36; Dash N., 2000, ENVIRON HAZARDS-UK, V2, P119, DOI DOI 10.1016/S1464-2867(01)00008-0; David CC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150190; de Albuquerque JP, 2015, INT J GEOGR INF SCI, V29, P667, DOI 10.1080/13658816.2014.996567; Dow K, 2002, NAT HAZARDS REV, V3, P12, DOI DOI 10.1061/(ASCE)1527-6988(2002)3:1(12); Dow K., 2000, ENVIRON HAZARDS-UK, V2, P143, DOI [DOI 10.1016/S1464-2867(01)00014-6, 10.1016/S1464-2867(01)00014-6]; Duggan M., 2016, SOCIAL MEDIA UPDATE; Gall M, 2011, SUSTAINABILITY-BASEL, V3, P2157, DOI 10.3390/su3112157; Gerber MS, 2014, DECIS SUPPORT SYST, V61, P115, DOI 10.1016/j.dss.2014.02.003; Graham M, 2013, GUARDIAN; Gupta A, 2013, PROCEEDINGS OF THE SIXTH INTERNATIONAL CONFERENCE ON INFORMATION AND COMMUNICATIONS TECHNOLOGIES AND DEVELOPMENT, VOL 2, P45, DOI 10.1145/2517899.2517929; Hasan S., 2013, P 2 ACM SIGKDD INT W, DOI [10.1145/2505821.2505823, DOI 10.1145/2505821.2505823]; Hasan S, 2011, J TRANSP ENG, V137, P341, DOI 10.1061/(ASCE)TE.1943-5436.0000223; Hazard Management Group Inc, 1985, S CAR HURR EV STUD B; Hecht B., 2014, P INT AAAI C WEB SOC, V8, P197; Herfort B, 2014, LECT NOTES GEOINF CA, P55, DOI 10.1007/978-3-319-03611-3_4; Hsiang S.M., 2014, NATL BUREAU EC RES W, DOI DOI 10.3386/W20352; HUANG QY, 2015, ISPRS INT J GEO-INF, V4, P1549, DOI [DOI 10.3390/JIGI4031549, DOI 10.3390/IJGI4031549]; HVRI (Hazards & Vulnerability Research Institute), SPAT HAZ EV LOSS DAT; Internet Live Stats, 2017, TWITT US STAT; Kent JD, 2013, CARTOGR GEOGR INF SC, V40, P78, DOI 10.1080/15230406.2013.776727; Kimanuka O., 2015, THE NEW TIMES; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Kryvasheyeu Y, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500779; Kryvasheyeu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117288; Li J, 2010, ELECTR J INF SYS DEV, V42; Li LN, 2013, CARTOGR GEOGR INF SC, V40, P61, DOI 10.1080/15230406.2013.777139; Li ZH, 2019, COMPUT ECON, V54, P1359, DOI 10.1007/s10614-016-9644-6; Lindell M.K., 2005, NAT HAZARD REV, V6, P171, DOI DOI 10.1061/(ASCE)1527-6988(2005)6:4(171); Mandel B., 2012, P 2 WORKSH LANG SOC, P27; Meier Patrick, 2015, DIGITAL HUMANITARIAN; Mislove A, 2011, P 5 INT C WEBL SOC M, P554; Murray-Tuite P, 2013, TRANSPORT RES C-EMER, V27, P25, DOI 10.1016/j.trc.2012.11.005; Murthy D, 2017, SOC SCI RES, V63, P356, DOI 10.1016/j.ssresearch.2016.09.015; Palen L, 2009, SOC SCI COMPUT REV, V27, P467, DOI 10.1177/0894439309332302; Roick O, 2013, T GIS, V17, P763, DOI 10.1111/tgis.12032; Sadri A.M., 2017, UNDERSTANDING INFORM; Sadri A. M., 2017, ARXIV170401706; Sadri AM, 2015, TRANSPORT RES REC, P1; Sadri AM, 2017, J CHOICE MODEL, P1; Sadri AM, 2017, NAT HAZARDS REV, V18, DOI 10.1061/(ASCE)NH.1527-6996.0000244; Sadri AM, 2014, TRANSPORT RES C-EMER, V48, P37, DOI 10.1016/j.trc.2014.08.008; Sadri AM, 2014, J TRANSP ENG, V140, P61, DOI 10.1061/(ASCE)TE.1943-5436.0000613; Sadri AM, 2013, TRANSPORT RES C-EMER, V32, P21, DOI 10.1016/j.trc.2013.03.009; Sakai T, 2011, PANCREAS, V40, P403, DOI 10.1097/MPA.0b013e318204e815; Sakaki T., 2010, P 19 INT C WORLD WID, P851, DOI [10.1145/1772690.1772777, DOI 10.1145/1772690.1772777, 10.1145/1772690.1772777.]; San Su Y., 2013, SOCIAL MEDIA EMERGEN; Shelton T, 2014, GEOFORUM, V52, P167, DOI 10.1016/j.geoforum.2014.01.006; Shih TH, 2009, EDUC RES REV-NETH, V4, P26, DOI 10.1016/j.edurev.2008.01.003; Sinclair M, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-132; Smith AB, 2013, NAT HAZARDS, V67, P387, DOI 10.1007/s11069-013-0566-5; Smyth JD, 2010, AM BEHAV SCI, V53, P1423, DOI 10.1177/0002764210361695; South Carolina Department of Transportation (SCDOT), 2017, AV ANN DAIL TRAFF; Steiger E, 2015, T GIS, V19, P809, DOI 10.1111/tgis.12132; Stewart S.R., 2017, HURRICANE MATTHEW, P1, DOI AL142016; The-Minh Nguyen, 2013, Journal of Convergence Information Technology, V8, P707, DOI 10.4156/jcit.vol8.issue11.79; Twitter, 2016, TWITT US CO FACTS; Ukkusuri SV, 2014, TRANSPORT RES REC, P110, DOI 10.3141/2459-13; Wang Q, 2014, METHOD ENZYMOL, V548, P23, DOI 10.1016/B978-0-12-397918-6.00002-1; Wang Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154547; Widener MJ, 2014, APPL GEOGR, V54, P189, DOI 10.1016/j.apgeog.2014.07.017; Wu HC, 2012, TRANSPORT RES F-TRAF, V15, P445, DOI 10.1016/j.trf.2012.03.005; Wukich Clayton, 2015, J Emerg Manag, V13, P281, DOI 10.5055/jem.2015.0242; Zhai SX, 2015, APPL GEOGR, V63, P113, DOI 10.1016/j.apgeog.2015.06.006	75	85	86	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0181701	10.1371/journal.pone.0181701	http://dx.doi.org/10.1371/journal.pone.0181701			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1ED	28753667	Green Published, Green Submitted, gold			2022-12-26	WOS:000406579300023
J	Forleo, C; D'Erchia, AM; Sorrentino, S; Manzari, C; Chiara, M; Iacoviello, M; Guaricci, AI; De Santis, D; Musci, RL; La Spada, A; Marangelli, V; Pesole, G; Favale, S				Forleo, Cinzia; D'Erchia, Anna Maria; Sorrentino, Sandro; Manzari, Caterina; Chiara, Matteo; Iacoviello, Massimo; Guaricci, Andrea Igoren; De Santis, Delia; Musci, Rita Leonarda; La Spada, Antonino; Marangelli, Vito; Pesole, Graziano; Favale, Stefano			Targeted next-generation sequencing detects novel gene - phenotype associations and expands the mutational spectrum in cardiomyopathies	PLOS ONE			English	Article							RIGHT-VENTRICULAR CARDIOMYOPATHY; SUDDEN CARDIAC DEATH; CARDIOLOGY WORKING GROUP; 2011 ACCF/AHA GUIDELINE; HYPERTROPHIC CARDIOMYOPATHY; TASK-FORCE; AMERICAN-COLLEGE; EUROPEAN-SOCIETY; HEART-FAILURE; RECEPTOR POLYMORPHISMS	Cardiomyopathies are a heterogeneous group of primary diseases of the myocardium, including hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), and arrhythmogenic right ventricular cardiomyopathy (ARVC), with higher morbidity and mortality. These diseases are genetically diverse and associated with rare mutations in a large number of genes, many of which overlap among the phenotypes. To better investigate the genetic overlap between these three phenotypes and to identify new genotype-phenotype correlations, we designed a custom gene panel consisting of 115 genes known to be associated with cardiomyopathic phenotypes and channelopathies. A cohort of 38 unrelated patients, 16 affected by DCM, 14 by HCM and 8 by ARVC, was recruited for the study on the basis of more severe phenotypes and family history of cardiomyopathy and/or sudden death. We detected a total of 142 rare variants in 40 genes, and all patients were found to be carriers of at least one rare variant. Twenty-eight of the 142 rare variants were also predicted as potentially pathogenic variants and found in 26 patients. In 23 out of 38 patients, we found at least one novel potential gene-phenotype association. In particular, we detected three variants in OBSCN gene in ARVC patients, four variants in ANK2 gene and two variants in DLG1, TRPM4, and AKAP9 genes in DCM patients, two variants in PSEN2 gene and four variants in AKAP9 gene in HCM patients. Overall, our results confirmed that cardiomyopathic patients could carry multiple rare gene variants; in addition, our investigation of the genetic overlap among cardiomyopathies revealed new gene-phenotype associations. Furthermore, as our study confirms, data obtained using targeted next-generation sequencing could provide a remarkable contribution to the molecular diagnosis of cardiomyopathies, early identification of patients at risk for arrhythmia development, and better clinical management of cardiomyopathic patients.	[Forleo, Cinzia; Sorrentino, Sandro; Iacoviello, Massimo; Guaricci, Andrea Igoren; De Santis, Delia; Musci, Rita Leonarda; La Spada, Antonino; Marangelli, Vito; Favale, Stefano] Univ Bari Aldo Moro, Dept Emergency & Organ Transplantat, Cardiol Unit, Bari, Italy; [D'Erchia, Anna Maria; Pesole, Graziano] Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy; [D'Erchia, Anna Maria; Manzari, Caterina; Pesole, Graziano] CNR, Inst Biomembranes Bioenerget & Mol Biotechnol IBI, Bari, Italy; [Chiara, Matteo] Univ Milan, Dept Biosci, Milan, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR); University of Milan	Forleo, C (corresponding author), Univ Bari Aldo Moro, Dept Emergency & Organ Transplantat, Cardiol Unit, Bari, Italy.; D'Erchia, AM (corresponding author), Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy.; D'Erchia, AM (corresponding author), CNR, Inst Biomembranes Bioenerget & Mol Biotechnol IBI, Bari, Italy.	cinzia.forleo@uniba.it; annamaria.derchia@uniba.it	D'Erchia, Anna maria/K-9001-2016; Iacoviello, Massimo/AAW-4962-2021; Marangelli, Vito/AAG-9705-2021; Pesole, Graziano/K-5283-2019	Iacoviello, Massimo/0000-0001-9613-5062; Guaricci, Andrea Igoren/0000-0001-7133-4401; CHIARA, MATTEO/0000-0003-3983-4961; Forleo, Cinzia/0000-0002-9452-4037	Regione Puglia, "Aiuti a Sostegno dei Cluster Tecnologici Regionali" [MTJU9H8]; Institute of Cardiology grant [00474210Lib03]	Regione Puglia, "Aiuti a Sostegno dei Cluster Tecnologici Regionali"; Institute of Cardiology grant	This work was supported by Regione Puglia, "Aiuti a Sostegno dei Cluster Tecnologici Regionali", Project MTJU9H8: DICLIMAX: Strumentazione per diagnostica clinica basata su Next Generation sequencing di acidi nucleici, to GP and SF. Institute of Cardiology grant, 00474210Lib03, to SF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman MJ, 2011, EUROPACE, V13, P1077, DOI 10.1093/europace/eur245; Akinrinade O, 2016, CLIN GENET, V90, P49, DOI 10.1111/cge.12741; Akinrinade O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145284; Arbustini E, 2000, J AM COLL CARDIOL, V35, P1760, DOI 10.1016/S0735-1097(00)00650-1; Arimura T, 2007, BIOCHEM BIOPH RES CO, V362, P281, DOI 10.1016/j.bbrc.2007.07.183; Bauce B, 2010, HEART RHYTHM, V7, P22, DOI 10.1016/j.hrthm.2009.09.070; Begay RL, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002645; Biagini E, 2014, AM J CARDIOL, V114, P769, DOI 10.1016/j.amjcard.2014.05.065; Boczek NJ, 2015, CIRC-ARRHYTHMIA ELEC, V8, P1122, DOI 10.1161/CIRCEP.115.002745; Brion M, 2015, FORENSIC SCI INT-GEN, V18, P160, DOI 10.1016/j.fsigen.2015.07.010; Cahill TJ, 2013, CIRC RES, V113, P660, DOI 10.1161/CIRCRESAHA.113.300282; Calkins H, 2015, CIRC J, V79, P901, DOI 10.1253/circj.CJ-15-0288; Campuzano O, 2015, INT J MOL SCI, V16, P25773, DOI 10.3390/ijms161025773; Cecconi M, 2016, INT J MOL MED, V38, P1111, DOI 10.3892/ijmm.2016.2732; Christensen AH, 2008, CIRC-ARRHYTHMIA ELEC, V1, P317, DOI 10.1161/CIRCEP.108.785865; Christiansen SL, 2016, EUR J HUM GENET, V24, P1797, DOI 10.1038/ejhg.2016.118; Corrado D, 2006, JAMA-J AM MED ASSOC, V296, P1593, DOI 10.1001/jama.296.13.1593; D'Antonio M, 2014, IEEE HPCS; de Villiers CP, 2014, CIRC-CARDIOVASC GENE, V7, P599, DOI 10.1161/CIRCGENETICS.113.000580; Diegoli M, 2011, J AM COLL CARDIOL, V58, P925, DOI 10.1016/j.jacc.2011.01.072; El-Haou S, 2009, CIRC RES, V104, P758, DOI 10.1161/CIRCRESAHA.108.191007; Elliott P, 2004, LANCET, V363, P1881, DOI 10.1016/S0140-6736(04)16358-7; Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342; Elliott P, 2010, CIRC-CARDIOVASC GENE, V3, P314, DOI 10.1161/CIRCGENETICS.110.937805; Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284; Faita F, 2012, WORLD J CARDIOL, V4, P288, DOI 10.4330/wjc.v4.i10.288; Forleo C, 2004, AM J MED, V117, P451, DOI 10.1016/j.amjmed.2004.04.012; Forleo C, 2007, J CARDIOVASC MED, V8, P589, DOI 10.2459/01.JCM.0000281710.51304.03; Forleo C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121723; Gersh BJ, 2011, J AM COLL CARDIOL, V58, pE212, DOI 10.1016/j.jacc.2011.06.011; Gersh BJ, 2011, J AM COLL CARDIOL, V58, P2703, DOI 10.1016/j.jacc.2011.10.825; Gigli M, 2016, FRONT CARDIOVASC MED, V3, DOI 10.3389/fcvm.2016.00021; Girolami F, 2010, J AM COLL CARDIOL, V55, P1444, DOI 10.1016/j.jacc.2009.11.062; Golbus JR, 2014, CIRC-CARDIOVASC GENE, V7, P751, DOI 10.1161/CIRCGENETICS.113.000578; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Hershberger RE, 2011, J AM COLL CARDIOL, V57, P1641, DOI 10.1016/j.jacc.2011.01.015; Iacoviello M, 2007, J AM COLL CARDIOL, V50, P225, DOI 10.1016/j.jacc.2007.02.071; Judge Daniel P, 2010, Curr Treat Options Cardiovasc Med, V12, P566, DOI 10.1007/s11936-010-0092-7; Klauke B, 2010, HUM MOL GENET, V19, P4595, DOI 10.1093/hmg/ddq387; Kontrogianni-Konstantopoulos A, 2009, PHYSIOL REV, V89, P1217, DOI 10.1152/physrev.00017.2009; Kuhl A, 2008, EUR J HUM GENET, V16, P367, DOI 10.1038/sj.ejhg.5201980; Laforet P, 1998, NEUROLOGY, V51, P1454, DOI 10.1212/WNL.51.5.1454; Lopes LR, 2015, HEART, V101, P294, DOI 10.1136/heartjnl-2014-306387; Lopez-Ayala JM, 2015, CLIN GENET, V88, P172, DOI 10.1111/cge.12458; Marcou CA YD, 2012, CIRCULATION, V126; Marcus FI, 2010, EUR HEART J, V31, P806, DOI [10.1093/eurheartj/ehq025, 10.1161/CIRCULATIONAHA.108.840827]; Marcus FI, 2010, CIRCULATION, V121, P1533, DOI 10.1161/CIRCULATIONAHA.108.840827; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; Maron Barry J., 2003, Journal of the American College of Cardiology, V42, P1687, DOI 10.1016/S0735-1097(03)00941-0; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Marsman RF, 2014, NAT REV CARDIOL, V11, P96, DOI 10.1038/nrcardio.2013.186; Marston S., 2017, BIOPHYS REV; Marston S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138568; MCKENNA WJ, 1994, BRIT HEART J, V71, P215; McNair WP, 2011, J AM COLL CARDIOL, V57, P2160, DOI 10.1016/j.jacc.2010.09.084; McNair WP, 2004, CIRCULATION, V110, P2163, DOI 10.1161/01.CIR.0000144458.58660.BB; Melberg A, 1999, ANN NEUROL, V46, P684, DOI 10.1002/1531-8249(199911)46:5<684::AID-ANA2>3.0.CO;2-#; Mestroni L, 1999, EUR HEART J, V20, P93, DOI 10.1053/euhj.1998.1145; Mogensen J, 2015, EUR HEART J, V36, P1367, DOI 10.1093/eurheartj/ehv122; Morini E, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00055; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Olivotto I, 2008, MAYO CLIN PROC, V83, P630, DOI 10.4065/83.6.630; Otten E, 2010, HEART RHYTHM, V7, P1058, DOI 10.1016/j.hrthm.2010.04.023; Perez-Serra A, 2016, INT J CARDIOL, V224, P461, DOI 10.1016/j.ijcard.2016.09.068; Perry NA, 2013, IUBMB LIFE, V65, P479, DOI 10.1002/iub.1157; PICKERING JG, 1989, PACE, V12, P1317, DOI 10.1111/j.1540-8159.1989.tb05045.x; Pilichou K, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0407-1; Priori SG, 2015, EUR HEART J, V36, P2793, DOI 10.1093/eurheartj/ehv316; Quarta G, 2012, EUR HEART J, V33, P1128, DOI 10.1093/eurheartj/ehr451; Que DD, 2015, EUROPACE, V17, P1770, DOI 10.1093/europace/euv042; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Roma-Rodrigues C, 2014, APPL CLIN GENET, V7, P195, DOI 10.2147/TACG.S49126; Rowland TJ, 2016, J AM COLL CARDIOL, V68, P2237, DOI 10.1016/j.jacc.2016.08.052; Sen-Chowdhry S, 2010, CIRC-CARDIOVASC GENE, V3, P323, DOI 10.1161/CIRCGENETICS.109.935262; Sen-Chowdhry S, 2010, ANNU REV MED, V61, P233, DOI 10.1146/annurev.med.052208.130419; Sturm Amy Curry, 2013, Curr Heart Fail Rep, V10, P63, DOI 10.1007/s11897-012-0124-6; Taylor M, 2011, CIRCULATION, V124, P876, DOI 10.1161/CIRCULATIONAHA.110.005405; Teekakirikul P, 2013, J MOL DIAGN, V15, P158, DOI 10.1016/j.jmoldx.2012.09.002; THIENE G, 1988, NEW ENGL J MED, V318, P129, DOI 10.1056/NEJM198801213180301; Tiso N, 2001, HUM MOL GENET, V10, P189, DOI 10.1093/hmg/10.3.189; Towbin JA, 2014, CIRC J, V78, P2347, DOI 10.1253/circj.CJ-14-0893; Watkins H, 2011, NEW ENGL J MED, V364, P1643, DOI 10.1056/NEJMra0902923; Willis BC, 2015, AM J PHYSIOL-HEART C, V308, pH1463, DOI 10.1152/ajpheart.00176.2015; Zhao Y, 2015, INT J MOL MED, V36, P1479, DOI 10.3892/ijmm.2015.2361	85	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181842	10.1371/journal.pone.0181842	http://dx.doi.org/10.1371/journal.pone.0181842			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750076	Green Published, gold, Green Submitted			2022-12-26	WOS:000406575700088
J	Gao, C; Sun, JL; Wang, CQ; Dong, YM; Xiao, SH; Wang, XJ; Jiao, ZG				Gao, Chao; Sun, Jianlei; Wang, Chongqi; Dong, Yumei; Xiao, Shouhua; Wang, Xingjun; Jiao, Zigao			Genome-wide analysis of basic/helix-loop-helix gene family in peanut and assessment of its roles in pod development	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FAMILY; CULTIVATED PEANUT; ARACHIS-DURANENSIS; PHYTOCHROME-B; BHLH PROTEIN; ARABIDOPSIS; RICE; PIF3; IDENTIFICATION; REGULATORS	The basic/helix-loop-helix (bHLH) proteins constitute a superfamily of transcription factors that are known to play a range of regulatory roles in eukaryotes. Over the past few decades, many bHLH family genes have been well-characterized in model plants, such as Arabidopsis, rice and tomato. However, the bHLH protein family in peanuts has not yet been systematically identified and characterized. Here, 132 and 129 bHLH proteins were identified from two wild ancestral diploid subgenomes of cultivated tetraploid peanuts, Arachis duranensis (AA) and Arachis ipaensis (BB), respectively. Phylogenetic analysis indicated that these bHLHs could be classified into 19 subfamilies. Distribution mapping results showed that peanut bHLH genes were randomly and unevenly distributed within the 10 AA chromosomes and 10 BB chromosomes. In addition, 120 bHLH gene pairs between the AA-subgenome and BB-subgenome were found to be orthologous and 101 of these pairs were highly syntenic in AA and BB chromosomes. Furthermore, we confirmed that 184 bHLH genes expressed in different tissues, 22 of which exhibited tissue-specific expression. Meanwhile, we identified 61 bHLH genes that may be potentially involved in peanut-specific subterranean. Our comprehensive genomic analysis provides a foundation for future functional dissection and understanding of the regulatory mechanisms of bHLH transcription factors in peanuts.	[Gao, Chao; Sun, Jianlei; Wang, Chongqi; Dong, Yumei; Xiao, Shouhua; Jiao, Zigao] Shandong Acad Agr Sci, Inst Vegetables & Flowers, Shandong Key Lab Greenhouse Vegetable Biol, Jinan, Peoples R China; [Wang, Xingjun] Shandong Acad Agr Sci, Biotechnol Res Ctr, Jinan, Peoples R China; [Wang, Xingjun] Shandong Prov Key Lab Crop Genet Improvement Ecol, Jinan, Peoples R China	Shandong Academy of Agricultural Sciences; Shandong Academy of Agricultural Sciences	Jiao, ZG (corresponding author), Shandong Acad Agr Sci, Inst Vegetables & Flowers, Shandong Key Lab Greenhouse Vegetable Biol, Jinan, Peoples R China.	zigaojiao5@163.com			National Technical System of Watermelon and Melon Industry [CARS-26]; Shandong Province Germplasm Innovation and Utilization Project	National Technical System of Watermelon and Melon Industry; Shandong Province Germplasm Innovation and Utilization Project	This work was financially supported by the National Technical System of Watermelon and Melon Industry (CARS-26) and Shandong Province Germplasm Innovation and Utilization Project (2014-2017).	Atchley WR, 1999, J MOL EVOL, V48, P501, DOI 10.1007/PL00006494; Bertioli DJ, 2011, PLANT GENET RESOUR-C, V9, P134, DOI 10.1017/S1479262110000444; Bertioli DJ, 2016, NAT GENET, V48, P438, DOI 10.1038/ng.3517; Carretero-Paulet L, 2010, PLANT PHYSIOL, V153, P1398, DOI 10.1104/pp.110.153593; Chen XP, 2016, P NATL ACAD SCI USA, V113, P6785, DOI 10.1073/pnas.1600899113; Du H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-106; Favero AP, 2006, CROP SCI, V46, P1546, DOI 10.2135/cropsci2005.09-0331; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; Henriksson M, 1996, ADV CANCER RES, V68, P109, DOI 10.1016/S0065-230X(08)60353-X; Hudson KA, 2015, INT J GENOMICS, V2015, DOI 10.1155/2015/603182; Huq E, 2002, EMBO J, V21, P2441, DOI 10.1093/emboj/21.10.2441; Jiang CZ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r46; Jones S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-226; Jung KH, 2005, PLANT CELL, V17, P2705, DOI 10.1105/tpc.105.034090; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Ledent V, 2001, GENOME RES, V11, P754, DOI 10.1101/gr.177001; Li XL, 2016, PLANT PHYSIOL, V170, P2478, DOI 10.1104/pp.15.01827; Li XX, 2006, PLANT PHYSIOL, V141, P1167, DOI 10.1104/pp.106.080580; LUDWIG SR, 1989, P NATL ACAD SCI USA, V86, P7092, DOI 10.1073/pnas.86.18.7092; Martinez-Garcia JF, 2000, SCIENCE, V288, P859, DOI 10.1126/science.288.5467.859; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Moretzsohn MC, 2013, ANN BOT-LONDON, V111, P113, DOI 10.1093/aob/mcs237; MURRE C, 1994, BBA-GENE STRUCT EXPR, V1218, P129, DOI 10.1016/0167-4781(94)90001-9; Nair SK, 2000, NATURE, V404, P715, DOI 10.1038/35008182; Ni M, 1998, CELL, V95, P657, DOI 10.1016/S0092-8674(00)81636-0; Ni M, 1999, NATURE, V400, P781, DOI 10.1038/23500; Payne CT, 2000, GENETICS, V156, P1349; Pires N, 2010, MOL BIOL EVOL, V27, P862, DOI 10.1093/molbev/msp288; Robinson KA, 2000, NUCLEIC ACIDS RES, V28, P4460, DOI 10.1093/nar/28.22.4460; Sakamoto W, 2001, PLANT CELL PHYSIOL, V42, P982, DOI 10.1093/pcp/pce128; Seijo G, 2007, AM J BOT, V94, P1963, DOI 10.3732/ajb.94.12.1963; SHARP PA, 1981, CELL, V23, P643, DOI 10.1016/0092-8674(81)90425-6; Song XM, 2014, MOL GENET GENOMICS, V289, P77, DOI 10.1007/s00438-013-0791-3; Soy J, 2014, J EXP BOT, V65, P2925, DOI 10.1093/jxb/ert465; Soy J, 2012, PLANT J, V71, P390, DOI 10.1111/j.1365-313X.2012.04992.x; Sun H, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1209-2; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Wang JY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1249-2; Wang YJ, 2003, THEOR APPL GENET, V107, P1402, DOI 10.1007/s00122-003-1378-x; Xiong YQ, 2005, PLANT MOL BIOL, V59, P191, DOI 10.1007/s11103-005-6503-6; Zhang XY, 2015, SCI REP-UK, V5, DOI [10.1038/srep09940, 10.1038/srep09803]; Zhang Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003244	42	33	37	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181843	10.1371/journal.pone.0181843	http://dx.doi.org/10.1371/journal.pone.0181843			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750081	Green Published, Green Submitted, gold			2022-12-26	WOS:000406575700089
J	Lorca, RA; Ma, XF; England, SK				Lorca, Ramon A.; Ma, Xiaofeng; England, Sarah K.			The unique N-terminal sequence of the BKCa channel alpha-subunit determines its modulation by beta-subunits	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNEL; CA2+-ACTIVATED K+ CHANNELS; LARGE-CONDUCTANCE; SMOOTH-MUSCLE; HUMAN MYOMETRIUM; CA CHANNELS; CALCIUM; VOLTAGE; PHOSPHORYLATION; DOMAINS	Large conductance voltage-and Ca2+-activated K+ (BKCa) channels are essential regulators of membrane excitability in a wide variety of cells and tissues. An important mechanism of modulation of BKCa channel activity is its association with auxiliary subunits. In smooth muscle cells, the most predominant regulatory subunit of BKCa channels is the beta 1-subunit. We have previously described that BKCa channels with distinctive N-terminal ends (starting with the amino acid sequence MDAL, MSSN or MANG) are differentially modulated by the beta 1-subunit, but not by the beta 2. Here we extended our studies to understand how the distinct N-teminal regions differentially modulate channel activity by beta-subunits. We recorded inside-out single-channel currents from HEK293T cells co-expressing the BKCa containing three N-terminal sequences with two beta 1-beta 2 chimeric constructs containing the extracellular loop of beta 1 or beta 2, and the transmembrane and cytoplasmic domains of beta 2 or beta 1, respectively. Both beta chimeric constructs induced leftward shifts of voltage-activation curves of channels starting with MANG and MDAL, in the presence of 10 or 100 mu M intracellular Ca2+. However, MSSN showed no shift of the voltage-activation, at the same Ca2+ concentrations. The presence of the extracellular loop of beta 1 in the chimera resembled results seen with the full beta 1 subunit, suggesting that the extracellular region of beta 1 might be responsible for the lack of modulation observed in MSSN. We further studied a poly-serine stretch present in the N-terminal region of MSSN and observed that the voltage-activation curves of BKCa channels either containing or lacking this poly-serine stretch were leftward shifted by beta 1-subunit in a similar way. Overall, our results provide further insights into the mechanism of modulation of the different N-terminal regions of the BKCa channel by beta-subunits and highlight the extension of this region of the channel as a form of modulation of channel activity.	[Lorca, Ramon A.; Ma, Xiaofeng; England, Sarah K.] Washington Univ St Louis, Dept Obstet & Gynecol, Ctr Reprod Hlth Sci, St Louis, MO 63130 USA; [Lorca, Ramon A.] Univ Colorado Denver, Dept Obstet & Gynecol, Div Reprod Sci, Aurora, CO 80045 USA	Washington University (WUSTL); Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Lorca, RA (corresponding author), Washington Univ St Louis, Dept Obstet & Gynecol, Ctr Reprod Hlth Sci, St Louis, MO 63130 USA.; Lorca, RA (corresponding author), Univ Colorado Denver, Dept Obstet & Gynecol, Div Reprod Sci, Aurora, CO 80045 USA.	ramon.lorca@ucdenver.edu			National Institutes of Health [5R01HD037831-13]; American Heart Association Postdoctoral fellowship [AHA/12POST10660000]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD088590, R01HD037831] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Postdoctoral fellowship(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health 5R01HD037831-13 to S.K.E. and American Heart Association Postdoctoral fellowship AHA/12POST10660000 to R.A.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; Alioua A, 2008, J BIOL CHEM, V283, P4808, DOI 10.1074/jbc.M709802200; Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Berkefeld H, 2006, SCIENCE, V314, P615, DOI 10.1126/science.1132915; Brainard AM, 2005, AM J PHYSIOL-CELL PH, V289, pC49, DOI 10.1152/ajpcell.00399.2004; Bravo-Zehnder M, 2000, P NATL ACAD SCI USA, V97, P13114, DOI 10.1073/pnas.240455697; BRAYDEN JE, 1992, SCIENCE, V256, P532, DOI 10.1126/science.1373909; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Castillo K, 2015, P NATL ACAD SCI USA, V112, P4809, DOI 10.1073/pnas.1504378112; Chen LN, 2005, J BIOL CHEM, V280, P21418, DOI 10.1074/jbc.M413955200; Erxleben C, 2002, J BIOL CHEM, V277, P27045, DOI 10.1074/jbc.M203087200; Gonzalez-Perez V, 2012, NATURE, V485, P133, DOI 10.1038/nature10994; Gruslova A, 2012, J GEN PHYSIOL, V139, P57, DOI 10.1085/jgp.201110698; Havukainen H, 2012, J EXP BIOL, V215, P1837, DOI 10.1242/jeb.065623; Howard MB, 2004, PROTEIN SCI, V13, P1422, DOI 10.1110/ps.03511604; Jiang GJ, 1997, P ROY SOC B-BIOL SCI, V264, P731, DOI 10.1098/rspb.1997.0104; KNAUS HG, 1994, J BIOL CHEM, V269, P3921; Korovkina VP, 2006, J PHYSIOL-LONDON, V573, P329, DOI 10.1113/jphysiol.2006.106922; Korovkina VP, 2001, AM J PHYSIOL-CELL PH, V281, pC361, DOI 10.1152/ajpcell.2001.281.1.C361; Kuntamallappanavar G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109306; Kyle BD, 2013, FASEB J, V27, P2027, DOI 10.1096/fj.12-223669; Leo MD, 2014, P NATL ACAD SCI USA, V111, P2361, DOI 10.1073/pnas.1317527111; Lim HH, 1999, GENE, V240, P35, DOI 10.1016/S0378-1119(99)00398-4; Lorca RA, 2014, J BIOL CHEM, V289, P10095, DOI 10.1074/jbc.M113.521526; Lu T, 2010, CIRC RES, V106, P1164, DOI 10.1161/CIRCRESAHA.109.209767; Matharoo-Ball B, 2003, BIOL REPROD, V68, P2135, DOI 10.1095/biolreprod.102.010454; MCCOBB DP, 1995, AM J PHYSIOL-HEART C, V269, pH767, DOI 10.1152/ajpheart.1995.269.3.H767; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; Morrow JP, 2006, P NATL ACAD SCI USA, V103, P5096, DOI 10.1073/pnas.0600907103; Orio P, 2006, J GEN PHYSIOL, V127, P191, DOI 10.1085/jgp.200509370; Orio P, 2005, J GEN PHYSIOL, V125, P395, DOI 10.1085/jgp.200409236; PEREZ G, 1994, AM J PHYSIOL, V266, pC1459, DOI 10.1152/ajpcell.1994.266.5.C1459; Pluger S, 2000, CIRC RES, V87, pE53, DOI 10.1161/01.RES.87.11.e53; Schubert R, 2001, TRENDS PHARMACOL SCI, V22, P505, DOI 10.1016/S0165-6147(00)01775-2; Scott RS, 2011, PFLUG ARCH EUR J PHY, V462, P545, DOI 10.1007/s00424-011-0991-9; Shmygol A, 2007, J PHYSIOL-LONDON, V581, P445, DOI 10.1113/jphysiol.2007.129452; Sun XH, 2013, J NEUROSCI, V33, P11253, DOI 10.1523/JNEUROSCI.0620-13.2013; Tanaka Y, 1997, J PHYSIOL-LONDON, V502, P545, DOI 10.1111/j.1469-7793.1997.545bj.x; Tian LJ, 2001, J BIOL CHEM, V276, P7717, DOI 10.1074/jbc.C000741200; Uebele VN, 2000, J BIOL CHEM, V275, P23211, DOI 10.1074/jbc.M910187199; Wallner M, 1999, P NATL ACAD SCI USA, V96, P4137, DOI 10.1073/pnas.96.7.4137; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; Wallner M, 1995, RECEPTOR CHANNEL, V3, P185; Yan JS, 2008, MOL CELL PROTEOMICS, V7, P2188, DOI 10.1074/mcp.M800063-MCP200; Yan JS, 2012, P NATL ACAD SCI USA, V109, P7917, DOI 10.1073/pnas.1205435109; Yazejian B, 2000, NAT NEUROSCI, V3, P566, DOI 10.1038/75737	47	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0182068	10.1371/journal.pone.0182068	http://dx.doi.org/10.1371/journal.pone.0182068			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750098	Green Published, Green Submitted, gold			2022-12-26	WOS:000406575700129
J	Shih, CH; Chang, YJ; Huang, WC; Jang, TH; Kung, HJ; Wang, WC; Yang, MH; Lin, MC; Huang, SF; Chou, SW; Chang, E; Chiu, H; Shieh, TY; Chen, YJ; Wang, LH; Chen, L				Shih, C-H; Chang, Y-J; Huang, W-C; Jang, T-H; Kung, H-J; Wang, W-C; Yang, M-H; Lin, M-C; Huang, S-F; Chou, S-W; Chang, E.; Chiu, H.; Shieh, T-Y; Chen, Y-J; Wang, L-H; Chen, L.			EZH2-mediated upregulation of ROS1 oncogene promotes oral cancer metastasis	ONCOGENE			English	Article							SQUAMOUS-CELL CARCINOMA; GROWTH-FACTOR RECEPTOR; AVIAN-SARCOMA VIRUS-UR2; NF-KAPPA-B; PHOSPHATIDYLINOSITOL 3-KINASE; FUSION PROTEINS; C-ROS; GENE; EXPRESSION; CAVITY	Current anti-epidermal growth factor receptor (EGFR) therapy for oral cancer does not provide satisfactory efficacy due to drug resistance or reduced EGFR level. As an alternative candidate target for therapy, here we identified an oncogene, ROS1, as an important driver for oral squamous cell carcinoma (OSCC) metastasis. Among tumors from 188 oral cancer patients, upregulated ROS1 expression strongly correlated with metastasis to lung and lymph nodes. Mechanistic studies uncover that the activated ROS1 results from highly expressed ROS1 gene instead of gene rearrangement, a phenomenon distinct from other cancers. Our data further reveal a novel mechanism that reduced histone methyltransferase EZH2 leads to a lower trimethylation of histone H3 lysine 27 suppressive modification, relaxes chromatin, and promotes the accessibility of the transcription factor STAT1 to the enhancer and the intron regions of ROS1 target genes, CXCL1 and GLI1, for upregulating their expressions. Down-regulation of ROS1 in highly invasive OSCC cells, nevertheless, reduces cell proliferation and inhibits metastasis to lung in the tail-vein injection and the oral cavity xenograft models. Our findings highlight ROS1 as a candidate biomarker and therapeutic target for OSCC. Finally, we demonstrate that co-targeting of ROS1 and EGFR could potentially offer an effective oral cancer therapy.	[Shih, C-H; Chang, Y-J; Lin, M-C; Chou, S-W; Chang, E.; Chiu, H.; Chen, L.] Natl Tsing Hua Univ, Inst Mol Med, Hsinchu, Taiwan; [Huang, W-C; Jang, T-H; Kung, H-J; Huang, S-F; Wang, L-H] Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan, Miaoli County, Taiwan; [Kung, H-J] Univ Calif Davis, Sch Med, Sacramento, CA 95817 USA; [Wang, W-C] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Yang, M-H] Natl Yang Ming Univ, Dept Biotechnol, Taipei, Taiwan; [Yang, M-H] Natl Yang Ming Univ, Lab Sci Med, Taipei, Taiwan; [Shieh, T-Y] Kaohsiung Med Univ, Dept Oral Hyg, Kaohsiung, Taiwan; [Chen, Y-J] MacKay Mem Hosp, Dept Radiat Oncol, Taipei, Taiwan; [Chen, L.] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan; [Wang, L-H] China Med Univ, Presidents Off, Taichung, Taiwan	National Tsing Hua University; National Health Research Institutes - Taiwan; University of California System; University of California Davis; National Tsing Hua University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Kaohsiung Medical University; Mackay Memorial Hospital; National Tsing Hua University; China Medical University Taiwan	Wang, LH (corresponding author), Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan, Miaoli County, Taiwan.; Chen, L (corresponding author), Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan.; Chen, L (corresponding author), Natl Tsing Hua Univ, Inst Mol Med, Hsinchu, Taiwan.; Wang, LH (corresponding author), China Med Univ, Presidents Off, Taichung, Taiwan.	lu-hai.wang@nhri.org.tw; lchen@life.nthu.edu.tw	Chen, Linyi/AAV-2632-2020; Wang, Wen-Ching/ABI-2253-2020; Yang, Muh-Hwa/AAE-4691-2020	Chen, Linyi/0000-0001-7258-8817; Wang, Wen-Ching/0000-0002-7422-3667; Chang, Yu-Jung/0000-0002-4781-0946	Ministry of Science and Technology, Taiwan [NSC 105-2320-B-007-002-MY3, NSC 106-2811-B-007-001]; National Tsing Hua University, Taiwan [104N2739E1, 105N722CV7, 105N183DE1]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Tsing Hua University, Taiwan	This study was supported by grants from Ministry of Science and Technology, Taiwan (NSC 105-2320-B-007-002-MY3) and National Tsing Hua University, Taiwan (104N2739E1 and 105N722CV7) and postdoctoral fellowships from Ministry of Science and Technology, Taiwan (NSC 106-2811-B-007-001 to YJC) and National Tsing Hua University, Taiwan (105N183DE1 to YJC). We thank Professor Rong-Long Pan for commenting on our manuscript.	BIRCHMEIER C, 1990, P NATL ACAD SCI USA, V87, P4799, DOI 10.1073/pnas.87.12.4799; BIRCHMEIER C, 1986, MOL CELL BIOL, V6, P3109, DOI 10.1128/MCB.6.9.3109; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Burke SJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE131, DOI 10.1152/ajpendo.00347.2013; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Davare MA, 2013, P NATL ACAD SCI USA, V110, P19519, DOI 10.1073/pnas.1319583110; Davies KD, 2013, CLIN CANCER RES, V19, P4040, DOI 10.1158/1078-0432.CCR-12-2851; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Dionne KR, 2015, INT J CANCER, V136, P503, DOI 10.1002/ijc.28754; Ernani V, 2015, ONCOLOGY-BASEL, V89, P187, DOI 10.1159/000398801; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Ettl T, 2012, HUM PATHOL, V43, P921, DOI 10.1016/j.humpath.2011.08.006; Fan HX, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0041-5; FELDMAN RA, 1982, J VIROL, V42, P228, DOI 10.1128/JVI.42.1.228-236.1982; Filbin MG, 2013, NAT MED, V19, P1518, DOI 10.1038/nm.3328; Huang WC, 2014, CANCER RES, V74, P751, DOI 10.1158/0008-5472.CAN-13-1297; Johnson N W, 2011, Adv Dent Res, V23, P237, DOI 10.1177/0022034511402082; Jun HJ, 2012, CANCER RES, V72, P3764, DOI 10.1158/0008-5472.CAN-11-3990; Jun HJ, 2009, CANCER RES, V69, P2180, DOI 10.1158/0008-5472.CAN-08-3351; Kawanishi H, 2008, CLIN CANCER RES, V14, P2579, DOI 10.1158/1078-0432.CCR-07-1922; Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036; Kimura I, 2016, ONCOL LETT, V11, P201, DOI 10.3892/ol.2015.3833; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lin SC, 2004, J ORAL PATHOL MED, V33, P79, DOI 10.1111/j.1600-0714.2004.00034.x; Lu YC, 2012, CANCER PREV RES, V5, P665, DOI 10.1158/1940-6207.CAPR-11-0358; Markopoulos AK, 2012, OPEN DENT J, V6, P126, DOI 10.2174/1874210601206010126; MATSUSHIME H, 1986, MOL CELL BIOL, V6, P3000, DOI 10.1128/MCB.6.8.3000; Mimeault M, 2010, PHARMACOL REV, V62, P497, DOI 10.1124/pr.109.002329; MOMOSE F, 1989, J ORAL PATHOL MED, V18, P391, DOI 10.1111/j.1600-0714.1989.tb01570.x; Moon C, 2010, EXP BIOL MED, V235, P907, DOI 10.1258/ebm.2009.009181; Nguyen KT, 2002, J BIOL CHEM, V277, P11107, DOI 10.1074/jbc.M108166200; O'Donnell RK, 2005, ONCOGENE, V24, P1244, DOI 10.1038/sj.onc.1208285; Okumura K, 1996, J CANCER RES CLIN, V122, P243, DOI 10.1007/BF01209653; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Ryott M, 2009, EUR J CANCER, V45, P1700, DOI 10.1016/j.ejca.2009.02.027; Sashida G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5177; Shaib W, 2012, J ONCOL, V2012, DOI 10.1155/2012/521215; SHIBUYA M, 1982, J VIROL, V42, P143, DOI 10.1128/JVI.42.1.143-152.1982; Timp W, 2013, NAT REV CANCER, V13, P497, DOI 10.1038/nrc3486; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tsien CI, 2013, HEAD NECK-J SCI SPEC, V35, P1323, DOI 10.1002/hed.23128; Uttamsingh S, 2003, J BIOL CHEM, V278, P18798, DOI 10.1074/jbc.M211522200; Vermorken JB, 2007, J CLIN ONCOL, V25, P2171, DOI 10.1200/JCO.2006.06.7447; WANG LH, 1982, J VIROL, V41, P833, DOI 10.1128/JVI.41.3.833-841.1982; Wang YF, 2012, HEAD NECK-J SCI SPEC, V34, P1556, DOI 10.1002/hed.21958; Warnakulasuriya S, 2010, ORAL ONCOL, V46, P407, DOI 10.1016/j.oraloncology.2010.02.015; Xiong QH, 1996, MOL CELL BIOL, V16, P1509; Yang C C, 2001, Zhonghua Yi Xue Za Zhi (Taipei), V64, P357; Zingg D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7051; Zong CS, 1997, J BIOL CHEM, V272, P1500, DOI 10.1074/jbc.272.3.1500	51	27	28	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 23	2017	36	47					6542	6554		10.1038/onc.2017.262	http://dx.doi.org/10.1038/onc.2017.262			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FN5LN	28759046	Green Published			2022-12-26	WOS:000416049200004
J	Tomita, H; Katsuyama, Y; Minami, H; Ohnishi, Y				Tomita, Hiroya; Katsuyama, Yohei; Minami, Hiromichi; Ohnishi, Yasuo			Identification and characterization of a bacterial cytochrome P450 monooxygenase catalyzing the 3-nitration of tyrosine in rufomycin biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-OXYGENASE AURF; AMINO-ACID; NONRIBOSOMAL PEPTIDE; PSEUDOMONAS-PUTIDA; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PYRROLOMYCIN-A; STREPTOMYCES; GENE; CHLORAMPHENICOL	Rufomycin is a circular heptapeptide with anti-mycobacterial activity and is produced by Streptomyces atratus ATCC 14046. Its structure contains three non-proteinogenic amino acids, N-dimethylallyltryptophan, trans-2-crotylglycine, and 3-nitrotyrosine (3NTyr). Although the rufomycin structure was already reported in the 1960s, its biosynthesis, including 3NTyr generation, remains unclear. To elucidate the rufomycin biosynthetic pathway, we assembled a draft genome sequence of S. atratus and identified the rufomycin biosynthetic gene cluster (ruf cluster), consisting of 20 ORFs (rufA-rufT). We found a putative heptamodular nonribosomal peptide synthetase encoded by rufT, a putative tryptophan N-dimethylallyltransferase encoded by rufP, and a putative trimodular type I polyketide synthase encoded by rufEF. Moreover, the ruf cluster contains an apparent operon harboring putative cytochrome P450 (rufO) and nitric oxide synthase (rufN) genes. A similar operon, txtDE, is responsible for the formation of 4-nitrotryptophan in thaxtomin biosynthesis; the cytochrome P450 TxtE catalyzes the 4-nitration of Trp. Therefore, we hypothesized that RufO should catalyze the Tyr 3-nitration. Disruption of rufO abolished rufomycin production by S. atratus, which was restored when 3NTyr was added to the culture medium of the disruptant. Recombinant RufO protein exhibited Tyr 3-nitration activity both in vitro and in vivo. Spectroscopic analysis further revealed that RufO recognizes Tyr as the substrate with a dissociation constant of similar to 0.1 mu M. These results indicate that RufO is an unprecedented cytochrome P450 that catalyzes Tyr nitration. Taken together with the results of an in silico analysis of the ruf cluster, we propose a rufomycin biosynthetic pathway in S. atratus.	[Tomita, Hiroya; Katsuyama, Yohei; Ohnishi, Yasuo] Univ Tokyo, Dept Biotechnol, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1,Yayoi, Tokyo 1138657, Japan; [Tomita, Hiroya; Katsuyama, Yohei; Ohnishi, Yasuo] Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, 7,Gobancho, Tokyo 1020076, Japan; [Minami, Hiromichi] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, 1-308,Suematsu, Nonoichi, Ishikawa 9218836, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Ishikawa Prefecture University	Katsuyama, Y; Ohnishi, Y (corresponding author), Univ Tokyo, Dept Biotechnol, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1,Yayoi, Tokyo 1138657, Japan.	aykatsu@mail.ecc.u-tokyo.ac.jp; ayasuo@mail.ecc.u-tokyo.ac.jp	Tomita, Hiroya/GQY-9725-2022	Tomita, Hiroya/0000-0001-7967-921X; Katsuyama, Yohei/0000-0003-4905-5320; Ohnishi, Yasuo/0000-0001-7633-9236	CREST; JST, Japan [JPMJCR13B3]; Japan Society for the Promotion of Science (JSPS); Amano Enzyme Inc., Japan;  [17J06071]	CREST(Core Research for Evolutional Science and Technology (CREST)); JST, Japan(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Amano Enzyme Inc., Japan; 	This work was supported in part by CREST, JST, Grant JPMJCR13B3, Japan; the Japan Society for the Promotion of Science (JSPS) A3 Foresight Program; Grant-in-Aid for JSPS Research Fellow 17J06071; and Amano Enzyme Inc., Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Barry SM, 2012, NAT CHEM BIOL, V8, P814, DOI 10.1038/nchembio.1048; Bisang C, 1999, NATURE, V401, P502, DOI 10.1038/46829; Bushley KE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003496; CARY LW, 1971, FEBS LETT, V17, P145, DOI 10.1016/0014-5793(71)80584-7; Chanco E, 2014, BIOORGAN MED CHEM, V22, P5569, DOI 10.1016/j.bmc.2014.06.002; Chang FC, 1998, CURR MICROBIOL, V36, P125, DOI 10.1007/PL00006755; Choi YS, 2008, P NATL ACAD SCI USA, V105, P6858, DOI 10.1073/pnas.0712073105; Cobb RE, 2015, ACS SYNTH BIOL, V4, P723, DOI 10.1021/sb500351f; Dodani SC, 2016, NAT CHEM, V8, P419, DOI [10.1038/nchem.2474, 10.1038/NCHEM.2474]; Dodani SC, 2014, CHEMBIOCHEM, V15, P2259, DOI 10.1002/cbic.201402241; EZAKI N, 1981, J ANTIBIOT, V34, P1363, DOI 10.7164/antibiotics.34.1363; EZAKI N, 1983, J ANTIBIOT, V36, P1263, DOI 10.7164/antibiotics.36.1263; FUJINO M, 1964, CHEM PHARM BULL, V12, P1390; Gober JG, 2017, ACS CHEM BIOL, V12, P1726, DOI 10.1021/acschembio.7b00358; He J, 2004, J AM CHEM SOC, V126, P3694, DOI 10.1021/ja039328t; Higashide E., 1968, J AGR CHEM SOC JPN, V42, P394; Hudson GA, 2015, J AM CHEM SOC, V137, P16012, DOI 10.1021/jacs.5b10194; KANEDA M, 1981, J ANTIBIOT, V34, P1366, DOI 10.7164/antibiotics.34.1366; Keatinge-Clay AT, 2007, CHEM BIOL, V14, P898, DOI 10.1016/j.chembiol.2007.07.009; Kers JA, 2005, MOL MICROBIOL, V55, P1025, DOI 10.1111/j.1365-2958.2004.04461.x; Knoot CJ, 2016, J BIOL INORG CHEM, V21, P589, DOI 10.1007/s00775-016-1363-x; KOGA H, 1989, J BIOCHEM-TOKYO, V106, P831, DOI 10.1093/oxfordjournals.jbchem.a122939; KOYAMA M, 1983, J ANTIBIOT, V36, P1483, DOI 10.7164/antibiotics.36.1483; KOYAMA M, 1981, J ANTIBIOT, V34, P1569, DOI 10.7164/antibiotics.34.1569; Kudo F, 2016, CHEMBIOCHEM, V17, P233, DOI 10.1002/cbic.201500533; KUNZ DA, 1981, J BACTERIOL, V148, P72, DOI 10.1128/JB.148.1.72-82.1981; Lambooy P. K., 2000, PCT Int Appl., Patent No. [WO2000078798 A1, 2000078798, WO 2000078798 Al 20001228]; Lee JK, 2005, J BIOL CHEM, V280, P36719, DOI 10.1074/jbc.M505334200; Lu HG, 2012, TETRAHEDRON, V68, P7651, DOI 10.1016/j.tet.2012.06.036; Molnar I, 2005, APPL ENVIRON MICROB, V71, P6977, DOI 10.1128/AEM.71.11.6977-6985.2005; Nakagawa A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1327; OFFENZELLER M, 1993, J BIOL CHEM, V268, P26127; OMURA T, 1964, J BIOL CHEM, V239, P2379; Paranthaman S, 2003, APPL ENVIRON MICROB, V69, P84, DOI 10.1128/AEM.69.1.84-91.2003; Parry R, 2011, NAT PROD REP, V28, P152, DOI 10.1039/c0np00024h; Payton M, 2001, MICROBIOL-SGM, V147, P1137, DOI 10.1099/00221287-147-5-1137; Ratnayake AS, 2008, J NAT PROD, V71, P1923, DOI 10.1021/np800401h; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Renner MK, 1999, J AM CHEM SOC, V121, P11273, DOI 10.1021/ja992482o; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Schultz AW, 2010, J NAT PROD, V73, P373, DOI 10.1021/np9006876; Sugai Y, 2016, NAT CHEM BIOL, V12, P73, DOI [10.1038/NCHEMBIO.1991, 10.1038/nchembio.1991]; TAKITA T, 1964, J ANTIBIOT, V17, P129; TAKITA T, 1964, J ANTIBIOT, V17, P90; TAKITA T, 1962, J ANTIBIOT, V15, P46; TAKITA T, 1964, J ANTIBIOT, V17, P264; Walsh CT, 2013, ANGEW CHEM INT EDIT, V52, P7098, DOI 10.1002/anie.201208344; Winkler R, 2007, CHEMBIOCHEM, V8, P973, DOI 10.1002/cbic.200700042; Yu FF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056597; Zenno S, 1996, J BACTERIOL, V178, P4508, DOI 10.1128/jb.178.15.4508-4514.1996; Zhang XJ, 2007, ANTIMICROB AGENTS CH, V51, P946, DOI 10.1128/AAC.01214-06; Zhao B, 2008, J BIOL CHEM, V283, P8183, DOI 10.1074/jbc.M710421200; Zuo R, 2017, SCI REP, V7	54	32	32	5	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15859	15869		10.1074/jbc.M117.791269	http://dx.doi.org/10.1074/jbc.M117.791269			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28774961	Green Published, hybrid			2022-12-26	WOS:000411512200023
J	Lucas, JL; Tacheny, EA; Ferris, A; Galusha, M; Srivastava, AK; Ganguly, A; Williams, PM; Sachs, MC; Thurin, M; Tricoli, JV; Ricker, W; Gildersleeve, JC				Lucas, Julie L.; Tacheny, Erin A.; Ferris, Allison; Galusha, Michelle; Srivastava, Apurva K.; Ganguly, Aniruddha; Williams, P. Mickey; Sachs, Michael C.; Thurin, Magdalena; Tricoli, James V.; Ricker, Winnie; Gildersleeve, Jeffrey C.			Development and validation of a Luminex assay for detection of a predictive biomarker for PROSTVAC-VF therapy	PLOS ONE			English	Article							POLYSACCHARIDE MICROARRAY TECHNOLOGY; RESISTANT PROSTATE-CANCER; ANTI-GLYCAN ANTIBODIES; BURKHOLDERIA-PSEUDOMALLEI; SURVIVAL; IMMUNOTHERAPY; DIAGNOSIS; GLYCOME; VACCINE; HUMANS	Cancer therapies can provide substantially improved survival in some patients while other seemingly similar patients receive little or no benefit. Strategies to identify patients likely to respond well to a given therapy could significantly improve health care outcomes by maximizing clinical benefits while reducing toxicities and adverse effects. Using a glycan microarray assay, we recently reported that pretreatment serum levels of IgM specific to blood group A trisaccharide (BG-A(tri)) correlate positively with overall survival of cancer patients on PROSTVAC-VF therapy. The results suggested anti-BG-A(tri) IgM measured prior to treatment could serve as a biomarker for identifying patients likely to benefit from PROSTVAC-VF. For continued development and clinical application of serum IgM specific to BG-Atri as a predictive biomarker, a clinical assay was needed. In this study, we developed and validated a Luminex-based clinical assay for measuring serum IgM specific to BG-Atri. IgM levels were measured with the Luminex assay and compared to levels measured using the microarray for 126 healthy individuals and 77 prostate cancer patients. This assay provided reproducible and consistent results with low %CVs, and tolerance ranges were established for the assay. IgM levels measured using the Luminex assay were found to be highly correlated to the microarray results with R values of 0.93-0.95. This assay is a Laboratory Developed Test (LDT) and is suitable for evaluating thousands of serum samples in CLIA certified laboratories that have validated the assay. In addition, the study demonstrates that discoveries made using neoglycoprotein-based microarrays can be readily migrated to a clinical assay.	[Lucas, Julie L.; Tacheny, Erin A.; Ferris, Allison; Galusha, Michelle] MRIGlobal, Gaithersburg, MD USA; [Srivastava, Apurva K.] Leidos Biomed Res Inc, Pharmacodynam Biomarker Program, Appl Dev Res Directorate, Frederick Natl Lab Canc Res, Frederick, MD USA; [Ganguly, Aniruddha; Thurin, Magdalena] NCI, Canc Diag Program, Div Canc Treatment & Diag, NIH, Bethesda, MD 20892 USA; [Williams, P. Mickey] Frederick Natl Lab Canc Res, Mol Characterizat & Clin Assay Dev Lab, Frederick, MD USA; [Sachs, Michael C.] NCI, Biostat Branch, Biometr Res Program, NIH, Bethesda, MD 20892 USA; [Tricoli, James V.] NCI, Diagnost Biomarkers & Technol Branch, Canc Diag Program, Div Canc Treatment & Diag, Rockville, MD USA; [Ricker, Winnie] Informat Management Serv Inc, Rockville, MD USA; [Gildersleeve, Jeffrey C.] NCI, Biol Chem Lab, Ctr Canc Res, NIH, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Information Management Services, Inc.; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gildersleeve, JC (corresponding author), NCI, Biol Chem Lab, Ctr Canc Res, NIH, Frederick, MD 21701 USA.	gildersj@mail.nih.gov		Sachs, Michael/0000-0002-1279-8676; Lucas, Julie/0000-0001-6094-1740; Gildersleeve, Jeffrey/0000-0002-3744-6423	Clinical Assay Development Program of the National Cancer Institute; Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC011055] Funding Source: NIH RePORTER	Clinical Assay Development Program of the National Cancer Institute; Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the Clinical Assay Development Program of the National Cancer Institute for support of this project. This work was supported in part by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One author was employed by a commercial company, Information Management Services, Inc. This funder provided support in the form of salaries for author W.R., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions" section.	Anish C, 2013, ACS CHEM BIOL, V8, P2412, DOI 10.1021/cb400602k; [Anonymous], 2016, CANC MED, V5, P1361; [Anonymous], 2016, SCI REP, V5, P1361; Arthur CM, 2014, CURR OPIN CHEM BIOL, V18, P55, DOI 10.1016/j.cbpa.2013.12.017; Atkins MB, 2015, SEMIN ONCOL, V42, P518, DOI 10.1053/j.seminoncol.2015.05.001; Campbell CT, 2014, P NATL ACAD SCI USA, V111, pE1749, DOI 10.1073/pnas.1314722111; Campbell CT, 2013, CLIN CANCER RES, V19, P1290, DOI 10.1158/1078-0432.CCR-12-2478; Campbell Christopher T, 2010, Curr Protoc Chem Biol, V2, P37, DOI 10.1002/9780470559277.ch090228; de Gramont A, 2015, NAT REV CLIN ONCOL, V12, P197, DOI 10.1038/nrclinonc.2014.202; Dotan N, 2006, LUPUS, V15, P442, DOI 10.1191/0961203306lu2331oa; Elshal MF, 2006, METHODS, V38, P317, DOI 10.1016/j.ymeth.2005.11.010; Geissner A, 2016, ANNU REV ANAL CHEM, V9, P223, DOI 10.1146/annurev-anchem-071015-041641; Gestwicki JE, 2002, J AM CHEM SOC, V124, P14922, DOI 10.1021/ja027184x; Gildersleeve JC, 2016, GLYCOBIOLOGY, V26, P443, DOI 10.1093/glycob/cwv171; Giraldo J, 2002, PHARMACOL THERAPEUT, V95, P21, DOI 10.1016/S0163-7258(02)00223-1; Gotze S, 2014, ANGEW CHEM INT EDIT, V53, P13701, DOI 10.1002/anie.201406706; Gulley JL, 2010, CANCER IMMUNOL IMMUN, V59, P663, DOI 10.1007/s00262-009-0782-8; Heimburg-Molinaro J, 2013, INT J PARASITOL, V43, P901, DOI 10.1016/j.ijpara.2013.05.012; Jacob F, 2012, INT J CANCER, V130, P138, DOI 10.1002/ijc.26002; Jayaraman N, 2009, CHEM SOC REV, V38, P3463, DOI 10.1039/b815961k; Kantoff PW, 2010, J CLIN ONCOL, V28, P1099, DOI 10.1200/JCO.2009.25.0597; Kettman JR, 1998, CYTOMETRY, V33, P234, DOI 10.1002/(SICI)1097-0320(19981001)33:2<234::AID-CYTO19>3.3.CO;2-5; Li Q, 2010, INT J CANCER, V126, P459, DOI 10.1002/ijc.24716; Luyai AE, 2014, GLYCOBIOLOGY, V24, P602, DOI 10.1093/glycob/cwu029; Madan RA, 2012, SEMIN ONCOL, V39, P296, DOI 10.1053/j.seminoncol.2012.02.010; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Muthana SM, 2015, ONCOTARGET, V6, P32244, DOI 10.18632/oncotarget.4993; Muthana SM, 2014, CANCER BIOMARK, V14, P29, DOI 10.3233/CBM-130383; Padler-Karavani V, 2011, CANCER RES, V71, P3352, DOI 10.1158/0008-5472.CAN-10-4102; Palma AS, 2014, CURR OPIN CHEM BIOL, V18, P87, DOI 10.1016/j.cbpa.2014.01.007; Park S, 2013, CHEM SOC REV, V42, P4310, DOI 10.1039/c2cs35401b; Parthasarathy N, 2008, CARBOHYD RES, V343, P2783, DOI 10.1016/j.carres.2008.05.021; Parthasarathy N, 2008, J CARBOHYD CHEM, V27, P32, DOI 10.1080/07328300802030761; Parthasarathy N, 2006, DIAGN MICR INFEC DIS, V56, P329, DOI 10.1016/j.diagmicrobio.2006.04.018; Rillahan CD, 2011, ANNU REV BIOCHEM, V80, P797, DOI 10.1146/annurev-biochem-061809-152236; Roy R, 1996, CURR OPIN STRUC BIOL, V6, P692, DOI 10.1016/S0959-440X(96)80037-6; Stowell C P, 1980, Adv Carbohydr Chem Biochem, V37, P225; Williams PM, 2012, CLIN CANCER RES, V18, P1531, DOI 10.1158/1078-0432.CCR-11-2203	38	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182739	10.1371/journal.pone.0182739	http://dx.doi.org/10.1371/journal.pone.0182739			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771597	Green Published, gold, Green Submitted			2022-12-26	WOS:000406853600153
J	Nanjareddy, K; Arthikala, MK; Gomez, BM; Blanco, L; Lara, M				Nanjareddy, Kalpana; Arthikala, Manoj-Kumar; Gomez, Brenda-Mariana; Blanco, Lourdes; Lara, Miguel			Differentially expressed genes in mycorrhized and nodulated roots of common bean are associated with defense, cell wall architecture, N metabolism, and P metabolism	PLOS ONE			English	Article							NADPH OXIDASE GENE; PHASEOLUS-VULGARIS; TRANSCRIPTION FACTOR; MEDICAGO-TRUNCATULA; LOTUS-JAPONICUS; PHOSPHATE HOMEOSTASIS; PURINE BIOSYNTHESIS; BOTRYTIS-CINEREA; DOWN-REGULATION; RNA-SEQ	Legumes participate in two important endosymbiotic associations, with phosphorus-acquiring arbuscular mycorrhiza (AM, soil fungi) and with nitrogen-fixing bacterial rhizobia. These divergent symbionts share a common symbiotic signal transduction pathway that facilitates the establishment of mycorrhization and nodulation in legumes. However, the unique and shared downstream genes essential for AM and nodule development have not been identified in crop legumes. Here, we used ion torrent next-generation sequencing to perform comparative transcriptomics of common bean (Phaseolus vulgaris) roots colonized by AM or rhizobia. We analyzed global gene expression profiles to identify unique and shared differentially expressed genes (DEGs) that regulate these two symbiotic interactions, and quantitatively compared DEG profiles. We identified 3,219 (1,959 upregulated and 1,260 downregulated) and 2,645 (1,247 upregulated and 1,398 downregulated) unigenes that were differentially expressed in response to mycorrhizal or rhizobial colonization, respectively, compared with uninoculated roots. We obtained quantitative expression profiles of unique and shared genes involved in processes related to defense, cell wall structure, N metabolism, and P metabolism in mycorrhized and nodulated roots. KEGG pathway analysis indicated that most genes involved in jasmonic acid and salicylic acid signaling, N metabolism, and inositol phosphate metabolism are variably expressed during symbiotic interactions. These combined data provide valuable information on symbiotic gene signaling networks that respond to mycorrhizal and rhizobial colonization, and serve as a guide for future genetic strategies to enhance P uptake and N-fixing capacity to increase the net yield of this valuable grain legume.	[Nanjareddy, Kalpana; Arthikala, Manoj-Kumar; Gomez, Brenda-Mariana; Blanco, Lourdes; Lara, Miguel] UNAM, Escuela Nacl Estudios Super Unidad Leon, Ciencias Agrogenom, Guanajuato, Mexico; [Blanco, Lourdes] UNAM, Inst Fisiol Celular, Ciudad Univ, Coyoacan, Ciudad De Mexic, Mexico; [Lara, Miguel] UNAM, Inst Biol, Ciudad Univ, Coyoacan, Ciudad De Mexic, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Arthikala, MK (corresponding author), UNAM, Escuela Nacl Estudios Super Unidad Leon, Ciencias Agrogenom, Guanajuato, Mexico.	manojarthik@gmail.com	Arthikala, Manoj/ACX-5368-2022; Arthikala, Manoj-Kumar/H-1331-2016	Arthikala, Manoj-Kumar/0000-0002-4535-6524	Direccion General de Asuntos del Personal Academic (DGAPA/PAPIIT-UNAM) [IA205115, IA205117]; Consejo Nacional de Ciencia y Tecnologia (CONACYT) [240614]	Direccion General de Asuntos del Personal Academic (DGAPA/PAPIIT-UNAM); Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors wish to acknowledge Direccion General de Asuntos del Personal Academic (DGAPA/PAPIIT-UNAM) for funding this research (Grant no. IA205115 and IA205117 to MKA). The work was partially supported by the Consejo Nacional de Ciencia y Tecnologia (CONACYT grant no. 240614 to ML).	Arthikala MK, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1011932; Arthikala MK, 2014, NEW PHYTOL, V202, P886, DOI 10.1111/nph.12714; Arthikala MK, 2013, PLANT CELL PHYSIOL, V54, P1391, DOI 10.1093/pcp/pct089; Asamizu E, 2008, PLANT PHYSIOL, V147, P2030, DOI 10.1104/pp.108.118141; Aslam SN, 2008, CURR BIOL, V18, P1078, DOI 10.1016/j.cub.2008.06.061; Azarakhsh M, 2015, J EXP BOT, V66, P7181, DOI 10.1093/jxb/erv414; Bapaume L, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00223; Barea JM, 2005, J EXP BOT, V56, P1761, DOI 10.1093/jxb/eri197; Barraza A, 2013, NEW PHYTOL, V197, P194, DOI 10.1111/nph.12002; Battaglia M, 2014, PLANT PHYSIOL, V164, P1430, DOI 10.1104/pp.113.230896; Besserer A, 2006, PLOS BIOL, V4, P1239, DOI 10.1371/journal.pbio.0040226; Boscari A, 2013, PLANT PHYSIOL, V161, P425, DOI 10.1104/pp.112.208538; Broughton WJ, 2000, J BACTERIOL, V182, P5641, DOI 10.1128/JB.182.20.5641-5652.2000; BROUGHTON WJ, 1971, BIOCHEM J, V125, P1075, DOI 10.1042/bj1251075; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Ceballos I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070633; Cerri MR, 2012, PLANT PHYSIOL, V160, P2155, DOI 10.1104/pp.112.203190; Cheng YX, 2011, PLANT J, V66, P781, DOI 10.1111/j.1365-313X.2011.04538.x; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Cruaud C, 2015, PLANT J, V84, P1; David R, 1998, MOL PLANT MICROBE IN, V11, P489, DOI 10.1094/MPMI.1998.11.6.489; De Hoff PL, 2009, MOL GENET GENOMICS, V282, P1, DOI 10.1007/s00438-009-0460-8; Deguchi Y, 2007, DNA RES, V14, P117, DOI 10.1093/dnares/dsm014; Diaz C, 2008, PLANT PHYSIOL, V147, P1437, DOI 10.1104/pp.108.119040; Ding Y, 2012, PLANT J, V70, P866, DOI 10.1111/j.1365-313X.2012.04936.x; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Estrada-Navarrete G, 2016, PLANT CELL, V28, P2326, DOI 10.1105/tpc.15.01012; Zanetti ME, 2010, PLANT CELL, V22, P4142, DOI 10.1105/tpc.110.079137; Ferrari S, 2003, PLANT J, V35, P193, DOI 10.1046/j.1365-313X.2003.01794.x; Frenzel A, 2005, MOL PLANT MICROBE IN, V18, P771, DOI 10.1094/MPMI-18-0771; Frenzel A, 2006, PLANTA, V224, P792, DOI 10.1007/s00425-006-0262-8; Gaude N, 2012, PLANT J, V69, P510, DOI 10.1111/j.1365-313X.2011.04810.x; Genre A, 2013, NEW PHYTOL, V198, P179, DOI 10.1111/nph.12146; Gobbato E, 2012, CURR BIOL, V22, P2236, DOI 10.1016/j.cub.2012.09.044; Gomez SK, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-10; Govindarajulu M, 2005, NATURE, V435, P819, DOI 10.1038/nature03610; Guether M, 2009, NEW PHYTOL, V182, P200, DOI 10.1111/j.1469-8137.2008.02725.x; Guo WB, 2011, PLANT J, V66, P541, DOI 10.1111/j.1365-313X.2011.04511.x; Handa Y, 2015, PLANT CELL PHYSIOL, V56, P1490, DOI 10.1093/pcp/pcv071; Heckmann Ab., 2009, PLANT CELL, V21, P545; Hogekamp C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-306; Hogekamp C, 2011, PLANT PHYSIOL, V157, P2023, DOI 10.1104/pp.111.186635; Islas-Flores T, 2011, MOL PLANT MICROBE IN, V24, P819, DOI 10.1094/MPMI-11-10-0261; Jiang YJ, 2016, PLANT PHYSIOL, V171, P2771, DOI 10.1104/pp.16.00747; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kaewthai N, 2013, PLANT PHYSIOL, V161, P440, DOI 10.1104/pp.112.207308; Kalo P, 2005, SCIENCE, V308, P1786, DOI 10.1126/science.1110951; Kanehisa M, 2016, METHODS MOL BIOL, V1374, P55, DOI 10.1007/978-1-4939-3167-5_3; Kaschuk G, 2010, SOIL BIOL BIOCHEM, V42, P125, DOI 10.1016/j.soilbio.2009.10.017; Kashofer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070714; Kawamura Y, 2009, PLANT CELL PHYSIOL, V50, P924, DOI 10.1093/pcp/pcp044; Kistner C, 2005, PLANT CELL, V17, P2217, DOI 10.1105/tpc.105.032714; Kuo HF, 2014, PLANT J, V80, P503, DOI 10.1111/tpj.12650; Laloum T, 2014, PLANT J, V79, P757, DOI 10.1111/tpj.12587; Laporte P, 2014, J EXP BOT, V65, P481, DOI 10.1093/jxb/ert392; Larrainzar E, 2015, PLANT PHYSIOL, V169, P233, DOI 10.1104/pp.15.00350; Lionetti V, 2017, PLANT PHYSL; Maillet F, 2011, NATURE, V469, P58, DOI 10.1038/nature09622; Maldonado-Mendoza IE, 2005, GENE, V345, P191, DOI 10.1016/j.gene.2004.10.028; Marone D, 2013, INT J MOL SCI, V14, P7302, DOI 10.3390/ijms14047302; Marowa P, 2016, PLANT CELL REP, V35, P949, DOI 10.1007/s00299-016-1948-4; Marsh JF, 2007, PLANT PHYSIOL, V144, P324, DOI 10.1104/pp.106.093021; MARTINEZROMERO E, 1991, INT J SYST BACTERIOL, V41, P417, DOI 10.1099/00207713-41-3-417; Masson-Boivin C, 2009, TRENDS MICROBIOL, V17, P458, DOI 10.1016/j.tim.2009.07.004; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; Meghvansi MK, 2008, EUR J SOIL BIOL, V44, P316, DOI 10.1016/j.ejsobi.2008.03.003; Miller AJ, 2008, J EXP BOT, V59, P111, DOI 10.1093/jxb/erm208; Miller RO, 1998, HANDBOOK OF REFERENCE METHODS FOR PLANT ANALYSIS, P57; Montiel J, 2012, PLANT CELL PHYSIOL, V53, P1751, DOI 10.1093/pcp/pcs120; Murray JD, 2007, SCIENCE, V315, P101, DOI 10.1126/science.1132514; Murray JD, 2013, MOL PLANT, V6, P1381, DOI 10.1093/mp/sst090; Nanjareddy K, 2016, PLANT PHYSIOL, V172, P2002, DOI 10.1104/pp.16.00844; Nanjareddy K, 2014, J INTEGR PLANT BIOL, V56, P281, DOI 10.1111/jipb.12156; O'Rourke JA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-866; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; Oldroyd GED, 2013, NAT REV MICROBIOL, V11, P252, DOI 10.1038/nrmicro2990; Plett JM, 2014, NEW PHYTOL, V202, P270, DOI 10.1111/nph.12655; Ramirez M, 2005, PLANT PHYSIOL, V137, P1211, DOI 10.1104/pp.104.054999; Ramirez M, 1999, MOL PLANT MICROBE IN, V12, P1008, DOI 10.1094/MPMI.1999.12.11.1008; REMY W, 1994, P NATL ACAD SCI USA, V91, P11841, DOI 10.1073/pnas.91.25.11841; Rich MK, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00238; Rodriguez-Lopez J, 2014, MOL PLANT MICROBE IN, V27, P18, DOI 10.1094/MPMI-07-13-0200-R; Rogers C, 2014, J EXP BOT, V65, P1939, DOI 10.1093/jxb/eru098; Roux B, 2014, PLANT J, V77, P817, DOI 10.1111/tpj.12442; Sanchez-Lopez R, 2011, PLANT CELL ENVIRON, V34, P2109, DOI 10.1111/j.1365-3040.2011.02408.x; Smit P, 2005, SCIENCE, V308, P1789, DOI 10.1126/science.1111025; Smith PMC, 2002, PLANT PHYSIOL, V128, P793, DOI 10.1104/pp.010912; Smith SE, 2011, PLANT PHYSIOL, V156, P1050, DOI 10.1104/pp.111.174581; Smith SE, 2011, ANNU REV PLANT BIOL, V62, P227, DOI 10.1146/annurev-arplant-042110-103846; Smith SE, 2003, PLANT PHYSIOL, V133, P16, DOI 10.1104/pp.103.024380; Soyano T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003352; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Suza WP, 2008, PLANTA, V227, P1221, DOI 10.1007/s00425-008-0694-4; Takeda N, 2015, PLANT PHYSIOL, V167, P545, DOI 10.1104/pp.114.247700; THEODOROU ME, 1993, PLANT PHYSIOL, V101, P339, DOI 10.1104/pp.101.2.339; Tirichine L, 2007, SCIENCE, V315, P104, DOI 10.1126/science.1132397; Tromas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044742; Underwood W, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00085; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vernie T, 2008, PLANT CELL, V20, P2696, DOI 10.1105/tpc.108.059857; Wang YN, 2014, PLANT CELL, V26, P4782, DOI 10.1105/tpc.114.131607; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Williams SP, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00067; Xue L, 2015, PLANT PHYSIOL, V167, P854, DOI 10.1104/pp.114.255430; Zrenner R, 2006, ANNU REV PLANT BIOL, V57, P805, DOI 10.1146/annurev.arplant.57.032905.105421; Zucchero JC, 2001, MOL PLANT MICROBE IN, V14, P1463, DOI 10.1094/MPMI.2001.14.12.1463	108	17	19	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182328	10.1371/journal.pone.0182328	http://dx.doi.org/10.1371/journal.pone.0182328			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771548	gold, Green Submitted, Green Published			2022-12-26	WOS:000406853600090
J	Bai, HX; Mao, Y; Shen, L; Xu, XL; Gao, F; Zhang, ZB; Li, B; Jonas, JB				Bai, Hai Xia; Mao, Ying; Shen, Ling; Xu, Xiao Lin; Gao, Fei; Zhang, Zhi Bao; Li, Bin; Jonas, Jost B.			Bruch' s membrane thickness in relationship to axial length	PLOS ONE			English	Article							PROGRESSIVE ADDITION LENSES; RETINAL-PIGMENT EPITHELIUM; CHOROIDAL THICKNESS; HIGH MYOPIA; AGE; DEFOCUS; GLAUCOMA; GROWTH; EYE	Purpose To assess a potential role of Bruch' s membrane (BM) in the biomechanics of the eye, we measured its thickness and the density of retinal pigment epithelium (RPE) cells in various ocular regions in eyes of varying axial length. Methods Human globes, enucleated because of an ocular tumor or end-stage glaucoma were prepared for histological examination. Using light microscopy, the histological slides were histo-morphometrically examined applying a digitized image analysis system. Results The study included 104 eyes with a mean axial length of 27.9 +/- 3.2 mm (range: 22.6mm-36.5mm). In eyes without congenital glaucoma, BM was significantly thickest (P<0.001) at the ora serrata, followed by the posterior pole, the midpoint between equator and posterior pole (MBEPP), and finally the equator. BM thickness was not significantly correlated with axial length (ora serrata: P = 0.93; equator: P = 0.31; MBEPP: P = 0.15; posterior pole: P = 0.35). RPE cell density in the pre-equatorial region (P = 0.02; regression coefficient r = -0.24) and in the retro-equatorial region (P = 0.03; r = -0.22) decreased with longer axial length, while RPE cell density at the ora serrata (P = 0.35), the MBEPP (P = 0.06; r = -0.19) and the posterior pole (P = 0.38) was not significantly correlated with axial length. Highly myopic eyes with congenital glaucoma showed a tendency towards lower BM thickness and lower RPE cell density at all locations. Conclusions BM thickness, in contrast to scleral and choroidal thickness, was independent of axial length in eyes without congenital glaucoma. In association with an axial elongation associated decrease in the RPE cell density in the midperiphery, the findings support the notion of a biomechanical role BM may play in the process of emmetropization/myopization.	[Bai, Hai Xia; Mao, Ying; Shen, Ling; Xu, Xiao Lin; Gao, Fei; Zhang, Zhi Bao; Li, Bin] Capital Med Univ, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Inst Ophthalmol, Beijing Tongren Eye Ctr,Beijing Tongren Hosp, Beijing, Peoples R China; [Shen, Ling] Harbin Med Univ, Affiliated Hosp 2, Dept Ophthalmol, Harbin, Heilongjiang, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany	Capital Medical University; Harbin Medical University; Ruprecht Karls University Heidelberg	Li, B (corresponding author), Capital Med Univ, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Inst Ophthalmol, Beijing Tongren Eye Ctr,Beijing Tongren Hosp, Beijing, Peoples R China.; Jonas, JB (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany.	libin43_99@163.com; Jost.Jonas@medma.uni-heidelberg.de	Shen, Ling/AAF-9067-2020; Bai, Haixia/HDO-0641-2022					Benavente-Perez A, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-14524; Berntsen DA, 2013, INVEST OPHTH VIS SCI, V54, P5761, DOI 10.1167/iovs.13-11904; Chong NHV, 2005, AM J PATHOL, V166, P241, DOI 10.1016/S0002-9440(10)62248-1; Curcio CA, 2012, STRUCTURE FUNCTION P; Dithmar S, 2000, INVEST OPHTH VIS SCI, V41, P2035; Guymer R, 1999, PROG RETIN EYE RES, V18, P59, DOI 10.1016/S1350-9462(98)00012-3; Hasebe S, 2014, INVEST OPHTH VIS SCI, V55, P7177, DOI 10.1167/iovs.12-11462; Heine, 1899, ARCH AUGENHEILKD, V38, P277; Jiang WJ, 2017, EBIOMEDICINE, V17, P134, DOI 10.1016/j.ebiom.2017.02.021; Jonas JB, 2017, RETINA          0112, DOI [10.1097/IAE.0000000000001464, DOI 10.1097/IAE.0000000000001464]; Jonas JB, 2017, ACTA OPHTHALMOL, V95, pE22, DOI 10.1111/aos.13188; Jonas JB, 2016, INVEST OPHTH VIS SCI, V57, P1791, DOI 10.1167/iovs.15-18529; Jonas JB, 2016, ACTA OPHTHALMOL, V94, P147, DOI 10.1111/aos.12937; Jonas JB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136833; Jonas JB, 2014, ACTA OPHTHALMOL, V92, pE470, DOI 10.1111/aos.12372; Jonas RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138701; NEWSOME DA, 1987, CURR EYE RES, V6, P1211, DOI 10.3109/02713688709025231; Okubo A, 1999, INVEST OPHTH VIS SCI, V40, P443; PAULEIKHOFF D, 1990, OPHTHALMOLOGY, V97, P171; RAMRATTAN RS, 1994, INVEST OPHTH VIS SCI, V35, P2857; Shao L, 2014, AM J OPHTHALMOL, V158, P702, DOI 10.1016/j.ajo.2014.05.023; Shen L, 2016, GRAEF ARCH CLIN EXP, V254, P1779, DOI 10.1007/s00417-016-3345-7; Shen L, 2016, RETINA-J RET VIT DIS, V36, P1579, DOI 10.1097/IAE.0000000000000947; Smith EL, 2010, INVEST OPHTH VIS SCI, V51, P3864, DOI 10.1167/iovs.09-4969; Vurgese S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029692; Yan F, 2007, OPHTHALMOLOGICA, V221, P244, DOI 10.1159/000101926	26	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182080	10.1371/journal.pone.0182080	http://dx.doi.org/10.1371/journal.pone.0182080			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767664	Green Published, Green Submitted, gold			2022-12-26	WOS:000406768200043
J	Lorite, J; Serrano, F; Lorenzo, A; Canadas, EM; Ballesteros, M; Penas, J				Lorite, Juan; Serrano, Fabio; Lorenzo, Adrian; Canadas, Eva M.; Ballesteros, Miguel; Penas, Julio			Rock climbing alters plant species composition, cover, and richness in Mediterranean limestone cliffs	PLOS ONE			English	Article							NIAGARA-ESCARPMENT; VEGETATION; ECOLOGY; JURA; CONSERVATION; COMMUNITIES; HOTSPOTS; PARK	Rock climbing is among the outdoor activities that have undergone the highest growth since the second half of the 20th century. As a result, cliff habitats, historically one of the least disturbed by human colonization worldwide, are facing more intense human pressure than ever before. However, there is little data on the impact of this activity in plant-communities, and such information is indispensable for adequate manager decision-making. The goal of this study was to determine the impact of rock climbing on plant communities in terms of cover, richness, and composition in relation to climbing intensity on typical Mediterranean limestone cliffs. Three rock-climbing sites were selected in the Baetic range (SE Spain), corresponding to qualitative categories of climbing frequentation: i) "low" (low frequentation with intermittent climbing), ii) "medium" (high frequentation without overcrowding), and iii) "high" (high frequentation with overcrowding). Within each site, we selected climbing routes and adjacent areas free of climbing, then we carried out a photoplot-based sampling by rappelling. We analysed the images to calculate: richness, species cover, and total cover. This study shows that rock climbing negatively affected the cliff plant community at all three study sites. A significant decrease in plant cover, species richness and a shift in the community composition were recorded for climbed areas, the cover being the variable most sensitive to rock climbing. Impact observed proved to be related to the frequentation level. Low-frequentation sites, with usually more specialized climbers, underwent relatively mild damages, whereas at high frequentation sites the impact was severe and the conservation of the species, especially rare ones, became jeopardized. Our study is the first one available to investigate climbing impact on plant communities in Mediterranean areas, but more research on the impact of rock climbing is needed to assess the regulation of this activity. Regarding management guidelines, we propose a management guideline protocol to evaluate climbing routes and design: i) "Sites free of climbing", ii) "Strictly regulated climbing routes", iii) "Mildly regulated climbing routes", or iv) "Free climbing routes".	[Lorite, Juan; Serrano, Fabio; Lorenzo, Adrian; Canadas, Eva M.; Ballesteros, Miguel; Penas, Julio] Univ Granada, Dept Botany, Granada, Spain; [Lorite, Juan] Interuniv Inst Earth Syst Research, Granada, Spain	University of Granada	Lorite, J (corresponding author), Univ Granada, Dept Botany, Granada, Spain.; Lorite, J (corresponding author), Interuniv Inst Earth Syst Research, Granada, Spain.	jlorite@ugr.es	Lorite, Juan/F-4690-2011; Cañadas, Eva M./A-8928-2011; Ballesteros, Miguel/AAR-6399-2021	Lorite, Juan/0000-0003-4617-8069; Cañadas, Eva M./0000-0003-1348-553X; Ballesteros, Miguel/0000-0003-1583-1133	Regional Government of Andalusia [P11-RNM-7061]	Regional Government of Andalusia(Junta de Andalucia)	Funding was provided by the Regional Government of Andalusia (Junta de Andalucia, Proyectos de Excelencia, P11-RNM-7061).	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Andalucia Munilla D., 2005, GUIA ESCALADA DEPORT; [Anonymous], 2009, CAS PARC NAT BARC; Attarian A., 2008, CLIMBING MANAGEMENT; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baur B, 2007, NOVA HEDWIGIA, V85, P429, DOI 10.1127/0029-5035/2007/0085-0429; BENZING DH, 2000, BROMELIACEAE PROFILE; BLANCA G., 2011, FLORA VASCULAR ANDAL; Camp RJ, 1998, CONSERV BIOL, V12, P1302, DOI 10.1046/j.1523-1739.1998.97363.x; Canadas EM, 2014, BIOL CONSERV, V170, P282, DOI 10.1016/j.biocon.2013.12.007; Clark P, 2015, APPL VEG SCI, V18, P705, DOI 10.1111/avsc.12172; Cordell HK, 2012, OUTDOOR RECREATION N; de Lange PJ, 2004, BIOL CONSERV, V117, P49, DOI 10.1016/S0006-3207(03)00262-3; Elzinga CL, 2015, MEASURING MONITORING, P36; Farris M., 1995, EFFECTS ROCK CLIMBIN; Farris MA, 1998, CAN J BOT, V76, P1981, DOI 10.1139/b98-178; Garcia MB, METODO CENSO SEGUIMI; Herter W., 1996, XEROTHERMVEGETATION; Herter W., 1993, GEFAHRDUNG XEROTHERM; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Kelly PE, 1997, CONSERV BIOL, V11, P1125, DOI 10.1046/j.1523-1739.1997.96248.x; Kuntz KL, 2006, PLANT ECOL, V185, P239, DOI 10.1007/s11258-006-9101-z; Kuntz KL, 2006, CONSERV BIOL, V20, P821, DOI 10.1111/j.1523-1739.2006.00367.x; Larson D.W., 2000, CAMBRIDGE STUDIES EC; LIDDLE M, 1997, RECREATION ECOLOGY E; Luttge U., 1997, PHYSL ECOLOGY TROPIC; McMillan MA, 2002, CONSERV BIOL, V16, P389, DOI 10.1046/j.1523-1739.2002.00377.x; Medail F, 1997, ANN MO BOT GARD, V84, P112, DOI 10.2307/2399957; Medail F, 2009, J BIOGEOGR, V36, P1333, DOI 10.1111/j.1365-2699.2008.02051.x; Monz CA, 2013, FRONT ECOL ENVIRON, V11, P441, DOI 10.1890/120358; Monz Christopher A., 1994, Bulletin of the Ecological Society of America, V75, P158; Muller S, 2004, CAN J BOT, V82, P862, DOI [10.1139/B04-058, 10.1139/b04-058]; MuMIn K., MULTIMODEL INFERENCE; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Newsome D., 2012, NATURAL AREA TOURISM; Noe FP, 1997, J ENVIRON MANAGE, V49, P323, DOI 10.1006/jema.1995.0093; NUZZO VA, 1995, AM MIDL NAT, V133, P229, DOI 10.2307/2426387; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Perez-Raya F, 1988, AN JARDIN BOT MADRID, V45, P356; Polunin O., 1980, FLOWERS GREECE BALKA; Regato P, 2008, MEDITERRANEAN MOUNTA; Rusterholz HP, 2004, APPL VEG SCI, V7, P35, DOI 10.1658/1402-2001(2004)007[0035:EORCOP]2.0.CO;2; Thompson JD, 2005, PLANT EVOLUTION MEDI; Valis T., 1991, ESCARPMENT CLIMBERS; Vera J.A., 2004, GEOLOGIA ESPANA; Vogler F, 2011, J APPL ECOL, V48, P899, DOI 10.1111/j.1365-2664.2011.01992.x; Wezel A, 2007, J NAT CONSERV, V15, P84, DOI 10.1016/j.jnc.2007.03.002	47	16	16	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182414	10.1371/journal.pone.0182414	http://dx.doi.org/10.1371/journal.pone.0182414			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767727	Green Submitted, Green Published, gold			2022-12-26	WOS:000406768200079
J	Rossen, J; Buman, MP; Johansson, UB; Yngve, A; Ainsworth, B; Brismar, K; Hagstromer, M				Rossen, Jenny; Buman, Matthew P.; Johansson, Unn-Britt; Yngve, Agneta; Ainsworth, Barbara; Brismar, Kerstin; Hagstromer, Maria			Reallocating bouted sedentary time to non-bouted sedentary time, light activity and moderate-vigorous physical activity in adults with prediabetes and type 2 diabetes	PLOS ONE			English	Article							SITTING TIME; PREVENTION; MORTALITY; BEHAVIOR; RISK; SUBSTITUTION; ASSOCIATIONS; METAANALYSIS; STATEMENT; BREAKING	Aim The aim of this study was to investigate the potential associations of reallocating 30 minutes sedentary time in long bouts (>60 min) to sedentary time in non-bouts, light intensity physical activity (LPA) and moderate-to vigorous physical activity (MVPA) with cardiometabolic risk factors in a population diagnosed with prediabetes or type 2 diabetes. Methods Participants diagnosed with prediabetes and type 2 diabetes (n = 124, 50% men, mean [SD] age = 63.8 [7.5] years) were recruited to the physical activity intervention Sophia Step Study. For this study baseline data was used with a cross-sectional design. Time spent in sedentary behaviors in bouts (>60 min) and non-bouts (accrued in <60 min bouts) and physical activity was measured using the ActiGraph GT1M. Associations of reallocating bouted sedentary time to non-bouted sedentary time, LPA and MVPA with cardiometabolic risk factors were examined using an isotemporal substitution framework with linear regression models. Results Reallocating 30 minutes sedentary time in bouts to MVPA was associated with lower waist circumference (b = -4.30 95% CI:-7.23, -1.38 cm), lower BMI (b = -1.46 95% CI:-2.60, -0.33 kg/m(2)) and higher HDL cholesterol levels (b = 0.11 95% CI: 0.02, 0.21 kg/m(2). Similar associations were seen for reallocation of sedentary time in non-bouts to MVPA. Reallocating sedentary time in bouts to LPA was associated only with lower waist circumference. Conclusion Reallocation of sedentary time in bouts as well as non-bouts to MVPA, but not to LPA, was beneficially associated with waist circumference, BMI and HDL cholesterol in individuals with prediabetes and type 2 diabetes. The results of this study confirm the importance of reallocation sedentary time to MVPA.	[Rossen, Jenny; Johansson, Unn-Britt; Yngve, Agneta] Sophiahemmet Univ, Stockholm, Sweden; [Rossen, Jenny; Johansson, Unn-Britt] Karolinska Inst, Sodersjukhuset, Dept Clin Sci & Educ, Stockholm, Sweden; [Buman, Matthew P.; Ainsworth, Barbara] Arizona State Univ, Sch Nutr & Hlth Promot, Coll Hlth Solut, Phoenix, AZ USA; [Yngve, Agneta] Uppsala Univ, Dept Food Nutr & Dietet, Uppsala, Sweden; [Brismar, Kerstin] Karolinska Inst, Dept Mol Med & Surg, Karolinska Univ Hosp, Rolf Luft Res Ctr Diabet & Endocrinol, Stockholm, Sweden; [Hagstromer, Maria] Karolinska Inst, Div Physiotherapy, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Hagstromer, Maria] Karolinska Univ Hosp, Allied Hlth Profess Funct, Funct Area Occupat Therapy & Physiotherapy, Stockholm, Sweden	Sophiahemmet University; Karolinska Institutet; Sodersjukhuset Hospital; Arizona State University; Arizona State University-Downtown Phoenix; Uppsala University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Rossen, J (corresponding author), Sophiahemmet Univ, Stockholm, Sweden.; Rossen, J (corresponding author), Karolinska Inst, Sodersjukhuset, Dept Clin Sci & Educ, Stockholm, Sweden.	jenny.rossen@shh.se	Buman, Matthew/AAJ-4447-2020	Buman, Matthew/0000-0002-5130-3162; Johansson, Unn-Britt/0000-0003-3309-136X; Yngve, Agneta/0000-0002-7165-279X; Rossen, Jenny/0000-0003-4920-252X	Sophiahemmet Foundation; Swedish Diabetes Foundation; King Gustav V and Queen Victoria's Order of Freemasons research foundation; Forte (Vardalsstiftelsen); Skandia; Sibling Svensson's Foundation for Medical Research	Sophiahemmet Foundation; Swedish Diabetes Foundation; King Gustav V and Queen Victoria's Order of Freemasons research foundation; Forte (Vardalsstiftelsen); Skandia; Sibling Svensson's Foundation for Medical Research	The work was supported by the following: Sophiahemmet Foundation, http://www.sophiahemmet.se/ The Swedish Diabetes Foundation, http://www.diabetes.se/diabetestormen; The King Gustav V and Queen Victoria's Order of Freemasons research foundation, https://www.frimurarorden.se/orgaresation/barmhartighetsverksamhet/frimurarstiftelsen/ Forte (Vardalsstiftelsen), http://forte.se/en/ Skandia, https://www.skandia.se/forsaloaterbjudande/halsa/forskning/; and Sibling Svensson's Foundation for Medical Research, http://www.stiftelseansokan.se/Pages/Svensson.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Sophiahemmet Foundation, The Swedish Diabetes Foundation, The King Gustav V and Queen Victoria's Order of Freemasons research foundation, Forte (Vardalsstiftelsen), Skandia and Sibling Svensson's Foundation for Medical Research.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; Buman MP, 2014, AM J EPIDEMIOL, V179, P323, DOI 10.1093/aje/kwt292; Chastin SFM, 2015, OBESITY, V23, P1800, DOI 10.1002/oby.21180; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; Colberg SR, 2016, DIABETES CARE, V39, P2065, DOI 10.2337/dc16-1728; Colberg SR, 2010, MED SCI SPORT EXER, V42, P2282, DOI 10.1249/MSS.0b013e3181eeb61c; Cooper AR, 2012, DIABETOLOGIA, V55, P589, DOI 10.1007/s00125-011-2408-x; Dempsey PC, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0797-4; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Ekblom-Bak E, 2016, J PHYS ACT HEALTH, V13, P697, DOI 10.1123/jpah.2015-0611; Ekblom-Bak E, 2016, EUR J PREV CARDIOL, V23, P967, DOI 10.1177/2047487315619734; Ekelund U, 2016, LANCET, V388, P1302, DOI 10.1016/S0140-6736(16)30370-1; Falconer CL, 2015, MED SCI SPORT EXER, V47, P2070, DOI 10.1249/MSS.0000000000000651; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Hamer M, 2014, BMJ OPEN DIAB RES CA, V2, DOI 10.1136/bmjdrc-2014-000030; Hart TL, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-62; Healy GN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119140; Henson J, 2016, DIABETES-METAB RES, V32, P213, DOI 10.1002/dmrr.2759; Henson J, 2016, DIABETES CARE, V39, P130, DOI 10.2337/dc15-1240; Matthews CE, 2008, AM J EPIDEMIOL, P167; Matthews CE, 2015, MED SCI SPORT EXER, V47, P1833, DOI 10.1249/MSS.0000000000000621; Mekary RA, 2009, INT J OBESITY, V33, P1039, DOI 10.1038/ijo.2009.127; Robson J, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/2052-1847-7-2; Rossen J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1941-9; Strath SJ, 2013, CIRCULATION, V128, P2259, DOI 10.1161/01.cir.0000435708.67487.da; Taylor-Piliae RE, 2006, AM J EPIDEMIOL, V164, P598, DOI 10.1093/aje/kwj248; Unick JL, 2016, MED SCI SPORTS EXERC, V48, P2437; Wing RR, 2011, DIABETES CARE, V34, P1481, DOI 10.2337/dc10-2415; Yates T, 2015, PREV MED, V76, P79, DOI 10.1016/j.ypmed.2015.04.005; Yngve A, 2003, MED SCI SPORT EXER, V35, P320, DOI 10.1249/01.MSS.0000048829.75758.A0; Zethelius B, 2014, EUR J PREV CARDIOL, V21, P244, DOI 10.1177/2047487313510893; Zethelius B, 2011, DIABETES RES CLIN PR, V93, P276, DOI 10.1016/j.diabres.2011.05.037	33	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0181053	10.1371/journal.pone.0181053	http://dx.doi.org/10.1371/journal.pone.0181053			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753626	Green Published, Green Submitted, gold			2022-12-26	WOS:000406579300010
J	Igielski, R; Kepczynska, E				Igielski, Rafal; Kepczynska, Ewa			Gene expression and metabolite profiling of gibberellin biosynthesis during induction of somatic embryogenesis in Medicago truncatula Gaertn	PLOS ONE			English	Article							ENDOGENOUS HORMONE LEVELS; CARROT DAUCUS-CAROTA; TRANSCRIPTION FACTOR; PHASEOLUS-COCCINEUS; ABSCISIC-ACID; IN-VITRO; ARABIDOPSIS-THALIANA; GROWTH-REGULATORS; SUSPENSION-CULTURE; DEVELOPING SEEDS	Gibberellins (GAs) are involved in the regulation of numerous developmental processes in plants including zygotic embryogenesis, but their biosynthesis and role during somatic embryogenesis (SE) is mostly unknown. In this study we show that during three week-long induction phase, when cells of leaf explants from non-embryogenic genotype (M9) and embryogenic variant (M9-10a) were forming the callus, all the bioactive gibberellins from non-13-hydroxylation (GA(4), GA(7)) and 13-hydroxylation (GA(1), GA(5), GA(3), GA(6)) pathways were present, but the contents of only a few of them differed between the tested lines. The GA(53) and GA(19) substrates synthesized by the 13-hydroxylation pathway accumulated specifically in the M9-10a line after the first week of induction; subsequently, among the bioactive gibberellins detected, only the content of GA(3) increased and appeared to be connected with acquisition of embryogenic competence. We fully annotated 20 Medicago truncatula orthologous genes coding the enzymes which catalyze all the known reactions of gibberellin biosynthesis. Our results indicate that, within all the genes tested, expression of only three: MtCPS, MtGA3ox1 and MtGA3ox2, was specific to embryogenic explants and reflected the changes observed in GA(53), GA(19) and GA(3) contents. Moreover, by analyzing expression of MtBBM, SE marker gene, we confirmed the inhibitory effect of manipulation in GA(s) metabolism, applying exogenous GA(3), which not only impaired the production of somatic embryos, but also significantly decreased expression of this gene.	[Igielski, Rafal; Kepczynska, Ewa] Univ Szczecin, Dept Plant Biotechnol, Szczecin, Poland	University of Szczecin	Kepczynska, E (corresponding author), Univ Szczecin, Dept Plant Biotechnol, Szczecin, Poland.	ekepcz@univ.szczecin.pl		Kepczynska, Ewa/0000-0001-7833-3807	Polish National Scientific Centre [NN 303801340]	Polish National Scientific Centre	This work was supported by the Polish National Scientific Centre Grant No. NN 303801340; (https://www.ncn.gov.pl/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida AM, 2012, PHYSIOL PLANTARUM, V146, P236, DOI 10.1111/j.1399-3054.2012.01633.x; Araujo SD, 2004, PLANT CELL TISS ORG, V78, P123, DOI 10.1023/B:TICU.0000022540.98231.f8; Arnold S., 2002, PLANT CELL TISS ORG, V69, P223; Belmonte MF, 2013, P NATL ACAD SCI USA, V110, pE435, DOI 10.1073/pnas.1222061110; BIDDINGTON NL, 1992, PLANT GROWTH REGUL, V11, P81, DOI 10.1007/BF00024438; Boutilier K, 2002, PLANT CELL, V14, P1737, DOI 10.1105/tpc.001941; Braybrook SA, 2006, P NATL ACAD SCI USA, V103, P3468, DOI 10.1073/pnas.0511331103; Chen JT, 2003, PLANT CELL TISS ORG, V72, P105, DOI 10.1023/A:1021235700751; CIONINI PG, 1976, PLANTA, V131, P115, DOI 10.1007/BF00389979; Curaba J, 2004, PLANT PHYSIOL, V136, P3660, DOI 10.1104/pp.104.047266; daCunha ACG, 1997, PLANT CELL TISS ORG, V47, P1; DAS AB, 1995, PLANT CELL REP, V15, P147, DOI 10.1007/BF01690273; Davidson SE, 2003, PLANT PHYSIOL, V131, P335, DOI 10.1104/pp.012963; Dayan J, 2012, PLANT CELL, V24, P66, DOI 10.1105/tpc.111.093096; ElS Ouakfaoui, 2010, PLANT MOL BIOL, V74, P313; Eriksson S, 2006, PLANT CELL, V18, P2172, DOI 10.1105/tpc.106.042317; Feher A., 2014, BIOCHIM BIOPHYS ACTA, V1849, P1; Fleet CM, 2003, PLANT PHYSIOL, V132, P830, DOI 10.1104/pp.103.021725; Florez SL, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0479-4; FUJIMURA T, 1975, PLANT SCI LETT, V5, P359, DOI 10.1016/0304-4211(75)90001-2; Gazzarrini S, 2004, DEV CELL, V7, P373, DOI 10.1016/j.devcel.2004.06.017; Giacomelli L, 2013, J EXP BOT, V64, P4403, DOI 10.1093/jxb/ert251; Han FM, 2011, GENE, V473, P23, DOI 10.1016/j.gene.2010.10.010; Hedden P, 2016, ANN PLANT REV, V49, P1; Hedden P., 2016, ANN PLANT REV, V49, p73 ; Hedden P, 2012, BIOCHEM J, V444, P11, DOI 10.1042/BJ20120245; Heidmann I, 2011, PLANT CELL REP, V30, P1107, DOI 10.1007/s00299-011-1018-x; Henry R, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00074; Hita O, 1997, ACTA PHYSIOL PLANT, V19, P333, DOI 10.1007/s11738-997-0010-0; HOOLEY R, 1994, PLANT MOL BIOL, V26, P1529, DOI 10.1007/BF00016489; Horstman A, 2015, DEVELOPMENT, V142, P454, DOI 10.1242/dev.117168; Huang B, 2015, PHARMACOGN MAG, V11, P574, DOI 10.4103/0973-1296.160443; Hutchinson MJ, 1997, PLANT CELL REP, V16, P435, DOI [10.1007/s002990050255, 10.1007/BF01146789]; Imin N, 2007, J EXP BOT, V58, P439, DOI 10.1093/jxb/erl224; Indoliya Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep23050; Irikova T, 2012, PLANT GROWTH REGUL, V67, P191, DOI 10.1007/s10725-012-9676-4; J. Regulation of Medicago sativa, 2001, PLANT GROWTH REGUL, V36, P91; Jimenez VM, 2005, PLANT GROWTH REGUL, V47, P91, DOI 10.1007/s10725-005-3478-x; Jimenez VM, 2005, PLANT CELL REP, V23, P567, DOI 10.1007/s00299-004-0869-9; Jimenez VM, 2001, PHYSIOL PLANTARUM, V111, P389, DOI 10.1034/j.1399-3054.2001.1110317.x; Jimenez VM, 2000, VITIS, V39, P151; Jimenez VM, 2001, PLANT SCI, V160, P247, DOI 10.1016/S0168-9452(00)00382-4; Kamada H, 2005, PLANT BIOTECHNOL, V22, P253, DOI DOI 10.5511/plantbiotechnology.22.253; Kanno Y, 2010, PLANT CELL PHYSIOL, V51, P1988, DOI 10.1093/pcp/pcq158; Kawashima T, 2010, TRENDS PLANT SCI, V15, P23, DOI 10.1016/j.tplants.2009.11.002; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KOMAMINE A, 1992, IN VITRO CELL DEV-PL, V28P, P11; Kulinska-Lukaszek K, 2012, BIOL PLANTARUM, V56, P389, DOI 10.1007/s10535-012-0105-3; LI BC, 1995, PLANT CELL REP, V14, P529, DOI 10.1007/BF00232789; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lulsdorf MM, 2013, PLANT GROWTH REGUL, V71, P191, DOI 10.1007/s10725-013-9819-2; Magome H, 2013, P NATL ACAD SCI USA, V110, P1947, DOI 10.1073/pnas.1215788110; Miroshnichenko D., 2009, Australian Journal of Crop Science, V3, P83; Mitsuhashi W, 2003, BIOSCI BIOTECH BIOCH, V67, P2438, DOI 10.1271/bbb.67.2438; Montero-Cortes M, 2010, PLANT CELL REP, V29, P1049, DOI 10.1007/s00299-010-0890-0; Nadeau CD, 2011, PLANT PHYSIOL, V156, P897, DOI 10.1104/pp.111.172577; Neves L. O. Das, 1999, Plant Cell Reports, V18, P398; Nic-Can GI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072160; NOLAN KE, 1989, PLANT CELL REP, V8, P278, DOI 10.1007/BF00274129; Nolan KE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099908; NOMA M, 1982, PLANTA, V155, P369, DOI 10.1007/BF00394464; Nomura T, 2013, PLANT CELL PHYSIOL, V54, P1837, DOI 10.1093/pcp/pct125; Olimpieri I, 2011, PLANT SCI, V180, P496, DOI 10.1016/j.plantsci.2010.11.004; Ortowska A, 2016, PLANT CELL TISS ORG, V129, P119; Ortu G, 2012, MOL PLANT, V5, P951, DOI 10.1093/mp/sss027; PIAGGESI A, 1989, PLANT PHYSIOL, V91, P362, DOI 10.1104/pp.91.1.362; PICCIARELLI P, 1986, PLANT PHYSIOL, V82, P298, DOI 10.1104/pp.82.1.298; Pullman GS, 2005, PLANT CELL REP, V23, P596, DOI 10.1007/s00299-004-0880-1; Regnault T, 2014, PLANT J, V80, P462, DOI 10.1111/tpj.12648; Reinecke DM, 2013, PLANT PHYSIOL, V163, P929, DOI 10.1104/pp.113.225987; Rieu I, 2008, PLANT J, V53, P488, DOI 10.1111/j.1365-313X.2007.03356.x; Rittenberg D, 1940, J BIOL CHEM, V133, P737; Rose RJ, 2010, PLANT DEVELOPMENTAL BIOLOGY: BIOTECHNOLOGICAL PERSPECTIVES VOL 2, P3, DOI 10.1007/978-3-642-04670-4_1; Rose RJ, 2013, SOMATIC EMBRYOGENESI, P146; Sakamoto T, 2004, PLANT PHYSIOL, V134, P1642, DOI 10.1104/pp.103.033696; SANKHLA A, 1992, PLANT CELL REP, V11, P368, DOI 10.1007/BF00233368; Santos D, 2002, PLANT CELL TISS ORG, V70, P155, DOI 10.1023/A:1016369921067; SCHENK RU, 1972, CAN J BOTANY, V50, P199, DOI 10.1139/b72-026; Seki H, 2008, P NATL ACAD SCI USA, V105, P14204, DOI 10.1073/pnas.0803876105; Shimizu K, 1997, PLANT CELL TISS ORG, V50, P27, DOI 10.1023/A:1005910710066; Silverstone AL, 1997, PLANT J, V12, P9, DOI 10.1046/j.1365-313X.1997.12010009.x; Singh DP, 2002, PLANT CELL, V14, P3133, DOI 10.1105/tpc.003046; Slater SMH, 2013, PLANT CELL REP, V32, P1939, DOI 10.1007/s00299-013-1505-3; Smertenko A, 2014, J EXP BOT, V65, P1343, DOI 10.1093/jxb/eru005; Duque AS, 2007, PLANT CELL TISS ORG, V90, P325, DOI 10.1007/s11240-007-9268-6; Solfanelli C, 2005, PLANT CELL PHYSIOL, V46, P1116, DOI 10.1093/pcp/pci124; Srinivasan C, 2007, PLANTA, V225, P341, DOI 10.1007/s00425-006-0358-1; Steele KP, 2010, AM J BOT, V97, P1142, DOI 10.3732/ajb.1000009; Stone SL, 2008, P NATL ACAD SCI USA, V105, P3151, DOI 10.1073/pnas.0712364105; Su YH, 2014, CURR TOP DEV BIOL, V108, P35, DOI 10.1016/B978-0-12-391498-9.00010-3; Suboti A, 2009, AFR J BIOTECHNOL, V8, P3223; Sun TP, 1997, PHYSIOL PLANTARUM, V101, P701, DOI 10.1111/j.1399-3054.1997.tb01054.x; Thomas TD, 2006, CHIN J BIOTECHNOL, V22, P465, DOI DOI 10.1016/S1872-2075(06)60039-3; Tokuji Y, 2003, J PLANT PHYSIOL, V160, P133, DOI 10.1078/0176-1617-00892; Urbanova T, 2013, TALANTA, V112, P85, DOI 10.1016/j.talanta.2013.03.068; Vondrakova Z, 2016, VEGETATIVE PROPAGATI, P123; Wang H, 2004, PLANT CELL, V16, P1206, DOI 10.1105/tpc.021261; WANG SY, 1987, PLANT PHYSIOL, V84, P1051, DOI 10.1104/pp.84.4.1051; Wang XD, 2011, ANN BOT-LONDON, V107, P599, DOI 10.1093/aob/mcq269; Weller JL, 2009, PLANT CELL, V21, P800, DOI 10.1105/tpc.108.063628; Yamaguchi S, 1998, PLANT PHYSIOL, V116, P1271, DOI 10.1104/pp.116.4.1271; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; YEUNG EC, 1993, PLANT CELL, V5, P1371, DOI 10.1105/tpc.5.10.1371; Yi J, 2016, J EXP BOT, V67, P2425, DOI 10.1093/jxb/erw052; Zheng QL, 2016, PLANT PHYSIOL, V172, P2374, DOI 10.1104/pp.16.00564	106	20	23	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0182055	10.1371/journal.pone.0182055	http://dx.doi.org/10.1371/journal.pone.0182055			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750086	Green Published, Green Submitted, gold			2022-12-26	WOS:000406575700124
J	Zhou, Y; Huang, T; Zhang, J; Wong, CC; Zhang, B; Dong, Y; Wu, F; Tong, JHM; Wu, WKK; Cheng, ASL; Yu, J; Kang, W; To, KF				Zhou, Y.; Huang, T.; Zhang, J.; Wong, C. C.; Zhang, B.; Dong, Y.; Wu, F.; Tong, J. H. M.; Wu, W. K. K.; Cheng, A. S. L.; Yu, J.; Kang, W.; To, K. F.			TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis	ONCOGENE			English	Article							INHIBITS CELL-PROLIFERATION; GROWTH-FACTOR CTGF; HEPATOCELLULAR-CARCINOMA; THERAPEUTIC TARGET; TUMOR-SUPPRESSOR; CANCER GENOMICS; BREAST-CANCER; EXPRESSION; CLASSIFICATION; YAP1	TEA domain (TEAD) transcription factors are key components of the Hippo-YAP1 signaling pathway, but their functional role and regulatory mechanisms remain unclear. This study aims to comprehensively explore the expression pattern and functional role of TEAD family in gastric carcinogenesis and investigate its regulation by microRNAs (miRNAs). The mRNA and protein expression of TEAD family were examined by quantitative reverse transcription-PCR (qRT-PCR) and western blot. Their functional roles were determined by in vitro and in vivo studies. The clinicopathological association of TEAD4 in gastric cancer (GC) was studied using immunohistochemistry on tissue microarray. The prediction of miRNAs, which potentially target TEAD1/4, was performed by TargetScan and miRDB. The regulation of TEAD1/4 by miRNAs was confirmed by qRT-PCR, western blot and luciferase assays. TEAD1/4 were overexpressed in GC cell lines and primary GC tissues. Knockdown of TEAD1/4 induced a significant anticancer effect in vitro and in vivo. TEAD1 was confirmed to be a direct target of miR-377-3p and miR-4269, while TEAD4 was negatively regulated by miR-1343-3p and miR-4269. Among them, miR-4269 was the most effective inhibitor of TEAD1/4. Ectopic expression of these miRNAs substantiated their tumor-suppressive effects. In primary GC tumors, downregulation of miR-4269 was associated with poor disease-specific survival and showed a negative correlation with TEAD4. TEAD1 and TEAD4 are oncogenic factors, whose aberrant activation are, in part, mediated by the silence of miR-377-3p, miR-1343-3p and miR-4269. For the first time, the nuclear accumulated TEAD4 and downregulated miR-4269 are proposed to serve as novel prognostic biomarkers in GC.	[Zhou, Y.; Huang, T.; Zhang, J.; Wu, F.; Tong, J. H. M.; Kang, W.; To, K. F.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, State Key Lab Oncol South China, Shatin, Hong Kong, Peoples R China; [Zhou, Y.; Huang, T.; Zhang, J.; Wong, C. C.; Dong, Y.; Wu, W. K. K.; Yu, J.; Kang, W.; To, K. F.] Chinese Univ Hong Kong, Inst Digest Dis, Partner State Key Lab Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Zhou, Y.; Huang, T.; Zhang, J.; Tong, J. H. M.; Kang, W.; To, K. F.] Chinese Univ Hong Kong, Sir YK Pao Canc Ctr, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Huang, T.; Cheng, A. S. L.; Yu, J.; Kang, W.; To, K. F.] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China; [Zhang, B.] Nanjing Univ, Affiliated Drum Tower Hosp, Dept Gastroenterol, Med Sch, Nanjing, Jiangsu, Peoples R China; [Wu, W. K. K.] Chinese Univ Hong Kong, Dept Anaesthesia & Intens Care, Hong Kong, Hong Kong, Peoples R China; [Cheng, A. S. L.] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Yu, J.] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; State Key Lab Oncology South China; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen; Nanjing University; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Kang, W; To, KF (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, State Key Lab Oncol South China, Shatin, Hong Kong, Peoples R China.	weikang@cuhk.edu.hk; kfto@cuhk.edu.hk	Cheng, Alfred SL/C-3327-2014; KANG, Wei/C-5451-2016; wu, william/HII-5817-2022; Wong, Chi Chun/C-4636-2016; Wu, William K.K./A-3277-2009; Jun, Yu/D-8569-2015	Cheng, Alfred SL/0000-0003-2345-6951; KANG, Wei/0000-0002-4651-677X; Wu, William K.K./0000-0002-5662-5240; Jun, Yu/0000-0001-5008-2153	General Research Fund (RGC) from Research Grants Council of Hong Kong [CUHK14114414, CUHK14110016]	General Research Fund (RGC) from Research Grants Council of Hong Kong	We acknowledge the TCGA research Network (http://cancergenome.nih.gov/), The UCSC Cancer Genomics Browser (https://genome-cancer.ucsc.edu/) and NCI Center for Cancer Genomics Office (http://gdc.nci.nih.gov/) for providing the gastric cancer data set and analysis. This study is supported by General Research Fund (RGC Reference No. CUHK14114414 and CUHK14110016) from The Research Grants Council of Hong Kong.	Bai N, 2013, CANCER BIOL THER, V14, P511, DOI 10.4161/cbt.24345; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen GL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117714; Chiang DY, 2008, CANCER RES, V68, P6779, DOI 10.1158/0008-5472.CAN-08-0742; Chu CY, 2008, J BIOMED SCI, V15, P675, DOI 10.1007/s11373-008-9264-9; de la Cova C, 2006, SEMIN CANCER BIOL, V16, P303, DOI 10.1016/j.semcancer.2006.07.010; Ding L, 2010, CELL RES, V20, P784, DOI 10.1038/cr.2010.79; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Guo C, 2015, INT J CLIN EXP PATHO, V8, P1690; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Huang TT, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0493-7; Jiao S, 2014, CANCER CELL, V25, P166, DOI 10.1016/j.ccr.2014.01.010; Kang W, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0323-3; Kang W, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0281-3; Kang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033919; Kang W, 2011, CLIN CANCER RES, V17, P2130, DOI 10.1158/1078-0432.CCR-10-2467; Knight JF, 2008, BRIT J CANCER, V99, P1849, DOI 10.1038/sj.bjc.6604774; Lamar JM, 2012, P NATL ACAD SCI USA, V109, pE2441, DOI 10.1073/pnas.1212021109; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Li N, 2015, AM J CANCER RES, V5, P1158; Lim B, 2014, CARCINOGENESIS, V35, P1020, DOI 10.1093/carcin/bgt409; Mao B, 2014, ONCOGENE, V33, P1468, DOI 10.1038/onc.2013.88; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Murray-Stewart T, 2016, ONCOGENE, V35, P5480, DOI 10.1038/onc.2016.91; Nowee ME, 2007, J PATHOL, V213, P46, DOI 10.1002/path.2217; Perra A, 2014, J HEPATOL, V61, P1088, DOI 10.1016/j.jhep.2014.06.033; Pobbati AV, 2013, CANCER BIOL THER, V14, P390, DOI 10.4161/cbt.23788; Qian ZL, 2014, GENE CHROMOSOME CANC, V53, P883, DOI 10.1002/gcc.22196; Qiao Y, 2016, ONCOGENE, V35, P2664, DOI 10.1038/onc.2015.338; Sala-Torra O, 2007, BLOOD, V109, P3080, DOI 10.1182/blood-2006-06-031096; Schutte U, 2014, TRANSL ONCOL, V7, P309, DOI 10.1016/j.tranon.2014.02.005; Shin G, 2011, CANCER INFORM, V10, P149, DOI 10.4137/CIN.S7226; Skotheim RI, 2006, CELL ONCOL, V28, P315; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tsukamoto Y, 2010, CANCER RES, V70, P2339, DOI 10.1158/0008-5472.CAN-09-2777; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015; Wadhwa R, 2013, NAT REV CLIN ONCOL, V10, P643, DOI 10.1038/nrclinonc.2013.170; Wang CY, 2015, ONCOTARGET, V6, P17685, DOI 10.18632/oncotarget.3779; Wang RY, 2015, BIOMED PHARMACOTHER, V70, P64, DOI 10.1016/j.biopha.2015.01.012; Wanjin H, 2014, PLOS ONE, V9; Xia JT, 2012, J PATHOL, V227, P470, DOI 10.1002/path.4030; Zehentmayr F, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0198-1; Zhang XT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116979; ZHOU YH, 2016, INT J MOL SCI, V17	48	53	54	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 23	2017	36	47					6518	6530		10.1038/onc.2017.257	http://dx.doi.org/10.1038/onc.2017.257			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FN5LN	28759040	Green Published, hybrid			2022-12-26	WOS:000416049200002
J	Velmurugan, KR; Varghese, RT; Fonville, NC; Garner, HR				Velmurugan, K. R.; Varghese, R. T.; Fonville, N. C.; Garner, H. R.			High-depth, high-accuracy microsatellite genotyping enables precision lung cancer risk classification	ONCOGENE			English	Article							BREAST-CANCER; INSTABILITY; VARIANTS; REVEALS; ACTIVATION; SIGNATURE; LYMPHOMA; PATTERNS; GAINS; GENES	There remains a large discrepancy between the known genetic contributions to cancer and that which can be explained by genomic variants, both inherited and somatic. Recently, understudied repetitive DNA regions called microsatellites have been identified as genetic risk markers for a number of diseases including various cancers (breast, ovarian and brain). In this study, we demonstrate an integrated process for identifying and further evaluating microsatellite-based risk markers for lung cancer using data from the cancer genome atlas and the 1000 genomes project. Comparing whole-exome germline sequencing data from 488 TCGA lung cancer samples to germline exome data from 390 control samples from the 1000 genomes project, we identified 119 potentially informative microsatellite loci. These loci were found to be able to distinguish between cancer and control samples with sensitivity and specificity ratios over 0.8. Then these loci, supplemented with additional loci from other cancers and controls, were evaluated using a target enrichment kit and sample-multiplexed nextgen sequencing. Thirteen of the 119 risk markers were found to be informative in a well powered study (40.99 for a 0.95 confidence interval) using high-depth (579x +/- 315) nextgen sequencing of 30 lung cancer and 89 control samples, resulting in sensitivity and specificity ratios of 0.90 and 0.94, respectively. When 8 loci harvested from the bioinformatic analysis of other cancers are added to the classifier, then the sensitivity and specificity rise to 0.93 and 0.97, respectively. Analysis of the genes harboring these loci revealed two genes (ARID1B and REL) and two significantly enriched pathways (chromatin organization and cellular stress response) suggesting that the process of lung carcinogenesis is linked to chromatin remodeling, inflammation, and tumor microenvironment restructuring. We illustrate that high-depth sequencing enables a high-precision microsatellite-based risk classifier analysis approach. This microsatellite-based platform confirms the potential to create clinically actionable diagnostics for lung cancer.	[Velmurugan, K. R.; Varghese, R. T.; Garner, H. R.] Edward Via Coll Osteopath Med, Dept Biol Sci, Ctr Bioinformat & Genet, Blacksburg, VA 24060 USA; [Velmurugan, K. R.; Varghese, R. T.; Garner, H. R.] Edward Via Coll Osteopath Med, Primary Care Res Network, 2265 Kraft Dr, Blacksburg, VA 24060 USA; [Velmurugan, K. R.; Varghese, R. T.; Garner, H. R.] Gibbs Canc Ctr & Res Inst, Dept Biol Sci, Spartanburg, SC USA; [Fonville, N. C.] Riverside Law LLP, Glenhardie Corp Ctr, Dept Biol Sci, Wayne, PA USA		Garner, HR (corresponding author), Edward Via Coll Osteopath Med, Primary Care Res Network, 2265 Kraft Dr, Blacksburg, VA 24060 USA.; Garner, HR (corresponding author), Edward Via Coll Osteopath Med, Ctr Bioinformat & Genet, 2265 Kraft Dr, Blacksburg, VA 24060 USA.	skipgarner@gmail.com			Bradley Engineering Foundation; National Science Foundation [OCI-1124123]	Bradley Engineering Foundation; National Science Foundation(National Science Foundation (NSF))	This work was funded by a grant from the Bradley Engineering Foundation to the Edward Via College of Osteopathic Medicine, and computing was supported by a grant from the National Science Foundation (OCI-1124123). We wish to thank Zalman Vaksman and Lauren J. McIver for programming assistance. We also wish to thank Nicholas Kinney for assistance with statistical computations and manuscript preparation, and Ramu Anandakrishnan for manuscript review.	[Anonymous], 2016, CANC FACTS FIG 2016; Bavarva JH, 2014, ONCOTARGET, V5, P4788, DOI 10.18632/oncotarget.2033; Bavarva JH, 2014, AGING-US, V6, P511, DOI 10.18632/aging.100674; Biegel JA, 2014, AM J MED GENET C, V166, P350, DOI 10.1002/ajmg.c.31410; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Budworth Helen, 2013, Methods Mol Biol, V1010, P3, DOI 10.1007/978-1-62703-411-1_1; Campbell JD, 2016, NAT GENET, V48, P607, DOI 10.1038/ng.3564; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351; Fonville NC, 2015, ONCOTARGET, V6, P11407, DOI 10.18632/oncotarget.2933; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Freimer NB, 1996, CIBA F SYMP, V197, P51; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Geismann C, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.417; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Guilmatre A, 2013, HUM MUTAT, V34, P1304, DOI 10.1002/humu.22359; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hanse RJ, 2016, NAT MED, V22, P1342, DOI 10.1038/nm.4191; Hasnis E, 2007, J PHYSIOL PHARMACOL, V58, P275; Huang HT, 2015, ONCOL REP, V33, P283, DOI 10.3892/or.2014.3584; Hunter JE, 2016, BRIT J CANCER, V114, P1, DOI 10.1038/bjc.2015.410; Institute NC, 2016, SEER STAT FACT SHEET; Joos S, 2002, BLOOD, V99, P1381, DOI 10.1182/blood.V99.4.1381; Karunasena E, 2015, ONCOTARGET, V6, P22038, DOI 10.18632/oncotarget.4194; Karunasena E, 2014, ONCOTARGET, V5, P6003, DOI 10.18632/oncotarget.2076; Khursheed M, 2013, BRIT J CANCER, V108, P2056, DOI 10.1038/bjc.2013.200; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Li YF, 2010, LANCET ONCOL, V11, P321, DOI 10.1016/S1470-2045(10)70042-5; Lian Y, 2005, BIOINFORMATICS, V21, P1358, DOI 10.1093/bioinformatics/bti180; Lu H, 2011, CANCER RES, V71, P6867, DOI 10.1158/0008-5472.CAN-11-2460; McIver LJ, 2014, BREAST CANCER RES TR, V145, P791, DOI 10.1007/s10549-014-2908-8; McIver LJ, 2013, GENE, V516, P328, DOI 10.1016/j.gene.2012.12.068; McIver LJ, 2011, GENOMICS, V97, P193, DOI 10.1016/j.ygeno.2011.01.001; Rivera GA, 2016, ADV EXP MED BIOL, V893, P43, DOI 10.1007/978-3-319-24223-1_3; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Society AC, 2016, NONSM CELL LUNG CANC; Society AC, 2016, WHAT IS NONSM CELL L; Team RDC, 2010, R LANG ENV STAT COMP; Vaksman Z, 2015, ONCOTARGET, V6, P5760, DOI 10.18632/oncotarget.3306; Vargas AJ, 2016, NAT REV CANCER, V16, P525, DOI 10.1038/nrc.2016.56; Wagner AH, 2016, NUCLEIC ACIDS RES, V44, pD1036, DOI 10.1093/nar/gkv1165; Waterborg JH, 2000, J BIOL CHEM, V275, P13007, DOI 10.1074/jbc.275.17.13007; Weniger MA, 2007, GENE CHROMOSOME CANC, V46, P406, DOI 10.1002/gcc.20420; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	49	8	8	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 16	2017	36	46					6383	6390		10.1038/onc.2017.256	http://dx.doi.org/10.1038/onc.2017.256			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FM9WN	28759038	hybrid, Green Published			2022-12-26	WOS:000415622900003
J	Ohkura, S; Usui, S; Takashima, S; Takuwa, N; Yoshioka, K; Okamoto, Y; Inagaki, Y; Sugimoto, N; Kitano, T; Takamura, M; Wada, T; Kaneko, S; Takuwa, Y				Ohkura, Sei-ichiro; Usui, Soichiro; Takashima, Shin-ichiro; Takuwa, Noriko; Yoshioka, Kazuaki; Okamoto, Yasuo; Inagaki, Yutaka; Sugimoto, Naotoshi; Kitano, Teppei; Takamura, Masayuki; Wada, Takashi; Kaneko, Shuichi; Takuwa, Yoh			Augmented sphingosine 1 phosphate receptor-1 signaling in cardiac fibroblasts induces cardiac hypertrophy and fibrosis through angiotensin II and interleukin-6	PLOS ONE			English	Article							PERSISTENT STAT3 ACTIVATION; TRANSGENIC MICE; IN-VIVO; HEART; CARDIOMYOCYTES; STIMULATION; EXPRESSION; CYTOKINES; MYOCYTES; FAILURE	Background: Cardiac fibroblasts, together with cardiomyocytes, occupy the majority of cells in the myocardium and are involved in myocardial remodeling. The lysophospholipid mediator sphigosine-1-phosphate (S1P) regulates functions of cardiovascular cells through multiple receptors including S1PR1-S1PR3. S1PR1 but not other S1P receptors was upregulated in angiotensin II-induced hypertrophic hearts. Therefore, we investigated a role of S1PR1 in fibroblasts for cardiac remodeling by employing transgenic mice that overexpressed S1PR1 under the control of a-smooth muscle actin promoter. In S1PR1-transgenic mouse heart, fibroblasts and/or myofibroblasts were hyperplastic, and those cells as well as vascular smooth muscle cells overexpressed S1PR1. Transgenic mice developed bi-ventricular hypertrophy by 12-week-old and diffuse interstitial fibrosis by 24-week-old without hemodynamic stress. Cardiac remodeling in transgenic mice was associated with greater ERK phosphorylation, upregulation of fetal genes, and systolic dysfunction. Transgenic mouse heart showed increased mRNA expression of angiotensin-converting enzyme and interleukin-6 (IL-6). Isolated fibroblasts from transgenic mice exhibited enhanced generation of angiotensin II, which in turn stimulated IL-6 release. Either an AT1 blocker or angiotensin-converting enzyme inhibitor prevented development of cardiac hypertrophy and fibrosis, systolic dysfunction and increased IL-6 expression in transgenic mice. Finally, administration of anti-IL-6 antibody abolished an increase in tyrosine phosphorylation of STAT3, a major signaling molecule downstream of IL-6, in the transgenic mouse heart and prevented development of cardiac hypertrophy in transgenic mice. These results demonstrate a promoting role of S1PR1 in cardiac fibroblasts for cardiac remodeling, in which angiotensin II D AT1 and IL-6 are involved.	[Ohkura, Sei-ichiro; Takashima, Shin-ichiro; Takuwa, Noriko; Yoshioka, Kazuaki; Okamoto, Yasuo; Sugimoto, Naotoshi; Takuwa, Yoh] Kanazawa Univ, Dept Physiol, Sch Med, Kanazawa, Ishikawa, Japan; [Ohkura, Sei-ichiro; Usui, Soichiro; Takashima, Shin-ichiro; Kitano, Teppei; Takamura, Masayuki; Kaneko, Shuichi] Kanazawa Univ, Dept Syst Biol, Sch Med, Kanazawa, Ishikawa, Japan; [Takuwa, Noriko] Ishikawa Prefectural Nursing Univ, Dept Hlth & Med Sci, Kahoku, Ishikawa, Japan; [Inagaki, Yutaka] Tokai Univ, Ctr Matrix Biol & Med, Grad Sch Med, Hiratsuka, Kanagawa, Japan; [Wada, Takashi] Kanazawa Univ, Dept Nephrol & Lab Med, Sch Med, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University; Tokai University; Kanazawa University	Takuwa, Y (corresponding author), Kanazawa Univ, Dept Physiol, Sch Med, Kanazawa, Ishikawa, Japan.	ytakuwa@med.kanazawa-u.ac.jp	KITANO, Teppei/L-3947-2015; USUI, Soichiro/GQH-4849-2022; Yoshioka, Kazuaki/G-1038-2013; Sugimoto, Naotoshi/C-4739-2015	Yoshioka, Kazuaki/0000-0002-8631-3846; Sugimoto, Naotoshi/0000-0003-1995-5002; TAKUWA, Noriko/0000-0002-4278-2704; Usui, Soichiro/0000-0003-1752-8082	ministry of Education, Science, Sports and Culture of Japan; Japan Society for the Promotion of Science [15K09135, 15H04673]; JST; Grants-in-Aid for Scientific Research [17K08532, 15H04673] Funding Source: KAKEN	ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the ministry of Education, Science, Sports and Culture of Japan, the Japan Society for the Promotion of Science (15K09135, 15H04673), and grants for Core Research for Evolutional Science and Technology from JST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Coles B, 2007, AM J PATHOL, V171, P315, DOI 10.2353/ajpath.2007.061078; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Higashiyama R, 2009, GASTROENTEROLOGY, V137, P1459, DOI 10.1053/j.gastro.2009.07.006; HIROTA H, 1995, P NATL ACAD SCI USA, V92, P4862, DOI 10.1073/pnas.92.11.4862; Jaffre F, 2009, CIRC RES, V104, P113, DOI 10.1161/CIRCRESAHA.108.180976; Kaclm R, 2007, J MOL CELL CARDIOL, V43, P85, DOI 10.1016/j.yjmcc.2007.04.007; Lee H, 2010, NAT MED, V16, P1421, DOI 10.1038/nm.2250; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8; MARRERO MB, 1995, NATURE, V375, P247, DOI 10.1038/375247a0; Mazzolai L, 1998, HYPERTENSION, V31, P1324, DOI 10.1161/01.HYP.31.6.1324; Means CK, 2007, AM J PHYSIOL-HEART C, V292, pH2944, DOI 10.1152/ajpheart.01331.2006; Means CK, 2009, CARDIOVASC RES, V82, P193, DOI 10.1093/cvr/cvp086; Moore-Morris T, 2014, J CLIN INVEST, V124, P2921, DOI 10.1172/JCI74783; Morisco C, 2003, AM J PHYSIOL-HEART C, V284, pH1043, DOI 10.1152/ajpheart.00990.2002; Paradis P, 2000, P NATL ACAD SCI USA, V97, P931, DOI 10.1073/pnas.97.2.931; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Reudelhuber TL, 2007, HYPERTENSION, V49, P1196, DOI 10.1161/HYPERTENSIONAHA.106.075085; Robert P, 2001, J MOL CELL CARDIOL, V33, P1589, DOI 10.1006/jmcc.2001.1433; Sano M, 2000, J BIOL CHEM, V275, P29717, DOI 10.1074/jbc.M003128200; Sekiguchi K, 1999, CIRC RES, V85, P1000; Takeda N, 2010, J CLIN INVEST, V120, P254, DOI 10.1172/JCI40295; Takuwa N, 2010, CARDIOVASC RES, V85, P484, DOI 10.1093/cvr/cvp312; Takuwa Y, 2012, BIOFACTORS, V38, P329, DOI 10.1002/biof.1030; van Kats JP, 2001, J BIOL CHEM, V276, P44012, DOI 10.1074/jbc.M106132200; Xiao HD, 2004, AM J PATHOL, V165, P1019, DOI 10.1016/S0002-9440(10)63363-9; Yeh CC, 2009, AM J PHYSIOL-HEART C, V296, pH1193, DOI 10.1152/ajpheart.01032.2008; Yuen CY, 2012, CIRC RES, V111, pE55, DOI 10.1161/CIRCRESAHA.112.271361; Zeisberg EM, 2010, CIRC RES, V107, P1304, DOI 10.1161/CIRCRESAHA.110.231910	31	41	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182329	10.1371/journal.pone.0182329	http://dx.doi.org/10.1371/journal.pone.0182329			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771545	Green Submitted, Green Published, gold			2022-12-26	WOS:000406853600091
J	Shen, Y; Qiu, CC; Li, YD; Shi, W; Rui, XX				Shen, Yang; Qiu, Chenchen; Li, Yande; Shi, Wen; Rui, Xiaoxi			An analytical solution for two-dimensional vacuum preloading combined with electro-osmosis consolidation using EKG electrodes	PLOS ONE			English	Article								China is a country with vast territory, but economic development and population growth have reduced the usable land resources in recent years. Therefore, reclamation by pumping and filling is carried out in eastern coastal regions of China in order to meet the needs of urbanization. However, large areas of reclaimed land need rapid drainage consolidation treatment. Based on past researches on how to improve the treatment efficiency of soft clay using vacuum preloading combined with electro-osmosis, a two-dimensional drainage plane model was proposed according to the Terzaghi and Esrig consolidation theory. However, the analytical solution using two-dimensional plane model was never involved. Current analytical solutions can't have a thorough theoretical analysis of practical engineering and give relevant guidance. Considering the smearing effect and the rectangle arrangement pattern, an analytical solution is derived to describe the behavior of pore-water and the consolidation process by using EKG (electro-kinetic geo synthetics) materials. The functions of EKG materials include drainage, electric conduction and corrosion resistance. Comparison with test results is carried out to verify the analytical solution. It is found that the measured value is larger than the applied vacuum degree because of the stacking effect of the vacuum preloading and electro-osmosis. The trends of the mean measured value and the mean analytical value processes are comparable. Therefore, the consolidation model can accurately assess the change in pore-water pressure and the consolidation process during vacuum preloading combined with electro-osmosis.	[Shen, Yang; Qiu, Chenchen; Shi, Wen; Rui, Xiaoxi] Hohai Univ, Key Lab, Minist Educ Geomech & Embankment Engn, Nanjing, Jiangsu, Peoples R China; [Li, Yande] Tianjin Port & Waterway Prospect & Design Res Ins, China Commun Construct Co Ltd, Tianjin, Peoples R China	Hohai University	Qiu, CC (corresponding author), Hohai Univ, Key Lab, Minist Educ Geomech & Embankment Engn, Nanjing, Jiangsu, Peoples R China.	ccqiu92@163.com			111 Project [B13024]; Fundamental Research Funds for the Central Universities [2015B17114]; China Communications Construction Co., Ltd.; Tianjin Port & Waterway Prospection & Design Research Institute Co., Ltd.	111 Project(Ministry of Education, China - 111 Project); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China Communications Construction Co., Ltd.; Tianjin Port & Waterway Prospection & Design Research Institute Co., Ltd.	Financial support was received from the 111 Project (B13024) and Fundamental Research Funds for the Central Universities (2015B17114); China Communications Construction Co., Ltd. Tianjin Port & Waterway Prospection & Design Research Institute Co., Ltd. provided support in the form of salary for author YL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the author are articulated in the 'author contributions' section.; The authors would like to acknowledge the financial support of the 111 Project (B13024) and Fundamental Research Funds for the Central Universities (2015B17114).	[陈允进 Chen Yunjin], 2010, [工程地质学报, Journal of Engineering Geology], V18, P703; Chew SH, 2004, GEOTEXT GEOMEMBRANES, V22, P17, DOI 10.1016/S0266-1144(03)00049-9; Esrig MI., 1968, J SOIL MECH FDN DIV, V94, P899, DOI [DOI 10.1061/JSFEAQ.0001178, 10.1061/JSFEAQ.0001178]; [房营光 Fang Yingguang], 2006, [华南理工大学学报. 自然科学版, Journal of South China University of Technology. Natural Science Edition], V34, P70; Gao Z. Y., 2000, CHINA HARBOUR ENG, V10, P58, DOI [10.3969/j.issn.1003-3688.2000.05.014, DOI 10.3969/J.ISSN.1003-3688.2000.05.014]; Glendinning S, 2008, GEOSYNTH INT, V15, P192, DOI 10.1680/gein.2008.15.3.192; Glendinning S, 2006, GEOSYNTHETICS, VOLS 1-4, P527; [龚晓南 Gong Xiaonan], 2002, [哈尔滨建筑大学学报, Journal of harbin university of architecture and engineering], V35, P7; Li J., 2012, PORT WATERWAY ENG, P133, DOI [10.16233/j.cnki.issn1002-4972.2012.03.033, DOI 10.16233/J.CNKI.ISSN1002-4972.2012.03.033]; Liu ZH, 2013, J DISASTER PREVENTIO, V39, P671; LO KY, 1991, CAN GEOTECH J, V28, P74, DOI 10.1139/t91-008; Shang JQ, 1997, CAN GEOTECH J, V34, P78, DOI 10.1139/cgj-34-1-78; Shang JQ, 1998, CAN GEOTECH J, V35, P491, DOI 10.1139/cgj-35-3-491; Su JQ, 2001, CHINESE J GEOTECHNIC, V25, P125; Wan TY., 1976, J GEOTECH ENG DIV, V102, P473, DOI DOI 10.1061/AJGEB6.0000270; Wu Hui, 2012, Journal of Tsinghua University (Science and Technology), V52, P182; Xu W, 2011, J HOHAI U NATURAL SC, V39, P671; Yoshikuni H, 1974, SOILS FOUND, V14, P36	18	7	9	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0180974	10.1371/journal.pone.0180974	http://dx.doi.org/10.1371/journal.pone.0180974			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771496	Green Published, gold, Green Submitted			2022-12-26	WOS:000406853600009
J	Yamada, A; Niikura, R; Maki, K; Nakamura, M; Watabe, H; Fujishiro, M; Oka, S; Fujimori, S; Nakajima, A; Ohmiya, N; Matsumoto, T; Tanaka, S; Koike, K; Sakamoto, C				Yamada, Atsuo; Niikura, Ryota; Maki, Koutarou; Nakamura, Masanao; Watabe, Hirotsugu; Fujishiro, Mitsuhiro; Oka, Shiro; Fujimori, Shunji; Nakajima, Atsushi; Ohmiya, Naoki; Matsumoto, Takayuki; Tanaka, Shinji; Koike, Kazuhiko; Sakamoto, Choitsu			Proton pump inhibitor therapy did not increase the prevalence of small-bowel injury: A propensity-matched analysis	PLOS ONE			English	Article							INTESTINAL MUCOSAL INJURY; RISK-FACTORS; CAPSULE ENDOSCOPY; LANSOPRAZOLE; PREVENTION; DISEASE; USERS	Background Previous studies have reported that the suppression of acid secretion by using proton pump inhibitors (PPIs) results in dysbiosis of the small-bowel microbiota, leading to exacerbated small-bowel injuries, including erosions and ulcers. This study was designed to assess the association between PPI therapy and small-bowel lesions after adjustment for the differences in baseline characteristics between users and non-users of PPIs. Methods We retrospectively studied patients suspected to be suffering from small-bowel diseases, who underwent capsule endoscopy between 2010 and 2013. We used propensity matching to adjust for the differences in baseline characteristics between users and non-users of PPIs. The outcomes included the prevalence of small-bowel lesions: erosion, ulcer, angioectasia, varices, and tumor. Results We selected 327 patient pairs for analysis after propensity matching, and found no significant differences in the prevalence of small-bowel injuries, including erosions and ulcers, between users and non-users of PPIs. Two subgroup analyses of the effect of the type of PPI and the effect of PPI therapy in users and non-users of nonsteroidal anti-inflammatory drugs indicated no significant differences in the prevalence of small-bowel injuries in these two groups. Conclusion PPI therapy did not increase the prevalence of small-bowel injury, regardless of the type of PPI used and the use of nonsteroidal anti-inflammatory drugs.	[Yamada, Atsuo; Niikura, Ryota; Fujishiro, Mitsuhiro; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Maki, Koutarou; Fujimori, Shunji; Sakamoto, Choitsu] Nippon Med Sch, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Nakamura, Masanao] Nagoya Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Nagoya, Aichi, Japan; [Watabe, Hirotsugu] Wakamiya Watabe Clin, Chiba, Japan; [Fujishiro, Mitsuhiro] Univ Tokyo, Dept Endoscopy & Endoscop Surg, Tokyo, Japan; [Oka, Shiro; Tanaka, Shinji] Hiroshima Univ Hosp, Dept Endoscopy, Hiroshima, Japan; [Nakajima, Atsushi] Yokohama City Univ, Sch Med, Div Gastroenterol & Hepatol, Yokohama, Kanagawa, Japan; [Ohmiya, Naoki] Fujita Hlth Univ, Sch Med, Dept Gastroenterol, Toyoake, Aichi, Japan; [Matsumoto, Takayuki] Iwate Med Univ, Dept Internal Med, Div Gastroenterol, Morioka, Iwate, Japan	University of Tokyo; Nippon Medical School; Nagoya University; University of Tokyo; Hiroshima University; Yokohama City University; Fujita Health University; Iwate Medical University	Yamada, A (corresponding author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan.	yamada-a@umin.ac.jp	藤城, 光弘/AAN-3131-2020; Oka, Shiro/AAZ-8368-2021		Ministry of Health, Labour and Welfare [H23-NI-045]; Japanese Association for Capsule Endoscopy	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japanese Association for Capsule Endoscopy	This study was partly supported by the Ministry of Health, Labour and Welfare (H23-NI-045), and The Japanese Association for Capsule Endoscopy. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NS, 2010, AM J GASTROENTEROL, V105, P2533, DOI 10.1038/ajg.2010.445; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; De Palma GD, 2005, GASTROINTEST ENDOSC, V62, P529, DOI 10.1016/S0016-5107(05)01588-9; Endo H, 2014, GASTROINTEST ENDOSC, V80, P826, DOI 10.1016/j.gie.2014.03.024; Graham DY, 2005, CLIN GASTROENTEROL H, V3, P55, DOI 10.1016/S1542-3565(04)00603-2; Higuchi K, 2009, J CLIN BIOCHEM NUTR, V45, P125, DOI 10.3164/jcbn.SR09-58; Ishihara M, 2014, ALIMENT PHARM THER, V40, P538, DOI 10.1111/apt.12858; Keuchel M, 2006, ATLAS VIDEO CAPSULE; Kuramoto T, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-85; Lombardo L, 2010, CLIN GASTROENTEROL H, V8, P504, DOI 10.1016/j.cgh.2009.12.022; Maiden L, 2005, GASTROENTEROLOGY, V128, P1172, DOI 10.1053/j.gastro.2005.03.020; Raju Gottumukkala S, 2007, Gastroenterology, V133, P1694, DOI 10.1053/j.gastro.2007.06.008; Sachs G, 1997, PHARMACOTHERAPY, V17, P22; Tang SJ, 2004, GASTROINTEST ENDOSC, V60, P129, DOI 10.1016/S0016-5107(04)01458-0; Wallace JL, 2011, GASTROENTEROLOGY, V141, P1314, DOI 10.1053/j.gastro.2011.06.075; Washio E, 2016, CLIN GASTROENTEROL H, V14, P809, DOI 10.1016/j.cgh.2015.10.022; Watanabe T, 2013, DIGEST LIVER DIS, V45, P390, DOI 10.1016/j.dld.2012.12.005; Wolfe MM, 2000, GASTROENTEROLOGY, V118, pS9, DOI 10.1016/S0016-5085(00)70004-7; Yamada A, 2015, WORLD J GASTROENTERO, V21, P7242, DOI 10.3748/wjg.v21.i23.7242; Yoda Y, 2010, J PHYSIOL PHARMACOL, V61, P287	20	2	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182586	10.1371/journal.pone.0182586	http://dx.doi.org/10.1371/journal.pone.0182586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771618	Green Published, gold, Green Submitted			2022-12-26	WOS:000406853600146
J	Yan, JG; Zhang, P; Jiao, FJ; Wang, QZ; He, F; Zhang, Q; Zhang, Z; Lv, ZX; Peng, X; Cai, HW; Tian, B				Yan, Jianguo; Zhang, Pei; Jiao, Fengjuan; Wang, Qingzhi; He, Feng; Zhang, Qian; Zhang, Zheng; Lv, Zexi; Peng, Xiang; Cai, Hongwei; Tian, Bo			Quantitative proteomics in A30P*A53T alpha-synuclein transgenic mice reveals upregulation of Sel1l	PLOS ONE			English	Article							PARKINSONS-DISEASE; EXPRESSION	alpha-Synuclein is an abundantly expressed neuronal protein that is at the center of focus in understanding a group of neurodegenerative disorders called synucleinopathies, which are characterized by the intracellular presence of aggregated alpha-synuclein. However, the mechanism of alpha-synuclein biology in synucleinopathies pathogenesis is not fully understood. In this study, mice overexpressing human A30P*A53T alpha-synuclein were evaluated by a motor behavior test and count of TH-positive neurons, and then two-dimensional liquid chromatography- tandem mass spectrometry coupled with tandem mass tags (TMTs) labeling was employed to quantitatively identify the differentially expressed proteins of substantia nigra pars compacta (SNpc) tissue samples that were obtained from the alpha-synuclein transgenic mice and wild type controls. The number of SNpc dopaminergic neurons and the motor behavior were unchanged in A30P*A53T transgenic mice at the age of 6 months. Of the 4,715 proteins identified by proteomic techniques, 271 were differentially expressed, including 249 upregulated and 22 downregulated proteins. These alterations were primarily associated with mitochondrial dysfunction, oxidative stress, ubiquitin-proteasome system impairment, and endoplasmic reticulum (ER) stress. Some obviously changed proteins, which were validated by western blotting and immunofluorescence staining, including Sel1l and Sdhc, may be involved in the alpha-synuclein pathologies of synucleinopathies. A biological pathway analysis of common related proteins showed that the proteins were linked to a total of 31 KEGG pathways. Our findings suggest that these identified proteins may serve as novel therapeutic targets for synucleinopathies.	[Yan, Jianguo; Zhang, Pei; Jiao, Fengjuan; Wang, Qingzhi; He, Feng; Zhang, Qian; Zhang, Zheng; Lv, Zexi; Peng, Xiang; Cai, Hongwei; Tian, Bo] Huazhong Univ Sci & Technol, Tongji Med Sch, Dept Neurobiol, Wuhan, Hubei, Peoples R China; [Yan, Jianguo; Zhang, Pei; Jiao, Fengjuan; Wang, Qingzhi; He, Feng; Zhang, Qian; Zhang, Zheng; Lv, Zexi; Peng, Xiang; Cai, Hongwei; Tian, Bo] Minist Educ, Key Lab Neurol Dis, Wuhan, Hubei, Peoples R China; [Yan, Jianguo; Zhang, Pei; Jiao, Fengjuan; Wang, Qingzhi; He, Feng; Zhang, Qian; Zhang, Zheng; Lv, Zexi; Peng, Xiang; Cai, Hongwei; Tian, Bo] Huazhong Univ Sci & Technol, Collaborat Innovat Ctr Brain Sci, Inst Brain Res, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Tian, B (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Sch, Dept Neurobiol, Wuhan, Hubei, Peoples R China.; Tian, B (corresponding author), Minist Educ, Key Lab Neurol Dis, Wuhan, Hubei, Peoples R China.; Tian, B (corresponding author), Huazhong Univ Sci & Technol, Collaborat Innovat Ctr Brain Sci, Inst Brain Res, Wuhan, Hubei, Peoples R China.	tianbo@mails.tjmu.edu.cn	TIAN, BO/G-2354-2011	TIAN, BO/0000-0002-8318-3046	National Natural Science Foundation of China [31371384, 31571044, 31600821]; Program for New Century Excellent Talents in University [NCET-10-0415]; China Postdoctoral Scientific Foundation [2015M582226]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); China Postdoctoral Scientific Foundation(China Postdoctoral Science Foundation)	This work was supported financially by National Natural Science Foundation of China (No. 31371384, 31571044 to B.T. and No. 31600821 to P.Z.), Program for New Century Excellent Talents in University (No. NCET-10-0415 to B.T.), and China Postdoctoral Scientific Foundation (No. 2015M582226 to P.Z.).; This work was supported financially by the National Natural Science Foundation of China (No. 31371384, 31571044 to B.T. and No. 31600821 to P.Z.), the Program for New Century Excellent Talents in University (No. NCET-10-0415 to B.T.), and the China Postdoctoral Scientific Foundation (No. 2015M582226 to P.Z.).	Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; Burre J, 2017, COLD SPRING HARBOR P; Caviness John N, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS203, DOI 10.1016/S1353-8020(11)70063-3; Chung CY, 2017, CELL SYSTEMS; Dehay B, 2016, REV NEUROL-FRANCE, V172, P371, DOI 10.1016/j.neurol.2016.04.003; Diaz-Castro B, 2012, MOL CELL BIOL, V32, P3347, DOI 10.1128/MCB.00128-12; Glaab E, 2015, NEUROBIOL DIS, V74, P1, DOI 10.1016/j.nbd.2014.11.002; Higashida H, 2017, J PHYSIOL SCI, V67, P11, DOI 10.1007/s12576-016-0462-3; Ingelsson M, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00408; Ishii N, 2007, MITOCHONDRION, V7, P24, DOI 10.1016/j.mito.2006.11.012; Jin D, 2012, NEUROCHEM INT, V61, P907, DOI 10.1016/j.neuint.2011.12.021; Kim WS, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0073-2; Lin XM, 2015, BBA-PROTEINS PROTEOM, V1854, P779, DOI 10.1016/j.bbapap.2015.01.007; Mangieri LR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093257; Mercado G, 2016, BRAIN RES, V1648, P626, DOI 10.1016/j.brainres.2016.04.042; Mercado G, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00039; Michel PP, 2016, NEURON, V90, P675, DOI 10.1016/j.neuron.2016.03.038; Omura T, 2012, J MOL NEUROSCI, V46, P527, DOI 10.1007/s12031-011-9638-8; Ozgul S, 2015, NEUROCHEM INT, V85-86, P1, DOI 10.1016/j.neuint.2015.03.007; Pal R, 2015, INT REV NEUROBIOL, V121, P25, DOI 10.1016/bs.irn.2015.05.002; Prasad K, 2011, EUR J NEUROSCI, V33, P642, DOI 10.1111/j.1460-9568.2010.07558.x; Richfield EK, 2002, EXP NEUROL, V175, P35, DOI 10.1006/exnr.2002.7882; Saltini G, 2006, NEUROSCI LETT, V398, P53, DOI 10.1016/j.neulet.2005.12.038; Smith LM, 2016, NEUROSCIENCE, V324, P238, DOI 10.1016/j.neuroscience.2016.03.012; Thiruchelvam MJ, 2004, EUR J NEUROSCI, V19, P845, DOI 10.1111/j.0953-816X.2004.03139.x; Wang ES, 2013, CELL PHYSIOL BIOCHEM, V31, P625, DOI 10.1159/000350082; Wang QS, 2015, BRAIN, V138, P1247, DOI 10.1093/brain/awv034	27	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182092	10.1371/journal.pone.0182092	http://dx.doi.org/10.1371/journal.pone.0182092			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771510	Green Submitted, gold, Green Published			2022-12-26	WOS:000406853600060
J	Kulkarni, S; Sharda, S; Watve, M				Kulkarni, Shubhankar; Sharda, Sakshi; Watve, Milind			Bi-stability in type 2 diabetes mellitus multi-organ signalling network	PLOS ONE			English	Article							BETA-CELL REGENERATION; MALE-MICE LACKING; HORMONE-DEPENDENT AGGRESSION; INSULIN-RESISTANCE; TREADMILL EXERCISE; GLUCOSE-TOLERANCE; TESTOSTERONE; DIAZOXIDE; SUPPRESSION; DOPAMINE	Type 2 diabetes mellitus (T2DM) is believed to be irreversible although no component of the pathophysiology is irreversible. We show here with a network model that the apparent irreversibility is contributed by the structure of the network of inter-organ signalling. A network model comprising all known inter-organ signals in T2DM showed bi-stability with one insulin sensitive and one insulin resistant attractor. The bi-stability was made robust by multiple positive feedback loops suggesting an evolved allostatic system rather than a homeostatic system. In the absence of the complete network, impaired insulin signalling alone failed to give a stable insulin resistant or hyperglycemic state. The model made a number of correlational predictions many of which were validated by empirical data. The current treatment practice targeting obesity, insulin resistance, beta cell function and normalization of plasma glucose failed to reverse T2DM in the model. However certain behavioural and neuro-endocrine interventions ensured a reversal. These results suggest novel prevention and treatment approaches which need to be tested empirically.	[Kulkarni, Shubhankar; Watve, Milind] Indian Inst Sci Educ & Res, Biol, Pune, Maharashtra, India; [Sharda, Sakshi] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland	Indian Institute of Science Education & Research (IISER) Pune; University of Bern	Watve, M (corresponding author), Indian Inst Sci Educ & Res, Biol, Pune, Maharashtra, India.	milind@iiserpune.ac.in		Kulkarni, Shubhankar/0000-0001-6538-7152; Watve, Milind/0000-0003-0730-8393				ALBERT DJ, 1992, PHYSIOL BEHAV, V52, P773, DOI 10.1016/0031-9384(92)90413-V; ALBERT DJ, 1991, PHYSIOL BEHAV, V49, P673, DOI 10.1016/0031-9384(91)90300-D; Alemzadeh R, 1996, METABOLISM, V45, P334, DOI 10.1016/S0026-0495(96)90287-5; ALEMZADEH R, 1993, ENDOCRINOLOGY, V133, P705, DOI 10.1210/en.133.2.705; Alemzadeh R, 2004, METABOLISM, V53, P441, DOI 10.1016/j.metabol.2003.10.027; Alemzadeh R, 2002, EUR J ENDOCRINOL, V146, P871, DOI 10.1530/eje.0.1460871; Alemzadeh R, 2008, METABOLISM, V57, P1597, DOI 10.1016/j.metabol.2008.06.017; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Belsare PV, 2010, MED HYPOTHESES, V74, P578, DOI 10.1016/j.mehy.2009.09.014; Bliziotes M, 2000, BONE, V26, P15, DOI 10.1016/S8756-3282(99)00232-X; Borcherding DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025537; Brand SJ, 2002, PHARMACOL TOXICOL, V91, P414, DOI 10.1034/j.1600-0773.2002.910621.x; Chae CH, 2009, NEUROCHEM INT, V55, P208, DOI 10.1016/j.neuint.2009.02.024; Cheng CW, 2017, CELL, V168, P775, DOI 10.1016/j.cell.2017.01.040; Chiavegatto S, 2001, P NATL ACAD SCI USA, V98, P1277, DOI 10.1073/pnas.031487198; Corbett SJ, 2009, AM J HUM BIOL, V21, P587, DOI 10.1002/ajhb.20937; Corkey BE, 2012, DIABETES CARE, V35, P2432, DOI 10.2337/dc12-0825; Corkey BE, 2012, DIABETES, V61, P4, DOI 10.2337/db11-1483; DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013; DeFronzo RA, 2013, DIABETES CARE, V36, pS127, DOI 10.2337/dcS13-2011; Demas GE, 1999, J NEUROSCI, V19; Demas GE, 1997, MOL MED, V3, P610, DOI 10.1007/BF03401818; Doves Watve M., 2013, DIPLOMATS DIABETES D, V1st; Ertek S, 2012, ARCH MED SCI, V8, P47, DOI 10.5114/aoms.2012.27280; Falahati-Nini A, 2000, J CLIN INVEST, V106, P1553, DOI 10.1172/JCI10942; FARRELL PA, 1987, ACTA PHYSIOL SCAND, V130, P619, DOI 10.1111/j.1748-1716.1987.tb08184.x; Ferrer J, 2011, CELL METAB, V13, P357, DOI 10.1016/j.cmet.2011.03.014; Gammie SC, 1999, J NEUROSCI, V19, P8027; Gluckman PD, 2005, TRENDS ECOL EVOL, V20, P527, DOI 10.1016/j.tree.2005.08.001; Hakonen E, 2011, DIABETOLOGIA, V54, P1735, DOI 10.1007/s00125-011-2153-1; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Hwang DY, 2007, INT J MOL MED, V19, P65; Jasnow AM, 2002, HORM BEHAV, V42, P13, DOI 10.1006/hbeh.2002.1797; Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305; Kriegsfeld LJ, 1997, BRAIN RES, V769, P66, DOI 10.1016/S0006-8993(97)00688-4; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Lin J, 2002, BIOCHEM BIOPH RES CO, V291, P701, DOI 10.1006/bbrc.2002.6500; MACLEAN N, 1955, Diabetes, V4, P367; Meier JJ, 2006, DIABETOLOGIA, V49, P1838, DOI 10.1007/s00125-006-0308-2; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; NELSON RJ, 1995, NATURE, V378, P383, DOI 10.1038/378383a0; NEXO E, 1988, SCAND J CLIN LAB INV, V48, P269, DOI 10.3109/00365518809167494; O'Connell T, 2002, J CLIN ENDOCR METAB, V87, P4356, DOI 10.1210/jc.2002-020343; OHNEDA A, 1975, TOHOKU J EXP MED, V116, P103, DOI 10.1620/tjem.116.103; Pories WJ, 2012, DIABETES CARE, V35, P2438, DOI 10.2337/dc12-0684; Robertson RP, 2003, DIABETES, V52, P581, DOI 10.2337/diabetes.52.3.581; Sanchez O, 2007, AM J PHYSIOL-REG I, V293, pR1908, DOI 10.1152/ajpregu.00113.2007; Sapolsky RM, 1997, AM J PHYSIOL-REG I, V273, pR1346, DOI 10.1152/ajpregu.1997.273.4.R1346; Sartori C, 2009, ENDOCRINOLOGY, V150, P5311, DOI 10.1210/en.2009-0425; Sattler F, 2014, J GERONTOL GERIATR R, V3; Schmid C, 2013, J ENDOCRINOL, V219, pR37, DOI 10.1530/JOE-13-0285; Schreuder T, 2005, DIABETES OBES METAB, V7, P239, DOI 10.1111/j.1463-1326.2004.00449.x; Schwarz PB, 2011, J NEUROPHYSIOL, V106, P1299, DOI 10.1152/jn.00230.2011; Shanik MH, 2008, DIABETES CARE, V31, pS262, DOI 10.2337/dc08-s264; Song WJ, 2014, CELL METAB, V19, P667, DOI 10.1016/j.cmet.2014.03.005; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stranahan AM, 2009, HIPPOCAMPUS, V19, P951, DOI 10.1002/hipo.20577; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; van Erp AMM, 2000, J NEUROSCI, V20, P9320; van Weenen JED, 2011, EXP DIABETES RES, DOI 10.1155/2011/928523; Velasquez-Mieyer PA, 2003, INT J OBESITY, V27, P219, DOI 10.1038/sj.ijo.802227; Volek JS, 1997, J APPL PHYSIOL, V82, P49, DOI 10.1063/1.365847; Watve MG, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-61; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Whyte LJ, 2010, METABOLISM, V59, P1421, DOI 10.1016/j.metabol.2010.01.002; Yamaoka T, 2002, BIOCHEM BIOPH RES CO, V296, P1039, DOI 10.1016/S0006-291X(02)02000-4	67	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0181536	10.1371/journal.pone.0181536	http://dx.doi.org/10.1371/journal.pone.0181536			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767672	Green Published, gold, Green Submitted			2022-12-26	WOS:000406768200026
J	Liu, XH; Wang, WJ; Song, GF; Wei, X; Zeng, YJ; Han, PX; Wang, DT; Shao, MM; Wu, J; Sun, HL; Xiong, GL; Li, SM				Liu, Xinhui; Wang, Wenjing; Song, Gaofeng; Wei, Xian; Zeng, Youjia; Han, Pengxun; Wang, Dongtao; Shao, Mumin; Wu, Juan; Sun, Huili; Xiong, Guoliang; Li, Shunmin			Astragaloside IV ameliorates diabetic nephropathy by modulating the mitochondrial quality control network	PLOS ONE			English	Article							KIDNEY-DISEASE; DYSFUNCTION; PATHOPHYSIOLOGY; MITOPHAGY; INJURY; RATS	The aim of this study was to investigate the effect and possible mechanism of Astragaloside IV (AS-IV) on retarding the progression of diabetic nephropathy (DN) in a type 2 diabetic animal model, db/db mice. Eight-week-old male db/db diabetic mice and their nondiabetic littermate control db/m mice were used in the present study. AS-IV was administered to the db/db mice by adding it to standard feed at a dose of 1g/kg for 12 weeks. Renal injury was assessed by urinary albumin excretion (UAE) and Periodic acid-Schiff staining. The protein expression levels of mitochondrial quality-control-associated proteins were evaluated using Western blotting and immunohistochemical staining analysis. At the end of the experiment, db/db mice showed overt renal injury, as evidenced by increased UAE, increased urinary Nacetyl-beta-D-glucosaminidase (NAG), expansion of mesangial matrix, and increased renal tubular area. AS-IV administration significantly reduced UAE and urinary NAG and ameliorated the renal pathologic injury seen in db/db mice. Furthermore, the expression of dynamin-related protein 1 (Drp-1), mitochondrial fission protein 1 (Fis-1), and mitochondrial fission factor (MFF), the main regulators of mitochondrial fission, was significantly increased in db/db mice. Moreover, PTEN-induced putative kinase 1 (PINK1)/Parkin-mediated mitophagy was abnormally activated in db/db mice. AS-IV significantly reduced renal Drp-1, Fis1, and MFF expression and downregulated PINK1/Parkin-mediated mitophagy in db/db mice. However, mitochondrial biogenesis and mitochondrial fusion-associated protein levels were not significantly different between db/m and db/db mice in our study, with or without AS-IV treatment. In conclusion, administration of AS-IV could retard DN progression in type 2 diabetes mice, which might be associated with restoration of the mitochondrial quality control network.	[Liu, Xinhui; Wang, Wenjing; Song, Gaofeng; Wei, Xian; Zeng, Youjia; Han, Pengxun; Wang, Dongtao; Sun, Huili; Xiong, Guoliang; Li, Shunmin] Guangzhou Univ Chinese Med, Shenzhen Tradit Chinese Med Hosp, Dept Nephrol, Shenzhen, Guangdong, Peoples R China; [Shao, Mumin] Guangzhou Univ Chinese Med, Shenzhen Tradit Chinese Med Hosp, Dept Pathol, Shenzhen, Guangdong, Peoples R China; [Wu, Juan] Zhejiang Prov Peoples Hosp, Dept Nephrol, Hangzhou, Zhejiang, Peoples R China	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; Zhejiang Provincial People's Hospital	Li, SM (corresponding author), Guangzhou Univ Chinese Med, Shenzhen Tradit Chinese Med Hosp, Dept Nephrol, Shenzhen, Guangdong, Peoples R China.	zyylishunmin@163.com		Wu, Juan/0000-0002-2660-0587; Shao, Mumin/0000-0001-9327-1261	National Natural Science Foundation of China [81603437, 81373565, 81600516]; China Postdoctoral Science Foundation [2015M570701]; Natural Science Foundation of Guangdong Province [2015A030310252]; Science and Technology Innovation Committee of Shenzhen [JCYJ20150401163247223, JCYJ20130329155553733, JSGG20141017103353178, JCYJ20140408152909279]; Health and Family Planning Commission of Shenzhen Municipality [201505014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Innovation Committee of Shenzhen; Health and Family Planning Commission of Shenzhen Municipality	The present study was supported by the National Natural Science Foundation of China (grant no. 81603437, 81373565, and 81600516), the Project Funded by China Postdoctoral Science Foundation (grant no. 2015M570701), the Natural Science Foundation of Guangdong Province (grant no. 2015A030310252), the Science and Technology Innovation Committee of Shenzhen (grant no. JCYJ20150401163247223, JCYJ20130329155553733, JSGG20141017103353178, and JCYJ20140408152909279), and the Health and Family Planning Commission of Shenzhen Municipality (grant no. 201505014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayanga BA, 2016, J AM SOC NEPHROL, V27, P2733, DOI 10.1681/ASN.2015101096; Che RC, 2014, AM J PHYSIOL-RENAL, V306, pF367, DOI 10.1152/ajprenal.00571.2013; Chen JG, 2014, EUR J PHARMACOL, V736, P86, DOI 10.1016/j.ejphar.2014.04.037; Ding Y, 2015, J ENDOCRINOL, V224, pR15, DOI 10.1530/JOE-14-0437; Eiyama A, 2015, CURR OPIN CELL BIOL, V33, P95, DOI 10.1016/j.ceb.2015.01.002; Fischer F, 2012, TRENDS BIOCHEM SCI, V37, P284, DOI 10.1016/j.tibs.2012.02.004; Gui DK, 2013, CYTOKINE, V61, P970, DOI 10.1016/j.cyto.2013.01.008; Gui DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039824; Hallan S, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0748-0; Higgins GC, 2014, BRIT J PHARMACOL, V171, P1917, DOI 10.1111/bph.12503; Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI [10.1042/BSE0470069, 10.1042/bse0470069]; Kabekkodu SP, 2015, MITOCHONDRION, V24, P93, DOI 10.1016/j.mito.2015.07.008; Li L, 2016, FUNDAM CLIN PHARM; Saran R, 2016, AM J KIDNEY DIS, V67, pS1, DOI 10.1053/j.ajkd.2015.12.014; Sharma K, 2013, J AM SOC NEPHROL, V24, P1901, DOI 10.1681/ASN.2013020126; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Smith MA, 2012, ARCH BIOCHEM BIOPHYS, V523, P161, DOI 10.1016/j.abb.2012.04.020; Sun QR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098866; Wang ZS, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0031-7; Xiao L, 2014, DIABETES, V63, P1366, DOI 10.2337/db13-1412; Zhan M, 2015, J AM SOC NEPHROL, V26, P1304, DOI 10.1681/ASN.2014050457; Zhan M, 2013, KIDNEY INT, V83, P568, DOI 10.1038/ki.2012.441	22	35	39	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182558	10.1371/journal.pone.0182558	http://dx.doi.org/10.1371/journal.pone.0182558			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767702	Green Published, gold, Green Submitted			2022-12-26	WOS:000406768200087
J	McMichael, L; Edson, D; Smith, C; Mayer, D; Smith, I; Kopp, S; Meers, J; Field, H				McMichael, Lee; Edson, Daniel; Smith, Craig; Mayer, David; Smith, Ina; Kopp, Steven; Meers, Joanne; Field, Hume			Physiological stress and Hendra virus in flying-foxes (Pteropus spp.), Australia	PLOS ONE			English	Article							GLUCOCORTICOIDS; DISEASE; REPRODUCTION; PTEROPODIDAE; POPULATIONS; CHIROPTERA; INFECTION; ALECTO; BATS	Pteropid bats (flying-foxes) are the natural reservoir of Hendra virus, an emergent paramyxovirus responsible for fatal infection in horses and humans in Australia. Pteropus alecto (the Black flying-fox) and the paraphyletic P. conspicillatus (the Spectacled flying-fox) appear to be the primary reservoir hosts. Previous studies have suggested that physiological and ecological factors may underpin infection dynamics in flying-foxes, and subsequent spillover to horses and in turn humans. We sought to examine temporal trends in urinary cortisol concentration in wild Australian flying-fox populations, to elucidate the putative relationship between Hendra virus infection and physiological stress. Pooled and individual urine samples were non-invasively collected from under roosting flying-foxes at two latitudinally disparate regions in the eastern Australian state of Queensland. Hendra virus detection, and (in individual urine samples) sex and species determination were PCR-based. Urinary cortisol measurement used a validated enzyme immunoassay. We found no direct correlation between increased urinary cortisol and Hendra virus excretion, but our findings do suggest a biologically plausible association between low winter temperatures and elevated cortisol levels in P. alecto in the lower latitude Southeast Queensland roosts. We hypothesize an indirect association between low winter temperatures and increased Hendra virus infection and excretion, mediated by the physiological cost of thermoregulation. Our findings and our approach are directly relevant to elaboration of the disease ecology of Nipah virus and other emerging henipaviruses in bats. More broadly, they inform investigation of emerging disease infection dynamics across the wildlife/livestock/human interface.	[McMichael, Lee; Kopp, Steven; Meers, Joanne] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia; [McMichael, Lee; Edson, Daniel; Smith, Craig] Biosecur Queensland, Dept Agr & Fisheries, Brisbane, Qld, Australia; [Edson, Daniel] Dept Agr & Water Resources, Canberra, ACT, Australia; [Mayer, David] Dept Agr & Fisheries, Brisbane, Qld, Australia; [Smith, Ina] Australian Anim Hlth Lab, Geelong, Vic, Australia; [Field, Hume] EcoHlth Alliance, New York, NY USA	University of Queensland; Queensland Department of Agriculture & Fisheries; Commonwealth Scientific & Industrial Research Organisation (CSIRO); EcoHealth Alliance	McMichael, L (corresponding author), Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia.; McMichael, L (corresponding author), Biosecur Queensland, Dept Agr & Fisheries, Brisbane, Qld, Australia.	l.mcmichael@uq.edu.au	Kopp, Steven/G-8223-2014; Mayer, David G/F-8616-2011; McMichael, Lee UQ/C-7948-2018; Smith, Ina/H-7225-2013	Kopp, Steven/0000-0001-7912-4556; Mayer, David G/0000-0001-9564-9176; McMichael, Lee UQ/0000-0002-7675-4859; Smith, Ina/0000-0001-5807-3737	National Hendra Virus Research Program - Queensland, New South Wales; Australian governments; Australian Biosecurity Cooperative Research Centre for Emerging Infectious Diseases; Australian Postgraduate Award program through the University of Queensland	National Hendra Virus Research Program - Queensland, New South Wales; Australian governments(Australian Government); Australian Biosecurity Cooperative Research Centre for Emerging Infectious Diseases(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Postgraduate Award program through the University of Queensland	We acknowledge funding from the National Hendra Virus Research Program supported by the Queensland, New South Wales and Australian governments, and the (previous) Australian Biosecurity Cooperative Research Centre for Emerging Infectious Diseases. Doctoral scholarship support for Lee McMichael was provided by the (then) Australian Biosecurity Cooperative Research Centre for Emerging Infectious Diseases and by the Australian Postgraduate Award program through the University of Queensland.	Almeida FC, 2014, MOL PHYLOGENET EVOL, V77, P83, DOI 10.1016/j.ympev.2014.03.009; [Anonymous], 2015, GENSTAT WIND REL 16; Bartolomucci A, 2000, BRAIN RES B, V62, P173; Beery AK, 2012, BIOL LETTERS, V8, P1063, DOI 10.1098/rsbl.2012.0747; Breed AC, 2011, PLOS ONE, V6, P1, DOI DOI 10.1371/J0URNAL.P0NE.0028816; Bureau of Meteorology, 2015, CLIN DAT ONL; Busch DS, 2009, BIOL CONSERV, V142, P2844, DOI 10.1016/j.biocon.2009.08.013; Churchill S, 2008, AUSTR BATS, V2nd; Edson D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140670; Edson D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125881; Field H., 2004, THESIS; Field H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144055; Goldspink LK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128835; GUIDRY AJ, 1976, AM J VET RES, V37, P1195; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Hawley DM, 2011, FUNCT ECOL, V25, P48, DOI 10.1111/j.1365-2435.2010.01753.x; Hing S, 2016, WILDLIFE RES, V43, P51, DOI 10.1071/WR15183; Klose SM, 2009, BIOL LETTERS, V5, P758, DOI 10.1098/rsbl.2009.0563; Krishna A, 1998, J EXP ZOOL, V281, P201, DOI 10.1002/(SICI)1097-010X(19980615)281:3<201::AID-JEZ5>3.0.CO;2-R; Lewanzik D, 2012, GEN COMP ENDOCR, V177, P104, DOI 10.1016/j.ygcen.2012.02.021; McCullagh P, 1989, GEN LINEAR MODELS; McMichael L, 2017, J WILDLIFE DIS, V53, P111, DOI 10.7589/2016-05-100; McMichael L, 2016, ECOHEALTH, V13, P49, DOI 10.1007/s10393-016-1113-0; McMichael LA, 2014, ECOHEALTH, V11, P400, DOI 10.1007/s10393-014-0954-7; Melville DF, 2012, THERIOGENOLOGY, V77, P652, DOI 10.1016/j.theriogenology.2011.09.012; MURRAY K, 1995, SCIENCE, V268, P94, DOI 10.1126/science.7701348; Ostner J, 2008, BEHAV ECOL SOCIOBIOL, V62, P627, DOI 10.1007/s00265-007-0487-y; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Plowright RK, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2124; Reeder DM, 2006, J COMP PHYSIOL B, V176, P513, DOI 10.1007/s00360-006-0073-z; Reeder DM, 2004, J EXP ZOOL PART A, V301A, P682, DOI 10.1002/jez.a.58; Roberts BJ, 2012, AUSTRAL ECOL, V37, P12, DOI 10.1111/j.1442-9993.2011.02243.x; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sies H, 2005, J NUTR, V135, P969, DOI 10.1093/jn/135.5.969; Smith C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099965; Smith IL, 2001, J VIROL METHODS, V98, P33, DOI 10.1016/S0166-0934(01)00354-8; Srivastava RK, 2008, J EXP ZOOL PART A, V309A, P94, DOI 10.1002/jez.440; Thomas SA, 1997, NATURE, V387, P94, DOI 10.1038/387094a0; WIDMAIER EP, 1993, J EXP ZOOL, V265, P533, DOI 10.1002/jez.1402650509	39	17	17	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182171	10.1371/journal.pone.0182171	http://dx.doi.org/10.1371/journal.pone.0182171			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767708	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000406768200050
J	Simo-Riudalbas, M; Metallinou, M; de Pous, P; Els, J; Jayasinghe, S; Pentek-Zakar, E; Wilms, T; Al-Saadi, S; Carranza, S				Simo-Riudalbas, Marc; Metallinou, Margarita; de Pous, Philip; Els, Johannes; Jayasinghe, Sithum; Pentek-Zakar, Erika; Wilms, Thomas; Al-Saadi, Saleh; Carranza, Salvador			Cryptic diversity in Ptyodactylus (Reptilia: Gekkonidae) from the northern Hajar Mountains of Oman and the United Arab Emirates uncovered by an integrative taxonomic approach	PLOS ONE			English	Article							SQUAMATA GEKKONIDAE; RED-SEA; GECKOS; DIVERSIFICATION; BIOGEOGRAPHY; SYSTEMATICS; AFRICA; TECTONICS; EVOLUTION; PATTERNS	The Hajar Mountains of south-eastern Arabia form an isolated massif surrounded by the sea to the east and by a large desert to the west. As a result of their old geological origin, geographical isolation, complex topography and local climate, these mountains provide an important refuge for endemic and relict species of plants and animals. With 19 species restricted to the Hajar Mountains, reptiles are the vertebrate group with the highest level of endemicity, becoming an excellent model for understanding the patterns and processes that generate and shape diversity in this arid mountain range. The geckos of the Ptyodactylus hasselquistii species complex are the largest geckos in Arabia and are found widely distributed across the Arabian Mountains, constituting a very important component of the reptile mountain fauna. Preliminary analyses suggested that their diversity in the Hajar Mountains may be higher than expected and that their systematics should be revised. In order to tackle these questions, we inferred a nearly complete calibrated phylogeny of the genus Ptyodactylus to identify the origin of the Hajar Mountains lineages using information from two mitochondrial and four nuclear genes. Genetic variability within the Hajar Mountains was further investigated using 68 specimens of Ptyodactylus from 46 localities distributed across the entire mountain range and sequenced for the same genes as above. The molecular phylogenies and morphological analyses as well as niche comparisons indicate the presence of two very old sister cryptic species living in allopatry: one restricted to the extreme northern Hajar Mountains and described as a new species herein; the other distributed across the rest of the Hajar Mountains that can be confidently assigned to the species P. orlovi. Similar to recent findings in the geckos of the genus Asaccus, the results of the present study uncover more hidden diversity in the northern Hajar Mountains and stress once again the importance of this unique mountain range as a hot spot of biodiversity and a priority focal point for reptile conservation in Arabia.	[Simo-Riudalbas, Marc; Metallinou, Margarita; de Pous, Philip; Carranza, Salvador] Univ Pompeu Fabra, CSIC, Inst Evolutionary Biol, Passeig Maritim Barceloneta 37-49, Barcelona, Spain; [Els, Johannes; Jayasinghe, Sithum] Breeding Ctr Endangered Arabian Wildlife Environm, Sharjah, U Arab Emirates; [Pentek-Zakar, Erika] Univ Debrecen, Inst Anim Sci Biotechnol & Nat Conservat, Debrecen, Hungary; [Wilms, Thomas] Allwetterzoo Munster, Sentruper Str 315, Munster, Germany; [Al-Saadi, Saleh] Minist Environm & Climate Affairs, Thaqafah St, Muscat, Oman	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; University of Debrecen	Carranza, S (corresponding author), Univ Pompeu Fabra, CSIC, Inst Evolutionary Biol, Passeig Maritim Barceloneta 37-49, Barcelona, Spain.	salvador.carranza@ibe.upf-csic.es	Carranza, Salvador/A-2126-2012	Carranza, Salvador/0000-0002-5378-3008; Els, Johannes/0000-0002-5614-1887	Ministerio de Economia y Competitividad, Spain [CGL2012-36970, CGL2015-70390-P]; FEDER; Ministry of Environment and Climate Affairs, Oman [22412027]; Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya [2014-SGR-1532]; FPI grant from the Ministerio de Economia y Competitividad, Spain [BES-2013-064248]	Ministerio de Economia y Competitividad, Spain; FEDER(European Commission); Ministry of Environment and Climate Affairs, Oman; Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya(Generalitat de Catalunya); FPI grant from the Ministerio de Economia y Competitividad, Spain	This work was funded by grants CGL2012-36970 and CGL2015-70390-P from the Ministerio de Economia y Competitividad, Spain (cofunded by FEDER) to SC, the project 'Field study for the conservation of reptiles in Oman', Ministry of Environment and Climate Affairs, Oman (Ref: 22412027) to SC and grant 2014-SGR-1532 from the Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya to SC. MSR is funded by a FPI grant from the Ministerio de Economia y Competitividad, Spain (BES-2013-064248).	Adams M, 2014, SYST BIOL, V63, P518, DOI 10.1093/sysbio/syu017; Alsharhan A.S., 2001, HYDROGEOLOGY ARID RE; Anderson J, 1898, ZOOLOGY OF EGYPT; Arnold E.N., 1986, Fauna of Saudi Arabia, V8, P385; Arnold E.N, 1977, P59; ARNOLD E N, 1972, Zoologische Mededelingen (Leiden), V47, P111; Arnold E. N., 1980, J OMAN STUDIES SPECI, P273; Arnold E.N., 1977, J OMAN STUDIES SPECI, V1, P81; Arnold E. Nicholas, 1994, Fauna of Saudi Arabia, V14, P424; ARNOLD EN, 1993, J ZOOL, V229, P353, DOI 10.1111/j.1469-7998.1993.tb02642.x; Baha El Din S., 2006, GUIDE REPTILES AMPHI; Barata M, 2015, AFR J HERPETOL, V64, P1, DOI 10.1080/21564574.2014.967815; Barata M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-167; Barata M, 2012, BIOL J LINN SOC, V106, P828, DOI 10.1111/j.1095-8312.2012.01903.x; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bosworth W, 2005, J AFR EARTH SCI, V43, P334, DOI 10.1016/j.jafrearsci.2005.07.020; Boughman JW, 2002, TRENDS ECOL EVOL, V17, P571, DOI 10.1016/S0169-5347(02)02595-8; Brinkmann K, 2009, J ARID ENVIRON, V73, P1035, DOI 10.1016/j.jaridenv.2009.05.002; Brito D, 2010, BASIC APPL ECOL, V11, P709, DOI 10.1016/j.baae.2010.09.007; Brito JC, 2014, BIOL REV, V89, P215, DOI 10.1111/brv.12049; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Busais SM, 2011, VERTEBR ZOOL, V61, P267; Carranza S, 2016, PEERJ, V4, DOI 10.7717/peerj.2371; Carranza S, 2012, ZOOTAXA, P1; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Costello MJ, 2013, SCIENCE, V339, P413, DOI 10.1126/science.1230318; de Pous P, 2016, J ZOOL SYST EVOL RES, V54, P67, DOI 10.1111/jzs.12107; de Queiroz K, 1998, ENDLESS FORMS, P57; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Disi A.M., 2001, AMPHIBIANS REPTILES; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgell HS., 2006, ARABINA DESERTS NATU; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flot JF, 2010, MOL ECOL RESOUR, V10, P162, DOI 10.1111/j.1755-0998.2009.02732.x; FRANKENBERG E, 1974, Journal of Herpetology, V8, P59, DOI 10.2307/1563077; Funk WC, 2012, P ROY SOC B-BIOL SCI, V279, P1806, DOI 10.1098/rspb.2011.1653; Gamble C, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039429, 10.1371/journal.pone.0035982]; Gamble T, 2011, J EVOLUTION BIOL, V24, P231, DOI 10.1111/j.1420-9101.2010.02184.x; Gamble T, 2008, J BIOGEOGR, V35, P88, DOI 10.1111/j.1365-2699.2007.01770.x; Garcia-Porta J, J BIOGEOGR IN PRESS; Garcia-Porta J, 2016, MOL PHYLOGENET EVOL, V98, P288, DOI 10.1016/j.ympev.2016.02.007; Gardner AS, 2013, AMPHIBIAND REPTILES; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; GHAZANFAR SA, 1991, J BIOGEOGR, V18, P299, DOI 10.2307/2845400; Glennie K., 2006, OMANS GEOLOGICAL HER; Glennie KW, 2001, EVOLUTION EMIRATES L; Glor RE, 2003, EVOLUTION, V57, P2383; Gomez-Diaz E, 2012, MOL ECOL, V21, P4074, DOI 10.1111/j.1365-294X.2012.05672.x; Harmon LJ, 2008, SYST BIOL, V57, P562, DOI 10.1080/10635150802304779; Harrigan RJ, 2008, MOL ECOL RESOUR, V8, P1239, DOI 10.1111/j.1755-0998.2008.02241.x; Harrison D., 1976, J OMAN STUDIES, V1, P181; Harrison D., 1977, J OMAN STUDIES SPECI, V1, P10; Hawlitschek O, 2013, ZOOL SCR, V42, P135, DOI 10.1111/zsc.12001; HEIMES P, 1987, Salamandra, V23, P212; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Loveridge Arthur, 1947, BULL MUS CAMP ZOOL HARVARD UNIV, V98, P1; Mandaville J.P., 1977, J OMAN STUDIES SPECI, P229; Metallinou M, 2015, MOL PHYLOGENET EVOL, V85, P208, DOI 10.1016/j.ympev.2015.02.010; Metallinou M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-258; Metallinou M, 2013, ZOOTAXA, V 3745, P449, DOI 10.11646/zootaxa.3745.4.3; Mila B, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-192; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Perera A, 2010, MOL PHYLOGENET EVOL, V54, P634, DOI 10.1016/j.ympev.2009.10.020; Powney GD, 2010, GLOBAL ECOL BIOGEOGR, V19, P386, DOI 10.1111/j.1466-8238.2009.00521.x; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Ricateau R., 1980, J PETROL GEOL, V3, P139; ROBERTSON AHF, 1990, GEOL SOC SPEC PUBL, V49, P251, DOI 10.1144/GSL.SP.1992.049.01.17; Rodder D, 2011, GLOBAL ECOL BIOGEOGR, V20, P915, DOI 10.1111/j.1466-8238.2011.00659.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Schonrogge K, 2002, BIOL J LINN SOC, V75, P291, DOI 10.1111/j.1095-8312.2002.tb02070.x; Searle MP, 2014, GEOARABIA, V19, P135; SEARLE MP, 1988, J GEOL SOC LONDON, V145, P43, DOI 10.1144/gsjgs.145.1.0043; Silvestro D., 2011, ORG DIVERS EVOL, V12, P335, DOI [10.1007/sI3127-011-0056-0, DOI 10.1007/S13127-011-0056-0]; Sindaco R, 2012, ZOOL SCR, V41, P346, DOI 10.1111/j.1463-6409.2012.00540.x; Sindaco R, 2008, MONOGRAFIE SOC HERPE; Smid J, 2017, ORG DIVERS EVOL, V17, P267, DOI 10.1007/s13127-016-0293-3; Smid J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064018; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tamar K, 2016, MOL PHYLOGENET EVOL, V97, P55, DOI 10.1016/j.ympev.2015.12.021; Trabucco A, 2009, CGIAR CONSORT SPATIA; Uetz P., 2020, REPTILE DATABASE; Vasconcelos R, 2014, ZOOTAXA, V3835, P501, DOI 10.11646/zootaxa.3835.4.4; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Werner Y. L., 1965, Salamandra, V1, P15; Werner Yehudah L., 1993, Revista Espanola de Herpetologia, V7, P47; Werner Yehudah L., 1994, Revista Espanola de Herpetologia, V8, P105; WERNER YL, 1978, ISR J ZOOL, V27, P176; Wilcox TP, 2002, MOL PHYLOGENET EVOL, V25, P361, DOI 10.1016/S1055-7903(02)00244-0	96	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0180397	10.1371/journal.pone.0180397	http://dx.doi.org/10.1371/journal.pone.0180397			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767644	Green Published, Green Submitted, gold			2022-12-26	WOS:000406768200007
J	Xi, JM; Chen, JY; Xu, ML; Yang, HY; Luo, J; Pan, Y; Wang, XD; Qiu, LJ; Yang, JJ; Sun, QM				Xi, Juemin; Chen, Junying; Xu, Miaoling; Yang, Hongying; Luo, Jia; Pan, Yue; Wang, Xiaodan; Qiu, Lijuan; Yang, Jiajia; Sun, Qiangming			Genetic variability and functional implication of the long control region in HPV-16 variants in Southwest China	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; FACTOR-BINDING PROFILES; OPEN-ACCESS DATABASE; CERVICAL-CANCER; TRANSCRIPTION; FOXA1; E6; SUPPRESSES; WORLDWIDE; RECEPTOR	HPV-16 long control region (LCR) has been shown to be the most variable region of the HPV-16 genome and may play important roles in viral persistence and the development of cervical cancer. This study aimed to assess the risk of HPV-16 LCR variants for cervical cancer in women of Southwest China. 2146 cervical scrapings of volunteer outpatients and 74 cervical cancer tissues were screened. 14 entire HPV-16 LCRs from asymptomatic carriers and 34 entire HPV-16 LCRs from cervical cancer patients were successfully amplified and sequenced to align to others described. 58 different point mutations were detected in 54 nucleotide sites of HPV-16 LCR. G7193T and G7521A variants, accounting for 100% of the infections, were predicted to locate at the binding site for FOXA1 and SOX9, respectively. A7730C variant which showed a high mutation frequency in cervical cancer was predicted to be a binding site for the cellular transcription factor PHOX2A. In addition, phylogenetic analysis displayed a high prevalence of A lineage in HPV-16 LCR in this Southwest China population. This study may help understanding of the intrinsic geographical relatedness and the correlations between LCR mutations and the development of carcinogenic lesions in Southwest China population. And it provides useful data for the further study of the biological function of HPV-16 LCR variants.	[Xi, Juemin; Chen, Junying; Luo, Jia; Pan, Yue; Wang, Xiaodan; Qiu, Lijuan; Yang, Jiajia; Sun, Qiangming] Chinese Acad Med Sci, Inst Med Biol, Kunming, Yunnan, Peoples R China; [Xi, Juemin; Chen, Junying; Luo, Jia; Pan, Yue; Wang, Xiaodan; Qiu, Lijuan; Yang, Jiajia; Sun, Qiangming] Peking Union Med Coll, Kunming, Yunnan, Peoples R China; [Xi, Juemin; Chen, Junying; Luo, Jia; Pan, Yue; Wang, Xiaodan; Qiu, Lijuan; Yang, Jiajia; Sun, Qiangming] Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Kunming, Yunnan, Peoples R China; [Xi, Juemin; Chen, Junying; Luo, Jia; Pan, Yue; Wang, Xiaodan; Qiu, Lijuan; Yang, Jiajia; Sun, Qiangming] Yunnan Key Lab Vector Borne Infect Dis, Kunming, Yunnan, Peoples R China; [Xu, Miaoling] Kunming Med Univ, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China; [Yang, Hongying] Kunming Med Univ, Affiliated Hosp 3, Yunnan Prov Tumor Hosp, Kunming, Yunnan, Peoples R China; [Luo, Jia] Kunming Med Univ, Kunming, Yunnan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Diseases; Kunming Medical University; Kunming Medical University; Kunming Medical University	Sun, QM (corresponding author), Chinese Acad Med Sci, Inst Med Biol, Kunming, Yunnan, Peoples R China.; Sun, QM (corresponding author), Peking Union Med Coll, Kunming, Yunnan, Peoples R China.; Sun, QM (corresponding author), Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Kunming, Yunnan, Peoples R China.; Sun, QM (corresponding author), Yunnan Key Lab Vector Borne Infect Dis, Kunming, Yunnan, Peoples R China.	msun08@yahoo.com	Sun, Qiangming/GYE-2002-2022		CAMS Innovation Fund for Medical Sciences (CIFMS) [2016-I2M-3-026]; National Natural Science Foundation of China [81171946]; National "Twelfth Five Year" "major new drug discovery" technology major projects [2012ZX09104-302]; Natural Science Foundation of Yunnan Province [2009ZC187M, 2012F6188, 2016FA029]	CAMS Innovation Fund for Medical Sciences (CIFMS); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National "Twelfth Five Year" "major new drug discovery" technology major projects; Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province)	This research was supported by CAMS Innovation Fund for Medical Sciences (CIFMS) (grant no. 2016-I2M-3-026, http://www.pumc.edu.cn/), the National Natural Science Foundation of China (grant no. 81171946, http://www.nsfc.gov.cn/), the National "Twelfth Five Year" "major new drug discovery" technology major projects (grant no. 2012ZX09104-302, http://www.most.gov.cn/), the Natural Science Foundation of Yunnan Province (grant no. 2009ZC187M, 2012F6188 and 2016FA029, http://www.ynstc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Penghua Wang of Department of Microbiology & Immunology, School of Medicine, New York Medical College for proofreading and reviewing our manuscript. This research was supported by CAMS Innovation Fund for Medical Sciences (CIFMS) (grant no. 2016-12M-3-026), the National Natural Science Foundation of China (grant no. 81171946), and the Natural Science Foundation of Yunnan Province (grant no. 2012FB188 and 2016FA029).	Ayatollahi M, 2005, J TROP PEDIATRICS, V51, P136, DOI 10.1093/tropej/fmh101; Cornet I, 2012, J VIROL, V86, P6855, DOI 10.1128/JVI.00483-12; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; DONG XP, 1994, INT J CANCER, V58, P803, DOI 10.1002/ijc.2910580609; Findlay VJ, 2013, ADV CANCER RES, V119, P1, DOI 10.1016/B978-0-12-407190-2.00001-0; Ghittoni R, 2015, ECANCERMEDICALSCIENC, V9, DOI 10.3332/ecancer.2015.526; HO L, 1993, J VIROL, V67, P6413, DOI 10.1128/JVI.67.11.6413-6423.1993; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Jin HJ, 2013, CANCER RES, V73, P3725, DOI 10.1158/0008-5472.CAN-12-3468; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Li Z, 2012, CELL, V148, P72, DOI 10.1016/j.cell.2011.11.026; Lin L, 2002, CANCER RES, V62, P5273; Liu Y, 2017, SCI REP, V7, P263; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Mosmann Jessica P, 2015, Asian Pac J Cancer Prev, V16, P1151; Pan Z, 2010, NEOPLASMA, V57, P123, DOI 10.4149/neo_2010_02_123; Pande S, 2008, J CLIN MICROBIOL, V46, P1060, DOI 10.1128/JCM.02202-07; Pientong C, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-30; Qu WM, 1997, J CLIN MICROBIOL, V35, P1304, DOI 10.1128/JCM.35.6.1304-1310.1997; ROMANCZUK H, 1990, J VIROL, V64, P2849, DOI 10.1128/JVI.64.6.2849-2859.1990; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Sichero L, 2007, INT J CANCER, V120, P1763, DOI 10.1002/ijc.22481; Soeda E, 2006, VIROLOGY, V351, P29, DOI 10.1016/j.virol.2006.03.016; Sun ZR, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-459; Wang HY, 2015, ONCOTARGET, V6, P20711, DOI 10.18632/oncotarget.4133; Wang JY, 2014, ONCOL REP, V31, P1225, DOI 10.3892/or.2014.2982; Wang R, 2016, AM J CANCER RES, V6, P173; Xi LF, 2007, CANCER EPIDEM BIOMAR, V16, P4, DOI 10.1158/1055-9965.EPI-06-0670; Yamada T, 1997, J VIROL, V71, P2463, DOI 10.1128/JVI.71.3.2463-2472.1997; Yang L, 2010, INFECT GENET EVOL, V21, P395; Yue YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055204	34	19	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182388	10.1371/journal.pone.0182388	http://dx.doi.org/10.1371/journal.pone.0182388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767682	gold, Green Published, Green Submitted			2022-12-26	WOS:000406768200075
J	Young, PW; Kim, AA; Wamicwe, J; Nyagah, L; Kiama, C; Stover, J; Oduor, J; Rogena, EA; Walong, E; Zielinski-Gutierrez, E; Imbwaga, A; Sirengo, M; Kellogg, TA; De Cock, KM				Young, Peter W.; Kim, Andrea A.; Wamicwe, Joyce; Nyagah, Lilly; Kiama, Catherine; Stover, John; Oduor, Johansen; Rogena, Emily A.; Walong, Edwin; Zielinski-Gutierrez, Emily; Imbwaga, Andrew; Sirengo, Martin; Kellogg, Timothy A.; De Cock, Kevin M.			HIV-associated mortality in the era of antiretroviral therapy scale-up - Nairobi, Kenya, 2015	PLOS ONE			English	Article							PROJECTION PACKAGE; PATIENTS LOST; FOLLOW-UP; AIDS; PROGRAMS; ADULTS; TRENDS; MODEL; NEED	Background Declines in HIV prevalence and increases in antiretroviral treatment coverage have been documented in Kenya, but population-level mortality associated with HIV has not been directly measured. In urban areas where a majority of deaths pass through mortuaries, mortuary-based studies have the potential to contribute to our understanding of excess mortality among HIV-infected persons. We used results from a cross-sectional mortuary-based HIV surveillance study to estimate the association between HIV and mortality for Nairobi, the capital city of Kenya. Methods and findings HIV seropositivity in cadavers measured at the two largest mortuaries in Nairobi was used to estimate HIV prevalence in adult deaths. Model-based estimates of the HIV-infected and uninfected population for Nairobi were used to calculate a standardized mortality ratio and population-attributable fraction for mortality among the infected versus uninfected population. Monte Carlo simulation was used to assess sensitivity to epidemiological assumptions. When standardized to the age and sex distribution of expected deaths, the estimated HIV positivity among adult deaths aged 15 years and above in Nairobi was 20.9% (95% CI 17.7- 24.6%). The standardized mortality ratio of deaths among HIV-infected versus uninfected adults was 4.35 (95% CI 3.67-5.15), while the risk difference was 0.016 (95% CI 0.013- 0.019). The HIV population attributable mortality fraction was 0.161 (95% CI 0.131-0.190). Sensitivity analyses demonstrated robustness of results. Conclusions Although 73.6% of adult PLHIV receive antiretrovirals in Nairobi, their risk of death is four-fold greater than in the uninfected, while 16.1% of all adult deaths in the city can be attributed to HIV infection. In order to further reduce HIV-associated mortality, high-burden countries may need to reach very high levels of diagnosis, treatment coverage, retention in care, and viral suppression.	[Young, Peter W.; Kim, Andrea A.; Zielinski-Gutierrez, Emily; De Cock, Kevin M.] US Ctr Dis Control & Prevent CDC, DGHT, Nairobi, Kenya; [Wamicwe, Joyce; Nyagah, Lilly; Sirengo, Martin] Minist Hlth, Natl AIDS & STI Control Programme, Nairobi, Kenya; [Kiama, Catherine] Minist Hlth, Field Epidemiol Training Program, Nairobi, Kenya; [Stover, John] Avenir Hlth, Glastonbury, CT USA; [Oduor, Johansen] Minist Hlth, Div Forens & Pathol Serv, Nairobi, Kenya; [Rogena, Emily A.; Walong, Edwin] Univ Nairobi, Nairobi, Kenya; [Rogena, Emily A.; Walong, Edwin] Kenyatta Natl Hosp, Nairobi, Kenya; [Imbwaga, Andrew] Kenya Natl Bur Stat, Nairobi, Kenya; [Kellogg, Timothy A.] Univ Calif San Francisco, Nairobi, Kenya	University of Nairobi; Kenyatta National Hospital	Young, PW (corresponding author), US Ctr Dis Control & Prevent CDC, DGHT, Nairobi, Kenya.	pyoung1@cdc.gov		Walong, Edwin/0000-0003-1579-1880; Stover, John/0000-0001-7236-1989	U.S. President's Emergency Plan for AIDS Relief (PEPFAR) [PS001814, GH000069]	U.S. President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This publication was made possible by support from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through cooperative agreements [#PS001814, GH000069] through CDC, Division of Global HIV & TB (DGHT). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An MW, 2009, BIOMETRICS, V65, P301, DOI 10.1111/j.1541-0420.2008.01043.x; [Anonymous], 2015, AIDS INF ONL DAT; Black AK, 2015, BURDEN HIV PUBLIC HO, P2788; Civil Registration Services (CRS), 2014, KEN VIT STAT REP 201; DECOCK KM, 1990, SCIENCE, V249, P793, DOI 10.1126/science.2167515; Fox MP, 2010, TROP MED INT HEALTH, V15, P405, DOI 10.1111/j.1365-3156.2010.02473.x; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2016, GLOB AIDS UPD 2016; Kenya National Bureau of Statistics, 2012, KEN POP HOUS CENS AN, VXIV; National AIDS / STI Control Program, 2014, KEN AIDS IND SURV 20; Newson RB, 2013, STATA J, V13, P672, DOI 10.1177/1536867X1301300402; Nsanzimana S, 2015, LANCET GLOB HEALTH, V3, pE169, DOI 10.1016/S2214-109X(14)70364-X; Ramaswamy C, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv146; Reniers G, 2009, AIDS, V23, P511, DOI 10.1097/QAD.0b013e32832403d0; Stover J, 2006, SEX TRANSM INFECT, V82, pIII45, DOI 10.1136/sti.2006.020172; Stover J, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010157; Stover J, 2014, AIDS, V28, pS427, DOI 10.1097/QAD.0000000000000483; Stover J, 2012, SEX TRANSM INFECT, V88, pI11, DOI 10.1136/sextrans-2012-050640; UNAIDS, THE CIT REP	20	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0181837	10.1371/journal.pone.0181837	http://dx.doi.org/10.1371/journal.pone.0181837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767714	gold, Green Submitted, Green Published			2022-12-26	WOS:000406768200038
J	Alandiyjany, MN; Croxall, NJ; Grove, JI; Delahay, RM				Alandiyjany, Maher N.; Croxall, Nicola J.; Grove, Jane I.; Delahay, Robin M.			A role for the tfs3 ICE-encoded type IV secretion system in pro-inflammatory signalling by the Helicobacter pylori Ser/Thr kinase, CtkA	PLOS ONE			English	Article							CAG PATHOGENICITY ISLAND; PLASTICITY REGION GENES; NECROSIS-FACTOR-ALPHA; GASTRIC-CANCER; AGROBACTERIUM-TUMEFACIENS; GASTRODUODENAL DISEASES; DUODENAL-ULCER; GENOMIC ISLAND; HOST-CELLS; PROTEIN	Two distinct type IV secretion systems (T4SSs) can be identified in certain Helicobacter pylori strains, encoded on mobile genetic elements termed tfs3 and tfs4. Although their function remains unknown, both have been implicated in clinical outcomes of H. pylori infection. Here we provide evidence that the Tfs3 T4SS is required for activity of the pro-inflammatory Ser/Thr kinase protein, CtkA, in a gastric epithelial cell infection model. Previously, purified recombinant CtkA protein has been shown to upregulate NF-kappaB signalling and induce TNF-alpha and IL-8 cytokine secretion from cultured macrophages suggesting that it may potentiate the H. pylori-mediated inflammatory response. In this study, we show that CtkA expressed from its native host, H. pylori has a similar capacity for stimulation of a pro-inflammatory response from gastric epithelial cells. CtkA interaction was found to be dependent upon a complement of tfs3 T4SS genes, but independent of the T4SSs encoded by either tfs4 or the cag pathogenicity island. Moreover, the availability of CtkA for host cell interaction was shown to be conditional upon the carboxyl-terminus of CtkA, encoding a putative conserved secretion signal common to other variably encoded Tfs3 proteins. Collectively, our observations indicate a role for the Tfs3 T4SS in CtkA-mediated pro-inflammatory signalling by H. pylori and identify CtkA as a likely Tfs3 T4SS secretion substrate.	[Delahay, Robin M.] Nottingham Univ Hosp NHS Trust, NIHR Nottingham Digest Dis Biomed Res Unit, Nottingham, England; Univ Nottingham, Nottingham, England; [Alandiyjany, Maher N.] Umm Al Qura Univ, Fac Appl Med Sci, Lab Med Dept, Al Abdeyah, Makkah, Saudi Arabia	Nottingham University Hospital NHS Trust; University of Nottingham; Umm Al Qura University	Delahay, RM (corresponding author), Nottingham Univ Hosp NHS Trust, NIHR Nottingham Digest Dis Biomed Res Unit, Nottingham, England.	rob.delahay@nottingham.ac.uk		Delahay, Rob/0000-0002-7108-565X; Grove, Jane/0000-0002-9950-7201	Medical Research Council [G0901104]; National Institute for Health Research (NIHR), through the NIHR Biomedical Research Unit in Gastrointestinal and Liver Diseases at Nottingham University Hospitals NHS Trust and the University of Nottingham; King Abdullah Scholarship from Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia; MRC [G0901104] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR), through the NIHR Biomedical Research Unit in Gastrointestinal and Liver Diseases at Nottingham University Hospitals NHS Trust and the University of Nottingham; King Abdullah Scholarship from Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council [grant number G0901104] (https.//www.mrc.ac.uk/) to RMD and performed in facilities supported in part by the National Institute for Health Research (NIHR), through the NIHR Biomedical Research Unit in Gastrointestinal and Liver Diseases at Nottingham University Hospitals NHS Trust and the University of Nottingham. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. MNA was supported by a King Abdullah Scholarship from Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Medical Research Council [grant number G0901104] (https:// www.mrc.ac.uk/) to RMD. We thank members of the Helicobacter Research Group, Nottingham for helpful discussions and comments during this study.	Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Alvi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022530; Atmakuri K, 2003, MOL MICROBIOL, V49, P1699, DOI 10.1046/j.1365-2958.2003.03669.x; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; BLASER MJ, 1995, CANCER RES, V55, P2111; Brandt S, 2005, P NATL ACAD SCI, V102; Bridge DR, 2013, GUT MICROBES, V4, P101, DOI 10.4161/gmic.23797; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Christie PJ, 2004, BBA-MOL CELL RES, V1694, P219, DOI 10.1016/j.bbamcr.2004.02.013; Cook KW, 2014, GUT, V63, P1550, DOI 10.1136/gutjnl-2013-306253; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; Fischer W, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-310; Fischer W, 2010, NUCLEIC ACIDS RES, V38, P6089, DOI 10.1093/nar/gkq378; Gorrell RJ, 2013, CELL MICROBIOL, V15, P554, DOI 10.1111/cmi.12055; Graham JE, 2002, GASTROENTEROLOGY, V123, P1637, DOI 10.1053/gast.2002.36589; Grove JI, 2013, J BIOL CHEM, V288, P26385, DOI 10.1074/jbc.M113.496430; Hohlfeld S, 2006, MOL MICROBIOL, V59, P1624, DOI 10.1111/j.1365-2958.2006.05050.x; Houghton J, 2005, GASTROENTEROLOGY, V128, P1567, DOI 10.1053/j.gastro.2005.03.037; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Jakubowski SJ, 2005, J BACTERIOL, V187, P3486, DOI 10.1128/JB.187.10.3486-3495.2005; Kersulyte D, 2003, J BACTERIOL, V185, P3764, DOI 10.1128/JB.185.13.3764-3772.2003; Kersulyte D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006859; Kim DJ, 2010, P NATL ACAD SCI USA, V107, P21418, DOI 10.1073/pnas.1010153107; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Lu H, 2005, GASTROENTEROLOGY, V128, P833, DOI 10.1053/j.gastro.2005.01.009; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Occhialini A, 2000, INFECT IMMUN, V68, P6240, DOI 10.1128/IAI.68.11.6240-6249.2000; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Rizwan M, 2008, J BACTERIOL, V190, P1146, DOI 10.1128/JB.01309-07; Romo-Gonzalez C, 2009, INFECT IMMUN, V77, P2201, DOI 10.1128/IAI.01284-08; Santos A, 2003, J CLIN MICROBIOL, V41, P1651, DOI 10.1128/JCM.41.4.1651-1655.2003; Shiota S, 2010, GUT PATHOG, V2, DOI 10.1186/1757-4749-2-13; Simone M, 2001, MOL MICROBIOL, V41, P1283, DOI 10.1046/j.1365-2958.2001.02582.x; Stein M, 2000, P NATL ACAD SCI USA, V97, P1263, DOI 10.1073/pnas.97.3.1263; Suganuma M, 2005, J CANCER RES CLIN, V131, P305, DOI 10.1007/s00432-004-0652-x; Sugimoto M, 2012, J CLIN MICROBIOL, V50, P441, DOI 10.1128/JCM.00906-11; Tenguria S, 2014, INT J MED MICROBIOL, V304, P1066, DOI 10.1016/j.ijmm.2014.07.017; Vergunst AC, 2005, P NATL ACAD SCI USA, V102, P832, DOI 10.1073/pnas.0406241102; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Yakoob J, 2010, GUT LIVER, V4, P345, DOI 10.5009/gnl.2010.4.3.345; Yokozaki H, 2000, PATHOL INT, V50, P767, DOI 10.1046/j.1440-1827.2000.01117.x	41	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0182144	10.1371/journal.pone.0182144	http://dx.doi.org/10.1371/journal.pone.0182144			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28759055	Green Published, gold			2022-12-26	WOS:000406579300051
J	Auger, JP; Chuzeville, S; Roy, D; Mathieu-Denoncourt, A; Xu, JG; Grenier, D; Gottschalk, M				Auger, Jean-Philippe; Chuzeville, Sarah; Roy, David; Mathieu-Denoncourt, Annabelle; Xu, Jianguo; Grenier, Daniel; Gottschalk, Marcelo			The bias of experimental design, including strain background, in the determination of critical Streptococcus suis serotype 2 virulence factors	PLOS ONE			English	Article							FIBRONECTIN-BINDING PROTEIN; EXTRACELLULAR-MATRIX PROTEINS; BIOFILM FORMATION; MOUSE STRAINS; PORPHYROMONAS-GINGIVALIS; SURFACE PROTEIN; SEQUENCE TYPE-7; SWINE PATHOGEN; INFECTION; IDENTIFICATION	Streptococcus suis serotype 2 is an important porcine bacterial pathogen and emerging zoonotic agent mainly responsible for sudden death, septic shock, and meningitis. However, serotype 2 strains are genotypically and phenotypically heterogeneous. Though a multitude of virulence factors have been described for S. suis serotype 2, the lack of a clear definition regarding which ones are truly "critical" has created inconsistencies that have only recently been highlighted. Herein, the involvement of two factors previously described as being critical for S. suis serotype 2 virulence, whether the dipeptidyl peptidase IV and autolysin, were evaluated with regards to different ascribed functions using prototype strains belonging to important sequence types. Results demonstrate a lack of reproducibility with previously published data. In fact, the role of the dipeptidyl peptidase IV and autolysin as critical virulence factors could not be confirmed. Though certain in vitro functions may be ascribed to these factors, their roles are not unique for S. suis, probably due to compensation by other factors. As such, variations and discrepancies in experimental design, including in vitro assays, cell lines, and animal models, are an important source of differences between results. Moreover, the use of different sequence types in this study demonstrates that the role attributed to a virulence factor may vary according to the S. suis serotype 2 strain background. Consequently, it is necessary to establish standard experimental designs according to the experiment and purpose in order to facilitate comparison between laboratories. Alongside, studies should include strains of diverse origins in order to prevent erroneous and biased conclusions that could affect future studies.	[Auger, Jean-Philippe; Chuzeville, Sarah; Roy, David; Mathieu-Denoncourt, Annabelle; Grenier, Daniel; Gottschalk, Marcelo] Univ Montreal, Swine & Poultry Infect Dis Res Ctr CRIPA, Fac Vet Med, St Hyacinthe, PQ, Canada; [Auger, Jean-Philippe; Chuzeville, Sarah; Roy, David; Mathieu-Denoncourt, Annabelle; Gottschalk, Marcelo] Univ Montreal, Res Grp Infect Dis Prod Anim GREMIP, Fac Vet Med, St Hyacinthe, PQ, Canada; [Xu, Jianguo] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, Beijing, Peoples R China; [Grenier, Daniel] Laval Univ, Oral Ecol Res Grp GREB, Fac Dent, Quebec City, PQ, Canada	Universite de Montreal; Universite de Montreal; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Laval University	Gottschalk, M (corresponding author), Univ Montreal, Swine & Poultry Infect Dis Res Ctr CRIPA, Fac Vet Med, St Hyacinthe, PQ, Canada.; Gottschalk, M (corresponding author), Univ Montreal, Res Grp Infect Dis Prod Anim GREMIP, Fac Vet Med, St Hyacinthe, PQ, Canada.	marcelo.gottschalk@umontreal.ca			Natural Sciences and Engineering Research Council of Canada [154280]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Natural Sciences and Engineering Research Council of Canada to MG (grant #154280; http.//www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baums Christoph Georg, 2009, Animal Health Research Reviews, V10, P65, DOI 10.1017/S146625230999003X; Berry AM, 2000, INFECT IMMUN, V68, P133, DOI 10.1128/IAI.68.1.133-140.2000; Biondo C, 2014, INFECT IMMUN, V82, P4508, DOI 10.1128/IAI.02104-14; Biondo C, 2014, MBIO, V5, DOI 10.1128/mBio.01428-14; Bonifait L, 2008, APPL ENVIRON MICROB, V74, P4969, DOI 10.1128/AEM.00558-08; Clais S, 2014, PATHOG DIS, V70, P408, DOI 10.1111/2049-632X.12156; de Greeff A, 2002, INFECT IMMUN, V70, P1319, DOI 10.1128/IAI.70.3.1319-1325.2002; Dominguez-Punaro MC, 2007, J IMMUNOL, V179, P1842, DOI 10.4049/jimmunol.179.3.1842; Dominguez-Punaro MD, 2008, INFECT IMMUN, V76, P3901, DOI 10.1128/IAI.00350-08; Esgleas M, 2005, FEMS MICROBIOL LETT, V244, P33, DOI 10.1016/j.femsle.2005.01.017; Esgleas M, 2008, MICROBIOL-SGM, V154, P2668, DOI 10.1099/mic.0.2008/017145-0; Fittipaldi N, 2012, FUTURE MICROBIOL, V7, P259, DOI [10.2217/FMB.11.149, 10.2217/fmb.11.149]; Fittipaldi N, 2011, EMERG INFECT DIS, V17, P2239, DOI 10.3201/eid1712.110609; Ge JC, 2009, CURR MICROBIOL, V59, P248, DOI 10.1007/s00284-009-9425-8; Goldsmith JR, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/817341; GOTTSCHALK M, 1992, VET MICROBIOL, V30, P59, DOI 10.1016/0378-1135(92)90094-A; Gottschalk M., 2012, DIS SWINE, P841; Goyette-Desjardins G, 2016, INFECT IMMUN, V84, P2059, DOI 10.1128/IAI.00139-16; Goyette-Desjardins G, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.45; HOVELIUS B, 1979, ACTA PATH MICRO IM B, V87, P45; Ju CX, 2012, J BACTERIOL, V194, P1464, DOI 10.1128/JB.06231-11; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kumagai Y, 2000, INFECT IMMUN, V68, P716, DOI 10.1128/IAI.68.2.716-724.2000; Lachance C, 2013, INFECT IMMUN, V81, P1928, DOI 10.1128/IAI.01317-12; Lalonde M, 2000, MICROBIOL-SGM, V146, P1913, DOI 10.1099/00221287-146-8-1913; Li M, 2015, VIRULENCE, V6, P643, DOI 10.1080/21505594.2015.1056971; Li Q, 2017, MICROBIOL RES, V196, P17, DOI 10.1016/j.micres.2016.11.011; Li Q, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00082; Li W, 2013, VET MICROBIOL, V162, P186, DOI 10.1016/j.vetmic.2012.09.004; Maeda H, 1996, MICROBIOL IMMUNOL, V40, P685, DOI 10.1111/j.1348-0421.1996.tb01129.x; MARCO AJ, 1992, LAB ANIM, V26, P200, DOI 10.1258/002367792780740549; O'Connor TJ, 2012, SCIENCE, V338, P1440, DOI 10.1126/science.1229556; Pian YY, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00019; Pian YY, 2012, INFECT IMMUN, V80, P2402, DOI 10.1128/IAI.06294-11; Roy D, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5030047; Rupp ME, 2001, METHOD ENZYMOL, V336, P206, DOI 10.1016/S0076-6879(01)36591-6; Segura M, 2017, TRENDS MICR IN PRESS, P2244; Segura M, 2016, FEBS LETT, V590, P3772, DOI 10.1002/1873-3468.12364; Sellers RS, 2012, VET PATHOL, V49, P32, DOI 10.1177/0300985811429314; Slater JD, 2003, VET MICROBIOL, V93, P197, DOI 10.1016/S0378-1135(03)00030-0; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; Takamatsu D, 2001, PLASMID, V45, P101, DOI 10.1006/plas.2000.1510; Trede NS, 2001, TRENDS IMMUNOL, V22, P302, DOI 10.1016/S1471-4906(01)01939-1; Vaillancourt K, 2013, J MED MICROBIOL, V62, P1073, DOI 10.1099/jmm.0.057877-0; Vanier G, 2008, VET MICROBIOL, V127, P417, DOI 10.1016/j.vetmic.2007.08.032; Wang JP, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01001; Wang KC, 2007, BERL MUNCH TIERARZTL, V120, P207, DOI 10.2376/0005-9366-120-207; Wang YC, 2013, INFECT IMMUN, V81, P4498, DOI 10.1128/IAI.00818-13; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; Watanabe H, 2004, SHOCK, V22, P460, DOI 10.1097/01.shk.0000142249.08135.e9; Willenborg J, 2011, MICROBIOL-SGM, V157, P1823, DOI 10.1099/mic.0.046417-0; Willenborg J, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5030051; Ye CY, 2008, EMERG INFECT DIS, V14, P787, DOI 10.3201/eid1405.070437; Ye CY, 2006, EMERG INFECT DIS, V12, P1203, DOI 10.3201/eid1708.060232; Yu YF, 2016, MOL BIOSYST, V12, P1948, DOI 10.1039/c6mb00059b; Zhang H, 2014, J MICROBIOL, V52, P963, DOI 10.1007/s12275-014-4311-x; Zhang YY, 2016, MICROBIOL RES, V185, P45, DOI 10.1016/j.micres.2016.02.002; Zheng H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087866	58	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0181920	10.1371/journal.pone.0181920	http://dx.doi.org/10.1371/journal.pone.0181920			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753679	Green Published, Green Submitted, gold			2022-12-26	WOS:000406579300034
J	Henrich, B; Kretzmer, F; Deenen, RA; Kohrer, K				Henrich, Birgit; Kretzmer, Freya; Deenen, Rene; Koehrer, Karl			Validation of a novel Mho microarray for a comprehensive characterisation of the Mycoplasma hominis action in HeLa cell infection	PLOS ONE			English	Article							OLIGOPEPTIDE TRANSPORT-SYSTEM; HELICOBACTER-PYLORI; EPITHELIAL-CELLS; GENE-EXPRESSION; OPPA; PROTEIN; ADHERENCE; HYOPNEUMONIAE; APOPTOSIS; NUCLEASE	Mycoplasma hominis is the second smallest facultative pathogen of the human urogenital tract. With less than 600 protein-encoding genes, it represents an ideal model organism for the study of host-pathogen interactions. For a comprehensive characterisation of the M. hominis action in infection a customized Mho microarray, which was based on two genome sequences (PG21 and LBD-4), was designed to analyze the dynamics of the mycoplasma transcriptome during infection and validated for M. hominis strain FBG. RNA preparation was evaluated and adapted to ensure the highest recovery of mycoplasmal mRNAs from in vitro HeLa cell infection assays. Following cRNA hybridization, the read-out strategy of the hybridization results was optimized and confirmed by RT-PCR. A statistically robust infection assay with M. hominis strain FBG enabled the identification of differentially regulated key effector molecules such as critical cytoadhesins (4 h post infection (pI)), invasins (48 h pI) and proteins associated with establishing chronic infection of the host (336 h pI). Of the 294 differentially regulated genes (> 2-fold) 128 (43.5%) encoded hypothetical proteins, including lipoproteins that seem to play a central role as virulence factors at each stage of infection: P75 as a novel cytoadhesin candidate, which is also differentially upregulated in chronic infection; the MHO_2100 protein, a postulated invasin and the MHO_730-protein, a novel ecto-nuclease and domain of an ABC transporter, the function of which in chronic infection has still to be elucidated. Implementation of the M. hominis microarray strategy led to a comprehensive identification of to date unknown candidates for virulence factors at relevant stages of host cell infection.	[Henrich, Birgit; Kretzmer, Freya] Heinrich Heine Univ Duesseldorf, Fac Med, Inst Med Microbiol, Dusseldorf, Germany; [Henrich, Birgit; Kretzmer, Freya] Heinrich Heine Univ Duesseldorf, Fac Med, Hosp Hyg, Dusseldorf, Germany; [Kretzmer, Freya; Deenen, Rene; Koehrer, Karl] Heinrich Heine Univ Duesseldorf, Fac Med, Biol & Med Res Ctr BMFZ, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Henrich, B (corresponding author), Heinrich Heine Univ Duesseldorf, Fac Med, Inst Med Microbiol, Dusseldorf, Germany.; Henrich, B (corresponding author), Heinrich Heine Univ Duesseldorf, Fac Med, Hosp Hyg, Dusseldorf, Germany.	birgit.henrich@uni-duesseldorf.de			Research Commission of the Medical Faculty, Heinrich-Heine University Dusseldorf	Research Commission of the Medical Faculty, Heinrich-Heine University Dusseldorf	The authors BH and KK received specific funding for this study by the Research Commission of the Medical Faculty, Heinrich-Heine University Dusseldorf.	Aktories K, 2011, FEBS J, V278, P4526, DOI 10.1111/j.1742-4658.2011.08113.x; Allen-Daniels MJ, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.01.032; Barykova YA, 2011, ONCOTARGET, V2, P289; Bent ZW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077834; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cacciotto C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057775; Calcutt MJ, 2015, GENOME ANNOUNC, V3; Degrange S, 2008, ANTIMICROB AGENTS CH, V52, P742, DOI 10.1128/AAC.00960-07; Diaz-Garcia FJ, 2006, HUM REPROD, V21, P1591, DOI 10.1093/humrep/del032; Echenique-Rivera H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002027; Feng SH, 1999, MOL CELL BIOL, V19, P7995; Flori L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-123; Garzoni C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-171; Gdoura R, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-129; Goret J, 2016, FUTURE MICROBIOL, V11, P179, DOI 10.2217/fmb.15.130; Hallamaa KM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-124; Hegde S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163603; Henrich B, 1999, J BACTERIOL, V181, P4873, DOI 10.1128/JB.181.16.4873-4878.1999; HENRICH B, 1993, INFECT IMMUN, V61, P2945, DOI 10.1128/IAI.61.7.2945-2951.1993; Hertzen E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035218; Hopfe M, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-46; Hopfe M, 2011, INT J MED MICROBIOL, V301, P77; Hopfe M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054219; Hopfe M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-185; Hopfe M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-55; JENSEN LT, 1995, INFECT IMMUN, V63, P3336, DOI 10.1128/IAI.63.9.3336-3347.1995; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Khan S, 2016, TUMOR BIOL, V37, P10805, DOI 10.1007/s13277-016-4970-9; Khan SM, 2001, MOL BIOCHEM PARASIT, V117, P1, DOI 10.1016/S0166-6851(01)00333-4; Kitzerow A, 2001, MOL MICROBIOL, V41, P279, DOI 10.1046/j.1365-2958.2001.02524.x; Kitzerow A, 1999, J MED MICROBIOL, V48, P485, DOI 10.1099/00222615-48-5-485; Kwon AR, 2012, NUCLEIC ACIDS RES, V40, P4216, DOI 10.1093/nar/gkr1305; Li LB, 2010, J BACTERIOL, V192, P4876, DOI 10.1128/JB.00401-10; MacKenzie CR, 2010, INT J INFECT DIS, V14, pE307, DOI 10.1016/j.ijid.2010.02.2253; Madsen ML, 2008, INFECT IMMUN, V76, P658, DOI 10.1128/IAI.01291-07; McClure R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133982; Mendes JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145765; Mobius N, 2012, METHODS MOL BIOL, V903, P235, DOI 10.1007/978-1-61779-937-2_15; OLSON LD, 1993, J BACTERIOL, V175, P3224, DOI 10.1128/JB.175.10.3224-3227.1993; Pereyre S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000677; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ponting CP, 1997, PROTEIN SCI, V6, P459; Rabatinova A, 2013, J BACTERIOL, V195, P2603, DOI 10.1128/JB.00188-13; Ren D, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-263; Samolski I, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-217; Schmidt JA, 2007, J BACTERIOL, V189, P3414, DOI 10.1128/JB.01835-06; Skapski A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025291; Targosz A, 2006, J PHYSIOL PHARMACOL, V57, P265; TAYLORROBINSON D, 1991, INT J EXP PATHOL, V72, P705; Waites KB, 2005, CLIN MICROBIOL REV, V18, P757, DOI 10.1128/CMR.18.4.757-789.2005; Westermann AJ, 2012, NAT REV MICROBIOL, V10, P618, DOI 10.1038/nrmicro2852; Wium M, 2015, GENE, V558, P31, DOI 10.1016/j.gene.2014.12.036; Xu J, 2015, APPL MICROBIOL BIOT, V99, P1859, DOI 10.1007/s00253-014-6185-6; Xu WJ, 2016, METHODS MOL BIOL, V1361, P57, DOI 10.1007/978-1-4939-3079-1_3; ZHANG H, 2016, INT J MOL SCI, V17, DOI DOI 10.3390/IJMS17050628; Zhang QJ, 1997, MOL MICROBIOL, V25, P859, DOI 10.1111/j.1365-2958.1997.mmi509.x	57	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0181383	10.1371/journal.pone.0181383	http://dx.doi.org/10.1371/journal.pone.0181383			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753664	Green Published, gold, Green Submitted			2022-12-26	WOS:000406579300016
J	Kumar, S; Marriott, CE; Alhasawi, NF; Bone, AJ; Macfarlane, WM				Kumar, Sandeep; Marriott, Claire E.; Alhasawi, Nouf F.; Bone, Adrian J.; Macfarlane, Wendy M.			The role of tumour suppressor PDCD4 in beta cell death in hypoxia	PLOS ONE			English	Article							PANCREATIC-ISLETS; OXIDANT STRESS; NITRIC-OXIDE; EXPRESSION; APOPTOSIS; PROTEIN; CANCER; CARCINOMA; OXYGEN; TRANSPLANTATION	Objective Hypoxia is known to induce pancreatic beta cell dysfunction and apoptosis. Changes in Programmed Cell Death Gene 4 (PDCD4) expression have previously been linked with beta cell neogenesis and function. Our aim was to investigate the effects of hypoxia on cell viability, PDCD4 expression and subcellular localisation. Methods MIN6 beta cells and ARIP ductal cells were exposed to 1% (hypoxia) or 21% O-2 (normoxia) for 12 or 24 hours. MTT assay, HPI staining, scanning electron microscopy, western blotting and immunocytochemistry analyses were performed to determine the effect of hypoxia on cell viability, morphology and PDCD4 expression. Results 24 hour exposure to hypoxia resulted in similar to 70% loss of beta cell viability (P<0.001) compared to normoxia. Both HPI staining and SEM analysis demonstrated beta cell apoptosis and necrosis after 12 hours exposure to hypoxia. ARIP cells also displayed hypoxia-induced apoptosis and altered surface morphology after 24 hours, but no significant growth difference (p>0.05) was observed between hypoxic and normoxic conditions. Significantly higher expression of PDCD4 was observed in both beta cells (P< 0.001) and ductal (P< 0.01) cells under hypoxic conditions compared to controls. PDCD4 expression was localised to the cytoplasm of both beta cells and ductal cells, with no observed effects of hypoxia, normoxia or serum free conditions on intracellular shuttling of PDCD4. Conclusion These findings indicate that hypoxia-induced expression of PDCD4 is associated with increased beta cell death and suggests that PDCD4 may be an important factor in regulating beta cell survival during hypoxic stress.	[Kumar, Sandeep; Marriott, Claire E.; Alhasawi, Nouf F.; Bone, Adrian J.; Macfarlane, Wendy M.] Univ Brighton, Sch Pharm & Biomol Sci, Diabet Res Grp, Brighton, E Sussex, England	University of Brighton	Macfarlane, WM (corresponding author), Univ Brighton, Sch Pharm & Biomol Sci, Diabet Res Grp, Brighton, E Sussex, England.	w.m.macfarlane@brighton.ac.uk	Bone, Adrian/AAI-4575-2021		Diabetes Research Group, University of Brighton; Kuwaiti Cultural Office; Diabetes Research Group, University of Brighton, UK	Diabetes Research Group, University of Brighton; Kuwaiti Cultural Office; Diabetes Research Group, University of Brighton, UK	SK was funded by the Diabetes Research Group, University of Brighton. NFA was funded by the Kuwaiti Cultural Office. The Kuwaiti Cultural Office had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.; SK was supported by the Diabetes Research Group, University of Brighton, UK.	Allgayer H, 2010, CRIT REV ONCOL HEMAT, V73, P185, DOI 10.1016/j.critrevonc.2009.09.001; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bohm M, 2003, ONCOGENE, V22, P4905, DOI 10.1038/sj.onc.1206710; Brissova M, 2008, DIABETES, V57, P2269, DOI 10.2337/db08-0814; Carinci F, 2005, INT J IMMUNOPATH PH, V18, P513, DOI 10.1177/039463200501800311; Carlsson PO, 2011, UPSALA J MED SCI, V116, P1, DOI 10.3109/03009734.2010.548609; Carlsson PO, 1998, DIABETES, V47, P1027, DOI 10.2337/diabetes.47.7.1027; Carlsson PO, 2002, J CLIN ENDOCR METAB, V87, P5418, DOI 10.1210/jc.2002-020728; Chauhan D, 2002, ONCOGENE, V21, P1346, DOI 10.1038/sj.onc.1205205; Chen Y, 2003, J PATHOL, V200, P640, DOI 10.1002/path.1378; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Fang WY, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-32; Fassan M, 2011, VIRCHOWS ARCH, V458, P413, DOI 10.1007/s00428-011-1046-5; Ferris WF, 2011, PANCREAS, V40, P61, DOI 10.1097/MPA.0b013e3181f5f1ab; Gao F, 2007, ONCOL REP, V17, P123; Goke A, 2002, BIOCHEM BIOPH RES CO, V297, P78, DOI 10.1016/S0006-291X(02)02129-0; Goke R, 2004, AM J PHYSIOL-CELL PH, V287, pC1541, DOI 10.1152/ajpcell.00025.2004; Guo PT, 2013, ONCOL REP, V29, P1007, DOI 10.3892/or.2013.2232; Guo Xiaoling, 2011, Genes Cancer, V2, P818, DOI 10.1177/1947601911431082; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Hans- Jurgen Rode P. D., DORIS EISEL INGE FRO, P174; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hering BJ, 2004, AM J TRANSPLANT, V4, P390, DOI 10.1046/j.1600-6143.2003.00351.x; Hwang SK, 2007, GENE THER, V14, P1353, DOI 10.1038/sj.gt.3302983; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Johnson JD, 2010, ADV EXP MED BIOL, V654, P447, DOI 10.1007/978-90-481-3271-3_19; Lankat-Buttgereit B, 2008, APOPTOSIS, V13, P157, DOI 10.1007/s10495-007-0153-x; Lankat-Buttgereit B, 2009, BIOL CELL, V101, P309, DOI 10.1042/BC20080191; Lau J, 2009, CURR OPIN ORGAN TRAN, V14, P688, DOI 10.1097/MOT.0b013e32833239ff; Lazard D, 2012, DIABETES-METAB RES, V28, P475, DOI 10.1002/dmrr.2294; Leupold JH, 2007, ONCOGENE, V26, P4550, DOI 10.1038/sj.onc.1210234; MATSUHASHI S, 1987, EXP CELL RES, V170, P351, DOI 10.1016/0014-4827(87)90312-0; Matsuhashi S, 2007, EXP DERMATOL, V16, P179, DOI 10.1111/j.1600-0625.2006.00531.x; Mohazzab-H KM, 2000, ADV EXP MED BIOL, V475, P249; Mudduluru G, 2007, CANCER-AM CANCER SOC, V110, P1697, DOI 10.1002/cncr.22983; Oleinick NL, 2002, PHOTOCH PHOTOBIO SCI, V1, P1, DOI 10.1039/b108586g; Olsson R, 2011, DIABETES, V60, P2350, DOI 10.2337/db09-0490; Rao GN, 2000, J BIOL CHEM, V275, P16993, DOI 10.1074/jbc.275.22.16993; Ruan QG, 2011, P NATL ACAD SCI USA, V108, P12030, DOI 10.1073/pnas.1101450108; Said SI, 2000, FREE RADICAL BIO MED, V28, P1300, DOI 10.1016/S0891-5849(00)00289-6; Sato Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194738; Shibahara K, 1995, GENE, V166, P297, DOI 10.1016/0378-1119(95)00607-9; Silver K, 2001, PANCREAS, V22, P141, DOI 10.1097/00006676-200103000-00006; Tan XD, 2000, J CELL SCI, V113, P2149; Wang N, 2013, EXP PHYSIOL, V98, P1376, DOI 10.1113/expphysiol.2013.072454; Wang Q, 2013, DIABETES, V62, P4132, DOI 10.2337/db13-0097; Wei N, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-70; Wen YH, 2007, ONCOL REP, V18, P1387; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2006, MOL CELL BIOL, V26, P1297, DOI 10.1128/MCB.26.4.1297-1306.2006; Zhang CJ, 2000, BIOCHEM PHARMACOL, V59, P203, DOI 10.1016/S0006-2952(99)00324-X; Zhang D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.240; ZHANG N, 2004, DIABETES, V53	53	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181235	10.1371/journal.pone.0181235	http://dx.doi.org/10.1371/journal.pone.0181235			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750063	Green Published, gold, Green Submitted			2022-12-26	WOS:000406575700033
J	Li, LH; Ju, TC; Hsieh, CY; Dong, WC; Chen, WT; Hua, KF; Chen, WJ				Li, Lan-Hui; Ju, Tz-Chuen; Hsieh, Chih-Yu; Dong, Wei-Chih; Chen, Wan-Tze; Hua, Kuo-Feng; Chen, Wei-Jung			A synthetic cationic antimicrobial peptide inhibits inflammatory response and the NLRP3 inflammasome by neutralizing LPS and ATP	PLOS ONE			English	Article							NF-KAPPA-B; HOST-DEFENSE PEPTIDES; PROTEIN-KINASE-C; CELL-LINE; APOPTOSIS; LL-37; LIPOPOLYSACCHARIDE; SUPPRESSION; MECHANISMS; EXPRESSION	Antimicrobial peptides (AMPs) are one of the most important defense mechanisms against bacterial infections in insects, plants, non-mammalian vertebrates, and mammals. In the present study, a class of synthetic AMPs was evaluated for anti-inflammatory activity. One cationic AMP, GW-A2, demonstrated the ability to inhibit the expression levels of nitric oxide (NO), inducible NO synthase (iNOS), cyclooxygenase-2 (COX-2), tumor necrosis factor-a (TNF-alpha) and interleukin-6 (IL-6) in lipopolysaccharide (LPS)-activated macrophages. GW-A2 reduced LPS-induced increases in the phosphorylation of mitogen-activated protein kinase and protein kinase C-alpha/delta and the activation of NF-kappa B. GW-A2 also inhibited NLRP3 inflammasome activation induced by LPS and ATP. Furthermore, in the mice injected with LPS, GW-A2 reduced (1) the concentration of IL-1 beta, IL-6 and TNF-alpha in the serum; (2) the concentration of TNF-alpha in the peritoneal lavage; (3) the expression levels of iNOS, COX-2 and NLRP3 in the liver and lung; (4) the infiltration of polymorphonuclear neutrophils in the liver and lung. The underlying mechanisms for the anti-inflammatory activity of GW-A2 were found to be partially due to LPS and ATP neutralization. These results provide insights into how GW-A2 inhibits inflammation and the NLRP3 inflammasome and provide a foundation for the design of rational therapeutics for inflammation-related diseases.	[Li, Lan-Hui] Taipei City Hosp, Lisen Chinese Med & Kunming Branch, Dept Lab Med, Taipei, Taiwan; [Ju, Tz-Chuen] St Marys Jr Coll Med Nursing & Management, Dept Nursing, Ilan, Taiwan; [Hsieh, Chih-Yu; Dong, Wei-Chih; Chen, Wan-Tze; Hua, Kuo-Feng; Chen, Wei-Jung] Natl Ilan Univ, Dept Biotechnol & Anim Sci, Ilan, Taiwan; [Hua, Kuo-Feng] Natl Def Med Ctr, Triserv Gen Hosp, Dept Pathol, Taipei, Taiwan	Taipei City Hospital; National Ilan University; National Defense Medical Center; Tri-Service General Hospital	Hua, KF; Chen, WJ (corresponding author), Natl Ilan Univ, Dept Biotechnol & Anim Sci, Ilan, Taiwan.; Hua, KF (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Pathol, Taipei, Taiwan.	kuofenghua@gmail.com; wjchen@niu.edu.tw	Hsieh, Chih-Yu/GWQ-8343-2022; JU, TZCHUEN/ABD-6081-2021; Chen, Wei-Jung Chen/B-4910-2012	JU, TZCHUEN/0000-0003-2968-4138; Hsieh, Chih-Yu/0000-0001-9770-6779; Hua, Kuo-Feng/0000-0001-8436-8299	 [MOST 105-2628-B-197-001-MY3]		Funding provided by MOST 105-2628-B-197-001-MY3; https://www.most.gov.tw/.	Baeuerle PA, 1998, CELL, V95, P729, DOI 10.1016/S0092-8674(00)81694-3; Bhattacharjya S, 2016, CURR TOP MED CHEM, V16, P4, DOI 10.2174/1568026615666150703121943; Bradshaw JP, 2003, BIODRUGS, V17, P233, DOI 10.2165/00063030-200317040-00002; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brown KL, 2011, J IMMUNOL, V186, P5497, DOI 10.4049/jimmunol.1002508; Chai H, 2014, INT J MED CHEM, V2014, DOI 10.1155/2014/809283; Chao LK, 2010, J AGR FOOD CHEM, V58, P3472, DOI 10.1021/jf904207m; Chen YLS, 2012, PEPTIDES, V36, P257, DOI 10.1016/j.peptides.2012.05.011; Chiu Y, 2011, J APPL MICROBIOL, V110, P80, DOI 10.1111/j.1365-2672.2010.04856.x; Chou HT, 2008, INT J ANTIMICROB AG, V32, P130, DOI 10.1016/j.ijantimicag.2008.04.003; Chou HT, 2010, PEPTIDES, V31, P1811, DOI 10.1016/j.peptides.2010.06.021; Chu HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126390; Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550; Dowling JK, 2012, CRIT REV BIOCHEM MOL, V47, P424, DOI 10.3109/10409238.2012.694844; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Gordon YJ, 2005, CURR EYE RES, V30, P505, DOI 10.1080/02713680590968637; Guzman-Rodriguez JJ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/735087; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hilchie AL, 2013, NAT CHEM BIOL, V9, P761, DOI [10.1038/NCHEMBIO.1393, 10.1038/nchembio.1393]; Hilpert K, 2010, ANTIMICROB AGENTS CH, V54, P4480, DOI 10.1128/AAC.01664-09; Hong CY, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2206557; Hu Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102767; Hua KF, 2015, INFECT IMMUN, V83, P3396, DOI 10.1128/IAI.00125-15; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Jimenez-Dalmaroni MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007411; Jin CC, 2010, J CLIN IMMUNOL, V30, P628, DOI 10.1007/s10875-010-9440-3; Kaconis Y, 2011, BIOPHYS J, V100, P2652, DOI 10.1016/j.bpj.2011.04.041; Lee M, 2015, BIOCHEM PHARMACOL, V94, P130, DOI [10.1016/j.bcP.2015.02.003, 10.1016/j.bcp.2015.02.003]; Liao PC, 2013, INFLAMM RES, V62, P89, DOI 10.1007/s00011-012-0555-2; Liao PC, 2010, J AGR FOOD CHEM, V58, P10445, DOI 10.1021/jf102812t; Mansour SC, 2014, TRENDS IMMUNOL, V35, P443, DOI 10.1016/j.it.2014.07.004; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mookherjee N, 2009, J IMMUNOL, V183, P2688, DOI 10.4049/jimmunol.0802586; Nagaoka I, 2004, INFLAMM RES, V53, P609, DOI 10.1007/s00011-004-1300-2; Ogryzko NV, 2014, DIS MODEL MECH, V7, P259, DOI 10.1242/dmm.013029; Pan WR, 2013, J DAIRY SCI, V96, P7511, DOI 10.3168/jds.2013-7285; Pan WR, 2015, MOL CELL BIOCHEM, V400, P77, DOI 10.1007/s11010-014-2264-3; Rekha RS, 2015, AUTOPHAGY, V11, P1688, DOI 10.1080/15548627.2015.1075110; Ryder MP, 2014, COLLOID SURFACE B, V120, P81, DOI 10.1016/j.colsurfb.2014.05.004; Schmidtchen A, 2015, J COLLOID INTERF SCI, V449, P136, DOI 10.1016/j.jcis.2014.11.024; Schuerholz T, 2012, CRIT CARE, V16, DOI 10.1186/cc11220; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Scott MG, 2000, CRIT REV IMMUNOL, V20, P407; Shen CJ, 2010, J APPL MICROBIOL, V108, P1398, DOI 10.1111/j.1365-2672.2009.04544.x; Shih CC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163690; Shim DW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126871; Sun J, 2015, IMMUNITY, V43, P304, DOI 10.1016/j.immuni.2015.07.013; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tripathi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124706; Tsai WC, 2015, J APPL MICROBIOL, V118, P27, DOI 10.1111/jam.12672; Tsai YL, 2017, SCI REP-UK, V7, DOI 10.1038/srep41123; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wertenbruch S, 2015, DIGESTION, V91, P307, DOI 10.1159/000368304; Yang FL, 2011, J BIOL CHEM, V286, P21041, DOI 10.1074/jbc.M111.222091; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zeytun A, 2010, CRIT REV IMMUNOL, V30, P53, DOI 10.1615/CritRevImmunol.v30.i1.40	57	26	26	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0182057	10.1371/journal.pone.0182057	http://dx.doi.org/10.1371/journal.pone.0182057			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750089	Green Submitted, Green Published, gold			2022-12-26	WOS:000406575700126
J	Xu, FF; Wang, KY; Wang, N; Li, GQ; Liu, DH				Xu, Fangfang; Wang, Kevin Yueju; Wang, Nan; Li, Gangqiang; Liu, Dehu			Modified human glucagon-like peptide-1 (GLP-1) produced in E-coli has a long-acting therapeutic effect in type 2 diabetic mice	PLOS ONE			English	Article							ALBUMIN FUSION PROTEIN; IN-VIVO; PICHIA-PASTORIS; EXPRESSION; MELLITUS; ANALOG; CONSTRUCTION; PURIFICATION; BL21(DE3); IV	Glucagon-like peptide 1 (GLP-1) is a very potent insulinotropic hormone secreted into the blood stream after eating. Thus, it has potential to be used in therapeutic treatment of diabetes. The half-life of GLP-1, however, is very short due to its rapid cleavage by dipeptidyl peptidase IV (DPP-IV). This presents a great challenge if it is to be used as a therapeutic drug. GLP-1, like many other small peptides, is commonly produced through chemical synthesis, but is limited by cost and product quantity. In order to overcome these problems, a sequence encoding a six codon-optimized tandem repeats of modified GLP-1 was constructed and expressed in the E. coli to produce a protease-resistant protein, 6xmGLP-1. The purified recombinant 6xmGLP-1, with a yield of approximately 20 mg/L, could be digested with trypsin to obtain single peptides. The single mGLP-1 peptides significantly stimulated the proliferation of a mouse pancreatic beta cell line, MIN6. The recombinant peptide also greatly improved the oral glucose tolerance test of mice, exerted a positive glucoregulatory effect, and most notably had a glucose lowering effect for as long as 16.7 hours in mice altered to create a type 2 diabetic condition and exerted a positive glucoregulatory effect in db/db mice. These results indicate that recombinant 6xmGLP-1 has great potential to be used as an effective and cost-efficient drug for the treatment of type 2 diabetes.	[Xu, Fangfang; Wang, Nan; Li, Gangqiang; Liu, Dehu] Chinese Acad Agr Sci, Inst Biotechnol Res, Beijing, Peoples R China; [Wang, Kevin Yueju] Northeastern State Univ, Nat Sci Dept, Broken Arrow, OK USA	Chinese Academy of Agricultural Sciences	Liu, DH (corresponding author), Chinese Acad Agr Sci, Inst Biotechnol Res, Beijing, Peoples R China.	liudehu2006@126.com			National Biotechnology Development Plan [2016ZX08005-004]; Researcher Foundation of the Chinese Academy of Agricultural Sciences	National Biotechnology Development Plan; Researcher Foundation of the Chinese Academy of Agricultural Sciences	This work was supported by the National Biotechnology Development Plan (2016ZX08005-004), and the Researcher Foundation of the Chinese Academy of Agricultural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERLE AM, 1994, BIOCHEM BIOPH RES CO, V200, P102, DOI 10.1006/bbrc.1994.1420; BELL GI, 1983, NATURE, V304, P368, DOI 10.1038/304368a0; Brandsma M., 2009, Open Biotechnology Journal, V3, P57, DOI 10.2174/1874070700903010057; Chen P, 2007, BIOORG MED CHEM LETT, V17, P5853, DOI 10.1016/j.bmcl.2007.08.030; Dou WF, 2008, PROTEIN EXPRES PURIF, V61, P45, DOI 10.1016/j.pep.2008.04.012; Edwards CMB, 2005, ANN MED, V37, P314, DOI 10.1080/07853890510037400; Farilla L, 2003, ENDOCRINOLOGY, V144, P5149, DOI 10.1210/en.2003-0323; Gavin JR, 1997, DIABETES CARE, V20, P1183; GOKE B, 1995, DIGESTION, V56, P493, DOI 10.1159/000201282; GOKE R, 1993, J BIOL CHEM, V268, P19650; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Hou JH, 2007, BIOTECHNOL LETT, V29, P1439, DOI 10.1007/s10529-007-9427-1; Johnson LM, 2014, J AM CHEM SOC, V136, P12848, DOI 10.1021/ja507168t; Jomori T, 2008, WIPO Patent, Patent No. [056726, 2008056726]; KIEFFER TJ, 1995, ENDOCRINOLOGY, V136, P3585, DOI 10.1210/en.136.8.3585; Kong YL, 2016, ENZYME MICROB TECH, V82, P105, DOI 10.1016/j.enzmictec.2015.09.001; Kushwaha RN, 2015, CHEM BIOL DRUG DES, V85, P439, DOI 10.1111/cbdd.12426; Li Y, 2011, PEPTIDES, V32, P1303, DOI 10.1016/j.peptides.2011.04.001; Ma BC, 2013, CURR PHARM BIOTECHNO, V14, P985; Malik Dhirendra Kumar, 2007, Current Drug Delivery, V4, P141; Perfetti R, 2000, EUR J ENDOCRINOL, V143, P717, DOI 10.1530/eje.0.1430717; Qian K, 2015, BIOTECHNOL BIOPROC E, V20, P694, DOI 10.1007/s12257-014-0818-6; Reedtz- Runge S, 2016, United States Patent, Patent No. [9498534, 20169498534]; Stoffers DA, 2000, DIABETES, V49, P741, DOI 10.2337/diabetes.49.5.741; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Tu PP, 2015, CURR PHARM BIOTECHNO, V16, P564, DOI 10.2174/138920101606150407114815; VonWK Reichetzeder C, 2014, CURR OPIN NEPHROL HY, V23, P54; Wu Ri, 2015, Yichuan, V37, P183, DOI 10.16288/j.yczz.14-206; Xu FF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171601; Zimmet P, 2016, NAT REV ENDOCRINOL, V12, P616, DOI 10.1038/nrendo.2016.105	30	3	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181939	10.1371/journal.pone.0181939	http://dx.doi.org/10.1371/journal.pone.0181939			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750064	Green Published, Green Submitted, gold			2022-12-26	WOS:000406575700103
J	Fujishita, T; Kojima, Y; Kajino-Sakamoto, R; Taketo, MM; Aoki, M				Fujishita, T.; Kojima, Y.; Kajino-Sakamoto, R.; Taketo, M. M.; Aoki, M.			Tumor microenvironment confers mTOR inhibitor resistance in invasive intestinal adenocarcinoma	ONCOGENE			English	Article							RENAL-CELL CARCINOMA; APC(DELTA-716) MICE; ANTITUMOR-ACTIVITY; COLORECTAL-CANCER; KINASE INHIBITOR; POLYP FORMATION; BREAST-CANCER; AZD8055; THERAPY; GRB10	Mechanistic target of rapamycin (mTOR) complex 1 (mTORC1) is frequently activated in cancers and can be counteracted with the clinical mTORC1 inhibitors everolimus and temsirolimus. Although mTORC1 and dual mTORC1/2 inhibitors are currently under development to treat various malignancies, the emergence of drug resistance has proven to be a major complication. Using the cis-Apc/Smad4 mouse model of locally invasive intestinal adenocarcinoma, we show that administration of everolimus or the dual mTORC1/2 inhibitor AZD8055 significantly reduces the growth of intestinal tumors. In contrast, although everolimus treatment at earlier phase of tumor progression delayed invasion of the tumors, both inhibitors exhibited little effect on blocking invasion of the tumors when administered later in their progression. Biochemical and immunohistochemical analyses revealed that treatment of cis-Apc/Smad4 mice with everolimus or AZD8055 induced marked increases in epidermal growth factor receptor (EGFR) and MEK/ERK signaling in tumor epithelial and stromal cells, respectively. Notably, co-administration of AZD8055 and the EGFR inhibitor erlotinib or the MEK inhibitor trametinib was sufficient to suppress tumor invasion in cis-Apc/Smad4 mice. These data indicate that mTOR inhibitor resistance in invasive intestinal tumors involves feedback signaling from both cancer epithelial and stromal cells, highlighting the role of tumor microenvironment in drug resistance, and support that simultaneous inhibition of mTOR and EGFR or MEK may be more effective in treating colon cancer.	[Fujishita, T.; Kojima, Y.; Kajino-Sakamoto, R.; Aoki, M.] Aichi Canc Ctr, Div Mol Pathol, Res Inst, Nagoya, Aichi, Japan; [Fujishita, T.; Taketo, M. M.] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Sakyo Ku, Yoshida Konoe Cho, Kyoto, Japan; [Aoki, M.] Nagoya Univ, Grad Sch Med, Program Funct Construct Med, Dept Canc Genet, Nagoya, Aichi, Japan	Aichi Cancer Center; Kyoto University; Nagoya University	Aoki, M (corresponding author), Aichi Canc Ctr, Div Mol Pathol, Res Inst, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	msaoki@aichi-cc.jp	Aoki, Masahiro/A-5149-2016; Fujishita, Teruaki/O-1367-2019	Aoki, Masahiro/0000-0003-4316-9490; Fujishita, Teruaki/0000-0002-4397-2438	JSPS KAKENHI [24790382]; Third Term Comprehensive Control Research for Cancer from the Ministry of Health, Labour and Welfare; Yasuda Medical Foundation; Suzuken Memorial Foundation; Nagono Medical Foundation; Shimabara Science Promotion Foundation; Takeda Science Foundation; Princess Takamatsu Cancer Research Fund; Grants-in-Aid for Scientific Research [26111005] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Third Term Comprehensive Control Research for Cancer from the Ministry of Health, Labour and Welfare; Yasuda Medical Foundation; Suzuken Memorial Foundation; Nagono Medical Foundation; Shimabara Science Promotion Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Princess Takamatsu Cancer Research Fund; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank PM McSheehy for everolimus; M Oshima, T Kitamura, M Sonoshita, S Arimura, F Kakizaki, A Deguchi, K Sakuma and K Aoki for discussions; and R Mitsuya, M Tsuda, A Kojima, K Kobori and Y Goto for technical assistance. This work was supported by JSPS KAKENHI Grant Number 24790382 (to TF), Third Term Comprehensive Control Research for Cancer from the Ministry of Health, Labour and Welfare (to MA), The Yasuda Medical Foundation, Suzuken Memorial Foundation, Nagono Medical Foundation, The Shimabara Science Promotion Foundation (to TF), Takeda Science Foundation (to TF and MA), and Princess Takamatsu Cancer Research Fund (to MA).	Chen SM, 2014, INT J CANCER, V135, P2462, DOI 10.1002/ijc.28880; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; Easton JB, 2006, ONCOGENE, V25, P6436, DOI 10.1038/sj.onc.1209886; Fujishita T, 2008, P NATL ACAD SCI USA, V105, P13544, DOI 10.1073/pnas.0800041105; Fujishita T, 2015, CANCER SCI, V106, P692, DOI 10.1111/cas.12670; Fujishita T, 2011, GASTROENTEROLOGY, V140, P1556, DOI 10.1053/j.gastro.2011.02.007; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; He WM, 1998, J BIOL CHEM, V273, P6860, DOI 10.1074/jbc.273.12.6860; Herszenyi L, 2012, INT J MOL SCI, V13, P13240, DOI 10.3390/ijms131013240; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Holt SV, 2012, CANCER RES, V72, P1804, DOI 10.1158/0008-5472.CAN-11-1780; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Jiang Q, 2011, CANCER RES, V71, P4074, DOI 10.1158/0008-5472.CAN-10-3968; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kitamura T, 2007, NAT GENET, V39, P467, DOI 10.1038/ng1997; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Metcalfe C, 2010, CANCER RES, V70, P6629, DOI 10.1158/0008-5472.CAN-10-1616; Mohamed A, 2013, AM J PATHOL, V183, P1096, DOI 10.1016/j.ajpath.2013.07.005; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Oshima H, 2012, J GASTROENTEROL, V47, P97, DOI 10.1007/s00535-011-0523-6; OSHIMA M, 1995, P NATL ACAD SCI USA, V92, P4482, DOI 10.1073/pnas.92.10.4482; Rodrik-Outmezguine VS, 2011, CANCER DISCOV, V1, P248, DOI 10.1158/2159-8290.CD-11-0085; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Wander SA, 2011, J CLIN INVEST, V121, P1231, DOI 10.1172/JCI44145; Wang Q, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0066417, 10.1371/journal.pone.0068894]; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484	28	25	25	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 16	2017	36	46					6480	6489		10.1038/onc.2017.242	http://dx.doi.org/10.1038/onc.2017.242			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FM9WN	28759045				2022-12-26	WOS:000415622900011
J	English, CA; Sherman, W; Meng, WL; Gierasch, LM				English, Charles A.; Sherman, Woody; Meng, Wenli; Gierasch, Lila M.			The Hsp70 interdomain linker is a dynamic switch that enables allosteric communication between two structured domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-BINDING DOMAIN; ALPHA-SYNUCLEIN AGGREGATION; MOLECULAR CHAPERONE DNAK; CONFORMATIONAL-CHANGES; SECONDARY STRUCTURE; CRYSTAL-STRUCTURE; PK(A) VALUES; AMINO-ACIDS; ATPASE; NUCLEOTIDE	Hsp70 molecular chaperones play key roles in cellular protein homeostasis by binding to exposed hydrophobic regions of incompletely folded or aggregated proteins. This crucial Hsp70 function relies on allosteric communication between two well-structured domains: an N-terminal nucleotide-binding domain (NBD) and a C-terminal substrate-binding domain (SBD), which are tethered by an interdomain linker. ATP or ADP binding to the NBD alters the substrate-binding affinity of the SBD, triggering functionally essential cycles of substrate binding and release. The interdomain linker is a well-structured participant in the interdomain interface in ATP-bound Hsp70s. By contrast, in the ADP-bound state, exemplified by the Escherichia coli Hsp70 DnaK, the interdomain linker is flexible. Hsp70 interdomain linker sequences are highly conserved; moreover, mutations in this region compromise interdomain allostery. To better understand the role of this region in Hsp70 allostery, we used molecular dynamics simulations to explore the conformational landscape of the interdomain linker in ADP-bound DnaK and supported our simulations by strategic experimental data. We found that while the interdomain linker samples many conformations, it behaves as three relatively ordered segments connected by hinges. As a consequence, the distances and orientations between the NBD and SBD are limited. Additionally, the C-terminal region of the linker forms previously unreported, transient interactions with the SBD, and the predominant linker-docking site is available in only one allosteric state, that with high affinity for substrate. This preferential binding implicates the interdomain linker as a dynamic allosteric switch. The linker-binding site on the SBD is a potential target for small molecule modulators of the Hsp70 allosteric cycle.	[English, Charles A.; Sherman, Woody; Meng, Wenli; Gierasch, Lila M.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Sherman, Woody; Gierasch, Lila M.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA; [Sherman, Woody] Schrodinger Inc, Cambridge, MA 02142 USA; [Sherman, Woody] Silicon Therapeut, 300 A St, Boston, MA 02210 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Gierasch, LM (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA.	gierasch@biochem.umass.edu	Sherman, Woody/AAF-6952-2020	Sherman, Woody/0000-0001-9079-1376	University of Massachusetts (Amherst, MA); Schrodinger Inc.; NIGMS, National Institutes of Health [5R01GM027616-37, 1R35GM118161-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118161, R01GM027616] Funding Source: NIH RePORTER	University of Massachusetts (Amherst, MA); Schrodinger Inc.; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the University of Massachusetts (Amherst, MA) and Schrodinger Inc. through an Academic-Industry Fellowship as well as NIGMS, National Institutes of Health, Grants 5R01GM027616-37 and 1R35GM118161-01 (to L.M.G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abisambra JF, 2012, J MOL BIOL, V421, P653, DOI 10.1016/j.jmb.2012.02.003; Ahmad A, 2010, INT J BIOL MACROMOL, V46, P275, DOI 10.1016/j.ijbiomac.2009.12.017; Aurora R, 1998, PROTEIN SCI, V7, P21, DOI 10.1002/pro.5560070103; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; Chiappori F, 2016, SCI REP-UK, V6, DOI 10.1038/srep23474; Chiappori F, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002844; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Eastman P, 2013, J CHEM THEORY COMPUT, V9, P461, DOI 10.1021/ct300857j; Eastman P, 2010, COMPUT SCI ENG, V12, P34, DOI 10.1109/MCSE.2010.27; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; FarzadFard F, 2008, J STRUCT BIOL, V161, P101, DOI 10.1016/j.jsb.2007.09.024; Gao XC, 2015, MOL CELL, V59, P781, DOI 10.1016/j.molcel.2015.07.012; Gierasch L. M., 2016, STRUCTURE ACTION MOL, P1; Goloudina AR, 2012, CANCER LETT, V325, P117, DOI 10.1016/j.canlet.2012.06.003; Han WJ, 2001, FEBS LETT, V497, P55, DOI 10.1016/S0014-5793(01)02435-8; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Jinwal UK, 2009, J NEUROSCI, V29, P12079, DOI 10.1523/JNEUROSCI.3345-09.2009; KAMATHLOEB AS, 1995, J BIOL CHEM, V270, P30051; Kathuria SV, 2016, PROTEIN SCI, V25, P662, DOI 10.1002/pro.2860; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Leu JIJ, 2014, ACS CHEM BIOL, V9, P2508, DOI 10.1021/cb500236y; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Mayer MP, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00058; McGibbon RT, 2015, BIOPHYS J, V109, P1528, DOI 10.1016/j.bpj.2015.08.015; McLean PJ, 2004, BIOCHEM BIOPH RES CO, V321, P665, DOI 10.1016/j.bbrc.2004.07.021; Murphy ME, 2013, CARCINOGENESIS, V34, P1181, DOI 10.1093/carcin/bgt111; Nylandsted J, 2000, ANN NY ACAD SCI, V926, P122; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Penkler D, 2017, J CHEM INF MODEL, V57, P1359, DOI 10.1021/acs.jcim.6b00775; Piana S, 2011, BIOPHYS J, V100, pL47, DOI 10.1016/j.bpj.2011.03.051; Qi RF, 2013, NAT STRUCT MOL BIOL, V20, P900, DOI 10.1038/nsmb.2583; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; Rousaki A, 2011, J MOL BIOL, V411, P614, DOI 10.1016/j.jmb.2011.06.003; Smock RG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.65; Stetz G, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005299; Stetz G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143752; Swain JF, 2006, J BIOL CHEM, V281, P1605, DOI 10.1074/jbc.M509356200; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; SWINDELLS MB, 1995, NAT STRUCT BIOL, V2, P596, DOI 10.1038/nsb0795-596; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Torrance GM, 2009, J MOL BIOL, V385, P1076, DOI 10.1016/j.jmb.2008.11.007; Vogel M, 2006, J BIOL CHEM, V281, P38705, DOI 10.1074/jbc.M609020200; Wang H, 1998, BIOCHEMISTRY-US, V37, P7929, DOI 10.1021/bi9800855; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Yang J, 2015, STRUCTURE, V23, P2191, DOI 10.1016/j.str.2015.10.012; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002	54	41	41	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14765	14774		10.1074/jbc.M117.789313	http://dx.doi.org/10.1074/jbc.M117.789313			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28754691	Green Published, hybrid			2022-12-26	WOS:000409902100005
J	Etti, IC; Abdullah, R; Kadir, A; Hashim, NM; Yeap, SK; Imam, MU; Ramli, F; Malami, I; Lam, KL; Etti, U; Waziri, P; Rahman, M				Etti, Imaobong Christopher; Abdullah, Rasedee; Kadir, Arifah; Hashim, Najihah Mohd; Yeap, Swee Keong; Imam, Mustapha Umar; Ramli, Faiqah; Malami, Ibrahim; Lam, Kian Lim; Etti, Ubong; Waziri, Peter; Rahman, Marsitoh			The molecular mechanism of the anticancer effect of Artonin E in MDA-MB 231 triple negative breast cancer cells	PLOS ONE			English	Article							IN-VITRO; APOPTOSIS; DEATH; CYCLE; EXPRESSION; SURVIVAL; GROWTH; DNA; PROLIFERATION; INHIBITION	Nature has provided us with a wide spectrum of disease healing phytochemicals like Artonin E, obtained from the root bark of Artocarpus elasticus. This molecule had been predicted to be drug-like, possessing unique medicinal properties. Despite strides made in chemotherapy, prognosis of the heterogenous aggressive triple negative breast cancer is still poor. This study was conducted to investigate the mechanism of inhibition of Artonin E, a prenylated flavonoid on MDA-MB 231 triple negative breast cancer cell, with a view of mitigating the hallmarks displayed by these tumors. The anti-proliferative effect, mode of cell death and the mechanism of apoptosis induction were investigated. Artonin E, was seen to effectively relinquish MDA-MB 231 breast cancer cells of their apoptosis evading capacity, causing a half-maximal growth inhibition at low concentrations (14.3, 13.9 and 9.8 mu M) after the tested time points (24, 48 and 72 hours), respectively. The mode of cell death was observed to be apoptosis with defined characteristics. Artonin E was seen to induce the activation of both extrinsic and intrinsic caspases initiators of apoptosis. It also enhanced the release of total reactive oxygen species which polarized the mitochondrial membrane, compounding the release of cytochrome c. Gene expression studies revealed the upregulation of TNF-related apoptosis inducing ligand and proapoptotic genes with down regulation of anti-apoptotic genes and proteins. A G2/M cell cycle arrest was also observed and was attributed to the observed upregulation of p21 independent of the p53 status. Interestingly, livin, a new member of the inhibitors of apoptosis was confirmed to be significantly repressed. In all, Artonin E showed the potential as a promising candidate to combat the aggressive triple negative breast cancer.	[Etti, Imaobong Christopher] Univ Putra Malaysia, Fac Vet Med, Pharmacol & Toxicol, Serdang, Malaysia; [Etti, Imaobong Christopher] Univ Uyo, Dept Pharmacol & Toxicol, Uyo, Nigeria; [Abdullah, Rasedee] Univ Putra Malaysia, Fac Vet Med, Dept Vet Pathol & Microbiol, Serdang, Malaysia; [Kadir, Arifah] Dept Vet Preclin Sci, Fac Vet Med, Dept Vet Preclin Sci, Selangor, Malaysia; [Hashim, Najihah Mohd; Rahman, Marsitoh] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia; [Yeap, Swee Keong] Univ Putra Malaysia, Inst Biosci, Lab Vaccine & Immunotherapeut, Serdang, Malaysia; [Imam, Mustapha Umar] Zhengzhou Univ, Sch Publ Hlth, Zhengzhou, Henan, Peoples R China; [Ramli, Faiqah] Univ Technol Malaysia, Inst Bioprod Dev, Johor Baharu, Malaysia; [Malami, Ibrahim; Waziri, Peter] Univ Putra Malaysia, Inst Biosci, MAKNA Canc Res Lab, Serdang, Malaysia; [Lam, Kian Lim] Univ Tunku Abdul Rahman, Fac Med & Hlth Sci, Selangor, Malaysia; [Etti, Ubong] Obafemi Awolowo Univ, Dept Biochem, Ife, Nigeria	Universiti Putra Malaysia; University of Uyo; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Malaya; Universiti Putra Malaysia; Zhengzhou University; Universiti Teknologi Malaysia; Universiti Putra Malaysia; Universiti Tunku Abdul Rahman (UTAR); Obafemi Awolowo University	Etti, IC (corresponding author), Univ Putra Malaysia, Fac Vet Med, Pharmacol & Toxicol, Serdang, Malaysia.; Etti, IC (corresponding author), Univ Uyo, Dept Pharmacol & Toxicol, Uyo, Nigeria.; Abdullah, R (corresponding author), Univ Putra Malaysia, Fac Vet Med, Dept Vet Pathol & Microbiol, Serdang, Malaysia.	ettiimaobong@gmail.com; rasedee@upm.edu.my	Rasedee, Abdullah/E-9119-2013; Hashim, Najihah Mohd/J-5508-2015; Yeap, Swee Keong/H-9285-2013; Imam, Mustapha U/K-3490-2012; Malami, Ibrahim/C-4513-2019; Etti, Imaobong/AAE-4969-2022	Rasedee, Abdullah/0000-0001-6625-508X; Hashim, Najihah Mohd/0000-0003-1133-7998; Yeap, Swee Keong/0000-0002-4736-0674; Imam, Mustapha U/0000-0001-9888-4809; Malami, Ibrahim/0000-0001-9271-6927; 	Ministry of Science, Technology and Innovation Malaysia [5450742]	Ministry of Science, Technology and Innovation Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	This study was supported financially by the Ministry of Science, Technology and Innovation Malaysia (Vote No. 5450742).	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Abu N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105244; Alexandre J, 2006, INT J CANCER, V119, P41, DOI 10.1002/ijc.21685; Althuis MD, 2003, BRIT J CANCER, V88, P50, DOI 10.1038/sj.bjc.6600691; Anand P, 2008, PHARM RES-DORDR, V25, P2097, DOI 10.1007/s11095-008-9661-9; Brauchle E, 2014, SCI REP-UK, V4, DOI 10.1038/srep04698; Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Carou MC, 2015, ACTA HISTOCHEM, V117, P92, DOI 10.1016/j.acthis.2014.11.006; Coughlin SS, 2009, CANCER EPIDEMIOL, V33, P315, DOI 10.1016/j.canep.2009.10.003; Crown J, 2012, ANN ONCOL, V23, P56, DOI 10.1093/annonc/mds196; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; EASTON DF, 1993, AM J HUM GENET, V52, P678; Eliassen AH, 2006, JAMA-J AM MED ASSOC, V296, P193, DOI 10.1001/jama.296.2.193; Emi M, 2005, BREAST CANCER RES, V7, pR940, DOI 10.1186/bcr1323; Etti I, 2016, MOLECULES, V21, DOI 10.3390/molecules21070839; Ferlay J, GLOBOCAN 2012 V1 0 C; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Gerl R, 2005, CARCINOGENESIS, V26, P263, DOI 10.1093/carcin/bgh283; Gluz O, 2009, ANN ONCOL, V20, P1913, DOI 10.1093/annonc/mdp492; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Haglund C, 2012, CANCER CHEMOTH PHARM, V69, P697, DOI 10.1007/s00280-011-1746-1; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hassan M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/150845; Hepworth SJ, 1999, PHYS MED BIOL, V44, P1875, DOI 10.1088/0031-9155/44/8/302; Jin HS, 2006, BIOCHEM J, V399, P335, DOI 10.1042/BJ20060612; Jolly SP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162825; Laurent A, 2005, CANCER RES, V65, P948; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Lin YS, 2005, INT J CANCER, V116, P779, DOI 10.1002/ijc.20980; Logue SE, 2009, NAT PROTOC, V4, P1383, DOI 10.1038/nprot.2009.143; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Mcilwain DR, 2016, COLD SPRING HARB PER, V24, P1; McPherson K, 2000, BMJ-BRIT MED J, V321, P624, DOI 10.1136/bmj.321.7261.624; Mingo-Sion AM, 2004, ONCOGENE, V23, P596, DOI 10.1038/sj.onc.1207147; Mistry P, 2004, J BIOL CHEM, V279, P1482, DOI 10.1074/jbc.M310413200; Molina-Cruz A, 2012, P NATL ACAD SCI USA, V109, pE1957, DOI 10.1073/pnas.1121183109; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Musthapa I., 2010, Medicinal Plants, V2, P157; Nagata S, 2003, CELL DEATH DIFFER, V10, P108, DOI 10.1038/sj.cdd.4401161; Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055; Obexer P, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00197; Ou JM, 2014, INT J ONCOL, V44, P276, DOI 10.3892/ijo.2013.2171; Park DJ, 1998, BIOTECHNIQUES, V24, P558, DOI 10.2144/98244bm07; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Rayner BS, 2006, J NEUROCHEM, V97, P211, DOI 10.1111/j.1471-4159.2006.03726.x; REDDY GR, 1991, BIOCHEM PHARMACOL, V41, P115, DOI 10.1016/0006-2952(91)90018-Z; Samie N, 2016, SCI REP-UK, V6, DOI 10.1038/srep24172; Shen YQ, 2013, INT J MOL SCI, V14, P13093, DOI 10.3390/ijms140713093; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Song Y, 2014, J MED PLANT HERBAL T, V2, P6; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wafa K, 2015, AUSTIN J PHARM THERA, V3, P1067; Wang YH, 2004, J NAT PROD, V67, P757, DOI 10.1021/np030467y; Wurstle ML, 2012, EXP CELL RES, V318, P1213, DOI 10.1016/j.yexcr.2012.02.013; Yang YL, 2010, LEUKEMIA RES, V34, P18, DOI 10.1016/j.leukres.2009.07.023; Yeung MC, 2002, BIOTECHNIQUES, V33, P734, DOI 10.2144/02334bm03; Zajmi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128157	60	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182357	10.1371/journal.pone.0182357	http://dx.doi.org/10.1371/journal.pone.0182357			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771532	Green Published, Green Submitted, gold			2022-12-26	WOS:000406853600096
J	Pinter, M; Haupt, L; Hucke, F; Bota, S; Bucsics, T; Trauner, M; Peck-Radosavljevic, M; Sieghart, W				Pinter, Matthias; Haupt, Lukas; Hucke, Florian; Bota, Simona; Bucsics, Theresa; Trauner, Michael; Peck-Radosavljevic, Markus; Sieghart, Wolfgang			The impact of thyroid hormones on patients with hepatocellular carcinoma	PLOS ONE			English	Article							NONTHYROIDAL ILLNESS SYNDROME; FATTY LIVER-DISEASE; HYPOTHYROIDISM; RISK; DYSFUNCTION; CANCER; TRIIODOTHYRONINE; PROLIFERATION; ASSOCIATION; REGRESSION	Background & aims Hypothyroidism has recently been proposed as predisposing factor for HCC development. However, the role of thyroid hormones (TH) in established HCC is largely unclear. We investigated the impact of TH on clinical characteristics and prognosis of HCC patients. Methods Of 838 patients diagnosed with nonsurgical HCC at the Division of Gastroenterology and Hepatology/Medical University of Vienna between 1992 and 2012, 667 patients fulfilled the inclusion criteria. The associations of thyroid function tests with patient, liver, and tumor characteristics as well as their impact on overall survival (OS) were investigated. Results Thyroid hormone substitution was more often observed in patients with low thyroid-stimulating hormone (TSH) concentration and in patients with elevated free tetraiodthyronine (fT4). Patients with high TSH (>3.77uU/ml) concentrations had larger tumors, while the opposite was true for patients with low TSH (<0.44uU/ml) concentrations. Subjects with elevated fT4 (>1.66ng/dl) were more likely to have elevated CRP. While TSH was only associated with OS in univariate analysis (<= 1.7 vs. >1.7uU/ml, median OS (95%CI), 12.3 (8.9-15.7 months) vs. 7.3 months (5.4-9.2 months); p = 0.003), fT(4) (<= 1.66 vs. >1.66ng/dl, median OS (95% CI), 10.6 (7.5-13.6 months) vs. 3.3 months (2.2-4.3 months); p = 0.007) remained an independent prognostic factor for OS (HR (95% CI) for fT(4)>1.66ng/dl, 2.1 (1.3-3.3); p = 0.002) in multivariate analysis. Conclusions TSH and fT(4) were associated with prognostic factors of HCC (i.e., tumor size, CRP level). Elevated fT(4) concentrations were independently associated with poor prognosis in HCC. Further studies are needed to characterize the role of TH in HCC in detail.	[Pinter, Matthias; Haupt, Lukas; Hucke, Florian; Bota, Simona; Bucsics, Theresa; Trauner, Michael; Peck-Radosavljevic, Markus; Sieghart, Wolfgang] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria; [Pinter, Matthias; Hucke, Florian; Bota, Simona; Bucsics, Theresa; Peck-Radosavljevic, Markus; Sieghart, Wolfgang] Liver Canc HCC Study Grp Vienna, Vienna, Austria; [Hucke, Florian; Bota, Simona; Peck-Radosavljevic, Markus] Klinikum Klagenfurt Worthersee, Dept Gastroenterol & Hepatol Endocrinol & Nephrol, Klagenfurt, Austria	Medical University of Vienna	Sieghart, W (corresponding author), Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria.; Sieghart, W (corresponding author), Liver Canc HCC Study Grp Vienna, Vienna, Austria.	wolfgang.sieghart@meduniwien.ac.at		Trauner, Michael/0000-0002-1275-6425; Mullner-Bucsics, Theresa/0000-0003-3901-4111; Pinter, Matthias/0000-0002-7260-532X	Austrian Science Funds (FWF) [J 3747-B28]	Austrian Science Funds (FWF)(Austrian Science Fund (FWF))	M.P. was supported by an Erwin-Schroedinger Fellowship by the Austrian Science Funds (FWF; project number: J 3747-B28).	Ahmadieh H, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/725410; Antonelli A, 2004, AM J MED, V117, P10, DOI 10.1016/j.amjmed.2004.01.023; Asvold BO, 2009, J CLIN ENDOCR METAB, V94, P5023, DOI 10.1210/jc.2009-1180; Biondi B, 2010, J CLIN ENDOCR METAB, V95, P3614, DOI 10.1210/jc.2010-1245; Brenta G, 2011, J THROID RES, V2011, DOI 10.4061/2011/152850; Brown AR, 2013, INT J MOL SCI, V14, P16240, DOI 10.3390/ijms140816240; Chen RN, 2008, ENDOCRINOLOGY, V149, P3817, DOI 10.1210/en.2007-0989; Chi HC, 2012, CELL DEATH DIFFER, V19, P1802, DOI 10.1038/cdd.2012.58; Chung GE, 2012, J HEPATOL, V57, P150, DOI 10.1016/j.jhep.2012.02.027; Cristofanilli M, 2005, CANCER-AM CANCER SOC, V103, P1122, DOI 10.1002/cncr.20881; El-Serag HB, 2004, GASTROENTEROLOGY, V126, P460, DOI 10.1053/j.gastro.2003.10.065; Eshraghian A, 2014, WORLD J GASTROENTERO, V20, P8102, DOI 10.3748/wjg.v20.i25.8102; Frau C, 2015, HEPATOLOGY, V61, P249, DOI 10.1002/hep.27399; Gonzalez-Sancho JM, 2003, CANCER LETT, V192, P121, DOI 10.1016/S0304-3835(02)00614-6; Hassan MM, 2009, HEPATOLOGY, V49, P1563, DOI 10.1002/hep.22793; Heimbach J, 2017, HEPATOLOGY; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Hucke F, 2011, WIEN KLIN WOCHENSCHR, V123, P542, DOI 10.1007/s00508-011-0033-9; Hulbert AJ, 2000, BIOL REV, V75, P519, DOI 10.1017/S146479310000556X; Larsson SC, 2007, BRIT J CANCER, V97, P1005, DOI 10.1038/sj.bjc.6603932; Ledda-Columbano GM, 2000, CANCER RES, V60, P603; Lehrer S, 2001, PROSTATE CANCER P D, V4, P232, DOI 10.1038/sj.pcan.4500542; Lin KH, 2000, ENDOCRINOLOGY, V141, P2540, DOI 10.1210/en.141.7.2540; Lin YH, 2015, J HEPATOL, V62, P1328, DOI 10.1016/j.jhep.2014.12.035; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Pagadala MR, 2012, DIGEST DIS SCI, V57, P528, DOI 10.1007/s10620-011-2006-2; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Perra A, 2016, ENDOCR-RELAT CANCER, V23, pR353, DOI 10.1530/ERC-16-0152; Perra A, 2009, HEPATOLOGY, V49, P1287, DOI 10.1002/hep.22750; PERROS P, 1995, DIABETIC MED, V12, P622, DOI 10.1111/j.1464-5491.1995.tb00553.x; Pinter M, 2016, ESMO OPEN, V1, DOI 10.1136/esmoopen-2016-000042; Pucci E., 2000, International Journal of Obesity, V24, pS109; Reddy A, 2007, CLIN GASTROENTEROL H, V5, P118, DOI 10.1016/j.cgh.2006.07.011; Riesenbeck LM, 2011, WORLD J UROL, V29, P807, DOI 10.1007/s00345-010-0627-2; Rodriguez-Torres M, 2008, ANN HEPATOL, V7, P72, DOI 10.1016/S1665-2681(19)31891-5; Rossi JF, 2015, CLIN CANCER RES, V21, P1248, DOI 10.1158/1078-0432.CCR-14-2291; Schmidinger M, 2011, CANCER-AM CANCER SOC, V117, P534, DOI 10.1002/cncr.25422; Sieghart W, 2013, HEPATOLOGY, V57, P2224, DOI 10.1002/hep.26057; Sinha RA, 2014, TRENDS ENDOCRIN MET, V25, P538, DOI 10.1016/j.tem.2014.07.001; Srivastava J, 2015, J BIOL CHEM, V290, P15549, DOI 10.1074/jbc.M115.649707; Tarantino G, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-89; Vyakaranam Sapna, 2014, Int J Health Sci Res, V4, P147; Wan SS, 2015, HEPATOLOGY, V62, P1304, DOI 10.1002/hep.27867; Warner MH, 2010, J ENDOCRINOL, V205, P1, DOI 10.1677/JOE-09-0412; Wu SM, 2011, ONCOGENE, V30, P2057, DOI 10.1038/onc.2010.585; Wu SM, 2013, CELL MOL LIFE SCI, V70, P1915, DOI 10.1007/s00018-012-1146-7	47	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0181878	10.1371/journal.pone.0181878	http://dx.doi.org/10.1371/journal.pone.0181878			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771610	gold, Green Published, Green Submitted			2022-12-26	WOS:000406853600042
J	Schenkman, KA; Carlbom, DJ; Bulger, EM; Ciesielski, WA; Fisk, DM; Sheehan, KL; Asplund, KM; Shaver, JM; Arakaki, LSL				Schenkman, Kenneth A.; Carlbom, David J.; Bulger, Eileen M.; Ciesielski, Wayne A.; Fisk, Dana M.; Sheehan, Kellie L.; Asplund, Karin M.; Shaver, Jeremy M.; Arakaki, Lorilee S. L.			Muscle oxygenation as an indicator of shock severity in patients with suspected severe sepsis or septic shock	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; RESUSCITATION; LACTATE; IMPACT	Purpose The aim of this pilot study was to evaluate the potential of a new noninvasive optical measurement of muscle oxygenation (MOx) to identify shock severity in patients with suspected sepsis. Methods We enrolled 51 adult patients in the emergency department (ED) who presented with possible sepsis using traditional Systematic Inflammatory Response Syndrome criteria or who triggered a "Code Sepsis." Noninvasive MOx measurements were made from the first dorsal interosseous muscles of the hand once potential sepsis/septic shock was identified, as soon as possible after admission to the ED. Shock severity was defined by concurrent systolic blood pressure, heart rate, and serum lactate levels. MOx was also measured in a control group of 17 healthy adults. Results Mean (+/- SD) MOx in the healthy control group was 91.0 +/- 5.5% (n = 17). Patients with mild, moderate, and severe shock had mean MOx values of 79.4 +/- 21.2%, 48.6 +/- 28.6%, and 42.2 +/- 4.7%, respectively. Mean MOx for the mild and moderate shock severity categories were statistically different from healthy controls and from each other based on two-sample t-tests (p < 0.05). Conclusions We demonstrate that noninvasive measurement of MOx was associated with clinical assessment of shock severity in suspected severe sepsis or septic shock. The ability of MOx to detect even mild septic shock has meaningful implications for emergency care, where decisions about triage and therapy must be made quickly and accurately. Future longitudinal studies may validate these findings and the value of MOx in monitoring patient status as treatment is administered.	[Schenkman, Kenneth A.; Ciesielski, Wayne A.; Fisk, Dana M.; Sheehan, Kellie L.; Arakaki, Lorilee S. L.] Univ Washington, Dept Pediat, Div Crit Care Med, Seattle, WA 98195 USA; [Schenkman, Kenneth A.; Asplund, Karin M.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Schenkman, Kenneth A.] Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA; [Carlbom, David J.] Univ Washington, Div Pulm & Crit Care, Dept Med, Seattle, WA 98195 USA; [Bulger, Eileen M.] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Shaver, Jeremy M.] Eigenvector Res Inc, Wenatchee, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Schenkman, KA (corresponding author), Univ Washington, Dept Pediat, Div Crit Care Med, Seattle, WA 98195 USA.; Schenkman, KA (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.; Schenkman, KA (corresponding author), Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA.	ken.schenkman@seattlechildrens.org		Shaver, Jeremy/0000-0002-4853-5130	Seattle Medic One Foundation; Wallace H. Coulter Foundation; Life Sciences Discovery Fund; University of Washington Center for Commercialization	Seattle Medic One Foundation; Wallace H. Coulter Foundation; Life Sciences Discovery Fund; University of Washington Center for Commercialization	Funding for this study was provided by grants from The Seattle Medic One Foundation, The Wallace H. Coulter Foundation, The Life Sciences Discovery Fund, and the University of Washington Center for Commercialization. Eigenvector Research, Inc. employs Jeremy M Shaver, who was a paid consultant by the University of Washington to help with development of our analytic algorithm, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2014, NEW ENGL J MED, DOI DOI 10.1056/NEJMoa1401602; Arakaki LSL, 2013, ANAL CHIM ACTA, V785, P27, DOI 10.1016/j.aca.2013.05.003; Bateman RM, 2003, CRIT CARE, V7, P359, DOI 10.1186/cc2353; Bickler PE, 2013, ANESTH ANALG, V117, P813, DOI 10.1213/ANE.0b013e318297d763; Carlbom DJ, 2007, CRIT CARE MED, V35, P2525, DOI 10.1097/01.ccm.0000298122.49245.d7; Chawla Lakhmir S, 2008, J Intensive Care Med, V23, P122, DOI 10.1177/0885066607312985; Davie SN, 2012, ANESTHESIOLOGY, V116, P834, DOI 10.1097/ALN.0b013e31824c00d7; De Backer D, 2013, CRIT CARE MED, V41, P791, DOI 10.1097/CCM.0b013e3182742e8b; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI DOI 10.1007/s00134-012-2769-8; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Ducrocq N, 2013, MINERVA ANESTESIOL, V79, P1049; Durandy Y, 2011, PERFUSION-UK, V26, P441, DOI 10.1177/0267659111408755; Georger JF, 2010, INTENS CARE MED, V36, P1882, DOI 10.1007/s00134-010-2013-3; Gomez H, 2014, SHOCK, V41, P3, DOI 10.1097/SHK.0000000000000052; Hirsch Jennifer C, 2010, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V13, P51, DOI 10.1053/j.pcsu.2010.01.005; Kjelland Colleen B, 2010, J Intensive Care Med, V25, P286, DOI 10.1177/0885066610371191; Lima A, 2011, CRIT CARE MED, V39, P1649, DOI 10.1097/CCM.0b013e3182186675; Lumley T, 2002, ANNU REV PUBL HEALTH, V23, P151, DOI 10.1146/annurev.publhealth.23.100901.140546; Martens H., 1992, MULTIVARIATE CALIBRA; Neto AS, 2014, J TRAUMA ACUTE CARE, V76, P226, DOI 10.1097/TA.0b013e3182a9221f; Parsikia A, 2014, SHOCK, V42, P199, DOI 10.1097/SHK.0000000000000208; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Shapiro NI, 2011, CRIT CARE, V15, DOI 10.1186/cc10463; Strehlow MC, 2010, EMERG MED CLIN N AM, V28, P57, DOI 10.1016/j.emc.2009.09.006; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; [No title captured]; [No title captured]; [No title captured]	29	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182351	10.1371/journal.pone.0182351	http://dx.doi.org/10.1371/journal.pone.0182351			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	28771567	gold, Green Submitted, Green Published			2022-12-26	WOS:000406853600095
J	Espinosa-Cueto, P; Magallanes-Puebla, A; Castellanos, C; Mancilla, R				Espinosa-Cueto, Patricia; Magallanes-Puebla, Alejandro; Castellanos, Carlos; Mancilla, Raul			Dendritic cells that phagocytose apoptotic macrophages loaded with mycobacterial antigens activate CD8 T cells via cross-presentation	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; TUBERCULOSIS; INFECTION; BLEBS; INTERLEUKIN-10; INDUCTION; INGESTION; DC	While homeostatic apoptosis is immunologically silent, macrophage apoptosis during Mycobacterium tuberculosis infection can potentially induce an immune response against the mycobacteria. To examine the role of dendritic cells in this response, macrophage apoptosis was induced by incubating the macrophage with cell wall extracts of mycobacteria expressing LpqH. The apoptogenic proteins of the cell wall extracts were engulfed by the macrophage and then were translocated from the cytosol to the nuclei of the dying cells. Dendritic cells that engulfed the apoptotic macrophages acquired an immunogenic phenotype that included upregulation of MHC-I, increased expression of the costimulatory molecules, CD40, CD80, and CD86, and increased production of IL-12, IL-10, TNF-alpha, and TGF-beta. In addition, the dendritic cells triggered a proliferative response of CD8(+) T cells with IFN-gamma production via cross-presentation. Taken together, these findings support a model in which phagocytosis of whole apoptotic cells carrying mycobacterial antigens promotes a potentially protective immune response.	[Espinosa-Cueto, Patricia; Magallanes-Puebla, Alejandro; Castellanos, Carlos; Mancilla, Raul] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico	Mancilla, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Mexico City, DF, Mexico.	mancilla@biomedicas.unam.mx	Magallanes-Puebla, Alejandro/GQI-0001-2022	Magallanes-Puebla, Alejandro/0000-0001-9679-4949	Consejo Nacional de Ciencia y Tecnologia in Mexico [41588-M]; National Institutes of Health Tuberculosis Research Materials (Colorado State University, Fort Collins, CO, USA) [NO1-AI-40091]	Consejo Nacional de Ciencia y Tecnologia in Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Institutes of Health Tuberculosis Research Materials (Colorado State University, Fort Collins, CO, USA)	This work was supported by Grant 41588-M and a Student grant (Registro 154208) from the Consejo Nacional de Ciencia y Tecnologia in Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A monoclonal antibody to LpqH was kindly donated by the National Institutes of Health Tuberculosis Research Materials (Contract NO1-AI-40091; Colorado State University, Fort Collins, CO, USA). We also thank Miguel Tapia for conducting the confocal microscopy studies.	Abebe M, 2010, EUR J IMMUNOL, V40, P291, DOI 10.1002/eji.200939856; Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Behar SM, 2011, MUCOSAL IMMUNOL, V4, P279, DOI 10.1038/mi.2011.3; Buendia B, 1999, J CELL SCI, V112, P1743; Cruz FM, 2017, ANNU REV IMMUNOL, V35, P149, DOI 10.1146/annurev-immunol-041015-055254; Desch AN, 2011, J EXP MED, V208, P1789, DOI 10.1084/jem.20110538; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fransen JH, 2009, AUTOIMMUNITY, V42, P325, DOI 10.1080/08916930902828049; Fransen JH, 2009, ARTHRITIS RHEUM-US, V60, P2304, DOI 10.1002/art.24719; Haeryfar SMM, 2004, J IMMUNOL, V173, P3581, DOI 10.4049/jimmunol.173.6.3581; HARRIS DP, 1991, J IMMUNOL, V147, P2706; Henderson RA, 1997, J IMMUNOL, V159, P635; Heufler C, 1996, EUR J IMMUNOL, V26, P659, DOI 10.1002/eji.1830260323; INABA K, 1993, J EXP MED, V178, P479, DOI 10.1084/jem.178.2.479; Inaba K, 2009, CURRENT PROTOCOLS IM; Ip WK, 2004, J IMMUNOL, V173, P189, DOI 10.4049/jimmunol.173.1.189; Jiang HR, 2002, J LEUKOCYTE BIOL, V72, P978; Keane J, 1997, INFECT IMMUN, V65, P298, DOI 10.1128/IAI.65.1.298-304.1997; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kita H, 2003, J AUTOIMMUN, V21, P175, DOI 10.1016/S0896-8411(03)00089-1; Koch F, 1996, J EXP MED, V184, P741, DOI 10.1084/jem.184.2.741; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Lin PL, 2015, SEMIN IMMUNOPATHOL, V37, P239, DOI 10.1007/s00281-015-0490-8; Maynard CL, 2008, IMMUNOL REV, V226, P219, DOI 10.1111/j.1600-065X.2008.00711.x; MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; Oddo M, 1998, J IMMUNOL, V160, P5448; Rodriguez A, 1999, NAT CELL BIOL, V1, P362, DOI 10.1038/14058; Ruben JM, 2014, CANCER IMMUNOL IMMUN, V63, P335, DOI 10.1007/s00262-013-1515-6; Sanchez A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/950503; Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906; Sly LM, 2003, J IMMUNOL, V170, P430, DOI 10.4049/jimmunol.170.1.430; Spadaro F, 2012, BLOOD, V119, P1407, DOI 10.1182/blood-2011-06-363564; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Velmurugan K, 2007, PLOS PATHOG, V3, P972, DOI 10.1371/journal.ppat.0030110; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Yamada Y, 2011, ARCH BIOCHEM BIOPHYS, V506, P188, DOI 10.1016/j.abb.2010.11.011	38	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182126	10.1371/journal.pone.0182126	http://dx.doi.org/10.1371/journal.pone.0182126			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767693	Green Published, gold, Green Submitted			2022-12-26	WOS:000406768200045
J	Harrison, SE; Harvey, MS; Cooper, SJB; Austin, AD; Rix, MG				Harrison, Sophie E.; Harvey, Mark S.; Cooper, Steve J. B.; Austin, Andrew D.; Rix, Michael G.			Across the Indian Ocean: A remarkable example of trans-oceanic dispersal in an austral mygalomorph spider	PLOS ONE			English	Article							MOLECULAR PHYLOGENETICS; GENUS MOGGRIDGEA; ARANEAE; BIOGEOGRAPHY; ANCIENT; MIGIDAE; ORIGIN; HEXATHELIDAE; VICARIANCE; EVOLUTION	The Migidae are a family of austral trapdoor spiders known to show a highly restricted and disjunct distribution pattern. Here, we aim to investigate the phylogeny and historical biogeography of the group, which was previously thought to be vicariant in origin, and examine the biogeographic origins of the genus Moggridgea using a dated multi-gene phylogeny. Moggridgea specimens were sampled from southern Australia and Africa, and Bertmainus was sampled from Western Australia. Sanger sequencing methods were used to generate a robust six marker molecular dataset consisting of the nuclear genes 18S rRNA, 28S rRNA, ITS rRNA, XPNPEP3 and H3 and the mitochondrial gene COI. Bayesian and Maximum Likelihood methods were used to analyse the dataset, and the key dispersal nodes were dated using BEAST. Based on our data, we demonstrate that Moggridgea rainbowi from Kangaroo Island, Australia is a valid member of the otherwise African genus Moggridgea. Molecular clock dating analyses show that the inter-specific divergence of M. rainbowi from African congeners is between 2.27-16.02 million years ago (Mya). This divergence date significantly post-dates the separation of Africa from Gondwana (95 Mya) and therefore does not support a vicariant origin for Australian Moggridgea. It also pre-dates human colonisation of Kangaroo Island, a result which is further supported by the intra-specific divergence date of 1.10-6.39 Mya between separate populations on Kangaroo Island. These analyses provide strong support for the hypothesis that Moggridgea colonised Australia via long-distance trans-Indian Ocean dispersal, representing the first such documented case in a mygalomorph spider.	[Harrison, Sophie E.; Cooper, Steve J. B.; Austin, Andrew D.; Rix, Michael G.] Univ Adelaide, Sch Biol Sci, Australian Ctr Evolutionary Biol & Biodivers, Adelaide, SA, Australia; [Harvey, Mark S.; Rix, Michael G.] Western Australian Museum, Dept Terr Zool, Welshpool Dc, WA, Australia; [Harvey, Mark S.] Univ Western Australia, Sch Biol, Crawley, WA, Australia; [Harvey, Mark S.] Edith Cowan Univ, Sch Nat Sci, Joondalup, WA, Australia; [Cooper, Steve J. B.] South Australian Museum, Evolutionary Biol Unit, North Terrace, Adelaide, SA, Australia; [Rix, Michael G.] Queensland Museum, Biodivers & Geosci Program, South Brisbane, Qld, Australia	University of Adelaide; Western Australian Museum; University of Western Australia; Edith Cowan University; South Australian Museum; Queensland Museum	Harrison, SE (corresponding author), Univ Adelaide, Sch Biol Sci, Australian Ctr Evolutionary Biol & Biodivers, Adelaide, SA, Australia.	sophie.e.harrison@adelaide.edu.au	Harvey, Mark/P-4265-2019	Harvey, Mark/0000-0003-1482-0109	Australian Biological Resources Study [CT212-07]; Bioplatforms Australia DNA Barcoding Project; Australian Research Council [LP120200092]; Nature Foundation of South Australia	Australian Biological Resources Study; Bioplatforms Australia DNA Barcoding Project; Australian Research Council(Australian Research Council); Nature Foundation of South Australia	This work was supported by Australian Biological Resources Study, https://www.environment.gov.au/science/abrs, grant number: CT212-07, author who received the funding: S.H.; Bioplatforms Australia DNA Barcoding Project, http://www.bioplatforms.com/, authors who received the funding: S.C., A.A.; The Australian Research Council, http://www.arc.gov.au/, grant number: LP120200092, authors who received the funding: A.A., S.C., M.R., M.H.; and The Nature Foundation of South Australia, https://www.naturefoundation.org.au/, author who received the funding: S.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUM DA, 1995, ANN MO BOT GARD, V82, P440, DOI 10.2307/2399893; Bell G, 1997, KANGAROO ISLAND THIS; Bond JE, 2006, MOL PHYLOGENET EVOL, V41, P70, DOI 10.1016/j.ympev.2006.04.026; Bond JE, 2014, CURR BIOL, V24, P1765, DOI 10.1016/j.cub.2014.06.034; Bond JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038753; Bond JE, 2001, MOL ECOL, V10, P899, DOI 10.1046/j.1365-294X.2001.01233.x; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Canals M, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00220; Ceccarelli S. F., 2016, PLOS ONE, V11; Churchill Tracey B., 1992, Memoirs of the Queensland Museum, V32, P9; Colgan DJ, 1998, AUST J; Cooper SJB, 2011, MOL ECOL, V20, P3219, DOI 10.1111/j.1365-294X.2011.05160.x; COYLE FA, 1985, J ARACHNOL, V13, P291; COYLE FA, 1983, J ARACHNOL, V11, P283; COYLE FA, 1994, J ARACHNOL, V22, P225; Crisp M, 2004, PHILOS T R SOC B, V359, P1551, DOI 10.1098/rstb.2004.1528; Darwin C, 1859, ORIGIN SPECIES MEANS; DAVIES M, 2002, NATURAL HIST KANGARO; de Queiroz A., 2014, MONKEYS VOYAGE IMPRO; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Ferretti N, 2012, SYST BIODIVERS, V10, P179, DOI 10.1080/14772000.2012.694375; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Framenau V. W., 2014, GUIDE SPIDERS AUSTR; Gamble T, 2011, J EVOLUTION BIOL, V24, P231, DOI 10.1111/j.1420-9101.2010.02184.x; Gillespie RG, 2002, ANNU REV ENTOMOL, V47, P595, DOI 10.1146/annurev.ento.47.091201.145244; Gillespie RG, 2012, TRENDS ECOL EVOL, V27, P47, DOI 10.1016/j.tree.2011.08.009; Giribet G, 2010, INVERTEBR SYST, V24, P1, DOI 10.1071/IS10009; GRISWOLD C E, 1987, Annals of the Natal Museum, V28, P1; Griswold Charles E., 2001, Occasional Papers California Academy of Sciences, V151, P1; Harrison SE, 2016, AUSTRAL ENTOMOL, V55, P208, DOI 10.1111/aen.12172; Harvey MS, 2002, INVERTEBR SYST, V16, P555, DOI 10.1071/IS02009; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HAYASHI M., 2015, BMC EVOLUTIONARY BIO, V15, P1, DOI DOI 10.1186/S12862-014-0274-0; Hendrixson BE, 2015, INSECT CONSERV DIVER, V8, P120, DOI 10.1111/icad.12089; Perez SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068029; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; LEGENDRE R, 1979, ANN BIOL-PARIS, V18, P37; MAIN B. Y., 1957, WEST AUSTRALIAN NAT, V5, P209; Main B.Y., 1978, Bulletin of the British Arachnological Society, V4, P161; Main B.Y., 1981, Monographiae Biologicae, V41, P853; MAIN BARBARA YORK, 1956, WEST AUSTRALIAN NAT, V5, P73; MAIN BY, 1991, J NAT HIST, V25, P383, DOI 10.1080/00222939100770271; McGlone MS, 2005, J BIOGEOGR, V32, P739, DOI 10.1111/j.1365-2699.2005.01278.x; Miller M.A., 2010, P GAT COMP ENV WORKS; Neall VE, 2008, PHILOS T R SOC B, V363, P3293, DOI 10.1098/rstb.2008.0119; NELSON G, 1978, Journal of the History of Biology, V11, P269, DOI 10.1007/BF00389302; Nelson G., 1981, SYSTEMATICS BIOGEORA; Opatova V, 2014, INVERTEBR SYST, V28, P361, DOI 10.1071/IS14004; Platnick N.I., 1981, Revue Arachnologique, V3, P85; PLATNICK NI, 1991, J NAT HIST, V25, P1083, DOI 10.1080/00222939100770701; PLATNICK NI, 1976, SYST ZOOL, V25, P101, DOI 10.2307/2412735; Rambaut A, 2010, FIGTREE V131; Rambaut A., 2014, TRACER V1 6; RAVEN RJ, 1985, B AM MUS NAT HIST, V182, P1; RAVEN RJ, 1986, J ARACHNOL, V14, P47; RAVEN RJ, 1980, J ARACHNOL, V8, P251; RAVEN RJ, 1984, AUST J ZOOL, V32, P379, DOI 10.1071/ZO9840379; Raven RJ, 1988, AM MUS NOVIT, V2929, P1; Rix MG, 2008, MOL PHYLOGENET EVOL, V46, P1031, DOI 10.1016/j.ympev.2007.11.001; Rix MG, 2017, MOL PHYLOGENET EVOL, V109, P302, DOI 10.1016/j.ympev.2017.01.008; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; ROEWER C.F., 1963, INSECTS MICRONESIA, V3, P104; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Saaristo Michael I., 2002, Phelsuma, V10, P1; Sanmartin I, 2004, SYST BIOL, V53, P216, DOI 10.1080/10635150490423430; Schluter T., 2008, GEOLOGICAL ATLAS AFR; Schwarz MP, 2006, SYST BIOL, V55, P31, DOI 10.1080/10635150500431148; Simon E., 1891, Proceedings of the Zoological Society, P549; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Yang ZH, 1996, TRENDS ECOL EVOL, V11, P367, DOI 10.1016/0169-5347(96)10041-0; Yoder AD, 1996, P NATL ACAD SCI USA, V93, P5122, DOI 10.1073/pnas.93.10.5122; Yoder AD, 2006, ANNU REV ECOL EVOL S, V37, P405, DOI 10.1146/annurev.ecolsys.37.091305.110239; York Main Barbara, 1993, Memoirs of the Queensland Museum, V33, P599	77	22	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0180139	10.1371/journal.pone.0180139	http://dx.doi.org/10.1371/journal.pone.0180139			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767648	Green Published, Green Submitted, gold			2022-12-26	WOS:000406768200006
J	Ngalesoni, F; Ruhago, G; Mayige, M; Oliveira, TC; Robberstad, B; Norheim, OF; Higashi, H				Ngalesoni, Frida; Ruhago, George; Mayige, Mary; Oliveira, Tiago Cravo; Robberstad, Bjarne; Norheim, Ole Frithjof; Higashi, Hideki			Cost-effectiveness analysis of population-based tobacco control strategies in the prevention of cardiovascular diseases in Tanzania	PLOS ONE			English	Article							SMOKING-CESSATION; CIGARETTE-SMOKING; REDUCING SMOKING; HEALTH; IMPACT; PREVALENCE; INDICATORS; TRENDS; TAXES	Background Tobacco consumption contributes significantly to the global burden of disease. The prevalence of smoking is estimated to be increasing in many low-income countries, including Tanzania, especially among women and youth. Even so, the implementation of tobacco control measures has been discouraging in the country. Efforts to foster investment in tobacco control are hindered by lack of evidence on what works and at what cost. Aims We aim to estimate the cost and cost-effectiveness of population-based tobacco control strategies in the prevention of cardiovascular diseases (CVD) in Tanzania. Materials and methods A cost-effectiveness analysis was performed using an Excel-based Markov model, from a governmental perspective. We employed an ingredient approach and step-down methodologies in the costing exercise following a government perspective. Epidemiological data and efficacy inputs were derived from the literature. We used disability-adjusted life years (DALYs) averted as the outcome measure. A probabilistic sensitivity analysis was carried out with Ersatz to incorporate uncertainties in the model parameters. Results Our model results showed that all five tobacco control strategies were very cost-effective since they fell below the ceiling ratio of one GDP per capita suggested by the WHO. Increase in tobacco taxes was the most cost-effective strategy, while a workplace smoking ban was the least cost-effective option, with a cost-effectiveness ratio of US$5 and US$267, respectively. Conclusions Even though all five interventions are deemed very cost-effective in the prevention of CVD in Tanzania, more research on budget impact analysis is required to further assess the government's ability to implement these interventions.	[Ngalesoni, Frida] Minist Hlth Community Dev Gender Elderly & Childr, Dar Es Salaam, Tanzania; [Ngalesoni, Frida; Norheim, Ole Frithjof] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Ruhago, George] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania; [Mayige, Mary] Tanzania Natl Inst Med Res, Dar Es Salaam, Tanzania; [Oliveira, Tiago Cravo] Inst Hlth Metr & Evaluat, Seattle, WA USA; [Robberstad, Bjarne] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Higashi, Hideki] Japan Int Cooperat Agcy, Lusaka, Zambia	University of Bergen; Muhimbili University of Health & Allied Sciences; National Institute of Medical Research; Institute for Health Metrics & Evaluation; University of Bergen	Ngalesoni, F (corresponding author), Minist Hlth Community Dev Gender Elderly & Childr, Dar Es Salaam, Tanzania.; Ngalesoni, F (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway.	fngalesoni@gmail.com	Norheim, Ole Frithjof/AAC-8771-2020; Higashi, Hideki/D-3797-2011; Mayige, Mary/GLU-6412-2022; Robberstad, Bjarne/AAG-9322-2020	Norheim, Ole Frithjof/0000-0002-5748-5956; Higashi, Hideki/0000-0002-5534-0905; Mayige, Mary/0000-0003-4861-7870; Robberstad, Bjarne/0000-0002-0708-2016; Ruhago, George Mugambage/0000-0001-7469-7822	Norwegian State Education Loan Fund (Statens Lakekassen); University of Bergen; Ministry of Health, Community Development, Gender, Elderly and Children, Tanzania	Norwegian State Education Loan Fund (Statens Lakekassen); University of Bergen; Ministry of Health, Community Development, Gender, Elderly and Children, Tanzania	Funded by Norwegian State Education Loan Fund (Statens Lakekassen), University of Bergen and the Ministry of Health, Community Development, Gender, Elderly and Children, Tanzania. The funders had no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2013, WHO GLOBAL HLTH OBSE; [Anonymous], 1985, THEORY PRACTICE ECON; [Anonymous], 2009, ERSATZ USER GUIDE; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Bank of Tanzania, 2012, FIN MARK INT FOR EXC; Bank of Tanzania, 2012, INT RAT STRUCT 2012; Bank W, 1999, DEV PRACTICE CURBING; Barendregt Jan J, 2003, Popul Health Metr, V1, P4, DOI 10.1186/1478-7954-1-4; Barendregt JJ, 1997, NEW ENGL J MED, V337, P1052, DOI 10.1056/NEJM199710093371506; Barendregt JJ, 2009, ERSATZ VER 1 3; Bilano V, 2015, LANCET, V385, P966, DOI 10.1016/S0140-6736(15)60264-1; Boutayeb Abdesslam, 2005, Int J Equity Health, V4, P2, DOI 10.1186/1475-9276-4-2; Bovet P, 2002, INT J EPIDEMIOL, V31, P240, DOI 10.1093/ije/31.1.240; Carreras G, 2011, EUROPEAN J PUBLIC HL; Carrin G, 2010, HLTH SYSTEMS POLICY; Chaloupka FJ, 2012, TOB CONTROL, V21, P172, DOI 10.1136/tobaccocontrol-2011-050417; Doran CM, 2010, ADDICT BEHAV, V35, P1089, DOI 10.1016/j.addbeh.2010.07.010; Drope J, 2011, TOBACCO CONTROL AFRI; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Edejer T, 2003, MAKING CHOICES HLTH; Ekpu VU, 2015, TOB USE INSIGHTS, V8, P1, DOI 10.4137/TUI.S15628; Ezzati M, 2004, COMP QUANTIFICATION; Farrelly MC, 2009, AM J PREV MED, V36, P379, DOI 10.1016/j.amepre.2009.01.019; Flessa S., 2009, COSTING HLTH CARE SE; Gartner CE, 2009, TOB CONTROL, V18, P183, DOI 10.1136/tc.2008.027615; Goodchild M, 2016, B WORLD HEALTH ORGAN, V94, P250, DOI 10.2471/BLT.15.164707; Gray A., 2011, APPL METHODS COST EF; Hammond D, 2004, CAN J PUBLIC HEALTH, V95, P201, DOI 10.1007/BF03403649; Hawkins SS, 2010, TOBACCO CONTROL; Higashi H, 2011, APPL HEALTH ECON HEA, V9, P183, DOI 10.2165/11539640-000000000-00000; Hoang Van Kinh, 2006, Health Res Policy Syst, V4, P6; Hyland A, 2006, HEALTH EDUC RES, V21, P348, DOI 10.1093/her/cyl048; Hyland A, 2009, EUR J PUBLIC HEALTH, V19, P198, DOI 10.1093/eurpub/ckn141; Institute of Health Metrics and Evaluation, 2013, GBD COMP GLOB DEATHS; Institute of Health Metrics and Evaluation, 2013, GBD COMP GLOB BOTH S; Kidane A, 2014, DEMAND CIGARETTES TA; Kids TF, 2015, TOBACCO CONTROL LAWS; Krol M, 2013, PHARMACOECONOMICS, V31, P537, DOI 10.1007/s40273-013-0056-3; Laxminarayan R, 2004, HEALTH ECON, V13, P1191, DOI 10.1002/hec.932; Levy David T, 2004, J Public Health Manag Pract, V10, P338; Levy DT, 2006, SOC SCI MED, V62, P1819, DOI 10.1016/j.socscimed.2005.08.043; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Liu YL, 2006, SOC SCI MED, V63, P2784, DOI 10.1016/j.socscimed.2006.06.019; Longo DR, 2001, TOB CONTROL, V10, P267, DOI 10.1136/tc.10.3.267; Mayige M, 2015, MAGNITUDE N IN PRESS; Mendez D, 1998, AM J EPIDEMIOL, V148, P249; Murray Christopher JL, 2003, Popul Health Metr, V1, P1, DOI 10.1186/1478-7954-1-1; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; National Bureau of Statistics, 2013, POP AG SEX; National bureau of Statistics (NBS), 2004, TANZ DEM HLTH SURV; National Bureau of Statistics (NBS) [Tanzania] & ICF Macro, 2010, TANZ DEM HLTH SURV; NBS (Tanzania National Bureau of Statistics), 2002, TANZ POP HOUS CENS 2; Network of African Science Academies, 2013, PREV TOB EP AFR CALL; Ortego M, 2012, BMJ-BRIT MED J, P344; Pampel F, 2008, SOC SCI MED, V66, P1772, DOI 10.1016/j.socscimed.2007.12.003; PATTEN CA, 1995, TOB CONTROL, V4, P36; Rasmussen SR, 2005, EUR J PUBLIC HEALTH, V15, P601, DOI 10.1093/eurpub/cki024; Sussman Steve, 2007, Nicotine Tob Res, V9 Suppl 3, pS447, DOI 10.1080/14622200701587078; United Republic of Tanzania, 2003, TOB PROD REG ACT; United Republic of Tanzania, 1970, TOB IMP TAX ACT; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Weatherly H, 2009, HEALTH POLICY, V93, P85, DOI 10.1016/j.healthpol.2009.07.012; WHO, 2010, WHO TECHNICAL MANUAL ON TOBACCO TAX ADMINISTRARTION, P1; WHO, 2015, TOB FREE IN TFI; WHO, 2002, HLTH REP 2002; WHO, 2011, SCAL ACT NONC DIS MU; Wilson LM, 2012, J ENV PUBLIC HLTH, P2012; Wipfli H, 2004, TOB CONTROL, V13, P433, DOI 10.1136/tc.2003.006106; World Bank, 2014, WORLD DEV IND 2014; World Health Organization, 2008, WHO REP GLOB TOB EP; World Health Organization, 2015, CHOOSING INT AR COST; World Health Organization, 2011, COSTS HLTH EFF COST; World Health Organization, 2010, PACK ESS NONC PEN DI; World Health Organization, 2015, FRAM CONV TOB CONTR; World Health Organization, 2012, WHO GLOB REP MORT AT; World Health Organization-WHO, 2013, WHO REP GLOB TOB EP	77	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182113	10.1371/journal.pone.0182113	http://dx.doi.org/10.1371/journal.pone.0182113			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC3VT	28767722	Green Published, Green Submitted, gold			2022-12-26	WOS:000406768200044
J	Rahman, MK; Rahman, MS				Rahman, Md. Khaledur; Rahman, M. Sohel			] CRISPRpred: A flexible and efficient tool for sgRNAs on-target activity prediction in CRISPR/Cas9 systems	PLOS ONE			English	Article							GENOME; DESIGN	The CRISPR/Cas9-sgRNA system has recently become a popular tool for genome editing and a very hot topic in the field of medical research. In this system, Cas9 protein is directed to a desired location for gene engineering and cleaves target DNA sequence which is complementary to a 20-nucleotide guide sequence found within the sgRNA. A lot of experimental efforts, ranging from in vivo selection to in silico modeling, have been made for efficient designing of sgRNAs in CRISPR/Cas9 system. In this article, we present a novel tool, called CRISPRpred, for efficient in silico prediction of sgRNAs on-target activity which is based on the applications of Support Vector Machine (SVM) model. To conduct experiments, we have used a benchmark dataset of 17 genes and 5310 guide sequences where there are only 20% true values. CRISPRpred achieves Area Under Receiver Operating Characteristics Curve (AUROC-Curve), Area Under Precision Recall Curve (AUPR-Curve) and maximum Matthews Correlation Coefficient (MCC) as 0.85, 0.56 and 0.48, respectively. Our tool shows approximately 5% improvement in AUPR-Curve and after analyzing all evaluation metrics, we find that CRISPRpred is better than the current state-of-the-art. CRISPRpred is enough flexible to extract relevant features and use them in a learning algorithm.	[Rahman, Md. Khaledur; Rahman, M. Sohel] Bangladesh Univ Engn & Technol, AlEDA Grp, Dept Comp Sci & Engn, Dhaka, Bangladesh; [Rahman, Md. Khaledur] United Int Univ, Dept Comp Sci & Engn, Dhaka, Bangladesh	Bangladesh University of Engineering & Technology (BUET); United International University (UIU)	Rahman, MK; Rahman, MS (corresponding author), Bangladesh Univ Engn & Technol, AlEDA Grp, Dept Comp Sci & Engn, Dhaka, Bangladesh.; Rahman, MK (corresponding author), United Int Univ, Dept Comp Sci & Engn, Dhaka, Bangladesh.	khaledur@cse.uiu.ac.bd; msrahman@cse.buet.ac.bd	Rahman, Mohammad Sohelur/AAJ-7376-2020; Rahman, Mohammad Saifur/GZM-5483-2022; Rahman, Khaledur/N-9843-2019	Rahman, Mohammad Sohelur/0000-0002-4489-2202; Rahman, Mohammad Saifur/0000-0002-9887-4456; Rahman, Md. Khaledur/0000-0002-0166-2992; Rahman, Md. Khaledur/0000-0002-8784-5406	INSPIRE Strategic Partnership Award	INSPIRE Strategic Partnership Award	This research work is part of an ongoing CASR research project of Bangladesh University of Engineering and Technology (BUET). It is also partially supported by an INSPIRE Strategic Partnership Award (M. Sohel Rahman), administered by British Council, Bangladesh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research work is part of an ongoing CASR research project of Bangladesh University of Engineering and Technology (BUET). It is also partially supported by an INSPIRE Strategic Partnership Award (M. Sohel Rahman), administered by British Council, Bangladesh. Authors would like to thank Dr. Miguel and Dr. Jennifer Listgarten for providing supporting documents and directions.	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Blin K, 2016, SYNTHETIC SYSTEMS BI; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Chari R, 2015, NAT METHODS, V12, P823, DOI [10.1038/NMETH.3473, 10.1038/nmeth.3473]; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davis J., 2006, P 23 INT C MACH LEAR, P233, DOI [10.1145/1143844.1143874, DOI 10.1145/1143844.1143874]; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Ho TT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1198; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kursa MB, J STAT SOFTWARE, V36; Liang G, 2016, SCI REPORTS, P6; Liu H, 2015, BIOINFORMATICS; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Montague TG, 2014, NUCL ACIDS RES; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Wong N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0784-0; Xiao A, 2014, BIOINFORMATICS, V30, P1180, DOI 10.1093/bioinformatics/btt764; Xie SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100448; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Zhu LHJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108424	34	40	43	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0181943	10.1371/journal.pone.0181943	http://dx.doi.org/10.1371/journal.pone.0181943			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767689	Green Published, Green Submitted, gold			2022-12-26	WOS:000406768200040
J	Ruzicka, M; Kulhanek, P; Radova, L; Cechova, A; Spackova, N; Fajkusova, L; Reblova, K				Ruzicka, Michal; Kulhanek, Petr; Radova, Lenka; Cechova, Andrea; Spackova, Nada; Fajkusova, Lenka; Reblova, Kamila			DNA mutation motifs in the genes associated with inherited diseases	PLOS ONE			English	Article							REPAIR PROTEIN MUTS; MISMATCH REPAIR; STRAND ASYMMETRIES; CONFORMATIONAL-CHANGES; BENDING PROPENSITY; METHYLATION; RECOGNITION; MECHANISMS; HOTSPOTS; COMPLEX	Mutations in human genes can be responsible for inherited genetic disorders and cancer. Mutations can arise due to environmental factors or spontaneously. It has been shown that certain DNA sequences are more prone to mutate. These sites are termed hotspots and exhibit a higher mutation frequency than expected by chance. In contrast, DNA sequences with lower mutation frequencies than expected by chance are termed coldspots. Mutation hotspots are usually derived from a mutation spectrum, which reflects particular population where an effect of a common ancestor plays a role. To detect coldspots/hotspots unaffected by population bias, we analysed the presence of germline mutations obtained from HGMD database in the 5-nucleotide segments repeatedly occurring in genes associated with common inherited disorders, in particular, the PAH, LDLR, CFTR, F8, and F9 genes. Statistically significant sequences (mutational motifs) rarely associated with mutations (coldspots) and frequently associated with mutations (hotspots) exhibited characteristic sequence patterns, e.g. coldspots contained purine tract while hotspots showed alternating purine-pyrimidine bases, often with the presence of CpG dinucleotide. Using molecular dynamics simulations and free energy calculations, we analysed the global bending properties of two selected coldspots and two hotspots with a G/T mismatch. We observed that the coldspots were inherently more flexible than the hotspots. We assume that this property might be critical for effective mismatch repair as DNA with a mutation recognized by MutS alpha protein is noticeably bent.	[Ruzicka, Michal; Kulhanek, Petr; Radova, Lenka; Cechova, Andrea; Reblova, Kamila] Masaryk Univ, CEITEC Cent European Inst Technol, Kamenice 5, Brno, Czech Republic; [Ruzicka, Michal; Spackova, Nada] Masaryk Univ, Fac Sci, Dept Condensed Matter Phys, Kotlarska 2, Brno, Czech Republic; [Kulhanek, Petr] Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, Kamenice 5, Brno, Czech Republic; [Fajkusova, Lenka] Univ Hosp Brno, Ctr Mol Biol & Gene Therapy, Jihlavska 20, Brno, Czech Republic; [Fajkusova, Lenka] Masaryk Univ, Jihlavska 20, Brno, Czech Republic	Masaryk University Brno; Masaryk University Brno; Masaryk University Brno; University Hospital Brno; Masaryk University Brno	Reblova, K (corresponding author), Masaryk Univ, CEITEC Cent European Inst Technol, Kamenice 5, Brno, Czech Republic.	kristina@physics.muni.cz	Kulhanek, Petr/ACQ-4620-2022; Fajkusova, Lenka/K-5217-2018; Špačková, Naďa/AAK-3532-2020; Kulhanek, Petr/D-6884-2012	Kulhanek, Petr/0000-0002-4152-6514; Kulhanek, Petr/0000-0002-4152-6514; Radova, Lenka/0000-0001-8103-148X	Grant Agency of the Czech Republic [GM16-11619S/2016]; Ministry of Education, Youth and Sports of the Czech Republic under the project CEITEC [LQ1601]; Ministry of Education, Youth and Sports from the Large Infrastructures for Research, Experimental Development and Innovations project "IT4Innovations National Supercomputing Center" [LM2015070]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic under the project CEITEC; Ministry of Education, Youth and Sports from the Large Infrastructures for Research, Experimental Development and Innovations project "IT4Innovations National Supercomputing Center"	This research was financially supported by Grant Agency of the Czech Republic (GM16-11619S/2016) and by the Ministry of Education, Youth and Sports of the Czech Republic under the project CEITEC 2020 (LQ1601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Computational resources were provided by the CESNET LM2015042 and the CERIT Scientific Cloud LM2015085, provided under the programme "Projects of Large Research, Development, and Innovations Infrastructures". This work was supported by The Ministry of Education, Youth and Sports from the Large Infrastructures for Research, Experimental Development and Innovations project "IT4Innovations National Supercomputing Center LM2015070".	Baarends WM, 2001, REPRODUCTION, V121, P31, DOI 10.1530/rep.0.1210031; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Brodie Of Brodie EB, 2005, PHYS REV LETT, V94; BRUKNER I, 1995, EMBO J, V14, P1812, DOI 10.1002/j.1460-2075.1995.tb07169.x; Buckova H, 2016, BRIT J DERMATOL, V174, P405, DOI 10.1111/bjd.13918; Case DA, 2014, AMBER 14; Chen CL, 2011, MOL BIOL EVOL, V28, P2327, DOI 10.1093/molbev/msr056; Chen JQ, 2009, MOL BIOL EVOL, V26, P1523, DOI 10.1093/molbev/msp063; Chien Yin-Hsiu, 2004, Hum Mutat, V23, P206, DOI 10.1002/humu.9215; Chiu YH, 2012, J HUM GENET, V57, P145, DOI 10.1038/jhg.2011.146; Chuzhanova NA, 2003, HUM MUTAT, V21, P28, DOI 10.1002/humu.10146; Cooper D. N., 1993, HUMAN GENE MUTATION; Cooper DN, 2011, HUM MUTAT, V32, P1075, DOI 10.1002/humu.21557; Cooper David N, 2010, Hum Genomics, V4, P406; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Darve E, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2829861; Drsata T, 2013, WILEY INTERDISCIPLIN, P355; Drsata T, 2014, NUCLEIC ACIDS RES, V42, P7383, DOI 10.1093/nar/gku338; Gabrielian A, 1996, FEBS LETT, V393, P65, DOI 10.1016/0014-5793(96)00855-1; Gorman J, 2007, MOL CELL, V28, P359, DOI 10.1016/j.molcel.2007.09.008; Gragg H, 2002, MOL CELL BIOL, V22, P8756, DOI 10.1128/MCB.22.24.8756-8762.2002; GRAUR D, 2000, FUNDAMENTALS MOL EVO; Grodecka L, 2014, GENE CHROMOSOME CANC, V53, P798, DOI 10.1002/gcc.22186; Grodecka L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089570; Groothuizen FS, 2015, ELIFE, V4, DOI 10.7554/eLife.06744; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hingorani MM, 2016, DNA REPAIR, V38, P24, DOI 10.1016/j.dnarep.2015.11.017; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ivani I, 2016, NAT METHODS, V13, P55, DOI [10.1038/NMETH.3658, 10.1038/nmeth.3658]; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2013, COLD SPRING HARBOR P, V5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Kass SU, 1997, CURR BIOL, V7, P157, DOI 10.1016/S0960-9822(97)70086-1; Krawczak M, 1998, AM J HUM GENET, V63, P474, DOI 10.1086/301965; Kroutil LC, 1996, BIOCHEMISTRY-US, V35, P1046, DOI 10.1021/bi952178h; Kulhanek P, 2013, PMFLIB A TOOLKIT FRE; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Lelievre T, 2008, NONLINEARITY, V21, P1155, DOI 10.1088/0951-7715/21/6/001; Locher KP, 2004, CURR OPIN STRUC BIOL, V14, P426, DOI 10.1016/j.sbi.2004.06.005; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; MODRICH P, 1991, ANNU REV GENET, V25, P229, DOI 10.1146/annurev.ge.25.120191.001305; Neuberger MS, 2003, TRENDS BIOCHEM SCI, V28, P305, DOI 10.1016/S0968-0004(03)00111-7; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Ollila J, 1996, FEBS LETT, V396, P119, DOI 10.1016/0014-5793(96)01075-7; Qiu RY, 2012, EMBO J, V31, P2528, DOI 10.1038/emboj.2012.95; Raiteri P, 2006, J PHYS CHEM B, V110, P3533, DOI 10.1021/jp054359r; Rogozin IB, 2003, MUTAT RES-REV MUTAT, V544, P65, DOI 10.1016/S1383-5742(03)00032-2; Rogozin Igor B., 2003, Briefings in Bioinformatics, V4, P210, DOI 10.1093/bib/4.3.210; Ruscio JZ, 2006, BIOPHYS J, V91, P4121, DOI 10.1529/biophysj.106.082099; Sharma A, 2013, J MOL BIOL, V425, P4192, DOI 10.1016/j.jmb.2013.08.011; Sharma M, 2013, J PHYS CHEM B, V117, P6194, DOI 10.1021/jp403127a; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; Thoma F, 1999, EMBO J, V18, P6585, DOI 10.1093/emboj/18.23.6585; Touchon M, 2005, P NATL ACAD SCI USA, V102, P9836, DOI 10.1073/pnas.0500577102; Touchon M, 2004, NUCLEIC ACIDS RES, V32, P4969, DOI 10.1093/nar/gkh823; Touchon M, 2003, FEBS LETT, V555, P579, DOI 10.1016/S0014-5793(03)01306-1; Tran HT, 1997, MOL CELL BIOL, V17, P2859, DOI 10.1128/MCB.17.5.2859; van der Heijden T, 2012, P NATL ACAD SCI USA, V109, pE2514, DOI 10.1073/pnas.1205659109; Wang H, 2003, P NATL ACAD SCI USA, V100, P14822, DOI 10.1073/pnas.2433654100; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018	64	12	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2017	12	8							e0182377	10.1371/journal.pone.0182377	http://dx.doi.org/10.1371/journal.pone.0182377			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VT	28767725	Green Submitted, Green Published, gold			2022-12-26	WOS:000406768200074
J	Lee, A; Cheng, KC; Liu, JR				Lee, An; Cheng, Kuan-Chen; Liu, Je-Ruei			Isolation and characterization of a Bacillus amyloliquefaciens strain with zearalenone removal ability and its probiotic potential	PLOS ONE			English	Article							FOOD; MYCOTOXIN; CEREUS; GROWTH; DETOXIFICATION; DEGRADATION; BINDING; SPP.; OCHRATOXIN; METABOLISM	Zearalenone (ZEN) is a non-steroidal estrogenic mycotoxin produced by Fusarium species, which has been shown to be associated with reproductive disorders in livestock, and to a lesser extent with hyperoestrogenic syndromes in humans. The aim of this study was to characterize a Bacillus amyloliquefaciens strain with ZEN removal ability. A pure culture of a strain designated LN isolated from moldy corn samples showed a high ZEN removal capability. Based on microscopic observations, biochemical characteristics, and phylogenetic analysis of the 16S rRNA gene sequence, LN was identified as B. amyloliquefaciens. After incubation of B. amyloliquefaciens LN in Luria-Bertani (LB) medium containing 3.5 ppm of ZEN, the ZEN concentration fell below the detection limit within 24 h. In ZEN-contaminated corn meal medium, B. amyloliquefaciens LN decreased ZEN concentration by 92% after 36 h of incubation. In phosphate-buffered saline (PBS) containing 5 ppm of ZEN, B. amyloliquefaciens LN reduced the ZEN concentration from 5 ppm to 3.28 ppm immediately after coming into contact with ZEN, and further reduced the ZEN concentration to 0.36 ppm after 4 h of incubation. The amounts of ZEN adsorbed by the cells of B. amyloliquefaciens LN did not increase with the extension of incubation time, indicating that B. amyloliquefaciens LN not only possessed ZEN adsorption ability, but also exhibited the ability to degrade ZEN. In addition, B. amyloliquefaciens LN was non-hemolytic, non-enterotoxin producing, and displayed probiotic characteristics including acidic tolerance, bile salt tolerance, and anti-pathogenic activities. These findings suggest that B. amyloliquefaciens LN has a potential to be used as a feed additive to reduce the concentrations of ZEN in feedstuffs.	[Lee, An; Cheng, Kuan-Chen] Natl Taiwan Univ, Grad Inst Food Sci & Technol, Taipei, Taiwan; [Lee, An; Cheng, Kuan-Chen; Liu, Je-Ruei] Natl Taiwan Univ, Inst Biotechnol, Taipei, Taiwan; [Liu, Je-Ruei] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan; [Liu, Je-Ruei] Acad Sinica, Agr Biotechnol Res Ctr, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan	Cheng, KC (corresponding author), Natl Taiwan Univ, Grad Inst Food Sci & Technol, Taipei, Taiwan.; Cheng, KC; Liu, JR (corresponding author), Natl Taiwan Univ, Inst Biotechnol, Taipei, Taiwan.; Liu, JR (corresponding author), Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan.; Liu, JR (corresponding author), Acad Sinica, Agr Biotechnol Res Ctr, Taipei, Taiwan.	kccheng@ntu.edu.tw; jrliu@ntu.edu.tw		LIU, JE-RUEI/0000-0002-2152-7536	National Taiwan University from the Ministry of Science and Technology [MOST 105-2313-B-002-042-MY3]; National Taiwan University from the Council of Agriculture, Executive Yuan, Republic of China [105AS-2.3.3-AD-U1, 106AS-2.3.3-AD-U1]	National Taiwan University from the Ministry of Science and Technology; National Taiwan University from the Council of Agriculture, Executive Yuan, Republic of China	This research was conducted using funds provided by National Taiwan University, grant MOST 105-2313-B-002-042-MY3 from the Ministry of Science and Technology, and grants 105AS-2.3.3-AD-U1 and 106AS-2.3.3-AD-U1 from the Council of Agriculture, Executive Yuan, Republic of China. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed ST, 2014, POULTRY SCI, V93, P1963, DOI 10.3382/ps.2013-03718; Altalhi A. D., 2007, American Journal of Biochemistry and Biotechnology, V3, P150; Altalhi AD, 2009, J HAZARD MATER, V161, P1166, DOI 10.1016/j.jhazmat.2008.04.068; [Anonymous], 2002, GUIDELINES EVALUATIO; Belcoeil PA, 2003, VET RES, V34, P737, DOI 10.1051/vetres:2003031; Bernardeau M, 2013, CLIN MICROBIOL INFEC, V19, P321, DOI 10.1111/1469-0691.12130; Biagi G., 2009, Biotechnology in Animal Husbandry, V25, P539; Boudergue C., 2009, EFSA SUPP PUBL, V6, P22, DOI [DOI 10.2903/SP.EFSA.2009.EN-22, 10.2903/sp.efsa.2009.EN-22]; Chang XJ, 2015, FOOD ADDIT CONTAM A, V32, P564, DOI 10.1080/19440049.2014.991948; Cho KJ, 2010, BIOTECHNOL LETT, V32, P1921, DOI 10.1007/s10529-010-0373-y; Datta AR, 2013, FOOD ADDIT CONTAM A, V30, P1437, DOI 10.1080/19440049.2012.728722; DERODRIGUEZ CAS, 1985, J PEDIATR-US, V107, P393, DOI 10.1016/S0022-3476(85)80513-8; Desjardins AE, 2007, INT J FOOD MICROBIOL, V119, P47, DOI 10.1016/j.ijfoodmicro.2007.07.024; El-Nezami H, 2004, J AGR FOOD CHEM, V52, P4577, DOI 10.1021/jf049924m; El-Nezami H, 2002, APPL ENVIRON MICROB, V68, P3545, DOI 10.1128/AEM.68.7.3545-3549.2002; Fontana L, 2013, BRIT J NUTR, V109, pS35, DOI 10.1017/S0007114512004011; From C, 2005, APPL ENVIRON MICROB, V71, P1178, DOI 10.1128/AEM.71.3.1178-1183.2005; Guinebretiere MH, 2002, J CLIN MICROBIOL, V40, P3053, DOI 10.1128/JCM.40.8.3053-3056.2002; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Haskard C, 2000, CHEM-BIOL INTERACT, V128, P39, DOI 10.1016/S0009-2797(00)00186-1; Hussein HS, 2001, TOXICOLOGY, V167, P101, DOI 10.1016/S0300-483X(01)00471-1; Islam VIH, 2011, PROBIOTICS ANTIMICRO, V3, P175, DOI 10.1007/s12602-011-9081-8; Jiang SZ, 2011, J ANIM SCI, V89, P3008, DOI 10.2527/jas.2010-3658; Jiang SZ, 2010, ASIAN AUSTRAL J ANIM, V23, P74; Jin LZ, 1998, LETT APPL MICROBIOL, V27, P183, DOI 10.1046/j.1472-765X.1998.00405.x; Kabak B, 2006, CRIT REV FOOD SCI, V46, P593, DOI 10.1080/10408390500436185; Kakeya H, 2002, BIOSCI BIOTECH BIOCH, V66, P2723, DOI 10.1271/bbb.66.2723; Kriszt R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043608; Larsen N, 2014, APPL MICROBIOL BIOT, V98, P1105, DOI 10.1007/s00253-013-5343-6; Li Y, 2015, POULTRY SCI, V94, P1504, DOI 10.3382/ps/pev124; Lisboa MP, 2006, INT MICROBIOL, V9, P111; Liu JR, 2005, APPL ENVIRON MICROB, V71, P6769, DOI 10.1128/AEM.71.11.6769-6775.2005; Logan NA, 2012, J APPL MICROBIOL, V112, P417, DOI 10.1111/j.1365-2672.2011.05204.x; Malekinejad H, 2005, VET RES, V36, P799, DOI 10.1051/vetres:2005034; Malekinejad H, 2007, BIOL REPROD, V77, P840, DOI 10.1095/biolreprod.107.062711; Mateo JJ, 2001, J CHROMATOGR A, V918, P99, DOI 10.1016/S0021-9673(01)00704-X; Megharaj M, 1997, LETT APPL MICROBIOL, V24, P329, DOI 10.1046/j.1472-765X.1997.00053.x; Molnar O, 2004, SYST APPL MICROBIOL, V27, P661, DOI 10.1078/0723202042369947; Montgomery D.C., 2012, DESIGN ANAL EXPT; Niderkorn V, 2009, J APPL MICROBIOL, V106, P977, DOI 10.1111/j.1365-2672.2008.04065.x; Ouoba LII, 2008, INT J FOOD MICROBIOL, V124, P224, DOI 10.1016/j.ijfoodmicro.2008.03.026; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pariza MW, 2015, REGUL TOXICOL PHARM, V73, P164, DOI 10.1016/j.yrtph.2015.07.003; Petchkongkaew A, 2008, J APPL MICROBIOL, V104, P1495, DOI 10.1111/j.1365-2672.2007.03700.x; Popiel D, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-82; PRIEST FG, 1987, INT J SYST BACTERIOL, V37, P69, DOI 10.1099/00207713-37-1-69; Richard JL, 2007, INT J FOOD MICROBIOL, V119, P3, DOI 10.1016/j.ijfoodmicro.2007.07.019; Rodrigues I, 2012, TOXINS, V4, P663, DOI 10.3390/toxins4090663; Siahmoshteh F, 2017, INT J FOOD MICROBIOL, V254, P47, DOI 10.1016/j.ijfoodmicro.2017.05.011; Takahashi-Ando N, 2002, BIOCHEM J, V365, P1, DOI 10.1042/BJ20020450; Tewari A, 2015, J FOOD SCI TECH MYS, V52, P2500, DOI 10.1007/s13197-014-1344-4; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tinyiro SE, 2011, FOLIA MICROBIOL, V56, P321, DOI 10.1007/s12223-011-0047-8; Vos P., 2009, BERGEYS MANUAL SYSTE, V3; Waldeck J, 2006, APPL ENVIRON MICROB, V72, P7879, DOI 10.1128/AEM.00938-06; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wu WJ, 2013, FOOD SCI BIOTECHNOL, V22, P433, DOI 10.1007/s10068-013-0098-5; Yi PJ, 2011, WORLD J MICROB BIOT, V27, P1035, DOI 10.1007/s11274-010-0548-7; Zinedine A, 2007, FOOD CHEM TOXICOL, V45, P1, DOI 10.1016/j.fct.2006.07.030	59	40	45	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2017	12	8							e0182220	10.1371/journal.pone.0182220	http://dx.doi.org/10.1371/journal.pone.0182220			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3VC	28763483	Green Submitted, Green Published, gold			2022-12-26	WOS:000406766500052
J	Porciani, A; Diop, M; Moiroux, N; Kadoke-Lambi, T; Cohuet, A; Chandre, F; Dormont, L; Pennetier, C				Porciani, Angelique; Diop, Malal; Moiroux, Nicolas; Kadoke-Lambi, Tatiana; Cohuet, Anna; Chandre, Fabrice; Dormont, Laurent; Pennetier, Cedric			Influence of pyrethroid-treated bed net on host seeking behavior of Anopheles gambiae s. s. carrying the kdr allele	PLOS ONE			English	Article							INSECTICIDE RESISTANCE; MALARIA VECTOR; AVOIDANCE; CULICIDAE; CHEMICALS; MOSQUITOS; RESPONSES; DIPTERA; IMPACT	The use of long lasting insecticide nets (LLINs) treated with pyrethroid is known for its major contribution in malaria control. However, LLINs are suspected to induce behavioral changes in malaria vectors, which may in turn drastically affect their efficacy against Plasmodium sp. transmission. In sub Saharan Africa, where malaria imposes the heaviest burden, the main malaria vectors are widely resistant to pyrethroids, the insecticide family used on LLINs, which also threatens LLIN efficiency. There is therefore a crucial need for deciphering how insecticide-impregnated materials might affect the host-seeking behavior of malaria vectors in regards to insecticide resistance. In this study, we explored the impact of permethrin-impregnated net on the host attractiveness for Anopheles gambiae mosquitoes, either susceptible to insecticides, or carrying the insecticide resistance conferring allele kdr. Groups of female mosquitoes were released in a dual-choice olfactometer and their movements towards an attractive odor source (a rabbit) protected by insecticide-treated (ITN) or untreated nets (UTN) were monitored. Kdr homozygous mosquitoes, resistant to insecticides, were more attracted by a host behind an ITN than an UTN, while the presence of insecticide on the net did not affect the choice of susceptible mosquitoes. These results suggest that permethrin-impregnated net is detectable by malaria vectors and that the kdr mutation impacts their response to a LLIN protected host. We discuss the implication of these results for malaria vector control.	[Porciani, Angelique; Diop, Malal; Pennetier, Cedric] UM1 UM2 CNRS 5290 IRD 224, MiVEGEC, IRD, Cotonou, Benin; [Porciani, Angelique; Diop, Malal; Kadoke-Lambi, Tatiana; Pennetier, Cedric] CREC, Cotonou, Benin; [Moiroux, Nicolas; Cohuet, Anna; Chandre, Fabrice] UM1 UM2 CNRS 5290 IRD 224, MiVEGEC, IRD, Montpellier, France; [Dormont, Laurent] CNRS, UMR 5175, CEFE, Montpellier, France	Institut de Recherche pour le Developpement (IRD); Entomological Research Center of Cotonou (CREC); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Porciani, A (corresponding author), UM1 UM2 CNRS 5290 IRD 224, MiVEGEC, IRD, Cotonou, Benin.; Porciani, A (corresponding author), CREC, Cotonou, Benin.	angelique.porciani@gmail.com	Moiroux, Nicolas/AFT-2925-2022; Chandre, Fabrice/Q-3429-2019; Diop, Malal M/AAF-9151-2020; Cohuet, Anna/B-2745-2017	Moiroux, Nicolas/0000-0001-6755-6167; Chandre, Fabrice/0000-0002-1994-9705; Diop, Malal/0000-0002-9985-158X; Cohuet, Anna/0000-0002-1876-5656; Porciani, Angelique/0000-0003-2816-1212; Pennetier, Cedric/0000-0002-3362-6371	Institut de recherche pour le developpement; French ministry of foreign affairs	Institut de recherche pour le developpement; French ministry of foreign affairs	Funded by Institut de recherche pour le developpement: student and experiment funding. French ministry of foreign affairs.	Achee NL, 2009, J AM MOSQUITO CONTR, V25, P156, DOI 10.2987/08-5831.1; Angioy AM, 2003, CHEM SENSES, V28, P279, DOI 10.1093/chemse/28.4.279; [Anonymous], 2019, GUID LAB FIELD TEST; [Anonymous], 2014, R LANG ENV STAT COMP; Berticat C, 2002, GENET RES, V79, P41, DOI 10.1017/S001667230100547X; Bohbot JD, 2011, MED VET ENTOMOL, V25, P436, DOI 10.1111/j.1365-2915.2011.00949.x; Bomann W., SAFE ARE PYRETHROID; Bouvier G, 2006, SCI TOTAL ENVIRON, V366, P74, DOI 10.1016/j.scitotenv.2005.08.016; Carde RT, 2010, OLFACTION VECTOR HOS; Chareonviriyaphap T, 1997, J AM MOSQUITO CONTR, V13, P171; Chareonviriyaphap T, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-280; Cohuet A, 2010, TRENDS PARASITOL, V26, P130, DOI 10.1016/j.pt.2009.12.001; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005; Corbel V, 2012, LANCET INFECT DIS; Corbel V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-113; Dekker T, 2001, PHYSIOL ENTOMOL, V26, P124, DOI 10.1046/j.1365-3032.2001.00225.x; Deletre E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082103; Diop MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121755; Djegbe A I, 2013, MODIFICATION PHYSIOL; Garrett-Jones C, 1969, B WHO, V40; GARRETTJONES C, 1980, B ENTOMOL RES, V70, P165, DOI 10.1017/S0007485300007422; Gatton ML, 2013, EVOLUTION, V67, P1218, DOI 10.1111/evo.12063; Geier M, 1999, ENTOMOL EXP APPL, V92, P9, DOI 10.1023/A:1003797623701; Georghiou GP., 1972, ANNU REV ECOL EVOL S, V3, P133, DOI DOI 10.1146/ANNUREV.ES.03.110172.001025; Gouagna L- C, 2009, AM J TROP MED HYG, P81; Grieco JP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000716; Guidobaldi F, 2014, J PHYSL PARIS; Hansson BS, 1999, INSECT OLFACTION, P125; LINDSAY SW, 1991, MED VET ENTOMOL, V5, P477, DOI 10.1111/j.1365-2915.1991.tb00576.x; Lockwood J.A., 1984, Bulletin of the Entomological Society of America, V30, P41; Malima RC, 2009, MED VET ENTOMOL, V23, P317, DOI 10.1111/j.1365-2915.2009.00837.x; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Miller JR, 2009, J ECON ENTOMOL, V102, P2056, DOI 10.1603/029.102.0606; Mitri C, 2015, MALARIA J, P14; Moiroux N, 2012, J INFECT DIS; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Ndiath MO, 2014, PLOS ONE, P9; Parker JEA, 2015, SCI REP-UK, V5, DOI 10.1038/srep13392; Platt N, 2015, HEREDITY, V115, P243, DOI 10.1038/hdy.2015.33; PLEASS RJ, 1993, B ENTOMOL RES, V83, P133, DOI 10.1017/S0007485300041870; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Siegert PY, 2009, J ECON ENTOMOL, V102, P2061, DOI 10.1603/029.102.0607; Takken W, 1997, ANN TROP MED PARASIT, V91, pS119, DOI 10.1080/00034989761427; Thomas MB, 2016, P NATL ACAD SCI USA, V113, P8900, DOI 10.1073/pnas.1609889113; Vais H, 2000, J GEN PHYSIOL, V115, P305, DOI 10.1085/jgp.115.3.305; Viana M, 2016, P NATL ACAD SCI USA, V113, P8975, DOI 10.1073/pnas.1603431113; Zaim M, 2000, MED VET ENTOMOL, V14, P1, DOI 10.1046/j.1365-2915.2000.00211.x	50	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0164518	10.1371/journal.pone.0164518	http://dx.doi.org/10.1371/journal.pone.0164518			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759566	Green Published, Green Submitted, gold			2022-12-26	WOS:000406761600001
J	Singh, KD; Zheng, X; Milstein, S; Keller, M; Roschitzki, B; Grossmann, J; Hengartner, MO				Singh, Kapil Dev; Zheng, Xue; Milstein, Stuart; Keller, Martin; Roschitzki, Bernd; Grossmann, Jonas; Hengartner, Michael O.			Differential regulation of germ line apoptosis and germ cell differentiation by CPEB family members in C. elegans	PLOS ONE			English	Article							RNA-BINDING PROTEINS; CYTOPLASMIC POLYADENYLATION; CAENORHABDITIS-ELEGANS; BIOCONDUCTOR PACKAGE; EXPRESSION ANALYSIS; GENETIC-CONTROL; AMINO-ACIDS; BIOLOGY; PATHWAY; DEATH	Cytoplasmic polyadenylation element binding (CPEB) proteins are evolutionary conserved RNA-binding proteins that control mRNA polyadenylation and translation. Orthologs in humans and other vertebrates are mainly involved in oogenesis. This is also the case for the C. elegans CPEB family member CPB-3, whereas two further CPEB proteins (CPB-1 and FOG-1) are involved in spermatogenesis. Here we describe the characterisation of a new missense allele of cpb-3 and show that loss of cpb-3 function leads to an increase in physiological germ cell death. To better understand the interaction and effect of C. elegans CPEB proteins on processes such as physiological apoptosis, germ cell differentiation, and regulation of gene expression, we characterised changes in the transcriptome and proteome of C. elegans CPEB mutants. Our results show that, despite their sequence similarities CPEB family members tend to have distinct overall effects on gene expression (both at the transcript and protein levels). This observation is consistent with the distinct phenotypes observed in the various CPEB family mutants.	[Singh, Kapil Dev; Zheng, Xue; Keller, Martin; Hengartner, Michael O.] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Singh, Kapil Dev; Zheng, Xue; Keller, Martin] Univ Zurich, PhD Program Mol Life Sci, Zurich, Switzerland; [Singh, Kapil Dev; Zheng, Xue; Keller, Martin; Roschitzki, Bernd; Grossmann, Jonas] ETH, Zurich, Switzerland; [Milstein, Stuart] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Roschitzki, Bernd; Grossmann, Jonas] Univ Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland; [Milstein, Stuart] Alnylam Pharmaceut, Cambridge, MA USA	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Cold Spring Harbor Laboratory; University of Zurich	Hengartner, MO (corresponding author), Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland.	michael.hengartner@uzh.ch		Hengartner, Michael/0000-0002-7584-596X; Singh, Kapil Dev/0000-0002-5682-0708	Swiss National Science Foundation [31003A_143932]; Kanton of Zurich; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Kanton of Zurich; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Swiss National Science Foundation (grant No. 31003A_143932; http://www.snf.ch) and the Kanton of Zurich to MOH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bally-Cuif L, 1998, MECH DEVELOP, V77, P31, DOI 10.1016/S0925-4773(98)00109-9; Boag PR, 2005, DEVELOPMENT, V132, P4975, DOI 10.1242/dev.02060; Bodenhofer U, 2015, BIOINFORMATICS, V31, P3997, DOI 10.1093/bioinformatics/btv494; BRENNER S, 1974, GENETICS, V77, P71; Carlson M., 2015, DB GENOME WIDE ANNOT; Charif D., 2007, SEQINR 10 2 CONTRIBU, P207, DOI [10.1007/978-3-540-35306-5_10, DOI 10.1007/978-3-540-35306-5_10]; Cho SC, 2004, GENOME RES, V14, P1207, DOI 10.1101/gr.2639304; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; CRICK F, 1970, NATURE, V227, P561, DOI 10.1038/227561a0; Doxakis E, 2014, NEUROSCI BULL, V30, P610, DOI 10.1007/s12264-014-1443-7; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; Fernandez-Miranda G, 2012, AGEING RES REV, V11, P460, DOI 10.1016/j.arr.2012.03.004; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fredens J, 2011, NAT METHODS, V8, P845, DOI [10.1038/NMETH.1675, 10.1038/nmeth.1675]; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Geiger T, 2011, NAT PROTOC, V6, P147, DOI 10.1038/nprot.2010.192; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Hake LE, 1998, MOL CELL BIOL, V18, P685, DOI 10.1128/MCB.18.2.685; Hasegawa E, 2006, DEV BIOL, V295, P689, DOI 10.1016/j.ydbio.2006.04.002; HODGKIN J, 1991, P ROY SOC B-BIOL SCI, V246, P19, DOI 10.1098/rspb.1991.0119; Ivshina M, 2014, ANNU REV CELL DEV BI, V30, P393, DOI 10.1146/annurev-cellbio-101011-155831; Jin SW, 2001, GENETICS, V159, P1617; Kall L, 2008, J PROTEOME RES, V7, P29, DOI 10.1021/pr700600n; Kandel ER, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-14; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; Kolde Raivo, 2015, F1000Res, V4, P574, DOI 10.12688/f1000research.6925.1; Kritikou EA, 2006, GENE DEV, V20, P2279, DOI 10.1101/gad.384506; LANTZ V, 1994, GENE DEV, V8, P598, DOI 10.1101/gad.8.5.598; Larance M, 2011, NAT METHODS, V8, P849, DOI [10.1038/NMETH.1679, 10.1038/nmeth.1679]; Lettre G, 2004, CELL DEATH DIFFER, V11, P1198, DOI 10.1038/sj.cdd.4401488; Luitjens C, 2000, GENE DEV, V14, P2596, DOI 10.1101/gad.831700; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Ortiz MA, 2014, G3-GENES GENOM GENET, V4, P1765, DOI 10.1534/g3.114.012351; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Racki WJ, 2006, DEVELOPMENT, V133, P4527, DOI 10.1242/dev.02651; Rahnenfuhrer J., 2010, TOPGO ENRICHMENT ANA, DOI [10.18129/B9.bioc.topGO, DOI 10.18129/B9.BIOC.TOPGO]; RCore Team, 2020, R LANG ENV STAT COMP; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schuster-Bockler B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-7; Sendoel A, 2009, ENCY LIFE SCI, P1; Sendoel A, 2014, NAT CELL BIOL, V16, P812, DOI 10.1038/ncb3010; Simms D., 1993, FOCUS, V15, P99, DOI [DOI 10.1016/0003-267061)80041-X, DOI 10.1016/0003-2670(61)80041-X]; Singh KD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149418; Spencer WC, 2011, GENOME RES, V21, P325, DOI 10.1101/gr.114595.110; StebbinsBoaz B, 1996, EMBO J, V15, P2582, DOI 10.1002/j.1460-2075.1996.tb00616.x; Stein L, 2001, NUCLEIC ACIDS RES, V29, P82, DOI 10.1093/nar/29.1.82; Subasic D, 2015, GENOME RES, V25, P1680, DOI 10.1101/gr.183160.114; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang M, 2012, MOL CELL PROTEOMICS, V11, P492, DOI 10.1074/mcp.O111.014704; Welk JF, 2001, GENE, V263, P113, DOI 10.1016/S0378-1119(00)00588-6	63	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2017	12	7							e0182270	10.1371/journal.pone.0182270	http://dx.doi.org/10.1371/journal.pone.0182270			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC3TH	28759574	gold, Green Accepted, Green Published			2022-12-26	WOS:000406761600069
J	Kalacheva, NV; Eliseikina, MG; Frolova, LT; Dolmatov, IY				Kalacheva, Nadezhda V.; Eliseikina, Marina G.; Frolova, Lidia T.; Dolmatov, Igor Yu.			Regeneration of the digestive system in the crinoid Himerometra robustipinna occurs by transdifferentiation of neurosecretory-like cells	PLOS ONE			English	Article							OLIGOMETRA-SERRIPINNA ECHINODERMATA; BRITTLESTAR AMPHIPHOLIS-KOCHII; STAR ANTEDON MEDITERRANEA; FEATHER STAR; ARM REGENERATION; SEA-CUCUMBER; MULTIPOTENT EPITHELIUM; INTESTINE REGENERATION; HOLOTHURIA-GLABERRIMA; JUXTALIGAMENTAL CELLS	The structure and regeneration of the digestive system in the crinoid Himerometra robustipinna (Carpenter, 1881) were studied. The gut comprises a spiral tube forming radial lateral processes, which gives it a five-lobed shape. The digestive tube consists of three segments: esophagus, intestine, and rectum. The epithelia of these segments have different cell compositions. Regeneration of the gut after autotomy of the visceral mass progresses very rapidly. Within 6 h after autotomy, an aggregation consisting of amoebo-cytes, coelomic epithelial cells and juxtaligamental cells (neurosecretory neurons) forms on the inner surface of the skeletal calyx. At 12 h post-autotomy, transdifferentiation of the juxtaligamental cells starts. At 24 h post-autotomy these cells undergo a mesenchymal-epithelial-like transition, resulting in the formation of the luminal epithelium of the gut. Specialization of the intestinal epithelial cells begins on day 2 post-autotomy. At this stage animals acquire the mouth and anal opening. On day 4 post-autotomy the height of both the enterocytes and the visceral mass gradually increases. Proliferation does not play any noticeable role in gut regeneration. The immersion of animals in a 10(-7) M solution of colchicine neither stopped formation of the lost structures nor caused accumulation of mitoses in tissues. Weakly EdU-labeled nuclei were observed in the gut only on day 2 post-autotomy and were not detected at later regeneration stages. Single mitotically dividing cells were recorded during the same period. It is concluded that juxtaligamental cells play a major role in gut regeneration in H. robustipinna. The main mechanisms of morphogenesis are cell migration and transdifferentiation.	[Kalacheva, Nadezhda V.; Eliseikina, Marina G.; Frolova, Lidia T.; Dolmatov, Igor Yu.] Russian Acad Sci, AV Zhirmunsky Inst Marine Biol, Far Eastern Branch, Natl Sci Ctr Marine Biol, Vladivostok, Russia; [Kalacheva, Nadezhda V.; Eliseikina, Marina G.; Dolmatov, Igor Yu.] Far Eastern Fed Univ, Vladivostok, Russia	Russian Academy of Sciences; National Scientific Center of Marine Biology, Far East Branch of the Russian Academy of Sciences; Far Eastern Federal University	Dolmatov, IY (corresponding author), Russian Acad Sci, AV Zhirmunsky Inst Marine Biol, Far Eastern Branch, Natl Sci Ctr Marine Biol, Vladivostok, Russia.; Dolmatov, IY (corresponding author), Far Eastern Fed Univ, Vladivostok, Russia.	idolmatov@mail.ru	Kalacheva, Nadezhda V/P-6096-2014; Dolmatov, Igor Yu/A-7704-2014; Eliseikina, Marina/AAN-4573-2020; Frolova, Lidia/ABC-3876-2020	Dolmatov, Igor Yu/0000-0003-3923-8131; Eliseikina, Marina/0000-0001-5361-6261; 	Russian Foundation for Basic Research [17-04-01334]; Asia Pacific Network for Global Change Research [CAF2015-RR13-NMY-Dautova]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Asia Pacific Network for Global Change Research	This work was supported by The Russian Foundation for Basic Research (grant No 17-04-01334), http://www.rfbr.ru/rffi/eng for IYD, and Asia Pacific Network for Global Change Research (grant CAF2015-RR13-NMY-Dautova), https://www.apn-gcr.org/ for IYD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMEMIYA S, 1992, NATURE, V357, P546, DOI 10.1038/357546a0; Becker SF, 2016, CURR OPIN GENET DEV, V40, P154, DOI 10.1016/j.gde.2016.06.014; Biressi A, 2010, ZOOMORPHOLOGY, V129, P1, DOI 10.1007/s00435-009-0095-7; Bobrovskaya NV, 2014, BIOL BULL-US, V226, P81, DOI 10.1086/BBLv226n2p81; Bobrovskaya NV, 2012, 14 INT ECH C C BOOKL, P90; Borisenko IE, 2015, PEERJ, V3, DOI 10.7717/peerj.1211; Candelaria AG, 2006, CELL TISSUE RES, V325, P55, DOI 10.1007/s00441-006-0170-z; Candia-Carnevali MD, 2009, STEM CELLS IN MARINE ORGANISMS, P165, DOI 10.1007/978-90-481-2767-2_7; Carlson B. M., 2007, PRINCIPLES REGENERAT; Carlson BM, 1998, CELLULAR AND MOLECULAR BASIS OF REGENERATION: FROM INVERTEBRATES TO HUMANS, P45; Carnevali MDC, 2006, ISJ-INVERT SURVIV J, V3, P64; CARNEVALI MDC, 1993, J EXP ZOOL, V267, P299, DOI 10.1002/jez.1402670308; CARNEVALI MDC, 1995, J EXP ZOOL, V272, P464, DOI 10.1002/jez.1402720608; Carnevali MDC, 2001, MICROSC RES TECHNIQ, V55, P403; Charlina NA, 2009, INVERTEBR BIOL, V128, P145, DOI 10.1111/j.1744-7410.2009.00160.x; Chia F.S., 1994, P169; Clark A.H., 1915, B US NATL MUSEUM, V82, P1, DOI [https://doi.org/10.5479/si.03629236.82.i, DOI 10.5479/2FSI.03629236.82.I]; Cobaleda C, 2008, CURR OPIN IMMUNOL, V20, P139, DOI 10.1016/j.coi.2008.03.017; Cocco G, 2010, EUR J INTERN MED, V21, P503, DOI 10.1016/j.ejim.2010.09.010; Czarkwiani A, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0149-x; Day RC, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-54; Dendy A., 1886, Studies Biol Lab Owen's Coll Manchester, Vi, P299; DIETRICH HF, 1975, STAIN TECHNOL, V50, P351, DOI 10.3109/10520297509117086; DOBSON WE, 1989, ZOOMORPHOLOGY, V108, P323, DOI 10.1007/BF00312273; Dolmatov IY, 2014, RUSS J MAR BIOL+, V40, P228, DOI 10.1134/S1063074014030031; Dolmatov I.Yu., 1992, Monographs in Developmental Biology, V23, P40; Dolmatov IY, 2012, RUSS J MAR BIOL+, V38, P243, DOI 10.1134/S1063074012030042; Dolmatov I. Yu, 1996, Ontogenez, V27, P256; Dolmatov IY, 2009, ZH OBSHCH BIOL, V70, P316; Dolmatov IY, 2001, MICROSC RES TECHNIQ, V55, P452, DOI 10.1002/jemt.1190.abs; Dolmatov IY, 2016, ZOOMORPHOLOGY, P1; Dolmatov YuI, 1999, RUSS J MAR BIOL, V25, P225; Eguchi G, 1993, CURR OPIN CELL BIOL, V5, P1023, DOI 10.1016/0955-0674(93)90087-7; Eguizabal C, 2013, SEMIN REPROD MED, V31, P82, DOI 10.1055/s-0032-1331802; Eliseikina MG., 2010, ECHINODERMS, P163; Feral J.-P., 1982, P191; FONTAINE AR, 1962, SCIENCE, V138, P908, DOI 10.1126/science.138.3543.908; Frolova LT, 2010, BIOL BULL-US, V218, P303, DOI 10.1086/BBLv218n3p303; Fu LN, 2014, CELL RES, V24, P141, DOI 10.1038/cr.2013.165; FUJIWARA S, 1992, DEV GROWTH DIFFER, V34, P463; Gahn Forest J, 2010, Integr Comp Biol, V50, p514a, DOI 10.1093/icb/icq155; Garcia-Arraras JE, 1998, J EXP ZOOL, V281, P288, DOI 10.1002/(SICI)1097-010X(19980701)281:4<288::AID-JEZ5>3.0.CO;2-K; Garcia-Arraras JE, 2010, CURR PHARM DESIGN, V16, P942, DOI 10.2174/138161210790883426; Glauert A.M., 1998, BIOL SPECIMEN PREPAR; Heinzeller Thomas, 1994, P9; HOLLAND ND, 1991, MAR BIOL, V111, P113, DOI 10.1007/BF01986352; HOLLAND ND, 1994, ECHINODERMS THROUGH TIME, P217; Hu CP, 2013, INT J MOL MED, V32, P347, DOI 10.3892/ijmm.2013.1387; Jarriault S, 2008, P NATL ACAD SCI USA, V105, P3790, DOI 10.1073/pnas.0712159105; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; Kamenev YO, 2013, TISSUE CELL, V45, P126, DOI 10.1016/j.tice.2012.10.002; KAWAMURA K, 1994, INT J DEV BIOL, V38, P369; Kawamura K, 2013, DEV BIOL, V384, P343, DOI 10.1016/j.ydbio.2013.10.004; Korotkova G., 1997, REGENERATION ANIMALS; LAHAYE CA, 1984, ZOOMORPHOLOGY, V104, P252, DOI 10.1007/BF00312039; Lawrence JM, 2013, ECHINODERMS IN A CHANGING WORLD, P53; LEIBSON NL, 1989, ZOOL ZH, V68, P67; Lin ZY, 2016, KAOHSIUNG J MED SCI, V32, P68, DOI 10.1016/j.kjms.2015.12.006; Liu Y, 2010, CELL BIOL INT, V34, P1075, DOI 10.1042/CBI20100516; Mashanov VS, 2011, BIOL BULL-US, V221, P93, DOI 10.1086/BBLv221n1p93; Mashanov VS, 2017, FRONT ZOOL, V14, DOI 10.1186/s12983-017-0196-y; Mashanov VS, 2005, BIOL BULL-US, V209, P184, DOI 10.2307/3593108; Mashanova VS, 2007, RUSS J MAR BIOL, V33, P110, DOI 10.1134/S1063074007020058; Meyer D.L., 1988, P519; MEYER DL, 1985, PALEOBIOLOGY, V11, P154, DOI 10.1017/S0094837300011477; MLADENOV PV, 1989, ROUX ARCH DEV BIOL, V198, P19, DOI 10.1007/BF00376366; Morata G, 2016, CURR OPIN GENET DEV, V40, P11, DOI 10.1016/j.gde.2016.05.008; Mozzi D, 2006, CENT EUR J BIOL, V1, P609, DOI 10.2478/s11535-006-0042-2; Murray G, 2004, CELL TISSUE RES, V318, P515, DOI 10.1007/s00441-004-0978-3; Reinardy HC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133860; Riddle MR, 2013, DEVELOPMENT, V140, P4844, DOI 10.1242/dev.103010; Sebastian Carlos, 2014, Critical Reviews in Oncogenesis, V19, P363; Shekhani MT, 2013, AM J STEM CELLS, V2, P52; Singh S, 2016, ELIFE, V5, DOI [10.7554/elife.12717, 10.7554/eLife.12717]; Sisakhtnezhad S, 2012, CELL TISSUE RES, V348, P379, DOI 10.1007/s00441-012-1403-y; Smiley Scott, 1994, P401; Tanaka EM, 2011, DEV CELL, V21, P172, DOI 10.1016/j.devcel.2011.06.016; Thorndyke MC, 2001, CAN J ZOOL, V79, P1171, DOI 10.1139/cjz-79-7-1171; Torelle E., 1910, ZOOL ANZ, V35, P15; Vogt G, 2012, STEM CELL REV REP, V8, P305, DOI 10.1007/s12015-011-9303-1; Vorontsova M. A., 1960, ASEXUAL PROPAGATION; Wilkie I.C., 1996, Echinoderm Studies, V5, P61; Wilkie Iain C, 2016, PLoS One, V11, pe0167533, DOI 10.1371/journal.pone.0167533; WILKIE IC, 1979, CELL TISSUE RES, V197, P515; Wilkie IC, 2005, PROG MOLEC, V39, P221; Wilkie IC, 2001, MICROSC RES TECHNIQ, V55, P369, DOI 10.1002/jemt.1185; WILKIE IC, 1984, MAR BEHAV PHYSIOL, V11, P1, DOI 10.1080/10236248409387032	87	14	14	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0182001	10.1371/journal.pone.0182001	http://dx.doi.org/10.1371/journal.pone.0182001			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753616	Green Submitted, Green Published, gold			2022-12-26	WOS:000406579300040
J	Medina-Puche, L; Castello, MJ; Canet, JV; Lamilla, J; Colombo, ML; Tornero, P				Medina-Puche, Laura; Jose Castello, Maria; Vicente Canet, Juan; Lamilla, Julian; Laura Colombo, Maria; Tornero, Pablo			beta-carbonic anhydrases play a role in salicylic acid perception in Arabidopsis	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; DISEASE RESISTANCE; SIGNAL-TRANSDUCTION; NEGATIVE REGULATION; DEFENSE RESPONSES; AVIRULENCE GENE; NPR1; EXPRESSION; CLONING; PROTEIN	The plant hormone salicylic acid (SA) is required for defense responses. NON EXPRESSER OF PATHOGENESIS RELATED 1 (NPR1) and NON RECOGNITION OF BTH-4 (NRB4) are required for the response to SA in Arabidopsis (Arabidopsis thaliana). Here, we isolated several interactors of NRB4 using yeast two-hybrid assays. Two of these interactors, beta CA1 and beta CA2, are beta-carbonic anhydrase family proteins. Since double mutant beta ca1 beta ca2 plants did not show any obvious phenotype, we investigated other beta CAs and found that NRB4 also interacts with beta CA3 and beta CA4. Moreover, several beta CAs interacted with NPR1 in yeast, including one that interacted in a SA-dependent manner. This interaction was abolished in loss-of-function alleles of NPR1. Interactions between beta CAs and both NRB4 and NPR1 were also detected in planta, with evidence for a triple interaction, NRB4-beta CA1-NPR1. The quintuple mutant beta ca1 beta ca2 beta ca3 beta ca4 beta ca6 showed partial insensitivity to SA. These findings suggest that one of the functions of carbonic anhydrases is to modulate the perception of SA in plants.	[Medina-Puche, Laura; Jose Castello, Maria; Vicente Canet, Juan; Lamilla, Julian; Laura Colombo, Maria; Tornero, Pablo] Univ Politecn Valencia, CSIC, IBMCP, Valencia, Spain; [Medina-Puche, Laura] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Ctr Plant Stress Biol PSC, Shanghai, Peoples R China; [Vicente Canet, Juan] Univ Bradford, Fac Life Sci, Bradford, W Yorkshire, England; [Lamilla, Julian] Univ Mil Nueva Granada, Fac Ciencias Basicas & Aplicadas, Lab Biotecnol Vegetal, Kilometro 2 Via Cajica Zipaquira, Costado Oriental, Colombia; [Laura Colombo, Maria] Univ Nacl La Plata, Fac Ciencias Exactas, CIProVe, Calle 47 Esquina 115, La Plata, Buenos Aires, Argentina	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Bradford; National University of La Plata	Tornero, P (corresponding author), Univ Politecn Valencia, CSIC, IBMCP, Valencia, Spain.	ptornero@ibmcp.upv.es	Medina-Puche, Laura/AAF-4474-2020; Lamilla, Julian/AAJ-5090-2021; Medina-Puche, Laura/L-2388-2013	Medina-Puche, Laura/0000-0001-8362-8087; Medina-Puche, Laura/0000-0001-8362-8087; Tornero, Pablo/0000-0001-9755-7726; Lamilla, Julian/0000-0001-5395-6055	"Ministerio de Economia y Competitividad" of Spain [BIO2013-45444-P]; "Generalitat Valenciana" of Spain [ACOMP/2013/052]; CONICET (Argentina); Erasmus Mundus Action 2, Arcoiris Project (EU)	"Ministerio de Economia y Competitividad" of Spain(Spanish Government); "Generalitat Valenciana" of Spain(Center for Forestry Research & Experimentation (CIEF)); CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Erasmus Mundus Action 2, Arcoiris Project (EU)	This study was supported by "Ministerio de Economia y Competitividad" of Spain (grant BIO2013-45444-P to PT, http://mmidi.mineco.gob.es/portal/site/MICINN/) and "Generalitat Valenciana" of Spain (grant ACOMP/2013/052 to PT, http://www.ceice.gva.es/web/ciencia/becas-ayudas-y-subvenciones-cientificas). MLC was awarded with a fellowship from CONICET (Argentina, http://convocatorias.conicet.gov.ar/becas/) and Erasmus Mundus Action 2, Arcoiris Project (EU, http://www.arcoiris.polito.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badger MR, 2003, J EXP BOT, V54, P609, DOI 10.1093/jxb/erg076; Belda-Palazon B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046907; BURNELL JN, 1990, PLANT PHYSIOL, V92, P37, DOI 10.1104/pp.92.1.37; Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Cai G, 2009, STRUCTURE, V17, P559, DOI 10.1016/j.str.2009.01.016; Canet JV, 2010, PLANT BIOTECHNOL J, V8, P126, DOI 10.1111/j.1467-7652.2009.00468.x; Canet JV, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-199; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Chadick JZ, 2005, TRENDS BIOCHEM SCI, V30, P264, DOI 10.1016/j.tibs.2005.03.001; CHEN ZX, 1993, P NATL ACAD SCI USA, V90, P9533, DOI 10.1073/pnas.90.20.9533; Ciannamea S, 2006, J EXP BOT, V57, P3419, DOI 10.1093/jxb/erl144; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; DEBENER T, 1991, PLANT J, V1, P289, DOI 10.1046/j.1365-313X.1991.t01-7-00999.x; DeFraia CT, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-28; DELANEY TP, 1995, P NATL ACAD SCI USA, V92, P6602, DOI 10.1073/pnas.92.14.6602; DiMario RJ, 2016, PLANT PHYSIOL, V171, P280, DOI 10.1104/pp.15.01990; Engineer CB, 2014, NATURE, V513, P246, DOI 10.1038/nature13452; Fabre N, 2007, PLANT CELL ENVIRON, V30, P617, DOI 10.1111/j.1365-3040.2007.01651.x; Ferreira FJ, 2008, PLANT PHYSIOL, V147, P585, DOI 10.1104/pp.108.118661; Feys BJ, 2001, EMBO J, V20, P5400, DOI 10.1093/emboj/20.19.5400; Frommer WB, 2010, SCIENCE, V327, P275, DOI 10.1126/science.1186022; Frost SC, 2014, SUBCELL BIOCHEM, V75, P1, DOI 10.1007/978-94-007-7359-2; Frye CA, 2001, P NATL ACAD SCI USA, V98, P373, DOI 10.1073/pnas.011405198; Fu ZQ, 2012, NATURE, V486, P228, DOI 10.1038/nature11162; Glazebrook J, 1996, GENETICS, V143, P973; Hinsch M, 1996, MOL PLANT MICROBE IN, V9, P55, DOI 10.1094/MPMI-9-0055; Hoang CV, 2002, PLANT PHYSIOL, V128, P1417, DOI 10.1104/pp.010879; Hu HH, 2015, PLANT PHYSIOL, V169, P1168, DOI 10.1104/pp.15.00646; Hu HH, 2010, NAT CELL BIOL, V12, P87, DOI 10.1038/ncb2009; Huang WE, 2005, ENVIRON MICROBIOL, V7, P1339, DOI 10.1111/j.1462-5822.2005.00821.x; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Innocenti A, 2008, BIOORGAN MED CHEM, V16, P7424, DOI 10.1016/j.bmc.2008.06.013; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kaul T, 2011, J PLANT PHYSIOL, V168, P601, DOI 10.1016/j.jplph.2010.08.007; Kerppola TK, 2009, CHEM SOC REV, V38, P2876, DOI 10.1039/b909638h; Kinkema M, 2000, PLANT CELL, V12, P2339, DOI 10.1105/tpc.12.12.2339; Kumar D, 2003, P NATL ACAD SCI USA, V100, P16101, DOI 10.1073/pnas.0307162100; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lawton K, 1995, MOL PLANT MICROBE IN, V8, P863, DOI 10.1094/MPMI-8-0863; Lawton KA, 1996, PLANT J, V10, P71, DOI 10.1046/j.1365-313X.1996.10010071.x; Lewis JD, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000894; Li X, 1999, CELL, V98, P329, DOI 10.1016/S0092-8674(00)81962-5; Macho AP, 2010, NEW PHYTOL, V187, P1018, DOI 10.1111/j.1469-8137.2010.03381.x; Maier F, 2011, MOL PLANT PATHOL, V12, P73, DOI 10.1111/j.1364-3703.2010.00653.x; Manohar M, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00777; Moroney JV, 2001, PLANT CELL ENV, V24; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nawrath C, 2002, PLANT CELL, V14, P275, DOI 10.1105/tpc.010376; Neish AC, 1939, BIOCHEM J, V33, P300, DOI 10.1042/bj0330300; PROVART NJ, 1993, PLANT MOL BIOL, V22, P937, DOI 10.1007/BF00028967; Puri N, 1997, MOL PLANT MICROBE IN, V10, P247, DOI 10.1094/MPMI.1997.10.2.247; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Restrepo S, 2005, MOL PLANT MICROBE IN, V18, P913, DOI 10.1094/MPMI-18-0913; Ritter C, 1996, PLANT CELL, V8, P251, DOI 10.1105/tpc.8.2.251; Seyfferth C, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00697; Shah J, 1997, MOL PLANT MICROBE IN, V10, P69, DOI 10.1094/MPMI.1997.10.1.69; Slaymaker DH, 2002, P NATL ACAD SCI USA, V99, P11640, DOI 10.1073/pnas.182427699; Tian MY, 2012, PLANT J, V72, P1027, DOI 10.1111/tpj.12016; Tornero P, 2001, PLANT J, V28, P475, DOI 10.1046/j.1365-313X.2001.01136.x; Tornero P, 2002, PLANT CELL, V14, P1005, DOI 10.1105/tpc.001032; van Leeuwen H, 2007, PLANT CELL, V19, P2099, DOI 10.1105/tpc.107.050641; Canet JV, 2012, PLANT CELL, V24, P4220, DOI 10.1105/tpc.112.103028; Canet JV, 2010, PLANT CELL ENVIRON, V33, P1911, DOI 10.1111/j.1365-3040.2010.02194.x; Vicente MRS, 2011, J EXP BOT, V62, P3321, DOI 10.1093/jxb/err031; Vidal M, 1999, NUCLEIC ACIDS RES, V27, P919, DOI 10.1093/nar/27.4.919; Wang YQ, 2009, J BIOL CHEM, V284, P2131, DOI 10.1074/jbc.M806782200; Weigel RR, 2005, PLANT CELL, V17, P1279, DOI 10.1105/tpc.104.027441; Weigel RR, 2001, PLANT MOL BIOL, V46, P143, DOI 10.1023/A:1010652620115; WILBUR KM, 1948, J BIOL CHEM, V176, P147; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Wu YuanQi, 2012, Agricultural Biotechnology, V1, P1; Zhang YL, 2003, PLANT CELL, V15, P2647, DOI 10.1105/tpc.014894; Zhang YL, 2006, PLANT J, V48, P647, DOI 10.1111/j.1365-313X.2006.02903.x; Zhou JM, 2000, MOL PLANT MICROBE IN, V13, P191, DOI 10.1094/MPMI.2000.13.2.191	78	24	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2017	12	7							e0181820	10.1371/journal.pone.0181820	http://dx.doi.org/10.1371/journal.pone.0181820			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1ED	28753666	Green Published, Green Submitted, gold			2022-12-26	WOS:000406579300027
J	Akinlua, JT; Meakin, R; Freemantle, N				Akinlua, James Tosin; Meakin, Richard; Freemantle, Nick			Beliefs about hypertension among Nigerian immigrants to the United Kingdom: A qualitative study	PLOS ONE			English	Article							BLOOD-PRESSURE; RISK-FACTORS; CARDIOVASCULAR-DISEASE; ETHNIC-GROUPS; HEALTH; AUSTRALIA; MEDICATION; CHILDREN; OBESITY; EUROPE	Objective The aim of the study was to elicit beliefs about hypertension among Nigerian immigrants in the United Kingdom. Background The distributions of cardiovascular risk factors and diseases are not shared equally across ethnic and economic groups in the United Kingdom. Its burden is more clustered among minority ethnic populations and migrant groups including black African Nigerian migrants. Similar patterns have been reported across Europe, Australia, Canada, Nordic countries and the United States of America. There are about 300 distinct ethnic groups in Nigeria and reliable information about their beliefs about hypertension is not available. Given that the United Kingdom has a large community of Nigerian immigrants from these different ethnocultural backgrounds, understanding their unique beliefs about hypertension may help promote appropriate care for this population in the United Kingdom and Nigeria. Setting A single Pentecostal church community in West London Participants Twenty-seven Nigerian migrant members of the church entered and completed the study Methods and outcome measure A qualitative interview study was conducted. The interviews were analysed using thematic framework analysis. The outcome measures were emerging themes from the thematic framework analysis. Results Participants expressed beliefs in four major areas related to hypertension: (1) The Meaning of the term hypertension, (2) Perceptions of causation, (3) Effects of hypertension, and (4) Perceptions of treatment. The study revealed a diversity of beliefs about hypertension which incorporated both orthodox and culturally framed ideas. Conclusions This study identified important beliefs among Nigerian migrants about hypertension that can contribute to our understanding of the management of hypertension in this group and suggests the need for further research to determine whether these beliefs may be representative of this group.	[Akinlua, James Tosin; Meakin, Richard; Freemantle, Nick] UCL, Med Sch, Dept Primary Care & Populat Hlth, London, England	University of London; University College London	Freemantle, N (corresponding author), UCL, Med Sch, Dept Primary Care & Populat Hlth, London, England.	Nicholas.freemantle@ucl.ac.uk		Meakin, Richard/0000-0003-2382-6844	NYSC Presidential Scholarship Scheme through the Nigerian Universities Commission/Tertiary Education Fund	NYSC Presidential Scholarship Scheme through the Nigerian Universities Commission/Tertiary Education Fund	This review forms part of research work towards a PhD (AKINLUAJT) at the University College London, funded by the NYSC Presidential Scholarship Scheme through the Nigerian Universities Commission/Tertiary Education Fund. The sponsor had no role in study design, data collection, analysis, interpretation, or writing of the report.	Adeniyi M.A., 2015, WORLD J PHARM SCI, V3, P368; Agyemang C, 2003, J HUM HYPERTENS, V17, P523, DOI 10.1038/sj.jhh.1001586; Agyemang C, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0709-0; Agyemang C, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-7; Akinlua JT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154287; Alidu L, 2017, BMC PSYCHOL, V5; [Anonymous], 2013, WORLD MIGR REP 2013; [Anonymous], 2017, HLTH MIGR UK WHAT DO; [Anonymous], THEORISING SOCIAL EX; Atulomah N.O., 2010, ACTA SATECH, V3, P143; Azubuike SO., 2014, ARCH MED HEALTH SCI, V2, P23, DOI [10.4103/2321-4848.133791, DOI 10.4103/2321-4848.133791]; Beune EJAJ, 2006, J HUM HYPERTENS, V20, P946, DOI 10.1038/sj.jhh.1002094; Bhopal R, 2002, AM J PUBLIC HEALTH, V92, P156, DOI 10.2105/AJPH.92.2.156-a; Blumhagen D, 1984, CULT MED PSYCHIAT, P197; Boutin-Foster C, 2007, ETHNIC DIS, V17, P29; Bovet P, 2002, B WORLD HEALTH ORGAN, V80, P33; Cappuccio FP, 1997, HEART, V78, P555, DOI 10.1136/hrt.78.6.555; CHATURVEDI N, 1993, HYPERTENSION, V22, P90, DOI 10.1161/01.HYP.22.1.90; Cooper R, 1997, AM J HYPERTENS, V10, P804, DOI 10.1016/S0895-7061(97)00211-2; Cooper RS, 1998, COUNCIL HIGH BLOOD P; CRUICKSHANK JK, 1991, LANCET, V338, P842, DOI 10.1016/0140-6736(91)91501-K; CRUICKSHANK JK, 1983, POSTGRAD MED J, V59, P622, DOI 10.1136/pgmj.59.696.622; Davidson N, 2004, J PAEDIATR CHILD H, V40, P562, DOI 10.1111/j.1440-1754.2004.00465.x; De Maeseneer J, 2012, LANCET, V379, P1860, DOI 10.1016/S0140-6736(11)61135-5; DULA A, 1994, CAMB Q HEALTHC ETHIC, V3, P347, DOI 10.1017/S0963180100005168; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Familoni BO, 2004, J NATL MED ASSOC, V96, P620; Havranek EP, 2015, CIRCULATION, V132, P873, DOI 10.1161/CIR.0000000000000228; Health Survey for England, 2017, DIGITAL NHS UK; HEURTINROBERTS S, 1992, AM J HYPERTENS, V5, P787, DOI 10.1093/ajh/5.11.787; Horne R, 1999, J PSYCHOSOM RES, V47, P555, DOI 10.1016/S0022-3999(99)00057-4; Horowitz CR, 2004, SOC SCI MED, V58, P631, DOI 10.1016/S0277-9536(03)00232-6; Ike SO, 2010, T ROY SOC TROP MED H, V104, P55, DOI 10.1016/j.trstmh.2009.07.029; Issaka A, 2016, NUTR DIET, V73, P28, DOI 10.1111/1747-0080.12167; Jayaweera H, 2013, COMPAS BLOG     0212; Jayaweera H, 2010, SOC SCI MED, V71, P1002, DOI 10.1016/j.socscimed.2010.05.039; Joffres M, 2017, HYPERTENSION PREVALE; Kleinman A., 1980, PATIENTS HEALERS CON; Lindstrom J, 2010, HORM METAB RES, V42, pS37, DOI 10.1055/s-0029-1240975; MANATUNGA AK, 1993, HYPERTENSION, V22, P84, DOI 10.1161/01.HYP.22.1.84; Martin JA, 2006, MED J AUSTRALIA, V185, P607, DOI 10.5694/j.1326-5377.2006.tb00726.x; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; McSweeney J C, 1997, Image J Nurs Sch, V29, P243; MORGAN M, 1988, SOCIOL HEALTH ILL, V10, P561, DOI 10.1111/1467-9566.ep10837256; NICE, 2009, MED ADH INV PAT DEC; Nyagua JQ, 2008, RURAL REMOTE HEALTH, V8; Okwuonu C. G., 2014, International Journal of Medicine and Biomedical Research, V3, P121; Onyut Lamaro P, 2009, Confl Health, V3, P6, DOI 10.1186/1752-1505-3-6; Possidente CJ, 2005, AM J HEALTH-SYST PH, V62, P1311, DOI 10.1093/ajhp/62.12.1311; Rechel B, 2013, LANCET, V381, P1235, DOI 10.1016/S0140-6736(12)62086-8; Renzaho AMN, 2014, J IMMIGR MINOR HEALT, V16, P86, DOI 10.1007/s10903-013-9791-y; Stellinga-Boelen AAM, 2007, EUR J PUBLIC HEALTH, V17, P555, DOI 10.1093/eurpub/ckm013; Taylor KD, 2012, ETHNIC HEALTH, V17, P615, DOI 10.1080/13557858.2013.771151; Weinman J, 1996, PSYCHOL HEALTH, V11, P431, DOI 10.1080/08870449608400270; Weiss, 1997, TRANSCULT PSYCHIATRY, V34, P235, DOI [DOI 10.1177/136346159703400204, 10.1177/136346159703400204]; Whitty CJM, 1999, ATHEROSCLEROSIS, V142, P279, DOI 10.1016/S0021-9150(98)00239-1; Worth H, 2003, AIDS EDUC PREV, V15, P346, DOI 10.1521/aeap.15.5.346.23819	57	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181909	10.1371/journal.pone.0181909	http://dx.doi.org/10.1371/journal.pone.0181909			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1CT	28750080	gold, Green Published, Green Submitted			2022-12-26	WOS:000406575700101
